Citrus Sinensis ID: 020221

---

Local Sequence Feature Prediction

Residue Number Marker
--------10--------20--------30--------40--------50--------60--------70--------80--------90-------100-------110-------120-------130-------140-------150-------160-------170-------180-------190-------200-------210-------220-------230-------240-------250-------260-------270-------280-------290-------300-------310-------320-------33
Protein Sequence
MGCECSKLSACCSGSEYGEAAPEAQDVENEEKPGVDNVPVFCEYSIETLRTATSGFAMENIVSEHGEKAPNVVYKGKLENQFRIAVKRFNRSAWPDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDGRSYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLASRCLQYEPRERPNPRSLVTALVTLQKDTELYLSLPWVMLA
Secondary Structure (PSIPRED)
cccccccccccccccccccccccccccccccccccccccccccccHHHHHHHHccccccccccccccccccccEEEEEccccEEEEEEccccccccHHHHHHHHHHHHHcccccccccccccccccEEEEEEEEcccccHHHHHcccccccccHHHHHHHHHHHHHHHHHHHccccccccccccccccccccccccccccccccccccccEEEEccccccHHHHHccccccccccEEHHHHHHHHHccccccccHHHHHHHcccccccccccccccccHHHHHHHHHHHHHHccccccccccHHHHHHHHHcccccccccccccccccc
Secondary Structure Prediction (SSPRO)
cccEEEEEEEEEcccccccccccccccccccccccccccccccEcHHHHHHHHccccHHHHHHHccccccccEEEcEcccccEEEEEEccccccccHHHHHHHHHHHHHHHHHHHHHEEEEEEccccEEEEEEEcccccHHHHHcccccccccHHHHHHHHHHHHHHHHHHHccccEEEEccHHcHEEEcccccccHcHccHEEEcccccEEEEEEccccHHHHHcccccccHHHHHHHHHHHHHHcccccccHHHHHHHHcccHHHHccHHHcccccHHHHHHHHHHHHHHHcccHcccccHHHHHHHHcccccccccccccccEEEc
Coil and Loop (DISEMBL)
mgcecsklsaccsgseygeaapeaqdveneekpgvdnvpvFCEYSIETLRTATSGFAMENIVsehgekapnvvykgkLENQFRIAVKRFNRSAWPDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVaeympndtlAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHdlnayrivfdddvnprlscfglmknsrdgrsystnlaftppeylrtgrvtpesvMYSFGTLLLDLlsgkhippshaldlirdrniqtltdsclegqfssdeGTELVRLASRclqyeprerpnprSLVTALVTLQKDTELYLSLPWVMLA
Flexible Loop (DISEMBL)
mgcecsklsaccsgseyGEAAPEAQDveneekpgvdnVPVFCEYSIETLRTATSGFAMENIVSehgekapnvvyKGKLENQFRIAVKRFNRSAWPDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLmknsrdgrsystnlaftppeylrtgrvTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLegqfssdegtELVRLASRCLqyeprerpnprslVTALVTLqkdtelylslpwvmla
Low Complexity Region (SEG)
MGCECSKLSACCSGSEYGEAAPEAQDVENEEKPGVDNVPVFCEYSIETLRTATSGFAMENIVSEHGEKAPNVVYKGKLENQFRIAVKRFNRSAWPDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDGRSYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLASRCLQYEPRERPNPRSLVTALVTLQKDTELYLSLPWVMLA
Disordered region (IsUnstruct)
***********************************DNVPVFCEYSIETLRTATSGFAMENIVSEHGEKAPNVVYKGKLENQFRIAVKRFNRSAWPDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDGRSYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFS***GTELVRLASRCLQY*********SLVTALVTLQKDTELYLSLPWVM**
Disordered Region (DISOPRED)
****************************************FCEYSIETLRTATSGFAMENIVSEHGEKAPNVVYKGKLENQFRIAVKRFNRSAWPDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDGRSYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLASRCLQYEPRERPNPRSLVTALVTLQK****YLSLPWVMLA
Disordered Region (DISEMBL)
********SACCSGSEYGEAAPEAQDVENEEKPGVDNVPVFCEYSIETLRTATSGFAMENIVSEHGEKAPNVVYKGKLENQFRIAVKRFNRSAWPDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDGRSYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLASRCLQYEPRERPNPRSLVTALVTLQKDTELYLSLPWVMLA
Disordered Region (DISPRO)
*GCECSKLSACCSG*************************VFCEYSIETLRTATSGFAMENIVSEHGEKAPNVVYKGKLENQFRIAVKRFNRSAWPDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDGRSYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLASRCLQYEPRERPNPRSLVTALVTLQKDTELYLSLPWVMLA
Transmembrane Helix (TMHMM)
ooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Transmembrane Helix (HMMTOP)
ooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Transmembrane Helix (MEMSAT)
oooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooohhhhhhhhhhhhhhhhhhhhiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiii
TM Helix, Signal Peptide (MEMSAT_SVM)
oooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooohhhhhhhhhhhhhhhhiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiii
TM Helix, Signal Peptide (Phobius)
ooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Signal Peptide (SignalP HMM Mode)
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
Signal Peptide (SignalP NN Mode)
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
Coiled Coils (COILS)
MGCECSKLSACCSGSEYGEAAPEAQDVENEEKPGVDNVPVFCEYSIETLRTATSGFAMENIVSEHGEKAPNVVYKGKLENQFRIAVKRFNRSAWPDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDGRSYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLASRCLQYEPRERPNPRSLVTALVTLQKDTELYLSLPWVMLA
Positional Conservation
no confident homologs detected

---

Close Homologs for Annotation Transfer

Close Homologs in SWISS-PROT Database Detected by BLAST

Original result of BLAST against SWISS-PROT Database

ID	Length	Definition	RBH(Q2H)	RBH(H2Q)	Q cover	H cover	Identity	E-value
Query	329	2.2.26 [Sep-21-2011]
Q9FHD7	487	Probable serine/threonine	yes	no	0.969	0.655	0.802	1e-155
Q944A7	512	Probable serine/threonine	no	no	0.857	0.550	0.687	1e-117
Q7XJT7	465	Probable inactive recepto	no	no	0.899	0.636	0.459	4e-75
Q06548	410	Protein kinase APK1A, chl	no	no	0.939	0.753	0.319	8e-39
Q9SFT7	414	Serine/threonine-protein	no	no	0.887	0.705	0.341	2e-37
P46573	412	Protein kinase APK1B, chl	no	no	0.841	0.672	0.324	1e-36
Q8H186	389	Probable receptor-like pr	no	no	0.814	0.688	0.323	2e-36
P43298	942	Probable receptor protein	no	no	0.811	0.283	0.322	7e-35
Q8GXZ3	410	Serine/threonine-protein	no	no	0.814	0.653	0.333	9e-35
O48814	395	Serine/threonine-protein	no	no	0.869	0.724	0.314	1e-34

>sp|Q9FHD7|Y5126_ARATH Probable serine/threonine-protein kinase At5g41260 OS=Arabidopsis thaliana GN=At5g41260 PE=1 SV=1

 Score =  548 bits (1413), Expect = e-155,   Method: Compositional matrix adjust.
 Identities = 256/319 (80%), Positives = 288/319 (90%)

Query: 1   MGCECSKLSACCSGSEYGEAAPEAQDVENEEKPGVDNVPVFCEYSIETLRTATSGFAMEN 60
           MGCE SKLSA C  SE G + P+   ++ E +   +++P F E+SIET+R ATSGFA EN
Sbjct: 1   MGCEVSKLSALCCVSESGRSNPDVTGLDEEGRGESNDLPQFREFSIETIRNATSGFAAEN 60

Query: 61  IVSEHGEKAPNVVYKGKLENQFRIAVKRFNRSAWPDARQFLEEARAVGQLRNRRLANLLG 120
           IVSEHGE+APNVVYKGKLENQ RIAVKRFNR +WPD+RQFLEEA+AVGQLRN R+ANLLG
Sbjct: 61  IVSEHGERAPNVVYKGKLENQRRIAVKRFNRKSWPDSRQFLEEAKAVGQLRNHRMANLLG 120

Query: 121 CCCEGDERLLVAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYH 180
           CC E +ERLL+AE+MPN+TLAKHLFHWE+QPMKWAMRLRVALHIA+ALEYCTSK RALYH
Sbjct: 121 CCYEDEERLLIAEFMPNETLAKHLFHWESQPMKWAMRLRVALHIAQALEYCTSKGRALYH 180

Query: 181 DLNAYRIVFDDDVNPRLSCFGLMKNSRDGRSYSTNLAFTPPEYLRTGRVTPESVMYSFGT 240
           DLNAYR++FDDD NPRLSCFGLMKNSRDG+SYSTNLAFTPPEYLRTGRVTPESV+YSFGT
Sbjct: 181 DLNAYRVLFDDDANPRLSCFGLMKNSRDGKSYSTNLAFTPPEYLRTGRVTPESVIYSFGT 240

Query: 241 LLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLASRCLQYEPRER 300
           LLLDLLSGKHIPPSHALDLIRDRNIQ L DS LEGQFSSD+GTEL+RLASRCLQYEPRER
Sbjct: 241 LLLDLLSGKHIPPSHALDLIRDRNIQMLMDSGLEGQFSSDDGTELIRLASRCLQYEPRER 300

Query: 301 PNPRSLVTALVTLQKDTEL 319
           PNP+SLV+A++ LQKD E+
Sbjct: 301 PNPKSLVSAMIPLQKDLEI 319

Arabidopsis thaliana (taxid: 3702)
EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1

>sp|Q944A7|Y4523_ARATH Probable serine/threonine-protein kinase At4g35230 OS=Arabidopsis thaliana GN=At4g35230 PE=1 SV=1

 Score =  423 bits (1087), Expect = e-117,   Method: Compositional matrix adjust.
 Identities = 194/282 (68%), Positives = 238/282 (84%)

Query: 38  VPVFCEYSIETLRTATSGFAMENIVSEHGEKAPNVVYKGKLENQFRIAVKRFNRSAWPDA 97
           +P F E+S   L+ AT+ F+ +NIVSE GEKAPN+VYKG+L+N+  IAVK+F + AWP+ 
Sbjct: 55  IPSFSEFSFADLKAATNNFSSDNIVSESGEKAPNLVYKGRLQNRRWIAVKKFTKMAWPEP 114

Query: 98  RQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAEYMPNDTLAKHLFHWETQPMKWAMR 157
           +QF EEA  VG+LR+ RLANL+G CC+GDERLLVAE+MPNDTLAKHLFHWE Q ++WAMR
Sbjct: 115 KQFAEEAWGVGKLRHNRLANLIGYCCDGDERLLVAEFMPNDTLAKHLFHWENQTIEWAMR 174

Query: 158 LRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDGRSYSTNLA 217
           LRV  +IAEAL+YC+++ R LYHDLNAYR++FD+D +PRLSCFGLMKNSRDG+SYSTNLA
Sbjct: 175 LRVGYYIAEALDYCSTEGRPLYHDLNAYRVLFDEDGDPRLSCFGLMKNSRDGKSYSTNLA 234

Query: 218 FTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQF 277
           +TPPEYLR GRVTPESV YSFGT+LLDLLSGKHIPPSHALD+IR +NI  L DS LEG+F
Sbjct: 235 YTPPEYLRNGRVTPESVTYSFGTVLLDLLSGKHIPPSHALDMIRGKNIILLMDSHLEGKF 294

Query: 278 SSDEGTELVRLASRCLQYEPRERPNPRSLVTALVTLQKDTEL 319
           S++E T +V LAS+CLQYEPRERPN + LV  L  LQ  +++
Sbjct: 295 STEEATVVVELASQCLQYEPRERPNTKDLVATLAPLQTKSDV 336

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q7XJT7|SSP_ARATH Probable inactive receptor-like kinase SSP OS=Arabidopsis thaliana GN=SSP PE=1 SV=1

 Score =  281 bits (719), Expect = 4e-75,   Method: Compositional matrix adjust.
 Identities = 146/318 (45%), Positives = 206/318 (64%), Gaps = 22/318 (6%)

Query: 1   MGCECSKLSACCSGSEYGEAAPEAQDVENEEKPGVDNVPVFCEYSIETLRTATSGFAMEN 60
           MGC C  LS     S          D  +E + G    P   ++S   L+TAT+ F+ EN
Sbjct: 1   MGC-CYSLS-----STVDPVQDHTTDASSEPRNGGGEDPPLTKFSFSALKTATNHFSPEN 54

Query: 61  IVSEHGEKAPNVVYKGKLENQFRIAVKRFNRSAWPDARQFLEEARAVGQLRNRRLANLLG 120
           IVS+   +  +VV+KG+L+N   +A+KRFN  AW D + FLEEA+ VG+LR++RL NL+G
Sbjct: 55  IVSD---QTSDVVFKGRLQNGGFVAIKRFNNMAWSDPKLFLEEAQRVGKLRHKRLVNLIG 111

Query: 121 CCCEGDERLLVAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYH 180
            CC+GD+R LVA++M NDTLAK LF  + Q M W++RLRVA  +AEAL+YC +   A Y+
Sbjct: 112 YCCDGDKRFLVADFMANDTLAKRLFQRKYQTMDWSIRLRVAYFVAEALDYCNTAGFASYN 171

Query: 181 DLNAYRIVFDDDVNPRLSCFGLMKNSRDGRSYSTNLAFTPPEYLRTGRVTPESVMYSFGT 240
           +L+AY+++FD+D +  LSCFGLMK   + +             + TG V PE+V+Y FGT
Sbjct: 172 NLSAYKVLFDEDGDACLSCFGLMKEINNDQ-------------ITTGSVNPENVIYRFGT 218

Query: 241 LLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLASRCLQYEPRER 300
           +L++LLSGK IPPSHA ++I  +N+  L D  L+G+FS DE   + +LAS+CL+YE +E 
Sbjct: 219 VLVNLLSGKQIPPSHAPEMIHRKNVFKLMDPYLKGKFSIDEANVVYKLASQCLKYEGQES 278

Query: 301 PNPRSLVTALVTLQKDTE 318
           PN + +V  L TLQ  TE
Sbjct: 279 PNTKEIVATLETLQTRTE 296

Probable inactive protein kinase that activates the YODA MAP kinase cascade, regulating the asymmetric first division, and thus embryo polarity. Acts as an adapter at the plasma membrane, possibly recruiting an activator.

Arabidopsis thaliana (taxid: 3702)

>sp|Q06548|APK1A_ARATH Protein kinase APK1A, chloroplastic OS=Arabidopsis thaliana GN=APK1A PE=2 SV=1

 Score =  160 bits (406), Expect = 8e-39,   Method: Compositional matrix adjust.
 Identities = 111/347 (31%), Positives = 168/347 (48%), Gaps = 38/347 (10%)

Query: 3   CECSKLSACCSGSEYGEAAPEAQDVENEEKPGVDN----VPVFCEYSIETLRTATSGFAM 58
            E S  S      + G    +A  V     P  +      P    +S   L++AT  F  
Sbjct: 11  AESSGASTKYDAKDIGSLGSKASSVSVRPSPRTEGEILQSPNLKSFSFAELKSATRNFRP 70

Query: 59  ENIVSEHGEKAPNVVYKGKLENQ----------FRIAVKRFNRSAWPDARQFLEEARAVG 108
           ++++   GE     V+KG ++ +            IAVK+ N+  W   +++L E   +G
Sbjct: 71  DSVL---GEGGFGCVFKGWIDEKSLTASRPGTGLVIAVKKLNQDGWQGHQEWLAEVNYLG 127

Query: 109 QLRNRRLANLLGCCCEGDERLLVAEYMPNDTLAKHLFH--WETQPMKWAMRLRVALHIAE 166
           Q  +R L  L+G C E + RLLV E+MP  +L  HLF      QP+ W +RL+VAL  A+
Sbjct: 128 QFSHRHLVKLIGYCLEDEHRLLVYEFMPRGSLENHLFRRGLYFQPLSWKLRLKVALGAAK 187

Query: 167 ALEYCTSKE-RALYHDLNAYRIVFDDDVNPRLSCFGLMKNS--RDGRSYSTNL----AFT 219
            L +  S E R +Y D     I+ D + N +LS FGL K+    D    ST +     + 
Sbjct: 188 GLAFLHSSETRVIYRDFKTSNILLDSEYNAKLSDFGLAKDGPIGDKSHVSTRVMGTHGYA 247

Query: 220 PPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIP----PSHALD--------LIRDRNIQT 267
            PEYL TG +T +S +YSFG +LL+LLSG+       PS   +        L+  R I  
Sbjct: 248 APEYLATGHLTTKSDVYSFGVVLLELLSGRRAVDKNRPSGERNLVEWAKPYLVNKRKIFR 307

Query: 268 LTDSCLEGQFSSDEGTELVRLASRCLQYEPRERPNPRSLVTALVTLQ 314
           + D+ L+ Q+S +E  ++  L+ RCL  E + RPN   +V+ L  +Q
Sbjct: 308 VIDNRLQDQYSMEEACKVATLSLRCLTTEIKLRPNMSEVVSHLEHIQ 354

Possible bi-functional kinase. In vitro, it exhibits serine/threonine activity. In vivo, can phosphorylate tyrosine residues of limited substrates.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9SFT7|Y3707_ARATH Serine/threonine-protein kinase At3g07070 OS=Arabidopsis thaliana GN=At3g07070 PE=2 SV=1

 Score =  156 bits (394), Expect = 2e-37,   Method: Compositional matrix adjust.
 Identities = 112/328 (34%), Positives = 162/328 (49%), Gaps = 36/328 (10%)

Query: 25  QDVENEEKPGVDNVPVFCEYSIETLRTATSGFAMENIVSEHGEKAPNVVYKGKLENQFRI 84
           Q+  N+E   V N      +S   L TAT  F  E ++   GE     VYKGKLE    I
Sbjct: 48  QNKNNDEDKEVTNNIAAQTFSFRELATATKNFRQECLI---GEGGFGRVYKGKLEKTGMI 104

Query: 85  -AVKRFNRSAWPDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAEYMPNDTLAKH 143
            AVK+ +R+     ++F+ E   +  L ++ L NL+G C +GD+RLLV EYM   +L  H
Sbjct: 105 VAVKQLDRNGLQGNKEFIVEVLMLSLLHHKHLVNLIGYCADGDQRLLVYEYMSRGSLEDH 164

Query: 144 LFHW--ETQPMKWAMRLRVALHIAEALEYCTSKER--ALYHDLNAYRIVFDDDVNPRLSC 199
           L     +  P+ W  R+R+AL  A  LEY   K     +Y DL A  I+ D + N +LS 
Sbjct: 165 LLDLTPDQIPLDWDTRIRIALGAAMGLEYLHDKANPPVIYRDLKAANILLDGEFNAKLSD 224

Query: 200 FGLMKNS--RDGRSYSTNL----AFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPP 253
           FGL K     D +  S+ +     +  PEY RTG++T +S +YSFG +LL+L++G+ +  
Sbjct: 225 FGLAKLGPVGDKQHVSSRVMGTYGYCAPEYQRTGQLTTKSDVYSFGVVLLELITGRRV-- 282

Query: 254 SHALDLIRDRNIQTLT-----------------DSCLEGQFSSDEGTELVRLASRCLQYE 296
              +D  R ++ Q L                  D  LEG F      + V +A+ CLQ E
Sbjct: 283 ---IDTTRPKDEQNLVTWAQPVFKEPSRFPELADPSLEGVFPEKALNQAVAVAAMCLQEE 339

Query: 297 PRERPNPRSLVTALVTLQKDTELYLSLP 324
              RP    +VTAL  L    +  +S+P
Sbjct: 340 ATVRPLMSDVVTALGFLGTAPDGSISVP 367

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|P46573|APK1B_ARATH Protein kinase APK1B, chloroplastic OS=Arabidopsis thaliana GN=APK1B PE=2 SV=2

 Score =  153 bits (387), Expect = 1e-36,   Method: Compositional matrix adjust.
 Identities = 101/311 (32%), Positives = 160/311 (51%), Gaps = 34/311 (10%)

Query: 39  PVFCEYSIETLRTATSGFAMENIVSEHGEKAPNVVYKGKLENQ----------FRIAVKR 88
           P    ++   L+ AT  F  ++++ E G  +   V+KG ++ Q            IAVK+
Sbjct: 52  PNLKSFTFAELKAATRNFRPDSVLGEGGFGS---VFKGWIDEQTLTASKPGTGVVIAVKK 108

Query: 89  FNRSAWPDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAEYMPNDTLAKHLFHWE 148
            N+  W   +++L E   +GQ  +  L  L+G C E + RLLV E+MP  +L  HLF   
Sbjct: 109 LNQDGWQGHQEWLAEVNYLGQFSHPNLVKLIGYCLEDEHRLLVYEFMPRGSLENHLFRRG 168

Query: 149 T--QPMKWAMRLRVALHIAEALEYCTSKERA-LYHDLNAYRIVFDDDVNPRLSCFGLMKN 205
           +  QP+ W +RL+VAL  A+ L +  + E + +Y D     I+ D + N +LS FGL K+
Sbjct: 169 SYFQPLSWTLRLKVALGAAKGLAFLHNAETSVIYRDFKTSNILLDSEYNAKLSDFGLAKD 228

Query: 206 --SRDGRSYSTNL----AFTPPEYLRTGRVTPESVMYSFGTLLLDLLSG-----KHIPPS 254
             + D    ST +     +  PEYL TG +T +S +YS+G +LL++LSG     K+ PP 
Sbjct: 229 GPTGDKSHVSTRIMGTYGYAAPEYLATGHLTTKSDVYSYGVVLLEVLSGRRAVDKNRPPG 288

Query: 255 HAL-------DLIRDRNIQTLTDSCLEGQFSSDEGTELVRLASRCLQYEPRERPNPRSLV 307
                      L   R +  + D+ L+ Q+S +E  ++  LA RCL +E + RPN   +V
Sbjct: 289 EQKLVEWARPLLANKRKLFRVIDNRLQDQYSMEEACKVATLALRCLTFEIKLRPNMNEVV 348

Query: 308 TALVTLQKDTE 318
           + L  +Q   E
Sbjct: 349 SHLEHIQTLNE 359

Possible bi-functional kinase. In vitro, it exhibits serine/threonine activity. In vivo, can phosphorylate tyrosine residues of limited substrates.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q8H186|Y3545_ARATH Probable receptor-like protein kinase At3g55450 OS=Arabidopsis thaliana GN=At3g55450 PE=1 SV=1

 Score =  153 bits (386), Expect = 2e-36,   Method: Compositional matrix adjust.
 Identities = 98/303 (32%), Positives = 155/303 (51%), Gaps = 35/303 (11%)

Query: 44  YSIETLRTATSGFAMENIVSEHGEKAPNVVYKGKLE----------NQFRIAVKRFNRSA 93
           +S   L+ AT  F  +++V   GE     V++G L+          +   IAVKR N   
Sbjct: 49  FSFNELKLATRNFRSDSVV---GEGGFGCVFRGWLDETTLTPTKSSSGLVIAVKRLNPDG 105

Query: 94  WPDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAEYMPNDTLAKHLF---HWETQ 150
           +   R++L E   +GQL +  L  L+G C E ++RLLV E+M   +L  HLF   + + +
Sbjct: 106 FQGHREWLTEINYLGQLSHPNLVKLIGYCLEDEQRLLVYEFMHKGSLENHLFANGNKDFK 165

Query: 151 PMKWAMRLRVALHIAEALEYCTSKE-RALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDG 209
           P+ W +R++VAL  A+ L +  S   + +Y D+ A  I+ D D N +LS FGL ++   G
Sbjct: 166 PLSWILRIKVALDAAKGLAFLHSDPVKVIYRDIKASNILLDSDFNAKLSDFGLARDGPMG 225

Query: 210 -RSYST-----NLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGK----HIPPSHALDL 259
            +SY +        +  PEY+ TG +   S +YSFG +LL+LL G+    H  P+   +L
Sbjct: 226 EQSYVSTRVMGTFGYAAPEYVSTGHLNARSDVYSFGVVLLELLCGRQALDHNRPAKEQNL 285

Query: 260 I--------RDRNIQTLTDSCLEGQFSSDEGTELVRLASRCLQYEPRERPNPRSLVTALV 311
           +          R +  + D+ L  Q+  +    L  +A +CL +EP+ RP    +V ALV
Sbjct: 286 VDWARPYLTSRRKVLLIVDTRLNSQYKPEGAVRLASIAVQCLSFEPKSRPTMDQVVRALV 345

Query: 312 TLQ 314
            LQ
Sbjct: 346 QLQ 348

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|P43298|TMK1_ARATH Probable receptor protein kinase TMK1 OS=Arabidopsis thaliana GN=TMK1 PE=2 SV=1

 Score =  148 bits (373), Expect = 7e-35,   Method: Compositional matrix adjust.
 Identities = 99/307 (32%), Positives = 166/307 (54%), Gaps = 40/307 (13%)

Query: 45  SIETLRTATSGFAMENIVSEHGEKAPNVVYKGKLENQFRIAVKRFNRS--AWPDARQFLE 102
           SI+ LR+ T+ F+ +NI+   G     VVYKG+L +  +IAVKR      A     +F  
Sbjct: 577 SIQVLRSVTNNFSSDNIL---GSGGFGVVYKGELHDGTKIAVKRMENGVIAGKGFAEFKS 633

Query: 103 EARAVGQLRNRRLANLLGCCCEGDERLLVAEYMPNDTLAKHLFHWE---TQPMKWAMRLR 159
           E   + ++R+R L  LLG C +G+E+LLV EYMP  TL++HLF W     +P+ W  RL 
Sbjct: 634 EIAVLTKVRHRHLVTLLGYCLDGNEKLLVYEYMPQGTLSRHLFEWSEEGLKPLLWKQRLT 693

Query: 160 VALHIAEALEYC--TSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDGR-SYSTNL 216
           +AL +A  +EY    + +  ++ DL    I+  DD+  +++ FGL++ + +G+ S  T +
Sbjct: 694 LALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGKGSIETRI 753

Query: 217 AFT----PPEYLRTGRVTPESVMYSFGTLLLDLLSGK----HIPPSHALDLI-------- 260
           A T     PEY  TGRVT +  +YSFG +L++L++G+       P  ++ L+        
Sbjct: 754 AGTFGYLAPEYAVTGRVTTKVDVYSFGVILMELITGRKSLDESQPEESIHLVSWFKRMYI 813

Query: 261 -RDRNIQTLTDSCLEGQFSSDEGT-----ELVRLASRCLQYEPRERPN---PRSLVTALV 311
            ++ + +   D+ ++     DE T      +  LA  C   EP +RP+     +++++LV
Sbjct: 814 NKEASFKKAIDTTID----LDEETLASVHTVAELAGHCCAREPYQRPDMGHAVNILSSLV 869

Query: 312 TLQKDTE 318
            L K ++
Sbjct: 870 ELWKPSD 876

Probable receptor.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q8GXZ3|Y5102_ARATH Serine/threonine-protein kinase At5g01020 OS=Arabidopsis thaliana GN=At5g01020 PE=1 SV=1

 Score =  147 bits (372), Expect = 9e-35,   Method: Compositional matrix adjust.
 Identities = 99/297 (33%), Positives = 144/297 (48%), Gaps = 29/297 (9%)

Query: 44  YSIETLRTATSGFAMENIVSEHGEKAPNVVYKGKLENQFRI-------AVKRFNRSAWPD 96
           +++  L T T  F  + I+ E G      VYKG +++  R+       AVK  N+     
Sbjct: 57  FTLFELETITKSFRPDYILGEGGF---GTVYKGYIDDNLRVGLKSLPVAVKVLNKEGLQG 113

Query: 97  ARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAEYMPNDTLAKHLFHWETQPMKWAM 156
            R++L E   +GQLR+  L  L+G CCE D RLLV E+M   +L  HLF   T P+ W+ 
Sbjct: 114 HREWLTEVNFLGQLRHPNLVKLIGYCCEDDHRLLVYEFMLRGSLENHLFRKTTAPLSWSR 173

Query: 157 RLRVALHIAEALEYCTSKER-ALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDG--RSYS 213
           R+ +AL  A+ L +  + ER  +Y D     I+ D D   +LS FGL K    G     S
Sbjct: 174 RMMIALGAAKGLAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDETHVS 233

Query: 214 TNL----AFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGK----HIPPSHALDLI----- 260
           T +     +  PEY+ TG +T  S +YSFG +LL++L+G+       PS   +L+     
Sbjct: 234 TRVMGTYGYAAPEYVMTGHLTARSDVYSFGVVLLEMLTGRKSVDKTRPSKEQNLVDWARP 293

Query: 261 ---RDRNIQTLTDSCLEGQFSSDEGTELVRLASRCLQYEPRERPNPRSLVTALVTLQ 314
                R +  + D  LE Q+S     +   LA  CL   P+ RP    +V  L  LQ
Sbjct: 294 KLNDKRKLLQIIDPRLENQYSVRAAQKACSLAYYCLSQNPKARPLMSDVVETLEPLQ 350

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|O48814|BIK1_ARATH Serine/threonine-protein kinase BIK1 OS=Arabidopsis thaliana GN=BIK1 PE=1 SV=1

 Score =  147 bits (370), Expect = 1e-34,   Method: Compositional matrix adjust.
 Identities = 102/324 (31%), Positives = 161/324 (49%), Gaps = 38/324 (11%)

Query: 24  AQDVENEEKPGVDNVPVFCEYSIETLRTATSGFAMENIVSEHGEKAPNVVYKGKLENQ-- 81
           AQ  E E    + + PV   ++   L+ AT  F  ++++   GE     V+KG L+    
Sbjct: 39  AQKTEGEI---LSSTPV-KSFTFNELKLATRNFRPDSVI---GEGGFGCVFKGWLDESTL 91

Query: 82  --------FRIAVKRFNRSAWPDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAE 133
                     IAVK+ N+  +   R++L E   +GQL +  L  L+G C E + RLLV E
Sbjct: 92  TPTKPGTGLVIAVKKLNQEGFQGHREWLTEINYLGQLSHPNLVKLIGYCLEDEHRLLVYE 151

Query: 134 YMPNDTLAKHLFHWET--QPMKWAMRLRVALHIAEALEYCTSKE-RALYHDLNAYRIVFD 190
           +M   +L  HLF      +P+ W +R+ VAL  A+ L +  S   + +Y D+ A  I+ D
Sbjct: 152 FMQKGSLENHLFRRGAYFKPLPWFLRVNVALDAAKGLAFLHSDPVKVIYRDIKASNILLD 211

Query: 191 DDVNPRLSCFGLMKNSRDGR-SYST-----NLAFTPPEYLRTGRVTPESVMYSFGTLLLD 244
            D N +LS FGL ++   G  SY +        +  PEY+ +G +   S +YSFG LLL+
Sbjct: 212 ADYNAKLSDFGLARDGPMGDLSYVSTRVMGTYGYAAPEYMSSGHLNARSDVYSFGVLLLE 271

Query: 245 LLSGK----HIPPSHALDLI--------RDRNIQTLTDSCLEGQFSSDEGTELVRLASRC 292
           +LSGK    H  P+   +L+          R +  + D+ L+ Q+  +E   +  +A +C
Sbjct: 272 ILSGKRALDHNRPAKEENLVDWARPYLTSKRKVLLIVDNRLDTQYLPEEAVRMASVAVQC 331

Query: 293 LQYEPRERPNPRSLVTALVTLQKD 316
           L +EP+ RP    +V AL  LQ +
Sbjct: 332 LSFEPKSRPTMDQVVRALQQLQDN 355

Required to activate the resistance responses to necrotrophic pathogens. Phosphorylates FLS2 and BAK1.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

Close Homologs in the Non-Redundant Database Detected by BLAST

Original result of BLAST against Nonredundant Database

GI	Length	Definition	Q cover	H cover	Identity	E-value
Query	329
224071868	487	predicted protein [Populus trichocarpa]	0.969	0.655	0.846	1e-161
224058519	488	predicted protein [Populus trichocarpa]	0.969	0.653	0.827	1e-159
225426412	488	PREDICTED: probable serine/threonine-pro	0.969	0.653	0.843	1e-159
225454188	491	PREDICTED: probable serine/threonine-pro	0.969	0.649	0.830	1e-158
297805526	487	kinase family protein [Arabidopsis lyrat	0.969	0.655	0.805	1e-154
356520418	491	PREDICTED: probable serine/threonine-pro	0.969	0.649	0.808	1e-154
15237604	487	putative serine/threonine-protein kinase	0.969	0.655	0.802	1e-154
357520451	495	Protein kinase-like protein [Medicago tr	0.969	0.644	0.819	1e-153
449452322	486	PREDICTED: probable serine/threonine-pro	0.963	0.652	0.827	1e-153
356504529	491	PREDICTED: probable serine/threonine-pro	0.969	0.649	0.799	1e-153

>gi|224071868|ref|XP_002303586.1| predicted protein [Populus trichocarpa] gi|222841018|gb|EEE78565.1| predicted protein [Populus trichocarpa]

 Score =  573 bits (1478), Expect = e-161,   Method: Compositional matrix adjust.
 Identities = 270/319 (84%), Positives = 294/319 (92%)

Query: 1   MGCECSKLSACCSGSEYGEAAPEAQDVENEEKPGVDNVPVFCEYSIETLRTATSGFAMEN 60
           MGCECSKLS CC  S+Y  + PE ++  NEEK  +D++P F EY+IETLR ATSGF++EN
Sbjct: 1   MGCECSKLSKCCWSSDYNGSVPEDRNEVNEEKSELDDLPAFREYNIETLRMATSGFSVEN 60

Query: 61  IVSEHGEKAPNVVYKGKLENQFRIAVKRFNRSAWPDARQFLEEARAVGQLRNRRLANLLG 120
           IVSEHGEKAPNVVYKGKLENQ R+AVKRFNRSAWPDARQFLEEARAVGQLRN RLANLLG
Sbjct: 61  IVSEHGEKAPNVVYKGKLENQRRVAVKRFNRSAWPDARQFLEEARAVGQLRNHRLANLLG 120

Query: 121 CCCEGDERLLVAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYH 180
           CC EGDERLLVAE+MPNDTLAKHLFHWET+PMKWAMRLRVALH+A+ALEYCTSK RALYH
Sbjct: 121 CCGEGDERLLVAEFMPNDTLAKHLFHWETKPMKWAMRLRVALHLAQALEYCTSKGRALYH 180

Query: 181 DLNAYRIVFDDDVNPRLSCFGLMKNSRDGRSYSTNLAFTPPEYLRTGRVTPESVMYSFGT 240
           DLNAYRIVFDD+ NPRLSCFGLMKN RDG+SYSTNLAFTPPEYLRTGRV PESV+YSFGT
Sbjct: 181 DLNAYRIVFDDEGNPRLSCFGLMKNRRDGKSYSTNLAFTPPEYLRTGRVIPESVIYSFGT 240

Query: 241 LLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLASRCLQYEPRER 300
           LLLDLLSGKHIPPSHALDLIRDRNIQ LTDSCLEGQF++D+GTELVRLASRCLQYEPRER
Sbjct: 241 LLLDLLSGKHIPPSHALDLIRDRNIQMLTDSCLEGQFTNDDGTELVRLASRCLQYEPRER 300

Query: 301 PNPRSLVTALVTLQKDTEL 319
           PN +SLV AL+ LQKDTE+
Sbjct: 301 PNSKSLVAALIPLQKDTEV 319

Source: Populus trichocarpa

Species: Populus trichocarpa

Genus: Populus

Family: Salicaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|224058519|ref|XP_002299534.1| predicted protein [Populus trichocarpa] gi|222846792|gb|EEE84339.1| predicted protein [Populus trichocarpa]

 Score =  568 bits (1463), Expect = e-159,   Method: Compositional matrix adjust.
 Identities = 264/319 (82%), Positives = 292/319 (91%)

Query: 1   MGCECSKLSACCSGSEYGEAAPEAQDVENEEKPGVDNVPVFCEYSIETLRTATSGFAMEN 60
           MGCECSKL+ CC  S+Y  + PE  + + EE+  +D++P F EY+IETLR ATSGF++EN
Sbjct: 1   MGCECSKLTKCCWSSDYNGSVPEDHNEDKEERSELDDLPAFREYNIETLRMATSGFSVEN 60

Query: 61  IVSEHGEKAPNVVYKGKLENQFRIAVKRFNRSAWPDARQFLEEARAVGQLRNRRLANLLG 120
           IVSEHGEKAPNVVYKGKLENQ RI VKRFNRS+WPDARQFLEEAR VGQLRN RLANLLG
Sbjct: 61  IVSEHGEKAPNVVYKGKLENQRRIVVKRFNRSSWPDARQFLEEARTVGQLRNHRLANLLG 120

Query: 121 CCCEGDERLLVAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYH 180
           CCCEGDERLLV+E+MPNDTLAKHLFHWETQPMKWAMRLRVALH+A+ALEYC SK RALYH
Sbjct: 121 CCCEGDERLLVSEFMPNDTLAKHLFHWETQPMKWAMRLRVALHLAQALEYCASKGRALYH 180

Query: 181 DLNAYRIVFDDDVNPRLSCFGLMKNSRDGRSYSTNLAFTPPEYLRTGRVTPESVMYSFGT 240
           DLNAYR+VFDD+ NPRLSCFGLMKNS DG+SYSTNLAFTPPEYLRTGRVT ESV+YSFGT
Sbjct: 181 DLNAYRVVFDDEGNPRLSCFGLMKNSIDGKSYSTNLAFTPPEYLRTGRVTAESVIYSFGT 240

Query: 241 LLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLASRCLQYEPRER 300
           LLLDLLSGKHIPPSHALDLIRDRNIQ L+DSCLEGQF++D+GTELVRLASRCLQYEPRER
Sbjct: 241 LLLDLLSGKHIPPSHALDLIRDRNIQMLSDSCLEGQFANDDGTELVRLASRCLQYEPRER 300

Query: 301 PNPRSLVTALVTLQKDTEL 319
           PNP+SLV AL+ LQKDTE+
Sbjct: 301 PNPKSLVAALIPLQKDTEV 319

Source: Populus trichocarpa

Species: Populus trichocarpa

Genus: Populus

Family: Salicaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|225426412|ref|XP_002270065.1| PREDICTED: probable serine/threonine-protein kinase At5g41260 [Vitis vinifera] gi|297742525|emb|CBI34674.3| unnamed protein product [Vitis vinifera]

 Score =  566 bits (1458), Expect = e-159,   Method: Compositional matrix adjust.
 Identities = 269/319 (84%), Positives = 288/319 (90%)

Query: 1   MGCECSKLSACCSGSEYGEAAPEAQDVENEEKPGVDNVPVFCEYSIETLRTATSGFAMEN 60
           MGC+CSK   CC  SE      E   VENEE    D++P F EY+I+ LR ATSGFA EN
Sbjct: 1   MGCQCSKFWVCCWDSEQKGLVVEPPSVENEENSEADDLPAFHEYTIDQLRMATSGFAAEN 60

Query: 61  IVSEHGEKAPNVVYKGKLENQFRIAVKRFNRSAWPDARQFLEEARAVGQLRNRRLANLLG 120
           IVSEHGEKAPNVVYKGKLENQ RIAVKRFN+SAWPDARQFLEEAR+VGQLRN RLANLLG
Sbjct: 61  IVSEHGEKAPNVVYKGKLENQRRIAVKRFNKSAWPDARQFLEEARSVGQLRNHRLANLLG 120

Query: 121 CCCEGDERLLVAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYH 180
           CC EGDERLLVAE+MPNDTLAKHLFHWETQPMKWAMRLRVAL++A+ALEYCTSK RALYH
Sbjct: 121 CCSEGDERLLVAEFMPNDTLAKHLFHWETQPMKWAMRLRVALYLAQALEYCTSKGRALYH 180

Query: 181 DLNAYRIVFDDDVNPRLSCFGLMKNSRDGRSYSTNLAFTPPEYLRTGRVTPESVMYSFGT 240
           DLNAYRIVFDDD +PRLSCFG+MKNSRDG+SYSTNLAFTPPEYLRTGRVTPESVMYSFGT
Sbjct: 181 DLNAYRIVFDDDGDPRLSCFGMMKNSRDGKSYSTNLAFTPPEYLRTGRVTPESVMYSFGT 240

Query: 241 LLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLASRCLQYEPRER 300
           LLLDLLSGKHIPPSHALDLIRDRNIQ LTDSCLEGQFSSD+GTELVRLASRCLQYEPRER
Sbjct: 241 LLLDLLSGKHIPPSHALDLIRDRNIQMLTDSCLEGQFSSDDGTELVRLASRCLQYEPRER 300

Query: 301 PNPRSLVTALVTLQKDTEL 319
           PNP+SLV AL+ LQK+TE+
Sbjct: 301 PNPKSLVAALIPLQKETEV 319

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|225454188|ref|XP_002272416.1| PREDICTED: probable serine/threonine-protein kinase At5g41260 [Vitis vinifera] gi|297745267|emb|CBI40347.3| unnamed protein product [Vitis vinifera]

 Score =  563 bits (1451), Expect = e-158,   Method: Compositional matrix adjust.
 Identities = 265/319 (83%), Positives = 291/319 (91%)

Query: 1   MGCECSKLSACCSGSEYGEAAPEAQDVENEEKPGVDNVPVFCEYSIETLRTATSGFAMEN 60
           MGC+CSKL+ CC  S++  +  EA DV+N EK  VD +PVFCEY+ E L+ ATSGFA+EN
Sbjct: 1   MGCQCSKLAPCCWDSQFKGSVLEAPDVDNGEKSEVDYLPVFCEYTFEQLKNATSGFAVEN 60

Query: 61  IVSEHGEKAPNVVYKGKLENQFRIAVKRFNRSAWPDARQFLEEARAVGQLRNRRLANLLG 120
           IVSEHGEKAPNVVYKGKLENQ RIAVKRFNR AWPDARQF EEARAVGQLRN RLANLLG
Sbjct: 61  IVSEHGEKAPNVVYKGKLENQRRIAVKRFNRVAWPDARQFSEEARAVGQLRNHRLANLLG 120

Query: 121 CCCEGDERLLVAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYH 180
           CCCE +ERLLVAEYMPN+TLAKHLFHWETQPMKWAMRLRV LH+A+ALEYCT + RALYH
Sbjct: 121 CCCEDNERLLVAEYMPNETLAKHLFHWETQPMKWAMRLRVVLHLAQALEYCTGRGRALYH 180

Query: 181 DLNAYRIVFDDDVNPRLSCFGLMKNSRDGRSYSTNLAFTPPEYLRTGRVTPESVMYSFGT 240
           DLNAYRI+FD+D NPRLSCFGLMKNSRDG+SYSTNLAFTPPEYLRTGRVTPESV+YSFGT
Sbjct: 181 DLNAYRILFDEDGNPRLSCFGLMKNSRDGKSYSTNLAFTPPEYLRTGRVTPESVIYSFGT 240

Query: 241 LLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLASRCLQYEPRER 300
           LLLDLLSGKHIPPSHALDLIRDRN+Q LTDSCLEGQF++D+GTELVRLASRCLQYEPRER
Sbjct: 241 LLLDLLSGKHIPPSHALDLIRDRNLQMLTDSCLEGQFTNDDGTELVRLASRCLQYEPRER 300

Query: 301 PNPRSLVTALVTLQKDTEL 319
           PNP+SLV AL  LQK+TE+
Sbjct: 301 PNPKSLVAALTPLQKETEV 319

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|297805526|ref|XP_002870647.1| kinase family protein [Arabidopsis lyrata subsp. lyrata] gi|297316483|gb|EFH46906.1| kinase family protein [Arabidopsis lyrata subsp. lyrata]

 Score =  551 bits (1420), Expect = e-154,   Method: Compositional matrix adjust.
 Identities = 257/319 (80%), Positives = 289/319 (90%)

Query: 1   MGCECSKLSACCSGSEYGEAAPEAQDVENEEKPGVDNVPVFCEYSIETLRTATSGFAMEN 60
           MGCE SKLSA C  SE G + P+   ++ E +   +++P F E+SIET+R ATSGFA EN
Sbjct: 1   MGCEVSKLSALCCVSESGRSNPDVTGLDEEGRGESNDLPQFREFSIETIRNATSGFAAEN 60

Query: 61  IVSEHGEKAPNVVYKGKLENQFRIAVKRFNRSAWPDARQFLEEARAVGQLRNRRLANLLG 120
           IVSEHGE+APNVVYKGKLENQ RIAVKRFNR +WPD+RQFLEEA+AVGQLRN R+ANLLG
Sbjct: 61  IVSEHGERAPNVVYKGKLENQRRIAVKRFNRKSWPDSRQFLEEAKAVGQLRNHRMANLLG 120

Query: 121 CCCEGDERLLVAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYH 180
           CC EG+ERLL+AE+MPN+TLAKHLFHWE+QPMKWAMRLRVALHIA+ALEYCTSK RALYH
Sbjct: 121 CCYEGEERLLIAEFMPNETLAKHLFHWESQPMKWAMRLRVALHIAQALEYCTSKGRALYH 180

Query: 181 DLNAYRIVFDDDVNPRLSCFGLMKNSRDGRSYSTNLAFTPPEYLRTGRVTPESVMYSFGT 240
           DLNAYR++FDDD NPRLSCFGLMKNSRDG+SYSTNLAFTPPEYLRTGRVTPESV+YSFGT
Sbjct: 181 DLNAYRVLFDDDANPRLSCFGLMKNSRDGKSYSTNLAFTPPEYLRTGRVTPESVIYSFGT 240

Query: 241 LLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLASRCLQYEPRER 300
           LLLDLLSGKHIPPSHALDLIRDRNIQ L DS LEGQFSSD+GTEL+RLASRCLQYEPRER
Sbjct: 241 LLLDLLSGKHIPPSHALDLIRDRNIQMLMDSGLEGQFSSDDGTELIRLASRCLQYEPRER 300

Query: 301 PNPRSLVTALVTLQKDTEL 319
           PNP+SLV+A++ LQKD E+
Sbjct: 301 PNPKSLVSAMIPLQKDLEI 319

Source: Arabidopsis lyrata subsp. lyrata

Species: Arabidopsis lyrata

Genus: Arabidopsis

Family: Brassicaceae

Order: Brassicales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|356520418|ref|XP_003528859.1| PREDICTED: probable serine/threonine-protein kinase At5g41260-like [Glycine max]

 Score =  550 bits (1417), Expect = e-154,   Method: Compositional matrix adjust.
 Identities = 258/319 (80%), Positives = 285/319 (89%)

Query: 1   MGCECSKLSACCSGSEYGEAAPEAQDVENEEKPGVDNVPVFCEYSIETLRTATSGFAMEN 60
           MG +CS+L  CC  S+   +  E  D E E+   V N P F EY++E L+ ATSGFA+EN
Sbjct: 1   MGIQCSRLIPCCVDSQVKASVIETPDAEIEDSSEVSNWPTFREYTLEQLKNATSGFAVEN 60

Query: 61  IVSEHGEKAPNVVYKGKLENQFRIAVKRFNRSAWPDARQFLEEARAVGQLRNRRLANLLG 120
           IVSEHGEKAPNVVYKGKLENQ RIAVKRFNR+AWPDARQFLEEAR+VGQLRN+RLANLLG
Sbjct: 61  IVSEHGEKAPNVVYKGKLENQMRIAVKRFNRNAWPDARQFLEEARSVGQLRNQRLANLLG 120

Query: 121 CCCEGDERLLVAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYH 180
           CCCEG+ERLLVAEYMPN+TLAKHLFHWETQPMKWAMRLRV LH+A+ALEYCTSK RALYH
Sbjct: 121 CCCEGEERLLVAEYMPNETLAKHLFHWETQPMKWAMRLRVVLHLAQALEYCTSKGRALYH 180

Query: 181 DLNAYRIVFDDDVNPRLSCFGLMKNSRDGRSYSTNLAFTPPEYLRTGRVTPESVMYSFGT 240
           DLNAYR++FD+D NPRLS FGLMKNSRDG+SYSTNLAFTPPEYLRTGRVTPESV+YSFGT
Sbjct: 181 DLNAYRVLFDEDGNPRLSSFGLMKNSRDGKSYSTNLAFTPPEYLRTGRVTPESVIYSFGT 240

Query: 241 LLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLASRCLQYEPRER 300
           LLLDLLSGKHIPPSHALD+IR RN+Q LTDSCLEGQFS D+GTELVRLASRCLQYEPRER
Sbjct: 241 LLLDLLSGKHIPPSHALDVIRGRNLQMLTDSCLEGQFSDDDGTELVRLASRCLQYEPRER 300

Query: 301 PNPRSLVTALVTLQKDTEL 319
           PNP+SLV AL  LQK+TE+
Sbjct: 301 PNPKSLVVALAPLQKETEV 319

Source: Glycine max

Species: Glycine max

Genus: Glycine

Family: Fabaceae

Order: Fabales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|15237604|ref|NP_198942.1| putative serine/threonine-protein kinase [Arabidopsis thaliana] gi|75333858|sp|Q9FHD7.1|Y5126_ARATH RecName: Full=Probable serine/threonine-protein kinase At5g41260 gi|10177770|dbj|BAB11102.1| protein kinase-like [Arabidopsis thaliana] gi|115311489|gb|ABI93925.1| At5g41260 [Arabidopsis thaliana] gi|332007275|gb|AED94658.1| putative serine/threonine-protein kinase [Arabidopsis thaliana]

 Score =  548 bits (1413), Expect = e-154,   Method: Compositional matrix adjust.
 Identities = 256/319 (80%), Positives = 288/319 (90%)

Query: 1   MGCECSKLSACCSGSEYGEAAPEAQDVENEEKPGVDNVPVFCEYSIETLRTATSGFAMEN 60
           MGCE SKLSA C  SE G + P+   ++ E +   +++P F E+SIET+R ATSGFA EN
Sbjct: 1   MGCEVSKLSALCCVSESGRSNPDVTGLDEEGRGESNDLPQFREFSIETIRNATSGFAAEN 60

Query: 61  IVSEHGEKAPNVVYKGKLENQFRIAVKRFNRSAWPDARQFLEEARAVGQLRNRRLANLLG 120
           IVSEHGE+APNVVYKGKLENQ RIAVKRFNR +WPD+RQFLEEA+AVGQLRN R+ANLLG
Sbjct: 61  IVSEHGERAPNVVYKGKLENQRRIAVKRFNRKSWPDSRQFLEEAKAVGQLRNHRMANLLG 120

Query: 121 CCCEGDERLLVAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYH 180
           CC E +ERLL+AE+MPN+TLAKHLFHWE+QPMKWAMRLRVALHIA+ALEYCTSK RALYH
Sbjct: 121 CCYEDEERLLIAEFMPNETLAKHLFHWESQPMKWAMRLRVALHIAQALEYCTSKGRALYH 180

Query: 181 DLNAYRIVFDDDVNPRLSCFGLMKNSRDGRSYSTNLAFTPPEYLRTGRVTPESVMYSFGT 240
           DLNAYR++FDDD NPRLSCFGLMKNSRDG+SYSTNLAFTPPEYLRTGRVTPESV+YSFGT
Sbjct: 181 DLNAYRVLFDDDANPRLSCFGLMKNSRDGKSYSTNLAFTPPEYLRTGRVTPESVIYSFGT 240

Query: 241 LLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLASRCLQYEPRER 300
           LLLDLLSGKHIPPSHALDLIRDRNIQ L DS LEGQFSSD+GTEL+RLASRCLQYEPRER
Sbjct: 241 LLLDLLSGKHIPPSHALDLIRDRNIQMLMDSGLEGQFSSDDGTELIRLASRCLQYEPRER 300

Query: 301 PNPRSLVTALVTLQKDTEL 319
           PNP+SLV+A++ LQKD E+
Sbjct: 301 PNPKSLVSAMIPLQKDLEI 319

Source: Arabidopsis thaliana

Species: Arabidopsis thaliana

Genus: Arabidopsis

Family: Brassicaceae

Order: Brassicales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|357520451|ref|XP_003630514.1| Protein kinase-like protein [Medicago truncatula] gi|355524536|gb|AET04990.1| Protein kinase-like protein [Medicago truncatula]

 Score =  548 bits (1412), Expect = e-153,   Method: Compositional matrix adjust.
 Identities = 263/321 (81%), Positives = 286/321 (89%), Gaps = 2/321 (0%)

Query: 1   MGCECSKLSACCSGSEYGEA-APEAQDVENEEKPGVDN-VPVFCEYSIETLRTATSGFAM 58
           MGC  SK S CC  +E G    PEA   ENE+     N +  F EY+I+ LR ATSGFA+
Sbjct: 7   MGCNFSKYSTCCCSTEQGGVQVPEANIEENEDNNVEGNGLASFREYTIDQLRKATSGFAI 66

Query: 59  ENIVSEHGEKAPNVVYKGKLENQFRIAVKRFNRSAWPDARQFLEEARAVGQLRNRRLANL 118
           ENIVSEHGEKAPNVVYKGKLENQ RIAVKRFN+S WPDA QFLEEARAVGQLR++RLANL
Sbjct: 67  ENIVSEHGEKAPNVVYKGKLENQVRIAVKRFNKSNWPDAHQFLEEARAVGQLRSQRLANL 126

Query: 119 LGCCCEGDERLLVAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERAL 178
           LGCCCEGDERLLV+EYM NDTLAKHLFHWETQPMKWAMRLRVAL++A+ALEYCTSK RAL
Sbjct: 127 LGCCCEGDERLLVSEYMSNDTLAKHLFHWETQPMKWAMRLRVALYLAQALEYCTSKGRAL 186

Query: 179 YHDLNAYRIVFDDDVNPRLSCFGLMKNSRDGRSYSTNLAFTPPEYLRTGRVTPESVMYSF 238
           YHDLNAYR++FDDD NP+LSCFGLMKNSRDG+SYSTNLAFTPPEYLRTGRVTPESV YSF
Sbjct: 187 YHDLNAYRVLFDDDFNPKLSCFGLMKNSRDGKSYSTNLAFTPPEYLRTGRVTPESVTYSF 246

Query: 239 GTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLASRCLQYEPR 298
           GTLLLDLLSGKHIPPSHALDLIRDRN+Q+LTDSCLEGQFS DEGTELVRLASRCLQ EPR
Sbjct: 247 GTLLLDLLSGKHIPPSHALDLIRDRNLQSLTDSCLEGQFSDDEGTELVRLASRCLQSEPR 306

Query: 299 ERPNPRSLVTALVTLQKDTEL 319
           ERPNP+SLVTAL+ LQKD+E+
Sbjct: 307 ERPNPKSLVTALIPLQKDSEV 327

Source: Medicago truncatula

Species: Medicago truncatula

Genus: Medicago

Family: Fabaceae

Order: Fabales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|449452322|ref|XP_004143908.1| PREDICTED: probable serine/threonine-protein kinase At5g41260-like [Cucumis sativus] gi|449495800|ref|XP_004159948.1| PREDICTED: probable serine/threonine-protein kinase At5g41260-like [Cucumis sativus]

 Score =  547 bits (1409), Expect = e-153,   Method: Compositional matrix adjust.
 Identities = 264/319 (82%), Positives = 287/319 (89%), Gaps = 2/319 (0%)

Query: 1   MGCECSKLSACCSGSEYGEAAPEAQDVENEEKPGVDNVPVFCEYSIETLRTATSGFAMEN 60
           MGCECSK S C  GSE  +      D E+  K   D +P F E++I+ LRTATSGFA+EN
Sbjct: 1   MGCECSKFSDCF-GSEETKPVARVPDNESIGKSEFD-LPAFREFTIDQLRTATSGFAVEN 58

Query: 61  IVSEHGEKAPNVVYKGKLENQFRIAVKRFNRSAWPDARQFLEEARAVGQLRNRRLANLLG 120
           IVSEHGEKAPNVVYKGKL+NQ RIAVKRFNRSAWPDARQFL+EARAVGQLRN+RLANLLG
Sbjct: 59  IVSEHGEKAPNVVYKGKLDNQRRIAVKRFNRSAWPDARQFLDEARAVGQLRNQRLANLLG 118

Query: 121 CCCEGDERLLVAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYH 180
           CC EG+ERLLVAE+MPN+TLAKHLFHWE QPMKW+MRLRVALH+A+ALEYCTSK RALYH
Sbjct: 119 CCFEGEERLLVAEFMPNETLAKHLFHWENQPMKWSMRLRVALHLAQALEYCTSKGRALYH 178

Query: 181 DLNAYRIVFDDDVNPRLSCFGLMKNSRDGRSYSTNLAFTPPEYLRTGRVTPESVMYSFGT 240
           DLNAYRIVFDD+ NPRLSCFGLMKNSRDGRSYSTNLAFTPPEYLRTG +TPESV+YSFGT
Sbjct: 179 DLNAYRIVFDDEGNPRLSCFGLMKNSRDGRSYSTNLAFTPPEYLRTGGITPESVIYSFGT 238

Query: 241 LLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLASRCLQYEPRER 300
           LLLDLLSGKHIPPSHALDLIRDRNIQ LTDSCLEGQFS+DEGTELVRLASRCLQYEPRER
Sbjct: 239 LLLDLLSGKHIPPSHALDLIRDRNIQMLTDSCLEGQFSNDEGTELVRLASRCLQYEPRER 298

Query: 301 PNPRSLVTALVTLQKDTEL 319
           PN +SLVTAL+ LQKD E+
Sbjct: 299 PNTKSLVTALIPLQKDLEV 317

Source: Cucumis sativus

Species: Cucumis sativus

Genus: Cucumis

Family: Cucurbitaceae

Order: Cucurbitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|356504529|ref|XP_003521048.1| PREDICTED: probable serine/threonine-protein kinase At5g41260-like [Glycine max]

 Score =  546 bits (1406), Expect = e-153,   Method: Compositional matrix adjust.
 Identities = 255/319 (79%), Positives = 284/319 (89%)

Query: 1   MGCECSKLSACCSGSEYGEAAPEAQDVENEEKPGVDNVPVFCEYSIETLRTATSGFAMEN 60
           MG +CS+L  CC  S+   +  E  D E E+     N P F E+++E L+ ATSGFA+EN
Sbjct: 1   MGIQCSRLIPCCVDSQVKASVIETPDAEIEDSSEASNWPTFREFTLEQLKNATSGFAVEN 60

Query: 61  IVSEHGEKAPNVVYKGKLENQFRIAVKRFNRSAWPDARQFLEEARAVGQLRNRRLANLLG 120
           IVSEHGEKAPNVVYKGKLENQ RIAVKRFNR+AWPDARQFLEE+R+VGQLRN+RLANLLG
Sbjct: 61  IVSEHGEKAPNVVYKGKLENQMRIAVKRFNRNAWPDARQFLEESRSVGQLRNQRLANLLG 120

Query: 121 CCCEGDERLLVAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYH 180
           CCCEG+ERLLVAEYMPN+TLAKHLFHWETQPMKWAMRLRV LH+A+ALEYCTSK RALYH
Sbjct: 121 CCCEGEERLLVAEYMPNETLAKHLFHWETQPMKWAMRLRVVLHLAQALEYCTSKGRALYH 180

Query: 181 DLNAYRIVFDDDVNPRLSCFGLMKNSRDGRSYSTNLAFTPPEYLRTGRVTPESVMYSFGT 240
           DLNAYR++FD+D NPRLS FGLMKNSRDG+SYSTNLAFTPPEYLRTGRVTPESV+YSFGT
Sbjct: 181 DLNAYRVLFDEDGNPRLSSFGLMKNSRDGKSYSTNLAFTPPEYLRTGRVTPESVIYSFGT 240

Query: 241 LLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLASRCLQYEPRER 300
           LLLDLLSGKHIPPSHALD+IR RN+Q LTDSCLEGQFS D+GTELVRLASRCLQYEPRER
Sbjct: 241 LLLDLLSGKHIPPSHALDVIRGRNLQMLTDSCLEGQFSDDDGTELVRLASRCLQYEPRER 300

Query: 301 PNPRSLVTALVTLQKDTEL 319
           PNP+SLV AL  LQK+TE+
Sbjct: 301 PNPKSLVAALAPLQKETEV 319

Source: Glycine max

Species: Glycine max

Genus: Glycine

Family: Fabaceae

Order: Fabales

Phylum: Streptophyta

Superkingdom: Eukaryota

---

Prediction of Gene Ontology (GO) Terms

Close Homologs with Gene Ontology terms Detected by BLAST

Original result of BLAST against Gene Ontology (AMIGO)

ID	Length	Definition	Q cover	H cover	Identity	E-value
Query	329
TAIR|locus:2155115	487	BSK8 "brassinosteroid-signalin	0.969	0.655	0.802	3.9e-140
TAIR|locus:2031279	487	BSK7 "brassinosteroid-signalin	0.963	0.650	0.815	5.6e-139
TAIR|locus:2127118	489	BSK3 "brassinosteroid-signalin	0.966	0.650	0.780	5.2e-136
TAIR|locus:2198160	483	BSK4 "brassinosteroid-signalin	0.960	0.654	0.742	3.6e-128
TAIR|locus:2154538	489	BSK5 "brassinosteroid-signalin	0.957	0.644	0.730	3.4e-125
TAIR|locus:2084475	490	BSK6 "brassinosteroid-signalin	0.957	0.642	0.703	4.1e-120
TAIR|locus:2122058	512	BSK1 "brassinosteroid-signalin	0.881	0.566	0.678	3.5e-107
TAIR|locus:2142315	489	BSK2 "brassinosteroid-signalin	0.957	0.644	0.603	9.8e-103
TAIR|locus:2083499	477	BSK9 "brassinosteroid-signalin	0.890	0.614	0.641	4.9e-101
TAIR|locus:2150074	499	BSK10 "brassinosteroid-signali	0.966	0.637	0.589	2e-97

TAIR|locus:2155115 BSK8 "brassinosteroid-signaling kinase 8" [Arabidopsis thaliana (taxid:3702)]

 Score = 1371 (487.7 bits), Expect = 3.9e-140, P = 3.9e-140
 Identities = 256/319 (80%), Positives = 288/319 (90%)

Query:     1 MGCECSKLSACCSGSEYGEAAPEAQDVENEEKPGVDNVPVFCEYSIETLRTATSGFAMEN 60
             MGCE SKLSA C  SE G + P+   ++ E +   +++P F E+SIET+R ATSGFA EN
Sbjct:     1 MGCEVSKLSALCCVSESGRSNPDVTGLDEEGRGESNDLPQFREFSIETIRNATSGFAAEN 60

Query:    61 IVSEHGEKAPNVVYKGKLENQFRIAVKRFNRSAWPDARQFLEEARAVGQLRNRRLANLLG 120
             IVSEHGE+APNVVYKGKLENQ RIAVKRFNR +WPD+RQFLEEA+AVGQLRN R+ANLLG
Sbjct:    61 IVSEHGERAPNVVYKGKLENQRRIAVKRFNRKSWPDSRQFLEEAKAVGQLRNHRMANLLG 120

Query:   121 CCCEGDERLLVAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYH 180
             CC E +ERLL+AE+MPN+TLAKHLFHWE+QPMKWAMRLRVALHIA+ALEYCTSK RALYH
Sbjct:   121 CCYEDEERLLIAEFMPNETLAKHLFHWESQPMKWAMRLRVALHIAQALEYCTSKGRALYH 180

Query:   181 DLNAYRIVFDDDVNPRLSCFGLMKNSRDGRSYSTNLAFTPPEYLRTGRVTPESVMYSFGT 240
             DLNAYR++FDDD NPRLSCFGLMKNSRDG+SYSTNLAFTPPEYLRTGRVTPESV+YSFGT
Sbjct:   181 DLNAYRVLFDDDANPRLSCFGLMKNSRDGKSYSTNLAFTPPEYLRTGRVTPESVIYSFGT 240

Query:   241 LLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLASRCLQYEPRER 300
             LLLDLLSGKHIPPSHALDLIRDRNIQ L DS LEGQFSSD+GTEL+RLASRCLQYEPRER
Sbjct:   241 LLLDLLSGKHIPPSHALDLIRDRNIQMLMDSGLEGQFSSDDGTELIRLASRCLQYEPRER 300

Query:   301 PNPRSLVTALVTLQKDTEL 319
             PNP+SLV+A++ LQKD E+
Sbjct:   301 PNPKSLVSAMIPLQKDLEI 319

GO:0004672 "protein kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM;IDA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0009627 "systemic acquired resistance" evidence=RCA

GO:0031347 "regulation of defense response" evidence=RCA

TAIR|locus:2031279 BSK7 "brassinosteroid-signaling kinase 7" [Arabidopsis thaliana (taxid:3702)]

 Score = 1360 (483.8 bits), Expect = 5.6e-139, P = 5.6e-139
 Identities = 260/319 (81%), Positives = 285/319 (89%)

Query:     1 MGCECSKLSACCSGSEYGEAAPEAQDVENEEKPGVDN-VPVFCEYSIETLRTATSGFAME 59
             MGCE SKL A C  S+  E +       +E++ G  N +P F E+SIETLR ATSGFA E
Sbjct:     1 MGCEVSKLCAFCCVSD-PEGSNHGVTGLDEDRRGEGNDLPQFREFSIETLRNATSGFATE 59

Query:    60 NIVSEHGEKAPNVVYKGKLENQFRIAVKRFNRSAWPDARQFLEEARAVGQLRNRRLANLL 119
             NIVSEHGEKAPNVVYKGKL+NQ RIAVKRFNR AWPD+RQFLEEA+AVGQLRN R+ANLL
Sbjct:    60 NIVSEHGEKAPNVVYKGKLDNQRRIAVKRFNRKAWPDSRQFLEEAKAVGQLRNYRMANLL 119

Query:   120 GCCCEGDERLLVAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALY 179
             GCC EG+ERLLVAE+MPN+TLAKHLFHWE+QPMKWAMRLRVALHIA+ALEYCT K RALY
Sbjct:   120 GCCYEGEERLLVAEFMPNETLAKHLFHWESQPMKWAMRLRVALHIAQALEYCTGKGRALY 179

Query:   180 HDLNAYRIVFDDDVNPRLSCFGLMKNSRDGRSYSTNLAFTPPEYLRTGRVTPESVMYSFG 239
             HDLNAYR++FDDD NPRLSCFGLMKNSRDG+SYSTNLAFTPPEYLRTGRVTPESVMYS+G
Sbjct:   180 HDLNAYRVLFDDDSNPRLSCFGLMKNSRDGKSYSTNLAFTPPEYLRTGRVTPESVMYSYG 239

Query:   240 TLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLASRCLQYEPRE 299
             TLLLDLLSGKHIPPSHALDLIRDRNIQ L DSCLEGQFSSD+GTEL+RLASRCLQYEPRE
Sbjct:   240 TLLLDLLSGKHIPPSHALDLIRDRNIQMLIDSCLEGQFSSDDGTELIRLASRCLQYEPRE 299

Query:   300 RPNPRSLVTALVTLQKDTE 318
             RPNP+SLVTA++ LQKD E
Sbjct:   300 RPNPKSLVTAMIPLQKDLE 318

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM;IDA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0009506 "plasmodesma" evidence=IDA

TAIR|locus:2127118 BSK3 "brassinosteroid-signaling kinase 3" [Arabidopsis thaliana (taxid:3702)]

 Score = 1332 (473.9 bits), Expect = 5.2e-136, P = 5.2e-136
 Identities = 249/319 (78%), Positives = 282/319 (88%)

Query:     1 MGCECSKLSACCSGSEYGEAAPEAQDVENEEKPGVDNVPVFCEYSIETLRTATSGFAMEN 60
             MG +CS LS CC  + +  A  EA DV+N E   + +VP F EY++E L+ ATSGFA+E 
Sbjct:     1 MGGQCSSLS-CCRNTSHKTAVLEAPDVDNGESSEITDVPNFREYTLEQLKAATSGFAVEY 59

Query:    61 IVSEHGEKAPNVVYKGKLENQFRIAVKRFNRSAWPDARQFLEEARAVGQLRNRRLANLLG 120
             IVSEHGEKAPNVVYKGKLENQ +IAVKRF R AWPD+RQFLEEAR+VGQLR+ R+ANLLG
Sbjct:    60 IVSEHGEKAPNVVYKGKLENQKKIAVKRFTRMAWPDSRQFLEEARSVGQLRSERMANLLG 119

Query:   121 CCCEGDERLLVAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYH 180
             CCCEGDERLLVAE+MPN+TLAKHLFHWETQPMKW MRLRV L++A+ALEYCTSK R LYH
Sbjct:   120 CCCEGDERLLVAEFMPNETLAKHLFHWETQPMKWTMRLRVVLYLAQALEYCTSKGRTLYH 179

Query:   181 DLNAYRIVFDDDVNPRLSCFGLMKNSRDGRSYSTNLAFTPPEYLRTGRVTPESVMYSFGT 240
             DLNAYR++FD++ NPRLS FGLMKNSRDG+SYSTNLAFTPPEYLRTGR+TPESV+YSFGT
Sbjct:   180 DLNAYRVLFDEECNPRLSTFGLMKNSRDGKSYSTNLAFTPPEYLRTGRITPESVIYSFGT 239

Query:   241 LLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLASRCLQYEPRER 300
             LLLDLLSGKHIPPSHALDLIRDRN+QTLTDSCL+GQFS  +GTELVRLASRCLQYE RER
Sbjct:   240 LLLDLLSGKHIPPSHALDLIRDRNLQTLTDSCLDGQFSDSDGTELVRLASRCLQYEARER 299

Query:   301 PNPRSLVTALVTLQKDTEL 319
             PN +SLVTAL  LQK+TE+
Sbjct:   300 PNTKSLVTALTPLQKETEV 318

GO:0004672 "protein kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM;IDA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0016020 "membrane" evidence=IDA

GO:0009742 "brassinosteroid mediated signaling pathway" evidence=IMP

GO:0009506 "plasmodesma" evidence=IDA

TAIR|locus:2198160 BSK4 "brassinosteroid-signaling kinase 4" [Arabidopsis thaliana (taxid:3702)]

 Score = 1258 (447.9 bits), Expect = 3.6e-128, P = 3.6e-128
 Identities = 237/319 (74%), Positives = 276/319 (86%)

Query:     1 MGCECSKLSACCSGSEYGEAAPEAQDVENEEKPGVDNVPVFCEYSIETLRTATSGFAMEN 60
             MG + SK+  CCS   +   A EA DVEN+E   V+ V  F EYS+E L+ ATS FA+EN
Sbjct:     1 MGGQSSKIGTCCS---HKTTALEAPDVENKENGEVNGVHSFREYSLEQLKIATSCFALEN 57

Query:    61 IVSEHGEKAPNVVYKGKLENQFRIAVKRFNRSAWPDARQFLEEARAVGQLRNRRLANLLG 120
             +VSEHGE APNVVY+GKLEN  +IA+KRF+ +AWPD RQFLEEAR VGQLR++R+ANLLG
Sbjct:    58 VVSEHGETAPNVVYQGKLENHMKIAIKRFSGTAWPDPRQFLEEARLVGQLRSKRMANLLG 117

Query:   121 CCCEGDERLLVAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYH 180
              CCEG ERLLVAE+MPN+TLAKHLFHW+T+PMKWAMRLRVAL+I+EALEYC++    LYH
Sbjct:   118 YCCEGGERLLVAEFMPNETLAKHLFHWDTEPMKWAMRLRVALYISEALEYCSNNGHTLYH 177

Query:   181 DLNAYRIVFDDDVNPRLSCFGLMKNSRDGRSYSTNLAFTPPEYLRTGRVTPESVMYSFGT 240
             DLNAYR++FD++ NPRLS FGLMKNSRDG+SYSTNLAFTPPEYLRTGR+T ESV+YSFGT
Sbjct:   178 DLNAYRVLFDEECNPRLSTFGLMKNSRDGKSYSTNLAFTPPEYLRTGRITAESVIYSFGT 237

Query:   241 LLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLASRCLQYEPRER 300
             LLLDLL+GKHIPPSHALDLIRDRN+QTLTDSCLEGQFS  +GTELVRL S CLQYE RER
Sbjct:   238 LLLDLLTGKHIPPSHALDLIRDRNLQTLTDSCLEGQFSDSDGTELVRLTSCCLQYEARER 297

Query:   301 PNPRSLVTALVTLQKDTEL 319
             PN +SLVTAL++LQKDTE+
Sbjct:   298 PNIKSLVTALISLQKDTEV 316

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM;IDA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

TAIR|locus:2154538 BSK5 "brassinosteroid-signaling kinase 5" [Arabidopsis thaliana (taxid:3702)]

 Score = 1230 (438.0 bits), Expect = 3.4e-125, P = 3.4e-125
 Identities = 233/319 (73%), Positives = 271/319 (84%)

Query:     1 MGCECSKLSACCSGSEYGEAAPEAQDVENEEKPGVDNVPVFCEYSIETLRTATSGFAMEN 60
             MG  CSKLS C   +       EA D++N    G D++P F E+S + LR AT GF+ ++
Sbjct:     1 MGPRCSKLSLCWWPTHLKSTHNEASDLDN----GTDDLPSFTEFSFDQLRAATCGFSTDS 56

Query:    61 IVSEHGEKAPNVVYKGKLENQFRIAVKRFNRSAWPDARQFLEEARAVGQLRNRRLANLLG 120
             IVSEHG KAPNVVYKG+LE+   IAVKRFNRSAWPD RQFLEEA+AVGQLRN RLANL+G
Sbjct:    57 IVSEHGVKAPNVVYKGRLEDDRWIAVKRFNRSAWPDTRQFLEEAKAVGQLRNERLANLIG 116

Query:   121 CCCEGDERLLVAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYH 180
              CCEGDERLLVAE+MP +TL+KHLFHW++QPMKW+MRLRVAL++A+ALEYC+SK RALYH
Sbjct:   117 FCCEGDERLLVAEFMPFETLSKHLFHWDSQPMKWSMRLRVALYLAQALEYCSSKGRALYH 176

Query:   181 DLNAYRIVFDDDVNPRLSCFGLMKNSRDGRSYSTNLAFTPPEYLRTGRVTPESVMYSFGT 240
             DLNAYRI+FD D NPRLSCFGLMKNSRDG+SYSTNLAFTPPEYLRTGRV PESV+YSFGT
Sbjct:   177 DLNAYRILFDQDGNPRLSCFGLMKNSRDGKSYSTNLAFTPPEYLRTGRVIPESVVYSFGT 236

Query:   241 LLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLASRCLQYEPRER 300
             LLLDLLSGKHIPPSHALDLIR +N   L DSCL+G FS+D+GT+LVRLASRCLQYE RER
Sbjct:   237 LLLDLLSGKHIPPSHALDLIRGKNFLMLMDSCLDGHFSNDDGTDLVRLASRCLQYEARER 296

Query:   301 PNPRSLVTALVTLQKDTEL 319
             PN +SLV++L  LQK+T++
Sbjct:   297 PNVKSLVSSLAPLQKETDI 315

GO:0004672 "protein kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM;IDA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0009506 "plasmodesma" evidence=IDA

TAIR|locus:2084475 BSK6 "brassinosteroid-signaling kinase 6" [Arabidopsis thaliana (taxid:3702)]

 Score = 1182 (421.1 bits), Expect = 4.1e-120, P = 4.1e-120
 Identities = 225/320 (70%), Positives = 269/320 (84%)

Query:     1 MGCECSKLSACCSGSEYGEAAP-EAQDVENEEKPGVDNVPVFCEYSIETLRTATSGFAME 59
             MG  CSK S C   S +  A+  E+ D+EN  K      P F E+ +E L++AT GF+ +
Sbjct:     1 MGARCSKFSFCLFPSHFKSASVLESPDIENGGKVW----PTFKEFKLEQLKSATGGFSSD 56

Query:    60 NIVSEHGEKAPNVVYKGKLENQFRIAVKRFNRSAWPDARQFLEEARAVGQLRNRRLANLL 119
             NIVSEHGEKAPNVVY+G+L++   IAVKRFNR AW D RQFL+EA+AVG LR+ RLANL+
Sbjct:    57 NIVSEHGEKAPNVVYRGRLDDGRLIAVKRFNRLAWADHRQFLDEAKAVGSLRSDRLANLI 116

Query:   120 GCCCEGDERLLVAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALY 179
             GCC EG+ERLLVAE+MP++TLAKHLFHWE  PMKWAMRLRVAL +A+ALEYC++K RALY
Sbjct:   117 GCCFEGEERLLVAEFMPHETLAKHLFHWENNPMKWAMRLRVALCLAQALEYCSNKGRALY 176

Query:   180 HDLNAYRIVFDDDVNPRLSCFGLMKNSRDGRSYSTNLAFTPPEYLRTGRVTPESVMYSFG 239
             HDLNAYR++FD D NPRLSCFGLMKNSRDG+SYSTNLAFTPPEYLRTGRVTPESV++SFG
Sbjct:   177 HDLNAYRVLFDKDGNPRLSCFGLMKNSRDGKSYSTNLAFTPPEYLRTGRVTPESVVFSFG 236

Query:   240 TLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLASRCLQYEPRE 299
             T+LLDL+SGKHIPPSHALDLIR +N   L DS LEG FS+++GTELVRLA+RCLQYE RE
Sbjct:   237 TVLLDLMSGKHIPPSHALDLIRGKNCAMLMDSALEGHFSNEDGTELVRLATRCLQYEARE 296

Query:   300 RPNPRSLVTALVTLQKDTEL 319
             RPN +SLVT+LVTLQK++++
Sbjct:   297 RPNVKSLVTSLVTLQKESDV 316

GO:0004672 "protein kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM;IDA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

TAIR|locus:2122058 BSK1 "brassinosteroid-signaling kinase 1" [Arabidopsis thaliana (taxid:3702)]

 Score = 1060 (378.2 bits), Expect = 3.5e-107, P = 3.5e-107
 Identities = 198/292 (67%), Positives = 240/292 (82%)

Query:    34 GVDNVPVFCEYSIETLRTATSGFAMENIVSEHGEKAPNVVYKGKLENQFRIAVKRFNRSA 93
             G   +P F E+S   L+ AT+ F+ +NIVSE GEKAPN+VYKG+L+N+  IAVK+F + A
Sbjct:    51 GGGGIPSFSEFSFADLKAATNNFSSDNIVSESGEKAPNLVYKGRLQNRRWIAVKKFTKMA 110

Query:    94 WPDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAEYMPNDTLAKHLFHWETQPMK 153
             WP+ +QF EEA  VG+LR+ RLANL+G CC+GDERLLVAE+MPNDTLAKHLFHWE Q ++
Sbjct:   111 WPEPKQFAEEAWGVGKLRHNRLANLIGYCCDGDERLLVAEFMPNDTLAKHLFHWENQTIE 170

Query:   154 WAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDGRSYS 213
             WAMRLRV  +IAEAL+YC+++ R LYHDLNAYR++FD+D +PRLSCFGLMKNSRDG+SYS
Sbjct:   171 WAMRLRVGYYIAEALDYCSTEGRPLYHDLNAYRVLFDEDGDPRLSCFGLMKNSRDGKSYS 230

Query:   214 TNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCL 273
             TNLA+TPPEYLR GRVTPESV YSFGT+LLDLLSGKHIPPSHALD+IR +NI  L DS L
Sbjct:   231 TNLAYTPPEYLRNGRVTPESVTYSFGTVLLDLLSGKHIPPSHALDMIRGKNIILLMDSHL 290

Query:   274 EGQFSSDEGTELVRLASRCLQYEPRERPNPRSLVTALVTLQ--KDTELYLSL 323
             EG+FS++E T +V LAS+CLQYEPRERPN + LV  L  LQ   D   Y+ L
Sbjct:   291 EGKFSTEEATVVVELASQCLQYEPRERPNTKDLVATLAPLQTKSDVPSYVML 342

GO:0004672 "protein kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM;IDA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0005773 "vacuole" evidence=IDA

GO:0016020 "membrane" evidence=IDA

GO:0005515 "protein binding" evidence=IPI

GO:0009742 "brassinosteroid mediated signaling pathway" evidence=IDA

GO:0009737 "response to abscisic acid stimulus" evidence=IDA

GO:0009506 "plasmodesma" evidence=IDA

GO:0006499 "N-terminal protein myristoylation" evidence=RCA

TAIR|locus:2142315 BSK2 "brassinosteroid-signaling kinase 2" [Arabidopsis thaliana (taxid:3702)]

 Score = 1018 (363.4 bits), Expect = 9.8e-103, P = 9.8e-103
 Identities = 193/320 (60%), Positives = 251/320 (78%)

Query:     1 MGCECSKLSACCSGSEYGEAAPEAQDVENEEKPGVDN-VPVFCEYSIETLRTATSGFAME 59
             MGC  SK +   S  +   +AP   +  N ++  VD  +  F E+ +  LR AT+GF+  
Sbjct:     1 MGCLHSKTANLPSSDD--PSAPNKPESVNGDQ--VDQEIQNFKEFELNELRKATNGFSPS 56

Query:    60 NIVSEHGEKAPNVVYKGKLENQFRIAVKRFNRSAWPDARQFLEEARAVGQLRNRRLANLL 119
              IVSE GEKAPNVVY+GKLE    +A+KRF+R +WPDA+QF+ EA  VG+LRN+R+ +L+
Sbjct:    57 CIVSEGGEKAPNVVYRGKLEGNHLVAIKRFSRQSWPDAQQFVVEATGVGKLRNKRIVSLI 116

Query:   120 GCCCEGDERLLVAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALY 179
             GCC EGDERLLVAEYMPNDTL+KHLFHWE QP+ W MR+R+A +IAEAL+YC  + R +Y
Sbjct:   117 GCCAEGDERLLVAEYMPNDTLSKHLFHWEKQPLPWDMRVRIADYIAEALDYCNIENRKIY 176

Query:   180 HDLNAYRIVFDDDVNPRLSCFGLMKNSRDGRSYSTNLAFTPPEYLRTGRVTPESVMYSFG 239
             HDLNAYRI+FD++ +PRLS FGLMKNSRDG+SYSTNLA+TPPE+LRTGRV PESV++S+G
Sbjct:   177 HDLNAYRILFDEEGDPRLSTFGLMKNSRDGKSYSTNLAYTPPEFLRTGRVIPESVIFSYG 236

Query:   240 TLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLASRCLQYEPRE 299
             T+LLDLLSGKHIPPSHALD+IR +N   L DS LEGQ+++D+ T+LV LAS+CLQ E ++
Sbjct:   237 TILLDLLSGKHIPPSHALDIIRGKNALLLMDSSLEGQYANDDATKLVDLASKCLQSEAKD 296

Query:   300 RPNPRSLVTALVTLQKDTEL 319
             RP+ + L++A+  LQK  E+
Sbjct:   297 RPDTKFLLSAVAPLQKQEEV 316

GO:0004672 "protein kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM;IDA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0009742 "brassinosteroid mediated signaling pathway" evidence=IDA

TAIR|locus:2083499 BSK9 "brassinosteroid-signaling kinase 9" [Arabidopsis thaliana (taxid:3702)]

 Score = 1002 (357.8 bits), Expect = 4.9e-101, P = 4.9e-101
 Identities = 188/293 (64%), Positives = 230/293 (78%)

Query:    28 ENEEKPGVDNVPVFCEYSIETLRTATSGFAMENIVSEHGEKAPNVVYKGKLENQFRIAVK 87
             +N+E+      P F E+S+E LR AT GF+ +NIVSEH E+ PN+VYKG+L +  +IAVK
Sbjct:    13 DNKEEDEGSTCPNFLEFSLEQLRVATDGFSADNIVSEHNERVPNIVYKGQLNDGRKIAVK 72

Query:    88 RFNRSAWPDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAEYMPNDTLAKHLFHW 147
             RF R +WPD+ +F+EEA+AVG+ R+  +ANL+GCC EG ERLLVAEYMPN+TLAKHLFHW
Sbjct:    73 RFQRLSWPDSLEFIEEAQAVGRCRSEHMANLIGCCSEGHERLLVAEYMPNETLAKHLFHW 132

Query:   148 ETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSR 207
             E +PMKW MRLRVALH A ALEYC      LYHDLN YRI+FD   NPRLSCFGLMK SR
Sbjct:   133 EKRPMKWEMRLRVALHTATALEYCNDWGIDLYHDLNTYRILFDKVGNPRLSCFGLMKCSR 192

Query:   208 DGRSYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQT 267
             +G+SYSTNLAF PPEYLR G V PESV +SFGTLLLDL+SG+HIPP+HALDL R +N   
Sbjct:   193 EGKSYSTNLAFAPPEYLRLGTVIPESVTFSFGTLLLDLMSGRHIPPNHALDLFRGKNYLV 252

Query:   268 LTDSCLEGQFSSDEGTELVRLASRCLQYEPRERPNPRSLVTALVTLQKDTELY 320
             L DS L+GQFS ++ TEL+ LASRCL+ EP ERP+ + L++AL  L+K  EL+
Sbjct:   253 LMDSALDGQFSDEDRTELIHLASRCLRPEPDERPSIKFLMSALSRLEKRAELW 305

GO:0004672 "protein kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

TAIR|locus:2150074 BSK10 "brassinosteroid-signaling kinase 10" [Arabidopsis thaliana (taxid:3702)]

 Score = 968 (345.8 bits), Expect = 2.0e-97, P = 2.0e-97
 Identities = 191/324 (58%), Positives = 232/324 (71%)

Query:     1 MGCECSKLSACCSGSEYGEAAPEAQDVENEEKPGVDN----VP-VFCEYSIETLRTATSG 55
             MGC C K S   S S     +    D+EN  +   D+     P +F E+S+E LR AT G
Sbjct:     1 MGCICFK-SWRRSSSSPSITSTVIDDLENVREYDADDDGGHYPLIFREFSLEQLRIATDG 59

Query:    56 FAMENIVSEHGEKAPNVVYKGKLENQFRIAVKRFNRSAWPDARQFLEEARAVGQLRNRRL 115
             F+  NIVSEH +  PN+VYKGKL +  RIAVKRF R +WPD  +F+ EA+AVG+LR+  +
Sbjct:    60 FSAGNIVSEHNDSVPNIVYKGKLGDGRRIAVKRFQRLSWPDPFEFINEAQAVGRLRSEHM 119

Query:   116 ANLLGCCCEGDERLLVAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKE 175
             ANL+GCCC+ +ERLLVAEYMPN TLAKHLFHWE +PMKW MRL+VALH A ALEYC  K 
Sbjct:   120 ANLIGCCCDDNERLLVAEYMPNGTLAKHLFHWEKRPMKWEMRLKVALHTARALEYCNDKG 179

Query:   176 RALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDGRSYSTNLAFTPPEYLRTGRVTPESVM 235
               LYHDLN YRI+FD    P+LSCFGLMKNS +G+ YSTNLAF PPEYLR G V  ESV 
Sbjct:   180 IDLYHDLNPYRIMFDKTGIPKLSCFGLMKNSHEGKIYSTNLAFAPPEYLRLGTVIAESVT 239

Query:   236 YSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLASRCLQY 295
             +SFGTLLLDL+SG+HIPP+HALDL R +N   L DS L+GQFS ++ TEL+ +ASRC + 
Sbjct:   240 FSFGTLLLDLMSGRHIPPNHALDLFRGKNYLVLMDSALDGQFSDEDRTELIHVASRCFKT 299

Query:   296 EPRERPNPRSLVTALVTLQKDTEL 319
             EP ERP+ + L   L  LQK  +L
Sbjct:   300 EPEERPSIKFLKATLSRLQKRAKL 323

GO:0004672 "protein kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

---

Prediction of Enzyme Commission (EC) Number

EC Number Prediction by Annotation Transfer from SWISS-PROT Entries

Original result of BLAST against SWISS-PROT

ID	Name	Annotated EC number	Identity	Query coverage	Hit coverage	RBH(Q2H)	RBH(H2Q)
Q9FHD7	Y5126_ARATH	2, ., 7, ., 1, 1, ., 1	0.8025	0.9696	0.6550	yes	no

EC Number Prediction by Ezypred Server

Original result from Ezypred Server

Fail to connect to Ezypred Server

EC Number Prediction by EFICAz Software

No EC number assignment, probably not an enzyme!

---

Prediction of Functionally Associated Proteins

Functionally Associated Proteins Detected by STRING

Original result from the STRING server

Your Input: estExt_fgenesh4_pg.C_LG_III1037 hypothetical protein (487 aa) (Populus trichocarpa)

Predicted Functional Partners:

Sorry, there are no predicted associations at the current settings.

---

Conserved Domains and Related Protein Families

Conserved Domains Detected by RPS-BLAST

Original result of RPS-BLAST against CDD database part I

ID	Length	Definition	E-value
Query	329
cd00180	215	cd00180, PKc, Catalytic domain of Protein Kinases	8e-27
smart00221	258	smart00221, STYKc, Protein kinase; unclassified sp	1e-23
smart00219	257	smart00219, TyrKc, Tyrosine kinase, catalytic doma	2e-22
cd00192	262	cd00192, PTKc, Catalytic domain of Protein Tyrosin	2e-21
pfam07714	258	pfam07714, Pkinase_Tyr, Protein tyrosine kinase	5e-21
cd05039	256	cd05039, PTKc_Csk_like, Catalytic domain of C-term	7e-19
pfam00069	260	pfam00069, Pkinase, Protein kinase domain	7e-19
cd05041	251	cd05041, PTKc_Fes_like, Catalytic domain of Fes-li	2e-17
smart00220	254	smart00220, S_TKc, Serine/Threonine protein kinase	6e-16
cd05083	254	cd05083, PTKc_Chk, Catalytic domain of the Protein	2e-15
cd05085	250	cd05085, PTKc_Fer, Catalytic domain of the Protein	2e-14
PLN00113	968	PLN00113, PLN00113, leucine-rich repeat receptor-l	1e-13
cd05084	252	cd05084, PTKc_Fes, Catalytic domain of the Protein	1e-13
cd05049	280	cd05049, PTKc_Trk, Catalytic domain of the Protein	5e-13
cd05148	261	cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro	1e-12
cd05082	256	cd05082, PTKc_Csk, Catalytic domain of the Protein	2e-12
cd05048	283	cd05048, PTKc_Ror, Catalytic Domain of the Protein	2e-12
cd05061	288	cd05061, PTKc_InsR, Catalytic domain of the Protei	3e-12
COG0515	384	COG0515, SPS1, Serine/threonine protein kinase [Ge	3e-12
cd05067	260	cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro	3e-12
cd05038	284	cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai	4e-12
cd05059	256	cd05059, PTKc_Tec_like, Catalytic domain of Tec-li	6e-12
cd05062	277	cd05062, PTKc_IGF-1R, Catalytic domain of the Prot	1e-11
cd05113	256	cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro	1e-11
cd05080	283	cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma	4e-11
cd05078	258	cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat	5e-11
cd05114	256	cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro	6e-11
cd05034	261	cd05034, PTKc_Src_like, Catalytic domain of Src ki	6e-11
cd05093	288	cd05093, PTKc_TrkB, Catalytic domain of the Protei	1e-10
cd05070	260	cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro	1e-10
cd05035	273	cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li	2e-10
cd05069	260	cd05069, PTKc_Yes, Catalytic domain of the Protein	2e-10
cd05094	291	cd05094, PTKc_TrkC, Catalytic domain of the Protei	2e-10
cd05072	261	cd05072, PTKc_Lyn, Catalytic domain of the Protein	2e-10
cd05071	262	cd05071, PTKc_Src, Catalytic domain of the Protein	3e-10
cd05112	256	cd05112, PTKc_Itk, Catalytic domain of the Protein	4e-10
cd05052	263	cd05052, PTKc_Abl, Catalytic domain of the Protein	2e-09
cd05123	250	cd05123, STKc_AGC, Catalytic domain of AGC family	3e-09
cd05033	266	cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec	5e-09
cd05032	277	cd05032, PTKc_InsR_like, Catalytic domain of Insul	7e-09
cd05068	261	cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re	7e-09
cd05122	253	cd05122, PKc_STE, Catalytic domain of STE family P	2e-08
cd08529	256	cd08529, STKc_FA2-like, Catalytic domain of the Pr	2e-08
cd05075	272	cd05075, PTKc_Axl, Catalytic domain of the Protein	3e-08
cd08217	265	cd08217, STKc_Nek2, Catalytic domain of the Protei	3e-08
cd05037	259	cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom	9e-08
cd05097	295	cd05097, PTKc_DDR_like, Catalytic domain of Discoi	1e-07
cd05064	266	cd05064, PTKc_EphR_A10, Catalytic domain of the Pr	1e-07
cd05045	290	cd05045, PTKc_RET, Catalytic domain of the Protein	1e-07
cd05096	304	cd05096, PTKc_DDR1, Catalytic domain of the Protei	1e-07
cd05073	260	cd05073, PTKc_Hck, Catalytic domain of the Protein	2e-07
cd05058	262	cd05058, PTKc_Met_Ron, Catalytic domain of the Pro	4e-07
cd05090	283	cd05090, PTKc_Ror1, Catalytic domain of the Protei	4e-07
cd05050	288	cd05050, PTKc_Musk, Catalytic domain of the Protei	4e-07
cd05063	268	cd05063, PTKc_EphR_A2, Catalytic domain of the Pro	1e-06
cd05044	269	cd05044, PTKc_c-ros, Catalytic domain of the Prote	1e-06
cd05077	262	cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) do	1e-06
cd05100	334	cd05100, PTKc_FGFR3, Catalytic domain of the Prote	1e-06
cd05060	257	cd05060, PTKc_Syk_like, Catalytic domain of Spleen	2e-06
cd05076	274	cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) do	2e-06
cd05092	280	cd05092, PTKc_TrkA, Catalytic domain of the Protei	3e-06
cd05040	257	cd05040, PTKc_Ack_like, Catalytic domain of the Pr	3e-06
cd06610	267	cd06610, STKc_OSR1_SPAK, Catalytic domain of the P	4e-06
cd05036	277	cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro	6e-06
cd05056	270	cd05056, PTKc_FAK, Catalytic domain of the Protein	6e-06
cd05110	303	cd05110, PTKc_HER4, Catalytic domain of the Protei	2e-05
cd05046	275	cd05046, PTK_CCK4, Pseudokinase domain of the Prot	2e-05
cd06642	277	cd06642, STKc_STK25-YSK1, Catalytic domain of the	3e-05
cd05065	269	cd05065, PTKc_EphR_B, Catalytic domain of the Prot	3e-05
cd06655	296	cd06655, STKc_PAK2, Catalytic domain of the Protei	5e-05
cd05095	296	cd05095, PTKc_DDR2, Catalytic domain of the Protei	6e-05
cd05630	285	cd05630, STKc_GRK6, Catalytic domain of the Protei	7e-05
cd05101	304	cd05101, PTKc_FGFR2, Catalytic domain of the Prote	8e-05
cd05098	307	cd05098, PTKc_FGFR1, Catalytic domain of the Prote	9e-05
cd05057	279	cd05057, PTKc_EGFR_like, Catalytic domain of Epide	1e-04
cd05066	267	cd05066, PTKc_EphR_A, Catalytic domain of the Prot	1e-04
cd05081	284	cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2)	1e-04
cd05099	314	cd05099, PTKc_FGFR4, Catalytic domain of the Prote	1e-04
cd06620	284	cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of	2e-04
cd06654	296	cd06654, STKc_PAK1, Catalytic domain of the Protei	2e-04
cd06656	297	cd06656, STKc_PAK3, Catalytic domain of the Protei	3e-04
cd07840	287	cd07840, STKc_CDK9_like, Catalytic domain of Cycli	3e-04
cd05079	284	cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma	5e-04
cd05576	237	cd05576, STKc_RPK118_like, Catalytic domain of the	5e-04
cd06624	268	cd06624, STKc_ASK, Catalytic domain of the Protein	6e-04
cd05055	302	cd05055, PTKc_PDGFR, Catalytic domain of the Prote	7e-04
cd05109	279	cd05109, PTKc_HER2, Catalytic domain of the Protei	7e-04
cd05577	277	cd05577, STKc_GRK, Catalytic domain of the Protein	8e-04
cd05042	269	cd05042, PTKc_Aatyk, Catalytic domain of the Prote	8e-04
cd05091	283	cd05091, PTKc_Ror2, Catalytic domain of the Protei	0.001
cd06647	293	cd06647, STKc_PAK_I, Catalytic domain of the Prote	0.001
cd06612	256	cd06612, STKc_MST1_2, Catalytic domain of the Prot	0.001
cd05053	293	cd05053, PTKc_FGFR, Catalytic domain of the Protei	0.001
cd05612	291	cd05612, STKc_PRKX_like, Catalytic domain of PRKX-	0.002
cd05583	288	cd05583, STKc_MSK_N, N-terminal catalytic domain o	0.002
cd05590	320	cd05590, STKc_nPKC_eta, Catalytic domain of the Pr	0.003
cd05118	283	cd05118, STKc_CMGC, Catalytic domain of CMGC famil	0.004
cd05575	323	cd05575, STKc_SGK, Catalytic domain of the Protein	0.004

>gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases

 Score =  104 bits (262), Expect = 8e-27
 Identities = 55/245 (22%), Positives = 91/245 (37%), Gaps = 49/245 (20%)

Query: 72  VVYKGK-LENQFRIAVKRFNRSAWPDARQ-FLEEARAVGQLRNRRLANLLGCCCEGDERL 129
            VY  +  +   ++A+K   +       +  L E   + +L +  +  L G   + +   
Sbjct: 8   TVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVFEDENHLY 67

Query: 130 LVAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYH-DLNAYRI- 187
           LV EY    +L   L   E   +     LR+ L I E LEY  S    + H DL    I 
Sbjct: 68  LVMEYCEGGSLKDLLKENE-GKLSEDEILRILLQILEGLEYLHSNG--IIHRDLKPENIL 124

Query: 188 VFDDDVNPRLSCFGLMKNSRDGRSYST----NLAFTPPEYLR-TGRVTPESVMYSFGTLL 242
           +  D+   +L+ FGL K     +S         A+  PE L   G  + +S ++S G +L
Sbjct: 125 LDSDNGKVKLADFGLSKLLTSDKSLLKTIVGTPAYMAPEVLLGKGYYSEKSDIWSLGVIL 184

Query: 243 LDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLASRCLQYEPRERPN 302
            +L            DLIR                             + LQ +P +RP+
Sbjct: 185 YEL--------PELKDLIR-----------------------------KMLQKDPEKRPS 207

Query: 303 PRSLV 307
            + ++
Sbjct: 208 AKEIL 212

Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215

>gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity

 Score = 97.2 bits (243), Expect = 1e-23
 Identities = 71/260 (27%), Positives = 114/260 (43%), Gaps = 36/260 (13%)

Query: 72  VVYKGKL-----ENQFRIAVKRFNRSAWPDARQ-FLEEARAVGQLRNRRLANLLGCCCEG 125
            VYKG L       +  +AVK     A     + FL EAR + +L +  +  LLG C E 
Sbjct: 14  EVYKGTLKGKGDGKEVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPNIVKLLGVCTEE 73

Query: 126 DERLLVAEYMPN----DTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYH- 180
           +  ++V EYMP     D L K+      + +  +  L  AL IA  +EY  SK     H 
Sbjct: 74  EPLMIVMEYMPGGDLLDYLRKN----RPKELSLSDLLSFALQIARGMEYLESKN--FIHR 127

Query: 181 DLNAYRIVFDDDVNPRLSCFGLMKNSRDGRSYSTNLA-----FTPPEYLRTGRVTPESVM 235
           DL A   +  +++  ++S FGL ++  D   Y          +  PE L+ G+ T +S +
Sbjct: 128 DLAARNCLVGENLVVKISDFGLSRDLYDDDYYKVKGGKLPIRWMAPESLKEGKFTSKSDV 187

Query: 236 YSFGTLLLDLLS-GK----HIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLAS 290
           +SFG LL ++ + G+     +  +  L+ ++         +C           EL +L  
Sbjct: 188 WSFGVLLWEIFTLGEEPYPGMSNAEVLEYLKKGYRLPKPPNCPP---------ELYKLML 238

Query: 291 RCLQYEPRERPNPRSLVTAL 310
           +C   +P +RP    LV  L
Sbjct: 239 QCWAEDPEDRPTFSELVEIL 258

Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258

>gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain

 Score = 93.7 bits (234), Expect = 2e-22
 Identities = 70/260 (26%), Positives = 111/260 (42%), Gaps = 37/260 (14%)

Query: 72  VVYKGKLE-----NQFRIAVKRFNRSAWPDARQ-FLEEARAVGQLRNRRLANLLGCCCEG 125
            VYKGKL+      +  +AVK     A     + FL EAR + +L +  +  LLG C E 
Sbjct: 14  EVYKGKLKGKGGKKKVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPNVVKLLGVCTEE 73

Query: 126 DERLLVAEYMPN----DTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYH- 180
           +   +V EYM        L K+        +  +  L  AL IA  +EY  SK     H 
Sbjct: 74  EPLYIVMEYMEGGDLLSYLRKN-----RPKLSLSDLLSFALQIARGMEYLESKN--FIHR 126

Query: 181 DLNAYRIVFDDDVNPRLSCFGLMKNSRDGRSYSTNLA-----FTPPEYLRTGRVTPESVM 235
           DL A   +  +++  ++S FGL ++  D   Y          +  PE L+ G+ T +S +
Sbjct: 127 DLAARNCLVGENLVVKISDFGLSRDLYDDDYYRKRGGKLPIRWMAPESLKEGKFTSKSDV 186

Query: 236 YSFGTLLLDLLS-GK----HIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLAS 290
           +SFG LL ++ + G+     +     L+ +++        +C           EL  L  
Sbjct: 187 WSFGVLLWEIFTLGEQPYPGMSNEEVLEYLKNGYRLPQPPNCPP---------ELYDLML 237

Query: 291 RCLQYEPRERPNPRSLVTAL 310
           +C   +P +RP    LV  L
Sbjct: 238 QCWAEDPEDRPTFSELVEIL 257

Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257

>gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases

 Score = 91.1 bits (227), Expect = 2e-21
 Identities = 74/262 (28%), Positives = 113/262 (43%), Gaps = 33/262 (12%)

Query: 72  VVYKGKL----ENQFRIAVKRFNRSAWPDAR-QFLEEARAVGQLRNRRLANLLGCCCEGD 126
            VYKGKL         +AVK     A  + R  FL+EAR + +L +  +  LLG C E +
Sbjct: 10  EVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRLLGVCTEEE 69

Query: 127 ERLLVAEYMPNDTLAKHL-------FHWETQPMKWAMRLRVALHIAEALEYCTSKERALY 179
              LV EYM    L  +L          E   +     L  A+ IA+ +EY  SK + ++
Sbjct: 70  PLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASK-KFVH 128

Query: 180 HDLNAYRIVFDDDVNPRLSCFGLMKNSRDGRSYSTN------LAFTPPEYLRTGRVTPES 233
            DL A   +  +D+  ++S FGL ++  D   Y         + +  PE L+ G  T +S
Sbjct: 129 RDLAARNCLVGEDLVVKISDFGLSRDVYDDDYYRKKTGGKLPIRWMAPESLKDGIFTSKS 188

Query: 234 VMYSFGTLLLDLLS-GKH----IPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRL 288
            ++SFG LL ++ + G      +     L+ +R        + C +         EL  L
Sbjct: 189 DVWSFGVLLWEIFTLGATPYPGLSNEEVLEYLRKGYRLPKPEYCPD---------ELYEL 239

Query: 289 ASRCLQYEPRERPNPRSLVTAL 310
              C Q +P +RP    LV  L
Sbjct: 240 MLSCWQLDPEDRPTFSELVERL 261

Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262

>gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase

 Score = 90.3 bits (225), Expect = 5e-21
 Identities = 73/257 (28%), Positives = 116/257 (45%), Gaps = 30/257 (11%)

Query: 72  VVYKGKL-----ENQFRIAVKRFNRSAWPDARQ-FLEEARAVGQLRNRRLANLLGCCCEG 125
            VYKG L       + ++AVK     A  + R+ FLEEA  + +L +  +  LLG C +G
Sbjct: 14  EVYKGTLKGDGEGTETKVAVKTLKEGASEEEREEFLEEASIMKKLSHPNIVRLLGVCTQG 73

Query: 126 DERLLVAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYH-DLNA 184
           +   +V EYMP   L   L     + +     L++AL IA+ +EY  SK     H DL A
Sbjct: 74  EPLYIVTEYMPGGDLLDFL-RKHGEKLTLKDLLQMALQIAKGMEYLESKN--FVHRDLAA 130

Query: 185 YRIVFDDDVNPRLSCFGLMKN-SRDGRSYSTNLAFTP-----PEYLRTGRVTPESVMYSF 238
              +  +++  ++S FGL ++   D           P     PE L+ G+ T +S ++SF
Sbjct: 131 RNCLVTENLVVKISDFGLSRDIYEDDYYRKRGGGKLPIKWMAPESLKDGKFTSKSDVWSF 190

Query: 239 GTLLLDLLSG-----KHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLASRCL 293
           G LL ++ +        +     L+L+ D       ++C +         EL  L  +C 
Sbjct: 191 GVLLWEIFTLGEQPYPGMSNEEVLELLEDGYRLPRPENCPD---------ELYELMLQCW 241

Query: 294 QYEPRERPNPRSLVTAL 310
            Y+P +RP    LV  L
Sbjct: 242 AYDPEDRPTFSELVEDL 258

Length = 258

>gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases

 Score = 84.0 bits (208), Expect = 7e-19
 Identities = 55/181 (30%), Positives = 90/181 (49%), Gaps = 4/181 (2%)

Query: 73  VYKGKLENQFRIAVKRFNRSAWPDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVA 132
           V  G    Q ++AVK     +   A+ FL EA  +  LR+  L  LLG   +G+   +V 
Sbjct: 22  VMLGDYRGQ-KVAVKCLKDDS-TAAQAFLAEASVMTTLRHPNLVQLLGVVLQGNPLYIVT 79

Query: 133 EYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDD 192
           EYM   +L  +L       +  A +L  AL + E +EY   K   ++ DL A  ++  +D
Sbjct: 80  EYMAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLEEKN-FVHRDLAARNVLVSED 138

Query: 193 VNPRLSCFGLMKNSRDGRSYST-NLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHI 251
           +  ++S FGL K +  G+      + +T PE LR  + + +S ++SFG LL ++ S   +
Sbjct: 139 LVAKVSDFGLAKEASQGQDSGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRV 198

Query: 252 P 252
           P
Sbjct: 199 P 199

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256

>gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain

 Score = 84.2 bits (209), Expect = 7e-19
 Identities = 62/247 (25%), Positives = 96/247 (38%), Gaps = 16/247 (6%)

Query: 72  VVYKGKLEN-QFRIAVKRFNRS--AWPDARQFLEEARAVGQLRNRRLANLLGCCCEGDER 128
            VYK K +     +AVK   +        +    E R + +L +  +  L+    + D  
Sbjct: 14  TVYKAKHKGTGKIVAVKILKKRSEKSKKDQTARREIRILRRLSHPNIVRLIDAFEDKDHL 73

Query: 129 LLVAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYH-DLNAYRI 187
            LV EY     L  +L      P+      ++AL I   LEY  S    + H DL    I
Sbjct: 74  YLVMEYCEGGDLFDYLS--RGGPLSEDEAKKIALQILRGLEYLHS--NGIIHRDLKPENI 129

Query: 188 VFDDDVNPRLSCFGLMKNSRDGRSYSTNLAFTP----PEYLRTGR-VTPESVMYSFGTLL 242
           + D++   +++ FGL K      S  T    TP    PE L  G    P+  ++S G +L
Sbjct: 130 LLDENGVVKIADFGLAKKLLKSSSSLTTFVGTPWYMAPEVLLGGNGYGPKVDVWSLGVIL 189

Query: 243 LDLLSGKHIPPSHALD--LIRDRNIQTLTDSCLEGQFSSDEGTELVRLASRCLQYEPRER 300
            +LL+GK       +   L   R I        +    S    E   L  +CL  +P +R
Sbjct: 190 YELLTGKPPFSGENILDQLQLIRRILG-PPLEFDEPKWSSGSEEAKDLIKKCLNKDPSKR 248

Query: 301 PNPRSLV 307
           P    ++
Sbjct: 249 PTAEEIL 255

Length = 260

>gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases

 Score = 80.2 bits (198), Expect = 2e-17
 Identities = 65/239 (27%), Positives = 108/239 (45%), Gaps = 19/239 (7%)

Query: 73  VYKGKLENQFRIAVKRFNRSAWPDARQ-FLEEARAVGQLRNRRLANLLGCCCEGDERLLV 131
           VYKG L+    +AVK    +  PD ++ FL+EA  + Q  +  +  L+G C +     +V
Sbjct: 11  VYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIV 70

Query: 132 AEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDD 191
            E +P  +L   L   + + +     L+++L  A  +EY  SK   ++ DL A   +  +
Sbjct: 71  MELVPGGSLLTFLRKKKNR-LTVKKLLQMSLDAAAGMEYLESKN-CIHRDLAARNCLVGE 128

Query: 192 DVNPRLSCFGLMKNSRDGRSYSTN-------LAFTPPEYLRTGRVTPESVMYSFGTLLLD 244
           +   ++S FG M    +G  Y+ +       + +T PE L  GR T ES ++S+G LL +
Sbjct: 129 NNVLKISDFG-MSREEEGGIYTVSDGLKQIPIKWTAPEALNYGRYTSESDVWSYGILLWE 187

Query: 245 LLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGT--ELVRLASRCLQYEPRERP 301
             S    P           N QT        +  + +    E+ RL  +C  Y+P  RP
Sbjct: 188 TFSLGDTPYPGM------SNQQTRERIESGYRMPAPQLCPEEIYRLMLQCWAYDPENRP 240

Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251

>gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain

 Score = 75.6 bits (187), Expect = 6e-16
 Identities = 51/252 (20%), Positives = 84/252 (33%), Gaps = 34/252 (13%)

Query: 72  VVYKGK-LENQFRIAVKRFNRS-AWPDARQFLEEARAVGQLRNRRLANLLGCCCEGDERL 129
            VY  +  +    +A+K   +     D  + L E + + +L++  +  L     + D+  
Sbjct: 14  KVYLARDKKTGKLVAIKVIKKKKIKKDRERILREIKILKKLKHPNIVRLYDVFEDEDKLY 73

Query: 130 LVAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLN-AYR-- 186
           LV EY     L   L          A        I  ALEY         H     +R  
Sbjct: 74  LVMEYCEGGDLFDLLKKRGRLSEDEA--RFYLRQILSALEYL--------HSKGIVHRDL 123

Query: 187 ----IVFDDDVNPRLSCFGLMKNSRDGRSYSTN---LAFTPPEYLRTGRVTPESVMYSFG 239
               I+ D+D + +L+ FGL +    G   +T      +  PE L          ++S G
Sbjct: 124 KPENILLDEDGHVKLADFGLARQLDPGEKLTTFVGTPEYMAPEVLLGKGYGKAVDIWSLG 183

Query: 240 TLLLDLLSGK-----HIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLASRCLQ 294
            +L +LL+GK               I                  S E  +L+R   + L 
Sbjct: 184 VILYELLTGKPPFPGDDQLLELFKKIGKPKPPFPPPEWD----ISPEAKDLIR---KLLV 236

Query: 295 YEPRERPNPRSL 306
            +P +R      
Sbjct: 237 KDPEKRLTAEEA 248

Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254

>gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase

 Score = 74.6 bits (183), Expect = 2e-15
 Identities = 65/251 (25%), Positives = 115/251 (45%), Gaps = 20/251 (7%)

Query: 66  GEKAPNVVYKGKLENQFRIAVKRFNRSAWPDARQFLEEARAVGQLRNRRLANLLGCCCEG 125
           GE     V +G+   Q ++AVK  N      A+ FLEE   + +L ++ L  LLG     
Sbjct: 15  GEGEFGAVLQGEYTGQ-KVAVK--NIKCDVTAQAFLEETAVMTKLHHKNLVRLLGVILH- 70

Query: 126 DERLLVAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAY 185
           +   +V E M    L   L       +     L+ +L +AE +EY  SK + ++ DL A 
Sbjct: 71  NGLYIVMELMSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLESK-KLVHRDLAAR 129

Query: 186 RIVFDDDVNPRLSCFGLMK-NSRDGRSYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLD 244
            I+  +D   ++S FGL +  S    +    + +T PE L+  + + +S ++S+G LL +
Sbjct: 130 NILVSEDGVAKVSDFGLARVGSMGVDNSKLPVKWTAPEALKHKKFSSKSDVWSYGVLLWE 189

Query: 245 LLS-GKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTE----LVRLASRCLQYEPRE 299
           + S G+   P  +L  +++         C+E  +  +        +  L + C + EP++
Sbjct: 190 VFSYGRAPYPKMSLKEVKE---------CVEKGYRMEPPEGCPADVYVLMTSCWETEPKK 240

Query: 300 RPNPRSLVTAL 310
           RP+   L   L
Sbjct: 241 RPSFHKLREKL 251

Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254

>gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer

 Score = 71.6 bits (175), Expect = 2e-14
 Identities = 63/236 (26%), Positives = 107/236 (45%), Gaps = 14/236 (5%)

Query: 73  VYKGKLENQFRIAVKRFNRSAWPDAR-QFLEEARAVGQLRNRRLANLLGCCCEGDERLLV 131
           V+KG L+++  +AVK        + + +FL EAR + Q  +  +  L+G C +     +V
Sbjct: 11  VFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIV 70

Query: 132 AEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDD 191
            E +P       L   +   +K    ++ AL  A  + Y  SK   ++ DL A   +  +
Sbjct: 71  MELVPGGDFLSFL-RKKKDELKTKQLVKFALDAAAGMAYLESKN-CIHRDLAARNCLVGE 128

Query: 192 DVNPRLSCFGLMKNSRDGRSYSTNLA-----FTPPEYLRTGRVTPESVMYSFGTLLLDLL 246
           +   ++S FG+ +   DG   S+ L      +T PE L  GR + ES ++S+G LL +  
Sbjct: 129 NNVLKISDFGMSRQEDDGIYSSSGLKQIPIKWTAPEALNYGRYSSESDVWSYGILLWETF 188

Query: 247 SGKHIP-PSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLASRCLQYEPRERP 301
           S    P P       R++  +    SC   Q   D   ++ ++  RC  Y+P  RP
Sbjct: 189 SLGVCPYPGMTNQQAREQVEKGYRMSC--PQKCPD---DVYKVMQRCWDYKPENRP 239

Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250

>gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional

 Score = 71.4 bits (175), Expect = 1e-13
 Identities = 69/292 (23%), Positives = 124/292 (42%), Gaps = 42/292 (14%)

Query: 48  TLRTATSGFAMENIVSEHGEKAPNVVYKGK-LENQFRIAVKRFNRSAWPDARQFLEEARA 106
           T+    S    EN++S   + A    YKGK ++N  +  VK  N      + +  +    
Sbjct: 684 TINDILSSLKEENVISRGKKGAS---YKGKSIKNGMQFVVKEINDVNSIPSSEIAD---- 736

Query: 107 VGQLRNRRLANLLGCCCEGDERLLVAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAE 166
           +G+L++  +  L+G C       L+ EY+    L++ L     + + W  R ++A+ IA+
Sbjct: 737 MGKLQHPNIVKLIGLCRSEKGAYLIHEYIEGKNLSEVL-----RNLSWERRRKIAIGIAK 791

Query: 167 ALEY--CTSKERALYHDLNAYRIVFDDDVNPRLSCFGL-----MKNSRDGRSYSTNLAFT 219
           AL +  C      +  +L+  +I+ D    P L    L             S     A+ 
Sbjct: 792 ALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHL-RLSLPGLLCTDTKCFISS-----AYV 845

Query: 220 PPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHA--------LDLIR----DRNIQT 267
            PE   T  +T +S +Y FG +L++LL+GK   P+ A        ++  R    D ++  
Sbjct: 846 APETRETKDITEKSDIYGFGLILIELLTGKS--PADAEFGVHGSIVEWARYCYSDCHLDM 903

Query: 268 LTDSCLEGQFSSD--EGTELVRLASRCLQYEPRERPNPRSLVTALVTLQKDT 317
             D  + G  S +  E  E++ LA  C   +P  RP    ++  L +  + +
Sbjct: 904 WIDPSIRGDVSVNQNEIVEVMNLALHCTATDPTARPCANDVLKTLESASRSS 955

Length = 968

>gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes

 Score = 69.3 bits (169), Expect = 1e-13
 Identities = 65/250 (26%), Positives = 112/250 (44%), Gaps = 18/250 (7%)

Query: 73  VYKGKLE-NQFRIAVKRFNRSAWPDAR-QFLEEARAVGQLRNRRLANLLGCCCEGDERLL 130
           V+ G+L  +   +AVK    +  PD + +FL+EAR + Q  +  +  L+G C +     +
Sbjct: 11  VFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYI 70

Query: 131 VAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFD 190
           V E +        L   E   +K    +++  + A  +EY  SK   ++ DL A   +  
Sbjct: 71  VMELVQGGDFLTFL-RTEGPRLKVKELIQMVENAAAGMEYLESKH-CIHRDLAARNCLVT 128

Query: 191 DDVNPRLSCFGLMKNSRDGRSYSTN------LAFTPPEYLRTGRVTPESVMYSFGTLLLD 244
           +    ++S FG+ +   DG   ST       + +T PE L  GR + ES ++SFG LL +
Sbjct: 129 EKNVLKISDFGMSREEEDGVYASTGGMKQIPVKWTAPEALNYGRYSSESDVWSFGILLWE 188

Query: 245 LLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGT--ELVRLASRCLQYEPRERPN 302
             S   +P ++        N QT        +    E     + RL  RC +Y+P +RP+
Sbjct: 189 AFSLGAVPYANL------SNQQTREAIEQGVRLPCPELCPDAVYRLMERCWEYDPGQRPS 242

Query: 303 PRSLVTALVT 312
             ++   L +
Sbjct: 243 FSTVHQELQS 252

Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252

>gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases

 Score = 67.9 bits (166), Expect = 5e-13
 Identities = 56/220 (25%), Positives = 97/220 (44%), Gaps = 37/220 (16%)

Query: 61  IVSEHGEKAPNVVYKGKLEN------QFRIAVKRFNRSAWPDARQ-FLEEARAVGQLRNR 113
           +  E GE A   V+ G+  +      +  +AVK    +A  DAR+ F  EA  +   ++ 
Sbjct: 9   LKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHE 68

Query: 114 RLANLLGCCCEGDERLLVAEYMPNDTLAKHL------------FHWETQPMKWAMRLRVA 161
            +    G C EGD  ++V EYM +  L K L                   +  +  L++A
Sbjct: 69  NIVKFYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIA 128

Query: 162 LHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDGRSYSTN------ 215
           + IA  + Y  S +  ++ DL     +   D+  ++  FG+   SRD   Y+T+      
Sbjct: 129 VQIASGMVYLAS-QHFVHRDLATRNCLVGYDLVVKIGDFGM---SRD--VYTTDYYRVGG 182

Query: 216 -----LAFTPPEYLRTGRVTPESVMYSFGTLLLDLLS-GK 249
                + + PPE +   + T ES ++SFG +L ++ + GK
Sbjct: 183 HTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGK 222

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280

>gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk

 Score = 66.7 bits (163), Expect = 1e-12
 Identities = 46/184 (25%), Positives = 92/184 (50%), Gaps = 5/184 (2%)

Query: 73  VYKGKLENQFRIAVKRFNRSAWPDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVA 132
           V++G  +N+ R+A+K          + F +E +A+ +LR++ L +L   C  G+   ++ 
Sbjct: 22  VWEGLWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISLFAVCSVGEPVYIIT 81

Query: 133 EYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDD 192
           E M   +L   L   E Q +  A  + +A  +AE + Y   +  +++ DL A  I+  +D
Sbjct: 82  ELMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLEEQ-NSIHRDLAARNILVGED 140

Query: 193 VNPRLSCFGLMKNSRDG--RSYSTNLAF--TPPEYLRTGRVTPESVMYSFGTLLLDLLSG 248
           +  +++ FGL +  ++    S    + +  T PE    G  + +S ++SFG LL ++ + 
Sbjct: 141 LVCKVADFGLARLIKEDVYLSSDKKIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTY 200

Query: 249 KHIP 252
             +P
Sbjct: 201 GQVP 204

Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261

>gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase

 Score = 65.8 bits (160), Expect = 2e-12
 Identities = 54/181 (29%), Positives = 88/181 (48%), Gaps = 10/181 (5%)

Query: 74  YKGKLENQFRIAVKRFNRSAWPDARQFLEEARAVGQLRNRRLANLLGCCCEGDERL-LVA 132
           Y+G      ++AVK     A   A+ FL EA  + QLR+  L  LLG   E    L +V 
Sbjct: 27  YRGN-----KVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVT 79

Query: 133 EYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDD 192
           EYM   +L  +L       +     L+ +L + EA+EY  +    ++ DL A  ++  +D
Sbjct: 80  EYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEANN-FVHRDLAARNVLVSED 138

Query: 193 VNPRLSCFGLMKNSRDGRSYST-NLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHI 251
              ++S FGL K +   +      + +T PE LR  + + +S ++SFG LL ++ S   +
Sbjct: 139 NVAKVSDFGLTKEASSTQDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRV 198

Query: 252 P 252
           P
Sbjct: 199 P 199

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256

>gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors

 Score = 65.9 bits (161), Expect = 2e-12
 Identities = 69/297 (23%), Positives = 120/297 (40%), Gaps = 54/297 (18%)

Query: 56  FAMENI--VSEHGEKAPNVVYKGKL------ENQFRIAVKRFNRSAWPDARQ-FLEEARA 106
             +  +  + E GE A   VYKG+L       +   +A+K    +A P  +Q F +EA  
Sbjct: 2   IPLSAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAEL 61

Query: 107 VGQLRNRRLANLLGCCCEGDERLLVAEYMPNDTLAKHLF-------------HWETQPMK 153
           +  L++  +  LLG C +     ++ EY+ +  L + L                  +   
Sbjct: 62  MSDLQHPNIVCLLGVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSL 121

Query: 154 WAMR-LRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDGRSY 212
                L +A+ IA  +EY +S    ++ DL A   +  + +  ++S FGL   SRD   Y
Sbjct: 122 DCSDFLHIAIQIAAGMEYLSSHH-FVHRDLAARNCLVGEGLTVKISDFGL---SRDI--Y 175

Query: 213 STN-----------LAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIP-----PSHA 256
           S +           + + PPE +  G+ T ES ++SFG +L ++ S    P         
Sbjct: 176 SADYYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYGFSNQEV 235

Query: 257 LDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLASRCLQYEPRERPNPRSLVTALVTL 313
           +++IR R +    + C            +  L   C    P  RP  + + T L + 
Sbjct: 236 IEMIRSRQLLPCPEDC---------PARVYALMIECWNEIPARRPRFKDIHTRLRSW 283

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283

>gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor

 Score = 65.8 bits (160), Expect = 3e-12
 Identities = 71/277 (25%), Positives = 114/277 (41%), Gaps = 36/277 (12%)

Query: 60  NIVSEHGEKAPNVVYKG------KLENQFRIAVKRFNRSAWPDAR-QFLEEARAVGQLRN 112
            ++ E G+ +  +VY+G      K E + R+AVK  N SA    R +FL EA  +     
Sbjct: 9   TLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTC 68

Query: 113 RRLANLLGCCCEGDERLLVAEYMPNDTLAKHLFHW----ETQPMKWAMRLR----VALHI 164
             +  LLG   +G   L+V E M +  L  +L       E  P +    L+    +A  I
Sbjct: 69  HHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEI 128

Query: 165 AEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKN------SRDGRSYSTNLAF 218
           A+ + Y  +K + ++ DL A   +   D   ++  FG+ ++       R G      + +
Sbjct: 129 ADGMAYLNAK-KFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRW 187

Query: 219 TPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIP-----PSHALDLIRDRNIQTLTDSCL 273
             PE L+ G  T  S M+SFG +L ++ S    P         L  + D       D+C 
Sbjct: 188 MAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLKFVMDGGYLDQPDNCP 247

Query: 274 EGQFSSDEGTELVRLASRCLQYEPRERPNPRSLVTAL 310
           E          +  L   C Q+ P+ RP    +V  L
Sbjct: 248 E---------RVTDLMRMCWQFNPKMRPTFLEIVNLL 275

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288

>gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair]

 Score = 66.7 bits (161), Expect = 3e-12
 Identities = 58/274 (21%), Positives = 95/274 (34%), Gaps = 29/274 (10%)

Query: 60  NIVSEHGEKAPNVVYKGKLENQFRIAVKRFNRSAWPD---ARQFLEEARAVGQLR-NRRL 115
            I+ + GE +   VY  +  ++  +A+K   +          +FL E + +  L     +
Sbjct: 3   RILRKLGEGSFGEVYLAR--DRKLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNI 60

Query: 116 ANLLGCCCEGDERLLVAEYMPNDTLAKHL-FHWETQPMKWAMRLRVALHIAEALEYCTSK 174
             L     +     LV EY+   +L   L       P+  +  L +   I  ALEY  SK
Sbjct: 61  VKLYDFFQDEGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHSK 120

Query: 175 ERALYHDLNAYRIVFD-DDVNPRLSCFGLMKNSRDGRSYSTN----------LAFTPPEY 223
              ++ D+    I+ D D    +L  FGL K   D  S S+             +  PE 
Sbjct: 121 -GIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGYMAPEV 179

Query: 224 LR---TGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRD---RNIQTLTDSCLEGQF 277
           L        +  S ++S G  L +LL+G                 + I  L    L    
Sbjct: 180 LLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELPTPSLASPL 239

Query: 278 SSDEG----TELVRLASRCLQYEPRERPNPRSLV 307
           S             L  + L  +P+ R +  S +
Sbjct: 240 SPSNPELISKAASDLLKKLLAKDPKNRLSSSSDL 273

Length = 384

>gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk

 Score = 65.3 bits (159), Expect = 3e-12
 Identities = 62/242 (25%), Positives = 110/242 (45%), Gaps = 28/242 (11%)

Query: 73  VYKGKLENQFRIAVKRFNR-SAWPDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLV 131
           V+ G      ++A+K   + S  P+A  FL EA  + QL++ RL  L     + +   ++
Sbjct: 22  VWMGYYNGHTKVAIKSLKQGSMSPEA--FLAEANLMKQLQHPRLVRLYAVVTQ-EPIYII 78

Query: 132 AEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDD 191
            EYM N +L   L   E   +     + +A  IAE + +   K   ++ DL A  I+  +
Sbjct: 79  TEYMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIERKN-YIHRDLRAANILVSE 137

Query: 192 DVNPRLSCFGLMK-------NSRDGRSYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLD 244
            +  +++ FGL +        +R+G  +   + +T PE +  G  T +S ++SFG LL +
Sbjct: 138 TLCCKIADFGLARLIEDNEYTAREGAKFP--IKWTAPEAINYGTFTIKSDVWSFGILLTE 195

Query: 245 LLSGKHIPPSHALDLIRDRNIQTL-----TDSCLEGQFSSDEGTELVRLASRCLQYEPRE 299
           +++   IP     +    +N++        D+C E         EL  L   C + +P E
Sbjct: 196 IVTYGRIPYPGMTNPEVIQNLERGYRMPRPDNCPE---------ELYELMRLCWKEKPEE 246

Query: 300 RP 301
           RP
Sbjct: 247 RP 248

Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260

>gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases

 Score = 65.1 bits (159), Expect = 4e-12
 Identities = 68/269 (25%), Positives = 114/269 (42%), Gaps = 33/269 (12%)

Query: 73  VYKGKLENQF-----RIAVKRFNRSAWPDARQFLEEARAVGQLRN---RRLANLLGCCCE 124
           V   + +        ++AVK  N S     R   E  R +  LR      +    G C +
Sbjct: 20  VELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFE--REIEILRTLDHENIVKYKGVCEK 77

Query: 125 GDER--LLVAEYMPNDTLAKHL-FHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHD 181
              R   L+ EY+P+ +L  +L  H +   +K    L  +  I + ++Y  S+ R ++ D
Sbjct: 78  PGGRSLRLIMEYLPSGSLRDYLQRHRDQINLK--RLLLFSSQICKGMDYLGSQ-RYIHRD 134

Query: 182 LNAYRIVFDDDVNPRLSCFGLMK--NSRDGRSYSTNLAFTP-----PEYLRTGRVTPESV 234
           L A  I+ + +   ++S FGL K         Y      +P     PE LRT + +  S 
Sbjct: 135 LAARNILVESEDLVKISDFGLAKVLPEDKDYYYVKEPGESPIFWYAPECLRTSKFSSASD 194

Query: 235 MYSFGTLLLDLLS-GKH--IPPSHALDLI---RDRNIQT-LTDSCLEGQ-FSSDEG--TE 284
           ++SFG  L +L + G     PP+  L +I   + + I T L +   EG+          E
Sbjct: 195 VWSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQGQMIVTRLLELLKEGERLPRPPSCPDE 254

Query: 285 LVRLASRCLQYEPRERPNPRSLVTALVTL 313
           +  L   C + EP++RP+   L+  +  L
Sbjct: 255 VYDLMKLCWEAEPQDRPSFADLILIVDRL 283

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284

>gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases

 Score = 64.4 bits (157), Expect = 6e-12
 Identities = 65/260 (25%), Positives = 113/260 (43%), Gaps = 24/260 (9%)

Query: 62  VSEHGEKAPNVVYKGKLENQFRIAVKRFNRSAWPDARQFLEEARAVGQLRNRRLANLLGC 121
           + E G     VV+ GK   +  +A+K     A  +   F+EEA+ + +L +  L  L G 
Sbjct: 9   LKELGSGQFGVVHLGKWRGKIDVAIKMIREGAMSE-DDFIEEAKVMMKLSHPNLVQLYGV 67

Query: 122 CCEGDERLLVAEYMPNDTLAKHLFHWETQPMKWAMR--LRVALHIAEALEYCTSKERALY 179
           C +     +V EYM N  L  +L     +  K      L +   + EA+EY  S    ++
Sbjct: 68  CTKQRPIFIVTEYMANGCLLNYL---RERKGKLGTEWLLDMCSDVCEAMEYLESNG-FIH 123

Query: 180 HDLNAYRIVFDDDVNPRLSCFGLMKNSRDGRSYSTN-----LAFTPPEYLRTGRVTPESV 234
            DL A   +  +D   ++S FGL +   D +  S+      + + PPE     R + +S 
Sbjct: 124 RDLAARNCLVGEDNVVKVSDFGLARYVLDDQYTSSQGTKFPVKWAPPEVFDYSRFSSKSD 183

Query: 235 MYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDE----GTELVRLAS 290
           ++SFG L+ ++ S   +P        R  N + + +S   G +         TE+  +  
Sbjct: 184 VWSFGVLMWEVFSEGKMPYE------RFSNSEVV-ESVSAG-YRLYRPKLAPTEVYTIMY 235

Query: 291 RCLQYEPRERPNPRSLVTAL 310
            C   +P +RP  + L++ L
Sbjct: 236 SCWHEKPEDRPAFKKLLSQL 255

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256

>gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor

 Score = 63.9 bits (155), Expect = 1e-11
 Identities = 64/273 (23%), Positives = 120/273 (43%), Gaps = 36/273 (13%)

Query: 64  EHGEKAPNVVYKG------KLENQFRIAVKRFNRSAWPDAR-QFLEEARAVGQLRNRRLA 116
           E G+ +  +VY+G      K E + R+A+K  N +A    R +FL EA  + +     + 
Sbjct: 13  ELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVV 72

Query: 117 NLLGCCCEGDERLLVAEYMPNDTLAKHL--FHWETQ------PMKWAMRLRVALHIAEAL 168
            LLG   +G   L++ E M    L  +L     E +      P      +++A  IA+ +
Sbjct: 73  RLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGM 132

Query: 169 EYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKN------SRDGRSYSTNLAFTPPE 222
            Y  +  + ++ DL A   +  +D   ++  FG+ ++       R G      + +  PE
Sbjct: 133 AYLNAN-KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPE 191

Query: 223 YLRTGRVTPESVMYSFGTLLLDLLSGKHIP-----PSHALDLIRDRNIQTLTDSCLEGQF 277
            L+ G  T  S ++SFG +L ++ +    P         L  + +  +    D+C +  F
Sbjct: 192 SLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSNEQVLRFVMEGGLLDKPDNCPDMLF 251

Query: 278 SSDEGTELVRLASRCLQYEPRERPNPRSLVTAL 310
                 EL+R+   C QY P+ RP+   +++++
Sbjct: 252 ------ELMRM---CWQYNPKMRPSFLEIISSI 275

Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277

>gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome

 Score = 63.4 bits (154), Expect = 1e-11
 Identities = 58/256 (22%), Positives = 115/256 (44%), Gaps = 34/256 (13%)

Query: 72  VVYKGKLENQFRIAVKRFNRSAWPDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLV 131
           VV  GK   Q+ +A+K     +  +  +F+EEA+ + +L + +L  L G C +     +V
Sbjct: 19  VVKYGKWRGQYDVAIKMIKEGSMSE-DEFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYIV 77

Query: 132 AEYMPN----DTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRI 187
            EYM N    + L +H   ++   +     L +   + E + Y  SK+  ++ DL A   
Sbjct: 78  TEYMSNGCLLNYLREHGKRFQPSQL-----LEMCKDVCEGMAYLESKQ-FIHRDLAARNC 131

Query: 188 VFDDDVNPRLSCFGLMKNSRDGRSYST-----NLAFTPPEYLRTGRVTPESVMYSFGTLL 242
           + DD    ++S FGL +   D    S+      + ++PPE L   + + +S +++FG L+
Sbjct: 132 LVDDQGCVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLM 191

Query: 243 LDLLSGKHIPPSHALDLIRDR-NIQTLTDSCLEG------QFSSDEGTELVRLASRCLQY 295
            ++ S   +P         +R N     +   +G        +S+   ++  +   C   
Sbjct: 192 WEVYSLGKMP--------YERFNNSETVEKVSQGLRLYRPHLASE---KVYAIMYSCWHE 240

Query: 296 EPRERPNPRSLVTALV 311
           +  ERP  + L++++ 
Sbjct: 241 KAEERPTFQQLLSSIE 256

Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256

>gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

 Score = 62.2 bits (151), Expect = 4e-11
 Identities = 60/250 (24%), Positives = 102/250 (40%), Gaps = 24/250 (9%)

Query: 84  IAVKRFNRSAWPDARQ-FLEEARAVGQLRNRRLANLLGCCCEGDER--LLVAEYMPNDTL 140
           +AVK   R         + +E   +  L +  +    GCC E   +   L+ EY+P  +L
Sbjct: 36  VAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGKGLQLIMEYVPLGSL 95

Query: 141 AKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCF 200
             +L       +  A  L  A  I E + Y  S+   ++ DL A  ++ D+D   ++  F
Sbjct: 96  RDYL---PKHKLNLAQLLLFAQQICEGMAYLHSQ-HYIHRDLAARNVLLDNDRLVKIGDF 151

Query: 201 GLMKNSRDGRSY-------STNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLS---GKH 250
           GL K   +G  Y        + + +   E L+  + +  S ++SFG  L +LL+    K 
Sbjct: 152 GLAKAVPEGHEYYRVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLTHCDSKQ 211

Query: 251 IPPSHALDLIRDRNIQT----LTDSCLEGQ---FSSDEGTELVRLASRCLQYEPRERPNP 303
            PP    ++I  +  Q     L +    G       +   E+  L   C + E + RP  
Sbjct: 212 SPPKKFEEMIGPKQGQMTVVRLIELLERGMRLPCPKNCPQEVYILMKNCWETEAKFRPTF 271

Query: 304 RSLVTALVTL 313
           RSL+  L  +
Sbjct: 272 RSLIPILKEM 281

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283

>gnl|CDD|133209 cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

 Score = 61.8 bits (150), Expect = 5e-11
 Identities = 60/222 (27%), Positives = 106/222 (47%), Gaps = 21/222 (9%)

Query: 100 FLEEARAVGQLRNRRLANLLGCCCEGDERLLVAEYMPNDTLAKHL-FHWETQPMKWAMRL 158
           F E A  + QL ++ L    G C  GDE ++V EY+   +L  +L  +     + W  +L
Sbjct: 46  FFEAASMMSQLSHKHLVLNYGVCVCGDESIMVQEYVKFGSLDTYLKKNKNLINISW--KL 103

Query: 159 RVALHIAEALEYCTSKERALYH-DLNAYRIVFDDDVNPRLSCFGLMKNSRDGRSYST--- 214
            VA  +A AL +   +++ L H ++ A  ++   + + +      +K S  G S +    
Sbjct: 104 EVAKQLAWALHFL--EDKGLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISITVLPK 161

Query: 215 -----NLAFTPPEYLRTGR-VTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTL 268
                 + + PPE +   + ++  +  +SFGT L ++ SG   P S ALD    + +Q  
Sbjct: 162 EILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLS-ALD--SQKKLQFY 218

Query: 269 TDSCLEGQFSSDEGTELVRLASRCLQYEPRERPNPRSLVTAL 310
            D     Q  + + TEL  L ++C+ YEP  RP+ R+++  L
Sbjct: 219 ED---RHQLPAPKWTELANLINQCMDYEPDFRPSFRAIIRDL 257

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 258

>gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase

 Score = 61.4 bits (149), Expect = 6e-11
 Identities = 61/254 (24%), Positives = 109/254 (42%), Gaps = 32/254 (12%)

Query: 72  VVYKGKLENQFRIAVKRFNRSAWPDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLV 131
           VV+ GK   Q ++A+K  N  A  +   F+EEA+ + +L + +L  L G C +     +V
Sbjct: 19  VVHLGKWRAQIKVAIKAINEGAMSE-EDFIEEAKVMMKLSHPKLVQLYGVCTQQKPLYIV 77

Query: 132 AEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDD 191
            E+M N  L  +L   + +  K  M L +   + E +EY   +   ++ DL A   +   
Sbjct: 78  TEFMENGCLLNYLRQRQGKLSK-DMLLSMCQDVCEGMEY-LERNSFIHRDLAARNCLVSS 135

Query: 192 DVNPRLSCFGLMKNSRDGRSYSTNLA-----FTPPEYLRTGRVTPESVMYSFGTLLLDLL 246
               ++S FG+ +   D    S++ A     ++PPE     + + +S ++SFG L+ ++ 
Sbjct: 136 TGVVKVSDFGMTRYVLDDEYTSSSGAKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVF 195

Query: 247 SGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVR--LAS--------RCLQYE 296
           +   +P        +  N + +             G  L R  LAS         C   +
Sbjct: 196 TEGKMP------FEKKSNYEVVE--------MISRGFRLYRPKLASMTVYEVMYSCWHEK 241

Query: 297 PRERPNPRSLVTAL 310
           P  RP    L+ A+
Sbjct: 242 PEGRPTFAELLRAI 255

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256

>gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases

 Score = 61.6 bits (150), Expect = 6e-11
 Identities = 50/187 (26%), Positives = 93/187 (49%), Gaps = 11/187 (5%)

Query: 73  VYKGKLENQFRIAVKRFNRSAWPDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVA 132
           V+ G      ++AVK   +        FL+EA+ + +LR+ +L  L   C E +   +V 
Sbjct: 22  VWMGTWNGTTKVAVKTL-KPGTMSPEAFLQEAQIMKKLRHDKLVQLYAVCSEEEPIYIVT 80

Query: 133 EYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDD 192
           EYM   +L   L   E + ++    + +A  IAE + Y  S+   ++ DL A  I+  ++
Sbjct: 81  EYMSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLESR-NYIHRDLAARNILVGEN 139

Query: 193 VNPRLSCFGLMK-------NSRDGRSYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDL 245
           +  +++ FGL +        +R+G  +   + +T PE    GR T +S ++SFG LL ++
Sbjct: 140 LVCKIADFGLARLIEDDEYTAREGAKFP--IKWTAPEAANYGRFTIKSDVWSFGILLTEI 197

Query: 246 LSGKHIP 252
           ++   +P
Sbjct: 198 VTYGRVP 204

Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261

>gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B

 Score = 60.9 bits (147), Expect = 1e-10
 Identities = 62/270 (22%), Positives = 114/270 (42%), Gaps = 42/270 (15%)

Query: 79  ENQFRIAVKRFNRSAWPDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAEYMPND 138
           +++  +AVK    ++    + F  EA  +  L++  +    G C EGD  ++V EYM + 
Sbjct: 33  QDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLIMVFEYMKHG 92

Query: 139 TLAKHL--------FHWETQP---MKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRI 187
            L K L           E      +  +  L +A  IA  + Y  S +  ++ DL     
Sbjct: 93  DLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLAS-QHFVHRDLATRNC 151

Query: 188 VFDDDVNPRLSCFGLMKNSRDGRSYSTN-----------LAFTPPEYLRTGRVTPESVMY 236
           +  +++  ++  FG+   SRD   YST+           + + PPE +   + T ES ++
Sbjct: 152 LVGENLLVKIGDFGM---SRD--VYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVW 206

Query: 237 SFGTLLLDLLS-GK----HIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLASR 291
           S G +L ++ + GK     +  +  ++ I    +     +C +         E+  L   
Sbjct: 207 SLGVVLWEIFTYGKQPWYQLSNNEVIECITQGRVLQRPRTCPK---------EVYDLMLG 257

Query: 292 CLQYEPRERPNPRSLVTALVTLQKDTELYL 321
           C Q EP  R N + + + L  L K + +YL
Sbjct: 258 CWQREPHMRLNIKEIHSLLQNLAKASPVYL 287

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288

>gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk

 Score = 60.4 bits (146), Expect = 1e-10
 Identities = 60/238 (25%), Positives = 107/238 (44%), Gaps = 20/238 (8%)

Query: 73  VYKGKLENQFRIAVKRFNRSAW-PDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLV 131
           V+ G      ++AVK        P++  FLEEA+ + +LR+ +L  L     E +   +V
Sbjct: 22  VWMGTWNGNTKVAVKTLKPGTMSPES--FLEEAQIMKKLRHDKLVQLYAVVSE-EPIYIV 78

Query: 132 AEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDD 191
            EYM   +L   L   E + +K    + +A  +A  + Y   +   ++ DL +  I+  D
Sbjct: 79  TEYMSKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAY-IERMNYIHRDLRSANILVGD 137

Query: 192 DVNPRLSCFGLMK-------NSRDGRSYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLD 244
            +  +++ FGL +        +R G  +   + +T PE    GR T +S ++SFG LL +
Sbjct: 138 GLVCKIADFGLARLIEDNEYTARQGAKFP--IKWTAPEAALYGRFTIKSDVWSFGILLTE 195

Query: 245 LLSGKHIP-PSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLASRCLQYEPRERP 301
           L++   +P P      + +R +    +         D    L  L  +C + +P ERP
Sbjct: 196 LVTKGRVPYPG-----MNNREVLEQVERGYRMPCPQDCPISLHELMLQCWKKDPEERP 248

Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260

>gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases

 Score = 60.2 bits (146), Expect = 2e-10
 Identities = 59/272 (21%), Positives = 107/272 (39%), Gaps = 37/272 (13%)

Query: 66  GEKAPNVVYKGKLE----NQFRIAVK--RFNRSAWPDARQFLEEARAVGQLRNRRLANLL 119
           GE     V +G+L     +Q ++AVK  + +   + +  +FL EA  +    +  +  L+
Sbjct: 8   GEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLI 67

Query: 120 GCCCEGDER------LLVAEYMPNDTLAKHLFH--WETQPMKWA--MRLRVALHIAEALE 169
           G C E          +++  +M +  L   L +      P K      L+  + IA  +E
Sbjct: 68  GVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGME 127

Query: 170 YCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDGRSYSTNLAFTPP------EY 223
           Y +++   ++ DL A   +  +D+   ++ FGL K    G  Y        P      E 
Sbjct: 128 YLSNR-NFIHRDLAARNCMLREDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVKWIAIES 186

Query: 224 LRTGRVTPESVMYSFGTLLLDLLSGKHIP-----PSHALDLIRDRNIQTLTDSCLEGQFS 278
           L     T +S +++FG  + ++ +    P          D +R  N     + CL+    
Sbjct: 187 LADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVENHEIYDYLRHGNRLKQPEDCLD---- 242

Query: 279 SDEGTELVRLASRCLQYEPRERPNPRSLVTAL 310
                EL  L   C + +P++RP    L   L
Sbjct: 243 -----ELYDLMYSCWRADPKDRPTFTKLREVL 269

Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273

>gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes

 Score = 60.1 bits (145), Expect = 2e-10
 Identities = 60/238 (25%), Positives = 111/238 (46%), Gaps = 20/238 (8%)

Query: 73  VYKGKLENQFRIAVKRFNR-SAWPDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLV 131
           V+ G      ++A+K     +  P+A  FL+EA+ + +LR+ +L  L     E +   +V
Sbjct: 22  VWMGTWNGTTKVAIKTLKPGTMMPEA--FLQEAQIMKKLRHDKLVPLYAVVSE-EPIYIV 78

Query: 132 AEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDD 191
            E+M   +L   L   + + +K    + +A  IA+ + Y   +   ++ DL A  I+  D
Sbjct: 79  TEFMGKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAY-IERMNYIHRDLRAANILVGD 137

Query: 192 DVNPRLSCFGLMK-------NSRDGRSYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLD 244
           ++  +++ FGL +        +R G  +   + +T PE    GR T +S ++SFG LL +
Sbjct: 138 NLVCKIADFGLARLIEDNEYTARQGAKFP--IKWTAPEAALYGRFTIKSDVWSFGILLTE 195

Query: 245 LLSGKHIP-PSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLASRCLQYEPRERP 301
           L++   +P P      + ++  +     C +G   S     L  L   C + +P ERP
Sbjct: 196 LVTKGRVPYPGMVNREVLEQVERGYRMPCPQGCPES-----LHELMKLCWKKDPDERP 248

Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260

>gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C

 Score = 60.0 bits (145), Expect = 2e-10
 Identities = 63/273 (23%), Positives = 114/273 (41%), Gaps = 45/273 (16%)

Query: 79  ENQFRIAVKRFNRSAWPDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAEYMPND 138
           +++  +AVK          + F  EA  +  L++  +    G C +GD  ++V EYM + 
Sbjct: 33  KDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKFYGVCGDGDPLIMVFEYMKHG 92

Query: 139 TLAKHL--------FHWETQPMK------WAMRLRVALHIAEALEYCTSKERALYHDLNA 184
            L K L           + QP +       +  L +A  IA  + Y  S +  ++ DL  
Sbjct: 93  DLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLAS-QHFVHRDLAT 151

Query: 185 YRIVFDDDVNPRLSCFGLMKNSRDGRSYSTN-----------LAFTPPEYLRTGRVTPES 233
              +   ++  ++  FG+   SRD   YST+           + + PPE +   + T ES
Sbjct: 152 RNCLVGANLLVKIGDFGM---SRD--VYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTES 206

Query: 234 VMYSFGTLLLDLLS-GK----HIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRL 288
            ++SFG +L ++ + GK     +  +  ++ I    +      C +         E+  +
Sbjct: 207 DVWSFGVILWEIFTYGKQPWFQLSNTEVIECITQGRVLERPRVCPK---------EVYDI 257

Query: 289 ASRCLQYEPRERPNPRSLVTALVTLQKDTELYL 321
              C Q EP++R N + +   L  L K T +YL
Sbjct: 258 MLGCWQREPQQRLNIKEIYKILHALGKATPIYL 290

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291

>gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn

 Score = 59.7 bits (144), Expect = 2e-10
 Identities = 45/187 (24%), Positives = 88/187 (47%), Gaps = 11/187 (5%)

Query: 73  VYKGKLENQFRIAVKRFNRSAWPDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVA 132
           V+ G   N  ++AVK   +      + FLEEA  +  L++ +L  L     + +   ++ 
Sbjct: 22  VWMGYYNNSTKVAVKTL-KPGTMSVQAFLEEANLMKTLQHDKLVRLYAVVTKEEPIYIIT 80

Query: 133 EYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDD 192
           EYM   +L   L   E   +     +  +  IAE + Y   ++  ++ DL A  ++  + 
Sbjct: 81  EYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAY-IERKNYIHRDLRAANVLVSES 139

Query: 193 VNPRLSCFGLMK-------NSRDGRSYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDL 245
           +  +++ FGL +        +R+G  +   + +T PE +  G  T +S ++SFG LL ++
Sbjct: 140 LMCKIADFGLARVIEDNEYTAREGAKFP--IKWTAPEAINFGSFTIKSDVWSFGILLYEI 197

Query: 246 LSGKHIP 252
           ++   IP
Sbjct: 198 VTYGKIP 204

Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261

>gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src

 Score = 59.3 bits (143), Expect = 3e-10
 Identities = 60/238 (25%), Positives = 106/238 (44%), Gaps = 20/238 (8%)

Query: 73  VYKGKLENQFRIAVKRFNRSAW-PDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLV 131
           V+ G      R+A+K        P+A  FL+EA+ + +LR+ +L  L     E +   +V
Sbjct: 22  VWMGTWNGTTRVAIKTLKPGTMSPEA--FLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIV 78

Query: 132 AEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDD 191
            EYM   +L   L     + ++    + +A  IA  + Y   +   ++ DL A  I+  +
Sbjct: 79  TEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAY-VERMNYVHRDLRAANILVGE 137

Query: 192 DVNPRLSCFGLMK-------NSRDGRSYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLD 244
           ++  +++ FGL +        +R G  +   + +T PE    GR T +S ++SFG LL +
Sbjct: 138 NLVCKVADFGLARLIEDNEYTARQGAKFP--IKWTAPEAALYGRFTIKSDVWSFGILLTE 195

Query: 245 LLSGKHIP-PSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLASRCLQYEPRERP 301
           L +   +P P      + D+  +     C       +    L  L  +C + EP ERP
Sbjct: 196 LTTKGRVPYPGMVNREVLDQVERGYRMPC-----PPECPESLHDLMCQCWRKEPEERP 248

Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262

>gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase

 Score = 59.2 bits (143), Expect = 4e-10
 Identities = 48/198 (24%), Positives = 92/198 (46%), Gaps = 12/198 (6%)

Query: 62  VSEHGEKAPNVVYKGKLENQFRIAVKRFNRSAWPDARQFLEEARAVGQLRNRRLANLLGC 121
           V E G     +V+ G    + ++A+K     A  +   F+EEA+ + +L + +L  L G 
Sbjct: 9   VQEIGSGQFGLVWLGYWLEKRKVAIKTIREGAMSE-EDFIEEAQVMMKLSHPKLVQLYGV 67

Query: 122 CCEGDERLLVAEYMPNDTLAKHLFHWETQPMKWAMR--LRVALHIAEALEYCTSKERALY 179
           C E     LV E+M +  L+ +L     Q  K++    L + L + E + Y  S    ++
Sbjct: 68  CTERSPICLVFEFMEHGCLSDYL---RAQRGKFSQETLLGMCLDVCEGMAYLESSN-VIH 123

Query: 180 HDLNAYRIVFDDDVNPRLSCFGLMKNSRDGRSYSTN-----LAFTPPEYLRTGRVTPESV 234
            DL A   +  ++   ++S FG+ +   D +  S+      + ++ PE     + + +S 
Sbjct: 124 RDLAARNCLVGENQVVKVSDFGMTRFVLDDQYTSSTGTKFPVKWSSPEVFSFSKYSSKSD 183

Query: 235 MYSFGTLLLDLLSGKHIP 252
           ++SFG L+ ++ S    P
Sbjct: 184 VWSFGVLMWEVFSEGKTP 201

Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256

>gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase

 Score = 57.2 bits (138), Expect = 2e-09
 Identities = 57/240 (23%), Positives = 109/240 (45%), Gaps = 21/240 (8%)

Query: 84  IAVKRFNRSAWPDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAEYMPNDTLAKH 143
           +AVK           +FL+EA  + ++++  L  LLG C       ++ E+M    L  +
Sbjct: 34  VAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDY 92

Query: 144 LFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLM 203
           L     Q +   + L +A  I+ A+EY   K   ++ DL A   +  ++   +++ FGL 
Sbjct: 93  LRECNRQEVNAVVLLYMATQISSAMEYLEKKN-FIHRDLAARNCLVGENHLVKVADFGLS 151

Query: 204 KNSRDGRSYSTN------LAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHAL 257
           +    G +Y+ +      + +T PE L   + + +S +++FG LL ++ +   + P   +
Sbjct: 152 RLMT-GDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIAT-YGMSPYPGI 209

Query: 258 DLIRDRNIQTLTDSCLEGQFSSD--EG--TELVRLASRCLQYEPRERPNPRSLVTALVTL 313
           DL     +  L    LE  +  +  EG   ++  L   C Q+ P +RP+   +  A  T+
Sbjct: 210 DL---SQVYEL----LEKGYRMERPEGCPPKVYELMRACWQWNPSDRPSFAEIHQAFETM 262

Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263

>gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases

 Score = 56.0 bits (136), Expect = 3e-09
 Identities = 55/182 (30%), Positives = 76/182 (41%), Gaps = 18/182 (9%)

Query: 126 DERL-LVAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNA 184
           +E+L LV EY P   L  HL        + A R   A  I  ALEY  S    +Y DL  
Sbjct: 65  EEKLYLVLEYAPGGELFSHLSKEGRFSEERA-RFYAA-EIVLALEYLHSL-GIIYRDLKP 121

Query: 185 YRIVFDDDVNPRLSCFGLMKNSRDGRSYSTNLAFTP----PEYLRTGRVTPESVMYSFGT 240
             I+ D D + +L+ FGL K      S +     TP    PE L           +S G 
Sbjct: 122 ENILLDADGHIKLTDFGLAKELSSEGSRTNTFCGTPEYLAPEVLLGKGYGKAVDWWSLGV 181

Query: 241 LLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQ--FSSDEGTELVRLASRCLQYEPR 298
           LL ++L+GK  PP +A       + + + +  L+    F      E   L S  LQ +P 
Sbjct: 182 LLYEMLTGK--PPFYA------EDRKEIYEKILKDPLRFPEFLSPEARDLISGLLQKDPT 233

Query: 299 ER 300
           +R
Sbjct: 234 KR 235

Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250

>gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases

 Score = 55.8 bits (135), Expect = 5e-09
 Identities = 63/267 (23%), Positives = 112/267 (41%), Gaps = 40/267 (14%)

Query: 64  EHGEKAPNVVYKGKLENQFR----IAVKRFNRSAWPDAR-QFLEEARAVGQLRNRRLANL 118
           E GE     V +G+L+   +    +A+K     +    R  FL EA  +GQ  +  +  L
Sbjct: 16  EFGE-----VCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIRL 70

Query: 119 LGCCCEGDERLLVAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERAL 178
            G   +    +++ EYM N +L K L   + +       + +   IA  ++Y +  E   
Sbjct: 71  EGVVTKSRPVMIITEYMENGSLDKFLRENDGK-FTVGQLVGMLRGIASGMKYLS--EMNY 127

Query: 179 YH-DLNAYRIVFDDDVNPRLSCFGLMKNSRDGRS-YSTN-----LAFTPPEYLRTGRVTP 231
            H DL A  I+ + ++  ++S FGL +   D  + Y+T      + +T PE +   + T 
Sbjct: 128 VHRDLAARNILVNSNLVCKVSDFGLSRRLEDSEATYTTKGGKIPIRWTAPEAIAYRKFTS 187

Query: 232 ESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTD--------SCLEGQFSSDEGT 283
            S ++SFG ++ +++S    P     D+     I+ + D         C           
Sbjct: 188 ASDVWSFGIVMWEVMSYGERP---YWDMSNQDVIKAVEDGYRLPPPMDCPSA-------- 236

Query: 284 ELVRLASRCLQYEPRERPNPRSLVTAL 310
            L +L   C Q +  ERP    +V+ L
Sbjct: 237 -LYQLMLDCWQKDRNERPTFSQIVSTL 262

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266

>gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases

 Score = 55.4 bits (134), Expect = 7e-09
 Identities = 65/279 (23%), Positives = 118/279 (42%), Gaps = 48/279 (17%)

Query: 56  FAMENIV--SEHGEKAPNVVYKGKLEN------QFRIAVKRFN-RSAWPDARQFLEEARA 106
              E I    E G+ +  +VY+G  +       + R+A+K  N  ++  +  +FL EA  
Sbjct: 3   LPREKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASV 62

Query: 107 VGQLRNRRLANLLGCCCEGDERLLVAEYMPNDTLAKHL--------FHWETQPMKWAMRL 158
           + +     +  LLG    G   L+V E M    L  +L         +    P      +
Sbjct: 63  MKEFNCHHVVRLLGVVSTGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFI 122

Query: 159 RVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDGRSYSTN--- 215
           ++A  IA+ + Y  +K + ++ DL A   +  +D+  ++  FG+   +RD   Y T+   
Sbjct: 123 QMAAEIADGMAYLAAK-KFVHRDLAARNCMVAEDLTVKIGDFGM---TRD--IYETDYYR 176

Query: 216 --------LAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIP---PSH--ALDLIRD 262
                   + +  PE L+ G  T +S ++SFG +L ++ +    P    S+   L  + D
Sbjct: 177 KGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLSNEEVLKFVID 236

Query: 263 RNIQTLTDSCLEGQFSSDEGTELVRLASRCLQYEPRERP 301
                L ++C +         +L+ L   C QY P+ RP
Sbjct: 237 GGHLDLPENCPD---------KLLELMRMCWQYNPKMRP 266

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277

>gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases

 Score = 55.5 bits (134), Expect = 7e-09
 Identities = 44/187 (23%), Positives = 91/187 (48%), Gaps = 11/187 (5%)

Query: 73  VYKGKLENQFRIAVKRFNRSAWPDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVA 132
           V++G   N   +AVK   +    D + FL EA+ + +LR+ +L  L   C   +   +V 
Sbjct: 22  VWEGLWNNTTPVAVKTL-KPGTMDPKDFLAEAQIMKKLRHPKLIQLYAVCTLEEPIYIVT 80

Query: 133 EYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDD 192
           E M   +L ++L     + +K    + +A  +A  + Y  + +  ++ DL A  ++  ++
Sbjct: 81  ELMKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLEA-QNYIHRDLAARNVLVGEN 139

Query: 193 VNPRLSCFGLMK-------NSRDGRSYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDL 245
              +++ FGL +        +R+G  +   + +T PE     R + +S ++SFG LL ++
Sbjct: 140 NICKVADFGLARVIKEDIYEAREGAKFP--IKWTAPEAALYNRFSIKSDVWSFGILLTEI 197

Query: 246 LSGKHIP 252
           ++   +P
Sbjct: 198 VTYGRMP 204

Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261

>gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases

 Score = 54.1 bits (131), Expect = 2e-08
 Identities = 53/241 (21%), Positives = 93/241 (38%), Gaps = 23/241 (9%)

Query: 72  VVYKGK-LENQFRIAVKRFNRSAWPDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLL 130
            VYK +       +A+K     +     + + E + + + ++  +    G   + DE  +
Sbjct: 15  EVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYGSYLKKDELWI 74

Query: 131 VAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFD 190
           V E+    +L K L     Q +  +    V   + + LEY  S    ++ D+ A  I+  
Sbjct: 75  VMEFCSGGSL-KDLLKSTNQTLTESQIAYVCKELLKGLEYLHSN-GIIHRDIKAANILLT 132

Query: 191 DDVNPRLSCFGLMKNSRDGRSYSTNLAFTP----PEYLRTGRVTPESVMYSFGTLLLDLL 246
            D   +L  FGL     D ++    +  TP    PE +       ++ ++S G   ++L 
Sbjct: 133 SDGEVKLIDFGLSAQLSDTKA-RNTMVGTPYWMAPEVINGKPYDYKADIWSLGITAIELA 191

Query: 247 SGKHIPPSH------ALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLASRCLQYEPRER 300
            GK  PP        AL  I       L       +  SDE  + +    +CLQ  P +R
Sbjct: 192 EGK--PPYSELPPMKALFKIATNGPPGL----RNPEKWSDEFKDFL---KKCLQKNPEKR 242

Query: 301 P 301
           P
Sbjct: 243 P 243

Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253

>gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains

 Score = 54.1 bits (130), Expect = 2e-08
 Identities = 57/252 (22%), Positives = 106/252 (42%), Gaps = 19/252 (7%)

Query: 66  GEKAPNVVYKGKLENQFRI-AVKRFNRSAWPDARQ--FLEEARAVGQLRNRRLANLLGCC 122
           G+ +  VV+K   +   R+ A+K+ + S      +   ++EAR + +L +  +       
Sbjct: 9   GKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYESF 68

Query: 123 CEGDERLLVAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDL 182
            +  +  +V EY  N  L K L     +P+      R  + I   L +  SK + L+ D+
Sbjct: 69  LDKGKLNIVMEYAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLHSK-KILHRDI 127

Query: 183 NAYRIVFDDDVNPRLSCFGLMKNSRDGRSYSTNLAFTP----PEYLRTGRVTPESVMYSF 238
            +  +  D   N ++   G+ K   D  +++  +  TP    PE         +S +++ 
Sbjct: 128 KSLNLFLDAYDNVKIGDLGVAKLLSDNTNFANTIVGTPYYLSPELCEDKPYNEKSDVWAL 187

Query: 239 GTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQF---SSDEGTELVRLASRCLQY 295
           G +L +  +GKH  P  A       N   L    + G F   S     +L +L  +CL  
Sbjct: 188 GVVLYECCTGKH--PFDA------NNQGALILKIIRGVFPPVSQMYSQQLAQLIDQCLTK 239

Query: 296 EPRERPNPRSLV 307
           + R+RP+   L+
Sbjct: 240 DYRQRPDTFQLL 251

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256

>gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl

 Score = 53.9 bits (129), Expect = 3e-08
 Identities = 63/265 (23%), Positives = 109/265 (41%), Gaps = 42/265 (15%)

Query: 66  GEKAPNVVYKGKL---ENQFRIAVKRF-----NRSAWPDARQFLEEARAVGQLRNRRLAN 117
           GE     V +G+L   ++  ++AVK        RS   D   FL EA  + +  +  +  
Sbjct: 8   GEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMED---FLSEAVCMKEFDHPNVMR 64

Query: 118 LLGCCCEGDER------LLVAEYMPNDTLAKHLFHWE--TQP--MKWAMRLRVALHIAEA 167
           L+G C +  E       +++  +M +  L   L +      P  +   M ++    IA  
Sbjct: 65  LIGVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASG 124

Query: 168 LEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKN------SRDGRSYSTNLAFTPP 221
           +EY +SK   ++ DL A   + ++++N  ++ FGL K        R GR     + +   
Sbjct: 125 MEYLSSK-SFIHRDLAARNCMLNENMNVCVADFGLSKKIYNGDYYRQGRIAKMPVKWIAI 183

Query: 222 EYLRTGRVTPESVMYSFGTLLLDLLSGKHIP-----PSHALDLIRDRNIQTLTDSCLEGQ 276
           E L     T +S ++SFG  + ++ +    P      S   D +R  N       CL+G 
Sbjct: 184 ESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVENSEIYDYLRQGNRLKQPPDCLDGL 243

Query: 277 FSSDEGTELVRLASRCLQYEPRERP 301
           +S         L S C    P++RP
Sbjct: 244 YS---------LMSSCWLLNPKDRP 259

Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272

>gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2

 Score = 53.4 bits (129), Expect = 3e-08
 Identities = 40/156 (25%), Positives = 61/156 (39%), Gaps = 19/156 (12%)

Query: 158 LRVALHIAEALEYC----TSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDGRSYS 213
            R+   +  AL  C          L+ DL    I  D + N +L  FGL K      S++
Sbjct: 108 WRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKILGHDSSFA 167

Query: 214 TNLAFTP----PEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHA---LDLIRDRNIQ 266
                TP    PE L       +S ++S G L+ +L +    PP  A   L L     I+
Sbjct: 168 KTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALS--PPFTARNQLQLA--SKIK 223

Query: 267 TLTDSCLEGQFSSDEGTELVRLASRCLQYEPRERPN 302
                 +  ++SS    EL  +    L  +P +RP+
Sbjct: 224 EGKFRRIPYRYSS----ELNEVIKSMLNVDPDKRPS 255

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265

>gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases

 Score = 52.1 bits (125), Expect = 9e-08
 Identities = 59/234 (25%), Positives = 96/234 (41%), Gaps = 36/234 (15%)

Query: 96  DARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAEYMPNDTLAKHLFHWETQPMKWA 155
           D+  F E A  + QL ++ L  L G C   DE ++V EY+    L   L H E   +   
Sbjct: 44  DSLAFFETASLMSQLSHKHLVKLYGVCVR-DENIMVEEYVKFGPLDVFL-HREKNNVSLH 101

Query: 156 MRLRVALHIAEALEYCTSKE--------RALY---HDLNAYRIVFDDDVNPRLSCFGLMK 204
            +L VA  +A AL Y   K+        + +    + LN   + F    +P +    L +
Sbjct: 102 WKLDVAKQLASALHYLEDKKLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIPITVLSR 161

Query: 205 NSRDGRSYSTNLAFTPPEYLRTGRVTPESVM--YSFGTLLLDLLSGKHIP-----PSHAL 257
             R  R       +  PE +R G+ +       +SFGT LL++ S    P      S   
Sbjct: 162 EERVERI-----PWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSSEKE 216

Query: 258 DLIRDRNIQTLTDSCLEGQFSSDEGTELVRLASRCLQYEPRERPNPRSLVTALV 311
              +D++   + D             EL  L ++C  Y+P +RP+ R+++  L 
Sbjct: 217 RFYQDQHRLPMPDC-----------AELANLINQCWTYDPTKRPSFRAILRDLN 259

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259

>gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases

 Score = 52.3 bits (125), Expect = 1e-07
 Identities = 56/261 (21%), Positives = 104/261 (39%), Gaps = 44/261 (16%)

Query: 84  IAVKRFNRSAWPDARQ-FLEEARAVGQLRNRRLANLLGCCCEGDERLLVAEYMPNDTLAK 142
           +AVK         AR  FL+E + + +L+N  +  LLG C   D   ++ EYM N  L +
Sbjct: 47  VAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIRLLGVCVSDDPLCMITEYMENGDLNQ 106

Query: 143 HLFHWETQP----------MKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDD 192
            L   E +           +  A  L +A+ IA  ++Y  S    ++ DL     +  + 
Sbjct: 107 FLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASLN-FVHRDLATRNCLVGNH 165

Query: 193 VNPRLSCFGLMKNSRDGRSYSTNLAFTPP------EYLRTGRVTPESVMYSFGTLLLDLL 246
              +++ FG+ +N   G  Y        P      E +  G+ T  S +++FG  L ++ 
Sbjct: 166 YTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMF 225

Query: 247 SGKHIPPSHALDLIRDRNIQTLTDSCL---EGQFSSDEGTE------------LVRLASR 291
           +           L +++    L+D  +    G+F  ++G +            + +L  R
Sbjct: 226 T-----------LCKEQPYSLLSDEQVIENTGEFFRNQGRQIYLSQTPLCPSPVFKLMMR 274

Query: 292 CLQYEPRERPNPRSLVTALVT 312
           C   + ++RP    +   L  
Sbjct: 275 CWSRDIKDRPTFNKIHHFLRE 295

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295

>gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10

 Score = 51.8 bits (124), Expect = 1e-07
 Identities = 40/157 (25%), Positives = 76/157 (48%), Gaps = 11/157 (7%)

Query: 98  RQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAEYMPNDTLAKHLFHWETQPMKWAMR 157
           R FL EA  +GQ  +  +  L G    G+  ++V EYM N  L   L   E Q +  A +
Sbjct: 51  RGFLAEALTLGQFDHSNIVRLEGVITRGNTMMIVTEYMSNGALDSFLRKHEGQLV--AGQ 108

Query: 158 LRVALH-IAEALEYCTSKERALYHD-LNAYRIVFDDDVNPRLSCFGLMKNSRDGRSYSTN 215
           L   L  +A  ++Y +  E    H  L A++++ + D+  ++S F  ++  +    Y+T 
Sbjct: 109 LMGMLPGLASGMKYLS--EMGYVHKGLAAHKVLVNSDLVCKISGFRRLQEDKSEAIYTTM 166

Query: 216 -----LAFTPPEYLRTGRVTPESVMYSFGTLLLDLLS 247
                + +  PE ++    +  S ++SFG ++ +++S
Sbjct: 167 SGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMS 203

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266

>gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein

 Score = 51.9 bits (124), Expect = 1e-07
 Identities = 54/253 (21%), Positives = 100/253 (39%), Gaps = 46/253 (18%)

Query: 84  IAVKRFNRSAWP-DARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAEYMPNDTL-- 140
           +AVK    +A   + R  L E   + Q+ +  +  L G C +    LL+ EY    +L  
Sbjct: 33  VAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRS 92

Query: 141 --------------------AKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYH 180
                               + +L + + + +     +  A  I+  ++Y    E  L H
Sbjct: 93  FLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLA--EMKLVH 150

Query: 181 -DLNAYRIVFDDDVNPRLSCFGLMKNSRDGRSYSTN------LAFTPPEYLRTGRVTPES 233
            DL A  ++  +    ++S FGL ++  +  SY         + +   E L     T +S
Sbjct: 151 RDLAARNVLVAEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQS 210

Query: 234 VMYSFGTLLLDLLS-GKH----IPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRL 288
            ++SFG LL ++++ G +    I P    +L++        ++C E         E+  L
Sbjct: 211 DVWSFGVLLWEIVTLGGNPYPGIAPERLFNLLKTGYRMERPENCSE---------EMYNL 261

Query: 289 ASRCLQYEPRERP 301
              C + EP +RP
Sbjct: 262 MLTCWKQEPDKRP 274

Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290

>gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1

 Score = 51.9 bits (124), Expect = 1e-07
 Identities = 63/268 (23%), Positives = 111/268 (41%), Gaps = 52/268 (19%)

Query: 84  IAVKRFNRSAWPDARQ-FLEEARAVGQLRNRRLANLLGCCCEGDERLLVAEYMPNDTLAK 142
           +AVK     A  +AR  FL+E + + +L++  +  LLG C + D   ++ EYM N  L +
Sbjct: 49  VAVKILRPDANKNARNDFLKEVKILSRLKDPNIIRLLGVCVDEDPLCMITEYMENGDLNQ 108

Query: 143 HLFHWETQ-----------------PMKWAMRLRVALHIAEALEYCTSKERALYHDLNAY 185
            L                        + ++  L VAL IA  ++Y +S    ++ DL   
Sbjct: 109 FLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSLN-FVHRDLATR 167

Query: 186 RIVFDDDVNPRLSCFGLMKNSRDGRSYSTNLAFTPP------EYLRTGRVTPESVMYSFG 239
             +  +++  +++ FG+ +N   G  Y        P      E +  G+ T  S +++FG
Sbjct: 168 NCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFG 227

Query: 240 TLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCL---EGQFSSDEGTE------------ 284
             L ++L            L +++    LTD  +    G+F  D+G +            
Sbjct: 228 VTLWEILM-----------LCKEQPYGELTDEQVIENAGEFFRDQGRQVYLFRPPPCPQG 276

Query: 285 LVRLASRCLQYEPRERPNPRSLVTALVT 312
           L  L  +C   + RERP   S + A +T
Sbjct: 277 LYELMLQCWSRDCRERP-SFSDIHAFLT 303

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304

>gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase

 Score = 51.2 bits (122), Expect = 2e-07
 Identities = 50/215 (23%), Positives = 92/215 (42%), Gaps = 27/215 (12%)

Query: 100 FLEEARAVGQLRNRRLANLLGCCCEGDERLLVAEYMPNDTLAKHLFHWETQPMKWAMRLR 159
           FL EA  +  L++ +L  L     + +   ++ E+M   +L   L   E         + 
Sbjct: 48  FLAEANVMKTLQHDKLVKLHAVVTK-EPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLID 106

Query: 160 VALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMK-------NSRDGRSY 212
            +  IAE + +   +   ++ DL A  I+    +  +++ FGL +        +R+G  +
Sbjct: 107 FSAQIAEGMAF-IEQRNYIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKF 165

Query: 213 STNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIP------PSHALDLIRDRNIQ 266
              + +T PE +  G  T +S ++SFG LL+++++   IP      P     L R   + 
Sbjct: 166 P--IKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERGYRMP 223

Query: 267 TLTDSCLEGQFSSDEGTELVRLASRCLQYEPRERP 301
              ++C E         EL  +  RC +  P ERP
Sbjct: 224 R-PENCPE---------ELYNIMMRCWKNRPEERP 248

Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260

>gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron

 Score = 50.2 bits (120), Expect = 4e-07
 Identities = 66/257 (25%), Positives = 114/257 (44%), Gaps = 32/257 (12%)

Query: 72  VVYKGKL--ENQFRI--AVKRFNR-SAWPDARQFLEEARAVGQLRNRRLANLLGCCCEGD 126
            VY G L   +  +I  AVK  NR +   +  QFL+E   +    +  + +LLG C   +
Sbjct: 10  CVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSE 69

Query: 127 -ERLLVAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAY 185
              L+V  YM +  L ++    ET        +   L +A+ +EY  SK + ++ DL A 
Sbjct: 70  GSPLVVLPYMKHGDL-RNFIRSETHNPTVKDLIGFGLQVAKGMEYLASK-KFVHRDLAAR 127

Query: 186 RIVFDDDVNPRLSCFGLMKNSRDGRSYSTN--------LAFTPPEYLRTGRVTPESVMYS 237
             + D+    +++ FGL ++  D   YS +        + +   E L+T + T +S ++S
Sbjct: 128 NCMLDESFTVKVADFGLARDIYDKEYYSVHNHTGAKLPVKWMALESLQTQKFTTKSDVWS 187

Query: 238 FGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEG------QFSSDEGTELVRLASR 291
           FG LL +L++ +  PP        D +   +T   L+G      ++  D    L  +   
Sbjct: 188 FGVLLWELMT-RGAPP------YPDVDSFDITVYLLQGRRLLQPEYCPD---PLYEVMLS 237

Query: 292 CLQYEPRERPNPRSLVT 308
           C   +P  RP    LV+
Sbjct: 238 CWHPKPEMRPTFSELVS 254

Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262

>gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1

 Score = 50.4 bits (120), Expect = 4e-07
 Identities = 63/284 (22%), Positives = 118/284 (41%), Gaps = 48/284 (16%)

Query: 62  VSEHGEKAPNVVYKGKL-----ENQFRIAVKRF----NRSAWPDARQFLEEARAVGQLRN 112
           + E GE A   +YKG L     ++   +A+K      N   W +   F +EA  + +L +
Sbjct: 10  MEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGE---FQQEASLMAELHH 66

Query: 113 RRLANLLGCCCEGDERLLVAEYMPNDTLAKHLFHW-----------ETQPMKWAMR---- 157
             +  LLG   +     ++ EY+    L + L              E   +K ++     
Sbjct: 67  PNIVCLLGVVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDF 126

Query: 158 LRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDGRSYSTN-- 215
           L +A+ IA  +EY +S    ++ DL A  I+  + ++ ++S  GL +       Y     
Sbjct: 127 LHIAIQIAAGMEYLSS-HFFVHKDLAARNILIGEQLHVKISDLGLSREIYSADYYRVQPK 185

Query: 216 ----LAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIP-----PSHALDLIRDRNIQ 266
               + + PPE +  G+ + +S ++SFG +L ++ S    P         ++++R R + 
Sbjct: 186 SLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFSNQEVIEMVRKRQLL 245

Query: 267 TLTDSCLEGQFSSDEGTELVRLASRCLQYEPRERPNPRSLVTAL 310
             ++ C    +S         L + C Q  P  RP  + + T L
Sbjct: 246 PCSEDCPPRMYS---------LMTECWQEGPSRRPRFKDIHTRL 280

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283

>gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase

 Score = 50.2 bits (120), Expect = 4e-07
 Identities = 65/268 (24%), Positives = 108/268 (40%), Gaps = 49/268 (18%)

Query: 68  KAPNVVYKGKLENQFRIAVKRFNRSAWPDAR-QFLEEARAVGQLRNRRLANLLGCCCEGD 126
           +AP ++     E    +AVK     A  D +  F  EA  + +  +  +  LLG C  G 
Sbjct: 25  RAPGLL---PYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVKLLGVCAVGK 81

Query: 127 ERLLVAEYMPNDTLAKHLFH----WETQ----------------PMKWAMRLRVALHIAE 166
              L+ EYM    L + L H     +                  P+    +L +A  +A 
Sbjct: 82  PMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAA 141

Query: 167 ALEYCTSKERALYH-DLNAYRIVFDDDVNPRLSCFGLMKN--SRDGRSYSTNLA----FT 219
            + Y +  ER   H DL     +  +++  +++ FGL +N  S D    S N A    + 
Sbjct: 142 GMAYLS--ERKFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKASENDAIPIRWM 199

Query: 220 PPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALD------LIRDRNIQTLTDSCL 273
           PPE +   R T ES ++++G +L ++ S   + P + +        +RD N+ +  D+C 
Sbjct: 200 PPESIFYNRYTTESDVWAYGVVLWEIFS-YGMQPYYGMAHEEVIYYVRDGNVLSCPDNC- 257

Query: 274 EGQFSSDEGTELVRLASRCLQYEPRERP 301
                     EL  L   C    P +RP
Sbjct: 258 --------PLELYNLMRLCWSKLPSDRP 277

Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288

>gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2

 Score = 49.2 bits (117), Expect = 1e-06
 Identities = 52/198 (26%), Positives = 92/198 (46%), Gaps = 23/198 (11%)

Query: 64  EHGEKAPNVVYKGKLE----NQFRIAVKRFNRSAWPDARQ-FLEEARAVGQLRNRRLANL 118
           E GE     V++G L+     +  +A+K          RQ FL EA  +GQ  +  +  L
Sbjct: 17  EFGE-----VFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRL 71

Query: 119 LGCCCEGDERLLVAEYMPNDTLAKHL--FHWETQPMKWAMRLRVALHIAEALEYCTSKER 176
            G   +    +++ EYM N  L K+L     E    +    LR    IA  ++Y  S   
Sbjct: 72  EGVVTKFKPAMIITEYMENGALDKYLRDHDGEFSSYQLVGMLR---GIAAGMKY-LSDMN 127

Query: 177 ALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDG--RSYSTN-----LAFTPPEYLRTGRV 229
            ++ DL A  I+ + ++  ++S FGL +   D    +Y+T+     + +T PE +   + 
Sbjct: 128 YVHRDLAARNILVNSNLECKVSDFGLSRVLEDDPEGTYTTSGGKIPIRWTAPEAIAYRKF 187

Query: 230 TPESVMYSFGTLLLDLLS 247
           T  S ++SFG ++ +++S
Sbjct: 188 TSASDVWSFGIVMWEVMS 205

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268

>gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros

 Score = 49.1 bits (117), Expect = 1e-06
 Identities = 56/256 (21%), Positives = 102/256 (39%), Gaps = 35/256 (13%)

Query: 73  VYKGKL-------ENQFRIAVKRFNRSAWPDAR-QFLEEARAVGQLRNRRLANLLGCCCE 124
           VY+G             R+AVK   + A    + +FL+EA  +    +  +  LLG C  
Sbjct: 11  VYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLL 70

Query: 125 GDERLLVAEYMPNDTLAKHLFHWETQPMKWAM-----RLRVALHIAEALEYCTSKERALY 179
            + + ++ E M    L  +L     +     +      L + L +A+   Y   +   ++
Sbjct: 71  NEPQYIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVY-LEQMHFIH 129

Query: 180 HDLNAYRIV-----FDDDVNPRLSCFGLMKNSRDGRSYST------NLAFTPPEYLRTGR 228
            DL A   +     +D D   ++  FGL ++      Y         + +  PE L  G+
Sbjct: 130 RDLAARNCLVSEKGYDADRVVKIGDFGLARDIYKSDYYRKEGEGLLPVRWMAPESLLDGK 189

Query: 229 VTPESVMYSFGTLLLDLLSGKHIP-PSHALDLIRDRNIQTLTDSCLEGQFSSDEGT--EL 285
            T +S ++SFG L+ ++L+    P P+         N + L      G+    E    ++
Sbjct: 190 FTTQSDVWSFGVLMWEILTLGQQPYPALN-------NQEVLQHVTAGGRLQKPENCPDKI 242

Query: 286 VRLASRCLQYEPRERP 301
            +L + C   +P ERP
Sbjct: 243 YQLMTNCWAQDPSERP 258

Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269

>gnl|CDD|173643 cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1

 Score = 48.8 bits (116), Expect = 1e-06
 Identities = 54/244 (22%), Positives = 104/244 (42%), Gaps = 24/244 (9%)

Query: 76  GKLENQFRIAVKRFNRSAWPDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAEYM 135
              E + ++ +K  + S    +  F E A  + Q+ ++ +  L G C    E ++V E++
Sbjct: 27  YSYEKEIKVILKVLDPSHRDISLAFFETASMMRQVSHKHIVLLYGVCVRDVENIMVEEFV 86

Query: 136 PNDTLAKHLF-HWETQPMKWAMRLRVALHIAEALEYCTSKERALYH------DLNAYRIV 188
               L   LF H ++  +    + +VA  +A AL Y   K+  L H      ++   R  
Sbjct: 87  EFGPL--DLFMHRKSDVLTTPWKFKVAKQLASALSYLEDKD--LVHGNVCTKNILLAREG 142

Query: 189 FDDDVNP--RLSCFGLMKNSRDGRSYSTNLAFTPPEYLRTGRV-TPESVMYSFGTLLLDL 245
            D +  P  +LS  G+       +     + +  PE +   +  +  +  +SFGT L ++
Sbjct: 143 IDGECGPFIKLSDPGIPITVLSRQECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEI 202

Query: 246 LSGKHIPPSHALDLIRDRNIQTLTDSCLEGQF--SSDEGTELVRLASRCLQYEPRERPNP 303
                IP       ++D+ +    +   EGQ    +    EL  L + C+ Y+P +RP  
Sbjct: 203 CYNGEIP-------LKDKTLAE-KERFYEGQCMLVTPSCKELADLMTHCMNYDPNQRPFF 254

Query: 304 RSLV 307
           R+++
Sbjct: 255 RAIM 258

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 262

>gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3

 Score = 49.2 bits (117), Expect = 1e-06
 Identities = 56/254 (22%), Positives = 104/254 (40%), Gaps = 41/254 (16%)

Query: 101 LEEARAVGQLRNRRLANLLGCCCEGDERLLVAEYMPNDTLAKHLFHWETQPMKWAMR--- 157
           +E  + +G+ +N  + NLLG C +     ++ EY     L ++L       M ++     
Sbjct: 68  MEMMKMIGKHKN--IINLLGACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCK 125

Query: 158 -----------LRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNS 206
                      +  A  +A  +EY  S+ + ++ DL A  ++  +D   +++ FGL ++ 
Sbjct: 126 LPEEQLTFKDLVSCAYQVARGMEYLASQ-KCIHRDLAARNVLVTEDNVMKIADFGLARDV 184

Query: 207 RDGRSY--STN----LAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSG-----KHIPPSH 255
            +   Y  +TN    + +  PE L     T +S ++SFG LL ++ +        IP   
Sbjct: 185 HNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEE 244

Query: 256 ALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLASRCLQYEPRERPNPRSLVT----ALV 311
              L+++ +      +C           EL  +   C    P +RP  + LV      L 
Sbjct: 245 LFKLLKEGHRMDKPANCTH---------ELYMIMRECWHAVPSQRPTFKQLVEDLDRVLT 295

Query: 312 TLQKDTELYLSLPW 325
               D  L LS+P+
Sbjct: 296 VTSTDEYLDLSVPF 309

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334

>gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases

 Score = 48.5 bits (116), Expect = 2e-06
 Identities = 45/183 (24%), Positives = 83/183 (45%), Gaps = 12/183 (6%)

Query: 73  VYKGKLENQFRIAVKRFNRSAWP-DARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLV 131
           VY  K   +  +AVK   +       ++FL EA  + QL +  +  L+G  C+G+  +LV
Sbjct: 15  VYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLIG-VCKGEPLMLV 73

Query: 132 AEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDD 191
            E  P   L K+L   + + +  +    +A  +A  + Y  SK   ++ DL A  ++  +
Sbjct: 74  MELAPLGPLLKYLK--KRREIPVSDLKELAHQVAMGMAYLESK-HFVHRDLAARNVLLVN 130

Query: 192 DVNPRLSCFGLMKNSRDGRSYSTN-------LAFTPPEYLRTGRVTPESVMYSFGTLLLD 244
               ++S FG+ +    G  Y          L +  PE +  G+ + +S ++S+G  L +
Sbjct: 131 RHQAKISDFGMSRALGAGSDYYRATTAGRWPLKWYAPECINYGKFSSKSDVWSYGVTLWE 190

Query: 245 LLS 247
             S
Sbjct: 191 AFS 193

Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257

>gnl|CDD|133207 cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

 Score = 48.0 bits (114), Expect = 2e-06
 Identities = 63/247 (25%), Positives = 109/247 (44%), Gaps = 34/247 (13%)

Query: 81  QFRIAVKRFNRSAWPDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAEYMPNDTL 140
           + R+ +K  + S    A  F E A  + Q+ +  LA + G C  G E ++V E++ +  L
Sbjct: 44  ELRVVLKVLDPSHRDIALAFFETASLMSQVSHIHLAFVHGVCVRGSENIMVEEFVEHGPL 103

Query: 141 AKHLFHWETQ-PMKWAMRLRVALHIAEALEYCTSKERALYH------DLNAYRIVFDDDV 193
              L   + + P+ W  ++ VA  +A AL Y   K   L H      ++   R+   +  
Sbjct: 104 DVCLRKEKGRVPVAW--KITVAQQLASALSYLEDKN--LVHGNVCAKNILLARLGLAEGT 159

Query: 194 NP--RLS--CFGLMKNSRDGRSYSTNLAFTPPEYLRTG-RVTPESVMYSFGTLLLDLLSG 248
           +P  +LS         SR+ R     + +  PE +  G  ++  +  +SFGT LL++   
Sbjct: 160 SPFIKLSDPGVSFTALSREERV--ERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFD 217

Query: 249 KHIP-----PSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLASRCLQYEPRERPNP 303
             +P     PS   +   ++  +    SC           EL  L S+CL YEP +RP+ 
Sbjct: 218 GEVPLKERTPSEK-ERFYEKKHRLPEPSC----------KELATLISQCLTYEPTQRPSF 266

Query: 304 RSLVTAL 310
           R+++  L
Sbjct: 267 RTILRDL 273

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 274

>gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A

 Score = 47.7 bits (113), Expect = 3e-06
 Identities = 68/273 (24%), Positives = 110/273 (40%), Gaps = 52/273 (19%)

Query: 64  EHGEKAPNVVYKGKLEN------QFRIAVKRFNRSAWPDARQ-FLEEARAVGQLRNRRLA 116
           E GE A   V+  +  N      +  +AVK   + A   ARQ F  EA  +  L+++ + 
Sbjct: 12  ELGEGAFGKVFLAECHNLLPEQDKMLVAVKAL-KEASESARQDFQREAELLTVLQHQHIV 70

Query: 117 NLLGCCCEGDERLLVAEYMPNDTL----------AKHLFHWETQP---MKWAMRLRVALH 163
              G C EG   L+V EYM +  L          AK L   E      +     L +A  
Sbjct: 71  RFYGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQ 130

Query: 164 IAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDGRSYSTN-------- 215
           IA  + Y  S    ++ DL     +    +  ++  FG+   SRD   YST+        
Sbjct: 131 IASGMVYLASLH-FVHRDLATRNCLVGQGLVVKIGDFGM---SRD--IYSTDYYRVGGRT 184

Query: 216 ---LAFTPPEYLRTGRVTPESVMYSFGTLLLDLLS-GK----HIPPSHALDLIRDRNIQT 267
              + + PPE +   + T ES ++SFG +L ++ + GK     +  + A++ I       
Sbjct: 185 MLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQLSNTEAIECITQGRELE 244

Query: 268 LTDSCLEGQFSSDEGTELVRLASRCLQYEPRER 300
              +C           E+  +   C Q EP++R
Sbjct: 245 RPRTC---------PPEVYAIMQGCWQREPQQR 268

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280

>gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase

 Score = 47.8 bits (114), Expect = 3e-06
 Identities = 51/226 (22%), Positives = 87/226 (38%), Gaps = 26/226 (11%)

Query: 100 FLEEARAVGQLRNRRLANLLGCCCEGDERLLVAEYMPNDTLAKHLFHWETQPMKWAMRLR 159
           FL+EA  +  L +  L  L G        ++V E  P  +L   L          +    
Sbjct: 43  FLKEAAIMHSLDHENLIRLYGVVLT-HPLMMVTELAPLGSLLDRLRKDALGHFLISTLCD 101

Query: 160 VALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDGRSYSTN---- 215
            A+ IA  + Y  SK R ++ DL A  I+   D   ++  FGLM+       +       
Sbjct: 102 YAVQIANGMRYLESK-RFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVMEEHL 160

Query: 216 ---LAFTPPEYLRTGRVTPESVMYSFGTLLLDLLS-----GKHIPPSHALDLIRDRNIQT 267
               A+  PE LRT   +  S ++ FG  L ++ +        +  S  L  I D+  + 
Sbjct: 161 KVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGLSGSQILKKI-DKEGER 219

Query: 268 LT--DSCLEGQFSSDEGTELVRLASRCLQYEPRERPNPRSLVTALV 311
           L   ++C +         ++  +  +C  + P +RP   +L   L 
Sbjct: 220 LERPEACPQ---------DIYNVMLQCWAHNPADRPTFAALREFLP 256

Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257

>gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase

 Score = 47.4 bits (113), Expect = 4e-06
 Identities = 59/266 (22%), Positives = 100/266 (37%), Gaps = 27/266 (10%)

Query: 60  NIVSEHGEKAPNVVYKGK-LENQFRIAVKRFNRSAWP-DARQFLEEARAVGQLRNRRLAN 117
            ++   G  A  VVY    L N  ++A+KR +         +  +E +A+ Q  +  +  
Sbjct: 4   ELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVK 63

Query: 118 LLGCCCEGDERLLVAEYMPNDTLA---KHLFHWETQPMKW-AMRLRVALHIAEALEYCTS 173
                  GDE  LV  Y+   +L    K  +          A  L+  L   + LEY  S
Sbjct: 64  YYTSFVVGDELWLVMPYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVL---KGLEYLHS 120

Query: 174 KERALYHDLNAYRIVFDDDVNPRLSCFG----LMKNSRDGRSYSTNLAFTP----PEYLR 225
             + ++ D+ A  I+  +D + +++ FG    L       R        TP    PE + 
Sbjct: 121 NGQ-IHRDIKAGNILLGEDGSVKIADFGVSASLADGGDRTRKVRKTFVGTPCWMAPEVME 179

Query: 226 TGRVTPESV-MYSFGTLLLDLLSGK----HIPPSHALDLIRDRNIQTLTDSCLEGQFSSD 280
                     ++SFG   ++L +G       PP   L L    +  +L       ++S  
Sbjct: 180 QVHGYDFKADIWSFGITAIELATGAAPYSKYPPMKVLMLTLQNDPPSLETGADYKKYSK- 238

Query: 281 EGTELVRLASRCLQYEPRERPNPRSL 306
                 ++ S CLQ +P +RP    L
Sbjct: 239 ---SFRKMISLCLQKDPSKRPTAEEL 261

Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267

>gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase

 Score = 46.7 bits (111), Expect = 6e-06
 Identities = 53/250 (21%), Positives = 97/250 (38%), Gaps = 42/250 (16%)

Query: 84  IAVKRFNRSAWP-DARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAEYMPNDTLAK 142
           +AVK    S    D   FL EA  + +  ++ +  L+G   E   R ++ E M    L  
Sbjct: 39  VAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVRLIGVSFERLPRFILLELMAGGDLKS 98

Query: 143 HLFHWE---TQPMKWAMR--LRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRL 197
            L        +P    M+  L  A  +A+  +Y       ++ D+ A   +        L
Sbjct: 99  FLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEEN-HFIHRDIAARNCL--------L 149

Query: 198 SC-----------FGLMKNSRDGRSYSTN------LAFTPPEYLRTGRVTPESVMYSFGT 240
           +C           FG+ ++      Y         + + PPE    G  T ++ ++SFG 
Sbjct: 150 TCKGPGRVAKIADFGMARDIYRASYYRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGV 209

Query: 241 LLLDLLSGKHIP-PSHALDLIRDRNIQTLTDSCLEGQFSSDEG--TELVRLASRCLQYEP 297
           LL ++ S  ++P P          N + +      G+    +G    + R+ + C Q+ P
Sbjct: 210 LLWEIFSLGYMPYPGR-------TNQEVMEFVTGGGRLDPPKGCPGPVYRIMTDCWQHTP 262

Query: 298 RERPNPRSLV 307
            +RPN  +++
Sbjct: 263 EDRPNFATIL 272

Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277

>gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase

 Score = 46.6 bits (111), Expect = 6e-06
 Identities = 56/249 (22%), Positives = 96/249 (38%), Gaps = 23/249 (9%)

Query: 73  VYKGKLENQFRIAVKRFNRSAWPDARQ-FLEEARAVGQLRNRRLANLLGCCCEGDERLLV 131
           VY      +  +AVK       P  R+ FL+EA  + Q  +  +  L+G   E +   +V
Sbjct: 26  VYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKLIGVITE-NPVWIV 84

Query: 132 AEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDD 191
            E  P   L  +L       +  A  +  +  ++ AL Y  SK R ++ D+ A  ++   
Sbjct: 85  MELAPLGELRSYL-QVNKYSLDLASLILYSYQLSTALAYLESK-RFVHRDIAARNVLVSS 142

Query: 192 DVNPRLSCFGLMKNSRDGRSYSTNLAFTP-----PEYLRTGRVTPESVMYSFGTLLLDLL 246
               +L  FGL +   D   Y  +    P     PE +   R T  S ++ FG  + ++L
Sbjct: 143 PDCVKLGDFGLSRYLEDESYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEIL 202

Query: 247 S-GKH----IPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLASRCLQYEPRERP 301
             G      +  +  +  I +     +  +C            L  L ++C  Y+P +RP
Sbjct: 203 MLGVKPFQGVKNNDVIGRIENGERLPMPPNC---------PPTLYSLMTKCWAYDPSKRP 253

Query: 302 NPRSLVTAL 310
               L   L
Sbjct: 254 RFTELKAQL 262

Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270

>gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4

 Score = 45.4 bits (107), Expect = 2e-05
 Identities = 60/269 (22%), Positives = 113/269 (42%), Gaps = 21/269 (7%)

Query: 66  GEKAPNVVYKGKL-----ENQFRIAVKRFNRSAWPDAR-QFLEEARAVGQLRNRRLANLL 119
           G  A   VYKG         +  +A+K  N +  P A  +F++EA  +  + +  L  LL
Sbjct: 16  GSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRLL 75

Query: 120 GCCCEGDERLLVAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALY 179
           G C     + LV + MP+  L  ++ H     +   + L   + IA+ + Y   +ER L 
Sbjct: 76  GVCLSPTIQ-LVTQLMPHGCLLDYV-HEHKDNIGSQLLLNWCVQIAKGMMYL--EERRLV 131

Query: 180 H-DLNAYRIVFDDDVNPRLSCFGLMK-NSRDGRSYSTNLAFTPPEYL-----RTGRVTPE 232
           H DL A  ++     + +++ FGL +    D + Y+ +    P +++        + T +
Sbjct: 132 HRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPIKWMALECIHYRKFTHQ 191

Query: 233 SVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLASRC 292
           S ++S+G  + +L++    P     D I  R I  L +             ++  +  +C
Sbjct: 192 SDVWSYGVTIWELMTFGGKP----YDGIPTREIPDLLEKGERLPQPPICTIDVYMVMVKC 247

Query: 293 LQYEPRERPNPRSLVTALVTLQKDTELYL 321
              +   RP  + L      + +D + YL
Sbjct: 248 WMIDADSRPKFKELAAEFSRMARDPQRYL 276

Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303

>gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4

 Score = 45.1 bits (107), Expect = 2e-05
 Identities = 48/223 (21%), Positives = 92/223 (41%), Gaps = 16/223 (7%)

Query: 100 FLEEARAVGQLRNRRLANLLGCCCEGDERLLVAEYMPNDTLAKHLF-------HWETQPM 152
           F  E     +L ++ +  LLG C E +   ++ EY     L + L          +  P+
Sbjct: 55  FRRELDMFRKLSHKNVVRLLGLCREAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPL 114

Query: 153 KWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDGRSY 212
               ++ +   IA  +++  S  R ++ DL A   +       ++S   L K+  +   Y
Sbjct: 115 STKQKVALCTQIALGMDH-LSNARFVHRDLAARNCLVSSQREVKVSLLSLSKDVYNSEYY 173

Query: 213 STN-----LAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQT 267
                   L +  PE ++    + +S ++SFG L+ ++ +   +P      L  +  +  
Sbjct: 174 KLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFY---GLSDEEVLNR 230

Query: 268 LTDSCLEGQFSSDEGTELVRLASRCLQYEPRERPNPRSLVTAL 310
           L    LE        + L +L +RC    P++RP+   LV+AL
Sbjct: 231 LQAGKLELPVPEGCPSRLYKLMTRCWAVNPKDRPSFSELVSAL 273

Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275

>gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1

 Score = 44.7 bits (105), Expect = 3e-05
 Identities = 53/243 (21%), Positives = 104/243 (42%), Gaps = 19/243 (7%)

Query: 73  VYKGKLENQFR--IAVKRFN-RSAWPDARQFLEEARAVGQLRNRRLANLLGCCCEGDERL 129
           VYKG ++N+ +  +A+K  +   A  +     +E   + Q  +  +    G   +G +  
Sbjct: 20  VYKG-IDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGSYLKGTKLW 78

Query: 130 LVAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVF 189
           ++ EY+   +    L   +  P++      +   I + L+Y  S ER ++ D+ A  ++ 
Sbjct: 79  IIMEYLGGGSALDLL---KPGPLEETYIATILREILKGLDYLHS-ERKIHRDIKAANVLL 134

Query: 190 DDDVNPRLSCFGLMKNSRDGRSYSTNLAFTP----PEYLRTGRVTPESVMYSFGTLLLDL 245
            +  + +L+ FG+     D +        TP    PE ++      ++ ++S G   ++L
Sbjct: 135 SEQGDVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIEL 194

Query: 246 LSGKHIPPSHALDLIRDRN-IQTLTDSCLEGQFSSDEGTELVRLASRCLQYEPRERPNPR 304
             G+  PP+  L  +R    I   +   LEGQ+S             CL  +PR RP  +
Sbjct: 195 AKGE--PPNSDLHPMRVLFLIPKNSPPTLEGQYSK----PFKEFVEACLNKDPRFRPTAK 248

Query: 305 SLV 307
            L+
Sbjct: 249 ELL 251

Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277

>gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors

 Score = 44.5 bits (105), Expect = 3e-05
 Identities = 50/201 (24%), Positives = 97/201 (48%), Gaps = 27/201 (13%)

Query: 64  EHGEKAPNVVYKGKLE----NQFRIAVKRFNRSAWPDA--RQFLEEARAVGQLRNRRLAN 117
           E GE     V +G+L+     +  +A+K   +S + +   R FL EA  +GQ  +  + +
Sbjct: 16  EFGE-----VCRGRLKLPGKREIFVAIKTL-KSGYTEKQRRDFLSEASIMGQFDHPNIIH 69

Query: 118 LLGCCCEGDERLLVAEYMPNDTLAKHLFHWETQ--PMKWAMRLRVALHIAEALEYCTSKE 175
           L G   +    +++ E+M N  L   L   + Q   ++    LR    IA  ++Y  S+ 
Sbjct: 70  LEGVVTKSRPVMIITEFMENGALDSFLRQNDGQFTVIQLVGMLR---GIAAGMKY-LSEM 125

Query: 176 RALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDGRS---YSTNLA------FTPPEYLRT 226
             ++ DL A  I+ + ++  ++S FGL +   D  S   Y+++L       +T PE +  
Sbjct: 126 NYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSSLGGKIPIRWTAPEAIAY 185

Query: 227 GRVTPESVMYSFGTLLLDLLS 247
            + T  S ++S+G ++ +++S
Sbjct: 186 RKFTSASDVWSYGIVMWEVMS 206

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269

>gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2

 Score = 43.9 bits (103), Expect = 5e-05
 Identities = 38/174 (21%), Positives = 77/174 (44%), Gaps = 10/174 (5%)

Query: 84  IAVKRFNRSAWPDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAEYMPNDTLAKH 143
           +A+K+ N    P     + E   + +L+N  + N L     GDE  +V EY+   +L   
Sbjct: 47  VAIKQINLQKQPKKELIINEILVMKELKNPNIVNFLDSFLVGDELFVVMEYLAGGSLTDV 106

Query: 144 LFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLM 203
           +        + A   R  L   +ALE+  + +  ++ D+ +  ++   D + +L+ FG  
Sbjct: 107 VTETCMDEAQIAAVCRECL---QALEFLHANQ-VIHRDIKSDNVLLGMDGSVKLTDFGFC 162

Query: 204 KNSRDGRSYSTNLAFTP----PEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPP 253
                 +S  + +  TP    PE +      P+  ++S G + ++++ G+  PP
Sbjct: 163 AQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGE--PP 214

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296

>gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2

 Score = 43.7 bits (103), Expect = 6e-05
 Identities = 50/210 (23%), Positives = 88/210 (41%), Gaps = 27/210 (12%)

Query: 84  IAVKRFNRSAWPDARQ-FLEEARAVGQLRNRRLANLLGCCCEGDERLLVAEYMPNDTLAK 142
           +AVK     A  +AR  FL+E + + +L++  +  LL  C   D   ++ EYM N  L +
Sbjct: 49  VAVKMLREDANKNARNDFLKEIKIMSRLKDPNIIRLLAVCITSDPLCMITEYMENGDLNQ 108

Query: 143 HLFHWETQP---------MKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDV 193
            L   E Q          + ++  + +A  IA  ++Y +S    ++ DL     +   + 
Sbjct: 109 FLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSLN-FVHRDLATRNCLVGKNY 167

Query: 194 NPRLSCFGLMKNSRDGRSYSTNLAFTPP------EYLRTGRVTPESVMYSFGTLLLDLLS 247
             +++ FG+ +N   G  Y        P      E +  G+ T  S +++FG  L ++L+
Sbjct: 168 TIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILT 227

Query: 248 -GKHIPPSHALD---------LIRDRNIQT 267
             K  P S   D           RD+  Q 
Sbjct: 228 LCKEQPYSQLSDEQVIENTGEFFRDQGRQV 257

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296

>gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6

 Score = 43.5 bits (102), Expect = 7e-05
 Identities = 57/228 (25%), Positives = 94/228 (41%), Gaps = 16/228 (7%)

Query: 77  KLENQFRIAVKRFNRSAWPDARQFLEEARAVGQLRNRRLANLLGCCCEGDERL-LVAEYM 135
           KLE + RI  KR   S   + +Q LE+        N R    L    E  + L LV   M
Sbjct: 32  KLEKK-RIK-KRKGESMALNEKQILEKV-------NSRFVVSLAYAYETKDALCLVLTLM 82

Query: 136 PNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNP 195
               L  H++H      +    +  A  I   LE    +ER +Y DL    I+ DD  + 
Sbjct: 83  NGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLED-LHQERIVYRDLKPENILLDDHGHI 141

Query: 196 RLSCFGLMKNSRDGRSYS---TNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIP 252
           R+S  GL  +  +G++       + +  PE ++  R T     ++ G LL ++++G+  P
Sbjct: 142 RISDLGLAVHVPEGQTIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQS-P 200

Query: 253 PSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLASRCLQYEPRER 300
                  I+   ++ L     E ++S     +   L    L  +P+ER
Sbjct: 201 FQQRKKKIKREEVERLVKEVQE-EYSEKFSPDARSLCKMLLCKDPKER 247

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285

>gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2

 Score = 43.5 bits (102), Expect = 8e-05
 Identities = 54/246 (21%), Positives = 104/246 (42%), Gaps = 40/246 (16%)

Query: 101 LEEARAVGQLRNRRLANLLGCCCEGDERLLVAEYMPNDTLAKHL---------FHWET-- 149
           +E  + +G+ +N  + NLLG C +     ++ EY     L ++L         + ++   
Sbjct: 71  MEMMKMIGKHKN--IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIAR 128

Query: 150 ---QPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMK-- 204
              + M +   +     +A  +EY  S ++ ++ DL A  ++  ++   +++ FGL +  
Sbjct: 129 VPDEQMTFKDLVSCTYQVARGMEYLAS-QKCIHRDLAARNVLVTENNVMKIADFGLARDV 187

Query: 205 NSRDGRSYSTN----LAFTPPEYLRTGRVTPESVMYSFGTLLLDL--LSGK---HIPPSH 255
           N+ D    +TN    + +  PE L     T +S ++SFG L+ ++  L G     IP   
Sbjct: 188 NNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEE 247

Query: 256 ALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLASRCLQYEPRERPNPRSLVTAL---VT 312
              L+++ +      +C           EL  +   C    P  RP  + LV  L   +T
Sbjct: 248 LFKLLKEGHRMDKPANCT---------NELYMMMRDCWHAIPSHRPTFKQLVEDLDRILT 298

Query: 313 LQKDTE 318
           L  + E
Sbjct: 299 LTTNEE 304

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304

>gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1

 Score = 43.5 bits (102), Expect = 9e-05
 Identities = 52/235 (22%), Positives = 97/235 (41%), Gaps = 37/235 (15%)

Query: 101 LEEARAVGQLRNRRLANLLGCCCEGDERLLVAEYMPNDTLAKHL--------------FH 146
           +E  + +G+ +N  + NLLG C +     ++ EY     L ++L                
Sbjct: 74  MEMMKMIGKHKN--IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQ 131

Query: 147 WETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNS 206
              + + +   +  A  +A  +EY  SK + ++ DL A  ++  +D   +++ FGL ++ 
Sbjct: 132 VPEEQLSFKDLVSCAYQVARGMEYLASK-KCIHRDLAARNVLVTEDNVMKIADFGLARDI 190

Query: 207 R--DGRSYSTN----LAFTPPEYLRTGRVTPESVMYSFGTLLLDL--LSGK---HIPPSH 255
              D    +TN    + +  PE L     T +S ++SFG LL ++  L G     +P   
Sbjct: 191 HHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEE 250

Query: 256 ALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLASRCLQYEPRERPNPRSLVTAL 310
              L+++ +      +C           EL  +   C    P +RP  + LV  L
Sbjct: 251 LFKLLKEGHRMDKPSNCTN---------ELYMMMRDCWHAVPSQRPTFKQLVEDL 296

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307

>gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases

 Score = 42.8 bits (101), Expect = 1e-04
 Identities = 44/200 (22%), Positives = 82/200 (41%), Gaps = 41/200 (20%)

Query: 73  VYKG-----KLENQFRIAVKRFNRSAWPDARQ-FLEEARAVGQLRNRRLANLLGCCCEGD 126
           VYKG       + +  +A+K       P A +  L+EA  +  + +  +  LLG C    
Sbjct: 23  VYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRLLGICL-SS 81

Query: 127 ERLLVAEYMP-----------NDTL-AKHLFHWETQPMKWAMRLRVALHIAEALEYCTSK 174
           +  L+ + MP            D + +++L +W  Q             IA+ + Y   +
Sbjct: 82  QVQLITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQ-------------IAKGMSYL--E 126

Query: 175 ERALYH-DLNAYRIVFDDDVNPRLSCFGLMKN-SRDGRSYSTNLAFTP-----PEYLRTG 227
           E+ L H DL A  ++     + +++ FGL K    D + Y       P      E +   
Sbjct: 127 EKRLVHRDLAARNVLVKTPQHVKITDFGLAKLLDVDEKEYHAEGGKVPIKWMALESILHR 186

Query: 228 RVTPESVMYSFGTLLLDLLS 247
             T +S ++S+G  + +L++
Sbjct: 187 IYTHKSDVWSYGVTVWELMT 206

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279

>gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors

 Score = 42.6 bits (100), Expect = 1e-04
 Identities = 41/161 (25%), Positives = 77/161 (47%), Gaps = 17/161 (10%)

Query: 98  RQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAEYMPNDT----LAKHLFHWETQPMK 153
           R FL EA  +GQ  +  + +L G   +    ++V EYM N +    L KH   +    + 
Sbjct: 50  RDFLSEASIMGQFDHPNIIHLEGVVTKSKPVMIVTEYMENGSLDAFLRKHDGQFTVIQLV 109

Query: 154 WAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDG--RS 211
             +R      IA  ++Y  S    ++ DL A  I+ + ++  ++S FGL +   D    +
Sbjct: 110 GMLR-----GIASGMKY-LSDMGYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEAA 163

Query: 212 YSTN-----LAFTPPEYLRTGRVTPESVMYSFGTLLLDLLS 247
           Y+T      + +T PE +   + T  S ++S+G ++ +++S
Sbjct: 164 YTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMS 204

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267

>gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

 Score = 42.4 bits (100), Expect = 1e-04
 Identities = 58/247 (23%), Positives = 101/247 (40%), Gaps = 30/247 (12%)

Query: 84  IAVKRFNRSAWPDARQFLEEARAVGQLRNRRLANLLGCCCEGDER--LLVAEYMP----N 137
           +AVK+   S     R F  E   +  L++  +    G C     R   LV EY+P     
Sbjct: 36  VAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLRLVMEYLPYGSLR 95

Query: 138 DTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRL 197
           D L KH    + + +     L  A  I + +EY  SK R ++ DL    I+ + +   ++
Sbjct: 96  DYLQKHRERLDHRKL-----LLYASQICKGMEYLGSK-RYVHRDLATRNILVESENRVKI 149

Query: 198 SCFGLMKNSRDGRSYST-------NLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKH 250
             FGL K     + Y          + +  PE L   + +  S ++SFG +L +L +   
Sbjct: 150 GDFGLTKVLPQDKEYYKVREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYSD 209

Query: 251 I---PPSHALDLI-RDRNIQTLTDSCLE-----GQFSSDEG--TELVRLASRCLQYEPRE 299
               PP+  + ++  D+  Q +    +E     G+  +  G   E+  +   C   +P +
Sbjct: 210 KSCSPPAEFMRMMGNDKQGQMIVYHLIELLKNNGRLPAPPGCPAEIYAIMKECWNNDPSQ 269

Query: 300 RPNPRSL 306
           RP+   L
Sbjct: 270 RPSFSEL 276

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284

>gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4

 Score = 42.6 bits (100), Expect = 1e-04
 Identities = 57/239 (23%), Positives = 98/239 (41%), Gaps = 36/239 (15%)

Query: 111 RNRRLANLLGCCCEGDERLLVAEYMPNDTLAKHL--------------FHWETQPMKWAM 156
           +++ + NLLG C +     ++ EY     L + L                   + + +  
Sbjct: 76  KHKNIINLLGVCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKD 135

Query: 157 RLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDGRSY--ST 214
            +  A  +A  +EY  S+ R ++ DL A  ++  +D   +++ FGL +   D   Y  ++
Sbjct: 136 LVSCAYQVARGMEYLESR-RCIHRDLAARNVLVTEDNVMKIADFGLARGVHDIDYYKKTS 194

Query: 215 N----LAFTPPEYLRTGRVTPESVMYSFGTLLLDL--LSGKH---IPPSHALDLIRDRNI 265
           N    + +  PE L     T +S ++SFG L+ ++  L G     IP      L+R+ + 
Sbjct: 195 NGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPGIPVEELFKLLREGHR 254

Query: 266 QTLTDSCLEGQFSSDEGTELVRLASRCLQYEPRERPNPRSLVTAL-VTLQKDTELYLSL 323
                +C           EL  L   C    P +RP  + LV AL   L   +E YL L
Sbjct: 255 MDKPSNCTH---------ELYMLMRECWHAVPTQRPTFKQLVEALDKVLAAVSEEYLDL 304

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314

>gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases

 Score = 42.1 bits (99), Expect = 2e-04
 Identities = 39/164 (23%), Positives = 69/164 (42%), Gaps = 21/164 (12%)

Query: 159 RVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGL---MKNSRDGRSYSTN 215
           ++A+ + E L Y  +  R ++ D+    I+ +     +L  FG+   + NS       T+
Sbjct: 107 KIAVAVVEGLTYLYNVHRIMHRDIKPSNILVNSRGQIKLCDFGVSGELINSIADTFVGTS 166

Query: 216 LAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGK------------HIPPSHALDLIRDR 263
             +  PE ++ G+ T +S ++S G  +++L  GK               P   LDL++ +
Sbjct: 167 -TYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQ-Q 224

Query: 264 NIQTLTDSCLEGQFSSDEGTELVRLASRCLQYEPRERPNPRSLV 307
            +Q          F  D    L      CL  +P ERP P+ L 
Sbjct: 225 IVQEPPPRLPSSDFPED----LRDFVDACLLKDPTERPTPQQLC 264

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284

>gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1

 Score = 42.0 bits (98), Expect = 2e-04
 Identities = 42/193 (21%), Positives = 82/193 (42%), Gaps = 11/193 (5%)

Query: 66  GEKAPNVVYKG-KLENQFRIAVKRFNRSAWPDARQFLEEARAVGQLRNRRLANLLGCCCE 124
           G+ A   VY    +     +A+++ N    P     + E   + + +N  + N L     
Sbjct: 29  GQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLV 88

Query: 125 GDERLLVAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNA 184
           GDE  +V EY+   +L   +        + A   R  L   +ALE+  S +  ++ D+ +
Sbjct: 89  GDELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCRECL---QALEFLHSNQ-VIHRDIKS 144

Query: 185 YRIVFDDDVNPRLSCFGLMKNSRDGRSYSTNLAFTP----PEYLRTGRVTPESVMYSFGT 240
             I+   D + +L+ FG        +S  + +  TP    PE +      P+  ++S G 
Sbjct: 145 DNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGI 204

Query: 241 LLLDLLSGKHIPP 253
           + ++++ G+  PP
Sbjct: 205 MAIEMIEGE--PP 215

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296

>gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3

 Score = 41.6 bits (97), Expect = 3e-04
 Identities = 42/193 (21%), Positives = 82/193 (42%), Gaps = 11/193 (5%)

Query: 66  GEKAPNVVYKG-KLENQFRIAVKRFNRSAWPDARQFLEEARAVGQLRNRRLANLLGCCCE 124
           G+ A   VY    +     +A+K+ N    P     + E   + + +N  + N L     
Sbjct: 28  GQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLV 87

Query: 125 GDERLLVAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNA 184
           GDE  +V EY+   +L   +        + A   R  L   +AL++  S +  ++ D+ +
Sbjct: 88  GDELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCRECL---QALDFLHSNQ-VIHRDIKS 143

Query: 185 YRIVFDDDVNPRLSCFGLMKNSRDGRSYSTNLAFTP----PEYLRTGRVTPESVMYSFGT 240
             I+   D + +L+ FG        +S  + +  TP    PE +      P+  ++S G 
Sbjct: 144 DNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGI 203

Query: 241 LLLDLLSGKHIPP 253
           + ++++ G+  PP
Sbjct: 204 MAIEMVEGE--PP 214

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297

>gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases

 Score = 41.4 bits (98), Expect = 3e-04
 Identities = 43/146 (29%), Positives = 63/146 (43%), Gaps = 23/146 (15%)

Query: 130 LVAEYMPND---TLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYR 186
           +V EYM +D    L      +    +K  M+      + E L+Y  S    L+ D+    
Sbjct: 77  MVFEYMDHDLTGLLDSPEVKFTESQIKCYMK-----QLLEGLQYLHSN-GILHRDIKGSN 130

Query: 187 IVFDDDVNPRLSCFGLMK--NSRDGRSYSTNLAFT----PPEYLRTG--RVTPESVMYSF 238
           I+ ++D   +L+ FGL +    R+   Y TN   T    PPE L  G  R  PE  M+S 
Sbjct: 131 ILINNDGVLKLADFGLARPYTKRNSADY-TNRVITLWYRPPELL-LGATRYGPEVDMWSV 188

Query: 239 GTLLLDLLSGKHIPP----SHALDLI 260
           G +L +L  GK I         L+ I
Sbjct: 189 GCILAELFLGKPIFQGSTELEQLEKI 214

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287

>gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1

 Score = 40.7 bits (95), Expect = 5e-04
 Identities = 50/231 (21%), Positives = 101/231 (43%), Gaps = 34/231 (14%)

Query: 110 LRNRRLANLL---GCCCEGDER--LLVAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHI 164
           LRN    N++   G C E       L+ E++P+ +L ++L       +    +L+ A+ I
Sbjct: 60  LRNLYHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPR-NKNKINLKQQLKYAVQI 118

Query: 165 AEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDGRSYST-------NLA 217
            + ++Y  S++  ++ DL A  ++ + +   ++  FGL K     + Y T        + 
Sbjct: 119 CKGMDYLGSRQY-VHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDLDSPVF 177

Query: 218 FTPPEYLRTGRVTPESVMYSFGTLLLDLLSG------------KHIPPSHALDLIRDRNI 265
           +  PE L   +    S ++SFG  L +LL+             K I P+H   +   R +
Sbjct: 178 WYAPECLIQSKFYIASDVWSFGVTLYELLTYCDSESSPMTLFLKMIGPTHG-QMTVTRLV 236

Query: 266 QTLTDSCLEGQ---FSSDEGTELVRLASRCLQYEPRERPNPRSLVTALVTL 313
           + L     EG+      +   E+ +L  +C +++P +R   ++L+     +
Sbjct: 237 RVLE----EGKRLPRPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIEGFEAI 283

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284

>gnl|CDD|173667 cd05576, STKc_RPK118_like, Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins

 Score = 40.6 bits (95), Expect = 5e-04
 Identities = 47/182 (25%), Positives = 77/182 (42%), Gaps = 26/182 (14%)

Query: 126 DERLLVAEYMPNDTLAKHLFHW----ETQPMKWAMRLRVALHIAEALEYCTSKERALYHD 181
           D   LV ++     L  H+  +    E    +WA  + VAL   +AL     +E  +  D
Sbjct: 58  DSVFLVLQHAEGGKLWSHISKFLNIPEECVKRWAAEMVVAL---DALH----REGIVCRD 110

Query: 182 LNAYRIVFDDDVNPRLSCFGL---MKNSRDGRSYSTNLAFTPPEYLRTGRVTPESVMYSF 238
           LN   I+ DD  + +L+ F     +++S DG +      +  PE       T     +S 
Sbjct: 111 LNPNNILLDDRGHIQLTYFSRWSEVEDSCDGEAVEN--MYCAPEVGGISEETEACDWWSL 168

Query: 239 GTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLASRCLQYEPR 298
           G +L +LL+GK +   H         I T T   +  ++ S+E   L+    + LQ+ P 
Sbjct: 169 GAILFELLTGKTLVECHP------SGINTHTTLNIP-EWVSEEARSLL---QQLLQFNPT 218

Query: 299 ER 300
           ER
Sbjct: 219 ER 220

Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phosphate (SPP), a lipid messenger involved in many cellular events. RPK118 may be involved in transmitting SPP-mediated signaling. RPK118 also binds the antioxidant peroxiredoxin-3 (PRDX3). RPK118 may be involved in the transport of PRDX3 from the cytoplasm to its site of function in the mitochondria. Length = 237

>gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase

 Score = 40.6 bits (95), Expect = 6e-04
 Identities = 45/202 (22%), Positives = 77/202 (38%), Gaps = 26/202 (12%)

Query: 72  VVYKGK-LENQFRIAVKRFNRSAWPDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLL 130
           +VY  + L  Q RIA+K          +   EE      L++R +   LG   E     +
Sbjct: 23  IVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSDSENGFFKI 82

Query: 131 VAEYMPNDTLAKHL-FHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLN-AYRIV 188
             E +P  +L+  L   W          +     I E L+Y         HD    +R +
Sbjct: 83  FMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKY--------LHDNQIVHRDI 134

Query: 189 FDDDV--NP-----RLSCFGLMKN----SRDGRSYSTNLAFTPPEYLRTGR--VTPESVM 235
             D+V  N      ++S FG  K     +    +++  L +  PE +  G       + +
Sbjct: 135 KGDNVLVNTYSGVVKISDFGTSKRLAGINPCTETFTGTLQYMAPEVIDKGPRGYGAPADI 194

Query: 236 YSFGTLLLDLLSGKHIPPSHAL 257
           +S G  ++++ +GK  PP   L
Sbjct: 195 WSLGCTIVEMATGK--PPFIEL 214

Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268

>gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors

 Score = 40.5 bits (95), Expect = 7e-04
 Identities = 54/247 (21%), Positives = 100/247 (40%), Gaps = 20/247 (8%)

Query: 76  GKLENQFRIAVKRFNRSAWPDARQFL-EEARAVGQLRNR-RLANLLGCCCEGDERLLVAE 133
            K +   ++AVK    +A    R+ L  E + +  L N   + NLLG C  G   L++ E
Sbjct: 60  SKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIVNLLGACTIGGPILVITE 119

Query: 134 YMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDV 193
           Y     L   L       +     L  +  +A+ + +  SK   ++ DL A  ++     
Sbjct: 120 YCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAFLASKN-CIHRDLAARNVLLTHGK 178

Query: 194 NPRLSCFGLMKNSRDGRSY-STNLAFTP-----PEYLRTGRVTPESVMYSFGTLLLDLLS 247
             ++  FGL ++  +  +Y     A  P     PE +     T ES ++S+G LL ++ S
Sbjct: 179 IVKICDFGLARDIMNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFS 238

Query: 248 -GKHIPPSHALDLIRDRNIQTLTDS---CLEGQFSSDEGTELVRLASRCLQYEPRERPNP 303
            G +  P     +  D     L        + + +  E  ++++    C   +P +RP  
Sbjct: 239 LGSNPYP----GMPVDSKFYKLIKEGYRMAQPEHAPAEIYDIMK---TCWDADPLKRPTF 291

Query: 304 RSLVTAL 310
           + +V  +
Sbjct: 292 KQIVQLI 298

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302

>gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2

 Score = 40.4 bits (94), Expect = 7e-04
 Identities = 57/268 (21%), Positives = 110/268 (41%), Gaps = 19/268 (7%)

Query: 66  GEKAPNVVYKGKL----EN-QFRIAVKRFNRSAWPDA-RQFLEEARAVGQLRNRRLANLL 119
           G  A   VYKG      EN +  +A+K    +  P A ++ L+EA  +  + +  +  LL
Sbjct: 16  GSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRLL 75

Query: 120 GCCCEGDERLLVAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALY 179
           G C     +L V + MP   L  ++   + +     + L   + IA+ + Y   + R ++
Sbjct: 76  GICLTSTVQL-VTQLMPYGCLLDYVRENKDRIGSQDL-LNWCVQIAKGMSY-LEEVRLVH 132

Query: 180 HDLNAYRIVFDDDVNPRLSCFGLMKN-SRDGRSYSTNLAFTPPEYLRTG-----RVTPES 233
            DL A  ++     + +++ FGL +    D   Y  +    P +++        R T +S
Sbjct: 133 RDLAARNVLVKSPNHVKITDFGLARLLDIDETEYHADGGKVPIKWMALESILHRRFTHQS 192

Query: 234 VMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLASRCL 293
            ++S+G  + +L++    P     D I  R I  L +             ++  +  +C 
Sbjct: 193 DVWSYGVTVWELMTFGAKP----YDGIPAREIPDLLEKGERLPQPPICTIDVYMIMVKCW 248

Query: 294 QYEPRERPNPRSLVTALVTLQKDTELYL 321
             +   RP  R LV     + +D   ++
Sbjct: 249 MIDSECRPRFRELVDEFSRMARDPSRFV 276

Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279

>gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase

 Score = 40.2 bits (94), Expect = 8e-04
 Identities = 36/174 (20%), Positives = 67/174 (38%), Gaps = 6/174 (3%)

Query: 130 LVAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVF 189
           LV   M    L  H+++        A  +  A  I   LE+   + R +Y DL    ++ 
Sbjct: 70  LVMTLMNGGDLKYHIYNVGEPGFPEARAIFYAAQIICGLEH-LHQRRIVYRDLKPENVLL 128

Query: 190 DDDVNPRLSCFGL---MKNSRDGRSYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLL 246
           DD  N R+S  GL   +K  +  +  +    +  PE L+          ++ G  L +++
Sbjct: 129 DDHGNVRISDLGLAVELKGGKKIKGRAGTPGYMAPEVLQGEVYDFSVDWFALGCTLYEMI 188

Query: 247 SGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLASRCLQYEPRER 300
           +G   P     + +    ++  T   +  ++      E   L    LQ +P +R
Sbjct: 189 AG-RSPFRQRKEKVEKEELKRRTLE-MAVEYPDKFSPEAKDLCEALLQKDPEKR 240

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277

>gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases

 Score = 40.3 bits (94), Expect = 8e-04
 Identities = 47/210 (22%), Positives = 80/210 (38%), Gaps = 30/210 (14%)

Query: 83  RIAVKRFNRSAWPDAR-QFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAEYMPNDTLA 141
           R+ VK    SA PD +  FL+E +   +L +  +   LG C E    LLV E+ P   L 
Sbjct: 24  RVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEFCPLGDLK 83

Query: 142 KHL------FHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNP 195
            +L           Q     +  R+A  +A  L +   +   ++ DL         D++ 
Sbjct: 84  NYLRSNRGMVAQMAQKD---VLQRMACEVASGLLW-LHQADFIHSDLALRNCQLTADLSV 139

Query: 196 RLSCFGLMKNSRDGRSYSTN------LAFTPPEY-------LRTGRVTPESVMYSFGTLL 242
           ++  +GL         Y T       L +  PE        L     T +S ++S G  +
Sbjct: 140 KIGDYGLALEQYPEDYYITKDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTM 199

Query: 243 LDLLSGKHIPPSHALDL------IRDRNIQ 266
            +L +    P     D       +R+++I+
Sbjct: 200 WELFTAADQPYPDLSDEQVLKQVVREQDIK 229

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269

>gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2

 Score = 40.0 bits (93), Expect = 0.001
 Identities = 50/243 (20%), Positives = 100/243 (41%), Gaps = 33/243 (13%)

Query: 62  VSEHGEKAPNVVYKGKL------ENQFRIAVKRF-NRSAWPDARQFLEEARAVGQLRNRR 114
           + E GE     VYKG L      E    +A+K   +++  P   +F  EA    +L++  
Sbjct: 10  MEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPN 69

Query: 115 LANLLGCCCEGDERLLVAEYMPNDTLAKHLF----HWET------QPMKWAMR----LRV 160
           +  LLG   +     ++  Y  +  L + L     H +       + +K  +     + +
Sbjct: 70  IVCLLGVVTKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHI 129

Query: 161 ALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDGRSYST------ 214
              IA  +E+ +S    ++ DL    ++  D +N ++S  GL +       Y        
Sbjct: 130 VTQIAAGMEFLSS-HHVVHKDLATRNVLVFDKLNVKISDLGLFREVYAADYYKLMGNSLL 188

Query: 215 NLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIP-----PSHALDLIRDRNIQTLT 269
            + +  PE +  G+ + +S ++S+G +L ++ S    P         +++IR+R +    
Sbjct: 189 PIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVIEMIRNRQVLPCP 248

Query: 270 DSC 272
           D C
Sbjct: 249 DDC 251

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283

>gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase

 Score = 39.5 bits (92), Expect = 0.001
 Identities = 43/193 (22%), Positives = 82/193 (42%), Gaps = 11/193 (5%)

Query: 66  GEKAPNVVYKG-KLENQFRIAVKRFNRSAWPDARQFLEEARAVGQLRNRRLANLLGCCCE 124
           G+ A   VY    +     +A+K+ N    P     + E   + + ++  + N L     
Sbjct: 28  GQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVNYLDSYLV 87

Query: 125 GDERLLVAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNA 184
           GDE  +V EY+   +L   +   ET  M       V     +ALE+  S +  ++ D+ +
Sbjct: 88  GDELWVVMEYLAGGSLTDVVT--ETC-MDEGQIAAVCRECLQALEFLHSNQ-VIHRDIKS 143

Query: 185 YRIVFDDDVNPRLSCFGLMKNSRDGRSYSTNLAFTP----PEYLRTGRVTPESVMYSFGT 240
             I+   D + +L+ FG        +S  + +  TP    PE +      P+  ++S G 
Sbjct: 144 DNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGI 203

Query: 241 LLLDLLSGKHIPP 253
           + ++++ G+  PP
Sbjct: 204 MAIEMVEGE--PP 214

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293

>gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2

 Score = 39.6 bits (93), Expect = 0.001
 Identities = 35/147 (23%), Positives = 67/147 (45%), Gaps = 16/147 (10%)

Query: 168 LEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDGRSYSTNLAFTP----PEY 223
           LEY  S  + ++ D+ A  I+ +++   +L+ FG+     D  +    +  TP    PE 
Sbjct: 112 LEYLHSN-KKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMAKRNTVIGTPFWMAPEV 170

Query: 224 LRTGRVTPESVMYSFGTLLLDLLSGK----HIPPSHALDLIRDRNIQTLTDSCLEGQFSS 279
           ++      ++ ++S G   +++  GK     I P  A+ +I ++   TL+D     ++S 
Sbjct: 171 IQEIGYNNKADIWSLGITAIEMAEGKPPYSDIHPMRAIFMIPNKPPPTLSDP---EKWS- 226

Query: 280 DEGTELVRLASRCLQYEPRERPNPRSL 306
               E      +CL  +P ERP+   L
Sbjct: 227 ---PEFNDFVKKCLVKDPEERPSAIQL 250

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256

>gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors

 Score = 39.3 bits (92), Expect = 0.001
 Identities = 54/235 (22%), Positives = 96/235 (40%), Gaps = 37/235 (15%)

Query: 101 LEEARAVGQLRNRRLANLLGCCCEGDERLLVAEYM--------------PNDTLAKHLFH 146
           +E  + +G+ +N  + NLLG C +     +V EY               P +  +     
Sbjct: 66  MEMMKMIGKHKN--IINLLGVCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPR 123

Query: 147 WETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNS 206
              + +     +  A  +A  +E+  SK + ++ DL A  ++  +D   +++ FGL ++ 
Sbjct: 124 PPEETLTQKDLVSFAYQVARGMEFLASK-KCIHRDLAARNVLVTEDHVMKIADFGLARDI 182

Query: 207 RDGRSY--STN----LAFTPPEYLRTGRVTPESVMYSFGTLLLDL--LSGKHIP--PSHA 256
                Y  +TN    + +  PE L     T +S ++SFG LL ++  L G   P  P   
Sbjct: 183 HHIDYYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEE 242

Query: 257 L-DLIRDRNIQTLTDSCLEGQFSSDEGTELVRLASRCLQYEPRERPNPRSLVTAL 310
           L  L+++        +C +         EL  L   C    P +RP  + LV  L
Sbjct: 243 LFKLLKEGYRMEKPQNCTQ---------ELYHLMRDCWHEVPSQRPTFKQLVEDL 288

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293

>gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases

 Score = 39.3 bits (92), Expect = 0.002
 Identities = 52/186 (27%), Positives = 81/186 (43%), Gaps = 34/186 (18%)

Query: 103 EARAVGQLRNRRLANLLGCCCEGDERLL--VAEYMPNDTLAKHLFHWETQPMKWAMRLRV 160
           E R + ++ +  +  L     E D+R L  + EY+P   L  +L +        +  L  
Sbjct: 51  EKRVLKEVSHPFIIRLF--WTEHDQRFLYMLMEYVPGGELFSYLRNSGR--FSNSTGLFY 106

Query: 161 ALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDGRSYSTNLAFTP 220
           A  I  ALEY  SKE  +Y DL    I+ D + + +L+ FG  K  RD R+++  L  T 
Sbjct: 107 ASEIVCALEYLHSKE-IVYRDLKPENILLDKEGHIKLTDFGFAKKLRD-RTWT--LCGT- 161

Query: 221 PEYLRTGRVTPESVM----------YSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTD 270
           PEYL      PE +           ++ G L+ ++L G   PP        D N   + +
Sbjct: 162 PEYL-----APEVIQSKGHNKAVDWWALGILIYEMLVG--YPP------FFDDNPFGIYE 208

Query: 271 SCLEGQ 276
             L G+
Sbjct: 209 KILAGK 214

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291

>gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase

 Score = 38.6 bits (90), Expect = 0.002
 Identities = 48/199 (24%), Positives = 78/199 (39%), Gaps = 23/199 (11%)

Query: 61  IVSEHGEKAPNVVYKGKLENQFRIAVKRFNRSAWPDARQFLEEARAVGQLRNRRLANLLG 120
           +V + G      +Y  K+  +  I  K          RQ LE  R     R   L  L  
Sbjct: 18  LVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVR-----RCPFLVTLH- 71

Query: 121 CCCEGDERL-LVAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAE---ALEYCTSKER 176
              + D +L L+ +Y+    L  HL+  E           V ++IAE   AL+    +  
Sbjct: 72  YAFQTDTKLHLILDYVNGGELFTHLYQREHFTES-----EVRVYIAEIVLALD-HLHQLG 125

Query: 177 ALYHDLNAYRIVFDDDVNPRLSCFGLMK-----NSRDGRSYSTNLAFTPPEYLRTGRVTP 231
            +Y D+    I+ D + +  L+ FGL K           S+   + +  PE +R G    
Sbjct: 126 IIYRDIKLENILLDSEGHVVLTDFGLSKEFLAEEEERAYSFCGTIEYMAPEVIRGGSGGH 185

Query: 232 ESVM--YSFGTLLLDLLSG 248
           +  +  +S G L  +LL+G
Sbjct: 186 DKAVDWWSLGVLTFELLTG 204

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288

>gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta

 Score = 38.7 bits (90), Expect = 0.003
 Identities = 46/164 (28%), Positives = 71/164 (43%), Gaps = 13/164 (7%)

Query: 96  DARQFLEEARAVGQLRNRRLANLLGCCCEGDERLL-VAEYMPNDTLAKHLFHWETQPMKW 154
           D    + E R +   RN      L CC +  +RL  V E++    L   +FH +      
Sbjct: 38  DVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEFVNGGDL---MFHIQKSRRFD 94

Query: 155 AMRLRV-ALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNS-RDGRSY 212
             R R  A  I  AL +   K   +Y DL    ++ D + + +L+ FG+ K    +G++ 
Sbjct: 95  EARARFYAAEITSALMFLHDKG-IIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNGKTT 153

Query: 213 STNLAFTP----PEYLRTGRVTPESVMYSFGTLLLDLLSGKHIP 252
           ST    TP    PE L+     P    ++ G LL ++L G H P
Sbjct: 154 ST-FCGTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCG-HAP 195

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320

>gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases

 Score = 38.1 bits (89), Expect = 0.004
 Identities = 42/197 (21%), Positives = 80/197 (40%), Gaps = 13/197 (6%)

Query: 66  GEKAPNVVYKGK-LENQFRIAVKRFNR---SAWPDARQFLEEARAVGQLRNRRLANLLGC 121
           GE    VVYK +       +A+K+      S     +  L E + + +L +  +  LL  
Sbjct: 8   GEGTYGVVYKARDKLTGEIVAIKKIKLRFESEG-IPKTALREIKLLKELNHPNIIKLLDV 66

Query: 122 CCEGDERLLVAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHD 181
                +  LV E+M  DT    L     + +  ++       + + L +C      L+ D
Sbjct: 67  FRHKGDLYLVFEFM--DTDLYKLIKDRQRGLPESLIKSYLYQLLQGLAFC-HSHGILHRD 123

Query: 182 LNAYRIVFDDDVNPRLSCFGLMKNSR-DGRSYSTNLA---FTPPEYLRTGRVTPESV-MY 236
           L    ++ + +   +L+ FGL ++     R Y+  +    +  PE L   +     V ++
Sbjct: 124 LKPENLLINTEGVLKLADFGLARSFGSPVRPYTHYVVTRWYRAPELLLGDKGYSTPVDIW 183

Query: 237 SFGTLLLDLLSGKHIPP 253
           S G +  +LLS + + P
Sbjct: 184 SVGCIFAELLSRRPLFP 200

Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283

>gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase

 Score = 37.8 bits (88), Expect = 0.004
 Identities = 30/102 (29%), Positives = 44/102 (43%), Gaps = 7/102 (6%)

Query: 161 ALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDGRSYSTNLAFTP 220
           A  IA AL Y  S    +Y DL    I+ D   +  L+ FGL K   +    ++    TP
Sbjct: 102 AAEIASALGYLHSLN-IIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHSKTTSTFCGTP 160

Query: 221 ----PEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALD 258
               PE LR          +  G +L ++L G  +PP ++ D
Sbjct: 161 EYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYG--LPPFYSRD 200

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323

Conserved Domains Detected by HHsearch

Original result of HHsearch against CDD database

ID	Length	Definition	Probability
Query	329
KOG0581	364	consensus Mitogen-activated protein kinase kinase	100.0
KOG0615	475	consensus Serine/threonine protein kinase Chk2 and	100.0
KOG1187	361	consensus Serine/threonine protein kinase [Signal	100.0
KOG0192	362	consensus Tyrosine kinase specific for activated (	100.0
KOG0575	592	consensus Polo-like serine/threonine protein kinas	100.0
KOG0197	468	consensus Tyrosine kinases [Signal transduction me	100.0
KOG0595	429	consensus Serine/threonine-protein kinase involved	100.0
KOG0591	375	consensus NIMA (never in mitosis)-related G2-speci	100.0
KOG0598	357	consensus Ribosomal protein S6 kinase and related	100.0
KOG0593	396	consensus Predicted protein kinase KKIAMRE [Genera	100.0
KOG0578	550	consensus p21-activated serine/threonine protein k	100.0
KOG0198	313	consensus MEKK and related serine/threonine protei	100.0
KOG0659	318	consensus Cdk activating kinase (CAK)/RNA polymera	100.0
KOG0616	355	consensus cAMP-dependent protein kinase catalytic	100.0
KOG0600	560	consensus Cdc2-related protein kinase [Cell cycle	100.0
KOG0661	538	consensus MAPK related serine/threonine protein ki	100.0
KOG0583	370	consensus Serine/threonine protein kinase [Signal	100.0
KOG0592	604	consensus 3-phosphoinositide-dependent protein kin	100.0
KOG0582	516	consensus Ste20-like serine/threonine protein kina	100.0
KOG0605	550	consensus NDR and related serine/threonine kinases	100.0
KOG0193	678	consensus Serine/threonine protein kinase RAF [Sig	100.0
KOG0588	786	consensus Serine/threonine protein kinase [Cell cy	100.0
KOG0597	808	consensus Serine-threonine protein kinase FUSED [G	100.0
KOG1026	774	consensus Nerve growth factor receptor TRKA and re	100.0
cd05102	338	PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi	100.0
KOG0663	419	consensus Protein kinase PITSLRE and related kinas	100.0
KOG0585	576	consensus Ca2+/calmodulin-dependent protein kinase	100.0
cd05631	285	STKc_GRK4 Catalytic domain of the Protein Serine/T	100.0
PHA02988	283	hypothetical protein; Provisional	100.0
cd05612	291	STKc_PRKX_like Catalytic domain of PRKX-like Prote	100.0
cd05571	323	STKc_PKB Catalytic domain of the Protein Serine/Th	100.0
PTZ00263	329	protein kinase A catalytic subunit; Provisional	100.0
cd06649	331	PKc_MEK2 Catalytic domain of the dual-specificity	100.0
KOG0201	467	consensus Serine/threonine protein kinase [Signal	100.0
KOG0580	281	consensus Serine/threonine protein kinase [Cell cy	100.0
cd05585	312	STKc_YPK1_like Catalytic domain of Yeast Protein K	100.0
PTZ00426	340	cAMP-dependent protein kinase catalytic subunit; P	100.0
KOG0694	694	consensus Serine/threonine protein kinase [Signal	100.0
KOG0033	355	consensus Ca2+/calmodulin-dependent protein kinase	100.0
cd05593	328	STKc_PKB_gamma Catalytic domain of the Protein Ser	100.0
cd05600	333	STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p-	100.0
cd05595	323	STKc_PKB_beta Catalytic domain of the Protein Seri	100.0
KOG0589	426	consensus Serine/threonine protein kinase [General	100.0
KOG0194	474	consensus Protein tyrosine kinase [Signal transduc	100.0
cd07848	287	STKc_CDKL5 Catalytic domain of the Serine/Threonin	100.0
KOG4721	904	consensus Serine/threonine protein kinase, contain	100.0
cd07871	288	STKc_PCTAIRE3 Catalytic domain of the Serine/Threo	100.0
KOG1095	1025	consensus Protein tyrosine kinase [Signal transduc	100.0
KOG0660	359	consensus Mitogen-activated protein kinase [Signal	100.0
cd06650	333	PKc_MEK1 Catalytic domain of the dual-specificity	100.0
cd05064	266	PTKc_EphR_A10 Catalytic domain of the Protein Tyro	100.0
cd05072	261	PTKc_Lyn Catalytic domain of the Protein Tyrosine	100.0
PLN00034	353	mitogen-activated protein kinase kinase; Provision	100.0
cd05584	323	STKc_p70S6K Catalytic domain of the Protein Serine	100.0
cd05599	364	STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel	100.0
cd05573	350	STKc_ROCK_NDR_like Catalytic domain of ROCK- and N	100.0
cd05096	304	PTKc_DDR1 Catalytic domain of the Protein Tyrosine	100.0
cd05626	381	STKc_LATS2 Catalytic domain of the Protein Serine/	100.0
cd07869	303	STKc_PFTAIRE1 Catalytic domain of the Serine/Threo	100.0
cd05594	325	STKc_PKB_alpha Catalytic domain of the Protein Ser	100.0
cd05148	261	PTKc_Srm_Brk Catalytic domain of the Protein Tyros	100.0
cd05052	263	PTKc_Abl Catalytic domain of the Protein Tyrosine	100.0
KOG0611	668	consensus Predicted serine/threonine protein kinas	100.0
cd05106	374	PTKc_CSF-1R Catalytic domain of the Protein Tyrosi	100.0
cd05628	363	STKc_NDR1 Catalytic domain of the Protein Serine/T	100.0
cd05590	320	STKc_nPKC_eta Catalytic domain of the Protein Seri	100.0
cd05048	283	PTKc_Ror Catalytic Domain of the Protein Tyrosine	100.0
cd05104	375	PTKc_Kit Catalytic domain of the Protein Tyrosine	100.0
KOG0032	382	consensus Ca2+/calmodulin-dependent protein kinase	100.0
cd05608	280	STKc_GRK1 Catalytic domain of the Protein Serine/T	100.0
cd05605	285	STKc_GRK4_like Catalytic domain of G protein-coupl	100.0
cd05589	324	STKc_PKN Catalytic domain of the Protein Serine/Th	100.0
cd05114	256	PTKc_Tec_Rlk Catalytic domain of the Protein Tyros	100.0
KOG2345	302	consensus Serine/threonine protein kinase/TGF-beta	100.0
cd05607	277	STKc_GRK7 Catalytic domain of the Protein Serine/T	100.0
KOG0599	411	consensus Phosphorylase kinase gamma subunit [Carb	100.0
PF07714	259	Pkinase_Tyr: Protein tyrosine kinase Protein kinas	100.0
cd05591	321	STKc_nPKC_epsilon Catalytic domain of the Protein	100.0
KOG0658	364	consensus Glycogen synthase kinase-3 [Carbohydrate	100.0
cd07862	290	STKc_CDK6 Catalytic domain of the Serine/Threonine	100.0
cd05587	324	STKc_cPKC Catalytic domain of the Protein Serine/T	100.0
cd05620	316	STKc_nPKC_delta Catalytic domain of the Protein Se	100.0
cd05625	382	STKc_LATS1 Catalytic domain of the Protein Serine/	100.0
cd05614	332	STKc_MSK2_N N-terminal catalytic domain of the Pro	100.0
cd05629	377	STKc_NDR_like_fungal Catalytic domain of Fungal Nu	100.0
PTZ00267	478	NIMA-related protein kinase; Provisional	100.0
cd05592	316	STKc_nPKC_theta_delta Catalytic domain of the Prot	100.0
cd05596	370	STKc_ROCK Catalytic domain of the Protein Serine/T	100.0
cd05619	316	STKc_nPKC_theta Catalytic domain of the Protein Se	100.0
cd07859	338	STKc_TDY_MAPK_plant Catalytic domain of the Serine	100.0
cd05598	376	STKc_LATS Catalytic domain of the Protein Serine/T	100.0
cd05570	318	STKc_PKC Catalytic domain of the Protein Serine/Th	100.0
cd05049	280	PTKc_Trk Catalytic domain of the Protein Tyrosine	100.0
cd05588	329	STKc_aPKC Catalytic domain of the Protein Serine/T	100.0
cd05068	261	PTKc_Frk_like Catalytic domain of Fyn-related kina	100.0
cd05094	291	PTKc_TrkC Catalytic domain of the Protein Tyrosine	100.0
cd05618	329	STKc_aPKC_iota Catalytic domain of the Protein Ser	100.0
cd05093	288	PTKc_TrkB Catalytic domain of the Protein Tyrosine	100.0
cd05575	323	STKc_SGK Catalytic domain of the Protein Serine/Th	100.0
cd05616	323	STKc_cPKC_beta Catalytic domain of the Protein Ser	100.0
KOG0594	323	consensus Protein kinase PCTAIRE and related kinas	100.0
cd05601	330	STKc_CRIK Catalytic domain of the Protein Serine/T	100.0
cd06654	296	STKc_PAK1 Catalytic domain of the Protein Serine/T	100.0
cd05113	256	PTKc_Btk_Bmx Catalytic domain of the Protein Tyros	100.0
cd05582	318	STKc_RSK_N N-terminal catalytic domain of the Prot	100.0
KOG0579	1187	consensus Ste20-like serine/threonine protein kina	100.0
PHA03212	391	serine/threonine kinase US3; Provisional	100.0
cd05621	370	STKc_ROCK2 Catalytic domain of the Protein Serine/	100.0
cd08529	256	STKc_FA2-like Catalytic domain of the Protein Seri	100.0
cd05090	283	PTKc_Ror1 Catalytic domain of the Protein Tyrosine	100.0
cd08228	267	STKc_Nek6 Catalytic domain of the Protein Serine/T	100.0
cd05108	316	PTKc_EGFR Catalytic domain of the Protein Tyrosine	100.0
cd05604	325	STKc_SGK3 Catalytic domain of the Protein Serine/T	100.0
KOG0610	459	consensus Putative serine/threonine protein kinase	100.0
cd05105	400	PTKc_PDGFR_alpha Catalytic domain of the Protein T	100.0
cd06655	296	STKc_PAK2 Catalytic domain of the Protein Serine/T	100.0
cd05627	360	STKc_NDR2 Catalytic domain of the Protein Serine/T	100.0
cd06643	282	STKc_SLK Catalytic domain of the Protein Serine/Th	100.0
cd05091	283	PTKc_Ror2 Catalytic domain of the Protein Tyrosine	100.0
cd05054	337	PTKc_VEGFR Catalytic domain of the Protein Tyrosin	100.0
cd05067	260	PTKc_Lck_Blk Catalytic domain of the Protein Tyros	100.0
cd05033	266	PTKc_EphR Catalytic domain of Ephrin Receptor Prot	100.0
cd06644	292	STKc_STK10_LOK Catalytic domain of the Protein Ser	100.0
cd05089	297	PTKc_Tie1 Catalytic domain of the Protein Tyrosine	100.0
PTZ00283	496	serine/threonine protein kinase; Provisional	100.0
PTZ00036	440	glycogen synthase kinase; Provisional	100.0
cd05070	260	PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros	100.0
cd05071	262	PTKc_Src Catalytic domain of the Protein Tyrosine	100.0
KOG1989	738	consensus ARK protein kinase family [Signal transd	100.0
cd05084	252	PTKc_Fes Catalytic domain of the Protein Tyrosine	100.0
KOG0667	586	consensus Dual-specificity tyrosine-phosphorylatio	100.0
cd05602	325	STKc_SGK1 Catalytic domain of the Protein Serine/T	100.0
cd08229	267	STKc_Nek7 Catalytic domain of the Protein Serine/T	100.0
cd05081	284	PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of	100.0
cd07863	288	STKc_CDK4 Catalytic domain of the Serine/Threonine	100.0
cd05059	256	PTKc_Tec_like Catalytic domain of Tec-like Protein	100.0
cd06646	267	STKc_MAP4K5 Catalytic domain of the Protein Serine	100.0
cd05082	256	PTKc_Csk Catalytic domain of the Protein Tyrosine	100.0
cd05077	262	PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th	100.0
cd05078	258	PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain	100.0
cd05088	303	PTKc_Tie2 Catalytic domain of the Protein Tyrosine	100.0
cd05615	323	STKc_cPKC_alpha Catalytic domain of the Protein Se	100.0
cd05092	280	PTKc_TrkA Catalytic domain of the Protein Tyrosine	100.0
KOG0577	948	consensus Serine/threonine protein kinase [Signal	100.0
cd05116	257	PTKc_Syk Catalytic domain of the Protein Tyrosine	100.0
cd07853	372	STKc_NLK Catalytic domain of the Serine/Threonine	100.0
cd05080	283	PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the	100.0
cd05630	285	STKc_GRK6 Catalytic domain of the Protein Serine/T	100.0
cd05111	279	PTK_HER3 Pseudokinase domain of the Protein Tyrosi	100.0
cd05597	331	STKc_DMPK_like Catalytic domain of Myotonic Dystro	100.0
cd06611	280	STKc_SLK_like Catalytic domain of Ste20-like kinas	100.0
cd07872	309	STKc_PCTAIRE2 Catalytic domain of the Serine/Threo	100.0
cd05603	321	STKc_SGK2 Catalytic domain of the Protein Serine/T	100.0
cd05069	260	PTKc_Yes Catalytic domain of the Protein Tyrosine	100.0
cd06656	297	STKc_PAK3 Catalytic domain of the Protein Serine/T	100.0
cd06625	263	STKc_MEKK3_like Catalytic domain of MAP/ERK kinase	100.0
cd06615	308	PKc_MEK Catalytic domain of the dual-specificity P	100.0
cd07876	359	STKc_JNK2 Catalytic domain of the Serine/Threonine	100.0
cd05039	256	PTKc_Csk_like Catalytic domain of C-terminal Src k	100.0
cd05034	261	PTKc_Src_like Catalytic domain of Src kinase-like	100.0
cd06645	267	STKc_MAP4K3 Catalytic domain of the Protein Serine	100.0
cd06637	272	STKc_TNIK Catalytic domain of the Protein Serine/T	100.0
cd05617	327	STKc_aPKC_zeta Catalytic domain of the Protein Ser	100.0
cd06624	268	STKc_ASK Catalytic domain of the Protein Serine/Th	100.0
cd05622	371	STKc_ROCK1 Catalytic domain of the Protein Serine/	100.0
cd05632	285	STKc_GRK5 Catalytic domain of the Protein Serine/T	100.0
cd07874	355	STKc_JNK3 Catalytic domain of the Serine/Threonine	100.0
cd08227	327	PK_STRAD_alpha Pseudokinase domain of STE20-relate	100.0
cd05062	277	PTKc_IGF-1R Catalytic domain of the Protein Tyrosi	100.0
cd08219	255	STKc_Nek3 Catalytic domain of the Protein Serine/T	100.0
cd05109	279	PTKc_HER2 Catalytic domain of the Protein Tyrosine	100.0
cd05053	293	PTKc_FGFR Catalytic domain of the Protein Tyrosine	100.0
cd06619	279	PKc_MKK5 Catalytic domain of the dual-specificity	100.0
cd05098	307	PTKc_FGFR1 Catalytic domain of the Protein Tyrosin	100.0
KOG0574	502	consensus STE20-like serine/threonine kinase MST [	100.0
cd05115	257	PTKc_Zap-70 Catalytic domain of the Protein Tyrosi	100.0
cd08223	257	STKc_Nek4 Catalytic domain of the Protein Serine/T	100.0
KOG0196	996	consensus Tyrosine kinase, EPH (ephrin) receptor f	100.0
cd05076	274	PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th	100.0
cd05035	273	PTKc_Axl_like Catalytic Domain of Axl-like Protein	100.0
cd05101	304	PTKc_FGFR2 Catalytic domain of the Protein Tyrosin	100.0
cd05079	284	PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the	100.0
cd06622	286	PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS	100.0
cd07875	364	STKc_JNK1 Catalytic domain of the Serine/Threonine	100.0
cd00192	262	PTKc Catalytic domain of Protein Tyrosine Kinases.	100.0
cd05085	250	PTKc_Fer Catalytic domain of the Protein Tyrosine	100.0
cd08224	267	STKc_Nek6_Nek7 Catalytic domain of the Protein Ser	100.0
cd05055	302	PTKc_PDGFR Catalytic domain of the Protein Tyrosin	100.0
cd06610	267	STKc_OSR1_SPAK Catalytic domain of the Protein Ser	100.0
cd06613	262	STKc_MAP4K3_like Catalytic domain of Mitogen-activ	100.0
cd06612	256	STKc_MST1_2 Catalytic domain of the Protein Serine	100.0
PF00069	260	Pkinase: Protein kinase domain Protein kinase; unc	100.0
cd05065	269	PTKc_EphR_B Catalytic domain of the Protein Tyrosi	100.0
cd07878	343	STKc_p38beta_MAPK11 Catalytic domain of the Serine	100.0
cd05075	272	PTKc_Axl Catalytic domain of the Protein Tyrosine	100.0
cd06609	274	STKc_MST3_like Catalytic domain of Mammalian Ste20	100.0
cd08218	256	STKc_Nek1 Catalytic domain of the Protein Serine/T	100.0
cd05045	290	PTKc_RET Catalytic domain of the Protein Tyrosine	100.0
PHA03209	357	serine/threonine kinase US3; Provisional	100.0
cd05586	330	STKc_Sck1_like Catalytic domain of Suppressor of l	100.0
cd05087	269	PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein	100.0
cd05041	251	PTKc_Fes_like Catalytic domain of Fes-like Protein	100.0
cd06628	267	STKc_MAPKKK_Byr2_like Catalytic domain of fungal B	100.0
KOG4257	974	consensus Focal adhesion tyrosine kinase FAK, cont	100.0
cd05107	401	PTKc_PDGFR_beta Catalytic domain of the Protein Ty	100.0
cd05040	257	PTKc_Ack_like Catalytic domain of the Protein Tyro	100.0
cd05038	284	PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P	100.0
cd05042	269	PTKc_Aatyk Catalytic domain of the Protein Tyrosin	100.0
cd07873	301	STKc_PCTAIRE1 Catalytic domain of the Serine/Threo	100.0
cd05043	280	PTK_Ryk Pseudokinase domain of Ryk (Receptor relat	100.0
cd06658	292	STKc_PAK5 Catalytic domain of the Protein Serine/T	100.0
cd05623	332	STKc_MRCK_alpha Catalytic domain of the Protein Se	100.0
cd05073	260	PTKc_Hck Catalytic domain of the Protein Tyrosine	100.0
cd08221	256	STKc_Nek9 Catalytic domain of the Protein Serine/T	100.0
cd05036	277	PTKc_ALK_LTK Catalytic domain of the Protein Tyros	100.0
KOG4717	864	consensus Serine/threonine protein kinase [Signal	100.0
cd05063	268	PTKc_EphR_A2 Catalytic domain of the Protein Tyros	100.0
cd05058	262	PTKc_Met_Ron Catalytic domain of the Protein Tyros	100.0
cd07861	285	STKc_CDK1_euk Catalytic domain of the Serine/Threo	100.0
cd05032	277	PTKc_InsR_like Catalytic domain of Insulin Recepto	100.0
KOG4278	1157	consensus Protein tyrosine kinase [Signal transduc	100.0
cd06631	265	STKc_YSK4 Catalytic domain of the Protein Serine/T	100.0
KOG1094	807	consensus Discoidin domain receptor DDR1 [Signal t	100.0
cd05099	314	PTKc_FGFR4 Catalytic domain of the Protein Tyrosin	100.0
cd05624	331	STKc_MRCK_beta Catalytic domain of the Protein Ser	100.0
PHA03211	461	serine/threonine kinase US3; Provisional	100.0
cd05051	296	PTKc_DDR Catalytic domain of the Protein Tyrosine	100.0
cd08220	256	STKc_Nek8 Catalytic domain of the Protein Serine/T	100.0
cd05112	256	PTKc_Itk Catalytic domain of the Protein Tyrosine	100.0
cd05097	295	PTKc_DDR_like Catalytic domain of Discoidin Domain	100.0
cd05060	257	PTKc_Syk_like Catalytic domain of Spleen Tyrosine	100.0
cd05103	343	PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi	100.0
cd07868	317	STKc_CDK8 Catalytic domain of the Serine/Threonine	100.0
cd06607	307	STKc_TAO Catalytic domain of the Protein Serine/Th	100.0
cd06620	284	PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr	100.0
cd05066	267	PTKc_EphR_A Catalytic domain of the Protein Tyrosi	100.0
cd05050	288	PTKc_Musk Catalytic domain of the Protein Tyrosine	100.0
cd05037	259	PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the	100.0
cd05574	316	STKc_phototropin_like Catalytic domain of Phototro	100.0
cd05083	254	PTKc_Chk Catalytic domain of the Protein Tyrosine	100.0
PRK13184	932	pknD serine/threonine-protein kinase; Reviewed	100.0
cd06636	282	STKc_MAP4K4_6 Catalytic domain of the Protein Seri	100.0
cd06629	272	STKc_MAPKKK_Bck1_like Catalytic domain of fungal B	100.0
cd05061	288	PTKc_InsR Catalytic domain of the Protein Tyrosine	100.0
PTZ00284	467	protein kinase; Provisional	100.0
cd06642	277	STKc_STK25-YSK1 Catalytic domain of the Protein Se	100.0
cd05057	279	PTKc_EGFR_like Catalytic domain of Epidermal Growt	100.0
cd06659	297	STKc_PAK6 Catalytic domain of the Protein Serine/T	100.0
cd06640	277	STKc_MST4 Catalytic domain of the Protein Serine/T	100.0
cd05047	270	PTKc_Tie Catalytic domain of Tie Protein Tyrosine	100.0
cd07847	286	STKc_CDKL1_4 Catalytic domain of the Serine/Threon	100.0
PHA03207	392	serine/threonine kinase US3; Provisional	100.0
cd07839	284	STKc_CDK5 Catalytic domain of the Serine/Threonine	100.0
cd05095	296	PTKc_DDR2 Catalytic domain of the Protein Tyrosine	100.0
KOG0986	591	consensus G protein-coupled receptor kinase [Signa	100.0
cd05056	270	PTKc_FAK Catalytic domain of the Protein Tyrosine	100.0
KOG4279	1226	consensus Serine/threonine protein kinase [Signal	100.0
cd05100	334	PTKc_FGFR3 Catalytic domain of the Protein Tyrosin	100.0
cd06605	265	PKc_MAPKK Catalytic domain of the dual-specificity	100.0
cd07832	286	STKc_CCRK Catalytic domain of the Serine/Threonine	100.0
KOG3653	534	consensus Transforming growth factor beta/activin	100.0
cd05580	290	STKc_PKA Catalytic domain of the Protein Serine/Th	100.0
cd05086	268	PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi	100.0
cd06630	268	STKc_MEKK1 Catalytic domain of the Protein Serine/	100.0
PHA03390	267	pk1 serine/threonine-protein kinase 1; Provisional	100.0
cd06647	293	STKc_PAK_I Catalytic domain of the Protein Serine/	100.0
cd06608	275	STKc_myosinIII_like Catalytic domain of Class III	100.0
cd06626	264	STKc_MEKK4 Catalytic domain of the Protein Serine/	100.0
cd05110	303	PTKc_HER4 Catalytic domain of the Protein Tyrosine	100.0
KOG0604	400	consensus MAP kinase-activated protein kinase 2 [S	100.0
cd07860	284	STKc_CDK2_3 Catalytic domain of the Serine/Threoni	100.0
cd06651	266	STKc_MEKK3 Catalytic domain of the Protein Serine/	100.0
cd06632	258	STKc_MEKK1_plant Catalytic domain of the Protein S	100.0
KOG0983	391	consensus Mitogen-activated protein kinase (MAPK)	100.0
cd06648	285	STKc_PAK_II Catalytic domain of the Protein Serine	100.0
cd08225	257	STKc_Nek5 Catalytic domain of the Protein Serine/T	100.0
cd05578	258	STKc_Yank1 Catalytic domain of the Protein Serine/	100.0
cd06652	265	STKc_MEKK2 Catalytic domain of the Protein Serine/	100.0
cd05046	275	PTK_CCK4 Pseudokinase domain of the Protein Tyrosi	100.0
cd05609	305	STKc_MAST Catalytic domain of the Protein Serine/T	100.0
cd07846	286	STKc_CDKL2_3 Catalytic domain of the Serine/Threon	100.0
cd06638	286	STKc_myosinIIIA Catalytic domain of the Protein Se	100.0
PTZ00266	1021	NIMA-related protein kinase; Provisional	100.0
cd07867	317	STKc_CDC2L6 Catalytic domain of Serine/Threonine K	100.0
cd05044	269	PTKc_c-ros Catalytic domain of the Protein Tyrosin	100.0
cd08217	265	STKc_Nek2 Catalytic domain of the Protein Serine/T	100.0
cd06639	291	STKc_myosinIIIB Catalytic domain of the Protein Se	100.0
smart00219	258	TyrKc Tyrosine kinase, catalytic domain. Phosphotr	100.0
cd07844	291	STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like	100.0
cd06616	288	PKc_MKK4 Catalytic domain of the dual-specificity	100.0
cd06621	287	PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek	100.0
cd07843	293	STKc_CDC2L1 Catalytic domain of the Serine/Threoni	100.0
cd07833	288	STKc_CDKL Catalytic domain of Cyclin-Dependent pro	100.0
cd05611	260	STKc_Rim15_like Catalytic domain of fungal Rim15-l	100.0
cd06614	286	STKc_PAK Catalytic domain of the Protein Serine/Th	100.0
cd05572	262	STKc_cGK_PKG Catalytic domain of the Protein Serin	100.0
cd05577	277	STKc_GRK Catalytic domain of the Protein Serine/Th	100.0
cd06623	264	PKc_MAPKK_plant_like Catalytic domain of Plant dua	100.0
KOG0596	677	consensus Dual specificity; serine/threonine and t	100.0
PHA03210	501	serine/threonine kinase US3; Provisional	100.0
cd06657	292	STKc_PAK4 Catalytic domain of the Protein Serine/T	100.0
cd05122	253	PKc_STE Catalytic domain of STE family Protein Kin	100.0
cd07841	298	STKc_CDK7 Catalytic domain of the Serine/Threonine	100.0
cd08215	258	STKc_Nek Catalytic domain of the Protein Serine/Th	100.0
cd06917	277	STKc_NAK1_like Catalytic domain of Fungal Nak1-lik	100.0
cd06641	277	STKc_MST3 Catalytic domain of the Protein Serine/T	100.0
cd06635	317	STKc_TAO1 Catalytic domain of the Protein Serine/T	100.0
cd08528	269	STKc_Nek10 Catalytic domain of the Protein Serine/	100.0
cd06617	283	PKc_MKK3_6 Catalytic domain of the dual-specificit	100.0
cd05633	279	STKc_GRK3 Catalytic domain of the Protein Serine/T	100.0
cd07870	291	STKc_PFTAIRE2 Catalytic domain of the Serine/Threo	100.0
cd08226	328	PK_STRAD_beta Pseudokinase domain of STE20-related	100.0
cd06634	308	STKc_TAO2 Catalytic domain of the Protein Serine/T	100.0
cd07835	283	STKc_CDK1_like Catalytic domain of Cyclin-Dependen	100.0
cd06606	260	STKc_MAPKKK Catalytic domain of the Protein Serine	100.0
KOG0586	596	consensus Serine/threonine protein kinase [General	100.0
KOG0199	1039	consensus ACK and related non-receptor tyrosine ki	100.0
cd07831	282	STKc_MOK Catalytic domain of the Serine/Threonine	100.0
cd05074	273	PTKc_Tyro3 Catalytic domain of the Protein Tyrosin	100.0
cd06633	313	STKc_TAO3 Catalytic domain of the Protein Serine/T	100.0
cd07850	353	STKc_JNK Catalytic domain of the Serine/Threonine	100.0
cd05118	283	STKc_CMGC Catalytic domain of CMGC family Serine/T	100.0
cd06627	254	STKc_Cdc7_like Catalytic domain of Cell division c	100.0
cd07840	287	STKc_CDK9_like Catalytic domain of Cyclin-Dependen	100.0
cd05579	265	STKc_MAST_like Catalytic domain of Microtubule-ass	100.0
PLN00009	294	cyclin-dependent kinase A; Provisional	100.0
cd07837	295	STKc_CdkB_plant Catalytic domain of the Serine/Thr	100.0
cd07845	309	STKc_CDK10 Catalytic domain of the Serine/Threonin	100.0
cd07865	310	STKc_CDK9 Catalytic domain of the Serine/Threonine	100.0
cd05606	278	STKc_beta_ARK Catalytic domain of the Protein Seri	100.0
cd08216	314	PK_STRAD Pseudokinase domain of STE20-related kina	100.0
cd06653	264	STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina	100.0
KOG0607	463	consensus MAP kinase-interacting kinase and relate	100.0
cd07836	284	STKc_Pho85 Catalytic domain of the Serine/Threonin	100.0
cd07849	336	STKc_ERK1_2_like Catalytic domain of Extracellular	100.0
KOG0612	1317	consensus Rho-associated, coiled-coil containing p	100.0
cd07842	316	STKc_CDK8_like Catalytic domain of Cyclin-Dependen	100.0
cd07834	330	STKc_MAPK Catalytic domain of the Serine/Threonine	100.0
cd07855	334	STKc_ERK5 Catalytic domain of the Serine/Threonine	100.0
cd05581	280	STKc_PDK1 Catalytic domain of the Protein Serine/T	100.0
cd07838	287	STKc_CDK4_6_like Catalytic domain of Cyclin-Depend	100.0
cd07858	337	STKc_TEY_MAPK_plant Catalytic domain of the Serine	100.0
PHA02882	294	putative serine/threonine kinase; Provisional	100.0
KOG4645	1509	consensus MAPKKK (MAP kinase kinase kinase) SSK2 a	100.0
cd06618	296	PKc_MKK7 Catalytic domain of the dual-specificity	100.0
cd07830	283	STKc_MAK_like Catalytic domain of Male germ cell-A	100.0
cd08530	256	STKc_CNK2-like Catalytic domain of the Protein Ser	100.0
cd07829	282	STKc_CDK_like Catalytic domain of Cyclin-Dependent	100.0
KOG0690	516	consensus Serine/threonine protein kinase [Signal	100.0
KOG0584	632	consensus Serine/threonine protein kinase [General	100.0
cd05123	250	STKc_AGC Catalytic domain of AGC family Protein Se	100.0
cd07854	342	STKc_MAPK4_6 Catalytic domain of the Serine/Threon	100.0
PLN00113	968	leucine-rich repeat receptor-like protein kinase;	100.0
KOG0662	292	consensus Cyclin-dependent kinase CDK5 [Intracellu	100.0
cd05613	290	STKc_MSK1_N N-terminal catalytic domain of the Pro	100.0
cd07864	302	STKc_CDK12 Catalytic domain of the Serine/Threonin	100.0
cd08222	260	STKc_Nek11 Catalytic domain of the Protein Serine/	100.0
cd07852	337	STKc_MAPK15 Catalytic domain of the Serine/Threoni	100.0
KOG2052	513	consensus Activin A type IB receptor, serine/threo	100.0
KOG0668	338	consensus Casein kinase II, alpha subunit [Signal	100.0
cd07879	342	STKc_p38delta_MAPK13 Catalytic domain of the Serin	100.0
PTZ00024	335	cyclin-dependent protein kinase; Provisional	100.0
KOG0603	612	consensus Ribosomal protein S6 kinase [Signal tran	100.0
cd07866	311	STKc_BUR1 Catalytic domain of the Serine/Threonine	100.0
KOG0666	438	consensus Cyclin C-dependent kinase CDK8 [Transcri	100.0
cd05583	288	STKc_MSK_N N-terminal catalytic domain of the Prot	100.0
cd07880	343	STKc_p38gamma_MAPK12 Catalytic domain of the Serin	100.0
cd07851	343	STKc_p38 Catalytic domain of the Serine/Threonine	100.0
KOG1035	1351	consensus eIF-2alpha kinase GCN2 [Translation, rib	100.0
cd07877	345	STKc_p38alpha_MAPK14 Catalytic domain of the Serin	100.0
cd05576	237	STKc_RPK118_like Catalytic domain of the Protein S	100.0
cd07857	332	STKc_MPK1 Catalytic domain of the Serine/Threonine	100.0
KOG1006	361	consensus Mitogen-activated protein kinase (MAPK)	100.0
cd07856	328	STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre	100.0
KOG4236	888	consensus Serine/threonine protein kinase PKC mu/P	100.0
KOG0200	609	consensus Fibroblast/platelet-derived growth facto	100.0
cd05610	669	STKc_MASTL Catalytic domain of the Protein Serine/	100.0
KOG1025	1177	consensus Epidermal growth factor receptor EGFR an	100.0
KOG0669	376	consensus Cyclin T-dependent kinase CDK9 [Cell cyc	100.0
KOG4250	732	consensus TANK binding protein kinase TBK1 [Signal	100.0
KOG0587	953	consensus Traf2- and Nck-interacting kinase and re	100.0
KOG0671	415	consensus LAMMER dual specificity kinases [Signal	100.0
KOG0608	1034	consensus Warts/lats-like serine threonine kinases	100.0
KOG0696	683	consensus Serine/threonine protein kinase [Signal	100.0
smart00220	244	S_TKc Serine/Threonine protein kinases, catalytic	100.0
PLN03225	566	Serine/threonine-protein kinase SNT7; Provisional	100.0
KOG0614	732	consensus cGMP-dependent protein kinase [Signal tr	100.0
PLN03224	507	probable serine/threonine protein kinase; Provisio	100.0
KOG1151	775	consensus Tousled-like protein kinase [Signal tran	100.0
KOG0984	282	consensus Mitogen-activated protein kinase (MAPK)	100.0
KOG0695	593	consensus Serine/threonine protein kinase [Signal	100.0
KOG0664	449	consensus Nemo-like MAPK-related serine/threonine	100.0
KOG1024	563	consensus Receptor-like protein tyrosine kinase RY	100.0
KOG1027	903	consensus Serine/threonine protein kinase and endo	100.0
KOG1290	590	consensus Serine/threonine protein kinase [Signal	100.0
KOG0576	829	consensus Mitogen-activated protein kinase kinase	100.0
KOG0670	752	consensus U4/U6-associated splicing factor PRP4 [R	100.0
cd00180	215	PKc Catalytic domain of Protein Kinases. Protein K	100.0
KOG0665	369	consensus Jun-N-terminal kinase (JNK) [Signal tran	100.0
KOG1152	772	consensus Signal transduction serine/threonine kin	100.0
KOG1167	418	consensus Serine/threonine protein kinase of the C	99.97
KOG1345	378	consensus Serine/threonine kinase [Signal transduc	99.97
smart00221	225	STYKc Protein kinase; unclassified specificity. Ph	99.97
PLN00181	793	protein SPA1-RELATED; Provisional	99.97
smart00750	176	KIND kinase non-catalytic C-lobe domain. It is an	99.96
KOG0195	448	consensus Integrin-linked kinase [Signal transduct	99.96
KOG1164	322	consensus Casein kinase (serine/threonine/tyrosine	99.95
KOG1163	341	consensus Casein kinase (serine/threonine/tyrosine	99.95
KOG1165	449	consensus Casein kinase (serine/threonine/tyrosine	99.94
PRK09188	365	serine/threonine protein kinase; Provisional	99.93
KOG0590	601	consensus Checkpoint kinase and related serine/thr	99.93
COG0515	384	SPS1 Serine/threonine protein kinase [General func	99.92
cd05147	190	RIO1_euk RIO kinase family; eukaryotic RIO1, catal	99.91
PRK10359	232	lipopolysaccharide core biosynthesis protein; Prov	99.9
cd05145	190	RIO1_like RIO kinase family; RIO1, RIO3 and simila	99.89
KOG0603	612	consensus Ribosomal protein S6 kinase [Signal tran	99.89
KOG1023	484	consensus Natriuretic peptide receptor, guanylate	99.89
KOG1240	1431	consensus Protein kinase containing WD40 repeats [	99.88
KOG4158	598	consensus BRPK/PTEN-induced protein kinase [Signal	99.87
PF14531	288	Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_	99.87
PRK10345	210	hypothetical protein; Provisional	99.86
PRK12274	218	serine/threonine protein kinase; Provisional	99.85
KOG1166	974	consensus Mitotic checkpoint serine/threonine prot	99.85
smart00090	237	RIO RIO-like kinase.	99.83
PRK14879	211	serine/threonine protein kinase; Provisional	99.82
KOG1033	516	consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati	99.81
KOG0606	1205	consensus Microtubule-associated serine/threonine	99.81
TIGR03724	199	arch_bud32 Kae1-associated kinase Bud32. Members o	99.79
cd05144	198	RIO2_C RIO kinase family; RIO2, C-terminal catalyt	99.78
PRK09605	535	bifunctional UGMP family protein/serine/threonine	99.78
KOG0590	601	consensus Checkpoint kinase and related serine/thr	99.75
cd05120	155	APH_ChoK_like Aminoglycoside 3'-phosphotransferase	99.73
cd05119	187	RIO RIO kinase family, catalytic domain. The RIO k	99.72
PRK01723	239	3-deoxy-D-manno-octulosonic-acid kinase; Reviewed	99.71
TIGR01982	437	UbiB 2-polyprenylphenol 6-hydroxylase. This model	99.58
KOG0601	524	consensus Cyclin-dependent kinase WEE1 [Cell cycle	99.57
KOG1266	458	consensus Protein kinase [Signal transduction mech	99.53
PRK04750	537	ubiB putative ubiquinone biosynthesis protein UbiB	99.48
KOG0601	524	consensus Cyclin-dependent kinase WEE1 [Cell cycle	99.47
cd05151	170	ChoK Choline Kinase (ChoK). The ChoK subfamily is	99.47
KOG1243	690	consensus Protein kinase [General function predict	99.46
cd05146	197	RIO3_euk RIO kinase family; eukaryotic RIO3, catal	99.42
KOG3741	655	consensus Poly(A) ribonuclease subunit [RNA proces	99.33
cd05154	223	ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an	99.32
KOG0606	1205	consensus Microtubule-associated serine/threonine	99.3
COG3642	204	Mn2+-dependent serine/threonine protein kinase [Si	99.28
KOG3087	229	consensus Serine/threonine protein kinase [General	99.26
COG4248	637	Uncharacterized protein with protein kinase and he	99.18
PRK15123	268	lipopolysaccharide core heptose(I) kinase RfaP; Pr	99.17
PF01163	188	RIO1: RIO1 family; InterPro: IPR018934 Protein pho	99.09
KOG2137	700	consensus Protein kinase [Signal transduction mech	99.05
COG0478	304	RIO-like serine/threonine protein kinase fused to	98.92
PRK09902	216	hypothetical protein; Provisional	98.89
COG1718	268	RIO1 Serine/threonine protein kinase involved in c	98.87
PF06293	206	Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family;	98.81
COG0661	517	AarF Predicted unusual protein kinase [General fun	98.74
PF06176	229	WaaY: Lipopolysaccharide core biosynthesis protein	98.58
TIGR02172	226	Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou	98.52
KOG1235	538	consensus Predicted unusual protein kinase [Genera	98.51
COG2112	201	Predicted Ser/Thr protein kinase [Signal transduct	98.47
cd05150	244	APH Aminoglycoside 3'-phosphotransferase (APH). Th	98.41
KOG0576	829	consensus Mitogen-activated protein kinase kinase	98.39
PLN02876	822	acyl-CoA dehydrogenase	98.29
PF01636	239	APH: Phosphotransferase enzyme family This family	98.23
PF12260	188	PIP49_C: Protein-kinase domain of FAM69; InterPro:	98.22
KOG1035	1351	consensus eIF-2alpha kinase GCN2 [Translation, rib	98.21
PF10707	199	YrbL-PhoP_reg: PhoP regulatory network protein Yrb	98.2
PF13095	207	FTA2: Kinetochore Sim4 complex subunit FTA2	98.04
cd05155	235	APH_ChoK_like_1 Uncharacterized bacterial proteins	97.93
TIGR02721	256	ycfN_thiK thiamine kinase. Members of this family	97.89
PRK10593	297	hypothetical protein; Provisional	97.84
TIGR00938	307	thrB_alt homoserine kinase, Neisseria type. Homose	97.82
cd05157	235	ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes.	97.77
cd05153	296	HomoserineK_II Homoserine Kinase, type II. Homoser	97.77
PRK05231	319	homoserine kinase; Provisional	97.69
PRK09550	401	mtnK methylthioribose kinase; Reviewed	97.63
KOG2270	520	consensus Serine/threonine protein kinase involved	97.51
cd05156	302	ChoK_euk Choline Kinase (ChoK) in eukaryotes. The	97.33
COG3173	321	Predicted aminoglycoside phosphotransferase [Gener	97.3
cd05152	276	MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH	97.28
KOG2268	465	consensus Serine/threonine protein kinase [Signal	97.22
KOG1826	2724	consensus Ras GTPase activating protein RasGAP/neu	97.13
TIGR01767	370	MTRK 5-methylthioribose kinase. This enzyme is inv	97.05
PLN02756	418	S-methyl-5-thioribose kinase	97.04
PLN02236	344	choline kinase	97.03
KOG1093	725	consensus Predicted protein kinase (contains TBC a	96.83
TIGR02906	313	spore_CotS spore coat protein, CotS family. Member	96.64
PF03881	288	Fructosamin_kin: Fructosamine kinase; InterPro: IP	96.63
KOG1236	565	consensus Predicted unusual protein kinase [Genera	96.46
PRK11768	325	serine/threonine protein kinase; Provisional	96.34
PRK12396	409	5-methylribose kinase; Reviewed	96.29
PF07387	308	Seadorna_VP7: Seadornavirus VP7; InterPro: IPR0099	96.28
PLN02421	330	phosphotransferase, alcohol group as acceptor/kina	96.25
TIGR02904	309	spore_ysxE spore coat protein YsxE. Members of thi	96.21
COG2334	331	Putative homoserine kinase type II (protein kinase	96.09
COG5072	488	ALK1 Serine/threonine kinase of the haspin family	96.03
COG3001	286	Uncharacterized protein conserved in bacteria [Fun	95.64
PRK06148	1013	hypothetical protein; Provisional	95.56
PTZ00384	383	choline kinase; Provisional	94.83
PRK10271	188	thiK thiamine kinase; Provisional	94.03

>KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms]

Probab=100.00  E-value=1.6e-55  Score=375.85  Aligned_cols=248  Identities=17%  Similarity=0.234  Sum_probs=209.0

Q ss_pred             cccccccCCCCCCcEEEEEE-eCCCCEEEEEEeCCCCC-hhHHHHHHHHHHHhcCCCccccccceeeeeCCe-eEEEEec
Q 020221           58 MENIVSEHGEKAPNVVYKGK-LENQFRIAVKRFNRSAW-PDARQFLEEARAVGQLRNRRLANLLGCCCEGDE-RLLVAEY  134 (329)
Q Consensus        58 ~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~-~~lv~e~  134 (329)
                      +.+.++.||.|..|+||++. ..+++.+|+|.+..... ...+++.+|+++++..+||+||.++|+|..... +.|+|||
T Consensus        80 dle~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~~~isI~mEY  159 (364)
T KOG0581|consen   80 DLERLGVLGSGNGGTVYKVRHKPTGKIYALKVILLNIDPALQKQILRELEILRSCQSPYIVGFYGAFYSNGEEISICMEY  159 (364)
T ss_pred             HhhhhhhcccCCCcEEEEEEEcCCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCCceEEeehhh
Confidence            44566788999999999999 56788999999965533 346689999999999999999999999999884 9999999


Q ss_pred             CCCCCHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCCCCCeeeecccCcccCCCC--CCc
Q 020221          135 MPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDG--RSY  212 (329)
Q Consensus       135 ~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~--~~~  212 (329)
                      |++|||++++.  ..+.+++....+++.+|++||.|||+..+||||||||+|||++..|.+||+|||.+....+.  .++
T Consensus       160 MDgGSLd~~~k--~~g~i~E~~L~~ia~~VL~GL~YLh~~~~IIHRDIKPsNlLvNskGeVKicDFGVS~~lvnS~a~tf  237 (364)
T KOG0581|consen  160 MDGGSLDDILK--RVGRIPEPVLGKIARAVLRGLSYLHEERKIIHRDIKPSNLLVNSKGEVKICDFGVSGILVNSIANTF  237 (364)
T ss_pred             cCCCCHHHHHh--hcCCCCHHHHHHHHHHHHHHHHHHhhccCeeeccCCHHHeeeccCCCEEeccccccHHhhhhhcccc
Confidence            99999999996  34679999999999999999999997449999999999999999999999999998765443  577


Q ss_pred             cCcccccCcccccCCCCCCcccchhhhHHHHHHHhCCCCCCchhhHH-HhhhchhhhccccccCCCChH-HHHHHHHHHH
Q 020221          213 STNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDL-IRDRNIQTLTDSCLEGQFSSD-EGTELVRLAS  290 (329)
Q Consensus       213 ~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~-~~~~~~~li~  290 (329)
                      .||..|||||-+.+..|+.++||||||++++|+.+|+.|++...... ..-..+..+++. ..+..|.. +|+++++|+.
T Consensus       238 vGT~~YMsPERi~g~~Ys~~sDIWSLGLsllE~a~GrfP~~~~~~~~~~~~~Ll~~Iv~~-ppP~lP~~~fS~ef~~FV~  316 (364)
T KOG0581|consen  238 VGTSAYMSPERISGESYSVKSDIWSLGLSLLELAIGRFPYPPPNPPYLDIFELLCAIVDE-PPPRLPEGEFSPEFRSFVS  316 (364)
T ss_pred             cccccccChhhhcCCcCCcccceecccHHHHHHhhCCCCCCCcCCCCCCHHHHHHHHhcC-CCCCCCcccCCHHHHHHHH
Confidence            89999999999999999999999999999999999998876631000 000112222221 22345555 8999999999


Q ss_pred             HhcccCCCCCCCHHHHHH
Q 020221          291 RCLQYEPRERPNPRSLVT  308 (329)
Q Consensus       291 ~cl~~dp~~Rps~~~~l~  308 (329)
                      .||++||.+|||+.++++
T Consensus       317 ~CL~Kdp~~R~s~~qLl~  334 (364)
T KOG0581|consen  317 CCLRKDPSERPSAKQLLQ  334 (364)
T ss_pred             HHhcCCcccCCCHHHHhc
Confidence            999999999999999998

>KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=1.6e-55  Score=378.92  Aligned_cols=255  Identities=18%  Similarity=0.245  Sum_probs=214.6

Q ss_pred             CCcccccccCCCCCCcEEEEEE-eCCCCEEEEEEeCCCCChh-------HHHHHHHHHHHhcCCCccccccceeeeeCCe
Q 020221           56 FAMENIVSEHGEKAPNVVYKGK-LENQFRIAVKRFNRSAWPD-------ARQFLEEARAVGQLRNRRLANLLGCCCEGDE  127 (329)
Q Consensus        56 ~~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~-------~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~  127 (329)
                      ++.|.+.+.+|+|+||.|-+|. .++|+.||||++.......       ...+.+|+++|++|+|||||++.+++..++.
T Consensus       171 ~d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~~~ds  250 (475)
T KOG0615|consen  171 NDYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFEVPDS  250 (475)
T ss_pred             cceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeeecCCc
Confidence            3456677889999999999998 7889999999998753221       2235799999999999999999999999999


Q ss_pred             eEEEEecCCCCCHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCCC---CCeeeecccCcc
Q 020221          128 RLLVAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDD---VNPRLSCFGLMK  204 (329)
Q Consensus       128 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~---~~~kl~Dfg~a~  204 (329)
                      .|+||||++||.|.+.+.  .++.+.+.....+++||+.|+.|||++ ||+||||||+|||+..+   ..+||+|||+|+
T Consensus       251 ~YmVlE~v~GGeLfd~vv--~nk~l~ed~~K~~f~Qll~avkYLH~~-GI~HRDiKPeNILl~~~~e~~llKItDFGlAK  327 (475)
T KOG0615|consen  251 SYMVLEYVEGGELFDKVV--ANKYLREDLGKLLFKQLLTAVKYLHSQ-GIIHRDIKPENILLSNDAEDCLLKITDFGLAK  327 (475)
T ss_pred             eEEEEEEecCccHHHHHH--hccccccchhHHHHHHHHHHHHHHHHc-CcccccCCcceEEeccCCcceEEEecccchhh
Confidence            999999999999999887  556788888899999999999999999 99999999999999765   679999999999


Q ss_pred             cCCCC---CCccCcccccCcccccCCC---CCCcccchhhhHHHHHHHhCCCCCCchhhHH-HhhhchhhhccccccCCC
Q 020221          205 NSRDG---RSYSTNLAFTPPEYLRTGR---VTPESVMYSFGTLLLDLLSGKHIPPSHALDL-IRDRNIQTLTDSCLEGQF  277 (329)
Q Consensus       205 ~~~~~---~~~~~~~~y~aPE~~~~~~---~~~~~DvwslG~il~el~tg~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~  277 (329)
                      ....+   .+.+||+.|.|||++.+..   +..++|+||+||+||.+++|.+||.....+. ..++.......-  .+..
T Consensus       328 ~~g~~sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~~sl~eQI~~G~y~f--~p~~  405 (475)
T KOG0615|consen  328 VSGEGSFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTDPSLKEQILKGRYAF--GPLQ  405 (475)
T ss_pred             ccccceehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccCCccHHHHHhcCcccc--cChh
Confidence            88655   4678999999999998665   4458899999999999999999998765544 444433332221  1123


Q ss_pred             ChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhhccccccCccccccC
Q 020221          278 SSDEGTELVRLASRCLQYEPRERPNPRSLVTALVTLQKDTELYLSLPWVMLA  329 (329)
Q Consensus       278 ~~~~~~~~~~li~~cl~~dp~~Rps~~~~l~~L~~~~~~~~~~~~~p~~~~~  329 (329)
                      ....+++..+||.+||..||+.|||+.++|+              |||+..|
T Consensus       406 w~~Iseea~dlI~~mL~VdP~~R~s~~eaL~--------------hpW~~~~  443 (475)
T KOG0615|consen  406 WDRISEEALDLINWMLVVDPENRPSADEALN--------------HPWFKDA  443 (475)
T ss_pred             hhhhhHHHHHHHHHhhEeCcccCcCHHHHhc--------------Chhhhcc
Confidence            3567899999999999999999999999998              8998643

>KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.3e-53  Score=380.83  Aligned_cols=274  Identities=35%  Similarity=0.617  Sum_probs=234.3

Q ss_pred             cccccCHHHHHHHhcCCCcccccccCCCCCCcEEEEEEeCCCCEEEEEEeCCCCChhHHHHHHHHHHHhcCCCccccccc
Q 020221           40 VFCEYSIETLRTATSGFAMENIVSEHGEKAPNVVYKGKLENQFRIAVKRFNRSAWPDARQFLEEARAVGQLRNRRLANLL  119 (329)
Q Consensus        40 ~~~~~~~~~~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~  119 (329)
                      ....|+++++..+|++|+..+++   |+|+||.||+|..+++..||||++.....+...+|.+|+.++..++|||+|+++
T Consensus        61 ~~~~fs~~el~~AT~~Fs~~~~i---g~Ggfg~VYkG~l~~~~~vAVK~~~~~~~~~~~eF~~Ei~~ls~l~H~Nlv~Ll  137 (361)
T KOG1187|consen   61 PLRSFSYDELRKATNNFSESNLI---GEGGFGTVYKGVLSDGTVVAVKRLSSNSGQGEREFLNEVEILSRLRHPNLVKLL  137 (361)
T ss_pred             CcceeeHHHHHHHHhCCchhcce---ecCCCeEEEEEEECCCCEEEEEEecCCCCcchhHHHHHHHHHhcCCCcCcccEE
Confidence            67779999999999999999988   999999999999988889999988776543145699999999999999999999


Q ss_pred             eeeeeCC-eeEEEEecCCCCCHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCC--CccccccCCCceeeCCCCCee
Q 020221          120 GCCCEGD-ERLLVAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKE--RALYHDLNAYRIVFDDDVNPR  196 (329)
Q Consensus       120 ~~~~~~~-~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~--~ivH~dlkp~Nil~~~~~~~k  196 (329)
                      |||.+.+ ..+||+||+++|||.+.|.......++|.++.+|+.++|+||+|||...  .|+|||||++|||+|+++++|
T Consensus       138 GyC~e~~~~~~LVYEym~nGsL~d~L~~~~~~~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~~aK  217 (361)
T KOG1187|consen  138 GYCLEGGEHRLLVYEYMPNGSLEDHLHGKKGEPLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDFNAK  217 (361)
T ss_pred             EEEecCCceEEEEEEccCCCCHHHHhCCCCCCCCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCCCEE
Confidence            9999988 5999999999999999997633328899999999999999999999863  499999999999999999999


Q ss_pred             eecccCcccCCC-CCCc----cCcccccCcccccCCCCCCcccchhhhHHHHHHHhCCCCCCch-------h----hHHH
Q 020221          197 LSCFGLMKNSRD-GRSY----STNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSH-------A----LDLI  260 (329)
Q Consensus       197 l~Dfg~a~~~~~-~~~~----~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~-------~----~~~~  260 (329)
                      |+|||+|+.... ....    .||.+|+|||+...+..+.++||||||++|+||+||+.+....       .    ...+
T Consensus       218 lsDFGLa~~~~~~~~~~~~~~~gt~gY~~PEy~~~g~lt~KsDVySFGVvllElitgr~~~d~~~~~~~~~l~~w~~~~~  297 (361)
T KOG1187|consen  218 LSDFGLAKLGPEGDTSVSTTVMGTFGYLAPEYASTGKLTEKSDVYSFGVVLLELITGRKAVDQSRPRGELSLVEWAKPLL  297 (361)
T ss_pred             ccCccCcccCCccccceeeecCCCCccCChhhhccCCcCcccccccchHHHHHHHhCCcccCCCCCcccccHHHHHHHHH
Confidence            999999977654 3322    7899999999999999999999999999999999999754321       1    1233


Q ss_pred             hhhchhhhcccccc-CCCCh-HHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhhc
Q 020221          261 RDRNIQTLTDSCLE-GQFSS-DEGTELVRLASRCLQYEPRERPNPRSLVTALVTLQKD  316 (329)
Q Consensus       261 ~~~~~~~~~~~~~~-~~~~~-~~~~~~~~li~~cl~~dp~~Rps~~~~l~~L~~~~~~  316 (329)
                      ......+++++.+. ..++. .....+..+...|++.+|..||+|.+|++.|+.+...
T Consensus       298 ~~~~~~eiiD~~l~~~~~~~~~~~~~~~~~a~~C~~~~~~~RP~m~~Vv~~L~~~~~~  355 (361)
T KOG1187|consen  298 EEGKLREIVDPRLKEGEYPDEKEVKKLAELALRCLRPDPKERPTMSQVVKELEGILSL  355 (361)
T ss_pred             HCcchhheeCCCccCCCCChHHHHHHHHHHHHHHcCcCCCcCcCHHHHHHHHHhhccc
Confidence            34456677777665 45554 5667799999999999999999999999999776544

>KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms]

Probab=100.00  E-value=7.6e-53  Score=375.08  Aligned_cols=250  Identities=27%  Similarity=0.397  Sum_probs=214.3

Q ss_pred             ccCCCCCCcEEEEEEeCCCCEEEEEEeCCCCChh--HHHHHHHHHHHhcCCCccccccceeeeeCC-eeEEEEecCCCCC
Q 020221           63 SEHGEKAPNVVYKGKLENQFRIAVKRFNRSAWPD--ARQFLEEARAVGQLRNRRLANLLGCCCEGD-ERLLVAEYMPNDT  139 (329)
Q Consensus        63 ~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~--~~~~~~e~~~l~~l~h~niv~~~~~~~~~~-~~~lv~e~~~~gs  139 (329)
                      +.+|+|+||+||+|.+.+...||+|++.......  .+.|.+|+.+|.+++|||||+++|+|.++. ...+||||+++|+
T Consensus        47 ~~iG~G~~g~V~~~~~~g~~~vavK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~f~G~~~~~~~~~~iVtEy~~~Gs  126 (362)
T KOG0192|consen   47 EVLGSGSFGTVYKGKWRGTDVVAVKIISDPDFDDESRKAFRREASLLSRLRHPNIVQFYGACTSPPGSLCIVTEYMPGGS  126 (362)
T ss_pred             hhcccCCceeEEEEEeCCceeEEEEEecchhcChHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCceEEEEEeCCCCc
Confidence            3469999999999999766559999998764332  458999999999999999999999998877 7999999999999


Q ss_pred             HHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCC-ccccccCCCceeeCCCC-CeeeecccCcccCCC----CCCcc
Q 020221          140 LAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKER-ALYHDLNAYRIVFDDDV-NPRLSCFGLMKNSRD----GRSYS  213 (329)
Q Consensus       140 L~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~-ivH~dlkp~Nil~~~~~-~~kl~Dfg~a~~~~~----~~~~~  213 (329)
                      |.+++.......+++..+..++.||++||.|||++ + ||||||||+|||++.++ ++||+|||+++....    .....
T Consensus       127 L~~~l~~~~~~~l~~~~~l~~aldiArGm~YLH~~-~~iIHrDLK~~NiLv~~~~~~~KI~DFGlsr~~~~~~~~~~~~~  205 (362)
T KOG0192|consen  127 LSVLLHKKRKRKLPLKVRLRIALDIARGMEYLHSE-GPIIHRDLKSDNILVDLKGKTLKIADFGLSREKVISKTSMTSVA  205 (362)
T ss_pred             HHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcC-CCeeecccChhhEEEcCCCCEEEECCCccceeeccccccccCCC
Confidence            99999754467899999999999999999999999 8 99999999999999997 999999999976443    23367


Q ss_pred             CcccccCccccc--CCCCCCcccchhhhHHHHHHHhCCCCCCchhhHHHhhhchhhhccccccCCCChHHHHHHHHHHHH
Q 020221          214 TNLAFTPPEYLR--TGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLASR  291 (329)
Q Consensus       214 ~~~~y~aPE~~~--~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~  291 (329)
                      ||+.|||||++.  ...|+.++||||||+++|||+||+.||......    +....+.....++.++..+++.+..++..
T Consensus       206 GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~~----~~~~~v~~~~~Rp~~p~~~~~~l~~l~~~  281 (362)
T KOG0192|consen  206 GTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAPV----QVASAVVVGGLRPPIPKECPPHLSSLMER  281 (362)
T ss_pred             CCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCHH----HHHHHHHhcCCCCCCCccCCHHHHHHHHH
Confidence            899999999999  558999999999999999999999888754332    22223333445556677788999999999


Q ss_pred             hcccCCCCCCCHHHHHHHHHhhhhcc
Q 020221          292 CLQYEPRERPNPRSLVTALVTLQKDT  317 (329)
Q Consensus       292 cl~~dp~~Rps~~~~l~~L~~~~~~~  317 (329)
                      ||..||+.||++.+++..|+.+....
T Consensus       282 CW~~dp~~RP~f~ei~~~l~~~~~~~  307 (362)
T KOG0192|consen  282 CWLVDPSRRPSFLEIVSRLESIMSHI  307 (362)
T ss_pred             hCCCCCCcCCCHHHHHHHHHHHHHhh
Confidence            99999999999999999999887643

>KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=9e-53  Score=378.55  Aligned_cols=243  Identities=17%  Similarity=0.215  Sum_probs=215.3

Q ss_pred             CcccccccCCCCCCcEEEEEEe-CCCCEEEEEEeCCCC---ChhHHHHHHHHHHHhcCCCccccccceeeeeCCeeEEEE
Q 020221           57 AMENIVSEHGEKAPNVVYKGKL-ENQFRIAVKRFNRSA---WPDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVA  132 (329)
Q Consensus        57 ~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~  132 (329)
                      ..|+.-+.||+|+|+.||.++. .+|+.||+|++.+..   ....+.+.+|+++.+.|+|||||+++++|++.+++|||.
T Consensus        18 ~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs~nVYivL   97 (592)
T KOG0575|consen   18 KRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFEDSNNVYIVL   97 (592)
T ss_pred             ceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEeecCCceEEEE
Confidence            4566777779999999999995 899999999998742   233567899999999999999999999999999999999


Q ss_pred             ecCCCCCHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCCCCCeeeecccCcccCCCC---
Q 020221          133 EYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDG---  209 (329)
Q Consensus       133 e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~---  209 (329)
                      |+|..++|..+++  ..+.+++.+++.+++||+.||.|||+. +|+|||||..|++++++.++||+|||+|......   
T Consensus        98 ELC~~~sL~el~K--rrk~ltEpEary~l~QIv~GlkYLH~~-~IiHRDLKLGNlfL~~~~~VKIgDFGLAt~le~~~Er  174 (592)
T KOG0575|consen   98 ELCHRGSLMELLK--RRKPLTEPEARYFLRQIVEGLKYLHSL-GIIHRDLKLGNLFLNENMNVKIGDFGLATQLEYDGER  174 (592)
T ss_pred             EecCCccHHHHHH--hcCCCCcHHHHHHHHHHHHHHHHHHhc-CceecccchhheeecCcCcEEecccceeeeecCcccc
Confidence            9999999999987  567899999999999999999999999 9999999999999999999999999999887644   


Q ss_pred             -CCccCcccccCcccccCCCCCCcccchhhhHHHHHHHhCCCCCCchhhHHHhhhchhhhccccccCCCChHHHHHHHHH
Q 020221          210 -RSYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRL  288 (329)
Q Consensus       210 -~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  288 (329)
                       .+.+||+.|+|||++.....+..+||||+|||+|.|+.|++||..............      .....|...+.++++|
T Consensus       175 k~TlCGTPNYIAPEVl~k~gHsfEvDiWSlGcvmYtLL~G~PPFetk~vkety~~Ik~------~~Y~~P~~ls~~A~dL  248 (592)
T KOG0575|consen  175 KKTLCGTPNYIAPEVLNKSGHSFEVDIWSLGCVMYTLLVGRPPFETKTVKETYNKIKL------NEYSMPSHLSAEAKDL  248 (592)
T ss_pred             cceecCCCcccChhHhccCCCCCchhhhhhhhHHHhhhhCCCCcccchHHHHHHHHHh------cCcccccccCHHHHHH
Confidence             467899999999999988899999999999999999999999887655544433322      1234567889999999


Q ss_pred             HHHhcccCCCCCCCHHHHHH
Q 020221          289 ASRCLQYEPRERPNPRSLVT  308 (329)
Q Consensus       289 i~~cl~~dp~~Rps~~~~l~  308 (329)
                      |.++|+.||.+|||+++|+.
T Consensus       249 I~~lL~~~P~~Rpsl~~vL~  268 (592)
T KOG0575|consen  249 IRKLLRPNPSERPSLDEVLD  268 (592)
T ss_pred             HHHHhcCCcccCCCHHHHhc
Confidence            99999999999999999997

>KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=1.4e-52  Score=373.15  Aligned_cols=252  Identities=27%  Similarity=0.428  Sum_probs=216.9

Q ss_pred             ccccccCCCCCCcEEEEEEeCCCCEEEEEEeCCCCChhHHHHHHHHHHHhcCCCccccccceeeeeCCeeEEEEecCCCC
Q 020221           59 ENIVSEHGEKAPNVVYKGKLENQFRIAVKRFNRSAWPDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAEYMPND  138 (329)
Q Consensus        59 ~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g  138 (329)
                      .++++.||+|.||.||.|.+++...||+|.++... ...+.|.+|+++|++|+|+|||+++|+|..+..++||||||+.|
T Consensus       208 l~l~~~LG~G~FG~V~~g~~~~~~~vavk~ik~~~-m~~~~f~~Ea~iMk~L~H~~lV~l~gV~~~~~piyIVtE~m~~G  286 (468)
T KOG0197|consen  208 LKLIRELGSGQFGEVWLGKWNGSTKVAVKTIKEGS-MSPEAFLREAQIMKKLRHEKLVKLYGVCTKQEPIYIVTEYMPKG  286 (468)
T ss_pred             HHHHHHhcCCccceEEEEEEcCCCcccceEEeccc-cChhHHHHHHHHHHhCcccCeEEEEEEEecCCceEEEEEecccC
Confidence            35678899999999999999888899999998764 34578999999999999999999999999888999999999999


Q ss_pred             CHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCCCCCeeeecccCcccCCCCCCc-----c
Q 020221          139 TLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDGRSY-----S  213 (329)
Q Consensus       139 sL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~-----~  213 (329)
                      +|.++|+...+..+...+.+.++.|||+|++||+++ ++|||||.++||||+++..+||+|||+|+...+..-.     .
T Consensus       287 sLl~yLr~~~~~~l~~~~Ll~~a~qIaeGM~YLes~-~~IHRDLAARNiLV~~~~~vKIsDFGLAr~~~d~~Y~~~~~~k  365 (468)
T KOG0197|consen  287 SLLDYLRTREGGLLNLPQLLDFAAQIAEGMAYLESK-NYIHRDLAARNILVDEDLVVKISDFGLARLIGDDEYTASEGGK  365 (468)
T ss_pred             cHHHHhhhcCCCccchHHHHHHHHHHHHHHHHHHhC-CccchhhhhhheeeccCceEEEcccccccccCCCceeecCCCC
Confidence            999999876677889999999999999999999999 9999999999999999999999999999954443211     1


Q ss_pred             CcccccCcccccCCCCCCcccchhhhHHHHHHHhCCCCC-CchhhHHHhhhchhhhccccccCCCChHHHHHHHHHHHHh
Q 020221          214 TNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIP-PSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLASRC  292 (329)
Q Consensus       214 ~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~c  292 (329)
                      -.+.|.|||.+..+.|+.+||||||||+||||+|.+..+ +......+     ...++...+-+.|..+|+++.++|..|
T Consensus       366 fPIkWtAPEa~~~~~FS~kSDVWSFGVlL~E~fT~G~~py~~msn~ev-----~~~le~GyRlp~P~~CP~~vY~lM~~C  440 (468)
T KOG0197|consen  366 FPIKWTAPEALNYGKFSSKSDVWSFGVLLWELFTYGRVPYPGMSNEEV-----LELLERGYRLPRPEGCPDEVYELMKSC  440 (468)
T ss_pred             CCceecCHHHHhhCCcccccceeehhhhHHHHhccCCCCCCCCCHHHH-----HHHHhccCcCCCCCCCCHHHHHHHHHH
Confidence            247899999999999999999999999999999966544 43333222     333444455566888999999999999


Q ss_pred             cccCCCCCCCHHHHHHHHHhhhhcc
Q 020221          293 LQYEPRERPNPRSLVTALVTLQKDT  317 (329)
Q Consensus       293 l~~dp~~Rps~~~~l~~L~~~~~~~  317 (329)
                      |..+|++|||++.+...|+.+....
T Consensus       441 W~~~P~~RPtF~~L~~~l~~~~~~~  465 (468)
T KOG0197|consen  441 WHEDPEDRPTFETLREVLEDFFTST  465 (468)
T ss_pred             hhCCcccCCCHHHHHHHHHHhhhcc
Confidence            9999999999999999998876543

>KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms]

Probab=100.00  E-value=5.2e-52  Score=357.45  Aligned_cols=246  Identities=19%  Similarity=0.265  Sum_probs=204.5

Q ss_pred             CCcccccccCCCCCCcEEEEEE-eCCCCEEEEEEeCCCC--ChhHHHHHHHHHHHhcCCCccccccceeeeeCCeeEEEE
Q 020221           56 FAMENIVSEHGEKAPNVVYKGK-LENQFRIAVKRFNRSA--WPDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVA  132 (329)
Q Consensus        56 ~~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~  132 (329)
                      ..+|.+.+.||.|+||+||+|+ .+++..||||.+....  ....+-+..|+.+|+.++|||||.++++++.++.+||||
T Consensus         9 ~~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~~~i~lVM   88 (429)
T KOG0595|consen    9 VGDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKLNKKLVELLLSEIKILKELKHPNIVRLLDCIEDDDFIYLVM   88 (429)
T ss_pred             cccceehhhccCcceEEEEEeEeccCCceEEeeeehhhccCHHHHHHHHHHHHHHHhcCCcceeeEEEEEecCCeEEEEE
Confidence            4556777788999999999999 5668899999998773  333555789999999999999999999999999999999


Q ss_pred             ecCCCCCHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCCC------CCeeeecccCcccC
Q 020221          133 EYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDD------VNPRLSCFGLMKNS  206 (329)
Q Consensus       133 e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~------~~~kl~Dfg~a~~~  206 (329)
                      |||.||+|.+|++  ....+++..++.++.|++.||++||++ +||||||||+|||++..      -.+||+|||+|+..
T Consensus        89 EyC~gGDLs~yi~--~~~~l~e~t~r~Fm~QLA~alq~L~~~-~IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGfAR~L  165 (429)
T KOG0595|consen   89 EYCNGGDLSDYIR--RRGRLPEATARHFMQQLASALQFLHEN-NIIHRDLKPQNILLSTTARNDTSPVLKIADFGFARFL  165 (429)
T ss_pred             EeCCCCCHHHHHH--HcCCCCHHHHHHHHHHHHHHHHHHHHC-CeeeccCCcceEEeccCCCCCCCceEEecccchhhhC
Confidence            9999999999997  445899999999999999999999999 99999999999999754      45899999999998


Q ss_pred             CCCC---CccCcccccCcccccCCCCCCcccchhhhHHHHHHHhCCCCCCchhhHHHhhhchhhhccccccCCCChHHHH
Q 020221          207 RDGR---SYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGT  283 (329)
Q Consensus       207 ~~~~---~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  283 (329)
                      .++.   +.+|++-|||||++..++|+.|+|+||+|++||++++|+.||..............   ........+...+.
T Consensus       166 ~~~~~a~tlcGSplYMAPEV~~~~~YdAKADLWSiG~Ilyq~l~g~~Pf~a~t~~eL~~~~~k---~~~~~~~~~~~~s~  242 (429)
T KOG0595|consen  166 QPGSMAETLCGSPLYMAPEVIMSQQYDAKADLWSIGTILYQCLTGKPPFDAETPKELLLYIKK---GNEIVPVLPAELSN  242 (429)
T ss_pred             CchhHHHHhhCCccccCHHHHHhccccchhhHHHHHHHHHHHHhCCCCccccCHHHHHHHHhc---cccccCchhhhccC
Confidence            8764   56899999999999999999999999999999999999998876655444332111   11122233444555


Q ss_pred             HHHHHHHHhcccCCCCCCCHHHHH
Q 020221          284 ELVRLASRCLQYEPRERPNPRSLV  307 (329)
Q Consensus       284 ~~~~li~~cl~~dp~~Rps~~~~l  307 (329)
                      ...+++...+..+|.+|-+..+-.
T Consensus       243 ~~~~Ll~~ll~~~~~~~~~~~~~~  266 (429)
T KOG0595|consen  243 PLRELLISLLQRNPKDRISFEDFF  266 (429)
T ss_pred             chhhhhhHHHhcCccccCchHHhh
Confidence            666788888888888777666554

>KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=3e-52  Score=342.68  Aligned_cols=250  Identities=19%  Similarity=0.242  Sum_probs=211.0

Q ss_pred             CcccccccCCCCCCcEEEEEE-eCCCCEEEEEEeCCCCCh--hHHHHHHHHHHHhcCCCccccccce-eeeeCCe-eEEE
Q 020221           57 AMENIVSEHGEKAPNVVYKGK-LENQFRIAVKRFNRSAWP--DARQFLEEARAVGQLRNRRLANLLG-CCCEGDE-RLLV  131 (329)
Q Consensus        57 ~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~--~~~~~~~e~~~l~~l~h~niv~~~~-~~~~~~~-~~lv  131 (329)
                      ..|.++++||+|.||+||++. ..+|..+|.|.++-....  ..++...|+.+|+.|+|||||++++ .+.+... ++||
T Consensus        19 ~~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~evlniv   98 (375)
T KOG0591|consen   19 ADYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMMDAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDNEVLNIV   98 (375)
T ss_pred             HHHHHHHHHcCCcchheEEeeeccCcchhhhhhcchhhccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccchhhHHH
Confidence            347788889999999999998 788999999999854322  3456889999999999999999998 4555444 8999


Q ss_pred             EecCCCCCHHhhhccC--CCCCCCHHHHHHHHHHHHHHHHHhhc--CCC--ccccccCCCceeeCCCCCeeeecccCccc
Q 020221          132 AEYMPNDTLAKHLFHW--ETQPMKWAMRLRVALHIAEALEYCTS--KER--ALYHDLNAYRIVFDDDVNPRLSCFGLMKN  205 (329)
Q Consensus       132 ~e~~~~gsL~~~l~~~--~~~~~~~~~~~~i~~~i~~~l~~lH~--~~~--ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~  205 (329)
                      ||||..|+|...++..  ..+.+++..+|+++.|++.||..+|.  . +  ++||||||.||+++++|.+||+|||+++.
T Consensus        99 mE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~-r~~VmHRDIKPaNIFl~~~gvvKLGDfGL~r~  177 (375)
T KOG0591|consen   99 MELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIP-RGTVMHRDIKPANIFLTANGVVKLGDFGLGRF  177 (375)
T ss_pred             HHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhcccc-ccceeeccCcchheEEcCCCceeeccchhHhH
Confidence            9999999999998753  34678999999999999999999999  4 4  89999999999999999999999999998


Q ss_pred             CCCCC----CccCcccccCcccccCCCCCCcccchhhhHHHHHHHhCCCCCCchhhHHHhhhchhhhccccccCCCC-hH
Q 020221          206 SRDGR----SYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFS-SD  280 (329)
Q Consensus       206 ~~~~~----~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~  280 (329)
                      +....    +.+|||.||+||.+.+.+|++++||||+||++|||+.-++||.++............-.     ++.| ..
T Consensus       178 l~s~~tfA~S~VGTPyYMSPE~i~~~~Y~~kSDiWslGCllyEMcaL~~PF~g~n~~~L~~KI~qgd~-----~~~p~~~  252 (375)
T KOG0591|consen  178 LSSKTTFAHSLVGTPYYMSPERIHESGYNFKSDIWSLGCLLYEMCALQSPFYGDNLLSLCKKIEQGDY-----PPLPDEH  252 (375)
T ss_pred             hcchhHHHHhhcCCCcccCHHHHhcCCCCcchhHHHHHHHHHHHHhcCCCcccccHHHHHHHHHcCCC-----CCCcHHH
Confidence            87664    56899999999999999999999999999999999999999988866555444333322     2234 66


Q ss_pred             HHHHHHHHHHHhcccCCCCCCCHHHHHHHHHh
Q 020221          281 EGTELVRLASRCLQYEPRERPNPRSLVTALVT  312 (329)
Q Consensus       281 ~~~~~~~li~~cl~~dp~~Rps~~~~l~~L~~  312 (329)
                      .|.++..++..|+..||+.||+.-.+++.+..
T Consensus       253 YS~~l~~li~~ci~vd~~~RP~t~~~v~di~~  284 (375)
T KOG0591|consen  253 YSTDLRELINMCIAVDPEQRPDTVPYVQDIQS  284 (375)
T ss_pred             hhhHHHHHHHHHccCCcccCCCcchHHHHHHH
Confidence            89999999999999999999985555544443

>KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms]

Probab=100.00  E-value=5e-51  Score=348.14  Aligned_cols=239  Identities=20%  Similarity=0.245  Sum_probs=207.5

Q ss_pred             CCcccccccCCCCCCcEEEEEE-eCCCCEEEEEEeCCCCC---hhHHHHHHHHHHHhcCCCccccccceeeeeCCeeEEE
Q 020221           56 FAMENIVSEHGEKAPNVVYKGK-LENQFRIAVKRFNRSAW---PDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLV  131 (329)
Q Consensus        56 ~~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv  131 (329)
                      .+++++++.||+|+||.|+.++ .++++.+|+|++++...   ...+....|..+|..++||.||+++..|+++..+|||
T Consensus        24 ~~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt~~kLylV  103 (357)
T KOG0598|consen   24 PDDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSFQTEEKLYLV  103 (357)
T ss_pred             hhheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEecccCCeEEEE
Confidence            3456677888999999999998 66789999999987542   2345678999999999999999999999999999999


Q ss_pred             EecCCCCCHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCCCCCeeeecccCcccCCC---
Q 020221          132 AEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRD---  208 (329)
Q Consensus       132 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~---  208 (329)
                      +||+.||.|...|.  +...+++..+..++.+|+.||.|||++ |||||||||+|||+|.+|+++|+|||+++....   
T Consensus       104 ld~~~GGeLf~hL~--~eg~F~E~~arfYlaEi~lAL~~LH~~-gIiyRDlKPENILLd~~GHi~LtDFgL~k~~~~~~~  180 (357)
T KOG0598|consen  104 LDYLNGGELFYHLQ--REGRFSEDRARFYLAEIVLALGYLHSK-GIIYRDLKPENILLDEQGHIKLTDFGLCKEDLKDGD  180 (357)
T ss_pred             EeccCCccHHHHHH--hcCCcchhHHHHHHHHHHHHHHHHHhC-CeeeccCCHHHeeecCCCcEEEeccccchhcccCCC
Confidence            99999999999996  567899999999999999999999999 999999999999999999999999999985332   


Q ss_pred             -CCCccCcccccCcccccCCCCCCcccchhhhHHHHHHHhCCCCCCchhhHHHhhhchhhhccccccCCCChHHHHHHHH
Q 020221          209 -GRSYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVR  287 (329)
Q Consensus       209 -~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  287 (329)
                       ..+.+||+.|||||++.+..|+..+|+||+|+++|||++|.+||.......+.........     ...+.-.+.+.++
T Consensus       181 ~t~tfcGT~eYmAPEil~~~gy~~~vDWWsLGillYeML~G~pPF~~~~~~~~~~~I~~~k~-----~~~p~~ls~~ard  255 (357)
T KOG0598|consen  181 ATRTFCGTPEYMAPEILLGKGYDKAVDWWSLGILLYEMLTGKPPFYAEDVKKMYDKILKGKL-----PLPPGYLSEEARD  255 (357)
T ss_pred             ccccccCCccccChHHHhcCCCCcccchHhHHHHHHHHhhCCCCCcCccHHHHHHHHhcCcC-----CCCCccCCHHHHH
Confidence             2456899999999999999999999999999999999999999988776655554443321     1234447889999


Q ss_pred             HHHHhcccCCCCCCC
Q 020221          288 LASRCLQYEPRERPN  302 (329)
Q Consensus       288 li~~cl~~dp~~Rps  302 (329)
                      ++.++|+.||++|..
T Consensus       256 ll~~LL~rdp~~RLg  270 (357)
T KOG0598|consen  256 LLKKLLKRDPRQRLG  270 (357)
T ss_pred             HHHHHhccCHHHhcC
Confidence            999999999999964

>KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only]

Probab=100.00  E-value=1.4e-50  Score=335.90  Aligned_cols=248  Identities=20%  Similarity=0.327  Sum_probs=201.5

Q ss_pred             CcccccccCCCCCCcEEEEEE-eCCCCEEEEEEeCCCCCh-h-HHHHHHHHHHHhcCCCccccccceeeeeCCeeEEEEe
Q 020221           57 AMENIVSEHGEKAPNVVYKGK-LENQFRIAVKRFNRSAWP-D-ARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAE  133 (329)
Q Consensus        57 ~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~-~-~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  133 (329)
                      +.|+.++++|+|+||+||+++ .++|+.||||++..+... . .+-.++|+++|++++|+|+|.++++|......+||+|
T Consensus         2 ekYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrrkrklhLVFE   81 (396)
T KOG0593|consen    2 EKYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESEDDPVVKKIALREIRMLKQLKHENLVNLIEVFRRKRKLHLVFE   81 (396)
T ss_pred             cHHhhhhccccCcceEEEEeccCCcccEEEEEeeccCCccHHHHHHHHHHHHHHHhcccchHHHHHHHHHhcceeEEEee
Confidence            357788899999999999999 677999999999876532 2 3347899999999999999999999999999999999


Q ss_pred             cCCCCCHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCCCCCeeeecccCcccCC-CCC--
Q 020221          134 YMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSR-DGR--  210 (329)
Q Consensus       134 ~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~-~~~--  210 (329)
                      ||+. ++.+.|.+ ....++...+..+++|++.|+.|+|++ +++||||||+|||++.+|.+||+|||+|+... ++.  
T Consensus        82 ~~dh-TvL~eLe~-~p~G~~~~~vk~~l~Q~l~ai~~cHk~-n~IHRDIKPENILit~~gvvKLCDFGFAR~L~~pgd~Y  158 (396)
T KOG0593|consen   82 YCDH-TVLHELER-YPNGVPSELVKKYLYQLLKAIHFCHKN-NCIHRDIKPENILITQNGVVKLCDFGFARTLSAPGDNY  158 (396)
T ss_pred             ecch-HHHHHHHh-ccCCCCHHHHHHHHHHHHHHhhhhhhc-CeecccCChhheEEecCCcEEeccchhhHhhcCCcchh
Confidence            9988 55555543 556789999999999999999999999 99999999999999999999999999999876 443  


Q ss_pred             -CccCcccccCcccccC-CCCCCcccchhhhHHHHHHHhCCCCCCchh-hHHHh------hh-------------chhhh
Q 020221          211 -SYSTNLAFTPPEYLRT-GRVTPESVMYSFGTLLLDLLSGKHIPPSHA-LDLIR------DR-------------NIQTL  268 (329)
Q Consensus       211 -~~~~~~~y~aPE~~~~-~~~~~~~DvwslG~il~el~tg~~~~~~~~-~~~~~------~~-------------~~~~~  268 (329)
                       .++.|.+|.|||.+.| .+|...+||||+||++.||++|.+.||+.. .+...      ..             ....+
T Consensus       159 TDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDiDQLy~I~ktLG~L~prhq~iF~~N~~F~Gv  238 (396)
T KOG0593|consen  159 TDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRSDIDQLYLIRKTLGNLIPRHQSIFSSNPFFHGV  238 (396)
T ss_pred             hhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcchHHHHHHHHHHHcccCHHHHHHhccCCceeee
Confidence             4567999999999987 569999999999999999999998887652 11110      00             00000


Q ss_pred             cccc------ccCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 020221          269 TDSC------LEGQFSSDEGTELVRLASRCLQYEPRERPNPRSLVT  308 (329)
Q Consensus       269 ~~~~------~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~~~l~  308 (329)
                      .-+.      +...+ +..+.-+.+++..||..||++|++-++++.
T Consensus       239 ~lP~~~~~epLe~k~-p~~s~~~ld~~k~cL~~dP~~R~sc~qll~  283 (396)
T KOG0593|consen  239 RLPEPEHPEPLERKY-PKISNVLLDLLKKCLKMDPDDRLSCEQLLH  283 (396)
T ss_pred             ecCCCCCccchhhhc-ccchHHHHHHHHHHhcCCccccccHHHHhc
Confidence            0000      00011 235678999999999999999999999985

>KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=4e-50  Score=358.71  Aligned_cols=248  Identities=18%  Similarity=0.280  Sum_probs=213.0

Q ss_pred             cCCCcccccccCCCCCCcEEEEEE-eCCCCEEEEEEeCCCCChhHHHHHHHHHHHhcCCCccccccceeeeeCCeeEEEE
Q 020221           54 SGFAMENIVSEHGEKAPNVVYKGK-LENQFRIAVKRFNRSAWPDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVA  132 (329)
Q Consensus        54 ~~~~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~  132 (329)
                      +.-..|....++|+|+-|.||.+. ..+++.||||.+........+-+.+|+.+|+..+|+|||.+++.|..++.+|+||
T Consensus       270 dP~~~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q~~keLilnEi~Vm~~~~H~NiVnfl~Sylv~deLWVVM  349 (550)
T KOG0578|consen  270 DPRSKYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRKQPKKELLLNEILVMRDLHHPNIVNFLDSYLVGDELWVVM  349 (550)
T ss_pred             ChhhhhcchhhhccccccceeeeeeccCCceEEEEEEEeccCCchhhhHHHHHHHHhccchHHHHHHHHhcccceeEEEE
Confidence            344456666778999999999998 6778899999999888776777899999999999999999999999999999999


Q ss_pred             ecCCCCCHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCCCCCeeeecccCcccCCCC---
Q 020221          133 EYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDG---  209 (329)
Q Consensus       133 e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~---  209 (329)
                      ||+++|+|.+.+   ....+++.++..|.++++.||+|||.+ ||+|||||.+|||++.+|.+||+|||++..+...   
T Consensus       350 Eym~ggsLTDvV---t~~~~~E~qIA~Icre~l~aL~fLH~~-gIiHrDIKSDnILL~~~g~vKltDFGFcaqi~~~~~K  425 (550)
T KOG0578|consen  350 EYMEGGSLTDVV---TKTRMTEGQIAAICREILQGLKFLHAR-GIIHRDIKSDNILLTMDGSVKLTDFGFCAQISEEQSK  425 (550)
T ss_pred             eecCCCchhhhh---hcccccHHHHHHHHHHHHHHHHHHHhc-ceeeeccccceeEeccCCcEEEeeeeeeeccccccCc
Confidence            999999999998   556699999999999999999999999 9999999999999999999999999998776554   


Q ss_pred             -CCccCcccccCcccccCCCCCCcccchhhhHHHHHHHhCCCCCCchhhHHHhhhchhhhccccccCCCChHHHHHHHHH
Q 020221          210 -RSYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRL  288 (329)
Q Consensus       210 -~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  288 (329)
                       .+.+||+.|||||++....|.+++||||||++++||+-|.+||..+.--  + ............-..+...|+++++|
T Consensus       426 R~TmVGTPYWMAPEVvtrk~YG~KVDIWSLGIMaIEMveGEPPYlnE~Pl--r-AlyLIa~ng~P~lk~~~klS~~~kdF  502 (550)
T KOG0578|consen  426 RSTMVGTPYWMAPEVVTRKPYGPKVDIWSLGIMAIEMVEGEPPYLNENPL--R-ALYLIATNGTPKLKNPEKLSPELKDF  502 (550)
T ss_pred             cccccCCCCccchhhhhhcccCccccchhhhhHHHHHhcCCCCccCCChH--H-HHHHHhhcCCCCcCCccccCHHHHHH
Confidence             3568999999999999999999999999999999999999888653211  0 00000111112223467789999999


Q ss_pred             HHHhcccCCCCCCCHHHHHH
Q 020221          289 ASRCLQYEPRERPNPRSLVT  308 (329)
Q Consensus       289 i~~cl~~dp~~Rps~~~~l~  308 (329)
                      +.+||..|+++|++|.++|+
T Consensus       503 L~~cL~~dv~~RasA~eLL~  522 (550)
T KOG0578|consen  503 LDRCLVVDVEQRASAKELLE  522 (550)
T ss_pred             HHHHhhcchhcCCCHHHHhc
Confidence            99999999999999999998

>KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=1.1e-49  Score=344.82  Aligned_cols=251  Identities=20%  Similarity=0.294  Sum_probs=204.3

Q ss_pred             ccccccCCCCCCcEEEEEE-eCCCCEEEEEEeCCCCChhHHHHHHHHHHHhcCCCccccccceeeeeCC--eeEEEEecC
Q 020221           59 ENIVSEHGEKAPNVVYKGK-LENQFRIAVKRFNRSAWPDARQFLEEARAVGQLRNRRLANLLGCCCEGD--ERLLVAEYM  135 (329)
Q Consensus        59 ~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~--~~~lv~e~~  135 (329)
                      +...+.||+|+||+||++. .++|...|||.+........+.+.+|+++|..++|||||+.+|......  .+++.|||+
T Consensus        19 ~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~~~~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~~~i~mEy~   98 (313)
T KOG0198|consen   19 WSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELEDSPTSESLEREIRILSRLNHPNIVQYYGSSSSRENDEYNIFMEYA   98 (313)
T ss_pred             hhhhccccCccceEEEEEEecCCCcceeeeeeecccchhHHHHHHHHHHHHhCCCCCEEeeCCccccccCeeeEeeeecc
Confidence            4455667999999999999 4558899999998765444677899999999999999999999754444  689999999


Q ss_pred             CCCCHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCC-CCCeeeecccCcccCCC------
Q 020221          136 PNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDD-DVNPRLSCFGLMKNSRD------  208 (329)
Q Consensus       136 ~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~-~~~~kl~Dfg~a~~~~~------  208 (329)
                      ++|||.+++.+..+ .+++..+..+.+|++.||+|||++ |++||||||+|||++. ++.+||+|||+++....      
T Consensus        99 ~~GsL~~~~~~~g~-~l~E~~v~~ytr~iL~GL~ylHs~-g~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~~~~~~~~~  176 (313)
T KOG0198|consen   99 PGGSLSDLIKRYGG-KLPEPLVRRYTRQILEGLAYLHSK-GIVHCDIKPANILLDPSNGDVKLADFGLAKKLESKGTKSD  176 (313)
T ss_pred             CCCcHHHHHHHcCC-CCCHHHHHHHHHHHHHHHHHHHhC-CEeccCcccceEEEeCCCCeEEeccCcccccccccccccc
Confidence            99999999986444 799999999999999999999999 9999999999999999 79999999999886552      


Q ss_pred             -CCCccCcccccCcccccCCC-CCCcccchhhhHHHHHHHhCCCCCCchhhHHHhhhchhhhccccccCCCChHHHHHHH
Q 020221          209 -GRSYSTNLAFTPPEYLRTGR-VTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELV  286 (329)
Q Consensus       209 -~~~~~~~~~y~aPE~~~~~~-~~~~~DvwslG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  286 (329)
                       .....||+.|||||++.++. ....+|||||||++.||+||..|+... .... .......... ..+.+|...+.+.+
T Consensus       177 ~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~-~~~~-~~~~~ig~~~-~~P~ip~~ls~~a~  253 (313)
T KOG0198|consen  177 SELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEF-FEEA-EALLLIGRED-SLPEIPDSLSDEAK  253 (313)
T ss_pred             ccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhh-cchH-HHHHHHhccC-CCCCCCcccCHHHH
Confidence             22467899999999999643 445999999999999999998776542 0000 0111111111 22366777899999


Q ss_pred             HHHHHhcccCCCCCCCHHHHHHHHHhhh
Q 020221          287 RLASRCLQYEPRERPNPRSLVTALVTLQ  314 (329)
Q Consensus       287 ~li~~cl~~dp~~Rps~~~~l~~L~~~~  314 (329)
                      +|+..|+..||++||||.+++++.--..
T Consensus       254 ~Fl~~C~~~~p~~Rpta~eLL~hpf~~~  281 (313)
T KOG0198|consen  254 DFLRKCFKRDPEKRPTAEELLEHPFLKQ  281 (313)
T ss_pred             HHHHHHhhcCcccCcCHHHHhhChhhhc
Confidence            9999999999999999999998654433

>KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair]

Probab=100.00  E-value=4.9e-49  Score=321.34  Aligned_cols=248  Identities=21%  Similarity=0.282  Sum_probs=203.6

Q ss_pred             cccccccCCCCCCcEEEEEE-eCCCCEEEEEEeCCCCChh--HHHHHHHHHHHhcCCCccccccceeeeeCCeeEEEEec
Q 020221           58 MENIVSEHGEKAPNVVYKGK-LENQFRIAVKRFNRSAWPD--ARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAEY  134 (329)
Q Consensus        58 ~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~--~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  134 (329)
                      .|..++.+|+|.||+||+|+ ..+|+.||||+++.....+  .....+|++.|+.++|+||+.++++|...+.+.||+||
T Consensus         3 rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel~h~nIi~LiD~F~~~~~l~lVfEf   82 (318)
T KOG0659|consen    3 RYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDGINRTALREIKLLQELKHPNIIELIDVFPHKSNLSLVFEF   82 (318)
T ss_pred             hhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccccCccHHHHHHHHHHHHccCcchhhhhhhccCCCceEEEEEe
Confidence            46677888999999999999 7789999999998764332  34578999999999999999999999999999999999


Q ss_pred             CCCCCHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCCCCCeeeecccCcccCCCCCC---
Q 020221          135 MPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDGRS---  211 (329)
Q Consensus       135 ~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~~---  211 (329)
                      ++. +|...+++ +...++..++..++.++++||+|||++ .|+||||||.|+|++.+|.+||+|||+|+.+.....   
T Consensus        83 m~t-dLe~vIkd-~~i~l~pa~iK~y~~m~LkGl~y~H~~-~IlHRDlKPnNLLis~~g~lKiADFGLAr~f~~p~~~~~  159 (318)
T KOG0659|consen   83 MPT-DLEVVIKD-KNIILSPADIKSYMLMTLKGLAYCHSK-WILHRDLKPNNLLISSDGQLKIADFGLARFFGSPNRIQT  159 (318)
T ss_pred             ccc-cHHHHhcc-cccccCHHHHHHHHHHHHHHHHHHHhh-hhhcccCCccceEEcCCCcEEeecccchhccCCCCcccc
Confidence            987 89999976 566789999999999999999999999 999999999999999999999999999998765432   


Q ss_pred             -ccCcccccCcccccCCC-CCCcccchhhhHHHHHHHhCCCCCCchhhHHHhhhch-----------------------h
Q 020221          212 -YSTNLAFTPPEYLRTGR-VTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNI-----------------------Q  266 (329)
Q Consensus       212 -~~~~~~y~aPE~~~~~~-~~~~~DvwslG~il~el~tg~~~~~~~~~~~~~~~~~-----------------------~  266 (329)
                       .+.|.+|.|||.+.|.+ |...+||||.|||+.||+.|.+.+++...-.-.....                       .
T Consensus       160 ~~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG~sDidQL~~If~~LGTP~~~~WP~~~~lpdY~~~~  239 (318)
T KOG0659|consen  160 HQVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPGDSDIDQLSKIFRALGTPTPDQWPEMTSLPDYVKIQ  239 (318)
T ss_pred             cceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCCCchHHHHHHHHHHcCCCCcccCccccccccHHHHh
Confidence             25689999999998776 9999999999999999999997666542110000000                       0


Q ss_pred             hhccccccCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 020221          267 TLTDSCLEGQFSSDEGTELVRLASRCLQYEPRERPNPRSLVTA  309 (329)
Q Consensus       267 ~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~~~l~~  309 (329)
                      ....+.... .-...+.++.+|+..+|.+||.+|+|++|++++
T Consensus       240 ~~P~~~~~~-lf~aas~d~ldLl~~m~~ynP~~Rita~qaL~~  281 (318)
T KOG0659|consen  240 QFPKPPLNN-LFPAASSDALDLLSKMLTYNPKKRITASQALKH  281 (318)
T ss_pred             cCCCCcccc-ccccccHHHHHHHHhhhccCchhcccHHHHhcc
Confidence            000111111 223456778999999999999999999999973

>KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms]

Probab=100.00  E-value=1.9e-49  Score=328.33  Aligned_cols=253  Identities=18%  Similarity=0.225  Sum_probs=218.2

Q ss_pred             CcccccccCCCCCCcEEEEEE-eCCCCEEEEEEeCCCCChhH---HHHHHHHHHHhcCCCccccccceeeeeCCeeEEEE
Q 020221           57 AMENIVSEHGEKAPNVVYKGK-LENQFRIAVKRFNRSAWPDA---RQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVA  132 (329)
Q Consensus        57 ~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~---~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~  132 (329)
                      ++++.++.+|.|+||.|.+++ ..+|..+|+|++.....-..   +...+|..+|+.+.||.++++++.+.+.+++++||
T Consensus        44 ~dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d~~~lymvm  123 (355)
T KOG0616|consen   44 QDFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKDNSNLYMVM  123 (355)
T ss_pred             hhhhheeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEeeccCCeEEEEE
Confidence            345677888999999999999 56788999999987654333   34678999999999999999999999999999999


Q ss_pred             ecCCCCCHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCCCCCeeeecccCcccCCCC-CC
Q 020221          133 EYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDG-RS  211 (329)
Q Consensus       133 e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~-~~  211 (329)
                      ||++||.|.++++  +.+.+++..++.++.||+.||+|||+. +|++|||||+|||+|.+|.+||+|||+|+..... -+
T Consensus       124 eyv~GGElFS~Lr--k~~rF~e~~arFYAAeivlAleylH~~-~iiYRDLKPENiLlD~~G~iKitDFGFAK~v~~rT~T  200 (355)
T KOG0616|consen  124 EYVPGGELFSYLR--KSGRFSEPHARFYAAEIVLALEYLHSL-DIIYRDLKPENLLLDQNGHIKITDFGFAKRVSGRTWT  200 (355)
T ss_pred             eccCCccHHHHHH--hcCCCCchhHHHHHHHHHHHHHHHHhc-CeeeccCChHHeeeccCCcEEEEeccceEEecCcEEE
Confidence            9999999999997  667899999999999999999999999 9999999999999999999999999999977655 45


Q ss_pred             ccCcccccCcccccCCCCCCcccchhhhHHHHHHHhCCCCCCchhhHHHhhhchhhhccccccCCCChHHHHHHHHHHHH
Q 020221          212 YSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLASR  291 (329)
Q Consensus       212 ~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~  291 (329)
                      .+||+.|+|||.+....++.++|.|||||++|||+.|.+||..+....+.+.....      .-.+|..++.++++|+..
T Consensus       201 lCGTPeYLAPEii~sk~ynkavDWWalGVLIYEMlaG~pPF~~~~~~~iY~KI~~~------~v~fP~~fs~~~kdLl~~  274 (355)
T KOG0616|consen  201 LCGTPEYLAPEIIQSKGYNKAVDWWALGVLIYEMLAGYPPFYDDNPIQIYEKILEG------KVKFPSYFSSDAKDLLKK  274 (355)
T ss_pred             ecCCccccChHHhhcCCCCcchhHHHHHHHHHHHHcCCCCCcCCChHHHHHHHHhC------cccCCcccCHHHHHHHHH
Confidence            68999999999999999999999999999999999999999876554333333322      124678889999999999


Q ss_pred             hcccCCCCCCCHHHHHHHHHhhhhccccccCccccc
Q 020221          292 CLQYEPRERPNPRSLVTALVTLQKDTELYLSLPWVM  327 (329)
Q Consensus       292 cl~~dp~~Rps~~~~l~~L~~~~~~~~~~~~~p~~~  327 (329)
                      +|+.|-.+|         +-.++.+..-...|||+.
T Consensus       275 LL~vD~t~R---------~gnlknG~~dIk~H~wF~  301 (355)
T KOG0616|consen  275 LLQVDLTKR---------FGNLKNGVEDIKNHPWFK  301 (355)
T ss_pred             HHhhhhHhh---------hcCcCCCccccccCcccc
Confidence            999999988         445555667777788864

>KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=2.2e-49  Score=348.94  Aligned_cols=248  Identities=22%  Similarity=0.258  Sum_probs=202.8

Q ss_pred             CcccccccCCCCCCcEEEEEE-eCCCCEEEEEEeCCCC--ChhHHHHHHHHHHHhcCCCccccccceeeeeC--CeeEEE
Q 020221           57 AMENIVSEHGEKAPNVVYKGK-LENQFRIAVKRFNRSA--WPDARQFLEEARAVGQLRNRRLANLLGCCCEG--DERLLV  131 (329)
Q Consensus        57 ~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~--~~~~lv  131 (329)
                      +.|+.+++||+|.||.||+|+ ..+|+.||+|+++.+.  .....-..+||.+|++|.||||+++.+...+.  ..+|||
T Consensus       117 ~~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~~~~siYlV  196 (560)
T KOG0600|consen  117 DSFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEKEGFPITAIREIKILRRLDHPNIIKLEEIVTSKLSGSIYLV  196 (560)
T ss_pred             HHHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccCCCcchHHHHHHHHHHHhcCCCcccceeeEEEecCCceEEEE
Confidence            446778899999999999999 7789999999998765  33355578999999999999999999998876  689999


Q ss_pred             EecCCCCCHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCCCCCeeeecccCcccCCCCC-
Q 020221          132 AEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDGR-  210 (329)
Q Consensus       132 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~-  210 (329)
                      +|||+. +|.-++.. ..-.|++.++..+++|++.||+|||++ |++|||||.+|||||++|.+||+|||+|+++.... 
T Consensus       197 FeYMdh-DL~GLl~~-p~vkft~~qIKc~mkQLl~Gl~~cH~~-gvlHRDIK~SNiLidn~G~LKiaDFGLAr~y~~~~~  273 (560)
T KOG0600|consen  197 FEYMDH-DLSGLLSS-PGVKFTEPQIKCYMKQLLEGLEYCHSR-GVLHRDIKGSNILIDNNGVLKIADFGLARFYTPSGS  273 (560)
T ss_pred             Eecccc-hhhhhhcC-CCcccChHHHHHHHHHHHHHHHHHhhc-CeeeccccccceEEcCCCCEEeccccceeeccCCCC
Confidence            999988 79888854 456899999999999999999999999 99999999999999999999999999999765543 


Q ss_pred             ----CccCcccccCcccccCCC-CCCcccchhhhHHHHHHHhCCCCCCchhhHHHhhhchhhh--------cc-------
Q 020221          211 ----SYSTNLAFTPPEYLRTGR-VTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTL--------TD-------  270 (329)
Q Consensus       211 ----~~~~~~~y~aPE~~~~~~-~~~~~DvwslG~il~el~tg~~~~~~~~~~~~~~~~~~~~--------~~-------  270 (329)
                          +.+.|++|.|||.+.|.. |+..+|+||.||||.||++|++.+++..-- .+-..+..+        +.       
T Consensus       274 ~~~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tEv-eQl~kIfklcGSP~e~~W~~~kLP~~  352 (560)
T KOG0600|consen  274 APYTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGRTEV-EQLHKIFKLCGSPTEDYWPVSKLPHA  352 (560)
T ss_pred             cccccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCccHH-HHHHHHHHHhCCCChhccccccCCcc
Confidence                345689999999999876 999999999999999999999877654210 000000000        00       


Q ss_pred             ccccCC--C-------ChHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 020221          271 SCLEGQ--F-------SSDEGTELVRLASRCLQYEPRERPNPRSLVT  308 (329)
Q Consensus       271 ~~~~~~--~-------~~~~~~~~~~li~~cl~~dp~~Rps~~~~l~  308 (329)
                      ...+..  +       ...+++...+|+..+|..||++|.||.++++
T Consensus       353 ~~~kp~~~y~r~l~E~~~~~~~~~l~Ll~~lL~ldP~kR~tA~~aL~  399 (560)
T KOG0600|consen  353 TIFKPQQPYKRRLRETFKDFPASALDLLEKLLSLDPDKRGTASSALQ  399 (560)
T ss_pred             cccCCCCcccchHHHHhccCCHHHHHHHHHHhccCccccccHHHHhc
Confidence            000000  0       1245788999999999999999999999986

>KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.9e-49  Score=346.97  Aligned_cols=247  Identities=19%  Similarity=0.299  Sum_probs=205.1

Q ss_pred             CcccccccCCCCCCcEEEEEE-eCCCCEEEEEEeCCCCChhHHH--HHHHHHHHhcCC-CccccccceeeeeCC-eeEEE
Q 020221           57 AMENIVSEHGEKAPNVVYKGK-LENQFRIAVKRFNRSAWPDARQ--FLEEARAVGQLR-NRRLANLLGCCCEGD-ERLLV  131 (329)
Q Consensus        57 ~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~--~~~e~~~l~~l~-h~niv~~~~~~~~~~-~~~lv  131 (329)
                      ..|.+++++|.|.||.||+|+ ..++..||||+++..... .++  -++|++.|+++. ||||+++.+++.+.+ .+++|
T Consensus        10 ~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s-~ee~~nLREvksL~kln~hpniikL~Evi~d~~~~L~fV   88 (538)
T KOG0661|consen   10 DRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYS-WEECMNLREVKSLRKLNPHPNIIKLKEVIRDNDRILYFV   88 (538)
T ss_pred             HHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhcc-HHHHHHHHHHHHHHhcCCCCcchhhHHHhhccCceEeee
Confidence            458889999999999999999 777889999999876533 333  478999999998 999999999998887 99999


Q ss_pred             EecCCCCCHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCCCCCeeeecccCcccCCCC--
Q 020221          132 AEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDG--  209 (329)
Q Consensus       132 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~--  209 (329)
                      ||||+. +|.++++.+ ++.+++..+..|+.||++||+|+|.+ |++|||+||+|||+..+..+||+|||+|+.....  
T Consensus        89 fE~Md~-NLYqLmK~R-~r~fse~~irnim~QilqGL~hiHk~-GfFHRDlKPENiLi~~~~~iKiaDFGLARev~SkpP  165 (538)
T KOG0661|consen   89 FEFMDC-NLYQLMKDR-NRLFSESDIRNIMYQILQGLAHIHKH-GFFHRDLKPENILISGNDVIKIADFGLAREVRSKPP  165 (538)
T ss_pred             HHhhhh-hHHHHHhhc-CCcCCHHHHHHHHHHHHHHHHHHHhc-CcccccCChhheEecccceeEecccccccccccCCC
Confidence            999977 899999875 78999999999999999999999999 9999999999999999999999999999976654  


Q ss_pred             -CCccCcccccCccccc-CCCCCCcccchhhhHHHHHHHhCCCCCCchh-hHHHhh----------------hchhhhc-
Q 020221          210 -RSYSTNLAFTPPEYLR-TGRVTPESVMYSFGTLLLDLLSGKHIPPSHA-LDLIRD----------------RNIQTLT-  269 (329)
Q Consensus       210 -~~~~~~~~y~aPE~~~-~~~~~~~~DvwslG~il~el~tg~~~~~~~~-~~~~~~----------------~~~~~~~-  269 (329)
                       ..++.|.+|.|||++. .+.|+.+.|||++|||++|+.+-++.||+.. .+.+..                ..+...+ 
T Consensus       166 YTeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~Dqi~KIc~VLGtP~~~~~~eg~~La~~mn  245 (538)
T KOG0661|consen  166 YTEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGASEIDQIYKICEVLGTPDKDSWPEGYNLASAMN  245 (538)
T ss_pred             cchhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCcHHHHHHHHHHHhCCCccccchhHHHHHHHhc
Confidence             4567899999999875 4569999999999999999999999888642 111100                0000000 


Q ss_pred             -------cccccCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 020221          270 -------DSCLEGQFSSDEGTELVRLASRCLQYEPRERPNPRSLVT  308 (329)
Q Consensus       270 -------~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~~~l~  308 (329)
                             ...+....+ ..+.++.+++..|++.||++||||.++++
T Consensus       246 f~~P~~~~~~l~~L~p-~~s~~~~~li~~ll~WDP~kRpTA~~al~  290 (538)
T KOG0661|consen  246 FRFPQVKPSPLKDLLP-NASSEAASLIERLLAWDPDKRPTASQALQ  290 (538)
T ss_pred             cCCCcCCCCChHHhCc-ccCHHHHHHHHHHhcCCCccCccHHHHhc
Confidence                   000111122 37889999999999999999999999998

>KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=5.2e-48  Score=347.01  Aligned_cols=244  Identities=20%  Similarity=0.232  Sum_probs=208.2

Q ss_pred             CCcccccccCCCCCCcEEEEEE-eCCCCEEEEEEeCCC----CC-hhHHHHHHHHHHHhcCC-CccccccceeeeeCCee
Q 020221           56 FAMENIVSEHGEKAPNVVYKGK-LENQFRIAVKRFNRS----AW-PDARQFLEEARAVGQLR-NRRLANLLGCCCEGDER  128 (329)
Q Consensus        56 ~~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~----~~-~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~~~  128 (329)
                      ...|.+.+.||+|+||.|+.|. ..++..||+|++...    .. ...+.+.+|+.+++.++ ||||+++++++.....+
T Consensus        16 ~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~~~~   95 (370)
T KOG0583|consen   16 IGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATPTKI   95 (370)
T ss_pred             cCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecCCeE
Confidence            4467788888999999999998 667899999977664    11 22445678999999998 99999999999999999


Q ss_pred             EEEEecCCCCCHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCCC-CCeeeecccCcccCC
Q 020221          129 LLVAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDD-VNPRLSCFGLMKNSR  207 (329)
Q Consensus       129 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~-~~~kl~Dfg~a~~~~  207 (329)
                      ++||||+.+|+|.+++.+  ...+.+..+..+++|+++|++|||++ ||+||||||+|||++.+ +++||+|||++....
T Consensus        96 ~ivmEy~~gGdL~~~i~~--~g~l~E~~ar~~F~Qlisav~y~H~~-gi~HRDLK~ENilld~~~~~~Kl~DFG~s~~~~  172 (370)
T KOG0583|consen   96 YIVMEYCSGGDLFDYIVN--KGRLKEDEARKYFRQLISAVAYCHSR-GIVHRDLKPENILLDGNEGNLKLSDFGLSAISP  172 (370)
T ss_pred             EEEEEecCCccHHHHHHH--cCCCChHHHHHHHHHHHHHHHHHHhC-CEeeCCCCHHHEEecCCCCCEEEeccccccccC
Confidence            999999999999999974  57889999999999999999999999 99999999999999999 999999999998772


Q ss_pred             -C---CCCccCcccccCcccccCCC-CC-CcccchhhhHHHHHHHhCCCCCCchhhHHHhhhchhhhccccccCCCChHH
Q 020221          208 -D---GRSYSTNLAFTPPEYLRTGR-VT-PESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDE  281 (329)
Q Consensus       208 -~---~~~~~~~~~y~aPE~~~~~~-~~-~~~DvwslG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  281 (329)
                       .   ..+.+|++.|+|||++.+.. |+ .++||||+||+||.|++|..||.......+......    .  ...+|..+
T Consensus       173 ~~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~~~~~l~~ki~~----~--~~~~p~~~  246 (370)
T KOG0583|consen  173 GEDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDSNVPNLYRKIRK----G--EFKIPSYL  246 (370)
T ss_pred             CCCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCccHHHHHHHHhc----C--CccCCCCc
Confidence             2   24678999999999999877 76 689999999999999999999987544433333111    1  12345555


Q ss_pred             -HHHHHHHHHHhcccCCCCCCCHHHHHH
Q 020221          282 -GTELVRLASRCLQYEPRERPNPRSLVT  308 (329)
Q Consensus       282 -~~~~~~li~~cl~~dp~~Rps~~~~l~  308 (329)
                       ++++++|+.+||..||.+|+|+.+++.
T Consensus       247 ~S~~~~~Li~~mL~~~P~~R~t~~~i~~  274 (370)
T KOG0583|consen  247 LSPEARSLIEKMLVPDPSTRITLLEILE  274 (370)
T ss_pred             CCHHHHHHHHHHcCCCcccCCCHHHHhh
Confidence             899999999999999999999999995

>KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms]

Probab=100.00  E-value=1.1e-48  Score=347.21  Aligned_cols=241  Identities=20%  Similarity=0.252  Sum_probs=207.1

Q ss_pred             ccccccCCCCCCcEEEEEE-eCCCCEEEEEEeCCCC---ChhHHHHHHHHHHHhcC-CCccccccceeeeeCCeeEEEEe
Q 020221           59 ENIVSEHGEKAPNVVYKGK-LENQFRIAVKRFNRSA---WPDARQFLEEARAVGQL-RNRRLANLLGCCCEGDERLLVAE  133 (329)
Q Consensus        59 ~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e  133 (329)
                      +.+.+.+|.|+|++|++|+ ..+++.+|||++.+..   ....+.+..|-.+|..| .||.|++|+-.|++...+|+|+|
T Consensus        75 F~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~sLYFvLe  154 (604)
T KOG0592|consen   75 FKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDEESLYFVLE  154 (604)
T ss_pred             cchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeecccceEEEEE
Confidence            4445556999999999999 6788999999997653   22234577899999999 79999999999999999999999


Q ss_pred             cCCCCCHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCCCCCeeeecccCcccCCCC----
Q 020221          134 YMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDG----  209 (329)
Q Consensus       134 ~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~----  209 (329)
                      |+++|+|.++|.  +-+.+++..++.++.||+.||+|||+. |||||||||+|||+|.+++++|+|||.|+...+.    
T Consensus       155 ~A~nGdll~~i~--K~Gsfde~caR~YAAeIldAleylH~~-GIIHRDlKPENILLd~dmhikITDFGsAK~l~~~~~~~  231 (604)
T KOG0592|consen  155 YAPNGDLLDLIK--KYGSFDETCARFYAAEILDALEYLHSN-GIIHRDLKPENILLDKDGHIKITDFGSAKILSPSQKSQ  231 (604)
T ss_pred             ecCCCcHHHHHH--HhCcchHHHHHHHHHHHHHHHHHHHhc-CceeccCChhheeEcCCCcEEEeeccccccCChhhccc
Confidence            999999999997  457899999999999999999999999 9999999999999999999999999998754321    


Q ss_pred             -------------CCccCcccccCcccccCCCCCCcccchhhhHHHHHHHhCCCCCCchhhHHHhhhchhhhccccccCC
Q 020221          210 -------------RSYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQ  276 (329)
Q Consensus       210 -------------~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~  276 (329)
                                   .+++||-.|.+||++.+...+..+|+|+||||||+|+.|.+||.......+-+..+.      +...
T Consensus       232 ~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~~~~sDiWAlGCilyQmlaG~PPFra~NeyliFqkI~~------l~y~  305 (604)
T KOG0592|consen  232 ENPVDPNQASSRRSSFVGTAEYVSPELLNDSPAGPSSDLWALGCILYQMLAGQPPFRAANEYLIFQKIQA------LDYE  305 (604)
T ss_pred             cCccCcccccCcccceeeeecccCHHHhcCCCCCcccchHHHHHHHHHHhcCCCCCccccHHHHHHHHHH------hccc
Confidence                         246789999999999999999999999999999999999988876543333332222      3345


Q ss_pred             CChHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 020221          277 FSSDEGTELVRLASRCLQYEPRERPNPRSLVT  308 (329)
Q Consensus       277 ~~~~~~~~~~~li~~cl~~dp~~Rps~~~~l~  308 (329)
                      ++..+++.+.+|+.+.|..||.+|+|..+|.+
T Consensus       306 fp~~fp~~a~dLv~KLLv~dp~~Rlt~~qIk~  337 (604)
T KOG0592|consen  306 FPEGFPEDARDLIKKLLVRDPSDRLTSQQIKA  337 (604)
T ss_pred             CCCCCCHHHHHHHHHHHccCccccccHHHHhh
Confidence            67788899999999999999999999988876

>KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.1e-47  Score=333.69  Aligned_cols=253  Identities=17%  Similarity=0.228  Sum_probs=208.2

Q ss_pred             CCCcccccccCCCCCCcEEEEEE-eCCCCEEEEEEeCCCCCh-hHHHHHHHHHHHhcCCCccccccceeeeeCCeeEEEE
Q 020221           55 GFAMENIVSEHGEKAPNVVYKGK-LENQFRIAVKRFNRSAWP-DARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVA  132 (329)
Q Consensus        55 ~~~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~  132 (329)
                      +-+.|++...||.|.-++||+|. ...++.||||++....-. +.+.+.+|++.++.++||||++++..|..+..+|+||
T Consensus        24 n~~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~~ld~l~kE~~~msl~~HPNIv~~~~sFvv~~~LWvVm  103 (516)
T KOG0582|consen   24 NAKDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNNDLDALRKEVQTMSLIDHPNIVTYHCSFVVDSELWVVM  103 (516)
T ss_pred             CccceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhhhHHHHHHHHHHhhhcCCCCcceEEEEEEecceeEEee
Confidence            44668888888999999999999 778899999999876533 3578999999999999999999999999999999999


Q ss_pred             ecCCCCCHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCCCCCeeeecccCcccC-CCC--
Q 020221          133 EYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNS-RDG--  209 (329)
Q Consensus       133 e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~-~~~--  209 (329)
                      .||.+||+.+.+...-...+.+..+..|.+++++||.|||.+ |.||||||+.|||++.+|.+||+|||.+-.. ..+  
T Consensus       104 pfMa~GS~ldIik~~~~~Gl~E~~Ia~iLre~LkaL~YLH~~-G~IHRdvKAgnILi~~dG~VkLadFgvsa~l~~~G~R  182 (516)
T KOG0582|consen  104 PFMAGGSLLDIIKTYYPDGLEEASIATILREVLKALDYLHQN-GHIHRDVKAGNILIDSDGTVKLADFGVSASLFDSGDR  182 (516)
T ss_pred             hhhcCCcHHHHHHHHccccccHHHHHHHHHHHHHHHHHHHhc-CceecccccccEEEcCCCcEEEcCceeeeeecccCce
Confidence            999999999999765566799999999999999999999999 9999999999999999999999999975332 222  


Q ss_pred             -----CCccCcccccCcccccCC--CCCCcccchhhhHHHHHHHhCCCCCCchhhHHHhhhchhhhccc----cccCCCC
Q 020221          210 -----RSYSTNLAFTPPEYLRTG--RVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDS----CLEGQFS  278 (329)
Q Consensus       210 -----~~~~~~~~y~aPE~~~~~--~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~  278 (329)
                           ....||+.|||||++...  .|+.|+||||||++..||.+|..||.....-.+....+....+.    .......
T Consensus       183 ~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pPmkvLl~tLqn~pp~~~t~~~~~d~~  262 (516)
T KOG0582|consen  183 QVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYPPMKVLLLTLQNDPPTLLTSGLDKDED  262 (516)
T ss_pred             eeEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCChHHHHHHHhcCCCCCcccccCChHHh
Confidence                 345789999999996543  49999999999999999999998875432222222222222111    1111112


Q ss_pred             hHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 020221          279 SDEGTELVRLASRCLQYEPRERPNPRSLVT  308 (329)
Q Consensus       279 ~~~~~~~~~li~~cl~~dp~~Rps~~~~l~  308 (329)
                      ...+..+.+++..||.+||.+|||+++++.
T Consensus       263 k~~~ksf~e~i~~CL~kDP~kRptAskLlk  292 (516)
T KOG0582|consen  263 KKFSKSFREMIALCLVKDPSKRPTASKLLK  292 (516)
T ss_pred             hhhcHHHHHHHHHHhhcCcccCCCHHHHhc
Confidence            335779999999999999999999999996

>KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only]

Probab=100.00  E-value=9.8e-48  Score=341.09  Aligned_cols=248  Identities=16%  Similarity=0.151  Sum_probs=205.6

Q ss_pred             CCCcccccccCCCCCCcEEEEEE-eCCCCEEEEEEeCCCCChh---HHHHHHHHHHHhcCCCccccccceeeeeCCeeEE
Q 020221           55 GFAMENIVSEHGEKAPNVVYKGK-LENQFRIAVKRFNRSAWPD---ARQFLEEARAVGQLRNRRLANLLGCCCEGDERLL  130 (329)
Q Consensus        55 ~~~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~---~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l  130 (329)
                      ..++++++..||+|+||.||+++ .++|+.+|+|++++...-.   ..-++.|-.+|....+|+||+++..|++..++||
T Consensus       139 ~~~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD~~~LYL  218 (550)
T KOG0605|consen  139 SLDDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSFQDKEYLYL  218 (550)
T ss_pred             CcccchhheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEecCCCeeEE
Confidence            45667788888999999999999 7789999999998864332   4457889999999999999999999999999999


Q ss_pred             EEecCCCCCHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCCCCCeeeecccCcccCC---
Q 020221          131 VAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSR---  207 (329)
Q Consensus       131 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~---  207 (329)
                      ||||++||++..+|.  +...+++..+..++.+++.|+..||.. |+|||||||+|+|||..|++||+|||++.-..   
T Consensus       219 iMEylPGGD~mTLL~--~~~~L~e~~arfYiaE~vlAI~~iH~~-gyIHRDIKPdNlLiD~~GHiKLSDFGLs~gl~~~~  295 (550)
T KOG0605|consen  219 IMEYLPGGDMMTLLM--RKDTLTEDWARFYIAETVLAIESIHQL-GYIHRDIKPDNLLIDAKGHIKLSDFGLSTGLDKKH  295 (550)
T ss_pred             EEEecCCccHHHHHH--hcCcCchHHHHHHHHHHHHHHHHHHHc-CcccccCChhheeecCCCCEeeccccccchhhhhh
Confidence            999999999999997  567899999999999999999999999 99999999999999999999999999974210   


Q ss_pred             -----------------------C-----C--------------------CCccCcccccCcccccCCCCCCcccchhhh
Q 020221          208 -----------------------D-----G--------------------RSYSTNLAFTPPEYLRTGRVTPESVMYSFG  239 (329)
Q Consensus       208 -----------------------~-----~--------------------~~~~~~~~y~aPE~~~~~~~~~~~DvwslG  239 (329)
                                             .     .                    .+.+|||.|+|||++.+..|+...|+||||
T Consensus       296 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kgY~~~cDwWSLG  375 (550)
T KOG0605|consen  296 RIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKGYGKECDWWSLG  375 (550)
T ss_pred             hhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCCCCccccHHHHH
Confidence                                   0     0                    023578999999999999999999999999


Q ss_pred             HHHHHHHhCCCCCCchhhHHHhhhchhhhccccccCCCChHHHHHHHHHHHHhcccCCCCCCC---HHHHHH
Q 020221          240 TLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLASRCLQYEPRERPN---PRSLVT  308 (329)
Q Consensus       240 ~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps---~~~~l~  308 (329)
                      ||+|||+.|-+||..+.....-.....-  ...+..+.....+.++.+||.+|+. ||++|..   +.||.+
T Consensus       376 ~ImyEmLvGyPPF~s~tp~~T~rkI~nw--r~~l~fP~~~~~s~eA~DLI~rll~-d~~~RLG~~G~~EIK~  444 (550)
T KOG0605|consen  376 CIMYEMLVGYPPFCSETPQETYRKIVNW--RETLKFPEEVDLSDEAKDLITRLLC-DPENRLGSKGAEEIKK  444 (550)
T ss_pred             HHHHHHHhCCCCCCCCCHHHHHHHHHHH--hhhccCCCcCcccHHHHHHHHHHhc-CHHHhcCcccHHHHhc
Confidence            9999999999999876554433332221  1112222334567899999999999 9999975   444443

>KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms]

Probab=100.00  E-value=6.6e-48  Score=346.12  Aligned_cols=262  Identities=21%  Similarity=0.324  Sum_probs=214.3

Q ss_pred             cccccCCCCCCcEEEEEEeCCCCEEEEEEeCCCCChh--HHHHHHHHHHHhcCCCccccccceeeeeCCeeEEEEecCCC
Q 020221           60 NIVSEHGEKAPNVVYKGKLENQFRIAVKRFNRSAWPD--ARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAEYMPN  137 (329)
Q Consensus        60 ~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~--~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~  137 (329)
                      .+...||+|+||+||+|.|.+  .||||++.......  .+.|++|+..+++-+|.||+-+.|+|..+.. .||+.+|+|
T Consensus       395 ~l~~rIGsGsFGtV~Rg~whG--dVAVK~Lnv~~pt~~qlqaFKnEVa~lkkTRH~NIlLFMG~~~~p~~-AIiTqwCeG  471 (678)
T KOG0193|consen  395 LLGERIGSGSFGTVYRGRWHG--DVAVKLLNVDDPTPEQLQAFKNEVAVLKKTRHENILLFMGACMNPPL-AIITQWCEG  471 (678)
T ss_pred             hccceeccccccceeeccccc--ceEEEEEecCCCCHHHHHHHHHHHHHHhhcchhhheeeehhhcCCce-eeeehhccC
Confidence            355677999999999999855  59999998875443  5679999999999999999999999987766 999999999


Q ss_pred             CCHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCCCCCeeeecccCcccCCC------CCC
Q 020221          138 DTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRD------GRS  211 (329)
Q Consensus       138 gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~------~~~  211 (329)
                      .+|..+++. ....+...+...|++||++|+.|||.+ +|||||||..||++.+++.|||+|||++..-..      ...
T Consensus       472 sSLY~hlHv-~etkfdm~~~idIAqQiaqGM~YLHAK-~IIHrDLKSnNIFl~~~~kVkIgDFGLatvk~~w~g~~q~~q  549 (678)
T KOG0193|consen  472 SSLYTHLHV-QETKFDMNTTIDIAQQIAQGMDYLHAK-NIIHRDLKSNNIFLHEDLKVKIGDFGLATVKTRWSGEQQLEQ  549 (678)
T ss_pred             chhhhhccc-hhhhhhHHHHHHHHHHHHHhhhhhhhh-hhhhhhccccceEEccCCcEEEecccceeeeeeeccccccCC
Confidence            999999976 446789999999999999999999999 999999999999999999999999999864221      122


Q ss_pred             ccCcccccCcccccC---CCCCCcccchhhhHHHHHHHhCCCCCCchhhHHHhhhchhhhccccccCCCChHHHHHHHHH
Q 020221          212 YSTNLAFTPPEYLRT---GRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRL  288 (329)
Q Consensus       212 ~~~~~~y~aPE~~~~---~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  288 (329)
                      ..+...|||||+++.   .+|++.+||||||+++|||++|..|+.....+.+.-..-.....+.+ .....+++.++.+|
T Consensus       550 p~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPysi~~~dqIifmVGrG~l~pd~-s~~~s~~pk~mk~L  628 (678)
T KOG0193|consen  550 PHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYSIQNRDQIIFMVGRGYLMPDL-SKIRSNCPKAMKRL  628 (678)
T ss_pred             CccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcCCCChhheEEEecccccCccc-hhhhccCHHHHHHH
Confidence            356688999999974   35999999999999999999999888754433332222222111111 11235678899999


Q ss_pred             HHHhcccCCCCCCCHHHHHHHHHhhhh---ccccccCccccc
Q 020221          289 ASRCLQYEPRERPNPRSLVTALVTLQK---DTELYLSLPWVM  327 (329)
Q Consensus       289 i~~cl~~dp~~Rps~~~~l~~L~~~~~---~~~~~~~~p~~~  327 (329)
                      +..||+.++++||.+.+|+..|+.+.+   +..-++|+|-++
T Consensus       629 l~~C~~~~~~eRP~F~~il~~l~~l~~~~pki~RS~S~P~~~  670 (678)
T KOG0193|consen  629 LSDCWKFDREERPLFPQLLSKLEELLPSLPKINRSASEPVLL  670 (678)
T ss_pred             HHHHHhcCcccCccHHHHHHHHHHhhhcccccccCcCccchh
Confidence            999999999999999999998888876   347778888765

>KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=1.2e-47  Score=347.44  Aligned_cols=246  Identities=17%  Similarity=0.241  Sum_probs=217.0

Q ss_pred             cCCCcccccccCCCCCCcEEEEEE-eCCCCEEEEEEeCCCC-C--hhHHHHHHHHHHHhcCCCccccccceeeeeCCeeE
Q 020221           54 SGFAMENIVSEHGEKAPNVVYKGK-LENQFRIAVKRFNRSA-W--PDARQFLEEARAVGQLRNRRLANLLGCCCEGDERL  129 (329)
Q Consensus        54 ~~~~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~-~--~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~  129 (329)
                      +....+++-+.||.|+-|.|..|+ ..+|+.+|||++.... .  .....+.+|+-+|+.+.|||++++++++.+..++|
T Consensus         9 ~tiGpwkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~~~~ly   88 (786)
T KOG0588|consen    9 NTIGPWKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWENKQHLY   88 (786)
T ss_pred             ccccceeccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeeeccCceEE
Confidence            445667788889999999999999 6789999999998762 1  12345789999999999999999999999999999


Q ss_pred             EEEecCCCCCHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCCCCCeeeecccCcccCCCC
Q 020221          130 LVAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDG  209 (329)
Q Consensus       130 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~  209 (329)
                      +|.||+++|.|.+++.  ..+++++.++.++++||+.|+.|+|.. +|+|||+||+|+|+|..+++||+|||+|....++
T Consensus        89 lvlEyv~gGELFdylv--~kG~l~e~eaa~ff~QIi~gv~yCH~~-~icHRDLKpENlLLd~~~nIKIADFGMAsLe~~g  165 (786)
T KOG0588|consen   89 LVLEYVPGGELFDYLV--RKGPLPEREAAHFFRQILDGVSYCHAF-NICHRDLKPENLLLDVKNNIKIADFGMASLEVPG  165 (786)
T ss_pred             EEEEecCCchhHHHHH--hhCCCCCHHHHHHHHHHHHHHHHHhhh-cceeccCCchhhhhhcccCEeeeccceeecccCC
Confidence            9999999999999998  567899999999999999999999999 9999999999999999999999999999877666


Q ss_pred             C---CccCcccccCcccccCCCCCC-cccchhhhHHHHHHHhCCCCCCchhhHHHhhhchhhhccccccCCCChHHHHHH
Q 020221          210 R---SYSTNLAFTPPEYLRTGRVTP-ESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTEL  285 (329)
Q Consensus       210 ~---~~~~~~~y~aPE~~~~~~~~~-~~DvwslG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  285 (329)
                      .   +.+|.+.|.|||+++|.+|+- ++||||.|||||.|+||+.||.++....+.........      ..|...++++
T Consensus       166 klLeTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdDdNir~LLlKV~~G~f------~MPs~Is~ea  239 (786)
T KOG0588|consen  166 KLLETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDDDNIRVLLLKVQRGVF------EMPSNISSEA  239 (786)
T ss_pred             ccccccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCCccHHHHHHHHHcCcc------cCCCcCCHHH
Confidence            4   568999999999999999764 89999999999999999999988776655444333322      3567889999


Q ss_pred             HHHHHHhcccCCCCCCCHHHHHH
Q 020221          286 VRLASRCLQYEPRERPNPRSLVT  308 (329)
Q Consensus       286 ~~li~~cl~~dp~~Rps~~~~l~  308 (329)
                      ++|+.+|+..||++|.|.++|+.
T Consensus       240 QdLLr~ml~VDp~~RiT~~eI~k  262 (786)
T KOG0588|consen  240 QDLLRRMLDVDPSTRITTEEILK  262 (786)
T ss_pred             HHHHHHHhccCccccccHHHHhh
Confidence            99999999999999999999998

>KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only]

Probab=100.00  E-value=8.5e-48  Score=342.58  Aligned_cols=241  Identities=19%  Similarity=0.259  Sum_probs=210.5

Q ss_pred             cccccccCCCCCCcEEEEEE-eCCCCEEEEEEeCCCCChh--HHHHHHHHHHHhcCCCccccccceeeeeCCeeEEEEec
Q 020221           58 MENIVSEHGEKAPNVVYKGK-LENQFRIAVKRFNRSAWPD--ARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAEY  134 (329)
Q Consensus        58 ~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~--~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  134 (329)
                      .|.+.+.||+|+||+||||+ ..+.+.||+|.+.+.....  .+.+.+|+++++.++||||+.++++|++..++|+|.||
T Consensus         3 ~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~lkHpniv~m~esfEt~~~~~vVte~   82 (808)
T KOG0597|consen    3 QYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRNEKELKNLRQEVRILRSLKHPNIVEMLESFETSAHLWVVTEY   82 (808)
T ss_pred             chhHHHHhcCCccceeeecccccceeEEEEEEehhcCCchHHHHHHHHHHHHHHhcCCcchhhHHHhhcccceEEEEehh
Confidence            35566677999999999999 5678899999998765443  55689999999999999999999999999999999999


Q ss_pred             CCCCCHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCCCCCeeeecccCcccCCCCC----
Q 020221          135 MPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDGR----  210 (329)
Q Consensus       135 ~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~----  210 (329)
                      +.| +|..+|.  ....++++.+..++.+++.||.|||+. +|+|||+||.|||++..+++|++|||+|+......    
T Consensus        83 a~g-~L~~il~--~d~~lpEe~v~~~a~~LVsaL~yLhs~-rilhrd~kPqniLl~~~~~~KlcdFg~Ar~m~~~t~vlt  158 (808)
T KOG0597|consen   83 AVG-DLFTILE--QDGKLPEEQVRAIAYDLVSALYYLHSN-RILHRDMKPQNILLEKGGTLKLCDFGLARAMSTNTSVLT  158 (808)
T ss_pred             hhh-hHHHHHH--hccCCCHHHHHHHHHHHHHHHHHHHhc-CcccccCCcceeeecCCCceeechhhhhhhcccCceeee
Confidence            987 9999997  567899999999999999999999999 99999999999999999999999999998766553    


Q ss_pred             CccCcccccCcccccCCCCCCcccchhhhHHHHHHHhCCCCCCchhhHHHhhhchhhhccccccCCCChHHHHHHHHHHH
Q 020221          211 SYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLAS  290 (329)
Q Consensus       211 ~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~  290 (329)
                      ...||+.|||||+..++.|+..+|+||+||++||+.+|++||.....-.....+..+   +   ..+|...+..+..|+.
T Consensus       159 sikGtPlYmAPElv~e~pyd~~sDlWslGcilYE~~~G~PPF~a~si~~Lv~~I~~d---~---v~~p~~~S~~f~nfl~  232 (808)
T KOG0597|consen  159 SIKGTPLYMAPELVEEQPYDHTSDLWSLGCILYELYVGQPPFYARSITQLVKSILKD---P---VKPPSTASSSFVNFLQ  232 (808)
T ss_pred             eccCcccccCHHHHcCCCccchhhHHHHHHHHHHHhcCCCCchHHHHHHHHHHHhcC---C---CCCcccccHHHHHHHH
Confidence            457899999999999999999999999999999999999998765543333322221   1   1345678899999999


Q ss_pred             HhcccCCCCCCCHHHHHH
Q 020221          291 RCLQYEPRERPNPRSLVT  308 (329)
Q Consensus       291 ~cl~~dp~~Rps~~~~l~  308 (329)
                      ..|.+||.+|.|..+++.
T Consensus       233 gLL~kdP~~RltW~~Ll~  250 (808)
T KOG0597|consen  233 GLLIKDPAQRLTWTDLLG  250 (808)
T ss_pred             HHhhcChhhcccHHHHhc
Confidence            999999999999999986

>KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport]

Probab=100.00  E-value=1.5e-47  Score=356.92  Aligned_cols=257  Identities=25%  Similarity=0.342  Sum_probs=215.1

Q ss_pred             ccccccCCCCCCcEEEEEEeC------CCCEEEEEEeCCCCCh-hHHHHHHHHHHHhcCCCccccccceeeeeCCeeEEE
Q 020221           59 ENIVSEHGEKAPNVVYKGKLE------NQFRIAVKRFNRSAWP-DARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLV  131 (329)
Q Consensus        59 ~~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv  131 (329)
                      ....++||+|+||.||+|...      +.+.||||.++..... ..++|++|++.+..++|||||+++|+|..++..++|
T Consensus       488 i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a~~~~~~dF~REaeLla~l~H~nIVrLlGVC~~~~P~~Mv  567 (774)
T KOG1026|consen  488 IVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKAENQARQDFRREAELLAELQHPNIVRLLGVCREGDPLCMV  567 (774)
T ss_pred             eeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEccCCeeEEE
Confidence            345678899999999999842      3467999999988766 466799999999999999999999999999999999


Q ss_pred             EecCCCCCHHhhhccC--------CCCC----CCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCCCCCeeeec
Q 020221          132 AEYMPNDTLAKHLFHW--------ETQP----MKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSC  199 (329)
Q Consensus       132 ~e~~~~gsL~~~l~~~--------~~~~----~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~D  199 (329)
                      +|||..|+|..+|+..        .+..    ++..+.+.|+.|||.|+.||-+. .+|||||..+|+||.++..|||+|
T Consensus       568 FEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~-~FVHRDLATRNCLVge~l~VKIsD  646 (774)
T KOG1026|consen  568 FEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSH-HFVHRDLATRNCLVGENLVVKISD  646 (774)
T ss_pred             EEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhC-cccccchhhhhceeccceEEEecc
Confidence            9999999999999743        1223    78899999999999999999998 999999999999999999999999


Q ss_pred             ccCcccCCCCCCc------cCcccccCcccccCCCCCCcccchhhhHHHHHHHhCC-CCCCchhhHHHhhhchhhhcccc
Q 020221          200 FGLMKNSRDGRSY------STNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGK-HIPPSHALDLIRDRNIQTLTDSC  272 (329)
Q Consensus       200 fg~a~~~~~~~~~------~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~-~~~~~~~~~~~~~~~~~~~~~~~  272 (329)
                      ||+++.....+-+      .-.++|||||.+..++|+.+||||||||+|||+++-. -|+.+...+.+....    ....
T Consensus       647 fGLsRdiYssDYYk~~~~t~lPIRWMppEsIly~kFTteSDVWs~GVvLWEIFsyG~QPy~glSn~EVIe~i----~~g~  722 (774)
T KOG1026|consen  647 FGLSRDIYSSDYYKVRGNTLLPIRWMPPESILYGKFTTESDVWSFGVVLWEIFSYGKQPYYGLSNQEVIECI----RAGQ  722 (774)
T ss_pred             cccchhhhhhhhhcccCCceeeeecCCHHHhhcCcccchhhhhhhhhhhhhhhccccCcccccchHHHHHHH----HcCC
Confidence            9999875544322      2358999999999999999999999999999999955 455443333333222    2222


Q ss_pred             ccCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhhcccccc
Q 020221          273 LEGQFSSDEGTELVRLASRCLQYEPRERPNPRSLVTALVTLQKDTELYL  321 (329)
Q Consensus       273 ~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~~~l~~L~~~~~~~~~~~  321 (329)
                      + -..|..+|.++..||..||+.+|++||++++|-..|+..-+..+...
T Consensus       723 l-L~~Pe~CP~~vY~LM~~CW~~~P~~RPsF~eI~~~L~~~~~~s~~~~  770 (774)
T KOG1026|consen  723 L-LSCPENCPTEVYSLMLECWNENPKRRPSFKEIHSRLQAWAQASPKYS  770 (774)
T ss_pred             c-ccCCCCCCHHHHHHHHHHhhcCcccCCCHHHHHHHHHHHHhcCcccc
Confidence            2 34678899999999999999999999999999999999877655443

>cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3

Probab=100.00  E-value=2.3e-46  Score=337.20  Aligned_cols=254  Identities=21%  Similarity=0.318  Sum_probs=201.8

Q ss_pred             cccccccCCCCCCcEEEEEEe------CCCCEEEEEEeCCCCCh-hHHHHHHHHHHHhcC-CCccccccceeeeeC-Cee
Q 020221           58 MENIVSEHGEKAPNVVYKGKL------ENQFRIAVKRFNRSAWP-DARQFLEEARAVGQL-RNRRLANLLGCCCEG-DER  128 (329)
Q Consensus        58 ~~~~~~~lg~G~~g~V~~~~~------~~~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~-~~~  128 (329)
                      .+++.+.||+|+||.||+|..      .++..||+|++...... ....+.+|+.++..+ +||||+++++++... ...
T Consensus         8 ~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~   87 (338)
T cd05102           8 RLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGATASEHKALMSELKILIHIGNHLNVVNLLGACTKPNGPL   87 (338)
T ss_pred             HceeeeEeccCCcceEEEEEEeccCCcccchhhheeccccccchHHHHHHHHHHHHHHHhccCcceeeEEeEecCCCCce
Confidence            466778889999999999973      23467999999765322 345688999999999 899999999988664 458


Q ss_pred             EEEEecCCCCCHHhhhccCC------------------------------------------------------------
Q 020221          129 LLVAEYMPNDTLAKHLFHWE------------------------------------------------------------  148 (329)
Q Consensus       129 ~lv~e~~~~gsL~~~l~~~~------------------------------------------------------------  148 (329)
                      +++|||+++|+|.+++....                                                            
T Consensus        88 ~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  167 (338)
T cd05102          88 MVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQETDDLW  167 (338)
T ss_pred             EEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccchhccccc
Confidence            89999999999999886421                                                            


Q ss_pred             CCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCCCCCeeeecccCcccCCCCC------CccCcccccCcc
Q 020221          149 TQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDGR------SYSTNLAFTPPE  222 (329)
Q Consensus       149 ~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~------~~~~~~~y~aPE  222 (329)
                      ...+++..+..++.|++.||+|||++ +++||||||+||+++.++.+||+|||+++......      ...+++.|+|||
T Consensus       168 ~~~l~~~~~~~~~~qi~~aL~~LH~~-~ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~y~aPE  246 (338)
T cd05102         168 KSPLTMEDLICYSFQVARGMEFLASR-KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLPLKWMAPE  246 (338)
T ss_pred             cCCCCHHHHHHHHHHHHHHHHHHHHC-CEECCCCccceEEEcCCCcEEEeecccccccccCcchhcccCCCCCccccCcH
Confidence            13477888999999999999999999 99999999999999999999999999997643221      223457899999


Q ss_pred             cccCCCCCCcccchhhhHHHHHHHh-CCCCCCchhhHHHhhhchhhhccccccCCCChHHHHHHHHHHHHhcccCCCCCC
Q 020221          223 YLRTGRVTPESVMYSFGTLLLDLLS-GKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLASRCLQYEPRERP  301 (329)
Q Consensus       223 ~~~~~~~~~~~DvwslG~il~el~t-g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rp  301 (329)
                      ++.+..++.++||||||+++|||++ |..||...........    ..........+...++++.+++.+||+.||++||
T Consensus       247 ~~~~~~~~~~sDiwslG~il~el~~~g~~pf~~~~~~~~~~~----~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RP  322 (338)
T cd05102         247 SIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINEEFCQ----RLKDGTRMRAPENATPEIYRIMLACWQGDPKERP  322 (338)
T ss_pred             HhhcCCCCcccCHHHHHHHHHHHHhCCCCCCCCCCccHHHHH----HHhcCCCCCCCCCCCHHHHHHHHHHccCChhhCc
Confidence            9998889999999999999999997 8877764322111111    1111111223455678899999999999999999


Q ss_pred             CHHHHHHHHHhhhhc
Q 020221          302 NPRSLVTALVTLQKD  316 (329)
Q Consensus       302 s~~~~l~~L~~~~~~  316 (329)
                      |+.++++.|+++..+
T Consensus       323 s~~el~~~l~~~~~~  337 (338)
T cd05102         323 TFSALVEILGDLLQE  337 (338)
T ss_pred             CHHHHHHHHHHHHhc
Confidence            999999999988653

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V

>KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only]

Probab=100.00  E-value=4.5e-47  Score=318.90  Aligned_cols=254  Identities=18%  Similarity=0.238  Sum_probs=205.0

Q ss_pred             HhcCCCcccccccCCCCCCcEEEEEE-eCCCCEEEEEEeCCCCChh--HHHHHHHHHHHhcCCCccccccceeeeeC--C
Q 020221           52 ATSGFAMENIVSEHGEKAPNVVYKGK-LENQFRIAVKRFNRSAWPD--ARQFLEEARAVGQLRNRRLANLLGCCCEG--D  126 (329)
Q Consensus        52 ~~~~~~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~--~~~~~~e~~~l~~l~h~niv~~~~~~~~~--~  126 (329)
                      ..+..+.|+++..|++|+||.||+|+ ..+++.||+|+++......  .-..++|+.+|...+|||||.+-.+....  +
T Consensus        71 gCrsv~efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~~d  150 (419)
T KOG0663|consen   71 GCRSVEEFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEGFPITSLREINILLKARHPNIVEVKEVVVGSNMD  150 (419)
T ss_pred             CcccHHHHHHHhhcccCcceeEEEeccCCcceeEEeeecccccccCCCcchhHHHHHHHHhcCCCCeeeeEEEEeccccc
Confidence            34556778888999999999999999 6678899999998765322  22468999999999999999998887543  6


Q ss_pred             eeEEEEecCCCCCHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCCCCCeeeecccCcccC
Q 020221          127 ERLLVAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNS  206 (329)
Q Consensus       127 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~  206 (329)
                      .+|+|||||+. +|.+++... .+++...++.-++.|+++|++|||.+ .|+|||||++|+|++..|.+||+|||+|+.+
T Consensus       151 ~iy~VMe~~Eh-DLksl~d~m-~q~F~~~evK~L~~QlL~glk~lH~~-wilHRDLK~SNLLm~~~G~lKiaDFGLAR~y  227 (419)
T KOG0663|consen  151 KIYIVMEYVEH-DLKSLMETM-KQPFLPGEVKTLMLQLLRGLKHLHDN-WILHRDLKTSNLLLSHKGILKIADFGLAREY  227 (419)
T ss_pred             eeeeeHHHHHh-hHHHHHHhc-cCCCchHHHHHHHHHHHHHHHHHhhc-eeEecccchhheeeccCCcEEecccchhhhh
Confidence            79999999987 899998653 36899999999999999999999999 9999999999999999999999999999987


Q ss_pred             CCC----CCccCcccccCcccccCCC-CCCcccchhhhHHHHHHHhCCCCCCchhh-HHHhh------------------
Q 020221          207 RDG----RSYSTNLAFTPPEYLRTGR-VTPESVMYSFGTLLLDLLSGKHIPPSHAL-DLIRD------------------  262 (329)
Q Consensus       207 ~~~----~~~~~~~~y~aPE~~~~~~-~~~~~DvwslG~il~el~tg~~~~~~~~~-~~~~~------------------  262 (329)
                      ...    ...+.|.+|.|||.+.+.. |+...||||+|||+.|++++++.|++..- +.+..                  
T Consensus       228 gsp~k~~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE~dQl~~If~llGtPte~iwpg~~~  307 (419)
T KOG0663|consen  228 GSPLKPYTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKSEIDQLDKIFKLLGTPSEAIWPGYSE  307 (419)
T ss_pred             cCCcccCcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCchHHHHHHHHHHhCCCccccCCCccc
Confidence            655    4456799999999998876 99999999999999999999988876421 11100                  


Q ss_pred             ------hchhhhccccccCCCChH-HHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 020221          263 ------RNIQTLTDSCLEGQFSSD-EGTELVRLASRCLQYEPRERPNPRSLVT  308 (329)
Q Consensus       263 ------~~~~~~~~~~~~~~~~~~-~~~~~~~li~~cl~~dp~~Rps~~~~l~  308 (329)
                            ..........++..++.. .++...+|+..+|.+||.+|.||.+.|+
T Consensus       308 lp~~k~~~f~~~pyn~lr~kF~~~~lse~g~~Lln~llt~dP~kR~tA~~~L~  360 (419)
T KOG0663|consen  308 LPAVKKMTFSEHPYNNLRKKFGALSLSEQGFDLLNKLLTYDPGKRITAEDGLK  360 (419)
T ss_pred             cchhhccccCCCCchhhhhhccccccchhHHHHHHHHhccCccccccHHHhhc
Confidence                  000000111111222222 5688999999999999999999999997

>KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=1.6e-46  Score=328.50  Aligned_cols=244  Identities=17%  Similarity=0.182  Sum_probs=199.5

Q ss_pred             CcccccccCCCCCCcEEEEEE-eCCCCEEEEEEeCCCCC--------------hhHHHHHHHHHHHhcCCCcccccccee
Q 020221           57 AMENIVSEHGEKAPNVVYKGK-LENQFRIAVKRFNRSAW--------------PDARQFLEEARAVGQLRNRRLANLLGC  121 (329)
Q Consensus        57 ~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~--------------~~~~~~~~e~~~l~~l~h~niv~~~~~  121 (329)
                      -.|++++.||+|.||.|-+|. ..+++.||||++.+...              ...+...+|+.+|+++.|||||+++++
T Consensus        97 Nqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nVV~LiEv  176 (576)
T KOG0585|consen   97 NQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNVVKLIEV  176 (576)
T ss_pred             hheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCeeEEEEe
Confidence            346788899999999999999 66789999999965321              124578899999999999999999999


Q ss_pred             eeeC--CeeEEEEecCCCCCHHhhhccCCCCC-CCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCCCCCeeee
Q 020221          122 CCEG--DERLLVAEYMPNDTLAKHLFHWETQP-MKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLS  198 (329)
Q Consensus       122 ~~~~--~~~~lv~e~~~~gsL~~~l~~~~~~~-~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~  198 (329)
                      ..++  +.+|||+|||..|.+...-   .... +++.+++.+++++..||+|||.+ ||+||||||+|+|++++|++||+
T Consensus       177 LDDP~s~~~YlVley~s~G~v~w~p---~d~~els~~~Ar~ylrDvv~GLEYLH~Q-giiHRDIKPsNLLl~~~g~VKIs  252 (576)
T KOG0585|consen  177 LDDPESDKLYLVLEYCSKGEVKWCP---PDKPELSEQQARKYLRDVVLGLEYLHYQ-GIIHRDIKPSNLLLSSDGTVKIS  252 (576)
T ss_pred             ecCcccCceEEEEEeccCCccccCC---CCcccccHHHHHHHHHHHHHHHHHHHhc-CeeccccchhheEEcCCCcEEee
Confidence            8765  6899999999988764432   4445 89999999999999999999999 99999999999999999999999


Q ss_pred             cccCcccCCCC---------CCccCcccccCcccccCCC----CCCcccchhhhHHHHHHHhCCCCCCchhhHHHhhhch
Q 020221          199 CFGLMKNSRDG---------RSYSTNLAFTPPEYLRTGR----VTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNI  265 (329)
Q Consensus       199 Dfg~a~~~~~~---------~~~~~~~~y~aPE~~~~~~----~~~~~DvwslG~il~el~tg~~~~~~~~~~~~~~~~~  265 (329)
                      |||.+.....+         ....||+.|+|||.+.++.    ...+.||||+||+||.|+.|+.||.++..-.......
T Consensus       253 DFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~~~~~~~l~~KIv  332 (576)
T KOG0585|consen  253 DFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFFDDFELELFDKIV  332 (576)
T ss_pred             ccceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCcccchHHHHHHHHh
Confidence            99998765332         1357899999999988743    4468999999999999999999998765433333322


Q ss_pred             hhhccccccCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 020221          266 QTLTDSCLEGQFSSDEGTELVRLASRCLQYEPRERPNPRSLVT  308 (329)
Q Consensus       266 ~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~~~l~  308 (329)
                      ...    +.-+...+..+++++||.++|.+||++|.+..+|..
T Consensus       333 n~p----L~fP~~pe~~e~~kDli~~lL~KdP~~Ri~l~~ik~  371 (576)
T KOG0585|consen  333 NDP----LEFPENPEINEDLKDLIKRLLEKDPEQRITLPDIKL  371 (576)
T ss_pred             cCc----ccCCCcccccHHHHHHHHHHhhcChhheeehhhhee
Confidence            221    221222356889999999999999999999999987

>cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4

Probab=100.00  E-value=2.7e-46  Score=328.91  Aligned_cols=247  Identities=17%  Similarity=0.222  Sum_probs=201.5

Q ss_pred             ccccccCCCCCCcEEEEEE-eCCCCEEEEEEeCCCCC---hhHHHHHHHHHHHhcCCCccccccceeeeeCCeeEEEEec
Q 020221           59 ENIVSEHGEKAPNVVYKGK-LENQFRIAVKRFNRSAW---PDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAEY  134 (329)
Q Consensus        59 ~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  134 (329)
                      |++++.||+|+||.||++. ..+++.||+|.+.....   .....+.+|+++++.++|+||+++.+++.+.+..++|+||
T Consensus         2 f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~~~~~lv~e~   81 (285)
T cd05631           2 FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYETKDALCLVLTI   81 (285)
T ss_pred             ceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEccCCeEEEEEEe
Confidence            3456677999999999998 56789999999875432   2233577899999999999999999999999999999999


Q ss_pred             CCCCCHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCCCCCeeeecccCcccCCCC---CC
Q 020221          135 MPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDG---RS  211 (329)
Q Consensus       135 ~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~---~~  211 (329)
                      +++|+|.+++.......+++..+..++.|++.||+|||+. +++||||||+||++++++.++|+|||++......   ..
T Consensus        82 ~~~g~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~-~iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~  160 (285)
T cd05631          82 MNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQRE-RIVYRDLKPENILLDDRGHIRISDLGLAVQIPEGETVRG  160 (285)
T ss_pred             cCCCcHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhC-CEEeCCCCHHHEEECCCCCEEEeeCCCcEEcCCCCeecC
Confidence            9999999888654445789999999999999999999999 9999999999999999999999999998765433   23


Q ss_pred             ccCcccccCcccccCCCCCCcccchhhhHHHHHHHhCCCCCCchhhHHHhhhchhhhccccccCCCChHHHHHHHHHHHH
Q 020221          212 YSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLASR  291 (329)
Q Consensus       212 ~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~  291 (329)
                      ..|+..|+|||++.+..++.++||||||+++|+|++|..||..................  ....++...++++.+|+.+
T Consensus       161 ~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~--~~~~~~~~~s~~~~~li~~  238 (285)
T cd05631         161 RVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKERVKREEVDRRVKE--DQEEYSEKFSEDAKSICRM  238 (285)
T ss_pred             CCCCCCccCHhhhcCCCCCcccCchhHHHHHHHHHhCCCCCCCCCcchhHHHHHHHhhc--ccccCCccCCHHHHHHHHH
Confidence            46789999999999889999999999999999999999888653221111111111111  1123445677899999999


Q ss_pred             hcccCCCCCCC-----HHHHHH
Q 020221          292 CLQYEPRERPN-----PRSLVT  308 (329)
Q Consensus       292 cl~~dp~~Rps-----~~~~l~  308 (329)
                      ||+.||++||+     ++++++
T Consensus       239 ~l~~~P~~R~~~~~~~~~~~~~  260 (285)
T cd05631         239 LLTKNPKERLGCRGNGAAGVKQ  260 (285)
T ss_pred             HhhcCHHHhcCCCCCCHHHHhc
Confidence            99999999997     788887

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i

>PHA02988 hypothetical protein; Provisional

Probab=100.00  E-value=1.3e-45  Score=324.21  Aligned_cols=245  Identities=16%  Similarity=0.243  Sum_probs=203.0

Q ss_pred             cCCCCCCcEEEEEEeCCCCEEEEEEeCCCCChh---HHHHHHHHHHHhcCCCccccccceeeee----CCeeEEEEecCC
Q 020221           64 EHGEKAPNVVYKGKLENQFRIAVKRFNRSAWPD---ARQFLEEARAVGQLRNRRLANLLGCCCE----GDERLLVAEYMP  136 (329)
Q Consensus        64 ~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~---~~~~~~e~~~l~~l~h~niv~~~~~~~~----~~~~~lv~e~~~  136 (329)
                      .+|+|++|.||+|.+ +|+.||||.+.......   .+.+.+|+.+++.++||||+++++++.+    ....++||||++
T Consensus        27 ~i~~g~~~~v~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~~~~~~~~lv~Ey~~  105 (283)
T PHA02988         27 LIKENDQNSIYKGIF-NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLILEYCT  105 (283)
T ss_pred             EEeeCCceEEEEEEE-CCEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEecccCCCceEEEEEeCC
Confidence            359999999999998 57799999998654333   4567899999999999999999999876    357899999999


Q ss_pred             CCCHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCCCCCeeeecccCcccCCCC-CCccCc
Q 020221          137 NDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDG-RSYSTN  215 (329)
Q Consensus       137 ~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~-~~~~~~  215 (329)
                      +|+|.+++.  ....+++.....++.|++.||.|||+..+++||||||+||++++++.+||+|||++...... ....++
T Consensus       106 ~g~L~~~l~--~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~Hrdlkp~nill~~~~~~kl~dfg~~~~~~~~~~~~~~~  183 (283)
T PHA02988        106 RGYLREVLD--KEKDLSFKTKLDMAIDCCKGLYNLYKYTNKPYKNLTSVSFLVTENYKLKIICHGLEKILSSPPFKNVNF  183 (283)
T ss_pred             CCcHHHHHh--hCCCCChhHHHHHHHHHHHHHHHHHhcCCCCCCcCChhhEEECCCCcEEEcccchHhhhccccccccCc
Confidence            999999996  34578999999999999999999998448899999999999999999999999998754433 234578


Q ss_pred             ccccCcccccC--CCCCCcccchhhhHHHHHHHhCCCCCCchhhHHHhhhchhhhccccccCCCChHHHHHHHHHHHHhc
Q 020221          216 LAFTPPEYLRT--GRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLASRCL  293 (329)
Q Consensus       216 ~~y~aPE~~~~--~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl  293 (329)
                      ..|+|||++.+  ..++.++||||||+++|||++|..||...........    +.....+...+...++++.+++.+||
T Consensus       184 ~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~~~~~~~~----i~~~~~~~~~~~~~~~~l~~li~~cl  259 (283)
T PHA02988        184 MVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLTTKEIYDL----IINKNNSLKLPLDCPLEIKCIVEACT  259 (283)
T ss_pred             ccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCCCHHHHHHH----HHhcCCCCCCCCcCcHHHHHHHHHHh
Confidence            89999999976  6799999999999999999999998865433222221    11111222344467889999999999


Q ss_pred             ccCCCCCCCHHHHHHHHHhhhh
Q 020221          294 QYEPRERPNPRSLVTALVTLQK  315 (329)
Q Consensus       294 ~~dp~~Rps~~~~l~~L~~~~~  315 (329)
                      +.||++|||+.++++.|+.+..
T Consensus       260 ~~dp~~Rps~~ell~~l~~~~~  281 (283)
T PHA02988        260 SHDSIKRPNIKEILYNLSLYKF  281 (283)
T ss_pred             cCCcccCcCHHHHHHHHHHHHh
Confidence            9999999999999999998764

>cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.1e-46  Score=330.61  Aligned_cols=242  Identities=18%  Similarity=0.184  Sum_probs=202.5

Q ss_pred             cccccccCCCCCCcEEEEEEe-CCCCEEEEEEeCCCCC---hhHHHHHHHHHHHhcCCCccccccceeeeeCCeeEEEEe
Q 020221           58 MENIVSEHGEKAPNVVYKGKL-ENQFRIAVKRFNRSAW---PDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAE  133 (329)
Q Consensus        58 ~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  133 (329)
                      .|++++.||+|+||.||++.. .+++.||+|++.....   ...+.+.+|+.+++.++||||+++++++.+....++|||
T Consensus         2 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e   81 (291)
T cd05612           2 DLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQRFLYMLME   81 (291)
T ss_pred             CceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhccCCeEEEEEe
Confidence            456777889999999999994 4688999999865422   224557889999999999999999999999999999999


Q ss_pred             cCCCCCHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCCCCCeeeecccCcccCCCC-CCc
Q 020221          134 YMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDG-RSY  212 (329)
Q Consensus       134 ~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~-~~~  212 (329)
                      |+++|+|.+++.  ....+++..+..++.|++.||+|||++ |++||||||+||+++.++.+||+|||++...... ...
T Consensus        82 ~~~~~~L~~~~~--~~~~~~~~~~~~~~~qi~~~l~~lH~~-~i~H~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~~~~~  158 (291)
T cd05612          82 YVPGGELFSYLR--NSGRFSNSTGLFYASEIVCALEYLHSK-EIVYRDLKPENILLDKEGHIKLTDFGFAKKLRDRTWTL  158 (291)
T ss_pred             CCCCCCHHHHHH--HcCCCCHHHHHHHHHHHHHHHHHHHHC-CeeecCCCHHHeEECCCCCEEEEecCcchhccCCcccc
Confidence            999999999986  345789999999999999999999999 9999999999999999999999999998765443 234


Q ss_pred             cCcccccCcccccCCCCCCcccchhhhHHHHHHHhCCCCCCchhhHHHhhhchhhhccccccCCCChHHHHHHHHHHHHh
Q 020221          213 STNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLASRC  292 (329)
Q Consensus       213 ~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~c  292 (329)
                      .|++.|+|||++.+..++.++||||||+++|+|++|..||...............      ...++...++.+.+++.+|
T Consensus       159 ~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~i~~~------~~~~~~~~~~~~~~li~~~  232 (291)
T cd05612         159 CGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFDDNPFGIYEKILAG------KLEFPRHLDLYAKDLIKKL  232 (291)
T ss_pred             cCChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhC------CcCCCccCCHHHHHHHHHH
Confidence            6889999999999888999999999999999999999888654332222221111      1123445578899999999


Q ss_pred             cccCCCCCCC-----HHHHHH
Q 020221          293 LQYEPRERPN-----PRSLVT  308 (329)
Q Consensus       293 l~~dp~~Rps-----~~~~l~  308 (329)
                      |..||.+||+     +.++++
T Consensus       233 l~~dp~~R~~~~~~~~~~~l~  253 (291)
T cd05612         233 LVVDRTRRLGNMKNGADDVKN  253 (291)
T ss_pred             cCCCHHHccCCccCCHHHHhc
Confidence            9999999995     888886

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt

>cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B

Probab=100.00  E-value=2.8e-46  Score=334.58  Aligned_cols=236  Identities=18%  Similarity=0.233  Sum_probs=198.7

Q ss_pred             cCCCCCCcEEEEEE-eCCCCEEEEEEeCCCC---ChhHHHHHHHHHHHhcCCCccccccceeeeeCCeeEEEEecCCCCC
Q 020221           64 EHGEKAPNVVYKGK-LENQFRIAVKRFNRSA---WPDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAEYMPNDT  139 (329)
Q Consensus        64 ~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gs  139 (329)
                      .||+|+||.||++. ..+++.||+|++....   ......+.+|+.+++.++||||+++.+++...+..++||||+++|+
T Consensus         2 ~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~~   81 (323)
T cd05571           2 LLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYANGGE   81 (323)
T ss_pred             eeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCCEEEEEEeCCCCCc
Confidence            46999999999998 5678899999987542   2234457789999999999999999999999999999999999999


Q ss_pred             HHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCCCCCeeeecccCcccCCCC----CCccCc
Q 020221          140 LAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDG----RSYSTN  215 (329)
Q Consensus       140 L~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~----~~~~~~  215 (329)
                      |.+++.  ....+++..+..++.||+.||+|||+. ||+||||||+||+++.++.+||+|||+++.....    ....|+
T Consensus        82 L~~~l~--~~~~~~~~~~~~~~~qi~~~L~~lH~~-~ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~~~gt  158 (323)
T cd05571          82 LFFHLS--RERVFSEDRARFYGAEIVSALGYLHSC-DVVYRDLKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGT  158 (323)
T ss_pred             HHHHHH--HcCCCCHHHHHHHHHHHHHHHHHHHhC-CeEeCCCCHHHEEECCCCCEEEeeCCCCcccccCCCcccceecC
Confidence            999886  446789999999999999999999999 9999999999999999999999999998753221    234689


Q ss_pred             ccccCcccccCCCCCCcccchhhhHHHHHHHhCCCCCCchhhHHHhhhchhhhccccccCCCChHHHHHHHHHHHHhccc
Q 020221          216 LAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLASRCLQY  295 (329)
Q Consensus       216 ~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~  295 (329)
                      +.|+|||++.+..++.++|||||||++|||++|..||...............      ...++...++++.+++.+||..
T Consensus       159 ~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~~~~~------~~~~p~~~~~~~~~li~~~L~~  232 (323)
T cd05571         159 PEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILME------EIRFPRTLSPEAKSLLAGLLKK  232 (323)
T ss_pred             ccccChhhhcCCCCCccccCcccchhhhhhhcCCCCCCCCCHHHHHHHHHcC------CCCCCCCCCHHHHHHHHHHccC
Confidence            9999999999888999999999999999999999988655433322221111      1234556778999999999999


Q ss_pred             CCCCCC-----CHHHHHH
Q 020221          296 EPRERP-----NPRSLVT  308 (329)
Q Consensus       296 dp~~Rp-----s~~~~l~  308 (329)
                      ||++||     ++.++++
T Consensus       233 dP~~R~~~~~~~~~~ll~  250 (323)
T cd05571         233 DPKQRLGGGPEDAKEIME  250 (323)
T ss_pred             CHHHcCCCCCCCHHHHHc
Confidence            999999     7888886

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be

>PTZ00263 protein kinase A catalytic subunit; Provisional

Probab=100.00  E-value=3.4e-46  Score=334.79  Aligned_cols=244  Identities=15%  Similarity=0.178  Sum_probs=203.4

Q ss_pred             CCcccccccCCCCCCcEEEEEEe-CCCCEEEEEEeCCCC---ChhHHHHHHHHHHHhcCCCccccccceeeeeCCeeEEE
Q 020221           56 FAMENIVSEHGEKAPNVVYKGKL-ENQFRIAVKRFNRSA---WPDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLV  131 (329)
Q Consensus        56 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv  131 (329)
                      +..|++.+.||+|+||.||++.. .+++.||+|++....   ....+.+.+|+.+++.++||||+++++++.+++..++|
T Consensus        17 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv   96 (329)
T PTZ00263         17 LSDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDENRVYFL   96 (329)
T ss_pred             chheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEcCCEEEEE
Confidence            45677888899999999999994 568899999987542   12345688999999999999999999999999999999


Q ss_pred             EecCCCCCHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCCCCCeeeecccCcccCCCC-C
Q 020221          132 AEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDG-R  210 (329)
Q Consensus       132 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~-~  210 (329)
                      |||+.+|+|.+++.  ....+++..+..++.|++.||.|||+. +++||||||+|||++.++.+||+|||++...... .
T Consensus        97 ~e~~~~~~L~~~l~--~~~~~~~~~~~~~~~qi~~aL~~LH~~-~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~  173 (329)
T PTZ00263         97 LEFVVGGELFTHLR--KAGRFPNDVAKFYHAELVLAFEYLHSK-DIIYRDLKPENLLLDNKGHVKVTDFGFAKKVPDRTF  173 (329)
T ss_pred             EcCCCCChHHHHHH--HcCCCCHHHHHHHHHHHHHHHHHHHHC-CeeecCCCHHHEEECCCCCEEEeeccCceEcCCCcc
Confidence            99999999999986  345788999999999999999999999 9999999999999999999999999999765443 2


Q ss_pred             CccCcccccCcccccCCCCCCcccchhhhHHHHHHHhCCCCCCchhhHHHhhhchhhhccccccCCCChHHHHHHHHHHH
Q 020221          211 SYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLAS  290 (329)
Q Consensus       211 ~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~  290 (329)
                      ...|++.|+|||++.+..++.++||||||+++|+|++|..||.............    ..  ...++...+..+.+++.
T Consensus       174 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~----~~--~~~~p~~~~~~~~~li~  247 (329)
T PTZ00263        174 TLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDDTPFRIYEKIL----AG--RLKFPNWFDGRARDLVK  247 (329)
T ss_pred             eecCChhhcCHHHHcCCCCCCcceeechHHHHHHHHcCCCCCCCCCHHHHHHHHh----cC--CcCCCCCCCHHHHHHHH
Confidence            4568899999999998889999999999999999999999886543222221111    11  11234446678999999


Q ss_pred             HhcccCCCCCCC-----HHHHHH
Q 020221          291 RCLQYEPRERPN-----PRSLVT  308 (329)
Q Consensus       291 ~cl~~dp~~Rps-----~~~~l~  308 (329)
                      +||+.||.+||+     +.+++.
T Consensus       248 ~~L~~dP~~R~~~~~~~~~~ll~  270 (329)
T PTZ00263        248 GLLQTDHTKRLGTLKGGVADVKN  270 (329)
T ss_pred             HHhhcCHHHcCCCCCCCHHHHhc
Confidence            999999999997     577775

>cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2

Probab=100.00  E-value=2.8e-45  Score=329.21  Aligned_cols=251  Identities=18%  Similarity=0.229  Sum_probs=202.5

Q ss_pred             CcccccccCCCCCCcEEEEEE-eCCCCEEEEEEeCCCCCh-hHHHHHHHHHHHhcCCCccccccceeeeeCCeeEEEEec
Q 020221           57 AMENIVSEHGEKAPNVVYKGK-LENQFRIAVKRFNRSAWP-DARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAEY  134 (329)
Q Consensus        57 ~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  134 (329)
                      ..|++++.||+|+||.||++. ..++..+|+|.+...... ..+.+.+|+++++.++||||+++++++...+..++||||
T Consensus         5 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~   84 (331)
T cd06649           5 DDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEH   84 (331)
T ss_pred             ccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEeec
Confidence            456778888999999999999 456888999998765322 345689999999999999999999999999999999999


Q ss_pred             CCCCCHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCCCCCeeeecccCcccCCCC--CCc
Q 020221          135 MPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDG--RSY  212 (329)
Q Consensus       135 ~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~--~~~  212 (329)
                      +++++|.+++.  ....+++..+..++.|++.||.|||++++++|+||||+||+++.++.++|+|||++......  ...
T Consensus        85 ~~~~~L~~~l~--~~~~~~~~~~~~~~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~  162 (331)
T cd06649          85 MDGGSLDQVLK--EAKRIPEEILGKVSIAVLRGLAYLREKHQIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSF  162 (331)
T ss_pred             CCCCcHHHHHH--HcCCCCHHHHHHHHHHHHHHHHHHhhcCCEEcCCCChhhEEEcCCCcEEEccCcccccccccccccC
Confidence            99999999986  34568999999999999999999998646999999999999999999999999998755432  234


Q ss_pred             cCcccccCcccccCCCCCCcccchhhhHHHHHHHhCCCCCCchhhHHHhhhchhh-------------------------
Q 020221          213 STNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQT-------------------------  267 (329)
Q Consensus       213 ~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~~~~~~~~-------------------------  267 (329)
                      .++..|+|||++.+..++.++||||||+++|||++|+.||...............                         
T Consensus       163 ~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  242 (331)
T cd06649         163 VGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPPPDAKELEAIFGRPVVDGEEGEPHSISPRPRPPGRPVSG  242 (331)
T ss_pred             CCCcCcCCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccccCCccccCcccccccccccc
Confidence            6789999999999888999999999999999999999988643222111100000                         


Q ss_pred             -----------------hccccccCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 020221          268 -----------------LTDSCLEGQFSSDEGTELVRLASRCLQYEPRERPNPRSLVTA  309 (329)
Q Consensus       268 -----------------~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~~~l~~  309 (329)
                                       +.............++++.+|+.+||+.||++|||+.+++++
T Consensus       243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~~P~~Rpt~~ell~h  301 (331)
T cd06649         243 HGMDSRPAMAIFELLDYIVNEPPPKLPNGVFTPDFQEFVNKCLIKNPAERADLKMLMNH  301 (331)
T ss_pred             cccccccchhHHHHHHHHHhCCCcCCCCccccHHHHHHHHHHccCCcccCCCHHHHhcC
Confidence                             000000000112356789999999999999999999999983

Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst

>KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3.9e-47  Score=329.82  Aligned_cols=242  Identities=15%  Similarity=0.253  Sum_probs=205.5

Q ss_pred             ccccccCCCCCCcEEEEEE-eCCCCEEEEEEeCCCCC-hhHHHHHHHHHHHhcCCCccccccceeeeeCCeeEEEEecCC
Q 020221           59 ENIVSEHGEKAPNVVYKGK-LENQFRIAVKRFNRSAW-PDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAEYMP  136 (329)
Q Consensus        59 ~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~  136 (329)
                      |+.+..||+|.||.||+|. ..+++.||+|++..... ...+++.+|+.+|..++++||.++++.+..+..+|++||||.
T Consensus        15 ~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~~deIediqqei~~Ls~~~~~~it~yygsyl~g~~LwiiMey~~   94 (467)
T KOG0201|consen   15 YTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEEAEDEIEDIQQEISVLSQCDSPNITEYYGSYLKGTKLWIIMEYCG   94 (467)
T ss_pred             cccchhccccccceeeeeeeccccceEEEEEechhhcchhhHHHHHHHHHHHhcCcchHHhhhhheeecccHHHHHHHhc
Confidence            4455677999999999999 56788999999987643 346778999999999999999999999999999999999999


Q ss_pred             CCCHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCCCCCeeeecccCcccCCCC----CCc
Q 020221          137 NDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDG----RSY  212 (329)
Q Consensus       137 ~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~----~~~  212 (329)
                      +|++.+.+.  ....+.+..+..++++++.||.|||.. +.+|||||+.|||+..+|.+|++|||.+......    .++
T Consensus        95 gGsv~~lL~--~~~~~~E~~i~~ilre~l~~l~ylH~~-~kiHrDIKaanil~s~~g~vkl~DfgVa~ql~~~~~rr~tf  171 (467)
T KOG0201|consen   95 GGSVLDLLK--SGNILDEFEIAVILREVLKGLDYLHSE-KKIHRDIKAANILLSESGDVKLADFGVAGQLTNTVKRRKTF  171 (467)
T ss_pred             Ccchhhhhc--cCCCCccceeeeehHHHHHHhhhhhhc-ceecccccccceeEeccCcEEEEecceeeeeechhhccccc
Confidence            999999995  334448888899999999999999999 9999999999999999999999999998765433    567


Q ss_pred             cCcccccCcccccCCCCCCcccchhhhHHHHHHHhCCCCCCchhhHHHhhhchhhhccccccCCCChHHHHHHHHHHHHh
Q 020221          213 STNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLASRC  292 (329)
Q Consensus       213 ~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~c  292 (329)
                      .||+.|||||++.+..|+.++||||||++.+||.+|.+|+.....     ....-.+.....+.+...+++.+++|+..|
T Consensus       172 vGTPfwMAPEVI~~~~Y~~KADIWSLGITaiEla~GePP~s~~hP-----mrvlflIpk~~PP~L~~~~S~~~kEFV~~C  246 (467)
T KOG0201|consen  172 VGTPFWMAPEVIKQSGYDTKADIWSLGITAIELAKGEPPHSKLHP-----MRVLFLIPKSAPPRLDGDFSPPFKEFVEAC  246 (467)
T ss_pred             cccccccchhhhccccccchhhhhhhhHHHHHHhcCCCCCcccCc-----ceEEEeccCCCCCccccccCHHHHHHHHHH
Confidence            899999999999988899999999999999999999976643211     111122233333344457889999999999


Q ss_pred             cccCCCCCCCHHHHHH
Q 020221          293 LQYEPRERPNPRSLVT  308 (329)
Q Consensus       293 l~~dp~~Rps~~~~l~  308 (329)
                      |++||+.||+|.+++.
T Consensus       247 L~k~P~~RpsA~~LLK  262 (467)
T KOG0201|consen  247 LDKNPEFRPSAKELLK  262 (467)
T ss_pred             hhcCcccCcCHHHHhh
Confidence            9999999999999986

>KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=2.6e-46  Score=301.15  Aligned_cols=243  Identities=21%  Similarity=0.266  Sum_probs=210.6

Q ss_pred             ccccccCCCCCCcEEEEEE-eCCCCEEEEEEeCCCCC---hhHHHHHHHHHHHhcCCCccccccceeeeeCCeeEEEEec
Q 020221           59 ENIVSEHGEKAPNVVYKGK-LENQFRIAVKRFNRSAW---PDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAEY  134 (329)
Q Consensus        59 ~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  134 (329)
                      .++-+.||+|-||.||.|+ .+++..||+|++.+...   +...++.+|+++-+.|+||||+++++++.+....||++||
T Consensus        24 feigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd~~riyLilEy  103 (281)
T KOG0580|consen   24 FEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYFHDSKRIYLILEY  103 (281)
T ss_pred             ccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhheeccceeEEEEEe
Confidence            3445556999999999999 66788999999876542   2346789999999999999999999999999999999999


Q ss_pred             CCCCCHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCCCCCeeeecccCcccCC--CCCCc
Q 020221          135 MPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSR--DGRSY  212 (329)
Q Consensus       135 ~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~--~~~~~  212 (329)
                      ...|+|...|+......+++.....+++|++.||.|+|.+ +++||||||+|+|++..+.+||+|||-+....  ...+.
T Consensus       104 a~~gel~k~L~~~~~~~f~e~~~a~Yi~q~A~Al~y~h~k-~VIhRdiKpenlLlg~~~~lkiAdfGwsV~~p~~kR~tl  182 (281)
T KOG0580|consen  104 APRGELYKDLQEGRMKRFDEQRAATYIKQLANALLYCHLK-RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSNKRKTL  182 (281)
T ss_pred             cCCchHHHHHHhcccccccccchhHHHHHHHHHHHHhccC-CcccCCCCHHHhccCCCCCeeccCCCceeecCCCCceee
Confidence            9999999999876777899999999999999999999999 99999999999999999999999999876543  33567


Q ss_pred             cCcccccCcccccCCCCCCcccchhhhHHHHHHHhCCCCCCchhhHHHhhhchhhhccccccCCCChHHHHHHHHHHHHh
Q 020221          213 STNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLASRC  292 (329)
Q Consensus       213 ~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~c  292 (329)
                      +||..|.+||+..+...+..+|+|++|++.||++.|.+||.....+........      .+..+|...+.++.++|.+|
T Consensus       183 cgt~dyl~pEmv~~~~hd~~Vd~w~lgvl~yeflvg~ppFes~~~~etYkrI~k------~~~~~p~~is~~a~dlI~~l  256 (281)
T KOG0580|consen  183 CGTLDYLPPEMVEGRGHDKFVDLWSLGVLCYEFLVGLPPFESQSHSETYKRIRK------VDLKFPSTISGGAADLISRL  256 (281)
T ss_pred             ecccccCCHhhcCCCCccchhhHHHHHHHHHHHHhcCCchhhhhhHHHHHHHHH------ccccCCcccChhHHHHHHHH
Confidence            899999999999999999999999999999999999998876553333322221      22335677889999999999


Q ss_pred             cccCCCCCCCHHHHHH
Q 020221          293 LQYEPRERPNPRSLVT  308 (329)
Q Consensus       293 l~~dp~~Rps~~~~l~  308 (329)
                      +.++|.+|.+..++++
T Consensus       257 l~~~p~~r~~l~~v~~  272 (281)
T KOG0580|consen  257 LVKNPIERLALTEVMD  272 (281)
T ss_pred             hccCccccccHHHHhh
Confidence            9999999999999998

>cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.9e-45  Score=327.59  Aligned_cols=235  Identities=18%  Similarity=0.205  Sum_probs=195.9

Q ss_pred             CCCCCCcEEEEEE-eCCCCEEEEEEeCCCC---ChhHHHHHHHHHHHhcCCCccccccceeeeeCCeeEEEEecCCCCCH
Q 020221           65 HGEKAPNVVYKGK-LENQFRIAVKRFNRSA---WPDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAEYMPNDTL  140 (329)
Q Consensus        65 lg~G~~g~V~~~~-~~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL  140 (329)
                      ||+|+||.||++. ..+++.||+|.+....   ......+.+|+.+++.++||||+++++++...+..++||||+++|+|
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L   80 (312)
T cd05585           1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGGEL   80 (312)
T ss_pred             CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecCCeEEEEEcCCCCCcH
Confidence            5999999999999 4568899999986532   22345678899999999999999999999999999999999999999


Q ss_pred             HhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCCCCCeeeecccCcccCCCC----CCccCcc
Q 020221          141 AKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDG----RSYSTNL  216 (329)
Q Consensus       141 ~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~----~~~~~~~  216 (329)
                      .+++.  ....+++..+..++.|++.||.|||++ +++||||||+||+++.++.++|+|||++......    ....||+
T Consensus        81 ~~~l~--~~~~~~~~~~~~~~~qi~~~l~~lH~~-~i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~  157 (312)
T cd05585          81 FHHLQ--REGRFDLSRARFYTAELLCALENLHKF-NVIYRDLKPENILLDYQGHIALCDFGLCKLNMKDDDKTNTFCGTP  157 (312)
T ss_pred             HHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHhC-CeEeCCCCHHHeEECCCCcEEEEECcccccCccCCCccccccCCc
Confidence            99986  345689999999999999999999999 9999999999999999999999999998753322    2346889


Q ss_pred             cccCcccccCCCCCCcccchhhhHHHHHHHhCCCCCCchhhHHHhhhchhhhccccccCCCChHHHHHHHHHHHHhcccC
Q 020221          217 AFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLASRCLQYE  296 (329)
Q Consensus       217 ~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~d  296 (329)
                      .|+|||++.+..++.++||||||+++|+|++|..||..............    .  ...++...++++.+++.+||..|
T Consensus       158 ~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~~~~~~~~~~~----~--~~~~~~~~~~~~~~li~~~L~~d  231 (312)
T cd05585         158 EYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYDENVNEMYRKILQ----E--PLRFPDGFDRDAKDLLIGLLSRD  231 (312)
T ss_pred             ccCCHHHHcCCCCCCccceechhHHHHHHHhCCCCcCCCCHHHHHHHHHc----C--CCCCCCcCCHHHHHHHHHHcCCC
Confidence            99999999988899999999999999999999998876543332222111    1  12345567788999999999999


Q ss_pred             CCCCCC---HHHHHH
Q 020221          297 PRERPN---PRSLVT  308 (329)
Q Consensus       297 p~~Rps---~~~~l~  308 (329)
                      |++||+   +.++++
T Consensus       232 p~~R~~~~~~~e~l~  246 (312)
T cd05585         232 PTRRLGYNGAQEIKN  246 (312)
T ss_pred             HHHcCCCCCHHHHHc
Confidence            999985   555554

Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl

>PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional

Probab=100.00  E-value=1.7e-45  Score=331.30  Aligned_cols=244  Identities=17%  Similarity=0.203  Sum_probs=202.5

Q ss_pred             CCcccccccCCCCCCcEEEEEEeC-C-CCEEEEEEeCCCC---ChhHHHHHHHHHHHhcCCCccccccceeeeeCCeeEE
Q 020221           56 FAMENIVSEHGEKAPNVVYKGKLE-N-QFRIAVKRFNRSA---WPDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLL  130 (329)
Q Consensus        56 ~~~~~~~~~lg~G~~g~V~~~~~~-~-~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l  130 (329)
                      +..|.+++.||+|+||.||+|... + +..||+|.+....   ....+.+.+|+.+++.++||||+++++++.+.+..++
T Consensus        29 ~~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~l  108 (340)
T PTZ00426         29 YEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDESYLYL  108 (340)
T ss_pred             hhhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEEeCCEEEE
Confidence            445778888899999999999843 3 3689999986432   2234567889999999999999999999999999999


Q ss_pred             EEecCCCCCHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCCCCCeeeecccCcccCCCC-
Q 020221          131 VAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDG-  209 (329)
Q Consensus       131 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~-  209 (329)
                      ||||+++|+|.+++.  ....+++..+..++.|++.||.|||+. +++||||||+|||++.++.++|+|||++...... 
T Consensus       109 v~Ey~~~g~L~~~i~--~~~~~~~~~~~~~~~qi~~aL~~LH~~-~ivHrDLkp~NILl~~~~~ikL~DFG~a~~~~~~~  185 (340)
T PTZ00426        109 VLEFVIGGEFFTFLR--RNKRFPNDVGCFYAAQIVLIFEYLQSL-NIVYRDLKPENLLLDKDGFIKMTDFGFAKVVDTRT  185 (340)
T ss_pred             EEeCCCCCcHHHHHH--HcCCCCHHHHHHHHHHHHHHHHHHHHC-CeEccCCCHHHEEECCCCCEEEecCCCCeecCCCc
Confidence            999999999999986  345789999999999999999999999 9999999999999999999999999999765432 


Q ss_pred             CCccCcccccCcccccCCCCCCcccchhhhHHHHHHHhCCCCCCchhhHHHhhhchhhhccccccCCCChHHHHHHHHHH
Q 020221          210 RSYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLA  289 (329)
Q Consensus       210 ~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li  289 (329)
                      ....||+.|+|||++.+..++.++|||||||++|||++|..||................      ..++...++.+.+++
T Consensus       186 ~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~i~~~~------~~~p~~~~~~~~~li  259 (340)
T PTZ00426        186 YTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYANEPLLIYQKILEGI------IYFPKFLDNNCKHLM  259 (340)
T ss_pred             ceecCChhhcCHHHHhCCCCCccccccchhhHHHHHhcCCCCCCCCCHHHHHHHHhcCC------CCCCCCCCHHHHHHH
Confidence            34568999999999998889999999999999999999999887543322222211111      123455677899999


Q ss_pred             HHhcccCCCCCC-----CHHHHHH
Q 020221          290 SRCLQYEPRERP-----NPRSLVT  308 (329)
Q Consensus       290 ~~cl~~dp~~Rp-----s~~~~l~  308 (329)
                      .+||+.||++|+     +++++++
T Consensus       260 ~~~l~~dp~~R~~~~~~~~~~~~~  283 (340)
T PTZ00426        260 KKLLSHDLTKRYGNLKKGAQNVKE  283 (340)
T ss_pred             HHHcccCHHHcCCCCCCCHHHHHc
Confidence            999999999995     7888876

>KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.4e-45  Score=335.83  Aligned_cols=239  Identities=19%  Similarity=0.287  Sum_probs=205.2

Q ss_pred             CCCcccccccCCCCCCcEEEEEE-eCCCCEEEEEEeCCCCC---hhHHHHHHHHHHHhcC-CCccccccceeeeeCCeeE
Q 020221           55 GFAMENIVSEHGEKAPNVVYKGK-LENQFRIAVKRFNRSAW---PDARQFLEEARAVGQL-RNRRLANLLGCCCEGDERL  129 (329)
Q Consensus        55 ~~~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~  129 (329)
                      +....++++.||+|+||+|+++. ..+++.+|||.++++..   .+.+....|.+++... +||.++.++..|++.+++|
T Consensus       366 ~l~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~~~l~  445 (694)
T KOG0694|consen  366 TLDDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQTKEHLF  445 (694)
T ss_pred             cccceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccccccCCeEE
Confidence            34556778888999999999999 56688999999998742   3455677788877777 6999999999999999999


Q ss_pred             EEEecCCCCCHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCCCCCeeeecccCcccCC--
Q 020221          130 LVAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSR--  207 (329)
Q Consensus       130 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~--  207 (329)
                      +||||+.||++....   ....+++..+..++..|+.||.|||++ ||||||||.+|||+|.+|++||+|||+++...  
T Consensus       446 fvmey~~Ggdm~~~~---~~~~F~e~rarfyaAev~l~L~fLH~~-~IIYRDlKLdNiLLD~eGh~kiADFGlcKe~m~~  521 (694)
T KOG0694|consen  446 FVMEYVAGGDLMHHI---HTDVFSEPRARFYAAEVVLGLQFLHEN-GIIYRDLKLDNLLLDTEGHVKIADFGLCKEGMGQ  521 (694)
T ss_pred             EEEEecCCCcEEEEE---ecccccHHHHHHHHHHHHHHHHHHHhc-CceeeecchhheEEcccCcEEecccccccccCCC
Confidence            999999999954444   557899999999999999999999999 99999999999999999999999999998643  


Q ss_pred             --CCCCccCcccccCcccccCCCCCCcccchhhhHHHHHHHhCCCCCCchhhHHHhhhchhhhccccccCCCChHHHHHH
Q 020221          208 --DGRSYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTEL  285 (329)
Q Consensus       208 --~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  285 (329)
                        ...+.+||+.|+|||++.+..|+..+|+|||||+||||+.|..||+++.-+.+-+....+      ...+|..++.+.
T Consensus       522 g~~TsTfCGTpey~aPEil~e~~Yt~aVDWW~lGVLlyeML~Gq~PF~gddEee~FdsI~~d------~~~yP~~ls~ea  595 (694)
T KOG0694|consen  522 GDRTSTFCGTPEFLAPEVLTEQSYTRAVDWWGLGVLLYEMLVGESPFPGDDEEEVFDSIVND------EVRYPRFLSKEA  595 (694)
T ss_pred             CCccccccCChhhcChhhhccCcccchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcC------CCCCCCcccHHH
Confidence              335678999999999999999999999999999999999999999977655444433321      224677889999


Q ss_pred             HHHHHHhcccCCCCCCCH
Q 020221          286 VRLASRCLQYEPRERPNP  303 (329)
Q Consensus       286 ~~li~~cl~~dp~~Rps~  303 (329)
                      ..++.++|..+|++|..+
T Consensus       596 ~~il~~ll~k~p~kRLG~  613 (694)
T KOG0694|consen  596 IAIMRRLLRKNPEKRLGS  613 (694)
T ss_pred             HHHHHHHhccCcccccCC
Confidence            999999999999999865

>KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms]

Probab=100.00  E-value=1.4e-47  Score=309.62  Aligned_cols=245  Identities=20%  Similarity=0.233  Sum_probs=210.0

Q ss_pred             ccccccCCCCCCcEEEEEE-eCCCCEEEEEEeCCCC--ChhHHHHHHHHHHHhcCCCccccccceeeeeCCeeEEEEecC
Q 020221           59 ENIVSEHGEKAPNVVYKGK-LENQFRIAVKRFNRSA--WPDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAEYM  135 (329)
Q Consensus        59 ~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~  135 (329)
                      |.+...||+|.|+.|+++. ..+|+.+|+|++....  ..+.+++.+|+++.+.|+||||+++.+...+....++|+|++
T Consensus        13 y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~LqHP~IvrL~~ti~~~~~~ylvFe~m   92 (355)
T KOG0033|consen   13 YDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVFDLV   92 (355)
T ss_pred             hhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccccHHHHHHHHHHHHhcCCCcEeehhhhhcccceeEEEEecc
Confidence            4455566999999999998 6778889998876442  235778999999999999999999999999999999999999


Q ss_pred             CCCCHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeC---CCCCeeeecccCcccCCCCCC-
Q 020221          136 PNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFD---DDVNPRLSCFGLMKNSRDGRS-  211 (329)
Q Consensus       136 ~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~---~~~~~kl~Dfg~a~~~~~~~~-  211 (329)
                      .|++|..-+..  ..-+++..+..+++||+.+|.|+|.+ +|||||+||+|+|+.   ....+||+|||+|....++.. 
T Consensus        93 ~G~dl~~eIV~--R~~ySEa~aSH~~rQiLeal~yCH~n-~IvHRDvkP~nllLASK~~~A~vKL~~FGvAi~l~~g~~~  169 (355)
T KOG0033|consen   93 TGGELFEDIVA--REFYSEADASHCIQQILEALAYCHSN-GIVHRDLKPENLLLASKAKGAAVKLADFGLAIEVNDGEAW  169 (355)
T ss_pred             cchHHHHHHHH--HHHHHHHHHHHHHHHHHHHHHHHHhc-CceeccCChhheeeeeccCCCceeecccceEEEeCCcccc
Confidence            99999877753  35678999999999999999999999 999999999999995   334599999999998886543 


Q ss_pred             --ccCcccccCcccccCCCCCCcccchhhhHHHHHHHhCCCCCCchhhHHHhhhchhhhccccccCCCChHHHHHHHHHH
Q 020221          212 --YSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLA  289 (329)
Q Consensus       212 --~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li  289 (329)
                        ..||+.|||||++...+|+..+|||+.||+||-|+.|..||+++....+.++......+-  .++.-+..+++.++|+
T Consensus       170 ~G~~GtP~fmaPEvvrkdpy~kpvDiW~cGViLfiLL~G~~PF~~~~~~rlye~I~~g~yd~--~~~~w~~is~~Ak~Lv  247 (355)
T KOG0033|consen  170 HGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYEQIKAGAYDY--PSPEWDTVTPEAKSLI  247 (355)
T ss_pred             ccccCCCcccCHHHhhcCCCCCcchhhhhhHHHHHHHhCCCCCCCccHHHHHHHHhccccCC--CCcccCcCCHHHHHHH
Confidence              467999999999999999999999999999999999999999877666666655544432  2334456789999999


Q ss_pred             HHhcccCCCCCCCHHHHHH
Q 020221          290 SRCLQYEPRERPNPRSLVT  308 (329)
Q Consensus       290 ~~cl~~dp~~Rps~~~~l~  308 (329)
                      .+||..||.+|.|+.|+|+
T Consensus       248 rrML~~dP~kRIta~EAL~  266 (355)
T KOG0033|consen  248 RRMLTVNPKKRITADEALK  266 (355)
T ss_pred             HHHhccChhhhccHHHHhC
Confidence            9999999999999999998

>cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma

Probab=100.00  E-value=3.2e-45  Score=328.27  Aligned_cols=237  Identities=18%  Similarity=0.234  Sum_probs=198.2

Q ss_pred             cCCCCCCcEEEEEE-eCCCCEEEEEEeCCCC---ChhHHHHHHHHHHHhcCCCccccccceeeeeCCeeEEEEecCCCCC
Q 020221           64 EHGEKAPNVVYKGK-LENQFRIAVKRFNRSA---WPDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAEYMPNDT  139 (329)
Q Consensus        64 ~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gs  139 (329)
                      .||+|+||.||++. ..+++.||+|++....   ......+.+|+++++.++||||+++.+++...+..++||||+++|+
T Consensus         2 ~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~Ey~~~g~   81 (328)
T cd05593           2 LLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVNGGE   81 (328)
T ss_pred             eeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCEEEEEEeCCCCCC
Confidence            46999999999998 5578899999997542   2234567889999999999999999999999999999999999999


Q ss_pred             HHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCCCCCeeeecccCcccCCCC----CCccCc
Q 020221          140 LAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDG----RSYSTN  215 (329)
Q Consensus       140 L~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~----~~~~~~  215 (329)
                      |..++.  ....+++.++..++.||+.||+|||++ +++||||||+|||++.++.+||+|||++......    ....|+
T Consensus        82 L~~~l~--~~~~l~~~~~~~~~~qi~~aL~~LH~~-~ivHrDikp~NIll~~~~~~kL~DfG~~~~~~~~~~~~~~~~gt  158 (328)
T cd05593          82 LFFHLS--RERVFSEDRTRFYGAEIVSALDYLHSG-KIVYRDLKLENLMLDKDGHIKITDFGLCKEGITDAATMKTFCGT  158 (328)
T ss_pred             HHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHhC-CeEecccCHHHeEECCCCcEEEecCcCCccCCCcccccccccCC
Confidence            998886  345789999999999999999999999 9999999999999999999999999998753221    234688


Q ss_pred             ccccCcccccCCCCCCcccchhhhHHHHHHHhCCCCCCchhhHHHhhhchhhhccccccCCCChHHHHHHHHHHHHhccc
Q 020221          216 LAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLASRCLQY  295 (329)
Q Consensus       216 ~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~  295 (329)
                      +.|+|||++.+..++.++||||||+++|+|++|..||..............      ....++...++++.+++.+||..
T Consensus       159 ~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~~~~~~~~~~------~~~~~p~~~~~~~~~li~~~L~~  232 (328)
T cd05593         159 PEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILM------EDIKFPRTLSADAKSLLSGLLIK  232 (328)
T ss_pred             cCccChhhhcCCCCCccCCccccchHHHHHhhCCCCCCCCCHHHHHHHhcc------CCccCCCCCCHHHHHHHHHHcCC
Confidence            999999999988899999999999999999999998865433322221111      11134456678899999999999


Q ss_pred             CCCCCC-----CHHHHHHH
Q 020221          296 EPRERP-----NPRSLVTA  309 (329)
Q Consensus       296 dp~~Rp-----s~~~~l~~  309 (329)
                      ||++||     ++.+++++
T Consensus       233 dP~~R~~~~~~~~~~il~h  251 (328)
T cd05593         233 DPNKRLGGGPDDAKEIMRH  251 (328)
T ss_pred             CHHHcCCCCCCCHHHHhcC
Confidence            999997     88998863

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate

>cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=3.7e-45  Score=328.75  Aligned_cols=249  Identities=17%  Similarity=0.155  Sum_probs=203.6

Q ss_pred             cccccccCCCCCCcEEEEEEe-CCCCEEEEEEeCCCC---ChhHHHHHHHHHHHhcCCCccccccceeeeeCCeeEEEEe
Q 020221           58 MENIVSEHGEKAPNVVYKGKL-ENQFRIAVKRFNRSA---WPDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAE  133 (329)
Q Consensus        58 ~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  133 (329)
                      .|++++.||+|+||.||+|.. .+++.||+|++....   ......+.+|++++..++||||+++++++..++..++|||
T Consensus         2 ~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e   81 (333)
T cd05600           2 DFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDDEYLYLAME   81 (333)
T ss_pred             CcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEcCCEEEEEEe
Confidence            466778889999999999994 468899999987542   1234567889999999999999999999999999999999


Q ss_pred             cCCCCCHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCCCCCeeeecccCcccCCCC-CCc
Q 020221          134 YMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDG-RSY  212 (329)
Q Consensus       134 ~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~-~~~  212 (329)
                      |+++++|.+++.  ....+++..+..++.||+.||.|||+. +++||||||+||+++.++.+||+|||++...... ...
T Consensus        82 ~~~g~~L~~~l~--~~~~l~~~~~~~~~~qi~~~l~~lH~~-~ivH~dlkp~Nil~~~~~~~kL~Dfg~a~~~~~~~~~~  158 (333)
T cd05600          82 YVPGGDFRTLLN--NLGVLSEDHARFYMAEMFEAVDALHEL-GYIHRDLKPENFLIDASGHIKLTDFGLSKGIVTYANSV  158 (333)
T ss_pred             CCCCCCHHHHHH--HcCCCCHHHHHHHHHHHHHHHHHHHHC-CccccCCCHHHEEECCCCCEEEEeCcCCcccccccCCc
Confidence            999999999996  345689999999999999999999999 9999999999999999999999999998765442 345


Q ss_pred             cCcccccCcccccCCCCCCcccchhhhHHHHHHHhCCCCCCchhhHHHhhhchh--hhccccccCCCChHHHHHHHHHHH
Q 020221          213 STNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQ--TLTDSCLEGQFSSDEGTELVRLAS  290 (329)
Q Consensus       213 ~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~li~  290 (329)
                      .|++.|+|||++.+..++.++||||||+++|||++|..||..............  ...............+.++.+++.
T Consensus       159 ~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~s~~~~~li~  238 (333)
T cd05600         159 VGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNETWENLKYWKETLQRPVYDDPRFNLSDEAWDLIT  238 (333)
T ss_pred             ccCccccChhHhcCCCCCCccceecchHHHhhhhhCCCCCCCCCHHHHHHHHHhccccccCCCCCccccccCHHHHHHHH
Confidence            689999999999988999999999999999999999998865433222111110  001000000001245788999999


Q ss_pred             HhcccCCCCCCCHHHHHHH
Q 020221          291 RCLQYEPRERPNPRSLVTA  309 (329)
Q Consensus       291 ~cl~~dp~~Rps~~~~l~~  309 (329)
                      +||..+|++||++.+++++
T Consensus       239 ~~l~~~~~rr~s~~~ll~h  257 (333)
T cd05600         239 KLINDPSRRFGSLEDIKNH  257 (333)
T ss_pred             HHhhChhhhcCCHHHHHhC
Confidence            9999999999999999974

Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis.

>cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta

Probab=100.00  E-value=2.9e-45  Score=327.88  Aligned_cols=236  Identities=18%  Similarity=0.241  Sum_probs=196.9

Q ss_pred             cCCCCCCcEEEEEE-eCCCCEEEEEEeCCCC---ChhHHHHHHHHHHHhcCCCccccccceeeeeCCeeEEEEecCCCCC
Q 020221           64 EHGEKAPNVVYKGK-LENQFRIAVKRFNRSA---WPDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAEYMPNDT  139 (329)
Q Consensus        64 ~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gs  139 (329)
                      .||+|+||.||++. ..+|+.||+|++....   ......+.+|+++++.++||||+++++++...+..++||||+++|+
T Consensus         2 ~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~E~~~~~~   81 (323)
T cd05595           2 LLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGGE   81 (323)
T ss_pred             eeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecCCEEEEEEeCCCCCc
Confidence            46999999999998 4578899999987542   2234457789999999999999999999999999999999999999


Q ss_pred             HHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCCCCCeeeecccCcccCCCC----CCccCc
Q 020221          140 LAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDG----RSYSTN  215 (329)
Q Consensus       140 L~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~----~~~~~~  215 (329)
                      |..++.  ....+++..+..++.||+.||.|||++ |++||||||+|||+++++.+||+|||++......    ....|+
T Consensus        82 L~~~l~--~~~~~~~~~~~~~~~qi~~aL~~LH~~-~ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~gt  158 (323)
T cd05595          82 LFFHLS--RERVFTEERARFYGAEIVSALEYLHSR-DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGT  158 (323)
T ss_pred             HHHHHH--HcCCCCHHHHHHHHHHHHHHHHHHHHC-CeEecCCCHHHEEEcCCCCEEecccHHhccccCCCCccccccCC
Confidence            998886  345789999999999999999999999 9999999999999999999999999998753221    234688


Q ss_pred             ccccCcccccCCCCCCcccchhhhHHHHHHHhCCCCCCchhhHHHhhhchhhhccccccCCCChHHHHHHHHHHHHhccc
Q 020221          216 LAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLASRCLQY  295 (329)
Q Consensus       216 ~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~  295 (329)
                      +.|+|||++.+..++.++||||||+++|+|++|..||...............      ...++...++++.+++.+||+.
T Consensus       159 ~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~~~~~------~~~~p~~~~~~~~~li~~~L~~  232 (323)
T cd05595         159 PEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILME------EIRFPRTLSPEAKSLLAGLLKK  232 (323)
T ss_pred             cCcCCcccccCCCCCchhchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHhcC------CCCCCCCCCHHHHHHHHHHccC
Confidence            9999999999889999999999999999999999888654333222211111      1123456678999999999999


Q ss_pred             CCCCCC-----CHHHHHH
Q 020221          296 EPRERP-----NPRSLVT  308 (329)
Q Consensus       296 dp~~Rp-----s~~~~l~  308 (329)
                      ||++||     ++.++++
T Consensus       233 dP~~R~~~~~~~~~~~l~  250 (323)
T cd05595         233 DPKQRLGGGPSDAKEVME  250 (323)
T ss_pred             CHHHhCCCCCCCHHHHHc
Confidence            999998     7888876

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in

>KOG0589 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=7.5e-46  Score=329.03  Aligned_cols=247  Identities=19%  Similarity=0.199  Sum_probs=218.6

Q ss_pred             CcccccccCCCCCCcEEEEEE-eCCCCEEEEEEeCCCCChh--HHHHHHHHHHHhcCCCccccccceeeeeCCe-eEEEE
Q 020221           57 AMENIVSEHGEKAPNVVYKGK-LENQFRIAVKRFNRSAWPD--ARQFLEEARAVGQLRNRRLANLLGCCCEGDE-RLLVA  132 (329)
Q Consensus        57 ~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~--~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~-~~lv~  132 (329)
                      +.|..++.+|+|+||.++..+ ..+++.+++|.+.......  .+...+|+.++++++|||||.+.+.|...+. .+|+|
T Consensus         4 ~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~~hP~iv~y~ds~~~~~~~l~Ivm   83 (426)
T KOG0589|consen    4 DNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPERRSAIQEMDLLSKLLHPNIVEYKDSFEEDGQLLCIVM   83 (426)
T ss_pred             chhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCchhhHHHHHHHHHHHhccCCCeeeeccchhcCCceEEEEE
Confidence            467888899999999999998 4567799999998765333  3457899999999999999999999988887 99999


Q ss_pred             ecCCCCCHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCCCCCeeeecccCcccCCCCC--
Q 020221          133 EYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDGR--  210 (329)
Q Consensus       133 e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~--  210 (329)
                      +||+||+|.+.+.+.+...+++..+..++.|++.|+.|||++ +|+|||||+.||+++.++.++|+|||+|+...+..  
T Consensus        84 ~Y~eGg~l~~~i~~~k~~~f~E~~i~~~~~Q~~~av~ylH~~-~iLHRDlK~~Nifltk~~~VkLgDfGlaK~l~~~~~~  162 (426)
T KOG0589|consen   84 EYCEGGDLAQLIKEQKGVLFPEERILKWFVQILLAVNYLHEN-RVLHRDLKCANIFLTKDKKVKLGDFGLAKILNPEDSL  162 (426)
T ss_pred             eecCCCCHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhh-hhhcccchhhhhhccccCceeecchhhhhhcCCchhh
Confidence            999999999999876667889999999999999999999988 99999999999999999999999999999876653  


Q ss_pred             --CccCcccccCcccccCCCCCCcccchhhhHHHHHHHhCCCCCCchhhHHHhhhchhhhccccccCCCChHHHHHHHHH
Q 020221          211 --SYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRL  288 (329)
Q Consensus       211 --~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  288 (329)
                        +..||+.|++||.+.+.+|+.++|||||||++|||++-+++|..................     +.+...+.+++.+
T Consensus       163 a~tvvGTp~YmcPEil~d~pYn~KSDiWsLGC~~yEm~~lk~aF~a~~m~~Li~ki~~~~~~-----Plp~~ys~el~~l  237 (426)
T KOG0589|consen  163 ASTVVGTPYYMCPEILSDIPYNEKSDIWSLGCCLYEMCTLKPAFKASNMSELILKINRGLYS-----PLPSMYSSELRSL  237 (426)
T ss_pred             hheecCCCcccCHHHhCCCCCCccCcchhhcchHHHHHhcccccCccchHHHHHHHhhccCC-----CCCccccHHHHHH
Confidence              568999999999999999999999999999999999999988877666665555554433     4567788999999


Q ss_pred             HHHhcccCCCCCCCHHHHHHH
Q 020221          289 ASRCLQYEPRERPNPRSLVTA  309 (329)
Q Consensus       289 i~~cl~~dp~~Rps~~~~l~~  309 (329)
                      +..||..+|+.||++.+++..
T Consensus       238 v~~~l~~~P~~RPsa~~LL~~  258 (426)
T KOG0589|consen  238 VKSMLRKNPEHRPSALELLRR  258 (426)
T ss_pred             HHHHhhcCCccCCCHHHHhhC
Confidence            999999999999999999975

>KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.5e-45  Score=332.88  Aligned_cols=252  Identities=25%  Similarity=0.380  Sum_probs=210.9

Q ss_pred             ccccCCCCCCcEEEEEEeC--CC---CEEEEEEeCCCC---ChhHHHHHHHHHHHhcCCCccccccceeeeeCCeeEEEE
Q 020221           61 IVSEHGEKAPNVVYKGKLE--NQ---FRIAVKRFNRSA---WPDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVA  132 (329)
Q Consensus        61 ~~~~lg~G~~g~V~~~~~~--~~---~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~  132 (329)
                      +.++||+|+||.||+|.+.  ++   ..||+|..+...   .....++.+|.++|+.++|||||+++|++.....+++||
T Consensus       161 l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~yGVa~~~~Pl~ivm  240 (474)
T KOG0194|consen  161 LGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRFYGVAVLEEPLMLVM  240 (474)
T ss_pred             ccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCccEEEE
Confidence            3467899999999999843  22   238999988532   344667999999999999999999999999999999999


Q ss_pred             ecCCCCCHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCCCCCeeeecccCcccCCCCCC-
Q 020221          133 EYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDGRS-  211 (329)
Q Consensus       133 e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~~-  211 (329)
                      |+|.||+|.++|+. ....++..+...++.+.++||+|||++ +++||||..+|+|++.++.+||+|||+++....... 
T Consensus       241 El~~gGsL~~~L~k-~~~~v~~~ek~~~~~~AA~Gl~YLh~k-~~IHRDIAARNcL~~~~~~vKISDFGLs~~~~~~~~~  318 (474)
T KOG0194|consen  241 ELCNGGSLDDYLKK-NKKSLPTLEKLRFCYDAARGLEYLHSK-NCIHRDIAARNCLYSKKGVVKISDFGLSRAGSQYVMK  318 (474)
T ss_pred             EecCCCcHHHHHHh-CCCCCCHHHHHHHHHHHHhHHHHHHHC-CCcchhHhHHHheecCCCeEEeCccccccCCcceeec
Confidence            99999999999975 333699999999999999999999999 999999999999999999999999999876542221 


Q ss_pred             ---ccCcccccCcccccCCCCCCcccchhhhHHHHHHHh-CCCCCCchhhHHHhhhchhhhccccccCCCChHHHHHHHH
Q 020221          212 ---YSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLS-GKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVR  287 (329)
Q Consensus       212 ---~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t-g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  287 (329)
                         ......|+|||.+....|++++|||||||++||+++ |..|++......+.....    ....+...+...+.++..
T Consensus       319 ~~~~klPirWLAPEtl~~~~~s~kTDV~sfGV~~~Eif~~g~~Py~g~~~~~v~~kI~----~~~~r~~~~~~~p~~~~~  394 (474)
T KOG0194|consen  319 KFLKKLPIRWLAPETLNTGIFSFKTDVWSFGVLLWEIFENGAEPYPGMKNYEVKAKIV----KNGYRMPIPSKTPKELAK  394 (474)
T ss_pred             cccccCcceecChhhhccCccccccchhheeeeEEeeeccCCCCCCCCCHHHHHHHHH----hcCccCCCCCCCHHHHHH
Confidence               124588999999999999999999999999999999 677777655444433331    222333455677889999


Q ss_pred             HHHHhcccCCCCCCCHHHHHHHHHhhhhccc
Q 020221          288 LASRCLQYEPRERPNPRSLVTALVTLQKDTE  318 (329)
Q Consensus       288 li~~cl~~dp~~Rps~~~~l~~L~~~~~~~~  318 (329)
                      ++.+||..||++||+|.++.+.|+.+.+...
T Consensus       395 ~~~~c~~~~p~~R~tm~~i~~~l~~~~~~~~  425 (474)
T KOG0194|consen  395 VMKQCWKKDPEDRPTMSTIKKKLEALEKKKE  425 (474)
T ss_pred             HHHHhccCChhhccCHHHHHHHHHHHHhccc
Confidence            9999999999999999999999999987654

>cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5

Probab=100.00  E-value=7.2e-45  Score=320.02  Aligned_cols=248  Identities=18%  Similarity=0.218  Sum_probs=197.5

Q ss_pred             cccccccCCCCCCcEEEEEEe-CCCCEEEEEEeCCCCC--hhHHHHHHHHHHHhcCCCccccccceeeeeCCeeEEEEec
Q 020221           58 MENIVSEHGEKAPNVVYKGKL-ENQFRIAVKRFNRSAW--PDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAEY  134 (329)
Q Consensus        58 ~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  134 (329)
                      .|++++.||+|+||+||++.. .+++.||+|++.....  ...+.+.+|+++++.++||||+++++++...+..++||||
T Consensus         2 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~   81 (287)
T cd07848           2 KFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEAFRRRGKLYLVFEY   81 (287)
T ss_pred             CceEEEEecccCCEEEEEEEECCCCcEEEEEEEecccccccchhhHHHHHHHHHhCCCccccchhhhEecCCEEEEEEec
Confidence            366778889999999999995 4678999999876432  2345678999999999999999999999999999999999


Q ss_pred             CCCCCHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCCCCCeeeecccCcccCCCC-----
Q 020221          135 MPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDG-----  209 (329)
Q Consensus       135 ~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~-----  209 (329)
                      ++++++..+..  ....+++..+..++.|++.||.|||+. +++|+||||+||+++.++.+||+|||++......     
T Consensus        82 ~~~~~l~~~~~--~~~~~~~~~~~~~~~qi~~~L~~lH~~-~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~  158 (287)
T cd07848          82 VEKNMLELLEE--MPNGVPPEKVRSYIYQLIKAIHWCHKN-DIVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSNANY  158 (287)
T ss_pred             CCCCHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHC-CeecCCCCHHHEEEcCCCcEEEeeccCcccccccccccc
Confidence            99876665443  345689999999999999999999999 9999999999999999999999999998765432     


Q ss_pred             CCccCcccccCcccccCCCCCCcccchhhhHHHHHHHhCCCCCCchhhHHHhhhchh--------------------hhc
Q 020221          210 RSYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQ--------------------TLT  269 (329)
Q Consensus       210 ~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~~~~~~~--------------------~~~  269 (329)
                      ....+++.|+|||++.+..++.++||||||+++|+|++|+.||+.............                    ...
T Consensus       159 ~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (287)
T cd07848         159 TEYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPLPAEQMKLFYSNPRFHGLR  238 (287)
T ss_pred             cccccccccCCcHHHcCCCCCCchhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCHHHHHhhhccchhcccc
Confidence            234578899999999988899999999999999999999988865422111000000                    000


Q ss_pred             ccccc------CCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 020221          270 DSCLE------GQFSSDEGTELVRLASRCLQYEPRERPNPRSLVT  308 (329)
Q Consensus       270 ~~~~~------~~~~~~~~~~~~~li~~cl~~dp~~Rps~~~~l~  308 (329)
                      .+...      .......+.++.+|+.+||+.||++|||++++++
T Consensus       239 ~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l~  283 (287)
T cd07848         239 FPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLN  283 (287)
T ss_pred             cCcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence            00000      0011235678999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes

>KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms]

Probab=100.00  E-value=3.9e-46  Score=332.16  Aligned_cols=246  Identities=21%  Similarity=0.320  Sum_probs=210.2

Q ss_pred             CCcccccccCCCCCCcEEEEEEeCCCCEEEEEEeCCCCChhHHHHHHHHHHHhcCCCccccccceeeeeCCeeEEEEecC
Q 020221           56 FAMENIVSEHGEKAPNVVYKGKLENQFRIAVKRFNRSAWPDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAEYM  135 (329)
Q Consensus        56 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~  135 (329)
                      |+...-++-+|.|+.|-||+|++.+ +.||||+++.-.       ..+|+-|+.|+|+||+.+.|+|.....++||||||
T Consensus       123 Fe~IsELeWlGSGaQGAVF~Grl~n-etVAVKKV~elk-------ETdIKHLRkLkH~NII~FkGVCtqsPcyCIiMEfC  194 (904)
T KOG4721|consen  123 FEEISELEWLGSGAQGAVFLGRLHN-ETVAVKKVRELK-------ETDIKHLRKLKHPNIITFKGVCTQSPCYCIIMEFC  194 (904)
T ss_pred             HHHhhhhhhhccCcccceeeeeccC-ceehhHHHhhhh-------hhhHHHHHhccCcceeeEeeeecCCceeEEeeecc
Confidence            3333345677999999999999854 489999986433       24778899999999999999999888999999999


Q ss_pred             CCCCHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCCCCCeeeecccCcccCCCC---CCc
Q 020221          136 PNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDG---RSY  212 (329)
Q Consensus       136 ~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~---~~~  212 (329)
                      ..|-|..+|+  ..+.++......|..+|+.|+.|||.. .|||||||.-||||.-+..+||+|||.++...+.   ..+
T Consensus       195 a~GqL~~VLk--a~~~itp~llv~Wsk~IA~GM~YLH~h-KIIHRDLKSPNiLIs~~d~VKIsDFGTS~e~~~~STkMSF  271 (904)
T KOG4721|consen  195 AQGQLYEVLK--AGRPITPSLLVDWSKGIAGGMNYLHLH-KIIHRDLKSPNILISYDDVVKISDFGTSKELSDKSTKMSF  271 (904)
T ss_pred             ccccHHHHHh--ccCccCHHHHHHHHHHhhhhhHHHHHh-hHhhhccCCCceEeeccceEEeccccchHhhhhhhhhhhh
Confidence            9999999997  567889999999999999999999998 9999999999999999999999999998866554   356


Q ss_pred             cCcccccCcccccCCCCCCcccchhhhHHHHHHHhCCCCCCchhhHHHhhhchhhhccccccCCCChHHHHHHHHHHHHh
Q 020221          213 STNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLASRC  292 (329)
Q Consensus       213 ~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~c  292 (329)
                      .||+.|||||++...+.++|+|||||||+||||+||..|+-+-...    .++-.+-...+....|..++..|.-|+++|
T Consensus       272 aGTVaWMAPEvIrnePcsEKVDIwSfGVVLWEmLT~EiPYkdVdss----AIIwGVGsNsL~LpvPstcP~GfklL~Kqc  347 (904)
T KOG4721|consen  272 AGTVAWMAPEVIRNEPCSEKVDIWSFGVVLWEMLTGEIPYKDVDSS----AIIWGVGSNSLHLPVPSTCPDGFKLLLKQC  347 (904)
T ss_pred             hhhHhhhCHHHhhcCCcccccceehhHHHHHHHHhcCCCccccchh----eeEEeccCCcccccCcccCchHHHHHHHHH
Confidence            8999999999999999999999999999999999999876432211    222333344556667888899999999999


Q ss_pred             cccCCCCCCCHHHHHHHHHhhhhc
Q 020221          293 LQYEPRERPNPRSLVTALVTLQKD  316 (329)
Q Consensus       293 l~~dp~~Rps~~~~l~~L~~~~~~  316 (329)
                      |+..|-.||++++++.+|+-...+
T Consensus       348 w~sKpRNRPSFrqil~HldIa~pe  371 (904)
T KOG4721|consen  348 WNSKPRNRPSFRQILLHLDIASPE  371 (904)
T ss_pred             HhcCCCCCccHHHHHHHHhhcCHH
Confidence            999999999999999999876543

>cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase

Probab=100.00  E-value=8e-45  Score=320.03  Aligned_cols=250  Identities=18%  Similarity=0.234  Sum_probs=198.4

Q ss_pred             CCcccccccCCCCCCcEEEEEE-eCCCCEEEEEEeCCCCCh-hHHHHHHHHHHHhcCCCccccccceeeeeCCeeEEEEe
Q 020221           56 FAMENIVSEHGEKAPNVVYKGK-LENQFRIAVKRFNRSAWP-DARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAE  133 (329)
Q Consensus        56 ~~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  133 (329)
                      .+.|.+++.||.|+||.||+|. ..++..||+|.+...... ....+.+|+++++.++||||+++++++...+..++|||
T Consensus         4 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e   83 (288)
T cd07871           4 LETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDIIHTERCLTLVFE   83 (288)
T ss_pred             cccceEeeEEecCCCEEEEEEEECCCCCEEEEEEecccccCCcchhHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEEe
Confidence            4567888889999999999998 456889999998754322 23467789999999999999999999998899999999


Q ss_pred             cCCCCCHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCCCCCeeeecccCcccCCCC----
Q 020221          134 YMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDG----  209 (329)
Q Consensus       134 ~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~----  209 (329)
                      |+++ +|.+++.. ....+++..+..++.||+.||+|||++ |++||||||+||+++.++.+||+|||++......    
T Consensus        84 ~~~~-~l~~~l~~-~~~~~~~~~~~~~~~qi~~aL~~LH~~-~ivH~dlkp~Nil~~~~~~~kl~DfG~~~~~~~~~~~~  160 (288)
T cd07871          84 YLDS-DLKQYLDN-CGNLMSMHNVKIFMFQLLRGLSYCHKR-KILHRDLKPQNLLINEKGELKLADFGLARAKSVPTKTY  160 (288)
T ss_pred             CCCc-CHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHhC-CcccCCCCHHHEEECCCCCEEECcCcceeeccCCCccc
Confidence            9975 89988854 334578999999999999999999999 9999999999999999999999999998754322    


Q ss_pred             CCccCcccccCcccccC-CCCCCcccchhhhHHHHHHHhCCCCCCchhhHHHhhhchhh-------hcccc---------
Q 020221          210 RSYSTNLAFTPPEYLRT-GRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQT-------LTDSC---------  272 (329)
Q Consensus       210 ~~~~~~~~y~aPE~~~~-~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~~~~~~~~-------~~~~~---------  272 (329)
                      ....+++.|+|||++.+ ..++.++||||+|+++|+|++|..||...............       .....         
T Consensus       161 ~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (288)
T cd07871         161 SNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHLIFRLLGTPTEETWPGITSNEEFRSY  240 (288)
T ss_pred             cCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhccccchhhhcc
Confidence            23456889999998875 45889999999999999999999888654332211111000       00000         


Q ss_pred             ccC--------CCChHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 020221          273 LEG--------QFSSDEGTELVRLASRCLQYEPRERPNPRSLVT  308 (329)
Q Consensus       273 ~~~--------~~~~~~~~~~~~li~~cl~~dp~~Rps~~~~l~  308 (329)
                      ...        ......+.++.+|+.+||..||.+|||+.++++
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dp~~R~t~~~~l~  284 (288)
T cd07871         241 LFPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAALR  284 (288)
T ss_pred             ccCccCCCchHHhCCCCCHHHHHHHHHhcCcCcccCCCHHHHhc
Confidence            000        001234678899999999999999999999997

Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament

>KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.7e-45  Score=353.22  Aligned_cols=252  Identities=24%  Similarity=0.378  Sum_probs=209.1

Q ss_pred             ccccccCCCCCCcEEEEEEeCC--C----CEEEEEEeCCCC-ChhHHHHHHHHHHHhcCCCccccccceeeeeCCeeEEE
Q 020221           59 ENIVSEHGEKAPNVVYKGKLEN--Q----FRIAVKRFNRSA-WPDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLV  131 (329)
Q Consensus        59 ~~~~~~lg~G~~g~V~~~~~~~--~----~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv  131 (329)
                      -.+.+.||+|+||.||.|...+  +    ..||+|.+.... .+...+|.+|..+|+.++|||||+++|++.+....+|+
T Consensus       694 v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~~~~~~i~  773 (1025)
T KOG1095|consen  694 VTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRLSSEQEVSDFLKEALLMSKFDHPNIVSLIGVCLDSGPPLIL  773 (1025)
T ss_pred             eEeeeeeccccccceEEEEEecCCCCccceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCcceeeEEEeecCCCCcEEE
Confidence            3455678999999999998433  3    349999998764 34566799999999999999999999999999999999


Q ss_pred             EecCCCCCHHhhhccCC-----CCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCCCCCeeeecccCcccC
Q 020221          132 AEYMPNDTLAKHLFHWE-----TQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNS  206 (329)
Q Consensus       132 ~e~~~~gsL~~~l~~~~-----~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~  206 (329)
                      +|||++|+|..+|++.+     ...++..+.+.++.|||+|+.||+++ ++|||||..+|+|+++...+||+|||+|+..
T Consensus       774 leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~-~fvHRDLAaRNCLL~~~r~VKIaDFGlArDi  852 (1025)
T KOG1095|consen  774 LEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESK-HFVHRDLAARNCLLDERRVVKIADFGLARDI  852 (1025)
T ss_pred             ehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhC-CCcCcchhhhheeecccCcEEEcccchhHhh
Confidence            99999999999998631     45678999999999999999999999 9999999999999999999999999999954


Q ss_pred             CCCCC------ccCcccccCcccccCCCCCCcccchhhhHHHHHHHhCCCCCCchhhHHHhhhchhh-hccccccCCCCh
Q 020221          207 RDGRS------YSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQT-LTDSCLEGQFSS  279 (329)
Q Consensus       207 ~~~~~------~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~  279 (329)
                      ....-      ..-...|||||.+.++.|+.++|||||||+|||++|.+.+|+.+...    ..+.. +.... +-..|.
T Consensus       853 y~~~yyr~~~~a~lPvkWm~PEsl~d~iFtskSDvWsFGVllWEifslG~~PY~~~~n----~~v~~~~~~gg-RL~~P~  927 (1025)
T KOG1095|consen  853 YDKDYYRKHGEAMLPVKWMPPESLKDGIFTSKSDVWSFGVLLWEIFSLGATPYPSRSN----FEVLLDVLEGG-RLDPPS  927 (1025)
T ss_pred             hhchheeccCccccceecCCHHHHhhcccccccchhhhHHHHHHHHhCCCCCCCCcch----HHHHHHHHhCC-ccCCCC
Confidence            43321      12247899999999999999999999999999999977655433211    11111 22222 445677


Q ss_pred             HHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhhc
Q 020221          280 DEGTELVRLASRCLQYEPRERPNPRSLVTALVTLQKD  316 (329)
Q Consensus       280 ~~~~~~~~li~~cl~~dp~~Rps~~~~l~~L~~~~~~  316 (329)
                      .++..+.++|.+||+.+|++||++..+++.+..+...
T Consensus       928 ~CP~~ly~lM~~CW~~~pe~RP~F~~i~~q~~~i~~~  964 (1025)
T KOG1095|consen  928 YCPEKLYQLMLQCWKHDPEDRPSFRTIVEQDPAISNA  964 (1025)
T ss_pred             CCChHHHHHHHHHccCChhhCccHHHHHhhhhhhhhh
Confidence            8889999999999999999999999999988888664

>KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.7e-45  Score=313.17  Aligned_cols=244  Identities=20%  Similarity=0.309  Sum_probs=196.8

Q ss_pred             ccccCCCCCCcEEEEEE-eCCCCEEEEEEeCCC--CChhHHHHHHHHHHHhcCCCccccccceeeee-----CCeeEEEE
Q 020221           61 IVSEHGEKAPNVVYKGK-LENQFRIAVKRFNRS--AWPDARQFLEEARAVGQLRNRRLANLLGCCCE-----GDERLLVA  132 (329)
Q Consensus        61 ~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~-----~~~~~lv~  132 (329)
                      .++.+|+|+||.|.++. ..+|+.||+|++...  ....++...+|++.|+.++|+||+.+.+.+..     -..+|+|+
T Consensus        26 ~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~~f~DvYiV~  105 (359)
T KOG0660|consen   26 LIEPIGRGAYGVVCSAKDKRTGEKVAIKKILNPFENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRDKFNDVYLVF  105 (359)
T ss_pred             ccccccCcceeeEEEEEEcCCCCEeehhhhhhhhhchHHHHHHHHHHHHHHHhcCCCcceEEeecccccccccceeEEeh
Confidence            36778999999999998 667899999999843  44457788999999999999999999998855     25689999


Q ss_pred             ecCCCCCHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCCCCCeeeecccCcccCCCC---
Q 020221          133 EYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDG---  209 (329)
Q Consensus       133 e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~---  209 (329)
                      |+|+. +|...++  .++.++...+..+++|+++||+|+|+. +++||||||+|+|++.+..+||+|||+|+.....   
T Consensus       106 elMet-DL~~iik--~~~~L~d~H~q~f~YQiLrgLKyiHSA-nViHRDLKPsNll~n~~c~lKI~DFGLAR~~~~~~~~  181 (359)
T KOG0660|consen  106 ELMET-DLHQIIK--SQQDLTDDHAQYFLYQILRGLKYIHSA-NVIHRDLKPSNLLLNADCDLKICDFGLARYLDKFFED  181 (359)
T ss_pred             hHHhh-HHHHHHH--cCccccHHHHHHHHHHHHHhcchhhcc-cccccccchhheeeccCCCEEeccccceeeccccCcc
Confidence            99955 8999986  445599999999999999999999999 9999999999999999999999999999977431   


Q ss_pred             ---CCccCcccccCcccccC-CCCCCcccchhhhHHHHHHHhCCCCCCchhh-------------------HHHhhhchh
Q 020221          210 ---RSYSTNLAFTPPEYLRT-GRVTPESVMYSFGTLLLDLLSGKHIPPSHAL-------------------DLIRDRNIQ  266 (329)
Q Consensus       210 ---~~~~~~~~y~aPE~~~~-~~~~~~~DvwslG~il~el~tg~~~~~~~~~-------------------~~~~~~~~~  266 (329)
                         ..+..|.+|.|||.+.. ..|+...||||+|||+.||++|++.|++...                   ..+......
T Consensus       182 ~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v~Ql~lI~~~lGtP~~e~l~~i~s~~ar  261 (359)
T KOG0660|consen  182 GFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKDYVHQLQLILELLGTPSEEDLQKIRSEKAR  261 (359)
T ss_pred             cchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCCchHHHHHHHHHhcCCCCHHHHHHhccHHHH
Confidence               34567999999998764 4599999999999999999999998876421                   111100011


Q ss_pred             hhcccc---ccCC---CChHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 020221          267 TLTDSC---LEGQ---FSSDEGTELVRLASRCLQYEPRERPNPRSLVT  308 (329)
Q Consensus       267 ~~~~~~---~~~~---~~~~~~~~~~~li~~cl~~dp~~Rps~~~~l~  308 (329)
                      ..+...   .+..   .-+..++.+.+|+.+||..||.+|+|++++++
T Consensus       262 ~yi~slp~~p~~~f~~~fp~a~p~AidLlekmL~fdP~kRita~eAL~  309 (359)
T KOG0660|consen  262 PYIKSLPQIPKQPFSSIFPNANPLAIDLLEKMLVFDPKKRITAEEALA  309 (359)
T ss_pred             HHHHhCCCCCCCCHHHHcCCCCHHHHHHHHHHhccCccccCCHHHHhc
Confidence            111100   0001   11246789999999999999999999999997

>cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1

Probab=100.00  E-value=2.2e-44  Score=323.48  Aligned_cols=250  Identities=19%  Similarity=0.274  Sum_probs=199.9

Q ss_pred             CcccccccCCCCCCcEEEEEEe-CCCCEEEEEEeCCCCCh-hHHHHHHHHHHHhcCCCccccccceeeeeCCeeEEEEec
Q 020221           57 AMENIVSEHGEKAPNVVYKGKL-ENQFRIAVKRFNRSAWP-DARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAEY  134 (329)
Q Consensus        57 ~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  134 (329)
                      ..|++++.||+|+||.||++.. .++..+|+|.+...... ....+.+|+++++.++|+||+++++++.+.+..++||||
T Consensus         5 ~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~   84 (333)
T cd06650           5 DDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEH   84 (333)
T ss_pred             hhhheeccccCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCcccceeEEEEECCEEEEEEec
Confidence            3467778889999999999994 46888999988765322 345688999999999999999999999999999999999


Q ss_pred             CCCCCHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCCCCCeeeecccCcccCCCC--CCc
Q 020221          135 MPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDG--RSY  212 (329)
Q Consensus       135 ~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~--~~~  212 (329)
                      +++++|.+++.  ....+++..+..++.|++.||.|||+..+++|+||||+||+++.++.+||+|||++......  ...
T Consensus        85 ~~~~~L~~~l~--~~~~~~~~~~~~~~~~l~~~l~~lH~~~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~~~~~~  162 (333)
T cd06650          85 MDGGSLDQVLK--KAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSF  162 (333)
T ss_pred             CCCCcHHHHHH--HcCCCCHHHHHHHHHHHHHHHHHHHhcCCEEecCCChhhEEEcCCCCEEEeeCCcchhhhhhccccC
Confidence            99999999986  34568899999999999999999998547999999999999999999999999998754332  334


Q ss_pred             cCcccccCcccccCCCCCCcccchhhhHHHHHHHhCCCCCCchhhHHHhhhc---hh-----------------------
Q 020221          213 STNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRN---IQ-----------------------  266 (329)
Q Consensus       213 ~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~~~~~---~~-----------------------  266 (329)
                      .++..|+|||++.+..++.++||||||+++|+|++|..||............   ..                       
T Consensus       163 ~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  242 (333)
T cd06650         163 VGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPPPDAKELELMFGCPVEGDPAESETSPRPRPPGRPLSSYG  242 (333)
T ss_pred             CCCccccCHHHhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcchhHHHHHhcCcccCCccccccCcccCCccchhhhhc
Confidence            6789999999999888999999999999999999999887643221111000   00                       


Q ss_pred             ----------hhccccc---cCCC-ChHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 020221          267 ----------TLTDSCL---EGQF-SSDEGTELVRLASRCLQYEPRERPNPRSLVT  308 (329)
Q Consensus       267 ----------~~~~~~~---~~~~-~~~~~~~~~~li~~cl~~dp~~Rps~~~~l~  308 (329)
                                .......   .... ....+.++.+|+.+||+.||++|||+.+++.
T Consensus       243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~P~~Rpt~~ell~  298 (333)
T cd06650         243 PDSRPPMAIFELLDYIVNEPPPKLPSGVFGAEFQDFVNKCLIKNPAERADLKQLMV  298 (333)
T ss_pred             ccccccccHHHHHHHHhcCCCccCCCCCcCHHHHHHHHHhccCCcccCcCHHHHhh
Confidence                      0000000   0001 1124578999999999999999999999986

Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst

>cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10

Probab=100.00  E-value=2.6e-44  Score=313.15  Aligned_cols=249  Identities=19%  Similarity=0.275  Sum_probs=202.6

Q ss_pred             cccccccCCCCCCcEEEEEEeC----CCCEEEEEEeCCCCChh-HHHHHHHHHHHhcCCCccccccceeeeeCCeeEEEE
Q 020221           58 MENIVSEHGEKAPNVVYKGKLE----NQFRIAVKRFNRSAWPD-ARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVA  132 (329)
Q Consensus        58 ~~~~~~~lg~G~~g~V~~~~~~----~~~~vavK~~~~~~~~~-~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~  132 (329)
                      .+++.+.||+|+||.||+|.+.    .+..||+|.++...... ...+.+|+..++.++||||+++++++..++..++||
T Consensus         6 ~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~   85 (266)
T cd05064           6 SIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRLEGVITRGNTMMIVT   85 (266)
T ss_pred             HeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEecCCCcEEEE
Confidence            4567777899999999999742    35689999998754322 346889999999999999999999999999999999


Q ss_pred             ecCCCCCHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCCCCCeeeecccCcccCCCCC--
Q 020221          133 EYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDGR--  210 (329)
Q Consensus       133 e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~--  210 (329)
                      ||+++|+|.+++.. ....+++..++.++.|++.||+|||+. +++||||||+||+++.++.++++|||.+.......  
T Consensus        86 e~~~~~~L~~~l~~-~~~~l~~~~~~~~~~~i~~al~~lH~~-~iiH~dikp~nili~~~~~~~l~dfg~~~~~~~~~~~  163 (266)
T cd05064          86 EYMSNGALDSFLRK-HEGQLVAGQLMGMLPGLASGMKYLSEM-GYVHKGLAAHKVLVNSDLVCKISGFRRLQEDKSEAIY  163 (266)
T ss_pred             EeCCCCcHHHHHHh-CCCCCCHHHHHHHHHHHHHHHHHHHHC-CEeeccccHhhEEEcCCCcEEECCCcccccccccchh
Confidence            99999999999864 335789999999999999999999999 99999999999999999999999999876533221  


Q ss_pred             ---CccCcccccCcccccCCCCCCcccchhhhHHHHHHHh-CCCCCCchhhHHHhhhchhhhccccccCCCChHHHHHHH
Q 020221          211 ---SYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLS-GKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELV  286 (329)
Q Consensus       211 ---~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t-g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  286 (329)
                         ...++..|+|||.+.+..++.++||||||+++||+++ |..||.............     .......+..++..+.
T Consensus       164 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~p~~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~  238 (266)
T cd05064         164 TTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDMSGQDVIKAVE-----DGFRLPAPRNCPNLLH  238 (266)
T ss_pred             cccCCCCceeecCHHHHhhCCccchhHHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHH-----CCCCCCCCCCCCHHHH
Confidence               1234568999999998899999999999999999775 887775433222211111     1112233456678899


Q ss_pred             HHHHHhcccCCCCCCCHHHHHHHHHhh
Q 020221          287 RLASRCLQYEPRERPNPRSLVTALVTL  313 (329)
Q Consensus       287 ~li~~cl~~dp~~Rps~~~~l~~L~~~  313 (329)
                      +++.+||+.+|++||++.++++.|.++
T Consensus       239 ~li~~c~~~~p~~RP~~~~i~~~l~~~  265 (266)
T cd05064         239 QLMLDCWQKERGERPRFSQIHSILSKM  265 (266)
T ss_pred             HHHHHHcCCCchhCCCHHHHHHHHHhh
Confidence            999999999999999999999998764

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor

>cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn

Probab=100.00  E-value=2.7e-44  Score=311.99  Aligned_cols=250  Identities=22%  Similarity=0.323  Sum_probs=207.5

Q ss_pred             CcccccccCCCCCCcEEEEEEeCCCCEEEEEEeCCCCChhHHHHHHHHHHHhcCCCccccccceeeeeCCeeEEEEecCC
Q 020221           57 AMENIVSEHGEKAPNVVYKGKLENQFRIAVKRFNRSAWPDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAEYMP  136 (329)
Q Consensus        57 ~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~  136 (329)
                      +.+++++.||+|+||.||+|...++..||+|.+.... ...+.+.+|+.+++.++|+||+++++.+...+..++++||++
T Consensus         6 ~~~~~~~~lg~g~~g~v~~~~~~~~~~v~iK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~   84 (261)
T cd05072           6 ESIKLVKKLGAGQFGEVWMGYYNNSTKVAVKTLKPGT-MSVQAFLEEANLMKTLQHDKLVRLYAVVTKEEPIYIITEYMA   84 (261)
T ss_pred             HHeEEeeecCCcCCceEEEEEecCCceEEEEEccCCc-hhHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcEEEEecCC
Confidence            4577888999999999999998778889999987644 235678999999999999999999999999999999999999


Q ss_pred             CCCHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCCCCCeeeecccCcccCCCCC-----C
Q 020221          137 NDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDGR-----S  211 (329)
Q Consensus       137 ~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~-----~  211 (329)
                      +++|.+++.......+++..+..++.|++.||+|||+. +++|+||||+||+++.++.++|+|||++.......     .
T Consensus        85 ~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~LH~~-~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~~~~~~  163 (261)
T cd05072          85 KGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERK-NYIHRDLRAANVLVSESLMCKIADFGLARVIEDNEYTAREG  163 (261)
T ss_pred             CCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC-CeeccccchhhEEecCCCcEEECCCccceecCCCceeccCC
Confidence            99999998754556789999999999999999999999 99999999999999999999999999997654432     1


Q ss_pred             ccCcccccCcccccCCCCCCcccchhhhHHHHHHHh-CCCCCCchhhHHHhhhchhhhccccccCCCChHHHHHHHHHHH
Q 020221          212 YSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLS-GKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLAS  290 (329)
Q Consensus       212 ~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t-g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~  290 (329)
                      ..++..|+|||.+.+..++.++||||||+++|+|++ |..|+...............     .........+.++.+++.
T Consensus       164 ~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~li~  238 (261)
T cd05072         164 AKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMSNSDVMSALQRG-----YRMPRMENCPDELYDIMK  238 (261)
T ss_pred             CccceecCCHHHhccCCCChhhhhhhhHHHHHHHHccCCCCCCCCCHHHHHHHHHcC-----CCCCCCCCCCHHHHHHHH
Confidence            234567999999988889999999999999999998 88777654322222211111     111222345678999999


Q ss_pred             HhcccCCCCCCCHHHHHHHHHhh
Q 020221          291 RCLQYEPRERPNPRSLVTALVTL  313 (329)
Q Consensus       291 ~cl~~dp~~Rps~~~~l~~L~~~  313 (329)
                      +||..+|++||++.++.+.|+++
T Consensus       239 ~~l~~~p~~Rp~~~~i~~~l~~~  261 (261)
T cd05072         239 TCWKEKAEERPTFDYLQSVLDDF  261 (261)
T ss_pred             HHccCCcccCcCHHHHHHHHhcC
Confidence            99999999999999999999864

Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa

>PLN00034 mitogen-activated protein kinase kinase; Provisional

Probab=100.00  E-value=9.8e-45  Score=328.45  Aligned_cols=245  Identities=17%  Similarity=0.182  Sum_probs=195.7

Q ss_pred             CCCcccccccCCCCCCcEEEEEE-eCCCCEEEEEEeCCCCCh-hHHHHHHHHHHHhcCCCccccccceeeeeCCeeEEEE
Q 020221           55 GFAMENIVSEHGEKAPNVVYKGK-LENQFRIAVKRFNRSAWP-DARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVA  132 (329)
Q Consensus        55 ~~~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~  132 (329)
                      .+..++.++.||+|+||.||++. ..+++.||+|++...... ....+.+|+++++.++|+||+++++++...+..++||
T Consensus        72 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~  151 (353)
T PLN00034         72 SLSELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQVLL  151 (353)
T ss_pred             CHHHHhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCCcHHHHHHHHHHHHHHHhCCCCCcceeeeEeccCCeEEEEE
Confidence            45566778889999999999998 457889999999755432 2456889999999999999999999999999999999


Q ss_pred             ecCCCCCHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCCCCCeeeecccCcccCCCC---
Q 020221          133 EYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDG---  209 (329)
Q Consensus       133 e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~---  209 (329)
                      ||+++++|....      ...+..+..++.||+.||.|||+. +++||||||+|||+++++.+||+|||++......   
T Consensus       152 e~~~~~~L~~~~------~~~~~~~~~i~~qi~~aL~~LH~~-~ivHrDlkp~NIll~~~~~~kL~DfG~~~~~~~~~~~  224 (353)
T PLN00034        152 EFMDGGSLEGTH------IADEQFLADVARQILSGIAYLHRR-HIVHRDIKPSNLLINSAKNVKIADFGVSRILAQTMDP  224 (353)
T ss_pred             ecCCCCcccccc------cCCHHHHHHHHHHHHHHHHHHHHC-CEeecCCCHHHEEEcCCCCEEEcccccceeccccccc
Confidence            999999986532      346778889999999999999999 9999999999999999999999999998765432   


Q ss_pred             -CCccCcccccCcccccC-----CCCCCcccchhhhHHHHHHHhCCCCCCchhhHHHhhhchhhhccccccCCCChHHHH
Q 020221          210 -RSYSTNLAFTPPEYLRT-----GRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGT  283 (329)
Q Consensus       210 -~~~~~~~~y~aPE~~~~-----~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  283 (329)
                       ....|+..|+|||++..     ...+.++|||||||++|||++|+.||........... ..... .......+...+.
T Consensus       225 ~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~-~~~~~-~~~~~~~~~~~~~  302 (353)
T PLN00034        225 CNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQGDWASL-MCAIC-MSQPPEAPATASR  302 (353)
T ss_pred             ccccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccHHHH-HHHHh-ccCCCCCCCccCH
Confidence             23468899999998753     2245689999999999999999988863221111100 00000 0111223445678


Q ss_pred             HHHHHHHHhcccCCCCCCCHHHHHH
Q 020221          284 ELVRLASRCLQYEPRERPNPRSLVT  308 (329)
Q Consensus       284 ~~~~li~~cl~~dp~~Rps~~~~l~  308 (329)
                      ++.+|+.+||+.||++|||+.++++
T Consensus       303 ~l~~li~~~l~~~P~~Rpt~~ell~  327 (353)
T PLN00034        303 EFRHFISCCLQREPAKRWSAMQLLQ  327 (353)
T ss_pred             HHHHHHHHHccCChhhCcCHHHHhc
Confidence            8999999999999999999999998

>cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase

Probab=100.00  E-value=2.1e-44  Score=322.44  Aligned_cols=237  Identities=19%  Similarity=0.238  Sum_probs=195.8

Q ss_pred             ccCCCCCCcEEEEEEe----CCCCEEEEEEeCCCC----ChhHHHHHHHHHHHhcCCCccccccceeeeeCCeeEEEEec
Q 020221           63 SEHGEKAPNVVYKGKL----ENQFRIAVKRFNRSA----WPDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAEY  134 (329)
Q Consensus        63 ~~lg~G~~g~V~~~~~----~~~~~vavK~~~~~~----~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  134 (329)
                      +.||+|+||.||++..    .+++.||+|.+....    ......+.+|+.+++.++||||+++++++...+..++||||
T Consensus         2 ~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~e~   81 (323)
T cd05584           2 KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGGKLYLILEY   81 (323)
T ss_pred             ceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecCCeEEEEEeC
Confidence            4679999999999974    357889999987532    12234567899999999999999999999999999999999


Q ss_pred             CCCCCHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCCCCCeeeecccCcccCCCC----C
Q 020221          135 MPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDG----R  210 (329)
Q Consensus       135 ~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~----~  210 (329)
                      +++++|.+++.  ....+++..+..++.|++.||.|||++ +++||||||+||+++.++.+||+|||++......    .
T Consensus        82 ~~~~~L~~~~~--~~~~~~~~~~~~~~~qi~~~l~~lH~~-~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~  158 (323)
T cd05584          82 LSGGELFMHLE--REGIFMEDTACFYLSEISLALEHLHQQ-GIIYRDLKPENILLDAQGHVKLTDFGLCKESIHEGTVTH  158 (323)
T ss_pred             CCCchHHHHHH--HcCCCCHHHHHHHHHHHHHHHHHHHHC-CeecCCCCHHHeEECCCCCEEEeeCcCCeecccCCCccc
Confidence            99999999886  345678889999999999999999999 9999999999999999999999999998643222    2


Q ss_pred             CccCcccccCcccccCCCCCCcccchhhhHHHHHHHhCCCCCCchhhHHHhhhchhhhccccccCCCChHHHHHHHHHHH
Q 020221          211 SYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLAS  290 (329)
Q Consensus       211 ~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~  290 (329)
                      ...|++.|+|||++.+..++.++||||||+++|||++|..||............    ...  ....+...++++.+++.
T Consensus       159 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~pf~~~~~~~~~~~~----~~~--~~~~~~~~~~~~~~li~  232 (323)
T cd05584         159 TFCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAENRKKTIDKI----LKG--KLNLPPYLTPEARDLLK  232 (323)
T ss_pred             ccCCCccccChhhccCCCCCCcceecccHHHHHHHhcCCCCCCCCCHHHHHHHH----HcC--CCCCCCCCCHHHHHHHH
Confidence            345789999999999888999999999999999999999888654332222111    111  11234556788999999


Q ss_pred             HhcccCCCCCC-----CHHHHHH
Q 020221          291 RCLQYEPRERP-----NPRSLVT  308 (329)
Q Consensus       291 ~cl~~dp~~Rp-----s~~~~l~  308 (329)
                      +||+.||++||     ++.++++
T Consensus       233 ~~l~~~p~~R~~~~~~~~~~l~~  255 (323)
T cd05584         233 KLLKRNPSSRLGAGPGDAAEVQS  255 (323)
T ss_pred             HHcccCHhHcCCCCCCCHHHHhc
Confidence            99999999999     7888876

Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in

>cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=7.4e-45  Score=330.70  Aligned_cols=245  Identities=16%  Similarity=0.131  Sum_probs=198.1

Q ss_pred             cccccccCCCCCCcEEEEEE-eCCCCEEEEEEeCCCC---ChhHHHHHHHHHHHhcCCCccccccceeeeeCCeeEEEEe
Q 020221           58 MENIVSEHGEKAPNVVYKGK-LENQFRIAVKRFNRSA---WPDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAE  133 (329)
Q Consensus        58 ~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  133 (329)
                      .|++++.||+|+||+||++. ..+++.||||++....   ......+.+|+++++.++||||+++++++.+++..++|||
T Consensus         2 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~E   81 (364)
T cd05599           2 DFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQDENYLYLIME   81 (364)
T ss_pred             CceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCeEEEEEC
Confidence            45677788999999999999 4568899999997532   1234457889999999999999999999999999999999


Q ss_pred             cCCCCCHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCCCCCeeeecccCcccCCCCC---
Q 020221          134 YMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDGR---  210 (329)
Q Consensus       134 ~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~---  210 (329)
                      |+++|+|.+++.  ....+++..+..++.|++.||+|||+. +++||||||+|||++.++.++|+|||++.......   
T Consensus        82 ~~~~g~L~~~l~--~~~~l~~~~~~~~~~qi~~aL~~lH~~-~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~  158 (364)
T cd05599          82 YLPGGDMMTLLM--KKDTFTEEETRFYIAETILAIDSIHKL-GYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHRTE  158 (364)
T ss_pred             CCCCcHHHHHHH--HcCCCCHHHHHHHHHHHHHHHHHHHHC-CeEeccCCHHHeEECCCCCEEEeecccceecccccccc
Confidence            999999999986  345689999999999999999999999 99999999999999999999999999986432110   


Q ss_pred             ---------------------------------------CccCcccccCcccccCCCCCCcccchhhhHHHHHHHhCCCC
Q 020221          211 ---------------------------------------SYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHI  251 (329)
Q Consensus       211 ---------------------------------------~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~~  251 (329)
                                                             ...||+.|+|||++.+..++.++|||||||++|||++|..|
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~G~~P  238 (364)
T cd05599         159 FYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEMLVGYPP  238 (364)
T ss_pred             ccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCCCCCeeeeecchhHHHHhhcCCCC
Confidence                                                   13588999999999988899999999999999999999988


Q ss_pred             CCchhhHHHhhhchhhhccccccCCCChHHHHHHHHHHHHhcccCCCCCCC---HHHHHH
Q 020221          252 PPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLASRCLQYEPRERPN---PRSLVT  308 (329)
Q Consensus       252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps---~~~~l~  308 (329)
                      |...............  ............++++.+++.+|+. +|.+|++   +.++++
T Consensus       239 f~~~~~~~~~~~i~~~--~~~~~~~~~~~~s~~~~~li~~ll~-~p~~R~~~~~~~~ll~  295 (364)
T cd05599         239 FCSDNPQETYRKIINW--KETLQFPDEVPLSPEAKDLIKRLCC-EAERRLGNNGVNEIKS  295 (364)
T ss_pred             CCCCCHHHHHHHHHcC--CCccCCCCCCCCCHHHHHHHHHHcc-CHhhcCCCCCHHHHhc
Confidence            8654332221111110  0001111112357789999999996 9999998   888887

Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica

>cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=8.7e-45  Score=328.47  Aligned_cols=246  Identities=20%  Similarity=0.204  Sum_probs=202.3

Q ss_pred             cccccccCCCCCCcEEEEEEe-CCCCEEEEEEeCCCC---ChhHHHHHHHHHHHhcCCCccccccceeeeeCCeeEEEEe
Q 020221           58 MENIVSEHGEKAPNVVYKGKL-ENQFRIAVKRFNRSA---WPDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAE  133 (329)
Q Consensus        58 ~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  133 (329)
                      .|.+++.||+|+||+||++.. .+++.||+|++....   ......+.+|++++..++|+||+++++++.+.+..++|||
T Consensus         2 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e   81 (350)
T cd05573           2 DFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQDEEHLYLVME   81 (350)
T ss_pred             CceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhheecCCeEEEEEc
Confidence            466778889999999999994 478899999987542   1234568889999999999999999999999999999999


Q ss_pred             cCCCCCHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCCCCCeeeecccCcccCCCCC---
Q 020221          134 YMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDGR---  210 (329)
Q Consensus       134 ~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~---  210 (329)
                      |+++++|.+++.+  ...+++..+..++.|++.||.|||+. |++||||||+||+++.++.++|+|||++.......   
T Consensus        82 ~~~~~~L~~~l~~--~~~l~~~~~~~i~~qi~~aL~~LH~~-giiH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~  158 (350)
T cd05573          82 YMPGGDLMNLLIR--KDVFPEETARFYIAELVLALDSVHKL-GFIHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDRE  158 (350)
T ss_pred             CCCCCCHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHC-CeeccCCCHHHeEECCCCCEEeecCCCCccCcccCccc
Confidence            9999999999964  36789999999999999999999999 99999999999999999999999999987654332   


Q ss_pred             ------------------------------CccCcccccCcccccCCCCCCcccchhhhHHHHHHHhCCCCCCchhhHHH
Q 020221          211 ------------------------------SYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLI  260 (329)
Q Consensus       211 ------------------------------~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~  260 (329)
                                                    ...||+.|+|||++.+..++.++|||||||++|||++|..||........
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~~~  238 (350)
T cd05573         159 YYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPPFYSDTLQET  238 (350)
T ss_pred             ccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCceeeEecchhhhhhccCCCCCCCCCHHHH
Confidence                                          33578999999999999999999999999999999999998865543222


Q ss_pred             hhhchhhhccccccCCCChHHHHHHHHHHHHhcccCCCCCCC-HHHHHHH
Q 020221          261 RDRNIQTLTDSCLEGQFSSDEGTELVRLASRCLQYEPRERPN-PRSLVTA  309 (329)
Q Consensus       261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps-~~~~l~~  309 (329)
                      ...... .. ...........++++.+++..||. ||++||+ +.+++++
T Consensus       239 ~~~i~~-~~-~~~~~p~~~~~~~~~~~li~~ll~-dp~~R~~s~~~ll~h  285 (350)
T cd05573         239 YNKIIN-WK-ESLRFPPDPPVSPEAIDLICRLLC-DPEDRLGSFEEIKSH  285 (350)
T ss_pred             HHHHhc-cC-CcccCCCCCCCCHHHHHHHHHHcc-ChhhcCCCHHHHhcC
Confidence            211111 00 111111112257889999999997 9999999 9999973

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the

>cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1

Probab=100.00  E-value=3.8e-44  Score=318.14  Aligned_cols=253  Identities=21%  Similarity=0.290  Sum_probs=197.4

Q ss_pred             cccccccCCCCCCcEEEEEEeCC-----------------CCEEEEEEeCCCCCh-hHHHHHHHHHHHhcCCCccccccc
Q 020221           58 MENIVSEHGEKAPNVVYKGKLEN-----------------QFRIAVKRFNRSAWP-DARQFLEEARAVGQLRNRRLANLL  119 (329)
Q Consensus        58 ~~~~~~~lg~G~~g~V~~~~~~~-----------------~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~~~  119 (329)
                      .+.+.+.||+|+||.||++.+.+                 +..||+|.+...... ....+.+|++++..++||||++++
T Consensus         6 ~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~   85 (304)
T cd05096           6 HLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVKILSRLKDPNIIRLL   85 (304)
T ss_pred             hCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCCCHHHHHHHHHHHHHHhhcCCCCeeEEE
Confidence            46677788999999999997432                 346999999865433 345688999999999999999999


Q ss_pred             eeeeeCCeeEEEEecCCCCCHHhhhccCC-----------------CCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccc
Q 020221          120 GCCCEGDERLLVAEYMPNDTLAKHLFHWE-----------------TQPMKWAMRLRVALHIAEALEYCTSKERALYHDL  182 (329)
Q Consensus       120 ~~~~~~~~~~lv~e~~~~gsL~~~l~~~~-----------------~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dl  182 (329)
                      +++.+.+..+++|||+.+|+|.+++....                 ...+++..+..++.||+.||.|||+. +++||||
T Consensus        86 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~-~ivH~dl  164 (304)
T cd05096          86 GVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSL-NFVHRDL  164 (304)
T ss_pred             EEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHC-CccccCc
Confidence            99999899999999999999999885321                 12467889999999999999999999 9999999


Q ss_pred             CCCceeeCCCCCeeeecccCcccCCCCC------CccCcccccCcccccCCCCCCcccchhhhHHHHHHHhCC--CCCCc
Q 020221          183 NAYRIVFDDDVNPRLSCFGLMKNSRDGR------SYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGK--HIPPS  254 (329)
Q Consensus       183 kp~Nil~~~~~~~kl~Dfg~a~~~~~~~------~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~--~~~~~  254 (329)
                      ||+|||++.++.+||+|||++.......      ...++..|+|||++.++.++.++||||||+++|+|+++.  .|+..
T Consensus       165 kp~Nill~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p~~~  244 (304)
T cd05096         165 ATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILMLCKEQPYGE  244 (304)
T ss_pred             chhheEEcCCccEEECCCccceecccCceeEecCcCCCCccccCHHHHhcCCCCchhhhHHHHHHHHHHHHccCCCCCCc
Confidence            9999999999999999999987654332      223467899999998888999999999999999999754  34432


Q ss_pred             hhhHHHhhhchhhhcc--ccccCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 020221          255 HALDLIRDRNIQTLTD--SCLEGQFSSDEGTELVRLASRCLQYEPRERPNPRSLVTALV  311 (329)
Q Consensus       255 ~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~~~l~~L~  311 (329)
                      ................  .......+..++..+.+++.+||+.||++|||+.++.+.|+
T Consensus       245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~~i~~~l~  303 (304)
T cd05096         245 LTDEQVIENAGEFFRDQGRQVYLFRPPPCPQGLYELMLQCWSRDCRERPSFSDIHAFLT  303 (304)
T ss_pred             CCHHHHHHHHHHHhhhccccccccCCCCCCHHHHHHHHHHccCCchhCcCHHHHHHHHh
Confidence            2221111111100000  00111123456788999999999999999999999998876

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k

>cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2

Probab=100.00  E-value=1.6e-44  Score=330.25  Aligned_cols=246  Identities=17%  Similarity=0.174  Sum_probs=196.9

Q ss_pred             cccccccCCCCCCcEEEEEE-eCCCCEEEEEEeCCCCC---hhHHHHHHHHHHHhcCCCccccccceeeeeCCeeEEEEe
Q 020221           58 MENIVSEHGEKAPNVVYKGK-LENQFRIAVKRFNRSAW---PDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAE  133 (329)
Q Consensus        58 ~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  133 (329)
                      .+++++.||+|+||+||+|. ..+++.||+|++.....   .....+.+|+++++.++|+||+++++++.+.+..++|||
T Consensus         2 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lv~E   81 (381)
T cd05626           2 MFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMD   81 (381)
T ss_pred             CceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecCCEEEEEEe
Confidence            46678888999999999998 56788999999976432   234568899999999999999999999999999999999


Q ss_pred             cCCCCCHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCCCCCeeeecccCcccCCC-----
Q 020221          134 YMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRD-----  208 (329)
Q Consensus       134 ~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~-----  208 (329)
                      |+++|+|.+++.  ....+++..+..++.||+.||.|||+. ||+||||||+|||++.++.++|+|||++.....     
T Consensus        82 ~~~gg~L~~~l~--~~~~~~e~~~~~~~~qi~~aL~~LH~~-givHrDlKp~Nili~~~~~~kL~DFGl~~~~~~~~~~~  158 (381)
T cd05626          82 YIPGGDMMSLLI--RMEVFPEVLARFYIAELTLAIESVHKM-GFIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHNSK  158 (381)
T ss_pred             cCCCCcHHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHhC-CeeecCCcHHHEEECCCCCEEEeeCcCCcccccccccc
Confidence            999999999986  345689999999999999999999999 999999999999999999999999998753210     


Q ss_pred             ----------------------------------------------CCCccCcccccCcccccCCCCCCcccchhhhHHH
Q 020221          209 ----------------------------------------------GRSYSTNLAFTPPEYLRTGRVTPESVMYSFGTLL  242 (329)
Q Consensus       209 ----------------------------------------------~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il  242 (329)
                                                                    .....||+.|+|||++.+..++.++|||||||++
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlG~il  238 (381)
T cd05626         159 YYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSVGVIL  238 (381)
T ss_pred             cccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCCCCCCccceeehhhHH
Confidence                                                          0123588999999999988899999999999999


Q ss_pred             HHHHhCCCCCCchhhHHHhhhchhhhccccccCCCChHHHHHHHHHHHH--hcccCCCCCCCHHHHHH
Q 020221          243 LDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLASR--CLQYEPRERPNPRSLVT  308 (329)
Q Consensus       243 ~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~--cl~~dp~~Rps~~~~l~  308 (329)
                      |||++|..||..............  .............++++.+++.+  |+..+|..||++.++++
T Consensus       239 ~elltG~~Pf~~~~~~~~~~~i~~--~~~~~~~~~~~~~s~~~~dli~~ll~~~~~~~~R~~~~~~l~  304 (381)
T cd05626         239 FEMLVGQPPFLAPTPTETQLKVIN--WENTLHIPPQVKLSPEAVDLITKLCCSAEERLGRNGADDIKA  304 (381)
T ss_pred             HHHHhCCCCCcCCCHHHHHHHHHc--cccccCCCCCCCCCHHHHHHHHHHccCcccccCCCCHHHHhc
Confidence            999999998865432222111110  01111111122457889999988  44556667999999997

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po

>cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase

Probab=100.00  E-value=2.5e-44  Score=319.21  Aligned_cols=249  Identities=18%  Similarity=0.190  Sum_probs=193.9

Q ss_pred             CcccccccCCCCCCcEEEEEEe-CCCCEEEEEEeCCCCCh-hHHHHHHHHHHHhcCCCccccccceeeeeCCeeEEEEec
Q 020221           57 AMENIVSEHGEKAPNVVYKGKL-ENQFRIAVKRFNRSAWP-DARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAEY  134 (329)
Q Consensus        57 ~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  134 (329)
                      +.|++++.||+|+||.||+|.. .+++.||+|++...... ....+.+|+.+++.++||||+++++++.+....++||||
T Consensus         5 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~   84 (303)
T cd07869           5 DSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIVLLHDIIHTKETLTLVFEY   84 (303)
T ss_pred             ccceEeeeEEecCCEEEEEEEECCCCCEEEEEEeccccccccchhHHHHHHHHhhCCCCCcCeEEEEEecCCeEEEEEEC
Confidence            4577888889999999999994 47889999998754322 234577899999999999999999999999999999999


Q ss_pred             CCCCCHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCCCCCeeeecccCcccCCCC----C
Q 020221          135 MPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDG----R  210 (329)
Q Consensus       135 ~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~----~  210 (329)
                      +. ++|.+++.. ....+++..+..++.|++.||+|||+. +++||||||+||+++.++.+||+|||++......    .
T Consensus        85 ~~-~~l~~~~~~-~~~~~~~~~~~~~~~qi~~al~~lH~~-~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~  161 (303)
T cd07869          85 VH-TDLCQYMDK-HPGGLHPENVKLFLFQLLRGLSYIHQR-YILHRDLKPQNLLISDTGELKLADFGLARAKSVPSHTYS  161 (303)
T ss_pred             CC-cCHHHHHHh-CCCCCCHHHHHHHHHHHHHHHHHHHHC-CeecCCCCHHHEEECCCCCEEECCCCcceeccCCCccCC
Confidence            96 578887754 345688999999999999999999999 9999999999999999999999999998653322    2


Q ss_pred             CccCcccccCcccccCC-CCCCcccchhhhHHHHHHHhCCCCCCchhhH-HHhhhchh-------h----------hccc
Q 020221          211 SYSTNLAFTPPEYLRTG-RVTPESVMYSFGTLLLDLLSGKHIPPSHALD-LIRDRNIQ-------T----------LTDS  271 (329)
Q Consensus       211 ~~~~~~~y~aPE~~~~~-~~~~~~DvwslG~il~el~tg~~~~~~~~~~-~~~~~~~~-------~----------~~~~  271 (329)
                      ...+++.|+|||++.+. .++.++||||||+++|+|++|..||...... ........       .          ....
T Consensus       162 ~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  241 (303)
T cd07869         162 NEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQDQLERIFLVLGTPNEDTWPGVHSLPHFKPE  241 (303)
T ss_pred             CCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhCCCChhhccchhhccccccc
Confidence            34568899999998754 4888999999999999999999988642110 00000000       0          0000


Q ss_pred             cccCCCC---------hHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 020221          272 CLEGQFS---------SDEGTELVRLASRCLQYEPRERPNPRSLVT  308 (329)
Q Consensus       272 ~~~~~~~---------~~~~~~~~~li~~cl~~dp~~Rps~~~~l~  308 (329)
                      ......+         ...+.++.+++.+||+.||++|||+.++++
T Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s~~~~l~  287 (303)
T cd07869         242 RFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALS  287 (303)
T ss_pred             cccccCCccHHHHhhccCCChHHHHHHHHHhccCchhccCHHHHhc
Confidence            0000000         012467889999999999999999999997

Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an

>cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha

Probab=100.00  E-value=7.7e-45  Score=325.56  Aligned_cols=237  Identities=19%  Similarity=0.245  Sum_probs=196.8

Q ss_pred             cCCCCCCcEEEEEE-eCCCCEEEEEEeCCCC---ChhHHHHHHHHHHHhcCCCccccccceeeeeCCeeEEEEecCCCCC
Q 020221           64 EHGEKAPNVVYKGK-LENQFRIAVKRFNRSA---WPDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAEYMPNDT  139 (329)
Q Consensus        64 ~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gs  139 (329)
                      .||+|+||.||++. ..+++.||+|++....   ......+.+|+++++.++||||+++.+++...+..++||||+++|+
T Consensus         2 ~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~~   81 (325)
T cd05594           2 LLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGGE   81 (325)
T ss_pred             eeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCCEEEEEEeCCCCCc
Confidence            46999999999998 5678899999987542   2234457789999999999999999999999999999999999999


Q ss_pred             HHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhc-CCCccccccCCCceeeCCCCCeeeecccCcccCCCC----CCccC
Q 020221          140 LAKHLFHWETQPMKWAMRLRVALHIAEALEYCTS-KERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDG----RSYST  214 (329)
Q Consensus       140 L~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~-~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~----~~~~~  214 (329)
                      |..++.  ....+++..+..++.||+.||.|||+ . |++||||||+|||++.++.+||+|||++......    ....|
T Consensus        82 L~~~l~--~~~~l~~~~~~~~~~qi~~aL~~lH~~~-~ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~g  158 (325)
T cd05594          82 LFFHLS--RERVFSEDRARFYGAEIVSALDYLHSEK-NVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKTFCG  158 (325)
T ss_pred             HHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHhcC-CEEecCCCCCeEEECCCCCEEEecCCCCeecCCCCcccccccC
Confidence            998886  34578999999999999999999997 6 9999999999999999999999999998753221    23468


Q ss_pred             cccccCcccccCCCCCCcccchhhhHHHHHHHhCCCCCCchhhHHHhhhchhhhccccccCCCChHHHHHHHHHHHHhcc
Q 020221          215 NLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLASRCLQ  294 (329)
Q Consensus       215 ~~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~  294 (329)
                      ++.|+|||++.+..++.++||||||+++|+|++|..||...............      ...++...++++.+++.+||+
T Consensus       159 t~~y~aPE~~~~~~~~~~~DiwslG~il~el~tG~~Pf~~~~~~~~~~~i~~~------~~~~p~~~~~~~~~li~~~L~  232 (325)
T cd05594         159 TPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILME------EIRFPRTLSPEAKSLLSGLLK  232 (325)
T ss_pred             CcccCCHHHHccCCCCCccccccccceeeeeccCCCCCCCCCHHHHHHHHhcC------CCCCCCCCCHHHHHHHHHHhh
Confidence            89999999999888999999999999999999999988654433222211111      112345567889999999999


Q ss_pred             cCCCCCC-----CHHHHHHH
Q 020221          295 YEPRERP-----NPRSLVTA  309 (329)
Q Consensus       295 ~dp~~Rp-----s~~~~l~~  309 (329)
                      .||++|+     ++.+++++
T Consensus       233 ~dP~~R~~~~~~~~~~il~h  252 (325)
T cd05594         233 KDPKQRLGGGPDDAKEIMQH  252 (325)
T ss_pred             cCHHHhCCCCCCCHHHHhcC
Confidence            9999997     89998863

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien

>cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk

Probab=100.00  E-value=3.5e-44  Score=311.23  Aligned_cols=249  Identities=22%  Similarity=0.373  Sum_probs=209.5

Q ss_pred             ccccccCCCCCCcEEEEEEeCCCCEEEEEEeCCCCChhHHHHHHHHHHHhcCCCccccccceeeeeCCeeEEEEecCCCC
Q 020221           59 ENIVSEHGEKAPNVVYKGKLENQFRIAVKRFNRSAWPDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAEYMPND  138 (329)
Q Consensus        59 ~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g  138 (329)
                      |.+++.||.|+||.||+|...++..+++|.+..........+.+|+.+++.++|+||+++++++......+++|||++++
T Consensus         8 y~~~~~ig~g~~~~vy~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~   87 (261)
T cd05148           8 FTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISLFAVCSVGEPVYIITELMEKG   87 (261)
T ss_pred             HHHhhhhccCCCccEEEeEecCCCcEEEEeccccchhhHHHHHHHHHHHhcCCCcchhheeeeEecCCCeEEEEeecccC
Confidence            56677889999999999997778899999998776555678899999999999999999999999999999999999999


Q ss_pred             CHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCCCCCeeeecccCcccCCCCC----CccC
Q 020221          139 TLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDGR----SYST  214 (329)
Q Consensus       139 sL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~----~~~~  214 (329)
                      +|.+++.+.....+++..+..++.|++.||.|||+. +++|+||||+||++++++.++|+|||.+.......    ...+
T Consensus        88 ~L~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~-~i~h~dl~~~nilv~~~~~~kl~d~g~~~~~~~~~~~~~~~~~  166 (261)
T cd05148          88 SLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLEEQ-NSIHRDLAARNILVGEDLVCKVADFGLARLIKEDVYLSSDKKI  166 (261)
T ss_pred             CHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHC-CeeccccCcceEEEcCCceEEEccccchhhcCCccccccCCCC
Confidence            999999765556789999999999999999999999 99999999999999999999999999987654332    2234


Q ss_pred             cccccCcccccCCCCCCcccchhhhHHHHHHHh-CCCCCCchhhHHHhhhchhhhccccccCCCChHHHHHHHHHHHHhc
Q 020221          215 NLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLS-GKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLASRCL  293 (329)
Q Consensus       215 ~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t-g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl  293 (329)
                      +..|+|||.+.+..++.++||||||+++|+|++ |..|+.............     ...+...+...++++.+++.+||
T Consensus       167 ~~~~~~PE~~~~~~~~~~~DiwslG~~l~~l~~~g~~p~~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~i~~~l  241 (261)
T cd05148         167 PYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMNNHEVYDQIT-----AGYRMPCPAKCPQEIYKIMLECW  241 (261)
T ss_pred             ceEecCHHHHccCCCCchhhHHHHHHHHHHHHcCCCCCCCcCCHHHHHHHHH-----hCCcCCCCCCCCHHHHHHHHHHc
Confidence            578999999988889999999999999999998 677665433222211111     11222334566788999999999


Q ss_pred             ccCCCCCCCHHHHHHHHHhh
Q 020221          294 QYEPRERPNPRSLVTALVTL  313 (329)
Q Consensus       294 ~~dp~~Rps~~~~l~~L~~~  313 (329)
                      +.||++|||+.++++.|+.+
T Consensus       242 ~~~p~~Rpt~~~l~~~L~~~  261 (261)
T cd05148         242 AAEPEDRPSFKALREELDNI  261 (261)
T ss_pred             CCCchhCcCHHHHHHHHhcC
Confidence            99999999999999999864

Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom

>cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase

Probab=100.00  E-value=5.8e-44  Score=310.37  Aligned_cols=249  Identities=22%  Similarity=0.344  Sum_probs=206.7

Q ss_pred             cccccccCCCCCCcEEEEEE-eCCCCEEEEEEeCCCCChhHHHHHHHHHHHhcCCCccccccceeeeeCCeeEEEEecCC
Q 020221           58 MENIVSEHGEKAPNVVYKGK-LENQFRIAVKRFNRSAWPDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAEYMP  136 (329)
Q Consensus        58 ~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~  136 (329)
                      .+.+.+.||+|+||.||+|. .++++.||+|.+.... .....+.+|++.++.++|+||+++++++......+++|||++
T Consensus         7 ~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~   85 (263)
T cd05052           7 DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMT   85 (263)
T ss_pred             HeEEeeecCCcccceEEEEEEecCCceEEEEEecCCc-hHHHHHHHHHHHHHhCCCCChhheEEEEcCCCCcEEEEEeCC
Confidence            35566778999999999999 4558889999987654 335678899999999999999999999999999999999999


Q ss_pred             CCCHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCCCCCeeeecccCcccCCCCCC-----
Q 020221          137 NDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDGRS-----  211 (329)
Q Consensus       137 ~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~~-----  211 (329)
                      +++|.+++.......+++..+..++.|++.||+|||++ +++|+||||+||++++++.++|+|||++........     
T Consensus        86 ~~~L~~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~-~i~H~dlkp~nil~~~~~~~kl~df~~~~~~~~~~~~~~~~  164 (263)
T cd05052          86 YGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKK-NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAG  164 (263)
T ss_pred             CCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhC-CEeecccCcceEEEcCCCcEEeCCCccccccccceeeccCC
Confidence            99999998754455689999999999999999999999 999999999999999999999999999876544321     


Q ss_pred             ccCcccccCcccccCCCCCCcccchhhhHHHHHHHh-CCCCCCchhhHHHhhhchhhhccccccCCCChHHHHHHHHHHH
Q 020221          212 YSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLS-GKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLAS  290 (329)
Q Consensus       212 ~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t-g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~  290 (329)
                      ...+..|+|||.+.+..++.++||||||+++|||++ |..|++...........     ........+...+.++.+++.
T Consensus       165 ~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~li~  239 (263)
T cd05052         165 AKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELL-----EKGYRMERPEGCPPKVYELMR  239 (263)
T ss_pred             CCCccccCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH-----HCCCCCCCCCCCCHHHHHHHH
Confidence            123567999999998889999999999999999998 77777654333222111     111222344556789999999


Q ss_pred             HhcccCCCCCCCHHHHHHHHHhh
Q 020221          291 RCLQYEPRERPNPRSLVTALVTL  313 (329)
Q Consensus       291 ~cl~~dp~~Rps~~~~l~~L~~~  313 (329)
                      +||+.||++|||+.++++.|+.+
T Consensus       240 ~cl~~~p~~Rp~~~~l~~~l~~~  262 (263)
T cd05052         240 ACWQWNPSDRPSFAEIHQAFETM  262 (263)
T ss_pred             HHccCCcccCCCHHHHHHHHHhh
Confidence            99999999999999999999875

Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays

>KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=3.4e-45  Score=314.71  Aligned_cols=243  Identities=17%  Similarity=0.245  Sum_probs=210.9

Q ss_pred             CcccccccCCCCCCcEEEEEE-eCCCCEEEEEEeCCCCChhHH---HHHHHHHHHhcCCCccccccceeeeeCCeeEEEE
Q 020221           57 AMENIVSEHGEKAPNVVYKGK-LENQFRIAVKRFNRSAWPDAR---QFLEEARAVGQLRNRRLANLLGCCCEGDERLLVA  132 (329)
Q Consensus        57 ~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~---~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~  132 (329)
                      -.|++.+.||.|.||.|-++. ...|..||||.++++...+.+   .+.+|+++|..|+||||+.++.+|+..+.+.|||
T Consensus        53 HRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVFENkdKIvivM  132 (668)
T KOG0611|consen   53 HRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFENKDKIVIVM  132 (668)
T ss_pred             hHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhhcCCceEEEEE
Confidence            347788889999999999998 688999999999887654443   4789999999999999999999999999999999


Q ss_pred             ecCCCCCHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCCCCCeeeecccCcccCCCC---
Q 020221          133 EYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDG---  209 (329)
Q Consensus       133 e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~---  209 (329)
                      ||..+|.|.+|+.  +.+.+++..+..+++||.+|+.|+|.+ +++|||||.+|||+|.|+++||+|||++-.+.+.   
T Consensus       133 EYaS~GeLYDYiS--er~~LsErEaRhfFRQIvSAVhYCHkn-rVvHRDLKLENILLD~N~NiKIADFGLSNly~~~kfL  209 (668)
T KOG0611|consen  133 EYASGGELYDYIS--ERGSLSEREARHFFRQIVSAVHYCHKN-RVVHRDLKLENILLDQNNNIKIADFGLSNLYADKKFL  209 (668)
T ss_pred             EecCCccHHHHHH--HhccccHHHHHHHHHHHHHHHHHHhhc-cceecccchhheeecCCCCeeeeccchhhhhccccHH
Confidence            9999999999997  567899999999999999999999999 9999999999999999999999999999877766   


Q ss_pred             CCccCcccccCcccccCCCCC-CcccchhhhHHHHHHHhCCCCCCchhhHHHhhhchhhhccccccCCCChHHHHHHHHH
Q 020221          210 RSYSTNLAFTPPEYLRTGRVT-PESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRL  288 (329)
Q Consensus       210 ~~~~~~~~y~aPE~~~~~~~~-~~~DvwslG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  288 (329)
                      .+++|++-|.+||.++|.+|. +.+|-||||++||.|+.|..||.+.....+..+.......       .+..+.+..-|
T Consensus       210 qTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~Dhk~lvrQIs~GaYr-------EP~~PSdA~gL  282 (668)
T KOG0611|consen  210 QTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGRDHKRLVRQISRGAYR-------EPETPSDASGL  282 (668)
T ss_pred             HHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCchHHHHHHHhhccccc-------CCCCCchHHHH
Confidence            467899999999999999876 5799999999999999999999876555444433322221       12234567789


Q ss_pred             HHHhcccCCCCCCCHHHHHHH
Q 020221          289 ASRCLQYEPRERPNPRSLVTA  309 (329)
Q Consensus       289 i~~cl~~dp~~Rps~~~~l~~  309 (329)
                      |.+||..||++|-|..+|..+
T Consensus       283 IRwmLmVNP~RRATieDiAsH  303 (668)
T KOG0611|consen  283 IRWMLMVNPERRATIEDIASH  303 (668)
T ss_pred             HHHHHhcCcccchhHHHHhhh
Confidence            999999999999999999864

>cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor

Probab=100.00  E-value=1.5e-44  Score=329.29  Aligned_cols=252  Identities=21%  Similarity=0.345  Sum_probs=201.5

Q ss_pred             cccccccCCCCCCcEEEEEEe------CCCCEEEEEEeCCCCCh-hHHHHHHHHHHHhcC-CCccccccceeeeeCCeeE
Q 020221           58 MENIVSEHGEKAPNVVYKGKL------ENQFRIAVKRFNRSAWP-DARQFLEEARAVGQL-RNRRLANLLGCCCEGDERL  129 (329)
Q Consensus        58 ~~~~~~~lg~G~~g~V~~~~~------~~~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~  129 (329)
                      .+.+.+.||+|+||.||++..      .+++.||+|.+...... ....+.+|+++++.+ +|+||+++++++......+
T Consensus        39 ~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~~h~nIv~~~~~~~~~~~~~  118 (374)
T cd05106          39 NLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKILSHLGQHKNIVNLLGACTHGGPVL  118 (374)
T ss_pred             HceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCCHHHHHHHHHHHHHHHhhccCCceeeEeeEecCCCCeE
Confidence            356677789999999999873      22457999999765433 345688999999999 8999999999999999999


Q ss_pred             EEEecCCCCCHHhhhccCC-------------------------------------------------------------
Q 020221          130 LVAEYMPNDTLAKHLFHWE-------------------------------------------------------------  148 (329)
Q Consensus       130 lv~e~~~~gsL~~~l~~~~-------------------------------------------------------------  148 (329)
                      +||||+++|+|.+++....                                                             
T Consensus       119 lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  198 (374)
T cd05106         119 VITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSSSQSSDSK  198 (374)
T ss_pred             EeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCcccccccccccc
Confidence            9999999999999885311                                                             


Q ss_pred             -------CCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCCCCCeeeecccCcccCCCCCC------ccCc
Q 020221          149 -------TQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDGRS------YSTN  215 (329)
Q Consensus       149 -------~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~~------~~~~  215 (329)
                             ...+++..+..++.||+.||.|||++ +++||||||+||++++++.++|+|||++........      ..++
T Consensus       199 ~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~-giiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~  277 (374)
T cd05106         199 DEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASK-NCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVVKGNARLP  277 (374)
T ss_pred             chhccCCCCCcCHHHHHHHHHHHHHHHHHHHHC-CEEeccCchheEEEeCCCeEEEeeceeeeeccCCcceeeccCCCCc
Confidence                   12478889999999999999999999 999999999999999999999999999876443221      2234


Q ss_pred             ccccCcccccCCCCCCcccchhhhHHHHHHHh-CCCCCCchhhHHHhhhchhhhccccccCCCChHHHHHHHHHHHHhcc
Q 020221          216 LAFTPPEYLRTGRVTPESVMYSFGTLLLDLLS-GKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLASRCLQ  294 (329)
Q Consensus       216 ~~y~aPE~~~~~~~~~~~DvwslG~il~el~t-g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~  294 (329)
                      ..|+|||++.+..++.++||||||+++|+|++ |..||+.......    .............+...++++.+++.+||+
T Consensus       278 ~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~~~----~~~~~~~~~~~~~~~~~~~~l~~li~~cl~  353 (374)
T cd05106         278 VKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILVNSK----FYKMVKRGYQMSRPDFAPPEIYSIMKMCWN  353 (374)
T ss_pred             cceeCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCccccccHH----HHHHHHcccCccCCCCCCHHHHHHHHHHcC
Confidence            67999999988889999999999999999997 8887765432111    111111112222334457889999999999


Q ss_pred             cCCCCCCCHHHHHHHHHhhh
Q 020221          295 YEPRERPNPRSLVTALVTLQ  314 (329)
Q Consensus       295 ~dp~~Rps~~~~l~~L~~~~  314 (329)
                      .||++|||+.++++.|+++.
T Consensus       354 ~dp~~RPs~~~l~~~l~~~~  373 (374)
T cd05106         354 LEPTERPTFSQISQLIQRQL  373 (374)
T ss_pred             CChhhCcCHHHHHHHHHHHh
Confidence            99999999999999998863

Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti

>cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1

Probab=100.00  E-value=1.9e-44  Score=327.78  Aligned_cols=247  Identities=12%  Similarity=0.082  Sum_probs=195.3

Q ss_pred             cccccccCCCCCCcEEEEEE-eCCCCEEEEEEeCCCCC---hhHHHHHHHHHHHhcCCCccccccceeeeeCCeeEEEEe
Q 020221           58 MENIVSEHGEKAPNVVYKGK-LENQFRIAVKRFNRSAW---PDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAE  133 (329)
Q Consensus        58 ~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  133 (329)
                      ++++++.||+|+||+||++. ..+++.||+|++.....   .....+.+|+.++..++|+||+++++.+.+....++|||
T Consensus         2 ~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~~~~lv~E   81 (363)
T cd05628           2 DFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQDKLNLYLIME   81 (363)
T ss_pred             CceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEecCCeEEEEEc
Confidence            45677788999999999998 55688999999975321   223457889999999999999999999999999999999


Q ss_pred             cCCCCCHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCCCCCeeeecccCcccCCCC----
Q 020221          134 YMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDG----  209 (329)
Q Consensus       134 ~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~----  209 (329)
                      |+++|+|.+++.  ....+++..+..++.|++.||.|||++ ||+||||||+|||++.++.+||+|||+++.....    
T Consensus        82 ~~~gg~L~~~l~--~~~~l~~~~~~~~~~qi~~aL~~lH~~-givHrDlKp~NILi~~~~~vkL~DFGla~~~~~~~~~~  158 (363)
T cd05628          82 FLPGGDMMTLLM--KKDTLTEEETQFYIAETVLAIDSIHQL-GFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRTE  158 (363)
T ss_pred             CCCCCcHHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHhC-CeEecCCCHHHeEECCCCCEEEeeccCccccccccccc
Confidence            999999999986  345789999999999999999999999 9999999999999999999999999998643211    


Q ss_pred             -----------------------------------CCccCcccccCcccccCCCCCCcccchhhhHHHHHHHhCCCCCCc
Q 020221          210 -----------------------------------RSYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPS  254 (329)
Q Consensus       210 -----------------------------------~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~~~~~  254 (329)
                                                         ....||+.|+|||++.+..++.++|||||||++|||++|..||..
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~~Pf~~  238 (363)
T cd05628         159 FYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPFCS  238 (363)
T ss_pred             ccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCCCCCchhhhhhHHHHHHHHhCCCCCCC
Confidence                                               123688999999999988899999999999999999999998865


Q ss_pred             hhhHHHhhhchhhhccccccCCCChHHHHHHHHHHHHhcc--cCCCCCCCHHHHHHH
Q 020221          255 HALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLASRCLQ--YEPRERPNPRSLVTA  309 (329)
Q Consensus       255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~--~dp~~Rps~~~~l~~  309 (329)
                      ....................  .....++++.+++.+++.  .++..||++.+++++
T Consensus       239 ~~~~~~~~~i~~~~~~~~~p--~~~~~s~~~~~li~~l~~~~~~r~~r~~~~ei~~h  293 (363)
T cd05628         239 ETPQETYKKVMNWKETLIFP--PEVPISEKAKDLILRFCCEWEHRIGAPGVEEIKTN  293 (363)
T ss_pred             CCHHHHHHHHHcCcCcccCC--CcCCCCHHHHHHHHHHcCChhhcCCCCCHHHHhCC
Confidence            43322222111100000001  112346788889888654  233356899999873

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus

>cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta

Probab=100.00  E-value=1.8e-44  Score=322.38  Aligned_cols=231  Identities=20%  Similarity=0.257  Sum_probs=191.6

Q ss_pred             cCCCCCCcEEEEEEe-CCCCEEEEEEeCCCC---ChhHHHHHHHHHHHhcC-CCccccccceeeeeCCeeEEEEecCCCC
Q 020221           64 EHGEKAPNVVYKGKL-ENQFRIAVKRFNRSA---WPDARQFLEEARAVGQL-RNRRLANLLGCCCEGDERLLVAEYMPND  138 (329)
Q Consensus        64 ~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~~~g  138 (329)
                      .||+|+||+||++.. .+++.||+|++....   ....+.+..|..++..+ +||||+++++++...+..++||||+++|
T Consensus         2 ~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~Ey~~~g   81 (320)
T cd05590           2 VLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEFVNGG   81 (320)
T ss_pred             eeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEEcCCCCc
Confidence            469999999999994 568899999987532   22345567888888876 6999999999999999999999999999


Q ss_pred             CHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCCCCCeeeecccCcccCCC----CCCccC
Q 020221          139 TLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRD----GRSYST  214 (329)
Q Consensus       139 sL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~----~~~~~~  214 (329)
                      +|.+++.  ....+++..+..++.|++.||.|||+. +++||||||+||+++.++.++|+|||++.....    .....|
T Consensus        82 ~L~~~i~--~~~~l~~~~~~~~~~ql~~~L~~lH~~-~ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~~~~~~~~~~~g  158 (320)
T cd05590          82 DLMFHIQ--KSRRFDEARARFYAAEITSALMFLHDK-GIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNGKTTSTFCG  158 (320)
T ss_pred             hHHHHHH--HcCCCCHHHHHHHHHHHHHHHHHHHHC-CeEeCCCCHHHeEECCCCcEEEeeCCCCeecCcCCCccccccc
Confidence            9999886  345789999999999999999999999 999999999999999999999999999875322    123467


Q ss_pred             cccccCcccccCCCCCCcccchhhhHHHHHHHhCCCCCCchhhHHHhhhchhhhccccccCCCChHHHHHHHHHHHHhcc
Q 020221          215 NLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLASRCLQ  294 (329)
Q Consensus       215 ~~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~  294 (329)
                      ++.|+|||++.+..++.++||||||+++|+|++|+.||...............      ....+...+.++.+++.+||+
T Consensus       159 t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~i~~~------~~~~~~~~~~~~~~li~~~L~  232 (320)
T cd05590         159 TPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILND------EVVYPTWLSQDAVDILKAFMT  232 (320)
T ss_pred             CccccCHHHHcCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHHHHHHHHhcC------CCCCCCCCCHHHHHHHHHHcc
Confidence            89999999999888999999999999999999999988655433322222111      112344567889999999999


Q ss_pred             cCCCCCCCH
Q 020221          295 YEPRERPNP  303 (329)
Q Consensus       295 ~dp~~Rps~  303 (329)
                      .||++||++
T Consensus       233 ~dP~~R~~~  241 (320)
T cd05590         233 KNPTMRLGS  241 (320)
T ss_pred             cCHHHCCCC
Confidence            999999998

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal

>cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors

Probab=100.00  E-value=4.6e-44  Score=314.21  Aligned_cols=251  Identities=24%  Similarity=0.370  Sum_probs=204.3

Q ss_pred             CcccccccCCCCCCcEEEEEEeCC-C-----CEEEEEEeCCCCCh-hHHHHHHHHHHHhcCCCccccccceeeeeCCeeE
Q 020221           57 AMENIVSEHGEKAPNVVYKGKLEN-Q-----FRIAVKRFNRSAWP-DARQFLEEARAVGQLRNRRLANLLGCCCEGDERL  129 (329)
Q Consensus        57 ~~~~~~~~lg~G~~g~V~~~~~~~-~-----~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~  129 (329)
                      .++++++.||+|+||.||+|.... +     ..||+|.+...... ....+.+|++.++.++||||+++++++......+
T Consensus         5 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~   84 (283)
T cd05048           5 SAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVCLLGVCTKEQPTC   84 (283)
T ss_pred             HHcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCCCHHHHHHHHHHHHHHHhcCCcccceEEEEEcCCCceE
Confidence            346677888999999999998432 2     57999998765433 2456889999999999999999999998888999


Q ss_pred             EEEecCCCCCHHhhhccCCC--------------CCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCCCCCe
Q 020221          130 LVAEYMPNDTLAKHLFHWET--------------QPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNP  195 (329)
Q Consensus       130 lv~e~~~~gsL~~~l~~~~~--------------~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~  195 (329)
                      ++|||+++++|.+++.....              ..+++..+..++.|++.||.|||+. +++|+||||+||++++++.+
T Consensus        85 ~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~-~i~H~dlkp~Nil~~~~~~~  163 (283)
T cd05048          85 MLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSH-HFVHRDLAARNCLVGEGLTV  163 (283)
T ss_pred             EEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhC-CeeccccccceEEEcCCCcE
Confidence            99999999999999864211              4578899999999999999999999 99999999999999999999


Q ss_pred             eeecccCcccCCCCC------CccCcccccCcccccCCCCCCcccchhhhHHHHHHHh-CCCCCCchhhHHHhhhchhhh
Q 020221          196 RLSCFGLMKNSRDGR------SYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLS-GKHIPPSHALDLIRDRNIQTL  268 (329)
Q Consensus       196 kl~Dfg~a~~~~~~~------~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t-g~~~~~~~~~~~~~~~~~~~~  268 (329)
                      +|+|||++.......      ...+++.|+|||.+.+..++.++||||||+++|||++ |..||.............   
T Consensus       164 ~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~slG~il~el~~~g~~p~~~~~~~~~~~~i~---  240 (283)
T cd05048         164 KISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYGFSNQEVIEMIR---  240 (283)
T ss_pred             EECCCcceeeccccccccccCCCcccccccCHHHhccCcCchhhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHH---
Confidence            999999987543321      2244678999999988889999999999999999998 887776433322222111   


Q ss_pred             ccccccCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhh
Q 020221          269 TDSCLEGQFSSDEGTELVRLASRCLQYEPRERPNPRSLVTALVTL  313 (329)
Q Consensus       269 ~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~~~l~~L~~~  313 (329)
                        .......+..++.++.+|+.+||+.||++||++.++++.|+.+
T Consensus       241 --~~~~~~~~~~~~~~~~~l~~~c~~~~p~~Rp~~~~i~~~l~~~  283 (283)
T cd05048         241 --SRQLLPCPEDCPARVYALMIECWNEIPARRPRFKDIHTRLRSW  283 (283)
T ss_pred             --cCCcCCCcccCCHHHHHHHHHHccCChhhCcCHHHHHHHHhcC
Confidence              1112234556788999999999999999999999999999763

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer

>cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit

Probab=100.00  E-value=2.3e-44  Score=328.26  Aligned_cols=251  Identities=21%  Similarity=0.309  Sum_probs=199.3

Q ss_pred             cccccccCCCCCCcEEEEEEe------CCCCEEEEEEeCCCC-ChhHHHHHHHHHHHhcC-CCccccccceeeeeCCeeE
Q 020221           58 MENIVSEHGEKAPNVVYKGKL------ENQFRIAVKRFNRSA-WPDARQFLEEARAVGQL-RNRRLANLLGCCCEGDERL  129 (329)
Q Consensus        58 ~~~~~~~lg~G~~g~V~~~~~------~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~  129 (329)
                      .+++.+.||+|+||.||+|..      .++..||+|+++... ....+.+.+|+++++.+ +||||+++++++..++..+
T Consensus        36 ~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~~~~~~~  115 (375)
T cd05104          36 RLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHINIVNLLGACTVGGPTL  115 (375)
T ss_pred             HeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcCcHHHHHHHHHHHHHHHhcCCcceeeeeeeeccCCcce
Confidence            356677789999999999963      345689999997543 23345688999999999 8999999999999999999


Q ss_pred             EEEecCCCCCHHhhhccCC-------------------------------------------------------------
Q 020221          130 LVAEYMPNDTLAKHLFHWE-------------------------------------------------------------  148 (329)
Q Consensus       130 lv~e~~~~gsL~~~l~~~~-------------------------------------------------------------  148 (329)
                      +||||+++|+|.+++....                                                             
T Consensus       116 lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  195 (375)
T cd05104         116 VITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRSVRSGSYI  195 (375)
T ss_pred             eeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCcccccccccccccccccceec
Confidence            9999999999999886421                                                             


Q ss_pred             ------------CCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCCCCCeeeecccCcccCCCCCC-----
Q 020221          149 ------------TQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDGRS-----  211 (329)
Q Consensus       149 ------------~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~~-----  211 (329)
                                  ...+++..+..++.||+.||.|||+. +++||||||+||+++.++.+||+|||++........     
T Consensus       196 ~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~-~ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~~  274 (375)
T cd05104         196 DQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASK-NCIHRDLAARNILLTHGRITKICDFGLARDIRNDSNYVVKG  274 (375)
T ss_pred             ccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHC-CeeccCCchhhEEEECCCcEEEecCccceeccCcccccccC
Confidence                        12468889999999999999999999 999999999999999999999999999876543321     


Q ss_pred             -ccCcccccCcccccCCCCCCcccchhhhHHHHHHHh-CCCCCCchhhHHHhhhchhhhccccccCCCChHHHHHHHHHH
Q 020221          212 -YSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLS-GKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLA  289 (329)
Q Consensus       212 -~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t-g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li  289 (329)
                       ..++..|+|||++.+..++.++||||||+++|||++ |..|+..........    ...........+...+.++.+++
T Consensus       275 ~~~~~~~y~aPE~~~~~~~~~~sDi~slG~~l~ellt~g~~p~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~l~~li  350 (375)
T cd05104         275 NARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPVDSKFY----KMIKEGYRMLSPECAPSEMYDIM  350 (375)
T ss_pred             CCCCCcceeChhHhcCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCCCchHHHH----HHHHhCccCCCCCCCCHHHHHHH
Confidence             223467999999998899999999999999999998 666654332111111    11111111122334467899999


Q ss_pred             HHhcccCCCCCCCHHHHHHHHHhh
Q 020221          290 SRCLQYEPRERPNPRSLVTALVTL  313 (329)
Q Consensus       290 ~~cl~~dp~~Rps~~~~l~~L~~~  313 (329)
                      .+||+.||++|||+.++++.|++.
T Consensus       351 ~~cl~~dP~~RPs~~eil~~l~~~  374 (375)
T cd05104         351 KSCWDADPLKRPTFKQIVQLIEQQ  374 (375)
T ss_pred             HHHccCChhHCcCHHHHHHHHHhh
Confidence            999999999999999999999863

Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce

>KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms]

Probab=100.00  E-value=3e-44  Score=322.59  Aligned_cols=246  Identities=19%  Similarity=0.169  Sum_probs=210.2

Q ss_pred             CcccccccCCCCCCcEEEEEE-eCCCCEEEEEEeCCCCChh---HHHHHHHHHHHhcCC-CccccccceeeeeCCeeEEE
Q 020221           57 AMENIVSEHGEKAPNVVYKGK-LENQFRIAVKRFNRSAWPD---ARQFLEEARAVGQLR-NRRLANLLGCCCEGDERLLV  131 (329)
Q Consensus        57 ~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~---~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~~~~lv  131 (329)
                      ..|++.+.||+|.||.||+++ ..+|+.+|+|.+.+.....   ...+.+|+.+|+.++ |||||.+.+++.+...+++|
T Consensus        35 ~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~~~~~lv  114 (382)
T KOG0032|consen   35 EKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFEDPDSVYLV  114 (382)
T ss_pred             ccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcCCeEEEE
Confidence            346666788999999999999 5559999999998765433   357899999999998 99999999999999999999


Q ss_pred             EecCCCCCHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCC----CCCeeeecccCcccCC
Q 020221          132 AEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDD----DVNPRLSCFGLMKNSR  207 (329)
Q Consensus       132 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~----~~~~kl~Dfg~a~~~~  207 (329)
                      ||++.||.|.+.+...   .+++.++..++.|++.+++|||+. |++|||+||+|+|+..    ++.++++|||++....
T Consensus       115 mEL~~GGeLfd~i~~~---~~sE~da~~~~~~il~av~~lH~~-gvvHrDlKpEN~L~~~~~~~~~~ik~~DFGla~~~~  190 (382)
T KOG0032|consen  115 MELCEGGELFDRIVKK---HYSERDAAGIIRQILEAVKYLHSL-GVVHRDLKPENLLLASKDEGSGRIKLIDFGLAKFIK  190 (382)
T ss_pred             EEecCCchHHHHHHHc---cCCHHHHHHHHHHHHHHHHHHHhC-CceeccCCHHHeeeccccCCCCcEEEeeCCCceEcc
Confidence            9999999999999754   399999999999999999999999 9999999999999963    3579999999999877


Q ss_pred             CC---CCccCcccccCcccccCCCCCCcccchhhhHHHHHHHhCCCCCCchhhHHHhhhchhhhccccccCCCChHHHHH
Q 020221          208 DG---RSYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTE  284 (329)
Q Consensus       208 ~~---~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  284 (329)
                      .+   ....||+.|+|||++....|+..+||||+|+++|.|++|.+||.................  .......+..+..
T Consensus       191 ~~~~~~~~~Gtp~y~APEvl~~~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~~~~~~~i~~~~~--~f~~~~w~~is~~  268 (382)
T KOG0032|consen  191 PGERLHTIVGTPEYVAPEVLGGRPYGDEVDVWSIGVILYILLSGVPPFWGETEFEIFLAILRGDF--DFTSEPWDDISES  268 (382)
T ss_pred             CCceEeeecCCccccCchhhcCCCCCcccchhHHHHHHHHHhhCCCCCcCCChhHHHHHHHcCCC--CCCCCCccccCHH
Confidence            63   345789999999999999999999999999999999999999987654433332222211  1222334566899


Q ss_pred             HHHHHHHhcccCCCCCCCHHHHHH
Q 020221          285 LVRLASRCLQYEPRERPNPRSLVT  308 (329)
Q Consensus       285 ~~~li~~cl~~dp~~Rps~~~~l~  308 (329)
                      +.+++..++..||..|+|+.++++
T Consensus       269 akd~i~~ll~~dp~~R~ta~~~L~  292 (382)
T KOG0032|consen  269 AKDFIRKLLEFDPRKRLTAAQALQ  292 (382)
T ss_pred             HHHHHHHhcccCcccCCCHHHHhc
Confidence            999999999999999999999999

>cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1

Probab=100.00  E-value=2.7e-44  Score=315.43  Aligned_cols=241  Identities=19%  Similarity=0.242  Sum_probs=195.3

Q ss_pred             CCCCCCcEEEEEE-eCCCCEEEEEEeCCCCCh---hHHHHHHHHHHHhcCCCccccccceeeeeCCeeEEEEecCCCCCH
Q 020221           65 HGEKAPNVVYKGK-LENQFRIAVKRFNRSAWP---DARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAEYMPNDTL  140 (329)
Q Consensus        65 lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~---~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL  140 (329)
                      ||+|+||+||++. ..+++.+|+|.+......   ..+.+..|+++++.++|+||+++.+++......++||||+++|+|
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L   80 (280)
T cd05608           1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNGGDL   80 (280)
T ss_pred             CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCCeEEEEEeCCCCCCH
Confidence            5999999999998 457889999998754322   234567899999999999999999999998999999999999999


Q ss_pred             HhhhccC--CCCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCCCCCeeeecccCcccCCCCC----CccC
Q 020221          141 AKHLFHW--ETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDGR----SYST  214 (329)
Q Consensus       141 ~~~l~~~--~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~----~~~~  214 (329)
                      ..++...  ....+++..+..++.||+.||.|||+. +++||||||+||++++++.++|+|||++.......    ...+
T Consensus        81 ~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~-~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~g  159 (280)
T cd05608          81 RYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQR-RIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQSKTKGYAG  159 (280)
T ss_pred             HHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHC-CcccCCCCHHHEEECCCCCEEEeeCccceecCCCCccccccCC
Confidence            8877432  335689999999999999999999999 99999999999999999999999999987654332    3467


Q ss_pred             cccccCcccccCCCCCCcccchhhhHHHHHHHhCCCCCCchhhHHHhhhchhhhccccccCCCChHHHHHHHHHHHHhcc
Q 020221          215 NLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLASRCLQ  294 (329)
Q Consensus       215 ~~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~  294 (329)
                      ++.|+|||++.+..++.++||||||+++|+|++|+.||...................  ....+...++++.+++.+||+
T Consensus       160 ~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~li~~~l~  237 (280)
T cd05608         160 TPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRILND--SVTYPDKFSPASKSFCEALLA  237 (280)
T ss_pred             CcCccCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCcchhHHHHHHhhccc--CCCCcccCCHHHHHHHHHHhc
Confidence            899999999999999999999999999999999998886432111111111111111  112345577899999999999


Q ss_pred             cCCCCCC-----CHHHHHH
Q 020221          295 YEPRERP-----NPRSLVT  308 (329)
Q Consensus       295 ~dp~~Rp-----s~~~~l~  308 (329)
                      .||++||     +++++++
T Consensus       238 ~~P~~R~~~~~~~~~~~l~  256 (280)
T cd05608         238 KDPEKRLGFRDGNCDGLRT  256 (280)
T ss_pred             CCHHHhcCCCCCCHHHHhc
Confidence            9999999     6777776

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g

>cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.8e-44  Score=316.14  Aligned_cols=248  Identities=17%  Similarity=0.207  Sum_probs=202.1

Q ss_pred             ccccccCCCCCCcEEEEEE-eCCCCEEEEEEeCCCCCh---hHHHHHHHHHHHhcCCCccccccceeeeeCCeeEEEEec
Q 020221           59 ENIVSEHGEKAPNVVYKGK-LENQFRIAVKRFNRSAWP---DARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAEY  134 (329)
Q Consensus        59 ~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~---~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  134 (329)
                      |++++.||+|+||+||++. ..+++.||+|++......   ....+.+|+.+++.++||||+++++.+..++..++||||
T Consensus         2 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~   81 (285)
T cd05605           2 FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTL   81 (285)
T ss_pred             ceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecCCCeEEEEEec
Confidence            4566777999999999999 456889999998754322   233467899999999999999999999998999999999


Q ss_pred             CCCCCHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCCCCCeeeecccCcccCCCCC---C
Q 020221          135 MPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDGR---S  211 (329)
Q Consensus       135 ~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~---~  211 (329)
                      +++|+|.+.+.......+++..+..++.|++.||.|||+. +++|+||||+||++++++.++|+|||++.......   .
T Consensus        82 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~-~ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~~~~~  160 (285)
T cd05605          82 MNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLHRE-RIVYRDLKPENILLDDYGHIRISDLGLAVEIPEGETIRG  160 (285)
T ss_pred             cCCCcHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHHC-CcEecCCCHHHEEECCCCCEEEeeCCCceecCCCCcccc
Confidence            9999999888654445789999999999999999999999 99999999999999999999999999987654332   2


Q ss_pred             ccCcccccCcccccCCCCCCcccchhhhHHHHHHHhCCCCCCchhhHHHhhhchhhhccccccCCCChHHHHHHHHHHHH
Q 020221          212 YSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLASR  291 (329)
Q Consensus       212 ~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~  291 (329)
                      ..++..|+|||++.+..++.++||||+|+++|++++|..||...............+..  ....++...+..+.+++..
T Consensus       161 ~~~~~~y~aPE~~~~~~~~~~~Diws~G~~l~el~~g~~pf~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~li~~  238 (285)
T cd05605         161 RVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEKVKREEVERRVKE--DQEEYSEKFSEAARSICRQ  238 (285)
T ss_pred             ccCCCCccCcHHhcCCCCCccccchhHHHHHHHHHHCCCCCCCCchhhHHHHHHHHhhh--cccccCcccCHHHHHHHHH
Confidence            36788999999999888999999999999999999999888654322111111111111  1123345577889999999


Q ss_pred             hcccCCCCCC-----CHHHHHHH
Q 020221          292 CLQYEPRERP-----NPRSLVTA  309 (329)
Q Consensus       292 cl~~dp~~Rp-----s~~~~l~~  309 (329)
                      ||..||++||     ++.+++++
T Consensus       239 ~l~~~P~~R~~~~~~~~~~l~~~  261 (285)
T cd05605         239 LLTKDPGFRLGCRGEGAEEVKAH  261 (285)
T ss_pred             HccCCHHHhcCCCCCCHHHHhcC
Confidence            9999999999     88888763

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5,

>cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N

Probab=100.00  E-value=3e-44  Score=321.59  Aligned_cols=240  Identities=19%  Similarity=0.279  Sum_probs=194.8

Q ss_pred             ccccccCCCCCCcEEEEEE-eCCCCEEEEEEeCCCC---ChhHHHHHHHHHHH---hcCCCccccccceeeeeCCeeEEE
Q 020221           59 ENIVSEHGEKAPNVVYKGK-LENQFRIAVKRFNRSA---WPDARQFLEEARAV---GQLRNRRLANLLGCCCEGDERLLV  131 (329)
Q Consensus        59 ~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~---~~~~~~~~~e~~~l---~~l~h~niv~~~~~~~~~~~~~lv  131 (329)
                      |++++.||+|+||.||++. ..+++.||+|+++...   ....+.+.+|++++   +.++||||+++++++......++|
T Consensus         1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv   80 (324)
T cd05589           1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTEDHVCFV   80 (324)
T ss_pred             CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcCCEEEEE
Confidence            3567788999999999998 4568899999997542   12234566666554   566899999999999999999999


Q ss_pred             EecCCCCCHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCCCCCeeeecccCcccCCCC--
Q 020221          132 AEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDG--  209 (329)
Q Consensus       132 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~--  209 (329)
                      |||+++++|...+.   ...+++..+..++.|++.||.|||+. |++||||||+||+++.++.+||+|||++......  
T Consensus        81 ~E~~~~~~L~~~~~---~~~l~~~~~~~~~~qi~~al~~lH~~-~ivHrdlkp~Nill~~~~~~kL~Dfg~~~~~~~~~~  156 (324)
T cd05589          81 MEYAAGGDLMMHIH---TDVFSEPRAVFYAACVVLGLQYLHEN-KIVYRDLKLDNLLLDTEGFVKIADFGLCKEGMGFGD  156 (324)
T ss_pred             EcCCCCCcHHHHhh---cCCCCHHHHHHHHHHHHHHHHHHHhC-CeEecCCCHHHeEECCCCcEEeCcccCCccCCCCCC
Confidence            99999999998884   45799999999999999999999999 9999999999999999999999999998653222  


Q ss_pred             --CCccCcccccCcccccCCCCCCcccchhhhHHHHHHHhCCCCCCchhhHHHhhhchhhhccccccCCCChHHHHHHHH
Q 020221          210 --RSYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVR  287 (329)
Q Consensus       210 --~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  287 (329)
                        ....|++.|+|||.+.+..++.++||||||+++|+|++|..||...............      ....+...++++.+
T Consensus       157 ~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~G~~pf~~~~~~~~~~~i~~~------~~~~p~~~~~~~~~  230 (324)
T cd05589         157 RTSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPGDDEEEVFDSIVND------EVRYPRFLSREAIS  230 (324)
T ss_pred             cccccccCccccCHhHhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhC------CCCCCCCCCHHHHH
Confidence              2346789999999999888999999999999999999999988654333222211111      11234556788999


Q ss_pred             HHHHhcccCCCCCC-----CHHHHHH
Q 020221          288 LASRCLQYEPRERP-----NPRSLVT  308 (329)
Q Consensus       288 li~~cl~~dp~~Rp-----s~~~~l~  308 (329)
                      ++.+||+.||++||     ++.++++
T Consensus       231 li~~~L~~dP~~R~~~~~~~~~~l~~  256 (324)
T cd05589         231 IMRRLLRRNPERRLGSGEKDAEDVKK  256 (324)
T ss_pred             HHHHHhhcCHhHcCCCCCCCHHHHhh
Confidence            99999999999999     4666665

Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved

>cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase

Probab=100.00  E-value=7.5e-44  Score=308.41  Aligned_cols=246  Identities=22%  Similarity=0.336  Sum_probs=201.0

Q ss_pred             CcccccccCCCCCCcEEEEEEeCCCCEEEEEEeCCCCChhHHHHHHHHHHHhcCCCccccccceeeeeCCeeEEEEecCC
Q 020221           57 AMENIVSEHGEKAPNVVYKGKLENQFRIAVKRFNRSAWPDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAEYMP  136 (329)
Q Consensus        57 ~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~  136 (329)
                      +++++++.||+|+||.||++.+.++..+|+|.+.... .....+.+|+.+++.++||||+++++++......+++|||++
T Consensus         4 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~a~K~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~~~   82 (256)
T cd05114           4 SELTFMKELGSGQFGVVHLGKWRAQIKVAIKAINEGA-MSEEDFIEEAKVMMKLSHPKLVQLYGVCTQQKPLYIVTEFME   82 (256)
T ss_pred             HHcEEeeEecCCcCceEEEEEeccCceEEEEecccCC-ccHHHHHHHHHHHHHCCCCCceeEEEEEccCCCEEEEEEcCC
Confidence            3466778889999999999998777889999987544 234678899999999999999999999999999999999999


Q ss_pred             CCCHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCCCCCeeeecccCcccCCCCC-----C
Q 020221          137 NDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDGR-----S  211 (329)
Q Consensus       137 ~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~-----~  211 (329)
                      +|+|.+++... ...+++..+..++.|++.||.|||++ +++|+||||+||++++++.++|+|||.+.......     .
T Consensus        83 ~~~L~~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~-~i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~~~~~~~~~~~  160 (256)
T cd05114          83 NGCLLNYLRQR-QGKLSKDMLLSMCQDVCEGMEYLERN-SFIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEYTSSSG  160 (256)
T ss_pred             CCcHHHHHHhC-ccCCCHHHHHHHHHHHHHHHHHHHHC-CccccccCcceEEEcCCCeEEECCCCCccccCCCceeccCC
Confidence            99999998642 34689999999999999999999999 99999999999999999999999999987643322     1


Q ss_pred             ccCcccccCcccccCCCCCCcccchhhhHHHHHHHh-CCCCCCchhhHHHhhhchhhhccccccCCCChHHHHHHHHHHH
Q 020221          212 YSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLS-GKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLAS  290 (329)
Q Consensus       212 ~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t-g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~  290 (329)
                      ..++..|+|||++.+..++.++|+||||+++|+|++ |..|+...............     .....+...+.++.+++.
T Consensus       161 ~~~~~~y~aPE~~~~~~~~~~~Di~s~G~~l~el~~~g~~p~~~~~~~~~~~~i~~~-----~~~~~~~~~~~~~~~li~  235 (256)
T cd05114         161 AKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSNYEVVEMISRG-----FRLYRPKLASMTVYEVMY  235 (256)
T ss_pred             CCCchhhCChhhcccCccchhhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCC-----CCCCCCCCCCHHHHHHHH
Confidence            223567999999988889999999999999999999 77766543322221111111     111223345678999999


Q ss_pred             HhcccCCCCCCCHHHHHHHH
Q 020221          291 RCLQYEPRERPNPRSLVTAL  310 (329)
Q Consensus       291 ~cl~~dp~~Rps~~~~l~~L  310 (329)
                      +||+.||++||++.++++.|
T Consensus       236 ~c~~~~p~~Rps~~~l~~~l  255 (256)
T cd05114         236 SCWHEKPEGRPTFAELLRAI  255 (256)
T ss_pred             HHccCCcccCcCHHHHHHhh
Confidence            99999999999999999876

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h

>KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms]

Probab=100.00  E-value=1e-44  Score=293.38  Aligned_cols=255  Identities=19%  Similarity=0.190  Sum_probs=209.6

Q ss_pred             CCcccccccCCCCCCcEEEEEE-eCCCCEEEEEEeCCCCChhHHHHHHHHHHHhcCCCccccccceeeeeCC-----eeE
Q 020221           56 FAMENIVSEHGEKAPNVVYKGK-LENQFRIAVKRFNRSAWPDARQFLEEARAVGQLRNRRLANLLGCCCEGD-----ERL  129 (329)
Q Consensus        56 ~~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~-----~~~  129 (329)
                      -.+|++.+.+|+|+|+-||.++ ..++..+|+|++.-....+.+..++|++..++++|||+++++++...+.     ..|
T Consensus        20 ~~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D~~~~~y   99 (302)
T KOG2345|consen   20 NKRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHSQEDIEEALREIDNHRKFNSPNVLRLVDHQLREEKDGKHEAY   99 (302)
T ss_pred             CceEEEeeeecCCCceeeeeecccCcccchhhheeeccchHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhccCceeEE
Confidence            3568899999999999999999 7888999999998887777888999999999999999999999875443     489


Q ss_pred             EEEecCCCCCHHhhhccC--CCCCCCHHHHHHHHHHHHHHHHHhhcCCC--ccccccCCCceeeCCCCCeeeecccCccc
Q 020221          130 LVAEYMPNDTLAKHLFHW--ETQPMKWAMRLRVALHIAEALEYCTSKER--ALYHDLNAYRIVFDDDVNPRLSCFGLMKN  205 (329)
Q Consensus       130 lv~e~~~~gsL~~~l~~~--~~~~~~~~~~~~i~~~i~~~l~~lH~~~~--ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~  205 (329)
                      |+++|...|||.+.+.+.  ++..+++.+++.|+.++++||++||+. .  ++||||||.|||+.+.+.+++.|||.++.
T Consensus       100 ll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~-~~~yAH~DiKP~NILls~~~~~vl~D~GS~~~  178 (302)
T KOG2345|consen  100 LLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEK-EPPYAHRDIKPANILLSDSGLPVLMDLGSATQ  178 (302)
T ss_pred             EEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhcc-CCcccccCCCcceeEecCCCceEEEeccCccc
Confidence            999999999999999764  344689999999999999999999998 6  99999999999999999999999999875


Q ss_pred             CCCC-------------CCccCcccccCccccc---CCCCCCcccchhhhHHHHHHHhCCCCCCchhhHHHhhhch-hhh
Q 020221          206 SRDG-------------RSYSTNLAFTPPEYLR---TGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNI-QTL  268 (329)
Q Consensus       206 ~~~~-------------~~~~~~~~y~aPE~~~---~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~~~~~~-~~~  268 (329)
                      ..-.             .....|..|.|||.+.   +...++++|||||||+||+|+.|..||.....   ..+.+ ..+
T Consensus       179 a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~~~---~GgSlaLAv  255 (302)
T KOG2345|consen  179 APIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERIYQ---QGGSLALAV  255 (302)
T ss_pred             cceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchHHhh---cCCeEEEee
Confidence            4321             1224578999999986   55688999999999999999999988753211   11111 111


Q ss_pred             ccccccCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhh
Q 020221          269 TDSCLEGQFSSDEGTELVRLASRCLQYEPRERPNPRSLVTALVTLQ  314 (329)
Q Consensus       269 ~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~~~l~~L~~~~  314 (329)
                      ......-+.....|+.+.+++++|++.||.+||++.+++..++.+.
T Consensus       256 ~n~q~s~P~~~~yse~l~~lik~mlqvdP~qRP~i~~ll~~~d~Li  301 (302)
T KOG2345|consen  256 QNAQISIPNSSRYSEALHQLIKSMLQVDPNQRPTIPELLSKLDDLI  301 (302)
T ss_pred             eccccccCCCCCccHHHHHHHHHHhcCCcccCCCHHHHHHHHHhhc
Confidence            1212222223347899999999999999999999999999988753

>cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7

Probab=100.00  E-value=3.4e-44  Score=314.25  Aligned_cols=245  Identities=16%  Similarity=0.197  Sum_probs=195.5

Q ss_pred             CCCCCCcEEEEEE-eCCCCEEEEEEeCCCCC---hhHHHHHHHHHHHhcCCCccccccceeeeeCCeeEEEEecCCCCCH
Q 020221           65 HGEKAPNVVYKGK-LENQFRIAVKRFNRSAW---PDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAEYMPNDTL  140 (329)
Q Consensus        65 lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL  140 (329)
                      ||+|+||.||++. ..+|+.+|+|.+.....   .....+..|+++++.++||||+++.+++..+...++||||+++++|
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~~~~lv~e~~~g~~L   80 (277)
T cd05607           1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGGDL   80 (277)
T ss_pred             CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEecCCeEEEEEecCCCCCH
Confidence            5999999999998 45689999999865321   1233456799999999999999999999999999999999999999


Q ss_pred             HhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCCCCCeeeecccCcccCCCCC---CccCccc
Q 020221          141 AKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDGR---SYSTNLA  217 (329)
Q Consensus       141 ~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~---~~~~~~~  217 (329)
                      .+.+.......+++..+..++.|++.||+|||+. +++||||||+||++++++.++|+|||++.......   ...++..
T Consensus        81 ~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~-~ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~  159 (277)
T cd05607          81 KYHIYNVGERGLEMERVIHYSAQITCGILHLHSM-DIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGKTITQRAGTNG  159 (277)
T ss_pred             HHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHC-CEEEccCChHhEEEcCCCCEEEeeceeeeecCCCceeeccCCCCC
Confidence            9888654555689999999999999999999999 99999999999999999999999999987654432   2457889


Q ss_pred             ccCcccccCCCCCCcccchhhhHHHHHHHhCCCCCCchhhHHHhhhchhhhccccccCCCChHHHHHHHHHHHHhcccCC
Q 020221          218 FTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLASRCLQYEP  297 (329)
Q Consensus       218 y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp  297 (329)
                      |+|||++.+..++.++||||||+++|+|++|..|+...................... ......++++.+++.+||+.||
T Consensus       160 y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~L~~~P  238 (277)
T cd05607         160 YMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKDHKEKVAKEELKRRTLEDEVK-FEHQNFTEESKDICRLFLAKKP  238 (277)
T ss_pred             ccCHHHHccCCCCCchhHHHHHHHHHHHHhCCCCCCCCcchhhHHHHHHHhhccccc-cccccCCHHHHHHHHHHhccCH
Confidence            999999998889999999999999999999998875432111111111111111111 1113457789999999999999


Q ss_pred             CCCCCHHHHHHHHH
Q 020221          298 RERPNPRSLVTALV  311 (329)
Q Consensus       298 ~~Rps~~~~l~~L~  311 (329)
                      ++||+++++++.+.
T Consensus       239 ~~R~~~~~~~~~~~  252 (277)
T cd05607         239 EDRLGSREKNDDPR  252 (277)
T ss_pred             hhCCCCccchhhhh
Confidence            99999977664443

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr

>KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism]

Probab=100.00  E-value=2.3e-45  Score=301.13  Aligned_cols=246  Identities=19%  Similarity=0.210  Sum_probs=203.2

Q ss_pred             cccccccCCCCCCcEEEEEE-eCCCCEEEEEEeCCCCCh----h----HHHHHHHHHHHhcC-CCccccccceeeeeCCe
Q 020221           58 MENIVSEHGEKAPNVVYKGK-LENQFRIAVKRFNRSAWP----D----ARQFLEEARAVGQL-RNRRLANLLGCCCEGDE  127 (329)
Q Consensus        58 ~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~----~----~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~  127 (329)
                      .|+-.+.+|+|..++|.++. ..+|+.+|+|++......    .    .+.-.+|+.+|+++ -||+|+++.++++++..
T Consensus        18 ~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~yes~sF   97 (411)
T KOG0599|consen   18 KYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVYESDAF   97 (411)
T ss_pred             hcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeeccCcch
Confidence            33334445999999999988 667889999998653211    1    23356899999999 59999999999999999


Q ss_pred             eEEEEecCCCCCHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCCCCCeeeecccCcccCC
Q 020221          128 RLLVAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSR  207 (329)
Q Consensus       128 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~  207 (329)
                      +++|+|.|+.|.|.++|.  ..-.+++....+|++|+..|++|||.+ +||||||||+|||+|++.+++|+|||+++...
T Consensus        98 ~FlVFdl~prGELFDyLt--s~VtlSEK~tR~iMrqlfegVeylHa~-~IVHRDLKpENILlddn~~i~isDFGFa~~l~  174 (411)
T KOG0599|consen   98 VFLVFDLMPRGELFDYLT--SKVTLSEKETRRIMRQLFEGVEYLHAR-NIVHRDLKPENILLDDNMNIKISDFGFACQLE  174 (411)
T ss_pred             hhhhhhhcccchHHHHhh--hheeecHHHHHHHHHHHHHHHHHHHHh-hhhhcccChhheeeccccceEEeccceeeccC
Confidence            999999999999999996  456789999999999999999999999 99999999999999999999999999999988


Q ss_pred             CCC---CccCcccccCccccc------CCCCCCcccchhhhHHHHHHHhCCCCCCchhhHHHhhhchhhhccccccCCCC
Q 020221          208 DGR---SYSTNLAFTPPEYLR------TGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFS  278 (329)
Q Consensus       208 ~~~---~~~~~~~y~aPE~~~------~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  278 (329)
                      ++.   ..+||++|.|||.+.      ...|+..+|+|++|+|+|.|+.|.+||.....-.+..........  ...+.-
T Consensus       175 ~GekLrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHRkQmlMLR~ImeGkyq--F~speW  252 (411)
T KOG0599|consen  175 PGEKLRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWHRKQMLMLRMIMEGKYQ--FRSPEW  252 (411)
T ss_pred             CchhHHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhHHHHHHHHHHHHhcccc--cCCcch
Confidence            875   568999999999875      234888999999999999999999888654332222222222211  222334


Q ss_pred             hHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 020221          279 SDEGTELVRLASRCLQYEPRERPNPRSLVT  308 (329)
Q Consensus       279 ~~~~~~~~~li~~cl~~dp~~Rps~~~~l~  308 (329)
                      .+.+.+..+||.+||+.||.+|.|++++|.
T Consensus       253 adis~~~KdLIsrlLqVdp~~Ritake~La  282 (411)
T KOG0599|consen  253 ADISATVKDLISRLLQVDPTKRITAKEALA  282 (411)
T ss_pred             hhccccHHHHHHHHHeeCchhcccHHHHhc
Confidence            677899999999999999999999999997

>PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity

Probab=100.00  E-value=3e-45  Score=317.87  Aligned_cols=244  Identities=27%  Similarity=0.455  Sum_probs=194.5

Q ss_pred             ccccCCCCCCcEEEEEEeC-----CCCEEEEEEeCCCCCh-hHHHHHHHHHHHhcCCCccccccceeeeeCCeeEEEEec
Q 020221           61 IVSEHGEKAPNVVYKGKLE-----NQFRIAVKRFNRSAWP-DARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAEY  134 (329)
Q Consensus        61 ~~~~lg~G~~g~V~~~~~~-----~~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  134 (329)
                      +.+.||.|+||.||+|.+.     .+..|+||.++..... ..+.+.+|++.++.++||||++++|++......++|+||
T Consensus         3 ~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~~~lv~e~   82 (259)
T PF07714_consen    3 LIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPSSSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENEPLFLVMEY   82 (259)
T ss_dssp             EEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTTSSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSSSEEEEEE-
T ss_pred             EeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccccccccceeeeecccccccccccccccccccccccccccccccc
Confidence            4567899999999999965     3578999999765433 367899999999999999999999999988889999999


Q ss_pred             CCCCCHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCCCCCeeeecccCcccCCCC-----
Q 020221          135 MPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDG-----  209 (329)
Q Consensus       135 ~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~-----  209 (329)
                      +++|+|.+++.......+++..+..++.|++.||.|||++ +++|+||+++||+++.++.+||+|||++......     
T Consensus        83 ~~~g~L~~~L~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~-~iiH~~l~~~nill~~~~~~Kl~~f~~~~~~~~~~~~~~  161 (259)
T PF07714_consen   83 CPGGSLDDYLKSKNKEPLSEQQRLSIAIQIAEALSYLHSN-NIIHGNLSPSNILLDSNGQVKLSDFGLSRPISEKSKYKN  161 (259)
T ss_dssp             -TTEBHHHHHHHTCTTTSBHHHHHHHHHHHHHHHHHHHHT-TEEEST-SGGGEEEETTTEEEEESTTTGEETTTSSSEEE
T ss_pred             cccccccccccccccccccccccccccccccccccccccc-ccccccccccccccccccccccccccccccccccccccc
Confidence            9999999999875467899999999999999999999999 9999999999999999999999999998776322     


Q ss_pred             -CCccCcccccCcccccCCCCCCcccchhhhHHHHHHHh-CCCCCCchhhHHHhhhchhhhccccccCCCChHHHHHHHH
Q 020221          210 -RSYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLS-GKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVR  287 (329)
Q Consensus       210 -~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t-g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  287 (329)
                       ........|+|||.+.+..++.++||||||+++|||++ |..|+............     ....+...+..++..+.+
T Consensus       162 ~~~~~~~~~~~aPE~~~~~~~~~ksDVysfG~~l~ei~~~~~~p~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~  236 (259)
T PF07714_consen  162 DSSQQLPLRYLAPEVLKDGEYTKKSDVYSFGMLLYEILTLGKFPFSDYDNEEIIEKL-----KQGQRLPIPDNCPKDIYS  236 (259)
T ss_dssp             STTSESGGGGS-HHHHHHSEESHHHHHHHHHHHHHHHHTTSSGTTTTSCHHHHHHHH-----HTTEETTSBTTSBHHHHH
T ss_pred             ccccccccccccccccccccccccccccccccccccccccccccccccccccccccc-----cccccceeccchhHHHHH
Confidence             22345678999999998889999999999999999999 56665443222221111     111222344556788999


Q ss_pred             HHHHhcccCCCCCCCHHHHHHHH
Q 020221          288 LASRCLQYEPRERPNPRSLVTAL  310 (329)
Q Consensus       288 li~~cl~~dp~~Rps~~~~l~~L  310 (329)
                      ++..||+.||++|||+.++++.|
T Consensus       237 li~~C~~~~p~~RPs~~~i~~~L  259 (259)
T PF07714_consen  237 LIQQCWSHDPEKRPSFQEILQEL  259 (259)
T ss_dssp             HHHHHT-SSGGGS--HHHHHHHH
T ss_pred             HHHHHcCCChhhCcCHHHHHhcC
Confidence            99999999999999999999876

Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A ....

>cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon

Probab=100.00  E-value=3.2e-44  Score=321.00  Aligned_cols=236  Identities=17%  Similarity=0.238  Sum_probs=194.3

Q ss_pred             cCCCCCCcEEEEEEe-CCCCEEEEEEeCCCC---ChhHHHHHHHHHHHhcC-CCccccccceeeeeCCeeEEEEecCCCC
Q 020221           64 EHGEKAPNVVYKGKL-ENQFRIAVKRFNRSA---WPDARQFLEEARAVGQL-RNRRLANLLGCCCEGDERLLVAEYMPND  138 (329)
Q Consensus        64 ~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~~~g  138 (329)
                      .||+|+||.||+|.. .+++.||+|++....   ....+.+..|.+++..+ +||||+++++++...+..++||||++++
T Consensus         2 ~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~   81 (321)
T cd05591           2 VLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEYVNGG   81 (321)
T ss_pred             ccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEEeCCCCC
Confidence            469999999999984 567899999987542   22344567888888866 7999999999999999999999999999


Q ss_pred             CHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCCCCCeeeecccCcccCCCC----CCccC
Q 020221          139 TLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDG----RSYST  214 (329)
Q Consensus       139 sL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~----~~~~~  214 (329)
                      +|..++.  ....+++..+..++.|++.||.|||+. +++||||||+||+++.++.++|+|||++......    ....|
T Consensus        82 ~L~~~l~--~~~~~~~~~~~~~~~qi~~aL~~LH~~-~ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~g  158 (321)
T cd05591          82 DLMFQIQ--RSRKFDEPRSRFYAAEVTLALMFLHRH-GVIYRDLKLDNILLDAEGHCKLADFGMCKEGILNGVTTTTFCG  158 (321)
T ss_pred             cHHHHHH--HcCCCCHHHHHHHHHHHHHHHHHHHHC-CeeccCCCHHHeEECCCCCEEEeecccceecccCCcccccccc
Confidence            9999886  445789999999999999999999999 9999999999999999999999999998753222    23457


Q ss_pred             cccccCcccccCCCCCCcccchhhhHHHHHHHhCCCCCCchhhHHHhhhchhhhccccccCCCChHHHHHHHHHHHHhcc
Q 020221          215 NLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLASRCLQ  294 (329)
Q Consensus       215 ~~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~  294 (329)
                      ++.|+|||++.+..++.++||||||+++|+|++|..||..............    .  ....+...++++.+++.+||+
T Consensus       159 t~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~~~~~~i~~----~--~~~~p~~~~~~~~~ll~~~L~  232 (321)
T cd05591         159 TPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEADNEDDLFESILH----D--DVLYPVWLSKEAVSILKAFMT  232 (321)
T ss_pred             CccccCHHHHcCCCCCCccceechhHHHHHHhcCCCCCCCCCHHHHHHHHHc----C--CCCCCCCCCHHHHHHHHHHhc
Confidence            8999999999988899999999999999999999998865543322222111    1  112334467889999999999


Q ss_pred             cCCCCCC-------CHHHHHH
Q 020221          295 YEPRERP-------NPRSLVT  308 (329)
Q Consensus       295 ~dp~~Rp-------s~~~~l~  308 (329)
                      .||++||       ++.++++
T Consensus       233 ~dp~~R~~~~~~~~~~~~~~~  253 (321)
T cd05591         233 KNPNKRLGCVASQGGEDAIKQ  253 (321)
T ss_pred             cCHHHcCCCCCCCCCHHHHhc
Confidence            9999999       7777775

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to

>KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism]

Probab=100.00  E-value=1.6e-45  Score=313.82  Aligned_cols=241  Identities=22%  Similarity=0.271  Sum_probs=191.0

Q ss_pred             cccCCCCCCcEEEEEE-eCCCCEEEEEEeCCCCChhHHHHHHHHHHHhcCCCccccccceeeeeCC-----eeEEEEecC
Q 020221           62 VSEHGEKAPNVVYKGK-LENQFRIAVKRFNRSAWPDARQFLEEARAVGQLRNRRLANLLGCCCEGD-----ERLLVAEYM  135 (329)
Q Consensus        62 ~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~-----~~~lv~e~~  135 (329)
                      .+.+|.|+||.||+|. ..+++.||||++-.+..    .--+|+++|+.++|||||++..+|....     ...+||||+
T Consensus        29 ~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r----~knrEl~im~~l~HpNIV~L~~~f~~~~~~d~~~lnlVleym  104 (364)
T KOG0658|consen   29 VRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDKR----YKNRELQIMRKLDHPNIVRLLYFFSSSTESDEVYLNLVLEYM  104 (364)
T ss_pred             eEEEeecccceEEEEEEcCCCceeEEEEecCCCC----cCcHHHHHHHhcCCcCeeeEEEEEEecCCCchhHHHHHHHhc
Confidence            3455999999999999 55678999999866542    2236999999999999999998885532     345899999


Q ss_pred             CCCCHHhhhccC--CCCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCCC-CCeeeecccCcccCCCCC--
Q 020221          136 PNDTLAKHLFHW--ETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDD-VNPRLSCFGLMKNSRDGR--  210 (329)
Q Consensus       136 ~~gsL~~~l~~~--~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~-~~~kl~Dfg~a~~~~~~~--  210 (329)
                      +. +|..+++..  .++.++.-.++-+.+||++||.|||+. ||+||||||.|+|+|.+ |.+||+|||.|+....+.  
T Consensus       105 P~-tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~~-~IcHRDIKPqNlLvD~~tg~LKicDFGSAK~L~~~epn  182 (364)
T KOG0658|consen  105 PE-TLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHSH-GICHRDIKPQNLLVDPDTGVLKICDFGSAKVLVKGEPN  182 (364)
T ss_pred             hH-HHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHhc-CcccCCCChheEEEcCCCCeEEeccCCcceeeccCCCc
Confidence            88 899988632  256788888999999999999999998 99999999999999965 899999999999876654  


Q ss_pred             -CccCcccccCcccccCCC-CCCcccchhhhHHHHHHHhCCCCCCchhhHHHh----------------hhc-------h
Q 020221          211 -SYSTNLAFTPPEYLRTGR-VTPESVMYSFGTLLLDLLSGKHIPPSHALDLIR----------------DRN-------I  265 (329)
Q Consensus       211 -~~~~~~~y~aPE~~~~~~-~~~~~DvwslG~il~el~tg~~~~~~~~~~~~~----------------~~~-------~  265 (329)
                       ++..+..|.|||.+.|.. |+.+.||||.||++.||+-|++.|+++......                ...       .
T Consensus       183 iSYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~s~~dQL~eIik~lG~Pt~e~I~~mn~~y~~~~~  262 (364)
T KOG0658|consen  183 ISYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGDSSVDQLVEIIKVLGTPTREDIKSMNPNYTEFKF  262 (364)
T ss_pred             eeEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCCCHHHHHHHHHHHhCCCCHHHHhhcCcccccccC
Confidence             455688999999999876 999999999999999999999988875221110                000       0


Q ss_pred             hhhccccccCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 020221          266 QTLTDSCLEGQFSSDEGTELVRLASRCLQYEPRERPNPRSLVT  308 (329)
Q Consensus       266 ~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~~~l~  308 (329)
                      ..+....+..-+....++++.+|+.++|.++|.+|.++.+++.
T Consensus       263 p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l~  305 (364)
T KOG0658|consen  263 PQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLSALEALA  305 (364)
T ss_pred             cccccccceeecccCCCHHHHHHHHHHhccChhhcCCHHHHhc
Confidence            0000000111133456789999999999999999999999985

>cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6

Probab=100.00  E-value=5.3e-44  Score=314.98  Aligned_cols=249  Identities=18%  Similarity=0.226  Sum_probs=192.6

Q ss_pred             cccccccCCCCCCcEEEEEEe--CCCCEEEEEEeCCCCCh--hHHHHHHHHHHHhcC---CCccccccceeee-----eC
Q 020221           58 MENIVSEHGEKAPNVVYKGKL--ENQFRIAVKRFNRSAWP--DARQFLEEARAVGQL---RNRRLANLLGCCC-----EG  125 (329)
Q Consensus        58 ~~~~~~~lg~G~~g~V~~~~~--~~~~~vavK~~~~~~~~--~~~~~~~e~~~l~~l---~h~niv~~~~~~~-----~~  125 (329)
                      .|++++.||+|+||.||++..  .++..||+|.+......  ....+.+|+.+++.+   +||||+++++++.     ..
T Consensus         2 ~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~~   81 (290)
T cd07862           2 QYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDRE   81 (290)
T ss_pred             CcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCCCC
Confidence            467778889999999999984  34678999998754322  233456677776665   6999999999875     24


Q ss_pred             CeeEEEEecCCCCCHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCCCCCeeeecccCccc
Q 020221          126 DERLLVAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKN  205 (329)
Q Consensus       126 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~  205 (329)
                      ...++||||+. ++|.+++.......+++..+..++.|++.||.|||++ +++||||||+||+++.++.+||+|||++..
T Consensus        82 ~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~-~iiH~dlkp~Nil~~~~~~~kl~Dfg~~~~  159 (290)
T cd07862          82 TKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSH-RVVHRDLKPQNILVTSSGQIKLADFGLARI  159 (290)
T ss_pred             CcEEEEEccCC-CCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHC-CeeeCCCCHHHEEEcCCCCEEEccccceEe
Confidence            56899999997 5899998754556689999999999999999999999 999999999999999999999999999876


Q ss_pred             CCCC---CCccCcccccCcccccCCCCCCcccchhhhHHHHHHHhCCCCCCchhhHHHhhhchhhhc-------------
Q 020221          206 SRDG---RSYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLT-------------  269 (329)
Q Consensus       206 ~~~~---~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~~~~~~~~~~-------------  269 (329)
                      ....   ....+++.|+|||.+.+..++.++||||||+++|||++|..||.................             
T Consensus       160 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  239 (290)
T cd07862         160 YSFQMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDVAL  239 (290)
T ss_pred             ccCCcccccccccccccChHHHhCCCCCCccchHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhhchhhhcc
Confidence            5432   234578999999999888899999999999999999999988765422111111100000             


Q ss_pred             -ccccc--C-----CCChHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 020221          270 -DSCLE--G-----QFSSDEGTELVRLASRCLQYEPRERPNPRSLVT  308 (329)
Q Consensus       270 -~~~~~--~-----~~~~~~~~~~~~li~~cl~~dp~~Rps~~~~l~  308 (329)
                       .....  .     ......++.+.+++.+||+.||++|||+.++++
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~  286 (290)
T cd07862         240 PRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS  286 (290)
T ss_pred             cchhccCCCCCCHHHHccCCCHHHHHHHHHHhccCchhcCCHHHHhc
Confidence             00000  0     011235678899999999999999999999997

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla

>cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C

Probab=100.00  E-value=3.4e-44  Score=321.24  Aligned_cols=236  Identities=19%  Similarity=0.236  Sum_probs=193.9

Q ss_pred             ccccccCCCCCCcEEEEEE-eCCCCEEEEEEeCCCC---ChhHHHHHHHHHHHhcCCC-ccccccceeeeeCCeeEEEEe
Q 020221           59 ENIVSEHGEKAPNVVYKGK-LENQFRIAVKRFNRSA---WPDARQFLEEARAVGQLRN-RRLANLLGCCCEGDERLLVAE  133 (329)
Q Consensus        59 ~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h-~niv~~~~~~~~~~~~~lv~e  133 (329)
                      |++++.||+|+||.||+|. ..+++.||+|++....   ....+.+..|.+++..++| ++|+++.+++.+.+..++|||
T Consensus         2 y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E   81 (324)
T cd05587           2 FNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVME   81 (324)
T ss_pred             ceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCEEEEEEc
Confidence            5677888999999999998 4567899999987542   2234567789999999975 568888999988899999999


Q ss_pred             cCCCCCHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCCCCCeeeecccCcccCCC----C
Q 020221          134 YMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRD----G  209 (329)
Q Consensus       134 ~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~----~  209 (329)
                      |+++|+|.+++.  ....+++..+..++.||+.||.|||++ +++||||||+|||++.++.++|+|||++.....    .
T Consensus        82 ~~~~g~L~~~~~--~~~~~~~~~~~~~~~qi~~al~~lH~~-~ivH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~~~~~  158 (324)
T cd05587          82 YVNGGDLMYHIQ--QVGKFKEPHAVFYAAEIAIGLFFLHSK-GIIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGGKTT  158 (324)
T ss_pred             CCCCCcHHHHHH--HcCCCCHHHHHHHHHHHHHHHHHHHHC-CeEecCCCHHHeEEcCCCCEEEeecCcceecCCCCCce
Confidence            999999999886  345689999999999999999999999 999999999999999999999999999864321    1


Q ss_pred             CCccCcccccCcccccCCCCCCcccchhhhHHHHHHHhCCCCCCchhhHHHhhhchhhhccccccCCCChHHHHHHHHHH
Q 020221          210 RSYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLA  289 (329)
Q Consensus       210 ~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li  289 (329)
                      ....|++.|+|||++.+..++.++||||||+++|+|++|..||..............      ....++...++++.+++
T Consensus       159 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~~~~~~i~~------~~~~~~~~~~~~~~~li  232 (324)
T cd05587         159 RTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQSIME------HNVSYPKSLSKEAVSIC  232 (324)
T ss_pred             eeecCCccccChhhhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHc------CCCCCCCCCCHHHHHHH
Confidence            234578999999999998899999999999999999999988865433222221111      11234455678899999


Q ss_pred             HHhcccCCCCCCCH
Q 020221          290 SRCLQYEPRERPNP  303 (329)
Q Consensus       290 ~~cl~~dp~~Rps~  303 (329)
                      .+||..||++|++.
T Consensus       233 ~~~l~~~P~~R~~~  246 (324)
T cd05587         233 KGLLTKHPAKRLGC  246 (324)
T ss_pred             HHHhhcCHHHcCCC
Confidence            99999999999976

Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory

>cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta

Probab=100.00  E-value=3.7e-44  Score=319.82  Aligned_cols=236  Identities=19%  Similarity=0.216  Sum_probs=193.2

Q ss_pred             cCCCCCCcEEEEEEe-CCCCEEEEEEeCCCC---ChhHHHHHHHHHHHhcC-CCccccccceeeeeCCeeEEEEecCCCC
Q 020221           64 EHGEKAPNVVYKGKL-ENQFRIAVKRFNRSA---WPDARQFLEEARAVGQL-RNRRLANLLGCCCEGDERLLVAEYMPND  138 (329)
Q Consensus        64 ~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~~~g  138 (329)
                      .||+|+||.||++.. .+++.||+|.++...   .........|..++... +||||+++++++.+.+..++||||+.+|
T Consensus         2 ~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~g   81 (316)
T cd05620           2 VLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFLNGG   81 (316)
T ss_pred             eeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEECCCCCC
Confidence            469999999999994 568899999997542   12344567788887754 8999999999999999999999999999


Q ss_pred             CHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCCCCCeeeecccCcccCCC----CCCccC
Q 020221          139 TLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRD----GRSYST  214 (329)
Q Consensus       139 sL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~----~~~~~~  214 (329)
                      +|..++.  ....+++..+..++.|++.||+|||++ |++||||||+||+++.++.++|+|||++.....    .....|
T Consensus        82 ~L~~~i~--~~~~~~~~~~~~~~~qi~~~l~~lH~~-~ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~g  158 (316)
T cd05620          82 DLMFHIQ--DKGRFDLYRATFYAAEIVCGLQFLHSK-GIIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGDNRASTFCG  158 (316)
T ss_pred             cHHHHHH--HcCCCCHHHHHHHHHHHHHHHHHHHHC-CeEecCCCHHHeEECCCCCEEeCccCCCeecccCCCceeccCC
Confidence            9999886  345689999999999999999999999 999999999999999999999999999874321    223467


Q ss_pred             cccccCcccccCCCCCCcccchhhhHHHHHHHhCCCCCCchhhHHHhhhchhhhccccccCCCChHHHHHHHHHHHHhcc
Q 020221          215 NLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLASRCLQ  294 (329)
Q Consensus       215 ~~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~  294 (329)
                      ++.|+|||++.+..++.++||||||+++|+|++|..||..............      .....+...+.++.+++.+||.
T Consensus       159 t~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~Pf~~~~~~~~~~~~~~------~~~~~~~~~~~~~~~li~~~l~  232 (316)
T cd05620         159 TPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGDDEDELFESIRV------DTPHYPRWITKESKDILEKLFE  232 (316)
T ss_pred             CcCccCHHHHcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHh------CCCCCCCCCCHHHHHHHHHHcc
Confidence            8999999999988999999999999999999999998865543322221111      1122344567789999999999


Q ss_pred             cCCCCCCCHH-HHHH
Q 020221          295 YEPRERPNPR-SLVT  308 (329)
Q Consensus       295 ~dp~~Rps~~-~~l~  308 (329)
                      .||++||++. ++++
T Consensus       233 ~dP~~R~~~~~~~~~  247 (316)
T cd05620         233 RDPTRRLGVVGNIRG  247 (316)
T ss_pred             CCHHHcCCChHHHHc
Confidence            9999999984 5553

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I

>cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1

Probab=100.00  E-value=3.6e-44  Score=328.12  Aligned_cols=245  Identities=17%  Similarity=0.164  Sum_probs=195.9

Q ss_pred             cccccccCCCCCCcEEEEEE-eCCCCEEEEEEeCCCCC---hhHHHHHHHHHHHhcCCCccccccceeeeeCCeeEEEEe
Q 020221           58 MENIVSEHGEKAPNVVYKGK-LENQFRIAVKRFNRSAW---PDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAE  133 (329)
Q Consensus        58 ~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  133 (329)
                      .+++++.||+|+||+||+|. ..+++.||+|++.....   .....+.+|+++++.++|+||+++++.+.+.+..++|||
T Consensus         2 ~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~~~~lv~E   81 (382)
T cd05625           2 MFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMD   81 (382)
T ss_pred             CcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeCCEEEEEEe
Confidence            35677888999999999998 56788999999875421   224467889999999999999999999999999999999


Q ss_pred             cCCCCCHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCCCCCeeeecccCcccCCC-----
Q 020221          134 YMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRD-----  208 (329)
Q Consensus       134 ~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~-----  208 (329)
                      |+++|+|.+++.+  ...+++..+..++.||+.||.|||++ +|+||||||+|||++.++.+||+|||++.....     
T Consensus        82 ~~~gg~L~~~l~~--~~~~~e~~~~~~~~qi~~al~~lH~~-~ivHrDlKp~NILl~~~g~~kL~DFGla~~~~~~~~~~  158 (382)
T cd05625          82 YIPGGDMMSLLIR--MGIFPEDLARFYIAELTCAVESVHKM-GFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSK  158 (382)
T ss_pred             CCCCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhC-CeecCCCCHHHEEECCCCCEEEeECCCCcccccccccc
Confidence            9999999999863  35688999999999999999999999 999999999999999999999999999742210     


Q ss_pred             ----------------------------------------------CCCccCcccccCcccccCCCCCCcccchhhhHHH
Q 020221          209 ----------------------------------------------GRSYSTNLAFTPPEYLRTGRVTPESVMYSFGTLL  242 (329)
Q Consensus       209 ----------------------------------------------~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il  242 (329)
                                                                    .....||+.|+|||++.+..++.++|||||||++
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvil  238 (382)
T cd05625         159 YYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVIL  238 (382)
T ss_pred             ccccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCCCCCCeeeEEechHHH
Confidence                                                          0123578999999999988899999999999999


Q ss_pred             HHHHhCCCCCCchhhHHHhhhchhhhccccccCCCChHHHHHHHHHHHHhcccCCCCCCC---HHHHHH
Q 020221          243 LDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLASRCLQYEPRERPN---PRSLVT  308 (329)
Q Consensus       243 ~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps---~~~~l~  308 (329)
                      |||++|..||..............  .............++++.+++.+++ .+|++|++   +.++++
T Consensus       239 ~elltG~~Pf~~~~~~~~~~~i~~--~~~~~~~p~~~~~s~~~~~li~~l~-~~p~~R~~~~~~~ei~~  304 (382)
T cd05625         239 YEMLVGQPPFLAQTPLETQMKVIN--WQTSLHIPPQAKLSPEASDLIIKLC-RGPEDRLGKNGADEIKA  304 (382)
T ss_pred             HHHHhCCCCCCCCCHHHHHHHHHc--cCCCcCCCCcccCCHHHHHHHHHHc-cCHhHcCCCCCHHHHhc
Confidence            999999998865432221111111  0111111112345778899998876 59999997   777775

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an

>cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2

Probab=100.00  E-value=3.3e-44  Score=322.39  Aligned_cols=245  Identities=18%  Similarity=0.214  Sum_probs=196.2

Q ss_pred             ccccccCCCCCCcEEEEEEe----CCCCEEEEEEeCCCC----ChhHHHHHHHHHHHhcC-CCccccccceeeeeCCeeE
Q 020221           59 ENIVSEHGEKAPNVVYKGKL----ENQFRIAVKRFNRSA----WPDARQFLEEARAVGQL-RNRRLANLLGCCCEGDERL  129 (329)
Q Consensus        59 ~~~~~~lg~G~~g~V~~~~~----~~~~~vavK~~~~~~----~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~  129 (329)
                      |++++.||+|+||.||++..    .+++.||+|++....    ....+.+.+|+.++..+ +|+||+++++++...+..+
T Consensus         2 y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~   81 (332)
T cd05614           2 FELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEAKLH   81 (332)
T ss_pred             ceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecCCEEE
Confidence            56778889999999999874    357899999986532    12234577899999999 5999999999999999999


Q ss_pred             EEEecCCCCCHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCCCCCeeeecccCcccCCCC
Q 020221          130 LVAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDG  209 (329)
Q Consensus       130 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~  209 (329)
                      +||||+++|+|.+++.  ....+++..+..++.||+.||.|||+. +++||||||+|||++.++.+||+|||++......
T Consensus        82 lv~e~~~~g~L~~~l~--~~~~~~~~~~~~~~~qi~~~l~~lH~~-~ivHrDlkp~Nili~~~~~~kl~DfG~~~~~~~~  158 (332)
T cd05614          82 LILDYVSGGEMFTHLY--QRDNFSEDEVRFYSGEIILALEHLHKL-GIVYRDIKLENILLDSEGHVVLTDFGLSKEFLSE  158 (332)
T ss_pred             EEEeCCCCCcHHHHHH--HcCCCCHHHHHHHHHHHHHHHHHHHHC-CcEecCCCHHHeEECCCCCEEEeeCcCCcccccc
Confidence            9999999999999986  345689999999999999999999999 9999999999999999999999999998754322


Q ss_pred             -----CCccCcccccCcccccCCC-CCCcccchhhhHHHHHHHhCCCCCCchhhHHHhhhchhhhccccccCCCChHHHH
Q 020221          210 -----RSYSTNLAFTPPEYLRTGR-VTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGT  283 (329)
Q Consensus       210 -----~~~~~~~~y~aPE~~~~~~-~~~~~DvwslG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  283 (329)
                           ....||+.|+|||++.+.. ++.++||||||+++|||++|..||...............+..  .....+...++
T Consensus       159 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~  236 (332)
T cd05614         159 EKERTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQSEVSRRILK--CDPPFPSFIGP  236 (332)
T ss_pred             CCCccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCCCCCCCHHHHHHHHhc--CCCCCCCCCCH
Confidence                 2346889999999998654 788999999999999999999887532111000000111111  11234455678


Q ss_pred             HHHHHHHHhcccCCCCCC-----CHHHHHH
Q 020221          284 ELVRLASRCLQYEPRERP-----NPRSLVT  308 (329)
Q Consensus       284 ~~~~li~~cl~~dp~~Rp-----s~~~~l~  308 (329)
                      .+.+++.+||+.||++||     ++.++++
T Consensus       237 ~~~~li~~~l~~dp~~R~~~~~~~~~~~l~  266 (332)
T cd05614         237 EAQDLLHKLLRKDPKKRLGAGPQGASEIKE  266 (332)
T ss_pred             HHHHHHHHHcCCCHHHcCCCCCCCHHHHHc
Confidence            899999999999999999     6777776

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph

>cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=3.6e-44  Score=327.61  Aligned_cols=245  Identities=16%  Similarity=0.112  Sum_probs=195.9

Q ss_pred             cccccccCCCCCCcEEEEEE-eCCCCEEEEEEeCCCC---ChhHHHHHHHHHHHhcCCCccccccceeeeeCCeeEEEEe
Q 020221           58 MENIVSEHGEKAPNVVYKGK-LENQFRIAVKRFNRSA---WPDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAE  133 (329)
Q Consensus        58 ~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  133 (329)
                      .|.+++.||.|+||.||++. ..+++.||+|++....   ....+.+.+|+++++.++||||+++++++.+....++|||
T Consensus         2 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~E   81 (377)
T cd05629           2 DFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQDAQYLYLIME   81 (377)
T ss_pred             CceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCeeEEEEe
Confidence            45677888999999999998 5678899999986532   1224567889999999999999999999999999999999


Q ss_pred             cCCCCCHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCCCCCeeeecccCcccCCCC----
Q 020221          134 YMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDG----  209 (329)
Q Consensus       134 ~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~----  209 (329)
                      |+++|+|.+++.  ....+++..+..++.|++.||+|||+. |++||||||+|||++.++.++|+|||+++.....    
T Consensus        82 ~~~gg~L~~~l~--~~~~~~~~~~~~~~~ql~~aL~~LH~~-givHrDlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~  158 (377)
T cd05629          82 FLPGGDLMTMLI--KYDTFSEDVTRFYMAECVLAIEAVHKL-GFIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQHDSA  158 (377)
T ss_pred             CCCCCcHHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHhC-CeeccCCCHHHEEECCCCCEEEeecccccccccccccc
Confidence            999999999986  345789999999999999999999999 9999999999999999999999999998532110    


Q ss_pred             -----------------------------------------------CCccCcccccCcccccCCCCCCcccchhhhHHH
Q 020221          210 -----------------------------------------------RSYSTNLAFTPPEYLRTGRVTPESVMYSFGTLL  242 (329)
Q Consensus       210 -----------------------------------------------~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il  242 (329)
                                                                     ....||+.|+|||++.+..++.++|||||||++
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil  238 (377)
T cd05629         159 YYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDWWSLGAIM  238 (377)
T ss_pred             cccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccCCCCCceeeEecchhh
Confidence                                                           013578999999999988899999999999999


Q ss_pred             HHHHhCCCCCCchhhHHHhhhchhhhccccccCCCChHHHHHHHHHHHHhcccCCCCC---CCHHHHHH
Q 020221          243 LDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLASRCLQYEPRER---PNPRSLVT  308 (329)
Q Consensus       243 ~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~R---ps~~~~l~  308 (329)
                      |||++|..||............... ... ..-......+.++.+++.+||. +|.+|   +++.++++
T Consensus       239 ~elltG~~Pf~~~~~~~~~~~i~~~-~~~-~~~p~~~~~s~~~~dli~~lL~-~~~~r~~r~~~~~~l~  304 (377)
T cd05629         239 FECLIGWPPFCSENSHETYRKIINW-RET-LYFPDDIHLSVEAEDLIRRLIT-NAENRLGRGGAHEIKS  304 (377)
T ss_pred             hhhhcCCCCCCCCCHHHHHHHHHcc-CCc-cCCCCCCCCCHHHHHHHHHHhc-CHhhcCCCCCHHHHhc
Confidence            9999999888654322211111110 000 0101112356789999999997 77765   59999887

Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of

>PTZ00267 NIMA-related protein kinase; Provisional

Probab=100.00  E-value=6.1e-44  Score=334.91  Aligned_cols=245  Identities=18%  Similarity=0.202  Sum_probs=203.2

Q ss_pred             cccccccCCCCCCcEEEEEEe-CC-CCEEEEEEeCCCCChhHHHHHHHHHHHhcCCCccccccceeeeeCCeeEEEEecC
Q 020221           58 MENIVSEHGEKAPNVVYKGKL-EN-QFRIAVKRFNRSAWPDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAEYM  135 (329)
Q Consensus        58 ~~~~~~~lg~G~~g~V~~~~~-~~-~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~  135 (329)
                      .|.+.+.+|+|++|.||++.. .+ +..||+|.+..........+.+|+.+++.++||||+++++++...+..++||||+
T Consensus        68 ~y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~E~~  147 (478)
T PTZ00267         68 MYVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLNDERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLLIMEYG  147 (478)
T ss_pred             eEEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEECCEEEEEEECC
Confidence            477888889999999999983 34 6789999876655444556788999999999999999999999999999999999


Q ss_pred             CCCCHHhhhccC--CCCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCCCCCeeeecccCcccCCCC----
Q 020221          136 PNDTLAKHLFHW--ETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDG----  209 (329)
Q Consensus       136 ~~gsL~~~l~~~--~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~----  209 (329)
                      ++|+|.+++.+.  ....+++..+..++.|++.||.|||+. +|+||||||+|||++.++.+||+|||++......    
T Consensus       148 ~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~-~ivHrDlkp~NIll~~~~~~kL~DFgla~~~~~~~~~~  226 (478)
T PTZ00267        148 SGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSR-KMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVSLD  226 (478)
T ss_pred             CCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhC-CEEECCcCHHhEEECCCCcEEEEeCcCceecCCccccc
Confidence            999999887532  344688999999999999999999999 9999999999999999999999999999865432    


Q ss_pred             --CCccCcccccCcccccCCCCCCcccchhhhHHHHHHHhCCCCCCchhhHHHhhhchhhhccccccCCCChHHHHHHHH
Q 020221          210 --RSYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVR  287 (329)
Q Consensus       210 --~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  287 (329)
                        ....||+.|+|||++.+..++.++||||||+++|+|++|..||.................     ...+...+.++.+
T Consensus       227 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~Pf~~~~~~~~~~~~~~~~~-----~~~~~~~s~~~~~  301 (478)
T PTZ00267        227 VASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKGPSQREIMQQVLYGKY-----DPFPCPVSSGMKA  301 (478)
T ss_pred             cccccCCCccccCHhHhCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCC-----CCCCccCCHHHHH
Confidence              234589999999999988899999999999999999999988865433222222111111     1234456788999


Q ss_pred             HHHHhcccCCCCCCCHHHHHH
Q 020221          288 LASRCLQYEPRERPNPRSLVT  308 (329)
Q Consensus       288 li~~cl~~dp~~Rps~~~~l~  308 (329)
                      ++..||..||++||++.+++.
T Consensus       302 li~~~L~~dP~~Rps~~~~l~  322 (478)
T PTZ00267        302 LLDPLLSKNPALRPTTQQLLH  322 (478)
T ss_pred             HHHHHhccChhhCcCHHHHHh
Confidence            999999999999999999875

>cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta

Probab=100.00  E-value=6.4e-44  Score=318.27  Aligned_cols=236  Identities=19%  Similarity=0.263  Sum_probs=192.1

Q ss_pred             cCCCCCCcEEEEEEe-CCCCEEEEEEeCCCC---ChhHHHHHHHHHHHhcC-CCccccccceeeeeCCeeEEEEecCCCC
Q 020221           64 EHGEKAPNVVYKGKL-ENQFRIAVKRFNRSA---WPDARQFLEEARAVGQL-RNRRLANLLGCCCEGDERLLVAEYMPND  138 (329)
Q Consensus        64 ~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~~~g  138 (329)
                      .||+|+||.||+|.. .+++.||+|.++...   ....+.+..|..++... +||||+++++++......++||||+++|
T Consensus         2 ~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~gg   81 (316)
T cd05592           2 VLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEYLNGG   81 (316)
T ss_pred             eeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCCC
Confidence            469999999999994 567899999987542   12234456677777654 8999999999999999999999999999


Q ss_pred             CHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCCCCCeeeecccCcccCCCC----CCccC
Q 020221          139 TLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDG----RSYST  214 (329)
Q Consensus       139 sL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~----~~~~~  214 (329)
                      +|..++.  ....+++..+..++.|++.||.|||+. +++||||||+||+++.++.+||+|||++......    ....|
T Consensus        82 ~L~~~~~--~~~~~~~~~~~~~~~qi~~al~~LH~~-~ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~~~~~~~g  158 (316)
T cd05592          82 DLMFHIQ--SSGRFDEARARFYAAEIICGLQFLHKK-GIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGEGKASTFCG  158 (316)
T ss_pred             cHHHHHH--HcCCCCHHHHHHHHHHHHHHHHHHHHC-CEEeCCCCHHHeEECCCCCEEEccCcCCeECCCCCCccccccC
Confidence            9999886  345689999999999999999999999 9999999999999999999999999998754322    23467


Q ss_pred             cccccCcccccCCCCCCcccchhhhHHHHHHHhCCCCCCchhhHHHhhhchhhhccccccCCCChHHHHHHHHHHHHhcc
Q 020221          215 NLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLASRCLQ  294 (329)
Q Consensus       215 ~~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~  294 (329)
                      |+.|+|||++.+..++.++||||||+++|+|++|..||.............    .  ....++...+.++.+++.+||+
T Consensus       159 t~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~Pf~~~~~~~~~~~i~----~--~~~~~~~~~~~~~~~ll~~~l~  232 (316)
T cd05592         159 TPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHGEDEDELFDSIL----N--DRPHFPRWISKEAKDCLSKLFE  232 (316)
T ss_pred             CccccCHHHHcCCCCCCcccchhHHHHHHHHHhCCCCCCCCCHHHHHHHHH----c--CCCCCCCCCCHHHHHHHHHHcc
Confidence            899999999998889999999999999999999999886544332222111    1  1123345567889999999999


Q ss_pred             cCCCCCCCHH-HHHH
Q 020221          295 YEPRERPNPR-SLVT  308 (329)
Q Consensus       295 ~dp~~Rps~~-~~l~  308 (329)
                      .||++||++. ++++
T Consensus       233 ~~P~~R~~~~~~l~~  247 (316)
T cd05592         233 RDPTKRLGVDGDIRQ  247 (316)
T ss_pred             CCHHHcCCChHHHHc
Confidence            9999999875 5544

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp

>cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase

Probab=100.00  E-value=5.3e-44  Score=325.28  Aligned_cols=246  Identities=16%  Similarity=0.143  Sum_probs=200.5

Q ss_pred             CCCcccccccCCCCCCcEEEEEE-eCCCCEEEEEEeCCCC---ChhHHHHHHHHHHHhcCCCccccccceeeeeCCeeEE
Q 020221           55 GFAMENIVSEHGEKAPNVVYKGK-LENQFRIAVKRFNRSA---WPDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLL  130 (329)
Q Consensus        55 ~~~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l  130 (329)
                      ....|++++.||+|+||.||++. ..+++.||+|.+....   ......+.+|+.+++.++||||+++++++.++...++
T Consensus        41 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~~~~~~l  120 (370)
T cd05596          41 KAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQDDKYLYM  120 (370)
T ss_pred             CHHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEEEE
Confidence            44567788889999999999998 4568899999986432   1223457789999999999999999999999999999


Q ss_pred             EEecCCCCCHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCCCCCeeeecccCcccCCCC-
Q 020221          131 VAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDG-  209 (329)
Q Consensus       131 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~-  209 (329)
                      ||||+++|+|.+++.   ...+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||++...... 
T Consensus       121 v~Ey~~gg~L~~~l~---~~~l~~~~~~~~~~qi~~aL~~LH~~-~ivHrDLkp~NILl~~~~~~kL~DfG~~~~~~~~~  196 (370)
T cd05596         121 VMEYMPGGDLVNLMS---NYDIPEKWARFYTAEVVLALDAIHSM-GFIHRDVKPDNMLLDKSGHLKLADFGTCMKMDANG  196 (370)
T ss_pred             EEcCCCCCcHHHHHH---hcCCCHHHHHHHHHHHHHHHHHHHHC-CeeccCCCHHHEEEcCCCCEEEEeccceeeccCCC
Confidence            999999999999884   34688899999999999999999999 9999999999999999999999999998765432 


Q ss_pred             ----CCccCcccccCcccccCC----CCCCcccchhhhHHHHHHHhCCCCCCchhhHHHhhhchhhhccccccCCCC--h
Q 020221          210 ----RSYSTNLAFTPPEYLRTG----RVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFS--S  279 (329)
Q Consensus       210 ----~~~~~~~~y~aPE~~~~~----~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~  279 (329)
                          ....|++.|+|||++.+.    .++.++|||||||++|||++|..||.............    .......++  .
T Consensus       197 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~----~~~~~~~~~~~~  272 (370)
T cd05596         197 MVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIM----DHKNSLTFPDDI  272 (370)
T ss_pred             cccCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCCHHHHHHHHH----cCCCcCCCCCcC
Confidence                234688999999998653    37889999999999999999999887654332222111    111011122  2


Q ss_pred             HHHHHHHHHHHHhcccCCCC--CCCHHHHHH
Q 020221          280 DEGTELVRLASRCLQYEPRE--RPNPRSLVT  308 (329)
Q Consensus       280 ~~~~~~~~li~~cl~~dp~~--Rps~~~~l~  308 (329)
                      ..+.++.+++.+||..+|++  |+++.++++
T Consensus       273 ~~s~~~~~li~~~L~~~p~r~~R~s~~ell~  303 (370)
T cd05596         273 EISKQAKDLICAFLTDREVRLGRNGVDEIKS  303 (370)
T ss_pred             CCCHHHHHHHHHHccChhhccCCCCHHHHhc
Confidence            45789999999999999988  999999987

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in

>cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta

Probab=100.00  E-value=5.6e-44  Score=318.58  Aligned_cols=236  Identities=19%  Similarity=0.229  Sum_probs=192.8

Q ss_pred             cCCCCCCcEEEEEEe-CCCCEEEEEEeCCCC---ChhHHHHHHHHHHHhcC-CCccccccceeeeeCCeeEEEEecCCCC
Q 020221           64 EHGEKAPNVVYKGKL-ENQFRIAVKRFNRSA---WPDARQFLEEARAVGQL-RNRRLANLLGCCCEGDERLLVAEYMPND  138 (329)
Q Consensus        64 ~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~~~g  138 (329)
                      .||+|+||.||+|.. .+++.||+|.++...   .........|..++... +||||+++++++.+.+..++||||+++|
T Consensus         2 ~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ey~~~g   81 (316)
T cd05619           2 MLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEYLNGG   81 (316)
T ss_pred             eeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEEeCCCCC
Confidence            469999999999994 557899999987642   12234566777887764 8999999999999999999999999999


Q ss_pred             CHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCCCCCeeeecccCcccCCC----CCCccC
Q 020221          139 TLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRD----GRSYST  214 (329)
Q Consensus       139 sL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~----~~~~~~  214 (329)
                      +|..++.  ....+++.++..++.|++.||.|||+. +++||||||+||+++.++.++|+|||++.....    .....|
T Consensus        82 ~L~~~l~--~~~~~~~~~~~~~~~qi~~al~~LH~~-~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~g  158 (316)
T cd05619          82 DLMFHIQ--SCHKFDLPRATFYAAEIICGLQFLHSK-GIVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDAKTCTFCG  158 (316)
T ss_pred             cHHHHHH--HcCCCCHHHHHHHHHHHHHHHHHHHhC-CeEeCCCCHHHEEECCCCCEEEccCCcceECCCCCCceeeecC
Confidence            9999986  345689999999999999999999999 999999999999999999999999999875322    123467


Q ss_pred             cccccCcccccCCCCCCcccchhhhHHHHHHHhCCCCCCchhhHHHhhhchhhhccccccCCCChHHHHHHHHHHHHhcc
Q 020221          215 NLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLASRCLQ  294 (329)
Q Consensus       215 ~~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~  294 (329)
                      +..|+|||++.+..++.++||||||+++|+|++|..||..............      ....++...+.++.+++.+||+
T Consensus       159 t~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~~~~~i~~------~~~~~~~~~~~~~~~li~~~l~  232 (316)
T cd05619         159 TPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHGHDEEELFQSIRM------DNPCYPRWLTREAKDILVKLFV  232 (316)
T ss_pred             CccccCHHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHh------CCCCCCccCCHHHHHHHHHHhc
Confidence            8999999999988899999999999999999999988865433222221111      1112344567789999999999


Q ss_pred             cCCCCCCCHH-HHHH
Q 020221          295 YEPRERPNPR-SLVT  308 (329)
Q Consensus       295 ~dp~~Rps~~-~~l~  308 (329)
                      .||++||++. ++++
T Consensus       233 ~~P~~R~~~~~~l~~  247 (316)
T cd05619         233 REPERRLGVKGDIRQ  247 (316)
T ss_pred             cCHhhcCCChHHHHc
Confidence            9999999997 5654

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in

>cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants

Probab=100.00  E-value=5.3e-44  Score=321.73  Aligned_cols=246  Identities=19%  Similarity=0.294  Sum_probs=192.1

Q ss_pred             ccccccCCCCCCcEEEEEE-eCCCCEEEEEEeCCCC--ChhHHHHHHHHHHHhcCCCccccccceeeeeC-----CeeEE
Q 020221           59 ENIVSEHGEKAPNVVYKGK-LENQFRIAVKRFNRSA--WPDARQFLEEARAVGQLRNRRLANLLGCCCEG-----DERLL  130 (329)
Q Consensus        59 ~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~-----~~~~l  130 (329)
                      |++.+.||+|+||.||+|. ..+++.||+|++....  ......+.+|+++++.++||||+++++++...     ...++
T Consensus         2 y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~l   81 (338)
T cd07859           2 YKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIYV   81 (338)
T ss_pred             eEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhccchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceEEE
Confidence            5677788999999999999 5578899999987532  22345688999999999999999999987543     35799


Q ss_pred             EEecCCCCCHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCCCCCeeeecccCcccCCCC-
Q 020221          131 VAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDG-  209 (329)
Q Consensus       131 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~-  209 (329)
                      ||||+. ++|.+++.  ....+++..+..++.||+.||.|||+. +++||||||+|||++.++.+||+|||+++..... 
T Consensus        82 v~e~~~-~~L~~~l~--~~~~~~~~~~~~i~~qi~~aL~~LH~~-~ivH~dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~  157 (338)
T cd07859          82 VFELME-SDLHQVIK--ANDDLTPEHHQFFLYQLLRALKYIHTA-NVFHRDLKPKNILANADCKLKICDFGLARVAFNDT  157 (338)
T ss_pred             EEecCC-CCHHHHHH--hcccCCHHHHHHHHHHHHHHHHHHHHC-CeecCCCCHHHeEECCCCcEEEccCcccccccccc
Confidence            999996 58998886  345689999999999999999999999 9999999999999999999999999998754321 


Q ss_pred             ------CCccCcccccCcccccC--CCCCCcccchhhhHHHHHHHhCCCCCCchhhHHHh-------------------h
Q 020221          210 ------RSYSTNLAFTPPEYLRT--GRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIR-------------------D  262 (329)
Q Consensus       210 ------~~~~~~~~y~aPE~~~~--~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~~-------------------~  262 (329)
                            ....++..|+|||++.+  ..++.++||||||+++|+|++|+.||.........                   .
T Consensus       158 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~i~~  237 (338)
T cd07859         158 PTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLITDLLGTPSPETISRVRN  237 (338)
T ss_pred             CccccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhhh
Confidence                  23457899999999875  56899999999999999999999887643211100                   0


Q ss_pred             hchhhhcc---ccccCCC---ChHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 020221          263 RNIQTLTD---SCLEGQF---SSDEGTELVRLASRCLQYEPRERPNPRSLVT  308 (329)
Q Consensus       263 ~~~~~~~~---~~~~~~~---~~~~~~~~~~li~~cl~~dp~~Rps~~~~l~  308 (329)
                      ........   .......   ....++++.+++.+||+.||++|||+.++++
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~e~l~  289 (338)
T cd07859         238 EKARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEALA  289 (338)
T ss_pred             hhHHHHHHhhcccCCCchHHhcCCCChHHHHHHHHHcCcCcccCCCHHHHhc
Confidence            00000000   0000000   0124567899999999999999999999997

Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos

>cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor

Probab=100.00  E-value=2.6e-44  Score=328.50  Aligned_cols=245  Identities=17%  Similarity=0.165  Sum_probs=197.9

Q ss_pred             cccccccCCCCCCcEEEEEE-eCCCCEEEEEEeCCCCC---hhHHHHHHHHHHHhcCCCccccccceeeeeCCeeEEEEe
Q 020221           58 MENIVSEHGEKAPNVVYKGK-LENQFRIAVKRFNRSAW---PDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAE  133 (329)
Q Consensus        58 ~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  133 (329)
                      .|++++.||+|+||.||++. ..+++.||+|++.....   .....+.+|+++++.++|+||+++++.+.+++..++|||
T Consensus         2 ~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~E   81 (376)
T cd05598           2 MFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMD   81 (376)
T ss_pred             CceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcCCEEEEEEe
Confidence            57788889999999999998 55688999999865321   224457889999999999999999999999999999999


Q ss_pred             cCCCCCHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCCCCCeeeecccCcccCCC-----
Q 020221          134 YMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRD-----  208 (329)
Q Consensus       134 ~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~-----  208 (329)
                      |+++|+|.+++.  ....+++..+..++.||+.||+|||++ +|+||||||+|||++.++.++|+|||++.....     
T Consensus        82 ~~~~g~L~~~i~--~~~~~~~~~~~~~~~qi~~al~~lH~~-~ivHrDlkp~Nill~~~~~ikL~DFG~a~~~~~~~~~~  158 (376)
T cd05598          82 YIPGGDMMSLLI--RLGIFEEDLARFYIAELTCAIESVHKM-GFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSK  158 (376)
T ss_pred             CCCCCcHHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHHC-CeEeCCCCHHHEEECCCCCEEEEeCCCCcccccccccc
Confidence            999999999986  345688999999999999999999999 999999999999999999999999999742210     


Q ss_pred             ------------------------------------------CCCccCcccccCcccccCCCCCCcccchhhhHHHHHHH
Q 020221          209 ------------------------------------------GRSYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLL  246 (329)
Q Consensus       209 ------------------------------------------~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~  246 (329)
                                                                .....||+.|+|||++.+..++.++|||||||++|||+
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyell  238 (376)
T cd05598         159 YYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYEML  238 (376)
T ss_pred             ccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCCCCcceeeeeccceeeehh
Confidence                                                      01235889999999999888999999999999999999


Q ss_pred             hCCCCCCchhhHHHhhhchhhhccccccCCCChHHHHHHHHHHHHhcccCCCCCC---CHHHHHH
Q 020221          247 SGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLASRCLQYEPRERP---NPRSLVT  308 (329)
Q Consensus       247 tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rp---s~~~~l~  308 (329)
                      +|+.||..............  .............++++.+++.+|+ .+|++|+   ++.++++
T Consensus       239 ~G~~Pf~~~~~~~~~~~i~~--~~~~~~~~~~~~~s~~~~~li~~l~-~~p~~R~~~~t~~ell~  300 (376)
T cd05598         239 VGQPPFLADTPAETQLKVIN--WETTLHIPSQAKLSREASDLILRLC-CGAEDRLGKNGADEIKA  300 (376)
T ss_pred             hCCCCCCCCCHHHHHHHHhc--cCccccCCCCCCCCHHHHHHHHHHh-cCHhhcCCCCCHHHHhC
Confidence            99998865433222111111  0111111122345778899999977 5999999   8899887

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation.

>cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C

Probab=100.00  E-value=6.1e-44  Score=318.74  Aligned_cols=236  Identities=19%  Similarity=0.261  Sum_probs=195.0

Q ss_pred             cCCCCCCcEEEEEEe-CCCCEEEEEEeCCCC---ChhHHHHHHHHHHHhcC-CCccccccceeeeeCCeeEEEEecCCCC
Q 020221           64 EHGEKAPNVVYKGKL-ENQFRIAVKRFNRSA---WPDARQFLEEARAVGQL-RNRRLANLLGCCCEGDERLLVAEYMPND  138 (329)
Q Consensus        64 ~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~~~g  138 (329)
                      .||+|+||+||++.. .+++.||+|+++...   ......+.+|..+++.+ +||||+++++++...+..++||||+++|
T Consensus         2 ~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~   81 (318)
T cd05570           2 VLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYVNGG   81 (318)
T ss_pred             eeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCCC
Confidence            469999999999984 467899999987542   22345567888888888 6999999999999999999999999999


Q ss_pred             CHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCCCCCeeeecccCcccCCCC----CCccC
Q 020221          139 TLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDG----RSYST  214 (329)
Q Consensus       139 sL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~----~~~~~  214 (329)
                      +|..++.  ....+++..+..++.|++.||.|||+. +++||||||+||+++.++.++|+|||++......    ....+
T Consensus        82 ~L~~~~~--~~~~l~~~~~~~~~~qi~~~l~~LH~~-~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~g  158 (318)
T cd05570          82 DLMFHIQ--RSGRFDEPRARFYAAEIVLGLQFLHER-GIIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGVTTSTFCG  158 (318)
T ss_pred             CHHHHHH--HcCCCCHHHHHHHHHHHHHHHHHHHhC-CeEccCCCHHHeEECCCCcEEecccCCCeecCcCCCcccceec
Confidence            9999886  345799999999999999999999999 9999999999999999999999999998643221    23357


Q ss_pred             cccccCcccccCCCCCCcccchhhhHHHHHHHhCCCCCCchhhHHHhhhchhhhccccccCCCChHHHHHHHHHHHHhcc
Q 020221          215 NLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLASRCLQ  294 (329)
Q Consensus       215 ~~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~  294 (329)
                      ++.|+|||++.+..++.++|||||||++|+|++|..||..............    .  ....+...+.++.+++.+||.
T Consensus       159 ~~~y~aPE~~~~~~~~~~~DiwslGvil~~l~~G~~pf~~~~~~~~~~~i~~----~--~~~~~~~~~~~~~~li~~~l~  232 (318)
T cd05570         159 TPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGDDEDELFQSILE----D--EVRYPRWLSKEAKSILKSFLT  232 (318)
T ss_pred             CccccCHHHhcCCCCCcchhhhhHHHHHHHHhhCCCCCCCCCHHHHHHHHHc----C--CCCCCCcCCHHHHHHHHHHcc
Confidence            8999999999998999999999999999999999998865433222221111    1  112344567889999999999


Q ss_pred             cCCCCCCCH-----HHHHH
Q 020221          295 YEPRERPNP-----RSLVT  308 (329)
Q Consensus       295 ~dp~~Rps~-----~~~l~  308 (329)
                      .||++||++     .++++
T Consensus       233 ~dP~~R~s~~~~~~~~ll~  251 (318)
T cd05570         233 KNPEKRLGCLPTGEQDIKG  251 (318)
T ss_pred             CCHHHcCCCCCCCHHHHhc
Confidence            999999999     77775

Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re

>cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases

Probab=100.00  E-value=1.4e-43  Score=310.67  Aligned_cols=249  Identities=22%  Similarity=0.328  Sum_probs=203.7

Q ss_pred             cccccccCCCCCCcEEEEEEeC------CCCEEEEEEeCCCCCh-hHHHHHHHHHHHhcCCCccccccceeeeeCCeeEE
Q 020221           58 MENIVSEHGEKAPNVVYKGKLE------NQFRIAVKRFNRSAWP-DARQFLEEARAVGQLRNRRLANLLGCCCEGDERLL  130 (329)
Q Consensus        58 ~~~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l  130 (329)
                      .+.+++.+|+|+||.||+|...      ++..||+|.+...... ..+.+.+|+++++.++|+||+++++++......++
T Consensus         6 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l   85 (280)
T cd05049           6 TIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVKFYGVCTEGDPPIM   85 (280)
T ss_pred             HhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccCCHHHHHHHHHHHHHHHhcCCCCchheeeEEecCCCeEE
Confidence            4567778899999999999853      2478999999876544 35678999999999999999999999999999999


Q ss_pred             EEecCCCCCHHhhhccCC------------CCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCCCCCeeee
Q 020221          131 VAEYMPNDTLAKHLFHWE------------TQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLS  198 (329)
Q Consensus       131 v~e~~~~gsL~~~l~~~~------------~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~  198 (329)
                      +|||+++++|.+++....            ...+++..+..++.|++.||.|||++ +++|+||||+||+++.++.++|+
T Consensus        86 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~-~i~h~dlkp~nili~~~~~~kl~  164 (280)
T cd05049          86 VFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQ-HFVHRDLATRNCLVGYDLVVKIG  164 (280)
T ss_pred             EEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhC-CeeccccccceEEEcCCCeEEEC
Confidence            999999999999986421            23578899999999999999999999 99999999999999999999999


Q ss_pred             cccCcccCCCC------CCccCcccccCcccccCCCCCCcccchhhhHHHHHHHh-CCCCCCchhhHHHhhhchhhhccc
Q 020221          199 CFGLMKNSRDG------RSYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLS-GKHIPPSHALDLIRDRNIQTLTDS  271 (329)
Q Consensus       199 Dfg~a~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t-g~~~~~~~~~~~~~~~~~~~~~~~  271 (329)
                      |||++......      ....+++.|+|||++.+..++.++||||||+++|+|++ |..|+...............    
T Consensus       165 d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~e~~~~g~~p~~~~~~~~~~~~~~~~----  240 (280)
T cd05049         165 DFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLSNEEVIECITQG----  240 (280)
T ss_pred             CcccceecccCcceecCCCCcccceecChhhhccCCcchhhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcC----
Confidence            99998754322      12234678999999999899999999999999999998 88877554333222211111    


Q ss_pred             cccCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHh
Q 020221          272 CLEGQFSSDEGTELVRLASRCLQYEPRERPNPRSLVTALVT  312 (329)
Q Consensus       272 ~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~~~l~~L~~  312 (329)
                       .....+...+..+.+++.+||+.||++||++.++++.|++
T Consensus       241 -~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~l~~  280 (280)
T cd05049         241 -RLLQRPRTCPSEVYDIMLGCWKRDPQQRINIKDIHERLQK  280 (280)
T ss_pred             -CcCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhhC
Confidence             1112234567889999999999999999999999998863

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt

>cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C

Probab=100.00  E-value=7.8e-44  Score=319.47  Aligned_cols=240  Identities=15%  Similarity=0.217  Sum_probs=193.4

Q ss_pred             cCCCCCCcEEEEEE-eCCCCEEEEEEeCCCC---ChhHHHHHHHHHHHhcC-CCccccccceeeeeCCeeEEEEecCCCC
Q 020221           64 EHGEKAPNVVYKGK-LENQFRIAVKRFNRSA---WPDARQFLEEARAVGQL-RNRRLANLLGCCCEGDERLLVAEYMPND  138 (329)
Q Consensus        64 ~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~~~g  138 (329)
                      .||+|+||.||++. ..+++.||+|+++...   ....+.+.+|..++..+ +||||+++++++.+....++||||+++|
T Consensus         2 ~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~e~~~~g   81 (329)
T cd05588           2 VIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEFVSGG   81 (329)
T ss_pred             eEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEEeCCCCC
Confidence            46999999999998 4568899999997642   22344578899999888 7999999999999999999999999999


Q ss_pred             CHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCCCCCeeeecccCcccCCC----CCCccC
Q 020221          139 TLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRD----GRSYST  214 (329)
Q Consensus       139 sL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~----~~~~~~  214 (329)
                      +|..++.  ....+++..+..++.|++.||.|||++ |++||||||+||+++.++.+||+|||++.....    .....|
T Consensus        82 ~L~~~~~--~~~~l~~~~~~~~~~qi~~~l~~lH~~-~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~~~~~~~~~g  158 (329)
T cd05588          82 DLMFHMQ--RQRKLPEEHARFYSAEISLALNFLHER-GIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPGDTTSTFCG  158 (329)
T ss_pred             CHHHHHH--HcCCCCHHHHHHHHHHHHHHHHHHHHC-CeEecCCCHHHeEECCCCCEEECcCccccccccCCCccccccC
Confidence            9998885  346799999999999999999999999 999999999999999999999999999864221    123467


Q ss_pred             cccccCcccccCCCCCCcccchhhhHHHHHHHhCCCCCCchhhHH-----HhhhchhhhccccccCCCChHHHHHHHHHH
Q 020221          215 NLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDL-----IRDRNIQTLTDSCLEGQFSSDEGTELVRLA  289 (329)
Q Consensus       215 ~~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~~~~~li  289 (329)
                      |+.|+|||++.+..++.++|+||||+++|+|++|..||.......     ........+...  ....+...+.++.+++
T Consensus       159 t~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~--~~~~p~~~~~~~~~li  236 (329)
T cd05588         159 TPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVILEK--QIRIPRSLSVKASSVL  236 (329)
T ss_pred             CccccCHHHHcCCCCCCccceechHHHHHHHHHCCCCcccccccccccccchHHHHHHHHcC--CCCCCCCCCHHHHHHH
Confidence            899999999999889999999999999999999998874211000     000001111111  1124455678899999


Q ss_pred             HHhcccCCCCCCC------HHHHHH
Q 020221          290 SRCLQYEPRERPN------PRSLVT  308 (329)
Q Consensus       290 ~~cl~~dp~~Rps------~~~~l~  308 (329)
                      .+||+.||++||+      +.++++
T Consensus       237 ~~~L~~dP~~R~~~~~~~~~~~i~~  261 (329)
T cd05588         237 KGFLNKDPKERLGCHPQTGFRDIKS  261 (329)
T ss_pred             HHHhccCHHHcCCCCCCCCHHHHhc
Confidence            9999999999998      566664

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl

>cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=2e-43  Score=306.55  Aligned_cols=249  Identities=21%  Similarity=0.317  Sum_probs=205.6

Q ss_pred             cccccccCCCCCCcEEEEEEeCCCCEEEEEEeCCCCChhHHHHHHHHHHHhcCCCccccccceeeeeCCeeEEEEecCCC
Q 020221           58 MENIVSEHGEKAPNVVYKGKLENQFRIAVKRFNRSAWPDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAEYMPN  137 (329)
Q Consensus        58 ~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~  137 (329)
                      .+++.+.||+|++|.||+|...+++.||+|.++.... ..+++.+|+++++.++|+||+++++++...+..+++|||+++
T Consensus         7 ~~~~~~~lg~g~~~~v~~~~~~~~~~v~iK~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~   85 (261)
T cd05068           7 SIQLLRKLGAGQFGEVWEGLWNNTTPVAVKTLKPGTM-DPKDFLAEAQIMKKLRHPKLIQLYAVCTLEEPIYIVTELMKY   85 (261)
T ss_pred             heeeEEEecccCCccEEEEEecCCeEEEEEeeCCCcc-cHHHHHHHHHHHHHCCCCCccceeEEEecCCCeeeeeecccC
Confidence            3566778899999999999977778899999976542 356788999999999999999999999999999999999999


Q ss_pred             CCHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCCCCCeeeecccCcccCCCCCC--ccC-
Q 020221          138 DTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDGRS--YST-  214 (329)
Q Consensus       138 gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~~--~~~-  214 (329)
                      ++|.+++.......+++..+..++.|++.||.|||++ +++|+||||+||++++++.++|+|||++........  ..+ 
T Consensus        86 ~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~-~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~  164 (261)
T cd05068          86 GSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLEAQ-NYIHRDLAARNVLVGENNICKVADFGLARVIKEDIYEAREGA  164 (261)
T ss_pred             CcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhC-CeeeccCCcceEEEcCCCCEEECCcceEEEccCCcccccCCC
Confidence            9999999754445789999999999999999999999 999999999999999999999999999876543221  112 


Q ss_pred             --cccccCcccccCCCCCCcccchhhhHHHHHHHh-CCCCCCchhhHHHhhhchhhhccccccCCCChHHHHHHHHHHHH
Q 020221          215 --NLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLS-GKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLASR  291 (329)
Q Consensus       215 --~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t-g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~  291 (329)
                        +..|+|||++.+..++.++||||||+++|+|++ |..|+.............     .......+...+..+.+++.+
T Consensus       165 ~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~li~~  239 (261)
T cd05068         165 KFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMTNAEVLQQVD-----QGYRMPCPPGCPKELYDIMLD  239 (261)
T ss_pred             cCceeccCccccccCCCCchhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHH-----cCCCCCCCCcCCHHHHHHHHH
Confidence              357999999998889999999999999999999 777765433222221111     111122344567889999999


Q ss_pred             hcccCCCCCCCHHHHHHHHHhh
Q 020221          292 CLQYEPRERPNPRSLVTALVTL  313 (329)
Q Consensus       292 cl~~dp~~Rps~~~~l~~L~~~  313 (329)
                      ||+.||++||++.++++.|+.+
T Consensus       240 ~l~~~P~~Rp~~~~l~~~l~~~  261 (261)
T cd05068         240 CWKEDPDDRPTFETLQWKLEDF  261 (261)
T ss_pred             HhhcCcccCCCHHHHHHHHhcC
Confidence            9999999999999999999863

Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a

>cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C

Probab=100.00  E-value=1.9e-43  Score=311.65  Aligned_cols=257  Identities=23%  Similarity=0.330  Sum_probs=208.9

Q ss_pred             cccccccCCCCCCcEEEEEEe------CCCCEEEEEEeCCCCChhHHHHHHHHHHHhcCCCccccccceeeeeCCeeEEE
Q 020221           58 MENIVSEHGEKAPNVVYKGKL------ENQFRIAVKRFNRSAWPDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLV  131 (329)
Q Consensus        58 ~~~~~~~lg~G~~g~V~~~~~------~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv  131 (329)
                      .+.+.+.||+|+||.||++..      .++..+++|.+........+.+.+|++.++.++|+||+++++++......++|
T Consensus         6 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   85 (291)
T cd05094           6 DIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKFYGVCGDGDPLIMV   85 (291)
T ss_pred             HeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCccHHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCceEEE
Confidence            456667889999999999973      23456999998776655566789999999999999999999999999999999


Q ss_pred             EecCCCCCHHhhhccCC--------------CCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCCCCCeee
Q 020221          132 AEYMPNDTLAKHLFHWE--------------TQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRL  197 (329)
Q Consensus       132 ~e~~~~gsL~~~l~~~~--------------~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl  197 (329)
                      |||+++++|.+++....              ...+++..+..++.|++.||+|||++ +++|+||||+||+++.++.++|
T Consensus        86 ~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~-~i~H~dlkp~Nil~~~~~~~~l  164 (291)
T cd05094          86 FEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQ-HFVHRDLATRNCLVGANLLVKI  164 (291)
T ss_pred             EecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhC-CeeecccCcceEEEccCCcEEE
Confidence            99999999999986421              23478999999999999999999999 9999999999999999999999


Q ss_pred             ecccCcccCCCC------CCccCcccccCcccccCCCCCCcccchhhhHHHHHHHh-CCCCCCchhhHHHhhhchhhhcc
Q 020221          198 SCFGLMKNSRDG------RSYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLS-GKHIPPSHALDLIRDRNIQTLTD  270 (329)
Q Consensus       198 ~Dfg~a~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t-g~~~~~~~~~~~~~~~~~~~~~~  270 (329)
                      +|||++......      ....++..|+|||.+.+..++.++||||||+++|+|++ |..|+...............   
T Consensus       165 ~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~---  241 (291)
T cd05094         165 GDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNTEVIECITQG---  241 (291)
T ss_pred             CCCCcccccCCCceeecCCCCCcceeecChHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhCC---
Confidence            999998754332      12334678999999998889999999999999999999 88776543322222111111   


Q ss_pred             ccccCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhhccccc
Q 020221          271 SCLEGQFSSDEGTELVRLASRCLQYEPRERPNPRSLVTALVTLQKDTELY  320 (329)
Q Consensus       271 ~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~~~l~~L~~~~~~~~~~  320 (329)
                        .....+...+..+.+++.+||+.||++|||+.++++.|+++.+.+..+
T Consensus       242 --~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~v~~~l~~~~~~~~~~  289 (291)
T cd05094         242 --RVLERPRVCPKEVYDIMLGCWQREPQQRLNIKEIYKILHALGKATPIY  289 (291)
T ss_pred             --CCCCCCccCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHhhcCcc
Confidence              111223345678999999999999999999999999999998865543

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n

>cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota

Probab=100.00  E-value=1e-43  Score=318.62  Aligned_cols=235  Identities=17%  Similarity=0.221  Sum_probs=189.8

Q ss_pred             cCCCCCCcEEEEEE-eCCCCEEEEEEeCCCC---ChhHHHHHHHHHHHhcC-CCccccccceeeeeCCeeEEEEecCCCC
Q 020221           64 EHGEKAPNVVYKGK-LENQFRIAVKRFNRSA---WPDARQFLEEARAVGQL-RNRRLANLLGCCCEGDERLLVAEYMPND  138 (329)
Q Consensus        64 ~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~~~g  138 (329)
                      .||+|+||.||++. ..+++.||+|++....   ......+.+|+.++..+ +||||+++++++...+..++||||+++|
T Consensus         2 ~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~~~   81 (329)
T cd05618           2 VIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNGG   81 (329)
T ss_pred             eeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEEeCCCCC
Confidence            46999999999999 4567899999997642   22344577888888776 7999999999999999999999999999


Q ss_pred             CHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCCCCCeeeecccCcccCCC----CCCccC
Q 020221          139 TLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRD----GRSYST  214 (329)
Q Consensus       139 sL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~----~~~~~~  214 (329)
                      +|..++.  ....+++..+..++.|++.||.|||++ +++||||||+||+++.++.+||+|||++.....    .....|
T Consensus        82 ~L~~~~~--~~~~l~~~~~~~i~~qi~~~l~~lH~~-~ivH~Dikp~Nili~~~~~~kL~DfG~~~~~~~~~~~~~~~~g  158 (329)
T cd05618          82 DLMFHMQ--RQRKLPEEHARFYSAEISLALNYLHER-GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSTFCG  158 (329)
T ss_pred             CHHHHHH--HcCCCCHHHHHHHHHHHHHHHHHHHHC-CeeeCCCCHHHEEECCCCCEEEeeCCccccccCCCCccccccC
Confidence            9998886  445789999999999999999999999 999999999999999999999999999875322    123467


Q ss_pred             cccccCcccccCCCCCCcccchhhhHHHHHHHhCCCCCCchhhH-----HHhhhchhhhccccccCCCChHHHHHHHHHH
Q 020221          215 NLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALD-----LIRDRNIQTLTDSCLEGQFSSDEGTELVRLA  289 (329)
Q Consensus       215 ~~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li  289 (329)
                      |+.|+|||++.+..++.++||||||+++|+|++|..||......     .........+...  ....+...+..+.+++
T Consensus       159 t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~i~~~--~~~~p~~~~~~~~~ll  236 (329)
T cd05618         159 TPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEK--QIRIPRSLSVKAASVL  236 (329)
T ss_pred             CccccCHHHHcCCCCCCccceecccHHHHHHhhCCCCCccCCCcCCcccccHHHHHHHHhcC--CCCCCCCCCHHHHHHH
Confidence            89999999999989999999999999999999999887421000     0000001111111  1234556678899999


Q ss_pred             HHhcccCCCCCCCH
Q 020221          290 SRCLQYEPRERPNP  303 (329)
Q Consensus       290 ~~cl~~dp~~Rps~  303 (329)
                      .+||+.||++||++
T Consensus       237 ~~~L~~dP~~R~~~  250 (329)
T cd05618         237 KSFLNKDPKERLGC  250 (329)
T ss_pred             HHHhcCCHHHcCCC
Confidence            99999999999984

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o

>cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B

Probab=100.00  E-value=2.1e-43  Score=310.97  Aligned_cols=256  Identities=23%  Similarity=0.321  Sum_probs=206.8

Q ss_pred             cccccccCCCCCCcEEEEEEe------CCCCEEEEEEeCCCCChhHHHHHHHHHHHhcCCCccccccceeeeeCCeeEEE
Q 020221           58 MENIVSEHGEKAPNVVYKGKL------ENQFRIAVKRFNRSAWPDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLV  131 (329)
Q Consensus        58 ~~~~~~~lg~G~~g~V~~~~~------~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv  131 (329)
                      .+.+.+.+|+|+||.||++..      .++..+|+|.+........+.+.+|+++++.++||||+++++++...+..+++
T Consensus         6 ~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   85 (288)
T cd05093           6 NIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLIMV   85 (288)
T ss_pred             HeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCcCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEEE
Confidence            355667789999999999973      23456899998776545566789999999999999999999999999999999


Q ss_pred             EecCCCCCHHhhhccCC-----------CCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCCCCCeeeecc
Q 020221          132 AEYMPNDTLAKHLFHWE-----------TQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCF  200 (329)
Q Consensus       132 ~e~~~~gsL~~~l~~~~-----------~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Df  200 (329)
                      +||+++++|.+++....           ...+++..+..++.|++.||+|||+. |++||||||+||++++++.++|+||
T Consensus        86 ~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~-~i~H~dlkp~Nili~~~~~~kl~df  164 (288)
T cd05093          86 FEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQ-HFVHRDLATRNCLVGENLLVKIGDF  164 (288)
T ss_pred             EEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhC-CeeecccCcceEEEccCCcEEeccC
Confidence            99999999999986321           13489999999999999999999999 9999999999999999999999999


Q ss_pred             cCcccCCCCC------CccCcccccCcccccCCCCCCcccchhhhHHHHHHHh-CCCCCCchhhHHHhhhchhhhccccc
Q 020221          201 GLMKNSRDGR------SYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLS-GKHIPPSHALDLIRDRNIQTLTDSCL  273 (329)
Q Consensus       201 g~a~~~~~~~------~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t-g~~~~~~~~~~~~~~~~~~~~~~~~~  273 (329)
                      |++.......      ...++..|+|||++.+..++.++||||||+++|+|++ |..|+................     
T Consensus       165 g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t~g~~p~~~~~~~~~~~~i~~~~-----  239 (288)
T cd05093         165 GMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIECITQGR-----  239 (288)
T ss_pred             CccccccCCceeecCCCCCccccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCC-----
Confidence            9987543321      2233568999999998889999999999999999999 776665433222221111111     


Q ss_pred             cCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhhcccc
Q 020221          274 EGQFSSDEGTELVRLASRCLQYEPRERPNPRSLVTALVTLQKDTEL  319 (329)
Q Consensus       274 ~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~~~l~~L~~~~~~~~~  319 (329)
                      ....+...+.++.+++.+||+.||.+|||+.+++..|+.+.+....
T Consensus       240 ~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~v~~~l~~~~~~~~~  285 (288)
T cd05093         240 VLQRPRTCPKEVYDLMLGCWQREPHMRLNIKEIHSLLQNLAKASPV  285 (288)
T ss_pred             cCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHHHhccc
Confidence            1112334567899999999999999999999999999999876544

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly

>cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase

Probab=100.00  E-value=8.5e-44  Score=318.54  Aligned_cols=232  Identities=20%  Similarity=0.230  Sum_probs=189.5

Q ss_pred             cCCCCCCcEEEEEEe-CCCCEEEEEEeCCCCC---hhHHHHHHHHH-HHhcCCCccccccceeeeeCCeeEEEEecCCCC
Q 020221           64 EHGEKAPNVVYKGKL-ENQFRIAVKRFNRSAW---PDARQFLEEAR-AVGQLRNRRLANLLGCCCEGDERLLVAEYMPND  138 (329)
Q Consensus        64 ~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~---~~~~~~~~e~~-~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g  138 (329)
                      .||+|+||+||++.. .+++.||+|++.....   .....+..|.. +++.++||||+++++.+...+..++||||+++|
T Consensus         2 ~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~g   81 (323)
T cd05575           2 VIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKLYFVLDYVNGG   81 (323)
T ss_pred             eeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCCEEEEEEcCCCCC
Confidence            469999999999994 5788999999875421   12334555554 567789999999999999999999999999999


Q ss_pred             CHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCCCCCeeeecccCcccCCCC----CCccC
Q 020221          139 TLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDG----RSYST  214 (329)
Q Consensus       139 sL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~----~~~~~  214 (329)
                      +|..++.  ....+++..+..++.||+.||.|||++ |++||||||+|||++.++.+||+|||++......    ....|
T Consensus        82 ~L~~~l~--~~~~~~~~~~~~~~~qi~~~l~~lH~~-givH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~~g  158 (323)
T cd05575          82 ELFFHLQ--RERSFPEPRARFYAAEIASALGYLHSL-NIIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHSKTTSTFCG  158 (323)
T ss_pred             CHHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHHC-CeEeCCCCHHHeEECCCCcEEEeccCCCcccccCCCccccccC
Confidence            9999886  345789999999999999999999999 9999999999999999999999999998753222    23457


Q ss_pred             cccccCcccccCCCCCCcccchhhhHHHHHHHhCCCCCCchhhHHHhhhchhhhccccccCCCChHHHHHHHHHHHHhcc
Q 020221          215 NLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLASRCLQ  294 (329)
Q Consensus       215 ~~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~  294 (329)
                      ++.|+|||++.+..++.++||||||+++|+|++|..||................      ...+...++++.+++.+||+
T Consensus       159 t~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~------~~~~~~~~~~~~~li~~~l~  232 (323)
T cd05575         159 TPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRDTAEMYDNILNKP------LRLKPNISVSARHLLEGLLQ  232 (323)
T ss_pred             ChhhcChhhhcCCCCCccccccccchhhhhhhcCCCCCCCCCHHHHHHHHHcCC------CCCCCCCCHHHHHHHHHHhh
Confidence            899999999998889999999999999999999999887544332222211111      12233457889999999999


Q ss_pred             cCCCCCCCHH
Q 020221          295 YEPRERPNPR  304 (329)
Q Consensus       295 ~dp~~Rps~~  304 (329)
                      .||++||++.
T Consensus       233 ~~p~~R~~~~  242 (323)
T cd05575         233 KDRTKRLGAK  242 (323)
T ss_pred             cCHHhCCCCC
Confidence            9999999985

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr

>cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta

Probab=100.00  E-value=8.9e-44  Score=318.40  Aligned_cols=236  Identities=18%  Similarity=0.234  Sum_probs=194.0

Q ss_pred             ccccccCCCCCCcEEEEEE-eCCCCEEEEEEeCCCCC---hhHHHHHHHHHHHhcC-CCccccccceeeeeCCeeEEEEe
Q 020221           59 ENIVSEHGEKAPNVVYKGK-LENQFRIAVKRFNRSAW---PDARQFLEEARAVGQL-RNRRLANLLGCCCEGDERLLVAE  133 (329)
Q Consensus        59 ~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e  133 (329)
                      |++++.||+|+||.||++. ..+++.||+|++.....   ...+.+..|..++..+ +|++|+++.+++.+.+..++|||
T Consensus         2 f~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E   81 (323)
T cd05616           2 FNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMDRLYFVME   81 (323)
T ss_pred             ceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCCEEEEEEc
Confidence            5567778999999999998 45678999999875421   2234466778888777 58999999999999999999999


Q ss_pred             cCCCCCHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCCCCCeeeecccCcccCCC----C
Q 020221          134 YMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRD----G  209 (329)
Q Consensus       134 ~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~----~  209 (329)
                      |+++|+|.+++.  ....+++..+..++.|++.||+|||+. +++||||||+|||++.++.+||+|||++.....    .
T Consensus        82 ~~~~g~L~~~~~--~~~~~~~~~~~~~~~qi~~aL~~LH~~-~ivHrDlkp~Nill~~~~~~kL~DfG~~~~~~~~~~~~  158 (323)
T cd05616          82 YVNGGDLMYQIQ--QVGRFKEPHAVFYAAEIAIGLFFLHSK-GIIYRDLKLDNVMLDSEGHIKIADFGMCKENMWDGVTT  158 (323)
T ss_pred             CCCCCCHHHHHH--HcCCCCHHHHHHHHHHHHHHHHHHHHC-CEEecCCCHHHeEECCCCcEEEccCCCceecCCCCCcc
Confidence            999999999886  345689999999999999999999999 999999999999999999999999999875332    2


Q ss_pred             CCccCcccccCcccccCCCCCCcccchhhhHHHHHHHhCCCCCCchhhHHHhhhchhhhccccccCCCChHHHHHHHHHH
Q 020221          210 RSYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLA  289 (329)
Q Consensus       210 ~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li  289 (329)
                      ....|++.|+|||++.+..++.++|||||||++|||++|..||..............    .  ...++...+.++.+++
T Consensus       159 ~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~----~--~~~~p~~~s~~~~~li  232 (323)
T cd05616         159 KTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIME----H--NVAYPKSMSKEAVAIC  232 (323)
T ss_pred             ccCCCChhhcCHHHhcCCCCCCccchhchhHHHHHHHhCCCCCCCCCHHHHHHHHHh----C--CCCCCCcCCHHHHHHH
Confidence            234678999999999998999999999999999999999998865443322222111    1  1234556678899999


Q ss_pred             HHhcccCCCCCCCH
Q 020221          290 SRCLQYEPRERPNP  303 (329)
Q Consensus       290 ~~cl~~dp~~Rps~  303 (329)
                      .+||+.||++|++.
T Consensus       233 ~~~l~~~p~~R~~~  246 (323)
T cd05616         233 KGLMTKHPGKRLGC  246 (323)
T ss_pred             HHHcccCHHhcCCC
Confidence            99999999999985

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and

>KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only]

Probab=100.00  E-value=6.5e-44  Score=304.20  Aligned_cols=251  Identities=18%  Similarity=0.196  Sum_probs=199.3

Q ss_pred             CcccccccCCCCCCcEEEEEE-eCCCCEEEEEEeCCCCCh--hHHHHHHHHHHHhcCCCcc-ccccceeeeeCC------
Q 020221           57 AMENIVSEHGEKAPNVVYKGK-LENQFRIAVKRFNRSAWP--DARQFLEEARAVGQLRNRR-LANLLGCCCEGD------  126 (329)
Q Consensus        57 ~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~--~~~~~~~e~~~l~~l~h~n-iv~~~~~~~~~~------  126 (329)
                      ..+..++++|+|+||+||+|+ ..+|+.||+|+++.....  ......+|+.+++.++|+| |+.+.+++...+      
T Consensus        11 ~~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~~~   90 (323)
T KOG0594|consen   11 FDYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEEEGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRGIG   90 (323)
T ss_pred             HHHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccccCCCchhhHHHHHHHHhCCCcceEEEEeeeeecccccccc
Confidence            345566678999999999999 677899999999876532  2345789999999999999 999999998776      


Q ss_pred             eeEEEEecCCCCCHHhhhccCCC--CCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCCCCCeeeecccCcc
Q 020221          127 ERLLVAEYMPNDTLAKHLFHWET--QPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMK  204 (329)
Q Consensus       127 ~~~lv~e~~~~gsL~~~l~~~~~--~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~  204 (329)
                      .+++|+||++. +|..++.....  ..++...+..+++||+.||+|||++ +|+||||||.|||+++.|.+||+|||+|+
T Consensus        91 ~l~lvfe~~d~-DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~~-~IlHRDLKPQNlLi~~~G~lKlaDFGlAr  168 (323)
T KOG0594|consen   91 KLYLVFEFLDR-DLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHSH-GILHRDLKPQNLLISSSGVLKLADFGLAR  168 (323)
T ss_pred             eEEEEEEeecc-cHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHhC-CeecccCCcceEEECCCCcEeeeccchHH
Confidence            78999999977 89999975332  4678889999999999999999999 99999999999999999999999999998


Q ss_pred             cCC-CC---CCccCcccccCcccccCC-CCCCcccchhhhHHHHHHHhCCCCCCchhhHHHhhhchhhh-------cccc
Q 020221          205 NSR-DG---RSYSTNLAFTPPEYLRTG-RVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTL-------TDSC  272 (329)
Q Consensus       205 ~~~-~~---~~~~~~~~y~aPE~~~~~-~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~~~~~~~~~-------~~~~  272 (329)
                      ... +.   ....+|.+|.|||++.+. .|+...||||+|||+.||++++..|+..............+       ++..
T Consensus       169 a~~ip~~~yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se~~ql~~If~~lGtP~e~~Wp~v  248 (323)
T KOG0594|consen  169 AFSIPMRTYTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDSEIDQLFRIFRLLGTPNEKDWPGV  248 (323)
T ss_pred             HhcCCcccccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCcHHHHHHHHHHHcCCCCccCCCCc
Confidence            655 22   344678999999999987 49999999999999999999998887653211111110000       0000


Q ss_pred             ---------ccCCC-Ch-------HHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 020221          273 ---------LEGQF-SS-------DEGTELVRLASRCLQYEPRERPNPRSLVTA  309 (329)
Q Consensus       273 ---------~~~~~-~~-------~~~~~~~~li~~cl~~dp~~Rps~~~~l~~  309 (329)
                               ..... +.       ...+...+++.+||+++|.+|.|+..++++
T Consensus       249 ~~~~~~k~~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R~Sa~~al~h  302 (323)
T KOG0594|consen  249 SSLPDYKAPFPKWPGPKDLSSILPKLDPDGIELLSKLLQYDPAKRISAKGALTH  302 (323)
T ss_pred             cccccccccCcCCCCccchHHhccccCccHHHHHHHHhccCcccCcCHHHHhcC
Confidence                     00000 11       112588999999999999999999999985

>cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase

Probab=100.00  E-value=3.3e-44  Score=322.18  Aligned_cols=246  Identities=16%  Similarity=0.129  Sum_probs=199.2

Q ss_pred             cccccccCCCCCCcEEEEEE-eCCCCEEEEEEeCCCCC---hhHHHHHHHHHHHhcCCCccccccceeeeeCCeeEEEEe
Q 020221           58 MENIVSEHGEKAPNVVYKGK-LENQFRIAVKRFNRSAW---PDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAE  133 (329)
Q Consensus        58 ~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  133 (329)
                      .|.+.+.||+|+||+||++. ..+++.||+|+++....   ...+.+.+|+.+++.++|+||+++++++.+.+..++|||
T Consensus         2 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~~~~lv~e   81 (330)
T cd05601           2 DFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQDKDNLYLVME   81 (330)
T ss_pred             CceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEecCCeEEEEEC
Confidence            35677788999999999998 55788999999976432   234457889999999999999999999999999999999


Q ss_pred             cCCCCCHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCCCCCeeeecccCcccCCCCC---
Q 020221          134 YMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDGR---  210 (329)
Q Consensus       134 ~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~---  210 (329)
                      |+++|+|.+++.+ ....+++..+..++.|++.||.|||+. +++||||||+||+++.++.+||+|||++.......   
T Consensus        82 ~~~~~~L~~~l~~-~~~~l~~~~~~~~~~qi~~aL~~lH~~-~i~H~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~  159 (330)
T cd05601          82 YQPGGDLLSLLNR-YEDQFDEDMAQFYLAELVLAIHSVHQM-GYVHRDIKPENVLIDRTGHIKLADFGSAARLTANKMVN  159 (330)
T ss_pred             CCCCCCHHHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHHC-CeEcccCchHheEECCCCCEEeccCCCCeECCCCCcee
Confidence            9999999999964 235789999999999999999999999 99999999999999999999999999997654332   


Q ss_pred             --CccCcccccCccccc------CCCCCCcccchhhhHHHHHHHhCCCCCCchhhHHHhhhchhhhccccccCCCChHHH
Q 020221          211 --SYSTNLAFTPPEYLR------TGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEG  282 (329)
Q Consensus       211 --~~~~~~~y~aPE~~~------~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  282 (329)
                        ...+++.|+|||++.      ...++.++||||||+++|+|++|..||...............  ............+
T Consensus       160 ~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~i~~~--~~~~~~~~~~~~~  237 (330)
T cd05601         160 SKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSAKTYNNIMNF--QRFLKFPEDPKVS  237 (330)
T ss_pred             eecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCCHHHHHHHHHcC--CCccCCCCCCCCC
Confidence              235789999999986      455788999999999999999999988654433222211111  0011111122457


Q ss_pred             HHHHHHHHHhcccCCCCCCCHHHHHH
Q 020221          283 TELVRLASRCLQYEPRERPNPRSLVT  308 (329)
Q Consensus       283 ~~~~~li~~cl~~dp~~Rps~~~~l~  308 (329)
                      .++.+++..||. ||++|||+.++++
T Consensus       238 ~~~~~li~~ll~-~p~~R~t~~~l~~  262 (330)
T cd05601         238 SDFLDLIQSLLC-GQKERLGYEGLCC  262 (330)
T ss_pred             HHHHHHHHHHcc-ChhhCCCHHHHhC
Confidence            789999999997 9999999999986

Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor

>cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1

Probab=100.00  E-value=2.2e-43  Score=312.09  Aligned_cols=249  Identities=18%  Similarity=0.242  Sum_probs=206.7

Q ss_pred             hcCCCcccccccCCCCCCcEEEEEE-eCCCCEEEEEEeCCCCChhHHHHHHHHHHHhcCCCccccccceeeeeCCeeEEE
Q 020221           53 TSGFAMENIVSEHGEKAPNVVYKGK-LENQFRIAVKRFNRSAWPDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLV  131 (329)
Q Consensus        53 ~~~~~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv  131 (329)
                      .+....|.+++.+|+|+||.||++. ..+++.|++|.+........+.+.+|+.+++.+.|+|++++++.+..+...++|
T Consensus        16 ~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~v~~~~~~~~~~~~~~lv   95 (296)
T cd06654          16 GDPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVV   95 (296)
T ss_pred             CCcccceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCcchHHHHHHHHHHHHhCCCCCEeeEEEEEEeCCEEEEe
Confidence            4445667888889999999999998 457889999999876666667788999999999999999999999999999999


Q ss_pred             EecCCCCCHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCCCCCeeeecccCcccCCCCC-
Q 020221          132 AEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDGR-  210 (329)
Q Consensus       132 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~-  210 (329)
                      |||+++++|.+++.   ...+++.++..++.|++.||.|||+. +++|+||||+||+++.++.++|+|||++....... 
T Consensus        96 ~e~~~~~~L~~~~~---~~~~~~~~~~~i~~ql~~aL~~LH~~-gi~H~dLkp~Nill~~~~~~kl~dfg~~~~~~~~~~  171 (296)
T cd06654          96 MEYLAGGSLTDVVT---ETCMDEGQIAAVCRECLQALEFLHSN-QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS  171 (296)
T ss_pred             ecccCCCCHHHHHH---hcCCCHHHHHHHHHHHHHHHHHHHHC-CcccCCCCHHHEEEcCCCCEEECccccchhcccccc
Confidence            99999999999984   34688999999999999999999999 99999999999999999999999999987543322 


Q ss_pred             ---CccCcccccCcccccCCCCCCcccchhhhHHHHHHHhCCCCCCchhhHHHhhhchhhhccccccCCCChHHHHHHHH
Q 020221          211 ---SYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVR  287 (329)
Q Consensus       211 ---~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  287 (329)
                         ...+++.|+|||.+.+..++.++||||||+++|+|++|..||.............   .........+...++.+.+
T Consensus       172 ~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~l~~  248 (296)
T cd06654         172 KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIA---TNGTPELQNPEKLSAIFRD  248 (296)
T ss_pred             ccCcccCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCHHHhHHHHh---cCCCCCCCCccccCHHHHH
Confidence               2357789999999998889999999999999999999998886543211111111   1111111223456778999


Q ss_pred             HHHHhcccCCCCCCCHHHHHH
Q 020221          288 LASRCLQYEPRERPNPRSLVT  308 (329)
Q Consensus       288 li~~cl~~dp~~Rps~~~~l~  308 (329)
                      ++.+||..||++||++.++++
T Consensus       249 li~~~l~~~p~~Rpt~~eil~  269 (296)
T cd06654         249 FLNRCLDMDVEKRGSAKELLQ  269 (296)
T ss_pred             HHHHHCcCCcccCcCHHHHhh
Confidence            999999999999999999997

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome

Probab=100.00  E-value=2.2e-43  Score=305.62  Aligned_cols=247  Identities=23%  Similarity=0.352  Sum_probs=201.8

Q ss_pred             CcccccccCCCCCCcEEEEEEeCCCCEEEEEEeCCCCChhHHHHHHHHHHHhcCCCccccccceeeeeCCeeEEEEecCC
Q 020221           57 AMENIVSEHGEKAPNVVYKGKLENQFRIAVKRFNRSAWPDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAEYMP  136 (329)
Q Consensus        57 ~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~  136 (329)
                      .++.+++.+|+|+||+||++...++..+|+|.+..... ....+.+|+.+++.++||||+++++++......+++|||+.
T Consensus         4 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~aik~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~   82 (256)
T cd05113           4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSM-SEDEFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYIVTEYMS   82 (256)
T ss_pred             HHeEEeeEecCcccceEEEEEecCCCcEEEEEcCCCcc-cHHHHHHHHHHHhcCCCCCeeeEEEEEccCCCcEEEEEcCC
Confidence            34677888899999999999977777799999876543 34678999999999999999999999988889999999999


Q ss_pred             CCCHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCCCCCeeeecccCcccCCCCC-----C
Q 020221          137 NDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDGR-----S  211 (329)
Q Consensus       137 ~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~-----~  211 (329)
                      +++|.+++.. ....+++..+..++.|++.||+|||+. +++|+||||+||++++++.+||+|||.+.......     .
T Consensus        83 ~~~l~~~i~~-~~~~~~~~~~~~~~~~i~~~l~~lH~~-~i~H~dl~p~nili~~~~~~kl~d~g~~~~~~~~~~~~~~~  160 (256)
T cd05113          83 NGCLLNYLRE-HGKRFQPSQLLEMCKDVCEGMAYLESK-QFIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEYTSSVG  160 (256)
T ss_pred             CCcHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHhC-CeeccccCcceEEEcCCCCEEECCCccceecCCCceeecCC
Confidence            9999999864 234689999999999999999999999 99999999999999999999999999987554332     1


Q ss_pred             ccCcccccCcccccCCCCCCcccchhhhHHHHHHHh-CCCCCCchhhHHHhhhchhhhccccccCCCChHHHHHHHHHHH
Q 020221          212 YSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLS-GKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLAS  290 (329)
Q Consensus       212 ~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t-g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~  290 (329)
                      ..++..|+|||.+.+..++.++||||||+++|+|++ |..|+...............     .....+...+..+.+++.
T Consensus       161 ~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~li~  235 (256)
T cd05113         161 SKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFNNSETVEKVSQG-----LRLYRPHLASEKVYAIMY  235 (256)
T ss_pred             CccChhhCCHHHHhcCcccchhHHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHhcC-----CCCCCCCCCCHHHHHHHH
Confidence            223567999999988889999999999999999998 77766433222221111111     111223345688999999


Q ss_pred             HhcccCCCCCCCHHHHHHHHH
Q 020221          291 RCLQYEPRERPNPRSLVTALV  311 (329)
Q Consensus       291 ~cl~~dp~~Rps~~~~l~~L~  311 (329)
                      +||..||++||++.+++..|+
T Consensus       236 ~cl~~~p~~Rp~~~~ll~~~~  256 (256)
T cd05113         236 SCWHEKAEERPTFQQLLSSIE  256 (256)
T ss_pred             HHcCCCcccCCCHHHHHHhhC
Confidence            999999999999999998763

Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds

>cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase

Probab=100.00  E-value=3.5e-44  Score=320.32  Aligned_cols=234  Identities=17%  Similarity=0.193  Sum_probs=194.0

Q ss_pred             ccCCCCCCcEEEEEEe----CCCCEEEEEEeCCCCCh--hHHHHHHHHHHHhcCCCccccccceeeeeCCeeEEEEecCC
Q 020221           63 SEHGEKAPNVVYKGKL----ENQFRIAVKRFNRSAWP--DARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAEYMP  136 (329)
Q Consensus        63 ~~lg~G~~g~V~~~~~----~~~~~vavK~~~~~~~~--~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~  136 (329)
                      +.||+|+||.||++..    .+++.+|+|++......  ....+.+|+++++.++||||+++++++...+..++||||++
T Consensus         2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~   81 (318)
T cd05582           2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKLHYAFQTEGKLYLILDFLR   81 (318)
T ss_pred             ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhCCCCCcccEEEEEEcCCEEEEEEcCCC
Confidence            4579999999999873    35789999999754321  23456789999999999999999999999999999999999


Q ss_pred             CCCHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCCCCCeeeecccCcccCCCC----CCc
Q 020221          137 NDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDG----RSY  212 (329)
Q Consensus       137 ~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~----~~~  212 (329)
                      +|+|.+++.  ....+++..+..++.|++.||.|||+. +++||||||+||++++++.++|+|||++......    ...
T Consensus        82 ~~~L~~~l~--~~~~l~~~~~~~~~~qi~~~l~~lH~~-~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~~~~~~  158 (318)
T cd05582          82 GGDLFTRLS--KEVMFTEEDVKFYLAELALALDHLHSL-GIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYSF  158 (318)
T ss_pred             CCcHHHHHH--HcCCCCHHHHHHHHHHHHHHHHHHHHC-CEecCCCCHHHeEECCCCcEEEeeccCCcccCCCCCceecc
Confidence            999999986  345689999999999999999999999 9999999999999999999999999998764433    234


Q ss_pred             cCcccccCcccccCCCCCCcccchhhhHHHHHHHhCCCCCCchhhHHHhhhchhhhccccccCCCChHHHHHHHHHHHHh
Q 020221          213 STNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLASRC  292 (329)
Q Consensus       213 ~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~c  292 (329)
                      .|++.|+|||.+.+..++.++||||||+++|+|++|+.||..............    .  ....+...++++.+++.+|
T Consensus       159 ~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~i~~----~--~~~~p~~~~~~~~~li~~~  232 (318)
T cd05582         159 CGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGKDRKETMTMILK----A--KLGMPQFLSPEAQSLLRAL  232 (318)
T ss_pred             cCChhhcCHHHHcCCCCCCccceeccceEeeeeccCCCCCCCCCHHHHHHHHHc----C--CCCCCCCCCHHHHHHHHHH
Confidence            578999999999988899999999999999999999988865433222221111    1  1123455678899999999


Q ss_pred             cccCCCCCCCHHH
Q 020221          293 LQYEPRERPNPRS  305 (329)
Q Consensus       293 l~~dp~~Rps~~~  305 (329)
                      |+.||++||++.+
T Consensus       233 l~~~P~~R~~a~~  245 (318)
T cd05582         233 FKRNPANRLGAGP  245 (318)
T ss_pred             hhcCHhHcCCCCC
Confidence            9999999999655

Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate

>KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=6.8e-45  Score=327.74  Aligned_cols=250  Identities=18%  Similarity=0.220  Sum_probs=207.3

Q ss_pred             cCCCcccccccCCCCCCcEEEEEE-eCCCCEEEEEEeCCCCChhHHHHHHHHHHHhcCCCccccccceeeeeCCeeEEEE
Q 020221           54 SGFAMENIVSEHGEKAPNVVYKGK-LENQFRIAVKRFNRSAWPDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVA  132 (329)
Q Consensus        54 ~~~~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~  132 (329)
                      +.-+.+++++.||.|+||.||++. ...+-..|.|++........++++-|+++|..++||+||++++.|...+.+|++.
T Consensus        29 nP~d~WeIiGELGDGAFGKVyKA~nket~~lAAaKvIetkseEELEDylVEIeILa~CdHP~ivkLl~ayy~enkLwili  108 (1187)
T KOG0579|consen   29 NPRDHWEIIGELGDGAFGKVYKAVNKETKLLAAAKVIETKSEEELEDYLVEIEILAECDHPVIVKLLSAYYFENKLWILI  108 (1187)
T ss_pred             CHHHHHHHHhhhcCccchhhhhhhcccchhhhhhhhhcccchhHHhhhhhhhhhhhcCCChHHHHHHHHHhccCceEEEE
Confidence            344557899999999999999999 4445556788887777777889999999999999999999999999999999999


Q ss_pred             ecCCCCCHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCCCCCeeeecccCcccC----CC
Q 020221          133 EYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNS----RD  208 (329)
Q Consensus       133 e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~----~~  208 (329)
                      |||.||..+..+.. -+..+++.++..+++|++.||.|||++ +|||||||..|||++-+|.++|+|||.+-..    ..
T Consensus       109 EFC~GGAVDaimlE-L~r~LtE~QIqvvc~q~ldALn~LHs~-~iIHRDLKAGNiL~TldGdirLADFGVSAKn~~t~qk  186 (1187)
T KOG0579|consen  109 EFCGGGAVDAIMLE-LGRVLTEDQIQVVCYQVLDALNWLHSQ-NIIHRDLKAGNILLTLDGDIRLADFGVSAKNKSTRQK  186 (1187)
T ss_pred             eecCCchHhHHHHH-hccccchHHHHHHHHHHHHHHHHHhhc-chhhhhccccceEEEecCcEeeecccccccchhHHhh
Confidence            99999999888775 457899999999999999999999999 9999999999999999999999999986532    23


Q ss_pred             CCCccCcccccCccccc-----CCCCCCcccchhhhHHHHHHHhCCCCCCchhhHHHhhhchhhhccccccCCCChHHHH
Q 020221          209 GRSYSTNLAFTPPEYLR-----TGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGT  283 (329)
Q Consensus       209 ~~~~~~~~~y~aPE~~~-----~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  283 (329)
                      ..++.||++|||||+..     +.+|+.++||||||++|.||..+.+|...-  ..++.-.....-++ .....|..++.
T Consensus       187 RDsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHhel--npMRVllKiaKSeP-PTLlqPS~Ws~  263 (1187)
T KOG0579|consen  187 RDSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHEL--NPMRVLLKIAKSEP-PTLLQPSHWSR  263 (1187)
T ss_pred             hccccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCcccc--chHHHHHHHhhcCC-CcccCcchhhh
Confidence            45789999999999875     567999999999999999999999654322  11111110000011 11124677899


Q ss_pred             HHHHHHHHhcccCCCCCCCHHHHHH
Q 020221          284 ELVRLASRCLQYEPRERPNPRSLVT  308 (329)
Q Consensus       284 ~~~~li~~cl~~dp~~Rps~~~~l~  308 (329)
                      .|.+|+..||..||..||++.++++
T Consensus       264 ~F~DfLk~cL~Knp~~Rp~aaqll~  288 (1187)
T KOG0579|consen  264 SFSDFLKRCLVKNPRNRPPAAQLLK  288 (1187)
T ss_pred             HHHHHHHHHHhcCCccCCCHHHHhh
Confidence            9999999999999999999999998

>PHA03212 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=3.4e-43  Score=321.58  Aligned_cols=242  Identities=17%  Similarity=0.189  Sum_probs=193.2

Q ss_pred             CcccccccCCCCCCcEEEEEE-eCCCCEEEEEEeCCCCChhHHHHHHHHHHHhcCCCccccccceeeeeCCeeEEEEecC
Q 020221           57 AMENIVSEHGEKAPNVVYKGK-LENQFRIAVKRFNRSAWPDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAEYM  135 (329)
Q Consensus        57 ~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~  135 (329)
                      ..|.+++.||+|+||.||++. ..+++.||+|....      ..+.+|+++++.++||||+++++++......++++|++
T Consensus        92 ~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~~------~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e~~  165 (391)
T PHA03212         92 AGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQR------GGTATEAHILRAINHPSIIQLKGTFTYNKFTCLILPRY  165 (391)
T ss_pred             CCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechhh------hhhHHHHHHHHhCCCCCCCCEeEEEEECCeeEEEEecC
Confidence            458888999999999999998 56788999997532      34678999999999999999999999999999999998


Q ss_pred             CCCCHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCCCCCeeeecccCcccCCCC-----C
Q 020221          136 PNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDG-----R  210 (329)
Q Consensus       136 ~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~-----~  210 (329)
                      . ++|..++.  ....+++..++.++.|++.||.|||++ +|+||||||+||+++.++.++|+|||++......     .
T Consensus       166 ~-~~L~~~l~--~~~~l~~~~~~~i~~qi~~aL~ylH~~-~IvHrDiKP~NIll~~~~~vkL~DFG~a~~~~~~~~~~~~  241 (391)
T PHA03212        166 K-TDLYCYLA--AKRNIAICDILAIERSVLRAIQYLHEN-RIIHRDIKAENIFINHPGDVCLGDFGAACFPVDINANKYY  241 (391)
T ss_pred             C-CCHHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHhC-CcccCCCChHhEEEcCCCCEEEEeCCcccccccccccccc
Confidence            5 58888886  345689999999999999999999999 9999999999999999999999999998653221     2


Q ss_pred             CccCcccccCcccccCCCCCCcccchhhhHHHHHHHhCCCCCCchhh-----------HHHhhh--------------ch
Q 020221          211 SYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHAL-----------DLIRDR--------------NI  265 (329)
Q Consensus       211 ~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~-----------~~~~~~--------------~~  265 (329)
                      ...||+.|+|||++.+..++.++||||||+++|||++|..|+.....           ..+...              ..
T Consensus       242 ~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~l~~i~~~~g~~p~~~~~~~~~~~  321 (391)
T PHA03212        242 GWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLIIRRSGTHPNEFPIDAQANL  321 (391)
T ss_pred             cccCccCCCChhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCcCCcccccccCchhHHHHHHHHHhcCChhhcCcchhHHH
Confidence            34689999999999988899999999999999999999977643210           000000              00


Q ss_pred             hhhc----c-----ccccCCC--ChHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 020221          266 QTLT----D-----SCLEGQF--SSDEGTELVRLASRCLQYEPRERPNPRSLVT  308 (329)
Q Consensus       266 ~~~~----~-----~~~~~~~--~~~~~~~~~~li~~cl~~dp~~Rps~~~~l~  308 (329)
                      ....    .     +..+..+  ....+.++.+|+.+||+.||++|||+.++++
T Consensus       322 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~mL~~dP~~Rpta~elL~  375 (391)
T PHA03212        322 DEIYIGLAKKSSRKPGSRPLWTNLYELPIDLEYLICKMLAFDAHHRPSAEALLD  375 (391)
T ss_pred             HHHHHHHHhccCCCCCCCCCHHHHhhhhhhHHHHHHHHhcCChhhCCCHHHHhc
Confidence            0000    0     0000000  0134678999999999999999999999997

>cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2

Probab=100.00  E-value=1.4e-43  Score=322.33  Aligned_cols=245  Identities=17%  Similarity=0.157  Sum_probs=198.0

Q ss_pred             CCcccccccCCCCCCcEEEEEE-eCCCCEEEEEEeCCCC---ChhHHHHHHHHHHHhcCCCccccccceeeeeCCeeEEE
Q 020221           56 FAMENIVSEHGEKAPNVVYKGK-LENQFRIAVKRFNRSA---WPDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLV  131 (329)
Q Consensus        56 ~~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv  131 (329)
                      ...|++++.||+|+||.||++. ..+++.+|+|.+....   ......+.+|+.+++.++||||+++++++.++...++|
T Consensus        42 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~~lv  121 (370)
T cd05621          42 AEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDDKYLYMV  121 (370)
T ss_pred             HHHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEE
Confidence            3567788889999999999999 4568899999986422   12234577899999999999999999999999999999


Q ss_pred             EecCCCCCHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCCCCCeeeecccCcccCCCC--
Q 020221          132 AEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDG--  209 (329)
Q Consensus       132 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~--  209 (329)
                      |||+++|+|.+++.   ...+++..+..++.||+.||+|||++ +|+||||||+|||+++++.+||+|||++......  
T Consensus       122 ~Ey~~gg~L~~~l~---~~~~~~~~~~~~~~qil~aL~~LH~~-~IvHrDLKp~NILl~~~~~~kL~DFG~a~~~~~~~~  197 (370)
T cd05621         122 MEYMPGGDLVNLMS---NYDVPEKWAKFYTAEVVLALDAIHSM-GLIHRDVKPDNMLLDKHGHLKLADFGTCMKMDETGM  197 (370)
T ss_pred             EcCCCCCcHHHHHH---hcCCCHHHHHHHHHHHHHHHHHHHHC-CeEecCCCHHHEEECCCCCEEEEecccceecccCCc
Confidence            99999999999984   34688999999999999999999999 9999999999999999999999999998765432  


Q ss_pred             ---CCccCcccccCcccccCCC----CCCcccchhhhHHHHHHHhCCCCCCchhhHHHhhhchhhhccccccCCCC--hH
Q 020221          210 ---RSYSTNLAFTPPEYLRTGR----VTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFS--SD  280 (329)
Q Consensus       210 ---~~~~~~~~y~aPE~~~~~~----~~~~~DvwslG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~  280 (329)
                         ....||+.|+|||++.+..    ++.++||||||+++|+|++|..||...........    +........++  ..
T Consensus       198 ~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~~~~~~~~----i~~~~~~~~~p~~~~  273 (370)
T cd05621         198 VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLVGTYSK----IMDHKNSLNFPEDVE  273 (370)
T ss_pred             eecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCCHHHHHHH----HHhCCcccCCCCccc
Confidence               2346899999999987543    77899999999999999999998876543222211    11111111122  24


Q ss_pred             HHHHHHHHHHHhcccCCCC--CCCHHHHHH
Q 020221          281 EGTELVRLASRCLQYEPRE--RPNPRSLVT  308 (329)
Q Consensus       281 ~~~~~~~li~~cl~~dp~~--Rps~~~~l~  308 (329)
                      .+..+.+++..||..++.+  |+++.++++
T Consensus       274 ~s~~~~~li~~~L~~~~~r~~R~~~~e~l~  303 (370)
T cd05621         274 ISKHAKNLICAFLTDREVRLGRNGVEEIKQ  303 (370)
T ss_pred             CCHHHHHHHHHHccCchhccCCCCHHHHhc
Confidence            5788999999999865544  889999988

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found

>cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains

Probab=100.00  E-value=4.9e-43  Score=303.00  Aligned_cols=244  Identities=20%  Similarity=0.266  Sum_probs=203.6

Q ss_pred             ccccccCCCCCCcEEEEEEe-CCCCEEEEEEeCCCC--ChhHHHHHHHHHHHhcCCCccccccceeeeeCCeeEEEEecC
Q 020221           59 ENIVSEHGEKAPNVVYKGKL-ENQFRIAVKRFNRSA--WPDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAEYM  135 (329)
Q Consensus        59 ~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~  135 (329)
                      |.+.+.+|+|++|.||++.. .+++.|++|.+....  ......+.+|+++++.++|||++++++++...+..++++||+
T Consensus         2 ~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   81 (256)
T cd08529           2 FEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYESFLDKGKLNIVMEYA   81 (256)
T ss_pred             ceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCCHHHHHHHHHHHHHHHhcCCCCeehheeeeccCCEEEEEEEeC
Confidence            44566779999999999994 568899999987542  234566889999999999999999999999999999999999


Q ss_pred             CCCCHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCCCCCeeeecccCcccCCCCC----C
Q 020221          136 PNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDGR----S  211 (329)
Q Consensus       136 ~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~----~  211 (329)
                      ++++|.+++.......+++..+..++.|++.||.|||+. +++|+||||+||+++.++.++|+|||++.......    .
T Consensus        82 ~~~~L~~~l~~~~~~~~~~~~~~~i~~~l~~al~~lH~~-~i~h~dl~~~nili~~~~~~~l~df~~~~~~~~~~~~~~~  160 (256)
T cd08529          82 ENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLHSK-KILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTNFANT  160 (256)
T ss_pred             CCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC-CcccCCCCcceEEEeCCCCEEEcccccceeccCccchhhc
Confidence            999999999764456789999999999999999999999 99999999999999999999999999987654432    2


Q ss_pred             ccCcccccCcccccCCCCCCcccchhhhHHHHHHHhCCCCCCchhhHHHhhhchhhhccccccCCCChHHHHHHHHHHHH
Q 020221          212 YSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLASR  291 (329)
Q Consensus       212 ~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~  291 (329)
                      ..+++.|+|||++.+..++.++|+||||+++++|++|..|+................     ....+...+.++.+++.+
T Consensus       161 ~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~i~~  235 (256)
T cd08529         161 IVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDANNQGALILKIIRGV-----FPPVSQMYSQQLAQLIDQ  235 (256)
T ss_pred             cccCccccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCC-----CCCCccccCHHHHHHHHH
Confidence            356788999999998889999999999999999999998886544322222211111     122333567789999999


Q ss_pred             hcccCCCCCCCHHHHHH
Q 020221          292 CLQYEPRERPNPRSLVT  308 (329)
Q Consensus       292 cl~~dp~~Rps~~~~l~  308 (329)
                      ||+.+|++||++.++++
T Consensus       236 ~l~~~p~~Rp~~~~ll~  252 (256)
T cd08529         236 CLTKDYRQRPDTFQLLR  252 (256)
T ss_pred             HccCCcccCcCHHHHhh
Confidence            99999999999999998

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc

>cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1

Probab=100.00  E-value=4.2e-43  Score=308.23  Aligned_cols=251  Identities=23%  Similarity=0.351  Sum_probs=201.6

Q ss_pred             CCcccccccCCCCCCcEEEEEEe-----CCCCEEEEEEeCCCCCh-hHHHHHHHHHHHhcCCCccccccceeeeeCCeeE
Q 020221           56 FAMENIVSEHGEKAPNVVYKGKL-----ENQFRIAVKRFNRSAWP-DARQFLEEARAVGQLRNRRLANLLGCCCEGDERL  129 (329)
Q Consensus        56 ~~~~~~~~~lg~G~~g~V~~~~~-----~~~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~  129 (329)
                      ++.+++.+.||+|+||.||+|..     .++..+++|.+...... ....+.+|+.+++.++||||+++++++..+...+
T Consensus         4 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~   83 (283)
T cd05090           4 LSAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCLLGVVTQEQPVC   83 (283)
T ss_pred             hhhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCceE
Confidence            34567788899999999999973     24578999999754432 3456889999999999999999999999999999


Q ss_pred             EEEecCCCCCHHhhhccCC---------------CCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCCCCC
Q 020221          130 LVAEYMPNDTLAKHLFHWE---------------TQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVN  194 (329)
Q Consensus       130 lv~e~~~~gsL~~~l~~~~---------------~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~  194 (329)
                      ++|||+++++|.+++....               ...+++.++..++.|++.||.|||++ +++|+||||+||++++++.
T Consensus        84 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~-~i~H~dlkp~nili~~~~~  162 (283)
T cd05090          84 MLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSH-FFVHKDLAARNILIGEQLH  162 (283)
T ss_pred             EEEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhc-CeehhccccceEEEcCCCc
Confidence            9999999999999885211               23478889999999999999999999 9999999999999999999


Q ss_pred             eeeecccCcccCCCC------CCccCcccccCcccccCCCCCCcccchhhhHHHHHHHh-CCCCCCchhhHHHhhhchhh
Q 020221          195 PRLSCFGLMKNSRDG------RSYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLS-GKHIPPSHALDLIRDRNIQT  267 (329)
Q Consensus       195 ~kl~Dfg~a~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t-g~~~~~~~~~~~~~~~~~~~  267 (329)
                      +||+|||++......      ....++..|+|||++.+..++.++||||||+++|||++ |..||.............. 
T Consensus       163 ~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~g~~p~~~~~~~~~~~~~~~-  241 (283)
T cd05090         163 VKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFSNQEVIEMVRK-  241 (283)
T ss_pred             EEeccccccccccCCcceecccCCCccceecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHc-
Confidence            999999998764332      12234567999999988889999999999999999999 7766644322211111111 


Q ss_pred             hccccccCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHh
Q 020221          268 LTDSCLEGQFSSDEGTELVRLASRCLQYEPRERPNPRSLVTALVT  312 (329)
Q Consensus       268 ~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~~~l~~L~~  312 (329)
                          ......+..+++.+.+++.+||+.||++||++.++++.|..
T Consensus       242 ----~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~  282 (283)
T cd05090         242 ----RQLLPCSEDCPPRMYSLMTECWQEGPSRRPRFKDIHTRLRS  282 (283)
T ss_pred             ----CCcCCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHhhc
Confidence                11112344567889999999999999999999999998864

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly

>cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6

Probab=100.00  E-value=5.9e-43  Score=304.51  Aligned_cols=255  Identities=16%  Similarity=0.195  Sum_probs=205.9

Q ss_pred             CcccccccCCCCCCcEEEEEE-eCCCCEEEEEEeCCCC---ChhHHHHHHHHHHHhcCCCccccccceeeeeCCeeEEEE
Q 020221           57 AMENIVSEHGEKAPNVVYKGK-LENQFRIAVKRFNRSA---WPDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVA  132 (329)
Q Consensus        57 ~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~  132 (329)
                      ..|++.+.||+|+||.||+|. ..+++.||+|.+....   ......+.+|+++++.++||||+++++++...+..++++
T Consensus         2 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~   81 (267)
T cd08228           2 ANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIEDNELNIVL   81 (267)
T ss_pred             cceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEECCeEEEEE
Confidence            346677788999999999999 5578899999876432   222446888999999999999999999999999999999


Q ss_pred             ecCCCCCHHhhhccC--CCCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCCCCCeeeecccCcccCCCCC
Q 020221          133 EYMPNDTLAKHLFHW--ETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDGR  210 (329)
Q Consensus       133 e~~~~gsL~~~l~~~--~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~  210 (329)
                      ||+++++|.+++...  ....+++..+..++.|++.||.|||++ +++|+||||+||+++.++.++|+|||++.......
T Consensus        82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~-~i~H~dl~~~nil~~~~~~~~l~d~g~~~~~~~~~  160 (267)
T cd08228          82 ELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSR-RVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKT  160 (267)
T ss_pred             EecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhC-CeeCCCCCHHHEEEcCCCCEEECccccceeccchh
Confidence            999999999887532  234578999999999999999999999 99999999999999999999999999987654332


Q ss_pred             ----CccCcccccCcccccCCCCCCcccchhhhHHHHHHHhCCCCCCchhhHHHhhhchhhhccccccCCCChHHHHHHH
Q 020221          211 ----SYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELV  286 (329)
Q Consensus       211 ----~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  286 (329)
                          ...++..|+|||.+.+..++.++|+||||+++|+|++|+.|+..........  ...+.........+...+..+.
T Consensus       161 ~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~  238 (267)
T cd08228         161 TAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLFSL--CQKIEQCDYPPLPTEHYSEKLR  238 (267)
T ss_pred             HHHhcCCCCccccChhhhccCCCCchhhHHHHHHHHHHHhcCCCCCccccccHHHH--HHHHhcCCCCCCChhhcCHHHH
Confidence                3457789999999988889999999999999999999998875432211110  0111111111122335667899


Q ss_pred             HHHHHhcccCCCCCCCHHHHHHHHHhhh
Q 020221          287 RLASRCLQYEPRERPNPRSLVTALVTLQ  314 (329)
Q Consensus       287 ~li~~cl~~dp~~Rps~~~~l~~L~~~~  314 (329)
                      +++.+||+.+|++||++.++++.+++++
T Consensus       239 ~li~~cl~~~p~~Rp~~~~vl~~~~~~~  266 (267)
T cd08228         239 ELVSMCIYPDPDQRPDIGYVHQIAKQMH  266 (267)
T ss_pred             HHHHHHCCCCcccCcCHHHHHHHHHHhc
Confidence            9999999999999999999999998864

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase

>cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor

Probab=100.00  E-value=3.6e-43  Score=313.55  Aligned_cols=252  Identities=18%  Similarity=0.274  Sum_probs=202.2

Q ss_pred             cccccccCCCCCCcEEEEEEe-CCCC----EEEEEEeCCCCC-hhHHHHHHHHHHHhcCCCccccccceeeeeCCeeEEE
Q 020221           58 MENIVSEHGEKAPNVVYKGKL-ENQF----RIAVKRFNRSAW-PDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLV  131 (329)
Q Consensus        58 ~~~~~~~lg~G~~g~V~~~~~-~~~~----~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv  131 (329)
                      ++++++.||+|+||.||+|.+ .+++    .||+|.+..... ...+.+.+|+.+++.++||||+++++++.. ...+++
T Consensus         8 ~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~-~~~~~v   86 (316)
T cd05108           8 EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLT-STVQLI   86 (316)
T ss_pred             hceeeeeeecCCCceEEEEEEecCCCccceeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcC-CCceee
Confidence            466777789999999999984 3343    389999875432 335678899999999999999999999865 467899


Q ss_pred             EecCCCCCHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCCCCCeeeecccCcccCCCCCC
Q 020221          132 AEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDGRS  211 (329)
Q Consensus       132 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~~  211 (329)
                      +||+++|+|.+++.. ....+++..+..++.||+.||+|||+. +++||||||+||++++++.+||+|||+++.......
T Consensus        87 ~e~~~~g~l~~~l~~-~~~~~~~~~~~~~~~qi~~~L~~LH~~-~iiH~dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~  164 (316)
T cd05108          87 TQLMPFGCLLDYVRE-HKDNIGSQYLLNWCVQIAKGMNYLEER-RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGADEK  164 (316)
T ss_pred             eecCCCCCHHHHHHh-ccccCCHHHHHHHHHHHHHHHHHHHhc-CeeccccchhheEecCCCcEEEccccccccccCCCc
Confidence            999999999999864 344688999999999999999999999 999999999999999999999999999986543321


Q ss_pred             ------ccCcccccCcccccCCCCCCcccchhhhHHHHHHHh-CCCCCCchhhHHHhhhchhhhccccccCCCChHHHHH
Q 020221          212 ------YSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLS-GKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTE  284 (329)
Q Consensus       212 ------~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t-g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  284 (329)
                            ...+..|+|||++.+..++.++||||||+++|||++ |..|+..........     ..........+..++.+
T Consensus       165 ~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slGv~l~el~t~g~~p~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~  239 (316)
T cd05108         165 EYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISS-----ILEKGERLPQPPICTID  239 (316)
T ss_pred             ceeccCCccceeecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHH-----HHhCCCCCCCCCCCCHH
Confidence                  123567999999998899999999999999999998 787765432222111     11111111223445678


Q ss_pred             HHHHHHHhcccCCCCCCCHHHHHHHHHhhhhcc
Q 020221          285 LVRLASRCLQYEPRERPNPRSLVTALVTLQKDT  317 (329)
Q Consensus       285 ~~~li~~cl~~dp~~Rps~~~~l~~L~~~~~~~  317 (329)
                      +.+++.+||..||++||++.+++..|..+.++.
T Consensus       240 ~~~li~~cl~~~p~~Rps~~~l~~~l~~~~~~~  272 (316)
T cd05108         240 VYMIMVKCWMIDADSRPKFRELIIEFSKMARDP  272 (316)
T ss_pred             HHHHHHHHccCChhhCcCHHHHHHHHHHHHcCC
Confidence            999999999999999999999999999887654

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor

>cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3

Probab=100.00  E-value=8.1e-44  Score=318.92  Aligned_cols=237  Identities=17%  Similarity=0.190  Sum_probs=191.9

Q ss_pred             cCCCCCCcEEEEEE-eCCCCEEEEEEeCCCC---ChhHHHHHHHHH-HHhcCCCccccccceeeeeCCeeEEEEecCCCC
Q 020221           64 EHGEKAPNVVYKGK-LENQFRIAVKRFNRSA---WPDARQFLEEAR-AVGQLRNRRLANLLGCCCEGDERLLVAEYMPND  138 (329)
Q Consensus        64 ~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~---~~~~~~~~~e~~-~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g  138 (329)
                      .||+|+||.||++. ..+|+.+|+|++....   ......+..|.. +++.++||||+++++++...+..++||||+++|
T Consensus         2 ~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~~lv~e~~~~~   81 (325)
T cd05604           2 VIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVLDFVNGG   81 (325)
T ss_pred             ceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCCEEEEEEcCCCCC
Confidence            46999999999998 5578899999987542   122334555654 467789999999999999999999999999999


Q ss_pred             CHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCCCCCeeeecccCcccCCC----CCCccC
Q 020221          139 TLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRD----GRSYST  214 (329)
Q Consensus       139 sL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~----~~~~~~  214 (329)
                      +|..++.  ....+++..+..++.||+.||.|||+. |++||||||+|||++.++.+||+|||++.....    .....|
T Consensus        82 ~L~~~l~--~~~~~~~~~~~~~~~qi~~al~~lH~~-givH~Dlkp~NIll~~~~~~kL~DfG~~~~~~~~~~~~~~~~g  158 (325)
T cd05604          82 ELFFHLQ--RERSFPEPRARFYAAEIASALGYLHSI-NIVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQSDTTTTFCG  158 (325)
T ss_pred             CHHHHHH--HcCCCCHHHHHHHHHHHHHHHHHHHHC-CeeecCCCHHHeEECCCCCEEEeecCCcccCCCCCCCcccccC
Confidence            9998886  456789999999999999999999999 999999999999999999999999999875322    123458


Q ss_pred             cccccCcccccCCCCCCcccchhhhHHHHHHHhCCCCCCchhhHHHhhhchhhhccccccCCCChHHHHHHHHHHHHhcc
Q 020221          215 NLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLASRCLQ  294 (329)
Q Consensus       215 ~~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~  294 (329)
                      ++.|+|||++.+..++.++||||||+++|+|++|..||................      ...+...+..+.+++..||.
T Consensus       159 t~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~~~~~~~~~~------~~~~~~~~~~~~~ll~~ll~  232 (325)
T cd05604         159 TPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYCRDVAEMYDNILHKP------LVLRPGASLTAWSILEELLE  232 (325)
T ss_pred             ChhhCCHHHHcCCCCCCcCccccccceehhhhcCCCCCCCCCHHHHHHHHHcCC------ccCCCCCCHHHHHHHHHHhc
Confidence            899999999999899999999999999999999999887654333322221111      11223456788999999999


Q ss_pred             cCCCCCCCHHHHHHH
Q 020221          295 YEPRERPNPRSLVTA  309 (329)
Q Consensus       295 ~dp~~Rps~~~~l~~  309 (329)
                      .||.+||++++.++.
T Consensus       233 ~~p~~R~~~~~~~~~  247 (325)
T cd05604         233 KDRQRRLGAKEDFLE  247 (325)
T ss_pred             cCHHhcCCCCCCHHH
Confidence            999999998644433

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels,

>KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=1.6e-43  Score=305.30  Aligned_cols=249  Identities=18%  Similarity=0.192  Sum_probs=206.6

Q ss_pred             CCCcccccccCCCCCCcEEEEEEe-CCCCEEEEEEeCCCCChh---HHHHHHHHHHHhcCCCccccccceeeeeCCeeEE
Q 020221           55 GFAMENIVSEHGEKAPNVVYKGKL-ENQFRIAVKRFNRSAWPD---ARQFLEEARAVGQLRNRRLANLLGCCCEGDERLL  130 (329)
Q Consensus        55 ~~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~---~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l  130 (329)
                      ++...++++.||.|.-|+||++.. .++..+|+|++.+.....   ......|.++|+.++||.++.+++.++.....++
T Consensus        75 ~l~~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet~~~~cl  154 (459)
T KOG0610|consen   75 GLRHFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASFETDKYSCL  154 (459)
T ss_pred             CHHHHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhheeeccceeEE
Confidence            456678889999999999999995 456899999998765433   3346779999999999999999999999999999


Q ss_pred             EEecCCCCCHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCCCCCeeeecccCcccCC---
Q 020221          131 VAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSR---  207 (329)
Q Consensus       131 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~---  207 (329)
                      +||||+||+|..++++...+.+++..++.++.+++-||+|||.. |||+|||||+||||-++|++-|+||.++....   
T Consensus       155 ~meyCpGGdL~~LrqkQp~~~fse~~aRFYaAEvl~ALEYLHml-GivYRDLKPENILvredGHIMLsDFDLS~~~~~~P  233 (459)
T KOG0610|consen  155 VMEYCPGGDLHSLRQKQPGKRFSESAARFYAAEVLLALEYLHML-GIVYRDLKPENILVREDGHIMLSDFDLSLRCPVSP  233 (459)
T ss_pred             EEecCCCccHHHHHhhCCCCccchhhHHHHHHHHHHHHHHHHhh-ceeeccCCcceeEEecCCcEEeeeccccccCCCCC
Confidence            99999999999999887788899999999999999999999999 99999999999999999999999999853110   


Q ss_pred             -------------------------------C-C-------------------------CCccCcccccCcccccCCCCC
Q 020221          208 -------------------------------D-G-------------------------RSYSTNLAFTPPEYLRTGRVT  230 (329)
Q Consensus       208 -------------------------------~-~-------------------------~~~~~~~~y~aPE~~~~~~~~  230 (329)
                                                     . .                         .+++||-.|.|||++.|...+
T Consensus       234 t~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI~G~GHg  313 (459)
T KOG0610|consen  234 TLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEVIRGEGHG  313 (459)
T ss_pred             eeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccceeeecCCCC
Confidence                                           0 0                         023567889999999999999


Q ss_pred             CcccchhhhHHHHHHHhCCCCCCchhhHHHhhhchhhhccccccCCCChHHHHHHHHHHHHhcccCCCCCCC----HHHH
Q 020221          231 PESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLASRCLQYEPRERPN----PRSL  306 (329)
Q Consensus       231 ~~~DvwslG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps----~~~~  306 (329)
                      .++|+|+|||++|||+.|.-||-+...+.....    ++...+.-.-....+..+++||.++|.+||.+|..    |.+|
T Consensus       314 sAVDWWtfGIflYEmLyG~TPFKG~~~~~Tl~N----Iv~~~l~Fp~~~~vs~~akDLIr~LLvKdP~kRlg~~rGA~eI  389 (459)
T KOG0610|consen  314 SAVDWWTFGIFLYEMLYGTTPFKGSNNKETLRN----IVGQPLKFPEEPEVSSAAKDLIRKLLVKDPSKRLGSKRGAAEI  389 (459)
T ss_pred             chhhHHHHHHHHHHHHhCCCCcCCCCchhhHHH----HhcCCCcCCCCCcchhHHHHHHHHHhccChhhhhccccchHHh
Confidence            999999999999999999999977654433322    22222222222366789999999999999999998    5555


Q ss_pred             HH
Q 020221          307 VT  308 (329)
Q Consensus       307 l~  308 (329)
                      -+
T Consensus       390 K~  391 (459)
T KOG0610|consen  390 KR  391 (459)
T ss_pred             hc
Confidence            44

>cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha

Probab=100.00  E-value=2.9e-43  Score=322.39  Aligned_cols=253  Identities=21%  Similarity=0.279  Sum_probs=202.5

Q ss_pred             cccccccCCCCCCcEEEEEEeC------CCCEEEEEEeCCCCCh-hHHHHHHHHHHHhcCC-CccccccceeeeeCCeeE
Q 020221           58 MENIVSEHGEKAPNVVYKGKLE------NQFRIAVKRFNRSAWP-DARQFLEEARAVGQLR-NRRLANLLGCCCEGDERL  129 (329)
Q Consensus        58 ~~~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~~~~  129 (329)
                      .+.+.+.||+|+||.||+|...      .+..||+|++...... ..+.+.+|+++++.+. ||||+++++++.+....+
T Consensus        38 ~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~~~~~~~~  117 (400)
T cd05105          38 GLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTARSSEKQALMSELKIMTHLGPHLNIVNLLGACTKSGPIY  117 (400)
T ss_pred             ceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCCeeeEEEEEccCCceE
Confidence            4566778899999999999842      1346999999765433 3456899999999996 999999999999999999


Q ss_pred             EEEecCCCCCHHhhhccCC-------------------------------------------------------------
Q 020221          130 LVAEYMPNDTLAKHLFHWE-------------------------------------------------------------  148 (329)
Q Consensus       130 lv~e~~~~gsL~~~l~~~~-------------------------------------------------------------  148 (329)
                      +||||+++|+|.+++....                                                             
T Consensus       118 lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  197 (400)
T cd05105         118 IITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYVPMLEIKEA  197 (400)
T ss_pred             EEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccchhhhhhhh
Confidence            9999999999998875321                                                             


Q ss_pred             ---------------------------------CCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCCCCCe
Q 020221          149 ---------------------------------TQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNP  195 (329)
Q Consensus       149 ---------------------------------~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~  195 (329)
                                                       ...+++..+..++.|++.||.|||+. +++|+||||+||++++++.+
T Consensus       198 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~-~ivH~dikp~Nill~~~~~~  276 (400)
T cd05105         198 SKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASK-NCVHRDLAARNVLLAQGKIV  276 (400)
T ss_pred             hhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhC-CeeCCCCChHhEEEeCCCEE
Confidence                                             12477888899999999999999999 99999999999999999999


Q ss_pred             eeecccCcccCCCCC------CccCcccccCcccccCCCCCCcccchhhhHHHHHHHh-CCCCCCchhhHHHhhhchhhh
Q 020221          196 RLSCFGLMKNSRDGR------SYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLS-GKHIPPSHALDLIRDRNIQTL  268 (329)
Q Consensus       196 kl~Dfg~a~~~~~~~------~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t-g~~~~~~~~~~~~~~~~~~~~  268 (329)
                      ||+|||++.......      ...++..|+|||.+.+..++.++||||||+++|+|++ |..|++....+.....    .
T Consensus       277 kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt~g~~P~~~~~~~~~~~~----~  352 (400)
T cd05105         277 KICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPYPGMIVDSTFYN----K  352 (400)
T ss_pred             EEEeCCcceeccccccccccCCcCCCcceEChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCcccchhHHHHH----H
Confidence            999999987643322      2234578999999998889999999999999999997 7777764322211111    1


Q ss_pred             ccccccCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhh
Q 020221          269 TDSCLEGQFSSDEGTELVRLASRCLQYEPRERPNPRSLVTALVTLQK  315 (329)
Q Consensus       269 ~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~~~l~~L~~~~~  315 (329)
                      .........+...+.++.+++.+||+.||++|||+.++.+.|+++.+
T Consensus       353 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~l~~l~~  399 (400)
T cd05105         353 IKSGYRMAKPDHATQEVYDIMVKCWNSEPEKRPSFLHLSDIVESLLP  399 (400)
T ss_pred             HhcCCCCCCCccCCHHHHHHHHHHCccCHhHCcCHHHHHHHHHHHcC
Confidence            11111222345567889999999999999999999999999998754

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-

>cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2

Probab=100.00  E-value=5.5e-43  Score=309.51  Aligned_cols=252  Identities=17%  Similarity=0.242  Sum_probs=207.6

Q ss_pred             HHHhcCCCcccccccCCCCCCcEEEEEE-eCCCCEEEEEEeCCCCChhHHHHHHHHHHHhcCCCccccccceeeeeCCee
Q 020221           50 RTATSGFAMENIVSEHGEKAPNVVYKGK-LENQFRIAVKRFNRSAWPDARQFLEEARAVGQLRNRRLANLLGCCCEGDER  128 (329)
Q Consensus        50 ~~~~~~~~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~  128 (329)
                      ....+....|.+++.+|.|++|.||++. ..+++.|++|.+........+.+.+|+..++.++|||++++++++......
T Consensus        12 ~~~~~~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~   91 (296)
T cd06655          12 VSIGDPKKKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVNFLDSFLVGDEL   91 (296)
T ss_pred             HhcCCCcceEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEecccCchHHHHHHHHHHHHhcCCCceeeeeeeEecCceE
Confidence            3344445568888889999999999998 567889999999776555566788999999999999999999999999999


Q ss_pred             EEEEecCCCCCHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCCCCCeeeecccCcccCCC
Q 020221          129 LLVAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRD  208 (329)
Q Consensus       129 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~  208 (329)
                      ++|+||+++++|..++.   ...+++.++..++.|++.||.|||+. |++|+||||+||+++.++.++|+|||++.....
T Consensus        92 ~lv~e~~~~~~L~~~~~---~~~l~~~~~~~i~~~l~~al~~LH~~-~i~H~dL~p~Nili~~~~~~kl~dfg~~~~~~~  167 (296)
T cd06655          92 FVVMEYLAGGSLTDVVT---ETCMDEAQIAAVCRECLQALEFLHAN-QVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITP  167 (296)
T ss_pred             EEEEEecCCCcHHHHHH---hcCCCHHHHHHHHHHHHHHHHHHHHC-CcccCCCCHHHEEECCCCCEEEccCccchhccc
Confidence            99999999999999884   34689999999999999999999999 999999999999999999999999999875443


Q ss_pred             CC----CccCcccccCcccccCCCCCCcccchhhhHHHHHHHhCCCCCCchhhHHHhhhchhhhccccccCCCChHHHHH
Q 020221          209 GR----SYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTE  284 (329)
Q Consensus       209 ~~----~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  284 (329)
                      ..    ...++..|+|||.+.+..++.++|+||||+++|+|++|..||..............   ........+...++.
T Consensus       168 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~~lltg~~pf~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~  244 (296)
T cd06655         168 EQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIAT---NGTPELQNPEKLSPI  244 (296)
T ss_pred             ccccCCCcCCCccccCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHh---cCCcccCCcccCCHH
Confidence            32    23567899999999988899999999999999999999988755322111111100   000111223456778


Q ss_pred             HHHHHHHhcccCCCCCCCHHHHHH
Q 020221          285 LVRLASRCLQYEPRERPNPRSLVT  308 (329)
Q Consensus       285 ~~~li~~cl~~dp~~Rps~~~~l~  308 (329)
                      +.+++.+||..||++||++.++++
T Consensus       245 ~~~li~~~l~~dp~~Rpt~~~il~  268 (296)
T cd06655         245 FRDFLNRCLEMDVEKRGSAKELLQ  268 (296)
T ss_pred             HHHHHHHHhhcChhhCCCHHHHhh
Confidence            999999999999999999999997

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2

Probab=100.00  E-value=9.9e-44  Score=322.74  Aligned_cols=245  Identities=12%  Similarity=0.101  Sum_probs=195.3

Q ss_pred             cccccccCCCCCCcEEEEEE-eCCCCEEEEEEeCCCC---ChhHHHHHHHHHHHhcCCCccccccceeeeeCCeeEEEEe
Q 020221           58 MENIVSEHGEKAPNVVYKGK-LENQFRIAVKRFNRSA---WPDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAE  133 (329)
Q Consensus        58 ~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  133 (329)
                      .+++++.||+|+||.||++. ..+++.||+|++....   ......+.+|+.++..++|+||+++++.+.+.+..++|||
T Consensus         2 ~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~E   81 (360)
T cd05627           2 DFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQDKRNLYLIME   81 (360)
T ss_pred             CceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEEe
Confidence            35667788999999999998 4568899999987532   2234567889999999999999999999999999999999


Q ss_pred             cCCCCCHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCCCCCeeeecccCcccCCCC----
Q 020221          134 YMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDG----  209 (329)
Q Consensus       134 ~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~----  209 (329)
                      |+++|+|.+++.  ....+++..+..++.|++.||.|||++ |++||||||+||+++.++.++|+|||++......    
T Consensus        82 ~~~gg~L~~~l~--~~~~l~~~~~~~~~~qi~~~L~~lH~~-givHrDLkp~NIli~~~~~vkL~DfG~~~~~~~~~~~~  158 (360)
T cd05627          82 FLPGGDMMTLLM--KKDTLSEEATQFYIAETVLAIDAIHQL-GFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRTE  158 (360)
T ss_pred             CCCCccHHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHHC-CeEccCCCHHHEEECCCCCEEEeeccCCcccccccccc
Confidence            999999999986  345689999999999999999999999 9999999999999999999999999998643211    


Q ss_pred             -----------------------------------CCccCcccccCcccccCCCCCCcccchhhhHHHHHHHhCCCCCCc
Q 020221          210 -----------------------------------RSYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPS  254 (329)
Q Consensus       210 -----------------------------------~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~~~~~  254 (329)
                                                         ....||+.|+|||++.+..++.++|||||||++|||++|..||..
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvilyel~tG~~Pf~~  238 (360)
T cd05627         159 FYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPFCS  238 (360)
T ss_pred             cccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCCCCCcceeccccceeeecccCCCCCCC
Confidence                                               123588999999999998999999999999999999999998865


Q ss_pred             hhhHHHhhhchhhhccccccCCCChHHHHHHHHHHHHhcccCCCCCCC---HHHHHH
Q 020221          255 HALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLASRCLQYEPRERPN---PRSLVT  308 (329)
Q Consensus       255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps---~~~~l~  308 (329)
                      ............. ... .........++++.+++.+++ .||++|++   +.++++
T Consensus       239 ~~~~~~~~~i~~~-~~~-~~~p~~~~~s~~~~~li~~l~-~~p~~R~~~~~~~ei~~  292 (360)
T cd05627         239 ETPQETYRKVMNW-KET-LVFPPEVPISEKAKDLILRFC-TDSENRIGSNGVEEIKS  292 (360)
T ss_pred             CCHHHHHHHHHcC-CCc-eecCCCCCCCHHHHHHHHHhc-cChhhcCCCCCHHHHhc
Confidence            4433222211110 000 000011125678999999877 49999985   566665

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul

>cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase

Probab=100.00  E-value=7e-43  Score=306.65  Aligned_cols=245  Identities=17%  Similarity=0.204  Sum_probs=199.3

Q ss_pred             ccccccCCCCCCcEEEEEEe-CCCCEEEEEEeCCCCChhHHHHHHHHHHHhcCCCccccccceeeeeCCeeEEEEecCCC
Q 020221           59 ENIVSEHGEKAPNVVYKGKL-ENQFRIAVKRFNRSAWPDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAEYMPN  137 (329)
Q Consensus        59 ~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~  137 (329)
                      |++++.||+|+||.||++.. .++..+++|.+........+.+.+|+++++.++|||++++++++..+...++++||+++
T Consensus         7 ~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~~v~e~~~~   86 (282)
T cd06643           7 WEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCAG   86 (282)
T ss_pred             HHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCCCHHHHHHHHHHHHHHHHCCCCCeeeEEEEEeeCCEEEEEEEecCC
Confidence            46777889999999999994 45778999998766555566788999999999999999999999999999999999999


Q ss_pred             CCHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCCCCCeeeecccCcccCCCC----CCcc
Q 020221          138 DTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDG----RSYS  213 (329)
Q Consensus       138 gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~----~~~~  213 (329)
                      ++|..++.+ ....+++..+..++.|++.||.|||+. +++|+||||+||+++.++.++|+|||++......    ....
T Consensus        87 ~~l~~~~~~-~~~~l~~~~~~~~~~qi~~~L~~LH~~-~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~  164 (282)
T cd06643          87 GAVDAVMLE-LERPLTEPQIRVVCKQTLEALNYLHEN-KIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSFI  164 (282)
T ss_pred             CcHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHHC-CeeecCCCcccEEEccCCCEEEcccccccccccccccccccc
Confidence            999888754 345789999999999999999999999 9999999999999999999999999998654322    2345


Q ss_pred             CcccccCccccc-----CCCCCCcccchhhhHHHHHHHhCCCCCCchhhHHHhhhchhhhccccccCCCChHHHHHHHHH
Q 020221          214 TNLAFTPPEYLR-----TGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRL  288 (329)
Q Consensus       214 ~~~~y~aPE~~~-----~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  288 (329)
                      ++..|+|||++.     +..++.++||||||+++|+|++|..|+.................   .....+...+.++.++
T Consensus       165 ~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~l  241 (282)
T cd06643         165 GTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEP---PTLAQPSRWSSEFKDF  241 (282)
T ss_pred             ccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccCHHHHHHHHhhcCC---CCCCCccccCHHHHHH
Confidence            788999999884     34477899999999999999999987754322111111111100   0112234567789999


Q ss_pred             HHHhcccCCCCCCCHHHHHH
Q 020221          289 ASRCLQYEPRERPNPRSLVT  308 (329)
Q Consensus       289 i~~cl~~dp~~Rps~~~~l~  308 (329)
                      +.+||+.||++||++.++++
T Consensus       242 i~~~l~~~p~~Rp~~~~il~  261 (282)
T cd06643         242 LKKCLEKNVDARWTTTQLLQ  261 (282)
T ss_pred             HHHHccCChhhCcCHHHHhc
Confidence            99999999999999999987

Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration.

>cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2

Probab=100.00  E-value=3.8e-43  Score=308.47  Aligned_cols=250  Identities=20%  Similarity=0.282  Sum_probs=201.5

Q ss_pred             CcccccccCCCCCCcEEEEEEeC------CCCEEEEEEeCCCCChh-HHHHHHHHHHHhcCCCccccccceeeeeCCeeE
Q 020221           57 AMENIVSEHGEKAPNVVYKGKLE------NQFRIAVKRFNRSAWPD-ARQFLEEARAVGQLRNRRLANLLGCCCEGDERL  129 (329)
Q Consensus        57 ~~~~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~~~~-~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~  129 (329)
                      +.+++++.||.|+||.||+|...      .++.||+|++....... ...+.+|+.++..++||||+++++++......+
T Consensus         5 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~   84 (283)
T cd05091           5 STVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKEQPLS   84 (283)
T ss_pred             HHHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCCCceE
Confidence            44677788899999999999843      24789999998654332 356888999999999999999999999999999


Q ss_pred             EEEecCCCCCHHhhhccC--------------CCCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCCCCCe
Q 020221          130 LVAEYMPNDTLAKHLFHW--------------ETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNP  195 (329)
Q Consensus       130 lv~e~~~~gsL~~~l~~~--------------~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~  195 (329)
                      +++||+.+++|.+++...              ....+++..+..++.|++.||.|||+. +++||||||+||++++++.+
T Consensus        85 ~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~-gi~H~dlkp~Nil~~~~~~~  163 (283)
T cd05091          85 MIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSH-HVVHKDLATRNVLVFDKLNV  163 (283)
T ss_pred             EEEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHc-CccccccchhheEecCCCce
Confidence            999999999999988421              123478888999999999999999999 99999999999999999999


Q ss_pred             eeecccCcccCCCCC------CccCcccccCcccccCCCCCCcccchhhhHHHHHHHh-CCCCCCchhhHHHhhhchhhh
Q 020221          196 RLSCFGLMKNSRDGR------SYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLS-GKHIPPSHALDLIRDRNIQTL  268 (329)
Q Consensus       196 kl~Dfg~a~~~~~~~------~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t-g~~~~~~~~~~~~~~~~~~~~  268 (329)
                      ||+|||+++......      ...+++.|+|||.+.+..++.++||||||+++|||++ |..|+...........    +
T Consensus       164 kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~----i  239 (283)
T cd05091         164 KISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVIEM----I  239 (283)
T ss_pred             EecccccccccccchheeeccCccCCccccCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH----H
Confidence            999999987543322      2234678999999988889999999999999999998 6655543322222111    1


Q ss_pred             ccccccCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHh
Q 020221          269 TDSCLEGQFSSDEGTELVRLASRCLQYEPRERPNPRSLVTALVT  312 (329)
Q Consensus       269 ~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~~~l~~L~~  312 (329)
                      .. ......+..++..+.+++.+||+.+|++||++.++++.|++
T Consensus       240 ~~-~~~~~~~~~~~~~~~~li~~cl~~~p~~RP~~~~i~~~l~~  282 (283)
T cd05091         240 RN-RQVLPCPDDCPAWVYTLMLECWNEFPSRRPRFKDIHSRLRT  282 (283)
T ss_pred             Hc-CCcCCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHhhC
Confidence            11 11123455678889999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly

>cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors

Probab=100.00  E-value=3.8e-43  Score=315.84  Aligned_cols=253  Identities=20%  Similarity=0.301  Sum_probs=200.8

Q ss_pred             cccccccCCCCCCcEEEEEEe-C-----CCCEEEEEEeCCCCCh-hHHHHHHHHHHHhcC-CCccccccceeeeeC-Cee
Q 020221           58 MENIVSEHGEKAPNVVYKGKL-E-----NQFRIAVKRFNRSAWP-DARQFLEEARAVGQL-RNRRLANLLGCCCEG-DER  128 (329)
Q Consensus        58 ~~~~~~~lg~G~~g~V~~~~~-~-----~~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~-~~~  128 (329)
                      .+++.+.||+|+||.||+|.. .     +++.||+|+++..... ..+.+.+|+.++..+ +|+||+++++++... ...
T Consensus         8 ~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~~~~~~~   87 (337)
T cd05054           8 RLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATASEYKALMTELKILIHIGHHLNVVNLLGACTKPGGPL   87 (337)
T ss_pred             HhhhhcccccCcCceEEeccccccccccccceeeeeeccCCCCHHHHHHHHHHHHHHHhhccCcchhheeeeEecCCCCE
Confidence            467788889999999999963 2     2468999998765422 245678899999999 799999999988654 568


Q ss_pred             EEEEecCCCCCHHhhhccCC-----------------------------------------------------------C
Q 020221          129 LLVAEYMPNDTLAKHLFHWE-----------------------------------------------------------T  149 (329)
Q Consensus       129 ~lv~e~~~~gsL~~~l~~~~-----------------------------------------------------------~  149 (329)
                      ++++||+++++|.+++....                                                           .
T Consensus        88 ~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  167 (337)
T cd05054          88 MVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEGDELYK  167 (337)
T ss_pred             EEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchhhhHHhh
Confidence            89999999999999885321                                                           1


Q ss_pred             CCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCCCCCeeeecccCcccCCCCC------CccCcccccCccc
Q 020221          150 QPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDGR------SYSTNLAFTPPEY  223 (329)
Q Consensus       150 ~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~------~~~~~~~y~aPE~  223 (329)
                      ..+++..+..++.||+.||+|||++ +|+||||||+||+++.++.++|+|||++.......      ...++..|+|||+
T Consensus       168 ~~l~~~~~~~~~~qi~~aL~~lH~~-~ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~~~~~~~~~~~~~y~aPE~  246 (337)
T cd05054         168 EPLTLEDLISYSFQVARGMEFLASR-KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPES  246 (337)
T ss_pred             cCCCHHHHHHHHHHHHHHHHHHHhC-CeecCCCCcceEEEeCCCcEEEeccccchhcccCcchhhccCCCCCccccCcHH
Confidence            2678999999999999999999999 99999999999999999999999999997653321      2234578999999


Q ss_pred             ccCCCCCCcccchhhhHHHHHHHh-CCCCCCchhhHHHhhhchhhhccccccCCCChHHHHHHHHHHHHhcccCCCCCCC
Q 020221          224 LRTGRVTPESVMYSFGTLLLDLLS-GKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLASRCLQYEPRERPN  302 (329)
Q Consensus       224 ~~~~~~~~~~DvwslG~il~el~t-g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps  302 (329)
                      +.+..++.++|||||||++|||++ |..||.........    ............+...++++.+++.+||+.+|++||+
T Consensus       247 ~~~~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~RPs  322 (337)
T cd05054         247 IFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDEEF----CRRLKEGTRMRAPEYATPEIYSIMLDCWHNNPEDRPT  322 (337)
T ss_pred             hcCCCCCccccHHHHHHHHHHHHHcCCCCCCCCCccHHH----HHHHhccCCCCCCccCCHHHHHHHHHHccCChhhCcC
Confidence            999999999999999999999998 88776532111110    0111111112233455678999999999999999999


Q ss_pred             HHHHHHHHHhhhh
Q 020221          303 PRSLVTALVTLQK  315 (329)
Q Consensus       303 ~~~~l~~L~~~~~  315 (329)
                      +.+++++|+++.+
T Consensus       323 ~~ell~~l~~~~~  335 (337)
T cd05054         323 FSELVEILGDLLQ  335 (337)
T ss_pred             HHHHHHHHHHHHh
Confidence            9999999998765

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto

>cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk

Probab=100.00  E-value=6.6e-43  Score=303.17  Aligned_cols=247  Identities=23%  Similarity=0.346  Sum_probs=204.1

Q ss_pred             cccccccCCCCCCcEEEEEEeCCCCEEEEEEeCCCCChhHHHHHHHHHHHhcCCCccccccceeeeeCCeeEEEEecCCC
Q 020221           58 MENIVSEHGEKAPNVVYKGKLENQFRIAVKRFNRSAWPDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAEYMPN  137 (329)
Q Consensus        58 ~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~  137 (329)
                      .+++++.||+|+||.||+|...+++.||+|.+..... ....+.+|+.+++.++|+|++++++++ ..+..++++||+.+
T Consensus         7 ~~~~~~~ig~G~~g~v~~~~~~~~~~~a~K~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~-~~~~~~~v~e~~~~   84 (260)
T cd05067           7 TLKLVKKLGAGQFGEVWMGYYNGHTKVAIKSLKQGSM-SPEAFLAEANLMKQLQHPRLVRLYAVV-TQEPIYIITEYMEN   84 (260)
T ss_pred             HceeeeeeccCccceEEeeecCCCceEEEEEecCCCC-cHHHHHHHHHHHHhcCCcCeeeEEEEE-ccCCcEEEEEcCCC
Confidence            4677888999999999999987888999999986553 356788999999999999999999886 45678999999999


Q ss_pred             CCHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCCCCCeeeecccCcccCCCCC-----Cc
Q 020221          138 DTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDGR-----SY  212 (329)
Q Consensus       138 gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~-----~~  212 (329)
                      ++|.+++.......+++.++..++.|++.||+|||+. +++|+||||+||++++++.++|+|||++.......     ..
T Consensus        85 ~~L~~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~-~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~~~~~~~  163 (260)
T cd05067          85 GSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIERK-NYIHRDLRAANILVSETLCCKIADFGLARLIEDNEYTAREGA  163 (260)
T ss_pred             CCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcC-CeecccccHHhEEEcCCCCEEEccCcceeecCCCCcccccCC
Confidence            9999998654556789999999999999999999999 99999999999999999999999999987654221     12


Q ss_pred             cCcccccCcccccCCCCCCcccchhhhHHHHHHHh-CCCCCCchhhHHHhhhchhhhccccccCCCChHHHHHHHHHHHH
Q 020221          213 STNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLS-GKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLASR  291 (329)
Q Consensus       213 ~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t-g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~  291 (329)
                      .++..|+|||++.+..++.++||||||+++|++++ |..|+............     ........+...+.++.+++.+
T Consensus       164 ~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~li~~  238 (260)
T cd05067         164 KFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMTNPEVIQNL-----ERGYRMPRPDNCPEELYELMRL  238 (260)
T ss_pred             cccccccCHHHhccCCcCcccchHHHHHHHHHHHhCCCCCCCCCChHHHHHHH-----HcCCCCCCCCCCCHHHHHHHHH
Confidence            34568999999998889999999999999999999 88777544322222111     1111122334456789999999


Q ss_pred             hcccCCCCCCCHHHHHHHHHh
Q 020221          292 CLQYEPRERPNPRSLVTALVT  312 (329)
Q Consensus       292 cl~~dp~~Rps~~~~l~~L~~  312 (329)
                      ||+.+|++||++++++..|+.
T Consensus       239 ~l~~~p~~Rp~~~~l~~~l~~  259 (260)
T cd05067         239 CWKEKPEERPTFEYLRSVLED  259 (260)
T ss_pred             HccCChhhCCCHHHHHHHhhc
Confidence            999999999999999999875

Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr

>cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases

Probab=100.00  E-value=1.1e-42  Score=302.85  Aligned_cols=248  Identities=22%  Similarity=0.313  Sum_probs=202.0

Q ss_pred             ccccccCCCCCCcEEEEEEeC----CCCEEEEEEeCCCCCh-hHHHHHHHHHHHhcCCCccccccceeeeeCCeeEEEEe
Q 020221           59 ENIVSEHGEKAPNVVYKGKLE----NQFRIAVKRFNRSAWP-DARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAE  133 (329)
Q Consensus        59 ~~~~~~lg~G~~g~V~~~~~~----~~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  133 (329)
                      +++.+.||+|+||.||+|.+.    +...||+|.+...... ....+.+|+.+++.++||||+++++++......+++||
T Consensus         6 ~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e   85 (266)
T cd05033           6 VTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIRLEGVVTKSRPVMIITE   85 (266)
T ss_pred             ceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCcceEeEEEecCCceEEEEE
Confidence            455667799999999999853    2457999998765433 34568899999999999999999999998899999999


Q ss_pred             cCCCCCHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCCCCCeeeecccCcccCCCCC---
Q 020221          134 YMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDGR---  210 (329)
Q Consensus       134 ~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~---  210 (329)
                      |+++++|.+++.. ....+++..+..++.|++.||.|||+. +++|+||||+||++++++.++|+|||++.......   
T Consensus        86 ~~~~~~L~~~~~~-~~~~~~~~~~~~~~~~l~~~l~~Lh~~-~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~~~~~~  163 (266)
T cd05033          86 YMENGSLDKFLRE-NDGKFTVGQLVGMLRGIASGMKYLSEM-NYVHRDLAARNILVNSNLVCKVSDFGLSRRLEDSEATY  163 (266)
T ss_pred             cCCCCCHHHHHHh-ccCCCCHHHHHHHHHHHHHHHHHHHhC-CcccCCCCcceEEEcCCCCEEECccchhhcccccccce
Confidence            9999999999864 334789999999999999999999999 99999999999999999999999999988764211   


Q ss_pred             ---CccCcccccCcccccCCCCCCcccchhhhHHHHHHHh-CCCCCCchhhHHHhhhchhhhccccccCCCChHHHHHHH
Q 020221          211 ---SYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLS-GKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELV  286 (329)
Q Consensus       211 ---~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t-g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  286 (329)
                         ...++..|+|||.+.+..++.++||||||+++|+|++ |..|+..............     ......+...++.+.
T Consensus       164 ~~~~~~~~~~y~~Pe~~~~~~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~-----~~~~~~~~~~~~~l~  238 (266)
T cd05033         164 TTKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDMSNQDVIKAVED-----GYRLPPPMDCPSALY  238 (266)
T ss_pred             eccCCCCCccccChhhhccCCCccccchHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHc-----CCCCCCCCCCCHHHH
Confidence               1223567999999998889999999999999999998 8777654332222211111     111123345678899


Q ss_pred             HHHHHhcccCCCCCCCHHHHHHHHHhh
Q 020221          287 RLASRCLQYEPRERPNPRSLVTALVTL  313 (329)
Q Consensus       287 ~li~~cl~~dp~~Rps~~~~l~~L~~~  313 (329)
                      +++.+||+.+|++||++.++++.|+++
T Consensus       239 ~li~~cl~~~p~~Rp~~~ei~~~l~~~  265 (266)
T cd05033         239 QLMLDCWQKDRNERPTFSQIVSTLDKM  265 (266)
T ss_pred             HHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence            999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment

>cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase

Probab=100.00  E-value=7.6e-43  Score=308.00  Aligned_cols=255  Identities=17%  Similarity=0.205  Sum_probs=205.1

Q ss_pred             HHHHhcCCCcccccccCCCCCCcEEEEEEe-CCCCEEEEEEeCCCCChhHHHHHHHHHHHhcCCCccccccceeeeeCCe
Q 020221           49 LRTATSGFAMENIVSEHGEKAPNVVYKGKL-ENQFRIAVKRFNRSAWPDARQFLEEARAVGQLRNRRLANLLGCCCEGDE  127 (329)
Q Consensus        49 ~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~  127 (329)
                      +.+-....+.|++++.+|.|+||.||+|.. .+++.+++|.+........+.+.+|+.+++.++|+|++++++.+.....
T Consensus         4 ~~~~~~~~~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~   83 (292)
T cd06644           4 VRRDLDPNEVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAFYWDGK   83 (292)
T ss_pred             hhcccCcchhhhhhheecCCCCeEEEEEEECCCCceEEEEEeccCCHHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeCCe
Confidence            334444556788899999999999999994 5588999999987665556778899999999999999999999999999


Q ss_pred             eEEEEecCCCCCHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCCCCCeeeecccCcccCC
Q 020221          128 RLLVAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSR  207 (329)
Q Consensus       128 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~  207 (329)
                      .++||||+++++|..++.+ ....+++..+..++.|++.||.|||+. +++|+||||+||+++.++.++|+|||++....
T Consensus        84 ~~lv~e~~~~~~l~~~~~~-~~~~l~~~~~~~~~~ql~~~l~~lH~~-~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~  161 (292)
T cd06644          84 LWIMIEFCPGGAVDAIMLE-LDRGLTEPQIQVICRQMLEALQYLHSM-KIIHRDLKAGNVLLTLDGDIKLADFGVSAKNV  161 (292)
T ss_pred             EEEEEecCCCCcHHHHHHh-hcCCCCHHHHHHHHHHHHHHHHHHhcC-CeeecCCCcceEEEcCCCCEEEccCccceecc
Confidence            9999999999999887754 345689999999999999999999999 99999999999999999999999999876533


Q ss_pred             CC----CCccCcccccCcccccC-----CCCCCcccchhhhHHHHHHHhCCCCCCchhhHHHhhhchhhhccccccCCCC
Q 020221          208 DG----RSYSTNLAFTPPEYLRT-----GRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFS  278 (329)
Q Consensus       208 ~~----~~~~~~~~y~aPE~~~~-----~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  278 (329)
                      ..    ....++..|+|||++.+     ..++.++|+||||+++|+|++|..|+............... ..  .....+
T Consensus       162 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~~-~~--~~~~~~  238 (292)
T cd06644         162 KTLQRRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKS-EP--PTLSQP  238 (292)
T ss_pred             ccccccceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccccHHHHHHHHhcC-CC--ccCCCC
Confidence            22    23356789999999853     34778999999999999999999877543221111111110 00  011223


Q ss_pred             hHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 020221          279 SDEGTELVRLASRCLQYEPRERPNPRSLVT  308 (329)
Q Consensus       279 ~~~~~~~~~li~~cl~~dp~~Rps~~~~l~  308 (329)
                      ...+.++.+++.+||..||++||++.++++
T Consensus       239 ~~~~~~~~~li~~~l~~~p~~Rp~~~~il~  268 (292)
T cd06644         239 SKWSMEFRDFLKTALDKHPETRPSAAQLLE  268 (292)
T ss_pred             cccCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence            456678999999999999999999999987

Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types.

>cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1

Probab=100.00  E-value=9.8e-43  Score=308.08  Aligned_cols=259  Identities=20%  Similarity=0.283  Sum_probs=205.9

Q ss_pred             CcccccccCCCCCCcEEEEEEeC-CC--CEEEEEEeCCCC-ChhHHHHHHHHHHHhcC-CCccccccceeeeeCCeeEEE
Q 020221           57 AMENIVSEHGEKAPNVVYKGKLE-NQ--FRIAVKRFNRSA-WPDARQFLEEARAVGQL-RNRRLANLLGCCCEGDERLLV  131 (329)
Q Consensus        57 ~~~~~~~~lg~G~~g~V~~~~~~-~~--~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~lv  131 (329)
                      +.+.+.+.||+|+||.||+|... ++  ..+++|.++... ....+.+.+|++++..+ +||||+++++++...+..+++
T Consensus         2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv   81 (297)
T cd05089           2 EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLLGACENRGYLYIA   81 (297)
T ss_pred             ccceeeeeecCCCcceEEEEEecCCCCcceeEEEEccccCCHHHHHHHHHHHHHHHhhcCCCchhheEEEEccCCcceEE
Confidence            45667778899999999999853 33  347888887432 23356788999999999 799999999999988999999


Q ss_pred             EecCCCCCHHhhhccCC--------------CCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCCCCCeee
Q 020221          132 AEYMPNDTLAKHLFHWE--------------TQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRL  197 (329)
Q Consensus       132 ~e~~~~gsL~~~l~~~~--------------~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl  197 (329)
                      +||+++++|.+++....              ...+++..+..++.|++.||+|||+. |++|+||||+||++++++.+||
T Consensus        82 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~-~ivH~dlkp~Nill~~~~~~kl  160 (297)
T cd05089          82 IEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEK-QFIHRDLAARNVLVGENLASKI  160 (297)
T ss_pred             EEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHC-CcccCcCCcceEEECCCCeEEE
Confidence            99999999999986421              13478899999999999999999999 9999999999999999999999


Q ss_pred             ecccCcccCCCC---CCccCcccccCcccccCCCCCCcccchhhhHHHHHHHh-CCCCCCchhhHHHhhhchhhhccccc
Q 020221          198 SCFGLMKNSRDG---RSYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLS-GKHIPPSHALDLIRDRNIQTLTDSCL  273 (329)
Q Consensus       198 ~Dfg~a~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t-g~~~~~~~~~~~~~~~~~~~~~~~~~  273 (329)
                      +|||++......   .....+..|+|||++.+..++.++||||||+++|||++ |..||..............     ..
T Consensus       161 ~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t~g~~pf~~~~~~~~~~~~~~-----~~  235 (297)
T cd05089         161 ADFGLSRGEEVYVKKTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTCAELYEKLPQ-----GY  235 (297)
T ss_pred             CCcCCCccccceeccCCCCcCccccCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhc-----CC
Confidence            999998643221   11122457999999988889999999999999999998 8877755433322221111     11


Q ss_pred             cCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhhcccccc
Q 020221          274 EGQFSSDEGTELVRLASRCLQYEPRERPNPRSLVTALVTLQKDTELYL  321 (329)
Q Consensus       274 ~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~~~l~~L~~~~~~~~~~~  321 (329)
                      ....+..++.++.+++.+||+.||.+||++.++++.|+.+..+.....
T Consensus       236 ~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~~~~~~~~~  283 (297)
T cd05089         236 RMEKPRNCDDEVYELMRQCWRDRPYERPPFAQISVQLSRMLEARKAYV  283 (297)
T ss_pred             CCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhhcccc
Confidence            222334567789999999999999999999999999999987655443

Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations.

>PTZ00283 serine/threonine protein kinase; Provisional

Probab=100.00  E-value=2.5e-43  Score=331.15  Aligned_cols=247  Identities=17%  Similarity=0.200  Sum_probs=202.4

Q ss_pred             CcccccccCCCCCCcEEEEEE-eCCCCEEEEEEeCCCCC--hhHHHHHHHHHHHhcCCCccccccceeeeeCC-------
Q 020221           57 AMENIVSEHGEKAPNVVYKGK-LENQFRIAVKRFNRSAW--PDARQFLEEARAVGQLRNRRLANLLGCCCEGD-------  126 (329)
Q Consensus        57 ~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~-------  126 (329)
                      ..|.+.+.||+|+||+||++. ..+++.||||.+.....  .....+.+|+..+..++|+|++++...+...+       
T Consensus        32 ~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~~~~~~~  111 (496)
T PTZ00283         32 KKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDPRNPENV  111 (496)
T ss_pred             CCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCCHHHHHHHHHHHHHHhcCCCCcEEEeecceecccccCcccc
Confidence            356777788999999999998 56789999999876532  23456788999999999999999887764332       


Q ss_pred             -eeEEEEecCCCCCHHhhhccC--CCCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCCCCCeeeecccCc
Q 020221          127 -ERLLVAEYMPNDTLAKHLFHW--ETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLM  203 (329)
Q Consensus       127 -~~~lv~e~~~~gsL~~~l~~~--~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a  203 (329)
                       ..++||||+++|+|.+++...  ....+++..+..++.|++.||.|||+. +|+||||||+|||++.++.+||+|||++
T Consensus       112 ~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~~-~IiHrDLKP~NILl~~~~~vkL~DFGls  190 (496)
T PTZ00283        112 LMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSK-HMIHRDIKSANILLCSNGLVKLGDFGFS  190 (496)
T ss_pred             eEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhC-CEecCCCCHHHEEEeCCCCEEEEecccC
Confidence             367999999999999988642  235689999999999999999999999 9999999999999999999999999998


Q ss_pred             ccCCCC------CCccCcccccCcccccCCCCCCcccchhhhHHHHHHHhCCCCCCchhhHHHhhhchhhhccccccCCC
Q 020221          204 KNSRDG------RSYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQF  277 (329)
Q Consensus       204 ~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  277 (329)
                      +.....      ....||+.|+|||++.+..++.++||||||+++|||++|..||................     ....
T Consensus       191 ~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~k~DVwSlGvilyeLltG~~Pf~~~~~~~~~~~~~~~~-----~~~~  265 (496)
T PTZ00283        191 KMYAATVSDDVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGENMEEVMHKTLAGR-----YDPL  265 (496)
T ss_pred             eeccccccccccccccCCcceeCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcCC-----CCCC
Confidence            754322      23468899999999999889999999999999999999999887654433322222211     1223


Q ss_pred             ChHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 020221          278 SSDEGTELVRLASRCLQYEPRERPNPRSLVTA  309 (329)
Q Consensus       278 ~~~~~~~~~~li~~cl~~dp~~Rps~~~~l~~  309 (329)
                      +...++++.+++.+||+.||++||++.+++++
T Consensus       266 ~~~~~~~l~~li~~~L~~dP~~RPs~~ell~~  297 (496)
T PTZ00283        266 PPSISPEMQEIVTALLSSDPKRRPSSSKLLNM  297 (496)
T ss_pred             CCCCCHHHHHHHHHHcccChhhCcCHHHHHhC
Confidence            45667899999999999999999999999864

>PTZ00036 glycogen synthase kinase; Provisional

Probab=100.00  E-value=1.6e-43  Score=328.62  Aligned_cols=246  Identities=21%  Similarity=0.268  Sum_probs=190.0

Q ss_pred             CcccccccCCCCCCcEEEEEE-eCCCCEEEEEEeCCCCChhHHHHHHHHHHHhcCCCccccccceeeeeC--------Ce
Q 020221           57 AMENIVSEHGEKAPNVVYKGK-LENQFRIAVKRFNRSAWPDARQFLEEARAVGQLRNRRLANLLGCCCEG--------DE  127 (329)
Q Consensus        57 ~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~--------~~  127 (329)
                      ..|.+.+.||+|+||.||+|. ..+++.||||++....    ....+|+.+++.++||||+++.+++...        ..
T Consensus        66 ~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~----~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~~~~~~  141 (440)
T PTZ00036         66 KSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDP----QYKNRELLIMKNLNHINIIFLKDYYYTECFKKNEKNIF  141 (440)
T ss_pred             CeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCc----chHHHHHHHHHhcCCCCCcceeeeEeecccccCCCceE
Confidence            357788888999999999999 4568899999986543    2345799999999999999998876432        24


Q ss_pred             eEEEEecCCCCCHHhhhcc--CCCCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCCCC-CeeeecccCcc
Q 020221          128 RLLVAEYMPNDTLAKHLFH--WETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDV-NPRLSCFGLMK  204 (329)
Q Consensus       128 ~~lv~e~~~~gsL~~~l~~--~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~-~~kl~Dfg~a~  204 (329)
                      +++||||+++ +|.+++..  .....+++..+..++.||+.||.|||+. +|+||||||+|||++.++ .+||+|||+++
T Consensus       142 l~lvmE~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~~-~IiHrDLKp~NILl~~~~~~vkL~DFGla~  219 (440)
T PTZ00036        142 LNVVMEFIPQ-TVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSK-FICHRDLKPQNLLIDPNTHTLKLCDFGSAK  219 (440)
T ss_pred             EEEEEecCCc-cHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHC-CEecCCcCHHHEEEcCCCCceeeeccccch
Confidence            6789999986 67776642  1346789999999999999999999999 999999999999999665 69999999998


Q ss_pred             cCCCC---CCccCcccccCcccccCC-CCCCcccchhhhHHHHHHHhCCCCCCchhhHHHhhhchhh-------------
Q 020221          205 NSRDG---RSYSTNLAFTPPEYLRTG-RVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQT-------------  267 (329)
Q Consensus       205 ~~~~~---~~~~~~~~y~aPE~~~~~-~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~~~~~~~~-------------  267 (329)
                      .....   ....+++.|+|||++.+. .++.++|||||||++|||++|.+||...............             
T Consensus       220 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~p~~~~~~~~~  299 (440)
T PTZ00036        220 NLLAGQRSVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQLVRIIQVLGTPTEDQLKEMN  299 (440)
T ss_pred             hccCCCCcccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhc
Confidence            65433   234678999999998764 5899999999999999999999888654221111110000             


Q ss_pred             ----------hccccccCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 020221          268 ----------LTDSCLEGQFSSDEGTELVRLASRCLQYEPRERPNPRSLVT  308 (329)
Q Consensus       268 ----------~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~~~l~  308 (329)
                                +....+...++...++++.+|+.+||..||++|||+.++++
T Consensus       300 ~~~~~~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~ta~e~l~  350 (440)
T PTZ00036        300 PNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALA  350 (440)
T ss_pred             hhhhcccCCccCchhHHHHhccCCCHHHHHHHHHHCCCChhHCcCHHHHhC
Confidence                      00000111123345678999999999999999999999996

>cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk

Probab=100.00  E-value=8.9e-43  Score=302.36  Aligned_cols=247  Identities=24%  Similarity=0.362  Sum_probs=203.1

Q ss_pred             cccccccCCCCCCcEEEEEEeCCCCEEEEEEeCCCCChhHHHHHHHHHHHhcCCCccccccceeeeeCCeeEEEEecCCC
Q 020221           58 MENIVSEHGEKAPNVVYKGKLENQFRIAVKRFNRSAWPDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAEYMPN  137 (329)
Q Consensus        58 ~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~  137 (329)
                      .+++++.+|+|+||.||++...++..+|+|.+..... ..+.+.+|+.+++.++|+|++++++++. ....+++|||+++
T Consensus         7 ~~~~~~~ig~g~~~~v~~~~~~~~~~~~~k~~~~~~~-~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~lv~e~~~~   84 (260)
T cd05070           7 SLQLIKKLGNGQFGEVWMGTWNGNTKVAVKTLKPGTM-SPESFLEEAQIMKKLRHDKLVQLYAVVS-EEPIYIVTEYMSK   84 (260)
T ss_pred             HhhhhheeccccCceEEEEEecCCceeEEEEecCCCC-CHHHHHHHHHHHHhcCCCceEEEEeEEC-CCCcEEEEEecCC
Confidence            4667788899999999999987888899999986543 3457899999999999999999999874 4678999999999


Q ss_pred             CCHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCCCCCeeeecccCcccCCCCC-----Cc
Q 020221          138 DTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDGR-----SY  212 (329)
Q Consensus       138 gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~-----~~  212 (329)
                      ++|.+++.......+++.++..++.|++.||.|||+. +++|+||||+||++++++.++|+|||++.......     ..
T Consensus        85 ~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~-~i~H~di~p~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~  163 (260)
T cd05070          85 GSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIERM-NYIHRDLRSANILVGDGLVCKIADFGLARLIEDNEYTARQGA  163 (260)
T ss_pred             CcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHC-CcccCCCccceEEEeCCceEEeCCceeeeeccCcccccccCC
Confidence            9999999754455689999999999999999999999 99999999999999999999999999987654322     12


Q ss_pred             cCcccccCcccccCCCCCCcccchhhhHHHHHHHh-CCCCCCchhhHHHhhhchhhhccccccCCCChHHHHHHHHHHHH
Q 020221          213 STNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLS-GKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLASR  291 (329)
Q Consensus       213 ~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t-g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~  291 (329)
                      .++..|+|||.+.+..++.++|+||||+++|+|++ |..||...........     .........+...+..+.+++.+
T Consensus       164 ~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~li~~  238 (260)
T cd05070         164 KFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMNNREVLEQ-----VERGYRMPCPQDCPISLHELMLQ  238 (260)
T ss_pred             CCCccccChHHHhcCCCcchhhhHHHHHHHHHHHhcCCCCCCCCCHHHHHHH-----HHcCCCCCCCCcCCHHHHHHHHH
Confidence            34567999999988889999999999999999999 6766654332221111     11112223455667889999999


Q ss_pred             hcccCCCCCCCHHHHHHHHHh
Q 020221          292 CLQYEPRERPNPRSLVTALVT  312 (329)
Q Consensus       292 cl~~dp~~Rps~~~~l~~L~~  312 (329)
                      ||..||++|||+.++.+.|+.
T Consensus       239 ~l~~~p~~Rpt~~~l~~~l~~  259 (260)
T cd05070         239 CWKKDPEERPTFEYLQSFLED  259 (260)
T ss_pred             HcccCcccCcCHHHHHHHHhc
Confidence            999999999999999998875

Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r

>cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src

Probab=100.00  E-value=1.2e-42  Score=301.94  Aligned_cols=248  Identities=23%  Similarity=0.334  Sum_probs=201.7

Q ss_pred             cccccccCCCCCCcEEEEEEeCCCCEEEEEEeCCCCChhHHHHHHHHHHHhcCCCccccccceeeeeCCeeEEEEecCCC
Q 020221           58 MENIVSEHGEKAPNVVYKGKLENQFRIAVKRFNRSAWPDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAEYMPN  137 (329)
Q Consensus        58 ~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~  137 (329)
                      .|++.+.||+|+||.||+|...++..||+|++..... ..+.+.+|+++++.++|+||+++++.+. ....+++|||+++
T Consensus         7 ~~~~~~~lg~g~~~~v~~~~~~~~~~valK~~~~~~~-~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~lv~e~~~~   84 (262)
T cd05071           7 SLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTM-SPEAFLQEAQVMKKLRHEKLVQLYAVVS-EEPIYIVTEYMSK   84 (262)
T ss_pred             HeeEeeecCCCCCCcEEEEEecCCceEEEEecccCcc-CHHHHHHHHHHHHhCCCCCcceEEEEEC-CCCcEEEEEcCCC
Confidence            4778888999999999999976666899999986442 3457889999999999999999998874 4568999999999


Q ss_pred             CCHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCCCCCeeeecccCcccCCCCC-----Cc
Q 020221          138 DTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDGR-----SY  212 (329)
Q Consensus       138 gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~-----~~  212 (329)
                      |+|.+++.......+++..+..++.|++.||+|||+. +++|+||||+||++++++.++|+|||.+.......     ..
T Consensus        85 ~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~-~i~H~dl~p~Nill~~~~~~~L~dfg~~~~~~~~~~~~~~~~  163 (262)
T cd05071          85 GSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERM-NYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGA  163 (262)
T ss_pred             CcHHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHHC-CccccccCcccEEEcCCCcEEeccCCceeeccccccccccCC
Confidence            9999999753445679999999999999999999999 99999999999999999999999999987554332     12


Q ss_pred             cCcccccCcccccCCCCCCcccchhhhHHHHHHHh-CCCCCCchhhHHHhhhchhhhccccccCCCChHHHHHHHHHHHH
Q 020221          213 STNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLS-GKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLASR  291 (329)
Q Consensus       213 ~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t-g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~  291 (329)
                      .++..|+|||+..+..++.++||||||+++|+|++ |..|+..............     ......+...+..+.+++.+
T Consensus       164 ~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~ellt~g~~p~~~~~~~~~~~~~~~-----~~~~~~~~~~~~~l~~li~~  238 (262)
T cd05071         164 KFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVER-----GYRMPCPPECPESLHDLMCQ  238 (262)
T ss_pred             cccceecCHhHhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCChHHHHHHHhc-----CCCCCCccccCHHHHHHHHH
Confidence            34567999999988889999999999999999999 6655544322222111111     11112344567889999999


Q ss_pred             hcccCCCCCCCHHHHHHHHHhh
Q 020221          292 CLQYEPRERPNPRSLVTALVTL  313 (329)
Q Consensus       292 cl~~dp~~Rps~~~~l~~L~~~  313 (329)
                      ||+.||++||++.++++.|+..
T Consensus       239 ~l~~~p~~Rp~~~~~~~~l~~~  260 (262)
T cd05071         239 CWRKEPEERPTFEYLQAFLEDY  260 (262)
T ss_pred             HccCCcccCCCHHHHHHHHHHh
Confidence            9999999999999999998864

Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo

>KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms]

Probab=100.00  E-value=2e-43  Score=330.71  Aligned_cols=250  Identities=17%  Similarity=0.152  Sum_probs=208.5

Q ss_pred             ccccccCCCCCCcEEEEEEeCCC-CEEEEEEeCCCCChhHHHHHHHHHHHhcCC-Cccccccceee-ee------CCeeE
Q 020221           59 ENIVSEHGEKAPNVVYKGKLENQ-FRIAVKRFNRSAWPDARQFLEEARAVGQLR-NRRLANLLGCC-CE------GDERL  129 (329)
Q Consensus        59 ~~~~~~lg~G~~g~V~~~~~~~~-~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~~~~~~-~~------~~~~~  129 (329)
                      .++.+.|.+|+|+.||.+....+ ..+|+|++...+....+.+.+|+++|+.|+ |+|||.+++.. ..      .-+++
T Consensus        39 v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~~~~~~Evl  118 (738)
T KOG1989|consen   39 VTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVNDEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSSNNGVWEVL  118 (738)
T ss_pred             EEEEEEEccCCcEEEEEEEecCCCceeeeeeeecCCHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccCCCceeEEE
Confidence            45667789999999999995554 999999998888778888999999999997 99999999932 21      13578


Q ss_pred             EEEecCCCCCHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcC-CCccccccCCCceeeCCCCCeeeecccCcccCCC
Q 020221          130 LVAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSK-ERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRD  208 (329)
Q Consensus       130 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~-~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~  208 (329)
                      |.||||.+|+|.+++..+....|++.++++|+.++++|+++||.. ..|||||||.+|||++.+++.||||||.|.-...
T Consensus       119 lLmEyC~gg~Lvd~mn~Rlq~~lte~eVLkIf~dv~~AVa~mH~~~pPiIHRDLKiENvLls~~g~~KLCDFGSatt~~~  198 (738)
T KOG1989|consen  119 LLMEYCKGGSLVDFMNTRLQTRLTEDEVLKIFYDVCEAVAAMHYLKPPIIHRDLKIENVLLSADGNYKLCDFGSATTKIL  198 (738)
T ss_pred             eehhhccCCcHHHHHHHHHhccCChHHHHHHHHHHHHHHHHHhcCCCccchhhhhhhheEEcCCCCEEeCcccccccccC
Confidence            999999999999999876667799999999999999999999986 3499999999999999999999999999864332


Q ss_pred             CC-------------CccCcccccCccccc---CCCCCCcccchhhhHHHHHHHhCCCCCCchhhHHHhhhchhhhcccc
Q 020221          209 GR-------------SYSTNLAFTPPEYLR---TGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSC  272 (329)
Q Consensus       209 ~~-------------~~~~~~~y~aPE~~~---~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~  272 (329)
                      ..             ...+|+.|+|||++.   +..+++|+|||+|||+||-|+....||.....        ..++...
T Consensus       199 ~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~sg~--------laIlng~  270 (738)
T KOG1989|consen  199 SPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEESGK--------LAILNGN  270 (738)
T ss_pred             CCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcCcc--------eeEEecc
Confidence            21             124689999999874   67799999999999999999999999865411        2233322


Q ss_pred             ccCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhhc
Q 020221          273 LEGQFSSDEGTELVRLASRCLQYEPRERPNPRSLVTALVTLQKD  316 (329)
Q Consensus       273 ~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~~~l~~L~~~~~~  316 (329)
                      ..-+-.+..+..+.+||..||+.||++||++.+++..+-++...
T Consensus       271 Y~~P~~p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~~~~~l~~~  314 (738)
T KOG1989|consen  271 YSFPPFPNYSDRLKDLIRTMLQPNPDERPNIYQVLEEIFELANK  314 (738)
T ss_pred             ccCCCCccHHHHHHHHHHHHhccCcccCCCHHHHHHHHHHHhcC
Confidence            22222356789999999999999999999999999999998764

>cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes

Probab=100.00  E-value=1.2e-42  Score=300.21  Aligned_cols=241  Identities=25%  Similarity=0.380  Sum_probs=195.7

Q ss_pred             cCCCCCCcEEEEEEe-CCCCEEEEEEeCCCCCh-hHHHHHHHHHHHhcCCCccccccceeeeeCCeeEEEEecCCCCCHH
Q 020221           64 EHGEKAPNVVYKGKL-ENQFRIAVKRFNRSAWP-DARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAEYMPNDTLA  141 (329)
Q Consensus        64 ~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~  141 (329)
                      .||+|+||.||+|.. .+++.+|+|.+...... ....+.+|+++++.++||||+++++++......++||||+++++|.
T Consensus         2 ~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~   81 (252)
T cd05084           2 RIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDFL   81 (252)
T ss_pred             ccCcccCccEEEEEEecCCceEEEEecCccCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCeEEEEeeccCCcHH
Confidence            469999999999984 57889999988754332 3456899999999999999999999999999999999999999999


Q ss_pred             hhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCCCCCeeeecccCcccCCCCCC------ccCc
Q 020221          142 KHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDGRS------YSTN  215 (329)
Q Consensus       142 ~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~~------~~~~  215 (329)
                      +++.. ....+++..+..++.|++.||.|||++ +++|+||||+||+++.++.++|+|||++........      ...+
T Consensus        82 ~~~~~-~~~~~~~~~~~~~~~qi~~~L~~lH~~-~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~  159 (252)
T cd05084          82 TFLRT-EGPRLKVKELIQMVENAAAGMEYLESK-HCIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGGMKQIP  159 (252)
T ss_pred             HHHHh-CCCCCCHHHHHHHHHHHHHHHHHHHhC-CccccccchheEEEcCCCcEEECccccCcccccccccccCCCCCCc
Confidence            99864 334689999999999999999999999 999999999999999999999999999875443211      1123


Q ss_pred             ccccCcccccCCCCCCcccchhhhHHHHHHHh-CCCCCCchhhHHHhhhchhhhccccccCCCChHHHHHHHHHHHHhcc
Q 020221          216 LAFTPPEYLRTGRVTPESVMYSFGTLLLDLLS-GKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLASRCLQ  294 (329)
Q Consensus       216 ~~y~aPE~~~~~~~~~~~DvwslG~il~el~t-g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~  294 (329)
                      ..|+|||.+.+..++.++||||||+++|+|++ |..|+..........     ..........+...+..+.+++.+||.
T Consensus       160 ~~y~aPE~~~~~~~~~~~Dv~slG~il~e~~~~~~~p~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~li~~~l~  234 (252)
T cd05084         160 VKWTAPEALNYGRYSSESDVWSFGILLWEAFSLGAVPYANLSNQQTRE-----AIEQGVRLPCPELCPDAVYRLMERCWE  234 (252)
T ss_pred             eeecCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccCHHHHHH-----HHHcCCCCCCcccCCHHHHHHHHHHcC
Confidence            56999999998889999999999999999998 665553322111111     111112223445567889999999999


Q ss_pred             cCCCCCCCHHHHHHHHH
Q 020221          295 YEPRERPNPRSLVTALV  311 (329)
Q Consensus       295 ~dp~~Rps~~~~l~~L~  311 (329)
                      .||++|||+.++++.|+
T Consensus       235 ~~p~~Rps~~~~~~~l~  251 (252)
T cd05084         235 YDPGQRPSFSTVHQELQ  251 (252)
T ss_pred             CChhhCcCHHHHHHHHh
Confidence            99999999999999876

Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular

>KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only]

Probab=100.00  E-value=2e-43  Score=321.31  Aligned_cols=195  Identities=18%  Similarity=0.191  Sum_probs=173.7

Q ss_pred             cccccccCCCCCCcEEEEEE-eCCCCEEEEEEeCCCCChhHHHHHHHHHHHhcCC-C-----ccccccceeeeeCCeeEE
Q 020221           58 MENIVSEHGEKAPNVVYKGK-LENQFRIAVKRFNRSAWPDARQFLEEARAVGQLR-N-----RRLANLLGCCCEGDERLL  130 (329)
Q Consensus        58 ~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h-----~niv~~~~~~~~~~~~~l  130 (329)
                      .|++++.||+|+||.|-+|. ..+++.||||+++... .-..+...|+.+|..|+ |     -|+|+++++|...++++|
T Consensus       187 rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~k-~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~fr~Hlci  265 (586)
T KOG0667|consen  187 RYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNKK-RFLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYFRNHLCI  265 (586)
T ss_pred             EEEEEEEecccccceeEEEEecCCCcEEEEEeeccCh-HHHHHHHHHHHHHHHHhccCCCCCeeEEEeeeccccccceee
Confidence            45778999999999999999 6779999999998765 33566778999999996 4     389999999999999999


Q ss_pred             EEecCCCCCHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCCC--CCeeeecccCcccCCC
Q 020221          131 VAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDD--VNPRLSCFGLMKNSRD  208 (329)
Q Consensus       131 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~--~~~kl~Dfg~a~~~~~  208 (329)
                      |+|.+.. +|.+++++.+-..++...++.++.||+.||.+||+. +|||+||||+|||+.+.  ..+||+|||.++....
T Consensus       266 VfELL~~-NLYellK~n~f~Glsl~~ir~~~~Qil~~L~~L~~l-~IIHcDLKPENILL~~~~r~~vKVIDFGSSc~~~q  343 (586)
T KOG0667|consen  266 VFELLST-NLYELLKNNKFRGLSLPLVRKFAQQILTALLFLHEL-GIIHCDLKPENILLKDPKRSRIKVIDFGSSCFESQ  343 (586)
T ss_pred             eehhhhh-hHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhC-CeeeccCChhheeeccCCcCceeEEecccccccCC
Confidence            9999966 899999987778899999999999999999999998 99999999999999744  3699999999987665


Q ss_pred             C-CCccCcccccCcccccCCCCCCcccchhhhHHHHHHHhCCCCCCch
Q 020221          209 G-RSYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSH  255 (329)
Q Consensus       209 ~-~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~  255 (329)
                      . ..+..+..|.|||++.|.+|+.+.||||||||+.||++|.+.|+++
T Consensus       344 ~vytYiQSRfYRAPEVILGlpY~~~IDmWSLGCIlAEL~tG~PLfpG~  391 (586)
T KOG0667|consen  344 RVYTYIQSRFYRAPEVILGLPYDTAIDMWSLGCILAELFTGEPLFPGD  391 (586)
T ss_pred             cceeeeeccccccchhhccCCCCCccceeehhhhHHhHhcCccccCCC
Confidence            4 3556778999999999999999999999999999999999888765

>cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1

Probab=100.00  E-value=3e-43  Score=315.24  Aligned_cols=236  Identities=19%  Similarity=0.212  Sum_probs=190.2

Q ss_pred             cCCCCCCcEEEEEEe-CCCCEEEEEEeCCCCC---hhHHHHHHHHH-HHhcCCCccccccceeeeeCCeeEEEEecCCCC
Q 020221           64 EHGEKAPNVVYKGKL-ENQFRIAVKRFNRSAW---PDARQFLEEAR-AVGQLRNRRLANLLGCCCEGDERLLVAEYMPND  138 (329)
Q Consensus        64 ~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~---~~~~~~~~e~~-~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g  138 (329)
                      .||+|+||+||++.. .+++.||+|++.....   .....+..|.. +++.++||||+++++++...+..++||||++++
T Consensus         2 ~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~~lv~e~~~~~   81 (325)
T cd05602           2 VIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYINGG   81 (325)
T ss_pred             eeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCCeEEEEEeCCCCC
Confidence            469999999999994 5678899999875321   11233444444 567889999999999999999999999999999


Q ss_pred             CHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCCCCCeeeecccCcccCCC----CCCccC
Q 020221          139 TLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRD----GRSYST  214 (329)
Q Consensus       139 sL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~----~~~~~~  214 (329)
                      +|.+++.  ....+++..+..++.||+.||.|||+. |++||||||+||+++.++.++|+|||++.....    .....|
T Consensus        82 ~L~~~~~--~~~~~~~~~~~~~~~qi~~~L~~lH~~-giiHrDlkp~Nili~~~~~~kl~DfG~a~~~~~~~~~~~~~~g  158 (325)
T cd05602          82 ELFYHLQ--RERCFLEPRARFYAAEIASALGYLHSL-NIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNGTTSTFCG  158 (325)
T ss_pred             cHHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHHC-CeEecCCCHHHeEECCCCCEEEccCCCCcccccCCCCcccccC
Confidence            9999886  345688889999999999999999999 999999999999999999999999999875322    123468


Q ss_pred             cccccCcccccCCCCCCcccchhhhHHHHHHHhCCCCCCchhhHHHhhhchhhhccccccCCCChHHHHHHHHHHHHhcc
Q 020221          215 NLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLASRCLQ  294 (329)
Q Consensus       215 ~~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~  294 (329)
                      ++.|+|||++.+..++.++||||||+++|+|++|..||...............      ....+...+..+.+++.+||+
T Consensus       159 t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~------~~~~~~~~~~~~~~li~~~l~  232 (325)
T cd05602         159 TPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILNK------PLQLKPNITNSARHLLEGLLQ  232 (325)
T ss_pred             CccccCHHHHcCCCCCCccccccccHHHHHHhcCCCCCCCCCHHHHHHHHHhC------CcCCCCCCCHHHHHHHHHHcc
Confidence            89999999999988999999999999999999999988754433222221111      112234567889999999999


Q ss_pred             cCCCCCCCHHHHHH
Q 020221          295 YEPRERPNPRSLVT  308 (329)
Q Consensus       295 ~dp~~Rps~~~~l~  308 (329)
                      .||.+||++.+.+.
T Consensus       233 ~~p~~R~~~~~~~~  246 (325)
T cd05602         233 KDRTKRLGAKDDFM  246 (325)
T ss_pred             cCHHHCCCCCCCHH
Confidence            99999999875443

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt

>cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7

Probab=100.00  E-value=1.1e-42  Score=302.75  Aligned_cols=255  Identities=17%  Similarity=0.215  Sum_probs=206.5

Q ss_pred             CcccccccCCCCCCcEEEEEE-eCCCCEEEEEEeCCCCC---hhHHHHHHHHHHHhcCCCccccccceeeeeCCeeEEEE
Q 020221           57 AMENIVSEHGEKAPNVVYKGK-LENQFRIAVKRFNRSAW---PDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVA  132 (329)
Q Consensus        57 ~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~  132 (329)
                      ..|++.+.||+|+||.||++. ..++..+++|.+.....   .....+.+|+.+++.++|+||+++++++..++..+++|
T Consensus         2 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~   81 (267)
T cd08229           2 ANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVL   81 (267)
T ss_pred             chhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEeCCeEEEEE
Confidence            346677788999999999999 56788999998865332   22456889999999999999999999999999999999


Q ss_pred             ecCCCCCHHhhhccC--CCCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCCCCCeeeecccCcccCCCCC
Q 020221          133 EYMPNDTLAKHLFHW--ETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDGR  210 (329)
Q Consensus       133 e~~~~gsL~~~l~~~--~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~  210 (329)
                      ||+++++|.+++...  ....+++..+..++.|++.||.|||+. +++|+||||+||+++.++.++|+|||++.......
T Consensus        82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~-~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~  160 (267)
T cd08229          82 ELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSR-RVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKT  160 (267)
T ss_pred             EecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHC-CeecCCCCHHHEEEcCCCCEEECcchhhhccccCC
Confidence            999999999988632  235689999999999999999999999 99999999999999999999999999987654332


Q ss_pred             ----CccCcccccCcccccCCCCCCcccchhhhHHHHHHHhCCCCCCchhhHHHhhhchhhhccccccCCCChHHHHHHH
Q 020221          211 ----SYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELV  286 (329)
Q Consensus       211 ----~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  286 (329)
                          ...++..|+|||.+.+..++.++|+||||+++|+|++|..|+.....+....  ...+.........+...++++.
T Consensus       161 ~~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~  238 (267)
T cd08229         161 TAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSL--CKKIEQCDYPPLPSDHYSEELR  238 (267)
T ss_pred             cccccccCCcCccCHHHhcCCCccchhhHHHHHHHHHHHHhCCCCcccccchHHHH--hhhhhcCCCCCCCcccccHHHH
Confidence                2357789999999988889999999999999999999998875432211110  0111111111112235678999


Q ss_pred             HHHHHhcccCCCCCCCHHHHHHHHHhhh
Q 020221          287 RLASRCLQYEPRERPNPRSLVTALVTLQ  314 (329)
Q Consensus       287 ~li~~cl~~dp~~Rps~~~~l~~L~~~~  314 (329)
                      +++.+||+.||++|||+.+|++.+.++.
T Consensus       239 ~li~~~l~~~p~~Rpt~~~i~~~~~~~~  266 (267)
T cd08229         239 QLVNMCINPDPEKRPDITYVYDVAKRMH  266 (267)
T ss_pred             HHHHHhcCCCcccCCCHHHHHHHHhhhc
Confidence            9999999999999999999999998763

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase.

>cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

Probab=100.00  E-value=9.5e-43  Score=306.09  Aligned_cols=254  Identities=20%  Similarity=0.312  Sum_probs=200.9

Q ss_pred             cccccccCCCCCCcEEEEEEe-----CCCCEEEEEEeCCCCChhHHHHHHHHHHHhcCCCccccccceeeee--CCeeEE
Q 020221           58 MENIVSEHGEKAPNVVYKGKL-----ENQFRIAVKRFNRSAWPDARQFLEEARAVGQLRNRRLANLLGCCCE--GDERLL  130 (329)
Q Consensus        58 ~~~~~~~lg~G~~g~V~~~~~-----~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~--~~~~~l  130 (329)
                      .+++++.||+|+||.||++..     .++..||+|.+........+.+.+|+++++.++||||+++.+++..  ....++
T Consensus         5 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~l   84 (284)
T cd05081           5 HLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLRL   84 (284)
T ss_pred             cceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCCCCceEE
Confidence            456778889999999999974     2578899999987665556778999999999999999999998644  346889


Q ss_pred             EEecCCCCCHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCCCCCeeeecccCcccCCCCC
Q 020221          131 VAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDGR  210 (329)
Q Consensus       131 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~  210 (329)
                      |+||+++++|.+++.+ ....+++..+..++.|++.||.|||+. |++|+||||+||++++++.++|+|||++.......
T Consensus        85 v~e~~~~~~L~~~l~~-~~~~l~~~~~~~~~~~l~~aL~~LH~~-~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~~  162 (284)
T cd05081          85 VMEYLPYGSLRDYLQK-HRERLDHRKLLLYASQICKGMEYLGSK-RYVHRDLATRNILVESENRVKIGDFGLTKVLPQDK  162 (284)
T ss_pred             EEEecCCCCHHHHHHh-cCcCCCHHHHHHHHHHHHHHHHHHHHC-CceeccCCHhhEEECCCCeEEECCCcccccccCCC
Confidence            9999999999999864 234689999999999999999999999 99999999999999999999999999988654332


Q ss_pred             C-------ccCcccccCcccccCCCCCCcccchhhhHHHHHHHhCCCCCCchhhHHHh---hh--------chhhhcccc
Q 020221          211 S-------YSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIR---DR--------NIQTLTDSC  272 (329)
Q Consensus       211 ~-------~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~~---~~--------~~~~~~~~~  272 (329)
                      .       ..++..|+|||.+.+..++.++||||||++++||++|..++.........   ..        .........
T Consensus       163 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  242 (284)
T cd05081         163 EYYKVREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYSDKSCSPPAEFMRMMGNDKQGQMIVYHLIELLKNN  242 (284)
T ss_pred             cceeecCCCCCceEeeCHHHhccCCcChHHHHHHHHHHHHHHhhcCCcCCCcchhhhhhcccccccccchHHHHHHHhcC
Confidence            2       12234699999999888999999999999999999987654322111110   00        000111111


Q ss_pred             ccCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhh
Q 020221          273 LEGQFSSDEGTELVRLASRCLQYEPRERPNPRSLVTALVTL  313 (329)
Q Consensus       273 ~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~~~l~~L~~~  313 (329)
                      .....+...+.++.+++.+||+.+|++|||+.++++.|+.+
T Consensus       243 ~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~~  283 (284)
T cd05081         243 GRLPAPPGCPAEIYAIMKECWNNDPSQRPSFSELALQVEAI  283 (284)
T ss_pred             CcCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHhc
Confidence            11122345677899999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th

>cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4

Probab=100.00  E-value=5.8e-43  Score=307.98  Aligned_cols=248  Identities=15%  Similarity=0.166  Sum_probs=192.0

Q ss_pred             ccccccCCCCCCcEEEEEE-eCCCCEEEEEEeCCCCCh--hHHHHHHHHHHHhcC---CCccccccceeeee-----CCe
Q 020221           59 ENIVSEHGEKAPNVVYKGK-LENQFRIAVKRFNRSAWP--DARQFLEEARAVGQL---RNRRLANLLGCCCE-----GDE  127 (329)
Q Consensus        59 ~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~--~~~~~~~e~~~l~~l---~h~niv~~~~~~~~-----~~~  127 (329)
                      |++++.||+|+||+||++. ..+++.||+|.+......  ....+.+|+.+++.+   +||||+++++++..     ...
T Consensus         2 y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~~~   81 (288)
T cd07863           2 YEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRETK   81 (288)
T ss_pred             ceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCCce
Confidence            5677788999999999998 557889999998754322  223456677776665   69999999998754     245


Q ss_pred             eEEEEecCCCCCHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCCCCCeeeecccCcccCC
Q 020221          128 RLLVAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSR  207 (329)
Q Consensus       128 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~  207 (329)
                      .++++||+.+ +|.+++.......+++..+..++.|++.||.|||+. |++|+||||+||+++.++.+||+|||++....
T Consensus        82 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~-~ivH~dikp~Nili~~~~~~kl~dfg~~~~~~  159 (288)
T cd07863          82 VTLVFEHVDQ-DLRTYLDKVPPPGLPAETIKDLMRQFLRGLDFLHAN-CIVHRDLKPENILVTSGGQVKLADFGLARIYS  159 (288)
T ss_pred             EEEEEccccc-CHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhC-CeecCCCCHHHEEECCCCCEEECccCcccccc
Confidence            7999999975 898888654455689999999999999999999999 99999999999999999999999999987654


Q ss_pred             CC---CCccCcccccCcccccCCCCCCcccchhhhHHHHHHHhCCCCCCchhhHHHhhhchhhh-------cc-------
Q 020221          208 DG---RSYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTL-------TD-------  270 (329)
Q Consensus       208 ~~---~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~~~~~~~~~-------~~-------  270 (329)
                      ..   ....++..|+|||++.+..++.++||||||+++|+|++|.+||................       ..       
T Consensus       160 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (288)
T cd07863         160 CQMALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWPRDVTLPR  239 (288)
T ss_pred             CcccCCCccccccccCchHhhCCCCCCcchhhhHHHHHHHHHhCCcCcCCCCHHHHHHHHHHHhCCCChhhCcccccccc
Confidence            33   23456889999999998889999999999999999999998775432211111100000       00       


Q ss_pred             cccc-------CCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 020221          271 SCLE-------GQFSSDEGTELVRLASRCLQYEPRERPNPRSLVT  308 (329)
Q Consensus       271 ~~~~-------~~~~~~~~~~~~~li~~cl~~dp~~Rps~~~~l~  308 (329)
                      ....       .......+.++.+++.+||+.||++|||+.+++.
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~l~  284 (288)
T cd07863         240 GAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQ  284 (288)
T ss_pred             cccCCCCCCchHHhCcCcCHHHHHHHHHHhccCcccCCCHHHHhc
Confidence            0000       0011235678899999999999999999999997

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou

>cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases

Probab=100.00  E-value=8.6e-43  Score=301.84  Aligned_cols=245  Identities=24%  Similarity=0.361  Sum_probs=199.4

Q ss_pred             cccccccCCCCCCcEEEEEEeCCCCEEEEEEeCCCCChhHHHHHHHHHHHhcCCCccccccceeeeeCCeeEEEEecCCC
Q 020221           58 MENIVSEHGEKAPNVVYKGKLENQFRIAVKRFNRSAWPDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAEYMPN  137 (329)
Q Consensus        58 ~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~  137 (329)
                      ++.+.+.||+|+||.||++...++..+|+|.+..... ....+.+|+++++.++||||+++++++...+..++||||+++
T Consensus         5 ~~~~~~~lg~G~~~~v~~~~~~~~~~~~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~   83 (256)
T cd05059           5 ELTFLKELGSGQFGVVHLGKWRGKIDVAIKMIREGAM-SEDDFIEEAKVMMKLSHPNLVQLYGVCTKQRPIFIVTEYMAN   83 (256)
T ss_pred             HcchhhhhccCCCceEEEeEecCCccEEEEEeccCCC-CHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCceEEEEecCCC
Confidence            3556777899999999999977777899999875442 345688899999999999999999999988999999999999


Q ss_pred             CCHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCCCCCeeeecccCcccCCCCCC-----c
Q 020221          138 DTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDGRS-----Y  212 (329)
Q Consensus       138 gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~~-----~  212 (329)
                      ++|.+++.. ....+++..+..++.|++.||+|||+. +++|+||||+||++++++.++|+|||++....+...     .
T Consensus        84 ~~L~~~l~~-~~~~~~~~~~~~i~~qi~~~l~~lH~~-~i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~~~~~~~~~~~~  161 (256)
T cd05059          84 GCLLNYLRE-RKGKLGTEWLLDMCSDVCEAMEYLESN-GFIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQYTSSQGT  161 (256)
T ss_pred             CCHHHHHHh-cccCCCHHHHHHHHHHHHHHHHHHHHC-CcccccccHhhEEECCCCcEEECCcccceecccccccccCCC
Confidence            999999864 234689999999999999999999999 999999999999999999999999999876543221     1


Q ss_pred             cCcccccCcccccCCCCCCcccchhhhHHHHHHHh-CCCCCCchhhHHHhhhchhhhccccccCCCChHHHHHHHHHHHH
Q 020221          213 STNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLS-GKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLASR  291 (329)
Q Consensus       213 ~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t-g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~  291 (329)
                      .++..|+|||.+.+..++.++||||||+++|++++ |..|+............     ........+...+.++.+++.+
T Consensus       162 ~~~~~y~~Pe~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~li~~  236 (256)
T cd05059         162 KFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSNSEVVESV-----SAGYRLYRPKLAPTEVYTIMYS  236 (256)
T ss_pred             CCCccccCHHHhccCCCCchhhHHHHHHHHHHHhccCCCCCCCCCHHHHHHHH-----HcCCcCCCCCCCCHHHHHHHHH
Confidence            22357999999998889999999999999999999 66665432222111111     1111222344567899999999


Q ss_pred             hcccCCCCCCCHHHHHHHH
Q 020221          292 CLQYEPRERPNPRSLVTAL  310 (329)
Q Consensus       292 cl~~dp~~Rps~~~~l~~L  310 (329)
                      ||..+|++|||+.++++.|
T Consensus       237 cl~~~p~~Rpt~~~~l~~l  255 (256)
T cd05059         237 CWHEKPEDRPAFKKLLSQL  255 (256)
T ss_pred             HhcCChhhCcCHHHHHHHh
Confidence            9999999999999999876

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows

>cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5

Probab=100.00  E-value=6e-43  Score=304.57  Aligned_cols=249  Identities=16%  Similarity=0.172  Sum_probs=200.6

Q ss_pred             CCcccccccCCCCCCcEEEEEE-eCCCCEEEEEEeCCCCChhHHHHHHHHHHHhcCCCccccccceeeeeCCeeEEEEec
Q 020221           56 FAMENIVSEHGEKAPNVVYKGK-LENQFRIAVKRFNRSAWPDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAEY  134 (329)
Q Consensus        56 ~~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  134 (329)
                      ...|++++.||+|+||.||+|. ..+++.||+|++..........+.+|+.+++.++||||+++++++......++|+||
T Consensus         8 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~~~~~iv~e~   87 (267)
T cd06646           8 QHDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAYFGSYLSREKLWICMEY   87 (267)
T ss_pred             hhhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCccchHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEEEEEEeC
Confidence            3467788889999999999999 467889999999766544556688999999999999999999999999999999999


Q ss_pred             CCCCCHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCCCCCeeeecccCcccCCCC----C
Q 020221          135 MPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDG----R  210 (329)
Q Consensus       135 ~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~----~  210 (329)
                      +++++|.+++.  ....+++..+..++.|++.||.|||+. +++|+||+|+||+++.++.++|+|||++......    .
T Consensus        88 ~~~~~L~~~~~--~~~~~~~~~~~~~~~qi~~~l~~lH~~-~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~~~~~  164 (267)
T cd06646          88 CGGGSLQDIYH--VTGPLSELQIAYVCRETLQGLAYLHSK-GKMHRDIKGANILLTDNGDVKLADFGVAAKITATIAKRK  164 (267)
T ss_pred             CCCCcHHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHHC-CccccCCCHHHEEECCCCCEEECcCccceeecccccccC
Confidence            99999999886  345689999999999999999999999 9999999999999999999999999998754322    2


Q ss_pred             CccCcccccCccccc---CCCCCCcccchhhhHHHHHHHhCCCCCCchhhHHHhhhc-hhhhccccccCCCChHHHHHHH
Q 020221          211 SYSTNLAFTPPEYLR---TGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRN-IQTLTDSCLEGQFSSDEGTELV  286 (329)
Q Consensus       211 ~~~~~~~y~aPE~~~---~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~  286 (329)
                      ...++..|+|||.+.   ...++.++|+||||+++|+|++|+.|+............ ......+..  ......+.++.
T Consensus       165 ~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~  242 (267)
T cd06646         165 SFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMSKSNFQPPKL--KDKTKWSSTFH  242 (267)
T ss_pred             ccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchhhhheeeecCCCCCCCC--ccccccCHHHH
Confidence            345678999999874   344778999999999999999999876432211110000 000001100  11234567899


Q ss_pred             HHHHHhcccCCCCCCCHHHHHHH
Q 020221          287 RLASRCLQYEPRERPNPRSLVTA  309 (329)
Q Consensus       287 ~li~~cl~~dp~~Rps~~~~l~~  309 (329)
                      +++.+||+.||++|||++++++.
T Consensus       243 ~li~~~l~~~P~~Rp~~~~il~~  265 (267)
T cd06646         243 NFVKISLTKNPKKRPTAERLLTH  265 (267)
T ss_pred             HHHHHHhhCChhhCcCHHHHhcC
Confidence            99999999999999999999974

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated

>cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase

Probab=100.00  E-value=1.1e-42  Score=301.00  Aligned_cols=248  Identities=25%  Similarity=0.350  Sum_probs=203.0

Q ss_pred             CcccccccCCCCCCcEEEEEEeCCCCEEEEEEeCCCCChhHHHHHHHHHHHhcCCCccccccceeee-eCCeeEEEEecC
Q 020221           57 AMENIVSEHGEKAPNVVYKGKLENQFRIAVKRFNRSAWPDARQFLEEARAVGQLRNRRLANLLGCCC-EGDERLLVAEYM  135 (329)
Q Consensus        57 ~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~-~~~~~~lv~e~~  135 (329)
                      ..+.+.+.+|+|+||.||++... +..+|+|.++...  ..+.+.+|+.+++.++|+|++++++++. .++..++++||+
T Consensus         6 ~~~~~~~~lg~g~~~~v~~~~~~-~~~~~~k~~~~~~--~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e~~   82 (256)
T cd05082           6 KELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYM   82 (256)
T ss_pred             HhCeeeeeecccCCCeEEEEEEc-CCcEEEEEeCCCc--hHHHHHHHHHHHHhCCCCCeeeEEEEEEcCCCceEEEEECC
Confidence            45667788899999999999864 6689999987543  3457889999999999999999999764 456789999999


Q ss_pred             CCCCHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCCCCCeeeecccCcccCCCCC-CccC
Q 020221          136 PNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDGR-SYST  214 (329)
Q Consensus       136 ~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~-~~~~  214 (329)
                      ++++|.+++.+.....+++..+..++.|++.||+|||++ |++|+||||+||++++++.+||+|||++....... ....
T Consensus        83 ~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~-~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~  161 (256)
T cd05082          83 AKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEAN-NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKL  161 (256)
T ss_pred             CCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhC-CEeccccchheEEEcCCCcEEecCCccceeccccCCCCcc
Confidence            999999999754445689999999999999999999999 99999999999999999999999999987644332 2334


Q ss_pred             cccccCcccccCCCCCCcccchhhhHHHHHHHh-CCCCCCchhhHHHhhhchhhhccccccCCCChHHHHHHHHHHHHhc
Q 020221          215 NLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLS-GKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLASRCL  293 (329)
Q Consensus       215 ~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t-g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl  293 (329)
                      +..|+|||++.+..++.++||||||+++|+|++ |..|+..............     ......+...++.+.+++.+||
T Consensus       162 ~~~y~aPE~~~~~~~~~~~Dv~slG~i~~~l~~~g~~p~~~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~li~~~l  236 (256)
T cd05082         162 PVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEK-----GYKMDAPDGCPPVVYDVMKQCW  236 (256)
T ss_pred             ceeecCHHHHccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhc-----CCCCCCCCCCCHHHHHHHHHHh
Confidence            568999999988889999999999999999998 8877654433322211111     1122334556788999999999


Q ss_pred             ccCCCCCCCHHHHHHHHHhh
Q 020221          294 QYEPRERPNPRSLVTALVTL  313 (329)
Q Consensus       294 ~~dp~~Rps~~~~l~~L~~~  313 (329)
                      +.||++|||+.++++.|+++
T Consensus       237 ~~~p~~Rpt~~~l~~~l~~~  256 (256)
T cd05082         237 HLDAATRPSFLQLREQLEHI  256 (256)
T ss_pred             cCChhhCcCHHHHHHHHhcC
Confidence            99999999999999998864

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re

>cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1

Probab=100.00  E-value=9.6e-43  Score=302.66  Aligned_cols=239  Identities=19%  Similarity=0.338  Sum_probs=191.5

Q ss_pred             cCCCCCCcEEEEEEeCC-------------CCEEEEEEeCCCCChhHHHHHHHHHHHhcCCCccccccceeeeeCCeeEE
Q 020221           64 EHGEKAPNVVYKGKLEN-------------QFRIAVKRFNRSAWPDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLL  130 (329)
Q Consensus        64 ~lg~G~~g~V~~~~~~~-------------~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l  130 (329)
                      .||+|+||.||+|.+.+             ...|++|.+..........+.+|+.+++.++||||+++++++......++
T Consensus         2 ~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~~~~~l   81 (262)
T cd05077           2 HLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQVSHKHIVLLYGVCVRDVENIM   81 (262)
T ss_pred             ccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhhhhHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCEE
Confidence            46999999999998432             23589998876654445578889999999999999999999998889999


Q ss_pred             EEecCCCCCHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCCCCC-------eeeecccCc
Q 020221          131 VAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVN-------PRLSCFGLM  203 (329)
Q Consensus       131 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~-------~kl~Dfg~a  203 (329)
                      +|||+++++|..++.. ....+++..+..++.|++.||+|||++ +++||||||+||+++.++.       ++++|||++
T Consensus        82 v~e~~~~~~l~~~~~~-~~~~~~~~~~~~i~~qi~~~l~~lH~~-~ivH~dlkp~Nill~~~~~~~~~~~~~~l~d~g~~  159 (262)
T cd05077          82 VEEFVEFGPLDLFMHR-KSDVLTTPWKFKVAKQLASALSYLEDK-DLVHGNVCTKNILLAREGIDGECGPFIKLSDPGIP  159 (262)
T ss_pred             EEecccCCCHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHhhhC-CeECCCCCcccEEEecCCccCCCCceeEeCCCCCC
Confidence            9999999999988854 345689999999999999999999999 9999999999999987664       899999998


Q ss_pred             ccCCCCCCccCcccccCccccc-CCCCCCcccchhhhHHHHHHHh-CCCCCCchhhHHHhhhchhhhccccccCCCChHH
Q 020221          204 KNSRDGRSYSTNLAFTPPEYLR-TGRVTPESVMYSFGTLLLDLLS-GKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDE  281 (329)
Q Consensus       204 ~~~~~~~~~~~~~~y~aPE~~~-~~~~~~~~DvwslG~il~el~t-g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  281 (329)
                      ..........++..|+|||.+. +..++.++||||||+++|||++ |..|+..........     ......  ......
T Consensus       160 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~-----~~~~~~--~~~~~~  232 (262)
T cd05077         160 ITVLSRQECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTLAEKER-----FYEGQC--MLVTPS  232 (262)
T ss_pred             ccccCcccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCcchhHHHH-----HHhcCc--cCCCCC
Confidence            7766555566788999999887 4568889999999999999985 665554332211111     011100  112223


Q ss_pred             HHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 020221          282 GTELVRLASRCLQYEPRERPNPRSLVTALV  311 (329)
Q Consensus       282 ~~~~~~li~~cl~~dp~~Rps~~~~l~~L~  311 (329)
                      ++++.+++.+||+.||++||++.++++.|+
T Consensus       233 ~~~~~~li~~cl~~dp~~Rp~~~~il~~~~  262 (262)
T cd05077         233 CKELADLMTHCMNYDPNQRPFFRAIMRDIN  262 (262)
T ss_pred             hHHHHHHHHHHcCCChhhCcCHHHHHHhcC
Confidence            568999999999999999999999998763

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom

>cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

Probab=100.00  E-value=2.5e-43  Score=305.53  Aligned_cols=240  Identities=24%  Similarity=0.365  Sum_probs=194.4

Q ss_pred             cCCCCCCcEEEEEEeC-C-------CCEEEEEEeCCCCChhHHHHHHHHHHHhcCCCccccccceeeeeCCeeEEEEecC
Q 020221           64 EHGEKAPNVVYKGKLE-N-------QFRIAVKRFNRSAWPDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAEYM  135 (329)
Q Consensus        64 ~lg~G~~g~V~~~~~~-~-------~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~  135 (329)
                      .||.|+||+||+|... .       ...+++|.+........+.+.+|+.+++.++|||++++++++..+...++||||+
T Consensus         2 ~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~   81 (258)
T cd05078           2 SLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLVLNYGVCVCGDESIMVQEYV   81 (258)
T ss_pred             CCCcccchhheeeeecccccccccccchhhHHhhcchhHHHHHHHHHHHHHHHhCCCCChhheeeEEEeCCCcEEEEecC
Confidence            4699999999999843 2       2348888887655445567889999999999999999999999989999999999


Q ss_pred             CCCCHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCCCCC--------eeeecccCcccCC
Q 020221          136 PNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVN--------PRLSCFGLMKNSR  207 (329)
Q Consensus       136 ~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~--------~kl~Dfg~a~~~~  207 (329)
                      ++|+|.+++.. ....+++..+..++.||+.||+|||++ +++||||||+||+++.++.        ++++|||++....
T Consensus        82 ~~g~L~~~l~~-~~~~~~~~~~~~~~~qi~~~l~~lH~~-~iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g~~~~~~  159 (258)
T cd05078          82 KFGSLDTYLKK-NKNLINISWKLEVAKQLAWALHFLEDK-GLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISITVL  159 (258)
T ss_pred             CCCcHHHHHhc-CCCCCCHHHHHHHHHHHHHHHHHHHHC-CeecCCCccceEEEecccccccCCCceEEecccccccccC
Confidence            99999999864 334689999999999999999999999 9999999999999987765        5999999988776


Q ss_pred             CCCCccCcccccCcccccCC-CCCCcccchhhhHHHHHHHhCCCCCCchhhHHHhhhchhhhccccccCCCChHHHHHHH
Q 020221          208 DGRSYSTNLAFTPPEYLRTG-RVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELV  286 (329)
Q Consensus       208 ~~~~~~~~~~y~aPE~~~~~-~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  286 (329)
                      ......++..|+|||++.+. .++.++||||||+++|+|++|..++...........    ....  ....+...+.++.
T Consensus       160 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~~~~~~----~~~~--~~~~~~~~~~~~~  233 (258)
T cd05078         160 PKEILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQKKLQ----FYED--RHQLPAPKWTELA  233 (258)
T ss_pred             CchhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhccHHHHHH----HHHc--cccCCCCCcHHHH
Confidence            66666788899999999864 478899999999999999999654433221111111    1111  1223444567899


Q ss_pred             HHHHHhcccCCCCCCCHHHHHHHHH
Q 020221          287 RLASRCLQYEPRERPNPRSLVTALV  311 (329)
Q Consensus       287 ~li~~cl~~dp~~Rps~~~~l~~L~  311 (329)
                      +++.+||+.||++|||++++++.|+
T Consensus       234 ~li~~~l~~~p~~Rps~~~il~~l~  258 (258)
T cd05078         234 NLINQCMDYEPDFRPSFRAIIRDLN  258 (258)
T ss_pred             HHHHHHhccChhhCCCHHHHHHhcC
Confidence            9999999999999999999998763

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity

>cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2

Probab=100.00  E-value=9.1e-43  Score=309.15  Aligned_cols=259  Identities=21%  Similarity=0.306  Sum_probs=204.3

Q ss_pred             CCcccccccCCCCCCcEEEEEEe-CCCC--EEEEEEeCCCCC-hhHHHHHHHHHHHhcC-CCccccccceeeeeCCeeEE
Q 020221           56 FAMENIVSEHGEKAPNVVYKGKL-ENQF--RIAVKRFNRSAW-PDARQFLEEARAVGQL-RNRRLANLLGCCCEGDERLL  130 (329)
Q Consensus        56 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~--~vavK~~~~~~~-~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~l  130 (329)
                      +..+.+.+.||+|+||.||+|.. .++.  .+++|.+..... .....+.+|+.++..+ +|+||+++++++...+..++
T Consensus         6 ~~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~~~~~l   85 (303)
T cd05088           6 WNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYL   85 (303)
T ss_pred             hhhceeeeeecCCCCceEEEEEEccCCceeeEEEEEecccCCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCCCCceE
Confidence            44566777789999999999984 3443  467877765332 2345688899999999 89999999999999999999


Q ss_pred             EEecCCCCCHHhhhccCC--------------CCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCCCCCee
Q 020221          131 VAEYMPNDTLAKHLFHWE--------------TQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPR  196 (329)
Q Consensus       131 v~e~~~~gsL~~~l~~~~--------------~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~k  196 (329)
                      ++||+++++|.+++....              ...+++.++..++.|++.||+|||+. |++||||||+||+++.++.++
T Consensus        86 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~-gi~H~dlkp~Nili~~~~~~k  164 (303)
T cd05088          86 AIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK-QFIHRDLAARNILVGENYVAK  164 (303)
T ss_pred             EEEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhC-CccccccchheEEecCCCcEE
Confidence            999999999999986421              23578999999999999999999999 999999999999999999999


Q ss_pred             eecccCcccCCCC---CCccCcccccCcccccCCCCCCcccchhhhHHHHHHHh-CCCCCCchhhHHHhhhchhhhcccc
Q 020221          197 LSCFGLMKNSRDG---RSYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLS-GKHIPPSHALDLIRDRNIQTLTDSC  272 (329)
Q Consensus       197 l~Dfg~a~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t-g~~~~~~~~~~~~~~~~~~~~~~~~  272 (329)
                      |+|||++......   .....+..|+|||.+.+..++.++||||||+++|+|+| |..||............     ...
T Consensus       165 l~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~-----~~~  239 (303)
T cd05088         165 IADFGLSRGQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKL-----PQG  239 (303)
T ss_pred             eCccccCcccchhhhcccCCCcccccCHHHHhccCCcccccchhhhhHHHHHHhcCCCCcccCChHHHHHHH-----hcC
Confidence            9999998643221   11123567999999988889999999999999999998 88776543322221111     111


Q ss_pred             ccCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhhccccc
Q 020221          273 LEGQFSSDEGTELVRLASRCLQYEPRERPNPRSLVTALVTLQKDTELY  320 (329)
Q Consensus       273 ~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~~~l~~L~~~~~~~~~~  320 (329)
                      .....+...++++.+++.+||+.+|++||++.++++.|+.+.+.....
T Consensus       240 ~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~l~~~~~~~~~~  287 (303)
T cd05088         240 YRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEERKTY  287 (303)
T ss_pred             CcCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhhhhh
Confidence            122233445678999999999999999999999999999987765433

Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A

>cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha

Probab=100.00  E-value=5.1e-43  Score=313.40  Aligned_cols=235  Identities=17%  Similarity=0.241  Sum_probs=192.4

Q ss_pred             cccccCCCCCCcEEEEEE-eCCCCEEEEEEeCCCC---ChhHHHHHHHHHHHhcCC-CccccccceeeeeCCeeEEEEec
Q 020221           60 NIVSEHGEKAPNVVYKGK-LENQFRIAVKRFNRSA---WPDARQFLEEARAVGQLR-NRRLANLLGCCCEGDERLLVAEY  134 (329)
Q Consensus        60 ~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~~~~lv~e~  134 (329)
                      +..+.||+|+||+||++. ..+++.||+|++....   ....+.+..|..++..+. |++|+++.+++.+.+..++||||
T Consensus         3 ~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~Ey   82 (323)
T cd05615           3 NFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDRLYFVMEY   82 (323)
T ss_pred             eEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecCCEEEEEEcC
Confidence            455667999999999998 4568899999987542   223445778888888885 67788899999888999999999


Q ss_pred             CCCCCHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCCCCCeeeecccCcccCCCC----C
Q 020221          135 MPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDG----R  210 (329)
Q Consensus       135 ~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~----~  210 (329)
                      +++|+|.+++.  ....+++.++..++.|++.||.|||++ |++||||||+||+++.++.++|+|||++......    .
T Consensus        83 ~~~g~L~~~i~--~~~~l~~~~~~~i~~qi~~al~~lH~~-~ivHrDikp~Nill~~~~~ikL~Dfg~~~~~~~~~~~~~  159 (323)
T cd05615          83 VNGGDLMYHIQ--QVGKFKEPQAVFYAAEISVGLFFLHRR-GIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVDGVTTR  159 (323)
T ss_pred             CCCCcHHHHHH--HcCCCCHHHHHHHHHHHHHHHHHHHHC-CeeccCCCHHHeEECCCCCEEEeccccccccCCCCcccc
Confidence            99999999886  345689999999999999999999999 9999999999999999999999999998753322    2


Q ss_pred             CccCcccccCcccccCCCCCCcccchhhhHHHHHHHhCCCCCCchhhHHHhhhchhhhccccccCCCChHHHHHHHHHHH
Q 020221          211 SYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLAS  290 (329)
Q Consensus       211 ~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~  290 (329)
                      ...|++.|+|||++.+..++.++||||||+++|+|++|..||..............    .  ...++...+.++.+++.
T Consensus       160 ~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~~~~~~i~~----~--~~~~p~~~~~~~~~li~  233 (323)
T cd05615         160 TFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDEDELFQSIME----H--NVSYPKSLSKEAVSICK  233 (323)
T ss_pred             CccCCccccCHHHHcCCCCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHh----C--CCCCCccCCHHHHHHHH
Confidence            34578999999999988899999999999999999999988865433322222111    1  11234556788999999


Q ss_pred             HhcccCCCCCCCH
Q 020221          291 RCLQYEPRERPNP  303 (329)
Q Consensus       291 ~cl~~dp~~Rps~  303 (329)
                      +||+.||++|++.
T Consensus       234 ~~l~~~p~~R~~~  246 (323)
T cd05615         234 GLMTKHPSKRLGC  246 (323)
T ss_pred             HHcccCHhhCCCC
Confidence            9999999999985

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a

>cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A

Probab=100.00  E-value=8.8e-43  Score=305.79  Aligned_cols=249  Identities=22%  Similarity=0.308  Sum_probs=201.1

Q ss_pred             CcccccccCCCCCCcEEEEEEe------CCCCEEEEEEeCCCCChhHHHHHHHHHHHhcCCCccccccceeeeeCCeeEE
Q 020221           57 AMENIVSEHGEKAPNVVYKGKL------ENQFRIAVKRFNRSAWPDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLL  130 (329)
Q Consensus        57 ~~~~~~~~lg~G~~g~V~~~~~------~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l  130 (329)
                      ..+.+.+.+|+|+||.||++..      .++..+|+|.+..........+.+|+++++.++|+||+++++++......++
T Consensus         5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l   84 (280)
T cd05092           5 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRFYGVCTEGRPLLM   84 (280)
T ss_pred             HhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcCCHHHHHHHHHHHHHHhcCCCCCCceEEEEEecCCceEE
Confidence            4456778889999999999963      2356799999887665556779999999999999999999999999999999


Q ss_pred             EEecCCCCCHHhhhccCCC-------------CCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCCCCCeee
Q 020221          131 VAEYMPNDTLAKHLFHWET-------------QPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRL  197 (329)
Q Consensus       131 v~e~~~~gsL~~~l~~~~~-------------~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl  197 (329)
                      ++||+++++|.+++.....             ..+++..+..++.|++.||+|||+. +++|+||||+||++++++.++|
T Consensus        85 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~-~i~H~dlkp~nil~~~~~~~kL  163 (280)
T cd05092          85 VFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASL-HFVHRDLATRNCLVGQGLVVKI  163 (280)
T ss_pred             EEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHC-CeecccccHhhEEEcCCCCEEE
Confidence            9999999999999864321             3478999999999999999999999 9999999999999999999999


Q ss_pred             ecccCcccCCCCC------CccCcccccCcccccCCCCCCcccchhhhHHHHHHHh-CCCCCCchhhHHHhhhchhhhcc
Q 020221          198 SCFGLMKNSRDGR------SYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLS-GKHIPPSHALDLIRDRNIQTLTD  270 (329)
Q Consensus       198 ~Dfg~a~~~~~~~------~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t-g~~~~~~~~~~~~~~~~~~~~~~  270 (329)
                      +|||++.......      ...+++.|+|||.+.+..++.++||||||+++|+|++ |..|+...........    ...
T Consensus       164 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~----~~~  239 (280)
T cd05092         164 GDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQLSNTEAIEC----ITQ  239 (280)
T ss_pred             CCCCceeEcCCCceeecCCCccccccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCccCCHHHHHHH----HHc
Confidence            9999986543221      2234578999999998889999999999999999998 7766543322111111    111


Q ss_pred             ccccCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 020221          271 SCLEGQFSSDEGTELVRLASRCLQYEPRERPNPRSLVTALV  311 (329)
Q Consensus       271 ~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~~~l~~L~  311 (329)
                       ......+..+++.+.+++.+||+.||++||++.++++.|+
T Consensus       240 -~~~~~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~l~~~l~  279 (280)
T cd05092         240 -GRELERPRTCPPEVYAIMQGCWQREPQQRMVIKDIHSRLQ  279 (280)
T ss_pred             -CccCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHh
Confidence             1111223456678999999999999999999999999886

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory

>KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=7e-44  Score=318.96  Aligned_cols=244  Identities=20%  Similarity=0.241  Sum_probs=205.8

Q ss_pred             cccccCCCCCCcEEEEEE-eCCCCEEEEEEeCCCCChh---HHHHHHHHHHHhcCCCccccccceeeeeCCeeEEEEecC
Q 020221           60 NIVSEHGEKAPNVVYKGK-LENQFRIAVKRFNRSAWPD---ARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAEYM  135 (329)
Q Consensus        60 ~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~---~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~  135 (329)
                      .-++.||-|+||-||-+. ..+.+.||||++.-...+.   ++++.+|+..|+.+.|||++.+.|+|......|||||||
T Consensus        29 ~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre~TaWLVMEYC  108 (948)
T KOG0577|consen   29 SDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLREHTAWLVMEYC  108 (948)
T ss_pred             HHHHHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeeccchHHHHHHHH
Confidence            345677999999999999 6778899999998765443   667899999999999999999999999999999999999


Q ss_pred             CCCCHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCCCCCeeeecccCcccCCCCCCccCc
Q 020221          136 PNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDGRSYSTN  215 (329)
Q Consensus       136 ~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~  215 (329)
                      -| |-.+++.- ..+++.+..+..|..+.+.||+|||+. +.||||||..|||+++.|.|||+|||.|....+..+++||
T Consensus       109 lG-SAsDlleV-hkKplqEvEIAAi~~gaL~gLaYLHS~-~~IHRDiKAGNILLse~g~VKLaDFGSAsi~~PAnsFvGT  185 (948)
T KOG0577|consen  109 LG-SASDLLEV-HKKPLQEVEIAAITHGALQGLAYLHSH-NRIHRDIKAGNILLSEPGLVKLADFGSASIMAPANSFVGT  185 (948)
T ss_pred             hc-cHHHHHHH-HhccchHHHHHHHHHHHHHHHHHHHHh-hHHhhhccccceEecCCCeeeeccccchhhcCchhcccCC
Confidence            65 77777643 456889999999999999999999999 9999999999999999999999999999999999999999


Q ss_pred             ccccCccccc---CCCCCCcccchhhhHHHHHHHhCCCCCCchhhHHHhhhchhhhccccccCCCChHHHHHHHHHHHHh
Q 020221          216 LAFTPPEYLR---TGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLASRC  292 (329)
Q Consensus       216 ~~y~aPE~~~---~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~c  292 (329)
                      +.|||||++.   .+.|+-++||||||++..||.-+++|.+....-...-.    +-..-.+.....+++..|+.|+..|
T Consensus       186 PywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnMNAMSALYH----IAQNesPtLqs~eWS~~F~~Fvd~C  261 (948)
T KOG0577|consen  186 PYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYH----IAQNESPTLQSNEWSDYFRNFVDSC  261 (948)
T ss_pred             ccccchhHheeccccccCCccceeeccchhhhhhhcCCCccCchHHHHHHH----HHhcCCCCCCCchhHHHHHHHHHHH
Confidence            9999999874   67799999999999999999999977654321111111    1111111122467899999999999


Q ss_pred             cccCCCCCCCHHHHHHHH
Q 020221          293 LQYEPRERPNPRSLVTAL  310 (329)
Q Consensus       293 l~~dp~~Rps~~~~l~~L  310 (329)
                      |+.-|++|||..+++.+-
T Consensus       262 LqKipqeRptse~ll~H~  279 (948)
T KOG0577|consen  262 LQKIPQERPTSEELLKHR  279 (948)
T ss_pred             HhhCcccCCcHHHHhhcc
Confidence            999999999999998743

>cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase

Probab=100.00  E-value=1.3e-42  Score=300.96  Aligned_cols=241  Identities=20%  Similarity=0.268  Sum_probs=196.0

Q ss_pred             cCCCCCCcEEEEEEe---CCCCEEEEEEeCCCCC--hhHHHHHHHHHHHhcCCCccccccceeeeeCCeeEEEEecCCCC
Q 020221           64 EHGEKAPNVVYKGKL---ENQFRIAVKRFNRSAW--PDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAEYMPND  138 (329)
Q Consensus        64 ~lg~G~~g~V~~~~~---~~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g  138 (329)
                      +||+|+||.||+|.+   .++..+|+|++.....  ...+.+.+|+.+++.++||||+++++++. ....++||||++++
T Consensus         2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-~~~~~lv~e~~~~~   80 (257)
T cd05116           2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMIGICE-AESWMLVMELAELG   80 (257)
T ss_pred             cCCCcCCcceEEeEEecCCCceEEEEEEccCCCCcHHHHHHHHHHHHHHHhCCCCCcceEEEEEc-CCCcEEEEecCCCC
Confidence            579999999999964   3578899999875432  23456889999999999999999999875 46778999999999


Q ss_pred             CHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCCCCCeeeecccCcccCCCCCC-------
Q 020221          139 TLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDGRS-------  211 (329)
Q Consensus       139 sL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~~-------  211 (329)
                      +|.+++.  ....+++..+..++.|++.||.|||++ |++|+||||+||++++++.++|+|||++........       
T Consensus        81 ~L~~~l~--~~~~~~~~~~~~i~~qi~~al~~lH~~-~i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~  157 (257)
T cd05116          81 PLNKFLQ--KNKHVTEKNITELVHQVSMGMKYLEET-NFVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAKTH  157 (257)
T ss_pred             cHHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHHC-CEeecccchhhEEEcCCCeEEECCCccccccCCCCCeeeecCC
Confidence            9999986  345689999999999999999999999 999999999999999999999999999876543321       


Q ss_pred             ccCcccccCcccccCCCCCCcccchhhhHHHHHHHh-CCCCCCchhhHHHhhhchhhhccccccCCCChHHHHHHHHHHH
Q 020221          212 YSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLS-GKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLAS  290 (329)
Q Consensus       212 ~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t-g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~  290 (329)
                      ..++..|+|||.+....++.++|+||||+++|||++ |..||..........     .+........+...++++.+++.
T Consensus       158 ~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~-----~i~~~~~~~~~~~~~~~l~~li~  232 (257)
T cd05116         158 GKWPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKGNEVTQ-----MIESGERMECPQRCPPEMYDLMK  232 (257)
T ss_pred             CCCCccccCHhHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHH-----HHHCCCCCCCCCCCCHHHHHHHH
Confidence            123478999999988889999999999999999998 887775432221111     11111222345567789999999


Q ss_pred             HhcccCCCCCCCHHHHHHHHHhh
Q 020221          291 RCLQYEPRERPNPRSLVTALVTL  313 (329)
Q Consensus       291 ~cl~~dp~~Rps~~~~l~~L~~~  313 (329)
                      +||+.||++||++.+|...|++.
T Consensus       233 ~~~~~~p~~Rp~~~~i~~~l~~~  255 (257)
T cd05116         233 LCWTYGVDERPGFAVVELRLRNY  255 (257)
T ss_pred             HHhccCchhCcCHHHHHHHHhcc
Confidence            99999999999999999998763

Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio

>cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase

Probab=100.00  E-value=5e-43  Score=319.51  Aligned_cols=246  Identities=18%  Similarity=0.221  Sum_probs=193.6

Q ss_pred             ccccccCCCCCCcEEEEEE-eCCCCEEEEEEeCCCC--ChhHHHHHHHHHHHhcCCCccccccceeeeeCC-----eeEE
Q 020221           59 ENIVSEHGEKAPNVVYKGK-LENQFRIAVKRFNRSA--WPDARQFLEEARAVGQLRNRRLANLLGCCCEGD-----ERLL  130 (329)
Q Consensus        59 ~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~-----~~~l  130 (329)
                      +++++.||+|+||.||++. ..+++.||+|++....  ....+.+.+|+++++.++|+||+++++++....     ..++
T Consensus         2 ~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l   81 (372)
T cd07853           2 VEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEIYV   81 (372)
T ss_pred             CcccceeeeCCCEEEEEEEECCCCCEEEEEeccccccchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceEEE
Confidence            3456777999999999999 4578999999987542  223456889999999999999999999998766     7899


Q ss_pred             EEecCCCCCHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCCCCCeeeecccCcccCCCC-
Q 020221          131 VAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDG-  209 (329)
Q Consensus       131 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~-  209 (329)
                      |+||+.+ +|.+.+.  ....+++..+..++.||+.||.|||+. +++||||||+|||++.++.+||+|||++...... 
T Consensus        82 v~e~~~~-~l~~~~~--~~~~l~~~~~~~~~~qi~~aL~~LH~~-~ivH~dlkp~Nili~~~~~~kL~Dfg~a~~~~~~~  157 (372)
T cd07853          82 VTELMQS-DLHKIIV--SPQPLSSDHVKVFLYQILRGLKYLHSA-GILHRDIKPGNLLVNSNCVLKICDFGLARVEEPDE  157 (372)
T ss_pred             Eeecccc-CHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHhC-CeeCCCCChHHEEECCCCCEEeccccceeecccCc
Confidence            9999974 7888775  446789999999999999999999999 9999999999999999999999999998754332 


Q ss_pred             ----CCccCcccccCcccccCCC-CCCcccchhhhHHHHHHHhCCCCCCchhhHHHhhhch-------------------
Q 020221          210 ----RSYSTNLAFTPPEYLRTGR-VTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNI-------------------  265 (329)
Q Consensus       210 ----~~~~~~~~y~aPE~~~~~~-~~~~~DvwslG~il~el~tg~~~~~~~~~~~~~~~~~-------------------  265 (329)
                          ....++..|+|||++.+.. ++.++|||||||++|||++|+.||.............                   
T Consensus       158 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~  237 (372)
T cd07853         158 SKHMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLITDLLGTPSLEAMRSACEGAR  237 (372)
T ss_pred             cccCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHHhhHHHH
Confidence                1234678899999988754 7889999999999999999998885432111100000                   


Q ss_pred             hhhcccccc-------CCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 020221          266 QTLTDSCLE-------GQFSSDEGTELVRLASRCLQYEPRERPNPRSLVT  308 (329)
Q Consensus       266 ~~~~~~~~~-------~~~~~~~~~~~~~li~~cl~~dp~~Rps~~~~l~  308 (329)
                      ..+......       .......++++.+|+.+||+.||++|||+.++++
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~  287 (372)
T cd07853         238 AHILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADALA  287 (372)
T ss_pred             HHHHhCCCCCCchHHhcccCCCCCHHHHHHHHHhCCCChhhCcCHHHHhc
Confidence            000000000       0112234678999999999999999999999997

Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription

>cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

Probab=100.00  E-value=1.2e-42  Score=305.25  Aligned_cols=251  Identities=23%  Similarity=0.310  Sum_probs=199.5

Q ss_pred             cccccCCCCCCcEEEEEEe-----CCCCEEEEEEeCCCCC-hhHHHHHHHHHHHhcCCCccccccceeeeeC--CeeEEE
Q 020221           60 NIVSEHGEKAPNVVYKGKL-----ENQFRIAVKRFNRSAW-PDARQFLEEARAVGQLRNRRLANLLGCCCEG--DERLLV  131 (329)
Q Consensus        60 ~~~~~lg~G~~g~V~~~~~-----~~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~--~~~~lv  131 (329)
                      .+++.||+|+||+||++..     .++..||+|.+..... .....+.+|+++++.++||||+++++++...  ...+++
T Consensus         7 ~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv   86 (283)
T cd05080           7 KKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGKGLQLI   86 (283)
T ss_pred             eeceecccCCCcEEEEeeEccccCCCCceEEEEEeccccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCceEEEE
Confidence            6777889999999988652     3577899999876543 2345688999999999999999999987653  468899


Q ss_pred             EecCCCCCHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCCCCCeeeecccCcccCCCCC-
Q 020221          132 AEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDGR-  210 (329)
Q Consensus       132 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~-  210 (329)
                      |||+++++|.+++.   ...+++.++..++.|++.||.|||++ +++|+||||+||++++++.++|+|||++....... 
T Consensus        87 ~e~~~~~~l~~~~~---~~~l~~~~~~~i~~~l~~~l~~lH~~-~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~  162 (283)
T cd05080          87 MEYVPLGSLRDYLP---KHKLNLAQLLLFAQQICEGMAYLHSQ-HYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHE  162 (283)
T ss_pred             ecCCCCCCHHHHHH---HcCCCHHHHHHHHHHHHHHHHHHHHC-CeeccccChheEEEcCCCcEEEeecccccccCCcch
Confidence            99999999999985   34699999999999999999999999 99999999999999999999999999987654332 


Q ss_pred             ------CccCcccccCcccccCCCCCCcccchhhhHHHHHHHhCCCCCCchhhH--HHhhh--------chhhhcccccc
Q 020221          211 ------SYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALD--LIRDR--------NIQTLTDSCLE  274 (329)
Q Consensus       211 ------~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~--~~~~~--------~~~~~~~~~~~  274 (329)
                            ...++..|+|||.+.+..++.++||||||+++|+|++|..|+......  .....        ...........
T Consensus       163 ~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  242 (283)
T cd05080         163 YYRVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLTHCDSKQSPPKKFEEMIGPKQGQMTVVRLIELLERGMR  242 (283)
T ss_pred             hhccCCCCCCCceeeCHhHhcccCCCcccccHHHHHHHHHHHhCCCCCCCCcchhhhhhcccccccchhhhhhhhhcCCC
Confidence                  123456799999998888999999999999999999999776432110  00000        01111111112


Q ss_pred             CCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhh
Q 020221          275 GQFSSDEGTELVRLASRCLQYEPRERPNPRSLVTALVTLQ  314 (329)
Q Consensus       275 ~~~~~~~~~~~~~li~~cl~~dp~~Rps~~~~l~~L~~~~  314 (329)
                      ...+...+.++.+++.+||+.||++|||+.++++.|+.+.
T Consensus       243 ~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~i~~~l~~~~  282 (283)
T cd05080         243 LPCPKNCPQEVYILMKNCWETEAKFRPTFRSLIPILKEMH  282 (283)
T ss_pred             CCCCCCCCHHHHHHHHHHhccChhhCCCHHHHHHHHHHhh
Confidence            2234556789999999999999999999999999998864

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign

>cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6

Probab=100.00  E-value=5e-43  Score=308.15  Aligned_cols=246  Identities=20%  Similarity=0.271  Sum_probs=199.0

Q ss_pred             cccccCCCCCCcEEEEEE-eCCCCEEEEEEeCCCCCh---hHHHHHHHHHHHhcCCCccccccceeeeeCCeeEEEEecC
Q 020221           60 NIVSEHGEKAPNVVYKGK-LENQFRIAVKRFNRSAWP---DARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAEYM  135 (329)
Q Consensus        60 ~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~---~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~  135 (329)
                      ++.+.||+|+||+||++. ..+++.||+|.+......   ....+.+|+.+++.++|+|++.+.+.+.+.+..++||||+
T Consensus         3 ~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~   82 (285)
T cd05630           3 RQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTLM   82 (285)
T ss_pred             eeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEecCCEEEEEEEec
Confidence            344556999999999998 557889999998754322   2345678999999999999999999999999999999999


Q ss_pred             CCCCHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCCCCCeeeecccCcccCCCCC---Cc
Q 020221          136 PNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDGR---SY  212 (329)
Q Consensus       136 ~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~---~~  212 (329)
                      ++++|.+++.......+++..+..++.|++.||.|||+. +++|+||||+||+++.++.++|+|||++.......   ..
T Consensus        83 ~g~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~-~iiH~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~  161 (285)
T cd05630          83 NGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLHQE-RIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQTIKGR  161 (285)
T ss_pred             CCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhC-CEEeCCCCHHHEEECCCCCEEEeeccceeecCCCccccCC
Confidence            999999988654445689999999999999999999999 99999999999999999999999999987654332   23


Q ss_pred             cCcccccCcccccCCCCCCcccchhhhHHHHHHHhCCCCCCchhhHHHhhhchhhhccccccCCCChHHHHHHHHHHHHh
Q 020221          213 STNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLASRC  292 (329)
Q Consensus       213 ~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~c  292 (329)
                      .++..|+|||++.+..++.++||||||+++|+|++|..||......... ......... .....+...++++.+++.+|
T Consensus       162 ~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~-~~~~~~~~~-~~~~~~~~~~~~~~~li~~~  239 (285)
T cd05630         162 VGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKR-EEVERLVKE-VQEEYSEKFSPDARSLCKML  239 (285)
T ss_pred             CCCccccChHHHcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCccchH-HHHHhhhhh-hhhhcCccCCHHHHHHHHHH
Confidence            6789999999999888999999999999999999999888643211000 011111111 11123445677899999999


Q ss_pred             cccCCCCCCC-----HHHHHH
Q 020221          293 LQYEPRERPN-----PRSLVT  308 (329)
Q Consensus       293 l~~dp~~Rps-----~~~~l~  308 (329)
                      |+.||++|||     +.++++
T Consensus       240 l~~~p~~R~s~~~~~~~~~~~  260 (285)
T cd05630         240 LCKDPKERLGCQGGGAREVKE  260 (285)
T ss_pred             hhcCHHHccCCCCCchHHHHc
Confidence            9999999999     888887

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as

>cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3

Probab=100.00  E-value=2.3e-42  Score=303.04  Aligned_cols=252  Identities=18%  Similarity=0.247  Sum_probs=200.0

Q ss_pred             cccccccCCCCCCcEEEEEEe-CCCC----EEEEEEeCCCCCh-hHHHHHHHHHHHhcCCCccccccceeeeeCCeeEEE
Q 020221           58 MENIVSEHGEKAPNVVYKGKL-ENQF----RIAVKRFNRSAWP-DARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLV  131 (329)
Q Consensus        58 ~~~~~~~lg~G~~g~V~~~~~-~~~~----~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv  131 (329)
                      ++++++.||+|+||+||+|.+ .++.    .+++|.+...... ...++..|+..++.+.||||+++++++. +...+++
T Consensus         8 ~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~-~~~~~~i   86 (279)
T cd05111           8 ELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRLLGICP-GASLQLV   86 (279)
T ss_pred             hceeccccCccCCcceEEEEEcCCCCceeeEEEEeecccccchHHHHHHHHHHHHHhcCCCCCcceEEEEEC-CCccEEE
Confidence            456677889999999999984 3443    4788887654322 2356778888999999999999999875 4567899


Q ss_pred             EecCCCCCHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCCCCCeeeecccCcccCCCCC-
Q 020221          132 AEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDGR-  210 (329)
Q Consensus       132 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~-  210 (329)
                      +||+++|+|.+++.. ....+++..+..++.|++.||.|||++ +++|+||||+||++++++.+||+|||+++...... 
T Consensus        87 ~e~~~~gsL~~~l~~-~~~~~~~~~~~~i~~qi~~~l~~lH~~-~iiH~dlkp~nili~~~~~~kl~Dfg~~~~~~~~~~  164 (279)
T cd05111          87 TQLSPLGSLLDHVRQ-HRDSLDPQRLLNWCVQIAKGMYYLEEH-RMVHRNLAARNILLKSDSIVQIADFGVADLLYPDDK  164 (279)
T ss_pred             EEeCCCCcHHHHHHh-cccCCCHHHHHHHHHHHHHHHHHHHHC-CEeccccCcceEEEcCCCcEEEcCCccceeccCCCc
Confidence            999999999999964 345789999999999999999999999 99999999999999999999999999997653321 


Q ss_pred             -----CccCcccccCcccccCCCCCCcccchhhhHHHHHHHh-CCCCCCchhhHHHhhhchhhhccccccCCCChHHHHH
Q 020221          211 -----SYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLS-GKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTE  284 (329)
Q Consensus       211 -----~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t-g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  284 (329)
                           ...++..|+|||.+.+..++.++||||||+++||+++ |..|+.........     ...........+..++.+
T Consensus       165 ~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~  239 (279)
T cd05111         165 KYFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRPHEVP-----DLLEKGERLAQPQICTID  239 (279)
T ss_pred             ccccCCCCCcccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHH-----HHHHCCCcCCCCCCCCHH
Confidence                 2235678999999998889999999999999999998 88776543222111     111111111223335567


Q ss_pred             HHHHHHHhcccCCCCCCCHHHHHHHHHhhhhcc
Q 020221          285 LVRLASRCLQYEPRERPNPRSLVTALVTLQKDT  317 (329)
Q Consensus       285 ~~~li~~cl~~dp~~Rps~~~~l~~L~~~~~~~  317 (329)
                      +.+++..||..||++|||+.++++.|..+....
T Consensus       240 ~~~li~~c~~~~p~~Rps~~el~~~l~~~~~~~  272 (279)
T cd05111         240 VYMVMVKCWMIDENVRPTFKELANEFTRMARDP  272 (279)
T ss_pred             HHHHHHHHcCCCcccCcCHHHHHHHHHHHHhCC
Confidence            899999999999999999999999999987644

Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r

>cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=7.9e-43  Score=313.22  Aligned_cols=249  Identities=18%  Similarity=0.137  Sum_probs=195.9

Q ss_pred             cccccccCCCCCCcEEEEEE-eCCCCEEEEEEeCCCC---ChhHHHHHHHHHHHhcCCCccccccceeeeeCCeeEEEEe
Q 020221           58 MENIVSEHGEKAPNVVYKGK-LENQFRIAVKRFNRSA---WPDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAE  133 (329)
Q Consensus        58 ~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  133 (329)
                      .|++++.||+|+||+||++. ..+++.||+|++....   ....+.+.+|+.++..++|+||+++++++.+.+..++|||
T Consensus         2 ~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e   81 (331)
T cd05597           2 DFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQDENNLYLVMD   81 (331)
T ss_pred             CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEecCCeEEEEEe
Confidence            46778888999999999999 5568899999986421   1224457889999999999999999999999999999999


Q ss_pred             cCCCCCHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCCCCCeeeecccCcccCCCCC---
Q 020221          134 YMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDGR---  210 (329)
Q Consensus       134 ~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~---  210 (329)
                      |+++|+|.+++.+ ....+++..+..++.||+.||+|||++ +++||||||+|||++.++.++|+|||++.......   
T Consensus        82 ~~~g~~L~~~l~~-~~~~~~~~~~~~~~~qi~~~l~~lH~~-~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~  159 (331)
T cd05597          82 YYVGGDLLTLLSK-FEDRLPEDMARFYLAEMVLAIDSVHQL-GYVHRDIKPDNVLLDKNGHIRLADFGSCLRLLADGTVQ  159 (331)
T ss_pred             cCCCCcHHHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHhC-CeEECCCCHHHEEECCCCCEEEEECCceeecCCCCCcc
Confidence            9999999999864 345689999999999999999999999 99999999999999999999999999986544322   


Q ss_pred             --CccCcccccCcccccC-----CCCCCcccchhhhHHHHHHHhCCCCCCchhhHHHhhhchhhhccccccCCCChHHHH
Q 020221          211 --SYSTNLAFTPPEYLRT-----GRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGT  283 (329)
Q Consensus       211 --~~~~~~~y~aPE~~~~-----~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  283 (329)
                        ...|++.|+|||++.+     ..++.++||||||+++|+|++|..||................ ............++
T Consensus       160 ~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~i~~~~-~~~~~~~~~~~~~~  238 (331)
T cd05597         160 SNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHK-EHFQFPPDVTDVSE  238 (331)
T ss_pred             ccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCCCHHHHHHHHHcCC-CcccCCCccCCCCH
Confidence              2357899999999863     347889999999999999999999886543322211111100 00000111123577


Q ss_pred             HHHHHHHHhcccCCCC--CCCHHHHHHH
Q 020221          284 ELVRLASRCLQYEPRE--RPNPRSLVTA  309 (329)
Q Consensus       284 ~~~~li~~cl~~dp~~--Rps~~~~l~~  309 (329)
                      ++.+++.+|+..++++  ||++.+++++
T Consensus       239 ~~~~li~~ll~~~~~r~~r~~~~~~l~h  266 (331)
T cd05597         239 EAKDLIRRLICSPETRLGRNGLQDFKDH  266 (331)
T ss_pred             HHHHHHHHHccCcccccCCCCHHHHhcC
Confidence            8999999988654443  7899999883

Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy,

>cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=8.4e-43  Score=305.79  Aligned_cols=249  Identities=16%  Similarity=0.225  Sum_probs=203.4

Q ss_pred             CCCcccccccCCCCCCcEEEEEEe-CCCCEEEEEEeCCCCChhHHHHHHHHHHHhcCCCccccccceeeeeCCeeEEEEe
Q 020221           55 GFAMENIVSEHGEKAPNVVYKGKL-ENQFRIAVKRFNRSAWPDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAE  133 (329)
Q Consensus        55 ~~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  133 (329)
                      ..+.|.+++.||.|+||.||++.. .+++.+|+|.+........+.+.+|+++++.++|||++++++.+..+...++|||
T Consensus         3 ~~~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   82 (280)
T cd06611           3 PNDIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYFYENKLWILIE   82 (280)
T ss_pred             chhHHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeCCHHHHHHHHHHHHHHHhCCCCceeEEEEEEecCCeEEEEee
Confidence            445678888899999999999995 5688999999987665556778899999999999999999999999999999999


Q ss_pred             cCCCCCHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCCCCCeeeecccCcccCCCC----
Q 020221          134 YMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDG----  209 (329)
Q Consensus       134 ~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~----  209 (329)
                      |+++++|.+++.. ....+++..+..++.|++.||.|||+. +++|+||||+||+++.++.++|+|||++......    
T Consensus        83 ~~~~~~L~~~~~~-~~~~l~~~~~~~~~~ql~~~l~~lh~~-~i~h~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~~  160 (280)
T cd06611          83 FCDGGALDSIMLE-LERGLTEPQIRYVCRQMLEALNFLHSH-KVIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTLQKR  160 (280)
T ss_pred             ccCCCcHHHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHHC-CcccCCCChhhEEECCCCCEEEccCccchhhccccccc
Confidence            9999999998864 345689999999999999999999999 9999999999999999999999999987654332    


Q ss_pred             CCccCcccccCccccc-----CCCCCCcccchhhhHHHHHHHhCCCCCCchhhHHHhhhchhhhccccccCCCChHHHHH
Q 020221          210 RSYSTNLAFTPPEYLR-----TGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTE  284 (329)
Q Consensus       210 ~~~~~~~~y~aPE~~~-----~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  284 (329)
                      ....++..|+|||.+.     +..++.++|+||||+++|+|++|..|+................ .  .....+...+.+
T Consensus       161 ~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~-~--~~~~~~~~~~~~  237 (280)
T cd06611         161 DTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNPMRVLLKILKSE-P--PTLDQPSKWSSS  237 (280)
T ss_pred             ceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCCHHHHHHHHhcCC-C--CCcCCcccCCHH
Confidence            2235688899999875     3447789999999999999999998875432211111111100 0  011123456778


Q ss_pred             HHHHHHHhcccCCCCCCCHHHHHH
Q 020221          285 LVRLASRCLQYEPRERPNPRSLVT  308 (329)
Q Consensus       285 ~~~li~~cl~~dp~~Rps~~~~l~  308 (329)
                      +.+++..||+.||++||++.++++
T Consensus       238 ~~~li~~~l~~~p~~Rps~~~il~  261 (280)
T cd06611         238 FNDFLKSCLVKDPDDRPTAAELLK  261 (280)
T ss_pred             HHHHHHHHhccChhhCcCHHHHhc
Confidence            999999999999999999999987

Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti

>cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase

Probab=100.00  E-value=7.5e-43  Score=310.53  Aligned_cols=250  Identities=18%  Similarity=0.257  Sum_probs=197.3

Q ss_pred             CCcccccccCCCCCCcEEEEEE-eCCCCEEEEEEeCCCCCh-hHHHHHHHHHHHhcCCCccccccceeeeeCCeeEEEEe
Q 020221           56 FAMENIVSEHGEKAPNVVYKGK-LENQFRIAVKRFNRSAWP-DARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAE  133 (329)
Q Consensus        56 ~~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  133 (329)
                      ...|.+++.||+|+||.||+|. ..++..||+|.+...... ....+.+|+++++.++||||+++++++..++..++|||
T Consensus         5 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   84 (309)
T cd07872           5 METYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIVHTDKSLTLVFE   84 (309)
T ss_pred             CCceEEEEEecccCCEEEEEEEecCCCCeEEEEEeeccccCCcchhHHHHHHHHHhCCCCCcceEEEEEeeCCeEEEEEe
Confidence            4567888899999999999998 446788999998754322 23457789999999999999999999999999999999


Q ss_pred             cCCCCCHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCCCCCeeeecccCcccCCCC----
Q 020221          134 YMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDG----  209 (329)
Q Consensus       134 ~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~----  209 (329)
                      |+++ +|.+++.. ....+++..+..++.|++.||.|||+. |++||||||+||+++.++.+||+|||++......    
T Consensus        85 ~~~~-~l~~~~~~-~~~~~~~~~~~~~~~qi~~aL~~lH~~-~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~  161 (309)
T cd07872          85 YLDK-DLKQYMDD-CGNIMSMHNVKIFLYQILRGLAYCHRR-KVLHRDLKPQNLLINERGELKLADFGLARAKSVPTKTY  161 (309)
T ss_pred             CCCC-CHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHHC-CeecCCCCHHHEEECCCCCEEECccccceecCCCcccc
Confidence            9976 88888754 334578999999999999999999999 9999999999999999999999999998754322    


Q ss_pred             CCccCcccccCcccccC-CCCCCcccchhhhHHHHHHHhCCCCCCchhhHHHhhhchhh-------hccc----------
Q 020221          210 RSYSTNLAFTPPEYLRT-GRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQT-------LTDS----------  271 (329)
Q Consensus       210 ~~~~~~~~y~aPE~~~~-~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~~~~~~~~-------~~~~----------  271 (329)
                      ....++..|+|||.+.+ ..++.++||||||+++|+|++|..||...............       ....          
T Consensus       162 ~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  241 (309)
T cd07872         162 SNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFRLLGTPTEETWPGISSNDEFKNY  241 (309)
T ss_pred             ccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhhcchhhhhhh
Confidence            23356789999998865 45888999999999999999999888654322111110000       0000          


Q ss_pred             cccC-------CCChHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 020221          272 CLEG-------QFSSDEGTELVRLASRCLQYEPRERPNPRSLVT  308 (329)
Q Consensus       272 ~~~~-------~~~~~~~~~~~~li~~cl~~dp~~Rps~~~~l~  308 (329)
                      ....       ......++++.+++.+||..||++|||+.++++
T Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~  285 (309)
T cd07872         242 NFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMK  285 (309)
T ss_pred             hcCccCCCchhhhccCCCHHHHHHHHHhccCChhhCCCHHHHhc
Confidence            0000       011235678999999999999999999999997

Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play

>cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2

Probab=100.00  E-value=4.5e-43  Score=313.63  Aligned_cols=232  Identities=19%  Similarity=0.233  Sum_probs=188.9

Q ss_pred             cCCCCCCcEEEEEEe-CCCCEEEEEEeCCCCC---hhHHHHHHHHH-HHhcCCCccccccceeeeeCCeeEEEEecCCCC
Q 020221           64 EHGEKAPNVVYKGKL-ENQFRIAVKRFNRSAW---PDARQFLEEAR-AVGQLRNRRLANLLGCCCEGDERLLVAEYMPND  138 (329)
Q Consensus        64 ~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~---~~~~~~~~e~~-~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g  138 (329)
                      .||+|+||.||++.. .+++.||+|++.....   .....+.+|.. +++.++||||+++++++.+.+..++||||++++
T Consensus         2 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~~   81 (321)
T cd05603           2 VIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKLYFVLDYVNGG   81 (321)
T ss_pred             eeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCCEEEEEEcCCCCC
Confidence            469999999999994 5688999999875321   12234555554 578889999999999999999999999999999


Q ss_pred             CHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCCCCCeeeecccCcccCCCC----CCccC
Q 020221          139 TLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDG----RSYST  214 (329)
Q Consensus       139 sL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~----~~~~~  214 (329)
                      +|...+.  ....+++..+..++.||+.||.|||+. +++||||||+||+++.++.+||+|||++......    ....+
T Consensus        82 ~L~~~l~--~~~~~~~~~~~~~~~qi~~~L~~lH~~-~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~~g  158 (321)
T cd05603          82 ELFFHLQ--RERCFLEPRARFYAAEVASAIGYLHSL-NIIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPEETTSTFCG  158 (321)
T ss_pred             CHHHHHH--HcCCCCHHHHHHHHHHHHHHHHHHHHC-CeEeccCCHHHeEECCCCCEEEccCCCCccCCCCCCccccccC
Confidence            9998885  345688899999999999999999999 9999999999999999999999999998753221    23457


Q ss_pred             cccccCcccccCCCCCCcccchhhhHHHHHHHhCCCCCCchhhHHHhhhchhhhccccccCCCChHHHHHHHHHHHHhcc
Q 020221          215 NLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLASRCLQ  294 (329)
Q Consensus       215 ~~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~  294 (329)
                      ++.|+|||++.+..++.++||||||+++|||++|..||...............      ....+...+.++.+++.+||+
T Consensus       159 t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~------~~~~~~~~~~~~~~li~~~l~  232 (321)
T cd05603         159 TPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYSRDVSQMYDNILHK------PLQLPGGKTVAACDLLVGLLH  232 (321)
T ss_pred             CcccCCHHHhcCCCCCCcCcccccchhhhhhhcCCCCCCCCCHHHHHHHHhcC------CCCCCCCCCHHHHHHHHHHcc
Confidence            89999999999888999999999999999999999988665433322221111      112344567789999999999


Q ss_pred             cCCCCCCCHH
Q 020221          295 YEPRERPNPR  304 (329)
Q Consensus       295 ~dp~~Rps~~  304 (329)
                      .||.+||++.
T Consensus       233 ~~p~~R~~~~  242 (321)
T cd05603         233 KDQRRRLGAK  242 (321)
T ss_pred             CCHhhcCCCC
Confidence            9999999864

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1.

>cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes

Probab=100.00  E-value=2e-42  Score=300.25  Aligned_cols=247  Identities=22%  Similarity=0.324  Sum_probs=201.4

Q ss_pred             cccccccCCCCCCcEEEEEEeCCCCEEEEEEeCCCCChhHHHHHHHHHHHhcCCCccccccceeeeeCCeeEEEEecCCC
Q 020221           58 MENIVSEHGEKAPNVVYKGKLENQFRIAVKRFNRSAWPDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAEYMPN  137 (329)
Q Consensus        58 ~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~  137 (329)
                      .+++.+.||+|++|.||++...++..+|+|.+..... ..+.+.+|+++++.++|+|++++++++. ....+++|||+.+
T Consensus         7 ~~~~~~~ig~g~~~~v~~~~~~~~~~~~lK~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~~~~   84 (260)
T cd05069           7 SLRLDVKLGQGCFGEVWMGTWNGTTKVAIKTLKPGTM-MPEAFLQEAQIMKKLRHDKLVPLYAVVS-EEPIYIVTEFMGK   84 (260)
T ss_pred             HeeeeeeecCcCCCeEEEEEEcCCceEEEEEcccCCc-cHHHHHHHHHHHHhCCCCCeeeEEEEEc-CCCcEEEEEcCCC
Confidence            3566777899999999999977767899999875442 3456889999999999999999998874 4678999999999


Q ss_pred             CCHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCCCCCeeeecccCcccCCCCC-----Cc
Q 020221          138 DTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDGR-----SY  212 (329)
Q Consensus       138 gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~-----~~  212 (329)
                      ++|.+++.......+++..+..++.|++.||.|||+. +++|+||||+||++++++.++|+|||++.......     ..
T Consensus        85 ~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~-~i~H~dl~~~Nill~~~~~~~l~dfg~~~~~~~~~~~~~~~~  163 (260)
T cd05069          85 GSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIERM-NYIHRDLRAANILVGDNLVCKIADFGLARLIEDNEYTARQGA  163 (260)
T ss_pred             CCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhC-CEeecccCcceEEEcCCCeEEECCCccceEccCCcccccCCC
Confidence            9999999754445689999999999999999999999 99999999999999999999999999987654322     12


Q ss_pred             cCcccccCcccccCCCCCCcccchhhhHHHHHHHh-CCCCCCchhhHHHhhhchhhhccccccCCCChHHHHHHHHHHHH
Q 020221          213 STNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLS-GKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLASR  291 (329)
Q Consensus       213 ~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t-g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~  291 (329)
                      .++..|+|||...+..++.++||||||+++|+|++ |..|+..............     ......+...+..+.+++.+
T Consensus       164 ~~~~~y~~Pe~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~li~~  238 (260)
T cd05069         164 KFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMVNREVLEQVER-----GYRMPCPQGCPESLHELMKL  238 (260)
T ss_pred             ccchhhCCHHHhccCCcChHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHc-----CCCCCCCcccCHHHHHHHHH
Confidence            34567999999988889999999999999999999 7766654332222211111     11122345567889999999


Q ss_pred             hcccCCCCCCCHHHHHHHHHh
Q 020221          292 CLQYEPRERPNPRSLVTALVT  312 (329)
Q Consensus       292 cl~~dp~~Rps~~~~l~~L~~  312 (329)
                      ||+.||++||++.++++.|+.
T Consensus       239 ~l~~~p~~Rp~~~~i~~~l~~  259 (260)
T cd05069         239 CWKKDPDERPTFEYIQSFLED  259 (260)
T ss_pred             HccCCcccCcCHHHHHHHHhc
Confidence            999999999999999999875

Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an

>cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3

Probab=100.00  E-value=7.8e-43  Score=308.70  Aligned_cols=252  Identities=17%  Similarity=0.242  Sum_probs=207.5

Q ss_pred             HHHhcCCCcccccccCCCCCCcEEEEEE-eCCCCEEEEEEeCCCCChhHHHHHHHHHHHhcCCCccccccceeeeeCCee
Q 020221           50 RTATSGFAMENIVSEHGEKAPNVVYKGK-LENQFRIAVKRFNRSAWPDARQFLEEARAVGQLRNRRLANLLGCCCEGDER  128 (329)
Q Consensus        50 ~~~~~~~~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~  128 (329)
                      ....+....|.+++.||+|+||.||++. ..+++.||+|.+........+.+.+|+.+++.++|+|++++++++..+...
T Consensus        12 ~~~~~~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~   91 (297)
T cd06656          12 VSVGDPKKKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDEL   91 (297)
T ss_pred             cccCChhhhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCEE
Confidence            3344555778888999999999999999 467889999999876655566788999999999999999999999999999


Q ss_pred             EEEEecCCCCCHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCCCCCeeeecccCcccCCC
Q 020221          129 LLVAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRD  208 (329)
Q Consensus       129 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~  208 (329)
                      ++||||+++++|.+++.   ...+++.++..++.|++.||.|||+. +++|+||||+||+++.++.++|+|||++.....
T Consensus        92 ~lv~e~~~~~~L~~~~~---~~~~~~~~~~~~~~~l~~~L~~LH~~-~i~H~dL~p~Nili~~~~~~~l~Dfg~~~~~~~  167 (297)
T cd06656          92 WVVMEYLAGGSLTDVVT---ETCMDEGQIAAVCRECLQALDFLHSN-QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITP  167 (297)
T ss_pred             EEeecccCCCCHHHHHH---hCCCCHHHHHHHHHHHHHHHHHHHHC-CcccCCCCHHHEEECCCCCEEECcCccceEccC
Confidence            99999999999999984   35688999999999999999999999 999999999999999999999999999875443


Q ss_pred             CC----CccCcccccCcccccCCCCCCcccchhhhHHHHHHHhCCCCCCchhhHHHhhhchhhhccccccCCCChHHHHH
Q 020221          209 GR----SYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTE  284 (329)
Q Consensus       209 ~~----~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  284 (329)
                      ..    ...+++.|+|||.+.+..++.++|+||||+++|++++|..||.........   .............+...+..
T Consensus       168 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slGvil~~l~tg~~pf~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~  244 (297)
T cd06656         168 EQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRAL---YLIATNGTPELQNPERLSAV  244 (297)
T ss_pred             CccCcCcccCCccccCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcchhe---eeeccCCCCCCCCccccCHH
Confidence            32    235678899999999888999999999999999999999887543211110   00000011111223456678


Q ss_pred             HHHHHHHhcccCCCCCCCHHHHHH
Q 020221          285 LVRLASRCLQYEPRERPNPRSLVT  308 (329)
Q Consensus       285 ~~~li~~cl~~dp~~Rps~~~~l~  308 (329)
                      +.+++.+||..||++||++.++++
T Consensus       245 ~~~li~~~l~~~p~~Rps~~~il~  268 (297)
T cd06656         245 FRDFLNRCLEMDVDRRGSAKELLQ  268 (297)
T ss_pred             HHHHHHHHccCChhhCcCHHHHhc
Confidence            999999999999999999999998

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2e-42  Score=300.46  Aligned_cols=243  Identities=18%  Similarity=0.225  Sum_probs=199.0

Q ss_pred             ccccccCCCCCCcEEEEEE-eCCCCEEEEEEeCCCCCh-----hHHHHHHHHHHHhcCCCccccccceeeeeCCeeEEEE
Q 020221           59 ENIVSEHGEKAPNVVYKGK-LENQFRIAVKRFNRSAWP-----DARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVA  132 (329)
Q Consensus        59 ~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~-----~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~  132 (329)
                      +.+.+.+|+|++|.||++. ..+++.+|+|.+......     ..+.+.+|+++++.++||||+++++++......++++
T Consensus         4 ~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~   83 (263)
T cd06625           4 WRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDDETLSIFM   83 (263)
T ss_pred             ccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEccCCeEEEEE
Confidence            3445566999999999998 456889999998754311     2346788999999999999999999999999999999


Q ss_pred             ecCCCCCHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCCCCCeeeecccCcccCCCC---
Q 020221          133 EYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDG---  209 (329)
Q Consensus       133 e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~---  209 (329)
                      ||+++++|.+.+.  ....+++..+..++.|++.||.|||+. +++|+||+|+||++++++.++|+|||++......   
T Consensus        84 e~~~~~~l~~~~~--~~~~~~~~~~~~~~~~l~~~l~~lH~~-~i~H~dl~p~nilv~~~~~~~l~dfg~~~~~~~~~~~  160 (263)
T cd06625          84 EYMPGGSVKDQLK--AYGALTETVTRKYTRQILEGVEYLHSN-MIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICSS  160 (263)
T ss_pred             EECCCCcHHHHHH--HhCCCCHHHHHHHHHHHHHHHHHHHhC-CeecCCCCHHHEEEcCCCCEEEeecccceeccccccc
Confidence            9999999999886  345688999999999999999999999 9999999999999999999999999998754322   


Q ss_pred             ----CCccCcccccCcccccCCCCCCcccchhhhHHHHHHHhCCCCCCchhhHHHhhhchhhhccccccCCCChHHHHHH
Q 020221          210 ----RSYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTEL  285 (329)
Q Consensus       210 ----~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  285 (329)
                          ....++..|+|||++.+..++.++||||||+++|+|++|+.||...........    ..........+...+..+
T Consensus       161 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~  236 (263)
T cd06625         161 GTGMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWAEFEAMAAIFK----IATQPTNPQLPSHVSPDA  236 (263)
T ss_pred             cccccCCCcCccccCcceeccCCCCchhhhHHHHHHHHHHHhCCCCccccchHHHHHH----HhccCCCCCCCccCCHHH
Confidence                223467889999999988899999999999999999999988754322111111    111111223455667889


Q ss_pred             HHHHHHhcccCCCCCCCHHHHHH
Q 020221          286 VRLASRCLQYEPRERPNPRSLVT  308 (329)
Q Consensus       286 ~~li~~cl~~dp~~Rps~~~~l~  308 (329)
                      .+++.+||..+|++|||+.++++
T Consensus       237 ~~li~~~l~~~p~~Rpt~~~ll~  259 (263)
T cd06625         237 RNFLRRTFVENAKKRPSAEELLR  259 (263)
T ss_pred             HHHHHHHhhcCcccCCCHHHHhh
Confidence            99999999999999999999998

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t

>cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase

Probab=100.00  E-value=1.9e-42  Score=307.74  Aligned_cols=250  Identities=18%  Similarity=0.242  Sum_probs=199.5

Q ss_pred             cccccccCCCCCCcEEEEEE-eCCCCEEEEEEeCCCCCh-hHHHHHHHHHHHhcCCCccccccceeeeeCCeeEEEEecC
Q 020221           58 MENIVSEHGEKAPNVVYKGK-LENQFRIAVKRFNRSAWP-DARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAEYM  135 (329)
Q Consensus        58 ~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~  135 (329)
                      .+++++.||+|+||.||++. ..++..+|+|.+...... ...++.+|+++++.++||||+++++++..++..++++||+
T Consensus         2 ~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ey~   81 (308)
T cd06615           2 DFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAIRNQIIRELKVLHECNSPYIVGFYGAFYSDGEISICMEHM   81 (308)
T ss_pred             CceEEeeccCCCCeEEEEEEEcCCCeEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCEEEEEeecc
Confidence            35677788999999999998 456888999998765332 2456889999999999999999999999999999999999


Q ss_pred             CCCCHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCCCCCeeeecccCcccCCCC--CCcc
Q 020221          136 PNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDG--RSYS  213 (329)
Q Consensus       136 ~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~--~~~~  213 (329)
                      ++++|.+++..  ...+++..+..++.|++.||.|||+..+++|+||||+||++++++.++|+|||++......  ....
T Consensus        82 ~~~~L~~~l~~--~~~~~~~~~~~~~~~i~~~l~~lH~~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~  159 (308)
T cd06615          82 DGGSLDQVLKK--AGRIPENILGKISIAVLRGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFV  159 (308)
T ss_pred             CCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhhCCEEECCCChHHEEEecCCcEEEccCCCcccccccccccCC
Confidence            99999999863  3668999999999999999999997438999999999999999999999999998754332  3346


Q ss_pred             CcccccCcccccCCCCCCcccchhhhHHHHHHHhCCCCCCchhhHHHhhhc---hhhh----------------------
Q 020221          214 TNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRN---IQTL----------------------  268 (329)
Q Consensus       214 ~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~~~~~---~~~~----------------------  268 (329)
                      ++..|+|||.+.+..++.++|+||||+++|+|++|..|+............   ....                      
T Consensus       160 ~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (308)
T cd06615         160 GTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPPDAKELEAMFGRPVSEGEAKESHRPVSGHPPDSPRPMAI  239 (308)
T ss_pred             CCcCccChhHhcCCCCCccchHHHHHHHHHHHHhCCCCCCCcchhhHHHhhcCccccccccCCcccccCCCCCccchhhH
Confidence            788999999998888999999999999999999999887543221111000   0000                      


Q ss_pred             ---cccc---ccCCCC-hHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 020221          269 ---TDSC---LEGQFS-SDEGTELVRLASRCLQYEPRERPNPRSLVTA  309 (329)
Q Consensus       269 ---~~~~---~~~~~~-~~~~~~~~~li~~cl~~dp~~Rps~~~~l~~  309 (329)
                         .+..   .....+ ...+.++.+++.+||..||++|||+.+++++
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~  287 (308)
T cd06615         240 FELLDYIVNEPPPKLPSGAFSDEFQDFVDKCLKKNPKERADLKELTKH  287 (308)
T ss_pred             HHHHHHHhcCCCccCcCcccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence               0000   000111 1256789999999999999999999999983

Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down

>cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2

Probab=100.00  E-value=1.6e-42  Score=314.69  Aligned_cols=246  Identities=15%  Similarity=0.192  Sum_probs=192.3

Q ss_pred             CcccccccCCCCCCcEEEEEE-eCCCCEEEEEEeCCCC--ChhHHHHHHHHHHHhcCCCccccccceeeeeCC------e
Q 020221           57 AMENIVSEHGEKAPNVVYKGK-LENQFRIAVKRFNRSA--WPDARQFLEEARAVGQLRNRRLANLLGCCCEGD------E  127 (329)
Q Consensus        57 ~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~------~  127 (329)
                      ..|.+++.||+|+||.||++. ..+++.||+|++....  ......+.+|+.+++.++||||+++++++....      .
T Consensus        21 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~  100 (359)
T cd07876          21 KRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEEFQD  100 (359)
T ss_pred             hceEEEEEeecCCCEEEEEEEEcCCCceeEEEEecccccchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCccccce
Confidence            457778888999999999998 4568899999997542  233456789999999999999999999885443      4


Q ss_pred             eEEEEecCCCCCHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCCCCCeeeecccCcccCC
Q 020221          128 RLLVAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSR  207 (329)
Q Consensus       128 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~  207 (329)
                      .++||||+.+ +|...+.    ..+++..+..++.|++.||.|||+. |++||||||+||+++.++.+||+|||++....
T Consensus       101 ~~lv~e~~~~-~l~~~~~----~~~~~~~~~~~~~qi~~~L~~LH~~-~ivHrDlkp~NIl~~~~~~~kl~Dfg~a~~~~  174 (359)
T cd07876         101 VYLVMELMDA-NLCQVIH----MELDHERMSYLLYQMLCGIKHLHSA-GIIHRDLKPSNIVVKSDCTLKILDFGLARTAC  174 (359)
T ss_pred             eEEEEeCCCc-CHHHHHh----ccCCHHHHHHHHHHHHHHHHHHHhC-CcccCCCCHHHEEECCCCCEEEecCCCccccc
Confidence            7999999976 5766653    3478899999999999999999999 99999999999999999999999999987543


Q ss_pred             CC---CCccCcccccCcccccCCCCCCcccchhhhHHHHHHHhCCCCCCchhhHHHhhhc------------------hh
Q 020221          208 DG---RSYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRN------------------IQ  266 (329)
Q Consensus       208 ~~---~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~~~~~------------------~~  266 (329)
                      ..   ....+|+.|+|||++.+..++.++||||||+++|+|++|..||............                  ..
T Consensus       175 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  254 (359)
T cd07876         175 TNFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLGTPSAEFMNRLQPTVR  254 (359)
T ss_pred             cCccCCCCcccCCCCCchhccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCcHHHHHHHHHHHH
Confidence            32   2346788999999999889999999999999999999999888643211000000                  00


Q ss_pred             hhccc--ccc----------------CCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 020221          267 TLTDS--CLE----------------GQFSSDEGTELVRLASRCLQYEPRERPNPRSLVT  308 (329)
Q Consensus       267 ~~~~~--~~~----------------~~~~~~~~~~~~~li~~cl~~dp~~Rps~~~~l~  308 (329)
                      .....  ...                .......++++.+|+.+||..||++|||+.++++
T Consensus       255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~  314 (359)
T cd07876         255 NYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISVDEALR  314 (359)
T ss_pred             HHHhhCCCCCCcchhhhccccccccccccccccchhHHHHHHHHhccCcccCCCHHHHhc
Confidence            00000  000                0011123567899999999999999999999998

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn

>cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=2.3e-42  Score=299.05  Aligned_cols=248  Identities=26%  Similarity=0.392  Sum_probs=205.7

Q ss_pred             cccccccCCCCCCcEEEEEEeCCCCEEEEEEeCCCCChhHHHHHHHHHHHhcCCCccccccceeeeeCCeeEEEEecCCC
Q 020221           58 MENIVSEHGEKAPNVVYKGKLENQFRIAVKRFNRSAWPDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAEYMPN  137 (329)
Q Consensus        58 ~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~  137 (329)
                      .+++.+.+|.|+||.||++... ++.||+|.+..... ..+.+.+|+.+++.++|+||+++++++......++||||+++
T Consensus         7 ~~~~~~~ig~g~~g~v~~~~~~-~~~v~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~   84 (256)
T cd05039           7 ELKLGATIGKGEFGDVMLGDYR-GQKVAVKCLKDDST-AAQAFLAEASVMTTLRHPNLVQLLGVVLQGNPLYIVTEYMAK   84 (256)
T ss_pred             hccceeeeecCCCceEEEEEec-CcEEEEEEeccchh-HHHHHHHHHHHHHhcCCcceeeeEEEEcCCCCeEEEEEecCC
Confidence            3556677899999999999874 67899999987654 466789999999999999999999999888999999999999


Q ss_pred             CCHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCCCCCeeeecccCcccCCCCCC-ccCcc
Q 020221          138 DTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDGRS-YSTNL  216 (329)
Q Consensus       138 gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~~-~~~~~  216 (329)
                      ++|.+++.......+++..+..++.|++.||.|||+. +++|+||||+||+++.++.++|+|||.+........ ...+.
T Consensus        85 ~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~-~i~H~di~p~Nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~  163 (256)
T cd05039          85 GSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLEEK-NFVHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQDSGKLPV  163 (256)
T ss_pred             CcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhC-CccchhcccceEEEeCCCCEEEcccccccccccccccCCCcc
Confidence            9999999754444789999999999999999999999 999999999999999999999999999886643322 23356


Q ss_pred             cccCcccccCCCCCCcccchhhhHHHHHHHh-CCCCCCchhhHHHhhhchhhhccccccCCCChHHHHHHHHHHHHhccc
Q 020221          217 AFTPPEYLRTGRVTPESVMYSFGTLLLDLLS-GKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLASRCLQY  295 (329)
Q Consensus       217 ~y~aPE~~~~~~~~~~~DvwslG~il~el~t-g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~  295 (329)
                      .|+|||.+.+..++.++||||||++++++++ |..|+..............     ......+...++++.+++.+||..
T Consensus       164 ~~~ape~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~li~~~l~~  238 (256)
T cd05039         164 KWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPHVEK-----GYRMEAPEGCPPEVYKVMKDCWEL  238 (256)
T ss_pred             cccCchhhcCCcCCcHHHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhc-----CCCCCCccCCCHHHHHHHHHHhcc
Confidence            7999999988889999999999999999997 8777654433222211111     112223445678899999999999


Q ss_pred             CCCCCCCHHHHHHHHHhh
Q 020221          296 EPRERPNPRSLVTALVTL  313 (329)
Q Consensus       296 dp~~Rps~~~~l~~L~~~  313 (329)
                      +|++|||+.++++.|+++
T Consensus       239 ~p~~Rp~~~~l~~~l~~~  256 (256)
T cd05039         239 DPAKRPTFKQLREQLALI  256 (256)
T ss_pred             ChhhCcCHHHHHHHHhcC
Confidence            999999999999999764

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk

>cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=2.5e-42  Score=299.58  Aligned_cols=248  Identities=25%  Similarity=0.377  Sum_probs=205.5

Q ss_pred             cccccccCCCCCCcEEEEEEeCCCCEEEEEEeCCCCChhHHHHHHHHHHHhcCCCccccccceeeeeCCeeEEEEecCCC
Q 020221           58 MENIVSEHGEKAPNVVYKGKLENQFRIAVKRFNRSAWPDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAEYMPN  137 (329)
Q Consensus        58 ~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~  137 (329)
                      .+.+.+.||.|+||.||++..++++.+|+|.+..... ....+.+|+.+++.++|+||+++++++......+++|||+++
T Consensus         7 ~~~i~~~ig~g~~~~v~~~~~~~~~~~~vK~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~   85 (261)
T cd05034           7 SLKLERKLGAGQFGEVWMGTWNGTTKVAVKTLKPGTM-SPEAFLQEAQIMKKLRHDKLVQLYAVCSEEEPIYIVTEYMSK   85 (261)
T ss_pred             heeeeeeeccCcceEEEEEEEcCCceEEEEEecCCcc-CHHHHHHHHHHHhhCCCCCEeeeeeeeecCCceEEEEeccCC
Confidence            4567778899999999999977778899999886543 356789999999999999999999999888899999999999


Q ss_pred             CCHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCCCCCeeeecccCcccCCCCC-----Cc
Q 020221          138 DTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDGR-----SY  212 (329)
Q Consensus       138 gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~-----~~  212 (329)
                      ++|.+++.......+++..+..++.|++.||.|||++ +++|+||||+||++++++.++|+|||++.......     ..
T Consensus        86 ~~L~~~i~~~~~~~~~~~~~~~~~~~i~~al~~lh~~-~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~  164 (261)
T cd05034          86 GSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLESR-NYIHRDLAARNILVGENLVCKIADFGLARLIEDDEYTAREGA  164 (261)
T ss_pred             CCHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhC-CcccCCcchheEEEcCCCCEEECccccceeccchhhhhhhcc
Confidence            9999999764456789999999999999999999999 99999999999999999999999999987654321     12


Q ss_pred             cCcccccCcccccCCCCCCcccchhhhHHHHHHHh-CCCCCCchhhHHHhhhchhhhccccccCCCChHHHHHHHHHHHH
Q 020221          213 STNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLS-GKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLASR  291 (329)
Q Consensus       213 ~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t-g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~  291 (329)
                      ..+..|+|||.+.+..++.++|+||||++++++++ |+.|+..............     ......+...+.++.+++.+
T Consensus       165 ~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~i~~  239 (261)
T cd05034         165 KFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGMTNREVLEQVER-----GYRMPRPPNCPEELYDLMLQ  239 (261)
T ss_pred             CCCccccCHHHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHc-----CCCCCCCCCCCHHHHHHHHH
Confidence            23467999999998889999999999999999999 8877754332222211111     11122334457789999999


Q ss_pred             hcccCCCCCCCHHHHHHHHHh
Q 020221          292 CLQYEPRERPNPRSLVTALVT  312 (329)
Q Consensus       292 cl~~dp~~Rps~~~~l~~L~~  312 (329)
                      ||+.+|++||++.++.+.|+.
T Consensus       240 ~l~~~p~~Rp~~~~l~~~l~~  260 (261)
T cd05034         240 CWDKDPEERPTFEYLQSFLED  260 (261)
T ss_pred             HcccCcccCCCHHHHHHHHhc
Confidence            999999999999999998875

Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t

>cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3

Probab=100.00  E-value=1.3e-42  Score=302.38  Aligned_cols=246  Identities=15%  Similarity=0.165  Sum_probs=199.0

Q ss_pred             cccccccCCCCCCcEEEEEE-eCCCCEEEEEEeCCCCChhHHHHHHHHHHHhcCCCccccccceeeeeCCeeEEEEecCC
Q 020221           58 MENIVSEHGEKAPNVVYKGK-LENQFRIAVKRFNRSAWPDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAEYMP  136 (329)
Q Consensus        58 ~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~  136 (329)
                      .|.+.+.||+|+||.||++. ..+++.||+|.++.........+.+|+.+++.++||||+++++++...+..++++||++
T Consensus        10 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~~~~~lv~e~~~   89 (267)
T cd06645          10 DFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVAYFGSYLRRDKLWICMEFCG   89 (267)
T ss_pred             HHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEEEeccC
Confidence            46677778999999999998 55688999999987654555668889999999999999999999999999999999999


Q ss_pred             CCCHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCCCCCeeeecccCcccCCCC----CCc
Q 020221          137 NDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDG----RSY  212 (329)
Q Consensus       137 ~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~----~~~  212 (329)
                      +++|.+++.  ....+++.++..++.|++.||.|||+. |++|+||||+||+++.++.++|+|||++......    ...
T Consensus        90 ~~~L~~~~~--~~~~~~~~~~~~~~~~i~~~l~~lH~~-~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~~~~~~~~  166 (267)
T cd06645          90 GGSLQDIYH--VTGPLSESQIAYVSRETLQGLYYLHSK-GKMHRDIKGANILLTDNGHVKLADFGVSAQITATIAKRKSF  166 (267)
T ss_pred             CCcHHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHHC-CeecCCCCHHHEEECCCCCEEECcceeeeEccCcccccccc
Confidence            999999886  345789999999999999999999999 9999999999999999999999999998654322    234


Q ss_pred             cCcccccCccccc---CCCCCCcccchhhhHHHHHHHhCCCCCCchhhHHHhhhc-hhhhccccccCCCChHHHHHHHHH
Q 020221          213 STNLAFTPPEYLR---TGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRN-IQTLTDSCLEGQFSSDEGTELVRL  288 (329)
Q Consensus       213 ~~~~~y~aPE~~~---~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~l  288 (329)
                      .++..|+|||++.   ...++.++|+||||+++|+|++|..|+............ ......+...  .....+..+.++
T Consensus       167 ~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~l  244 (267)
T cd06645         167 IGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMTKSNFQPPKLK--DKMKWSNSFHHF  244 (267)
T ss_pred             cCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccchhhHHhhhccCCCCCccc--ccCCCCHHHHHH
Confidence            6788999999874   445888999999999999999999877543211111000 0001111100  112346789999


Q ss_pred             HHHhcccCCCCCCCHHHHHH
Q 020221          289 ASRCLQYEPRERPNPRSLVT  308 (329)
Q Consensus       289 i~~cl~~dp~~Rps~~~~l~  308 (329)
                      +.+||+.||++||++.++++
T Consensus       245 i~~~l~~~P~~R~~~~~ll~  264 (267)
T cd06645         245 VKMALTKNPKKRPTAEKLLQ  264 (267)
T ss_pred             HHHHccCCchhCcCHHHHhc
Confidence            99999999999999999987

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated

>cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase

Probab=100.00  E-value=1.5e-42  Score=302.84  Aligned_cols=244  Identities=14%  Similarity=0.210  Sum_probs=194.9

Q ss_pred             ccccccCCCCCCcEEEEEE-eCCCCEEEEEEeCCCCChhHHHHHHHHHHHhcC-CCccccccceeeeeC------CeeEE
Q 020221           59 ENIVSEHGEKAPNVVYKGK-LENQFRIAVKRFNRSAWPDARQFLEEARAVGQL-RNRRLANLLGCCCEG------DERLL  130 (329)
Q Consensus        59 ~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~------~~~~l  130 (329)
                      |++.+.+|+|+||.||+|. ..+++.||+|.+.... .....+.+|+.+++.+ +|+|++++++++...      ...++
T Consensus         8 y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~~~~i   86 (272)
T cd06637           8 FELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG-DEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQLWL   86 (272)
T ss_pred             hhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCC-ccHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCCCcEEEE
Confidence            4455667999999999998 4568899999987654 3345688999999998 699999999998653      46899


Q ss_pred             EEecCCCCCHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCCCCCeeeecccCcccCCCC-
Q 020221          131 VAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDG-  209 (329)
Q Consensus       131 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~-  209 (329)
                      +|||+.+++|.+++.......+++..+..++.|++.||+|||++ +++|+||||+||++++++.++|+|||++...... 
T Consensus        87 v~e~~~~~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~-~ivh~dl~~~nili~~~~~~~l~Dfg~~~~~~~~~  165 (272)
T cd06637          87 VMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQH-KVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTV  165 (272)
T ss_pred             EEEcCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHC-CCccCCCCHHHEEECCCCCEEEccCCCceeccccc
Confidence            99999999999998754455789999999999999999999999 9999999999999999999999999998754322 


Q ss_pred             ---CCccCcccccCccccc-----CCCCCCcccchhhhHHHHHHHhCCCCCCchhhHHHhhhchhhhccccccCCCChHH
Q 020221          210 ---RSYSTNLAFTPPEYLR-----TGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDE  281 (329)
Q Consensus       210 ---~~~~~~~~y~aPE~~~-----~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  281 (329)
                         ....++..|+|||++.     +..++.++||||||+++|+|++|..|+...........    ..............
T Consensus       166 ~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~~~~~~~----~~~~~~~~~~~~~~  241 (272)
T cd06637         166 GRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFL----IPRNPAPRLKSKKW  241 (272)
T ss_pred             ccCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccCHHHHHHH----HhcCCCCCCCCCCc
Confidence               2345788999999986     33588899999999999999999987753321111111    01111111122345


Q ss_pred             HHHHHHHHHHhcccCCCCCCCHHHHHH
Q 020221          282 GTELVRLASRCLQYEPRERPNPRSLVT  308 (329)
Q Consensus       282 ~~~~~~li~~cl~~dp~~Rps~~~~l~  308 (329)
                      +.++.+++.+||..||++|||+.+++.
T Consensus       242 ~~~~~~li~~~l~~~p~~Rpt~~~il~  268 (272)
T cd06637         242 SKKFQSFIESCLVKNHSQRPTTEQLMK  268 (272)
T ss_pred             CHHHHHHHHHHcCCChhhCCCHHHHhh
Confidence            678999999999999999999999998

Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ

>cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta

Probab=100.00  E-value=8.3e-43  Score=312.59  Aligned_cols=236  Identities=18%  Similarity=0.225  Sum_probs=190.6

Q ss_pred             cCCCCCCcEEEEEE-eCCCCEEEEEEeCCCCC---hhHHHHHHHHHHHhcC-CCccccccceeeeeCCeeEEEEecCCCC
Q 020221           64 EHGEKAPNVVYKGK-LENQFRIAVKRFNRSAW---PDARQFLEEARAVGQL-RNRRLANLLGCCCEGDERLLVAEYMPND  138 (329)
Q Consensus        64 ~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~~~g  138 (329)
                      .||+|+||.||++. ..+++.||+|++.....   ...+.+.+|+.++..+ +||||+++++++...+..++||||+++|
T Consensus         2 ~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~   81 (327)
T cd05617           2 VIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYVNGG   81 (327)
T ss_pred             eeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEEeCCCCC
Confidence            46999999999998 55678999999986432   2344578899998888 6999999999999999999999999999


Q ss_pred             CHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCCCCCeeeecccCcccCCC----CCCccC
Q 020221          139 TLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRD----GRSYST  214 (329)
Q Consensus       139 sL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~----~~~~~~  214 (329)
                      +|..++.  ....+++..+..++.|++.||+|||++ +++||||||+||+++.++.+||+|||++.....    .....|
T Consensus        82 ~L~~~~~--~~~~l~~~~~~~~~~qi~~al~~lH~~-~ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~g  158 (327)
T cd05617          82 DLMFHMQ--RQRKLPEEHARFYAAEICIALNFLHER-GIIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPGDTTSTFCG  158 (327)
T ss_pred             cHHHHHH--HcCCCCHHHHHHHHHHHHHHHHHHHHC-CeeccCCCHHHEEEeCCCCEEEeccccceeccCCCCceecccC
Confidence            9998885  345799999999999999999999999 999999999999999999999999999875321    123468


Q ss_pred             cccccCcccccCCCCCCcccchhhhHHHHHHHhCCCCCCchhhHH---HhhhchhhhccccccCCCChHHHHHHHHHHHH
Q 020221          215 NLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDL---IRDRNIQTLTDSCLEGQFSSDEGTELVRLASR  291 (329)
Q Consensus       215 ~~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~  291 (329)
                      ++.|+|||++.+..++.++||||||+++|+|++|..||.......   ............  ....+...+..+.+++.+
T Consensus       159 t~~y~aPE~~~~~~~~~~~DiwslGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~--~~~~p~~~~~~~~~li~~  236 (327)
T cd05617         159 TPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVILEK--PIRIPRFLSVKASHVLKG  236 (327)
T ss_pred             CcccCCHHHHCCCCCCchheeehhHHHHHHHHhCCCCCCccCCCcccccHHHHHHHHHhC--CCCCCCCCCHHHHHHHHH
Confidence            899999999998899999999999999999999998884211000   000001111111  122455567889999999


Q ss_pred             hcccCCCCCCCHH
Q 020221          292 CLQYEPRERPNPR  304 (329)
Q Consensus       292 cl~~dp~~Rps~~  304 (329)
                      ||..||++|+++.
T Consensus       237 ~L~~dP~~R~~~~  249 (327)
T cd05617         237 FLNKDPKERLGCQ  249 (327)
T ss_pred             HhccCHHHcCCCC
Confidence            9999999999853

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways

>cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase

Probab=100.00  E-value=1.7e-42  Score=301.91  Aligned_cols=250  Identities=18%  Similarity=0.252  Sum_probs=200.3

Q ss_pred             HHhcCCCcccccccCCCCCCcEEEEEE-eCCCCEEEEEEeCCCCChhHHHHHHHHHHHhcCCCccccccceeeeeCCeeE
Q 020221           51 TATSGFAMENIVSEHGEKAPNVVYKGK-LENQFRIAVKRFNRSAWPDARQFLEEARAVGQLRNRRLANLLGCCCEGDERL  129 (329)
Q Consensus        51 ~~~~~~~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~  129 (329)
                      .+++++.....+   |+|+||.||+|. ..++..|++|.+........+.+.+|+.+++.++|+||+++++++..++..+
T Consensus         5 ~~~~~~~~~~~l---g~g~~g~v~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~   81 (268)
T cd06624           5 YEYDENGERVVL---GKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSDSENGFFK   81 (268)
T ss_pred             cccccCCceEEE---ecCCceEEEEeEecCCCcEEEEEEecCCCHHHHHHHHHHHHHHHhcCCCCeeeeeeeeccCCEEE
Confidence            345555555544   999999999998 5567889999988776666778999999999999999999999999999999


Q ss_pred             EEEecCCCCCHHhhhccCCCCCC--CHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCC-CCCeeeecccCcccC
Q 020221          130 LVAEYMPNDTLAKHLFHWETQPM--KWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDD-DVNPRLSCFGLMKNS  206 (329)
Q Consensus       130 lv~e~~~~gsL~~~l~~~~~~~~--~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~-~~~~kl~Dfg~a~~~  206 (329)
                      +++||+++++|.+++... ...+  ++..+..++.|++.||.|||++ +++|+||||+||+++. ++.++|+|||++...
T Consensus        82 lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~~~qi~~al~~lH~~-~i~h~dl~p~nil~~~~~~~~~l~dfg~~~~~  159 (268)
T cd06624          82 IFMEQVPGGSLSALLRSK-WGPLKDNEQTIIFYTKQILEGLKYLHDN-QIVHRDIKGDNVLVNTYSGVVKISDFGTSKRL  159 (268)
T ss_pred             EEEecCCCCCHHHHHHHh-cccCCCcHHHHHHHHHHHHHHHHHHHHC-CEeecCCCHHHEEEcCCCCeEEEecchhheec
Confidence            999999999999998642 2344  7888999999999999999999 9999999999999986 678999999998654


Q ss_pred             CCC----CCccCcccccCcccccCCC--CCCcccchhhhHHHHHHHhCCCCCCchhhHHHhhhchhhhccccccCCCChH
Q 020221          207 RDG----RSYSTNLAFTPPEYLRTGR--VTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSD  280 (329)
Q Consensus       207 ~~~----~~~~~~~~y~aPE~~~~~~--~~~~~DvwslG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  280 (329)
                      ...    ....++..|+|||++.+..  ++.++|+||||+++|+|++|..|+............   ..........+..
T Consensus       160 ~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~~~~~~~---~~~~~~~~~~~~~  236 (268)
T cd06624         160 AGINPCTETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQAAMFK---VGMFKIHPEIPES  236 (268)
T ss_pred             ccCCCccccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccChhhhHhh---hhhhccCCCCCcc
Confidence            322    2235688999999987544  788999999999999999999877532111110000   0000112234556


Q ss_pred             HHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 020221          281 EGTELVRLASRCLQYEPRERPNPRSLVT  308 (329)
Q Consensus       281 ~~~~~~~li~~cl~~dp~~Rps~~~~l~  308 (329)
                      .++++.+++.+||+.+|++|||+.+++.
T Consensus       237 ~~~~~~~li~~~l~~~p~~Rpt~~~ll~  264 (268)
T cd06624         237 LSAEAKNFILRCFEPDPDKRASAHDLLQ  264 (268)
T ss_pred             cCHHHHHHHHHHcCCCchhCCCHHHHHh
Confidence            7788999999999999999999999998

Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina

>cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1

Probab=100.00  E-value=9.2e-43  Score=317.17  Aligned_cols=251  Identities=17%  Similarity=0.140  Sum_probs=198.3

Q ss_pred             cCCCcccccccCCCCCCcEEEEEE-eCCCCEEEEEEeCCCC---ChhHHHHHHHHHHHhcCCCccccccceeeeeCCeeE
Q 020221           54 SGFAMENIVSEHGEKAPNVVYKGK-LENQFRIAVKRFNRSA---WPDARQFLEEARAVGQLRNRRLANLLGCCCEGDERL  129 (329)
Q Consensus        54 ~~~~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~  129 (329)
                      -....|++++.||+|+||.||++. ..+++.+|+|++....   ......+.+|+.+++.++||||+++++++.++...+
T Consensus        40 ~~~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~~  119 (371)
T cd05622          40 MKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYLY  119 (371)
T ss_pred             cchhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEE
Confidence            344567788888999999999999 4568899999986422   122345778999999999999999999999999999


Q ss_pred             EEEecCCCCCHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCCCCCeeeecccCcccCCCC
Q 020221          130 LVAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDG  209 (329)
Q Consensus       130 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~  209 (329)
                      +||||+++|+|.+++.   ...++...+..++.||+.||.|||++ +|+||||||+|||++.++.+||+|||++......
T Consensus       120 lv~Ey~~gg~L~~~~~---~~~~~~~~~~~~~~qi~~aL~~LH~~-~ivHrDLkp~NIll~~~~~ikL~DfG~a~~~~~~  195 (371)
T cd05622         120 MVMEYMPGGDLVNLMS---NYDVPEKWARFYTAEVVLALDAIHSM-GFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKE  195 (371)
T ss_pred             EEEcCCCCCcHHHHHH---hcCCCHHHHHHHHHHHHHHHHHHHHC-CEEeCCCCHHHEEECCCCCEEEEeCCceeEcCcC
Confidence            9999999999999985   34588899999999999999999999 9999999999999999999999999998765432


Q ss_pred             -----CCccCcccccCcccccCCC----CCCcccchhhhHHHHHHHhCCCCCCchhhHHHhhhchhhhccccccCCCChH
Q 020221          210 -----RSYSTNLAFTPPEYLRTGR----VTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSD  280 (329)
Q Consensus       210 -----~~~~~~~~y~aPE~~~~~~----~~~~~DvwslG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  280 (329)
                           ....||+.|+|||++.+..    ++.++|||||||++|||++|..||................ .. ........
T Consensus       196 ~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~-~~-~~~~~~~~  273 (371)
T cd05622         196 GMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHK-NS-LTFPDDND  273 (371)
T ss_pred             CcccccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCCCHHHHHHHHHcCC-Cc-ccCCCcCC
Confidence                 2346899999999987543    7889999999999999999999887554322221111110 00 11111235


Q ss_pred             HHHHHHHHHHHhcccCCCC--CCCHHHHHHHH
Q 020221          281 EGTELVRLASRCLQYEPRE--RPNPRSLVTAL  310 (329)
Q Consensus       281 ~~~~~~~li~~cl~~dp~~--Rps~~~~l~~L  310 (329)
                      .+.++.+++..||..++.+  |+++.+++++.
T Consensus       274 ~s~~~~~li~~~L~~~~~r~~r~~~~ei~~h~  305 (371)
T cd05622         274 ISKEAKNLICAFLTDREVRLGRNGVEEIKRHL  305 (371)
T ss_pred             CCHHHHHHHHHHcCChhhhcCCCCHHHHhcCc
Confidence            6788999999999844433  67888888743

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an

>cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5

Probab=100.00  E-value=1.5e-42  Score=305.10  Aligned_cols=247  Identities=19%  Similarity=0.233  Sum_probs=199.4

Q ss_pred             cccccCCCCCCcEEEEEE-eCCCCEEEEEEeCCCCCh---hHHHHHHHHHHHhcCCCccccccceeeeeCCeeEEEEecC
Q 020221           60 NIVSEHGEKAPNVVYKGK-LENQFRIAVKRFNRSAWP---DARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAEYM  135 (329)
Q Consensus        60 ~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~---~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~  135 (329)
                      +..+.||.|+||+||++. ..+++.+|+|.+......   ....+.+|+++++.++|+|++.+.+.+..++..+++|||+
T Consensus         3 ~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~   82 (285)
T cd05632           3 RQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYETKDALCLVLTIM   82 (285)
T ss_pred             eEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEecCCEEEEEEEec
Confidence            344556999999999998 457889999998654321   2345778999999999999999999999999999999999


Q ss_pred             CCCCHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCCCCCeeeecccCcccCCCC---CCc
Q 020221          136 PNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDG---RSY  212 (329)
Q Consensus       136 ~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~---~~~  212 (329)
                      ++++|.+.+.......+++..+..++.|++.||.|||+. +++||||||+||++++++.++|+|||++......   ...
T Consensus        83 ~~~~L~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~-~iiH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~  161 (285)
T cd05632          83 NGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLHRE-NTVYRDLKPENILLDDYGHIRISDLGLAVKIPEGESIRGR  161 (285)
T ss_pred             cCccHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC-CeeecCCCHHHEEECCCCCEEEecCCcceecCCCCcccCC
Confidence            999999888654455799999999999999999999999 9999999999999999999999999998654332   234


Q ss_pred             cCcccccCcccccCCCCCCcccchhhhHHHHHHHhCCCCCCchhhHHHhhhchhhhccccccCCCChHHHHHHHHHHHHh
Q 020221          213 STNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLASRC  292 (329)
Q Consensus       213 ~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~c  292 (329)
                      .++..|+|||++.+..++.++|+||||+++|+|++|..||...................  ...++...+.++.+|+..|
T Consensus       162 ~g~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~P~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~li~~~  239 (285)
T cd05632         162 VGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKVKREEVDRRVLET--EEVYSAKFSEEAKSICKML  239 (285)
T ss_pred             CCCcCccChHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhhcc--ccccCccCCHHHHHHHHHH
Confidence            67899999999998889999999999999999999998886543221111111111111  1123445677899999999


Q ss_pred             cccCCCCCCC-----HHHHHHH
Q 020221          293 LQYEPRERPN-----PRSLVTA  309 (329)
Q Consensus       293 l~~dp~~Rps-----~~~~l~~  309 (329)
                      |+.||++||+     +.+++++
T Consensus       240 l~~~P~~R~~~~~~~~~~l~~~  261 (285)
T cd05632         240 LTKDPKQRLGCQEEGAGEVKRH  261 (285)
T ss_pred             ccCCHhHcCCCcccChHHHHcC
Confidence            9999999999     7777763

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with

>cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3

Probab=100.00  E-value=1e-42  Score=315.63  Aligned_cols=247  Identities=15%  Similarity=0.212  Sum_probs=193.8

Q ss_pred             CCcccccccCCCCCCcEEEEEE-eCCCCEEEEEEeCCCCC--hhHHHHHHHHHHHhcCCCccccccceeeeeC------C
Q 020221           56 FAMENIVSEHGEKAPNVVYKGK-LENQFRIAVKRFNRSAW--PDARQFLEEARAVGQLRNRRLANLLGCCCEG------D  126 (329)
Q Consensus        56 ~~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~------~  126 (329)
                      ...|.+++.||+|+||.||++. ...++.||+|++.....  .....+.+|+.+++.++||||+++++++...      .
T Consensus        16 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~   95 (355)
T cd07874          16 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEEFQ   95 (355)
T ss_pred             hhceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCcccChHHHHHHHHHHHHHHHhCCCchhceeeeeeccccccccc
Confidence            3457778888999999999998 45688999999976432  2345678899999999999999999988543      3


Q ss_pred             eeEEEEecCCCCCHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCCCCCeeeecccCcccC
Q 020221          127 ERLLVAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNS  206 (329)
Q Consensus       127 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~  206 (329)
                      ..+++|||+++ +|...+.    ..+++..+..++.|++.||.|||+. |++||||||+||+++.++.+||+|||+++..
T Consensus        96 ~~~lv~e~~~~-~l~~~~~----~~l~~~~~~~~~~qi~~aL~~LH~~-givHrDikp~Nill~~~~~~kl~Dfg~~~~~  169 (355)
T cd07874          96 DVYLVMELMDA-NLCQVIQ----MELDHERMSYLLYQMLCGIKHLHSA-GIIHRDLKPSNIVVKSDCTLKILDFGLARTA  169 (355)
T ss_pred             eeEEEhhhhcc-cHHHHHh----hcCCHHHHHHHHHHHHHHHHHHHhC-CcccCCCChHHEEECCCCCEEEeeCcccccC
Confidence            57999999976 6777663    3588899999999999999999999 9999999999999999999999999999765


Q ss_pred             CCC---CCccCcccccCcccccCCCCCCcccchhhhHHHHHHHhCCCCCCchhhHHHhhhchh-----------------
Q 020221          207 RDG---RSYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQ-----------------  266 (329)
Q Consensus       207 ~~~---~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~~~~~~~-----------------  266 (329)
                      ...   ....++..|+|||++.+..++.++||||||+++|+|++|..||..............                 
T Consensus       170 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  249 (355)
T cd07874         170 GTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTV  249 (355)
T ss_pred             CCccccCCccccCCccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhhcHHH
Confidence            443   234678999999999988899999999999999999999998865422111000000                 


Q ss_pred             -hhcccc---------------c---cCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 020221          267 -TLTDSC---------------L---EGQFSSDEGTELVRLASRCLQYEPRERPNPRSLVT  308 (329)
Q Consensus       267 -~~~~~~---------------~---~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~~~l~  308 (329)
                       ......               .   ....+...+.++.+++.+||+.||++|||+.++++
T Consensus       250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rps~~ell~  310 (355)
T cd07874         250 RNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEALQ  310 (355)
T ss_pred             HHHHhcCCccccccchhhccccccccccccccccchHHHHHHHHHhcCCchhcCCHHHHhc
Confidence             000000               0   00011223567899999999999999999999998

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok

>cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha

Probab=100.00  E-value=1.3e-42  Score=311.31  Aligned_cols=247  Identities=15%  Similarity=0.160  Sum_probs=192.1

Q ss_pred             ccccCCCC--CCcEEEEEE-eCCCCEEEEEEeCCCCC--hhHHHHHHHHHHHhcCCCccccccceeeeeCCeeEEEEecC
Q 020221           61 IVSEHGEK--APNVVYKGK-LENQFRIAVKRFNRSAW--PDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAEYM  135 (329)
Q Consensus        61 ~~~~lg~G--~~g~V~~~~-~~~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~  135 (329)
                      +++.||+|  +|++||++. ..+|+.||+|.+.....  ...+.+.+|+++++.++||||+++++++..++..++|+||+
T Consensus         2 ~~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~   81 (327)
T cd08227           2 LLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFM   81 (327)
T ss_pred             hhhhccccccceEEEEEEeecccCcEEEEEEechhhccHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEECCEEEEEEecc
Confidence            45567888  778999998 56789999999976532  22345778999999999999999999999999999999999


Q ss_pred             CCCCHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCCCCCeeeecccCcccCCCC------
Q 020221          136 PNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDG------  209 (329)
Q Consensus       136 ~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~------  209 (329)
                      ++|+|.+++.......+++..+..++.|++.||.|||++ +++||||||+||+++.++.++++||+........      
T Consensus        82 ~~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~-~iiH~dlkp~Nil~~~~~~~~l~~~~~~~~~~~~~~~~~~  160 (327)
T cd08227          82 AYGSAKDLICTHFMDGMSELAIAYILQGVLKALDYIHHM-GYVHRSVKASHILISVDGKVYLSGLRSNLSMINHGQRLRV  160 (327)
T ss_pred             CCCcHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHC-CEecCCCChhhEEEecCCcEEEcccchhhccccccccccc
Confidence            999999998654445689999999999999999999999 9999999999999999999999999864332111      


Q ss_pred             -----CCccCcccccCcccccC--CCCCCcccchhhhHHHHHHHhCCCCCCchhhHHHhhhchhhhc----cc-------
Q 020221          210 -----RSYSTNLAFTPPEYLRT--GRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLT----DS-------  271 (329)
Q Consensus       210 -----~~~~~~~~y~aPE~~~~--~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~~~~~~~~~~----~~-------  271 (329)
                           ....++..|+|||++.+  ..++.++||||||+++|+|++|..||.................    +.       
T Consensus       161 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (327)
T cd08227         161 VHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCLLDTTTIPAEE  240 (327)
T ss_pred             cccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCCcchhHHHHHHhcCCccccccccchhhhh
Confidence                 11235677999999876  3588999999999999999999988754221111100000000    00       


Q ss_pred             -----------------------------cccCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 020221          272 -----------------------------CLEGQFSSDEGTELVRLASRCLQYEPRERPNPRSLVT  308 (329)
Q Consensus       272 -----------------------------~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~~~l~  308 (329)
                                                   ..........++++.+++.+||+.||++|||+.++++
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~ell~  306 (327)
T cd08227         241 LTMKPSRSGANSGLGESTTVSTPRPSNGESSSHPYNRTFSPHFHHFVEQCLQRNPDARPSASTLLN  306 (327)
T ss_pred             cccCCcccCCcCCCCcccccCCcCccccCCcccccccccCHHHHHHHHHHHhhCchhcCCHHHHhc
Confidence                                         0000112234678999999999999999999999997

Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype

>cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor

Probab=100.00  E-value=1.6e-42  Score=303.61  Aligned_cols=248  Identities=21%  Similarity=0.343  Sum_probs=197.3

Q ss_pred             ccccccCCCCCCcEEEEEEeC------CCCEEEEEEeCCCCC-hhHHHHHHHHHHHhcCCCccccccceeeeeCCeeEEE
Q 020221           59 ENIVSEHGEKAPNVVYKGKLE------NQFRIAVKRFNRSAW-PDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLV  131 (329)
Q Consensus        59 ~~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv  131 (329)
                      +++.+.+|+|+||.||+|...      .+..||+|++..... .....+.+|+.+++.++||||+++++++..+...++|
T Consensus         8 ~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv   87 (277)
T cd05062           8 ITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVI   87 (277)
T ss_pred             ceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCeEEE
Confidence            556677799999999998742      246799999865432 2345688999999999999999999999988999999


Q ss_pred             EecCCCCCHHhhhccCC--------CCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCCCCCeeeecccCc
Q 020221          132 AEYMPNDTLAKHLFHWE--------TQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLM  203 (329)
Q Consensus       132 ~e~~~~gsL~~~l~~~~--------~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a  203 (329)
                      |||+++++|.+++.+..        ...+++..+..++.|++.||.|||+. +++|+||||+||++++++.++|+|||++
T Consensus        88 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~-~~vH~dlkp~Nil~~~~~~~~l~dfg~~  166 (277)
T cd05062          88 MELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNAN-KFVHRDLAARNCMVAEDFTVKIGDFGMT  166 (277)
T ss_pred             EecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHC-CcccCCcchheEEEcCCCCEEECCCCCc
Confidence            99999999999986421        12357888999999999999999999 9999999999999999999999999998


Q ss_pred             ccCCCCC------CccCcccccCcccccCCCCCCcccchhhhHHHHHHHh-CCCCCCchhhHHHhhhchhhhccccccCC
Q 020221          204 KNSRDGR------SYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLS-GKHIPPSHALDLIRDRNIQTLTDSCLEGQ  276 (329)
Q Consensus       204 ~~~~~~~------~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t-g~~~~~~~~~~~~~~~~~~~~~~~~~~~~  276 (329)
                      .......      ...++..|+|||.+.+..++.++||||||+++|||++ |..|+.............    .. ....
T Consensus       167 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~p~~~~~~~~~~~~~~----~~-~~~~  241 (277)
T cd05062         167 RDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSNEQVLRFVM----EG-GLLD  241 (277)
T ss_pred             cccCCcceeecCCCCccCHhhcChhHhhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHH----cC-CcCC
Confidence            7543321      1234678999999998889999999999999999999 566665432222211111    11 1112


Q ss_pred             CChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHh
Q 020221          277 FSSDEGTELVRLASRCLQYEPRERPNPRSLVTALVT  312 (329)
Q Consensus       277 ~~~~~~~~~~~li~~cl~~dp~~Rps~~~~l~~L~~  312 (329)
                      .+...+..+.+++.+||+.||++|||+.++++.|++
T Consensus       242 ~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~~  277 (277)
T cd05062         242 KPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKE  277 (277)
T ss_pred             CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHhhC
Confidence            334566789999999999999999999999998863

Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh

>cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3

Probab=100.00  E-value=2e-42  Score=299.25  Aligned_cols=245  Identities=16%  Similarity=0.205  Sum_probs=203.6

Q ss_pred             ccccccCCCCCCcEEEEEE-eCCCCEEEEEEeCCCC-ChhHHHHHHHHHHHhcCCCccccccceeeeeCCeeEEEEecCC
Q 020221           59 ENIVSEHGEKAPNVVYKGK-LENQFRIAVKRFNRSA-WPDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAEYMP  136 (329)
Q Consensus        59 ~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~  136 (329)
                      |.+.+.+|+|+||.||++. ..+++.+|+|.++... ....+.+.+|+.+++.++|+|++++++.+.+.+..++++||++
T Consensus         2 y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~   81 (255)
T cd08219           2 YNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKESFEADGHLYIVMEYCD   81 (255)
T ss_pred             ceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCcchHHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEeeCC
Confidence            4567788999999999998 4568899999986543 2345668889999999999999999999999999999999999


Q ss_pred             CCCHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCCCCCeeeecccCcccCCCCC----Cc
Q 020221          137 NDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDGR----SY  212 (329)
Q Consensus       137 ~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~----~~  212 (329)
                      +++|.+++.......+++..+..++.|++.||.|||+. +++|+||||+||++++++.++++|||.+.......    ..
T Consensus        82 ~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~-~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~~~~~~  160 (255)
T cd08219          82 GGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIHEK-RVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGAYACTY  160 (255)
T ss_pred             CCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHhhC-CcccCCCCcceEEECCCCcEEEcccCcceeecccccccccc
Confidence            99999988654556689999999999999999999999 99999999999999999999999999987554322    34


Q ss_pred             cCcccccCcccccCCCCCCcccchhhhHHHHHHHhCCCCCCchhhHHHhhhchhhhccccccCCCChHHHHHHHHHHHHh
Q 020221          213 STNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLASRC  292 (329)
Q Consensus       213 ~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~c  292 (329)
                      .++..|+|||++.+..++.++|+||||+++|+|++|..||...............     .....+...+..+.+++.+|
T Consensus       161 ~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~li~~~  235 (255)
T cd08219         161 VGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQANSWKNLILKVCQG-----SYKPLPSHYSYELRSLIKQM  235 (255)
T ss_pred             cCCccccCHHHHccCCcCchhhhhhhchhheehhhccCCCCCCCHHHHHHHHhcC-----CCCCCCcccCHHHHHHHHHH
Confidence            5778899999998888999999999999999999999888654332222111111     11123445677899999999


Q ss_pred             cccCCCCCCCHHHHHHH
Q 020221          293 LQYEPRERPNPRSLVTA  309 (329)
Q Consensus       293 l~~dp~~Rps~~~~l~~  309 (329)
                      |+.||++||++.+++..
T Consensus       236 l~~~P~~Rp~~~~il~~  252 (255)
T cd08219         236 FKRNPRSRPSATTILSR  252 (255)
T ss_pred             HhCCcccCCCHHHHhhc
Confidence            99999999999999864

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati

>cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2

Probab=100.00  E-value=4.4e-42  Score=301.15  Aligned_cols=252  Identities=20%  Similarity=0.282  Sum_probs=201.2

Q ss_pred             cccccccCCCCCCcEEEEEE-eCCCC----EEEEEEeCCCCCh-hHHHHHHHHHHHhcCCCccccccceeeeeCCeeEEE
Q 020221           58 MENIVSEHGEKAPNVVYKGK-LENQF----RIAVKRFNRSAWP-DARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLV  131 (329)
Q Consensus        58 ~~~~~~~lg~G~~g~V~~~~-~~~~~----~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv  131 (329)
                      .+++++.||+|+||+||+|. ..++.    .||+|.+...... ....+.+|+.+++.++|+||+++++++.. ...+++
T Consensus         8 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~-~~~~l~   86 (279)
T cd05109           8 ELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRLLGICLT-STVQLV   86 (279)
T ss_pred             heeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCCCHHHHHHHHHHHHHHHhcCCCCCceEEEEEcC-CCcEEE
Confidence            35566778999999999998 44444    4899998765432 34568899999999999999999998865 467899


Q ss_pred             EecCCCCCHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCCCCCeeeecccCcccCCCCCC
Q 020221          132 AEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDGRS  211 (329)
Q Consensus       132 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~~  211 (329)
                      +||+++|+|.+++.. ....+++..+..++.|++.||+|||++ +++|+||||+||++++++.+||+|||+++.......
T Consensus        87 ~~~~~~g~l~~~l~~-~~~~~~~~~~~~~~~qi~~~L~~lH~~-~iiH~dlkp~Nil~~~~~~~kL~dfG~~~~~~~~~~  164 (279)
T cd05109          87 TQLMPYGCLLDYVRE-NKDRIGSQDLLNWCVQIAKGMSYLEEV-RLVHRDLAARNVLVKSPNHVKITDFGLARLLDIDET  164 (279)
T ss_pred             EEcCCCCCHHHHHhh-ccCCCCHHHHHHHHHHHHHHHHHHHHC-CeeccccccceEEEcCCCcEEECCCCceeecccccc
Confidence            999999999999864 335689999999999999999999999 999999999999999999999999999876543221


Q ss_pred             ------ccCcccccCcccccCCCCCCcccchhhhHHHHHHHh-CCCCCCchhhHHHhhhchhhhccccccCCCChHHHHH
Q 020221          212 ------YSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLS-GKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTE  284 (329)
Q Consensus       212 ------~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t-g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  284 (329)
                            ..++..|+|||.+.+..++.++||||||+++|||++ |..|+..........     .+........+...+.+
T Consensus       165 ~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~  239 (279)
T cd05109         165 EYHADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPAREIPD-----LLEKGERLPQPPICTID  239 (279)
T ss_pred             eeecCCCccchhhCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH-----HHHCCCcCCCCccCCHH
Confidence                  223567999999988889999999999999999998 776654332221111     11111112233456778


Q ss_pred             HHHHHHHhcccCCCCCCCHHHHHHHHHhhhhcc
Q 020221          285 LVRLASRCLQYEPRERPNPRSLVTALVTLQKDT  317 (329)
Q Consensus       285 ~~~li~~cl~~dp~~Rps~~~~l~~L~~~~~~~  317 (329)
                      +.+++.+||..||++||++.++++.|+++....
T Consensus       240 ~~~li~~~l~~dp~~Rp~~~~l~~~l~~~~~~~  272 (279)
T cd05109         240 VYMIMVKCWMIDSECRPRFRELVDEFSRMARDP  272 (279)
T ss_pred             HHHHHHHHcCCChhhCcCHHHHHHHHHHhhcCC
Confidence            999999999999999999999999999887655

Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve

>cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors

Probab=100.00  E-value=2.4e-42  Score=304.87  Aligned_cols=250  Identities=22%  Similarity=0.314  Sum_probs=202.6

Q ss_pred             ccccccCCCCCCcEEEEEEeC------CCCEEEEEEeCCCCC-hhHHHHHHHHHHHhcC-CCccccccceeeeeCCeeEE
Q 020221           59 ENIVSEHGEKAPNVVYKGKLE------NQFRIAVKRFNRSAW-PDARQFLEEARAVGQL-RNRRLANLLGCCCEGDERLL  130 (329)
Q Consensus        59 ~~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~l  130 (329)
                      +++.+.||+|+||.||++...      +...+|+|.+..... .....+.+|++++..+ +|+||+++++++...+..++
T Consensus        14 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~l   93 (293)
T cd05053          14 LTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGVCTQEGPLYV   93 (293)
T ss_pred             eEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCCCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEcCCCCeEE
Confidence            556677899999999999843      236799999876432 2345688999999999 79999999999999999999


Q ss_pred             EEecCCCCCHHhhhccC--------------CCCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCCCCCee
Q 020221          131 VAEYMPNDTLAKHLFHW--------------ETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPR  196 (329)
Q Consensus       131 v~e~~~~gsL~~~l~~~--------------~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~k  196 (329)
                      +|||+++|+|.+++...              ....+++..+..++.|++.||.|||+. +++|+||||+||++++++.++
T Consensus        94 i~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~-~ivH~dlkp~Nil~~~~~~~k  172 (293)
T cd05053          94 VVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASK-KCIHRDLAARNVLVTEDHVMK  172 (293)
T ss_pred             EEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHC-CccccccceeeEEEcCCCeEE
Confidence            99999999999998542              234688999999999999999999999 999999999999999999999


Q ss_pred             eecccCcccCCCCC------CccCcccccCcccccCCCCCCcccchhhhHHHHHHHh-CCCCCCchhhHHHhhhchhhhc
Q 020221          197 LSCFGLMKNSRDGR------SYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLS-GKHIPPSHALDLIRDRNIQTLT  269 (329)
Q Consensus       197 l~Dfg~a~~~~~~~------~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t-g~~~~~~~~~~~~~~~~~~~~~  269 (329)
                      |+|||++.......      ...++..|+|||.+.+..++.++||||||+++|+|++ |..|++.............   
T Consensus       173 L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~---  249 (293)
T cd05053         173 IADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEELFKLLKE---  249 (293)
T ss_pred             eCccccccccccccceeccCCCCCCccccCHHHhccCCcCcccceeehhhHHHHHhcCCCCCCCCCCHHHHHHHHHc---
Confidence            99999987654322      1223567999999988889999999999999999998 7777665433222221111   


Q ss_pred             cccccCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhh
Q 020221          270 DSCLEGQFSSDEGTELVRLASRCLQYEPRERPNPRSLVTALVTLQ  314 (329)
Q Consensus       270 ~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~~~l~~L~~~~  314 (329)
                        ......+...+..+.+++.+||..||++|||+.++++.|+.+.
T Consensus       250 --~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~eil~~l~~~~  292 (293)
T cd05053         250 --GYRMEKPQNCTQELYHLMRDCWHEVPSQRPTFKQLVEDLDRML  292 (293)
T ss_pred             --CCcCCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHHHHhh
Confidence              1112234456778999999999999999999999999998763

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation,

>cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5

Probab=100.00  E-value=3.1e-42  Score=302.19  Aligned_cols=243  Identities=18%  Similarity=0.255  Sum_probs=195.5

Q ss_pred             ccccccCCCCCCcEEEEEE-eCCCCEEEEEEeCCCCC-hhHHHHHHHHHHHhcCCCccccccceeeeeCCeeEEEEecCC
Q 020221           59 ENIVSEHGEKAPNVVYKGK-LENQFRIAVKRFNRSAW-PDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAEYMP  136 (329)
Q Consensus        59 ~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~  136 (329)
                      +++++.||+|+||.||++. ..+++.||+|.+..... ...+.+.+|+++++.++||||+++++++......++|+||++
T Consensus         3 ~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~   82 (279)
T cd06619           3 IQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAFFVENRISICTEFMD   82 (279)
T ss_pred             chheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCCChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEECCEEEEEEecCC
Confidence            4566778999999999998 56788999999876532 234568899999999999999999999999999999999999


Q ss_pred             CCCHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCCCCCeeeecccCcccCCCC--CCccC
Q 020221          137 NDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDG--RSYST  214 (329)
Q Consensus       137 ~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~--~~~~~  214 (329)
                      +++|..+.      .+++..+..++.|++.||.|||+. +++|+||||+||+++.++.++|+|||++......  ....+
T Consensus        83 ~~~l~~~~------~~~~~~~~~~~~qi~~~l~~lH~~-~i~H~dlkp~Nill~~~~~~~l~dfg~~~~~~~~~~~~~~~  155 (279)
T cd06619          83 GGSLDVYR------KIPEHVLGRIAVAVVKGLTYLWSL-KILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNSIAKTYVG  155 (279)
T ss_pred             CCChHHhh------cCCHHHHHHHHHHHHHHHHHHHHC-CEeeCCCCHHHEEECCCCCEEEeeCCcceecccccccCCCC
Confidence            99986543      468888999999999999999999 9999999999999999999999999998754432  33467


Q ss_pred             cccccCcccccCCCCCCcccchhhhHHHHHHHhCCCCCCchhhHH---HhhhchhhhccccccCCCChHHHHHHHHHHHH
Q 020221          215 NLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDL---IRDRNIQTLTDSCLEGQFSSDEGTELVRLASR  291 (329)
Q Consensus       215 ~~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~  291 (329)
                      +..|+|||++.+..++.++|+||||+++|+|++|..||.......   ......................++++.+++.+
T Consensus       156 ~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~  235 (279)
T cd06619         156 TNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQCIVDEDPPVLPVGQFSEKFVHFITQ  235 (279)
T ss_pred             ChhhcCceeecCCCCCCcchHHHHHHHHHHHHhCCCCchhhcccccccchHHHHHHHhccCCCCCCCCcCCHHHHHHHHH
Confidence            889999999998889999999999999999999998875321100   00000111111111111123356789999999


Q ss_pred             hcccCCCCCCCHHHHHH
Q 020221          292 CLQYEPRERPNPRSLVT  308 (329)
Q Consensus       292 cl~~dp~~Rps~~~~l~  308 (329)
                      ||+.||++||+++++++
T Consensus       236 ~l~~~P~~Rp~~~eil~  252 (279)
T cd06619         236 CMRKQPKERPAPENLMD  252 (279)
T ss_pred             HhhCChhhCCCHHHHhc
Confidence            99999999999999998

Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p

>cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1

Probab=100.00  E-value=2.8e-42  Score=306.62  Aligned_cols=254  Identities=21%  Similarity=0.302  Sum_probs=205.0

Q ss_pred             cccccccCCCCCCcEEEEEEeC--------CCCEEEEEEeCCCC-ChhHHHHHHHHHHHhcC-CCccccccceeeeeCCe
Q 020221           58 MENIVSEHGEKAPNVVYKGKLE--------NQFRIAVKRFNRSA-WPDARQFLEEARAVGQL-RNRRLANLLGCCCEGDE  127 (329)
Q Consensus        58 ~~~~~~~lg~G~~g~V~~~~~~--------~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~  127 (329)
                      .+.+.+.||+|+||.||++...        +...+|+|.+.... ......+.+|+.+++.+ +|+||+++++++...+.
T Consensus        19 ~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~   98 (307)
T cd05098          19 RLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGP   98 (307)
T ss_pred             HeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCCChHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCCc
Confidence            4677888999999999999742        23569999998653 23355688899999999 79999999999999999


Q ss_pred             eEEEEecCCCCCHHhhhccCC--------------CCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCCCC
Q 020221          128 RLLVAEYMPNDTLAKHLFHWE--------------TQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDV  193 (329)
Q Consensus       128 ~~lv~e~~~~gsL~~~l~~~~--------------~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~  193 (329)
                      .++||||+++|+|.+++....              ...+++.++..++.|++.||+|||+. |++|+||||+||+++.++
T Consensus        99 ~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~-gi~H~dlkp~Nill~~~~  177 (307)
T cd05098          99 LYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASK-KCIHRDLAARNVLVTEDN  177 (307)
T ss_pred             eEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHC-CcccccccHHheEEcCCC
Confidence            999999999999999996432              13478999999999999999999999 999999999999999999


Q ss_pred             CeeeecccCcccCCCCC------CccCcccccCcccccCCCCCCcccchhhhHHHHHHHh-CCCCCCchhhHHHhhhchh
Q 020221          194 NPRLSCFGLMKNSRDGR------SYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLS-GKHIPPSHALDLIRDRNIQ  266 (329)
Q Consensus       194 ~~kl~Dfg~a~~~~~~~------~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t-g~~~~~~~~~~~~~~~~~~  266 (329)
                      .++|+|||++.......      ...++..|+|||.+.+..++.++||||||+++|+|++ |..|+............  
T Consensus       178 ~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~~g~~p~~~~~~~~~~~~~--  255 (307)
T cd05098         178 VMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKLL--  255 (307)
T ss_pred             cEEECCCcccccccccchhhccccCCCccceeChHHhccCCCCcHHHHHHHHHHHHHHHcCCCCCCCcCCHHHHHHHH--
Confidence            99999999987654321      1123467999999998889999999999999999998 66666543332222111  


Q ss_pred             hhccccccCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhhcc
Q 020221          267 TLTDSCLEGQFSSDEGTELVRLASRCLQYEPRERPNPRSLVTALVTLQKDT  317 (329)
Q Consensus       267 ~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~~~l~~L~~~~~~~  317 (329)
                         ........+...+.++.+++.+||..+|++|||+.++++.|+++.+..
T Consensus       256 ---~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~~l~~~~~~~  303 (307)
T cd05098         256 ---KEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILALT  303 (307)
T ss_pred             ---HcCCCCCCCCcCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHHHh
Confidence               111122334556789999999999999999999999999999987653

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms]

Probab=100.00  E-value=1.3e-44  Score=300.56  Aligned_cols=244  Identities=17%  Similarity=0.237  Sum_probs=208.1

Q ss_pred             ccccccCCCCCCcEEEEEE-eCCCCEEEEEEeCCCCChhHHHHHHHHHHHhcCCCccccccceeeeeCCeeEEEEecCCC
Q 020221           59 ENIVSEHGEKAPNVVYKGK-LENQFRIAVKRFNRSAWPDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAEYMPN  137 (329)
Q Consensus        59 ~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~  137 (329)
                      +.++++||+|+||.||++. ..+|+.+|+|.+....  +.+++.+|+.++++.+.|++|+++|.|.....+|+|||||.-
T Consensus        35 FDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV~s--DLQEIIKEISIMQQC~S~yVVKYYGSYFK~sDLWIVMEYCGA  112 (502)
T KOG0574|consen   35 FDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPVDT--DLQEIIKEISIMQQCKSKYVVKYYGSYFKHSDLWIVMEYCGA  112 (502)
T ss_pred             HHHHHHhcCCcchHHHHHHHhccCcEEEEEecCccc--hHHHHHHHHHHHHHcCCchhhhhhhhhccCCceEeehhhcCC
Confidence            3466788999999999998 5679999999987643  688999999999999999999999999999999999999999


Q ss_pred             CCHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCCCCCeeeecccCcccCCCC----CCcc
Q 020221          138 DTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDG----RSYS  213 (329)
Q Consensus       138 gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~----~~~~  213 (329)
                      ||+.+.++- ++++++++.+..+++..+.||+|||.. .-+|||||..|||++-+|.+||+|||.|....+.    .+..
T Consensus       113 GSiSDI~R~-R~K~L~E~EIs~iL~~TLKGL~YLH~~-~KIHRDIKAGNILLNT~G~AKLADFGVAGQLTDTMAKRNTVI  190 (502)
T KOG0574|consen  113 GSISDIMRA-RRKPLSEQEISAVLRDTLKGLQYLHDL-KKIHRDIKAGNILLNTDGIAKLADFGVAGQLTDTMAKRNTVI  190 (502)
T ss_pred             CcHHHHHHH-hcCCccHHHHHHHHHHHHhHHHHHHHH-HHHHhhcccccEEEcccchhhhhhccccchhhhhHHhhCccc
Confidence            999998865 678999999999999999999999998 8899999999999999999999999999876654    4668


Q ss_pred             CcccccCcccccCCCCCCcccchhhhHHHHHHHhCCCCCCchhhHHHhhhchhhhccccccCCCChHHHHHHHHHHHHhc
Q 020221          214 TNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLASRCL  293 (329)
Q Consensus       214 ~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl  293 (329)
                      ||+-|||||++..-.|+.++||||||++..||.-|++|+.+-  ..++. .......+...-.-|..++.++.+++++||
T Consensus       191 GTPFWMAPEVI~EIGY~~~ADIWSLGITaIEMAEG~PPYsDI--HPMRA-IFMIPT~PPPTF~KPE~WS~~F~DFi~~CL  267 (502)
T KOG0574|consen  191 GTPFWMAPEVIEEIGYDTKADIWSLGITAIEMAEGRPPYSDI--HPMRA-IFMIPTKPPPTFKKPEEWSSEFNDFIRSCL  267 (502)
T ss_pred             cCcccccHHHHHHhccchhhhHhhhcchhhhhhcCCCCcccc--cccce-eEeccCCCCCCCCChHhhhhHHHHHHHHHh
Confidence            999999999999999999999999999999999999766432  11111 111111111122345678999999999999


Q ss_pred             ccCCCCCCCHHHHHHH
Q 020221          294 QYEPRERPNPRSLVTA  309 (329)
Q Consensus       294 ~~dp~~Rps~~~~l~~  309 (329)
                      -.+|++|-|+.+++++
T Consensus       268 iK~PE~R~TA~~L~~H  283 (502)
T KOG0574|consen  268 IKKPEERKTALRLCEH  283 (502)
T ss_pred             cCCHHHHHHHHHHhhh
Confidence            9999999999999873

>cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa

Probab=100.00  E-value=3.9e-42  Score=297.99  Aligned_cols=242  Identities=20%  Similarity=0.284  Sum_probs=195.6

Q ss_pred             cCCCCCCcEEEEEEeC---CCCEEEEEEeCCCCCh-hHHHHHHHHHHHhcCCCccccccceeeeeCCeeEEEEecCCCCC
Q 020221           64 EHGEKAPNVVYKGKLE---NQFRIAVKRFNRSAWP-DARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAEYMPNDT  139 (329)
Q Consensus        64 ~lg~G~~g~V~~~~~~---~~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gs  139 (329)
                      .||+|+||.||+|.+.   ++..||+|.+...... ..+.+.+|+.+++.++|+||+++++++. ....++||||+++++
T Consensus         2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~-~~~~~lv~e~~~~~~   80 (257)
T cd05115           2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIGVCE-AEALMLVMEMASGGP   80 (257)
T ss_pred             ccCCCCcccEEEEEEecCCCceeEEEEEcccccChHHHHHHHHHHHHHHhcCCCCeEEEEEEEc-CCCeEEEEEeCCCCC
Confidence            3699999999999743   4557999998765432 2456889999999999999999999875 457899999999999


Q ss_pred             HHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCCCCCeeeecccCcccCCCCCC-------c
Q 020221          140 LAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDGRS-------Y  212 (329)
Q Consensus       140 L~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~~-------~  212 (329)
                      |.+++.. ....+++..++.++.|++.||.|||++ +++|+||||+||+++.++.+||+|||++........       .
T Consensus        81 L~~~l~~-~~~~~~~~~~~~~~~~i~~~l~~lH~~-~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~  158 (257)
T cd05115          81 LNKFLSG-KKDEITVSNVVELMHQVSMGMKYLEGK-NFVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKARSAG  158 (257)
T ss_pred             HHHHHHh-CCCCCCHHHHHHHHHHHHHHHHHHHhc-CeeecccchheEEEcCCCcEEeccCCccccccCCccceeccCCC
Confidence            9999864 345789999999999999999999999 999999999999999999999999999875433221       1


Q ss_pred             cCcccccCcccccCCCCCCcccchhhhHHHHHHHh-CCCCCCchhhHHHhhhchhhhccccccCCCChHHHHHHHHHHHH
Q 020221          213 STNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLS-GKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLASR  291 (329)
Q Consensus       213 ~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t-g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~  291 (329)
                      .++..|+|||.+.+..++.++||||||+++|++++ |..|+..........     ..........+...++++.+++.+
T Consensus       159 ~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~l~~li~~  233 (257)
T cd05115         159 KWPLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPYKKMKGPEVMS-----FIEQGKRLDCPAECPPEMYALMKD  233 (257)
T ss_pred             CCCcccCCHHHHccCCCCchhhHHHHHHHHHHHhcCCCCCcCcCCHHHHHH-----HHHCCCCCCCCCCCCHHHHHHHHH
Confidence            22467999999988889999999999999999996 887765432221111     111112223445567899999999


Q ss_pred             hcccCCCCCCCHHHHHHHHHhh
Q 020221          292 CLQYEPRERPNPRSLVTALVTL  313 (329)
Q Consensus       292 cl~~dp~~Rps~~~~l~~L~~~  313 (329)
                      ||..||++||++.++.+.|+.+
T Consensus       234 c~~~~~~~Rp~~~~i~~~l~~~  255 (257)
T cd05115         234 CWIYKWEDRPNFAKVEERMRTY  255 (257)
T ss_pred             HcCCChhhCcCHHHHHHHHhhh
Confidence            9999999999999999998864

Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho

>cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4

Probab=100.00  E-value=3.9e-42  Score=297.64  Aligned_cols=244  Identities=16%  Similarity=0.184  Sum_probs=200.7

Q ss_pred             ccccccCCCCCCcEEEEEE-eCCCCEEEEEEeCCCCC--hhHHHHHHHHHHHhcCCCccccccceeeee-CCeeEEEEec
Q 020221           59 ENIVSEHGEKAPNVVYKGK-LENQFRIAVKRFNRSAW--PDARQFLEEARAVGQLRNRRLANLLGCCCE-GDERLLVAEY  134 (329)
Q Consensus        59 ~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~~~~~~~~-~~~~~lv~e~  134 (329)
                      |++++.+|.|++|.||++. ..+++.+|+|.+.....  ...+.+.+|+++++.++|+|++++.+.+.. ....++++||
T Consensus         2 y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e~   81 (257)
T cd08223           2 YCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIVMGF   81 (257)
T ss_pred             ceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecCCCCEEEEEecc
Confidence            6677888999999999998 45678999999875432  234568889999999999999999988764 3467899999


Q ss_pred             CCCCCHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCCCCCeeeecccCcccCCCC----C
Q 020221          135 MPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDG----R  210 (329)
Q Consensus       135 ~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~----~  210 (329)
                      +++++|.+++.......+++.++..++.|++.||.+||+. +++|+||||+||++++++.++|+|||++......    .
T Consensus        82 ~~~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~l~~lH~~-~i~H~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~  160 (257)
T cd08223          82 CEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLHEK-HILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQCDMAS  160 (257)
T ss_pred             cCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC-CeeccCCCchhEEEecCCcEEEecccceEEecccCCccc
Confidence            9999999998754455689999999999999999999999 9999999999999999999999999998755332    2


Q ss_pred             CccCcccccCcccccCCCCCCcccchhhhHHHHHHHhCCCCCCchhhHHHhhhchhhhccccccCCCChHHHHHHHHHHH
Q 020221          211 SYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLAS  290 (329)
Q Consensus       211 ~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~  290 (329)
                      ...+++.|+|||++.+..++.++|+||||+++++|++|+.|+...............     .....+...++++.+++.
T Consensus       161 ~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~li~  235 (257)
T cd08223         161 TLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAKDMNSLVYRIIEG-----KLPPMPKDYSPELGELIA  235 (257)
T ss_pred             cccCCcCccChhHhcCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhc-----CCCCCccccCHHHHHHHH
Confidence            335678999999999888999999999999999999999887654332222111111     112234556789999999


Q ss_pred             HhcccCCCCCCCHHHHHH
Q 020221          291 RCLQYEPRERPNPRSLVT  308 (329)
Q Consensus       291 ~cl~~dp~~Rps~~~~l~  308 (329)
                      +||+.||++|||+.++++
T Consensus       236 ~~l~~~p~~Rp~~~~~l~  253 (257)
T cd08223         236 TMLSKRPEKRPSVKSILR  253 (257)
T ss_pred             HHhccCcccCCCHHHHhc
Confidence            999999999999999998

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown.

>KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms]

Probab=100.00  E-value=3.6e-44  Score=329.63  Aligned_cols=251  Identities=21%  Similarity=0.310  Sum_probs=214.9

Q ss_pred             cccccCCCCCCcEEEEEEeC----CCCEEEEEEeCCCCChh-HHHHHHHHHHHhcCCCccccccceeeeeCCeeEEEEec
Q 020221           60 NIVSEHGEKAPNVVYKGKLE----NQFRIAVKRFNRSAWPD-ARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAEY  134 (329)
Q Consensus        60 ~~~~~lg~G~~g~V~~~~~~----~~~~vavK~~~~~~~~~-~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  134 (329)
                      ++-+.||.|.||.|++|.++    ....||||.++....+. ..+|+.|..+|.+++||||++|.|+........||.||
T Consensus       632 ~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~GytekqrrdFL~EAsIMGQFdHPNIIrLEGVVTks~PvMIiTEy  711 (996)
T KOG0196|consen  632 KIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIRLEGVVTKSKPVMIITEY  711 (996)
T ss_pred             EEEEEEecccccceecccccCCCCcceeEEEeeeccCccHHHHhhhhhhhhhcccCCCCcEEEEEEEEecCceeEEEhhh
Confidence            34456799999999999853    24679999999876543 45699999999999999999999999999999999999


Q ss_pred             CCCCCHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCCCCCeeeecccCcccCCCCCCc--
Q 020221          135 MPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDGRSY--  212 (329)
Q Consensus       135 ~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~--  212 (329)
                      |++|+|+.+|++.. ..+++-++..+.+.|+.|++||-+. |+|||||..+|||++.+..+|++|||+++...++...  
T Consensus       712 MENGsLDsFLR~~D-GqftviQLVgMLrGIAsGMkYLsdm-~YVHRDLAARNILVNsnLvCKVsDFGLSRvledd~~~~y  789 (996)
T KOG0196|consen  712 MENGSLDSFLRQND-GQFTVIQLVGMLRGIASGMKYLSDM-NYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEAAY  789 (996)
T ss_pred             hhCCcHHHHHhhcC-CceEeehHHHHHHHHHHHhHHHhhc-CchhhhhhhhheeeccceEEEeccccceeecccCCCccc
Confidence            99999999998744 5599999999999999999999999 9999999999999999999999999999987665422  


Q ss_pred             ---cC--cccccCcccccCCCCCCcccchhhhHHHHHHHh-CCCCCCchhhHHHhhhchhhhccccccCCCChHHHHHHH
Q 020221          213 ---ST--NLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLS-GKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELV  286 (329)
Q Consensus       213 ---~~--~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t-g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  286 (329)
                         .|  .++|.|||.+...+++.++||||||+++||.++ |.+|+.+.....+.+     -++...+-+.|.++|..+.
T Consensus       790 tt~GGKIPiRWTAPEAIa~RKFTsASDVWSyGIVmWEVmSyGERPYWdmSNQdVIk-----aIe~gyRLPpPmDCP~aL~  864 (996)
T KOG0196|consen  790 TTLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVIK-----AIEQGYRLPPPMDCPAALY  864 (996)
T ss_pred             cccCCccceeecChhHhhhcccCchhhccccceEEEEecccCCCcccccchHHHHH-----HHHhccCCCCCCCCcHHHH
Confidence               11  378999999999999999999999999999887 667776543333332     3333455566889999999


Q ss_pred             HHHHHhcccCCCCCCCHHHHHHHHHhhhhcc
Q 020221          287 RLASRCLQYEPRERPNPRSLVTALVTLQKDT  317 (329)
Q Consensus       287 ~li~~cl~~dp~~Rps~~~~l~~L~~~~~~~  317 (329)
                      +|+..||++|-.+||.+.+|+..|+++...+
T Consensus       865 qLMldCWqkdR~~RP~F~qiV~~lDklIrnP  895 (996)
T KOG0196|consen  865 QLMLDCWQKDRNRRPKFAQIVSTLDKLIRNP  895 (996)
T ss_pred             HHHHHHHHHHhhcCCCHHHHHHHHHHHhcCc
Confidence            9999999999999999999999999997653

>cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

Probab=100.00  E-value=2.4e-42  Score=302.14  Aligned_cols=238  Identities=24%  Similarity=0.382  Sum_probs=189.7

Q ss_pred             cCCCCCCcEEEEEEeC-------------------------CCCEEEEEEeCCCCChhHHHHHHHHHHHhcCCCcccccc
Q 020221           64 EHGEKAPNVVYKGKLE-------------------------NQFRIAVKRFNRSAWPDARQFLEEARAVGQLRNRRLANL  118 (329)
Q Consensus        64 ~lg~G~~g~V~~~~~~-------------------------~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~  118 (329)
                      .||+|+||.||+|...                         ....|++|.+..........+.+|+.+++.++||||+++
T Consensus         2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~~~~l~h~niv~~   81 (274)
T cd05076           2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSHRDIALAFFETASLMSQVSHIHLAFV   81 (274)
T ss_pred             CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHHHHHHHHHHHHHHHHhcCCCCCeeeE
Confidence            5799999999999731                         124589999876554445568889999999999999999


Q ss_pred             ceeeeeCCeeEEEEecCCCCCHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCCCC-----
Q 020221          119 LGCCCEGDERLLVAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDV-----  193 (329)
Q Consensus       119 ~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~-----  193 (329)
                      ++++.+....++||||+++|+|..++.+ ....+++..+..++.|++.||+|||++ +++||||||+||+++..+     
T Consensus        82 ~~~~~~~~~~~lv~ey~~~g~L~~~l~~-~~~~~~~~~~~~i~~qi~~~l~~lH~~-~iiH~dlkp~Nill~~~~~~~~~  159 (274)
T cd05076          82 HGVCVRGSENIMVEEFVEHGPLDVCLRK-EKGRVPVAWKITVAQQLASALSYLEDK-NLVHGNVCAKNILLARLGLAEGT  159 (274)
T ss_pred             EEEEEeCCceEEEEecCCCCcHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHcC-CccCCCCCcccEEEeccCcccCc
Confidence            9999999999999999999999998864 345689999999999999999999999 999999999999997644     


Q ss_pred             --CeeeecccCcccCCCCCCccCcccccCcccccC-CCCCCcccchhhhHHHHHHH-hCCCCCCchhhHHHhhhchhhhc
Q 020221          194 --NPRLSCFGLMKNSRDGRSYSTNLAFTPPEYLRT-GRVTPESVMYSFGTLLLDLL-SGKHIPPSHALDLIRDRNIQTLT  269 (329)
Q Consensus       194 --~~kl~Dfg~a~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwslG~il~el~-tg~~~~~~~~~~~~~~~~~~~~~  269 (329)
                        .++++|||++..........++..|+|||.+.+ ..++.++||||||+++||++ +|..|+..........     ..
T Consensus       160 ~~~~kl~d~g~~~~~~~~~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~-----~~  234 (274)
T cd05076         160 SPFIKLSDPGVSFTALSREERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERTPSEKER-----FY  234 (274)
T ss_pred             cceeeecCCccccccccccccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCccccChHHHHH-----HH
Confidence              379999999876554445567788999998875 45889999999999999995 6776664332211111     11


Q ss_pred             cccccCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 020221          270 DSCLEGQFSSDEGTELVRLASRCLQYEPRERPNPRSLVTAL  310 (329)
Q Consensus       270 ~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~~~l~~L  310 (329)
                      ..  ....+...++.+.+++.+||+.+|++|||+.++++.|
T Consensus       235 ~~--~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~il~~L  273 (274)
T cd05076         235 EK--KHRLPEPSCKELATLISQCLTYEPTQRPSFRTILRDL  273 (274)
T ss_pred             Hh--ccCCCCCCChHHHHHHHHHcccChhhCcCHHHHHHhh
Confidence            11  0112233346799999999999999999999999876

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt

>cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases

Probab=100.00  E-value=6.1e-42  Score=298.94  Aligned_cols=248  Identities=22%  Similarity=0.349  Sum_probs=197.7

Q ss_pred             cccccCCCCCCcEEEEEEeC-C---CCEEEEEEeCCCCC--hhHHHHHHHHHHHhcCCCccccccceeeeeCCe------
Q 020221           60 NIVSEHGEKAPNVVYKGKLE-N---QFRIAVKRFNRSAW--PDARQFLEEARAVGQLRNRRLANLLGCCCEGDE------  127 (329)
Q Consensus        60 ~~~~~lg~G~~g~V~~~~~~-~---~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~------  127 (329)
                      .+.+.+|+|+||.||+|... +   +..||+|.++....  .....+.+|++.++.++||||+++++++.....      
T Consensus         2 ~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~   81 (273)
T cd05035           2 KLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKIPK   81 (273)
T ss_pred             ccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccCcc
Confidence            45567799999999999843 2   36799999886532  234568899999999999999999998865543      


Q ss_pred             eEEEEecCCCCCHHhhhccC----CCCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCCCCCeeeecccCc
Q 020221          128 RLLVAEYMPNDTLAKHLFHW----ETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLM  203 (329)
Q Consensus       128 ~~lv~e~~~~gsL~~~l~~~----~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a  203 (329)
                      .++++||+++++|..++...    ....+++..+..++.|++.||.|||+. +++|+||||+||++++++.+||+|||++
T Consensus        82 ~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~-~i~H~dlkp~Nil~~~~~~~kl~dfg~~  160 (273)
T cd05035          82 PMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNR-NFIHRDLAARNCMLREDMTVCVADFGLS  160 (273)
T ss_pred             cEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhC-CeeccccchheEEECCCCeEEECCccce
Confidence            78999999999999888532    224689999999999999999999999 9999999999999999999999999998


Q ss_pred             ccCCCCCC------ccCcccccCcccccCCCCCCcccchhhhHHHHHHHh-CCCCCCchhhHHHhhhchhhhccccccCC
Q 020221          204 KNSRDGRS------YSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLS-GKHIPPSHALDLIRDRNIQTLTDSCLEGQ  276 (329)
Q Consensus       204 ~~~~~~~~------~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t-g~~~~~~~~~~~~~~~~~~~~~~~~~~~~  276 (329)
                      +.......      ...+..|+|||.+.+..++.++||||||+++|||++ |..|+...........    +... ....
T Consensus       161 ~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~SlG~il~el~~~g~~p~~~~~~~~~~~~----~~~~-~~~~  235 (273)
T cd05035         161 KKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVENHEIYDY----LRHG-NRLK  235 (273)
T ss_pred             eeccccccccccccccCCccccCHhhcccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCHHHHHHH----HHcC-CCCC
Confidence            76543321      223568999999988889999999999999999999 6666544322211111    1111 1122


Q ss_pred             CChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhh
Q 020221          277 FSSDEGTELVRLASRCLQYEPRERPNPRSLVTALVTL  313 (329)
Q Consensus       277 ~~~~~~~~~~~li~~cl~~dp~~Rps~~~~l~~L~~~  313 (329)
                      .+...+.++.+++.+||+.||++|||+.++++.|+++
T Consensus       236 ~~~~~~~~~~~li~~~l~~~p~~Rp~~~e~~~~l~~~  272 (273)
T cd05035         236 QPEDCLDELYDLMYSCWRADPKDRPTFTKLREVLENI  272 (273)
T ss_pred             CCcCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence            3455678999999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu

>cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2

Probab=100.00  E-value=3.5e-42  Score=305.54  Aligned_cols=252  Identities=19%  Similarity=0.306  Sum_probs=203.0

Q ss_pred             cccccccCCCCCCcEEEEEEe--------CCCCEEEEEEeCCCC-ChhHHHHHHHHHHHhcC-CCccccccceeeeeCCe
Q 020221           58 MENIVSEHGEKAPNVVYKGKL--------ENQFRIAVKRFNRSA-WPDARQFLEEARAVGQL-RNRRLANLLGCCCEGDE  127 (329)
Q Consensus        58 ~~~~~~~lg~G~~g~V~~~~~--------~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~  127 (329)
                      .+.+.+.||+|+||.||++..        .++..||+|.+.... ....+.+.+|+.+++.+ +||||+++++++.....
T Consensus        16 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~   95 (304)
T cd05101          16 KLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGP   95 (304)
T ss_pred             HeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccccchHHHHHHHHHHHHHHhhccCCCchheeEEEecCCc
Confidence            355667789999999999973        124579999987543 23356788999999999 89999999999999999


Q ss_pred             eEEEEecCCCCCHHhhhccCC--------------CCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCCCC
Q 020221          128 RLLVAEYMPNDTLAKHLFHWE--------------TQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDV  193 (329)
Q Consensus       128 ~~lv~e~~~~gsL~~~l~~~~--------------~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~  193 (329)
                      .+++|||+++++|.+++.+..              ...+++.++..++.|++.||.|||++ |++|+||||+||++++++
T Consensus        96 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~-givH~dlkp~Nili~~~~  174 (304)
T cd05101          96 LYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQ-KCIHRDLAARNVLVTENN  174 (304)
T ss_pred             eEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHC-CeeecccccceEEEcCCC
Confidence            999999999999999986531              23578889999999999999999999 999999999999999999


Q ss_pred             CeeeecccCcccCCCCC------CccCcccccCcccccCCCCCCcccchhhhHHHHHHHh-CCCCCCchhhHHHhhhchh
Q 020221          194 NPRLSCFGLMKNSRDGR------SYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLS-GKHIPPSHALDLIRDRNIQ  266 (329)
Q Consensus       194 ~~kl~Dfg~a~~~~~~~------~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t-g~~~~~~~~~~~~~~~~~~  266 (329)
                      .++|+|||++.......      ...++..|+|||++.+..++.++||||||+++|+|++ |..|+..............
T Consensus       175 ~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~  254 (304)
T cd05101         175 VMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFKLLKE  254 (304)
T ss_pred             cEEECCCccceecccccccccccCCCCCceeeCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHc
Confidence            99999999987654322      1234567999999988889999999999999999998 6666654333322221111


Q ss_pred             hhccccccCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhh
Q 020221          267 TLTDSCLEGQFSSDEGTELVRLASRCLQYEPRERPNPRSLVTALVTLQK  315 (329)
Q Consensus       267 ~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~~~l~~L~~~~~  315 (329)
                           ......+...+.++.+++.+||..+|++|||+.++++.|+++..
T Consensus       255 -----~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~l~~l~~~~~  298 (304)
T cd05101         255 -----GHRMDKPANCTNELYMMMRDCWHAIPSHRPTFKQLVEDLDRILT  298 (304)
T ss_pred             -----CCcCCCCCCCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHHHH
Confidence                 11112344567889999999999999999999999999999865

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1

Probab=100.00  E-value=3.9e-42  Score=302.25  Aligned_cols=253  Identities=18%  Similarity=0.314  Sum_probs=199.5

Q ss_pred             ccccccCCCCCCcEEEEEEe-----CCCCEEEEEEeCCCC-ChhHHHHHHHHHHHhcCCCccccccceeeeeC--CeeEE
Q 020221           59 ENIVSEHGEKAPNVVYKGKL-----ENQFRIAVKRFNRSA-WPDARQFLEEARAVGQLRNRRLANLLGCCCEG--DERLL  130 (329)
Q Consensus        59 ~~~~~~lg~G~~g~V~~~~~-----~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~--~~~~l  130 (329)
                      +.+++.||+|+||.||++..     .++..||+|.+.... ......+.+|+++++.++|||++++.+++...  ...++
T Consensus         6 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~l   85 (284)
T cd05079           6 LKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGIKL   85 (284)
T ss_pred             hhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccccHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCCceEE
Confidence            46778889999999999973     357889999987553 22345688999999999999999999988765  56899


Q ss_pred             EEecCCCCCHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCCCCCeeeecccCcccCCCCC
Q 020221          131 VAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDGR  210 (329)
Q Consensus       131 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~  210 (329)
                      +|||+++++|.+++.+ ....+++..+..++.|++.||+|||++ |++|+||||+||++++++.++|+|||++.......
T Consensus        86 v~e~~~g~~L~~~l~~-~~~~~~~~~~~~i~~~i~~aL~~lH~~-gi~H~dlkp~Nil~~~~~~~~l~dfg~~~~~~~~~  163 (284)
T cd05079          86 IMEFLPSGSLKEYLPR-NKNKINLKQQLKYAVQICKGMDYLGSR-QYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDK  163 (284)
T ss_pred             EEEccCCCCHHHHHHh-ccCCCCHHHHHHHHHHHHHHHHHHHHC-CeeecccchheEEEcCCCCEEECCCccccccccCc
Confidence            9999999999999854 234689999999999999999999999 99999999999999999999999999987654322


Q ss_pred             -------CccCcccccCcccccCCCCCCcccchhhhHHHHHHHhCCCCCCchhhHHHh-------h---hchhhhccccc
Q 020221          211 -------SYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIR-------D---RNIQTLTDSCL  273 (329)
Q Consensus       211 -------~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~~-------~---~~~~~~~~~~~  273 (329)
                             ...++..|+|||++.+..++.++||||||+++|+|+++..|..........       .   ...........
T Consensus       164 ~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~ellt~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  243 (284)
T cd05079         164 EYYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLTYCDSESSPMTLFLKMIGPTHGQMTVTRLVRVLEEGK  243 (284)
T ss_pred             cceeecCCCCCCccccCHHHhccCCCCccccchhhhhhhhhhhcCCCCCccccchhhhhcccccccccHHHHHHHHHcCc
Confidence                   234566799999998888999999999999999999987543221100000       0   00000011111


Q ss_pred             cCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhh
Q 020221          274 EGQFSSDEGTELVRLASRCLQYEPRERPNPRSLVTALVTL  313 (329)
Q Consensus       274 ~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~~~l~~L~~~  313 (329)
                      ....+..++..+.+|+.+||+.||++|||+.++++.|+.+
T Consensus       244 ~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~~~  283 (284)
T cd05079         244 RLPRPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIEGFEAI  283 (284)
T ss_pred             cCCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHHhh
Confidence            1122345678999999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a

>cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=3.5e-42  Score=302.77  Aligned_cols=249  Identities=17%  Similarity=0.258  Sum_probs=201.2

Q ss_pred             cccccccCCCCCCcEEEEEEe-CCCCEEEEEEeCCCC-ChhHHHHHHHHHHHhcCCCccccccceeeeeCCeeEEEEecC
Q 020221           58 MENIVSEHGEKAPNVVYKGKL-ENQFRIAVKRFNRSA-WPDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAEYM  135 (329)
Q Consensus        58 ~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~  135 (329)
                      ++++++.||+|+||.||++.. .+++.||+|.+.... ......+.+|+++++.++|+||+++++.+...+..++|+||+
T Consensus         2 ~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~   81 (286)
T cd06622           2 EIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGAFFIEGAVYMCMEYM   81 (286)
T ss_pred             hhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeecccCHHHHHHHHHHHHHHHhcCCCcHHhhhhheecCCeEEEEEeec
Confidence            467888899999999999995 478899999887543 223457889999999999999999999999999999999999


Q ss_pred             CCCCHHhhhccCC-CCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCCCCCeeeecccCcccCCCC--CCc
Q 020221          136 PNDTLAKHLFHWE-TQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDG--RSY  212 (329)
Q Consensus       136 ~~gsL~~~l~~~~-~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~--~~~  212 (329)
                      ++++|..++.... ...+++..+..++.|++.||.|||+..+++|+||||+||+++.++.++|+|||++......  ...
T Consensus        82 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~  161 (286)
T cd06622          82 DAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEHNIIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVASLAKTN  161 (286)
T ss_pred             CCCCHHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCEeeCCCCHHHEEECCCCCEEEeecCCcccccCCccccC
Confidence            9999998885421 2378999999999999999999997439999999999999999999999999998764332  233


Q ss_pred             cCcccccCcccccCCC------CCCcccchhhhHHHHHHHhCCCCCCchhhHHHhhhchhhhccccccCCCChHHHHHHH
Q 020221          213 STNLAFTPPEYLRTGR------VTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELV  286 (329)
Q Consensus       213 ~~~~~y~aPE~~~~~~------~~~~~DvwslG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  286 (329)
                      .++..|+|||.+.+..      ++.++|+||||+++|+|++|..||........... ....... .....+..++.++.
T Consensus       162 ~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~-~~~~~~~-~~~~~~~~~~~~~~  239 (286)
T cd06622         162 IGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYANIFAQ-LSAIVDG-DPPTLPSGYSDDAQ  239 (286)
T ss_pred             CCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcchhhHHHH-HHHHhhc-CCCCCCcccCHHHH
Confidence            5678899999986443      57899999999999999999998865432222111 1111111 12234556788999


Q ss_pred             HHHHHhcccCCCCCCCHHHHHH
Q 020221          287 RLASRCLQYEPRERPNPRSLVT  308 (329)
Q Consensus       287 ~li~~cl~~dp~~Rps~~~~l~  308 (329)
                      +++.+||..+|++||++.++++
T Consensus       240 ~li~~~l~~~p~~Rp~~~~l~~  261 (286)
T cd06622         240 DFVAKCLNKIPNRRPTYAQLLE  261 (286)
T ss_pred             HHHHHHcccCcccCCCHHHHhc
Confidence            9999999999999999999997

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1

Probab=100.00  E-value=2.5e-42  Score=314.01  Aligned_cols=246  Identities=15%  Similarity=0.202  Sum_probs=193.4

Q ss_pred             CcccccccCCCCCCcEEEEEE-eCCCCEEEEEEeCCCC--ChhHHHHHHHHHHHhcCCCccccccceeeeeC------Ce
Q 020221           57 AMENIVSEHGEKAPNVVYKGK-LENQFRIAVKRFNRSA--WPDARQFLEEARAVGQLRNRRLANLLGCCCEG------DE  127 (329)
Q Consensus        57 ~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~------~~  127 (329)
                      ..|.+++.||+|+||.||++. ...++.||||++....  ......+.+|+.+++.++||||+++++++...      ..
T Consensus        24 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~~~~  103 (364)
T cd07875          24 KRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQD  103 (364)
T ss_pred             cceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccccCchhHHHHHHHHHHHHhcCCCCccccceeecccccccccCe
Confidence            457777888999999999998 4568889999997542  23345678899999999999999999987543      35


Q ss_pred             eEEEEecCCCCCHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCCCCCeeeecccCcccCC
Q 020221          128 RLLVAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSR  207 (329)
Q Consensus       128 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~  207 (329)
                      .++||||+++ +|...+.    ..+++..+..++.|++.||.|||++ |++||||||+||+++.++.+||+|||++....
T Consensus       104 ~~lv~e~~~~-~l~~~~~----~~~~~~~~~~~~~qi~~aL~~LH~~-~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~  177 (364)
T cd07875         104 VYIVMELMDA-NLCQVIQ----MELDHERMSYLLYQMLCGIKHLHSA-GIIHRDLKPSNIVVKSDCTLKILDFGLARTAG  177 (364)
T ss_pred             EEEEEeCCCC-CHHHHHH----hcCCHHHHHHHHHHHHHHHHHHhhC-CeecCCCCHHHEEECCCCcEEEEeCCCccccC
Confidence            7999999976 6777763    3478899999999999999999999 99999999999999999999999999997654


Q ss_pred             CC---CCccCcccccCcccccCCCCCCcccchhhhHHHHHHHhCCCCCCchhhHHHhhhchhhhc---------------
Q 020221          208 DG---RSYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLT---------------  269 (329)
Q Consensus       208 ~~---~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~~~~~~~~~~---------------  269 (329)
                      ..   ....++..|+|||++.+..++.++||||||+++|+|++|+.||.................               
T Consensus       178 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  257 (364)
T cd07875         178 TSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQPTVR  257 (364)
T ss_pred             CCCcccCCcccCCcCCHHHHhCCCCCchhhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHhhhHHHH
Confidence            43   234678999999999998999999999999999999999988865322111111000000               


Q ss_pred             ---ccc-----------c-------cCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 020221          270 ---DSC-----------L-------EGQFSSDEGTELVRLASRCLQYEPRERPNPRSLVT  308 (329)
Q Consensus       270 ---~~~-----------~-------~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~~~l~  308 (329)
                         ...           .       ........+.++.+++.+||..||++|||+.++++
T Consensus       258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~R~t~~e~L~  317 (364)
T cd07875         258 TYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQ  317 (364)
T ss_pred             HHHhhCCCcCCCChHhhCccccccccccccccccHHHHHHHHHhcCcCcccCCCHHHHhc
Confidence               000           0       00011123467899999999999999999999998

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn

>cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases

Probab=100.00  E-value=6.6e-42  Score=296.42  Aligned_cols=242  Identities=29%  Similarity=0.415  Sum_probs=201.8

Q ss_pred             cCCCCCCcEEEEEEeC-C---CCEEEEEEeCCCCChh-HHHHHHHHHHHhcCCCccccccceeeeeCCeeEEEEecCCCC
Q 020221           64 EHGEKAPNVVYKGKLE-N---QFRIAVKRFNRSAWPD-ARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAEYMPND  138 (329)
Q Consensus        64 ~lg~G~~g~V~~~~~~-~---~~~vavK~~~~~~~~~-~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g  138 (329)
                      .||+|+||.||++... .   +..+++|.+....... .+.+.+|++.++.++|+|++++++++......+++|||++++
T Consensus         2 ~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~   81 (262)
T cd00192           2 KLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLVLEYMEGG   81 (262)
T ss_pred             ccccCCceEEEEEEEecCCCCCceEEeEeeccccchhHHHHHHHHHHHHhhcCCCChheeeeeecCCCceEEEEEeccCC
Confidence            4699999999999954 3   7889999998765443 567899999999999999999999999989999999999999


Q ss_pred             CHHhhhccCC-------CCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCCCCCeeeecccCcccCCCC--
Q 020221          139 TLAKHLFHWE-------TQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDG--  209 (329)
Q Consensus       139 sL~~~l~~~~-------~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~--  209 (329)
                      +|.+++....       ...+++..+..++.|++.||+|||++ +++|+||+|+||++++++.++|+|||.+......  
T Consensus        82 ~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~-~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~~~~  160 (262)
T cd00192          82 DLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASK-KFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDDDY  160 (262)
T ss_pred             cHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcC-CcccCccCcceEEECCCCcEEEcccccccccccccc
Confidence            9999997531       36789999999999999999999999 9999999999999999999999999999876543  


Q ss_pred             ----CCccCcccccCcccccCCCCCCcccchhhhHHHHHHHhC-CCCCCchhhHHHhhhchhhhccccccCCCChHHHHH
Q 020221          210 ----RSYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSG-KHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTE  284 (329)
Q Consensus       210 ----~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  284 (329)
                          ....++..|+|||.+.+..++.++||||||+++++|+++ ..|+..............     ......+...+.+
T Consensus       161 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~-----~~~~~~~~~~~~~  235 (262)
T cd00192         161 YRKKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSNEEVLEYLRK-----GYRLPKPEYCPDE  235 (262)
T ss_pred             cccccCCCcCccccCHHHhccCCcchhhccHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHc-----CCCCCCCccCChH
Confidence                233467889999999888899999999999999999994 766654422222211111     1222344556889


Q ss_pred             HHHHHHHhcccCCCCCCCHHHHHHHHH
Q 020221          285 LVRLASRCLQYEPRERPNPRSLVTALV  311 (329)
Q Consensus       285 ~~~li~~cl~~dp~~Rps~~~~l~~L~  311 (329)
                      +.+++.+||..||++|||+.++++.|+
T Consensus       236 ~~~li~~~l~~~p~~Rps~~~l~~~l~  262 (262)
T cd00192         236 LYELMLSCWQLDPEDRPTFSELVERLE  262 (262)
T ss_pred             HHHHHHHHccCCcccCcCHHHHHHhhC
Confidence            999999999999999999999998873

Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan

>cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer

Probab=100.00  E-value=7.3e-42  Score=294.80  Aligned_cols=241  Identities=25%  Similarity=0.397  Sum_probs=198.6

Q ss_pred             cCCCCCCcEEEEEEeCCCCEEEEEEeCCCCChh-HHHHHHHHHHHhcCCCccccccceeeeeCCeeEEEEecCCCCCHHh
Q 020221           64 EHGEKAPNVVYKGKLENQFRIAVKRFNRSAWPD-ARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAEYMPNDTLAK  142 (329)
Q Consensus        64 ~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~-~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~  142 (329)
                      .||+|+||.||+|...++..+|+|.+....... ...+.+|+++++.++||||+++++++...+..++||||+++++|.+
T Consensus         2 ~ig~g~~g~vy~~~~~~~~~~a~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~   81 (250)
T cd05085           2 LLGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIVMELVPGGDFLS   81 (250)
T ss_pred             ccCCCCCceEEEEEecCCcEEEEEecCCcCCHHHHHHHHHHHHHHHhCCCCCcCeEEEEEecCCccEEEEECCCCCcHHH
Confidence            469999999999997788899999987664332 3468899999999999999999999999999999999999999999


Q ss_pred             hhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCCCCCeeeecccCcccCCCCC-----CccCccc
Q 020221          143 HLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDGR-----SYSTNLA  217 (329)
Q Consensus       143 ~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~-----~~~~~~~  217 (329)
                      ++.. ....+++..+..++.|++.+|.|+|+. +++|+||||+||+++.++.++|+|||++.......     ...++..
T Consensus        82 ~~~~-~~~~~~~~~~~~~~~~i~~~l~~lH~~-~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~  159 (250)
T cd05085          82 FLRK-KKDELKTKQLVKFALDAAAGMAYLESK-NCIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIYSSSGLKQIPIK  159 (250)
T ss_pred             HHHh-cCCCCCHHHHHHHHHHHHHHHHHHHhC-CeeecccChheEEEcCCCeEEECCCccceeccccccccCCCCCCccc
Confidence            8864 334678999999999999999999999 99999999999999999999999999986543321     1233567


Q ss_pred             ccCcccccCCCCCCcccchhhhHHHHHHHh-CCCCCCchhhHHHhhhchhhhccccccCCCChHHHHHHHHHHHHhcccC
Q 020221          218 FTPPEYLRTGRVTPESVMYSFGTLLLDLLS-GKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLASRCLQYE  296 (329)
Q Consensus       218 y~aPE~~~~~~~~~~~DvwslG~il~el~t-g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~d  296 (329)
                      |+|||++.+..++.++||||||+++|++++ |..||.............     .......+...+..+.+++.+||+.+
T Consensus       160 y~aPE~~~~~~~~~~~Di~slG~ll~~~~~~g~~p~~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~li~~~l~~~  234 (250)
T cd05085         160 WTAPEALNYGRYSSESDVWSYGILLWETFSLGVCPYPGMTNQQAREQVE-----KGYRMSCPQKCPDDVYKVMQRCWDYK  234 (250)
T ss_pred             ccCHHHhccCCCCchhHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHH-----cCCCCCCCCCCCHHHHHHHHHHcccC
Confidence            999999998889999999999999999998 777775443322221111     11122334456788999999999999


Q ss_pred             CCCCCCHHHHHHHHH
Q 020221          297 PRERPNPRSLVTALV  311 (329)
Q Consensus       297 p~~Rps~~~~l~~L~  311 (329)
                      |++||++.++++.|.
T Consensus       235 p~~Rp~~~~l~~~l~  249 (250)
T cd05085         235 PENRPKFSELQKELA  249 (250)
T ss_pred             cccCCCHHHHHHHhc
Confidence            999999999998874

Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c

>cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7

Probab=100.00  E-value=7.6e-42  Score=297.36  Aligned_cols=253  Identities=19%  Similarity=0.235  Sum_probs=205.4

Q ss_pred             cccccccCCCCCCcEEEEEEeC-CCCEEEEEEeCCCC---ChhHHHHHHHHHHHhcCCCccccccceeeeeCCeeEEEEe
Q 020221           58 MENIVSEHGEKAPNVVYKGKLE-NQFRIAVKRFNRSA---WPDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAE  133 (329)
Q Consensus        58 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  133 (329)
                      .|++.+.||+|+||.||+|... +++.||+|.++...   ....+.+.+|+++++.++|+|++++++++...+..+++||
T Consensus         3 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~~~~~lv~e   82 (267)
T cd08224           3 NFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIENNELNIVLE   82 (267)
T ss_pred             ceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEEe
Confidence            4566777899999999999954 78899999886432   2224568899999999999999999999999999999999


Q ss_pred             cCCCCCHHhhhccC--CCCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCCCCCeeeecccCcccCCCC--
Q 020221          134 YMPNDTLAKHLFHW--ETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDG--  209 (329)
Q Consensus       134 ~~~~gsL~~~l~~~--~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~--  209 (329)
                      |+++++|.+++.+.  ....+++.++..++.+++.||.|||+. |++|+||+|+||+++.++.++|+|||++......  
T Consensus        83 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~-~i~h~dl~p~nil~~~~~~~~l~d~~~~~~~~~~~~  161 (267)
T cd08224          83 LADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSK-RIMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTT  161 (267)
T ss_pred             cCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHhC-CEecCCcChhhEEECCCCcEEEeccceeeeccCCCc
Confidence            99999999988642  235589999999999999999999999 9999999999999999999999999998754332  


Q ss_pred             --CCccCcccccCcccccCCCCCCcccchhhhHHHHHHHhCCCCCCchhhHHHhhhchhhhccccccCCCCh-HHHHHHH
Q 020221          210 --RSYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSS-DEGTELV  286 (329)
Q Consensus       210 --~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~  286 (329)
                        ....++..|+|||.+.+..++.++|+||||+++|+|++|..|+..........   ............+. ..+..+.
T Consensus       162 ~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~  238 (267)
T cd08224         162 AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSL---CKKIEKCDYPPLPADHYSEELR  238 (267)
T ss_pred             ccceecCCccccCHHHhccCCCCchhcHHHHHHHHHHHHHCCCCcccCCccHHHH---HhhhhcCCCCCCChhhcCHHHH
Confidence              22356788999999998889999999999999999999998875432211100   00011111112222 5667899


Q ss_pred             HHHHHhcccCCCCCCCHHHHHHHHHhhh
Q 020221          287 RLASRCLQYEPRERPNPRSLVTALVTLQ  314 (329)
Q Consensus       287 ~li~~cl~~dp~~Rps~~~~l~~L~~~~  314 (329)
                      +++.+||..+|++|||+.++++.|+++.
T Consensus       239 ~~i~~cl~~~p~~Rp~~~~il~~~~~~~  266 (267)
T cd08224         239 DLVSRCINPDPEKRPDISYVLQVAKEMH  266 (267)
T ss_pred             HHHHHHcCCCcccCCCHHHHHHHHHHhc
Confidence            9999999999999999999999999874

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a

>cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors

Probab=100.00  E-value=4.2e-42  Score=304.72  Aligned_cols=250  Identities=20%  Similarity=0.315  Sum_probs=201.2

Q ss_pred             ccccccCCCCCCcEEEEEEe------CCCCEEEEEEeCCCCC-hhHHHHHHHHHHHhcC-CCccccccceeeeeCCeeEE
Q 020221           59 ENIVSEHGEKAPNVVYKGKL------ENQFRIAVKRFNRSAW-PDARQFLEEARAVGQL-RNRRLANLLGCCCEGDERLL  130 (329)
Q Consensus        59 ~~~~~~lg~G~~g~V~~~~~------~~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~l  130 (329)
                      +.+.+.||+|+||.||++..      ..+..||+|.+..... ...+.+.+|+.+++.+ +|+||+++++++...+..++
T Consensus        37 ~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~l  116 (302)
T cd05055          37 LSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIVNLLGACTIGGPILV  116 (302)
T ss_pred             eEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccCChHHHHHHHHHHHHHHhccCCCCcceEEEEEecCCceEE
Confidence            45666779999999999973      1345799999876532 2345688999999999 79999999999999999999


Q ss_pred             EEecCCCCCHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCCCCCeeeecccCcccCCCCC
Q 020221          131 VAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDGR  210 (329)
Q Consensus       131 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~  210 (329)
                      +|||+.+|+|.+++.......+++.++..++.|++.||.|||++ +++|+||||+||+++.++.++++|||++.......
T Consensus       117 v~e~~~~~~L~~~i~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~-~ivH~dlkp~Nil~~~~~~~~l~dfg~~~~~~~~~  195 (302)
T cd05055         117 ITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAFLASK-NCIHRDLAARNVLLTHGKIVKICDFGLARDIMNDS  195 (302)
T ss_pred             EEEcCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHC-CeehhhhccceEEEcCCCeEEECCCcccccccCCC
Confidence            99999999999999653444589999999999999999999999 99999999999999999999999999987554322


Q ss_pred             ------CccCcccccCcccccCCCCCCcccchhhhHHHHHHHh-CCCCCCchhhHHHhhhchhhhccccccCCCChHHHH
Q 020221          211 ------SYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLS-GKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGT  283 (329)
Q Consensus       211 ------~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t-g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  283 (329)
                            ...++..|+|||.+.+..++.++||||||+++|+|++ |..|+...........    ..........+...++
T Consensus       196 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~t~g~~p~~~~~~~~~~~~----~~~~~~~~~~~~~~~~  271 (302)
T cd05055         196 NYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGMPVDSKFYK----LIKEGYRMAQPEHAPA  271 (302)
T ss_pred             ceeecCCCCcccccCCHhhhccCCCCcHhHHHHHHHHHHHHHhCCCCCcCCCCchHHHHH----HHHcCCcCCCCCCCCH
Confidence                  1234578999999998889999999999999999998 8877654322211111    1111111122334567


Q ss_pred             HHHHHHHHhcccCCCCCCCHHHHHHHHHhh
Q 020221          284 ELVRLASRCLQYEPRERPNPRSLVTALVTL  313 (329)
Q Consensus       284 ~~~~li~~cl~~dp~~Rps~~~~l~~L~~~  313 (329)
                      ++.+++.+||..+|++|||+.++++.|+++
T Consensus       272 ~~~~li~~cl~~~p~~Rpt~~ell~~l~~~  301 (302)
T cd05055         272 EIYDIMKTCWDADPLKRPTFKQIVQLIGKQ  301 (302)
T ss_pred             HHHHHHHHHcCCCchhCcCHHHHHHHHHhh
Confidence            899999999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept

>cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase

Probab=100.00  E-value=6.1e-42  Score=297.84  Aligned_cols=250  Identities=21%  Similarity=0.289  Sum_probs=201.5

Q ss_pred             cccccccCCCCCCcEEEEEE-eCCCCEEEEEEeCCCCC-hhHHHHHHHHHHHhcCCCccccccceeeeeCCeeEEEEecC
Q 020221           58 MENIVSEHGEKAPNVVYKGK-LENQFRIAVKRFNRSAW-PDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAEYM  135 (329)
Q Consensus        58 ~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~  135 (329)
                      .|++.+.+|.|+||+||+|. ..++..+++|++..... ...+.+.+|++.++.++|+|++++++.+..+...++++|++
T Consensus         2 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~~   81 (267)
T cd06610           2 DYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTSFVVGDELWLVMPYL   81 (267)
T ss_pred             cceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcchHHHHHHHHHHHHHhcCCCCEEEEEEEEeeCCEEEEEEecc
Confidence            35677778999999999999 45688999999876432 24567899999999999999999999999999999999999


Q ss_pred             CCCCHHhhhccCCC-CCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCCCCCeeeecccCcccCCCCC----
Q 020221          136 PNDTLAKHLFHWET-QPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDGR----  210 (329)
Q Consensus       136 ~~gsL~~~l~~~~~-~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~----  210 (329)
                      ++++|.+++..... ..+++..+..++.|++.||+|||+. |++|+||+|+||++++++.++|+|||++.......    
T Consensus        82 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lh~~-~i~h~~l~p~ni~~~~~~~~~l~df~~~~~~~~~~~~~~  160 (267)
T cd06610          82 SGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSN-GQIHRDIKAGNILLGEDGSVKIADFGVSASLADGGDRTR  160 (267)
T ss_pred             CCCcHHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhC-CeecCCCCHHhEEEcCCCCEEEcccchHHHhccCccccc
Confidence            99999999965322 5689999999999999999999999 99999999999999999999999999986554432    


Q ss_pred             ----CccCcccccCcccccCC-CCCCcccchhhhHHHHHHHhCCCCCCchhhHHHhhhchhhhccccccCCCChHHHHHH
Q 020221          211 ----SYSTNLAFTPPEYLRTG-RVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTEL  285 (329)
Q Consensus       211 ----~~~~~~~y~aPE~~~~~-~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  285 (329)
                          ...++..|+|||.+... .++.++|+||||+++|+|++|..|+.............................++++
T Consensus       161 ~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (267)
T cd06610         161 KVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPMKVLMLTLQNDPPSLETGADYKKYSKSF  240 (267)
T ss_pred             cccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccChhhhHHHHhcCCCCCcCCccccccccHHH
Confidence                22467889999998877 6889999999999999999999887543222111111111111110111113567889


Q ss_pred             HHHHHHhcccCCCCCCCHHHHHH
Q 020221          286 VRLASRCLQYEPRERPNPRSLVT  308 (329)
Q Consensus       286 ~~li~~cl~~dp~~Rps~~~~l~  308 (329)
                      .+++.+||..||++||++.+++.
T Consensus       241 ~~li~~~l~~~p~~Rp~~~~ll~  263 (267)
T cd06610         241 RKMISLCLQKDPSKRPTAEELLK  263 (267)
T ss_pred             HHHHHHHcCCChhhCcCHHHHhh
Confidence            99999999999999999999998

Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1

>cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.1e-41  Score=295.54  Aligned_cols=248  Identities=15%  Similarity=0.163  Sum_probs=202.8

Q ss_pred             cccccccCCCCCCcEEEEEEe-CCCCEEEEEEeCCCCChhHHHHHHHHHHHhcCCCccccccceeeeeCCeeEEEEecCC
Q 020221           58 MENIVSEHGEKAPNVVYKGKL-ENQFRIAVKRFNRSAWPDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAEYMP  136 (329)
Q Consensus        58 ~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~  136 (329)
                      .+++.+.+|.|+||.||++.. .+++.+++|.+........+.+.+|+++++.++||||+++++++......+++|||+.
T Consensus         4 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~l~~e~~~   83 (262)
T cd06613           4 DYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGSYLRRDKLWIVMEYCG   83 (262)
T ss_pred             ceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCchhhHHHHHHHHHHHHhCCCCChhceEEEEEeCCEEEEEEeCCC
Confidence            456777789999999999984 5678899999987665566789999999999999999999999999999999999999


Q ss_pred             CCCHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCCCCCeeeecccCcccCCCC----CCc
Q 020221          137 NDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDG----RSY  212 (329)
Q Consensus       137 ~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~----~~~  212 (329)
                      +++|.+++.. ....+++..+..++.|++.||.|||+. +++|+||+|+||+++.++.++|+|||++......    ...
T Consensus        84 ~~~l~~~~~~-~~~~l~~~~~~~~~~ql~~~l~~lh~~-~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~~~~~~  161 (262)
T cd06613          84 GGSLQDIYQV-TRGPLSELQIAYVCRETLKGLAYLHET-GKIHRDIKGANILLTEDGDVKLADFGVSAQLTATIAKRKSF  161 (262)
T ss_pred             CCcHHHHHHh-hccCCCHHHHHHHHHHHHHHHHHHHhC-CceecCCChhhEEECCCCCEEECccccchhhhhhhhccccc
Confidence            9999998864 335789999999999999999999999 9999999999999999999999999998765432    233


Q ss_pred             cCcccccCcccccCC---CCCCcccchhhhHHHHHHHhCCCCCCchhhHHHhhhchhhhccccccCCCChHHHHHHHHHH
Q 020221          213 STNLAFTPPEYLRTG---RVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLA  289 (329)
Q Consensus       213 ~~~~~y~aPE~~~~~---~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li  289 (329)
                      .++..|+|||.+.+.   .++.++|+||||+++|+|++|..|+................... .....+...+.++.+++
T Consensus       162 ~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~li  240 (262)
T cd06613         162 IGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPMRALFLISKSNFPP-PKLKDKEKWSPVFHDFI  240 (262)
T ss_pred             cCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCC-ccccchhhhhHHHHHHH
Confidence            567889999998876   78899999999999999999998875432111111111110011 01112345678899999


Q ss_pred             HHhcccCCCCCCCHHHHHH
Q 020221          290 SRCLQYEPRERPNPRSLVT  308 (329)
Q Consensus       290 ~~cl~~dp~~Rps~~~~l~  308 (329)
                      .+||..||++|||+.+++.
T Consensus       241 ~~~l~~~p~~Rpt~~~il~  259 (262)
T cd06613         241 KKCLTKDPKKRPTATKLLQ  259 (262)
T ss_pred             HHHcCCChhhCCCHHHHhc
Confidence            9999999999999999987

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ

>cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2

Probab=100.00  E-value=5e-42  Score=296.64  Aligned_cols=244  Identities=16%  Similarity=0.205  Sum_probs=200.8

Q ss_pred             cccccccCCCCCCcEEEEEEeC-CCCEEEEEEeCCCCChhHHHHHHHHHHHhcCCCccccccceeeeeCCeeEEEEecCC
Q 020221           58 MENIVSEHGEKAPNVVYKGKLE-NQFRIAVKRFNRSAWPDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAEYMP  136 (329)
Q Consensus        58 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~  136 (329)
                      .|++.+.+|.|+||.||++... +++.+++|.+.....  .+.+.+|+++++.++|+||+++++.+......++++||++
T Consensus         4 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~--~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~   81 (256)
T cd06612           4 VFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEED--LQEIIKEISILKQCDSPYIVKYYGSYFKNTDLWIVMEYCG   81 (256)
T ss_pred             cchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHHH--HHHHHHHHHHHHhCCCCcEeeeeeeeecCCcEEEEEecCC
Confidence            3556677799999999999954 478999999876532  6679999999999999999999999999999999999999


Q ss_pred             CCCHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCCCCCeeeecccCcccCCCCC----Cc
Q 020221          137 NDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDGR----SY  212 (329)
Q Consensus       137 ~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~----~~  212 (329)
                      +++|.+++.. ....+++..+..++.|++.||.|||+. +++|+||+|+||++++++.++|+|||++.......    ..
T Consensus        82 ~~~L~~~l~~-~~~~l~~~~~~~~~~~l~~~l~~lh~~-~i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~~~~~~~~~~~  159 (256)
T cd06612          82 AGSVSDIMKI-TNKTLTEEEIAAILYQTLKGLEYLHSN-KKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMAKRNTV  159 (256)
T ss_pred             CCcHHHHHHh-CccCCCHHHHHHHHHHHHHHHHHHHHC-CcccCCCCcceEEECCCCcEEEcccccchhcccCccccccc
Confidence            9999999854 346789999999999999999999999 99999999999999999999999999987654432    23


Q ss_pred             cCcccccCcccccCCCCCCcccchhhhHHHHHHHhCCCCCCchhhHHHhhhchhhhccccccCCCChHHHHHHHHHHHHh
Q 020221          213 STNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLASRC  292 (329)
Q Consensus       213 ~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~c  292 (329)
                      .++..|+|||.+.+..++.++||||||+++|+|++|..|+..............   ........+...+.++.+++.+|
T Consensus       160 ~~~~~y~~PE~~~~~~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~i~~~  236 (256)
T cd06612         160 IGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSDIHPMRAIFMIPN---KPPPTLSDPEKWSPEFNDFVKKC  236 (256)
T ss_pred             cCCccccCHHHHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCcchhhhhhhhcc---CCCCCCCchhhcCHHHHHHHHHH
Confidence            467899999999988899999999999999999999988754321111100000   00001112334567899999999


Q ss_pred             cccCCCCCCCHHHHHH
Q 020221          293 LQYEPRERPNPRSLVT  308 (329)
Q Consensus       293 l~~dp~~Rps~~~~l~  308 (329)
                      |+.||++|||+.++++
T Consensus       237 l~~~P~~Rps~~~il~  252 (256)
T cd06612         237 LVKDPEERPSAIQLLQ  252 (256)
T ss_pred             HhcChhhCcCHHHHhc
Confidence            9999999999999998

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a

>PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity

Probab=100.00  E-value=4.2e-43  Score=304.00  Aligned_cols=247  Identities=25%  Similarity=0.364  Sum_probs=199.0

Q ss_pred             ccccccCCCCCCcEEEEEE-eCCCCEEEEEEeCCCCChhHH--HHHHHHHHHhcCCCccccccceeeeeCCeeEEEEecC
Q 020221           59 ENIVSEHGEKAPNVVYKGK-LENQFRIAVKRFNRSAWPDAR--QFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAEYM  135 (329)
Q Consensus        59 ~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~--~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~  135 (329)
                      |++++.||+|+||+||++. ..+++.+|+|.+.........  ...+|+.+++.++||||+++++++......+++|||+
T Consensus         1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~v~~~~   80 (260)
T PF00069_consen    1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEEREENIREIKILRRLRHPNIVQILDVFQDDNYLYIVMEYC   80 (260)
T ss_dssp             EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHHHHHHHHHHHHHHHHHTBTTBCHEEEEEEESSEEEEEEEEE
T ss_pred             CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccccccccchhhhhhhcccccccccccccccccccccccccccccc
Confidence            5677888999999999999 455678999999887644332  2456999999999999999999999999999999999


Q ss_pred             CCCCHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCCCCCeeeecccCcccC----CCCCC
Q 020221          136 PNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNS----RDGRS  211 (329)
Q Consensus       136 ~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~----~~~~~  211 (329)
                      .+++|.+++.  ....+++..+..++.|++.||.+||+. +++|+||||+||++++++.++|+|||.+...    .....
T Consensus        81 ~~~~L~~~l~--~~~~~~~~~~~~~~~qi~~~L~~Lh~~-~i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~~~~~~~~~~  157 (260)
T PF00069_consen   81 PGGSLQDYLQ--KNKPLSEEEILKIAYQILEALAYLHSK-GIVHRDIKPENILLDENGEVKLIDFGSSVKLSENNENFNP  157 (260)
T ss_dssp             TTEBHHHHHH--HHSSBBHHHHHHHHHHHHHHHHHHHHT-TEEESSBSGGGEEESTTSEEEESSGTTTEESTSTTSEBSS
T ss_pred             cccccccccc--ccccccccccccccccccccccccccc-cccccccccccccccccccccccccccccccccccccccc
Confidence            9999999996  456789999999999999999999999 9999999999999999999999999998742    22234


Q ss_pred             ccCcccccCccccc-CCCCCCcccchhhhHHHHHHHhCCCCCCchhhHHHhhhchhhhcccc-ccCCCChHHHHHHHHHH
Q 020221          212 YSTNLAFTPPEYLR-TGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSC-LEGQFSSDEGTELVRLA  289 (329)
Q Consensus       212 ~~~~~~y~aPE~~~-~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~li  289 (329)
                      ..++..|+|||++. +..++.++||||+|+++++|++|..|+.................... .........++++.+++
T Consensus       158 ~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li  237 (260)
T PF00069_consen  158 FVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEESNSDDQLEIIEKILKRPLPSSSQQSREKSEELRDLI  237 (260)
T ss_dssp             SSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTSSHHHHHHHHHHHHHTHHHHHTTSHTTSHHHHHHHH
T ss_pred             ccccccccccccccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccccccchhHHHHHHHH
Confidence            56788999999998 77899999999999999999999988765411111111100000000 00011112248999999


Q ss_pred             HHhcccCCCCCCCHHHHHH
Q 020221          290 SRCLQYEPRERPNPRSLVT  308 (329)
Q Consensus       290 ~~cl~~dp~~Rps~~~~l~  308 (329)
                      .+||+.||++|||+.++++
T Consensus       238 ~~~l~~~p~~R~~~~~l~~  256 (260)
T PF00069_consen  238 KKMLSKDPEQRPSAEELLK  256 (260)
T ss_dssp             HHHSSSSGGGSTTHHHHHT
T ss_pred             HHHccCChhHCcCHHHHhc
Confidence            9999999999999999998

Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A ....

>cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors

Probab=100.00  E-value=5.2e-42  Score=299.02  Aligned_cols=249  Identities=21%  Similarity=0.291  Sum_probs=201.3

Q ss_pred             cccccccCCCCCCcEEEEEEeC-CC---CEEEEEEeCCCC-ChhHHHHHHHHHHHhcCCCccccccceeeeeCCeeEEEE
Q 020221           58 MENIVSEHGEKAPNVVYKGKLE-NQ---FRIAVKRFNRSA-WPDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVA  132 (329)
Q Consensus        58 ~~~~~~~lg~G~~g~V~~~~~~-~~---~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~  132 (329)
                      .+++.+.||+|+||.||+|... ++   ..||+|.+.... ......+..|+.+++.++||||+++++++..+...+++|
T Consensus         5 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~   84 (269)
T cd05065           5 CVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSRPVMIIT   84 (269)
T ss_pred             HeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCcCcceEEEEECCCCceEEEE
Confidence            4567778899999999999843 33   369999987653 223567899999999999999999999999889999999


Q ss_pred             ecCCCCCHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCCCCCeeeecccCcccCCCCCC-
Q 020221          133 EYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDGRS-  211 (329)
Q Consensus       133 e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~~-  211 (329)
                      ||+++++|.+++.. ....+++.++..++.|++.||.|||+. |++|+||||+||+++.++.++|+|||++........ 
T Consensus        85 e~~~~~~L~~~l~~-~~~~~~~~~~~~i~~~l~~al~~lH~~-g~~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~~~~  162 (269)
T cd05065          85 EFMENGALDSFLRQ-NDGQFTVIQLVGMLRGIAAGMKYLSEM-NYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSD  162 (269)
T ss_pred             ecCCCCcHHHHHhh-CCCCCCHHHHHHHHHHHHHHHHHHHHC-CEeecccChheEEEcCCCcEEECCCccccccccCccc
Confidence            99999999999864 345689999999999999999999999 999999999999999999999999999875433221 


Q ss_pred             ------ccC--cccccCcccccCCCCCCcccchhhhHHHHHHHh-CCCCCCchhhHHHhhhchhhhccccccCCCChHHH
Q 020221          212 ------YST--NLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLS-GKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEG  282 (329)
Q Consensus       212 ------~~~--~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t-g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  282 (329)
                            ..+  +..|+|||.+.+..++.++||||||+++||+++ |..|+.............     .......+.+++
T Consensus       163 ~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~e~l~~g~~p~~~~~~~~~~~~i~-----~~~~~~~~~~~~  237 (269)
T cd05065         163 PTYTSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVINAIE-----QDYRLPPPMDCP  237 (269)
T ss_pred             cccccccCCCcceeecCHhHhccCcccchhhhhhhHHHHHHHhcCCCCCCCCCCHHHHHHHHH-----cCCcCCCcccCC
Confidence                  111  347999999998889999999999999999886 887775433222221111     111122334567


Q ss_pred             HHHHHHHHHhcccCCCCCCCHHHHHHHHHhh
Q 020221          283 TELVRLASRCLQYEPRERPNPRSLVTALVTL  313 (329)
Q Consensus       283 ~~~~~li~~cl~~dp~~Rps~~~~l~~L~~~  313 (329)
                      ..+.+++.+||..+|++||++.+++..|+.+
T Consensus       238 ~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~  268 (269)
T cd05065         238 TALHQLMLDCWQKDRNARPKFGQIVSTLDKM  268 (269)
T ss_pred             HHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence            7899999999999999999999999998864

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr

>cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase

Probab=100.00  E-value=3.1e-42  Score=311.01  Aligned_cols=247  Identities=18%  Similarity=0.255  Sum_probs=193.0

Q ss_pred             CcccccccCCCCCCcEEEEEE-eCCCCEEEEEEeCCCCCh--hHHHHHHHHHHHhcCCCccccccceeeeeC------Ce
Q 020221           57 AMENIVSEHGEKAPNVVYKGK-LENQFRIAVKRFNRSAWP--DARQFLEEARAVGQLRNRRLANLLGCCCEG------DE  127 (329)
Q Consensus        57 ~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~--~~~~~~~e~~~l~~l~h~niv~~~~~~~~~------~~  127 (329)
                      ..|.+++.||+|+||+||++. ..+++.||+|++......  ..+.+.+|+++++.++||||+++++++...      ..
T Consensus        15 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~   94 (343)
T cd07878          15 ERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSIENFNE   94 (343)
T ss_pred             hhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhhhhHHHHHHHHHHHHHHhcCCCchhhhhhhhcccccccccCc
Confidence            457778888999999999998 567889999998764322  245577899999999999999999887543      35


Q ss_pred             eEEEEecCCCCCHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCCCCCeeeecccCcccCC
Q 020221          128 RLLVAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSR  207 (329)
Q Consensus       128 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~  207 (329)
                      .+++++++ +++|.+++   ....+++..+..++.||+.||.|||+. +++||||||+||++++++.+||+|||++....
T Consensus        95 ~~~~~~~~-~~~l~~~~---~~~~l~~~~~~~i~~qi~~aL~~LH~~-~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~  169 (343)
T cd07878          95 VYLVTNLM-GADLNNIV---KCQKLSDEHVQFLIYQLLRGLKYIHSA-GIIHRDLKPSNVAVNEDCELRILDFGLARQAD  169 (343)
T ss_pred             EEEEeecC-CCCHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHC-CeecccCChhhEEECCCCCEEEcCCccceecC
Confidence            68999988 67898887   345799999999999999999999999 99999999999999999999999999998654


Q ss_pred             CC-CCccCcccccCcccccC-CCCCCcccchhhhHHHHHHHhCCCCCCchhhHHHhhhch-------hhhccccc-----
Q 020221          208 DG-RSYSTNLAFTPPEYLRT-GRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNI-------QTLTDSCL-----  273 (329)
Q Consensus       208 ~~-~~~~~~~~y~aPE~~~~-~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~~~~~~-------~~~~~~~~-----  273 (329)
                      .. ....++..|+|||++.+ ..++.++||||||+++|+|++|..||+............       ........     
T Consensus       170 ~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  249 (343)
T cd07878         170 DEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYIDQLKRIMEVVGTPSPEVLKKISSEHAR  249 (343)
T ss_pred             CCcCCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhcchhhHH
Confidence            43 34567899999999876 458899999999999999999998886532211110000       00000000     


Q ss_pred             -----cCCCC--------hHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 020221          274 -----EGQFS--------SDEGTELVRLASRCLQYEPRERPNPRSLVT  308 (329)
Q Consensus       274 -----~~~~~--------~~~~~~~~~li~~cl~~dp~~Rps~~~~l~  308 (329)
                           ....+        ...++.+.+++.+||..||++|||+.++++
T Consensus       250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dp~~R~s~~ell~  297 (343)
T cd07878         250 KYIQSLPHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEALA  297 (343)
T ss_pred             HHhhccccccchhHHHhccCCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence                 00000        123456889999999999999999999997

Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is

>cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl

Probab=100.00  E-value=8.5e-42  Score=298.04  Aligned_cols=247  Identities=23%  Similarity=0.316  Sum_probs=194.4

Q ss_pred             ccccCCCCCCcEEEEEEeCC-CC--EEEEEEeCCCC--ChhHHHHHHHHHHHhcCCCccccccceeeeeC------CeeE
Q 020221           61 IVSEHGEKAPNVVYKGKLEN-QF--RIAVKRFNRSA--WPDARQFLEEARAVGQLRNRRLANLLGCCCEG------DERL  129 (329)
Q Consensus        61 ~~~~lg~G~~g~V~~~~~~~-~~--~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~------~~~~  129 (329)
                      +.+.||+|+||.||+|...+ +.  .+|+|.++...  ....+.+.+|+++++.++|+||+++++++...      ...+
T Consensus         3 i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~   82 (272)
T cd05075           3 LGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPSPV   82 (272)
T ss_pred             cccccCcccCceEEEeEEccCCCeeeEEEEecccCcCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCCCcE
Confidence            34567999999999998544 32  58999887643  23356788999999999999999999987432      2568


Q ss_pred             EEEecCCCCCHHhhhccC----CCCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCCCCCeeeecccCccc
Q 020221          130 LVAEYMPNDTLAKHLFHW----ETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKN  205 (329)
Q Consensus       130 lv~e~~~~gsL~~~l~~~----~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~  205 (329)
                      +++||+.+|+|.+++...    ....+++..+..++.|++.||.|||++ +++||||||+||++++++.++|+|||++..
T Consensus        83 ~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~-~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~  161 (272)
T cd05075          83 VILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSK-SFIHRDLAARNCMLNENMNVCVADFGLSKK  161 (272)
T ss_pred             EEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHC-CeeccccchhheEEcCCCCEEECCCCcccc
Confidence            999999999999877421    234578999999999999999999999 999999999999999999999999999886


Q ss_pred             CCCCC------CccCcccccCcccccCCCCCCcccchhhhHHHHHHHh-CCCCCCchhhHHHhhhchhhhccccccCCCC
Q 020221          206 SRDGR------SYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLS-GKHIPPSHALDLIRDRNIQTLTDSCLEGQFS  278 (329)
Q Consensus       206 ~~~~~------~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t-g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  278 (329)
                      .....      ...++..|+|||.+.+..++.++||||||+++|+|++ |..|+.............     .......+
T Consensus       162 ~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~-----~~~~~~~~  236 (272)
T cd05075         162 IYNGDYYRQGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVENSEIYDYLR-----QGNRLKQP  236 (272)
T ss_pred             cCcccceecCCcccCCcccCCHHHccCCCcChHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHH-----cCCCCCCC
Confidence            54322      2234568999999998889999999999999999999 666665432221111111     11111223


Q ss_pred             hHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhh
Q 020221          279 SDEGTELVRLASRCLQYEPRERPNPRSLVTALVTL  313 (329)
Q Consensus       279 ~~~~~~~~~li~~cl~~dp~~Rps~~~~l~~L~~~  313 (329)
                      ...+..+.+++.+||+.||++|||+.++++.|+++
T Consensus       237 ~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~~~  271 (272)
T cd05075         237 PDCLDGLYSLMSSCWLLNPKDRPSFETLRCELEKA  271 (272)
T ss_pred             CCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence            45667899999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor

>cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=6e-42  Score=299.43  Aligned_cols=242  Identities=15%  Similarity=0.229  Sum_probs=200.3

Q ss_pred             cccccccCCCCCCcEEEEEE-eCCCCEEEEEEeCCCC-ChhHHHHHHHHHHHhcCCCccccccceeeeeCCeeEEEEecC
Q 020221           58 MENIVSEHGEKAPNVVYKGK-LENQFRIAVKRFNRSA-WPDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAEYM  135 (329)
Q Consensus        58 ~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~  135 (329)
                      .|++++.+|.|++|.||++. ..+++.||+|.+.... ......+.+|+++++.++|+|++++.+++.++...++|+||+
T Consensus         2 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~   81 (274)
T cd06609           2 LFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITKYYGSFLKGSKLWIIMEYC   81 (274)
T ss_pred             hhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccccchHHHHHHHHHHHHHHcCCCCeeeeeEEEEECCeEEEEEEee
Confidence            35667778999999999999 4568899999987653 333556889999999999999999999999999999999999


Q ss_pred             CCCCHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCCCCCeeeecccCcccCCCC----CC
Q 020221          136 PNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDG----RS  211 (329)
Q Consensus       136 ~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~----~~  211 (329)
                      ++++|.+++..   ..+++..+..++.|++.||.|||+. +++|+||+|+||++++++.++|+|||++......    ..
T Consensus        82 ~~~~L~~~~~~---~~~~~~~~~~~~~ql~~~l~~lh~~-~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~~~~~  157 (274)
T cd06609          82 GGGSCLDLLKP---GKLDETYIAFILREVLLGLEYLHEE-GKIHRDIKAANILLSEEGDVKLADFGVSGQLTSTMSKRNT  157 (274)
T ss_pred             CCCcHHHHHhh---cCCCHHHHHHHHHHHHHHHHHHHhC-CcccCCCCHHHEEECCCCCEEEcccccceeeccccccccc
Confidence            99999999853   3789999999999999999999999 9999999999999999999999999998765543    23


Q ss_pred             ccCcccccCcccccCCCCCCcccchhhhHHHHHHHhCCCCCCchhhHHHhhhchhhhccccccCCCChH-HHHHHHHHHH
Q 020221          212 YSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSD-EGTELVRLAS  290 (329)
Q Consensus       212 ~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~li~  290 (329)
                      ..++..|+|||.+.+..++.++||||||+++|+|++|..|+.............     .......+.. .++++.+++.
T Consensus       158 ~~~~~~y~~PE~~~~~~~~~~sDv~slG~il~~l~tg~~p~~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~l~  232 (274)
T cd06609         158 FVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLSDLHPMRVLFLIP-----KNNPPSLEGNKFSKPFKDFVS  232 (274)
T ss_pred             ccCCccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccCchHHHHHHhh-----hcCCCCCcccccCHHHHHHHH
Confidence            456778999999998889999999999999999999998875432111111111     1111122222 6778999999


Q ss_pred             HhcccCCCCCCCHHHHHH
Q 020221          291 RCLQYEPRERPNPRSLVT  308 (329)
Q Consensus       291 ~cl~~dp~~Rps~~~~l~  308 (329)
                      +||..||++|||++++++
T Consensus       233 ~~l~~~p~~Rpt~~~il~  250 (274)
T cd06609         233 LCLNKDPKERPSAKELLK  250 (274)
T ss_pred             HHhhCChhhCcCHHHHhh
Confidence            999999999999999987

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN)

>cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1

Probab=100.00  E-value=5.3e-42  Score=296.68  Aligned_cols=244  Identities=18%  Similarity=0.195  Sum_probs=203.3

Q ss_pred             ccccccCCCCCCcEEEEEE-eCCCCEEEEEEeCCCC--ChhHHHHHHHHHHHhcCCCccccccceeeeeCCeeEEEEecC
Q 020221           59 ENIVSEHGEKAPNVVYKGK-LENQFRIAVKRFNRSA--WPDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAEYM  135 (329)
Q Consensus        59 ~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~  135 (329)
                      |.+++.+|+|+||.||++. ..+++.||+|.+....  ....+.+.+|+.+++.++||||+++++++...+..++|+||+
T Consensus         2 y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~   81 (256)
T cd08218           2 YVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQESFEENGNLYIVMDYC   81 (256)
T ss_pred             ceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCChHHHHHHHHHHHHHHhCCCCCeeeeEeeecCCCeEEEEEecC
Confidence            5667788999999999998 5578899999986532  233457889999999999999999999999999999999999


Q ss_pred             CCCCHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCCCCCeeeecccCcccCCCCC----C
Q 020221          136 PNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDGR----S  211 (329)
Q Consensus       136 ~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~----~  211 (329)
                      .+++|.+++.......+++.++..++.|++.||.|||+. +++|+||+|+||+++.++.++++|||++.......    .
T Consensus        82 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~-~i~h~~l~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~  160 (256)
T cd08218          82 EGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHVHDR-KILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVELART  160 (256)
T ss_pred             CCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhC-CEecCCCCHHHEEEcCCCCEEEeeccceeecCcchhhhhh
Confidence            999999988653445688999999999999999999999 99999999999999999999999999987654432    2


Q ss_pred             ccCcccccCcccccCCCCCCcccchhhhHHHHHHHhCCCCCCchhhHHHhhhchhhhccccccCCCChHHHHHHHHHHHH
Q 020221          212 YSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLASR  291 (329)
Q Consensus       212 ~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~  291 (329)
                      ..+++.|+|||++.+..++.++|+||||+++++|++|..|+...............     .....+...+.++.+++.+
T Consensus       161 ~~~~~~~~~pe~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~li~~  235 (256)
T cd08218         161 CIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEAGNMKNLVLKIIRG-----SYPPVSSHYSYDLRNLVSQ  235 (256)
T ss_pred             ccCCccccCHHHhCCCCCCCccchhHHHHHHHHHHcCCCCccCCCHHHHHHHHhcC-----CCCCCcccCCHHHHHHHHH
Confidence            34678899999999888999999999999999999999887654333222111111     1122345567889999999


Q ss_pred             hcccCCCCCCCHHHHHH
Q 020221          292 CLQYEPRERPNPRSLVT  308 (329)
Q Consensus       292 cl~~dp~~Rps~~~~l~  308 (329)
                      ||+.+|++||++.++++
T Consensus       236 ~l~~~p~~Rp~~~~vl~  252 (256)
T cd08218         236 LFKRNPRDRPSVNSILE  252 (256)
T ss_pred             HhhCChhhCcCHHHHhh
Confidence            99999999999999998

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti

>cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein

Probab=100.00  E-value=7.5e-42  Score=301.37  Aligned_cols=251  Identities=20%  Similarity=0.285  Sum_probs=202.4

Q ss_pred             ccccccCCCCCCcEEEEEEeC------CCCEEEEEEeCCCCC-hhHHHHHHHHHHHhcCCCccccccceeeeeCCeeEEE
Q 020221           59 ENIVSEHGEKAPNVVYKGKLE------NQFRIAVKRFNRSAW-PDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLV  131 (329)
Q Consensus        59 ~~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv  131 (329)
                      +.+.+.||+|+||.||+|...      +...+++|.+..... ...+.+.+|+.+++.++||||+++++.+...+..+++
T Consensus         2 ~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv   81 (290)
T cd05045           2 LVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIKLYGACSQDGPLLLI   81 (290)
T ss_pred             ccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCCcEEE
Confidence            345667799999999999842      235688998876543 2345688999999999999999999999999999999


Q ss_pred             EecCCCCCHHhhhccCC----------------------CCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceee
Q 020221          132 AEYMPNDTLAKHLFHWE----------------------TQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVF  189 (329)
Q Consensus       132 ~e~~~~gsL~~~l~~~~----------------------~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~  189 (329)
                      +||+.+++|.+++....                      ...+++..++.++.|++.||+|||+. +++|+||||+||++
T Consensus        82 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~-~ivH~dikp~nill  160 (290)
T cd05045          82 VEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEM-KLVHRDLAARNVLV  160 (290)
T ss_pred             EEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHC-CeehhhhhhheEEE
Confidence            99999999999875321                      13578899999999999999999999 99999999999999


Q ss_pred             CCCCCeeeecccCcccCCCCC------CccCcccccCcccccCCCCCCcccchhhhHHHHHHHh-CCCCCCchhhHHHhh
Q 020221          190 DDDVNPRLSCFGLMKNSRDGR------SYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLS-GKHIPPSHALDLIRD  262 (329)
Q Consensus       190 ~~~~~~kl~Dfg~a~~~~~~~------~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t-g~~~~~~~~~~~~~~  262 (329)
                      ++++.++|+|||++.......      ...++..|+|||.+.+..++.++||||||+++|+|++ |..|+.......+..
T Consensus       161 ~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~  240 (290)
T cd05045         161 AEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIAPERLFN  240 (290)
T ss_pred             cCCCcEEeccccccccccCccchhcccCCCCCccccCHHHHccCCcchHhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Confidence            999999999999987543322      1234568999999988889999999999999999998 887765443222221


Q ss_pred             hchhhhccccccCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhh
Q 020221          263 RNIQTLTDSCLEGQFSSDEGTELVRLASRCLQYEPRERPNPRSLVTALVTLQK  315 (329)
Q Consensus       263 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~~~l~~L~~~~~  315 (329)
                      .     .........+...+.++.+++.+||+.||++||++.++++.|+++-.
T Consensus       241 ~-----~~~~~~~~~~~~~~~~~~~~i~~cl~~~P~~Rp~~~~i~~~l~~~~~  288 (290)
T cd05045         241 L-----LKTGYRMERPENCSEEMYNLMLTCWKQEPDKRPTFADISKELEKMMV  288 (290)
T ss_pred             H-----HhCCCCCCCCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHHHHh
Confidence            1     11111222345567889999999999999999999999999998764

Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi

>PHA03209 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=1.5e-41  Score=307.87  Aligned_cols=242  Identities=13%  Similarity=0.176  Sum_probs=188.8

Q ss_pred             cccccccCCCCCCcEEEEEEe-CCCCEEEEEEeCCCCChhHHHHHHHHHHHhcCCCccccccceeeeeCCeeEEEEecCC
Q 020221           58 MENIVSEHGEKAPNVVYKGKL-ENQFRIAVKRFNRSAWPDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAEYMP  136 (329)
Q Consensus        58 ~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~  136 (329)
                      .|++++.||+|+||.||+|.. .++..||+|+.....      ...|+.+++.++|+||+++++++......++|+|++.
T Consensus        67 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~~------~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~  140 (357)
T PHA03209         67 GYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKGT------TLIEAMLLQNVNHPSVIRMKDTLVSGAITCMVLPHYS  140 (357)
T ss_pred             CcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCccc------cHHHHHHHHhCCCCCCcChhheEEeCCeeEEEEEccC
Confidence            477888889999999999994 456789999854322      3468999999999999999999999999999999995


Q ss_pred             CCCHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCCCCCeeeecccCcccCCCC---CCcc
Q 020221          137 NDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDG---RSYS  213 (329)
Q Consensus       137 ~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~---~~~~  213 (329)
                       ++|.+++.. ....+++..+..++.||+.||.|||+. +|+||||||+||+++.++.++|+|||++......   ....
T Consensus       141 -~~l~~~l~~-~~~~~~~~~~~~i~~qi~~aL~~LH~~-~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~~  217 (357)
T PHA03209        141 -SDLYTYLTK-RSRPLPIDQALIIEKQILEGLRYLHAQ-RIIHRDVKTENIFINDVDQVCIGDLGAAQFPVVAPAFLGLA  217 (357)
T ss_pred             -CcHHHHHHh-ccCCCCHHHHHHHHHHHHHHHHHHHHC-CeecCCCCHHHEEECCCCCEEEecCccccccccCccccccc
Confidence             588888854 446789999999999999999999999 9999999999999999999999999998753322   2346


Q ss_pred             CcccccCcccccCCCCCCcccchhhhHHHHHHHhCCCCCCchhh----HHH--hhhchhhhc------ccccc-------
Q 020221          214 TNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHAL----DLI--RDRNIQTLT------DSCLE-------  274 (329)
Q Consensus       214 ~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~----~~~--~~~~~~~~~------~~~~~-------  274 (329)
                      ||..|+|||++.+..++.++||||||+++|||+++..++.....    ...  ....+...+      .....       
T Consensus       218 gt~~y~aPE~~~~~~~~~~~DiwSlGvvl~ell~~~~~~f~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~  297 (357)
T PHA03209        218 GTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTIFEDPPSTPEEYVKSCHSHLLKIISTLKVHPEEFPRDPGSRL  297 (357)
T ss_pred             ccccccCCeecCCCCCCchhhHHHHHHHHHHHHHcCCccccCCCCcHHHHHHHHHHHHHHHHHHhccChhhcCCCCccHH
Confidence            78999999999988999999999999999999997655432100    000  000000000      00000       


Q ss_pred             ------------CCC-------ChHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 020221          275 ------------GQF-------SSDEGTELVRLASRCLQYEPRERPNPRSLVT  308 (329)
Q Consensus       275 ------------~~~-------~~~~~~~~~~li~~cl~~dp~~Rps~~~~l~  308 (329)
                                  ...       ....+.++.++|.+||+.||++|||+.++++
T Consensus       298 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rpta~e~l~  350 (357)
T PHA03209        298 VRGFIEYASLERQPYTRYPCFQRVNLPIDGEFLVHKMLTFDAAMRPSAEEILN  350 (357)
T ss_pred             HHHHHhhcccCCCcccccHHHhccCCCchHHHHHHHHHcCCcccCcCHHHHhc
Confidence                        000       0123456778999999999999999999998

>cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=8.4e-43  Score=313.04  Aligned_cols=235  Identities=17%  Similarity=0.181  Sum_probs=186.8

Q ss_pred             CCCCCCcEEEEEE-eCCCCEEEEEEeCCCCCh---hHHHHHHHHHHHhcC---CCccccccceeeeeCCeeEEEEecCCC
Q 020221           65 HGEKAPNVVYKGK-LENQFRIAVKRFNRSAWP---DARQFLEEARAVGQL---RNRRLANLLGCCCEGDERLLVAEYMPN  137 (329)
Q Consensus        65 lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~---~~~~~~~e~~~l~~l---~h~niv~~~~~~~~~~~~~lv~e~~~~  137 (329)
                      ||+|+||+||++. ..+++.||+|++......   .......|..++...   .||||+++++.+.+....++||||+++
T Consensus         1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~e~~~~   80 (330)
T cd05586           1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDYMSG   80 (330)
T ss_pred             CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEEcCCCC
Confidence            5999999999998 456889999998653211   223345566666655   699999999999999999999999999


Q ss_pred             CCHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCCCCCeeeecccCcccCCCC----CCcc
Q 020221          138 DTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDG----RSYS  213 (329)
Q Consensus       138 gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~----~~~~  213 (329)
                      |+|..++.  ....+++..+..++.||+.||+|||++ +++||||||+|||++.++.++|+|||++......    ....
T Consensus        81 g~L~~~l~--~~~~~~~~~~~~~~~qil~al~~LH~~-~ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~~~~~~~  157 (330)
T cd05586          81 GELFWHLQ--KEGRFSEDRAKFYIAELVLALEHLHKY-DIVYRDLKPENILLDATGHIALCDFGLSKANLTDNKTTNTFC  157 (330)
T ss_pred             ChHHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHHC-CeEeccCCHHHeEECCCCCEEEecCCcCcCCCCCCCCccCcc
Confidence            99999886  446789999999999999999999999 9999999999999999999999999998753222    2346


Q ss_pred             CcccccCcccccCCC-CCCcccchhhhHHHHHHHhCCCCCCchhhHHHhhhchhhhccccccCCCC-hHHHHHHHHHHHH
Q 020221          214 TNLAFTPPEYLRTGR-VTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFS-SDEGTELVRLASR  291 (329)
Q Consensus       214 ~~~~y~aPE~~~~~~-~~~~~DvwslG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~li~~  291 (329)
                      ||..|+|||++.+.. ++.++||||||+++|+|++|..||................      ..++ ...++++.+++.+
T Consensus       158 gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~~~~~~~~i~~~~------~~~~~~~~~~~~~~li~~  231 (330)
T cd05586         158 GTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDTQQMYRNIAFGK------VRFPKNVLSDEGRQFVKG  231 (330)
T ss_pred             CCccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCCCHHHHHHHHHcCC------CCCCCccCCHHHHHHHHH
Confidence            889999999987654 8899999999999999999999886654332222111110      0111 2356789999999


Q ss_pred             hcccCCCCCCC----HHHHHH
Q 020221          292 CLQYEPRERPN----PRSLVT  308 (329)
Q Consensus       292 cl~~dp~~Rps----~~~~l~  308 (329)
                      ||+.||++||+    +.++++
T Consensus       232 ~L~~~P~~R~~~~~~~~~ll~  252 (330)
T cd05586         232 LLNRNPQHRLGAHRDAVELKE  252 (330)
T ss_pred             HcCCCHHHCCCCCCCHHHHhc
Confidence            99999999994    555554

Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of

>cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3

Probab=100.00  E-value=1e-41  Score=297.22  Aligned_cols=246  Identities=21%  Similarity=0.254  Sum_probs=189.8

Q ss_pred             cCCCCCCcEEEEEEeCC---CCEEEEEEeCCCCCh-hHHHHHHHHHHHhcCCCccccccceeeeeCCeeEEEEecCCCCC
Q 020221           64 EHGEKAPNVVYKGKLEN---QFRIAVKRFNRSAWP-DARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAEYMPNDT  139 (329)
Q Consensus        64 ~lg~G~~g~V~~~~~~~---~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gs  139 (329)
                      .||+|+||.||+|...+   +..+|+|.++..... ....+.+|+.+++.++||||+++++++.+....++||||+++|+
T Consensus         2 ~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~   81 (269)
T cd05087           2 EIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEFCPLGD   81 (269)
T ss_pred             cccccCCceEEEEEEcCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCCcEEEEECCCCCc
Confidence            57999999999998533   457999998765432 23468889999999999999999999998889999999999999


Q ss_pred             HHhhhccCC---CCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCCCCCeeeecccCcccCCCCC------
Q 020221          140 LAKHLFHWE---TQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDGR------  210 (329)
Q Consensus       140 L~~~l~~~~---~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~------  210 (329)
                      |.+++....   ....++..+..++.|++.||+|||+. +++|+||||+||+++.++.++|+|||++.......      
T Consensus        82 L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~-~i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~~~~~~~  160 (269)
T cd05087          82 LKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKN-NFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYVTPD  160 (269)
T ss_pred             HHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHC-CEeccccCcceEEEcCCCcEEECCccccccccCcceeecCC
Confidence            999986422   22456778889999999999999999 99999999999999999999999999986543221      


Q ss_pred             CccCcccccCcccccCC-------CCCCcccchhhhHHHHHHHh-CCCCCCchhhHHHhhhchhhhccccccCCCChHHH
Q 020221          211 SYSTNLAFTPPEYLRTG-------RVTPESVMYSFGTLLLDLLS-GKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEG  282 (329)
Q Consensus       211 ~~~~~~~y~aPE~~~~~-------~~~~~~DvwslG~il~el~t-g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  282 (329)
                      ...++..|+|||++.+.       .++.++||||||+++|||++ |..||......................+......+
T Consensus       161 ~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (269)
T cd05087         161 QLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQVLTYTVREQQLKLPKPRLKLPLS  240 (269)
T ss_pred             CcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChHHHHHHHhhcccCCCCCCccCCCCC
Confidence            23456789999988642       35789999999999999996 88777543222211111111111111122223456


Q ss_pred             HHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 020221          283 TELVRLASRCLQYEPRERPNPRSLVTALV  311 (329)
Q Consensus       283 ~~~~~li~~cl~~dp~~Rps~~~~l~~L~  311 (329)
                      ..+.+++..|| .+|++|||+.+|+..|+
T Consensus       241 ~~~~~l~~~c~-~~P~~Rpt~~~l~~~l~  268 (269)
T cd05087         241 DRWYEVMQFCW-LQPEQRPSAEEVHLLLS  268 (269)
T ss_pred             hHHHHHHHHHh-cCcccCCCHHHHHHHhc
Confidence            77899999999 68999999999998764

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells

>cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases

Probab=100.00  E-value=9.2e-42  Score=294.34  Aligned_cols=241  Identities=27%  Similarity=0.421  Sum_probs=198.6

Q ss_pred             cCCCCCCcEEEEEEeCCCCEEEEEEeCCCCCh-hHHHHHHHHHHHhcCCCccccccceeeeeCCeeEEEEecCCCCCHHh
Q 020221           64 EHGEKAPNVVYKGKLENQFRIAVKRFNRSAWP-DARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAEYMPNDTLAK  142 (329)
Q Consensus        64 ~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~  142 (329)
                      .||+|+||.||++...+++.|++|.+...... ....+.+|+++++.++|+||+++++++......++++||+.+++|.+
T Consensus         2 ~lg~g~~g~v~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~l~~   81 (251)
T cd05041           2 KIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVMELVPGGSLLT   81 (251)
T ss_pred             ccccCCCceEEEEEEeCCCcEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeEEEEEEEecCCCeEEEEEcCCCCcHHH
Confidence            56999999999999766889999998876544 45678999999999999999999999999999999999999999999


Q ss_pred             hhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCCCCCeeeecccCcccCCCCCC------ccCcc
Q 020221          143 HLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDGRS------YSTNL  216 (329)
Q Consensus       143 ~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~~------~~~~~  216 (329)
                      ++.. ....+++..+..++.+++.||.|||++ +++|+||+|+||+++.++.++|+|||++........      ...+.
T Consensus        82 ~l~~-~~~~~~~~~~~~~~~~~~~~l~~lH~~-~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~  159 (251)
T cd05041          82 FLRK-KKNRLTVKKLLQMSLDAAAGMEYLESK-NCIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGLKQIPI  159 (251)
T ss_pred             HHHh-cCCCCCHHHHHHHHHHHHHHHHHHHhC-CEehhhcCcceEEEcCCCcEEEeeccccccccCCcceeccccCccee
Confidence            9864 334688999999999999999999999 999999999999999999999999999876542221      12245


Q ss_pred             cccCcccccCCCCCCcccchhhhHHHHHHHh-CCCCCCchhhHHHhhhchhhhccccccCCCChHHHHHHHHHHHHhccc
Q 020221          217 AFTPPEYLRTGRVTPESVMYSFGTLLLDLLS-GKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLASRCLQY  295 (329)
Q Consensus       217 ~y~aPE~~~~~~~~~~~DvwslG~il~el~t-g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~  295 (329)
                      .|+|||.+.++.++.++|+||||+++|+|++ |..|+............     ........+...+.++.+++.+||..
T Consensus       160 ~y~~PE~~~~~~~~~~~Di~slG~i~~~l~t~~~~p~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~li~~~l~~  234 (251)
T cd05041         160 KWTAPEALNYGRYTSESDVWSYGILLWETFSLGDTPYPGMSNQQTRERI-----ESGYRMPAPQLCPEEIYRLMLQCWAY  234 (251)
T ss_pred             ccCChHhhccCCCCcchhHHHHHHHHHHHHhccCCCCccCCHHHHHHHH-----hcCCCCCCCccCCHHHHHHHHHHhcc
Confidence            6999999988889999999999999999999 66555443222211111     11112223455678999999999999


Q ss_pred             CCCCCCCHHHHHHHHH
Q 020221          296 EPRERPNPRSLVTALV  311 (329)
Q Consensus       296 dp~~Rps~~~~l~~L~  311 (329)
                      +|++|||+.++++.|+
T Consensus       235 ~p~~Rp~~~ell~~l~  250 (251)
T cd05041         235 DPENRPSFSEIYNELQ  250 (251)
T ss_pred             ChhhCcCHHHHHHHhh
Confidence            9999999999999886

Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k

>cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases

Probab=100.00  E-value=8.1e-42  Score=297.35  Aligned_cols=241  Identities=18%  Similarity=0.291  Sum_probs=198.1

Q ss_pred             cccccCCCCCCcEEEEEE-eCCCCEEEEEEeCCCCChh---------HHHHHHHHHHHhcCCCccccccceeeeeCCeeE
Q 020221           60 NIVSEHGEKAPNVVYKGK-LENQFRIAVKRFNRSAWPD---------ARQFLEEARAVGQLRNRRLANLLGCCCEGDERL  129 (329)
Q Consensus        60 ~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~---------~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~  129 (329)
                      .+.+.||.|++|.||+|. ..+++.+|+|.+.......         .+.+.+|+.+++.++||||+++++++......+
T Consensus         3 ~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~   82 (267)
T cd06628           3 IKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDADHLN   82 (267)
T ss_pred             cccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCccE
Confidence            344567999999999998 4567899999887643221         245788999999999999999999999999999


Q ss_pred             EEEecCCCCCHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCCCCCeeeecccCcccCCCC
Q 020221          130 LVAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDG  209 (329)
Q Consensus       130 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~  209 (329)
                      +++||+++++|.+++.+  ...+++..+..++.|++.||.|||+. +++|+||+|+||++++++.++|+|||.++.....
T Consensus        83 lv~e~~~~~~L~~~l~~--~~~l~~~~~~~~~~~l~~~l~~lH~~-~ivH~di~p~nil~~~~~~~~l~dfg~~~~~~~~  159 (267)
T cd06628          83 IFLEYVPGGSVAALLNN--YGAFEETLVRNFVRQILKGLNYLHNR-GIIHRDIKGANILVDNKGGIKISDFGISKKLEAN  159 (267)
T ss_pred             EEEEecCCCCHHHHHHh--ccCccHHHHHHHHHHHHHHHHHHHhc-CcccccCCHHHEEEcCCCCEEecccCCCcccccc
Confidence            99999999999999963  35688999999999999999999999 9999999999999999999999999998765421


Q ss_pred             ----------CCccCcccccCcccccCCCCCCcccchhhhHHHHHHHhCCCCCCchhhHHHhhhchhhhccccccCCCCh
Q 020221          210 ----------RSYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSS  279 (329)
Q Consensus       210 ----------~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  279 (329)
                                ....++..|+|||.+.+..++.++|+||||+++|+|++|..||.........    ..... ......+.
T Consensus       160 ~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~----~~~~~-~~~~~~~~  234 (267)
T cd06628         160 SLSTKTNGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQLQAI----FKIGE-NASPEIPS  234 (267)
T ss_pred             cccCCccccccccCCCcCccChhHhccCCCCchhhhHHHHHHHHHHhhCCCCCCCccHHHHH----HHHhc-cCCCcCCc
Confidence                      1234678899999999888999999999999999999999888643221111    11111 12223445


Q ss_pred             HHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 020221          280 DEGTELVRLASRCLQYEPRERPNPRSLVT  308 (329)
Q Consensus       280 ~~~~~~~~li~~cl~~dp~~Rps~~~~l~  308 (329)
                      ..+..+.+++.+||+.||++||++.++++
T Consensus       235 ~~~~~~~~li~~~l~~~p~~Rp~~~~il~  263 (267)
T cd06628         235 NISSEAIDFLEKTFEIDHNKRPTAAELLK  263 (267)
T ss_pred             ccCHHHHHHHHHHccCCchhCcCHHHHhh
Confidence            56788999999999999999999999998

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate

>KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms]

Probab=100.00  E-value=2e-42  Score=311.32  Aligned_cols=245  Identities=24%  Similarity=0.356  Sum_probs=212.9

Q ss_pred             ccCCCCCCcEEEEEEeCC-----CCEEEEEEeCCCC-ChhHHHHHHHHHHHhcCCCccccccceeeeeCCeeEEEEecCC
Q 020221           63 SEHGEKAPNVVYKGKLEN-----QFRIAVKRFNRSA-WPDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAEYMP  136 (329)
Q Consensus        63 ~~lg~G~~g~V~~~~~~~-----~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~  136 (329)
                      +.||.|.||.||+|.+.+     .-.||||..+.+. ..+.+.|++|..+|+.++||||++++|+|.+ ...|||||+++
T Consensus       395 r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t~d~tekflqEa~iMrnfdHphIikLIGv~~e-~P~WivmEL~~  473 (974)
T KOG4257|consen  395 RLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCTPDDTEKFLQEASIMRNFDHPHIIKLIGVCVE-QPMWIVMELAP  473 (974)
T ss_pred             HhhcCCcccceeeeEecccccCcceeeeeehhccCCChhhHHHHHHHHHHHHhCCCcchhheeeeeec-cceeEEEeccc
Confidence            567999999999998533     2458999998864 3456779999999999999999999999954 68999999999


Q ss_pred             CCCHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCCCCCeeeecccCcccCCCCCCcc---
Q 020221          137 NDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDGRSYS---  213 (329)
Q Consensus       137 ~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~~---  213 (329)
                      .|.|..||.. +...++......++.||+.||+|||++ +.|||||..+|||+.....+||+|||+++...+..-+.   
T Consensus       474 ~GELr~yLq~-nk~sL~l~tL~ly~~Qi~talaYLeSk-rfVHRDIAaRNiLVsSp~CVKLaDFGLSR~~ed~~yYkaS~  551 (974)
T KOG4257|consen  474 LGELREYLQQ-NKDSLPLRTLTLYCYQICTALAYLESK-RFVHRDIAARNILVSSPQCVKLADFGLSRYLEDDAYYKASR  551 (974)
T ss_pred             chhHHHHHHh-ccccchHHHHHHHHHHHHHHHHHHHhh-chhhhhhhhhheeecCcceeeecccchhhhccccchhhccc
Confidence            9999999976 556789999999999999999999999 99999999999999999999999999999877765433   


Q ss_pred             --CcccccCcccccCCCCCCcccchhhhHHHHHHHhCC-CCCCchhhHHHhhhchhhhccccccCCCChHHHHHHHHHHH
Q 020221          214 --TNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGK-HIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLAS  290 (329)
Q Consensus       214 --~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~  290 (329)
                        -.+.|||||.++...++.++|||-|||.+||+++-+ .||.+     +.+.+....++..-+.+.|+.+|+.+..++.
T Consensus       552 ~kLPIKWmaPESINfRrFTtASDVWMFgVCmWEIl~lGvkPfqg-----vkNsDVI~~iEnGeRlP~P~nCPp~LYslms  626 (974)
T KOG4257|consen  552 GKLPIKWMAPESINFRRFTTASDVWMFGVCMWEILSLGVKPFQG-----VKNSDVIGHIENGERLPCPPNCPPALYSLMS  626 (974)
T ss_pred             cccceeecCccccchhcccchhhHHHHHHHHHHHHHhcCCcccc-----ccccceEEEecCCCCCCCCCCCChHHHHHHH
Confidence              246799999999999999999999999999998744 55543     4445555566666777889999999999999


Q ss_pred             HhcccCCCCCCCHHHHHHHHHhhhh
Q 020221          291 RCLQYEPRERPNPRSLVTALVTLQK  315 (329)
Q Consensus       291 ~cl~~dp~~Rps~~~~l~~L~~~~~  315 (329)
                      +||++||.+||.+.++...|..+..
T Consensus       627 kcWayeP~kRPrftei~~~lsdv~q  651 (974)
T KOG4257|consen  627 KCWAYEPSKRPRFTEIKAILSDVLQ  651 (974)
T ss_pred             HHhccCcccCCcHHHHHHHHHHHHH
Confidence            9999999999999999999988865

>cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta

Probab=100.00  E-value=4.1e-42  Score=314.72  Aligned_cols=250  Identities=20%  Similarity=0.303  Sum_probs=200.1

Q ss_pred             ccccccCCCCCCcEEEEEEeC------CCCEEEEEEeCCCCCh-hHHHHHHHHHHHhcCC-CccccccceeeeeCCeeEE
Q 020221           59 ENIVSEHGEKAPNVVYKGKLE------NQFRIAVKRFNRSAWP-DARQFLEEARAVGQLR-NRRLANLLGCCCEGDERLL  130 (329)
Q Consensus        59 ~~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~~~~l  130 (329)
                      +.+.+.||+|+||.||+|.+.      .+..||+|++...... ..+.+.+|+.++..+. ||||+++++++......++
T Consensus        39 ~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~~H~niv~~~~~~~~~~~~~i  118 (401)
T cd05107          39 LVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARSSEKQALMSELKIMSHLGPHLNIVNLLGACTKGGPIYI  118 (401)
T ss_pred             eehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCChhHHHHHHHHHHHHHhcCCCCCeEEEEEEEccCCCcEE
Confidence            456677899999999999853      3467999999865433 2446889999999997 9999999999999899999


Q ss_pred             EEecCCCCCHHhhhccCC--------------------------------------------------------------
Q 020221          131 VAEYMPNDTLAKHLFHWE--------------------------------------------------------------  148 (329)
Q Consensus       131 v~e~~~~gsL~~~l~~~~--------------------------------------------------------------  148 (329)
                      |+||+++|+|.+++....                                                              
T Consensus       119 v~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  198 (401)
T cd05107         119 ITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADYVPMQDMKGT  198 (401)
T ss_pred             EEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCccchhcchhh
Confidence            999999999999886421                                                              


Q ss_pred             ----------------------------------CCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCCCCC
Q 020221          149 ----------------------------------TQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVN  194 (329)
Q Consensus       149 ----------------------------------~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~  194 (329)
                                                        ...+++..+..++.|++.||.|||+. +++||||||+|||+++++.
T Consensus       199 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~-~ivHrdlkp~NiLl~~~~~  277 (401)
T cd05107         199 VKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASK-NCVHRDLAARNVLICEGKL  277 (401)
T ss_pred             hhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcC-CcCcccCCcceEEEeCCCE
Confidence                                              12357778899999999999999999 9999999999999999999


Q ss_pred             eeeecccCcccCCCC------CCccCcccccCcccccCCCCCCcccchhhhHHHHHHHh-CCCCCCchhhHHHhhhchhh
Q 020221          195 PRLSCFGLMKNSRDG------RSYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLS-GKHIPPSHALDLIRDRNIQT  267 (329)
Q Consensus       195 ~kl~Dfg~a~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t-g~~~~~~~~~~~~~~~~~~~  267 (329)
                      ++|+|||+++.....      ....++..|+|||.+.+..++.++||||||+++|||++ |+.|+.........    ..
T Consensus       278 ~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~e~l~~g~~P~~~~~~~~~~----~~  353 (401)
T cd05107         278 VKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPYPELPMNEQF----YN  353 (401)
T ss_pred             EEEEecCcceecccccccccCCCcCCCCceeChHHhcCCCCCcHhHHHHHHHHHHHHHHcCCCCCCCCCchHHH----HH
Confidence            999999998754322      12345678999999998889999999999999999998 77666432211111    11


Q ss_pred             hccccccCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhh
Q 020221          268 LTDSCLEGQFSSDEGTELVRLASRCLQYEPRERPNPRSLVTALVTL  313 (329)
Q Consensus       268 ~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~~~l~~L~~~  313 (329)
                      ......+...+...+.++.+++.+||..+|++||+++++++.|+.+
T Consensus       354 ~~~~~~~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L~~~  399 (401)
T cd05107         354 AIKRGYRMAKPAHASDEIYEIMQKCWEEKFEIRPDFSQLVHLVGDL  399 (401)
T ss_pred             HHHcCCCCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHH
Confidence            1111112233445678999999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D

>cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase

Probab=100.00  E-value=9.9e-42  Score=295.16  Aligned_cols=242  Identities=22%  Similarity=0.297  Sum_probs=197.8

Q ss_pred             cCCCCCCcEEEEEEeCC--C--CEEEEEEeCCCCC-hhHHHHHHHHHHHhcCCCccccccceeeeeCCeeEEEEecCCCC
Q 020221           64 EHGEKAPNVVYKGKLEN--Q--FRIAVKRFNRSAW-PDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAEYMPND  138 (329)
Q Consensus        64 ~lg~G~~g~V~~~~~~~--~--~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g  138 (329)
                      .||+|++|.||++.+.+  +  ..||+|.+..... ...+.+.+|+..++.++||||+++++.+.. ...++++||++++
T Consensus         2 ~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~~~~~   80 (257)
T cd05040           2 KLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLYGVVLT-HPLMMVTELAPLG   80 (257)
T ss_pred             cCCccCcccEEeeeEecCCCCceEEEEeecCCcccHHHHHHHHHHHHHHhhcCCCCccceeEEEcC-CeEEEEEEecCCC
Confidence            46999999999998533  3  3699999988765 456678999999999999999999999987 8899999999999


Q ss_pred             CHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCCCCCeeeecccCcccCCCCC-------C
Q 020221          139 TLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDGR-------S  211 (329)
Q Consensus       139 sL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~-------~  211 (329)
                      +|.+++.+.....+++..+..++.|++.||.|||++ +++|+||||+||+++.++.+||+|||++.......       .
T Consensus        81 ~L~~~l~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~-~i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~  159 (257)
T cd05040          81 SLLDRLRKDALGHFLISTLCDYAVQIANGMRYLESK-RFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVMEEH  159 (257)
T ss_pred             cHHHHHHhcccccCcHHHHHHHHHHHHHHHHHHHhC-CccccccCcccEEEecCCEEEeccccccccccccccceecccC
Confidence            999999753335689999999999999999999999 99999999999999999999999999987654421       2


Q ss_pred             ccCcccccCcccccCCCCCCcccchhhhHHHHHHHh-CCCCCCchhhHHHhhhchhhhccccccCCCChHHHHHHHHHHH
Q 020221          212 YSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLS-GKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLAS  290 (329)
Q Consensus       212 ~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t-g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~  290 (329)
                      ..++..|+|||.+.+..++.++||||||+++|+|++ |..|+..............    .......+...+..+.+++.
T Consensus       160 ~~~~~~y~~pE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~li~  235 (257)
T cd05040         160 LKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGLSGSQILKKIDK----EGERLERPEACPQDIYNVML  235 (257)
T ss_pred             CCCCceecCHHHhcccCcCchhhhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHh----cCCcCCCCccCCHHHHHHHH
Confidence            345678999999998889999999999999999998 8877643322221111111    11111223445778999999


Q ss_pred             HhcccCCCCCCCHHHHHHHHH
Q 020221          291 RCLQYEPRERPNPRSLVTALV  311 (329)
Q Consensus       291 ~cl~~dp~~Rps~~~~l~~L~  311 (329)
                      +||+.+|++|||+.++++.|.
T Consensus       236 ~~l~~~p~~Rps~~~~~~~l~  256 (257)
T cd05040         236 QCWAHNPADRPTFAALREFLP  256 (257)
T ss_pred             HHCCCCcccCCCHHHHHHHhc
Confidence            999999999999999999874

Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and

>cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases

Probab=100.00  E-value=4.7e-42  Score=301.36  Aligned_cols=255  Identities=22%  Similarity=0.329  Sum_probs=203.9

Q ss_pred             CcccccccCCCCCCcEEEEEEeC-----CCCEEEEEEeCCCCCh-hHHHHHHHHHHHhcCCCccccccceeeee--CCee
Q 020221           57 AMENIVSEHGEKAPNVVYKGKLE-----NQFRIAVKRFNRSAWP-DARQFLEEARAVGQLRNRRLANLLGCCCE--GDER  128 (329)
Q Consensus        57 ~~~~~~~~lg~G~~g~V~~~~~~-----~~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~~~~~~~~--~~~~  128 (329)
                      ..+++++.||+|+||.||++.+.     +++.+|+|.+...... ..+.+.+|++.++.++|+||+++++++..  ....
T Consensus         4 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~~~~~   83 (284)
T cd05038           4 RHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIVKYKGVCEKPGGRSL   83 (284)
T ss_pred             hhchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccchHHHHHHHHHHHHHHhCCCCChheEEeeeecCCCCce
Confidence            34567788899999999999843     3678999999876543 45678999999999999999999998876  5578


Q ss_pred             EEEEecCCCCCHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCCCCCeeeecccCcccCCC
Q 020221          129 LLVAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRD  208 (329)
Q Consensus       129 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~  208 (329)
                      +++|||+++++|.+++.. ....+++..+..++.|++.||+|||++ +++|+||||+||+++.++.++|+|||++.....
T Consensus        84 ~lv~e~~~~~~l~~~l~~-~~~~~~~~~~~~~~~~l~~aL~~lH~~-~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~  161 (284)
T cd05038          84 RLIMEYLPSGSLRDYLQR-HRDQINLKRLLLFSSQICKGMDYLGSQ-RYIHRDLAARNILVESEDLVKISDFGLAKVLPE  161 (284)
T ss_pred             EEEEecCCCCCHHHHHHh-CccccCHHHHHHHHHHHHHHHHHHHhC-CeecCCCCHHhEEEcCCCCEEEccccccccccc
Confidence            999999999999999964 233589999999999999999999999 999999999999999999999999999887653


Q ss_pred             CCC-------ccCcccccCcccccCCCCCCcccchhhhHHHHHHHhCCCCCCchhhHHHh----------hhchhhhccc
Q 020221          209 GRS-------YSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIR----------DRNIQTLTDS  271 (329)
Q Consensus       209 ~~~-------~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~~----------~~~~~~~~~~  271 (329)
                      ...       ...+..|+|||.+.+..++.++||||||+++++|++|..|+.........          .......+..
T Consensus       162 ~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  241 (284)
T cd05038         162 DKDYYYVKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQGQMIVTRLLELLKE  241 (284)
T ss_pred             CCcceeccCCCCCcccccCcHHHccCCCCcccchHHHhhhhheeeccCCCcccccchhccccccccccccHHHHHHHHHc
Confidence            221       22345699999998888999999999999999999999876443211110          0011111111


Q ss_pred             cccCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhh
Q 020221          272 CLEGQFSSDEGTELVRLASRCLQYEPRERPNPRSLVTALVTL  313 (329)
Q Consensus       272 ~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~~~l~~L~~~  313 (329)
                      ......+..++.++.+++.+||..+|++|||+.++++.|+.+
T Consensus       242 ~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~i  283 (284)
T cd05038         242 GERLPRPPSCPDEVYDLMKLCWEAEPQDRPSFADLILIVDRL  283 (284)
T ss_pred             CCcCCCCccCCHHHHHHHHHHhccChhhCCCHHHHHHHHhhc
Confidence            112222345567899999999999999999999999999876

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut

>cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases

Probab=100.00  E-value=8.4e-42  Score=297.74  Aligned_cols=245  Identities=20%  Similarity=0.277  Sum_probs=187.8

Q ss_pred             cCCCCCCcEEEEEEeCC---CCEEEEEEeCCCCCh-hHHHHHHHHHHHhcCCCccccccceeeeeCCeeEEEEecCCCCC
Q 020221           64 EHGEKAPNVVYKGKLEN---QFRIAVKRFNRSAWP-DARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAEYMPNDT  139 (329)
Q Consensus        64 ~lg~G~~g~V~~~~~~~---~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gs  139 (329)
                      .||+|+||.||+|...+   ...+++|.+...... ....+.+|+..++.++|+||+++++.+......++||||+++|+
T Consensus         2 ~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~~~~lv~e~~~~g~   81 (269)
T cd05042           2 EIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEFCPLGD   81 (269)
T ss_pred             cCCccCCceEEEEEEecCCCCeEEEEeecCccCChHHHHHHHHHHHHHHhCCCCCcceEEEEECCCCceEEEEEeCCCCc
Confidence            57999999999997432   356888887654322 23467899999999999999999999999999999999999999


Q ss_pred             HHhhhccCCC---CCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCCCCCeeeecccCcccCCCC------C
Q 020221          140 LAKHLFHWET---QPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDG------R  210 (329)
Q Consensus       140 L~~~l~~~~~---~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~------~  210 (329)
                      |.+++.....   ...++.....++.||+.||+|||+. +++||||||+||++++++.+||+|||++......      .
T Consensus        82 L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~-~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~~~  160 (269)
T cd05042          82 LKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQA-DFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYITKD  160 (269)
T ss_pred             HHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHhc-CEecccccHhheEecCCCcEEEeccccccccccchheeccC
Confidence            9999865321   2346788899999999999999999 9999999999999999999999999998653222      1


Q ss_pred             CccCcccccCcccccC-------CCCCCcccchhhhHHHHHHHh-CCCCCCchhhHHHhhhchhhhccccccCCCChHHH
Q 020221          211 SYSTNLAFTPPEYLRT-------GRVTPESVMYSFGTLLLDLLS-GKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEG  282 (329)
Q Consensus       211 ~~~~~~~y~aPE~~~~-------~~~~~~~DvwslG~il~el~t-g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  282 (329)
                      ...++..|+|||++..       ..++.++||||||+++|||++ |..|+.........................+...+
T Consensus       161 ~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (269)
T cd05042         161 CHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQVLKQVVREQDIKLPKPQLDLKYS  240 (269)
T ss_pred             CCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCHHHHHHHHhhccCccCCCCcccccCC
Confidence            2234567999998743       346789999999999999999 55555433222111111111111112223344567


Q ss_pred             HHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 020221          283 TELVRLASRCLQYEPRERPNPRSLVTAL  310 (329)
Q Consensus       283 ~~~~~li~~cl~~dp~~Rps~~~~l~~L  310 (329)
                      ..+.+++..|| .||++|||+.+|++.|
T Consensus       241 ~~~~~~~~~~~-~dp~~Rpt~~~v~~~l  267 (269)
T cd05042         241 DRWYEVMQFCW-LDPETRPTAEEVHELL  267 (269)
T ss_pred             HHHHHHHHHHh-cCcccccCHHHHHHHh
Confidence            88899999999 5999999999999876

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina

>cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase

Probab=100.00  E-value=5.4e-42  Score=303.88  Aligned_cols=251  Identities=17%  Similarity=0.249  Sum_probs=198.5

Q ss_pred             CCCcccccccCCCCCCcEEEEEEe-CCCCEEEEEEeCCCCC-hhHHHHHHHHHHHhcCCCccccccceeeeeCCeeEEEE
Q 020221           55 GFAMENIVSEHGEKAPNVVYKGKL-ENQFRIAVKRFNRSAW-PDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVA  132 (329)
Q Consensus        55 ~~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~  132 (329)
                      .++.|.+++.||.|+||.||++.. .+++.||+|.+..... .....+.+|+.+++.++||||+++++++..+...++|+
T Consensus         4 ~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~   83 (301)
T cd07873           4 KLETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVF   83 (301)
T ss_pred             cccceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEecccccCchhHHHHHHHHHHhcCCCCcceEEEEEecCCeEEEEE
Confidence            456788889999999999999984 4678999999875432 22345778999999999999999999999999999999


Q ss_pred             ecCCCCCHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCCCCCeeeecccCcccCCCC---
Q 020221          133 EYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDG---  209 (329)
Q Consensus       133 e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~---  209 (329)
                      ||+.+ +|.+++.. ....+++..+..++.|++.||.|||+. +++|+||||+||++++++.++|+|||++......   
T Consensus        84 e~~~~-~l~~~l~~-~~~~~~~~~~~~~~~qi~~aL~~lH~~-~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~  160 (301)
T cd07873          84 EYLDK-DLKQYLDD-CGNSINMHNVKLFLFQLLRGLNYCHRR-KVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKT  160 (301)
T ss_pred             ecccc-CHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHhC-CeeCCCCCHHHEEECCCCcEEECcCcchhccCCCCCc
Confidence            99974 89888864 345688999999999999999999999 9999999999999999999999999998754322   


Q ss_pred             -CCccCcccccCcccccCC-CCCCcccchhhhHHHHHHHhCCCCCCchhhHHHhhhch-------hhhcccc--------
Q 020221          210 -RSYSTNLAFTPPEYLRTG-RVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNI-------QTLTDSC--------  272 (329)
Q Consensus       210 -~~~~~~~~y~aPE~~~~~-~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~~~~~~-------~~~~~~~--------  272 (329)
                       ....++..|+|||.+.+. .++.++||||||+++|+|++|..||.............       .......        
T Consensus       161 ~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (301)
T cd07873         161 YSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNEEFKS  240 (301)
T ss_pred             ccccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChhhchhhhccccccc
Confidence             223457899999988754 47889999999999999999998886543221111000       0000000        


Q ss_pred             -----ccC----CCChHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 020221          273 -----LEG----QFSSDEGTELVRLASRCLQYEPRERPNPRSLVT  308 (329)
Q Consensus       273 -----~~~----~~~~~~~~~~~~li~~cl~~dp~~Rps~~~~l~  308 (329)
                           ...    ......++++.+++.+||..||.+|||+.++++
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~eil~  285 (301)
T cd07873         241 YNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMK  285 (301)
T ss_pred             cccCccccccHHhhcCCCCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence                 000    011235678899999999999999999999998

Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl

>cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase)

Probab=100.00  E-value=9.5e-42  Score=299.12  Aligned_cols=252  Identities=19%  Similarity=0.241  Sum_probs=203.1

Q ss_pred             ccccccCCCCCCcEEEEEEeCC-----CCEEEEEEeCCCCC-hhHHHHHHHHHHHhcCCCccccccceeeee-CCeeEEE
Q 020221           59 ENIVSEHGEKAPNVVYKGKLEN-----QFRIAVKRFNRSAW-PDARQFLEEARAVGQLRNRRLANLLGCCCE-GDERLLV  131 (329)
Q Consensus        59 ~~~~~~lg~G~~g~V~~~~~~~-----~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~-~~~~~lv  131 (329)
                      +.+.+.||+|+||.||+|...+     +..|++|.+..... .....+.+|+.+++.++|+||+++++++.. +...+++
T Consensus         8 ~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~~   87 (280)
T cd05043           8 VTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILPILHVCIEDGEPPFVL   87 (280)
T ss_pred             eEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCCCEEE
Confidence            4556677999999999999654     68899999875532 234568899999999999999999998765 4678999


Q ss_pred             EecCCCCCHHhhhccCCC------CCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCCCCCeeeecccCccc
Q 020221          132 AEYMPNDTLAKHLFHWET------QPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKN  205 (329)
Q Consensus       132 ~e~~~~gsL~~~l~~~~~------~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~  205 (329)
                      ++|+++++|.+++.....      ..+++.++..++.|++.||+|||+. +++|+||||+||++++++.+||+|||+++.
T Consensus        88 ~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~-~i~H~di~p~nil~~~~~~~kl~d~g~~~~  166 (280)
T cd05043          88 YPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKR-GVIHKDIAARNCVIDEELQVKITDNALSRD  166 (280)
T ss_pred             EEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHC-CEeecccCHhhEEEcCCCcEEECCCCCccc
Confidence            999999999999864322      4689999999999999999999999 999999999999999999999999999976


Q ss_pred             CCCCC------CccCcccccCcccccCCCCCCcccchhhhHHHHHHHh-CCCCCCchhhHHHhhhchhhhccccccCCCC
Q 020221          206 SRDGR------SYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLS-GKHIPPSHALDLIRDRNIQTLTDSCLEGQFS  278 (329)
Q Consensus       206 ~~~~~------~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t-g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  278 (329)
                      .....      ...++..|+|||++.+..++.++||||||+++||+++ |..|+.............     .......+
T Consensus       167 ~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~-----~~~~~~~~  241 (280)
T cd05043         167 LFPMDYHCLGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEIDPFEMAAYLK-----DGYRLAQP  241 (280)
T ss_pred             ccCCceEEeCCCCCcchhccCHHHHhcCCCCchhhHHHhHHHHHHHhcCCCCCcCcCCHHHHHHHHH-----cCCCCCCC
Confidence            54322      2234677999999988889999999999999999999 887765432222211111     11111223


Q ss_pred             hHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhhc
Q 020221          279 SDEGTELVRLASRCLQYEPRERPNPRSLVTALVTLQKD  316 (329)
Q Consensus       279 ~~~~~~~~~li~~cl~~dp~~Rps~~~~l~~L~~~~~~  316 (329)
                      ..+++++.+++.+||..||++|||+.++++.|+.+.+.
T Consensus       242 ~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~~~~~~  279 (280)
T cd05043         242 INCPDELFAVMACCWALDPEERPSFSQLVQCLTDFHAQ  279 (280)
T ss_pred             CcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHhc
Confidence            44577899999999999999999999999999998764

Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It

>cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5

Probab=100.00  E-value=3.1e-42  Score=304.13  Aligned_cols=239  Identities=18%  Similarity=0.243  Sum_probs=196.8

Q ss_pred             ccCCCCCCcEEEEEE-eCCCCEEEEEEeCCCCChhHHHHHHHHHHHhcCCCccccccceeeeeCCeeEEEEecCCCCCHH
Q 020221           63 SEHGEKAPNVVYKGK-LENQFRIAVKRFNRSAWPDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAEYMPNDTLA  141 (329)
Q Consensus        63 ~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~  141 (329)
                      ..||+|+||.||++. ..++..||+|.+........+.+.+|+..++.++|+|++++++.+..++..+++|||+++++|.
T Consensus        28 ~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~lv~e~~~~~~L~  107 (292)
T cd06658          28 IKIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVMEFLEGGALT  107 (292)
T ss_pred             hcccCCCCeEEEEEEECCCCCEEEEEEEecchHHHHHHHHHHHHHHHhCCCCcHHHHHHheecCCeEEEEEeCCCCCcHH
Confidence            456999999999998 4568899999987665555667889999999999999999999999999999999999999999


Q ss_pred             hhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCCCCCeeeecccCcccCCCC----CCccCccc
Q 020221          142 KHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDG----RSYSTNLA  217 (329)
Q Consensus       142 ~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~----~~~~~~~~  217 (329)
                      +++.   ...+++..+..++.|++.||.|||+. +++|+||||+||++++++.++|+|||++......    ....++..
T Consensus       108 ~~~~---~~~l~~~~~~~~~~qi~~~l~~LH~~-~ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~~~~~~~~~~~~~~~  183 (292)
T cd06658         108 DIVT---HTRMNEEQIATVCLSVLRALSYLHNQ-GVIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVPKRKSLVGTPY  183 (292)
T ss_pred             HHHh---cCCCCHHHHHHHHHHHHHHHHHHHHC-CEeecCCCHHHEEEcCCCCEEEccCcchhhcccccccCceeecCcc
Confidence            9884   34689999999999999999999999 9999999999999999999999999998654322    22356789


Q ss_pred             ccCcccccCCCCCCcccchhhhHHHHHHHhCCCCCCchhhHHHhhhchhhhccccccCCCChHHHHHHHHHHHHhcccCC
Q 020221          218 FTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLASRCLQYEP  297 (329)
Q Consensus       218 y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp  297 (329)
                      |+|||.+.+..++.++||||||+++|||++|..|+........... ..........  .....+..+.+++.+||..||
T Consensus       184 y~aPE~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~-~~~~~~~~~~--~~~~~~~~~~~li~~~l~~~P  260 (292)
T cd06658         184 WMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNEPPLQAMRR-IRDNLPPRVK--DSHKVSSVLRGFLDLMLVREP  260 (292)
T ss_pred             ccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHH-HHhcCCCccc--cccccCHHHHHHHHHHccCCh
Confidence            9999999888899999999999999999999988764332211111 1111111111  122356789999999999999


Q ss_pred             CCCCCHHHHHH
Q 020221          298 RERPNPRSLVT  308 (329)
Q Consensus       298 ~~Rps~~~~l~  308 (329)
                      ++|||+.++++
T Consensus       261 ~~Rpt~~~il~  271 (292)
T cd06658         261 SQRATAQELLQ  271 (292)
T ss_pred             hHCcCHHHHhh
Confidence            99999999997

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express

>cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha

Probab=100.00  E-value=3.9e-42  Score=308.92  Aligned_cols=249  Identities=17%  Similarity=0.139  Sum_probs=196.2

Q ss_pred             cccccccCCCCCCcEEEEEEe-CCCCEEEEEEeCCCC---ChhHHHHHHHHHHHhcCCCccccccceeeeeCCeeEEEEe
Q 020221           58 MENIVSEHGEKAPNVVYKGKL-ENQFRIAVKRFNRSA---WPDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAE  133 (329)
Q Consensus        58 ~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  133 (329)
                      .|++++.||+|+||.||++.. .+++.+|+|++....   ......+.+|+.++..++|+||+++++++.+.+..++|||
T Consensus         2 ~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e   81 (332)
T cd05623           2 DFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQDENNLYLVMD   81 (332)
T ss_pred             CceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCEEEEEEe
Confidence            466778889999999999994 457889999986422   1223447789999999999999999999999999999999


Q ss_pred             cCCCCCHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCCCCCeeeecccCcccCCCC----
Q 020221          134 YMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDG----  209 (329)
Q Consensus       134 ~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~----  209 (329)
                      |+++|+|.+++.+ ....+++..+..++.||+.||.|||+. +++||||||+||+++.++.++|+|||++......    
T Consensus        82 y~~~g~L~~~l~~-~~~~l~~~~~~~~~~qi~~al~~lH~~-~iiHrDlkp~Nili~~~~~~kL~DfG~a~~~~~~~~~~  159 (332)
T cd05623          82 YYVGGDLLTLLSK-FEDRLPEDMARFYLAEMVIAIDSVHQL-HYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQ  159 (332)
T ss_pred             ccCCCcHHHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHHC-CeEecCCCHHHEEECCCCCEEEeecchheecccCCcce
Confidence            9999999999964 235689999999999999999999999 9999999999999999999999999998654322    


Q ss_pred             -CCccCcccccCccccc-----CCCCCCcccchhhhHHHHHHHhCCCCCCchhhHHHhhhchhhhccccccCCCChHHHH
Q 020221          210 -RSYSTNLAFTPPEYLR-----TGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGT  283 (329)
Q Consensus       210 -~~~~~~~~y~aPE~~~-----~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  283 (329)
                       ....||+.|+|||++.     ...++.++||||||+++|||++|+.||................. ...........++
T Consensus       160 ~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~~~-~~~~p~~~~~~s~  238 (332)
T cd05623         160 SSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKE-RFQFPAQVTDVSE  238 (332)
T ss_pred             ecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCCCHHHHHHHHhCCCc-cccCCCccccCCH
Confidence             1246889999999986     34588899999999999999999998876543222222111110 0001111234678


Q ss_pred             HHHHHHHHhcccCCCC--CCCHHHHHHH
Q 020221          284 ELVRLASRCLQYEPRE--RPNPRSLVTA  309 (329)
Q Consensus       284 ~~~~li~~cl~~dp~~--Rps~~~~l~~  309 (329)
                      ++.+++.+|+..++++  |+++.+++++
T Consensus       239 ~~~~li~~ll~~~~~r~~r~~~~~~~~h  266 (332)
T cd05623         239 DAKDLIRRLICSREHRLGQNGIEDFKQH  266 (332)
T ss_pred             HHHHHHHHHccChhhhcCCCCHHHHhCC
Confidence            8999999999765554  6889999874

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw

>cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase

Probab=100.00  E-value=1.3e-41  Score=295.04  Aligned_cols=248  Identities=20%  Similarity=0.310  Sum_probs=202.4

Q ss_pred             cccccccCCCCCCcEEEEEEeCCCCEEEEEEeCCCCChhHHHHHHHHHHHhcCCCccccccceeeeeCCeeEEEEecCCC
Q 020221           58 MENIVSEHGEKAPNVVYKGKLENQFRIAVKRFNRSAWPDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAEYMPN  137 (329)
Q Consensus        58 ~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~  137 (329)
                      .+++.+.+|+|+||.||++...++..+|+|.+.... .....+.+|+++++.++|+||+++.+.+.. ...+++|||+++
T Consensus         7 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~iK~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~v~e~~~~   84 (260)
T cd05073           7 SLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGS-MSVEAFLAEANVMKTLQHDKLVKLHAVVTK-EPIYIITEFMAK   84 (260)
T ss_pred             ceeEEeEecCccceEEEEEEecCCccEEEEecCCCh-hHHHHHHHHHHHHHhcCCCCcceEEEEEcC-CCeEEEEEeCCC
Confidence            456777889999999999997777789999887643 235678899999999999999999999877 778999999999


Q ss_pred             CCHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCCCCCeeeecccCcccCCCCCC-----c
Q 020221          138 DTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDGRS-----Y  212 (329)
Q Consensus       138 gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~~-----~  212 (329)
                      ++|.+++.......+++..+..++.|++.||.|||+. +++|+||||+||+++.++.++|+|||.+........     .
T Consensus        85 ~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~-~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~~~~~~  163 (260)
T cd05073          85 GSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQR-NYIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGA  163 (260)
T ss_pred             CcHHHHHHhCCccccCHHHHHHHHHHHHHHHHHHHhC-CccccccCcceEEEcCCCcEEECCCcceeeccCCCcccccCC
Confidence            9999999754455678899999999999999999999 999999999999999999999999999876543221     1


Q ss_pred             cCcccccCcccccCCCCCCcccchhhhHHHHHHHh-CCCCCCchhhHHHhhhchhhhccccccCCCChHHHHHHHHHHHH
Q 020221          213 STNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLS-GKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLASR  291 (329)
Q Consensus       213 ~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t-g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~  291 (329)
                      .++..|+|||++.+..++.++|+||||+++|++++ |..|+...............     .....+...+.++.+++.+
T Consensus       164 ~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~i~~  238 (260)
T cd05073         164 KFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERG-----YRMPRPENCPEELYNIMMR  238 (260)
T ss_pred             cccccccCHhHhccCCcCccccchHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhCC-----CCCCCcccCCHHHHHHHHH
Confidence            23467999999988889999999999999999999 77776544322222111111     1112234556789999999


Q ss_pred             hcccCCCCCCCHHHHHHHHHhh
Q 020221          292 CLQYEPRERPNPRSLVTALVTL  313 (329)
Q Consensus       292 cl~~dp~~Rps~~~~l~~L~~~  313 (329)
                      ||+.+|++||++.+++..|+.+
T Consensus       239 ~l~~~p~~Rp~~~~l~~~L~~~  260 (260)
T cd05073         239 CWKNRPEERPTFEYIQSVLDDF  260 (260)
T ss_pred             HcccCcccCcCHHHHHHHHhcC
Confidence            9999999999999999998753

Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa

>cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9

Probab=100.00  E-value=1.5e-41  Score=293.94  Aligned_cols=245  Identities=18%  Similarity=0.190  Sum_probs=203.2

Q ss_pred             ccccccCCCCCCcEEEEEE-eCCCCEEEEEEeCCCC--ChhHHHHHHHHHHHhcCCCccccccceeeeeCCeeEEEEecC
Q 020221           59 ENIVSEHGEKAPNVVYKGK-LENQFRIAVKRFNRSA--WPDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAEYM  135 (329)
Q Consensus        59 ~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~  135 (329)
                      |+.++.+|+|+||.||.+. ..+++.+++|.+....  ....+.+.+|+++++.++|+||+++++++.+....+++|||+
T Consensus         2 y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~~~e~~   81 (256)
T cd08221           2 YIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNHFMDDNTLLIEMEYA   81 (256)
T ss_pred             ceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccchhHHHHHHHHHHHHHhCCCCCeeEEEeEEecCCeEEEEEEec
Confidence            5667778999999999998 5668899999987543  233556889999999999999999999999999999999999


Q ss_pred             CCCCHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCCCCCeeeecccCcccCCCCC----C
Q 020221          136 PNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDGR----S  211 (329)
Q Consensus       136 ~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~----~  211 (329)
                      ++++|.+++.+.....+++.++..++.|++.||.|||+. +++|+||+|+||++++++.+||+|||++.......    .
T Consensus        82 ~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~-~i~h~dl~p~ni~~~~~~~~kl~d~~~~~~~~~~~~~~~~  160 (256)
T cd08221          82 NGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHKA-GILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYSMAET  160 (256)
T ss_pred             CCCcHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhC-CccccCCChHhEEEeCCCCEEECcCcceEEcccccccccc
Confidence            999999999754445689999999999999999999999 99999999999999999999999999987654332    3


Q ss_pred             ccCcccccCcccccCCCCCCcccchhhhHHHHHHHhCCCCCCchhhHHHhhhchhhhccccccCCCChHHHHHHHHHHHH
Q 020221          212 YSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLASR  291 (329)
Q Consensus       212 ~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~  291 (329)
                      ..+++.|.|||.+.+..++.++|+||||+++|+|++|..|+..............    .. ....+...+.++.+++.+
T Consensus       161 ~~~~~~y~ape~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~~~~~~~----~~-~~~~~~~~~~~~~~~i~~  235 (256)
T cd08221         161 VVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDATNPLNLVVKIVQ----GN-YTPVVSVYSSELISLVHS  235 (256)
T ss_pred             cCCCccccCHhhcCCCCCCCcchhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHc----CC-CCCCccccCHHHHHHHHH
Confidence            4578899999999888889999999999999999999988765432222211111    11 112234557789999999


Q ss_pred             hcccCCCCCCCHHHHHHH
Q 020221          292 CLQYEPRERPNPRSLVTA  309 (329)
Q Consensus       292 cl~~dp~~Rps~~~~l~~  309 (329)
                      ||..+|++||++.++++.
T Consensus       236 ~l~~~p~~R~s~~~ll~~  253 (256)
T cd08221         236 LLQQDPEKRPTADEVLDQ  253 (256)
T ss_pred             HcccCcccCCCHHHHhhC
Confidence            999999999999999983

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa

>cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase

Probab=100.00  E-value=7.6e-42  Score=299.37  Aligned_cols=248  Identities=20%  Similarity=0.303  Sum_probs=198.9

Q ss_pred             ccccccCCCCCCcEEEEEEeC------CCCEEEEEEeCCCCCh-hHHHHHHHHHHHhcCCCccccccceeeeeCCeeEEE
Q 020221           59 ENIVSEHGEKAPNVVYKGKLE------NQFRIAVKRFNRSAWP-DARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLV  131 (329)
Q Consensus        59 ~~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv  131 (329)
                      +.+++.||+|++|.||+|...      .+..|++|.+...... ....+.+|+.+++.++|+||+++++++.+....+++
T Consensus         8 ~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv   87 (277)
T cd05036           8 ITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVRLIGVSFERLPRFIL   87 (277)
T ss_pred             cEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCcEEE
Confidence            456677799999999999854      4578999988755433 244688999999999999999999999888899999


Q ss_pred             EecCCCCCHHhhhccCCC-----CCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCCCC---CeeeecccCc
Q 020221          132 AEYMPNDTLAKHLFHWET-----QPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDV---NPRLSCFGLM  203 (329)
Q Consensus       132 ~e~~~~gsL~~~l~~~~~-----~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~---~~kl~Dfg~a  203 (329)
                      |||+++++|.+++.+...     ..+++..+..++.||+.||.|||++ +++|+||||+||+++.++   .++|+|||++
T Consensus        88 ~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~-~ivH~dlkp~nil~~~~~~~~~~kl~dfg~~  166 (277)
T cd05036          88 LELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEEN-HFIHRDIAARNCLLTCKGPGRVAKIADFGMA  166 (277)
T ss_pred             EecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHC-CEeecccchheEEEeccCCCcceEeccCccc
Confidence            999999999999864321     2588999999999999999999999 999999999999998655   5999999998


Q ss_pred             ccCCCCC------CccCcccccCcccccCCCCCCcccchhhhHHHHHHHh-CCCCCCchhhHHHhhhchhhhccccccCC
Q 020221          204 KNSRDGR------SYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLS-GKHIPPSHALDLIRDRNIQTLTDSCLEGQ  276 (329)
Q Consensus       204 ~~~~~~~------~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t-g~~~~~~~~~~~~~~~~~~~~~~~~~~~~  276 (329)
                      +......      ....+..|+|||++.+..++.++||||||+++|+|++ |..||...........     ........
T Consensus       167 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~~g~~pf~~~~~~~~~~~-----~~~~~~~~  241 (277)
T cd05036         167 RDIYRASYYRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQEVMEF-----VTGGGRLD  241 (277)
T ss_pred             cccCCccceecCCCCCccHhhCCHHHHhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH-----HHcCCcCC
Confidence            7653221      1122467999999998889999999999999999997 7777655433222111     11112223


Q ss_pred             CChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHh
Q 020221          277 FSSDEGTELVRLASRCLQYEPRERPNPRSLVTALVT  312 (329)
Q Consensus       277 ~~~~~~~~~~~li~~cl~~dp~~Rps~~~~l~~L~~  312 (329)
                      .+...+..+.+++.+||+.+|++|||+.+++++|+.
T Consensus       242 ~~~~~~~~~~~~i~~cl~~~p~~Rps~~~vl~~l~~  277 (277)
T cd05036         242 PPKGCPGPVYRIMTDCWQHTPEDRPNFATILERIQY  277 (277)
T ss_pred             CCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHhhC
Confidence            345567889999999999999999999999998863

Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well

>KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.8e-42  Score=305.70  Aligned_cols=251  Identities=17%  Similarity=0.241  Sum_probs=211.4

Q ss_pred             ccccccCCCCCCcEEEEEE-eCCCCEEEEEEeCCCCChh--HHHHHHHHHHHhcCCCccccccceeeeeCCeeEEEEecC
Q 020221           59 ENIVSEHGEKAPNVVYKGK-LENQFRIAVKRFNRSAWPD--ARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAEYM  135 (329)
Q Consensus        59 ~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~--~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~  135 (329)
                      |.+-+.||+|.|+.|-+++ .-+|+.||||++.+.....  ...+.+|++.|+.++|||||+++++......+|||+|+-
T Consensus        20 YDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~st~hlfqEVRCMKLVQHpNiVRLYEViDTQTKlyLiLELG   99 (864)
T KOG4717|consen   20 YDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTLSTGHLFQEVRCMKLVQHPNIVRLYEVIDTQTKLYLILELG   99 (864)
T ss_pred             ehhhhhhcCCceehhhhhhhhcccceeEEEEecccccchhhhhHHHHHHHHHHHhcCcCeeeeeehhcccceEEEEEEec
Confidence            4455667999999999998 6689999999998875443  345889999999999999999999999999999999999


Q ss_pred             CCCCHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeC-CCCCeeeecccCcccCCCCC---C
Q 020221          136 PNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFD-DDVNPRLSCFGLMKNSRDGR---S  211 (329)
Q Consensus       136 ~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~-~~~~~kl~Dfg~a~~~~~~~---~  211 (329)
                      ++|+|.+||-. ....+.+..+.+++.||+.|+.|+|.. .+|||||||+||++. .-|-+||.|||++-.+.++.   +
T Consensus       100 D~GDl~DyImK-He~Gl~E~La~kYF~QI~~AI~YCHqL-HVVHRDLKPENVVFFEKlGlVKLTDFGFSNkf~PG~kL~T  177 (864)
T KOG4717|consen  100 DGGDLFDYIMK-HEEGLNEDLAKKYFAQIVHAISYCHQL-HVVHRDLKPENVVFFEKLGLVKLTDFGFSNKFQPGKKLTT  177 (864)
T ss_pred             CCchHHHHHHh-hhccccHHHHHHHHHHHHHHHHHHhhh-hhhcccCCcceeEEeeecCceEeeeccccccCCCcchhhc
Confidence            99999999975 456799999999999999999999999 999999999999886 46789999999998888774   5


Q ss_pred             ccCcccccCcccccCCCCCC-cccchhhhHHHHHHHhCCCCCCchhhHHHhhhchhhhccccccCCCChHHHHHHHHHHH
Q 020221          212 YSTNLAFTPPEYLRTGRVTP-ESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLAS  290 (329)
Q Consensus       212 ~~~~~~y~aPE~~~~~~~~~-~~DvwslG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~  290 (329)
                      .+|.+.|.|||.+.|..|+. .+||||||||||.|++|+.||...........    ++ .+ ....|...+.++++||.
T Consensus       178 sCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeANDSETLTm----Im-DC-KYtvPshvS~eCrdLI~  251 (864)
T KOG4717|consen  178 SCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEANDSETLTM----IM-DC-KYTVPSHVSKECRDLIQ  251 (864)
T ss_pred             ccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccccchhhhhh----hh-cc-cccCchhhhHHHHHHHH
Confidence            57899999999999998775 79999999999999999988865433222211    11 11 23467889999999999


Q ss_pred             HhcccCCCCCCCHHHHHH--HHHhhhhcc
Q 020221          291 RCLQYEPRERPNPRSLVT--ALVTLQKDT  317 (329)
Q Consensus       291 ~cl~~dp~~Rps~~~~l~--~L~~~~~~~  317 (329)
                      .||..||.+|-+.++|..  +|+.+.+..
T Consensus       252 sMLvRdPkkRAslEeI~s~~Wlq~~D~~~  280 (864)
T KOG4717|consen  252 SMLVRDPKKRASLEEIVSTSWLQAGDRGL  280 (864)
T ss_pred             HHHhcCchhhccHHHHhccccccCCCCCc
Confidence            999999999999999985  444444433

>cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2

Probab=100.00  E-value=1.1e-41  Score=296.82  Aligned_cols=247  Identities=21%  Similarity=0.285  Sum_probs=199.7

Q ss_pred             cccccCCCCCCcEEEEEEeC-CC---CEEEEEEeCCCC-ChhHHHHHHHHHHHhcCCCccccccceeeeeCCeeEEEEec
Q 020221           60 NIVSEHGEKAPNVVYKGKLE-NQ---FRIAVKRFNRSA-WPDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAEY  134 (329)
Q Consensus        60 ~~~~~lg~G~~g~V~~~~~~-~~---~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  134 (329)
                      +..+.+|+|+||.||+|... ++   ..+|+|.+.... ....+.+.+|+++++.++|+|++++.+++...+..+++|||
T Consensus         8 ~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   87 (268)
T cd05063           8 TKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLEGVVTKFKPAMIITEY   87 (268)
T ss_pred             eEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCCCeeEEEEEEccCCCcEEEEEc
Confidence            34455699999999999853 33   379999987653 23355688999999999999999999999999999999999


Q ss_pred             CCCCCHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCCCCCeeeecccCcccCCCCCC---
Q 020221          135 MPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDGRS---  211 (329)
Q Consensus       135 ~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~~---  211 (329)
                      +++++|.+++.. ....+++.++..++.|++.||.|||+. +++|+||||+||++++++.++|+|||++........   
T Consensus        88 ~~~~~L~~~~~~-~~~~~~~~~~~~~~~~l~~al~~lH~~-~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~~~~~~  165 (268)
T cd05063          88 MENGALDKYLRD-HDGEFSSYQLVGMLRGIAAGMKYLSDM-NYVHRDLAARNILVNSNLECKVSDFGLSRVLEDDPEGTY  165 (268)
T ss_pred             CCCCCHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHHC-CeeccccchhhEEEcCCCcEEECCCccceecccccccce
Confidence            999999999864 345689999999999999999999999 999999999999999999999999999875543221   


Q ss_pred             ----ccCcccccCcccccCCCCCCcccchhhhHHHHHHHh-CCCCCCchhhHHHhhhchhhhccccccCCCChHHHHHHH
Q 020221          212 ----YSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLS-GKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELV  286 (329)
Q Consensus       212 ----~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t-g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  286 (329)
                          ...+..|+|||++.+..++.++||||||+++|+|++ |..|+..............     ......+.+.+.++.
T Consensus       166 ~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~il~ell~~g~~p~~~~~~~~~~~~i~~-----~~~~~~~~~~~~~~~  240 (268)
T cd05063         166 TTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMSNHEVMKAIND-----GFRLPAPMDCPSAVY  240 (268)
T ss_pred             eccCCCcCceecCHHHhhcCCcChHhHHHHHHHHHHHHHhCCCCCCCcCCHHHHHHHHhc-----CCCCCCCCCCCHHHH
Confidence                112356999999988889999999999999999997 8887754332222211111     112223345678899


Q ss_pred             HHHHHhcccCCCCCCCHHHHHHHHHhh
Q 020221          287 RLASRCLQYEPRERPNPRSLVTALVTL  313 (329)
Q Consensus       287 ~li~~cl~~dp~~Rps~~~~l~~L~~~  313 (329)
                      +++.+||+.+|++||++.++++.|+++
T Consensus       241 ~li~~c~~~~p~~Rp~~~~i~~~l~~~  267 (268)
T cd05063         241 QLMLQCWQQDRARRPRFVDIVNLLDKL  267 (268)
T ss_pred             HHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence            999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored

>cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron

Probab=100.00  E-value=1.1e-41  Score=295.64  Aligned_cols=245  Identities=24%  Similarity=0.330  Sum_probs=191.9

Q ss_pred             cCCCCCCcEEEEEEeC----CCCEEEEEEeCCCC-ChhHHHHHHHHHHHhcCCCccccccceeee-eCCeeEEEEecCCC
Q 020221           64 EHGEKAPNVVYKGKLE----NQFRIAVKRFNRSA-WPDARQFLEEARAVGQLRNRRLANLLGCCC-EGDERLLVAEYMPN  137 (329)
Q Consensus        64 ~lg~G~~g~V~~~~~~----~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~-~~~~~~lv~e~~~~  137 (329)
                      .||+|+||.||+|...    +...+|+|.+.... ....+.+.+|+.+++.++||||+++++++. .++..++++||+.+
T Consensus         2 ~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~~~   81 (262)
T cd05058           2 VIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVLPYMKH   81 (262)
T ss_pred             cccccCCceEEEEEEecCCCceEEEEEEecCccCCHHHHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEEEEecCCC
Confidence            4699999999999842    23579999986433 234567889999999999999999999775 35568899999999


Q ss_pred             CCHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCCCCCeeeecccCcccCCCC--------
Q 020221          138 DTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDG--------  209 (329)
Q Consensus       138 gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~--------  209 (329)
                      ++|.+++.+ .....++..+..++.|++.||.|||+. +++|+||||+||++++++.+||+|||++......        
T Consensus        82 ~~L~~~~~~-~~~~~~~~~~~~~~~~i~~~l~~lH~~-~i~H~dlk~~nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~  159 (262)
T cd05058          82 GDLRNFIRS-ETHNPTVKDLIGFGLQVAKGMEYLASK-KFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVHNH  159 (262)
T ss_pred             CCHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHhC-CccccccCcceEEEcCCCcEEECCccccccccCCcceeeccc
Confidence            999999864 234567888899999999999999999 9999999999999999999999999998754321        


Q ss_pred             CCccCcccccCcccccCCCCCCcccchhhhHHHHHHHhCCCCCCch-hhHHHhhhchhhhccccccCCCChHHHHHHHHH
Q 020221          210 RSYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSH-ALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRL  288 (329)
Q Consensus       210 ~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  288 (329)
                      ....++..|+|||.+.+..++.++||||||+++|||++|+.|+... ........    +. .......+...+..+.++
T Consensus       160 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~----~~-~~~~~~~~~~~~~~~~~l  234 (262)
T cd05058         160 TGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVDSFDITVY----LL-QGRRLLQPEYCPDPLYEV  234 (262)
T ss_pred             ccCcCCccccChhHhccCccchHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH----Hh-cCCCCCCCCcCCHHHHHH
Confidence            1223456899999998888999999999999999999976544322 11111111    11 111112233456789999


Q ss_pred             HHHhcccCCCCCCCHHHHHHHHHhhhh
Q 020221          289 ASRCLQYEPRERPNPRSLVTALVTLQK  315 (329)
Q Consensus       289 i~~cl~~dp~~Rps~~~~l~~L~~~~~  315 (329)
                      +.+||..+|++||++.++++.|+++..
T Consensus       235 i~~cl~~~p~~Rp~~~~il~~l~~~~~  261 (262)
T cd05058         235 MLSCWHPKPEMRPTFSELVSRIEQIFS  261 (262)
T ss_pred             HHHHcCCChhhCCCHHHHHHHHHHHhc
Confidence            999999999999999999999998753

Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca

>cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like

Probab=100.00  E-value=6.6e-42  Score=300.75  Aligned_cols=248  Identities=19%  Similarity=0.226  Sum_probs=194.4

Q ss_pred             ccccccCCCCCCcEEEEEEe-CCCCEEEEEEeCCCCC--hhHHHHHHHHHHHhcCCCccccccceeeeeCCeeEEEEecC
Q 020221           59 ENIVSEHGEKAPNVVYKGKL-ENQFRIAVKRFNRSAW--PDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAEYM  135 (329)
Q Consensus        59 ~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~  135 (329)
                      |++++.||+|++|.||+|.. .+++.||+|.+.....  .....+.+|+.+++.++|||++++++++..+...++||||+
T Consensus         2 y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~   81 (285)
T cd07861           2 YTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDVLMQESRLYLIFEFL   81 (285)
T ss_pred             ceEeeEecccCceEEEEEEECCCCcEEEEEEeccccccCCchHHHHHHHHHHHhcCCCCEeeeEEEEeeCCeEEEEEecC
Confidence            56777889999999999994 5688999999875432  22456788999999999999999999999999999999999


Q ss_pred             CCCCHHhhhccCC-CCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCCCCCeeeecccCcccCCCC----C
Q 020221          136 PNDTLAKHLFHWE-TQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDG----R  210 (329)
Q Consensus       136 ~~gsL~~~l~~~~-~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~----~  210 (329)
                      . ++|.+++.... ...+++..+..++.|++.||.|||+. +++|+||||+||+++.++.++|+|||++......    .
T Consensus        82 ~-~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~-~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~  159 (285)
T cd07861          82 S-MDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSR-RVLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPVRVYT  159 (285)
T ss_pred             C-CCHHHHHhcCCCCCcCCHHHHHHHHHHHHHHHHHHHhC-CeeecCCCHHHEEEcCCCcEEECcccceeecCCCccccc
Confidence            7 58888875433 25689999999999999999999999 9999999999999999999999999998754322    1


Q ss_pred             CccCcccccCcccccCC-CCCCcccchhhhHHHHHHHhCCCCCCchhhHHHhhhchh--------------------hhc
Q 020221          211 SYSTNLAFTPPEYLRTG-RVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQ--------------------TLT  269 (329)
Q Consensus       211 ~~~~~~~y~aPE~~~~~-~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~~~~~~~--------------------~~~  269 (329)
                      ...+++.|+|||.+.+. .++.++||||||+++++|++|+.||..............                    ...
T Consensus       160 ~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (285)
T cd07861         160 HEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQLFRIFRILGTPTEDVWPGVTSLPDYKNTF  239 (285)
T ss_pred             CCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhcchhhHHHHhhc
Confidence            23457889999988754 478899999999999999999987754321111000000                    000


Q ss_pred             ccccc---CCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 020221          270 DSCLE---GQFSSDEGTELVRLASRCLQYEPRERPNPRSLVT  308 (329)
Q Consensus       270 ~~~~~---~~~~~~~~~~~~~li~~cl~~dp~~Rps~~~~l~  308 (329)
                      .....   .......++++.+++.+||..||++|||+.+++.
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~ll~  281 (285)
T cd07861         240 PKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALN  281 (285)
T ss_pred             cccCcchhHHhcCCCCHHHHHHHHHHhcCChhhCCCHHHHhc
Confidence            00000   0011235678899999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2

>cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=9.1e-42  Score=298.64  Aligned_cols=248  Identities=23%  Similarity=0.367  Sum_probs=200.7

Q ss_pred             cccccccCCCCCCcEEEEEEeC------CCCEEEEEEeCCCCC-hhHHHHHHHHHHHhcCCCccccccceeeeeCCeeEE
Q 020221           58 MENIVSEHGEKAPNVVYKGKLE------NQFRIAVKRFNRSAW-PDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLL  130 (329)
Q Consensus        58 ~~~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l  130 (329)
                      .+.+.+.||+|+||.||++...      .+..||+|.+..... .....+.+|+++++.++|+||+++++++......++
T Consensus         7 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~   86 (277)
T cd05032           7 KITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVRLLGVVSTGQPTLV   86 (277)
T ss_pred             HeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCccCHHHHHHHHHHHHHHHhCCCCceeEEEEEEcCCCCcEE
Confidence            4567778899999999999853      236899999876542 234568899999999999999999999999999999


Q ss_pred             EEecCCCCCHHhhhccCC--------CCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCCCCCeeeecccC
Q 020221          131 VAEYMPNDTLAKHLFHWE--------TQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGL  202 (329)
Q Consensus       131 v~e~~~~gsL~~~l~~~~--------~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~  202 (329)
                      +|||+++++|.+++....        ...+++..+..++.|++.||.|||+. +++|+||||+||+++.++.++|+|||+
T Consensus        87 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~-~i~H~di~p~nill~~~~~~kl~dfg~  165 (277)
T cd05032          87 VMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAK-KFVHRDLAARNCMVAEDLTVKIGDFGM  165 (277)
T ss_pred             EEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhC-CccccccChheEEEcCCCCEEECCccc
Confidence            999999999999986422        22468889999999999999999999 999999999999999999999999999


Q ss_pred             cccCCCC------CCccCcccccCcccccCCCCCCcccchhhhHHHHHHHh-CCCCCCchhhHHHhhhchhhhccccccC
Q 020221          203 MKNSRDG------RSYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLS-GKHIPPSHALDLIRDRNIQTLTDSCLEG  275 (329)
Q Consensus       203 a~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t-g~~~~~~~~~~~~~~~~~~~~~~~~~~~  275 (329)
                      ++.....      ....++..|+|||.+.+..++.++||||||+++||+++ |..|+.............     .....
T Consensus       166 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~~-----~~~~~  240 (277)
T cd05032         166 TRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLSNEEVLKFVI-----DGGHL  240 (277)
T ss_pred             chhhccCcccccCCCCCccccccCHHHHhcCCCCcccchHHHHHHHHHhhccCCCCCccCCHHHHHHHHh-----cCCCC
Confidence            8754332      12234678999999988889999999999999999998 777765433222221111     11112


Q ss_pred             CCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 020221          276 QFSSDEGTELVRLASRCLQYEPRERPNPRSLVTALV  311 (329)
Q Consensus       276 ~~~~~~~~~~~~li~~cl~~dp~~Rps~~~~l~~L~  311 (329)
                      ..+...+.++.+++.+||+.+|++|||+.++++.|+
T Consensus       241 ~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~  276 (277)
T cd05032         241 DLPENCPDKLLELMRMCWQYNPKMRPTFLEIVSSLK  276 (277)
T ss_pred             CCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHhc
Confidence            234456789999999999999999999999999876

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological

>KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=8.6e-43  Score=313.65  Aligned_cols=249  Identities=21%  Similarity=0.336  Sum_probs=215.2

Q ss_pred             ccccCCCCCCcEEEEEEeCC-CCEEEEEEeCCCCChhHHHHHHHHHHHhcCCCccccccceeeeeCCeeEEEEecCCCCC
Q 020221           61 IVSEHGEKAPNVVYKGKLEN-QFRIAVKRFNRSAWPDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAEYMPNDT  139 (329)
Q Consensus        61 ~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gs  139 (329)
                      ...+||-|.||.||.|.|+. ...||||.++.+.. ..++|+.|..+|+.++|||+|+++|+|.....+|||+|||..|+
T Consensus       271 MkhKLGGGQYGeVYeGvWKkyslTvAVKtLKEDtM-eveEFLkEAAvMKeikHpNLVqLLGVCT~EpPFYIiTEfM~yGN  349 (1157)
T KOG4278|consen  271 MKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM-EVEEFLKEAAVMKEIKHPNLVQLLGVCTHEPPFYIITEFMCYGN  349 (1157)
T ss_pred             eeeccCCCcccceeeeeeeccceeeehhhhhhcch-hHHHHHHHHHHHHhhcCccHHHHhhhhccCCCeEEEEecccCcc
Confidence            34567999999999999654 67899999988763 47789999999999999999999999999999999999999999


Q ss_pred             HHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCCCCCeeeecccCcccCCCCC--CccC---
Q 020221          140 LAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDGR--SYST---  214 (329)
Q Consensus       140 L~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~--~~~~---  214 (329)
                      |.+||++.+...++.-..+.++.||.+|++||..+ ++|||||..+|+|+.++..+|++|||++++...+.  .+.|   
T Consensus       350 LLdYLRecnr~ev~avvLlyMAtQIsSaMeYLEkk-nFIHRDLAARNCLVgEnhiVKvADFGLsRlMtgDTYTAHAGAKF  428 (1157)
T KOG4278|consen  350 LLDYLRECNRSEVPAVVLLYMATQISSAMEYLEKK-NFIHRDLAARNCLVGENHIVKVADFGLSRLMTGDTYTAHAGAKF  428 (1157)
T ss_pred             HHHHHHHhchhhcchhHHHHHHHHHHHHHHHHHHh-hhhhhhhhhhhccccccceEEeeccchhhhhcCCceecccCccC
Confidence            99999987777788888999999999999999999 99999999999999999999999999998765442  2223   


Q ss_pred             cccccCcccccCCCCCCcccchhhhHHHHHHHhCC-CCCCchhhHHHhhhchhhhccccccCCCChHHHHHHHHHHHHhc
Q 020221          215 NLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGK-HIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLASRCL  293 (329)
Q Consensus       215 ~~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl  293 (329)
                      .+.|.|||.+..+.++.++|||+|||+||||.|-+ .|++.-...     ....+++...+-.-|..|++.+.+|+.+||
T Consensus       429 PIKWTAPEsLAyNtFSiKSDVWAFGVLLWEIATYGMsPYPGidlS-----qVY~LLEkgyRM~~PeGCPpkVYeLMraCW  503 (1157)
T KOG4278|consen  429 PIKWTAPESLAYNTFSIKSDVWAFGVLLWEIATYGMSPYPGIDLS-----QVYGLLEKGYRMDGPEGCPPKVYELMRACW  503 (1157)
T ss_pred             cccccCcccccccccccchhhHHHHHHHHHHHhcCCCCCCCccHH-----HHHHHHhccccccCCCCCCHHHHHHHHHHh
Confidence            47899999999999999999999999999998854 566654332     233444555555667889999999999999


Q ss_pred             ccCCCCCCCHHHHHHHHHhhhhc
Q 020221          294 QYEPRERPNPRSLVTALVTLQKD  316 (329)
Q Consensus       294 ~~dp~~Rps~~~~l~~L~~~~~~  316 (329)
                      +.+|.+||++.++-+.++.+-.+
T Consensus       504 ~WsPsDRPsFaeiHqafEtmf~~  526 (1157)
T KOG4278|consen  504 NWSPSDRPSFAEIHQAFETMFSS  526 (1157)
T ss_pred             cCCcccCccHHHHHHHHHHHhcc
Confidence            99999999999999999987544

>cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4

Probab=100.00  E-value=9.2e-42  Score=296.76  Aligned_cols=244  Identities=17%  Similarity=0.226  Sum_probs=198.5

Q ss_pred             ccccccCCCCCCcEEEEEEeCCCCEEEEEEeCCCCCh------hHHHHHHHHHHHhcCCCccccccceeeeeCCeeEEEE
Q 020221           59 ENIVSEHGEKAPNVVYKGKLENQFRIAVKRFNRSAWP------DARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVA  132 (329)
Q Consensus        59 ~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~------~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~  132 (329)
                      +.+.+.||.|+||.||+|...++..+|+|.+......      ....+.+|+++++.++|+||+++++++.+.+..++++
T Consensus         2 ~~~~~~ig~g~~~~v~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~   81 (265)
T cd06631           2 WTKGEVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDDNTISIFM   81 (265)
T ss_pred             ccccceEeccCCeEEEEEEEcCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecCCeEEEEE
Confidence            4455667999999999999778889999998754321      1345788999999999999999999999999999999


Q ss_pred             ecCCCCCHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCCCCCeeeecccCcccCCC----
Q 020221          133 EYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRD----  208 (329)
Q Consensus       133 e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~----  208 (329)
                      ||+++++|.+++.+  ...+++..+..++.|++.||+|||+. +++|+||+|+||+++.++.++|+|||++.....    
T Consensus        82 e~~~~~~L~~~l~~--~~~~~~~~~~~~~~qi~~~l~~lH~~-~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~  158 (265)
T cd06631          82 EFVPGGSISSILNR--FGPLPEPVFCKYTKQILDGVAYLHNN-CVVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLH  158 (265)
T ss_pred             ecCCCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhC-CcccCCcCHHhEEECCCCeEEeccchhhHhhhhcccc
Confidence            99999999999863  35688999999999999999999999 999999999999999999999999998865321    


Q ss_pred             ------CCCccCcccccCcccccCCCCCCcccchhhhHHHHHHHhCCCCCCchhhHHHhhhchhhhccccccCCCChHHH
Q 020221          209 ------GRSYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEG  282 (329)
Q Consensus       209 ------~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  282 (329)
                            .....++..|+|||++.+..++.++||||||+++|+|++|..||............ .  .........+...+
T Consensus       159 ~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~-~--~~~~~~~~~~~~~~  235 (265)
T cd06631         159 GTHSNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLASMDRLAAMFYI-G--AHRGLMPRLPDSFS  235 (265)
T ss_pred             ccccccccccCCCccccChhhhcCCCCcchhhHHHHHHHHHHHHhCCCccccCChHHHHHHh-h--hccCCCCCCCCCCC
Confidence                  12335678999999999888999999999999999999999887542211111000 0  00011122344567


Q ss_pred             HHHHHHHHHhcccCCCCCCCHHHHHH
Q 020221          283 TELVRLASRCLQYEPRERPNPRSLVT  308 (329)
Q Consensus       283 ~~~~~li~~cl~~dp~~Rps~~~~l~  308 (329)
                      .++.+++.+||..+|++||++.++++
T Consensus       236 ~~~~~~i~~~l~~~p~~Rp~~~~~l~  261 (265)
T cd06631         236 AAAIDFVTSCLTRDQHERPSALQLLR  261 (265)
T ss_pred             HHHHHHHHHHhcCCcccCCCHHHHhc
Confidence            88999999999999999999999998

Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals.

>KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms]

Probab=100.00  E-value=1.2e-42  Score=310.56  Aligned_cols=252  Identities=21%  Similarity=0.300  Sum_probs=208.8

Q ss_pred             cccccCCCCCCcEEEEEEeCCCCEEEEEEeCCCCChhH-HHHHHHHHHHhcCCCccccccceeeeeCCeeEEEEecCCCC
Q 020221           60 NIVSEHGEKAPNVVYKGKLENQFRIAVKRFNRSAWPDA-RQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAEYMPND  138 (329)
Q Consensus        60 ~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~-~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g  138 (329)
                      .+.++||+|.||.|..+...++..||||+++....... .+|.+|+++|.+++||||+.++|+|..++.+++|+||+++|
T Consensus       541 ~~~ekiGeGqFGEVhLCeveg~lkVAVK~Lr~~a~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~DePicmI~EYmEnG  620 (807)
T KOG1094|consen  541 RFKEKIGEGQFGEVHLCEVEGPLKVAVKILRPDATKNARNDFLKEIKILSRLKHPNIVELLGVCVQDDPLCMITEYMENG  620 (807)
T ss_pred             ehhhhhcCcccceeEEEEecCceEEEEeecCcccchhHHHHHHHHHHHHhccCCCCeeEEEeeeecCCchHHHHHHHhcC
Confidence            45678999999999999988889999999998765544 78999999999999999999999999999999999999999


Q ss_pred             CHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCCCCCeeeecccCcccCCCCCCc------
Q 020221          139 TLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDGRSY------  212 (329)
Q Consensus       139 sL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~------  212 (329)
                      +|.+++.........-....+|+.||+.|++||.+. ++|||||.++|+|+|.++++||+|||+++....+..+      
T Consensus       621 DLnqFl~aheapt~~t~~~vsi~tqiasgmaYLes~-nfVHrd~a~rNcLv~~e~~iKiadfgmsR~lysg~yy~vqgr~  699 (807)
T KOG1094|consen  621 DLNQFLSAHELPTAETAPGVSICTQIASGMAYLESL-NFVHRDLATRNCLVDGEFTIKIADFGMSRNLYSGDYYRVQGRA  699 (807)
T ss_pred             cHHHHHHhccCcccccchhHHHHHHHHHHHHHHHhh-chhhccccccceeecCcccEEecCcccccccccCCceeeecce
Confidence            999999764434445566778999999999999999 9999999999999999999999999999976655433      


Q ss_pred             cCcccccCcccccCCCCCCcccchhhhHHHHHHHh--CCCCCCchhhHHHhhhchhhhccccc---cCCCChHHHHHHHH
Q 020221          213 STNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLS--GKHIPPSHALDLIRDRNIQTLTDSCL---EGQFSSDEGTELVR  287 (329)
Q Consensus       213 ~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t--g~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~  287 (329)
                      .-.++|||+|.+..++++.++|+|+||+++||+++  ...|+.....+.+.+. ...+.+...   -...|.-++..+.+
T Consensus       700 vlpiRwmawEsillgkFttaSDvWafgvTlwE~~~~C~e~Py~~lt~e~vven-~~~~~~~~~~~~~l~~P~~cp~~lye  778 (807)
T KOG1094|consen  700 VLPIRWMAWESILLGKFTTASDVWAFGVTLWEVFMLCREQPYSQLTDEQVVEN-AGEFFRDQGRQVVLSRPPACPQGLYE  778 (807)
T ss_pred             eeeeeehhHHHHHhccccchhhhhhhHHHHHHHHHHHhhCchhhhhHHHHHHh-hhhhcCCCCcceeccCCCcCcHHHHH
Confidence            33589999999999999999999999999999966  4456654433333222 222222111   11235567888999


Q ss_pred             HHHHhcccCCCCCCCHHHHHHHHHhh
Q 020221          288 LASRCLQYEPRERPNPRSLVTALVTL  313 (329)
Q Consensus       288 li~~cl~~dp~~Rps~~~~l~~L~~~  313 (329)
                      ++..||..|-++||+++++...|++.
T Consensus       779 lml~Cw~~es~~RPsFe~lh~~lq~~  804 (807)
T KOG1094|consen  779 LMLRCWRRESEQRPSFEQLHLFLQED  804 (807)
T ss_pred             HHHHHhchhhhcCCCHHHHHHHHHHh
Confidence            99999999999999999999888764

>cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4

Probab=100.00  E-value=1.5e-41  Score=302.91  Aligned_cols=253  Identities=22%  Similarity=0.317  Sum_probs=202.7

Q ss_pred             cccccccCCCCCCcEEEEEEeC--------CCCEEEEEEeCCCCC-hhHHHHHHHHHHHhcC-CCccccccceeeeeCCe
Q 020221           58 MENIVSEHGEKAPNVVYKGKLE--------NQFRIAVKRFNRSAW-PDARQFLEEARAVGQL-RNRRLANLLGCCCEGDE  127 (329)
Q Consensus        58 ~~~~~~~lg~G~~g~V~~~~~~--------~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~  127 (329)
                      .+.+.+.||+|+||.||++...        ....+|+|.+..... .....+.+|+.+++.+ +||||+++++++.....
T Consensus        13 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~   92 (314)
T cd05099          13 RLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKNIINLLGVCTQEGP   92 (314)
T ss_pred             HeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCCChHHHHHHHHHHHHHHhccCCCCeeeEEEEEccCCc
Confidence            3556778899999999999731        245799999876432 2345688999999999 69999999999988889


Q ss_pred             eEEEEecCCCCCHHhhhccCC--------------CCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCCCC
Q 020221          128 RLLVAEYMPNDTLAKHLFHWE--------------TQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDV  193 (329)
Q Consensus       128 ~~lv~e~~~~gsL~~~l~~~~--------------~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~  193 (329)
                      .++++||+++|+|.+++....              ...+++.++..++.|++.||.|||++ |++|+||||+||+++.++
T Consensus        93 ~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~-gi~H~dlkp~Nill~~~~  171 (314)
T cd05099          93 LYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESR-RCIHRDLAARNVLVTEDN  171 (314)
T ss_pred             eEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHC-CeeeccccceeEEEcCCC
Confidence            999999999999999986422              23578999999999999999999999 999999999999999999


Q ss_pred             CeeeecccCcccCCCCC------CccCcccccCcccccCCCCCCcccchhhhHHHHHHHh-CCCCCCchhhHHHhhhchh
Q 020221          194 NPRLSCFGLMKNSRDGR------SYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLS-GKHIPPSHALDLIRDRNIQ  266 (329)
Q Consensus       194 ~~kl~Dfg~a~~~~~~~------~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t-g~~~~~~~~~~~~~~~~~~  266 (329)
                      .+||+|||+++......      ...++..|+|||.+.+..++.++||||||+++|+|++ |..|+..............
T Consensus       172 ~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~~~~~~~  251 (314)
T cd05099         172 VMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPGIPVEELFKLLRE  251 (314)
T ss_pred             cEEEccccccccccccccccccccCCCCccccCHHHHccCCcCccchhhHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHc
Confidence            99999999997654321      1123457999999998889999999999999999999 7766654332222211111


Q ss_pred             hhccccccCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhhc
Q 020221          267 TLTDSCLEGQFSSDEGTELVRLASRCLQYEPRERPNPRSLVTALVTLQKD  316 (329)
Q Consensus       267 ~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~~~l~~L~~~~~~  316 (329)
                           ......+..++.++.+++.+||+.||++|||+.++++.|+++...
T Consensus       252 -----~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~l~~~~~~  296 (314)
T cd05099         252 -----GHRMDKPSNCTHELYMLMRECWHAVPTQRPTFKQLVEALDKVLAA  296 (314)
T ss_pred             -----CCCCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHHH
Confidence                 111123445667899999999999999999999999999999763

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta

Probab=100.00  E-value=4.2e-42  Score=308.55  Aligned_cols=248  Identities=17%  Similarity=0.127  Sum_probs=195.3

Q ss_pred             cccccccCCCCCCcEEEEEE-eCCCCEEEEEEeCCCC---ChhHHHHHHHHHHHhcCCCccccccceeeeeCCeeEEEEe
Q 020221           58 MENIVSEHGEKAPNVVYKGK-LENQFRIAVKRFNRSA---WPDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAE  133 (329)
Q Consensus        58 ~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  133 (329)
                      .|++++.||+|+||.||++. ..+++.||+|.+....   ......+.+|..++..++|+||+++++++.+.+..++|||
T Consensus         2 ~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~~~~~lv~E   81 (331)
T cd05624           2 DFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQDENYLYLVMD   81 (331)
T ss_pred             CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEEe
Confidence            46778888999999999999 4567889999986532   1223447788999999999999999999999999999999


Q ss_pred             cCCCCCHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCCCCCeeeecccCcccCCCCC---
Q 020221          134 YMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDGR---  210 (329)
Q Consensus       134 ~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~---  210 (329)
                      |+++|+|.+++.+ ....+++..+..++.|++.||+|||++ +++||||||+||+++.++.+||+|||++.......   
T Consensus        82 y~~gg~L~~~l~~-~~~~l~~~~~~~~~~qi~~~L~~lH~~-~iiHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~  159 (331)
T cd05624          82 YYVGGDLLTLLSK-FEDRLPEDMARFYIAEMVLAIHSIHQL-HYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDGTVQ  159 (331)
T ss_pred             CCCCCcHHHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHHC-CeeeccCchHHEEEcCCCCEEEEeccceeeccCCCcee
Confidence            9999999999964 235689999999999999999999999 99999999999999999999999999987654322   


Q ss_pred             --CccCcccccCcccccC-----CCCCCcccchhhhHHHHHHHhCCCCCCchhhHHHhhhchhhhccccccCCCChHHHH
Q 020221          211 --SYSTNLAFTPPEYLRT-----GRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGT  283 (329)
Q Consensus       211 --~~~~~~~y~aPE~~~~-----~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  283 (329)
                        ...|++.|+|||++.+     +.++.++||||||+++|+|++|+.||................. ...........++
T Consensus       160 ~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~~~-~~~~p~~~~~~~~  238 (331)
T cd05624         160 SSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHEE-RFQFPSHITDVSE  238 (331)
T ss_pred             eccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCCCHHHHHHHHHcCCC-cccCCCccccCCH
Confidence              2458899999999875     4578899999999999999999998865433222211111000 0000111234578


Q ss_pred             HHHHHHHHhcccCCCC--CCCHHHHHH
Q 020221          284 ELVRLASRCLQYEPRE--RPNPRSLVT  308 (329)
Q Consensus       284 ~~~~li~~cl~~dp~~--Rps~~~~l~  308 (329)
                      ++.+++.+|+..++++  |+++.++++
T Consensus       239 ~~~~li~~ll~~~~~~~~~~~~~~~~~  265 (331)
T cd05624         239 EAKDLIQRLICSRERRLGQNGIEDFKK  265 (331)
T ss_pred             HHHHHHHHHccCchhhcCCCCHHHHhc
Confidence            8999999999876554  457888776

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues.

>PHA03211 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=5.9e-42  Score=317.57  Aligned_cols=242  Identities=18%  Similarity=0.204  Sum_probs=189.6

Q ss_pred             cccccccCCCCCCcEEEEEEe-CCCCEEEEEEeCCCCChhHHHHHHHHHHHhcCCCccccccceeeeeCCeeEEEEecCC
Q 020221           58 MENIVSEHGEKAPNVVYKGKL-ENQFRIAVKRFNRSAWPDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAEYMP  136 (329)
Q Consensus        58 ~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~  136 (329)
                      .|.+.+.||+|+||.||++.. ..++.||+|....      ..+.+|+++++.++|+||+++++++..++..+++||++.
T Consensus       170 gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~~------~~~~~E~~iL~~L~HpnIv~l~~~~~~~~~~~lv~e~~~  243 (461)
T PHA03211        170 GFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGWY------ASSVHEARLLRRLSHPAVLALLDVRVVGGLTCLVLPKYR  243 (461)
T ss_pred             CeEEEEEEccCCCeEEEEEEECCCCCEEEEecccc------cCHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEEccC
Confidence            366778889999999999994 4578899996432      235689999999999999999999999999999999995


Q ss_pred             CCCHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCCCCCeeeecccCcccCCCCC------
Q 020221          137 NDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDGR------  210 (329)
Q Consensus       137 ~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~------  210 (329)
                       ++|..++.. ....+++.++..++.|++.||.|||++ ||+||||||+|||++.++.++|+|||+++......      
T Consensus       244 -~~L~~~l~~-~~~~l~~~~~~~i~~qi~~aL~yLH~~-gIvHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~  320 (461)
T PHA03211        244 -SDLYTYLGA-RLRPLGLAQVTAVARQLLSAIDYIHGE-GIIHRDIKTENVLVNGPEDICLGDFGAACFARGSWSTPFHY  320 (461)
T ss_pred             -CCHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHHC-CEEECcCCHHHEEECCCCCEEEcccCCceeccccccccccc
Confidence             588888854 334799999999999999999999999 99999999999999999999999999987643321      


Q ss_pred             CccCcccccCcccccCCCCCCcccchhhhHHHHHHHhCCCCCCchh------------hHHHhhhchh-hhcccc-----
Q 020221          211 SYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHA------------LDLIRDRNIQ-TLTDSC-----  272 (329)
Q Consensus       211 ~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~------------~~~~~~~~~~-~~~~~~-----  272 (329)
                      ...||..|+|||++.+..++.++|||||||++|||++|..++....            ...+...... ......     
T Consensus       321 ~~~GT~~Y~APE~~~~~~~~~~sDvwSlGviL~El~~g~~~lf~~~~~~~~~~~~~~l~~~i~~~~~~~~~~~~~~~~~l  400 (461)
T PHA03211        321 GIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAAVHTASLFSASRGDERRPYDAQILRIIRQAQVHVDEFPQHAGSRL  400 (461)
T ss_pred             ccCCCcCCcCHHHHcCCCCCchHHHHHHHHHHHHHHHcCCCcccCCcccccCCcHHHHHHHHHhhccccccCCCCcchHH
Confidence            2358999999999999889999999999999999999875443211            1111110000 000000     


Q ss_pred             -----------ccC-----CCC--hHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 020221          273 -----------LEG-----QFS--SDEGTELVRLASRCLQYEPRERPNPRSLVT  308 (329)
Q Consensus       273 -----------~~~-----~~~--~~~~~~~~~li~~cl~~dp~~Rps~~~~l~  308 (329)
                                 ...     .+.  ...+..+.+|+.+||+.||.+|||+.|+|+
T Consensus       401 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~DP~~RPsa~elL~  454 (461)
T PHA03211        401 VSQYRHRAARNRRPAYTRPAWTRYYKLDLDVEYLVCRALTFDGARRPSAAELLR  454 (461)
T ss_pred             HHHHHhhhhcccCCccCCcchhhhccccchHHHHHHHHcccChhhCcCHHHHhh
Confidence                       000     000  023457899999999999999999999999

>cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors

Probab=100.00  E-value=1.2e-41  Score=300.83  Aligned_cols=255  Identities=19%  Similarity=0.273  Sum_probs=199.4

Q ss_pred             CcccccccCCCCCCcEEEEEEeCC-----------------CCEEEEEEeCCCCCh-hHHHHHHHHHHHhcCCCcccccc
Q 020221           57 AMENIVSEHGEKAPNVVYKGKLEN-----------------QFRIAVKRFNRSAWP-DARQFLEEARAVGQLRNRRLANL  118 (329)
Q Consensus        57 ~~~~~~~~lg~G~~g~V~~~~~~~-----------------~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~~  118 (329)
                      ..+++++.||+|+||.||++...+                 +..||+|.+...... ..+.+.+|+++++.++||||+++
T Consensus         5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~   84 (296)
T cd05051           5 QPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVKILSRLSDPNIARL   84 (296)
T ss_pred             hhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccCHHHHHHHHHHHHHHHhcCCCCEeEE
Confidence            356788889999999999987432                 245899998865433 35578899999999999999999


Q ss_pred             ceeeeeCCeeEEEEecCCCCCHHhhhccCC---------CCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceee
Q 020221          119 LGCCCEGDERLLVAEYMPNDTLAKHLFHWE---------TQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVF  189 (329)
Q Consensus       119 ~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~---------~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~  189 (329)
                      ++++...+..++++||+++++|.+++.+..         ...+++..++.++.|++.||+|||+. +++|+||||+||++
T Consensus        85 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~-~i~H~dlkp~Nili  163 (296)
T cd05051          85 LGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESL-NFVHRDLATRNCLV  163 (296)
T ss_pred             EEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHc-Cccccccchhceee
Confidence            999998899999999999999999986432         12689999999999999999999999 99999999999999


Q ss_pred             CCCCCeeeecccCcccCCCCC------CccCcccccCcccccCCCCCCcccchhhhHHHHHHHh--CCCCCCchhhHHHh
Q 020221          190 DDDVNPRLSCFGLMKNSRDGR------SYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLS--GKHIPPSHALDLIR  261 (329)
Q Consensus       190 ~~~~~~kl~Dfg~a~~~~~~~------~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t--g~~~~~~~~~~~~~  261 (329)
                      +.++.++|+|||++.......      ...++..|+|||.+.+..++.++||||||+++|+|++  +..|+.........
T Consensus       164 ~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p~~~~~~~~~~  243 (296)
T cd05051         164 GKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQPYEHLTDQQVI  243 (296)
T ss_pred             cCCCceEEccccceeecccCcceeecCcCCCCceecCHHHhhcCCCCccchhhhhHHHHHHHHhcCCCCCCCCcChHHHH
Confidence            999999999999987543321      2234678999999988889999999999999999998  44444332211111


Q ss_pred             hhchhhhc--cccccCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHh
Q 020221          262 DRNIQTLT--DSCLEGQFSSDEGTELVRLASRCLQYEPRERPNPRSLVTALVT  312 (329)
Q Consensus       262 ~~~~~~~~--~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~~~l~~L~~  312 (329)
                      ........  ........+...+.++.+++.+||+.||++|||+.++++.|++
T Consensus       244 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~el~~~L~~  296 (296)
T cd05051         244 ENAGHFFRDDGRQIYLPRPPNCPKDIYELMLECWRRDEEDRPTFREIHLFLQR  296 (296)
T ss_pred             HHHHhccccccccccCCCccCCCHHHHHHHHHHhccChhcCCCHHHHHHHhcC
Confidence            11111000  0001111233456789999999999999999999999998863

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke

>cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8

Probab=100.00  E-value=1.6e-41  Score=293.58  Aligned_cols=244  Identities=18%  Similarity=0.207  Sum_probs=201.8

Q ss_pred             ccccccCCCCCCcEEEEEE-eCCCCEEEEEEeCCCCC--hhHHHHHHHHHHHhcCCCccccccceeeeeCCeeEEEEecC
Q 020221           59 ENIVSEHGEKAPNVVYKGK-LENQFRIAVKRFNRSAW--PDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAEYM  135 (329)
Q Consensus        59 ~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~  135 (329)
                      |.+++.||+|+||.||++. ..+++.+|+|.+.....  ...+.+.+|+++++.++|||++++++.+...+..++|+||+
T Consensus         2 y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~   81 (256)
T cd08220           2 YEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYENFLEDKALMIVMEYA   81 (256)
T ss_pred             ceEEEEecccCceEEEEEEEcCCCcEEEEEEEeccccccHHHHHHHHHHHHHhhCCCCchhheeeeEecCCEEEEEEecC
Confidence            5667778999999999998 45688999999876432  23556889999999999999999999998889999999999


Q ss_pred             CCCCHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCCCC-CeeeecccCcccCCCCC---C
Q 020221          136 PNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDV-NPRLSCFGLMKNSRDGR---S  211 (329)
Q Consensus       136 ~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~-~~kl~Dfg~a~~~~~~~---~  211 (329)
                      ++++|.+++.......+++..+..++.+++.||.|||++ +++|+||+|+||++++++ .++|+|||++.......   .
T Consensus        82 ~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~-~i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~~~~~  160 (256)
T cd08220          82 PGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVHTK-LILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKSKAYT  160 (256)
T ss_pred             CCCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhC-CeecCCCCHHHEEEcCCCCEEEEccCCCceecCCCccccc
Confidence            999999999754455689999999999999999999999 999999999999998554 58999999987655432   2


Q ss_pred             ccCcccccCcccccCCCCCCcccchhhhHHHHHHHhCCCCCCchhhHHHhhhchhhhccccccCCCChHHHHHHHHHHHH
Q 020221          212 YSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLASR  291 (329)
Q Consensus       212 ~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~  291 (329)
                      ..++..|+|||.+.+..++.++||||||+++|+|++|+.|+...............     .....+...+.++.+++.+
T Consensus       161 ~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~-----~~~~~~~~~~~~l~~li~~  235 (256)
T cd08220         161 VVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEAANLPALVLKIMSG-----TFAPISDRYSPDLRQLILS  235 (256)
T ss_pred             cccCCcccCchhccCCCCCcccchHHHHHHHHHHHhCCCCcccCchHHHHHHHHhc-----CCCCCCCCcCHHHHHHHHH
Confidence            45678999999999888999999999999999999999887654332222111111     1122344567889999999


Q ss_pred             hcccCCCCCCCHHHHHH
Q 020221          292 CLQYEPRERPNPRSLVT  308 (329)
Q Consensus       292 cl~~dp~~Rps~~~~l~  308 (329)
                      ||..||++|||+.++++
T Consensus       236 ~l~~~p~~Rpt~~~ll~  252 (256)
T cd08220         236 MLNLDPSKRPQLSQIMA  252 (256)
T ss_pred             HccCChhhCCCHHHHhh
Confidence            99999999999999998

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with

>cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase

Probab=100.00  E-value=1.4e-41  Score=294.02  Aligned_cols=246  Identities=22%  Similarity=0.336  Sum_probs=200.3

Q ss_pred             CcccccccCCCCCCcEEEEEEeCCCCEEEEEEeCCCCChhHHHHHHHHHHHhcCCCccccccceeeeeCCeeEEEEecCC
Q 020221           57 AMENIVSEHGEKAPNVVYKGKLENQFRIAVKRFNRSAWPDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAEYMP  136 (329)
Q Consensus        57 ~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~  136 (329)
                      +.+.+.+.||+|+||.||++.+.++..+|+|.+..... ....+.+|+++++.++|||++++++++......++++||+.
T Consensus         4 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~k~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~   82 (256)
T cd05112           4 SELTLVQEIGSGQFGLVWLGYWLEKRKVAIKTIREGAM-SEEDFIEEAQVMMKLSHPKLVQLYGVCTERSPICLVFEFME   82 (256)
T ss_pred             hHeEEEeeecCcccceEEEEEEeCCCeEEEEECCCCCC-CHHHHHHHHHHHHhCCCCCeeeEEEEEccCCceEEEEEcCC
Confidence            34667788899999999999976677899999875543 34578899999999999999999999988899999999999


Q ss_pred             CCCHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCCCCCeeeecccCcccCCCCC-----C
Q 020221          137 NDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDGR-----S  211 (329)
Q Consensus       137 ~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~-----~  211 (329)
                      +++|.+++.. ....+++..+..++.|++.||+|||+. +++|+||||+||+++.++.++|+|||++.......     .
T Consensus        83 ~~~L~~~~~~-~~~~~~~~~~~~~~~~l~~~l~~lH~~-~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~~~~~~  160 (256)
T cd05112          83 HGCLSDYLRA-QRGKFSQETLLGMCLDVCEGMAYLESS-NVIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQYTSSTG  160 (256)
T ss_pred             CCcHHHHHHh-CccCCCHHHHHHHHHHHHHHHHHHHHC-CccccccccceEEEcCCCeEEECCCcceeecccCcccccCC
Confidence            9999999864 334688999999999999999999999 99999999999999999999999999987543321     1


Q ss_pred             ccCcccccCcccccCCCCCCcccchhhhHHHHHHHh-CCCCCCchhhHHHhhhchhhhccccccCCCChHHHHHHHHHHH
Q 020221          212 YSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLS-GKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLAS  290 (329)
Q Consensus       212 ~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t-g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~  290 (329)
                      ...+..|+|||.+.+..++.++||||||+++|||++ |..|+..............     ......+...+.++.+++.
T Consensus       161 ~~~~~~~~aPe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~l~~  235 (256)
T cd05112         161 TKFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYENRSNSEVVETINA-----GFRLYKPRLASQSVYELMQ  235 (256)
T ss_pred             CccchhhcCHhHhccCCcChHHHHHHHHHHHHHHHcCCCCCCCcCCHHHHHHHHhC-----CCCCCCCCCCCHHHHHHHH
Confidence            223568999999998889999999999999999998 7776654332222211111     0111122334678999999


Q ss_pred             HhcccCCCCCCCHHHHHHHH
Q 020221          291 RCLQYEPRERPNPRSLVTAL  310 (329)
Q Consensus       291 ~cl~~dp~~Rps~~~~l~~L  310 (329)
                      +||+.+|++|||+.++++.|
T Consensus       236 ~~l~~~p~~Rp~~~~~l~~l  255 (256)
T cd05112         236 HCWKERPEDRPSFSLLLHQL  255 (256)
T ss_pred             HHcccChhhCCCHHHHHHhh
Confidence            99999999999999999876

Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ

>cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.2e-41  Score=300.79  Aligned_cols=254  Identities=20%  Similarity=0.270  Sum_probs=197.2

Q ss_pred             cccccccCCCCCCcEEEEEEeCC---------------CCEEEEEEeCCCCCh-hHHHHHHHHHHHhcCCCcccccccee
Q 020221           58 MENIVSEHGEKAPNVVYKGKLEN---------------QFRIAVKRFNRSAWP-DARQFLEEARAVGQLRNRRLANLLGC  121 (329)
Q Consensus        58 ~~~~~~~lg~G~~g~V~~~~~~~---------------~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~~~~~  121 (329)
                      .+++.+.||+|+||.||++...+               ...||+|.++..... ....+.+|+++++.++|+|+++++++
T Consensus         6 ~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~   85 (295)
T cd05097           6 QLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIRLLGV   85 (295)
T ss_pred             hCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCcCeEEEE
Confidence            56778889999999999987422               235899999765333 24568899999999999999999999


Q ss_pred             eeeCCeeEEEEecCCCCCHHhhhccCC----------CCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCC
Q 020221          122 CCEGDERLLVAEYMPNDTLAKHLFHWE----------TQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDD  191 (329)
Q Consensus       122 ~~~~~~~~lv~e~~~~gsL~~~l~~~~----------~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~  191 (329)
                      +......++||||+++++|.+++....          ...+++..+..++.|++.||.|||+. +++|+||||+||++++
T Consensus        86 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~-~i~H~dlkp~Nill~~  164 (295)
T cd05097          86 CVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASL-NFVHRDLATRNCLVGN  164 (295)
T ss_pred             EcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhc-CeeccccChhhEEEcC
Confidence            999999999999999999999885421          12468889999999999999999999 9999999999999999


Q ss_pred             CCCeeeecccCcccCCCCC------CccCcccccCcccccCCCCCCcccchhhhHHHHHHHhCC--CCCCchhhHHHhhh
Q 020221          192 DVNPRLSCFGLMKNSRDGR------SYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGK--HIPPSHALDLIRDR  263 (329)
Q Consensus       192 ~~~~kl~Dfg~a~~~~~~~------~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~--~~~~~~~~~~~~~~  263 (329)
                      ++.+||+|||++.......      ...++..|+|||.+.+..++.++||||||+++++|+++.  .|+...........
T Consensus       165 ~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~~l~el~~~~~~~p~~~~~~~~~~~~  244 (295)
T cd05097         165 HYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQPYSLLSDEQVIEN  244 (295)
T ss_pred             CCcEEecccccccccccCcceeccCcCcCceeecChhhhccCCcCchhhHHHHHHHHHHHHHcCCCCCCcccChHHHHHH
Confidence            9999999999987543322      123356899999998888999999999999999999843  34433222211111


Q ss_pred             chhhhc--cccccCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHh
Q 020221          264 NIQTLT--DSCLEGQFSSDEGTELVRLASRCLQYEPRERPNPRSLVTALVT  312 (329)
Q Consensus       264 ~~~~~~--~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~~~l~~L~~  312 (329)
                      ......  ........+...++.+.+++.+||+.||++|||+.++++.|++
T Consensus       245 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~~l~~  295 (295)
T cd05097         245 TGEFFRNQGRQIYLSQTPLCPSPVFKLMMRCWSRDIKDRPTFNKIHHFLRE  295 (295)
T ss_pred             HHHhhhhccccccCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHhC
Confidence            110000  0001111233456789999999999999999999999998863

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including

>cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.7e-41  Score=293.76  Aligned_cols=242  Identities=23%  Similarity=0.344  Sum_probs=196.2

Q ss_pred             cCCCCCCcEEEEEEe-CC---CCEEEEEEeCCCCCh-hHHHHHHHHHHHhcCCCccccccceeeeeCCeeEEEEecCCCC
Q 020221           64 EHGEKAPNVVYKGKL-EN---QFRIAVKRFNRSAWP-DARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAEYMPND  138 (329)
Q Consensus        64 ~lg~G~~g~V~~~~~-~~---~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g  138 (329)
                      .||+|+||.||+|.+ ..   +..+|+|.+...... ..+.+.+|+++++.++|+|++++++++. ....+++|||++++
T Consensus         2 ~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~v~e~~~~~   80 (257)
T cd05060           2 ELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLIGVCK-GEPLMLVMELAPLG   80 (257)
T ss_pred             ccCccCceeEEEeEeeccCCCcceEEEEecccccchHHHHHHHHHHHHHHhcCCCCeeeEEEEEc-CCceEEEEEeCCCC
Confidence            579999999999973 22   268999999876542 3556889999999999999999999875 56789999999999


Q ss_pred             CHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCCCCCeeeecccCcccCCCCCCc------
Q 020221          139 TLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDGRSY------  212 (329)
Q Consensus       139 sL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~------  212 (329)
                      +|.+++.+  ...+++..+..++.|++.||+|||.. +++|+||||+||+++.++.++|+|||++.........      
T Consensus        81 ~L~~~l~~--~~~~~~~~~~~~~~qi~~~l~~lh~~-~i~H~di~p~nili~~~~~~kl~df~~~~~~~~~~~~~~~~~~  157 (257)
T cd05060          81 PLLKYLKK--RREIPVSDLKELAHQVAMGMAYLESK-HFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRATTA  157 (257)
T ss_pred             cHHHHHHh--CCCCCHHHHHHHHHHHHHHHHHHhhc-CeeccCcccceEEEcCCCcEEeccccccceeecCCcccccccC
Confidence            99999973  34789999999999999999999999 9999999999999999999999999998765433221      


Q ss_pred             -cCcccccCcccccCCCCCCcccchhhhHHHHHHHh-CCCCCCchhhHHHhhhchhhhccccccCCCChHHHHHHHHHHH
Q 020221          213 -STNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLS-GKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLAS  290 (329)
Q Consensus       213 -~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t-g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~  290 (329)
                       .++..|+|||.+.+..++.++||||||+++|++++ |..|+...........     .........+...+..+.+++.
T Consensus       158 ~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~~g~~p~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~l~~li~  232 (257)
T cd05060         158 GRWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKGAEVIAM-----LESGERLPRPEECPQEIYSIML  232 (257)
T ss_pred             ccccccccCHHHhcCCCCCccchHHHHHHHHHHHHcCCCCCcccCCHHHHHHH-----HHcCCcCCCCCCCCHHHHHHHH
Confidence             12357999999998889999999999999999998 7776644322111111     1111122334556788999999


Q ss_pred             HhcccCCCCCCCHHHHHHHHHhhh
Q 020221          291 RCLQYEPRERPNPRSLVTALVTLQ  314 (329)
Q Consensus       291 ~cl~~dp~~Rps~~~~l~~L~~~~  314 (329)
                      +||..+|++||++.++++.|+.+.
T Consensus       233 ~cl~~~p~~Rp~~~~l~~~l~~~~  256 (257)
T cd05060         233 SCWKYRPEDRPTFSELESTFRRDP  256 (257)
T ss_pred             HHhcCChhhCcCHHHHHHHHHhcc
Confidence            999999999999999999998763

Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi

>cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2

Probab=100.00  E-value=1.1e-41  Score=307.32  Aligned_cols=254  Identities=20%  Similarity=0.278  Sum_probs=198.9

Q ss_pred             cccccccCCCCCCcEEEEEEe------CCCCEEEEEEeCCCCCh-hHHHHHHHHHHHhcC-CCccccccceeeeeC-Cee
Q 020221           58 MENIVSEHGEKAPNVVYKGKL------ENQFRIAVKRFNRSAWP-DARQFLEEARAVGQL-RNRRLANLLGCCCEG-DER  128 (329)
Q Consensus        58 ~~~~~~~lg~G~~g~V~~~~~------~~~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~-~~~  128 (329)
                      .+++.+.||+|+||.||+|..      .+++.||||.++..... ....+.+|+.++..+ +|+||+++++++... ...
T Consensus         8 ~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~   87 (343)
T cd05103           8 RLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPL   87 (343)
T ss_pred             HhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCCChHHHHHHHHHHHHHHhccCCccHhhhcceeecCCCce
Confidence            467788889999999999973      34678999999765432 345688999999999 689999999988654 567


Q ss_pred             EEEEecCCCCCHHhhhccCC------------------------------------------------------------
Q 020221          129 LLVAEYMPNDTLAKHLFHWE------------------------------------------------------------  148 (329)
Q Consensus       129 ~lv~e~~~~gsL~~~l~~~~------------------------------------------------------------  148 (329)
                      +++|||+++|+|.+++....                                                            
T Consensus        88 ~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  167 (343)
T cd05103          88 MVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEAE  167 (343)
T ss_pred             EEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccchhhhhh
Confidence            89999999999999886421                                                            


Q ss_pred             -----CCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCCCCCeeeecccCcccCCCCC------CccCccc
Q 020221          149 -----TQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDGR------SYSTNLA  217 (329)
Q Consensus       149 -----~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~------~~~~~~~  217 (329)
                           ...+++.++..++.|++.||+|||++ +++||||||+||+++.++.++|+|||++.......      ...++..
T Consensus       168 ~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~-~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~  246 (343)
T cd05103         168 QEDLYKKVLTLEDLICYSFQVAKGMEFLASR-KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLK  246 (343)
T ss_pred             hhhhhhccCCHHHHHHHHHHHHHHHHHHHhC-CeecCCCccCeEEEcCCCcEEEEecccccccccCcchhhcCCCCCCcc
Confidence                 12367888899999999999999999 99999999999999999999999999987643221      1234567


Q ss_pred             ccCcccccCCCCCCcccchhhhHHHHHHHh-CCCCCCchhhHHHhhhchhhhccccccCCCChHHHHHHHHHHHHhcccC
Q 020221          218 FTPPEYLRTGRVTPESVMYSFGTLLLDLLS-GKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLASRCLQYE  296 (329)
Q Consensus       218 y~aPE~~~~~~~~~~~DvwslG~il~el~t-g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~d  296 (329)
                      |+|||.+.+..++.++||||||+++|+|++ |..|++........    ............+...++++.+++..||+.|
T Consensus       247 y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~cl~~~  322 (343)
T cd05103         247 WMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEF----CRRLKEGTRMRAPDYTTPEMYQTMLDCWHGE  322 (343)
T ss_pred             eECcHHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCccccHHH----HHHHhccCCCCCCCCCCHHHHHHHHHHccCC
Confidence            999999988889999999999999999997 77666542211110    0111111111223334678999999999999


Q ss_pred             CCCCCCHHHHHHHHHhhhhc
Q 020221          297 PRERPNPRSLVTALVTLQKD  316 (329)
Q Consensus       297 p~~Rps~~~~l~~L~~~~~~  316 (329)
                      |++|||+.+++++|+.+.+.
T Consensus       323 p~~Rps~~eil~~l~~~~~~  342 (343)
T cd05103         323 PSQRPTFSELVEHLGNLLQA  342 (343)
T ss_pred             hhhCcCHHHHHHHHHHHHhc
Confidence            99999999999999988653

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp

>cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8

Probab=100.00  E-value=1.7e-41  Score=302.82  Aligned_cols=242  Identities=16%  Similarity=0.226  Sum_probs=182.5

Q ss_pred             ccCCCCCCcEEEEEEeC---CCCEEEEEEeCCCCChhHHHHHHHHHHHhcCCCccccccceeeee--CCeeEEEEecCCC
Q 020221           63 SEHGEKAPNVVYKGKLE---NQFRIAVKRFNRSAWPDARQFLEEARAVGQLRNRRLANLLGCCCE--GDERLLVAEYMPN  137 (329)
Q Consensus        63 ~~lg~G~~g~V~~~~~~---~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~--~~~~~lv~e~~~~  137 (329)
                      ++||+|+||+||+|...   +++.+|+|.+.....  ...+.+|+++++.++||||+++++++..  ....++++||+.+
T Consensus         7 ~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~~--~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~~   84 (317)
T cd07868           7 CKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGI--SMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAEH   84 (317)
T ss_pred             cccccCCCeEEEEEEEccCCCCceEEEEEECCCCC--cHHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEEeccCC
Confidence            45799999999999853   467899999876542  3457789999999999999999998854  4568999999865


Q ss_pred             CCHHhhhccC-------CCCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceee----CCCCCeeeecccCcccC
Q 020221          138 DTLAKHLFHW-------ETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVF----DDDVNPRLSCFGLMKNS  206 (329)
Q Consensus       138 gsL~~~l~~~-------~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~----~~~~~~kl~Dfg~a~~~  206 (329)
                       +|.+++...       ....+++..+..++.||+.||.|||++ |++||||||+|||+    +.++.+||+|||++...
T Consensus        85 -~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~-~ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~a~~~  162 (317)
T cd07868          85 -DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHAN-WVLHRDLKPANILVMGEGPERGRVKIADMGFARLF  162 (317)
T ss_pred             -CHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhC-CEEcCCCCHHHEEEecCCCCcCcEEEeecCceecc
Confidence             788876421       123588999999999999999999999 99999999999999    45678999999999765


Q ss_pred             CCC-------CCccCcccccCcccccCC-CCCCcccchhhhHHHHHHHhCCCCCCchhhH-------------HHhhh--
Q 020221          207 RDG-------RSYSTNLAFTPPEYLRTG-RVTPESVMYSFGTLLLDLLSGKHIPPSHALD-------------LIRDR--  263 (329)
Q Consensus       207 ~~~-------~~~~~~~~y~aPE~~~~~-~~~~~~DvwslG~il~el~tg~~~~~~~~~~-------------~~~~~--  263 (329)
                      ...       ....+|+.|+|||++.+. .++.++||||+||++|+|++|..||.....+             .+...  
T Consensus       163 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~  242 (317)
T cd07868         163 NSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIFNVMG  242 (317)
T ss_pred             CCCCccccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccCCcccccccccccHHHHHHHHHhcC
Confidence            432       234568899999998774 4888999999999999999999887432110             00000  


Q ss_pred             --------chh------hhccccccCC------------CChHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 020221          264 --------NIQ------TLTDSCLEGQ------------FSSDEGTELVRLASRCLQYEPRERPNPRSLVT  308 (329)
Q Consensus       264 --------~~~------~~~~~~~~~~------------~~~~~~~~~~~li~~cl~~dp~~Rps~~~~l~  308 (329)
                              ...      ..........            .....+.++.+++.+||+.||++|||++++++
T Consensus       243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~t~~e~l~  313 (317)
T cd07868         243 FPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQAMQ  313 (317)
T ss_pred             CCChHHhHHHhhccchhhhhhhhhccccCcccccchHHhcCCCCChHHHHHHHHHhccCcccCCCHHHHhc
Confidence                    000      0000000000            00012346889999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p

>cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins

Probab=100.00  E-value=2.1e-41  Score=301.01  Aligned_cols=246  Identities=19%  Similarity=0.225  Sum_probs=199.2

Q ss_pred             CcccccccCCCCCCcEEEEEEe-CCCCEEEEEEeCCCCC---hhHHHHHHHHHHHhcCCCccccccceeeeeCCeeEEEE
Q 020221           57 AMENIVSEHGEKAPNVVYKGKL-ENQFRIAVKRFNRSAW---PDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVA  132 (329)
Q Consensus        57 ~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~  132 (329)
                      ..|.+++.+|+|+||.||++.. .+++.||+|.+.....   ...+.+.+|+++++.++|||++++.+++.+....++|+
T Consensus        15 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~lv~   94 (307)
T cd06607          15 KLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREHTAWLVM   94 (307)
T ss_pred             hhhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeCCeEEEEH
Confidence            4466777889999999999984 5688999999865432   22356889999999999999999999999999999999


Q ss_pred             ecCCCCCHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCCCCCeeeecccCcccCCCCCCc
Q 020221          133 EYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDGRSY  212 (329)
Q Consensus       133 e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~  212 (329)
                      ||+.+ +|.+++.. ....+++..+..++.|++.||.|||+. +++|+||+|+||+++.++.++|+|||++.........
T Consensus        95 e~~~g-~l~~~~~~-~~~~l~~~~~~~~~~ql~~~L~~LH~~-~i~H~dl~p~nIl~~~~~~~kL~dfg~~~~~~~~~~~  171 (307)
T cd06607          95 EYCLG-SASDILEV-HKKPLQEVEIAAICHGALQGLAYLHSH-ERIHRDIKAGNILLTEPGTVKLADFGSASLVSPANSF  171 (307)
T ss_pred             HhhCC-CHHHHHHH-cccCCCHHHHHHHHHHHHHHHHHHHHC-CceecCCCcccEEECCCCCEEEeecCcceecCCCCCc
Confidence            99974 77777643 345689999999999999999999999 9999999999999999999999999999877666666


Q ss_pred             cCcccccCccccc---CCCCCCcccchhhhHHHHHHHhCCCCCCchhhHHHhhhchhhhccccccCCCChHHHHHHHHHH
Q 020221          213 STNLAFTPPEYLR---TGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLA  289 (329)
Q Consensus       213 ~~~~~y~aPE~~~---~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li  289 (329)
                      .++..|+|||++.   ...++.++||||||+++|+|++|..|+..............    .......+...+..+.+++
T Consensus       172 ~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~li  247 (307)
T cd06607         172 VGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQ----NDSPTLSSNDWSDYFRNFV  247 (307)
T ss_pred             cCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCccHHHHHHHHhc----CCCCCCCchhhCHHHHHHH
Confidence            7888999999874   35588899999999999999999987754322111111100    0011111234677899999


Q ss_pred             HHhcccCCCCCCCHHHHHHH
Q 020221          290 SRCLQYEPRERPNPRSLVTA  309 (329)
Q Consensus       290 ~~cl~~dp~~Rps~~~~l~~  309 (329)
                      .+||..||++||++.+++.+
T Consensus       248 ~~~l~~~p~~Rp~~~~il~~  267 (307)
T cd06607         248 DSCLQKIPQDRPSSEELLKH  267 (307)
T ss_pred             HHHhcCChhhCcCHHHHhcC
Confidence            99999999999999999873

Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily

>cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=9.2e-42  Score=299.92  Aligned_cols=255  Identities=20%  Similarity=0.284  Sum_probs=204.4

Q ss_pred             CcccccccCCCCCCcEEEEEE-eCCCCEEEEEEeCCCCC-hhHHHHHHHHHHHhcCCCccccccceeeeeCCeeEEEEec
Q 020221           57 AMENIVSEHGEKAPNVVYKGK-LENQFRIAVKRFNRSAW-PDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAEY  134 (329)
Q Consensus        57 ~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  134 (329)
                      ..+++++.||+|+||+||++. ..+++.||+|++..... ...+.+.+|+++++.++||||+++++++......++|+||
T Consensus         5 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   84 (284)
T cd06620           5 EDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAFLNENNICMCMEF   84 (284)
T ss_pred             HHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecCcchHHHHHHHHHHHHHHcCCCCcceEeeeEecCCEEEEEEec
Confidence            456778888999999999998 55688999998875432 3356788999999999999999999999999999999999


Q ss_pred             CCCCCHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCCCCCeeeecccCcccCCCC--CCc
Q 020221          135 MPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDG--RSY  212 (329)
Q Consensus       135 ~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~--~~~  212 (329)
                      +++++|.+++.  ....+++..+..++.+++.||.|||+..+++|+||+|+||++++++.++|+|||++......  ...
T Consensus        85 ~~~~~L~~~~~--~~~~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl~p~nil~~~~~~~~l~d~gl~~~~~~~~~~~~  162 (284)
T cd06620          85 MDCGSLDRIYK--KGGPIPVEILGKIAVAVVEGLTYLYNVHRIMHRDIKPSNILVNSRGQIKLCDFGVSGELINSIADTF  162 (284)
T ss_pred             CCCCCHHHHHH--hccCCCHHHHHHHHHHHHHHHHHHHHhcCeeccCCCHHHEEECCCCcEEEccCCcccchhhhccCcc
Confidence            99999999886  34568999999999999999999997448999999999999999999999999998654322  234


Q ss_pred             cCcccccCcccccCCCCCCcccchhhhHHHHHHHhCCCCCCchhhHH----Hh---hhchhhhccccccCCCC-hHHHHH
Q 020221          213 STNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDL----IR---DRNIQTLTDSCLEGQFS-SDEGTE  284 (329)
Q Consensus       213 ~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~----~~---~~~~~~~~~~~~~~~~~-~~~~~~  284 (329)
                      .++..|+|||++.+..++.++|+||||+++|++++|..||.......    ..   ........... ....+ ...+.+
T Consensus       163 ~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~  241 (284)
T cd06620         163 VGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQIVQEP-PPRLPSSDFPED  241 (284)
T ss_pred             ccCcccCCHHHHccCCCCccchHHHHHHHHHHHHhCCCCCcccchhhhhhhhhhHHHHHHHHHhhcc-CCCCCchhcCHH
Confidence            67899999999988889999999999999999999998876432210    00   00111111111 11112 236678


Q ss_pred             HHHHHHHhcccCCCCCCCHHHHHHHHHhhh
Q 020221          285 LVRLASRCLQYEPRERPNPRSLVTALVTLQ  314 (329)
Q Consensus       285 ~~~li~~cl~~dp~~Rps~~~~l~~L~~~~  314 (329)
                      +.+++.+||..||++|||+.+++++..-++
T Consensus       242 ~~~li~~~l~~dp~~Rpt~~e~~~~~~~~~  271 (284)
T cd06620         242 LRDFVDACLLKDPTERPTPQQLCAMPPFIQ  271 (284)
T ss_pred             HHHHHHHHhcCCcccCcCHHHHhcCccccc
Confidence            999999999999999999999998654443

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors

Probab=100.00  E-value=1.6e-41  Score=295.66  Aligned_cols=249  Identities=22%  Similarity=0.298  Sum_probs=201.4

Q ss_pred             cccccccCCCCCCcEEEEEEeC-C---CCEEEEEEeCCCCCh-hHHHHHHHHHHHhcCCCccccccceeeeeCCeeEEEE
Q 020221           58 MENIVSEHGEKAPNVVYKGKLE-N---QFRIAVKRFNRSAWP-DARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVA  132 (329)
Q Consensus        58 ~~~~~~~lg~G~~g~V~~~~~~-~---~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~  132 (329)
                      .+++.+.||+|+||.||+|... +   +..+|+|.+...... ..+.+.+|+.+++.++||||+++++++...+..+++|
T Consensus         5 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   84 (267)
T cd05066           5 CIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSKPVMIVT   84 (267)
T ss_pred             HeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEEEE
Confidence            4566778899999999999842 2   347999998764422 3456889999999999999999999999999999999


Q ss_pred             ecCCCCCHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCCCCCeeeecccCcccCCCCCC-
Q 020221          133 EYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDGRS-  211 (329)
Q Consensus       133 e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~~-  211 (329)
                      ||+++++|.+++.. ....+++.++..++.|++.||.|||+. +++|+||||+||+++.++.++|+|||++........ 
T Consensus        85 e~~~~~~L~~~~~~-~~~~~~~~~~~~i~~~i~~~l~~lH~~-~i~h~dlkp~nili~~~~~~~l~dfg~~~~~~~~~~~  162 (267)
T cd05066          85 EYMENGSLDAFLRK-HDGQFTVIQLVGMLRGIASGMKYLSDM-GYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEA  162 (267)
T ss_pred             EcCCCCCHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHHC-CEeehhhchhcEEECCCCeEEeCCCCcccccccccce
Confidence            99999999999864 335689999999999999999999999 999999999999999999999999999876543321 


Q ss_pred             ------ccCcccccCcccccCCCCCCcccchhhhHHHHHHHh-CCCCCCchhhHHHhhhchhhhccccccCCCChHHHHH
Q 020221          212 ------YSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLS-GKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTE  284 (329)
Q Consensus       212 ------~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t-g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  284 (329)
                            ...+..|+|||.+.+..++.++|+||||+++|++++ |..|+...............     .....+...++.
T Consensus       163 ~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~ell~~g~~p~~~~~~~~~~~~~~~~-----~~~~~~~~~~~~  237 (267)
T cd05066         163 AYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSNQDVIKAIEEG-----YRLPAPMDCPAA  237 (267)
T ss_pred             eeecCCCccceeecCHhHhccCccCchhhhHHHHHHHHHHhcCCCCCcccCCHHHHHHHHhCC-----CcCCCCCCCCHH
Confidence                  112457999999998889999999999999999886 88776543222111111111     112233456788


Q ss_pred             HHHHHHHhcccCCCCCCCHHHHHHHHHhh
Q 020221          285 LVRLASRCLQYEPRERPNPRSLVTALVTL  313 (329)
Q Consensus       285 ~~~li~~cl~~dp~~Rps~~~~l~~L~~~  313 (329)
                      +.+++.+||+.+|++||++.++++.|+++
T Consensus       238 ~~~li~~~l~~~p~~Rp~~~~i~~~l~~~  266 (267)
T cd05066         238 LHQLMLDCWQKDRNERPKFEQIVSILDKL  266 (267)
T ss_pred             HHHHHHHHcccCchhCCCHHHHHHHHHhh
Confidence            99999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul

>cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase

Probab=100.00  E-value=1.3e-41  Score=299.50  Aligned_cols=249  Identities=22%  Similarity=0.333  Sum_probs=199.6

Q ss_pred             cccccccCCCCCCcEEEEEEeC------CCCEEEEEEeCCCCCh-hHHHHHHHHHHHhcCCCccccccceeeeeCCeeEE
Q 020221           58 MENIVSEHGEKAPNVVYKGKLE------NQFRIAVKRFNRSAWP-DARQFLEEARAVGQLRNRRLANLLGCCCEGDERLL  130 (329)
Q Consensus        58 ~~~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l  130 (329)
                      ++++++.||+|+||.||++...      ++..||+|.+...... ....+.+|+.+++.++||||+++++++..+...++
T Consensus         6 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~~~~~~l   85 (288)
T cd05050           6 NIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVKLLGVCAVGKPMCL   85 (288)
T ss_pred             hceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCcCHHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCccEE
Confidence            4567778899999999999853      4678999998765432 24568899999999999999999999999999999


Q ss_pred             EEecCCCCCHHhhhccCC--------------------CCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeC
Q 020221          131 VAEYMPNDTLAKHLFHWE--------------------TQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFD  190 (329)
Q Consensus       131 v~e~~~~gsL~~~l~~~~--------------------~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~  190 (329)
                      ++||+++++|.+++....                    ...+++..++.++.|++.||.|||++ +++|+||||+||+++
T Consensus        86 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~-~i~H~dl~p~nil~~  164 (288)
T cd05050          86 LFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSER-KFVHRDLATRNCLVG  164 (288)
T ss_pred             EEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhC-CeecccccHhheEec
Confidence            999999999999986321                    12468889999999999999999999 999999999999999


Q ss_pred             CCCCeeeecccCcccCCCCC------CccCcccccCcccccCCCCCCcccchhhhHHHHHHHh-CCCCCCchhhHHHhhh
Q 020221          191 DDVNPRLSCFGLMKNSRDGR------SYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLS-GKHIPPSHALDLIRDR  263 (329)
Q Consensus       191 ~~~~~kl~Dfg~a~~~~~~~------~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t-g~~~~~~~~~~~~~~~  263 (329)
                      +++.++|+|||++.......      ....+..|+|||.+.+..++.++||||||+++|+|++ |..|+...........
T Consensus       165 ~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~~~~p~~~~~~~~~~~~  244 (288)
T cd05050         165 ENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYYGMAHEEVIYY  244 (288)
T ss_pred             CCCceEECccccceecccCccccccCCCccChhhcCHHHHhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHH
Confidence            99999999999987543221      2233567999999988889999999999999999998 6666643322221111


Q ss_pred             chhhhccccccCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHh
Q 020221          264 NIQTLTDSCLEGQFSSDEGTELVRLASRCLQYEPRERPNPRSLVTALVT  312 (329)
Q Consensus       264 ~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~~~l~~L~~  312 (329)
                          +.... ....+...+.++.+++.+||+.||++|||+.++++.|++
T Consensus       245 ----~~~~~-~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~el~~~l~~  288 (288)
T cd05050         245 ----VRDGN-VLSCPDNCPLELYNLMRLCWSKLPSDRPSFASINRILQR  288 (288)
T ss_pred             ----HhcCC-CCCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHhhC
Confidence                11111 112234567889999999999999999999999998874

Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M

>cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases

Probab=100.00  E-value=1e-41  Score=295.26  Aligned_cols=237  Identities=25%  Similarity=0.384  Sum_probs=189.6

Q ss_pred             cCCCCCCcEEEEEEeCC-C----------CEEEEEEeCCCCChhHHHHHHHHHHHhcCCCccccccceeeeeCCeeEEEE
Q 020221           64 EHGEKAPNVVYKGKLEN-Q----------FRIAVKRFNRSAWPDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVA  132 (329)
Q Consensus        64 ~lg~G~~g~V~~~~~~~-~----------~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~  132 (329)
                      .||+|+||.||+|...+ +          ..+++|.+...... ...+.+|+.+++.++||||+++++++.. ...++|+
T Consensus         2 ~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~-~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~lv~   79 (259)
T cd05037           2 HLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRD-SLAFFETASLMSQLSHKHLVKLYGVCVR-DENIMVE   79 (259)
T ss_pred             cccccccceEEEEEEeccCCccccCCccceeeeeeccccchhh-HHHHHHHHHHHHcCCCcchhheeeEEec-CCcEEEE
Confidence            46999999999999543 3          25788887665433 5678899999999999999999999987 7889999


Q ss_pred             ecCCCCCHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCCCC-------CeeeecccCccc
Q 020221          133 EYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDV-------NPRLSCFGLMKN  205 (329)
Q Consensus       133 e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~-------~~kl~Dfg~a~~  205 (329)
                      ||+++|+|.+++.. ....+++..+..++.|++.||+|||++ +++|+||||+||+++.++       .++|+|||++..
T Consensus        80 e~~~~~~L~~~l~~-~~~~~~~~~~~~~~~~i~~~l~~LH~~-~i~H~dlkp~Nill~~~~~~~~~~~~~kl~Dfg~a~~  157 (259)
T cd05037          80 EYVKFGPLDVFLHR-EKNNVSLHWKLDVAKQLASALHYLEDK-KLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIPIT  157 (259)
T ss_pred             EcCCCCcHHHHHHh-hccCCCHHHHHHHHHHHHHHHHHHhhC-CeecccCccceEEEecCccccCCceeEEeCCCCcccc
Confidence            99999999999864 223689999999999999999999999 999999999999999887       799999999987


Q ss_pred             CCCCCCccCcccccCcccccCC--CCCCcccchhhhHHHHHHHhCCC-CCCchhhHHHhhhchhhhccccccCCCChHHH
Q 020221          206 SRDGRSYSTNLAFTPPEYLRTG--RVTPESVMYSFGTLLLDLLSGKH-IPPSHALDLIRDRNIQTLTDSCLEGQFSSDEG  282 (329)
Q Consensus       206 ~~~~~~~~~~~~y~aPE~~~~~--~~~~~~DvwslG~il~el~tg~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  282 (329)
                      ........++..|+|||++.+.  .++.++||||||+++|+|++|.. |+........... ..   .   ....+....
T Consensus       158 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~~~~~~~-~~---~---~~~~~~~~~  230 (259)
T cd05037         158 VLSREERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSSEKERF-YQ---D---QHRLPMPDC  230 (259)
T ss_pred             cccccccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCCchhHHHH-Hh---c---CCCCCCCCc
Confidence            6655555677889999999876  68899999999999999999643 3322211111100 00   0   111122223


Q ss_pred             HHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 020221          283 TELVRLASRCLQYEPRERPNPRSLVTALV  311 (329)
Q Consensus       283 ~~~~~li~~cl~~dp~~Rps~~~~l~~L~  311 (329)
                      ..+.+++.+||..+|++|||+.++++.|+
T Consensus       231 ~~~~~li~~~l~~~p~~Rpt~~~il~~l~  259 (259)
T cd05037         231 AELANLINQCWTYDPTKRPSFRAILRDLN  259 (259)
T ss_pred             hHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence            78999999999999999999999998763

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki

>cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.6e-41  Score=302.81  Aligned_cols=246  Identities=18%  Similarity=0.177  Sum_probs=200.5

Q ss_pred             cccccccCCCCCCcEEEEEEe-CCCCEEEEEEeCCCCCh---hHHHHHHHHHHHhcCCCccccccceeeeeCCeeEEEEe
Q 020221           58 MENIVSEHGEKAPNVVYKGKL-ENQFRIAVKRFNRSAWP---DARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAE  133 (329)
Q Consensus        58 ~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~---~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  133 (329)
                      .|++.+.||+|++|.||++.. .+++.+|+|.+......   ..+.+..|++.++.++|+||+++++.+......+++||
T Consensus         2 ~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e   81 (316)
T cd05574           2 HFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQTETYLCLVMD   81 (316)
T ss_pred             ceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeeecCCEEEEEEE
Confidence            356677789999999999994 45889999999765433   34568889999999999999999999999999999999


Q ss_pred             cCCCCCHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCCCCCeeeecccCcccCCCCC---
Q 020221          134 YMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDGR---  210 (329)
Q Consensus       134 ~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~---  210 (329)
                      |+.+++|.+++.......+++..+..++.|++.||+|||+. +++|+||||+||+++.++.++|+|||++.......   
T Consensus        82 ~~~~~~L~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~-~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~~  160 (316)
T cd05574          82 YCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLALEYLHLL-GIVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPPPV  160 (316)
T ss_pred             ecCCCCHHHHHHhCCCCccCHHHHHHHHHHHHHHHHHHHHC-CeeccCCChHHeEEcCCCCEEEeecchhhccccccccc
Confidence            99999999998754456789999999999999999999999 99999999999999999999999999876432211   


Q ss_pred             ------------------------------CccCcccccCcccccCCCCCCcccchhhhHHHHHHHhCCCCCCchhhHHH
Q 020221          211 ------------------------------SYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLI  260 (329)
Q Consensus       211 ------------------------------~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~  260 (329)
                                                    ...|+..|+|||++.+..++.++||||||+++|+|++|..||........
T Consensus       161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~  240 (316)
T cd05574         161 SKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTPFKGSNRDET  240 (316)
T ss_pred             ccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCCCCchHHHHHHHHHHHHHhhCCCCCCCCchHHH
Confidence                                          22467789999999988899999999999999999999998865432221


Q ss_pred             hhhchhhhccccccCCCChHHHHHHHHHHHHhcccCCCCCCC----HHHHHH
Q 020221          261 RDRNIQTLTDSCLEGQFSSDEGTELVRLASRCLQYEPRERPN----PRSLVT  308 (329)
Q Consensus       261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps----~~~~l~  308 (329)
                      ...    ..............+.++.+++.+||..||++|||    +.++++
T Consensus       241 ~~~----~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~ll~  288 (316)
T cd05574         241 FSN----ILKKEVTFPGSPPVSSSARDLIRKLLVKDPSKRLGSKRGAAEIKQ  288 (316)
T ss_pred             HHH----HhcCCccCCCccccCHHHHHHHHHHccCCHhHCCCchhhHHHHHc
Confidence            111    11111111111225789999999999999999999    777776

Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin

>cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase

Probab=100.00  E-value=1.3e-41  Score=294.12  Aligned_cols=246  Identities=25%  Similarity=0.369  Sum_probs=200.5

Q ss_pred             CcccccccCCCCCCcEEEEEEeCCCCEEEEEEeCCCCChhHHHHHHHHHHHhcCCCccccccceeeeeCCeeEEEEecCC
Q 020221           57 AMENIVSEHGEKAPNVVYKGKLENQFRIAVKRFNRSAWPDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAEYMP  136 (329)
Q Consensus        57 ~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~  136 (329)
                      ..+++.+.+|+|+||.||++.. +++.+|+|.+....  ..+.+.+|+.+++.++|||++++++++.. +..+++|||++
T Consensus         6 ~~~~~~~~lg~g~~g~v~~~~~-~~~~~~iK~~~~~~--~~~~~~~e~~~l~~~~~~~i~~~~~~~~~-~~~~~v~e~~~   81 (254)
T cd05083           6 QKLTLGEIIGEGEFGAVLQGEY-TGQKVAVKNIKCDV--TAQAFLEETAVMTKLHHKNLVRLLGVILH-NGLYIVMELMS   81 (254)
T ss_pred             HHceeeeeeccCCCCceEeccc-CCCceEEEeecCcc--hHHHHHHHHHHHHhCCCCCcCeEEEEEcC-CCcEEEEECCC
Confidence            4467778889999999999975 56689999987543  34568899999999999999999998865 45799999999


Q ss_pred             CCCHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCCCCCeeeecccCcccCCCCC-CccCc
Q 020221          137 NDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDGR-SYSTN  215 (329)
Q Consensus       137 ~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~-~~~~~  215 (329)
                      +++|.+++.......+++..+..++.|++.||.|||+. |++|+||||+||+++.++.++|+|||++....... ....+
T Consensus        82 ~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~al~~lH~~-~~~H~dl~p~nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~  160 (254)
T cd05083          82 KGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLESK-KLVHRDLAARNILVSEDGVAKVSDFGLARVGSMGVDNSKLP  160 (254)
T ss_pred             CCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhC-CeeccccCcceEEEcCCCcEEECCCccceeccccCCCCCCC
Confidence            99999999754445689999999999999999999999 99999999999999999999999999987654332 22345


Q ss_pred             ccccCcccccCCCCCCcccchhhhHHHHHHHh-CCCCCCchhhHHHhhhchhhhccccccCCCChHHHHHHHHHHHHhcc
Q 020221          216 LAFTPPEYLRTGRVTPESVMYSFGTLLLDLLS-GKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLASRCLQ  294 (329)
Q Consensus       216 ~~y~aPE~~~~~~~~~~~DvwslG~il~el~t-g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~  294 (329)
                      ..|+|||.+.+..++.++|+||||+++|+|++ |..|+..............     ......+...+.++.+++.+||+
T Consensus       161 ~~y~~pe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~li~~~l~  235 (254)
T cd05083         161 VKWTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKMSLKEVKECVEK-----GYRMEPPEGCPADVYVLMTSCWE  235 (254)
T ss_pred             ceecCHHHhccCCcCchhhHHHHHHHHHHHHhCCCCCCccCCHHHHHHHHhC-----CCCCCCCCcCCHHHHHHHHHHcC
Confidence            67999999988889999999999999999998 7777654433322221111     11222334567889999999999


Q ss_pred             cCCCCCCCHHHHHHHHHh
Q 020221          295 YEPRERPNPRSLVTALVT  312 (329)
Q Consensus       295 ~dp~~Rps~~~~l~~L~~  312 (329)
                      .+|++||++.++++.|++
T Consensus       236 ~~p~~Rp~~~~l~~~l~~  253 (254)
T cd05083         236 TEPKKRPSFHKLREKLEK  253 (254)
T ss_pred             CChhhCcCHHHHHHHHcc
Confidence            999999999999998763

Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki

>PRK13184 pknD serine/threonine-protein kinase; Reviewed

Probab=100.00  E-value=1.2e-41  Score=329.78  Aligned_cols=256  Identities=19%  Similarity=0.189  Sum_probs=203.4

Q ss_pred             CcccccccCCCCCCcEEEEEE-eCCCCEEEEEEeCCCCCh---hHHHHHHHHHHHhcCCCccccccceeeeeCCeeEEEE
Q 020221           57 AMENIVSEHGEKAPNVVYKGK-LENQFRIAVKRFNRSAWP---DARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVA  132 (329)
Q Consensus        57 ~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~---~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~  132 (329)
                      ..|++++.||+|+||.||+|. ..+++.||+|++......   ..+.+.+|+++++.++||||+++++++.+++..+++|
T Consensus         2 grYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~~~lyLVM   81 (932)
T PRK13184          2 QRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSDGDPVYYTM   81 (932)
T ss_pred             CCeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeCCEEEEEE
Confidence            457788888999999999998 456889999999764322   2456889999999999999999999999999999999


Q ss_pred             ecCCCCCHHhhhccCC---------CCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCCCCCeeeecccCc
Q 020221          133 EYMPNDTLAKHLFHWE---------TQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLM  203 (329)
Q Consensus       133 e~~~~gsL~~~l~~~~---------~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a  203 (329)
                      ||+++++|.+++.+..         ....++..+..++.||+.||+|||++ |++||||||+||+++.++.++|+|||++
T Consensus        82 EY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~-GIIHRDLKPeNILLd~dg~vKLiDFGLA  160 (932)
T PRK13184         82 PYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSK-GVLHRDLKPDNILLGLFGEVVILDWGAA  160 (932)
T ss_pred             EcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHC-CccccCCchheEEEcCCCCEEEEecCcc
Confidence            9999999999885321         12456778899999999999999999 9999999999999999999999999998


Q ss_pred             ccCCCC----------------------CCccCcccccCcccccCCCCCCcccchhhhHHHHHHHhCCCCCCchhhHHHh
Q 020221          204 KNSRDG----------------------RSYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIR  261 (329)
Q Consensus       204 ~~~~~~----------------------~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~~  261 (329)
                      ......                      ....||+.|+|||.+.+..++.++||||||+++|||+||..||.........
T Consensus       161 k~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~S~kSDIWSLGVILyELLTG~~PF~~~~~~ki~  240 (932)
T PRK13184        161 IFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPYRRKKGRKIS  240 (932)
T ss_pred             eecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCCCCcHhHHHHHHHHHHHHHHCCCCCCCcchhhhh
Confidence            755110                      1235789999999999989999999999999999999999887653222111


Q ss_pred             hhchhhhccccccCCCChHHHHHHHHHHHHhcccCCCCCC-CHHHHHHHHHhhhhc
Q 020221          262 DRNIQTLTDSCLEGQFSSDEGTELVRLASRCLQYEPRERP-NPRSLVTALVTLQKD  316 (329)
Q Consensus       262 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rp-s~~~~l~~L~~~~~~  316 (329)
                      ..  .....+. ........++.+.+++.+||+.||++|| +++++++.|+...+.
T Consensus       241 ~~--~~i~~P~-~~~p~~~iP~~L~~LI~rcL~~DP~kR~ss~eeLl~~Le~~lq~  293 (932)
T PRK13184        241 YR--DVILSPI-EVAPYREIPPFLSQIAMKALAVDPAERYSSVQELKQDLEPHLQG  293 (932)
T ss_pred             hh--hhccChh-hccccccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhc
Confidence            11  0011110 0001124567899999999999999996 677788888877553

>cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6

Probab=100.00  E-value=1.2e-41  Score=298.88  Aligned_cols=245  Identities=14%  Similarity=0.208  Sum_probs=195.0

Q ss_pred             cccccccCCCCCCcEEEEEE-eCCCCEEEEEEeCCCCChhHHHHHHHHHHHhcC-CCccccccceeeee------CCeeE
Q 020221           58 MENIVSEHGEKAPNVVYKGK-LENQFRIAVKRFNRSAWPDARQFLEEARAVGQL-RNRRLANLLGCCCE------GDERL  129 (329)
Q Consensus        58 ~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~------~~~~~  129 (329)
                      .+++.+.+|+|+||.||+|. ..+++.+|+|.+.... .....+..|+.+++.+ +|+|++++++++..      ....+
T Consensus        17 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~~~~   95 (282)
T cd06636          17 IFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTE-DEEEEIKLEINMLKKYSHHRNIATYYGAFIKKSPPGHDDQLW   95 (282)
T ss_pred             hhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecCh-HHHHHHHHHHHHHHHhcCCCcEEEEeeehhcccccCCCCEEE
Confidence            34556667999999999999 4668899999986644 2345678899999998 69999999998853      45789


Q ss_pred             EEEecCCCCCHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCCCCCeeeecccCcccCCC-
Q 020221          130 LVAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRD-  208 (329)
Q Consensus       130 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~-  208 (329)
                      ++|||+.+|+|.+++.......+++..+..++.|++.||.|||+. +++|+||+|+||++++++.++|+|||++..... 
T Consensus        96 iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~-~ivH~dl~~~nili~~~~~~~l~dfg~~~~~~~~  174 (282)
T cd06636          96 LVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRGLAHLHAH-KVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRT  174 (282)
T ss_pred             EEEEeCCCCcHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHC-CcccCCCCHHHEEECCCCCEEEeeCcchhhhhcc
Confidence            999999999999998764556688999999999999999999999 999999999999999999999999999875432 


Q ss_pred             ---CCCccCcccccCccccc-----CCCCCCcccchhhhHHHHHHHhCCCCCCchhhHHHhhhchhhhccccccCCCChH
Q 020221          209 ---GRSYSTNLAFTPPEYLR-----TGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSD  280 (329)
Q Consensus       209 ---~~~~~~~~~y~aPE~~~-----~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  280 (329)
                         .....++..|+|||.+.     +..++.++|+||||+++|+|++|..||.........    ...............
T Consensus       175 ~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~----~~~~~~~~~~~~~~~  250 (282)
T cd06636         175 VGRRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMRAL----FLIPRNPPPKLKSKK  250 (282)
T ss_pred             ccCCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccccCHHhhh----hhHhhCCCCCCcccc
Confidence               22345788999999875     345888999999999999999999877543211111    111111111112234


Q ss_pred             HHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 020221          281 EGTELVRLASRCLQYEPRERPNPRSLVT  308 (329)
Q Consensus       281 ~~~~~~~li~~cl~~dp~~Rps~~~~l~  308 (329)
                      .+.++.+++.+||..||++|||+.++++
T Consensus       251 ~~~~~~~li~~cl~~~p~~Rp~~~ell~  278 (282)
T cd06636         251 WSKKFIDFIEGCLVKNYLSRPSTEQLLK  278 (282)
T ss_pred             cCHHHHHHHHHHhCCChhhCcCHHHHhc
Confidence            6778999999999999999999999998

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea

>cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases

Probab=100.00  E-value=1.6e-41  Score=296.38  Aligned_cols=247  Identities=19%  Similarity=0.222  Sum_probs=195.6

Q ss_pred             ccccccCCCCCCcEEEEEE-eCCCCEEEEEEeCCCCCh----------hHHHHHHHHHHHhcCCCccccccceeeeeCCe
Q 020221           59 ENIVSEHGEKAPNVVYKGK-LENQFRIAVKRFNRSAWP----------DARQFLEEARAVGQLRNRRLANLLGCCCEGDE  127 (329)
Q Consensus        59 ~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~----------~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~  127 (329)
                      |.+.+.||.|+||.||+|. ..+++.+|+|.+......          ..+.+.+|+.+++.++|+|++++++++.....
T Consensus         3 ~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~   82 (272)
T cd06629           3 WVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTEEY   82 (272)
T ss_pred             eeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEeccCCc
Confidence            4455677999999999998 456889999988642111          12357789999999999999999999999999


Q ss_pred             eEEEEecCCCCCHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCCCCCeeeecccCcccCC
Q 020221          128 RLLVAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSR  207 (329)
Q Consensus       128 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~  207 (329)
                      .++|+||+++++|.+++.+  ...+++..+..++.|++.||.|||++ +++|+||+|+||+++.++.++++|||++....
T Consensus        83 ~~lv~e~~~~~~L~~~l~~--~~~l~~~~~~~~~~qi~~~l~~lH~~-~i~H~dl~~~nil~~~~~~~~l~d~~~~~~~~  159 (272)
T cd06629          83 LSIFLEYVPGGSIGSCLRT--YGRFEEQLVRFFTEQVLEGLAYLHSK-GILHRDLKADNLLVDADGICKISDFGISKKSD  159 (272)
T ss_pred             eEEEEecCCCCcHHHHHhh--ccCCCHHHHHHHHHHHHHHHHHHhhC-CeeecCCChhhEEEcCCCeEEEeecccccccc
Confidence            9999999999999999864  35789999999999999999999999 99999999999999999999999999987544


Q ss_pred             CC------CCccCcccccCcccccCCC--CCCcccchhhhHHHHHHHhCCCCCCchhhHHHhhhchhhhccccccCCCCh
Q 020221          208 DG------RSYSTNLAFTPPEYLRTGR--VTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSS  279 (329)
Q Consensus       208 ~~------~~~~~~~~y~aPE~~~~~~--~~~~~DvwslG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  279 (329)
                      ..      ....++..|+|||.+....  ++.++|+||||+++|++++|..|+...........................
T Consensus       160 ~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (272)
T cd06629         160 DIYDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAIAAMFKLGNKRSAPPIPPDVSM  239 (272)
T ss_pred             ccccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcchHHHHHHhhccccCCcCCccccc
Confidence            32      1235678899999987654  788999999999999999999887543221111100000011111111223


Q ss_pred             HHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 020221          280 DEGTELVRLASRCLQYEPRERPNPRSLVT  308 (329)
Q Consensus       280 ~~~~~~~~li~~cl~~dp~~Rps~~~~l~  308 (329)
                      ..+.++.+++.+||..||++|||+.++++
T Consensus       240 ~~~~~~~~li~~~l~~~p~~Rps~~~il~  268 (272)
T cd06629         240 NLSPVALDFLNACFTINPDNRPTARELLQ  268 (272)
T ss_pred             cCCHHHHHHHHHHhcCChhhCCCHHHHhh
Confidence            45789999999999999999999999998

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte

>cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor

Probab=100.00  E-value=1.7e-41  Score=298.82  Aligned_cols=251  Identities=24%  Similarity=0.338  Sum_probs=198.7

Q ss_pred             cccccccCCCCCCcEEEEEEeC------CCCEEEEEEeCCCCCh-hHHHHHHHHHHHhcCCCccccccceeeeeCCeeEE
Q 020221           58 MENIVSEHGEKAPNVVYKGKLE------NQFRIAVKRFNRSAWP-DARQFLEEARAVGQLRNRRLANLLGCCCEGDERLL  130 (329)
Q Consensus        58 ~~~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l  130 (329)
                      .+++++.||+|+||.||+|...      .+..||+|.+...... ....+.+|+..++.++||||+++++++......++
T Consensus         7 ~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l   86 (288)
T cd05061           7 KITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVRLLGVVSKGQPTLV   86 (288)
T ss_pred             HceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcEE
Confidence            4667788899999999999742      2457999998755422 23457889999999999999999999998899999


Q ss_pred             EEecCCCCCHHhhhccCC--------CCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCCCCCeeeecccC
Q 020221          131 VAEYMPNDTLAKHLFHWE--------TQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGL  202 (329)
Q Consensus       131 v~e~~~~gsL~~~l~~~~--------~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~  202 (329)
                      +|||+++|+|.+++....        ....++..+..++.|++.||.|||++ +++|+||||+||++++++.++|+|||+
T Consensus        87 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~-~i~H~dikp~nili~~~~~~~L~Dfg~  165 (288)
T cd05061          87 VMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAK-KFVHRDLAARNCMVAHDFTVKIGDFGM  165 (288)
T ss_pred             EEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhC-CCcCCCCChheEEEcCCCcEEECcCCc
Confidence            999999999999996421        13346778899999999999999999 999999999999999999999999999


Q ss_pred             cccCCCCC------CccCcccccCcccccCCCCCCcccchhhhHHHHHHHh-CCCCCCchhhHHHhhhchhhhccccccC
Q 020221          203 MKNSRDGR------SYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLS-GKHIPPSHALDLIRDRNIQTLTDSCLEG  275 (329)
Q Consensus       203 a~~~~~~~------~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t-g~~~~~~~~~~~~~~~~~~~~~~~~~~~  275 (329)
                      ++......      ...++..|+|||.+.+..++.++|+||||+++|||++ |..|+............    ... ...
T Consensus       166 ~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~DvwslG~~l~el~~~~~~p~~~~~~~~~~~~~----~~~-~~~  240 (288)
T cd05061         166 TRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLKFV----MDG-GYL  240 (288)
T ss_pred             cccccccccccccCCCcccccccCHHHhccCCCChHhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHH----HcC-CCC
Confidence            87543221      1233567999999998889999999999999999999 56555433222221111    111 111


Q ss_pred             CCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhh
Q 020221          276 QFSSDEGTELVRLASRCLQYEPRERPNPRSLVTALVTLQ  314 (329)
Q Consensus       276 ~~~~~~~~~~~~li~~cl~~dp~~Rps~~~~l~~L~~~~  314 (329)
                      ..+...++.+.+++.+||+.||++|||+.++++.|+...
T Consensus       241 ~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~~~  279 (288)
T cd05061         241 DQPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDDL  279 (288)
T ss_pred             CCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHhhc
Confidence            223445678999999999999999999999999888764

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta

>PTZ00284 protein kinase; Provisional

Probab=100.00  E-value=1e-41  Score=319.58  Aligned_cols=248  Identities=18%  Similarity=0.175  Sum_probs=185.9

Q ss_pred             CcccccccCCCCCCcEEEEEE-eCCCCEEEEEEeCCCCChhHHHHHHHHHHHhcCCC------ccccccceeeeeC-Cee
Q 020221           57 AMENIVSEHGEKAPNVVYKGK-LENQFRIAVKRFNRSAWPDARQFLEEARAVGQLRN------RRLANLLGCCCEG-DER  128 (329)
Q Consensus        57 ~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h------~niv~~~~~~~~~-~~~  128 (329)
                      ..|++++.||+|+||+||++. ..+++.||||+++... ........|++++..++|      .+++++++++... ...
T Consensus       129 ~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~-~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~~~~~~~~  207 (467)
T PTZ00284        129 QRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVP-KYTRDAKIEIQFMEKVRQADPADRFPLMKIQRYFQNETGHM  207 (467)
T ss_pred             CcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecch-hhHHHHHHHHHHHHHHhhcCcccCcceeeeEEEEEcCCceE
Confidence            346778888999999999998 4567889999997532 223345667777776654      4588888888654 578


Q ss_pred             EEEEecCCCCCHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCCCC---------------
Q 020221          129 LLVAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDV---------------  193 (329)
Q Consensus       129 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~---------------  193 (329)
                      ++|||++ +++|.+++.  ....+++..+..++.||+.||.|||++.||+||||||+|||++.++               
T Consensus       208 ~iv~~~~-g~~l~~~l~--~~~~l~~~~~~~i~~qi~~aL~yLH~~~gIiHrDlKP~NILl~~~~~~~~~~~~~~~~~~~  284 (467)
T PTZ00284        208 CIVMPKY-GPCLLDWIM--KHGPFSHRHLAQIIFQTGVALDYFHTELHLMHTDLKPENILMETSDTVVDPVTNRALPPDP  284 (467)
T ss_pred             EEEEecc-CCCHHHHHH--HcCCCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCHHHEEEecCCcccccccccccCCCC
Confidence            8999988 668888886  3457899999999999999999999733999999999999998665               


Q ss_pred             -CeeeecccCcccCCCC-CCccCcccccCcccccCCCCCCcccchhhhHHHHHHHhCCCCCCchhhHHHhhhc---h---
Q 020221          194 -NPRLSCFGLMKNSRDG-RSYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRN---I---  265 (329)
Q Consensus       194 -~~kl~Dfg~a~~~~~~-~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~~~~~---~---  265 (329)
                       .+||+|||.+...... ....||+.|+|||++.+..++.++|||||||++|||++|+.||............   .   
T Consensus       285 ~~vkl~DfG~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~g~~  364 (467)
T PTZ00284        285 CRVRICDLGGCCDERHSRTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTGKLLYDTHDNLEHLHLMEKTLGRL  364 (467)
T ss_pred             ceEEECCCCccccCccccccccCCccccCcHHhhcCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCC
Confidence             4999999987654332 3457899999999999999999999999999999999999888643211100000   0   


Q ss_pred             -------------hhhcccc--ccCCC---------------ChHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 020221          266 -------------QTLTDSC--LEGQF---------------SSDEGTELVRLASRCLQYEPRERPNPRSLVT  308 (329)
Q Consensus       266 -------------~~~~~~~--~~~~~---------------~~~~~~~~~~li~~cl~~dp~~Rps~~~~l~  308 (329)
                                   ..+....  +....               .....+.+.+||.+||..||++|||+.++++
T Consensus       365 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~ta~e~L~  437 (467)
T PTZ00284        365 PSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVREVIRDDLLCDLIYGLLHYDRQKRLNARQMTT  437 (467)
T ss_pred             CHHHHhhccchhHHHHhhhcccccccCCHHHHHhhhcccchhhhhchHHHHHHHHHhCCcChhhCCCHHHHhc
Confidence                         0000000  00000               0012456889999999999999999999998

>cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1

Probab=100.00  E-value=1.1e-41  Score=298.24  Aligned_cols=241  Identities=17%  Similarity=0.273  Sum_probs=198.5

Q ss_pred             ccccccCCCCCCcEEEEEE-eCCCCEEEEEEeCCCC-ChhHHHHHHHHHHHhcCCCccccccceeeeeCCeeEEEEecCC
Q 020221           59 ENIVSEHGEKAPNVVYKGK-LENQFRIAVKRFNRSA-WPDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAEYMP  136 (329)
Q Consensus        59 ~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~  136 (329)
                      |..++.||+|+||.||+|. ..++..||+|.+.... ....+.+.+|+++++.++||||+++++++......++|+||++
T Consensus         6 y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~   85 (277)
T cd06642           6 FTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGSYLKGTKLWIIMEYLG   85 (277)
T ss_pred             HHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEeccccchHHHHHHHHHHHHHHcCCCCccHhhhcccccCCceEEEEEccC
Confidence            4455667999999999998 4567889999987543 2334568899999999999999999999999999999999999


Q ss_pred             CCCHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCCCCCeeeecccCcccCCCCC----Cc
Q 020221          137 NDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDGR----SY  212 (329)
Q Consensus       137 ~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~----~~  212 (329)
                      +++|.+++.   ...+++..+..++.|++.|+.|||++ +++|+||+|+||++++++.++++|||++.......    ..
T Consensus        86 ~~~L~~~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~-~ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~~~~~~  161 (277)
T cd06642          86 GGSALDLLK---PGPLEETYIATILREILKGLDYLHSE-RKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTF  161 (277)
T ss_pred             CCcHHHHhh---cCCCCHHHHHHHHHHHHHHHHHHhcC-CeeccCCChheEEEeCCCCEEEccccccccccCcchhhhcc
Confidence            999999884   45789999999999999999999999 99999999999999999999999999987654332    23


Q ss_pred             cCcccccCcccccCCCCCCcccchhhhHHHHHHHhCCCCCCchhhHHHhhhchhhhccccccCCCChHHHHHHHHHHHHh
Q 020221          213 STNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLASRC  292 (329)
Q Consensus       213 ~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~c  292 (329)
                      .++..|+|||.+.+..++.++|+||||+++|||++|..|+..........     ..............+.++.+++.+|
T Consensus       162 ~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~li~~~  236 (277)
T cd06642         162 VGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDLHPMRVLF-----LIPKNSPPTLEGQYSKPFKEFVEAC  236 (277)
T ss_pred             cCcccccCHHHhCcCCCchhhhHHHHHHHHHHHHhCCCCCcccchhhHHh-----hhhcCCCCCCCcccCHHHHHHHHHH
Confidence            46788999999998889999999999999999999998765332111111     1111112223345677899999999


Q ss_pred             cccCCCCCCCHHHHHH
Q 020221          293 LQYEPRERPNPRSLVT  308 (329)
Q Consensus       293 l~~dp~~Rps~~~~l~  308 (329)
                      |+.+|++||++.++++
T Consensus       237 l~~~p~~Rp~~~~il~  252 (277)
T cd06642         237 LNKDPRFRPTAKELLK  252 (277)
T ss_pred             ccCCcccCcCHHHHHH
Confidence            9999999999999998

Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25

>cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=3e-41  Score=295.83  Aligned_cols=253  Identities=19%  Similarity=0.263  Sum_probs=204.6

Q ss_pred             cccccccCCCCCCcEEEEEEe-CCCC----EEEEEEeCCCCCh-hHHHHHHHHHHHhcCCCccccccceeeeeCCeeEEE
Q 020221           58 MENIVSEHGEKAPNVVYKGKL-ENQF----RIAVKRFNRSAWP-DARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLV  131 (329)
Q Consensus        58 ~~~~~~~lg~G~~g~V~~~~~-~~~~----~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv  131 (329)
                      .+++++.||+|+||.||+|.. .++.    .+|+|.+...... ....+.+|+..++.++||||+++++++.. ...+++
T Consensus         8 ~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~v   86 (279)
T cd05057           8 ELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRLLGICLS-SQVQLI   86 (279)
T ss_pred             HcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEec-CceEEE
Confidence            356777889999999999984 3332    5899988766432 34568899999999999999999999876 789999


Q ss_pred             EecCCCCCHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCCCCCeeeecccCcccCCCCCC
Q 020221          132 AEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDGRS  211 (329)
Q Consensus       132 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~~  211 (329)
                      +||+++|+|.+++.+ ....+++..+..++.|++.||+|||+. +++|+||||+||++++++.++|+|||++........
T Consensus        87 ~e~~~~g~L~~~l~~-~~~~~~~~~~~~~~~qi~~~l~~LH~~-~i~H~di~p~nil~~~~~~~kL~dfg~~~~~~~~~~  164 (279)
T cd05057          87 TQLMPLGCLLDYVRN-HKDNIGSQYLLNWCVQIAKGMSYLEEK-RLVHRDLAARNVLVKTPQHVKITDFGLAKLLDVDEK  164 (279)
T ss_pred             EecCCCCcHHHHHHh-ccCCCCHHHHHHHHHHHHHHHHHHHhC-CEEecccCcceEEEcCCCeEEECCCcccccccCccc
Confidence            999999999999864 344689999999999999999999998 999999999999999999999999999976543322


Q ss_pred             ------ccCcccccCcccccCCCCCCcccchhhhHHHHHHHh-CCCCCCchhhHHHhhhchhhhccccccCCCChHHHHH
Q 020221          212 ------YSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLS-GKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTE  284 (329)
Q Consensus       212 ------~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t-g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  284 (329)
                            ..++..|+|||.+....++.++|+||||+++||+++ |..|+..............     ......+..++..
T Consensus       165 ~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~-----~~~~~~~~~~~~~  239 (279)
T cd05057         165 EYHAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPAVEIPDLLEK-----GERLPQPPICTID  239 (279)
T ss_pred             ceecCCCcccccccCHHHhhcCCcCchhhHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhC-----CCCCCCCCCCCHH
Confidence                  112467999999988889999999999999999998 8877755433322221111     1111223345678


Q ss_pred             HHHHHHHhcccCCCCCCCHHHHHHHHHhhhhccc
Q 020221          285 LVRLASRCLQYEPRERPNPRSLVTALVTLQKDTE  318 (329)
Q Consensus       285 ~~~li~~cl~~dp~~Rps~~~~l~~L~~~~~~~~  318 (329)
                      +.+++.+||..||++||++.++++.|.++.++..
T Consensus       240 ~~~~~~~~l~~~p~~Rp~~~~l~~~l~~~~~~~~  273 (279)
T cd05057         240 VYMVLVKCWMIDAESRPTFKELINEFSKMARDPQ  273 (279)
T ss_pred             HHHHHHHHcCCChhhCCCHHHHHHHHHHHHhCCc
Confidence            9999999999999999999999999999877553

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea

>cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6

Probab=100.00  E-value=1.1e-41  Score=301.28  Aligned_cols=240  Identities=17%  Similarity=0.228  Sum_probs=197.0

Q ss_pred             ccCCCCCCcEEEEEEe-CCCCEEEEEEeCCCCChhHHHHHHHHHHHhcCCCccccccceeeeeCCeeEEEEecCCCCCHH
Q 020221           63 SEHGEKAPNVVYKGKL-ENQFRIAVKRFNRSAWPDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAEYMPNDTLA  141 (329)
Q Consensus        63 ~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~  141 (329)
                      ..||+|+||.||++.. .+++.||+|.+........+.+.+|+.+++.++|||++++++.+..+...++++||+++++|.
T Consensus        27 ~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~iv~e~~~~~~L~  106 (297)
T cd06659          27 IKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLMEFLQGGALT  106 (297)
T ss_pred             hhcCCCCceeEEEEEEcCCCCEEEEEEEEecccchHHHHHHHHHHHHhCCCCchhhhhhheeeCCeEEEEEecCCCCCHH
Confidence            4569999999999984 568899999987655455567889999999999999999999999999999999999999999


Q ss_pred             hhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCCCCCeeeecccCcccCCCC----CCccCccc
Q 020221          142 KHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDG----RSYSTNLA  217 (329)
Q Consensus       142 ~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~----~~~~~~~~  217 (329)
                      .++.   ...+++..+..++.|++.||.|||+. +++|+||||+||+++.++.++|+|||++......    ....++..
T Consensus       107 ~~~~---~~~~~~~~~~~~~~qi~~~L~~LH~~-~ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~~~~~~~~~~~~~~~  182 (297)
T cd06659         107 DIVS---QTRLNEEQIATVCESVLQALCYLHSQ-GVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKSLVGTPY  182 (297)
T ss_pred             HHHh---hcCCCHHHHHHHHHHHHHHHHHHHhC-CeecCCCCHHHeEEccCCcEEEeechhHhhcccccccccceecCcc
Confidence            9873   35689999999999999999999999 9999999999999999999999999998654332    23457889


Q ss_pred             ccCcccccCCCCCCcccchhhhHHHHHHHhCCCCCCchhhHHHhhhchhhhccccccCCCChHHHHHHHHHHHHhcccCC
Q 020221          218 FTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLASRCLQYEP  297 (329)
Q Consensus       218 y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp  297 (329)
                      |+|||++.+..++.++||||||+++++|++|..|+............ ......  ........+..+.+++.+||+.+|
T Consensus       183 y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~-~~~~~~--~~~~~~~~~~~l~~~i~~~l~~~P  259 (297)
T cd06659         183 WMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRL-RDSPPP--KLKNAHKISPVLRDFLERMLTREP  259 (297)
T ss_pred             ccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH-hccCCC--CccccCCCCHHHHHHHHHHhcCCc
Confidence            99999999888999999999999999999999887543221111111 000000  011123456789999999999999


Q ss_pred             CCCCCHHHHHHH
Q 020221          298 RERPNPRSLVTA  309 (329)
Q Consensus       298 ~~Rps~~~~l~~  309 (329)
                      ++||++.+++++
T Consensus       260 ~~Rps~~~ll~~  271 (297)
T cd06659         260 QERATAQELLDH  271 (297)
T ss_pred             ccCcCHHHHhhC
Confidence            999999999983

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i

>cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4

Probab=100.00  E-value=2.9e-41  Score=295.72  Aligned_cols=243  Identities=16%  Similarity=0.258  Sum_probs=202.0

Q ss_pred             cccccccCCCCCCcEEEEEEe-CCCCEEEEEEeCCCC-ChhHHHHHHHHHHHhcCCCccccccceeeeeCCeeEEEEecC
Q 020221           58 MENIVSEHGEKAPNVVYKGKL-ENQFRIAVKRFNRSA-WPDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAEYM  135 (329)
Q Consensus        58 ~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~  135 (329)
                      .|..++.||.|+||.||+|.. .++..||+|.+.... ......+.+|+.+++.+.|+||+++++.+.++...++||||+
T Consensus         5 ~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   84 (277)
T cd06640           5 LFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKGTKLWIIMEYL   84 (277)
T ss_pred             hhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEeccccHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEEecC
Confidence            355667789999999999984 467899999987543 233566889999999999999999999999999999999999


Q ss_pred             CCCCHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCCCCCeeeecccCcccCCCCC----C
Q 020221          136 PNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDGR----S  211 (329)
Q Consensus       136 ~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~----~  211 (329)
                      ++++|.+++.   ...+++.++..++.|++.||.|||+. +++|+||+|+||+++.++.++++|||++.......    .
T Consensus        85 ~~~~L~~~i~---~~~l~~~~~~~~~~~l~~~l~~lh~~-~ivH~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~~~~~  160 (277)
T cd06640          85 GGGSALDLLR---AGPFDEFQIATMLKEILKGLDYLHSE-KKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNT  160 (277)
T ss_pred             CCCcHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhC-CccCcCCChhhEEEcCCCCEEEcccccceeccCCcccccc
Confidence            9999999884   35688999999999999999999999 99999999999999999999999999986654322    2


Q ss_pred             ccCcccccCcccccCCCCCCcccchhhhHHHHHHHhCCCCCCchhhHHHhhhchhhhccccccCCCChHHHHHHHHHHHH
Q 020221          212 YSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLASR  291 (329)
Q Consensus       212 ~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~  291 (329)
                      ..++..|+|||++.+..++.++|+||||+++|+|++|..|+..........     ..........+...+..+.+++.+
T Consensus       161 ~~~~~~y~apE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~li~~  235 (277)
T cd06640         161 FVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMHPMRVLF-----LIPKNNPPTLTGEFSKPFKEFIDA  235 (277)
T ss_pred             ccCcccccCHhHhccCCCccHHHHHHHHHHHHHHHHCCCCCCCcChHhHhh-----hhhcCCCCCCchhhhHHHHHHHHH
Confidence            346788999999988889999999999999999999998775432211111     111112233445678899999999


Q ss_pred             hcccCCCCCCCHHHHHHH
Q 020221          292 CLQYEPRERPNPRSLVTA  309 (329)
Q Consensus       292 cl~~dp~~Rps~~~~l~~  309 (329)
                      ||..+|++||++.+++++
T Consensus       236 ~l~~~p~~Rp~~~~il~~  253 (277)
T cd06640         236 CLNKDPSFRPTAKELLKH  253 (277)
T ss_pred             HcccCcccCcCHHHHHhC
Confidence            999999999999999874

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter

>cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases

Probab=100.00  E-value=2.8e-41  Score=294.67  Aligned_cols=245  Identities=22%  Similarity=0.310  Sum_probs=195.0

Q ss_pred             cCCCCCCcEEEEEEeC-CCC--EEEEEEeCCCC-ChhHHHHHHHHHHHhcC-CCccccccceeeeeCCeeEEEEecCCCC
Q 020221           64 EHGEKAPNVVYKGKLE-NQF--RIAVKRFNRSA-WPDARQFLEEARAVGQL-RNRRLANLLGCCCEGDERLLVAEYMPND  138 (329)
Q Consensus        64 ~lg~G~~g~V~~~~~~-~~~--~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~~~g  138 (329)
                      .||+|+||.||+|... ++.  .+++|.+.... ....+.+.+|+++++.+ +||||+++++++...+..+++|||++++
T Consensus         2 ~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~~   81 (270)
T cd05047           2 VIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHG   81 (270)
T ss_pred             cCCCCCCceEEEEEEcCCCCeeEEEEEEccccCCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEEEeCCCC
Confidence            4699999999999853 443  47888887543 23355788999999999 7999999999999989999999999999


Q ss_pred             CHHhhhccCC--------------CCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCCCCCeeeecccCcc
Q 020221          139 TLAKHLFHWE--------------TQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMK  204 (329)
Q Consensus       139 sL~~~l~~~~--------------~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~  204 (329)
                      +|.+++....              ...+++.++..++.|++.||+|||+. +++|+||||+||++++++.++|+|||++.
T Consensus        82 ~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~-~i~H~dikp~nili~~~~~~kl~dfgl~~  160 (270)
T cd05047          82 NLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK-QFIHRDLAARNILVGENYVAKIADFGLSR  160 (270)
T ss_pred             cHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHC-CEeecccccceEEEcCCCeEEECCCCCcc
Confidence            9999986421              12478999999999999999999999 99999999999999999999999999985


Q ss_pred             cCCCC---CCccCcccccCcccccCCCCCCcccchhhhHHHHHHHh-CCCCCCchhhHHHhhhchhhhccccccCCCChH
Q 020221          205 NSRDG---RSYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLS-GKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSD  280 (329)
Q Consensus       205 ~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t-g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  280 (329)
                      .....   .....+..|+|||++.+..++.++||||||+++|||++ |..||............     ........+..
T Consensus       161 ~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~~~~~-----~~~~~~~~~~~  235 (270)
T cd05047         161 GQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKL-----PQGYRLEKPLN  235 (270)
T ss_pred             ccchhhhccCCCCccccCChHHHccCCCCchhhHHHHHHHHHHHHcCCCCCccccCHHHHHHHH-----hCCCCCCCCCc
Confidence            33211   11223567999999988889999999999999999997 88777543322221111     11111123344


Q ss_pred             HHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhh
Q 020221          281 EGTELVRLASRCLQYEPRERPNPRSLVTALVTLQ  314 (329)
Q Consensus       281 ~~~~~~~li~~cl~~dp~~Rps~~~~l~~L~~~~  314 (329)
                      .+.++.+++.+||..||.+|||+.++++.|+++.
T Consensus       236 ~~~~~~~li~~~l~~~p~~Rps~~~il~~l~~~~  269 (270)
T cd05047         236 CDDEVYDLMRQCWREKPYERPSFAQILVSLNRML  269 (270)
T ss_pred             CCHHHHHHHHHHcccChhhCCCHHHHHHHHHHhh
Confidence            5678999999999999999999999999998864

Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l

>cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4

Probab=100.00  E-value=1.6e-41  Score=298.36  Aligned_cols=248  Identities=20%  Similarity=0.254  Sum_probs=195.9

Q ss_pred             cccccccCCCCCCcEEEEEEe-CCCCEEEEEEeCCCCC--hhHHHHHHHHHHHhcCCCccccccceeeeeCCeeEEEEec
Q 020221           58 MENIVSEHGEKAPNVVYKGKL-ENQFRIAVKRFNRSAW--PDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAEY  134 (329)
Q Consensus        58 ~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  134 (329)
                      .|++++.+|+|++|.||++.. .+++.||+|++.....  ...+.+.+|+++++.++|+|++++++++..+...++||||
T Consensus         2 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e~   81 (286)
T cd07847           2 KYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEVFRRKRKLHLVFEY   81 (286)
T ss_pred             ceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeecccCccccHHHHHHHHHHHhCCCCCEeeeeeEEeeCCEEEEEEec
Confidence            356777889999999999995 4688999999865432  2234578899999999999999999999999999999999


Q ss_pred             CCCCCHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCCCCCeeeecccCcccCCCCC----
Q 020221          135 MPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDGR----  210 (329)
Q Consensus       135 ~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~----  210 (329)
                      +++++|..++.  ....+++..+..++.|++.||.|||+. +++|+||||+||+++.++.++|+|||++.......    
T Consensus        82 ~~~~~l~~~~~--~~~~~~~~~~~~~~~ql~~~l~~LH~~-~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~  158 (286)
T cd07847          82 CDHTVLNELEK--NPRGVPEHLIKKIIWQTLQAVNFCHKH-NCIHRDVKPENILITKQGQIKLCDFGFARILTGPGDDYT  158 (286)
T ss_pred             cCccHHHHHHh--CCCCCCHHHHHHHHHHHHHHHHHHHHC-CceecCCChhhEEEcCCCcEEECccccceecCCCccccc
Confidence            99988877764  344689999999999999999999999 99999999999999999999999999987654433    


Q ss_pred             CccCcccccCcccccC-CCCCCcccchhhhHHHHHHHhCCCCCCchhhHHHhhhc---hhhh-------c----------
Q 020221          211 SYSTNLAFTPPEYLRT-GRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRN---IQTL-------T----------  269 (329)
Q Consensus       211 ~~~~~~~y~aPE~~~~-~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~~~~~---~~~~-------~----------  269 (329)
                      ...++..|+|||.+.+ ..++.++||||||+++|+|++|..||............   ....       .          
T Consensus       159 ~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (286)
T cd07847         159 DYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRKTLGDLIPRHQQIFSTNQFFKGLS  238 (286)
T ss_pred             CcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChHHhhhccccccccccc
Confidence            3456788999999876 44788999999999999999999887643211110000   0000       0          


Q ss_pred             cccccCC-----CChHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 020221          270 DSCLEGQ-----FSSDEGTELVRLASRCLQYEPRERPNPRSLVT  308 (329)
Q Consensus       270 ~~~~~~~-----~~~~~~~~~~~li~~cl~~dp~~Rps~~~~l~  308 (329)
                      .+.....     .....+..+.+++.+||+.||++||++.+++.
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~  282 (286)
T cd07847         239 IPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLE  282 (286)
T ss_pred             CCCcccccCHHHHhccCCHHHHHHHHHHhcCCccccCCHHHHhc
Confidence            0000000     01234678999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio

>PHA03207 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=8.5e-42  Score=313.24  Aligned_cols=242  Identities=16%  Similarity=0.182  Sum_probs=193.3

Q ss_pred             cccccccCCCCCCcEEEEEEeC---CCCEEEEEEeCCCCChhHHHHHHHHHHHhcCCCccccccceeeeeCCeeEEEEec
Q 020221           58 MENIVSEHGEKAPNVVYKGKLE---NQFRIAVKRFNRSAWPDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAEY  134 (329)
Q Consensus        58 ~~~~~~~lg~G~~g~V~~~~~~---~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  134 (329)
                      .|++++.||+|+||.||++...   .+..||+|.+....     ...+|+++++.++||||+++++++......+++||+
T Consensus        93 ~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~~-----~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~e~  167 (392)
T PHA03207         93 QYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGGK-----TPGREIDILKTISHRAIINLIHAYRWKSTVCMVMPK  167 (392)
T ss_pred             ceEEEEeecCCCCeEEEEEEEcCCccceeEEEEeccccc-----cHHHHHHHHHhcCCCCccceeeeEeeCCEEEEEehh
Confidence            4788899999999999999742   35789999886532     346799999999999999999999999999999999


Q ss_pred             CCCCCHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCCCCCeeeecccCcccCCCCC----
Q 020221          135 MPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDGR----  210 (329)
Q Consensus       135 ~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~----  210 (329)
                      +. ++|.+++.  ....+++..+..++.||+.||.|||++ ||+||||||+|||++.++.++|+|||++.......    
T Consensus       168 ~~-~~l~~~l~--~~~~l~~~~~~~i~~ql~~aL~~LH~~-givHrDlkp~Nill~~~~~~~l~DfG~a~~~~~~~~~~~  243 (392)
T PHA03207        168 YK-CDLFTYVD--RSGPLPLEQAITIQRRLLEALAYLHGR-GIIHRDVKTENIFLDEPENAVLGDFGAACKLDAHPDTPQ  243 (392)
T ss_pred             cC-CCHHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHHC-CccccCCCHHHEEEcCCCCEEEccCccccccCccccccc
Confidence            86 58888884  456789999999999999999999999 99999999999999999999999999987544322    


Q ss_pred             --CccCcccccCcccccCCCCCCcccchhhhHHHHHHHhCCCCCCchhhHH-------Hhhhc---hhh-----------
Q 020221          211 --SYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDL-------IRDRN---IQT-----------  267 (329)
Q Consensus       211 --~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~-------~~~~~---~~~-----------  267 (329)
                        ...||+.|+|||++.+..++.++|||||||++|||++|+.||.......       +....   ...           
T Consensus       244 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~l~~i~~~~~~~~~~~~~~~~~~~~~  323 (392)
T PHA03207        244 CYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSIIRCMQVHPLEFPQNGSTNLCK  323 (392)
T ss_pred             ccccccccCccCHhHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCCCCcHHHHHHHHHHhccCccccCCccchhHHH
Confidence              3468899999999998889999999999999999999999886432110       00000   000           


Q ss_pred             ---hccccccCCC--C-----hHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 020221          268 ---LTDSCLEGQF--S-----SDEGTELVRLASRCLQYEPRERPNPRSLVT  308 (329)
Q Consensus       268 ---~~~~~~~~~~--~-----~~~~~~~~~li~~cl~~dp~~Rps~~~~l~  308 (329)
                         ......+..+  +     ...+.++.+++.+||..||++|||+.+++.
T Consensus       324 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~Rpsa~e~l~  374 (392)
T PHA03207        324 HFKQYAIVLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQEFRPSAQDILS  374 (392)
T ss_pred             HHHhhcccccCCccccchhhccCcchhHHHHHHHHhccChhhCCCHHHHhh
Confidence               0000000000  0     123567899999999999999999999998

>cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5

Probab=100.00  E-value=6.2e-42  Score=300.82  Aligned_cols=247  Identities=18%  Similarity=0.199  Sum_probs=193.2

Q ss_pred             ccccccCCCCCCcEEEEEEe-CCCCEEEEEEeCCCCCh--hHHHHHHHHHHHhcCCCccccccceeeeeCCeeEEEEecC
Q 020221           59 ENIVSEHGEKAPNVVYKGKL-ENQFRIAVKRFNRSAWP--DARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAEYM  135 (329)
Q Consensus        59 ~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~--~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~  135 (329)
                      |++++.||+|+||.||++.. .+|+.+|+|.++.....  ....+.+|+++++.++|+||+++++++.+....++++||+
T Consensus         2 y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   81 (284)
T cd07839           2 YEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDVLHSDKKLTLVFEYC   81 (284)
T ss_pred             ceeEEEecccCCeEEEEEEECCCCcEEEEEEeecccccccCccchhHHHHHHHhcCCCCeeeHHHHhccCCceEEEEecC
Confidence            55667789999999999994 57889999998754321  2345778999999999999999999999999999999999


Q ss_pred             CCCCHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCCCCCeeeecccCcccCCCCC----C
Q 020221          136 PNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDGR----S  211 (329)
Q Consensus       136 ~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~----~  211 (329)
                      .+ +|.+++.. ....+++..+..++.||+.||.|||+. +++|+||||+||+++.++.++|+|||++.......    .
T Consensus        82 ~~-~l~~~~~~-~~~~~~~~~~~~~~~qi~~al~~LH~~-~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~  158 (284)
T cd07839          82 DQ-DLKKYFDS-CNGDIDPEIVKSFMFQLLKGLAFCHSH-NVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVRCYSA  158 (284)
T ss_pred             CC-CHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHHC-CEecCCCCHHHEEEcCCCcEEECccchhhccCCCCCCcCC
Confidence            75 78887754 345689999999999999999999999 99999999999999999999999999987654322    2


Q ss_pred             ccCcccccCcccccCCC-CCCcccchhhhHHHHHHHhCCCCCCchhh-HHHhhhch--------------hhhcccc---
Q 020221          212 YSTNLAFTPPEYLRTGR-VTPESVMYSFGTLLLDLLSGKHIPPSHAL-DLIRDRNI--------------QTLTDSC---  272 (329)
Q Consensus       212 ~~~~~~y~aPE~~~~~~-~~~~~DvwslG~il~el~tg~~~~~~~~~-~~~~~~~~--------------~~~~~~~---  272 (329)
                      ..++..|+|||++.+.. ++.++||||||+++|+|++|+.|+..... ........              .......   
T Consensus       159 ~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (284)
T cd07839         159 EVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEESWPGVSKLPDYKPYP  238 (284)
T ss_pred             CccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCCCCHHHHHHHHHHHhCCCChHHhHHhhhcccccccC
Confidence            34578899999987654 78899999999999999999987543211 11000000              0000000   


Q ss_pred             -cc-----CCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 020221          273 -LE-----GQFSSDEGTELVRLASRCLQYEPRERPNPRSLVT  308 (329)
Q Consensus       273 -~~-----~~~~~~~~~~~~~li~~cl~~dp~~Rps~~~~l~  308 (329)
                       ..     .......++++.+++.+||+.||++|||+.++++
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~il~  280 (284)
T cd07839         239 MYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQ  280 (284)
T ss_pred             CCCCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCHHHHhc
Confidence             00     0111235688999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also

>cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2

Probab=100.00  E-value=2.9e-41  Score=298.49  Aligned_cols=254  Identities=20%  Similarity=0.290  Sum_probs=197.3

Q ss_pred             cccccccCCCCCCcEEEEEEeC-----------------CCCEEEEEEeCCCCCh-hHHHHHHHHHHHhcCCCccccccc
Q 020221           58 MENIVSEHGEKAPNVVYKGKLE-----------------NQFRIAVKRFNRSAWP-DARQFLEEARAVGQLRNRRLANLL  119 (329)
Q Consensus        58 ~~~~~~~lg~G~~g~V~~~~~~-----------------~~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~~~  119 (329)
                      .+++.+.||+|+||.||++...                 ++..+|+|.+...... ..+.+.+|+.+++.++|+||++++
T Consensus         6 ~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~   85 (296)
T cd05095           6 RLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIKIMSRLKDPNIIRLL   85 (296)
T ss_pred             hceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEE
Confidence            3567778899999999998532                 2446999999765332 346789999999999999999999


Q ss_pred             eeeeeCCeeEEEEecCCCCCHHhhhccCC---------CCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeC
Q 020221          120 GCCCEGDERLLVAEYMPNDTLAKHLFHWE---------TQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFD  190 (329)
Q Consensus       120 ~~~~~~~~~~lv~e~~~~gsL~~~l~~~~---------~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~  190 (329)
                      +++...+..+++|||+++++|.+++....         ...+++.++..++.|++.||+|||+. +++|+||||+||+++
T Consensus        86 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~-~i~H~dlkp~Nili~  164 (296)
T cd05095          86 AVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSL-NFVHRDLATRNCLVG  164 (296)
T ss_pred             EEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHC-CeecccCChheEEEc
Confidence            99999999999999999999999986422         12467889999999999999999999 999999999999999


Q ss_pred             CCCCeeeecccCcccCCCCC------CccCcccccCcccccCCCCCCcccchhhhHHHHHHHh--CCCCCCchhhHHHhh
Q 020221          191 DDVNPRLSCFGLMKNSRDGR------SYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLS--GKHIPPSHALDLIRD  262 (329)
Q Consensus       191 ~~~~~kl~Dfg~a~~~~~~~------~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t--g~~~~~~~~~~~~~~  262 (329)
                      .++.++|+|||++.......      ...++..|+|||...++.++.++||||||+++|||++  |..|+..........
T Consensus       165 ~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~DiwSlG~~l~el~~~~~~~p~~~~~~~~~~~  244 (296)
T cd05095         165 KNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQPYSQLSDEQVIE  244 (296)
T ss_pred             CCCCEEeccCcccccccCCcceeccCcCcCccccCCHHHHhcCCccchhhhhHHHHHHHHHHHhCCCCCccccChHHHHH
Confidence            99999999999987643322      1223568999999888889999999999999999998  555554322211111


Q ss_pred             hchhhhcc--ccccCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHh
Q 020221          263 RNIQTLTD--SCLEGQFSSDEGTELVRLASRCLQYEPRERPNPRSLVTALVT  312 (329)
Q Consensus       263 ~~~~~~~~--~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~~~l~~L~~  312 (329)
                      ........  .......+..+++.+.+++.+||+.||++||++.++++.|++
T Consensus       245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~  296 (296)
T cd05095         245 NTGEFFRDQGRQVYLPKPALCPDSLYKLMLSCWRRNAKERPSFQEIHATLLE  296 (296)
T ss_pred             HHHHHHhhccccccCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHHhC
Confidence            11000000  000111234456889999999999999999999999998863

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit

>KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms]

Probab=100.00  E-value=4.9e-43  Score=305.02  Aligned_cols=244  Identities=18%  Similarity=0.230  Sum_probs=207.7

Q ss_pred             cCCCcccccccCCCCCCcEEEEEE-eCCCCEEEEEEeCCCCCh---hHHHHHHHHHHHhcCCCccccccceeeeeCCeeE
Q 020221           54 SGFAMENIVSEHGEKAPNVVYKGK-LENQFRIAVKRFNRSAWP---DARQFLEEARAVGQLRNRRLANLLGCCCEGDERL  129 (329)
Q Consensus        54 ~~~~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~---~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~  129 (329)
                      +.|..++++   |+|+||.||-++ ..+|+.+|+|++.+....   .....++|-++|..++.+.||.+..+|.+.+.++
T Consensus       185 n~F~~~Rvl---GkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAfeTkd~LC  261 (591)
T KOG0986|consen  185 NTFRVYRVL---GKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYAFETKDALC  261 (591)
T ss_pred             cceeeeEEE---ecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeeecCCCceE
Confidence            667777777   999999999998 678999999988654311   2234678999999999999999999999999999


Q ss_pred             EEEecCCCCCHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCCCCCeeeecccCcccCCCC
Q 020221          130 LVAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDG  209 (329)
Q Consensus       130 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~  209 (329)
                      +|+..|.||+|.-.|.+..+..++++.+..++.+|+.||++||.. +||+||+||+|||+|++|+++|+|.|+|..+..+
T Consensus       262 lVLtlMNGGDLkfHiyn~g~~gF~e~ra~FYAAEi~cGLehlH~~-~iVYRDLKPeNILLDd~GhvRISDLGLAvei~~g  340 (591)
T KOG0986|consen  262 LVLTLMNGGDLKFHIYNHGNPGFDEQRARFYAAEIICGLEHLHRR-RIVYRDLKPENILLDDHGHVRISDLGLAVEIPEG  340 (591)
T ss_pred             EEEEeecCCceeEEeeccCCCCCchHHHHHHHHHHHhhHHHHHhc-ceeeccCChhheeeccCCCeEeeccceEEecCCC
Confidence            999999999999999887778999999999999999999999999 9999999999999999999999999999988877


Q ss_pred             CCc---cCcccccCcccccCCCCCCcccchhhhHHHHHHHhCCCCCCchhhHHHhh-hchhhhccccccCCCChHHHHHH
Q 020221          210 RSY---STNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRD-RNIQTLTDSCLEGQFSSDEGTEL  285 (329)
Q Consensus       210 ~~~---~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~  285 (329)
                      ...   .||.+|||||++.++.|+.+.|+|||||+||||+.|+.||..... .++. .....+..  ....+++.+|+++
T Consensus       341 ~~~~~rvGT~GYMAPEvl~ne~Y~~s~Dwf~lGCllYemi~G~sPFr~~Ke-Kvk~eEvdrr~~~--~~~ey~~kFS~ea  417 (591)
T KOG0986|consen  341 KPIRGRVGTVGYMAPEVLQNEVYDFSPDWFSLGCLLYEMIAGHSPFRQRKE-KVKREEVDRRTLE--DPEEYSDKFSEEA  417 (591)
T ss_pred             CccccccCcccccCHHHHcCCcccCCccHHHHHhHHHHHHcccCchhhhhh-hhhHHHHHHHHhc--chhhcccccCHHH
Confidence            543   689999999999999999999999999999999999998865321 1111 11111111  2235678899999


Q ss_pred             HHHHHHhcccCCCCCCCHH
Q 020221          286 VRLASRCLQYEPRERPNPR  304 (329)
Q Consensus       286 ~~li~~cl~~dp~~Rps~~  304 (329)
                      .++....|+.||++|...+
T Consensus       418 kslc~~LL~Kdp~~RLGcr  436 (591)
T KOG0986|consen  418 KSLCEGLLTKDPEKRLGCR  436 (591)
T ss_pred             HHHHHHHHccCHHHhccCC
Confidence            9999999999999997554

>cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase

Probab=100.00  E-value=3.2e-41  Score=294.24  Aligned_cols=250  Identities=22%  Similarity=0.289  Sum_probs=201.1

Q ss_pred             ccccccCCCCCCcEEEEEEeCC----CCEEEEEEeCCCC-ChhHHHHHHHHHHHhcCCCccccccceeeeeCCeeEEEEe
Q 020221           59 ENIVSEHGEKAPNVVYKGKLEN----QFRIAVKRFNRSA-WPDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAE  133 (329)
Q Consensus        59 ~~~~~~lg~G~~g~V~~~~~~~----~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  133 (329)
                      +.+.+.+|+|+||.||+|...+    ...|++|...... ....+.+.+|+.+++.++||||+++++++.+ ...+++||
T Consensus         8 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-~~~~lv~e   86 (270)
T cd05056           8 ITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKLIGVITE-NPVWIVME   86 (270)
T ss_pred             ceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcCCHHHHHHHHHHHHHHHhCCCCchhceeEEEcC-CCcEEEEE
Confidence            4566677999999999998432    3468999887654 3345578999999999999999999998865 56789999


Q ss_pred             cCCCCCHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCCCCCeeeecccCcccCCCCCC--
Q 020221          134 YMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDGRS--  211 (329)
Q Consensus       134 ~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~~--  211 (329)
                      |+++++|.+++.. ....+++..+..++.|++.||.|||+. +++|+||||+||+++.++.++|+|||++........  
T Consensus        87 ~~~~~~L~~~l~~-~~~~~~~~~~~~~~~~l~~~l~~lH~~-~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~~  164 (270)
T cd05056          87 LAPLGELRSYLQV-NKYSLDLASLILYSYQLSTALAYLESK-RFVHRDIAARNVLVSSPDCVKLGDFGLSRYLEDESYYK  164 (270)
T ss_pred             cCCCCcHHHHHHh-CCCCCCHHHHHHHHHHHHHHHHHHHhC-CeeccccChheEEEecCCCeEEccCceeeeccccccee
Confidence            9999999999964 334689999999999999999999999 999999999999999999999999999876543321  


Q ss_pred             ---ccCcccccCcccccCCCCCCcccchhhhHHHHHHHh-CCCCCCchhhHHHhhhchhhhccccccCCCChHHHHHHHH
Q 020221          212 ---YSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLS-GKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVR  287 (329)
Q Consensus       212 ---~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t-g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  287 (329)
                         ..++..|+|||.+....++.++||||||++++++++ |..||.............     .......+..++.++.+
T Consensus       165 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~  239 (270)
T cd05056         165 ASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVKNNDVIGRIE-----NGERLPMPPNCPPTLYS  239 (270)
T ss_pred             cCCCCccccccChhhhccCCCCchhhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHH-----cCCcCCCCCCCCHHHHH
Confidence               123457999999988889999999999999999996 887775443222111111     11111234556788999


Q ss_pred             HHHHhcccCCCCCCCHHHHHHHHHhhhhc
Q 020221          288 LASRCLQYEPRERPNPRSLVTALVTLQKD  316 (329)
Q Consensus       288 li~~cl~~dp~~Rps~~~~l~~L~~~~~~  316 (329)
                      ++.+||..+|++|||+.++++.|+.+..+
T Consensus       240 li~~~l~~~P~~Rpt~~~~~~~l~~~~~~  268 (270)
T cd05056         240 LMTKCWAYDPSKRPRFTELKAQLSDILQE  268 (270)
T ss_pred             HHHHHcCCChhhCcCHHHHHHHHHHHHhc
Confidence            99999999999999999999999998754

Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions

>KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.3e-42  Score=315.84  Aligned_cols=240  Identities=18%  Similarity=0.308  Sum_probs=204.0

Q ss_pred             cCCCCCCcEEEEEE-eCCCCEEEEEEeCCCCChhHHHHHHHHHHHhcCCCccccccceeeeeCCeeEEEEecCCCCCHHh
Q 020221           64 EHGEKAPNVVYKGK-LENQFRIAVKRFNRSAWPDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAEYMPNDTLAK  142 (329)
Q Consensus        64 ~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~  142 (329)
                      .+|+|.||+||-|+ .++...+|||.+........+.+..|+..-+.++|.|||+++|.+..++.+-|.||-++||||.+
T Consensus       582 VLGKGTYG~VYA~RD~~tqvrIaIKEIpekdsr~~QPLhEEIaLH~~LrHkNIVrYLGs~senGf~kIFMEqVPGGSLSs  661 (1226)
T KOG4279|consen  582 VLGKGTYGTVYAARDMDTQVRIAIKEIPEKDSREVQPLHEEIALHSTLRHKNIVRYLGSVSENGFFKIFMEQVPGGSLSS  661 (1226)
T ss_pred             EeecCceeEEEeeccccceeEEEeeecccccchhhccHHHHHHHHHHHhhHhHHHHhhccCCCCeEEEEeecCCCCcHHH
Confidence            36999999999999 66778899999998887778889999999999999999999999999999999999999999999


Q ss_pred             hhccCCCCCC--CHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeC-CCCCeeeecccCcccCCC----CCCccCc
Q 020221          143 HLFHWETQPM--KWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFD-DDVNPRLSCFGLMKNSRD----GRSYSTN  215 (329)
Q Consensus       143 ~l~~~~~~~~--~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~-~~~~~kl~Dfg~a~~~~~----~~~~~~~  215 (329)
                      +|+. +=+++  .+.+...+.+||+.||.|||++ .|||||||-+|||++ -.|.+||+|||.++....    ..++.||
T Consensus       662 LLrs-kWGPlKDNEstm~fYtkQILeGLkYLHen-~IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAginP~TETFTGT  739 (1226)
T KOG4279|consen  662 LLRS-KWGPLKDNESTMNFYTKQILEGLKYLHEN-KIVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAGINPCTETFTGT  739 (1226)
T ss_pred             HHHh-ccCCCccchhHHHHHHHHHHHHhhhhhhc-ceeeccccCCcEEEeeccceEEecccccchhhccCCccccccccc
Confidence            9964 33445  7889999999999999999999 999999999999997 568899999998876443    3467899


Q ss_pred             ccccCcccccCCC--CCCcccchhhhHHHHHHHhCCCCCCchhhHHHhhhchhhhccccccCCCChHHHHHHHHHHHHhc
Q 020221          216 LAFTPPEYLRTGR--VTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLASRCL  293 (329)
Q Consensus       216 ~~y~aPE~~~~~~--~~~~~DvwslG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl  293 (329)
                      ..|||||++..++  |...+|||||||++.||.||++||..-.....   .+-.+-.-...+++|.+.+++.+.+|.+|+
T Consensus       740 LQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~ElgspqA---AMFkVGmyKvHP~iPeelsaeak~FilrcF  816 (1226)
T KOG4279|consen  740 LQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSPQA---AMFKVGMYKVHPPIPEELSAEAKNFILRCF  816 (1226)
T ss_pred             hhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCChhH---hhhhhcceecCCCCcHHHHHHHHHHHHHHc
Confidence            9999999998765  99999999999999999999988743211100   011111112456788999999999999999


Q ss_pred             ccCCCCCCCHHHHHH
Q 020221          294 QYEPRERPNPRSLVT  308 (329)
Q Consensus       294 ~~dp~~Rps~~~~l~  308 (329)
                      ..||.+||+|.+++.
T Consensus       817 epd~~~R~sA~~LL~  831 (1226)
T KOG4279|consen  817 EPDPCDRPSAKDLLQ  831 (1226)
T ss_pred             CCCcccCccHHHhcc
Confidence            999999999999986

>cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3

Probab=100.00  E-value=3.5e-41  Score=303.05  Aligned_cols=253  Identities=21%  Similarity=0.307  Sum_probs=203.4

Q ss_pred             ccccccCCCCCCcEEEEEEeC--------CCCEEEEEEeCCCCC-hhHHHHHHHHHHHhcC-CCccccccceeeeeCCee
Q 020221           59 ENIVSEHGEKAPNVVYKGKLE--------NQFRIAVKRFNRSAW-PDARQFLEEARAVGQL-RNRRLANLLGCCCEGDER  128 (329)
Q Consensus        59 ~~~~~~lg~G~~g~V~~~~~~--------~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~  128 (329)
                      +++.+.||+|+||.||++...        ....||+|.+..... ...+.+.+|+++++.+ +||||+++++++......
T Consensus        14 ~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~   93 (334)
T cd05100          14 LTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPL   93 (334)
T ss_pred             eeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccccCHHHHHHHHHHHHHHHhhcCCCCeeeeeEEEccCCce
Confidence            567788899999999999731        123689998875432 2356788999999999 799999999999998999


Q ss_pred             EEEEecCCCCCHHhhhccCC--------------CCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCCCCC
Q 020221          129 LLVAEYMPNDTLAKHLFHWE--------------TQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVN  194 (329)
Q Consensus       129 ~lv~e~~~~gsL~~~l~~~~--------------~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~  194 (329)
                      ++++||+++|+|.+++....              ...+++.++..++.|++.||.|||++ +++|+||||+||++++++.
T Consensus        94 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~-givH~dlkp~Nill~~~~~  172 (334)
T cd05100          94 YVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQ-KCIHRDLAARNVLVTEDNV  172 (334)
T ss_pred             EEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHC-CeeccccccceEEEcCCCc
Confidence            99999999999999986421              23478889999999999999999999 9999999999999999999


Q ss_pred             eeeecccCcccCCCCC------CccCcccccCcccccCCCCCCcccchhhhHHHHHHHh-CCCCCCchhhHHHhhhchhh
Q 020221          195 PRLSCFGLMKNSRDGR------SYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLS-GKHIPPSHALDLIRDRNIQT  267 (329)
Q Consensus       195 ~kl~Dfg~a~~~~~~~------~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t-g~~~~~~~~~~~~~~~~~~~  267 (329)
                      ++|+|||+++......      ...++..|+|||++.+..++.++||||||+++|||++ |..|+.............. 
T Consensus       173 ~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~-  251 (334)
T cd05100         173 MKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEELFKLLKE-  251 (334)
T ss_pred             EEECCcccceecccccccccccCCCcCceEcCHHHhccCCcCchhhhHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHc-
Confidence            9999999987654322      1123467999999998889999999999999999998 6666654433322221111 


Q ss_pred             hccccccCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhhcc
Q 020221          268 LTDSCLEGQFSSDEGTELVRLASRCLQYEPRERPNPRSLVTALVTLQKDT  317 (329)
Q Consensus       268 ~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~~~l~~L~~~~~~~  317 (329)
                          ......+...+.++.+++.+||+.+|++|||+.++++.|+.+....
T Consensus       252 ----~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~ell~~l~~~~~~~  297 (334)
T cd05100         252 ----GHRMDKPANCTHELYMIMRECWHAVPSQRPTFKQLVEDLDRVLTVT  297 (334)
T ss_pred             ----CCCCCCCCCCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHhhhc
Confidence                1112234455778999999999999999999999999999987543

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase

Probab=100.00  E-value=1.4e-41  Score=295.50  Aligned_cols=246  Identities=19%  Similarity=0.282  Sum_probs=200.1

Q ss_pred             ccccccCCCCCCcEEEEEEe-CCCCEEEEEEeCCCCC-hhHHHHHHHHHHHhcCCCccccccceeeeeCCeeEEEEecCC
Q 020221           59 ENIVSEHGEKAPNVVYKGKL-ENQFRIAVKRFNRSAW-PDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAEYMP  136 (329)
Q Consensus        59 ~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~  136 (329)
                      +++.+.||.|++|.||++.. .+++.+++|.+..... .....+.+|++.++.++||||+++++.+......++++||++
T Consensus         3 ~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~   82 (265)
T cd06605           3 LEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGAFYNNGDISICMEYMD   82 (265)
T ss_pred             chHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccChHHHHHHHHHHHHHHHCCCCchhhhheeeecCCEEEEEEEecC
Confidence            45666779999999999995 4688999999877643 334568899999999999999999999999999999999999


Q ss_pred             CCCHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhc-CCCccccccCCCceeeCCCCCeeeecccCcccCCCC--CCcc
Q 020221          137 NDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTS-KERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDG--RSYS  213 (329)
Q Consensus       137 ~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~-~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~--~~~~  213 (329)
                      +++|.+++... ...+++..+..++.|++.||+|||+ . +++|+||||+||++++++.++|+|||.+......  ....
T Consensus        83 ~~~L~~~~~~~-~~~~~~~~~~~~~~~l~~~l~~lH~~~-~i~H~dl~~~ni~~~~~~~~~l~d~g~~~~~~~~~~~~~~  160 (265)
T cd06605          83 GGSLDKILKEV-QGRIPERILGKIAVAVLKGLTYLHEKH-KIIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSLAKTFV  160 (265)
T ss_pred             CCcHHHHHHHc-cCCCCHHHHHHHHHHHHHHHHHHcCCC-CeecCCCCHHHEEECCCCCEEEeecccchhhHHHHhhccc
Confidence            99999998642 2678999999999999999999999 7 9999999999999999999999999998654322  1256


Q ss_pred             CcccccCcccccCCCCCCcccchhhhHHHHHHHhCCCCCCchhh--HHHhhhchhhhccccccCCCChH-HHHHHHHHHH
Q 020221          214 TNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHAL--DLIRDRNIQTLTDSCLEGQFSSD-EGTELVRLAS  290 (329)
Q Consensus       214 ~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~li~  290 (329)
                      ++..|+|||.+.+..++.++||||||+++++|++|..|+.....  .... ......... .....+.. .+.++.+++.
T Consensus       161 ~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~-~~~~~~~~~-~~~~~~~~~~~~~~~~li~  238 (265)
T cd06605         161 GTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPENDPPDGIF-ELLQYIVNE-PPPRLPSGKFSPDFQDFVN  238 (265)
T ss_pred             CChhccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCccccccccHH-HHHHHHhcC-CCCCCChhhcCHHHHHHHH
Confidence            77899999999988899999999999999999999988754310  0000 001111111 11122222 6788999999


Q ss_pred             HhcccCCCCCCCHHHHHH
Q 020221          291 RCLQYEPRERPNPRSLVT  308 (329)
Q Consensus       291 ~cl~~dp~~Rps~~~~l~  308 (329)
                      +||..||++|||+.+++.
T Consensus       239 ~~l~~~p~~Rpt~~~ll~  256 (265)
T cd06605         239 LCLIKDPRERPSYKELLE  256 (265)
T ss_pred             HHcCCCchhCcCHHHHhh
Confidence            999999999999999997

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity

>cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase

Probab=100.00  E-value=2.8e-41  Score=296.78  Aligned_cols=247  Identities=21%  Similarity=0.288  Sum_probs=197.0

Q ss_pred             ccccccCCCCCCcEEEEEEe-CCCCEEEEEEeCCCCC--hhHHHHHHHHHHHhcCCCccccccceeeeeCCeeEEEEecC
Q 020221           59 ENIVSEHGEKAPNVVYKGKL-ENQFRIAVKRFNRSAW--PDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAEYM  135 (329)
Q Consensus        59 ~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~  135 (329)
                      |++.+.+|+|++|.||+|.. .++..||+|++.....  .....+.+|+.+++.++||||+++++++..+...++|+||+
T Consensus         2 y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~   81 (286)
T cd07832           2 YKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDVFPHGSGFVLVMEYM   81 (286)
T ss_pred             ceEEeecccCCCcEEEEEEECCCCceEEEEEEEcccccchhhHHHHHHHHHHHhCCCCCCcceeeEEecCCeeEEEeccc
Confidence            56778889999999999994 5688999999876542  23457889999999999999999999999999999999999


Q ss_pred             CCCCHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCCCCCeeeecccCcccCCCCC-----
Q 020221          136 PNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDGR-----  210 (329)
Q Consensus       136 ~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~-----  210 (329)
                       +++|.+++.. ....+++.++..++.|++.||.|||+. +++|+||||+||+++.++.++|+|||++.......     
T Consensus        82 -~~~L~~~~~~-~~~~~~~~~~~~~~~~i~~~l~~lH~~-~i~H~dl~p~ni~~~~~~~~~l~dfg~~~~~~~~~~~~~~  158 (286)
T cd07832          82 -PSDLSEVLRD-EERPLPEAQVKSYMRMLLKGVAYMHAN-GIMHRDLKPANLLISADGVLKIADFGLARLFSEEEPRLYS  158 (286)
T ss_pred             -CCCHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHHC-CeecCCcCHHHEEEcCCCcEEEeeeeecccccCCCCCccc
Confidence             9999998864 336789999999999999999999999 99999999999999999999999999987654432     


Q ss_pred             CccCcccccCcccccCCC-CCCcccchhhhHHHHHHHhCCCCCCchhhHHHhhhchhhhc----------------ccc-
Q 020221          211 SYSTNLAFTPPEYLRTGR-VTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLT----------------DSC-  272 (329)
Q Consensus       211 ~~~~~~~y~aPE~~~~~~-~~~~~DvwslG~il~el~tg~~~~~~~~~~~~~~~~~~~~~----------------~~~-  272 (329)
                      ...++..|+|||.+.+.. ++.++||||+|+++++|++|.+++.................                ... 
T Consensus       159 ~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (286)
T cd07832         159 HQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGENDIEQLAIVFRTLGTPNEETWPGLTSLPDYNKIT  238 (286)
T ss_pred             cccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCCCHHHHHHHHHHHcCCCChHHHhhccCcchhhccc
Confidence            345688999999987554 68899999999999999999766543321111000000000                000 


Q ss_pred             cc-------CCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 020221          273 LE-------GQFSSDEGTELVRLASRCLQYEPRERPNPRSLVT  308 (329)
Q Consensus       273 ~~-------~~~~~~~~~~~~~li~~cl~~dp~~Rps~~~~l~  308 (329)
                      ..       .......+.++.+++.+||..||++|||+++++.
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~l~  281 (286)
T cd07832         239 FPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALR  281 (286)
T ss_pred             CCCCCcchHHHhCCCccHHHHHHHHHHhccChhhCCCHHHHhh
Confidence            00       0011234688999999999999999999999998

Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea

>KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=1.1e-41  Score=298.11  Aligned_cols=248  Identities=18%  Similarity=0.279  Sum_probs=196.3

Q ss_pred             ccccccCCCCCCcEEEEEEeCCCCEEEEEEeCCCCChhHHHHHHHHHHHhc--CCCccccccceeeeeCC----eeEEEE
Q 020221           59 ENIVSEHGEKAPNVVYKGKLENQFRIAVKRFNRSAWPDARQFLEEARAVGQ--LRNRRLANLLGCCCEGD----ERLLVA  132 (329)
Q Consensus        59 ~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~--l~h~niv~~~~~~~~~~----~~~lv~  132 (329)
                      ..+++.+|+|+||.||+|.+.+ +.||||++...   ..+.|.+|-.+...  ++|+||++++++-..+.    .++||+
T Consensus       212 l~l~eli~~Grfg~V~KaqL~~-~~VAVKifp~~---~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~~eywLVt  287 (534)
T KOG3653|consen  212 LQLLELIGRGRFGCVWKAQLDN-RLVAVKIFPEQ---EKQSFQNEKNIYSLPGMKHENILQFIGAEKRGTADRMEYWLVT  287 (534)
T ss_pred             hhhHHHhhcCccceeehhhccC-ceeEEEecCHH---HHHHHHhHHHHHhccCccchhHHHhhchhccCCccccceeEEe
Confidence            3445566999999999999855 69999999863   35567777666555  58999999999887666    899999


Q ss_pred             ecCCCCCHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcC--------CCccccccCCCceeeCCCCCeeeecccCcc
Q 020221          133 EYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSK--------ERALYHDLNAYRIVFDDDVNPRLSCFGLMK  204 (329)
Q Consensus       133 e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~--------~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~  204 (329)
                      +|.++|||.++|   +...++|....+++..|++||+|||+.        ..|+|||||.+|||+.+|++..|+|||+|.
T Consensus       288 ~fh~kGsL~dyL---~~ntisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTccIaDFGLAl  364 (534)
T KOG3653|consen  288 EFHPKGSLCDYL---KANTISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTCCIADFGLAL  364 (534)
T ss_pred             eeccCCcHHHHH---HhccccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcEEeeccceeE
Confidence            999999999999   567899999999999999999999973        569999999999999999999999999998


Q ss_pred             cCCCCC------CccCcccccCcccccCCC-CC-----CcccchhhhHHHHHHHhCCCCC-------Cch----------
Q 020221          205 NSRDGR------SYSTNLAFTPPEYLRTGR-VT-----PESVMYSFGTLLLDLLSGKHIP-------PSH----------  255 (329)
Q Consensus       205 ~~~~~~------~~~~~~~y~aPE~~~~~~-~~-----~~~DvwslG~il~el~tg~~~~-------~~~----------  255 (329)
                      .+.++.      ..+||.+|||||++.+.. +.     .+.||||+|.+||||+++..-.       +..          
T Consensus       365 ~~~p~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~~~vp~Yqlpfe~evG~hP  444 (534)
T KOG3653|consen  365 RLEPGKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDADPGPVPEYQLPFEAEVGNHP  444 (534)
T ss_pred             EecCCCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccccCCCCCcccCchhHHhcCCC
Confidence            776553      357899999999998654 33     3689999999999999975321       111          


Q ss_pred             hhHHHhhhchhhhccccccCCCCh-----HHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhhcc
Q 020221          256 ALDLIRDRNIQTLTDSCLEGQFSS-----DEGTELVRLASRCLQYEPRERPNPRSLVTALVTLQKDT  317 (329)
Q Consensus       256 ~~~~~~~~~~~~~~~~~~~~~~~~-----~~~~~~~~li~~cl~~dp~~Rps~~~~l~~L~~~~~~~  317 (329)
                      ..+.++.-...    ...++.++.     ....-+++.+..||+.||+.|.|+.-+.+++..+..-.
T Consensus       445 t~e~mq~~VV~----kK~RP~~p~~W~~h~~~~~l~et~EeCWDhDaeARLTA~Cv~eR~~~l~~~~  507 (534)
T KOG3653|consen  445 TLEEMQELVVR----KKQRPKIPDAWRKHAGMAVLCETIEECWDHDAEARLTAGCVEERMAELMMLW  507 (534)
T ss_pred             CHHHHHHHHHh----hccCCCChhhhhcCccHHHHHHHHHHHcCCchhhhhhhHHHHHHHHHHhccC
Confidence            11122211111    112223332     23567899999999999999999999999999887644

>cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase

Probab=100.00  E-value=2.8e-41  Score=297.71  Aligned_cols=242  Identities=19%  Similarity=0.236  Sum_probs=200.6

Q ss_pred             cccccccCCCCCCcEEEEEE-eCCCCEEEEEEeCCCCC---hhHHHHHHHHHHHhcCCCccccccceeeeeCCeeEEEEe
Q 020221           58 MENIVSEHGEKAPNVVYKGK-LENQFRIAVKRFNRSAW---PDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAE  133 (329)
Q Consensus        58 ~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  133 (329)
                      .|.+++.||+|+||.||++. ..+++.+|+|.+.....   ...+.+.+|+++++.++||||+++++++..+...++|||
T Consensus         2 ~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e   81 (290)
T cd05580           2 DFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDSNLYLVME   81 (290)
T ss_pred             ceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEEcCCeEEEEEe
Confidence            35677788999999999999 45688999999875432   234568889999999999999999999999999999999


Q ss_pred             cCCCCCHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCCCCCeeeecccCcccCCCC-CCc
Q 020221          134 YMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDG-RSY  212 (329)
Q Consensus       134 ~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~-~~~  212 (329)
                      |+++++|.+++..  ...+++..+..++.|++.||.|||+. |++|+||+|+||+++.++.++|+|||++...... ...
T Consensus        82 ~~~~~~L~~~~~~--~~~l~~~~~~~~~~qil~~l~~lH~~-~i~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~~~~~  158 (290)
T cd05580          82 YVPGGELFSHLRK--SGRFPEPVARFYAAQVVLALEYLHSL-DIVYRDLKPENLLLDSDGYIKITDFGFAKRVKGRTYTL  158 (290)
T ss_pred             cCCCCCHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHC-CEecCCCCHHHEEECCCCCEEEeeCCCccccCCCCCCC
Confidence            9999999999863  46789999999999999999999999 9999999999999999999999999998765544 234


Q ss_pred             cCcccccCcccccCCCCCCcccchhhhHHHHHHHhCCCCCCchhhHHHhhhchhhhccccccCCCChHHHHHHHHHHHHh
Q 020221          213 STNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLASRC  292 (329)
Q Consensus       213 ~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~c  292 (329)
                      .+++.|+|||.+.+...+.++||||||+++|+|++|..|+.............    .  .....+...+..+.+++.+|
T Consensus       159 ~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~----~--~~~~~~~~~~~~l~~li~~~  232 (290)
T cd05580         159 CGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPFFDDNPIQIYEKIL----E--GKVRFPSFFSPDAKDLIRNL  232 (290)
T ss_pred             CCCccccChhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHh----c--CCccCCccCCHHHHHHHHHH
Confidence            57889999999988888999999999999999999998876543222211111    1  11223445578899999999


Q ss_pred             cccCCCCCC-----CHHHHHH
Q 020221          293 LQYEPRERP-----NPRSLVT  308 (329)
Q Consensus       293 l~~dp~~Rp-----s~~~~l~  308 (329)
                      |..||++|+     ++.++++
T Consensus       233 l~~~p~~R~~~~~~~~~~l~~  253 (290)
T cd05580         233 LQVDLTKRLGNLKNGVNDIKN  253 (290)
T ss_pred             ccCCHHHccCcccCCHHHHHc
Confidence            999999999     6777765

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi

>cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2

Probab=100.00  E-value=5.5e-41  Score=292.56  Aligned_cols=246  Identities=18%  Similarity=0.225  Sum_probs=186.9

Q ss_pred             cCCCCCCcEEEEEEeCCC---CEEEEEEeCCCCC-hhHHHHHHHHHHHhcCCCccccccceeeeeCCeeEEEEecCCCCC
Q 020221           64 EHGEKAPNVVYKGKLENQ---FRIAVKRFNRSAW-PDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAEYMPNDT  139 (329)
Q Consensus        64 ~lg~G~~g~V~~~~~~~~---~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gs  139 (329)
                      .||+|+||.||++...++   ..+++|.+..... ...+.+.+|+..++.++||||+++++.+......+++|||+++|+
T Consensus         2 ~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~   81 (268)
T cd05086           2 EIGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLGQCVEAIPYLLVFEYCELGD   81 (268)
T ss_pred             cCCCCcCceEEEEEEEcCCCcceEEEEEecCCCChHHHHHHHHHHHHHhccCCcchhheEEEecCCCccEEEEecCCCCc
Confidence            479999999999974332   3466777765432 335678999999999999999999999999899999999999999


Q ss_pred             HHhhhccCC--CCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCCCCCeeeecccCcccCCC------CCC
Q 020221          140 LAKHLFHWE--TQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRD------GRS  211 (329)
Q Consensus       140 L~~~l~~~~--~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~------~~~  211 (329)
                      |.+++.+..  ....++..+..++.||+.||+|||+. +++|+||||+||+++.++.++|+|||++.....      ...
T Consensus        82 L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~-~i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~  160 (268)
T cd05086          82 LKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKH-NFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIETEDD  160 (268)
T ss_pred             HHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHC-CeeccCCccceEEEcCCccEEecccccccccCcchhhhcccC
Confidence            999986432  23456778889999999999999999 999999999999999999999999998754221      123


Q ss_pred             ccCcccccCcccccC-------CCCCCcccchhhhHHHHHHHhCCC-CCCchhhHHHhhhchhhhccccccCCCChHHHH
Q 020221          212 YSTNLAFTPPEYLRT-------GRVTPESVMYSFGTLLLDLLSGKH-IPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGT  283 (329)
Q Consensus       212 ~~~~~~y~aPE~~~~-------~~~~~~~DvwslG~il~el~tg~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  283 (329)
                      ..++..|+|||++..       ..++.++||||||+++|||+++.. |+.....................++..+...++
T Consensus       161 ~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (268)
T cd05086         161 KCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSDREVLNHVIKDQQVKLFKPQLELPYSE  240 (268)
T ss_pred             CcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhhcccccCCCccCCCCcH
Confidence            456788999998753       235779999999999999998654 443222111111111111111122333444677


Q ss_pred             HHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 020221          284 ELVRLASRCLQYEPRERPNPRSLVTALV  311 (329)
Q Consensus       284 ~~~~li~~cl~~dp~~Rps~~~~l~~L~  311 (329)
                      .+.+++..|| .+|++||+++++++.|.
T Consensus       241 ~~~~l~~~c~-~~P~~Rp~~~~i~~~l~  267 (268)
T cd05086         241 RWYEVLQFCW-LSPEKRATAEEVHRLLT  267 (268)
T ss_pred             HHHHHHHHHh-hCcccCCCHHHHHHHhc
Confidence            8999999999 78999999999998774

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage

>cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1

Probab=100.00  E-value=3.3e-41  Score=293.58  Aligned_cols=244  Identities=18%  Similarity=0.289  Sum_probs=198.1

Q ss_pred             ccccCCCCCCcEEEEEE-eCCCCEEEEEEeCCCCC------hhHHHHHHHHHHHhcCCCccccccceeeeeCCeeEEEEe
Q 020221           61 IVSEHGEKAPNVVYKGK-LENQFRIAVKRFNRSAW------PDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAE  133 (329)
Q Consensus        61 ~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~------~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  133 (329)
                      ..+.||+|++|.||++. ..+++.+|+|.+.....      ...+.+.+|++.++.++|+||+++++++.+++..++|+|
T Consensus         4 ~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~v~e   83 (268)
T cd06630           4 KGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDSHFNLFVE   83 (268)
T ss_pred             ccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceeccCCeEEEEEe
Confidence            34556999999999998 56788999999875431      124568899999999999999999999999999999999


Q ss_pred             cCCCCCHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCCCC-CeeeecccCcccCCCC---
Q 020221          134 YMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDV-NPRLSCFGLMKNSRDG---  209 (329)
Q Consensus       134 ~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~-~~kl~Dfg~a~~~~~~---  209 (329)
                      |+++++|.+++.  ....+++..+..++.|++.||.|||++ |++|+||+|+||+++.++ .++|+|||.+......   
T Consensus        84 ~~~~~~L~~~l~--~~~~~~~~~~~~~~~ql~~al~~LH~~-~i~H~~i~~~nil~~~~~~~~~l~dfg~~~~~~~~~~~  160 (268)
T cd06630          84 WMAGGSVSHLLS--KYGAFKEAVIINYTEQLLRGLSYLHEN-QIIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGTG  160 (268)
T ss_pred             ccCCCcHHHHHH--HhCCCCHHHHHHHHHHHHHHHHHHHhC-CeecCCCCHHHEEEcCCCCEEEEccccccccccccccc
Confidence            999999999986  345788999999999999999999999 999999999999998776 5999999998765432   


Q ss_pred             -----CCccCcccccCcccccCCCCCCcccchhhhHHHHHHHhCCCCCCchhhHHHhhhchhhhccccccCCCChHHHHH
Q 020221          210 -----RSYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTE  284 (329)
Q Consensus       210 -----~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  284 (329)
                           ....++..|+|||.+.+..++.++|+||+|+++++|++|..|+........... .............+...+++
T Consensus       161 ~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~  239 (268)
T cd06630         161 AGEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLAL-IFKIASATTAPSIPEHLSPG  239 (268)
T ss_pred             CCccccccccccceeCHhHhccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcchHHH-HHHHhccCCCCCCchhhCHH
Confidence                 123467889999999888899999999999999999999988754321111111 11111111223455667889


Q ss_pred             HHHHHHHhcccCCCCCCCHHHHHH
Q 020221          285 LVRLASRCLQYEPRERPNPRSLVT  308 (329)
Q Consensus       285 ~~~li~~cl~~dp~~Rps~~~~l~  308 (329)
                      +.+++.+||..+|++||++.++++
T Consensus       240 ~~~~i~~~l~~~p~~R~~~~~ll~  263 (268)
T cd06630         240 LRDVTLRCLELQPEDRPPSRELLK  263 (268)
T ss_pred             HHHHHHHHcCCCcccCcCHHHHhc
Confidence            999999999999999999999998

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their

>PHA03390 pk1 serine/threonine-protein kinase 1; Provisional

Probab=100.00  E-value=3.8e-41  Score=293.42  Aligned_cols=251  Identities=15%  Similarity=0.146  Sum_probs=196.9

Q ss_pred             HHHHHHhcCCCcccccccCCCCCCcEEEEEE-eCCCCEEEEEEeCCCCChhHHHHHHHHHHHhcC-CCccccccceeeee
Q 020221           47 ETLRTATSGFAMENIVSEHGEKAPNVVYKGK-LENQFRIAVKRFNRSAWPDARQFLEEARAVGQL-RNRRLANLLGCCCE  124 (329)
Q Consensus        47 ~~~~~~~~~~~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~  124 (329)
                      .++....+++...+.++ +|+|+||.||++. ..++..+|+|.+........     |+.....+ +|||++++++.+..
T Consensus         7 ~~~~~~~~~~~~~~~~~-lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~-----e~~~~~~~~~h~~iv~~~~~~~~   80 (267)
T PHA03390          7 SELVQFLKNCEIVKKLK-LIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNAI-----EPMVHQLMKDNPNFIKLYYSVTT   80 (267)
T ss_pred             HHHHHHHHhhcccccee-ecCCCceEEEEEEEcCCCcEEEEEEEehhhcchh-----hHHHHHHhhcCCCEEEEEEEEec
Confidence            34444445555544444 6999999999998 56788899999875432211     22222222 79999999999999


Q ss_pred             CCeeEEEEecCCCCCHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCCCC-CeeeecccCc
Q 020221          125 GDERLLVAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDV-NPRLSCFGLM  203 (329)
Q Consensus       125 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~-~~kl~Dfg~a  203 (329)
                      .+..++||||+++++|.+++..  ...+++..+..++.|++.||.|||+. +++|+||||+||+++.++ .++|+|||++
T Consensus        81 ~~~~~iv~e~~~~~~L~~~l~~--~~~l~~~~~~~~~~qi~~~l~~lH~~-~i~H~dl~p~nil~~~~~~~~~l~dfg~~  157 (267)
T PHA03390         81 LKGHVLIMDYIKDGDLFDLLKK--EGKLSEAEVKKIIRQLVEALNDLHKH-NIIHNDIKLENVLYDRAKDRIYLCDYGLC  157 (267)
T ss_pred             CCeeEEEEEcCCCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhC-CeeeCCCCHHHEEEeCCCCeEEEecCccc
Confidence            9999999999999999999863  34889999999999999999999999 999999999999999988 9999999998


Q ss_pred             ccCCCCCCccCcccccCcccccCCCCCCcccchhhhHHHHHHHhCCCCCCchhhHHHhhhchhhhccccccCCCChHHHH
Q 020221          204 KNSRDGRSYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGT  283 (329)
Q Consensus       204 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  283 (329)
                      ..........++..|+|||++.+..++.++||||||+++|+|++|..|+..................  .....+...++
T Consensus       158 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~  235 (267)
T PHA03390        158 KIIGTPSCYDGTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDEDEELDLESLLKRQQ--KKLPFIKNVSK  235 (267)
T ss_pred             eecCCCccCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCcchhhHHHHHHhhc--ccCCcccccCH
Confidence            8776666667889999999999888999999999999999999999887643222111111111111  11123345788


Q ss_pred             HHHHHHHHhcccCCCCCCC-HHHHHH
Q 020221          284 ELVRLASRCLQYEPRERPN-PRSLVT  308 (329)
Q Consensus       284 ~~~~li~~cl~~dp~~Rps-~~~~l~  308 (329)
                      .+.+++.+||+.||++||+ ++++++
T Consensus       236 ~~~~li~~~l~~~p~~R~~~~~~~l~  261 (267)
T PHA03390        236 NANDFVQSMLKYNINYRLTNYNEIIK  261 (267)
T ss_pred             HHHHHHHHHhccChhhCCchHHHHhc
Confidence            9999999999999999996 699997

>cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase

Probab=100.00  E-value=1.9e-41  Score=299.22  Aligned_cols=247  Identities=18%  Similarity=0.250  Sum_probs=202.0

Q ss_pred             CCCcccccccCCCCCCcEEEEEE-eCCCCEEEEEEeCCCCChhHHHHHHHHHHHhcCCCccccccceeeeeCCeeEEEEe
Q 020221           55 GFAMENIVSEHGEKAPNVVYKGK-LENQFRIAVKRFNRSAWPDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAE  133 (329)
Q Consensus        55 ~~~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  133 (329)
                      ....|.+++.+|+|+||.||++. ..++..|++|.+........+.+.+|+.+++.++|||++++++.+......++|+|
T Consensus        17 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e   96 (293)
T cd06647          17 PKKKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVNYLDSYLVGDELWVVME   96 (293)
T ss_pred             chhhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEeccccchHHHHHHHHHHHHhhcCCCCeeehhheeeeCCcEEEEEe
Confidence            34567778888999999999998 45678999999876554556678899999999999999999999999999999999


Q ss_pred             cCCCCCHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCCCCCeeeecccCcccCCCCC---
Q 020221          134 YMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDGR---  210 (329)
Q Consensus       134 ~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~---  210 (329)
                      |+++++|.+++.   ...+++..+..++.|++.||.|||+. +++|+||+|+||+++.++.++|+|||++.......   
T Consensus        97 ~~~~~~L~~~~~---~~~l~~~~~~~i~~~l~~al~~LH~~-gi~H~dL~p~Nili~~~~~~kL~dfg~~~~~~~~~~~~  172 (293)
T cd06647          97 YLAGGSLTDVVT---ETCMDEGQIAAVCRECLQALEFLHSN-QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKR  172 (293)
T ss_pred             cCCCCcHHHHHh---hcCCCHHHHHHHHHHHHHHHHHHHhC-CEeeccCCHHHEEEcCCCCEEEccCcceeccccccccc
Confidence            999999999984   34688999999999999999999999 99999999999999999999999999876544332   


Q ss_pred             -CccCcccccCcccccCCCCCCcccchhhhHHHHHHHhCCCCCCchhhHHHhhhchhhhccccccCCCChHHHHHHHHHH
Q 020221          211 -SYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLA  289 (329)
Q Consensus       211 -~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li  289 (329)
                       ...+++.|+|||.+.+..++.++|+||||+++|++++|..||........... .  ..........+...+..+.+++
T Consensus       173 ~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~~~~~-~--~~~~~~~~~~~~~~~~~l~~li  249 (293)
T cd06647         173 STMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYL-I--ATNGTPELQNPEKLSAIFRDFL  249 (293)
T ss_pred             ccccCChhhcCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhheee-h--hcCCCCCCCCccccCHHHHHHH
Confidence             23567889999999888899999999999999999999988764322111000 0  0001111112334567899999


Q ss_pred             HHhcccCCCCCCCHHHHHH
Q 020221          290 SRCLQYEPRERPNPRSLVT  308 (329)
Q Consensus       290 ~~cl~~dp~~Rps~~~~l~  308 (329)
                      .+||+.+|++||++.+++.
T Consensus       250 ~~~l~~~p~~Rp~~~~il~  268 (293)
T cd06647         250 NRCLEMDVEKRGSAKELLQ  268 (293)
T ss_pred             HHHccCChhhCcCHHHHhc
Confidence            9999999999999999997

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi

>cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=4.8e-41  Score=293.31  Aligned_cols=247  Identities=15%  Similarity=0.184  Sum_probs=196.7

Q ss_pred             CcccccccCCCCCCcEEEEEEe-CCCCEEEEEEeCCCCChhHHHHHHHHHHHhcC-CCccccccceeeeeCC------ee
Q 020221           57 AMENIVSEHGEKAPNVVYKGKL-ENQFRIAVKRFNRSAWPDARQFLEEARAVGQL-RNRRLANLLGCCCEGD------ER  128 (329)
Q Consensus        57 ~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~------~~  128 (329)
                      ..|++++.+|+|++|.||+|.. .+++.+++|.+..... ..+.+.+|+.+++.+ .|+||+++++++....      ..
T Consensus         6 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~~~   84 (275)
T cd06608           6 GIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIED-EEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGNDDQL   84 (275)
T ss_pred             hheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCch-hHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCcceEE
Confidence            4466777889999999999995 4678899999876553 346788999999999 6999999999986543      48


Q ss_pred             EEEEecCCCCCHHhhhccCC--CCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCCCCCeeeecccCcccC
Q 020221          129 LLVAEYMPNDTLAKHLFHWE--TQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNS  206 (329)
Q Consensus       129 ~lv~e~~~~gsL~~~l~~~~--~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~  206 (329)
                      +++|||+++++|.+++....  ...+++..+..++.|++.||.|||+. +++|+||+|+||++++++.++|+|||++...
T Consensus        85 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~-~i~H~~l~p~ni~~~~~~~~~l~d~~~~~~~  163 (275)
T cd06608          85 WLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHEN-KVIHRDIKGQNILLTKNAEVKLVDFGVSAQL  163 (275)
T ss_pred             EEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcC-CcccCCCCHHHEEEccCCeEEECCCccceec
Confidence            99999999999999886432  45789999999999999999999999 9999999999999999999999999998654


Q ss_pred             CCC----CCccCcccccCcccccC-----CCCCCcccchhhhHHHHHHHhCCCCCCchhhHHHhhhchhhhccccccCCC
Q 020221          207 RDG----RSYSTNLAFTPPEYLRT-----GRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQF  277 (329)
Q Consensus       207 ~~~----~~~~~~~~y~aPE~~~~-----~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  277 (329)
                      ...    ....++..|+|||++..     ..++.++||||||+++++|++|..|+..................   ....
T Consensus       164 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~---~~~~  240 (275)
T cd06608         164 DSTLGRRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPMRALFKIPRNPPP---TLKS  240 (275)
T ss_pred             ccchhhhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccchHHHHHHhhccCCC---CCCc
Confidence            332    23456788999998753     23778999999999999999999887543211111111111111   1112


Q ss_pred             ChHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 020221          278 SSDEGTELVRLASRCLQYEPRERPNPRSLVT  308 (329)
Q Consensus       278 ~~~~~~~~~~li~~cl~~dp~~Rps~~~~l~  308 (329)
                      +...+.++.+++.+||..||++|||+.++++
T Consensus       241 ~~~~~~~~~~li~~~l~~dp~~Rpt~~~ll~  271 (275)
T cd06608         241 PENWSKKFNDFISECLIKNYEQRPFMEELLE  271 (275)
T ss_pred             hhhcCHHHHHHHHHHhhcChhhCcCHHHHhc
Confidence            2346778999999999999999999999998

Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I

>cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4

Probab=100.00  E-value=8.9e-41  Score=290.13  Aligned_cols=243  Identities=19%  Similarity=0.276  Sum_probs=198.9

Q ss_pred             ccccccCCCCCCcEEEEEE-eCCCCEEEEEEeCCCCCh--hHHHHHHHHHHHhcCCCccccccceeeeeCCeeEEEEecC
Q 020221           59 ENIVSEHGEKAPNVVYKGK-LENQFRIAVKRFNRSAWP--DARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAEYM  135 (329)
Q Consensus        59 ~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~--~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~  135 (329)
                      |.+.+.||+|+||.||++. ..+++.|++|.++.....  ..+.+.+|+++++.++|+||+++++.+...+..++++||+
T Consensus         2 y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~lv~e~~   81 (264)
T cd06626           2 WQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGVEVHREKVYIFMEYC   81 (264)
T ss_pred             ceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccchHHHHHHHHHHHHHHhCCCCChhheeeeEecCCEEEEEEecC
Confidence            5566778999999999998 457889999999876543  4667899999999999999999999998899999999999


Q ss_pred             CCCCHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCCCCCeeeecccCcccCCCCC-----
Q 020221          136 PNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDGR-----  210 (329)
Q Consensus       136 ~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~-----  210 (329)
                      ++++|.+++..  ...+++..+..++.|++.||.|||+. +++|+||+|+||++++++.++|+|||++.......     
T Consensus        82 ~~~~L~~~~~~--~~~~~~~~~~~i~~~i~~~l~~lh~~-~i~H~dl~~~nil~~~~~~~kl~d~g~~~~~~~~~~~~~~  158 (264)
T cd06626          82 SGGTLEELLEH--GRILDEHVIRVYTLQLLEGLAYLHSH-GIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMGE  158 (264)
T ss_pred             CCCcHHHHHhh--cCCCChHHHHHHHHHHHHHHHHHHHC-CcccCCCCHHHEEECCCCCEEEcccccccccCCCCCcccc
Confidence            99999999863  34578899999999999999999999 99999999999999999999999999987654332     


Q ss_pred             ---CccCcccccCcccccCCC---CCCcccchhhhHHHHHHHhCCCCCCchhhHHHhhhchhhhccccccCCCCh--HHH
Q 020221          211 ---SYSTNLAFTPPEYLRTGR---VTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSS--DEG  282 (329)
Q Consensus       211 ---~~~~~~~y~aPE~~~~~~---~~~~~DvwslG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~  282 (329)
                         ...++..|+|||++.+..   .+.++||||||++++++++|..||...............    ......+.  ..+
T Consensus       159 ~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~~~~~~~~~~~----~~~~~~~~~~~~~  234 (264)
T cd06626         159 EVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNEFQIMFHVGA----GHKPPIPDSLQLS  234 (264)
T ss_pred             cccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcchHHHHHHHhc----CCCCCCCcccccC
Confidence               134578999999998766   888999999999999999999887543211111000110    11112222  237


Q ss_pred             HHHHHHHHHhcccCCCCCCCHHHHHH
Q 020221          283 TELVRLASRCLQYEPRERPNPRSLVT  308 (329)
Q Consensus       283 ~~~~~li~~cl~~dp~~Rps~~~~l~  308 (329)
                      +.+.+++.+||+.+|++||++.+++.
T Consensus       235 ~~~~~li~~~l~~~p~~R~~~~~i~~  260 (264)
T cd06626         235 PEGKDFLDRCLESDPKKRPTASELLQ  260 (264)
T ss_pred             HHHHHHHHHHccCCcccCCCHHHHhc
Confidence            78899999999999999999999998

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4

>cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4

Probab=100.00  E-value=5.2e-41  Score=297.90  Aligned_cols=251  Identities=20%  Similarity=0.303  Sum_probs=198.5

Q ss_pred             ccccccCCCCCCcEEEEEEe-CCCC----EEEEEEeCCCCChh-HHHHHHHHHHHhcCCCccccccceeeeeCCeeEEEE
Q 020221           59 ENIVSEHGEKAPNVVYKGKL-ENQF----RIAVKRFNRSAWPD-ARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVA  132 (329)
Q Consensus        59 ~~~~~~lg~G~~g~V~~~~~-~~~~----~vavK~~~~~~~~~-~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~  132 (329)
                      ++.++.||+|+||.||++.. .++.    .+|+|.+....... ...+.+|+.+++.++||||+++++++.. ...++++
T Consensus         9 ~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~-~~~~~v~   87 (303)
T cd05110           9 LKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRLLGVCLS-PTIQLVT   87 (303)
T ss_pred             ceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEcC-CCceeee
Confidence            34566779999999999984 4443    57899887654322 3468899999999999999999999865 4567999


Q ss_pred             ecCCCCCHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCCCCCeeeecccCcccCCCCC--
Q 020221          133 EYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDGR--  210 (329)
Q Consensus       133 e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~--  210 (329)
                      ||+++|+|.+++.. ....+++..+..++.|++.||.|||++ +++|+||||+||++++++.+||+|||++.......  
T Consensus        88 e~~~~g~l~~~~~~-~~~~~~~~~~~~~~~qi~~~L~~LH~~-~ivH~dikp~Nill~~~~~~kL~Dfg~~~~~~~~~~~  165 (303)
T cd05110          88 QLMPHGCLLDYVHE-HKDNIGSQLLLNWCVQIAKGMMYLEER-RLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKE  165 (303)
T ss_pred             hhcCCCCHHHHHHh-cccCCCHHHHHHHHHHHHHHHHHHhhc-CeeccccccceeeecCCCceEEccccccccccCcccc
Confidence            99999999999864 344688999999999999999999999 99999999999999999999999999997654322  


Q ss_pred             ----CccCcccccCcccccCCCCCCcccchhhhHHHHHHHh-CCCCCCchhhHHHhhhchhhhccccccCCCChHHHHHH
Q 020221          211 ----SYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLS-GKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTEL  285 (329)
Q Consensus       211 ----~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t-g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  285 (329)
                          ...++..|+|||.+.+..++.++||||||+++|||++ |+.|+...........     .........+...+..+
T Consensus       166 ~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~el~t~g~~p~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~  240 (303)
T cd05110         166 YNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPTREIPDL-----LEKGERLPQPPICTIDV  240 (303)
T ss_pred             cccCCCccccccCCHHHhccCCCChHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHH-----HHCCCCCCCCCCCCHHH
Confidence                1223568999999998889999999999999999997 7777654322221111     11111112233456789


Q ss_pred             HHHHHHhcccCCCCCCCHHHHHHHHHhhhhcc
Q 020221          286 VRLASRCLQYEPRERPNPRSLVTALVTLQKDT  317 (329)
Q Consensus       286 ~~li~~cl~~dp~~Rps~~~~l~~L~~~~~~~  317 (329)
                      .+++..||..+|++||++.++++.|+.+.++.
T Consensus       241 ~~li~~c~~~~p~~Rp~~~~l~~~l~~~~~~~  272 (303)
T cd05110         241 YMVMVKCWMIDADSRPKFKELAAEFSRMARDP  272 (303)
T ss_pred             HHHHHHHcCCChhhCcCHHHHHHHHHHHHhch
Confidence            99999999999999999999999999986553

Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin

>KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms]

Probab=100.00  E-value=3.5e-42  Score=285.62  Aligned_cols=240  Identities=17%  Similarity=0.146  Sum_probs=195.6

Q ss_pred             ccCCCCCCcEEEEEE-eCCCCEEEEEEeCCCCChhHHHHHHHHHHHhcC-CCccccccceeeee----CCeeEEEEecCC
Q 020221           63 SEHGEKAPNVVYKGK-LENQFRIAVKRFNRSAWPDARQFLEEARAVGQL-RNRRLANLLGCCCE----GDERLLVAEYMP  136 (329)
Q Consensus        63 ~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~----~~~~~lv~e~~~  136 (329)
                      +.||-|-.|.|-.+. ..+++.+|+|++...     +..++|++.-... .|||||+++++|..    ...+.+|||.|+
T Consensus        68 qvLG~GinGkV~~C~~k~T~ekfALKvL~Ds-----~KARrEVeLHw~~s~h~~iV~IidVyeNs~~~rkcLLiVmE~me  142 (400)
T KOG0604|consen   68 QVLGAGINGKVVQCVHKRTQEKFALKVLLDS-----PKARREVELHWMASGHPHIVSIIDVYENSYQGRKCLLIVMECME  142 (400)
T ss_pred             hhhccccCCceEEEEeccchhhhHHHHHhcC-----HHHHhHhhhhhhhcCCCceEEeehhhhhhccCceeeEeeeeccc
Confidence            456999999999998 667999999998753     3457888876666 69999999999854    245789999999


Q ss_pred             CCCHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeC---CCCCeeeecccCcccCCCC---C
Q 020221          137 NDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFD---DDVNPRLSCFGLMKNSRDG---R  210 (329)
Q Consensus       137 ~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~---~~~~~kl~Dfg~a~~~~~~---~  210 (329)
                      ||.|.+.+.++..+.+++.++..|++||+.|+.|||+. +|.||||||+|+|..   .|..+||+|||+|+.....   .
T Consensus       143 GGeLfsriq~~g~~afTErea~eI~~qI~~Av~~lH~~-nIAHRDlKpENLLyt~t~~na~lKLtDfGFAK~t~~~~~L~  221 (400)
T KOG0604|consen  143 GGELFSRIQDRGDQAFTEREASEIMKQIGLAVRYLHSM-NIAHRDLKPENLLYTTTSPNAPLKLTDFGFAKETQEPGDLM  221 (400)
T ss_pred             chHHHHHHHHcccccchHHHHHHHHHHHHHHHHHHHhc-chhhccCChhheeeecCCCCcceEecccccccccCCCcccc
Confidence            99999999987888899999999999999999999999 999999999999996   4567999999999876643   2


Q ss_pred             CccCcccccCcccccCCCCCCcccchhhhHHHHHHHhCCCCCCchhhHHHhhhchhhhcccc--ccCCCChHHHHHHHHH
Q 020221          211 SYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSC--LEGQFSSDEGTELVRL  288 (329)
Q Consensus       211 ~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~l  288 (329)
                      +.+-|+.|.|||++...+|+...|+||+||++|.|++|.+||+...-..+..+....+....  ...+.-...|++..++
T Consensus       222 TPc~TPyYvaPevlg~eKydkscdmwSlgVimYIlLCGyPPFYS~hg~aispgMk~rI~~gqy~FP~pEWs~VSe~aKdl  301 (400)
T KOG0604|consen  222 TPCFTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKRRIRTGQYEFPEPEWSCVSEAAKDL  301 (400)
T ss_pred             CCcccccccCHHHhCchhcCCCCCccchhHHHHHhhcCCCcccccCCccCChhHHhHhhccCccCCChhHhHHHHHHHHH
Confidence            34558999999999999999999999999999999999998865422111111111111111  1111224578999999


Q ss_pred             HHHhcccCCCCCCCHHHHHH
Q 020221          289 ASRCLQYEPRERPNPRSLVT  308 (329)
Q Consensus       289 i~~cl~~dp~~Rps~~~~l~  308 (329)
                      |+.+|..+|.+|.|+.++++
T Consensus       302 IR~LLkt~PteRlTI~~~m~  321 (400)
T KOG0604|consen  302 IRKLLKTEPTERLTIEEVMD  321 (400)
T ss_pred             HHHHhcCCchhheeHHHhhc
Confidence            99999999999999999998

>cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3

Probab=100.00  E-value=3.4e-41  Score=296.15  Aligned_cols=248  Identities=18%  Similarity=0.250  Sum_probs=195.3

Q ss_pred             ccccccCCCCCCcEEEEEEe-CCCCEEEEEEeCCCCCh--hHHHHHHHHHHHhcCCCccccccceeeeeCCeeEEEEecC
Q 020221           59 ENIVSEHGEKAPNVVYKGKL-ENQFRIAVKRFNRSAWP--DARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAEYM  135 (329)
Q Consensus        59 ~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~--~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~  135 (329)
                      |++++.||.|++|.||+|.. .+++.||+|.+......  ....+.+|+++++.++||||+++++++.+....+++|||+
T Consensus         2 y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~   81 (284)
T cd07860           2 FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFL   81 (284)
T ss_pred             ceeeeeecCCCceEEEEEEECCCCCEEEEEEccccccccccchHHHHHHHHHHhcCCCCCcchhhhcccCCcEEEEeecc
Confidence            45677789999999999984 56889999998754322  2356889999999999999999999999999999999999


Q ss_pred             CCCCHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCCCCCeeeecccCcccCCCC----CC
Q 020221          136 PNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDG----RS  211 (329)
Q Consensus       136 ~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~----~~  211 (329)
                      . ++|.+++.......+++..+..++.|++.||+|||+. +++|+||+|+||+++.++.++|+|||++......    ..
T Consensus        82 ~-~~l~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~-~i~H~~l~p~nill~~~~~~~l~dfg~~~~~~~~~~~~~~  159 (284)
T cd07860          82 H-QDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCHSH-RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTH  159 (284)
T ss_pred             c-cCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHC-CeecCCCCHHHEEECCCCCEEEeeccchhhcccCcccccc
Confidence            6 5899888654556789999999999999999999999 9999999999999999999999999998754332    12


Q ss_pred             ccCcccccCcccccCCC-CCCcccchhhhHHHHHHHhCCCCCCchhhHHHhhhchhhh--------------------cc
Q 020221          212 YSTNLAFTPPEYLRTGR-VTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTL--------------------TD  270 (329)
Q Consensus       212 ~~~~~~y~aPE~~~~~~-~~~~~DvwslG~il~el~tg~~~~~~~~~~~~~~~~~~~~--------------------~~  270 (329)
                      ..++..|+|||.+.+.. ++.++||||||+++|+|+||+.||................                    ..
T Consensus       160 ~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (284)
T cd07860         160 EVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSLPDYKPSFP  239 (284)
T ss_pred             ccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhhhhHHHHHHhhcc
Confidence            34578899999887655 6788999999999999999998876543211110000000                    00


Q ss_pred             cccc---CCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 020221          271 SCLE---GQFSSDEGTELVRLASRCLQYEPRERPNPRSLVT  308 (329)
Q Consensus       271 ~~~~---~~~~~~~~~~~~~li~~cl~~dp~~Rps~~~~l~  308 (329)
                      ....   .......++++.+++.+||+.||++|||+.+++.
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~  280 (284)
T cd07860         240 KWARQDFSKVVPPLDEDGRDLLSQMLHYDPNKRISAKAALA  280 (284)
T ss_pred             cccccCHHHHcccCCHHHHHHHHHhcCCCcccCCCHHHHhc
Confidence            0000   0011234577899999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex

>cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3

Probab=100.00  E-value=6.1e-41  Score=291.85  Aligned_cols=241  Identities=18%  Similarity=0.232  Sum_probs=192.2

Q ss_pred             cccccCCCCCCcEEEEEE-eCCCCEEEEEEeCCCCC-----hhHHHHHHHHHHHhcCCCccccccceeeee--CCeeEEE
Q 020221           60 NIVSEHGEKAPNVVYKGK-LENQFRIAVKRFNRSAW-----PDARQFLEEARAVGQLRNRRLANLLGCCCE--GDERLLV  131 (329)
Q Consensus        60 ~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~-----~~~~~~~~e~~~l~~l~h~niv~~~~~~~~--~~~~~lv  131 (329)
                      ...+.+|+|+||.||++. ..++..|++|.+.....     .....+.+|+.+++.++||||+++++++..  ....+++
T Consensus         5 ~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~l~   84 (266)
T cd06651           5 RRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTLTIF   84 (266)
T ss_pred             cccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCEEEEE
Confidence            344556999999999998 45688999999865421     123457889999999999999999998865  3578899


Q ss_pred             EecCCCCCHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCCCCCeeeecccCcccCCCC--
Q 020221          132 AEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDG--  209 (329)
Q Consensus       132 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~--  209 (329)
                      +||+++++|.+++.+  ...+++.....++.|++.||+|||+. +++|+||+|+||+++.++.++|+|||++......  
T Consensus        85 ~e~~~~~~L~~~l~~--~~~l~~~~~~~~~~qi~~~l~~LH~~-~i~H~~l~p~nil~~~~~~~~l~dfg~~~~~~~~~~  161 (266)
T cd06651          85 MEYMPGGSVKDQLKA--YGALTESVTRKYTRQILEGMSYLHSN-MIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICM  161 (266)
T ss_pred             EeCCCCCcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHhC-CeeeCCCCHHHEEECCCCCEEEccCCCccccccccc
Confidence            999999999999863  34688999999999999999999999 9999999999999999999999999998754321  


Q ss_pred             -----CCccCcccccCcccccCCCCCCcccchhhhHHHHHHHhCCCCCCchhhHHHhhhchhhhccccccCCCChHHHHH
Q 020221          210 -----RSYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTE  284 (329)
Q Consensus       210 -----~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  284 (329)
                           ....++..|+|||.+.+..++.++||||||+++|+|++|..||..........    ...........+...++.
T Consensus       162 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~el~~g~~pf~~~~~~~~~~----~~~~~~~~~~~~~~~~~~  237 (266)
T cd06651         162 SGTGIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAEYEAMAAIF----KIATQPTNPQLPSHISEH  237 (266)
T ss_pred             cCCccccCCccccccCHHHhCCCCCCchhhhHHHHHHHHHHHHCCCCccccchHHHHH----HHhcCCCCCCCchhcCHH
Confidence                 12346788999999998889999999999999999999998875432111111    111111123344556677


Q ss_pred             HHHHHHHhcccCCCCCCCHHHHHH
Q 020221          285 LVRLASRCLQYEPRERPNPRSLVT  308 (329)
Q Consensus       285 ~~~li~~cl~~dp~~Rps~~~~l~  308 (329)
                      +.+++ +||..+|++||++.++++
T Consensus       238 ~~~li-~~~~~~p~~Rp~~~eil~  260 (266)
T cd06651         238 ARDFL-GCIFVEARHRPSAEELLR  260 (266)
T ss_pred             HHHHH-HHhcCChhhCcCHHHHhc
Confidence            88888 688899999999999998

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development

>cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1

Probab=100.00  E-value=5.9e-41  Score=290.19  Aligned_cols=242  Identities=20%  Similarity=0.223  Sum_probs=198.0

Q ss_pred             cccccCCCCCCcEEEEEEeC-CCCEEEEEEeCCCCC-----hhHHHHHHHHHHHhcCCCccccccceeeeeCCeeEEEEe
Q 020221           60 NIVSEHGEKAPNVVYKGKLE-NQFRIAVKRFNRSAW-----PDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAE  133 (329)
Q Consensus        60 ~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~-----~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  133 (329)
                      ...+.||+|++|.||+|... ++..|++|.+.....     ...+.+.+|+++++.++|+||+++++++..+...++++|
T Consensus         3 ~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e   82 (258)
T cd06632           3 RKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREEDNLYIFLE   82 (258)
T ss_pred             cccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEecCCeEEEEEE
Confidence            34456799999999999954 788999999865431     234568899999999999999999999999999999999


Q ss_pred             cCCCCCHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCCCCCeeeecccCcccCCCC---C
Q 020221          134 YMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDG---R  210 (329)
Q Consensus       134 ~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~---~  210 (329)
                      |+++++|.+++.+  ...+++..+..++.|++.||+|||+. +++|+||+|+||+++.++.+||+|||++......   .
T Consensus        83 ~~~~~~L~~~~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~-~i~H~dl~~~ni~~~~~~~~kl~d~~~~~~~~~~~~~~  159 (258)
T cd06632          83 LVPGGSLAKLLKK--YGSFPEPVIRLYTRQILLGLEYLHDR-NTVHRDIKGANILVDTNGVVKLADFGMAKQVVEFSFAK  159 (258)
T ss_pred             ecCCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHC-CcccCCCCHHHEEECCCCCEEEccCccceecccccccc
Confidence            9999999999863  34688999999999999999999999 9999999999999999999999999998764433   2


Q ss_pred             CccCcccccCcccccCCC-CCCcccchhhhHHHHHHHhCCCCCCchhhHHHhhhchhhhccccccCCCChHHHHHHHHHH
Q 020221          211 SYSTNLAFTPPEYLRTGR-VTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLA  289 (329)
Q Consensus       211 ~~~~~~~y~aPE~~~~~~-~~~~~DvwslG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li  289 (329)
                      ...++..|+|||.+.... ++.++|+||||+++|+|++|..||...........    ..........+...++.+.+++
T Consensus       160 ~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~li  235 (258)
T cd06632         160 SFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEGVAAVFK----IGRSKELPPIPDHLSDEAKDFI  235 (258)
T ss_pred             ccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCcHHHHHHH----HHhcccCCCcCCCcCHHHHHHH
Confidence            345788899999988766 88999999999999999999988754321111100    0110111233455678899999


Q ss_pred             HHhcccCCCCCCCHHHHHH
Q 020221          290 SRCLQYEPRERPNPRSLVT  308 (329)
Q Consensus       290 ~~cl~~dp~~Rps~~~~l~  308 (329)
                      .+||+.+|++||++.+++.
T Consensus       236 ~~~l~~~p~~Rp~~~~~l~  254 (258)
T cd06632         236 LKCLQRDPSLRPTAAELLE  254 (258)
T ss_pred             HHHhhcCcccCcCHHHHhc
Confidence            9999999999999999998

Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops

>KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms]

Probab=100.00  E-value=2e-42  Score=283.89  Aligned_cols=245  Identities=19%  Similarity=0.265  Sum_probs=197.6

Q ss_pred             cccccCCCCCCcEEEEEE-eCCCCEEEEEEeCCCC-ChhHHHHHHHHHHHhcC-CCccccccceeeeeCCeeEEEEecCC
Q 020221           60 NIVSEHGEKAPNVVYKGK-LENQFRIAVKRFNRSA-WPDARQFLEEARAVGQL-RNRRLANLLGCCCEGDERLLVAEYMP  136 (329)
Q Consensus        60 ~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~~  136 (329)
                      +.++.+|.|+.|.|++++ ..+|..+|||.++... ....+.++..+.++..- ++|.||+.+|+|.....+++.||.|.
T Consensus        95 ~~l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~n~dV~IcMelMs  174 (391)
T KOG0983|consen   95 ENLGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVQCFGYFITNTDVFICMELMS  174 (391)
T ss_pred             hhHHhhcCCCccceEEEEEcccceEEEEEeecccCCHHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeCchHHHHHHHHH
Confidence            456778999999999999 5668899999998764 33345567777765554 58999999999999999999999985


Q ss_pred             CCCHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCCCCCeeeecccCcccCCCC---CCcc
Q 020221          137 NDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDG---RSYS  213 (329)
Q Consensus       137 ~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~---~~~~  213 (329)
                      - .+..++++ -.+++++.-+-++...++.||.||..+++|+|||+||+|||+|+.|++|++|||++.+.-+.   ....
T Consensus       175 ~-C~ekLlkr-ik~piPE~ilGk~tva~v~AL~YLKeKH~viHRDvKPSNILlDe~GniKlCDFGIsGrlvdSkAhtrsA  252 (391)
T KOG0983|consen  175 T-CAEKLLKR-IKGPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILLDERGNIKLCDFGISGRLVDSKAHTRSA  252 (391)
T ss_pred             H-HHHHHHHH-hcCCchHHhhhhhHHHHHHHHHHHHHhcceeecccCccceEEccCCCEEeecccccceeeccccccccc
Confidence            4 45565544 45679999999999999999999999999999999999999999999999999998765544   3446


Q ss_pred             CcccccCcccccCC---CCCCcccchhhhHHHHHHHhCCCCCCchhhHHHhhhchhhhccccccCCCChHHHHHHHHHHH
Q 020221          214 TNLAFTPPEYLRTG---RVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLAS  290 (329)
Q Consensus       214 ~~~~y~aPE~~~~~---~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~  290 (329)
                      |.+.|||||-+.-.   .|+-++||||||++|+||.||..|+.....+...-..+..-.++.+++.  ..+++.+++|+.
T Consensus       253 GC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~tdFe~ltkvln~ePP~L~~~--~gFSp~F~~fv~  330 (391)
T KOG0983|consen  253 GCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCKTDFEVLTKVLNEEPPLLPGH--MGFSPDFQSFVK  330 (391)
T ss_pred             CCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCCccHHHHHHHHhcCCCCCCcc--cCcCHHHHHHHH
Confidence            78999999988643   4888999999999999999999998875444333222222222333322  237899999999


Q ss_pred             HhcccCCCCCCCHHHHHH
Q 020221          291 RCLQYEPRERPNPRSLVT  308 (329)
Q Consensus       291 ~cl~~dp~~Rps~~~~l~  308 (329)
                      .||+.|+.+||.+.++++
T Consensus       331 ~CL~kd~r~RP~Y~~Ll~  348 (391)
T KOG0983|consen  331 DCLTKDHRKRPKYNKLLE  348 (391)
T ss_pred             HHhhcCcccCcchHHHhc
Confidence            999999999999999987

>cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase

Probab=100.00  E-value=4.8e-41  Score=295.57  Aligned_cols=239  Identities=17%  Similarity=0.236  Sum_probs=196.9

Q ss_pred             ccCCCCCCcEEEEEE-eCCCCEEEEEEeCCCCChhHHHHHHHHHHHhcCCCccccccceeeeeCCeeEEEEecCCCCCHH
Q 020221           63 SEHGEKAPNVVYKGK-LENQFRIAVKRFNRSAWPDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAEYMPNDTLA  141 (329)
Q Consensus        63 ~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~  141 (329)
                      +.||+|++|.||++. ..+++.+++|.+........+.+.+|+.+++.++|||++++++++...+..++++||+++++|.
T Consensus        25 ~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~~~~~v~e~~~~~~L~  104 (285)
T cd06648          25 VKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVMEFLEGGALT  104 (285)
T ss_pred             eEeccCCCeEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHHcCCCChheEEEEEEcCCeEEEEEeccCCCCHH
Confidence            455999999999998 4578899999987655445566889999999999999999999999999999999999999999


Q ss_pred             hhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCCCCCeeeecccCcccCCCC----CCccCccc
Q 020221          142 KHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDG----RSYSTNLA  217 (329)
Q Consensus       142 ~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~----~~~~~~~~  217 (329)
                      +++..   ..+++..+..++.|++.||+|||+. +++|+||+|+||+++.++.++|+|||++......    ....++..
T Consensus       105 ~~~~~---~~~~~~~~~~~~~ql~~~l~~lH~~-~i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~  180 (285)
T cd06648         105 DIVTH---TRMNEEQIATVCLAVLKALSFLHAQ-GVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVPRRKSLVGTPY  180 (285)
T ss_pred             HHHHh---CCCCHHHHHHHHHHHHHHHHHHHhC-CeecCCCChhhEEEcCCCcEEEcccccchhhccCCcccccccCCcc
Confidence            99853   5689999999999999999999999 9999999999999999999999999987654332    22357889


Q ss_pred             ccCcccccCCCCCCcccchhhhHHHHHHHhCCCCCCchhhHHHhhhchhhhccccccCCCChHHHHHHHHHHHHhcccCC
Q 020221          218 FTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLASRCLQYEP  297 (329)
Q Consensus       218 y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp  297 (329)
                      |+|||.+.+..++.++||||||+++|+|++|..|+............... ....  ...+...+..+.+++.+||+.+|
T Consensus       181 y~aPE~~~~~~~~~~~Dv~slGv~l~ell~g~~p~~~~~~~~~~~~~~~~-~~~~--~~~~~~~~~~l~~li~~~l~~~p  257 (285)
T cd06648         181 WMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFNEPPLQAMKRIRDN-LPPK--LKNLHKVSPRLRSFLDRMLVRDP  257 (285)
T ss_pred             ccCHHHhcCCCCCCcccHHHHHHHHHHHHhCCCCCcCCCHHHHHHHHHhc-CCCC--CcccccCCHHHHHHHHHHcccCh
Confidence            99999998888999999999999999999999887543322111111111 1111  11122356789999999999999


Q ss_pred             CCCCCHHHHHH
Q 020221          298 RERPNPRSLVT  308 (329)
Q Consensus       298 ~~Rps~~~~l~  308 (329)
                      ++||++.++++
T Consensus       258 ~~Rpt~~~il~  268 (285)
T cd06648         258 AQRATAAELLN  268 (285)
T ss_pred             hhCcCHHHHcc
Confidence            99999999997

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun

>cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5

Probab=100.00  E-value=6.6e-41  Score=289.82  Aligned_cols=244  Identities=17%  Similarity=0.254  Sum_probs=199.9

Q ss_pred             ccccccCCCCCCcEEEEEEe-CCCCEEEEEEeCCCCC--hhHHHHHHHHHHHhcCCCccccccceeeeeCCeeEEEEecC
Q 020221           59 ENIVSEHGEKAPNVVYKGKL-ENQFRIAVKRFNRSAW--PDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAEYM  135 (329)
Q Consensus        59 ~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~  135 (329)
                      |.+.+.+|.|+||.||++.. .++..+|+|.+.....  ...+.+.+|+++++.++|+|++++++.+......++++||+
T Consensus         2 ~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~   81 (257)
T cd08225           2 YEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFASFQENGRLFIVMEYC   81 (257)
T ss_pred             ceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccchhhHHHHHHHHHHHhCCCCChhhhhheeccCCeEEEEEecC
Confidence            45566779999999999994 4678899999876422  23456789999999999999999999999999999999999


Q ss_pred             CCCCHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCCCCC-eeeecccCcccCCCCC----
Q 020221          136 PNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVN-PRLSCFGLMKNSRDGR----  210 (329)
Q Consensus       136 ~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~-~kl~Dfg~a~~~~~~~----  210 (329)
                      ++++|.+++.......+++..+..++.|++.||.|||+. +++|+||||+||++++++. ++|+|||.+.......    
T Consensus        82 ~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~-~i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~~~~~  160 (257)
T cd08225          82 DGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIHDR-KILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSMELAY  160 (257)
T ss_pred             CCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHC-CcccccCCHHHEEEcCCCCeEEecccccchhccCCccccc
Confidence            999999998754445689999999999999999999999 9999999999999998864 6999999987655432    


Q ss_pred             CccCcccccCcccccCCCCCCcccchhhhHHHHHHHhCCCCCCchhhHHHhhhchhhhccccccCCCChHHHHHHHHHHH
Q 020221          211 SYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLAS  290 (329)
Q Consensus       211 ~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~  290 (329)
                      ...+++.|+|||++.+..++.++|+||||++++++++|..|+.................     .......+.++.+++.
T Consensus       161 ~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~-----~~~~~~~~~~~~~~i~  235 (257)
T cd08225         161 TCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGNNLHQLVLKICQGYF-----APISPNFSRDLRSLIS  235 (257)
T ss_pred             ccCCCccccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHhcccC-----CCCCCCCCHHHHHHHH
Confidence            23467889999999888899999999999999999999988764433222221111111     1223345678999999


Q ss_pred             HhcccCCCCCCCHHHHHH
Q 020221          291 RCLQYEPRERPNPRSLVT  308 (329)
Q Consensus       291 ~cl~~dp~~Rps~~~~l~  308 (329)
                      +||..+|++|||+.++++
T Consensus       236 ~~l~~~p~~Rpt~~~ll~  253 (257)
T cd08225         236 QLFKVSPRDRPSITSILK  253 (257)
T ss_pred             HHhccChhhCcCHHHHhh
Confidence            999999999999999998

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown.

>cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1

Probab=100.00  E-value=3.2e-41  Score=292.24  Aligned_cols=244  Identities=20%  Similarity=0.220  Sum_probs=201.3

Q ss_pred             ccccccCCCCCCcEEEEEEe-CCCCEEEEEEeCCCCC---hhHHHHHHHHHHHhcCCCccccccceeeeeCCeeEEEEec
Q 020221           59 ENIVSEHGEKAPNVVYKGKL-ENQFRIAVKRFNRSAW---PDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAEY  134 (329)
Q Consensus        59 ~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  134 (329)
                      |++.+.||.|+||.||++.. .+++.||+|.+.....   ...+.+.+|++.++.++||||+++++.+..+...++|+||
T Consensus         2 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   81 (258)
T cd05578           2 FELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQDEENMYLVVDL   81 (258)
T ss_pred             ceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhcCCCeEEEEEeC
Confidence            55677789999999999995 4688999999975432   2356788999999999999999999999999999999999


Q ss_pred             CCCCCHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCCCCCeeeecccCcccCCCC---CC
Q 020221          135 MPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDG---RS  211 (329)
Q Consensus       135 ~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~---~~  211 (329)
                      +.+++|..++..  ...+++..+..++.|++.||.|||+. +++|+||+|+||++++++.++|+|||++......   ..
T Consensus        82 ~~~~~L~~~l~~--~~~l~~~~~~~~~~~i~~~l~~lh~~-~i~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~  158 (258)
T cd05578          82 LLGGDLRYHLSQ--KVKFSEEQVKFWICEIVLALEYLHSK-GIIHRDIKPDNILLDEQGHVHITDFNIATKVTPDTLTTS  158 (258)
T ss_pred             CCCCCHHHHHHh--cCCcCHHHHHHHHHHHHHHHHHHHhC-CeeccCCCHHHeEEcCCCCEEEeecccccccCCCccccc
Confidence            999999999863  35789999999999999999999999 9999999999999999999999999998765543   23


Q ss_pred             ccCcccccCcccccCCCCCCcccchhhhHHHHHHHhCCCCCCchhhHHHhhhchhhhccccccCCCChHHHHHHHHHHHH
Q 020221          212 YSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLASR  291 (329)
Q Consensus       212 ~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~  291 (329)
                      ..++..|+|||.+.+..++.++|+||||+++|+|++|..|+........ .........  .....+...+..+.+++.+
T Consensus       159 ~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~-~~~~~~~~~--~~~~~~~~~~~~~~~~i~~  235 (258)
T cd05578         159 TSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRTIR-DQIRAKQET--ADVLYPATWSTEAIDAINK  235 (258)
T ss_pred             cCCChhhcCHHHHcccCCCCcccchhhHHHHHHHHhCCCCCCCCCccHH-HHHHHHhcc--ccccCcccCcHHHHHHHHH
Confidence            4567889999999888899999999999999999999988765432100 000111110  2223455567899999999


Q ss_pred             hcccCCCCCCCH--HHHHH
Q 020221          292 CLQYEPRERPNP--RSLVT  308 (329)
Q Consensus       292 cl~~dp~~Rps~--~~~l~  308 (329)
                      ||..||++||++  +++++
T Consensus       236 ~l~~~p~~R~~~~~~~l~~  254 (258)
T cd05578         236 LLERDPQKRLGDNLKDLKN  254 (258)
T ss_pred             HccCChhHcCCccHHHHhc
Confidence            999999999999  77665

Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A.

>cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2

Probab=100.00  E-value=1.1e-40  Score=290.07  Aligned_cols=242  Identities=17%  Similarity=0.184  Sum_probs=194.4

Q ss_pred             ccccccCCCCCCcEEEEEE-eCCCCEEEEEEeCCCCC-----hhHHHHHHHHHHHhcCCCccccccceeeeeC--CeeEE
Q 020221           59 ENIVSEHGEKAPNVVYKGK-LENQFRIAVKRFNRSAW-----PDARQFLEEARAVGQLRNRRLANLLGCCCEG--DERLL  130 (329)
Q Consensus        59 ~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~-----~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~--~~~~l  130 (329)
                      +++.+.+|+|+||.||++. ..++..||+|.+.....     ...+.+.+|+++++.++||||+++++++.+.  ..+++
T Consensus         4 ~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~   83 (265)
T cd06652           4 WRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERTLSI   83 (265)
T ss_pred             ceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCCceEEE
Confidence            4556667999999999998 45688999998864321     2245688899999999999999999988663  46789


Q ss_pred             EEecCCCCCHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCCCCCeeeecccCcccCCC--
Q 020221          131 VAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRD--  208 (329)
Q Consensus       131 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~--  208 (329)
                      ++||+++++|.+++.+  ...+++.....++.|++.||.|||+. +++|+||||+||+++.++.++|+|||++.....  
T Consensus        84 v~e~~~~~~L~~~l~~--~~~~~~~~~~~~~~~l~~~l~~lH~~-~i~H~dl~p~nil~~~~~~~~l~Dfg~~~~~~~~~  160 (265)
T cd06652          84 FMEHMPGGSIKDQLKS--YGALTENVTRKYTRQILEGVSYLHSN-MIVHRDIKGANILRDSVGNVKLGDFGASKRLQTIC  160 (265)
T ss_pred             EEEecCCCcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHhC-CEecCCCCHHHEEecCCCCEEECcCcccccccccc
Confidence            9999999999999863  34578889999999999999999999 999999999999999999999999999875432  


Q ss_pred             -----CCCccCcccccCcccccCCCCCCcccchhhhHHHHHHHhCCCCCCchhhHHHhhhchhhhccccccCCCChHHHH
Q 020221          209 -----GRSYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGT  283 (329)
Q Consensus       209 -----~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  283 (329)
                           .....++..|+|||.+.+..++.++||||||+++|+|++|+.|+..........    ...........+...+.
T Consensus       161 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~----~~~~~~~~~~~~~~~~~  236 (265)
T cd06652         161 LSGTGMKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAEFEAMAAIF----KIATQPTNPVLPPHVSD  236 (265)
T ss_pred             ccccccccCCCCccccChhhhcCCCCCcchhHHHHHHHHHHHhhCCCCCCccchHHHHH----HHhcCCCCCCCchhhCH
Confidence                 123457789999999988889999999999999999999998875432111111    11111112334556678


Q ss_pred             HHHHHHHHhcccCCCCCCCHHHHHH
Q 020221          284 ELVRLASRCLQYEPRERPNPRSLVT  308 (329)
Q Consensus       284 ~~~~li~~cl~~dp~~Rps~~~~l~  308 (329)
                      .+.+++.+||. +|++||+++++++
T Consensus       237 ~~~~~i~~~l~-~p~~Rp~~~~il~  260 (265)
T cd06652         237 HCRDFLKRIFV-EAKLRPSADELLR  260 (265)
T ss_pred             HHHHHHHHHhc-ChhhCCCHHHHhc
Confidence            89999999994 9999999999998

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re

>cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4

Probab=100.00  E-value=7.1e-41  Score=292.75  Aligned_cols=249  Identities=20%  Similarity=0.307  Sum_probs=198.9

Q ss_pred             cccccccCCCCCCcEEEEEEeC------CCCEEEEEEeCCCCCh-hHHHHHHHHHHHhcCCCccccccceeeeeCCeeEE
Q 020221           58 MENIVSEHGEKAPNVVYKGKLE------NQFRIAVKRFNRSAWP-DARQFLEEARAVGQLRNRRLANLLGCCCEGDERLL  130 (329)
Q Consensus        58 ~~~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l  130 (329)
                      .+.+++.+|+|+||.||++...      +.+.+++|.+...... ..+.+.+|+++++.++|+||+++++++.+....++
T Consensus         6 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l   85 (275)
T cd05046           6 NLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVVRLLGLCREAEPHYM   85 (275)
T ss_pred             hceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCccchHHHHHHHHHHHHHHhcCCcceeeeEEEECCCCcceE
Confidence            4567778899999999999843      2467999998765433 34678999999999999999999999988889999


Q ss_pred             EEecCCCCCHHhhhccCCC-------CCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCCCCCeeeecccCc
Q 020221          131 VAEYMPNDTLAKHLFHWET-------QPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLM  203 (329)
Q Consensus       131 v~e~~~~gsL~~~l~~~~~-------~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a  203 (329)
                      ||||+++++|.+++.....       ..+++..+..++.|++.||+|||+. +++|+||||+||+++.++.++++|||++
T Consensus        86 v~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~-~i~H~dlkp~Nili~~~~~~~l~~~~~~  164 (275)
T cd05046          86 ILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNA-RFVHRDLAARNCLVSSQREVKVSLLSLS  164 (275)
T ss_pred             EEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhc-CcccCcCccceEEEeCCCcEEEcccccc
Confidence            9999999999999864331       1589999999999999999999999 9999999999999999999999999998


Q ss_pred             ccCCCC-----CCccCcccccCcccccCCCCCCcccchhhhHHHHHHHh-CCCCCCchhhHHHhhhchhhhccccccCCC
Q 020221          204 KNSRDG-----RSYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLS-GKHIPPSHALDLIRDRNIQTLTDSCLEGQF  277 (329)
Q Consensus       204 ~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t-g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  277 (329)
                      ......     ....++..|+|||.+.+..++.++||||||+++|+|++ |..||.............    ........
T Consensus       165 ~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~~~~~p~~~~~~~~~~~~~~----~~~~~~~~  240 (275)
T cd05046         165 KDVYNSEYYKLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSDEEVLNRLQ----AGKLELPV  240 (275)
T ss_pred             cccCcccccccCCceeEEeecChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCccccchHHHHHHHH----cCCcCCCC
Confidence            643321     22244677999999988888899999999999999999 555554322221111111    11111122


Q ss_pred             ChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 020221          278 SSDEGTELVRLASRCLQYEPRERPNPRSLVTALV  311 (329)
Q Consensus       278 ~~~~~~~~~~li~~cl~~dp~~Rps~~~~l~~L~  311 (329)
                      +..++..+.+++.+||..||++|||+.++++.|.
T Consensus       241 ~~~~~~~l~~~i~~~l~~~p~~Rp~~~~~l~~l~  274 (275)
T cd05046         241 PEGCPSRLYKLMTRCWAVNPKDRPSFSELVSALG  274 (275)
T ss_pred             CCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhc
Confidence            3456778999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s

>cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase

Probab=100.00  E-value=8.9e-41  Score=296.66  Aligned_cols=248  Identities=17%  Similarity=0.135  Sum_probs=197.6

Q ss_pred             cccccccCCCCCCcEEEEEE-eCCCCEEEEEEeCCCCC---hhHHHHHHHHHHHhcCCCccccccceeeeeCCeeEEEEe
Q 020221           58 MENIVSEHGEKAPNVVYKGK-LENQFRIAVKRFNRSAW---PDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAE  133 (329)
Q Consensus        58 ~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  133 (329)
                      .|++++.+|+|+||.||++. ..+++.|++|.+.....   .....+.+|+++++.++||||+++++.+..++..++|||
T Consensus         2 ~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e   81 (305)
T cd05609           2 DFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFETKRHLCMVME   81 (305)
T ss_pred             CceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEecCCEEEEEEe
Confidence            35667778999999999999 45678999999876532   224567889999999999999999999999999999999


Q ss_pred             cCCCCCHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCCCCCeeeecccCcccCCCC----
Q 020221          134 YMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDG----  209 (329)
Q Consensus       134 ~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~----  209 (329)
                      |+++++|.+++..  ...+++..+..++.|++.||.|||+. +++|+||||+||++++++.++|+|||+++.....    
T Consensus        82 ~~~g~~L~~~l~~--~~~~~~~~~~~~~~~i~~~l~~lH~~-~i~H~dl~p~NIll~~~~~~~l~dfg~~~~~~~~~~~~  158 (305)
T cd05609          82 YVEGGDCATLLKN--IGALPVDMARMYFAETVLALEYLHNY-GIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTN  158 (305)
T ss_pred             cCCCCcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHC-CccccCCchHHEEECCCCCEEEeeCCCccccCcCcccc
Confidence            9999999999963  35689999999999999999999999 9999999999999999999999999987631100    


Q ss_pred             ---------------CCccCcccccCcccccCCCCCCcccchhhhHHHHHHHhCCCCCCchhhHHHhhhchhhhcccccc
Q 020221          210 ---------------RSYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLE  274 (329)
Q Consensus       210 ---------------~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~  274 (329)
                                     ....++..|+|||.+.+..++.++|+||||+++|+|++|..||..................   .
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~vl~el~~g~~pf~~~~~~~~~~~~~~~~~~---~  235 (305)
T cd05609         159 LYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVISDDIE---W  235 (305)
T ss_pred             ccccccccchhhccccCCccCccccCchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccC---C
Confidence                           1124577899999998888999999999999999999999988654333222222111110   0


Q ss_pred             CCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 020221          275 GQFSSDEGTELVRLASRCLQYEPRERPNPRSLVTALV  311 (329)
Q Consensus       275 ~~~~~~~~~~~~~li~~cl~~dp~~Rps~~~~l~~L~  311 (329)
                      .......+.++.+++.+||+.||++||++.++.+.|+
T Consensus       236 ~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~ll~  272 (305)
T cd05609         236 PEGDEALPADAQDLISRLLRQNPLERLGTGGAFEVKQ  272 (305)
T ss_pred             CCccccCCHHHHHHHHHHhccChhhccCccCHHHHHh
Confidence            1111245778999999999999999999655554443

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a

>cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3

Probab=100.00  E-value=3.4e-41  Score=296.33  Aligned_cols=248  Identities=20%  Similarity=0.265  Sum_probs=195.1

Q ss_pred             cccccccCCCCCCcEEEEEEe-CCCCEEEEEEeCCCCCh--hHHHHHHHHHHHhcCCCccccccceeeeeCCeeEEEEec
Q 020221           58 MENIVSEHGEKAPNVVYKGKL-ENQFRIAVKRFNRSAWP--DARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAEY  134 (329)
Q Consensus        58 ~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~--~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  134 (329)
                      .|++++.||+|+||.||++.. .+++.||+|.+......  ..+.+.+|+++++.++||||+++++++..+...++|+||
T Consensus         2 ~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   81 (286)
T cd07846           2 KYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEVFRRKKRLYLVFEF   81 (286)
T ss_pred             ceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcchhhHHHHHHHHHHHhcCCcchhhHHHhcccCCeEEEEEec
Confidence            356778889999999999995 46889999998654322  245678899999999999999999999999999999999


Q ss_pred             CCCCCHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCCCCCeeeecccCcccCCCCC----
Q 020221          135 MPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDGR----  210 (329)
Q Consensus       135 ~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~----  210 (329)
                      +++++|..+..  ....+++..+..++.|++.||+|||+. +++|+||+|+||++++++.++|+|||++.......    
T Consensus        82 ~~~~~l~~~~~--~~~~~~~~~~~~~~~~i~~~l~~LH~~-~i~h~~l~p~ni~~~~~~~~~l~dfg~~~~~~~~~~~~~  158 (286)
T cd07846          82 VDHTVLDDLEK--YPNGLDESRVRKYLFQILRGIEFCHSH-NIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYT  158 (286)
T ss_pred             CCccHHHHHHh--ccCCCCHHHHHHHHHHHHHHHHHHHHC-CccccCCCHHHEEECCCCcEEEEeeeeeeeccCCccccC
Confidence            99988887764  334589999999999999999999999 99999999999999999999999999987643322    


Q ss_pred             CccCcccccCcccccCC-CCCCcccchhhhHHHHHHHhCCCCCCchhhHHHhhhchh----------------hhccccc
Q 020221          211 SYSTNLAFTPPEYLRTG-RVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQ----------------TLTDSCL  273 (329)
Q Consensus       211 ~~~~~~~y~aPE~~~~~-~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~~~~~~~----------------~~~~~~~  273 (329)
                      ...++..|+|||++.+. .++.++||||||+++|+|++|..|++.............                .......
T Consensus       159 ~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (286)
T cd07846         159 DYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGNLIPRHQEIFQKNPLFAGMR  238 (286)
T ss_pred             cccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHhCCCchhhHHHhccchHhhccc
Confidence            23467889999998754 477899999999999999999977754321110000000                0000000


Q ss_pred             cC---------CCChHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 020221          274 EG---------QFSSDEGTELVRLASRCLQYEPRERPNPRSLVT  308 (329)
Q Consensus       274 ~~---------~~~~~~~~~~~~li~~cl~~dp~~Rps~~~~l~  308 (329)
                      ..         ......+..+.+++.+||..+|++||++.++++
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~  282 (286)
T cd07846         239 LPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLH  282 (286)
T ss_pred             cccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHHhc
Confidence            00         011235678999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI

>cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin

Probab=100.00  E-value=1e-40  Score=293.44  Aligned_cols=247  Identities=14%  Similarity=0.145  Sum_probs=193.2

Q ss_pred             CcccccccCCCCCCcEEEEEE-eCCCCEEEEEEeCCCCChhHHHHHHHHHHHhcC-CCccccccceeee-----eCCeeE
Q 020221           57 AMENIVSEHGEKAPNVVYKGK-LENQFRIAVKRFNRSAWPDARQFLEEARAVGQL-RNRRLANLLGCCC-----EGDERL  129 (329)
Q Consensus        57 ~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~-----~~~~~~  129 (329)
                      ..+++++.||+|+||.||++. ..+++.+|+|.+..... ....+.+|+.+++.+ +||||+++++++.     .+...+
T Consensus        18 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~-~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~~~~   96 (286)
T cd06638          18 DTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIHD-IDEEIEAEYNILKALSDHPNVVKFYGMYYKKDVKNGDQLW   96 (286)
T ss_pred             cceeeeeeeccCCCcEEEEEEECCCCceeEEEeeccccc-hHHHHHHHHHHHHHHhcCCCeeeeeeeeeecccCCCCeEE
Confidence            345677778999999999998 45678999998865432 235678899999999 6999999999874     345789


Q ss_pred             EEEecCCCCCHHhhhccC--CCCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCCCCCeeeecccCcccCC
Q 020221          130 LVAEYMPNDTLAKHLFHW--ETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSR  207 (329)
Q Consensus       130 lv~e~~~~gsL~~~l~~~--~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~  207 (329)
                      ++|||+++++|.+++...  ....+++..+..++.|++.||.|||+. +++|+||||+||+++.++.++|+|||++....
T Consensus        97 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~-~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~  175 (286)
T cd06638          97 LVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVN-KTIHRDVKGNNILLTTEGGVKLVDFGVSAQLT  175 (286)
T ss_pred             EEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHhC-CccccCCCHHhEEECCCCCEEEccCCceeecc
Confidence            999999999999887531  235688999999999999999999999 99999999999999999999999999987644


Q ss_pred             CC----CCccCcccccCcccccC-----CCCCCcccchhhhHHHHHHHhCCCCCCchhhHHHhhhchhhhccccccCCCC
Q 020221          208 DG----RSYSTNLAFTPPEYLRT-----GRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFS  278 (329)
Q Consensus       208 ~~----~~~~~~~~y~aPE~~~~-----~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  278 (329)
                      ..    ....++..|+|||++..     ..++.++||||||+++|+|++|..|+............... ..  .....+
T Consensus       176 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~~~~~~~~~~~-~~--~~~~~~  252 (286)
T cd06638         176 STRLRRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPMRALFKIPRN-PP--PTLHQP  252 (286)
T ss_pred             cCCCccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCchhHHHhhcccc-CC--CcccCC
Confidence            32    23357889999998753     34788999999999999999999887543211111110000 00  011122


Q ss_pred             hHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 020221          279 SDEGTELVRLASRCLQYEPRERPNPRSLVT  308 (329)
Q Consensus       279 ~~~~~~~~~li~~cl~~dp~~Rps~~~~l~  308 (329)
                      ...+.++.+++.+||+.||++|||+.++++
T Consensus       253 ~~~~~~~~~li~~~l~~~p~~Rps~~ell~  282 (286)
T cd06638         253 ELWSNEFNDFIRKCLTKDYEKRPTVSDLLQ  282 (286)
T ss_pred             CCcCHHHHHHHHHHccCCcccCCCHHHHhh
Confidence            334678999999999999999999999998

Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear

>PTZ00266 NIMA-related protein kinase; Provisional

Probab=100.00  E-value=2.7e-41  Score=328.75  Aligned_cols=248  Identities=18%  Similarity=0.217  Sum_probs=194.7

Q ss_pred             CCcccccccCCCCCCcEEEEEE-eCCCCEEEEEEeCCCCC--hhHHHHHHHHHHHhcCCCccccccceeeee--CCeeEE
Q 020221           56 FAMENIVSEHGEKAPNVVYKGK-LENQFRIAVKRFNRSAW--PDARQFLEEARAVGQLRNRRLANLLGCCCE--GDERLL  130 (329)
Q Consensus        56 ~~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~~~~~~~~--~~~~~l  130 (329)
                      +..|.+++.||.|+||+||++. ..++..+|+|.+.....  .....+..|+.+++.++||||+++++++..  ...++|
T Consensus        12 l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de~~~~lyI   91 (1021)
T PTZ00266         12 LNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDRFLNKANQKLYI   91 (1021)
T ss_pred             cCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccccCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEecCCCEEEE
Confidence            4568888999999999999999 45678899999875432  234568899999999999999999998854  356899


Q ss_pred             EEecCCCCCHHhhhccC--CCCCCCHHHHHHHHHHHHHHHHHhhcC------CCccccccCCCceeeCC-----------
Q 020221          131 VAEYMPNDTLAKHLFHW--ETQPMKWAMRLRVALHIAEALEYCTSK------ERALYHDLNAYRIVFDD-----------  191 (329)
Q Consensus       131 v~e~~~~gsL~~~l~~~--~~~~~~~~~~~~i~~~i~~~l~~lH~~------~~ivH~dlkp~Nil~~~-----------  191 (329)
                      ||||+++++|.++|...  ....+++..++.|+.||+.||.|||..      .+|+|+||||+|||++.           
T Consensus        92 VMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~lg~i~~~  171 (1021)
T PTZ00266         92 LMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQ  171 (1021)
T ss_pred             EEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCcccccccccc
Confidence            99999999999998642  235689999999999999999999984      15999999999999964           


Q ss_pred             ------CCCeeeecccCcccCCCC---CCccCcccccCcccccC--CCCCCcccchhhhHHHHHHHhCCCCCCchhhHHH
Q 020221          192 ------DVNPRLSCFGLMKNSRDG---RSYSTNLAFTPPEYLRT--GRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLI  260 (329)
Q Consensus       192 ------~~~~kl~Dfg~a~~~~~~---~~~~~~~~y~aPE~~~~--~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~  260 (329)
                            .+.+||+|||++......   ....+|+.|+|||++.+  ..++.++|||||||+||+|++|..||........
T Consensus       172 ~~n~ng~~iVKLsDFGlAr~l~~~s~~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLTGk~PF~~~~~~~q  251 (1021)
T PTZ00266        172 ANNLNGRPIAKIGDFGLSKNIGIESMAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPFHKANNFSQ  251 (1021)
T ss_pred             ccccCCCCceEEccCCccccccccccccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHHCCCCCCcCCcHHH
Confidence                  345899999998765433   23467999999999864  3488899999999999999999988854321111


Q ss_pred             hhhchhhhccccccCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 020221          261 RDRNIQTLTDSCLEGQFSSDEGTELVRLASRCLQYEPRERPNPRSLVT  308 (329)
Q Consensus       261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~~~l~  308 (329)
                      .   ... +..... ......+.++.+||..||..+|++||++.+++.
T Consensus       252 l---i~~-lk~~p~-lpi~~~S~eL~dLI~~~L~~dPeeRPSa~QlL~  294 (1021)
T PTZ00266        252 L---ISE-LKRGPD-LPIKGKSKELNILIKNLLNLSAKERPSALQCLG  294 (1021)
T ss_pred             H---HHH-HhcCCC-CCcCCCCHHHHHHHHHHhcCChhHCcCHHHHhc
Confidence            0   000 110000 111234678999999999999999999999994

>cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6

Probab=100.00  E-value=6.5e-41  Score=299.00  Aligned_cols=241  Identities=15%  Similarity=0.237  Sum_probs=181.6

Q ss_pred             cCCCCCCcEEEEEEeC---CCCEEEEEEeCCCCChhHHHHHHHHHHHhcCCCccccccceeeee--CCeeEEEEecCCCC
Q 020221           64 EHGEKAPNVVYKGKLE---NQFRIAVKRFNRSAWPDARQFLEEARAVGQLRNRRLANLLGCCCE--GDERLLVAEYMPND  138 (329)
Q Consensus        64 ~lg~G~~g~V~~~~~~---~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~--~~~~~lv~e~~~~g  138 (329)
                      .||+|+||.||+|...   ++..||+|.+.....  ...+.+|+++++.++||||+++++++..  ....++++||+.+ 
T Consensus         8 ~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~~--~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~~-   84 (317)
T cd07867           8 KVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGI--SMSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLFDYAEH-   84 (317)
T ss_pred             EeccCCCeeEEEEEecCCCccceEEEEEecCCCC--cHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEEEeeeCC-
Confidence            5699999999999854   357899999876442  3457789999999999999999998853  4678999999875 


Q ss_pred             CHHhhhccC-------CCCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceee----CCCCCeeeecccCcccCC
Q 020221          139 TLAKHLFHW-------ETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVF----DDDVNPRLSCFGLMKNSR  207 (329)
Q Consensus       139 sL~~~l~~~-------~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~----~~~~~~kl~Dfg~a~~~~  207 (329)
                      +|.+++...       ....+++..+..++.|++.||.|||+. +++||||||+||++    +.++.+||+|||+++...
T Consensus        85 ~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~-~ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~a~~~~  163 (317)
T cd07867          85 DLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHAN-WVLHRDLKPANILVMGEGPERGRVKIADMGFARLFN  163 (317)
T ss_pred             cHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhC-CEEcCCCCHHHEEEccCCCCCCcEEEeeccceeccC
Confidence            787776421       123578899999999999999999999 99999999999999    566789999999997654


Q ss_pred             CC-------CCccCcccccCcccccCC-CCCCcccchhhhHHHHHHHhCCCCCCchhhHHHh---------hh-------
Q 020221          208 DG-------RSYSTNLAFTPPEYLRTG-RVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIR---------DR-------  263 (329)
Q Consensus       208 ~~-------~~~~~~~~y~aPE~~~~~-~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~~---------~~-------  263 (329)
                      ..       ....+|..|+|||++.+. .++.++||||||+++|||+||..||.....+...         ..       
T Consensus       164 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~  243 (317)
T cd07867         164 SPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPFHHDQLDRIFSVMGF  243 (317)
T ss_pred             CCcccccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCcccccccccccccccHHHHHHHHHhcCC
Confidence            32       223568899999998764 4888999999999999999999877432110000         00       


Q ss_pred             ----chhh---------hccccccC------------CCChHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 020221          264 ----NIQT---------LTDSCLEG------------QFSSDEGTELVRLASRCLQYEPRERPNPRSLVT  308 (329)
Q Consensus       264 ----~~~~---------~~~~~~~~------------~~~~~~~~~~~~li~~cl~~dp~~Rps~~~~l~  308 (329)
                          ....         ........            ......+..+.+++.+||..||.+|||+.++++
T Consensus       244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dP~~R~t~~e~l~  313 (317)
T cd07867         244 PADKDWEDIRKMPEYPTLQKDFRRTTYANSSLIKYMEKHKVKPDSKVFLLLQKLLTMDPTKRITSEQALQ  313 (317)
T ss_pred             CChhhhhhhhhcccchhhhhhhcccccCCchhhhhhhcccCCCChHHHHHHHHHhccCcccccCHHHHhc
Confidence                0000         00000000            001112356889999999999999999999998

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as

>cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros

Probab=100.00  E-value=6.8e-41  Score=291.84  Aligned_cols=243  Identities=22%  Similarity=0.347  Sum_probs=195.6

Q ss_pred             cCCCCCCcEEEEEEeCC-------CCEEEEEEeCCCCC-hhHHHHHHHHHHHhcCCCccccccceeeeeCCeeEEEEecC
Q 020221           64 EHGEKAPNVVYKGKLEN-------QFRIAVKRFNRSAW-PDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAEYM  135 (329)
Q Consensus        64 ~lg~G~~g~V~~~~~~~-------~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~  135 (329)
                      .||+|+||.||+|...+       ++.+|+|.+..... .....+.+|+.+++.++||||+++++++......+++|||+
T Consensus         2 ~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~   81 (269)
T cd05044           2 FLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYIIMELM   81 (269)
T ss_pred             ccccccceeEEeeeecccccCcccceeehhhhhhcccchhhHHHHHHHHHHHHhcCCCCeeeEeeeecCCCCeEEEEecc
Confidence            46999999999998532       25799998865432 33557889999999999999999999999888999999999


Q ss_pred             CCCCHHhhhccCC-----CCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCCCC-----CeeeecccCccc
Q 020221          136 PNDTLAKHLFHWE-----TQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDV-----NPRLSCFGLMKN  205 (329)
Q Consensus       136 ~~gsL~~~l~~~~-----~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~-----~~kl~Dfg~a~~  205 (329)
                      ++++|.+++.+..     ...+++.++..++.|++.||.|||+. +++|+||||+||+++.++     .++++|||++..
T Consensus        82 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~-~i~H~dl~p~nil~~~~~~~~~~~~~l~dfg~~~~  160 (269)
T cd05044          82 EGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQM-HFIHRDLAARNCLVSEKGYDADRVVKIGDFGLARD  160 (269)
T ss_pred             CCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhC-CcccCCCChheEEEecCCCCCCcceEECCcccccc
Confidence            9999999986421     23478899999999999999999999 999999999999999877     899999999875


Q ss_pred             CCCCC------CccCcccccCcccccCCCCCCcccchhhhHHHHHHHh-CCCCCCchhhHHHhhhchhhhccccccCCCC
Q 020221          206 SRDGR------SYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLS-GKHIPPSHALDLIRDRNIQTLTDSCLEGQFS  278 (329)
Q Consensus       206 ~~~~~------~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t-g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  278 (329)
                      .....      ....+..|+|||++.+..++.++||||||+++|+|++ |..|++..........     .........+
T Consensus       161 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt~g~~p~~~~~~~~~~~~-----~~~~~~~~~~  235 (269)
T cd05044         161 IYKSDYYRKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALNNQEVLQH-----VTAGGRLQKP  235 (269)
T ss_pred             cccccccccCcccCCCccccCHHHHccCCcccchhHHHHHHHHHHHHHcCCCCCcccCHHHHHHH-----HhcCCccCCc
Confidence            43221      2234578999999998889999999999999999998 8877754322211111     1111112234


Q ss_pred             hHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHh
Q 020221          279 SDEGTELVRLASRCLQYEPRERPNPRSLVTALVT  312 (329)
Q Consensus       279 ~~~~~~~~~li~~cl~~dp~~Rps~~~~l~~L~~  312 (329)
                      ...+..+.+++.+||..+|++||++.++++.|++
T Consensus       236 ~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~  269 (269)
T cd05044         236 ENCPDKIYQLMTNCWAQDPSERPTFDRIQEILQN  269 (269)
T ss_pred             ccchHHHHHHHHHHcCCCcccCCCHHHHHHHHhC
Confidence            4567889999999999999999999999998863

Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male

>cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2

Probab=100.00  E-value=1.3e-40  Score=288.92  Aligned_cols=244  Identities=18%  Similarity=0.242  Sum_probs=201.1

Q ss_pred             ccccccCCCCCCcEEEEEE-eCCCCEEEEEEeCCCCC--hhHHHHHHHHHHHhcCCCccccccceeeee--CCeeEEEEe
Q 020221           59 ENIVSEHGEKAPNVVYKGK-LENQFRIAVKRFNRSAW--PDARQFLEEARAVGQLRNRRLANLLGCCCE--GDERLLVAE  133 (329)
Q Consensus        59 ~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~~~~~~~~--~~~~~lv~e  133 (329)
                      |++++.+|.|+||.||++. ..+++.+|+|.+.....  ...+.+.+|+++++.++|+||+++++++..  +...++++|
T Consensus         2 y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~e   81 (265)
T cd08217           2 YEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIVME   81 (265)
T ss_pred             ceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccCCHHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEEEEeh
Confidence            5677788999999999998 55778999999875432  234568889999999999999999997754  456899999


Q ss_pred             cCCCCCHHhhhccC--CCCCCCHHHHHHHHHHHHHHHHHhh-----cCCCccccccCCCceeeCCCCCeeeecccCcccC
Q 020221          134 YMPNDTLAKHLFHW--ETQPMKWAMRLRVALHIAEALEYCT-----SKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNS  206 (329)
Q Consensus       134 ~~~~gsL~~~l~~~--~~~~~~~~~~~~i~~~i~~~l~~lH-----~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~  206 (329)
                      |+++++|.+++...  ....+++..++.++.|++.||.|||     +. +++|+||+|+||++++++.++|+|||++...
T Consensus        82 ~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~-~i~h~dl~p~nili~~~~~~kl~d~g~~~~~  160 (265)
T cd08217          82 YCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGN-TVLHRDLKPANIFLDANNNVKLGDFGLAKIL  160 (265)
T ss_pred             hccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccC-cceecCCCHHHEEEecCCCEEEecccccccc
Confidence            99999999998642  2457899999999999999999999     87 9999999999999999999999999998876


Q ss_pred             CCCC----CccCcccccCcccccCCCCCCcccchhhhHHHHHHHhCCCCCCchhhHHHhhhchhhhccccccCCCChHHH
Q 020221          207 RDGR----SYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEG  282 (329)
Q Consensus       207 ~~~~----~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  282 (329)
                      ....    ...++..|+|||.+.+..++.++|+||||+++++|++|..|+............     ........+...+
T Consensus       161 ~~~~~~~~~~~~~~~~~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~-----~~~~~~~~~~~~~  235 (265)
T cd08217         161 GHDSSFAKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTARNQLQLASKI-----KEGKFRRIPYRYS  235 (265)
T ss_pred             cCCcccccccccCCCccChhhhcCCCCCchhHHHHHHHHHHHHHHCCCcccCcCHHHHHHHH-----hcCCCCCCccccC
Confidence            5433    345788999999999888999999999999999999999887654322222111     1111223445667


Q ss_pred             HHHHHHHHHhcccCCCCCCCHHHHHH
Q 020221          283 TELVRLASRCLQYEPRERPNPRSLVT  308 (329)
Q Consensus       283 ~~~~~li~~cl~~dp~~Rps~~~~l~  308 (329)
                      .++.+++.+||+.+|++||++.++++
T Consensus       236 ~~~~~l~~~~l~~~p~~Rp~~~~il~  261 (265)
T cd08217         236 SELNEVIKSMLNVDPDKRPSTEELLQ  261 (265)
T ss_pred             HHHHHHHHHHccCCcccCCCHHHHhh
Confidence            88999999999999999999999998

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi

>cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin

Probab=100.00  E-value=8.7e-41  Score=294.69  Aligned_cols=247  Identities=15%  Similarity=0.118  Sum_probs=194.1

Q ss_pred             CcccccccCCCCCCcEEEEEE-eCCCCEEEEEEeCCCCChhHHHHHHHHHHHhcC-CCccccccceeeeeC-----CeeE
Q 020221           57 AMENIVSEHGEKAPNVVYKGK-LENQFRIAVKRFNRSAWPDARQFLEEARAVGQL-RNRRLANLLGCCCEG-----DERL  129 (329)
Q Consensus        57 ~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~-----~~~~  129 (329)
                      ..|.+++.+|+|+||.||++. ..+++.+|+|.+..... ....+.+|+.+++.+ +|||++++++++...     +..+
T Consensus        22 ~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~~-~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~~~~~~~~~~~  100 (291)
T cd06639          22 DTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPISD-VDEEIEAEYNILQSLPNHPNVVKFYGMFYKADKLVGGQLW  100 (291)
T ss_pred             CCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEeccccc-HHHHHHHHHHHHHHhcCCCCeEEEEEEEEeccccCCCeeE
Confidence            345666777999999999999 46788999999875432 245677899999998 799999999998653     3589


Q ss_pred             EEEecCCCCCHHhhhccC--CCCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCCCCCeeeecccCcccCC
Q 020221          130 LVAEYMPNDTLAKHLFHW--ETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSR  207 (329)
Q Consensus       130 lv~e~~~~gsL~~~l~~~--~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~  207 (329)
                      +|+||+++++|.+++...  ....+++..+..++.|++.||.|||+. +++|+||||+||+++.++.++|+|||++....
T Consensus       101 lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~-~ivH~dlkp~nili~~~~~~kl~dfg~~~~~~  179 (291)
T cd06639         101 LVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNN-RIIHRDVKGNNILLTTEGGVKLVDFGVSAQLT  179 (291)
T ss_pred             EEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhC-CeeccCCCHHHEEEcCCCCEEEeecccchhcc
Confidence            999999999999987532  345689999999999999999999999 99999999999999999999999999987544


Q ss_pred             CC----CCccCcccccCcccccCC-----CCCCcccchhhhHHHHHHHhCCCCCCchhhHHHhhhchhhhccccccCCCC
Q 020221          208 DG----RSYSTNLAFTPPEYLRTG-----RVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFS  278 (329)
Q Consensus       208 ~~----~~~~~~~~y~aPE~~~~~-----~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  278 (329)
                      ..    ....++..|+|||.+...     .++.++||||||+++|+|++|..|+..................   ....+
T Consensus       180 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~~~~~~~~~~~~~~---~~~~~  256 (291)
T cd06639         180 STRLRRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPVKTLFKIPRNPPP---TLLHP  256 (291)
T ss_pred             cccccccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCcHHHHHHHHhcCCCC---CCCcc
Confidence            32    233567889999987643     2678999999999999999999887543221111111111000   11123


Q ss_pred             hHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 020221          279 SDEGTELVRLASRCLQYEPRERPNPRSLVT  308 (329)
Q Consensus       279 ~~~~~~~~~li~~cl~~dp~~Rps~~~~l~  308 (329)
                      ...+..+.+++.+||+.||++||++.++++
T Consensus       257 ~~~~~~l~~li~~~l~~~p~~Rps~~~il~  286 (291)
T cd06639         257 EKWCRSFNHFISQCLIKDFEARPSVTHLLE  286 (291)
T ss_pred             cccCHHHHHHHHHHhhcChhhCcCHHHHhc
Confidence            345678999999999999999999999998

Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre

>smart00219 TyrKc Tyrosine kinase, catalytic domain

Probab=100.00  E-value=1.4e-40  Score=287.71  Aligned_cols=244  Identities=28%  Similarity=0.432  Sum_probs=198.2

Q ss_pred             ccccCCCCCCcEEEEEEeCC-----CCEEEEEEeCCCCCh-hHHHHHHHHHHHhcCCCccccccceeeeeCCeeEEEEec
Q 020221           61 IVSEHGEKAPNVVYKGKLEN-----QFRIAVKRFNRSAWP-DARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAEY  134 (329)
Q Consensus        61 ~~~~lg~G~~g~V~~~~~~~-----~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  134 (329)
                      +.+.+|.|+||.||++...+     +..||+|.+...... ..+.+.+|+..++.++|+||+++++++.+.+..+++|||
T Consensus         3 ~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~i~e~   82 (258)
T smart00219        3 LGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDADEQQIEEFLREARIMRKLDHPNIVKLLGVCTEEEPLMIVMEY   82 (258)
T ss_pred             ccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCChHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCeeEEEEec
Confidence            45667999999999999543     378999999766543 466789999999999999999999999998999999999


Q ss_pred             CCCCCHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCCCCCeeeecccCcccCCCCCC---
Q 020221          135 MPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDGRS---  211 (329)
Q Consensus       135 ~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~~---  211 (329)
                      +++++|.+++.......+++.++..++.|++.||+|||+. +++|+||||+||++++++.++|+|||++........   
T Consensus        83 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~-~~~h~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~  161 (258)
T smart00219       83 MEGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLESK-NFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYKK  161 (258)
T ss_pred             cCCCCHHHHHHhhhhccCCHHHHHHHHHHHHHHHHHHhcC-CeeecccccceEEEccCCeEEEcccCCceeccccccccc
Confidence            9999999998643333389999999999999999999999 999999999999999999999999999876554321   


Q ss_pred             --ccCcccccCcccccCCCCCCcccchhhhHHHHHHHh-CCCCCCchhhHHHhhhchhhhccccccCCCChHHHHHHHHH
Q 020221          212 --YSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLS-GKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRL  288 (329)
Q Consensus       212 --~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t-g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  288 (329)
                        ..++..|+|||.+.+..++.++||||+|+++++|++ |..|+..............     ......+...+.++.++
T Consensus       162 ~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~i~~~l~~~g~~p~~~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~  236 (258)
T smart00219      162 KGGKLPIRWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGESPYPGMSNEEVLEYLKK-----GYRLPKPENCPPEIYKL  236 (258)
T ss_pred             ccCCCcccccChHHhccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhc-----CCCCCCCCcCCHHHHHH
Confidence              225678999999988889999999999999999998 5555543322222111111     11122334467889999


Q ss_pred             HHHhcccCCCCCCCHHHHHHHH
Q 020221          289 ASRCLQYEPRERPNPRSLVTAL  310 (329)
Q Consensus       289 i~~cl~~dp~~Rps~~~~l~~L  310 (329)
                      +.+||..||++|||+.++++.|
T Consensus       237 i~~~l~~~p~~Rpt~~~ll~~l  258 (258)
T smart00219      237 MLQCWAEDPEDRPTFSELVEIL  258 (258)
T ss_pred             HHHHCcCChhhCcCHHHHHhhC
Confidence            9999999999999999998764

Phosphotransferases. Tyrosine-specific kinase subfamily.

>cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases

Probab=100.00  E-value=1.2e-40  Score=293.75  Aligned_cols=250  Identities=18%  Similarity=0.261  Sum_probs=193.2

Q ss_pred             CCcccccccCCCCCCcEEEEEEe-CCCCEEEEEEeCCCCCh-hHHHHHHHHHHHhcCCCccccccceeeeeCCeeEEEEe
Q 020221           56 FAMENIVSEHGEKAPNVVYKGKL-ENQFRIAVKRFNRSAWP-DARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAE  133 (329)
Q Consensus        56 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  133 (329)
                      ...|++++.||+|++|.||++.. .+++.||+|.+...... ....+.+|+++++.++|+||+++++++.+....++|||
T Consensus         4 ~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   83 (291)
T cd07844           4 LETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDLKHANIVTLHDIIHTKKTLTLVFE   83 (291)
T ss_pred             ccceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEecccccCCchhHHHHHHHHhhCCCcceeeEEEEEecCCeEEEEEe
Confidence            34577888889999999999994 46889999998754322 22346789999999999999999999999999999999


Q ss_pred             cCCCCCHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCCCCCeeeecccCcccCCCC----
Q 020221          134 YMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDG----  209 (329)
Q Consensus       134 ~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~----  209 (329)
                      |+.+ +|.+++.. ....+++..+..++.|++.||.|||+. +++|+||||+||+++.++.++|+|||++......    
T Consensus        84 ~~~~-~L~~~~~~-~~~~~~~~~~~~~~~ql~~al~~lH~~-~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~  160 (291)
T cd07844          84 YLDT-DLKQYMDD-CGGGLSMHNVRLFLFQLLRGLAYCHQR-RVLHRDLKPQNLLISERGELKLADFGLARAKSVPSKTY  160 (291)
T ss_pred             cCCC-CHHHHHHh-CCCCCCHHHHHHHHHHHHHHHHHHHhC-CeecccCCHHHEEEcCCCCEEECccccccccCCCCccc
Confidence            9985 89998864 334789999999999999999999999 9999999999999999999999999998653321    


Q ss_pred             CCccCcccccCcccccCC-CCCCcccchhhhHHHHHHHhCCCCCCchhh--HHHhhh--c----hhhhccc---------
Q 020221          210 RSYSTNLAFTPPEYLRTG-RVTPESVMYSFGTLLLDLLSGKHIPPSHAL--DLIRDR--N----IQTLTDS---------  271 (329)
Q Consensus       210 ~~~~~~~~y~aPE~~~~~-~~~~~~DvwslG~il~el~tg~~~~~~~~~--~~~~~~--~----~~~~~~~---------  271 (329)
                      ....++..|+|||++.+. .++.++||||+|+++|+|++|..||.....  +.....  .    .......         
T Consensus       161 ~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (291)
T cd07844         161 SNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVEDQLHKIFRVLGTPTEETWPGVSSNPEFKP  240 (291)
T ss_pred             cccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHhcCCCChhhhhhhhhcccccc
Confidence            122357789999998754 488899999999999999999988754321  100000  0    0000000         


Q ss_pred             -ccc----C---CCChHHH--HHHHHHHHHhcccCCCCCCCHHHHHH
Q 020221          272 -CLE----G---QFSSDEG--TELVRLASRCLQYEPRERPNPRSLVT  308 (329)
Q Consensus       272 -~~~----~---~~~~~~~--~~~~~li~~cl~~dp~~Rps~~~~l~  308 (329)
                       ...    .   ......+  .++.+++.+||+.||++|||+.++++
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~Rps~~e~l~  287 (291)
T cd07844         241 YSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMK  287 (291)
T ss_pred             ccccccCChhHHHhCcCCCCchhHHHHHHHHhccCcccccCHHHHhc
Confidence             000    0   0000122  67889999999999999999999998

Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the

>cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4

Probab=100.00  E-value=5.3e-41  Score=295.59  Aligned_cols=249  Identities=18%  Similarity=0.217  Sum_probs=192.5

Q ss_pred             ccccccCCCCCCcEEEEEE-eCCCCEEEEEEeCCCCC-hhHHHHHHHHHHHhcCC-CccccccceeeeeCCeeEEEEecC
Q 020221           59 ENIVSEHGEKAPNVVYKGK-LENQFRIAVKRFNRSAW-PDARQFLEEARAVGQLR-NRRLANLLGCCCEGDERLLVAEYM  135 (329)
Q Consensus        59 ~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~~~~lv~e~~  135 (329)
                      +..++.||+|+||.||++. ..+++.+|+|.+..... .....+.+|+.++..+. |+||+++++++..+...+++|||+
T Consensus         6 ~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~~~~~~e~~   85 (288)
T cd06616           6 LKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGDCWICMELM   85 (288)
T ss_pred             hHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccChHHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCCcEEEEEecc
Confidence            3345667999999999998 45688999999876432 33456889999999996 999999999999889999999998


Q ss_pred             CCCCHHhhh---ccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCCCCCeeeecccCcccCCCC---
Q 020221          136 PNDTLAKHL---FHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDG---  209 (329)
Q Consensus       136 ~~gsL~~~l---~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~---  209 (329)
                      .. ++.++.   .......+++..+..++.|++.||+|||+..+++||||||+||+++.++.++|+|||++......   
T Consensus        86 ~~-~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~  164 (288)
T cd06616          86 DI-SLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEELKIIHRDVKPSNILLDRNGNIKLCDFGISGQLVDSIAK  164 (288)
T ss_pred             cC-CHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhcCCeeccCCCHHHEEEccCCcEEEeecchhHHhccCCcc
Confidence            65 555533   22234678999999999999999999997448999999999999999999999999998754332   


Q ss_pred             CCccCcccccCcccccCC---CCCCcccchhhhHHHHHHHhCCCCCCchhhHHHhhhchhhhccccccCCCChHHHHHHH
Q 020221          210 RSYSTNLAFTPPEYLRTG---RVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELV  286 (329)
Q Consensus       210 ~~~~~~~~y~aPE~~~~~---~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  286 (329)
                      ....++..|+|||++.+.   .++.++||||||+++|+|++|+.||..................+......+...+.++.
T Consensus       165 ~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~  244 (288)
T cd06616         165 TRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWNSVFDQLTQVVKGDPPILSNSEEREFSPSFV  244 (288)
T ss_pred             ccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcchHHHHHhhhcCCCCCcCCCcCCCccCHHHH
Confidence            233567889999998866   58889999999999999999998875432100000000000111111122234678899


Q ss_pred             HHHHHhcccCCCCCCCHHHHHH
Q 020221          287 RLASRCLQYEPRERPNPRSLVT  308 (329)
Q Consensus       287 ~li~~cl~~dp~~Rps~~~~l~  308 (329)
                      +|+.+||+.||++|||+.+++.
T Consensus       245 ~li~~~l~~~p~~Rpt~~~i~~  266 (288)
T cd06616         245 NFINLCLIKDESKRPKYKELLE  266 (288)
T ss_pred             HHHHHHccCChhhCcCHHHHhc
Confidence            9999999999999999999997

Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates

>cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=2.5e-40  Score=291.27  Aligned_cols=248  Identities=17%  Similarity=0.239  Sum_probs=196.6

Q ss_pred             ccccccCCCCCCcEEEEEEe-CCCCEEEEEEeCCCCC-hhHHHHHHHHHHHhcCCCccccccceeeeeC--CeeEEEEec
Q 020221           59 ENIVSEHGEKAPNVVYKGKL-ENQFRIAVKRFNRSAW-PDARQFLEEARAVGQLRNRRLANLLGCCCEG--DERLLVAEY  134 (329)
Q Consensus        59 ~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~--~~~~lv~e~  134 (329)
                      ++.++.||.|++|.||++.. .+++.+|+|.+..... .....+.+|+++++.++||||+++++++.+.  ..+++||||
T Consensus         3 ~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~   82 (287)
T cd06621           3 IVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGIAMEY   82 (287)
T ss_pred             eEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCCchHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeEEEEEEe
Confidence            45667779999999999995 5688999999876533 3355688999999999999999999988553  478999999


Q ss_pred             CCCCCHHhhhccC--CCCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCCCCCeeeecccCcccCCCC--C
Q 020221          135 MPNDTLAKHLFHW--ETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDG--R  210 (329)
Q Consensus       135 ~~~gsL~~~l~~~--~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~--~  210 (329)
                      +++++|.+++...  ....+++..+..++.|++.||.|||+. +++|+||+|+||++++++.++|+|||++......  .
T Consensus        83 ~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~-~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~~  161 (287)
T cd06621          83 CEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSR-KIIHRDIKPSNILLTRKGQVKLCDFGVSGELVNSLAG  161 (287)
T ss_pred             cCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC-CcccCCCCHHHEEEecCCeEEEeeccccccccccccc
Confidence            9999998876431  345688999999999999999999999 9999999999999999999999999998754332  2


Q ss_pred             CccCcccccCcccccCCCCCCcccchhhhHHHHHHHhCCCCCCchhh-----HHHhhhchhhhccccccCCCC--hHHHH
Q 020221          211 SYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHAL-----DLIRDRNIQTLTDSCLEGQFS--SDEGT  283 (329)
Q Consensus       211 ~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~--~~~~~  283 (329)
                      ...++..|+|||.+.+..++.++||||||+++|+|++|..|+.....     ...... ..............  ...++
T Consensus       162 ~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~  240 (287)
T cd06621         162 TFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSY-IVNMPNPELKDEPGNGIKWSE  240 (287)
T ss_pred             cccCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccCCCCChHHHHHH-HhcCCchhhccCCCCCCchHH
Confidence            34567889999999988899999999999999999999988764311     001110 00000011111111  23577


Q ss_pred             HHHHHHHHhcccCCCCCCCHHHHHH
Q 020221          284 ELVRLASRCLQYEPRERPNPRSLVT  308 (329)
Q Consensus       284 ~~~~li~~cl~~dp~~Rps~~~~l~  308 (329)
                      ++.+++.+||..||++|||+.++++
T Consensus       241 ~~~~li~~~l~~~p~~Rpt~~eil~  265 (287)
T cd06621         241 EFKDFIKQCLEKDPTRRPTPWDMLE  265 (287)
T ss_pred             HHHHHHHHHcCCCcccCCCHHHHHh
Confidence            8999999999999999999999998

Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1

Probab=100.00  E-value=7.5e-41  Score=295.40  Aligned_cols=250  Identities=17%  Similarity=0.223  Sum_probs=196.0

Q ss_pred             CCcccccccCCCCCCcEEEEEEe-CCCCEEEEEEeCCCCChh--HHHHHHHHHHHhcCCCccccccceeeeeC--CeeEE
Q 020221           56 FAMENIVSEHGEKAPNVVYKGKL-ENQFRIAVKRFNRSAWPD--ARQFLEEARAVGQLRNRRLANLLGCCCEG--DERLL  130 (329)
Q Consensus        56 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~--~~~~~~e~~~l~~l~h~niv~~~~~~~~~--~~~~l  130 (329)
                      ...|++++.||.|+||.||+|.. .+++.+++|.++......  ...+.+|+.+++.++||||+++.+++...  ...++
T Consensus         4 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~l   83 (293)
T cd07843           4 VDEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVVVGSNLDKIYM   83 (293)
T ss_pred             hhhhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeeccccccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCCCcEEE
Confidence            34567778889999999999995 468899999997553222  23567899999999999999999998777  88999


Q ss_pred             EEecCCCCCHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCCCCCeeeecccCcccCCCC-
Q 020221          131 VAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDG-  209 (329)
Q Consensus       131 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~-  209 (329)
                      |+||+.+ +|.+++.. ....+++..+..++.|++.||+|||+. +++|+||||+||+++.++.++|+|||++...... 
T Consensus        84 v~e~~~~-~L~~~~~~-~~~~l~~~~~~~i~~qi~~aL~~LH~~-~i~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~  160 (293)
T cd07843          84 VMEYVEH-DLKSLMET-MKQPFLQSEVKCLMLQLLSGVAHLHDN-WILHRDLKTSNLLLNNRGILKICDFGLAREYGSPL  160 (293)
T ss_pred             EehhcCc-CHHHHHHh-ccCCCCHHHHHHHHHHHHHHHHHHHHC-CeeeccCCHHHEEECCCCcEEEeecCceeeccCCc
Confidence            9999975 89888864 234689999999999999999999999 9999999999999999999999999998765443 


Q ss_pred             ---CCccCcccccCcccccCCC-CCCcccchhhhHHHHHHHhCCCCCCchhhHHHhhhchh-------------------
Q 020221          210 ---RSYSTNLAFTPPEYLRTGR-VTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQ-------------------  266 (329)
Q Consensus       210 ---~~~~~~~~y~aPE~~~~~~-~~~~~DvwslG~il~el~tg~~~~~~~~~~~~~~~~~~-------------------  266 (329)
                         ....++..|+|||.+.+.. ++.++|+||||+++|+|++|..||..............                   
T Consensus       161 ~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (293)
T cd07843         161 KPYTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKIFKLLGTPTEKIWPGFSELPGA  240 (293)
T ss_pred             cccccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchHHHHHhhccchh
Confidence               2234578899999987654 68899999999999999999987754321111110000                   


Q ss_pred             ------hhccccccCCCChH-HHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 020221          267 ------TLTDSCLEGQFSSD-EGTELVRLASRCLQYEPRERPNPRSLVT  308 (329)
Q Consensus       267 ------~~~~~~~~~~~~~~-~~~~~~~li~~cl~~dp~~Rps~~~~l~  308 (329)
                            ..........++.. .++.+.+++.+||+.||++|||+.++++
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~ell~  289 (293)
T cd07843         241 KKKTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALK  289 (293)
T ss_pred             cccccccccchhhhccccccCCChHHHHHHHHHhccCccccCCHHHHhc
Confidence                  00000111122222 4778999999999999999999999998

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the

>cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases

Probab=100.00  E-value=9.1e-41  Score=293.86  Aligned_cols=248  Identities=20%  Similarity=0.276  Sum_probs=196.8

Q ss_pred             cccccccCCCCCCcEEEEEEe-CCCCEEEEEEeCCCC--ChhHHHHHHHHHHHhcCCCccccccceeeeeCCeeEEEEec
Q 020221           58 MENIVSEHGEKAPNVVYKGKL-ENQFRIAVKRFNRSA--WPDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAEY  134 (329)
Q Consensus        58 ~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  134 (329)
                      .|++.+.||+|+||.||+|.. .+++.||+|.++...  ....+.+.+|+++++.++|+||+++++++..++..++++||
T Consensus         2 ~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~   81 (288)
T cd07833           2 KYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEAFRRKGRLYLVFEY   81 (288)
T ss_pred             ceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcccccchhHHHHHHHHHHhcCCCCeeehhheEEECCEEEEEEec
Confidence            356777889999999999984 468899999987543  22345688999999999999999999999999999999999


Q ss_pred             CCCCCHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCCCCCeeeecccCcccCCCCC----
Q 020221          135 MPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDGR----  210 (329)
Q Consensus       135 ~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~----  210 (329)
                      ++++.+..+..  ....+++..+..++.|++.||.|||.. +++|+||+|+||++++++.++|+|||++.......    
T Consensus        82 ~~~~~l~~~~~--~~~~~~~~~~~~~~~~i~~~l~~LH~~-~i~H~dl~~~ni~~~~~~~~kl~d~g~~~~~~~~~~~~~  158 (288)
T cd07833          82 VERTLLELLEA--SPGGLPPDAVRSYIWQLLQAIAYCHSH-NIIHRDIKPENILVSESGVLKLCDFGFARALRARPASPL  158 (288)
T ss_pred             CCCCHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHC-CeecCCCCHHHeEECCCCCEEEEeeecccccCCCccccc
Confidence            99876665553  345689999999999999999999999 99999999999999999999999999987655432    


Q ss_pred             -CccCcccccCcccccCC-CCCCcccchhhhHHHHHHHhCCCCCCchhhHHHhhhch--------------------h--
Q 020221          211 -SYSTNLAFTPPEYLRTG-RVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNI--------------------Q--  266 (329)
Q Consensus       211 -~~~~~~~y~aPE~~~~~-~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~~~~~~--------------------~--  266 (329)
                       ...++..|+|||++.+. .++.++||||||+++|+|++|..|+.............                    .  
T Consensus       159 ~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (288)
T cd07833         159 TDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCLGPLPPSHQELFSSNPRFAGV  238 (288)
T ss_pred             cCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHhhhcccCcccccc
Confidence             34567889999999888 78899999999999999999998775432110000000                    0  


Q ss_pred             hhccc----cccCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 020221          267 TLTDS----CLEGQFSSDEGTELVRLASRCLQYEPRERPNPRSLVT  308 (329)
Q Consensus       267 ~~~~~----~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~~~l~  308 (329)
                      ...+.    .....++..+++++.+++.+||..+|++|||+++++.
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~  284 (288)
T cd07833         239 AFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQ  284 (288)
T ss_pred             ccCCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhcccHHHHhc
Confidence            00000    0000122334788999999999999999999999997

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning

>cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.5e-40  Score=288.26  Aligned_cols=241  Identities=17%  Similarity=0.164  Sum_probs=191.7

Q ss_pred             ccCCCCCCcEEEEEE-eCCCCEEEEEEeCCCCCh---hHHHHHHHHHHH-hcCCCccccccceeeeeCCeeEEEEecCCC
Q 020221           63 SEHGEKAPNVVYKGK-LENQFRIAVKRFNRSAWP---DARQFLEEARAV-GQLRNRRLANLLGCCCEGDERLLVAEYMPN  137 (329)
Q Consensus        63 ~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~---~~~~~~~e~~~l-~~l~h~niv~~~~~~~~~~~~~lv~e~~~~  137 (329)
                      +.+|.|+||.||+|. ..+++.||+|.+......   ....+..|...+ ...+|+|++++++++...+..++++||+++
T Consensus         2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~   81 (260)
T cd05611           2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYLNG   81 (260)
T ss_pred             ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEEEeccCC
Confidence            457999999999998 456889999998754321   122344555444 445899999999999999999999999999


Q ss_pred             CCHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCCCCCeeeecccCcccCCCCCCccCccc
Q 020221          138 DTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDGRSYSTNLA  217 (329)
Q Consensus       138 gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~  217 (329)
                      ++|.+++.  ....+++..+..++.|++.||.|||+. +++|+||+|+||++++++.++|+|||++..........++..
T Consensus        82 ~~L~~~l~--~~~~~~~~~~~~i~~qi~~aL~~lH~~-~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~  158 (260)
T cd05611          82 GDCASLIK--TLGGLPEDWAKQYIAEVVLGVEDLHQR-GIIHRDIKPENLLIDQTGHLKLTDFGLSRNGLENKKFVGTPD  158 (260)
T ss_pred             CCHHHHHH--HcCCCCHHHHHHHHHHHHHHHHHHHHC-CeecCCCCHHHeEECCCCcEEEeecccceeccccccCCCCcC
Confidence            99999986  335689999999999999999999999 999999999999999999999999999887665556678889


Q ss_pred             ccCcccccCCCCCCcccchhhhHHHHHHHhCCCCCCchhhHHHhhhchhhhccccccCCCChHHHHHHHHHHHHhcccCC
Q 020221          218 FTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLASRCLQYEP  297 (329)
Q Consensus       218 y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp  297 (329)
                      |+|||.+.+..++.++||||||+++|+|++|..|+..................  ........+++++.+++.+||+.||
T Consensus       159 y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~i~~~l~~~p  236 (260)
T cd05611         159 YLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAETPDAVFDNILSRRIN--WPEEVKEFCSPEAVDLINRLLCMDP  236 (260)
T ss_pred             ccChhhhcCCCCcchhhhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcccC--CCCcccccCCHHHHHHHHHHccCCH
Confidence            99999998888899999999999999999999887654333222111111110  1111223457889999999999999


Q ss_pred             CCCCCHHHHHH
Q 020221          298 RERPNPRSLVT  308 (329)
Q Consensus       298 ~~Rps~~~~l~  308 (329)
                      ++||++.++.+
T Consensus       237 ~~R~~~~~~~~  247 (260)
T cd05611         237 AKRLGANGYQE  247 (260)
T ss_pred             HHccCCCcHHH
Confidence            99997765544

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do

>cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase

Probab=100.00  E-value=2.2e-40  Score=291.44  Aligned_cols=247  Identities=17%  Similarity=0.233  Sum_probs=200.9

Q ss_pred             CCcccccccCCCCCCcEEEEEEeC-CCCEEEEEEeCCCCChhHHHHHHHHHHHhcCCCccccccceeeeeCCeeEEEEec
Q 020221           56 FAMENIVSEHGEKAPNVVYKGKLE-NQFRIAVKRFNRSAWPDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAEY  134 (329)
Q Consensus        56 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  134 (329)
                      ...++....+|+|++|.||++... ++..+++|.+..... ..+.+.+|++.++.++|+|++++++.+......++++||
T Consensus        18 ~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~   96 (286)
T cd06614          18 RELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQ-NKELIINEILIMKDCKHPNIVDYYDSYLVGDELWVVMEY   96 (286)
T ss_pred             cccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCch-hHHHHHHHHHHHHHCCCCCeeEEEEEEEECCEEEEEEec
Confidence            344556667799999999999954 678999999986554 456788999999999999999999999999999999999


Q ss_pred             CCCCCHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCCCCCeeeecccCcccCCCC----C
Q 020221          135 MPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDG----R  210 (329)
Q Consensus       135 ~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~----~  210 (329)
                      +++++|.+++.... ..+++..+..++.|++.||.|||+. |++|+||+|+||+++.++.++|+|||++......    .
T Consensus        97 ~~~~~L~~~l~~~~-~~l~~~~~~~i~~~i~~~L~~lH~~-gi~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~~~  174 (286)
T cd06614          97 MDGGSLTDIITQNF-VRMNEPQIAYVCREVLQGLEYLHSQ-NVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEKSKRN  174 (286)
T ss_pred             cCCCcHHHHHHHhc-cCCCHHHHHHHHHHHHHHHHHHHhC-CeeeCCCChhhEEEcCCCCEEECccchhhhhccchhhhc
Confidence            99999999997422 3789999999999999999999998 9999999999999999999999999987654332    2


Q ss_pred             CccCcccccCcccccCCCCCCcccchhhhHHHHHHHhCCCCCCchhhHHHhhhchhhhccccccCCCChHHHHHHHHHHH
Q 020221          211 SYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLAS  290 (329)
Q Consensus       211 ~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~  290 (329)
                      ...++..|+|||.+.+..++.++|+||||+++|+|++|..|+..................   ....+..++.++.+++.
T Consensus       175 ~~~~~~~y~~PE~~~~~~~~~~~Dv~slGvil~~l~~g~~p~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~l~~li~  251 (286)
T cd06614         175 SVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLREPPLRALFLITTKGIP---PLKNPEKWSPEFKDFLN  251 (286)
T ss_pred             cccCCcccCCHhHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCC---CCcchhhCCHHHHHHHH
Confidence            234678899999998888999999999999999999999877543221111111111111   11112235678999999


Q ss_pred             HhcccCCCCCCCHHHHHH
Q 020221          291 RCLQYEPRERPNPRSLVT  308 (329)
Q Consensus       291 ~cl~~dp~~Rps~~~~l~  308 (329)
                      +||+.+|.+||++.+++.
T Consensus       252 ~~l~~~p~~Rpt~~~il~  269 (286)
T cd06614         252 KCLVKDPEKRPSAEELLQ  269 (286)
T ss_pred             HHhccChhhCcCHHHHhh
Confidence            999999999999999986

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou

>cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase

Probab=100.00  E-value=1.5e-40  Score=288.63  Aligned_cols=239  Identities=16%  Similarity=0.188  Sum_probs=196.3

Q ss_pred             CCCCCCcEEEEEEe-CCCCEEEEEEeCCCCC---hhHHHHHHHHHHHhcCCCccccccceeeeeCCeeEEEEecCCCCCH
Q 020221           65 HGEKAPNVVYKGKL-ENQFRIAVKRFNRSAW---PDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAEYMPNDTL  140 (329)
Q Consensus        65 lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL  140 (329)
                      ||.|++|.||++.. .+++.+|+|.+.....   ...+.+.+|+++++.++||||+++++.+.++...++++||+++++|
T Consensus         1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L   80 (262)
T cd05572           1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYMLMEYCLGGEL   80 (262)
T ss_pred             CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCccEEEEecCCCCcH
Confidence            59999999999995 4588999999876432   2345688999999999999999999999999999999999999999


Q ss_pred             HhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCCCCCeeeecccCcccCCCC---CCccCccc
Q 020221          141 AKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDG---RSYSTNLA  217 (329)
Q Consensus       141 ~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~---~~~~~~~~  217 (329)
                      .+++.+  ...+++..+..++.|++.||.|||+. +++|+||+|+||+++.++.++|+|||++......   ....++..
T Consensus        81 ~~~l~~--~~~l~~~~~~~~~~~i~~~l~~lH~~-~~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~  157 (262)
T cd05572          81 WTILRD--RGLFDEYTARFYIACVVLAFEYLHNR-GIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQKTWTFCGTPE  157 (262)
T ss_pred             HHHHhh--cCCCCHHHHHHHHHHHHHHHHHHhhC-CcccCCCCHHHEEEcCCCCEEEeeCCcccccCcccccccccCCcC
Confidence            999963  34689999999999999999999999 9999999999999999999999999998866543   23456788


Q ss_pred             ccCcccccCCCCCCcccchhhhHHHHHHHhCCCCCCchhhHHHhhhchhhhccccccCCCChHHHHHHHHHHHHhcccCC
Q 020221          218 FTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLASRCLQYEP  297 (329)
Q Consensus       218 y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp  297 (329)
                      |+|||.+.+..++.++|+||||+++|+|++|..|+.....+..  ...............+...++++.+++.+||..||
T Consensus       158 ~~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p  235 (262)
T cd05572         158 YVAPEIILNKGYDFSVDYWSLGILLYELLTGRPPFGEDDEDPM--EIYNDILKGNGKLEFPNYIDKAAKDLIKQLLRRNP  235 (262)
T ss_pred             ccChhHhcCCCCCChhhhhhhHHHHHHHHhCCCCcCCCCCCHH--HHHHHHhccCCCCCCCcccCHHHHHHHHHHccCCh
Confidence            9999999888899999999999999999999988765431110  00111111112223444457899999999999999


Q ss_pred             CCCCC-----HHHHHH
Q 020221          298 RERPN-----PRSLVT  308 (329)
Q Consensus       298 ~~Rps-----~~~~l~  308 (329)
                      ++||+     +.++++
T Consensus       236 ~~R~~~~~~~~~~l~~  251 (262)
T cd05572         236 EERLGNLKGGIKDIKK  251 (262)
T ss_pred             hhCcCCcccCHHHHhc
Confidence            99999     778777

Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi

>cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase

Probab=100.00  E-value=1.2e-40  Score=291.77  Aligned_cols=241  Identities=18%  Similarity=0.242  Sum_probs=193.7

Q ss_pred             CCCCCCcEEEEEE-eCCCCEEEEEEeCCCCC---hhHHHHHHHHHHHhcCCCccccccceeeeeCCeeEEEEecCCCCCH
Q 020221           65 HGEKAPNVVYKGK-LENQFRIAVKRFNRSAW---PDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAEYMPNDTL  140 (329)
Q Consensus        65 lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL  140 (329)
                      ||+|+||+||++. ..+++.+|+|.+.....   .....+.+|+++++.++|||++++.+++...+..++||||+++++|
T Consensus         1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L   80 (277)
T cd05577           1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLVMTLMNGGDL   80 (277)
T ss_pred             CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCCeEEEEEecCCCCcH
Confidence            5899999999998 45688999999865321   2234567899999999999999999999999999999999999999


Q ss_pred             HhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCCCCCeeeecccCcccCCCC---CCccCccc
Q 020221          141 AKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDG---RSYSTNLA  217 (329)
Q Consensus       141 ~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~---~~~~~~~~  217 (329)
                      .+++.+.....+++..+..++.|++.||.|||+. +++|+||+|+||++++++.++|+|||.+......   ....++..
T Consensus        81 ~~~l~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~-~i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~  159 (277)
T cd05577          81 KYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQR-RIVYRDLKPENVLLDDHGNVRISDLGLAVELKGGKKIKGRAGTPG  159 (277)
T ss_pred             HHHHHHcCcCCCCHHHHHHHHHHHHHHHHHHHhC-CcccCCCCHHHEEECCCCCEEEccCcchhhhccCCccccccCCCC
Confidence            9998754445789999999999999999999999 9999999999999999999999999998754432   22356778


Q ss_pred             ccCcccccCCCCCCcccchhhhHHHHHHHhCCCCCCchhhHHHhhhchhhhccccccCCCChHHHHHHHHHHHHhcccCC
Q 020221          218 FTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLASRCLQYEP  297 (329)
Q Consensus       218 y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp  297 (329)
                      |+|||++.+..++.++||||||+++++|++|+.||..................  .....+...++.+.+++.+||+.||
T Consensus       160 y~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~li~~~l~~~p  237 (277)
T cd05577         160 YMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQRKEKVEKEELKRRTLE--MAVEYPDKFSPEAKDLCEALLQKDP  237 (277)
T ss_pred             cCCHHHhcCCCCCchhhhHHHHHHHHHHhhCCCCCCCCcccccHHHHHhcccc--ccccCCccCCHHHHHHHHHHccCCh
Confidence            99999998888999999999999999999999887543221111111111111  1122344567899999999999999


Q ss_pred             CCCC-----CHHHHHH
Q 020221          298 RERP-----NPRSLVT  308 (329)
Q Consensus       298 ~~Rp-----s~~~~l~  308 (329)
                      ++||     ++.+++.
T Consensus       238 ~~R~~~~~~~~~~ll~  253 (277)
T cd05577         238 EKRLGCRGGSADEVRE  253 (277)
T ss_pred             hHccCCCcccHHHHHh
Confidence            9999     6666765

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of

>cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins

Probab=100.00  E-value=2.4e-40  Score=287.35  Aligned_cols=242  Identities=19%  Similarity=0.292  Sum_probs=202.0

Q ss_pred             ccccccCCCCCCcEEEEEEeC-CCCEEEEEEeCCCCC-hhHHHHHHHHHHHhcCCCccccccceeeeeCCeeEEEEecCC
Q 020221           59 ENIVSEHGEKAPNVVYKGKLE-NQFRIAVKRFNRSAW-PDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAEYMP  136 (329)
Q Consensus        59 ~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~  136 (329)
                      +++.+.||.|++|.||++... +++.|++|++..... .....+.+|+..+..++|+|++++++++......++++||++
T Consensus         3 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~   82 (264)
T cd06623           3 LERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGAFYKEGEISIVLEYMD   82 (264)
T ss_pred             ceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCeeeEEEEEccCCeEEEEEEecC
Confidence            456677799999999999954 589999999887654 335678999999999999999999999999999999999999


Q ss_pred             CCCHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhc-CCCccccccCCCceeeCCCCCeeeecccCcccCCCCC----C
Q 020221          137 NDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTS-KERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDGR----S  211 (329)
Q Consensus       137 ~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~-~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~----~  211 (329)
                      +++|.+++..  ...+++..+..++.|++.||.|||+ . +++|+||+|+||+++.++.++|+|||.+.......    .
T Consensus        83 ~~~L~~~l~~--~~~l~~~~~~~~~~~l~~~l~~lh~~~-~~~H~~l~~~ni~~~~~~~~~l~df~~~~~~~~~~~~~~~  159 (264)
T cd06623          83 GGSLADLLKK--VGKIPEPVLAYIARQILKGLDYLHTKR-HIIHRDIKPSNLLINSKGEVKIADFGISKVLENTLDQCNT  159 (264)
T ss_pred             CCcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHhccC-CCccCCCCHHHEEECCCCCEEEccCccceecccCCCcccc
Confidence            9999999963  3678999999999999999999999 8 99999999999999999999999999987654432    2


Q ss_pred             ccCcccccCcccccCCCCCCcccchhhhHHHHHHHhCCCCCCchh---hHHHhhhchhhhccccccCCCChH-HHHHHHH
Q 020221          212 YSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHA---LDLIRDRNIQTLTDSCLEGQFSSD-EGTELVR  287 (329)
Q Consensus       212 ~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~  287 (329)
                      ..++..|+|||.+.+..++.++|+||||+++|+|++|..|+....   .......    +... .....+.. .+..+.+
T Consensus       160 ~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~----~~~~-~~~~~~~~~~~~~l~~  234 (264)
T cd06623         160 FVGTVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFPFLPPGQPSFFELMQA----ICDG-PPPSLPAEEFSPEFRD  234 (264)
T ss_pred             eeecccccCHhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCccccccCHHHHHHH----HhcC-CCCCCCcccCCHHHHH
Confidence            346788999999998889999999999999999999998875442   1111111    1111 11122333 6788999


Q ss_pred             HHHHhcccCCCCCCCHHHHHH
Q 020221          288 LASRCLQYEPRERPNPRSLVT  308 (329)
Q Consensus       288 li~~cl~~dp~~Rps~~~~l~  308 (329)
                      ++.+||..+|++||++.++++
T Consensus       235 li~~~l~~~p~~R~~~~~ll~  255 (264)
T cd06623         235 FISACLQKDPKKRPSAAELLQ  255 (264)
T ss_pred             HHHHHccCChhhCCCHHHHHh
Confidence            999999999999999999998

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of

>KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=3.4e-41  Score=299.87  Aligned_cols=245  Identities=17%  Similarity=0.200  Sum_probs=197.6

Q ss_pred             CcccccccCCCCCCcEEEEEEeCCCCEEEEEEeCCCC--ChhHHHHHHHHHHHhcCC-CccccccceeeeeCCeeEEEEe
Q 020221           57 AMENIVSEHGEKAPNVVYKGKLENQFRIAVKRFNRSA--WPDARQFLEEARAVGQLR-NRRLANLLGCCCEGDERLLVAE  133 (329)
Q Consensus        57 ~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~~~~lv~e  133 (329)
                      ..|+++++||.|+-+.||++...+..-+|+|++....  .+...-|.+|+..|.+|+ |.+|+++++|-..++.+|+|||
T Consensus       361 ~~Yeilk~iG~GGSSkV~kV~~s~~~iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~d~~lYmvmE  440 (677)
T KOG0596|consen  361 REYEILKQIGSGGSSKVFKVLNSDKQIYALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVTDGYLYMVME  440 (677)
T ss_pred             chhhHHHhhcCCCcceeeeeecCCCcchhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEeeeeccCceEEEEee
Confidence            4578899999999999999997777788888875542  334667999999999995 9999999999999999999999


Q ss_pred             cCCCCCHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCCCCCeeeecccCcccCCCCC---
Q 020221          134 YMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDGR---  210 (329)
Q Consensus       134 ~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~---  210 (329)
                      |-+. +|...|.+.......| .+..+.+||+.++.++|.. ||||.||||.|+|+- .|.+||+|||+|.......   
T Consensus       441 ~Gd~-DL~kiL~k~~~~~~~~-~lk~ywkqML~aV~~IH~~-gIVHSDLKPANFLlV-kG~LKLIDFGIA~aI~~DTTsI  516 (677)
T KOG0596|consen  441 CGDI-DLNKILKKKKSIDPDW-FLKFYWKQMLLAVKTIHQH-GIVHSDLKPANFLLV-KGRLKLIDFGIANAIQPDTTSI  516 (677)
T ss_pred             cccc-cHHHHHHhccCCCchH-HHHHHHHHHHHHHHHHHHh-ceeecCCCcccEEEE-eeeEEeeeechhcccCccccce
Confidence            9755 8999997643333334 8889999999999999999 999999999999997 6899999999998776653   


Q ss_pred             ---CccCcccccCcccccCC-----------CCCCcccchhhhHHHHHHHhCCCCCCchhhHHHhhhchhhhccccccCC
Q 020221          211 ---SYSTNLAFTPPEYLRTG-----------RVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQ  276 (329)
Q Consensus       211 ---~~~~~~~y~aPE~~~~~-----------~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~  276 (329)
                         ++.||+.||+||.+...           +..+++||||||||||+|+.|+.||..-.   .....+..+.++...-+
T Consensus       517 ~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~~---n~~aKl~aI~~P~~~Ie  593 (677)
T KOG0596|consen  517 VKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQII---NQIAKLHAITDPNHEIE  593 (677)
T ss_pred             eeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHHH---HHHHHHHhhcCCCcccc
Confidence               56899999999988532           26789999999999999999997764321   01123444555543333


Q ss_pred             CChHHH-HHHHHHHHHhcccCCCCCCCHHHHHH
Q 020221          277 FSSDEG-TELVRLASRCLQYEPRERPNPRSLVT  308 (329)
Q Consensus       277 ~~~~~~-~~~~~li~~cl~~dp~~Rps~~~~l~  308 (329)
                      ++..-+ .++.++++.||+.||++||+..++|+
T Consensus       594 fp~~~~~~~li~~mK~CL~rdPkkR~si~eLLq  626 (677)
T KOG0596|consen  594 FPDIPENDELIDVMKCCLARDPKKRWSIPELLQ  626 (677)
T ss_pred             ccCCCCchHHHHHHHHHHhcCcccCCCcHHHhc
Confidence            443222 34999999999999999999999998

>PHA03210 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=5e-41  Score=316.42  Aligned_cols=249  Identities=16%  Similarity=0.179  Sum_probs=182.7

Q ss_pred             CcccccccCCCCCCcEEEEEEeC--CCCEEEEE------------------EeCCCCChhHHHHHHHHHHHhcCCCcccc
Q 020221           57 AMENIVSEHGEKAPNVVYKGKLE--NQFRIAVK------------------RFNRSAWPDARQFLEEARAVGQLRNRRLA  116 (329)
Q Consensus        57 ~~~~~~~~lg~G~~g~V~~~~~~--~~~~vavK------------------~~~~~~~~~~~~~~~e~~~l~~l~h~niv  116 (329)
                      ..|++++.||+|+||+||++...  ++...+.|                  .+.. .......+.+|+++++.++||||+
T Consensus       148 ~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~-~~~~~~~~~~Ei~il~~l~HpnIv  226 (501)
T PHA03210        148 AHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKA-GSRAAIQLENEILALGRLNHENIL  226 (501)
T ss_pred             hccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhc-chHHHHHHHHHHHHHHhCCCCCcC
Confidence            46888899999999999998742  22222222                  1111 112244578999999999999999


Q ss_pred             ccceeeeeCCeeEEEEecCCCCCHHhhhccCC---CCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCCCC
Q 020221          117 NLLGCCCEGDERLLVAEYMPNDTLAKHLFHWE---TQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDV  193 (329)
Q Consensus       117 ~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~---~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~  193 (329)
                      ++++++...+..+++++++.+ +|..++....   ........+..++.||+.||.|||++ ||+||||||+|||++.++
T Consensus       227 ~l~~~~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~~-gIiHrDLKP~NILl~~~~  304 (501)
T PHA03210        227 KIEEILRSEANTYMITQKYDF-DLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDK-KLIHRDIKLENIFLNCDG  304 (501)
T ss_pred             cEeEEEEECCeeEEEEecccc-CHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHhC-CeecCCCCHHHEEECCCC
Confidence            999999999999999999865 6777764321   12234567788999999999999999 999999999999999999


Q ss_pred             CeeeecccCcccCCCCC-----CccCcccccCcccccCCCCCCcccchhhhHHHHHHHhCCCCCCchhh----HHHhhhc
Q 020221          194 NPRLSCFGLMKNSRDGR-----SYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHAL----DLIRDRN  264 (329)
Q Consensus       194 ~~kl~Dfg~a~~~~~~~-----~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~----~~~~~~~  264 (329)
                      .+||+|||++.......     ...|+..|+|||++.+..++.++|||||||++|||++|..+|.....    .......
T Consensus       305 ~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~~~~~p~~~~~~~~~~~~~~~~  384 (501)
T PHA03210        305 KIVLGDFGTAMPFEKEREAFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLSHDFCPIGDGGGKPGKQLLKII  384 (501)
T ss_pred             CEEEEeCCCceecCcccccccccccCCcCCCCchhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCccCCCCCHHHHHHHHH
Confidence            99999999997654432     24689999999999998999999999999999999999865432211    0000000


Q ss_pred             -h-----h----------hhcccc-c---cCCCC-----hHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 020221          265 -I-----Q----------TLTDSC-L---EGQFS-----SDEGTELVRLASRCLQYEPRERPNPRSLVT  308 (329)
Q Consensus       265 -~-----~----------~~~~~~-~---~~~~~-----~~~~~~~~~li~~cl~~dp~~Rps~~~~l~  308 (329)
                       .     .          ..+... .   ....+     ...+.++.+++.+||+.||++|||+.+++.
T Consensus       385 ~~~~~~~~~~p~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~li~kmL~~DP~~Rpsa~elL~  453 (501)
T PHA03210        385 DSLSVCDEEFPDPPCKLFDYIDSAEIDHAGHSVPPLIRNLGLPADFEYPLVKMLTFDWHLRPGAAELLA  453 (501)
T ss_pred             HhcccChhhcCCcHHHHHHHhhhhhcccCccchhhHHHhcCCChHHHHHHHHHhccCcccCcCHHHHhh
Confidence             0     0          000000 0   00000     113456788899999999999999999997

>cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4

Probab=100.00  E-value=2.3e-40  Score=292.12  Aligned_cols=239  Identities=17%  Similarity=0.229  Sum_probs=196.3

Q ss_pred             ccCCCCCCcEEEEEEe-CCCCEEEEEEeCCCCChhHHHHHHHHHHHhcCCCccccccceeeeeCCeeEEEEecCCCCCHH
Q 020221           63 SEHGEKAPNVVYKGKL-ENQFRIAVKRFNRSAWPDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAEYMPNDTLA  141 (329)
Q Consensus        63 ~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~  141 (329)
                      ..||+|+||.||++.. .+++.||+|++..........+.+|+.+++.++|+|++++++.+..++..+++|||+++++|.
T Consensus        26 ~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~  105 (292)
T cd06657          26 IKIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGALT  105 (292)
T ss_pred             HHcCCCCCeEEEEEEEcCCCeEEEEEEecccchhHHHHHHHHHHHHHhcCCcchhheeeEEEeCCEEEEEEecCCCCcHH
Confidence            3569999999999984 578899999987655445567889999999999999999999999999999999999999999


Q ss_pred             hhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCCCCCeeeecccCcccCCCC----CCccCccc
Q 020221          142 KHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDG----RSYSTNLA  217 (329)
Q Consensus       142 ~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~----~~~~~~~~  217 (329)
                      +++.   ...+++..+..++.|++.||+|||+. |++|+||+|+||+++.++.++|+|||++......    ....++..
T Consensus       106 ~~~~---~~~~~~~~~~~~~~ql~~~l~~lH~~-givH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~  181 (292)
T cd06657         106 DIVT---HTRMNEEQIAAVCLAVLKALSVLHAQ-GVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKSLVGTPY  181 (292)
T ss_pred             HHHh---cCCCCHHHHHHHHHHHHHHHHHHHHC-CeecCCCCHHHEEECCCCCEEEcccccceecccccccccccccCcc
Confidence            9874   34689999999999999999999999 9999999999999999999999999987654332    22456788


Q ss_pred             ccCcccccCCCCCCcccchhhhHHHHHHHhCCCCCCchhhHHHhhhchhhhccccccCCCChHHHHHHHHHHHHhcccCC
Q 020221          218 FTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLASRCLQYEP  297 (329)
Q Consensus       218 y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp  297 (329)
                      |+|||.+.+..++.++|+||||+++|+|++|..|+............... .....  ......++.+.+++.+||+.||
T Consensus       182 y~~pE~~~~~~~~~~~Dv~slGvil~el~tg~~p~~~~~~~~~~~~~~~~-~~~~~--~~~~~~~~~l~~li~~~l~~~P  258 (292)
T cd06657         182 WMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDN-LPPKL--KNLHKVSPSLKGFLDRLLVRDP  258 (292)
T ss_pred             ccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhh-CCccc--CCcccCCHHHHHHHHHHHhCCc
Confidence            99999998888899999999999999999999887654322211111111 11111  0123356788999999999999


Q ss_pred             CCCCCHHHHHH
Q 020221          298 RERPNPRSLVT  308 (329)
Q Consensus       298 ~~Rps~~~~l~  308 (329)
                      .+||++.+++.
T Consensus       259 ~~R~~~~~ll~  269 (292)
T cd06657         259 AQRATAAELLK  269 (292)
T ss_pred             ccCcCHHHHhc
Confidence            99999999997

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo

>cd05122 PKc_STE Catalytic domain of STE family Protein Kinases

Probab=100.00  E-value=3.7e-40  Score=283.65  Aligned_cols=245  Identities=18%  Similarity=0.239  Sum_probs=202.5

Q ss_pred             ccccccCCCCCCcEEEEEEe-CCCCEEEEEEeCCCCChhHHHHHHHHHHHhcCCCccccccceeeeeCCeeEEEEecCCC
Q 020221           59 ENIVSEHGEKAPNVVYKGKL-ENQFRIAVKRFNRSAWPDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAEYMPN  137 (329)
Q Consensus        59 ~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~  137 (329)
                      |.+.+.+|+|++|.||++.. .+++.+++|++..........+.+|++.++.++|+|++++++.+......++++||+++
T Consensus         2 y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~   81 (253)
T cd05122           2 FEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYGSYLKKDELWIVMEFCSG   81 (253)
T ss_pred             ceeeeeeccCCceEEEEEEECCCCcEEEEEEecccchhHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEecCCC
Confidence            45566779999999999995 46889999999876654567789999999999999999999999988999999999999


Q ss_pred             CCHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCCCCCeeeecccCcccCCCC---CCccC
Q 020221          138 DTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDG---RSYST  214 (329)
Q Consensus       138 gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~---~~~~~  214 (329)
                      ++|.+++... ...+++..+..++.|++.||.+||.. +++|+||+|+||++++++.++|+|||.+......   ....+
T Consensus        82 ~~L~~~~~~~-~~~~~~~~~~~i~~~i~~~l~~lh~~-~i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~~~~~~  159 (253)
T cd05122          82 GSLKDLLKST-NQTLTESQIAYVCKELLKGLEYLHSN-GIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKARNTMVG  159 (253)
T ss_pred             CcHHHHHhhc-CCCCCHHHHHHHHHHHHHHHHHhhcC-CEecCCCCHHHEEEccCCeEEEeeccccccccccccccceec
Confidence            9999998642 25789999999999999999999998 9999999999999999999999999998776654   34567


Q ss_pred             cccccCcccccCCCCCCcccchhhhHHHHHHHhCCCCCCchhhHHHhhhchhhhccccccCCCChHHHHHHHHHHHHhcc
Q 020221          215 NLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLASRCLQ  294 (329)
Q Consensus       215 ~~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~  294 (329)
                      +..|+|||.+.+..++.++|+||||+++++|++|..|+...................   ...+...+..+.+++.+||+
T Consensus       160 ~~~~~~PE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~i~~~l~  236 (253)
T cd05122         160 TPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPPYSELPPMKALFKIATNGPPG---LRNPEKWSDEFKDFLKKCLQ  236 (253)
T ss_pred             CCcccCHHHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhcCCCC---cCcccccCHHHHHHHHHHcc
Confidence            889999999988889999999999999999999998876542111111111100110   01112236789999999999


Q ss_pred             cCCCCCCCHHHHHH
Q 020221          295 YEPRERPNPRSLVT  308 (329)
Q Consensus       295 ~dp~~Rps~~~~l~  308 (329)
                      .||++|||+.+++.
T Consensus       237 ~~p~~R~t~~~~l~  250 (253)
T cd05122         237 KNPEKRPTAEQLLK  250 (253)
T ss_pred             CChhhCCCHHHHhc
Confidence            99999999999998

Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core

>cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7

Probab=100.00  E-value=1.8e-40  Score=293.67  Aligned_cols=247  Identities=20%  Similarity=0.189  Sum_probs=193.5

Q ss_pred             ccccccCCCCCCcEEEEEEe-CCCCEEEEEEeCCCCCh-----hHHHHHHHHHHHhcCCCccccccceeeeeCCeeEEEE
Q 020221           59 ENIVSEHGEKAPNVVYKGKL-ENQFRIAVKRFNRSAWP-----DARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVA  132 (329)
Q Consensus        59 ~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~-----~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~  132 (329)
                      |++++.||.|++|.||+|.. .+++.||+|.+......     ....+..|+++++.++|+||+++++++.+....++||
T Consensus         2 y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~   81 (298)
T cd07841           2 YEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGHKSNINLVF   81 (298)
T ss_pred             ceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeecCCEEEEEE
Confidence            45566789999999999994 56889999999765432     2345678999999999999999999999989999999


Q ss_pred             ecCCCCCHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCCCCCeeeecccCcccCCCCC--
Q 020221          133 EYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDGR--  210 (329)
Q Consensus       133 e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~--  210 (329)
                      ||+ +++|.+++.+. ...+++..+..++.||+.||.|||++ +++|+||+|+||+++.++.++|+|||++.......  
T Consensus        82 e~~-~~~L~~~i~~~-~~~~~~~~~~~~~~qi~~al~~lH~~-~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~~~  158 (298)
T cd07841          82 EFM-ETDLEKVIKDK-SIVLTPADIKSYMLMTLRGLEYLHSN-WILHRDLKPNNLLIASDGVLKLADFGLARSFGSPNRK  158 (298)
T ss_pred             ccc-CCCHHHHHhcc-CCCCCHHHHHHHHHHHHHHHHHHHhC-CeeecCCChhhEEEcCCCCEEEccceeeeeccCCCcc
Confidence            999 88999999642 23689999999999999999999999 99999999999999999999999999987654432  


Q ss_pred             --CccCcccccCcccccC-CCCCCcccchhhhHHHHHHHhCCCCCCchhhHHHhhhchhh-----------------hcc
Q 020221          211 --SYSTNLAFTPPEYLRT-GRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQT-----------------LTD  270 (329)
Q Consensus       211 --~~~~~~~y~aPE~~~~-~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~~~~~~~~-----------------~~~  270 (329)
                        ...++..|+|||.+.+ ..++.++|+||||+++++|++|..++...............                 ...
T Consensus       159 ~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (298)
T cd07841         159 MTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDIDQLGKIFEALGTPTEENWPGVTSLPDYVE  238 (298)
T ss_pred             ccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCccHHHHHHHHHHcCCCchhhhhhccccccccc
Confidence              2245678999998865 35788999999999999999997655432211110000000                 000


Q ss_pred             ccccC-----CCChHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 020221          271 SCLEG-----QFSSDEGTELVRLASRCLQYEPRERPNPRSLVT  308 (329)
Q Consensus       271 ~~~~~-----~~~~~~~~~~~~li~~cl~~dp~~Rps~~~~l~  308 (329)
                      .....     ......+..+.+++.+||+.||++|||+.++++
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~  281 (298)
T cd07841         239 FKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALE  281 (298)
T ss_pred             ccccCCcchhhhcccccHHHHHHHHHHhcCCcccCcCHHHHhh
Confidence            00000     011234678999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is

>cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase

Probab=100.00  E-value=3.1e-40  Score=285.31  Aligned_cols=244  Identities=20%  Similarity=0.244  Sum_probs=204.9

Q ss_pred             ccccccCCCCCCcEEEEEEe-CCCCEEEEEEeCCCCC--hhHHHHHHHHHHHhcCCCccccccceeeeeCCeeEEEEecC
Q 020221           59 ENIVSEHGEKAPNVVYKGKL-ENQFRIAVKRFNRSAW--PDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAEYM  135 (329)
Q Consensus        59 ~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~  135 (329)
                      |.+.+.+|.|+||.||++.. .+++.+++|++.....  ...+.+.+|++.++.++|+|++++.+.+......++++||+
T Consensus         2 y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~lv~e~~   81 (258)
T cd08215           2 YEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYESFEEKGKLCIVMEYA   81 (258)
T ss_pred             ceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccCChHHHHHHHHHHHHHHhcCCCChhheEEEEecCCEEEEEEEec
Confidence            45667789999999999994 4688999999986543  34567889999999999999999999999999999999999


Q ss_pred             CCCCHHhhhccCC--CCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCCCCCeeeecccCcccCCCCC---
Q 020221          136 PNDTLAKHLFHWE--TQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDGR---  210 (329)
Q Consensus       136 ~~gsL~~~l~~~~--~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~---  210 (329)
                      ++++|.+++.+..  ...+++..+..++.+++.||.|||+. +++|+||+|+||+++.++.++|+|||++.......   
T Consensus        82 ~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~-~~~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~  160 (258)
T cd08215          82 DGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSR-KILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTVDLA  160 (258)
T ss_pred             CCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHhC-CEecccCChHHeEEcCCCcEEECCccceeecccCccee
Confidence            9999999987532  46789999999999999999999999 99999999999999999999999999987654442   


Q ss_pred             -CccCcccccCcccccCCCCCCcccchhhhHHHHHHHhCCCCCCchhhHHHhhhchhhhccccccCCCChHHHHHHHHHH
Q 020221          211 -SYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLA  289 (329)
Q Consensus       211 -~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li  289 (329)
                       ...+++.|+|||.+.+..++.++|+||+|+++++|++|..|+................     ....+...+.++.+++
T Consensus       161 ~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~i  235 (258)
T cd08215         161 KTVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGENLLELALKILKGQ-----YPPIPSQYSSELRNLV  235 (258)
T ss_pred             cceeeeecccChhHhccCCCCccccHHHHHHHHHHHHcCCCCCCCCcHHHHHHHHhcCC-----CCCCCCCCCHHHHHHH
Confidence             2356788999999988889999999999999999999998875543332222221111     2233446678899999


Q ss_pred             HHhcccCCCCCCCHHHHHH
Q 020221          290 SRCLQYEPRERPNPRSLVT  308 (329)
Q Consensus       290 ~~cl~~dp~~Rps~~~~l~  308 (329)
                      .+||..+|++|||+.++++
T Consensus       236 ~~~l~~~p~~Rp~~~~ll~  254 (258)
T cd08215         236 SSLLQKDPEERPSIAQILQ  254 (258)
T ss_pred             HHHcCCChhhCcCHHHHhc
Confidence            9999999999999999998

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They

>cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.9e-40  Score=289.17  Aligned_cols=241  Identities=18%  Similarity=0.247  Sum_probs=196.1

Q ss_pred             ccccccCCCCCCcEEEEEE-eCCCCEEEEEEeCCCC-ChhHHHHHHHHHHHhcCC---CccccccceeeeeCCeeEEEEe
Q 020221           59 ENIVSEHGEKAPNVVYKGK-LENQFRIAVKRFNRSA-WPDARQFLEEARAVGQLR---NRRLANLLGCCCEGDERLLVAE  133 (329)
Q Consensus        59 ~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~---h~niv~~~~~~~~~~~~~lv~e  133 (329)
                      |++++.+|+|+||.||+|. ..+++.+|+|.+.... ......+.+|+.+++.++   |||++++++++..+...+++||
T Consensus         3 y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~~~~lv~e   82 (277)
T cd06917           3 YQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGPRLWIIME   82 (277)
T ss_pred             hhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCCCchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCCEEEEEEe
Confidence            4566778999999999999 4678899999987643 233556888999999986   9999999999999999999999


Q ss_pred             cCCCCCHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCCCCCeeeecccCcccCCCCC---
Q 020221          134 YMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDGR---  210 (329)
Q Consensus       134 ~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~---  210 (329)
                      |+++++|.+++..   ..+++..+..++.|++.||.|||+. +++|+||+|+||++++++.++|+|||++.......   
T Consensus        83 ~~~~~~L~~~~~~---~~l~~~~~~~i~~~i~~~l~~lh~~-~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~~~  158 (277)
T cd06917          83 YAEGGSVRTLMKA---GPIAEKYISVIIREVLVALKYIHKV-GVIHRDIKAANILVTNTGNVKLCDFGVAALLNQNSSKR  158 (277)
T ss_pred             cCCCCcHHHHHHc---cCCCHHHHHHHHHHHHHHHHHHHhC-CcccCCcCHHHEEEcCCCCEEEccCCceeecCCCcccc
Confidence            9999999999843   4789999999999999999999999 99999999999999999999999999987654432   


Q ss_pred             -CccCcccccCcccccCC-CCCCcccchhhhHHHHHHHhCCCCCCchhhHHHhhhchhhhccccccCCCCh-HHHHHHHH
Q 020221          211 -SYSTNLAFTPPEYLRTG-RVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSS-DEGTELVR  287 (329)
Q Consensus       211 -~~~~~~~y~aPE~~~~~-~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~  287 (329)
                       ...++..|+|||.+.++ .++.++|+||||+++|+|++|..|+............     ........+. ..+.++.+
T Consensus       159 ~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~  233 (277)
T cd06917         159 STFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAFRAMMLI-----PKSKPPRLEDNGYSKLLRE  233 (277)
T ss_pred             ccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCChhhhhhcc-----ccCCCCCCCcccCCHHHHH
Confidence             23577889999988754 4788999999999999999999887543222111110     0001111222 25678999


Q ss_pred             HHHHhcccCCCCCCCHHHHHH
Q 020221          288 LASRCLQYEPRERPNPRSLVT  308 (329)
Q Consensus       288 li~~cl~~dp~~Rps~~~~l~  308 (329)
                      ++..||..||++||++.+++.
T Consensus       234 ~i~~~l~~~p~~R~~~~~il~  254 (277)
T cd06917         234 FVAACLDEEPKERLSAEELLK  254 (277)
T ss_pred             HHHHHcCCCcccCcCHHHHhh
Confidence            999999999999999999986

Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent

>cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3

Probab=100.00  E-value=3e-40  Score=289.23  Aligned_cols=242  Identities=16%  Similarity=0.247  Sum_probs=199.3

Q ss_pred             ccccccCCCCCCcEEEEEEe-CCCCEEEEEEeCCCCC-hhHHHHHHHHHHHhcCCCccccccceeeeeCCeeEEEEecCC
Q 020221           59 ENIVSEHGEKAPNVVYKGKL-ENQFRIAVKRFNRSAW-PDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAEYMP  136 (329)
Q Consensus        59 ~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~  136 (329)
                      +.+++.||.|+||.||+|.. .++..+|+|.+..... .....+.+|+..++.++||||+++++++..+...++|+||++
T Consensus         6 ~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~   85 (277)
T cd06641           6 FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYLG   85 (277)
T ss_pred             hhhheeEeecCCeEEEEEEECCCCcEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCEeEEEEEEEeCCeEEEEEEeCC
Confidence            45667789999999999984 5688999999865432 234568899999999999999999999999999999999999


Q ss_pred             CCCHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCCCCCeeeecccCcccCCCCC----Cc
Q 020221          137 NDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDGR----SY  212 (329)
Q Consensus       137 ~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~----~~  212 (329)
                      +++|.+++.   ...+++..+..++.|++.|+.|||+. +++|+||+|+||+++.++.++|+|||++.......    ..
T Consensus        86 ~~~l~~~i~---~~~~~~~~~~~~~~~l~~~l~~lh~~-~i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~~~~~~~~~~~  161 (277)
T cd06641          86 GGSALDLLE---PGPLDETQIATILREILKGLDYLHSE-KKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTF  161 (277)
T ss_pred             CCcHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHccC-CeecCCCCHHhEEECCCCCEEEeecccceecccchhhhccc
Confidence            999999884   45689999999999999999999999 99999999999999999999999999987544322    23


Q ss_pred             cCcccccCcccccCCCCCCcccchhhhHHHHHHHhCCCCCCchhhHHHhhhchhhhccccccCCCChHHHHHHHHHHHHh
Q 020221          213 STNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLASRC  292 (329)
Q Consensus       213 ~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~c  292 (329)
                      .++..|+|||.+.+..++.++|+||||+++|+|++|..|+...........     .........+...+.++.+++.+|
T Consensus       162 ~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~i~~~  236 (277)
T cd06641         162 VGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHSELHPMKVLFL-----IPKNNPPTLEGNYSKPLKEFVEAC  236 (277)
T ss_pred             cCCccccChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCccchHHHHHH-----HhcCCCCCCCcccCHHHHHHHHHH
Confidence            567889999999888889999999999999999999987754322111111     111112223445678899999999


Q ss_pred             cccCCCCCCCHHHHHHH
Q 020221          293 LQYEPRERPNPRSLVTA  309 (329)
Q Consensus       293 l~~dp~~Rps~~~~l~~  309 (329)
                      |..+|++||++.+++++
T Consensus       237 l~~~p~~Rp~~~~~l~~  253 (277)
T cd06641         237 LNKEPSFRPTAKELLKH  253 (277)
T ss_pred             ccCChhhCcCHHHHHhC
Confidence            99999999999999984

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int

>cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1

Probab=100.00  E-value=6e-40  Score=292.89  Aligned_cols=250  Identities=17%  Similarity=0.227  Sum_probs=201.4

Q ss_pred             ccccccCCCCCCcEEEEEE-eCCCCEEEEEEeCCCCC---hhHHHHHHHHHHHhcCCCccccccceeeeeCCeeEEEEec
Q 020221           59 ENIVSEHGEKAPNVVYKGK-LENQFRIAVKRFNRSAW---PDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAEY  134 (329)
Q Consensus        59 ~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  134 (329)
                      +..++.||+|+||.||++. ..++..+|+|.+.....   .....+.+|+++++.++|+|++++++++.++...++||||
T Consensus        27 f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~  106 (317)
T cd06635          27 FTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLVMEY  106 (317)
T ss_pred             hhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCeEEEEEeC
Confidence            4456677999999999999 45688999999875432   2245688899999999999999999999999999999999


Q ss_pred             CCCCCHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCCCCCeeeecccCcccCCCCCCccC
Q 020221          135 MPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDGRSYST  214 (329)
Q Consensus       135 ~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~~~  214 (329)
                      +.+ +|.+.+.. ....+++.++..++.|++.||.|||+. +++|+||+|+||+++.++.++|+|||++..........+
T Consensus       107 ~~g-~l~~~~~~-~~~~l~~~~~~~i~~~i~~~l~~lH~~-~i~H~dL~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~  183 (317)
T cd06635         107 CLG-SASDLLEV-HKKPLQEVEIAAITHGALQGLAYLHSH-NMIHRDIKAGNILLTEPGQVKLADFGSASIASPANSFVG  183 (317)
T ss_pred             CCC-CHHHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHHC-CcccCCCCcccEEECCCCCEEEecCCCccccCCcccccC
Confidence            975 78777643 345689999999999999999999999 999999999999999999999999999887766666778


Q ss_pred             cccccCccccc---CCCCCCcccchhhhHHHHHHHhCCCCCCchhhHHHhhhchhhhccccccCCCChHHHHHHHHHHHH
Q 020221          215 NLAFTPPEYLR---TGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLASR  291 (329)
Q Consensus       215 ~~~y~aPE~~~---~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~  291 (329)
                      +..|+|||++.   ++.++.++||||||+++|+|++|..|+.............    ............++.+.+++.+
T Consensus       184 ~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~----~~~~~~~~~~~~~~~l~~li~~  259 (317)
T cd06635         184 TPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIA----QNESPTLQSNEWSDYFRNFVDS  259 (317)
T ss_pred             CccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHH----hccCCCCCCccccHHHHHHHHH
Confidence            89999999874   4568889999999999999999998875432211111111    1111111233456789999999


Q ss_pred             hcccCCCCCCCHHHHHHHHHhhhh
Q 020221          292 CLQYEPRERPNPRSLVTALVTLQK  315 (329)
Q Consensus       292 cl~~dp~~Rps~~~~l~~L~~~~~  315 (329)
                      ||+.+|++||++.++++++-.+..
T Consensus       260 ~l~~~p~~Rpt~~~il~~~~~~~~  283 (317)
T cd06635         260 CLQKIPQDRPTSEELLKHMFVLRE  283 (317)
T ss_pred             HccCCcccCcCHHHHHhChhhhcc
Confidence            999999999999999986554443

Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron

>cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10

Probab=100.00  E-value=3.7e-40  Score=287.28  Aligned_cols=249  Identities=17%  Similarity=0.262  Sum_probs=198.5

Q ss_pred             ccccccCCCCCCcEEEEEEeCC--CCEEEEEEeCCCC----------ChhHHHHHHHHHHHhc-CCCccccccceeeeeC
Q 020221           59 ENIVSEHGEKAPNVVYKGKLEN--QFRIAVKRFNRSA----------WPDARQFLEEARAVGQ-LRNRRLANLLGCCCEG  125 (329)
Q Consensus        59 ~~~~~~lg~G~~g~V~~~~~~~--~~~vavK~~~~~~----------~~~~~~~~~e~~~l~~-l~h~niv~~~~~~~~~  125 (329)
                      |.+.+.||+|+||.||++....  ++.+|+|.+....          .....++.+|+.++.. ++||||+++++++...
T Consensus         2 y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~   81 (269)
T cd08528           2 YAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLEN   81 (269)
T ss_pred             chhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEccC
Confidence            4566778999999999999543  6889999886432          1223456778888765 6999999999999999


Q ss_pred             CeeEEEEecCCCCCHHhhhccC--CCCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCCCCCeeeecccCc
Q 020221          126 DERLLVAEYMPNDTLAKHLFHW--ETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLM  203 (329)
Q Consensus       126 ~~~~lv~e~~~~gsL~~~l~~~--~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a  203 (329)
                      +..+++|||+++++|.+++...  ....+++..++.++.|++.||.|||+..+++|+||+|+||+++.++.++|+|||.+
T Consensus        82 ~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~i~H~dl~~~nil~~~~~~~~l~dfg~~  161 (269)
T cd08528          82 DRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKEKRIVHRDLTPNNIMLGEDDKVTITDFGLA  161 (269)
T ss_pred             CeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccCCceeecCCCHHHEEECCCCcEEEecccce
Confidence            9999999999999999887432  34568999999999999999999996338999999999999999999999999998


Q ss_pred             ccCCCC---CCccCcccccCcccccCCCCCCcccchhhhHHHHHHHhCCCCCCchhhHHHhhhchhhhccccccCCCChH
Q 020221          204 KNSRDG---RSYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSD  280 (329)
Q Consensus       204 ~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  280 (329)
                      ......   ....++..|+|||.+.+..++.++|+||||+++|+|++|..|+..................    ......
T Consensus       162 ~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~~----~~~~~~  237 (269)
T cd08528         162 KQKQPESKLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTNMLSLATKIVEAVYE----PLPEGM  237 (269)
T ss_pred             eecccccccccccCcccCcChhhhcCCCCchHHHHHHHHHHHHHHHhCCCcccccCHHHHHHHHhhccCC----cCCccc
Confidence            765543   2345678899999999888999999999999999999999877544332222221111111    111223


Q ss_pred             HHHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 020221          281 EGTELVRLASRCLQYEPRERPNPRSLVTALV  311 (329)
Q Consensus       281 ~~~~~~~li~~cl~~dp~~Rps~~~~l~~L~  311 (329)
                      .++.+.+++.+||+.||++||++.++..++.
T Consensus       238 ~~~~l~~li~~cl~~~p~~Rp~~~e~~~~~~  268 (269)
T cd08528         238 YSEDVTDVITSCLTPDAEARPDIIQVSAMIS  268 (269)
T ss_pred             CCHHHHHHHHHHCCCCCccCCCHHHHHHHhc
Confidence            5678999999999999999999999998875

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24.

>cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6

Probab=100.00  E-value=2.4e-40  Score=290.57  Aligned_cols=244  Identities=19%  Similarity=0.268  Sum_probs=191.0

Q ss_pred             cccccccCCCCCCcEEEEEEe-CCCCEEEEEEeCCCCC-hhHHHHHHHHHH-HhcCCCccccccceeeeeCCeeEEEEec
Q 020221           58 MENIVSEHGEKAPNVVYKGKL-ENQFRIAVKRFNRSAW-PDARQFLEEARA-VGQLRNRRLANLLGCCCEGDERLLVAEY  134 (329)
Q Consensus        58 ~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~-~~~~~~~~e~~~-l~~l~h~niv~~~~~~~~~~~~~lv~e~  134 (329)
                      ++.+++.||+|+||.||++.. .+|+.||+|.+..... .....+..|+.. ++.++|||++++++++......++++||
T Consensus         2 ~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~~~~lv~e~   81 (283)
T cd06617           2 DLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFYGALFREGDVWICMEV   81 (283)
T ss_pred             CceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCcHHHHHHHHHHHHHHHHcCCCCeeeeeEEEecCCcEEEEhhh
Confidence            356677789999999999994 5689999999876532 223445566665 6667899999999999999999999999


Q ss_pred             CCCCCHHhhhccC--CCCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCCCCCeeeecccCcccCCCCC--
Q 020221          135 MPNDTLAKHLFHW--ETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDGR--  210 (329)
Q Consensus       135 ~~~gsL~~~l~~~--~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~--  210 (329)
                      ++ ++|.+++...  ....+++..++.++.|++.||.|||++.+++|+||||+||+++.++.+||+|||++.......  
T Consensus        82 ~~-~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~i~h~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~  160 (283)
T cd06617          82 MD-TSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKLSVIHRDVKPSNVLINRNGQVKLCDFGISGYLVDSVAK  160 (283)
T ss_pred             hc-ccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhcCCeecCCCCHHHEEECCCCCEEEeeccccccccccccc
Confidence            97 5888877542  235689999999999999999999985489999999999999999999999999987654322  


Q ss_pred             -CccCcccccCcccccC----CCCCCcccchhhhHHHHHHHhCCCCCCchh--hHHHhhhchhhhccccccCCC-ChHHH
Q 020221          211 -SYSTNLAFTPPEYLRT----GRVTPESVMYSFGTLLLDLLSGKHIPPSHA--LDLIRDRNIQTLTDSCLEGQF-SSDEG  282 (329)
Q Consensus       211 -~~~~~~~y~aPE~~~~----~~~~~~~DvwslG~il~el~tg~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~-~~~~~  282 (329)
                       ...++..|+|||.+.+    ..++.++|+||||+++|+|++|..|+....  .+...     ..... ..... ....+
T Consensus       161 ~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~-----~~~~~-~~~~~~~~~~~  234 (283)
T cd06617         161 TIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTPFQQLK-----QVVEE-PSPQLPAEKFS  234 (283)
T ss_pred             ccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCccccCHHHHH-----HHHhc-CCCCCCccccC
Confidence             2356788999998865    346889999999999999999998875321  11111     11111 11111 12357


Q ss_pred             HHHHHHHHHhcccCCCCCCCHHHHHH
Q 020221          283 TELVRLASRCLQYEPRERPNPRSLVT  308 (329)
Q Consensus       283 ~~~~~li~~cl~~dp~~Rps~~~~l~  308 (329)
                      .++.+++.+||..+|++||++.++++
T Consensus       235 ~~l~~li~~~l~~~p~~Rp~~~~il~  260 (283)
T cd06617         235 PEFQDFVNKCLKKNYKERPNYPELLQ  260 (283)
T ss_pred             HHHHHHHHHHccCChhhCcCHHHHhc
Confidence            78999999999999999999999997

Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs

>cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3

Probab=100.00  E-value=2.4e-40  Score=290.19  Aligned_cols=238  Identities=18%  Similarity=0.186  Sum_probs=186.8

Q ss_pred             CCCCCCcEEEEEEe-CCCCEEEEEEeCCCCCh---hHHHHHHHHHHHh---cCCCccccccceeeeeCCeeEEEEecCCC
Q 020221           65 HGEKAPNVVYKGKL-ENQFRIAVKRFNRSAWP---DARQFLEEARAVG---QLRNRRLANLLGCCCEGDERLLVAEYMPN  137 (329)
Q Consensus        65 lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~---~~~~~~~e~~~l~---~l~h~niv~~~~~~~~~~~~~lv~e~~~~  137 (329)
                      ||+|+||.||++.. .+++.+|+|.+......   ....+.+|..+++   ...|||++.+.+++...+..++||||+++
T Consensus         2 lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~   81 (279)
T cd05633           2 IGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILDLMNG   81 (279)
T ss_pred             cccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEEEEecCCC
Confidence            59999999999984 56889999998654321   1222344444333   34799999999999888999999999999


Q ss_pred             CCHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCCCCCeeeecccCcccCCCC--CCccCc
Q 020221          138 DTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDG--RSYSTN  215 (329)
Q Consensus       138 gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~--~~~~~~  215 (329)
                      ++|.+++.  ....+++..+..++.|++.||.|||+. +++|+||||+||++++++.++|+|||++......  ....++
T Consensus        82 ~~L~~~i~--~~~~l~~~~~~~i~~qi~~al~~lH~~-~ivH~dikp~Nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~  158 (279)
T cd05633          82 GDLHYHLS--QHGVFSEKEMRFYATEIILGLEHMHNR-FVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASVGT  158 (279)
T ss_pred             CCHHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHHC-CcCCCCCCHHHEEECCCCCEEEccCCcceeccccCccCcCCC
Confidence            99999886  345689999999999999999999999 9999999999999999999999999998654332  234578


Q ss_pred             ccccCcccccC-CCCCCcccchhhhHHHHHHHhCCCCCCchhhHHHhhhchhhhccccccCCCChHHHHHHHHHHHHhcc
Q 020221          216 LAFTPPEYLRT-GRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLASRCLQ  294 (329)
Q Consensus       216 ~~y~aPE~~~~-~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~  294 (329)
                      ..|+|||.+.+ ..++.++|+||||+++|+|++|..||..........  ..... .......+...+.++.+++.+||.
T Consensus       159 ~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~--~~~~~-~~~~~~~~~~~~~~~~~li~~~l~  235 (279)
T cd05633         159 HGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHE--IDRMT-LTVNVELPDSFSPELKSLLEGLLQ  235 (279)
T ss_pred             cCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcCHHH--HHHHh-hcCCcCCccccCHHHHHHHHHHhc
Confidence            99999998864 458899999999999999999998875432111100  00000 011223445677899999999999


Q ss_pred             cCCCCCC-----CHHHHHH
Q 020221          295 YEPRERP-----NPRSLVT  308 (329)
Q Consensus       295 ~dp~~Rp-----s~~~~l~  308 (329)
                      .||++||     |++++++
T Consensus       236 ~~p~~R~~~~~~~~~~~~~  254 (279)
T cd05633         236 RDVSKRLGCLGRGAQEVKE  254 (279)
T ss_pred             CCHHHhcCCCCCCHHHHHh
Confidence            9999999     5998887

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi

>cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase

Probab=100.00  E-value=4.7e-40  Score=290.03  Aligned_cols=249  Identities=17%  Similarity=0.190  Sum_probs=191.7

Q ss_pred             CcccccccCCCCCCcEEEEEE-eCCCCEEEEEEeCCCCChh-HHHHHHHHHHHhcCCCccccccceeeeeCCeeEEEEec
Q 020221           57 AMENIVSEHGEKAPNVVYKGK-LENQFRIAVKRFNRSAWPD-ARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAEY  134 (329)
Q Consensus        57 ~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~-~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  134 (329)
                      ..|.+++.||+|+||.||+|. ..++..||+|.+....... ...+.+|+.+++.++|+||+++.+++..+...++|+||
T Consensus         5 ~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~   84 (291)
T cd07870           5 TSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIVLLHDIIHTKETLTFVFEY   84 (291)
T ss_pred             ceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCcCCCcHHHHHHHHHHHhcCCCCEeEEEEEEecCCeEEEEEec
Confidence            346777888999999999998 4568899999987653222 33567899999999999999999999998999999999


Q ss_pred             CCCCCHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCCCCCeeeecccCcccCCCC----C
Q 020221          135 MPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDG----R  210 (329)
Q Consensus       135 ~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~----~  210 (329)
                      +. ++|.+.+.. ....+++..+..++.|++.||.|||+. +++|+||||+||+++.++.++|+|||++......    .
T Consensus        85 ~~-~~l~~~~~~-~~~~~~~~~~~~~~~qi~~~L~~lH~~-~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~~~~~  161 (291)
T cd07870          85 MH-TDLAQYMIQ-HPGGLHPYNVRLFMFQLLRGLAYIHGQ-HILHRDLKPQNLLISYLGELKLADFGLARAKSIPSQTYS  161 (291)
T ss_pred             cc-CCHHHHHHh-CCCCCCHHHHHHHHHHHHHHHHHHHhC-CcccCCCChHHEEEcCCCcEEEeccccccccCCCCCCCC
Confidence            96 577777643 234578888999999999999999999 9999999999999999999999999998753322    2


Q ss_pred             CccCcccccCcccccCC-CCCCcccchhhhHHHHHHHhCCCCCCchhhH--HHhhh----------------chhhhccc
Q 020221          211 SYSTNLAFTPPEYLRTG-RVTPESVMYSFGTLLLDLLSGKHIPPSHALD--LIRDR----------------NIQTLTDS  271 (329)
Q Consensus       211 ~~~~~~~y~aPE~~~~~-~~~~~~DvwslG~il~el~tg~~~~~~~~~~--~~~~~----------------~~~~~~~~  271 (329)
                      ...++..|+|||++.+. .++.++||||||+++|+|++|..||......  .....                ........
T Consensus       162 ~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  241 (291)
T cd07870         162 SEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVFEQLEKIWTVLGVPTEDTWPGVSKLPNYKPE  241 (291)
T ss_pred             CccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHHHHcCCCChhhhhhhhhcccccch
Confidence            23467889999998764 4788999999999999999999877532211  00000                00000000


Q ss_pred             cccCCCC---------hHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 020221          272 CLEGQFS---------SDEGTELVRLASRCLQYEPRERPNPRSLVT  308 (329)
Q Consensus       272 ~~~~~~~---------~~~~~~~~~li~~cl~~dp~~Rps~~~~l~  308 (329)
                      ......+         ...+..+.+++.+|+..||++|||+.+++.
T Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp~~R~t~~~~l~  287 (291)
T cd07870         242 WFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALL  287 (291)
T ss_pred             hccccCCcchhhhccccCCChHHHHHHHHHhCcCcccCcCHHHHhc
Confidence            0000000         012568899999999999999999999998

Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess

>cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta

Probab=100.00  E-value=3.7e-40  Score=295.62  Aligned_cols=242  Identities=17%  Similarity=0.203  Sum_probs=188.7

Q ss_pred             CCCCCcEEEEEEe-CCCCEEEEEEeCCCCCh--hHHHHHHHHHHHhcCCCccccccceeeeeCCeeEEEEecCCCCCHHh
Q 020221           66 GEKAPNVVYKGKL-ENQFRIAVKRFNRSAWP--DARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAEYMPNDTLAK  142 (329)
Q Consensus        66 g~G~~g~V~~~~~-~~~~~vavK~~~~~~~~--~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~  142 (329)
                      |.|+||+||++.. .+++.||+|++......  ..+.+.+|+.+++.++||||+++++++..++..++++||+.+++|.+
T Consensus         9 g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~~v~e~~~~~~l~~   88 (328)
T cd08226           9 GFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMAYGSANS   88 (328)
T ss_pred             cccCceeEEEEEEcCCCcEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEeeeEecCCceEEEEecccCCCHHH
Confidence            4449999999994 57899999998754322  24568889999999999999999999999999999999999999999


Q ss_pred             hhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCCCCCeeeecccCcccCCCC-----------CC
Q 020221          143 HLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDG-----------RS  211 (329)
Q Consensus       143 ~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~-----------~~  211 (329)
                      ++.+.....+++..+..++.|++.||.|||+. +++||||||+||+++.++.++++||+.+......           ..
T Consensus        89 ~l~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~-~ivHrDlkp~Nill~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  167 (328)
T cd08226          89 LLKTYFPEGMSEALIGNILFGALRGLNYLHQN-GYIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQKAKVVYDFPQF  167 (328)
T ss_pred             HHHhhcccCCCHHHHHHHHHHHHHHHHHHHhC-CeecCCCCHHHEEEeCCCcEEEechHHHhhhhccCcccccccccccc
Confidence            98764455689999999999999999999999 9999999999999999999999999754322111           01


Q ss_pred             ccCcccccCcccccCC--CCCCcccchhhhHHHHHHHhCCCCCCchhhHHHhhhchh-----------------------
Q 020221          212 YSTNLAFTPPEYLRTG--RVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQ-----------------------  266 (329)
Q Consensus       212 ~~~~~~y~aPE~~~~~--~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~~~~~~~-----------------------  266 (329)
                      ..++..|+|||++.+.  .++.++||||||+++|+|++|..|+..............                       
T Consensus       168 ~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  247 (328)
T cd08226         168 STSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQMLLQKLKGPPYSPLDITTFPCEESRMKNSQ  247 (328)
T ss_pred             ccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcChHHHHHHHhcCCCCCCccccccchhhhhhccch
Confidence            1235679999998764  478899999999999999999988764321111100000                       


Q ss_pred             ------------------hhccccccCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 020221          267 ------------------TLTDSCLEGQFSSDEGTELVRLASRCLQYEPRERPNPRSLVT  308 (329)
Q Consensus       267 ------------------~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~~~l~  308 (329)
                                        ...........+..++..+.+|+.+||..||++|||+.++++
T Consensus       248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpta~e~l~  307 (328)
T cd08226         248 SGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVELCLQQDPEKRPSASSLLS  307 (328)
T ss_pred             hhhhcccccchhccccccccccccccchhhhhhhHHHHHHHHHHccCCcccCCCHHHHhh
Confidence                              000000111123446788999999999999999999999985

Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig

>cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2

Probab=100.00  E-value=5.6e-40  Score=291.92  Aligned_cols=244  Identities=19%  Similarity=0.218  Sum_probs=196.7

Q ss_pred             ccccccCCCCCCcEEEEEE-eCCCCEEEEEEeCCCC---ChhHHHHHHHHHHHhcCCCccccccceeeeeCCeeEEEEec
Q 020221           59 ENIVSEHGEKAPNVVYKGK-LENQFRIAVKRFNRSA---WPDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAEY  134 (329)
Q Consensus        59 ~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  134 (329)
                      +..++.+|.|+||.||+|. ..+++.+|+|.+....   ....+.+.+|+++++.++|+|++++.+++......++|+||
T Consensus        17 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   96 (308)
T cd06634          17 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEY   96 (308)
T ss_pred             HHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEcCCeeEEEEEc
Confidence            4456677999999999999 4567889999986432   22345678899999999999999999999999999999999


Q ss_pred             CCCCCHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCCCCCeeeecccCcccCCCCCCccC
Q 020221          135 MPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDGRSYST  214 (329)
Q Consensus       135 ~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~~~  214 (329)
                      +. |+|.+.+.. ....+++.++..++.|++.||.|||+. +++|+||+|+||+++.++.++|+|||++..........+
T Consensus        97 ~~-~~l~~~~~~-~~~~l~~~~~~~~~~~l~~~l~~LH~~-~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~  173 (308)
T cd06634          97 CL-GSASDLLEV-HKKPLQEVEIAAVTHGALQGLAYLHSH-NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANXFVG  173 (308)
T ss_pred             cC-CCHHHHHHH-cCCCCCHHHHHHHHHHHHHHHHHHHhC-CcccCCCCHHhEEECCCCcEEECCcccceeecCcccccC
Confidence            96 578777653 345689999999999999999999999 999999999999999999999999999887766666678


Q ss_pred             cccccCccccc---CCCCCCcccchhhhHHHHHHHhCCCCCCchhhHHHhhhchhhhccccccCCCChHHHHHHHHHHHH
Q 020221          215 NLAFTPPEYLR---TGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLASR  291 (329)
Q Consensus       215 ~~~y~aPE~~~---~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~  291 (329)
                      +..|+|||.+.   ...++.++||||||+++|+|++|..|+................    .........+..+.+++.+
T Consensus       174 ~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~~~~li~~  249 (308)
T cd06634         174 TPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNE----SPALQSGHWSEYFRNFVDS  249 (308)
T ss_pred             CccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccccHHHHHHHHhhcC----CCCcCcccccHHHHHHHHH
Confidence            89999999874   3457889999999999999999998875432211111111111    1111123467789999999


Q ss_pred             hcccCCCCCCCHHHHHHH
Q 020221          292 CLQYEPRERPNPRSLVTA  309 (329)
Q Consensus       292 cl~~dp~~Rps~~~~l~~  309 (329)
                      ||+.+|++||++.+++..
T Consensus       250 cl~~~P~~Rp~~~~ll~~  267 (308)
T cd06634         250 CLQKIPQDRPTSEVLLKH  267 (308)
T ss_pred             HhhCCcccCCCHHHHhhC
Confidence            999999999999999983

Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin

>cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases

Probab=100.00  E-value=4.1e-40  Score=289.13  Aligned_cols=247  Identities=18%  Similarity=0.236  Sum_probs=193.8

Q ss_pred             cccccCCCCCCcEEEEEEe-CCCCEEEEEEeCCCCCh--hHHHHHHHHHHHhcCCCccccccceeeeeCCeeEEEEecCC
Q 020221           60 NIVSEHGEKAPNVVYKGKL-ENQFRIAVKRFNRSAWP--DARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAEYMP  136 (329)
Q Consensus        60 ~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~--~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~  136 (329)
                      ++++.+|.|++|.||+|.. .+|..||+|++......  ....+.+|++.++.++|||++++++++..++..++++||++
T Consensus         2 ~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~~~~iv~e~~~   81 (283)
T cd07835           2 QKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDVVHSENKLYLVFEFLD   81 (283)
T ss_pred             chheEecCCCCeEEEEEEEcCCCCEEEEEEeecccccccchhHHHHHHHHHHhcCCCCccCHhheeccCCeEEEEEeccC
Confidence            4567789999999999984 57889999998754322  23567889999999999999999999999999999999995


Q ss_pred             CCCHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCCCCCeeeecccCcccCCCC----CCc
Q 020221          137 NDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDG----RSY  212 (329)
Q Consensus       137 ~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~----~~~  212 (329)
                       ++|.+++.......+++..+..++.|++.||.|||++ +++|+||+|+||+++.++.++|+|||++......    ...
T Consensus        82 -~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~-~~~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~  159 (283)
T cd07835          82 -LDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCHSH-RVLHRDLKPQNLLIDREGALKLADFGLARAFGVPVRTYTHE  159 (283)
T ss_pred             -cCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHC-CeeCCCCCHHHEEEcCCCcEEEeecccccccCCCccccCcc
Confidence             5899988643334689999999999999999999999 9999999999999999999999999998754322    122


Q ss_pred             cCcccccCcccccCC-CCCCcccchhhhHHHHHHHhCCCCCCchhhHHHhhhchh-----------------hhcccc--
Q 020221          213 STNLAFTPPEYLRTG-RVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQ-----------------TLTDSC--  272 (329)
Q Consensus       213 ~~~~~y~aPE~~~~~-~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~~~~~~~-----------------~~~~~~--  272 (329)
                      .++..|+|||++.+. .++.++||||||+++|+|++|..||..............                 ......  
T Consensus       160 ~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (283)
T cd07835         160 VVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQLFRIFRTLGTPDEDVWPGVTSLPDYKPTFPK  239 (283)
T ss_pred             ccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhhhhhchhhhhhccc
Confidence            457889999988764 478899999999999999999988754322111000000                 000000  


Q ss_pred             ----ccCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 020221          273 ----LEGQFSSDEGTELVRLASRCLQYEPRERPNPRSLVT  308 (329)
Q Consensus       273 ----~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~~~l~  308 (329)
                          .........+.++.+++.+||+.||++|||+.++++
T Consensus       240 ~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~  279 (283)
T cd07835         240 WARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQ  279 (283)
T ss_pred             ccccchhhhcCCCCHHHHHHHHHHhcCChhhCcCHHHHhc
Confidence                000112234578999999999999999999999997

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc

>cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase

Probab=100.00  E-value=6.3e-40  Score=283.33  Aligned_cols=244  Identities=18%  Similarity=0.227  Sum_probs=201.9

Q ss_pred             ccccccCCCCCCcEEEEEEeC-CCCEEEEEEeCCCCC--hhHHHHHHHHHHHhcCCCccccccceeeeeC--CeeEEEEe
Q 020221           59 ENIVSEHGEKAPNVVYKGKLE-NQFRIAVKRFNRSAW--PDARQFLEEARAVGQLRNRRLANLLGCCCEG--DERLLVAE  133 (329)
Q Consensus        59 ~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~--~~~~lv~e  133 (329)
                      +.+.+.||+|++|.||+|... ++..|++|.+.....  ...+.+.+|+..++.++|+||+++++.+...  ...++++|
T Consensus         2 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e   81 (260)
T cd06606           2 WTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIFLE   81 (260)
T ss_pred             ceeeeEeeecCceEEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEEEEEE
Confidence            344566799999999999954 788999999876553  3356788999999999999999999999888  88999999


Q ss_pred             cCCCCCHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCCCCCeeeecccCcccCCCCC---
Q 020221          134 YMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDGR---  210 (329)
Q Consensus       134 ~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~---  210 (329)
                      |+++++|.+++.+  ...+++..+..++.|++.||+|||+. +++|+||+|+||+++.++.++|+|||.+.......   
T Consensus        82 ~~~~~~L~~~~~~--~~~~~~~~~~~~~~~l~~~l~~lh~~-~~~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~~  158 (260)
T cd06606          82 YVSGGSLSSLLKK--FGKLPEPVIRKYTRQILEGLAYLHSN-GIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGE  158 (260)
T ss_pred             ecCCCcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHC-CccccCCCHHHEEEcCCCCEEEcccccEEecccccccc
Confidence            9999999999874  33889999999999999999999998 99999999999999999999999999987655442   


Q ss_pred             ---CccCcccccCcccccCCCCCCcccchhhhHHHHHHHhCCCCCCchhhHHHhhhchhhhccccccCCCChHHHHHHHH
Q 020221          211 ---SYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVR  287 (329)
Q Consensus       211 ---~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  287 (329)
                         ...++..|+|||.+.+...+.++||||||+++++|++|..|+........   ..............+...+..+.+
T Consensus       159 ~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~l~~  235 (260)
T cd06606         159 GTGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSELGNPMA---ALYKIGSSGEPPEIPEHLSEEAKD  235 (260)
T ss_pred             cccCCCCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHH---HHHhccccCCCcCCCcccCHHHHH
Confidence               24567899999999988899999999999999999999988755431100   011111111222345556789999


Q ss_pred             HHHHhcccCCCCCCCHHHHHH
Q 020221          288 LASRCLQYEPRERPNPRSLVT  308 (329)
Q Consensus       288 li~~cl~~dp~~Rps~~~~l~  308 (329)
                      ++.+||..||++||++.++++
T Consensus       236 ~i~~~l~~~p~~Rp~~~~ll~  256 (260)
T cd06606         236 FLRKCLRRDPKKRPTADELLQ  256 (260)
T ss_pred             HHHHhCcCChhhCCCHHHHhh
Confidence            999999999999999999998

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK

>KOG0586 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=6.2e-41  Score=302.40  Aligned_cols=247  Identities=19%  Similarity=0.289  Sum_probs=212.2

Q ss_pred             hcCCCcccccccCCCCCCcEEEEEE-eCCCCEEEEEEeCCCCChh--HHHHHHHHHHHhcCCCccccccceeeeeCCeeE
Q 020221           53 TSGFAMENIVSEHGEKAPNVVYKGK-LENQFRIAVKRFNRSAWPD--ARQFLEEARAVGQLRNRRLANLLGCCCEGDERL  129 (329)
Q Consensus        53 ~~~~~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~--~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~  129 (329)
                      .+.+..|.+++.||.|.|+.|.+++ ..++..||+|.+.+.....  .+.+.+|+++|..+.|||||+++.+......++
T Consensus        52 ~~~vg~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~~~~k~~rev~imk~l~HPnIvkl~~v~~t~~~ly  131 (596)
T KOG0586|consen   52 SNSVGLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPSKRQKLGREVDIMKSLNHPNIVKLFSVIETEATLY  131 (596)
T ss_pred             cccccceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccChHHHHHHHHHHHHHHhcCCcceeeeeeeeeecceeE
Confidence            3556678899999999999999999 5678899999998875332  355889999999999999999999999999999


Q ss_pred             EEEecCCCCCHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCCCCCeeeecccCcccCCCC
Q 020221          130 LVAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDG  209 (329)
Q Consensus       130 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~  209 (329)
                      +||||+.+|.+.+++.  +...+.+..+..++.|+.+|++|||++ +|+|||||++|||++.+.++||+|||++..+..+
T Consensus       132 lV~eya~~ge~~~yl~--~~gr~~e~~ar~~F~q~vsaveYcH~k-~ivHrdLk~eNilL~~~mnikIaDfgfS~~~~~~  208 (596)
T KOG0586|consen  132 LVMEYASGGELFDYLV--KHGRMKEKEARAKFRQIVSAVEYCHSK-NIVHRDLKAENILLDENMNIKIADFGFSTFFDYG  208 (596)
T ss_pred             EEEEeccCchhHHHHH--hcccchhhhhhhhhHHHHHHHHHHhhc-ceeccccchhhcccccccceeeeccccceeeccc
Confidence            9999999999999998  445566689999999999999999999 9999999999999999999999999999877654


Q ss_pred             ---CCccCcccccCcccccCCCCC-CcccchhhhHHHHHHHhCCCCCCchhhHHHhhhchhhhccccccCCCChHHHHHH
Q 020221          210 ---RSYSTNLAFTPPEYLRTGRVT-PESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTEL  285 (329)
Q Consensus       210 ---~~~~~~~~y~aPE~~~~~~~~-~~~DvwslG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  285 (329)
                         .+.+|++.|.|||++.+..++ +.+|+||+|++||.|+.|..||.+......+...+..      ...++.-.+.+.
T Consensus       209 ~~lqt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~~lk~Lr~rvl~g------k~rIp~~ms~dc  282 (596)
T KOG0586|consen  209 LMLQTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQNLKELRPRVLRG------KYRIPFYMSCDC  282 (596)
T ss_pred             ccccccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCcccccccchheee------eecccceeechh
Confidence               467899999999999988854 6899999999999999999998766544443332221      113455567889


Q ss_pred             HHHHHHhcccCCCCCCCHHHHHH
Q 020221          286 VRLASRCLQYEPRERPNPRSLVT  308 (329)
Q Consensus       286 ~~li~~cl~~dp~~Rps~~~~l~  308 (329)
                      .++|+.+|-++|.+|++..++..
T Consensus       283 e~lLrk~lvl~Pskr~~~dqim~  305 (596)
T KOG0586|consen  283 EDLLRKFLVLNPSKRGPCDQIMK  305 (596)
T ss_pred             HHHHHHhhccCccccCCHHHhhh
Confidence            99999999999999999999986

>KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=4e-41  Score=306.25  Aligned_cols=244  Identities=21%  Similarity=0.298  Sum_probs=203.5

Q ss_pred             ccccCCCCCCcEEEEEEeCC--C--CEEEEEEeCCCCCh-hHHHHHHHHHHHhcCCCccccccceeeeeCCeeEEEEecC
Q 020221           61 IVSEHGEKAPNVVYKGKLEN--Q--FRIAVKRFNRSAWP-DARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAEYM  135 (329)
Q Consensus        61 ~~~~lg~G~~g~V~~~~~~~--~--~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~  135 (329)
                      +.+.||+|.||.|++|.|..  |  -.||||+++.+... ...+|++|+.+|.+|+|+|+++++|+..+ ....+|+|++
T Consensus       114 l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~~mddflrEas~M~~L~H~hliRLyGvVl~-qp~mMV~ELa  192 (1039)
T KOG0199|consen  114 LYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNAIMDDFLREASHMLKLQHPHLIRLYGVVLD-QPAMMVFELA  192 (1039)
T ss_pred             HHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccchhHHHHHHHHHHHHhccCcceeEEeeeecc-chhhHHhhhc
Confidence            34556999999999998643  3  45999999987655 56789999999999999999999999876 7889999999


Q ss_pred             CCCCHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCCCCCeeeecccCcccCCCCCCc---
Q 020221          136 PNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDGRSY---  212 (329)
Q Consensus       136 ~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~---  212 (329)
                      +.|||.+.|+......|.......++.||+.||.||.++ ++|||||..+|+|+.....+||+|||+.+....+...   
T Consensus       193 plGSLldrLrka~~~~llv~~Lcdya~QiA~aM~YLesk-rlvHRDLAARNlllasprtVKI~DFGLmRaLg~ned~Yvm  271 (1039)
T KOG0199|consen  193 PLGSLLDRLRKAKKAILLVSRLCDYAMQIAKAMQYLESK-RLVHRDLAARNLLLASPRTVKICDFGLMRALGENEDMYVM  271 (1039)
T ss_pred             ccchHHHHHhhccccceeHHHHHHHHHHHHHHHHHHhhh-hhhhhhhhhhhheecccceeeeecccceeccCCCCcceEe
Confidence            999999999875667788899999999999999999999 9999999999999999999999999999876654322   


Q ss_pred             ----cCcccccCcccccCCCCCCcccchhhhHHHHHHHhCCCCCCchhhHHHhhhchhhhccccccCCCChHHHHHHHHH
Q 020221          213 ----STNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRL  288 (329)
Q Consensus       213 ----~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  288 (329)
                          .....|.|||.+....|+.++|||+|||++|||+|++.-++.+..    ...+...++..-+-.-+..+++++.++
T Consensus       272 ~p~rkvPfAWCaPEsLrh~kFShaSDvWmyGVTiWEMFtyGEePW~G~~----g~qIL~~iD~~erLpRPk~csedIY~i  347 (1039)
T KOG0199|consen  272 APQRKVPFAWCAPESLRHRKFSHASDVWMYGVTIWEMFTYGEEPWVGCR----GIQILKNIDAGERLPRPKYCSEDIYQI  347 (1039)
T ss_pred             cCCCcCcccccCHhHhccccccccchhhhhhhhHHhhhccCCCCCCCCC----HHHHHHhccccccCCCCCCChHHHHHH
Confidence                234679999999999999999999999999999997754333211    111222333333444577899999999


Q ss_pred             HHHhcccCCCCCCCHHHHHHHH
Q 020221          289 ASRCLQYEPRERPNPRSLVTAL  310 (329)
Q Consensus       289 i~~cl~~dp~~Rps~~~~l~~L  310 (329)
                      +..||+.+|++|||+..|.+.+
T Consensus       348 mk~cWah~paDRptFsair~~~  369 (1039)
T KOG0199|consen  348 MKNCWAHNPADRPTFSAIREDL  369 (1039)
T ss_pred             HHHhccCCccccccHHHHHHhH
Confidence            9999999999999999997444

>cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase

Probab=100.00  E-value=5.7e-40  Score=287.93  Aligned_cols=246  Identities=17%  Similarity=0.206  Sum_probs=190.5

Q ss_pred             ccccccCCCCCCcEEEEEE-eCCCCEEEEEEeCCCCCh-hHHHHHHHHHHHhcCC-CccccccceeeeeC--CeeEEEEe
Q 020221           59 ENIVSEHGEKAPNVVYKGK-LENQFRIAVKRFNRSAWP-DARQFLEEARAVGQLR-NRRLANLLGCCCEG--DERLLVAE  133 (329)
Q Consensus        59 ~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~--~~~~lv~e  133 (329)
                      |++++.+|+|+||.||++. ..+++.||+|.+...... ......+|+..+..+. |+|++++++++.+.  +..++|+|
T Consensus         1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv~e   80 (282)
T cd07831           1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALVFE   80 (282)
T ss_pred             CceEeeccccccceEEEEEEcCCCcEEEEEEehhccCCchhhhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEEEe
Confidence            3567788999999999998 556889999998764322 2233457888888885 99999999999887  88999999


Q ss_pred             cCCCCCHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCCCCCeeeecccCcccCCCCC---
Q 020221          134 YMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDGR---  210 (329)
Q Consensus       134 ~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~---  210 (329)
                      |+.+ +|.+.+.. ....+++..+..++.|++.||+|||+. +++|+||+|+||+++. +.++|+|||++.......   
T Consensus        81 ~~~~-~l~~~l~~-~~~~~~~~~~~~~~~qi~~~L~~LH~~-~i~H~dl~p~ni~l~~-~~~kl~dfg~~~~~~~~~~~~  156 (282)
T cd07831          81 LMDM-NLYELIKG-RKRPLPEKRVKSYMYQLLKSLDHMHRN-GIFHRDIKPENILIKD-DILKLADFGSCRGIYSKPPYT  156 (282)
T ss_pred             cCCc-cHHHHHHh-ccCCCCHHHHHHHHHHHHHHHHHHHHC-CceecccCHHHEEEcC-CCeEEEecccccccccCCCcC
Confidence            9975 88887754 235689999999999999999999999 9999999999999999 999999999987654332   


Q ss_pred             CccCcccccCcccccC-CCCCCcccchhhhHHHHHHHhCCCCCCchhhHHHhhhch-------hh---hccc--cccCC-
Q 020221          211 SYSTNLAFTPPEYLRT-GRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNI-------QT---LTDS--CLEGQ-  276 (329)
Q Consensus       211 ~~~~~~~y~aPE~~~~-~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~~~~~~-------~~---~~~~--~~~~~-  276 (329)
                      ...++..|+|||.+.. ..++.++||||||+++|||++|..||+............       ..   ....  ..... 
T Consensus       157 ~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (282)
T cd07831         157 EYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNELDQIAKIHDVLGTPDAEVLKKFRKSRHMNYNF  236 (282)
T ss_pred             CCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCCHHHHHHHHHHHcCCCCHHHHHhhcccccccccC
Confidence            3346789999997654 457889999999999999999998886532211100000       00   0000  00000 


Q ss_pred             ----------CChHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 020221          277 ----------FSSDEGTELVRLASRCLQYEPRERPNPRSLVT  308 (329)
Q Consensus       277 ----------~~~~~~~~~~~li~~cl~~dp~~Rps~~~~l~  308 (329)
                                .....+.++.+++.+||..||++||++.++++
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~  278 (282)
T cd07831         237 PSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALR  278 (282)
T ss_pred             cccccccHHHHcccccHHHHHHHHHHhccCcccccCHHHHhh
Confidence                      11235789999999999999999999999998

Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation.

>cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3

Probab=100.00  E-value=7.6e-40  Score=285.87  Aligned_cols=248  Identities=20%  Similarity=0.293  Sum_probs=193.9

Q ss_pred             cccccCCCCCCcEEEEEEeC----CCCEEEEEEeCCCC--ChhHHHHHHHHHHHhcCCCccccccceeeeeCC------e
Q 020221           60 NIVSEHGEKAPNVVYKGKLE----NQFRIAVKRFNRSA--WPDARQFLEEARAVGQLRNRRLANLLGCCCEGD------E  127 (329)
Q Consensus        60 ~~~~~lg~G~~g~V~~~~~~----~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~------~  127 (329)
                      .+.+.||+|+||.||+|...    +++.||+|.+....  ....+++.+|+++++.++||||+++++++....      .
T Consensus         2 ~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~   81 (273)
T cd05074           2 TLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLPI   81 (273)
T ss_pred             cchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCcccc
Confidence            34566799999999999842    36789999987653  223556889999999999999999999875532      2


Q ss_pred             eEEEEecCCCCCHHhhhccC----CCCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCCCCCeeeecccCc
Q 020221          128 RLLVAEYMPNDTLAKHLFHW----ETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLM  203 (329)
Q Consensus       128 ~~lv~e~~~~gsL~~~l~~~----~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a  203 (329)
                      .+++++|+.+|+|..++...    ....+++..+..++.|++.||+|||++ +++|+||||+||++++++.++|+|||++
T Consensus        82 ~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~-~i~H~dikp~nili~~~~~~kl~dfg~~  160 (273)
T cd05074          82 PMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSK-NFIHRDLAARNCMLNENMTVCVADFGLS  160 (273)
T ss_pred             eEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhC-CEeecccchhhEEEcCCCCEEECccccc
Confidence            47889999999998876421    123578899999999999999999999 9999999999999999999999999998


Q ss_pred             ccCCCCC------CccCcccccCcccccCCCCCCcccchhhhHHHHHHHh-CCCCCCchhhHHHhhhchhhhccccccCC
Q 020221          204 KNSRDGR------SYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLS-GKHIPPSHALDLIRDRNIQTLTDSCLEGQ  276 (329)
Q Consensus       204 ~~~~~~~------~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t-g~~~~~~~~~~~~~~~~~~~~~~~~~~~~  276 (329)
                      .......      ...++..|++||.+.+..++.++||||||+++|+|++ |..|+..............     .....
T Consensus       161 ~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~sDi~slG~il~el~~~g~~p~~~~~~~~~~~~~~~-----~~~~~  235 (273)
T cd05074         161 KKIYSGDYYRQGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVENSEIYNYLIK-----GNRLK  235 (273)
T ss_pred             ccccCCcceecCCCccCchhhcCHhHHhcCccchhhhhHHHHHHHHHHhhCCCCCCCCCCHHHHHHHHHc-----CCcCC
Confidence            7654322      2234567999999988889999999999999999999 6665543322211111111     01111


Q ss_pred             CChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhh
Q 020221          277 FSSDEGTELVRLASRCLQYEPRERPNPRSLVTALVTL  313 (329)
Q Consensus       277 ~~~~~~~~~~~li~~cl~~dp~~Rps~~~~l~~L~~~  313 (329)
                      .+...+..+.+++.+||+.+|++|||+.++++.|+.+
T Consensus       236 ~~~~~~~~~~~l~~~~l~~~p~~Rps~~~~~~~l~~~  272 (273)
T cd05074         236 QPPDCLEDVYELMCQCWSPEPKCRPSFQHLRDQLELI  272 (273)
T ss_pred             CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence            2334567899999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac

>cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3

Probab=100.00  E-value=1.4e-39  Score=289.97  Aligned_cols=242  Identities=19%  Similarity=0.223  Sum_probs=195.0

Q ss_pred             cccccCCCCCCcEEEEEE-eCCCCEEEEEEeCCCCC---hhHHHHHHHHHHHhcCCCccccccceeeeeCCeeEEEEecC
Q 020221           60 NIVSEHGEKAPNVVYKGK-LENQFRIAVKRFNRSAW---PDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAEYM  135 (329)
Q Consensus        60 ~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~  135 (329)
                      ..+..+|+|+||+||+|. ..+++.|++|.+.....   ...+.+.+|+++++.++|||++++++++.+....+++|||+
T Consensus        24 ~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~  103 (313)
T cd06633          24 VGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAWLVMEYC  103 (313)
T ss_pred             hcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEEecC
Confidence            344567999999999998 45688999999875432   22456788999999999999999999999999999999999


Q ss_pred             CCCCHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCCCCCeeeecccCcccCCCCCCccCc
Q 020221          136 PNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDGRSYSTN  215 (329)
Q Consensus       136 ~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~  215 (329)
                      . ++|.+++.. ....+++.++..++.|++.||.|||+. |++|+||+|+||+++.++.++|+|||++..........++
T Consensus       104 ~-~~l~~~l~~-~~~~l~~~~~~~~~~qi~~al~~LH~~-gi~H~dl~p~nili~~~~~~kL~dfg~~~~~~~~~~~~~~  180 (313)
T cd06633         104 L-GSASDLLEV-HKKPLQEVEIAAITHGALQGLAYLHSH-NMIHRDIKAGNILLTEPGQVKLADFGSASKSSPANSFVGT  180 (313)
T ss_pred             C-CCHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHHC-CeecCCCChhhEEECCCCCEEEeecCCCcccCCCCCcccc
Confidence            6 478877754 345689999999999999999999999 9999999999999999999999999998766655566788


Q ss_pred             ccccCccccc---CCCCCCcccchhhhHHHHHHHhCCCCCCchhhHHHhhhchhhhccccccCCCChHHHHHHHHHHHHh
Q 020221          216 LAFTPPEYLR---TGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLASRC  292 (329)
Q Consensus       216 ~~y~aPE~~~---~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~c  292 (329)
                      ..|+|||++.   ...++.++||||||+++|+|++|..|+................    .........+..+.+++.+|
T Consensus       181 ~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~l~~li~~~  256 (313)
T cd06633         181 PYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQND----SPTLQSNEWTDSFRGFVDYC  256 (313)
T ss_pred             ccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcC----CCCCCccccCHHHHHHHHHH
Confidence            8999999984   3568889999999999999999998875532211111111111    11111233456799999999


Q ss_pred             cccCCCCCCCHHHHHH
Q 020221          293 LQYEPRERPNPRSLVT  308 (329)
Q Consensus       293 l~~dp~~Rps~~~~l~  308 (329)
                      |+.+|++||++.+++.
T Consensus       257 l~~~P~~Rp~~~~~l~  272 (313)
T cd06633         257 LQKIPQERPASAELLR  272 (313)
T ss_pred             ccCChhhCcCHHHHhc
Confidence            9999999999999997

Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co

>cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase

Probab=100.00  E-value=7.3e-40  Score=296.64  Aligned_cols=246  Identities=15%  Similarity=0.205  Sum_probs=192.7

Q ss_pred             CcccccccCCCCCCcEEEEEE-eCCCCEEEEEEeCCCC--ChhHHHHHHHHHHHhcCCCccccccceeeeeC------Ce
Q 020221           57 AMENIVSEHGEKAPNVVYKGK-LENQFRIAVKRFNRSA--WPDARQFLEEARAVGQLRNRRLANLLGCCCEG------DE  127 (329)
Q Consensus        57 ~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~------~~  127 (329)
                      ..|++++.||+|+||.||++. ..+++.||+|.+....  ......+.+|+.+++.++|+||+++++++...      ..
T Consensus        16 ~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~   95 (353)
T cd07850          16 KRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEEFQD   95 (353)
T ss_pred             cceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCccccChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCccccCc
Confidence            346677788999999999999 5578899999986532  23345677899999999999999999987543      35


Q ss_pred             eEEEEecCCCCCHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCCCCCeeeecccCcccCC
Q 020221          128 RLLVAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSR  207 (329)
Q Consensus       128 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~  207 (329)
                      .++||||+.+ +|.+.+..    .++...+..++.|++.||+|||+. |++|+||||+||+++.++.++|+|||++....
T Consensus        96 ~~lv~e~~~~-~l~~~~~~----~l~~~~~~~~~~ql~~aL~~LH~~-gi~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~  169 (353)
T cd07850          96 VYLVMELMDA-NLCQVIQM----DLDHERMSYLLYQMLCGIKHLHSA-GIIHRDLKPSNIVVKSDCTLKILDFGLARTAG  169 (353)
T ss_pred             EEEEEeccCC-CHHHHHhh----cCCHHHHHHHHHHHHHHHHHHHhC-CeeeCCCCHHHEEECCCCCEEEccCccceeCC
Confidence            7999999965 88887742    288999999999999999999999 99999999999999999999999999997654


Q ss_pred             CCC---CccCcccccCcccccCCCCCCcccchhhhHHHHHHHhCCCCCCchhhHHHhhhchh------------------
Q 020221          208 DGR---SYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQ------------------  266 (329)
Q Consensus       208 ~~~---~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~~~~~~~------------------  266 (329)
                      ...   ...++..|+|||.+.+..++.++||||||+++|+|++|+.||..............                  
T Consensus       170 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  249 (353)
T cd07850         170 TSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGTVLFPGTDHIDQWNKIIEQLGTPSDEFMSRLQPTVR  249 (353)
T ss_pred             CCCCCCCCcccccccCHHHHhCCCCCCchhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHhhhhhh
Confidence            432   23567889999999988899999999999999999999988764321110000000                  


Q ss_pred             hhc---------------cccc----cCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 020221          267 TLT---------------DSCL----EGQFSSDEGTELVRLASRCLQYEPRERPNPRSLVT  308 (329)
Q Consensus       267 ~~~---------------~~~~----~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~~~l~  308 (329)
                      ...               ....    ....+...++++.+++.+||+.||++|||+.++++
T Consensus       250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eiL~  310 (353)
T cd07850         250 NYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRISVDDALQ  310 (353)
T ss_pred             HHhhcCCCCCCcchhhhCcccccCcccccccccchhHHHHHHHHHcCCChhhCcCHHHHhc
Confidence            000               0000    00001234677899999999999999999999997

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK

>cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases

Probab=100.00  E-value=5.5e-40  Score=288.06  Aligned_cols=247  Identities=19%  Similarity=0.253  Sum_probs=197.3

Q ss_pred             ccccccCCCCCCcEEEEEEe-CCCCEEEEEEeCCCCCh--hHHHHHHHHHHHhcCCCccccccceeeeeCCeeEEEEecC
Q 020221           59 ENIVSEHGEKAPNVVYKGKL-ENQFRIAVKRFNRSAWP--DARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAEYM  135 (329)
Q Consensus        59 ~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~--~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~  135 (329)
                      |++++.||+|++|.||++.. .+++.+++|.+......  ....+.+|+++++.++|+||+++++++..+...++++||+
T Consensus         1 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~   80 (283)
T cd05118           1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDVFRHKGDLYLVFEFM   80 (283)
T ss_pred             CccceeeecCCCceEEEEEcCCCCcEEEEEEeccccccchhHHHHHHHHHHHHHhcCCCcchHHHhhccCCCEEEEEecc
Confidence            34567789999999999984 57889999998765432  3456888999999999999999999999999999999999


Q ss_pred             CCCCHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCCCCCeeeecccCcccCCCCC----C
Q 020221          136 PNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDGR----S  211 (329)
Q Consensus       136 ~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~----~  211 (329)
                      ++ +|.+.+.. ....+++..+..++.|++.||.|||+. +++|+||||+||+++.++.++|+|||.+.......    .
T Consensus        81 ~~-~l~~~l~~-~~~~~~~~~~~~~~~~i~~~l~~LH~~-~i~H~dl~p~nili~~~~~~~l~df~~~~~~~~~~~~~~~  157 (283)
T cd05118          81 DT-DLYKLIKD-RQRGLPESLIKSYLYQLLQGLAFCHSH-GILHRDLKPENLLINTEGVLKLADFGLARSFGSPVRPYTH  157 (283)
T ss_pred             CC-CHHHHHHh-hcccCCHHHHHHHHHHHHHHHHHHHHC-CeeecCcCHHHEEECCCCcEEEeeeeeeEecCCCcccccC
Confidence            76 88888764 335789999999999999999999999 99999999999999999999999999987655432    3


Q ss_pred             ccCcccccCcccccCC-CCCCcccchhhhHHHHHHHhCCCCCCchhhHHHhhhchhhh-------cccc-----------
Q 020221          212 YSTNLAFTPPEYLRTG-RVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTL-------TDSC-----------  272 (329)
Q Consensus       212 ~~~~~~y~aPE~~~~~-~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~~~~~~~~~-------~~~~-----------  272 (329)
                      ..++..|+|||.+.+. .++.++|+||||+++|+|++|+.||+...............       ....           
T Consensus       158 ~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (283)
T cd05118         158 YVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQLFKIFRTLGTPDPEVWPKFTSLARNYKFSF  237 (283)
T ss_pred             ccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCchHhcccchhhhhhhhhhh
Confidence            4567789999998876 68899999999999999999998876543211110000000       0000           


Q ss_pred             ------ccCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 020221          273 ------LEGQFSSDEGTELVRLASRCLQYEPRERPNPRSLVT  308 (329)
Q Consensus       273 ------~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~~~l~  308 (329)
                            .........+.++.+++.+||+.||.+||++.+++.
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~  279 (283)
T cd05118         238 PKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALA  279 (283)
T ss_pred             ccccccCHHHhhhhhCHHHHHHHHHHhccCcccCcCHHHHhh
Confidence                  000111245788999999999999999999999998

Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They

>cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.4e-39  Score=280.77  Aligned_cols=242  Identities=19%  Similarity=0.276  Sum_probs=202.0

Q ss_pred             ccccccCCCCCCcEEEEEE-eCCCCEEEEEEeCCCCC--hhHHHHHHHHHHHhcCCCccccccceeeeeCCeeEEEEecC
Q 020221           59 ENIVSEHGEKAPNVVYKGK-LENQFRIAVKRFNRSAW--PDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAEYM  135 (329)
Q Consensus        59 ~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~  135 (329)
                      |.+.+.||+|++|.||++. ..+++.+++|.+.....  ...+.+.+|+++++.++|+|++++++++.+....++++||+
T Consensus         2 y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~   81 (254)
T cd06627           2 YQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGSIETSDSLYIILEYA   81 (254)
T ss_pred             ceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccCHHHHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEEecC
Confidence            4566777999999999998 44678999999987654  34567899999999999999999999999999999999999


Q ss_pred             CCCCHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCCCCCeeeecccCcccCCCCCC----
Q 020221          136 PNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDGRS----  211 (329)
Q Consensus       136 ~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~~----  211 (329)
                      ++++|.+++..  ...+++..+..++.|++.||.|||+. |++|+||+|+||+++.++.++|+|||++........    
T Consensus        82 ~~~~L~~~~~~--~~~l~~~~~~~~~~~i~~~l~~lH~~-~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~~~~  158 (254)
T cd06627          82 ENGSLRQIIKK--FGPFPESLVAVYVYQVLQGLAYLHEQ-GVIHRDIKAANILTTKDGVVKLADFGVATKLNDVSKDDAS  158 (254)
T ss_pred             CCCcHHHHHHh--ccCCCHHHHHHHHHHHHHHHHHHhhC-CcccCCCCHHHEEECCCCCEEEeccccceecCCCcccccc
Confidence            99999999863  36789999999999999999999999 999999999999999999999999999886654432    


Q ss_pred             ccCcccccCcccccCCCCCCcccchhhhHHHHHHHhCCCCCCchhhHHHhhhchhhhccccccCCCChHHHHHHHHHHHH
Q 020221          212 YSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLASR  291 (329)
Q Consensus       212 ~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~  291 (329)
                      ..++..|+|||...+...+.++||||+|+++++|++|..|+.............     .......+...+..+.+++.+
T Consensus       159 ~~~~~~y~~pe~~~~~~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~i~~  233 (254)
T cd06627         159 VVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPPYYDLNPMAALFRIV-----QDDHPPLPEGISPELKDFLMQ  233 (254)
T ss_pred             cccchhhcCHhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHh-----ccCCCCCCCCCCHHHHHHHHH
Confidence            456788999999887778899999999999999999998775432111111111     111223445567889999999


Q ss_pred             hcccCCCCCCCHHHHHH
Q 020221          292 CLQYEPRERPNPRSLVT  308 (329)
Q Consensus       292 cl~~dp~~Rps~~~~l~  308 (329)
                      ||..+|++|||+.+++.
T Consensus       234 ~l~~~p~~R~~~~~~l~  250 (254)
T cd06627         234 CFQKDPNLRPTAKQLLK  250 (254)
T ss_pred             HHhCChhhCcCHHHHhc
Confidence            99999999999999986

Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast

>cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases

Probab=100.00  E-value=8.9e-40  Score=287.21  Aligned_cols=247  Identities=21%  Similarity=0.246  Sum_probs=194.6

Q ss_pred             ccccccCCCCCCcEEEEEEe-CCCCEEEEEEeCCCC--ChhHHHHHHHHHHHhcCCCccccccceeeeeC--CeeEEEEe
Q 020221           59 ENIVSEHGEKAPNVVYKGKL-ENQFRIAVKRFNRSA--WPDARQFLEEARAVGQLRNRRLANLLGCCCEG--DERLLVAE  133 (329)
Q Consensus        59 ~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~--~~~~lv~e  133 (329)
                      |++++.+|.|++|.||+|.. .+++.+|+|.+....  ......+.+|+++++.++|+|++++++++...  ...++|+|
T Consensus         1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e   80 (287)
T cd07840           1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVFE   80 (287)
T ss_pred             CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEecccccccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEEEec
Confidence            35667789999999999995 458899999998763  22345688899999999999999999999887  78999999


Q ss_pred             cCCCCCHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCCCCCeeeecccCcccCCCCC---
Q 020221          134 YMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDGR---  210 (329)
Q Consensus       134 ~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~---  210 (329)
                      |+++ +|.+++.. ....+++..+..++.|++.||+|||+. +++|+||+|+||++++++.++|+|||++.......   
T Consensus        81 ~~~~-~l~~~~~~-~~~~~~~~~~~~i~~~i~~al~~LH~~-~~~h~dl~p~nil~~~~~~~~l~d~g~~~~~~~~~~~~  157 (287)
T cd07840          81 YMDH-DLTGLLDS-PEVKFTESQIKCYMKQLLEGLQYLHSN-GILHRDIKGSNILINNDGVLKLADFGLARPYTKRNSAD  157 (287)
T ss_pred             cccc-cHHHHHhc-cCCCCCHHHHHHHHHHHHHHHHHHHHC-CceeccCcHHHeEEcCCCCEEEccccceeeccCCCccc
Confidence            9975 89888864 235789999999999999999999999 99999999999999999999999999987655432   


Q ss_pred             --CccCcccccCcccccCC-CCCCcccchhhhHHHHHHHhCCCCCCchhhHHHhhhchhhhc------------------
Q 020221          211 --SYSTNLAFTPPEYLRTG-RVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLT------------------  269 (329)
Q Consensus       211 --~~~~~~~y~aPE~~~~~-~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~~~~~~~~~~------------------  269 (329)
                        ...++..|+|||.+.+. .++.++||||||+++|+|++|..|+.................                  
T Consensus       158 ~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (287)
T cd07840         158 YTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTELEQLEKIFELCGSPTDENWPGVSKLPWFEN  237 (287)
T ss_pred             ccccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchhhccccccchhhhh
Confidence              22456789999987654 478899999999999999999988754432211111100000                  


Q ss_pred             -------cccccCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 020221          270 -------DSCLEGQFSSDEGTELVRLASRCLQYEPRERPNPRSLVT  308 (329)
Q Consensus       270 -------~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~~~l~  308 (329)
                             .......+...+++++.+++.+||..||++||++.++++
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~  283 (287)
T cd07840         238 LKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQ  283 (287)
T ss_pred             ccccccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCcCHHHHhh
Confidence                   000000011113778999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po

>cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins

Probab=100.00  E-value=7.6e-40  Score=284.10  Aligned_cols=235  Identities=20%  Similarity=0.224  Sum_probs=193.0

Q ss_pred             CCCCCCcEEEEEEeC-CCCEEEEEEeCCCCC---hhHHHHHHHHHHHhcCCCccccccceeeeeCCeeEEEEecCCCCCH
Q 020221           65 HGEKAPNVVYKGKLE-NQFRIAVKRFNRSAW---PDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAEYMPNDTL  140 (329)
Q Consensus        65 lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL  140 (329)
                      +|.|+||.||++... +++.+++|.+.....   ...+.+.+|+++++.++|+||+++++.+..+...++++||+++++|
T Consensus         1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L   80 (265)
T cd05579           1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEYLPGGDL   80 (265)
T ss_pred             CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheecCcEEEEEEecCCCCcH
Confidence            489999999999954 588999999876543   2345688899999999999999999999999999999999999999


Q ss_pred             HhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCCCCCeeeecccCcccCCCC-----------
Q 020221          141 AKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDG-----------  209 (329)
Q Consensus       141 ~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~-----------  209 (329)
                      .+++.+  ...+++..+..++.|++.||.|||+. +++|+||+|+||++++++.++|+|||++......           
T Consensus        81 ~~~l~~--~~~~~~~~~~~i~~qi~~~L~~lH~~-~i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~  157 (265)
T cd05579          81 ASLLEN--VGSLDEDVARIYIAEIVLALEYLHSN-GIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKE  157 (265)
T ss_pred             HHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHc-CeecCCCCHHHeEEcCCCCEEEEecccchhcccCccccccccccc
Confidence            999864  34789999999999999999999999 9999999999999999999999999998754332           


Q ss_pred             -CCccCcccccCcccccCCCCCCcccchhhhHHHHHHHhCCCCCCchhhHHHhhhchhhhccccccCCCChH--HHHHHH
Q 020221          210 -RSYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSD--EGTELV  286 (329)
Q Consensus       210 -~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~  286 (329)
                       ....++..|+|||.+.+...+.++||||||+++++|++|..|+................      ...+..  .+..+.
T Consensus       158 ~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~------~~~~~~~~~~~~~~  231 (265)
T cd05579         158 DKRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHGETPEEIFQNILNGK------IEWPEDVEVSDEAI  231 (265)
T ss_pred             ccCcccCccccCHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCC------cCCCccccCCHHHH
Confidence             12345678999999988888999999999999999999998876544332222111111      112222  378899


Q ss_pred             HHHHHhcccCCCCCCCH---HHHHH
Q 020221          287 RLASRCLQYEPRERPNP---RSLVT  308 (329)
Q Consensus       287 ~li~~cl~~dp~~Rps~---~~~l~  308 (329)
                      +++.+||+.+|++|||+   .++++
T Consensus       232 ~~i~~~l~~~p~~Rpt~~~~~~~l~  256 (265)
T cd05579         232 DLISKLLVPDPEKRLGAKSIEEIKN  256 (265)
T ss_pred             HHHHHHhcCCHhhcCCCccHHHHhc
Confidence            99999999999999999   55554

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re

>PLN00009 cyclin-dependent kinase A; Provisional

Probab=100.00  E-value=8.5e-40  Score=288.78  Aligned_cols=250  Identities=19%  Similarity=0.207  Sum_probs=193.5

Q ss_pred             CcccccccCCCCCCcEEEEEEe-CCCCEEEEEEeCCCCC--hhHHHHHHHHHHHhcCCCccccccceeeeeCCeeEEEEe
Q 020221           57 AMENIVSEHGEKAPNVVYKGKL-ENQFRIAVKRFNRSAW--PDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAE  133 (329)
Q Consensus        57 ~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  133 (329)
                      ..|++.+.||+|++|.||+|.. .+++.||+|.+.....  .....+.+|+++++.++||||+++++++......++|||
T Consensus         2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   81 (294)
T PLN00009          2 DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKRLYLVFE   81 (294)
T ss_pred             CceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhccccccchHHHHHHHHHHHhccCCCEeeEEEEEecCCeEEEEEe
Confidence            4567778889999999999994 4688999999865432  223567889999999999999999999999999999999


Q ss_pred             cCCCCCHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCC-CCCeeeecccCcccCCCC---
Q 020221          134 YMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDD-DVNPRLSCFGLMKNSRDG---  209 (329)
Q Consensus       134 ~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~-~~~~kl~Dfg~a~~~~~~---  209 (329)
                      |+++ +|.+.+.......+++..+..++.||+.||+|||++ +++|+||+|+||+++. ++.+||+|||++......   
T Consensus        82 ~~~~-~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~-~i~H~dl~p~nill~~~~~~~kl~dfg~~~~~~~~~~~  159 (294)
T PLN00009         82 YLDL-DLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCHSH-RVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRT  159 (294)
T ss_pred             cccc-cHHHHHHhCCCCCcCHHHHHHHHHHHHHHHHHHHhC-CeeCCCCCcceEEEECCCCEEEEcccccccccCCCccc
Confidence            9964 788877644444568889999999999999999999 9999999999999985 567999999998754322   


Q ss_pred             -CCccCcccccCcccccCC-CCCCcccchhhhHHHHHHHhCCCCCCchhhHHHhhhchh-------hhcc----------
Q 020221          210 -RSYSTNLAFTPPEYLRTG-RVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQ-------TLTD----------  270 (329)
Q Consensus       210 -~~~~~~~~y~aPE~~~~~-~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~~~~~~~-------~~~~----------  270 (329)
                       ....+++.|+|||++.+. .++.++||||||+++|+|+||..||..............       ....          
T Consensus       160 ~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (294)
T PLN00009        160 FTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDELFKIFRILGTPNEETWPGVTSLPDYKS  239 (294)
T ss_pred             cccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhccccccchhhhh
Confidence             223457889999988764 478899999999999999999988754322111110000       0000          


Q ss_pred             --ccccC----CCChHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 020221          271 --SCLEG----QFSSDEGTELVRLASRCLQYEPRERPNPRSLVT  308 (329)
Q Consensus       271 --~~~~~----~~~~~~~~~~~~li~~cl~~dp~~Rps~~~~l~  308 (329)
                        +....    ......++++.+++.+||+.||++||++.++++
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~l~  283 (294)
T PLN00009        240 AFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALE  283 (294)
T ss_pred             hcccCCCCCHHHhCcCCChHHHHHHHHHccCChhhCcCHHHHhc
Confidence              00000    011234678999999999999999999999997

>cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase

Probab=100.00  E-value=6.6e-40  Score=289.52  Aligned_cols=248  Identities=17%  Similarity=0.183  Sum_probs=190.8

Q ss_pred             ccccccCCCCCCcEEEEEE-eCCCCEEEEEEeCCCCCh--hHHHHHHHHHHHhcCC-CccccccceeeeeCCe-----eE
Q 020221           59 ENIVSEHGEKAPNVVYKGK-LENQFRIAVKRFNRSAWP--DARQFLEEARAVGQLR-NRRLANLLGCCCEGDE-----RL  129 (329)
Q Consensus        59 ~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~--~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~~-----~~  129 (329)
                      |++.+.||+|+||.||+|. ..+++.||+|.+......  ....+.+|+.+++.+. |+||+++++++.....     .+
T Consensus         3 y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~~~~   82 (295)
T cd07837           3 YEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKPSLY   82 (295)
T ss_pred             ceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhccccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCceEE
Confidence            5566777999999999999 456889999998754322  2356788999999995 6999999999876655     89


Q ss_pred             EEEecCCCCCHHhhhccCC---CCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCC-CCCeeeecccCccc
Q 020221          130 LVAEYMPNDTLAKHLFHWE---TQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDD-DVNPRLSCFGLMKN  205 (329)
Q Consensus       130 lv~e~~~~gsL~~~l~~~~---~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~-~~~~kl~Dfg~a~~  205 (329)
                      ++|||+++ +|.+++....   ...+++..+..++.||+.||.|||++ +++|+||+|+||+++. ++.++|+|||++..
T Consensus        83 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~-~i~H~dl~~~nil~~~~~~~~kl~dfg~~~~  160 (295)
T cd07837          83 LVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKH-GVMHRDLKPQNLLVDKQKGLLKIADLGLGRA  160 (295)
T ss_pred             EEeeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHHC-CeeecCCChHHEEEecCCCeEEEeeccccee
Confidence            99999986 7888875422   34689999999999999999999999 9999999999999998 88999999999875


Q ss_pred             CCCC----CCccCcccccCcccccCC-CCCCcccchhhhHHHHHHHhCCCCCCchhhHHHhhhchhhh-------cc---
Q 020221          206 SRDG----RSYSTNLAFTPPEYLRTG-RVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTL-------TD---  270 (329)
Q Consensus       206 ~~~~----~~~~~~~~y~aPE~~~~~-~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~~~~~~~~~-------~~---  270 (329)
                      ....    ....+++.|+|||++.+. .++.++|+||||+++|+|++|..||................       ..   
T Consensus       161 ~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (295)
T cd07837         161 FSIPVKSYTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQLLHIFKLLGTPTEQVWPGVS  240 (295)
T ss_pred             cCCCccccCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHhCCCChhhCcchh
Confidence            4322    123457789999988654 47899999999999999999998876432211110000000       00   


Q ss_pred             --------cccc----CCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 020221          271 --------SCLE----GQFSSDEGTELVRLASRCLQYEPRERPNPRSLVT  308 (329)
Q Consensus       271 --------~~~~----~~~~~~~~~~~~~li~~cl~~dp~~Rps~~~~l~  308 (329)
                              +...    .......+.++.+++.+||..||++||++.+++.
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R~~~~eil~  290 (295)
T cd07837         241 KLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALT  290 (295)
T ss_pred             hccchhhcCcccchhHHHhccccCHHHHHHHHHHccCChhhcCCHHHHhc
Confidence                    0000    0011235678999999999999999999999998

Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm

>cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10

Probab=100.00  E-value=8.2e-40  Score=290.97  Aligned_cols=251  Identities=21%  Similarity=0.239  Sum_probs=194.0

Q ss_pred             CCCcccccccCCCCCCcEEEEEEe-CCCCEEEEEEeCCCCChh--HHHHHHHHHHHhcCCCccccccceeeeeC--CeeE
Q 020221           55 GFAMENIVSEHGEKAPNVVYKGKL-ENQFRIAVKRFNRSAWPD--ARQFLEEARAVGQLRNRRLANLLGCCCEG--DERL  129 (329)
Q Consensus        55 ~~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~--~~~~~~e~~~l~~l~h~niv~~~~~~~~~--~~~~  129 (329)
                      ....|++++.||+|+||.||+|.. .+++.||+|.+.......  ...+.+|+.+++.++|+|++++++++...  +..+
T Consensus         5 ~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~   84 (309)
T cd07845           5 SVTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEVVVGKHLDSIF   84 (309)
T ss_pred             cccceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCCCCcchhhHHHHHHHhCCCCCCcceEEEEecCCCCeEE
Confidence            445677888889999999999994 568899999987543221  23456899999999999999999998654  5689


Q ss_pred             EEEecCCCCCHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCCCCCeeeecccCcccCCCC
Q 020221          130 LVAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDG  209 (329)
Q Consensus       130 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~  209 (329)
                      +||||+.+ +|.+++.. ....+++.++..++.|++.||.|||+. +++|+||||+||++++++.++|+|||++......
T Consensus        85 lv~e~~~~-~l~~~l~~-~~~~l~~~~~~~~~~qi~~~l~~lH~~-~i~H~dl~p~nil~~~~~~~kL~dfg~~~~~~~~  161 (309)
T cd07845          85 LVMEYCEQ-DLASLLDN-MPTPFSESQVKCLMLQLLRGLQYLHEN-FIIHRDLKVSNLLLTDKGCLKIADFGLARTYGLP  161 (309)
T ss_pred             EEEecCCC-CHHHHHHh-cccCCCHHHHHHHHHHHHHHHHHHHhC-CeecCCCCHHHEEECCCCCEEECccceeeecCCc
Confidence            99999975 78888754 236789999999999999999999999 9999999999999999999999999998765433


Q ss_pred             C----CccCcccccCcccccC-CCCCCcccchhhhHHHHHHHhCCCCCCchhhHHHhhhchhh-------hcc-------
Q 020221          210 R----SYSTNLAFTPPEYLRT-GRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQT-------LTD-------  270 (329)
Q Consensus       210 ~----~~~~~~~y~aPE~~~~-~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~~~~~~~~-------~~~-------  270 (329)
                      .    ...++..|+|||.+.+ ..++.++||||||+++|+|++|..||...............       ...       
T Consensus       162 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  241 (309)
T cd07845         162 AKPMTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEIEQLDLIIQLLGTPNESIWPGFSDLPL  241 (309)
T ss_pred             cCCCCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChhhchhhhcccc
Confidence            1    2234678999999875 44788999999999999999999887644322111110000       000       


Q ss_pred             --cc-cc-CCC------ChHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 020221          271 --SC-LE-GQF------SSDEGTELVRLASRCLQYEPRERPNPRSLVT  308 (329)
Q Consensus       271 --~~-~~-~~~------~~~~~~~~~~li~~cl~~dp~~Rps~~~~l~  308 (329)
                        .. .. ...      ....++++.+++.+||..||++|||+.+++.
T Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~~il~  289 (309)
T cd07845         242 VGKFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALE  289 (309)
T ss_pred             cccccccCCCCCchHHhccccCHHHHHHHHHHhcCChhhCcCHHHHhc
Confidence              00 00 000      0124678899999999999999999999997

Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing

>cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9

Probab=100.00  E-value=1.1e-39  Score=289.84  Aligned_cols=250  Identities=18%  Similarity=0.232  Sum_probs=190.3

Q ss_pred             CCCcccccccCCCCCCcEEEEEE-eCCCCEEEEEEeCCCCCh--hHHHHHHHHHHHhcCCCccccccceeeeeCC-----
Q 020221           55 GFAMENIVSEHGEKAPNVVYKGK-LENQFRIAVKRFNRSAWP--DARQFLEEARAVGQLRNRRLANLLGCCCEGD-----  126 (329)
Q Consensus        55 ~~~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~--~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~-----  126 (329)
                      ....|++++.||+|+||.||++. ..+++.||+|.+......  ....+.+|+++++.++||||+++++++....     
T Consensus        10 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~   89 (310)
T cd07865          10 EVSKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPYNR   89 (310)
T ss_pred             hhhheEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcCCchhHHHHHHHHHHhCCCCCccceEEEEecccccccC
Confidence            34557788889999999999999 456889999998654322  2334678999999999999999999886543     


Q ss_pred             ---eeEEEEecCCCCCHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCCCCCeeeecccCc
Q 020221          127 ---ERLLVAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLM  203 (329)
Q Consensus       127 ---~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a  203 (329)
                         ..++||||+.+ +|.+.+.. ....+++.++..++.|++.||.|||+. +++|+||||+||+++.++.++|+|||++
T Consensus        90 ~~~~~~lv~e~~~~-~l~~~l~~-~~~~~~~~~~~~i~~qi~~al~~lH~~-~i~H~dl~p~nil~~~~~~~kl~dfg~~  166 (310)
T cd07865          90 YKGSFYLVFEFCEH-DLAGLLSN-KNVKFTLSEIKKVMKMLLNGLYYIHRN-KILHRDMKAANILITKDGILKLADFGLA  166 (310)
T ss_pred             CCceEEEEEcCCCc-CHHHHHHh-cccCCCHHHHHHHHHHHHHHHHHHHHC-CeeccCCCHHHEEECCCCcEEECcCCCc
Confidence               45999999965 78887754 334689999999999999999999999 9999999999999999999999999998


Q ss_pred             ccCCCCC--------CccCcccccCcccccCCC-CCCcccchhhhHHHHHHHhCCCCCCchhhHHHhhhchhhhc-----
Q 020221          204 KNSRDGR--------SYSTNLAFTPPEYLRTGR-VTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLT-----  269 (329)
Q Consensus       204 ~~~~~~~--------~~~~~~~y~aPE~~~~~~-~~~~~DvwslG~il~el~tg~~~~~~~~~~~~~~~~~~~~~-----  269 (329)
                      .......        ...++..|+|||.+.+.. ++.++||||||+++|+|++|..|+........... ...+.     
T Consensus       167 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~~~~~~~~~-~~~~~~~~~~  245 (310)
T cd07865         167 RAFSLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQLTL-ISQLCGSITP  245 (310)
T ss_pred             ccccCCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHH-HHHHhCCCCh
Confidence            7543321        223567899999887654 78899999999999999999977754322111000 00000     


Q ss_pred             ---ccc----------ccCC---------CChHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 020221          270 ---DSC----------LEGQ---------FSSDEGTELVRLASRCLQYEPRERPNPRSLVT  308 (329)
Q Consensus       270 ---~~~----------~~~~---------~~~~~~~~~~~li~~cl~~dp~~Rps~~~~l~  308 (329)
                         +..          ....         .+...+..+.+++.+||..||++|||+.++++
T Consensus       246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~dli~~~l~~~P~~R~t~~e~l~  306 (310)
T cd07865         246 EVWPGVDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRIDADTALN  306 (310)
T ss_pred             hhcccccchhhhhhccCCCccchhhHHhcccccCCHHHHHHHHHHhcCChhhccCHHHHhc
Confidence               000          0000         00112456789999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl

>cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase

Probab=100.00  E-value=2.5e-39  Score=283.67  Aligned_cols=238  Identities=19%  Similarity=0.191  Sum_probs=187.4

Q ss_pred             CCCCCCcEEEEEE-eCCCCEEEEEEeCCCCChh---HHHHHHHH---HHHhcCCCccccccceeeeeCCeeEEEEecCCC
Q 020221           65 HGEKAPNVVYKGK-LENQFRIAVKRFNRSAWPD---ARQFLEEA---RAVGQLRNRRLANLLGCCCEGDERLLVAEYMPN  137 (329)
Q Consensus        65 lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~---~~~~~~e~---~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~  137 (329)
                      ||+|+||.||++. ..+++.||+|.+.......   ...+..|.   +.++...||||+++.+++.+.+..++||||+.+
T Consensus         2 ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~g   81 (278)
T cd05606           2 IGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMNG   81 (278)
T ss_pred             cccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCEEEEEEecCCC
Confidence            5999999999998 4568899999987643221   11233343   344455799999999999999999999999999


Q ss_pred             CCHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCCCCCeeeecccCcccCCCC--CCccCc
Q 020221          138 DTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDG--RSYSTN  215 (329)
Q Consensus       138 gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~--~~~~~~  215 (329)
                      ++|..++.  ....+++..+..++.|++.||.|||+. +++|+||||+||+++.++.++|+|||++......  ....++
T Consensus        82 ~~L~~~l~--~~~~l~~~~~~~~~~ql~~~l~~lH~~-~i~H~di~p~nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~  158 (278)
T cd05606          82 GDLHYHLS--QHGVFSEAEMRFYAAEIILGLEHMHNR-FVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASVGT  158 (278)
T ss_pred             CcHHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHHC-CEEcCCCCHHHEEECCCCCEEEccCcCccccCccCCcCcCCC
Confidence            99999886  345689999999999999999999999 9999999999999999999999999998754332  234678


Q ss_pred             ccccCcccccCC-CCCCcccchhhhHHHHHHHhCCCCCCchhhHHHhhhchhhhccccccCCCChHHHHHHHHHHHHhcc
Q 020221          216 LAFTPPEYLRTG-RVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLASRCLQ  294 (329)
Q Consensus       216 ~~y~aPE~~~~~-~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~  294 (329)
                      ..|+|||.+.++ .++.++||||+|+++|+|++|..||...........  .... .......+...+.++.+++.+||.
T Consensus       159 ~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~~~~--~~~~-~~~~~~~~~~~s~~~~~li~~~l~  235 (278)
T cd05606         159 HGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEI--DRMT-LTMAVELPDSFSPELRSLLEGLLQ  235 (278)
T ss_pred             cCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCccchHHH--HHHh-hccCCCCCCcCCHHHHHHHHHHhh
Confidence            999999998755 588999999999999999999988764411111000  0000 011223444567899999999999


Q ss_pred             cCCCCCC-----CHHHHHH
Q 020221          295 YEPRERP-----NPRSLVT  308 (329)
Q Consensus       295 ~dp~~Rp-----s~~~~l~  308 (329)
                      .||++||     ++.++++
T Consensus       236 ~~p~~R~~~~~~~~~~ll~  254 (278)
T cd05606         236 RDVNRRLGCLGRGAQEVKE  254 (278)
T ss_pred             cCHHhccCCCCCCHHHHHh
Confidence            9999999     9999986

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co

>cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein

Probab=100.00  E-value=1.8e-39  Score=289.31  Aligned_cols=239  Identities=18%  Similarity=0.212  Sum_probs=186.2

Q ss_pred             CCcEEEEEE-eCCCCEEEEEEeCCC--CChhHHHHHHHHHHHhcCCCccccccceeeeeCCeeEEEEecCCCCCHHhhhc
Q 020221           69 APNVVYKGK-LENQFRIAVKRFNRS--AWPDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAEYMPNDTLAKHLF  145 (329)
Q Consensus        69 ~~g~V~~~~-~~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~  145 (329)
                      ++|.||.+. ..+++.||+|++...  .....+.+.+|++.++.++|+||+++++++......+++|||+++++|.+++.
T Consensus        12 ~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~~~~~~l~~~l~   91 (314)
T cd08216          12 DLMIVHLAKHKPTNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMAYGSCEDLLK   91 (314)
T ss_pred             CCceEEEEEecCCCCEEEEEEEeccccchhHHHHHHHHHHHHHhcCCcchhhhhheeecCCeEEEEEeccCCCCHHHHHH
Confidence            445555555 336889999998765  23345678999999999999999999999999999999999999999999997


Q ss_pred             cCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCCCCCeeeecccCcccCCCC-----------CCccC
Q 020221          146 HWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDG-----------RSYST  214 (329)
Q Consensus       146 ~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~-----------~~~~~  214 (329)
                      +.....+++..+..++.|++.||.|||+. +++|+||||+||+++.++.++|+|||.+......           ....+
T Consensus        92 ~~~~~~~~~~~~~~~~~~l~~~L~~LH~~-~ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~~~~~~~~~~~~~~~~  170 (314)
T cd08216          92 THFPEGLPELAIAFILKDVLNALDYIHSK-GFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVVHDFPKSSVK  170 (314)
T ss_pred             HhcccCCCHHHHHHHHHHHHHHHHHHHHC-CeecCCCCcceEEEecCCceEEecCccceeeccccccccccccccccccc
Confidence            54455689999999999999999999999 9999999999999999999999999987643221           12345


Q ss_pred             cccccCcccccCC--CCCCcccchhhhHHHHHHHhCCCCCCchhhHHHhhhchh----hhc-------------------
Q 020221          215 NLAFTPPEYLRTG--RVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQ----TLT-------------------  269 (329)
Q Consensus       215 ~~~y~aPE~~~~~--~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~~~~~~~----~~~-------------------  269 (329)
                      +..|+|||++.+.  .++.++||||||+++|+|++|..||..............    ...                   
T Consensus       171 ~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  250 (314)
T cd08216         171 NLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQMLLEKVRGTVPCLLDKSTYPLYEDSMSQSRSSN  250 (314)
T ss_pred             cccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCccccccCchhhhcCCcCcccccc
Confidence            6789999998763  488899999999999999999988764321111000000    000                   


Q ss_pred             -----cccccCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 020221          270 -----DSCLEGQFSSDEGTELVRLASRCLQYEPRERPNPRSLVT  308 (329)
Q Consensus       270 -----~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~~~l~  308 (329)
                           ............+.++.+++.+||..||++|||+.++++
T Consensus       251 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~  294 (314)
T cd08216         251 EHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLN  294 (314)
T ss_pred             cccchhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcCHHHHhc
Confidence                 000011122345678999999999999999999999997

Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc

>cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.4e-39  Score=281.48  Aligned_cols=242  Identities=17%  Similarity=0.195  Sum_probs=196.1

Q ss_pred             ccccccCCCCCCcEEEEEE-eCCCCEEEEEEeCCCC-----ChhHHHHHHHHHHHhcCCCccccccceeeeeC--CeeEE
Q 020221           59 ENIVSEHGEKAPNVVYKGK-LENQFRIAVKRFNRSA-----WPDARQFLEEARAVGQLRNRRLANLLGCCCEG--DERLL  130 (329)
Q Consensus        59 ~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~-----~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~--~~~~l  130 (329)
                      |++.+.||+|+||.||++. ..+++.||+|.+....     ......+.+|+++++.++|+||+++++++.+.  ...++
T Consensus         4 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~   83 (264)
T cd06653           4 WRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKLSI   83 (264)
T ss_pred             eeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCCEEEE
Confidence            5566677999999999998 4568899999875321     22345688999999999999999999998664  46889


Q ss_pred             EEecCCCCCHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCCCCCeeeecccCcccCCCC-
Q 020221          131 VAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDG-  209 (329)
Q Consensus       131 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~-  209 (329)
                      ++||+++++|.+++..  ...+++.....++.|++.||.|||+. +++|+||||+||+++.++.++|+|||++...... 
T Consensus        84 v~e~~~~~~L~~~~~~--~~~l~~~~~~~~~~~i~~al~~LH~~-~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~  160 (264)
T cd06653          84 FVEYMPGGSIKDQLKA--YGALTENVTRRYTRQILQGVSYLHSN-MIVHRDIKGANILRDSAGNVKLGDFGASKRIQTIC  160 (264)
T ss_pred             EEEeCCCCcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHhC-CEecCCCCHHHEEEcCCCCEEECcccccccccccc
Confidence            9999999999999863  34588999999999999999999999 9999999999999999999999999998754321 


Q ss_pred             ------CCccCcccccCcccccCCCCCCcccchhhhHHHHHHHhCCCCCCchhhHHHhhhchhhhccccccCCCChHHHH
Q 020221          210 ------RSYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGT  283 (329)
Q Consensus       210 ------~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  283 (329)
                            ....++..|+|||.+.+..++.++|+||||+++++|++|..||.........    ............+...++
T Consensus       161 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~----~~~~~~~~~~~~p~~~~~  236 (264)
T cd06653         161 MSGTGIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWAEYEAMAAI----FKIATQPTKPMLPDGVSD  236 (264)
T ss_pred             ccCccccccCCcccccCHhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCccCHHHHH----HHHHcCCCCCCCCcccCH
Confidence                  1235678899999999888999999999999999999999887543211111    111111122345667788


Q ss_pred             HHHHHHHHhcccCCCCCCCHHHHHH
Q 020221          284 ELVRLASRCLQYEPRERPNPRSLVT  308 (329)
Q Consensus       284 ~~~~li~~cl~~dp~~Rps~~~~l~  308 (329)
                      ++.+++.+||. +|..||++.+++.
T Consensus       237 ~~~~~i~~~l~-~~~~r~~~~~~~~  260 (264)
T cd06653         237 ACRDFLKQIFV-EEKRRPTAEFLLR  260 (264)
T ss_pred             HHHHHHHHHhc-CcccCccHHHHhc
Confidence            99999999998 6799999999887

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho

>KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=4.5e-40  Score=275.34  Aligned_cols=240  Identities=18%  Similarity=0.215  Sum_probs=195.4

Q ss_pred             cCCCCCCcEEEEEE-eCCCCEEEEEEeCCCCChhHHHHHHHHHHHhcCC-CccccccceeeeeCCeeEEEEecCCCCCHH
Q 020221           64 EHGEKAPNVVYKGK-LENQFRIAVKRFNRSAWPDARQFLEEARAVGQLR-NRRLANLLGCCCEGDERLLVAEYMPNDTLA  141 (329)
Q Consensus        64 ~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~~~~lv~e~~~~gsL~  141 (329)
                      .||+|+|+.|-.++ +.+|..+|||++.+........+.+|++++...+ |+||++++++|+++..+|||||-|.||+|.
T Consensus        85 ~LGeGAyasVqtcv~i~t~~EYAVKiidKq~gHsR~RvfREVe~f~~Cqgh~nilqLiefFEdd~~FYLVfEKm~GGplL  164 (463)
T KOG0607|consen   85 LLGEGAYASVQTCVSIQTGKEYAVKIIDKQPGHSRSRVFREVETFYQCQGHKNILQLIEFFEDDTRFYLVFEKMRGGPLL  164 (463)
T ss_pred             HhcCccceeeeeeeeeccchhhhhhhhhcCCchHHHHHHHHHHHHHHhcCCccHHHHHHHhcccceEEEEEecccCchHH
Confidence            46999999999998 8899999999998887666778999999999995 999999999999999999999999999999


Q ss_pred             hhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCCCC---CeeeecccCcccCCCC---------
Q 020221          142 KHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDV---NPRLSCFGLMKNSRDG---------  209 (329)
Q Consensus       142 ~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~---~~kl~Dfg~a~~~~~~---------  209 (329)
                      +.|.  +...+++.++.++.++|+.||.|||.+ ||.|||+||+|||-....   -+||+||.+.......         
T Consensus       165 shI~--~~~~F~E~EAs~vvkdia~aLdFlH~k-gIAHRDlKPENiLC~~pn~vsPvKiCDfDLgSg~k~~~~~spastP  241 (463)
T KOG0607|consen  165 SHIQ--KRKHFNEREASRVVKDIASALDFLHTK-GIAHRDLKPENILCESPNKVSPVKICDFDLGSGIKLNNDCSPASTP  241 (463)
T ss_pred             HHHH--HhhhccHHHHHHHHHHHHHHHHHHhhc-CcccccCCccceeecCCCCcCceeeeccccccccccCCCCCCCCCc
Confidence            9997  567899999999999999999999999 999999999999997544   3899999887543221         


Q ss_pred             --CCccCcccccCccccc---CC--CCCCcccchhhhHHHHHHHhCCCCCCchhhH-----------HHhhhchhhhccc
Q 020221          210 --RSYSTNLAFTPPEYLR---TG--RVTPESVMYSFGTLLLDLLSGKHIPPSHALD-----------LIRDRNIQTLTDS  271 (329)
Q Consensus       210 --~~~~~~~~y~aPE~~~---~~--~~~~~~DvwslG~il~el~tg~~~~~~~~~~-----------~~~~~~~~~~~~~  271 (329)
                        .+.+|+-.|||||+..   +.  .|+.+.|.||||||||-|++|.+||.+..-.           .-.+.....+-+.
T Consensus       242 ~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg~dCGWdrGe~Cr~CQ~~LFesIQEG  321 (463)
T KOG0607|consen  242 ELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEG  321 (463)
T ss_pred             cccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccCCcCCccCCCccHHHHHHHHHHHhcc
Confidence              1234567899999763   32  3888999999999999999999998653110           0011111111111


Q ss_pred             cccCCCC----hHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 020221          272 CLEGQFS----SDEGTELVRLASRCLQYEPRERPNPRSLVT  308 (329)
Q Consensus       272 ~~~~~~~----~~~~~~~~~li~~cl~~dp~~Rps~~~~l~  308 (329)
                        ...+|    ...|.+..+++..+|..|+.+|.++.++++
T Consensus       322 --kYeFPdkdWahIS~eakdlisnLlvrda~~rlsa~~vln  360 (463)
T KOG0607|consen  322 --KYEFPDKDWAHISSEAKDLISNLLVRDAKQRLSAAQVLN  360 (463)
T ss_pred             --CCcCChhhhHHhhHHHHHHHHHHHhccHHhhhhhhhccC
Confidence              11233    357889999999999999999999999998

>cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85

Probab=100.00  E-value=9.9e-40  Score=286.75  Aligned_cols=248  Identities=17%  Similarity=0.250  Sum_probs=195.0

Q ss_pred             ccccccCCCCCCcEEEEEEe-CCCCEEEEEEeCCCCCh-hHHHHHHHHHHHhcCCCccccccceeeeeCCeeEEEEecCC
Q 020221           59 ENIVSEHGEKAPNVVYKGKL-ENQFRIAVKRFNRSAWP-DARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAEYMP  136 (329)
Q Consensus        59 ~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~  136 (329)
                      |++++.||.|++|.||+|.. .+++.||+|.++..... ....+.+|+.+++.++|+||+++++++...+..++||||++
T Consensus         2 y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~   81 (284)
T cd07836           2 FKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHDVIHTENKLMLVFEYMD   81 (284)
T ss_pred             ceEeeeeccCCceEEEEEEECCCCeEEEEEEecccccccchHHHHHHHHHHHhhcCCCEeeeeeeEeeCCcEEEEEecCC
Confidence            55677889999999999995 56889999998765432 24567789999999999999999999999999999999998


Q ss_pred             CCCHHhhhccCC-CCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCCCCCeeeecccCcccCCCC----CC
Q 020221          137 NDTLAKHLFHWE-TQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDG----RS  211 (329)
Q Consensus       137 ~gsL~~~l~~~~-~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~----~~  211 (329)
                      + +|.+++.... ...+++..+..++.|++.||.|||+. +++|+||||+||++++++.++|+|||++......    ..
T Consensus        82 ~-~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~-~i~h~dl~p~ni~~~~~~~~~l~d~g~~~~~~~~~~~~~~  159 (284)
T cd07836          82 K-DLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHEN-RVLHRDLKPQNLLINKRGELKLADFGLARAFGIPVNTFSN  159 (284)
T ss_pred             c-cHHHHHHhcCCCCCcCHHHHHHHHHHHHHHHHHHHHC-CeeeCCCCHHHEEECCCCcEEEeecchhhhhcCCcccccc
Confidence            5 8888875422 24689999999999999999999999 9999999999999999999999999998654322    22


Q ss_pred             ccCcccccCcccccCC-CCCCcccchhhhHHHHHHHhCCCCCCchhhHHHhhhchhhh-----------cc-ccccC---
Q 020221          212 YSTNLAFTPPEYLRTG-RVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTL-----------TD-SCLEG---  275 (329)
Q Consensus       212 ~~~~~~y~aPE~~~~~-~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~~~~~~~~~-----------~~-~~~~~---  275 (329)
                      ..++..|+|||.+.+. .++.++||||||+++|+|++|..|+................           .. +....   
T Consensus       160 ~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (284)
T cd07836         160 EVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFRIMGTPTESTWPGISQLPEYKPTFP  239 (284)
T ss_pred             ccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhHHHHhcCchhccccc
Confidence            3457889999988664 47889999999999999999998876443221111110000           00 00000   


Q ss_pred             --------CCChHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 020221          276 --------QFSSDEGTELVRLASRCLQYEPRERPNPRSLVT  308 (329)
Q Consensus       276 --------~~~~~~~~~~~~li~~cl~~dp~~Rps~~~~l~  308 (329)
                              ......+..+.+++..||+.||++||++.++++
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~  280 (284)
T cd07836         240 RYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQ  280 (284)
T ss_pred             CCChHHHHHHhhhcCcHHHHHHHHHhcCCcccCCCHHHHhc
Confidence                    011234678899999999999999999999997

Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment.

>cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases

Probab=100.00  E-value=7.2e-40  Score=294.72  Aligned_cols=252  Identities=17%  Similarity=0.252  Sum_probs=193.2

Q ss_pred             cccccccCCCCCCcEEEEEE-eCCCCEEEEEEeCCCC-ChhHHHHHHHHHHHhcCCCccccccceeeeeC-----CeeEE
Q 020221           58 MENIVSEHGEKAPNVVYKGK-LENQFRIAVKRFNRSA-WPDARQFLEEARAVGQLRNRRLANLLGCCCEG-----DERLL  130 (329)
Q Consensus        58 ~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~-----~~~~l  130 (329)
                      .|++.+.||+|+||.||+|. ..+++.||+|.+.... ......+.+|+.+++.++|+||+++++++...     ...++
T Consensus         6 ~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l   85 (336)
T cd07849           6 RYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESFNDVYI   85 (336)
T ss_pred             ceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEecccccchhHHHHHHHHHHHHhCCCCCcCchhheeecccccccceEEE
Confidence            46677788999999999998 5578899999986432 22345678899999999999999999886543     35799


Q ss_pred             EEecCCCCCHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCCCCCeeeecccCcccCCCCC
Q 020221          131 VAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDGR  210 (329)
Q Consensus       131 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~  210 (329)
                      ++||+.+ +|...+   ....+++..+..++.|++.||.|||+. +++|+||||+||+++.++.++|+|||++.......
T Consensus        86 v~e~~~~-~l~~~~---~~~~l~~~~~~~i~~ql~~aL~~LH~~-~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~  160 (336)
T cd07849          86 VQELMET-DLYKLI---KTQHLSNDHIQYFLYQILRGLKYIHSA-NVLHRDLKPSNLLLNTNCDLKICDFGLARIADPEH  160 (336)
T ss_pred             Eehhccc-CHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHhC-CeeccCCCHHHEEECCCCCEEECcccceeeccccc
Confidence            9999975 888877   446799999999999999999999999 99999999999999999999999999987543321


Q ss_pred             -------CccCcccccCcccccC-CCCCCcccchhhhHHHHHHHhCCCCCCchhhHHHhhhc-----------hhh----
Q 020221          211 -------SYSTNLAFTPPEYLRT-GRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRN-----------IQT----  267 (329)
Q Consensus       211 -------~~~~~~~y~aPE~~~~-~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~~~~~-----------~~~----  267 (329)
                             ...++..|+|||.+.+ ..++.++||||||+++|+|++|+.||+...........           ...    
T Consensus       161 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (336)
T cd07849         161 DHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLHQLNLILGVLGTPSQEDLNCIISL  240 (336)
T ss_pred             cccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHHhhch
Confidence                   2356788999998754 45888999999999999999999887643211100000           000    


Q ss_pred             ----hccccc-cCC-----CChHHHHHHHHHHHHhcccCCCCCCCHHHHHHH--HHhhh
Q 020221          268 ----LTDSCL-EGQ-----FSSDEGTELVRLASRCLQYEPRERPNPRSLVTA--LVTLQ  314 (329)
Q Consensus       268 ----~~~~~~-~~~-----~~~~~~~~~~~li~~cl~~dp~~Rps~~~~l~~--L~~~~  314 (329)
                          ...... ...     .....++++.+++.+||+.||++|||+.+++++  ++...
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~e~l~hp~~~~~~  299 (336)
T cd07849         241 RARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALAHPYLEQYH  299 (336)
T ss_pred             hhhhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCcCHHHHhcCccccccC
Confidence                000000 000     011246789999999999999999999999985  44443

Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase

>KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.5e-40  Score=316.37  Aligned_cols=247  Identities=19%  Similarity=0.172  Sum_probs=205.4

Q ss_pred             cCCCcccccccCCCCCCcEEEEEE-eCCCCEEEEEEeCCC---CChhHHHHHHHHHHHhcCCCccccccceeeeeCCeeE
Q 020221           54 SGFAMENIVSEHGEKAPNVVYKGK-LENQFRIAVKRFNRS---AWPDARQFLEEARAVGQLRNRRLANLLGCCCEGDERL  129 (329)
Q Consensus        54 ~~~~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~  129 (329)
                      -+-+++++++.||+|+||.|..++ ..+++.||+|++.+.   ......-|..|-.+|..-..+-|+++..+|++..++|
T Consensus        72 l~~~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyAFQD~~~LY  151 (1317)
T KOG0612|consen   72 LKAEDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYAFQDERYLY  151 (1317)
T ss_pred             CCHHhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHHhcCccceE
Confidence            344567788888999999999999 567889999999762   2223345888999999999999999999999999999


Q ss_pred             EEEecCCCCCHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCCCCCeeeecccCcccCC-C
Q 020221          130 LVAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSR-D  208 (329)
Q Consensus       130 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~-~  208 (329)
                      +|||||+||+|..++.+..  .+++..++.++.+|.-||..||+. |+|||||||+|||+|.+|++||+|||.+-... +
T Consensus       152 lVMdY~pGGDlltLlSk~~--~~pE~~ArFY~aEiVlAldslH~m-gyVHRDiKPDNvLld~~GHikLADFGsClkm~~d  228 (1317)
T KOG0612|consen  152 LVMDYMPGGDLLTLLSKFD--RLPEDWARFYTAEIVLALDSLHSM-GYVHRDIKPDNVLLDKSGHIKLADFGSCLKMDAD  228 (1317)
T ss_pred             EEEecccCchHHHHHhhcC--CChHHHHHHHHHHHHHHHHHHHhc-cceeccCCcceeEecccCcEeeccchhHHhcCCC
Confidence            9999999999999997433  799999999999999999999999 99999999999999999999999999876655 3


Q ss_pred             C----CCccCcccccCccccc----C-CCCCCcccchhhhHHHHHHHhCCCCCCchhhHHHhhhchhhhccccccCCCC-
Q 020221          209 G----RSYSTNLAFTPPEYLR----T-GRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFS-  278 (329)
Q Consensus       209 ~----~~~~~~~~y~aPE~~~----~-~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-  278 (329)
                      +    ...+|||.|++||++.    + +.|....|+||+||++|||+.|.-||+.+..-.....++.. . ..+  .+| 
T Consensus       229 G~V~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYadslveTY~KIm~h-k-~~l--~FP~  304 (1317)
T KOG0612|consen  229 GTVRSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYADSLVETYGKIMNH-K-ESL--SFPD  304 (1317)
T ss_pred             CcEEeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchHHHHHHHHHHHhch-h-hhc--CCCc
Confidence            3    2457999999999985    3 45999999999999999999999999877554443332221 1 111  233 


Q ss_pred             -hHHHHHHHHHHHHhcccCCCCCCC---HHHHHH
Q 020221          279 -SDEGTELVRLASRCLQYEPRERPN---PRSLVT  308 (329)
Q Consensus       279 -~~~~~~~~~li~~cl~~dp~~Rps---~~~~l~  308 (329)
                       .+.|+++.+||.+.+. +|+.|..   ++++.+
T Consensus       305 ~~~VSeeakdLI~~ll~-~~e~RLgrngiedik~  337 (1317)
T KOG0612|consen  305 ETDVSEEAKDLIEALLC-DREVRLGRNGIEDIKN  337 (1317)
T ss_pred             ccccCHHHHHHHHHHhc-ChhhhcccccHHHHHh
Confidence             4589999999999994 8999988   777776

>cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases

Probab=100.00  E-value=1.4e-39  Score=290.24  Aligned_cols=248  Identities=17%  Similarity=0.221  Sum_probs=190.9

Q ss_pred             ccccccCCCCCCcEEEEEEe-C--CCCEEEEEEeCCCC---ChhHHHHHHHHHHHhcCCCccccccceeeeeC--CeeEE
Q 020221           59 ENIVSEHGEKAPNVVYKGKL-E--NQFRIAVKRFNRSA---WPDARQFLEEARAVGQLRNRRLANLLGCCCEG--DERLL  130 (329)
Q Consensus        59 ~~~~~~lg~G~~g~V~~~~~-~--~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~--~~~~l  130 (329)
                      |.+++.||+|+||.||+|.. .  ++..||+|.+....   ....+.+.+|+.+++.++||||+++++++.+.  ...++
T Consensus         2 y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~l   81 (316)
T cd07842           2 YEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEHADKSVYL   81 (316)
T ss_pred             ceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCCceEEE
Confidence            45677789999999999995 3  57899999998743   23345678899999999999999999999887  78999


Q ss_pred             EEecCCCCCHHhhhccC---CCCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCC----CCCeeeecccCc
Q 020221          131 VAEYMPNDTLAKHLFHW---ETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDD----DVNPRLSCFGLM  203 (329)
Q Consensus       131 v~e~~~~gsL~~~l~~~---~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~----~~~~kl~Dfg~a  203 (329)
                      ||||+++ +|.+.+...   ....+++..++.++.|++.||.|||+. +++|+||||+||+++.    ++.+||+|||++
T Consensus        82 v~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~-~i~h~dlkp~Nil~~~~~~~~~~~kl~Dfg~~  159 (316)
T cd07842          82 LFDYAEH-DLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSN-WVLHRDLKPANILVMGEGPERGVVKIGDLGLA  159 (316)
T ss_pred             EEeCCCc-CHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhC-CEeeCCCCHHHEEEcCCCCccceEEECCCccc
Confidence            9999976 677766422   123688999999999999999999999 9999999999999999    999999999998


Q ss_pred             ccCCCC-------CCccCcccccCcccccCC-CCCCcccchhhhHHHHHHHhCCCCCCchhhHH---------Hhhhch-
Q 020221          204 KNSRDG-------RSYSTNLAFTPPEYLRTG-RVTPESVMYSFGTLLLDLLSGKHIPPSHALDL---------IRDRNI-  265 (329)
Q Consensus       204 ~~~~~~-------~~~~~~~~y~aPE~~~~~-~~~~~~DvwslG~il~el~tg~~~~~~~~~~~---------~~~~~~-  265 (329)
                      ......       ....++..|+|||++.+. .++.++||||||+++++|++|..|+.......         ...... 
T Consensus       160 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (316)
T cd07842         160 RLFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQRDQLERIFE  239 (316)
T ss_pred             cccCCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCcccccccchhHHHHHHHHHH
Confidence            764332       223457889999988764 48889999999999999999998775332111         000000 


Q ss_pred             -------------------hhhccccccCCCC-----------hHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 020221          266 -------------------QTLTDSCLEGQFS-----------SDEGTELVRLASRCLQYEPRERPNPRSLVT  308 (329)
Q Consensus       266 -------------------~~~~~~~~~~~~~-----------~~~~~~~~~li~~cl~~dp~~Rps~~~~l~  308 (329)
                                         ....+......++           ...+.++.+++.+||+.||++|||+.++++
T Consensus       240 ~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~eil~  312 (316)
T cd07842         240 VLGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLRKLLEYDPTKRITAEEALE  312 (316)
T ss_pred             HhCCCchhHHHHHhhcccchhhhhhccCCCCCCccHHHHHHhccCCCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence                               0000000000111           034567899999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the

>cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase

Probab=100.00  E-value=1.2e-39  Score=292.60  Aligned_cols=254  Identities=20%  Similarity=0.297  Sum_probs=200.5

Q ss_pred             ccccccCCCCCCcEEEEEEe-CCCCEEEEEEeCCCC--ChhHHHHHHHHHHHhcCCCccccccceeeeeCC-----eeEE
Q 020221           59 ENIVSEHGEKAPNVVYKGKL-ENQFRIAVKRFNRSA--WPDARQFLEEARAVGQLRNRRLANLLGCCCEGD-----ERLL  130 (329)
Q Consensus        59 ~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~-----~~~l  130 (329)
                      |.+.+.||+|++|.||++.. .+++.+|+|++....  ....+.+.+|+.+++.++|+||+++.+++....     ..++
T Consensus         2 y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~l   81 (330)
T cd07834           2 YELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDVYI   81 (330)
T ss_pred             ceeeeeecCCCCeEEEEEEeCCCCcEEEEEeeccccccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccceEE
Confidence            55667789999999999994 458899999987653  233567889999999999999999999987765     7899


Q ss_pred             EEecCCCCCHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCCCCCeeeecccCcccCCCCC
Q 020221          131 VAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDGR  210 (329)
Q Consensus       131 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~  210 (329)
                      +|||+.+ +|.+++.+  ...+++..+..++.|++.||+|||+. |++|+||||+||+++.++.++|+|||++.......
T Consensus        82 v~e~~~~-~l~~~l~~--~~~l~~~~~~~i~~~l~~~l~~LH~~-gi~H~dlkp~nili~~~~~~~L~dfg~~~~~~~~~  157 (330)
T cd07834          82 VTELMET-DLHKVIKS--PQPLTDDHIQYFLYQILRGLKYLHSA-NVIHRDLKPSNILVNSNCDLKICDFGLARGVDPDE  157 (330)
T ss_pred             Eecchhh-hHHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHHhC-CeecCCCCHHHEEEcCCCCEEEcccCceEeecccc
Confidence            9999975 89888863  34789999999999999999999999 99999999999999999999999999988655432


Q ss_pred             -------CccCcccccCcccccCC-CCCCcccchhhhHHHHHHHhCCCCCCchhhHHHhhhchhhh--------------
Q 020221          211 -------SYSTNLAFTPPEYLRTG-RVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTL--------------  268 (329)
Q Consensus       211 -------~~~~~~~y~aPE~~~~~-~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~~~~~~~~~--------------  268 (329)
                             ...++..|+|||.+.+. .++.++|+||||+++|+|++|..||................              
T Consensus       158 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  237 (330)
T cd07834         158 DEKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQLNLIVEVLGTPSEEDLKFITSE  237 (330)
T ss_pred             cccccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHhcCCCChhHhhhcccc
Confidence                   23467889999999887 78899999999999999999998886543221111110000              


Q ss_pred             -----cc---cc---ccCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHH--HHhhhhc
Q 020221          269 -----TD---SC---LEGQFSSDEGTELVRLASRCLQYEPRERPNPRSLVTA--LVTLQKD  316 (329)
Q Consensus       269 -----~~---~~---~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~~~l~~--L~~~~~~  316 (329)
                           ..   ..   .........++++.+++.+||+.||++||++.+++.+  ++.+...
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~~~~~~~  298 (330)
T cd07834         238 KARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALAHPYLAQLHDP  298 (330)
T ss_pred             chhhHHhhcccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCCHHHHHhCccHHhhccc
Confidence                 00   00   0000112356789999999999999999999999983  5555443

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and

>cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5

Probab=100.00  E-value=1.5e-39  Score=292.50  Aligned_cols=247  Identities=17%  Similarity=0.257  Sum_probs=191.7

Q ss_pred             cccccccCCCCCCcEEEEEE-eCCCCEEEEEEeCCCCC--hhHHHHHHHHHHHhcCCCccccccceeeee----CCeeEE
Q 020221           58 MENIVSEHGEKAPNVVYKGK-LENQFRIAVKRFNRSAW--PDARQFLEEARAVGQLRNRRLANLLGCCCE----GDERLL  130 (329)
Q Consensus        58 ~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~~~~~~~~----~~~~~l  130 (329)
                      .|++.+.||+|+||.||++. ..+++.||+|++.....  .....+.+|+.+++.++||||+++++++..    ....++
T Consensus         6 ~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~l   85 (334)
T cd07855           6 RYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFKDVYV   85 (334)
T ss_pred             ceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccccccchHHHHHHHHHHHhcCCCCccCHHHhccccCCCCceEEE
Confidence            34566677999999999998 55689999999876432  234567889999999999999999988753    356899


Q ss_pred             EEecCCCCCHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCCCCCeeeecccCcccCCCCC
Q 020221          131 VAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDGR  210 (329)
Q Consensus       131 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~  210 (329)
                      |+||+. ++|.+++.  ....+++..+..++.|++.||.|||+. +++|+||||+||+++.++.++|+|||++.......
T Consensus        86 v~e~~~-~~l~~~~~--~~~~~~~~~~~~i~~qi~~aL~~LH~~-~ivH~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~  161 (334)
T cd07855          86 VMDLME-SDLHHIIH--SDQPLTEEHIRYFLYQLLRGLKYIHSA-NVIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSP  161 (334)
T ss_pred             EEehhh-hhHHHHhc--cCCCCCHHHHHHHHHHHHHHHHHHHHC-CeecCCCCHHHEEEcCCCcEEecccccceeecccC
Confidence            999996 58988885  345589999999999999999999999 99999999999999999999999999986543221


Q ss_pred             --------CccCcccccCcccccC-CCCCCcccchhhhHHHHHHHhCCCCCCchhhHHHhh-------------------
Q 020221          211 --------SYSTNLAFTPPEYLRT-GRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRD-------------------  262 (329)
Q Consensus       211 --------~~~~~~~y~aPE~~~~-~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~~~-------------------  262 (329)
                              ...++..|+|||.+.+ ..++.++||||||+++|+|++|..||..........                   
T Consensus       162 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~~~~~~~~~~~g~~~~~~~~~~~~  241 (334)
T cd07855         162 TEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKLILSVLGSPSEEVLNRIGS  241 (334)
T ss_pred             cCCCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCChHHHHHHHHHHhCCChhHhhhhhch
Confidence                    2356788999998865 458899999999999999999998886532111000                   


Q ss_pred             hchhhhccccc-cCC-----CChHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 020221          263 RNIQTLTDSCL-EGQ-----FSSDEGTELVRLASRCLQYEPRERPNPRSLVT  308 (329)
Q Consensus       263 ~~~~~~~~~~~-~~~-----~~~~~~~~~~~li~~cl~~dp~~Rps~~~~l~  308 (329)
                      ........... ...     .....++++.+++.+||+.||++||++.+++.
T Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~  293 (334)
T cd07855         242 DRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQ  293 (334)
T ss_pred             hhHHHHHhhcccCCCCCHHHHcccCCHHHHHHHHHHccCChhhCcCHHHHHh
Confidence            00000000000 000     11234788999999999999999999999997

Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the

>cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1

Probab=100.00  E-value=1.6e-39  Score=284.52  Aligned_cols=242  Identities=21%  Similarity=0.248  Sum_probs=199.3

Q ss_pred             cccccccCCCCCCcEEEEEE-eCCCCEEEEEEeCCCC---ChhHHHHHHHHHHHhcCC-CccccccceeeeeCCeeEEEE
Q 020221           58 MENIVSEHGEKAPNVVYKGK-LENQFRIAVKRFNRSA---WPDARQFLEEARAVGQLR-NRRLANLLGCCCEGDERLLVA  132 (329)
Q Consensus        58 ~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~~~~lv~  132 (329)
                      .|.+.+.||+|+||.||++. ..+++.||+|++....   ......+.+|.++++.++ |+||+++++++...+..+++|
T Consensus         2 ~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv~   81 (280)
T cd05581           2 DFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENLYFVL   81 (280)
T ss_pred             CceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCCceEEEEE
Confidence            35667778999999999999 4578899999987632   122356788999999998 999999999999999999999


Q ss_pred             ecCCCCCHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCCCCCeeeecccCcccCCCCC--
Q 020221          133 EYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDGR--  210 (329)
Q Consensus       133 e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~--  210 (329)
                      |++++++|.+++.+  ...+++..+..++.|++.||.|||+. +++|+||+|+||+++.++.++++|||++.......  
T Consensus        82 e~~~~~~L~~~l~~--~~~l~~~~~~~i~~ql~~~l~~Lh~~-~~~H~dl~~~ni~i~~~~~~~l~df~~~~~~~~~~~~  158 (280)
T cd05581          82 EYAPNGELLQYIRK--YGSLDEKCTRFYAAEILLALEYLHSK-GIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSP  158 (280)
T ss_pred             cCCCCCcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHC-CeeecCCCHHHeEECCCCCEEecCCccccccCCcccc
Confidence            99999999999963  34799999999999999999999999 99999999999999999999999999987544322  


Q ss_pred             ----------------------CccCcccccCcccccCCCCCCcccchhhhHHHHHHHhCCCCCCchhhHHHhhhchhhh
Q 020221          211 ----------------------SYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTL  268 (329)
Q Consensus       211 ----------------------~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~~~~~~~~~  268 (329)
                                            ...++..|+|||.+.+..++.++|+||||++++++++|..|+...........    .
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~----~  234 (280)
T cd05581         159 ESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSNEYLTFQK----I  234 (280)
T ss_pred             ccCCCCCccccccccccccccccccCCccccCHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCccHHHHHHH----H
Confidence                                  12356889999999888899999999999999999999988764432111111    1


Q ss_pred             ccccccCCCChHHHHHHHHHHHHhcccCCCCCCCH----HHHHH
Q 020221          269 TDSCLEGQFSSDEGTELVRLASRCLQYEPRERPNP----RSLVT  308 (329)
Q Consensus       269 ~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~----~~~l~  308 (329)
                      ..  .....+...++.+.+++.+||+.||++||++    .++++
T Consensus       235 ~~--~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ll~  276 (280)
T cd05581         235 LK--LEYSFPPNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKA  276 (280)
T ss_pred             Hh--cCCCCCCccCHHHHHHHHHHhcCCHhhCCCcccCHHHHhc
Confidence            11  1223445567889999999999999999999    88877

Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto

>cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases

Probab=100.00  E-value=5e-39  Score=282.55  Aligned_cols=248  Identities=19%  Similarity=0.217  Sum_probs=191.9

Q ss_pred             ccccccCCCCCCcEEEEEEeC-CCCEEEEEEeCCCCChh--HHHHHHHHHHHhcC---CCccccccceeeeeCCe-----
Q 020221           59 ENIVSEHGEKAPNVVYKGKLE-NQFRIAVKRFNRSAWPD--ARQFLEEARAVGQL---RNRRLANLLGCCCEGDE-----  127 (329)
Q Consensus        59 ~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~--~~~~~~e~~~l~~l---~h~niv~~~~~~~~~~~-----  127 (329)
                      |++++.+|+|+||.||++... +++.||+|.+.......  ...+.+|+.+++.+   +|+|++++++++.....     
T Consensus         1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~   80 (287)
T cd07838           1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRELK   80 (287)
T ss_pred             CeEEEEecccCceEEEEEEECCCCCEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCce
Confidence            345677899999999999954 58899999997543221  23456677766655   69999999999987766     


Q ss_pred             eEEEEecCCCCCHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCCCCCeeeecccCcccCC
Q 020221          128 RLLVAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSR  207 (329)
Q Consensus       128 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~  207 (329)
                      .+++|||+.+ +|.+++.......+++..+..++.|++.||.|||+. +++|+||+|+||+++.++.++|+|||++....
T Consensus        81 ~~l~~e~~~~-~l~~~l~~~~~~~l~~~~~~~~~~~i~~al~~LH~~-~i~h~~l~~~nili~~~~~~~l~dfg~~~~~~  158 (287)
T cd07838          81 LTLVFEHVDQ-DLATYLSKCPKPGLPPETIKDLMRQLLRGVDFLHSH-RIVHRDLKPQNILVTSDGQVKIADFGLARIYS  158 (287)
T ss_pred             eEEEehhccc-CHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHC-CeeeccCChhhEEEccCCCEEEeccCcceecc
Confidence            9999999975 898888654444689999999999999999999999 99999999999999999999999999987654


Q ss_pred             CCC---CccCcccccCcccccCCCCCCcccchhhhHHHHHHHhCCCCCCchhhHHHhhhchhhh----------------
Q 020221          208 DGR---SYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTL----------------  268 (329)
Q Consensus       208 ~~~---~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~~~~~~~~~----------------  268 (329)
                      ...   ...++..|+|||++.+..++.++|+||||+++|+|++|..|+................                
T Consensus       159 ~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~s~G~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (287)
T cd07838         159 FEMALTSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELFRRRPLFRGTSEADQLDKIFDVIGLPSEEEWPRNVSLPR  238 (287)
T ss_pred             CCcccccccccccccChHHhccCCCCCcchhhhHHHHHHHHHhCCCcccCCChHHHHHHHHHHcCCCChHhcCCCcccch
Confidence            332   2346788999999998889999999999999999999987765433221111111000                


Q ss_pred             --cccccc---CCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 020221          269 --TDSCLE---GQFSSDEGTELVRLASRCLQYEPRERPNPRSLVT  308 (329)
Q Consensus       269 --~~~~~~---~~~~~~~~~~~~~li~~cl~~dp~~Rps~~~~l~  308 (329)
                        ......   .......++.+.+++.+||+.||++||++.+++.
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~il~  283 (287)
T cd07838         239 SSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQ  283 (287)
T ss_pred             hhcccccccchhhhhhhhhHHHHHHHHHHhccCCccCCCHHHHhc
Confidence              000000   0111245678899999999999999999999997

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both

>cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants

Probab=100.00  E-value=1.9e-39  Score=292.11  Aligned_cols=254  Identities=17%  Similarity=0.255  Sum_probs=196.2

Q ss_pred             cccccccCCCCCCcEEEEEE-eCCCCEEEEEEeCCCC--ChhHHHHHHHHHHHhcCCCccccccceeeeeC-----CeeE
Q 020221           58 MENIVSEHGEKAPNVVYKGK-LENQFRIAVKRFNRSA--WPDARQFLEEARAVGQLRNRRLANLLGCCCEG-----DERL  129 (329)
Q Consensus        58 ~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~-----~~~~  129 (329)
                      .|.+++.||+|+||+||++. ..+++.||+|.+....  ......+.+|+.+++.++|+||+++++++...     ...+
T Consensus         6 ~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~~~~   85 (337)
T cd07858           6 KYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFNDVY   85 (337)
T ss_pred             ceeEEEEeccCCCeEEEEEEecCCCCeEEEEEecccccccchhHHHHHHHHHHHhcCCCCccchHHheecccccccCcEE
Confidence            35667778999999999998 5578899999987542  22345677899999999999999999987543     3579


Q ss_pred             EEEecCCCCCHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCCCCCeeeecccCcccCCCC
Q 020221          130 LVAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDG  209 (329)
Q Consensus       130 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~  209 (329)
                      +++||+. ++|.+++.  ....+++..+..++.|++.||.|||++ +++|+||||+||+++.++.++|+|||++......
T Consensus        86 lv~e~~~-~~L~~~~~--~~~~l~~~~~~~i~~qi~~aL~~LH~~-~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~  161 (337)
T cd07858          86 IVYELMD-TDLHQIIR--SSQTLSDDHCQYFLYQLLRGLKYIHSA-NVLHRDLKPSNLLLNANCDLKICDFGLARTTSEK  161 (337)
T ss_pred             EEEeCCC-CCHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHhC-CEecCCCCHHHEEEcCCCCEEECcCccccccCCC
Confidence            9999996 58988886  345789999999999999999999999 9999999999999999999999999998765433


Q ss_pred             ----CCccCcccccCcccccC-CCCCCcccchhhhHHHHHHHhCCCCCCchhhHHHhh-------------------hch
Q 020221          210 ----RSYSTNLAFTPPEYLRT-GRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRD-------------------RNI  265 (329)
Q Consensus       210 ----~~~~~~~~y~aPE~~~~-~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~~~-------------------~~~  265 (329)
                          ....++..|+|||.+.+ ..++.++||||||+++|+|++|..||..........                   ...
T Consensus       162 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  241 (337)
T cd07858         162 GDFMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVHQLKLITELLGSPSEEDLGFIRNEKA  241 (337)
T ss_pred             cccccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCChHHhhhcCchhh
Confidence                23356788999998765 458899999999999999999998875432110000                   000


Q ss_pred             hhhc---ccccc---CCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHH--HHhhhh
Q 020221          266 QTLT---DSCLE---GQFSSDEGTELVRLASRCLQYEPRERPNPRSLVTA--LVTLQK  315 (329)
Q Consensus       266 ~~~~---~~~~~---~~~~~~~~~~~~~li~~cl~~dp~~Rps~~~~l~~--L~~~~~  315 (329)
                      ....   .....   .......++++.+++.+||+.||++|||+.+++++  +..+..
T Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rps~~ell~h~~~~~~~~  299 (337)
T cd07858         242 RRYIRSLPYTPRQSFARLFPHANPLAIDLLEKMLVFDPSKRITVEEALAHPYLASLHD  299 (337)
T ss_pred             hHHHHhcCcccccCHHHHcccCCHHHHHHHHHHhcCChhhccCHHHHHcCcchhhhcC
Confidence            0000   00000   00112457889999999999999999999999985  555443

Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati

>PHA02882 putative serine/threonine kinase; Provisional

Probab=100.00  E-value=2.4e-39  Score=285.96  Aligned_cols=250  Identities=12%  Similarity=0.056  Sum_probs=181.9

Q ss_pred             CcccccccCCCCCCcEEEEEEeCC----CCEEEEEEeCCCCChhHH-----------HHHHHHHHHhcCCCcccccccee
Q 020221           57 AMENIVSEHGEKAPNVVYKGKLEN----QFRIAVKRFNRSAWPDAR-----------QFLEEARAVGQLRNRRLANLLGC  121 (329)
Q Consensus        57 ~~~~~~~~lg~G~~g~V~~~~~~~----~~~vavK~~~~~~~~~~~-----------~~~~e~~~l~~l~h~niv~~~~~  121 (329)
                      ..|++.+.||+|+||.||+|...+    +..+|+|...........           ....+...+..++|+|+++++++
T Consensus        12 ~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~   91 (294)
T PHA02882         12 KEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPKYYGC   91 (294)
T ss_pred             CceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCcEEEe
Confidence            357788888999999999998543    455667764433221110           12233445666789999999987


Q ss_pred             eeeCC----eeEEEEecCCCCCHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCCCCCeee
Q 020221          122 CCEGD----ERLLVAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRL  197 (329)
Q Consensus       122 ~~~~~----~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl  197 (329)
                      +....    ..+++++++.. ++.+.+..  ....++..+..++.|++.||.|||+. +++||||||+|||++.++.++|
T Consensus        92 ~~~~~~~~~~~~~~~~~~~~-~~~~~~~~--~~~~~~~~~~~i~~qi~~~l~~lH~~-~iiHrDiKp~Nill~~~~~~~l  167 (294)
T PHA02882         92 GSFKRCRMYYRFILLEKLVE-NTKEIFKR--IKCKNKKLIKNIMKDMLTTLEYIHEH-GISHGDIKPENIMVDGNNRGYI  167 (294)
T ss_pred             eeEecCCceEEEEEEehhcc-CHHHHHHh--hccCCHHHHHHHHHHHHHHHHHHHhC-CeecCCCCHHHEEEcCCCcEEE
Confidence            65443    34678887754 67666642  23467888999999999999999999 9999999999999999999999


Q ss_pred             ecccCcccCCCC-----------CCccCcccccCcccccCCCCCCcccchhhhHHHHHHHhCCCCCCchhh-HHHhhhch
Q 020221          198 SCFGLMKNSRDG-----------RSYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHAL-DLIRDRNI  265 (329)
Q Consensus       198 ~Dfg~a~~~~~~-----------~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~-~~~~~~~~  265 (329)
                      +|||+++.....           ....||+.|+|||++.+..++.++||||||++++||++|..||..... ........
T Consensus       168 ~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~~~~~~DiwSlG~~l~el~~g~~P~~~~~~~~~~~~~~~  247 (294)
T PHA02882        168 IDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLKWAGIKLPWKGFGHNGNLIHAAK  247 (294)
T ss_pred             EEcCCceeeccCCcccccccccccccCCCccccCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCccccchHHHHHhH
Confidence            999998754211           123588999999999998999999999999999999999988754411 11111111


Q ss_pred             hhhccccccC-CCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 020221          266 QTLTDSCLEG-QFSSDEGTELVRLASRCLQYEPRERPNPRSLVTAL  310 (329)
Q Consensus       266 ~~~~~~~~~~-~~~~~~~~~~~~li~~cl~~dp~~Rps~~~~l~~L  310 (329)
                      .+.......+ ......++++.+++..||..+|++||++.++++.|
T Consensus       248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~rp~~~~l~~~~  293 (294)
T PHA02882        248 CDFIKRLHEGKIKIKNANKFIYDFIECVTKLSYEEKPDYDALIKIF  293 (294)
T ss_pred             HHHHHHhhhhhhccCCCCHHHHHHHHHHHhCCCCCCCCHHHHHHhh
Confidence            1111111111 11234468899999999999999999999999876

>KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=1.7e-41  Score=326.45  Aligned_cols=239  Identities=17%  Similarity=0.202  Sum_probs=199.9

Q ss_pred             cCCCCCCcEEEEEE-eCCCCEEEEEEeCCCCCh--hHHHHHHHHHHHhcCCCccccccceeeeeCCeeEEEEecCCCCCH
Q 020221           64 EHGEKAPNVVYKGK-LENQFRIAVKRFNRSAWP--DARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAEYMPNDTL  140 (329)
Q Consensus        64 ~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~--~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL  140 (329)
                      +||.|.||.||.+. .++|...|+|.+......  ..+.+.+|..++..++|||+|+++|+-.+.+..+|.||||++|+|
T Consensus      1242 ~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRekv~IFMEyC~~GsL 1321 (1509)
T KOG4645|consen 1242 FIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSDHKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHREKVYIFMEYCEGGSL 1321 (1509)
T ss_pred             ccCCcceeeeEEeecCCccchhhhhhhhcCccccccCcchHHHHHHHHhccCccccccCceeecHHHHHHHHHHhccCcH
Confidence            56999999999999 788999999988654322  244578899999999999999999999999999999999999999


Q ss_pred             HhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCCCCCeeeecccCcccCCCCC--------Cc
Q 020221          141 AKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDGR--------SY  212 (329)
Q Consensus       141 ~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~--------~~  212 (329)
                      .+.+.  .++..++.....+..|++.|++|||+. |||||||||.||+++.+|.+|++|||.|.......        ..
T Consensus      1322 a~ll~--~gri~dE~vt~vyt~qll~gla~LH~~-gIVHRDIK~aNI~Ld~~g~iK~~DFGsa~ki~~~~~~~~~el~~~ 1398 (1509)
T KOG4645|consen 1322 ASLLE--HGRIEDEMVTRVYTKQLLEGLAYLHEH-GIVHRDIKPANILLDFNGLIKYGDFGSAVKIKNNAQTMPGELQSM 1398 (1509)
T ss_pred             HHHHH--hcchhhhhHHHHHHHHHHHHHHHHHhc-CceecCCCccceeeecCCcEEeecccceeEecCchhcCCHHHHhh
Confidence            99986  445677888888999999999999999 99999999999999999999999999998765442        34


Q ss_pred             cCcccccCcccccCCC---CCCcccchhhhHHHHHHHhCCCCCCchhhHHHhhhchhhhccccccCCCChHHHHHHHHHH
Q 020221          213 STNLAFTPPEYLRTGR---VTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLA  289 (329)
Q Consensus       213 ~~~~~y~aPE~~~~~~---~~~~~DvwslG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li  289 (329)
                      .||+.|||||++.+..   -..++||||+||+++||+||+.|+..-..+..    +.-.+...-.+.+|...+.+..+|+
T Consensus      1399 ~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dne~a----IMy~V~~gh~Pq~P~~ls~~g~dFl 1474 (1509)
T KOG4645|consen 1399 MGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDNEWA----IMYHVAAGHKPQIPERLSSEGRDFL 1474 (1509)
T ss_pred             cCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccchhH----HHhHHhccCCCCCchhhhHhHHHHH
Confidence            6899999999998644   55689999999999999999998753321111    1111122233456777999999999


Q ss_pred             HHhcccCCCCCCCHHHHHHH
Q 020221          290 SRCLQYEPRERPNPRSLVTA  309 (329)
Q Consensus       290 ~~cl~~dp~~Rps~~~~l~~  309 (329)
                      ..||..||+.|.++.|++++
T Consensus      1475 e~Cl~~dP~~Rw~~~qlle~ 1494 (1509)
T KOG4645|consen 1475 EHCLEQDPKMRWTASQLLEH 1494 (1509)
T ss_pred             HHHHhcCchhhhHHHHHHHh
Confidence            99999999999999988874

>cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7

Probab=100.00  E-value=4.9e-39  Score=284.29  Aligned_cols=250  Identities=18%  Similarity=0.262  Sum_probs=192.7

Q ss_pred             CCCcccccccCCCCCCcEEEEEEeC-CCCEEEEEEeCCCCCh-hHHHHHHHHHHHhcC-CCccccccceeeeeCCeeEEE
Q 020221           55 GFAMENIVSEHGEKAPNVVYKGKLE-NQFRIAVKRFNRSAWP-DARQFLEEARAVGQL-RNRRLANLLGCCCEGDERLLV  131 (329)
Q Consensus        55 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~lv  131 (329)
                      ++..+.+.+.+|+|+||.||++... +++.||||.++..... ....+..|+..+... .|+||+++++++.+....+++
T Consensus        13 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~v   92 (296)
T cd06618          13 DLNDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVKCYGYFITDSDVFIC   92 (296)
T ss_pred             CcchheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCChHHHHHHHHHHHHHHhccCCCchHhhheeeecCCeEEEE
Confidence            3455677888899999999999965 4889999999764322 334566777766666 599999999999999999999


Q ss_pred             EecCCCCCHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCCCCCeeeecccCcccCCCCC-
Q 020221          132 AEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDGR-  210 (329)
Q Consensus       132 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~-  210 (329)
                      |||+.+ +|.+++.. ....+++..+..++.|++.||.|||+..+++|+||+|+||++++++.++|+|||++....... 
T Consensus        93 ~e~~~~-~l~~l~~~-~~~~l~~~~~~~i~~~i~~~l~~lH~~~~i~H~dl~p~nill~~~~~~kL~dfg~~~~~~~~~~  170 (296)
T cd06618          93 MELMST-CLDKLLKR-IQGPIPEDILGKMTVAIVKALHYLKEKHGVIHRDVKPSNILLDASGNVKLCDFGISGRLVDSKA  170 (296)
T ss_pred             eeccCc-CHHHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHhhCCEecCCCcHHHEEEcCCCCEEECccccchhccCCCc
Confidence            999854 77776654 234789999999999999999999974399999999999999999999999999987654322 


Q ss_pred             --CccCcccccCcccccCCC----CCCcccchhhhHHHHHHHhCCCCCCchhhHHHhhhchhhhccccc-cCCCChHHHH
Q 020221          211 --SYSTNLAFTPPEYLRTGR----VTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCL-EGQFSSDEGT  283 (329)
Q Consensus       211 --~~~~~~~y~aPE~~~~~~----~~~~~DvwslG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~  283 (329)
                        ...++..|+|||.+.+..    ++.++||||||+++|+|++|+.||........   .......... ........+.
T Consensus       171 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~  247 (296)
T cd06618         171 KTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTEFE---VLTKILQEEPPSLPPNEGFSP  247 (296)
T ss_pred             ccCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchhHHH---HHHHHhcCCCCCCCCCCCCCH
Confidence              224567899999987553    78899999999999999999988754211100   0011111110 0011123567


Q ss_pred             HHHHHHHHhcccCCCCCCCHHHHHHH
Q 020221          284 ELVRLASRCLQYEPRERPNPRSLVTA  309 (329)
Q Consensus       284 ~~~~li~~cl~~dp~~Rps~~~~l~~  309 (329)
                      ++.+++.+||..||++||++.+++.+
T Consensus       248 ~l~~li~~~l~~~p~~Rp~~~~il~~  273 (296)
T cd06618         248 DFCSFVDLCLTKDHRKRPKYRELLQH  273 (296)
T ss_pred             HHHHHHHHHccCChhhCCCHHHHhcC
Confidence            89999999999999999999999973

Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it

>cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases

Probab=100.00  E-value=4e-39  Score=282.74  Aligned_cols=247  Identities=17%  Similarity=0.277  Sum_probs=193.0

Q ss_pred             cccccCCCCCCcEEEEEEe-CCCCEEEEEEeCCCCCh-hHHHHHHHHHHHhcCC-CccccccceeeeeCCeeEEEEecCC
Q 020221           60 NIVSEHGEKAPNVVYKGKL-ENQFRIAVKRFNRSAWP-DARQFLEEARAVGQLR-NRRLANLLGCCCEGDERLLVAEYMP  136 (329)
Q Consensus        60 ~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~~~~lv~e~~~  136 (329)
                      .+.+.||+|++|+||+|.. .+++.|++|.+...... ......+|+..++.++ |+|++++++++..++..++||||+ 
T Consensus         2 ~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~~-   80 (283)
T cd07830           2 KVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNEHPNIVKLKEVFRENDELYFVFEYM-   80 (283)
T ss_pred             eeheeeccCCceEEEEEEECCCCcEEEEEEehhhccchhHHHHHHHHHHHHhccCCCCchhHHHHhhcCCcEEEEEecC-
Confidence            4567789999999999995 45788999998765322 2233567899999998 999999999999999999999999 


Q ss_pred             CCCHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCCCCCeeeecccCcccCCCCC---Ccc
Q 020221          137 NDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDGR---SYS  213 (329)
Q Consensus       137 ~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~---~~~  213 (329)
                      +++|.+++.......+++..+..++.|++.+|.|||++ +++|+||+|+||++++++.++|+|||++.......   ...
T Consensus        81 ~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~-~i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~~~~~~~~~~~  159 (283)
T cd07830          81 EGNLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIHKH-GFFHRDLKPENLLVSGPEVVKIADFGLAREIRSRPPYTDYV  159 (283)
T ss_pred             CCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHHC-CcccCCCChhhEEEcCCCCEEEeecccceeccCCCCcCCCC
Confidence            77999988754445789999999999999999999999 99999999999999999999999999987655432   345


Q ss_pred             CcccccCcccccC-CCCCCcccchhhhHHHHHHHhCCCCCCchhhHHHhhhch-----------------hhhcccccc-
Q 020221          214 TNLAFTPPEYLRT-GRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNI-----------------QTLTDSCLE-  274 (329)
Q Consensus       214 ~~~~y~aPE~~~~-~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~~~~~~-----------------~~~~~~~~~-  274 (329)
                      ++..|+|||++.+ ..++.++|+||||+++++|++|..|++............                 ......... 
T Consensus       160 ~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (283)
T cd07830         160 STRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQDWPEGYKLASKLGFRFPQ  239 (283)
T ss_pred             CcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCChHHHHHHHHHhcCCCChhhhhhHhhhhccccccccc
Confidence            6788999998854 447889999999999999999998775442211110000                 000000000 


Q ss_pred             ------CCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 020221          275 ------GQFSSDEGTELVRLASRCLQYEPRERPNPRSLVT  308 (329)
Q Consensus       275 ------~~~~~~~~~~~~~li~~cl~~dp~~Rps~~~~l~  308 (329)
                            .......+..+.+++.+||+.||++|||+.+++.
T Consensus       240 ~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~  279 (283)
T cd07830         240 FAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQ  279 (283)
T ss_pred             cccccHHHHcccCCHHHHHHHHHhcccCcccCCCHHHHhh
Confidence                  0001122578999999999999999999999987

Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili

>cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains

Probab=100.00  E-value=5.7e-39  Score=277.42  Aligned_cols=244  Identities=16%  Similarity=0.236  Sum_probs=202.0

Q ss_pred             ccccccCCCCCCcEEEEEE-eCCCCEEEEEEeCCCCC--hhHHHHHHHHHHHhcCCCccccccceeeeeCCeeEEEEecC
Q 020221           59 ENIVSEHGEKAPNVVYKGK-LENQFRIAVKRFNRSAW--PDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAEYM  135 (329)
Q Consensus        59 ~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~  135 (329)
                      |++.+.+|.|+||.||++. ..+++.+++|.+.....  .....+.+|+++++.++|+||+++.+++......++|+||+
T Consensus         2 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~   81 (256)
T cd08530           2 FKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAFLDGNKLCIVMEYA   81 (256)
T ss_pred             ceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhccHHHHHHHHHHHHHHHhCCCCCchhhhhhhccCCEEEEEehhc
Confidence            4566778999999999998 55788999999876432  23456788999999999999999999999999999999999


Q ss_pred             CCCCHHhhhccC--CCCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCCCCCeeeecccCcccCCCC--CC
Q 020221          136 PNDTLAKHLFHW--ETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDG--RS  211 (329)
Q Consensus       136 ~~gsL~~~l~~~--~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~--~~  211 (329)
                      ++++|.+++.+.  ....+++..+..++.|++.||.|||+. |++|+||+|+||++++++.++|+|||++......  ..
T Consensus        82 ~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~~-~i~h~~l~~~ni~~~~~~~~kl~d~g~~~~~~~~~~~~  160 (256)
T cd08530          82 PFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQ-KILHRDLKSANILLVANDLVKIGDLGISKVLKKNMAKT  160 (256)
T ss_pred             CCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhC-CcccCCCCcceEEEecCCcEEEeeccchhhhccCCccc
Confidence            999999988642  235689999999999999999999999 9999999999999999999999999998765443  22


Q ss_pred             ccCcccccCcccccCCCCCCcccchhhhHHHHHHHhCCCCCCchhhHHHhhhchhhhccccccCCCChHHHHHHHHHHHH
Q 020221          212 YSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLASR  291 (329)
Q Consensus       212 ~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~  291 (329)
                      ..++..|+|||.+.+..++.++|+||||+++++|++|..|+..............     ......+...+.++.+++.+
T Consensus       161 ~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~li~~  235 (256)
T cd08530         161 QIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARSMQDLRYKVQR-----GKYPPIPPIYSQDLQNFIRS  235 (256)
T ss_pred             ccCCccccCHHHHCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhc-----CCCCCCchhhCHHHHHHHHH
Confidence            3467899999999988899999999999999999999988765433222221111     11122344677889999999


Q ss_pred             hcccCCCCCCCHHHHHH
Q 020221          292 CLQYEPRERPNPRSLVT  308 (329)
Q Consensus       292 cl~~dp~~Rps~~~~l~  308 (329)
                      ||..+|++||++.++++
T Consensus       236 ~l~~~p~~Rp~~~~~l~  252 (256)
T cd08530         236 MLQVKPKLRPNCDKILA  252 (256)
T ss_pred             HcCCCcccCCCHHHHhc
Confidence            99999999999999997

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an

>cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases

Probab=100.00  E-value=4.7e-39  Score=282.00  Aligned_cols=246  Identities=22%  Similarity=0.264  Sum_probs=194.8

Q ss_pred             cccccCCCCCCcEEEEEEe-CCCCEEEEEEeCCCC--ChhHHHHHHHHHHHhcCCCccccccceeeeeCCeeEEEEecCC
Q 020221           60 NIVSEHGEKAPNVVYKGKL-ENQFRIAVKRFNRSA--WPDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAEYMP  136 (329)
Q Consensus        60 ~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~  136 (329)
                      ++.+.||+|.+|.||+|.. .+++.+|+|.+....  ....+.+.+|+.+++.++|+|++++++++.+....++|+||+.
T Consensus         2 ~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~~   81 (282)
T cd07829           2 EKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDVIHTERKLYLVFEYCD   81 (282)
T ss_pred             eeehcccccCcceEEEeeecCCCcEEEEEEeccccccccccHHHHHHHHHHHhcCCCCHHHHHhhhhcCCceEEEecCcC
Confidence            3456679999999999994 568999999998753  2234567889999999999999999999999999999999998


Q ss_pred             CCCHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCCCCCeeeecccCcccCCCCC----Cc
Q 020221          137 NDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDGR----SY  212 (329)
Q Consensus       137 ~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~----~~  212 (329)
                      + +|.+++.+. ...+++..+..++.|++.||.|||+. +++|+||+|+||++++++.++|+|||++.......    ..
T Consensus        82 ~-~l~~~i~~~-~~~~~~~~~~~~~~~i~~~l~~LH~~-~i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~~~~~~~~~~~  158 (282)
T cd07829          82 M-DLKKYLDKR-PGPLSPNLIKSIMYQLLRGLAYCHSH-RILHRDLKPQNILINRDGVLKLADFGLARAFGIPLRTYTHE  158 (282)
T ss_pred             c-CHHHHHHhh-ccCCCHHHHHHHHHHHHHHHHHHHHC-CcccCCCChheEEEcCCCCEEEecCCcccccCCCccccCcc
Confidence            4 899999642 24789999999999999999999999 99999999999999999999999999987654332    23


Q ss_pred             cCcccccCcccccCC-CCCCcccchhhhHHHHHHHhCCCCCCchhhHHHhhhchh--------------------hhccc
Q 020221          213 STNLAFTPPEYLRTG-RVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQ--------------------TLTDS  271 (329)
Q Consensus       213 ~~~~~y~aPE~~~~~-~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~~~~~~~--------------------~~~~~  271 (329)
                      ..+..|+|||.+.+. .++.++||||||++++||++|..|+..............                    .....
T Consensus       159 ~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (282)
T cd07829         159 VVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQLFKIFQILGTPTEESWPGVTKLPDYKPTFPK  238 (282)
T ss_pred             ccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHHHhCCCcHHHHHhhcccccccccccc
Confidence            346789999998776 688899999999999999999887765432211111000                    00000


Q ss_pred             cccC---CCChHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 020221          272 CLEG---QFSSDEGTELVRLASRCLQYEPRERPNPRSLVT  308 (329)
Q Consensus       272 ~~~~---~~~~~~~~~~~~li~~cl~~dp~~Rps~~~~l~  308 (329)
                      ....   ......+..+.+++.+||..||++||++.+++.
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~  278 (282)
T cd07829         239 FPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRISAKEALK  278 (282)
T ss_pred             cCccchHHhcccccHHHHHHHHHhhccCcccCCCHHHHhh
Confidence            0000   001123678999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the

>KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.8e-40  Score=277.28  Aligned_cols=234  Identities=18%  Similarity=0.225  Sum_probs=199.8

Q ss_pred             ccccccCCCCCCcEEEEEE-eCCCCEEEEEEeCCCCChhHHH---HHHHHHHHhcCCCccccccceeeeeCCeeEEEEec
Q 020221           59 ENIVSEHGEKAPNVVYKGK-LENQFRIAVKRFNRSAWPDARQ---FLEEARAVGQLRNRRLANLLGCCCEGDERLLVAEY  134 (329)
Q Consensus        59 ~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~---~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  134 (329)
                      +..++.||+|.||.|.+++ ..+++.+|+|++++...-..++   -..|-++|+..+||.+..+...|+..+.+++||||
T Consensus       170 FdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsFQt~drlCFVMey  249 (516)
T KOG0690|consen  170 FDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSFQTQDRLCFVMEY  249 (516)
T ss_pred             hhHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhhccCceEEEEEEE
Confidence            3456666999999999998 6789999999998765333333   45688999999999999999999999999999999


Q ss_pred             CCCCCHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCCCCCeeeecccCcccCC----CCC
Q 020221          135 MPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSR----DGR  210 (329)
Q Consensus       135 ~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~----~~~  210 (329)
                      ..||.|.-.|.  ..+.+++...+.+..+|+.||.|||++ +||+||+|.+|.++|.+|++||+|||+++..-    ...
T Consensus       250 anGGeLf~HLs--rer~FsE~RtRFYGaEIvsAL~YLHs~-~ivYRDlKLENLlLDkDGHIKitDFGLCKE~I~~g~t~k  326 (516)
T KOG0690|consen  250 ANGGELFFHLS--RERVFSEDRTRFYGAEIVSALGYLHSR-NIVYRDLKLENLLLDKDGHIKITDFGLCKEEIKYGDTTK  326 (516)
T ss_pred             ccCceEeeehh--hhhcccchhhhhhhHHHHHHhhhhhhC-CeeeeechhhhheeccCCceEeeecccchhcccccceec
Confidence            99999988886  457799999999999999999999999 99999999999999999999999999987532    235


Q ss_pred             CccCcccccCcccccCCCCCCcccchhhhHHHHHHHhCCCCCCchhhHHHhhhchhhhccccccCCCChHHHHHHHHHHH
Q 020221          211 SYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLAS  290 (329)
Q Consensus       211 ~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~  290 (329)
                      +++||+.|.|||++.+..|...+|+|.+||++|||++|+.||.....+..-.-....      .-.+|...+++...|+.
T Consensus       327 TFCGTPEYLAPEVleDnDYgraVDWWG~GVVMYEMmCGRLPFyn~dh~kLFeLIl~e------d~kFPr~ls~eAktLLs  400 (516)
T KOG0690|consen  327 TFCGTPEYLAPEVLEDNDYGRAVDWWGVGVVMYEMMCGRLPFYNKDHEKLFELILME------DLKFPRTLSPEAKTLLS  400 (516)
T ss_pred             cccCChhhcCchhhccccccceeehhhhhHHHHHHHhccCcccccchhHHHHHHHhh------hccCCccCCHHHHHHHH
Confidence            678999999999999999999999999999999999999999865444333222221      11366778899999999


Q ss_pred             HhcccCCCCCC
Q 020221          291 RCLQYEPRERP  301 (329)
Q Consensus       291 ~cl~~dp~~Rp  301 (329)
                      .+|..||.+|.
T Consensus       401 GLL~kdP~kRL  411 (516)
T KOG0690|consen  401 GLLKKDPKKRL  411 (516)
T ss_pred             HHhhcChHhhc
Confidence            99999999996

>KOG0584 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=1.8e-40  Score=299.87  Aligned_cols=237  Identities=16%  Similarity=0.226  Sum_probs=191.2

Q ss_pred             cCCCCCCcEEEEEE-eCCCCEEEEEEeCCC----CChhHHHHHHHHHHHhcCCCccccccceeeeeCCe--eEEEEecCC
Q 020221           64 EHGEKAPNVVYKGK-LENQFRIAVKRFNRS----AWPDARQFLEEARAVGQLRNRRLANLLGCCCEGDE--RLLVAEYMP  136 (329)
Q Consensus        64 ~lg~G~~g~V~~~~-~~~~~~vavK~~~~~----~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~--~~lv~e~~~  136 (329)
                      .||+|+|-+||+|. -.+|..||--.++..    .....+.|..|+.+|+.|+||||++++.+|.+..+  +.+|+|++.
T Consensus        47 vLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n~~in~iTEL~T  126 (632)
T KOG0584|consen   47 VLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDNKTINFITELFT  126 (632)
T ss_pred             hcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCCCceeeeeeeccc
Confidence            46999999999998 445766775444322    22335779999999999999999999999988765  789999999


Q ss_pred             CCCHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcC-CCccccccCCCceeeC-CCCCeeeecccCcccCCCC--CCc
Q 020221          137 NDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSK-ERALYHDLNAYRIVFD-DDVNPRLSCFGLMKNSRDG--RSY  212 (329)
Q Consensus       137 ~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~-~~ivH~dlkp~Nil~~-~~~~~kl~Dfg~a~~~~~~--~~~  212 (329)
                      .|+|..|++  +.+.++...+..|++||+.||.|||++ ..|+|||||.+||+|+ ..|.|||+|+|+|......  ...
T Consensus       127 SGtLr~Y~k--k~~~vn~kaik~W~RQILkGL~yLHs~~PPIIHRDLKCDNIFinG~~G~VKIGDLGLAtl~r~s~aksv  204 (632)
T KOG0584|consen  127 SGTLREYRK--KHRRVNIKAIKSWCRQILKGLVYLHSQDPPIIHRDLKCDNIFVNGNLGEVKIGDLGLATLLRKSHAKSV  204 (632)
T ss_pred             CCcHHHHHH--HhccCCHHHHHHHHHHHHHHhhhhhcCCCCccccccccceEEEcCCcCceeecchhHHHHhhcccccee
Confidence            999999997  566788899999999999999999986 5799999999999998 5688999999999865543  456


Q ss_pred             cCcccccCcccccCCCCCCcccchhhhHHHHHHHhCCCCCCchhh-HHHhhhchhhhccccccCCCChHHHHHHHHHHHH
Q 020221          213 STNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHAL-DLIRDRNIQTLTDSCLEGQFSSDEGTELVRLASR  291 (329)
Q Consensus       213 ~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~  291 (329)
                      .|||.|||||+.. ..|++.+||||||+.++||+|+..|+..... ..+.......+.+..+.    .---+++++||.+
T Consensus       205 IGTPEFMAPEmYE-E~YnE~VDVYaFGMCmLEMvT~eYPYsEC~n~AQIYKKV~SGiKP~sl~----kV~dPevr~fIek  279 (632)
T KOG0584|consen  205 IGTPEFMAPEMYE-ENYNELVDVYAFGMCMLEMVTSEYPYSECTNPAQIYKKVTSGIKPAALS----KVKDPEVREFIEK  279 (632)
T ss_pred             ccCccccChHHHh-hhcchhhhhhhhhHHHHHHHhccCChhhhCCHHHHHHHHHcCCCHHHhh----ccCCHHHHHHHHH
Confidence            8999999999987 7899999999999999999999988754321 22222222222222211    1124689999999


Q ss_pred             hcccCCCCCCCHHHHHH
Q 020221          292 CLQYEPRERPNPRSLVT  308 (329)
Q Consensus       292 cl~~dp~~Rps~~~~l~  308 (329)
                      ||.. ..+|||+.++|+
T Consensus       280 Cl~~-~~~R~sa~eLL~  295 (632)
T KOG0584|consen  280 CLAT-KSERLSAKELLK  295 (632)
T ss_pred             HhcC-chhccCHHHHhh
Confidence            9999 999999999996

>cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases

Probab=100.00  E-value=6.7e-39  Score=276.10  Aligned_cols=235  Identities=22%  Similarity=0.246  Sum_probs=195.5

Q ss_pred             CCCCCCcEEEEEEe-CCCCEEEEEEeCCCCCh---hHHHHHHHHHHHhcCCCccccccceeeeeCCeeEEEEecCCCCCH
Q 020221           65 HGEKAPNVVYKGKL-ENQFRIAVKRFNRSAWP---DARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAEYMPNDTL  140 (329)
Q Consensus        65 lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~---~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL  140 (329)
                      ||+|+||.||++.. .+++.+++|.+......   ....+..|+++++.++|+|++++++.+..+...+++|||+++++|
T Consensus         1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L   80 (250)
T cd05123           1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLVLEYAPGGEL   80 (250)
T ss_pred             CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeecCCeeEEEEecCCCCcH
Confidence            59999999999995 45889999998765422   345688899999999999999999999999999999999999999


Q ss_pred             HhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCCCCCeeeecccCcccCCCC----CCccCcc
Q 020221          141 AKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDG----RSYSTNL  216 (329)
Q Consensus       141 ~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~----~~~~~~~  216 (329)
                      .+++..  ...+++..+..++.|++.||.|||+. +++|+||+|+||+++.++.++|+|||++......    ....++.
T Consensus        81 ~~~l~~--~~~l~~~~~~~~~~qi~~~l~~lh~~-~~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~  157 (250)
T cd05123          81 FSHLSK--EGRFSEERARFYAAEIVLALEYLHSL-GIIYRDLKPENILLDADGHIKLTDFGLAKELSSEGSRTNTFCGTP  157 (250)
T ss_pred             HHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHC-CceecCCCcceEEEcCCCcEEEeecCcceecccCCCcccCCcCCc
Confidence            999963  34689999999999999999999998 9999999999999999999999999998765442    2345678


Q ss_pred             cccCcccccCCCCCCcccchhhhHHHHHHHhCCCCCCchhhHHHhhhchhhhccccccCCCChHHHHHHHHHHHHhcccC
Q 020221          217 AFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLASRCLQYE  296 (329)
Q Consensus       217 ~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~d  296 (329)
                      .|+|||.+.+...+.++|+||||+++|++++|..|+..............      .....+...+..+.+++.+||..|
T Consensus       158 ~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~------~~~~~~~~~~~~l~~~i~~~l~~~  231 (250)
T cd05123         158 EYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYAEDRKEIYEKILK------DPLRFPEFLSPEARDLISGLLQKD  231 (250)
T ss_pred             cccChHHhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhc------CCCCCCCCCCHHHHHHHHHHhcCC
Confidence            99999999888889999999999999999999988754432222111111      112344455788999999999999


Q ss_pred             CCCCCCH---HHHHH
Q 020221          297 PRERPNP---RSLVT  308 (329)
Q Consensus       297 p~~Rps~---~~~l~  308 (329)
                      |++||++   .++++
T Consensus       232 p~~R~~~~~~~~l~~  246 (250)
T cd05123         232 PTKRLGSGGAEEIKA  246 (250)
T ss_pred             HhhCCCcccHHHHHh
Confidence            9999999   56665

Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the

>cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6

Probab=100.00  E-value=2.3e-39  Score=292.07  Aligned_cols=247  Identities=16%  Similarity=0.223  Sum_probs=190.4

Q ss_pred             CcccccccCCCCCCcEEEEEE-eCCCCEEEEEEeCCCCChhHHHHHHHHHHHhcCCCccccccceeeeeC----------
Q 020221           57 AMENIVSEHGEKAPNVVYKGK-LENQFRIAVKRFNRSAWPDARQFLEEARAVGQLRNRRLANLLGCCCEG----------  125 (329)
Q Consensus        57 ~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~----------  125 (329)
                      ..|.+.+.||.|+||.||+|. ..+++.||+|.+........+.+.+|+++++.++||||+++++++...          
T Consensus         5 ~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~   84 (342)
T cd07854           5 SRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTEDVGS   84 (342)
T ss_pred             cceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCCchHHHHHHHHHHHHhcCCCcchhhHhhhccccccccccccc
Confidence            346677788999999999998 456889999998776655567788999999999999999999776543          


Q ss_pred             ----CeeEEEEecCCCCCHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeC-CCCCeeeecc
Q 020221          126 ----DERLLVAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFD-DDVNPRLSCF  200 (329)
Q Consensus       126 ----~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~-~~~~~kl~Df  200 (329)
                          ...++++||+.+ +|.+++.   ...+++..+..++.|++.||.|||+. |++|+||||+||+++ +++.++++||
T Consensus        85 ~~~~~~~~lv~e~~~~-~L~~~~~---~~~l~~~~~~~~~~qi~~aL~~LH~~-givH~dikp~Nili~~~~~~~kl~df  159 (342)
T cd07854          85 LTELNSVYIVQEYMET-DLANVLE---QGPLSEEHARLFMYQLLRGLKYIHSA-NVLHRDLKPANVFINTEDLVLKIGDF  159 (342)
T ss_pred             ccccceEEEEeecccc-cHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHhC-CcccCCCCHHHEEEcCCCceEEECCc
Confidence                357899999974 8988873   35689999999999999999999999 999999999999997 4567899999


Q ss_pred             cCcccCCCC-------CCccCcccccCcccccC-CCCCCcccchhhhHHHHHHHhCCCCCCchhhHHHhhhchhh-----
Q 020221          201 GLMKNSRDG-------RSYSTNLAFTPPEYLRT-GRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQT-----  267 (329)
Q Consensus       201 g~a~~~~~~-------~~~~~~~~y~aPE~~~~-~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~~~~~~~~-----  267 (329)
                      |.+......       ....++..|+|||.+.+ ..++.++||||||+++|+|++|+.||...............     
T Consensus       160 g~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~  239 (342)
T cd07854         160 GLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQLILESVPVVR  239 (342)
T ss_pred             ccceecCCccccccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCC
Confidence            998754322       12245778999998754 45888999999999999999999888543211110000000     


Q ss_pred             -------------hcc-ccccCC-----CChHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 020221          268 -------------LTD-SCLEGQ-----FSSDEGTELVRLASRCLQYEPRERPNPRSLVT  308 (329)
Q Consensus       268 -------------~~~-~~~~~~-----~~~~~~~~~~~li~~cl~~dp~~Rps~~~~l~  308 (329)
                                   ... ......     .....+.++.+++.+||+.||++|||+.+++.
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~  299 (342)
T cd07854         240 EEDRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAEEALM  299 (342)
T ss_pred             hHHhhhhhhhhhhhhhhcccccCCCHHHHccCCCHHHHHHHHHHhCCCchhccCHHHHhC
Confidence                         000 000000     11234578999999999999999999999996

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi

>PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional

Probab=100.00  E-value=9.9e-39  Score=324.04  Aligned_cols=244  Identities=25%  Similarity=0.426  Sum_probs=195.1

Q ss_pred             ccCCCCCCcEEEEEEe-CCCCEEEEEEeCCCCChhHHHHHHHHHHHhcCCCccccccceeeeeCCeeEEEEecCCCCCHH
Q 020221           63 SEHGEKAPNVVYKGKL-ENQFRIAVKRFNRSAWPDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAEYMPNDTLA  141 (329)
Q Consensus        63 ~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~  141 (329)
                      ..+|+|+||.||+|.. .++..||+|.+......    ...|++.++.++||||+++++++.+....++||||+++|+|.
T Consensus       696 ~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~----~~~~~~~l~~l~HpnIv~~~~~~~~~~~~~lv~Ey~~~g~L~  771 (968)
T PLN00113        696 NVISRGKKGASYKGKSIKNGMQFVVKEINDVNSI----PSSEIADMGKLQHPNIVKLIGLCRSEKGAYLIHEYIEGKNLS  771 (968)
T ss_pred             cEEccCCCeeEEEEEECCCCcEEEEEEccCCccc----cHHHHHHHhhCCCCCcceEEEEEEcCCCCEEEEeCCCCCcHH
Confidence            3459999999999994 67889999998754322    134688999999999999999999999999999999999999


Q ss_pred             hhhccCCCCCCCHHHHHHHHHHHHHHHHHhh---cCCCccccccCCCceeeCCCCCeeeecccCcccCCCCCCccCcccc
Q 020221          142 KHLFHWETQPMKWAMRLRVALHIAEALEYCT---SKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDGRSYSTNLAF  218 (329)
Q Consensus       142 ~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH---~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~y  218 (329)
                      +++.     .++|..+..++.|++.||+|||   +. +++||||||+||+++.++..++. ||.+..........++..|
T Consensus       772 ~~l~-----~l~~~~~~~i~~~ia~~L~yLH~~~~~-~iiH~dlkp~Nil~~~~~~~~~~-~~~~~~~~~~~~~~~t~~y  844 (968)
T PLN00113        772 EVLR-----NLSWERRRKIAIGIAKALRFLHCRCSP-AVVVGNLSPEKIIIDGKDEPHLR-LSLPGLLCTDTKCFISSAY  844 (968)
T ss_pred             HHHh-----cCCHHHHHHHHHHHHHHHHHhccCCCC-CeecCCCCHHhEEECCCCceEEE-eccccccccCCCccccccc
Confidence            9994     3899999999999999999999   66 99999999999999998888775 6665544334445678999


Q ss_pred             cCcccccCCCCCCcccchhhhHHHHHHHhCCCCCCchh------hHHHh----hhchhhhccccccC--CCChHHHHHHH
Q 020221          219 TPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHA------LDLIR----DRNIQTLTDSCLEG--QFSSDEGTELV  286 (329)
Q Consensus       219 ~aPE~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~------~~~~~----~~~~~~~~~~~~~~--~~~~~~~~~~~  286 (329)
                      +|||++.+..++.++|||||||++|||+||+.|+....      .....    ........++....  ..+.....++.
T Consensus       845 ~aPE~~~~~~~~~~sDv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  924 (968)
T PLN00113        845 VAPETRETKDITEKSDIYGFGLILIELLTGKSPADAEFGVHGSIVEWARYCYSDCHLDMWIDPSIRGDVSVNQNEIVEVM  924 (968)
T ss_pred             cCcccccCCCCCcccchhhHHHHHHHHHhCCCCCCcccCCCCcHHHHHHHhcCccchhheeCccccCCCCccHHHHHHHH
Confidence            99999998899999999999999999999998874321      00000    00111122222221  22345566888


Q ss_pred             HHHHHhcccCCCCCCCHHHHHHHHHhhhhcc
Q 020221          287 RLASRCLQYEPRERPNPRSLVTALVTLQKDT  317 (329)
Q Consensus       287 ~li~~cl~~dp~~Rps~~~~l~~L~~~~~~~  317 (329)
                      +++.+||+.||++|||+.++++.|+.+.+..
T Consensus       925 ~l~~~Cl~~~P~~RPt~~evl~~L~~~~~~~  955 (968)
T PLN00113        925 NLALHCTATDPTARPCANDVLKTLESASRSS  955 (968)
T ss_pred             HHHHhhCcCCchhCcCHHHHHHHHHHhhccc
Confidence            9999999999999999999999999997744

>KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms]

Probab=100.00  E-value=1.4e-39  Score=252.09  Aligned_cols=247  Identities=18%  Similarity=0.237  Sum_probs=197.0

Q ss_pred             ccccccCCCCCCcEEEEEE-eCCCCEEEEEEeCCCCCh--hHHHHHHHHHHHhcCCCccccccceeeeeCCeeEEEEecC
Q 020221           59 ENIVSEHGEKAPNVVYKGK-LENQFRIAVKRFNRSAWP--DARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAEYM  135 (329)
Q Consensus        59 ~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~--~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~  135 (329)
                      |...++||+|.||+||+++ +.+++.||+|.++.+...  ......+|+.+++.++|.|||++++....+..+-+|+|||
T Consensus         4 ydkmekigegtygtvfkarn~~t~eivalkrvrlddddegvpssalreicllkelkhknivrl~dvlhsdkkltlvfe~c   83 (292)
T KOG0662|consen    4 YDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEFC   83 (292)
T ss_pred             hHHHHhhcCCcceeeEecccCCccceEEEEEEeccCCCCCCcHHHHHHHHHHHHhhhcceeehhhhhccCceeEEeHHHh
Confidence            4456678999999999999 778999999999865422  2445789999999999999999999998899999999999


Q ss_pred             CCCCHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCCCCCeeeecccCcccCCCC----CC
Q 020221          136 PNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDG----RS  211 (329)
Q Consensus       136 ~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~----~~  211 (329)
                      .. +|..++.. -+..++.+.+..++.|+++||.|+|+. +++|||+||.|.|++.+|.+|++|||+++-+.-.    ..
T Consensus        84 dq-dlkkyfds-lng~~d~~~~rsfmlqllrgl~fchsh-nvlhrdlkpqnllin~ngelkladfglarafgipvrcysa  160 (292)
T KOG0662|consen   84 DQ-DLKKYFDS-LNGDLDPEIVRSFMLQLLRGLGFCHSH-NVLHRDLKPQNLLINRNGELKLADFGLARAFGIPVRCYSA  160 (292)
T ss_pred             hH-HHHHHHHh-cCCcCCHHHHHHHHHHHHhhhhhhhhh-hhhhccCCcceEEeccCCcEEecccchhhhcCCceEeeec
Confidence            76 78888854 456789999999999999999999999 9999999999999999999999999999865533    23


Q ss_pred             ccCcccccCcccccCCC-CCCcccchhhhHHHHHHHhCCC-CCCchhhHHHhhhchhhhc-------cc-------cccC
Q 020221          212 YSTNLAFTPPEYLRTGR-VTPESVMYSFGTLLLDLLSGKH-IPPSHALDLIRDRNIQTLT-------DS-------CLEG  275 (329)
Q Consensus       212 ~~~~~~y~aPE~~~~~~-~~~~~DvwslG~il~el~tg~~-~~~~~~~~~~~~~~~~~~~-------~~-------~~~~  275 (329)
                      ...|.+|.+|.++.+.+ |+.+.|+||.|||+.|+...+. .|++...+....+.....-       +.       ..-+
T Consensus       161 evvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfpg~dvddqlkrif~~lg~p~ed~wps~t~lpdyk~yp  240 (292)
T KOG0662|consen  161 EVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEDQWPSMTKLPDYKPYP  240 (292)
T ss_pred             eeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCCCcHHHHHHHHHHHhCCCccccCCccccCCCCcccC
Confidence            35689999999999887 8999999999999999987554 4555443322222111110       00       0001


Q ss_pred             CCC---------hHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 020221          276 QFS---------SDEGTELVRLASRCLQYEPRERPNPRSLVT  308 (329)
Q Consensus       276 ~~~---------~~~~~~~~~li~~cl~~dp~~Rps~~~~l~  308 (329)
                      .++         +..+..-++++...|.-+|.+|.+++.+++
T Consensus       241 ~ypattswsqivp~lns~grdllqkll~cnp~qrisaeaalq  282 (292)
T KOG0662|consen  241 IYPATTSWSQIVPKLNSTGRDLLQKLLKCNPAQRISAEAALQ  282 (292)
T ss_pred             CccccchHHHHhhhhcchhHHHHHHHhccCcccccCHHHHhc
Confidence            111         123456689999999999999999999988

>cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1

Probab=100.00  E-value=5.9e-39  Score=282.85  Aligned_cols=245  Identities=17%  Similarity=0.227  Sum_probs=193.9

Q ss_pred             ccccccCCCCCCcEEEEEEe----CCCCEEEEEEeCCCCC----hhHHHHHHHHHHHhcC-CCccccccceeeeeCCeeE
Q 020221           59 ENIVSEHGEKAPNVVYKGKL----ENQFRIAVKRFNRSAW----PDARQFLEEARAVGQL-RNRRLANLLGCCCEGDERL  129 (329)
Q Consensus        59 ~~~~~~lg~G~~g~V~~~~~----~~~~~vavK~~~~~~~----~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~  129 (329)
                      |++.+.||.|+||.||++..    .+|..||+|.+.....    ...+.+.+|++++..+ +|+||+++.+.+..+...+
T Consensus         2 y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~   81 (290)
T cd05613           2 FELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDTKLH   81 (290)
T ss_pred             ceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecCCeEE
Confidence            45667789999999999984    3688999999875321    2235578899999999 5999999999998888999


Q ss_pred             EEEecCCCCCHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCCCCCeeeecccCcccCCCC
Q 020221          130 LVAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDG  209 (329)
Q Consensus       130 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~  209 (329)
                      +|+||+++++|.+++..  ...+++..+..++.|++.||.|||+. +++|+||+|+||+++.++.++|+|||++......
T Consensus        82 lv~e~~~~~~L~~~l~~--~~~l~~~~~~~~~~qi~~al~~lH~~-~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~  158 (290)
T cd05613          82 LILDYINGGELFTHLSQ--RERFKEQEVQIYSGEIVLALEHLHKL-GIIYRDIKLENILLDSNGHVVLTDFGLSKEFHED  158 (290)
T ss_pred             EEEecCCCCcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHhC-CeeccCCCHHHeEECCCCCEEEeeCccceecccc
Confidence            99999999999999863  45688999999999999999999999 9999999999999999999999999998765432


Q ss_pred             C-----CccCcccccCcccccCC--CCCCcccchhhhHHHHHHHhCCCCCCchhhHHHhhhchhhhccccccCCCChHHH
Q 020221          210 R-----SYSTNLAFTPPEYLRTG--RVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEG  282 (329)
Q Consensus       210 ~-----~~~~~~~y~aPE~~~~~--~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  282 (329)
                      .     ...++..|+|||.+.+.  .++.++||||||+++|+|++|..|+..................  ....++...+
T Consensus       159 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~  236 (290)
T cd05613         159 EVERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKNSQAEISRRILK--SEPPYPQEMS  236 (290)
T ss_pred             cccccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCccccHHHHHHHhhc--cCCCCCccCC
Confidence            1     23477899999998753  4778999999999999999999887532111000001111111  1122345567


Q ss_pred             HHHHHHHHHhcccCCCCCC-----CHHHHHH
Q 020221          283 TELVRLASRCLQYEPRERP-----NPRSLVT  308 (329)
Q Consensus       283 ~~~~~li~~cl~~dp~~Rp-----s~~~~l~  308 (329)
                      +.+.+++.+||+.||++||     ++.+++.
T Consensus       237 ~~~~~ll~~~l~~~p~~R~~~~~~~~~~l~~  267 (290)
T cd05613         237 ALAKDIIQRLLMKDPKKRLGCGPSDADEIKK  267 (290)
T ss_pred             HHHHHHHHHHhcCCHHHhcCCCCCCHHHHHc
Confidence            8899999999999999997     6677765

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph

>cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12

Probab=100.00  E-value=5.5e-39  Score=284.59  Aligned_cols=248  Identities=21%  Similarity=0.230  Sum_probs=190.5

Q ss_pred             cccccccCCCCCCcEEEEEEe-CCCCEEEEEEeCCCCC--hhHHHHHHHHHHHhcCCCccccccceeeeeCC--------
Q 020221           58 MENIVSEHGEKAPNVVYKGKL-ENQFRIAVKRFNRSAW--PDARQFLEEARAVGQLRNRRLANLLGCCCEGD--------  126 (329)
Q Consensus        58 ~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~--------  126 (329)
                      .|.+.+.+|+|+||.||+|.. .+++.||+|.++....  .....+.+|+++++.++|||++++++++.+..        
T Consensus         8 ~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~~~~~~   87 (302)
T cd07864           8 KFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDALDFKKD   87 (302)
T ss_pred             hhheeeeecccCCEEEEEEEECCCCcEEEEEEEeecccccCchHHHHHHHHHHHhCCCCCeeeeeheecCcchhhhcccc
Confidence            355667779999999999995 4688999999975432  22345778999999999999999999886654        


Q ss_pred             --eeEEEEecCCCCCHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCCCCCeeeecccCcc
Q 020221          127 --ERLLVAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMK  204 (329)
Q Consensus       127 --~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~  204 (329)
                        ..++++||+++ ++...+.. ....+++..+..++.|++.||+|||+. +++|+||||+||++++++.+||+|||++.
T Consensus        88 ~~~~~lv~e~~~~-~l~~~l~~-~~~~~~~~~~~~i~~qi~~aL~~LH~~-~i~H~dl~p~nili~~~~~~kl~dfg~~~  164 (302)
T cd07864          88 KGAFYLVFEYMDH-DLMGLLES-GLVHFSEDHIKSFMKQLLEGLNYCHKK-NFLHRDIKCSNILLNNKGQIKLADFGLAR  164 (302)
T ss_pred             CCcEEEEEcccCc-cHHHHHhc-CCCCCCHHHHHHHHHHHHHHHHHHHhC-CeecCCCCHHHEEECCCCcEEeCcccccc
Confidence              78999999986 77777754 345789999999999999999999999 99999999999999999999999999987


Q ss_pred             cCCCCC-----CccCcccccCcccccCC-CCCCcccchhhhHHHHHHHhCCCCCCchhhHHHhhhchh-------hhccc
Q 020221          205 NSRDGR-----SYSTNLAFTPPEYLRTG-RVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQ-------TLTDS  271 (329)
Q Consensus       205 ~~~~~~-----~~~~~~~y~aPE~~~~~-~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~~~~~~~-------~~~~~  271 (329)
                      ......     ...++..|+|||.+.+. .++.++||||||+++++|++|+.|+..............       .....
T Consensus       165 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  244 (302)
T cd07864         165 LYNSEESRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQELAQLELISRLCGSPCPAVWPD  244 (302)
T ss_pred             cccCCcccccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhccc
Confidence            654332     12346789999988654 478899999999999999999977754321111000000       00000


Q ss_pred             c----c----------c---CCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 020221          272 C----L----------E---GQFSSDEGTELVRLASRCLQYEPRERPNPRSLVT  308 (329)
Q Consensus       272 ~----~----------~---~~~~~~~~~~~~~li~~cl~~dp~~Rps~~~~l~  308 (329)
                      .    .          .   .......+..+.+++..||..||++||++.+++.
T Consensus       245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~  298 (302)
T cd07864         245 VIKLPYFNTMKPKKQYRRRLREEFSFIPTPALDLLDHMLTLDPSKRCTAEEALN  298 (302)
T ss_pred             ccccccccccccccccccchhhhcCCCCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence            0    0          0   0001124678999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely

>cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11

Probab=100.00  E-value=6.8e-39  Score=277.94  Aligned_cols=243  Identities=16%  Similarity=0.192  Sum_probs=194.0

Q ss_pred             ccccccCCCCCCcEEEEEEe-CCCCEEEEEEeCCCC-----ChhHHHHHHHHHHHhcCCCccccccceeeeeCCeeEEEE
Q 020221           59 ENIVSEHGEKAPNVVYKGKL-ENQFRIAVKRFNRSA-----WPDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVA  132 (329)
Q Consensus        59 ~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~-----~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~  132 (329)
                      |.+.+.||+|+||.||++.. ..+..+++|.++...     ......+..|+.+++.++||||+++++++.+....++++
T Consensus         2 y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   81 (260)
T cd08222           2 YILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLERDAFCIIT   81 (260)
T ss_pred             ceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhcCCceEEEE
Confidence            55667889999999999984 334456666655321     122345677899999999999999999999889999999


Q ss_pred             ecCCCCCHHhhhccC--CCCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCCCCCeeeecccCcccCCCCC
Q 020221          133 EYMPNDTLAKHLFHW--ETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDGR  210 (329)
Q Consensus       133 e~~~~gsL~~~l~~~--~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~  210 (329)
                      ||+++++|.+++...  ....+++..+..++.|++.||.|||+. +++|+||+|+||++++ +.++|+|||++.......
T Consensus        82 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~-~i~h~~l~~~nili~~-~~~~l~d~g~~~~~~~~~  159 (260)
T cd08222          82 EYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQR-RILHRDLKAKNIFLKN-NLLKIGDFGVSRLLMGSC  159 (260)
T ss_pred             EeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHc-CccccCCChhheEeec-CCEeecccCceeecCCCc
Confidence            999999999888532  345789999999999999999999999 9999999999999975 569999999987654322


Q ss_pred             ----CccCcccccCcccccCCCCCCcccchhhhHHHHHHHhCCCCCCchhhHHHhhhchhhhccccccCCCChHHHHHHH
Q 020221          211 ----SYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELV  286 (329)
Q Consensus       211 ----~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  286 (329)
                          ...++..|+|||.+.+..++.++|+||||+++|+|++|..|+..............     ......+...+.++.
T Consensus       160 ~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~  234 (260)
T cd08222         160 DLATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFEGQNFLSVVLRIVE-----GPTPSLPETYSRQLN  234 (260)
T ss_pred             ccccCCCCCcCccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHc-----CCCCCCcchhcHHHH
Confidence                33567889999999888889999999999999999999988764432222111111     112233456778999


Q ss_pred             HHHHHhcccCCCCCCCHHHHHH
Q 020221          287 RLASRCLQYEPRERPNPRSLVT  308 (329)
Q Consensus       287 ~li~~cl~~dp~~Rps~~~~l~  308 (329)
                      +++.+||..||++||++.++++
T Consensus       235 ~li~~~l~~~p~~Rp~~~~il~  256 (260)
T cd08222         235 SIMQSMLNKDPSLRPSAAEILR  256 (260)
T ss_pred             HHHHHHhcCChhhCcCHHHHhh
Confidence            9999999999999999999998

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check

>cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15

Probab=100.00  E-value=5.3e-39  Score=289.22  Aligned_cols=252  Identities=21%  Similarity=0.292  Sum_probs=192.6

Q ss_pred             cccccccCCCCCCcEEEEEEe-CCCCEEEEEEeCCCC--ChhHHHHHHHHHHHhcC-CCccccccceeeeeC--CeeEEE
Q 020221           58 MENIVSEHGEKAPNVVYKGKL-ENQFRIAVKRFNRSA--WPDARQFLEEARAVGQL-RNRRLANLLGCCCEG--DERLLV  131 (329)
Q Consensus        58 ~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~--~~~~lv  131 (329)
                      .|.+.+.||+|+||.||+|.. .+++.+|+|++....  ......+.+|+.+++.+ +||||+++++++...  ...++|
T Consensus         8 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~~~~lv   87 (337)
T cd07852           8 KYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNVIKAENDKDIYLV   87 (337)
T ss_pred             HHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccCcchhhhhhhHHHHHHHHhcCCCCccceeeeeccCCCceEEEE
Confidence            355666779999999999995 468899999886532  22345577899999999 999999999988643  468999


Q ss_pred             EecCCCCCHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCCCCCeeeecccCcccCCCCC-
Q 020221          132 AEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDGR-  210 (329)
Q Consensus       132 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~-  210 (329)
                      |||+.+ +|..++..   ..+++..+..++.||+.||.|||+. |++|+||||+||+++.++.++|+|||++....... 
T Consensus        88 ~e~~~~-~L~~~~~~---~~~~~~~~~~i~~qi~~~L~~LH~~-~i~H~dl~p~nill~~~~~~kl~d~g~~~~~~~~~~  162 (337)
T cd07852          88 FEYMET-DLHAVIRA---NILEDVHKRYIMYQLLKALKYIHSG-NVIHRDLKPSNILLNSDCRVKLADFGLARSLSELEE  162 (337)
T ss_pred             eccccc-CHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHC-CeecCCCCHHHEEEcCCCcEEEeeccchhccccccc
Confidence            999975 89998853   3788999999999999999999999 99999999999999999999999999987543322 


Q ss_pred             --------CccCcccccCcccccC-CCCCCcccchhhhHHHHHHHhCCCCCCchhhHHHhhhc-----------------
Q 020221          211 --------SYSTNLAFTPPEYLRT-GRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRN-----------------  264 (329)
Q Consensus       211 --------~~~~~~~y~aPE~~~~-~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~~~~~-----------------  264 (329)
                              ...++..|+|||.+.+ ..++.++||||||+++|+|++|+.||............                 
T Consensus       163 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  242 (337)
T cd07852         163 NPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKIIEVIGPPSAEDIESIKS  242 (337)
T ss_pred             cccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHHHh
Confidence                    2346788999998765 45788999999999999999999887543211110000                 


Q ss_pred             --hhhhcccccc------CCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHH--HHhhh
Q 020221          265 --IQTLTDSCLE------GQFSSDEGTELVRLASRCLQYEPRERPNPRSLVTA--LVTLQ  314 (329)
Q Consensus       265 --~~~~~~~~~~------~~~~~~~~~~~~~li~~cl~~dp~~Rps~~~~l~~--L~~~~  314 (329)
                        ..........      .......+.++.+++.+||+.||++|||+.+++++  ++.+.
T Consensus       243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~~il~~~~~~~~~  302 (337)
T cd07852         243 PFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTAEEALEHPYVAQFH  302 (337)
T ss_pred             hhHHHhhhhcccccccchhhhccCCCHHHHHHHHHhccCCcccccCHHHHhhChhhhhhc
Confidence              0000000000      00111256789999999999999999999999975  55553

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul

>KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.7e-39  Score=281.24  Aligned_cols=249  Identities=17%  Similarity=0.229  Sum_probs=194.9

Q ss_pred             cccccCCCCCCcEEEEEEeCCCCEEEEEEeCCCCChhHHHHHHHHHHHhcC--CCccccccceeeeeC----CeeEEEEe
Q 020221           60 NIVSEHGEKAPNVVYKGKLENQFRIAVKRFNRSAWPDARQFLEEARAVGQL--RNRRLANLLGCCCEG----DERLLVAE  133 (329)
Q Consensus        60 ~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l--~h~niv~~~~~~~~~----~~~~lv~e  133 (329)
                      .+++.+|+|.||.||+|.|. |+.||||++....   .+.+.+|.++.+.+  +|+||+.++++-..+    ..+|||++
T Consensus       214 ~L~e~IGkGRyGEVwrG~wr-Ge~VAVKiF~srd---E~SWfrEtEIYqTvmLRHENILgFIaaD~~~~gs~TQLwLvTd  289 (513)
T KOG2052|consen  214 VLQEIIGKGRFGEVWRGRWR-GEDVAVKIFSSRD---ERSWFRETEIYQTVMLRHENILGFIAADNKDNGSWTQLWLVTD  289 (513)
T ss_pred             EEEEEecCccccceeecccc-CCceEEEEecccc---hhhhhhHHHHHHHHHhccchhhhhhhccccCCCceEEEEEeee
Confidence            45677899999999999995 5689999998765   34567888888775  999999999875433    36899999


Q ss_pred             cCCCCCHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhc-------CCCccccccCCCceeeCCCCCeeeecccCcccC
Q 020221          134 YMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTS-------KERALYHDLNAYRIVFDDDVNPRLSCFGLMKNS  206 (329)
Q Consensus       134 ~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~-------~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~  206 (329)
                      |.+.|||.|||   ....++-...++++..+++||++||.       ++.|.|||||..|||+..++.+.|+|+|+|...
T Consensus       290 YHe~GSL~DyL---~r~tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn~~C~IADLGLAv~h  366 (513)
T KOG2052|consen  290 YHEHGSLYDYL---NRNTVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRH  366 (513)
T ss_pred             cccCCcHHHHH---hhccCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccCCcEEEeeceeeEEe
Confidence            99999999999   55789999999999999999999996       367999999999999999999999999999765


Q ss_pred             CCC--------CCccCcccccCcccccCCC----C--CCcccchhhhHHHHHHHhCC----------CCCCc-----hhh
Q 020221          207 RDG--------RSYSTNLAFTPPEYLRTGR----V--TPESVMYSFGTLLLDLLSGK----------HIPPS-----HAL  257 (329)
Q Consensus       207 ~~~--------~~~~~~~~y~aPE~~~~~~----~--~~~~DvwslG~il~el~tg~----------~~~~~-----~~~  257 (329)
                      ...        ...+||.+|||||++....    |  -..+||||||+++||+.-+.          .||.+     -..
T Consensus       367 ~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~~ggi~eey~~Pyyd~Vp~DPs~  446 (513)
T KOG2052|consen  367 DSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRCESGGIVEEYQLPYYDVVPSDPSF  446 (513)
T ss_pred             cccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhhcCCEehhhcCCcccCCCCCCCH
Confidence            433        3457999999999987532    2  23699999999999997643          23221     122


Q ss_pred             HHHhhhchhhhccccccCCC-ChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhh
Q 020221          258 DLIRDRNIQTLTDSCLEGQF-SSDEGTELVRLASRCLQYEPRERPNPRSLVTALVTLQK  315 (329)
Q Consensus       258 ~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~li~~cl~~dp~~Rps~~~~l~~L~~~~~  315 (329)
                      +.++.-...+.+.+.....+ ..+.-..+.++|+.||..+|..|.|+-.+-..|.++.+
T Consensus       447 eeMrkVVCv~~~RP~ipnrW~s~~~l~~m~klMkeCW~~Np~aRltALriKKtl~~l~~  505 (513)
T KOG2052|consen  447 EEMRKVVCVQKLRPNIPNRWKSDPALRVMAKLMKECWYANPAARLTALRIKKTLAKLSN  505 (513)
T ss_pred             HHHhcceeecccCCCCCcccccCHHHHHHHHHHHHhhcCCchhhhHHHHHHHHHHHHhc
Confidence            22322222222222222222 34566789999999999999999999999999988875

>KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription]

Probab=100.00  E-value=2.9e-40  Score=264.75  Aligned_cols=257  Identities=18%  Similarity=0.253  Sum_probs=207.2

Q ss_pred             ccCHHHHHHHhcCCCcccccccCCCCCCcEEEEEE-eCCCCEEEEEEeCCCCChhHHHHHHHHHHHhcCC-Cccccccce
Q 020221           43 EYSIETLRTATSGFAMENIVSEHGEKAPNVVYKGK-LENQFRIAVKRFNRSAWPDARQFLEEARAVGQLR-NRRLANLLG  120 (329)
Q Consensus        43 ~~~~~~~~~~~~~~~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~~~~  120 (329)
                      -++++.......+-+.|++++++|+|.|+.||.|. ..+.+.++||+++...   .+.+.+|+.+|+.|. ||||+++++
T Consensus        24 YWdYE~~~i~wg~~ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKPVk---kkKIkREikIL~nL~gg~NIi~L~D  100 (338)
T KOG0668|consen   24 YWDYESLVIDWGNQDDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKPVK---KKKIKREIKILQNLRGGPNIIKLLD  100 (338)
T ss_pred             hcchhheeeeccccchHHHHHHHcCccHhhHhcccccCCCceEEEeeechHH---HHHHHHHHHHHHhccCCCCeeehhh
Confidence            35566655556777889999999999999999998 7788899999998643   567899999999997 999999999


Q ss_pred             eeeeC--CeeEEEEecCCCCCHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeC-CCCCeee
Q 020221          121 CCCEG--DERLLVAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFD-DDVNPRL  197 (329)
Q Consensus       121 ~~~~~--~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~-~~~~~kl  197 (329)
                      ...++  ....||+||+.+.+...+.     +.++..++..++.+++.||.|+|+. ||+|||+||.|+++| +...++|
T Consensus       101 iV~Dp~SktpaLiFE~v~n~Dfk~ly-----~tl~d~dIryY~~elLkALdyCHS~-GImHRDVKPhNvmIdh~~rkLrl  174 (338)
T KOG0668|consen  101 IVKDPESKTPSLIFEYVNNTDFKQLY-----PTLTDYDIRYYIYELLKALDYCHSM-GIMHRDVKPHNVMIDHELRKLRL  174 (338)
T ss_pred             hhcCccccCchhHhhhhccccHHHHh-----hhhchhhHHHHHHHHHHHHhHHHhc-CcccccCCcceeeechhhceeee
Confidence            99776  4578999999998877766     4688889999999999999999999 999999999999999 5567999


Q ss_pred             ecccCcccCCCCCCcc---CcccccCcccccCCC-CCCcccchhhhHHHHHHHhCCCCCCchhhH--HH-----------
Q 020221          198 SCFGLMKNSRDGRSYS---TNLAFTPPEYLRTGR-VTPESVMYSFGTLLLDLLSGKHIPPSHALD--LI-----------  260 (329)
Q Consensus       198 ~Dfg~a~~~~~~~~~~---~~~~y~aPE~~~~~~-~~~~~DvwslG~il~el~tg~~~~~~~~~~--~~-----------  260 (329)
                      +|||+|.+..++..+.   .+..|..||.+.+-+ |+.+-|+|||||++..|+..+.||+.+...  ..           
T Consensus       175 IDWGLAEFYHp~~eYnVRVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFhG~dN~DQLVkIakVLGt~e  254 (338)
T KOG0668|consen  175 IDWGLAEFYHPGKEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVKIAKVLGTDE  254 (338)
T ss_pred             eecchHhhcCCCceeeeeeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccCCCCCHHHHHHHHHHhChHH
Confidence            9999999999887653   467899999987655 899999999999999999999998754111  00           


Q ss_pred             -----h------hhchhhh--------ccccccCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 020221          261 -----R------DRNIQTL--------TDSCLEGQFSSDEGTELVRLASRCLQYEPRERPNPRSLVT  308 (329)
Q Consensus       261 -----~------~~~~~~~--------~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~~~l~  308 (329)
                           .      ......+        +............++++.+|+...|.+|..+||||.|++.
T Consensus       255 l~~Yl~KY~i~Ldp~~~~i~~~~~rk~w~~Fi~~~n~hl~~peaiDlldklLrYDHqeRlTakEam~  321 (338)
T KOG0668|consen  255 LYAYLNKYQIDLDPQFEDILGRHSRKPWSRFINSENQHLVSPEAIDLLDKLLRYDHQERLTAKEAMA  321 (338)
T ss_pred             HHHHHHHHccCCChhHhhHhhccccccHHHhCCccccccCChHHHHHHHHHHhhccccccchHHHhc
Confidence                 0      0000111        1111111122235689999999999999999999999997

>cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase

Probab=100.00  E-value=8.6e-39  Score=288.38  Aligned_cols=253  Identities=15%  Similarity=0.234  Sum_probs=193.6

Q ss_pred             CcccccccCCCCCCcEEEEEE-eCCCCEEEEEEeCCCCC--hhHHHHHHHHHHHhcCCCccccccceeeeeC------Ce
Q 020221           57 AMENIVSEHGEKAPNVVYKGK-LENQFRIAVKRFNRSAW--PDARQFLEEARAVGQLRNRRLANLLGCCCEG------DE  127 (329)
Q Consensus        57 ~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~------~~  127 (329)
                      ..|.+.+.||+|+||.||+|. ..+++.||+|++.....  .....+.+|+.+++.++||||+++++++...      ..
T Consensus        15 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~   94 (342)
T cd07879          15 ERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEFQD   94 (342)
T ss_pred             cceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCccccccchhHHHHHHHHHHhcCCCCccchhheecccccCCCCce
Confidence            446667778999999999999 45788999999875421  2234578899999999999999999988654      34


Q ss_pred             eEEEEecCCCCCHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCCCCCeeeecccCcccCC
Q 020221          128 RLLVAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSR  207 (329)
Q Consensus       128 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~  207 (329)
                      .++++||+.. +|..++    ...+++..+..++.|++.||+|||+. +++||||||+||+++.++.++|+|||++....
T Consensus        95 ~~lv~e~~~~-~l~~~~----~~~~~~~~~~~~~~qi~~aL~~LH~~-~i~H~dlkp~NIll~~~~~~kL~dfg~~~~~~  168 (342)
T cd07879          95 FYLVMPYMQT-DLQKIM----GHPLSEDKVQYLVYQMLCGLKYIHSA-GIIHRDLKPGNLAVNEDCELKILDFGLARHAD  168 (342)
T ss_pred             EEEEeccccc-CHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC-CcccCCCCHHHEEECCCCCEEEeeCCCCcCCC
Confidence            6899999965 676654    23689999999999999999999999 99999999999999999999999999987654


Q ss_pred             CC-CCccCcccccCcccccC-CCCCCcccchhhhHHHHHHHhCCCCCCchhhHHHhhhchh-------------------
Q 020221          208 DG-RSYSTNLAFTPPEYLRT-GRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQ-------------------  266 (329)
Q Consensus       208 ~~-~~~~~~~~y~aPE~~~~-~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~~~~~~~-------------------  266 (329)
                      .. ....++..|+|||.+.+ ..++.++||||||+++|||++|+.||..............                   
T Consensus       169 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  248 (342)
T cd07879         169 AEMTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGPEFVQKLEDKAAK  248 (342)
T ss_pred             CCCCCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHhcccchH
Confidence            32 23456788999999876 4588899999999999999999998865432111110000                   


Q ss_pred             hh---ccccccCCC---ChHHHHHHHHHHHHhcccCCCCCCCHHHHHHH--HHhhhh
Q 020221          267 TL---TDSCLEGQF---SSDEGTELVRLASRCLQYEPRERPNPRSLVTA--LVTLQK  315 (329)
Q Consensus       267 ~~---~~~~~~~~~---~~~~~~~~~~li~~cl~~dp~~Rps~~~~l~~--L~~~~~  315 (329)
                      ..   .....+...   ....++.+.+++.+||+.||++||++.+++.+  ++..++
T Consensus       249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~~~~e~l~h~~f~~~~~  305 (342)
T cd07879         249 SYIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEALEHPYFDSFRD  305 (342)
T ss_pred             HHHhhcCCcccchHHHHhcCCCHHHHHHHHHHcCCChhhCcCHHHHhcCcchhhccc
Confidence            00   000000000   01245678999999999999999999999964  665554

Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13

>PTZ00024 cyclin-dependent protein kinase; Provisional

Probab=100.00  E-value=8.9e-39  Score=287.52  Aligned_cols=242  Identities=19%  Similarity=0.205  Sum_probs=188.8

Q ss_pred             ccCCCCCCcEEEEEE-eCCCCEEEEEEeCCCCChh--------------HHHHHHHHHHHhcCCCccccccceeeeeCCe
Q 020221           63 SEHGEKAPNVVYKGK-LENQFRIAVKRFNRSAWPD--------------ARQFLEEARAVGQLRNRRLANLLGCCCEGDE  127 (329)
Q Consensus        63 ~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~--------------~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~  127 (329)
                      +.||.|+||+||++. ..+++.||+|++.......              ...+.+|+++++.++|+||+++++++...+.
T Consensus        15 ~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~   94 (335)
T PTZ00024         15 AHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLVDVYVEGDF   94 (335)
T ss_pred             hcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeeeeEEEecCCc
Confidence            457999999999999 4568899999987543221              1246789999999999999999999999999


Q ss_pred             eEEEEecCCCCCHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCCCCCeeeecccCcccCC
Q 020221          128 RLLVAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSR  207 (329)
Q Consensus       128 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~  207 (329)
                      .+++|||+. ++|.+++.  ....+++.....++.|++.||.|||+. +++|+||+|+||+++.++.++|+|||++....
T Consensus        95 ~~lv~e~~~-~~l~~~l~--~~~~~~~~~~~~~~~ql~~aL~~LH~~-~i~H~dl~~~nill~~~~~~kl~dfg~~~~~~  170 (335)
T PTZ00024         95 INLVMDIMA-SDLKKVVD--RKIRLTESQVKCILLQILNGLNVLHKW-YFMHRDLSPANIFINSKGICKIADFGLARRYG  170 (335)
T ss_pred             EEEEEeccc-cCHHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHhC-CeecccccHHHeEECCCCCEEECCccceeecc
Confidence            999999997 58999885  345689999999999999999999999 99999999999999999999999999986544


Q ss_pred             CC------------------CCccCcccccCcccccCCC-CCCcccchhhhHHHHHHHhCCCCCCchhhHHHhhhchhhh
Q 020221          208 DG------------------RSYSTNLAFTPPEYLRTGR-VTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTL  268 (329)
Q Consensus       208 ~~------------------~~~~~~~~y~aPE~~~~~~-~~~~~DvwslG~il~el~tg~~~~~~~~~~~~~~~~~~~~  268 (329)
                      ..                  ....++..|+|||.+.+.. ++.++|+||||+++|+|++|..|+................
T Consensus       171 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~i~~~~  250 (335)
T PTZ00024        171 YPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGENEIDQLGRIFELL  250 (335)
T ss_pred             cccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHh
Confidence            10                  1123467899999987654 7889999999999999999998876443211111000000


Q ss_pred             c---cc----------------cccC---CCChHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 020221          269 T---DS----------------CLEG---QFSSDEGTELVRLASRCLQYEPRERPNPRSLVT  308 (329)
Q Consensus       269 ~---~~----------------~~~~---~~~~~~~~~~~~li~~cl~~dp~~Rps~~~~l~  308 (329)
                      .   ..                ....   ......+.++.+++..||+.||++|||+.+++.
T Consensus       251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~  312 (335)
T PTZ00024        251 GTPNEDNWPQAKKLPLYTEFTPRKPKDLKTIFPNASDDAIDLLQSLLKLNPLERISAKEALK  312 (335)
T ss_pred             CCCchhhCcchhhcccccccCcCCcccHHHhCcCCChHHHHHHHHHcCCCchhccCHHHHhc
Confidence            0   00                0000   001234678899999999999999999999997

>KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.7e-39  Score=294.51  Aligned_cols=240  Identities=19%  Similarity=0.210  Sum_probs=199.6

Q ss_pred             cCCCcccccccCCCCCCcEEEEEE-eCCCCEEEEEEeCCCCChhHHHHHHHHHHHhcC-CCccccccceeeeeCCeeEEE
Q 020221           54 SGFAMENIVSEHGEKAPNVVYKGK-LENQFRIAVKRFNRSAWPDARQFLEEARAVGQL-RNRRLANLLGCCCEGDERLLV  131 (329)
Q Consensus        54 ~~~~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~lv  131 (329)
                      ..+..|++...+|.|+|+.|..+. ..+++..++|++......    ..+|+.++... +||||+++.+.+.++.+.|+|
T Consensus       319 ~~~~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~~~~----~~~e~~~~~~~~~h~niv~~~~v~~~~~~~~~v  394 (612)
T KOG0603|consen  319 PFTESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKRADD----NQDEIPISLLVRDHPNIVKSHDVYEDGKEIYLV  394 (612)
T ss_pred             CcchhhccccccCCCCccceeeeeccccccchhheeccccccc----cccccchhhhhcCCCcceeecceecCCceeeee
Confidence            446778888889999999999998 667889999999876322    23577666665 799999999999999999999


Q ss_pred             EecCCCCCHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceee-CCCCCeeeecccCcccCCCCC
Q 020221          132 AEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVF-DDDVNPRLSCFGLMKNSRDGR  210 (329)
Q Consensus       132 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~-~~~~~~kl~Dfg~a~~~~~~~  210 (329)
                      ||.+.++-+.+.+..   .+.....+..|+.+|+.|+.|||++ |+|||||||+|||+ ++.++++|+|||.++......
T Consensus       395 ~e~l~g~ell~ri~~---~~~~~~e~~~w~~~lv~Av~~LH~~-gvvhRDLkp~NIL~~~~~g~lrltyFG~a~~~~~~~  470 (612)
T KOG0603|consen  395 MELLDGGELLRRIRS---KPEFCSEASQWAAELVSAVDYLHEQ-GVVHRDLKPGNILLDGSAGHLRLTYFGFWSELERSC  470 (612)
T ss_pred             ehhccccHHHHHHHh---cchhHHHHHHHHHHHHHHHHHHHhc-CeeecCCChhheeecCCCCcEEEEEechhhhCchhh
Confidence            999999988887753   2233377888999999999999998 99999999999999 689999999999998877662


Q ss_pred             C-ccCcccccCcccccCCCCCCcccchhhhHHHHHHHhCCCCCCchhhHHHhhhchhhhccccccCCCChHHHHHHHHHH
Q 020221          211 S-YSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLA  289 (329)
Q Consensus       211 ~-~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li  289 (329)
                      . ..-|..|.|||++....+++++|+||||++||+|++|+.|+......       .++......+.+....|.++++|+
T Consensus       471 ~tp~~t~~y~APEvl~~~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~-------~ei~~~i~~~~~s~~vS~~AKdLl  543 (612)
T KOG0603|consen  471 DTPALTLQYVAPEVLAIQEYTEACDWWSLGVLLYEMLTGRTLFAAHPAG-------IEIHTRIQMPKFSECVSDEAKDLL  543 (612)
T ss_pred             cccchhhcccChhhhccCCCCcchhhHHHHHHHHHHHhCCCccccCCch-------HHHHHhhcCCccccccCHHHHHHH
Confidence            2 24578899999999888999999999999999999999988654332       122222233445577899999999


Q ss_pred             HHhcccCCCCCCCHHHHHH
Q 020221          290 SRCLQYEPRERPNPRSLVT  308 (329)
Q Consensus       290 ~~cl~~dp~~Rps~~~~l~  308 (329)
                      .+||+.||.+||++.++..
T Consensus       544 ~~LL~~dP~~Rl~~~~i~~  562 (612)
T KOG0603|consen  544 QQLLQVDPALRLGADEIGA  562 (612)
T ss_pred             HHhccCChhhCcChhhhcc
Confidence            9999999999999999997

>cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins

Probab=100.00  E-value=1.1e-38  Score=283.57  Aligned_cols=250  Identities=18%  Similarity=0.226  Sum_probs=189.4

Q ss_pred             CCcccccccCCCCCCcEEEEEE-eCCCCEEEEEEeCCCCCh--hHHHHHHHHHHHhcCCCccccccceeeeeC-------
Q 020221           56 FAMENIVSEHGEKAPNVVYKGK-LENQFRIAVKRFNRSAWP--DARQFLEEARAVGQLRNRRLANLLGCCCEG-------  125 (329)
Q Consensus        56 ~~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~--~~~~~~~e~~~l~~l~h~niv~~~~~~~~~-------  125 (329)
                      ...|.+++.||+|+||.||++. ..+++.+|+|.+......  ....+.+|+++++.++||||+++++++...       
T Consensus         7 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~   86 (311)
T cd07866           7 LRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDMAVERPDKSKRK   86 (311)
T ss_pred             cccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCCcchhHHHHHHHHHhcCCCCccchhhheeccccccccc
Confidence            3567788888999999999999 456889999998654322  234567899999999999999999887543       


Q ss_pred             -CeeEEEEecCCCCCHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCCCCCeeeecccCcc
Q 020221          126 -DERLLVAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMK  204 (329)
Q Consensus       126 -~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~  204 (329)
                       ..+++++||+.+ +|...+.. ....+++..+..++.|++.||.|||+. |++|+||||+||++++++.++|+|||++.
T Consensus        87 ~~~~~lv~~~~~~-~l~~~~~~-~~~~~~~~~~~~i~~~l~~al~~lH~~-~i~H~dl~p~nil~~~~~~~~l~dfg~~~  163 (311)
T cd07866          87 RGSVYMVTPYMDH-DLSGLLEN-PSVKLTESQIKCYMLQLLEGINYLHEN-HILHRDIKAANILIDNQGILKIADFGLAR  163 (311)
T ss_pred             CceEEEEEecCCc-CHHHHHhc-cccCCCHHHHHHHHHHHHHHHHHHHhC-CeecCCCCHHHEEECCCCCEEECcCccch
Confidence             346999999976 67776643 345799999999999999999999999 99999999999999999999999999987


Q ss_pred             cCCCCC---------------CccCcccccCcccccCC-CCCCcccchhhhHHHHHHHhCCCCCCchhhHHHhhhchh--
Q 020221          205 NSRDGR---------------SYSTNLAFTPPEYLRTG-RVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQ--  266 (329)
Q Consensus       205 ~~~~~~---------------~~~~~~~y~aPE~~~~~-~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~~~~~~~--  266 (329)
                      ......               ...++..|+|||.+.+. .++.++||||||+++|+|++|..|+..............  
T Consensus       164 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~~~~~~~~~~~~~~  243 (311)
T cd07866         164 PYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDIDQLHLIFKLC  243 (311)
T ss_pred             hccCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHh
Confidence            543221               11346779999988654 488899999999999999999987754322111110000  


Q ss_pred             ---------------hhccccccCCCC-------hHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 020221          267 ---------------TLTDSCLEGQFS-------SDEGTELVRLASRCLQYEPRERPNPRSLVT  308 (329)
Q Consensus       267 ---------------~~~~~~~~~~~~-------~~~~~~~~~li~~cl~~dp~~Rps~~~~l~  308 (329)
                                     ...........+       ...++.+.+++.+||..||++|||+.+++.
T Consensus       244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~t~~ell~  307 (311)
T cd07866         244 GTPTEETWPGWRSLPGCEGVHSFTNYPRTLEERFGKLGPEGLDLLSKLLSLDPYKRLTASDALE  307 (311)
T ss_pred             CCCChhhchhhhhcccccccccCCCCCccHHHHcccCChhHHHHHHHHcccCcccCcCHHHHhc
Confidence                           000000000001       123467899999999999999999999998

Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic

>KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription]

Probab=100.00  E-value=5.2e-40  Score=274.05  Aligned_cols=254  Identities=15%  Similarity=0.201  Sum_probs=195.3

Q ss_pred             CCCcccccccCCCCCCcEEEEEEeC-C----CCEEEEEEeCCCCC--hhHHHHHHHHHHHhcCCCccccccceeeee-CC
Q 020221           55 GFAMENIVSEHGEKAPNVVYKGKLE-N----QFRIAVKRFNRSAW--PDARQFLEEARAVGQLRNRRLANLLGCCCE-GD  126 (329)
Q Consensus        55 ~~~~~~~~~~lg~G~~g~V~~~~~~-~----~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~~~~~~~~-~~  126 (329)
                      ....|+.++.||+|.||.||++... +    .+.+|+|+++....  .-.....+|+..++.++|||++.+..++.. +.
T Consensus        22 ~l~~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~d~  101 (438)
T KOG0666|consen   22 DLFEYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGISMSACREIALLRELKHPNVISLVKVFLSHDK  101 (438)
T ss_pred             HHHHhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCCcCHHHHHHHHHHHHhcCCcchhHHHHHhccCc
Confidence            3456889999999999999999632 2    24699999986522  123457899999999999999999999877 78


Q ss_pred             eeEEEEecCCCCCHHhhhccC---CCCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCCC----CCeeeec
Q 020221          127 ERLLVAEYMPNDTLAKHLFHW---ETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDD----VNPRLSC  199 (329)
Q Consensus       127 ~~~lv~e~~~~gsL~~~l~~~---~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~----~~~kl~D  199 (329)
                      .+++++||.+. +|++.|+-.   +.+.++...+..|++||+.|+.|||++ =++||||||.||++..+    |.+||+|
T Consensus       102 ~v~l~fdYAEh-DL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~N-WvlHRDLKPaNIlvmgdgperG~VKIaD  179 (438)
T KOG0666|consen  102 KVWLLFDYAEH-DLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSN-WVLHRDLKPANILVMGDGPERGRVKIAD  179 (438)
T ss_pred             eEEEEehhhhh-hHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhh-heeeccCCcceEEEeccCCccCeeEeec
Confidence            89999999987 799888632   335688999999999999999999999 89999999999999877    8999999


Q ss_pred             ccCcccCCCC-------CCccCcccccCcccccCCC-CCCcccchhhhHHHHHHHhCCCCCCchhhHHHhh--------h
Q 020221          200 FGLMKNSRDG-------RSYSTNLAFTPPEYLRTGR-VTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRD--------R  263 (329)
Q Consensus       200 fg~a~~~~~~-------~~~~~~~~y~aPE~~~~~~-~~~~~DvwslG~il~el~tg~~~~~~~~~~~~~~--------~  263 (329)
                      ||+++.+.+.       ...+.|.+|.|||.+.|.. |+.+.|||++|||..||+|-.+.|.....+....        .
T Consensus       180 lGlaR~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~g~E~k~~~~~Pfq~dQl~  259 (438)
T KOG0666|consen  180 LGLARLFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFKGREEKIKTKNPFQHDQLD  259 (438)
T ss_pred             ccHHHHhhccccccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCccccchhhhcccCCCchHHHHH
Confidence            9999876543       3456789999999999887 9999999999999999999887665431111000        0


Q ss_pred             chhhhcc---------------------ccccCCCCh-----------HHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 020221          264 NIQTLTD---------------------SCLEGQFSS-----------DEGTELVRLASRCLQYEPRERPNPRSLVTAL  310 (329)
Q Consensus       264 ~~~~~~~---------------------~~~~~~~~~-----------~~~~~~~~li~~cl~~dp~~Rps~~~~l~~L  310 (329)
                      .+..++.                     ......+..           .-++...+|+..+|.+||-+|.|+++++++.
T Consensus       260 rIf~vLG~Pt~~~Wp~lkk~Pe~q~~ls~f~~~~~~n~sL~~~~~~~k~k~~~a~~LL~klL~yDP~kRIta~qAleh~  338 (438)
T KOG0666|consen  260 RIFEVLGTPTDKDWPDLKKMPEYQTLLSDFRRHYYDNVSLHKYYHKHKVKDPSALDLLQKLLTYDPIKRITAEQALEHP  338 (438)
T ss_pred             HHHHHcCCCccccchhhhhCcchHHHHHHhHHhhcCcchHHHHHHHhcCCCchHHHHHHHHhccCchhhccHHHHhccc
Confidence            0000000                     000000000           0134578999999999999999999999853

>cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase

Probab=100.00  E-value=1.3e-38  Score=280.35  Aligned_cols=249  Identities=18%  Similarity=0.216  Sum_probs=195.7

Q ss_pred             ccccccCCCCCCcEEEEEEe----CCCCEEEEEEeCCCCC----hhHHHHHHHHHHHhcC-CCccccccceeeeeCCeeE
Q 020221           59 ENIVSEHGEKAPNVVYKGKL----ENQFRIAVKRFNRSAW----PDARQFLEEARAVGQL-RNRRLANLLGCCCEGDERL  129 (329)
Q Consensus        59 ~~~~~~lg~G~~g~V~~~~~----~~~~~vavK~~~~~~~----~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~  129 (329)
                      +.+.+.||.|++|.||++..    .++..||+|.++....    ...+.+.+|++++..+ +||||+++.+.+..+...+
T Consensus         2 ~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~~~~   81 (288)
T cd05583           2 FELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDTKLH   81 (288)
T ss_pred             ceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecCCEEE
Confidence            45667789999999999873    3567899999875321    2234578899999999 5999999999999999999


Q ss_pred             EEEecCCCCCHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCCCCCeeeecccCcccCCCC
Q 020221          130 LVAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDG  209 (329)
Q Consensus       130 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~  209 (329)
                      +||||+++++|.+++.  ....+++..+..++.|++.||.|||+. +++|+||+|+||+++.++.++|+|||++......
T Consensus        82 lv~e~~~~~~L~~~~~--~~~~~~~~~~~~~~~ql~~~l~~lH~~-~~~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~  158 (288)
T cd05583          82 LILDYVNGGELFTHLY--QREHFTESEVRVYIAEIVLALDHLHQL-GIIYRDIKLENILLDSEGHVVLTDFGLSKEFLAE  158 (288)
T ss_pred             EEEecCCCCcHHHHHh--hcCCcCHHHHHHHHHHHHHHHHHHHHC-CeeccCCCHHHeEECCCCCEEEEECccccccccc
Confidence            9999999999999886  345688999999999999999999999 9999999999999999999999999998754332


Q ss_pred             C-----CccCcccccCcccccCCC--CCCcccchhhhHHHHHHHhCCCCCCchhhHHHhhhchhhhccccccCCCChHHH
Q 020221          210 R-----SYSTNLAFTPPEYLRTGR--VTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEG  282 (329)
Q Consensus       210 ~-----~~~~~~~y~aPE~~~~~~--~~~~~DvwslG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  282 (329)
                      .     ...++..|+|||.+.+..  .+.++|+||||+++|+|++|..|+...................  ....+...+
T Consensus       159 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~  236 (288)
T cd05583         159 EEERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQNSQSEISRRILKS--KPPFPKTMS  236 (288)
T ss_pred             cccccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCcccchHHHHHHHHHcc--CCCCCcccC
Confidence            2     234678999999987655  7789999999999999999998875321110000001111111  122344466


Q ss_pred             HHHHHHHHHhcccCCCCCCCHHHHHHHHHh
Q 020221          283 TELVRLASRCLQYEPRERPNPRSLVTALVT  312 (329)
Q Consensus       283 ~~~~~li~~cl~~dp~~Rps~~~~l~~L~~  312 (329)
                      ..+.+++.+||+.||++|||+.++.+.|+.
T Consensus       237 ~~l~~li~~~l~~~p~~R~t~~~~~~~l~~  266 (288)
T cd05583         237 AEARDFIQKLLEKDPKKRLGANGADEIKNH  266 (288)
T ss_pred             HHHHHHHHHHhcCCHhhccCcchHHHHhcC
Confidence            789999999999999999998877765543

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines

>cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase

Probab=100.00  E-value=2.1e-38  Score=285.98  Aligned_cols=253  Identities=15%  Similarity=0.204  Sum_probs=195.1

Q ss_pred             CcccccccCCCCCCcEEEEEE-eCCCCEEEEEEeCCCCCh--hHHHHHHHHHHHhcCCCccccccceeeeeCC------e
Q 020221           57 AMENIVSEHGEKAPNVVYKGK-LENQFRIAVKRFNRSAWP--DARQFLEEARAVGQLRNRRLANLLGCCCEGD------E  127 (329)
Q Consensus        57 ~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~--~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~------~  127 (329)
                      ..|.+++.||+|+||.||++. ..++..||+|.+......  ....+.+|+++++.++||||+++++++....      .
T Consensus        15 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~   94 (343)
T cd07880          15 DRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSLDRFHD   94 (343)
T ss_pred             cceEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCccceeeeecCCccccccce
Confidence            346678888999999999998 567889999998654322  2345789999999999999999999886543      4


Q ss_pred             eEEEEecCCCCCHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCCCCCeeeecccCcccCC
Q 020221          128 RLLVAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSR  207 (329)
Q Consensus       128 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~  207 (329)
                      .++|+||+ +++|.+++.   ...+++..+..++.|++.||.|||+. |++|+||||+||++++++.++|+|||++....
T Consensus        95 ~~lv~e~~-~~~l~~~~~---~~~l~~~~~~~i~~qi~~al~~LH~~-gi~H~dlkp~Nill~~~~~~kl~dfg~~~~~~  169 (343)
T cd07880          95 FYLVMPFM-GTDLGKLMK---HEKLSEDRIQFLVYQMLKGLKYIHAA-GIIHRDLKPGNLAVNEDCELKILDFGLARQTD  169 (343)
T ss_pred             EEEEEecC-CCCHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhC-CeecCCCCHHHEEEcCCCCEEEeecccccccc
Confidence            58999998 668988874   45789999999999999999999999 99999999999999999999999999987654


Q ss_pred             CCC-CccCcccccCcccccC-CCCCCcccchhhhHHHHHHHhCCCCCCchhhHHHhhhch-------------------h
Q 020221          208 DGR-SYSTNLAFTPPEYLRT-GRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNI-------------------Q  266 (329)
Q Consensus       208 ~~~-~~~~~~~y~aPE~~~~-~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~~~~~~-------------------~  266 (329)
                      ... ...++..|+|||.+.+ ..++.++|+||||+++|+|++|..||.............                   .
T Consensus       170 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  249 (343)
T cd07880         170 SEMTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLMEIMKVTGTPSKEFVQKLQSEDAK  249 (343)
T ss_pred             cCccccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHhhcchhHH
Confidence            432 3456889999999876 358889999999999999999998876432111100000                   0


Q ss_pred             hhcccc---cc---CCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHH--HHHhhh
Q 020221          267 TLTDSC---LE---GQFSSDEGTELVRLASRCLQYEPRERPNPRSLVT--ALVTLQ  314 (329)
Q Consensus       267 ~~~~~~---~~---~~~~~~~~~~~~~li~~cl~~dp~~Rps~~~~l~--~L~~~~  314 (329)
                      ......   ..   .......++++.+++.+|+..||++|||+.+++.  .++...
T Consensus       250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~t~~~~l~~~~~~~~~  305 (343)
T cd07880         250 NYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEALAHPYFEEFH  305 (343)
T ss_pred             HHHHhccccCcchHHHhccCCChHHHHHHHHHcCCChhhCCCHHHHhcCccHhhhc
Confidence            000000   00   0011235677999999999999999999999994  444443

Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12

>cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase

Probab=100.00  E-value=9.2e-39  Score=288.30  Aligned_cols=247  Identities=19%  Similarity=0.242  Sum_probs=193.2

Q ss_pred             CcccccccCCCCCCcEEEEEEe-CCCCEEEEEEeCCCC--ChhHHHHHHHHHHHhcCCCccccccceeeeeCCe------
Q 020221           57 AMENIVSEHGEKAPNVVYKGKL-ENQFRIAVKRFNRSA--WPDARQFLEEARAVGQLRNRRLANLLGCCCEGDE------  127 (329)
Q Consensus        57 ~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~------  127 (329)
                      ..|.+++.||+|++|.||+|.. .+++.||+|++....  ....+.+.+|+.+++.++|+|++++.+++.....      
T Consensus        15 ~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~   94 (343)
T cd07851          15 DRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLEDFQD   94 (343)
T ss_pred             CceEEEEEeccCCceEEEEEEECCCCcEEEEEecccccchhhHHHHHHHHHHHHHhccCCCHHHHHHHhhcccccccccc
Confidence            3466778889999999999994 567899999987542  2234567789999999999999999998765544      


Q ss_pred             eEEEEecCCCCCHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCCCCCeeeecccCcccCC
Q 020221          128 RLLVAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSR  207 (329)
Q Consensus       128 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~  207 (329)
                      .++|+||+ +++|.+++.   ...+++..+..++.|++.||.|||+. |++|+||||+||++++++.++|+|||++....
T Consensus        95 ~~lv~e~~-~~~L~~~~~---~~~l~~~~~~~~~~ql~~aL~~LH~~-gi~H~dlkp~Nill~~~~~~kL~dfg~~~~~~  169 (343)
T cd07851          95 VYLVTHLM-GADLNNIVK---CQKLSDDHIQFLVYQILRGLKYIHSA-GIIHRDLKPSNIAVNEDCELKILDFGLARHTD  169 (343)
T ss_pred             EEEEEecC-CCCHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHC-CeecCCCCHHHeEECCCCCEEEcccccccccc
Confidence            89999998 569999884   45799999999999999999999999 99999999999999999999999999987654


Q ss_pred             CC-CCccCcccccCcccccCC-CCCCcccchhhhHHHHHHHhCCCCCCchhhHHHhhhchhh-------h----------
Q 020221          208 DG-RSYSTNLAFTPPEYLRTG-RVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQT-------L----------  268 (329)
Q Consensus       208 ~~-~~~~~~~~y~aPE~~~~~-~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~~~~~~~~-------~----------  268 (329)
                      .. ....++..|+|||.+.+. .++.++||||||+++|++++|..||+..............       .          
T Consensus       170 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~  249 (343)
T cd07851         170 DEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQLKRIMNLVGTPDEELLQKISSESAR  249 (343)
T ss_pred             ccccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHhhccchhHH
Confidence            33 334567889999988653 5788999999999999999999888654322111110000       0          


Q ss_pred             --ccc---cccCC---CChHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 020221          269 --TDS---CLEGQ---FSSDEGTELVRLASRCLQYEPRERPNPRSLVT  308 (329)
Q Consensus       269 --~~~---~~~~~---~~~~~~~~~~~li~~cl~~dp~~Rps~~~~l~  308 (329)
                        ...   .....   .....++++.+++.+||+.||++|||+.+++.
T Consensus       250 ~~~~~~~~~~~~~~~~~~~~~s~~l~dli~~~l~~~P~~Rpt~~ell~  297 (343)
T cd07851         250 NYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALA  297 (343)
T ss_pred             HHHHhccccCCCCHHHHhccCCHHHHHHHHHhCCCChhhCCCHHHHhc
Confidence              000   00000   01123678999999999999999999999987

Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK

>KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis]

Probab=100.00  E-value=7.4e-39  Score=306.92  Aligned_cols=242  Identities=19%  Similarity=0.234  Sum_probs=182.5

Q ss_pred             ccccccCCCCCCcEEEEEE-eCCCCEEEEEEeCCCCCh-hHHHHHHHHHHHhcCCCccccccceeeeeC-----------
Q 020221           59 ENIVSEHGEKAPNVVYKGK-LENQFRIAVKRFNRSAWP-DARQFLEEARAVGQLRNRRLANLLGCCCEG-----------  125 (329)
Q Consensus        59 ~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~~~~~~~~~-----------  125 (329)
                      ++.++.||+|+||.||+++ .-+|..||||++...... ....+.+|+..|++|+|||||+++..|.+.           
T Consensus       481 FEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~~~~ei~~  560 (1351)
T KOG1035|consen  481 FEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKASDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAELTVLEIVA  560 (1351)
T ss_pred             hHHHHHhcCCCCceEEEEeecccchhhhhhhccCchHHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCccccccccc
Confidence            3444555999999999999 568999999999887522 234588999999999999999987644110           


Q ss_pred             --------------------------------------------------------------------------------
Q 020221          126 --------------------------------------------------------------------------------  125 (329)
Q Consensus       126 --------------------------------------------------------------------------------  125 (329)
                                                                                                      
T Consensus       561 ~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~tS~~e~~~  640 (1351)
T KOG1035|consen  561 SDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNTSDSEGSV  640 (1351)
T ss_pred             cchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCcccccccccccccccccccCCcc
Confidence                                                                                            


Q ss_pred             ----------------------------CeeEEEEecCCCCCHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCc
Q 020221          126 ----------------------------DERLLVAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERA  177 (329)
Q Consensus       126 ----------------------------~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~i  177 (329)
                                                  ..+||-||||+..+|.+++.+ +...-.....++++++|+.||+|+|++ |+
T Consensus       641 ~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~-N~~~~~~d~~wrLFreIlEGLaYIH~~-gi  718 (1351)
T KOG1035|consen  641 ILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRR-NHFNSQRDEAWRLFREILEGLAYIHDQ-GI  718 (1351)
T ss_pred             ccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHh-cccchhhHHHHHHHHHHHHHHHHHHhC-ce
Confidence                                        014789999999777777753 222225678899999999999999999 99


Q ss_pred             cccccCCCceeeCCCCCeeeecccCcccCC----------------------CCCCccCcccccCcccccCCC---CCCc
Q 020221          178 LYHDLNAYRIVFDDDVNPRLSCFGLMKNSR----------------------DGRSYSTNLAFTPPEYLRTGR---VTPE  232 (329)
Q Consensus       178 vH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~----------------------~~~~~~~~~~y~aPE~~~~~~---~~~~  232 (329)
                      |||||||.||++|+++.+||+|||+|+...                      +.....||.-|+|||++.+..   |+.|
T Consensus       719 IHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~~~~~~~Yn~K  798 (1351)
T KOG1035|consen  719 IHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLSDTSSNKYNSK  798 (1351)
T ss_pred             eeccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhcccccccccch
Confidence            999999999999999999999999997611                      112346788999999998654   9999


Q ss_pred             ccchhhhHHHHHHHhCCCCCCchhhHHHhhhchhhhcccccc--CCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 020221          233 SVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLE--GQFSSDEGTELVRLASRCLQYEPRERPNPRSLVT  308 (329)
Q Consensus       233 ~DvwslG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~li~~cl~~dp~~Rps~~~~l~  308 (329)
                      +||||||++++||+.-   |.-..   .+...+..+.+....  ..+..+.-+.-.++|.++++.||.+||||.++|+
T Consensus       799 iDmYSLGIVlFEM~yP---F~TsM---ERa~iL~~LR~g~iP~~~~f~~~~~~~e~slI~~Ll~hdP~kRPtA~eLL~  870 (1351)
T KOG1035|consen  799 IDMYSLGIVLFEMLYP---FGTSM---ERASILTNLRKGSIPEPADFFDPEHPEEASLIRWLLSHDPSKRPTATELLN  870 (1351)
T ss_pred             hhhHHHHHHHHHHhcc---CCchH---HHHHHHHhcccCCCCCCcccccccchHHHHHHHHHhcCCCccCCCHHHHhh
Confidence            9999999999999953   33221   111112222222111  1123334456678999999999999999999986

>cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase

Probab=100.00  E-value=2.3e-38  Score=285.84  Aligned_cols=254  Identities=18%  Similarity=0.236  Sum_probs=193.3

Q ss_pred             HHHHHHhcCCCcccccccCCCCCCcEEEEEE-eCCCCEEEEEEeCCCCC--hhHHHHHHHHHHHhcCCCccccccceeee
Q 020221           47 ETLRTATSGFAMENIVSEHGEKAPNVVYKGK-LENQFRIAVKRFNRSAW--PDARQFLEEARAVGQLRNRRLANLLGCCC  123 (329)
Q Consensus        47 ~~~~~~~~~~~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~~~~~~~  123 (329)
                      .++...+++   |.+++.||+|+||.||++. ..+++.||+|++.....  ...+.+.+|+.+++.++||||+++.+++.
T Consensus        10 ~~~~~~~~~---y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~   86 (345)
T cd07877          10 KTIWEVPER---YQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFT   86 (345)
T ss_pred             HHHhhccCc---eEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHHHHHHcCCCcccceeeeee
Confidence            344444444   5566777999999999998 56788999999875432  22456788999999999999999999875


Q ss_pred             eC------CeeEEEEecCCCCCHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCCCCCeee
Q 020221          124 EG------DERLLVAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRL  197 (329)
Q Consensus       124 ~~------~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl  197 (329)
                      ..      ...+++++++ +++|.+.+.   ...+++..+..++.|++.||+|||+. +++|+||||+||++++++.++|
T Consensus        87 ~~~~~~~~~~~~lv~~~~-~~~L~~~~~---~~~l~~~~~~~i~~qi~~aL~~LH~~-~ivH~dlkp~NIll~~~~~~kl  161 (345)
T cd07877          87 PARSLEEFNDVYLVTHLM-GADLNNIVK---CQKLTDDHVQFLIYQILRGLKYIHSA-DIIHRDLKPSNLAVNEDCELKI  161 (345)
T ss_pred             ecccccccccEEEEehhc-ccCHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHC-CeeecCCChHHEEEcCCCCEEE
Confidence            43      3467888876 679988874   34689999999999999999999999 9999999999999999999999


Q ss_pred             ecccCcccCCCCC-CccCcccccCcccccC-CCCCCcccchhhhHHHHHHHhCCCCCCchhhHHHhhhchh-------hh
Q 020221          198 SCFGLMKNSRDGR-SYSTNLAFTPPEYLRT-GRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQ-------TL  268 (329)
Q Consensus       198 ~Dfg~a~~~~~~~-~~~~~~~y~aPE~~~~-~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~~~~~~~-------~~  268 (329)
                      +|||++....... ...++..|+|||.+.+ ..++.++||||||+++|+|++|..||+.............       ..
T Consensus       162 ~dfg~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~  241 (345)
T cd07877         162 LDFGLARHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAEL  241 (345)
T ss_pred             ecccccccccccccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHH
Confidence            9999987654432 3456889999998866 4588899999999999999999988764321111000000       00


Q ss_pred             c---------------cccccCC---CChHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 020221          269 T---------------DSCLEGQ---FSSDEGTELVRLASRCLQYEPRERPNPRSLVT  308 (329)
Q Consensus       269 ~---------------~~~~~~~---~~~~~~~~~~~li~~cl~~dp~~Rps~~~~l~  308 (329)
                      .               .......   .....++++.+++.+||..||++||++.+++.
T Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~  299 (345)
T cd07877         242 LKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALA  299 (345)
T ss_pred             HhhcccHhHHHHHHHhcccCCcchhhhcCCCCHHHHHHHHHHcCCChhhcCCHHHHhc
Confidence            0               0000000   01124678899999999999999999999997

Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14

>cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins

Probab=100.00  E-value=1.6e-38  Score=272.11  Aligned_cols=218  Identities=19%  Similarity=0.206  Sum_probs=177.4

Q ss_pred             CCCcEEEEEE-eCCCCEEEEEEeCCCCChhHHHHHHHHHHHhcCCCccccccceeeeeCCeeEEEEecCCCCCHHhhhcc
Q 020221           68 KAPNVVYKGK-LENQFRIAVKRFNRSAWPDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAEYMPNDTLAKHLFH  146 (329)
Q Consensus        68 G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~  146 (329)
                      |.+|.||++. ..+++.+|+|.+....     .+.+|...+....||||+++++++.+....+++|||+++|+|.+++..
T Consensus         4 g~~~~v~~~~~~~~~~~~~~K~i~~~~-----~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~   78 (237)
T cd05576           4 GVIDKVLLVMDTRTQQTFILKGLRKSS-----EYSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGGKLWSHISK   78 (237)
T ss_pred             cccceEEEEEEccCCcEEEEEeecchh-----hhhhHHHHHHhcCCCceeehhhheecCCeEEEEEecCCCCCHHHHHHH
Confidence            8899999999 5678899999987643     223455555566799999999999999999999999999999998863


Q ss_pred             CCCCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCCCCCeeeecccCcccCCCC-CCccCcccccCccccc
Q 020221          147 WETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDG-RSYSTNLAFTPPEYLR  225 (329)
Q Consensus       147 ~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~-~~~~~~~~y~aPE~~~  225 (329)
                        ...+++..+..++.|++.||.|||+. +++|+||||+||+++.++.++++|||.+...... ....++..|+|||.+.
T Consensus        79 --~~~l~~~~~~~~~~ql~~~l~~lH~~-~i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~y~aPE~~~  155 (237)
T cd05576          79 --FLNIPEECVKRWAAEMVVALDALHRE-GIVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDSCDGEAVENMYCAPEVGG  155 (237)
T ss_pred             --hcCCCHHHHHHHHHHHHHHHHHHHhC-CeeccCCCHHHEEEcCCCCEEEecccchhccccccccCCcCccccCCcccC
Confidence              34689999999999999999999999 9999999999999999999999999987654433 2334567799999998


Q ss_pred             CCCCCCcccchhhhHHHHHHHhCCCCCCchhhHHHhhhchhhhccccccCCCChHHHHHHHHHHHHhcccCCCCCCCH
Q 020221          226 TGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLASRCLQYEPRERPNP  303 (329)
Q Consensus       226 ~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~  303 (329)
                      +..++.++|+||+|+++|+|++|..|+......          .........+...++.+.+++.+||+.||++||++
T Consensus       156 ~~~~~~~~DvwslG~il~el~~g~~~~~~~~~~----------~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~~~  223 (237)
T cd05576         156 ISEETEACDWWSLGAILFELLTGKTLVECHPSG----------INTHTTLNIPEWVSEEARSLLQQLLQFNPTERLGA  223 (237)
T ss_pred             CCCCCchhhHHHHHHHHHHHHHCcchhhcCchh----------cccccccCCcccCCHHHHHHHHHHccCCHHHhcCC
Confidence            888999999999999999999999664321100          00011112344567889999999999999999997

Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha

>cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1

Probab=100.00  E-value=3.6e-38  Score=283.26  Aligned_cols=246  Identities=18%  Similarity=0.239  Sum_probs=187.2

Q ss_pred             ccccccCCCCCCcEEEEEEe-CC--CCEEEEEEeCCCC--ChhHHHHHHHHHHHhcC-CCccccccceeeeeC----Cee
Q 020221           59 ENIVSEHGEKAPNVVYKGKL-EN--QFRIAVKRFNRSA--WPDARQFLEEARAVGQL-RNRRLANLLGCCCEG----DER  128 (329)
Q Consensus        59 ~~~~~~lg~G~~g~V~~~~~-~~--~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~----~~~  128 (329)
                      |++.+.||+|+||.||++.. .+  +..||+|.+....  ....+.+.+|+.+++.+ +||||+++++.+...    ...
T Consensus         2 y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~~   81 (332)
T cd07857           2 YELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFNEL   81 (332)
T ss_pred             ceEEEEccccCCeEEEEEEeCCCCcCceEEEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCCcE
Confidence            45667789999999999994 34  7789999987532  12245678899999999 599999999875332    457


Q ss_pred             EEEEecCCCCCHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCCCCCeeeecccCcccCCC
Q 020221          129 LLVAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRD  208 (329)
Q Consensus       129 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~  208 (329)
                      +++++|+. ++|.+.+.  ....+++..+..++.||+.||.|||+. |++|+||||+||+++.++.++|+|||++.....
T Consensus        82 ~~~~e~~~-~~L~~~l~--~~~~~~~~~~~~~~~qi~~aL~~LH~~-givH~dlkp~Nili~~~~~~kl~Dfg~a~~~~~  157 (332)
T cd07857          82 YLYEELME-ADLHQIIR--SGQPLTDAHFQSFIYQILCGLKYIHSA-NVLHRDLKPGNLLVNADCELKICDFGLARGFSE  157 (332)
T ss_pred             EEEEeccc-CCHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHhC-CcccCCCCHHHeEEcCCCCEEeCcCCCceeccc
Confidence            88899986 58998885  456789999999999999999999999 999999999999999999999999999875432


Q ss_pred             C--------CCccCcccccCcccccC-CCCCCcccchhhhHHHHHHHhCCCCCCchhhHHHhhhchh-------------
Q 020221          209 G--------RSYSTNLAFTPPEYLRT-GRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQ-------------  266 (329)
Q Consensus       209 ~--------~~~~~~~~y~aPE~~~~-~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~~~~~~~-------------  266 (329)
                      .        ....++..|+|||++.+ ..++.++||||||+++|+|++|..||..............             
T Consensus       158 ~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (332)
T cd07857         158 NPGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQLNQILQVLGTPDEETLSRI  237 (332)
T ss_pred             ccccccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCCHHHHHHHHHHHhCCCCHHHHHhh
Confidence            2        12357889999998765 4588999999999999999999987754321111100000             


Q ss_pred             ------hh---cccccc---CCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 020221          267 ------TL---TDSCLE---GQFSSDEGTELVRLASRCLQYEPRERPNPRSLVT  308 (329)
Q Consensus       267 ------~~---~~~~~~---~~~~~~~~~~~~~li~~cl~~dp~~Rps~~~~l~  308 (329)
                            ..   ......   .......+..+.+++.+||+.||++|||+.+++.
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~ll~  291 (332)
T cd07857         238 GSPKAQNYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKRISVEEALE  291 (332)
T ss_pred             hhhhHHHHHHhccccCCcchHhhCCCCCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence                  00   000000   0011123578999999999999999999999985

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co

>KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms]

Probab=100.00  E-value=1.8e-40  Score=271.33  Aligned_cols=244  Identities=18%  Similarity=0.229  Sum_probs=193.7

Q ss_pred             cccCCCCCCcEEEEEE-eCCCCEEEEEEeCCCCC-hhHHHHHHHHHHHhc-CCCccccccceeeeeCCeeEEEEecCCCC
Q 020221           62 VSEHGEKAPNVVYKGK-LENQFRIAVKRFNRSAW-PDARQFLEEARAVGQ-LRNRRLANLLGCCCEGDERLLVAEYMPND  138 (329)
Q Consensus        62 ~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~-l~h~niv~~~~~~~~~~~~~lv~e~~~~g  138 (329)
                      ++.||+|+||+|+|-. ..+|+.+|||.++.... .+.++++.|.+...+ -+.||||+++|++...+..|+.||+|+- 
T Consensus        69 lg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~~keq~rll~e~d~~mks~~cp~IVkfyGa~F~EGdcWiCMELMd~-  147 (361)
T KOG1006|consen   69 LGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNIEKEQKRLLMEHDTVMKSSNCPNIVKFYGALFSEGDCWICMELMDI-  147 (361)
T ss_pred             HHHhcCCcchhhhhhhcCccCcEEEEEEeeeccchHHHHHHHHHHHHHHhhcCCcHHHHHhhhhhcCCceeeeHHHHhh-
Confidence            4567999999999998 66799999999987764 334568888886554 4799999999999999999999999965 


Q ss_pred             CHHhhhcc---CCCCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCCCCCeeeecccCcccCCCC---CCc
Q 020221          139 TLAKHLFH---WETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDG---RSY  212 (329)
Q Consensus       139 sL~~~l~~---~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~---~~~  212 (329)
                      ||..+...   -....++++-+-.|..-...||.||.....|+|||+||+|||++..|.+||+|||++....+.   ...
T Consensus       148 SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~lkiIHRDvKPSNILldr~G~vKLCDFGIcGqLv~SiAkT~d  227 (361)
T KOG1006|consen  148 SLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEELKIIHRDVKPSNILLDRHGDVKLCDFGICGQLVDSIAKTVD  227 (361)
T ss_pred             hHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHHhhhhhccCChhheEEecCCCEeeecccchHhHHHHHHhhhc
Confidence            77765432   234568888888999999999999998779999999999999999999999999998765433   334


Q ss_pred             cCcccccCcccccC--CCCCCcccchhhhHHHHHHHhCCCCCCchhhHHHhhhchhhhccc--ccc-CCCChHHHHHHHH
Q 020221          213 STNLAFTPPEYLRT--GRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDS--CLE-GQFSSDEGTELVR  287 (329)
Q Consensus       213 ~~~~~y~aPE~~~~--~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~--~~~-~~~~~~~~~~~~~  287 (329)
                      .|...|||||-+..  ..|+-++||||||++|+|+.||..|+.  .|+.+.++....+...  .+. .....+.+..+..
T Consensus       228 aGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr--~w~svfeql~~Vv~gdpp~l~~~~~~~~~s~~~~~  305 (361)
T KOG1006|consen  228 AGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYR--KWDSVFEQLCQVVIGDPPILLFDKECVHYSFSMVR  305 (361)
T ss_pred             cCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcc--hHHHHHHHHHHHHcCCCCeecCcccccccCHHHHH
Confidence            67889999998863  348999999999999999999995554  4444444433333211  111 1112347889999


Q ss_pred             HHHHhcccCCCCCCCHHHHHH
Q 020221          288 LASRCLQYEPRERPNPRSLVT  308 (329)
Q Consensus       288 li~~cl~~dp~~Rps~~~~l~  308 (329)
                      ++..||.+|-..||++.+++.
T Consensus       306 fintCl~Kd~~~Rpky~~Lk~  326 (361)
T KOG1006|consen  306 FINTCLIKDRSDRPKYDDLKK  326 (361)
T ss_pred             HHHHHhhcccccCcchhhhhc
Confidence            999999999999999999875

>cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1

Probab=100.00  E-value=4.1e-38  Score=282.25  Aligned_cols=246  Identities=17%  Similarity=0.260  Sum_probs=191.1

Q ss_pred             ccccccCCCCCCcEEEEEE-eCCCCEEEEEEeCCCC--ChhHHHHHHHHHHHhcCCCccccccceeeee-CCeeEEEEec
Q 020221           59 ENIVSEHGEKAPNVVYKGK-LENQFRIAVKRFNRSA--WPDARQFLEEARAVGQLRNRRLANLLGCCCE-GDERLLVAEY  134 (329)
Q Consensus        59 ~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~-~~~~~lv~e~  134 (329)
                      |.+++.||.|+||.||++. ..+++.||+|++....  ....+.+.+|+++++.++||||+++.+++.. ....++++||
T Consensus        12 y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~lv~e~   91 (328)
T cd07856          12 YVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIFISPLEDIYFVTEL   91 (328)
T ss_pred             eEEEEeecccCCeEEEEEEECCCCCEEEEEEecccccccchhHHHHHHHHHHHhcCCCCeeeEeeeEecCCCcEEEEeeh
Confidence            5566777999999999998 5578899999886532  2234567889999999999999999998865 4678999999


Q ss_pred             CCCCCHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCCCCCeeeecccCcccCCCC-CCcc
Q 020221          135 MPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDG-RSYS  213 (329)
Q Consensus       135 ~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~-~~~~  213 (329)
                      + +++|..++.   ...+++..+..++.|++.||.|||+. +++|+||+|+||++++++.++|+|||.+...... ....
T Consensus        92 ~-~~~L~~~~~---~~~~~~~~~~~~~~ql~~aL~~LH~~-~iiH~dl~p~Nili~~~~~~~l~dfg~~~~~~~~~~~~~  166 (328)
T cd07856          92 L-GTDLHRLLT---SRPLEKQFIQYFLYQILRGLKYVHSA-GVVHRDLKPSNILINENCDLKICDFGLARIQDPQMTGYV  166 (328)
T ss_pred             h-ccCHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhC-CcccCCCCHHHEeECCCCCEEeCccccccccCCCcCCCc
Confidence            8 458988884   45688888999999999999999999 9999999999999999999999999998754433 2345


Q ss_pred             CcccccCcccccC-CCCCCcccchhhhHHHHHHHhCCCCCCchhhHHHh---------------h----hchhhhcccc-
Q 020221          214 TNLAFTPPEYLRT-GRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIR---------------D----RNIQTLTDSC-  272 (329)
Q Consensus       214 ~~~~y~aPE~~~~-~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~~---------------~----~~~~~~~~~~-  272 (329)
                      ++..|+|||.+.+ ..++.++||||||+++|+|++|..||+........               .    .......... 
T Consensus       167 ~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  246 (328)
T cd07856         167 STRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPPDDVINTICSENTLRFVQSLP  246 (328)
T ss_pred             ccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhccchhhHHHHhhcc
Confidence            6788999998766 46889999999999999999999887643211000               0    0000000000 


Q ss_pred             ccCCCC-----hHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 020221          273 LEGQFS-----SDEGTELVRLASRCLQYEPRERPNPRSLVTA  309 (329)
Q Consensus       273 ~~~~~~-----~~~~~~~~~li~~cl~~dp~~Rps~~~~l~~  309 (329)
                      .....+     ...++++.+++.+||+.+|++||++.+++.+
T Consensus       247 ~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~ell~~  288 (328)
T cd07856         247 KREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALAH  288 (328)
T ss_pred             ccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence            000111     2346789999999999999999999999873

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U

>KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms]

Probab=100.00  E-value=1.2e-39  Score=288.61  Aligned_cols=238  Identities=21%  Similarity=0.220  Sum_probs=198.5

Q ss_pred             cCCCCCCcEEEEEE-eCCCCEEEEEEeCCCCChh--HHHHHHHHHHHhcCCCccccccceeeeeCCeeEEEEecCCCCCH
Q 020221           64 EHGEKAPNVVYKGK-LENQFRIAVKRFNRSAWPD--ARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAEYMPNDTL  140 (329)
Q Consensus        64 ~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~--~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL  140 (329)
                      .||.|.||+||-|. .++|+.||||++.+-....  ..++++|+.+|+.+.||.||.+--.|++++.+|+|||-+.| +.
T Consensus       571 vLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kqesqlR~EVaILq~l~HPGiV~le~M~ET~ervFVVMEKl~G-DM  649 (888)
T KOG4236|consen  571 VLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQESQLRNEVAILQNLHHPGIVNLECMFETPERVFVVMEKLHG-DM  649 (888)
T ss_pred             hccCCcceeeecceecccCceeeeeeeecccCCCchHHHHHHHHHHHHhcCCCCeeEEEEeecCCceEEEEehhhcc-hH
Confidence            46999999999999 6789999999997654322  35689999999999999999999999999999999999955 67


Q ss_pred             HhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCC---CCCeeeecccCcccCCCC---CCccC
Q 020221          141 AKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDD---DVNPRLSCFGLMKNSRDG---RSYST  214 (329)
Q Consensus       141 ~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~---~~~~kl~Dfg~a~~~~~~---~~~~~  214 (329)
                      ..+|...+...+++.....++.||+.||.|||.+ ||+|+||||+|||+..   --.+||+|||+|+.+...   .+..|
T Consensus       650 LEMILSsEkgRL~er~TkFlvtQIL~ALr~LH~k-nIvHCDLKPENVLLas~~~FPQvKlCDFGfARiIgEksFRrsVVG  728 (888)
T KOG4236|consen  650 LEMILSSEKGRLPERITKFLVTQILVALRYLHFK-NIVHCDLKPENVLLASASPFPQVKLCDFGFARIIGEKSFRRSVVG  728 (888)
T ss_pred             HHHHHHhhcccchHHHHHHHHHHHHHHHHHhhhc-ceeeccCCchheeeccCCCCCceeeccccceeecchhhhhhhhcC
Confidence            7777666778899999999999999999999999 9999999999999964   346999999999987764   46789


Q ss_pred             cccccCcccccCCCCCCcccchhhhHHHHHHHhCCCCCCchhhHHHhhhchh-hhccccccCCCChHHHHHHHHHHHHhc
Q 020221          215 NLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQ-TLTDSCLEGQFSSDEGTELVRLASRCL  293 (329)
Q Consensus       215 ~~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~li~~cl  293 (329)
                      |+.|.|||++....|+.+-||||+|||+|.-++|..||..+.  .+.++... .++.   ......+.+++..+||...|
T Consensus       729 TPAYLaPEVLrnkGyNrSLDMWSVGVIiYVsLSGTFPFNEdE--dIndQIQNAaFMy---Pp~PW~eis~~AidlIn~LL  803 (888)
T KOG4236|consen  729 TPAYLAPEVLRNKGYNRSLDMWSVGVIIYVSLSGTFPFNEDE--DINDQIQNAAFMY---PPNPWSEISPEAIDLINNLL  803 (888)
T ss_pred             CccccCHHHHhhccccccccceeeeEEEEEEecccccCCCcc--chhHHhhcccccc---CCCchhhcCHHHHHHHHHHH
Confidence            999999999999999999999999999999999998776442  22222111 1111   11223567889999999999


Q ss_pred             ccCCCCCCCHHHHHH
Q 020221          294 QYEPRERPNPRSLVT  308 (329)
Q Consensus       294 ~~dp~~Rps~~~~l~  308 (329)
                      +..-.+|.|....+.
T Consensus       804 qVkm~kRysvdk~ls  818 (888)
T KOG4236|consen  804 QVKMRKRYSVDKSLS  818 (888)
T ss_pred             HHHHHHhcchHhhcc
Confidence            999999999887665

>KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=7.4e-38  Score=299.61  Aligned_cols=249  Identities=21%  Similarity=0.309  Sum_probs=204.2

Q ss_pred             ccCCCCCCcEEEEEEeC--------CCCEEEEEEeCCCCCh-hHHHHHHHHHHHhcC-CCccccccceeeeeCCeeEEEE
Q 020221           63 SEHGEKAPNVVYKGKLE--------NQFRIAVKRFNRSAWP-DARQFLEEARAVGQL-RNRRLANLLGCCCEGDERLLVA  132 (329)
Q Consensus        63 ~~lg~G~~g~V~~~~~~--------~~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~lv~  132 (329)
                      +.+|.|.||.|++|...        ....||||.++..... +.+.+..|+++|+.+ +|+||+.++|+|...+..++|+
T Consensus       302 ~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~~~~~~~~~El~~m~~~g~H~niv~llG~~t~~~~~~~v~  381 (609)
T KOG0200|consen  302 KYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASSSEKKDLMSELNVLKELGKHPNIVNLLGACTQDGPLYVIV  381 (609)
T ss_pred             ceeecccccceEeEEEeecccccccceEEEEEEecccccCcHHHHHHHHHHHHHHHhcCCcchhhheeeeccCCceEEEE
Confidence            36799999999999732        1457999999876433 456789999999999 6999999999999989999999


Q ss_pred             ecCCCCCHHhhhccCC------------C--CCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCCCCCeeee
Q 020221          133 EYMPNDTLAKHLFHWE------------T--QPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLS  198 (329)
Q Consensus       133 e~~~~gsL~~~l~~~~------------~--~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~  198 (329)
                      ||+..|+|.++++..+            .  ..++..+.+.++.||+.|++||+++ +++||||..+|||+..+..+||+
T Consensus       382 Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~-~~vHRDLAaRNVLi~~~~~~kIa  460 (609)
T KOG0200|consen  382 EYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASV-PCVHRDLAARNVLITKNKVIKIA  460 (609)
T ss_pred             EeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhC-CccchhhhhhhEEecCCCEEEEc
Confidence            9999999999997533            0  2388899999999999999999999 99999999999999999999999


Q ss_pred             cccCcccCCCCCCc-----c--CcccccCcccccCCCCCCcccchhhhHHHHHHHhCCCCCCchhhHHHhhhchhhhccc
Q 020221          199 CFGLMKNSRDGRSY-----S--TNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDS  271 (329)
Q Consensus       199 Dfg~a~~~~~~~~~-----~--~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~  271 (329)
                      |||+|+...+...+     .  -...|||||.+....|+.++||||||++||||+|.+.+|..+..   ....+...+..
T Consensus       461 DFGlar~~~~~~~y~~~~~~~~LP~kWmApEsl~~~~ft~kSDVWSfGI~L~EifsLG~~PYp~~~---~~~~l~~~l~~  537 (609)
T KOG0200|consen  461 DFGLARDHYNKDYYRTKSSAGTLPVKWMAPESLFDRVFTSKSDVWSFGILLWEIFTLGGTPYPGIP---PTEELLEFLKE  537 (609)
T ss_pred             cccceeccCCCCceEecCCCCccceeecCHHHhccCcccccchhhHHHHHHHHHhhCCCCCCCCCC---cHHHHHHHHhc
Confidence            99999865544322     1  23459999999998999999999999999999997765443311   00111123334


Q ss_pred             cccCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhh
Q 020221          272 CLEGQFSSDEGTELVRLASRCLQYEPRERPNPRSLVTALVTLQK  315 (329)
Q Consensus       272 ~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~~~l~~L~~~~~  315 (329)
                      ..+...|..++.++.+++..||+.+|++||++.++.+.++....
T Consensus       538 G~r~~~P~~c~~eiY~iM~~CW~~~p~~RP~F~~~~~~~~~~l~  581 (609)
T KOG0200|consen  538 GNRMEQPEHCSDEIYDLMKSCWNADPEDRPTFSECVEFFEKHLQ  581 (609)
T ss_pred             CCCCCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHHHHHHH
Confidence            44555677788999999999999999999999999999999643

>cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase

Probab=100.00  E-value=1e-37  Score=302.70  Aligned_cols=146  Identities=21%  Similarity=0.219  Sum_probs=129.4

Q ss_pred             CCcccccccCCCCCCcEEEEEEe-CCCCEEEEEEeCCCCC---hhHHHHHHHHHHHhcCCCccccccceeeeeCCeeEEE
Q 020221           56 FAMENIVSEHGEKAPNVVYKGKL-ENQFRIAVKRFNRSAW---PDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLV  131 (329)
Q Consensus        56 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv  131 (329)
                      +..|.+++.||.|+||.||+|.. .+++.||+|+++....   .....+.+|+.+++.++|+||+++++.+......++|
T Consensus         3 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lV   82 (669)
T cd05610           3 IEEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQSANNVYLV   82 (669)
T ss_pred             cCCEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEECCEEEEE
Confidence            45677888899999999999995 4688999999975432   2235688899999999999999999999999999999


Q ss_pred             EecCCCCCHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCCCCCeeeecccCcc
Q 020221          132 AEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMK  204 (329)
Q Consensus       132 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~  204 (329)
                      |||+.+++|.+++..  ...+++..++.++.||+.||.|||.. +|+||||||+|||++.++.++|+|||+++
T Consensus        83 mEy~~g~~L~~li~~--~~~l~~~~~~~i~~qil~aL~yLH~~-gIiHrDLKP~NILl~~~g~vkL~DFGls~  152 (669)
T cd05610          83 MEYLIGGDVKSLLHI--YGYFDEEMAVKYISEVALALDYLHRH-GIIHRDLKPDNMLISNEGHIKLTDFGLSK  152 (669)
T ss_pred             EeCCCCCCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhC-CEEeCCccHHHEEEcCCCCEEEEeCCCCc
Confidence            999999999999863  35688999999999999999999999 99999999999999999999999999864

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481

>KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=3.1e-38  Score=291.85  Aligned_cols=256  Identities=20%  Similarity=0.271  Sum_probs=212.1

Q ss_pred             cccccCCCCCCcEEEEEE-eCCC----CEEEEEEeCCCCC-hhHHHHHHHHHHHhcCCCccccccceeeeeCCeeEEEEe
Q 020221           60 NIVSEHGEKAPNVVYKGK-LENQ----FRIAVKRFNRSAW-PDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAE  133 (329)
Q Consensus        60 ~~~~~lg~G~~g~V~~~~-~~~~----~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  133 (329)
                      +..+.||+|+||+||+|. ...|    -+||+|++..... ...+++..|+-.|.+++|||+++++|+|.... +.||++
T Consensus       699 kk~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s~-~qlvtq  777 (1177)
T KOG1025|consen  699 KKDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFTSPKASIELLDEALRMASLDHPNLLRLLGVCMLST-LQLVTQ  777 (1177)
T ss_pred             hhhceeccccceeEEeeeEecCCceecceeEEEEeeccCCchhhHHHHHHHHHHhcCCCchHHHHhhhcccch-HHHHHH
Confidence            345678999999999998 4443    5689999876543 34567999999999999999999999997654 889999


Q ss_pred             cCCCCCHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCCCCCeeeecccCcccCCCCCCc-
Q 020221          134 YMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDGRSY-  212 (329)
Q Consensus       134 ~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~-  212 (329)
                      |++.|+|.++++. ....+-.+..+.|..||++||.|||.+ +++||||..+|||+..-..+||.|||+++........ 
T Consensus       778 ~mP~G~LlDyvr~-hr~~igsq~lLnw~~QIAkgM~YLe~q-rlVHrdLaaRNVLVksP~hvkitdfgla~ll~~d~~ey  855 (1177)
T KOG1025|consen  778 LMPLGCLLDYVRE-HRDNIGSQDLLNWCYQIAKGMKYLEEQ-RLVHRDLAARNVLVKSPNHVKITDFGLAKLLAPDEKEY  855 (1177)
T ss_pred             hcccchHHHHHHH-hhccccHHHHHHHHHHHHHHHHHHHhc-chhhhhhhhhheeecCCCeEEEEecchhhccCcccccc
Confidence            9999999999976 566788899999999999999999999 9999999999999999999999999999987655322 


Q ss_pred             -----cCcccccCcccccCCCCCCcccchhhhHHHHHHHhCC-CCCCchhhHHHhhhchhhhccccccCCCChHHHHHHH
Q 020221          213 -----STNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGK-HIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELV  286 (329)
Q Consensus       213 -----~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  286 (329)
                           ...+.|||-|.+....|+.++|||||||++||++|-+ .|+.....+.     +...++...+-..|+.++-++-
T Consensus       856 ~~~~gK~pikwmale~i~~~~~thqSDVWsfGVtiWElmTFGa~Py~gi~~~e-----I~dlle~geRLsqPpiCtiDVy  930 (1177)
T KOG1025|consen  856 SAPGGKVPIKWMALESIRIRKYTHQSDVWSFGVTIWELMTFGAKPYDGIPAEE-----IPDLLEKGERLSQPPICTIDVY  930 (1177)
T ss_pred             cccccccCcHHHHHHHhhccCCCchhhhhhhhhhHHHHHhcCCCccCCCCHHH-----hhHHHhccccCCCCCCccHHHH
Confidence                 2357799999999999999999999999999999944 4554433322     2333333344456777888999


Q ss_pred             HHHHHhcccCCCCCCCHHHHHHHHHhhhhccccccCc
Q 020221          287 RLASRCLQYEPRERPNPRSLVTALVTLQKDTELYLSL  323 (329)
Q Consensus       287 ~li~~cl~~dp~~Rps~~~~l~~L~~~~~~~~~~~~~  323 (329)
                      .++.+||..|++.||+++++...+.++.++..-+.+.
T Consensus       931 ~~mvkCwmid~~~rp~fkel~~~fs~~ardpqryl~i  967 (1177)
T KOG1025|consen  931 MVMVKCWMIDADSRPTFKELAEEFSRMARDPQRYLVI  967 (1177)
T ss_pred             HHHHHHhccCcccCccHHHHHHHHHHHhcCcceEeee
Confidence            9999999999999999999999999998776554443

>KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=2.7e-39  Score=262.63  Aligned_cols=251  Identities=16%  Similarity=0.222  Sum_probs=191.7

Q ss_pred             CcccccccCCCCCCcEEEEEE-eCCCCEEEEEEeCCCC--ChhHHHHHHHHHHHhcCCCccccccceeeeeC--------
Q 020221           57 AMENIVSEHGEKAPNVVYKGK-LENQFRIAVKRFNRSA--WPDARQFLEEARAVGQLRNRRLANLLGCCCEG--------  125 (329)
Q Consensus        57 ~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~--------  125 (329)
                      +.|+.+.++|+|.||.||+++ .++|+.||+|++-...  ..-.....+|+++|..++|+|++.+++.|...        
T Consensus        17 ~~yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneKeGfpitalreikiL~~lkHenv~nliEic~tk~Tp~~r~r   96 (376)
T KOG0669|consen   17 SKYEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPTNRDR   96 (376)
T ss_pred             hHHHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhccccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCCccccc
Confidence            446677788999999999999 6678889998764422  11234568999999999999999999988542        


Q ss_pred             CeeEEEEecCCCCCHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCCCCCeeeecccCccc
Q 020221          126 DERLLVAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKN  205 (329)
Q Consensus       126 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~  205 (329)
                      ..+++|+++|+. +|.-+|.+ ....++..++..+++++..||.|+|+. .|+|||+|+.|+||+.+|.+||+|||+++.
T Consensus        97 ~t~ylVf~~ceh-DLaGlLsn-~~vr~sls~Ikk~Mk~Lm~GL~~iHr~-kilHRDmKaaNvLIt~dgilklADFGlar~  173 (376)
T KOG0669|consen   97 ATFYLVFDFCEH-DLAGLLSN-RKVRFSLSEIKKVMKGLMNGLYYIHRN-KILHRDMKAANVLITKDGILKLADFGLARA  173 (376)
T ss_pred             ceeeeeHHHhhh-hHHHHhcC-ccccccHHHHHHHHHHHHHHHHHHHHh-hHHhhcccHhhEEEcCCceEEeeccccccc
Confidence            358999999987 79988864 346789999999999999999999999 999999999999999999999999999975


Q ss_pred             CCCCC--------CccCcccccCcccccCCC-CCCcccchhhhHHHHHHHhCCCCCCchhhHH-------Hhhhchhhhc
Q 020221          206 SRDGR--------SYSTNLAFTPPEYLRTGR-VTPESVMYSFGTLLLDLLSGKHIPPSHALDL-------IRDRNIQTLT  269 (329)
Q Consensus       206 ~~~~~--------~~~~~~~y~aPE~~~~~~-~~~~~DvwslG~il~el~tg~~~~~~~~~~~-------~~~~~~~~~~  269 (329)
                      +....        +...|.+|.+||.+.|.. |+++.|||+.|||+.||+||.+.+.+.....       .-.....+++
T Consensus       174 fs~~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqgnteqqql~~Is~LcGs~tkevW  253 (376)
T KOG0669|consen  174 FSTSKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGNTEQQQLHLISQLCGSITKEVW  253 (376)
T ss_pred             eecccccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccCChHHHHHHHHHHHhccCCcccC
Confidence            44322        224489999999988765 9999999999999999999997665431110       0000011111


Q ss_pred             cccc---------cCCCC-------------hHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 020221          270 DSCL---------EGQFS-------------SDEGTELVRLASRCLQYEPRERPNPRSLVTAL  310 (329)
Q Consensus       270 ~~~~---------~~~~~-------------~~~~~~~~~li~~cl~~dp~~Rps~~~~l~~L  310 (329)
                      +...         .++.+             -.-.++..+|+.+++..||.+|+++.+++++-
T Consensus       254 P~~d~lpL~~sie~ePl~~~~~rkv~n~~kp~~kd~~a~dLle~ll~~DP~kR~~ad~alnh~  316 (376)
T KOG0669|consen  254 PNVDNLPLYQSIELEPLPKGQKRKVKNRLKPYVKDDEALDLLEKLLKLDPTKRIDADQALNHD  316 (376)
T ss_pred             CCcccchHHHhccCCCCCcchhhhhhhhcccccCChhHHHHHHHHhccCcccCcchHhhhchh
Confidence            1000         00000             00124788999999999999999999999753

>KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms]

Probab=100.00  E-value=1.5e-37  Score=284.28  Aligned_cols=251  Identities=20%  Similarity=0.237  Sum_probs=192.3

Q ss_pred             ccCCCCCCcEEEEEE-eCCCCEEEEEEeCCCC-ChhHHHHHHHHHHHhcCCCccccccceeeeeC------CeeEEEEec
Q 020221           63 SEHGEKAPNVVYKGK-LENQFRIAVKRFNRSA-WPDARQFLEEARAVGQLRNRRLANLLGCCCEG------DERLLVAEY  134 (329)
Q Consensus        63 ~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~------~~~~lv~e~  134 (329)
                      +.+|+|+||.||+|+ ..+|..||||.++... ....+...+|+++|++++|+|||+++++-.+.      ....++|||
T Consensus        19 e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~~~vlvmEy   98 (732)
T KOG4250|consen   19 ERLGKGAFGNVYRGRNKETGRLVAVKTFNKESSLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTRLPVLVMEY   98 (732)
T ss_pred             hhhcCCccceeeeecccccccchhHHhhhhhcccchHHHHHHHHHHHHHcCchhhhhhcccCCccccCcccccceEEEee
Confidence            445999999999999 7789999999998753 23456788999999999999999999986543      356899999


Q ss_pred             CCCCCHHhhhccCC-CCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeC--CCC--CeeeecccCcccCCCC
Q 020221          135 MPNDTLAKHLFHWE-TQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFD--DDV--NPRLSCFGLMKNSRDG  209 (329)
Q Consensus       135 ~~~gsL~~~l~~~~-~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~--~~~--~~kl~Dfg~a~~~~~~  209 (329)
                      |.+|||...+.+.+ ...+++.+.+.+..++..||.|||++ ||+||||||.||++-  ++|  ..||+|||.|+...++
T Consensus        99 C~gGsL~~~L~~PEN~~GLpE~e~l~lL~d~~~al~~LrEn-~IvHRDlKP~NIvl~~Gedgq~IyKLtDfG~Arel~d~  177 (732)
T KOG4250|consen   99 CSGGSLRKVLNSPENAYGLPESEFLDLLSDLVSALRHLREN-GIVHRDLKPGNIVLQIGEDGQSIYKLTDFGAARELDDN  177 (732)
T ss_pred             cCCCcHHHHhcCcccccCCCHHHHHHHHHHHHHHHHHHHHc-CceeccCCCCcEEEeecCCCceEEeeecccccccCCCC
Confidence            99999999997653 35799999999999999999999998 999999999999994  334  4799999999988877


Q ss_pred             C---CccCcccccCcccccC-CCCCCcccchhhhHHHHHHHhCCCCCCchhhHH-----Hh---hhchhhhc---ccc--
Q 020221          210 R---SYSTNLAFTPPEYLRT-GRVTPESVMYSFGTLLLDLLSGKHIPPSHALDL-----IR---DRNIQTLT---DSC--  272 (329)
Q Consensus       210 ~---~~~~~~~y~aPE~~~~-~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~-----~~---~~~~~~~~---~~~--  272 (329)
                      .   +..||..|.+||+... +.|+..+|.|||||++|+++||..||-....+.     +.   .+....+.   ...  
T Consensus       178 s~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p~~~pk~~~~~~~~~~tkkp~~v~i~~~~~eN  257 (732)
T KOG4250|consen  178 SLFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIPFGGPKNNKEIMWHIITKKPSGVAIGAQEEEN  257 (732)
T ss_pred             CeeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCcCCCccccchhhhhhhccCCCceeEeeecccC
Confidence            5   4579999999999985 779999999999999999999999884332111     00   00000000   000  


Q ss_pred             ----ccC--CCC----hHHHHHHHHHHHHhcccCCCCCC--CHHHHHHHHHhhh
Q 020221          273 ----LEG--QFS----SDEGTELVRLASRCLQYEPRERP--NPRSLVTALVTLQ  314 (329)
Q Consensus       273 ----~~~--~~~----~~~~~~~~~li~~cl~~dp~~Rp--s~~~~l~~L~~~~  314 (329)
                          +..  +++    ......+...+..+|.-+|.+|.  ...+.-..+..+.
T Consensus       258 gpv~~s~~lP~p~~Ls~~l~~~~~kwLa~~L~~~~~~~~~~~~~~~Fa~~~dIL  311 (732)
T KOG4250|consen  258 GPVEWSSTLPQPNHLSRGLATRLTKWLASMLEWNPRKRGHEGFDRFFAEVDDIL  311 (732)
T ss_pred             CceeeeccCCCcccccHHHHhhhhHHHHHHHhhhHHHhCCCCcchHHHHHHHHH
Confidence                001  112    22334566778888888999998  5555555554443

>KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=4.8e-37  Score=286.25  Aligned_cols=247  Identities=15%  Similarity=0.216  Sum_probs=202.8

Q ss_pred             CcccccccCCCCCCcEEEEEE-eCCCCEEEEEEeCCCCChhHHHHHHHHHHHhcC-CCccccccceeeee-----CCeeE
Q 020221           57 AMENIVSEHGEKAPNVVYKGK-LENQFRIAVKRFNRSAWPDARQFLEEARAVGQL-RNRRLANLLGCCCE-----GDERL  129 (329)
Q Consensus        57 ~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~-----~~~~~  129 (329)
                      +..+++..+|.|.+|.||+++ .++++.+|+|++...... .+++..|..+++.. .|||++.++|++.-     ++.+|
T Consensus        19 d~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~~d~-deEiE~eynil~~~~~hpnv~~fyg~~~k~~~~~~DqLW   97 (953)
T KOG0587|consen   19 DIFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPTEDE-EEEIELEYNMLKKYSHHPNVATFYGAFIKKDPGNGDQLW   97 (953)
T ss_pred             CccEEEEEEeeccceeEEEEeeeecCceeeeEeecCCccc-cHHHHHHHHHHHhccCCCCcceEEEEEEEecCCCCCeEE
Confidence            334556666999999999999 778889999998876533 45677889999998 59999999999853     57899


Q ss_pred             EEEecCCCCCHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCCCCCeeeecccCcccCCCC
Q 020221          130 LVAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDG  209 (329)
Q Consensus       130 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~  209 (329)
                      ||||||.+||..+++.+..+..+.|..+..|+++++.|+.+||.. .++|||||-.|||++.++.+||+|||.+......
T Consensus        98 LVMEfC~gGSVTDLVKn~~g~rl~E~~IaYI~re~lrgl~HLH~n-kviHRDikG~NiLLT~e~~VKLvDFGvSaQldsT  176 (953)
T KOG0587|consen   98 LVMEFCGGGSVTDLVKNTKGNRLKEEWIAYILREILRGLAHLHNN-KVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDST  176 (953)
T ss_pred             EEeeccCCccHHHHHhhhcccchhhHHHHHHHHHHHHHHHHHhhc-ceeeecccCceEEEeccCcEEEeeeeeeeeeecc
Confidence            999999999999999887788899999999999999999999999 9999999999999999999999999998765433


Q ss_pred             ----CCccCcccccCcccccC-----CCCCCcccchhhhHHHHHHHhCCCCCCchhhHHHhhhchhhhccccccCCCChH
Q 020221          210 ----RSYSTNLAFTPPEYLRT-----GRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSD  280 (329)
Q Consensus       210 ----~~~~~~~~y~aPE~~~~-----~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  280 (329)
                          .+..||+.|||||++.-     ..|+.++|+||||++..||.-|.+|+-+.. . ++ ........+.....-+..
T Consensus       177 ~grRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmH-P-mr-aLF~IpRNPPPkLkrp~k  253 (953)
T KOG0587|consen  177 VGRRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMH-P-MR-ALFLIPRNPPPKLKRPKK  253 (953)
T ss_pred             cccccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCcc-h-hh-hhccCCCCCCccccchhh
Confidence                45678999999999863     348889999999999999999996653221 1 11 011111122222234677


Q ss_pred             HHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 020221          281 EGTELVRLASRCLQYEPRERPNPRSLVT  308 (329)
Q Consensus       281 ~~~~~~~li~~cl~~dp~~Rps~~~~l~  308 (329)
                      .++++.++|..||..|-++||+..++++
T Consensus       254 Ws~~FndFIs~cL~Kd~e~RP~~~~ll~  281 (953)
T KOG0587|consen  254 WSKKFNDFISTCLVKDYEQRPSTEELLK  281 (953)
T ss_pred             HHHHHHHHHHHHHhhccccCcchhhhcc
Confidence            8999999999999999999999999986

>KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms]

Probab=100.00  E-value=1e-37  Score=266.92  Aligned_cols=249  Identities=16%  Similarity=0.164  Sum_probs=195.0

Q ss_pred             CcccccccCCCCCCcEEEEEE-eCCCCEEEEEEeCCCCChhHHHHHHHHHHHhcCC--Cc----cccccceeeeeCCeeE
Q 020221           57 AMENIVSEHGEKAPNVVYKGK-LENQFRIAVKRFNRSAWPDARQFLEEARAVGQLR--NR----RLANLLGCCCEGDERL  129 (329)
Q Consensus        57 ~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~--h~----niv~~~~~~~~~~~~~  129 (329)
                      ..|.+++.+|+|.||.|-.+. ...+..||+|+++.-.. -.+..+-|+++|+++.  .|    -+|++.+++.-.++.+
T Consensus        89 ~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V~k-YreAa~iEi~vLqki~~~DP~g~~rcv~m~~wFdyrghiC  167 (415)
T KOG0671|consen   89 NRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKNVDK-YREAALIEIEVLQKINESDPNGKFRCVQMRDWFDYRGHIC  167 (415)
T ss_pred             cceehhhhhcCCcccceEEEeecCCCceehHHHHHHHHH-HhhHHHHHHHHHHHHHhcCCCCceEEEeeehhhhccCceE
Confidence            346788888999999999998 44578899999976431 1334567999999993  23    3788888898889999


Q ss_pred             EEEecCCCCCHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeC-------------------
Q 020221          130 LVAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFD-------------------  190 (329)
Q Consensus       130 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~-------------------  190 (329)
                      ||+|.+ |-|+.+++.+.+-.+++..++..+++|++.+++|||+. +++|-||||+|||+.                   
T Consensus       168 ivfell-G~S~~dFlk~N~y~~fpi~~ir~m~~QL~~sv~fLh~~-kl~HTDLKPENILfvss~~~~~~~~k~~~~~~r~  245 (415)
T KOG0671|consen  168 IVFELL-GLSTFDFLKENNYIPFPIDHIRHMGYQLLESVAFLHDL-KLTHTDLKPENILFVSSEYFKTYNPKKKVCFIRP  245 (415)
T ss_pred             EEEecc-ChhHHHHhccCCccccchHHHHHHHHHHHHHHHHHHhc-ceeecCCChheEEEeccceEEEeccCCccceecc
Confidence            999998 55999999876677899999999999999999999999 999999999999992                   


Q ss_pred             -CCCCeeeecccCcccCCCCC-CccCcccccCcccccCCCCCCcccchhhhHHHHHHHhCCCCCCchhhHH-------Hh
Q 020221          191 -DDVNPRLSCFGLMKNSRDGR-SYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDL-------IR  261 (329)
Q Consensus       191 -~~~~~kl~Dfg~a~~~~~~~-~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~-------~~  261 (329)
                       .+..++++|||.|+...... ..+.|..|.|||++.+..++...||||+||||+||.||...|+......       +.
T Consensus       246 ~ks~~I~vIDFGsAtf~~e~hs~iVsTRHYRAPEViLgLGwS~pCDvWSiGCIL~ElytG~~LFqtHen~EHLaMMerIl  325 (415)
T KOG0671|consen  246 LKSTAIKVIDFGSATFDHEHHSTIVSTRHYRAPEVILGLGWSQPCDVWSIGCILVELYTGETLFQTHENLEHLAMMERIL  325 (415)
T ss_pred             CCCcceEEEecCCcceeccCcceeeeccccCCchheeccCcCCccCceeeeeEEEEeeccceecccCCcHHHHHHHHHhh
Confidence             12358999999998766554 4567999999999999999999999999999999999998776542111       00


Q ss_pred             hhchhh-----------------------------hcccccc----CCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 020221          262 DRNIQT-----------------------------LTDSCLE----GQFSSDEGTELVRLASRCLQYEPRERPNPRSLVT  308 (329)
Q Consensus       262 ~~~~~~-----------------------------~~~~~~~----~~~~~~~~~~~~~li~~cl~~dp~~Rps~~~~l~  308 (329)
                      +.....                             +.+.+..    ....+....++.+|+..||..||.+|+|+.|+++
T Consensus       326 Gp~P~~mi~r~~~~Kyf~~~rldw~e~~~~~~~k~v~~~ckpl~~~~~~~d~e~~~LfDLl~~mL~fDP~~RiTl~EAL~  405 (415)
T KOG0671|consen  326 GPIPSRMIKKTRKEKYFRRGRLDWPEVSSKGKSKYVFEPCKPLKKYMLQDDLEHVQLFDLLRRMLEFDPARRITLREALS  405 (415)
T ss_pred             CCCcHHHhhhhhhHhhhhcccccCccccccccchhhhcCCccHHHHhccCcHHHhHHHHHHHHHHccCccccccHHHHhc
Confidence            000000                             0000000    0011334568999999999999999999999998

>KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=2e-37  Score=279.58  Aligned_cols=247  Identities=17%  Similarity=0.175  Sum_probs=195.4

Q ss_pred             HHHHhcCCCcccccccCCCCCCcEEEEEE-eCCCCEEEEEEeCCCCChhHH---HHHHHHHHHhcCCCccccccceeeee
Q 020221           49 LRTATSGFAMENIVSEHGEKAPNVVYKGK-LENQFRIAVKRFNRSAWPDAR---QFLEEARAVGQLRNRRLANLLGCCCE  124 (329)
Q Consensus        49 ~~~~~~~~~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~---~~~~e~~~l~~l~h~niv~~~~~~~~  124 (329)
                      |+++-=+-+.+..|+.||-|+||.|.++. .++...+|+|.+++.+.-...   -+..|..||..-+.+-||+|+..|++
T Consensus       621 LkRaKMdKSmFvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyySFQD  700 (1034)
T KOG0608|consen  621 LKRAKMDKSMFVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYSFQD  700 (1034)
T ss_pred             HHHhhccccceEEEeeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEEecc
Confidence            33333344556678899999999999998 667788999999875433222   35779999999999999999999999


Q ss_pred             CCeeEEEEecCCCCCHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCCCCCeeeecccCcc
Q 020221          125 GDERLLVAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMK  204 (329)
Q Consensus       125 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~  204 (329)
                      .+++|+||||++||++-.+|.  ...-|.+..++.++.++.+|+++.|.. |+|||||||+|||||.+|++||.|||++.
T Consensus       701 kdnLYFVMdYIPGGDmMSLLI--rmgIFeE~LARFYIAEltcAiesVHkm-GFIHRDiKPDNILIDrdGHIKLTDFGLCT  777 (1034)
T KOG0608|consen  701 KDNLYFVMDYIPGGDMMSLLI--RMGIFEEDLARFYIAELTCAIESVHKM-GFIHRDIKPDNILIDRDGHIKLTDFGLCT  777 (1034)
T ss_pred             CCceEEEEeccCCccHHHHHH--HhccCHHHHHHHHHHHHHHHHHHHHhc-cceecccCccceEEccCCceeeeeccccc
Confidence            999999999999999999887  456789999999999999999999999 99999999999999999999999999975


Q ss_pred             cCC---------CC-------------------------------------CCccCcccccCcccccCCCCCCcccchhh
Q 020221          205 NSR---------DG-------------------------------------RSYSTNLAFTPPEYLRTGRVTPESVMYSF  238 (329)
Q Consensus       205 ~~~---------~~-------------------------------------~~~~~~~~y~aPE~~~~~~~~~~~Dvwsl  238 (329)
                      -+.         .+                                     ...+||+.|+|||++....++...|+||.
T Consensus       778 GfRWTHdskYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g~~q~cdwws~  857 (1034)
T KOG0608|consen  778 GFRWTHDSKYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTGYTQLCDWWSV  857 (1034)
T ss_pred             cceeccccccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccCccccchhhHh
Confidence            211         00                                     02357899999999999999999999999


Q ss_pred             hHHHHHHHhCCCCCCchhhHHHhhhchhhhccccccCCCChHHHHHHHHHHHHhcccCCCCCC
Q 020221          239 GTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLASRCLQYEPRERP  301 (329)
Q Consensus       239 G~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rp  301 (329)
                      |||||||+.|+.||....-.....  ...-+...+.-.+...++++..++|.++. -+++.|.
T Consensus       858 gvil~em~~g~~pf~~~tp~~tq~--kv~nw~~~l~~~~~~~ls~e~~~li~kLc-~sad~RL  917 (1034)
T KOG0608|consen  858 GVILYEMLVGQPPFLADTPGETQY--KVINWRNFLHIPYQGNLSKEALDLIQKLC-CSADSRL  917 (1034)
T ss_pred             hHHHHHHhhCCCCccCCCCCccee--eeeehhhccccccccccCHHHHHHHHHHh-cChhhhh
Confidence            999999999999886543211111  11112233333445567788888887655 3677775

>KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.9e-37  Score=267.64  Aligned_cols=236  Identities=19%  Similarity=0.243  Sum_probs=197.3

Q ss_pred             cccccccCCCCCCcEEEEEE-eCCCCEEEEEEeCCCCCh---hHHHHHHHHHHHhcC-CCccccccceeeeeCCeeEEEE
Q 020221           58 MENIVSEHGEKAPNVVYKGK-LENQFRIAVKRFNRSAWP---DARQFLEEARAVGQL-RNRRLANLLGCCCEGDERLLVA  132 (329)
Q Consensus        58 ~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~---~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~lv~  132 (329)
                      +.+++..||.|+||.|.++. ..+.+.+|||+++++..-   +.+--+.|-++|..- +-|.++++..++++-+.+|+||
T Consensus       350 DFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQTmDRLyFVM  429 (683)
T KOG0696|consen  350 DFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQTMDRLYFVM  429 (683)
T ss_pred             ccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhhhhhheeeEE
Confidence            45667777999999999998 556788999999876422   122234566777766 6789999999999999999999


Q ss_pred             ecCCCCCHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCCCCCeeeecccCcccCC----C
Q 020221          133 EYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSR----D  208 (329)
Q Consensus       133 e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~----~  208 (329)
                      ||+.||+|--.++  .-..+.+..+..++.+|+-||-|||++ ||++||||.+||++|.+|++||+|||+++..-    .
T Consensus       430 EyvnGGDLMyhiQ--Q~GkFKEp~AvFYAaEiaigLFFLh~k-gIiYRDLKLDNvmLd~eGHiKi~DFGmcKEni~~~~T  506 (683)
T KOG0696|consen  430 EYVNGGDLMYHIQ--QVGKFKEPVAVFYAAEIAIGLFFLHSK-GIIYRDLKLDNVMLDSEGHIKIADFGMCKENIFDGVT  506 (683)
T ss_pred             EEecCchhhhHHH--HhcccCCchhhhhhHHHHHHhhhhhcC-CeeeeeccccceEeccCCceEeeecccccccccCCcc
Confidence            9999999998886  345688889999999999999999999 99999999999999999999999999987532    2


Q ss_pred             CCCccCcccccCcccccCCCCCCcccchhhhHHHHHHHhCCCCCCchhhHHHhhhchhhhccccccCCCChHHHHHHHHH
Q 020221          209 GRSYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRL  288 (329)
Q Consensus       209 ~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  288 (329)
                      ..+.+||+.|+|||.+...+|..++|+|||||+||||+.|++||..+.-+.+-...    .+..  -.+|...|.+...+
T Consensus       507 TkTFCGTPdYiAPEIi~YqPYgksvDWWa~GVLLyEmlaGQpPFdGeDE~elF~aI----~ehn--vsyPKslSkEAv~i  580 (683)
T KOG0696|consen  507 TKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQAI----MEHN--VSYPKSLSKEAVAI  580 (683)
T ss_pred             eeeecCCCcccccceEEecccccchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHH----HHcc--CcCcccccHHHHHH
Confidence            24678999999999999999999999999999999999999988876554443332    2222  24678889999999


Q ss_pred             HHHhcccCCCCCCC
Q 020221          289 ASRCLQYEPRERPN  302 (329)
Q Consensus       289 i~~cl~~dp~~Rps  302 (329)
                      .+..|..+|.+|..
T Consensus       581 ckg~ltK~P~kRLG  594 (683)
T KOG0696|consen  581 CKGLLTKHPGKRLG  594 (683)
T ss_pred             HHHHhhcCCccccC
Confidence            99999999999964

>smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain

Probab=100.00  E-value=7.3e-36  Score=255.15  Aligned_cols=234  Identities=21%  Similarity=0.250  Sum_probs=192.5

Q ss_pred             CCcEEEEEEeC-CCCEEEEEEeCCCCChh-HHHHHHHHHHHhcCCCccccccceeeeeCCeeEEEEecCCCCCHHhhhcc
Q 020221           69 APNVVYKGKLE-NQFRIAVKRFNRSAWPD-ARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAEYMPNDTLAKHLFH  146 (329)
Q Consensus        69 ~~g~V~~~~~~-~~~~vavK~~~~~~~~~-~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~  146 (329)
                      +||.||++... +++.+++|++....... .+.+.+|++.++.++|+|++++++.+......++++||+.+++|.+++..
T Consensus         1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~~~   80 (244)
T smart00220        1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKKRERILREISILKKLKHPNIVRLYDVFEDEDKLYLVMEYCDGGDLFDLLKK   80 (244)
T ss_pred             CceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHhCCCCcHHHHHhheeeCCEEEEEEeCCCCCCHHHHHHh
Confidence            47899999954 58899999998765444 67899999999999999999999999988999999999999999999863


Q ss_pred             CCCCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCCCCCeeeecccCcccCCCC---CCccCcccccCccc
Q 020221          147 WETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDG---RSYSTNLAFTPPEY  223 (329)
Q Consensus       147 ~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~---~~~~~~~~y~aPE~  223 (329)
                        ...+++..+..++.+++.++.+||.. +++|+||+|+||++++++.++++|||.+......   ....++..|++||.
T Consensus        81 --~~~~~~~~~~~~~~~l~~~l~~lh~~-~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~pE~  157 (244)
T smart00220       81 --RGRLSEDEARFYARQILSALEYLHSN-GIIHRDLKPENILLDEDGHVKLADFGLARQLDPGGLLTTFVGTPEYMAPEV  157 (244)
T ss_pred             --ccCCCHHHHHHHHHHHHHHHHHHHHc-CeecCCcCHHHeEECCCCcEEEccccceeeeccccccccccCCcCCCCHHH
Confidence              22389999999999999999999999 9999999999999999999999999998876553   34557789999999


Q ss_pred             ccCCCCCCcccchhhhHHHHHHHhCCCCCCc-hhhHHHhhhchhhhccccccCCCChHHHHHHHHHHHHhcccCCCCCCC
Q 020221          224 LRTGRVTPESVMYSFGTLLLDLLSGKHIPPS-HALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLASRCLQYEPRERPN  302 (329)
Q Consensus       224 ~~~~~~~~~~DvwslG~il~el~tg~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps  302 (329)
                      +.+..++.++||||||++++++++|..|+.. .................   .......+.++.+++.+||..+|++||+
T Consensus       158 ~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~i~~~l~~~p~~Rp~  234 (244)
T smart00220      158 LLGKGYGKAVDVWSLGVILYELLTGKPPFPGDDQLLELFKKIGKPKPPF---PPPEWKISPEAKDLIRKLLVKDPEKRLT  234 (244)
T ss_pred             HccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhccCCCC---ccccccCCHHHHHHHHHHccCCchhccC
Confidence            9888889999999999999999999987755 22222211111111100   0001115678999999999999999999


Q ss_pred             HHHHHH
Q 020221          303 PRSLVT  308 (329)
Q Consensus       303 ~~~~l~  308 (329)
                      +.++++
T Consensus       235 ~~~~~~  240 (244)
T smart00220      235 AEEALQ  240 (244)
T ss_pred             HHHHhh
Confidence            999998

Phosphotransferases. Serine or threonine-specific kinase subfamily.

>PLN03225 Serine/threonine-protein kinase SNT7; Provisional

Probab=100.00  E-value=1.7e-36  Score=287.63  Aligned_cols=249  Identities=18%  Similarity=0.197  Sum_probs=165.0

Q ss_pred             CCCcccccccCCCCCCcEEEEEEe-CC----CCEEEEEEeCCCCChhHHHHHHHHHHHhcCCCcccccccee------ee
Q 020221           55 GFAMENIVSEHGEKAPNVVYKGKL-EN----QFRIAVKRFNRSAWPDARQFLEEARAVGQLRNRRLANLLGC------CC  123 (329)
Q Consensus        55 ~~~~~~~~~~lg~G~~g~V~~~~~-~~----~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~------~~  123 (329)
                      ....|.+.+.||+|+||.||+|.. .+    +..||+|++......  +....+  .+....+.++..+...      ..
T Consensus       130 ~~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~~--e~~~~e--~l~~~~~~~~~~~~~~~~~~~~~~  205 (566)
T PLN03225        130 KKDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGAV--EIWMNE--RVRRACPNSCADFVYGFLEPVSSK  205 (566)
T ss_pred             ccCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccchh--HHHHHH--HHHhhchhhHHHHHHhhhcccccc
Confidence            345677788889999999999994 45    689999998654321  111111  1122222233322221      23


Q ss_pred             eCCeeEEEEecCCCCCHHhhhccCCCC------------------CCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCC
Q 020221          124 EGDERLLVAEYMPNDTLAKHLFHWETQ------------------PMKWAMRLRVALHIAEALEYCTSKERALYHDLNAY  185 (329)
Q Consensus       124 ~~~~~~lv~e~~~~gsL~~~l~~~~~~------------------~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~  185 (329)
                      .....++|+||+.+++|.+++......                  ......+..++.|++.||.|||++ +|+||||||+
T Consensus       206 ~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~-gIiHRDLKP~  284 (566)
T PLN03225        206 KEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHST-GIVHRDVKPQ  284 (566)
T ss_pred             cCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHC-CEEeCcCCHH
Confidence            456899999999999999988642110                  012334668999999999999999 9999999999


Q ss_pred             ceeeCC-CCCeeeecccCcccCCCC-----CCccCcccccCcccccCC----------------------CCCCcccchh
Q 020221          186 RIVFDD-DVNPRLSCFGLMKNSRDG-----RSYSTNLAFTPPEYLRTG----------------------RVTPESVMYS  237 (329)
Q Consensus       186 Nil~~~-~~~~kl~Dfg~a~~~~~~-----~~~~~~~~y~aPE~~~~~----------------------~~~~~~Dvws  237 (329)
                      |||++. ++.+||+|||+++.....     ....+++.|+|||.+...                      .++.++||||
T Consensus       285 NILl~~~~~~~KL~DFGlA~~l~~~~~~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k~DVwS  364 (566)
T PLN03225        285 NIIFSEGSGSFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIYS  364 (566)
T ss_pred             HEEEeCCCCcEEEEeCCCccccccccccCCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCCcccHH
Confidence            999985 689999999999765432     344678999999965322                      2345679999


Q ss_pred             hhHHHHHHHhCCCCCCchhhHHHhhh---c--h---hhhccccccCC------CChHHHHHHHHHHHHhcccCCCCCCCH
Q 020221          238 FGTLLLDLLSGKHIPPSHALDLIRDR---N--I---QTLTDSCLEGQ------FSSDEGTELVRLASRCLQYEPRERPNP  303 (329)
Q Consensus       238 lG~il~el~tg~~~~~~~~~~~~~~~---~--~---~~~~~~~~~~~------~~~~~~~~~~~li~~cl~~dp~~Rps~  303 (329)
                      |||++|||+++..++...........   .  .   ...........      ..........+|+.+||+.||++|||+
T Consensus       365 lGviL~el~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~dLi~~mL~~dP~kR~ta  444 (566)
T PLN03225        365 AGLIFLQMAFPNLRSDSNLIQFNRQLKRNDYDLVAWRKLVEPRASPDLRRGFEVLDLDGGAGWELLKSMMRFKGRQRISA  444 (566)
T ss_pred             HHHHHHHHHhCcCCCchHHHHHHHHHHhcCCcHHHHHHhhccccchhhhhhhhhccccchHHHHHHHHHccCCcccCCCH
Confidence            99999999997754433211111000   0  0   00000000000      001112345689999999999999999


Q ss_pred             HHHHH
Q 020221          304 RSLVT  308 (329)
Q Consensus       304 ~~~l~  308 (329)
                      .++++
T Consensus       445 ~e~L~  449 (566)
T PLN03225        445 KAALA  449 (566)
T ss_pred             HHHhC
Confidence            99998

>KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.3e-37  Score=274.54  Aligned_cols=241  Identities=17%  Similarity=0.176  Sum_probs=203.9

Q ss_pred             CCCcccccccCCCCCCcEEEEEEeCCCC-EEEEEEeCCCCChh---HHHHHHHHHHHhcCCCccccccceeeeeCCeeEE
Q 020221           55 GFAMENIVSEHGEKAPNVVYKGKLENQF-RIAVKRFNRSAWPD---ARQFLEEARAVGQLRNRRLANLLGCCCEGDERLL  130 (329)
Q Consensus        55 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~-~vavK~~~~~~~~~---~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l  130 (329)
                      .+++.+++..||-|+||.|-++..++.. .+|+|++++...-+   .+-+..|-.+|...+.|.||+++..|.+...+|+
T Consensus       418 ~l~dl~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd~kyvYm  497 (732)
T KOG0614|consen  418 KLSDLKRIATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTFRDSKYVYM  497 (732)
T ss_pred             chhhhhhhhhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHhccchhhhh
Confidence            4455677889999999999999865543 38999988764333   3347789999999999999999999999999999


Q ss_pred             EEecCCCCCHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCCCCCeeeecccCcccCCCCC
Q 020221          131 VAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDGR  210 (329)
Q Consensus       131 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~  210 (329)
                      +||-|-||.|+..++  ..+.++..++..++.-++.|++|||++ |||+|||||+|.++|.+|-+||.|||+|+....+.
T Consensus       498 LmEaClGGElWTiLr--dRg~Fdd~tarF~~acv~EAfeYLH~k-~iIYRDLKPENllLd~~Gy~KLVDFGFAKki~~g~  574 (732)
T KOG0614|consen  498 LMEACLGGELWTILR--DRGSFDDYTARFYVACVLEAFEYLHRK-GIIYRDLKPENLLLDNRGYLKLVDFGFAKKIGSGR  574 (732)
T ss_pred             hHHhhcCchhhhhhh--hcCCcccchhhhhHHHHHHHHHHHHhc-CceeccCChhheeeccCCceEEeehhhHHHhccCC
Confidence            999999999999997  567899999999999999999999999 99999999999999999999999999999877664


Q ss_pred             ---CccCcccccCcccccCCCCCCcccchhhhHHHHHHHhCCCCCCchhhHHHhhhchhhhccccccCCCChHHHHHHHH
Q 020221          211 ---SYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVR  287 (329)
Q Consensus       211 ---~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  287 (329)
                         +++||+.|.|||.+.+...+.++|.||||+++|||++|.+||..-..-...+..+.    ..-.-.+|...+....+
T Consensus       575 KTwTFcGTpEYVAPEIILnKGHD~avDyWaLGIli~ELL~G~pPFs~~dpmktYn~ILk----Gid~i~~Pr~I~k~a~~  650 (732)
T KOG0614|consen  575 KTWTFCGTPEYVAPEIILNKGHDRAVDYWALGILIYELLTGSPPFSGVDPMKTYNLILK----GIDKIEFPRRITKTATD  650 (732)
T ss_pred             ceeeecCCcccccchhhhccCcchhhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHh----hhhhhhcccccchhHHH
Confidence               57899999999999999999999999999999999999988865433222222222    22222456677888999


Q ss_pred             HHHHhcccCCCCCCC
Q 020221          288 LASRCLQYEPRERPN  302 (329)
Q Consensus       288 li~~cl~~dp~~Rps  302 (329)
                      +++.+-..+|.+|..
T Consensus       651 Lik~LCr~~P~ERLG  665 (732)
T KOG0614|consen  651 LIKKLCRDNPTERLG  665 (732)
T ss_pred             HHHHHHhcCcHhhhc
Confidence            999999999999975

>PLN03224 probable serine/threonine protein kinase; Provisional

Probab=100.00  E-value=6.9e-35  Score=270.56  Aligned_cols=251  Identities=15%  Similarity=0.180  Sum_probs=175.3

Q ss_pred             CcccccccCCCCCCcEEEEEEe-----------------CCCCEEEEEEeCCCCChhHHHH--------------HHHHH
Q 020221           57 AMENIVSEHGEKAPNVVYKGKL-----------------ENQFRIAVKRFNRSAWPDARQF--------------LEEAR  105 (329)
Q Consensus        57 ~~~~~~~~lg~G~~g~V~~~~~-----------------~~~~~vavK~~~~~~~~~~~~~--------------~~e~~  105 (329)
                      +.+.+.++||+|+||+||+|..                 .+++.||||++........++|              ..|+.
T Consensus       145 d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~vE~~  224 (507)
T PLN03224        145 DDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMVEAY  224 (507)
T ss_pred             cCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHHHHH
Confidence            3455667779999999999963                 2356799999876543322233              34666


Q ss_pred             HHhcCCCccc-----cccceeeee--------CCeeEEEEecCCCCCHHhhhccCC----------------------CC
Q 020221          106 AVGQLRNRRL-----ANLLGCCCE--------GDERLLVAEYMPNDTLAKHLFHWE----------------------TQ  150 (329)
Q Consensus       106 ~l~~l~h~ni-----v~~~~~~~~--------~~~~~lv~e~~~~gsL~~~l~~~~----------------------~~  150 (329)
                      ++..++|.++     ++++++|..        .+..++||||+++++|.+++....                      ..
T Consensus       225 ~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~~~~  304 (507)
T PLN03224        225 MCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNMPQD  304 (507)
T ss_pred             HHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhcccc
Confidence            7777766543     667777643        356899999999999999885311                      11


Q ss_pred             CCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCCCCCeeeecccCcccCCCCCC-----ccCcccccCccccc
Q 020221          151 PMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDGRS-----YSTNLAFTPPEYLR  225 (329)
Q Consensus       151 ~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~~-----~~~~~~y~aPE~~~  225 (329)
                      .+++..+..++.|++.+|.|||+. +++||||||+||+++.++.+||+|||++........     ..+++.|+|||.+.
T Consensus       305 ~~~~~~~~~i~~ql~~aL~~lH~~-~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~g~~tp~Y~aPE~l~  383 (507)
T PLN03224        305 KRDINVIKGVMRQVLTGLRKLHRI-GIVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGINFNPLYGMLDPRYSPPEELV  383 (507)
T ss_pred             cCCHHHHHHHHHHHHHHHHHHHHC-CeecCCCchHhEEECCCCcEEEEeCcCccccccCCccCccccCCCcceeChhhhc
Confidence            346778899999999999999999 999999999999999999999999999875433221     12368999999875


Q ss_pred             CCC--------------------C--CCcccchhhhHHHHHHHhCCCCCCchh--hHH-Hhh--hch---hhhccccccC
Q 020221          226 TGR--------------------V--TPESVMYSFGTLLLDLLSGKHIPPSHA--LDL-IRD--RNI---QTLTDSCLEG  275 (329)
Q Consensus       226 ~~~--------------------~--~~~~DvwslG~il~el~tg~~~~~~~~--~~~-~~~--~~~---~~~~~~~~~~  275 (329)
                      ...                    +  ..+.||||+||++++|+++...+....  ... ...  ...   .........-
T Consensus       384 ~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~~~~~~~~~~~~~~r~~~~~~~~~  463 (507)
T PLN03224        384 MPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFNTELRQYDNDLNRWRMYKGQKYDF  463 (507)
T ss_pred             CCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhhhHHhhccchHHHHHhhcccCCCc
Confidence            322                    1  124799999999999999885332211  000 000  000   0000011111


Q ss_pred             CCChHHHHHHHHHHHHhcccCC---CCCCCHHHHHH
Q 020221          276 QFSSDEGTELVRLASRCLQYEP---RERPNPRSLVT  308 (329)
Q Consensus       276 ~~~~~~~~~~~~li~~cl~~dp---~~Rps~~~~l~  308 (329)
                      ...+..++...+|+.++|..+|   .+|+|+.++++
T Consensus       464 ~~~d~~s~~~~dLi~~LL~~~~~~~~~RlSa~eaL~  499 (507)
T PLN03224        464 SLLDRNKEAGWDLACKLITKRDQANRGRLSVGQALS  499 (507)
T ss_pred             ccccccChHHHHHHHHHhccCCCCcccCCCHHHHhC
Confidence            1223457889999999999866   68999999998

>KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.4e-35  Score=258.19  Aligned_cols=246  Identities=21%  Similarity=0.267  Sum_probs=191.8

Q ss_pred             ccccccCCCCCCcEEEEEE-eCCCCEEEEEEeCCCC-Chh------HHHHHHHHHHHhcCCCccccccceeeeeC-CeeE
Q 020221           59 ENIVSEHGEKAPNVVYKGK-LENQFRIAVKRFNRSA-WPD------ARQFLEEARAVGQLRNRRLANLLGCCCEG-DERL  129 (329)
Q Consensus        59 ~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~-~~~------~~~~~~e~~~l~~l~h~niv~~~~~~~~~-~~~~  129 (329)
                      |-++..||+|+|+.||++. +.....||||+-.... +.+      .+-..+|.++-+.|+||.||++++++.-+ +.++
T Consensus       465 YLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfslDtdsFC  544 (775)
T KOG1151|consen  465 YLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFSLDTDSFC  544 (775)
T ss_pred             HHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeeeeccccce
Confidence            4456778999999999998 6667789999865542 221      12356899999999999999999998654 6788


Q ss_pred             EEEecCCCCCHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcC-CCccccccCCCceeeC---CCCCeeeecccCccc
Q 020221          130 LVAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSK-ERALYHDLNAYRIVFD---DDVNPRLSCFGLMKN  205 (329)
Q Consensus       130 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~-~~ivH~dlkp~Nil~~---~~~~~kl~Dfg~a~~  205 (329)
                      -|+|||+|.+|+-||.  ..+.+++..++.|+.||+.||.||... ..|||-||||.|||+-   ..|.+||.|||+++.
T Consensus       545 TVLEYceGNDLDFYLK--QhklmSEKEARSIiMQiVnAL~YLNEikpPIIHYDLKPgNILLv~GtacGeIKITDFGLSKI  622 (775)
T KOG1151|consen  545 TVLEYCEGNDLDFYLK--QHKLMSEKEARSIIMQIVNALKYLNEIKPPIIHYDLKPGNILLVNGTACGEIKITDFGLSKI  622 (775)
T ss_pred             eeeeecCCCchhHHHH--hhhhhhHHHHHHHHHHHHHHHHHHhccCCCeeeeccCCccEEEecCcccceeEeeecchhhh
Confidence            9999999999999997  556789999999999999999999863 5799999999999994   567899999999986


Q ss_pred             CCCCC-----------CccCcccccCcccccCC----CCCCcccchhhhHHHHHHHhCCCCCCchhhH--HHhhhchhhh
Q 020221          206 SRDGR-----------SYSTNLAFTPPEYLRTG----RVTPESVMYSFGTLLLDLLSGKHIPPSHALD--LIRDRNIQTL  268 (329)
Q Consensus       206 ~~~~~-----------~~~~~~~y~aPE~~~~~----~~~~~~DvwslG~il~el~tg~~~~~~~~~~--~~~~~~~~~~  268 (329)
                      ..+..           ...||.+|.+||.+.-+    .++.++||||+|||+|.++.|+.||......  .+....+...
T Consensus       623 MdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhnqsQQdILqeNTIlkA  702 (775)
T KOG1151|consen  623 MDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQSQQDILQENTILKA  702 (775)
T ss_pred             ccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCchhHHHHHhhhchhcc
Confidence            55432           23679999999987633    3888999999999999999999998644221  1111111111


Q ss_pred             ccccccCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 020221          269 TDSCLEGQFSSDEGTELVRLASRCLQYEPRERPNPRSLVT  308 (329)
Q Consensus       269 ~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~~~l~  308 (329)
                        .-+.-+..+.++.+...||..||++.-++|.+..++..
T Consensus       703 --tEVqFP~KPvVsseAkaFIRRCLaYRKeDR~DV~qLA~  740 (775)
T KOG1151|consen  703 --TEVQFPPKPVVSSEAKAFIRRCLAYRKEDRIDVQQLAC  740 (775)
T ss_pred             --eeccCCCCCccCHHHHHHHHHHHHhhhhhhhhHHHHcc
Confidence              11111223456789999999999999999998888764

>KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms]

Probab=100.00  E-value=1.5e-35  Score=234.16  Aligned_cols=197  Identities=17%  Similarity=0.206  Sum_probs=165.7

Q ss_pred             ccccCCCCCCcEEEEEE-eCCCCEEEEEEeCCCCC-hhHHHHHHHHHHHhcC-CCccccccceeeeeCCeeEEEEecCCC
Q 020221           61 IVSEHGEKAPNVVYKGK-LENQFRIAVKRFNRSAW-PDARQFLEEARAVGQL-RNRRLANLLGCCCEGDERLLVAEYMPN  137 (329)
Q Consensus        61 ~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~~~  137 (329)
                      -+..||+|++|.|-+.+ ..+|+..|+|.++..-. +...+.++|+.+.... .+|.+|.++|...+....|+.||.|+.
T Consensus        50 ~i~elGrGayG~vekmrh~~sg~imAvKri~~tvn~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~regdvwIcME~M~t  129 (282)
T KOG0984|consen   50 GIEELGRGAYGVVEKMRHIQSGTIMAVKRIRATVNSQEQKRLLMDLDIIMRTVDCPFTVHFYGALFREGDVWICMELMDT  129 (282)
T ss_pred             hhhhhcCCccchhhheeeccCCeEEEEeeehhhcChHHHHHHHHhhhhhccCCCCCeEEEeehhhhccccEEEeHHHhhh
Confidence            34567999999999988 67899999999987643 3344578888876554 799999999999999999999999976


Q ss_pred             CCHHhhhccC--CCCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCCCCCeeeecccCcccCCCCC---Cc
Q 020221          138 DTLAKHLFHW--ETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDGR---SY  212 (329)
Q Consensus       138 gsL~~~l~~~--~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~---~~  212 (329)
                       ||..+.++.  .+..+++..+-+|+..+..||.|||++..++|||+||+|||++.+|++|++|||.+....+.-   ..
T Consensus       130 -Sldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~kL~vIHRDvKPsNiLIn~~GqVKiCDFGIsG~L~dSiAkt~d  208 (282)
T KOG0984|consen  130 -SLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHSKLSVIHRDVKPSNILINYDGQVKICDFGISGYLVDSIAKTMD  208 (282)
T ss_pred             -hHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHHHhhhhhccCCcceEEEccCCcEEEcccccceeehhhhHHHHh
Confidence             887766431  567889999999999999999999998899999999999999999999999999987655442   24


Q ss_pred             cCcccccCcccccCC----CCCCcccchhhhHHHHHHHhCCCCCCchhhH
Q 020221          213 STNLAFTPPEYLRTG----RVTPESVMYSFGTLLLDLLSGKHIPPSHALD  258 (329)
Q Consensus       213 ~~~~~y~aPE~~~~~----~~~~~~DvwslG~il~el~tg~~~~~~~~~~  258 (329)
                      .|...|||||.+..+    .|+-++||||||+++.||.+++.|+.....+
T Consensus       209 aGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~w~tp  258 (282)
T KOG0984|consen  209 AGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYESWGTP  258 (282)
T ss_pred             cCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhccccccccCCH
Confidence            677899999987633    5888999999999999999999887655443

>KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=5.5e-35  Score=246.57  Aligned_cols=241  Identities=17%  Similarity=0.242  Sum_probs=193.8

Q ss_pred             CcccccccCCCCCCcEEEEEE-eCCCCEEEEEEeCCCC---ChhHHHHHHHHHHHhcC-CCccccccceeeeeCCeeEEE
Q 020221           57 AMENIVSEHGEKAPNVVYKGK-LENQFRIAVKRFNRSA---WPDARQFLEEARAVGQL-RNRRLANLLGCCCEGDERLLV  131 (329)
Q Consensus        57 ~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~lv  131 (329)
                      .++.+++.||+|+|+.|..++ .++.+.+|+|++++.-   .++++....|-.+...- +||.+|.+..+|++...+++|
T Consensus       250 ~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfqtesrlffv  329 (593)
T KOG0695|consen  250 QDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQTESRLFFV  329 (593)
T ss_pred             ccceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhcccceEEEE
Confidence            445677888999999999999 6678899999987643   23345556666665555 699999999999999999999


Q ss_pred             EecCCCCCHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCCCCCeeeecccCcccC-CC--
Q 020221          132 AEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNS-RD--  208 (329)
Q Consensus       132 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~-~~--  208 (329)
                      .||++||+|--.+.  ..+.++++.++.+..+|+-||.|||++ ||++||||.+|+|+|..|++||.|+|+++.. .+  
T Consensus       330 ieyv~ggdlmfhmq--rqrklpeeharfys~ei~lal~flh~r-giiyrdlkldnvlldaeghikltdygmcke~l~~gd  406 (593)
T KOG0695|consen  330 IEYVNGGDLMFHMQ--RQRKLPEEHARFYSAEICLALNFLHER-GIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGLGPGD  406 (593)
T ss_pred             EEEecCcceeeehh--hhhcCcHHHhhhhhHHHHHHHHHHhhc-CeeeeeccccceEEccCCceeecccchhhcCCCCCc
Confidence            99999999977665  567899999999999999999999999 9999999999999999999999999998752 22  


Q ss_pred             -CCCccCcccccCcccccCCCCCCcccchhhhHHHHHHHhCCCCCCchhh---HH-HhhhchhhhccccccCCCChHHHH
Q 020221          209 -GRSYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHAL---DL-IRDRNIQTLTDSCLEGQFSSDEGT  283 (329)
Q Consensus       209 -~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~---~~-~~~~~~~~~~~~~~~~~~~~~~~~  283 (329)
                       ..+++||+.|+|||.+.+..|..++|+|+||++++||+.|+.||..-..   +. ......+.+++...  .+|...+-
T Consensus       407 ~tstfcgtpnyiapeilrgeeygfsvdwwalgvlmfemmagrspfdivgm~n~d~ntedylfqvilekqi--riprslsv  484 (593)
T KOG0695|consen  407 TTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIVGMDNPDMNTEDYLFQVILEKQI--RIPRSLSV  484 (593)
T ss_pred             ccccccCCCcccchhhhcccccCceehHHHHHHHHHHHHcCCCCcceecCCCcccchhHHHHHHHhhhcc--cccceeeh
Confidence             3467899999999999999999999999999999999999998843111   00 11111222222222  24555566


Q ss_pred             HHHHHHHHhcccCCCCCCC
Q 020221          284 ELVRLASRCLQYEPRERPN  302 (329)
Q Consensus       284 ~~~~li~~cl~~dp~~Rps  302 (329)
                      ....+++..|++||.+|..
T Consensus       485 kas~vlkgflnkdp~erlg  503 (593)
T KOG0695|consen  485 KASHVLKGFLNKDPKERLG  503 (593)
T ss_pred             hhHHHHHHhhcCCcHHhcC
Confidence            7788999999999999963

>KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=8.4e-36  Score=245.07  Aligned_cols=244  Identities=18%  Similarity=0.269  Sum_probs=189.2

Q ss_pred             ccCCCCCCcEEEEEE-eCCCCEEEEEEeCCCCC--hhHHHHHHHHHHHhcCCCccccccceeeeeC-----CeeEEEEec
Q 020221           63 SEHGEKAPNVVYKGK-LENQFRIAVKRFNRSAW--PDARQFLEEARAVGQLRNRRLANLLGCCCEG-----DERLLVAEY  134 (329)
Q Consensus        63 ~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~-----~~~~lv~e~  134 (329)
                      +-||.|+||.||..+ -.+|+.||+|++..-..  ...+.+.+|+++|..++|.|++..++..+-.     .++|+++|.
T Consensus        59 RPIGYGAFGVVWsVTDPRdgrrvalkK~pnvfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEiYV~TEL  138 (449)
T KOG0664|consen   59 RPIGYGAFGVVWSVTDPRSGKRVALKKMPNVFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQELYVLTEL  138 (449)
T ss_pred             CcccccceeEEEeccCCCCccchhHhhcchHHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHHHHHHHH
Confidence            456999999999998 56789999999876432  2345688999999999999999999887544     246788999


Q ss_pred             CCCCCHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCCCCCeeeecccCcccCCCCCCc--
Q 020221          135 MPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDGRSY--  212 (329)
Q Consensus       135 ~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~--  212 (329)
                      +.. +|...+.  ..+.++...+..+.+||++||+|||+. +|+||||||.|.|++.|-.+||+|||+++........  
T Consensus       139 mQS-DLHKIIV--SPQ~Ls~DHvKVFlYQILRGLKYLHsA-~ILHRDIKPGNLLVNSNCvLKICDFGLARvee~d~~~hM  214 (449)
T KOG0664|consen  139 MQS-DLHKIIV--SPQALTPDHVKVFVYQILRGLKYLHTA-NILHRDIKPGNLLVNSNCILKICDFGLARTWDQRDRLNM  214 (449)
T ss_pred             HHh-hhhheec--cCCCCCcchhhhhHHHHHhhhHHHhhc-chhhccCCCccEEeccCceEEecccccccccchhhhhhh
Confidence            865 7888876  567899999999999999999999999 9999999999999999999999999999876655432  


Q ss_pred             ---cCcccccCcccccCCC-CCCcccchhhhHHHHHHHhCCCCCCchh----hH------------HHh---hhchhhhc
Q 020221          213 ---STNLAFTPPEYLRTGR-VTPESVMYSFGTLLLDLLSGKHIPPSHA----LD------------LIR---DRNIQTLT  269 (329)
Q Consensus       213 ---~~~~~y~aPE~~~~~~-~~~~~DvwslG~il~el~tg~~~~~~~~----~~------------~~~---~~~~~~~~  269 (329)
                         ..|..|.|||.++|.. |+...||||+|||..||+.++..|....    .+            .++   ++....++
T Consensus       215 TqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq~PiqQL~lItdLLGTPs~EaMr~ACEGAk~H~L  294 (449)
T KOG0664|consen  215 THEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAAGPIEQLQMIIDLLGTPSQEAMKYACEGAKNHVL  294 (449)
T ss_pred             HHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhccChHHHHHHHHHHhCCCcHHHHHHHhhhhHHHhh
Confidence               3578999999999876 9999999999999999999887664320    00            010   00000111


Q ss_pred             cccccC---------CCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 020221          270 DSCLEG---------QFSSDEGTELVRLASRCLQYEPRERPNPRSLVTAL  310 (329)
Q Consensus       270 ~~~~~~---------~~~~~~~~~~~~li~~cl~~dp~~Rps~~~~l~~L  310 (329)
                      ....+.         ..+.....+...++.+++..||+.|.+..+++..+
T Consensus       295 R~~~k~Ps~~vLYtlsS~~~~~heav~~~~~~l~~d~dkris~~~A~~~~  344 (449)
T KOG0664|consen  295 RAGLRAPDTQRLYKIASPDDKNHEAVDLLQKLLHFDPDKRISVEEALQHR  344 (449)
T ss_pred             ccCCCCCCccceeeecCCcccchHHHHHHHHHhCCCCcccccHhhhcccc
Confidence            100000         01123345778889999999999999999888754

>KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms]

Probab=100.00  E-value=3.2e-34  Score=246.09  Aligned_cols=250  Identities=19%  Similarity=0.215  Sum_probs=202.2

Q ss_pred             cccCCCCCCcEEEEEEe------CCCCEEEEEEeCCCCCh-hHHHHHHHHHHHhcCCCccccccceeeee-CCeeEEEEe
Q 020221           62 VSEHGEKAPNVVYKGKL------ENQFRIAVKRFNRSAWP-DARQFLEEARAVGQLRNRRLANLLGCCCE-GDERLLVAE  133 (329)
Q Consensus        62 ~~~lg~G~~g~V~~~~~------~~~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~~~~~~~~-~~~~~lv~e  133 (329)
                      ...+-+|.||.||.|.|      ++.+.|-+|.++....+ ....+.+|.-.+..+.|||+.++.+++.+ ....+.++.
T Consensus       289 ~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~AS~iQv~~~L~es~lly~~sH~nll~V~~V~ie~~~~P~V~y~  368 (563)
T KOG1024|consen  289 SCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQHASQIQVNLLLQESMLLYGASHPNLLSVLGVSIEDYATPFVLYP  368 (563)
T ss_pred             hhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhcccHHHHHHHHHHHHHHhcCcCCCccceeEEEeeccCcceEEEe
Confidence            34458999999999954      34566888888776543 24458889999999999999999999855 467889999


Q ss_pred             cCCCCCHHhhhccC------CCCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCCCCCeeeecccCcccCC
Q 020221          134 YMPNDTLAKHLFHW------ETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSR  207 (329)
Q Consensus       134 ~~~~gsL~~~l~~~------~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~  207 (329)
                      ++.-|+|..++...      ..+.++-.+...++.|++.|++|||+. ++||.||..+|.++|+...+||+|-.+++...
T Consensus       369 ~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~-~ViHkDiAaRNCvIdd~LqVkltDsaLSRDLF  447 (563)
T KOG1024|consen  369 ATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNH-GVIHKDIAARNCVIDDQLQVKLTDSALSRDLF  447 (563)
T ss_pred             ccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhc-CcccchhhhhcceehhheeEEeccchhccccC
Confidence            99999999999721      234567788999999999999999999 99999999999999999999999999998766


Q ss_pred             CCC------CccCcccccCcccccCCCCCCcccchhhhHHHHHHHhCCCCCCchhhHHHhhhchhhhccccccCCCChHH
Q 020221          208 DGR------SYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDE  281 (329)
Q Consensus       208 ~~~------~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  281 (329)
                      +.+      .......||+||.+....|+..+|+||||++||||+|-+..|..+..+    ..+...+....+-..|.++
T Consensus       448 P~DYhcLGDnEnRPvkWMslEal~n~~yssasDvWsfGVllWELmtlg~~PyaeIDP----fEm~~ylkdGyRlaQP~NC  523 (563)
T KOG1024|consen  448 PGDYHCLGDNENRPVKWMSLEALQNSHYSSASDVWSFGVLLWELMTLGKLPYAEIDP----FEMEHYLKDGYRLAQPFNC  523 (563)
T ss_pred             cccccccCCCCCCcccccCHHHHhhhhhcchhhhHHHHHHHHHHHhcCCCCccccCH----HHHHHHHhccceecCCCCC
Confidence            543      334568899999999999999999999999999999865544333221    1122233333444567788


Q ss_pred             HHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhhc
Q 020221          282 GTELVRLASRCLQYEPRERPNPRSLVTALVTLQKD  316 (329)
Q Consensus       282 ~~~~~~li~~cl~~dp~~Rps~~~~l~~L~~~~~~  316 (329)
                      |.++..++.-||+.+|++||+++|+..-|.++.-.
T Consensus       524 PDeLf~vMacCWallpeeRPsf~Qlv~cLseF~~q  558 (563)
T KOG1024|consen  524 PDELFTVMACCWALLPEERPSFSQLVICLSEFHTQ  558 (563)
T ss_pred             cHHHHHHHHHHHhcCcccCCCHHHHHHHHHHHHHH
Confidence            99999999999999999999999999999887643

>KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms]

Probab=100.00  E-value=8.2e-35  Score=270.18  Aligned_cols=238  Identities=21%  Similarity=0.227  Sum_probs=178.8

Q ss_pred             CcccccccCCCCCCcE-EEEEEeCCCCEEEEEEeCCCCChhHHHHHHHHHHHhcC-CCccccccceeeeeCCeeEEEEec
Q 020221           57 AMENIVSEHGEKAPNV-VYKGKLENQFRIAVKRFNRSAWPDARQFLEEARAVGQL-RNRRLANLLGCCCEGDERLLVAEY  134 (329)
Q Consensus        57 ~~~~~~~~lg~G~~g~-V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~  134 (329)
                      ...+++   |.|+.|+ ||+|... ++.||||.+-...   ..-..+|++.|+.- .|||||++++.-.+....||..|.
T Consensus       512 ~~~eil---G~Gs~Gt~Vf~G~ye-~R~VAVKrll~e~---~~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~YIalEL  584 (903)
T KOG1027|consen  512 SPKEIL---GYGSNGTVVFRGVYE-GREVAVKRLLEEF---FDFAQREIQLLQESDEHPNVIRYYCSEQDRQFLYIALEL  584 (903)
T ss_pred             ccHHHc---ccCCCCcEEEEEeeC-CceehHHHHhhHh---HHHHHHHHHHHHhccCCCceEEEEeeccCCceEEEEehH
Confidence            344444   7777754 6999984 5599999986533   33457899999988 699999999998889999999999


Q ss_pred             CCCCCHHhhhccC--CCCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCC---C--CCeeeecccCcccCC
Q 020221          135 MPNDTLAKHLFHW--ETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDD---D--VNPRLSCFGLMKNSR  207 (329)
Q Consensus       135 ~~~gsL~~~l~~~--~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~---~--~~~kl~Dfg~a~~~~  207 (329)
                      |.. +|.+++...  +.....-...+....|+++||++||+. +||||||||.||||+-   +  ..++|+|||+++...
T Consensus       585 C~~-sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHsl-~iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKkl~  662 (903)
T KOG1027|consen  585 CAC-SLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLHSL-KIVHRDLKPQNILISVPSADGTLRAKISDFGLSKKLA  662 (903)
T ss_pred             hhh-hHHHHHhccccchhhcccccHHHHHHHHHHHHHHHHhc-ccccccCCCceEEEEccCCCcceeEEecccccccccC
Confidence            966 999999642  111111134578899999999999998 9999999999999975   3  468999999998765


Q ss_pred             CCC-------CccCcccccCcccccCCCCCCcccchhhhHHHHHHHhCC-CCCCchhhHHHhhhchhhhccccccCCCCh
Q 020221          208 DGR-------SYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGK-HIPPSHALDLIRDRNIQTLTDSCLEGQFSS  279 (329)
Q Consensus       208 ~~~-------~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  279 (329)
                      .+.       ...||-+|+|||++....-+..+||||+||++|+.++|+ +||.+. .+... ........-..-.. ..
T Consensus       663 ~~~sS~~r~s~~sGt~GW~APE~L~~~~~~~avDiFslGCvfyYvltgG~HpFGd~-~~R~~-NIl~~~~~L~~L~~-~~  739 (903)
T KOG1027|consen  663 GGKSSFSRLSGGSGTSGWQAPEQLREDRKTQAVDIFSLGCVFYYVLTGGSHPFGDS-LERQA-NILTGNYTLVHLEP-LP  739 (903)
T ss_pred             CCcchhhcccCCCCcccccCHHHHhccccCcccchhhcCceEEEEecCCccCCCch-HHhhh-hhhcCccceeeecc-Cc
Confidence            543       346899999999999988888999999999999999985 455332 22111 11111111000001 11


Q ss_pred             HHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 020221          280 DEGTELVRLASRCLQYEPRERPNPRSLVT  308 (329)
Q Consensus       280 ~~~~~~~~li~~cl~~dp~~Rps~~~~l~  308 (329)
                      ++  ++.+||.+|++.||..||+|.+|+.
T Consensus       740 d~--eA~dLI~~ml~~dP~~RPsa~~VL~  766 (903)
T KOG1027|consen  740 DC--EAKDLISRMLNPDPQLRPSATDVLN  766 (903)
T ss_pred             hH--HHHHHHHHhcCCCcccCCCHHHHhC
Confidence            22  8999999999999999999999986

>KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.1e-33  Score=248.80  Aligned_cols=131  Identities=16%  Similarity=0.195  Sum_probs=113.6

Q ss_pred             CcccccccCCCCCCcEEEEEE-eCCCCEEEEEEeCCCCChhHHHHHHHHHHHhcCC-----C---ccccccceeeee---
Q 020221           57 AMENIVSEHGEKAPNVVYKGK-LENQFRIAVKRFNRSAWPDARQFLEEARAVGQLR-----N---RRLANLLGCCCE---  124 (329)
Q Consensus        57 ~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-----h---~niv~~~~~~~~---  124 (329)
                      ..|.++++||=|.|++||++. ..+.+.||+|+++... .-.+..+.||++|+.++     |   .+||++++.|..   
T Consensus        78 gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKSAq-hYtEaAlDEIklL~~v~~~Dp~~~~~~~VV~LlD~FkhsGp  156 (590)
T KOG1290|consen   78 GRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKSAQ-HYTEAALDEIKLLQQVREGDPNDPGKKCVVQLLDHFKHSGP  156 (590)
T ss_pred             ceEEEEEeccccccceeEEEeeccCCeEEEEEEEehhh-HHHHHHHHHHHHHHHHHhcCCCCCCCceeeeeeccceecCC
Confidence            368899999999999999999 5667789999987643 23456788999999983     3   369999999854   


Q ss_pred             -CCeeEEEEecCCCCCHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceee
Q 020221          125 -GDERLLVAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVF  189 (329)
Q Consensus       125 -~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~  189 (329)
                       +.++++|+|++ |.+|..+|.....+.++...+..|++||+.||.|||.+.||||-||||+|||+
T Consensus       157 NG~HVCMVfEvL-GdnLLklI~~s~YrGlpl~~VK~I~~qvL~GLdYLH~ecgIIHTDlKPENvLl  221 (590)
T KOG1290|consen  157 NGQHVCMVFEVL-GDNLLKLIKYSNYRGLPLSCVKEICRQVLTGLDYLHRECGIIHTDLKPENVLL  221 (590)
T ss_pred             CCcEEEEEehhh-hhHHHHHHHHhCCCCCcHHHHHHHHHHHHHHHHHHHHhcCccccCCCcceeee
Confidence             56899999999 56899999877788999999999999999999999998899999999999999

>KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms]

Probab=100.00  E-value=7e-35  Score=264.55  Aligned_cols=250  Identities=16%  Similarity=0.175  Sum_probs=207.2

Q ss_pred             cCCCcccccccCCCCCCcEEEEEE-eCCCCEEEEEEeCCCCChhHHHHHHHHHHHhcCCCccccccceeeeeCCeeEEEE
Q 020221           54 SGFAMENIVSEHGEKAPNVVYKGK-LENQFRIAVKRFNRSAWPDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVA  132 (329)
Q Consensus        54 ~~~~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~  132 (329)
                      +.-++|+++..+|.|.||.|||++ ..+++..|+|+++.....+..-+.+|+-+++..+||||+-++|.+...+..|+.|
T Consensus        12 nP~ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkLep~dd~~~iqqei~~~~dc~h~nivay~gsylr~dklwicM   91 (829)
T KOG0576|consen   12 NPQDDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEPGDDFSGIQQEIGMLRDCRHPNIVAYFGSYLRRDKLWICM   91 (829)
T ss_pred             CCccchhheeeecCCcccchhhhcccccCchhhheeeeccCCccccccccceeeeecCCCcChHHHHhhhhhhcCcEEEE
Confidence            556778899999999999999999 6788999999999888777778889999999999999999999999999999999


Q ss_pred             ecCCCCCHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCCCCCeeeecccCcccCC----C
Q 020221          133 EYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSR----D  208 (329)
Q Consensus       133 e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~----~  208 (329)
                      |||.+|+|.+...  -..++++.++....++.++||+|||++ |-+|||||-.||++++.|.+|++|||.+-.+.    .
T Consensus        92 EycgggslQdiy~--~TgplselqiayvcRetl~gl~ylhs~-gk~hRdiKGanilltd~gDvklaDfgvsaqitati~K  168 (829)
T KOG0576|consen   92 EYCGGGSLQDIYH--VTGPLSELQIAYVCRETLQGLKYLHSQ-GKIHRDIKGANILLTDEGDVKLADFGVSAQITATIAK  168 (829)
T ss_pred             EecCCCcccceee--ecccchhHHHHHHHhhhhccchhhhcC-CcccccccccceeecccCceeecccCchhhhhhhhhh
Confidence            9999999999775  567899999999999999999999999 99999999999999999999999999876544    3


Q ss_pred             CCCccCcccccCccccc---CCCCCCcccchhhhHHHHHHHhCCCCCCchhh-HHHhhhchhhhccccccCCCChHHHHH
Q 020221          209 GRSYSTNLAFTPPEYLR---TGRVTPESVMYSFGTLLLDLLSGKHIPPSHAL-DLIRDRNIQTLTDSCLEGQFSSDEGTE  284 (329)
Q Consensus       209 ~~~~~~~~~y~aPE~~~---~~~~~~~~DvwslG~il~el~tg~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~  284 (329)
                      ...+.||+.|||||+..   .+.|+...|||++|++..|+---++|-+.... ....-......-.+.+  .-+...++.
T Consensus       169 rksfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfdlhpmr~l~LmTkS~~qpp~l--kDk~kws~~  246 (829)
T KOG0576|consen  169 RKSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFDLHPMRALFLMTKSGFQPPTL--KDKTKWSEF  246 (829)
T ss_pred             hhcccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCcccccchHHHHHHhhccCCCCCcc--cCCccchHH
Confidence            35778999999999764   45699999999999999999877754332110 0000000111111111  123456889


Q ss_pred             HHHHHHHhcccCCCCCCCHHHHHH
Q 020221          285 LVRLASRCLQYEPRERPNPRSLVT  308 (329)
Q Consensus       285 ~~~li~~cl~~dp~~Rps~~~~l~  308 (329)
                      |.+|++.++..+|++||+++.+++
T Consensus       247 fh~fvK~altknpKkRptaeklL~  270 (829)
T KOG0576|consen  247 FHNFVKGALTKNPKKRPTAEKLLQ  270 (829)
T ss_pred             HHHHHHHHhcCCCccCCChhhhee
Confidence            999999999999999999998875

>KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification]

Probab=100.00  E-value=2.3e-34  Score=254.69  Aligned_cols=248  Identities=16%  Similarity=0.168  Sum_probs=195.9

Q ss_pred             cccccccCCCCCCcEEEEEE-eCCCCEEEEEEeCCCCChhHHHHHHHHHHHhcCCC------ccccccceeeeeCCeeEE
Q 020221           58 MENIVSEHGEKAPNVVYKGK-LENQFRIAVKRFNRSAWPDARQFLEEARAVGQLRN------RRLANLLGCCCEGDERLL  130 (329)
Q Consensus        58 ~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h------~niv~~~~~~~~~~~~~l  130 (329)
                      .|++....|+|-|++|-.|. ...|+.||||++..... -.+.=+.|+++|+.|..      -|+++++..|...++++|
T Consensus       433 RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnNE~-M~KtGl~EleiLkKL~~AD~Edk~Hclrl~r~F~hknHLCl  511 (752)
T KOG0670|consen  433 RYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNNEV-MHKTGLKELEILKKLNDADPEDKFHCLRLFRHFKHKNHLCL  511 (752)
T ss_pred             eeEEEeccccceeeeeeeccccCCCCeeEEEEeecchH-HhhhhhHHHHHHHHhhccCchhhhHHHHHHHHhhhcceeEE
Confidence            46778888999999999998 44577999999987652 24455789999999952      389999999999999999


Q ss_pred             EEecCCCCCHHhhhccC-CCCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCCC-CCeeeecccCcccCCC
Q 020221          131 VAEYMPNDTLAKHLFHW-ETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDD-VNPRLSCFGLMKNSRD  208 (329)
Q Consensus       131 v~e~~~~gsL~~~l~~~-~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~-~~~kl~Dfg~a~~~~~  208 (329)
                      |+|-+. .+|.++|... ..-.+....+..+++|+.-||..|... |++|.||||+|||+++. ..+||||||.|.....
T Consensus       512 VFE~Ls-lNLRevLKKyG~nvGL~ikaVRsYaqQLflALklLK~c-~vlHaDIKPDNiLVNE~k~iLKLCDfGSA~~~~e  589 (752)
T KOG0670|consen  512 VFEPLS-LNLREVLKKYGRNVGLHIKAVRSYAQQLFLALKLLKKC-GVLHADIKPDNILVNESKNILKLCDFGSASFASE  589 (752)
T ss_pred             Eehhhh-chHHHHHHHhCcccceeehHHHHHHHHHHHHHHHHHhc-CeeecccCccceEeccCcceeeeccCcccccccc
Confidence            999884 4899999753 345678889999999999999999998 99999999999999865 5689999999987665


Q ss_pred             C--CCccCcccccCcccccCCCCCCcccchhhhHHHHHHHhCCCCCCchhhHHHh-------------------------
Q 020221          209 G--RSYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIR-------------------------  261 (329)
Q Consensus       209 ~--~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~~-------------------------  261 (329)
                      .  .++..+..|.|||.+.|.+|+...|+||+||+||||.||+..||+.....+.                         
T Consensus       590 neitPYLVSRFYRaPEIiLG~~yd~~iD~WSvgctLYElYtGkIlFpG~TNN~MLrl~me~KGk~p~KmlRKgqF~dqHF  669 (752)
T KOG0670|consen  590 NEITPYLVSRFYRAPEIILGLPYDYPIDTWSVGCTLYELYTGKILFPGRTNNQMLRLFMELKGKFPNKMLRKGQFKDQHF  669 (752)
T ss_pred             ccccHHHHHHhccCcceeecCcccCCccceeeceeeEEeeccceecCCCCcHHHHHHHHHhcCCCcHHHhhhcchhhhhc
Confidence            4  3455667899999999999999999999999999999999988865221111                         


Q ss_pred             ---------------hhchhhhc---cc------cc--cCCCCh---HHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 020221          262 ---------------DRNIQTLT---DS------CL--EGQFSS---DEGTELVRLASRCLQYEPRERPNPRSLVT  308 (329)
Q Consensus       262 ---------------~~~~~~~~---~~------~~--~~~~~~---~~~~~~~~li~~cl~~dp~~Rps~~~~l~  308 (329)
                                     ......++   .+      .+  ...++.   ....+|.+|+..||.+||++|.|..++|.
T Consensus       670 D~d~nf~~~e~D~vT~r~~~~vm~~vkPtkdl~s~l~~~q~~~deq~~~~~~~rdLLdkml~LdP~KRit~nqAL~  745 (752)
T KOG0670|consen  670 DQDLNFLYIEVDKVTEREKRTVMVNVKPTKDLGSELIAVQRLPDEQPKIVQQLRDLLDKMLILDPEKRITVNQALK  745 (752)
T ss_pred             ccccceEEEeccccccceeEEEecccCcchhHHHHHhccCCCCchhHHHHHHHHHHHHHHhccChhhcCCHHHHhc
Confidence                           00000000   00      00  001222   24578999999999999999999999998

>cd00180 PKc Catalytic domain of Protein Kinases

Probab=100.00  E-value=7e-32  Score=225.16  Aligned_cols=206  Identities=25%  Similarity=0.372  Sum_probs=182.4

Q ss_pred             CCCCCCcEEEEEEeC-CCCEEEEEEeCCCCCh-hHHHHHHHHHHHhcCCCccccccceeeeeCCeeEEEEecCCCCCHHh
Q 020221           65 HGEKAPNVVYKGKLE-NQFRIAVKRFNRSAWP-DARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAEYMPNDTLAK  142 (329)
Q Consensus        65 lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~  142 (329)
                      ||.|.+|.||++... +++.+++|++...... ..+.+.+|++.++.++|++++++++++......++++|++.+++|.+
T Consensus         1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~~~e~~~~~~l~~   80 (215)
T cd00180           1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYCEGGSLKD   80 (215)
T ss_pred             CCcCCceEEEEEEecCCCcEEEEEEeccccchhHHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeEEEEEecCCCCcHHH
Confidence            589999999999964 4889999999876543 34678999999999999999999999998899999999999899999


Q ss_pred             hhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCC-CCCeeeecccCcccCCCC----CCccCccc
Q 020221          143 HLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDD-DVNPRLSCFGLMKNSRDG----RSYSTNLA  217 (329)
Q Consensus       143 ~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~-~~~~kl~Dfg~a~~~~~~----~~~~~~~~  217 (329)
                      ++... ...+++..+..++.+++.++.+||+. +++|+||+|.||+++. ++.++|+|||.+......    ....+...
T Consensus        81 ~~~~~-~~~~~~~~~~~~~~~l~~~l~~lh~~-~~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~  158 (215)
T cd00180          81 LLKEN-EGKLSEDEILRILLQILEGLEYLHSN-GIIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKSLLKTIVGTPA  158 (215)
T ss_pred             HHHhc-cCCCCHHHHHHHHHHHHHHHHHHHhC-CeeccCCCHhhEEEeCCCCcEEEecCCceEEccCCcchhhcccCCCC
Confidence            98642 14689999999999999999999999 9999999999999999 899999999998766543    23456788


Q ss_pred             ccCcccccCC-CCCCcccchhhhHHHHHHHhCCCCCCchhhHHHhhhchhhhccccccCCCChHHHHHHHHHHHHhcccC
Q 020221          218 FTPPEYLRTG-RVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLASRCLQYE  296 (329)
Q Consensus       218 y~aPE~~~~~-~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~d  296 (329)
                      |++||.+... ..+.++|+|++|+++++|                                     ..+.+++..|++.|
T Consensus       159 ~~~pe~~~~~~~~~~~~D~~~lg~~~~~l-------------------------------------~~~~~~l~~~l~~~  201 (215)
T cd00180         159 YMAPEVLLGKGYYSEKSDIWSLGVILYEL-------------------------------------PELKDLIRKMLQKD  201 (215)
T ss_pred             ccChhHhcccCCCCchhhhHHHHHHHHHH-------------------------------------HHHHHHHHHHhhCC
Confidence            9999998877 788899999999999999                                     57889999999999


Q ss_pred             CCCCCCHHHHHHH
Q 020221          297 PRERPNPRSLVTA  309 (329)
Q Consensus       297 p~~Rps~~~~l~~  309 (329)
                      |++||++.++++.
T Consensus       202 p~~R~~~~~l~~~  214 (215)
T cd00180         202 PEKRPSAKEILEH  214 (215)
T ss_pred             cccCcCHHHHhhC
Confidence            9999999999874

Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which

>KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms]

Probab=100.00  E-value=2.5e-33  Score=234.95  Aligned_cols=241  Identities=18%  Similarity=0.234  Sum_probs=184.8

Q ss_pred             ccccCCCCCCcEEEEEE-eCCCCEEEEEEeCCC--CChhHHHHHHHHHHHhcCCCccccccceeeeeC------CeeEEE
Q 020221           61 IVSEHGEKAPNVVYKGK-LENQFRIAVKRFNRS--AWPDARQFLEEARAVGQLRNRRLANLLGCCCEG------DERLLV  131 (329)
Q Consensus        61 ~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~------~~~~lv  131 (329)
                      -++.+|.|+- .|-.+- .-.+++||+|++...  ....++...+|...+..+.|+||++++.++.-.      ..+|+|
T Consensus        21 nL~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~~~~e~y~v   99 (369)
T KOG0665|consen   21 NLKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRPFQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLEEFQEVYLV   99 (369)
T ss_pred             eecccCCCCc-eEEecchhhccCceehhhhcCccccCccchhhhhhhhhhhhhcccceeeeeeccCccccHHHHHhHHHH
Confidence            3455677876 454444 335779999998654  234466788999999999999999999988432      357999


Q ss_pred             EecCCCCCHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCCCCCeeeecccCcccCCCC--
Q 020221          132 AEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDG--  209 (329)
Q Consensus       132 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~--  209 (329)
                      ||+|.. +|...+.    ..++=.++..+..|+++|++|||+. ||+||||||+||++..+..+||.|||+|......  
T Consensus       100 ~e~m~~-nl~~vi~----~elDH~tis~i~yq~~~~ik~lhs~-~IihRdLkPsnivv~~~~~lKi~dfg~ar~e~~~~~  173 (369)
T KOG0665|consen  100 MELMDA-NLCQVIL----MELDHETISYILYQMLCGIKHLHSA-GIIHRDLKPSNIVVNSDCTLKILDFGLARTEDTDFM  173 (369)
T ss_pred             HHhhhh-HHHHHHH----HhcchHHHHHHHHHHHHHHHHHHhc-ceeecccCcccceecchhheeeccchhhcccCcccc
Confidence            999965 8888875    3466678899999999999999999 9999999999999999999999999999865544  


Q ss_pred             -CCccCcccccCcccccCCCCCCcccchhhhHHHHHHHhCCCCCCchhh-H---HHhh----------------------
Q 020221          210 -RSYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHAL-D---LIRD----------------------  262 (329)
Q Consensus       210 -~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~-~---~~~~----------------------  262 (329)
                       ..+..+..|.|||++-+-.+.+.+||||+||++.||++|...|++... +   .+..                      
T Consensus       174 mtpyVvtRyyrapevil~~~~ke~vdiwSvGci~gEli~~~Vlf~g~d~idQ~~ki~~~lgtpd~~F~~qL~~~~r~yv~  253 (369)
T KOG0665|consen  174 MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELILGTVLFPGKDHIDQWNKIIEQLGTPDPSFMKQLQPTVRNYVE  253 (369)
T ss_pred             cCchhheeeccCchheeccCCcccchhhhhhhHHHHHhhceEEecCchHHHHHHHHHHHhcCCCHHHHHHhhHHHHHHhh
Confidence             456788999999999888899999999999999999999988875411 0   0000                      


Q ss_pred             -------hchhhhc-cccccC--CCChHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 020221          263 -------RNIQTLT-DSCLEG--QFSSDEGTELVRLASRCLQYEPRERPNPRSLVT  308 (329)
Q Consensus       263 -------~~~~~~~-~~~~~~--~~~~~~~~~~~~li~~cl~~dp~~Rps~~~~l~  308 (329)
                             ....... +..+..  ..+...+..+++++.+||..||++|.|++++|.
T Consensus       254 ~~~~y~~~~f~~~fpD~~f~~~~e~~~~~~~~ardll~~MLvi~pe~Risv~daL~  309 (369)
T KOG0665|consen  254 NRPQYQAISFSELFPDSLFPVVLEGSKLDCSLARDLLSKMLVIDPEKRISVDDALR  309 (369)
T ss_pred             cChHhhccchhhhCCcccccccccCCccchHHHHHHHHHhhccChhhcccHHHHhc
Confidence                   0000000 000000  011223567899999999999999999999998

>KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms]

Probab=100.00  E-value=2.4e-33  Score=250.93  Aligned_cols=200  Identities=14%  Similarity=0.143  Sum_probs=172.2

Q ss_pred             HHhcCCCcccccccCCCCCCcEEEEEEe-CCCCEEEEEEeCCCCChh--------HHHHHHHHHHHhcCC---Ccccccc
Q 020221           51 TATSGFAMENIVSEHGEKAPNVVYKGKL-ENQFRIAVKRFNRSAWPD--------ARQFLEEARAVGQLR---NRRLANL  118 (329)
Q Consensus        51 ~~~~~~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~--------~~~~~~e~~~l~~l~---h~niv~~  118 (329)
                      ....+|+.|..++.+|.|+||.|+.|.+ .+...|++|.+.+...-.        .-.+-.|+++|..++   |+||+++
T Consensus       555 ~~~~k~s~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKl  634 (772)
T KOG1152|consen  555 KEYKKFSDYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKL  634 (772)
T ss_pred             eeecccccceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhh
Confidence            3456788899999999999999999994 456778999887643110        112456999999996   9999999


Q ss_pred             ceeeeeCCeeEEEEecC-CCCCHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCCCCCeee
Q 020221          119 LGCCCEGDERLLVAEYM-PNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRL  197 (329)
Q Consensus       119 ~~~~~~~~~~~lv~e~~-~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl  197 (329)
                      +++|++.+++||+||-. ++-+|.+++.  ....+++..+..|++|++.|+++||+. ||||||||-+|++++.+|-+||
T Consensus       635 LdfFEddd~yyl~te~hg~gIDLFd~IE--~kp~m~E~eAk~IFkQV~agi~hlh~~-~ivhrdikdenvivd~~g~~kl  711 (772)
T KOG1152|consen  635 LDFFEDDDYYYLETEVHGEGIDLFDFIE--FKPRMDEPEAKLIFKQVVAGIKHLHDQ-GIVHRDIKDENVIVDSNGFVKL  711 (772)
T ss_pred             hheeecCCeeEEEecCCCCCcchhhhhh--ccCccchHHHHHHHHHHHhcccccccc-CceecccccccEEEecCCeEEE
Confidence            99999999999999974 6678999996  456789999999999999999999999 9999999999999999999999


Q ss_pred             ecccCcccCCC--CCCccCcccccCcccccCCCCCC-cccchhhhHHHHHHHhCCCCCC
Q 020221          198 SCFGLMKNSRD--GRSYSTNLAFTPPEYLRTGRVTP-ESVMYSFGTLLLDLLSGKHIPP  253 (329)
Q Consensus       198 ~Dfg~a~~~~~--~~~~~~~~~y~aPE~~~~~~~~~-~~DvwslG~il~el~tg~~~~~  253 (329)
                      +|||.+.....  ...+.||..|.|||++.|.+|-- .-|||++|++||.++....|++
T Consensus       712 idfgsaa~~ksgpfd~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpyy  770 (772)
T KOG1152|consen  712 IDFGSAAYTKSGPFDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPYY  770 (772)
T ss_pred             eeccchhhhcCCCcceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCCc
Confidence            99999876554  46789999999999999988655 5899999999999999887764

>KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair]

Probab=99.97  E-value=4.2e-32  Score=235.34  Aligned_cols=243  Identities=21%  Similarity=0.280  Sum_probs=189.9

Q ss_pred             cccccccCCCCCCcEEEEEE-eC---CCCEEEEEEeCCCCChhHHHHHHHHHHHhcC-CCccccccceeeeeCCeeEEEE
Q 020221           58 MENIVSEHGEKAPNVVYKGK-LE---NQFRIAVKRFNRSAWPDARQFLEEARAVGQL-RNRRLANLLGCCCEGDERLLVA  132 (329)
Q Consensus        58 ~~~~~~~lg~G~~g~V~~~~-~~---~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~lv~  132 (329)
                      .+..+.+||.|.|++||++. ..   .+..||+|.+......  ..+.+|++.|..+ -+.||+++.+++...+...+|+
T Consensus        37 ~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts~p--~ri~~El~~L~~~gG~~ni~~~~~~~rnnd~v~ivl  114 (418)
T KOG1167|consen   37 AYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTSSP--SRILNELEMLYRLGGSDNIIKLNGCFRNNDQVAIVL  114 (418)
T ss_pred             hhhhhccccccchhhhhhhhHhhhccccceEeeeecccccCc--hHHHHHHHHHHHhccchhhhcchhhhccCCeeEEEe
Confidence            35677788999999999998 33   4678999999876643  5688999999999 4899999999999999999999


Q ss_pred             ecCCCCCHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeC-CCCCeeeecccCcccCC----
Q 020221          133 EYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFD-DDVNPRLSCFGLMKNSR----  207 (329)
Q Consensus       133 e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~-~~~~~kl~Dfg~a~~~~----  207 (329)
                      ||++..+..+++.     .++...+..+++.++.||+++|.+ |||||||||+|+|.+ ..+.-.|+|||+|....    
T Consensus       115 p~~~H~~f~~l~~-----~l~~~~i~~Yl~~ll~Al~~~h~~-GIvHRDiKpsNFL~n~~t~rg~LvDFgLA~~~d~~~~  188 (418)
T KOG1167|consen  115 PYFEHDRFRDLYR-----SLSLAEIRWYLRNLLKALAHLHKN-GIVHRDIKPSNFLYNRRTQRGVLVDFGLAQRYDGYQQ  188 (418)
T ss_pred             cccCccCHHHHHh-----cCCHHHHHHHHHHHHHHhhhhhcc-CccccCCCccccccccccCCceEEechhHHHHHhhhh
Confidence            9999999999884     477889999999999999999999 999999999999998 45678999999986100    


Q ss_pred             -------------C--C-----------------------------CCccCcccccCcccccCCC-CCCcccchhhhHHH
Q 020221          208 -------------D--G-----------------------------RSYSTNLAFTPPEYLRTGR-VTPESVMYSFGTLL  242 (329)
Q Consensus       208 -------------~--~-----------------------------~~~~~~~~y~aPE~~~~~~-~~~~~DvwslG~il  242 (329)
                                   +  +                             .+..||++|.|||++...+ .+.++||||.|+|+
T Consensus       189 ~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~QttaiDiws~GVI~  268 (418)
T KOG1167|consen  189 TEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPRQTTAIDIWSAGVIL  268 (418)
T ss_pred             hhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccCcCCccceeecccee
Confidence                         0  0                             0124789999999988665 78899999999999


Q ss_pred             HHHHhCCCCCCchhhH--------------HH-hhhchhh----------------------h-cccccc--------CC
Q 020221          243 LDLLSGKHIPPSHALD--------------LI-RDRNIQT----------------------L-TDSCLE--------GQ  276 (329)
Q Consensus       243 ~el~tg~~~~~~~~~~--------------~~-~~~~~~~----------------------~-~~~~~~--------~~  276 (329)
                      +-+++++.||.....+              .+ +......                      + ...+..        ..
T Consensus       269 Lslls~~~PFf~a~dd~~al~ei~tifG~~~mrk~A~l~g~~~l~~ksn~~~~~e~~~~f~s~~~~~~~~~~q~n~~~~~  348 (418)
T KOG1167|consen  269 LSLLSRRYPFFKAKDDADALAEIATIFGSAEMRKCAALPGRILLWQKSNIPTIPELRVNFETLHIESIYKSRQPNTEREI  348 (418)
T ss_pred             ehhhccccccccCccccchHHHHHHHhChHHHHHHhhcCCceeeeccccccccHHHHhchhccChhhcccccccceeecc
Confidence            9999999988643100              00 0000000                      0 000101        11


Q ss_pred             CChHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 020221          277 FSSDEGTELVRLASRCLQYEPRERPNPRSLVT  308 (329)
Q Consensus       277 ~~~~~~~~~~~li~~cl~~dp~~Rps~~~~l~  308 (329)
                      ..+..+..+.+++.+|+..||.+|.|++++|.
T Consensus       349 ~~d~~~~~~~dlLdk~le~np~kRitAEeALk  380 (418)
T KOG1167|consen  349 GSDVFPALLLDLLDKCLELNPQKRITAEDALK  380 (418)
T ss_pred             ccccccHHHHHHHHHHccCChhhcccHHHHhc
Confidence            11224568999999999999999999999997

>KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms]

Probab=99.97  E-value=3.2e-31  Score=217.74  Aligned_cols=247  Identities=19%  Similarity=0.209  Sum_probs=185.7

Q ss_pred             cccccccCCCCCCcEEEEEE-eCCCCEEEEEEeCCCCChhHHHHHHHHHHHhcC-CCcccccccee-eeeCCeeEEEEec
Q 020221           58 MENIVSEHGEKAPNVVYKGK-LENQFRIAVKRFNRSAWPDARQFLEEARAVGQL-RNRRLANLLGC-CCEGDERLLVAEY  134 (329)
Q Consensus        58 ~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~-~~~~~~~~lv~e~  134 (329)
                      .|.+.+.+|+|.||.+-++. ..+.+.+++|-++.... ...+|.+|..---.| .|.||+.-++. |++.+..++++||
T Consensus        25 ~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p~t-t~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~d~YvF~qE~  103 (378)
T KOG1345|consen   25 VYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRPQT-TQADFVREFHYSFFLSPHQHIIDTYEVAFQTSDAYVFVQEF  103 (378)
T ss_pred             hhhHHHHhcccceeeEEeeeccCCceEEEeeccCcchh-hHHHHHHHhccceeeccchhhhHHHHHHhhcCceEEEeecc
Confidence            46777888999999999999 55677899999887663 466899988766566 58999987764 6677888999999


Q ss_pred             CCCCCHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeC--CCCCeeeecccCcccCCCCCCc
Q 020221          135 MPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFD--DDVNPRLSCFGLMKNSRDGRSY  212 (329)
Q Consensus       135 ~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~--~~~~~kl~Dfg~a~~~~~~~~~  212 (329)
                      ++.|+|.+-+   ....+-+.-..+++.|+++|+.|+|++ ++||||||.+||||-  +.-.+||+|||..+........
T Consensus       104 aP~gdL~snv---~~~GigE~~~K~v~~ql~SAi~fMHsk-nlVHRdlK~eNiLif~~df~rvKlcDFG~t~k~g~tV~~  179 (378)
T KOG1345|consen  104 APRGDLRSNV---EAAGIGEANTKKVFAQLLSAIEFMHSK-NLVHRDLKAENILIFDADFYRVKLCDFGLTRKVGTTVKY  179 (378)
T ss_pred             Cccchhhhhc---CcccccHHHHHHHHHHHHHHHHHhhcc-chhhcccccceEEEecCCccEEEeeecccccccCceehh
Confidence            9999999988   567788889999999999999999999 999999999999994  3457999999998765443322


Q ss_pred             -cCcccccCcccccCC-----CCCCcccchhhhHHHHHHHhCCCCCCchhhH---HHhhhchhhhccccccCCCChHHHH
Q 020221          213 -STNLAFTPPEYLRTG-----RVTPESVMYSFGTLLLDLLSGKHIPPSHALD---LIRDRNIQTLTDSCLEGQFSSDEGT  283 (329)
Q Consensus       213 -~~~~~y~aPE~~~~~-----~~~~~~DvwslG~il~el~tg~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~  283 (329)
                       .-+..|.+||.....     ..++.+|+|.||++++.++||..|+......   .+.-........+.++. .-..+++
T Consensus       180 ~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka~~~d~~Y~~~~~w~~rk~~~~P~-~F~~fs~  258 (378)
T KOG1345|consen  180 LEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKASIMDKPYWEWEQWLKRKNPALPK-KFNPFSE  258 (378)
T ss_pred             hhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhhhccCchHHHHHHHhcccCccCch-hhcccCH
Confidence             235679999976532     2678999999999999999999877532111   11111111111111111 1134577


Q ss_pred             HHHHHHHHhcccCCCCCCCHHHHHHHH
Q 020221          284 ELVRLASRCLQYEPRERPNPRSLVTAL  310 (329)
Q Consensus       284 ~~~~li~~cl~~dp~~Rps~~~~l~~L  310 (329)
                      .+..+.++-|..+|++|-...++.+..
T Consensus       259 ~a~r~Fkk~lt~~~~drcki~~~kk~r  285 (378)
T KOG1345|consen  259 KALRLFKKSLTPRFKDRCKIWTAKKMR  285 (378)
T ss_pred             HHHHHHHHhcCCcccccchhHHHHHHH
Confidence            889999999999999996555555443

>smart00221 STYKc Protein kinase; unclassified specificity

Probab=99.97  E-value=4.8e-30  Score=216.98  Aligned_cols=191  Identities=24%  Similarity=0.267  Sum_probs=168.1

Q ss_pred             ccccCCCCCCcEEEEEEeC-CCCEEEEEEeCCCCCh-hHHHHHHHHHHHhcCCCccccccceeeeeCCeeEEEEecCCCC
Q 020221           61 IVSEHGEKAPNVVYKGKLE-NQFRIAVKRFNRSAWP-DARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAEYMPND  138 (329)
Q Consensus        61 ~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g  138 (329)
                      +.+.+|.|++|+||++... +++.+++|.+...... ..+.+.+|++.++.++|+|++++++++......++++|+++++
T Consensus         3 ~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~~~   82 (225)
T smart00221        3 LGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTEKQREEFLREIRILKKLKHPNIVKLYGVFEDPEPLYLVMEYCEGG   82 (225)
T ss_pred             eeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccchHHHHHHHHHHHHHHhCCCCChhhheeeeecCCceEEEEeccCCC
Confidence            4456799999999999954 4889999999876654 5678899999999999999999999998889999999999999


Q ss_pred             CHHhhhccCCCCC-CCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCCCCCeeeecccCcccCCCC-----CCc
Q 020221          139 TLAKHLFHWETQP-MKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDG-----RSY  212 (329)
Q Consensus       139 sL~~~l~~~~~~~-~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~-----~~~  212 (329)
                      +|.+++..  ... +++.....++.+++.++.+||+. +++|+|++|+||+++.++.++|+|||.+......     ...
T Consensus        83 ~L~~~~~~--~~~~~~~~~~~~~~~~l~~~l~~lh~~-~i~h~di~~~ni~v~~~~~~~l~d~g~~~~~~~~~~~~~~~~  159 (225)
T smart00221       83 DLFDYLRK--KGGKLSEEEARFYLRQILEALEYLHSL-GIVHRDLKPENILLGMDGLVKLADFGLARFIHRDLAALLKTV  159 (225)
T ss_pred             CHHHHHHh--cccCCCHHHHHHHHHHHHHHHHHHHhC-CeecCCCCHHHEEEcCCCCEEEeeCceeeEecCcccccccce
Confidence            99999864  223 88999999999999999999999 9999999999999999999999999998876554     344


Q ss_pred             cCcccccCcccc-cCCCCCCcccchhhhHHHHHHHhCCCCCCc
Q 020221          213 STNLAFTPPEYL-RTGRVTPESVMYSFGTLLLDLLSGKHIPPS  254 (329)
Q Consensus       213 ~~~~~y~aPE~~-~~~~~~~~~DvwslG~il~el~tg~~~~~~  254 (329)
                      .++..|++||.+ ....++.++|+|+||+++++|++|+.||..
T Consensus       160 ~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~  202 (225)
T smart00221      160 KGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFSG  202 (225)
T ss_pred             eccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCccc
Confidence            567889999998 666688899999999999999999988865

Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase.

>PLN00181 protein SPA1-RELATED; Provisional

Probab=99.97  E-value=5.3e-31  Score=261.48  Aligned_cols=190  Identities=17%  Similarity=0.150  Sum_probs=138.6

Q ss_pred             cCCC-ccccccceee-------eeCCeeEEEEecCCCCCHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccc
Q 020221          109 QLRN-RRLANLLGCC-------CEGDERLLVAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYH  180 (329)
Q Consensus       109 ~l~h-~niv~~~~~~-------~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~  180 (329)
                      .++| +||+.+++++       .....+++++|++ +++|.+++.. ....+++.++..++.||+.||.|||++ ||+||
T Consensus        28 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~-~~~~~~~~~~~~i~~qi~~al~~lH~~-gIvHr  104 (793)
T PLN00181         28 SLSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDN-PDRSVDAFECFHVFRQIVEIVNAAHSQ-GIVVH  104 (793)
T ss_pred             hhhHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhc-ccccccHHHHHHHHHHHHHHHHHHHhC-Ceeec
Confidence            3344 5777788876       2234677888987 5599999964 345699999999999999999999999 99999


Q ss_pred             ccCCCceeeCC-------------------CCCeeeecccCcccCCCC--------------------CCccCcccccCc
Q 020221          181 DLNAYRIVFDD-------------------DVNPRLSCFGLMKNSRDG--------------------RSYSTNLAFTPP  221 (329)
Q Consensus       181 dlkp~Nil~~~-------------------~~~~kl~Dfg~a~~~~~~--------------------~~~~~~~~y~aP  221 (329)
                      ||||+|||++.                   ++.+|++|||+++.....                    ....+|+.|+||
T Consensus       105 DlKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~AP  184 (793)
T PLN00181        105 NVRPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSWYTSP  184 (793)
T ss_pred             cCCchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcceECh
Confidence            99999999954                   455677777776532110                    012467889999


Q ss_pred             ccccCCCCCCcccchhhhHHHHHHHhCCCCCCchhhHHHhhhchhhhccccccCCCChHHHHHHHHHHHHhcccCCCCCC
Q 020221          222 EYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLASRCLQYEPRERP  301 (329)
Q Consensus       222 E~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rp  301 (329)
                      |++.+..++.++|||||||+||||++|..|+.... ... ........++    . .....+...+++.+||..||.+||
T Consensus       185 E~~~~~~~~~~sDVwSlGviL~ELl~~~~~~~~~~-~~~-~~~~~~~~~~----~-~~~~~~~~~~~~~~~L~~~P~~Rp  257 (793)
T PLN00181        185 EEDNGSSSNCASDVYRLGVLLFELFCPVSSREEKS-RTM-SSLRHRVLPP----Q-ILLNWPKEASFCLWLLHPEPSCRP  257 (793)
T ss_pred             hhhccCCCCchhhhhhHHHHHHHHhhCCCchhhHH-HHH-HHHHHhhcCh----h-hhhcCHHHHHHHHHhCCCChhhCc
Confidence            99999999999999999999999999886543221 111 0111111111    1 111234567889999999999999


Q ss_pred             CHHHHHH
Q 020221          302 NPRSLVT  308 (329)
Q Consensus       302 s~~~~l~  308 (329)
                      ++.++++
T Consensus       258 s~~eil~  264 (793)
T PLN00181        258 SMSELLQ  264 (793)
T ss_pred             ChHHHhh
Confidence            9999987

>smart00750 KIND kinase non-catalytic C-lobe domain

Probab=99.96  E-value=1.9e-29  Score=205.92  Aligned_cols=168  Identities=15%  Similarity=0.123  Sum_probs=129.1

Q ss_pred             CCHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCCCCCeeeecccCcccCCCCCCccCccc
Q 020221          138 DTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDGRSYSTNLA  217 (329)
Q Consensus       138 gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~  217 (329)
                      |||.+++.. ....+++.+++.++.|++.||.|||+. +      ||+||+++.++.+++  ||++....... ..+++.
T Consensus         1 GsL~~~l~~-~~~~l~~~~~~~i~~qi~~~L~~lH~~-~------kp~Nil~~~~~~~~~--fG~~~~~~~~~-~~g~~~   69 (176)
T smart00750        1 VSLADILEV-RGRPLNEEEIWAVCLQCLRALRELHRQ-A------KSGNILLTWDGLLKL--DGSVAFKTPEQ-SRVDPY   69 (176)
T ss_pred             CcHHHHHHH-hCCCCCHHHHHHHHHHHHHHHHHHHhc-C------CcccEeEcCccceee--ccceEeecccc-CCCccc
Confidence            689999864 345799999999999999999999999 6      999999999999999  99987655433 367899


Q ss_pred             ccCcccccCCCCCCcccchhhhHHHHHHHhCCCCCCchhh-HHHhhhchhhhcccccc-CCCChHHHH--HHHHHHHHhc
Q 020221          218 FTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHAL-DLIRDRNIQTLTDSCLE-GQFSSDEGT--ELVRLASRCL  293 (329)
Q Consensus       218 y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~-~~~~~~~~~~~~~~~~~-~~~~~~~~~--~~~~li~~cl  293 (329)
                      |+|||++.+..++.++||||||+++|||++|..|+..... ................. ...+...+.  ++.+++..||
T Consensus        70 y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~cl  149 (176)
T smart00750       70 FMAPEVIQGQSYTEKADIYSLGITLYEALDYELPYNEERELSAILEILLNGMPADDPRDRSNLESVSAARSFADFMRVCA  149 (176)
T ss_pred             ccChHHhcCCCCcchhhHHHHHHHHHHHHhCCCCccccchhcHHHHHHHHHhccCCccccccHHHHHhhhhHHHHHHHHH
Confidence            9999999999999999999999999999999988754321 11111111111111000 011223344  6999999999


Q ss_pred             ccCCCCCCCHHHHHHHHHhhhhc
Q 020221          294 QYEPRERPNPRSLVTALVTLQKD  316 (329)
Q Consensus       294 ~~dp~~Rps~~~~l~~L~~~~~~  316 (329)
                      ..||++||++.++++++..+...
T Consensus       150 ~~~p~~Rp~~~~ll~~~~~~~~~  172 (176)
T smart00750      150 SRLPQRREAANHYLAHCRALFAE  172 (176)
T ss_pred             hcccccccCHHHHHHHHHHHHHH
Confidence            99999999999999998877543

It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features

>KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms]

Probab=99.96  E-value=6.7e-30  Score=210.31  Aligned_cols=254  Identities=20%  Similarity=0.303  Sum_probs=200.1

Q ss_pred             CCCcccccccCCCCCCcEEEEEEeCCCCEEEEEEeCCCCChh--HHHHHHHHHHHhcCCCccccccceeeeeCCeeEEEE
Q 020221           55 GFAMENIVSEHGEKAPNVVYKGKLENQFRIAVKRFNRSAWPD--ARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVA  132 (329)
Q Consensus        55 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~--~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~  132 (329)
                      +++..+++-+|.+...|..|+|+++++ .+++|++.......  .++|..|.-.|+.+.||||+.++|.|..+.++.+|.
T Consensus       188 d~~~lnl~tkl~e~hsgelwrgrwqgn-divakil~vr~~t~risrdfneefp~lrifshpnilpvlgacnsppnlv~is  266 (448)
T KOG0195|consen  188 DVSSLNLITKLAESHSGELWRGRWQGN-DIVAKILNVREVTARISRDFNEEFPALRIFSHPNILPVLGACNSPPNLVIIS  266 (448)
T ss_pred             chhhhhhhhhhccCCCcccccccccCc-chhhhhhhhhhcchhhcchhhhhCcceeeecCCchhhhhhhccCCCCceEee
Confidence            345556677778888999999999655 68888887654332  356888999999999999999999999999999999


Q ss_pred             ecCCCCCHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccc-ccCCCceeeCCCCCeeeecccCcccCCCCCC
Q 020221          133 EYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYH-DLNAYRIVFDDDVNPRLSCFGLMKNSRDGRS  211 (329)
Q Consensus       133 e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~-dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~~  211 (329)
                      .||+.|||...+.......++-.++.+++.+|++|++|||+...++-| -|....+++|++.+++|+- +-+++......
T Consensus       267 q~mp~gslynvlhe~t~vvvd~sqav~faldiargmaflhslep~ipr~~lns~hvmidedltarism-ad~kfsfqe~g  345 (448)
T KOG0195|consen  267 QYMPFGSLYNVLHEQTSVVVDHSQAVRFALDIARGMAFLHSLEPMIPRFYLNSKHVMIDEDLTARISM-ADTKFSFQEVG  345 (448)
T ss_pred             eeccchHHHHHHhcCccEEEecchHHHHHHHHHhhHHHHhhcchhhhhhhcccceEEecchhhhheec-ccceeeeeccc
Confidence            999999999999865555567789999999999999999997677766 7889999999999888753 22333222222


Q ss_pred             ccCcccccCcccccCCC---CCCcccchhhhHHHHHHHhCCCCCCchhhHHHhhhchhhhccccccCCCChHHHHHHHHH
Q 020221          212 YSTNLAFTPPEYLRTGR---VTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRL  288 (329)
Q Consensus       212 ~~~~~~y~aPE~~~~~~---~~~~~DvwslG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  288 (329)
                      ..-.+.|++||.+...+   --..+|+|||.+++|||.|+..||.....  +.-+  ..+--..++..+|+..++.+.+|
T Consensus       346 r~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlsp--mecg--mkialeglrv~ippgis~hm~kl  421 (448)
T KOG0195|consen  346 RAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSP--MECG--MKIALEGLRVHIPPGISRHMNKL  421 (448)
T ss_pred             cccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCc--hhhh--hhhhhccccccCCCCccHHHHHH
Confidence            23358899999998765   33579999999999999999988754321  1111  11122335566788889999999


Q ss_pred             HHHhcccCCCCCCCHHHHHHHHHhhh
Q 020221          289 ASRCLQYEPRERPNPRSLVTALVTLQ  314 (329)
Q Consensus       289 i~~cl~~dp~~Rps~~~~l~~L~~~~  314 (329)
                      +.-|+..||.+||.+..++-.|+++.
T Consensus       422 m~icmnedpgkrpkfdmivpilekm~  447 (448)
T KOG0195|consen  422 MNICMNEDPGKRPKFDMIVPILEKMI  447 (448)
T ss_pred             HHHHhcCCCCcCCCcceehhhHHHhc
Confidence            99999999999999999999998864

>KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.95  E-value=4.1e-27  Score=210.10  Aligned_cols=257  Identities=16%  Similarity=0.141  Sum_probs=197.4

Q ss_pred             cccccccCCCCCCcEEEEEEeCCC--CEEEEEEeCCCCChhHHHHHHHHHHHhcCCC----ccccccceee-eeCCeeEE
Q 020221           58 MENIVSEHGEKAPNVVYKGKLENQ--FRIAVKRFNRSAWPDARQFLEEARAVGQLRN----RRLANLLGCC-CEGDERLL  130 (329)
Q Consensus        58 ~~~~~~~lg~G~~g~V~~~~~~~~--~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h----~niv~~~~~~-~~~~~~~l  130 (329)
                      .+.+.+.||+|+||.||.+.....  ..+|+|............+..|..++..+..    +++..+++.. ..+...++
T Consensus        19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~~~~~i   98 (322)
T KOG1164|consen   19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKPSVLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTEDFNFI   98 (322)
T ss_pred             ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCCccchhHHHHHHHHhhhcCCCCCCEEEEeccCCCceeEE
Confidence            688889999999999999995443  4789998876533322267778888888863    6888888888 47778999


Q ss_pred             EEecCCCCCHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCCC-----CCeeeecccCccc
Q 020221          131 VAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDD-----VNPRLSCFGLMKN  205 (329)
Q Consensus       131 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~-----~~~kl~Dfg~a~~  205 (329)
                      ||+.+ |.+|.++......+.++..++..++.|++.+|+++|+. |++||||||+|+++...     ..+.|.|||+++.
T Consensus        99 VM~l~-G~sL~dl~~~~~~~~fs~~T~l~ia~q~l~~l~~lH~~-G~iHRDiKp~N~~~g~~~~~~~~~~~llDfGlar~  176 (322)
T KOG1164|consen   99 VMSLL-GPSLEDLRKRNPPGRFSRKTVLRIAIQNLNALEDLHSK-GFIHRDIKPENFVVGQSSRSEVRTLYLLDFGLARR  176 (322)
T ss_pred             EEecc-CccHHHHHHhCCCCCcCHhHHHHHHHHHHHHHHHHHhc-CcccCCcCHHHeeecCCCCcccceEEEEecCCCcc
Confidence            99998 66999988654567899999999999999999999999 99999999999999854     4699999999982


Q ss_pred             CC--C--------C----CCccCcccccCcccccCCCCCCcccchhhhHHHHHHHhCCCCCCchhhHHHhhhchhhhccc
Q 020221          206 SR--D--------G----RSYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDS  271 (329)
Q Consensus       206 ~~--~--------~----~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~  271 (329)
                      ..  .        .    ....||..|+++....+...+++.|+||++.++.+++.|..|+........... .......
T Consensus       177 ~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e~~r~DDles~~Y~l~el~~g~LPW~~~~~~~~~~~-~~~~~~~  255 (322)
T KOG1164|consen  177 FKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIEQGRRDDLESLFYMLLELLKGSLPWEALEMTDLKSK-FEKDPRK  255 (322)
T ss_pred             ccccCCCCcccccCCCCccCCCCccccccHHHhCCCccCCchhhhhHHHHHHHHhcCCCCCccccccchHHH-HHHHhhh
Confidence            21  1        1    123489999999999999999999999999999999999877643321111111 1111111


Q ss_pred             cccCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhhcc
Q 020221          272 CLEGQFSSDEGTELVRLASRCLQYEPRERPNPRSLVTALVTLQKDT  317 (329)
Q Consensus       272 ~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~~~l~~L~~~~~~~  317 (329)
                      ..........+.++.++...+-..+...+|.+..+...|+......
T Consensus       256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pdy~~~~~~l~~~~~~~  301 (322)
T KOG1164|consen  256 LLTDRFGDLKPEEFAKILEYIDSLDYEDKPDYEKLAELLKDVFDSE  301 (322)
T ss_pred             hccccccCCChHHHHHHHHHhhccCCcCCCCHHHHHHHHHHHHHhc
Confidence            1111122334567888888888899999999999999988876654

>KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.95  E-value=1.8e-27  Score=192.64  Aligned_cols=254  Identities=16%  Similarity=0.164  Sum_probs=203.3

Q ss_pred             cccccccCCCCCCcEEEEEE-eCCCCEEEEEEeCCCCChhHHHHHHHHHHHhcCC-CccccccceeeeeCCeeEEEEecC
Q 020221           58 MENIVSEHGEKAPNVVYKGK-LENQFRIAVKRFNRSAWPDARQFLEEARAVGQLR-NRRLANLLGCCCEGDERLLVAEYM  135 (329)
Q Consensus        58 ~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~~~~lv~e~~  135 (329)
                      .|+++++||.|+||.+|.|. ..+|+.||+|.-.....  ..++..|..+...++ ...|..+..+..+.....+||+.+
T Consensus        16 ky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~a~--hpqL~yEskvY~iL~~g~GiP~i~~y~~e~~ynvlVMdLL   93 (341)
T KOG1163|consen   16 KYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSKAK--HPQLLYESKVYRILQGGVGIPHIRHYGTEKDYNVLVMDLL   93 (341)
T ss_pred             ceEEEEeecCCchhheeeeeeccCCceEEEEeecccCC--CcchhHHHHHHHHhccCCCCchhhhhccccccceeeeecc
Confidence            47899999999999999999 88899999999776543  345778999999997 467888888888889999999998


Q ss_pred             CCCCHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCCC---CCeeeecccCcccCCCC---
Q 020221          136 PNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDD---VNPRLSCFGLMKNSRDG---  209 (329)
Q Consensus       136 ~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~---~~~kl~Dfg~a~~~~~~---  209 (329)
                       |.||.+++. ...+.++..+++.++-||+.-++|+|.+ +++||||||+|+|+.-+   ..+.++|||+|+.+.+.   
T Consensus        94 -GPsLEdLfn-fC~R~ftmkTvLMLaDQml~RiEyvH~r-~fiHRDIKPdNFLMGlgrh~~kl~LIDFGLaKky~d~~t~  170 (341)
T KOG1163|consen   94 -GPSLEDLFN-FCSRRFTMKTVLMLADQMLSRIEYVHLR-NFIHRDIKPDNFLMGLGRHCNKLYLIDFGLAKKYRDIRTR  170 (341)
T ss_pred             -CccHHHHHH-HHhhhhhHHhHHHHHHHHHHHHHHHHhh-ccccccCCccceeeccccccceEEEEeccchhhhcccccc
Confidence             679999873 3667899999999999999999999999 99999999999999743   45889999999875543   


Q ss_pred             --------CCccCcccccCcccccCCCCCCcccchhhhHHHHHHHhCCCCCCchhhHHHhhhchhhhccccccC---CCC
Q 020221          210 --------RSYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEG---QFS  278 (329)
Q Consensus       210 --------~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~  278 (329)
                              ....||..|.+--...+...+.+.|+-|+|.+|.++.-|..|+.+-. ...+.+..+.+.+.....   ...
T Consensus       171 ~HIpyre~r~ltGTaRYASinAh~g~eqSRRDDmeSvgYvLmYfnrG~LPWQglk-a~tk~QKyEkI~EkK~s~~ie~LC  249 (341)
T KOG1163|consen  171 QHIPYREDRNLTGTARYASINAHLGIEQSRRDDMESVGYVLMYFNRGSLPWQGLK-AATKKQKYEKISEKKMSTPIEVLC  249 (341)
T ss_pred             ccCccccCCccceeeeehhhhhhhhhhhhhhhhhhhhcceeeeeecCCCcccccc-hhhHHHHHHHHHHhhcCCCHHHHh
Confidence                    34568899999888887788899999999999999999998775432 222333333332222111   123


Q ss_pred             hHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhhcc
Q 020221          279 SDEGTELVRLASRCLQYEPRERPNPRSLVTALVTLQKDT  317 (329)
Q Consensus       279 ~~~~~~~~~li~~cl~~dp~~Rps~~~~l~~L~~~~~~~  317 (329)
                      ...|.++.-.+..|-...-++-|++.-+.+.+.-+-...
T Consensus       250 ~G~P~EF~myl~Y~R~L~F~E~Pdy~ylrqlFriLfr~l  288 (341)
T KOG1163|consen  250 KGFPAEFAMYLNYCRGLGFEEKPDYMYLRQLFRILFRTL  288 (341)
T ss_pred             CCCcHHHHHHHHHHhhcCCCCCCcHHHHHHHHHHHHhhc
Confidence            456788999999999999999999998888777665543

>KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.94  E-value=9.5e-27  Score=196.54  Aligned_cols=253  Identities=16%  Similarity=0.182  Sum_probs=205.5

Q ss_pred             ccccccCCCCCCcEEEEEE-eCCCCEEEEEEeCCCCChhHHHHHHHHHHHhcC-CCccccccceeeeeCCeeEEEEecCC
Q 020221           59 ENIVSEHGEKAPNVVYKGK-LENQFRIAVKRFNRSAWPDARQFLEEARAVGQL-RNRRLANLLGCCCEGDERLLVAEYMP  136 (329)
Q Consensus        59 ~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~~  136 (329)
                      |++-++||+|+||.++.|+ +-+++.||||.-....  .+.++..|.+..+.| ..++|...+.+...+-+..||+|++ 
T Consensus        30 yrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPrkS--~APQLrdEYr~YKlL~g~~GIP~vYYFGqeG~~NiLVidLL-  106 (449)
T KOG1165|consen   30 YRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPRKS--EAPQLRDEYRTYKLLGGTEGIPQVYYFGQEGKYNILVIDLL-  106 (449)
T ss_pred             ceeccccccCcceeeecccccccCceEEEEeccccC--CcchHHHHHHHHHHHcCCCCCCceeeeccccchhhhhhhhh-
Confidence            6677888999999999998 6788999999866543  456788899999998 5799999999888888999999998 


Q ss_pred             CCCHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCCCC-----CeeeecccCcccCCCCC-
Q 020221          137 NDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDV-----NPRLSCFGLMKNSRDGR-  210 (329)
Q Consensus       137 ~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~-----~~kl~Dfg~a~~~~~~~-  210 (329)
                      |.||.+++ ++.++.++..++..++.||+.-++|+|++ .+|+|||||+|+||..-+     .+-++|||+|+.+.+.. 
T Consensus       107 GPSLEDLF-D~CgR~FSvKTV~miA~Qmi~rie~vH~k-~LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmAK~YrDp~T  184 (449)
T KOG1165|consen  107 GPSLEDLF-DLCGRRFSVKTVAMIAKQMITRIEYVHEK-DLIYRDIKPDNFLIGRPGTKDANVIHIIDFGMAKEYRDPKT  184 (449)
T ss_pred             CcCHHHHH-HHhcCcccHHhHHHHHHHHHHHHHHHHhc-ceeecccCccceeecCCCCCCCceEEEEeccchhhhcCccc
Confidence            67999977 55788999999999999999999999999 999999999999997443     48899999999766543 


Q ss_pred             ----------CccCcccccCcccccCCCCCCcccchhhhHHHHHHHhCCCCCCchhhHHHhhhchhhhccccc---cCCC
Q 020221          211 ----------SYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCL---EGQF  277 (329)
Q Consensus       211 ----------~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~  277 (329)
                                +..||-+||+--...|...+.+.|+-|+|-++++.+-|..|+.+-..+..+.. .+.+-+..-   ....
T Consensus       185 kqHIPYrE~KSLsGTARYMSINTHlGrEQSRRDDLEaLGHvFmYFLRGsLPWQGLKA~tnK~k-YeKIGe~Kr~T~i~~L  263 (449)
T KOG1165|consen  185 KQHIPYREHKSLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKADTNKEK-YEKIGETKRSTPIEVL  263 (449)
T ss_pred             cccCccccccccccceeeeEeeccccchhhhhhhHHHhhhhhhhhccCCCccccccCcchHHH-HHHhccccccCCHHHH
Confidence                      45789999999988898999999999999999999999988765432222111 111111110   1112


Q ss_pred             ChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhhcc
Q 020221          278 SSDEGTELVRLASRCLQYEPRERPNPRSLVTALVTLQKDT  317 (329)
Q Consensus       278 ~~~~~~~~~~li~~cl~~dp~~Rps~~~~l~~L~~~~~~~  317 (329)
                      ...+|.++...+...-.++-++-|++.-+...+..+....
T Consensus       264 c~g~P~efa~Yl~yvR~L~F~E~PDYdylr~Lf~dvldr~  303 (449)
T KOG1165|consen  264 CEGFPEEFATYLRYVRRLDFFETPDYDYLRKLFDDVLDRL  303 (449)
T ss_pred             HhcCHHHHHHHHHHHHhcCcccCCCHHHHHHHHHHHHHhc
Confidence            2446889999999999999999999999988888876643

>PRK09188 serine/threonine protein kinase; Provisional

Probab=99.93  E-value=1.6e-25  Score=199.90  Aligned_cols=156  Identities=15%  Similarity=-0.000  Sum_probs=120.5

Q ss_pred             ccccccCCCCCCcEEEEEEeC--CCCEEEEEEeCCCC-----ChhHHHHHHHHHHHhcCCCccccccceeeeeCCeeEEE
Q 020221           59 ENIVSEHGEKAPNVVYKGKLE--NQFRIAVKRFNRSA-----WPDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLV  131 (329)
Q Consensus        59 ~~~~~~lg~G~~g~V~~~~~~--~~~~vavK~~~~~~-----~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv  131 (329)
                      |.+.+.||+|+||+||+|...  +++.+|||++....     ......+.+|+++|+.++|+|++..+..   .+..++|
T Consensus        20 Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~---~~~~~LV   96 (365)
T PRK09188         20 FVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLA---TGKDGLV   96 (365)
T ss_pred             ceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEE---cCCcEEE
Confidence            556666799999999999853  57778999875331     1124458999999999999999863322   2468999


Q ss_pred             EecCCCCCHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccc-CCCceeeCCCCCeeeecccCcccCCCCC
Q 020221          132 AEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDL-NAYRIVFDDDVNPRLSCFGLMKNSRDGR  210 (329)
Q Consensus       132 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dl-kp~Nil~~~~~~~kl~Dfg~a~~~~~~~  210 (329)
                      |||+++++|.. +.  ...      ...++.+++.+|.|||+. ||+|||| ||+|||++.++.++|+|||+++......
T Consensus        97 mE~~~G~~L~~-~~--~~~------~~~~~~~i~~aL~~lH~~-gIiHrDL~KP~NILv~~~~~ikLiDFGlA~~~~~~~  166 (365)
T PRK09188         97 RGWTEGVPLHL-AR--PHG------DPAWFRSAHRALRDLHRA-GITHNDLAKPQNWLMGPDGEAAVIDFQLASVFRRRG  166 (365)
T ss_pred             EEccCCCCHHH-hC--ccc------hHHHHHHHHHHHHHHHHC-CCeeCCCCCcceEEEcCCCCEEEEECccceecccCc
Confidence            99999999963 21  111      146788999999999999 9999999 9999999999999999999998654432


Q ss_pred             ------------CccCcccccCcccccCC
Q 020221          211 ------------SYSTNLAFTPPEYLRTG  227 (329)
Q Consensus       211 ------------~~~~~~~y~aPE~~~~~  227 (329)
                                  ...++..|+|||.+...
T Consensus       167 ~~~~~~~~~d~~~~~~~~~~~~pe~~~~~  195 (365)
T PRK09188        167 ALYRIAAYEDLRHLLKHKRTYAPDALTPR  195 (365)
T ss_pred             chhhhhhhhhhhhhhccCccCCcccCChh
Confidence                        22356779999988643

>KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.93  E-value=2.2e-26  Score=218.25  Aligned_cols=242  Identities=15%  Similarity=0.084  Sum_probs=180.2

Q ss_pred             ccCCCCCCcEEEEEE-eCCCCEEEEEEeCCC--CChhH----HHHHHHHHHHhcCCCccccccceeeeeCCeeEEEEecC
Q 020221           63 SEHGEKAPNVVYKGK-LENQFRIAVKRFNRS--AWPDA----RQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAEYM  135 (329)
Q Consensus        63 ~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~--~~~~~----~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~  135 (329)
                      ..+|.|++|.|+... ....+..+.|.+...  .....    ..+..|+.+-..+.|+|++..+..+.+.....-.||||
T Consensus       324 ~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~~~~~~mE~~  403 (601)
T KOG0590|consen  324 RVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEIDGILQSMEYC  403 (601)
T ss_pred             ceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhcccchhhhhcc
Confidence            445999999888776 444445555554321  11111    12566777888899999988888777666666669999


Q ss_pred             CCCCHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCCCCCeeeecccCcccCCCC------
Q 020221          136 PNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDG------  209 (329)
Q Consensus       136 ~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~------  209 (329)
                      ++ +|..++..  ...+...++..+++|++.|+.|+|+. |+.|||+|++|++++.+|.+||+|||.+..+.-.      
T Consensus       404 ~~-Dlf~~~~~--~~~~~~~e~~c~fKqL~~Gv~y~h~~-GiahrdlK~enll~~~~g~lki~Dfg~~~vf~~~~e~~~~  479 (601)
T KOG0590|consen  404 PY-DLFSLVMS--NGKLTPLEADCFFKQLLRGVKYLHSM-GLAHRDLKLENLLVTENGILKIIDFGAASVFRYPWEKNIH  479 (601)
T ss_pred             cH-HHHHHHhc--ccccchhhhhHHHHHHHHHHHHHHhc-CceeccCccccEEEecCCceEEeecCcceeeccCcchhhh
Confidence            99 99998852  24688889999999999999999999 9999999999999999999999999998754433      


Q ss_pred             --CCccCcccccCcccccCCCCCCc-ccchhhhHHHHHHHhCCCCCCchhhHHHh---hhchhhhccccccCCCChHHHH
Q 020221          210 --RSYSTNLAFTPPEYLRTGRVTPE-SVMYSFGTLLLDLLSGKHIPPSHALDLIR---DRNIQTLTDSCLEGQFSSDEGT  283 (329)
Q Consensus       210 --~~~~~~~~y~aPE~~~~~~~~~~-~DvwslG~il~el~tg~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~  283 (329)
                        ....|+-+|+|||++.+..|++. .||||.|+++..|++|+.|+.........   ....................+.
T Consensus       480 ~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~lp~  559 (601)
T KOG0590|consen  480 ESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNSFKTNNYSDQRNIFEGPNRLLSLLPR  559 (601)
T ss_pred             hhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCccccccccccchhhhccccccccccChHHHHHhchh
Confidence              23467889999999999998885 89999999999999999776432211110   0000000000011112345788


Q ss_pred             HHHHHHHHhcccCCCCCCCHHHHHH
Q 020221          284 ELVRLASRCLQYEPRERPNPRSLVT  308 (329)
Q Consensus       284 ~~~~li~~cl~~dp~~Rps~~~~l~  308 (329)
                      +.+.++..+|+.||.+|.|+.+|++
T Consensus       560 ~~~~~~~~~l~~~P~~R~ti~~i~~  584 (601)
T KOG0590|consen  560 ETRIIIYRMLQLDPTKRITIEQILN  584 (601)
T ss_pred             hHHHHHHHHccCChhheecHHHHhh
Confidence            8999999999999999999999997

>COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair]

Probab=99.92  E-value=9.9e-24  Score=187.65  Aligned_cols=247  Identities=22%  Similarity=0.262  Sum_probs=192.2

Q ss_pred             ccccccCCCCCCcEEEEEEeCCCCEEEEEEeCCCCCh---hHHHHHHHHHHHhcCCCc-cccccceeeeeCCeeEEEEec
Q 020221           59 ENIVSEHGEKAPNVVYKGKLENQFRIAVKRFNRSAWP---DARQFLEEARAVGQLRNR-RLANLLGCCCEGDERLLVAEY  134 (329)
Q Consensus        59 ~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~---~~~~~~~e~~~l~~l~h~-niv~~~~~~~~~~~~~lv~e~  134 (329)
                      +.+.+.+|.|+||.||++...  ..+++|.+......   ....+.+|+..++.+.|+ +++++.+.+......++++++
T Consensus         2 ~~~~~~l~~g~~~~v~~~~~~--~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~   79 (384)
T COG0515           2 YRILRKLGEGSFGEVYLARDR--KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDEGSLYLVMEY   79 (384)
T ss_pred             ceeEEeecCCCCeEEEEEEec--cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEecCCEEEEEEec
Confidence            455667799999999999976  68999998876433   256789999999999888 799999999777778999999


Q ss_pred             CCCCCHHhhhccCCC-CCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCCCC-CeeeecccCcccCCCC---
Q 020221          135 MPNDTLAKHLFHWET-QPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDV-NPRLSCFGLMKNSRDG---  209 (329)
Q Consensus       135 ~~~gsL~~~l~~~~~-~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~-~~kl~Dfg~a~~~~~~---  209 (329)
                      +.++++.+++..... ..++......++.|++.++.|+|.. +++|||+||+||+++..+ .++++|||.+......   
T Consensus        80 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~H~~-~~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~~~~~~~  158 (384)
T COG0515          80 VDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHSK-GIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGST  158 (384)
T ss_pred             CCCCcHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHHhC-CeeccCCCHHHeeecCCCCeEEEeccCcceecCCCCcc
Confidence            999999977643111 2688999999999999999999999 999999999999999988 6999999998744332   


Q ss_pred             -------CCccCcccccCcccccC---CCCCCcccchhhhHHHHHHHhCCCCCCchhh----HHHhhhchhhhccccccC
Q 020221          210 -------RSYSTNLAFTPPEYLRT---GRVTPESVMYSFGTLLLDLLSGKHIPPSHAL----DLIRDRNIQTLTDSCLEG  275 (329)
Q Consensus       210 -------~~~~~~~~y~aPE~~~~---~~~~~~~DvwslG~il~el~tg~~~~~~~~~----~~~~~~~~~~~~~~~~~~  275 (329)
                             ....++..|+|||.+.+   .......|+||+|++++++++|..|+.....    .......... ..+....
T Consensus       159 ~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~-~~~~~~~  237 (384)
T COG0515         159 SSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILEL-PTPSLAS  237 (384)
T ss_pred             ccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccccHHHHHHHHHhc-CCccccc
Confidence                   34567899999999987   5788899999999999999999988544321    1111111111 1110011


Q ss_pred             CCC----hHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 020221          276 QFS----SDEGTELVRLASRCLQYEPRERPNPRSLVTA  309 (329)
Q Consensus       276 ~~~----~~~~~~~~~li~~cl~~dp~~Rps~~~~l~~  309 (329)
                      ...    ......+.+++..++..+|..|.+..+....
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~~  275 (384)
T COG0515         238 PLSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLSH  275 (384)
T ss_pred             ccCccccchhhHHHHHHHHHHHhcCchhcCCHHHHhhc
Confidence            111    1123678999999999999999998887764

>cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain

Probab=99.91  E-value=5.8e-24  Score=174.90  Aligned_cols=140  Identities=15%  Similarity=0.135  Sum_probs=109.1

Q ss_pred             cccCCCCCCcEEEEEEeCCCCEEEEEEeCCCCChh---------H-----------------HHHHHHHHHHhcCCCccc
Q 020221           62 VSEHGEKAPNVVYKGKLENQFRIAVKRFNRSAWPD---------A-----------------RQFLEEARAVGQLRNRRL  115 (329)
Q Consensus        62 ~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~---------~-----------------~~~~~e~~~l~~l~h~ni  115 (329)
                      .+.||+|++|.||+|...+|+.||+|+++......         .                 ....+|++.+..+.++++
T Consensus         2 ~~~ig~G~~~~Vy~a~~~~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~v   81 (190)
T cd05147           2 NGCISTGKEANVYHATTANGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAGI   81 (190)
T ss_pred             CCccccccceEEEEEECCCCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCCC
Confidence            35679999999999997789999999997643210         0                 112358999999988776


Q ss_pred             cccceeeeeCCeeEEEEecCCCCCHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHh-hcCCCccccccCCCceeeCCCCC
Q 020221          116 ANLLGCCCEGDERLLVAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYC-TSKERALYHDLNAYRIVFDDDVN  194 (329)
Q Consensus       116 v~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~l-H~~~~ivH~dlkp~Nil~~~~~~  194 (329)
                      ........  ...+|||||++++++.....  ....++..++..++.|++.+|.++ |+. |++||||||+||+++ ++.
T Consensus        82 ~~p~~~~~--~~~~iVmE~i~g~~l~~~~~--~~~~~~~~~~~~i~~qi~~~L~~l~H~~-giiHrDlkP~NIli~-~~~  155 (190)
T cd05147          82 PCPEPILL--KSHVLVMEFIGDDGWAAPRL--KDAPLSESKARELYLQVIQIMRILYQDC-RLVHADLSEYNLLYH-DGK  155 (190)
T ss_pred             CCCcEEEe--cCCEEEEEEeCCCCCcchhh--hcCCCCHHHHHHHHHHHHHHHHHHHHhC-CcccCCCCHHHEEEE-CCc
Confidence            44333222  23489999999877765432  345788999999999999999999 688 999999999999998 478


Q ss_pred             eeeecccCcccCC
Q 020221          195 PRLSCFGLMKNSR  207 (329)
Q Consensus       195 ~kl~Dfg~a~~~~  207 (329)
                      ++|+|||++....
T Consensus       156 v~LiDFG~a~~~~  168 (190)
T cd05147         156 LYIIDVSQSVEHD  168 (190)
T ss_pred             EEEEEccccccCC
Confidence            9999999987543

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c

>PRK10359 lipopolysaccharide core biosynthesis protein; Provisional

Probab=99.90  E-value=1.2e-23  Score=175.18  Aligned_cols=168  Identities=11%  Similarity=0.038  Sum_probs=129.4

Q ss_pred             cccccccCCCCCCcEEEEEEeCCCCEEEEEEeCCCCChhHHH---------HHHHHHHHhcCCCccccccceeeeeC---
Q 020221           58 MENIVSEHGEKAPNVVYKGKLENQFRIAVKRFNRSAWPDARQ---------FLEEARAVGQLRNRRLANLLGCCCEG---  125 (329)
Q Consensus        58 ~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~---------~~~e~~~l~~l~h~niv~~~~~~~~~---  125 (329)
                      .|+.++.+|.|+||.||.... ++..+|+|.+..........         +.+|++.+.++.|++|..+..++...   
T Consensus        32 ~y~~~~~l~~~~f~~v~l~~~-~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~~~~~~~  110 (232)
T PRK10359         32 NIKTIKVFRNIDDTKVSLIDT-DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFYLLAERK  110 (232)
T ss_pred             ceEEEEEecCCCceEEEEEec-CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEeeeecccc
Confidence            466777889999999999766 46689999998654333222         57899999999999999998886533   


Q ss_pred             -----CeeEEEEecCCCCCHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCCCCCeeeecc
Q 020221          126 -----DERLLVAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCF  200 (329)
Q Consensus       126 -----~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Df  200 (329)
                           ...+++|||++|.+|.++..      ++.    ....+++.++..+|.. |++|+|+||+||+++.++ ++|+||
T Consensus       111 ~~~~~~~~~lvmEyi~G~tL~~~~~------~~~----~~~~~i~~~l~~lH~~-gi~H~Dikp~Nili~~~g-i~liDf  178 (232)
T PRK10359        111 TLRYAHTYIMLIEYIEGVELNDMPE------ISE----DVKAKIKASIESLHQH-GMVSGDPHKGNFIVSKNG-LRIIDL  178 (232)
T ss_pred             cccccCCeEEEEEEECCccHHHhhh------ccH----HHHHHHHHHHHHHHHc-CCccCCCChHHEEEeCCC-EEEEEC
Confidence                 35789999999999988642      232    2456999999999999 999999999999999888 999999


Q ss_pred             cCcccCCCCCCccCcccccCcccccCCCCCCcccchhhhHHHHHHH
Q 020221          201 GLMKNSRDGRSYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLL  246 (329)
Q Consensus       201 g~a~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~  246 (329)
                      |...........        ..++....++.++|+||||+++..+.
T Consensus       179 g~~~~~~e~~a~--------d~~vler~y~~~~di~~lg~~~~~~~  216 (232)
T PRK10359        179 SGKRCTAQRKAK--------DRIDLERHYGIKNEIKDLGYYLLIYK  216 (232)
T ss_pred             CCcccccchhhH--------HHHHHHhHhcccccccceeEeehHHH
Confidence            987655322111        11333445677999999999887554

>cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain

Probab=99.89  E-value=1.2e-22  Score=167.61  Aligned_cols=141  Identities=15%  Similarity=0.148  Sum_probs=111.2

Q ss_pred             cccCCCCCCcEEEEEEeCCCCEEEEEEeCCCCCh---------------------h-----HHHHHHHHHHHhcCCCccc
Q 020221           62 VSEHGEKAPNVVYKGKLENQFRIAVKRFNRSAWP---------------------D-----ARQFLEEARAVGQLRNRRL  115 (329)
Q Consensus        62 ~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~---------------------~-----~~~~~~e~~~l~~l~h~ni  115 (329)
                      .+.||+|++|.||+|...+|+.||||+++.....                     .     ...+.+|.+.+..+.|+++
T Consensus         2 ~~~ig~G~~~~Vy~a~~~~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i   81 (190)
T cd05145           2 NGCISTGKEANVYHARTGDGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEAGV   81 (190)
T ss_pred             CceeecCCCcEEEEEEcCCCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhCCC
Confidence            4567999999999999668999999998865311                     0     1123578899999999987


Q ss_pred             cccceeeeeCCeeEEEEecCCCCCHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhc-CCCccccccCCCceeeCCCCC
Q 020221          116 ANLLGCCCEGDERLLVAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTS-KERALYHDLNAYRIVFDDDVN  194 (329)
Q Consensus       116 v~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~-~~~ivH~dlkp~Nil~~~~~~  194 (329)
                      .....+...  ..++||||++++++.....  ....++......++.|++.++.++|+ . |++||||||+||+++ ++.
T Consensus        82 ~~p~~~~~~--~~~lVmE~~~g~~~~~~~l--~~~~~~~~~~~~i~~~l~~~l~~lH~~~-givHrDlkP~NIll~-~~~  155 (190)
T cd05145          82 PVPEPILLK--KNVLVMEFIGDDGSPAPRL--KDVPLEEEEAEELYEQVVEQMRRLYQEA-GLVHGDLSEYNILYH-DGK  155 (190)
T ss_pred             CCceEEEec--CCEEEEEEecCCCchhhhh--hhccCCHHHHHHHHHHHHHHHHHHHHhC-CEecCCCChhhEEEE-CCC
Confidence            554443322  3489999999876544322  33467788999999999999999999 8 999999999999999 889


Q ss_pred             eeeecccCcccCCC
Q 020221          195 PRLSCFGLMKNSRD  208 (329)
Q Consensus       195 ~kl~Dfg~a~~~~~  208 (329)
                      ++|+|||++.....
T Consensus       156 ~~liDFG~a~~~~~  169 (190)
T cd05145         156 PYIIDVSQAVELDH  169 (190)
T ss_pred             EEEEEcccceecCC
Confidence            99999999976544

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro

>KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms]

Probab=99.89  E-value=4e-24  Score=194.82  Aligned_cols=224  Identities=15%  Similarity=0.170  Sum_probs=186.6

Q ss_pred             CCCCCCcEEEEEE----eCCCCEEEEEEeCCCCChh--HHHHHHHHHHHhcCC-CccccccceeeeeCCeeEEEEecCCC
Q 020221           65 HGEKAPNVVYKGK----LENQFRIAVKRFNRSAWPD--ARQFLEEARAVGQLR-NRRLANLLGCCCEGDERLLVAEYMPN  137 (329)
Q Consensus        65 lg~G~~g~V~~~~----~~~~~~vavK~~~~~~~~~--~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~~~~lv~e~~~~  137 (329)
                      +|+|.||.|+.+.    .+.++.+|+|.+++.....  ......|..++..++ ||.++++...++.+...++++++..+
T Consensus         2 lg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~ld~~rg   81 (612)
T KOG0603|consen    2 LGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRTHTKQERIILAFVHNTPFLVKLHYAFQTDGKLYLILDFLRG   81 (612)
T ss_pred             CCcCCCcchHHHHHhccccccchhhhhcccccccccccccccccHHHHHhhccCCCceeeeeeeeccccchhHhhhhccc
Confidence            5999999999775    3457789999887643211  123456788888886 99999999999999999999999999


Q ss_pred             CCHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCCCCCeeeecccCcccCCCCCCccCccc
Q 020221          138 DTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDGRSYSTNLA  217 (329)
Q Consensus       138 gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~  217 (329)
                      |.|...+.  ....+.+.....+..+++-+++++|.. +++|||+|++||+++.+|++++.|||+++..-.....+||..
T Consensus        82 g~lft~l~--~~~~f~~~~~~~~~aelaLald~lh~l-~iiyrd~k~enilld~~Ghi~~tdfglske~v~~~~~cgt~e  158 (612)
T KOG0603|consen   82 GDLFTRLS--KEVMFDELDVAFYLAELALALDHLHKL-GIAYRDYKLENVLLLLEGHIKLTDFGLSKEAVKEKIACGTYE  158 (612)
T ss_pred             chhhhccc--cCCchHHHHHHHHHHHHHHHHhhcchh-HHHHhcccccceeecccCccccCCchhhhHhHhhhhcccchh
Confidence            99988775  456678888889999999999999999 999999999999999999999999999988776666699999


Q ss_pred             ccCcccccCCCCCCcccchhhhHHHHHHHhCCCCCCchhhHHHhhhchhhhccccccCCCChHHHHHHHHHHHHhcccCC
Q 020221          218 FTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLASRCLQYEP  297 (329)
Q Consensus       218 y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp  297 (329)
                      |||||++.  .....+|.||||++.+||+||..||..+...        .+..  .....|...+..+++++..++..+|
T Consensus       159 ymApEI~~--gh~~a~D~ws~gvl~felltg~~pf~~~~~~--------~Il~--~~~~~p~~l~~~a~~~~~~l~~r~p  226 (612)
T KOG0603|consen  159 YRAPEIIN--GHLSAADWWSFGVLAFELLTGTLPFGGDTMK--------RILK--AELEMPRELSAEARSLFRQLFKRNP  226 (612)
T ss_pred             hhhhHhhh--ccCCcccchhhhhhHHHHhhCCCCCchHHHH--------HHhh--hccCCchhhhHHHHHHHHHHHhhCH
Confidence            99999988  5677899999999999999999988752211        1111  1234678889999999999999999


Q ss_pred             CCCCCH
Q 020221          298 RERPNP  303 (329)
Q Consensus       298 ~~Rps~  303 (329)
                      ..|.-.
T Consensus       227 ~nrLg~  232 (612)
T KOG0603|consen  227 ENRLGA  232 (612)
T ss_pred             HHHhcc
Confidence            999855

>KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms]

Probab=99.89  E-value=4.6e-23  Score=187.57  Aligned_cols=209  Identities=22%  Similarity=0.331  Sum_probs=164.3

Q ss_pred             HhcCCCccccccceeeeeCCeeEEEEecCCCCCHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCc-cccccCCC
Q 020221          107 VGQLRNRRLANLLGCCCEGDERLLVAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERA-LYHDLNAY  185 (329)
Q Consensus       107 l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~i-vH~dlkp~  185 (329)
                      |+.+.|.|+.+++|.+.++...+.|.+||..|+|.+.+.. ....+++.-....+++++.||.|||.. .| .|+.+++.
T Consensus         1 l~~l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~-~~~~~d~~F~~s~~rdi~~Gl~ylh~s-~i~~hg~l~s~   78 (484)
T KOG1023|consen    1 LRQLDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSN-EDIKLDYFFILSFIRDISKGLAYLHNS-PIGYHGALKSS   78 (484)
T ss_pred             CcccchhhhhhheeeEecCCceEEEEeeecCccHHhHHhc-cccCccHHHHHHHHHHHHHHHHHHhcC-cceeeeeeccc
Confidence            4578999999999999999999999999999999999975 567889999999999999999999998 55 89999999


Q ss_pred             ceeeCCCCCeeeecccCcccCCCC------CCccCcccccCcccccCCC-------CCCcccchhhhHHHHHHHhCCCCC
Q 020221          186 RIVFDDDVNPRLSCFGLMKNSRDG------RSYSTNLAFTPPEYLRTGR-------VTPESVMYSFGTLLLDLLSGKHIP  252 (329)
Q Consensus       186 Nil~~~~~~~kl~Dfg~a~~~~~~------~~~~~~~~y~aPE~~~~~~-------~~~~~DvwslG~il~el~tg~~~~  252 (329)
                      |.++|....+||+|||+.......      .......-|.|||.+.+..       .+.+.|+||||++++|+++++.||
T Consensus        79 nClvd~~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~r~~~~  158 (484)
T KOG1023|consen   79 NCLVDSRWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILFRSGPF  158 (484)
T ss_pred             cceeeeeEEEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHHhccCcc
Confidence            999999999999999998766431      1112235699999988642       456799999999999999999988


Q ss_pred             CchhhHHHhhhchhhh---ccccccCCCC-h-HHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhhcc
Q 020221          253 PSHALDLIRDRNIQTL---TDSCLEGQFS-S-DEGTELVRLASRCLQYEPRERPNPRSLVTALVTLQKDT  317 (329)
Q Consensus       253 ~~~~~~~~~~~~~~~~---~~~~~~~~~~-~-~~~~~~~~li~~cl~~dp~~Rps~~~~l~~L~~~~~~~  317 (329)
                      ...............+   ..+..++... . +.++++..++..||..+|+.||++.++-..++.+.+..
T Consensus       159 ~~~~~~~~~~eii~~~~~~~~~~~rP~i~~~~e~~~~l~~l~~~cw~e~P~~rPs~~~i~~~~~~~~~~~  228 (484)
T KOG1023|consen  159 DLRNLVEDPDEIILRVKKGGSNPFRPSIELLNELPPELLLLVARCWEEIPEKRPSIEQIRSKLLTINKGG  228 (484)
T ss_pred             ccccccCChHHHHHHHHhcCCCCcCcchhhhhhcchHHHHHHHHhcccChhhCccHHHHHhhhhhhcccc
Confidence            6532211111111111   1111222211 1 44568999999999999999999999999999998754

>KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms]

Probab=99.88  E-value=1.9e-23  Score=199.82  Aligned_cols=242  Identities=16%  Similarity=0.175  Sum_probs=177.9

Q ss_pred             cccccccCCCCCCcEEEEEEeCCCCEEEEEEeCCCC-ChhHHHHHHHHHH--HhcCCCccccccceeeeeCCeeEEEEec
Q 020221           58 MENIVSEHGEKAPNVVYKGKLENQFRIAVKRFNRSA-WPDARQFLEEARA--VGQLRNRRLANLLGCCCEGDERLLVAEY  134 (329)
Q Consensus        58 ~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~-~~~~~~~~~e~~~--l~~l~h~niv~~~~~~~~~~~~~lv~e~  134 (329)
                      ++...+.+|.+.|=.|.+|+.+.|. |+||++-+.. .-..+.+.++++.  ...+++||.+.+.-+-......|+|-+|
T Consensus        24 e~~~~~~LGstRFlKv~r~k~~eG~-vVvKVFvk~~p~~sL~~~~qrL~~ik~~l~~~pn~lPfqk~~~t~kAAylvRqy  102 (1431)
T KOG1240|consen   24 ECHYVENLGSTRFLKVARAKDREGL-VVVKVFVKQDPTISLRPFKQRLEEIKFALMKAPNCLPFQKVLVTDKAAYLVRQY  102 (1431)
T ss_pred             ceeeecccCchhhhhhhhccCCCce-EEEEEEeccCCCCCchHHHHHHHHHHHHhhcCCcccchHHHHHhhHHHHHHHHH
Confidence            4556677899999999999988885 9999986654 2234444443333  4556899999998887777788999999


Q ss_pred             CCCCCHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCCCCCeeeecccCcccCCCCC----
Q 020221          135 MPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDGR----  210 (329)
Q Consensus       135 ~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~----  210 (329)
                      ..+ +|.|.+.  .+.-+...+..-|+.|++.||..+|.. ||+|+|||.+|||++..+=+.|+||...+...-..    
T Consensus       103 vkh-nLyDRlS--TRPFL~~iEKkWiaFQLL~al~qcH~~-gVcHGDIKsENILiTSWNW~~LtDFAsFKPtYLPeDNPa  178 (1431)
T KOG1240|consen  103 VKH-NLYDRLS--TRPFLVLIEKKWIAFQLLKALSQCHKL-GVCHGDIKSENILITSWNWLYLTDFASFKPTYLPEDNPA  178 (1431)
T ss_pred             Hhh-hhhhhhc--cchHHHHHHHHHHHHHHHHHHHHHHHc-CccccccccceEEEeeechhhhhcccccCCccCCCCCcc
Confidence            866 8999884  334456778888999999999999999 99999999999999999999999998766432111    


Q ss_pred             -------CccCcccccCcccccCC----------C-CCCcccchhhhHHHHHHHhCCCCCCchh-hHHHhhh---chhhh
Q 020221          211 -------SYSTNLAFTPPEYLRTG----------R-VTPESVMYSFGTLLLDLLSGKHIPPSHA-LDLIRDR---NIQTL  268 (329)
Q Consensus       211 -------~~~~~~~y~aPE~~~~~----------~-~~~~~DvwslG~il~el~tg~~~~~~~~-~~~~~~~---~~~~~  268 (329)
                             +...-..|.|||-+...          . .+++.||||+||++.||++-+.|.+.-. .-..+.+   .....
T Consensus       179 df~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~LSQL~aYr~~~~~~~e~~  258 (1431)
T KOG1240|consen  179 DFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFTLSQLLAYRSGNADDPEQL  258 (1431)
T ss_pred             cceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCcccHHHHHhHhccCccCHHHH
Confidence                   11223579999977531          2 6678999999999999999765543221 1111111   11111


Q ss_pred             ccccccCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHh
Q 020221          269 TDSCLEGQFSSDEGTELVRLASRCLQYEPRERPNPRSLVTALVT  312 (329)
Q Consensus       269 ~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~~~l~~L~~  312 (329)
                      ++.     ++   ...++.++..|++.||++|.+|++.|+.-..
T Consensus       259 Le~-----Ie---d~~~Rnlil~Mi~rdPs~RlSAedyL~~yrG  294 (1431)
T KOG1240|consen  259 LEK-----IE---DVSLRNLILSMIQRDPSKRLSAEDYLQKYRG  294 (1431)
T ss_pred             HHh-----Cc---CccHHHHHHHHHccCchhccCHHHHHHhhhc
Confidence            111     11   2368899999999999999999999987443

>KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms]

Probab=99.87  E-value=5.2e-22  Score=171.78  Aligned_cols=194  Identities=15%  Similarity=0.145  Sum_probs=145.5

Q ss_pred             CCccccccceeeee---------------------------CCeeEEEEecCCCCCHHhhhccCCCCCCCHHHHHHHHHH
Q 020221          111 RNRRLANLLGCCCE---------------------------GDERLLVAEYMPNDTLAKHLFHWETQPMKWAMRLRVALH  163 (329)
Q Consensus       111 ~h~niv~~~~~~~~---------------------------~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~  163 (329)
                      +|||||++.++|.+                           +..+|+||..++. +|..++   ..+..+......++.|
T Consensus       274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY~~-tLr~yl---~~~~~s~r~~~~~laQ  349 (598)
T KOG4158|consen  274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRYRQ-TLREYL---WTRHRSYRTGRVILAQ  349 (598)
T ss_pred             CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcchh-hHHHHH---hcCCCchHHHHHHHHH
Confidence            59999999988754                           2347899998866 899999   4456677778889999


Q ss_pred             HHHHHHHhhcCCCccccccCCCceeeC--CCC--CeeeecccCcccCCC----------CCCccCcccccCcccccCCC-
Q 020221          164 IAEALEYCTSKERALYHDLNAYRIVFD--DDV--NPRLSCFGLMKNSRD----------GRSYSTNLAFTPPEYLRTGR-  228 (329)
Q Consensus       164 i~~~l~~lH~~~~ivH~dlkp~Nil~~--~~~--~~kl~Dfg~a~~~~~----------~~~~~~~~~y~aPE~~~~~~-  228 (329)
                      +++|+.|||.. |+.|||+|.+|||+.  +++  .+.++|||++--...          .....|.-..||||+....+ 
T Consensus       350 lLEav~hL~~h-gvAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~ta~PG  428 (598)
T KOG4158|consen  350 LLEAVTHLHKH-GVAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEIATAVPG  428 (598)
T ss_pred             HHHHHHHHHHc-cchhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCCcceecchhhhhcCCC
Confidence            99999999999 999999999999993  444  478999998643221          12334667789999886332 


Q ss_pred             -----CCCcccchhhhHHHHHHHhCCCCCCchhhHHHhhhchhhhccccccCCCChHHHHHHHHHHHHhcccCCCCCCCH
Q 020221          229 -----VTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLASRCLQYEPRERPNP  303 (329)
Q Consensus       229 -----~~~~~DvwslG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~  303 (329)
                           --.++|.|+.|.+.||+++...||+...........    ....-.+..++.+++.+++++...|+.||.+|++.
T Consensus       429 p~avvny~kAD~WA~GalaYEIfg~~NPFY~rGem~L~~r~----Yqe~qLPalp~~vpp~~rqlV~~lL~r~pskRvsp  504 (598)
T KOG4158|consen  429 PNAVVNYEKADTWAAGALAYEIFGRSNPFYKRGEMLLDTRT----YQESQLPALPSRVPPVARQLVFDLLKRDPSKRVSP  504 (598)
T ss_pred             CceeeccchhhhhhhhhhHHHHhccCCcccccchheechhh----hhhhhCCCCcccCChHHHHHHHHHhcCCccccCCc
Confidence                 234899999999999999999988752111111111    11112234567788999999999999999999998


Q ss_pred             HHHHHHHHhh
Q 020221          304 RSLVTALVTL  313 (329)
Q Consensus       304 ~~~l~~L~~~  313 (329)
                      .-+.+.|+-.
T Consensus       505 ~iAANvl~Ls  514 (598)
T KOG4158|consen  505 NIAANVLNLS  514 (598)
T ss_pred             cHHHhHHHHH
Confidence            8777766543

>PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A

Probab=99.87  E-value=1.4e-22  Score=173.92  Aligned_cols=227  Identities=20%  Similarity=0.188  Sum_probs=144.9

Q ss_pred             cccCCCCCCcEEEEEEe-CCCCEEEEEEeCCCCCh---hHHHHHHHHHHHhcCCC----------ccccccceeee----
Q 020221           62 VSEHGEKAPNVVYKGKL-ENQFRIAVKRFNRSAWP---DARQFLEEARAVGQLRN----------RRLANLLGCCC----  123 (329)
Q Consensus        62 ~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~---~~~~~~~e~~~l~~l~h----------~niv~~~~~~~----  123 (329)
                      .+.||.|+++.||.++. .+++.+|+|++......   ..+++.+|......+.+          -.++.-++...    
T Consensus        17 ~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~~i~~~   96 (288)
T PF14531_consen   17 GRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLLRIPGK   96 (288)
T ss_dssp             EEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEEEETTS
T ss_pred             ccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEEEEcCC
Confidence            34579999999999994 56899999998654422   35566777665555432          12222222211    


Q ss_pred             -----eCC--------eeEEEEecCCCCCHHhhhcc---CCC--CCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCC
Q 020221          124 -----EGD--------ERLLVAEYMPNDTLAKHLFH---WET--QPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAY  185 (329)
Q Consensus       124 -----~~~--------~~~lv~e~~~~gsL~~~l~~---~~~--~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~  185 (329)
                           ...        +.+++|+-+.+ +|.+++.-   ...  ..+....+..+..|+++.+++||+. |++|+||+|+
T Consensus        97 ~~~~~~~~~~~~~~v~n~~~l~P~~~~-dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~~-GlVHgdi~~~  174 (288)
T PF14531_consen   97 PPFFERGPGQSIYWVLNRFLLMPRAQG-DLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHSY-GLVHGDIKPE  174 (288)
T ss_dssp             -SEEEECETTEEEEEESEEEEEE--SE-EHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHT-TEEEST-SGG
T ss_pred             CcceecCCCCccceeehhhhccchhhh-cHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhhc-ceEeccccee
Confidence                 111        34678887744 88877531   111  1233455677779999999999999 9999999999


Q ss_pred             ceeeCCCCCeeeecccCcccCCCCCC-ccCcccccCcccccC--------CCCCCcccchhhhHHHHHHHhCCCCCCchh
Q 020221          186 RIVFDDDVNPRLSCFGLMKNSRDGRS-YSTNLAFTPPEYLRT--------GRVTPESVMYSFGTLLLDLLSGKHIPPSHA  256 (329)
Q Consensus       186 Nil~~~~~~~kl~Dfg~a~~~~~~~~-~~~~~~y~aPE~~~~--------~~~~~~~DvwslG~il~el~tg~~~~~~~~  256 (329)
                      |++++.+|.+.|+||+.......... ...+..|.+||....        ..++.+.|.|+||+++|.|+++..|+....
T Consensus       175 nfll~~~G~v~Lg~F~~~~r~g~~~~~~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly~lWC~~lPf~~~~  254 (288)
T PF14531_consen  175 NFLLDQDGGVFLGDFSSLVRAGTRYRCSEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITLYSLWCGRLPFGLSS  254 (288)
T ss_dssp             GEEE-TTS-EEE--GGGEEETTEEEEGGGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHHHHHHSS-STCCCG
T ss_pred             eEEEcCCCCEEEcChHHHeecCceeeccCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHHHHHHHccCCCCCCC
Confidence            99999999999999998765544333 344577999997643        237889999999999999999998875432


Q ss_pred             hHHHhhhchhhhccccccCCCChHHHHHHHHHHHHhcccCCCCC
Q 020221          257 LDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLASRCLQYEPRER  300 (329)
Q Consensus       257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~R  300 (329)
                      .......    .    . ..+. +.|+.++.||..+|+.||++|
T Consensus       255 ~~~~~~~----~----f-~~C~-~~Pe~v~~LI~~lL~~~~~~R  288 (288)
T PF14531_consen  255 PEADPEW----D----F-SRCR-DMPEPVQFLIRGLLQRNPEDR  288 (288)
T ss_dssp             GGSTSGG----G----G-TTSS----HHHHHHHHHHT-SSGGGS
T ss_pred             ccccccc----c----c-hhcC-CcCHHHHHHHHHHccCCcccC
Confidence            1111111    1    1 1233 788999999999999999988

>PRK10345 hypothetical protein; Provisional

Probab=99.86  E-value=5.4e-21  Score=158.78  Aligned_cols=133  Identities=14%  Similarity=0.104  Sum_probs=104.1

Q ss_pred             ccCCCCCCcEEEEEEeCCCCEEEEEEeCCCCChhHHHHHHHHHHHhcC-----CCccccccceeeeeCC---e-eEEEEe
Q 020221           63 SEHGEKAPNVVYKGKLENQFRIAVKRFNRSAWPDARQFLEEARAVGQL-----RNRRLANLLGCCCEGD---E-RLLVAE  133 (329)
Q Consensus        63 ~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-----~h~niv~~~~~~~~~~---~-~~lv~e  133 (329)
                      ..||+|+||.||. ...++. .+||++........+.+.+|++.++.+     +||||++++|++.+..   . +.+|+|
T Consensus         8 ~~LG~G~~~~Vy~-hp~~~~-k~IKv~~~~~~~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v~~~I~e   85 (210)
T PRK10345          8 SPLGTGRHRKCYA-HPEDAQ-RCIKIVYHRGDGGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYVYDVIAD   85 (210)
T ss_pred             ceecCCCceEEEE-CCCCcC-eEEEEEeccccchHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEEEEEEec
Confidence            3459999999996 323343 479998776544567799999999999     5799999999998763   3 337899


Q ss_pred             c--CCCCCHHhhhccCCCCCCCHHHHHHHHHHHHHHH-HHhhcCCCccccccCCCceeeCC----CCCeeeecccCc
Q 020221          134 Y--MPNDTLAKHLFHWETQPMKWAMRLRVALHIAEAL-EYCTSKERALYHDLNAYRIVFDD----DVNPRLSCFGLM  203 (329)
Q Consensus       134 ~--~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l-~~lH~~~~ivH~dlkp~Nil~~~----~~~~kl~Dfg~a  203 (329)
                      |  +.+++|.+++.+   ..+++.  ..++.+++.++ +|||+. +|+||||||+|||++.    +..++|+||+.+
T Consensus        86 ~~G~~~~tL~~~l~~---~~~~e~--~~~~~~~L~~l~~yLh~~-~IvhrDlKp~NILl~~~~~~~~~~~LiDg~G~  156 (210)
T PRK10345         86 FDGKPSITLTEFAEQ---CRYEED--VAQLRQLLKKLKRYLLDN-RIVTMELKPQNILCQRISESEVIPVVCDNIGE  156 (210)
T ss_pred             CCCCcchhHHHHHHc---ccccHh--HHHHHHHHHHHHHHHHHC-CEeecCCCHHHEEEeccCCCCCcEEEEECCCC
Confidence            9  557999999953   345555  35678888887 999999 9999999999999973    347999995543

>PRK12274 serine/threonine protein kinase; Provisional

Probab=99.85  E-value=7.4e-21  Score=155.35  Aligned_cols=177  Identities=15%  Similarity=0.093  Sum_probs=133.1

Q ss_pred             ccCCCCCCcEEEEEEeCCCCEEEEEEeCCCCChh----HHHHHHHHHHHhcCC-CccccccceeeeeCCeeEEEEecCCC
Q 020221           63 SEHGEKAPNVVYKGKLENQFRIAVKRFNRSAWPD----ARQFLEEARAVGQLR-NRRLANLLGCCCEGDERLLVAEYMPN  137 (329)
Q Consensus        63 ~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~----~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~~~~lv~e~~~~  137 (329)
                      ..+++|+||+||.+.. .+.+++.+.+.....-.    ...+.+|+++|+.+. |+++++++++    +..+++|||+.|
T Consensus         8 ~~l~~~~f~~v~~~~~-~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~----~~~~lvmeyI~G   82 (218)
T PRK12274          8 EPLKSDTFGRILLVRG-GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW----DGRHLDRSYLAG   82 (218)
T ss_pred             eeecCCCcceEEEeec-CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE----cCEEEEEeeecC
Confidence            4569999999997776 56688888877655421    124789999999995 5889998886    346999999999


Q ss_pred             CCHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccc-CCCceeeCCCCCeeeecccCcccCCCCCCc----
Q 020221          138 DTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDL-NAYRIVFDDDVNPRLSCFGLMKNSRDGRSY----  212 (329)
Q Consensus       138 gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dl-kp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~----  212 (329)
                      .+|...+.   .      ....++.|++.+|.++|+. |++|||| ||+|||++.++.++|+|||++.........    
T Consensus        83 ~~L~~~~~---~------~~~~~~~qi~~~L~~lH~~-GIvHrDL~kp~NILv~~~g~i~LIDFG~A~~~~~~~~~~r~L  152 (218)
T PRK12274         83 AAMYQRPP---R------GDLAYFRAARRLLQQLHRC-GVAHNDLAKEANWLVQEDGSPAVIDFQLAVRGNPRARWMRLL  152 (218)
T ss_pred             ccHHhhhh---h------hhHHHHHHHHHHHHHHHHC-cCccCCCCCcceEEEcCCCCEEEEECCCceecCCcchHHHHH
Confidence            88865431   1      1135778999999999999 9999999 799999999999999999999865543311    


Q ss_pred             -------------cCcccccCcccccCC-CCC-CcccchhhhHHHHHHHhCCCCCCc
Q 020221          213 -------------STNLAFTPPEYLRTG-RVT-PESVMYSFGTLLLDLLSGKHIPPS  254 (329)
Q Consensus       213 -------------~~~~~y~aPE~~~~~-~~~-~~~DvwslG~il~el~tg~~~~~~  254 (329)
                                   ..++.|+.|+...-. ..+ ...+.++-|..+|.++|++.+...
T Consensus       153 ~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~~  209 (218)
T PRK12274        153 AREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLHWE  209 (218)
T ss_pred             HHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCccc
Confidence                         124556666533221 222 456888999999999999976543

>KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=99.85  E-value=4.7e-21  Score=186.08  Aligned_cols=240  Identities=17%  Similarity=0.136  Sum_probs=173.0

Q ss_pred             ccccccCCCCCCcEEEEEEeCCCCEEEEEEeCCCCChhHHHHHHHHHHHhcCC---CccccccceeeeeCCeeEEEEecC
Q 020221           59 ENIVSEHGEKAPNVVYKGKLENQFRIAVKRFNRSAWPDARQFLEEARAVGQLR---NRRLANLLGCCCEGDERLLVAEYM  135 (329)
Q Consensus        59 ~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~---h~niv~~~~~~~~~~~~~lv~e~~  135 (329)
                      +.+-+.+|+|+||+||.|...+|+.||+|+-+....-.   |---.+++.+|+   -+.|..+..++.-.+.-++|+||.
T Consensus       700 ~~I~~e~G~g~y~~vy~a~~~~~~~~alK~e~P~~~WE---fYI~~q~~~RLk~~~~~~~~~~~~a~~~~~~S~lv~ey~  776 (974)
T KOG1166|consen  700 FCISKEIGEGSYGSVYVATHSNGKLVALKVEKPPNPWE---FYICLQVMERLKPQMLPSIMHISSAHVFQNASVLVSEYS  776 (974)
T ss_pred             EEEEeeeccccceEEEEeecCCCcEEEEEeecCCCcee---eeehHHHHHhhchhhhcchHHHHHHHccCCcceeeeecc
Confidence            44567789999999999997779999999987655322   111123333443   344555666666667789999999


Q ss_pred             CCCCHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeC-------CCCCeeeecccCccc---
Q 020221          136 PNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFD-------DDVNPRLSCFGLMKN---  205 (329)
Q Consensus       136 ~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~-------~~~~~kl~Dfg~a~~---  205 (329)
                      +.|||.+++.  ..+.+++.....++.||+..++.||.. +|||+||||+|+++.       +...++|+|||.+..   
T Consensus       777 ~~Gtlld~~N--~~~~m~e~lv~~~~~qml~ive~lH~~-~IIHgDiKPDNfll~~~~~~~~~~~~l~lIDfG~siDm~l  853 (974)
T KOG1166|consen  777 PYGTLLDLIN--TNKVMDEYLVMFFSCQMLRIVEHLHAM-GIIHGDIKPDNFLLRREICADSDSKGLYLIDFGRSIDMKL  853 (974)
T ss_pred             ccccHHHhhc--cCCCCCchhhhHHHHHHHHHHHHHHhc-ceecccCCcceeEeecccCCCCcccceEEEecccceeeeE
Confidence            9999999995  667789999999999999999999999 999999999999993       345699999998854   


Q ss_pred             CCCCCC---ccCcccccCcccccCCCCCCcccchhhhHHHHHHHhCCCCCCchhhHHHhhhchhhhccccccCCCChHHH
Q 020221          206 SRDGRS---YSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEG  282 (329)
Q Consensus       206 ~~~~~~---~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  282 (329)
                      +.++..   ..+|-.+-.+|+..|..++.++|.|+|+.+++.|+.|+..-       ..++....+... ++..+..+  
T Consensus       854 fp~~~~F~~~~~td~f~C~EM~~grpWtYq~DyfGlAa~~h~mLFG~y~q-------~~~g~~~~~~~~-~~Ry~~~~--  923 (974)
T KOG1166|consen  854 FPDGTKFKAVWHTDLFDCIEMREGRPWTYQIDYFGLAATVHVMLFGKYME-------VKNGSSWMVKTN-FPRYWKRD--  923 (974)
T ss_pred             cCCCcEEeeeeccccchhHHHhcCCCCchhhhhHHHHHHHHHHHHHHHHH-------hcCCcceecccc-chhhhhHH--
Confidence            334422   34578899999999999999999999999999999998321       111111111111 11112222  


Q ss_pred             HHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhh
Q 020221          283 TELVRLASRCLQYEPRERPNPRSLVTALVTLQK  315 (329)
Q Consensus       283 ~~~~~li~~cl~~dp~~Rps~~~~l~~L~~~~~  315 (329)
                       -+-++...+|+.|-..=|...++...|+....
T Consensus       924 -~W~~~F~~lLN~~~~~~p~l~~lr~~~~~~~~  955 (974)
T KOG1166|consen  924 -MWNKFFDLLLNPDCDTLPNLQELRTELEEVLA  955 (974)
T ss_pred             -HHHHHHHHHhCcCcccchhHHHHHHHHHHHHH
Confidence             34455666666555555777777777776543

>smart00090 RIO RIO-like kinase

Probab=99.83  E-value=8.9e-20  Score=155.08  Aligned_cols=142  Identities=15%  Similarity=0.102  Sum_probs=109.7

Q ss_pred             cccccccCCCCCCcEEEEEE--eCCCCEEEEEEeCCCCCh-------------------h-----HHHHHHHHHHHhcCC
Q 020221           58 MENIVSEHGEKAPNVVYKGK--LENQFRIAVKRFNRSAWP-------------------D-----ARQFLEEARAVGQLR  111 (329)
Q Consensus        58 ~~~~~~~lg~G~~g~V~~~~--~~~~~~vavK~~~~~~~~-------------------~-----~~~~~~e~~~l~~l~  111 (329)
                      .+.+.+.||+|++|.||+|.  ..+|+.||+|+++.....                   .     ...+.+|++.+..+.
T Consensus        29 ~~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~L~  108 (237)
T smart00090       29 LSAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQRLY  108 (237)
T ss_pred             hHHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHHHH
Confidence            45667778999999999998  568999999998754311                   0     122567999999997


Q ss_pred             Ccc--ccccceeeeeCCeeEEEEecCCCCCHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCC-ccccccCCCcee
Q 020221          112 NRR--LANLLGCCCEGDERLLVAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKER-ALYHDLNAYRIV  188 (329)
Q Consensus       112 h~n--iv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~-ivH~dlkp~Nil  188 (329)
                      +.+  +.+.++.    ...++||||+++++|.....  ....+.......++.|++.++.+||.. | ++|+||||+||+
T Consensus       109 ~~~i~~p~~~~~----~~~~lV~E~~~g~~L~~~~~--~~~~~~~~~~~~i~~qi~~~l~~LH~~-g~iiH~Dikp~NIl  181 (237)
T smart00090      109 EAGVPVPKPIAW----RRNVLVMEFIGGDGLPAPRL--KDVEPEEEEEFELYDDILEEMRKLYKE-GELVHGDLSEYNIL  181 (237)
T ss_pred             hcCCCCCeeeEe----cCceEEEEEecCCccccccc--ccCCcchHHHHHHHHHHHHHHHHHHhc-CCEEeCCCChhhEE
Confidence            533  3333332    23589999999988876543  233456667789999999999999999 8 999999999999


Q ss_pred             eCCCCCeeeecccCcccCC
Q 020221          189 FDDDVNPRLSCFGLMKNSR  207 (329)
Q Consensus       189 ~~~~~~~kl~Dfg~a~~~~  207 (329)
                      ++ ++.++|+|||.+....
T Consensus       182 i~-~~~i~LiDFg~a~~~~  199 (237)
T smart00090      182 VH-DGKVVIIDVSQSVELD  199 (237)
T ss_pred             EE-CCCEEEEEChhhhccC
Confidence            99 8899999999987543

>PRK14879 serine/threonine protein kinase; Provisional

Probab=99.82  E-value=2.6e-19  Score=150.37  Aligned_cols=134  Identities=16%  Similarity=0.168  Sum_probs=111.9

Q ss_pred             ccCCCCCCcEEEEEEeCCCCEEEEEEeCCCCChh--------HHHHHHHHHHHhcCCCccccccceeeeeCCeeEEEEec
Q 020221           63 SEHGEKAPNVVYKGKLENQFRIAVKRFNRSAWPD--------ARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAEY  134 (329)
Q Consensus        63 ~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~--------~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  134 (329)
                      +.||+|++|.||+|.. ++..+++|+........        ...+.+|+.++..+.|+++.....++......+++|||
T Consensus         2 ~~l~~G~~~~vy~~~~-~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~   80 (211)
T PRK14879          2 KLIKRGAEAEIYLGDF-LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPENFIIVMEY   80 (211)
T ss_pred             cccccCceEEEEEEee-CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCCCCEEEEEE
Confidence            4579999999999987 55679999866432211        23467899999999999988877777777888999999


Q ss_pred             CCCCCHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCCCCCeeeecccCccc
Q 020221          135 MPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKN  205 (329)
Q Consensus       135 ~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~  205 (329)
                      ++|++|.+.+..     ..+ ....++.+++.+|.++|.. +++|+|++|.||+++ ++.++++|||.+..
T Consensus        81 ~~G~~L~~~~~~-----~~~-~~~~i~~~i~~~l~~lH~~-~i~H~Dl~p~Nil~~-~~~~~liDf~~a~~  143 (211)
T PRK14879         81 IEGEPLKDLINS-----NGM-EELELSREIGRLVGKLHSA-GIIHGDLTTSNMILS-GGKIYLIDFGLAEF  143 (211)
T ss_pred             eCCcCHHHHHHh-----ccH-HHHHHHHHHHHHHHHHHhC-CcccCCCCcccEEEE-CCCEEEEECCcccC
Confidence            999999998853     112 7889999999999999999 999999999999999 78999999998764

>KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis]

Probab=99.81  E-value=1.8e-20  Score=168.00  Aligned_cols=168  Identities=23%  Similarity=0.349  Sum_probs=126.6

Q ss_pred             eeEEEEecCCCCCHHhhhccC-CCCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCCCCCeeeecccCccc
Q 020221          127 ERLLVAEYMPNDTLAKHLFHW-ETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKN  205 (329)
Q Consensus       127 ~~~lv~e~~~~gsL~~~l~~~-~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~  205 (329)
                      .++|.|++|...+|.+++.++ .....++...+.++.|++.|+.|   + +.+|+|+||.||++..+..+||+|||+...
T Consensus       330 ~lyI~Mn~c~~~tledWl~rr~~~e~~s~s~~~~~~~q~~~~~~y---k-~~ihrdlkp~nif~~~d~q~kIgDFgl~ts  405 (516)
T KOG1033|consen  330 YLYIQMNLCEKETLEDWLRRRRTGEERSLSLMLDIFKQIAPAVEY---K-GLIHRDLKPSNIFFSDDDQLKIGDFGLVTS  405 (516)
T ss_pred             chhhhhhhhhhhhHHHHhhCCCcccccchhHHHHHHHhhccchhh---c-cchhhhccccccccccchhhhhhhhhheee
Confidence            578999999999999999743 34556888999999999999999   7 899999999999999999999999999875


Q ss_pred             CCCCC----------CccCcccccCcccccCCCCCCcccchhhhHHHHHHHhCCCCCCchhhHHHhhhchhhhccccccC
Q 020221          206 SRDGR----------SYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEG  275 (329)
Q Consensus       206 ~~~~~----------~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~  275 (329)
                      .....          ...||..||+||.+.+..|+.++||||||++|+||++--   .-.   .........+.+..+.+
T Consensus       406 ~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~y~~kvdIyaLGlil~EL~~~f---~T~---~er~~t~~d~r~g~ip~  479 (516)
T KOG1033|consen  406 QDKDETVAPAAASHTQQVGTLLYMSPEQIRGQQYSEKVDIYALGLILAELLIQF---STQ---FERIATLTDIRDGIIPP  479 (516)
T ss_pred             cccCCcccchhhhhhhcccccccCCHHHHhhhhhhhhcchhhHHHHHHHHHHHh---ccH---HHHHHhhhhhhcCCCCh
Confidence            54433          346899999999999999999999999999999999721   100   01111122222222111


Q ss_pred             CCChHHHHHHHHHHHHhcccCCCCCCCHHH
Q 020221          276 QFSSDEGTELVRLASRCLQYEPRERPNPRS  305 (329)
Q Consensus       276 ~~~~~~~~~~~~li~~cl~~dp~~Rps~~~  305 (329)
                      .+..+ -+.-..|+.+++...|.+||++.+
T Consensus       480 ~~~~d-~p~e~~ll~~lls~~p~~RP~~~~  508 (516)
T KOG1033|consen  480 EFLQD-YPEEYTLLQQLLSPSPEERPSAIE  508 (516)
T ss_pred             HHhhc-CcHHHHHHHHhcCCCcccCchHHH
Confidence            11111 123457999999999999994433

>KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only]

Probab=99.81  E-value=4.7e-20  Score=176.57  Aligned_cols=201  Identities=18%  Similarity=0.179  Sum_probs=144.4

Q ss_pred             ccccccCCCCCCcEEEEEEeC-CCCEEEEEEeCCCCChhHHHHHHHHHHHhcCCCccccccceeeeeCCeeEEEEecCCC
Q 020221           59 ENIVSEHGEKAPNVVYKGKLE-NQFRIAVKRFNRSAWPDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAEYMPN  137 (329)
Q Consensus        59 ~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~  137 (329)
                      ++.|+.+..|+||-||..+++ +.+++|+|+ ++..     -+.+.  ++.....|               +.|      
T Consensus        85 f~~IklisngAygavylvrh~~trqrfa~ki-Nkq~-----lilRn--ilt~a~np---------------fvv------  135 (1205)
T KOG0606|consen   85 FNTIKLISNGAYGAVYLVRHKETRQRFAMKI-NKQN-----LILRN--ILTFAGNP---------------FVV------  135 (1205)
T ss_pred             cceeEeeccCCCCceeeeeccccccchhhcc-cccc-----hhhhc--cccccCCc---------------cee------
Confidence            445666699999999999854 567899944 3221     11111  22222222               222      


Q ss_pred             CCHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCCCCCeeeecccCcccCC----------
Q 020221          138 DTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSR----------  207 (329)
Q Consensus       138 gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~----------  207 (329)
                      |+=...+.  ....++.        +++.+++|||+. ||+|||+||+|.+|+.-|++|++|||+.+..-          
T Consensus       136 gDc~tllk--~~g~lPv--------dmvla~Eylh~y-givhrdlkpdnllIT~mGhiKlTDfgLsk~GLms~atnl~eg  204 (1205)
T KOG0606|consen  136 GDCATLLK--NIGPLPV--------DMVLAVEYLHSY-GIVHRDLKPDNLLITSMGHIKLTDFGLSKKGLMSLATNLKEG  204 (1205)
T ss_pred             chhhhhcc--cCCCCcc--------hhhHHhHhhccC-CeecCCCCCCcceeeecccccccchhhhhhhhhhccchhhhc
Confidence            23333343  2233443        237899999999 99999999999999999999999999976321          


Q ss_pred             ---------CCCCccCcccccCcccccCCCCCCcccchhhhHHHHHHHhCCCCCCchhhHHHhhhchhhhccccccCCCC
Q 020221          208 ---------DGRSYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFS  278 (329)
Q Consensus       208 ---------~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  278 (329)
                               ......||+.|+|||++....|...+|+|++|+|+||.+.|..||..+.-+.+....+...+.-   .+-.
T Consensus       205 ~I~k~t~Ef~dKqvcgTPeyiaPeVilrqgygkpvdwwamGiIlyeFLVgcvpffGdtpeelfg~visd~i~w---pE~d  281 (1205)
T KOG0606|consen  205 HIEKDTHEFQDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVISDDIEW---PEED  281 (1205)
T ss_pred             chHHHHHHhhhccccCCccccChhhhhhhccCCCccHHHHHHHHHHHheeeeeccCCCHHHHHhhhhhhhccc---cccC
Confidence                     1123478999999999999999999999999999999999999999887666665555444321   1123


Q ss_pred             hHHHHHHHHHHHHhcccCCCCCCC
Q 020221          279 SDEGTELVRLASRCLQYEPRERPN  302 (329)
Q Consensus       279 ~~~~~~~~~li~~cl~~dp~~Rps  302 (329)
                      ...++++++++.++|..+|..|.-
T Consensus       282 ea~p~Ea~dli~~LL~qnp~~Rlg  305 (1205)
T KOG0606|consen  282 EALPPEAQDLIEQLLRQNPLCRLG  305 (1205)
T ss_pred             cCCCHHHHHHHHHHHHhChHhhcc
Confidence            445789999999999999999963

>TIGR03724 arch_bud32 Kae1-associated kinase Bud32

Probab=99.79  E-value=3.9e-19  Score=147.92  Aligned_cols=129  Identities=18%  Similarity=0.208  Sum_probs=105.3

Q ss_pred             CCCCCCcEEEEEEeCCCCEEEEEEeCCCCCh--------hHHHHHHHHHHHhcCCCccccccceeeeeCCeeEEEEecCC
Q 020221           65 HGEKAPNVVYKGKLENQFRIAVKRFNRSAWP--------DARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAEYMP  136 (329)
Q Consensus        65 lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~--------~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~  136 (329)
                      ||+|+||.||++.+ ++..+++|........        ....+.+|++++..++|+++.....++......+++|||++
T Consensus         2 ig~G~~~~vy~~~~-~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~~~   80 (199)
T TIGR03724         2 IAKGAEAIIYLGDF-LGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPDNKTIVMEYIE   80 (199)
T ss_pred             CCCCceEEEEEeec-CCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECCCCEEEEEEEC
Confidence            69999999999996 4568999986543211        12456789999999998876665555666677899999999


Q ss_pred             CCCHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCCCCCeeeecccCccc
Q 020221          137 NDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKN  205 (329)
Q Consensus       137 ~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~  205 (329)
                      |++|.+.+...   ..      .++.+++.+|.+||+. +++|+|++|.||+++ ++.++++|||++..
T Consensus        81 g~~l~~~~~~~---~~------~~~~~i~~~l~~lH~~-gi~H~Dl~~~Nil~~-~~~~~liDfg~a~~  138 (199)
T TIGR03724        81 GKPLKDVIEEG---ND------ELLREIGRLVGKLHKA-GIVHGDLTTSNIIVR-DDKLYLIDFGLGKY  138 (199)
T ss_pred             CccHHHHHhhc---HH------HHHHHHHHHHHHHHHC-CeecCCCCcceEEEE-CCcEEEEECCCCcC
Confidence            99999887421   11      7899999999999999 999999999999999 89999999999865

Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine.

>cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain

Probab=99.78  E-value=1.7e-18  Score=143.89  Aligned_cols=137  Identities=17%  Similarity=0.127  Sum_probs=106.5

Q ss_pred             ccccccCCCCCCcEEEEEEeCCCCEEEEEEeCCCCCh----------------------hHHHHHHHHHHHhcCCCcc--
Q 020221           59 ENIVSEHGEKAPNVVYKGKLENQFRIAVKRFNRSAWP----------------------DARQFLEEARAVGQLRNRR--  114 (329)
Q Consensus        59 ~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~----------------------~~~~~~~e~~~l~~l~h~n--  114 (329)
                      +.+.+.||.|+||.||++...+|+.||||+++.....                      .......|...+..+.|++  
T Consensus        17 ~~~~~~i~~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~   96 (198)
T cd05144          17 ESLGNQIGVGKESDVYLALDPDGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALKALYEEGFP   96 (198)
T ss_pred             hhcCCccccCcceEEEEEEcCCCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHHHHHHcCCC
Confidence            4556678999999999999878999999987653211                      0112567888888887774  


Q ss_pred             ccccceeeeeCCeeEEEEecCCCCCHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCCCCC
Q 020221          115 LANLLGCCCEGDERLLVAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVN  194 (329)
Q Consensus       115 iv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~  194 (329)
                      +...++    ....+++|||+++++|.....        ......++.+++.++.++|.. |++|+||||+||++++++.
T Consensus        97 v~~~~~----~~~~~lv~e~~~g~~L~~~~~--------~~~~~~~~~~i~~~l~~lh~~-gi~H~Dl~p~Nill~~~~~  163 (198)
T cd05144          97 VPKPID----WNRHAVVMEYIDGVELYRVRV--------LEDPEEVLDEILEEIVKAYKH-GIIHGDLSEFNILVDDDEK  163 (198)
T ss_pred             CCceee----cCCceEEEEEeCCcchhhccc--------cccHHHHHHHHHHHHHHHHHC-CCCcCCCCcccEEEcCCCc
Confidence            333333    245689999999998876542        034567889999999999999 9999999999999999999


Q ss_pred             eeeecccCcccCCC
Q 020221          195 PRLSCFGLMKNSRD  208 (329)
Q Consensus       195 ~kl~Dfg~a~~~~~  208 (329)
                      ++|+|||.+.....
T Consensus       164 ~~liDfg~~~~~~~  177 (198)
T cd05144         164 IYIIDWPQMVSTDH  177 (198)
T ss_pred             EEEEECCccccCCC
Confidence            99999999865443

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom

>PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated

Probab=99.78  E-value=2e-18  Score=164.24  Aligned_cols=132  Identities=18%  Similarity=0.162  Sum_probs=106.9

Q ss_pred             ccccCCCCCCcEEEEEEeCCCCEEEEEE-eCCC-CC------hhHHHHHHHHHHHhcCCCccccccceeeeeCCeeEEEE
Q 020221           61 IVSEHGEKAPNVVYKGKLENQFRIAVKR-FNRS-AW------PDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVA  132 (329)
Q Consensus        61 ~~~~lg~G~~g~V~~~~~~~~~~vavK~-~~~~-~~------~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~  132 (329)
                      ..+.||+|+||+||++.+.+.. +++|+ +... ..      ...+.+.+|+++++.++|++++....++......++||
T Consensus       337 ~~~~iG~G~~g~Vy~~~~~~~~-~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~  415 (535)
T PRK09605        337 PDHLIGKGAEADIKKGEYLGRD-AVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDVDPEEKTIVM  415 (535)
T ss_pred             ccceeccCCcEEEEEEeecCcc-ceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEeCCCCEEEE
Confidence            3456799999999999875543 44443 2221 11      11245788999999999999988777777777889999


Q ss_pred             ecCCCCCHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCCCCCeeeecccCccc
Q 020221          133 EYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKN  205 (329)
Q Consensus       133 e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~  205 (329)
                      ||+++++|.+++.          ....++.+++.+|.+||+. +++|||+||+||++ .++.++|+|||+++.
T Consensus       416 E~~~g~~L~~~l~----------~~~~~~~~i~~~L~~lH~~-giiHrDlkp~NILl-~~~~~~liDFGla~~  476 (535)
T PRK09605        416 EYIGGKDLKDVLE----------GNPELVRKVGEIVAKLHKA-GIVHGDLTTSNFIV-RDDRLYLIDFGLGKY  476 (535)
T ss_pred             EecCCCcHHHHHH----------HHHHHHHHHHHHHHHHHhC-CCccCCCChHHEEE-ECCcEEEEeCccccc
Confidence            9999999999873          4567899999999999999 99999999999999 678999999999865

>KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.75  E-value=2.5e-19  Score=170.37  Aligned_cols=248  Identities=13%  Similarity=0.117  Sum_probs=187.7

Q ss_pred             CcccccccCCCCCCcEEEEEEe--CCCCEEEEEEeCCCC--ChhHHHHHHHHHHHhcCC-CccccccceeeeeCCeeEEE
Q 020221           57 AMENIVSEHGEKAPNVVYKGKL--ENQFRIAVKRFNRSA--WPDARQFLEEARAVGQLR-NRRLANLLGCCCEGDERLLV  131 (329)
Q Consensus        57 ~~~~~~~~lg~G~~g~V~~~~~--~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~~~~lv  131 (329)
                      ..+++++.+|+|+|+.|-....  +....+|+|.+....  .........|..+-..+. |+|++.+++....+...+++
T Consensus        20 ~~~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~~~~~~   99 (601)
T KOG0590|consen   20 SQYKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPPKSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSPRSYLLS   99 (601)
T ss_pred             ccccccccccccccchhhhhhhcCCCcceeeccCCCCCCCccchhhhcCccccccccccccccccccCCccCCCcccccc
Confidence            4466777789999999988874  334557777665543  222334455777777776 99999999999999999999


Q ss_pred             EecCCCCCHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhh-cCCCccccccCCCceeeCCCC-CeeeecccCcccCCC-
Q 020221          132 AEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCT-SKERALYHDLNAYRIVFDDDV-NPRLSCFGLMKNSRD-  208 (329)
Q Consensus       132 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH-~~~~ivH~dlkp~Nil~~~~~-~~kl~Dfg~a~~~~~-  208 (329)
                      .+|..++++.+-+........+....-.++.|+..++.|+| .. ++.|+|+||+|.+++..+ .++++|||+|..... 
T Consensus       100 ~~~s~g~~~f~~i~~~~~~~~~~~~~~~~~~ql~s~l~~~H~~~-~~~h~~ikP~n~~l~~s~~~l~~~df~~At~~~~~  178 (601)
T KOG0590|consen  100 LSYSDGGSLFSKISHPDSTGTSSSSASRYLPQLNSGLSYLHPEN-GVTHRDIKPSNSLLDESGSALKIADFGLATAYRNK  178 (601)
T ss_pred             cCcccccccccccccCCccCCCCcchhhhhhhhccCccccCccc-ccccCCCCCccchhccCCCcccCCCchhhcccccc
Confidence            99999999988773212225667778899999999999999 77 999999999999999999 999999999987666 


Q ss_pred             CC------CccC-cccccCcccccCC-CCCCcccchhhhHHHHHHHhCCCCCCchhhHHHhhhchhhhccccc--cCCCC
Q 020221          209 GR------SYST-NLAFTPPEYLRTG-RVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCL--EGQFS  278 (329)
Q Consensus       209 ~~------~~~~-~~~y~aPE~~~~~-~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~  278 (329)
                      ..      ...| ++.|+|||...+. ......|+||.|+++..+++|..|+.......   ...........  .....
T Consensus       179 ~g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~---~~~~~~~~~~~~~~~~~~  255 (601)
T KOG0590|consen  179 NGAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKD---GRYSSWKSNKGRFTQLPW  255 (601)
T ss_pred             CCcceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCcccccccc---ccceeecccccccccCcc
Confidence            21      2356 8999999999885 45668999999999999999998764432211   11111111111  11223


Q ss_pred             hHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 020221          279 SDEGTELVRLASRCLQYEPRERPNPRSLVT  308 (329)
Q Consensus       279 ~~~~~~~~~li~~cl~~dp~~Rps~~~~l~  308 (329)
                      ...+....+++..++..+|+.|.+.+++..
T Consensus       256 ~~~~~~~~~~l~k~l~~~~~~r~s~~~~~~  285 (601)
T KOG0590|consen  256 NSISDQAHDLLHKILKENPSNRLSIEELKL  285 (601)
T ss_pred             ccCChhhhhcccccccCCchhccccccccc
Confidence            455677889999999999999999888765

>cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family

Probab=99.73  E-value=1.2e-17  Score=132.01  Aligned_cols=134  Identities=15%  Similarity=0.041  Sum_probs=111.7

Q ss_pred             cccCCCCCCcEEEEEEeCCCCEEEEEEeCCCCChhHHHHHHHHHHHhcCCC--ccccccceeeeeCCeeEEEEecCCCCC
Q 020221           62 VSEHGEKAPNVVYKGKLENQFRIAVKRFNRSAWPDARQFLEEARAVGQLRN--RRLANLLGCCCEGDERLLVAEYMPNDT  139 (329)
Q Consensus        62 ~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h--~niv~~~~~~~~~~~~~lv~e~~~~gs  139 (329)
                      ++.+|.|.++.||++...+ ..+++|.......  ...+.+|+..+..++|  .++++++++....+..++++||+.+++
T Consensus         3 ~~~i~~g~~~~v~~~~~~~-~~~~iK~~~~~~~--~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~~v~e~~~g~~   79 (155)
T cd05120           3 IKLLKGGLTNRVYLLGTKD-EDYVLKINPSREK--GADREREVAILQLLARKGLPVPKVLASGESDGWSYLLMEWIEGET   79 (155)
T ss_pred             ceecccccccceEEEEecC-CeEEEEecCCCCc--hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCccEEEEEecCCee
Confidence            4567999999999999755 6899999876543  4568889999999976  588888888877788999999998876


Q ss_pred             HHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcC--CCccccccCCCceeeCCCCCeeeecccCcccCC
Q 020221          140 LAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSK--ERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSR  207 (329)
Q Consensus       140 L~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~--~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~  207 (329)
                      +..+         +......++.+++.+++++|..  .+++|+|++|+||+++..+.++++|||.+....
T Consensus        80 ~~~~---------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~~~~  140 (155)
T cd05120          80 LDEV---------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGYGP  140 (155)
T ss_pred             cccC---------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEecccccCCC
Confidence            6442         5567778899999999999984  269999999999999998999999999886543

The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves

>cd05119 RIO RIO kinase family, catalytic domain

Probab=99.72  E-value=6.7e-17  Score=133.03  Aligned_cols=137  Identities=15%  Similarity=0.141  Sum_probs=95.9

Q ss_pred             ccCCCCCCcEEEEEEeCCCCEEEEEEeCCCCChhH--HHH----------------------HHHHHHHhcCCCcc--cc
Q 020221           63 SEHGEKAPNVVYKGKLENQFRIAVKRFNRSAWPDA--RQF----------------------LEEARAVGQLRNRR--LA  116 (329)
Q Consensus        63 ~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~--~~~----------------------~~e~~~l~~l~h~n--iv  116 (329)
                      +.||+|+||.||++...+++.||||+++.......  ..+                      ..|.+.+..+.+.+  +.
T Consensus         3 ~~lg~G~~g~Vy~a~~~~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~   82 (187)
T cd05119           3 GPIGTGKEADVYLALDGDGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVPVP   82 (187)
T ss_pred             cccccccceeEEEEECCCCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCCCC
Confidence            45799999999999977889999999876432211  111                      23444555543322  33


Q ss_pred             ccceeeeeCCeeEEEEecCCCCCHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhc-CCCccccccCCCceeeCCCCCe
Q 020221          117 NLLGCCCEGDERLLVAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTS-KERALYHDLNAYRIVFDDDVNP  195 (329)
Q Consensus       117 ~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~-~~~ivH~dlkp~Nil~~~~~~~  195 (329)
                      +.++.    ...+++|||++++++.....  ...... ..+..++.+++.++.++|. . +++|+||||+||+++ ++.+
T Consensus        83 ~~~~~----~~~~lv~e~~~g~~~~~~~l--~~~~~~-~~~~~~~~~~~~~l~~lh~~~-~ivH~Dl~p~Nili~-~~~~  153 (187)
T cd05119          83 KPIDL----NRHVLVMEFIGGDGIPAPRL--KDVRLL-EDPEELYDQILELMRKLYREA-GLVHGDLSEYNILVD-DGKV  153 (187)
T ss_pred             ceEec----CCCEEEEEEeCCCCccChhh--hhhhhc-ccHHHHHHHHHHHHHHHhhcc-CcCcCCCChhhEEEE-CCcE
Confidence            33322    34689999999854332111  000111 5678899999999999999 7 999999999999999 8999


Q ss_pred             eeecccCcccCCC
Q 020221          196 RLSCFGLMKNSRD  208 (329)
Q Consensus       196 kl~Dfg~a~~~~~  208 (329)
                      +++|||.+.....
T Consensus       154 ~liDfg~a~~~~~  166 (187)
T cd05119         154 YIIDVPQAVEIDH  166 (187)
T ss_pred             EEEECcccccccC
Confidence            9999999865443

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct

>PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed

Probab=99.71  E-value=1.7e-16  Score=135.21  Aligned_cols=133  Identities=17%  Similarity=0.147  Sum_probs=101.1

Q ss_pred             CC-CCCCcEEEEEEeCCCCEEEEEEeCCCCC-------------hhHHHHHHHHHHHhcCCCccc--cccceeeeeC-C-
Q 020221           65 HG-EKAPNVVYKGKLENQFRIAVKRFNRSAW-------------PDARQFLEEARAVGQLRNRRL--ANLLGCCCEG-D-  126 (329)
Q Consensus        65 lg-~G~~g~V~~~~~~~~~~vavK~~~~~~~-------------~~~~~~~~e~~~l~~l~h~ni--v~~~~~~~~~-~-  126 (329)
                      +| .|+.|+||.+... +..+++|.+.....             .....+.+|++.+..++|+++  +..+++.... . 
T Consensus        39 lg~~~g~gtv~~v~~~-~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~~~~~  117 (239)
T PRK01723         39 VGSAKGRGTTWFVQTP-GVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVVRHGL  117 (239)
T ss_pred             eecCCCCccEEEEEeC-CceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeeeecCc
Confidence            35 6777889988875 55899998854221             112357889999999998875  5666654332 2 


Q ss_pred             --eeEEEEecCCC-CCHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCCCCCeeeecccCc
Q 020221          127 --ERLLVAEYMPN-DTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLM  203 (329)
Q Consensus       127 --~~~lv~e~~~~-gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a  203 (329)
                        ..++|+|++++ .+|.+++.+   ..++..    .+.+++.+|.+||+. ||+|+||||.|||++.++.++|+|||.+
T Consensus       118 ~~~~~lV~e~l~G~~~L~~~l~~---~~l~~~----~~~~i~~~l~~lH~~-GI~HrDlkp~NILv~~~~~v~LIDfg~~  189 (239)
T PRK01723        118 FYRADILIERIEGARDLVALLQE---APLSEE----QWQAIGQLIARFHDA-GVYHADLNAHNILLDPDGKFWLIDFDRG  189 (239)
T ss_pred             ceeeeEEEEecCCCCCHHHHHhc---CCCCHH----HHHHHHHHHHHHHHC-CCCCCCCCchhEEEcCCCCEEEEECCCc
Confidence              23599999997 689888742   345543    357899999999999 9999999999999999899999999988


Q ss_pred             ccC
Q 020221          204 KNS  206 (329)
Q Consensus       204 ~~~  206 (329)
                      ...
T Consensus       190 ~~~  192 (239)
T PRK01723        190 ELR  192 (239)
T ss_pred             ccC
Confidence            754

>TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase

Probab=99.58  E-value=8.1e-15  Score=135.44  Aligned_cols=140  Identities=17%  Similarity=0.142  Sum_probs=97.2

Q ss_pred             cCCCCCCcEEEEEEeCCCCEEEEEEeCCCCChhHH----------------------------------------HHHHH
Q 020221           64 EHGEKAPNVVYKGKLENQFRIAVKRFNRSAWPDAR----------------------------------------QFLEE  103 (329)
Q Consensus        64 ~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~----------------------------------------~~~~e  103 (329)
                      .+|.|++|.||+|+..+|+.||||+.+........                                        ++.+|
T Consensus       124 plasaSigQVh~A~l~~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf~~E  203 (437)
T TIGR01982       124 PLAAASIAQVHRARLVDGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDLRRE  203 (437)
T ss_pred             ceeeeehhheEEEEecCCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCHHHH
Confidence            46999999999999889999999998764211100                                        13334


Q ss_pred             HHHHhcC----CCccccccceeee-eCCeeEEEEecCCCCCHHhhhccCCCCCCCHHHHHHHHHHHHH-HHHHhhcCCCc
Q 020221          104 ARAVGQL----RNRRLANLLGCCC-EGDERLLVAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAE-ALEYCTSKERA  177 (329)
Q Consensus       104 ~~~l~~l----~h~niv~~~~~~~-~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~-~l~~lH~~~~i  177 (329)
                      .+.+..+    +|.+-+.+-..+. ..+..++||||++|++|.+.... .....+   ...++..++. .+..+|.. |+
T Consensus       204 a~n~~~~~~~~~~~~~v~vP~v~~~~~~~~vLvmE~i~G~~L~~~~~~-~~~~~~---~~~ia~~~~~~~l~ql~~~-g~  278 (437)
T TIGR01982       204 AANASELGENFKNDPGVYVPEVYWDRTSERVLTMEWIDGIPLSDIAAL-DEAGLD---RKALAENLARSFLNQVLRD-GF  278 (437)
T ss_pred             HHHHHHHHHhcCCCCCEEeCCEehhhcCCceEEEEeECCcccccHHHH-HhcCCC---HHHHHHHHHHHHHHHHHhC-Cc
Confidence            4444443    2333333333332 23457899999999999887642 111222   3456666665 46788998 99


Q ss_pred             cccccCCCceeeCCCCCeeeecccCcccCCC
Q 020221          178 LYHDLNAYRIVFDDDVNPRLSCFGLMKNSRD  208 (329)
Q Consensus       178 vH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~  208 (329)
                      +|+|+||.||+++.++.++++|||++....+
T Consensus       279 ~H~D~hPgNilv~~~g~i~liDfG~~~~l~~  309 (437)
T TIGR01982       279 FHADLHPGNIFVLKDGKIIALDFGIVGRLSE  309 (437)
T ss_pred             eeCCCCcccEEECCCCcEEEEeCCCeeECCH
Confidence            9999999999999999999999999876543

This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species.

>KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning]

Probab=99.57  E-value=4.9e-15  Score=135.58  Aligned_cols=239  Identities=20%  Similarity=0.242  Sum_probs=178.8

Q ss_pred             ccccCCC--CCCcEEEEEEe---CCCCEEEEEEeCCCCC--hhHHHHHHHHHHHhcC-CCccccccceeeeeCCeeEEEE
Q 020221           61 IVSEHGE--KAPNVVYKGKL---ENQFRIAVKRFNRSAW--PDARQFLEEARAVGQL-RNRRLANLLGCCCEGDERLLVA  132 (329)
Q Consensus        61 ~~~~lg~--G~~g~V~~~~~---~~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~lv~  132 (329)
                      +.+.+|.  |.+|.||.+..   .++..+|+|+-+....  .....-.+|+...+.+ .|+|.++....+...+..++-+
T Consensus       118 ~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~e~~~~lfiqt  197 (524)
T KOG0601|consen  118 ISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPPLDSKRKLREFLSHHKIDSHENPVRDSPAWEGSGILFIQT  197 (524)
T ss_pred             cccccccCCCCCceeecccCCcccCCcccccccccCCCCCccccccccchhhcccccCccccccccCcccccCCcceeee
Confidence            4456688  99999999975   4577899998554432  2222335677777777 5999999999999999999999


Q ss_pred             ecCCCCCHHhhhccCCCCCCCHHHHHHHHHHHHH----HHHHhhcCCCccccccCCCceeeCCC-CCeeeecccCcccCC
Q 020221          133 EYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAE----ALEYCTSKERALYHDLNAYRIVFDDD-VNPRLSCFGLMKNSR  207 (329)
Q Consensus       133 e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~----~l~~lH~~~~ivH~dlkp~Nil~~~~-~~~kl~Dfg~a~~~~  207 (329)
                      |++. .+|..+... ....++...++.+..+...    ||.++|.. +++|-|+||.||++..+ ...+++|||+...+.
T Consensus       198 E~~~-~sl~~~~~~-~~~~~p~~~l~~~~~~~~~~~~~al~~~hs~-~~~~~~~kp~~i~~~~~~~s~~~~df~~v~~i~  274 (524)
T KOG0601|consen  198 ELCG-ESLQSYCHT-PCNFLPDNLLWNSLRDWLSRDVTALSHLHSN-NIVHDDLKPANIFTTSDWTSCKLTDFGLVSKIS  274 (524)
T ss_pred             cccc-chhHHhhhc-ccccCCchhhhhHHhhhhhcccccccccCCC-cccccccchhheecccccceeecCCcceeEEcc
Confidence            9996 578887753 3344677788888888888    99999999 99999999999999988 889999999988766


Q ss_pred             CCC---------CccCcccccCcccccCCCCCCcccchhhhHHHHHHHhCCCCCCchhhHHHhhhchhhhccccccCCCC
Q 020221          208 DGR---------SYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFS  278 (329)
Q Consensus       208 ~~~---------~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  278 (329)
                      ++.         ...+...|++||+.. +.++...|+|++|.+..+-.++..++..+....+     ..........++.
T Consensus       275 ~~~~~~~~~~~~r~~~~~~Y~~ke~~~-~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W-----~~~r~~~ip~e~~  348 (524)
T KOG0601|consen  275 DGNFSSVFKVSKRPEGDCIYAAKELLN-GLATFASDIFSLGEVILEAILGSHLPSVGKNSSW-----SQLRQGYIPLEFC  348 (524)
T ss_pred             CCccccceeeeecCCCCceEeChhhhc-cccchHhhhcchhhhhHhhHhhcccccCCCCCCc-----cccccccCchhhh
Confidence            553         114567899999877 5678899999999999999998876644311111     1111111112223


Q ss_pred             hHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 020221          279 SDEGTELVRLASRCLQYEPRERPNPRSLVT  308 (329)
Q Consensus       279 ~~~~~~~~~li~~cl~~dp~~Rps~~~~l~  308 (329)
                      ..-+.++...+.++++.+|-.|++++.+.+
T Consensus       349 ~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~  378 (524)
T KOG0601|consen  349 EGGSSSLRSVTSQMLDEDPRLRLTAQILTA  378 (524)
T ss_pred             cCcchhhhhHHHHhcCcchhhhhHHHHHhc
Confidence            333556667999999999999999877664

>KOG1266 consensus Protein kinase [Signal transduction mechanisms]

Probab=99.53  E-value=2.4e-14  Score=121.87  Aligned_cols=201  Identities=18%  Similarity=0.209  Sum_probs=140.4

Q ss_pred             HHHHhcCCCccccccceeeeeC-----CeeEEEEecCCCCCHHhhhccC--CCCCCCHHHHHHHHHHHHHHHHHhhcC-C
Q 020221          104 ARAVGQLRNRRLANLLGCCCEG-----DERLLVAEYMPNDTLAKHLFHW--ETQPMKWAMRLRVALHIAEALEYCTSK-E  175 (329)
Q Consensus       104 ~~~l~~l~h~niv~~~~~~~~~-----~~~~lv~e~~~~gsL~~~l~~~--~~~~~~~~~~~~i~~~i~~~l~~lH~~-~  175 (329)
                      +..|-.+-|.|||++..|+.+.     ....++.||+..|+|..+|++.  ....+......+|..||+.||.|||+. .
T Consensus       118 FdnllqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs~~P  197 (458)
T KOG1266|consen  118 FDNLLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHSCDP  197 (458)
T ss_pred             HHHHHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhccCC
Confidence            3445556799999999998653     3578999999999999999753  345677888899999999999999985 4


Q ss_pred             CccccccCCCceeeCCCCCeeeecccCcccCCC---------CCCccCcccccCcccccCCCCCCcccchhhhHHHHHHH
Q 020221          176 RALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRD---------GRSYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLL  246 (329)
Q Consensus       176 ~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~---------~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~  246 (329)
                      .|+|+++..+.|++..+|-+|++---. .....         .....+.++|.|||.-.....+..+|||+||+..++|.
T Consensus       198 piihgnlTc~tifiq~ngLIkig~~ap-~s~h~s~~~~~~~Ek~~~~~~~g~~a~~sg~~tn~~~a~dIy~fgmcAlema  276 (458)
T KOG1266|consen  198 PIIHGNLTCDTIFIQHNGLIKIGSVAP-DSTHPSVNSTREAEKSVNTSLPGFSAPESGTTTNTTGASDIYKFGMCALEMA  276 (458)
T ss_pred             ccccCCcchhheeecCCceEEecccCc-cccchhhhhhhHhhhhccccCCccccCCcCcccccccchhhhhhhHHHHHHH
Confidence            689999999999999888888764221 11111         01123458899999877667788999999999999998


Q ss_pred             hCCCCCCchhhHHHhhhchhhhccccccCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhh
Q 020221          247 SGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLASRCLQYEPRERPNPRSLVTALVTL  313 (329)
Q Consensus       247 tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~~~l~~L~~~  313 (329)
                      .+..-+................+-..        ....-+.++..|+.-.|..||+|++++-+.-.+
T Consensus       277 ilEiq~tnseS~~~~ee~ia~~i~~l--------en~lqr~~i~kcl~~eP~~rp~ar~llfHpllf  335 (458)
T KOG1266|consen  277 ILEIQSTNSESKVEVEENIANVIIGL--------ENGLQRGSITKCLEGEPNGRPDARLLLFHPLLF  335 (458)
T ss_pred             HheeccCCCcceeehhhhhhhheeec--------cCccccCcCcccccCCCCCCcchhhhhcCceee
Confidence            87743221111111111111111100        011123578999999999999999998754433

>PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed

Probab=99.48  E-value=5.2e-14  Score=131.76  Aligned_cols=137  Identities=13%  Similarity=0.088  Sum_probs=90.2

Q ss_pred             ccCCCCCCcEEEEEEeCC-CCEEEEEEeCCCCChh----------------------------------HHH------HH
Q 020221           63 SEHGEKAPNVVYKGKLEN-QFRIAVKRFNRSAWPD----------------------------------ARQ------FL  101 (329)
Q Consensus        63 ~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~----------------------------------~~~------~~  101 (329)
                      +.+|.|++|.||+|+..+ |+.||||+.+..-...                                  .+.      +.
T Consensus       125 ~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~l~~ElD~~  204 (537)
T PRK04750        125 KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKTLHDELDLM  204 (537)
T ss_pred             hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHHHHHhhCHH
Confidence            467999999999999766 9999999998642110                                  011      23


Q ss_pred             HHHHHHhcC----CCccccccceeeee-CCeeEEEEecCCCCCHHhhhccCCCCC-----CCHHHHHHHHHHHHHHHHHh
Q 020221          102 EEARAVGQL----RNRRLANLLGCCCE-GDERLLVAEYMPNDTLAKHLFHWETQP-----MKWAMRLRVALHIAEALEYC  171 (329)
Q Consensus       102 ~e~~~l~~l----~h~niv~~~~~~~~-~~~~~lv~e~~~~gsL~~~l~~~~~~~-----~~~~~~~~i~~~i~~~l~~l  171 (329)
                      +|...+.++    .+.+.+.+-.++.+ .+..+|||||++|+.+.+...- ....     +....+..++.|+.      
T Consensus       205 ~Ea~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l-~~~g~d~~~la~~~v~~~~~Qif------  277 (537)
T PRK04750        205 REAANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAAL-RAAGTDMKLLAERGVEVFFTQVF------  277 (537)
T ss_pred             HHHHHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHH-HhcCCCHHHHHHHHHHHHHHHHH------
Confidence            333333333    23333443333332 3466799999999999874211 1122     33334444455544      


Q ss_pred             hcCCCccccccCCCceeeCCCC----CeeeecccCcccCCC
Q 020221          172 TSKERALYHDLNAYRIVFDDDV----NPRLSCFGLMKNSRD  208 (329)
Q Consensus       172 H~~~~ivH~dlkp~Nil~~~~~----~~kl~Dfg~a~~~~~  208 (329)
                       .. |++|+|+||.||+++.++    .++++|||++.....
T Consensus       278 -~~-GffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~~  316 (537)
T PRK04750        278 -RD-GFFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLNK  316 (537)
T ss_pred             -hC-CeeeCCCChHHeEEecCCCCCCeEEEEecceEEECCH
Confidence             45 999999999999999888    899999999876544

>KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning]

Probab=99.47  E-value=8.3e-14  Score=127.58  Aligned_cols=243  Identities=16%  Similarity=0.110  Sum_probs=178.5

Q ss_pred             cccccccCCCCCCcEEEEEEe--CCCCEEEEEEeCCCCChhHHH--HHHHHHHHhcC-CCccccccceeeeeCCeeEEEE
Q 020221           58 MENIVSEHGEKAPNVVYKGKL--ENQFRIAVKRFNRSAWPDARQ--FLEEARAVGQL-RNRRLANLLGCCCEGDERLLVA  132 (329)
Q Consensus        58 ~~~~~~~lg~G~~g~V~~~~~--~~~~~vavK~~~~~~~~~~~~--~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~lv~  132 (329)
                      +...+..||.|.|+.|+....  .++..+++|.+.........+  -..|+.+...+ .|.+++.....+..-...++-.
T Consensus       266 df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r~~~ip~  345 (524)
T KOG0601|consen  266 DFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQLRQGYIPL  345 (524)
T ss_pred             CcceeEEccCCccccceeeeecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCCCCccccccccCch
Confidence            345677889999999999873  467889999887765443333  35677777776 5888898888777777888999


Q ss_pred             ecCCCCCHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCCC-CCeeeecccCcccCCC--C
Q 020221          133 EYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDD-VNPRLSCFGLMKNSRD--G  209 (329)
Q Consensus       133 e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~-~~~kl~Dfg~a~~~~~--~  209 (329)
                      |||.++++...+.  ....+.+...+++..|++.++.++|++ .++|+|+||+||++..+ +..+++|||......-  .
T Consensus       346 e~~~~~s~~l~~~--~~~~~d~~~~~~~~~q~~~~l~~i~s~-~~~~~d~~psni~i~~~~~~~~~~~~~~~t~~~~~~~  422 (524)
T KOG0601|consen  346 EFCEGGSSSLRSV--TSQMLDEDPRLRLTAQILTALNVIHSK-LFVHLDVKPSNILISNDGFFSKLGDFGCWTRLAFSSG  422 (524)
T ss_pred             hhhcCcchhhhhH--HHHhcCcchhhhhHHHHHhccccccch-hhhcccccccceeeccchhhhhccccccccccceecc
Confidence            9999998877653  445677888999999999999999999 99999999999999876 7889999999864221  1


Q ss_pred             CCccCcccc-cCcccccCCCCCCcccchhhhHHHHHHHhCCCCCCchhhHHHhhhchhhhccccccCCCChHHHHHHHHH
Q 020221          210 RSYSTNLAF-TPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRL  288 (329)
Q Consensus       210 ~~~~~~~~y-~aPE~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  288 (329)
                      .....+..| .++.......+..++|++|||..+.+.+++....+...       ....+... ..... .....+++.+
T Consensus       423 ~~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~ls~~~~-------~~~~i~~~-~~p~~-~~~~~~~q~~  493 (524)
T KOG0601|consen  423 VFHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSPLSESGV-------QSLTIRSG-DTPNL-PGLKLQLQVL  493 (524)
T ss_pred             cccccccccccchhhccccccccccccccccccccccccCcccCcccc-------cceeeecc-cccCC-CchHHhhhhh
Confidence            122233334 35555556668899999999999999999996543321       11111111 11112 2233788889


Q ss_pred             HHHhcccCCCCCCCHHHHHHHHHh
Q 020221          289 ASRCLQYEPRERPNPRSLVTALVT  312 (329)
Q Consensus       289 i~~cl~~dp~~Rps~~~~l~~L~~  312 (329)
                      .+-+...|+..||.+.++..+.+.
T Consensus       494 ~kv~~~~~~~~~~l~~~l~~~~~~  517 (524)
T KOG0601|consen  494 LKVMINPDRKRRPSAVELSLHSEF  517 (524)
T ss_pred             hhhhcCCccccchhhhhhcccchh
Confidence            999999999999999888765443

>cd05151 ChoK Choline Kinase (ChoK)

Probab=99.47  E-value=2.8e-13  Score=109.54  Aligned_cols=127  Identities=15%  Similarity=0.061  Sum_probs=94.4

Q ss_pred             ccCCCCCCcEEEEEEeCCCCEEEEEEeCCCCChhHHHHHHHHHHHhcCCCcccc-ccceeeeeCCeeEEEEecCCCCCHH
Q 020221           63 SEHGEKAPNVVYKGKLENQFRIAVKRFNRSAWPDARQFLEEARAVGQLRNRRLA-NLLGCCCEGDERLLVAEYMPNDTLA  141 (329)
Q Consensus        63 ~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv-~~~~~~~~~~~~~lv~e~~~~gsL~  141 (329)
                      +.++.|.++.||++... +..+++|....... ....+.+|+.+++.+.+.+++ +++..  .....++||||+++.++.
T Consensus         4 ~~l~~G~~~~vy~~~~~-~~~~~lK~~~~~~~-~~~~~~~E~~~l~~l~~~~~~P~~~~~--~~~~~~lv~e~i~G~~l~   79 (170)
T cd05151           4 SPLKGGMTNKNYRVEVA-NKKYVVRIPGNGTE-LLINRENEAENSKLAAEAGIGPKLYYF--DPETGVLITEFIEGSELL   79 (170)
T ss_pred             eecCCcccCceEEEEEC-CeEEEEEeCCCCcc-cccCHHHHHHHHHHHHHhCCCCceEEE--eCCCCeEEEEecCCCccc
Confidence            45688999999999875 66899999765432 123467889999988655544 34433  234468999999998765


Q ss_pred             hhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCc-----cccccCCCceeeCCCCCeeeecccCccc
Q 020221          142 KHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERA-----LYHDLNAYRIVFDDDVNPRLSCFGLMKN  205 (329)
Q Consensus       142 ~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~i-----vH~dlkp~Nil~~~~~~~kl~Dfg~a~~  205 (329)
                      ...       .   ....++.+++.+|+.||.. ++     +|+|++|.||+++ ++.++++||+.+..
T Consensus        80 ~~~-------~---~~~~~~~~l~~~l~~LH~~-~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~~  136 (170)
T cd05151          80 TED-------F---SDPENLEKIAKLLKKLHSS-PLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAGM  136 (170)
T ss_pred             ccc-------c---cCHHHHHHHHHHHHHHhCC-CCCCceeecCCCCcCcEEEE-CCeEEEEecccccC
Confidence            420       1   1134568999999999998 64     9999999999999 67899999998753

The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph

>KOG1243 consensus Protein kinase [General function prediction only]

Probab=99.46  E-value=1.4e-12  Score=121.01  Aligned_cols=163  Identities=15%  Similarity=0.136  Sum_probs=128.0

Q ss_pred             eCCCCEEEEEEeCCCCChhHHHHHHHHHHHhcCCCccccccceeeeeCCeeEEEEecCCCCCHHhhhccCCCCCCCHHHH
Q 020221           78 LENQFRIAVKRFNRSAWPDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAEYMPNDTLAKHLFHWETQPMKWAMR  157 (329)
Q Consensus        78 ~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~  157 (329)
                      ..++.+|.|...............+.++.|+.++||||++++..+...+..|||+|-+.  -|..++.+     +.....
T Consensus        34 k~~~~~vsVF~~~~~~~~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~~~ylvTErV~--Pl~~~lk~-----l~~~~v  106 (690)
T KOG1243|consen   34 KADGGPVSVFVYKRSNGEVTELAKRAVKRLKTLRHPNILSYLDTTEEEGTLYLVTERVR--PLETVLKE-----LGKEEV  106 (690)
T ss_pred             eccCCceEEEEEeCCCchhhHHHHHHHHHhhhccCchhhhhhhhhcccCceEEEeeccc--cHHHHHHH-----hHHHHH
Confidence            56778899998887665334557788999999999999999999999999999999975  47777753     335667


Q ss_pred             HHHHHHHHHHHHHhhcCCCccccccCCCceeeCCCCCeeeecccCcccCCCCCC----ccCcccccCcccccCCCCCCcc
Q 020221          158 LRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDGRS----YSTNLAFTPPEYLRTGRVTPES  233 (329)
Q Consensus       158 ~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~~----~~~~~~y~aPE~~~~~~~~~~~  233 (329)
                      ...+.||+.||.|||.+.+++|++|.-+-|++++.|..||++|-++........    ...-..|..|+.+....  -..
T Consensus       107 ~~Gl~qIl~AL~FL~~d~~lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~~~~~~~~~~~~~s~~~P~~~~~s~--~s~  184 (690)
T KOG1243|consen  107 CLGLFQILAALSFLNDDCNLVHGNVCKDSVFVNESGEWKLGGLELVSKASGFNAPAKSLYLIESFDDPEEIDPSE--WSI  184 (690)
T ss_pred             HHHHHHHHHHHHHHhccCCeeeccEeeeeEEEcCCCcEEEeeeEEEeccccCCcccccchhhhcccChhhcCccc--cch
Confidence            778899999999999766999999999999999999999999988765443331    11123355665443222  246


Q ss_pred             cchhhhHHHHHHHhCC
Q 020221          234 VMYSFGTLLLDLLSGK  249 (329)
Q Consensus       234 DvwslG~il~el~tg~  249 (329)
                      |.|.||+++++++.|.
T Consensus       185 D~~~Lg~li~el~ng~  200 (690)
T KOG1243|consen  185 DSWGLGCLIEELFNGS  200 (690)
T ss_pred             hhhhHHHHHHHHhCcc
Confidence            9999999999999994

>cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain

Probab=99.42  E-value=4.7e-12  Score=103.55  Aligned_cols=136  Identities=10%  Similarity=0.118  Sum_probs=98.1

Q ss_pred             ccCCCCCCcEEEEEEeCC-------CCEEEEEEeCCCC---------------------Chh-HHH----HHHHHHHHhc
Q 020221           63 SEHGEKAPNVVYKGKLEN-------QFRIAVKRFNRSA---------------------WPD-ARQ----FLEEARAVGQ  109 (329)
Q Consensus        63 ~~lg~G~~g~V~~~~~~~-------~~~vavK~~~~~~---------------------~~~-~~~----~~~e~~~l~~  109 (329)
                      ..||.|--+.||.|...+       +..+|||+.+...                     ..+ .+.    ..+|++.|++
T Consensus         3 g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~r   82 (197)
T cd05146           3 GCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLKR   82 (197)
T ss_pred             CccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHHH
Confidence            456999999999998432       4789999874311                     011 112    2379999998


Q ss_pred             CC--CccccccceeeeeCCeeEEEEecCCCCCHHh-hhccCCCCCCCHHHHHHHHHHHHHHHHHh-hcCCCccccccCCC
Q 020221          110 LR--NRRLANLLGCCCEGDERLLVAEYMPNDTLAK-HLFHWETQPMKWAMRLRVALHIAEALEYC-TSKERALYHDLNAY  185 (329)
Q Consensus       110 l~--h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~-~l~~~~~~~~~~~~~~~i~~~i~~~l~~l-H~~~~ivH~dlkp~  185 (329)
                      +.  .-++.+.+++    ...+|||||+.+..+.. .+   ....++..+...+..+++.+|..+ |.. |++|+||++.
T Consensus        83 l~~~Gv~vP~pi~~----~~~~lvME~Ig~~~~~~~~L---kd~~~~~~~~~~i~~~i~~~l~~l~H~~-glVHGDLs~~  154 (197)
T cd05146          83 MQKAGIPCPEVVVL----KKHVLVMSFIGDDQVPAPKL---KDAKLNDEEMKNAYYQVLSMMKQLYKEC-NLVHADLSEY  154 (197)
T ss_pred             HHHcCCCCCeEEEe----cCCEEEEEEcCCCCccchhh---hccccCHHHHHHHHHHHHHHHHHHHHhC-CeecCCCCHH
Confidence            84  3456666654    46789999997653322 22   223455566778889999999999 787 9999999999


Q ss_pred             ceeeCCCCCeeeecccCcccCC
Q 020221          186 RIVFDDDVNPRLSCFGLMKNSR  207 (329)
Q Consensus       186 Nil~~~~~~~kl~Dfg~a~~~~  207 (329)
                      ||+++ ++.+.|+|||.+....
T Consensus       155 NIL~~-~~~v~iIDF~qav~~~  175 (197)
T cd05146         155 NMLWH-DGKVWFIDVSQSVEPT  175 (197)
T ss_pred             HEEEE-CCcEEEEECCCceeCC
Confidence            99997 4789999999876554

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown.

>KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification]

Probab=99.33  E-value=3.3e-11  Score=108.82  Aligned_cols=215  Identities=17%  Similarity=0.155  Sum_probs=150.6

Q ss_pred             CCcEEEEEE-eCCCCEEEEEEeCCCCChhHHHHHHHHHHHhcCCCccccccceeeee----CCeeEEEEecCCC-CCHHh
Q 020221           69 APNVVYKGK-LENQFRIAVKRFNRSAWPDARQFLEEARAVGQLRNRRLANLLGCCCE----GDERLLVAEYMPN-DTLAK  142 (329)
Q Consensus        69 ~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~----~~~~~lv~e~~~~-gsL~~  142 (329)
                      .-.+.|++. ..+|..|++|+++............-+++++++.|+|+|++.+++..    +..+++|++|.++ ++|.+
T Consensus       288 ~~~Ttyk~~s~~DG~~YvLkRlhg~r~~~~nk~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~TL~d  367 (655)
T KOG3741|consen  288 FSITTYKATSNVDGNAYVLKRLHGDRDQSTNKDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPTLYD  367 (655)
T ss_pred             ccceeEeeeeccCCceeeeeeeccccccCcccchHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCCchHHH
Confidence            446789998 56788999999955443433344556889999999999999998863    3578999999876 57776


Q ss_pred             hhccC-------------CCCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCCCCCeeeecccCcccCCCC
Q 020221          143 HLFHW-------------ETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDG  209 (329)
Q Consensus       143 ~l~~~-------------~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~  209 (329)
                      +....             .+...++..+|.++.|+..||.++|+. |+..+-|.+.+||++.+.+++|+..|+.......
T Consensus       368 ~~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHss-GLAck~L~~~kIlv~G~~RIriS~C~i~Dvl~~d  446 (655)
T KOG3741|consen  368 LYFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSS-GLACKTLDLKKILVTGKMRIRISGCGIMDVLQED  446 (655)
T ss_pred             HHccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHhc-CceeecccHhHeEeeCcceEEEecccceeeecCC
Confidence            55321             123467899999999999999999999 9999999999999999999999988876544433


Q ss_pred             CCccCcccccCcccccCCCCCCcccchhhhHHHHHHHhCCCCCCchhhHHHhhhchhhhccccccCCCChHHHHHHHHHH
Q 020221          210 RSYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLA  289 (329)
Q Consensus       210 ~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li  289 (329)
                      ..          |-+.   -..+-|.=.||.+++.|.||..-....  +..     ...    ....+....+.++++++
T Consensus       447 ~~----------~~le---~~Qq~D~~~lG~ll~aLAt~~~ns~~~--d~~-----~~s----~~~~I~~~yS~D~rn~v  502 (655)
T KOG3741|consen  447 PT----------EPLE---SQQQNDLRDLGLLLLALATGTENSNRT--DST-----QSS----HLTRITTTYSTDLRNVV  502 (655)
T ss_pred             CC----------cchh---HHhhhhHHHHHHHHHHHhhcccccccc--cch-----HHH----HHHHhhhhhhHHHHHHH
Confidence            20          1111   134678889999999999997421100  000     000    00112234566777777


Q ss_pred             HHhcccCCCCCCCHHHHHHH
Q 020221          290 SRCLQYEPRERPNPRSLVTA  309 (329)
Q Consensus       290 ~~cl~~dp~~Rps~~~~l~~  309 (329)
                      ......++++ -+..+++.+
T Consensus       503 ~yl~s~~~~~-ksI~~llp~  521 (655)
T KOG3741|consen  503 EYLESLNFRE-KSIQDLLPM  521 (655)
T ss_pred             HHHHhcCccc-ccHHHHHHH
Confidence            7777777776 456666544

>cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins

Probab=99.32  E-value=1.7e-11  Score=103.47  Aligned_cols=139  Identities=17%  Similarity=0.182  Sum_probs=105.6

Q ss_pred             cCCCCCCcEEEEEEeCCCCEEEEEEeCCCCC-hhHHHHHHHHHHHhcCCCc--cccccceeeeeC---CeeEEEEecCCC
Q 020221           64 EHGEKAPNVVYKGKLENQFRIAVKRFNRSAW-PDARQFLEEARAVGQLRNR--RLANLLGCCCEG---DERLLVAEYMPN  137 (329)
Q Consensus        64 ~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~--niv~~~~~~~~~---~~~~lv~e~~~~  137 (329)
                      .++.|..+.||++...+|..+++|....... .....+.+|.++++.+.+.  ++.+++.+....   +..+++|||++|
T Consensus         5 ~l~~G~~n~~~~v~~~~g~~~ilK~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~e~i~G   84 (223)
T cd05154           5 QLSGGQSNLTYLLTAGGGRRLVLRRPPPGALLPSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVMERVDG   84 (223)
T ss_pred             ecCCCccceEEEEEecCCcceEEEeCCCcccCcccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEEEEeCC
Confidence            4589999999999976667899999866432 1345678999999999653  456677766543   256899999999


Q ss_pred             CCHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcC-------------------------------------------
Q 020221          138 DTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSK-------------------------------------------  174 (329)
Q Consensus       138 gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~-------------------------------------------  174 (329)
                      .++.+.+.   ...++..+...++.+++.+|..||+.                                           
T Consensus        85 ~~l~~~~~---~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  161 (223)
T cd05154          85 RVLRDRLL---RPELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPAMERLL  161 (223)
T ss_pred             EecCCCCC---CCCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHHHHHHH
Confidence            88877552   13466777777788888888888741                                           


Q ss_pred             ------------CCccccccCCCceeeCC--CCCeeeecccCccc
Q 020221          175 ------------ERALYHDLNAYRIVFDD--DVNPRLSCFGLMKN  205 (329)
Q Consensus       175 ------------~~ivH~dlkp~Nil~~~--~~~~kl~Dfg~a~~  205 (329)
                                  ..++|+|++|.||++++  ++.+.|+||+.+..
T Consensus       162 ~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~~  206 (223)
T cd05154         162 RWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELATL  206 (223)
T ss_pred             HHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEecccccc
Confidence                        23589999999999998  56689999998754

This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain

>KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only]

Probab=99.30  E-value=1.4e-12  Score=126.12  Aligned_cols=240  Identities=15%  Similarity=0.119  Sum_probs=167.9

Q ss_pred             ccccccCCCCCCcEEEEEE-eCCCCEEEEEEeCCCC---ChhHHHHHHHHHHHhcCCCccccccceeeeeCCeeEEEEec
Q 020221           59 ENIVSEHGEKAPNVVYKGK-LENQFRIAVKRFNRSA---WPDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAEY  134 (329)
Q Consensus        59 ~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  134 (329)
                      ..+++-+-+|.++.++.+. -..|...+.|......   ....+....+-.++-...+|-++.....+.-....+|+++|
T Consensus       806 ~~i~~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p~~P~v~~~~~s~~~rsP~~L~~~~  885 (1205)
T KOG0606|consen  806 FEITKPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRTNDYESIRSKSNILITPRSPAVVRSFPSFPCRSPLPLVGHY  885 (1205)
T ss_pred             ceecccccCCCCcccccCCccccccccchhhhccchhhccccccccCCccCccccCCCCceecccCCCCCCCCcchhhHH
Confidence            3445556788888888776 3344444444433221   11222233333333334556666665555456788999999


Q ss_pred             CCCCCHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCCCCCeeeecccCcccCCC------
Q 020221          135 MPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRD------  208 (329)
Q Consensus       135 ~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~------  208 (329)
                      ..+++|...+++  ....+..-....+..+..++++||.. .+.|+|++|.|.+...+++.++.|||.......      
T Consensus       886 ~~~~~~~Skl~~--~~~~saepaRs~i~~~vqs~e~L~s~-~r~h~~~~p~~~l~~~~gh~~l~~~~t~~~vg~~~p~~~  962 (1205)
T KOG0606|consen  886 LNGGDLPSKLHN--SGCLSAEPARSPILERVQSLESLHSS-LRKHRDLKPDSLLIAYDGHRPLTDFGTLSKVGLIPPTTD  962 (1205)
T ss_pred             hccCCchhhhhc--CCCcccccccchhHHHHhhhhccccc-hhhcccccccchhhcccCCcccCccccccccccccCcCC
Confidence            999999998863  33466666777888899999999998 799999999999999999999999984321100      


Q ss_pred             -----------------------------CCCccCcccccCcccccCCCCCCcccchhhhHHHHHHHhCCCCCCchhhHH
Q 020221          209 -----------------------------GRSYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDL  259 (329)
Q Consensus       209 -----------------------------~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~  259 (329)
                                                   .....+|+.|.+||...+..-...+|+|++|++++|.++|..||....-..
T Consensus       963 ~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~hgs~ad~~~~g~~l~e~l~g~pp~na~tpq~ 1042 (1205)
T KOG0606|consen  963 LSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRRHGSAADWWSSGVCLFEVLTGIPPFNAETPQQ 1042 (1205)
T ss_pred             cccccccCccccccccccccccccchhhccccccCCCcccCCcccccccCCCcchhhhhhhhhhhhhcCCCCCCCcchhh
Confidence                                         001246789999999999999999999999999999999998887654443


Q ss_pred             HhhhchhhhccccccCCCChHHHHHHHHHHHHhcccCCCCCCCHH
Q 020221          260 IRDRNIQTLTDSCLEGQFSSDEGTELVRLASRCLQYEPRERPNPR  304 (329)
Q Consensus       260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~  304 (329)
                      +..........   ...-+...+++.++++...+..+|.+|..+.
T Consensus      1043 ~f~ni~~~~~~---~p~g~~~~s~~aq~~~~~ll~~~~~qr~~a~ 1084 (1205)
T KOG0606|consen 1043 IFENILNRDIP---WPEGPEEGSYEAQDLINRLLTEEPTQRLGAK 1084 (1205)
T ss_pred             hhhccccCCCC---CCCCccccChhhhhhhhhhhccCchhccCcc
Confidence            33222221111   1123455678899999999999999998765

>COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.28  E-value=5.9e-11  Score=94.12  Aligned_cols=131  Identities=18%  Similarity=0.180  Sum_probs=96.9

Q ss_pred             cCCCCCCcEEEEEEeCCCCEEEEEEeCCCC--ChhH------HHHHHHHHHHhcCCCccccccceeeeeCCeeEEEEecC
Q 020221           64 EHGEKAPNVVYKGKLENQFRIAVKRFNRSA--WPDA------RQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAEYM  135 (329)
Q Consensus        64 ~lg~G~~g~V~~~~~~~~~~vavK~~~~~~--~~~~------~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~  135 (329)
                      .+++|+-+.+|.+.+.+. .+++|.=.+..  .+..      ..-.+|+.++..++--.|..-.=+..+++...|+|||+
T Consensus         3 ~i~~GAEa~i~~~~~~g~-~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD~~~~~I~me~I   81 (204)
T COG3642           3 LIKQGAEAIIYLTDFLGL-PAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVDPDNGLIVMEYI   81 (204)
T ss_pred             hhhCCcceeEEeeeccCc-ceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCEEEEEEe
Confidence            358999999999987544 45555432221  1111      22467889988886555544444556788889999999


Q ss_pred             CCCCHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCCCCCeeeecccCcccC
Q 020221          136 PNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNS  206 (329)
Q Consensus       136 ~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~  206 (329)
                      +|-.|.+++...         ...++..+-.-+.-||.. ||+|+||.++||++...+ +.++|||++...
T Consensus        82 ~G~~lkd~l~~~---------~~~~~r~vG~~vg~lH~~-givHGDLTtsNiIl~~~~-i~~IDfGLg~~s  141 (204)
T COG3642          82 EGELLKDALEEA---------RPDLLREVGRLVGKLHKA-GIVHGDLTTSNIILSGGR-IYFIDFGLGEFS  141 (204)
T ss_pred             CChhHHHHHHhc---------chHHHHHHHHHHHHHHhc-CeecCCCccceEEEeCCc-EEEEECCccccc
Confidence            998888888531         256778888888999999 999999999999998665 999999998743

>KOG3087 consensus Serine/threonine protein kinase [General function prediction only]

Probab=99.26  E-value=6e-11  Score=93.76  Aligned_cols=142  Identities=18%  Similarity=0.175  Sum_probs=101.2

Q ss_pred             cccCCCCCCcEEEEEEeCCCCEEEEEE-eCCCC-Chh------HHHHHHHHHHHhcCCCccccccceeeeeCCeeEEEEe
Q 020221           62 VSEHGEKAPNVVYKGKLENQFRIAVKR-FNRSA-WPD------ARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAE  133 (329)
Q Consensus        62 ~~~lg~G~~g~V~~~~~~~~~~vavK~-~~~~~-~~~------~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  133 (329)
                      +..+-+|+-+.|+++.+. |+...||. +.+.- -+.      ...-.+|++.|.++.--.|.--.-++.+...-.|+||
T Consensus        12 l~likQGAEArv~~~~~~-Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~~~~i~ME   90 (229)
T KOG3087|consen   12 LELIKQGAEARVPRGSFS-GEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDTYGGQIYME   90 (229)
T ss_pred             ceeeeccceeeEeeeccC-CceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEecCCCeEEEE
Confidence            344588999999999985 44555554 33221 111      2345678998888764455444445667778899999


Q ss_pred             cCCC-CCHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCCCCC---eeeecccCccc
Q 020221          134 YMPN-DTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVN---PRLSCFGLMKN  205 (329)
Q Consensus       134 ~~~~-gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~---~kl~Dfg~a~~  205 (329)
                      |+++ .++.+++...............+++.|-..+.-||.. +++|+||..+||++..++.   +.++|||++..
T Consensus        91 ~~~g~~~vk~~i~~~~~~~~~d~~~~~~~~~iG~~igklH~n-diiHGDLTTSNill~~~~~~~~~~lIdfgls~~  165 (229)
T KOG3087|consen   91 FIDGASTVKDFILSTMEDESEDEGLAELARRIGELIGKLHDN-DIIHGDLTTSNILLRSDGNQITPILIDFGLSSV  165 (229)
T ss_pred             eccchhHHHHHHHHHccCcccchhHHHHHHHHHHHHHHhhhC-CeecccccccceEEecCCCcCceEEEeecchhc
Confidence            9977 4777877653333333344478899999999999999 9999999999999965543   58999999754

>COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only]

Probab=99.18  E-value=1.5e-09  Score=96.13  Aligned_cols=247  Identities=16%  Similarity=0.167  Sum_probs=157.6

Q ss_pred             ccCCCCCCcEEEEEE-eCCCCEEEEEEeCCCCChhHHHHHHHHHHHhcC-CCcccccccee------eeeC-CeeEEEEe
Q 020221           63 SEHGEKAPNVVYKGK-LENQFRIAVKRFNRSAWPDARQFLEEARAVGQL-RNRRLANLLGC------CCEG-DERLLVAE  133 (329)
Q Consensus        63 ~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~------~~~~-~~~~lv~e  133 (329)
                      +.||+|+-+.+|..- ..+   -+.|+..........   +-+..|... .||-+..-+.+      .-+. ....++|.
T Consensus        17 r~LgqGgea~ly~l~e~~d---~VAKIYh~Pppa~~a---qk~a~la~~p~~p~~~~rvaWPqa~L~G~~~~~~iGflmP   90 (637)
T COG4248          17 RPLGQGGEADLYTLGEVRD---QVAKIYHAPPPAAQA---QKVAELAATPDAPLLNYRVAWPQATLHGGRRGKVIGFLMP   90 (637)
T ss_pred             ccccCCccceeeecchhhc---hhheeecCCCchHHH---HHHHHhccCCCCcchhhhhcccHHHhhCCCccceeEEecc
Confidence            456999999999765 322   234666554433222   223344444 56644331211      1112 23678888


Q ss_pred             cCCCCCHHhhhccC-----CCCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCCCCCeeeecccCcccCCC
Q 020221          134 YMPNDTLAKHLFHW-----ETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRD  208 (329)
Q Consensus       134 ~~~~gsL~~~l~~~-----~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~  208 (329)
                      .+.+..--..+.+.     .-....|.-.++.++.++.+.+-||.. |.+-+|+.++|+|+++++.+.|.|-........
T Consensus        91 ~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~~-Gh~vGDVn~~~~lVsd~~~V~LVdsDsfqi~~n  169 (637)
T COG4248          91 KVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHEH-GHVVGDVNQNSFLVSDDSKVVLVDSDSFQINAN  169 (637)
T ss_pred             cCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHhc-CCcccccCccceeeecCceEEEEcccceeeccC
Confidence            87764322223221     123468999999999999999999999 999999999999999999999999665444333


Q ss_pred             CCC---ccCcccccCccccc-----CCCCCCcccchhhhHHHHHHHhC-CCCCCchh--------hH-HHhhhchhhhcc
Q 020221          209 GRS---YSTNLAFTPPEYLR-----TGRVTPESVMYSFGTLLLDLLSG-KHIPPSHA--------LD-LIRDRNIQTLTD  270 (329)
Q Consensus       209 ~~~---~~~~~~y~aPE~~~-----~~~~~~~~DvwslG~il~el~tg-~~~~~~~~--------~~-~~~~~~~~~~~~  270 (329)
                      +..   ..|...|.+||.-+     +-.-+...|.|.||+++++++.| ++||.+--        .+ .+.......-.+
T Consensus       170 g~~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI~~~~~ap~p~E~~Ia~g~f~ya~~  249 (637)
T COG4248         170 GTLHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGIPLISDAPNPLETDIAHGRFAYASD  249 (637)
T ss_pred             CceEecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCcccccCCCCCcchhhhhcceeeechh
Confidence            332   35678899999754     33456689999999999999998 56654310        00 000000000000


Q ss_pred             --cc---ccCCCC-hHHHHHHHHHHHHhcccC--CCCCCCHHHHHHHHHhhhhc
Q 020221          271 --SC---LEGQFS-SDEGTELVRLASRCLQYE--PRERPNPRSLVTALVTLQKD  316 (329)
Q Consensus       271 --~~---~~~~~~-~~~~~~~~~li~~cl~~d--p~~Rps~~~~l~~L~~~~~~  316 (329)
                        ..   ....+| .-.+++++.+..+|+...  +.-|||++..+..|..+...
T Consensus       250 ~~~g~~p~P~~~P~~~Lpp~vqAlF~qaF~~~~~~~~RP~a~aW~aAl~al~~~  303 (637)
T COG4248         250 QRRGLKPPPRSIPLSMLPPDVQALFQQAFTESGVATPRPTAKAWVAALDALRQQ  303 (637)
T ss_pred             ccCCCCCCCCCCChhhcCHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHHHHh
Confidence              00   001111 235788999999999763  56899999999999888765

>PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional

Probab=99.17  E-value=6e-10  Score=96.16  Aligned_cols=132  Identities=11%  Similarity=0.090  Sum_probs=96.6

Q ss_pred             EEEEEEeCCCCEEEEEEeCCCCChh-H----------HHHHHHHHHHhcCCCccc--cccceeeee-----CCeeEEEEe
Q 020221           72 VVYKGKLENQFRIAVKRFNRSAWPD-A----------RQFLEEARAVGQLRNRRL--ANLLGCCCE-----GDERLLVAE  133 (329)
Q Consensus        72 ~V~~~~~~~~~~vavK~~~~~~~~~-~----------~~~~~e~~~l~~l~h~ni--v~~~~~~~~-----~~~~~lv~e  133 (329)
                      .|.+..+ +|+.+.||......... .          ..+.+|...+..+..-+|  +..+++...     ...-+||+|
T Consensus        37 rvvr~~~-~g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~~~~s~LVte  115 (268)
T PRK15123         37 RTLRFEL-AGKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNPATRTSFIITE  115 (268)
T ss_pred             eEEEEEE-CCEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCccceeEEEEe
Confidence            4667766 56689999775433211 1          136788888888854333  344555533     234689999


Q ss_pred             cCCCC-CHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCC-------CCCeeeecccCccc
Q 020221          134 YMPND-TLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDD-------DVNPRLSCFGLMKN  205 (329)
Q Consensus       134 ~~~~g-sL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~-------~~~~kl~Dfg~a~~  205 (329)
                      ++++. +|.+++.+......+......++.+++..+.-||.. |++|+|++++|||++.       +..+.++||+.+..
T Consensus       116 ~l~~~~sL~~~~~~~~~~~~~~~~~~~ll~~la~~i~~LH~~-Gi~HgDL~~~NiLl~~~~~~~~~~~~~~LIDl~r~~~  194 (268)
T PRK15123        116 DLAPTISLEDYCADWATNPPDPRLKRMLIKRVATMVRDMHAA-GINHRDCYICHFLLHLPFPGREEDLKLSVIDLHRAQI  194 (268)
T ss_pred             eCCCCccHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHHC-cCccCCCChhhEEEeccccCCCCCceEEEEECCcccc
Confidence            99885 899888543334556677789999999999999999 9999999999999975       46799999998753

>PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases

Probab=99.09  E-value=4.8e-10  Score=91.37  Aligned_cols=126  Identities=19%  Similarity=0.188  Sum_probs=81.7

Q ss_pred             EEEEEEeCCCCEEEEEEeCCCCCh---------------------h-----HHHHHHHHHHHhcCCCc--cccccceeee
Q 020221           72 VVYKGKLENQFRIAVKRFNRSAWP---------------------D-----ARQFLEEARAVGQLRNR--RLANLLGCCC  123 (329)
Q Consensus        72 ~V~~~~~~~~~~vavK~~~~~~~~---------------------~-----~~~~~~e~~~l~~l~h~--niv~~~~~~~  123 (329)
                      .||.|...+|..+|+|+.+.....                     .     .....+|.+.|..+..-  ++.+.+++. 
T Consensus         1 ~Vy~~~~~~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~~-   79 (188)
T PF01163_consen    1 DVYHAIDPDGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDYN-   79 (188)
T ss_dssp             EEEEEEECTTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEEE-
T ss_pred             CEEEEECCCCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEEe-
Confidence            389999888889999998542100                     0     12356899999999755  456665442 


Q ss_pred             eCCeeEEEEecCC--CCCHHhhhccCCCCCCCHHHHHHHHHHHHHHHHH-hhcCCCccccccCCCceeeCCCCCeeeecc
Q 020221          124 EGDERLLVAEYMP--NDTLAKHLFHWETQPMKWAMRLRVALHIAEALEY-CTSKERALYHDLNAYRIVFDDDVNPRLSCF  200 (329)
Q Consensus       124 ~~~~~~lv~e~~~--~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~-lH~~~~ivH~dlkp~Nil~~~~~~~kl~Df  200 (329)
                         ...|||||++  |..+.. +..   ..++......++.+++..+.. +|.. |++|+|+.+.||+++++ .+.++||
T Consensus        80 ---~~~ivME~I~~~G~~~~~-l~~---~~~~~~~~~~~~~~il~~~~~~~~~~-givHGDLs~~NIlv~~~-~~~iIDf  150 (188)
T PF01163_consen   80 ---RNVIVMEYIGEDGVPLPR-LKD---VDLSPEEPKELLEEILEEIIKMLHKA-GIVHGDLSEYNILVDDG-KVYIIDF  150 (188)
T ss_dssp             ---TTEEEEE--EETTEEGGC-HHH---CGGGGSTHHHHHHHHHHHHHHHHHCT-TEEESS-STTSEEEETT-CEEE--G
T ss_pred             ---CCEEEEEecCCCccchhh-HHh---ccccchhHHHHHHHHHHHHHHHHHhc-CceecCCChhhEEeecc-eEEEEec
Confidence               4579999998  544433 321   112234456677888886655 4677 99999999999999987 9999999


Q ss_pred             cCcccCC
Q 020221          201 GLMKNSR  207 (329)
Q Consensus       201 g~a~~~~  207 (329)
                      |.+....
T Consensus       151 ~qav~~~  157 (188)
T PF01163_consen  151 GQAVDSS  157 (188)
T ss_dssp             TTEEETT
T ss_pred             CcceecC
Confidence            9886554

Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A.

>KOG2137 consensus Protein kinase [Signal transduction mechanisms]

Probab=99.05  E-value=5.1e-11  Score=111.16  Aligned_cols=145  Identities=20%  Similarity=0.278  Sum_probs=103.9

Q ss_pred             HHHHHHHHHhhcCCCccccccCCCceeeCCCCCeeeecccCcccCCCCCCc-------------cCcccccCcccccCCC
Q 020221          162 LHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDGRSY-------------STNLAFTPPEYLRTGR  228 (329)
Q Consensus       162 ~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~-------------~~~~~y~aPE~~~~~~  228 (329)
                      .+++.|+.|+|...++||++|.|++|.++.++..||+.|+++........+             .....|.|||++.+..
T Consensus       106 ~~v~dgl~flh~sAk~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~~~~  185 (700)
T KOG2137|consen  106 GNVADGLAFLHRSAKVVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLLGTT  185 (700)
T ss_pred             hcccchhhhhccCcceeecccchhheeeccCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhcccc
Confidence            344599999999889999999999999999999999999987655442221             1236799999999988


Q ss_pred             CCCcccchhhhHHHHHHHhCCCC-CCchhhHHHhhhchhhhccccccCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHH
Q 020221          229 VTPESVMYSFGTLLLDLLSGKHI-PPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLASRCLQYEPRERPNPRSLV  307 (329)
Q Consensus       229 ~~~~~DvwslG~il~el~tg~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~~~l  307 (329)
                      .+.++|+||+|+.+|.+..|+.+ +........  ..............+....+.++++=+.+++..++.-||++..+.
T Consensus       186 ~~~~sd~fSlG~li~~i~~~gk~i~~a~~~~~~--~~~~~~~~~~~~~~~s~~~p~el~~~l~k~l~~~~~~rp~~~~l~  263 (700)
T KOG2137|consen  186 NTPASDVFSLGVLIYTIYNGGKSIIAANGGLLS--YSFSRNLLNAGAFGYSNNLPSELRESLKKLLNGDSAVRPTLDLLL  263 (700)
T ss_pred             ccccccceeeeeEEEEEecCCcchhhccCCcch--hhhhhcccccccccccccCcHHHHHHHHHHhcCCcccCcchhhhh
Confidence            89999999999999999955533 221110000  001111111112224466788999999999999999999776654


Q ss_pred             H
Q 020221          308 T  308 (329)
Q Consensus       308 ~  308 (329)
                      .
T Consensus       264 ~  264 (700)
T KOG2137|consen  264 S  264 (700)
T ss_pred             c
Confidence            3

>COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms]

Probab=98.92  E-value=3.2e-08  Score=83.45  Aligned_cols=137  Identities=15%  Similarity=0.116  Sum_probs=97.2

Q ss_pred             ccccccCCCCCCcEEEEEEeCCCCEEEEEEeCCCCCh----------------------hHHHHHHHHHHHhcCCCc--c
Q 020221           59 ENIVSEHGEKAPNVVYKGKLENQFRIAVKRFNRSAWP----------------------DARQFLEEARAVGQLRNR--R  114 (329)
Q Consensus        59 ~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~----------------------~~~~~~~e~~~l~~l~h~--n  114 (329)
                      +.+-..||-|--+.||.|...+|..+|||.=+....+                      ......+|.++|+.|...  .
T Consensus        93 e~iG~~IGvGKEsdVY~~~~~~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G~~  172 (304)
T COG0478          93 EAIGTKIGVGKESDVYVAIDPKGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEGVK  172 (304)
T ss_pred             HhhccccccCccceEEEEECCCCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcCCC
Confidence            3344567999999999999989999999975432111                      112356899999999654  6


Q ss_pred             ccccceeeeeCCeeEEEEecCCCCCHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCCCCC
Q 020221          115 LANLLGCCCEGDERLLVAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVN  194 (329)
Q Consensus       115 iv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~  194 (329)
                      +.+-+++    +...+||||++|-.|...-       ++......++..|+.-+.-+-.. |+||+|+++-||+++++|.
T Consensus       173 VP~P~~~----nRHaVvMe~ieG~eL~~~r-------~~~en~~~il~~il~~~~~~~~~-GiVHGDlSefNIlV~~dg~  240 (304)
T COG0478         173 VPKPIAW----NRHAVVMEYIEGVELYRLR-------LDVENPDEILDKILEEVRKAYRR-GIVHGDLSEFNILVTEDGD  240 (304)
T ss_pred             CCCcccc----ccceeeeehcccceeeccc-------CcccCHHHHHHHHHHHHHHHHHc-CccccCCchheEEEecCCC
Confidence            6666654    4568999999886554321       12333444555555555555566 9999999999999999999


Q ss_pred             eeeecccCcccCC
Q 020221          195 PRLSCFGLMKNSR  207 (329)
Q Consensus       195 ~kl~Dfg~a~~~~  207 (329)
                      +.++||--+....
T Consensus       241 ~~vIDwPQ~v~~~  253 (304)
T COG0478         241 IVVIDWPQAVPIS  253 (304)
T ss_pred             EEEEeCcccccCC
Confidence            9999998665433

>PRK09902 hypothetical protein; Provisional

Probab=98.89  E-value=6.4e-08  Score=79.55  Aligned_cols=137  Identities=13%  Similarity=0.037  Sum_probs=101.4

Q ss_pred             CCCCCcEEEEEEeCCCCEEEEEEeCCCC------ChhHHHHHHHHHHHhcCCC--ccccccceeeeeC----CeeEEEEe
Q 020221           66 GEKAPNVVYKGKLENQFRIAVKRFNRSA------WPDARQFLEEARAVGQLRN--RRLANLLGCCCEG----DERLLVAE  133 (329)
Q Consensus        66 g~G~~g~V~~~~~~~~~~vavK~~~~~~------~~~~~~~~~e~~~l~~l~h--~niv~~~~~~~~~----~~~~lv~e  133 (329)
                      |+|+.+.|++....+. .+-+|.-...-      +.....|.+|+..+..+..  -.+.+........    ..-+||+|
T Consensus        27 ~rgG~SgV~r~~~~g~-~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pvf~~~~k~~~~~rA~LVTe  105 (216)
T PRK09902         27 RRNGMSGVQCVERNGK-KLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIVFGEAVKIEGEWRALLVTE  105 (216)
T ss_pred             CCCCcceEEEEEeCCc-EEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccceeeeeccCCceEEEEEEE
Confidence            7799999999887544 68888765211      1234678999999999853  2344444222111    23679999


Q ss_pred             cCCC-CCHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCCCCC--eeeecccCcc
Q 020221          134 YMPN-DTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVN--PRLSCFGLMK  204 (329)
Q Consensus       134 ~~~~-gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~--~kl~Dfg~a~  204 (329)
                      -+.+ -+|.+++.+......+......++.+++..+.-||+. |+.|+|+.+.||+++.++.  ++++||--++
T Consensus       106 ~L~g~~~L~~~l~~~~~~~~~~~~k~~il~~va~~ia~LH~~-Gv~Hgdly~khIll~~~g~~~v~lIDlEk~r  178 (216)
T PRK09902        106 DMAGFISIADWYAQHAVSPYSDEVRQAMLKAVALAFKKMHSV-NRQHGCCYVRHIYVKTEGKAEAGFLDLEKSR  178 (216)
T ss_pred             eCCCCccHHHHHhcCCcCCcchHHHHHHHHHHHHHHHHHHHC-CCcCCCCCHhheeecCCCCeeEEEEEhhccc
Confidence            7653 5888888653344567788889999999999999999 9999999999999986667  9999997654

>COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning]

Probab=98.87  E-value=4.9e-08  Score=81.43  Aligned_cols=160  Identities=20%  Similarity=0.202  Sum_probs=110.0

Q ss_pred             cccccCHHHHHHHhcCCCcccccccCCCCCCcEEEEEEeCCCCEEEEEEeCCCCChh-------------------HH--
Q 020221           40 VFCEYSIETLRTATSGFAMENIVSEHGEKAPNVVYKGKLENQFRIAVKRFNRSAWPD-------------------AR--   98 (329)
Q Consensus        40 ~~~~~~~~~~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~-------------------~~--   98 (329)
                      .+...+...+....+.-....+...|.+|--+.||+|...++..+|+|+++.....-                   .+  
T Consensus        31 v~D~~t~~~l~~L~~rg~i~~~~g~istGKEA~Vy~a~~~~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~l  110 (268)
T COG1718          31 VFDKRTLETLRRLLSRGVITELVGCISTGKEANVYLAETGDGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKL  110 (268)
T ss_pred             hhhhHHHHHHHHHhcCCceeeeEeeecCCcceEEEeeccCCCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHH
Confidence            334455667777777666677778889999999999998788899999986532110                   01  


Q ss_pred             ---HHHHHHHHHhcCC--CccccccceeeeeCCeeEEEEecCCCC-CHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhh
Q 020221           99 ---QFLEEARAVGQLR--NRRLANLLGCCCEGDERLLVAEYMPND-TLAKHLFHWETQPMKWAMRLRVALHIAEALEYCT  172 (329)
Q Consensus        99 ---~~~~e~~~l~~l~--h~niv~~~~~~~~~~~~~lv~e~~~~g-sL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH  172 (329)
                         ...+|+..|+++.  +-.+.+-+++.    ...|||||+... .-.-.|   ..-++...+...+..++++.+.-|-
T Consensus       111 v~~W~~kEf~NL~R~~eAGVrvP~Pi~~~----~nVLvMEfIg~~g~pAP~L---kDv~~e~~e~~~~~~~~v~~~~~l~  183 (268)
T COG1718         111 VFAWARKEFRNLKRAYEAGVRVPEPIAFR----NNVLVMEFIGDDGLPAPRL---KDVPLELEEAEGLYEDVVEYMRRLY  183 (268)
T ss_pred             HHHHHHHHHHHHHHHHHcCCCCCCceeec----CCeEEEEeccCCCCCCCCc---ccCCcCchhHHHHHHHHHHHHHHHH
Confidence               1234666666653  33333334332    457999998553 111122   2223334467788889999998887


Q ss_pred             cCCCccccccCCCceeeCCCCCeeeecccCcccCC
Q 020221          173 SKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSR  207 (329)
Q Consensus       173 ~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~  207 (329)
                      ...++||+||+.-|||+. ++.+.|+|||-|....
T Consensus       184 ~~a~LVHgDLSEyNiL~~-~~~p~iID~~QaV~~~  217 (268)
T COG1718         184 KEAGLVHGDLSEYNILVH-DGEPYIIDVSQAVTID  217 (268)
T ss_pred             HhcCcccccchhhheEEE-CCeEEEEECccccccC
Confidence            744999999999999999 8999999999876554

>PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases

Probab=98.81  E-value=4e-08  Score=81.98  Aligned_cols=106  Identities=20%  Similarity=0.197  Sum_probs=81.5

Q ss_pred             HHHHHHHHHHhcCCCc--cccccceeeeeC----CeeEEEEecCCCC-CHHhhhccCCCCCCCHHHHHHHHHHHHHHHHH
Q 020221           98 RQFLEEARAVGQLRNR--RLANLLGCCCEG----DERLLVAEYMPND-TLAKHLFHWETQPMKWAMRLRVALHIAEALEY  170 (329)
Q Consensus        98 ~~~~~e~~~l~~l~h~--niv~~~~~~~~~----~~~~lv~e~~~~g-sL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~  170 (329)
                      ....+|...+..+..-  ...+.+++....    ...++|+|++++. +|.+++.+..  ..+......++.+++..++-
T Consensus        56 ~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~~~--~~~~~~~~~ll~~l~~~i~~  133 (206)
T PF06293_consen   56 SRAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQWE--QLDPSQRRELLRALARLIAK  133 (206)
T ss_pred             hHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHhhc--ccchhhHHHHHHHHHHHHHH
Confidence            3467788877777433  344555555442    2458999999874 7999886322  26667788999999999999


Q ss_pred             hhcCCCccccccCCCceeeCCCC---CeeeecccCcccC
Q 020221          171 CTSKERALYHDLNAYRIVFDDDV---NPRLSCFGLMKNS  206 (329)
Q Consensus       171 lH~~~~ivH~dlkp~Nil~~~~~---~~kl~Dfg~a~~~  206 (329)
                      ||.. |++|+|+++.|||++.+.   .+.++||+.+...
T Consensus       134 lH~~-gi~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~~  171 (206)
T PF06293_consen  134 LHDA-GIYHGDLNPSNILVDPDDGQYRFYLIDLDRMRFR  171 (206)
T ss_pred             HHHC-cCCCCCCCcccEEEeCCCCceeEEEEcchhceeC
Confidence            9999 999999999999999877   7999999987643

Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane

>COG0661 AarF Predicted unusual protein kinase [General function prediction only]

Probab=98.74  E-value=5.7e-08  Score=90.85  Aligned_cols=141  Identities=13%  Similarity=0.101  Sum_probs=90.6

Q ss_pred             cCCCCCCcEEEEEEeCCCCEEEEEEeCCCCChhHH----------------------------------------HHHHH
Q 020221           64 EHGEKAPNVVYKGKLENQFRIAVKRFNRSAWPDAR----------------------------------------QFLEE  103 (329)
Q Consensus        64 ~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~----------------------------------------~~~~e  103 (329)
                      -++.++-|.||+|++.+|+.||||+.+.+-.....                                        ++.+|
T Consensus       132 PiAsASIaQVH~A~L~sG~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l~~ElDy~~E  211 (517)
T COG0661         132 PIASASIAQVHRAVLKSGEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRLREELDYRRE  211 (517)
T ss_pred             chhhhhHhhheeEEecCCCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHHHHHhCHHHH
Confidence            45889999999999999999999998764322110                                        12233


Q ss_pred             HHHHhcC----CCccccccceeeee-CCeeEEEEecCCCCCHHhhhccCCCCCCCHHHHHHHHHHHHHHH-HHhhcCCCc
Q 020221          104 ARAVGQL----RNRRLANLLGCCCE-GDERLLVAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEAL-EYCTSKERA  177 (329)
Q Consensus       104 ~~~l~~l----~h~niv~~~~~~~~-~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l-~~lH~~~~i  177 (329)
                      ...+..+    ++.--+++-.++++ .+...|+|||++|-.+.+...- +....+..   .++..++.+. ..+-.. |+
T Consensus       212 A~n~~~~~~nf~~~~~v~VP~V~we~t~~~VLtmE~i~Gi~i~d~~~l-~~~g~d~k---~ia~~~~~~f~~q~~~d-gf  286 (517)
T COG0661         212 AANAERFRENFKDDPDVYVPKVYWEYTTRRVLTMEWIDGIKISDIAAL-KSAGIDRK---ELAELLVRAFLRQLLRD-GF  286 (517)
T ss_pred             HHHHHHHHHHcCCCCCeEeceeehhccCCcEEEEEeeCCEecccHHHH-HhcCCCHH---HHHHHHHHHHHHHHHhc-Cc
Confidence            3333333    22222333333332 3567899999999888887432 23445532   2333333321 222234 99


Q ss_pred             cccccCCCceeeCCCCCeeeecccCcccCCCC
Q 020221          178 LYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDG  209 (329)
Q Consensus       178 vH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~  209 (329)
                      +|.|.+|.||+++.+|.+.+.|||+.....+.
T Consensus       287 fHaDpHpGNi~v~~~g~i~~lDfGi~g~l~~~  318 (517)
T COG0661         287 FHADPHPGNILVRSDGRIVLLDFGIVGRLDPK  318 (517)
T ss_pred             cccCCCccceEEecCCcEEEEcCcceecCCHH
Confidence            99999999999999999999999998765543

>PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY)

Probab=98.58  E-value=1.3e-06  Score=72.21  Aligned_cols=130  Identities=13%  Similarity=0.067  Sum_probs=81.8

Q ss_pred             ccCCCCCCcEEEEEEeCCCCEEEEEEeCCCCChhHHH---------HHHHHHHHhcCCCc---cccccceeeee-----C
Q 020221           63 SEHGEKAPNVVYKGKLENQFRIAVKRFNRSAWPDARQ---------FLEEARAVGQLRNR---RLANLLGCCCE-----G  125 (329)
Q Consensus        63 ~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~---------~~~e~~~l~~l~h~---niv~~~~~~~~-----~  125 (329)
                      +.+-......|.+-.. +|+.+++|..+....-..+.         ..+.+..+..++..   ....++.+...     .
T Consensus        37 kv~k~~~r~~ValIei-~~~kyIlK~pr~~~~r~er~~~sf~kg~~~~~l~~~~~~i~~~g~~~~~~~yl~~ekk~~~~~  115 (229)
T PF06176_consen   37 KVFKNTKRNYVALIEI-DGKKYILKEPREENRRPERRFKSFFKGSEYSRLINNTDKIRNEGFTEPADPYLAAEKKIFRYT  115 (229)
T ss_pred             EeecCCCccEEEEEEE-CCcEEEEeccchhhhhHHHHHHHHhccHHHHHHHHHHHHHHHcCccccccceeeeeeeeccce
Confidence            3334455556666666 45689999987654322222         22334444444322   22222222211     2


Q ss_pred             CeeEEEEecCCCCCHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCCCCCeeeecccCccc
Q 020221          126 DERLLVAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKN  205 (329)
Q Consensus       126 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~  205 (329)
                      ...+++|||++|..|.+...      ++.    .+...+..++.-||.. |++|+|.+|.|++++++ .++++||+..+.
T Consensus       116 ~~~~ll~EYIeG~~l~d~~~------i~e----~~~~ki~~~ikqlH~~-G~~HGD~hpgNFlv~~~-~i~iID~~~k~~  183 (229)
T PF06176_consen  116 SSYVLLMEYIEGVELNDIED------IDE----DLAEKIVEAIKQLHKH-GFYHGDPHPGNFLVSNN-GIRIIDTQGKRM  183 (229)
T ss_pred             eEEEEEEEEecCeecccchh------cCH----HHHHHHHHHHHHHHHc-CCccCCCCcCcEEEECC-cEEEEECccccc
Confidence            34578999999987766531      222    2456677889999999 99999999999999955 499999987653

The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process

>TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172

Probab=98.52  E-value=1.9e-06  Score=72.91  Aligned_cols=135  Identities=11%  Similarity=0.106  Sum_probs=81.7

Q ss_pred             cCCCCCCcEEEEEEeCCCCEEEEEEeCCCCChhHHHHHHHHHHHhcCCCcc--ccccceeeeeCCeeEEEEecCCCCC-H
Q 020221           64 EHGEKAPNVVYKGKLENQFRIAVKRFNRSAWPDARQFLEEARAVGQLRNRR--LANLLGCCCEGDERLLVAEYMPNDT-L  140 (329)
Q Consensus        64 ~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~n--iv~~~~~~~~~~~~~lv~e~~~~gs-L  140 (329)
                      .+|.|..+.||+.   .+..+++|......  ......+|.++++.+..-+  +.+.+++....+...++||+++|.+ +
T Consensus         8 ~i~~G~t~~~y~~---~~~~~VlR~~~~~~--~~~~i~~E~~~l~~l~~~glpvP~~~~~~~~~~~~glv~e~i~G~~~~   82 (226)
T TIGR02172         8 QTGEGGNGESYTH---KTGKWMLKLYNPGF--DKETIKREFDASRKVFSLGIPTPHPFDLVEDGGRLGLIYELIVGKRSF   82 (226)
T ss_pred             eecCCCCcceeEe---cCCCEEEEeCCCCC--CHHHHHHHHHHHHHHHHcCCCCCceEEEEecCCeeeeeeeecCCccch
Confidence            3599999999984   23467888887533  3345788999998885433  4666777766777889999998863 2


Q ss_pred             Hhhh---------------------ccCCCCCCCHHHH-HHHHH----------HHHHH-HHHhh---cCCCccccccCC
Q 020221          141 AKHL---------------------FHWETQPMKWAMR-LRVAL----------HIAEA-LEYCT---SKERALYHDLNA  184 (329)
Q Consensus       141 ~~~l---------------------~~~~~~~~~~~~~-~~i~~----------~i~~~-l~~lH---~~~~ivH~dlkp  184 (329)
                      ...+                     +............ ..+..          .+... ..+|.   ....++|+|+.|
T Consensus        83 ~~~~~~~~~~~~~l~~~la~~l~~lH~~~~~~~~l~~~~~~~~~~l~~~~~~~~~~~~~l~~~l~~~~~~~~~~HgD~~~  162 (226)
T TIGR02172        83 SRIISDNPSRLEEIAKIFAEMAKKLHSTKCDTSTFQSYKEKIRKFIEEKDFVPKDYKEKARAFIKEVPDTSTCLHGDFQI  162 (226)
T ss_pred             hhhhcCCHHHHHHHHHHHHHHHHHHhCCCCCCCcHHHHHHHHHHHHHhccCCCHHHHHHHHHHHHhCCCCCceEecCCCC
Confidence            1111                     0000011111100 00100          01111 11221   122468999999


Q ss_pred             CceeeCCCCCeeeecccCcc
Q 020221          185 YRIVFDDDVNPRLSCFGLMK  204 (329)
Q Consensus       185 ~Nil~~~~~~~kl~Dfg~a~  204 (329)
                      .||++++++ +.++||+.+.
T Consensus       163 ~Nii~~~~~-~~iIDwe~a~  181 (226)
T TIGR02172       163 GNLITSGKG-TYWIDLGDFG  181 (226)
T ss_pred             CcEEEcCCC-cEEEechhcC
Confidence            999999888 9999999865

This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636.

>KOG1235 consensus Predicted unusual protein kinase [General function prediction only]

Probab=98.51  E-value=9.8e-07  Score=82.48  Aligned_cols=141  Identities=14%  Similarity=0.069  Sum_probs=88.6

Q ss_pred             cCCCCCCcEEEEEEeCCCCEEEEEEeCCCCChhH---------------------------H----------HHHHHHHH
Q 020221           64 EHGEKAPNVVYKGKLENQFRIAVKRFNRSAWPDA---------------------------R----------QFLEEARA  106 (329)
Q Consensus        64 ~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~---------------------------~----------~~~~e~~~  106 (329)
                      .||..+.|.||+|+..+|+.||||+-++.-....                           +          +|.+|.+.
T Consensus       168 piaaASlaQVhrA~L~~G~~VaVKVQ~P~l~~~~~~Dl~~~~~~~~~l~k~~p~~~~~~lvdE~~~~L~~ELDF~~EA~N  247 (538)
T KOG1235|consen  168 PIAAASLAQVHRARLKNGEDVAVKVQHPGLEKLIMLDLRNLRLLAKVLQKFFPDFDLVWLVDEIAKSLPQELDFTKEAKN  247 (538)
T ss_pred             hhhhcchhheEEEEecCCCEEEEEecCcChHHHHHHHHHHHHHHHHHHHHhCcCCchhhHHHHHHhhhHhhcchHHHHHh
Confidence            4689999999999998999999999876432210                           0          12233332


Q ss_pred             ----HhcCCCcc---ccccceeeee-CCeeEEEEecCCCCCHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcc
Q 020221          107 ----VGQLRNRR---LANLLGCCCE-GDERLLVAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERAL  178 (329)
Q Consensus       107 ----l~~l~h~n---iv~~~~~~~~-~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~iv  178 (329)
                          ...+.|-+   -|.+-.++++ .....|+||||+|..+.+...- ....++...+..-+-+...-+-+  .. |++
T Consensus       248 ae~~~~~f~~~~~~~~V~VP~Vy~~~st~RVLtME~~~G~~i~Dl~~i-~~~gi~~~~i~~~l~~~~~~qIf--~~-Gff  323 (538)
T KOG1235|consen  248 AERFRENFKDFSLLTYVLVPKVYWDLSTKRVLTMEYVDGIKINDLDAI-DKRGISPHDILNKLVEAYLEQIF--KT-GFF  323 (538)
T ss_pred             HHHHHHHHHhcccccceeCCeehhhcCcceEEEEEecCCccCCCHHHH-HHcCCCHHHHHHHHHHHHHHHHH--hc-CCc
Confidence                22233444   1223333333 2467899999999877664321 34456655433333222221111  23 899


Q ss_pred             ccccCCCceeeC----CCCCeeeecccCcccCCC
Q 020221          179 YHDLNAYRIVFD----DDVNPRLSCFGLMKNSRD  208 (329)
Q Consensus       179 H~dlkp~Nil~~----~~~~~kl~Dfg~a~~~~~  208 (329)
                      |+|-+|.||++.    .++.+.+-|||+.....+
T Consensus       324 HaDPHPGNilv~~~~~~~~~ivllDhGl~~~is~  357 (538)
T KOG1235|consen  324 HADPHPGNILVRPNPEGDEEIVLLDHGLYAVISH  357 (538)
T ss_pred             cCCCCCCcEEEecCCCCCccEEEEcccccccccH
Confidence            999999999998    367899999999765543

>COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms]

Probab=98.47  E-value=1.6e-06  Score=68.64  Aligned_cols=131  Identities=18%  Similarity=0.180  Sum_probs=90.1

Q ss_pred             cccccCCCCCCcEEEEEEeCCCCEEEEEEeCCCCChhHHHHHHHHHHHhcCCCccccccceeeeeCCeeEEEEecCCCCC
Q 020221           60 NIVSEHGEKAPNVVYKGKLENQFRIAVKRFNRSAWPDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAEYMPNDT  139 (329)
Q Consensus        60 ~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gs  139 (329)
                      +..+.|+.|.+|.||++.+.++ .+|+|+-+.+.  ....+..|.++|..++..++.+-+..+   +..++.|||+.|-.
T Consensus        25 ~v~~~L~KG~~s~Vyl~~~~~~-~~a~Kvrr~ds--~r~~l~kEakiLeil~g~~~~p~vy~y---g~~~i~me~i~G~~   98 (201)
T COG2112          25 RVEKELAKGTTSVVYLGEWRGG-EVALKVRRRDS--PRRNLEKEAKILEILAGEGVTPEVYFY---GEDFIRMEYIDGRP   98 (201)
T ss_pred             hhhhhhhcccccEEEEeeccCc-eEEEEEecCCc--chhhHHHHHHHHHHhhhcCCCceEEEe---chhhhhhhhhcCcc
Confidence            3456779999999999999665 88999876654  346788999999999877766544333   34456699999988


Q ss_pred             HHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccC-CCceeeCCCCCeeeecccCcccC
Q 020221          140 LAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLN-AYRIVFDDDVNPRLSCFGLMKNS  206 (329)
Q Consensus       140 L~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlk-p~Nil~~~~~~~kl~Dfg~a~~~  206 (329)
                      |.+.-..     .+..+    ...++...--|-.. ||-|..+. |...++.+++.+.|+||..|+.-
T Consensus        99 L~~~~~~-----~~rk~----l~~vlE~a~~LD~~-GI~H~El~~~~k~vlv~~~~~~iIDFd~At~k  156 (201)
T COG2112          99 LGKLEIG-----GDRKH----LLRVLEKAYKLDRL-GIEHGELSRPWKNVLVNDRDVYIIDFDSATFK  156 (201)
T ss_pred             hhhhhhc-----ccHHH----HHHHHHHHHHHHHh-ccchhhhcCCceeEEecCCcEEEEEccchhhc
Confidence            8775421     12233    33444443333444 99999876 44555555569999999998743

>cd05150 APH Aminoglycoside 3'-phosphotransferase (APH)

Probab=98.41  E-value=3.5e-06  Score=72.27  Aligned_cols=74  Identities=15%  Similarity=0.138  Sum_probs=51.5

Q ss_pred             CCCCC-cEEEEEEeCCCCEEEEEEeCCCCChhHHHHHHHHHHHhcCC-CccccccceeeeeCCeeEEEEecCCCCCHHhh
Q 020221           66 GEKAP-NVVYKGKLENQFRIAVKRFNRSAWPDARQFLEEARAVGQLR-NRRLANLLGCCCEGDERLLVAEYMPNDTLAKH  143 (329)
Q Consensus        66 g~G~~-g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~  143 (329)
                      ..|.. +.||+....+ ..+.+|......   ...+.+|+++++.+. +--+.+++++....+..++|||+++|.+|...
T Consensus         7 ~~g~~~~~v~~~~~~~-~~~~vk~~~~~~---~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~i~G~~l~~~   82 (244)
T cd05150           7 TEGQSGATVYRLDGKN-PGLYLKIAPSGP---TYELEREAERLRWLAGKLPVPEVIDYGSDDGRAWLLTSAVPGVPAAAL   82 (244)
T ss_pred             CCCCCcCeEEEEcCCC-CcEEEEecCCCc---ccchHHHHHHHHHHHhcCCCCeEEEEEecCCccEEEEEeeCCccHhHh
Confidence            34444 7899998644 578888876543   335667888888874 33355667766655678999999999777643

The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio

>KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms]

Probab=98.39  E-value=1.2e-07  Score=88.31  Aligned_cols=176  Identities=10%  Similarity=-0.025  Sum_probs=127.9

Q ss_pred             cCCCCCCcEEEEEEeCCCCEEEEEEeCCCCChhHHHHHHHHHHHhcCCCcc-ccccceeeeeCCeeEEEEecCCCC-CHH
Q 020221           64 EHGEKAPNVVYKGKLENQFRIAVKRFNRSAWPDARQFLEEARAVGQLRNRR-LANLLGCCCEGDERLLVAEYMPND-TLA  141 (329)
Q Consensus        64 ~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~n-iv~~~~~~~~~~~~~lv~e~~~~g-sL~  141 (329)
                      ..++|+++.++|.+-...+....+.+...     ....-+++.|.+++||| .+..++.+..++..++.++++.++ +-.
T Consensus       249 ~fvK~altknpKkRptaeklL~h~fvs~~-----l~~rl~~eLLdK~n~P~~~v~~~~d~~~E~~~~i~~~i~s~~rs~~  323 (829)
T KOG0576|consen  249 NFVKGALTKNPKKRPTAEKLLQHPFVSQT-----LSRRLAIELLDKVNNPNPVVRYLEDYDGEDYLWIPMRICSTGRSSA  323 (829)
T ss_pred             HHHHHHhcCCCccCCChhhheeceeeccc-----hhhHHHHHHHHHccCCCCcccccccCCcccccchhhhhhcCCcccc
Confidence            34788999999987433334445555432     34456889999999999 777777777778899999999877 221


Q ss_pred             hhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCCCCCeeeecccCcccCCCC---CCccCcccc
Q 020221          142 KHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDG---RSYSTNLAF  218 (329)
Q Consensus       142 ~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~---~~~~~~~~y  218 (329)
                      ... ......+...+...+.+.-.++++++|+. --+|+|    ||+..+ +..+.+||+.+......   ....+++.|
T Consensus       324 ~~~-~~se~~~~~~~~~~~~r~et~~l~~l~~~-~~~~~d----~~l~s~-~~~~~~~~~v~~~L~~~~~~~t~~~~~~~  396 (829)
T KOG0576|consen  324 LEM-TVSEIALEQYQFAYPLRKETRPLAELHSS-YKVHRD----NILGSE-EEVKLLDFAVPPQLTRTMKPRTAIGTPEP  396 (829)
T ss_pred             ccC-ChhhHhhhhhhhhhhhhhhcccccccccc-cccCcc----cccccc-cccccccccCCcccCcccccccCCCCCCC
Confidence            111 00112233445556666777889999987 568888    777665 78899999988766554   456788999


Q ss_pred             cCcccccCCCCCCcccchhhhHHHHHHHhCCCC
Q 020221          219 TPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHI  251 (329)
Q Consensus       219 ~aPE~~~~~~~~~~~DvwslG~il~el~tg~~~  251 (329)
                      +|||+...+.+....|.|++|.--.++--|.+|
T Consensus       397 ~~pev~~~~~~~~~p~~~~~~~~~~~~ap~~pP  429 (829)
T KOG0576|consen  397 LAPEVIQENTIDGCPDSGSLAVSAIQMAPGLPP  429 (829)
T ss_pred             CCchhhcccccccCCCccCCCcchhhcCCCCCC
Confidence            999999999999999999999877777766654

>PLN02876 acyl-CoA dehydrogenase

Probab=98.29  E-value=1.1e-05  Score=81.03  Aligned_cols=80  Identities=15%  Similarity=0.258  Sum_probs=57.3

Q ss_pred             ccccCCCCCCcEEEEEEeCCC---CEEEEEEeCCCC-ChhHHHHHHHHHHHhcCC-Cccc--cccceeeeeC---CeeEE
Q 020221           61 IVSEHGEKAPNVVYKGKLENQ---FRIAVKRFNRSA-WPDARQFLEEARAVGQLR-NRRL--ANLLGCCCEG---DERLL  130 (329)
Q Consensus        61 ~~~~lg~G~~g~V~~~~~~~~---~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~-h~ni--v~~~~~~~~~---~~~~l  130 (329)
                      -+..++.|.++.+|+....++   ..+++|+..... ......+.+|.++++.+. |.++  .+++.++.+.   +..|+
T Consensus        42 ~v~~l~gG~sn~ty~l~~~~~~~~~~~VLR~~p~~~~~~~~~~~~rE~~~l~~L~~~~~vpVP~v~~~~~d~~v~G~~fl  121 (822)
T PLN02876         42 KVSQFGHGQSNPTFLLEVGNGGSVKRYVLRKKPPGKLLQSAHAVEREYQVLRALGEHTDVPVPKVYCLCTDASVIGTAFY  121 (822)
T ss_pred             eEEEeCCCCcCceEEEEECCCCcceeEEEEeCCCCccCccHHHHHHHHHHHHHHhhcCCCCCCcEEEEecCCCcCCCceE
Confidence            356678999999999886553   467888765433 123456889999999995 6665  6677776554   46789


Q ss_pred             EEecCCCCCH
Q 020221          131 VAEYMPNDTL  140 (329)
Q Consensus       131 v~e~~~~gsL  140 (329)
                      ||||++|..+
T Consensus       122 VME~v~G~~~  131 (822)
T PLN02876        122 IMEYLEGRIF  131 (822)
T ss_pred             EEEecCCccc
Confidence            9999988643

>PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily

Probab=98.23  E-value=1.2e-05  Score=67.97  Aligned_cols=77  Identities=21%  Similarity=0.294  Sum_probs=54.6

Q ss_pred             ccCCCCCCcEEEEEEeCCCCEEEEEEeCCCCChhHHHHHHHHHHHhcCCCc--cccccceeeee---CCeeEEEEecCCC
Q 020221           63 SEHGEKAPNVVYKGKLENQFRIAVKRFNRSAWPDARQFLEEARAVGQLRNR--RLANLLGCCCE---GDERLLVAEYMPN  137 (329)
Q Consensus        63 ~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~--niv~~~~~~~~---~~~~~lv~e~~~~  137 (329)
                      +.++.|..+.||+....++ .+++|.....  .....+.+|..+++.+...  .+.+++.....   ....+++|+++++
T Consensus         3 ~~l~~G~~n~~~~v~~~~~-~~vlK~~~~~--~~~~~~~~e~~~~~~l~~~~~pvP~~~~~~~~~~~~~~~~~~~~~i~g   79 (239)
T PF01636_consen    3 RPLSGGFSNRVYRVTTDDG-RYVLKFYRPP--DAAERLRREAAVLRQLAEHGIPVPRVLAFDTSDEFNGFPYLLMEYIPG   79 (239)
T ss_dssp             EEEEESSSSEEEEEEETTS-EEEEEEESSH--HHHHHHHHHHHHHHHHHHTTSBS--EEEEEEETEETSEEEEEEEEESS
T ss_pred             ccCCCCCeeeEEEEEECCc-EEEEEEeCCC--CCHHHHHHHHHHHHHHHhcCCCCceEEeecccccccccceEEEEEecc
Confidence            3458899999999998774 8999997664  3456677888888888533  24555553322   2357899999999


Q ss_pred             CCHHh
Q 020221          138 DTLAK  142 (329)
Q Consensus       138 gsL~~  142 (329)
                      .++..
T Consensus        80 ~~~~~   84 (239)
T PF01636_consen   80 RPLDD   84 (239)
T ss_dssp             EEHHH
T ss_pred             ccccc
Confidence            87776

; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B ....

>PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C)

Probab=98.22  E-value=4.5e-06  Score=68.36  Aligned_cols=100  Identities=22%  Similarity=0.266  Sum_probs=77.3

Q ss_pred             HHHHHHhcCCC-ccccccceeeeeCCeeEEEEecCCCCCHHhhhccC-CCCCCCHHHHHHHHHHHHHHHHHhhcC--CCc
Q 020221          102 EEARAVGQLRN-RRLANLLGCCCEGDERLLVAEYMPNDTLAKHLFHW-ETQPMKWAMRLRVALHIAEALEYCTSK--ERA  177 (329)
Q Consensus       102 ~e~~~l~~l~h-~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~-~~~~~~~~~~~~i~~~i~~~l~~lH~~--~~i  177 (329)
                      .|.-+++.+++ +++.+++|+|-    .+++.||...+++....... .-...+|..+.+|+.++++.+.+++..  +.+
T Consensus         8 ~E~lll~~l~~~~~~pk~lG~CG----~~~v~E~~~~~~~~~~~~~l~~~~~~~w~~R~~iA~~lL~~l~~l~~~~~~~~   83 (188)
T PF12260_consen    8 NEPLLLQLLQGSEPFPKLLGSCG----RFYVVEYVGAGSLYGIYRPLSQFLQSPWEQRAKIALQLLELLEELDHGPLGFF   83 (188)
T ss_pred             cHHHHHHHcCCCCCCCCeeeECC----CEEEEEeecCccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCCCcE
Confidence            47788888875 69999999993    37799999876664211000 112468999999999999999999873  144


Q ss_pred             cccccCCCceeeCCCCCeeeecccCccc
Q 020221          178 LYHDLNAYRIVFDDDVNPRLSCFGLMKN  205 (329)
Q Consensus       178 vH~dlkp~Nil~~~~~~~kl~Dfg~a~~  205 (329)
                      .-.|++++|+.+++++.+|++|...+..
T Consensus        84 ~lcDv~~~nfgv~~~~~lk~iDld~v~~  111 (188)
T PF12260_consen   84 YLCDVSPDNFGVNDDGRLKLIDLDDVFV  111 (188)
T ss_pred             EEeecchHHeEEeCCCcEEEEechhcch
Confidence            5559999999999999999999987643

Proteins in this uncharacterised family are described as transmembrane proteins.

>KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis]

Probab=98.21  E-value=6.4e-06  Score=81.94  Aligned_cols=195  Identities=18%  Similarity=0.134  Sum_probs=138.5

Q ss_pred             HHHHHHHHhcCCCccccccceeeeeCCe----eEEEEecCCCCCHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCC
Q 020221          100 FLEEARAVGQLRNRRLANLLGCCCEGDE----RLLVAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKE  175 (329)
Q Consensus       100 ~~~e~~~l~~l~h~niv~~~~~~~~~~~----~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~  175 (329)
                      ..-|...+..+.|+|++.++.+....-.    ..+..+++..-++...+.  .-..++..+.+.+..+...||.|+|+. 
T Consensus       229 ~E~e~~~l~k~~~~n~~~~~~~~le~~~~g~~~~v~~~~~s~~~~~~~~q--~v~~i~~~~~r~~~~~~~~GL~~~h~~-  305 (1351)
T KOG1035|consen  229 TEIELESLSKIAHDNLGGYFVYGLERLFRGIVLDVLQEICSKVELRSLLQ--SVGSIPLETLRILHQKLLEGLAYLHSL-  305 (1351)
T ss_pred             HHHHHHHHHhhccccccceeEEeehhhcchHHHHHHHhhcCccchHHHHh--hccccCHHHHHHHHHHHhhhHHHHHHh-
Confidence            4456777888899999999988754322    234567788878888775  445678889999999999999999998 


Q ss_pred             CccccccCCC---ceeeCCCCCeeee--cccCcccCCCCCC---ccCcccccCcccccCCCCCC--cccchhhhHHHHHH
Q 020221          176 RALYHDLNAY---RIVFDDDVNPRLS--CFGLMKNSRDGRS---YSTNLAFTPPEYLRTGRVTP--ESVMYSFGTLLLDL  245 (329)
Q Consensus       176 ~ivH~dlkp~---Nil~~~~~~~kl~--Dfg~a~~~~~~~~---~~~~~~y~aPE~~~~~~~~~--~~DvwslG~il~el  245 (329)
                      ...|.-+..+   +...+..+.+.++  ||+......+...   ......+.+||......+..  ..|+|.+|.....+
T Consensus       306 ~l~~v~L~~s~~~~~~~~~e~~~~~sl~~~~ss~~l~d~~~~~~~~~~~~~~~~e~~~~~~~~~~r~~dL~~lgll~~~~  385 (1351)
T KOG1035|consen  306 SLEHVVLSASSSKESTVDGEGVVAISLSDFDSSKPLPDNEKSFSDLLAEIRNADEDLKENTAKKSRLTDLWCLGLLLLQL  385 (1351)
T ss_pred             ccceeEEecccccccccCccceeecchhhhcccccCCCcccchhhcCccccccccccccccchhhhhhHHHHHHHHHhhh
Confidence            6666655555   5566677777777  8888776655432   23356688888877666544  47999999999999


Q ss_pred             HhCCCCCCchhhHHHhhhchhhhccccccCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHh
Q 020221          246 LSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLASRCLQYEPRERPNPRSLVTALVT  312 (329)
Q Consensus       246 ~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~~~l~~L~~  312 (329)
                      ..|..+....           ......+....    .....+...+|+..++++|+++.+++.+.-.
T Consensus       386 ~~~~~i~~~~-----------~~~~~~l~~~~----~~~~~d~~~~~~~~~~~~Rl~~~~ll~~~f~  437 (1351)
T KOG1035|consen  386 SQGEDISEKS-----------AVPVSLLDVLS----TSELLDALPKCLDEDSEERLSALELLTHPFL  437 (1351)
T ss_pred             hhcCcccccc-----------cchhhhhcccc----chhhhhhhhhhcchhhhhccchhhhhhchhc
Confidence            9988644211           11111111111    1157788999999999999999999975433

>PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP

Probab=98.20  E-value=2.9e-05  Score=63.91  Aligned_cols=126  Identities=18%  Similarity=0.071  Sum_probs=87.5

Q ss_pred             cCCCCCCcEEEEEEeCCCCEEEEEEeCCCC----------------ChhHHHHHHHHHHHhcCC------Ccccccccee
Q 020221           64 EHGEKAPNVVYKGKLENQFRIAVKRFNRSA----------------WPDARQFLEEARAVGQLR------NRRLANLLGC  121 (329)
Q Consensus        64 ~lg~G~~g~V~~~~~~~~~~vavK~~~~~~----------------~~~~~~~~~e~~~l~~l~------h~niv~~~~~  121 (329)
                      .+|+|+.-.||.--.  .....||+.....                ....++..+|+.....+.      +.+|.+++|+
T Consensus         8 ~i~~G~~R~cy~HP~--dp~~cIKV~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~E~~~y~~l~~~~~~~~~~i~r~~G~   85 (199)
T PF10707_consen    8 LIAQGGERDCYQHPD--DPNLCIKVMRPDRGERRRPFKRWLKRLRPKSRYRQNRRELRYYKQLSLRRGVDWSHIPRFYGF   85 (199)
T ss_pred             ccccCCCceEEECCC--CCCeEEEEEccccccccccchhHHHhhcccchhHHHHHHHHHHHHHhhccCCcccccccEeEE
Confidence            349999888887643  3457888887655                122455666766555554      7899999999


Q ss_pred             eeeCCeeEEEEecCCC------CCHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCCC--C
Q 020221          122 CCEGDERLLVAEYMPN------DTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDD--V  193 (329)
Q Consensus       122 ~~~~~~~~lv~e~~~~------gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~--~  193 (329)
                      ..+.--..+|+|.+.+      -||.+++.   ...++. .....+.   .-..||-+. +|+.+|++|.||++..+  +
T Consensus        86 veT~~G~Glv~e~I~d~dG~~s~TL~~~l~---~~~~~~-~~~~~L~---~f~~~l~~~-~Iv~~dl~~~NIv~~~~~~~  157 (199)
T PF10707_consen   86 VETNLGLGLVVELIRDADGNISPTLEDYLK---EGGLTE-ELRQALD---EFKRYLLDH-HIVIRDLNPHNIVVQRRDSG  157 (199)
T ss_pred             EecCCceEEEEEEEECCCCCcCccHHHHHH---cCCccH-HHHHHHH---HHHHHHHHc-CCeecCCCcccEEEEecCCC
Confidence            9998888999998632      36778873   344554 3333333   334566676 99999999999999532  2


Q ss_pred             --Ceeeec
Q 020221          194 --NPRLSC  199 (329)
Q Consensus       194 --~~kl~D  199 (329)
                        .+.|+|
T Consensus       158 ~~~lvlID  165 (199)
T PF10707_consen  158 EFRLVLID  165 (199)
T ss_pred             ceEEEEEe
Confidence              577887

PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner [].

>PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2

Probab=98.04  E-value=7.4e-05  Score=61.19  Aligned_cols=125  Identities=20%  Similarity=0.227  Sum_probs=86.6

Q ss_pred             CcccccccCCCCCC-cEEEEEEeCCCCEEEEEEeCC---CCC------------------hhHHHHHHHHHHHhcCC---
Q 020221           57 AMENIVSEHGEKAP-NVVYKGKLENQFRIAVKRFNR---SAW------------------PDARQFLEEARAVGQLR---  111 (329)
Q Consensus        57 ~~~~~~~~lg~G~~-g~V~~~~~~~~~~vavK~~~~---~~~------------------~~~~~~~~e~~~l~~l~---  111 (329)
                      ...+.++.||.|.- |.||++.+. |+.+|+|.+..   ...                  .-...|..|.++..+|+   
T Consensus        37 ~~I~flefLg~g~~~~~V~kv~I~-g~~YALKlf~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PF~~ECRAfgRLke~~  115 (207)
T PF13095_consen   37 DDIEFLEFLGHGSHDGYVFKVEID-GRIYALKLFRFWDYTEPDYTRERFAGHETSLSTPAHYADPFNCECRAFGRLKEAG  115 (207)
T ss_pred             CcEeeeeecCCCCceeEEEEEEEC-CeEEEEEEeeccccCCCccccccccccccccchhhhhcChHHHHHHhhHHHHhcc
Confidence            45667788899999 999999984 55999999322   110                  01124677888877774   


Q ss_pred             Cccc--cccceeeeeC------------------CeeEEEEecCCCCCHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHh
Q 020221          112 NRRL--ANLLGCCCEG------------------DERLLVAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYC  171 (329)
Q Consensus       112 h~ni--v~~~~~~~~~------------------~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~l  171 (329)
                      +.++  |+.+||..-.                  ....||.||++...           .++.    .-+.+|.+-+..+
T Consensus       116 ~e~~~Avkc~Gyl~L~~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~-----------~~~~----~~~~~~~~dl~~~  180 (207)
T PF13095_consen  116 REGLWAVKCHGYLLLTEDQQFEQLRQRGSDHRPLPIRAIVKDFVPDDP-----------PLQI----RDIPQMLRDLKIL  180 (207)
T ss_pred             ccCceEEEeeEEEEEchHHHHHHhhcccccCCCCccEEEEEeecCCcc-----------ccch----hHHHHHHHHHHHH
Confidence            4455  8888886221                  11356777765532           2222    3356777888899


Q ss_pred             hcCCCccccccCCCceeeCCCCCeeeecccCc
Q 020221          172 TSKERALYHDLNAYRIVFDDDVNPRLSCFGLM  203 (329)
Q Consensus       172 H~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a  203 (329)
                      |.. ||+-+|+++.|..     .-+|+|||.+
T Consensus       181 ~k~-gI~~~Dv~~~ny~-----~G~lvDfs~~  206 (207)
T PF13095_consen  181 HKL-GIVPRDVKPRNYR-----GGKLVDFSSS  206 (207)
T ss_pred             HHC-CeeeccCcccccc-----CCEEEecccC
Confidence            999 9999999999987     3389999865

>cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members

Probab=97.93  E-value=8.3e-05  Score=63.33  Aligned_cols=71  Identities=15%  Similarity=0.124  Sum_probs=42.3

Q ss_pred             CCCCCCc-EEEEEEeCCCCEEEEEEeCCCCChhHHHHHHHHHHHhcCCCc---cccccceeeeeC---CeeEEEEecCCC
Q 020221           65 HGEKAPN-VVYKGKLENQFRIAVKRFNRSAWPDARQFLEEARAVGQLRNR---RLANLLGCCCEG---DERLLVAEYMPN  137 (329)
Q Consensus        65 lg~G~~g-~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~---niv~~~~~~~~~---~~~~lv~e~~~~  137 (329)
                      ++.|+.. .||+..    ..+++|..+...  ....+.+|.+.+..+...   -+.+.++.....   ...+++|++++|
T Consensus         5 ~~~gG~~n~vy~~~----~~~VlR~~~~~~--~~~~~~~E~~~l~~L~~~~~v~vP~~~~~~~~~~~~~~~~~l~~~i~G   78 (235)
T cd05155           5 VDSGGTDNATFRLG----DDMSVRLPSAAG--YAGQVRKEQRWLPRLAPHLPLPVPEPLGKGEPGEGYPWPWSVYRWLEG   78 (235)
T ss_pred             ccCCCcccceEEcC----CceEEEcCCccc--hHHHHHHHHHHHHHHhccCCCCCCceeecCCCccCCCcceEEEEeecC
Confidence            4555554 588752    247778765432  244688899998887532   233333333221   235889999998


Q ss_pred             CCHH
Q 020221          138 DTLA  141 (329)
Q Consensus       138 gsL~  141 (329)
                      .++.
T Consensus        79 ~~l~   82 (235)
T cd05155          79 ETAT   82 (235)
T ss_pred             CCCC
Confidence            7664

The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista

>TIGR02721 ycfN_thiK thiamine kinase

Probab=97.89  E-value=0.00011  Score=63.43  Aligned_cols=134  Identities=13%  Similarity=0.096  Sum_probs=76.0

Q ss_pred             CCCCCcEEEEEEeCCCCEEEEEEeCCCCChhHHHHHHHHHHHhcCCCccc-cccceeeeeCCeeEEEEecCCCCCHHhh-
Q 020221           66 GEKAPNVVYKGKLENQFRIAVKRFNRSAWPDARQFLEEARAVGQLRNRRL-ANLLGCCCEGDERLLVAEYMPNDTLAKH-  143 (329)
Q Consensus        66 g~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~ni-v~~~~~~~~~~~~~lv~e~~~~gsL~~~-  143 (329)
                      ..|-.+.+|+... ++..+++|........-.-...+|..+++.+...++ .+++...    .-++|+||++|..+... 
T Consensus         5 ~~G~tn~~y~~~~-~~~~~vlR~~~~~~~~~~~~r~~E~~~l~~l~~~g~~P~~i~~~----~~~~v~e~i~G~~~~~~~   79 (256)
T TIGR02721         5 SGGLTNRSWRIEH-PGISFVWRPQSPVCKALGVDRQREYQILQALSALGLAPKPILVN----EHWLLVEWLEGEVITLDQ   79 (256)
T ss_pred             CCcCcCCeEEEEe-CCccEEEeeCCcccccccCcHHHHHHHHHHHHhcCCCCceEEEe----CCEEEEEeccCccccccc
Confidence            5577788998874 456788987654332211135678888888854333 3333332    23789999998665321 


Q ss_pred             -------------hc---cCC--CCCCCHH-HHHHHHHHH---------HHHHHHhhc-------CCCccccccCCCcee
Q 020221          144 -------------LF---HWE--TQPMKWA-MRLRVALHI---------AEALEYCTS-------KERALYHDLNAYRIV  188 (329)
Q Consensus       144 -------------l~---~~~--~~~~~~~-~~~~i~~~i---------~~~l~~lH~-------~~~ivH~dlkp~Nil  188 (329)
                                   +.   ...  ..+++.. ....+..++         ...+..+-.       ...++|+|+.|.||+
T Consensus        80 ~~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~H~Dl~~~Nil  159 (256)
T TIGR02721        80 FVALDLLLELAALLHQLHSQPRFGYPLSLKARIAHYWLQIDPARRTPEWLRLYKQFRSAPEPAPLPLAPLHMDVHAYNLV  159 (256)
T ss_pred             ccCchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHhcccccCChHHHHHHHHHHhccCCCCCCCeeecCCCCcCcEE
Confidence                         11   111  1112211 111221111         111221211       124799999999999


Q ss_pred             eCCCCCeeeecccCccc
Q 020221          189 FDDDVNPRLSCFGLMKN  205 (329)
Q Consensus       189 ~~~~~~~kl~Dfg~a~~  205 (329)
                      +++++ +.++||..+..
T Consensus       160 ~~~~~-~~lIDwE~a~~  175 (256)
T TIGR02721       160 VTPQG-LKLIDWEYASD  175 (256)
T ss_pred             EeCCC-CEEEeccccCc
Confidence            99877 78999998754

Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function.

>PRK10593 hypothetical protein; Provisional

Probab=97.84  E-value=0.0003  Score=62.12  Aligned_cols=77  Identities=12%  Similarity=0.036  Sum_probs=55.4

Q ss_pred             ccccCCCCCCcEEEEEEeCCCCEEEEEEeCCCCChhHHHHHHHHHHHhcCCC---ccccccceeeee---CCeeEEEEec
Q 020221           61 IVSEHGEKAPNVVYKGKLENQFRIAVKRFNRSAWPDARQFLEEARAVGQLRN---RRLANLLGCCCE---GDERLLVAEY  134 (329)
Q Consensus        61 ~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h---~niv~~~~~~~~---~~~~~lv~e~  134 (329)
                      -++.||.|..+.||.....++ .+.+|..+...  ....+..|...|+.+..   -.+.++++++..   .+..++|||+
T Consensus        18 ~~~~i~~G~~~~vy~~~~~~~-~~~~k~~~~~~--~~~~~~~Ea~~L~~L~~~~~vpVP~V~~~~~~~~~~g~~~LVmE~   94 (297)
T PRK10593         18 RVECISEQPYAALWALYDSQG-NPMPLMARSFS--TPGVAQQEAWKLSMLARSGTVRMPTVYGVMTHEQSPGPDVLLLER   94 (297)
T ss_pred             eeeecCCccceeEEEEEcCCC-CEEEEEecccc--cchHHHHHHHHHHHHccCCCCCcCcEEEEeccCCcCCCeEEEEec
Confidence            345679999999999986566 46677754311  23578889999988843   357777777644   3568999999


Q ss_pred             CCCCCH
Q 020221          135 MPNDTL  140 (329)
Q Consensus       135 ~~~gsL  140 (329)
                      +++.++
T Consensus        95 i~G~~~  100 (297)
T PRK10593         95 LRGVSV  100 (297)
T ss_pred             cCCEec
Confidence            998754

>TIGR00938 thrB_alt homoserine kinase, Neisseria type

Probab=97.82  E-value=0.00055  Score=60.80  Aligned_cols=158  Identities=13%  Similarity=0.156  Sum_probs=87.8

Q ss_pred             cCHHHHHHHhcCCCcc--cccccCCCCCCcEEEEEEeCCCCEEEEEEeCCCCChhHHHHHHHHHHHhcCCCcc--ccccc
Q 020221           44 YSIETLRTATSGFAME--NIVSEHGEKAPNVVYKGKLENQFRIAVKRFNRSAWPDARQFLEEARAVGQLRNRR--LANLL  119 (329)
Q Consensus        44 ~~~~~~~~~~~~~~~~--~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~n--iv~~~  119 (329)
                      .+.+++...-..|+..  ..++.++.|....+|+....++ .+++|+......  ...+..|.+++..|...+  +.+.+
T Consensus         7 ~~~~~l~~~l~~y~~~~~~~i~~~~~G~~n~~y~v~t~~~-~~vLK~~~~~~~--~~~i~~e~~~l~~L~~~g~pvp~~i   83 (307)
T TIGR00938         7 VSDEEMSSFLDGYDLGELLSLKGIAEGVENSNYLLTTDVG-RYILTLYEKRVK--AEELPFFLALTTHLAARGLPVPKPV   83 (307)
T ss_pred             CCHHHHHHHHHhcCCCCceeccccCCccccceEEEEeCCC-cEEEEEecCCCC--HHHHHHHHHHHHHHHHCCCCCCccc
Confidence            3445555544444332  2355667787789999876555 677888765321  234455666666663222  33433


Q ss_pred             eee------eeCCeeEEEEecCCCCCHH-----------hhhccC----CC-----CC----CCHHHHH-----------
Q 020221          120 GCC------CEGDERLLVAEYMPNDTLA-----------KHLFHW----ET-----QP----MKWAMRL-----------  158 (329)
Q Consensus       120 ~~~------~~~~~~~lv~e~~~~gsL~-----------~~l~~~----~~-----~~----~~~~~~~-----------  158 (329)
                      ...      ...+..+++++|++|.++.           ..+.+.    ..     ..    -.|....           
T Consensus        84 ~t~~g~~~~~~~g~~~~l~e~i~G~~~~~~~~~~~~~~G~~LA~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~l~  163 (307)
T TIGR00938        84 KSRDGRQLSTLAGKPACLVEFLQGLSVGRPTAMHCRPVGEVLAWMHLAGAHFPENRKNSLRLEAWHILAEKCFEAAPQLE  163 (307)
T ss_pred             cCCCCCeehhcCCeEEEEEEeCCCCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCCCCCCChHHHHHHHHhhhhcccccC
Confidence            321      1235678999999885432           111100    00     00    0111100           


Q ss_pred             -HHHHHHHHHHHHhhc------CCCccccccCCCceeeCCCCCeeeecccCcc
Q 020221          159 -RVALHIAEALEYCTS------KERALYHDLNAYRIVFDDDVNPRLSCFGLMK  204 (329)
Q Consensus       159 -~i~~~i~~~l~~lH~------~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~  204 (329)
                       .....+...+.++..      ..+++|+|+++.|+++++++...++||+.+.
T Consensus       164 ~~~~~~l~~~~~~l~~~~~~~~~~~l~HgD~~~~Nvl~~~~~~~~vIDfd~~~  216 (307)
T TIGR00938       164 AHMGAELDKELDYLDKFWPRDLPRGVIHADLFPDNVLFDGDSVKGVIDFYFAC  216 (307)
T ss_pred             HHHHHHHHHHHHHHHhhhhhcCCCccCCCCCCcCcEEEECCceEEEeeccccc
Confidence             001122334444432      1389999999999999988877899999864

Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase.

>cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes

Probab=97.77  E-value=0.00023  Score=60.48  Aligned_cols=72  Identities=19%  Similarity=0.150  Sum_probs=46.2

Q ss_pred             cCCCCCCcEEEEEEeCC--CCEEEEEEeCCCCChhHHHHHHHHHHHhcCCCccc-cccceeeeeCCeeEEEEecCCCCCH
Q 020221           64 EHGEKAPNVVYKGKLEN--QFRIAVKRFNRSAWPDARQFLEEARAVGQLRNRRL-ANLLGCCCEGDERLLVAEYMPNDTL  140 (329)
Q Consensus        64 ~lg~G~~g~V~~~~~~~--~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~ni-v~~~~~~~~~~~~~lv~e~~~~gsL  140 (329)
                      .+..|-...+|+....+  ++.|++|+....... .....+|+.+++.+...++ +++++...    -.++|||++|.++
T Consensus         5 ~l~gG~tN~~~~v~~~~~~~~~~vlR~~~~~~~~-~~d~~~E~~~~~~l~~~gl~P~v~~~~~----~~~l~e~i~G~~l   79 (235)
T cd05157           5 RFTGGITNKLVKVSNKEDNQDAVLVRVYGNKTEL-IIDRERELRIHKLLSKHGLAPKLYATFQ----NGLIYEFIPGRTL   79 (235)
T ss_pred             EcCCcccceEEEEEcCCCCCCeEEEEEccCCccc-eecHHHHHHHHHHHHhCCCCCeEEEEeC----CcEEEEeeCCCcC
Confidence            44677778999998654  668999987643221 1233578888888853333 34443322    2489999988765

ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo

>cd05153 HomoserineK_II Homoserine Kinase, type II

Probab=97.77  E-value=0.00061  Score=60.09  Aligned_cols=139  Identities=14%  Similarity=0.181  Sum_probs=81.8

Q ss_pred             cccCCCCCCcEEEEEEeCCCCEEEEEEeCCCCChhHHHHHHHHHHHhcCCCcc--cccccee------eeeCCeeEEEEe
Q 020221           62 VSEHGEKAPNVVYKGKLENQFRIAVKRFNRSAWPDARQFLEEARAVGQLRNRR--LANLLGC------CCEGDERLLVAE  133 (329)
Q Consensus        62 ~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~n--iv~~~~~------~~~~~~~~lv~e  133 (329)
                      ++.+..|....+|+....++ .+++|+....   ....+..|++++..+.+.+  +.+.+..      ....+..+++++
T Consensus        19 i~~i~~G~~n~~y~v~~~~~-~~vLr~~~~~---~~~~~~~e~~~l~~L~~~g~~vp~~i~~~~g~~~~~~~~~~~~l~~   94 (296)
T cd05153          19 FEGISAGIENTNYFVTTDSG-RYVLTLFEKV---SAEELPFFLALLDHLAERGLPVPRPIADRDGEYLSELAGKPAALVE   94 (296)
T ss_pred             eecccCccccceEEEEeCCC-cEEEEEcCCC---ChHhccHHHHHHHHHHHCCCCCCccccCCCCcEeeeeCCceEEEEE
Confidence            44567787789999876554 7888987652   2345667777777774322  3444332      122345689999


Q ss_pred             cCCCCCHHh-----------hhcc-------CCC-----CCCCHHHHH----------HHHHHHHHHHHHhhc------C
Q 020221          134 YMPNDTLAK-----------HLFH-------WET-----QPMKWAMRL----------RVALHIAEALEYCTS------K  174 (329)
Q Consensus       134 ~~~~gsL~~-----------~l~~-------~~~-----~~~~~~~~~----------~i~~~i~~~l~~lH~------~  174 (329)
                      +++|.++..           .+.+       ...     ....|....          .....+..++.++..      .
T Consensus        95 ~i~G~~~~~~~~~~~~~lg~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~~~~~~~  174 (296)
T cd05153          95 FLAGEHLTRPTAAHCRQIGEALARLHLAAQSFPGERNNLRGLAWIRELGKDLLPLLSAEDRALLADELARQDAFDPSDLP  174 (296)
T ss_pred             eCCCCCCCCCCHHHHHHHHHHHHHHHHHhccCCccCCCcCCcHHHHHHHHHhccccCHHHHHHHHHHHHHHHhhhhhcCC
Confidence            998866432           1100       000     011121110          011112233444432      1


Q ss_pred             CCccccccCCCceeeCCCCCeeeecccCcc
Q 020221          175 ERALYHDLNAYRIVFDDDVNPRLSCFGLMK  204 (329)
Q Consensus       175 ~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~  204 (329)
                      .+++|+|+.|.||++++++.+.|+||+.+.
T Consensus       175 ~~l~HgD~~~~Nil~~~~~~~~iIDfe~a~  204 (296)
T cd05153         175 RGVIHADLFRDNVLFDGDELSGVIDFYFAC  204 (296)
T ss_pred             CcCCccCcCcccEEEeCCceEEEeehhhhc
Confidence            368999999999999988778899999764

Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine.

>PRK05231 homoserine kinase; Provisional

Probab=97.69  E-value=0.0017  Score=58.03  Aligned_cols=160  Identities=13%  Similarity=0.110  Sum_probs=85.0

Q ss_pred             cccCHHHHHHHhcCCCccc--ccccCCCCCCcEEEEEEeCCCCEEEEEEeCCCCChhHHHHHHHHHHHhcCCCcc--ccc
Q 020221           42 CEYSIETLRTATSGFAMEN--IVSEHGEKAPNVVYKGKLENQFRIAVKRFNRSAWPDARQFLEEARAVGQLRNRR--LAN  117 (329)
Q Consensus        42 ~~~~~~~~~~~~~~~~~~~--~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~n--iv~  117 (329)
                      ...+.+++......|...+  -++.++.|....+|.....+| .+++|++...   ....+..|...+..|...+  +.+
T Consensus         5 t~ls~~~l~~~l~~y~~~~~~~~~~l~~G~~n~~y~v~t~~g-~~vLK~~~~~---~~~~l~~~~~~l~~L~~~glpvP~   80 (319)
T PRK05231          5 TDVSDDELAAFLAPYDLGELLSLKGIAEGIENSNFFLTTTQG-EYVLTLFERL---TAEDLPFFLGLMQHLAARGVPVPA   80 (319)
T ss_pred             ccCCHHHHHHHHHhcCCchhhccchhccccccceEEEEeCCC-cEEEEEeccC---ChHHhHHHHHHHHHHHHCCCCCCc
Confidence            4455666655555554322  234456777788999886566 6889987621   2233344555555542111  223


Q ss_pred             ccee------eeeCCeeEEEEecCCCCCHH-----------hhhccC----CC--------CCCCH-HHHHH--------
Q 020221          118 LLGC------CCEGDERLLVAEYMPNDTLA-----------KHLFHW----ET--------QPMKW-AMRLR--------  159 (329)
Q Consensus       118 ~~~~------~~~~~~~~lv~e~~~~gsL~-----------~~l~~~----~~--------~~~~~-~~~~~--------  159 (329)
                      .+..      ....+..+++++|++|..+.           ..+.+.    ..        ..+.| .....        
T Consensus        81 ~i~~~~G~~~~~~~g~~~~l~~~l~G~~~~~~~~~~~~~~G~~LA~lH~~~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~  160 (319)
T PRK05231         81 PVARRDGAALGELAGKPAAIVTFLEGKWPRAPTAAHCAEVGEMLARMHLAGRDFPLERPNLRGLAWWRELAPRLLPFLAD  160 (319)
T ss_pred             ceeCCCCCEeeeeCCEEEEEEEecCCCCCCCCCHHHHHHHHHHHHHHHhhhhcCCccCCCCCChHHHHHHHHHHhhccCh
Confidence            3321      12245678999999886431           111110    00        01111 11110        


Q ss_pred             ----HHHH-HHHHHHHhhc------CCCccccccCCCceeeCCCCCeeeecccCccc
Q 020221          160 ----VALH-IAEALEYCTS------KERALYHDLNAYRIVFDDDVNPRLSCFGLMKN  205 (329)
Q Consensus       160 ----i~~~-i~~~l~~lH~------~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~  205 (329)
                          ...+ +...+..+..      ..+++|+|+.|.||+++++...-++||+.+..
T Consensus       161 ~~~~~l~~~~~~~~~~~~~~~~~~lp~~liHgD~~~~Nil~~~~~~~~iIDf~~~~~  217 (319)
T PRK05231        161 EQAALLEAELAAQLAFLASAAWPALPRGVIHADLFRDNVLFEGDRLSGFIDFYFACN  217 (319)
T ss_pred             hHHHHHHHHHHHHHHhhhccccccCCcccCCCCCCCCcEEEECCceEEEEecccccC
Confidence                1111 1111222221      13799999999999999766668999998753

>PRK09550 mtnK methylthioribose kinase; Reviewed

Probab=97.63  E-value=0.0019  Score=59.03  Aligned_cols=76  Identities=14%  Similarity=0.079  Sum_probs=52.9

Q ss_pred             cccCCCCCCcEEEEEEeCCC-CEEEEEEeCCC------C-ChhHHHHHHHHHHHhcCC---CccccccceeeeeCCeeEE
Q 020221           62 VSEHGEKAPNVVYKGKLENQ-FRIAVKRFNRS------A-WPDARQFLEEARAVGQLR---NRRLANLLGCCCEGDERLL  130 (329)
Q Consensus        62 ~~~lg~G~~g~V~~~~~~~~-~~vavK~~~~~------~-~~~~~~~~~e~~~l~~l~---h~niv~~~~~~~~~~~~~l  130 (329)
                      .+.+|-|.++.||+....+| +.++||.-...      . .-..+....|.+.|+.+.   ..++.+++.+  +....++
T Consensus        31 ~~elggGn~N~VyrV~~~~g~~svIVKqa~p~~r~~g~~wpl~~eR~~~Eae~L~~l~~~~p~~VPkV~~~--D~~~~~l  108 (401)
T PRK09550         31 AREIGDGNLNLVFRVSDTEGGKSVIVKQALPYVRVVGESWPLTLDRARIEAEALKIQAKYVPDLVPKVYHY--DEELAVT  108 (401)
T ss_pred             eeEcCCCceEEEEEEEeCCCCeEEEEEecCcccccccccccccHHHHHHHHHHHHHHHhhCCCCCCeEEEE--CCCCCEE
Confidence            35679999999999997766 58999985321      1 123456677888888762   2356666655  4466789


Q ss_pred             EEecCCCCC
Q 020221          131 VAEYMPNDT  139 (329)
Q Consensus       131 v~e~~~~gs  139 (329)
                      |||++++..
T Consensus       109 VME~L~~~~  117 (401)
T PRK09550        109 VMEDLSDHK  117 (401)
T ss_pred             EEecCCCcc
Confidence            999998644

>KOG2270 consensus Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning]

Probab=97.51  E-value=0.0013  Score=58.41  Aligned_cols=140  Identities=16%  Similarity=0.148  Sum_probs=95.2

Q ss_pred             cccccCCCCCCcEEEEEEeCCCCEEEEEEeCCCC---------------------Chh-----HHHHHHHHHHHhcCCCc
Q 020221           60 NIVSEHGEKAPNVVYKGKLENQFRIAVKRFNRSA---------------------WPD-----ARQFLEEARAVGQLRNR  113 (329)
Q Consensus        60 ~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~---------------------~~~-----~~~~~~e~~~l~~l~h~  113 (329)
                      ++-+.|..|--+.||.+.-.+|..+|||+++-+-                     ..+     .-....|++-|.++...
T Consensus       147 ~inGCiSTGKEANVYHat~~dG~~~AIKIYKTSILvFKDRdRYV~GEfRFRhgyck~NPRKMVk~WAEKE~RNLkRl~~a  226 (520)
T KOG2270|consen  147 EINGCISTGKEANVYHATEEDGSEFAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKHNPRKMVKTWAEKEMRNLKRLNNA  226 (520)
T ss_pred             ecccccccCccceeEeeecCCCceEEEEEEeeeEEEEechhhhccceeeeecccccCCcHHHHHHHHHHHHHHHHHHHhc
Confidence            3446778899999999998888899999874210                     000     11245678888887655


Q ss_pred             cccccceeeeeCCeeEEEEecCCCCCHH-hhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCCC
Q 020221          114 RLANLLGCCCEGDERLLVAEYMPNDTLA-KHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDD  192 (329)
Q Consensus       114 niv~~~~~~~~~~~~~lv~e~~~~gsL~-~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~  192 (329)
                      .|..---+..  ....|||+|+....-. -.|   +...++...+..+-.+++.-+.-|-...++||.||+--|+|+. +
T Consensus       227 GIP~PePIlL--k~hVLVM~FlGrdgw~aPkL---Kd~~ls~~ka~~~Y~~~v~~MR~lY~~c~LVHADLSEfN~Lyh-d  300 (520)
T KOG2270|consen  227 GIPCPEPILL--KNHVLVMEFLGRDGWAAPKL---KDASLSTSKARELYQQCVRIMRRLYQKCRLVHADLSEFNLLYH-D  300 (520)
T ss_pred             CCCCCCceee--ecceEeeeeccCCCCcCccc---ccccCChHHHHHHHHHHHHHHHHHHHHhceeccchhhhhheEE-C
Confidence            5442221111  2457899998532211 122   4456777777777788888887776555999999999999998 5


Q ss_pred             CCeeeecccCccc
Q 020221          193 VNPRLSCFGLMKN  205 (329)
Q Consensus       193 ~~~kl~Dfg~a~~  205 (329)
                      |.+.|+|.+-+..
T Consensus       301 G~lyiIDVSQSVE  313 (520)
T KOG2270|consen  301 GKLYIIDVSQSVE  313 (520)
T ss_pred             CEEEEEEcccccc
Confidence            7899999876543

>cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes

Probab=97.33  E-value=0.0021  Score=56.94  Aligned_cols=72  Identities=22%  Similarity=0.291  Sum_probs=46.0

Q ss_pred             CCCCCCcEEEEEEeCC-------CCEEEEEEeCCCCChhHHHHHHHHHHHhcCCCccc-cccceeeeeCCeeEEEEecCC
Q 020221           65 HGEKAPNVVYKGKLEN-------QFRIAVKRFNRSAWPDARQFLEEARAVGQLRNRRL-ANLLGCCCEGDERLLVAEYMP  136 (329)
Q Consensus        65 lg~G~~g~V~~~~~~~-------~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~ni-v~~~~~~~~~~~~~lv~e~~~  136 (329)
                      +..|--..+|+....+       ++.+++|+..... .......+|.+++..+...++ .++++++.    -.+|+||++
T Consensus         6 l~gGltN~~y~v~~~~~~~~~~~~~~~vlRi~~~~~-~~~~~r~~E~~~~~~l~~~g~~P~~~~~~~----~~~v~e~i~   80 (302)
T cd05156           6 ISGGLTNAVYKVSLPDEDALSDEPRKVLLRVYGQSV-ELLIDRERELVVFARLSERNLGPKLYGIFP----NGRIEEFIP   80 (302)
T ss_pred             ecCcccceeEEEEcCCcccccCCCCeEEEEEecCCC-cceechHHHHHHHHHHHhCCCCCceEEEeC----CCchhheeC
Confidence            3456666889888654       5789999976643 223345678888888753333 34444442    246899988


Q ss_pred             CCCHH
Q 020221          137 NDTLA  141 (329)
Q Consensus       137 ~gsL~  141 (329)
                      |.++.
T Consensus        81 G~~l~   85 (302)
T cd05156          81 SRTLT   85 (302)
T ss_pred             CCcCC
Confidence            87664

The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer

>COG3173 Predicted aminoglycoside phosphotransferase [General function prediction only]

Probab=97.30  E-value=0.0063  Score=53.82  Aligned_cols=155  Identities=14%  Similarity=0.118  Sum_probs=85.2

Q ss_pred             cCCCcccccccCCCCCCcEEEEEEeCCCCEEEEEEeC-CCCChhHHHHHHHHHHHhcCCC--ccccccceeeeeCC--ee
Q 020221           54 SGFAMENIVSEHGEKAPNVVYKGKLENQFRIAVKRFN-RSAWPDARQFLEEARAVGQLRN--RRLANLLGCCCEGD--ER  128 (329)
Q Consensus        54 ~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~-~~~~~~~~~~~~e~~~l~~l~h--~niv~~~~~~~~~~--~~  128 (329)
                      ..+....+++.+..|.-..+|..... +++++++... ...........+|...++.+.-  --+...++.|.++.  ..
T Consensus        22 p~~~~~~~v~~~~~G~sn~t~~~~~~-~~~~vlR~P~~~~~~~~~~~~~re~~~i~~l~~~~vP~p~~~~~~~~~~~g~p  100 (321)
T COG3173          22 PGYAGLLIVEEISGGWSNDTFRLGDT-GQKYVLRKPPRGDPVESAHDEKREYRVIAALLDVDVPVPRAFGLCGEGYLGTP  100 (321)
T ss_pred             cCcCCCceeeeccCCcccceEEEecC-CceEEEecCCccccchhhhHHHhHHHHHHHhcCCCCCCcccccccccCCCCCc
Confidence            34444555555544444444554443 7788888321 1223334556677777777632  22344566666655  67


Q ss_pred             EEEEecCCCCCHHhhh------------------ccC------------CCCCCCHHHHHHHHHHH--------------
Q 020221          129 LLVAEYMPNDTLAKHL------------------FHW------------ETQPMKWAMRLRVALHI--------------  164 (329)
Q Consensus       129 ~lv~e~~~~gsL~~~l------------------~~~------------~~~~~~~~~~~~i~~~i--------------  164 (329)
                      |.||+|++|..+.+.+                  ...            ........+...+..+.              
T Consensus       101 f~v~~~veGe~~~~~~~~~~~~~~~~~~~l~~~La~LH~ida~~~~~~g~~~~~~~rql~~~~~~~~~~~~~~~~~~p~~  180 (321)
T COG3173         101 FYVMEWVEGEVVWSALPPESLGRQFALDALADFLAELHSIDAAGLPDPGKPNAYRGRQLARWDDEYRRAKKELGGRIPLA  180 (321)
T ss_pred             eEEEEEecceeccCcCCcccchHHHHHHHHHHHHHHHhCCCCcCCCCCCccCccccchhhHHHHHHHHHHHhccCCCchH
Confidence            9999999873222211                  100            00000011111111111              


Q ss_pred             HHHHHHhhcC-------CCccccccCCCceeeCCCCCeeeecccCcccCCCC
Q 020221          165 AEALEYCTSK-------ERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDG  209 (329)
Q Consensus       165 ~~~l~~lH~~-------~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~  209 (329)
                      ..-..+|+..       ..++|+|+.+.|++++..+-+-+.||+++....+.
T Consensus       181 ~~~~~Wl~~~~p~~~~~~~lvHGD~~~gNlii~~~~~~gVlDwe~~~lGDP~  232 (321)
T COG3173         181 DRLIKWLEANRPPWAGPPVLVHGDYRPGNLIIDPGRPTGVLDWELATLGDPL  232 (321)
T ss_pred             HHHHHHHHhcCCCcCCCceeeeCCcccCCEEEeCCCeeEEEeccccccCCcH
Confidence            1122344332       34799999999999998888999999998765443

>cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2')

Probab=97.28  E-value=0.0045  Score=54.05  Aligned_cols=30  Identities=23%  Similarity=0.215  Sum_probs=25.1

Q ss_pred             CccccccCCCceeeCCCCC-eeeecccCccc
Q 020221          176 RALYHDLNAYRIVFDDDVN-PRLSCFGLMKN  205 (329)
Q Consensus       176 ~ivH~dlkp~Nil~~~~~~-~kl~Dfg~a~~  205 (329)
                      .++|+|++|.||++++++. .-|+||+.+..
T Consensus       186 ~lvHGD~~~~Nilv~~~~~~~gviDWe~a~i  216 (276)
T cd05152         186 VLVHGDLHPGHILIDEDARVTGLIDWTEAKV  216 (276)
T ss_pred             eeEeCCCCCCcEEEeCCCCEEEEECcHhccc
Confidence            4799999999999997555 56999998754

MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported

>KOG2268 consensus Serine/threonine protein kinase [Signal transduction mechanisms; General function prediction only]

Probab=97.22  E-value=0.00066  Score=59.35  Aligned_cols=148  Identities=14%  Similarity=0.072  Sum_probs=97.0

Q ss_pred             cCHHHHHHHhcCCCcccccccCCCCCCcEEEEEEeCCCCEEEEEEeCCCCCh-----------------hH-----HHHH
Q 020221           44 YSIETLRTATSGFAMENIVSEHGEKAPNVVYKGKLENQFRIAVKRFNRSAWP-----------------DA-----RQFL  101 (329)
Q Consensus        44 ~~~~~~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~-----------------~~-----~~~~  101 (329)
                      +++..|....+.=.-+.+-.+||-|--+.||.+...+|.+.++|.-+....+                 .+     -...
T Consensus        79 yDyLAlktL~~R~~v~svGnqIGVGKESDIY~v~d~~G~~~~lK~HRLGRtSFR~Vk~kRDY~r~r~~~sWlyLSRlaa~  158 (465)
T KOG2268|consen   79 YDYLALKTLSNRGSVESVGNQIGVGKESDIYVVADEEGNPLILKLHRLGRTSFRNVKNKRDYLRKRKSGSWLYLSRLAAT  158 (465)
T ss_pred             chHHHHHHHHhcchhhhhccccccccccceEEEecCCCCchhHHHHhhhhhhHHHhhhhhhhHhcCCccchhhhHHHHHH
Confidence            3444454444444445566778999999999999988999999864322110                 11     1234


Q ss_pred             HHHHHHhcCC-Cc-cccccceeeeeCCeeEEEEecCCCCCHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCccc
Q 020221          102 EEARAVGQLR-NR-RLANLLGCCCEGDERLLVAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALY  179 (329)
Q Consensus       102 ~e~~~l~~l~-h~-niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH  179 (329)
                      +|+..|+.+. |. -+.+.+++    +..++|||++.+-.|...-.     -.+.   ..+...+..-+.-|... |+||
T Consensus       159 kEfafmkaL~e~gfpVPkpiD~----~RH~Vvmelv~g~Pl~~v~~-----v~d~---~~ly~~lm~~Iv~la~~-GlIH  225 (465)
T KOG2268|consen  159 KEFAFMKALYERGFPVPKPIDH----NRHCVVMELVDGYPLRQVRH-----VEDP---PTLYDDLMGLIVRLANH-GLIH  225 (465)
T ss_pred             HHHHHHHHHHHcCCCCCCcccc----cceeeHHHhhcccceeeeee-----cCCh---HHHHHHHHHHHHHHHHc-Ccee
Confidence            6777777774 22 23444443    45688999998876655321     1122   23334444455566666 9999


Q ss_pred             cccCCCceeeCCCCCeeeecccCcc
Q 020221          180 HDLNAYRIVFDDDVNPRLSCFGLMK  204 (329)
Q Consensus       180 ~dlkp~Nil~~~~~~~kl~Dfg~a~  204 (329)
                      +|..-=||++++++.++++||--..
T Consensus       226 gDFNEFNimv~dd~~i~vIDFPQmv  250 (465)
T KOG2268|consen  226 GDFNEFNIMVKDDDKIVVIDFPQMV  250 (465)
T ss_pred             cccchheeEEecCCCEEEeechHhh
Confidence            9999999999999999999997543

>KOG1826 consensus Ras GTPase activating protein RasGAP/neurofibromin [Defense mechanisms]

Probab=97.13  E-value=6.8e-05  Score=76.93  Aligned_cols=154  Identities=12%  Similarity=-0.079  Sum_probs=109.9

Q ss_pred             HHHHHHHHHhcCCCccccccceeee--eCCeeEEEEecCCCCCHHhhhccCCC--CCCCHHHHHHHHHHHHHHHHHhhcC
Q 020221           99 QFLEEARAVGQLRNRRLANLLGCCC--EGDERLLVAEYMPNDTLAKHLFHWET--QPMKWAMRLRVALHIAEALEYCTSK  174 (329)
Q Consensus        99 ~~~~e~~~l~~l~h~niv~~~~~~~--~~~~~~lv~e~~~~gsL~~~l~~~~~--~~~~~~~~~~i~~~i~~~l~~lH~~  174 (329)
                      ....|...++..+|+++.....-..  +....+..++|+.+|.+.+.+.+...  ..+...-+....++......-+|+.
T Consensus      1275 mll~e~de~~~~~h~~~~~~p~rI~ps~s~ee~~r~~~~~~g~~f~iIikg~ee~~~ld~~~v~~~~kvsvl~~~~~ls~ 1354 (2724)
T KOG1826|consen 1275 MLLSERDELREAKHYLTEVDPLRIPPSESTEEYIRSLYVEFGKLFSIIIKGLEESPDLDRSPVHLRHKVSVLNRNVILSL 1354 (2724)
T ss_pred             hhhhhhhhhhhhhceeeecccccCCCCCChHHHHHHHHHHHhHHHHHHHhccccCCcchhchHHHHHHHHHhccchhhhc
Confidence            3455666666778988876554332  23467899999999999998875322  2333333333334435555555553


Q ss_pred             C----CccccccCCCceeeCCCCCeeeecccCcccCCCCCC----ccCcccccCcccccCCCCCCcccchhhhHHHHHHH
Q 020221          175 E----RALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDGRS----YSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLL  246 (329)
Q Consensus       175 ~----~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~~----~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~  246 (329)
                      .    -.+|+++|+.|.++..+-+++++++|+.+...+...    ..+++.|++|+..+.-.++.++|+|..|+-+|+..
T Consensus      1355 tnlg~T~v~~~Lkf~lpmIVtny~v~~gk~gLdKIknp~~sf~Gl~l~sp~~v~qli~N~ik~t~rsdilr~s~~ly~rs 1434 (2724)
T KOG1826|consen 1355 TNLGNTNVSKSLKFTLPMIVTNYNVKLGKGGLDKIKNPVLSFFGLELCSPIYVLQLIKNEIKFTKRSDILRRSLSLYLRS 1434 (2724)
T ss_pred             ccCCccchhhhhhhhccceecCCcccccccccccccCchHhhhhhhhCCHHHHHHHHHHHHhhhhHHHHHHHHHHHHHHh
Confidence            2    248999999999999999999999999984444333    34567899999888888898899999999999998


Q ss_pred             hCCCCC
Q 020221          247 SGKHIP  252 (329)
Q Consensus       247 tg~~~~  252 (329)
                      -|..++
T Consensus      1435 ~~n~~f 1440 (2724)
T KOG1826|consen 1435 DGNAYF 1440 (2724)
T ss_pred             cccHHH
Confidence            888544

>TIGR01767 MTRK 5-methylthioribose kinase

Probab=97.05  E-value=0.0081  Score=53.96  Aligned_cols=74  Identities=16%  Similarity=0.013  Sum_probs=47.0

Q ss_pred             cCCCCCCcEEEEEEeCCC-CEEEEEEeCC-------CCChhHHHHHHHHHHHhcCC--CccccccceeeeeCCeeEEEEe
Q 020221           64 EHGEKAPNVVYKGKLENQ-FRIAVKRFNR-------SAWPDARQFLEEARAVGQLR--NRRLANLLGCCCEGDERLLVAE  133 (329)
Q Consensus        64 ~lg~G~~g~V~~~~~~~~-~~vavK~~~~-------~~~~~~~~~~~e~~~l~~l~--h~niv~~~~~~~~~~~~~lv~e  133 (329)
                      .+|-|....||++...+| +.|+||.-..       +-.-.......|...|+...  -|..++-+-+ .++....+|||
T Consensus         2 EigdGnlN~VfrV~~~~g~~svIVKQAlp~vRv~g~~wpl~~~R~~~E~~~L~~~~~~~P~~vP~vy~-~D~e~~~~vME   80 (370)
T TIGR01767         2 EVGDGNLNLVFHVYDQEGDRAAIVKQALPYVRVVGESWPLTLDRARIESSALIRQGEHVPHLVPRIFH-FDTEMAVTVME   80 (370)
T ss_pred             cCCCCceEEEEEEEcCCCCeeEEEEEcCHHHhhcCCCCCCCccHHHHHHHHHHHhhccCccccCeEEE-EccccceehHh
Confidence            468999999999996554 5899997431       11223445556777777663  3433333322 35567779999


Q ss_pred             cCCCC
Q 020221          134 YMPND  138 (329)
Q Consensus       134 ~~~~g  138 (329)
                      +++..
T Consensus        81 dL~~~   85 (370)
T TIGR01767        81 DLSHH   85 (370)
T ss_pred             hCccc
Confidence            98553

This enzyme is involved in the methionine salvage pathway in certain bacteria.

>PLN02756 S-methyl-5-thioribose kinase

Probab=97.04  E-value=0.014  Score=53.49  Aligned_cols=74  Identities=15%  Similarity=0.068  Sum_probs=49.2

Q ss_pred             ccccCCCCCCcEEEEEEeCCCCEEEEEEeCCCCC-------hhHHHHHHHHHHHhcCC---CccccccceeeeeCCeeEE
Q 020221           61 IVSEHGEKAPNVVYKGKLENQFRIAVKRFNRSAW-------PDARQFLEEARAVGQLR---NRRLANLLGCCCEGDERLL  130 (329)
Q Consensus        61 ~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~-------~~~~~~~~e~~~l~~l~---h~niv~~~~~~~~~~~~~l  130 (329)
                      ..+.+|-|....||+.... +..++||.-.....       -....-..|...|+.+.   ..++.+++.++.  +..++
T Consensus        36 ~~~eiggGn~N~VyrV~~~-~~svVVKqa~p~~r~vga~wpl~~~R~~~Ea~aL~~~~~~~p~~VPkVy~~de--d~~vl  112 (418)
T PLN02756         36 KIKEVGDGNLNFVYIVVSS-SGSFVIKQALPYIRCIGESWPMTKERAYFEATALREHGRLCPDHVPEVYHFDR--TMALI  112 (418)
T ss_pred             eEEEcCCCceeeEEEEEcC-CccEEEEeCCccccCCCccccCCccHHHHHHHHHHHhhhcCCCCCCeEEEECC--CCCEE
Confidence            3456799999999998864 45799998652111       12333445666666653   246777887775  55788


Q ss_pred             EEecCCC
Q 020221          131 VAEYMPN  137 (329)
Q Consensus       131 v~e~~~~  137 (329)
                      +||++++
T Consensus       113 vME~L~~  119 (418)
T PLN02756        113 GMRYLEP  119 (418)
T ss_pred             EEeecCC
Confidence            8999976

>PLN02236 choline kinase

Probab=97.03  E-value=0.0046  Score=55.79  Aligned_cols=138  Identities=13%  Similarity=0.099  Sum_probs=79.1

Q ss_pred             ccCCCCCCcEEEEEEeCC-----CCEEEEEEeCCCCChhHHHHHHHHHHHhcCCCcccc-ccceeeeeCCeeEEEEecCC
Q 020221           63 SEHGEKAPNVVYKGKLEN-----QFRIAVKRFNRSAWPDARQFLEEARAVGQLRNRRLA-NLLGCCCEGDERLLVAEYMP  136 (329)
Q Consensus        63 ~~lg~G~~g~V~~~~~~~-----~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv-~~~~~~~~~~~~~lv~e~~~  136 (329)
                      ..+.-|-...+|+....+     ++.|++|+......... .-.+|..+++.+..-++. ++++.+..    ..|.+|++
T Consensus        42 ~~l~gGlTN~~y~v~~~~~~~~~~~~~v~Ri~g~~t~~~i-dR~~E~~~~~~l~~~gl~P~~~~~~~~----g~v~efi~  116 (344)
T PLN02236         42 IPLKGAMTNEVFQIKWPTKEGNLGRKVLVRIYGEGVELFF-DRDDEIRTFECMSRHGQGPRLLGRFPN----GRVEEFIH  116 (344)
T ss_pred             EEcCCcccceeEEEEeCCCCCCCCCeEEEEEccCCCCeee-chHHHHHHHHHHHHcCCCCceEEEECC----ceEEEeeC
Confidence            344457778999987532     36799998876542222 236788888888544433 44555432    25899987


Q ss_pred             CCCHHhh-----------------hccCC--CC--CCCHHHHHHHHHHH-----------------HHHHHH----hhc-
Q 020221          137 NDTLAKH-----------------LFHWE--TQ--PMKWAMRLRVALHI-----------------AEALEY----CTS-  173 (329)
Q Consensus       137 ~gsL~~~-----------------l~~~~--~~--~~~~~~~~~i~~~i-----------------~~~l~~----lH~-  173 (329)
                      +.+|...                 +++..  ..  ...+.++..+..++                 ...+..    +.. 
T Consensus       117 g~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~~~~~~~~l~~~~~~~~~~~~~l~~~~~~L~~~~~~~  196 (344)
T PLN02236        117 ARTLSAADLRDPEISALIAAKLREFHSLDMPGPKNVLLWDRLRNWLKEAKNLCSPEEAKEFRLDSLEDEINLLEKELSGD  196 (344)
T ss_pred             CCCCCHHHcCChHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhhcCcchhhhcCHHHHHHHHHHHHHHhccc
Confidence            7665421                 11101  00  11233333333221                 111111    111 


Q ss_pred             --CCCccccccCCCceeeCC-CCCeeeecccCccc
Q 020221          174 --KERALYHDLNAYRIVFDD-DVNPRLSCFGLMKN  205 (329)
Q Consensus       174 --~~~ivH~dlkp~Nil~~~-~~~~kl~Dfg~a~~  205 (329)
                        ...++|+|+++.||++++ ++.+.++||..+..
T Consensus       197 ~~~~~~cH~Dl~~~Nil~~~~~~~~~lID~Eya~~  231 (344)
T PLN02236        197 DQEIGFCHNDLQYGNIMIDEETRAITIIDYEYASY  231 (344)
T ss_pred             CCCceEEeCCCCcCcEEEeCCCCcEEEEeehhccc
Confidence              125799999999999986 57899999988753

>KOG1093 consensus Predicted protein kinase (contains TBC and RHOD domains) [General function prediction only]

Probab=96.83  E-value=0.0037  Score=57.98  Aligned_cols=160  Identities=20%  Similarity=0.248  Sum_probs=89.1

Q ss_pred             hHHHHHHHHHHHhcCCCccccccceeeeeC-CeeEEEEecCCCCCHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcC
Q 020221           96 DARQFLEEARAVGQLRNRRLANLLGCCCEG-DERLLVAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSK  174 (329)
Q Consensus        96 ~~~~~~~e~~~l~~l~h~niv~~~~~~~~~-~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~  174 (329)
                      ...++.-..+.++.++|+|....+.+.... ....+|+|++ +.||.+.+..+.   +......              ..
T Consensus        25 ~s~~ilgr~~~lktl~~~~l~~yl~~~r~~~~r~IVV~e~~-~~Sled~~~~~~---l~~~s~~--------------~~   86 (725)
T KOG1093|consen   25 NSIQILGRFQYLKSLQHDNLCQYLDFSRGKHERVIVVMEHY-TMSLEDILKTGN---LKDESLL--------------AH   86 (725)
T ss_pred             cHHHHhhhhHHHHhhcCccceeeEeeecCccceEEEEehhh-ccchHHHHHhcc---cchhhhc--------------cc
Confidence            345677778999999999999988776433 3467889998 458999885322   2111100              11


Q ss_pred             CCccccccCCCceeeCCCCCeeeecccCcccCCCCCCccCcccccCcccccCCCCCCcccchhhhHHHHHHHhCCCCCCc
Q 020221          175 ERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDGRSYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPS  254 (329)
Q Consensus       175 ~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~~~~~  254 (329)
                       ++.|-     |++       +++| -++...              |-     ...+|+||||+|.++.++..|...+..
T Consensus        87 -~~~~~-----~~~-------~~td-~~~t~~--------------~~-----~~~pKsdVwsl~~i~~el~L~~~l~~~  133 (725)
T KOG1093|consen   87 -GVLHL-----NII-------YITD-HFLTKY--------------PS-----PIGPKSDVWSLGFIILELYLGISLEAE  133 (725)
T ss_pred             -cccee-----hhh-------hccc-cccccC--------------CC-----CCCcchhhhhHHHHHHHHHHhhHHHHH
Confidence             33332     122       2233 111000              00     111499999999999999998854332


Q ss_pred             hhhHHHhhhchhhhc-cccc------cCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHH
Q 020221          255 HALDLIRDRNIQTLT-DSCL------EGQFSSDEGTELVRLASRCLQYEPRERPNPRSLV  307 (329)
Q Consensus       255 ~~~~~~~~~~~~~~~-~~~~------~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~~~l  307 (329)
                      ......... +.... .+..      ...+.-.+...++++...|+...|..||...++.
T Consensus       134 ~~~s~~l~~-i~k~~~~d~~~~~~a~e~~~~~~~d~~~~~~~~~c~~~~~~ir~l~~~~~  192 (725)
T KOG1093|consen  134 LTESEYLEI-LLKYYTDDQELLSTAMEHLIQLLADKKRLPLLKKCLWLEPIIRPLPMELS  192 (725)
T ss_pred             HHHHHHHHH-HHHhccCchhHHHHHHHHHHHHhhhHhHHHHhccCCccccccccchhHHh
Confidence            111100000 00000 0000      0011224567788999999999999998655443

>TIGR02906 spore_CotS spore coat protein, CotS family

Probab=96.64  E-value=0.024  Score=50.24  Aligned_cols=28  Identities=14%  Similarity=0.070  Sum_probs=24.9

Q ss_pred             CccccccCCCceeeCCCCCeeeecccCcc
Q 020221          176 RALYHDLNAYRIVFDDDVNPRLSCFGLMK  204 (329)
Q Consensus       176 ~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~  204 (329)
                      +++|+|+.+.||+++. +.+.++||+.+.
T Consensus       188 ~liHgD~~~~Nil~~~-~~i~lIDfd~~~  215 (313)
T TIGR02906       188 GFCHQDYAYHNILLKD-NEVYVIDFDYCT  215 (313)
T ss_pred             ceEcCCCCcccEEEeC-CcEEEEECcccc
Confidence            7899999999999997 678999999754

Members of this family include the spore coat proteins CotS and YtaA from Bacillus subtilis and, from other endospore-forming bacteria, homologs that are more closely related to these two than to the spore coat proteins YutH and YsxE. The CotS family is more broadly distributed than YutH or YsxE, but still is not universal among spore-formers.

>PF03881 Fructosamin_kin: Fructosamine kinase; InterPro: IPR016477 Ketosamines derive from a non-enzymatic reaction between a sugar and a protein []

Probab=96.63  E-value=0.0096  Score=52.15  Aligned_cols=72  Identities=18%  Similarity=0.164  Sum_probs=45.1

Q ss_pred             ccCCCCCCcEEEEEEeCCCCEEEEEEeCCCCChhHHHHHHHHHHHhcCC---CccccccceeeeeCCeeEEEEecCCCC
Q 020221           63 SEHGEKAPNVVYKGKLENQFRIAVKRFNRSAWPDARQFLEEARAVGQLR---NRRLANLLGCCCEGDERLLVAEYMPND  138 (329)
Q Consensus        63 ~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~---h~niv~~~~~~~~~~~~~lv~e~~~~g  138 (329)
                      +.++-|.-..+|+.. .+++.+-||.-...   ....|..|..-|+.|.   .-.+.+.+++....+..+|++||++.+
T Consensus        23 ~~v~GG~i~~a~~~~-~~~~~~FvK~~~~~---~~~~f~~Ea~gL~~L~~~~~~~vP~vi~~G~~~~~~fLlle~l~~~   97 (288)
T PF03881_consen   23 EPVSGGDINEAYRLD-TDGGSYFVKVNSES---GRDMFEGEAEGLKALAEANPIRVPKVIAWGEYDDDAFLLLEFLEMG   97 (288)
T ss_dssp             EEE--SSSSEEEEEE-TTS-EEEEEEEEGG---GCCHHHHHHHHHHHHCHTTTSBS--EEEEEE-SSCCEEEEE-----
T ss_pred             EecCCCChhheEEEE-CCCccEEEEecChh---hHHHHHHHHHHHHHHHhcCCCCCCeEEEEEeecCCceEEEEeecCC
Confidence            345778888998887 56678999987632   2345777888777773   445778888887777789999999765

Ketosamine-3-kinases (KT3K), of which fructosamine-3-kinase (FN3K) is the best-known example, catalyse the phosphorylation of the ketosamine moiety of glycated proteins. The instability of a phosphorylated ketosamine leads to its degradation, and KT3K is thus thought to be involved in protein repair []. The function of the prokaryotic members of this group has not been established. However, several lines of evidence indicate that they may function as fructosamine-3-kinases (FN3K). First, they are similar to characterised FN3K from mouse and human. Second, the Escherichia coli members are found in close proximity on the genome to fructose-6-phosphate kinase (PfkB). Last, FN3K activity has been found in a Anacystis montana (Gloeocapsa montana Kutzing 1843) [], indicating such activity-directly demonstrated in eukaryotes-is nonetheless not confined to eukaryotes. This family includes eukaryotic fructosamine-3-kinase enzymes [] which may initiate a process leading to the deglycation of fructoselysine and of glycated proteins and in the phosphorylation of 1-deoxy-1-morpholinofructose, fructoselysine, fructoseglycine, fructose and glycated lysozyme. The family also includes bacterial members that have not been characterised but probably have a similar or identical function. For additional information please see [].; PDB: 3JR1_B 3F7W_A.

>KOG1236 consensus Predicted unusual protein kinase [General function prediction only]

Probab=96.46  E-value=0.011  Score=53.59  Aligned_cols=60  Identities=17%  Similarity=0.102  Sum_probs=44.7

Q ss_pred             eEEEEecCCCCCHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeC
Q 020221          128 RLLVAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFD  190 (329)
Q Consensus       128 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~  190 (329)
                      ..++-+|..|-++..++   .....++.-...++.-...|+--+---.+.+|.|++|.||++-
T Consensus       320 ~vl~E~~~~Gl~v~~~v---~~~~~pe~l~kkva~lg~~AllkMl~vDNFvHaDlHPGNVlir  379 (565)
T KOG1236|consen  320 LVLVETYERGLSVLRFV---KWKSQPEALVKKVAKLGVNALLKMLIVDNFVHADLHPGNVLIR  379 (565)
T ss_pred             ceeeeeccccccHHhhh---hcccChHHHHHHHHHHHHHHHHHHHHhhcceecccCCCcEEEE
Confidence            35666788888888888   4455666667777777777765554333899999999999994

>PRK11768 serine/threonine protein kinase; Provisional

Probab=96.34  E-value=0.24  Score=44.35  Aligned_cols=97  Identities=16%  Similarity=0.110  Sum_probs=53.8

Q ss_pred             ccccCHHHHHHHhcCC--CcccccccCCCCCCcEEEEEEeCCCCEEEEEEeCCCCChhHHHHHHHHHHHhcCCCcc--cc
Q 020221           41 FCEYSIETLRTATSGF--AMENIVSEHGEKAPNVVYKGKLENQFRIAVKRFNRSAWPDARQFLEEARAVGQLRNRR--LA  116 (329)
Q Consensus        41 ~~~~~~~~~~~~~~~~--~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~n--iv  116 (329)
                      +..++.+.+..+...+  .....+..++ +.-..||+....++..+++|+.+... ....++..|.+.+..+....  ++
T Consensus         8 ~~~l~p~~~~~a~~~~g~~~~~~~~~l~-s~eN~vy~v~~~~~~~~vlKv~r~~~-~~~~~i~~E~~~l~~L~~~gipv~   85 (325)
T PRK11768          8 FQTLTPDLILDALESLGLRVDGRLLALN-SYENRVYQFGDEDGRRVVAKFYRPER-WSDAQILEEHAFALELAEAEIPVV   85 (325)
T ss_pred             CCCCChHHHHHHHHHcCCCCccceEeec-cccceEEEEecCCCCEEEEEEcCccc-CCHHHHHHHHHHHHHHHHCCCCCC
Confidence            4445555555554333  2112222333 33467999987778789999886443 23456667777776663211  22


Q ss_pred             ccc---e--eeeeCCeeEEEEecCCCCC
Q 020221          117 NLL---G--CCCEGDERLLVAEYMPNDT  139 (329)
Q Consensus       117 ~~~---~--~~~~~~~~~lv~e~~~~gs  139 (329)
                      ...   |  ....++..+.++++++|..
T Consensus        86 ~p~~~~G~~~~~~~g~~~~l~~~~~G~~  113 (325)
T PRK11768         86 APLAFNGQTLHEHQGFRFALFPRRGGRA  113 (325)
T ss_pred             CCccCCCCEEEEECCEEEEEEeeeCCCC
Confidence            211   1  1122456778999987753

>PRK12396 5-methylribose kinase; Reviewed

Probab=96.29  E-value=0.031  Score=50.90  Aligned_cols=74  Identities=14%  Similarity=0.085  Sum_probs=48.5

Q ss_pred             cccCCCCCCcEEEEEEeC-CCCEEEEEEeCC------CCChhHHHHHHHHHHHhcCC--Ccc-ccccceeeeeCCeeEEE
Q 020221           62 VSEHGEKAPNVVYKGKLE-NQFRIAVKRFNR------SAWPDARQFLEEARAVGQLR--NRR-LANLLGCCCEGDERLLV  131 (329)
Q Consensus        62 ~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~------~~~~~~~~~~~e~~~l~~l~--h~n-iv~~~~~~~~~~~~~lv  131 (329)
                      ++.||-|.-.-||++... ++..|+||.-..      +-.-..++..-|.++|+...  -|. +.+++. + ++....+|
T Consensus        34 ~~eigdGnlN~VfrV~~~~~~~svIVKQAlp~vRv~~swpL~~~R~~~E~~aL~~~~~~~P~~VP~vy~-~-D~e~~~~v  111 (409)
T PRK12396         34 CKEIGDGNLNYVFRVWDEQKNISVIVKQAGDTARISDEFKLSTNRIRIESDVLQLEEELAPGLVPKVYL-F-DSVMNCCV  111 (409)
T ss_pred             eeEcCCCceEEEEEEeeCCCCceEEEEeccHhhccCCCCCCChHHHHHHHHHHHHHHhhCCCcCCeEEE-E-CcHHhhHH
Confidence            567799999999999964 356899986321      11223555667888887763  344 444443 3 45667788


Q ss_pred             EecCCC
Q 020221          132 AEYMPN  137 (329)
Q Consensus       132 ~e~~~~  137 (329)
                      ||+++.
T Consensus       112 MEdL~~  117 (409)
T PRK12396        112 MEDLSD  117 (409)
T ss_pred             HHhCcc
Confidence            998854

>PF07387 Seadorna_VP7: Seadornavirus VP7; InterPro: IPR009973 This family consists of several Seadornavirus specific VP7 proteins of around 305 residues in length

Probab=96.28  E-value=0.023  Score=47.28  Aligned_cols=151  Identities=13%  Similarity=0.063  Sum_probs=89.8

Q ss_pred             CCCcEEEEEEeCCCCEEEEEEeCCCCCh-hHHHHHHHHHHHhcCCCccccccceeeeeCCeeEEEEecCCCCCHHhhhcc
Q 020221           68 KAPNVVYKGKLENQFRIAVKRFNRSAWP-DARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAEYMPNDTLAKHLFH  146 (329)
Q Consensus        68 G~~g~V~~~~~~~~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~  146 (329)
                      ++.++.-.+.-+-| +..+|+++...-. ...-|..+.++++++.  .|+++..-  ......+|.|.|....       
T Consensus        73 ~gNsTl~~~kt~iG-~L~lKKi~slp~~~~~~~y~nky~v~Armh--GilrL~ND--n~~~yGvIlE~Cy~~~-------  140 (308)
T PF07387_consen   73 NGNSTLLIGKTKIG-PLFLKKIRSLPCCINDALYFNKYRVFARMH--GILRLKND--NNYKYGVILERCYKIK-------  140 (308)
T ss_pred             CCceEEEEeccccc-hhhhhhccCCCcccchhhhhhhhhHHHHhh--heeEeecC--CCceeEEEEeeccCcc-------
Confidence            44455555543334 4556666544333 2334677788888776  56666632  3446779999985421       


Q ss_pred             CCCCCCCHHHHHHHHHHHHHHHHHhh-cCCCccccccCCCceeeCCCCCeeeecccCcccCCCCCCccCcccccCccccc
Q 020221          147 WETQPMKWAMRLRVALHIAEALEYCT-SKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDGRSYSTNLAFTPPEYLR  225 (329)
Q Consensus       147 ~~~~~~~~~~~~~i~~~i~~~l~~lH-~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~y~aPE~~~  225 (329)
                          -...   -.+. .=+.+|.-.| +..+.+|+|..|+||+-|..|.+||.|-+.--        ..+..|.--|+  
T Consensus       141 ----i~~~---N~i~-agi~~L~~fH~~~~~~lHGD~np~NiM~D~~G~lKlVDP~~Ll--------~~~V~~vN~~Y--  202 (308)
T PF07387_consen  141 ----INFS---NFIT-AGIKDLMDFHSENQHCLHGDCNPDNIMCDKFGYLKLVDPVCLL--------ENQVNMVNIEY--  202 (308)
T ss_pred             ----cchh---HHHH-HhHHHHHHhhccCCCeecCCCChhheeecCCCCEEecChhhhh--------hheeeEEeeec--
Confidence                1111   1111 1135566678 34578999999999999999999999976421        11222333221  


Q ss_pred             CCCCCCcccchhhhHHHHHHHhCC
Q 020221          226 TGRVTPESVMYSFGTLLLDLLSGK  249 (329)
Q Consensus       226 ~~~~~~~~DvwslG~il~el~tg~  249 (329)
                       ...+.++.+-+|=..+++++...
T Consensus       203 -~~lT~~aE~~~fv~s~l~~v~~~  225 (308)
T PF07387_consen  203 -ESLTQEAEVKVFVKSCLKLVEKQ  225 (308)
T ss_pred             -cccChHHHHHHHHHHHHHHHHHH
Confidence             23456677777777777776654

The function of this family is unknown.

>PLN02421 phosphotransferase, alcohol group as acceptor/kinase

Probab=96.25  E-value=0.028  Score=50.46  Aligned_cols=136  Identities=15%  Similarity=0.162  Sum_probs=75.4

Q ss_pred             CCCCCCcEEEEEEeCC----CCEEEEEEeCCCCChhHHHHHHHHHHHhcCCCcccc-ccceeeeeCCeeEEEEecCCCCC
Q 020221           65 HGEKAPNVVYKGKLEN----QFRIAVKRFNRSAWPDARQFLEEARAVGQLRNRRLA-NLLGCCCEGDERLLVAEYMPNDT  139 (329)
Q Consensus        65 lg~G~~g~V~~~~~~~----~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv-~~~~~~~~~~~~~lv~e~~~~gs  139 (329)
                      +.-|=...+|+....+    +..|++|+....... .-.-.+|..+++.+..-++. ++++++..    .+|.+|+++.+
T Consensus        22 l~gGlTN~~~~v~~~~~~~~~~~~v~Ri~g~~t~~-~IdR~~E~~il~~l~~~gl~P~~l~~~~~----G~i~~fi~g~~   96 (330)
T PLN02421         22 ISGGITNLLLKVSVKEENGNEVSVTVRLFGPNTDY-VIDRERELQAIKYLSAAGFGAKLLGVFGN----GMIQSFINART   96 (330)
T ss_pred             eCCcccceEEEEEecCCCCCCceEEEEEecCCcCe-EechHHHHHHHHHHHhcCCCCceeEEeCC----cEeehhhcCCC
Confidence            3446667788887433    247999988654322 22235788888888654443 45555422    25889987765


Q ss_pred             HHh--------------hhccCCC------C-CCCHHHHHHHHHHH----------------------HHHHH---Hhh-
Q 020221          140 LAK--------------HLFHWET------Q-PMKWAMRLRVALHI----------------------AEALE---YCT-  172 (329)
Q Consensus       140 L~~--------------~l~~~~~------~-~~~~~~~~~i~~~i----------------------~~~l~---~lH-  172 (329)
                      |..              .+++...      . .-.+..+..+..++                      ..-+.   .+. 
T Consensus        97 l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~y~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~l~~~~~  176 (330)
T PLN02421         97 LTPSDMRKPKVAAEIAKELRRLHQVEIPGSKEPQLWNDIFKFYEKASTVKFEDPEKQKKYETISFEELRDEIVELKEITD  176 (330)
T ss_pred             CChHHCCCHHHHHHHHHHHHHHhCCCCCCCCCCcHHHHHHHHHHHhhhcccCcHHHhhhhcccCHHHHHHHHHHHHHHhc
Confidence            421              1111000      0 11233333332222                      11111   111 


Q ss_pred             cC---CCccccccCCCceeeCC-CCCeeeecccCccc
Q 020221          173 SK---ERALYHDLNAYRIVFDD-DVNPRLSCFGLMKN  205 (329)
Q Consensus       173 ~~---~~ivH~dlkp~Nil~~~-~~~~kl~Dfg~a~~  205 (329)
                      ..   .-.+|.|+.+.||++++ ++.++++||..|..
T Consensus       177 ~~~~~~v~CHnDl~~~NiL~~~~~~~l~lID~EYag~  213 (330)
T PLN02421        177 SLKAPVVFAHNDLLSGNLMLNEDEGKLYFIDFEYGSY  213 (330)
T ss_pred             cCCCCeEEEECCCCcccEEEeCCCCcEEEEcccccCC
Confidence            11   12689999999999974 57899999998754

>TIGR02904 spore_ysxE spore coat protein YsxE

Probab=96.21  E-value=0.066  Score=47.58  Aligned_cols=31  Identities=10%  Similarity=0.076  Sum_probs=27.9

Q ss_pred             CCccccccCCCceeeCCCCCeeeecccCccc
Q 020221          175 ERALYHDLNAYRIVFDDDVNPRLSCFGLMKN  205 (329)
Q Consensus       175 ~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~  205 (329)
                      .+++|+|+.++|+++++++.+.++||..+..
T Consensus       196 ~~lcHgD~~~~Nvl~~~~~~~~iIDfd~~~~  226 (309)
T TIGR02904       196 TVLVHGKLSLSHFLYDETRGGYFINFEKASF  226 (309)
T ss_pred             eeeeCCCCcHHhEEEcCCCCEEEEEhhhccc
Confidence            3789999999999999999999999998754

Members of this family are homologs of the Bacillus subtilis spore coat protein CotS. Members of this family, designated YsxE, are found only in the family Bacillaceae, from among the endospore-forming members of the Firmicutes branch of the Bacteria. As a rule, the ysxE gene is found immediately downstream of spoVID, a gene necessary for spore coat assembly. The protein has been shown to be part of the spore coat.

>COG2334 Putative homoserine kinase type II (protein kinase fold) [General function prediction only]

Probab=96.09  E-value=0.11  Score=46.57  Aligned_cols=145  Identities=17%  Similarity=0.297  Sum_probs=81.4

Q ss_pred             CCcccccccCCCCCCcEEEEEEeCCCCEEEEEEeCCCCChhHHHHHHHHHHHhcCCCccc------cccce----eeeeC
Q 020221           56 FAMENIVSEHGEKAPNVVYKGKLENQFRIAVKRFNRSAWPDARQFLEEARAVGQLRNRRL------ANLLG----CCCEG  125 (329)
Q Consensus        56 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~ni------v~~~~----~~~~~  125 (329)
                      +....-...|.. .-..+|+....+|.. ++|+.... . ...++..|...+.-+.-.++      ..+=|    ....+
T Consensus        25 ~g~~~~~~~l~s-~eN~~f~~~~~~g~~-iLki~~~~-~-~~~~i~~el~~l~~La~~~i~v~~Pl~~~dG~~l~~~~~~  100 (331)
T COG2334          25 YGLDGSLRGLNS-EENSNFRVQTEDGRY-ILKIYRPG-W-TRAEIPFELALLQHLAERGIPVPAPLPSLDGELLEALSGG  100 (331)
T ss_pred             cCcccccccccc-ccCceEEEEecCCCe-EEEEecCC-C-CHHHHHHHHHHHHHHHHcCCCCCCCccCCCcchhhhccCC
Confidence            333333344455 456799999777755 88888776 2 34456667777776632111      11111    11112


Q ss_pred             CeeEEEEecCCCCCHHh-h-----------h-------ccCC--CC----CCCHH-------------HHHHHHHHHHHH
Q 020221          126 DERLLVAEYMPNDTLAK-H-----------L-------FHWE--TQ----PMKWA-------------MRLRVALHIAEA  167 (329)
Q Consensus       126 ~~~~lv~e~~~~gsL~~-~-----------l-------~~~~--~~----~~~~~-------------~~~~i~~~i~~~  167 (329)
                      ...+-+++|++|..+.. .           +       ++..  ..    ...|.             .......++...
T Consensus       101 ~r~a~lf~~l~G~~~~~~~~~~~~~~lG~~LgrlH~a~~~f~~~~p~~~~~~~w~~~~~~~~~~~~~~~~~~l~a~~~~~  180 (331)
T COG2334         101 PRPAALFEYLPGRPLERDDNAEQLEELGRMLGRLHLALRGFPFERPNALRRLEWDILEPRALLRLDLVEPEDLRAALLAA  180 (331)
T ss_pred             ceeEEEEEecCCcCcCCCCcHHHHHHHHHHHHHHHHHhCcCCccCCCcccccchhhhcchhhhhhcccCchhhHHHHHHH
Confidence            36788999999877662 0           0       0001  00    11222             001122333333


Q ss_pred             HHHhhc-------CCC--ccccccCCCceeeCCCCC-eeeecccCcc
Q 020221          168 LEYCTS-------KER--ALYHDLNAYRIVFDDDVN-PRLSCFGLMK  204 (329)
Q Consensus       168 l~~lH~-------~~~--ivH~dlkp~Nil~~~~~~-~kl~Dfg~a~  204 (329)
                      +..+.+       ..+  +||+|+.|.||+++.+.. .-++||+.+.
T Consensus       181 ~~~~~~~~~~~lp~~~~~iIH~D~~~~NVl~d~~~~~~g~iDFdDa~  227 (331)
T COG2334         181 LDRLLARLPAHLPALGDQIIHGDLHPDNVLFDDDTDVSGFIDFDDAG  227 (331)
T ss_pred             HHHHHhhchhhCCcccceeeecCCCccceeEcCCCCeeeEEEccccc
Confidence            333333       223  899999999999998875 8899999764

>COG5072 ALK1 Serine/threonine kinase of the haspin family [Cell division and chromosome partitioning]

Probab=96.03  E-value=0.029  Score=50.17  Aligned_cols=75  Identities=16%  Similarity=0.050  Sum_probs=57.7

Q ss_pred             eeEEEEecCCCCCHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCCCCCeeeecccCcccC
Q 020221          127 ERLLVAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNS  206 (329)
Q Consensus       127 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~  206 (329)
                      ..|++|++- |++|. .+     ....+.+...++++-+..+.-+..+...-|||+.-.|||++ +|++-|+||-+++..
T Consensus       300 y~yl~~kdh-gt~is-~i-----k~~~~~e~lsff~s~~sil~~lekkf~fehrnlt~~niLId-~GnvtLIDfklsRl~  371 (488)
T COG5072         300 YLYLHFKDH-GTPIS-II-----KADRSEEELSFFWSCISILDILEKKFPFEHRNLTLDNILID-EGNVTLIDFKLSRLS  371 (488)
T ss_pred             EEEEEEecC-Cceee-ee-----ecccHHHHHHHHHHHHHHHhhhhhcCCcccccccccceeee-cCceEEEEeeeeecc
Confidence            456677764 33332 22     23467889999999998888887776788999999999999 999999999999854


Q ss_pred             CCC
Q 020221          207 RDG  209 (329)
Q Consensus       207 ~~~  209 (329)
                      .++
T Consensus       372 ~~q  374 (488)
T COG5072         372 YSQ  374 (488)
T ss_pred             cCC
Confidence            433

>COG3001 Uncharacterized protein conserved in bacteria [Function unknown]

Probab=95.64  E-value=0.16  Score=42.65  Aligned_cols=68  Identities=22%  Similarity=0.290  Sum_probs=46.9

Q ss_pred             cEEEEEE-e-CCCCEEEEEEeCCCCChhHHHHHHHHHHHhcCC---CccccccceeeeeCCeeEEEEecCCCCCHH
Q 020221           71 NVVYKGK-L-ENQFRIAVKRFNRSAWPDARQFLEEARAVGQLR---NRRLANLLGCCCEGDERLLVAEYMPNDTLA  141 (329)
Q Consensus        71 g~V~~~~-~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~---h~niv~~~~~~~~~~~~~lv~e~~~~gsL~  141 (329)
                      |.|..|. . .+..++-||+-...   ....|..|+.-|..+.   .-++.+.+.+..+.++.|+|+||++-+.+.
T Consensus        27 G~inea~~v~dg~~~~FvK~n~~~---~~~~f~AEa~gL~~la~s~ti~VP~vi~~G~~~~~sylVle~L~~~~~d   99 (286)
T COG3001          27 GDINEAWRLRDGTDPFFVKCNQRE---QLSMFTAEADGLELLARSNTITVPKVIAVGASRDHSYLVLEYLPTGPLD   99 (286)
T ss_pred             ccccceeEeecCCcceEEEecchh---hHHHHHHHHHHHHHHHhcCCccccceEEecCCCCeeEEEEeeccCCCCC
Confidence            3565554 2 34567888885432   2455777877777664   345777787888889999999999876554

>PRK06148 hypothetical protein; Provisional

Probab=95.56  E-value=0.41  Score=49.66  Aligned_cols=148  Identities=17%  Similarity=0.223  Sum_probs=80.1

Q ss_pred             cCCCcccccccCCCCCCcEEEEEEeCCCCEEEEEEeCCCCChhHHHHHHHHHHHhcC-------CCccccccc-ee----
Q 020221           54 SGFAMENIVSEHGEKAPNVVYKGKLENQFRIAVKRFNRSAWPDARQFLEEARAVGQL-------RNRRLANLL-GC----  121 (329)
Q Consensus        54 ~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-------~h~niv~~~-~~----  121 (329)
                      ..|.....++.|+ |..-.+|+....++..+++|+.+....  ......|.+.|.-|       .-|.+++-. |-    
T Consensus        22 ~~ygl~~~~~~L~-s~~d~nf~v~~~~g~~yVLKi~~~~~~--~~~~~~q~~~L~hL~~~~~glpvP~~i~t~~G~~~~~   98 (1013)
T PRK06148         22 QHFGISATATPLD-GERDLNFRLTTDDGADYILKIVNPSEP--RVESDFQTAALDHLAAVAPDLPVPRLIPSLSGASLAS   98 (1013)
T ss_pred             HHcCCceEEeecC-CcCCceEEEEeCCCCeEEEEEcCCccc--hhHHHHHHHHHHHHHhhCCCCCcCeeeecCCCCeEEE
Confidence            3444333345564 456788999877788899999986532  22333444455433       223333322 11    


Q ss_pred             eee-CC--eeEEEEecCCCCCHHhhh---------------------ccCCC----CCCCHHH-----------------
Q 020221          122 CCE-GD--ERLLVAEYMPNDTLAKHL---------------------FHWET----QPMKWAM-----------------  156 (329)
Q Consensus       122 ~~~-~~--~~~lv~e~~~~gsL~~~l---------------------~~~~~----~~~~~~~-----------------  156 (329)
                      ... .+  ..+-+++|++|..+.+..                     .....    ..+.|..                 
T Consensus        99 v~~~~G~~~~vrLl~~l~G~~l~~~~~~t~~~~~~lG~~larlh~al~~F~~p~~~r~~~Wdl~~~~~l~~~l~~i~d~~  178 (1013)
T PRK06148         99 AQDPDGEPRLLRLLSWLPGTPLAEAAPRTEALLDNLGRALGRLDRALQGFMHPGALRDLDWDLRHAGRARDRLHFIDDPE  178 (1013)
T ss_pred             eecCCCceEEEEEEeccCCCcHHhccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccccccccccchhhhhhhhhcCCHH
Confidence            111 11  466789999987665411                     00111    1122211                 


Q ss_pred             HHHHHHHHHHHHH-----Hhh--cCCCccccccCCCceeeCCCC--Cee-eecccCccc
Q 020221          157 RLRVALHIAEALE-----YCT--SKERALYHDLNAYRIVFDDDV--NPR-LSCFGLMKN  205 (329)
Q Consensus       157 ~~~i~~~i~~~l~-----~lH--~~~~ivH~dlkp~Nil~~~~~--~~k-l~Dfg~a~~  205 (329)
                      ...++.++.....     .+.  .. ++||.|+.+.|||++.++  .+. |+|||.+..
T Consensus       179 ~r~~l~~~~~~~~~~v~p~l~~Lp~-~vIHgDln~~NiLv~~~~~~~isGiIDFgDa~~  236 (1013)
T PRK06148        179 DRALVERFLARFERNVAPRLAALPA-QVIHNDANDYNILVDADDGERISGLIDFGDAVH  236 (1013)
T ss_pred             HHHHHHHHHHHHHHHHHHHHhcCCc-ceECCCCCcccEEEcCCCCcceEEEEECccccc
Confidence            1122223322221     111  23 799999999999999775  454 999998754

>PTZ00384 choline kinase; Provisional

Probab=94.83  E-value=0.22  Score=45.62  Aligned_cols=75  Identities=13%  Similarity=0.200  Sum_probs=43.7

Q ss_pred             cccCCCCCCcEEEEEEeCCC--CE-----EEEEEeCCCCChhHHHHHHHHHHHhcCCCccc-cccceeeeeCCeeEEEEe
Q 020221           62 VSEHGEKAPNVVYKGKLENQ--FR-----IAVKRFNRSAWPDARQFLEEARAVGQLRNRRL-ANLLGCCCEGDERLLVAE  133 (329)
Q Consensus        62 ~~~lg~G~~g~V~~~~~~~~--~~-----vavK~~~~~~~~~~~~~~~e~~~l~~l~h~ni-v~~~~~~~~~~~~~lv~e  133 (329)
                      ++.+.-|-.+.+|++...++  ..     |.++.... .....-.-.+|.++++.+...++ .++++.+.    -+++.|
T Consensus        55 i~~l~gGLTN~l~~v~~~~~~~~~~~~k~Vl~R~~g~-~~~l~IdR~~E~~i~~~Ls~~glgP~l~~~f~----~g~l~e  129 (383)
T PTZ00384         55 IKKMNNGITNQVYQATLVDGDKDRYPIKSVCIKKSST-YNSLVIDNDLQYNIAKLLGDNNFGPKIIGRFG----DFTIQE  129 (383)
T ss_pred             EEEeCCcccceEEEEEecCCCCCccccceEEEEeccC-CCceEeccHHHHHHHHHHHhCCCCCeEEEecC----CEEEEE
Confidence            34445577788999875432  12     44444322 11111223568889999865444 44555543    369999


Q ss_pred             cCCCCCHH
Q 020221          134 YMPNDTLA  141 (329)
Q Consensus       134 ~~~~gsL~  141 (329)
                      |++|-+|.
T Consensus       130 fIeGr~l~  137 (383)
T PTZ00384        130 WVEGNTMG  137 (383)
T ss_pred             EeccccCC
Confidence            99887664

>PRK10271 thiK thiamine kinase; Provisional

Probab=94.03  E-value=0.04  Score=44.84  Aligned_cols=30  Identities=20%  Similarity=0.170  Sum_probs=25.7

Q ss_pred             CccccccCCCceeeCCCCCeeeecccCcccC
Q 020221          176 RALYHDLNAYRIVFDDDVNPRLSCFGLMKNS  206 (329)
Q Consensus       176 ~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~  206 (329)
                      ..+|+|+.|.|+++++++ ++++||+.+...
T Consensus        78 ~p~H~D~~~~N~~~~~~~-~~lIDwe~a~~g  107 (188)
T PRK10271         78 APLHMDVHAGNLVHSASG-LRLIDWEYAGDG  107 (188)
T ss_pred             eeecCCCCCccEEEECCC-EEEEeCCcccCC
Confidence            458999999999998877 899999987543

---

Homologous Structure Templates

Structure Templates Detected by BLAST

Original result of BLAST against Protein Data Bank

ID	Length	Definition	E-value
Query	329
3tl8_A	349	The Avrptob-Bak1 Complex Reveals Two Structurally S		1e-25
3uim_A	326	Structural Basis For The Impact Of Phosphorylation		2e-25
2nry_A	307	Crystal Structure Of Irak-4 Length = 307		3e-20
2nru_A	307	Crystal Structure Of Irak-4 Length = 307		4e-20
2oib_A	301	Crystal Structure Of Irak4 Kinase Domain Apo Form L		5e-20
3hgk_A	327	Crystal Structure Of Effect Protein Avrptob Complex		5e-19
2qkw_B	321	Structural Basis For Activation Of Plant Immunity B		2e-18
2o8y_A	298	Apo Irak4 Kinase Domain Length = 298		4e-18
3oct_A	265	Crystal Structure Of Bruton's Tyrosine Kinase Mutan		6e-14
3k54_A	283	Structures Of Human Bruton's Tyrosine Kinase In Act		7e-14
3p08_A	267	Crystal Structure Of The Human Btk Kinase Domain Le		8e-14
3gen_A	283	The 1.6 A Crystal Structure Of Human Bruton's Tyros		8e-14
3pix_A	274	Crystal Structure Of Btk Kinase Domain Complexed Wi		9e-14
1k2p_A	263	Crystal Structure Of Bruton's Tyrosine Kinase Domai		9e-14
3ocs_A	271	Crystal Structure Of Bruton's Tyrosine Kinase In Co		1e-13
2z8c_A	303	Phosphorylated Insulin Receptor Tyrosine Kinase In		2e-13
1ir3_A	306	Phosphorylated Insulin Receptor Tyrosine Kinase In		2e-13
1irk_A	306	Crystal Structure Of The Tyrosine Kinase Domain Of		4e-13
3eta_A	317	Kinase Domain Of Insulin Receptor Complexed With A		4e-13
1i44_A	306	Crystallographic Studies Of An Activation Loop Muta		4e-13
1rqq_A	306	Crystal Structure Of The Insulin Receptor Kinase In		5e-13
1qpd_A	279	Structural Analysis Of The Lymphocyte-specific Kina		2e-12
3ekk_A	307	Insulin Receptor Kinase Complexed With An Inhibitor		3e-12
1p14_A	306	Crystal Structure Of A Catalytic-Loop Mutant Of The		3e-12
3kxz_A	287	The Complex Crystal Structure Of Lck With A Probe M		3e-12
2zm1_A	285	Crystal Structure Of Imidazo Pyrazin 1 Bound To The		3e-12
2ofv_A	277	Crystal Structure Of Aminoquinazoline 1 Bound To Lc		3e-12
1qpe_A	279	Structural Analysis Of The Lymphocyte-Specific Kina		3e-12
3bys_A	277	Co-Crystal Structure Of Lck And Aminopyrimidine Ami		3e-12
3bym_A	272	X-Ray Co-Crystal Structure Aminobenzimidazole Triaz		3e-12
2pl0_A	289	Lck Bound To Imatinib Length = 289		4e-12
2ofu_A	273	X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam		4e-12
3kmm_A	288	Structure Of Human Lck Kinase With A Small Molecule		4e-12
3lck_A	271	The Kinase Domain Of Human Lymphocyte Kinase (Lck),		4e-12
1k9a_A	450	Crystal Structure Analysis Of Full-Length Carboxyl-		4e-12
1byg_A	278	Kinase Domain Of Human C-Terminal Src Kinase (Csk)		4e-12
2og8_A	265	Crystal Structure Of Aminoquinazoline 36 Bound To L		4e-12
2of2_A	271	Crystal Structure Of Furanopyrimidine 8 Bound To Lc		4e-12
3d7u_A	263	Structural Basis For The Recognition Of C-Src By It		4e-12
3d7t_A	269	Structural Basis For The Recognition Of C-Src By It		7e-12
2zm3_A	308	Complex Structure Of Insulin-Like Growth Factor Rec		1e-11
3mpm_A	267	Lck Complexed With A Pyrazolopyrimidine Length = 26		1e-11
3qqu_A	301	Cocrystal Structure Of Unphosphorylated Igf With Py		2e-11
3i81_A	315	Crystal Structure Of Insulin-Like Growth Factor 1 R		2e-11
3o23_A	305	Human Unphosphorylated Igf1-R Kinase Domain In Comp		2e-11
1jqh_A	308	Igf-1 Receptor Kinase Domain Length = 308		2e-11
2oj9_A	307	Structure Of Igf-1r Kinase Domain Complexed With A		2e-11
1k3a_A	299	Structure Of The Insulin-Like Growth Factor 1 Recep		2e-11
1m7n_A	322	Crystal Structure Of Unactivated Apo Insulin-Like G		2e-11
3lvp_A	336	Crystal Structure Of Bisphosphorylated Igf1-R Kinas		3e-11
3lw0_A	304	Igf-1rk In Complex With Ligand Msc1609119a-1 Length		3e-11
1p4o_A	322	Structure Of Apo Unactivated Igf-1r Kinase Domain A		4e-11
3d94_A	301	Crystal Structure Of The Insulin-Like Growth Factor		5e-11
4asz_A	299	Crystal Structure Of Apo Trkb Kinase Domain Length		8e-11
3dk3_A	293	Crystal Structure Of Mutant Abl Kinase Domain In Co		2e-10
3cd3_A	377	Crystal Structure Of Phosphorylated Human Feline Sa		2e-10
3bkb_A	377	Crystal Structure Of Human Feline Sarcoma Viral Onc		3e-10
3dk6_A	293	Crystal Structure Of Mutant Abl Kinase Domain In Co		3e-10
3dk7_A	277	Crystal Structure Of Mutant Abl Kinase Domain In Co		3e-10
3oxz_A	284	Crystal Structure Of Abl Kinase Domain Bound With A		6e-10
2hiw_A	287	Crystal Structure Of Inactive Conformation Abl Kina		6e-10
2h8h_A	535	Src Kinase In Complex With A Quinazoline Inhibitor		6e-10
2e2b_A	293	Crystal Structure Of The C-Abl Kinase Domain In Com		6e-10
1yi6_A	276	C-Term Tail Segment Of Human Tyrosine Kinase (258-5		6e-10
2dq7_X	283	Crystal Structure Of Fyn Kinase Domain Complexed Wi		6e-10
2qoh_A	288	Crystal Structure Of Abl Kinase Bound With Ppy-a Le		7e-10
1fpu_A	293	Crystal Structure Of Abl Kinase Domain In Complex W		7e-10
3pyy_A	298	Discovery And Characterization Of A Cell-Permeable,		7e-10
2g1t_A	287	A Src-Like Inactive Conformation In The Abl Tyrosin		7e-10
3t9t_A	267	Crystal Structure Of Btk Mutant (F435t,K596r) Compl		7e-10
1ksw_A	452	Structure Of Human C-Src Tyrosine Kinase (Thr338gly		7e-10
3oy3_A	284	Crystal Structure Of Abl T315i Mutant Kinase Domain		7e-10
3miy_A	266	X-Ray Crystal Structure Of Itk Complexed With Sunit		7e-10
2bdf_A	279	Src Kinase In Complex With Inhibitor Ap23451 Length		8e-10
1fmk_A	452	Crystal Structure Of Human Tyrosine-Protein Kinase		9e-10
2z60_A	288	Crystal Structure Of The T315i Mutant Of Abl Kinase		9e-10
2hzi_A	277	Abl Kinase Domain In Complex With Pd180970 Length =		9e-10
2hyy_A	273	Human Abl Kinase Domain In Complex With Imatinib (S		1e-09
1y57_A	452	Structure Of Unphosphorylated C-Src In Complex With		1e-09
1sm2_A	264	Crystal Structure Of The Phosphorylated Interleukin		1e-09
3v5j_A	266	Crystal Structure Of Interleukin-2 Inducible T-Cell		1e-09
4hct_A	269	Crystal Structure Of Itk In Complex With Compound 5		1e-09
2hz0_A	270	Abl Kinase Domain In Complex With Nvp-Aeg082 Length		1e-09
3qri_A	277	The Crystal Structure Of Human Abl1 Kinase Domain I		1e-09
4fvp_A	289	Crystal Structure Of The Jak2 Pseudokinase Domain (		1e-09
2g2f_A	287	A Src-Like Inactive Conformation In The Abl Tyrosin		1e-09
2f4j_A	287	Structure Of The Kinase Domain Of An Imatinib-Resis		2e-09
3qrj_A	277	The Crystal Structure Of Human Abl1 Kinase Domain T		2e-09
3gvu_A	292	The Crystal Structure Of Human Abl2 In Complex With		2e-09
1yoj_A	283	Crystal Structure Of Src Kinase Domain Length = 283		2e-09
1yol_A	283	Crystal Structure Of Src Kinase Domain In Complex W		2e-09
2oiq_A	286	Crystal Structure Of Chicken C-Src Kinase Domain In		2e-09
3u4w_A	275	Src In Complex With Dna-Templated Macrocyclic Inhib		2e-09
3d7u_B	277	Structural Basis For The Recognition Of C-Src By It		2e-09
3dqw_A	286	C-Src Kinase Domain Thr338ile Mutant In Complex Wit		2e-09
3g6h_A	286	Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma		2e-09
3svv_A	286	Crystal Structure Of T338c C-Src Covalently Bound T		2e-09
3geq_A	286	Structural Basis For The Chemical Rescue Of Src Kin		2e-09
4fvr_A	289	Crystal Structure Of The Jak2 Pseudokinase Domain M		3e-09
2zv7_A	279	Lyn Tyrosine Kinase Domain, Apo Form Length = 279		3e-09
3sxr_A	268	Crystal Structure Of Bmx Non-Receptor Tyrosine Kina		3e-09
3qgw_A	286	Crystal Structure Of Itk Kinase Bound To An Inhibit		3e-09
3a4o_X	286	Lyn Kinase Domain Length = 286		3e-09
3oez_A	286	Crystal Structure Of The L317i Mutant Of The Chicke		3e-09
1opk_A	495	Structural Basis For The Auto-Inhibition Of C-Abl T		4e-09
2hwo_A	286	Crystal Structure Of Src Kinase Domain In Complex W		4e-09
2v7a_A	286	Crystal Structure Of The T315i Abl Mutant In Comple		4e-09
2ptk_A	453	Chicken Src Tyrosine Kinase Length = 453		4e-09
2fo0_A	495	Organization Of The Sh3-Sh2 Unit In Active And Inac		4e-09
2qq7_A	286	Crystal Structure Of Drug Resistant Src Kinase Doma		5e-09
2gqg_A	278	X-Ray Crystal Structure Of Dasatinib (Bms-354825) B		5e-09
1opl_A	537	Structural Basis For The Auto-Inhibition Of C-Abl T		5e-09
3lq8_A	302	Structure Of The Kinase Domain Of C-Met Bound To Xl		1e-08
2g15_A	318	Structural Characterization Of Autoinhibited C-Met		1e-08
3i5n_A	309	Crystal Structure Of C-Met With Triazolopyridazine		1e-08
2rfn_A	310	X-ray Structure Of C-met With Inhibitor. Length = 3		1e-08
2wgj_A	306	X-Ray Structure Of Pf-02341066 Bound To The Kinase		1e-08
3q6u_A	308	Structure Of The Apo Met Receptor Kinase In The Dua		1e-08
4gg5_A	319	Crystal Structure Of Cmet In Complex With Novel Inh		1e-08
2wd1_A	292	Human C-Met Kinase In Complex With Azaindole Inhibi		1e-08
3f66_A	298	Human C-Met Kinase In Complex With Quinoxaline Inhi		1e-08
3v5q_A	297	Discovery Of A Selective Trk Inhibitor With Efficac		2e-08
3pls_A	298	Ron In Complex With Ligand Amp-Pnp Length = 298		4e-08
1luf_A	343	Crystal Structure Of The Musk Tyrosine Kinase: Insi		8e-08
3nyx_A	302	Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T		9e-08
2ivs_A	314	Crystal Structure Of Non-Phosphorylated Ret Tyrosin		1e-07
3nz0_A	302	Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3		2e-07
3ugc_A	295	Structural Basis Of Jak2 Inhibition By The Type Ii		2e-07
4bbe_A	298	Aminoalkylpyrimidine Inhibitor Complexes With Jak2		3e-07
4aoj_A	329	Human Trka In Complex With The Inhibitor Az-23 Leng		4e-07
4f0i_A	300	Crystal Structure Of Apo Trka Length = 300		5e-07
4gt5_A	306	Crystal Structure Of The Inactive Trka Kinase Domai		6e-07
3lxn_A	318	Structural And Thermodynamic Characterization Of Th		6e-07
2xa4_A	298	Inhibitors Of Jak2 Kinase Domain Length = 298		6e-07
2w1i_A	326	Structure Determination Of Aurora Kinase In Complex		7e-07
3tjc_A	298	Co-Crystal Structure Of Jak2 With Thienopyridine 8		7e-07
2b7a_A	293	The Structural Basis Of Janus Kinase 2 Inhibition B		7e-07
4aqc_A	301	Triazolopyridine-Based Inhibitor Of Janus Kinase 2		7e-07
3q32_A	301	Structure Of Janus Kinase 2 With A Pyrrolotriazine		7e-07
4e4m_A	302	Jak2 Kinase (Jh1 Domain) In Complex With Compound 3		7e-07
4hge_A	300	Jak2 Kinase (Jh1 Domain) In Complex With Compound 8		7e-07
3e62_A	293	Fragment Based Discovery Of Jak-2 Inhibitors Length		7e-07
3lpb_A	295	Crystal Structure Of Jak2 Complexed With A Potent 2		7e-07
3io7_A	313	2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel		8e-07
3jy9_A	311	Janus Kinase 2 Inhibitors Length = 311		8e-07
3rvg_A	303	Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido		9e-07
1qcf_A	454	Crystal Structure Of Hck In Complex With A Src Fami		9e-07
2ivv_A	314	Crystal Structure Of Phosphorylated Ret Tyrosine Ki		1e-06
2ivt_A	314	Crystal Structure Of Phosphorylated Ret Tyrosine Ki		1e-06
1mqb_A	333	Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro		1e-06
2qok_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		1e-06
1ad5_A	438	Src Family Kinase Hck-Amp-Pnp Complex Length = 438		1e-06
2hk5_A	270	Hck Kinase In Complex With Lck Targetted Inhibitor		1e-06
2yjr_A	342	Structure Of F1174l Mutant Anaplastic Lymphoma Kina		1e-06
4e6d_A	298	Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W		1e-06
4fnw_A	327	Crystal Structure Of The Apo F1174l Anaplastic Lymp		2e-06
3gqi_A	326	Crystal Structure Of Activated Receptor Tyrosine Ki		2e-06
2r4b_A	321	Erbb4 Kinase Domain Complexed With A Thienopyrimidi		2e-06
2qof_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f		2e-06
2qod_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y602f		2e-06
2qoc_A	344	Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp		2e-06
3dzq_A	361	Human Epha3 Kinase Domain In Complex With Inhibitor		2e-06
2qoi_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		2e-06
3fxx_A	371	Human Epha3 Kinase And Juxtamembrane Region Bound T		2e-06
2gsf_A	373	The Human Epha3 Receptor Tyrosine Kinase And Juxtam		2e-06
2qoo_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		2e-06
2qol_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596:y		2e-06
3kxx_A	317	Structure Of The Mutant Fibroblast Growth Factor Re		2e-06
3bbt_B	328	Crystal Structure Of The Erbb4 Kinase In Complex Wi		2e-06
2yfx_A	327	Structure Of L1196m Mutant Anaplastic Lymphoma Kina		3e-06
3gql_A	326	Crystal Structure Of Activated Receptor Tyrosine Ki		3e-06
2yhv_A	342	Structure Of L1196m Mutant Anaplastic Lymphoma Kina		3e-06
2xb7_A	315	Structure Of Human Anaplastic Lymphoma Kinase In Co		3e-06
2xp2_A	327	Structure Of The Human Anaplastic Lymphoma Kinase I		3e-06
2qon_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		3e-06
3lct_A	344	Crystal Structure Of The Anaplastic Lymphoma Kinase		4e-06
4f0f_A	287	Crystal Structure Of The Roco4 Kinase Domain Bound		4e-06
3aox_A	344	X-Ray Crystal Structure Of Human Anaplastic Lymphom		4e-06
3l9p_A	367	Crystal Structure Of The Anaplastic Lymphoma Kinase		4e-06
4e1z_A	291	Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda		4e-06
4e20_A	290	Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda		4e-06
4fnz_A	327	Crystal Structure Of Human Anaplastic Lymphoma Kina		4e-06
4dce_A	333	Crystal Structure Of Human Anaplastic Lymphoma Kina		4e-06
2yjs_A	342	Structure Of C1156y Mutant Anaplastic Lymphoma Kina		5e-06
3tt0_A	382	Co-Structure Of Fibroblast Growth Factor Receptor 1		6e-06
4fob_A	353	Crystal Structure Of Human Anaplastic Lymphoma Kina		6e-06
3js2_A	317	Crystal Structure Of Minimal Kinase Domain Of Fibro		7e-06
4f63_A	309	Crystal Structure Of Human Fibroblast Growth Factor		7e-06
3rhx_B	306	Crystal Structure Of The Catalytic Domain Of Fgfr1		7e-06
1fgk_A	310	Crystal Structure Of The Tyrosine Kinase Domain Of		8e-06
4fnx_A	327	Crystal Structure Of The Apo R1275q Anaplastic Lymp		8e-06
3c4f_A	302	Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M		8e-06
2rei_A	318	Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep		1e-05
3zgw_A	347	Crystal Structure Of Maternal Embryonic Leucine Zip		1e-05
1jpa_A	312	Crystal Structure Of Unphosphorylated Ephb2 Recepto		1e-05
3cly_A	334	Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase		1e-05
2ogv_A	317	Crystal Structure Of The Autoinhibited Human C-Fms		1e-05
3nyn_A	576	Crystal Structure Of G Protein-Coupled Receptor Kin		1e-05
2pzr_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		1e-05
3kul_A	325	Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep		1e-05
2qob_A	344	Human Epha3 Kinase Domain, Base Structure Length =		1e-05
2p0c_A	313	Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro		1e-05
4f1o_A	287	Crystal Structure Of The L1180t Mutant Roco4 Kinase		2e-05
2acx_A	576	Crystal Structure Of G Protein Coupled Receptor Kin		2e-05
3ppz_A	309	Crystal Structure Of Ctr1 Kinase Domain In Complex		2e-05
2qo7_A	373	Human Epha3 Kinase And Juxtamembrane Region, Dephos		2e-05
3lcd_A	329	Inhibitor Bound To A Dfg-In Structure Of The Kinase		2e-05
3b2t_A	311	Structure Of Phosphotransferase Length = 311		2e-05
2r2p_A	295	Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep		2e-05
2hel_A	306	Crystal Structure Of A Mutant Epha4 Kinase Domain (		2e-05
3kul_B	325	Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep		2e-05
4f1m_A	287	Crystal Structure Of The G1179s Roco4 Kinase Domain		2e-05
1f3m_C	297	Crystal Structure Of Human SerineTHREONINE KINASE P		2e-05
3ri1_A	313	Crystal Structure Of The Catalytic Domain Of Fgfr2		2e-05
1gjo_A	316	The Fgfr2 Tyrosine Kinase Domain Length = 316		2e-05
2pvf_A	334	Crystal Structure Of Tyrosine Phosphorylated Activa		3e-05
1yhv_A	297	Crystal Structure Of Pak1 Kinase Domain With Two Po		3e-05
3q52_A	306	Structure Of Phosphorylated Pak1 Kinase Domain Leng		3e-05
2pzp_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		3e-05
2pvy_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		3e-05
3fxz_A	297	Crystal Structure Of Pak1 Kinase Domain With Ruthen		3e-05
3fzo_A	277	Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin		3e-05
4h1j_A	293	Crystal Structure Of Pyk2 With The Pyrazole 13a Len		4e-05
3cc6_A	281	Crystal Structure Of Kinase Domain Of Protein Tyros		4e-05
2psq_A	370	Crystal Structure Of Unphosphorylated Unactivated W		4e-05
3bea_A	333	Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P		4e-05
3p86_A	309	Crystal Structure Of Ctr1 Kinase Domain Mutant D676		5e-05
2rfd_A	324	Crystal Structure Of The Complex Between The Egfr K		6e-05
3kmw_A	271	Crystal Structure Of The IlkALPHA-Parvin Core Compl		7e-05
3lco_A	324	Inhibitor Bound To A Dfg-Out Structure Of The Kinas		7e-05
3q4z_A	306	Structure Of Unphosphorylated Pak1 Kinase Domain Le		8e-05
2vwi_A	303	Structure Of The Osr1 Kinase, A Hypertension Drug T		8e-05
3dak_A	290	Crystal Structure Of Domain-Swapped Osr1 Kinase Dom		9e-05
2hen_A	286	Crystal Structure Of The Ephb2 Receptor Kinase Doma		9e-05
2i1m_A	333	Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An		1e-04
2xyu_A	285	Crystal Structure Of Epha4 Kinase Domain In Complex		1e-04
2y6m_A	291	Crystal Structure Of Epha4 Kinase Domain Length = 2		1e-04
2pwl_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		1e-04
3hyh_A	275	Crystal Structure Of The Protein Kinase Domain Of Y		1e-04
3dae_A	283	Crystal Structure Of Phosphorylated Snf1 Kinase Dom		1e-04
2pz5_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		1e-04
2q0b_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		1e-04
3mn3_A	271	An Inhibited Conformation For The Protein Kinase Do		1e-04
2fh9_A	274	Structure And Dimerization Of The Kinase Domain Fro		1e-04
2i0v_A	335	C-Fms Tyrosine Kinase In Complex With A Quinolone I		2e-04
2gs2_A	330	Crystal Structure Of The Active Egfr Kinase Domain		2e-04
4g5p_A	330	Crystal Structure Of Egfr Kinase T790m In Complex W		2e-04
2py3_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		2e-04
3lzb_A	327	Egfr Kinase Domain Complexed With An Imidazo[2,1-B]		2e-04
3zzw_A	289	Crystal Structure Of The Kinase Domain Of Ror2 Leng		2e-04
4g5j_A	330	Crystal Structure Of Egfr Kinase In Complex With Bi		2e-04
4gt4_A	308	Structure Of Unliganded, Inactive Ror2 Kinase Domai		2e-04
2gs7_A	330	Crystal Structure Of The Inactive Egfr Kinase Domai		2e-04
3vjo_A	334	Crystal Structure Of The Wild-Type Egfr Kinase Doma		2e-04
4i23_A	329	Crystal Structure Of The Wild-type Egfr Kinase Doma		2e-04
3ika_A	331	Crystal Structure Of Egfr 696-1022 T790m Mutant Cov		2e-04
4i24_A	329	Structure Of T790m Egfr Kinase Domain Co-crystalliz		2e-04
2jiu_A	328	Crystal Structure Of Egfr Kinase Domain T790m Mutat		2e-04
1xkk_A	352	Egfr Kinase Domain Complexed With A Quinazoline Inh		2e-04
1m14_A	333	Tyrosine Kinase Domain From Epidermal Growth Factor		2e-04
2j5f_A	327	Crystal Structure Of Egfr Kinase Domain In Complex		2e-04
3bel_A	315	X-Ray Structure Of Egfr In Complex With Oxime Inhib		2e-04
3s95_A	310	Crystal Structure Of The Human Limk1 Kinase Domain		2e-04
2j5e_A	327	Crystal Structure Of Egfr Kinase Domain In Complex		2e-04
2jit_A	327	Crystal Structure Of Egfr Kinase Domain T790m Mutat		2e-04
4aw5_A	291	Complex Of The Ephb4 Kinase Domain With An Oxindole		2e-04
4hjo_A	337	Crystal Structure Of The Inactive Egfr Tyrosine Kin		2e-04
2jiv_A	328	Crystal Structure Of Egfr Kinase Domain T790m Mutat		2e-04
2qnj_A	328	Kinase And Ubiquitin-Associated Domains Of Mark3PAR		3e-04
2h6d_A	276	Protein Kinase Domain Of The Human 5'-Amp-Activated		4e-04
3uiu_A	306	Crystal Structure Of Apo-Pkr Kinase Domain Length =		4e-04
3ug1_A	334	Crystal Structure Of The Mutated Egfr Kinase Domain		4e-04
2itn_A	327	Crystal Structure Of Egfr Kinase Domain G719s Mutat		4e-04
2eb2_A	334	Crystal Structure Of Mutated Egfr Kinase Domain (G7		4e-04
2jkm_A	276	Focal Adhesion Kinase Catalytic Domain In Complex W		4e-04
2vwu_A	302	Ephb4 Kinase Domain Inhibitor Complex Length = 302		5e-04
2j0m_B	276	Crystal Structure A Two-Chain Complex Between The F		5e-04
2hak_A	328	Catalytic And Ubiqutin-Associated Domains Of Mark1P		6e-04
1zmu_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		7e-04
2r0i_A	327	Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len		8e-04

>pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349

Iteration: 1
 Score =  113 bits (283), Expect = 1e-25,   Method: Compositional matrix adjust.
 Identities = 88/308 (28%), Positives = 145/308 (47%), Gaps = 27/308 (8%)
Query: 26  DVENEEKPGVDNVPVFCEYSIETLRTATSGFAMENIVSEHGEKAPNVVYKGKLENQFRIA 85
           DV  EE P V ++     +S+  L+ A+  F+ +NI+   G      VYKG+L +   +A
Sbjct: 11  DVPAEEDPEV-HLGQLKRFSLRELQVASDNFSNKNIL---GRGGFGKVYKGRLADGTLVA 66
Query: 86  VKRFNRSAWPDAR-QFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAEYMPNDTLAKHL 144
           VKR           QF  E   +    +R L  L G C    ERLLV  YM N ++A  L
Sbjct: 67  VKRLKEERXQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCL 126
Query: 145 FHW-ETQP-MKWAMRLRVALHIAEALEYCTSK--ERALYHDLNAYRIVFDDDVNPRLSCF 200
               E+QP + W  R R+AL  A  L Y       + ++ D+ A  I+ D++    +  F
Sbjct: 127 RERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDF 186
Query: 201 GLMK--NSRDGR---SYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSH 255
           GL K  + +D     +    +    PEYL TG+ + ++ ++ +G +LL+L++G+      
Sbjct: 187 GLAKLMDYKDXHVXXAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLA 246
Query: 256 AL-------------DLIRDRNIQTLTDSCLEGQFSSDEGTELVRLASRCLQYEPRERPN 302
            L              L++++ ++ L D  L+G +  +E  +L+++A  C Q  P ERP 
Sbjct: 247 RLANDDDVMLLDWVKGLLKEKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPK 306
Query: 303 PRSLVTAL 310
              +V  L
Sbjct: 307 MSEVVRML 314

>pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326

Iteration: 1
 Score =  112 bits (281), Expect = 2e-25,   Method: Compositional matrix adjust.
 Identities = 88/308 (28%), Positives = 144/308 (46%), Gaps = 27/308 (8%)
Query: 26  DVENEEKPGVDNVPVFCEYSIETLRTATSGFAMENIVSEHGEKAPNVVYKGKLENQFRIA 85
           DV  EE P V ++     +S+  L+ A+  F  +NI+   G      VYKG+L +   +A
Sbjct: 3   DVPAEEDPEV-HLGQLKRFSLRELQVASDNFXNKNIL---GRGGFGKVYKGRLADGXLVA 58
Query: 86  VKRFNRSAWPDAR-QFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAEYMPNDTLAKHL 144
           VKR           QF  E   +    +R L  L G C    ERLLV  YM N ++A  L
Sbjct: 59  VKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCL 118
Query: 145 FHW-ETQP-MKWAMRLRVALHIAEALEYCTS--KERALYHDLNAYRIVFDDDVNPRLSCF 200
               E+QP + W  R R+AL  A  L Y       + ++ D+ A  I+ D++    +  F
Sbjct: 119 RERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDF 178
Query: 201 GLMK--NSRDGR---SYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSH 255
           GL K  + +D     +    +    PEYL TG+ + ++ ++ +G +LL+L++G+      
Sbjct: 179 GLAKLMDYKDXHVXXAVRGXIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLA 238
Query: 256 AL-------------DLIRDRNIQTLTDSCLEGQFSSDEGTELVRLASRCLQYEPRERPN 302
            L              L++++ ++ L D  L+G +  +E  +L+++A  C Q  P ERP 
Sbjct: 239 RLANDDDVMLLDWVKGLLKEKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPK 298
Query: 303 PRSLVTAL 310
              +V  L
Sbjct: 299 MSEVVRML 306

>pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307

Iteration: 1
 Score = 95.9 bits (237), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 83/302 (27%), Positives = 140/302 (46%), Gaps = 52/302 (17%)
Query: 41  FCEYSIETLRTATSGFAMENIV---SEHGEKAPNVVYKGKLENQFRIAVKRFNRSAWPD- 96
           F  +S   L+  T+ F    I    ++ GE    VVYKG + N   +AVK+   +A  D 
Sbjct: 12  FHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYVNNT-TVAVKKL--AAMVDI 68
Query: 97  -----ARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAEYMPNDTLAKHLFHWE-TQ 150
                 +QF +E + + + ++  L  LLG   +GD+  LV  YMPN +L   L   + T 
Sbjct: 69  TTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTP 128
Query: 151 PMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRD-- 208
           P+ W MR ++A   A  + +   +   ++ D+ +  I+ D+    ++S FGL + S    
Sbjct: 129 PLSWHMRCKIAQGAANGINFL-HENHHIHRDIKSANILLDEAFTAKISDFGLARASEKFA 187
Query: 209 -----GRSYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSG-----KHIPPSHAL- 257
                 R   T  A+  PE LR G +TP+S +YSFG +LL++++G     +H  P   L 
Sbjct: 188 QTVMXSRIVGTT-AYMAPEALR-GEITPKSDIYSFGVVLLEIITGLPAVDEHREPQLLLD 245
Query: 258 -------------DLIRDRNIQTLTDSCLEGQFSSDEGTELVRLASRCLQYEPRERPNPR 304
                        D I D+ +     + +E  +S         +AS+CL  +  +RP+ +
Sbjct: 246 IKEEIEDEEKTIEDYI-DKKMNDADSTSVEAMYS---------VASQCLHEKKNKRPDIK 295
Query: 305 SL 306
            +
Sbjct: 296 KV 297

>pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307

Iteration: 1
 Score = 95.5 bits (236), Expect = 4e-20,   Method: Compositional matrix adjust.
 Identities = 83/302 (27%), Positives = 140/302 (46%), Gaps = 52/302 (17%)
Query: 41  FCEYSIETLRTATSGFAMENIV---SEHGEKAPNVVYKGKLENQFRIAVKRFNRSAWPD- 96
           F  +S   L+  T+ F    I    ++ GE    VVYKG + N   +AVK+   +A  D 
Sbjct: 12  FHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYVNNT-TVAVKKL--AAMVDI 68
Query: 97  -----ARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAEYMPNDTLAKHLFHWE-TQ 150
                 +QF +E + + + ++  L  LLG   +GD+  LV  YMPN +L   L   + T 
Sbjct: 69  TTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTP 128
Query: 151 PMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRD-- 208
           P+ W MR ++A   A  + +   +   ++ D+ +  I+ D+    ++S FGL + S    
Sbjct: 129 PLSWHMRCKIAQGAANGINFL-HENHHIHRDIKSANILLDEAFTAKISDFGLARASEKFA 187
Query: 209 -----GRSYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSG-----KHIPPSHAL- 257
                 R   T  A+  PE LR G +TP+S +YSFG +LL++++G     +H  P   L 
Sbjct: 188 QTVMXXRIVGTT-AYMAPEALR-GEITPKSDIYSFGVVLLEIITGLPAVDEHREPQLLLD 245
Query: 258 -------------DLIRDRNIQTLTDSCLEGQFSSDEGTELVRLASRCLQYEPRERPNPR 304
                        D I D+ +     + +E  +S         +AS+CL  +  +RP+ +
Sbjct: 246 IKEEIEDEEKTIEDYI-DKKMNDADSTSVEAMYS---------VASQCLHEKKNKRPDIK 295
Query: 305 SL 306
            +
Sbjct: 296 KV 297

>pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301

Iteration: 1
 Score = 95.1 bits (235), Expect = 5e-20,   Method: Compositional matrix adjust.
 Identities = 83/302 (27%), Positives = 140/302 (46%), Gaps = 52/302 (17%)
Query: 41  FCEYSIETLRTATSGFAMENIV---SEHGEKAPNVVYKGKLENQFRIAVKRFNRSAWPD- 96
           F  +S   L+  T+ F    I    ++ GE    VVYKG + N   +AVK+   +A  D 
Sbjct: 6   FHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYVNNT-TVAVKKL--AAMVDI 62
Query: 97  -----ARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAEYMPNDTLAKHLFHWE-TQ 150
                 +QF +E + + + ++  L  LLG   +GD+  LV  YMPN +L   L   + T 
Sbjct: 63  TTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTP 122
Query: 151 PMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRD-- 208
           P+ W MR ++A   A  + +   +   ++ D+ +  I+ D+    ++S FGL + S    
Sbjct: 123 PLSWHMRCKIAQGAANGINFL-HENHHIHRDIKSANILLDEAFTAKISDFGLARASEKFA 181
Query: 209 -----GRSYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSG-----KHIPPSHAL- 257
                 R   T  A+  PE LR G +TP+S +YSFG +LL++++G     +H  P   L 
Sbjct: 182 QXVMXXRIVGTT-AYMAPEALR-GEITPKSDIYSFGVVLLEIITGLPAVDEHREPQLLLD 239
Query: 258 -------------DLIRDRNIQTLTDSCLEGQFSSDEGTELVRLASRCLQYEPRERPNPR 304
                        D I D+ +     + +E  +S         +AS+CL  +  +RP+ +
Sbjct: 240 IKEEIEDEEKTIEDYI-DKKMNDADSTSVEAMYS---------VASQCLHEKKNKRPDIK 289
Query: 305 SL 306
            +
Sbjct: 290 KV 291

>pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327

Iteration: 1
 Score = 91.7 bits (226), Expect = 5e-19,   Method: Compositional matrix adjust.
 Identities = 62/207 (29%), Positives = 107/207 (51%), Gaps = 14/207 (6%)
Query: 49  LRTATSGFAMENIVSEHGEKAPNVVYKGKLENQFRIAVKRFNRSAWPDARQFLEEARAVG 108
           L  AT+ F  + ++   G      VYKG L +  ++A+KR    +     +F  E   + 
Sbjct: 34  LEEATNNFDHKFLI---GHGVFGKVYKGVLRDGAKVALKRRTPESSQGIEEFETEIETLS 90
Query: 109 QLRNRRLANLLGCCCEGDERLLVAEYMPNDTLAKHLFHWE--TQPMKWAMRLRVALHIAE 166
             R+  L +L+G C E +E +L+ +YM N  L +HL+  +  T  M W  RL + +  A 
Sbjct: 91  FCRHPHLVSLIGFCDERNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAAR 150
Query: 167 ALEYCTSKERALYH-DLNAYRIVFDDDVNPRLSCFGLMKNSRD-GRSY-----STNLAFT 219
            L Y  +  RA+ H D+ +  I+ D++  P+++ FG+ K   + G+++        L + 
Sbjct: 151 GLHYLHT--RAIIHRDVKSINILLDENFVPKITDFGISKKGTELGQTHLXXVVKGTLGYI 208
Query: 220 PPEYLRTGRVTPESVMYSFGTLLLDLL 246
            PEY   GR+T +S +YSFG +L ++L
Sbjct: 209 DPEYFIKGRLTEKSDVYSFGVVLFEVL 235

>pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321

Iteration: 1
 Score = 90.1 bits (222), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 61/207 (29%), Positives = 103/207 (49%), Gaps = 14/207 (6%)
Query: 49  LRTATSGFAMENIVSEHGEKAPNVVYKGKLENQFRIAVKRFNRSAWPDARQFLEEARAVG 108
           L  AT+ F  + ++   G      VYKG L +  ++A+KR    +     +F  E   + 
Sbjct: 34  LEEATNNFDHKFLI---GHGVFGKVYKGVLRDGAKVALKRRTPESSQGIEEFETEIETLS 90
Query: 109 QLRNRRLANLLGCCCEGDERLLVAEYMPNDTLAKHLFHWE--TQPMKWAMRLRVALHIAE 166
             R+  L +L+G C E +E +L+ +YM N  L +HL+  +  T  M W  RL + +  A 
Sbjct: 91  FCRHPHLVSLIGFCDERNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAAR 150
Query: 167 ALEYCTSKERALYH-DLNAYRIVFDDDVNPRLSCFGLMKNSRD------GRSYSTNLAFT 219
            L Y  +  RA+ H D+ +  I+ D++  P+++ FG+ K   +             L + 
Sbjct: 151 GLHYLHT--RAIIHRDVKSINILLDENFVPKITDFGISKKGTELDQTHLXXVVKGTLGYI 208
Query: 220 PPEYLRTGRVTPESVMYSFGTLLLDLL 246
            PEY   GR+T +S +YSFG +L ++L
Sbjct: 209 DPEYFIKGRLTEKSDVYSFGVVLFEVL 235

>pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298

Iteration: 1
 Score = 88.6 bits (218), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 81/302 (26%), Positives = 136/302 (45%), Gaps = 52/302 (17%)
Query: 41  FCEYSIETLRTATSGFAMENIV---SEHGEKAPNVVYKGKLENQFRIAVKRFNRSAWPD- 96
           F  +S   L+  T+ F    I    ++ GE    VVYKG + N   +AVK+   +A  D 
Sbjct: 3   FHSFSFYELKNVTNNFDERPISVGGNKXGEGGFGVVYKGYVNNT-TVAVKKL--AAMVDI 59
Query: 97  -----ARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAEYMPNDTLAKHLFHWE-TQ 150
                 +QF +E +   + ++  L  LLG   +GD+  LV  Y PN +L   L   + T 
Sbjct: 60  TTEELKQQFDQEIKVXAKCQHENLVELLGFSSDGDDLCLVYVYXPNGSLLDRLSCLDGTP 119
Query: 151 PMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRD-- 208
           P+ W  R ++A   A  + +   +   ++ D+ +  I+ D+    ++S FGL + S    
Sbjct: 120 PLSWHXRCKIAQGAANGINFL-HENHHIHRDIKSANILLDEAFTAKISDFGLARASEKFA 178
Query: 209 -----GRSYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSG-----KHIPPSHAL- 257
                 R   T  A+  PE LR G +TP+S +YSFG +LL++++G     +H  P   L 
Sbjct: 179 QXVXXSRIVGTT-AYXAPEALR-GEITPKSDIYSFGVVLLEIITGLPAVDEHREPQLLLD 236
Query: 258 -------------DLIRDRNIQTLTDSCLEGQFSSDEGTELVRLASRCLQYEPRERPNPR 304
                        D I D+       + +E  +S         +AS+CL  +  +RP+ +
Sbjct: 237 IKEEIEDEEKTIEDYI-DKKXNDADSTSVEAXYS---------VASQCLHEKKNKRPDIK 286
Query: 305 SL 306
            +
Sbjct: 287 KV 288

>pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265

Iteration: 1
 Score = 74.7 bits (182), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 54/202 (26%), Positives = 97/202 (48%), Gaps = 16/202 (7%)
Query: 60  NIVSEHGEKAPNVVYKGKLENQFRIAVKRFNRSAWPDARQFLEEARAVGQLRNRRLANLL 119
             + E G     VV  GK   Q+ +A+K     +  +  +F+EEA+ +  L + +L  L 
Sbjct: 12  TFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSED-EFIEEAKVMMNLSHEKLVQLY 70
Query: 120 GCCCEGDERLLVAEYMPNDTLAKHL----FHWETQPMKWAMRLRVALHIAEALEYCTSKE 175
           G C +     ++ EYM N  L  +L      ++TQ +     L +   + EA+EY  SK+
Sbjct: 71  GVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQL-----LEMCKDVCEAMEYLESKQ 125
Query: 176 RALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDGRSYSTN-----LAFTPPEYLRTGRVT 230
             L+ DL A   + +D    ++S FGL +   D    S+      + ++PPE L   + +
Sbjct: 126 -FLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSRGSKFPVRWSPPEVLMYSKFS 184
Query: 231 PESVMYSFGTLLLDLLSGKHIP 252
            +S +++FG L+ ++ S   +P
Sbjct: 185 SKSDIWAFGVLMWEIYSLGKMP 206

>pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283

Iteration: 1
 Score = 74.7 bits (182), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 54/202 (26%), Positives = 97/202 (48%), Gaps = 16/202 (7%)
Query: 60  NIVSEHGEKAPNVVYKGKLENQFRIAVKRFNRSAWPDARQFLEEARAVGQLRNRRLANLL 119
             + E G     VV  GK   Q+ +A+K     +  +  +F+EEA+ +  L + +L  L 
Sbjct: 27  TFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSE-DEFIEEAKVMMNLSHEKLVQLY 85
Query: 120 GCCCEGDERLLVAEYMPNDTLAKHL----FHWETQPMKWAMRLRVALHIAEALEYCTSKE 175
           G C +     ++ EYM N  L  +L      ++TQ +     L +   + EA+EY  SK+
Sbjct: 86  GVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQL-----LEMCKDVCEAMEYLESKQ 140
Query: 176 RALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDGRSYST-----NLAFTPPEYLRTGRVT 230
             L+ DL A   + +D    ++S FGL +   D    S+      + ++PPE L   + +
Sbjct: 141 -FLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEETSSVGSKFPVRWSPPEVLMYSKFS 199
Query: 231 PESVMYSFGTLLLDLLSGKHIP 252
            +S +++FG L+ ++ S   +P
Sbjct: 200 SKSDIWAFGVLMWEIYSLGKMP 221

>pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267

Iteration: 1
 Score = 74.3 bits (181), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 54/203 (26%), Positives = 99/203 (48%), Gaps = 18/203 (8%)
Query: 60  NIVSEHGEKAPNVVYKGKLENQFRIAVKRFNRSAWPDARQFLEEARAVGQLRNRRLANLL 119
             + E G     VV  GK   Q+ +A+K     +  +  +F+EEA+ +  L + +L  L 
Sbjct: 11  TFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSED-EFIEEAKVMMNLSHEKLVQLY 69
Query: 120 GCCCEGDERLLVAEYMPNDTLAKHL----FHWETQPMKWAMRLRVALHIAEALEYCTSKE 175
           G C +     ++ EYM N  L  +L      ++TQ +     L +   + EA+EY  SK+
Sbjct: 70  GVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQL-----LEMCKDVCEAMEYLESKQ 124
Query: 176 RALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDGRSYSTNLA------FTPPEYLRTGRV 229
             L+ DL A   + +D    ++S FGL +   D   Y++++       ++PPE L   + 
Sbjct: 125 -FLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDE-YTSSVGSKFPVRWSPPEVLMYSKF 182
Query: 230 TPESVMYSFGTLLLDLLSGKHIP 252
           + +S +++FG L+ ++ S   +P
Sbjct: 183 SSKSDIWAFGVLMWEIYSLGKMP 205

>pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283

Iteration: 1
 Score = 74.3 bits (181), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 54/203 (26%), Positives = 99/203 (48%), Gaps = 18/203 (8%)
Query: 60  NIVSEHGEKAPNVVYKGKLENQFRIAVKRFNRSAWPDARQFLEEARAVGQLRNRRLANLL 119
             + E G     VV  GK   Q+ +A+K     +  +  +F+EEA+ +  L + +L  L 
Sbjct: 27  TFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSE-DEFIEEAKVMMNLSHEKLVQLY 85
Query: 120 GCCCEGDERLLVAEYMPNDTLAKHL----FHWETQPMKWAMRLRVALHIAEALEYCTSKE 175
           G C +     ++ EYM N  L  +L      ++TQ +     L +   + EA+EY  SK+
Sbjct: 86  GVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQL-----LEMCKDVCEAMEYLESKQ 140
Query: 176 RALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDGRSYSTNLA------FTPPEYLRTGRV 229
             L+ DL A   + +D    ++S FGL +   D   Y++++       ++PPE L   + 
Sbjct: 141 -FLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDE-YTSSVGSKFPVRWSPPEVLMYSKF 198
Query: 230 TPESVMYSFGTLLLDLLSGKHIP 252
           + +S +++FG L+ ++ S   +P
Sbjct: 199 SSKSDIWAFGVLMWEIYSLGKMP 221

>pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274

Iteration: 1
 Score = 74.3 bits (181), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 54/203 (26%), Positives = 99/203 (48%), Gaps = 18/203 (8%)
Query: 60  NIVSEHGEKAPNVVYKGKLENQFRIAVKRFNRSAWPDARQFLEEARAVGQLRNRRLANLL 119
             + E G     VV  GK   Q+ +A+K     +  +  +F+EEA+ +  L + +L  L 
Sbjct: 18  TFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSED-EFIEEAKVMMNLSHEKLVQLY 76
Query: 120 GCCCEGDERLLVAEYMPNDTLAKHL----FHWETQPMKWAMRLRVALHIAEALEYCTSKE 175
           G C +     ++ EYM N  L  +L      ++TQ +     L +   + EA+EY  SK+
Sbjct: 77  GVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQL-----LEMCKDVCEAMEYLESKQ 131
Query: 176 RALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDGRSYSTNLA------FTPPEYLRTGRV 229
             L+ DL A   + +D    ++S FGL +   D   Y++++       ++PPE L   + 
Sbjct: 132 -FLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDE-YTSSVGSKFPVRWSPPEVLMYSKF 189
Query: 230 TPESVMYSFGTLLLDLLSGKHIP 252
           + +S +++FG L+ ++ S   +P
Sbjct: 190 SSKSDIWAFGVLMWEIYSLGKMP 212

>pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263

Iteration: 1
 Score = 74.3 bits (181), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 54/203 (26%), Positives = 99/203 (48%), Gaps = 18/203 (8%)
Query: 60  NIVSEHGEKAPNVVYKGKLENQFRIAVKRFNRSAWPDARQFLEEARAVGQLRNRRLANLL 119
             + E G     VV  GK   Q+ +A+K     +  +  +F+EEA+ +  L + +L  L 
Sbjct: 7   TFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSED-EFIEEAKVMMNLSHEKLVQLY 65
Query: 120 GCCCEGDERLLVAEYMPNDTLAKHL----FHWETQPMKWAMRLRVALHIAEALEYCTSKE 175
           G C +     ++ EYM N  L  +L      ++TQ +     L +   + EA+EY  SK+
Sbjct: 66  GVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQL-----LEMCKDVCEAMEYLESKQ 120
Query: 176 RALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDGRSYSTNLA------FTPPEYLRTGRV 229
             L+ DL A   + +D    ++S FGL +   D   Y++++       ++PPE L   + 
Sbjct: 121 -FLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDE-YTSSVGSKFPVRWSPPEVLMYSKF 178
Query: 230 TPESVMYSFGTLLLDLLSGKHIP 252
           + +S +++FG L+ ++ S   +P
Sbjct: 179 SSKSDIWAFGVLMWEIYSLGKMP 201

>pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 54/203 (26%), Positives = 99/203 (48%), Gaps = 18/203 (8%)
Query: 60  NIVSEHGEKAPNVVYKGKLENQFRIAVKRFNRSAWPDARQFLEEARAVGQLRNRRLANLL 119
             + E G     VV  GK   Q+ +A+K     +  +  +F+EEA+ +  L + +L  L 
Sbjct: 12  TFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSED-EFIEEAKVMMNLSHEKLVQLY 70
Query: 120 GCCCEGDERLLVAEYMPNDTLAKHL----FHWETQPMKWAMRLRVALHIAEALEYCTSKE 175
           G C +     ++ EYM N  L  +L      ++TQ +     L +   + EA+EY  SK+
Sbjct: 71  GVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQL-----LEMCKDVCEAMEYLESKQ 125
Query: 176 RALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDGRSYSTNLA------FTPPEYLRTGRV 229
             L+ DL A   + +D    ++S FGL +   D   Y++++       ++PPE L   + 
Sbjct: 126 -FLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDE-YTSSVGSKFPVRWSPPEVLMYSKF 183
Query: 230 TPESVMYSFGTLLLDLLSGKHIP 252
           + +S +++FG L+ ++ S   +P
Sbjct: 184 SSKSDIWAFGVLMWEIYSLGKMP 206

>pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303

Iteration: 1
 Score = 73.2 bits (178), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 77/292 (26%), Positives = 125/292 (42%), Gaps = 41/292 (14%)
Query: 61  IVSEHGEKAPNVVYKG------KLENQFRIAVKRFNRSAWPDAR-QFLEEARAVGQLRNR 113
           ++ E G+ +  +VY+G      K E + R+AVK  N SA    R +FL EA  +      
Sbjct: 18  LLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCH 77
Query: 114 RLANLLGCCCEGDERLLVAEYMPNDTLAKHLFHWETQ--------PMKWAMRLRVALHIA 165
            +  LLG   +G   L+V E M +  L  +L     +        P      +++A  IA
Sbjct: 78  HVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIA 137
Query: 166 EALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKN------SRDGRSYSTNLAFT 219
           + + Y  +K + ++ DL A   +   D   ++  FG+ ++       R G      + + 
Sbjct: 138 DGMAYLNAK-KFVHRDLAARNCMVAHDFTVKIGDFGMTRDIXETDXXRKGGKGLLPVRWM 196
Query: 220 PPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIP-----PSHALDLIRDRNIQTLTDSCLE 274
            PE L+ G  T  S M+SFG +L ++ S    P         L  + D       D+C E
Sbjct: 197 APESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLKFVMDGGYLDQPDNCPE 256
Query: 275 GQFSSDEGTELVRLASRCLQYEPRERPNPRSLVTALVTLQKDTELYLSLPWV 326
                   T+L+R+   C Q+ P+ RP        +V L KD +L+ S P V
Sbjct: 257 ------RVTDLMRM---CWQFNPKMRPT----FLEIVNLLKD-DLHPSFPEV 294

>pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306

Iteration: 1
 Score = 72.8 bits (177), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 77/292 (26%), Positives = 125/292 (42%), Gaps = 41/292 (14%)
Query: 61  IVSEHGEKAPNVVYKG------KLENQFRIAVKRFNRSAWPDAR-QFLEEARAVGQLRNR 113
           ++ E G+ +  +VY+G      K E + R+AVK  N SA    R +FL EA  +      
Sbjct: 21  LLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCH 80
Query: 114 RLANLLGCCCEGDERLLVAEYMPNDTLAKHLFHWETQ--------PMKWAMRLRVALHIA 165
            +  LLG   +G   L+V E M +  L  +L     +        P      +++A  IA
Sbjct: 81  HVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIA 140
Query: 166 EALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKN------SRDGRSYSTNLAFT 219
           + + Y  +K + ++ DL A   +   D   ++  FG+ ++       R G      + + 
Sbjct: 141 DGMAYLNAK-KFVHRDLAARNCMVAHDFTVKIGDFGMTRDIXETDXXRKGGKGLLPVRWM 199
Query: 220 PPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIP-----PSHALDLIRDRNIQTLTDSCLE 274
            PE L+ G  T  S M+SFG +L ++ S    P         L  + D       D+C E
Sbjct: 200 APESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLKFVMDGGYLDQPDNCPE 259
Query: 275 GQFSSDEGTELVRLASRCLQYEPRERPNPRSLVTALVTLQKDTELYLSLPWV 326
                   T+L+R+   C Q+ P+ RP        +V L KD +L+ S P V
Sbjct: 260 ------RVTDLMRM---CWQFNPKMRPT----FLEIVNLLKD-DLHPSFPEV 297

>pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306

Iteration: 1
 Score = 72.4 bits (176), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 77/293 (26%), Positives = 125/293 (42%), Gaps = 41/293 (13%)
Query: 60  NIVSEHGEKAPNVVYKG------KLENQFRIAVKRFNRSAWPDAR-QFLEEARAVGQLRN 112
            ++ E G+ +  +VY+G      K E + R+AVK  N SA    R +FL EA  +     
Sbjct: 20  TLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTC 79
Query: 113 RRLANLLGCCCEGDERLLVAEYMPNDTLAKHLFHWETQ--------PMKWAMRLRVALHI 164
             +  LLG   +G   L+V E M +  L  +L     +        P      +++A  I
Sbjct: 80  HHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEI 139
Query: 165 AEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKN------SRDGRSYSTNLAF 218
           A+ + Y  +K + ++ DL A   +   D   ++  FG+ ++       R G      + +
Sbjct: 140 ADGMAYLNAK-KFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRW 198
Query: 219 TPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIP-----PSHALDLIRDRNIQTLTDSCL 273
             PE L+ G  T  S M+SFG +L ++ S    P         L  + D       D+C 
Sbjct: 199 MAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLKFVMDGGYLDQPDNCP 258
Query: 274 EGQFSSDEGTELVRLASRCLQYEPRERPNPRSLVTALVTLQKDTELYLSLPWV 326
           E        T+L+R+   C Q+ P+ RP        +V L KD +L+ S P V
Sbjct: 259 E------RVTDLMRM---CWQFNPKMRPT----FLEIVNLLKD-DLHPSFPEV 297

>pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317

Iteration: 1
 Score = 72.4 bits (176), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 77/292 (26%), Positives = 125/292 (42%), Gaps = 41/292 (14%)
Query: 61  IVSEHGEKAPNVVYKG------KLENQFRIAVKRFNRSAWPDAR-QFLEEARAVGQLRNR 113
           ++ E G+ +  +VY+G      K E + R+AVK  N SA    R +FL EA  +      
Sbjct: 20  LLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCH 79
Query: 114 RLANLLGCCCEGDERLLVAEYMPNDTLAKHLFHWETQ--------PMKWAMRLRVALHIA 165
            +  LLG   +G   L+V E M +  L  +L     +        P      +++A  IA
Sbjct: 80  HVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIA 139
Query: 166 EALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKN------SRDGRSYSTNLAFT 219
           + + Y  +K + ++ DL A   +   D   ++  FG+ ++       R G      + + 
Sbjct: 140 DGMAYLNAK-KFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWM 198
Query: 220 PPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIP-----PSHALDLIRDRNIQTLTDSCLE 274
            PE L+ G  T  S M+SFG +L ++ S    P         L  + D       D+C E
Sbjct: 199 APESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLKFVMDGGYLDQPDNCPE 258
Query: 275 GQFSSDEGTELVRLASRCLQYEPRERPNPRSLVTALVTLQKDTELYLSLPWV 326
                   T+L+R+   C Q+ P+ RP        +V L KD +L+ S P V
Sbjct: 259 ------RVTDLMRM---CWQFNPKMRPT----FLEIVNLLKD-DLHPSFPEV 296

>pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306

Iteration: 1
 Score = 72.4 bits (176), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 77/293 (26%), Positives = 125/293 (42%), Gaps = 41/293 (13%)
Query: 60  NIVSEHGEKAPNVVYKG------KLENQFRIAVKRFNRSAWPDAR-QFLEEARAVGQLRN 112
            ++ E G+ +  +VY+G      K E + R+AVK  N SA    R +FL EA  +     
Sbjct: 20  TLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTC 79
Query: 113 RRLANLLGCCCEGDERLLVAEYMPNDTLAKHLFHWETQ--------PMKWAMRLRVALHI 164
             +  LLG   +G   L+V E M +  L  +L     +        P      +++A  I
Sbjct: 80  HHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEI 139
Query: 165 AEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKN------SRDGRSYSTNLAF 218
           A+ + Y  +K + ++ DL A   +   D   ++  FG+ ++       R G      + +
Sbjct: 140 ADGMAYLNAK-KFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETAYYRKGGKGLLPVRW 198
Query: 219 TPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIP-----PSHALDLIRDRNIQTLTDSCL 273
             PE L+ G  T  S M+SFG +L ++ S    P         L  + D       D+C 
Sbjct: 199 MAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLKFVMDGGYLDQPDNCP 258
Query: 274 EGQFSSDEGTELVRLASRCLQYEPRERPNPRSLVTALVTLQKDTELYLSLPWV 326
           E        T+L+R+   C Q+ P+ RP        +V L KD +L+ S P V
Sbjct: 259 E------RVTDLMRM---CWQFNPKMRPT----FLEIVNLLKD-DLHPSFPEV 297

>pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306

Iteration: 1
 Score = 72.0 bits (175), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 77/292 (26%), Positives = 124/292 (42%), Gaps = 41/292 (14%)
Query: 61  IVSEHGEKAPNVVYKG------KLENQFRIAVKRFNRSAWPDAR-QFLEEARAVGQLRNR 113
           ++ E G+ +  +VY+G      K E + R+AVK  N SA    R +FL EA  +      
Sbjct: 21  LLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCH 80
Query: 114 RLANLLGCCCEGDERLLVAEYMPNDTLAKHLFHWETQ--------PMKWAMRLRVALHIA 165
            +  LLG   +G   L+V E M +  L  +L     +        P      +++A  IA
Sbjct: 81  HVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIA 140
Query: 166 EALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKN------SRDGRSYSTNLAFT 219
           + + Y  +K + ++ DL A   +   D   ++  FG+ ++       R G      + + 
Sbjct: 141 DGMAYLNAK-KFVHRDLAARNCMVAHDFTVKIGDFGMTRDIXETDXXRKGGKGLLPVRWM 199
Query: 220 PPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIP-----PSHALDLIRDRNIQTLTDSCLE 274
            PE L+ G  T  S M+SFG +L ++ S    P         L  + D       D+C E
Sbjct: 200 APESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLKFVMDGGYLDQPDNCPE 259
Query: 275 GQFSSDEGTELVRLASRCLQYEPRERPNPRSLVTALVTLQKDTELYLSLPWV 326
                   T+L+R+   C Q+ P  RP        +V L KD +L+ S P V
Sbjct: 260 ------RVTDLMRM---CWQFNPNMRPT----FLEIVNLLKD-DLHPSFPEV 297

>pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279

Iteration: 1
 Score = 69.7 bits (169), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 70/258 (27%), Positives = 115/258 (44%), Gaps = 32/258 (12%)
Query: 60  NIVSEHGEKAPNVVYKGKLENQFRIAVKRFNR-SAWPDARQFLEEARAVGQLRNRRLANL 118
            +V   G      V+ G      ++AVK   + S  PDA  FL EA  + QL+++RL  L
Sbjct: 16  KLVERLGAGQAGEVWMGYYNGHTKVAVKSLKQGSMSPDA--FLAEANLMKQLQHQRLVRL 73
Query: 119 LGCCCEGDERLLVAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERAL 178
                + +   ++ EYM N +L   L       +     L +A  IAE + +   +ER  
Sbjct: 74  YAVVTQ-EPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFI--EERNY 130
Query: 179 YH-DLNAYRIVFDDDVNPRLSCFGLMK-------NSRDGRSYSTNLAFTPPEYLRTGRVT 230
            H DL A  I+  D ++ +++ FGL +        +R+G  +   + +T PE +  G  T
Sbjct: 131 IHRDLRAANILVSDTLSCKIADFGLARLIEDAEXTAREGAKFP--IKWTAPEAINYGTFT 188
Query: 231 PESVMYSFGTLLLDLLSGKHIP------PSHALDLIRDRNIQTLTDSCLEGQFSSDEGTE 284
            +S ++SFG LL ++++   IP      P    +L R   +    D+C E         E
Sbjct: 189 IKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRM-VRPDNCPE---------E 238
Query: 285 LVRLASRCLQYEPRERPN 302
           L +L   C +  P +RP 
Sbjct: 239 LYQLMRLCWKERPEDRPT 256

>pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307

Iteration: 1
 Score = 69.3 bits (168), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 76/292 (26%), Positives = 124/292 (42%), Gaps = 41/292 (14%)
Query: 61  IVSEHGEKAPNVVYKG------KLENQFRIAVKRFNRSAWPDAR-QFLEEARAVGQLRNR 113
           ++ E G+ +  +VY+G      K E + R+AVK  N SA    R +FL EA  +      
Sbjct: 22  LLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCH 81
Query: 114 RLANLLGCCCEGDERLLVAEYMPNDTLAKHLFHWETQ--------PMKWAMRLRVALHIA 165
            +  LLG   +G   L+V E M +  L  +L     +        P      +++A  IA
Sbjct: 82  HVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIA 141
Query: 166 EALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKN------SRDGRSYSTNLAFT 219
           + + Y  +K + ++ +L A   +   D   ++  FG+ ++       R G      + + 
Sbjct: 142 DGMAYLNAK-KFVHRNLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWM 200
Query: 220 PPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIP-----PSHALDLIRDRNIQTLTDSCLE 274
            PE L+ G  T  S M+SFG +L ++ S    P         L  + D       D+C E
Sbjct: 201 APESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLKFVMDGGYLDQPDNCPE 260
Query: 275 GQFSSDEGTELVRLASRCLQYEPRERPNPRSLVTALVTLQKDTELYLSLPWV 326
                   T+L+R+   C Q+ P  RP        +V L KD +L+ S P V
Sbjct: 261 ------RVTDLMRM---CWQFNPNMRPT----FLEIVNLLKD-DLHPSFPEV 298

>pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306

Iteration: 1
 Score = 69.3 bits (168), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 76/292 (26%), Positives = 124/292 (42%), Gaps = 41/292 (14%)
Query: 61  IVSEHGEKAPNVVYKG------KLENQFRIAVKRFNRSAWPDAR-QFLEEARAVGQLRNR 113
           ++ E G+ +  +VY+G      K E + R+AVK  N SA    R +FL EA  +      
Sbjct: 21  LLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCH 80
Query: 114 RLANLLGCCCEGDERLLVAEYMPNDTLAKHLFHWETQ--------PMKWAMRLRVALHIA 165
            +  LLG   +G   L+V E M +  L  +L     +        P      +++A  IA
Sbjct: 81  HVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIA 140
Query: 166 EALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKN------SRDGRSYSTNLAFT 219
           + + Y  +K + ++ +L A   +   D   ++  FG+ ++       R G      + + 
Sbjct: 141 DGMAYLNAK-KFVHRNLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWM 199
Query: 220 PPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIP-----PSHALDLIRDRNIQTLTDSCLE 274
            PE L+ G  T  S M+SFG +L ++ S    P         L  + D       D+C E
Sbjct: 200 APESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLKFVMDGGYLDQPDNCPE 259
Query: 275 GQFSSDEGTELVRLASRCLQYEPRERPNPRSLVTALVTLQKDTELYLSLPWV 326
                   T+L+R+   C Q+ P  RP        +V L KD +L+ S P V
Sbjct: 260 ------RVTDLMRM---CWQFNPNMRPT----FLEIVNLLKD-DLHPSFPEV 297

>pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287

Iteration: 1
 Score = 69.3 bits (168), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 68/245 (27%), Positives = 112/245 (45%), Gaps = 32/245 (13%)
Query: 73  VYKGKLENQFRIAVKRFNR-SAWPDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLV 131
           V+ G      ++AVK   + S  PDA  FL EA  + QL+++RL  L     + +   ++
Sbjct: 37  VWMGYYNGHTKVAVKSLKQGSMSPDA--FLAEANLMKQLQHQRLVRLYAVVTQ-EPIYII 93
Query: 132 AEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYH-DLNAYRIVFD 190
            EYM N +L   L       +     L +A  IAE + +   +ER   H DL A  I+  
Sbjct: 94  TEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFI--EERNYIHRDLRAANILVS 151
Query: 191 DDVNPRLSCFGLMK-------NSRDGRSYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLL 243
           D ++ +++ FGL +        +R+G  +   + +T PE +  G  T +S ++SFG LL 
Sbjct: 152 DTLSCKIADFGLARLIEDNEXTAREGAKFP--IKWTAPEAINYGTFTIKSDVWSFGILLT 209
Query: 244 DLLSGKHIP------PSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLASRCLQYEP 297
           ++++   IP      P    +L R   +    D+C E         EL +L   C +  P
Sbjct: 210 EIVTHGRIPYPGMTNPEVIQNLERGYRM-VRPDNCPE---------ELYQLMRLCWKERP 259
Query: 298 RERPN 302
            +RP 
Sbjct: 260 EDRPT 264

>pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285

Iteration: 1
 Score = 69.3 bits (168), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 68/245 (27%), Positives = 112/245 (45%), Gaps = 32/245 (13%)
Query: 73  VYKGKLENQFRIAVKRFNR-SAWPDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLV 131
           V+ G      ++AVK   + S  PDA  FL EA  + QL+++RL  L     + +   ++
Sbjct: 35  VWMGYYNGHTKVAVKSLKQGSMSPDA--FLAEANLMKQLQHQRLVRLYAVVTQ-EPIYII 91
Query: 132 AEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYH-DLNAYRIVFD 190
            EYM N +L   L       +     L +A  IAE + +   +ER   H DL A  I+  
Sbjct: 92  TEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFI--EERNYIHRDLRAANILVS 149
Query: 191 DDVNPRLSCFGLMK-------NSRDGRSYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLL 243
           D ++ +++ FGL +        +R+G  +   + +T PE +  G  T +S ++SFG LL 
Sbjct: 150 DTLSCKIADFGLARLIEDNEXTAREGAKFP--IKWTAPEAINYGTFTIKSDVWSFGILLT 207
Query: 244 DLLSGKHIP------PSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLASRCLQYEP 297
           ++++   IP      P    +L R   +    D+C E         EL +L   C +  P
Sbjct: 208 EIVTHGRIPYPGMTNPEVIQNLERGYRM-VRPDNCPE---------ELYQLMRLCWKERP 257
Query: 298 RERPN 302
            +RP 
Sbjct: 258 EDRPT 262

>pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277

Iteration: 1
 Score = 68.9 bits (167), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 72/261 (27%), Positives = 117/261 (44%), Gaps = 32/261 (12%)
Query: 73  VYKGKLENQFRIAVKRFNR-SAWPDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLV 131
           V+ G      ++AVK   + S  PDA  FL EA  + QL+++RL  L     + +   ++
Sbjct: 34  VWMGYYNGHTKVAVKSLKQGSMSPDA--FLAEANLMKQLQHQRLVRLYAVVTQ-EPIYII 90
Query: 132 AEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYH-DLNAYRIVFD 190
            EYM N +L   L       +     L +A  IAE + +   +ER   H DL A  I+  
Sbjct: 91  TEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFI--EERNYIHRDLRAANILVS 148
Query: 191 DDVNPRLSCFGLMK-------NSRDGRSYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLL 243
           D ++ +++ FGL +        +R+G  +   + +T PE +  G  T +S ++SFG LL 
Sbjct: 149 DTLSCKIADFGLARLIEDNEYTAREGAKFP--IKWTAPEAINYGTFTIKSDVWSFGILLT 206
Query: 244 DLLSGKHIP------PSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLASRCLQYEP 297
           ++++   IP      P    +L R   +    D+C E         EL +L   C +  P
Sbjct: 207 EIVTHGRIPYPGMTNPEVIQNLERGYRM-VRPDNCPE---------ELYQLMRLCWKERP 256
Query: 298 RERPNPRSLVTALVTLQKDTE 318
            +RP    L + L      TE
Sbjct: 257 EDRPTFDYLRSVLEDFFTATE 277

>pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279

Iteration: 1
 Score = 68.9 bits (167), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 72/261 (27%), Positives = 117/261 (44%), Gaps = 32/261 (12%)
Query: 73  VYKGKLENQFRIAVKRFNR-SAWPDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLV 131
           V+ G      ++AVK   + S  PDA  FL EA  + QL+++RL  L     + +   ++
Sbjct: 29  VWMGYYNGHTKVAVKSLKQGSMSPDA--FLAEANLMKQLQHQRLVRLYAVVTQ-EPIYII 85
Query: 132 AEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYH-DLNAYRIVFD 190
            EYM N +L   L       +     L +A  IAE + +   +ER   H DL A  I+  
Sbjct: 86  TEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFI--EERNYIHRDLRAANILVS 143
Query: 191 DDVNPRLSCFGLMK-------NSRDGRSYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLL 243
           D ++ +++ FGL +        +R+G  +   + +T PE +  G  T +S ++SFG LL 
Sbjct: 144 DTLSCKIADFGLARLIEDNEXTAREGAKFP--IKWTAPEAINYGTFTIKSDVWSFGILLT 201
Query: 244 DLLSGKHIP------PSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLASRCLQYEP 297
           ++++   IP      P    +L R   +    D+C E         EL +L   C +  P
Sbjct: 202 EIVTHGRIPYPGMTNPEVIQNLERGYRM-VRPDNCPE---------ELYQLMRLCWKERP 251
Query: 298 RERPNPRSLVTALVTLQKDTE 318
            +RP    L + L      TE
Sbjct: 252 EDRPTFDYLRSVLEDFFTATE 272

>pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277

Iteration: 1
 Score = 68.9 bits (167), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 68/245 (27%), Positives = 112/245 (45%), Gaps = 32/245 (13%)
Query: 73  VYKGKLENQFRIAVKRFNR-SAWPDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLV 131
           V+ G      ++AVK   + S  PDA  FL EA  + QL+++RL  L     + +   ++
Sbjct: 35  VWMGYYNGHTKVAVKSLKQGSMSPDA--FLAEANLMKQLQHQRLVRLYAVVTQ-EPIYII 91
Query: 132 AEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYH-DLNAYRIVFD 190
            EYM N +L   L       +     L +A  IAE + +   +ER   H DL A  I+  
Sbjct: 92  TEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFI--EERNYIHRDLRAANILVS 149
Query: 191 DDVNPRLSCFGLMK-------NSRDGRSYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLL 243
           D ++ +++ FGL +        +R+G  +   + +T PE +  G  T +S ++SFG LL 
Sbjct: 150 DTLSCKIADFGLARLIEDNEYTAREGAKFP--IKWTAPEAINYGTFTIKSDVWSFGILLT 207
Query: 244 DLLSGKHIP------PSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLASRCLQYEP 297
           ++++   IP      P    +L R   +    D+C E         EL +L   C +  P
Sbjct: 208 EIVTHGRIPYPGMTNPEVIQNLERGYRM-VRPDNCPE---------ELYQLMRLCWKERP 257
Query: 298 RERPN 302
            +RP 
Sbjct: 258 EDRPT 262

>pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272

Iteration: 1
 Score = 68.9 bits (167), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 68/245 (27%), Positives = 112/245 (45%), Gaps = 32/245 (13%)
Query: 73  VYKGKLENQFRIAVKRFNR-SAWPDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLV 131
           V+ G      ++AVK   + S  PDA  FL EA  + QL+++RL  L     + +   ++
Sbjct: 30  VWMGYYNGHTKVAVKSLKQGSMSPDA--FLAEANLMKQLQHQRLVRLYAVVTQ-EPIYII 86
Query: 132 AEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYH-DLNAYRIVFD 190
            EYM N +L   L       +     L +A  IAE + +   +ER   H DL A  I+  
Sbjct: 87  TEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFI--EERNYIHRDLRAANILVS 144
Query: 191 DDVNPRLSCFGLMK-------NSRDGRSYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLL 243
           D ++ +++ FGL +        +R+G  +   + +T PE +  G  T +S ++SFG LL 
Sbjct: 145 DTLSCKIADFGLARLIEDNEXTAREGAKFP--IKWTAPEAINYGTFTIKSDVWSFGILLT 202
Query: 244 DLLSGKHIP------PSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLASRCLQYEP 297
           ++++   IP      P    +L R   +    D+C E         EL +L   C +  P
Sbjct: 203 EIVTHGRIPYPGMTNPEVIQNLERGYRM-VRPDNCPE---------ELYQLMRLCWKERP 252
Query: 298 RERPN 302
            +RP 
Sbjct: 253 EDRPT 257

>pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289

Iteration: 1
 Score = 68.9 bits (167), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 72/261 (27%), Positives = 117/261 (44%), Gaps = 32/261 (12%)
Query: 73  VYKGKLENQFRIAVKRFNR-SAWPDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLV 131
           V+ G      ++AVK   + S  PDA  FL EA  + QL+++RL  L     + +   ++
Sbjct: 39  VWMGYYNGHTKVAVKSLKQGSMSPDA--FLAEANLMKQLQHQRLVRLYAVVTQ-EPIYII 95
Query: 132 AEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYH-DLNAYRIVFD 190
            EYM N +L   L       +     L +A  IAE + +   +ER   H DL A  I+  
Sbjct: 96  TEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFI--EERNYIHRDLRAANILVS 153
Query: 191 DDVNPRLSCFGLMK-------NSRDGRSYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLL 243
           D ++ +++ FGL +        +R+G  +   + +T PE +  G  T +S ++SFG LL 
Sbjct: 154 DTLSCKIADFGLARLIEDNEYTAREGAKFP--IKWTAPEAINYGTFTIKSDVWSFGILLT 211
Query: 244 DLLSGKHIP------PSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLASRCLQYEP 297
           ++++   IP      P    +L R   +    D+C E         EL +L   C +  P
Sbjct: 212 EIVTHGRIPYPGMTNPEVIQNLERGYRM-VRPDNCPE---------ELYQLMRLCWKERP 261
Query: 298 RERPNPRSLVTALVTLQKDTE 318
            +RP    L + L      TE
Sbjct: 262 EDRPTFDYLRSVLEDFFTATE 282

>pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273

Iteration: 1
 Score = 68.9 bits (167), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 68/245 (27%), Positives = 112/245 (45%), Gaps = 32/245 (13%)
Query: 73  VYKGKLENQFRIAVKRFNR-SAWPDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLV 131
           V+ G      ++AVK   + S  PDA  FL EA  + QL+++RL  L     + +   ++
Sbjct: 31  VWMGYYNGHTKVAVKSLKQGSMSPDA--FLAEANLMKQLQHQRLVRLYAVVTQ-EPIYII 87
Query: 132 AEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYH-DLNAYRIVFD 190
            EYM N +L   L       +     L +A  IAE + +   +ER   H DL A  I+  
Sbjct: 88  TEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFI--EERNYIHRDLRAANILVS 145
Query: 191 DDVNPRLSCFGLMK-------NSRDGRSYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLL 243
           D ++ +++ FGL +        +R+G  +   + +T PE +  G  T +S ++SFG LL 
Sbjct: 146 DTLSCKIADFGLARLIEDNEXTAREGAKFP--IKWTAPEAINYGTFTIKSDVWSFGILLT 203
Query: 244 DLLSGKHIP------PSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLASRCLQYEP 297
           ++++   IP      P    +L R   +    D+C E         EL +L   C +  P
Sbjct: 204 EIVTHGRIPYPGMTNPEVIQNLERGYRM-VRPDNCPE---------ELYQLMRLCWKERP 253
Query: 298 RERPN 302
            +RP 
Sbjct: 254 EDRPT 258

>pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288

Iteration: 1
 Score = 68.9 bits (167), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 72/261 (27%), Positives = 117/261 (44%), Gaps = 32/261 (12%)
Query: 73  VYKGKLENQFRIAVKRFNR-SAWPDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLV 131
           V+ G      ++AVK   + S  PDA  FL EA  + QL+++RL  L     + +   ++
Sbjct: 38  VWMGYYNGHTKVAVKSLKQGSMSPDA--FLAEANLMKQLQHQRLVRLYAVVTQ-EPIYII 94
Query: 132 AEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYH-DLNAYRIVFD 190
            EYM N +L   L       +     L +A  IAE + +   +ER   H DL A  I+  
Sbjct: 95  TEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFI--EERNYIHRDLRAANILVS 152
Query: 191 DDVNPRLSCFGLMK-------NSRDGRSYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLL 243
           D ++ +++ FGL +        +R+G  +   + +T PE +  G  T +S ++SFG LL 
Sbjct: 153 DTLSCKIADFGLARLIEDNEXTAREGAKFP--IKWTAPEAINYGTFTIKSDVWSFGILLT 210
Query: 244 DLLSGKHIP------PSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLASRCLQYEP 297
           ++++   IP      P    +L R   +    D+C E         EL +L   C +  P
Sbjct: 211 EIVTHGRIPYPGMTNPEVIQNLERGYRM-VRPDNCPE---------ELYQLMRLCWKERP 260
Query: 298 RERPNPRSLVTALVTLQKDTE 318
            +RP    L + L      TE
Sbjct: 261 EDRPTFDYLRSVLEDFFTATE 281

>pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271

Iteration: 1
 Score = 68.9 bits (167), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 68/245 (27%), Positives = 112/245 (45%), Gaps = 32/245 (13%)
Query: 73  VYKGKLENQFRIAVKRFNR-SAWPDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLV 131
           V+ G      ++AVK   + S  PDA  FL EA  + QL+++RL  L     + +   ++
Sbjct: 29  VWMGYYNGHTKVAVKSLKQGSMSPDA--FLAEANLMKQLQHQRLVRLYAVVTQ-EPIYII 85
Query: 132 AEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYH-DLNAYRIVFD 190
            EYM N +L   L       +     L +A  IAE + +   +ER   H DL A  I+  
Sbjct: 86  TEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFI--EERNYIHRDLRAANILVS 143
Query: 191 DDVNPRLSCFGLMK-------NSRDGRSYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLL 243
           D ++ +++ FGL +        +R+G  +   + +T PE +  G  T +S ++SFG LL 
Sbjct: 144 DTLSCKIADFGLARLIEDNEXTAREGAKFP--IKWTAPEAINYGTFTIKSDVWSFGILLT 201
Query: 244 DLLSGKHIP------PSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLASRCLQYEP 297
           ++++   IP      P    +L R   +    D+C E         EL +L   C +  P
Sbjct: 202 EIVTHGRIPYPGMTNPEVIQNLERGYRM-VRPDNCPE---------ELYQLMRLCWKERP 251
Query: 298 RERPN 302
            +RP 
Sbjct: 252 EDRPT 256

>pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450

Iteration: 1
 Score = 68.9 bits (167), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 52/172 (30%), Positives = 84/172 (48%), Gaps = 5/172 (2%)
Query: 83  RIAVKRFNRSAWPDARQFLEEARAVGQLRNRRLANLLGCCCEGDERL-LVAEYMPNDTLA 141
           ++AVK     A   A+ FL EA  + QLR+  L  LLG   E    L +V EYM   +L 
Sbjct: 218 KVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLV 275
Query: 142 KHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFG 201
            +L       +     L+ +L + EA+EY       ++ DL A  ++  +D   ++S FG
Sbjct: 276 DYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGN-NFVHRDLAARNVLVSEDNVAKVSDFG 334
Query: 202 LMKNSRDGRSYST-NLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIP 252
           L K +   +      + +T PE LR  + + +S ++SFG LL ++ S   +P
Sbjct: 335 LTKEASSTQDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVP 386

>pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278

Iteration: 1
 Score = 68.9 bits (167), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 52/172 (30%), Positives = 84/172 (48%), Gaps = 5/172 (2%)
Query: 83  RIAVKRFNRSAWPDARQFLEEARAVGQLRNRRLANLLGCCCEGDERL-LVAEYMPNDTLA 141
           ++AVK     A   A+ FL EA  + QLR+  L  LLG   E    L +V EYM   +L 
Sbjct: 46  KVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLV 103
Query: 142 KHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFG 201
            +L       +     L+ +L + EA+EY       ++ DL A  ++  +D   ++S FG
Sbjct: 104 DYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNN-FVHRDLAARNVLVSEDNVAKVSDFG 162
Query: 202 LMKNSRDGRSYST-NLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIP 252
           L K +   +      + +T PE LR  + + +S ++SFG LL ++ S   +P
Sbjct: 163 LTKEASSTQDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVP 214

>pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265

Iteration: 1
 Score = 68.6 bits (166), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 68/245 (27%), Positives = 112/245 (45%), Gaps = 32/245 (13%)
Query: 73  VYKGKLENQFRIAVKRFNR-SAWPDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLV 131
           V+ G      ++AVK   + S  PDA  FL EA  + QL+++RL  L     + +   ++
Sbjct: 24  VWMGYYNGHTKVAVKSLKQGSMSPDA--FLAEANLMKQLQHQRLVRLYAVVTQ-EPIYII 80
Query: 132 AEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYH-DLNAYRIVFD 190
            EYM N +L   L       +     L +A  IAE + +   +ER   H DL A  I+  
Sbjct: 81  TEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFI--EERNYIHRDLRAANILVS 138
Query: 191 DDVNPRLSCFGLMK-------NSRDGRSYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLL 243
           D ++ +++ FGL +        +R+G  +   + +T PE +  G  T +S ++SFG LL 
Sbjct: 139 DTLSCKIADFGLARLIEDNEYTAREGAKFP--IKWTAPEAINYGTFTIKSDVWSFGILLT 196
Query: 244 DLLSGKHIP------PSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLASRCLQYEP 297
           ++++   IP      P    +L R   +    D+C E         EL +L   C +  P
Sbjct: 197 EIVTHGRIPYPGMTNPEVIQNLERGYRM-VRPDNCPE---------ELYQLMRLCWKERP 246
Query: 298 RERPN 302
            +RP 
Sbjct: 247 EDRPT 251

>pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271

Iteration: 1
 Score = 68.6 bits (166), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 68/245 (27%), Positives = 112/245 (45%), Gaps = 32/245 (13%)
Query: 73  VYKGKLENQFRIAVKRFNR-SAWPDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLV 131
           V+ G      ++AVK   + S  PDA  FL EA  + QL+++RL  L     + +   ++
Sbjct: 29  VWMGYYNGHTKVAVKSLKQGSMSPDA--FLAEANLMKQLQHQRLVRLYAVVTQ-EPIYII 85
Query: 132 AEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYH-DLNAYRIVFD 190
            EYM N +L   L       +     L +A  IAE + +   +ER   H DL A  I+  
Sbjct: 86  TEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFI--EERNYIHRDLRAANILVS 143
Query: 191 DDVNPRLSCFGLMK-------NSRDGRSYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLL 243
           D ++ +++ FGL +        +R+G  +   + +T PE +  G  T +S ++SFG LL 
Sbjct: 144 DTLSCKIADFGLARLIEDNEYTAREGAKFP--IKWTAPEAINYGTFTIKSDVWSFGILLT 201
Query: 244 DLLSGKHIP------PSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLASRCLQYEP 297
           ++++   IP      P    +L R   +    D+C E         EL +L   C +  P
Sbjct: 202 EIVTHGRIPYPGMTNPEVIQNLERGYRM-VRPDNCPE---------ELYQLMRLCWKERP 251
Query: 298 RERPN 302
            +RP 
Sbjct: 252 EDRPT 256

>pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263

Iteration: 1
 Score = 68.6 bits (166), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 52/172 (30%), Positives = 84/172 (48%), Gaps = 5/172 (2%)
Query: 83  RIAVKRFNRSAWPDARQFLEEARAVGQLRNRRLANLLGCCCEGDERL-LVAEYMPNDTLA 141
           ++AVK     A   A+ FL EA  + QLR+  L  LLG   E    L +V EYM   +L 
Sbjct: 31  KVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLV 88
Query: 142 KHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFG 201
            +L       +     L+ +L + EA+EY       ++ DL A  ++  +D   ++S FG
Sbjct: 89  DYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEG-NNFVHRDLAARNVLVSEDNVAKVSDFG 147
Query: 202 LMKNSRDGRSYST-NLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIP 252
           L K +   +      + +T PE LR  + + +S ++SFG LL ++ S   +P
Sbjct: 148 LTKEASSTQDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVP 199

>pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269

Iteration: 1
 Score = 68.2 bits (165), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 52/172 (30%), Positives = 83/172 (48%), Gaps = 5/172 (2%)
Query: 83  RIAVKRFNRSAWPDARQFLEEARAVGQLRNRRLANLLGCCCEGDERL-LVAEYMPNDTLA 141
           ++AVK     A   A+ FL EA  + QLR+  L  LLG   E    L +V EYM   +L 
Sbjct: 37  KVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLV 94
Query: 142 KHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFG 201
            +L       +     L+ +L + EA+EY       ++ DL A  ++  +D   ++S FG
Sbjct: 95  DYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGN-NFVHRDLAARNVLVSEDNVAKVSDFG 153
Query: 202 LMKNSRDGRSYST-NLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIP 252
           L K +   +      + +T PE LR    + +S ++SFG LL ++ S   +P
Sbjct: 154 LTKEASSTQDTGKLPVKWTAPEALREAAFSTKSDVWSFGILLWEIYSFGRVP 205

>pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 63/273 (23%), Positives = 120/273 (43%), Gaps = 36/273 (13%)
Query: 64  EHGEKAPNVVYKG------KLENQFRIAVKRFNRSAWPDAR-QFLEEARAVGQLRNRRLA 116
           E G+ +  +VY+G      K E + R+A+K  N +A    R +FL EA  + +     + 
Sbjct: 26  ELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVV 85
Query: 117 NLLGCCCEGDERLLVAEYMPNDTLAKHLFHWETQ--------PMKWAMRLRVALHIAEAL 168
            LLG   +G   L++ E M    L  +L     +        P   +  +++A  IA+ +
Sbjct: 86  RLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGEIADGM 145
Query: 169 EYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKN------SRDGRSYSTNLAFTPPE 222
            Y  +  + ++ DL A   +  +D   ++  FG+ ++       R G      + +  PE
Sbjct: 146 AYLNAN-KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIXETDXXRKGGKGLLPVRWMSPE 204
Query: 223 YLRTGRVTPESVMYSFGTLLLDLLSGKHIP-----PSHALDLIRDRNIQTLTDSCLEGQF 277
            L+ G  T  S ++SFG +L ++ +    P         L  + +  +    D+C +  F
Sbjct: 205 SLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVMEGGLLDKPDNCPDMLF 264
Query: 278 SSDEGTELVRLASRCLQYEPRERPNPRSLVTAL 310
                 EL+R+   C QY P+ RP+   +++++
Sbjct: 265 ------ELMRM---CWQYNPKMRPSFLEIISSI 288

>pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 67/245 (27%), Positives = 112/245 (45%), Gaps = 32/245 (13%)
Query: 73  VYKGKLENQFRIAVKRFNR-SAWPDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLV 131
           V+ G      ++AVK   + S  PDA  FL EA  + QL+++RL  L     + +   ++
Sbjct: 25  VWMGYYNGHTKVAVKSLKQGSMSPDA--FLAEANLMKQLQHQRLVRLYAVVTQ-EPIYII 81
Query: 132 AEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYH-DLNAYRIVFD 190
            EYM N +L   L       +     L +A  IAE + +   +ER   H +L A  I+  
Sbjct: 82  TEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFI--EERNYIHRNLRAANILVS 139
Query: 191 DDVNPRLSCFGLMK-------NSRDGRSYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLL 243
           D ++ +++ FGL +        +R+G  +   + +T PE +  G  T +S ++SFG LL 
Sbjct: 140 DTLSCKIADFGLARLIEDNEYTAREGAKFP--IKWTAPEAINYGTFTIKSDVWSFGILLT 197
Query: 244 DLLSGKHIP------PSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLASRCLQYEP 297
           ++++   IP      P    +L R   +    D+C E         EL +L   C +  P
Sbjct: 198 EIVTHGRIPYPGMTNPEVIQNLERGYRM-VRPDNCPE---------ELYQLMRLCWKERP 247
Query: 298 RERPN 302
            +RP 
Sbjct: 248 EDRPT 252

>pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 63/273 (23%), Positives = 120/273 (43%), Gaps = 36/273 (13%)
Query: 64  EHGEKAPNVVYKG------KLENQFRIAVKRFNRSAWPDAR-QFLEEARAVGQLRNRRLA 116
           E G+ +  +VY+G      K E + R+A+K  N +A    R +FL EA  + +     + 
Sbjct: 19  ELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVV 78
Query: 117 NLLGCCCEGDERLLVAEYMPNDTLAKHLFHWETQ--------PMKWAMRLRVALHIAEAL 168
            LLG   +G   L++ E M    L  +L     +        P   +  +++A  IA+ +
Sbjct: 79  RLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGEIADGM 138
Query: 169 EYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKN------SRDGRSYSTNLAFTPPE 222
            Y  +  + ++ DL A   +  +D   ++  FG+ ++       R G      + +  PE
Sbjct: 139 AYLNAN-KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPE 197
Query: 223 YLRTGRVTPESVMYSFGTLLLDLLSGKHIP-----PSHALDLIRDRNIQTLTDSCLEGQF 277
            L+ G  T  S ++SFG +L ++ +    P         L  + +  +    D+C +  F
Sbjct: 198 SLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVMEGGLLDKPDNCPDMLF 257
Query: 278 SSDEGTELVRLASRCLQYEPRERPNPRSLVTAL 310
                 EL+R+   C QY P+ RP+   +++++
Sbjct: 258 ------ELMRM---CWQYNPKMRPSFLEIISSI 281

>pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 63/273 (23%), Positives = 120/273 (43%), Gaps = 36/273 (13%)
Query: 64  EHGEKAPNVVYKG------KLENQFRIAVKRFNRSAWPDAR-QFLEEARAVGQLRNRRLA 116
           E G+ +  +VY+G      K E + R+A+K  N +A    R +FL EA  + +     + 
Sbjct: 25  ELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVV 84
Query: 117 NLLGCCCEGDERLLVAEYMPNDTLAKHLFHWETQ--------PMKWAMRLRVALHIAEAL 168
            LLG   +G   L++ E M    L  +L     +        P   +  +++A  IA+ +
Sbjct: 85  RLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGEIADGM 144
Query: 169 EYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKN------SRDGRSYSTNLAFTPPE 222
            Y  +  + ++ DL A   +  +D   ++  FG+ ++       R G      + +  PE
Sbjct: 145 AYLNAN-KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPE 203
Query: 223 YLRTGRVTPESVMYSFGTLLLDLLSGKHIP-----PSHALDLIRDRNIQTLTDSCLEGQF 277
            L+ G  T  S ++SFG +L ++ +    P         L  + +  +    D+C +  F
Sbjct: 204 SLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVMEGGLLDKPDNCPDMLF 263
Query: 278 SSDEGTELVRLASRCLQYEPRERPNPRSLVTAL 310
                 EL+R+   C QY P+ RP+   +++++
Sbjct: 264 ------ELMRM---CWQYNPKMRPSFLEIISSI 287

>pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 63/273 (23%), Positives = 120/273 (43%), Gaps = 36/273 (13%)
Query: 64  EHGEKAPNVVYKG------KLENQFRIAVKRFNRSAWPDAR-QFLEEARAVGQLRNRRLA 116
           E G+ +  +VY+G      K E + R+A+K  N +A    R +FL EA  + +     + 
Sbjct: 23  ELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVV 82
Query: 117 NLLGCCCEGDERLLVAEYMPNDTLAKHLFHWETQ--------PMKWAMRLRVALHIAEAL 168
            LLG   +G   L++ E M    L  +L     +        P   +  +++A  IA+ +
Sbjct: 83  RLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGEIADGM 142
Query: 169 EYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKN------SRDGRSYSTNLAFTPPE 222
            Y  +  + ++ DL A   +  +D   ++  FG+ ++       R G      + +  PE
Sbjct: 143 AYLNAN-KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPE 201
Query: 223 YLRTGRVTPESVMYSFGTLLLDLLSGKHIP-----PSHALDLIRDRNIQTLTDSCLEGQF 277
            L+ G  T  S ++SFG +L ++ +    P         L  + +  +    D+C +  F
Sbjct: 202 SLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVMEGGLLDKPDNCPDMLF 261
Query: 278 SSDEGTELVRLASRCLQYEPRERPNPRSLVTAL 310
                 EL+R+   C QY P+ RP+   +++++
Sbjct: 262 ------ELMRM---CWQYNPKMRPSFLEIISSI 285

>pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 63/273 (23%), Positives = 120/273 (43%), Gaps = 36/273 (13%)
Query: 64  EHGEKAPNVVYKG------KLENQFRIAVKRFNRSAWPDAR-QFLEEARAVGQLRNRRLA 116
           E G+ +  +VY+G      K E + R+A+K  N +A    R +FL EA  + +     + 
Sbjct: 26  ELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVV 85
Query: 117 NLLGCCCEGDERLLVAEYMPNDTLAKHLFHWETQ--------PMKWAMRLRVALHIAEAL 168
            LLG   +G   L++ E M    L  +L     +        P   +  +++A  IA+ +
Sbjct: 86  RLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGEIADGM 145
Query: 169 EYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKN------SRDGRSYSTNLAFTPPE 222
            Y  +  + ++ DL A   +  +D   ++  FG+ ++       R G      + +  PE
Sbjct: 146 AYLNAN-KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPE 204
Query: 223 YLRTGRVTPESVMYSFGTLLLDLLSGKHIP-----PSHALDLIRDRNIQTLTDSCLEGQF 277
            L+ G  T  S ++SFG +L ++ +    P         L  + +  +    D+C +  F
Sbjct: 205 SLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVMEGGLLDKPDNCPDMLF 264
Query: 278 SSDEGTELVRLASRCLQYEPRERPNPRSLVTAL 310
                 EL+R+   C QY P+ RP+   +++++
Sbjct: 265 ------ELMRM---CWQYNPKMRPSFLEIISSI 288

>pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 63/273 (23%), Positives = 120/273 (43%), Gaps = 36/273 (13%)
Query: 64  EHGEKAPNVVYKG------KLENQFRIAVKRFNRSAWPDAR-QFLEEARAVGQLRNRRLA 116
           E G+ +  +VY+G      K E + R+A+K  N +A    R +FL EA  + +     + 
Sbjct: 25  ELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVV 84
Query: 117 NLLGCCCEGDERLLVAEYMPNDTLAKHLFHWETQ--------PMKWAMRLRVALHIAEAL 168
            LLG   +G   L++ E M    L  +L     +        P   +  +++A  IA+ +
Sbjct: 85  RLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGEIADGM 144
Query: 169 EYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKN------SRDGRSYSTNLAFTPPE 222
            Y  +  + ++ DL A   +  +D   ++  FG+ ++       R G      + +  PE
Sbjct: 145 AYLNAN-KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPE 203
Query: 223 YLRTGRVTPESVMYSFGTLLLDLLSGKHIP-----PSHALDLIRDRNIQTLTDSCLEGQF 277
            L+ G  T  S ++SFG +L ++ +    P         L  + +  +    D+C +  F
Sbjct: 204 SLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVMEGGLLDKPDNCPDMLF 263
Query: 278 SSDEGTELVRLASRCLQYEPRERPNPRSLVTAL 310
                 EL+R+   C QY P+ RP+   +++++
Sbjct: 264 ------ELMRM---CWQYNPKMRPSFLEIISSI 287

>pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 63/273 (23%), Positives = 119/273 (43%), Gaps = 36/273 (13%)
Query: 64  EHGEKAPNVVYKG------KLENQFRIAVKRFNRSAWPDAR-QFLEEARAVGQLRNRRLA 116
           E G+ +  +VY+G      K E + R+A+K  N +A    R +FL EA  + +     + 
Sbjct: 17  ELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVV 76
Query: 117 NLLGCCCEGDERLLVAEYMPNDTLAKHLFHWETQ--------PMKWAMRLRVALHIAEAL 168
            LLG   +G   L++ E M    L  +L     +        P   +  +++A  IA+ +
Sbjct: 77  RLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGEIADGM 136
Query: 169 EYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKN------SRDGRSYSTNLAFTPPE 222
            Y  +  + ++ DL A   +  +D   ++  FG+ ++       R G      + +  PE
Sbjct: 137 AYLNAN-KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIXETDXXRKGGKGLLPVRWMSPE 195
Query: 223 YLRTGRVTPESVMYSFGTLLLDLLSGKHIP-----PSHALDLIRDRNIQTLTDSCLEGQF 277
            L+ G  T  S ++SFG +L ++ +    P         L  + +  +    D+C     
Sbjct: 196 SLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVMEGGLLDKPDNC----- 250
Query: 278 SSDEGTELVRLASRCLQYEPRERPNPRSLVTAL 310
             D   EL+R+   C QY P+ RP+   +++++
Sbjct: 251 -PDMLLELMRM---CWQYNPKMRPSFLEIISSI 279

>pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 63/273 (23%), Positives = 120/273 (43%), Gaps = 36/273 (13%)
Query: 64  EHGEKAPNVVYKG------KLENQFRIAVKRFNRSAWPDAR-QFLEEARAVGQLRNRRLA 116
           E G+ +  +VY+G      K E + R+A+K  N +A    R +FL EA  + +     + 
Sbjct: 32  ELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVV 91
Query: 117 NLLGCCCEGDERLLVAEYMPNDTLAKHLFHWETQ--------PMKWAMRLRVALHIAEAL 168
            LLG   +G   L++ E M    L  +L     +        P   +  +++A  IA+ +
Sbjct: 92  RLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGEIADGM 151
Query: 169 EYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKN------SRDGRSYSTNLAFTPPE 222
            Y  +  + ++ DL A   +  +D   ++  FG+ ++       R G      + +  PE
Sbjct: 152 AYLNAN-KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPE 210
Query: 223 YLRTGRVTPESVMYSFGTLLLDLLSGKHIP-----PSHALDLIRDRNIQTLTDSCLEGQF 277
            L+ G  T  S ++SFG +L ++ +    P         L  + +  +    D+C +  F
Sbjct: 211 SLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVMEGGLLDKPDNCPDMLF 270
Query: 278 SSDEGTELVRLASRCLQYEPRERPNPRSLVTAL 310
                 EL+R+   C QY P+ RP+   +++++
Sbjct: 271 ------ELMRM---CWQYNPKMRPSFLEIISSI 294

>pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336

Iteration: 1
 Score = 65.9 bits (159), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 63/273 (23%), Positives = 120/273 (43%), Gaps = 36/273 (13%)
Query: 64  EHGEKAPNVVYKG------KLENQFRIAVKRFNRSAWPDAR-QFLEEARAVGQLRNRRLA 116
           E G+ +  +VY+G      K E + R+A+K  N +A    R +FL EA  + +     + 
Sbjct: 54  ELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVV 113
Query: 117 NLLGCCCEGDERLLVAEYMPNDTLAKHLFHWETQ--------PMKWAMRLRVALHIAEAL 168
            LLG   +G   L++ E M    L  +L     +        P   +  +++A  IA+ +
Sbjct: 114 RLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGEIADGM 173
Query: 169 EYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKN------SRDGRSYSTNLAFTPPE 222
            Y  +  + ++ DL A   +  +D   ++  FG+ ++       R G      + +  PE
Sbjct: 174 AYLNAN-KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPE 232
Query: 223 YLRTGRVTPESVMYSFGTLLLDLLSGKHIP-----PSHALDLIRDRNIQTLTDSCLEGQF 277
            L+ G  T  S ++SFG +L ++ +    P         L  + +  +    D+C +  F
Sbjct: 233 SLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVMEGGLLDKPDNCPDMLF 292
Query: 278 SSDEGTELVRLASRCLQYEPRERPNPRSLVTAL 310
                 EL+R+   C QY P+ RP+   +++++
Sbjct: 293 ------ELMRM---CWQYNPKMRPSFLEIISSI 316

>pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304

Iteration: 1
 Score = 65.9 bits (159), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 63/273 (23%), Positives = 119/273 (43%), Gaps = 36/273 (13%)
Query: 64  EHGEKAPNVVYKG------KLENQFRIAVKRFNRSAWPDAR-QFLEEARAVGQLRNRRLA 116
           E G+ +  +VY+G      K E + R+A+K  N +A    R +FL EA  + +     + 
Sbjct: 22  ELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVV 81
Query: 117 NLLGCCCEGDERLLVAEYMPNDTLAKHLFHWE--------TQPMKWAMRLRVALHIAEAL 168
            LLG   +G   L++ E M    L  +L              P   +  +++A  IA+ +
Sbjct: 82  RLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGM 141
Query: 169 EYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKN------SRDGRSYSTNLAFTPPE 222
            Y  +  + ++ DL A   +  +D   ++  FG+ ++       R G      + +  PE
Sbjct: 142 AYLNAN-KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPE 200
Query: 223 YLRTGRVTPESVMYSFGTLLLDLLSGKHIP-----PSHALDLIRDRNIQTLTDSCLEGQF 277
            L+ G  T  S ++SFG +L ++ +    P         L  + +  +    D+C +  F
Sbjct: 201 SLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVMEGGLLDKPDNCPDMLF 260
Query: 278 SSDEGTELVRLASRCLQYEPRERPNPRSLVTAL 310
                 EL+R+   C QY P+ RP+   +++++
Sbjct: 261 ------ELMRM---CWQYNPKMRPSFLEIISSI 284

>pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322

Iteration: 1
 Score = 65.5 bits (158), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 63/273 (23%), Positives = 119/273 (43%), Gaps = 36/273 (13%)
Query: 64  EHGEKAPNVVYKG------KLENQFRIAVKRFNRSAWPDAR-QFLEEARAVGQLRNRRLA 116
           E G+ +  +VY+G      K E + R+A+K  N +A    R +FL EA  + +     + 
Sbjct: 32  ELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVV 91
Query: 117 NLLGCCCEGDERLLVAEYMPNDTLAKHLFHWE--------TQPMKWAMRLRVALHIAEAL 168
            LLG   +G   L++ E M    L  +L              P   +  +++A  IA+ +
Sbjct: 92  RLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGM 151
Query: 169 EYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKN------SRDGRSYSTNLAFTPPE 222
            Y  +  + ++ DL A   +  +D   ++  FG+ ++       R G      + +  PE
Sbjct: 152 AYLNAN-KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPE 210
Query: 223 YLRTGRVTPESVMYSFGTLLLDLLSGKHIP-----PSHALDLIRDRNIQTLTDSCLEGQF 277
            L+ G  T  S ++SFG +L ++ +    P         L  + +  +    D+C +  F
Sbjct: 211 SLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVMEGGLLDKPDNCPDMLF 270
Query: 278 SSDEGTELVRLASRCLQYEPRERPNPRSLVTAL 310
                 EL+R+   C QY P+ RP+   +++++
Sbjct: 271 ------ELMRM---CWQYNPKMRPSFLEIISSI 294

>pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301

Iteration: 1
 Score = 65.1 bits (157), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 63/273 (23%), Positives = 118/273 (43%), Gaps = 36/273 (13%)
Query: 64  EHGEKAPNVVYKG------KLENQFRIAVKRFNRSAWPDAR-QFLEEARAVGQLRNRRLA 116
           E G+ +  +VY+G      K E + R+A+K  N +A    R +FL EA  + +     + 
Sbjct: 19  ELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVV 78
Query: 117 NLLGCCCEGDERLLVAEYMPNDTLAKHLFHWETQ--------PMKWAMRLRVALHIAEAL 168
            LLG   +G   L++ E M    L  +L     +        P   +  +++A  IA+ +
Sbjct: 79  RLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGEIADGM 138
Query: 169 EYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKN------SRDGRSYSTNLAFTPPE 222
            Y  +  + ++ DL A      +D   ++  FG+ ++       R G      + +  PE
Sbjct: 139 AYLNAN-KFVHRDLAARNCXVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPE 197
Query: 223 YLRTGRVTPESVMYSFGTLLLDLLSGKHIP-----PSHALDLIRDRNIQTLTDSCLEGQF 277
            L+ G  T  S ++SFG +L ++ +    P         L  + +  +    D+C     
Sbjct: 198 SLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVMEGGLLDKPDNC----- 252
Query: 278 SSDEGTELVRLASRCLQYEPRERPNPRSLVTAL 310
             D   EL+R+   C QY P+ RP+   +++++
Sbjct: 253 -PDMLLELMRM---CWQYNPKMRPSFLEIISSI 281

>pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299

Iteration: 1
 Score = 64.3 bits (155), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 62/265 (23%), Positives = 113/265 (42%), Gaps = 28/265 (10%)
Query: 79  ENQFRIAVKRFNRSAWPDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAEYMPND 138
           +++  +AVK    ++    + F  EA  +  L++  +    G C EGD  ++V EYM + 
Sbjct: 41  QDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLIMVFEYMKHG 100
Query: 139 TLAKHL--------FHWETQP---MKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRI 187
            L K L           E  P   +  +  L +A  IA  + Y  S +  ++ DL     
Sbjct: 101 DLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLAS-QHFVHRDLATRNC 159
Query: 188 VFDDDVNPRLSCFGLMKNS------RDGRSYSTNLAFTPPEYLRTGRVTPESVMYSFGTL 241
           +  +++  ++  FG+ ++       R G      + + PPE +   + T ES ++S G +
Sbjct: 160 LVGENLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVV 219
Query: 242 LLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGT---ELVRLASRCLQYEPR 298
           L ++ +    P      L  +  I+ +T    +G+      T   E+  L   C Q EP 
Sbjct: 220 LWEIFTYGKQP---WYQLSNNEVIECIT----QGRVLQRPRTCPQEVYELMLGCWQREPH 272
Query: 299 ERPNPRSLVTALVTLQKDTELYLSL 323
            R N + + T L  L K + +YL +
Sbjct: 273 MRKNIKGIHTLLQNLAKASPVYLDI 297

>pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 59/259 (22%), Positives = 118/259 (45%), Gaps = 24/259 (9%)
Query: 73  VYKGKLEN-QFRIAVKRFNRSAWPDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLV 131
           VY+G  +     +AVK        +  +FL+EA  + ++++  L  LLG C       ++
Sbjct: 27  VYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYII 85
Query: 132 AEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDD 191
            E+M    L  +L     Q +   + L +A  I+ A+EY   K+  ++ DL A   +  +
Sbjct: 86  TEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYL-EKKNFIHRDLAARNCLVGE 144
Query: 192 DVNPRLSCFGLMKNSRDGRSYSTN------LAFTPPEYLRTGRVTPESVMYSFGTLLLDL 245
           +   +++ FGL +    G +++ +      + +T PE L   + + +S +++FG LL ++
Sbjct: 145 NHLVKVADFGLSR-LMTGDTFTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEI 203
Query: 246 LSGKHIP-----PSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLASRCLQYEPRER 300
            +    P     PS   +L+         + C E  +      EL+R    C Q+ P +R
Sbjct: 204 ATYGMSPYPGIDPSQVYELLEKDYRMERPEGCPEKVY------ELMR---ACWQWNPSDR 254
Query: 301 PNPRSLVTALVTLQKDTEL 319
           P+   +  A  T+ +++ +
Sbjct: 255 PSFAEIHQAFETMFQESSI 273

>pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 65/253 (25%), Positives = 112/253 (44%), Gaps = 18/253 (7%)
Query: 73  VYKGKLE-NQFRIAVKRFNRSAWPDAR-QFLEEARAVGQLRNRRLANLLGCCCEGDERLL 130
           V+ G+L  +   +AVK    +  PD + +FL+EAR + Q  +  +  L+G C +     +
Sbjct: 130 VFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYI 189
Query: 131 VAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFD 190
           V E +        L   E   ++    L++    A  +EY  SK   ++ DL A   +  
Sbjct: 190 VMELVQGGDFLTFL-RTEGARLRVKTLLQMVGDAAAGMEYLESK-CCIHRDLAARNCLVT 247
Query: 191 DDVNPRLSCFGLMKNSRDGRSYSTN------LAFTPPEYLRTGRVTPESVMYSFGTLLLD 244
           +    ++S FG+ +   DG   ++       + +T PE L  GR + ES ++SFG LL +
Sbjct: 248 EKNVLKISDFGMSREEADGVXAASGGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWE 307
Query: 245 LLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDE--GTELVRLASRCLQYEPRERPN 302
             S    P  +        N QT       G+    E     + RL  +C  YEP +RP+
Sbjct: 308 TFSLGASPYPNL------SNQQTREFVEKGGRLPCPELCPDAVFRLMEQCWAYEPGQRPS 361
Query: 303 PRSLVTALVTLQK 315
             ++   L +++K
Sbjct: 362 FSTIYQELQSIRK 374

>pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 65/253 (25%), Positives = 112/253 (44%), Gaps = 18/253 (7%)
Query: 73  VYKGKLE-NQFRIAVKRFNRSAWPDAR-QFLEEARAVGQLRNRRLANLLGCCCEGDERLL 130
           V+ G+L  +   +AVK    +  PD + +FL+EAR + Q  +  +  L+G C +     +
Sbjct: 130 VFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYI 189
Query: 131 VAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFD 190
           V E +        L   E   ++    L++    A  +EY  SK   ++ DL A   +  
Sbjct: 190 VMELVQGGDFLTFL-RTEGARLRVKTLLQMVGDAAAGMEYLESK-CCIHRDLAARNCLVT 247
Query: 191 DDVNPRLSCFGLMKNSRDGRSYSTN------LAFTPPEYLRTGRVTPESVMYSFGTLLLD 244
           +    ++S FG+ +   DG   ++       + +T PE L  GR + ES ++SFG LL +
Sbjct: 248 EKNVLKISDFGMSREEADGVYAASGGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWE 307
Query: 245 LLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDE--GTELVRLASRCLQYEPRERPN 302
             S    P  +        N QT       G+    E     + RL  +C  YEP +RP+
Sbjct: 308 TFSLGASPYPNL------SNQQTREFVEKGGRLPCPELCPDAVFRLMEQCWAYEPGQRPS 361
Query: 303 PRSLVTALVTLQK 315
             ++   L +++K
Sbjct: 362 FSTIYQELQSIRK 374

>pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 59/260 (22%), Positives = 116/260 (44%), Gaps = 26/260 (10%)
Query: 73  VYKGKLEN-QFRIAVKRFNRSAWPDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLV 131
           VY+G  +     +AVK        +  +FL+EA  + ++++  L  LLG C       ++
Sbjct: 27  VYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYII 85
Query: 132 AEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDD 191
            E+M    L  +L     Q +   + L +A  I+ A+EY   K+  ++ DL A   +  +
Sbjct: 86  TEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYL-EKKNFIHRDLAARNCLVGE 144
Query: 192 DVNPRLSCFGLMK-------NSRDGRSYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLD 244
           +   +++ FGL +        +  G  +   + +T PE L   + + +S +++FG LL +
Sbjct: 145 NHLVKVADFGLSRLMTGDTXTAHAGAKFP--IKWTAPESLAYNKFSIKSDVWAFGVLLWE 202
Query: 245 LLSGKHIP-----PSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLASRCLQYEPRE 299
           + +    P     PS   +L+         + C E  +      EL+R    C Q+ P +
Sbjct: 203 IATYGMSPYPGIDPSQVYELLEKDYRMERPEGCPEKVY------ELMR---ACWQWNPSD 253
Query: 300 RPNPRSLVTALVTLQKDTEL 319
           RP+   +  A  T+ +++ +
Sbjct: 254 RPSFAEIHQAFETMFQESSI 273

>pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277

Iteration: 1
 Score = 62.4 bits (150), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 59/260 (22%), Positives = 116/260 (44%), Gaps = 26/260 (10%)
Query: 73  VYKGKLEN-QFRIAVKRFNRSAWPDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLV 131
           VY+G  +     +AVK        +  +FL+EA  + ++++  L  LLG C       ++
Sbjct: 27  VYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYII 85
Query: 132 AEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDD 191
            E+M    L  +L     Q +   + L +A  I+ A+EY   K+  ++ DL A   +  +
Sbjct: 86  IEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYL-EKKNFIHRDLAARNCLVGE 144
Query: 192 DVNPRLSCFGLMK-------NSRDGRSYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLD 244
           +   +++ FGL +        +  G  +   + +T PE L   + + +S +++FG LL +
Sbjct: 145 NHLVKVADFGLSRLMTGDTXTAHAGAKFP--IKWTAPESLAYNKFSIKSDVWAFGVLLWE 202
Query: 245 LLSGKHIP-----PSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLASRCLQYEPRE 299
           + +    P     PS   +L+         + C E  +      EL+R    C Q+ P +
Sbjct: 203 IATYGMSPYPGIDPSQVYELLEKDYRMERPEGCPEKVY------ELMR---ACWQWNPSD 253
Query: 300 RPNPRSLVTALVTLQKDTEL 319
           RP+   +  A  T+ +++ +
Sbjct: 254 RPSFAEIHQAFETMFQESSI 273

>pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284

Iteration: 1
 Score = 61.6 bits (148), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 59/258 (22%), Positives = 120/258 (46%), Gaps = 22/258 (8%)
Query: 73  VYKGKLEN-QFRIAVKRFNRSAWPDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLV 131
           VY+G  +     +AVK        +  +FL+EA  + ++++  L  LLG C       ++
Sbjct: 29  VYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYII 87
Query: 132 AEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDD 191
            E+M    L  +L     Q +   + L +A  I+ A+EY   K+  ++ DL A   +  +
Sbjct: 88  TEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYL-EKKNFIHRDLAARNCLVGE 146
Query: 192 DVNPRLSCFGLMKNSRDGRSYSTN------LAFTPPEYLRTGRVTPESVMYSFGTLLLDL 245
           +   +++ FGL +    G +Y+ +      + +T PE L   + + +S +++FG LL ++
Sbjct: 147 NHLVKVADFGLSR-LMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEI 205
Query: 246 LSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSD--EG--TELVRLASRCLQYEPRERP 301
            +   + P   +DL +   +       LE  +  +  EG   ++  L   C Q+ P +RP
Sbjct: 206 AT-YGMSPYPGIDLSQVYEL-------LEKDYRMERPEGCPEKVYELMRACWQWNPSDRP 257
Query: 302 NPRSLVTALVTLQKDTEL 319
           +   +  A  T+ +++ +
Sbjct: 258 SFAEIHQAFETMFQESSI 275

>pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287

Iteration: 1
 Score = 61.6 bits (148), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 59/258 (22%), Positives = 120/258 (46%), Gaps = 22/258 (8%)
Query: 73  VYKGKLEN-QFRIAVKRFNRSAWPDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLV 131
           VY+G  +     +AVK        +  +FL+EA  + ++++  L  LLG C       ++
Sbjct: 31  VYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYII 89
Query: 132 AEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDD 191
            E+M    L  +L     Q +   + L +A  I+ A+EY   K+  ++ DL A   +  +
Sbjct: 90  TEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYL-EKKNFIHRDLAARNCLVGE 148
Query: 192 DVNPRLSCFGLMKNSRDGRSYSTN------LAFTPPEYLRTGRVTPESVMYSFGTLLLDL 245
           +   +++ FGL +    G +Y+ +      + +T PE L   + + +S +++FG LL ++
Sbjct: 149 NHLVKVADFGLSR-LMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEI 207
Query: 246 LSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSD--EG--TELVRLASRCLQYEPRERP 301
            +   + P   +DL +   +       LE  +  +  EG   ++  L   C Q+ P +RP
Sbjct: 208 AT-YGMSPYPGIDLSQVYEL-------LEKDYRMERPEGCPEKVYELMRACWQWNPSDRP 259
Query: 302 NPRSLVTALVTLQKDTEL 319
           +   +  A  T+ +++ +
Sbjct: 260 SFAEIHQAFETMFQESSI 277

>pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535

Iteration: 1
 Score = 61.6 bits (148), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 62/243 (25%), Positives = 105/243 (43%), Gaps = 28/243 (11%)
Query: 73  VYKGKLENQFRIAVKRFNRSAW-PDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLV 131
           V+ G      R+A+K        P+A  FL+EA+ + +LR+ +L  L     E +   +V
Sbjct: 283 VWMGTWNGTTRVAIKTLKPGTMSPEA--FLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIV 339
Query: 132 AEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDD 191
            EYM   +L   L     + ++    + +A  IA  + Y   +   ++ DL A  I+  +
Sbjct: 340 TEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYV-ERMNYVHRDLRAANILVGE 398
Query: 192 DVNPRLSCFGLMK-------NSRDGRSYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLD 244
           ++  +++ FGL +        +R G  +   + +T PE    GR T +S ++SFG LL +
Sbjct: 399 NLVCKVADFGLARLIEDNEYTARQGAKFP--IKWTAPEAALYGRFTIKSDVWSFGILLTE 456
Query: 245 LLSGKHIP-PS----HALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLASRCLQYEPRE 299
           L +   +P P       LD +           C E          L  L  +C + EP E
Sbjct: 457 LTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPE---------SLHDLMCQCWRKEPEE 507
Query: 300 RPN 302
           RP 
Sbjct: 508 RPT 510

>pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293

Iteration: 1
 Score = 61.6 bits (148), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 59/258 (22%), Positives = 120/258 (46%), Gaps = 22/258 (8%)
Query: 73  VYKGKLEN-QFRIAVKRFNRSAWPDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLV 131
           VY+G  +     +AVK        +  +FL+EA  + ++++  L  LLG C       ++
Sbjct: 34  VYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYII 92
Query: 132 AEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDD 191
            E+M    L  +L     Q +   + L +A  I+ A+EY   K+  ++ DL A   +  +
Sbjct: 93  TEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYL-EKKNFIHRDLAARNCLVGE 151
Query: 192 DVNPRLSCFGLMKNSRDGRSYSTN------LAFTPPEYLRTGRVTPESVMYSFGTLLLDL 245
           +   +++ FGL +    G +Y+ +      + +T PE L   + + +S +++FG LL ++
Sbjct: 152 NHLVKVADFGLSR-LMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEI 210
Query: 246 LSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSD--EG--TELVRLASRCLQYEPRERP 301
            +   + P   +DL +   +       LE  +  +  EG   ++  L   C Q+ P +RP
Sbjct: 211 AT-YGMSPYPGIDLSQVYEL-------LEKDYRMERPEGCPEKVYELMRACWQWNPSDRP 262
Query: 302 NPRSLVTALVTLQKDTEL 319
           +   +  A  T+ +++ +
Sbjct: 263 SFAEIHQAFETMFQESSI 280

>pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276

Iteration: 1
 Score = 61.6 bits (148), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 62/243 (25%), Positives = 105/243 (43%), Gaps = 28/243 (11%)
Query: 73  VYKGKLENQFRIAVKRFNRSAW-PDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLV 131
           V+ G      R+A+K        P+A  FL+EA+ + +LR+ +L  L     E +   +V
Sbjct: 24  VWMGTWNGTTRVAIKTLKPGTMSPEA--FLQEAQVMKKLRHEKLVQLYAVVSE-EPIXIV 80
Query: 132 AEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDD 191
            EYM   +L   L     + ++    + +A  IA  + Y   +   ++ DL A  I+  +
Sbjct: 81  TEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAY-VERMNYVHRDLRAANILVGE 139
Query: 192 DVNPRLSCFGLMK-------NSRDGRSYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLD 244
           ++  +++ FGL +        +R G  +   + +T PE    GR T +S ++SFG LL +
Sbjct: 140 NLVCKVADFGLARLIEDNEXTARQGAKFP--IKWTAPEAALYGRFTIKSDVWSFGILLTE 197
Query: 245 LLSGKHIP-PS----HALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLASRCLQYEPRE 299
           L +   +P P       LD +           C E          L  L  +C + EP E
Sbjct: 198 LTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPES---------LHDLMCQCWRKEPEE 248
Query: 300 RPN 302
           RP 
Sbjct: 249 RPT 251

>pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283

Iteration: 1
 Score = 61.6 bits (148), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 56/237 (23%), Positives = 104/237 (43%), Gaps = 18/237 (7%)
Query: 73  VYKGKLENQFRIAVKRFNRSAWPDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVA 132
           V+ G      ++A+K   +        FLEEA+ + +L++ +L  L     E +   +V 
Sbjct: 25  VWMGTWNGNTKVAIKTL-KPGTMSPESFLEEAQIMKKLKHDKLVQLYAVVSE-EPIYIVT 82
Query: 133 EYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDD 192
           EYM   +L   L   E + +K    + +A  +A  + Y   +   ++ DL +  I+  + 
Sbjct: 83  EYMNKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYI-ERMNYIHRDLRSANILVGNG 141
Query: 193 VNPRLSCFGLMK-------NSRDGRSYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDL 245
           +  +++ FGL +        +R G  +   + +T PE    GR T +S ++SFG LL +L
Sbjct: 142 LICKIADFGLARLIEDNEXTARQGAKFP--IKWTAPEAALYGRFTIKSDVWSFGILLTEL 199
Query: 246 LSGKHIP-PSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLASRCLQYEPRERP 301
           ++   +P P      + +R +    +         D    L  L   C + +P ERP
Sbjct: 200 VTKGRVPYPG-----MNNREVLEQVERGYRMPCPQDCPISLHELMIHCWKKDPEERP 251

>pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288

Iteration: 1
 Score = 61.2 bits (147), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 59/258 (22%), Positives = 120/258 (46%), Gaps = 22/258 (8%)
Query: 73  VYKGKLEN-QFRIAVKRFNRSAWPDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLV 131
           VY+G  +     +AVK        +  +FL+EA  + ++++  L  LLG C       ++
Sbjct: 29  VYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYII 87
Query: 132 AEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDD 191
            E+M    L  +L     Q +   + L +A  I+ A+EY   K+  ++ DL A   +  +
Sbjct: 88  TEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYL-EKKNFIHRDLAARNCLVGE 146
Query: 192 DVNPRLSCFGLMKNSRDGRSYSTN------LAFTPPEYLRTGRVTPESVMYSFGTLLLDL 245
           +   +++ FGL +    G +Y+ +      + +T PE L   + + +S +++FG LL ++
Sbjct: 147 NHLVKVADFGLSR-LMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEI 205
Query: 246 LSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSD--EG--TELVRLASRCLQYEPRERP 301
            +   + P   +DL +   +       LE  +  +  EG   ++  L   C Q+ P +RP
Sbjct: 206 AT-YGMSPYPGIDLSQVYEL-------LEKDYRMERPEGCPEKVYELMRACWQWNPSDRP 257
Query: 302 NPRSLVTALVTLQKDTEL 319
           +   +  A  T+ +++ +
Sbjct: 258 SFAEIHQAFETMFQESSI 275

>pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293

Iteration: 1
 Score = 61.2 bits (147), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 59/258 (22%), Positives = 120/258 (46%), Gaps = 22/258 (8%)
Query: 73  VYKGKLEN-QFRIAVKRFNRSAWPDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLV 131
           VY+G  +     +AVK        +  +FL+EA  + ++++  L  LLG C       ++
Sbjct: 34  VYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYII 92
Query: 132 AEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDD 191
            E+M    L  +L     Q +   + L +A  I+ A+EY   K+  ++ DL A   +  +
Sbjct: 93  TEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYL-EKKNFIHRDLAARNCLVGE 151
Query: 192 DVNPRLSCFGLMKNSRDGRSYSTN------LAFTPPEYLRTGRVTPESVMYSFGTLLLDL 245
           +   +++ FGL +    G +Y+ +      + +T PE L   + + +S +++FG LL ++
Sbjct: 152 NHLVKVADFGLSR-LMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEI 210
Query: 246 LSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSD--EG--TELVRLASRCLQYEPRERP 301
            +   + P   +DL +   +       LE  +  +  EG   ++  L   C Q+ P +RP
Sbjct: 211 AT-YGMSPYPGIDLSQVYEL-------LEKDYRMERPEGCPEKVYELMRACWQWNPSDRP 262
Query: 302 NPRSLVTALVTLQKDTEL 319
           +   +  A  T+ +++ +
Sbjct: 263 SFAEIHQAFETMFQESSI 280

>pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298

Iteration: 1
 Score = 61.2 bits (147), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 59/258 (22%), Positives = 120/258 (46%), Gaps = 22/258 (8%)
Query: 73  VYKGKLEN-QFRIAVKRFNRSAWPDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLV 131
           VY+G  +     +AVK        +  +FL+EA  + ++++  L  LLG C       ++
Sbjct: 42  VYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYII 100
Query: 132 AEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDD 191
            E+M    L  +L     Q +   + L +A  I+ A+EY   K+  ++ DL A   +  +
Sbjct: 101 TEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYL-EKKNFIHRDLAARNCLVGE 159
Query: 192 DVNPRLSCFGLMKNSRDGRSYSTN------LAFTPPEYLRTGRVTPESVMYSFGTLLLDL 245
           +   +++ FGL +    G +Y+ +      + +T PE L   + + +S +++FG LL ++
Sbjct: 160 NHLVKVADFGLSR-LMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEI 218
Query: 246 LSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSD--EG--TELVRLASRCLQYEPRERP 301
            +   + P   +DL +   +       LE  +  +  EG   ++  L   C Q+ P +RP
Sbjct: 219 AT-YGMSPYPGIDLSQVYEL-------LEKDYRMERPEGCPEKVYELMRACWQWNPSDRP 270
Query: 302 NPRSLVTALVTLQKDTEL 319
           +   +  A  T+ +++ +
Sbjct: 271 SFAEIHQAFETMFQESSI 288

>pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287

Iteration: 1
 Score = 61.2 bits (147), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 59/258 (22%), Positives = 120/258 (46%), Gaps = 22/258 (8%)
Query: 73  VYKGKLEN-QFRIAVKRFNRSAWPDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLV 131
           VY+G  +     +AVK        +  +FL+EA  + ++++  L  LLG C       ++
Sbjct: 31  VYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYII 89
Query: 132 AEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDD 191
            E+M    L  +L     Q +   + L +A  I+ A+EY   K+  ++ DL A   +  +
Sbjct: 90  TEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYL-EKKNFIHRDLAARNCLVGE 148
Query: 192 DVNPRLSCFGLMKNSRDGRSYSTN------LAFTPPEYLRTGRVTPESVMYSFGTLLLDL 245
           +   +++ FGL +    G +Y+ +      + +T PE L   + + +S +++FG LL ++
Sbjct: 149 NHLVKVADFGLSR-LMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEI 207
Query: 246 LSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSD--EG--TELVRLASRCLQYEPRERP 301
            +   + P   +DL +   +       LE  +  +  EG   ++  L   C Q+ P +RP
Sbjct: 208 AT-YGMSPYPGIDLSQVYEL-------LEKDYRMERPEGCPEKVYELMRACWQWNPSDRP 259
Query: 302 NPRSLVTALVTLQKDTEL 319
           +   +  A  T+ +++ +
Sbjct: 260 SFAEIHQAFETMFQESSI 277

>pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267

Iteration: 1
 Score = 61.2 bits (147), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 51/200 (25%), Positives = 92/200 (46%), Gaps = 12/200 (6%)
Query: 60  NIVSEHGEKAPNVVYKGKLENQFRIAVKRFNRSAWPDARQFLEEARAVGQLRNRRLANLL 119
             V E G     +V+ G   N+ ++A+K     A  +   F+EEA  + +L + +L  L 
Sbjct: 11  TFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSE-EDFIEEAEVMMKLSHPKLVQLY 69
Query: 120 GCCCEGDERLLVAEYMPNDTLAKHLFHWETQPMKWAMR--LRVALHIAEALEYCTSKERA 177
           G C E     LV E+M +  L+ +L    TQ   +A    L + L + E + Y   +   
Sbjct: 70  GVCLEQAPICLVTEFMEHGCLSDYL---RTQRGLFAAETLLGMCLDVCEGMAY-LEEACV 125
Query: 178 LYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDGRSYSTN-----LAFTPPEYLRTGRVTPE 232
           ++ DL A   +  ++   ++S FG+ +   D +  S+      + +  PE     R + +
Sbjct: 126 IHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRYSSK 185
Query: 233 SVMYSFGTLLLDLLSGKHIP 252
           S ++SFG L+ ++ S   IP
Sbjct: 186 SDVWSFGVLMWEVFSEGKIP 205

>pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452

Iteration: 1
 Score = 61.2 bits (147), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 61/243 (25%), Positives = 104/243 (42%), Gaps = 28/243 (11%)
Query: 73  VYKGKLENQFRIAVKRFNRSAW-PDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLV 131
           V+ G      R+A+K        P+A  FL+EA+ + +LR+ +L  L     E +   +V
Sbjct: 200 VWMGTWNGTTRVAIKTLKPGTMSPEA--FLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIV 256
Query: 132 AEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDD 191
            EYM   +L   L     + ++    + +A  IA  + Y   +   ++ DL A  I+  +
Sbjct: 257 GEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYV-ERMNYVHRDLRAANILVGE 315
Query: 192 DVNPRLSCFGLMK-------NSRDGRSYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLD 244
           ++  +++ FGL +        +R G  +   + +T PE    GR T +S ++SFG LL +
Sbjct: 316 NLVCKVADFGLARLIEDNEYTARQGAKFP--IKWTAPEAALYGRFTIKSDVWSFGILLTE 373
Query: 245 LLSGKHIP-----PSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLASRCLQYEPRE 299
           L +   +P         LD +           C E          L  L  +C + EP E
Sbjct: 374 LTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPES---------LHDLMCQCWRKEPEE 424
Query: 300 RPN 302
           RP 
Sbjct: 425 RPT 427

>pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284

Iteration: 1
 Score = 61.2 bits (147), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 59/258 (22%), Positives = 120/258 (46%), Gaps = 22/258 (8%)
Query: 73  VYKGKLEN-QFRIAVKRFNRSAWPDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLV 131
           VY+G  +     +AVK        +  +FL+EA  + ++++  L  LLG C       ++
Sbjct: 29  VYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYII 87
Query: 132 AEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDD 191
            E+M    L  +L     Q +   + L +A  I+ A+EY   K+  ++ DL A   +  +
Sbjct: 88  IEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYL-EKKNFIHRDLAARNCLVGE 146
Query: 192 DVNPRLSCFGLMKNSRDGRSYSTN------LAFTPPEYLRTGRVTPESVMYSFGTLLLDL 245
           +   +++ FGL +    G +Y+ +      + +T PE L   + + +S +++FG LL ++
Sbjct: 147 NHLVKVADFGLSR-LMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEI 205
Query: 246 LSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSD--EG--TELVRLASRCLQYEPRERP 301
            +   + P   +DL +   +       LE  +  +  EG   ++  L   C Q+ P +RP
Sbjct: 206 AT-YGMSPYPGIDLSQVYEL-------LEKDYRMERPEGCPEKVYELMRACWQWNPSDRP 257
Query: 302 NPRSLVTALVTLQKDTEL 319
           +   +  A  T+ +++ +
Sbjct: 258 SFAEIHQAFETMFQESSI 275

>pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266

Iteration: 1
 Score = 61.2 bits (147), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 51/200 (25%), Positives = 92/200 (46%), Gaps = 12/200 (6%)
Query: 60  NIVSEHGEKAPNVVYKGKLENQFRIAVKRFNRSAWPDARQFLEEARAVGQLRNRRLANLL 119
             V E G     +V+ G   N+ ++A+K     A  +   F+EEA  + +L + +L  L 
Sbjct: 10  TFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSE-EDFIEEAEVMMKLSHPKLVQLY 68
Query: 120 GCCCEGDERLLVAEYMPNDTLAKHLFHWETQPMKWAMR--LRVALHIAEALEYCTSKERA 177
           G C E     LV E+M +  L+ +L    TQ   +A    L + L + E + Y   +   
Sbjct: 69  GVCLEQAPICLVFEFMEHGCLSDYL---RTQRGLFAAETLLGMCLDVCEGMAYL-EEASV 124
Query: 178 LYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDGRSYSTN-----LAFTPPEYLRTGRVTPE 232
           ++ DL A   +  ++   ++S FG+ +   D +  S+      + +  PE     R + +
Sbjct: 125 IHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRYSSK 184
Query: 233 SVMYSFGTLLLDLLSGKHIP 252
           S ++SFG L+ ++ S   IP
Sbjct: 185 SDVWSFGVLMWEVFSEGKIP 204

>pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279

Iteration: 1
 Score = 61.2 bits (147), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 62/243 (25%), Positives = 105/243 (43%), Gaps = 28/243 (11%)
Query: 73  VYKGKLENQFRIAVKRFNRSAW-PDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLV 131
           V+ G      R+A+K        P+A  FL+EA+ + +LR+ +L  L     E +   +V
Sbjct: 27  VWMGTWNGTTRVAIKTLKPGTMSPEA--FLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIV 83
Query: 132 AEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDD 191
            EYM   +L   L     + ++    + +A  IA  + Y   +   ++ DL A  I+  +
Sbjct: 84  TEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAY-VERMNYVHRDLRAANILVGE 142
Query: 192 DVNPRLSCFGLMK-------NSRDGRSYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLD 244
           ++  +++ FGL +        +R G  +   + +T PE    GR T +S ++SFG LL +
Sbjct: 143 NLVCKVADFGLARLIEDNEYTARQGAKFP--IKWTAPEAALYGRFTIKSDVWSFGILLTE 200
Query: 245 LLSGKHIP-PS----HALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLASRCLQYEPRE 299
           L +   +P P       LD +           C E          L  L  +C + EP E
Sbjct: 201 LTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPES---------LHDLMCQCWRKEPEE 251
Query: 300 RPN 302
           RP 
Sbjct: 252 RPT 254

>pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452

Iteration: 1
 Score = 60.8 bits (146), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 61/243 (25%), Positives = 104/243 (42%), Gaps = 28/243 (11%)
Query: 73  VYKGKLENQFRIAVKRFNRSAW-PDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLV 131
           V+ G      R+A+K        P+A  FL+EA+ + +LR+ +L  L     E +   +V
Sbjct: 200 VWMGTWNGTTRVAIKTLKPGTMSPEA--FLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIV 256
Query: 132 AEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDD 191
            EYM   +L   L     + ++    + +A  IA  + Y   +   ++ DL A  I+  +
Sbjct: 257 TEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYV-ERMNYVHRDLRAANILVGE 315
Query: 192 DVNPRLSCFGLMK-------NSRDGRSYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLD 244
           ++  +++ FGL +        +R G  +   + +T PE    GR T +S ++SFG LL +
Sbjct: 316 NLVCKVADFGLARLIEDNEYTARQGAKFP--IKWTAPEAALYGRFTIKSDVWSFGILLTE 373
Query: 245 LLSGKHIP-----PSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLASRCLQYEPRE 299
           L +   +P         LD +           C E          L  L  +C + EP E
Sbjct: 374 LTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPES---------LHDLMCQCWRKEPEE 424
Query: 300 RPN 302
           RP 
Sbjct: 425 RPT 427

>pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288

Iteration: 1
 Score = 60.8 bits (146), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 59/258 (22%), Positives = 120/258 (46%), Gaps = 22/258 (8%)
Query: 73  VYKGKLEN-QFRIAVKRFNRSAWPDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLV 131
           VY+G  +     +AVK        +  +FL+EA  + ++++  L  LLG C       ++
Sbjct: 29  VYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYII 87
Query: 132 AEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDD 191
            E+M    L  +L     Q +   + L +A  I+ A+EY   K+  ++ DL A   +  +
Sbjct: 88  IEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYL-EKKNFIHRDLAARNCLVGE 146
Query: 192 DVNPRLSCFGLMKNSRDGRSYSTN------LAFTPPEYLRTGRVTPESVMYSFGTLLLDL 245
           +   +++ FGL +    G +Y+ +      + +T PE L   + + +S +++FG LL ++
Sbjct: 147 NHLVKVADFGLSR-LMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEI 205
Query: 246 LSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSD--EG--TELVRLASRCLQYEPRERP 301
            +   + P   +DL +   +       LE  +  +  EG   ++  L   C Q+ P +RP
Sbjct: 206 AT-YGMSPYPGIDLSQVYEL-------LEKDYRMERPEGCPEKVYELMRACWQWNPSDRP 257
Query: 302 NPRSLVTALVTLQKDTEL 319
           +   +  A  T+ +++ +
Sbjct: 258 SFAEIHQAFETMFQESSI 275

>pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277

Iteration: 1
 Score = 60.8 bits (146), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 59/256 (23%), Positives = 119/256 (46%), Gaps = 22/256 (8%)
Query: 73  VYKGKLEN-QFRIAVKRFNRSAWPDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLV 131
           VY+G  +     +AVK        +  +FL+EA  + ++++  L  LLG C       ++
Sbjct: 33  VYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYII 91
Query: 132 AEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDD 191
            E+M    L  +L     Q +   + L +A  I+ A+EY   K+  ++ DL A   +  +
Sbjct: 92  TEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYL-EKKNFIHRDLAARNCLVGE 150
Query: 192 DVNPRLSCFGLMKNSRDGRSYSTN------LAFTPPEYLRTGRVTPESVMYSFGTLLLDL 245
           +   +++ FGL +    G +Y+ +      + +T PE L   + + +S +++FG LL ++
Sbjct: 151 NHLVKVADFGLSR-LMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEI 209
Query: 246 LSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSD--EG--TELVRLASRCLQYEPRERP 301
            +   + P   +DL +   +       LE  +  +  EG   ++  L   C Q+ P +RP
Sbjct: 210 AT-YGMSPYPGIDLSQVYEL-------LEKDYRMERPEGCPEKVYELMRACWQWNPSDRP 261
Query: 302 NPRSLVTALVTLQKDT 317
           +   +  A  T+ +++
Sbjct: 262 SFAEIHQAFETMFQES 277

>pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 59/256 (23%), Positives = 119/256 (46%), Gaps = 22/256 (8%)
Query: 73  VYKGKLEN-QFRIAVKRFNRSAWPDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLV 131
           VY+G  +     +AVK        +  +FL+EA  + ++++  L  LLG C       ++
Sbjct: 29  VYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYII 87
Query: 132 AEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDD 191
            E+M    L  +L     Q +   + L +A  I+ A+EY   K+  ++ DL A   +  +
Sbjct: 88  TEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYL-EKKNFIHRDLAARNCLVGE 146
Query: 192 DVNPRLSCFGLMKNSRDGRSYSTN------LAFTPPEYLRTGRVTPESVMYSFGTLLLDL 245
           +   +++ FGL +    G +Y+ +      + +T PE L   + + +S +++FG LL ++
Sbjct: 147 NHLVKVADFGLSR-LMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEI 205
Query: 246 LSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSD--EG--TELVRLASRCLQYEPRERP 301
            +   + P   +DL +   +       LE  +  +  EG   ++  L   C Q+ P +RP
Sbjct: 206 AT-YGMSPYPGIDLSQVYEL-------LEKDYRMERPEGCPEKVYELMRACWQWNPSDRP 257
Query: 302 NPRSLVTALVTLQKDT 317
           +   +  A  T+ +++
Sbjct: 258 SFAEIHQAFETMFQES 273

>pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 61/243 (25%), Positives = 104/243 (42%), Gaps = 28/243 (11%)
Query: 73  VYKGKLENQFRIAVKRFNRSAW-PDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLV 131
           V+ G      R+A+K        P+A  FL+EA+ + +LR+ +L  L     E +   +V
Sbjct: 200 VWMGTWNGTTRVAIKTLKPGTMSPEA--FLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIV 256
Query: 132 AEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDD 191
            EYM   +L   L     + ++    + +A  IA  + Y   +   ++ DL A  I+  +
Sbjct: 257 TEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYV-ERMNYVHRDLRAANILVGE 315
Query: 192 DVNPRLSCFGLMK-------NSRDGRSYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLD 244
           ++  +++ FGL +        +R G  +   + +T PE    GR T +S ++SFG LL +
Sbjct: 316 NLVCKVADFGLARLIEDNEYTARQGAKFP--IKWTAPEAALYGRFTIKSDVWSFGILLTE 373
Query: 245 LLSGKHIP-----PSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLASRCLQYEPRE 299
           L +   +P         LD +           C E          L  L  +C + EP E
Sbjct: 374 LTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPES---------LHDLMCQCWRKEPEE 424
Query: 300 RPN 302
           RP 
Sbjct: 425 RPT 427

>pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264

Iteration: 1
 Score = 60.5 bits (145), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 51/200 (25%), Positives = 92/200 (46%), Gaps = 12/200 (6%)
Query: 60  NIVSEHGEKAPNVVYKGKLENQFRIAVKRFNRSAWPDARQFLEEARAVGQLRNRRLANLL 119
             V E G     +V+ G   N+ ++A+K     A  +   F+EEA  + +L + +L  L 
Sbjct: 8   TFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSE-EDFIEEAEVMMKLSHPKLVQLY 66
Query: 120 GCCCEGDERLLVAEYMPNDTLAKHLFHWETQPMKWAMR--LRVALHIAEALEYCTSKERA 177
           G C E     LV E+M +  L+ +L    TQ   +A    L + L + E + Y   +   
Sbjct: 67  GVCLEQAPICLVFEFMEHGCLSDYL---RTQRGLFAAETLLGMCLDVCEGMAY-LEEACV 122
Query: 178 LYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDGRSYSTN-----LAFTPPEYLRTGRVTPE 232
           ++ DL A   +  ++   ++S FG+ +   D +  S+      + +  PE     R + +
Sbjct: 123 IHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRYSSK 182
Query: 233 SVMYSFGTLLLDLLSGKHIP 252
           S ++SFG L+ ++ S   IP
Sbjct: 183 SDVWSFGVLMWEVFSEGKIP 202

>pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266

Iteration: 1
 Score = 60.5 bits (145), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 51/200 (25%), Positives = 92/200 (46%), Gaps = 12/200 (6%)
Query: 60  NIVSEHGEKAPNVVYKGKLENQFRIAVKRFNRSAWPDARQFLEEARAVGQLRNRRLANLL 119
             V E G     +V+ G   N+ ++A+K     A  +   F+EEA  + +L + +L  L 
Sbjct: 10  TFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSE-EDFIEEAEVMMKLSHPKLVQLY 68
Query: 120 GCCCEGDERLLVAEYMPNDTLAKHLFHWETQPMKWAMR--LRVALHIAEALEYCTSKERA 177
           G C E     LV E+M +  L+ +L    TQ   +A    L + L + E + Y   +   
Sbjct: 69  GVCLEQAPICLVFEFMEHGCLSDYL---RTQRGLFAAETLLGMCLDVCEGMAY-LEEACV 124
Query: 178 LYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDGRSYSTN-----LAFTPPEYLRTGRVTPE 232
           ++ DL A   +  ++   ++S FG+ +   D +  S+      + +  PE     R + +
Sbjct: 125 IHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRYSSK 184
Query: 233 SVMYSFGTLLLDLLSGKHIP 252
           S ++SFG L+ ++ S   IP
Sbjct: 185 SDVWSFGVLMWEVFSEGKIP 204

>pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269

Iteration: 1
 Score = 60.5 bits (145), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 51/200 (25%), Positives = 92/200 (46%), Gaps = 12/200 (6%)
Query: 60  NIVSEHGEKAPNVVYKGKLENQFRIAVKRFNRSAWPDARQFLEEARAVGQLRNRRLANLL 119
             V E G     +V+ G   N+ ++A+K     A  +   F+EEA  + +L + +L  L 
Sbjct: 13  TFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSE-EDFIEEAEVMMKLSHPKLVQLY 71
Query: 120 GCCCEGDERLLVAEYMPNDTLAKHLFHWETQPMKWAMR--LRVALHIAEALEYCTSKERA 177
           G C E     LV E+M +  L+ +L    TQ   +A    L + L + E + Y   +   
Sbjct: 72  GVCLEQAPICLVFEFMEHGCLSDYL---RTQRGLFAAETLLGMCLDVCEGMAY-LEEACV 127
Query: 178 LYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDGRSYSTN-----LAFTPPEYLRTGRVTPE 232
           ++ DL A   +  ++   ++S FG+ +   D +  S+      + +  PE     R + +
Sbjct: 128 IHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRYSSK 187
Query: 233 SVMYSFGTLLLDLLSGKHIP 252
           S ++SFG L+ ++ S   IP
Sbjct: 188 SDVWSFGVLMWEVFSEGKIP 207

>pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270

Iteration: 1
 Score = 60.5 bits (145), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 59/252 (23%), Positives = 116/252 (46%), Gaps = 22/252 (8%)
Query: 73  VYKGKLEN-QFRIAVKRFNRSAWPDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLV 131
           VY+G  +     +AVK        +  +FL+EA  + ++++  L  LLG C       ++
Sbjct: 29  VYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYII 87
Query: 132 AEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDD 191
            E+M    L  +L     Q +   + L +A  I+ A+EY   K+  ++ DL A   +  +
Sbjct: 88  TEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYL-EKKNFIHRDLAARNCLVGE 146
Query: 192 DVNPRLSCFGLMKNSRDGRSYSTN------LAFTPPEYLRTGRVTPESVMYSFGTLLLDL 245
           +   +++ FGL +    G +Y+ +      + +T PE L   + + +S +++FG LL ++
Sbjct: 147 NHLVKVADFGLSR-LMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEI 205
Query: 246 LSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSD--EG--TELVRLASRCLQYEPRERP 301
            +   + P   +DL +   +       LE  +  +  EG   ++  L   C Q+ P +RP
Sbjct: 206 AT-YGMSPYPGIDLSQVYEL-------LEKDYRMERPEGCPEKVYELMRACWQWNPSDRP 257
Query: 302 NPRSLVTALVTL 313
           +   +  A  T+
Sbjct: 258 SFAEIHQAFETM 269

>pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277

Iteration: 1
 Score = 60.5 bits (145), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 59/252 (23%), Positives = 116/252 (46%), Gaps = 22/252 (8%)
Query: 73  VYKGKLEN-QFRIAVKRFNRSAWPDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLV 131
           VY+G  +     +AVK        +  +FL+EA  + ++++  L  LLG C       ++
Sbjct: 34  VYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYII 92
Query: 132 AEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDD 191
            E+M    L  +L     Q +   + L +A  I+ A+EY   K+  ++ DL A   +  +
Sbjct: 93  TEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYL-EKKNFIHRDLAARNCLVGE 151
Query: 192 DVNPRLSCFGLMKNSRDGRSYSTN------LAFTPPEYLRTGRVTPESVMYSFGTLLLDL 245
           +   +++ FGL +    G +Y+ +      + +T PE L   + + +S +++FG LL ++
Sbjct: 152 NHLVKVADFGLSR-LMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEI 210
Query: 246 LSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSD--EG--TELVRLASRCLQYEPRERP 301
            +   + P   +DL +   +       LE  +  +  EG   ++  L   C Q+ P +RP
Sbjct: 211 AT-YGMSPYPGIDLSQVYEL-------LEKDYRMERPEGCPEKVYELMRACWQWNPSDRP 262
Query: 302 NPRSLVTALVTL 313
           +   +  A  T+
Sbjct: 263 SFAEIHQAFETM 274

>pdb|4FVP|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain (Apo Form) Length = 289

Iteration: 1
 Score = 60.5 bits (145), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 61/240 (25%), Positives = 109/240 (45%), Gaps = 19/240 (7%)
Query: 84  IAVKRFNRSAWPDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAEYMPNDTLAKH 143
           + +K  +++    +  F E A  + +L ++ L    G C  GDE +LV E++   +L  +
Sbjct: 43  VLLKVLDKAHRNYSESFFEAASMMSKLSHKHLVLNYGVCVCGDENILVQEFVKFGSLDTY 102
Query: 144 LFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYH-DLNAYRIVFDDDVNPRLSCFGL 202
           L       +    +L VA  +A A+ +   +E  L H ++ A  I+   + + +      
Sbjct: 103 L-KKNKNCINILWKLEVAKQLAAAMHFL--EENTLIHGNVCAKNILLIREEDRKTGNPPF 159
Query: 203 MKNSRDGRSYST--------NLAFTPPEYLRTGR-VTPESVMYSFGTLLLDLLSGKHIPP 253
           +K S  G S +          + + PPE +   + +   +  +SFGT L ++ SG   P 
Sbjct: 160 IKLSDPGISITVLPKDILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPL 219
Query: 254 SHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLASRCLQYEPRERPNPRSLVTALVTL 313
           S ALD    R +Q   D     Q  + +  EL  L + C+ YEP  RP+ R+++  L +L
Sbjct: 220 S-ALD--SQRKLQFYED---RHQLPAPKAAELANLINNCMDYEPDHRPSFRAIIRDLNSL 273

>pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287

Iteration: 1
 Score = 60.1 bits (144), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 59/258 (22%), Positives = 119/258 (46%), Gaps = 22/258 (8%)
Query: 73  VYKGKLEN-QFRIAVKRFNRSAWPDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLV 131
           VY+G  +     +AVK        +  +FL+EA  + ++++  L  LLG C       ++
Sbjct: 31  VYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYII 89
Query: 132 AEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDD 191
            E+M    L  +L     Q +   + L +A  I+ A+EY   K+  ++ DL A   +  +
Sbjct: 90  TEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYL-EKKNFIHRDLAARNCLVGE 148
Query: 192 DVNPRLSCFGLMKNSRDGRSYST------NLAFTPPEYLRTGRVTPESVMYSFGTLLLDL 245
           +   +++ FGL +    G +Y+        + +T PE L   + + +S +++FG LL ++
Sbjct: 149 NHLVKVADFGLSR-LMTGDTYTAPAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEI 207
Query: 246 LSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSD--EG--TELVRLASRCLQYEPRERP 301
            +   + P   +DL +   +       LE  +  +  EG   ++  L   C Q+ P +RP
Sbjct: 208 AT-YGMSPYPGIDLSQVYEL-------LEKDYRMERPEGCPEKVYELMRACWQWNPSDRP 259
Query: 302 NPRSLVTALVTLQKDTEL 319
           +   +  A  T+ +++ +
Sbjct: 260 SFAEIHQAFETMFQESSI 277

>pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 59/258 (22%), Positives = 119/258 (46%), Gaps = 22/258 (8%)
Query: 73  VYKGKLEN-QFRIAVKRFNRSAWPDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLV 131
           VY+G  +     +AVK        +  +FL+EA  + ++++  L  LLG C       ++
Sbjct: 30  VYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYII 88
Query: 132 AEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDD 191
            E+M    L  +L     Q +   + L +A  I+ A+EY   K+  ++ DL A   +  +
Sbjct: 89  TEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYL-EKKNFIHRDLAARNCLVGE 147
Query: 192 DVNPRLSCFGLMKNSRDGRSYST------NLAFTPPEYLRTGRVTPESVMYSFGTLLLDL 245
           +   +++ FGL +    G +Y+        + +T PE L   + + +S +++FG LL ++
Sbjct: 148 NHLVKVADFGLSR-LMTGDTYTAPAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEI 206
Query: 246 LSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSD--EG--TELVRLASRCLQYEPRERP 301
            +   + P   +DL +   +       LE  +  +  EG   ++  L   C Q+ P +RP
Sbjct: 207 AT-YGMSPYPGIDLSQVYEL-------LEKDYRMERPEGCPEKVYELMRACWQWNPSDRP 258
Query: 302 NPRSLVTALVTLQKDTEL 319
           +   +  A  T+ +++ +
Sbjct: 259 SFAEIHQAFETMFQESSI 276

>pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 59/252 (23%), Positives = 116/252 (46%), Gaps = 22/252 (8%)
Query: 73  VYKGKLEN-QFRIAVKRFNRSAWPDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLV 131
           VY+G  +     +AVK        +  +FL+EA  + ++++  L  LLG C       ++
Sbjct: 34  VYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYII 92
Query: 132 AEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDD 191
            E+M    L  +L     Q +   + L +A  I+ A+EY   K+  ++ DL A   +  +
Sbjct: 93  IEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYL-EKKNFIHRDLAARNCLVGE 151
Query: 192 DVNPRLSCFGLMKNSRDGRSYSTN------LAFTPPEYLRTGRVTPESVMYSFGTLLLDL 245
           +   +++ FGL +    G +Y+ +      + +T PE L   + + +S +++FG LL ++
Sbjct: 152 NHLVKVADFGLSR-LMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEI 210
Query: 246 LSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSD--EG--TELVRLASRCLQYEPRERP 301
            +   + P   +DL +   +       LE  +  +  EG   ++  L   C Q+ P +RP
Sbjct: 211 AT-YGMSPYPGIDLSQVYEL-------LEKDYRMERPEGCPEKVYELMRACWQWNPSDRP 262
Query: 302 NPRSLVTALVTL 313
           +   +  A  T+
Sbjct: 263 SFAEIHQAFETM 274

>pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 61/256 (23%), Positives = 117/256 (45%), Gaps = 22/256 (8%)
Query: 73  VYKGKLEN-QFRIAVKRFNRSAWPDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLV 131
           VY G  +     +AVK        +  +FL+EA  + ++++  L  LLG C       +V
Sbjct: 48  VYVGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTLEPPFYIV 106
Query: 132 AEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDD 191
            EYMP   L  +L     + +   + L +A  I+ A+EY   K+  ++ DL A   +  +
Sbjct: 107 TEYMPYGNLLDYLRECNREEVTAVVLLYMATQISSAMEYL-EKKNFIHRDLAARNCLVGE 165
Query: 192 DVNPRLSCFGLMKNSRDGRSYSTN------LAFTPPEYLRTGRVTPESVMYSFGTLLLDL 245
           +   +++ FGL +    G +Y+ +      + +T PE L     + +S +++FG LL ++
Sbjct: 166 NHVVKVADFGLSR-LMTGDTYTAHAGAKFPIKWTAPESLAYNTFSIKSDVWAFGVLLWEI 224
Query: 246 LSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSD--EG--TELVRLASRCLQYEPRERP 301
            +   + P   +DL +  ++       LE  +  +  EG   ++  L   C ++ P +RP
Sbjct: 225 AT-YGMSPYPGIDLSQVYDL-------LEKGYRMEQPEGCPPKVYELMRACWKWSPADRP 276
Query: 302 NPRSLVTALVTLQKDT 317
           +      A  T+  D+
Sbjct: 277 SFAETHQAFETMFHDS 292

>pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283

Iteration: 1
 Score = 59.7 bits (143), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 61/243 (25%), Positives = 105/243 (43%), Gaps = 28/243 (11%)
Query: 73  VYKGKLENQFRIAVKRFNRSAW-PDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLV 131
           V+ G      R+A+K        P+A  FL+EA+ + +LR+ +L  L     E +   +V
Sbjct: 31  VWMGTWNGTTRVAIKTLKPGTMSPEA--FLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIV 87
Query: 132 AEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDD 191
            EYM   +L   L     + ++    + ++  IA  + Y   +   ++ DL A  I+  +
Sbjct: 88  TEYMNKGSLLDFLKGETGKYLRLPQLVDMSAQIASGMAY-VERMNYVHRDLRAANILVGE 146
Query: 192 DVNPRLSCFGLMK-------NSRDGRSYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLD 244
           ++  +++ FGL +        +R G  +   + +T PE    GR T +S ++SFG LL +
Sbjct: 147 NLVCKVADFGLARLIEDNEWTARQGAKFP--IKWTAPEAALYGRFTIKSDVWSFGILLTE 204
Query: 245 LLSGKHIP-PS----HALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLASRCLQYEPRE 299
           L +   +P P       LD +           C E          L  L  +C + EP E
Sbjct: 205 LTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPES---------LHDLMCQCWRKEPEE 255
Query: 300 RPN 302
           RP 
Sbjct: 256 RPT 258

>pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283

Iteration: 1
 Score = 59.7 bits (143), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 61/243 (25%), Positives = 105/243 (43%), Gaps = 28/243 (11%)
Query: 73  VYKGKLENQFRIAVKRFNRSAW-PDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLV 131
           V+ G      R+A+K        P+A  FL+EA+ + +LR+ +L  L     E +   +V
Sbjct: 31  VWMGTWNGTTRVAIKTLKPGTMSPEA--FLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIV 87
Query: 132 AEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDD 191
            EYM   +L   L     + ++    + ++  IA  + Y   +   ++ DL A  I+  +
Sbjct: 88  TEYMNKGSLLDFLKGETGKYLRLPQLVDMSAQIASGMAY-VERMNYVHRDLRAANILVGE 146
Query: 192 DVNPRLSCFGLMK-------NSRDGRSYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLD 244
           ++  +++ FGL +        +R G  +   + +T PE    GR T +S ++SFG LL +
Sbjct: 147 NLVCKVADFGLARLIEDNEYTARQGAKFP--IKWTAPEAALYGRFTIKSDVWSFGILLTE 204
Query: 245 LLSGKHIP-PS----HALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLASRCLQYEPRE 299
           L +   +P P       LD +           C E          L  L  +C + EP E
Sbjct: 205 LTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPES---------LHDLMCQCWRKEPEE 255
Query: 300 RPN 302
           RP 
Sbjct: 256 RPT 258

>pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286

Iteration: 1
 Score = 59.7 bits (143), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 49/188 (26%), Positives = 89/188 (47%), Gaps = 14/188 (7%)
Query: 73  VYKGKLENQFRIAVKRFNRSAW-PDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLV 131
           V+ G      R+A+K        P+A  FL+EA+ + +LR+ +L  L     E +   +V
Sbjct: 34  VWMGTWNGTTRVAIKTLKPGTMSPEA--FLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIV 90
Query: 132 AEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDD 191
            EYM   +L   L     + ++    + +A  IA  + Y   +   ++ DL A  I+  +
Sbjct: 91  TEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAY-VERMNYVHRDLRAANILVGE 149
Query: 192 DVNPRLSCFGLMK-------NSRDGRSYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLD 244
           ++  +++ FGL +        +R G  +   + +T PE    GR T +S ++SFG LL +
Sbjct: 150 NLVCKVADFGLARLIEDNEYTARQGAKFP--IKWTAPEAALYGRFTIKSDVWSFGILLTE 207
Query: 245 LLSGKHIP 252
           L +   +P
Sbjct: 208 LTTKGRVP 215

>pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275

Iteration: 1
 Score = 59.7 bits (143), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 49/188 (26%), Positives = 89/188 (47%), Gaps = 14/188 (7%)
Query: 73  VYKGKLENQFRIAVKRFNRSAW-PDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLV 131
           V+ G      R+A+K        P+A  FL+EA+ + +LR+ +L  L     E +   +V
Sbjct: 23  VWMGTWNGTTRVAIKTLKPGTMSPEA--FLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIV 79
Query: 132 AEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDD 191
            EYM   +L   L     + ++    + +A  IA  + Y   +   ++ DL A  I+  +
Sbjct: 80  TEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAY-VERMNYVHRDLRAANILVGE 138
Query: 192 DVNPRLSCFGLMK-------NSRDGRSYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLD 244
           ++  +++ FGL +        +R G  +   + +T PE    GR T +S ++SFG LL +
Sbjct: 139 NLVCKVADFGLARLIEDNEYTARQGAKFP--IKWTAPEAALYGRFTIKSDVWSFGILLTE 196
Query: 245 LLSGKHIP 252
           L +   +P
Sbjct: 197 LTTKGRVP 204

>pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277

Iteration: 1
 Score = 59.7 bits (143), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 49/188 (26%), Positives = 89/188 (47%), Gaps = 14/188 (7%)
Query: 73  VYKGKLENQFRIAVKRFNRSAW-PDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLV 131
           V+ G      R+A+K        P+A  FL+EA+ + +LR+ +L  L     E +   +V
Sbjct: 25  VWMGTWNGTTRVAIKTLKPGTMSPEA--FLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIV 81
Query: 132 AEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDD 191
            EYM   +L   L     + ++    + +A  IA  + Y   +   ++ DL A  I+  +
Sbjct: 82  TEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAY-VERMNYVHRDLRAANILVGE 140
Query: 192 DVNPRLSCFGLMK-------NSRDGRSYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLD 244
           ++  +++ FGL +        +R G  +   + +T PE    GR T +S ++SFG LL +
Sbjct: 141 NLVCKVADFGLARLIEDNEYTARQGAKFP--IKWTAPEAALYGRFTIKSDVWSFGILLTE 198
Query: 245 LLSGKHIP 252
           L +   +P
Sbjct: 199 LTTKGRVP 206

>pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286

Iteration: 1
 Score = 59.7 bits (143), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 49/188 (26%), Positives = 89/188 (47%), Gaps = 14/188 (7%)
Query: 73  VYKGKLENQFRIAVKRFNRSAW-PDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLV 131
           V+ G      R+A+K        P+A  FL+EA+ + +LR+ +L  L     E +   +V
Sbjct: 34  VWMGTWNGTTRVAIKTLKPGTMSPEA--FLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIV 90
Query: 132 AEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDD 191
            EYM   +L   L     + ++    + +A  IA  + Y   +   ++ DL A  I+  +
Sbjct: 91  IEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAY-VERMNYVHRDLRAANILVGE 149
Query: 192 DVNPRLSCFGLMK-------NSRDGRSYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLD 244
           ++  +++ FGL +        +R G  +   + +T PE    GR T +S ++SFG LL +
Sbjct: 150 NLVCKVADFGLARLIEDNEXTARQGAKFP--IKWTAPEAALYGRFTIKSDVWSFGILLTE 207
Query: 245 LLSGKHIP 252
           L +   +P
Sbjct: 208 LTTKGRVP 215

>pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286

Iteration: 1
 Score = 59.7 bits (143), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 49/188 (26%), Positives = 89/188 (47%), Gaps = 14/188 (7%)
Query: 73  VYKGKLENQFRIAVKRFNRSAW-PDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLV 131
           V+ G      R+A+K        P+A  FL+EA+ + +LR+ +L  L     E +   +V
Sbjct: 34  VWMGTWNGTTRVAIKTLKPGTMSPEA--FLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIV 90
Query: 132 AEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDD 191
            EYM   +L   L     + ++    + +A  IA  + Y   +   ++ DL A  I+  +
Sbjct: 91  IEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAY-VERMNYVHRDLRAANILVGE 149
Query: 192 DVNPRLSCFGLMK-------NSRDGRSYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLD 244
           ++  +++ FGL +        +R G  +   + +T PE    GR T +S ++SFG LL +
Sbjct: 150 NLVCKVADFGLARLIEDNEYTARQGAKFP--IKWTAPEAALYGRFTIKSDVWSFGILLTE 207
Query: 245 LLSGKHIP 252
           L +   +P
Sbjct: 208 LTTKGRVP 215

>pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286

Iteration: 1
 Score = 59.7 bits (143), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 49/188 (26%), Positives = 89/188 (47%), Gaps = 14/188 (7%)
Query: 73  VYKGKLENQFRIAVKRFNRSAW-PDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLV 131
           V+ G      R+A+K        P+A  FL+EA+ + +LR+ +L  L     E +   +V
Sbjct: 34  VWMGTWNGTTRVAIKTLKPGTMSPEA--FLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIV 90
Query: 132 AEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDD 191
            EYM   +L   L     + ++    + +A  IA  + Y   +   ++ DL A  I+  +
Sbjct: 91  CEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAY-VERMNYVHRDLRAANILVGE 149
Query: 192 DVNPRLSCFGLMK-------NSRDGRSYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLD 244
           ++  +++ FGL +        +R G  +   + +T PE    GR T +S ++SFG LL +
Sbjct: 150 NLVCKVADFGLARLIEDNEYTARQGAKFP--IKWTAPEAALYGRFTIKSDVWSFGILLTE 207
Query: 245 LLSGKHIP 252
           L +   +P
Sbjct: 208 LTTKGRVP 215

>pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286

Iteration: 1
 Score = 59.3 bits (142), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 49/188 (26%), Positives = 89/188 (47%), Gaps = 14/188 (7%)
Query: 73  VYKGKLENQFRIAVKRFNRSAW-PDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLV 131
           V+ G      R+A+K        P+A  FL+EA+ + +LR+ +L  L     E +   +V
Sbjct: 34  VWMGTWNGTTRVAIKTLKPGTMSPEA--FLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIV 90
Query: 132 AEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDD 191
            EYM   +L   L     + ++    + +A  IA  + Y   +   ++ DL A  I+  +
Sbjct: 91  TEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAY-VERMNYVHRDLAAANILVGE 149
Query: 192 DVNPRLSCFGLMK-------NSRDGRSYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLD 244
           ++  +++ FGL +        +R G  +   + +T PE    GR T +S ++SFG LL +
Sbjct: 150 NLVCKVADFGLARLIEDNEYTARQGAKFP--IKWTAPEAALYGRFTIKSDVWSFGILLTE 207
Query: 245 LLSGKHIP 252
           L +   +P
Sbjct: 208 LTTKGRVP 215

>pdb|4FVR|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain Mutant V617f (Mg- Atp-Bound Form) Length = 289

Iteration: 1
 Score = 59.3 bits (142), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 60/227 (26%), Positives = 103/227 (45%), Gaps = 19/227 (8%)
Query: 97  ARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAEYMPNDTLAKHLFHWETQPMKWAM 156
           +  F E A  + +L ++ L    G C  GDE +LV E++   +L  +L       +    
Sbjct: 56  SESFFEAASMMSKLSHKHLVLNYGVCFCGDENILVQEFVKFGSLDTYLKK-NKNCINILW 114
Query: 157 RLRVALHIAEALEYCTSKERALYH-DLNAYRIVFDDDVNPRLSCFGLMKNSRDGRSYST- 214
           +L VA  +A A+ +   +E  L H ++ A  I+   + + +      +K S  G S +  
Sbjct: 115 KLEVAKQLAWAMHFL--EENTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVL 172
Query: 215 -------NLAFTPPEYLRTGR-VTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQ 266
                   + + PPE +   + +   +  +SFGT L ++ SG   P S ALD    R +Q
Sbjct: 173 PKDILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLS-ALD--SQRKLQ 229
Query: 267 TLTDSCLEGQFSSDEGTELVRLASRCLQYEPRERPNPRSLVTALVTL 313
              D     Q  + +  EL  L + C+ YEP  RP+ R+++  L +L
Sbjct: 230 FYED---RHQLPAPKAAELANLINNCMDYEPDHRPSFRAIIRDLNSL 273

>pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279

Iteration: 1
 Score = 59.3 bits (142), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 47/200 (23%), Positives = 91/200 (45%), Gaps = 11/200 (5%)
Query: 60  NIVSEHGEKAPNVVYKGKLENQFRIAVKRFNRSAWPDARQFLEEARAVGQLRNRRLANLL 119
            +V + G      V+ G   N  ++AVK   +      + FLEEA  +  L++ +L  L 
Sbjct: 15  KLVKKLGAGQFGEVWMGYYNNSTKVAVKTL-KPGTMSVQAFLEEANLMKTLQHDKLVRLY 73
Query: 120 GCCCEGDERLLVAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALY 179
               + +   ++ E+M   +L   L   E   +     +  +  IAE + Y   K   ++
Sbjct: 74  AVVTKEEPIYIITEFMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERKNY-IH 132
Query: 180 HDLNAYRIVFDDDVNPRLSCFGLMK-------NSRDGRSYSTNLAFTPPEYLRTGRVTPE 232
            DL A  ++  + +  +++ FGL +        +R+G  +   + +T PE +  G  T +
Sbjct: 133 RDLRAANVLVSESLMCKIADFGLARVIEDNEYTAREGAKFP--IKWTAPEAINFGCFTIK 190
Query: 233 SVMYSFGTLLLDLLSGKHIP 252
           S ++SFG LL ++++   IP
Sbjct: 191 SNVWSFGILLYEIVTYGKIP 210

>pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268

Iteration: 1
 Score = 59.3 bits (142), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 54/264 (20%), Positives = 118/264 (44%), Gaps = 18/264 (6%)
Query: 60  NIVSEHGEKAPNVVYKGKLENQFRIAVKRFNRSAWPDARQFLEEARAVGQLRNRRLANLL 119
            ++ E G     VV  GK + Q+ +AVK     +  +  +F +EA+ + +L + +L    
Sbjct: 11  TLLKELGSGQFGVVKLGKWKGQYDVAVKMIKEGSMSED-EFFQEAQTMMKLSHPKLVKFY 69
Query: 120 GCCCEGDERLLVAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALY 179
           G C +     +V EY+ N  L  +L     + ++ +  L +   + E + +  S  + ++
Sbjct: 70  GVCSKEYPIYIVTEYISNGCLLNYL-RSHGKGLEPSQLLEMCYDVCEGMAFLES-HQFIH 127
Query: 180 HDLNAYRIVFDDDVNPRLSCFGLMKNSRDGRSYST-----NLAFTPPEYLRTGRVTPESV 234
            DL A   + D D+  ++S FG+ +   D +  S+      + ++ PE     + + +S 
Sbjct: 128 RDLAARNCLVDRDLCVKVSDFGMTRYVLDDQYVSSVGTKFPVKWSAPEVFHYFKYSSKSD 187
Query: 235 MYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDS---CLEGQFSSDEGTELVRLASR 291
           +++FG L+ ++ S   +P     DL  +  +               +SD    + ++   
Sbjct: 188 VWAFGILMWEVFSLGKMP----YDLYTNSEVVLKVSQGHRLYRPHLASD---TIYQIMYS 240
Query: 292 CLQYEPRERPNPRSLVTALVTLQK 315
           C    P +RP  + L++++  L++
Sbjct: 241 CWHELPEKRPTFQQLLSSIEPLRE 264

>pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286

Iteration: 1
 Score = 59.3 bits (142), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 50/200 (25%), Positives = 92/200 (46%), Gaps = 12/200 (6%)
Query: 60  NIVSEHGEKAPNVVYKGKLENQFRIAVKRFNRSAWPDARQFLEEARAVGQLRNRRLANLL 119
             V E G     +V+ G   N+ ++A+K     +  +   F+EEA  + +L + +L  L 
Sbjct: 30  TFVQEIGSGQFGLVHLGYWLNKDKVAIKTIKEGSMSE-DDFIEEAEVMMKLSHPKLVQLY 88
Query: 120 GCCCEGDERLLVAEYMPNDTLAKHLFHWETQPMKWAMR--LRVALHIAEALEYCTSKERA 177
           G C E     LV E+M +  L+ +L    TQ   +A    L + L + E + Y   +   
Sbjct: 89  GVCLEQAPICLVFEFMEHGCLSDYL---RTQRGLFAAETLLGMCLDVCEGMAY-LEEACV 144
Query: 178 LYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDGRSYSTN-----LAFTPPEYLRTGRVTPE 232
           ++ DL A   +  ++   ++S FG+ +   D +  S+      + +  PE     R + +
Sbjct: 145 IHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRYSSK 204
Query: 233 SVMYSFGTLLLDLLSGKHIP 252
           S ++SFG L+ ++ S   IP
Sbjct: 205 SDVWSFGVLMWEVFSEGKIP 224

>pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286

Iteration: 1
 Score = 58.9 bits (141), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 46/187 (24%), Positives = 86/187 (45%), Gaps = 11/187 (5%)
Query: 73  VYKGKLENQFRIAVKRFNRSAWPDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVA 132
           V+ G   N  ++AVK   +      + FLEEA  +  L++ +L  L       +   ++ 
Sbjct: 29  VWMGYYNNSTKVAVKTL-KPGTMSVQAFLEEANLMKTLQHDKLVRLYAVVTREEPIYIIT 87
Query: 133 EYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDD 192
           EYM   +L   L   E   +     +  +  IAE + Y   K   ++ DL A  ++  + 
Sbjct: 88  EYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERK-NYIHRDLRAANVLVSES 146
Query: 193 VNPRLSCFGLMK-------NSRDGRSYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDL 245
           +  +++ FGL +        +R+G  +   + +T PE +  G  T +S ++SFG LL ++
Sbjct: 147 LMCKIADFGLARVIEDNEYTAREGAKFP--IKWTAPEAINFGCFTIKSDVWSFGILLYEI 204
Query: 246 LSGKHIP 252
           ++   IP
Sbjct: 205 VTYGKIP 211

>pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286

Iteration: 1
 Score = 58.9 bits (141), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 48/188 (25%), Positives = 89/188 (47%), Gaps = 14/188 (7%)
Query: 73  VYKGKLENQFRIAVKRFNRSAW-PDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLV 131
           V+ G      R+A+K        P+A  FL+EA+ + ++R+ +L  L     E +   +V
Sbjct: 34  VWMGTWNGTTRVAIKTLKPGTMSPEA--FLQEAQVMKKIRHEKLVQLYAVVSE-EPIYIV 90
Query: 132 AEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDD 191
            EYM   +L   L     + ++    + +A  IA  + Y   +   ++ DL A  I+  +
Sbjct: 91  TEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAY-VERMNYVHRDLRAANILVGE 149
Query: 192 DVNPRLSCFGLMK-------NSRDGRSYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLD 244
           ++  +++ FGL +        +R G  +   + +T PE    GR T +S ++SFG LL +
Sbjct: 150 NLVCKVADFGLARLIEDNEYTARQGAKFP--IKWTAPEAALYGRFTIKSDVWSFGILLTE 207
Query: 245 LLSGKHIP 252
           L +   +P
Sbjct: 208 LTTKGRVP 215

>pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495

Iteration: 1
 Score = 58.9 bits (141), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 58/259 (22%), Positives = 117/259 (45%), Gaps = 24/259 (9%)
Query: 73  VYKGKLEN-QFRIAVKRFNRSAWPDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLV 131
           VY+G  +     +AVK        +  +FL+EA  + ++++  L  LLG C       ++
Sbjct: 236 VYEGVWKKYSLTVAVKTLKEDTM-EVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYII 294
Query: 132 AEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDD 191
            E+M    L  +L     Q +   + L +A  I+ A+EY   K+  ++ +L A   +  +
Sbjct: 295 TEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYL-EKKNFIHRNLAARNCLVGE 353
Query: 192 DVNPRLSCFGLMKNSRDGRSYSTN------LAFTPPEYLRTGRVTPESVMYSFGTLLLDL 245
           +   +++ FGL +    G +Y+ +      + +T PE L   + + +S +++FG LL ++
Sbjct: 354 NHLVKVADFGLSR-LMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEI 412
Query: 246 LSGKHIPP-----SHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLASRCLQYEPRER 300
            +    P      S   +L+         + C E  +      EL+R    C Q+ P +R
Sbjct: 413 ATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEKVY------ELMRA---CWQWNPSDR 463
Query: 301 PNPRSLVTALVTLQKDTEL 319
           P+   +  A  T+ +++ +
Sbjct: 464 PSFAEIHQAFETMFQESSI 482

>pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286

Iteration: 1
 Score = 58.9 bits (141), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 49/188 (26%), Positives = 88/188 (46%), Gaps = 14/188 (7%)
Query: 73  VYKGKLENQFRIAVKRFNRSAW-PDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLV 131
           V+ G      R+A+K        P+A  FL+EA+ + +LR+ +L  L     E +   +V
Sbjct: 34  VWMGTWNGTTRVAIKTLKPGTMSPEA--FLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIV 90
Query: 132 AEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDD 191
            EYM    L   L     + ++    + +A  IA  + Y   +   ++ DL A  I+  +
Sbjct: 91  TEYMSKGCLLDFLKGEMGKYLRLPQLVDMAAQIASGMAY-VERMNYVHRDLRAANILVGE 149
Query: 192 DVNPRLSCFGLMK-------NSRDGRSYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLD 244
           ++  +++ FGL +        +R G  +   + +T PE    GR T +S ++SFG LL +
Sbjct: 150 NLVCKVADFGLARLIEDNEYTARQGAKFP--IKWTAPEAALYGRFTIKSDVWSFGILLTE 207
Query: 245 LLSGKHIP 252
           L +   +P
Sbjct: 208 LTTKGRVP 215

>pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286

Iteration: 1
 Score = 58.9 bits (141), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 58/259 (22%), Positives = 118/259 (45%), Gaps = 24/259 (9%)
Query: 73  VYKGKLEN-QFRIAVKRFNRSAWPDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLV 131
           VY+G  +     +AVK        +  +FL+EA  + ++++  L  LLG C       ++
Sbjct: 30  VYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYII 88
Query: 132 AEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDD 191
            E+M    L  +L     Q +   + L +A  I+ A+EY   K+  ++ DL A   +  +
Sbjct: 89  IEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYL-EKKNFIHRDLAARNCLVGE 147
Query: 192 DVNPRLSCFGLMK-------NSRDGRSYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLD 244
           +   +++ FGL +        +  G  +   + +T PE L   + + +S +++FG LL +
Sbjct: 148 NHLVKVADFGLSRLMTGDTXTAHAGAKFP--IKWTAPESLAYNKFSIKSDVWAFGVLLWE 205
Query: 245 LLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSD--EG--TELVRLASRCLQYEPRER 300
           + +   + P   +DL +   +       LE  +  +  EG   ++  L   C Q+ P +R
Sbjct: 206 IAT-YGMSPYPGIDLSQVYEL-------LEKDYRMERPEGCPEKVYELMRACWQWNPSDR 257
Query: 301 PNPRSLVTALVTLQKDTEL 319
           P+   +  A  T+ +++ +
Sbjct: 258 PSFAEIHQAFETMFQESSI 276

>pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453

Iteration: 1
 Score = 58.9 bits (141), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 49/188 (26%), Positives = 90/188 (47%), Gaps = 14/188 (7%)
Query: 73  VYKGKLENQFRIAVKRFN-RSAWPDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLV 131
           V+ G      R+A+K     +  P+A  FL+EA+ + +LR+ +L  L     E +   +V
Sbjct: 201 VWMGTWNGTTRVAIKTLKPGNMSPEA--FLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIV 257
Query: 132 AEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDD 191
            EYM   +L   L     + ++    + +A  IA  + Y   +   ++ DL A  I+  +
Sbjct: 258 TEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYV-ERMNYVHRDLRAANILVGE 316
Query: 192 DVNPRLSCFGLMK-------NSRDGRSYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLD 244
           ++  +++ FGL +        +R G  +   + +T PE    GR T +S ++SFG LL +
Sbjct: 317 NLVCKVADFGLGRLIEDNEYTARQGAKFP--IKWTAPEAALYGRFTIKSDVWSFGILLTE 374
Query: 245 LLSGKHIP 252
           L +   +P
Sbjct: 375 LTTKGRVP 382

>pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286

Iteration: 1
 Score = 58.5 bits (140), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 49/188 (26%), Positives = 88/188 (46%), Gaps = 14/188 (7%)
Query: 73  VYKGKLENQFRIAVKRFNRSAW-PDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLV 131
           V+ G      R+A+K        P+A  FL+EA+ + +LR+ +L  L     E +   +V
Sbjct: 34  VWMGTWNGTTRVAIKTLKPGTMSPEA--FLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIV 90
Query: 132 AEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDD 191
            EYM    L   L     + ++    + +A  IA  + Y   +   ++ DL A  I+  +
Sbjct: 91  MEYMSKGCLLDFLKGEMGKYLRLPQLVDMAAQIASGMAY-VERMNYVHRDLRAANILVGE 149
Query: 192 DVNPRLSCFGLMK-------NSRDGRSYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLD 244
           ++  +++ FGL +        +R G  +   + +T PE    GR T +S ++SFG LL +
Sbjct: 150 NLVCKVADFGLARLIEDNEYTARQGAKFP--IKWTAPEAALYGRFTIKSDVWSFGILLTE 207
Query: 245 LLSGKHIP 252
           L +   +P
Sbjct: 208 LTTKGRVP 215

>pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278

Iteration: 1
 Score = 58.5 bits (140), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 58/257 (22%), Positives = 117/257 (45%), Gaps = 24/257 (9%)
Query: 73  VYKGKLEN-QFRIAVKRFNRSAWPDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLV 131
           VY+G  +     +AVK        +  +FL+EA  + ++++  L  LLG C       ++
Sbjct: 34  VYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYII 92
Query: 132 AEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDD 191
            E+M    L  +L     Q +   + L +A  I+ A+EY   K+  ++ DL A   +  +
Sbjct: 93  TEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYL-EKKNFIHRDLAARNCLVGE 151
Query: 192 DVNPRLSCFGLMK-------NSRDGRSYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLD 244
           +   +++ FGL +        +  G  +   + +T PE L   + + +S +++FG LL +
Sbjct: 152 NHLVKVADFGLSRLMTGDTXTAHAGAKFP--IKWTAPESLAYNKFSIKSDVWAFGVLLWE 209
Query: 245 LLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSD--EG--TELVRLASRCLQYEPRER 300
           + +   + P   +DL +   +       LE  +  +  EG   ++  L   C Q+ P +R
Sbjct: 210 IAT-YGMSPYPGIDLSQVYEL-------LEKDYRMERPEGCPEKVYELMRACWQWNPSDR 261
Query: 301 PNPRSLVTALVTLQKDT 317
           P+   +  A  T+ +++
Sbjct: 262 PSFAEIHQAFETMFQES 278

>pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537

Iteration: 1
 Score = 58.5 bits (140), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 58/259 (22%), Positives = 117/259 (45%), Gaps = 24/259 (9%)
Query: 73  VYKGKLEN-QFRIAVKRFNRSAWPDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLV 131
           VY+G  +     +AVK        +  +FL+EA  + ++++  L  LLG C       ++
Sbjct: 275 VYEGVWKKYSLTVAVKTLKEDTM-EVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYII 333
Query: 132 AEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDD 191
            E+M    L  +L     Q +   + L +A  I+ A+EY   K+  ++ +L A   +  +
Sbjct: 334 TEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYL-EKKNFIHRNLAARNCLVGE 392
Query: 192 DVNPRLSCFGLMKNSRDGRSYSTN------LAFTPPEYLRTGRVTPESVMYSFGTLLLDL 245
           +   +++ FGL +    G +Y+ +      + +T PE L   + + +S +++FG LL ++
Sbjct: 393 NHLVKVADFGLSR-LMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEI 451
Query: 246 LSGKHIPP-----SHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLASRCLQYEPRER 300
            +    P      S   +L+         + C E  +      EL+R    C Q+ P +R
Sbjct: 452 ATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEKVY------ELMRA---CWQWNPSDR 502
Query: 301 PNPRSLVTALVTLQKDTEL 319
           P+   +  A  T+ +++ +
Sbjct: 503 PSFAEIHQAFETMFQESSI 521

>pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 52/195 (26%), Positives = 92/195 (47%), Gaps = 17/195 (8%)
Query: 73  VYKGKLEN----QFRIAVKRFNR-SAWPDARQFLEEARAVGQLRNRRLANLLGCCCEGDE 127
           VY G L +    +   AVK  NR +   +  QFL E   +    +  + +LLG C   + 
Sbjct: 44  VYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEG 103
Query: 128 R-LLVAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYR 186
             L+V  YM +  L ++    ET        +   L +A+ ++Y  SK + ++ DL A  
Sbjct: 104 SPLVVLPYMKHGDL-RNFIRNETHNPTVKDLIGFGLQVAKGMKYLASK-KFVHRDLAARN 161
Query: 187 IVFDDDVNPRLSCFGLMKNSRDGRSYSTN--------LAFTPPEYLRTGRVTPESVMYSF 238
            + D+    +++ FGL ++  D   YS +        + +   E L+T + T +S ++SF
Sbjct: 162 CMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSF 221
Query: 239 GTLLLDLLSGKHIPP 253
           G LL +L++ +  PP
Sbjct: 222 GVLLWELMT-RGAPP 235

>pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 52/195 (26%), Positives = 92/195 (47%), Gaps = 17/195 (8%)
Query: 73  VYKGKLEN----QFRIAVKRFNR-SAWPDARQFLEEARAVGQLRNRRLANLLGCCCEGDE 127
           VY G L +    +   AVK  NR +   +  QFL E   +    +  + +LLG C   + 
Sbjct: 64  VYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEG 123
Query: 128 R-LLVAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYR 186
             L+V  YM +  L ++    ET        +   L +A+ ++Y  SK + ++ DL A  
Sbjct: 124 SPLVVLPYMKHGDL-RNFIRNETHNPTVKDLIGFGLQVAKGMKYLASK-KFVHRDLAARN 181
Query: 187 IVFDDDVNPRLSCFGLMKNSRDGRSYSTN--------LAFTPPEYLRTGRVTPESVMYSF 238
            + D+    +++ FGL ++  D   YS +        + +   E L+T + T +S ++SF
Sbjct: 182 CMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSF 241
Query: 239 GTLLLDLLSGKHIPP 253
           G LL +L++ +  PP
Sbjct: 242 GVLLWELMT-RGAPP 255

>pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 52/195 (26%), Positives = 92/195 (47%), Gaps = 17/195 (8%)
Query: 73  VYKGKLEN----QFRIAVKRFNR-SAWPDARQFLEEARAVGQLRNRRLANLLGCCCEGDE 127
           VY G L +    +   AVK  NR +   +  QFL E   +    +  + +LLG C   + 
Sbjct: 45  VYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEG 104
Query: 128 R-LLVAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYR 186
             L+V  YM +  L ++    ET        +   L +A+ ++Y  SK + ++ DL A  
Sbjct: 105 SPLVVLPYMKHGDL-RNFIRNETHNPTVKDLIGFGLQVAKGMKYLASK-KFVHRDLAARN 162
Query: 187 IVFDDDVNPRLSCFGLMKNSRDGRSYSTN--------LAFTPPEYLRTGRVTPESVMYSF 238
            + D+    +++ FGL ++  D   YS +        + +   E L+T + T +S ++SF
Sbjct: 163 CMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSF 222
Query: 239 GTLLLDLLSGKHIPP 253
           G LL +L++ +  PP
Sbjct: 223 GVLLWELMT-RGAPP 236

>pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 52/195 (26%), Positives = 92/195 (47%), Gaps = 17/195 (8%)
Query: 73  VYKGKLEN----QFRIAVKRFNR-SAWPDARQFLEEARAVGQLRNRRLANLLGCCCEGDE 127
           VY G L +    +   AVK  NR +   +  QFL E   +    +  + +LLG C   + 
Sbjct: 46  VYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEG 105
Query: 128 R-LLVAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYR 186
             L+V  YM +  L ++    ET        +   L +A+ ++Y  SK + ++ DL A  
Sbjct: 106 SPLVVLPYMKHGDL-RNFIRNETHNPTVKDLIGFGLQVAKGMKYLASK-KFVHRDLAARN 163
Query: 187 IVFDDDVNPRLSCFGLMKNSRDGRSYSTN--------LAFTPPEYLRTGRVTPESVMYSF 238
            + D+    +++ FGL ++  D   YS +        + +   E L+T + T +S ++SF
Sbjct: 164 CMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSF 223
Query: 239 GTLLLDLLSGKHIPP 253
           G LL +L++ +  PP
Sbjct: 224 GVLLWELMT-RGAPP 237

>pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 52/195 (26%), Positives = 92/195 (47%), Gaps = 17/195 (8%)
Query: 73  VYKGKLEN----QFRIAVKRFNR-SAWPDARQFLEEARAVGQLRNRRLANLLGCCCEGDE 127
           VY G L +    +   AVK  NR +   +  QFL E   +    +  + +LLG C   + 
Sbjct: 43  VYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEG 102
Query: 128 R-LLVAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYR 186
             L+V  YM +  L ++    ET        +   L +A+ ++Y  SK + ++ DL A  
Sbjct: 103 SPLVVLPYMKHGDL-RNFIRNETHNPTVKDLIGFGLQVAKGMKYLASK-KFVHRDLAARN 160
Query: 187 IVFDDDVNPRLSCFGLMKNSRDGRSYSTN--------LAFTPPEYLRTGRVTPESVMYSF 238
            + D+    +++ FGL ++  D   YS +        + +   E L+T + T +S ++SF
Sbjct: 161 CMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSF 220
Query: 239 GTLLLDLLSGKHIPP 253
           G LL +L++ +  PP
Sbjct: 221 GVLLWELMT-RGAPP 234

>pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 52/195 (26%), Positives = 92/195 (47%), Gaps = 17/195 (8%)
Query: 73  VYKGKLEN----QFRIAVKRFNR-SAWPDARQFLEEARAVGQLRNRRLANLLGCCCEGDE 127
           VY G L +    +   AVK  NR +   +  QFL E   +    +  + +LLG C   + 
Sbjct: 46  VYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEG 105
Query: 128 R-LLVAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYR 186
             L+V  YM +  L ++    ET        +   L +A+ ++Y  SK + ++ DL A  
Sbjct: 106 SPLVVLPYMKHGDL-RNFIRNETHNPTVKDLIGFGLQVAKGMKYLASK-KFVHRDLAARN 163
Query: 187 IVFDDDVNPRLSCFGLMKNSRDGRSYSTN--------LAFTPPEYLRTGRVTPESVMYSF 238
            + D+    +++ FGL ++  D   YS +        + +   E L+T + T +S ++SF
Sbjct: 164 CMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSF 223
Query: 239 GTLLLDLLSGKHIPP 253
           G LL +L++ +  PP
Sbjct: 224 GVLLWELMT-RGAPP 237

>pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319

Iteration: 1
 Score = 57.0 bits (136), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 52/195 (26%), Positives = 92/195 (47%), Gaps = 17/195 (8%)
Query: 73  VYKGKLEN----QFRIAVKRFNR-SAWPDARQFLEEARAVGQLRNRRLANLLGCCCEGDE 127
           VY G L +    +   AVK  NR +   +  QFL E   +    +  + +LLG C   + 
Sbjct: 65  VYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEG 124
Query: 128 R-LLVAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYR 186
             L+V  YM +  L ++    ET        +   L +A+ ++Y  SK + ++ DL A  
Sbjct: 125 SPLVVLPYMKHGDL-RNFIRNETHNPTVKDLIGFGLQVAKGMKYLASK-KFVHRDLAARN 182
Query: 187 IVFDDDVNPRLSCFGLMKNSRDGRSYSTN--------LAFTPPEYLRTGRVTPESVMYSF 238
            + D+    +++ FGL ++  D   YS +        + +   E L+T + T +S ++SF
Sbjct: 183 CMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSF 242
Query: 239 GTLLLDLLSGKHIPP 253
           G LL +L++ +  PP
Sbjct: 243 GVLLWELMT-RGAPP 256

>pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292

Iteration: 1
 Score = 57.0 bits (136), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 52/195 (26%), Positives = 92/195 (47%), Gaps = 17/195 (8%)
Query: 73  VYKGKLEN----QFRIAVKRFNR-SAWPDARQFLEEARAVGQLRNRRLANLLGCCCEGDE 127
           VY G L +    +   AVK  NR +   +  QFL E   +    +  + +LLG C   + 
Sbjct: 38  VYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEG 97
Query: 128 R-LLVAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYR 186
             L+V  YM +  L ++    ET        +   L +A+ ++Y  SK + ++ DL A  
Sbjct: 98  SPLVVLPYMKHGDL-RNFIRNETHNPTVKDLIGFGLQVAKGMKYLASK-KFVHRDLAARN 155
Query: 187 IVFDDDVNPRLSCFGLMKNSRDGRSYSTN--------LAFTPPEYLRTGRVTPESVMYSF 238
            + D+    +++ FGL ++  D   YS +        + +   E L+T + T +S ++SF
Sbjct: 156 CMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSF 215
Query: 239 GTLLLDLLSGKHIPP 253
           G LL +L++ +  PP
Sbjct: 216 GVLLWELMT-RGAPP 229

>pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298

Iteration: 1
 Score = 57.0 bits (136), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 52/195 (26%), Positives = 92/195 (47%), Gaps = 17/195 (8%)
Query: 73  VYKGKLEN----QFRIAVKRFNR-SAWPDARQFLEEARAVGQLRNRRLANLLGCCCEGDE 127
           VY G L +    +   AVK  NR +   +  QFL E   +    +  + +LLG C   + 
Sbjct: 41  VYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEG 100
Query: 128 R-LLVAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYR 186
             L+V  YM +  L ++    ET        +   L +A+ ++Y  SK + ++ DL A  
Sbjct: 101 SPLVVLPYMKHGDL-RNFIRNETHNPTVKDLIGFGLQVAKGMKYLASK-KFVHRDLAARN 158
Query: 187 IVFDDDVNPRLSCFGLMKNSRDGRSYSTN--------LAFTPPEYLRTGRVTPESVMYSF 238
            + D+    +++ FGL ++  D   YS +        + +   E L+T + T +S ++SF
Sbjct: 159 CMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSF 218
Query: 239 GTLLLDLLSGKHIPP 253
           G LL +L++ +  PP
Sbjct: 219 GVLLWELMT-RGAPP 232

>pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297

Iteration: 1
 Score = 56.2 bits (134), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 60/260 (23%), Positives = 106/260 (40%), Gaps = 27/260 (10%)
Query: 79  ENQFRIAVKRFNRSAWPDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAEYMPND 138
           +++  +AVK          + F  EA  +  L++  +    G C +GD  ++V EYM + 
Sbjct: 43  KDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKFYGVCGDGDPLIMVFEYMKHG 102
Query: 139 TLAKHL--------FHWETQP------MKWAMRLRVALHIAEALEYCTSKERALYHDLNA 184
            L K L           + QP      +  +  L +A  IA  + Y  S +  ++ DL  
Sbjct: 103 DLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLAS-QHFVHRDLAT 161
Query: 185 YRIVFDDDVNPRLSCFGLMKNS------RDGRSYSTNLAFTPPEYLRTGRVTPESVMYSF 238
              +   ++  ++  FG+ ++       R G      + + PPE +   + T ES ++SF
Sbjct: 162 RNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSF 221
Query: 239 GTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDS-CLEGQFSSDEGTELVRLASRCLQYEP 297
           G +L ++ +    P      L     I+ +T    LE      +    V L   C Q EP
Sbjct: 222 GVILWEIFTYGKQP---WFQLSNTEVIECITQGRVLERPRVCPKEVYDVMLG--CWQREP 276
Query: 298 RERPNPRSLVTALVTLQKDT 317
           ++R N + +   L  L K T
Sbjct: 277 QQRLNIKEIYKILHALGKAT 296

>pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298

Iteration: 1
 Score = 55.5 bits (132), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 62/257 (24%), Positives = 116/257 (45%), Gaps = 22/257 (8%)
Query: 66  GEKAPNVVYKG----KLENQFRIAVKRFNR-SAWPDARQFLEEARAVGQLRNRRLANLLG 120
           G+    VVY G    + +N+ + A+K  +R +       FL E   +  L +  +  L+G
Sbjct: 30  GKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLALIG 89
Query: 121 CCC--EGDERLLVAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERAL 178
                EG   +L+  YM +  L + +   +  P    + +   L +A  +EY  ++++ +
Sbjct: 90  IMLPPEGLPHVLLP-YMCHGDLLQFIRSPQRNPTVKDL-ISFGLQVARGMEYL-AEQKFV 146
Query: 179 YHDLNAYRIVFDDDVNPRLSCFGLMKNSRDGRSYSTN--------LAFTPPEYLRTGRVT 230
           + DL A   + D+    +++ FGL ++  D   YS          + +T  E L+T R T
Sbjct: 147 HRDLAARNCMLDESFTVKVADFGLARDILDREYYSVQQHRHARLPVKWTALESLQTYRFT 206
Query: 231 PESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLAS 290
            +S ++SFG LL +LL+ +  PP   +D     +         + ++  D    L ++  
Sbjct: 207 TKSDVWSFGVLLWELLT-RGAPPYRHIDPFDLTHFLAQGRRLPQPEYCPD---SLYQVMQ 262
Query: 291 RCLQYEPRERPNPRSLV 307
           +C + +P  RP  R LV
Sbjct: 263 QCWEADPAVRPTFRVLV 279

>pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343

Iteration: 1
 Score = 54.7 bits (130), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 57/253 (22%), Positives = 98/253 (38%), Gaps = 44/253 (17%)
Query: 84  IAVKRFNRSAWPDAR-QFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAEYMPNDTLAK 142
           +AVK     A  D +  F  EA  + +  N  +  LLG C  G    L+ EYM    L +
Sbjct: 80  VAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNE 139
Query: 143 HLFHWETQ----------------------PMKWAMRLRVALHIAEALEYCTSKERALYH 180
            L                            P+  A +L +A  +A  + Y  S+ + ++ 
Sbjct: 140 FLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAY-LSERKFVHR 198
Query: 181 DLNAYRIVFDDDVNPRLSCFGLMKNSRDGRSYSTN------LAFTPPEYLRTGRVTPESV 234
           DL     +  +++  +++ FGL +N      Y  +      + + PPE +   R T ES 
Sbjct: 199 DLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESD 258
Query: 235 MYSFGTLLLDLLSGKHIP-----PSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLA 289
           ++++G +L ++ S    P         +  +RD NI    ++C           EL  L 
Sbjct: 259 VWAYGVVLWEIFSYGLQPYYGMAHEEVIYYVRDGNILACPENC---------PLELYNLM 309
Query: 290 SRCLQYEPRERPN 302
             C    P +RP+
Sbjct: 310 RLCWSKLPADRPS 322

>pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302

Iteration: 1
 Score = 54.3 bits (129), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 62/252 (24%), Positives = 105/252 (41%), Gaps = 24/252 (9%)
Query: 84  IAVKRFNRSAWPDARQ-FLEEARAVGQLRNRRLANLLGCCCEGDER--LLVAEYMPNDTL 140
           +AVK       P  R  + +E   +  L +  +    GCC +  E+   LV EY+P  +L
Sbjct: 46  VAVKALKADCGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDQGEKSLQLVMEYVPLGSL 105
Query: 141 AKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCF 200
             +L       +  A  L  A  I E + Y  S +  ++ +L A  ++ D+D   ++  F
Sbjct: 106 RDYL---PRHSIGLAQLLLFAQQICEGMAYLHS-QHYIHRNLAARNVLLDNDRLVKIGDF 161
Query: 201 GLMKNSRDGRSY-------STNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLS---GKH 250
           GL K   +G  Y        + + +  PE L+  +    S ++SFG  L +LL+      
Sbjct: 162 GLAKAVPEGHEYYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQ 221
Query: 251 IPPSHALDLI----RDRNIQTLTDSCLEGQFSSDEGT---ELVRLASRCLQYEPRERPNP 303
            PP+  L+LI        +  LT+    G+          E+  L   C + E   RP  
Sbjct: 222 SPPTKFLELIGIAQGQMTVLRLTELLERGERLPRPDKCPCEVYHLMKNCWETEASFRPTF 281
Query: 304 RSLVTALVTLQK 315
            +L+  L T+ +
Sbjct: 282 ENLIPILKTVHE 293

>pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314

Iteration: 1
 Score = 53.9 bits (128), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 58/252 (23%), Positives = 105/252 (41%), Gaps = 44/252 (17%)
Query: 84  IAVKRFNRSAWP-DARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAEYMPNDTL-- 140
           +AVK    +A P + R  L E   + Q+ +  +  L G C +    LL+ EY    +L  
Sbjct: 56  VAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRG 115
Query: 141 --------------------AKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYH 180
                               +  L H + + +     +  A  I++ ++Y  ++ + ++ 
Sbjct: 116 FLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYL-AEMKLVHR 174
Query: 181 DLNAYRIVFDDDVNPRLSCFGLMKNSRDGRSYSTN------LAFTPPEYLRTGRVTPESV 234
           DL A  I+  +    ++S FGL ++  +  SY         + +   E L     T +S 
Sbjct: 175 DLAARNILVAEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSD 234
Query: 235 MYSFGTLLLDL--LSGK---HIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLA 289
           ++SFG LL ++  L G     IPP    +L++  +     D+C E         E+ RL 
Sbjct: 235 VWSFGVLLWEIVTLGGNPYPGIPPERLFNLLKTGHRMERPDNCSE---------EMYRLM 285
Query: 290 SRCLQYEPRERP 301
            +C + EP +RP
Sbjct: 286 LQCWKQEPDKRP 297

>pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 61/252 (24%), Positives = 105/252 (41%), Gaps = 24/252 (9%)
Query: 84  IAVKRFNRSAWPDARQ-FLEEARAVGQLRNRRLANLLGCCCEGDER--LLVAEYMPNDTL 140
           +AVK       P  R  + +E   +  L +  +    GCC +  E+   LV EY+P  +L
Sbjct: 46  VAVKALKADCGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDQGEKSLQLVMEYVPLGSL 105
Query: 141 AKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCF 200
             +L       +  A  L  A  I E + Y  + +  ++ +L A  ++ D+D   ++  F
Sbjct: 106 RDYL---PRHSIGLAQLLLFAQQICEGMAYLHA-QHYIHRNLAARNVLLDNDRLVKIGDF 161
Query: 201 GLMKNSRDGRSY-------STNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLS---GKH 250
           GL K   +G  Y        + + +  PE L+  +    S ++SFG  L +LL+      
Sbjct: 162 GLAKAVPEGHEYYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQ 221
Query: 251 IPPSHALDLI----RDRNIQTLTDSCLEGQFSSDEGT---ELVRLASRCLQYEPRERPNP 303
            PP+  L+LI        +  LT+    G+          E+  L   C + E   RP  
Sbjct: 222 SPPTKFLELIGIAQGQMTVLRLTELLERGERLPRPDKCPCEVYHLMKNCWETEASFRPTF 281
Query: 304 RSLVTALVTLQK 315
            +L+  L T+ +
Sbjct: 282 ENLIPILKTVHE 293

>pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295

Iteration: 1
 Score = 53.1 bits (126), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 53/243 (21%), Positives = 102/243 (41%), Gaps = 22/243 (9%)
Query: 84  IAVKRFNRSAWPDARQFLEEARAVGQLRNRRLANLLGCCCEGDER--LLVAEYMPNDTLA 141
           +AVK+   S     R F  E   +  L++  +    G C     R   L+ EY+P  +L 
Sbjct: 42  VAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLR 101
Query: 142 KHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFG 201
            +L     + +     L+    I + +EY  +K R ++ DL    I+ +++   ++  FG
Sbjct: 102 DYL-QKHKERIDHIKLLQYTSQICKGMEYLGTK-RYIHRDLATRNILVENENRVKIGDFG 159
Query: 202 LMKNSRDGRSY-------STNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLS---GKHI 251
           L K     + +        + + +  PE L   + +  S ++SFG +L +L +       
Sbjct: 160 LTKVLPQDKEFFKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKS 219
Query: 252 PPSHALDLI-RDRNIQTLTDSCLE-----GQFSSDEG--TELVRLASRCLQYEPRERPNP 303
           PP+  + +I  D+  Q +    +E     G+    +G   E+  + + C      +RP+ 
Sbjct: 220 PPAEFMRMIGNDKQGQMIVFHLIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSF 279
Query: 304 RSL 306
           R L
Sbjct: 280 RDL 282

>pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298

Iteration: 1
 Score = 52.8 bits (125), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 53/243 (21%), Positives = 102/243 (41%), Gaps = 22/243 (9%)
Query: 84  IAVKRFNRSAWPDARQFLEEARAVGQLRNRRLANLLGCCCEGDER--LLVAEYMPNDTLA 141
           +AVK+   S     R F  E   +  L++  +    G C     R   L+ EY+P  +L 
Sbjct: 43  VAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLR 102
Query: 142 KHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFG 201
            +L     + +     L+    I + +EY  +K R ++ +L    I+ +++   ++  FG
Sbjct: 103 DYL-QKHKERIDHIKLLQYTSQICKGMEYLGTK-RYIHRNLATRNILVENENRVKIGDFG 160
Query: 202 LMKNSRDGRSY-------STNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLS---GKHI 251
           L K     + Y        + + +  PE L   + +  S ++SFG +L +L +       
Sbjct: 161 LTKVLPQDKEYYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKS 220
Query: 252 PPSHALDLI-RDRNIQTLTDSCLE-----GQFSSDEG--TELVRLASRCLQYEPRERPNP 303
           PP+  + +I  D+  Q +    +E     G+    +G   E+  + + C      +RP+ 
Sbjct: 221 PPAEFMRMIGNDKQGQMIVFHLIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSF 280
Query: 304 RSL 306
           R L
Sbjct: 281 RDL 283

>pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329

Iteration: 1
 Score = 52.0 bits (123), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 59/269 (21%), Positives = 109/269 (40%), Gaps = 34/269 (12%)
Query: 79  ENQFRIAVKRFNRSAWPDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAEYMPND 138
           +++  +AVK    ++    + F  EA  +  L+++ +    G C EG   L+V EYM + 
Sbjct: 69  QDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLLMVFEYMRHG 128
Query: 139 TL----------AKHLFHWET---QPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAY 185
            L          AK L   E     P+     L VA  +A  + Y       ++ DL   
Sbjct: 129 DLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLH-FVHRDLATR 187
Query: 186 RIVFDDDVNPRLSCFGLMKN------SRDGRSYSTNLAFTPPEYLRTGRVTPESVMYSFG 239
             +    +  ++  FG+ ++       R G      + + PPE +   + T ES ++SFG
Sbjct: 188 NCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFG 247
Query: 240 TLLLDLLS-GK----HIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLASRCLQ 294
            +L ++ + GK     +  + A+D I          +C           E+  +   C Q
Sbjct: 248 VVLWEIFTYGKQPWYQLSNTEAIDCITQGRELERPRAC---------PPEVYAIMRGCWQ 298
Query: 295 YEPRERPNPRSLVTALVTLQKDTELYLSL 323
            EP++R + + +   L  L +   +YL +
Sbjct: 299 REPQQRHSIKDVHARLQALAQAPPVYLDV 327

>pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300

Iteration: 1
 Score = 51.6 bits (122), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 59/269 (21%), Positives = 109/269 (40%), Gaps = 34/269 (12%)
Query: 79  ENQFRIAVKRFNRSAWPDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAEYMPND 138
           +++  +AVK    ++    + F  EA  +  L+++ +    G C EG   L+V EYM + 
Sbjct: 40  QDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLLMVFEYMRHG 99
Query: 139 TL----------AKHLFHWET---QPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAY 185
            L          AK L   E     P+     L VA  +A  + Y       ++ DL   
Sbjct: 100 DLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLH-FVHRDLATR 158
Query: 186 RIVFDDDVNPRLSCFGLMKN------SRDGRSYSTNLAFTPPEYLRTGRVTPESVMYSFG 239
             +    +  ++  FG+ ++       R G      + + PPE +   + T ES ++SFG
Sbjct: 159 NCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFG 218
Query: 240 TLLLDLLS-GK----HIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLASRCLQ 294
            +L ++ + GK     +  + A+D I          +C           E+  +   C Q
Sbjct: 219 VVLWEIFTYGKQPWYQLSNTEAIDCITQGRELERPRAC---------PPEVYAIMRGCWQ 269
Query: 295 YEPRERPNPRSLVTALVTLQKDTELYLSL 323
            EP++R + + +   L  L +   +YL +
Sbjct: 270 REPQQRHSIKDVHARLQALAQAPPVYLDV 298

>pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306

Iteration: 1
 Score = 51.6 bits (122), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 59/269 (21%), Positives = 109/269 (40%), Gaps = 34/269 (12%)
Query: 79  ENQFRIAVKRFNRSAWPDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAEYMPND 138
           +++  +AVK    ++    + F  EA  +  L+++ +    G C EG   L+V EYM + 
Sbjct: 46  QDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLLMVFEYMRHG 105
Query: 139 TL----------AKHLFHWET---QPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAY 185
            L          AK L   E     P+     L VA  +A  + Y       ++ DL   
Sbjct: 106 DLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLH-FVHRDLATR 164
Query: 186 RIVFDDDVNPRLSCFGLMKN------SRDGRSYSTNLAFTPPEYLRTGRVTPESVMYSFG 239
             +    +  ++  FG+ ++       R G      + + PPE +   + T ES ++SFG
Sbjct: 165 NCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFG 224
Query: 240 TLLLDLLS-GK----HIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLASRCLQ 294
            +L ++ + GK     +  + A+D I          +C           E+  +   C Q
Sbjct: 225 VVLWEIFTYGKQPWYQLSNTEAIDCITQGRELERPRAC---------PPEVYAIMRGCWQ 275
Query: 295 YEPRERPNPRSLVTALVTLQKDTELYLSL 323
            EP++R + + +   L  L +   +YL +
Sbjct: 276 REPQQRHSIKDVHARLQALAQAPPVYLDV 304

>pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318

Iteration: 1
 Score = 51.6 bits (122), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 63/255 (24%), Positives = 106/255 (41%), Gaps = 24/255 (9%)
Query: 84  IAVKRFNRSAWPDARQ-FLEEARAVGQLRNRRLANLLGCCCE-GDERL-LVAEYMPNDTL 140
           +AVK     A P  R  + +E   +  L +  +    GCC + G   L LV EY+P  +L
Sbjct: 63  VAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGAASLQLVMEYVPLGSL 122
Query: 141 AKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCF 200
             +L       +  A  L  A  I E + Y  + +  ++ DL A  ++ D+D   ++  F
Sbjct: 123 RDYL---PRHSIGLAQLLLFAQQICEGMAYLHA-QHYIHRDLAARNVLLDNDRLVKIGDF 178
Query: 201 GLMKNSRDGRSY-------STNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLS---GKH 250
           GL K   +G           + + +  PE L+  +    S ++SFG  L +LL+      
Sbjct: 179 GLAKAVPEGHEXYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQ 238
Query: 251 IPPSHALDLI----RDRNIQTLTDSCLEGQFSSDEG---TELVRLASRCLQYEPRERPNP 303
            PP+  L+LI        +  LT+    G+          E+  L   C + E   RP  
Sbjct: 239 SPPTKFLELIGIAQGQMTVLRLTELLERGERLPRPDKCPAEVYHLMKNCWETEASFRPTF 298
Query: 304 RSLVTALVTLQKDTE 318
            +L+  L T+ +  +
Sbjct: 299 ENLIPILKTVHEKYQ 313

>pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298

Iteration: 1
 Score = 51.6 bits (122), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 53/243 (21%), Positives = 101/243 (41%), Gaps = 22/243 (9%)
Query: 84  IAVKRFNRSAWPDARQFLEEARAVGQLRNRRLANLLGCCCEGDER--LLVAEYMPNDTLA 141
           +AVK+   S     R F  E   +  L++  +    G C     R   L+ EY+P  +L 
Sbjct: 45  VAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLR 104
Query: 142 KHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFG 201
            +L     + +     L+    I + +EY  +K R ++ DL    I+ +++   ++  FG
Sbjct: 105 DYL-QAHAERIDHIKLLQYTSQICKGMEYLGTK-RYIHRDLATRNILVENENRVKIGDFG 162
Query: 202 LMK-------NSRDGRSYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLS---GKHI 251
           L K         +      + + +  PE L   + +  S ++SFG +L +L +       
Sbjct: 163 LTKVLPQDKEXXKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKS 222
Query: 252 PPSHALDLI-RDRNIQTLTDSCLE-----GQFSSDEG--TELVRLASRCLQYEPRERPNP 303
           PP+  + +I  D+  Q +    +E     G+    +G   E+  + + C      +RP+ 
Sbjct: 223 PPAEFMRMIGNDKQGQMIVFHLIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSF 282
Query: 304 RSL 306
           R L
Sbjct: 283 RDL 285

>pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326

Iteration: 1
 Score = 51.6 bits (122), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 53/243 (21%), Positives = 101/243 (41%), Gaps = 22/243 (9%)
Query: 84  IAVKRFNRSAWPDARQFLEEARAVGQLRNRRLANLLGCCCEGDER--LLVAEYMPNDTLA 141
           +AVK+   S     R F  E   +  L++  +    G C     R   L+ EY+P  +L 
Sbjct: 73  VAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLR 132
Query: 142 KHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFG 201
            +L     + +     L+    I + +EY  +K R ++ DL    I+ +++   ++  FG
Sbjct: 133 DYL-QKHKERIDHIKLLQYTSQICKGMEYLGTK-RYIHRDLATRNILVENENRVKIGDFG 190
Query: 202 LMK-------NSRDGRSYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLS---GKHI 251
           L K         +      + + +  PE L   + +  S ++SFG +L +L +       
Sbjct: 191 LTKVLPQDKEXXKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKS 250
Query: 252 PPSHALDLI-RDRNIQTLTDSCLE-----GQFSSDEG--TELVRLASRCLQYEPRERPNP 303
           PP+  + +I  D+  Q +    +E     G+    +G   E+  + + C      +RP+ 
Sbjct: 251 PPAEFMRMIGNDKQGQMIVFHLIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSF 310
Query: 304 RSL 306
           R L
Sbjct: 311 RDL 313

>pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298

Iteration: 1
 Score = 51.6 bits (122), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 53/243 (21%), Positives = 101/243 (41%), Gaps = 22/243 (9%)
Query: 84  IAVKRFNRSAWPDARQFLEEARAVGQLRNRRLANLLGCCCEGDER--LLVAEYMPNDTLA 141
           +AVK+   S     R F  E   +  L++  +    G C     R   L+ EY+P  +L 
Sbjct: 45  VAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLR 104
Query: 142 KHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFG 201
            +L     + +     L+    I + +EY  +K R ++ DL    I+ +++   ++  FG
Sbjct: 105 DYL-QKHKERIDHIKLLQYTSQICKGMEYLGTK-RYIHRDLATRNILVENENRVKIGDFG 162
Query: 202 LMK-------NSRDGRSYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLS---GKHI 251
           L K         +      + + +  PE L   + +  S ++SFG +L +L +       
Sbjct: 163 LTKVLPQDKEXXKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKS 222
Query: 252 PPSHALDLI-RDRNIQTLTDSCLE-----GQFSSDEG--TELVRLASRCLQYEPRERPNP 303
           PP+  + +I  D+  Q +    +E     G+    +G   E+  + + C      +RP+ 
Sbjct: 223 PPAEFMRMIGNDKQGQMIVFHLIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSF 282
Query: 304 RSL 306
           R L
Sbjct: 283 RDL 285

>pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293

Iteration: 1
 Score = 51.2 bits (121), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 53/243 (21%), Positives = 101/243 (41%), Gaps = 22/243 (9%)
Query: 84  IAVKRFNRSAWPDARQFLEEARAVGQLRNRRLANLLGCCCEGDER--LLVAEYMPNDTLA 141
           +AVK+   S     R F  E   +  L++  +    G C     R   L+ EY+P  +L 
Sbjct: 40  VAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLR 99
Query: 142 KHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFG 201
            +L     + +     L+    I + +EY  +K R ++ DL    I+ +++   ++  FG
Sbjct: 100 DYL-QKHKERIDHIKLLQYTSQICKGMEYLGTK-RYIHRDLATRNILVENENRVKIGDFG 157
Query: 202 LMK-------NSRDGRSYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLS---GKHI 251
           L K         +      + + +  PE L   + +  S ++SFG +L +L +       
Sbjct: 158 LTKVLPQDKEXXKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKS 217
Query: 252 PPSHALDLI-RDRNIQTLTDSCLE-----GQFSSDEG--TELVRLASRCLQYEPRERPNP 303
           PP+  + +I  D+  Q +    +E     G+    +G   E+  + + C      +RP+ 
Sbjct: 218 PPAEFMRMIGNDKQGQMIVFHLIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSF 277
Query: 304 RSL 306
           R L
Sbjct: 278 RDL 280

>pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301

Iteration: 1
 Score = 51.2 bits (121), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 53/243 (21%), Positives = 101/243 (41%), Gaps = 22/243 (9%)
Query: 84  IAVKRFNRSAWPDARQFLEEARAVGQLRNRRLANLLGCCCEGDER--LLVAEYMPNDTLA 141
           +AVK+   S     R F  E   +  L++  +    G C     R   L+ EY+P  +L 
Sbjct: 48  VAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLR 107
Query: 142 KHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFG 201
            +L     + +     L+    I + +EY  +K R ++ DL    I+ +++   ++  FG
Sbjct: 108 DYL-QKHKERIDHIKLLQYTSQICKGMEYLGTK-RYIHRDLATRNILVENENRVKIGDFG 165
Query: 202 LMK-------NSRDGRSYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLS---GKHI 251
           L K         +      + + +  PE L   + +  S ++SFG +L +L +       
Sbjct: 166 LTKVLPQDKEXXKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKS 225
Query: 252 PPSHALDLI-RDRNIQTLTDSCLE-----GQFSSDEG--TELVRLASRCLQYEPRERPNP 303
           PP+  + +I  D+  Q +    +E     G+    +G   E+  + + C      +RP+ 
Sbjct: 226 PPAEFMRMIGNDKQGQMIVFHLIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSF 285
Query: 304 RSL 306
           R L
Sbjct: 286 RDL 288

>pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301

Iteration: 1
 Score = 51.2 bits (121), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 53/243 (21%), Positives = 101/243 (41%), Gaps = 22/243 (9%)
Query: 84  IAVKRFNRSAWPDARQFLEEARAVGQLRNRRLANLLGCCCEGDER--LLVAEYMPNDTLA 141
           +AVK+   S     R F  E   +  L++  +    G C     R   L+ EY+P  +L 
Sbjct: 42  VAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLR 101
Query: 142 KHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFG 201
            +L     + +     L+    I + +EY  +K R ++ DL    I+ +++   ++  FG
Sbjct: 102 DYL-QKHKERIDHIKLLQYTSQICKGMEYLGTK-RYIHRDLATRNILVENENRVKIGDFG 159
Query: 202 LMK-------NSRDGRSYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLS---GKHI 251
           L K         +      + + +  PE L   + +  S ++SFG +L +L +       
Sbjct: 160 LTKVLPQDKEXXKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKS 219
Query: 252 PPSHALDLI-RDRNIQTLTDSCLE-----GQFSSDEG--TELVRLASRCLQYEPRERPNP 303
           PP+  + +I  D+  Q +    +E     G+    +G   E+  + + C      +RP+ 
Sbjct: 220 PPAEFMRMIGNDKQGQMIVFHLIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSF 279
Query: 304 RSL 306
           R L
Sbjct: 280 RDL 282

>pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302

Iteration: 1
 Score = 51.2 bits (121), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 53/243 (21%), Positives = 101/243 (41%), Gaps = 22/243 (9%)
Query: 84  IAVKRFNRSAWPDARQFLEEARAVGQLRNRRLANLLGCCCEGDER--LLVAEYMPNDTLA 141
           +AVK+   S     R F  E   +  L++  +    G C     R   L+ EY+P  +L 
Sbjct: 49  VAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLR 108
Query: 142 KHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFG 201
            +L     + +     L+    I + +EY  +K R ++ DL    I+ +++   ++  FG
Sbjct: 109 DYL-QKHKERIDHIKLLQYTSQICKGMEYLGTK-RYIHRDLATRNILVENENRVKIGDFG 166
Query: 202 LMK-------NSRDGRSYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLS---GKHI 251
           L K         +      + + +  PE L   + +  S ++SFG +L +L +       
Sbjct: 167 LTKVLPQDKEXXKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKS 226
Query: 252 PPSHALDLI-RDRNIQTLTDSCLE-----GQFSSDEG--TELVRLASRCLQYEPRERPNP 303
           PP+  + +I  D+  Q +    +E     G+    +G   E+  + + C      +RP+ 
Sbjct: 227 PPAEFMRMIGNDKQGQMIVFHLIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSF 286
Query: 304 RSL 306
           R L
Sbjct: 287 RDL 289

>pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300

Iteration: 1
 Score = 51.2 bits (121), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 53/243 (21%), Positives = 101/243 (41%), Gaps = 22/243 (9%)
Query: 84  IAVKRFNRSAWPDARQFLEEARAVGQLRNRRLANLLGCCCEGDER--LLVAEYMPNDTLA 141
           +AVK+   S     R F  E   +  L++  +    G C     R   L+ EY+P  +L 
Sbjct: 47  VAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLR 106
Query: 142 KHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFG 201
            +L     + +     L+    I + +EY  +K R ++ DL    I+ +++   ++  FG
Sbjct: 107 DYL-QKHKERIDHIKLLQYTSQICKGMEYLGTK-RYIHRDLATRNILVENENRVKIGDFG 164
Query: 202 LMK-------NSRDGRSYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLS---GKHI 251
           L K         +      + + +  PE L   + +  S ++SFG +L +L +       
Sbjct: 165 LTKVLPQDKEXXKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKS 224
Query: 252 PPSHALDLI-RDRNIQTLTDSCLE-----GQFSSDEG--TELVRLASRCLQYEPRERPNP 303
           PP+  + +I  D+  Q +    +E     G+    +G   E+  + + C      +RP+ 
Sbjct: 225 PPAEFMRMIGNDKQGQMIVFHLIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSF 284
Query: 304 RSL 306
           R L
Sbjct: 285 RDL 287

>pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293

Iteration: 1
 Score = 51.2 bits (121), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 53/243 (21%), Positives = 101/243 (41%), Gaps = 22/243 (9%)
Query: 84  IAVKRFNRSAWPDARQFLEEARAVGQLRNRRLANLLGCCCEGDER--LLVAEYMPNDTLA 141
           +AVK+   S     R F  E   +  L++  +    G C     R   L+ EY+P  +L 
Sbjct: 41  VAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLR 100
Query: 142 KHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFG 201
            +L     + +     L+    I + +EY  +K R ++ DL    I+ +++   ++  FG
Sbjct: 101 DYL-QKHKERIDHIKLLQYTSQICKGMEYLGTK-RYIHRDLATRNILVENENRVKIGDFG 158
Query: 202 LMK-------NSRDGRSYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLS---GKHI 251
           L K         +      + + +  PE L   + +  S ++SFG +L +L +       
Sbjct: 159 LTKVLPQDKEXXKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKS 218
Query: 252 PPSHALDLI-RDRNIQTLTDSCLE-----GQFSSDEG--TELVRLASRCLQYEPRERPNP 303
           PP+  + +I  D+  Q +    +E     G+    +G   E+  + + C      +RP+ 
Sbjct: 219 PPAEFMRMIGNDKQGQMIVFHLIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSF 278
Query: 304 RSL 306
           R L
Sbjct: 279 RDL 281

>pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295

Iteration: 1
 Score = 51.2 bits (121), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 53/243 (21%), Positives = 101/243 (41%), Gaps = 22/243 (9%)
Query: 84  IAVKRFNRSAWPDARQFLEEARAVGQLRNRRLANLLGCCCEGDER--LLVAEYMPNDTLA 141
           +AVK+   S     R F  E   +  L++  +    G C     R   L+ EY+P  +L 
Sbjct: 42  VAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLR 101
Query: 142 KHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFG 201
            +L     + +     L+    I + +EY  +K R ++ DL    I+ +++   ++  FG
Sbjct: 102 DYL-QKHKERIDHIKLLQYTSQICKGMEYLGTK-RYIHRDLATRNILVENENRVKIGDFG 159
Query: 202 LMK-------NSRDGRSYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLS---GKHI 251
           L K         +      + + +  PE L   + +  S ++SFG +L +L +       
Sbjct: 160 LTKVLPQDKEXXKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKS 219
Query: 252 PPSHALDLI-RDRNIQTLTDSCLE-----GQFSSDEG--TELVRLASRCLQYEPRERPNP 303
           PP+  + +I  D+  Q +    +E     G+    +G   E+  + + C      +RP+ 
Sbjct: 220 PPAEFMRMIGNDKQGQMIVFHLIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSF 279
Query: 304 RSL 306
           R L
Sbjct: 280 RDL 282

>pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313

Iteration: 1
 Score = 51.2 bits (121), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 53/243 (21%), Positives = 101/243 (41%), Gaps = 22/243 (9%)
Query: 84  IAVKRFNRSAWPDARQFLEEARAVGQLRNRRLANLLGCCCEGDER--LLVAEYMPNDTLA 141
           +AVK+   S     R F  E   +  L++  +    G C     R   L+ EY+P  +L 
Sbjct: 60  VAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLR 119
Query: 142 KHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFG 201
            +L     + +     L+    I + +EY  +K R ++ DL    I+ +++   ++  FG
Sbjct: 120 DYL-QKHKERIDHIKLLQYTSQICKGMEYLGTK-RYIHRDLATRNILVENENRVKIGDFG 177
Query: 202 LMK-------NSRDGRSYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLS---GKHI 251
           L K         +      + + +  PE L   + +  S ++SFG +L +L +       
Sbjct: 178 LTKVLPQDKEXXKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKS 237
Query: 252 PPSHALDLI-RDRNIQTLTDSCLE-----GQFSSDEG--TELVRLASRCLQYEPRERPNP 303
           PP+  + +I  D+  Q +    +E     G+    +G   E+  + + C      +RP+ 
Sbjct: 238 PPAEFMRMIGNDKQGQMIVFHLIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSF 297
Query: 304 RSL 306
           R L
Sbjct: 298 RDL 300

>pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311

Iteration: 1
 Score = 51.2 bits (121), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 53/243 (21%), Positives = 101/243 (41%), Gaps = 22/243 (9%)
Query: 84  IAVKRFNRSAWPDARQFLEEARAVGQLRNRRLANLLGCCCEGDER--LLVAEYMPNDTLA 141
           +AVK+   S     R F  E   +  L++  +    G C     R   L+ EY+P  +L 
Sbjct: 60  VAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLR 119
Query: 142 KHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFG 201
            +L     + +     L+    I + +EY  +K R ++ DL    I+ +++   ++  FG
Sbjct: 120 DYL-QKHKERIDHIKLLQYTSQICKGMEYLGTK-RYIHRDLATRNILVENENRVKIGDFG 177
Query: 202 LMK-------NSRDGRSYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLS---GKHI 251
           L K         +      + + +  PE L   + +  S ++SFG +L +L +       
Sbjct: 178 LTKVLPQDKEXXKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKS 237
Query: 252 PPSHALDLI-RDRNIQTLTDSCLE-----GQFSSDEG--TELVRLASRCLQYEPRERPNP 303
           PP+  + +I  D+  Q +    +E     G+    +G   E+  + + C      +RP+ 
Sbjct: 238 PPAEFMRMIGNDKQGQMIVFHLIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSF 297
Query: 304 RSL 306
           R L
Sbjct: 298 RDL 300

>pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303

Iteration: 1
 Score = 51.2 bits (121), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 53/243 (21%), Positives = 101/243 (41%), Gaps = 22/243 (9%)
Query: 84  IAVKRFNRSAWPDARQFLEEARAVGQLRNRRLANLLGCCCEGDER--LLVAEYMPNDTLA 141
           +AVK+   S     R F  E   +  L++  +    G C     R   L+ EY+P  +L 
Sbjct: 46  VAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLR 105
Query: 142 KHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFG 201
            +L     + +     L+    I + +EY  +K R ++ DL    I+ +++   ++  FG
Sbjct: 106 DYL-QKHKERIDHIKLLQYTSQICKGMEYLGTK-RYIHRDLATRNILVENENRVKIGDFG 163
Query: 202 LMK-------NSRDGRSYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLS---GKHI 251
           L K         +      + + +  PE L   + +  S ++SFG +L +L +       
Sbjct: 164 LTKVLPQDKEXXKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKS 223
Query: 252 PPSHALDLI-RDRNIQTLTDSCLE-----GQFSSDEG--TELVRLASRCLQYEPRERPNP 303
           PP+  + +I  D+  Q +    +E     G+    +G   E+  + + C      +RP+ 
Sbjct: 224 PPAEFMRMIGNDKQGQMIVFHLIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSF 283
Query: 304 RSL 306
           R L
Sbjct: 284 RDL 286

>pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454

Iteration: 1
 Score = 51.2 bits (121), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 58/258 (22%), Positives = 110/258 (42%), Gaps = 26/258 (10%)
Query: 73  VYKGKLENQFRIAVKRFNRSAWPDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVA 132
           V+        ++AVK     +      FL EA  +  L++ +L  L     + +   ++ 
Sbjct: 204 VWMATYNKHTKVAVKTMKPGSM-SVEAFLAEANVMKTLQHDKLVKLHAVVTK-EPIYIIT 261
Query: 133 EYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDD 192
           E+M   +L   L   E         +  +  IAE + +   +   ++ DL A  I+    
Sbjct: 262 EFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQR-NYIHRDLRAANILVSAS 320
Query: 193 VNPRLSCFGLMK-------NSRDGRSYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDL 245
           +  +++ FGL +        +R+G  +   + +T PE +  G  T +S ++SFG LL+++
Sbjct: 321 LVCKIADFGLARVIEDNEYTAREGAKFP--IKWTAPEAINFGSFTIKSDVWSFGILLMEI 378
Query: 246 LSGKHIP-PSHA-LDLIR--DRNIQT-LTDSCLEGQFSSDEGTELVRLASRCLQYEPRER 300
           ++   IP P  +  ++IR  +R  +    ++C E         EL  +  RC +  P ER
Sbjct: 379 VTYGRIPYPGMSNPEVIRALERGYRMPRPENCPE---------ELYNIMMRCWKNRPEER 429
Query: 301 PNPRSLVTALVTLQKDTE 318
           P    + + L      TE
Sbjct: 430 PTFEYIQSVLDDFYTATE 447

>pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314

Iteration: 1
 Score = 50.8 bits (120), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 60/253 (23%), Positives = 103/253 (40%), Gaps = 46/253 (18%)
Query: 84  IAVKRFNRSAWP-DARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAEYMPNDTL-- 140
           +AVK    +A P + R  L E   + Q+ +  +  L G C +    LL+ EY    +L  
Sbjct: 56  VAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRG 115
Query: 141 --------------------AKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYH 180
                               +  L H + + +     +  A  I++ ++Y    E +L H
Sbjct: 116 FLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLA--EMSLVH 173
Query: 181 -DLNAYRIVFDDDVNPRLSCFGLMKNSRDGRSYSTN------LAFTPPEYLRTGRVTPES 233
            DL A  I+  +    ++S FGL ++  +  S          + +   E L     T +S
Sbjct: 174 RDLAARNILVAEGRKMKISDFGLSRDVYEEDSXVKRSQGRIPVKWMAIESLFDHIYTTQS 233
Query: 234 VMYSFGTLLLDL--LSGK---HIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRL 288
            ++SFG LL ++  L G     IPP    +L++  +     D+C E         E+ RL
Sbjct: 234 DVWSFGVLLWEIVTLGGNPYPGIPPERLFNLLKTGHRMERPDNCSE---------EMYRL 284
Query: 289 ASRCLQYEPRERP 301
             +C + EP +RP
Sbjct: 285 MLQCWKQEPDKRP 297

>pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314

Iteration: 1
 Score = 50.8 bits (120), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 57/252 (22%), Positives = 104/252 (41%), Gaps = 44/252 (17%)
Query: 84  IAVKRFNRSAWP-DARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAEYMPNDTL-- 140
           +AVK    +A P + R  L E   + Q+ +  +  L G C +    LL+ EY    +L  
Sbjct: 56  VAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRG 115
Query: 141 --------------------AKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYH 180
                               +  L H + + +     +  A  I++ ++Y  ++ + ++ 
Sbjct: 116 FLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYL-AEMKLVHR 174
Query: 181 DLNAYRIVFDDDVNPRLSCFGLMKNSRDGRSYSTN------LAFTPPEYLRTGRVTPESV 234
           DL A  I+  +    ++S FGL ++  +  S          + +   E L     T +S 
Sbjct: 175 DLAARNILVAEGRKMKISDFGLSRDVYEEDSXVKRSQGRIPVKWMAIESLFDHIYTTQSD 234
Query: 235 MYSFGTLLLDL--LSGK---HIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLA 289
           ++SFG LL ++  L G     IPP    +L++  +     D+C E         E+ RL 
Sbjct: 235 VWSFGVLLWEIVTLGGNPYPGIPPERLFNLLKTGHRMERPDNCSE---------EMYRLM 285
Query: 290 SRCLQYEPRERP 301
            +C + EP +RP
Sbjct: 286 LQCWKQEPDKRP 297

>pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333

Iteration: 1
 Score = 50.4 bits (119), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 58/253 (22%), Positives = 108/253 (42%), Gaps = 23/253 (9%)
Query: 73  VYKGKLEN-----QFRIAVKRFNRSAWPDAR-QFLEEARAVGQLRNRRLANLLGCCCEGD 126
           VYKG L+      +  +A+K          R  FL EA  +GQ  +  +  L G   +  
Sbjct: 60  VYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYK 119
Query: 127 ERLLVAEYMPNDTLAKHLFH--WETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNA 184
             +++ EYM N  L K L     E   ++    LR    IA  ++Y  +    ++ DL A
Sbjct: 120 PMMIITEYMENGALDKFLREKDGEFSVLQLVGMLR---GIAAGMKYLANMNY-VHRDLAA 175
Query: 185 YRIVFDDDVNPRLSCFGLMKNSRDG--RSYSTN-----LAFTPPEYLRTGRVTPESVMYS 237
             I+ + ++  ++S FGL +   D    +Y+T+     + +T PE +   + T  S ++S
Sbjct: 176 RNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWS 235
Query: 238 FGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLASRCLQYEP 297
           FG ++ ++++    P       + +  +    +         D  + + +L  +C Q E 
Sbjct: 236 FGIVMWEVMTYGERPYWE----LSNHEVMKAINDGFRLPTPMDCPSAIYQLMMQCWQQER 291
Query: 298 RERPNPRSLVTAL 310
             RP    +V+ L
Sbjct: 292 ARRPKFADIVSIL 304

>pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373

Iteration: 1
 Score = 50.4 bits (119), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 55/228 (24%), Positives = 100/228 (43%), Gaps = 17/228 (7%)
Query: 98  RQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAEYMPNDTLAKHLFHWETQ--PMKWA 155
           R FL EA  +GQ  +  +  L G   +    ++V EYM N +L   L   + Q   ++  
Sbjct: 91  RDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLV 150
Query: 156 MRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDG--RSYS 213
             LR    IA  ++Y  S    ++ DL A  I+ + ++  ++S FGL +   D    +Y+
Sbjct: 151 GMLR---GIASGMKYL-SDMGYVHRDLAARNILINSNLVCKVSDFGLARVLEDDPEAAYT 206
Query: 214 TN-----LAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTL 268
           T      + +T PE +   + T  S ++S+G +L +++S    P       + ++++   
Sbjct: 207 TRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWE----MSNQDVIKA 262
Query: 269 TDSCLEGQFSSDEGTELVRLASRCLQYEPRERPNPRSLVTALVTLQKD 316
            D         D    L +L   C Q +   RP    +V+ L  L ++
Sbjct: 263 VDEGYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKLIRN 310

>pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438

Iteration: 1
 Score = 50.4 bits (119), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 58/251 (23%), Positives = 108/251 (43%), Gaps = 22/251 (8%)
Query: 73  VYKGKLENQFRIAVKRFNRSAWPDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVA 132
           V+        ++AVK     +      FL EA  +  L++ +L  L     + +   ++ 
Sbjct: 198 VWMATYNKHTKVAVKTMKPGSM-SVEAFLAEANVMKTLQHDKLVKLHAVVTK-EPIYIIT 255
Query: 133 EYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDD 192
           E+M   +L   L   E         +  +  IAE + +   +   ++ DL A  I+    
Sbjct: 256 EFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQR-NYIHRDLRAANILVSAS 314
Query: 193 VNPRLSCFGLMKNSRDGRSYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIP 252
           +  +++ FGL   +R G  +   + +T PE +  G  T +S ++SFG LL+++++   IP
Sbjct: 315 LVCKIADFGL---ARVGAKFP--IKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIP 369
Query: 253 -PSHA-LDLIR--DRNIQT-LTDSCLEGQFSSDEGTELVRLASRCLQYEPRERPNPRSLV 307
            P  +  ++IR  +R  +    ++C E         EL  +  RC +  P ERP    + 
Sbjct: 370 YPGMSNPEVIRALERGYRMPRPENCPE---------ELYNIMMRCWKNRPEERPTFEYIQ 420
Query: 308 TALVTLQKDTE 318
           + L      TE
Sbjct: 421 SVLDDFYTATE 431

>pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270

Iteration: 1
 Score = 50.4 bits (119), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 55/242 (22%), Positives = 105/242 (43%), Gaps = 26/242 (10%)
Query: 73  VYKGKLENQFRIAVKRFNRSAWPDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVA 132
           V+        ++AVK     +      FL EA  +  L++ +L  L     + +   ++ 
Sbjct: 31  VWMATYNKHTKVAVKTMKPGSM-SVEAFLAEANVMKTLQHDKLVKLHAVVTK-EPIYIIT 88
Query: 133 EYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDD 192
           E+M   +L   L   E         +  +  IAE + +   +   ++ DL A  I+    
Sbjct: 89  EFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQR-NYIHRDLRAANILVSAS 147
Query: 193 VNPRLSCFGLMK-------NSRDGRSYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDL 245
           +  +++ FGL +        +R+G  +   + +T PE +  G  T +S ++SFG LL+++
Sbjct: 148 LVCKIADFGLARVIEDNEYTAREGAKFP--IKWTAPEAINFGSFTIKSDVWSFGILLMEI 205
Query: 246 LSGKHIP-PSHA-LDLIR--DRNIQT-LTDSCLEGQFSSDEGTELVRLASRCLQYEPRER 300
           ++   IP P  +  ++IR  +R  +    ++C E         EL  +  RC +  P ER
Sbjct: 206 VTYGRIPYPGMSNPEVIRALERGYRMPRPENCPE---------ELYNIMMRCWKNRPEER 256
Query: 301 PN 302
           P 
Sbjct: 257 PT 258

>pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score = 50.4 bits (119), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 61/261 (23%), Positives = 106/261 (40%), Gaps = 32/261 (12%)
Query: 66  GEKAPNVVYKGKLENQ------FRIAVKRFNR-SAWPDARQFLEEARAVGQLRNRRLANL 118
           G  A   VY+G++          ++AVK      +  D   FL EA  + +L ++ +   
Sbjct: 54  GHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKLNHQNIVRC 113
Query: 119 LGCCCEGDERLLVAEYMPNDTLAKHLFHWE---TQPMKWAMR--LRVALHIAEALEYCTS 173
           +G   +   R ++ E M    L   L       +QP   AM   L VA  IA   +Y   
Sbjct: 114 IGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQY-LE 172
Query: 174 KERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRD---------GRSYSTNLAFTPPEYL 224
           +   ++ D+ A   +       R++  G    +RD         G      + + PPE  
Sbjct: 173 ENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPPEAF 232
Query: 225 RTGRVTPESVMYSFGTLLLDLLSGKHIP-PSHALDLIRDRNIQTLTDSCLEGQFSSDEG- 282
             G  T ++  +SFG LL ++ S  ++P PS +       N + L      G+    +  
Sbjct: 233 MEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKS-------NQEVLEFVTSGGRMDPPKNC 285
Query: 283 -TELVRLASRCLQYEPRERPN 302
              + R+ ++C Q++P +RPN
Sbjct: 286 PGPVYRIMTQCWQHQPEDRPN 306

>pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298

Iteration: 1
 Score = 50.4 bits (119), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 52/243 (21%), Positives = 102/243 (41%), Gaps = 22/243 (9%)
Query: 84  IAVKRFNRSAWPDARQFLEEARAVGQLRNRRLANLLGCCCEGDER--LLVAEYMPNDTLA 141
           +AVK+   S     R F  E   +  L++  +    G C     R   L+ E++P  +L 
Sbjct: 45  VAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEFLPYGSLR 104
Query: 142 KHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFG 201
           ++L     + +     L+    I + +EY  +K R ++ DL    I+ +++   ++  FG
Sbjct: 105 EYL-QKHKERIDHIKLLQYTSQICKGMEYLGTK-RYIHRDLATRNILVENENRVKIGDFG 162
Query: 202 LMK-------NSRDGRSYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLS---GKHI 251
           L K         +      + + +  PE L   + +  S ++SFG +L +L +       
Sbjct: 163 LTKVLPQDKEXXKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKS 222
Query: 252 PPSHALDLI-RDRNIQTLTDSCLE-----GQFSSDEG--TELVRLASRCLQYEPRERPNP 303
           PP+  + +I  D+  Q +    +E     G+    +G   E+  + + C      +RP+ 
Sbjct: 223 PPAEFMRMIGNDKQGQMIVFHLIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSF 282
Query: 304 RSL 306
           R L
Sbjct: 283 RDL 285

>pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 61/261 (23%), Positives = 106/261 (40%), Gaps = 32/261 (12%)
Query: 66  GEKAPNVVYKGKLENQ------FRIAVKRFNR-SAWPDARQFLEEARAVGQLRNRRLANL 118
           G  A   VY+G++          ++AVK      +  D   FL EA  + +L ++ +   
Sbjct: 40  GHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKLNHQNIVRC 99
Query: 119 LGCCCEGDERLLVAEYMPNDTLAKHLFHWE---TQPMKWAMR--LRVALHIAEALEYCTS 173
           +G   +   R ++ E M    L   L       +QP   AM   L VA  IA   +Y   
Sbjct: 100 IGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQY-LE 158
Query: 174 KERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRD---------GRSYSTNLAFTPPEYL 224
           +   ++ D+ A   +       R++  G    +RD         G      + + PPE  
Sbjct: 159 ENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPPEAF 218
Query: 225 RTGRVTPESVMYSFGTLLLDLLSGKHIP-PSHALDLIRDRNIQTLTDSCLEGQFSSDEG- 282
             G  T ++  +SFG LL ++ S  ++P PS +       N + L      G+    +  
Sbjct: 219 MEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKS-------NQEVLEFVTSGGRMDPPKNC 271
Query: 283 -TELVRLASRCLQYEPRERPN 302
              + R+ ++C Q++P +RPN
Sbjct: 272 PGPVYRIMTQCWQHQPEDRPN 292

>pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 65/275 (23%), Positives = 113/275 (41%), Gaps = 45/275 (16%)
Query: 83  RIAVKRFNRSA----WPDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAEYMPND 138
           ++AVK     A      D    +E  + +G+ +N  + NLLG C +     ++ EY    
Sbjct: 62  KVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN--IINLLGACTQDGPLYVIVEYASKG 119
Query: 139 TLAKHL--------------FHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNA 184
            L ++L               H   + +     +  A  +A  +EY  SK + ++ DL A
Sbjct: 120 NLREYLQARRPPGLEFSFNPSHNPEEQLSSKDLVSCAYQVARGMEYLASK-KCIHRDLAA 178
Query: 185 YRIVFDDDVNPRLSCFGLMKNSR--DGRSYSTN----LAFTPPEYLRTGRVTPESVMYSF 238
             ++  +D   +++ FGL ++    D    +TN    + +  PE L     T +S ++SF
Sbjct: 179 RNVLVTEDNVMKIADFGLARDIHHIDXXKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSF 238
Query: 239 GTLLLDL--LSGK---HIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLASRCL 293
           G LL ++  L G     +P      L+++ +      +C           EL  +   C 
Sbjct: 239 GVLLWEIFTLGGSPYPGVPVEELFKLLKEGHRMDKPSNCT---------NELYMMMRDCW 289
Query: 294 QYEPRERPNPRSLVTAL---VTLQKDTE-LYLSLP 324
              P +RP  + LV  L   V L  + E L LS+P
Sbjct: 290 HAVPSQRPTFKQLVEDLDRIVALTSNQEXLDLSMP 324

>pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 60/271 (22%), Positives = 115/271 (42%), Gaps = 21/271 (7%)
Query: 66  GEKAPNVVYKGKL-----ENQFRIAVKRFNRSAWPDAR-QFLEEARAVGQLRNRRLANLL 119
           G  A   VYKG         +  +A+K  N +  P A  +F++EA  +  + +  L  LL
Sbjct: 47  GSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRLL 106
Query: 120 GCCCEGDERLLVAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALY 179
           G C     + LV + MP+  L +++ H     +   + L   + IA+ + Y   +ER L 
Sbjct: 107 GVCLSPTIQ-LVTQLMPHGCLLEYV-HEHKDNIGSQLLLNWCVQIAKGMMYL--EERRLV 162
Query: 180 H-DLNAYRIVFDDDVNPRLSCFGLMK-NSRDGRSYSTNLAFTPPEYL-----RTGRVTPE 232
           H DL A  ++     + +++ FGL +    D + Y+ +    P +++        + T +
Sbjct: 163 HRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPIKWMALECIHYRKFTHQ 222
Query: 233 SVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLASRC 292
           S ++S+G  + +L++    P     D I  R I  L +             ++  +  +C
Sbjct: 223 SDVWSYGVTIWELMTFGGKP----YDGIPTREIPDLLEKGERLPQPPICTIDVYMVMVKC 278
Query: 293 LQYEPRERPNPRSLVTALVTLQKDTELYLSL 323
              +   RP  + L      + +D + YL +
Sbjct: 279 WMIDADSRPKFKELAAEFSRMARDPQRYLVI 309

>pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 55/228 (24%), Positives = 100/228 (43%), Gaps = 17/228 (7%)
Query: 98  RQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAEYMPNDTLAKHLFHWETQ--PMKWA 155
           R FL EA  +GQ  +  +  L G   +    ++V EYM N +L   L   + Q   ++  
Sbjct: 91  RDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLV 150
Query: 156 MRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDG--RSYS 213
             LR    IA  ++Y  S    ++ DL A  I+ + ++  ++S FGL +   D    +Y+
Sbjct: 151 GMLR---GIASGMKYL-SDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYT 206
Query: 214 TN-----LAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTL 268
           T      + +T PE +   + T  S ++S+G +L +++S    P       + ++++   
Sbjct: 207 TRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWE----MSNQDVIKA 262
Query: 269 TDSCLEGQFSSDEGTELVRLASRCLQYEPRERPNPRSLVTALVTLQKD 316
            D         D    L +L   C Q +   RP    +V+ L  L ++
Sbjct: 263 VDEGYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKLIRN 310

>pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 55/228 (24%), Positives = 100/228 (43%), Gaps = 17/228 (7%)
Query: 98  RQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAEYMPNDTLAKHLFHWETQ--PMKWA 155
           R FL EA  +GQ  +  +  L G   +    ++V EYM N +L   L   + Q   ++  
Sbjct: 91  RDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLV 150
Query: 156 MRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDG--RSYS 213
             LR    IA  ++Y  S    ++ DL A  I+ + ++  ++S FGL +   D    +Y+
Sbjct: 151 GMLR---GIASGMKYL-SDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYT 206
Query: 214 TN-----LAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTL 268
           T      + +T PE +   + T  S ++S+G +L +++S    P       + ++++   
Sbjct: 207 TRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWE----MSNQDVIKA 262
Query: 269 TDSCLEGQFSSDEGTELVRLASRCLQYEPRERPNPRSLVTALVTLQKD 316
            D         D    L +L   C Q +   RP    +V+ L  L ++
Sbjct: 263 VDEGYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKLIRN 310

>pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 55/228 (24%), Positives = 100/228 (43%), Gaps = 17/228 (7%)
Query: 98  RQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAEYMPNDTLAKHLFHWETQ--PMKWA 155
           R FL EA  +GQ  +  +  L G   +    ++V EYM N +L   L   + Q   ++  
Sbjct: 62  RDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLV 121
Query: 156 MRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDG--RSYS 213
             LR    IA  ++Y  S    ++ DL A  I+ + ++  ++S FGL +   D    +Y+
Sbjct: 122 GMLR---GIASGMKYL-SDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYT 177
Query: 214 TN-----LAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTL 268
           T      + +T PE +   + T  S ++S+G +L +++S    P       + ++++   
Sbjct: 178 TRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWE----MSNQDVIKA 233
Query: 269 TDSCLEGQFSSDEGTELVRLASRCLQYEPRERPNPRSLVTALVTLQKD 316
            D         D    L +L   C Q +   RP    +V+ L  L ++
Sbjct: 234 VDEGYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKLIRN 281

>pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 55/228 (24%), Positives = 100/228 (43%), Gaps = 17/228 (7%)
Query: 98  RQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAEYMPNDTLAKHLFHWETQ--PMKWA 155
           R FL EA  +GQ  +  +  L G   +    ++V EYM N +L   L   + Q   ++  
Sbjct: 79  RDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLV 138
Query: 156 MRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDG--RSYS 213
             LR    IA  ++Y  S    ++ DL A  I+ + ++  ++S FGL +   D    +Y+
Sbjct: 139 GMLR---GIASGMKYL-SDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYT 194
Query: 214 TN-----LAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTL 268
           T      + +T PE +   + T  S ++S+G +L +++S    P       + ++++   
Sbjct: 195 TRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWE----MSNQDVIKA 250
Query: 269 TDSCLEGQFSSDEGTELVRLASRCLQYEPRERPNPRSLVTALVTLQKD 316
            D         D    L +L   C Q +   RP    +V+ L  L ++
Sbjct: 251 VDEGYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKLIRN 298

>pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 55/228 (24%), Positives = 100/228 (43%), Gaps = 17/228 (7%)
Query: 98  RQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAEYMPNDTLAKHLFHWETQ--PMKWA 155
           R FL EA  +GQ  +  +  L G   +    ++V EYM N +L   L   + Q   ++  
Sbjct: 91  RDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLV 150
Query: 156 MRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDG--RSYS 213
             LR    IA  ++Y  S    ++ DL A  I+ + ++  ++S FGL +   D    +Y+
Sbjct: 151 GMLR---GIASGMKYL-SDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYT 206
Query: 214 TN-----LAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTL 268
           T      + +T PE +   + T  S ++S+G +L +++S    P       + ++++   
Sbjct: 207 TRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWE----MSNQDVIKA 262
Query: 269 TDSCLEGQFSSDEGTELVRLASRCLQYEPRERPNPRSLVTALVTLQKD 316
            D         D    L +L   C Q +   RP    +V+ L  L ++
Sbjct: 263 VDEGYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKLIRN 310

>pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 55/228 (24%), Positives = 100/228 (43%), Gaps = 17/228 (7%)
Query: 98  RQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAEYMPNDTLAKHLFHWETQ--PMKWA 155
           R FL EA  +GQ  +  +  L G   +    ++V EYM N +L   L   + Q   ++  
Sbjct: 89  RDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLV 148
Query: 156 MRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDG--RSYS 213
             LR    IA  ++Y  S    ++ DL A  I+ + ++  ++S FGL +   D    +Y+
Sbjct: 149 GMLR---GIASGMKYL-SDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYT 204
Query: 214 TN-----LAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTL 268
           T      + +T PE +   + T  S ++S+G +L +++S    P       + ++++   
Sbjct: 205 TRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWE----MSNQDVIKA 260
Query: 269 TDSCLEGQFSSDEGTELVRLASRCLQYEPRERPNPRSLVTALVTLQKD 316
            D         D    L +L   C Q +   RP    +V+ L  L ++
Sbjct: 261 VDEGYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKLIRN 308

>pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 55/228 (24%), Positives = 100/228 (43%), Gaps = 17/228 (7%)
Query: 98  RQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAEYMPNDTLAKHLFHWETQ--PMKWA 155
           R FL EA  +GQ  +  +  L G   +    ++V EYM N +L   L   + Q   ++  
Sbjct: 91  RDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLV 150
Query: 156 MRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDG--RSYS 213
             LR    IA  ++Y  S    ++ DL A  I+ + ++  ++S FGL +   D    +Y+
Sbjct: 151 GMLR---GIASGMKYL-SDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYT 206
Query: 214 TN-----LAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTL 268
           T      + +T PE +   + T  S ++S+G +L +++S    P       + ++++   
Sbjct: 207 TRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWE----MSNQDVIKA 262
Query: 269 TDSCLEGQFSSDEGTELVRLASRCLQYEPRERPNPRSLVTALVTLQKD 316
            D         D    L +L   C Q +   RP    +V+ L  L ++
Sbjct: 263 VDEGYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKLIRN 310

>pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 55/228 (24%), Positives = 100/228 (43%), Gaps = 17/228 (7%)
Query: 98  RQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAEYMPNDTLAKHLFHWETQ--PMKWA 155
           R FL EA  +GQ  +  +  L G   +    ++V EYM N +L   L   + Q   ++  
Sbjct: 91  RDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLV 150
Query: 156 MRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDG--RSYS 213
             LR    IA  ++Y  S    ++ DL A  I+ + ++  ++S FGL +   D    +Y+
Sbjct: 151 GMLR---GIASGMKYL-SDMGFVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYT 206
Query: 214 TN-----LAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTL 268
           T      + +T PE +   + T  S ++S+G +L +++S    P       + ++++   
Sbjct: 207 TRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWE----MSNQDVIKA 262
Query: 269 TDSCLEGQFSSDEGTELVRLASRCLQYEPRERPNPRSLVTALVTLQKD 316
            D         D    L +L   C Q +   RP    +V+ L  L ++
Sbjct: 263 VDEGYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKLIRN 310

>pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 55/228 (24%), Positives = 100/228 (43%), Gaps = 17/228 (7%)
Query: 98  RQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAEYMPNDTLAKHLFHWETQ--PMKWA 155
           R FL EA  +GQ  +  +  L G   +    ++V EYM N +L   L   + Q   ++  
Sbjct: 91  RDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLV 150
Query: 156 MRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDG--RSYS 213
             LR    IA  ++Y  S    ++ DL A  I+ + ++  ++S FGL +   D    +Y+
Sbjct: 151 GMLR---GIASGMKYL-SDMGYVHRDLAARNILINSNLVCKVSDFGLGRVLEDDPEAAYT 206
Query: 214 TN-----LAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTL 268
           T      + +T PE +   + T  S ++S+G +L +++S    P       + ++++   
Sbjct: 207 TRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWE----MSNQDVIKA 262
Query: 269 TDSCLEGQFSSDEGTELVRLASRCLQYEPRERPNPRSLVTALVTLQKD 316
            D         D    L +L   C Q +   RP    +V+ L  L ++
Sbjct: 263 VDEGYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKLIRN 310

>pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 58/257 (22%), Positives = 106/257 (41%), Gaps = 41/257 (15%)
Query: 83  RIAVKRFNRSA----WPDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAEYMPND 138
           ++AVK     A      D    +E  + +G+ +N  + NLLG C +     ++ EY    
Sbjct: 62  KVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN--IINLLGACTQDGPLYVIVEYASKG 119
Query: 139 TLAKHLFHWETQPMKWAMR--------------LRVALHIAEALEYCTSKERALYHDLNA 184
            L ++L   E   ++++                +  A  +A  +EY  SK + ++ DL A
Sbjct: 120 NLREYLQAREPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASK-KCIHRDLAA 178
Query: 185 YRIVFDDDVNPRLSCFGLMKNSR--DGRSYSTN----LAFTPPEYLRTGRVTPESVMYSF 238
             ++  +D   +++ FGL ++    D    +TN    + +  PE L     T +S ++SF
Sbjct: 179 RNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSF 238
Query: 239 GTLLLDL--LSGK---HIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLASRCL 293
           G LL ++  L G     +P      L+++ +      +C           EL  +   C 
Sbjct: 239 GVLLWEIFTLGGSPYPGVPVEELFKLLKEGHRMDKPSNCT---------NELYMMMRDCW 289
Query: 294 QYEPRERPNPRSLVTAL 310
              P +RP  + LV  L
Sbjct: 290 HAVPSQRPTFKQLVEDL 306

>pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328

Iteration: 1
 Score = 49.7 bits (117), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 57/270 (21%), Positives = 114/270 (42%), Gaps = 19/270 (7%)
Query: 66  GEKAPNVVYKGKL-----ENQFRIAVKRFNRSAWPDAR-QFLEEARAVGQLRNRRLANLL 119
           G  A   VYKG         +  +A+K  N +  P A  +F++EA  +  + +  L  LL
Sbjct: 24  GSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRLL 83
Query: 120 GCCCEGDERLLVAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALY 179
           G C     + LV + MP+  L +++ H     +   + L   + IA+ + Y   + R ++
Sbjct: 84  GVCLSPTIQ-LVTQLMPHGCLLEYV-HEHKDNIGSQLLLNWCVQIAKGMMYLEER-RLVH 140
Query: 180 HDLNAYRIVFDDDVNPRLSCFGLMK-NSRDGRSYSTNLAFTPPEYL-----RTGRVTPES 233
            DL A  ++     + +++ FGL +    D + Y+ +    P +++        + T +S
Sbjct: 141 RDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPIKWMALECIHYRKFTHQS 200
Query: 234 VMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLASRCL 293
            ++S+G  + +L++    P     D I  R I  L +             ++  +  +C 
Sbjct: 201 DVWSYGVTIWELMTFGGKP----YDGIPTREIPDLLEKGERLPQPPICTIDVYMVMVKCW 256
Query: 294 QYEPRERPNPRSLVTALVTLQKDTELYLSL 323
             +   RP  + L      + +D + YL +
Sbjct: 257 MIDADSRPKFKELAAEFSRMARDPQRYLVI 286

>pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327

Iteration: 1
 Score = 49.7 bits (117), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 60/261 (22%), Positives = 105/261 (40%), Gaps = 32/261 (12%)
Query: 66  GEKAPNVVYKGKLENQ------FRIAVKRFNR-SAWPDARQFLEEARAVGQLRNRRLANL 118
           G  A   VY+G++          ++AVK      +  D   FL EA  + +  ++ +   
Sbjct: 39  GHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRC 98
Query: 119 LGCCCEGDERLLVAEYMPNDTLAKHLFHWE---TQPMKWAMR--LRVALHIAEALEYCTS 173
           +G   +   R ++ E M    L   L       +QP   AM   L VA  IA   +Y   
Sbjct: 99  IGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQY-LE 157
Query: 174 KERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRD---------GRSYSTNLAFTPPEYL 224
           +   ++ D+ A   +       R++  G    +RD         G      + + PPE  
Sbjct: 158 ENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPPEAF 217
Query: 225 RTGRVTPESVMYSFGTLLLDLLSGKHIP-PSHALDLIRDRNIQTLTDSCLEGQFSSDEG- 282
             G  T ++  +SFG LL ++ S  ++P PS +       N + L      G+    +  
Sbjct: 218 MEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKS-------NQEVLEFVTSGGRMDPPKNC 270
Query: 283 -TELVRLASRCLQYEPRERPN 302
              + R+ ++C Q++P +RPN
Sbjct: 271 PGPVYRIMTQCWQHQPEDRPN 291

>pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326

Iteration: 1
 Score = 49.3 bits (116), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 67/283 (23%), Positives = 115/283 (40%), Gaps = 45/283 (15%)
Query: 75  KGKLENQFRIAVKRFNRSA----WPDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLL 130
           K K     ++AVK     A      D    +E  + +G+ +N  + NLLG C +     +
Sbjct: 54  KDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN--IINLLGACTQDGPLYV 111
Query: 131 VAEYMPNDTLAKHL--------------FHWETQPMKWAMRLRVALHIAEALEYCTSKER 176
           + EY     L ++L               H   + +     +  A  +A  +EY  SK +
Sbjct: 112 IVEYASKGNLREYLQARRPPGLEYCYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASK-K 170
Query: 177 ALYHDLNAYRIVFDDDVNPRLSCFGLMKNSR--DGRSYSTN----LAFTPPEYLRTGRVT 230
            ++ DL A  ++  +D   +++ FGL ++    D    +TN    + +  PE L     T
Sbjct: 171 CIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYT 230
Query: 231 PESVMYSFGTLLLDL--LSGK---HIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTEL 285
            +S ++SFG LL ++  L G     +P      L+++ +      +C           EL
Sbjct: 231 HQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKLLKEGHRMDKPSNCT---------NEL 281
Query: 286 VRLASRCLQYEPRERPNPRSLVTAL---VTLQKDTE-LYLSLP 324
             +   C    P +RP  + LV  L   V L  + E L LS+P
Sbjct: 282 YMMMRDCWHAVPSQRPTFKQLVEDLDRIVALTSNQEYLDLSMP 324

>pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score = 49.3 bits (116), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 60/261 (22%), Positives = 105/261 (40%), Gaps = 32/261 (12%)
Query: 66  GEKAPNVVYKGKLENQ------FRIAVKRFNR-SAWPDARQFLEEARAVGQLRNRRLANL 118
           G  A   VY+G++          ++AVK      +  D   FL EA  + +  ++ +   
Sbjct: 54  GHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRC 113
Query: 119 LGCCCEGDERLLVAEYMPNDTLAKHLFHWE---TQPMKWAMR--LRVALHIAEALEYCTS 173
           +G   +   R ++ E M    L   L       +QP   AM   L VA  IA   +Y   
Sbjct: 114 IGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQY-LE 172
Query: 174 KERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRD---------GRSYSTNLAFTPPEYL 224
           +   ++ D+ A   +       R++  G    +RD         G      + + PPE  
Sbjct: 173 ENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPPEAF 232
Query: 225 RTGRVTPESVMYSFGTLLLDLLSGKHIP-PSHALDLIRDRNIQTLTDSCLEGQFSSDEG- 282
             G  T ++  +SFG LL ++ S  ++P PS +       N + L      G+    +  
Sbjct: 233 MEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKS-------NQEVLEFVTSGGRMDPPKNC 285
Query: 283 -TELVRLASRCLQYEPRERPN 302
              + R+ ++C Q++P +RPN
Sbjct: 286 PGPVYRIMTQCWQHQPEDRPN 306

>pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315

Iteration: 1
 Score = 49.3 bits (116), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 60/261 (22%), Positives = 105/261 (40%), Gaps = 32/261 (12%)
Query: 66  GEKAPNVVYKGKLENQ------FRIAVKRFNR-SAWPDARQFLEEARAVGQLRNRRLANL 118
           G  A   VY+G++          ++AVK      +  D   FL EA  + +  ++ +   
Sbjct: 31  GHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRC 90
Query: 119 LGCCCEGDERLLVAEYMPNDTLAKHLFHWE---TQPMKWAMR--LRVALHIAEALEYCTS 173
           +G   +   R ++ E M    L   L       +QP   AM   L VA  IA   +Y   
Sbjct: 91  IGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQY-LE 149
Query: 174 KERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRD---------GRSYSTNLAFTPPEYL 224
           +   ++ D+ A   +       R++  G    +RD         G      + + PPE  
Sbjct: 150 ENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPPEAF 209
Query: 225 RTGRVTPESVMYSFGTLLLDLLSGKHIP-PSHALDLIRDRNIQTLTDSCLEGQFSSDEG- 282
             G  T ++  +SFG LL ++ S  ++P PS +       N + L      G+    +  
Sbjct: 210 MEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKS-------NQEVLEFVTSGGRMDPPKNC 262
Query: 283 -TELVRLASRCLQYEPRERPN 302
              + R+ ++C Q++P +RPN
Sbjct: 263 PGPVYRIMTQCWQHQPEDRPN 283

>pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327

Iteration: 1
 Score = 49.3 bits (116), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 60/261 (22%), Positives = 105/261 (40%), Gaps = 32/261 (12%)
Query: 66  GEKAPNVVYKGKLENQ------FRIAVKRFNR-SAWPDARQFLEEARAVGQLRNRRLANL 118
           G  A   VY+G++          ++AVK      +  D   FL EA  + +  ++ +   
Sbjct: 39  GHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRC 98
Query: 119 LGCCCEGDERLLVAEYMPNDTLAKHLFHWE---TQPMKWAMR--LRVALHIAEALEYCTS 173
           +G   +   R ++ E M    L   L       +QP   AM   L VA  IA   +Y   
Sbjct: 99  IGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQY-LE 157
Query: 174 KERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRD---------GRSYSTNLAFTPPEYL 224
           +   ++ D+ A   +       R++  G    +RD         G      + + PPE  
Sbjct: 158 ENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPPEAF 217
Query: 225 RTGRVTPESVMYSFGTLLLDLLSGKHIP-PSHALDLIRDRNIQTLTDSCLEGQFSSDEG- 282
             G  T ++  +SFG LL ++ S  ++P PS +       N + L      G+    +  
Sbjct: 218 MEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKS-------NQEVLEFVTSGGRMDPPKNC 270
Query: 283 -TELVRLASRCLQYEPRERPN 302
              + R+ ++C Q++P +RPN
Sbjct: 271 PGPVYRIMTQCWQHQPEDRPN 291

>pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373

Iteration: 1
 Score = 49.3 bits (116), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 55/228 (24%), Positives = 100/228 (43%), Gaps = 17/228 (7%)
Query: 98  RQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAEYMPNDTLAKHLFHWETQ--PMKWA 155
           R FL EA  +GQ  +  +  L G   +    ++V E M N +L   L   + Q   ++  
Sbjct: 91  RDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEXMENGSLDSFLRKHDAQFTVIQLV 150
Query: 156 MRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDG--RSYS 213
             LR    IA  ++Y  S   A++ DL A  I+ + ++  ++S FGL +   D    +Y+
Sbjct: 151 GMLR---GIASGMKYL-SDMGAVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYT 206
Query: 214 TN-----LAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTL 268
           T      + +T PE +   + T  S ++S+G +L +++S    P       + ++++   
Sbjct: 207 TRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWE----MSNQDVIKA 262
Query: 269 TDSCLEGQFSSDEGTELVRLASRCLQYEPRERPNPRSLVTALVTLQKD 316
            D         D    L +L   C Q +   RP    +V+ L  L ++
Sbjct: 263 VDEGYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKLIRN 310

>pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344

Iteration: 1
 Score = 48.9 bits (115), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 60/261 (22%), Positives = 105/261 (40%), Gaps = 32/261 (12%)
Query: 66  GEKAPNVVYKGKLENQ------FRIAVKRFNR-SAWPDARQFLEEARAVGQLRNRRLANL 118
           G  A   VY+G++          ++AVK      +  D   FL EA  + +  ++ +   
Sbjct: 57  GHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRC 116
Query: 119 LGCCCEGDERLLVAEYMPNDTLAKHLFHWE---TQPMKWAMR--LRVALHIAEALEYCTS 173
           +G   +   R ++ E M    L   L       +QP   AM   L VA  IA   +Y   
Sbjct: 117 IGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQY-LE 175
Query: 174 KERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRD---------GRSYSTNLAFTPPEYL 224
           +   ++ D+ A   +       R++  G    +RD         G      + + PPE  
Sbjct: 176 ENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAGYYRKGGCAMLPVKWMPPEAF 235
Query: 225 RTGRVTPESVMYSFGTLLLDLLSGKHIP-PSHALDLIRDRNIQTLTDSCLEGQFSSDEG- 282
             G  T ++  +SFG LL ++ S  ++P PS +       N + L      G+    +  
Sbjct: 236 MEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKS-------NQEVLEFVTSGGRMDPPKNC 288
Query: 283 -TELVRLASRCLQYEPRERPN 302
              + R+ ++C Q++P +RPN
Sbjct: 289 PGPVYRIMTQCWQHQPEDRPN 309

>pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287

Iteration: 1
 Score = 48.9 bits (115), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 60/265 (22%), Positives = 112/265 (42%), Gaps = 22/265 (8%)
Query: 66  GEKAPNVVYKGKL-ENQFRIAVKRF-------NRSAWPDARQFLEEARAVGQLRNRRLAN 117
           G+    +V+KG+L +++  +A+K                 ++F  E   +  L +  +  
Sbjct: 28  GKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVK 87
Query: 118 LLGCCCEGDERLLVAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERA 177
           L G     +   +V E++P   L   L   +  P+KW+++LR+ L IA  +EY  ++   
Sbjct: 88  LYGLMH--NPPRMVMEFVPCGDLYHRLLD-KAHPIKWSVKLRLMLDIALGIEYMQNQNPP 144
Query: 178 LYH-DLNAYRIVFD--DDVNP---RLSCFGLMKNSRDGRS-YSTNLAFTPPEYLRTGR-- 228
           + H DL +  I     D+  P   +++ FGL + S    S    N  +  PE +      
Sbjct: 145 IVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQQSVHSVSGLLGNFQWMAPETIGAEEES 204
Query: 229 VTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRL 288
            T ++  YSF  +L  +L+G+   P       + + I  + +  L      D    L  +
Sbjct: 205 YTEKADTYSFAMILYTILTGEG--PFDEYSYGKIKFINMIREEGLRPTIPEDCPPRLRNV 262
Query: 289 ASRCLQYEPRERPNPRSLVTALVTL 313
              C   +P++RP+   +V  L  L
Sbjct: 263 IELCWSGDPKKRPHFSYIVKELSEL 287

>pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344

Iteration: 1
 Score = 48.9 bits (115), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 60/261 (22%), Positives = 105/261 (40%), Gaps = 32/261 (12%)
Query: 66  GEKAPNVVYKGKLENQ------FRIAVKRFNR-SAWPDARQFLEEARAVGQLRNRRLANL 118
           G  A   VY+G++          ++AVK      +  D   FL EA  + +  ++ +   
Sbjct: 56  GHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRC 115
Query: 119 LGCCCEGDERLLVAEYMPNDTLAKHLFHWE---TQPMKWAMR--LRVALHIAEALEYCTS 173
           +G   +   R ++ E M    L   L       +QP   AM   L VA  IA   +Y   
Sbjct: 116 IGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQY-LE 174
Query: 174 KERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRD---------GRSYSTNLAFTPPEYL 224
           +   ++ D+ A   +       R++  G    +RD         G      + + PPE  
Sbjct: 175 ENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPPEAF 234
Query: 225 RTGRVTPESVMYSFGTLLLDLLSGKHIP-PSHALDLIRDRNIQTLTDSCLEGQFSSDEG- 282
             G  T ++  +SFG LL ++ S  ++P PS +       N + L      G+    +  
Sbjct: 235 MEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKS-------NQEVLEFVTSGGRMDPPKNC 287
Query: 283 -TELVRLASRCLQYEPRERPN 302
              + R+ ++C Q++P +RPN
Sbjct: 288 PGPVYRIMTQCWQHQPEDRPN 308

>pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367

Iteration: 1
 Score = 48.9 bits (115), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 60/261 (22%), Positives = 105/261 (40%), Gaps = 32/261 (12%)
Query: 66  GEKAPNVVYKGKLENQ------FRIAVKRFNR-SAWPDARQFLEEARAVGQLRNRRLANL 118
           G  A   VY+G++          ++AVK      +  D   FL EA  + +  ++ +   
Sbjct: 80  GHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRC 139
Query: 119 LGCCCEGDERLLVAEYMPNDTLAKHLFHWE---TQPMKWAMR--LRVALHIAEALEYCTS 173
           +G   +   R ++ E M    L   L       +QP   AM   L VA  IA   +Y   
Sbjct: 140 IGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQY-LE 198
Query: 174 KERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRD---------GRSYSTNLAFTPPEYL 224
           +   ++ D+ A   +       R++  G    +RD         G      + + PPE  
Sbjct: 199 ENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAGYYRKGGCAMLPVKWMPPEAF 258
Query: 225 RTGRVTPESVMYSFGTLLLDLLSGKHIP-PSHALDLIRDRNIQTLTDSCLEGQFSSDEG- 282
             G  T ++  +SFG LL ++ S  ++P PS +       N + L      G+    +  
Sbjct: 259 MEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKS-------NQEVLEFVTSGGRMDPPKNC 311
Query: 283 -TELVRLASRCLQYEPRERPN 302
              + R+ ++C Q++P +RPN
Sbjct: 312 PGPVYRIMTQCWQHQPEDRPN 332

>pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291

Iteration: 1
 Score = 48.9 bits (115), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 62/255 (24%), Positives = 103/255 (40%), Gaps = 24/255 (9%)
Query: 84  IAVKRFNRSAWPDARQ-FLEEARAVGQLRNRRLANLLGCCCEGDER--LLVAEYMPNDTL 140
           +AVK       P  R  +  E   +  L +  +    GCC +  E+   LV EY+P  +L
Sbjct: 41  VAVKALKEGCGPQLRSGWQREIEILRTLYHEHIVKYKGCCEDQGEKSVQLVMEYVPLGSL 100
Query: 141 AKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCF 200
             +L       +  A  L  A  I E + Y  + +  ++  L A  ++ D+D   ++  F
Sbjct: 101 RDYL---PRHCVGLAQLLLFAQQICEGMAYLHA-QHYIHRALAARNVLLDNDRLVKIGDF 156
Query: 201 GLMKNSRDGRSY-------STNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLS---GKH 250
           GL K   +G  Y        + + +  PE L+  +    S ++SFG  L +LL+      
Sbjct: 157 GLAKAVPEGHEYYRVREDGDSPVFWYAPECLKECKFYYASDVWSFGVTLYELLTYCDSNQ 216
Query: 251 IPPSHALDLIRDRNIQT----LTDSCLEGQFSSDEG---TELVRLASRCLQYEPRERPNP 303
            P +   +LI     Q     LT+    G+          E+  L   C + E   RP  
Sbjct: 217 SPHTKFTELIGHTQGQMTVLRLTELLERGERLPRPDRCPCEIYHLMKNCWETEASFRPTF 276
Query: 304 RSLVTALVTLQKDTE 318
           ++LV  L T Q+  +
Sbjct: 277 QNLVPILQTAQEKYQ 291

>pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290

Iteration: 1
 Score = 48.9 bits (115), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 62/255 (24%), Positives = 103/255 (40%), Gaps = 24/255 (9%)
Query: 84  IAVKRFNRSAWPDARQ-FLEEARAVGQLRNRRLANLLGCCCEGDER--LLVAEYMPNDTL 140
           +AVK       P  R  +  E   +  L +  +    GCC +  E+   LV EY+P  +L
Sbjct: 40  VAVKALKEGCGPQLRSGWQREIEILRTLYHEHIVKYKGCCEDQGEKSVQLVMEYVPLGSL 99
Query: 141 AKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCF 200
             +L       +  A  L  A  I E + Y  + +  ++  L A  ++ D+D   ++  F
Sbjct: 100 RDYL---PRHCVGLAQLLLFAQQICEGMAYLHA-QHYIHRALAARNVLLDNDRLVKIGDF 155
Query: 201 GLMKNSRDGRSY-------STNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLS---GKH 250
           GL K   +G  Y        + + +  PE L+  +    S ++SFG  L +LL+      
Sbjct: 156 GLAKAVPEGHEYYRVREDGDSPVFWYAPECLKECKFYYASDVWSFGVTLYELLTYCDSNQ 215
Query: 251 IPPSHALDLIRDRNIQT----LTDSCLEGQFSSDEG---TELVRLASRCLQYEPRERPNP 303
            P +   +LI     Q     LT+    G+          E+  L   C + E   RP  
Sbjct: 216 SPHTKFTELIGHTQGQMTVLRLTELLERGERLPRPDRCPCEIYHLMKNCWETEASFRPTF 275
Query: 304 RSLVTALVTLQKDTE 318
           ++LV  L T Q+  +
Sbjct: 276 QNLVPILQTAQEKYQ 290

>pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327

Iteration: 1
 Score = 48.9 bits (115), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 60/261 (22%), Positives = 105/261 (40%), Gaps = 32/261 (12%)
Query: 66  GEKAPNVVYKGKLENQ------FRIAVKRFNR-SAWPDARQFLEEARAVGQLRNRRLANL 118
           G  A   VY+G++          ++AVK      +  D   FL EA  + +  ++ +   
Sbjct: 40  GHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRC 99
Query: 119 LGCCCEGDERLLVAEYMPNDTLAKHLFHWE---TQPMKWAMR--LRVALHIAEALEYCTS 173
           +G   +   R ++ E M    L   L       +QP   AM   L VA  IA   +Y   
Sbjct: 100 IGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQY-LE 158
Query: 174 KERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRD---------GRSYSTNLAFTPPEYL 224
           +   ++ D+ A   +       R++  G    +RD         G      + + PPE  
Sbjct: 159 ENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPPEAF 218
Query: 225 RTGRVTPESVMYSFGTLLLDLLSGKHIP-PSHALDLIRDRNIQTLTDSCLEGQFSSDEG- 282
             G  T ++  +SFG LL ++ S  ++P PS +       N + L      G+    +  
Sbjct: 219 MEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKS-------NQEVLEFVTSGGRMDPPKNC 271
Query: 283 -TELVRLASRCLQYEPRERPN 302
              + R+ ++C Q++P +RPN
Sbjct: 272 PGPVYRIMTQCWQHQPEDRPN 292

>pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333

Iteration: 1
 Score = 48.5 bits (114), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 60/261 (22%), Positives = 105/261 (40%), Gaps = 32/261 (12%)
Query: 66  GEKAPNVVYKGKLENQ------FRIAVKRFNR-SAWPDARQFLEEARAVGQLRNRRLANL 118
           G  A   VY+G++          ++AVK      +  D   FL EA  + +  ++ +   
Sbjct: 46  GHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRC 105
Query: 119 LGCCCEGDERLLVAEYMPNDTLAKHLFHWE---TQPMKWAMR--LRVALHIAEALEYCTS 173
           +G   +   R ++ E M    L   L       +QP   AM   L VA  IA   +Y   
Sbjct: 106 IGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQY-LE 164
Query: 174 KERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRD---------GRSYSTNLAFTPPEYL 224
           +   ++ D+ A   +       R++  G    +RD         G      + + PPE  
Sbjct: 165 ENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPPEAF 224
Query: 225 RTGRVTPESVMYSFGTLLLDLLSGKHIP-PSHALDLIRDRNIQTLTDSCLEGQFSSDEG- 282
             G  T ++  +SFG LL ++ S  ++P PS +       N + L      G+    +  
Sbjct: 225 MEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKS-------NQEVLEFVTSGGRMDPPKNC 277
Query: 283 -TELVRLASRCLQYEPRERPN 302
              + R+ ++C Q++P +RPN
Sbjct: 278 PGPVYRIMTQCWQHQPEDRPN 298

>pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score = 48.5 bits (114), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 60/261 (22%), Positives = 105/261 (40%), Gaps = 32/261 (12%)
Query: 66  GEKAPNVVYKGKLENQ------FRIAVKRFNRS-AWPDARQFLEEARAVGQLRNRRLANL 118
           G  A   VY+G++          ++AVK      +  D   FL EA  + +  ++ +   
Sbjct: 54  GHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVYSEQDELDFLMEALIISKFNHQNIVRC 113
Query: 119 LGCCCEGDERLLVAEYMPNDTLAKHLFHWE---TQPMKWAMR--LRVALHIAEALEYCTS 173
           +G   +   R ++ E M    L   L       +QP   AM   L VA  IA   +Y   
Sbjct: 114 IGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQY-LE 172
Query: 174 KERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRD---------GRSYSTNLAFTPPEYL 224
           +   ++ D+ A   +       R++  G    +RD         G      + + PPE  
Sbjct: 173 ENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPPEAF 232
Query: 225 RTGRVTPESVMYSFGTLLLDLLSGKHIP-PSHALDLIRDRNIQTLTDSCLEGQFSSDEG- 282
             G  T ++  +SFG LL ++ S  ++P PS +       N + L      G+    +  
Sbjct: 233 MEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKS-------NQEVLEFVTSGGRMDPPKNC 285
Query: 283 -TELVRLASRCLQYEPRERPN 302
              + R+ ++C Q++P +RPN
Sbjct: 286 PGPVYRIMTQCWQHQPEDRPN 306

>pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382

Iteration: 1
 Score = 48.1 bits (113), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 61/269 (22%), Positives = 109/269 (40%), Gaps = 44/269 (16%)
Query: 83  RIAVKRFNRSA----WPDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAEYMPND 138
           ++AVK     A      D    +E  + +G+ +N  + NLLG C +     ++ EY    
Sbjct: 103 KVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN--IINLLGACTQDGPLYVIVEYASKG 160
Query: 139 TLAKHL--------------FHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNA 184
            L ++L               H   + +     +  A  +A  +EY  SK + ++ DL A
Sbjct: 161 NLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASK-KCIHRDLAA 219
Query: 185 YRIVFDDDVNPRLSCFGLMKNSR--DGRSYSTN----LAFTPPEYLRTGRVTPESVMYSF 238
             ++  +D   +++ FGL ++    D    +TN    + +  PE L     T +S ++SF
Sbjct: 220 RNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSF 279
Query: 239 GTLLLDL--LSGK---HIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLASRCL 293
           G LL ++  L G     +P      L+++ +      +C           EL  +   C 
Sbjct: 280 GVLLWEIFTLGGSPYPGVPVEELFKLLKEGHRMDKPSNCT---------NELYMMMRDCW 330
Query: 294 QYEPRERPNPRSLVTAL---VTLQKDTEL 319
              P +RP  + LV  L   V L  + E+
Sbjct: 331 HAVPSQRPTFKQLVEDLDRIVALTSNQEM 359

>pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353

Iteration: 1
 Score = 48.1 bits (113), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 60/261 (22%), Positives = 105/261 (40%), Gaps = 32/261 (12%)
Query: 66  GEKAPNVVYKGKLENQ------FRIAVKRFNRS-AWPDARQFLEEARAVGQLRNRRLANL 118
           G  A   VY+G++          ++AVK      +  D   FL EA  + +  ++ +   
Sbjct: 66  GHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRC 125
Query: 119 LGCCCEGDERLLVAEYMPNDTLAKHLFHWE---TQPMKWAMR--LRVALHIAEALEYCTS 173
           +G   +   R ++ E M    L   L       +QP   AM   L VA  IA   +Y   
Sbjct: 126 IGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYL-E 184
Query: 174 KERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRD---------GRSYSTNLAFTPPEYL 224
           +   ++ D+ A   +       R++  G    +RD         G      + + PPE  
Sbjct: 185 ENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPPEAF 244
Query: 225 RTGRVTPESVMYSFGTLLLDLLSGKHIP-PSHALDLIRDRNIQTLTDSCLEGQFSSDEG- 282
             G  T ++  +SFG LL ++ S  ++P PS +       N + L      G+    +  
Sbjct: 245 MEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKS-------NQEVLEFVTSGGRMDPPKNC 297
Query: 283 -TELVRLASRCLQYEPRERPN 302
              + R+ ++C Q++P +RPN
Sbjct: 298 PGPVYRIMTQCWQHQPEDRPN 318

>pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317

Iteration: 1
 Score = 48.1 bits (113), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 58/257 (22%), Positives = 104/257 (40%), Gaps = 41/257 (15%)
Query: 83  RIAVKRFNRSA----WPDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAEYMPND 138
           ++AVK     A      D    +E  + +G+ +N  + NLLG C +     ++ EY    
Sbjct: 62  KVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN--IINLLGACTQDGPLYVIVEYASKG 119
Query: 139 TLAKHL--------------FHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNA 184
            L ++L               H   + +     +  A  +A  +EY  SK + ++ DL A
Sbjct: 120 NLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASK-KCIHRDLAA 178
Query: 185 YRIVFDDDVNPRLSCFGLMKNSR--DGRSYSTN----LAFTPPEYLRTGRVTPESVMYSF 238
             ++  +D   +++ FGL ++    D    +TN    + +  PE L     T +S ++SF
Sbjct: 179 RNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSF 238
Query: 239 GTLLLDL--LSGK---HIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLASRCL 293
           G LL ++  L G     +P      L+++ +      +C           EL  +   C 
Sbjct: 239 GVLLWEIFTLGGSPYPGVPVEELFKLLKEGHRMDKPSNCT---------NELYMMMRDCW 289
Query: 294 QYEPRERPNPRSLVTAL 310
              P +RP  + LV  L
Sbjct: 290 HAVPSQRPTFKQLVEDL 306

>pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309

Iteration: 1
 Score = 48.1 bits (113), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 58/257 (22%), Positives = 104/257 (40%), Gaps = 41/257 (15%)
Query: 83  RIAVKRFNRSA----WPDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAEYMPND 138
           ++AVK     A      D    +E  + +G+ +N  + NLLG C +     ++ EY    
Sbjct: 54  KVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN--IINLLGACTQDGPLYVIVEYASKG 111
Query: 139 TLAKHL--------------FHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNA 184
            L ++L               H   + +     +  A  +A  +EY  SK + ++ DL A
Sbjct: 112 NLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASK-KCIHRDLAA 170
Query: 185 YRIVFDDDVNPRLSCFGLMKNSR--DGRSYSTN----LAFTPPEYLRTGRVTPESVMYSF 238
             ++  +D   +++ FGL ++    D    +TN    + +  PE L     T +S ++SF
Sbjct: 171 RNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSF 230
Query: 239 GTLLLDL--LSGK---HIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLASRCL 293
           G LL ++  L G     +P      L+++ +      +C           EL  +   C 
Sbjct: 231 GVLLWEIFTLGGSPYPGVPVEELFKLLKEGHRMDKPSNCT---------NELYMMMRDCW 281
Query: 294 QYEPRERPNPRSLVTAL 310
              P +RP  + LV  L
Sbjct: 282 HAVPSQRPTFKQLVEDL 298

>pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306

Iteration: 1
 Score = 48.1 bits (113), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 58/257 (22%), Positives = 104/257 (40%), Gaps = 41/257 (15%)
Query: 83  RIAVKRFNRSA----WPDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAEYMPND 138
           ++AVK     A      D    +E  + +G+ +N  + NLLG C +     ++ EY    
Sbjct: 51  KVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN--IINLLGACTQDGPLYVIVEYASKG 108
Query: 139 TLAKHL--------------FHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNA 184
            L ++L               H   + +     +  A  +A  +EY  SK + ++ DL A
Sbjct: 109 NLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASK-KCIHRDLAA 167
Query: 185 YRIVFDDDVNPRLSCFGLMKNSR--DGRSYSTN----LAFTPPEYLRTGRVTPESVMYSF 238
             ++  +D   +++ FGL ++    D    +TN    + +  PE L     T +S ++SF
Sbjct: 168 RNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSF 227
Query: 239 GTLLLDL--LSGK---HIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLASRCL 293
           G LL ++  L G     +P      L+++ +      +C           EL  +   C 
Sbjct: 228 GVLLWEIFTLGGSPYPGVPVEELFKLLKEGHRMDKPSNCT---------NELYMMMRDCW 278
Query: 294 QYEPRERPNPRSLVTAL 310
              P +RP  + LV  L
Sbjct: 279 HAVPSQRPTFKQLVEDL 295

>pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310

Iteration: 1
 Score = 47.8 bits (112), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 58/257 (22%), Positives = 104/257 (40%), Gaps = 41/257 (15%)
Query: 83  RIAVKRFNRSA----WPDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAEYMPND 138
           ++AVK     A      D    +E  + +G+ +N  + NLLG C +     ++ EY    
Sbjct: 55  KVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN--IINLLGACTQDGPLYVIVEYASKG 112
Query: 139 TLAKHL--------------FHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNA 184
            L ++L               H   + +     +  A  +A  +EY  SK + ++ DL A
Sbjct: 113 NLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASK-KCIHRDLAA 171
Query: 185 YRIVFDDDVNPRLSCFGLMKNSR--DGRSYSTN----LAFTPPEYLRTGRVTPESVMYSF 238
             ++  +D   +++ FGL ++    D    +TN    + +  PE L     T +S ++SF
Sbjct: 172 RNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSF 231
Query: 239 GTLLLDL--LSGK---HIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLASRCL 293
           G LL ++  L G     +P      L+++ +      +C           EL  +   C 
Sbjct: 232 GVLLWEIFTLGGSPYPGVPVEELFKLLKEGHRMDKPSNCT---------NELYMMMRDCW 282
Query: 294 QYEPRERPNPRSLVTAL 310
              P +RP  + LV  L
Sbjct: 283 HAVPSQRPTFKQLVEDL 299

>pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327

Iteration: 1
 Score = 47.8 bits (112), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 62/262 (23%), Positives = 105/262 (40%), Gaps = 34/262 (12%)
Query: 66  GEKAPNVVYKGKLENQ------FRIAVKRFNR-SAWPDARQFLEEARAVGQLRNRRLANL 118
           G  A   VY+G++          ++AVK      +  D   FL EA  + +  ++ +   
Sbjct: 40  GHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRC 99
Query: 119 LGCCCEGDERLLVAEYMPNDTLAKHLFHWE---TQPMKWAMR--LRVALHIAEALEYCTS 173
           +G   +   R ++ E M    L   L       +QP   AM   L VA  IA   +Y   
Sbjct: 100 IGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYL-- 157
Query: 174 KERALYHDLNAYRIVFDDDVNP----RLSCFGLMKN------SRDGRSYSTNLAFTPPEY 223
           +E    H   A R        P    ++  FG+ ++       R G      + + PPE 
Sbjct: 158 EENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMAQDIYRASYYRKGGCAMLPVKWMPPEA 217
Query: 224 LRTGRVTPESVMYSFGTLLLDLLSGKHIP-PSHALDLIRDRNIQTLTDSCLEGQFSSDEG 282
              G  T ++  +SFG LL ++ S  ++P PS +       N + L      G+    + 
Sbjct: 218 FMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKS-------NQEVLEFVTSGGRMDPPKN 270
Query: 283 --TELVRLASRCLQYEPRERPN 302
               + R+ ++C Q++P +RPN
Sbjct: 271 CPGPVYRIMTQCWQHQPEDRPN 292

>pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302

Iteration: 1
 Score = 47.8 bits (112), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 60/265 (22%), Positives = 106/265 (40%), Gaps = 41/265 (15%)
Query: 75  KGKLENQFRIAVKRFNRSA----WPDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLL 130
           K K     ++AVK     A      D    +E  + +G+ +N  + NLLG C +     +
Sbjct: 39  KDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN--IINLLGACTQDGPLYV 96
Query: 131 VAEYMPNDTLAKHL--------------FHWETQPMKWAMRLRVALHIAEALEYCTSKER 176
           + EY     L ++L               H   + +     +  A  +A  +EY  SK +
Sbjct: 97  IVEYASKGNLREYLQARRPPGLEYCYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASK-K 155
Query: 177 ALYHDLNAYRIVFDDDVNPRLSCFGLMKNSR--DGRSYSTN----LAFTPPEYLRTGRVT 230
            ++ DL A  ++  +D   +++ FGL ++    D    +TN    + +  PE L     T
Sbjct: 156 CIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYT 215
Query: 231 PESVMYSFGTLLLDL--LSGK---HIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTEL 285
            +S ++SFG LL ++  L G     +P      L+++ +      +C           EL
Sbjct: 216 HQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKLLKEGHRMDKPSNCT---------NEL 266
Query: 286 VRLASRCLQYEPRERPNPRSLVTAL 310
             +   C    P +RP  + LV  L
Sbjct: 267 YMMMRDCWHAVPSQRPTFKQLVEDL 291

>pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318

Iteration: 1
 Score = 47.4 bits (111), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 57/225 (25%), Positives = 96/225 (42%), Gaps = 23/225 (10%)
Query: 98  RQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAEYMPNDTLAKHLFHWETQ--PMKWA 155
           R FL EA  +GQ  +  + +L G    G   ++V E+M N  L   L   + Q   ++  
Sbjct: 89  RDFLCEASIMGQFDHPNVVHLEGVVTRGKPVMIVIEFMENGALDAFLRKHDGQFTVIQLV 148
Query: 156 MRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDG--RSYS 213
             LR    IA  + Y       ++ DL A  I+ + ++  ++S FGL +   D     Y+
Sbjct: 149 GMLR---GIAAGMRYLADMG-YVHRDLAARNILVNSNLVCKVSDFGLSRVIEDDPEAVYT 204
Query: 214 TN-----LAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTL 268
           T      + +T PE ++  + T  S ++S+G ++ +++S    P         D + Q +
Sbjct: 205 TTGGKIPVRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERP-------YWDMSNQDV 257
Query: 269 TDSCLEGQ---FSSDEGTELVRLASRCLQYEPRERPNPRSLVTAL 310
             +  EG       D    L +L   C Q E  ERP    +V  L
Sbjct: 258 IKAIEEGYRLPAPMDCPAGLHQLMLDCWQKERAERPKFEQIVGIL 302

>pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312

Iteration: 1
 Score = 47.4 bits (111), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 40/161 (24%), Positives = 79/161 (49%), Gaps = 15/161 (9%)
Query: 98  RQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAEYMPNDTLAKHLFHWETQ--PMKWA 155
           R FL EA  +GQ  +  + +L G   +    +++ E+M N +L   L   + Q   ++  
Sbjct: 79  RDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQNDGQFTVIQLV 138
Query: 156 MRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDGRS---Y 212
             LR    IA  ++Y  +    ++ DL A  I+ + ++  ++S FGL +   D  S   Y
Sbjct: 139 GMLR---GIAAGMKYL-ADMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTY 194
Query: 213 STNLA------FTPPEYLRTGRVTPESVMYSFGTLLLDLLS 247
           ++ L       +T PE ++  + T  S ++S+G ++ +++S
Sbjct: 195 TSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMS 235

>pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334

Iteration: 1
 Score = 47.4 bits (111), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 66/283 (23%), Positives = 118/283 (41%), Gaps = 45/283 (15%)
Query: 73  VYKGKLENQFRIAVKRFNRSA----WPDARQFLEEARAVGQLRNRRLANLLGCCCEGDER 128
           + K K +    +AVK     A      D    +E  + +G+ +N  + NLLG C +    
Sbjct: 59  IDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN--IINLLGACTQDGPL 116
Query: 129 LLVAEYMPNDTLAKHLFHWETQPMKWAMRL-RV-------------ALHIAEALEYCTSK 174
            ++ EY     L ++L       M+++  + RV                +A  +EY  S 
Sbjct: 117 YVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLAS- 175
Query: 175 ERALYHDLNAYRIVFDDDVNPRLSCFGLMK--NSRDGRSYSTN----LAFTPPEYLRTGR 228
           ++ ++ DL A  ++  ++   +++ FGL +  N+ D    +TN    + +  PE L    
Sbjct: 176 QKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDXXKKTTNGRLPVKWMAPEALFDRV 235
Query: 229 VTPESVMYSFGTLLLDL--LSGK---HIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGT 283
            T +S ++SFG L+ ++  L G     IP      L+++ +      +C           
Sbjct: 236 YTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFKLLKEGHRMDKPANCT---------N 286
Query: 284 ELVRLASRCLQYEPRERPNPRSLVTAL---VTLQKDTELYLSL 323
           EL  +   C    P +RP  + LV  L   +TL  + E YL L
Sbjct: 287 ELYMMMRDCWHAVPSQRPTFKQLVEDLDRILTLTTNEE-YLDL 328

>pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317

Iteration: 1
 Score = 47.4 bits (111), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 50/251 (19%), Positives = 105/251 (41%), Gaps = 20/251 (7%)
Query: 76  GKLENQFRIAVKRFNRSAWPDARQ-FLEEARAVGQL-RNRRLANLLGCCCEGDERLLVAE 133
           GK +   ++AVK    +A  D ++  + E + +  L ++  + NLLG C  G   L++ E
Sbjct: 63  GKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGACTHGGPVLVITE 122
Query: 134 YMPNDTLAKHLFHW--------ETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAY 185
           Y     L   L           + +P++    L  +  +A+ + +  SK   ++ D+ A 
Sbjct: 123 YCCYGDLLNFLRRKAEADLDKEDGRPLELRDLLHFSSQVAQGMAFLASK-NCIHRDVAAR 181
Query: 186 RIVFDDDVNPRLSCFGLMKNSRDGRSYSTN------LAFTPPEYLRTGRVTPESVMYSFG 239
            ++  +    ++  FGL ++  +  +Y         + +  PE +     T +S ++S+G
Sbjct: 182 NVLLTNGHVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYG 241
Query: 240 TLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLASRCLQYEPRE 299
            LL ++ S    P  +   L+  +  + + D     Q  +     +  +   C   EP  
Sbjct: 242 ILLWEIFSLGLNP--YPGILVNSKFYKLVKDGYQMAQ-PAFAPKNIYSIMQACWALEPTH 298
Query: 300 RPNPRSLVTAL 310
           RP  + + + L
Sbjct: 299 RPTFQQICSFL 309

>pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576

Iteration: 1
 Score = 47.4 bits (111), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 48/203 (23%), Positives = 86/203 (42%), Gaps = 6/203 (2%)
Query: 101 LEEARAVGQLRNRRLANLLGCCCEGDERLLVAEYMPNDTLAKHLFHWETQPMKWAMRLRV 160
           L E + + ++ +R + +L       D   LV   M    L  H++H        A  +  
Sbjct: 232 LNEKQILEKVNSRFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFY 291
Query: 161 ALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDGRSYS---TNLA 217
           A  I   LE    +ER +Y DL    I+ DD  + R+S  GL  +  +G++       + 
Sbjct: 292 AAEICCGLED-LHRERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQTIKGRVGTVG 350
Query: 218 FTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQF 277
           +  PE ++  R T     ++ G LL ++++G+  P       I+   ++ L     E ++
Sbjct: 351 YMAPEVVKNERYTFSPDWWALGCLLYEMIAGQS-PFQQRKKKIKREEVERLVKEVPE-EY 408
Query: 278 SSDEGTELVRLASRCLQYEPRER 300
           S     +   L S+ L  +P ER
Sbjct: 409 SERFSPQARSLCSQLLCKDPAER 431

>pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 47.0 bits (110), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 61/267 (22%), Positives = 110/267 (41%), Gaps = 41/267 (15%)
Query: 73  VYKGKLENQFRIAVKRFNRSA----WPDARQFLEEARAVGQLRNRRLANLLGCCCEGDER 128
           + K K +    +AVK     A      D    +E  + +G+ +N  + NLLG C +    
Sbjct: 59  IDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN--IINLLGACTQDGPL 116
Query: 129 LLVAEYMPNDTLAKHLFHWETQPMKWAMRL-RV-------------ALHIAEALEYCTSK 174
            ++ EY     L ++L       M+++  + RV                +A  +EY  S 
Sbjct: 117 YVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLAS- 175
Query: 175 ERALYHDLNAYRIVFDDDVNPRLSCFGLMK--NSRDGRSYSTN----LAFTPPEYLRTGR 228
           ++ ++ DL A  ++  ++   R++ FGL +  N+ D    +TN    + +  PE L    
Sbjct: 176 QKCIHRDLAARNVLVTENNVMRIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRV 235
Query: 229 VTPESVMYSFGTLLLDL--LSGK---HIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGT 283
            T +S ++SFG L+ ++  L G     IP      L+++ +      +C           
Sbjct: 236 YTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFKLLKEGHRMDKPANCT---------N 286
Query: 284 ELVRLASRCLQYEPRERPNPRSLVTAL 310
           EL  +   C    P +RP  + LV  L
Sbjct: 287 ELYMMMRDCWHAVPSQRPTFKQLVEDL 313

>pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325

Iteration: 1
 Score = 47.0 bits (110), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 42/159 (26%), Positives = 74/159 (46%), Gaps = 13/159 (8%)
Query: 98  RQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAEYMPNDTLAKHLFHWETQ--PMKWA 155
           R FL EA  +GQ  +  +  L G    G   ++V EYM N +L   L   + Q   M+  
Sbjct: 95  RDFLSEASIMGQFDHPNIIRLEGVVTRGRLAMIVTEYMENGSLDTFLRTHDGQFTIMQLV 154
Query: 156 MRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRD--GRSYS 213
             LR    +   + Y  S    ++ DL A  ++ D ++  ++S FGL +   D    +Y+
Sbjct: 155 GMLR---GVGAGMRYL-SDLGYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAYT 210
Query: 214 TN-----LAFTPPEYLRTGRVTPESVMYSFGTLLLDLLS 247
           T      + +T PE +     +  S ++SFG ++ ++L+
Sbjct: 211 TTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLA 249

>pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344

Iteration: 1
 Score = 47.0 bits (110), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 54/228 (23%), Positives = 99/228 (43%), Gaps = 17/228 (7%)
Query: 98  RQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAEYMPNDTLAKHLFHWETQ--PMKWA 155
           R FL EA  +GQ  +  +  L G   +    ++V E M N +L   L   + Q   ++  
Sbjct: 62  RDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEXMENGSLDSFLRKHDAQFTVIQLV 121
Query: 156 MRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDG--RSYS 213
             LR    IA  ++Y  S    ++ DL A  I+ + ++  ++S FGL +   D    +Y+
Sbjct: 122 GMLR---GIASGMKYL-SDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYT 177
Query: 214 TN-----LAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTL 268
           T      + +T PE +   + T  S ++S+G +L +++S    P       + ++++   
Sbjct: 178 TRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWE----MSNQDVIKA 233
Query: 269 TDSCLEGQFSSDEGTELVRLASRCLQYEPRERPNPRSLVTALVTLQKD 316
            D         D    L +L   C Q +   RP    +V+ L  L ++
Sbjct: 234 VDEGYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKLIRN 281

>pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313

Iteration: 1
 Score = 47.0 bits (110), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 59/261 (22%), Positives = 109/261 (41%), Gaps = 32/261 (12%)
Query: 66  GEKAPNVVYKGKLENQ----FRIAVK--RFNRSAWPDARQFLEEARAVGQLRNRRLANLL 119
           GE     V +G L+ +     ++AVK  + + S+  +  +FL EA  +    +  +  LL
Sbjct: 43  GEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLL 102
Query: 120 GCCCEGDER-----LLVAEYMPNDTLAKHLFH--WETQPMKWAMR--LRVALHIAEALEY 170
           G C E   +     +++  +M    L  +L +   ET P    ++  L+  + IA  +EY
Sbjct: 103 GVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEY 162
Query: 171 CTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKN------SRDGRSYSTNLAFTPPEYL 224
            +++   L+ DL A   +  DD+   ++ FGL K        R GR     + +   E L
Sbjct: 163 LSNRN-FLHRDLAARNCMLRDDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESL 221
Query: 225 RTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEG---QFSSDE 281
                T +S +++FG  + ++ +    P     +         + D  L G   +   D 
Sbjct: 222 ADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQN-------HEMYDYLLHGHRLKQPEDC 274
Query: 282 GTELVRLASRCLQYEPRERPN 302
             EL  +   C + +P +RP 
Sbjct: 275 LDELYEIMYSCWRTDPLDRPT 295

>pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 59/265 (22%), Positives = 111/265 (41%), Gaps = 22/265 (8%)
Query: 66  GEKAPNVVYKGKL-ENQFRIAVKRF-------NRSAWPDARQFLEEARAVGQLRNRRLAN 117
           G+    +V+KG+L +++  +A+K                 ++F  E   +  L +  +  
Sbjct: 28  GKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVK 87
Query: 118 LLGCCCEGDERLLVAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERA 177
           L G     +   +V E++P   L   L   +  P+KW+++LR+ L IA  +EY  ++   
Sbjct: 88  LYGLMH--NPPRMVMEFVPCGDLYHRLLD-KAHPIKWSVKLRLMLDIALGIEYMQNQNPP 144
Query: 178 LYH-DLNAYRIVFD--DDVNP---RLSCFGLMKNSRDGRS-YSTNLAFTPPEYLRTGR-- 228
           + H DL +  I     D+  P   +++ FG  + S    S    N  +  PE +      
Sbjct: 145 IVHRDLRSPNIFLQSLDENAPVCAKVADFGTSQQSVHSVSGLLGNFQWMAPETIGAEEES 204
Query: 229 VTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRL 288
            T ++  YSF  +L  +L+G+   P       + + I  + +  L      D    L  +
Sbjct: 205 YTEKADTYSFAMILYTILTGEG--PFDEYSYGKIKFINMIREEGLRPTIPEDCPPRLRNV 262
Query: 289 ASRCLQYEPRERPNPRSLVTALVTL 313
              C   +P++RP+   +V  L  L
Sbjct: 263 IELCWSGDPKKRPHFSYIVKELSEL 287

>pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 48/203 (23%), Positives = 86/203 (42%), Gaps = 6/203 (2%)
Query: 101 LEEARAVGQLRNRRLANLLGCCCEGDERLLVAEYMPNDTLAKHLFHWETQPMKWAMRLRV 160
           L E + + ++ +R + +L       D   LV   M    L  H++H        A  +  
Sbjct: 232 LNEKQILEKVNSRFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFY 291
Query: 161 ALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDGRSYS---TNLA 217
           A  I   LE    +ER +Y DL    I+ DD  + R+S  GL  +  +G++       + 
Sbjct: 292 AAEICCGLED-LHRERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQTIKGRVGTVG 350
Query: 218 FTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQF 277
           +  PE ++  R T     ++ G LL ++++G+  P       I+   ++ L     E ++
Sbjct: 351 YMAPEVVKNERYTFSPDWWALGCLLYEMIAGQS-PFQQRKKKIKREEVERLVKEVPE-EY 408
Query: 278 SSDEGTELVRLASRCLQYEPRER 300
           S     +   L S+ L  +P ER
Sbjct: 409 SERFSPQARSLCSQLLCKDPAER 431

>pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 61/282 (21%), Positives = 116/282 (41%), Gaps = 26/282 (9%)
Query: 41  FCEYSIETLRTATSGFAMENIVSEHGEKAPNVVYKGKLENQFRIAVKRFNRSAWPDARQF 100
           +C+ +I+  +     F   +    HG    +V  K  +E  F    +R N        +F
Sbjct: 36  WCDLNIKE-KIGAGSFGTVHRAEWHGS---DVAVKILMEQDFH--AERVN--------EF 81
Query: 101 LEEARAVGQLRNRRLANLLGCCCEGDERLLVAEYMPNDTLAKHLFHWET--QPMKWAMRL 158
           L E   + +LR+  +   +G   +     +V EY+   +L + L H     + +    RL
Sbjct: 82  LREVAIMKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYR-LLHKSGAREQLDERRRL 140
Query: 159 RVALHIAEALEYCTSKERALYH-DLNAYRIVFDDDVNPRLSCFGLMKNSRDGRSYSTNLA 217
            +A  +A+ + Y  ++   + H DL +  ++ D     ++  FGL +        S   A
Sbjct: 141 SMAYDVAKGMNYLHNRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKASXFLXSKXAA 200
Query: 218 FTP----PEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCL 273
            TP    PE LR      +S +YSFG +L +L + +   P   L+    + +  +   C 
Sbjct: 201 GTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQ--PWGNLN--PAQVVAAVGFKCK 256
Query: 274 EGQFSSDEGTELVRLASRCLQYEPRERPNPRSLVTALVTLQK 315
             +   +   ++  +   C   EP +RP+  +++  L  L K
Sbjct: 257 RLEIPRNLNPQVAAIIEGCWTNEPWKRPSFATIMDLLRPLIK 298

>pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373

Iteration: 1
 Score = 46.6 bits (109), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 54/228 (23%), Positives = 99/228 (43%), Gaps = 17/228 (7%)
Query: 98  RQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAEYMPNDTLAKHLFHWETQ--PMKWA 155
           R FL EA  +GQ  +  +  L G   +    ++V E M N +L   L   + Q   ++  
Sbjct: 91  RDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEXMENGSLDSFLRKHDAQFTVIQLV 150
Query: 156 MRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDG--RSYS 213
             LR    IA  ++Y  S    ++ DL A  I+ + ++  ++S FGL +   D    +Y+
Sbjct: 151 GMLR---GIASGMKYL-SDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYT 206
Query: 214 TN-----LAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTL 268
           T      + +T PE +   + T  S ++S+G +L +++S    P       + ++++   
Sbjct: 207 TRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWE----MSNQDVIKA 262
Query: 269 TDSCLEGQFSSDEGTELVRLASRCLQYEPRERPNPRSLVTALVTLQKD 316
            D         D    L +L   C Q +   RP    +V+ L  L ++
Sbjct: 263 VDEGYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKLIRN 310

>pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329

Iteration: 1
 Score = 46.6 bits (109), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 50/251 (19%), Positives = 105/251 (41%), Gaps = 20/251 (7%)
Query: 76  GKLENQFRIAVKRFNRSAWPDARQ-FLEEARAVGQL-RNRRLANLLGCCCEGDERLLVAE 133
           GK +   ++AVK    +A  D ++  + E + +  L ++  + NLLG C  G   L++ E
Sbjct: 71  GKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGACTHGGPVLVITE 130
Query: 134 YMPNDTLAKHLFHW--------ETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAY 185
           Y     L   L           + +P++    L  +  +A+ + +  SK   ++ D+ A 
Sbjct: 131 YCCYGDLLNFLRRKAEADLDKEDGRPLELRDLLHFSSQVAQGMAFLASK-NCIHRDVAAR 189
Query: 186 RIVFDDDVNPRLSCFGLMKNSRDGRSYSTN------LAFTPPEYLRTGRVTPESVMYSFG 239
            ++  +    ++  FGL ++  +  +Y         + +  PE +     T +S ++S+G
Sbjct: 190 NVLLTNGHVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYG 249
Query: 240 TLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLASRCLQYEPRE 299
            LL ++ S    P  +   L+  +  + + D     Q  +     +  +   C   EP  
Sbjct: 250 ILLWEIFSLGLNP--YPGILVNSKFYKLVKDGYQMAQ-PAFAPKNIYSIMQACWALEPTH 306
Query: 300 RPNPRSLVTAL 310
           RP  + + + L
Sbjct: 307 RPTFQQICSFL 317

>pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311

Iteration: 1
 Score = 46.6 bits (109), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 60/265 (22%), Positives = 109/265 (41%), Gaps = 41/265 (15%)
Query: 75  KGKLENQFRIAVKRFNRSA----WPDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLL 130
           K K +    +AVK     A      D    +E  + +G+ +N  + NLLG C +     +
Sbjct: 48  KDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN--IINLLGACTQDGPLYV 105
Query: 131 VAEYMPNDTLAKHLFHWETQPMKWAMRL-RV-------------ALHIAEALEYCTSKER 176
           + EY     L ++L       M+++  + RV                +A  +EY  S ++
Sbjct: 106 IVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLAS-QK 164
Query: 177 ALYHDLNAYRIVFDDDVNPRLSCFGLMK--NSRDGRSYSTN----LAFTPPEYLRTGRVT 230
            ++ DL A  ++  ++   +++ FGL +  N+ D    +TN    + +  PE L     T
Sbjct: 165 CIHRDLTARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYT 224
Query: 231 PESVMYSFGTLLLDL--LSGK---HIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTEL 285
            +S ++SFG L+ ++  L G     IP      L+++ +      +C           EL
Sbjct: 225 HQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFKLLKEGHRMDKPANCT---------NEL 275
Query: 286 VRLASRCLQYEPRERPNPRSLVTAL 310
             +   C    P +RP  + LV  L
Sbjct: 276 YMMMRDCWHAVPSQRPTFKQLVEDL 300

>pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295

Iteration: 1
 Score = 46.6 bits (109), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 41/159 (25%), Positives = 78/159 (49%), Gaps = 13/159 (8%)
Query: 98  RQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAEYMPNDTLAKHLFHWETQ--PMKWA 155
           R FL EA  +GQ  +  + +L G   +    ++V EYM N +L   L   + Q   ++  
Sbjct: 68  RDFLGEASIMGQFDHPNIIHLEGVVTKSKPVMIVTEYMENGSLDTFLKKNDGQFTVIQLV 127
Query: 156 MRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDG--RSYS 213
             LR    I+  ++Y  S    ++ DL A  I+ + ++  ++S FGL +   D    +Y+
Sbjct: 128 GMLR---GISAGMKYL-SDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYT 183
Query: 214 TN-----LAFTPPEYLRTGRVTPESVMYSFGTLLLDLLS 247
           T      + +T PE +   + T  S ++S+G ++ +++S
Sbjct: 184 TRGGKIPIRWTAPEAIAFRKFTSASDVWSYGIVMWEVVS 222

>pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306

Iteration: 1
 Score = 46.2 bits (108), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 54/231 (23%), Positives = 101/231 (43%), Gaps = 23/231 (9%)
Query: 98  RQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAEYMPNDTLAKHLFHWETQPMKWAMR 157
           R FL EA  +GQ  +  + +L G   +    +++ EYM N +L   L        ++ + 
Sbjct: 75  RDFLSEASIMGQFDHPNIIHLEGVVTKCKPVMIITEYMENGSLDAFL---RKNDGRFTVI 131
Query: 158 LRVAL--HIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDG--RSYS 213
             V +   I   ++Y  S   A++ DL A  I+ + ++  ++S FG+ +   D    +Y+
Sbjct: 132 QLVGMLRGIGSGMKYL-SDMSAVHRDLAARNILVNSNLVCKVSDFGMSRVLEDDPEAAYT 190
Query: 214 TN-----LAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTL 268
           T      + +T PE +   + T  S ++S+G ++ +++S    P         D + Q +
Sbjct: 191 TRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERP-------YWDMSNQDV 243
Query: 269 TDSCLEGQF---SSDEGTELVRLASRCLQYEPRERPNPRSLVTALVTLQKD 316
             +  EG       D    L +L   C Q E  +RP    +V  L  L ++
Sbjct: 244 IKAIEEGYRLPPPMDCPIALHQLMLDCWQKERSDRPKFGQIVNMLDKLIRN 294

>pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325

Iteration: 1
 Score = 46.2 bits (108), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 41/159 (25%), Positives = 74/159 (46%), Gaps = 13/159 (8%)
Query: 98  RQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAEYMPNDTLAKHLFHWETQ--PMKWA 155
           R FL EA  +GQ  +  +  L G    G   ++V EYM N +L   L   + Q   M+  
Sbjct: 95  RDFLSEASIMGQFDHPNIIRLEGVVTRGRLAMIVTEYMENGSLDTFLRTHDGQFTIMQLV 154
Query: 156 MRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGL---MKNSRDGRSY 212
             LR    +   + Y  S    ++ DL A  ++ D ++  ++S FGL   +++  D    
Sbjct: 155 GMLR---GVGAGMRYL-SDLGYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAXT 210
Query: 213 STN----LAFTPPEYLRTGRVTPESVMYSFGTLLLDLLS 247
           +T     + +T PE +     +  S ++SFG ++ ++L+
Sbjct: 211 TTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLA 249

>pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287

Iteration: 1
 Score = 46.2 bits (108), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 59/265 (22%), Positives = 111/265 (41%), Gaps = 22/265 (8%)
Query: 66  GEKAPNVVYKGKL-ENQFRIAVKRF-------NRSAWPDARQFLEEARAVGQLRNRRLAN 117
           G+    +V+KG+L +++  +A+K                 ++F  E   +  L +  +  
Sbjct: 28  GKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVK 87
Query: 118 LLGCCCEGDERLLVAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERA 177
           L G     +   +V E++P   L   L   +  P+KW+++LR+ L IA  +EY  ++   
Sbjct: 88  LYGLMH--NPPRMVMEFVPCGDLYHRLLD-KAHPIKWSVKLRLMLDIALGIEYMQNQNPP 144
Query: 178 LYH-DLNAYRIVFD--DDVNP---RLSCFGLMKNSRDGRS-YSTNLAFTPPEYLRTGR-- 228
           + H DL +  I     D+  P   +++ F L + S    S    N  +  PE +      
Sbjct: 145 IVHRDLRSPNIFLQSLDENAPVCAKVADFSLSQQSVHSVSGLLGNFQWMAPETIGAEEES 204
Query: 229 VTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRL 288
            T ++  YSF  +L  +L+G+   P       + + I  + +  L      D    L  +
Sbjct: 205 YTEKADTYSFAMILYTILTGEG--PFDEYSYGKIKFINMIREEGLRPTIPEDCPPRLRNV 262
Query: 289 ASRCLQYEPRERPNPRSLVTALVTL 313
              C   +P++RP+   +V  L  L
Sbjct: 263 IELCWSGDPKKRPHFSYIVKELSEL 287

>pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297

Iteration: 1
 Score = 46.2 bits (108), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 42/193 (21%), Positives = 82/193 (42%), Gaps = 11/193 (5%)
Query: 66  GEKAPNVVYKG-KLENQFRIAVKRFNRSAWPDARQFLEEARAVGQLRNRRLANLLGCCCE 124
           G+ A   VY    +     +A+++ N    P     + E   + + +N  + N L     
Sbjct: 29  GQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLV 88
Query: 125 GDERLLVAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNA 184
           GDE  +V EY+   +L   +        + A   R  L   +ALE+  S +  ++ D+ +
Sbjct: 89  GDELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCRECL---QALEFLHSNQ-VIHRDIKS 144
Query: 185 YRIVFDDDVNPRLSCFGLMKNSRDGRSYSTNLAFTP----PEYLRTGRVTPESVMYSFGT 240
             I+   D + +L+ FG        +S  + +  TP    PE +      P+  ++S G 
Sbjct: 145 DNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGI 204
Query: 241 LLLDLLSGKHIPP 253
           + ++++ G+  PP
Sbjct: 205 MAIEMIEGE--PP 215

>pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313

Iteration: 1
 Score = 46.2 bits (108), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 60/267 (22%), Positives = 110/267 (41%), Gaps = 41/267 (15%)
Query: 73  VYKGKLENQFRIAVKRFNRSA----WPDARQFLEEARAVGQLRNRRLANLLGCCCEGDER 128
           + K K +    +AVK     A      D    +E  + +G+ +N  + NLLG C +    
Sbjct: 48  IDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN--IINLLGACTQDGPL 105
Query: 129 LLVAEYMPNDTLAKHLFHWETQPMKWAMRL-RV-------------ALHIAEALEYCTSK 174
            ++ EY     L ++L       M+++  + RV                +A  +EY  S 
Sbjct: 106 YVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLAS- 164
Query: 175 ERALYHDLNAYRIVFDDDVNPRLSCFGLMK--NSRDGRSYSTN----LAFTPPEYLRTGR 228
           ++ ++ DL A  ++  ++   +++ FGL +  N+ D    +TN    + +  PE L    
Sbjct: 165 QKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRV 224
Query: 229 VTPESVMYSFGTLLLDL--LSGK---HIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGT 283
            T +S ++SFG L+ ++  L G     IP      L+++ +      +C           
Sbjct: 225 YTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFKLLKEGHRMDKPANCT---------N 275
Query: 284 ELVRLASRCLQYEPRERPNPRSLVTAL 310
           EL  +   C    P +RP  + LV  L
Sbjct: 276 ELYMMMRDCWHAVPSQRPTFKQLVEDL 302

>pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316

Iteration: 1
 Score = 46.2 bits (108), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 60/267 (22%), Positives = 110/267 (41%), Gaps = 41/267 (15%)
Query: 73  VYKGKLENQFRIAVKRFNRSA----WPDARQFLEEARAVGQLRNRRLANLLGCCCEGDER 128
           + K K +    +AVK     A      D    +E  + +G+ +N  + NLLG C +    
Sbjct: 51  IDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN--IINLLGACTQDGPL 108
Query: 129 LLVAEYMPNDTLAKHLFHWETQPMKWAMRL-RV-------------ALHIAEALEYCTSK 174
            ++ EY     L ++L       M+++  + RV                +A  +EY  S 
Sbjct: 109 YVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLAS- 167
Query: 175 ERALYHDLNAYRIVFDDDVNPRLSCFGLMK--NSRDGRSYSTN----LAFTPPEYLRTGR 228
           ++ ++ DL A  ++  ++   +++ FGL +  N+ D    +TN    + +  PE L    
Sbjct: 168 QKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRV 227
Query: 229 VTPESVMYSFGTLLLDL--LSGK---HIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGT 283
            T +S ++SFG L+ ++  L G     IP      L+++ +      +C           
Sbjct: 228 YTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFKLLKEGHRMDKPANCT---------N 278
Query: 284 ELVRLASRCLQYEPRERPNPRSLVTAL 310
           EL  +   C    P +RP  + LV  L
Sbjct: 279 ELYMMMRDCWHAVPSQRPTFKQLVEDL 305

>pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334

Iteration: 1
 Score = 46.2 bits (108), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 65/283 (22%), Positives = 116/283 (40%), Gaps = 45/283 (15%)
Query: 73  VYKGKLENQFRIAVKRFNRSA----WPDARQFLEEARAVGQLRNRRLANLLGCCCEGDER 128
           + K K +    +AVK     A      D    +E  + +G+ +N  + NLLG C +    
Sbjct: 59  IDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN--IINLLGACTQDGPL 116
Query: 129 LLVAEYMPNDTLAKHL-----------FHWETQP---MKWAMRLRVALHIAEALEYCTSK 174
            ++ EY     L ++L           +     P   M +   +     +A  +EY  S 
Sbjct: 117 YVIVEYASKGNLREYLRARRPPGMEXSYDINRVPEEQMTFKDLVSCTYQLARGMEYLAS- 175
Query: 175 ERALYHDLNAYRIVFDDDVNPRLSCFGLMK--NSRDGRSYSTN----LAFTPPEYLRTGR 228
           ++ ++ DL A  ++  ++   +++ FGL +  N+ D    +TN    + +  PE L    
Sbjct: 176 QKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDXXKKTTNGRLPVKWMAPEALFDRV 235
Query: 229 VTPESVMYSFGTLLLDL--LSGK---HIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGT 283
            T +S ++SFG L+ ++  L G     IP      L+++ +      +C           
Sbjct: 236 YTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFKLLKEGHRMDKPANCT---------N 286
Query: 284 ELVRLASRCLQYEPRERPNPRSLVTAL---VTLQKDTELYLSL 323
           EL  +   C    P +RP  + LV  L   +TL  + E YL L
Sbjct: 287 ELYMMMRDCWHAVPSQRPTFKQLVEDLDRILTLTTNEE-YLDL 328

>pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297

Iteration: 1
 Score = 46.2 bits (108), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 42/193 (21%), Positives = 82/193 (42%), Gaps = 11/193 (5%)
Query: 66  GEKAPNVVYKG-KLENQFRIAVKRFNRSAWPDARQFLEEARAVGQLRNRRLANLLGCCCE 124
           G+ A   VY    +     +A+++ N    P     + E   + + +N  + N L     
Sbjct: 29  GQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLV 88
Query: 125 GDERLLVAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNA 184
           GDE  +V EY+   +L   +        + A   R  L   +ALE+  S +  ++ D+ +
Sbjct: 89  GDELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCRECL---QALEFLHSNQ-VIHRDIKS 144
Query: 185 YRIVFDDDVNPRLSCFGLMKNSRDGRSYSTNLAFTP----PEYLRTGRVTPESVMYSFGT 240
             I+   D + +L+ FG        +S  + +  TP    PE +      P+  ++S G 
Sbjct: 145 DNILLGMDGSVKLTDFGFCAQITPEQSKRSEMVGTPYWMAPEVVTRKAYGPKVDIWSLGI 204
Query: 241 LLLDLLSGKHIPP 253
           + ++++ G+  PP
Sbjct: 205 MAIEMIEGE--PP 215

>pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306

Iteration: 1
 Score = 46.2 bits (108), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 53/251 (21%), Positives = 102/251 (40%), Gaps = 20/251 (7%)
Query: 66  GEKAPNVVYKG-KLENQFRIAVKRFNRSAWPDARQFLEEARAVGQLRNRRLANLLGCCCE 124
           G+ A   VY    +     +A+++ N    P     + E   + + +N  + N L     
Sbjct: 30  GQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLV 89
Query: 125 GDERLLVAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNA 184
           GDE  +V EY+   +L   +        + A   R  L   +ALE+  S +  ++ D+ +
Sbjct: 90  GDELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCRECL---QALEFLHSNQ-VIHRDIKS 145
Query: 185 YRIVFDDDVNPRLSCFGLMKNSRDGRSYSTNLAFTP----PEYLRTGRVTPESVMYSFGT 240
             I+   D + +L+ FG        +S  + +  TP    PE +      P+  ++S G 
Sbjct: 146 DNILLGMDGSVKLTDFGFCAQITPEQSKRSXMVGTPYWMAPEVVTRKAYGPKVDIWSLGI 205
Query: 241 LLLDLLSGK----HIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLASRCLQYE 296
           + ++++ G+    +  P  AL LI        T+   E Q             +RCL+ +
Sbjct: 206 MAIEMIEGEPPYLNENPLRALYLIA-------TNGTPELQNPEKLSAIFRDFLNRCLEMD 258
Query: 297 PRERPNPRSLV 307
             +R + + L+
Sbjct: 259 VEKRGSAKELI 269

>pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324

Iteration: 1
 Score = 46.2 bits (108), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 60/267 (22%), Positives = 110/267 (41%), Gaps = 41/267 (15%)
Query: 73  VYKGKLENQFRIAVKRFNRSA----WPDARQFLEEARAVGQLRNRRLANLLGCCCEGDER 128
           + K K +    +AVK     A      D    +E  + +G+ +N  + NLLG C +    
Sbjct: 59  IDKDKPKEAVTVAVKMLKDDATEEDLSDLVSEMEMMKMIGKHKN--IINLLGACTQDGPL 116
Query: 129 LLVAEYMPNDTLAKHLFHWETQPMKWAMRL-RV-------------ALHIAEALEYCTSK 174
            ++ EY     L ++L       M+++  + RV                +A  +EY  S 
Sbjct: 117 YVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLAS- 175
Query: 175 ERALYHDLNAYRIVFDDDVNPRLSCFGLMK--NSRDGRSYSTN----LAFTPPEYLRTGR 228
           ++ ++ DL A  ++  ++   +++ FGL +  N+ D    +TN    + +  PE L    
Sbjct: 176 QKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRV 235
Query: 229 VTPESVMYSFGTLLLDL--LSGK---HIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGT 283
            T +S ++SFG L+ ++  L G     IP      L+++ +      +C           
Sbjct: 236 YTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFKLLKEGHRMDKPANCT---------N 286
Query: 284 ELVRLASRCLQYEPRERPNPRSLVTAL 310
           EL  +   C    P +RP  + LV  L
Sbjct: 287 ELYMMMRDCWHAVPSQRPTFKQLVEDL 313

>pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324

Iteration: 1
 Score = 45.8 bits (107), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 60/267 (22%), Positives = 110/267 (41%), Gaps = 41/267 (15%)
Query: 73  VYKGKLENQFRIAVKRFNRSA----WPDARQFLEEARAVGQLRNRRLANLLGCCCEGDER 128
           + K K +    +AVK     A      D    +E  + +G+ +N  + NLLG C +    
Sbjct: 59  IDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN--IINLLGACTQDGPL 116
Query: 129 LLVAEYMPNDTLAKHLFHWETQPMKWAMRL-RV-------------ALHIAEALEYCTSK 174
            ++ EY     L ++L       M+++  + RV                +A  +EY  S 
Sbjct: 117 YVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLAS- 175
Query: 175 ERALYHDLNAYRIVFDDDVNPRLSCFGLMK--NSRDGRSYSTN----LAFTPPEYLRTGR 228
           ++ ++ DL A  ++  ++   +++ FGL +  N+ D    +TN    + +  PE L    
Sbjct: 176 QKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKNTTNGRLPVKWMAPEALFDRV 235
Query: 229 VTPESVMYSFGTLLLDL--LSGK---HIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGT 283
            T +S ++SFG L+ ++  L G     IP      L+++ +      +C           
Sbjct: 236 YTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFKLLKEGHRMDKPANCT---------N 286
Query: 284 ELVRLASRCLQYEPRERPNPRSLVTAL 310
           EL  +   C    P +RP  + LV  L
Sbjct: 287 ELYMMMRDCWHAVPSQRPTFKQLVEDL 313

>pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297

Iteration: 1
 Score = 45.8 bits (107), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 42/193 (21%), Positives = 82/193 (42%), Gaps = 11/193 (5%)
Query: 66  GEKAPNVVYKG-KLENQFRIAVKRFNRSAWPDARQFLEEARAVGQLRNRRLANLLGCCCE 124
           G+ A   VY    +     +A+++ N    P     + E   + + +N  + N L     
Sbjct: 29  GQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLV 88
Query: 125 GDERLLVAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNA 184
           GDE  +V EY+   +L   +        + A   R  L   +ALE+  S +  ++ D+ +
Sbjct: 89  GDELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCRECL---QALEFLHSNQ-VIHRDIKS 144
Query: 185 YRIVFDDDVNPRLSCFGLMKNSRDGRSYSTNLAFTP----PEYLRTGRVTPESVMYSFGT 240
             I+   D + +L+ FG        +S  + +  TP    PE +      P+  ++S G 
Sbjct: 145 DNILLGMDGSVKLTDFGFCAQITPEQSKRSXMVGTPYWMAPEVVTRKAYGPKVDIWSLGI 204
Query: 241 LLLDLLSGKHIPP 253
           + ++++ G+  PP
Sbjct: 205 MAIEMIEGE--PP 215

>pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277

Iteration: 1
 Score = 45.8 bits (107), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 63/273 (23%), Positives = 107/273 (39%), Gaps = 29/273 (10%)
Query: 55  GFAMENIVSEH--GEKAPNVVYKGKLEN----QFRIAVKRFNRSAWPDARQ-FLEEARAV 107
           G A E++V     GE     VY+G   N    +  +AVK   +    D ++ F+ EA  +
Sbjct: 4   GIAREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIM 63
Query: 108 GQLRNRRLANLLGCCCEGDERLLVAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEA 167
             L +  +  L+G   E +   ++ E  P   L  H        +K    +  +L I +A
Sbjct: 64  KNLDHPHIVKLIGII-EEEPTWIIMELYPYGELG-HYLERNKNSLKVLTLVLYSLQICKA 121
Query: 168 LEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDGRSYSTNLAFTP-----PE 222
           + Y  S    ++ D+    I+       +L  FGL +   D   Y  ++   P     PE
Sbjct: 122 MAYLESI-NCVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKASVTRLPIKWMSPE 180
Query: 223 YLRTGRVTPESVMYSFGTLLLDLLS-GKH----IPPSHALDLIRDRNIQTLTDSCLEGQF 277
            +   R T  S ++ F   + ++LS GK     +     + ++   +     D C     
Sbjct: 181 SINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENKDVIGVLEKGDRLPKPDLC----- 235
Query: 278 SSDEGTELVRLASRCLQYEPRERPNPRSLVTAL 310
                  L  L +RC  Y+P +RP    LV +L
Sbjct: 236 ----PPVLYTLMTRCWDYDPSDRPRFTELVCSL 264

>pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293

Iteration: 1
 Score = 45.8 bits (107), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 63/273 (23%), Positives = 107/273 (39%), Gaps = 29/273 (10%)
Query: 55  GFAMENIVSEH--GEKAPNVVYKGKLEN----QFRIAVKRFNRSAWPDARQ-FLEEARAV 107
           G A E++V     GE     VY+G   N    +  +AVK   +    D ++ F+ EA  +
Sbjct: 20  GIAREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIM 79
Query: 108 GQLRNRRLANLLGCCCEGDERLLVAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEA 167
             L +  +  L+G   E +   ++ E  P   L  H        +K    +  +L I +A
Sbjct: 80  KNLDHPHIVKLIGII-EEEPTWIIMELYPYGELG-HYLERNKNSLKVLTLVLYSLQICKA 137
Query: 168 LEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDGRSYSTNLAFTP-----PE 222
           + Y  S    ++ D+    I+       +L  FGL +   D   Y  ++   P     PE
Sbjct: 138 MAYLESI-NCVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKASVTRLPIKWMSPE 196
Query: 223 YLRTGRVTPESVMYSFGTLLLDLLS-GKH----IPPSHALDLIRDRNIQTLTDSCLEGQF 277
            +   R T  S ++ F   + ++LS GK     +     + ++   +     D C     
Sbjct: 197 SINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENKDVIGVLEKGDRLPKPDLC----- 251
Query: 278 SSDEGTELVRLASRCLQYEPRERPNPRSLVTAL 310
                  L  L +RC  Y+P +RP    LV +L
Sbjct: 252 ----PPVLYTLMTRCWDYDPSDRPRFTELVCSL 280

>pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281

Iteration: 1
 Score = 45.4 bits (106), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 63/273 (23%), Positives = 107/273 (39%), Gaps = 29/273 (10%)
Query: 55  GFAMENIVSEH--GEKAPNVVYKGKLEN----QFRIAVKRFNRSAWPDARQ-FLEEARAV 107
           G A E++V     GE     VY+G   N    +  +AVK   +    D ++ F+ EA  +
Sbjct: 8   GIAREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIM 67
Query: 108 GQLRNRRLANLLGCCCEGDERLLVAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEA 167
             L +  +  L+G   E +   ++ E  P   L  H        +K    +  +L I +A
Sbjct: 68  KNLDHPHIVKLIGII-EEEPTWIIMELYPYGELG-HYLERNKNSLKVLTLVLYSLQICKA 125
Query: 168 LEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDGRSYSTNLAFTP-----PE 222
           + Y  S    ++ D+    I+       +L  FGL +   D   Y  ++   P     PE
Sbjct: 126 MAYLESI-NCVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKASVTRLPIKWMSPE 184
Query: 223 YLRTGRVTPESVMYSFGTLLLDLLS-GKH----IPPSHALDLIRDRNIQTLTDSCLEGQF 277
            +   R T  S ++ F   + ++LS GK     +     + ++   +     D C     
Sbjct: 185 SINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENKDVIGVLEKGDRLPKPDLC----- 239
Query: 278 SSDEGTELVRLASRCLQYEPRERPNPRSLVTAL 310
                  L  L +RC  Y+P +RP    LV +L
Sbjct: 240 ----PPVLYTLMTRCWDYDPSDRPRFTELVCSL 268

>pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370

Iteration: 1
 Score = 45.4 bits (106), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 60/267 (22%), Positives = 110/267 (41%), Gaps = 41/267 (15%)
Query: 73  VYKGKLENQFRIAVKRFNRSA----WPDARQFLEEARAVGQLRNRRLANLLGCCCEGDER 128
           + K K +    +AVK     A      D    +E  + +G+ +N  + NLLG C +    
Sbjct: 105 IDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN--IINLLGACTQDGPL 162
Query: 129 LLVAEYMPNDTLAKHLFHWETQPMKWAMRL-RV-------------ALHIAEALEYCTSK 174
            ++ EY     L ++L       M+++  + RV                +A  +EY  S 
Sbjct: 163 YVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLAS- 221
Query: 175 ERALYHDLNAYRIVFDDDVNPRLSCFGLMK--NSRDGRSYSTN----LAFTPPEYLRTGR 228
           ++ ++ DL A  ++  ++   +++ FGL +  N+ D    +TN    + +  PE L    
Sbjct: 222 QKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRV 281
Query: 229 VTPESVMYSFGTLLLDL--LSGK---HIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGT 283
            T +S ++SFG L+ ++  L G     IP      L+++ +      +C           
Sbjct: 282 YTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFKLLKEGHRMDKPANCT---------N 332
Query: 284 ELVRLASRCLQYEPRERPNPRSLVTAL 310
           EL  +   C    P +RP  + LV  L
Sbjct: 333 ELYMMMRDCWHAVPSQRPTFKQLVEDL 359

>pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333

Iteration: 1
 Score = 45.4 bits (106), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 54/255 (21%), Positives = 105/255 (41%), Gaps = 24/255 (9%)
Query: 76  GKLENQFRIAVKRFNRSAWPDARQ-FLEEARAVGQL-RNRRLANLLGCCCEGDERLLVAE 133
           GK +   ++AVK    +A  D ++  + E + +  L ++  + NLLG C  G   L++ E
Sbjct: 71  GKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGACTHGGPVLVITE 130
Query: 134 YMPNDTLAKHLFH----WETQP----MKWAMRLRVALH----IAEALEYCTSKERALYHD 181
           Y     L   L       ET P        +  R  LH    +A+ + +  SK   ++ D
Sbjct: 131 YCCYGDLLNFLRRKSRVLETDPAFAIANSTLSTRDLLHFSSQVAQGMAFLASKN-CIHRD 189
Query: 182 LNAYRIVFDDDVNPRLSCFGLMKNSRDGRSYSTN------LAFTPPEYLRTGRVTPESVM 235
           + A  ++  +    ++  FGL ++  +  +Y         + +  PE +     T +S +
Sbjct: 190 VAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDV 249
Query: 236 YSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLASRCLQY 295
           +S+G LL ++ S    P  +   L+  +  + + D     Q  +     +  +   C   
Sbjct: 250 WSYGILLWEIFSLGLNP--YPGILVNSKFYKLVKDGYQMAQ-PAFAPKNIYSIMQACWAL 306
Query: 296 EPRERPNPRSLVTAL 310
           EP  RP  + + + L
Sbjct: 307 EPTHRPTFQQICSFL 321

>pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309

Iteration: 1
 Score = 45.4 bits (106), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 60/282 (21%), Positives = 117/282 (41%), Gaps = 26/282 (9%)
Query: 41  FCEYSIETLRTATSGFAMENIVSEHGEKAPNVVYKGKLENQFRIAVKRFNRSAWPDARQF 100
           +C+ +I+  +     F   +    HG    +V  K  +E  F    +R N        +F
Sbjct: 36  WCDLNIKE-KIGAGSFGTVHRAEWHGS---DVAVKILMEQDFH--AERVN--------EF 81
Query: 101 LEEARAVGQLRNRRLANLLGCCCEGDERLLVAEYMPNDTLAKHLFHWET--QPMKWAMRL 158
           L E   + +LR+  +   +G   +     +V EY+   +L + L H     + +    RL
Sbjct: 82  LREVAIMKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYR-LLHKSGAREQLDERRRL 140
Query: 159 RVALHIAEALEYCTSKERALYH-DLNAYRIVFDDDVNPRLSCFGLMKNSRDGRSYSTNLA 217
            +A  +A+ + Y  ++   + H +L +  ++ D     ++  FGL +        S + A
Sbjct: 141 SMAYDVAKGMNYLHNRNPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKASTFLSSKSAA 200
Query: 218 FTP----PEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCL 273
            TP    PE LR      +S +YSFG +L +L + +   P   L+    + +  +   C 
Sbjct: 201 GTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQ--PWGNLN--PAQVVAAVGFKCK 256
Query: 274 EGQFSSDEGTELVRLASRCLQYEPRERPNPRSLVTALVTLQK 315
             +   +   ++  +   C   EP +RP+  +++  L  L K
Sbjct: 257 RLEIPRNLNPQVAAIIEGCWTNEPWKRPSFATIMDLLRPLIK 298

>pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324

Iteration: 1
 Score = 44.7 bits (104), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 56/274 (20%), Positives = 113/274 (41%), Gaps = 27/274 (9%)
Query: 66  GEKAPNVVYKGKL-----ENQFRIAVKRFNRSAWPDA-RQFLEEARAVGQLRNRRLANLL 119
           G  A   VYKG       + +  +A+K    +  P A ++ L+EA  +  + N  +  LL
Sbjct: 21  GSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLL 80
Query: 120 GCCCEGDERLLVAEYMPN----DTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKE 175
           G C     + L+ + MP     D + +H  +  +Q +     L   + IAE + Y   + 
Sbjct: 81  GICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYL-----LNWCVQIAEGMNYLEDR- 133
Query: 176 RALYHDLNAYRIVFDDDVNPRLSCFGLMK-NSRDGRSYSTNLAFTPPEYLRTGRV----- 229
           R ++ DL A  ++     + +++ FGL K    + + Y       P +++    +     
Sbjct: 134 RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIY 193
Query: 230 TPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLA 289
           T +S ++S+G  + +L++    P     D I    I ++ +             ++  + 
Sbjct: 194 THQSDVWSYGVTVWELMTFGSKP----YDGIPASEISSILEKGERLPQPPICTIDVYMIM 249
Query: 290 SRCLQYEPRERPNPRSLVTALVTLQKDTELYLSL 323
            +C   +   RP  R L+     + +D + YL +
Sbjct: 250 VKCWMIDADSRPKFRELIIEFSKMARDPQRYLVI 283

>pdb|3KMW|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Mgatp) Length = 271

Iteration: 1
 Score = 44.7 bits (104), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 62/273 (22%), Positives = 113/273 (41%), Gaps = 26/273 (9%)
Query: 56  FAMENIVSEHGEKAPNVVYKGKLENQFRIAVKRFNRSAWP--DARQFLEEARAVGQLRNR 113
           F   N +++  E     ++KG+ +    I VK      W    +R F EE   +    + 
Sbjct: 9   FKQLNFLTKLNENHSGELWKGRWQGN-DIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHP 67
Query: 114 RLANLLGCCCE--GDERLLVAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYC 171
            +  +LG C         L+  +MP  +L   L       +  +  ++ AL +A  + + 
Sbjct: 68  NVLPVLGACQSPPAPHPTLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFL 127
Query: 172 TSKERAL-YHDLNAYRIVFDDDVNPRLSCFGL-MKNSRDGRSYSTNLAFTPPEYLR---- 225
            + E  +  H LN+  ++ D+D+  R+S   +       GR Y+   A+  PE L+    
Sbjct: 128 HTLEPLIPRHALNSRSVMIDEDMTARISMADVKFSFQSPGRMYAP--AWVAPEALQKKPE 185
Query: 226 -TGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEG---QFSSDE 281
            T R + +  M+SF  LL +L++ + +P     DL    N++      LEG         
Sbjct: 186 DTNRRSAD--MWSFAVLLWELVT-REVP---FADL---SNMEIGMKVALEGLRPTIPPGI 236
Query: 282 GTELVRLASRCLQYEPRERPNPRSLVTALVTLQ 314
              + +L   C+  +P +RP    +V  L  +Q
Sbjct: 237 SPHVSKLMKICMNEDPAKRPKFDMIVPILEKMQ 269

>pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324

Iteration: 1
 Score = 44.7 bits (104), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 52/264 (19%), Positives = 109/264 (41%), Gaps = 33/264 (12%)
Query: 76  GKLENQFRIAVKRFNRSAWPDARQ-FLEEARAVGQL-RNRRLANLLGCCCEGDERLLVAE 133
           GK +   ++AVK    +A  D ++  + E + +  L ++  + NLLG C  G   L++ E
Sbjct: 56  GKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGACTHGGPVLVITE 115
Query: 134 Y----------------MPNDTLA-----KHLFHWETQPMKWAMRLRVALHIAEALEYCT 172
           Y                M   +LA     + L   + +P++    L  +  +A+ + +  
Sbjct: 116 YCCYGDLLNFLRRKAEAMLGPSLAPGQDPEGLDKEDGRPLELRDLLHFSSQVAQGMAFLA 175
Query: 173 SKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDGRSYSTN------LAFTPPEYLRT 226
           SK   ++ D+ A  ++  +    ++  FGL ++  +  +Y         + +  PE +  
Sbjct: 176 SK-NCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFD 234
Query: 227 GRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELV 286
              T +S ++S+G LL ++ S    P  +   L+  +  + + D     Q  +     + 
Sbjct: 235 CVYTVQSDVWSYGILLWEIFSLGLNP--YPGILVNSKFYKLVKDGYQMAQ-PAFAPKNIY 291
Query: 287 RLASRCLQYEPRERPNPRSLVTAL 310
            +   C   EP  RP  + + + L
Sbjct: 292 SIMQACWALEPTHRPTFQQICSFL 315

>pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306

Iteration: 1
 Score = 44.3 bits (103), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 52/251 (20%), Positives = 102/251 (40%), Gaps = 20/251 (7%)
Query: 66  GEKAPNVVYKG-KLENQFRIAVKRFNRSAWPDARQFLEEARAVGQLRNRRLANLLGCCCE 124
           G+ A   VY    +     +A+++ N    P     + E   + + +N  + N L     
Sbjct: 30  GQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLV 89
Query: 125 GDERLLVAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNA 184
           GDE  +V EY+   +L   +        + A   R  L   +ALE+  S +  ++ ++ +
Sbjct: 90  GDELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCRECL---QALEFLHSNQ-VIHRNIKS 145
Query: 185 YRIVFDDDVNPRLSCFGLMKNSRDGRSYSTNLAFTP----PEYLRTGRVTPESVMYSFGT 240
             I+   D + +L+ FG        +S  + +  TP    PE +      P+  ++S G 
Sbjct: 146 DNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGI 205
Query: 241 LLLDLLSGK----HIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLASRCLQYE 296
           + ++++ G+    +  P  AL LI        T+   E Q             +RCL+ +
Sbjct: 206 MAIEMIEGEPPYLNENPLRALYLIA-------TNGTPELQNPEKLSAIFRDFLNRCLEMD 258
Query: 297 PRERPNPRSLV 307
             +R + + L+
Sbjct: 259 VEKRGSAKELI 269

>pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303

Iteration: 1
 Score = 44.3 bits (103), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 51/246 (20%), Positives = 100/246 (40%), Gaps = 22/246 (8%)
Query: 83  RIAVKRFN-RSAWPDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAEYMPNDT-- 139
           ++A+KR N         + L+E +A+ Q  +  + +        DE  LV + +   +  
Sbjct: 42  KVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKDELWLVMKLLSGGSVL 101
Query: 140 -LAKHLF---HWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNP 195
            + KH+      ++  +  +    +   + E LEY   K   ++ D+ A  I+  +D + 
Sbjct: 102 DIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYL-HKNGQIHRDVKAGNILLGEDGSV 160
Query: 196 RLSCFGLMKNSRDGRSYSTN-----LAFTP----PEYLRTGR-VTPESVMYSFGTLLLDL 245
           +++ FG+      G   + N        TP    PE +   R    ++ ++SFG   ++L
Sbjct: 161 QIADFGVSAFLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIEL 220
Query: 246 LSG----KHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLASRCLQYEPRERP 301
            +G       PP   L L    +  +L     + +     G    ++ S CLQ +P +RP
Sbjct: 221 ATGAAPYHKYPPMKVLMLTLQNDPPSLETGVQDKEMLKKYGKSFRKMISLCLQKDPEKRP 280
Query: 302 NPRSLV 307
               L+
Sbjct: 281 TAAELL 286

>pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290

Iteration: 1
 Score = 44.3 bits (103), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 51/246 (20%), Positives = 100/246 (40%), Gaps = 22/246 (8%)
Query: 83  RIAVKRFN-RSAWPDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAEYMPNDT-- 139
           ++A+KR N         + L+E +A+ Q  +  + +        DE  LV + +   +  
Sbjct: 37  KVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKDELWLVMKLLSGGSVL 96
Query: 140 -LAKHLF---HWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNP 195
            + KH+      ++  +  +    +   + E LEY   K   ++ D+ A  I+  +D + 
Sbjct: 97  DIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYL-HKNGQIHRDVKAGNILLGEDGSV 155
Query: 196 RLSCFGLMKNSRDGRSYSTN-----LAFTP----PEYLRTGR-VTPESVMYSFGTLLLDL 245
           +++ FG+      G   + N        TP    PE +   R    ++ ++SFG   ++L
Sbjct: 156 QIADFGVSAFLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIEL 215
Query: 246 LSG----KHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLASRCLQYEPRERP 301
            +G       PP   L L    +  +L     + +     G    ++ S CLQ +P +RP
Sbjct: 216 ATGAAPYHKYPPMKVLMLTLQNDPPSLETGVQDKEMLKKYGKSFRKMISLCLQKDPEKRP 275
Query: 302 NPRSLV 307
               L+
Sbjct: 276 TAAELL 281

>pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286

Iteration: 1
 Score = 44.3 bits (103), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 39/161 (24%), Positives = 77/161 (47%), Gaps = 15/161 (9%)
Query: 98  RQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAEYMPNDTLAKHLFHWETQ--PMKWA 155
           R FL EA  +GQ  +  + +L G   +    +++ E+M N +L   L   + Q   ++  
Sbjct: 53  RDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQNDGQFTVIQLV 112
Query: 156 MRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDGRS---Y 212
             LR    IA  ++Y       ++  L A  I+ + ++  ++S FGL +   D  S   Y
Sbjct: 113 GMLR---GIAAGMKYLADMNY-VHRALAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTY 168
Query: 213 STNLA------FTPPEYLRTGRVTPESVMYSFGTLLLDLLS 247
           ++ L       +T PE ++  + T  S ++S+G ++ +++S
Sbjct: 169 TSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMS 209

>pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333

Iteration: 1
 Score = 44.3 bits (103), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 53/256 (20%), Positives = 106/256 (41%), Gaps = 26/256 (10%)
Query: 76  GKLENQFRIAVKRFNRSAWPDARQ-FLEEARAVGQL-RNRRLANLLGCCCEGDERLLVAE 133
           GK +   ++AVK    +A  D ++  + E + +  L ++  + NLLG C  G   L++ E
Sbjct: 71  GKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGACTHGGPVLVITE 130
Query: 134 YMPNDTLAKHLFH----WETQPMKWAMR---------LRVALHIAEALEYCTSKERALYH 180
           Y     L   L       ET P  +A+          L  +  +A+ + +  SK   ++ 
Sbjct: 131 YCCYGDLLNFLRRKSRVLETDP-AFAIANSTASTRDLLHFSSQVAQGMAFLASKN-CIHR 188
Query: 181 DLNAYRIVFDDDVNPRLSCFGLMKNSRDGRSYSTN------LAFTPPEYLRTGRVTPESV 234
           D+ A  ++  +    ++  FGL ++  +  +Y         + +  PE +     T +S 
Sbjct: 189 DVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSD 248
Query: 235 MYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLASRCLQ 294
           ++S+G LL ++ S    P  +   L+  +  + + D     Q  +     +  +   C  
Sbjct: 249 VWSYGILLWEIFSLGLNP--YPGILVNSKFYKLVKDGYQMAQ-PAFAPKNIYSIMQACWA 305
Query: 295 YEPRERPNPRSLVTAL 310
            EP  RP  + + + L
Sbjct: 306 LEPTHRPTFQQICSFL 321

>pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285

Iteration: 1
 Score = 44.3 bits (103), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 53/231 (22%), Positives = 100/231 (43%), Gaps = 23/231 (9%)
Query: 98  RQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAEYMPNDTLAKHLFHWETQPMKWAMR 157
           R FL EA  +GQ  +  + +L G   +    +++ EYM N +L   L        ++ + 
Sbjct: 54  RDFLSEASIMGQFDHPNIIHLEGVVTKCKPVMIITEYMENGSLDAFL---RKNDGRFTVI 110
Query: 158 LRVAL--HIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDG--RSYS 213
             V +   I   ++Y  S    ++ DL A  I+ + ++  ++S FG+ +   D    +Y+
Sbjct: 111 QLVGMLRGIGSGMKYL-SDMSYVHRDLAARNILVNSNLVCKVSDFGMSRVLEDDPEAAYT 169
Query: 214 TN-----LAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTL 268
           T      + +T PE +   + T  S ++S+G ++ +++S    P         D + Q +
Sbjct: 170 TRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERP-------YWDMSNQDV 222
Query: 269 TDSCLEGQF---SSDEGTELVRLASRCLQYEPRERPNPRSLVTALVTLQKD 316
             +  EG       D    L +L   C Q E  +RP    +V  L  L ++
Sbjct: 223 IKAIEEGYRLPPPMDCPIALHQLMLDCWQKERSDRPKFGQIVNMLDKLIRN 273

>pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291

Iteration: 1
 Score = 44.3 bits (103), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 53/231 (22%), Positives = 100/231 (43%), Gaps = 23/231 (9%)
Query: 98  RQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAEYMPNDTLAKHLFHWETQPMKWAMR 157
           R FL EA  +GQ  +  + +L G   +    +++ EYM N +L   L        ++ + 
Sbjct: 60  RDFLSEASIMGQFDHPNIIHLEGVVTKCKPVMIITEYMENGSLDAFL---RKNDGRFTVI 116
Query: 158 LRVAL--HIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDG--RSYS 213
             V +   I   ++Y  S    ++ DL A  I+ + ++  ++S FG+ +   D    +Y+
Sbjct: 117 QLVGMLRGIGSGMKYL-SDMSYVHRDLAARNILVNSNLVCKVSDFGMSRVLEDDPEAAYT 175
Query: 214 TN-----LAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTL 268
           T      + +T PE +   + T  S ++S+G ++ +++S    P         D + Q +
Sbjct: 176 TRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERP-------YWDMSNQDV 228
Query: 269 TDSCLEGQF---SSDEGTELVRLASRCLQYEPRERPNPRSLVTALVTLQKD 316
             +  EG       D    L +L   C Q E  +RP    +V  L  L ++
Sbjct: 229 IKAIEEGYRLPPPMDCPIALHQLMLDCWQKERSDRPKFGQIVNMLDKLIRN 279

>pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324

Iteration: 1
 Score = 43.9 bits (102), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 59/267 (22%), Positives = 110/267 (41%), Gaps = 41/267 (15%)
Query: 73  VYKGKLENQFRIAVKRFNRSA----WPDARQFLEEARAVGQLRNRRLANLLGCCCEGDER 128
           + K K +    +AVK     A      D    +E  + +G+ +N  + +LLG C +    
Sbjct: 59  IDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN--IIHLLGACTQDGPL 116
Query: 129 LLVAEYMPNDTLAKHLFHWETQPMKWAMRL-RV-------------ALHIAEALEYCTSK 174
            ++ EY     L ++L       M+++  + RV                +A  +EY  S 
Sbjct: 117 YVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLAS- 175
Query: 175 ERALYHDLNAYRIVFDDDVNPRLSCFGLMK--NSRDGRSYSTN----LAFTPPEYLRTGR 228
           ++ ++ DL A  ++  ++   +++ FGL +  N+ D    +TN    + +  PE L    
Sbjct: 176 QKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRV 235
Query: 229 VTPESVMYSFGTLLLDL--LSGK---HIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGT 283
            T +S ++SFG L+ ++  L G     IP      L+++ +      +C           
Sbjct: 236 YTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFKLLKEGHRMDKPANCT---------N 286
Query: 284 ELVRLASRCLQYEPRERPNPRSLVTAL 310
           EL  +   C    P +RP  + LV  L
Sbjct: 287 ELYMMMRDCWHAVPSQRPTFKQLVEDL 313

>pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275

Iteration: 1
 Score = 43.9 bits (102), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 45/174 (25%), Positives = 82/174 (47%), Gaps = 17/174 (9%)
Query: 83  RIAVKRFNRS--AWPDARQFLE-EARAVGQLRNRRLANLLGCCCEGDERLLVAEYMPNDT 139
           ++A+K  N+   A  D +  +E E   +  LR+  +  L       DE ++V EY  N+ 
Sbjct: 40  KVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIKSKDEIIMVIEYAGNE- 98
Query: 140 LAKHLFHWETQPMKWAMR--LRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRL 197
               LF +  Q  K + +   R    I  A+EYC  + + ++ DL    ++ D+ +N ++
Sbjct: 99  ----LFDYIVQRDKMSEQEARRFFQQIISAVEYC-HRHKIVHRDLKPENLLLDEHLNVKI 153
Query: 198 SCFGLMKNSRDGRSYSTNLA---FTPPEYLRTGRV--TPESVMYSFGTLLLDLL 246
           + FGL     DG    T+     +  PE + +G++   PE  ++S G +L  +L
Sbjct: 154 ADFGLSNIMTDGNFLKTSCGSPNYAAPEVI-SGKLYAGPEVDVWSCGVILYVML 206

>pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283

Iteration: 1
 Score = 43.9 bits (102), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 45/174 (25%), Positives = 82/174 (47%), Gaps = 17/174 (9%)
Query: 83  RIAVKRFNRS--AWPDARQFLE-EARAVGQLRNRRLANLLGCCCEGDERLLVAEYMPNDT 139
           ++A+K  N+   A  D +  +E E   +  LR+  +  L       DE ++V EY  N+ 
Sbjct: 41  KVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIKSKDEIIMVIEYAGNE- 99
Query: 140 LAKHLFHWETQPMKWAMR--LRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRL 197
               LF +  Q  K + +   R    I  A+EYC  + + ++ DL    ++ D+ +N ++
Sbjct: 100 ----LFDYIVQRDKMSEQEARRFFQQIISAVEYC-HRHKIVHRDLKPENLLLDEHLNVKI 154
Query: 198 SCFGLMKNSRDGRSYSTNLA---FTPPEYLRTGRV--TPESVMYSFGTLLLDLL 246
           + FGL     DG    T+     +  PE + +G++   PE  ++S G +L  +L
Sbjct: 155 ADFGLSNIMTDGNFLKTSCGSPNYAAPEVI-SGKLYAGPEVDVWSCGVILYVML 207

>pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 43.9 bits (102), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 59/267 (22%), Positives = 109/267 (40%), Gaps = 41/267 (15%)
Query: 73  VYKGKLENQFRIAVKRFNRSA----WPDARQFLEEARAVGQLRNRRLANLLGCCCEGDER 128
           + K K +    +AVK     A      D    +E  + +G+ +N  +  LLG C +    
Sbjct: 59  IDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN--IITLLGACTQDGPL 116
Query: 129 LLVAEYMPNDTLAKHLFHWETQPMKWAMRL-RV-------------ALHIAEALEYCTSK 174
            ++ EY     L ++L       M+++  + RV                +A  +EY  S 
Sbjct: 117 YVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLAS- 175
Query: 175 ERALYHDLNAYRIVFDDDVNPRLSCFGLMK--NSRDGRSYSTN----LAFTPPEYLRTGR 228
           ++ ++ DL A  ++  ++   +++ FGL +  N+ D    +TN    + +  PE L    
Sbjct: 176 QKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRV 235
Query: 229 VTPESVMYSFGTLLLDL--LSGK---HIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGT 283
            T +S ++SFG L+ ++  L G     IP      L+++ +      +C           
Sbjct: 236 YTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFKLLKEGHRMDKPANCT---------N 286
Query: 284 ELVRLASRCLQYEPRERPNPRSLVTAL 310
           EL  +   C    P +RP  + LV  L
Sbjct: 287 ELYMMMRDCWHAVPSQRPTFKQLVEDL 313

>pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 43.9 bits (102), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 59/267 (22%), Positives = 109/267 (40%), Gaps = 41/267 (15%)
Query: 73  VYKGKLENQFRIAVKRFNRSA----WPDARQFLEEARAVGQLRNRRLANLLGCCCEGDER 128
           + K K +    +AVK     A      D    +E  + +G+ +N  + NLLG C +    
Sbjct: 59  IDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN--IINLLGACTQDGPL 116
Query: 129 LLVAEYMPNDTLAKHLFHWETQPMKWAMRL-RV-------------ALHIAEALEYCTSK 174
            ++  Y     L ++L       M+++  + RV                +A  +EY  S 
Sbjct: 117 YVIVAYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLAS- 175
Query: 175 ERALYHDLNAYRIVFDDDVNPRLSCFGLMK--NSRDGRSYSTN----LAFTPPEYLRTGR 228
           ++ ++ DL A  ++  ++   +++ FGL +  N+ D    +TN    + +  PE L    
Sbjct: 176 QKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRV 235
Query: 229 VTPESVMYSFGTLLLDL--LSGK---HIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGT 283
            T +S ++SFG L+ ++  L G     IP      L+++ +      +C           
Sbjct: 236 YTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFKLLKEGHRMDKPANCT---------N 286
Query: 284 ELVRLASRCLQYEPRERPNPRSLVTAL 310
           EL  +   C    P +RP  + LV  L
Sbjct: 287 ELYMMMRDCWHAVPSQRPTFKQLVEDL 313

>pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271

Iteration: 1
 Score = 43.9 bits (102), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 45/174 (25%), Positives = 82/174 (47%), Gaps = 17/174 (9%)
Query: 83  RIAVKRFNRS--AWPDARQFLE-EARAVGQLRNRRLANLLGCCCEGDERLLVAEYMPNDT 139
           ++A+K  N+   A  D +  +E E   +  LR+  +  L       DE ++V EY  N+ 
Sbjct: 31  KVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIKSKDEIIMVIEYAGNE- 89
Query: 140 LAKHLFHWETQPMKWAMR--LRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRL 197
               LF +  Q  K + +   R    I  A+EYC  + + ++ DL    ++ D+ +N ++
Sbjct: 90  ----LFDYIVQRDKMSEQEARRFFQQIISAVEYC-HRHKIVHRDLKPENLLLDEHLNVKI 144
Query: 198 SCFGLMKNSRDGRSYSTNLA---FTPPEYLRTGRV--TPESVMYSFGTLLLDLL 246
           + FGL     DG    T+     +  PE + +G++   PE  ++S G +L  +L
Sbjct: 145 ADFGLSNIMTDGNFLKTSCGSPNYAAPEVI-SGKLYAGPEVDVWSCGVILYVML 197

>pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274

Iteration: 1
 Score = 43.9 bits (102), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 45/174 (25%), Positives = 82/174 (47%), Gaps = 17/174 (9%)
Query: 83  RIAVKRFNRS--AWPDARQFLE-EARAVGQLRNRRLANLLGCCCEGDERLLVAEYMPNDT 139
           ++A+K  N+   A  D +  +E E   +  LR+  +  L       DE ++V EY  N+ 
Sbjct: 35  KVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIKSKDEIIMVIEYAGNE- 93
Query: 140 LAKHLFHWETQPMKWAMR--LRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRL 197
               LF +  Q  K + +   R    I  A+EYC  + + ++ DL    ++ D+ +N ++
Sbjct: 94  ----LFDYIVQRDKMSEQEARRFFQQIISAVEYC-HRHKIVHRDLKPENLLLDEHLNVKI 148
Query: 198 SCFGLMKNSRDGRSYSTNLA---FTPPEYLRTGRV--TPESVMYSFGTLLLDLL 246
           + FGL     DG    T+     +  PE + +G++   PE  ++S G +L  +L
Sbjct: 149 ADFGLSNIMTDGNFLKTSCGSPNYAAPEVI-SGKLYAGPEVDVWSCGVILYVML 201

>pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335

Iteration: 1
 Score = 43.5 bits (101), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 49/257 (19%), Positives = 104/257 (40%), Gaps = 26/257 (10%)
Query: 76  GKLENQFRIAVKRFNRSAWPDARQ-FLEEARAVGQL-RNRRLANLLGCCCEGDERLLVAE 133
           GK +   ++AVK    +A  D ++  + E + +  L ++  + NLLG C  G   L++ E
Sbjct: 71  GKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGACTHGGPVLVITE 130
Query: 134 YMPNDTLAKHLFHWETQPMKWAMR--------------LRVALHIAEALEYCTSKERALY 179
           Y     L   L       ++++                L  +  +A+ + +  SK   ++
Sbjct: 131 YCCYGDLLNFLRRKRPPGLEYSYNPSHNPEEQLSSRDLLHFSSQVAQGMAFLASK-NCIH 189
Query: 180 HDLNAYRIVFDDDVNPRLSCFGLMKNSRDGRSYSTN------LAFTPPEYLRTGRVTPES 233
            D+ A  ++  +    ++  FGL ++  +  +Y         + +  PE +     T +S
Sbjct: 190 RDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQS 249
Query: 234 VMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLASRCL 293
            ++S+G LL ++ S    P  +   L+  +  + + D     Q  +     +  +   C 
Sbjct: 250 DVWSYGILLWEIFSLGLNP--YPGILVNSKFYKLVKDGYQMAQ-PAFAPKNIYSIMQACW 306
Query: 294 QYEPRERPNPRSLVTAL 310
             EP  RP  + + + L
Sbjct: 307 ALEPTHRPTFQQICSFL 323

>pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330

Iteration: 1
 Score = 43.5 bits (101), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 55/274 (20%), Positives = 113/274 (41%), Gaps = 27/274 (9%)
Query: 66  GEKAPNVVYKGKL-----ENQFRIAVKRFNRSAWPDA-RQFLEEARAVGQLRNRRLANLL 119
           G  A   VYKG       + +  +A+K    +  P A ++ L+EA  +  + N  +  LL
Sbjct: 27  GSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLL 86
Query: 120 GCCCEGDERLLVAEYMPN----DTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKE 175
           G C     + L+ + MP     D + +H  +  +Q +     L   + IA+ + Y   + 
Sbjct: 87  GICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYL-----LNWCVQIAKGMNYLEDR- 139
Query: 176 RALYHDLNAYRIVFDDDVNPRLSCFGLMK-NSRDGRSYSTNLAFTPPEYLRTGRV----- 229
           R ++ DL A  ++     + +++ FGL K    + + Y       P +++    +     
Sbjct: 140 RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIY 199
Query: 230 TPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLA 289
           T +S ++S+G  + +L++    P     D I    I ++ +             ++  + 
Sbjct: 200 THQSDVWSYGVTVWELMTFGSKP----YDGIPASEISSILEKGERLPQPPICTIDVYMIM 255
Query: 290 SRCLQYEPRERPNPRSLVTALVTLQKDTELYLSL 323
            +C   +   RP  R L+     + +D + YL +
Sbjct: 256 VKCWMIDADSRPKFRELIIEFSKMARDPQRYLVI 289

>pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330

Iteration: 1
 Score = 43.5 bits (101), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 55/274 (20%), Positives = 114/274 (41%), Gaps = 27/274 (9%)
Query: 66  GEKAPNVVYKGKL-----ENQFRIAVKRFNRSAWPDA-RQFLEEARAVGQLRNRRLANLL 119
           G  A   VYKG       + +  +A+K    +  P A ++ L+EA  +  + N  +  LL
Sbjct: 27  GSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLL 86
Query: 120 GCCCEGDERLLVAEYMPN----DTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKE 175
           G C     +L++ + MP     D + +H  +  +Q +     L   + IA+ + Y   + 
Sbjct: 87  GICLTSTVQLIM-QLMPFGCLLDYVREHKDNIGSQYL-----LNWCVQIAKGMNYLEDR- 139
Query: 176 RALYHDLNAYRIVFDDDVNPRLSCFGLMK-NSRDGRSYSTNLAFTPPEYLRTGRV----- 229
           R ++ DL A  ++     + +++ FGL K    + + Y       P +++    +     
Sbjct: 140 RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIY 199
Query: 230 TPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLA 289
           T +S ++S+G  + +L++    P     D I    I ++ +             ++  + 
Sbjct: 200 THQSDVWSYGVTVWELMTFGSKP----YDGIPASEISSILEKGERLPQPPICTIDVYMIM 255
Query: 290 SRCLQYEPRERPNPRSLVTALVTLQKDTELYLSL 323
            +C   +   RP  R L+     + +D + YL +
Sbjct: 256 VKCWMIDADSRPKFRELIIEFSKMARDPQRYLVI 289

>pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 43.5 bits (101), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 59/267 (22%), Positives = 109/267 (40%), Gaps = 41/267 (15%)
Query: 73  VYKGKLENQFRIAVKRFNRSA----WPDARQFLEEARAVGQLRNRRLANLLGCCCEGDER 128
           + K K +    +AVK     A      D    +E  + +G+ +N  + NLLG C +    
Sbjct: 59  IDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN--IINLLGACTQDGPL 116
Query: 129 LLVAEYMPNDTLAKHLFHWETQPMKWAMRL-RV-------------ALHIAEALEYCTSK 174
            ++  Y     L ++L       M+++  + RV                +A  +EY  S 
Sbjct: 117 YVIVGYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLAS- 175
Query: 175 ERALYHDLNAYRIVFDDDVNPRLSCFGLMK--NSRDGRSYSTN----LAFTPPEYLRTGR 228
           ++ ++ DL A  ++  ++   +++ FGL +  N+ D    +TN    + +  PE L    
Sbjct: 176 QKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRV 235
Query: 229 VTPESVMYSFGTLLLDL--LSGK---HIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGT 283
            T +S ++SFG L+ ++  L G     IP      L+++ +      +C           
Sbjct: 236 YTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFKLLKEGHRMDKPANCT---------N 286
Query: 284 ELVRLASRCLQYEPRERPNPRSLVTAL 310
           EL  +   C    P +RP  + LV  L
Sbjct: 287 ELYMMMRDCWHAVPSQRPTFKQLVEDL 313

>pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327

Iteration: 1
 Score = 43.5 bits (101), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 55/274 (20%), Positives = 113/274 (41%), Gaps = 27/274 (9%)
Query: 66  GEKAPNVVYKGKL-----ENQFRIAVKRFNRSAWPDA-RQFLEEARAVGQLRNRRLANLL 119
           G  A   VYKG       + +  +A+K    +  P A ++ L+EA  +  + N  +  LL
Sbjct: 24  GSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLL 83
Query: 120 GCCCEGDERLLVAEYMPN----DTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKE 175
           G C     + L+ + MP     D + +H  +  +Q +     L   + IA+ + Y   + 
Sbjct: 84  GICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYL-----LNWCVQIAKGMNYLEDR- 136
Query: 176 RALYHDLNAYRIVFDDDVNPRLSCFGLMK-NSRDGRSYSTNLAFTPPEYLRTGRV----- 229
           R ++ DL A  ++     + +++ FGL K    + + Y       P +++    +     
Sbjct: 137 RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIY 196
Query: 230 TPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLA 289
           T +S ++S+G  + +L++    P     D I    I ++ +             ++  + 
Sbjct: 197 THQSDVWSYGVTVWELMTFGSKP----YDGIPASEISSILEKGERLPQPPICTIDVYMIM 252
Query: 290 SRCLQYEPRERPNPRSLVTALVTLQKDTELYLSL 323
            +C   +   RP  R L+     + +D + YL +
Sbjct: 253 RKCWMIDADSRPKFRELIIEFSKMARDPQRYLVI 286

>pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289

Iteration: 1
 Score = 43.5 bits (101), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 52/244 (21%), Positives = 101/244 (41%), Gaps = 33/244 (13%)
Query: 61  IVSEHGEKAPNVVYKGKL------ENQFRIAVKRF-NRSAWPDARQFLEEARAVGQLRNR 113
            + E GE     VYKG L      E    +A+K   +++  P   +F  EA    +L++ 
Sbjct: 13  FMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHP 72
Query: 114 RLANLLGCCCEGDERLLVAEYMPNDTLAKHLF----HWET------QPMKWAMR----LR 159
            +  LLG   +     ++  Y  +  L + L     H +       + +K A+     + 
Sbjct: 73  NVVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVH 132
Query: 160 VALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDGRSYST----- 214
           +   IA  +EY +S    ++ DL    ++  D +N ++S  GL +       Y       
Sbjct: 133 LVAQIAAGMEYLSS-HHVVHKDLATRNVLVYDKLNVKISDLGLFREVYAADYYKLLGNSL 191
Query: 215 -NLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIP-----PSHALDLIRDRNIQTL 268
             + +  PE +  G+ + +S ++S+G +L ++ S    P         +++IR+R +   
Sbjct: 192 LPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVVEMIRNRQVLPC 251
Query: 269 TDSC 272
            D C
Sbjct: 252 PDDC 255

>pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330

Iteration: 1
 Score = 43.5 bits (101), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 55/274 (20%), Positives = 113/274 (41%), Gaps = 27/274 (9%)
Query: 66  GEKAPNVVYKGKL-----ENQFRIAVKRFNRSAWPDA-RQFLEEARAVGQLRNRRLANLL 119
           G  A   VYKG       + +  +A+K    +  P A ++ L+EA  +  + N  +  LL
Sbjct: 27  GSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLL 86
Query: 120 GCCCEGDERLLVAEYMPN----DTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKE 175
           G C     + L+ + MP     D + +H  +  +Q +     L   + IA+ + Y   + 
Sbjct: 87  GICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYL-----LNWCVQIAKGMNYLEDR- 139
Query: 176 RALYHDLNAYRIVFDDDVNPRLSCFGLMK-NSRDGRSYSTNLAFTPPEYLRTGRV----- 229
           R ++ DL A  ++     + +++ FGL K    + + Y       P +++    +     
Sbjct: 140 RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIY 199
Query: 230 TPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLA 289
           T +S ++S+G  + +L++    P     D I    I ++ +             ++  + 
Sbjct: 200 THQSDVWSYGVTVWELMTFGSKP----YDGIPASEISSILEKGERLPQPPICTIDVYMIM 255
Query: 290 SRCLQYEPRERPNPRSLVTALVTLQKDTELYLSL 323
            +C   +   RP  R L+     + +D + YL +
Sbjct: 256 VKCWMIDADSRPKFRELIIEFSKMARDPQRYLVI 289

>pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308

Iteration: 1
 Score = 43.5 bits (101), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 52/244 (21%), Positives = 101/244 (41%), Gaps = 33/244 (13%)
Query: 61  IVSEHGEKAPNVVYKGKL------ENQFRIAVKRF-NRSAWPDARQFLEEARAVGQLRNR 113
            + E GE     VYKG L      E    +A+K   +++  P   +F  EA    +L++ 
Sbjct: 30  FMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHP 89
Query: 114 RLANLLGCCCEGDERLLVAEYMPNDTLAKHLF----HWET------QPMKWAMR----LR 159
            +  LLG   +     ++  Y  +  L + L     H +       + +K A+     + 
Sbjct: 90  NVVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVH 149
Query: 160 VALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDGRSYST----- 214
           +   IA  +EY +S    ++ DL    ++  D +N ++S  GL +       Y       
Sbjct: 150 LVAQIAAGMEYLSS-HHVVHKDLATRNVLVYDKLNVKISDLGLFREVYAADYYKLLGNSL 208
Query: 215 -NLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIP-----PSHALDLIRDRNIQTL 268
             + +  PE +  G+ + +S ++S+G +L ++ S    P         +++IR+R +   
Sbjct: 209 LPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVVEMIRNRQVLPC 268
Query: 269 TDSC 272
            D C
Sbjct: 269 PDDC 272

>pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330

Iteration: 1
 Score = 43.5 bits (101), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 55/274 (20%), Positives = 113/274 (41%), Gaps = 27/274 (9%)
Query: 66  GEKAPNVVYKGKL-----ENQFRIAVKRFNRSAWPDA-RQFLEEARAVGQLRNRRLANLL 119
           G  A   VYKG       + +  +A+K    +  P A ++ L+EA  +  + N  +  LL
Sbjct: 27  GSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLL 86
Query: 120 GCCCEGDERLLVAEYMPN----DTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKE 175
           G C     + L+ + MP     D + +H  +  +Q +     L   + IA+ + Y   + 
Sbjct: 87  GICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYL-----LNWCVQIAKGMNYLEDR- 139
Query: 176 RALYHDLNAYRIVFDDDVNPRLSCFGLMK-NSRDGRSYSTNLAFTPPEYLRTGRV----- 229
           R ++ DL A  ++     + +++ FGL K    + + Y       P +++    +     
Sbjct: 140 RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIY 199
Query: 230 TPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLA 289
           T +S ++S+G  + +L++    P     D I    I ++ +             ++  + 
Sbjct: 200 THQSDVWSYGVTVWELMTFGSKP----YDGIPASEISSILEKGERLPQPPICTIDVYMIM 255
Query: 290 SRCLQYEPRERPNPRSLVTALVTLQKDTELYLSL 323
            +C   +   RP  R L+     + +D + YL +
Sbjct: 256 RKCWMIDADSRPKFRELIIEFSKMARDPQRYLVI 289

>pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334

Iteration: 1
 Score = 43.5 bits (101), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 55/274 (20%), Positives = 113/274 (41%), Gaps = 27/274 (9%)
Query: 66  GEKAPNVVYKGKL-----ENQFRIAVKRFNRSAWPDA-RQFLEEARAVGQLRNRRLANLL 119
           G  A   VYKG       + +  +A+K    +  P A ++ L+EA  +  + N  +  LL
Sbjct: 31  GSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLL 90
Query: 120 GCCCEGDERLLVAEYMPN----DTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKE 175
           G C     + L+ + MP     D + +H  +  +Q +     L   + IA+ + Y   + 
Sbjct: 91  GICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYL-----LNWCVQIAKGMNYLEDR- 143
Query: 176 RALYHDLNAYRIVFDDDVNPRLSCFGLMK-NSRDGRSYSTNLAFTPPEYLRTGRV----- 229
           R ++ DL A  ++     + +++ FGL K    + + Y       P +++    +     
Sbjct: 144 RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIY 203
Query: 230 TPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLA 289
           T +S ++S+G  + +L++    P     D I    I ++ +             ++  + 
Sbjct: 204 THQSDVWSYGVTVWELMTFGSKP----YDGIPASEISSILEKGERLPQPPICTIDVYMIM 259
Query: 290 SRCLQYEPRERPNPRSLVTALVTLQKDTELYLSL 323
            +C   +   RP  R L+     + +D + YL +
Sbjct: 260 VKCWMIDADSRPKFRELIIEFSKMARDPQRYLVI 293

>pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329

Iteration: 1
 Score = 43.5 bits (101), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 55/274 (20%), Positives = 113/274 (41%), Gaps = 27/274 (9%)
Query: 66  GEKAPNVVYKGKL-----ENQFRIAVKRFNRSAWPDA-RQFLEEARAVGQLRNRRLANLL 119
           G  A   VYKG       + +  +A+K    +  P A ++ L+EA  +  + N  +  LL
Sbjct: 26  GSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLL 85
Query: 120 GCCCEGDERLLVAEYMPN----DTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKE 175
           G C     + L+ + MP     D + +H  +  +Q +     L   + IA+ + Y   + 
Sbjct: 86  GICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYL-----LNWCVQIAKGMNYLEDR- 138
Query: 176 RALYHDLNAYRIVFDDDVNPRLSCFGLMK-NSRDGRSYSTNLAFTPPEYLRTGRV----- 229
           R ++ DL A  ++     + +++ FGL K    + + Y       P +++    +     
Sbjct: 139 RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIY 198
Query: 230 TPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLA 289
           T +S ++S+G  + +L++    P     D I    I ++ +             ++  + 
Sbjct: 199 THQSDVWSYGVTVWELMTFGSKP----YDGIPASEISSILEKGERLPQPPICTIDVYMIM 254
Query: 290 SRCLQYEPRERPNPRSLVTALVTLQKDTELYLSL 323
            +C   +   RP  R L+     + +D + YL +
Sbjct: 255 VKCWMIDADSRPKFRELIIEFSKMARDPQRYLVI 288

>pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331

Iteration: 1
 Score = 43.5 bits (101), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 55/274 (20%), Positives = 114/274 (41%), Gaps = 27/274 (9%)
Query: 66  GEKAPNVVYKGKL-----ENQFRIAVKRFNRSAWPDA-RQFLEEARAVGQLRNRRLANLL 119
           G  A   VYKG       + +  +A+K    +  P A ++ L+EA  +  + N  +  LL
Sbjct: 28  GSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLL 87
Query: 120 GCCCEGDERLLVAEYMPN----DTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKE 175
           G C     +L++ + MP     D + +H  +  +Q +     L   + IA+ + Y   + 
Sbjct: 88  GICLTSTVQLIM-QLMPFGCLLDYVREHKDNIGSQYL-----LNWCVQIAKGMNYLEDR- 140
Query: 176 RALYHDLNAYRIVFDDDVNPRLSCFGLMK-NSRDGRSYSTNLAFTPPEYLRTGRV----- 229
           R ++ DL A  ++     + +++ FGL K    + + Y       P +++    +     
Sbjct: 141 RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIY 200
Query: 230 TPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLA 289
           T +S ++S+G  + +L++    P     D I    I ++ +             ++  + 
Sbjct: 201 THQSDVWSYGVTVWELMTFGSKP----YDGIPASEISSILEKGERLPQPPICTIDVYMIM 256
Query: 290 SRCLQYEPRERPNPRSLVTALVTLQKDTELYLSL 323
            +C   +   RP  R L+     + +D + YL +
Sbjct: 257 VKCWMIDADSRPKFRELIIEFSKMARDPQRYLVI 290

>pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329

Iteration: 1
 Score = 43.5 bits (101), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 55/274 (20%), Positives = 114/274 (41%), Gaps = 27/274 (9%)
Query: 66  GEKAPNVVYKGKL-----ENQFRIAVKRFNRSAWPDA-RQFLEEARAVGQLRNRRLANLL 119
           G  A   VYKG       + +  +A+K    +  P A ++ L+EA  +  + N  +  LL
Sbjct: 26  GSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLL 85
Query: 120 GCCCEGDERLLVAEYMPN----DTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKE 175
           G C     +L++ + MP     D + +H  +  +Q +     L   + IA+ + Y   + 
Sbjct: 86  GICLTSTVQLIM-QLMPFGCLLDYVREHKDNIGSQYL-----LNWCVQIAKGMNYLEDR- 138
Query: 176 RALYHDLNAYRIVFDDDVNPRLSCFGLMK-NSRDGRSYSTNLAFTPPEYLRTGRV----- 229
           R ++ DL A  ++     + +++ FGL K    + + Y       P +++    +     
Sbjct: 139 RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIY 198
Query: 230 TPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLA 289
           T +S ++S+G  + +L++    P     D I    I ++ +             ++  + 
Sbjct: 199 THQSDVWSYGVTVWELMTFGSKP----YDGIPASEISSILEKGERLPQPPICTIDVYMIM 254
Query: 290 SRCLQYEPRERPNPRSLVTALVTLQKDTELYLSL 323
            +C   +   RP  R L+     + +D + YL +
Sbjct: 255 VKCWMIDADSRPKFRELIIEFSKMARDPQRYLVI 288

>pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328

Iteration: 1
 Score = 43.5 bits (101), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 55/274 (20%), Positives = 114/274 (41%), Gaps = 27/274 (9%)
Query: 66  GEKAPNVVYKGKL-----ENQFRIAVKRFNRSAWPDA-RQFLEEARAVGQLRNRRLANLL 119
           G  A   VYKG       + +  +A+K    +  P A ++ L+EA  +  + N  +  LL
Sbjct: 25  GSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLL 84
Query: 120 GCCCEGDERLLVAEYMPN----DTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKE 175
           G C     +L++ + MP     D + +H  +  +Q +     L   + IA+ + Y   + 
Sbjct: 85  GICLTSTVQLIM-QLMPFGCLLDYVREHKDNIGSQYL-----LNWCVQIAKGMNYLEDR- 137
Query: 176 RALYHDLNAYRIVFDDDVNPRLSCFGLMK-NSRDGRSYSTNLAFTPPEYLRTGRV----- 229
           R ++ DL A  ++     + +++ FGL K    + + Y       P +++    +     
Sbjct: 138 RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIY 197
Query: 230 TPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLA 289
           T +S ++S+G  + +L++    P     D I    I ++ +             ++  + 
Sbjct: 198 THQSDVWSYGVTVWELMTFGSKP----YDGIPASEISSILEKGERLPQPPICTIDVYMIM 253
Query: 290 SRCLQYEPRERPNPRSLVTALVTLQKDTELYLSL 323
            +C   +   RP  R L+     + +D + YL +
Sbjct: 254 VKCWMIDADSRPKFRELIIEFSKMARDPQRYLVI 287

>pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352

Iteration: 1
 Score = 43.5 bits (101), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 55/274 (20%), Positives = 113/274 (41%), Gaps = 27/274 (9%)
Query: 66  GEKAPNVVYKGKL-----ENQFRIAVKRFNRSAWPDA-RQFLEEARAVGQLRNRRLANLL 119
           G  A   VYKG       + +  +A+K    +  P A ++ L+EA  +  + N  +  LL
Sbjct: 49  GSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLL 108
Query: 120 GCCCEGDERLLVAEYMPN----DTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKE 175
           G C     + L+ + MP     D + +H  +  +Q +     L   + IA+ + Y   + 
Sbjct: 109 GICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYL-----LNWCVQIAKGMNYLEDR- 161
Query: 176 RALYHDLNAYRIVFDDDVNPRLSCFGLMK-NSRDGRSYSTNLAFTPPEYLRTGRV----- 229
           R ++ DL A  ++     + +++ FGL K    + + Y       P +++    +     
Sbjct: 162 RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIY 221
Query: 230 TPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLA 289
           T +S ++S+G  + +L++    P     D I    I ++ +             ++  + 
Sbjct: 222 THQSDVWSYGVTVWELMTFGSKP----YDGIPASEISSILEKGERLPQPPICTIDVYMIM 277
Query: 290 SRCLQYEPRERPNPRSLVTALVTLQKDTELYLSL 323
            +C   +   RP  R L+     + +D + YL +
Sbjct: 278 VKCWMIDADSRPKFRELIIEFSKMARDPQRYLVI 311

>pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333

Iteration: 1
 Score = 43.5 bits (101), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 55/274 (20%), Positives = 113/274 (41%), Gaps = 27/274 (9%)
Query: 66  GEKAPNVVYKGKL-----ENQFRIAVKRFNRSAWPDA-RQFLEEARAVGQLRNRRLANLL 119
           G  A   VYKG       + +  +A+K    +  P A ++ L+EA  +  + N  +  LL
Sbjct: 30  GSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLL 89
Query: 120 GCCCEGDERLLVAEYMPN----DTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKE 175
           G C     + L+ + MP     D + +H  +  +Q +     L   + IA+ + Y   + 
Sbjct: 90  GICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYL-----LNWCVQIAKGMNYLEDR- 142
Query: 176 RALYHDLNAYRIVFDDDVNPRLSCFGLMK-NSRDGRSYSTNLAFTPPEYLRTGRV----- 229
           R ++ DL A  ++     + +++ FGL K    + + Y       P +++    +     
Sbjct: 143 RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIY 202
Query: 230 TPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLA 289
           T +S ++S+G  + +L++    P     D I    I ++ +             ++  + 
Sbjct: 203 THQSDVWSYGVTVWELMTFGSKP----YDGIPASEISSILEKGERLPQPPICTIDVYMIM 258
Query: 290 SRCLQYEPRERPNPRSLVTALVTLQKDTELYLSL 323
            +C   +   RP  R L+     + +D + YL +
Sbjct: 259 VKCWMIDADSRPKFRELIIEFSKMARDPQRYLVI 292

>pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327

Iteration: 1
 Score = 43.5 bits (101), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 55/274 (20%), Positives = 113/274 (41%), Gaps = 27/274 (9%)
Query: 66  GEKAPNVVYKGKL-----ENQFRIAVKRFNRSAWPDA-RQFLEEARAVGQLRNRRLANLL 119
           G  A   VYKG       + +  +A+K    +  P A ++ L+EA  +  + N  +  LL
Sbjct: 24  GSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLL 83
Query: 120 GCCCEGDERLLVAEYMPN----DTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKE 175
           G C     + L+ + MP     D + +H  +  +Q +     L   + IA+ + Y   + 
Sbjct: 84  GICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYL-----LNWCVQIAKGMNYLEDR- 136
Query: 176 RALYHDLNAYRIVFDDDVNPRLSCFGLMK-NSRDGRSYSTNLAFTPPEYLRTGRV----- 229
           R ++ DL A  ++     + +++ FGL K    + + Y       P +++    +     
Sbjct: 137 RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIY 196
Query: 230 TPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLA 289
           T +S ++S+G  + +L++    P     D I    I ++ +             ++  + 
Sbjct: 197 THQSDVWSYGVTVWELMTFGSKP----YDGIPASEISSILEKGERLPQPPICTIDVYMIM 252
Query: 290 SRCLQYEPRERPNPRSLVTALVTLQKDTELYLSL 323
            +C   +   RP  R L+     + +D + YL +
Sbjct: 253 VKCWMIDADSRPKFRELIIEFSKMARDPQRYLVI 286

>pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315

Iteration: 1
 Score = 43.1 bits (100), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 55/274 (20%), Positives = 113/274 (41%), Gaps = 27/274 (9%)
Query: 66  GEKAPNVVYKGKL-----ENQFRIAVKRFNRSAWPDA-RQFLEEARAVGQLRNRRLANLL 119
           G  A   VYKG       + +  +A+K    +  P A ++ L+EA  +  + N  +  LL
Sbjct: 18  GSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLL 77
Query: 120 GCCCEGDERLLVAEYMPN----DTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKE 175
           G C     + L+ + MP     D + +H  +  +Q +     L   + IA+ + Y   + 
Sbjct: 78  GICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYL-----LNWCVQIAKGMNYLEDR- 130
Query: 176 RALYHDLNAYRIVFDDDVNPRLSCFGLMK-NSRDGRSYSTNLAFTPPEYLRTGRV----- 229
           R ++ DL A  ++     + +++ FGL K    + + Y       P +++    +     
Sbjct: 131 RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIY 190
Query: 230 TPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLA 289
           T +S ++S+G  + +L++    P     D I    I ++ +             ++  + 
Sbjct: 191 THQSDVWSYGVTVWELMTFGSKP----YDGIPASEISSILEKGERLPQPPICTIDVYMIM 246
Query: 290 SRCLQYEPRERPNPRSLVTALVTLQKDTELYLSL 323
            +C   +   RP  R L+     + +D + YL +
Sbjct: 247 VKCWMIDADSRPKFRELIIEFSKMARDPQRYLVI 280

>pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310

Iteration: 1
 Score = 43.1 bits (100), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 56/246 (22%), Positives = 103/246 (41%), Gaps = 27/246 (10%)
Query: 98  RQFLEEARAVGQLRNRRLANLLGCCCEGDERL-LVAEYMPNDTLAKHLFHWETQPMKWAM 156
           R FL+E + +  L +  +   +G   + D+RL  + EY+   TL   +   ++Q   W+ 
Sbjct: 52  RTFLKEVKVMRCLEHPNVLKFIGVLYK-DKRLNFITEYIKGGTLRGIIKSMDSQ-YPWSQ 109
Query: 157 RLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGL-------------- 202
           R+  A  IA  + Y  S    ++ DLN++  +  ++ N  ++ FGL              
Sbjct: 110 RVSFAKDIASGMAYLHSMN-IIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGL 168
Query: 203 --MKNSRDGRSYST--NLAFTPPEYLRTGRVTPESV-MYSFGTLLLDLLSGKHIPPSHAL 257
             +K     + Y+   N  +  PE +  GR   E V ++SFG +L +++   +  P +  
Sbjct: 169 RSLKKPDRKKRYTVVGNPYWMAPEMI-NGRSYDEKVDVFSFGIVLCEIIGRVNADPDY-- 225
Query: 258 DLIRDRNIQTLTDSCLEGQFSSDEGTELVRLASRCLQYEPRERPNPRSLVTALVTLQKDT 317
            L R  +        L+     +       +  RC   +P +RP+   L   L TL+   
Sbjct: 226 -LPRTMDFGLNVRGFLDRYCPPNCPPSFFPITVRCCDLDPEKRPSFVKLEHWLETLRMHL 284
Query: 318 ELYLSL 323
             +L L
Sbjct: 285 AGHLPL 290

>pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327

Iteration: 1
 Score = 43.1 bits (100), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 53/270 (19%), Positives = 110/270 (40%), Gaps = 19/270 (7%)
Query: 66  GEKAPNVVYKGKL-----ENQFRIAVKRFNRSAWPDA-RQFLEEARAVGQLRNRRLANLL 119
           G  A   VYKG       + +  +A+K    +  P A ++ L+EA  +  + N  +  LL
Sbjct: 24  GSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLL 83
Query: 120 GCCCEGDERLLVAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALY 179
           G C     + L+ + MP   L  ++   +   +     L   + IA+ + Y   + R ++
Sbjct: 84  GICLTSTVQ-LITQLMPFGXLLDYVREHKDN-IGSQYLLNWCVQIAKGMNYLEDR-RLVH 140
Query: 180 HDLNAYRIVFDDDVNPRLSCFGLMK-NSRDGRSYSTNLAFTPPEYLRTGRV-----TPES 233
            DL A  ++     + +++ FGL K    + + Y       P +++    +     T +S
Sbjct: 141 RDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQS 200
Query: 234 VMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLASRCL 293
            ++S+G  + +L++    P     D I    I ++ +             ++  +  +C 
Sbjct: 201 DVWSYGVTVWELMTFGSKP----YDGIPASEISSILEKGERLPQPPICTIDVYMIMVKCW 256
Query: 294 QYEPRERPNPRSLVTALVTLQKDTELYLSL 323
             +   RP  R L+     + +D + YL +
Sbjct: 257 MIDADSRPKFRELIIEFSKMARDPQRYLVI 286

>pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327

Iteration: 1
 Score = 43.1 bits (100), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 55/274 (20%), Positives = 114/274 (41%), Gaps = 27/274 (9%)
Query: 66  GEKAPNVVYKGKL-----ENQFRIAVKRFNRSAWPDA-RQFLEEARAVGQLRNRRLANLL 119
           G  A   VYKG       + +  +A+K    +  P A ++ L+EA  +  + N  +  LL
Sbjct: 24  GSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLL 83
Query: 120 GCCCEGDERLLVAEYMPN----DTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKE 175
           G C     +L++ + MP     D + +H  +  +Q +     L   + IA+ + Y   + 
Sbjct: 84  GICLTSTVQLIM-QLMPFGCLLDYVREHKDNIGSQYL-----LNWCVQIAKGMNYLEDR- 136
Query: 176 RALYHDLNAYRIVFDDDVNPRLSCFGLMK-NSRDGRSYSTNLAFTPPEYLRTGRV----- 229
           R ++ DL A  ++     + +++ FGL K    + + Y       P +++    +     
Sbjct: 137 RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIY 196
Query: 230 TPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLA 289
           T +S ++S+G  + +L++    P     D I    I ++ +             ++  + 
Sbjct: 197 THQSDVWSYGVTVWELMTFGSKP----YDGIPASEISSILEKGERLPQPPICTIDVYMIM 252
Query: 290 SRCLQYEPRERPNPRSLVTALVTLQKDTELYLSL 323
            +C   +   RP  R L+     + +D + YL +
Sbjct: 253 VKCWMIDADSRPKFRELIIEFSKMARDPQRYLVI 286

>pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291

Iteration: 1
 Score = 43.1 bits (100), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 41/162 (25%), Positives = 78/162 (48%), Gaps = 17/162 (10%)
Query: 98  RQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAEYMPNDTLAKHLFHWETQ--PMKWA 155
           R+FL EA  +GQ  +  +  L G        +++ E+M N  L   L   + Q   ++  
Sbjct: 60  REFLSEASIMGQFEHPNIIRLEGVVTNSMPVMILTEFMENGALDSFLRLNDGQFTVIQLV 119
Query: 156 MRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMK----NSRDGRS 211
             LR    IA  + Y  ++   ++ DL A  I+ + ++  ++S FGL +    NS D  +
Sbjct: 120 GMLR---GIASGMRYL-AEMSYVHRDLAARNILVNSNLVCKVSDFGLSRFLEENSSDP-T 174
Query: 212 YSTNLA------FTPPEYLRTGRVTPESVMYSFGTLLLDLLS 247
           Y+++L       +T PE +   + T  S  +S+G ++ +++S
Sbjct: 175 YTSSLGGKIPIRWTAPEAIAFRKFTSASDAWSYGIVMWEVMS 216

>pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337

Iteration: 1
 Score = 43.1 bits (100), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 55/274 (20%), Positives = 113/274 (41%), Gaps = 27/274 (9%)
Query: 66  GEKAPNVVYKGKL-----ENQFRIAVKRFNRSAWPDA-RQFLEEARAVGQLRNRRLANLL 119
           G  A   VYKG       + +  +A+K    +  P A ++ L+EA  +  + N  +  LL
Sbjct: 34  GSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLL 93
Query: 120 GCCCEGDERLLVAEYMPN----DTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKE 175
           G C     + L+ + MP     D + +H  +  +Q +     L   + IA+ + Y   + 
Sbjct: 94  GICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYL-----LNWCVQIAKGMNYLEDR- 146
Query: 176 RALYHDLNAYRIVFDDDVNPRLSCFGLMK-NSRDGRSYSTNLAFTPPEYLRTGRV----- 229
           R ++ DL A  ++     + +++ FGL K    + + Y       P +++    +     
Sbjct: 147 RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIY 206
Query: 230 TPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLA 289
           T +S ++S+G  + +L++    P     D I    I ++ +             ++  + 
Sbjct: 207 THQSDVWSYGVTVWELMTFGSKP----YDGIPASEISSILEKGERLPQPPICTIDVYMIM 262
Query: 290 SRCLQYEPRERPNPRSLVTALVTLQKDTELYLSL 323
            +C   +   RP  R L+     + +D + YL +
Sbjct: 263 RKCWMIDADSRPKFRELIIEFSKMARDPQRYLVI 296

>pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328

Iteration: 1
 Score = 43.1 bits (100), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 53/270 (19%), Positives = 111/270 (41%), Gaps = 19/270 (7%)
Query: 66  GEKAPNVVYKGKL-----ENQFRIAVKRFNRSAWPDA-RQFLEEARAVGQLRNRRLANLL 119
           G  A   VYKG       + +  +A+K    +  P A ++ L+EA  +  + N  +  LL
Sbjct: 25  GSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLL 84
Query: 120 GCCCEGDERLLVAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALY 179
           G C     +L++ + MP   L  ++   +   +     L   + IA+ + Y   + R ++
Sbjct: 85  GICLTSTVQLIM-QLMPFGXLLDYVREHKDN-IGSQYLLNWCVQIAKGMNYLEDR-RLVH 141
Query: 180 HDLNAYRIVFDDDVNPRLSCFGLMK-NSRDGRSYSTNLAFTPPEYLRTGRV-----TPES 233
            DL A  ++     + +++ FGL K    + + Y       P +++    +     T +S
Sbjct: 142 RDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQS 201
Query: 234 VMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLASRCL 293
            ++S+G  + +L++    P     D I    I ++ +             ++  +  +C 
Sbjct: 202 DVWSYGVTVWELMTFGSKP----YDGIPASEISSILEKGERLPQPPICTIDVYMIMVKCW 257
Query: 294 QYEPRERPNPRSLVTALVTLQKDTELYLSL 323
             +   RP  R L+     + +D + YL +
Sbjct: 258 MIDADSRPKFRELIIEFSKMARDPQRYLVI 287

>pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328

Iteration: 1
 Score = 42.7 bits (99), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 47/201 (23%), Positives = 84/201 (41%), Gaps = 19/201 (9%)
Query: 84  IAVKRFNRSAW-PDARQ-FLEEARAVGQLRNRRLANLLGCCCEGDERLLVAEYMPNDTLA 141
           +A+K  +++   P + Q    E R +  L +  +  L           L+ EY     + 
Sbjct: 40  VAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIETEKTLYLIMEYASGGEVF 99
Query: 142 KHLF-HWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCF 200
            +L  H   +  +   + R    I  A++YC  K R ++ DL A  ++ D D+N +++ F
Sbjct: 100 DYLVAHGRMKEKEARSKFR---QIVSAVQYCHQK-RIVHRDLKAENLLLDADMNIKIADF 155
Query: 201 GLMKNSRDGRSYSTNLAFTP---PEYLRTGRVT-PESVMYSFGTLLLDLLSGKHIPPSHA 256
           G       G    T     P   PE  +  +   PE  ++S G +L  L+SG     S  
Sbjct: 156 GFSNEFTVGGKLDTFCGSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSG-----SLP 210
Query: 257 LDLIRDRNIQTLTDSCLEGQF 277
            D    +N++ L +  L G++
Sbjct: 211 FD---GQNLKELRERVLRGKY 228

>pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276

Iteration: 1
 Score = 42.4 bits (98), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 53/235 (22%), Positives = 96/235 (40%), Gaps = 24/235 (10%)
Query: 83  RIAVKRFNRS---AWPDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAEYMPNDT 139
           ++AVK  NR    +     +   E + +   R+  +  L        +  +V EY+    
Sbjct: 38  KVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVISTPTDFFMVMEYVSGGE 97
Query: 140 LAKHL-FHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLS 198
           L  ++  H   + M+     R+   I  A++YC  +   ++ DL    ++ D  +N +++
Sbjct: 98  LFDYICKHGRVEEMEAR---RLFQQILSAVDYC-HRHMVVHRDLKPENVLLDAHMNAKIA 153
Query: 199 CFGLMKNSRDGRSYSTNLA---FTPPEYLRTGRV--TPESVMYSFGTLLLDLLSGKHIPP 253
            FGL     DG    T+     +  PE + +GR+   PE  ++S G +L  LL G  +P 
Sbjct: 154 DFGLSNMMSDGEFLRTSCGSPNYAAPEVI-SGRLYAGPEVDIWSCGVILYALLCGT-LP- 210
Query: 254 SHALDLIRDRNIQTLTDSCLEGQFSSDE--GTELVRLASRCLQYEPRERPNPRSL 306
                   D ++ TL      G F   E     +  L    LQ +P +R   + +
Sbjct: 211 ------FDDEHVPTLFKKIRGGVFYIPEYLNRSVATLLMHMLQVDPLKRATIKDI 259

>pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306

Iteration: 1
 Score = 42.4 bits (98), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 43/195 (22%), Positives = 81/195 (41%), Gaps = 18/195 (9%)
Query: 129 LLVAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIV 188
            +  E+    TL + +     + +   + L +   I + ++Y  SK + ++ DL    I 
Sbjct: 110 FIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIHSK-KLIHRDLKPSNIF 168
Query: 189 FDDDVNPRLSCFGLMKNSR-DGRSYSTN--LAFTPPEYLRTGRVTPESVMYSFGTLLLDL 245
             D    ++  FGL+ + + DG+   +   L +  PE + +     E  +Y+ G +L +L
Sbjct: 169 LVDTKQVKIGDFGLVTSLKNDGKRTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAEL 228
Query: 246 LSGKHIPPSHALDLIRD--RNIQTLTDSCLEGQFSSDEGTELVRLASRCLQYEPRERPNP 303
           L        H  D   +  +    L D  +   F   E T L +L S+    +P +RPN 
Sbjct: 229 L--------HVCDTAFETSKFFTDLRDGIISDIFDKKEKTLLQKLLSK----KPEDRPNT 276
Query: 304 RSLVTALVTLQKDTE 318
             ++  L   +K  E
Sbjct: 277 SEILRTLTVWKKSPE 291

>pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334

Iteration: 1
 Score = 42.4 bits (98), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 55/289 (19%), Positives = 117/289 (40%), Gaps = 33/289 (11%)
Query: 46  IETLRTATSGFAMENIVSEHGEKAPNVVYKGKLENQFRIAVKRFNRSAWPDA-RQFLEEA 104
           I+ L +   G   + +    GEK            +  +A+K    +  P A ++ L+EA
Sbjct: 27  IKVLSSGAFGTVYKGLWIPEGEKV-----------KIPVAIKELREATSPKANKEILDEA 75
Query: 105 RAVGQLRNRRLANLLGCCCEGDERLLVAEYMPN----DTLAKHLFHWETQPMKWAMRLRV 160
             +  + N  +  LLG C     +L++ + MP     D + +H  +  +Q +     L  
Sbjct: 76  YVMASVDNPHVCRLLGICLTSTVQLIM-QLMPFGCLLDYVREHKDNIGSQYL-----LNW 129
Query: 161 ALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMK-NSRDGRSYSTNLAFT 219
            + IA+ + Y   + R ++ DL A  ++     + +++ FGL K    + + Y       
Sbjct: 130 CVQIAKGMNYLEDR-RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKV 188
Query: 220 PPEYLRTGRV-----TPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLE 274
           P +++    +     T +S ++S+G  + +L++    P     D I    I ++ +    
Sbjct: 189 PIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKP----YDGIPASEISSILEKGER 244
Query: 275 GQFSSDEGTELVRLASRCLQYEPRERPNPRSLVTALVTLQKDTELYLSL 323
                    ++  +  +C   +   RP  R L+     + +D + YL +
Sbjct: 245 LPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDPQRYLVI 293

>pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327

Iteration: 1
 Score = 42.4 bits (98), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 55/289 (19%), Positives = 116/289 (40%), Gaps = 33/289 (11%)
Query: 46  IETLRTATSGFAMENIVSEHGEKAPNVVYKGKLENQFRIAVKRFNRSAWPDA-RQFLEEA 104
           I+ L +   G   + +    GEK            +  +A+K    +  P A ++ L+EA
Sbjct: 20  IKVLSSGAFGTVYKGLWIPEGEKV-----------KIPVAIKELREATSPKANKEILDEA 68
Query: 105 RAVGQLRNRRLANLLGCCCEGDERLLVAEYMPN----DTLAKHLFHWETQPMKWAMRLRV 160
             +  + N  +  LLG C     + L+ + MP     D + +H  +  +Q +     L  
Sbjct: 69  YVMASVDNPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYL-----LNW 122
Query: 161 ALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMK-NSRDGRSYSTNLAFT 219
            + IA+ + Y   + R ++ DL A  ++     + +++ FGL K    + + Y       
Sbjct: 123 CVQIAKGMNYLEDR-RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKV 181
Query: 220 PPEYLRTGRV-----TPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLE 274
           P +++    +     T +S ++S+G  + +L++    P     D I    I ++ +    
Sbjct: 182 PIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKP----YDGIPASEISSILEKGER 237
Query: 275 GQFSSDEGTELVRLASRCLQYEPRERPNPRSLVTALVTLQKDTELYLSL 323
                    ++  +  +C   +   RP  R L+     + +D + YL +
Sbjct: 238 LPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDPQRYLVI 286

>pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334

Iteration: 1
 Score = 42.4 bits (98), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 55/289 (19%), Positives = 116/289 (40%), Gaps = 33/289 (11%)
Query: 46  IETLRTATSGFAMENIVSEHGEKAPNVVYKGKLENQFRIAVKRFNRSAWPDA-RQFLEEA 104
           I+ L +   G   + +    GEK            +  +A+K    +  P A ++ L+EA
Sbjct: 27  IKVLSSGAFGTVYKGLWIPEGEKV-----------KIPVAIKELREATSPKANKEILDEA 75
Query: 105 RAVGQLRNRRLANLLGCCCEGDERLLVAEYMPN----DTLAKHLFHWETQPMKWAMRLRV 160
             +  + N  +  LLG C     + L+ + MP     D + +H  +  +Q +     L  
Sbjct: 76  YVMASVDNPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYL-----LNW 129
Query: 161 ALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMK-NSRDGRSYSTNLAFT 219
            + IA+ + Y   + R ++ DL A  ++     + +++ FGL K    + + Y       
Sbjct: 130 CVQIAKGMNYLEDR-RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKV 188
Query: 220 PPEYLRTGRV-----TPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLE 274
           P +++    +     T +S ++S+G  + +L++    P     D I    I ++ +    
Sbjct: 189 PIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKP----YDGIPASEISSILEKGER 244
Query: 275 GQFSSDEGTELVRLASRCLQYEPRERPNPRSLVTALVTLQKDTELYLSL 323
                    ++  +  +C   +   RP  R L+     + +D + YL +
Sbjct: 245 LPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDPQRYLVI 293

>pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 42.0 bits (97), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 47/228 (20%), Positives = 92/228 (40%), Gaps = 16/228 (7%)
Query: 99  QFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAEYMPNDTLA--KHLFHWETQPMKWAM 156
           +FL+EA  + Q  +  +  L+G   E    ++    M   TL   +         +  A 
Sbjct: 57  KFLQEALTMRQFDHPHIVKLIGVITENPVWII----MELCTLGELRSFLQVRKYSLDLAS 112
Query: 157 RLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDGRSYSTN- 215
            +  A  ++ AL Y  SK R ++ D+ A  ++   +   +L  FGL +   D   Y  + 
Sbjct: 113 LILYAYQLSTALAYLESK-RFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASK 171
Query: 216 ----LAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDS 271
               + +  PE +   R T  S ++ FG  + ++L     P       +++ ++    ++
Sbjct: 172 GKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKP----FQGVKNNDVIGRIEN 227
Query: 272 CLEGQFSSDEGTELVRLASRCLQYEPRERPNPRSLVTALVTLQKDTEL 319
                   +    L  L ++C  Y+P  RP    L   L T+ ++ +L
Sbjct: 228 GERLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEEEKL 275

>pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302

Iteration: 1
 Score = 42.0 bits (97), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 40/161 (24%), Positives = 75/161 (46%), Gaps = 15/161 (9%)
Query: 98  RQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAEYMPNDTLAKHLFHWETQ--PMKWA 155
           R+FL EA  +GQ  +  +  L G        +++ E+M N  L   L   + Q   ++  
Sbjct: 62  REFLSEASIMGQFEHPNIIRLEGVVTNSMPVMILTEFMENGALDSFLRLNDGQFTVIQLV 121
Query: 156 MRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMK----NSRDGRS 211
             LR    IA  + Y  ++   ++ DL A  I+ + ++  ++S FGL +    NS D   
Sbjct: 122 GMLR---GIASGMRYL-AEMSYVHRDLAARNILVNSNLVCKVSDFGLSRFLEENSSDPTE 177
Query: 212 YST-----NLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLS 247
            S+      + +T PE +   + T  S  +S+G ++ +++S
Sbjct: 178 TSSLGGKIPIRWTAPEAIAFRKFTSASDAWSYGIVMWEVMS 218

>pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276

Iteration: 1
 Score = 42.0 bits (97), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 47/228 (20%), Positives = 92/228 (40%), Gaps = 16/228 (7%)
Query: 99  QFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAEYMPNDTLA--KHLFHWETQPMKWAM 156
           +FL+EA  + Q  +  +  L+G   E    ++    M   TL   +         +  A 
Sbjct: 57  KFLQEALTMRQFDHPHIVKLIGVITENPVWII----MELCTLGELRSFLQVRKYSLDLAS 112
Query: 157 RLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDGRSYSTN- 215
            +  A  ++ AL Y  SK R ++ D+ A  ++   +   +L  FGL +   D   Y  + 
Sbjct: 113 LILYAYQLSTALAYLESK-RFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASK 171
Query: 216 ----LAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDS 271
               + +  PE +   R T  S ++ FG  + ++L     P       +++ ++    ++
Sbjct: 172 GKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKP----FQGVKNNDVIGRIEN 227
Query: 272 CLEGQFSSDEGTELVRLASRCLQYEPRERPNPRSLVTALVTLQKDTEL 319
                   +    L  L ++C  Y+P  RP    L   L T+ ++ +L
Sbjct: 228 GERLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEEEKL 275

>pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328

Iteration: 1
 Score = 41.6 bits (96), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 48/201 (23%), Positives = 83/201 (41%), Gaps = 19/201 (9%)
Query: 84  IAVKRFNRSAW-PDARQ-FLEEARAVGQLRNRRLANLLGCCCEGDERLLVAEYMPNDTLA 141
           +AVK  +++   P + Q    E R +  L +  +  L           LV EY     + 
Sbjct: 43  VAVKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIETEKTLYLVMEYASGGEVF 102
Query: 142 KHLF-HWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCF 200
            +L  H   +  +   + R    I  A++YC  K   ++ DL A  ++ D D+N +++ F
Sbjct: 103 DYLVAHGRMKEKEARAKFR---QIVSAVQYCHQK-YIVHRDLKAENLLLDGDMNIKIADF 158
Query: 201 GLMKNSRDGRSYSTNLAFTP---PEYLRTGRVT-PESVMYSFGTLLLDLLSGKHIPPSHA 256
           G       G    T     P   PE  +  +   PE  ++S G +L  L+SG     S  
Sbjct: 159 GFSNEFTVGNKLDTFCGSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSG-----SLP 213
Query: 257 LDLIRDRNIQTLTDSCLEGQF 277
            D    +N++ L +  L G++
Sbjct: 214 FD---GQNLKELRERVLRGKY 231

>pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327

Iteration: 1
 Score = 41.2 bits (95), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 46/201 (22%), Positives = 83/201 (41%), Gaps = 19/201 (9%)
Query: 84  IAVKRFNRSAWPDA--RQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAEYMPNDTLA 141
           +AVK  +++    +  ++   E R +  L +  +  L           LV EY     + 
Sbjct: 42  VAVKIIDKTQLNSSSLQKLFREVRIMKVLNHPNIVKLFEVIETEKTLYLVMEYASGGEVF 101
Query: 142 KHLF-HWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCF 200
            +L  H   +  +   + R    I  A++YC  K   ++ DL A  ++ D D+N +++ F
Sbjct: 102 DYLVAHGRMKEKEARAKFR---QIVSAVQYCHQK-FIVHRDLKAENLLLDADMNIKIADF 157
Query: 201 GLMKNSRDGRSYSTNLAFTP---PEYLRTGRVT-PESVMYSFGTLLLDLLSGKHIPPSHA 256
           G       G    T     P   PE  +  +   PE  ++S G +L  L+SG     S  
Sbjct: 158 GFSNEFTFGNKLDTFCGSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSG-----SLP 212
Query: 257 LDLIRDRNIQTLTDSCLEGQF 277
            D    +N++ L +  L G++
Sbjct: 213 FD---GQNLKELRERVLRGKY 230

>pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327

Iteration: 1
 Score = 41.2 bits (95), Expect = 8e-04,   Method: Compositional matrix adjust.
 Identities = 46/201 (22%), Positives = 83/201 (41%), Gaps = 19/201 (9%)
Query: 84  IAVKRFNRSAWPDA--RQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAEYMPNDTLA 141
           +AVK  +++    +  ++   E R +  L +  +  L           LV EY     + 
Sbjct: 42  VAVKIIDKTQLNSSSLQKLFREVRIMKVLNHPNIVKLFEVIETEKTLYLVMEYASGGEVF 101
Query: 142 KHLF-HWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCF 200
            +L  H   +  +   + R    I  A++YC  K   ++ DL A  ++ D D+N +++ F
Sbjct: 102 DYLVAHGRMKEKEARAKFR---QIVSAVQYCHQK-FIVHRDLKAENLLLDADMNIKIADF 157
Query: 201 GLMKNSRDGRSYSTNLAFTP---PEYLRTGRVT-PESVMYSFGTLLLDLLSGKHIPPSHA 256
           G       G    T     P   PE  +  +   PE  ++S G +L  L+SG     S  
Sbjct: 158 GFSNEFTFGNKLDTFCGSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSG-----SLP 212
Query: 257 LDLIRDRNIQTLTDSCLEGQF 277
            D    +N++ L +  L G++
Sbjct: 213 FD---GQNLKELRERVLRGKY 230

Structure Templates Detected by RPS-BLAST

Original result of RPS-BLAST against PDB70 database

ID	Length	Definition	E-value
Query	329
3uim_A	326	Brassinosteroid insensitive 1-associated receptor;	1e-61
2nru_A	307	Interleukin-1 receptor-associated kinase 4; inhibi	2e-60
2qkw_B	321	Protein kinase; three-helix bundle motif, AVRPTO-P	5e-59
3kmu_A	271	ILK, integrin-linked kinase; cell adhesion, ANK re	4e-26
3soc_A	322	Activin receptor type-2A; structural genomics cons	2e-25
3p86_A	309	Serine/threonine-protein kinase CTR1; ETR1, ERS1,	1e-23
3og7_A	289	AKAP9-BRAF fusion protein; proto-oncogene, V600E,	2e-21
2eva_A	307	TAK1 kinase - TAB1 chimera fusion protein; transfe	3e-21
3dtc_A	271	Mitogen-activated protein kinase kinase kinase 9;	1e-20
4f0f_A	287	Serine/threonine-protein kinase ROCO4; LRRK2, ATP-	2e-20
3lb7_A	307	RAF proto-oncogene serine/threonine-protein kinas;	2e-19
3s95_A	310	LIMK-1, LIM domain kinase 1; structural genomics,	2e-18
3kfa_A	288	Tyrosine-protein kinase ABL1; CML, drug resistance	2e-18
1byg_A	278	CSK, protein (C-terminal SRC kinase); protein kina	2e-18
3g2f_A	336	Bone morphogenetic protein receptor type-2; kinase	3e-18
2y4i_B	319	KSR2, HKSR2, kinase suppressor of RAS 2; transfera	3e-18
1opk_A	495	P150, C-ABL, proto-oncogene tyrosine-protein kinas	5e-18
1k9a_A	450	Carboxyl-terminal SRC kinase; COOH-terminal SRC ki	5e-18
1qcf_A	454	Haematopoetic cell kinase (HCK); tyrosine kinase-i	8e-18
3cbl_A	377	C-FES, proto-oncogene tyrosine-protein kinase FES/	1e-17
1fmk_A	452	C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros	1e-17
2h8h_A	535	Proto-oncogene tyrosine-protein kinase SRC; SRC ki	3e-17
3sxs_A	268	Cytoplasmic tyrosine-protein kinase BMX; transfera	6e-17
1qpc_A	279	LCK kinase; alpha beta fold, transferase; HET: PTR	4e-16
3t9t_A	267	Tyrosine-protein kinase ITK/TSK; kinase domain, al	8e-16
4fvq_A	289	Tyrosine-protein kinase JAK2; janus protein kinase	1e-15
3pls_A	298	Macrophage-stimulating protein receptor; protein k	1e-15
3gen_A	283	Tyrosine-protein kinase BTK; bruton'S tyrosine kin	2e-15
2j0j_A	656	Focal adhesion kinase 1; cell migration, FERM, tra	6e-15
1mqb_A	333	Ephrin type-A receptor 2; tyrosine protein kinase,	7e-15
1p4o_A	322	Insulin-like growth factor I receptor protein; IGF	1e-14
3lzb_A	327	Epidermal growth factor receptor; epidermal growth	1e-14
1mp8_A	281	Focal adhesion kinase 1; tyrosine protein kinase,	2e-14
3f66_A	298	Hepatocyte growth factor receptor; C-Met, protein	3e-14
4aoj_A	329	High affinity nerve growth factor receptor; transf	3e-14
2qol_A	373	Ephrin receptor; receptor tyrosine kinase, juxtame	4e-14
3qup_A	323	Tyrosine-protein kinase receptor TYRO3; protein ki	5e-14
3l9p_A	367	Anaplastic lymphoma kinase; kinase domain, ATP-bin	5e-14
3kul_A	325	Ephrin type-A receptor 8; ATP-binding, kinase, nuc	6e-14
2yfx_A	327	Tyrosine-protein kinase receptor; nucleotide-bindi	8e-14
2w1i_A	326	JAK2; chromosomal rearrangement, nucleotide-bindin	9e-14
3c1x_A	373	Hepatocyte growth factor receptor; receptor tyrosi	1e-13
3ugc_A	295	Tyrosine-protein kinase JAK2; small molecule inhib	2e-13
3poz_A	327	Epidermal growth factor receptor; kinase domain, a	2e-13
3kex_A	325	Receptor tyrosine-protein kinase ERBB-3; kinase do	2e-13
3lxp_A	318	Non-receptor tyrosine-protein kinase TYK2; JAK3, i	2e-13
2ozo_A	613	Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t	2e-13
3brb_A	313	Proto-oncogene tyrosine-protein kinase MER; ATP-bi	2e-13
1fvr_A	327	Tyrosine-protein kinase TIE-2; tyrosine kinase, tr	8e-13
3v5q_A	297	NT-3 growth factor receptor; kinase domain, kinase	1e-12
3cc6_A	281	Protein tyrosine kinase 2 beta; focal adhesion kin	2e-12
1xbb_A	291	Tyrosine-protein kinase SYK; gleevec, STI-571, ima	3e-12
1u59_A	287	Tyrosine-protein kinase ZAP-70; transferase; HET:	7e-12
3mdy_A	337	Bone morphogenetic protein receptor type-1B; compl	7e-12
1luf_A	343	Muscle-specific tyrosine kinase receptor MUSK; pho	3e-11
2pvf_A	334	Fibroblast growth factor receptor 2; kinase domain	5e-11
3zzw_A	289	Tyrosine-protein kinase transmembrane receptor RO;	5e-11
4e5w_A	302	Tyrosine-protein kinase JAK1; kinase domain, trans	5e-11
3tt0_A	382	Basic fibroblast growth factor receptor 1; kinase	8e-11
1b6c_B	342	TGF-B superfamily receptor type I; complex (isomer	1e-10
3gxj_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	2e-10
3lxl_A	327	Tyrosine-protein kinase JAK3; TYK2, inflammation,	3e-10
2psq_A	370	Fibroblast growth factor receptor 2; kinase domain	4e-10
1t46_A	313	HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom	7e-10
1u46_A	291	ACK-1, activated CDC42 kinase 1; tyrosine kinase,	7e-10
3q4u_A	301	Activin receptor type-1; structural genomics conso	7e-10
2i1m_A	333	Macrophage colony-stimulating factor 1 receptor; k	1e-09
2ivs_A	314	Proto-oncogene tyrosine-protein kinase receptor RE	1e-09
3q60_A	371	ROP5B; pseudokinase, transferase; HET: ATP; 1.72A	2e-09
1t4h_A	290	Serine/threonine-protein kinase WNK1; protein seri	3e-09
2xir_A	316	Vascular endothelial growth factor receptor 2; ang	2e-08
3p23_A	432	Serine/threonine-protein kinase/endoribonuclease;	2e-08
3byv_A	377	Rhoptry kinase; malaria, transferase, structural g	2e-08
1rjb_A	344	FL cytokine receptor; kinase, structure, autoinhib	4e-08
3dzo_A	413	Rhoptry kinase domain; parasitic disease, transfer	5e-08
4apc_A	350	Serine/threonine-protein kinase NEK1; transferase;	3e-07
2rio_A	434	Serine/threonine-protein kinase/endoribonuclease I	7e-07
3e7e_A	365	HBUB1, BUB1A, mitotic checkpoint serine/threonine-	8e-07
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	5e-06
2c30_A	321	Serine/threonine-protein kinase PAK 6; CRIB domain	5e-06
3uqc_A	286	Probable conserved transmembrane protein; structur	6e-06
1phk_A	298	Phosphorylase kinase; glycogen metabolism, transfe	9e-06
3fxz_A	297	Serine/threonine-protein kinase PAK 1; transferase	1e-05
1zy4_A	303	Serine/threonine-protein kinase GCN2; translation	1e-05
4eqm_A	294	Protein kinase; transferase; HET: ANP; 3.00A {Stap	1e-05
3fe3_A	328	MAP/microtubule affinity-regulating kinase 3; seri	2e-05
4g31_A	299	Eukaryotic translation initiation factor 2-alpha;	2e-05
2a19_B	284	Interferon-induced, double-stranded RNA-activated	3e-05
2w4o_A	349	Calcium/calmodulin-dependent protein kinase type I	3e-05
2y7j_A	365	Phosphorylase B kinase gamma catalytic chain, test	3e-05
2w5a_A	279	Serine/threonine-protein kinase NEK2; Ser/Thr prot	4e-05
2buj_A	317	Serine/threonine-protein kinase 16; transferase, A	6e-05
2wqm_A	310	Serine/threonine-protein kinase NEK7; ATP-binding,	8e-05
3is5_A	285	Calcium-dependent protein kinase; CDPK, structural	1e-04
3cek_A	313	Dual specificity protein kinase TTK; HMPS1, PYT, E	1e-04
3p1a_A	311	MYT1 kinase, membrane-associated tyrosine- and thr	1e-04
4g3f_A	336	NF-kappa-beta-inducing kinase; non-RD kinase, prot	2e-04
3mwu_A	486	Calmodulin-domain protein kinase 1; serine/threoni	3e-04
3fdn_A	279	Serine/threonine-protein kinase 6; aurora kinase i	3e-04
2zmd_A	390	Dual specificity protein kinase TTK; MPS1, T686A,	4e-04
3pvu_A	695	Beta-adrenergic receptor kinase 1; transferase, se	4e-04
3uto_A	573	Twitchin; kinase, muscle sarcomere, transferase; H	4e-04
2acx_A	576	G protein-coupled receptor kinase 6; GRK, G transf	5e-04
4ejn_A	446	RAC-alpha serine/threonine-protein kinase; AKT1, a	5e-04
3dbq_A	343	Dual specificity protein kinase TTK; MPS1 structur	6e-04
2h34_A	309	Serine/threonine-protein kinase PKNE; apoenzyme, t	6e-04

>3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326

 Score =  198 bits (506), Expect = 1e-61
 Identities = 87/310 (28%), Positives = 141/310 (45%), Gaps = 31/310 (10%)

Query: 26  DVENEEKPGVD--NVPVFCEYSIETLRTATSGFAMENIVSEHGEKAPNVVYKGKLENQFR 83
           DV  EE P V    +  F   S+  L+ A+  F+ +NI+   G      VYKG+L +   
Sbjct: 3   DVPAEEDPEVHLGQLKRF---SLRELQVASDNFSNKNIL---GRGGFGKVYKGRLADGTL 56

Query: 84  IAVKRFNR-SAWPDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAEYMPNDTLAK 142
           +AVKR           QF  E   +    +R L  L G C    ERLLV  YM N ++A 
Sbjct: 57  VAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVAS 116

Query: 143 HLF--HWETQPMKWAMRLRVALHIAEALEY--CTSKERALYHDLNAYRIVFDDDVNPRLS 198
            L        P+ W  R R+AL  A  L Y       + ++ D+ A  I+ D++    + 
Sbjct: 117 CLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVG 176

Query: 199 CFGLMKNSRDGRSY-STNLAFT----PPEYLRTGRVTPESVMYSFGTLLLDLLSGK---- 249
            FGL K      ++ +T +  T     PEYL TG+ + ++ ++ +G +LL+L++G+    
Sbjct: 177 DFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFD 236

Query: 250 -HIPP--------SHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLASRCLQYEPRER 300
                             L++++ ++ L D  L+G +  +E  +L+++A  C Q  P ER
Sbjct: 237 LARLANDDDVMLLDWVKGLLKEKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMER 296

Query: 301 PNPRSLVTAL 310
           P    +V  L
Sbjct: 297 PKMSEVVRML 306

>2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307

 Score =  194 bits (496), Expect = 2e-60
 Identities = 81/318 (25%), Positives = 140/318 (44%), Gaps = 44/318 (13%)

Query: 28  ENEEKPGVD-NVPVFCEYSIETLRTATSGFAMENIVSEH---GEKAPNVVYKGKLENQFR 83
           EN+     D     F   S   L+  T+ F    I       GE    VVYKG + N   
Sbjct: 1   ENKSLEVSDTRFHSF---SFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYVNNT-T 56

Query: 84  IAVKRFNRSAWPDA----RQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAEYMPNDT 139
           +AVK+             +QF +E + + + ++  L  LLG   +GD+  LV  YMPN +
Sbjct: 57  VAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGS 116

Query: 140 LAKHLFHWE-TQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYR------IVFDDD 192
           L   L   + T P+ W MR ++A   A  + +       L+ + + +R      I+ D+ 
Sbjct: 117 LLDRLSCLDGTPPLSWHMRCKIAQGAANGINF-------LHENHHIHRDIKSANILLDEA 169

Query: 193 VNPRLSCFGLMK-NSRDGRSY-STNLAFTP----PEYLRTGRVTPESVMYSFGTLLLDLL 246
              ++S FGL + + +  ++  ++ +  T     PE L  G +TP+S +YSFG +LL+++
Sbjct: 170 FTAKISDFGLARASEKFAQTVMTSRIVGTTAYMAPEAL-RGEITPKSDIYSFGVVLLEII 228

Query: 247 SGK-----HIPPSHALD-----LIRDRNIQTLTDSCLEGQFSSDEGTELVRLASRCLQYE 296
           +G      H  P   LD        ++ I+   D  +     S     +  +AS+CL  +
Sbjct: 229 TGLPAVDEHREPQLLLDIKEEIEDEEKTIEDYIDKKM-NDADSTSVEAMYSVASQCLHEK 287

Query: 297 PRERPNPRSLVTALVTLQ 314
             +RP+ + +   L  + 
Sbjct: 288 KNKRPDIKKVQQLLQEMT 305

>2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321

 Score =  191 bits (487), Expect = 5e-59
 Identities = 78/317 (24%), Positives = 140/317 (44%), Gaps = 28/317 (8%)

Query: 14  GSEYGEAAPEAQDVENEEKPGVDNVPVFCEYSIETLRTATSGFAMENIVSEHGEKAPNVV 73
           GS+Y +A     D  +                +  L  AT+ F  + ++   G      V
Sbjct: 2   GSKYSKATNSINDALSSSYLVPFESYRV---PLVDLEEATNNFDHKFLI---GHGVFGKV 55

Query: 74  YKGKLENQFRIAVKRFNRSAWPDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAE 133
           YKG L +  ++A+KR    +     +F  E   +   R+  L +L+G C E +E +L+ +
Sbjct: 56  YKGVLRDGAKVALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIGFCDERNEMILIYK 115

Query: 134 YMPNDTLAKHLF--HWETQPMKWAMRLRVALHIAEALEYCTSKERALYH-DLNAYRIVFD 190
           YM N  L +HL+     T  M W  RL + +  A  L Y     RA+ H D+ +  I+ D
Sbjct: 116 YMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYL--HTRAIIHRDVKSINILLD 173

Query: 191 DDVNPRLSCFGLMK-NSRDGRSY-STNLAFTP----PEYLRTGRVTPESVMYSFGTLLLD 244
           ++  P+++ FG+ K  +   +++ ST +  T     PEY   GR+T +S +YSFG +L +
Sbjct: 174 ENFVPKITDFGISKKGTELDQTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFE 233

Query: 245 LLSGK----HIPPSH-------ALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLASRCL 293
           +L  +       P         A++   +  ++ + D  L  +   +   +    A +CL
Sbjct: 234 VLCARSAIVQSLPREMVNLAEWAVESHNNGQLEQIVDPNLADKIRPESLRKFGDTAVKCL 293

Query: 294 QYEPRERPNPRSLVTAL 310
                +RP+   ++  L
Sbjct: 294 ALSSEDRPSMGDVLWKL 310

>3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271

 Score =  103 bits (260), Expect = 4e-26
 Identities = 48/262 (18%), Positives = 95/262 (36%), Gaps = 34/262 (12%)

Query: 72  VVYKGKLENQFRIAVKRFNRSAWPDA--RQFLEEARAVGQLRNRRLANLLGCCCEGDERL 129
            ++KG+ +    I VK      W     R F EE   +    +  +  +LG C       
Sbjct: 25  ELWKGRWQGN-DIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAPH 83

Query: 130 L--VAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYH-DLNAYR 186
              +  +MP  +L   L       +  +  ++ AL +A  + +  + E  +    LN+  
Sbjct: 84  PTLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLHTLEPLIPRHALNSRS 143

Query: 187 IVFDDDVNPRLSCFGLMKNSRDGRSY-STNLAFTP----PEYLRTGRVTPESV---MYSF 238
           ++ D+D+  R+S   +        S+ S    + P    PE L+            M+SF
Sbjct: 144 VMIDEDMTARISMADV------KFSFQSPGRMYAPAWVAPEALQKKPEDTNRRSADMWSF 197

Query: 239 GTLLLDLLSGK----HIPPSHALDLIRDRNIQ-TLTDSCLEGQFSSDEGTELVRLASRCL 293
             LL +L++ +     +        +    ++ T+                + +L   C+
Sbjct: 198 AVLLWELVTREVPFADLSNMEIGMKVALEGLRPTIPPGISP---------HVSKLMKICM 248

Query: 294 QYEPRERPNPRSLVTALVTLQK 315
             +P +RP    +V  L  +Q 
Sbjct: 249 NEDPAKRPKFDMIVPILEKMQD 270

>3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322

 Score =  102 bits (257), Expect = 2e-25
 Identities = 49/322 (15%), Positives = 105/322 (32%), Gaps = 57/322 (17%)

Query: 43  EYSIETLRTATSGFAMENIVSE--HGEKAPNVVYKGKLENQFRIAVKRFNRSAWPDARQF 100
           +   E L   +    +  + +    G      V+K +L N+  +AVK F      D + +
Sbjct: 13  DLGTENLYFQSMPLQLLEVKARGRFGC-----VWKAQLLNE-YVAVKIFPIQ---DKQSW 63

Query: 101 LEEA--RAVGQLRNRRLANLLGCCCEGD----ERLLVAEYMPNDTLAKHLFHWETQPMKW 154
             E    ++  +++  +   +G    G     +  L+  +    +L+  L       + W
Sbjct: 64  QNEYEVYSLPGMKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFLKA---NVVSW 120

Query: 155 AMRLRVALHIAEALEY--------CTSKERALYH-DLNAYRIVFDDDVNPRLSCFGLMKN 205
                +A  +A  L Y            + A+ H D+ +  ++  +++   ++ FGL   
Sbjct: 121 NELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALK 180

Query: 206 SRDGRSYSTNLAFT------PPEYLRTGRVTPESV-----MYSFGTLLLDLLSGK----- 249
              G+S               PE L               MY+ G +L +L S       
Sbjct: 181 FEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADG 240

Query: 250 -----------HIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGT-ELVRLASRCLQYEP 297
                       I    +L+ +++  +       L   +    G   L      C  ++ 
Sbjct: 241 PVDEYMLPFEEEIGQHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDA 300

Query: 298 RERPNPRSLVTALVTLQKDTEL 319
             R +   +   +  +Q+ T +
Sbjct: 301 EARLSAGCVGERITQMQRLTNI 322

>3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309

 Score = 97.4 bits (243), Expect = 1e-23
 Identities = 50/258 (19%), Positives = 106/258 (41%), Gaps = 23/258 (8%)

Query: 72  VVYKGKLENQFRIAVKRFNRSAWPDA--RQFLEEARAVGQLRNRRLANLLGCCCEGDERL 129
            V++ +      +AVK      +      +FL E   + +LR+  +   +G   +     
Sbjct: 52  TVHRAEWHGS-DVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPNLS 110

Query: 130 LVAEYMPNDTLAKHLFHWET-QPMKWAMRLRVALHIAEALEYCTSKERALYH-DLNAYRI 187
           +V EY+   +L + L      + +    RL +A  +A+ + Y  ++   + H +L +  +
Sbjct: 111 IVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRNPPIVHRNLKSPNL 170

Query: 188 VFDDDVNPRLSCFGLMKNSRDGRSYSTNLAFTP----PEYLRTGRVTPESVMYSFGTLLL 243
           + D     ++  FGL +        S + A TP    PE LR      +S +YSFG +L 
Sbjct: 171 LVDKKYTVKVCDFGLSRLKASTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILW 230

Query: 244 DLLSGK----HIPPSHALDLIRDRNIQ-TLTDSCLEGQFSSDEGTELVRLASRCLQYEPR 298
           +L + +    ++ P+  +  +  +  +  +  +            ++  +   C   EP 
Sbjct: 231 ELATLQQPWGNLNPAQVVAAVGFKCKRLEIPRNLNP---------QVAAIIEGCWTNEPW 281

Query: 299 ERPNPRSLVTALVTLQKD 316
           +RP+  +++  L  L K 
Sbjct: 282 KRPSFATIMDLLRPLIKS 299

>3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289

 Score = 91.2 bits (227), Expect = 2e-21
 Identities = 55/266 (20%), Positives = 109/266 (40%), Gaps = 38/266 (14%)

Query: 73  VYKGKLENQFRIAVKRFNRSAWPDA--RQFLEEARAVGQLRNRRLANLLGCCCEGDERL- 129
           VYKGK      +AVK  N +A      + F  E   + + R+  +   +G       +L 
Sbjct: 40  VYKGKWHGD--VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTA--PQLA 95

Query: 130 LVAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYH-DLNAYRIV 188
           +V ++    +L  HL H      +    + +A   A  ++Y  +K   + H DL +  I 
Sbjct: 96  IVTQWCEGSSLYHHL-HASETKFEMKKLIDIARQTARGMDYLHAKS--IIHRDLKSNNIF 152

Query: 189 FDDDVNPRLSCFGL--MKNSRDGRSYSTNLAFTP----PEYLRTGRVTPESV---MYSFG 239
             +D   ++  FGL   K+   G      L+ +     PE +R     P S    +Y+FG
Sbjct: 153 LHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFG 212

Query: 240 TLLLDLLSGK-----HIPPSHALDLI----RDRNIQTLTDSCLEGQFSSDEGTELVRLAS 290
            +L +L++G+            ++++       ++  +  +C +          + RL +
Sbjct: 213 IVLYELMTGQLPYSNINNRDQIIEMVGRGSLSPDLSKVRSNCPK---------RMKRLMA 263

Query: 291 RCLQYEPRERPNPRSLVTALVTLQKD 316
            CL+ +  ERP+   ++  +  L ++
Sbjct: 264 ECLKKKRDERPSFPRILAEIEELARE 289

>2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307

 Score = 90.9 bits (226), Expect = 3e-21
 Identities = 48/259 (18%), Positives = 102/259 (39%), Gaps = 31/259 (11%)

Query: 72  VVYKGKLENQFRIAVKRFNRSAWPDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLV 131
           VV K K   +  +A+K+       + + F+ E R + ++ +  +  L G C   +   LV
Sbjct: 23  VVCKAKWRAK-DVAIKQIESE--SERKAFIVELRQLSRVNHPNIVKLYGACL--NPVCLV 77

Query: 132 AEYMPNDTLAKHLFHWETQP-MKWAMRLRVALHIAEALEYC-TSKERALYH-DLNAYRIV 188
            EY    +L   L   E  P    A  +   L  ++ + Y  + + +AL H DL    ++
Sbjct: 78  MEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLL 137

Query: 189 FDDD-VNPRLSCFGLMKNSRDGRSYSTNLAFTP----PEYLRTGRVTPESVMYSFGTLLL 243
                   ++  FG    + D +++ TN   +     PE       + +  ++S+G +L 
Sbjct: 138 LVAGGTVLKICDFGT---ACDIQTHMTNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILW 194

Query: 244 DLLSGK------HIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLASRCLQYEP 297
           ++++ +        P    +  + +     L  +  +          +  L +RC   +P
Sbjct: 195 EVITRRKPFDEIGGPAFRIMWAVHNGTRPPLIKNLPK---------PIESLMTRCWSKDP 245

Query: 298 RERPNPRSLVTALVTLQKD 316
            +RP+   +V  +  L + 
Sbjct: 246 SQRPSMEEIVKIMTHLMRY 264

>3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271

 Score = 88.5 bits (220), Expect = 1e-20
 Identities = 53/266 (19%), Positives = 95/266 (35%), Gaps = 40/266 (15%)

Query: 72  VVYKGKLENQFRIAVKRFNRSAWPDA----RQFLEEARAVGQLRNRRLANLLGCCCEGDE 127
            VY+        +AVK        D         +EA+    L++  +  L G C +   
Sbjct: 22  KVYRAFWIGD-EVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLKEPN 80

Query: 128 RLLVAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYC-TSKERALYH-DLNAY 185
             LV E+     L + L     + +   + +  A+ IA  + Y        + H DL + 
Sbjct: 81  LCLVMEFARGGPLNRVL---SGKRIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSS 137

Query: 186 RIVFDDDVNPRLSC--------FGLMKNSRD-GRSYSTNLAFTP----PEYLRTGRVTPE 232
            I+    V              FGL   +R+  R+   + A       PE +R    +  
Sbjct: 138 NILILQKVENGDLSNKILKITDFGL---AREWHRTTKMSAAGAYAWMAPEVIRASMFSKG 194

Query: 233 SVMYSFGTLLLDLLSGK----HIPPSHALDLIRDRNIQ-TLTDSCLEGQFSSDEGTELVR 287
           S ++S+G LL +LL+G+     I        +    +   +  +C E            +
Sbjct: 195 SDVWSYGVLLWELLTGEVPFRGIDGLAVAYGVAMNKLALPIPSTCPE---------PFAK 245

Query: 288 LASRCLQYEPRERPNPRSLVTALVTL 313
           L   C   +P  RP+  +++  L T+
Sbjct: 246 LMEDCWNPDPHSRPSFTNILDQLTTI 271

>4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287

 Score = 88.1 bits (219), Expect = 2e-20
 Identities = 55/266 (20%), Positives = 106/266 (39%), Gaps = 42/266 (15%)

Query: 72  VVYKGK-LENQFRIAVKRFNRSAWPDA-------RQFLEEARAVGQLRNRRLANLLGCCC 123
           +V+KG+ ++++  +A+K                 ++F  E   +  L +  +  L G   
Sbjct: 34  LVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMH 93

Query: 124 EGDERLLVAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYH-DL 182
                 +V E++P   L   L   +  P+KW+++LR+ L IA  +EY  ++   + H DL
Sbjct: 94  NPP--RMVMEFVPCGDLYHRL-LDKAHPIKWSVKLRLMLDIALGIEYMQNQNPPIVHRDL 150

Query: 183 NAYRIVFDDDVNPRLSC-----FGLMKNSRDGRSYSTNLAFTP----PEYL--RTGRVTP 231
            +  I           C     FGL   S+      + L        PE +       T 
Sbjct: 151 RSPNIFLQSLDENAPVCAKVADFGL---SQQSVHSVSGLLGNFQWMAPETIGAEEESYTE 207

Query: 232 ESVMYSFGTLLLDLLSGK----HIPPSHA--LDLIRDRNIQ-TLTDSCLEGQFSSDEGTE 284
           ++  YSF  +L  +L+G+             +++IR+  ++ T+ + C            
Sbjct: 208 KADTYSFAMILYTILTGEGPFDEYSYGKIKFINMIREEGLRPTIPEDCPP---------R 258

Query: 285 LVRLASRCLQYEPRERPNPRSLVTAL 310
           L  +   C   +P++RP+   +V  L
Sbjct: 259 LRNVIELCWSGDPKKRPHFSYIVKEL 284

>3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310

 Score = 83.5 bits (207), Expect = 2e-18
 Identities = 50/278 (17%), Positives = 94/278 (33%), Gaps = 38/278 (13%)

Query: 73  VYKGKLENQFR-IAVKRFNRSAWPDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLV 131
             K         + +K   R      R FL+E + +  L +  +   +G   +      +
Sbjct: 26  AIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVLYKDKRLNFI 85

Query: 132 AEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYH-DLNAYRIVFD 190
            EY+   TL   +         W+ R+  A  IA  + Y  S    + H DLN++  +  
Sbjct: 86  TEYIKGGTLRGII-KSMDSQYPWSQRVSFAKDIASGMAYLHSMN--IIHRDLNSHNCLVR 142

Query: 191 DDVNPRLSCFGL--------------MKNSRDGRSYSTNLAFTP----PEYLRTGRVTPE 232
           ++ N  ++ FGL                  +  R     +   P    PE +       +
Sbjct: 143 ENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEK 202

Query: 233 SVMYSFGTLLLDLLSGKHIPP-----SHALDLIRDRNI-QTLTDSCLEGQFSSDEGTELV 286
             ++SFG +L +++   +  P     +    L     + +    +C              
Sbjct: 203 VDVFSFGIVLCEIIGRVNADPDYLPRTMDFGLNVRGFLDRYCPPNCPP---------SFF 253

Query: 287 RLASRCLQYEPRERPNPRSLVTALVTLQKDTELYLSLP 324
            +  RC   +P +RP+   L   L TL+     +L L 
Sbjct: 254 PITVRCCDLDPEKRPSFVKLEHWLETLRMHLAGHLPLG 291

>3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288

 Score = 82.7 bits (205), Expect = 2e-18
 Identities = 57/264 (21%), Positives = 110/264 (41%), Gaps = 24/264 (9%)

Query: 72  VVYKGKLENQ-FRIAVKRFNRSAWPDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLL 130
            VY+G  +     +AVK        +  +FL+EA  + ++++  L  LLG C       +
Sbjct: 28  EVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYI 86

Query: 131 VAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYH-DLNAYRIVF 189
           + E+M    L  +L     Q +   + L +A  I+ A+EY   K     H DL A   + 
Sbjct: 87  ITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKN--FIHRDLAARNCLV 144

Query: 190 DDDVNPRLSCFGLMKNSRDGRSYSTNLA-----FTPPEYLRTGRVTPESVMYSFGTLLLD 244
            ++   +++ FGL +        +   A     +T PE L   + + +S +++FG LL +
Sbjct: 145 GENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWE 204

Query: 245 LLSGKHIP-----PSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLASRCLQYEPRE 299
           + +    P      S   +L+         + C E         ++  L   C Q+ P +
Sbjct: 205 IATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPE---------KVYELMRACWQWNPSD 255

Query: 300 RPNPRSLVTALVTLQKDTELYLSL 323
           RP+   +  A  T+ +++ +   +
Sbjct: 256 RPSFAEIHQAFETMFQESSISDEV 279

>1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278

 Score = 82.6 bits (205), Expect = 2e-18
 Identities = 68/261 (26%), Positives = 105/261 (40%), Gaps = 29/261 (11%)

Query: 72  VVYKGKLENQFRIAVKRFNRSAWPDARQFLEEARAVGQLRNRRLANLLGCCCEGDERL-L 130
            V  G      ++AVK     A   A+ FL EA  + QLR+  L  LLG   E    L +
Sbjct: 36  DVMLGDYRGN-KVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYI 92

Query: 131 VAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYH-DLNAYRIVF 189
           V EYM   +L  +L       +     L+ +L + EA+EY         H DL A  ++ 
Sbjct: 93  VTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNN--FVHRDLAARNVLV 150

Query: 190 DDDVNPRLSCFGLMKNSRDGRSYSTNLAF----TPPEYLRTGRVTPESVMYSFGTLLLDL 245
            +D   ++S FGL   +++  S           T PE LR  + + +S ++SFG LL ++
Sbjct: 151 SEDNVAKVSDFGL---TKEASSTQDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEI 207

Query: 246 LS-GKH----IPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLASRCLQYEPRER 300
            S G+     IP    +  +         D C            +  +   C   +   R
Sbjct: 208 YSFGRVPYPRIPLKDVVPRVEKGYKMDAPDGCPP---------AVYEVMKNCWHLDAAMR 258

Query: 301 PNPRSLVTALVTLQKDTELYL 321
           P+   L   L  + K  EL+L
Sbjct: 259 PSFLQLREQLEHI-KTHELHL 278

>3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336

 Score = 83.4 bits (206), Expect = 3e-18
 Identities = 56/332 (16%), Positives = 105/332 (31%), Gaps = 68/332 (20%)

Query: 43  EYSIETLRTATSGFAMENIVSE--HGEKAPNVVYKGKLENQFRIAVKRFNRSAWPDARQF 100
           E +            +  ++    +G      VYKG L+ +  +AVK F+   + + + F
Sbjct: 2   EAAASEPSLDLDNLKLLELIGRGRYGA-----VYKGSLDERP-VAVKVFS---FANRQNF 52

Query: 101 LEEAR--AVGQLRNRRLANLLGCCCEGD-----ERLLVAEYMPNDTLAKHLFHWETQPMK 153
           + E     V  + +  +A  +            E LLV EY PN +L K+L         
Sbjct: 53  INEKNIYRVPLMEHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLSL---HTSD 109

Query: 154 WAMRLRVALHIAEALEY-------CTSKERALYH-DLNAYRIVFDDDVNPRLSCFGL--- 202
           W    R+A  +   L Y           + A+ H DLN+  ++  +D    +S FGL   
Sbjct: 110 WVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMR 169

Query: 203 -----MKNSRDGRSYSTNLAFTP----PEYLR-------TGRVTPESVMYSFGTLLLDLL 246
                +    +  + + +   T     PE L              +  MY+ G +  ++ 
Sbjct: 170 LTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIF 229

Query: 247 SGK------HIPPSHAL----DLIRDRNIQTLTDS-CLEGQ-------FSSDEGT--ELV 286
                       P + +    ++      + +      E Q       +  +      L 
Sbjct: 230 MRCTDLFPGESVPEYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLK 289

Query: 287 RLASRCLQYEPRERPNPRSLVTALVTLQKDTE 318
                C   +   R   +     +  L    E
Sbjct: 290 ETIEDCWDQDAEARLTAQXAEERMAELMMIWE 321

>2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319

 Score = 82.8 bits (205), Expect = 3e-18
 Identities = 45/269 (16%), Positives = 87/269 (32%), Gaps = 39/269 (14%)

Query: 72  VVYKGKLENQFRIAVKRFNRSAWPDA--RQFLEEARAVGQLRNRRLANLLGCCCEGDERL 129
            VY G+   +  +A++  +     +   + F  E  A  Q R+  +   +G C       
Sbjct: 48  QVYHGRWHGE--VAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMSPPHLA 105

Query: 130 LVAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYH-DLNAYRIV 188
           ++       TL   +       +      ++A  I + + Y  +K   + H DL +  + 
Sbjct: 106 IITSLCKGRTLYSVV-RDAKIVLDVNKTRQIAQEIVKGMGYLHAK--GILHKDLKSKNVF 162

Query: 189 FDDDVNPRLSCFGL--MKNSRDGRSYSTNLAFTP-------PEYLRTGRVTPESVM---- 235
           +D+     ++ FGL  +            L           PE +R      E       
Sbjct: 163 YDNG-KVVITDFGLFSISGVLQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFS 221

Query: 236 -----YSFGTLLLDLLSGK----HIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELV 286
                ++ GT+  +L + +      P    +  +       L+            G E+ 
Sbjct: 222 KHSDVFALGTIWYELHAREWPFKTQPAEAIIWQMGTGMKPNLSQ--------IGMGKEIS 273

Query: 287 RLASRCLQYEPRERPNPRSLVTALVTLQK 315
            +   C  +E  ERP    L+  L  L K
Sbjct: 274 DILLFCWAFEQEERPTFTKLMDMLEKLPK 302

>1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495

 Score = 83.7 bits (207), Expect = 5e-18
 Identities = 56/260 (21%), Positives = 109/260 (41%), Gaps = 24/260 (9%)

Query: 73  VYKGKLEN-QFRIAVKRFNRSAWPDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLV 131
           VY+G  +     +AVK        +  +FL+EA  + ++++  L  LLG C       ++
Sbjct: 236 VYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYII 294

Query: 132 AEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYH-DLNAYRIVFD 190
            E+M    L  +L     Q +   + L +A  I+ A+EY   K     H +L A   +  
Sbjct: 295 TEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKN--FIHRNLAARNCLVG 352

Query: 191 DDVNPRLSCFGLMKNSRDGRSYSTNLA-----FTPPEYLRTGRVTPESVMYSFGTLLLDL 245
           ++   +++ FGL +        +   A     +T PE L   + + +S +++FG LL ++
Sbjct: 353 ENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEI 412

Query: 246 LSGKHIP-----PSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLASRCLQYEPRER 300
            +    P      S   +L+         + C E         ++  L   C Q+ P +R
Sbjct: 413 ATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPE---------KVYELMRACWQWNPSDR 463

Query: 301 PNPRSLVTALVTLQKDTELY 320
           P+   +  A  T+ +++ + 
Sbjct: 464 PSFAEIHQAFETMFQESSIS 483

>1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450

 Score = 83.2 bits (206), Expect = 5e-18
 Identities = 67/260 (25%), Positives = 104/260 (40%), Gaps = 29/260 (11%)

Query: 73  VYKGKLENQFRIAVKRFNRSAWPDARQFLEEARAVGQLRNRRLANLLGCCCEGDERL-LV 131
           V  G      ++AVK     A   A+ FL EA  + QLR+  L  LLG   E    L +V
Sbjct: 209 VMLGDYRGN-KVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIV 265

Query: 132 AEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYH-DLNAYRIVFD 190
            EYM   +L  +L       +     L+ +L + EA+EY         H DL A  ++  
Sbjct: 266 TEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNN--FVHRDLAARNVLVS 323

Query: 191 DDVNPRLSCFGLMKNSRDGRSYSTNLAF----TPPEYLRTGRVTPESVMYSFGTLLLDLL 246
           +D   ++S FGL   +++  S           T PE LR  + + +S ++SFG LL ++ 
Sbjct: 324 EDNVAKVSDFGL---TKEASSTQDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIY 380

Query: 247 S-GKH----IPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLASRCLQYEPRERP 301
           S G+     IP    +  +         D C            +  +   C   +   RP
Sbjct: 381 SFGRVPYPRIPLKDVVPRVEKGYKMDAPDGCPP---------AVYDVMKNCWHLDAATRP 431

Query: 302 NPRSLVTALVTLQKDTELYL 321
               L   L  ++   EL+L
Sbjct: 432 TFLQLREQLEHIRTH-ELHL 450

>1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454

 Score = 82.8 bits (205), Expect = 8e-18
 Identities = 59/271 (21%), Positives = 105/271 (38%), Gaps = 39/271 (14%)

Query: 73  VYKGKLENQFRIAVKRFNRSAWPDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVA 132
           V+        ++AVK     +      FL EA  +  L++ +L  L     + +   ++ 
Sbjct: 204 VWMATYNKHTKVAVKTMKPGS-MSVEAFLAEANVMKTLQHDKLVKLHAVVTK-EPIYIIT 261

Query: 133 EYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYH-DLNAYRIVFDD 191
           E+M   +L   L   E         +  +  IAE + +   +     H DL A  I+   
Sbjct: 262 EFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRN--YIHRDLRAANILVSA 319

Query: 192 DVNPRLSCFGLMKNSRDGRSYSTNLA-----FTPPEYLRTGRVTPESVMYSFGTLLLDLL 246
            +  +++ FGL +   D    +   A     +T PE +  G  T +S ++SFG LL++++
Sbjct: 320 SLVCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIV 379

Query: 247 SGKHIP-PSHALDLIRDRNIQTLT-----------DSCLEGQFSSDEGTELVRLASRCLQ 294
           +   IP P  +       N + +            ++C E         EL  +  RC +
Sbjct: 380 TYGRIPYPGMS-------NPEVIRALERGYRMPRPENCPE---------ELYNIMMRCWK 423

Query: 295 YEPRERPNPRSLVTALVTLQKDTE-LYLSLP 324
             P ERP    + + L      TE  Y  +P
Sbjct: 424 NRPEERPTFEYIQSVLDDFYTATESQYEEIP 454

>3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377

 Score = 81.9 bits (203), Expect = 1e-17
 Identities = 62/258 (24%), Positives = 105/258 (40%), Gaps = 26/258 (10%)

Query: 73  VYKGKLENQ-FRIAVKRFNRSAWPDARQ-FLEEARAVGQLRNRRLANLLGCCCEGDERLL 130
           V+ G+L      +AVK    +  PD +  FL+EAR + Q  +  +  L+G C +     +
Sbjct: 130 VFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYI 189

Query: 131 VAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYH-DLNAYRIVF 189
           V E +        L   E   ++    L++    A  +EY  SK     H DL A   + 
Sbjct: 190 VMELVQGGDFLTFL-RTEGARLRVKTLLQMVGDAAAGMEYLESKC--CIHRDLAARNCLV 246

Query: 190 DDDVNPRLSCFGLMKNSRDGRSYSTNLAF------TPPEYLRTGRVTPESVMYSFGTLLL 243
            +    ++S FG+ +   DG   ++          T PE L  GR + ES ++SFG LL 
Sbjct: 247 TEKNVLKISDFGMSREEADGVYAASGGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLW 306

Query: 244 DLLSGKHIP-----PSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLASRCLQYEPR 298
           +  S    P          + +         + C +          + RL  +C  YEP 
Sbjct: 307 ETFSLGASPYPNLSNQQTREFVEKGGRLPCPELCPD---------AVFRLMEQCWAYEPG 357

Query: 299 ERPNPRSLVTALVTLQKD 316
           +RP+  ++   L +++K 
Sbjct: 358 QRPSFSTIYQELQSIRKR 375

>1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452

 Score = 82.1 bits (203), Expect = 1e-17
 Identities = 64/257 (24%), Positives = 101/257 (39%), Gaps = 24/257 (9%)

Query: 73  VYKGKLENQFRIAVKRFNRSAWPDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVA 132
           V+ G      R+A+K            FL+EA+ + +LR+ +L  L     E +   +V 
Sbjct: 200 VWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVT 257

Query: 133 EYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYH-DLNAYRIVFDD 191
           EYM   +L   L     + ++    + +A  IA  + Y         H DL A  I+  +
Sbjct: 258 EYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMN--YVHRDLRAANILVGE 315

Query: 192 DVNPRLSCFGLMKNSRDGRSYSTNLA-----FTPPEYLRTGRVTPESVMYSFGTLLLDLL 246
           ++  +++ FGL +   D    +   A     +T PE    GR T +S ++SFG LL +L 
Sbjct: 316 NLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELT 375

Query: 247 SGKHIP-----PSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLASRCLQYEPRERP 301
           +   +P         LD +           C E          L  L  +C + EP ERP
Sbjct: 376 TKGRVPYPGMVNREVLDQVERGYRMPCPPECPE---------SLHDLMCQCWRKEPEERP 426

Query: 302 NPRSLVTALVTLQKDTE 318
               L   L      TE
Sbjct: 427 TFEYLQAFLEDYFTSTE 443

>2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535

 Score = 81.5 bits (201), Expect = 3e-17
 Identities = 64/257 (24%), Positives = 101/257 (39%), Gaps = 24/257 (9%)

Query: 73  VYKGKLENQFRIAVKRFNRSAWPDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVA 132
           V+ G      R+A+K            FL+EA+ + +LR+ +L  L     E +   +V 
Sbjct: 283 VWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVT 340

Query: 133 EYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYH-DLNAYRIVFDD 191
           EYM   +L   L     + ++    + +A  IA  + Y         H DL A  I+  +
Sbjct: 341 EYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMN--YVHRDLRAANILVGE 398

Query: 192 DVNPRLSCFGLMKNSRDGRSYSTNLA-----FTPPEYLRTGRVTPESVMYSFGTLLLDLL 246
           ++  +++ FGL +   D    +   A     +T PE    GR T +S ++SFG LL +L 
Sbjct: 399 NLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELT 458

Query: 247 SGKHIP-----PSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLASRCLQYEPRERP 301
           +   +P         LD +           C E          L  L  +C + EP ERP
Sbjct: 459 TKGRVPYPGMVNREVLDQVERGYRMPCPPECPE---------SLHDLMCQCWRKEPEERP 509

Query: 302 NPRSLVTALVTLQKDTE 318
               L   L      TE
Sbjct: 510 TFEYLQAFLEDYFTSTE 526

>3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268

 Score = 78.4 bits (194), Expect = 6e-17
 Identities = 50/256 (19%), Positives = 109/256 (42%), Gaps = 24/256 (9%)

Query: 72  VVYKGKLENQFRIAVKRFNRSAWPDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLV 131
           VV  GK + Q+ +AVK     +     +F +EA+ + +L + +L    G C +     +V
Sbjct: 23  VVKLGKWKGQYDVAVKMIKEGS-MSEDEFFQEAQTMMKLSHPKLVKFYGVCSKEYPIYIV 81

Query: 132 AEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYH-DLNAYRIVFD 190
            EY+ N  L  +L     + ++ +  L +   + E + +  S +    H DL A   + D
Sbjct: 82  TEYISNGCLLNYL-RSHGKGLEPSQLLEMCYDVCEGMAFLESHQ--FIHRDLAARNCLVD 138

Query: 191 DDVNPRLSCFGLMKNSRDGRSYSTNLA-----FTPPEYLRTGRVTPESVMYSFGTLLLDL 245
            D+  ++S FG+ +   D +  S+        ++ PE     + + +S +++FG L+ ++
Sbjct: 139 RDLCVKVSDFGMTRYVLDDQYVSSVGTKFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEV 198

Query: 246 LSGKHIP-----PSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLASRCLQYEPRER 300
            S   +P      S  +  +   +         +          + ++   C    P +R
Sbjct: 199 FSLGKMPYDLYTNSEVVLKVSQGHRLYRPHLASD---------TIYQIMYSCWHELPEKR 249

Query: 301 PNPRSLVTALVTLQKD 316
           P  + L++++  L++ 
Sbjct: 250 PTFQQLLSSIEPLREK 265

>1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279

 Score = 76.1 bits (188), Expect = 4e-16
 Identities = 63/257 (24%), Positives = 106/257 (41%), Gaps = 24/257 (9%)

Query: 73  VYKGKLENQFRIAVKRFNRSAWPDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVA 132
           V+ G      ++AVK   + +      FL EA  + QL+++RL  L     + +   ++ 
Sbjct: 29  VWMGYYNGHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIYIIT 86

Query: 133 EYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYH-DLNAYRIVFDD 191
           EYM N +L   L       +     L +A  IAE + +   +     H DL A  I+  D
Sbjct: 87  EYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERN--YIHRDLRAANILVSD 144

Query: 192 DVNPRLSCFGLMKNSRDGRSYSTNLA-----FTPPEYLRTGRVTPESVMYSFGTLLLDLL 246
            ++ +++ FGL +   D    +   A     +T PE +  G  T +S ++SFG LL +++
Sbjct: 145 TLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIV 204

Query: 247 SGKHIP-----PSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLASRCLQYEPRERP 301
           +   IP         +  +         D+C E         EL +L   C +  P +RP
Sbjct: 205 THGRIPYPGMTNPEVIQNLERGYRMVRPDNCPE---------ELYQLMRLCWKERPEDRP 255

Query: 302 NPRSLVTALVTLQKDTE 318
               L + L      TE
Sbjct: 256 TFDYLRSVLEDFFTATE 272

>3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267

 Score = 74.9 bits (185), Expect = 8e-16
 Identities = 54/259 (20%), Positives = 98/259 (37%), Gaps = 32/259 (12%)

Query: 72  VVYKGKLENQFRIAVKRFNRSAWPDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLV 131
           +V+ G   N+ ++A+K     A      F+EEA  + +L + +L  L G C E     LV
Sbjct: 23  LVHLGYWLNKDKVAIKTIREGA-MSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLV 81

Query: 132 AEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYH-DLNAYRIVFD 190
            E+M +  L+ +L           + L + L + E + Y       + H DL A   +  
Sbjct: 82  TEFMEHGCLSDYLRTQRGLFAAETL-LGMCLDVCEGMAYLEEAC--VIHRDLAARNCL-- 136

Query: 191 DDVNPRLSC----FGLMKNSRDGRSYSTNLA-----FTPPEYLRTGRVTPESVMYSFGTL 241
             V          FG+ +   D +  S+        +  PE     R + +S ++SFG L
Sbjct: 137 --VGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVL 194

Query: 242 LLDLLSGKHIP-P----SHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLASRCLQYE 296
           + ++ S   IP      S  ++ I                        + ++ + C +  
Sbjct: 195 MWEVFSEGKIPYENRSNSEVVEDISTGFRLYKPRLAST---------HVYQIMNHCWRER 245

Query: 297 PRERPNPRSLVTALVTLQK 315
           P +RP    L+  L  + +
Sbjct: 246 PEDRPAFSRLLRQLAEIAE 264

>4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289

 Score = 75.4 bits (186), Expect = 1e-15
 Identities = 57/265 (21%), Positives = 104/265 (39%), Gaps = 37/265 (13%)

Query: 73  VYKGKL--------ENQFRIAVKRFNRSAWPDARQFLEEARAVGQLRNRRLANLLGCCCE 124
           ++KG           ++  + +K  +++    +  F E A  + +L ++ L    G C  
Sbjct: 24  IFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLVLNYGVCVC 83

Query: 125 GDERLLVAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYH-DLN 183
           GDE +LV E++   +L  +L       +    +L VA  +A A+ +       L H ++ 
Sbjct: 84  GDENILVQEFVKFGSLDTYL-KKNKNCINILWKLEVAKQLAAAMHFLEENT--LIHGNVC 140

Query: 184 AYRI-VFDDDVNPR-------LSCFGLMKNSRDGRSYSTNLAFTPPEYLRTGRV-TPESV 234
           A  I +  ++           LS  G+             + + PPE +   +     + 
Sbjct: 141 AKNILLIREEDRKTGNPPFIKLSDPGISITVLPKDILQERIPWVPPECIENPKNLNLATD 200

Query: 235 MYSFGTLLLDLLSGKHIP-----PSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLA 289
            +SFGT L ++ SG   P         L    DR            Q  + +  EL  L 
Sbjct: 201 KWSFGTTLWEICSGGDKPLSALDSQRKLQFYEDR-----------HQLPAPKAAELANLI 249

Query: 290 SRCLQYEPRERPNPRSLVTALVTLQ 314
           + C+ YEP  RP+ R+++  L +L 
Sbjct: 250 NNCMDYEPDHRPSFRAIIRDLNSLF 274

>3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298

 Score = 75.0 bits (185), Expect = 1e-15
 Identities = 62/274 (22%), Positives = 110/274 (40%), Gaps = 34/274 (12%)

Query: 73  VYKGKL----ENQFRIAVKRFNRSAWPDARQ-FLEEARAVGQLRNRRLANLLGCCCEGDE 127
           VY G+     +N+ + A+K  +R       + FL E   +  L +  +  L+G     + 
Sbjct: 37  VYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPEG 96

Query: 128 RLL-VAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYH-DLNAY 185
               +  YM +  L + +   +  P    + +   L +A  +EY   ++    H DL A 
Sbjct: 97  LPHVLLPYMCHGDLLQFIRSPQRNPTVKDL-ISFGLQVARGMEYLAEQK--FVHRDLAAR 153

Query: 186 RIVFDDDVNPRLSCFGLMKNSRDGRSYSTNLAF--------TPPEYLRTGRVTPESVMYS 237
             + D+    +++ FGL ++  D   YS             T  E L+T R T +S ++S
Sbjct: 154 NCMLDESFTVKVADFGLARDILDREYYSVQQHRHARLPVKWTALESLQTYRFTTKSDVWS 213

Query: 238 FGTLLLDLLS-GK----HIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLASRC 292
           FG LL +LL+ G     HI P      +         + C +          L ++  +C
Sbjct: 214 FGVLLWELLTRGAPPYRHIDPFDLTHFLAQGRRLPQPEYCPD---------SLYQVMQQC 264

Query: 293 LQYEPRERPNPRSLVTALVTLQKDT--ELYLSLP 324
            + +P  RP  R LV  +  +      + Y+ LP
Sbjct: 265 WEADPAVRPTFRVLVGEVEQIVSALLGDHYVQLP 298

>3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283

 Score = 74.2 bits (183), Expect = 2e-15
 Identities = 58/253 (22%), Positives = 108/253 (42%), Gaps = 24/253 (9%)

Query: 72  VVYKGKLENQFRIAVKRFNRSAWPDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLV 131
           VV  GK   Q+ +A+K     +     +F+EEA+ +  L + +L  L G C +     ++
Sbjct: 39  VVKYGKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFII 97

Query: 132 AEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYH-DLNAYRIVFD 190
            EYM N  L  +L     +     + L +   + EA+EY  SK+    H DL A   + +
Sbjct: 98  TEYMANGCLLNYLREMRHRFQTQQL-LEMCKDVCEAMEYLESKQ--FLHRDLAARNCLVN 154

Query: 191 DDVNPRLSCFGLMKNSRDGRSYSTNLA-----FTPPEYLRTGRVTPESVMYSFGTLLLDL 245
           D    ++S FGL +   D    S+  +     ++PPE L   + + +S +++FG L+ ++
Sbjct: 155 DQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEI 214

Query: 246 LSGKHIP-P----SHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLASRCLQYEPRER 300
            S   +P      S   + I             E         ++  +   C   +  ER
Sbjct: 215 YSLGKMPYERFTNSETAEHIAQGLRLYRPHLASE---------KVYTIMYSCWHEKADER 265

Query: 301 PNPRSLVTALVTL 313
           P  + L++ ++ +
Sbjct: 266 PTFKILLSNILDV 278

>2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656

 Score = 74.5 bits (183), Expect = 6e-15
 Identities = 53/263 (20%), Positives = 97/263 (36%), Gaps = 29/263 (11%)

Query: 73  VYKGKL----ENQFRIAVKRFNRSAWPDARQ-FLEEARAVGQLRNRRLANLLGCCCEGDE 127
           V++G           +A+K          R+ FL+EA  + Q  +  +  L+G     + 
Sbjct: 406 VHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIG-VITENP 464

Query: 128 RLLVAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYH-DLNAYR 186
             ++ E      L   L   +   +  A  +  A  ++ AL Y  SK     H D+ A  
Sbjct: 465 VWIIMELCTLGELRSFLQVRKFS-LDLASLILYAYQLSTALAYLESKR--FVHRDIAARN 521

Query: 187 IVFDDDVNPRLSCFGLMKNSRDGRSYSTNLA-----FTPPEYLRTGRVTPESVMYSFGTL 241
           ++   +   +L  FGL +   D   Y  +       +  PE +   R T  S ++ FG  
Sbjct: 522 VLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVC 581

Query: 242 LLDLLSGKHIP-----PSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLASRCLQYE 296
           + ++L     P      +  +  I +     +  +C            L  L ++C  Y+
Sbjct: 582 MWEILMHGVKPFQGVKNNDVIGRIENGERLPMPPNCPP---------TLYSLMTKCWAYD 632

Query: 297 PRERPNPRSLVTALVTLQKDTEL 319
           P  RP    L   L T+ ++ +L
Sbjct: 633 PSRRPRFTELKAQLSTILEEEKL 655

>1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333

 Score = 73.1 bits (180), Expect = 7e-15
 Identities = 60/275 (21%), Positives = 105/275 (38%), Gaps = 39/275 (14%)

Query: 73  VYKGKL-----ENQFRIAVKRFNRSAWPDARQ-FLEEARAVGQLRNRRLANLLGCCCEGD 126
           VYKG L     + +  +A+K          R  FL EA  +GQ  +  +  L G   +  
Sbjct: 60  VYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYK 119

Query: 127 ERLLVAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYH-DLNAY 185
             +++ EYM N  L K L   + +     + + +   IA  ++Y  +      H DL A 
Sbjct: 120 PMMIITEYMENGALDKFLREKDGEFSVLQL-VGMLRGIAAGMKYLANM--NYVHRDLAAR 176

Query: 186 RIVFDDDVNPRLSC----FGL---MKNSRDGRSYSTNLAF----TPPEYLRTGRVTPESV 234
            I+    VN  L C    FGL   +++  +    ++        T PE +   + T  S 
Sbjct: 177 NIL----VNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASD 232

Query: 235 MYSFGTLLLDLLSGKHIP-P----SHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLA 289
           ++SFG ++ ++++    P         +  I D         C            + +L 
Sbjct: 233 VWSFGIVMWEVMTYGERPYWELSNHEVMKAINDGFRLPTPMDCPS---------AIYQLM 283

Query: 290 SRCLQYEPRERPNPRSLVTALVTLQKDTELYLSLP 324
            +C Q E   RP    +V+ L  L +  +   +L 
Sbjct: 284 MQCWQQERARRPKFADIVSILDKLIRAPDSLKTLA 318

>1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322

 Score = 72.3 bits (178), Expect = 1e-14
 Identities = 57/278 (20%), Positives = 109/278 (39%), Gaps = 38/278 (13%)

Query: 73  VYKGKLENQF------RIAVKRFNRSAWPDARQ-FLEEARAVGQLRNRRLANLLGCCCEG 125
           VY+G  +         R+A+K  N +A    R  FL EA  + +     +  LLG   +G
Sbjct: 41  VYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQG 100

Query: 126 DERLLVAEYMPNDTLAKHL--------FHWETQPMKWAMRLRVALHIAEALEYCTSKERA 177
              L++ E M    L  +L         +    P   +  +++A  IA+ + Y  + +  
Sbjct: 101 QPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANK-- 158

Query: 178 LYH-DLNAYRIVFDDDVNPRLSCFGLMKNSRDGRSY--STNLAF----TPPEYLRTGRVT 230
             H DL A   +  +D   ++  FG+ ++  +   Y              PE L+ G  T
Sbjct: 159 FVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFT 218

Query: 231 PESVMYSFGTLLLDLLS-GKH----IPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTEL 285
             S ++SFG +L ++ +  +     +     L  + +  +    D+C +          L
Sbjct: 219 TYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVMEGGLLDKPDNCPD---------ML 269

Query: 286 VRLASRCLQYEPRERPNPRSLVTALVTLQKDTELYLSL 323
             L   C QY P+ RP+   +++++    +     +S 
Sbjct: 270 FELMRMCWQYNPKMRPSFLEIISSIKEEMEPGFREVSF 307

>3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327

 Score = 72.3 bits (178), Expect = 1e-14
 Identities = 52/271 (19%), Positives = 99/271 (36%), Gaps = 31/271 (11%)

Query: 72  VVYKGKL-----ENQFRIAVKRFNRSAWPDARQ-FLEEARAVGQLRNRRLANLLGCCCEG 125
            VYKG       + +  +A+K    +  P A +  L+EA  +  + N  +  LLG  C  
Sbjct: 30  TVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLG-ICLT 88

Query: 126 DERLLVAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYH-DLNA 184
               L+ + MP   L  ++       +     L   + IA+ + Y   +   L H DL A
Sbjct: 89  STVQLITQLMPFGCLLDYV-REHKDNIGSQYLLNWCVQIAKGMNYLEDRR--LVHRDLAA 145

Query: 185 YRIVFDDDVNPRLSCFGLMKNSRDGRSY--STNLAF----TPPEYLRTGRVTPESVMYSF 238
             ++     + +++ FGL K          +            E +     T +S ++S+
Sbjct: 146 RNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSY 205

Query: 239 GTLLLDLLS-GKH----IPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLASRCL 293
           G  + +L++ G      IP S    ++           C           ++  +  +C 
Sbjct: 206 GVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTI---------DVYMIMRKCW 256

Query: 294 QYEPRERPNPRSLVTALVTLQKDTELYLSLP 324
             +   RP  R L+     + +D + YL + 
Sbjct: 257 MIDADSRPKFRELIIEFSKMARDPQRYLVIQ 287

>1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281

 Score = 71.1 bits (175), Expect = 2e-14
 Identities = 51/263 (19%), Positives = 96/263 (36%), Gaps = 29/263 (11%)

Query: 72  VVYKGKL----ENQFRIAVKRFNRSAWPDARQ-FLEEARAVGQLRNRRLANLLGCCCEGD 126
            V++G           +A+K          R+ FL+EA  + Q  +  +  L+G     +
Sbjct: 30  DVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIG-VITEN 88

Query: 127 ERLLVAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYH-DLNAY 185
              ++ E      L   L   +      ++ +  A  ++ AL Y  SK     H D+ A 
Sbjct: 89  PVWIIMELCTLGELRSFLQVRKYSLDLASL-ILYAYQLSTALAYLESKR--FVHRDIAAR 145

Query: 186 RIVFDDDVNPRLSCFGLMKNSRDGRSYSTNLA-----FTPPEYLRTGRVTPESVMYSFGT 240
            ++   +   +L  FGL +   D   Y  +       +  PE +   R T  S ++ FG 
Sbjct: 146 NVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGV 205

Query: 241 LLLDLLSGKHIP-----PSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLASRCLQY 295
            + ++L     P      +  +  I +     +  +C            L  L ++C  Y
Sbjct: 206 CMWEILMHGVKPFQGVKNNDVIGRIENGERLPMPPNCPP---------TLYSLMTKCWAY 256

Query: 296 EPRERPNPRSLVTALVTLQKDTE 318
           +P  RP    L   L T+ ++ +
Sbjct: 257 DPSRRPRFTELKAQLSTILEEEK 279

>3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298

 Score = 71.1 bits (175), Expect = 3e-14
 Identities = 57/261 (21%), Positives = 100/261 (38%), Gaps = 38/261 (14%)

Query: 73  VYKGKL----ENQFRIAVKRFNRSAWPDARQ-FLEEARAVGQLRNRRLANLLGCCCEGDE 127
           VY G L      +   AVK  NR         FL E   +    +  + +LLG C   + 
Sbjct: 41  VYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEG 100

Query: 128 -RLLVAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYH-DLNAY 185
             L+V  YM +  L   + +    P    + +   L +A+ ++Y  SK+    H DL A 
Sbjct: 101 SPLVVLPYMKHGDLRNFIRNETHNPTVKDL-IGFGLQVAKGMKYLASKK--FVHRDLAAR 157

Query: 186 RIVFDDDVNPRLSCFGLMKNSRD------GRSYSTNLAF-----TPPEYLRTGRVTPESV 234
             + D+    +++ FGL   +RD         ++   A         E L+T + T +S 
Sbjct: 158 NCMLDEKFTVKVADFGL---ARDMYDKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSD 214

Query: 235 MYSFGTLLLDLLS-GK----HIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLA 289
           ++SFG LL +L++ G      +        +         + C +          L  + 
Sbjct: 215 VWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQPEYCPD---------PLYEVM 265

Query: 290 SRCLQYEPRERPNPRSLVTAL 310
            +C   +   RP+   LV+ +
Sbjct: 266 LKCWHPKAEMRPSFSELVSRI 286

>4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329

 Score = 71.6 bits (176), Expect = 3e-14
 Identities = 64/289 (22%), Positives = 104/289 (35%), Gaps = 56/289 (19%)

Query: 73  VYKGKLENQF------RIAVKRFNRSAWPDARQFLEEARAVGQLRNRRLANLLGCCCEGD 126
           V+  +  N         +AVK    ++    + F  EA  +  L+++ +    G C EG 
Sbjct: 57  VFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVCTEGR 116

Query: 127 ERLLVAEYMPNDTLAKHL-------------FHWETQPMKWAMRLRVALHIAEALEYCTS 173
             L+V EYM +  L + L                   P+     L VA  +A  + Y   
Sbjct: 117 PLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAG 176

Query: 174 KERALYH-DLNAYRIVFDDDVNPRLSC----FGLMKNSRD--GRSY---STNLAF----T 219
                 H DL   R      V   L      FG+   SRD     Y              
Sbjct: 177 LH--FVHRDLAT-RNCL---VGQGLVVKIGDFGM---SRDIYSTDYYRVGGRTMLPIRWM 227

Query: 220 PPEYLRTGRVTPESVMYSFGTLLLDLLS-GKH----IPPSHALDLIRDRNIQTLTDSCLE 274
           PPE +   + T ES ++SFG +L ++ + GK     +  + A+D I          +C  
Sbjct: 228 PPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTEAIDCITQGRELERPRACPP 287

Query: 275 GQFSSDEGTELVRLASRCLQYEPRERPNPRSLVTALVTLQKDTELYLSL 323
                    E+  +   C Q EP++R + + +   L  L +   +YL +
Sbjct: 288 ---------EVYAIMRGCWQREPQQRHSIKDVHARLQALAQAPPVYLDV 327

>2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373

 Score = 71.2 bits (175), Expect = 4e-14
 Identities = 57/274 (20%), Positives = 99/274 (36%), Gaps = 38/274 (13%)

Query: 73  VYKGKL----ENQFRIAVKRFNRSAWPDARQ-FLEEARAVGQLRNRRLANLLGCCCEGDE 127
           V  G+L    + +  +A+K          R+ FL EA  +GQ  +  +  L G   +   
Sbjct: 61  VCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKP 120

Query: 128 RLLVAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYH-DLNAYR 186
            ++V EYM N +L   L   + Q       + +   IA  ++Y +       H DL A  
Sbjct: 121 VMIVTEYMENGSLDSFLRKHDAQF-TVIQLVGMLRGIASGMKYLSDM--GYVHRDLAARN 177

Query: 187 IVFDDDVNPRLSC----FGLMKNSRDGRSY---STNLAF----TPPEYLRTGRVTPESVM 235
           I+    +N  L C    FGL +   D       +         T PE +   + T  S +
Sbjct: 178 IL----INSNLVCKVSDFGLGRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDV 233

Query: 236 YSFGTLLLDLLSGKHIP-----PSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLAS 290
           +S+G +L +++S    P         +  + +         C            L +L  
Sbjct: 234 WSYGIVLWEVMSYGERPYWEMSNQDVIKAVDEGYRLPPPMDCPA---------ALYQLML 284

Query: 291 RCLQYEPRERPNPRSLVTALVTLQKDTELYLSLP 324
            C Q +   RP    +V+ L  L ++      + 
Sbjct: 285 DCWQKDRNNRPKFEQIVSILDKLIRNPGSLKIIT 318

>3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323

 Score = 70.8 bits (174), Expect = 5e-14
 Identities = 51/277 (18%), Positives = 99/277 (35%), Gaps = 45/277 (16%)

Query: 73  VYKGKL----ENQFRIAVKRFNRSAWP--DARQFLEEARAVGQLRNRRLANLLGCCCEGD 126
           V + +L     +  ++AVK          D  +FL EA  + +  +  +A L+G      
Sbjct: 39  VREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKLVGVSLRSR 98

Query: 127 ER------LLVAEYMPN----DTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKER 176
            +      +++  +M +      L           +     +R  + IA  +EY +S+  
Sbjct: 99  AKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSRN- 157

Query: 177 ALYH-DLNAYRIVFDDDVNPRLSCFGLMKNSRD--GRSY---STNLAF----TPPEYLRT 226
              H DL A   +  +D+   ++ FGL   SR      Y                E L  
Sbjct: 158 -FIHRDLAARNCMLAEDMTVCVADFGL---SRKIYSGDYYRQGCASKLPVKWLALESLAD 213

Query: 227 GRVTPESVMYSFGTLLLDLLS-GK----HIPPSHALDLIRDRNIQTLTDSCLEGQFSSDE 281
              T  S +++FG  + ++++ G+     I  +   + +   N       C+E       
Sbjct: 214 NLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENAEIYNYLIGGNRLKQPPECME------- 266

Query: 282 GTELVRLASRCLQYEPRERPNPRSLVTALVTLQKDTE 318
             E+  L  +C   +P++RP+   L   L  +     
Sbjct: 267 --EVYDLMYQCWSADPKQRPSFTCLRMELENILGHLS 301

>3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367

 Score = 70.9 bits (174), Expect = 5e-14
 Identities = 58/283 (20%), Positives = 99/283 (34%), Gaps = 47/283 (16%)

Query: 73  VYKGKLEN------QFRIAVKRFNRSAWPDARQ-FLEEARAVGQLRNRRLANLLGCCCEG 125
           VY+G++          ++AVK             FL EA  + +  ++ +   +G   + 
Sbjct: 87  VYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQS 146

Query: 126 DERLLVAEYMPNDTLAKHL---FHWETQPMKWAMR--LRVALHIAEALEYCTSKERALYH 180
             R ++ E M    L   L       +QP   AM   L VA  IA   +Y         H
Sbjct: 147 LPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENH--FIH 204

Query: 181 -DLNAYRIVFDDDVNPRLSC----FGLMKNSRD--GRSY---STNLAF----TPPEYLRT 226
            D+ A R        P        FG+   +RD     Y              PPE    
Sbjct: 205 RDIAA-RNCLLTCPGPGRVAKIGDFGM---ARDIYRAGYYRKGGCAMLPVKWMPPEAFME 260

Query: 227 GRVTPESVMYSFGTLLLDLLS-GKH----IPPSHALDLIRDRNIQTLTDSCLEGQFSSDE 281
           G  T ++  +SFG LL ++ S G            L+ +          +C         
Sbjct: 261 GIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTSGGRMDPPKNCPG------- 313

Query: 282 GTELVRLASRCLQYEPRERPNPRSLVTALVTLQKDTELYLSLP 324
              + R+ ++C Q++P +RPN   ++  +    +D +  ++  
Sbjct: 314 --PVYRIMTQCWQHQPEDRPNFAIILERIEYCTQDPD-VINTA 353

>3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325

 Score = 70.4 bits (173), Expect = 6e-14
 Identities = 55/269 (20%), Positives = 96/269 (35%), Gaps = 38/269 (14%)

Query: 72  VVYKGKL----ENQFRIAVKRFNRSA-WPDARQFLEEARAVGQLRNRRLANLLGCCCEGD 126
            V  G+L    +    +A+K           R FL EA  +GQ  +  +  L G    G 
Sbjct: 64  EVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGR 123

Query: 127 ERLLVAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYH-DLNAY 185
             ++V EYM N +L   L   + Q       + +   +   + Y +       H DL A 
Sbjct: 124 LAMIVTEYMENGSLDTFLRTHDGQF-TIMQLVGMLRGVGAGMRYLSDL--GYVHRDLAAR 180

Query: 186 RIVFDDDVNPRLSC----FGL---MKNSRDGRSYSTNLAF----TPPEYLRTGRVTPESV 234
            ++    V+  L C    FGL   +++  D    +T        T PE +     +  S 
Sbjct: 181 NVL----VDSNLVCKVSDFGLSRVLEDDPDAAYTTTGGKIPIRWTAPEAIAFRTFSSASD 236

Query: 235 MYSFGTLLLDLLSGKHIP-----PSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLA 289
           ++SFG ++ ++L+    P         +  + +         C            L +L 
Sbjct: 237 VWSFGVVMWEVLAYGERPYWNMTNRDVISSVEEGYRLPAPMGCPH---------ALHQLM 287

Query: 290 SRCLQYEPRERPNPRSLVTALVTLQKDTE 318
             C   +  +RP    +V+ L  L +  E
Sbjct: 288 LDCWHKDRAQRPRFSQIVSVLDALIRSPE 316

>2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327

 Score = 70.0 bits (172), Expect = 8e-14
 Identities = 55/283 (19%), Positives = 97/283 (34%), Gaps = 47/283 (16%)

Query: 73  VYKGKLEN------QFRIAVKRFNRSAWPDARQ-FLEEARAVGQLRNRRLANLLGCCCEG 125
           VY+G++          ++AVK             FL EA  + +  ++ +   +G   + 
Sbjct: 46  VYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQS 105

Query: 126 DERLLVAEYMPNDTLAKHL-----FHWETQPMKWAMRLRVALHIAEALEYCTSKERALYH 180
             R ++ E M    L   L        +   +     L VA  IA   +Y         H
Sbjct: 106 LPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENH--FIH 163

Query: 181 -DLNAYRIVFDDDVNPRLSC----FGLMKNSRD--GRSY---STNLAF----TPPEYLRT 226
            D+ A R        P        FG+   +RD    SY              PPE    
Sbjct: 164 RDIAA-RNCLLTCPGPGRVAKIGDFGM---ARDIYRASYYRKGGCAMLPVKWMPPEAFME 219

Query: 227 GRVTPESVMYSFGTLLLDLLS-GKH----IPPSHALDLIRDRNIQTLTDSCLEGQFSSDE 281
           G  T ++  +SFG LL ++ S G            L+ +          +C         
Sbjct: 220 GIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTSGGRMDPPKNCPG------- 272

Query: 282 GTELVRLASRCLQYEPRERPNPRSLVTALVTLQKDTELYLSLP 324
              + R+ ++C Q++P +RPN   ++  +    +D +  ++  
Sbjct: 273 --PVYRIMTQCWQHQPEDRPNFAIILERIEYCTQDPD-VINTA 312

>2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326

 Score = 70.1 bits (172), Expect = 9e-14
 Identities = 54/279 (19%), Positives = 97/279 (34%), Gaps = 41/279 (14%)

Query: 72  VVYKGKLE-----NQFRIAVKRFNRSAWPDARQFLEEARAVGQLRNRRLANLLGCCCEGD 126
            V   + +         +AVK+   S     R F  E   +  L++  +    G C    
Sbjct: 56  SVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAG 115

Query: 127 ER--LLVAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYH-DLN 183
            R   L+ EY+P  +L  +L   + + +     L+    I + +EY  +K     H DL 
Sbjct: 116 RRNLKLIMEYLPYGSLRDYLQKHKER-IDHIKLLQYTSQICKGMEYLGTKR--YIHRDLA 172

Query: 184 AYRIVFDDDVNPRLSCFGLMKNSRDGRSY---STNLAF----TPPEYLRTGRVTPESVMY 236
              I+ +++   ++  FGL K     + Y               PE L   + +  S ++
Sbjct: 173 TRNILVENENRVKIGDFGLTKVLPQDKEYYKVKEPGESPIFWYAPESLTESKFSVASDVW 232

Query: 237 SFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELV----RLA--- 289
           SFG +L +L +      S   + +R            +GQ       EL+    RL    
Sbjct: 233 SFGVVLYELFTYIEKSKSPPAEFMRMIGNDK------QGQMIVFHLIELLKNNGRLPRPD 286

Query: 290 ----------SRCLQYEPRERPNPRSLVTALVTLQKDTE 318
                     + C      +RP+ R L   +  ++    
Sbjct: 287 GCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDQMA 325

>3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373

 Score = 70.2 bits (172), Expect = 1e-13
 Identities = 58/277 (20%), Positives = 105/277 (37%), Gaps = 40/277 (14%)

Query: 73  VYKGKL----ENQFRIAVKRFNRSAWPDARQ-FLEEARAVGQLRNRRLANLLGCCCEGDE 127
           VY G L      +   AVK  NR         FL E   +    +  + +LLG C   + 
Sbjct: 105 VYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEG 164

Query: 128 -RLLVAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYH-DLNAY 185
             L+V  YM +  L   + +    P    + +   L +A+ +++  SK+    H DL A 
Sbjct: 165 SPLVVLPYMKHGDLRNFIRNETHNPTVKDL-IGFGLQVAKGMKFLASKK--FVHRDLAAR 221

Query: 186 RIVFDDDVNPRLSCFGLMKNSRD------GRSYSTNLAF-----TPPEYLRTGRVTPESV 234
             + D+    +++ FGL   +RD         ++   A         E L+T + T +S 
Sbjct: 222 NCMLDEKFTVKVADFGL---ARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSD 278

Query: 235 MYSFGTLLLDLLS-GK----HIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLA 289
           ++SFG LL +L++ G      +        +         + C +          L  + 
Sbjct: 279 VWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQPEYCPD---------PLYEVM 329

Query: 290 SRCLQYEPRERPNPRSLVTALVTLQKDT--ELYLSLP 324
            +C   +   RP+   LV+ +  +      E Y+ + 
Sbjct: 330 LKCWHPKAEMRPSFSELVSRISAIFSTFIGEHYVHVN 366

>3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295

 Score = 68.9 bits (169), Expect = 2e-13
 Identities = 55/283 (19%), Positives = 97/283 (34%), Gaps = 49/283 (17%)

Query: 72  VVYKGKLE-----NQFRIAVKRFNRSAWPDARQFLEEARAVGQLRNRRLANLLGCCCEGD 126
            V   + +         +AVK+   S     R F  E   +  L++  +    G C    
Sbjct: 25  SVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAG 84

Query: 127 ER--LLVAEYMPN----DTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYH 180
            R   L+ EY+P     D L KH    +   +     L+    I + +EY  +K     H
Sbjct: 85  RRNLKLIMEYLPYGSLRDYLQKHKERIDHIKL-----LQYTSQICKGMEYLGTKR--YIH 137

Query: 181 -DLNAYRIVFDDDVNPRLSCFGLMKNSRDGRSY---STNLAF----TPPEYLRTGRVTPE 232
            DL    I+ +++   ++  FGL K     + +               PE L   + +  
Sbjct: 138 RDLATRNILVENENRVKIGDFGLTKVLPQDKEFFKVKEPGESPIFWYAPESLTESKFSVA 197

Query: 233 SVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELV----RL 288
           S ++SFG +L +L +      S   + +R            +GQ       EL+    RL
Sbjct: 198 SDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDK------QGQMIVFHLIELLKNNGRL 251

Query: 289 A-------------SRCLQYEPRERPNPRSLVTALVTLQKDTE 318
                         + C      +RP+ R L   +  ++ +  
Sbjct: 252 PRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDNMA 294

>3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327

 Score = 68.9 bits (169), Expect = 2e-13
 Identities = 52/271 (19%), Positives = 100/271 (36%), Gaps = 31/271 (11%)

Query: 72  VVYKGKL-----ENQFRIAVKRFNRSAWPDARQ-FLEEARAVGQLRNRRLANLLGCCCEG 125
            VYKG       + +  +A+K    +  P A +  L+EA  +  + N  +  LLG  C  
Sbjct: 30  TVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLG-ICLT 88

Query: 126 DERLLVAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYH-DLNA 184
               L+ + MP   L  ++       +     L   + IA+ + Y   +   L H DL A
Sbjct: 89  STVQLITQLMPFGCLLDYV-REHKDNIGSQYLLNWCVQIAKGMNYLEDRR--LVHRDLAA 145

Query: 185 YRIVFDDDVNPRLSCFGLMKNSRDGRSYSTN------LAFTPPEYLRTGRVTPESVMYSF 238
             ++     + +++ FGL K                 + +   E +     T +S ++S+
Sbjct: 146 RNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSY 205

Query: 239 GTLLLDLLS-GKH----IPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLASRCL 293
           G  + +L++ G      IP S    ++           C           ++  +  +C 
Sbjct: 206 GVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTI---------DVYMIMVKCW 256

Query: 294 QYEPRERPNPRSLVTALVTLQKDTELYLSLP 324
             +   RP  R L+     + +D + YL + 
Sbjct: 257 MIDADSRPKFRELIIEFSKMARDPQRYLVIQ 287

>3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325

 Score = 68.9 bits (169), Expect = 2e-13
 Identities = 46/272 (16%), Positives = 97/272 (35%), Gaps = 31/272 (11%)

Query: 72  VVYKGKLENQFR-----IAVKRFNRSAWPDARQ-FLEEARAVGQLRNRRLANLLGCCCEG 125
            V+KG    +       + +K     +   + Q   +   A+G L +  +  LLG  C G
Sbjct: 28  TVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRLLG-LCPG 86

Query: 126 DERLLVAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYH-DLNA 184
               LV +Y+P  +L  H+       +   + L   + IA+ + Y       + H +L A
Sbjct: 87  SSLQLVTQYLPLGSLLDHV-RQHRGALGPQLLLNWGVQIAKGMYYLEEHG--MVHRNLAA 143

Query: 185 YRIVFDDDVNPRLSCFGLMKNSRDGRSYSTN------LAFTPPEYLRTGRVTPESVMYSF 238
             ++       +++ FG+                   + +   E +  G+ T +S ++S+
Sbjct: 144 RNVLLKSPSQVQVADFGVADLLPPDDKQLLYSEAKTPIKWMALESIHFGKYTHQSDVWSY 203

Query: 239 GTLLLDLLS-GKH----IPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLASRCL 293
           G  + +L++ G      +  +   DL+           C           ++  +  +C 
Sbjct: 204 GVTVWELMTFGAEPYAGLRLAEVPDLLEKGERLAQPQICTI---------DVYMVMVKCW 254

Query: 294 QYEPRERPNPRSLVTALVTLQKDTELYLSLPW 325
             +   RP  + L      + +D   YL +  
Sbjct: 255 MIDENIRPTFKELANEFTRMARDPPRYLVIKR 286

>3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318

 Score = 68.9 bits (169), Expect = 2e-13
 Identities = 60/278 (21%), Positives = 96/278 (34%), Gaps = 43/278 (15%)

Query: 73  VYKGKLEN-----QFRIAVKRFNRSAWPDARQ-FLEEARAVGQLRNRRLANLLGCCCEGD 126
           V     +         +AVK     A P  R  + +E   +  L +  +    GCC +  
Sbjct: 47  VSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAG 106

Query: 127 ER--LLVAEYMPN----DTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYH 180
                LV EY+P     D L +H              L  A  I E + Y  ++     H
Sbjct: 107 AASLQLVMEYVPLGSLRDYLPRHSIGLAQL-------LLFAQQICEGMAYLHAQH--YIH 157

Query: 181 -DLNAYRIVFDDDVNPRLSCFGLMKNSRDGRSY---STNLAF----TPPEYLRTGRVTPE 232
            DL A  ++ D+D   ++  FGL K   +G  Y     +         PE L+  +    
Sbjct: 158 RDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAPECLKEYKFYYA 217

Query: 233 SVMYSFGTLLLDLLS--GKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEG-------- 282
           S ++SFG  L +LL+       P      +       +T   L      + G        
Sbjct: 218 SDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMTVLRLTELL--ERGERLPRPDK 275

Query: 283 --TELVRLASRCLQYEPRERPNPRSLVTALVTLQKDTE 318
              E+  L   C + E   RP   +L+  L T+ +  +
Sbjct: 276 CPAEVYHLMKNCWETEASFRPTFENLIPILKTVHEKYQ 313

>2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613

 Score = 69.6 bits (170), Expect = 2e-13
 Identities = 51/264 (19%), Positives = 94/264 (35%), Gaps = 30/264 (11%)

Query: 72  VVYKGKLEN---QFRIAVKRFNRSAWPDARQ-FLEEARAVGQLRNRRLANLLGCCCEGDE 127
            V +G       Q  +A+K   +       +  + EA+ + QL N  +  L+G  C+ + 
Sbjct: 351 SVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIG-VCQAEA 409

Query: 128 RLLVAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYH-DLNAYR 186
            +LV E      L K L     + +  +    +   ++  ++Y   K     H +L A  
Sbjct: 410 LMLVMEMAGGGPLHKFLVGKREE-IPVSNVAELLHQVSMGMKYLEEKN--FVHRNLAARN 466

Query: 187 IVFDDDVNPRLSCFGLMKNSRDGRSYSTN-------LAFTPPEYLRTGRVTPESVMYSFG 239
           ++  +    ++S FGL K      SY T        L +  PE +   + +  S ++S+G
Sbjct: 467 VLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYG 526

Query: 240 TLLLDLLSGKHIP-----PSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLASRCLQ 294
             + + LS    P         +  I           C           EL  L S C  
Sbjct: 527 VTMWEALSYGQKPYKKMKGPEVMAFIEQGKRMECPPECPP---------ELYALMSDCWI 577

Query: 295 YEPRERPNPRSLVTALVTLQKDTE 318
           Y+  +RP+  ++   +        
Sbjct: 578 YKWEDRPDFLTVEQRMRACYYSLA 601

>3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313

 Score = 68.5 bits (168), Expect = 2e-13
 Identities = 53/276 (19%), Positives = 100/276 (36%), Gaps = 44/276 (15%)

Query: 73  VYKGKL----ENQFRIAVK--RFNRSAWPDARQFLEEARAVGQLRNRRLANLLGCCCEGD 126
           V +G L        ++AVK  + + S+  +  +FL EA  +    +  +  LLG C E  
Sbjct: 50  VMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGVCIEMS 109

Query: 127 -----ERLLVAEYMPN----DTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERA 177
                + +++  +M        L         + +     L+  + IA  +EY +++   
Sbjct: 110 SQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNRN-- 167

Query: 178 LYH-DLNAYRIVFDDDVNPRLSCFGLMKNSRD--GRSY---STNLAF----TPPEYLRTG 227
             H DL A   +  DD+   ++ FGL   S+      Y                E L   
Sbjct: 168 FLHRDLAARNCMLRDDMTVCVADFGL---SKKIYSGDYYRQGRIAKMPVKWIAIESLADR 224

Query: 228 RVTPESVMYSFGTLLLDLLS-GK----HIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEG 282
             T +S +++FG  + ++ + G      +      D +   +     + CL+        
Sbjct: 225 VYTSKSDVWAFGVTMWEIATRGMTPYPGVQNHEMYDYLLHGHRLKQPEDCLD-------- 276

Query: 283 TELVRLASRCLQYEPRERPNPRSLVTALVTLQKDTE 318
            EL  +   C + +P +RP    L   L  L +   
Sbjct: 277 -ELYEIMYSCWRTDPLDRPTFSVLRLQLEKLLESLP 311

>1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327

 Score = 67.3 bits (165), Expect = 8e-13
 Identities = 58/282 (20%), Positives = 107/282 (37%), Gaps = 45/282 (15%)

Query: 73  VYKGKLENQF---RIAVKRFNRSAWPDARQ-FLEEARAVGQL-RNRRLANLLGCCCEGDE 127
           V K +++        A+KR    A  D  + F  E   + +L  +  + NLLG C     
Sbjct: 41  VLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGY 100

Query: 128 RLLVAEYMPNDTLAKHL--------------FHWETQPMKWAMRLRVALHIAEALEYCTS 173
             L  EY P+  L   L               +     +     L  A  +A  ++Y + 
Sbjct: 101 LYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQ 160

Query: 174 KERALYH-DLNAYRIVFDDDVNPRLSCFGLMKNSRDGRSY--STNLAF----TPPEYLRT 226
           K+    H DL A  I+  ++   +++ FGL   SR    Y   T           E L  
Sbjct: 161 KQ--FIHRDLAARNILVGENYVAKIADFGL---SRGQEVYVKKTMGRLPVRWMAIESLNY 215

Query: 227 GRVTPESVMYSFGTLLLDLLS-GKH----IPPSHALDLIRDRNIQTLTDSCLEGQFSSDE 281
              T  S ++S+G LL +++S G      +  +   + +          +C +       
Sbjct: 216 SVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGYRLEKPLNCDD------- 268

Query: 282 GTELVRLASRCLQYEPRERPNPRSLVTALVTLQKDTELYLSL 323
             E+  L  +C + +P ERP+   ++ +L  + ++ + Y++ 
Sbjct: 269 --EVYDLMRQCWREKPYERPSFAQILVSLNRMLEERKTYVNT 308

>3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297

 Score = 66.5 bits (163), Expect = 1e-12
 Identities = 58/281 (20%), Positives = 100/281 (35%), Gaps = 51/281 (18%)

Query: 73  VYKGKLEN------QFRIAVKRFNRSAWPDARQFLEEARAVGQLRNRRLANLLGCCCEGD 126
           V+  +  N      +  +AVK          + F  EA  +  L++  +    G C +GD
Sbjct: 31  VFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKFYGVCGDGD 90

Query: 127 ERLLVAEYMPN--------------DTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCT 172
             ++V EYM +                L           +  +  L +A  IA  + Y  
Sbjct: 91  PLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLA 150

Query: 173 SKERALYH-DLNAYRIVFDDDVNPRLSC----FGLMKNSRDGRSYS--TNLAF----TPP 221
           S+     H DL   R      V   L      FG+ ++      Y    +        PP
Sbjct: 151 SQH--FVHRDLAT-RNCL---VGANLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPP 204

Query: 222 EYLRTGRVTPESVMYSFGTLLLDLLS-GKH----IPPSHALDLIRDRNIQTLTDSCLEGQ 276
           E +   + T ES ++SFG +L ++ + GK     +  +  ++ I    +      C +  
Sbjct: 205 ESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNTEVIECITQGRVLERPRVCPK-- 262

Query: 277 FSSDEGTELVRLASRCLQYEPRERPNPRSLVTALVTLQKDT 317
                  E+  +   C Q EP++R N + +   L  L K T
Sbjct: 263 -------EVYDVMLGCWQREPQQRLNIKEIYKILHALGKAT 296

>3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281

 Score = 65.7 bits (161), Expect = 2e-12
 Identities = 55/263 (20%), Positives = 100/263 (38%), Gaps = 29/263 (11%)

Query: 72  VVYKGKLEN----QFRIAVKRFNRSAWPDARQ-FLEEARAVGQLRNRRLANLLGCCCEGD 126
            VY+G   N    +  +AVK   +    D ++ F+ EA  +  L +  +  L+G   E +
Sbjct: 27  EVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLIG-IIEEE 85

Query: 127 ERLLVAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYH-DLNAY 185
              ++ E  P   L  +L   +       + +  +L I +A+ Y  S      H D+   
Sbjct: 86  PTWIIMELYPYGELGHYLERNKNSLKVLTL-VLYSLQICKAMAYLESIN--CVHRDIAVR 142

Query: 186 RIVFDDDVNPRLSCFGLMKNSRDGRSYSTNLA-----FTPPEYLRTGRVTPESVMYSFGT 240
            I+       +L  FGL +   D   Y  ++      +  PE +   R T  S ++ F  
Sbjct: 143 NILVASPECVKLGDFGLSRYIEDEDYYKASVTRLPIKWMSPESINFRRFTTASDVWMFAV 202

Query: 241 LLLDLLSGKHIP-----PSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLASRCLQY 295
            + ++LS    P         + ++   +     D C            L  L +RC  Y
Sbjct: 203 CMWEILSFGKQPFFWLENKDVIGVLEKGDRLPKPDLCPP---------VLYTLMTRCWDY 253

Query: 296 EPRERPNPRSLVTALVTLQKDTE 318
           +P +RP    LV +L  + +  +
Sbjct: 254 DPSDRPRFTELVCSLSDVYQMEK 276

>1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291

 Score = 65.0 bits (159), Expect = 3e-12
 Identities = 54/264 (20%), Positives = 98/264 (37%), Gaps = 32/264 (12%)

Query: 72  VVYKGKLENQFR---IAVK--RFNRSAWPDARQFLEEARAVGQLRNRRLANLLGCCCEGD 126
            V KG  + +     +AVK  +   +      + L EA  + QL N  +  ++G  CE +
Sbjct: 32  TVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIG-ICEAE 90

Query: 127 ERLLVAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYH-DLNAY 185
             +LV E      L K+L   + + +K    + +   ++  ++Y         H DL A 
Sbjct: 91  SWMLVMEMAELGPLNKYLQ--QNRHVKDKNIIELVHQVSMGMKYLEESN--FVHRDLAAR 146

Query: 186 RIVFDDDVNPRLSCFGLMKNSRDGRSY---STNLAF----TPPEYLRTGRVTPESVMYSF 238
            ++       ++S FGL K  R   +Y    T+  +      PE +   + + +S ++SF
Sbjct: 147 NVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSF 206

Query: 239 GTLLLDLLSGKHIP-----PSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLASRCL 293
           G L+ +  S    P      S    ++           C           E+  L + C 
Sbjct: 207 GVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMGCPAGCPR---------EMYDLMNLCW 257

Query: 294 QYEPRERPNPRSLVTALVTLQKDT 317
            Y+   RP   ++   L     D 
Sbjct: 258 TYDVENRPGFAAVELRLRNYYYDV 281

>1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287

 Score = 64.2 bits (157), Expect = 7e-12
 Identities = 50/268 (18%), Positives = 92/268 (34%), Gaps = 38/268 (14%)

Query: 72  VVYKGKL---ENQFRIAVKRFNRSAWPDARQ-FLEEARAVGQLRNRRLANLLGCCCEGDE 127
            V +G     + Q  +A+K   +       +  + EA+ + QL N  +  L+G  C+ + 
Sbjct: 25  SVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIG-VCQAEA 83

Query: 128 RLLVAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYH-DLNAYR 186
            +LV E      L K L     + +  +    +   ++  ++Y   K     H DL A  
Sbjct: 84  LMLVMEMAGGGPLHKFLVGKREE-IPVSNVAELLHQVSMGMKYLEEKN--FVHRDLAARN 140

Query: 187 IVFDDDVNPRLSC----FGLMKNSRDGRSY---STNLAF----TPPEYLRTGRVTPESVM 235
           ++    +  R       FGL K      SY    +   +      PE +   + +  S +
Sbjct: 141 VL----LVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDV 196

Query: 236 YSFGTLLLDLLSGKHIP-----PSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLAS 290
           +S+G  + + LS    P         +  I           C           EL  L S
Sbjct: 197 WSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKRMECPPECPP---------ELYALMS 247

Query: 291 RCLQYEPRERPNPRSLVTALVTLQKDTE 318
            C  Y+  +RP+  ++   +        
Sbjct: 248 DCWIYKWEDRPDFLTVEQRMRACYYSLA 275

>3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337

 Score = 64.4 bits (157), Expect = 7e-12
 Identities = 53/294 (18%), Positives = 100/294 (34%), Gaps = 54/294 (18%)

Query: 73  VYKGKLENQFRIAVKRFNRSAWPDARQFLEEARAVGQLRNRRLANLL---GCCCEGDER- 128
           V+ GK   + ++AVK F      +   +  E   + Q    R  N+L       +G    
Sbjct: 53  VWMGKWRGE-KVAVKVFF---TTEEASWFRE-TEIYQTVLMRHENILGFIAADIKGTGSW 107

Query: 129 ---LLVAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEY------CTSKERALY 179
               L+ +Y  N +L  +L   ++  +     L++A      L +       T  + A+ 
Sbjct: 108 TQLYLITDYHENGSLYDYL---KSTTLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIA 164

Query: 180 H-DLNAYRIVFDDDVNPRLSCFGL----MKNSRDGRSYSTNLAFTP----PEYLRTGRVT 230
           H DL +  I+   +    ++  GL    + ++ +          T     PE L    + 
Sbjct: 165 HRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLD-ESLN 223

Query: 231 PESV-------MYSFGTLLLDLLSGKHI--------PPSHALDLIRDRNIQTLTDSCLEG 275
                      MYSFG +L ++               P H L              C++ 
Sbjct: 224 RNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPYHDLVPSDPSYEDMREIVCIKK 283

Query: 276 Q-------FSSDEGT-ELVRLASRCLQYEPRERPNPRSLVTALVTLQKDTELYL 321
                   +SSDE   ++ +L + C  + P  R     +   L  + +  ++ L
Sbjct: 284 LRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKTLAKMSESQDIKL 337

>1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343

 Score = 62.7 bits (153), Expect = 3e-11
 Identities = 66/296 (22%), Positives = 106/296 (35%), Gaps = 60/296 (20%)

Query: 73  VYKGKLENQF------RIAVKRFNRSAWPDARQ-FLEEARAVGQLRNRRLANLLGCCCEG 125
           V++ +            +AVK     A  D +  F  EA  + +  N  +  LLG C  G
Sbjct: 63  VFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAVG 122

Query: 126 DERLLVAEYMPNDTLAKHL----------------------FHWETQPMKWAMRLRVALH 163
               L+ EYM    L + L                            P+  A +L +A  
Sbjct: 123 KPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQ 182

Query: 164 IAEALEYCTSKERALYH-DLNAYRIVFDDDVNPRLSC----FGLMKNSRDGRSY--STNL 216
           +A  + Y + ++    H DL A R      V   +      FGL +N      Y    N 
Sbjct: 183 VAAGMAYLSERK--FVHRDL-ATRNCL---VGENMVVKIADFGLSRNIYSADYYKADGND 236

Query: 217 AF----TPPEYLRTGRVTPESVMYSFGTLLLDLLS-GKH----IPPSHALDLIRDRNIQT 267
           A      PPE +   R T ES ++++G +L ++ S G      +     +  +RD NI  
Sbjct: 237 AIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGMAHEEVIYYVRDGNILA 296

Query: 268 LTDSCLEGQFSSDEGTELVRLASRCLQYEPRERPNPRSLVTALVTLQKDTELYLSL 323
             ++C           EL  L   C    P +RP+  S+   L  + +  E  + +
Sbjct: 297 CPENCPL---------ELYNLMRLCWSKLPADRPSFCSIHRILQRMCERAEGTVGV 343

>2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334

 Score = 61.9 bits (151), Expect = 5e-11
 Identities = 58/290 (20%), Positives = 107/290 (36%), Gaps = 49/290 (16%)

Query: 73  VYKGKL--------ENQFRIAVKRFNRSAWPDARQ-FLEEARAVGQL-RNRRLANLLGCC 122
           V   +         +    +AVK     A        + E   +  + +++ + NLLG C
Sbjct: 51  VVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGAC 110

Query: 123 CEGDERLLVAEYMPNDTLAKHL--------------FHWETQPMKWAMRLRVALHIAEAL 168
            +     ++ EY     L ++L                   + M +   +     +A  +
Sbjct: 111 TQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGM 170

Query: 169 EYCTSKERALYH-DLNAYRIVFDDDVNPRLSCFGLMKNSRDGRSY--STNLAF----TPP 221
           EY  S++    H DL A  ++  ++   +++ FGL ++  +   Y  +TN         P
Sbjct: 171 EYLASQK--CIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAP 228

Query: 222 EYLRTGRVTPESVMYSFGTLLLDLLS-GKH----IPPSHALDLIRDRNIQTLTDSCLEGQ 276
           E L     T +S ++SFG L+ ++ + G      IP      L+++ +      +C    
Sbjct: 229 EALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFKLLKEGHRMDKPANCTN-- 286

Query: 277 FSSDEGTELVRLASRCLQYEPRERPNPRSLVTALVTLQKDT--ELYLSLP 324
                  EL  +   C    P +RP  + LV  L  +   T  E YL L 
Sbjct: 287 -------ELYMMMRDCWHAVPSQRPTFKQLVEDLDRILTLTTNEEYLDLS 329

>3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289

 Score = 61.5 bits (150), Expect = 5e-11
 Identities = 54/275 (19%), Positives = 98/275 (35%), Gaps = 52/275 (18%)

Query: 73  VYKGKLENQF------RIAVKRFNRSAWPDARQ-FLEEARAVGQLRNRRLANLLGCCCEG 125
           VYKG L           +A+K     A    R+ F  EA    +L++  +  LLG   + 
Sbjct: 25  VYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVCLLGVVTKD 84

Query: 126 DERLLVAEYMPN--------------DTLAKHLFHWETQPMKWAMRLRVALHIAEALEYC 171
               ++  Y  +              D  +          ++    + +   IA  +EY 
Sbjct: 85  QPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYL 144

Query: 172 TSKERALYH-DLNAYRIVFDDDVNPRLSC----FGLMKNSRDGRSYSTNLA------FTP 220
           +S    + H DL A R V    V  +L+      GL +       Y           +  
Sbjct: 145 SSHH--VVHKDL-ATRNVL---VYDKLNVKISDLGLFREVYAADYYKLLGNSLLPIRWMA 198

Query: 221 PEYLRTGRVTPESVMYSFGTLLLDLLSGKHIP-PSHA----LDLIRDRNIQTLTDSCLEG 275
           PE +  G+ + +S ++S+G +L ++ S    P   ++    +++IR+R +    D C   
Sbjct: 199 PEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVVEMIRNRQVLPCPDDCPA- 257

Query: 276 QFSSDEGTELVRLASRCLQYEPRERPNPRSLVTAL 310
                    +  L   C    P  RP  + + + L
Sbjct: 258 --------WVYALMIECWNEFPSRRPRFKDIHSRL 284

>4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302

 Score = 61.6 bits (150), Expect = 5e-11
 Identities = 50/275 (18%), Positives = 101/275 (36%), Gaps = 45/275 (16%)

Query: 73  VYKGKLE-----NQFRIAVKRFNRSAWPDARQ-FLEEARAVGQLRNRRLANLLGCCCEGD 126
           V   + +        ++AVK     +  +      +E   +  L +  +    G C E  
Sbjct: 37  VELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDG 96

Query: 127 ER--LLVAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYH-DLN 183
                L+ E++P+ +L ++L   + + +    +L+ A+ I + ++Y  S++    H DL 
Sbjct: 97  GNGIKLIMEFLPSGSLKEYLPKNKNK-INLKQQLKYAVQICKGMDYLGSRQ--YVHRDLA 153

Query: 184 AYRIVFDDDVNPRLSCFGLMKNSRDGRSY---STNLAF----TPPEYLRTGRVTPESVMY 236
           A  ++ + +   ++  FGL K     + Y     +         PE L   +    S ++
Sbjct: 154 ARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDRDSPVFWYAPECLMQSKFYIASDVW 213

Query: 237 SFGTLLLDLLS-GKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELV----RLAS- 290
           SFG  L +LL+         AL L               GQ +       +    RL   
Sbjct: 214 SFGVTLHELLTYCDSDSSPMALFLKMIGPTH--------GQMTVTRLVNTLKEGKRLPCP 265

Query: 291 ------------RCLQYEPRERPNPRSLVTALVTL 313
                       +C +++P  R + ++L+     L
Sbjct: 266 PNCPDEVYQLMRKCWEFQPSNRTSFQNLIEGFEAL 300

>3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382

 Score = 61.6 bits (150), Expect = 8e-11
 Identities = 57/282 (20%), Positives = 101/282 (35%), Gaps = 47/282 (16%)

Query: 73  VYKGKL--------ENQFRIAVKRFNRSAWPDARQ-FLEEARAVGQLRN-RRLANLLGCC 122
           V   +             ++AVK     A        + E   +  +   + + NLLG C
Sbjct: 85  VVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGAC 144

Query: 123 CEGDERLLVAEYMPNDTLAKHL--------------FHWETQPMKWAMRLRVALHIAEAL 168
            +     ++ EY     L ++L               H   + +     +  A  +A  +
Sbjct: 145 TQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGM 204

Query: 169 EYCTSKERALYH-DLNAYRIVFDDDVNPRLSCFGLMKNSRDGRSY--STNLAF----TPP 221
           EY  SK+    H DL A  ++  +D   +++ FGL ++      Y  +TN         P
Sbjct: 205 EYLASKK--CIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAP 262

Query: 222 EYLRTGRVTPESVMYSFGTLLLDLLS-GKH----IPPSHALDLIRDRNIQTLTDSCLEGQ 276
           E L     T +S ++SFG LL ++ + G      +P      L+++ +      +C    
Sbjct: 263 EALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKLLKEGHRMDKPSNCTN-- 320

Query: 277 FSSDEGTELVRLASRCLQYEPRERPNPRSLVTALVTLQKDTE 318
                  EL  +   C    P +RP  + LV  L  +   T 
Sbjct: 321 -------ELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVALTS 355

>1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342

 Score = 60.6 bits (147), Expect = 1e-10
 Identities = 47/289 (16%), Positives = 98/289 (33%), Gaps = 54/289 (18%)

Query: 73  VYKGKLENQFRIAVKRFNRSAWPDARQFLEEARAVGQLRNRRLANLL---GCCCEGD--- 126
           V++GK   +  +AVK F+     + R +  E   + Q    R  N+L       + +   
Sbjct: 58  VWRGKWRGE-EVAVKIFS---SREERSWFRE-AEIYQTVMLRHENILGFIAADNKDNGTW 112

Query: 127 -ERLLVAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEY------CTSKERALY 179
            +  LV++Y  + +L  +L       +     +++AL  A  L +       T  + A+ 
Sbjct: 113 TQLWLVSDYHEHGSLFDYL---NRYTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIA 169

Query: 180 H-DLNAYRIVFDDDVNPRLSCFGL----MKNSRDGRSYSTNLAFTP----PEYLRTGRVT 230
           H DL +  I+   +    ++  GL       +        +   T     PE L    + 
Sbjct: 170 HRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLD-DSIN 228

Query: 231 PESV-------MYSFGTLLLDLLSGKHI---PPSHAL---DLI-RDRNIQTLTDS-CLEG 275
            +         +Y+ G +  ++     I      + L   DL+  D +++ +    C + 
Sbjct: 229 MKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMRKVVCEQK 288

Query: 276 Q--------FSSDEGTELVRLASRCLQYEPRERPNPRSLVTALVTLQKD 316
                     S +    + ++   C       R     +   L  L + 
Sbjct: 289 LRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQ 337

>3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327

 Score = 59.7 bits (145), Expect = 3e-10
 Identities = 55/274 (20%), Positives = 101/274 (36%), Gaps = 34/274 (12%)

Query: 73  VYKGKL-----ENQFRIAVKRFNRSAWPDARQFLEEARAVGQLRNRRLANLLGCCCEGDE 127
           V   +           +AVK+   S     R F  E + +  L +  +    G       
Sbjct: 39  VELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYRGVSYGPGR 98

Query: 128 R--LLVAEYMPN----DTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHD 181
           +   LV EY+P+    D L +H    +   +     L  +  I + +EY  S+ R ++ D
Sbjct: 99  QSLRLVMEYLPSGCLRDFLQRHRARLDASRL-----LLYSSQICKGMEYLGSR-RCVHRD 152

Query: 182 LNAYRIVFDDDVNPRLSCFGLMKNSRDGRSY---STNLAF----TPPEYLRTGRVTPESV 234
           L A  I+ + + + +++ FGL K     + Y               PE L     + +S 
Sbjct: 153 LAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIFWYAPESLSDNIFSRQSD 212

Query: 235 MYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEG----------TE 284
           ++SFG +L +L +      S + + +R    +    +        +EG           E
Sbjct: 213 VWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDVPALSRLLELLEEGQRLPAPPACPAE 272

Query: 285 LVRLASRCLQYEPRERPNPRSLVTALVTLQKDTE 318
           +  L   C    P++RP+  +L   L  L   + 
Sbjct: 273 VHELMKLCWAPSPQDRPSFSALGPQLDMLWSGSR 306

>2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370

 Score = 59.3 bits (144), Expect = 4e-10
 Identities = 58/281 (20%), Positives = 97/281 (34%), Gaps = 61/281 (21%)

Query: 73  VYKGKL--------ENQFRIAVKRFNRSAWPDARQ-FLEEARAVGQL-RNRRLANLLGCC 122
           V   +         +    +AVK     A        + E   +  + +++ + NLLG C
Sbjct: 97  VVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGAC 156

Query: 123 CEGDERLLVAEYMPNDTLAKHL--------------FHWETQPMKWAMRLRVALHIAEAL 168
            +     ++ EY     L ++L                   + M +   +     +A  +
Sbjct: 157 TQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGM 216

Query: 169 EYCTSKERALYH-DLNAYRIVFDDDVNPRLSC----FGLMKNSRD--GRSY---STNLAF 218
           EY  S++    H DL A R V    V          FGL   +RD     Y   +TN   
Sbjct: 217 EYLASQK--CIHRDL-AARNVL---VTENNVMKIADFGL---ARDINNIDYYKKTTNGRL 267

Query: 219 ----TPPEYLRTGRVTPESVMYSFGTLLLDLLS-GKH----IPPSHALDLIRDRNIQTLT 269
                 PE L     T +S ++SFG L+ ++ + G      IP      L+++ +     
Sbjct: 268 PVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFKLLKEGHRMDKP 327

Query: 270 DSCLEGQFSSDEGTELVRLASRCLQYEPRERPNPRSLVTAL 310
            +C           EL  +   C    P +RP  + LV  L
Sbjct: 328 ANCTN---------ELYMMMRDCWHAVPSQRPTFKQLVEDL 359

>1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313

 Score = 58.4 bits (142), Expect = 7e-10
 Identities = 56/293 (19%), Positives = 97/293 (33%), Gaps = 62/293 (21%)

Query: 73  VYKGKL------ENQFRIAVKRFNRSAWPDARQ-FLEEARAVGQLRN-RRLANLLGCCCE 124
           V +         +    +AVK    SA    R+  + E + +  L N   + NLLG C  
Sbjct: 39  VVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTI 98

Query: 125 GDERLLVAEYMPNDTLAKHL----------------FHWETQPMKWAMRLRVALHIAEAL 168
           G   L++ EY     L   L                   +   +     L  +  +A+ +
Sbjct: 99  GGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGM 158

Query: 169 EYCTSKERALYH-DLNAYRIVFDDDVNPRLSC----FGLMKNSRD--GRSY---STNLAF 218
            +  SK     H DL A R +    +          FGL   +RD    S      N   
Sbjct: 159 AFLASKN--CIHRDLAA-RNIL---LTHGRITKICDFGL---ARDIKNDSNYVVKGNARL 209

Query: 219 ----TPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIP----PSHA--LDLIRDRNIQTL 268
                 PE +     T ES ++S+G  L +L S    P    P  +    +I++      
Sbjct: 210 PVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFYKMIKEGFRMLS 269

Query: 269 TDSCLEGQFSSDEGTELVRLASRCLQYEPRERPNPRSLVTALVTLQKDTELYL 321
            +             E+  +   C   +P +RP  + +V  +     ++  ++
Sbjct: 270 PEHAPA---------EMYDIMKTCWDADPLKRPTFKQIVQLIEKQISESTNHI 313

>1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291

 Score = 58.0 bits (141), Expect = 7e-10
 Identities = 57/261 (21%), Positives = 97/261 (37%), Gaps = 36/261 (13%)

Query: 72  VVYKGKL----ENQFRIAVK--RFNRSAWPDARQ-FLEEARAVGQLRNRRLANLLGCCCE 124
           VV +G+          +AVK  + +  + P+A   F+ E  A+  L +R L  L G    
Sbjct: 33  VVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYG-VVL 91

Query: 125 GDERLLVAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYH-DLN 183
                +V E  P  +L   L              R A+ +AE + Y  SK     H DL 
Sbjct: 92  TPPMKMVTELAPLGSLLDRL-RKHQGHFLLGTLSRYAVQVAEGMGYLESKR--FIHRDLA 148

Query: 184 AYRIVFDDDVNPRLSCFGLMKNSRDGRSY---STNLAF----TPPEYLRTGRVTPESVMY 236
           A  ++       ++  FGLM+       +     +         PE L+T   +  S  +
Sbjct: 149 ARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTW 208

Query: 237 SFGTLLLDLLSGKHIP-----PSHALDLIRDRNIQTLT--DSCLEGQFSSDEGTELVRLA 289
            FG  L ++ +    P      S  L  I D+  + L   + C +         ++  + 
Sbjct: 209 MFGVTLWEMFTYGQEPWIGLNGSQILHKI-DKEGERLPRPEDCPQ---------DIYNVM 258

Query: 290 SRCLQYEPRERPNPRSLVTAL 310
            +C  ++P +RP   +L   L
Sbjct: 259 VQCWAHKPEDRPTFVALRDFL 279

>3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301

 Score = 58.1 bits (141), Expect = 7e-10
 Identities = 36/199 (18%), Positives = 71/199 (35%), Gaps = 38/199 (19%)

Query: 73  VYKGKLENQFRIAVKRFNRSAWPDARQFLEEARAVGQLRNRRLANLL---GCCCEGD--- 126
           V++G  + +  +AVK F+     D + +  E   +      R  N+L             
Sbjct: 24  VWRGSWQGE-NVAVKIFS---SRDEKSWFRE-TELYNTVMLRHENILGFIASDMTSRHSS 78

Query: 127 -ERLLVAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEY------CTSKERALY 179
            +  L+  Y    +L  +L   +   +     LR+ L IA  L +       T  + A+ 
Sbjct: 79  TQLWLITHYHEMGSLYDYL---QLTTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPAIA 135

Query: 180 H-DLNAYRIVFDDDVNPRLSCFGL----MKNSRDGRSYSTNLAFTP----PEYLRTGRVT 230
           H DL +  I+   +    ++  GL     +++      +     T     PE L    + 
Sbjct: 136 HRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLD-ETIQ 194

Query: 231 PESV-------MYSFGTLL 242
            +         +++FG +L
Sbjct: 195 VDCFDSYKRVDIWAFGLVL 213

>2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333

 Score = 57.7 bits (140), Expect = 1e-09
 Identities = 52/289 (17%), Positives = 92/289 (31%), Gaps = 58/289 (20%)

Query: 73  VYKGKL------ENQFRIAVKRFNRSAWPDARQ-FLEEARAVGQLRN-RRLANLLGCCCE 124
           V +         +   ++AVK    +A  D ++  + E + +  L     + NLLG C  
Sbjct: 62  VVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGACTH 121

Query: 125 GDERLLVAEYMPN------------DTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCT 172
           G   L++ EY                      F            L  +  +A+ + +  
Sbjct: 122 GGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLA 181

Query: 173 SKERALYH-DLNAYRIVFDDDVNPRLSC----FGLMKNSRD--GRSY---STNLAF---- 218
           SK     H D+ A R V    +          FGL   +RD    S      N       
Sbjct: 182 SKN--CIHRDVAA-RNVL---LTNGHVAKIGDFGL---ARDIMNDSNYIVKGNARLPVKW 232

Query: 219 TPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIP----PSHA--LDLIRDRNIQTLTDSC 272
             PE +     T +S ++S+G LL ++ S    P      ++    L++D          
Sbjct: 233 MAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVNSKFYKLVKDGYQMAQPAFA 292

Query: 273 LEGQFSSDEGTELVRLASRCLQYEPRERPNPRSLVTALVTLQKDTELYL 321
            +          +  +   C   EP  RP  + + + L    ++     
Sbjct: 293 PK---------NIYSIMQACWALEPTHRPTFQQICSFLQEQAQEDRRER 332

>2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314

 Score = 57.2 bits (139), Expect = 1e-09
 Identities = 62/282 (21%), Positives = 104/282 (36%), Gaps = 58/282 (20%)

Query: 73  VYKGKL------ENQFRIAVKRFNRSAWPDARQ-FLEEARAVGQLRNRRLANLLGCCCEG 125
           V K              +AVK    +A P   +  L E   + Q+ +  +  L G C + 
Sbjct: 39  VVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIKLYGACSQD 98

Query: 126 DERLLVAEYMPNDTLAKHL----------------------FHWETQPMKWAMRLRVALH 163
              LL+ EY    +L   L                       H + + +     +  A  
Sbjct: 99  GPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQ 158

Query: 164 IAEALEYCTSKERALYH-DLNAYRIVFDDDVNPRLSCFGLMKNSRD--GRSY---STNLA 217
           I++ ++Y    +  L H DL A  I+  +    ++S FGL   SRD          +   
Sbjct: 159 ISQGMQYLAEMK--LVHRDLAARNILVAEGRKMKISDFGL---SRDVYEEDSYVKRSQGR 213

Query: 218 F----TPPEYLRTGRVTPESVMYSFGTLLLDLLS-GKH----IPPSHALDLIRDRNIQTL 268
                   E L     T +S ++SFG LL ++++ G +    IPP    +L++  +    
Sbjct: 214 IPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIPPERLFNLLKTGHRMER 273

Query: 269 TDSCLEGQFSSDEGTELVRLASRCLQYEPRERPNPRSLVTAL 310
            D+C E         E+ RL  +C + EP +RP    +   L
Sbjct: 274 PDNCSE---------EMYRLMLQCWKQEPDKRPVFADISKDL 306

>3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371

 Score = 57.0 bits (137), Expect = 2e-09
 Identities = 39/280 (13%), Positives = 68/280 (24%), Gaps = 49/280 (17%)

Query: 72  VVYKGK-LENQFRIAVKRFNRSA---WPDARQFLEEARAVGQLRNR---RLANLLGCCCE 124
           VV+  + +E     A+K F   A     +  +  E   A  +L         +       
Sbjct: 77  VVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLP 136

Query: 125 GD-----------------------ERLLVAEYMPND--TLAKHLFHWETQ--PMKWAMR 157
            D                         LL+      D   L   L               
Sbjct: 137 SDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAASVDLELLFSTLDFVYVFRGDEGILAL 196

Query: 158 LRVALHIAEALEYCTSKERALYH-DL---NAYRIVFDDDVNPRLSCFGL-MKNSRDGRSY 212
             +   +        SK   L H      N   +    D    L       K    G + 
Sbjct: 197 HILTAQLIRLAANLQSKG--LVHGHFTPDN---LFIMPDGRLMLGDVSALWKVGTRGPAS 251

Query: 213 STNLAFTPPEYL--RTGRVTPESVMYSFGTLLLDLLSGK---HIPPSHALDLIRDRNIQT 267
           S  + + P E+L   T   T     +  G  +  +        +         +  +++ 
Sbjct: 252 SVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLPFGLVTPGIKGSWKRPSLRV 311

Query: 268 LTDSCLEGQFSSDEGTELVRLASRCLQYEPRERPNPRSLV 307
                L     +     +  L  R L ++ R R  P   +
Sbjct: 312 PGTDSLAFGSCTPLPDFVKTLIGRFLNFDRRRRLLPLEAM 351

>1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290

 Score = 56.2 bits (136), Expect = 3e-09
 Identities = 44/249 (17%), Positives = 87/249 (34%), Gaps = 25/249 (10%)

Query: 73  VYKGK-LENQFRIAVKRFNRSAWP--DARQFLEEARAVGQLRNRRLANLLGCC---CEGD 126
           VYKG   E    +A            + ++F EEA  +  L++  +           +G 
Sbjct: 42  VYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGK 101

Query: 127 ERL-LVAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYH-DLNA 184
           + + LV E M + TL  +L     + MK  +       I + L++  ++   + H DL  
Sbjct: 102 KCIVLVTELMTSGTLKTYL--KRFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKC 159

Query: 185 YRIVFD-DDVNPRLSCFGLMKNSRDGRSYST--NLAFTPPEYLRTGRVTPESVMYSFGTL 241
             I       + ++   GL    R   + +      F  PE            +Y+FG  
Sbjct: 160 DNIFITGPTGSVKIGDLGLATLKRASFAKAVIGTPEFMAPEMYEEK-YDESVDVYAFGMC 218

Query: 242 LLDLLSGKH----IPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLASRCLQYEP 297
           +L++ + ++       +  +          +T       F      E+  +   C++   
Sbjct: 219 MLEMATSEYPYSECQNAAQIYRR-------VTSGVKPASFDKVAIPEVKEIIEGCIRQNK 271

Query: 298 RERPNPRSL 306
            ER + + L
Sbjct: 272 DERYSIKDL 280

>2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316

 Score = 54.2 bits (131), Expect = 2e-08
 Identities = 48/282 (17%), Positives = 93/282 (32%), Gaps = 47/282 (16%)

Query: 73  VYKGKL------ENQFRIAVKRFNRSAWPDARQ-FLEEARAVGQL-RNRRLANLLGCCCE 124
           V +              +AVK     A     +  + E + +  +  +  + NLLG C +
Sbjct: 43  VIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTK 102

Query: 125 GDE-RLLVAEYMPNDTLAKHL--------------FHWETQPMKWAMRLRVALHIAEALE 169
                +++ E+     L+ +L                     +     +  +  +A+ +E
Sbjct: 103 PGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGME 162

Query: 170 YCTSKERALYH-DLNAYRIVFDDDVNPRLSCFGLMKNSRDGRSY--STNLAF----TPPE 222
           +  S++    H DL A  I+  +    ++  FGL ++      Y    +         PE
Sbjct: 163 FLASRK--CIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPE 220

Query: 223 YLRTGRVTPESVMYSFGTLLLDLLSGKHIP------PSHALDLIRDRNIQTLTDSCLEGQ 276
            +     T +S ++SFG LL ++ S    P             +++       D      
Sbjct: 221 TIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMRAPDYTTP-- 278

Query: 277 FSSDEGTELVRLASRCLQYEPRERPNPRSLVTALVTLQKDTE 318
                  E+ +    C   EP +RP    LV  L  L +   
Sbjct: 279 -------EMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQANA 313

>3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432

 Score = 54.4 bits (131), Expect = 2e-08
 Identities = 46/260 (17%), Positives = 85/260 (32%), Gaps = 53/260 (20%)

Query: 72  VVYKGKLENQFRIAVKRFNRSAWPDARQFLEEARAVGQLRNRRLANLLG--------CCC 123
           +VY+G  +N+  +AVKR     +  A +   E +         L             C  
Sbjct: 40  IVYRGMFDNR-DVAVKRILPECFSFADR---EVQL--------LRESDEHPNVIRYFCTE 87

Query: 124 EGDERL-LVAEYMP----NDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERAL 178
           +  +   +  E            K   H   +P+   ++          L +  S    +
Sbjct: 88  KDRQFQYIAIELCAATLQEYVEQKDFAHLGLEPIT-LLQ-----QTTSGLAHLHSLN--I 139

Query: 179 YH-DLNAYRIVF-----DDDVNPRLSCFGLMKNSRDGRSYSTNLAF---TP----PEYLR 225
            H DL  + I+         +   +S FGL K    GR   +  +    T     PE L 
Sbjct: 140 VHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEGWIAPEMLS 199

Query: 226 ---TGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEG-QFSSDE 281
                  T    ++S G +   ++S    P   +L    +  +   +  CL   +     
Sbjct: 200 EDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQANILLGACSLDCLHPEKHEDVI 259

Query: 282 GTELVRLASRCLQYEPRERP 301
             EL+    + +  +P++RP
Sbjct: 260 ARELIE---KMIAMDPQKRP 276

>3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377

 Score = 53.9 bits (129), Expect = 2e-08
 Identities = 31/198 (15%), Positives = 56/198 (28%), Gaps = 36/198 (18%)

Query: 127 ERLLVAEYMPND--TLAKHLFHWETQ--PMKWAMRLRVALHIAEALEYCTSKERALYH-D 181
            R  +   M ++  T  + L    +    +    RL++ L +   L         L H  
Sbjct: 174 SRFFLYPRMQSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHH--YGLVHTY 231

Query: 182 L---NAYRIVFDDDVNPRLSCFGLMKNSRDGRSYSTNLAFTPPEYL-----------RTG 227
           L   +   IV D      L+ F  +         S +  F PPE             R  
Sbjct: 232 LRPVD---IVLDQRGGVFLTGFEHLVRDGARVVSSVSRGFEPPELEARRATISYHRDRRT 288

Query: 228 RVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFS-SDEGTELV 286
            +T     ++ G ++  +       P      I        ++       +       L+
Sbjct: 289 LMTFSFDAWALGLVIYWIWCAD--LP------ITKDAALGGSEWIFRSCKNIPQPVRALL 340

Query: 287 RLASRCLQYEPRERPNPR 304
                 L+Y   +R  P 
Sbjct: 341 E---GFLRYPKEDRLLPL 355

>1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344

 Score = 53.1 bits (128), Expect = 4e-08
 Identities = 57/299 (19%), Positives = 100/299 (33%), Gaps = 63/299 (21%)

Query: 73  VYKGKL------ENQFRIAVKRFNRSAWPDARQ-FLEEARAVGQL-RNRRLANLLGCCCE 124
           V               ++AVK     A    R+  + E + + QL  +  + NLLG C  
Sbjct: 61  VMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTL 120

Query: 125 GDERLLVAEYMPN---------------------DTLAKHLFHWETQPMKWAMRLRVALH 163
                L+ EY                        +   +     +   + +   L  A  
Sbjct: 121 SGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQ 180

Query: 164 IAEALEYCTSKERALYH-DLNAYRIVFDDDVNPRLSC----FGLMKNSRDGRSY--STNL 216
           +A+ +E+   K     H DL A R V    V          FGL ++     +Y    N 
Sbjct: 181 VAKGMEFLEFKS--CVHRDLAA-RNVL---VTHGKVVKICDFGLARDIMSDSNYVVRGNA 234

Query: 217 AF----TPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIP------PSHALDLIRDRNIQ 266
                   PE L  G  T +S ++S+G LL ++ S    P       ++   LI++    
Sbjct: 235 RLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPVDANFYKLIQNGFKM 294

Query: 267 TLTDSCLEGQFSSDEGTELVRLASRCLQYEPRERPNPRSLVTALVTL--QKDTELYLSL 323
                  E         E+  +   C  ++ R+RP+  +L + L       +  +Y ++
Sbjct: 295 DQPFYATE---------EIYIIMQSCWAFDSRKRPSFPNLTSFLGCQLADAEEAMYQNV 344

>3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413

 Score = 53.1 bits (127), Expect = 5e-08
 Identities = 36/214 (16%), Positives = 58/214 (27%), Gaps = 35/214 (16%)

Query: 129 LLVAEYMPNDTLAKHLFHW--ETQPMKWAMRLRVALHIAEALEYCTSKERALYH-DL--- 182
           L         T  + L       + +    RL++ L +   L         L H  L   
Sbjct: 183 LYPRMQSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHH--YGLVHTYLRPV 240

Query: 183 NAYRIVFDDDVNPRLSCFGLMKNSRDGRSYSTNLAFTPPEYL----------RTGRVTPE 232
           +   IV D      L+ F  +              F PPE                +T  
Sbjct: 241 D---IVLDQRGGVFLTGFEHLVRDGASAVSPIGRGFAPPETTAERMLPFGQHHPTLMTFA 297

Query: 233 SVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGT--ELVRLAS 290
              ++ G  +  +       P+     +             E  F S +     +  L  
Sbjct: 298 FDTWTLGLAIYWIWCAD--LPNTDDAALGG----------SEWIFRSCKNIPQPVRALLE 345

Query: 291 RCLQYEPRERPNPRSLVTALVTLQKDTELYLSLP 324
             L+Y   +R  P   +      Q  TEL  +LP
Sbjct: 346 GFLRYPKEDRLLPLQAMETPEYEQLRTELSAALP 379

>4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350

 Score = 50.1 bits (120), Expect = 3e-07
 Identities = 44/244 (18%), Positives = 87/244 (35%), Gaps = 19/244 (7%)

Query: 73  VYKGK-LENQFRIAVKRFNRSAWPDA--RQFLEEARAVGQLRNRRLANLLGCCCEGDERL 129
               K  E+  +  +K  N S        +   E   +  +++  +        E     
Sbjct: 40  AILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRESFEENGSLY 99

Query: 130 LVAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVF 189
           +V +Y     L K +   +    +    L   + I  AL++   + + L+ D+ +  I  
Sbjct: 100 IVMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVHDR-KILHRDIKSQNIFL 158

Query: 190 DDDVNPRLSCFGLMKNSRDGRSYSTNLAFTP----PEYLRTGRVTPESVMYSFGTLLLDL 245
             D   +L  FG+ +        +     TP    PE         +S +++ G +L +L
Sbjct: 159 TKDGTVQLGDFGIARVLNSTVELARACIGTPYYLSPEICENKPYNNKSDIWALGCVLYEL 218

Query: 246 LSGKHIPPSHALDLIRDRNIQTLTDSCLEGQF---SSDEGTELVRLASRCLQYEPRERPN 302
            + K      A       +++ L    + G F   S     +L  L S+  +  PR+RP+
Sbjct: 219 CTLK--HAFEA------GSMKNLVLKIISGSFPPVSLHYSYDLRSLVSQLFKRNPRDRPS 270

Query: 303 PRSL 306
             S+
Sbjct: 271 VNSI 274

>2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434

 Score = 49.4 bits (118), Expect = 7e-07
 Identities = 53/285 (18%), Positives = 92/285 (32%), Gaps = 82/285 (28%)

Query: 72  VVYKGKLENQFRIAVKRFNRSAWPDARQFLEEARAVGQLRNRRLANL--LGCCCEGDERL 129
           VV++G  + +  +AVKR        A     E + + +  +    N+    C    D  L
Sbjct: 31  VVFQGSFQGR-PVAVKRMLIDFCDIALM---EIKLLTESDDH--PNVIRYYCSETTDRFL 84

Query: 130 -LVAEYMPNDTL-----AKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLN 183
            +  E   N  L     +K++     +  K    + +   IA  + +         H L 
Sbjct: 85  YIALELC-NLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHL--------HSLK 135

Query: 184 --------------------AYRIVFDDDVNPRLSCFGLMKNSRDGRSYSTNLAFTP--- 220
                               A +    +++   +S FGL K    G+S        P   
Sbjct: 136 IIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQSSFRTNLNNPSGT 195

Query: 221 -----PEYLR-------TGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTL 268
                PE L          R+T    ++S G +   +LS    P        R+ NI   
Sbjct: 196 SGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGD--KYSRESNI--- 250

Query: 269 TDSCLEGQFS------------SDEGTELVRLASRCLQYEPRERP 301
               + G FS              E T+L+    + + ++P +RP
Sbjct: 251 ----IRGIFSLDEMKCLHDRSLIAEATDLIS---QMIDHDPLKRP 288

>3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365

 Score = 49.2 bits (117), Expect = 8e-07
 Identities = 27/265 (10%), Positives = 62/265 (23%), Gaps = 45/265 (16%)

Query: 72  VVYKGK------LENQFRIAVKRFNRSAWPDARQFLEEARAVGQLRNRRLANLLGCCCEG 125
            VY+         +N+ +  +K    +   +     +    +                  
Sbjct: 80  QVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQ 139

Query: 126 DERLLVAEYMPNDTLAKHL-----FHWETQPMKWAMRLRVALHIAEALEYCTSKERA--- 177
           +  +LV E     TL   +        +  P    +    A+ +   +E     E     
Sbjct: 140 NGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISF--AMRMLYMIEQVHDCEIIHGD 197

Query: 178 -------LYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDGRSYSTNLAFTP----PEY--- 223
                  L +         D      L   G    S D + +     FT       +   
Sbjct: 198 IKPDNFILGNGFLEQDDEDDLSAGLALIDLGQ---SIDMKLFPKGTIFTAKCETSGFQCV 254

Query: 224 -LRTGRVTPESV-MYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDE 281
            + + +     +  +     +  +L G ++        +++   +   +         D 
Sbjct: 255 EMLSNKPWNYQIDYFGVAATVYCMLFGTYMK-------VKNEGGECKPEGLFRRLPHLDM 307

Query: 282 GTELVRLASRCLQYEPRERPNPRSL 306
             E        L            L
Sbjct: 308 WNEFFH---VMLNIPDCHHLPSLDL 329

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332

 Score = 46.4 bits (110), Expect = 5e-06
 Identities = 38/197 (19%), Positives = 68/197 (34%), Gaps = 37/197 (18%)

Query: 133 EYMPNDTLAKHLFH-WETQPMKWAMRLRVALHIAEALEYCTSKERALYHDL---NAYRIV 188
           +    + L   +      +  +  + L + + IAEA+E+  SK   ++ DL   N   I 
Sbjct: 141 QLCRKENLKDWMNRRCSLEDREHGVCLHIFIQIAEAVEFLHSK-GLMHRDLKPSN---IF 196

Query: 189 FDDDVNPRLSCFGLMKNSRDGRSYSTNLAFTPPEYLRTGRV-TP---------------E 232
           F  D   ++  FGL+          T L   P     TG+V T                +
Sbjct: 197 FTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLYMSPEQIHGNNYSHK 256

Query: 233 SVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQF---SSDEGTELVRLA 289
             ++S G +L +LL                  ++ +TD     +F    + +  +   + 
Sbjct: 257 VDIFSLGLILFELLYSF--STQMER-------VRIITDVR-NLKFPLLFTQKYPQEHMMV 306

Query: 290 SRCLQYEPRERPNPRSL 306
              L   P ERP    +
Sbjct: 307 QDMLSPSPTERPEATDI 323

>2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321

 Score = 46.2 bits (110), Expect = 5e-06
 Identities = 45/250 (18%), Positives = 92/250 (36%), Gaps = 20/250 (8%)

Query: 66  GEKAPNVVYKGK-LENQFRIAVKRFNRSAWPDARQFLEEARAVGQLRNRRLANLLGCCCE 124
           GE +  +V   +   +  ++AVK  +            E   +   ++  +  +      
Sbjct: 54  GEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFNVVEMYKSYLV 113

Query: 125 GDERLLVAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNA 184
           G+E  ++ E++    L   +       +       V   + +AL Y  ++   ++ D+ +
Sbjct: 114 GEELWVLMEFLQGGALTDIV---SQVRLNEEQIATVCEAVLQALAYLHAQ-GVIHRDIKS 169

Query: 185 YRIVFDDDVNPRLSCFGLMKNSRDGRSYSTNLAFTP----PEYLRTGRVTPESVMYSFGT 240
             I+   D   +LS FG             +L  TP    PE +       E  ++S G 
Sbjct: 170 DSILLTLDGRVKLSDFGFCAQISKDVPKRKSLVGTPYWMAPEVISRSLYATEVDIWSLGI 229

Query: 241 LLLDLLSGK----HIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLASRCLQYE 296
           ++++++ G+       P  A+  +RD     L +S    + S      L     R L  +
Sbjct: 230 MVIEMVDGEPPYFSDSPVQAMKRLRDSPPPKLKNS---HKVSP----VLRDFLERMLVRD 282

Query: 297 PRERPNPRSL 306
           P+ER   + L
Sbjct: 283 PQERATAQEL 292

>3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286

 Score = 46.3 bits (110), Expect = 6e-06
 Identities = 39/256 (15%), Positives = 73/256 (28%), Gaps = 53/256 (20%)

Query: 61  IVSEHGEKAPNVVYKGKLENQFR-IAVK--RFNRSAWPDARQ-FLEEARAVGQLRNRRLA 116
           ++  HG   P   ++       R +A+           D  Q  L     + ++    +A
Sbjct: 35  LLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVA 94

Query: 117 NLLGCCCEGDERLLVAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKER 176
            +L         L+VAE++   +L +     +T P      +R    +A A +   +   
Sbjct: 95  RVLDVVHTRAGGLVVAEWIRGGSLQEVA---DTSPSPVGA-IRAMQSLAAAADA--AHRA 148

Query: 177 ALYHDLNAYRIVFDDDVNPRLSCFGLMKN---SRDGRSYSTNLAFTPPEYLRTGRVTPES 233
            +               +P             S DG       A  P          P+ 
Sbjct: 149 GVAL-----S-----IDHPS--------RVRVSIDGDVVLAYPATMPD-------ANPQD 183

Query: 234 VMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLE--------GQFSSDEGTEL 285
            +   G  L  LL  +   P     L        L  +  +             D   ++
Sbjct: 184 DIRGIGASLYALLVNR--WP-----LPEAGVRSGLAPAERDTAGQPIEPADIDRDIPFQI 236

Query: 286 VRLASRCLQYEPRERP 301
             +A+R +Q +   R 
Sbjct: 237 SAVAARSVQGDGGIRS 252

>1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298

 Score = 45.7 bits (109), Expect = 9e-06
 Identities = 37/164 (22%), Positives = 57/164 (34%), Gaps = 46/164 (28%)

Query: 163 HIAEALEYCTSKERALYHDLN-AYR------IVFDDDVNPRLSCFGLMKNSRDGRSYSTN 215
            + E +           H LN  +R      I+ DDD+N +L+ FG       G      
Sbjct: 132 ALLEVICAL--------HKLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKLRE- 182

Query: 216 LAFTP----PEYLRTGRV------TPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNI 265
           +  TP    PE +             E  M+S G ++  LL+G   PP         R  
Sbjct: 183 VCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAG--SPPFW------HRKQ 234

Query: 266 QTLTDSCLEGQFS---------SDEGTELVRLASRCLQYEPRER 300
             +    + G +          SD   +LV    R L  +P++R
Sbjct: 235 MLMLRMIMSGNYQFGSPEWDDYSDTVKDLVS---RFLVVQPQKR 275

>3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297

 Score = 45.4 bits (108), Expect = 1e-05
 Identities = 51/250 (20%), Positives = 100/250 (40%), Gaps = 20/250 (8%)

Query: 66  GEKAPNVVYKGK-LENQFRIAVKRFNRSAWPDARQFLEEARAVGQLRNRRLANLLGCCCE 124
           G+ A   VY    +     +A+++ N    P     + E   + + +N  + N L     
Sbjct: 29  GQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLV 88

Query: 125 GDERLLVAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNA 184
           GDE  +V EY+   +L   +       M       V     +ALE+  S  + ++ D+ +
Sbjct: 89  GDELWVVMEYLAGGSLTDVV---TETCMDEGQIAAVCRECLQALEFLHS-NQVIHRDIKS 144

Query: 185 YRIVFDDDVNPRLSCFGLMKNSRDGRSYSTNLAFTP----PEYLRTGRVTPESVMYSFGT 240
             I+   D + +L+ FG        +S  + +  TP    PE +      P+  ++S G 
Sbjct: 145 DNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGI 204

Query: 241 LLLDLLSGK----HIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLASRCLQYE 296
           + ++++ G+    +  P  AL LI       L +     + S+          +RCL+ +
Sbjct: 205 MAIEMIEGEPPYLNENPLRALYLIATNGTPELQNP---EKLSA----IFRDFLNRCLEMD 257

Query: 297 PRERPNPRSL 306
             +R + + L
Sbjct: 258 VEKRGSAKEL 267

>1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303

 Score = 45.4 bits (108), Expect = 1e-05
 Identities = 50/273 (18%), Positives = 90/273 (32%), Gaps = 60/273 (21%)

Query: 73  VYKG--KLENQFRIAVKRFNRSAWPDARQFLEEARAVGQLRNRRLANLLGCCCEGDERL- 129
           V K    L++++  A+K+   +        L E   +  L ++ +        E    + 
Sbjct: 22  VVKARNALDSRYY-AIKKIRHTE-EKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVK 79

Query: 130 ------------LVAEYMPNDTLAKHLFHWETQPMKW--AMRLRVALHIAEALEYCTSKE 175
                       +  EY  N TL   +    ++ +        R+   I EAL Y  S+ 
Sbjct: 80  PMTAVKKKSTLFIQMEYCENGTLYDLI---HSENLNQQRDEYWRLFRQILEALSYIHSQG 136

Query: 176 RALYH-DLNAYRIVFDDDVNPRLSCFGLMKNSRDGRSYSTNLAF--------------TP 220
             + H DL    I  D+  N ++  FGL KN           +               T 
Sbjct: 137 --IIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTA 194

Query: 221 ----PEYLR-TGRVTPESVMYSFGTLLLDLLSGKHIPPSHA------LDLIRDRNIQTLT 269
                E L  TG    +  MYS G +  +++     P S        L  +R  +I+   
Sbjct: 195 MYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY----PFSTGMERVNILKKLRSVSIE--- 247

Query: 270 DSCLEGQFSSDEGTELVRLASRCLQYEPRERPN 302
                  F  ++     ++    + ++P +RP 
Sbjct: 248 ---FPPDFDDNKMKVEKKIIRLLIDHDPNKRPG 277

>4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294

 Score = 44.9 bits (107), Expect = 1e-05
 Identities = 37/174 (21%), Positives = 72/174 (41%), Gaps = 23/174 (13%)

Query: 86  VKRFNRSAWPDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAEYMPNDTLAKHLF 145
           +KRF R           E     QL ++ + +++    E D   LV EY+   TL++++ 
Sbjct: 55  LKRFER-----------EVHNSSQLSHQNIVSMIDVDEEDDCYYLVMEYIEGPTLSEYIE 103

Query: 146 HWETQPMKWAMRLRVALHIAEALEYCTSKERALYH-DLNAYRIVFDDDVNPRLSCFGLMK 204
                P+     +     I + +++  + +  + H D+    I+ D +   ++  FG+ K
Sbjct: 104 --SHGPLSVDTAINFTNQILDGIKH--AHDMRIVHRDIKPQNILIDSNKTLKIFDFGIAK 159

Query: 205 NSRDGRSYSTNLAF-TP----PEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPP 253
              +     TN    T     PE  +       + +YS G +L ++L G+  PP
Sbjct: 160 ALSETSLTQTNHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGE--PP 211

>3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328

 Score = 44.6 bits (106), Expect = 2e-05
 Identities = 37/146 (25%), Positives = 62/146 (42%), Gaps = 19/146 (13%)

Query: 164 IAEALEYCTSKERALYH-DLNAYRIVFDDDVNPRLSCFGLMKNSRDGRSYST---NLAFT 219
           I  A++YC  K   + H DL A  ++ D D+N +++ FG       G           + 
Sbjct: 123 IVSAVQYCHQK--RIVHRDLKAENLLLDADMNIKIADFGFSNEFTVGGKLDAFCGAPPYA 180

Query: 220 PPEYLRTGR--VTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQF 277
            PE  + G+    PE  ++S G +L  L+SG  +P          +N++ L +  L G++
Sbjct: 181 APELFQ-GKKYDGPEVDVWSLGVILYTLVSG-SLP-------FDGQNLKELRERVLRGKY 231

Query: 278 S--SDEGTELVRLASRCLQYEPRERP 301
                  T+   L  R L   P +R 
Sbjct: 232 RIPFYMSTDCENLLKRFLVLNPIKRG 257

>4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299

 Score = 44.3 bits (105), Expect = 2e-05
 Identities = 56/269 (20%), Positives = 99/269 (36%), Gaps = 45/269 (16%)

Query: 72  VVYKG--KLENQFRIAVKRFNRSAWPDARQ-FLEEARAVGQLRNRRLANLLGCCCEGDER 128
           VV++   K+++    A+KR        AR+  + E +A+ +L +  +        E +  
Sbjct: 20  VVFEAKNKVDDCNY-AIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTT 78

Query: 129 L------------LVAEYMPNDTLAKHLFHWET-QPMKWAMRLRVALHIAEALEYCTSKE 175
                        +  +    + L   +    T +  + ++ L + L IAEA+E+  SK 
Sbjct: 79  EKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSKG 138

Query: 176 RALYH-DLNAYRIVFDDDVNPRLSCFGLMKNSRDGRSYSTNLAFTPPEYLRTGRV-TP-- 231
             L H DL    I F  D   ++  FGL+          T L   P     TG+V T   
Sbjct: 139 --LMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLY 196

Query: 232 -------------ESVMYSFGTLLLDLLSGKHIPPSHALDLIRD-RNIQTLTDSCLEGQF 277
                        +  ++S G +L +LL     P S  ++ +R   +++ L    L  Q 
Sbjct: 197 MSPEQIHGNSYSHKVDIFSLGLILFELL----YPFSTQMERVRTLTDVRNLKFPPLFTQK 252

Query: 278 SSDEGTELVRLASRCLQYEPRERPNPRSL 306
                     +    L   P ERP   ++
Sbjct: 253 YP----CEYVMVQDMLSPSPMERPEAINI 277

>2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284

 Score = 44.2 bits (105), Expect = 3e-05
 Identities = 34/181 (18%), Positives = 69/181 (38%), Gaps = 16/181 (8%)

Query: 130 LVAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVF 189
           +  E+    TL + +     + +   + L +   I + ++Y  SK + +  DL    I  
Sbjct: 97  IQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIHSK-KLINRDLKPSNIFL 155

Query: 190 DDDVNPRLSCFGLMKNSRDGRSYSTNLAFTP----PEYLRTGRVTPESVMYSFGTLLLDL 245
            D    ++  FGL+ + ++    + +   T     PE + +     E  +Y+ G +L +L
Sbjct: 156 VDTKQVKIGDFGLVTSLKNDGKRTRSKG-TLRYMSPEQISSQDYGKEVDLYALGLILAEL 214

Query: 246 LSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLASRCLQYEPRERPNPRS 305
           L         A +    +    L D  +   F      +   L  + L  +P +RPN   
Sbjct: 215 LH----VCDTAFE--TSKFFTDLRDGIISDIFDK----KEKTLLQKLLSKKPEDRPNTSE 264

Query: 306 L 306
           +
Sbjct: 265 I 265

>2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349

 Score = 44.2 bits (105), Expect = 3e-05
 Identities = 36/161 (22%), Positives = 59/161 (36%), Gaps = 42/161 (26%)

Query: 164 IAEALEYCTSKERALYHDLN-AYR------IVF---DDDVNPRLSCFGLMKNSRDGRSYS 213
           I EA+ Y         H+    +R      +++     D   +++ FGL K         
Sbjct: 157 ILEAVAYL--------HENGIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQVLMK 208

Query: 214 TNLAFTP----PEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLT 269
           T +  TP    PE LR     PE  M+S G +   LL G    P +      +R  Q + 
Sbjct: 209 T-VCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCG--FEPFYD-----ERGDQFMF 260

Query: 270 DSCLEGQFS---------SDEGTELVRLASRCLQYEPRERP 301
              L  ++          S    +LVR   + +  +P++R 
Sbjct: 261 RRILNCEYYFISPWWDEVSLNAKDLVR---KLIVLDPKKRL 298

>2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365

 Score = 44.3 bits (105), Expect = 3e-05
 Identities = 39/164 (23%), Positives = 59/164 (35%), Gaps = 46/164 (28%)

Query: 163 HIAEALEYCTSKERALYHDLN-AYR------IVFDDDVNPRLSCFGLMKNSRDGRSYSTN 215
            + EA+ +         H  N  +R      I+ DD++  RLS FG   +   G      
Sbjct: 208 SLLEAVSFL--------HANNIVHRDLKPENILLDDNMQIRLSDFGFSCHLEPGEKLRE- 258

Query: 216 LAFTP----PEYLRTGRV------TPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNI 265
           L  TP    PE L+            E  +++ G +L  LL+G   PP         R  
Sbjct: 259 LCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAG--SPP------FWHRRQ 310

Query: 266 QTLTDSCLEGQFS---------SDEGTELVRLASRCLQYEPRER 300
             +    +EGQ+          S    +L+    R LQ +P  R
Sbjct: 311 ILMLRMIMEGQYQFSSPEWDDRSSTVKDLIS---RLLQVDPEAR 351

>2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279

 Score = 43.4 bits (103), Expect = 4e-05
 Identities = 47/210 (22%), Positives = 74/210 (35%), Gaps = 35/210 (16%)

Query: 130 LVAEYMPNDTLAKHL--FHWETQPMKWAMRLRVALHIAEALEYCTSKERALYH----DLN 183
           +V EY     LA  +     E Q +     LRV   +  AL+ C  +    +     DL 
Sbjct: 84  IVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLK 143

Query: 184 AYRIVFDDDVNPRLSCFGLMKNSRDGRSYSTNLAFTP----PEYLRTGRVTPESVMYSFG 239
              +  D   N +L  FGL +      S++     TP    PE +       +S ++S G
Sbjct: 144 PANVFLDGKQNVKLGDFGLARILNHDTSFAKTFVGTPYYMSPEQMNRMSYNEKSDIWSLG 203

Query: 240 TLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQF---SSDEGTELVRLASRCLQYE 296
            LL +L +    PP  A       + + L     EG+F         EL  + +R L  +
Sbjct: 204 CLLYELCALM--PPFTA------FSQKELAGKIREGKFRRIPYRYSDELNEIITRMLNLK 255

Query: 297 PRERPNPRSLVTALVTLQKDTELYLSLPWV 326
              RP+   +              L  P +
Sbjct: 256 DYHRPSVEEI--------------LENPLI 271

>2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317

 Score = 43.1 bits (102), Expect = 6e-05
 Identities = 42/259 (16%), Positives = 78/259 (30%), Gaps = 39/259 (15%)

Query: 73  VYKGK-LENQFRIAVKRFNRSAWPDARQFLEEARAVGQLRNRRLANLLGCCCE----GDE 127
           V   + L +    A+KR       D  +   EA       +  +  L+  C        E
Sbjct: 45  VDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVAYCLRERGAKHE 104

Query: 128 RLLVAEYMPNDTLAKHLFHWETQPMKWAMR--LRVALHIAEALEYCTSKERALYH-DLNA 184
             L+  +    TL   +   + +         L + L I   LE   +K     H DL  
Sbjct: 105 AWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAK--GYAHRDLKP 162

Query: 185 YRIVFDDDVNPRLSCFGLMKNSRDGRSYSTNLAFTPPEYLRTG----------------R 228
             I+  D+  P L   G M  +      S           +                   
Sbjct: 163 TNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCV 222

Query: 229 VTPESVMYSFGTLLLDLLSGKH-----IPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGT 283
           +   + ++S G +L  ++ G+           ++ L     +          + SS    
Sbjct: 223 IDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDSVALAVQNQLSIPQSP----RHSSA--- 275

Query: 284 ELVRLASRCLQYEPRERPN 302
            L +L +  +  +P +RP+
Sbjct: 276 -LWQLLNSMMTVDPHQRPH 293

>2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310

 Score = 42.7 bits (101), Expect = 8e-05
 Identities = 46/251 (18%), Positives = 100/251 (39%), Gaps = 27/251 (10%)

Query: 73  VYKGK-LENQFRIAVKRFNRSAWPDAR---QFLEEARAVGQLRNRRLANLLGCCCEGDER 128
           VY+   L +   +A+K+       DA+     ++E   + QL +  +        E +E 
Sbjct: 48  VYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNEL 107

Query: 129 LLVAEYMPNDTLAKHL--FHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYR 186
            +V E      L++ +  F  + + +      +  + +  ALE+  S+ R ++ D+    
Sbjct: 108 NIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSR-RVMHRDIKPAN 166

Query: 187 IVFDDDVNPRLSCFGLMKNSRDGRSYSTNLAFTP----PEYLRTGRVTPESVMYSFGTLL 242
           +        +L   GL +      + + +L  TP    PE +       +S ++S G LL
Sbjct: 167 VFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLL 226

Query: 243 LDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFS-------SDEGTELVRLASRCLQY 295
            ++ + +   P +        N+ +L     +  +        S+E  +LV   + C+  
Sbjct: 227 YEMAALQ--SPFYG----DKMNLYSLCKKIEQCDYPPLPSDHYSEELRQLV---NMCINP 277

Query: 296 EPRERPNPRSL 306
           +P +RP+   +
Sbjct: 278 DPEKRPDVTYV 288

>3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285

 Score = 41.8 bits (99), Expect = 1e-04
 Identities = 25/161 (15%), Positives = 55/161 (34%), Gaps = 43/161 (26%)

Query: 163 HIAEALEYCTSKERALYHDLN-AYR------IVF---DDDVNPRLSCFGLMKNSRDGRSY 212
            +  AL Y         H  +  ++      I+F         ++  FGL +  +     
Sbjct: 132 QMMNALAYF--------HSQHVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSDEHS 183

Query: 213 STNLAFTP----PEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTL 268
           +     T     PE  +   VT +  ++S G ++  LL+G    P          +++ +
Sbjct: 184 TNAAG-TALYMAPEVFK-RDVTFKCDIWSAGVVMYFLLTGC--LPFT------GTSLEEV 233

Query: 269 TDSCLEGQFS--------SDEGTELVRLASRCLQYEPRERP 301
                  + +        + +  +L++   + L  +P  RP
Sbjct: 234 QQKATYKEPNYAVECRPLTPQAVDLLK---QMLTKDPERRP 271

>3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313

 Score = 41.9 bits (99), Expect = 1e-04
 Identities = 43/254 (16%), Positives = 90/254 (35%), Gaps = 35/254 (13%)

Query: 72  VVYKGKLENQFRIAVKRFNRSAWP--DARQFLEEARAVGQLR--NRRLANLLGCCCEGDE 127
            V++   E +   A+K  N           +  E   + +L+  + ++  L       D+
Sbjct: 43  KVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYE-ITDQ 101

Query: 128 RL-LVAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYH-DLNAY 185
            + +V E    D L   L   ++             ++ EA+         + H DL   
Sbjct: 102 YIYMVMECGNID-LNSWLKKKKSIDPWERKS--YWKNMLEAVHTIHQHG--IVHSDLKPA 156

Query: 186 RIVFDDDVNPRLSCFGLMKNSRDGRS--YSTNLAFTP----PEYLR-----------TGR 228
             +  D    +L  FG+    +   +     +   T     PE ++             +
Sbjct: 157 NFLIVDG-MLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSK 215

Query: 229 VTPESVMYSFGTLLLDLLSGKHIPP-SHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVR 287
           ++P+S ++S G +L  +  GK   P    ++ I    +  + D   E +F      +L  
Sbjct: 216 ISPKSDVWSLGCILYYMTYGK--TPFQQIINQIS--KLHAIIDPNHEIEFPDIPEKDLQD 271

Query: 288 LASRCLQYEPRERP 301
           +   CL+ +P++R 
Sbjct: 272 VLKCCLKRDPKQRI 285

>3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311

 Score = 41.9 bits (99), Expect = 1e-04
 Identities = 45/241 (18%), Positives = 80/241 (33%), Gaps = 28/241 (11%)

Query: 73  VYKG-KLENQFRIAVKRFNRSAWP--DARQFLEEARAVGQL-RNRRLANLLGCCCEGDER 128
           V+K    E+    AVKR         D  + L E  +  ++ ++     L     EG   
Sbjct: 73  VFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEGGIL 132

Query: 129 LLVAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIV 188
            L  E      L +H   W    +  A           AL +  S+   ++ D+    I 
Sbjct: 133 YLQTELCGPS-LQQHCEAWG-ASLPEAQVWGYLRDTLLALAHLHSQ-GLVHLDVKPANIF 189

Query: 189 FDDDVNPRLSCFGLMK--------NSRDGRSYSTNLAFTPPEYLRTGRVTPESVMYSFGT 240
                  +L  FGL+           ++G        +  PE L+       + ++S G 
Sbjct: 190 LGPRGRCKLGDFGLLVELGTAGAGEVQEGDPR-----YMAPELLQGSY-GTAADVFSLGL 243

Query: 241 LLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLASRCLQYEPRER 300
            +L++       P            Q L    L  +F++   +EL  +    L+ +P+ R
Sbjct: 244 TILEVACNME-LPHGG------EGWQQLRQGYLPPEFTAGLSSELRSVLVMMLEPDPKLR 296

Query: 301 P 301
            
Sbjct: 297 A 297

>4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336

 Score = 42.0 bits (99), Expect = 2e-04
 Identities = 50/246 (20%), Positives = 87/246 (35%), Gaps = 34/246 (13%)

Query: 73  VYKGK-LENQFRIAVKRFNRSAWPDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLV 131
           V++ K  +  F+ AVK+         R   EE  A   L + R+  L G   EG    + 
Sbjct: 74  VHRMKDKQTGFQCAVKKVRL---EVFRV--EELVACAGLSSPRIVPLYGAVREGPWVNIF 128

Query: 132 AEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDD 191
            E +   +L + +       +     L       E LEY  ++ R L+ D+ A  ++   
Sbjct: 129 MELLEGGSLGQLIKQMG--CLPEDRALYYLGQALEGLEYLHTR-RILHGDVKADNVLLSS 185

Query: 192 D-VNPRLSCFGL---MKNSRDGRSYSTNLAF--TP----PEYLRTGRVTPESVMYSFGTL 241
           D     L  FG    ++    G+S  T      T     PE +       +  ++S   +
Sbjct: 186 DGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCM 245

Query: 242 LLDLLSGKH----IPPSHALDLIRDRN--IQTLTDSCLEGQFSSDEGTELVRLASRCLQY 295
           +L +L+G H             I      I+ +  SC      +    + ++     L+ 
Sbjct: 246 MLHMLNGCHPWTQYFRGPLCLKIASEPPPIREIPPSC------APLTAQAIQ---EGLRK 296

Query: 296 EPRERP 301
           EP  R 
Sbjct: 297 EPVHRA 302

>3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486

 Score = 41.6 bits (98), Expect = 3e-04
 Identities = 34/166 (20%), Positives = 59/166 (35%), Gaps = 44/166 (26%)

Query: 159 RVALHIAEALEYCTSKERALYHDLN-AYR------IVF---DDDVNPRLSCFGLMKNSRD 208
           R+   +   + Y         H  N  +R      I+    + D + ++  FGL    + 
Sbjct: 125 RIIKQVFSGITYM--------HKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQ 176

Query: 209 GRSYSTNLAFTP----PEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRN 264
                     T     PE LR G    +  ++S G +L  LLSG   PP +       +N
Sbjct: 177 NTKMKD-RIGTAYYIAPEVLR-GTYDEKCDVWSAGVILYILLSGT--PPFYG------KN 226

Query: 265 IQTLTDSCLEGQFS---------SDEGTELVRLASRCLQYEPRERP 301
              +      G+++         SD+  +L+R   + L + P  R 
Sbjct: 227 EYDILKRVETGKYAFDLPQWRTISDDAKDLIR---KMLTFHPSLRI 269

>3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279

 Score = 40.7 bits (96), Expect = 3e-04
 Identities = 53/244 (21%), Positives = 89/244 (36%), Gaps = 35/244 (14%)

Query: 73  VYKGK-LENQFRIAVKRFNRSAWPDARQFLEEARAVGQLRN-----RRLA--NLLG--CC 122
           VY  +  +++F +A+K   ++        LE+A    QLR        L   N+L     
Sbjct: 25  VYLAREKQSKFILALKVLFKAQ-------LEKAGVEHQLRREVEIQSHLRHPNILRLYGY 77

Query: 123 CEGDERL-LVAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYH- 180
                R+ L+ EY P  T+ + L        +          +A AL YC SK   + H 
Sbjct: 78  FHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATY--ITELANALSYCHSKR--VIHR 133

Query: 181 DLNAYRIVFDDDVNPRLSCFGLMKNSRDGRSYST--NLAFTPPEYLRTGRVTPESVMYSF 238
           D+    ++       +++ FG   ++   R       L + PPE +       +  ++S 
Sbjct: 134 DIKPENLLLGSAGELKIADFGWSVHAPSSRRTDLCGTLDYLPPEMIEGRMHDEKVDLWSL 193

Query: 239 GTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFS--SDEGTELVRLASRCLQYE 296
           G L  + L GK  PP            Q         +F+           L SR L++ 
Sbjct: 194 GVLCYEFLVGK--PP------FEANTYQETYKRISRVEFTFPDFVTEGARDLISRLLKHN 245

Query: 297 PRER 300
           P +R
Sbjct: 246 PSQR 249

>2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390

 Score = 41.0 bits (96), Expect = 4e-04
 Identities = 41/253 (16%), Positives = 86/253 (33%), Gaps = 33/253 (13%)

Query: 72  VVYKGKLENQFRIAVKRFNRSAWP--DARQFLEEARAVGQLR--NRRLANLLGCCCEGDE 127
            V++   E +   A+K  N           +  E   + +L+  + ++  L         
Sbjct: 71  KVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQY 130

Query: 128 RLLVAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYH-DLNAYR 186
             +V E    D L   L   ++             ++ EA+         + H DL    
Sbjct: 131 IYMVMECGNID-LNSWLKKKKSIDPWERKS--YWKNMLEAVHTIHQHG--IVHSDLKPAN 185

Query: 187 IVFDDDVNPRLSCFGLMKNSRDGRS--YSTNLAFTP----PEYLR-----------TGRV 229
            +  D    +L  FG+    +   +     +         PE ++             ++
Sbjct: 186 FLIVDG-MLKLIDFGIANQMQPDTTSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKI 244

Query: 230 TPESVMYSFGTLLLDLLSGKHIPP-SHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRL 288
           +P+S ++S G +L  +  GK   P    ++ I    +  + D   E +F      +L  +
Sbjct: 245 SPKSDVWSLGCILYYMTYGK--TPFQQIINQIS--KLHAIIDPNHEIEFPDIPEKDLQDV 300

Query: 289 ASRCLQYEPRERP 301
              CL+ +P++R 
Sbjct: 301 LKCCLKRDPKQRI 313

>3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695

 Score = 41.0 bits (96), Expect = 4e-04
 Identities = 38/193 (19%), Positives = 64/193 (33%), Gaps = 24/193 (12%)

Query: 119 LGCCCEGDERL-LVAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAE---ALEYCTSK 174
           +       ++L  + + M    L  HL               +  + AE    LE+  ++
Sbjct: 257 MSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEA-----DMRFYAAEIILGLEHMHNR 311

Query: 175 ERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDGRSYSTNLAFTP----PEYLRTGRVT 230
              +Y DL    I+ D+  + R+S  GL  +    + ++     T     PE L+ G   
Sbjct: 312 -FVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHA--SVGTHGYMAPEVLQKGVAY 368

Query: 231 PESVMY-SFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQ--FSSDEGTELVR 287
             S  + S G +L  LL G    P         ++   +    L            EL  
Sbjct: 369 DSSADWFSLGCMLFKLLRGH--SPFRQHK---TKDKHEIDRMTLTMAVELPDSFSPELRS 423

Query: 288 LASRCLQYEPRER 300
           L    LQ +   R
Sbjct: 424 LLEGLLQRDVNRR 436

>3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573

 Score = 41.0 bits (96), Expect = 4e-04
 Identities = 45/242 (18%), Positives = 78/242 (32%), Gaps = 51/242 (21%)

Query: 85  AVKRFNRSAWPDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAEYMPN----DTL 140
           A K        D     +E + +  LR+  L NL     + +E +++ E+M      + +
Sbjct: 186 AAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKV 245

Query: 141 AKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLN-AYR------IVFDDDV 193
           A              MR      + + L +         H+ N  +       I+F    
Sbjct: 246 ADEHNKMSEDEAVEYMR-----QVCKGLCHM--------HENNYVHLDLKPENIMFTTKR 292

Query: 194 NPRLSC--FGLMKNSRDGRSYSTNLAFTP----PEYLRTGRVTPESVMYSFGTLLLDLLS 247
           +  L    FGL  +    +S       T     PE      V   + M+S G L   LLS
Sbjct: 293 SNELKLIDFGLTAHLDPKQSVKVTTG-TAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLS 351

Query: 248 GKHIPPSHALDLIRDRNIQTLTDSCLEGQFS---------SDEGTELVRLASRCLQYEPR 298
           G  + P          N      +     ++         S++G + +R   + L  +P 
Sbjct: 352 G--LSP------FGGENDDETLRNVKSCDWNMDDSAFSGISEDGKDFIR---KLLLADPN 400

Query: 299 ER 300
            R
Sbjct: 401 TR 402

>2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576

 Score = 40.9 bits (96), Expect = 5e-04
 Identities = 45/200 (22%), Positives = 72/200 (36%), Gaps = 35/200 (17%)

Query: 119 LGCCCEGDERL-LVAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAE---ALEYCTSK 174
           L    E  + L LV   M    L  H++H        A   R   + AE    LE    +
Sbjct: 249 LAYAYETKDALCLVLTLMNGGDLKFHIYHMGQAGFPEA---RAVFYAAEICCGLEDLHRE 305

Query: 175 ERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDGRSYSTNLAF--TPPEYLRTGRVTPE 232
            R +Y DL    I+ DD  + R+S  GL  +  +G++         T   Y+      PE
Sbjct: 306 -RIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQTIKG---RVGT-VGYM-----APE 355

Query: 233 SVMY----------SFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQ--FSSD 280
            V            + G LL ++++G+   P       +    + +     E    +S  
Sbjct: 356 VVKNERYTFSPDWWALGCLLYEMIAGQ--SPFQQRK--KKIKREEVERLVKEVPEEYSER 411

Query: 281 EGTELVRLASRCLQYEPRER 300
              +   L S+ L  +P ER
Sbjct: 412 FSPQARSLCSQLLCKDPAER 431

>4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446

 Score = 40.5 bits (95), Expect = 5e-04
 Identities = 50/198 (25%), Positives = 82/198 (41%), Gaps = 35/198 (17%)

Query: 119 LGCCCEGDERL-LVAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERA 177
           L    +  +RL  V EY     L  HL   E    +   R   A  I  AL+Y  S++  
Sbjct: 213 LKYSFQTHDRLCFVMEYANGGELFFHL-SRERVFSEDRARFYGA-EIVSALDYLHSEKNV 270

Query: 178 LYHDLNAYRIVFDDDVNPRLSCFGLMK-NSRDGRSYSTNLAF--TPPEYLRTGRVTPESV 234
           +Y DL    ++ D D + +++ FGL K   +DG +  T   F  T PEYL      PE +
Sbjct: 271 VYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKT---FCGT-PEYL-----APEVL 321

Query: 235 MY----------SFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEG--QFSSDEG 282
                         G ++ +++ G+   P        +++ + L +  L    +F    G
Sbjct: 322 EDNDYGRAVDWWGLGVVMYEMMCGR--LP------FYNQDHEKLFELILMEEIRFPRTLG 373

Query: 283 TELVRLASRCLQYEPRER 300
            E   L S  L+ +P++R
Sbjct: 374 PEAKSLLSGLLKKDPKQR 391

>3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343

 Score = 40.1 bits (94), Expect = 6e-04
 Identities = 43/254 (16%), Positives = 90/254 (35%), Gaps = 35/254 (13%)

Query: 72  VVYKGKLENQFRIAVKRFNRSAWP--DARQFLEEARAVGQLR--NRRLANLLGCCCEGDE 127
            V++   E +   A+K  N           +  E   + +L+  + ++  L       D+
Sbjct: 24  KVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYE-ITDQ 82

Query: 128 RL-LVAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYH-DLNAY 185
            + +V E    D L   L   ++             ++ EA+         + H DL   
Sbjct: 83  YIYMVMECGNID-LNSWLKKKKSIDPWERKS--YWKNMLEAVHTIHQH--GIVHSDLKPA 137

Query: 186 RIVFDDDVNPRLSCFGLMKNSRDGRSYSTNLAF--TP----PEYLR-----------TGR 228
             +  D    +L  FG+    +   +     +   T     PE ++             +
Sbjct: 138 NFLIVDG-MLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSK 196

Query: 229 VTPESVMYSFGTLLLDLLSGKHIPP-SHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVR 287
           ++P+S ++S G +L  +  GK   P    ++ I    +  + D   E +F      +L  
Sbjct: 197 ISPKSDVWSLGCILYYMTYGK--TPFQQIINQIS--KLHAIIDPNHEIEFPDIPEKDLQD 252

Query: 288 LASRCLQYEPRERP 301
           +   CL+ +P++R 
Sbjct: 253 VLKCCLKRDPKQRI 266

>2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309

 Score = 39.9 bits (94), Expect = 6e-04
 Identities = 35/180 (19%), Positives = 62/180 (34%), Gaps = 15/180 (8%)

Query: 83  RIAVK--RFNRSAWPDARQ-FLEEARAVGQLRNRRLANLLGCCCEGDERLLVAEYMPNDT 139
            +A+K      S+ P  R     EAR  G+L+   +  +        +  +    +    
Sbjct: 61  IVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEIDGQLYVDMRLINGVD 120

Query: 140 LAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYH-DLNAYRIVFDDDVNPRLS 198
           LA  L      P+     + +   I  AL+   +      H D+    I+   D    L 
Sbjct: 121 LAAMLR--RQGPLAPPRAVAIVRQIGSALDA--AHAAGATHRDVKPENILVSADDFAYLV 176

Query: 199 CFGLMKNSRDGRSYSTN-----LAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPP 253
            FG+   + D +          L +  PE       T  + +Y+   +L + L+G   PP
Sbjct: 177 DFGIASATTDEKLTQLGNTVGTLYYMAPERFSESHATYRADIYALTCVLYECLTGS--PP 234

Structure Templates Detected by HHsearch

Original result of HHsearch against PDB70 database

ID	Length	Definition	Probability
Query	329
4asz_A	299	BDNF/NT-3 growth factors receptor; transferase, TR	100.0
4fih_A	346	Serine/threonine-protein kinase PAK 4; kinase doma	100.0
4b9d_A	350	Serine/threonine-protein kinase NEK1; transferase,	100.0
4aoj_A	329	High affinity nerve growth factor receptor; transf	100.0
3omv_A	307	RAF proto-oncogene serine/threonine-protein kinas;	100.0
4gt4_A	308	Tyrosine-protein kinase transmembrane receptor RO;	100.0
4g3f_A	336	NF-kappa-beta-inducing kinase; non-RD kinase, prot	100.0
4fie_A	423	Serine/threonine-protein kinase PAK 4; kinase doma	100.0
4aw0_A	311	HPDK1, 3-phosphoinositide-dependent protein kinase	100.0
3hyh_A	275	Carbon catabolite-derepressing protein kinase; kin	100.0
3fpq_A	290	Serine/threonine-protein kinase WNK1; protein seri	100.0
3ubd_A	304	Ribosomal protein S6 kinase alpha-3; kinase-inhibi	100.0
4ase_A	353	Vascular endothelial growth factor receptor 2; tra	100.0
4g31_A	299	Eukaryotic translation initiation factor 2-alpha;	100.0
3hmm_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	100.0
4b99_A	398	Mitogen-activated protein kinase 7; transferase, i	100.0
4f9c_A	361	Cell division cycle 7-related protein kinase; Ser/	100.0
3uto_A	573	Twitchin; kinase, muscle sarcomere, transferase; H	100.0
3v5w_A	689	G-protein coupled receptor kinase 2; inhibitor com	100.0
3fxz_A	297	Serine/threonine-protein kinase PAK 1; transferase	100.0
3fe3_A	328	MAP/microtubule affinity-regulating kinase 3; seri	100.0
2qkw_B	321	Protein kinase; three-helix bundle motif, AVRPTO-P	100.0
3s95_A	310	LIMK-1, LIM domain kinase 1; structural genomics,	100.0
2c30_A	321	Serine/threonine-protein kinase PAK 6; CRIB domain	100.0
3zgw_A	347	Maternal embryonic leucine zipper kinase; transfer	100.0
3p86_A	309	Serine/threonine-protein kinase CTR1; ETR1, ERS1,	100.0
1o6l_A	337	RAC-beta serine/threonine protein kinase; protein	100.0
2yab_A	361	Death-associated protein kinase 2; apoptosis, tran	100.0
4hcu_A	269	Tyrosine-protein kinase ITK/TSK; transferase-trans	100.0
3kul_A	325	Ephrin type-A receptor 8; ATP-binding, kinase, nuc	100.0
2psq_A	370	Fibroblast growth factor receptor 2; kinase domain	100.0
1fot_A	318	TPK1 delta, CAMP-dependent protein kinase type 1;	100.0
3soa_A	444	Calcium/calmodulin-dependent protein kinase type a	100.0
3uim_A	326	Brassinosteroid insensitive 1-associated receptor;	100.0
1tki_A	321	Titin; serine kinase, muscle, autoinhibition; 2.00	100.0
3ugc_A	295	Tyrosine-protein kinase JAK2; small molecule inhib	100.0
3txo_A	353	PKC-L, NPKC-ETA, protein kinase C ETA type; phosph	100.0
2y0a_A	326	Death-associated protein kinase 1; transferase, ca	100.0
3sxs_A	268	Cytoplasmic tyrosine-protein kinase BMX; transfera	100.0
3o0g_A	292	Cell division protein kinase 5; kinase activator c	100.0
3niz_A	311	Rhodanese family protein; structural genomics, str	100.0
3uc3_A	361	Serine/threonine-protein kinase SRK2I; SNRK2, ABA	100.0
3gen_A	283	Tyrosine-protein kinase BTK; bruton'S tyrosine kin	100.0
2bdw_A	362	Hypothetical protein K11E8.1D; kinase, calmodulin	100.0
4fr4_A	384	YANK1, serine/threonine-protein kinase 32A; struct	100.0
1kob_A	387	Twitchin; kinase, intrasteric regulation; 2.30A {A	100.0
3cbl_A	377	C-FES, proto-oncogene tyrosine-protein kinase FES/	100.0
2zv2_A	298	Calcium/calmodulin-dependent protein kinase kinas;	100.0
4eqm_A	294	Protein kinase; transferase; HET: ANP; 3.00A {Stap	100.0
1qcf_A	454	Haematopoetic cell kinase (HCK); tyrosine kinase-i	100.0
1rdq_E	350	PKA C-alpha, CAMP-dependent protein kinase, alpha-	100.0
3kmu_A	271	ILK, integrin-linked kinase; cell adhesion, ANK re	100.0
4dc2_A	396	Protein kinase C IOTA type; kinase, substrate, cel	100.0
1xjd_A	345	Protein kinase C, theta type; PKC-theta, ATP, AMP,	100.0
2nru_A	307	Interleukin-1 receptor-associated kinase 4; inhibi	100.0
3tki_A	323	Serine/threonine-protein kinase CHK1; cell checkpo	100.0
1ob3_A	288	PFPK5, cell division control protein 2 homolog; tr	100.0
3a8x_A	345	Protein kinase C IOTA type; transferase; HET: TPO;	100.0
3l9p_A	367	Anaplastic lymphoma kinase; kinase domain, ATP-bin	100.0
3soc_A	322	Activin receptor type-2A; structural genomics cons	100.0
3h4j_B	336	AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin	100.0
1k9a_A	450	Carboxyl-terminal SRC kinase; COOH-terminal SRC ki	100.0
1luf_A	343	Muscle-specific tyrosine kinase receptor MUSK; pho	100.0
4fvq_A	289	Tyrosine-protein kinase JAK2; janus protein kinase	100.0
2x4f_A	373	Myosin light chain kinase family member 4; LUNG, b	100.0
2i0e_A	353	Protein kinase C-beta II; serine/threonine protein	100.0
3gni_B	389	Strad alpha; kinase fold, pseudokinase, alpha heli	100.0
3a62_A	327	Ribosomal protein S6 kinase beta-1; kinase domain,	100.0
2qol_A	373	Ephrin receptor; receptor tyrosine kinase, juxtame	100.0
3lb7_A	307	RAF proto-oncogene serine/threonine-protein kinas;	100.0
3dtc_A	271	Mitogen-activated protein kinase kinase kinase 9;	100.0
3c0i_A	351	Peripheral plasma membrane protein CASK; neurexin,	100.0
3tt0_A	382	Basic fibroblast growth factor receptor 1; kinase	100.0
3t9t_A	267	Tyrosine-protein kinase ITK/TSK; kinase domain, al	100.0
3v8s_A	410	RHO-associated protein kinase 1; dimerization, myo	100.0
1opk_A	495	P150, C-ABL, proto-oncogene tyrosine-protein kinas	100.0
3q4u_A	301	Activin receptor type-1; structural genomics conso	100.0
2pmi_A	317	Negative RE, cyclin-dependent protein kinase PHO85	100.0
4f0f_A	287	Serine/threonine-protein kinase ROCO4; LRRK2, ATP-	100.0
2w4o_A	349	Calcium/calmodulin-dependent protein kinase type I	100.0
1u5q_A	348	Serine/threonine protein kinase TAO2; transferase;	100.0
2eue_A	275	Carbon catabolite derepressing protein kinase; kin	100.0
1fmk_A	452	C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros	100.0
4ejn_A	446	RAC-alpha serine/threonine-protein kinase; AKT1, a	100.0
3p1a_A	311	MYT1 kinase, membrane-associated tyrosine- and thr	100.0
3llt_A	360	Serine/threonine kinase-1, pflammer; lammer kinase	100.0
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	100.0
3lxl_A	327	Tyrosine-protein kinase JAK3; TYK2, inflammation,	100.0
1csn_A	298	Casein kinase-1; phosphotransferase; HET: ATP; 2.0	100.0
3kfa_A	288	Tyrosine-protein kinase ABL1; CML, drug resistance	100.0
2y94_A	476	5'-AMP-activated protein kinase catalytic subunit;	100.0
2r5t_A	373	Serine/threonine-protein kinase SGK1; AGC protein	100.0
4aw2_A	437	Serine/threonine-protein kinase MRCK alpha; transf	100.0
4euu_A	319	Serine/threonine-protein kinase TBK1; ATP binding,	100.0
2a2a_A	321	Death-associated protein kinase 2; autoinhibition,	100.0
3fdn_A	279	Serine/threonine-protein kinase 6; aurora kinase i	100.0
3g33_A	308	Cell division protein kinase 4; Ser/Thr protein ki	100.0
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	100.0
2ivs_A	314	Proto-oncogene tyrosine-protein kinase receptor RE	100.0
2izr_A	330	Casein kinase I isoform gamma-3; serine/threonine-	100.0
3pls_A	298	Macrophage-stimulating protein receptor; protein k	100.0
1nxk_A	400	MAP kinase-activated protein kinase 2; MK2, phosph	100.0
3kk8_A	284	Calcium/calmodulin dependent protein kinase II; AT	100.0
2wqm_A	310	Serine/threonine-protein kinase NEK7; ATP-binding,	100.0
3qup_A	323	Tyrosine-protein kinase receptor TYRO3; protein ki	100.0
3ttj_A	464	Mitogen-activated protein kinase 10; JNK3, protein	100.0
3lxp_A	318	Non-receptor tyrosine-protein kinase TYK2; JAK3, i	100.0
3op5_A	364	Serine/threonine-protein kinase VRK1; adenosine tr	100.0
3f3z_A	277	Calcium/calmodulin-dependent protein kinase with d	100.0
1qpc_A	279	LCK kinase; alpha beta fold, transferase; HET: PTR	100.0
1mp8_A	281	Focal adhesion kinase 1; tyrosine protein kinase,	100.0
2jam_A	304	Calcium/calmodulin-dependent protein kinase type 1	100.0
3poz_A	327	Epidermal growth factor receptor; kinase domain, a	100.0
2vd5_A	412	DMPK protein; serine/threonine-protein kinase, kin	100.0
2ac3_A	316	MAP kinase-interacting serine/threonine kinase 2;	100.0
3cok_A	278	Serine/threonine-protein kinase PLK4; POLO-like ki	100.0
3og7_A	289	AKAP9-BRAF fusion protein; proto-oncogene, V600E,	100.0
3oz6_A	388	Mitogen-activated protein kinase 1, serine/threon	100.0
2acx_A	576	G protein-coupled receptor kinase 6; GRK, G transf	100.0
3dbq_A	343	Dual specificity protein kinase TTK; MPS1 structur	100.0
2h34_A	309	Serine/threonine-protein kinase PKNE; apoenzyme, t	100.0
1x8b_A	289	WEE1HU, WEE1-like protein kinase; cell cycle, tran	100.0
1t46_A	313	HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom	100.0
3rp9_A	458	Mitogen-activated protein kinase; structural genom	100.0
4agu_A	311	Cyclin-dependent kinase-like 1; transferase, phosp	100.0
1u59_A	287	Tyrosine-protein kinase ZAP-70; transferase; HET:	100.0
4e5w_A	302	Tyrosine-protein kinase JAK1; kinase domain, trans	100.0
1mqb_A	333	Ephrin type-A receptor 2; tyrosine protein kinase,	100.0
3hko_A	345	Calcium/calmodulin-dependent protein kinase with d	100.0
2pvf_A	334	Fibroblast growth factor receptor 2; kinase domain	100.0
2vgo_A	284	Serine/threonine-protein kinase 12-A; nucleotide-b	100.0
2eva_A	307	TAK1 kinase - TAB1 chimera fusion protein; transfe	100.0
2h8h_A	535	Proto-oncogene tyrosine-protein kinase SRC; SRC ki	100.0
3mtl_A	324	Cell division protein kinase 16; pctaire1, indirub	100.0
1rjb_A	344	FL cytokine receptor; kinase, structure, autoinhib	100.0
3is5_A	285	Calcium-dependent protein kinase; CDPK, structural	100.0
3kn6_A	325	Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1	100.0
3kex_A	325	Receptor tyrosine-protein kinase ERBB-3; kinase do	100.0
3dls_A	335	PAS domain-containing serine/threonine-protein KI;	100.0
1cm8_A	367	Phosphorylated MAP kinase P38-gamma; phosphorylati	100.0
3f66_A	298	Hepatocyte growth factor receptor; C-Met, protein	100.0
3gbz_A	329	Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-	100.0
2w1i_A	326	JAK2; chromosomal rearrangement, nucleotide-bindin	100.0
3eqc_A	360	Dual specificity mitogen-activated protein kinase;	100.0
3mwu_A	486	Calmodulin-domain protein kinase 1; serine/threoni	100.0
2zmd_A	390	Dual specificity protein kinase TTK; MPS1, T686A,	100.0
1fvr_A	327	Tyrosine-protein kinase TIE-2; tyrosine kinase, tr	100.0
2j7t_A	302	Serine/threonine-protein kinase 10; transferase, A	100.0
3c4z_A	543	Rhodopsin kinase; Ser/Thr kinase, RGS homology dom	100.0
1byg_A	278	CSK, protein (C-terminal SRC kinase); protein kina	100.0
3lzb_A	327	Epidermal growth factor receptor; epidermal growth	100.0
2ozo_A	613	Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t	100.0
3c1x_A	373	Hepatocyte growth factor receptor; receptor tyrosi	100.0
3nyv_A	484	Calmodulin-domain protein kinase 1; serine/threoni	100.0
2jii_A	352	Serine/threonine-protein kinase VRK3 molecule: VA	100.0
1p4o_A	322	Insulin-like growth factor I receptor protein; IGF	100.0
3pfq_A	674	PKC-B, PKC-beta, protein kinase C beta type; phosp	100.0
3mi9_A	351	Cell division protein kinase 9; P-TEFB, HIV-1, pro	100.0
2a19_B	284	Interferon-induced, double-stranded RNA-activated	100.0
3brb_A	313	Proto-oncogene tyrosine-protein kinase MER; ATP-bi	100.0
2qr7_A	342	Ribosomal protein S6 kinase alpha-3; kinase domain	100.0
3lij_A	494	Calcium/calmodulin dependent protein kinase with A	100.0
3gxj_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	100.0
3kvw_A	429	DYRK2, dual specificity tyrosine-phosphorylation-r	100.0
3lm5_A	327	Serine/threonine-protein kinase 17B; STK17B, serin	100.0
3nsz_A	330	CK II alpha, casein kinase II subunit alpha; inhib	100.0
4aaa_A	331	Cyclin-dependent kinase-like 2; transferase, phosp	100.0
2clq_A	295	Mitogen-activated protein kinase kinase kinase 5;	100.0
2yex_A	276	Serine/threonine-protein kinase CHK1; transferase,	100.0
3uzp_A	296	CKI-delta, CKID, casein kinase I isoform delta; CK	100.0
3a7i_A	303	MST3 kinase, serine/threonine kinase 24 (STE20 hom	100.0
2buj_A	317	Serine/threonine-protein kinase 16; transferase, A	100.0
4hgt_A	296	Casein kinase I isoform delta; CK1D, inhibitor, tr	100.0
1t4h_A	290	Serine/threonine-protein kinase WNK1; protein seri	100.0
3cc6_A	281	Protein tyrosine kinase 2 beta; focal adhesion kin	100.0
1xbb_A	291	Tyrosine-protein kinase SYK; gleevec, STI-571, ima	100.0
3i6u_A	419	CDS1, serine/threonine-protein kinase CHK2; Ser/Th	100.0
3com_A	314	Serine/threonine-protein kinase 4; MST1, STE20-lik	100.0
3bhy_A	283	Death-associated protein kinase 3; death associate	100.0
3ork_A	311	Serine/threonine protein kinase; structural genomi	100.0
3q5i_A	504	Protein kinase; CDPK, malaria, phosphotransferase,	100.0
2i1m_A	333	Macrophage colony-stimulating factor 1 receptor; k	100.0
1ua2_A	346	CAK, cell division protein kinase 7; cell cycle, p	100.0
3n9x_A	432	Phosphotransferase; malaria kinase, structural gen	100.0
3mdy_A	337	Bone morphogenetic protein receptor type-1B; compl	100.0
3ll6_A	337	Cyclin G-associated kinase; transferase, protein k	100.0
2r3i_A	299	Cell division protein kinase 2; serine/threonine-p	100.0
2fst_X	367	Mitogen-activated protein kinase 14; active mutant	100.0
2v62_A	345	Serine/threonine-protein kinase VRK2; transferase,	100.0
2owb_A	335	Serine/threonine-protein kinase PLK1; catalytic do	100.0
2rku_A	294	Serine/threonine-protein kinase PLK1; structure of	100.0
2yfx_A	327	Tyrosine-protein kinase receptor; nucleotide-bindi	100.0
2h6d_A	276	5'-AMP-activated protein kinase catalytic subunit	100.0
2w5a_A	279	Serine/threonine-protein kinase NEK2; Ser/Thr prot	100.0
3byv_A	377	Rhoptry kinase; malaria, transferase, structural g	100.0
2xir_A	316	Vascular endothelial growth factor receptor 2; ang	100.0
3q60_A	371	ROP5B; pseudokinase, transferase; HET: ATP; 1.72A	100.0
2y7j_A	365	Phosphorylase B kinase gamma catalytic chain, test	100.0
2vwi_A	303	Serine/threonine-protein kinase OSR1; STE kinase,	100.0
2xrw_A	371	Mitogen-activated protein kinase 8; transcription,	100.0
1wak_A	397	Serine/threonine-protein kinase SPRK1; SRPK, trans	100.0
1phk_A	298	Phosphorylase kinase; glycogen metabolism, transfe	100.0
1vzo_A	355	Ribosomal protein S6 kinase alpha 5; protein kinas	100.0
2x7f_A	326	TRAF2 and NCK-interacting protein kinase; serine/t	100.0
2wtk_C	305	Serine/threonine-protein kinase 11; transferase-me	100.0
1z57_A	339	Dual specificity protein kinase CLK1; protein tyro	100.0
3qyz_A	364	Mitogen-activated protein kinase 1; transferase, s	100.0
2pml_X	348	PFPK7, Ser/Thr protein kinase; phosphorylati trans	100.0
4fl3_A	635	Tyrosine-protein kinase SYK; transferase; HET: ANP	100.0
3eb0_A	383	Putative uncharacterized protein; kinase cryptospo	100.0
1zy4_A	303	Serine/threonine-protein kinase GCN2; translation	100.0
4eut_A	396	Serine/threonine-protein kinase TBK1; ATP binding,	100.0
1b6c_B	342	TGF-B superfamily receptor type I; complex (isomer	100.0
3g2f_A	336	Bone morphogenetic protein receptor type-2; kinase	100.0
3pg1_A	362	Mitogen-activated protein kinase, putative (MAP K	100.0
1u46_A	291	ACK-1, activated CDC42 kinase 1; tyrosine kinase,	100.0
3fme_A	290	Dual specificity mitogen-activated protein kinase;	100.0
2i6l_A	320	Mitogen-activated protein kinase 6; MAPK6, ERK3, e	100.0
4exu_A	371	Mitogen-activated protein kinase 13; P38 kinase, t	100.0
2ycf_A	322	Serine/threonine-protein kinase CHK2; transferase,	100.0
2b9h_A	353	MAP kinase FUS3, mitogen-activated protein kinase	100.0
3sv0_A	483	Casein kinase I-like; typical kinase domain fold,	100.0
3e7e_A	365	HBUB1, BUB1A, mitotic checkpoint serine/threonine-	100.0
3an0_A	340	Dual specificity mitogen-activated protein kinase;	100.0
1blx_A	326	Cyclin-dependent kinase 6; inhibitor protein, cycl	100.0
2vx3_A	382	Dual specificity tyrosine-phosphorylation- regula	100.0
3e3p_A	360	Protein kinase, putative glycogen synthase kinase;	100.0
2y4i_B	319	KSR2, HKSR2, kinase suppressor of RAS 2; transfera	100.0
1j1b_A	420	Glycogen synthase kinase-3 beta; complex, TAU, AMP	100.0
4e7w_A	394	Glycogen synthase kinase 3; GSK3, PTyr195, transfe	100.0
3fhr_A	336	MAP kinase-activated protein kinase 3; kinase-inhi	100.0
2eu9_A	355	Dual specificity protein kinase CLK3; kinase domai	100.0
3rgf_A	405	Cyclin-dependent kinase 8; protein kinase complex,	100.0
3coi_A	353	Mitogen-activated protein kinase 13; P38D, P38delt	100.0
2wei_A	287	Calmodulin-domain protein kinase 1, putative; nucl	100.0
2j0j_A	656	Focal adhesion kinase 1; cell migration, FERM, tra	100.0
3aln_A	327	Dual specificity mitogen-activated protein kinase;	100.0
3cek_A	313	Dual specificity protein kinase TTK; HMPS1, PYT, E	100.0
1q8y_A	373	SR protein kinase; transferase; HET: ADP ADE; 2.05	100.0
2rio_A	434	Serine/threonine-protein kinase/endoribonuclease I	100.0
3a99_A	320	Proto-oncogene serine/threonine-protein kinase PI;	100.0
2iwi_A	312	Serine/threonine-protein kinase PIM-2; nucleotide-	100.0
3p23_A	432	Serine/threonine-protein kinase/endoribonuclease;	100.0
2dyl_A	318	Dual specificity mitogen-activated protein kinase	100.0
3qa8_A	676	MGC80376 protein; kinase ubiquitin-like domain, ph	100.0
3m2w_A	299	MAP kinase-activated protein kinase 2; small molec	100.0
2vuw_A	336	Serine/threonine-protein kinase haspin; cell cycle	100.0
3uqc_A	286	Probable conserved transmembrane protein; structur	100.0
2pzi_A	681	Probable serine/threonine-protein kinase PKNG; ATP	100.0
3dzo_A	413	Rhoptry kinase domain; parasitic disease, transfer	100.0
4azs_A	569	Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15	100.0
3en9_A	540	Glycoprotease, O-sialoglycoprotein endopeptidase/p	99.95
1zar_A	282	RIO2 kinase; serine kinase, winged-helix, RIO doma	99.93
1zth_A	258	RIO1 serine protein kinase; ribosome biogenesis, r	99.86
4gyi_A	397	RIO2 kinase; protein kinase, ADP complex, phosphoa	99.77
3tm0_A	263	Aminoglycoside 3'-phosphotransferase; protein kina	99.46
1nd4_A	264	Aminoglycoside 3'-phosphotransferase; protein kina	99.33
3dxp_A	359	Putative acyl-COA dehydrogenase; protein kinase-li	99.25
3sg8_A	304	APH(2'')-ID; antibiotic resistance enzyme, transfe	99.05
3r70_A	320	Aminoglycoside phosphotransferase; structural geno	98.78
3tdw_A	306	Gentamicin resistance protein; kinase, phosphoryl	98.61
3d1u_A	288	Putative fructosamine-3-kinase; YP_290396.1, struc	98.58
4gkh_A	272	Aminoglycoside 3'-phosphotransferase APHA1-IAB; py	98.54
3ats_A	357	Putative uncharacterized protein; hypothetical pro	98.42
3ovc_A	362	Hygromycin-B 4-O-kinase; aminoglycoside phosphotra	98.4
2olc_A	397	MTR kinase, methylthioribose kinase; kinase ADP-2H	98.23
2q83_A	346	YTAA protein; 2635576, structural genomics, joint	98.2
2yle_A	229	Protein spire homolog 1; actin-binding protein, ac	97.97
3f7w_A	288	Putative fructosamine-3-kinase; YP_290396.1, struc	97.92
2ppq_A	322	HSK, HK, homoserine kinase; structural genomics, M	97.77
2pyw_A	420	Uncharacterized protein; 5-methylthioribose kinase	97.73
3jr1_A	312	Putative fructosamine-3-kinase; YP_719053.1, struc	97.71
1zyl_A	328	Hypothetical protein YIHE; putative protein kinase	97.67
3dxq_A	301	Choline/ethanolamine kinase family protein; NP_106	97.53
3csv_A	333	Aminoglycoside phosphotransferase; YP_614837.1, ph	97.5
1nw1_A	429	Choline kinase (49.2 KD); phospholipid synthesis,	97.36
3feg_A	379	Choline/ethanolamine kinase; non-protein kinase, c	97.22
3c5i_A	369	Choline kinase; choline, kinase, malaria, transfer	97.09
3i1a_A	339	Spectinomycin phosphotransferase; protein kinase,	96.89
2qg7_A	458	Ethanolamine kinase PV091845; malaria, SGC, struct	96.75
3mes_A	424	Choline kinase; malaria, structural genomics, stru	96.08
3f2s_A	401	CK, chetk-alpha, choline kinase alpha; non-protein	95.99
4ann_A	215	ESSB; membrane protein, membrane secretion, ESS ty	92.66
4ano_A	219	ESSB; membrane protein, membrane secretion, ESS ty	92.25
3cxl_A	463	N-chimerin; SH2, RHO-GAP, structural genomics cons	85.83

>4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A*

Probab=100.00  E-value=1.2e-61  Score=425.60  Aligned_cols=257  Identities=23%  Similarity=0.327  Sum_probs=215.8

Q ss_pred             cccccccCCCCCCcEEEEEEeC------CCCEEEEEEeCCCCChhHHHHHHHHHHHhcCCCccccccceeeeeCCeeEEE
Q 020221           58 MENIVSEHGEKAPNVVYKGKLE------NQFRIAVKRFNRSAWPDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLV  131 (329)
Q Consensus        58 ~~~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv  131 (329)
                      ++.+.+.||+|+||+||+|.+.      ++..||||+++.......++|.+|+++|+.++|||||+++|+|.+++..+||
T Consensus        14 ~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~lV   93 (299)
T 4asz_A           14 NIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLIMV   93 (299)
T ss_dssp             GEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEEEE
T ss_pred             HeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCCChHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEEEE
Confidence            4566788899999999999853      4678999999877655667899999999999999999999999999999999


Q ss_pred             EecCCCCCHHhhhccC-----------CCCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCCCCCeeeecc
Q 020221          132 AEYMPNDTLAKHLFHW-----------ETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCF  200 (329)
Q Consensus       132 ~e~~~~gsL~~~l~~~-----------~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Df  200 (329)
                      ||||++|+|.++|...           ....+++.++..++.||+.||.|||++ +|+||||||+|||+++++.+||+||
T Consensus        94 ~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~-~iiHRDlKp~NILl~~~~~~Ki~DF  172 (299)
T 4asz_A           94 FEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQ-HFVHRDLATRNCLVGENLLVKIGDF  172 (299)
T ss_dssp             EECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHHT-TCCCSCCSGGGEEECGGGCEEECCC
T ss_pred             EEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhC-CcccCccCHhhEEECCCCcEEECCc
Confidence            9999999999999642           235799999999999999999999999 9999999999999999999999999


Q ss_pred             cCcccCCCC------CCccCcccccCcccccCCCCCCcccchhhhHHHHHHHh-CCCCCCchhhHHHhhhchhhhccccc
Q 020221          201 GLMKNSRDG------RSYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLS-GKHIPPSHALDLIRDRNIQTLTDSCL  273 (329)
Q Consensus       201 g~a~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t-g~~~~~~~~~~~~~~~~~~~~~~~~~  273 (329)
                      |+|+.....      ....||+.|||||++.+..++.++|||||||++|||+| |+.||.......+......     ..
T Consensus       173 Gla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~k~DVwS~Gvvl~Ellt~G~~Pf~~~~~~~~~~~i~~-----~~  247 (299)
T 4asz_A          173 GMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIECITQ-----GR  247 (299)
T ss_dssp             SCHHHHTGGGCEEETTTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHH-----TC
T ss_pred             ccceecCCCCceeecCceecChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHc-----CC
Confidence            999754332      22357899999999999999999999999999999999 7888765443333222221     12


Q ss_pred             cCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhhccccc
Q 020221          274 EGQFSSDEGTELVRLASRCLQYEPRERPNPRSLVTALVTLQKDTELY  320 (329)
Q Consensus       274 ~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~~~l~~L~~~~~~~~~~  320 (329)
                      ....|..+++++.+|+.+||+.||++|||+.++++.|+++.+....+
T Consensus       248 ~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~~i~~~L~~~~~~~p~~  294 (299)
T 4asz_A          248 VLQRPRTCPQEVYELMLGCWQREPHMRKNIKGIHTLLQNLAKASPVY  294 (299)
T ss_dssp             CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHSCCC
T ss_pred             CCCCCccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhcCCcc
Confidence            23456677889999999999999999999999999999998765443

>4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A*

Probab=100.00  E-value=1.2e-61  Score=431.07  Aligned_cols=245  Identities=17%  Similarity=0.222  Sum_probs=210.7

Q ss_pred             CcccccccCCCCCCcEEEEEE-eCCCCEEEEEEeCCCCChhHHHHHHHHHHHhcCCCccccccceeeeeCCeeEEEEecC
Q 020221           57 AMENIVSEHGEKAPNVVYKGK-LENQFRIAVKRFNRSAWPDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAEYM  135 (329)
Q Consensus        57 ~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~  135 (329)
                      ..|+++++||+|+||+||+|. ..+|+.||||++........+.+.+|+++|+.++|||||++++++.+.+.+|||||||
T Consensus        74 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~ivmEy~  153 (346)
T 4fih_A           74 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFL  153 (346)
T ss_dssp             GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCSSGGGGHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEECCC
T ss_pred             HhcEEeEEeecCcCeEEEEEEECCCCCEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeCC
Confidence            457888999999999999999 4579999999997665455567889999999999999999999999999999999999


Q ss_pred             CCCCHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCCCCCeeeecccCcccCCCC----CC
Q 020221          136 PNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDG----RS  211 (329)
Q Consensus       136 ~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~----~~  211 (329)
                      ++|+|.+++.+   ..+++.++..++.||+.||+|||++ ||+||||||+|||++.++.+||+|||+|+.....    ..
T Consensus       154 ~gg~L~~~l~~---~~l~e~~~~~~~~qi~~aL~ylH~~-~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~~~~~~  229 (346)
T 4fih_A          154 EGGALTDIVTH---TRMNEEQIAAVCLAVLQALSVLHAQ-GVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKS  229 (346)
T ss_dssp             TTEEHHHHHHH---SCCCHHHHHHHHHHHHHHHHHHHHT-TEECCCCSGGGEEECTTCCEEECCCTTCEECCSSSCCBCC
T ss_pred             CCCcHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHC-CcccccCCHHHEEECCCCCEEEecCcCceecCCCCCcccc
Confidence            99999999853   5699999999999999999999999 9999999999999999999999999999865433    35


Q ss_pred             ccCcccccCcccccCCCCCCcccchhhhHHHHHHHhCCCCCCchhhHHHhhhchhhhccccccCCCChHHHHHHHHHHHH
Q 020221          212 YSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLASR  291 (329)
Q Consensus       212 ~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~  291 (329)
                      ..||+.|+|||++.+..|+.++|||||||++|||++|..||.................   .....+..+++++.+|+.+
T Consensus       230 ~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~---~~~~~~~~~s~~~~dli~~  306 (346)
T 4fih_A          230 LVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLP---PRLKNLHKVSPSLKGFLDR  306 (346)
T ss_dssp             CCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSSC---CCCSCGGGSCHHHHHHHHH
T ss_pred             cccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcCCC---CCCCccccCCHHHHHHHHH
Confidence            6799999999999999999999999999999999999999876543322222111111   1112335678899999999


Q ss_pred             hcccCCCCCCCHHHHHH
Q 020221          292 CLQYEPRERPNPRSLVT  308 (329)
Q Consensus       292 cl~~dp~~Rps~~~~l~  308 (329)
                      ||..||++|||+.|+++
T Consensus       307 ~L~~dP~~R~ta~e~l~  323 (346)
T 4fih_A          307 LLVRDPAQRATAAELLK  323 (346)
T ss_dssp             HSCSSTTTSCCHHHHTT
T ss_pred             HcCCChhHCcCHHHHhc
Confidence            99999999999999997

>4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A*

Probab=100.00  E-value=1.3e-61  Score=431.44  Aligned_cols=246  Identities=17%  Similarity=0.201  Sum_probs=208.2

Q ss_pred             CcccccccCCCCCCcEEEEEE-eCCCCEEEEEEeCCCCC--hhHHHHHHHHHHHhcCCCccccccceeeeeCCeeEEEEe
Q 020221           57 AMENIVSEHGEKAPNVVYKGK-LENQFRIAVKRFNRSAW--PDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAE  133 (329)
Q Consensus        57 ~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  133 (329)
                      +.|++++.||+|+||+||+|. ..+|+.||||++.....  ...+.+.+|+++|+.++|||||++++++.+.+.+|||||
T Consensus        24 e~Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~yiVmE  103 (350)
T 4b9d_A           24 EKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRESFEENGSLYIVMD  103 (350)
T ss_dssp             CCEEEEEEC------CEEEEEETTTCCEEEEEEEECTTSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             cceEEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHCCHHHHHHHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEe
Confidence            568999999999999999999 56789999999976542  235678999999999999999999999999999999999


Q ss_pred             cCCCCCHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCCCCCeeeecccCcccCCCC----
Q 020221          134 YMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDG----  209 (329)
Q Consensus       134 ~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~----  209 (329)
                      ||++|+|.+++.......+++.+++.++.||+.||.|||++ ||+||||||+|||++.++.+||+|||+|+.....    
T Consensus       104 y~~gg~L~~~i~~~~~~~~~e~~~~~~~~qi~~aL~ylH~~-~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~~~~  182 (350)
T 4b9d_A          104 YCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVHDR-KILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTVELA  182 (350)
T ss_dssp             CCTTCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHT-TCEETTCCGGGEEECTTCCEEECSTTEESCCCHHHHHH
T ss_pred             CCCCCcHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHC-CeeeccCCHHHEEECCCCCEEEcccccceeecCCcccc
Confidence            99999999999765566789999999999999999999999 9999999999999999999999999999876543    


Q ss_pred             CCccCcccccCcccccCCCCCCcccchhhhHHHHHHHhCCCCCCchhhHHHhhhchhhhccccccCCCChHHHHHHHHHH
Q 020221          210 RSYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLA  289 (329)
Q Consensus       210 ~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li  289 (329)
                      ....||+.|||||++.+..|+.++|||||||++|||++|+.||.......+.........     ...+..+++++.+|+
T Consensus       183 ~~~~GT~~YmAPE~l~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~~~-----~~~~~~~s~~~~~li  257 (350)
T 4b9d_A          183 RACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFEAGSMKNLVLKIISGSF-----PPVSLHYSYDLRSLV  257 (350)
T ss_dssp             HHHHSCCTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCC-----CCCCTTSCHHHHHHH
T ss_pred             cccCCCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcCCC-----CCCCccCCHHHHHHH
Confidence            234699999999999999999999999999999999999999987654443333222211     133456788999999


Q ss_pred             HHhcccCCCCCCCHHHHHH
Q 020221          290 SRCLQYEPRERPNPRSLVT  308 (329)
Q Consensus       290 ~~cl~~dp~~Rps~~~~l~  308 (329)
                      .+||+.||++|||+.++++
T Consensus       258 ~~~L~~dP~~R~s~~e~l~  276 (350)
T 4b9d_A          258 SQLFKRNPRDRPSVNSILE  276 (350)
T ss_dssp             HHHTCSSGGGSCCHHHHHT
T ss_pred             HHHccCChhHCcCHHHHhc
Confidence            9999999999999999987

>4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens}

Probab=100.00  E-value=7.5e-61  Score=425.97  Aligned_cols=257  Identities=22%  Similarity=0.318  Sum_probs=211.6

Q ss_pred             cccccccCCCCCCcEEEEEEeC------CCCEEEEEEeCCCCChhHHHHHHHHHHHhcCCCccccccceeeeeCCeeEEE
Q 020221           58 MENIVSEHGEKAPNVVYKGKLE------NQFRIAVKRFNRSAWPDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLV  131 (329)
Q Consensus        58 ~~~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv  131 (329)
                      +..+.++||+|+||+||+|.+.      +++.||||+++.......++|.+|+++|+.++|||||+++|+|.++...+||
T Consensus        42 d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~lV  121 (329)
T 4aoj_A           42 DIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLLMV  121 (329)
T ss_dssp             GEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEEEE
T ss_pred             HeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEE
Confidence            3455677899999999999853      4788999999877656677899999999999999999999999999999999


Q ss_pred             EecCCCCCHHhhhccCC-------------CCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCCCCCeeee
Q 020221          132 AEYMPNDTLAKHLFHWE-------------TQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLS  198 (329)
Q Consensus       132 ~e~~~~gsL~~~l~~~~-------------~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~  198 (329)
                      ||||++|+|.+++....             ...+++.++..++.||+.||+|||++ +|+||||||+|||+++++.+||+
T Consensus       122 ~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~-~iiHRDLKp~NILl~~~~~~Ki~  200 (329)
T 4aoj_A          122 FEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGL-HFVHRDLATRNCLVGQGLVVKIG  200 (329)
T ss_dssp             EECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHHT-TCCCSCCCGGGEEEETTTEEEEC
T ss_pred             EEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhcC-CeecccccHhhEEECCCCcEEEc
Confidence            99999999999996432             24689999999999999999999999 99999999999999999999999


Q ss_pred             cccCcccCCCC------CCccCcccccCcccccCCCCCCcccchhhhHHHHHHHh-CCCCCCchhhHHHhhhchhhhccc
Q 020221          199 CFGLMKNSRDG------RSYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLS-GKHIPPSHALDLIRDRNIQTLTDS  271 (329)
Q Consensus       199 Dfg~a~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t-g~~~~~~~~~~~~~~~~~~~~~~~  271 (329)
                      |||+++.....      ....||+.|||||++.+..++.++|||||||++|||+| |+.||.......+......     
T Consensus       201 DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~~sDvwS~Gvvl~Ellt~G~~Pf~~~~~~~~~~~i~~-----  275 (329)
T 4aoj_A          201 DFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTEAIDCITQ-----  275 (329)
T ss_dssp             CCC----------------CCCCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSSCHHHHHHHHHH-----
T ss_pred             ccccceeccCCCcceecCcccccccccChhhhcCCCCCccccccchHHHHHHHHcCCCCCCCCCCHHHHHHHHHc-----
Confidence            99999865432      23468899999999999999999999999999999999 7888765433322222111     


Q ss_pred             cccCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhhccccc
Q 020221          272 CLEGQFSSDEGTELVRLASRCLQYEPRERPNPRSLVTALVTLQKDTELY  320 (329)
Q Consensus       272 ~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~~~l~~L~~~~~~~~~~  320 (329)
                      ..+...|..+++++.+|+.+||+.||++|||+.+|++.|+.+.+.+...
T Consensus       276 g~~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~ei~~~L~~l~~~pp~~  324 (329)
T 4aoj_A          276 GRELERPRACPPEVYAIMRGCWQREPQQRHSIKDVHARLQALAQAPPVY  324 (329)
T ss_dssp             TCCCCCCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHHHHHHHHHSCC--
T ss_pred             CCCCCCcccccHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHhhCCccc
Confidence            1233456677899999999999999999999999999999998765444

>3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens}

Probab=100.00  E-value=2.7e-60  Score=417.14  Aligned_cols=255  Identities=18%  Similarity=0.277  Sum_probs=206.9

Q ss_pred             CCcccccccCCCCCCcEEEEEEeCCCCEEEEEEeCCCCC--hhHHHHHHHHHHHhcCCCccccccceeeeeCCeeEEEEe
Q 020221           56 FAMENIVSEHGEKAPNVVYKGKLENQFRIAVKRFNRSAW--PDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAE  133 (329)
Q Consensus        56 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  133 (329)
                      +++..+.+.||+|+||+||+|++.+  .||||+++....  ...+.|.+|+++++.++|||||++++++. .+.++||||
T Consensus        35 ~~~l~l~~~iG~G~fG~Vy~~~~~~--~vAvK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~-~~~~~iVmE  111 (307)
T 3omv_A           35 ASEVMLSTRIGSGSFGTVYKGKWHG--DVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMT-KDNLAIVTQ  111 (307)
T ss_dssp             TTSCCEEEECCCCSSSEEEEEESSS--EEEEEECCCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSSCEEEEE
T ss_pred             HHHeEEeeEEeeCCCcEEEEEEECC--cEEEEEEEecCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEE-CCeEEEEEE
Confidence            3456677889999999999999754  599999875432  33567999999999999999999999885 467899999


Q ss_pred             cCCCCCHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCCCCCeeeecccCcccCCCC----
Q 020221          134 YMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDG----  209 (329)
Q Consensus       134 ~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~----  209 (329)
                      ||++|+|.++|.. ....+++.++..|+.||+.||+|||++ +|+||||||+|||+++++.+||+|||+|+.....    
T Consensus       112 y~~gGsL~~~l~~-~~~~l~~~~~~~i~~qia~gL~yLH~~-~IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~~~~~~~  189 (307)
T 3omv_A          112 WCEGSSLYKHLHV-QETKFQMFQLIDIARQTAQGMDYLHAK-NIIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWSGSQ  189 (307)
T ss_dssp             CCSSCBHHHHHHT-SCCCCCHHHHHHHHHHHHHHHHHHHHT-TCBCSCCCSSSEEEETTEEEEECCCSSCBC--------
T ss_pred             cCCCCCHHHHHhh-cCCCCCHHHHHHHHHHHHHHHHHHHHC-CccCCccCHHHEEECCCCcEEEeeccCceecccCCcce
Confidence            9999999999964 345799999999999999999999999 9999999999999999999999999999865432    


Q ss_pred             --CCccCcccccCcccccC---CCCCCcccchhhhHHHHHHHhCCCCCCchhhH-HHhhhchhhhccccccCCCChHHHH
Q 020221          210 --RSYSTNLAFTPPEYLRT---GRVTPESVMYSFGTLLLDLLSGKHIPPSHALD-LIRDRNIQTLTDSCLEGQFSSDEGT  283 (329)
Q Consensus       210 --~~~~~~~~y~aPE~~~~---~~~~~~~DvwslG~il~el~tg~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~  283 (329)
                        ....||+.|||||++.+   +.|+.++|||||||+||||+||+.||...... ............+. ....+..+++
T Consensus       190 ~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~~~~~~~~~~~~~~~~p~-~~~~~~~~~~  268 (307)
T 3omv_A          190 QVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRDQIIFMVGRGYASPD-LSKLYKNCPK  268 (307)
T ss_dssp             ----CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHTTCCCCC-STTSCTTSCH
T ss_pred             eecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCCCChHHHHHHHHhcCCCCCC-cccccccchH
Confidence              23478999999999864   35899999999999999999999988653221 11111111111111 1234566788


Q ss_pred             HHHHHHHHhcccCCCCCCCHHHHHHHHHhhhhc
Q 020221          284 ELVRLASRCLQYEPRERPNPRSLVTALVTLQKD  316 (329)
Q Consensus       284 ~~~~li~~cl~~dp~~Rps~~~~l~~L~~~~~~  316 (329)
                      ++.+|+.+||+.||++|||+.+|++.|+.++..
T Consensus       269 ~l~~li~~cl~~dP~~RPs~~ei~~~Le~l~~~  301 (307)
T 3omv_A          269 AMKRLVADCVKKVKEERPLFPQILSSIELLQHS  301 (307)
T ss_dssp             HHHHHHHHHTCSSSTTSCCHHHHHHHHHHHHTT
T ss_pred             HHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhcc
Confidence            999999999999999999999999999988754

>4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A

Probab=100.00  E-value=1.1e-60  Score=421.02  Aligned_cols=251  Identities=20%  Similarity=0.276  Sum_probs=210.6

Q ss_pred             CcccccccCCCCCCcEEEEEEeC------CCCEEEEEEeCCCCC-hhHHHHHHHHHHHhcCCCccccccceeeeeCCeeE
Q 020221           57 AMENIVSEHGEKAPNVVYKGKLE------NQFRIAVKRFNRSAW-PDARQFLEEARAVGQLRNRRLANLLGCCCEGDERL  129 (329)
Q Consensus        57 ~~~~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~  129 (329)
                      +..+++++||+|+||+||+|.+.      +++.||||+++.... ...++|.+|+.+++.++|||||+++|+|.+++..+
T Consensus        26 ~~~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~~~~~~  105 (308)
T 4gt4_A           26 SAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVCLLGVVTKDQPLS  105 (308)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-CCC-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCE
T ss_pred             HHCeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECcccChHHHHHHHHHHHHHHhCCCCCCCCcceEEEECCEEE
Confidence            44667888999999999999852      467899999976543 33567999999999999999999999999999999


Q ss_pred             EEEecCCCCCHHhhhccCC--------------CCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCCCCCe
Q 020221          130 LVAEYMPNDTLAKHLFHWE--------------TQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNP  195 (329)
Q Consensus       130 lv~e~~~~gsL~~~l~~~~--------------~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~  195 (329)
                      ||||||++|+|.++|....              ...+++.++..++.||+.||+|||++ +||||||||+|||+++++.+
T Consensus       106 lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~-~iiHRDLK~~NILl~~~~~~  184 (308)
T 4gt4_A          106 MIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSH-HVVHKDLATRNVLVYDKLNV  184 (308)
T ss_dssp             EEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHHT-TCCCSCCSGGGEEECGGGCE
T ss_pred             EEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhC-CCCCCCccccceEECCCCCE
Confidence            9999999999999996421              23589999999999999999999999 99999999999999999999


Q ss_pred             eeecccCcccCCCC------CCccCcccccCcccccCCCCCCcccchhhhHHHHHHHh-CCCCCCchhhHHHhhhchhhh
Q 020221          196 RLSCFGLMKNSRDG------RSYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLS-GKHIPPSHALDLIRDRNIQTL  268 (329)
Q Consensus       196 kl~Dfg~a~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t-g~~~~~~~~~~~~~~~~~~~~  268 (329)
                      ||+|||+++.....      ....||+.|||||++.++.++.++|||||||+||||+| |..||.......+.....   
T Consensus       185 Ki~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~~s~ksDVwSfGvvl~El~t~g~~Pf~~~~~~~~~~~i~---  261 (308)
T 4gt4_A          185 KISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVVEMIR---  261 (308)
T ss_dssp             EECCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTCCHHHHHHHHH---
T ss_pred             EECCcccceeccCCCceeEecccccCCcccCHHHHhCCCCCccchhhhHHHHHHHHHhCCCCCCCCCCHHHHHHHHH---
Confidence            99999999764322      23467899999999999999999999999999999999 777776544333222211   


Q ss_pred             ccccccCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhh
Q 020221          269 TDSCLEGQFSSDEGTELVRLASRCLQYEPRERPNPRSLVTALVTL  313 (329)
Q Consensus       269 ~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~~~l~~L~~~  313 (329)
                        .....+.|..+++++.+|+.+||+.||++|||+.+|++.|+.+
T Consensus       262 --~~~~~~~p~~~~~~~~~li~~C~~~dP~~RPs~~ei~~~L~a~  304 (308)
T 4gt4_A          262 --NRQVLPCPDDCPAWVYALMIECWNEFPSRRPRFKDIHSRLRAW  304 (308)
T ss_dssp             --TTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTS
T ss_pred             --cCCCCCCcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHhc
Confidence              1222345677889999999999999999999999999999864

>4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A*

Probab=100.00  E-value=9.2e-61  Score=424.16  Aligned_cols=259  Identities=18%  Similarity=0.163  Sum_probs=216.4

Q ss_pred             CCcccccccCCCCCCcEEEEEE-eCCCCEEEEEEeCCCCChhHHHHHHHHHHHhcCCCccccccceeeeeCCeeEEEEec
Q 020221           56 FAMENIVSEHGEKAPNVVYKGK-LENQFRIAVKRFNRSAWPDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAEY  134 (329)
Q Consensus        56 ~~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  134 (329)
                      ...+++.++||+|+||+||+|. ..+|+.||||+++....     ..+|+.+++.++|||||++++++.+++.+||||||
T Consensus        57 ~~~~~~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~~-----~~~E~~il~~l~HpnIV~l~~~~~~~~~~~ivmEy  131 (336)
T 4g3f_A           57 VHWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVF-----RVEELVACAGLSSPRIVPLYGAVREGPWVNIFMEL  131 (336)
T ss_dssp             TTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTC-----CTHHHHTTTTCCCTTBCCEEEEEEETTEEEEEECC
T ss_pred             hhheEeCcEeccCCCeEEEEEEECCCCCEEEEEEECHHHh-----HHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEec
Confidence            4456777888999999999999 56789999999976542     24699999999999999999999999999999999


Q ss_pred             CCCCCHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCCCC-CeeeecccCcccCCCC----
Q 020221          135 MPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDV-NPRLSCFGLMKNSRDG----  209 (329)
Q Consensus       135 ~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~-~~kl~Dfg~a~~~~~~----  209 (329)
                      |++|+|.+++.+  ...+++.++..++.||+.||+|||++ +|+||||||+|||++.+| .+||+|||+|+.....    
T Consensus       132 ~~gg~L~~~l~~--~~~l~e~~~~~~~~qi~~aL~ylH~~-~IiHRDlKp~NILl~~~g~~vKl~DFGla~~~~~~~~~~  208 (336)
T 4g3f_A          132 LEGGSLGQLIKQ--MGCLPEDRALYYLGQALEGLEYLHTR-RILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGK  208 (336)
T ss_dssp             CTTCBHHHHHHH--HSSCCHHHHHHHHHHHHHHHHHHHTT-TEECSCCCGGGEEECTTSCCEEECCCTTCEEC-------
T ss_pred             cCCCcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHC-CceecccCHHHEEEeCCCCEEEEeeCCCCeEccCCCccc
Confidence            999999999973  45799999999999999999999999 999999999999999887 5999999999865432    


Q ss_pred             -----CCccCcccccCcccccCCCCCCcccchhhhHHHHHHHhCCCCCCchhhHHHhhhchhhhccccccCCCChHHHHH
Q 020221          210 -----RSYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTE  284 (329)
Q Consensus       210 -----~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  284 (329)
                           ....||+.|||||++.+..|+.++|||||||++|||+||..||.......+.........   .....+..++++
T Consensus       209 ~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~~~---~~~~~~~~~s~~  285 (336)
T 4g3f_A          209 SLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGPLCLKIASEPP---PIREIPPSCAPL  285 (336)
T ss_dssp             -----CCCCCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSTTTCCSCCHHHHHHSCC---GGGGSCTTSCHH
T ss_pred             ceecCCccccCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHHcCCC---CchhcCccCCHH
Confidence                 224699999999999999999999999999999999999999865432222111111111   112345677889


Q ss_pred             HHHHHHHhcccCCCCCCCHHHHHHHHHhhhhccccccCcccc
Q 020221          285 LVRLASRCLQYEPRERPNPRSLVTALVTLQKDTELYLSLPWV  326 (329)
Q Consensus       285 ~~~li~~cl~~dp~~Rps~~~~l~~L~~~~~~~~~~~~~p~~  326 (329)
                      +.+++.+||+.||++|||+.|++++|........ ...|||+
T Consensus       286 ~~~li~~~L~~dP~~R~sa~el~~~l~~~l~~~~-~l~hPw~  326 (336)
T 4g3f_A          286 TAQAIQEGLRKEPVHRASAMELRRKVGKALQEVG-GLKSPWK  326 (336)
T ss_dssp             HHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHTT-SSCSCSS
T ss_pred             HHHHHHHHccCCHhHCcCHHHHHHHHHHHHhhhh-hccCCCc
Confidence            9999999999999999999999999998876544 3679996

>4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens}

Probab=100.00  E-value=4.3e-60  Score=431.05  Aligned_cols=245  Identities=16%  Similarity=0.217  Sum_probs=211.1

Q ss_pred             CcccccccCCCCCCcEEEEEE-eCCCCEEEEEEeCCCCChhHHHHHHHHHHHhcCCCccccccceeeeeCCeeEEEEecC
Q 020221           57 AMENIVSEHGEKAPNVVYKGK-LENQFRIAVKRFNRSAWPDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAEYM  135 (329)
Q Consensus        57 ~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~  135 (329)
                      ..|+++++||+|+||.||+|. ..+|+.||||++........+.+.+|+.+|+.++|||||++++++.+.+.+|||||||
T Consensus       151 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~iVmEy~  230 (423)
T 4fie_A          151 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFL  230 (423)
T ss_dssp             GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEESTTCSSGGGHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred             HhcEeeeEeccCcCcEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHhCCCCCCCceEEEEEECCEEEEEEeCC
Confidence            458888999999999999999 5678999999998766555667899999999999999999999999999999999999


Q ss_pred             CCCCHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCCCCCeeeecccCcccCCCC----CC
Q 020221          136 PNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDG----RS  211 (329)
Q Consensus       136 ~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~----~~  211 (329)
                      ++|+|.+++.   ...+++.++..++.||+.||+|||++ ||+||||||+|||++.+|.+||+|||+|+.....    ..
T Consensus       231 ~gG~L~~~i~---~~~l~e~~~~~~~~qil~aL~ylH~~-~IiHRDiKp~NILl~~~g~vKl~DFGla~~~~~~~~~~~~  306 (423)
T 4fie_A          231 EGGALTDIVT---HTRMNEEQIAAVCLAVLQALSVLHAQ-GVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKS  306 (423)
T ss_dssp             TTEEHHHHHH---HSCCCHHHHHHHHHHHHHHHHHHHHT-TEECCCCSTTTEEECTTCCEEECCCTTCEECCSSCCCBCC
T ss_pred             CCCcHHHHHh---ccCCCHHHHHHHHHHHHHHHHHHHHC-CeecccCCHHHEEEcCCCCEEEecCccceECCCCCccccc
Confidence            9999999995   35699999999999999999999999 9999999999999999999999999999865433    34


Q ss_pred             ccCcccccCcccccCCCCCCcccchhhhHHHHHHHhCCCCCCchhhHHHhhhchhhhccccccCCCChHHHHHHHHHHHH
Q 020221          212 YSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLASR  291 (329)
Q Consensus       212 ~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~  291 (329)
                      ..||+.|||||++.+..|+.++|||||||++|||++|..||................. .  .......+++++.+||.+
T Consensus       307 ~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~-~--~~~~~~~~s~~~~dli~~  383 (423)
T 4fie_A          307 LVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLP-P--RLKNLHKVSPSLKGFLDR  383 (423)
T ss_dssp             CEECTTTCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCC-C--CCSCTTSSCHHHHHHHHH
T ss_pred             cccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcCCC-C--CCcccccCCHHHHHHHHH
Confidence            5789999999999999999999999999999999999999876543322222111111 1  112334578899999999


Q ss_pred             hcccCCCCCCCHHHHHH
Q 020221          292 CLQYEPRERPNPRSLVT  308 (329)
Q Consensus       292 cl~~dp~~Rps~~~~l~  308 (329)
                      ||..||++|||+.|+++
T Consensus       384 ~L~~dP~~R~ta~ell~  400 (423)
T 4fie_A          384 LLVRDPAQRATAAELLK  400 (423)
T ss_dssp             HSCSSTTTSCCHHHHTT
T ss_pred             HcCCChhHCcCHHHHhc
Confidence            99999999999999997

>4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ...

Probab=100.00  E-value=1.3e-60  Score=418.41  Aligned_cols=243  Identities=17%  Similarity=0.188  Sum_probs=210.8

Q ss_pred             CcccccccCCCCCCcEEEEEE-eCCCCEEEEEEeCCCC---ChhHHHHHHHHHHHhcCCCccccccceeeeeCCeeEEEE
Q 020221           57 AMENIVSEHGEKAPNVVYKGK-LENQFRIAVKRFNRSA---WPDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVA  132 (329)
Q Consensus        57 ~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~  132 (329)
                      ++|++++.||+|+||+||+|. ..+++.||||++....   ....+.+.+|+++|+.++|||||++++++.+.+.+||||
T Consensus        32 ~dy~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~yivm  111 (311)
T 4aw0_A           32 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGL  111 (311)
T ss_dssp             GGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             cccEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence            458889999999999999999 5678999999997532   233567899999999999999999999999999999999


Q ss_pred             ecCCCCCHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCCCCCeeeecccCcccCCCC---
Q 020221          133 EYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDG---  209 (329)
Q Consensus       133 e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~---  209 (329)
                      |||++|+|.+++.  ....+++.++..++.||+.||+|||++ ||+||||||+|||++.++.+||+|||+|+.....   
T Consensus       112 Ey~~gG~L~~~i~--~~~~l~e~~~~~~~~qi~~al~ylH~~-~IiHRDlKPeNILl~~~g~vKl~DFGla~~~~~~~~~  188 (311)
T 4aw0_A          112 SYAKNGELLKYIR--KIGSFDETCTRFYTAEIVSALEYLHGK-GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQ  188 (311)
T ss_dssp             CCCTTEEHHHHHH--HHSSCCHHHHHHHHHHHHHHHHHHHHT-TEECSCCSGGGEEECTTSCEEECCCTTCEECCTTTTC
T ss_pred             ecCCCCCHHHHHH--HcCCCCHHHHHHHHHHHHHHHHHHHHC-CCccCCCCHHHeEEcCCCCEEEEEcCCceecCCCCCc
Confidence            9999999999997  346799999999999999999999999 9999999999999999999999999999865432   


Q ss_pred             ---CCccCcccccCcccccCCCCCCcccchhhhHHHHHHHhCCCCCCchhhHHHhhhchhhhccccccCCCChHHHHHHH
Q 020221          210 ---RSYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELV  286 (329)
Q Consensus       210 ---~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  286 (329)
                         .+..||+.|||||++.+..|+.++||||+||++|||++|..||.......+.......      ...++...++++.
T Consensus       189 ~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~------~~~~p~~~s~~~~  262 (311)
T 4aw0_A          189 ARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEGLIFAKIIKL------EYDFPEKFFPKAR  262 (311)
T ss_dssp             CCBCCCCSCGGGCCHHHHHHSCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHT------CCCCCTTCCHHHH
T ss_pred             ccccCcccCcccCCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcC------CCCCCcccCHHHH
Confidence               2457999999999999999999999999999999999999999766544433332221      1234566788999


Q ss_pred             HHHHHhcccCCCCCCCHHHHHH
Q 020221          287 RLASRCLQYEPRERPNPRSLVT  308 (329)
Q Consensus       287 ~li~~cl~~dp~~Rps~~~~l~  308 (329)
                      +|+.+||..||++|||+.|++.
T Consensus       263 dli~~lL~~dp~~R~t~~e~~~  284 (311)
T 4aw0_A          263 DLVEKLLVLDATKRLGCEEMEG  284 (311)
T ss_dssp             HHHHHHSCSSGGGSTTSGGGTC
T ss_pred             HHHHHHccCCHhHCcChHHHcC
Confidence            9999999999999999998753

>3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A

Probab=100.00  E-value=1.2e-59  Score=406.68  Aligned_cols=243  Identities=19%  Similarity=0.255  Sum_probs=196.7

Q ss_pred             CCcccccccCCCCCCcEEEEEE-eCCCCEEEEEEeCCCCC---hhHHHHHHHHHHHhcCCCccccccceeeeeCCeeEEE
Q 020221           56 FAMENIVSEHGEKAPNVVYKGK-LENQFRIAVKRFNRSAW---PDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLV  131 (329)
Q Consensus        56 ~~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv  131 (329)
                      ...|++++.||+|+||+||+|. ..+++.||+|++.....   .....+.+|+++++.++|||||++++++.+.+..++|
T Consensus        12 ig~Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv   91 (275)
T 3hyh_A           12 IGNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIKSKDEIIMV   91 (275)
T ss_dssp             --CCEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred             eeCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEE
Confidence            3568888999999999999999 56789999999976432   2345689999999999999999999999999999999


Q ss_pred             EecCCCCCHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCCCCCeeeecccCcccCCCC--
Q 020221          132 AEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDG--  209 (329)
Q Consensus       132 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~--  209 (329)
                      |||+ +|+|.+++.+  ...+++.++..++.||+.||+|||++ ||+||||||+|||++.++.+||+|||+|+.....  
T Consensus        92 mEy~-~g~L~~~l~~--~~~l~e~~~~~~~~qi~~al~ylH~~-~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~~~  167 (275)
T 3hyh_A           92 IEYA-GNELFDYIVQ--RDKMSEQEARRFFQQIISAVEYCHRH-KIVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGNF  167 (275)
T ss_dssp             EECC-CEEHHHHHHH--SCSCCHHHHHHHHHHHHHHHHHHHHT-TCCCCCCCTTTEEECTTCCEEECCSSCC--------
T ss_pred             EeCC-CCCHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHC-CcccccCChHHeEECCCCCEEEeecCCCeecCCCCc
Confidence            9999 6799999873  46799999999999999999999999 9999999999999999999999999999865543  


Q ss_pred             -CCccCcccccCcccccCCCC-CCcccchhhhHHHHHHHhCCCCCCchhhHHHhhhchhhhccccccCCCChHHHHHHHH
Q 020221          210 -RSYSTNLAFTPPEYLRTGRV-TPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVR  287 (329)
Q Consensus       210 -~~~~~~~~y~aPE~~~~~~~-~~~~DvwslG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  287 (329)
                       ....||+.|+|||++.+..+ +.++||||+||++|+|+||+.||...............      ...++...++++.+
T Consensus       168 ~~~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~~~~~~~~~~i~~~------~~~~p~~~s~~~~~  241 (275)
T 3hyh_A          168 LKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDESIPVLFKNISNG------VYTLPKFLSPGAAG  241 (275)
T ss_dssp             -------CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHT------CCCCCTTSCHHHHH
T ss_pred             cCCeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcC------CCCCCCCCCHHHHH
Confidence             34579999999999998876 57999999999999999999999776544333322221      12345567889999


Q ss_pred             HHHHhcccCCCCCCCHHHHHH
Q 020221          288 LASRCLQYEPRERPNPRSLVT  308 (329)
Q Consensus       288 li~~cl~~dp~~Rps~~~~l~  308 (329)
                      |+.+||+.||++|||+.|+++
T Consensus       242 li~~~L~~dP~~R~s~~eil~  262 (275)
T 3hyh_A          242 LIKRMLIVNPLNRISIHEIMQ  262 (275)
T ss_dssp             HHHHHSCSSGGGSCCHHHHHH
T ss_pred             HHHHHccCChhHCcCHHHHHc
Confidence            999999999999999999998

>3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus}

Probab=100.00  E-value=1.7e-59  Score=409.22  Aligned_cols=241  Identities=19%  Similarity=0.252  Sum_probs=197.8

Q ss_pred             cccccCCCCCCcEEEEEE-eCCCCEEEEEEeCCCC--ChhHHHHHHHHHHHhcCCCccccccceeeee----CCeeEEEE
Q 020221           60 NIVSEHGEKAPNVVYKGK-LENQFRIAVKRFNRSA--WPDARQFLEEARAVGQLRNRRLANLLGCCCE----GDERLLVA  132 (329)
Q Consensus        60 ~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~----~~~~~lv~  132 (329)
                      ++.++||+|+||+||+|. ..++..||+|++....  ....+.+.+|+++++.++|||||++++++.+    ...++|||
T Consensus        29 ~~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~lvm  108 (290)
T 3fpq_A           29 KFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVT  108 (290)
T ss_dssp             EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEETTEEEEEEEE
T ss_pred             EeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEeeccCCCcEEEEEE
Confidence            455668999999999999 4568899999997543  2235668999999999999999999999865    34689999


Q ss_pred             ecCCCCCHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCC--ccccccCCCceeeC-CCCCeeeecccCcccCCCC
Q 020221          133 EYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKER--ALYHDLNAYRIVFD-DDVNPRLSCFGLMKNSRDG  209 (329)
Q Consensus       133 e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~--ivH~dlkp~Nil~~-~~~~~kl~Dfg~a~~~~~~  209 (329)
                      |||++|+|.+++.  ....+++..+..++.||+.||+|||++ +  |+||||||+|||++ .++.+||+|||+|+.....
T Consensus       109 Ey~~gg~L~~~l~--~~~~l~~~~~~~~~~qi~~aL~ylH~~-~~~IiHRDlKp~NILl~~~~g~vKl~DFGla~~~~~~  185 (290)
T 3fpq_A          109 ELMTSGTLKTYLK--RFKVMKIKVLRSWCRQILKGLQFLHTR-TPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRAS  185 (290)
T ss_dssp             ECCCSCBHHHHHH--HHSSCCHHHHHHHHHHHHHHHHHHHTS-SSCCCCCCCCGGGEEESSTTSCEEECCTTGGGGCCTT
T ss_pred             eCCCCCCHHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHHC-CCCEEecccChhheeEECCCCCEEEEeCcCCEeCCCC
Confidence            9999999999997  346799999999999999999999998 7  99999999999998 4899999999999865443


Q ss_pred             --CCccCcccccCcccccCCCCCCcccchhhhHHHHHHHhCCCCCCchhh-HHHhhhchhhhccccccCCCChHHHHHHH
Q 020221          210 --RSYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHAL-DLIRDRNIQTLTDSCLEGQFSSDEGTELV  286 (329)
Q Consensus       210 --~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  286 (329)
                        ....||+.|||||++.+ .|+.++|||||||++|||+||+.||..... ..+.........    ....+...++++.
T Consensus       186 ~~~~~~GTp~YmAPE~~~~-~y~~~~DiwSlGvilyelltg~~Pf~~~~~~~~~~~~i~~~~~----~~~~~~~~~~~~~  260 (290)
T 3fpq_A          186 FAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVK----PASFDKVAIPEVK  260 (290)
T ss_dssp             SBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTCC----CGGGGGCCCHHHH
T ss_pred             ccCCcccCccccCHHHcCC-CCCcHHHHHHHHHHHHHHHHCCCCCCCCCcHHHHHHHHHcCCC----CCCCCccCCHHHH
Confidence              34579999999999875 699999999999999999999998864321 112111111111    1122334567899


Q ss_pred             HHHHHhcccCCCCCCCHHHHHH
Q 020221          287 RLASRCLQYEPRERPNPRSLVT  308 (329)
Q Consensus       287 ~li~~cl~~dp~~Rps~~~~l~  308 (329)
                      +|+.+||+.||++|||+.++++
T Consensus       261 ~li~~~L~~dP~~R~s~~e~l~  282 (290)
T 3fpq_A          261 EIIEGCIRQNKDERYSIKDLLN  282 (290)
T ss_dssp             HHHHHHSCSSGGGSCCHHHHHT
T ss_pred             HHHHHHccCChhHCcCHHHHhc
Confidence            9999999999999999999998

>3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A*

Probab=100.00  E-value=1.5e-59  Score=411.48  Aligned_cols=243  Identities=17%  Similarity=0.188  Sum_probs=200.6

Q ss_pred             CcccccccCCCCCCcEEEEEEe----CCCCEEEEEEeCCCCC--hhHHHHHHHHHHHhcCCCccccccceeeeeCCeeEE
Q 020221           57 AMENIVSEHGEKAPNVVYKGKL----ENQFRIAVKRFNRSAW--PDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLL  130 (329)
Q Consensus        57 ~~~~~~~~lg~G~~g~V~~~~~----~~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l  130 (329)
                      ++|++++.||+|+||+||+|+.    .+++.||+|+++....  .....+.+|+++|+.++|||||++++++.+++.+++
T Consensus        24 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~i  103 (304)
T 3ubd_A           24 SQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKLHYAFQTEGKLYL  103 (304)
T ss_dssp             GGEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEEECC------CCCCCCCCTTEECEEEEEEETTEEEE
T ss_pred             cccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEE
Confidence            4588999999999999999984    2468899999975431  223457889999999999999999999999999999


Q ss_pred             EEecCCCCCHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCCCCCeeeecccCcccCCCC-
Q 020221          131 VAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDG-  209 (329)
Q Consensus       131 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~-  209 (329)
                      |||||++|+|.+++.  +...+++.++..++.||+.||+|||++ ||+||||||+|||++.++.+||+|||+|+..... 
T Consensus       104 vmEy~~gg~L~~~l~--~~~~l~e~~~~~~~~qi~~aL~ylH~~-~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~  180 (304)
T 3ubd_A          104 ILDFLRGGDLFTRLS--KEVMFTEEDVKFYLAELALALDHLHSL-GIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHE  180 (304)
T ss_dssp             EECCCTTCEEHHHHH--HHCCCCHHHHHHHHHHHHHHHHHHHHT-TCCCSSCCGGGEEECTTSCEEEESSEEEEC-----
T ss_pred             EEEcCCCCCHHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHHC-CCcCCCCCHHHeEEcCCCCEEecccccceeccCCC
Confidence            999999999999997  345799999999999999999999999 9999999999999999999999999999864332 


Q ss_pred             ---CCccCcccccCcccccCCCCCCcccchhhhHHHHHHHhCCCCCCchhhHHHhhhchhhhccccccCCCChHHHHHHH
Q 020221          210 ---RSYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELV  286 (329)
Q Consensus       210 ---~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  286 (329)
                         ....||+.|||||++.+..|+.++|||||||++|||+||..||...............      ...+|..+|+++.
T Consensus       181 ~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~------~~~~p~~~s~~~~  254 (304)
T 3ubd_A          181 KKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDRKETMTMILKA------KLGMPQFLSPEAQ  254 (304)
T ss_dssp             CCCCSCCCCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHC------CCCCCTTSCHHHH
T ss_pred             ccccccccCcccCCHHHhccCCCCCCCcccchHHHHHHHHhCCCCCCCcCHHHHHHHHHcC------CCCCCCcCCHHHH
Confidence               3467999999999999999999999999999999999999999766544333322221      1234566788999


Q ss_pred             HHHHHhcccCCCCCCCH-----HHHHH
Q 020221          287 RLASRCLQYEPRERPNP-----RSLVT  308 (329)
Q Consensus       287 ~li~~cl~~dp~~Rps~-----~~~l~  308 (329)
                      +|+.+||+.||++|||+     +++++
T Consensus       255 ~li~~~L~~dP~~R~ta~~~~~~eil~  281 (304)
T 3ubd_A          255 SLLRMLFKRNPANRLGAGPDGVEEIKR  281 (304)
T ss_dssp             HHHHHHTCSSGGGSTTCSTTTHHHHHT
T ss_pred             HHHHHHcccCHHHCCCCCcCCHHHHHc
Confidence            99999999999999985     56665

>4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A*

Probab=100.00  E-value=6.7e-58  Score=410.19  Aligned_cols=256  Identities=20%  Similarity=0.259  Sum_probs=212.0

Q ss_pred             CCcccccccCCCCCCcEEEEEEeCC------CCEEEEEEeCCCCCh-hHHHHHHHHHHHhcCCC-ccccccceeeeeC-C
Q 020221           56 FAMENIVSEHGEKAPNVVYKGKLEN------QFRIAVKRFNRSAWP-DARQFLEEARAVGQLRN-RRLANLLGCCCEG-D  126 (329)
Q Consensus        56 ~~~~~~~~~lg~G~~g~V~~~~~~~------~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h-~niv~~~~~~~~~-~  126 (329)
                      .+.+++.+.||+|+||+||+|.+.+      ++.||||.+...... ..+.+.+|+++|..++| ||||+++|+|.+. +
T Consensus        63 ~~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~~~~~~~~~~~E~~il~~l~hhpnIV~l~g~~~~~~~  142 (353)
T 4ase_A           63 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGG  142 (353)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECCTTS
T ss_pred             HHHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEccccChHHHHHHHHHHHHHHHcCCCCcEEEEEEEEEecCC
Confidence            4567888899999999999998432      367999999876543 35569999999999965 9999999998664 5


Q ss_pred             eeEEEEecCCCCCHHhhhccCC--------------CCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCCC
Q 020221          127 ERLLVAEYMPNDTLAKHLFHWE--------------TQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDD  192 (329)
Q Consensus       127 ~~~lv~e~~~~gsL~~~l~~~~--------------~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~  192 (329)
                      .+++|||||++|+|.++|+...              ...+++.++..++.||+.||+|||++ +||||||||+|||++++
T Consensus       143 ~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~~-~iiHRDLK~~NILl~~~  221 (353)
T 4ase_A          143 PLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR-KCIHRDLAARNILLSEK  221 (353)
T ss_dssp             CCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHHT-TCCCSCCSGGGEEECGG
T ss_pred             EEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhhC-CeecCccCccceeeCCC
Confidence            6899999999999999996421              23589999999999999999999999 99999999999999999


Q ss_pred             CCeeeecccCcccCCCCC------CccCcccccCcccccCCCCCCcccchhhhHHHHHHHh-CCCCCCchhhHHHhhhch
Q 020221          193 VNPRLSCFGLMKNSRDGR------SYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLS-GKHIPPSHALDLIRDRNI  265 (329)
Q Consensus       193 ~~~kl~Dfg~a~~~~~~~------~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t-g~~~~~~~~~~~~~~~~~  265 (329)
                      +.+||+|||+|+......      ...||+.|||||++.+..|+.++|||||||+||||+| |..||+........    
T Consensus       222 ~~vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~y~~ksDVwS~Gv~l~El~t~G~~Pf~~~~~~~~~----  297 (353)
T 4ase_A          222 NVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEF----  297 (353)
T ss_dssp             GCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHH----
T ss_pred             CCEEECcchhhhhcccCCCceeeccccccccccCHHHHhcCCCCCcccEeehHHHHHHHHhCCCCCCCCCCHHHHH----
Confidence            999999999998764432      2357889999999999999999999999999999998 78887653321111    


Q ss_pred             hhhccccccCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhhc
Q 020221          266 QTLTDSCLEGQFSSDEGTELVRLASRCLQYEPRERPNPRSLVTALVTLQKD  316 (329)
Q Consensus       266 ~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~~~l~~L~~~~~~  316 (329)
                      ...+....+...|..+++++.+++.+||+.||++|||+.+|+++|+++.+.
T Consensus       298 ~~~i~~g~~~~~p~~~~~~~~~li~~c~~~dP~~RPt~~eil~~L~~llq~  348 (353)
T 4ase_A          298 CRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQA  348 (353)
T ss_dssp             HHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             HHHHHcCCCCCCCccCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHHHH
Confidence            111222233445667788999999999999999999999999999998764

>4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A*

Probab=100.00  E-value=3.5e-56  Score=391.31  Aligned_cols=240  Identities=18%  Similarity=0.266  Sum_probs=188.3

Q ss_pred             cccccccCCCCCCcEEEEEE-eCCCCEEEEEEeCCCCCh-hHHHHHHHHHHHhcCCCccccccceeeeeCC---------
Q 020221           58 MENIVSEHGEKAPNVVYKGK-LENQFRIAVKRFNRSAWP-DARQFLEEARAVGQLRNRRLANLLGCCCEGD---------  126 (329)
Q Consensus        58 ~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~---------  126 (329)
                      +|++++.||+|+||+||+|. ..+++.||||+++..... ..+.+.+|+++|+.++|||||++++++.+.+         
T Consensus         6 dy~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~~~   85 (299)
T 4g31_A            6 DFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQPSS   85 (299)
T ss_dssp             HEEEEEEEEECC--EEEEEEETTTCCEEEEEEEEECSSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC---------
T ss_pred             hCEEeeEEecCCCeEEEEEEECCCCCEEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCccccccccC
Confidence            47788889999999999999 567899999999765433 3456899999999999999999999986544         


Q ss_pred             ---eeEEEEecCCCCCHHhhhccCCC-CCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCCCCCeeeecccC
Q 020221          127 ---ERLLVAEYMPNDTLAKHLFHWET-QPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGL  202 (329)
Q Consensus       127 ---~~~lv~e~~~~gsL~~~l~~~~~-~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~  202 (329)
                         .+|+|||||++|+|.+++..... ...++..++.++.||+.||+|||++ ||+||||||+|||++.++.+||+|||+
T Consensus        86 ~~~~l~ivmE~~~gg~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~ylH~~-~IiHRDlKp~NILl~~~~~vKl~DFGl  164 (299)
T 4g31_A           86 PKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSK-GLMHRDLKPSNIFFTMDDVVKVGDFGL  164 (299)
T ss_dssp             -CEEEEEEEECCCSCCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHHHT-TCCCCCCCGGGEEECTTCCEEECCCCC
T ss_pred             CCcEEEEEEecCCCCcHHHHHHhcCCCChhHHHHHHHHHHHHHHHHHHHHHC-cCccccCcHHHeEECCCCcEEEccCcc
Confidence               37899999999999999974322 2346677899999999999999999 999999999999999999999999999


Q ss_pred             cccCCCCC----------------CccCcccccCcccccCCCCCCcccchhhhHHHHHHHhCCCCCCchhhHHHhhhchh
Q 020221          203 MKNSRDGR----------------SYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQ  266 (329)
Q Consensus       203 a~~~~~~~----------------~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~~~~~~~  266 (329)
                      |+......                ...||+.|||||++.+..|+.++|||||||++|||++   ||...... .  ....
T Consensus       165 a~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyell~---Pf~~~~~~-~--~~~~  238 (299)
T 4g31_A          165 VTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY---PFSTQMER-V--RTLT  238 (299)
T ss_dssp             C--------------------------CCCTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHS---CCSSHHHH-H--HHHH
T ss_pred             ceecCCCccccccccccccccccCCcccCccccCHHHHcCCCCCCHHHHHHHHHHHHHHcc---CCCCccHH-H--HHHH
Confidence            98654321                2368999999999999999999999999999999996   55433211 1  0111


Q ss_pred             hhccccccCCCC---hHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 020221          267 TLTDSCLEGQFS---SDEGTELVRLASRCLQYEPRERPNPRSLVT  308 (329)
Q Consensus       267 ~~~~~~~~~~~~---~~~~~~~~~li~~cl~~dp~~Rps~~~~l~  308 (329)
                      .+.    ...++   ...++.+.+|+.+||+.||++|||+.++++
T Consensus       239 ~~~----~~~~p~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~  279 (299)
T 4g31_A          239 DVR----NLKFPPLFTQKYPCEYVMVQDMLSPSPMERPEAINIIE  279 (299)
T ss_dssp             HHH----TTCCCHHHHHHCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             HHh----cCCCCCCCcccCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence            111    11222   334567889999999999999999999987

>3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A*

Probab=100.00  E-value=1.3e-56  Score=395.66  Aligned_cols=255  Identities=15%  Similarity=0.161  Sum_probs=196.0

Q ss_pred             ccccccCCCCCCcEEEEEEeCCCCEEEEEEeCCCCChhHHHHHHHHHHHhcCCCccccccceeeeeCC----eeEEEEec
Q 020221           59 ENIVSEHGEKAPNVVYKGKLENQFRIAVKRFNRSAWPDARQFLEEARAVGQLRNRRLANLLGCCCEGD----ERLLVAEY  134 (329)
Q Consensus        59 ~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~----~~~lv~e~  134 (329)
                      +.+.+.||+|+||+||+|.+ +|+.||||++..... .......|+..+..++|||||++++++.+++    .++|||||
T Consensus         5 i~L~~~iG~G~fG~Vy~~~~-~g~~VAvK~l~~~~~-~~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~~~~~~~lV~Ey   82 (303)
T 3hmm_A            5 IVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSREE-RSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSDY   82 (303)
T ss_dssp             EEEEEEEEECSSSEEEEEEE-TTEEEEEEEECGGGH-HHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEEEC
T ss_pred             EEEEEEEeeCCCeEEEEEEE-CCEEEEEEEECccch-hhHHHHHHHHHHhcCCCCCCCcEEEEEEecCCCceEEEEEecC
Confidence            45567789999999999998 578999999975431 1222345666667889999999999997654    57999999


Q ss_pred             CCCCCHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcC-------CCccccccCCCceeeCCCCCeeeecccCcccCC
Q 020221          135 MPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSK-------ERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSR  207 (329)
Q Consensus       135 ~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~-------~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~  207 (329)
                      |++|+|.+++.+   ..+++..+.+++.|++.||+|||++       .+|+||||||+|||++.++++||+|||+|+...
T Consensus        83 ~~~gsL~~~l~~---~~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~  159 (303)
T 3hmm_A           83 HEHGSLFDYLNR---YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHD  159 (303)
T ss_dssp             CTTCBHHHHHHH---CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCTTCEEEE
T ss_pred             CCCCcHHHHHHh---CCCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCCEEEEeCCCCcccc
Confidence            999999999953   5699999999999999999999964       289999999999999999999999999997654


Q ss_pred             CCC--------CccCcccccCcccccCC------CCCCcccchhhhHHHHHHHhCCCCCCchhhH-----------HHhh
Q 020221          208 DGR--------SYSTNLAFTPPEYLRTG------RVTPESVMYSFGTLLLDLLSGKHIPPSHALD-----------LIRD  262 (329)
Q Consensus       208 ~~~--------~~~~~~~y~aPE~~~~~------~~~~~~DvwslG~il~el~tg~~~~~~~~~~-----------~~~~  262 (329)
                      ...        ...||+.|+|||++.+.      .++.++|||||||++|||+||..|+......           ....
T Consensus       160 ~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~~~~~~~p~~~~~~~~~~~~  239 (303)
T 3hmm_A          160 SATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVE  239 (303)
T ss_dssp             TTTTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSSCCHH
T ss_pred             CCCCceeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCCccccccccchhcccccchHH
Confidence            322        24689999999999764      3677999999999999999998654321000           0000


Q ss_pred             hchhhhccccccCCCC-----hHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhhccc
Q 020221          263 RNIQTLTDSCLEGQFS-----SDEGTELVRLASRCLQYEPRERPNPRSLVTALVTLQKDTE  318 (329)
Q Consensus       263 ~~~~~~~~~~~~~~~~-----~~~~~~~~~li~~cl~~dp~~Rps~~~~l~~L~~~~~~~~  318 (329)
                      .....+.....++..+     .+.+..+.+|+.+||+.||++||||.+|++.|+++.+...
T Consensus       240 ~~~~~~~~~~~rp~~p~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~~l~~~~~  300 (303)
T 3hmm_A          240 EMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQEG  300 (303)
T ss_dssp             HHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHHHC--
T ss_pred             HHHHHHhcccCCCCCCccccchHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHHHcC
Confidence            0111112222222232     3466789999999999999999999999999999987644

>4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens}

Probab=100.00  E-value=1.1e-54  Score=395.78  Aligned_cols=248  Identities=15%  Similarity=0.249  Sum_probs=200.7

Q ss_pred             CcccccccCCCCCCcEEEEEE-eCCCCEEEEEEeCCCCC--hhHHHHHHHHHHHhcCCCccccccceeeee------CCe
Q 020221           57 AMENIVSEHGEKAPNVVYKGK-LENQFRIAVKRFNRSAW--PDARQFLEEARAVGQLRNRRLANLLGCCCE------GDE  127 (329)
Q Consensus        57 ~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~~~~~~~~------~~~  127 (329)
                      +.|++++.||+|+||+||+|. ..+|+.||||+++....  ...+.+.+|+++|+.++|||||++++++..      .+.
T Consensus        54 ~~Y~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~~  133 (398)
T 4b99_A           54 DEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGEFKS  133 (398)
T ss_dssp             SSEEEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTTTCCC
T ss_pred             CCeEEEEEEecccCeEEEEEEECCCCCEEEEEEECccccchHHHHHHHHHHHHHHhcCCCCcceEeeeeecccccccCCE
Confidence            358899999999999999999 56799999999976542  234568899999999999999999998754      357


Q ss_pred             eEEEEecCCCCCHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCCCCCeeeecccCcccCC
Q 020221          128 RLLVAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSR  207 (329)
Q Consensus       128 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~  207 (329)
                      +|||||||+ |+|.+++.  ....+++.++..++.||+.||.|||++ ||+||||||+|||++.++.+||+|||+|+...
T Consensus       134 ~~ivmE~~~-g~L~~~i~--~~~~l~~~~~~~~~~qil~al~ylH~~-~iiHRDlKP~NIl~~~~~~~Ki~DFGla~~~~  209 (398)
T 4b99_A          134 VYVVLDLME-SDLHQIIH--SSQPLTLEHVRYFLYQLLRGLKYMHSA-QVIHRDLKPSNLLVNENCELKIGDFGMARGLC  209 (398)
T ss_dssp             EEEEEECCS-EEHHHHHT--SSSCCCHHHHHHHHHHHHHHHHHHHHT-TCBCCCCCGGGEEECTTCCEEECCCTTCBCC-
T ss_pred             EEEEEeCCC-CCHHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHHC-cCcCCCcCccccccCCCCCEEEeecceeeecc
Confidence            899999996 57999986  456899999999999999999999999 99999999999999999999999999998643


Q ss_pred             C--------CCCccCcccccCcccccCCC-CCCcccchhhhHHHHHHHhCCCCCCchhhHHHhhhchhhhcccc------
Q 020221          208 D--------GRSYSTNLAFTPPEYLRTGR-VTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSC------  272 (329)
Q Consensus       208 ~--------~~~~~~~~~y~aPE~~~~~~-~~~~~DvwslG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~------  272 (329)
                      .        .....||+.|+|||++.+.. ++.++||||+||++|||++|..||..................+.      
T Consensus       210 ~~~~~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF~g~~~~~~l~~I~~~~g~p~~~~~~~  289 (398)
T 4b99_A          210 TSPAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNYVHQLQLIMMVLGTPSPAVIQA  289 (398)
T ss_dssp             ------CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCGGGTC-
T ss_pred             cCccccccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCChHHhhh
Confidence            2        23467999999999988764 78999999999999999999999876533222111111000000      


Q ss_pred             ------------ccCC-------CChHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 020221          273 ------------LEGQ-------FSSDEGTELVRLASRCLQYEPRERPNPRSLVT  308 (329)
Q Consensus       273 ------------~~~~-------~~~~~~~~~~~li~~cl~~dp~~Rps~~~~l~  308 (329)
                                  ....       .....++++.+|+.+||..||++|||+.++++
T Consensus       290 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~  344 (398)
T 4b99_A          290 VGAERVRAYIQSLPPRQPVPWETVYPGADRQALSLLGRMLRFEPSARISAAAALR  344 (398)
T ss_dssp             ----CHHHHHHSSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred             hhhhhhhhhhhcCCCcCCCCHHHhCCCCCHHHHHHHHHHCcCChhHCcCHHHHhc
Confidence                        0000       01234678999999999999999999999998

>4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A*

Probab=100.00  E-value=9.9e-54  Score=385.36  Aligned_cols=243  Identities=19%  Similarity=0.226  Sum_probs=195.5

Q ss_pred             cccccccCCCCCCcEEEEEEe----CCCCEEEEEEeCCCCChhHHHHHHHHHHHhcC-CCccccccceeeeeCCeeEEEE
Q 020221           58 MENIVSEHGEKAPNVVYKGKL----ENQFRIAVKRFNRSAWPDARQFLEEARAVGQL-RNRRLANLLGCCCEGDERLLVA  132 (329)
Q Consensus        58 ~~~~~~~lg~G~~g~V~~~~~----~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~lv~  132 (329)
                      .|++++.||+|+||+||+|+.    .+++.||+|++....  ....+.+|+++|+.+ .||||+++++++.+.+++++||
T Consensus        22 ~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~--~~~~~~~E~~~l~~~~~h~nIv~l~~~~~~~~~~~lvm   99 (361)
T 4f9c_A           22 VFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPTS--HPIRIAAELQCLTVAGGQDNVMGVKYCFRKNDHVVIAM   99 (361)
T ss_dssp             TCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTTS--CHHHHHHHHHHHHHTCSBTTBCCCSEEEEETTEEEEEE
T ss_pred             cEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEcccc--CHHHHHHHHHHHHHhcCCCCCceEEEEEEECCEEEEEE
Confidence            478888999999999999974    246789999987654  345688999999998 6999999999999999999999


Q ss_pred             ecCCCCCHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCCC-CCeeeecccCcccCCCC--
Q 020221          133 EYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDD-VNPRLSCFGLMKNSRDG--  209 (329)
Q Consensus       133 e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~-~~~kl~Dfg~a~~~~~~--  209 (329)
                      ||+++|+|.+++.     .+++.++..++.||+.||+|||++ ||+||||||+|||++.+ +.+||+|||+|+...+.  
T Consensus       100 E~~~g~~L~~~~~-----~l~~~~~~~~~~qll~al~ylH~~-gIiHRDiKPeNiLl~~~~~~~kl~DFGla~~~~~~~~  173 (361)
T 4f9c_A          100 PYLEHESFLDILN-----SLSFQEVREYMLNLFKALKRIHQF-GIVHRDVKPSNFLYNRRLKKYALVDFGLAQGTHDTKI  173 (361)
T ss_dssp             ECCCCCCHHHHHT-----TCCHHHHHHHHHHHHHHHHHHHHT-TEECSCCSGGGEEEETTTTEEEECCCTTCEECTTCSC
T ss_pred             eCCCcccHHHHHc-----CCCHHHHHHHHHHHHHHHHHHHHC-CeEeCcCCHHHeEEeCCCCeEEECcCCCCcccCCccc
Confidence            9999999999983     489999999999999999999999 99999999999999876 79999999999754332  


Q ss_pred             ------------------------------CCccCcccccCcccccCCC-CCCcccchhhhHHHHHHHhCCCCCCchhhH
Q 020221          210 ------------------------------RSYSTNLAFTPPEYLRTGR-VTPESVMYSFGTLLLDLLSGKHIPPSHALD  258 (329)
Q Consensus       210 ------------------------------~~~~~~~~y~aPE~~~~~~-~~~~~DvwslG~il~el~tg~~~~~~~~~~  258 (329)
                                                    .+..||+.|+|||++.+.. ++.++||||+||++|||++|+.||.....+
T Consensus       174 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~il~ell~G~~Pf~~~~~~  253 (361)
T 4f9c_A          174 ELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLLSGRYPFYKASDD  253 (361)
T ss_dssp             GGGGGC--------------------------CCCCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSH
T ss_pred             cccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccchhhhHHHHHHHHHCCCCCCCCCCH
Confidence                                          1236899999999998764 899999999999999999999988543211


Q ss_pred             HHhhhchhh-------------------------------hcc------------------ccccCCCChHHHHHHHHHH
Q 020221          259 LIRDRNIQT-------------------------------LTD------------------SCLEGQFSSDEGTELVRLA  289 (329)
Q Consensus       259 ~~~~~~~~~-------------------------------~~~------------------~~~~~~~~~~~~~~~~~li  289 (329)
                      ...-..+..                               ...                  ...........++++.+|+
T Consensus       254 ~~~l~~I~~~~G~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~is~~a~DLl  333 (361)
T 4f9c_A          254 LTALAQIMTIRGSRETIQAAKTFGKSILCSKEVPAQDLRKLCERLRGMDSSTPKLTSDIQGHATNLEGWNEVPDEAYDLL  333 (361)
T ss_dssp             HHHHHHHHHHHCHHHHHHHHHHTTEEEEESSCCCCCCHHHHHHHHC----------------------CTTCCHHHHHHH
T ss_pred             HHHHHHHHHhcCCccchhhhhhccccccccccCcchhhhHHHHhhccccccccccccccccccccccccccCCHHHHHHH
Confidence            100000000                               000                  0000011123567899999


Q ss_pred             HHhcccCCCCCCCHHHHHH
Q 020221          290 SRCLQYEPRERPNPRSLVT  308 (329)
Q Consensus       290 ~~cl~~dp~~Rps~~~~l~  308 (329)
                      .+||..||++|||++|+++
T Consensus       334 ~~lL~~dP~~R~ta~eaL~  352 (361)
T 4f9c_A          334 DKLLDLNPASRITAEEALL  352 (361)
T ss_dssp             HHHTCSCTTTSCCHHHHHT
T ss_pred             HHHCcCChhHCcCHHHHhc
Confidence            9999999999999999998

>3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A

Probab=100.00  E-value=1e-53  Score=407.05  Aligned_cols=248  Identities=19%  Similarity=0.156  Sum_probs=211.9

Q ss_pred             CcccccccCCCCCCcEEEEEE-eCCCCEEEEEEeCCCCChhHHHHHHHHHHHhcCCCccccccceeeeeCCeeEEEEecC
Q 020221           57 AMENIVSEHGEKAPNVVYKGK-LENQFRIAVKRFNRSAWPDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAEYM  135 (329)
Q Consensus        57 ~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~  135 (329)
                      +.|++++.||+|+||+||+|. ..+|+.||+|++........+.+.+|+++|+.++|||||++++++.+...++||||||
T Consensus       157 ~~Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iv~E~~  236 (573)
T 3uto_A          157 DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFM  236 (573)
T ss_dssp             GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEECSSEEEEEEECC
T ss_pred             cccEEEEEEeeccCeEEEEEEECCCCCEEEEEEEeccchhhHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeec
Confidence            457888999999999999999 5678999999998776566677899999999999999999999999999999999999


Q ss_pred             CCCCHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCCC--CCeeeecccCcccCCCCC---
Q 020221          136 PNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDD--VNPRLSCFGLMKNSRDGR---  210 (329)
Q Consensus       136 ~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~--~~~kl~Dfg~a~~~~~~~---  210 (329)
                      ++|+|.+++.+ ....+++.++..++.||+.||.|||++ +|+||||||+|||++.+  +.+||+|||+|+......   
T Consensus       237 ~gg~L~~~i~~-~~~~l~e~~~~~~~~qi~~al~ylH~~-~iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~~~~~~~~~  314 (573)
T 3uto_A          237 SGGELFEKVAD-EHNKMSEDEAVEYMRQVCKGLCHMHEN-NYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVK  314 (573)
T ss_dssp             CCCBHHHHHTC-TTSCEEHHHHHHHHHHHHHHHHHHHHT-TEECCCCCGGGEEESSSSCCCEEECCCSSCEECCTTSEEE
T ss_pred             CCCcHHHHHHH-hCCCCCHHHHHHHHHHHHHHHHHHHHC-CeeeccCChhhccccCCCCCCEEEeeccceeEccCCCcee
Confidence            99999999864 345799999999999999999999999 99999999999999854  899999999998876553   


Q ss_pred             CccCcccccCcccccCCCCCCcccchhhhHHHHHHHhCCCCCCchhhHHHhhhchhhhccccccCCCChHHHHHHHHHHH
Q 020221          211 SYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLAS  290 (329)
Q Consensus       211 ~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~  290 (329)
                      ...||+.|+|||++.+..|+.++|||||||++|||++|..||..................  ........+++++.+||.
T Consensus       315 ~~~GT~~y~APEv~~~~~y~~~~DiWSlGvilyeml~G~~Pf~~~~~~~~~~~i~~~~~~--~~~~~~~~~s~~~~dli~  392 (573)
T 3uto_A          315 VTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWN--MDDSAFSGISEDGKDFIR  392 (573)
T ss_dssp             EECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCCC--CCSGGGTTSCHHHHHHHH
T ss_pred             eeEECccccCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHhCCCC--CCcccccCCCHHHHHHHH
Confidence            347899999999999999999999999999999999999998765443333222211111  111122456789999999


Q ss_pred             HhcccCCCCCCCHHHHHH
Q 020221          291 RCLQYEPRERPNPRSLVT  308 (329)
Q Consensus       291 ~cl~~dp~~Rps~~~~l~  308 (329)
                      +||..||++|||+.++++
T Consensus       393 ~~L~~dp~~R~t~~e~l~  410 (573)
T 3uto_A          393 KLLLADPNTRMTIHQALE  410 (573)
T ss_dssp             TTSCSSGGGSCCHHHHHH
T ss_pred             HHccCChhHCcCHHHHhc
Confidence            999999999999999998

>3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A

Probab=100.00  E-value=3e-53  Score=402.84  Aligned_cols=247  Identities=17%  Similarity=0.128  Sum_probs=202.6

Q ss_pred             CCcccccccCCCCCCcEEEEEE-eCCCCEEEEEEeCCCCC---hhHHHH---HHHHHHHhcCCCccccccceeeeeCCee
Q 020221           56 FAMENIVSEHGEKAPNVVYKGK-LENQFRIAVKRFNRSAW---PDARQF---LEEARAVGQLRNRRLANLLGCCCEGDER  128 (329)
Q Consensus        56 ~~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~---~~~~~~---~~e~~~l~~l~h~niv~~~~~~~~~~~~  128 (329)
                      ..+|++++.||+|+||+||+|. ..+|+.||||++.....   .....+   ..++.+++.++|||||++++++.+.+.+
T Consensus       188 lddf~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~~~~~l  267 (689)
T 3v5w_A          188 MNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKL  267 (689)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEE
T ss_pred             hHHeEEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEEEECCEE
Confidence            3568889999999999999999 56799999999964321   112223   3446677788999999999999999999


Q ss_pred             EEEEecCCCCCHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCCCCCeeeecccCcccCCC
Q 020221          129 LLVAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRD  208 (329)
Q Consensus       129 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~  208 (329)
                      ||||||++||+|.++|.  ....+++..+..++.||+.||.|||++ |||||||||+|||++.+|++||+|||+|+....
T Consensus       268 ylVmEy~~GGdL~~~l~--~~~~l~E~~a~~y~~qIl~aL~yLH~~-gIiHRDLKPeNILld~~G~vKL~DFGlA~~~~~  344 (689)
T 3v5w_A          268 SFILDLMNGGDLHYHLS--QHGVFSEADMRFYAAEIILGLEHMHNR-FVVYRDLKPANILLDEHGHVRISDLGLACDFSK  344 (689)
T ss_dssp             EEEECCCCSCBHHHHHH--HHCCCCHHHHHHHHHHHHHHHHHHHTT-TEECCCCSGGGEEECTTSCEEECCCTTCEECSS
T ss_pred             EEEEecCCCCcHHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHHC-CccccCCchHHeEEeCCCCEEecccceeeecCC
Confidence            99999999999999997  346799999999999999999999999 999999999999999999999999999987654


Q ss_pred             C--CCccCcccccCcccccC-CCCCCcccchhhhHHHHHHHhCCCCCCchhhHHHhhhchhhhccccccCCCChHHHHHH
Q 020221          209 G--RSYSTNLAFTPPEYLRT-GRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTEL  285 (329)
Q Consensus       209 ~--~~~~~~~~y~aPE~~~~-~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  285 (329)
                      .  .+.+||+.|||||++.+ ..|+.++|||||||++|||++|..||......... .....+..  ....++..+++++
T Consensus       345 ~~~~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~~~~~-~i~~~i~~--~~~~~p~~~S~~a  421 (689)
T 3v5w_A          345 KKPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKH-EIDRMTLT--MAVELPDSFSPEL  421 (689)
T ss_dssp             CCCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCGGGCCCHH-HHHHHHHH--CCCCCCTTSCHHH
T ss_pred             CCCCCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHH-HHHHhhcC--CCCCCCccCCHHH
Confidence            4  35689999999999975 56999999999999999999999998754321111 00111111  1224566788999


Q ss_pred             HHHHHHhcccCCCCCCC-----HHHHHH
Q 020221          286 VRLASRCLQYEPRERPN-----PRSLVT  308 (329)
Q Consensus       286 ~~li~~cl~~dp~~Rps-----~~~~l~  308 (329)
                      .+|+.+||..||++|++     +.+|++
T Consensus       422 ~dLI~~lL~~dP~~Rl~~~~~ga~ei~~  449 (689)
T 3v5w_A          422 RSLLEGLLQRDVNRRLGCLGRGAQEVKE  449 (689)
T ss_dssp             HHHHHHHTCSCGGGCTTCSSSTHHHHTT
T ss_pred             HHHHHHHccCCHhHCCCCCCCCHHHHhc
Confidence            99999999999999998     677776

>3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A*

Probab=100.00  E-value=7e-51  Score=358.89  Aligned_cols=247  Identities=17%  Similarity=0.239  Sum_probs=209.6

Q ss_pred             CCCcccccccCCCCCCcEEEEEE-eCCCCEEEEEEeCCCCChhHHHHHHHHHHHhcCCCccccccceeeeeCCeeEEEEe
Q 020221           55 GFAMENIVSEHGEKAPNVVYKGK-LENQFRIAVKRFNRSAWPDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAE  133 (329)
Q Consensus        55 ~~~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  133 (329)
                      ....|++++.||+|+||+||+|. ..+++.||+|++........+.+.+|+.+++.++||||+++++++..++..++|||
T Consensus        18 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e   97 (297)
T 3fxz_A           18 PKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVME   97 (297)
T ss_dssp             GGGTBCCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             hhhceeeeeeeccCCCeEEEEEEECCCCcEEEEEEeecccccHHHHHHHHHHHHhcCCCCCCCeEeEEEEECCEEEEEEE
Confidence            33557888889999999999999 56789999999976655567778999999999999999999999999999999999


Q ss_pred             cCCCCCHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCCCCCeeeecccCcccCCCC----
Q 020221          134 YMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDG----  209 (329)
Q Consensus       134 ~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~----  209 (329)
                      |+++|+|.+++.+   ..+++..+..++.|++.||.|||++ |++||||||+||+++.++.+||+|||++......    
T Consensus        98 ~~~~~~L~~~~~~---~~~~~~~~~~~~~qi~~~l~~lH~~-~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~  173 (297)
T 3fxz_A           98 YLAGGSLTDVVTE---TCMDEGQIAAVCRECLQALEFLHSN-QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKR  173 (297)
T ss_dssp             CCTTCBHHHHHHH---SCCCHHHHHHHHHHHHHHHHHHHHT-TEECCCCSGGGEEECTTCCEEECCCTTCEECCSTTCCB
T ss_pred             CCCCCCHHHHHhh---cCCCHHHHHHHHHHHHHHHHHHHhC-CceeCCCCHHHEEECCCCCEEEeeCCCceecCCccccc
Confidence            9999999999953   4689999999999999999999999 9999999999999999999999999998765433    


Q ss_pred             CCccCcccccCcccccCCCCCCcccchhhhHHHHHHHhCCCCCCchhhHHHhhhchhhhccccccCCCChHHHHHHHHHH
Q 020221          210 RSYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLA  289 (329)
Q Consensus       210 ~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li  289 (329)
                      ....||+.|+|||++.+..++.++||||||+++|+|++|..||...............   .......+...++.+.+++
T Consensus       174 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~li  250 (297)
T 3fxz_A          174 STMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATN---GTPELQNPEKLSAIFRDFL  250 (297)
T ss_dssp             CCCCSCGGGCCHHHHHCSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHH---CSCCCSCGGGSCHHHHHHH
T ss_pred             CCccCCcCccChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhC---CCCCCCCccccCHHHHHHH
Confidence            2346899999999999999999999999999999999999988654322211111111   1111223456788899999


Q ss_pred             HHhcccCCCCCCCHHHHHH
Q 020221          290 SRCLQYEPRERPNPRSLVT  308 (329)
Q Consensus       290 ~~cl~~dp~~Rps~~~~l~  308 (329)
                      .+||+.||++|||+.++++
T Consensus       251 ~~~l~~dp~~Rps~~ell~  269 (297)
T 3fxz_A          251 NRCLEMDVEKRGSAKELLQ  269 (297)
T ss_dssp             HHHSCSSTTTSCCHHHHTT
T ss_pred             HHHccCChhHCcCHHHHhh
Confidence            9999999999999999997

>3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A

Probab=100.00  E-value=1.9e-50  Score=360.80  Aligned_cols=245  Identities=20%  Similarity=0.294  Sum_probs=210.1

Q ss_pred             CCCcccccccCCCCCCcEEEEEEe-CCCCEEEEEEeCCCC--ChhHHHHHHHHHHHhcCCCccccccceeeeeCCeeEEE
Q 020221           55 GFAMENIVSEHGEKAPNVVYKGKL-ENQFRIAVKRFNRSA--WPDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLV  131 (329)
Q Consensus        55 ~~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv  131 (329)
                      ....|++++.||+|+||.||+|.. .+|+.||+|++....  ....+.+.+|+++++.++||||+++++++.+.+..++|
T Consensus        13 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv   92 (328)
T 3fe3_A           13 HIGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIETEKTLYLI   92 (328)
T ss_dssp             EETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred             ccCCEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEE
Confidence            345688889999999999999994 678999999997653  23356688999999999999999999999999999999


Q ss_pred             EecCCCCCHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCCCCCeeeecccCcccCCCC--
Q 020221          132 AEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDG--  209 (329)
Q Consensus       132 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~--  209 (329)
                      |||+++|+|.+++..  ...+++..+..++.|++.||+|||+. |++||||||+||+++.++.+||+|||++......  
T Consensus        93 ~e~~~~~~L~~~l~~--~~~l~~~~~~~~~~qi~~al~~lH~~-~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~  169 (328)
T 3fe3_A           93 MEYASGGEVFDYLVA--HGRMKEKEARSKFRQIVSAVQYCHQK-RIVHRDLKAENLLLDADMNIKIADFGFSNEFTVGGK  169 (328)
T ss_dssp             ECCCTTCBHHHHHHH--HCCCCHHHHHHHHHHHHHHHHHHHHT-TCCCSCCCGGGEEECTTSCEEECSTTCCGGGSSSCG
T ss_pred             EECCCCCcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHC-CEeccCCCHHHEEEcCCCCEEEeeccCceecCCCCc
Confidence            999999999999863  45699999999999999999999999 9999999999999999999999999999765543  


Q ss_pred             -CCccCcccccCcccccCCCCC-CcccchhhhHHHHHHHhCCCCCCchhhHHHhhhchhhhccccccCCCChHHHHHHHH
Q 020221          210 -RSYSTNLAFTPPEYLRTGRVT-PESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVR  287 (329)
Q Consensus       210 -~~~~~~~~y~aPE~~~~~~~~-~~~DvwslG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  287 (329)
                       ....||+.|+|||++.+..+. .++||||||+++|+|++|..||...............      ....+...++++.+
T Consensus       170 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~------~~~~p~~~s~~~~~  243 (328)
T 3fe3_A          170 LDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRG------KYRIPFYMSTDCEN  243 (328)
T ss_dssp             GGTTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHC------CCCCCTTSCHHHHH
T ss_pred             cccccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhC------CCCCCCCCCHHHHH
Confidence             345789999999999988865 6899999999999999999998776544443332221      11234556788999


Q ss_pred             HHHHhcccCCCCCCCHHHHHH
Q 020221          288 LASRCLQYEPRERPNPRSLVT  308 (329)
Q Consensus       288 li~~cl~~dp~~Rps~~~~l~  308 (329)
                      ++.+||..||++|||+.++++
T Consensus       244 li~~~L~~dP~~R~t~~eil~  264 (328)
T 3fe3_A          244 LLKRFLVLNPIKRGTLEQIMK  264 (328)
T ss_dssp             HHHHHCCSSTTTSCCHHHHTT
T ss_pred             HHHHHCCCChhHCcCHHHHhc
Confidence            999999999999999999997

>2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A*

Probab=100.00  E-value=8.7e-50  Score=355.62  Aligned_cols=259  Identities=24%  Similarity=0.424  Sum_probs=218.0

Q ss_pred             CcccccccCCCCCCcEEEEEEeCCCCEEEEEEeCCCCChhHHHHHHHHHHHhcCCCccccccceeeeeCCeeEEEEecCC
Q 020221           57 AMENIVSEHGEKAPNVVYKGKLENQFRIAVKRFNRSAWPDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAEYMP  136 (329)
Q Consensus        57 ~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~  136 (329)
                      ..|++.+.||+|+||.||+|...+++.||+|++........+.+.+|+++++.++||||+++++++...+..++||||++
T Consensus        39 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~  118 (321)
T 2qkw_B           39 NNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIGFCDERNEMILIYKYME  118 (321)
T ss_dssp             CCCSCCCCSCBCSSSEEEEEECTTCCEEEEEECCSCCSSHHHHHHHHHHGGGSCCCTTBCCEEEECCCTTCCEEEEECCT
T ss_pred             hccCccceeecCCCeeEEEEEECCCCEEEEEEecccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEEEcCC
Confidence            34556667799999999999988899999999987766667789999999999999999999999999999999999999


Q ss_pred             CCCHHhhhccCC--CCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCCCCCeeeecccCcccCCCC-----
Q 020221          137 NDTLAKHLFHWE--TQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDG-----  209 (329)
Q Consensus       137 ~gsL~~~l~~~~--~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~-----  209 (329)
                      +|+|.+++....  ...+++..+..++.|++.||.|||++ |++||||||+||+++.++.+||+|||++......     
T Consensus       119 ~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~-~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~  197 (321)
T 2qkw_B          119 NGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTR-AIIHRDVKSINILLDENFVPKITDFGISKKGTELDQTHL  197 (321)
T ss_dssp             TCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHHHT-TEECSCCCSTTEEECTTCCEEECCCTTCEECSSSSCCCC
T ss_pred             CCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhcCC-CeecCCCCHHHEEECCCCCEEEeeccccccccccccccc
Confidence            999999986432  23589999999999999999999999 9999999999999999999999999998754322     


Q ss_pred             -CCccCcccccCcccccCCCCCCcccchhhhHHHHHHHhCCCCCCchhhH-----------HHhhhchhhhccccccCCC
Q 020221          210 -RSYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALD-----------LIRDRNIQTLTDSCLEGQF  277 (329)
Q Consensus       210 -~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~-----------~~~~~~~~~~~~~~~~~~~  277 (329)
                       ....||+.|+|||++.+..++.++||||||+++|+|++|+.||......           ...........++......
T Consensus       198 ~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  277 (321)
T 2qkw_B          198 STVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESHNNGQLEQIVDPNLADKI  277 (321)
T ss_dssp             BCCCEEETTTCCHHHHHHCBCCTHHHHHHHHHHHHHHHHCCTTCSCSSSSSCCCHHHHTHHHHTTTCCCSSSSSSCTTCS
T ss_pred             ccccCCCccccCHHHhcCCCCCcccchHhHHHHHHHHHhCCCcccccCcHHHHHHHHHhhhccccccHHHhcChhhcccc
Confidence             2234789999999998888999999999999999999999887543211           1111122223333344456


Q ss_pred             ChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhhc
Q 020221          278 SSDEGTELVRLASRCLQYEPRERPNPRSLVTALVTLQKD  316 (329)
Q Consensus       278 ~~~~~~~~~~li~~cl~~dp~~Rps~~~~l~~L~~~~~~  316 (329)
                      +...+..+.+++.+||+.||++|||+.++++.|+.+.+-
T Consensus       278 ~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~l~~  316 (321)
T 2qkw_B          278 RPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLEYALRL  316 (321)
T ss_dssp             CHHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHS
T ss_pred             CHHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHhhc
Confidence            678899999999999999999999999999999998764

>3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens}

Probab=100.00  E-value=6.5e-50  Score=354.67  Aligned_cols=256  Identities=19%  Similarity=0.247  Sum_probs=214.0

Q ss_pred             CcccccccCCCCCCcEEEEEEe-CCCCEEEEEEeCCCCChhHHHHHHHHHHHhcCCCccccccceeeeeCCeeEEEEecC
Q 020221           57 AMENIVSEHGEKAPNVVYKGKL-ENQFRIAVKRFNRSAWPDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAEYM  135 (329)
Q Consensus        57 ~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~  135 (329)
                      +.+.+.+.||+|+||+||++.. .+++.||+|++........+.+.+|+++++.++||||+++++++.+....++||||+
T Consensus        10 ~~~~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~   89 (310)
T 3s95_A           10 SDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVLYKDKRLNFITEYI   89 (310)
T ss_dssp             GGEEEEEEEECCSSEEEEEEEETTTCCEEEEEEESCCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred             hHeeccceecCCCCEEEEEEEECCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCcCcccEEEEEecCCeeEEEEEec
Confidence            4567778889999999999994 568899999997766566778999999999999999999999999999999999999


Q ss_pred             CCCCHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCCCCCeeeecccCcccCCCCC-----
Q 020221          136 PNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDGR-----  210 (329)
Q Consensus       136 ~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~-----  210 (329)
                      ++++|.+++.. ....+++.++..++.|++.||+|||++ +++|+||||+||+++.++.+||+|||++.......     
T Consensus        90 ~~~~L~~~l~~-~~~~~~~~~~~~i~~qi~~al~~lH~~-~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~  167 (310)
T 3s95_A           90 KGGTLRGIIKS-MDSQYPWSQRVSFAKDIASGMAYLHSM-NIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEG  167 (310)
T ss_dssp             TTCBHHHHHHH-CCTTSCHHHHHHHHHHHHHHHHHHHHT-TEECSCCSTTSEEECTTSCEEECCCTTCEECC--------
T ss_pred             CCCcHHHHHHh-ccCCCCHHHHHHHHHHHHHHHHHHHhC-CccCCCCCcCeEEECCCCCEEEeecccceecccccccccc
Confidence            99999999975 356799999999999999999999999 99999999999999999999999999997643321     


Q ss_pred             -------------CccCcccccCcccccCCCCCCcccchhhhHHHHHHHhCCCCCCchhhHHHhhhchhhhccccccCCC
Q 020221          211 -------------SYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQF  277 (329)
Q Consensus       211 -------------~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  277 (329)
                                   ...||+.|+|||++.+..++.++||||||+++|+|++|..|++...........   ..........
T Consensus       168 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~~~~~~~~~~~~~~~---~~~~~~~~~~  244 (310)
T 3s95_A          168 LRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGL---NVRGFLDRYC  244 (310)
T ss_dssp             ------------CCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHTCCSSTTTSCBCTTSSB---CHHHHHHHTC
T ss_pred             cccccccccccccccCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHhcCCCCCcchhhhHHHHhh---hhhccccccC
Confidence                         346889999999999999999999999999999999999877543211111000   0011111123


Q ss_pred             ChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhhcc
Q 020221          278 SSDEGTELVRLASRCLQYEPRERPNPRSLVTALVTLQKDT  317 (329)
Q Consensus       278 ~~~~~~~~~~li~~cl~~dp~~Rps~~~~l~~L~~~~~~~  317 (329)
                      +..+++++.+++.+||+.||++|||+.++++.|+.+....
T Consensus       245 ~~~~~~~l~~li~~~l~~dP~~Rps~~~l~~~L~~l~~~~  284 (310)
T 3s95_A          245 PPNCPPSFFPITVRCCDLDPEKRPSFVKLEHWLETLRMHL  284 (310)
T ss_dssp             CTTCCTTHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred             CCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhc
Confidence            4556678999999999999999999999999999998754

>2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A*

Probab=100.00  E-value=3.8e-49  Score=351.54  Aligned_cols=260  Identities=16%  Similarity=0.203  Sum_probs=215.4

Q ss_pred             cccCHHHHHHHhcCCCc-------ccccccCCCCCCcEEEEEEeC-CCCEEEEEEeCCCCChhHHHHHHHHHHHhcCCCc
Q 020221           42 CEYSIETLRTATSGFAM-------ENIVSEHGEKAPNVVYKGKLE-NQFRIAVKRFNRSAWPDARQFLEEARAVGQLRNR  113 (329)
Q Consensus        42 ~~~~~~~~~~~~~~~~~-------~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~  113 (329)
                      ..++.+++..+++....       +...+.||+|+||.||+|... +|+.||||++........+.+.+|+.+++.++||
T Consensus        23 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~  102 (321)
T 2c30_A           23 GVVTHEQFKAALRMVVDQGDPRLLLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHF  102 (321)
T ss_dssp             --CCHHHHHHHHHTTSCSSCHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCSHHHHHHHHHHHTTCCCT
T ss_pred             CcCcHHHHHHHHhhccCCCCchhhhhccEEeccCCCeEEEEEEECCCCcEEEEEEEeccchhHHHHHHHHHHHHHhCCCC
Confidence            34778888877765322       344557799999999999954 7899999999877666677899999999999999


Q ss_pred             cccccceeeeeCCeeEEEEecCCCCCHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCCCC
Q 020221          114 RLANLLGCCCEGDERLLVAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDV  193 (329)
Q Consensus       114 niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~  193 (329)
                      ||+++++++...+..++||||+++++|.+++.   ...+++..+..++.|++.||.|||+. |++||||||+||+++.++
T Consensus       103 niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~---~~~l~~~~~~~i~~qi~~~L~~LH~~-~ivH~Dlkp~NIll~~~~  178 (321)
T 2c30_A          103 NVVEMYKSYLVGEELWVLMEFLQGGALTDIVS---QVRLNEEQIATVCEAVLQALAYLHAQ-GVIHRDIKSDSILLTLDG  178 (321)
T ss_dssp             TBCCEEEEEEETTEEEEEECCCCSCBHHHHHT---TCCCCHHHHHHHHHHHHHHHHHHHHT-TEECCCCSGGGEEECTTC
T ss_pred             CcceEEEEEEECCEEEEEEecCCCCCHHHHHH---hcCCCHHHHHHHHHHHHHHHHHHHHC-CeecCCCCHHHEEECCCC
Confidence            99999999999999999999999999999984   45799999999999999999999999 999999999999999999


Q ss_pred             CeeeecccCcccCCCC----CCccCcccccCcccccCCCCCCcccchhhhHHHHHHHhCCCCCCchhhHHHhhhchhhhc
Q 020221          194 NPRLSCFGLMKNSRDG----RSYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLT  269 (329)
Q Consensus       194 ~~kl~Dfg~a~~~~~~----~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~~~~~~~~~~  269 (329)
                      .+||+|||++......    ....||+.|+|||++.+..++.++||||||+++|+|++|..||............... .
T Consensus       179 ~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~pf~~~~~~~~~~~~~~~-~  257 (321)
T 2c30_A          179 RVKLSDFGFCAQISKDVPKRKSLVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLRDS-P  257 (321)
T ss_dssp             CEEECCCTTCEECCSSSCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHS-S
T ss_pred             cEEEeeeeeeeecccCccccccccCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcC-C
Confidence            9999999998765432    3456899999999999989999999999999999999999888654332222111111 1


Q ss_pred             cccccCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 020221          270 DSCLEGQFSSDEGTELVRLASRCLQYEPRERPNPRSLVT  308 (329)
Q Consensus       270 ~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~~~l~  308 (329)
                      .+  ........++++.+++.+||+.||++|||+.++++
T Consensus       258 ~~--~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~  294 (321)
T 2c30_A          258 PP--KLKNSHKVSPVLRDFLERMLVRDPQERATAQELLD  294 (321)
T ss_dssp             CC--CCTTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred             CC--CcCccccCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence            11  11123456788999999999999999999999998

>3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A*

Probab=100.00  E-value=2.4e-49  Score=351.03  Aligned_cols=258  Identities=19%  Similarity=0.298  Sum_probs=207.6

Q ss_pred             CCCcccccccCCCCCCcEEEEEEeCCCCEEEEEEeCCCCCh--hHHHHHHHHHHHhcCCCccccccceeeeeCCeeEEEE
Q 020221           55 GFAMENIVSEHGEKAPNVVYKGKLENQFRIAVKRFNRSAWP--DARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVA  132 (329)
Q Consensus        55 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~--~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~  132 (329)
                      .+..+++.+.||+|+||+||+|.. ++..||+|++......  ..+.+.+|+++++.++||||+++++++.+....++||
T Consensus        35 ~~~~y~i~~~lG~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~  113 (309)
T 3p86_A           35 PWCDLNIKEKIGAGSFGTVHRAEW-HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPNLSIVT  113 (309)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEE-TTEEEEEEEECCCCCSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTCCEEEE
T ss_pred             ChhHceeeeEeecCCCeEEEEEEE-CCCcEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCceEEEE
Confidence            345678888999999999999987 5678999999766432  3456889999999999999999999999999999999


Q ss_pred             ecCCCCCHHhhhccCCC-CCCCHHHHHHHHHHHHHHHHHhhcCCC--ccccccCCCceeeCCCCCeeeecccCcccCCCC
Q 020221          133 EYMPNDTLAKHLFHWET-QPMKWAMRLRVALHIAEALEYCTSKER--ALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDG  209 (329)
Q Consensus       133 e~~~~gsL~~~l~~~~~-~~~~~~~~~~i~~~i~~~l~~lH~~~~--ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~  209 (329)
                      ||+++|+|.+++..... ..+++..++.++.|++.||+|||+. |  ++||||||+||+++.++.+||+|||++......
T Consensus       114 e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~-~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~~~  192 (309)
T 3p86_A          114 EYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNR-NPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKAST  192 (309)
T ss_dssp             ECCTTCBHHHHHHSTTHHHHSCHHHHHHHHHHHHHHHHHHHTS-SSCCCCTTCCGGGEEECTTCCEEECCCC--------
T ss_pred             ecCCCCcHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcC-CCCEECCCCChhhEEEeCCCcEEECCCCCCcccccc
Confidence            99999999999964221 2389999999999999999999999 9  999999999999999999999999998754433


Q ss_pred             ----CCccCcccccCcccccCCCCCCcccchhhhHHHHHHHhCCCCCCchhhHHHhhhchhhhccccccCCCChHHHHHH
Q 020221          210 ----RSYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTEL  285 (329)
Q Consensus       210 ----~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  285 (329)
                          ....||+.|+|||++.+..++.++||||||+++|+|++|..||............    .........+..+++++
T Consensus       193 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~~----~~~~~~~~~~~~~~~~l  268 (309)
T 3p86_A          193 FLSSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNLNPAQVVAAV----GFKCKRLEIPRNLNPQV  268 (309)
T ss_dssp             ---------CCTTSCHHHHTTCCCCTTHHHHHHHHHHHHHHHCCCTTTTSCHHHHHHHH----HHSCCCCCCCTTSCHHH
T ss_pred             ccccccCCCCccccChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH----HhcCCCCCCCccCCHHH
Confidence                3456899999999999999999999999999999999999888654332222111    11112234556678899


Q ss_pred             HHHHHHhcccCCCCCCCHHHHHHHHHhhhhccc
Q 020221          286 VRLASRCLQYEPRERPNPRSLVTALVTLQKDTE  318 (329)
Q Consensus       286 ~~li~~cl~~dp~~Rps~~~~l~~L~~~~~~~~  318 (329)
                      .+++.+||+.||++|||+.++++.|+.+.+...
T Consensus       269 ~~li~~~l~~dP~~Rps~~~ll~~L~~~~~~~~  301 (309)
T 3p86_A          269 AAIIEGCWTNEPWKRPSFATIMDLLRPLIKSAV  301 (309)
T ss_dssp             HHHHHHHTCSSGGGSCCHHHHHHHHHHHHC---
T ss_pred             HHHHHHHccCChhhCcCHHHHHHHHHHHHHhCC
Confidence            999999999999999999999999999987643

>1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ...

Probab=100.00  E-value=3.1e-49  Score=353.93  Aligned_cols=243  Identities=17%  Similarity=0.228  Sum_probs=207.1

Q ss_pred             CcccccccCCCCCCcEEEEEEe-CCCCEEEEEEeCCCC---ChhHHHHHHHHHHHhcCCCccccccceeeeeCCeeEEEE
Q 020221           57 AMENIVSEHGEKAPNVVYKGKL-ENQFRIAVKRFNRSA---WPDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVA  132 (329)
Q Consensus        57 ~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~  132 (329)
                      ..|++++.||+|+||.||++.. .+++.||+|+++...   ......+.+|+.+++.++||||+++++++.+.+..++||
T Consensus         5 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lv~   84 (337)
T 1o6l_A            5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVM   84 (337)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             HHeEEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEEEEeCCEEEEEE
Confidence            4677888899999999999994 578999999997531   223566889999999999999999999999999999999


Q ss_pred             ecCCCCCHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCCCCCeeeecccCcccCCCC---
Q 020221          133 EYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDG---  209 (329)
Q Consensus       133 e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~---  209 (329)
                      ||+++|+|..++.  ....+++..+..++.||+.||.|||++ ||+||||||+|||++.++.+||+|||+++.....   
T Consensus        85 E~~~gg~L~~~l~--~~~~~~~~~~~~~~~qi~~aL~~LH~~-~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~~~~  161 (337)
T 1o6l_A           85 EYANGGELFFHLS--RERVFTEERARFYGAEIVSALEYLHSR-DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGAT  161 (337)
T ss_dssp             ECCTTCBHHHHHH--HHSCCCHHHHHHHHHHHHHHHHHHHHT-TCBCCCCCGGGEEECTTSCEEECCCTTCBCSCCTTCC
T ss_pred             eCCCCCcHHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHHC-CeecCcCCHHHEEECCCCCEEEeeccchhhcccCCCc
Confidence            9999999999986  345789999999999999999999999 9999999999999999999999999999763322   


Q ss_pred             -CCccCcccccCcccccCCCCCCcccchhhhHHHHHHHhCCCCCCchhhHHHhhhchhhhccccccCCCChHHHHHHHHH
Q 020221          210 -RSYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRL  288 (329)
Q Consensus       210 -~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  288 (329)
                       ....||+.|+|||++.+..++.++||||||+++|||++|..||...............      ...++...++++.++
T Consensus       162 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~------~~~~p~~~s~~~~~l  235 (337)
T 1o6l_A          162 MKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILME------EIRFPRTLSPEAKSL  235 (337)
T ss_dssp             BCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHC------CCCCCTTSCHHHHHH
T ss_pred             ccccccChhhCChhhhcCCCCCchhhcccchhHHHHHhcCCCCCCCCCHHHHHHHHHcC------CCCCCCCCCHHHHHH
Confidence             3456899999999999999999999999999999999999988765443332222211      123455678899999


Q ss_pred             HHHhcccCCCCCC-----CHHHHHH
Q 020221          289 ASRCLQYEPRERP-----NPRSLVT  308 (329)
Q Consensus       289 i~~cl~~dp~~Rp-----s~~~~l~  308 (329)
                      +.+||+.||++||     ++.++++
T Consensus       236 i~~lL~~dP~~R~g~~~~~~~ei~~  260 (337)
T 1o6l_A          236 LAGLLKKDPKQRLGGGPSDAKEVME  260 (337)
T ss_dssp             HHHHTCSSTTTSTTCSTTTHHHHHT
T ss_pred             HHHHhhcCHHHhcCCCCCCHHHHHc
Confidence            9999999999999     8999887

>2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A*

Probab=100.00  E-value=2.1e-49  Score=358.15  Aligned_cols=246  Identities=18%  Similarity=0.199  Sum_probs=205.8

Q ss_pred             cccccccCCCCCCcEEEEEE-eCCCCEEEEEEeCCCCCh------hHHHHHHHHHHHhcCCCccccccceeeeeCCeeEE
Q 020221           58 MENIVSEHGEKAPNVVYKGK-LENQFRIAVKRFNRSAWP------DARQFLEEARAVGQLRNRRLANLLGCCCEGDERLL  130 (329)
Q Consensus        58 ~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~------~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l  130 (329)
                      .|++.+.||+|+||+||++. ..+|+.||+|++......      ..+.+.+|+.+++.++||||+++++++.+....++
T Consensus        13 ~y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~l   92 (361)
T 2yab_A           13 FYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYENRTDVVL   92 (361)
T ss_dssp             TEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEE
T ss_pred             ceEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEEEeCCEEEE
Confidence            47788888999999999999 456889999999765322      24678999999999999999999999999999999


Q ss_pred             EEecCCCCCHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCCCC----CeeeecccCcccC
Q 020221          131 VAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDV----NPRLSCFGLMKNS  206 (329)
Q Consensus       131 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~----~~kl~Dfg~a~~~  206 (329)
                      ||||+++|+|.+++.  ....+++..+..++.||+.||.|||+. ||+||||||+||+++.++    .+||+|||++...
T Consensus        93 v~e~~~gg~L~~~l~--~~~~l~~~~~~~i~~qi~~aL~~LH~~-givHrDlkp~NIll~~~~~~~~~vkl~DFG~a~~~  169 (361)
T 2yab_A           93 ILELVSGGELFDFLA--QKESLSEEEATSFIKQILDGVNYLHTK-KIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEI  169 (361)
T ss_dssp             EEECCCSCBHHHHHT--TCSCCBHHHHHHHHHHHHHHHHHHHHT-TEECCCCSGGGEEESCTTSSSCCEEECCCSSCEEC
T ss_pred             EEEcCCCCcHHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHHC-CcccCCCCHHHEEEeCCCCCccCEEEEecCCceEc
Confidence            999999999999996  446799999999999999999999999 999999999999998777    7999999999876


Q ss_pred             CCC---CCccCcccccCcccccCCCCCCcccchhhhHHHHHHHhCCCCCCchhhHHHhhhchhhhccccccCCCChHHHH
Q 020221          207 RDG---RSYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGT  283 (329)
Q Consensus       207 ~~~---~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  283 (329)
                      ...   ....||+.|+|||++.+..++.++||||||+++|+|++|..||..................  .........++
T Consensus       170 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~--~~~~~~~~~s~  247 (361)
T 2yab_A          170 EDGVEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITAVSYD--FDEEFFSQTSE  247 (361)
T ss_dssp             CTTCCCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCCC--CCHHHHTTSCH
T ss_pred             CCCCccccCCCCccEECchHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCC--CCchhccCCCH
Confidence            543   3456899999999999889999999999999999999999988765433322221111110  00011123567


Q ss_pred             HHHHHHHHhcccCCCCCCCHHHHHH
Q 020221          284 ELVRLASRCLQYEPRERPNPRSLVT  308 (329)
Q Consensus       284 ~~~~li~~cl~~dp~~Rps~~~~l~  308 (329)
                      ++.+|+.+||..||++|||+.++++
T Consensus       248 ~~~~li~~~L~~dP~~R~t~~e~l~  272 (361)
T 2yab_A          248 LAKDFIRKLLVKETRKRLTIQEALR  272 (361)
T ss_dssp             HHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred             HHHHHHHHHCCCChhHCcCHHHHhc
Confidence            8999999999999999999999997

>4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A*

Probab=100.00  E-value=5.9e-49  Score=341.51  Aligned_cols=252  Identities=21%  Similarity=0.315  Sum_probs=214.0

Q ss_pred             CcccccccCCCCCCcEEEEEEeCCCCEEEEEEeCCCCChhHHHHHHHHHHHhcCCCccccccceeeeeCCeeEEEEecCC
Q 020221           57 AMENIVSEHGEKAPNVVYKGKLENQFRIAVKRFNRSAWPDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAEYMP  136 (329)
Q Consensus        57 ~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~  136 (329)
                      +.|++++.||+|+||.||++...+++.||+|++..... ..+.+.+|+++++.++||||+++++++.+....++||||++
T Consensus        10 ~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~   88 (269)
T 4hcu_A           10 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAM-SEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFME   88 (269)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTEEEEEEEECTTSB-CHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEEECCT
T ss_pred             hhceeeheecCCCccEEEEEEecCCCeEEEEEeccccc-CHHHHHHHHHHHHhCCCCCEeeEEEEEecCCceEEEEEeCC
Confidence            46788889999999999999987888999999987653 35678999999999999999999999999999999999999


Q ss_pred             CCCHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCCCCCeeeecccCcccCCCC-----CC
Q 020221          137 NDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDG-----RS  211 (329)
Q Consensus       137 ~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~-----~~  211 (329)
                      +++|.+++.. ....+++..++.++.|++.||.|||+. +++|+||||+||+++.++.++|+|||++......     ..
T Consensus        89 ~~~L~~~l~~-~~~~~~~~~~~~i~~~i~~~l~~lH~~-~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~  166 (269)
T 4hcu_A           89 HGCLSDYLRT-QRGLFAAETLLGMCLDVCEGMAYLEEA-CVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTG  166 (269)
T ss_dssp             TCBHHHHHHT-TTTCCCHHHHHHHHHHHHHHHHHHHHT-TCCCSCCCGGGEEECGGGCEEECCTTGGGGBCCHHHHSTTS
T ss_pred             CCcHHHHHHh-cCcccCHHHHHHHHHHHHHHHHHHHhC-CeecCCcchheEEEcCCCCEEeccccccccccccccccccC
Confidence            9999999964 445689999999999999999999999 9999999999999999999999999999765432     23


Q ss_pred             ccCcccccCcccccCCCCCCcccchhhhHHHHHHHh-CCCCCCchhhHHHhhhchhhhccccccCCCChHHHHHHHHHHH
Q 020221          212 YSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLS-GKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLAS  290 (329)
Q Consensus       212 ~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t-g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~  290 (329)
                      ..+++.|+|||.+.+..++.++||||||+++|+|++ |..||...............     .....+...++++.+++.
T Consensus       167 ~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~~g~~p~~~~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~li~  241 (269)
T 4hcu_A          167 TKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTG-----FRLYKPRLASTHVYQIMN  241 (269)
T ss_dssp             TTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTT-----CCCCCCTTSCHHHHHHHH
T ss_pred             cccccccCCHHHhcCCCCCchhhhHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhcC-----ccCCCCCcCCHHHHHHHH
Confidence            345778999999998899999999999999999999 78777654333322222111     122334456788999999


Q ss_pred             HhcccCCCCCCCHHHHHHHHHhhhhc
Q 020221          291 RCLQYEPRERPNPRSLVTALVTLQKD  316 (329)
Q Consensus       291 ~cl~~dp~~Rps~~~~l~~L~~~~~~  316 (329)
                      +||+.||++|||+.+++++|+++.+.
T Consensus       242 ~~l~~~p~~Rps~~~ll~~l~~l~~~  267 (269)
T 4hcu_A          242 HCWRERPEDRPAFSRLLRQLAEIAES  267 (269)
T ss_dssp             HHTCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred             HHccCCcccCcCHHHHHHHHHHHHHc
Confidence            99999999999999999999998764

>3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens}

Probab=100.00  E-value=4.2e-49  Score=351.85  Aligned_cols=255  Identities=20%  Similarity=0.282  Sum_probs=211.7

Q ss_pred             CcccccccCCCCCCcEEEEEEeC----CCCEEEEEEeCCCCCh-hHHHHHHHHHHHhcCCCccccccceeeeeCCeeEEE
Q 020221           57 AMENIVSEHGEKAPNVVYKGKLE----NQFRIAVKRFNRSAWP-DARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLV  131 (329)
Q Consensus        57 ~~~~~~~~lg~G~~g~V~~~~~~----~~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv  131 (329)
                      ..|++.+.||+|+||.||+|...    .+..||||++...... ..+.+.+|+.+++.++||||+++++++.+++..++|
T Consensus        49 ~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv  128 (325)
T 3kul_A           49 SRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGRLAMIV  128 (325)
T ss_dssp             GGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECGGGCCEEE
T ss_pred             hHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCccEEE
Confidence            45778888999999999999953    3446999999875433 345689999999999999999999999999999999


Q ss_pred             EecCCCCCHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCCCCCeeeecccCcccCCCCC-
Q 020221          132 AEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDGR-  210 (329)
Q Consensus       132 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~-  210 (329)
                      |||+++++|.+++.. ....+++..+..++.|++.||.|||+. +++||||||+||+++.++.+||+|||++....... 
T Consensus       129 ~e~~~~~~L~~~l~~-~~~~~~~~~~~~i~~qi~~~L~~LH~~-~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~  206 (325)
T 3kul_A          129 TEYMENGSLDTFLRT-HDGQFTIMQLVGMLRGVGAGMRYLSDL-GYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPD  206 (325)
T ss_dssp             EECCTTCBHHHHHHT-TTTCSCHHHHHHHHHHHHHHHHHHHHT-TEECSCCSGGGEEECTTCCEEECCCSSCEECC----
T ss_pred             eeCCCCCcHHHHHHh-cccCCCHHHHHHHHHHHHHHHHHHHHC-CeeCCCCCcceEEECCCCCEEECCCCcccccccCcc
Confidence            999999999999964 345799999999999999999999999 99999999999999999999999999998654432 


Q ss_pred             ------CccCcccccCcccccCCCCCCcccchhhhHHHHHHHh-CCCCCCchhhHHHhhhchhhhccccccCCCChHHHH
Q 020221          211 ------SYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLS-GKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGT  283 (329)
Q Consensus       211 ------~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t-g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  283 (329)
                            ...+|+.|+|||++.+..++.++||||||+++|+|++ |..||..............     ......+..+++
T Consensus       207 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~~-----~~~~~~~~~~~~  281 (325)
T 3kul_A          207 AAYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMTNRDVISSVEE-----GYRLPAPMGCPH  281 (325)
T ss_dssp             CCEECC---CCGGGSCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHHHHHHHT-----TCCCCCCTTCCH
T ss_pred             ceeeccCCCCcccccCHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHc-----CCCCCCCCCcCH
Confidence                  1234668999999998889999999999999999999 8887765433332222111     122234556778


Q ss_pred             HHHHHHHHhcccCCCCCCCHHHHHHHHHhhhhccc
Q 020221          284 ELVRLASRCLQYEPRERPNPRSLVTALVTLQKDTE  318 (329)
Q Consensus       284 ~~~~li~~cl~~dp~~Rps~~~~l~~L~~~~~~~~  318 (329)
                      ++.+++..||..||++|||+.++++.|+.+.+..+
T Consensus       282 ~l~~li~~~l~~dp~~Rps~~eil~~L~~l~~~~~  316 (325)
T 3kul_A          282 ALHQLMLDCWHKDRAQRPRFSQIVSVLDALIRSPE  316 (325)
T ss_dssp             HHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSCC
T ss_pred             HHHHHHHHHccCChhhCcCHHHHHHHHHHHHhCcc
Confidence            99999999999999999999999999999987654

>2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A

Probab=100.00  E-value=1.5e-48  Score=354.30  Aligned_cols=253  Identities=19%  Similarity=0.311  Sum_probs=211.0

Q ss_pred             CcccccccCCCCCCcEEEEEEe--------CCCCEEEEEEeCCCCCh-hHHHHHHHHHHHhcC-CCccccccceeeeeCC
Q 020221           57 AMENIVSEHGEKAPNVVYKGKL--------ENQFRIAVKRFNRSAWP-DARQFLEEARAVGQL-RNRRLANLLGCCCEGD  126 (329)
Q Consensus        57 ~~~~~~~~lg~G~~g~V~~~~~--------~~~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~  126 (329)
                      +.|++.+.||+|+||.||+|..        .++..||+|+++..... ..+.+.+|+.+++.+ +||||+++++++...+
T Consensus        81 ~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~  160 (370)
T 2psq_A           81 DKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDG  160 (370)
T ss_dssp             GGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTCBHHHHHHHHHHHHHHHHSCCCTTBCCEEEEECSSS
T ss_pred             HHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCcCHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEccCC
Confidence            4577888899999999999984        23567999999876433 345789999999999 8999999999999999


Q ss_pred             eeEEEEecCCCCCHHhhhccCC--------------CCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCCC
Q 020221          127 ERLLVAEYMPNDTLAKHLFHWE--------------TQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDD  192 (329)
Q Consensus       127 ~~~lv~e~~~~gsL~~~l~~~~--------------~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~  192 (329)
                      ..++||||+++|+|.+++....              ...+++..+..++.||+.||.|||++ |++||||||+|||++.+
T Consensus       161 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~-~ivHrDlkp~NIll~~~  239 (370)
T 2psq_A          161 PLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQ-KCIHRDLAARNVLVTEN  239 (370)
T ss_dssp             SCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHHT-TEECSCCCGGGEEECTT
T ss_pred             CEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhC-CeeccccchhhEEECCC
Confidence            9999999999999999997532              23579999999999999999999999 99999999999999999


Q ss_pred             CCeeeecccCcccCCCCC------CccCcccccCcccccCCCCCCcccchhhhHHHHHHHh-CCCCCCchhhHHHhhhch
Q 020221          193 VNPRLSCFGLMKNSRDGR------SYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLS-GKHIPPSHALDLIRDRNI  265 (329)
Q Consensus       193 ~~~kl~Dfg~a~~~~~~~------~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t-g~~~~~~~~~~~~~~~~~  265 (329)
                      +.+||+|||+++......      ...+++.|+|||++.+..++.++||||||+++|||++ |..||...........  
T Consensus       240 ~~~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~p~~~~~~~~~~~~--  317 (370)
T 2psq_A          240 NVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFKL--  317 (370)
T ss_dssp             CCEEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHH--
T ss_pred             CCEEEccccCCcccCcccceecccCCCcccceECHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH--
Confidence            999999999998654322      2345688999999999899999999999999999999 8877765433222211  


Q ss_pred             hhhccccccCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhh
Q 020221          266 QTLTDSCLEGQFSSDEGTELVRLASRCLQYEPRERPNPRSLVTALVTLQK  315 (329)
Q Consensus       266 ~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~~~l~~L~~~~~  315 (329)
                         +........+..++.++.+++.+||+.||++|||+.++++.|+++..
T Consensus       318 ---~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~L~~il~  364 (370)
T 2psq_A          318 ---LKEGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILT  364 (370)
T ss_dssp             ---HHTTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             ---HhcCCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHH
Confidence               11112233456678899999999999999999999999999999865

>1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7

Probab=100.00  E-value=1.1e-48  Score=347.74  Aligned_cols=244  Identities=18%  Similarity=0.214  Sum_probs=207.8

Q ss_pred             CCcccccccCCCCCCcEEEEEEe-CCCCEEEEEEeCCCC---ChhHHHHHHHHHHHhcCCCccccccceeeeeCCeeEEE
Q 020221           56 FAMENIVSEHGEKAPNVVYKGKL-ENQFRIAVKRFNRSA---WPDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLV  131 (329)
Q Consensus        56 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv  131 (329)
                      ...|++++.||+|+||.||++.. .+++.||+|++....   ....+.+.+|..+++.++||||+++++++.+....++|
T Consensus         5 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv   84 (318)
T 1fot_A            5 LQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMI   84 (318)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEE
T ss_pred             hHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEEEeCCEEEEE
Confidence            35678888999999999999994 578999999987532   12355678899999999999999999999999999999


Q ss_pred             EecCCCCCHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCCCCCeeeecccCcccCCCC-C
Q 020221          132 AEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDG-R  210 (329)
Q Consensus       132 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~-~  210 (329)
                      |||+++|+|.+++..  ...+++..+..++.||+.||.|||++ |++||||||+||+++.++.+||+|||+++..... .
T Consensus        85 ~e~~~gg~L~~~l~~--~~~~~~~~~~~~~~qi~~aL~~LH~~-~ivHrDlkp~NIll~~~g~~kL~Dfg~a~~~~~~~~  161 (318)
T 1fot_A           85 MDYIEGGELFSLLRK--SQRFPNPVAKFYAAEVCLALEYLHSK-DIIYRDLKPENILLDKNGHIKITDFGFAKYVPDVTY  161 (318)
T ss_dssp             ECCCCSCBHHHHHHH--TSSCCHHHHHHHHHHHHHHHHHHHTT-TEECCCCCGGGEEECTTSCEEECCCSSCEECSSCBC
T ss_pred             EeCCCCCCHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHC-CccccCCChheEEEcCCCCEEEeecCcceecCCccc
Confidence            999999999999973  45789999999999999999999999 9999999999999999999999999999865543 3


Q ss_pred             CccCcccccCcccccCCCCCCcccchhhhHHHHHHHhCCCCCCchhhHHHhhhchhhhccccccCCCChHHHHHHHHHHH
Q 020221          211 SYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLAS  290 (329)
Q Consensus       211 ~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~  290 (329)
                      ...||+.|+|||++.+..++.++||||||+++|||++|..||..............    .  ...++...++++.+++.
T Consensus       162 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~----~--~~~~p~~~~~~~~~li~  235 (318)
T 1fot_A          162 TLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILN----A--ELRFPPFFNEDVKDLLS  235 (318)
T ss_dssp             CCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHH----C--CCCCCTTSCHHHHHHHH
T ss_pred             cccCCccccCHhHhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHh----C--CCCCCCCCCHHHHHHHH
Confidence            45789999999999999999999999999999999999998876543322222211    1  12345567789999999


Q ss_pred             HhcccCCCCCC-----CHHHHHH
Q 020221          291 RCLQYEPRERP-----NPRSLVT  308 (329)
Q Consensus       291 ~cl~~dp~~Rp-----s~~~~l~  308 (329)
                      +||..||++||     ++.++++
T Consensus       236 ~lL~~dp~~R~~~~~~~~~~i~~  258 (318)
T 1fot_A          236 RLITRDLSQRLGNLQNGTEDVKN  258 (318)
T ss_dssp             HHTCSCTTTCTTSSTTTTHHHHT
T ss_pred             HHhccCHHHcCCCcCCCHHHHhc
Confidence            99999999999     8888886

>3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens}

Probab=100.00  E-value=1.8e-48  Score=360.89  Aligned_cols=246  Identities=17%  Similarity=0.183  Sum_probs=205.7

Q ss_pred             cccccccCCCCCCcEEEEEE-eCCCCEEEEEEeCCCCCh--hHHHHHHHHHHHhcCCCccccccceeeeeCCeeEEEEec
Q 020221           58 MENIVSEHGEKAPNVVYKGK-LENQFRIAVKRFNRSAWP--DARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAEY  134 (329)
Q Consensus        58 ~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~--~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  134 (329)
                      .|++++.||+|+||+||++. ..+++.+|+|++......  ..+.+.+|+.+++.++||||+++++++.+.+..++||||
T Consensus        12 ~Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv~E~   91 (444)
T 3soa_A           12 EYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSISEEGHHYLIFDL   91 (444)
T ss_dssp             HEEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSCHHHHHHHHHHHHHHHHHCCBTTBCCEEEEEECSSEEEEEECC
T ss_pred             CeEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCcCCCeEEEEEEECCEEEEEEEe
Confidence            47788888999999999998 567889999999765433  345688999999999999999999999999999999999


Q ss_pred             CCCCCHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeC---CCCCeeeecccCcccCCCCC-
Q 020221          135 MPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFD---DDVNPRLSCFGLMKNSRDGR-  210 (329)
Q Consensus       135 ~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~---~~~~~kl~Dfg~a~~~~~~~-  210 (329)
                      +.+|+|.+.+..  ...+++..+..++.||+.||.|||++ ||+||||||+|||++   .++.+||+|||++....... 
T Consensus        92 ~~gg~L~~~i~~--~~~~~e~~~~~i~~qil~aL~~lH~~-givHrDlKp~NIll~~~~~~~~vkL~DFG~a~~~~~~~~  168 (444)
T 3soa_A           92 VTGGELFEDIVA--REYYSEADASHCIQQILEAVLHCHQM-GVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQ  168 (444)
T ss_dssp             CBCCBHHHHHHH--CSCCCHHHHHHHHHHHHHHHHHHHHT-TCBCCCCSSTTEEESBSSTTCCEEECCCSSCBCCCTTCC
T ss_pred             CCCCCHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHC-CccccCCCHHHEEEeccCCCCcEEEccCceeEEecCCCc
Confidence            999999999874  45699999999999999999999999 999999999999998   56889999999997665432 


Q ss_pred             ---CccCcccccCcccccCCCCCCcccchhhhHHHHHHHhCCCCCCchhhHHHhhhchhhhccccccCCCChHHHHHHHH
Q 020221          211 ---SYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVR  287 (329)
Q Consensus       211 ---~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  287 (329)
                         ...||+.|+|||++.+..++.++||||||+++|+|++|..||..................  .........++++.+
T Consensus       169 ~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~--~~~~~~~~~s~~~~~  246 (444)
T 3soa_A          169 AWFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFWDEDQHRLYQQIKAGAYD--FPSPEWDTVTPEAKD  246 (444)
T ss_dssp             BCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCCC--CCTTTTTTSCHHHHH
T ss_pred             eeecccCCcccCCHHHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhCCCC--CCccccccCCHHHHH
Confidence               347899999999999989999999999999999999999998765444333322222111  111122356789999


Q ss_pred             HHHHhcccCCCCCCCHHHHHH
Q 020221          288 LASRCLQYEPRERPNPRSLVT  308 (329)
Q Consensus       288 li~~cl~~dp~~Rps~~~~l~  308 (329)
                      |+.+||+.||++|||+.++++
T Consensus       247 li~~~L~~dP~~Rpta~e~L~  267 (444)
T 3soa_A          247 LINKMLTINPSKRITAAEALK  267 (444)
T ss_dssp             HHHHHSCSSTTTSCCHHHHHH
T ss_pred             HHHHHcCCChhHCCCHHHHhc
Confidence            999999999999999999998

>3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A*

Probab=100.00  E-value=7.8e-49  Score=350.09  Aligned_cols=272  Identities=28%  Similarity=0.476  Sum_probs=222.3

Q ss_pred             CcccccCHHHHHHHhcCCCcccccccCCCCCCcEEEEEEeCCCCEEEEEEeCCCCCh-hHHHHHHHHHHHhcCCCccccc
Q 020221           39 PVFCEYSIETLRTATSGFAMENIVSEHGEKAPNVVYKGKLENQFRIAVKRFNRSAWP-DARQFLEEARAVGQLRNRRLAN  117 (329)
Q Consensus        39 ~~~~~~~~~~~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~  117 (329)
                      .....++..++....++|...+   .||+|+||.||+|...+++.||+|++...... ....+.+|+++++.++||||++
T Consensus        15 ~~~~~~~~~~~~~~~~~y~~~~---~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~   91 (326)
T 3uim_A           15 GQLKRFSLRELQVASDNFSNKN---ILGRGGFGKVYKGRLADGTLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLR   91 (326)
T ss_dssp             CCCEECCTHHHHTTTTSSCSTT---EEECCSSSEEEEECCSSSCCEEEEECCC-----CCCHHHHHHHGGGTCCCTTBCC
T ss_pred             CccceecHHHHHHHhhccccce---eEecCCCcEEEEEEecCCCEEEEEEeccccCchHHHHHHHHHHHHHhccCCCccc
Confidence            4456788888888877766554   45999999999999878899999999765422 2236889999999999999999


Q ss_pred             cceeeeeCCeeEEEEecCCCCCHHhhhccCC--CCCCCHHHHHHHHHHHHHHHHHhhcCC--CccccccCCCceeeCCCC
Q 020221          118 LLGCCCEGDERLLVAEYMPNDTLAKHLFHWE--TQPMKWAMRLRVALHIAEALEYCTSKE--RALYHDLNAYRIVFDDDV  193 (329)
Q Consensus       118 ~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~--~~~~~~~~~~~i~~~i~~~l~~lH~~~--~ivH~dlkp~Nil~~~~~  193 (329)
                      +++++......++||||+++|+|.+++....  ...+++..+..++.|++.||.|||+..  |++||||||+||+++.++
T Consensus        92 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nil~~~~~  171 (326)
T 3uim_A           92 LRGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEF  171 (326)
T ss_dssp             CCEEECCSSCCEEEEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGGGEEECTTC
T ss_pred             eEEEEecCCceEEEEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchhhEEECCCC
Confidence            9999999999999999999999999997543  235899999999999999999999863  899999999999999999


Q ss_pred             CeeeecccCcccCCCCC-----CccCcccccCcccccCCCCCCcccchhhhHHHHHHHhCCCCCCchhhHH---------
Q 020221          194 NPRLSCFGLMKNSRDGR-----SYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDL---------  259 (329)
Q Consensus       194 ~~kl~Dfg~a~~~~~~~-----~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~---------  259 (329)
                      .+||+|||++.......     ...||+.|+|||++.+..++.++||||||+++|+|++|..||.......         
T Consensus       172 ~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~  251 (326)
T 3uim_A          172 EAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDW  251 (326)
T ss_dssp             CEEECCCSSCEECCSSSSCEECCCCSCGGGCCHHHHHHSEECHHHHHHHHHHHHHHHHHCCCSBCHHHHTTTSCSBHHHH
T ss_pred             CEEeccCccccccCcccccccccccCCcCccCHHHhccCCCCccccchhHHHHHHHHHhCCCcccccccccccchhHHHH
Confidence            99999999997654322     2358999999999988889999999999999999999998885321110         


Q ss_pred             H----hhhchhhhccccccCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhh
Q 020221          260 I----RDRNIQTLTDSCLEGQFSSDEGTELVRLASRCLQYEPRERPNPRSLVTALVTL  313 (329)
Q Consensus       260 ~----~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~~~l~~L~~~  313 (329)
                      .    .........+.......+...++.+.+++.+||+.||++|||+.+++++|+..
T Consensus       252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~~  309 (326)
T 3uim_A          252 VKGLLKEKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEGD  309 (326)
T ss_dssp             HTTTTSSCCSTTSSCTTCTTSCCHHHHHHHHHHHHHHTCSCGGGSCCHHHHHHHHHTS
T ss_pred             HHHHhhchhhhhhcChhhccccCHHHHHHHHHHHHHHhCcCCccCCCHHHHHHHhcCc
Confidence            0    11112222333344456778899999999999999999999999999999864

>1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=3.2e-49  Score=351.99  Aligned_cols=248  Identities=16%  Similarity=0.179  Sum_probs=207.2

Q ss_pred             CCcccccccCCCCCCcEEEEEEe-CCCCEEEEEEeCCCCChhHHHHHHHHHHHhcCCCccccccceeeeeCCeeEEEEec
Q 020221           56 FAMENIVSEHGEKAPNVVYKGKL-ENQFRIAVKRFNRSAWPDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAEY  134 (329)
Q Consensus        56 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  134 (329)
                      ...|.+.+.||+|+||+||++.. .+++.+|+|.+.... .....+.+|+.+++.++||||+++++++.+.+..++||||
T Consensus         4 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~-~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~   82 (321)
T 1tki_A            4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKG-TDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEF   82 (321)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCT-HHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECC
T ss_pred             hhceEeeeEEecCCCeEEEEEEECCCCcEEEEEEEecCc-ccHHHHHHHHHHHHhCCCCCCCeEeEEEecCCEEEEEEEe
Confidence            35678888899999999999994 568899999997654 3455688999999999999999999999999999999999


Q ss_pred             CCCCCHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCC--CCCeeeecccCcccCCCCC--
Q 020221          135 MPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDD--DVNPRLSCFGLMKNSRDGR--  210 (329)
Q Consensus       135 ~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~--~~~~kl~Dfg~a~~~~~~~--  210 (329)
                      +++++|.+++.. ....+++..+..++.|++.||.|||+. |++||||||+||+++.  ++.+||+|||++.......  
T Consensus        83 ~~g~~L~~~l~~-~~~~~~~~~~~~i~~qi~~al~~lH~~-givH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~~~~~~~~~  160 (321)
T 1tki_A           83 ISGLDIFERINT-SAFELNEREIVSYVHQVCEALQFLHSH-NIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNF  160 (321)
T ss_dssp             CCCCBHHHHHTS-SSCCCCHHHHHHHHHHHHHHHHHHHHT-TEECCCCCGGGEEESSSSCCCEEECCCTTCEECCTTCEE
T ss_pred             CCCCCHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHHC-CCCcCCCCHHHEEEccCCCCCEEEEECCCCeECCCCCcc
Confidence            999999999954 335799999999999999999999999 9999999999999987  7899999999998765543  


Q ss_pred             -CccCcccccCcccccCCCCCCcccchhhhHHHHHHHhCCCCCCchhhHHHhhhchhhhccccccCCCChHHHHHHHHHH
Q 020221          211 -SYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLA  289 (329)
Q Consensus       211 -~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li  289 (329)
                       ...+|+.|+|||++.+..++.++||||||+++|+|++|..||...................  ........++++.+++
T Consensus       161 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~--~~~~~~~~s~~~~~li  238 (321)
T 1tki_A          161 RLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTF--DEEAFKEISIEAMDFV  238 (321)
T ss_dssp             EEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCC--CHHHHTTSCHHHHHHH
T ss_pred             ccccCChhhcCcHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCcCCCHHHHHHHHHcCCCCC--ChhhhccCCHHHHHHH
Confidence             2457899999999998889999999999999999999999887654333322222111110  0000123577899999


Q ss_pred             HHhcccCCCCCCCHHHHHH
Q 020221          290 SRCLQYEPRERPNPRSLVT  308 (329)
Q Consensus       290 ~~cl~~dp~~Rps~~~~l~  308 (329)
                      .+||..||++|||+.++++
T Consensus       239 ~~~L~~dp~~Rpt~~e~l~  257 (321)
T 1tki_A          239 DRLLVKERKSRMTASEALQ  257 (321)
T ss_dssp             HTTSCSSGGGSCCHHHHHH
T ss_pred             HHHcCCChhHCcCHHHHhc
Confidence            9999999999999999998

>3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ...

Probab=100.00  E-value=6.6e-49  Score=345.73  Aligned_cols=259  Identities=19%  Similarity=0.292  Sum_probs=210.8

Q ss_pred             CcccccccCCCCCCcEEEEEEe-----CCCCEEEEEEeCCCCChhHHHHHHHHHHHhcCCCccccccceeeee--CCeeE
Q 020221           57 AMENIVSEHGEKAPNVVYKGKL-----ENQFRIAVKRFNRSAWPDARQFLEEARAVGQLRNRRLANLLGCCCE--GDERL  129 (329)
Q Consensus        57 ~~~~~~~~lg~G~~g~V~~~~~-----~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~--~~~~~  129 (329)
                      ..|++++.||+|+||+||++.+     .+++.||+|++........+.+.+|+++++.++||||+++++++..  ....+
T Consensus        10 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~   89 (295)
T 3ugc_A           10 RHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLK   89 (295)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECHHHHTSCE
T ss_pred             HHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCceE
Confidence            4577888999999999999984     3578999999987765666789999999999999999999999854  35689


Q ss_pred             EEEecCCCCCHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCCCCCeeeecccCcccCCCC
Q 020221          130 LVAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDG  209 (329)
Q Consensus       130 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~  209 (329)
                      +||||+++++|.+++.. ....+++..+..++.|++.||.|||+. +++||||||+||+++.++.+||+|||++......
T Consensus        90 lv~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~~qi~~~l~~lH~~-~ivH~Dikp~Nil~~~~~~~kl~Dfg~~~~~~~~  167 (295)
T 3ugc_A           90 LIMEYLPYGSLRDYLQK-HKERIDHIKLLQYTSQICKGMEYLGTK-RYIHRDLATRNILVENENRVKIGDFGLTKVLPQD  167 (295)
T ss_dssp             EEEECCTTCBHHHHHHH-CGGGCCHHHHHHHHHHHHHHHHHHHHT-TCCCSCCSGGGEEEEETTEEEECCCCSCC-----
T ss_pred             EEEEeCCCCCHHHHHHh-cccccCHHHHHHHHHHHHHHHHHHhcC-CcccCCCCHhhEEEcCCCeEEEccCcccccccCC
Confidence            99999999999999965 334589999999999999999999999 9999999999999999999999999999865433


Q ss_pred             C-------CccCcccccCcccccCCCCCCcccchhhhHHHHHHHhCCCCCCchhhHHHhh-----------hchhhhccc
Q 020221          210 R-------SYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRD-----------RNIQTLTDS  271 (329)
Q Consensus       210 ~-------~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~~~-----------~~~~~~~~~  271 (329)
                      .       ...++..|+|||.+.+..++.++||||||+++|+|++|..|+..........           .........
T Consensus       168 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  247 (295)
T 3ugc_A          168 KEFFKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLKN  247 (295)
T ss_dssp             --------CTTCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTTCTTCSHHHHHHHHHCTTCCTHHHHHHHHHHHHT
T ss_pred             cceeeeccCCCCccceeCcHHhcCCCCChHHHHHHHHHHHHHHHhcccccCCChHHHHhhhcCccccchhHHHHHHHHhc
Confidence            2       2345677999999998899999999999999999999998775443221110           011111122


Q ss_pred             cccCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhhcc
Q 020221          272 CLEGQFSSDEGTELVRLASRCLQYEPRERPNPRSLVTALVTLQKDT  317 (329)
Q Consensus       272 ~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~~~l~~L~~~~~~~  317 (329)
                      ......+..+++++.+++.+||+.||++|||+.++++.|+++.+..
T Consensus       248 ~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~el~~~L~~l~~~l  293 (295)
T 3ugc_A          248 NGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDNM  293 (295)
T ss_dssp             TCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHC-
T ss_pred             cCcCCCCcCcCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHHhc
Confidence            2233445677889999999999999999999999999999998754

>3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens}

Probab=100.00  E-value=2.9e-49  Score=356.38  Aligned_cols=244  Identities=18%  Similarity=0.235  Sum_probs=203.7

Q ss_pred             CCcccccccCCCCCCcEEEEEE-eCCCCEEEEEEeCCCC---ChhHHHHHHHHHHHhcC-CCccccccceeeeeCCeeEE
Q 020221           56 FAMENIVSEHGEKAPNVVYKGK-LENQFRIAVKRFNRSA---WPDARQFLEEARAVGQL-RNRRLANLLGCCCEGDERLL  130 (329)
Q Consensus        56 ~~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~l  130 (329)
                      ...|++++.||+|+||.||++. ..+++.||+|+++...   ....+.+.+|..+++.+ +||||+++++++.+.+..++
T Consensus        22 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~l  101 (353)
T 3txo_A           22 IDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTPDRLFF  101 (353)
T ss_dssp             -CCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEE
T ss_pred             hhheEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEEEeCCEEEE
Confidence            4567888889999999999999 4568999999997532   12345678899999988 79999999999999999999


Q ss_pred             EEecCCCCCHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCCCCCeeeecccCcccCCCC-
Q 020221          131 VAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDG-  209 (329)
Q Consensus       131 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~-  209 (329)
                      ||||+++|+|..++..  ...+++..++.++.||+.||+|||++ ||+||||||+|||++.++.+||+|||+++..... 
T Consensus       102 v~E~~~gg~L~~~l~~--~~~~~~~~~~~~~~qi~~aL~~LH~~-givHrDlkp~NILl~~~g~ikL~DFG~a~~~~~~~  178 (353)
T 3txo_A          102 VMEFVNGGDLMFHIQK--SRRFDEARARFYAAEIISALMFLHDK-GIIYRDLKLDNVLLDHEGHCKLADFGMCKEGICNG  178 (353)
T ss_dssp             EEECCCSCBHHHHHHH--HSSCCHHHHHHHHHHHHHHHHHHHHT-TCBCCCCCGGGEEECTTSCEEECCCTTCBCSCC--
T ss_pred             EEeCCCCCcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHC-CCcccCCCHHHEEECCCCCEEEccccceeecccCC
Confidence            9999999999999963  45799999999999999999999999 9999999999999999999999999999854322 


Q ss_pred             ---CCccCcccccCcccccCCCCCCcccchhhhHHHHHHHhCCCCCCchhhHHHhhhchhhhccccccCCCChHHHHHHH
Q 020221          210 ---RSYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELV  286 (329)
Q Consensus       210 ---~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  286 (329)
                         ....||+.|+|||++.+..++.++||||||+++|||++|..||...............      ...++...++++.
T Consensus       179 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~------~~~~p~~~~~~~~  252 (353)
T 3txo_A          179 VTTATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILND------EVVYPTWLHEDAT  252 (353)
T ss_dssp             -------CCGGGCCHHHHHHHHCTTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHC------CCCCCTTSCHHHH
T ss_pred             ccccccCCCcCeEChhhcCCCCcCCccCCCcchHHHHHHHhCCCCCCCCCHHHHHHHHHcC------CCCCCCCCCHHHH
Confidence               3456899999999999888999999999999999999999998766544333322221      1234555678899


Q ss_pred             HHHHHhcccCCCCCCCH------HHHHH
Q 020221          287 RLASRCLQYEPRERPNP------RSLVT  308 (329)
Q Consensus       287 ~li~~cl~~dp~~Rps~------~~~l~  308 (329)
                      +++.+||+.||++||++      .++++
T Consensus       253 ~li~~lL~~dP~~R~~~~~~~~~~~il~  280 (353)
T 3txo_A          253 GILKSFMTKNPTMRLGSLTQGGEHAILR  280 (353)
T ss_dssp             HHHHHHTCSSGGGSTTSGGGTCTHHHHT
T ss_pred             HHHHHHhhhCHHHccCCcccCCHHHHhh
Confidence            99999999999999998      66765

>2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens}

Probab=100.00  E-value=2e-48  Score=347.70  Aligned_cols=246  Identities=17%  Similarity=0.174  Sum_probs=204.6

Q ss_pred             cccccccCCCCCCcEEEEEEe-CCCCEEEEEEeCCCCCh------hHHHHHHHHHHHhcCCCccccccceeeeeCCeeEE
Q 020221           58 MENIVSEHGEKAPNVVYKGKL-ENQFRIAVKRFNRSAWP------DARQFLEEARAVGQLRNRRLANLLGCCCEGDERLL  130 (329)
Q Consensus        58 ~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~------~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l  130 (329)
                      .|++.+.||+|+||.||++.. .+++.||+|++......      ..+.+.+|+.+++.++||||+++++++.+....++
T Consensus        12 ~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~l   91 (326)
T 2y0a_A           12 YYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVIL   91 (326)
T ss_dssp             HEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred             ceEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEE
Confidence            367778889999999999994 56889999998764322      35678999999999999999999999999999999


Q ss_pred             EEecCCCCCHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCCCC----CeeeecccCcccC
Q 020221          131 VAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDV----NPRLSCFGLMKNS  206 (329)
Q Consensus       131 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~----~~kl~Dfg~a~~~  206 (329)
                      ||||+++++|.+++.  ....+++..+..++.|++.||.|||+. +++||||||+||+++.++    .+||+|||++...
T Consensus        92 v~e~~~~~~L~~~l~--~~~~~~~~~~~~i~~qi~~al~~lH~~-~ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg~a~~~  168 (326)
T 2y0a_A           92 ILELVAGGELFDFLA--EKESLTEEEATEFLKQILNGVYYLHSL-QIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKI  168 (326)
T ss_dssp             EEECCCSCBHHHHHT--TSSCCBHHHHHHHHHHHHHHHHHHHHT-TEECCCCCGGGEEESCSSSSSCCEEECCCTTCEEC
T ss_pred             EEEcCCCCCHHHHHH--hcCCcCHHHHHHHHHHHHHHHHHHHHC-CeEcCCCCHHHEEEecCCCCCCCEEEEECCCCeEC
Confidence            999999999999996  446799999999999999999999999 999999999999999887    7999999999865


Q ss_pred             CCC---CCccCcccccCcccccCCCCCCcccchhhhHHHHHHHhCCCCCCchhhHHHhhhchhhhccccccCCCChHHHH
Q 020221          207 RDG---RSYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGT  283 (329)
Q Consensus       207 ~~~---~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  283 (329)
                      ...   ....+|+.|+|||++.+..++.++||||||+++|+|++|..||..................  .........++
T Consensus       169 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~  246 (326)
T 2y0a_A          169 DFGNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYE--FEDEYFSNTSA  246 (326)
T ss_dssp             CTTSCCCCCCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHTCCC--CCHHHHTTSCH
T ss_pred             CCCCccccccCCcCcCCceeecCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHHhcCCC--cCccccccCCH
Confidence            433   3456899999999999889999999999999999999999988655433222211111000  00011123467


Q ss_pred             HHHHHHHHhcccCCCCCCCHHHHHH
Q 020221          284 ELVRLASRCLQYEPRERPNPRSLVT  308 (329)
Q Consensus       284 ~~~~li~~cl~~dp~~Rps~~~~l~  308 (329)
                      .+.+++.+||..||++|||+.++++
T Consensus       247 ~~~~li~~~L~~dP~~Rpt~~e~l~  271 (326)
T 2y0a_A          247 LAKDFIRRLLVKDPKKRMTIQDSLQ  271 (326)
T ss_dssp             HHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred             HHHHHHHHHccCChhhCCCHHHHhc
Confidence            8999999999999999999999998

>3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A*

Probab=100.00  E-value=1.1e-48  Score=339.62  Aligned_cols=252  Identities=20%  Similarity=0.320  Sum_probs=211.9

Q ss_pred             CcccccccCCCCCCcEEEEEEeCCCCEEEEEEeCCCCChhHHHHHHHHHHHhcCCCccccccceeeeeCCeeEEEEecCC
Q 020221           57 AMENIVSEHGEKAPNVVYKGKLENQFRIAVKRFNRSAWPDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAEYMP  136 (329)
Q Consensus        57 ~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~  136 (329)
                      ..|++++.||+|+||.||++...++..||+|++..... ..+.+.+|+++++.++||||+++++++.+....++||||++
T Consensus         8 ~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~   86 (268)
T 3sxs_A            8 EEITLLKELGSGQFGVVKLGKWKGQYDVAVKMIKEGSM-SEDEFFQEAQTMMKLSHPKLVKFYGVCSKEYPIYIVTEYIS   86 (268)
T ss_dssp             GGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECBTTB-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEEECCT
T ss_pred             hheeeeeeeccCCCceEEEEEecCceeEEEEEeccCCC-cHHHHHHHHHHHHhCCCCCEeeEEEEEccCCceEEEEEccC
Confidence            45778888999999999999988888899999987653 35678999999999999999999999999999999999999


Q ss_pred             CCCHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCCCCCeeeecccCcccCCCCC-----C
Q 020221          137 NDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDGR-----S  211 (329)
Q Consensus       137 ~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~-----~  211 (329)
                      +++|.+++.. ....+++..++.++.|++.||.|||+. |++|+||||+||+++.++.++|+|||++.......     .
T Consensus        87 ~~~L~~~l~~-~~~~~~~~~~~~i~~qi~~~l~~lH~~-~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~~  164 (268)
T 3sxs_A           87 NGCLLNYLRS-HGKGLEPSQLLEMCYDVCEGMAFLESH-QFIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQYVSSVG  164 (268)
T ss_dssp             TCBHHHHHHH-HGGGCCHHHHHHHHHHHHHHHHHHHHT-TEEESSCSGGGEEECTTCCEEECCTTCEEECCTTCEEECCS
T ss_pred             CCcHHHHHHH-cCCCCCHHHHHHHHHHHHHHHHHHHHC-CeecCCcCcceEEECCCCCEEEccCccceecchhhhhcccC
Confidence            9999999964 344689999999999999999999999 99999999999999999999999999997654432     2


Q ss_pred             ccCcccccCcccccCCCCCCcccchhhhHHHHHHHh-CCCCCCchhhHHHhhhchhhhccccccCCCChHHHHHHHHHHH
Q 020221          212 YSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLS-GKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLAS  290 (329)
Q Consensus       212 ~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t-g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~  290 (329)
                      ..+++.|+|||.+.+..++.++||||||+++|+|++ |..||..............     ......+...++++.+++.
T Consensus       165 ~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~-----~~~~~~~~~~~~~l~~li~  239 (268)
T 3sxs_A          165 TKFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYTNSEVVLKVSQ-----GHRLYRPHLASDTIYQIMY  239 (268)
T ss_dssp             CCCCGGGCCHHHHHHSEEETTHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHT-----TCCCCCCTTSCHHHHHHHH
T ss_pred             CCcCcccCCHHHHhccCCchhhhhHHHHHHHHHHHcCCCCCccccChHHHHHHHHc-----CCCCCCCCcChHHHHHHHH
Confidence            345678999999998889999999999999999999 8877754433222221111     1112234445778999999


Q ss_pred             HhcccCCCCCCCHHHHHHHHHhhhhc
Q 020221          291 RCLQYEPRERPNPRSLVTALVTLQKD  316 (329)
Q Consensus       291 ~cl~~dp~~Rps~~~~l~~L~~~~~~  316 (329)
                      +||+.||++|||+.++++.|+.+.+.
T Consensus       240 ~~l~~~p~~Rps~~~ll~~L~~l~~~  265 (268)
T 3sxs_A          240 SCWHELPEKRPTFQQLLSSIEPLREK  265 (268)
T ss_dssp             HTTCSSGGGSCCHHHHHHHHGGGCC-
T ss_pred             HHcCCChhhCcCHHHHHHHHHHhhhc
Confidence            99999999999999999999998764

>3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A

Probab=100.00  E-value=3.6e-48  Score=340.63  Aligned_cols=249  Identities=17%  Similarity=0.195  Sum_probs=200.2

Q ss_pred             CcccccccCCCCCCcEEEEEEe-CCCCEEEEEEeCCCCC--hhHHHHHHHHHHHhcCCCccccccceeeeeCCeeEEEEe
Q 020221           57 AMENIVSEHGEKAPNVVYKGKL-ENQFRIAVKRFNRSAW--PDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAE  133 (329)
Q Consensus        57 ~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  133 (329)
                      ..|++++.||+|+||+||+|.. .+++.||+|++.....  .....+.+|+.+++.++||||+++++++.+.+..++|||
T Consensus         2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   81 (292)
T 3o0g_A            2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE   81 (292)
T ss_dssp             CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             CCceeeeEecCCCCeEEEEEEECCCCceEEEEeeeccCCcCCcchHHHHHHHHHhcCCCCCEeeEEeEEEeCCEEEEEEe
Confidence            4678888999999999999994 5688999999976542  234678899999999999999999999999999999999


Q ss_pred             cCCCCCHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCCCCCeeeecccCcccCCCC----
Q 020221          134 YMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDG----  209 (329)
Q Consensus       134 ~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~----  209 (329)
                      |+++ +|.+.+.. ....+++..+..++.|++.||.|||++ |++||||||+||+++.++.+||+|||++......    
T Consensus        82 ~~~~-~l~~~~~~-~~~~l~~~~~~~~~~ql~~~l~~lH~~-~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~  158 (292)
T 3o0g_A           82 FCDQ-DLKKYFDS-CNGDLDPEIVKSFLFQLLKGLGFCHSR-NVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCY  158 (292)
T ss_dssp             CCSE-EHHHHHHH-TTTCCCHHHHHHHHHHHHHHHHHHHHT-TEECCCCSGGGEEECTTSCEEECCCTTCEECCSCCSCC
T ss_pred             cCCC-CHHHHHHh-CCCCCCHHHHHHHHHHHHHHHHHHHhC-CeecCCCCHHHEEEcCCCCEEEeecccceecCCccccc
Confidence            9986 56666644 456799999999999999999999999 9999999999999999999999999999765422    


Q ss_pred             CCccCcccccCcccccCCC-CCCcccchhhhHHHHHHHhCCCCCCchh-hHHHhhhchhhhccc----------------
Q 020221          210 RSYSTNLAFTPPEYLRTGR-VTPESVMYSFGTLLLDLLSGKHIPPSHA-LDLIRDRNIQTLTDS----------------  271 (329)
Q Consensus       210 ~~~~~~~~y~aPE~~~~~~-~~~~~DvwslG~il~el~tg~~~~~~~~-~~~~~~~~~~~~~~~----------------  271 (329)
                      ....+|+.|+|||++.+.. ++.++||||||+++|+|++|+.|+.... ..............+                
T Consensus       159 ~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~  238 (292)
T 3o0g_A          159 SAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYKP  238 (292)
T ss_dssp             CSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGGGSTTCCC
T ss_pred             cCCccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhhhhhhcccccccc
Confidence            3446789999999998766 8999999999999999999988764332 111111111000000                


Q ss_pred             -------cccCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 020221          272 -------CLEGQFSSDEGTELVRLASRCLQYEPRERPNPRSLVT  308 (329)
Q Consensus       272 -------~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~~~l~  308 (329)
                             ..........++++.+|+.+||+.||++|||+.++++
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~  282 (292)
T 3o0g_A          239 YPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQ  282 (292)
T ss_dssp             CCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             cccccCCcchhhcccccChHHHHHHHHHhccChhhCCCHHHHhc
Confidence                   0001122346788999999999999999999999998

>3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A*

Probab=100.00  E-value=1.8e-48  Score=345.68  Aligned_cols=251  Identities=20%  Similarity=0.238  Sum_probs=200.6

Q ss_pred             CCCcccccccCCCCCCcEEEEEEeCCCCEEEEEEeCCCCCh--hHHHHHHHHHHHhcCCCccccccceeeeeCCeeEEEE
Q 020221           55 GFAMENIVSEHGEKAPNVVYKGKLENQFRIAVKRFNRSAWP--DARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVA  132 (329)
Q Consensus        55 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~--~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~  132 (329)
                      -...|++++.||+|+||+||+|...+++.||+|++......  ....+.+|+++++.++||||+++++++.+....++||
T Consensus        19 l~~~y~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~   98 (311)
T 3niz_A           19 LMEKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVIHSERCLTLVF   98 (311)
T ss_dssp             SSCEEEEEEEEEECSSCEEEEEEETTSCEEEEEEEC------CHHHHHHHHHHHHHHCCCTTBCCEEEEECCSSCEEEEE
T ss_pred             hHhhhHhhhhccCCCCeEEEEEEECCCCEEEEEEEecccccchhhHHHHHHHHHHHHcCCCCEeeeeeEEccCCEEEEEE
Confidence            34678899999999999999999878999999999765322  2456889999999999999999999999999999999


Q ss_pred             ecCCCCCHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCCCCCeeeecccCcccCCCC---
Q 020221          133 EYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDG---  209 (329)
Q Consensus       133 e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~---  209 (329)
                      ||+++ +|.+++.. ....+++..+..++.|++.||.|||+. |++||||||+||+++.++.+||+|||++......   
T Consensus        99 e~~~~-~l~~~~~~-~~~~~~~~~~~~~~~qi~~~l~~LH~~-~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~~~  175 (311)
T 3niz_A           99 EFMEK-DLKKVLDE-NKTGLQDSQIKIYLYQLLRGVAHCHQH-RILHRDLKPQNLLINSDGALKLADFGLARAFGIPVRS  175 (311)
T ss_dssp             ECCSE-EHHHHHHT-CTTCCCHHHHHHHHHHHHHHHHHHHHT-TEECCCCCGGGEEECTTCCEEECCCTTCEETTSCCC-
T ss_pred             cCCCC-CHHHHHHh-ccCCCCHHHHHHHHHHHHHHHHHHHHC-CcccCCCchHhEEECCCCCEEEccCcCceecCCCccc
Confidence            99985 78888764 445699999999999999999999999 9999999999999999999999999999765422   


Q ss_pred             -CCccCcccccCcccccC-CCCCCcccchhhhHHHHHHHhCCCCCCchhhHHHhhhchhhhcccc---------------
Q 020221          210 -RSYSTNLAFTPPEYLRT-GRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSC---------------  272 (329)
Q Consensus       210 -~~~~~~~~y~aPE~~~~-~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~---------------  272 (329)
                       ....+|+.|+|||++.+ ..++.++||||||+++|+|++|..||..................+.               
T Consensus       176 ~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~  255 (311)
T 3niz_A          176 YTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKIFSILGTPNPREWPQVQELPLWKQ  255 (311)
T ss_dssp             --CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSTTTHHHHHHHHHCCCCTTTSGGGTTSHHHHS
T ss_pred             ccCCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHCCCChHHhhhhhccchhhh
Confidence             23467899999999876 4589999999999999999999988865322211111110000000               


Q ss_pred             --c---c----CCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 020221          273 --L---E----GQFSSDEGTELVRLASRCLQYEPRERPNPRSLVT  308 (329)
Q Consensus       273 --~---~----~~~~~~~~~~~~~li~~cl~~dp~~Rps~~~~l~  308 (329)
                        .   .    .......++++.+|+.+||+.||++|||+.++++
T Consensus       256 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  300 (311)
T 3niz_A          256 RTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMN  300 (311)
T ss_dssp             CCCCCCCCCCHHHHSTTCCHHHHHHHHHHSCSCTTTSCCHHHHHT
T ss_pred             cccccccCCcHHHhCcccCHHHHHHHHHHcCCChhHCCCHHHHhc
Confidence              0   0    0011234678999999999999999999999998

>3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A

Probab=100.00  E-value=8.4e-49  Score=354.76  Aligned_cols=251  Identities=17%  Similarity=0.127  Sum_probs=196.5

Q ss_pred             CCCcccccccCCCCCCcEEEEEEe-CCCCEEEEEEeCCCCChhHHHHHHHHHHHhcCCCccccccceeeeeCCeeEEEEe
Q 020221           55 GFAMENIVSEHGEKAPNVVYKGKL-ENQFRIAVKRFNRSAWPDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAE  133 (329)
Q Consensus        55 ~~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  133 (329)
                      ....|++++.||+|+||+||++.. .+++.||+|++...... .+.+.+|+.+++.++||||+++++++.+....++|||
T Consensus        18 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e   96 (361)
T 3uc3_A           18 DSDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAAI-DENVQREIINHRSLRHPNIVRFKEVILTPTHLAIIME   96 (361)
T ss_dssp             CTTTEEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESSTTS-CHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred             CCCcEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecCccc-cHHHHHHHHHHHhCCCCCCCcEEEEEeeCCEEEEEEE
Confidence            345688999999999999999994 57889999999765432 3568899999999999999999999999999999999


Q ss_pred             cCCCCCHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCCCCC--eeeecccCcccCCC---
Q 020221          134 YMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVN--PRLSCFGLMKNSRD---  208 (329)
Q Consensus       134 ~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~--~kl~Dfg~a~~~~~---  208 (329)
                      |+++|+|.+++..  ...+++..+..++.|++.||+|||++ |++||||||+||+++.++.  +||+|||+++....   
T Consensus        97 ~~~~~~L~~~l~~--~~~~~~~~~~~i~~ql~~~L~~LH~~-~ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a~~~~~~~~  173 (361)
T 3uc3_A           97 YASGGELYERICN--AGRFSEDEARFFFQQLLSGVSYCHSM-QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ  173 (361)
T ss_dssp             CCCSCBHHHHHHH--HSSCCHHHHHHHHHHHHHHHHHHHHT-TCCSCCCCGGGEEECSSSSCCEEECCCCCC--------
T ss_pred             eCCCCCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHC-CcccCCCCHHHEEEcCCCCceEEEeecCccccccccCC
Confidence            9999999999863  45699999999999999999999999 9999999999999987765  99999999874332   


Q ss_pred             CCCccCcccccCcccccCCCCCCc-ccchhhhHHHHHHHhCCCCCCchhhHHHhhhchhhhccccccCCCChHHHHHHHH
Q 020221          209 GRSYSTNLAFTPPEYLRTGRVTPE-SVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVR  287 (329)
Q Consensus       209 ~~~~~~~~~y~aPE~~~~~~~~~~-~DvwslG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  287 (329)
                      .....||+.|+|||++.+..++.+ +||||||+++|+|++|..||...............+.............++++.+
T Consensus       174 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~  253 (361)
T 3uc3_A          174 PKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRDYRKTIQRILSVKYSIPDDIRISPECCH  253 (361)
T ss_dssp             -------CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC----CCCHHHHHHHHHTTCCCCCTTSCCCHHHHH
T ss_pred             CCCCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhcCCCCCCCcCCCCHHHHH
Confidence            234568999999999988887665 8999999999999999998865322111111111111111111122245788999


Q ss_pred             HHHHhcccCCCCCCCHHHHHHH
Q 020221          288 LASRCLQYEPRERPNPRSLVTA  309 (329)
Q Consensus       288 li~~cl~~dp~~Rps~~~~l~~  309 (329)
                      |+.+||..||++|||+.+++++
T Consensus       254 li~~~L~~dP~~Rps~~ell~h  275 (361)
T 3uc3_A          254 LISRIFVADPATRISIPEIKTH  275 (361)
T ss_dssp             HHHHHSCSCTTTSCCHHHHHTS
T ss_pred             HHHHHccCChhHCcCHHHHHhC
Confidence            9999999999999999999973

>3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A

Probab=100.00  E-value=3.5e-48  Score=339.02  Aligned_cols=252  Identities=23%  Similarity=0.356  Sum_probs=210.6

Q ss_pred             CcccccccCCCCCCcEEEEEEeCCCCEEEEEEeCCCCChhHHHHHHHHHHHhcCCCccccccceeeeeCCeeEEEEecCC
Q 020221           57 AMENIVSEHGEKAPNVVYKGKLENQFRIAVKRFNRSAWPDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAEYMP  136 (329)
Q Consensus        57 ~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~  136 (329)
                      ..|++++.||+|+||+||++...++..||+|++..... ..+.+.+|+++++.++||||+++++++.+....++||||++
T Consensus        24 ~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~  102 (283)
T 3gen_A           24 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSM-SEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMA  102 (283)
T ss_dssp             GGEEEEEECC---CEEEEEEEETTTEEEEEEEECTTSB-CHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEECCCT
T ss_pred             HHHHhHhhcCCCCCceEEEEEEcCCCeEEEEEecCCCC-CHHHHHHHHHHHhcCCCCCEeeEEEEEecCCCeEEEEeccC
Confidence            45778889999999999999988888999999987653 35678999999999999999999999999999999999999


Q ss_pred             CCCHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCCCCCeeeecccCcccCCCC-----CC
Q 020221          137 NDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDG-----RS  211 (329)
Q Consensus       137 ~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~-----~~  211 (329)
                      +++|.+++.. ....+++..+..++.|++.||.|||++ +++|+||||+||+++.++.++|+|||++......     ..
T Consensus       103 ~~~L~~~l~~-~~~~~~~~~~~~i~~qi~~~l~~lH~~-~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~  180 (283)
T 3gen_A          103 NGCLLNYLRE-MRHRFQTQQLLEMCKDVCEAMEYLESK-QFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVG  180 (283)
T ss_dssp             TCBHHHHHHC-GGGCCCHHHHHHHHHHHHHHHHHHHHT-TCCCSSCSGGGEEECTTSCEEECSTTGGGGBCCHHHHSTTS
T ss_pred             CCcHHHHHHH-hccCCCHHHHHHHHHHHHHHHHHHHHC-CccCCCCccceEEEcCCCCEEEccccccccccccccccccC
Confidence            9999999964 245699999999999999999999999 9999999999999999999999999999765432     23


Q ss_pred             ccCcccccCcccccCCCCCCcccchhhhHHHHHHHh-CCCCCCchhhHHHhhhchhhhccccccCCCChHHHHHHHHHHH
Q 020221          212 YSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLS-GKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLAS  290 (329)
Q Consensus       212 ~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t-g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~  290 (329)
                      ..+++.|+|||.+.+..++.++||||||+++|+|++ |..||..............     ......+...++.+.+++.
T Consensus       181 ~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~-----~~~~~~~~~~~~~l~~li~  255 (283)
T 3gen_A          181 SKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQ-----GLRLYRPHLASEKVYTIMY  255 (283)
T ss_dssp             TTSCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHT-----TCCCCCCTTCCHHHHHHHH
T ss_pred             CccCcccCCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCccccChhHHHHHHhc-----ccCCCCCCcCCHHHHHHHH
Confidence            345778999999998889999999999999999998 8877765433322222111     1122234455788999999


Q ss_pred             HhcccCCCCCCCHHHHHHHHHhhhhc
Q 020221          291 RCLQYEPRERPNPRSLVTALVTLQKD  316 (329)
Q Consensus       291 ~cl~~dp~~Rps~~~~l~~L~~~~~~  316 (329)
                      +||+.||++|||+.+++++|+.+.++
T Consensus       256 ~~l~~~p~~Rps~~~ll~~L~~~~~~  281 (283)
T 3gen_A          256 SCWHEKADERPTFKILLSNILDVMDE  281 (283)
T ss_dssp             HTTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             HHccCChhHCcCHHHHHHHHHHHhhc
Confidence            99999999999999999999998764

>2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B

Probab=100.00  E-value=2.9e-48  Score=351.33  Aligned_cols=246  Identities=18%  Similarity=0.212  Sum_probs=205.3

Q ss_pred             cccccccCCCCCCcEEEEEEe-CCCCEEEEEEeCCCCC--hhHHHHHHHHHHHhcCCCccccccceeeeeCCeeEEEEec
Q 020221           58 MENIVSEHGEKAPNVVYKGKL-ENQFRIAVKRFNRSAW--PDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAEY  134 (329)
Q Consensus        58 ~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  134 (329)
                      .|++++.||+|+||.||++.. .+++.||+|++.....  ...+.+.+|+.+++.++||||+++++++.+.+..++||||
T Consensus        30 ~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~e~  109 (362)
T 2bdw_A           30 NYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVFDL  109 (362)
T ss_dssp             HEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECC
T ss_pred             CeEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEEec
Confidence            477888889999999999994 5688999999976543  2345688999999999999999999999999999999999


Q ss_pred             CCCCCHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCCC---CCeeeecccCcccCCCCC-
Q 020221          135 MPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDD---VNPRLSCFGLMKNSRDGR-  210 (329)
Q Consensus       135 ~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~---~~~kl~Dfg~a~~~~~~~-  210 (329)
                      +++|+|.+++.  ....+++..+..++.||+.||.|||++ ||+||||||+|||++.+   +.+||+|||++....... 
T Consensus       110 ~~gg~L~~~l~--~~~~~~~~~~~~~~~qi~~al~~lH~~-~ivH~Dlkp~NIll~~~~~~~~~kl~DfG~a~~~~~~~~  186 (362)
T 2bdw_A          110 VTGGELFEDIV--AREFYSEADASHCIQQILESIAYCHSN-GIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEA  186 (362)
T ss_dssp             CCSCBHHHHHT--TCSCCCHHHHHHHHHHHHHHHHHHHHT-TCBCCCCSGGGEEESCSSTTCCEEECCCTTCBCCTTCCS
T ss_pred             CCCCCHHHHHH--HcCCCCHHHHHHHHHHHHHHHHHHHHC-CeEeccCchHHEEEecCCCCCCEEEeecCcceEecCCcc
Confidence            99999999886  445789999999999999999999999 99999999999999865   459999999998765443 


Q ss_pred             --CccCcccccCcccccCCCCCCcccchhhhHHHHHHHhCCCCCCchhhHHHhhhchhhhccccccCCCChHHHHHHHHH
Q 020221          211 --SYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRL  288 (329)
Q Consensus       211 --~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  288 (329)
                        ...||+.|+|||++.+..++.++||||||+++|+|++|..||..................  .........++++.+|
T Consensus       187 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~i~~~~~~--~~~~~~~~~~~~~~~l  264 (362)
T 2bdw_A          187 WHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYD--YPSPEWDTVTPEAKSL  264 (362)
T ss_dssp             CCCSCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCC--CCTTGGGGSCHHHHHH
T ss_pred             cccCCCCccccCHHHHccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCC--CCcccccCCCHHHHHH
Confidence              356899999999999889999999999999999999999988765433332222211111  0111123467889999


Q ss_pred             HHHhcccCCCCCCCHHHHHH
Q 020221          289 ASRCLQYEPRERPNPRSLVT  308 (329)
Q Consensus       289 i~~cl~~dp~~Rps~~~~l~  308 (329)
                      +.+||+.||++|||+.++++
T Consensus       265 i~~~L~~dP~~R~t~~e~l~  284 (362)
T 2bdw_A          265 IDSMLTVNPKKRITADQALK  284 (362)
T ss_dssp             HHHHSCSSGGGSCCHHHHTT
T ss_pred             HHHHcCCChhhCcCHHHHhc
Confidence            99999999999999999987

>4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens}

Probab=100.00  E-value=2.6e-48  Score=353.23  Aligned_cols=248  Identities=17%  Similarity=0.221  Sum_probs=204.6

Q ss_pred             CCCcccccccCCCCCCcEEEEEE-eCCCCEEEEEEeCCCC---ChhHHHHHHHHHHHhcCCCccccccceeeeeCCeeEE
Q 020221           55 GFAMENIVSEHGEKAPNVVYKGK-LENQFRIAVKRFNRSA---WPDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLL  130 (329)
Q Consensus        55 ~~~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l  130 (329)
                      ++..|++++.||+|+||.||++. ..+++.||+|++....   ....+.+.+|+++++.++||||+++++++.+....++
T Consensus        13 ~~~~y~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~l   92 (384)
T 4fr4_A           13 NFDHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQDEEDMFM   92 (384)
T ss_dssp             CGGGEEEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEE
T ss_pred             ChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEE
Confidence            35668889999999999999999 5568899999986532   2235678899999999999999999999999999999


Q ss_pred             EEecCCCCCHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCCCCCeeeecccCcccCCCC-
Q 020221          131 VAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDG-  209 (329)
Q Consensus       131 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~-  209 (329)
                      ||||+.+|+|..++.  ....+++..+..++.||+.||.|||+. ||+||||||+|||++.++.+||+|||++...... 
T Consensus        93 v~e~~~gg~L~~~l~--~~~~l~~~~~~~~~~qi~~aL~~LH~~-givHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~~  169 (384)
T 4fr4_A           93 VVDLLLGGDLRYHLQ--QNVHFKEETVKLFICELVMALDYLQNQ-RIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRET  169 (384)
T ss_dssp             EECCCTTEEHHHHHH--TTCCCCHHHHHHHHHHHHHHHHHHHHT-TEECCCCSGGGEEECTTSCEEECCCTTCEECCTTC
T ss_pred             EEecCCCCcHHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHHC-CceeccCcHHHeEECCCCCEEEeccceeeeccCCC
Confidence            999999999999997  456799999999999999999999999 9999999999999999999999999999865443 


Q ss_pred             --CCccCcccccCcccccC---CCCCCcccchhhhHHHHHHHhCCCCCCchhhHHHhhhchhhhccccccCCCChHHHHH
Q 020221          210 --RSYSTNLAFTPPEYLRT---GRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTE  284 (329)
Q Consensus       210 --~~~~~~~~y~aPE~~~~---~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  284 (329)
                        ....||+.|+|||++.+   ..++.++||||||+++|+|++|..||.......... ....+..  ....++..++++
T Consensus       170 ~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~-~~~~~~~--~~~~~p~~~s~~  246 (384)
T 4fr4_A          170 QITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKE-IVHTFET--TVVTYPSAWSQE  246 (384)
T ss_dssp             CBCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCCTTSCHHH-HHHHHHH--CCCCCCTTSCHH
T ss_pred             ceeccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCCCCCccHHH-HHHHHhh--cccCCCCcCCHH
Confidence              34578999999999874   458999999999999999999999886432111100 0011111  112345667889


Q ss_pred             HHHHHHHhcccCCCCCCC-HHHHHH
Q 020221          285 LVRLASRCLQYEPRERPN-PRSLVT  308 (329)
Q Consensus       285 ~~~li~~cl~~dp~~Rps-~~~~l~  308 (329)
                      +.+|+.+||+.||++||+ +.++++
T Consensus       247 ~~~li~~lL~~dP~~R~s~~~~l~~  271 (384)
T 4fr4_A          247 MVSLLKKLLEPNPDQRFSQLSDVQN  271 (384)
T ss_dssp             HHHHHHHHSCSSGGGSCCSHHHHHT
T ss_pred             HHHHHHHHhcCCHhHhcccHHHHHc
Confidence            999999999999999998 666654

>1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7

Probab=100.00  E-value=2.7e-48  Score=354.01  Aligned_cols=248  Identities=19%  Similarity=0.153  Sum_probs=208.0

Q ss_pred             CcccccccCCCCCCcEEEEEEe-CCCCEEEEEEeCCCCChhHHHHHHHHHHHhcCCCccccccceeeeeCCeeEEEEecC
Q 020221           57 AMENIVSEHGEKAPNVVYKGKL-ENQFRIAVKRFNRSAWPDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAEYM  135 (329)
Q Consensus        57 ~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~  135 (329)
                      ..|++++.||+|+||.||+|.. .+++.||+|++..........+.+|+++++.++||||+++++++.+....++||||+
T Consensus        51 ~~y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~E~~  130 (387)
T 1kob_A           51 DYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFL  130 (387)
T ss_dssp             GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEECC
T ss_pred             cceEEEEEEecCCCEEEEEEEECCCCCEEEEEEecccchhhHHHHHHHHHHHHhCCCcCCCeEEEEEEeCCEEEEEEEcC
Confidence            4578888899999999999994 578899999998766555667899999999999999999999999999999999999


Q ss_pred             CCCCHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCC--CCCeeeecccCcccCCCCC---
Q 020221          136 PNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDD--DVNPRLSCFGLMKNSRDGR---  210 (329)
Q Consensus       136 ~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~--~~~~kl~Dfg~a~~~~~~~---  210 (329)
                      ++|+|.+++.. ....+++..+..++.||+.||.|||+. |++||||||+|||++.  ++.+||+|||++.......   
T Consensus       131 ~gg~L~~~l~~-~~~~l~~~~~~~i~~qi~~aL~~LH~~-givHrDlkp~NIll~~~~~~~vkL~DFG~a~~~~~~~~~~  208 (387)
T 1kob_A          131 SGGELFDRIAA-EDYKMSEAEVINYMRQACEGLKHMHEH-SIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVK  208 (387)
T ss_dssp             CCCBHHHHTTC-TTCCBCHHHHHHHHHHHHHHHHHHHHT-TEECCCCCGGGEEESSTTCCCEEECCCTTCEECCTTSCEE
T ss_pred             CCCcHHHHHHh-hcCCCCHHHHHHHHHHHHHHHHHHHhC-CeeecccchHHeEEecCCCCceEEEecccceecCCCccee
Confidence            99999999864 345789999999999999999999999 9999999999999974  5779999999998765443   


Q ss_pred             CccCcccccCcccccCCCCCCcccchhhhHHHHHHHhCCCCCCchhhHHHhhhchhhhccccccCCCChHHHHHHHHHHH
Q 020221          211 SYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLAS  290 (329)
Q Consensus       211 ~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~  290 (329)
                      ...+|+.|+|||++.+..++.++||||||+++|+|++|..||.................  ..........++++.+|+.
T Consensus       209 ~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~i~~~~~--~~~~~~~~~~s~~~~~li~  286 (387)
T 1kob_A          209 VTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDW--EFDEDAFSSVSPEAKDFIK  286 (387)
T ss_dssp             EECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHCCC--CCCSSTTTTSCHHHHHHHH
T ss_pred             eeccCCCccCchhccCCCCCCcccEeeHhHHHHHHHhCCCCCCCCCHHHHHHHHHhCCC--CCCccccccCCHHHHHHHH
Confidence            34689999999999998899999999999999999999998876433222221111111  1112223456789999999


Q ss_pred             HhcccCCCCCCCHHHHHH
Q 020221          291 RCLQYEPRERPNPRSLVT  308 (329)
Q Consensus       291 ~cl~~dp~~Rps~~~~l~  308 (329)
                      +||+.||++|||+.++++
T Consensus       287 ~~L~~dP~~Rpt~~ell~  304 (387)
T 1kob_A          287 NLLQKEPRKRLTVHDALE  304 (387)
T ss_dssp             TTSCSSGGGSCCHHHHHT
T ss_pred             HHcCCChhHCcCHHHHhh
Confidence            999999999999999997

>3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A*

Probab=100.00  E-value=5.8e-49  Score=357.93  Aligned_cols=253  Identities=25%  Similarity=0.358  Sum_probs=210.8

Q ss_pred             CcccccccCCCCCCcEEEEEEeC-CCCEEEEEEeCCCCCh-hHHHHHHHHHHHhcCCCccccccceeeeeCCeeEEEEec
Q 020221           57 AMENIVSEHGEKAPNVVYKGKLE-NQFRIAVKRFNRSAWP-DARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAEY  134 (329)
Q Consensus        57 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  134 (329)
                      +.+.+.+.||+|+||.||+|... +++.||||.++..... ..+.+.+|+++++.++||||+++++++......++||||
T Consensus       114 ~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~  193 (377)
T 3cbl_A          114 EDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMEL  193 (377)
T ss_dssp             GGEEEEEEEEEETTEEEEEEEETTTCCEEEEEECCTTSCHHHHTTTTHHHHHHTTCCCTTBCCEEEEECSSSSCEEEEEC
T ss_pred             HHeEEeeEeccCCCCeEEEEEEecCCeEEEEEEccccCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEecCCCcEEEEEc
Confidence            45667788999999999999964 7889999999865432 234588999999999999999999999988999999999


Q ss_pred             CCCCCHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCCCCCeeeecccCcccCCCCC----
Q 020221          135 MPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDGR----  210 (329)
Q Consensus       135 ~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~----  210 (329)
                      +++|+|.+++.. ....+++..+..++.|++.||+|||++ +++||||||+|||++.++.+||+|||+++......    
T Consensus       194 ~~~g~L~~~l~~-~~~~~~~~~~~~~~~qi~~~l~~LH~~-~ivHrDlkp~Nil~~~~~~~kl~DfG~s~~~~~~~~~~~  271 (377)
T 3cbl_A          194 VQGGDFLTFLRT-EGARLRVKTLLQMVGDAAAGMEYLESK-CCIHRDLAARNCLVTEKNVLKISDFGMSREEADGVYAAS  271 (377)
T ss_dssp             CTTCBHHHHHHH-HGGGCCHHHHHHHHHHHHHHHHHHHHT-TEECSCCSGGGEEECTTCCEEECCGGGCEECTTSEEECC
T ss_pred             CCCCCHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHHC-CcCCcccCHHHEEEcCCCcEEECcCCCceecCCCceeec
Confidence            999999999964 334689999999999999999999999 99999999999999999999999999997644321    


Q ss_pred             --CccCcccccCcccccCCCCCCcccchhhhHHHHHHHh-CCCCCCchhhHHHhhhchhhhccccccCCCChHHHHHHHH
Q 020221          211 --SYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLS-GKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVR  287 (329)
Q Consensus       211 --~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t-g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  287 (329)
                        ...+++.|+|||.+.+..++.++||||||+++|||++ |..|+...........     .....+...+..+++++.+
T Consensus       272 ~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t~g~~p~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~l~~  346 (377)
T 3cbl_A          272 GGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGASPYPNLSNQQTREF-----VEKGGRLPCPELCPDAVFR  346 (377)
T ss_dssp             SSCCEEEGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCSSTTSCHHHHHHH-----HHTTCCCCCCTTCCHHHHH
T ss_pred             CCCCCCCcCcCCHhHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHH-----HHcCCCCCCCCCCCHHHHH
Confidence              1224678999999998889999999999999999998 8877765433222211     1112223345567789999


Q ss_pred             HHHHhcccCCCCCCCHHHHHHHHHhhhhc
Q 020221          288 LASRCLQYEPRERPNPRSLVTALVTLQKD  316 (329)
Q Consensus       288 li~~cl~~dp~~Rps~~~~l~~L~~~~~~  316 (329)
                      ++.+||+.||++|||+.++++.|+.+.+.
T Consensus       347 li~~cl~~dP~~Rps~~~i~~~L~~i~~~  375 (377)
T 3cbl_A          347 LMEQCWAYEPGQRPSFSTIYQELQSIRKR  375 (377)
T ss_dssp             HHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             HHHHHcCCCchhCcCHHHHHHHHHHHHhh
Confidence            99999999999999999999999998764

>2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens}

Probab=100.00  E-value=2.1e-48  Score=343.14  Aligned_cols=245  Identities=16%  Similarity=0.185  Sum_probs=198.4

Q ss_pred             CCcccccccCCCCCCcEEEEEE-eCCCCEEEEEEeCCCCCh--------------------------hHHHHHHHHHHHh
Q 020221           56 FAMENIVSEHGEKAPNVVYKGK-LENQFRIAVKRFNRSAWP--------------------------DARQFLEEARAVG  108 (329)
Q Consensus        56 ~~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~--------------------------~~~~~~~e~~~l~  108 (329)
                      ...|++.+.||+|+||.||+|. ..+++.||+|++......                          ..+.+.+|+++++
T Consensus        12 ~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~   91 (298)
T 2zv2_A           12 LNQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAILK   91 (298)
T ss_dssp             ETTEEEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHHHH
T ss_pred             ecceEEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHHHH
Confidence            3567888889999999999998 456889999998754311                          1245889999999


Q ss_pred             cCCCccccccceeeee--CCeeEEEEecCCCCCHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCc
Q 020221          109 QLRNRRLANLLGCCCE--GDERLLVAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYR  186 (329)
Q Consensus       109 ~l~h~niv~~~~~~~~--~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~N  186 (329)
                      .++||||+++++++.+  ....++||||+++++|.+++   ....+++..+..++.|++.||.|||++ |++||||||+|
T Consensus        92 ~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~---~~~~~~~~~~~~~~~qi~~~l~~lH~~-~ivH~Dlkp~N  167 (298)
T 2zv2_A           92 KLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVP---TLKPLSEDQARFYFQDLIKGIEYLHYQ-KIIHRDIKPSN  167 (298)
T ss_dssp             TCCCTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSS---CSSCCCHHHHHHHHHHHHHHHHHHHHT-TEECCCCCGGG
T ss_pred             hCCCCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHh---hcCCCCHHHHHHHHHHHHHHHHHHHHC-CeeccCCCHHH
Confidence            9999999999999976  56899999999999998876   456799999999999999999999999 99999999999


Q ss_pred             eeeCCCCCeeeecccCcccCCCC----CCccCcccccCcccccCCC---CCCcccchhhhHHHHHHHhCCCCCCchhhHH
Q 020221          187 IVFDDDVNPRLSCFGLMKNSRDG----RSYSTNLAFTPPEYLRTGR---VTPESVMYSFGTLLLDLLSGKHIPPSHALDL  259 (329)
Q Consensus       187 il~~~~~~~kl~Dfg~a~~~~~~----~~~~~~~~y~aPE~~~~~~---~~~~~DvwslG~il~el~tg~~~~~~~~~~~  259 (329)
                      |+++.++.+||+|||++......    ....+|+.|+|||.+.+..   ++.++||||||+++|+|++|..||.......
T Consensus       168 il~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~  247 (298)
T 2zv2_A          168 LLVGEDGHIKIADFGVSNEFKGSDALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMDERIMC  247 (298)
T ss_dssp             EEECTTSCEEECCCTTCEECSSSSCEECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHHSSCSSCCSSHHH
T ss_pred             EEECCCCCEEEecCCCccccccccccccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCccHHH
Confidence            99999999999999999865543    2356899999999998765   3678999999999999999999887654332


Q ss_pred             HhhhchhhhccccccCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 020221          260 IRDRNIQTLTDSCLEGQFSSDEGTELVRLASRCLQYEPRERPNPRSLVT  308 (329)
Q Consensus       260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~~~l~  308 (329)
                      ........    ..........++++.+++.+||+.||++|||+.++++
T Consensus       248 ~~~~~~~~----~~~~~~~~~~~~~l~~li~~~l~~dp~~R~s~~e~l~  292 (298)
T 2zv2_A          248 LHSKIKSQ----ALEFPDQPDIAEDLKDLITRMLDKNPESRIVVPEIKL  292 (298)
T ss_dssp             HHHHHHHC----CCCCCSSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred             HHHHHhcc----cCCCCCccccCHHHHHHHHHHhhcChhhCCCHHHHhc
Confidence            22211111    1111122345778999999999999999999999987

>4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp}

Probab=100.00  E-value=3.4e-48  Score=341.23  Aligned_cols=257  Identities=17%  Similarity=0.247  Sum_probs=210.3

Q ss_pred             CcccccccCCCCCCcEEEEEE-eCCCCEEEEEEeCCCCC---hhHHHHHHHHHHHhcCCCccccccceeeeeCCeeEEEE
Q 020221           57 AMENIVSEHGEKAPNVVYKGK-LENQFRIAVKRFNRSAW---PDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVA  132 (329)
Q Consensus        57 ~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~  132 (329)
                      ..|++++.||+|+||.||++. ..+++.||+|.+.....   ...+.+.+|+.+++.++||||+++++++.+.+..++||
T Consensus        11 ~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~   90 (294)
T 4eqm_A           11 ERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVDEEDDCYYLVM   90 (294)
T ss_dssp             TTEEEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEEECSSEEEEEE
T ss_pred             ccEEEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEEeeeeCCeEEEEE
Confidence            357788889999999999999 45788999999865432   23456889999999999999999999999999999999


Q ss_pred             ecCCCCCHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCCCCCeeeecccCcccCCCC---
Q 020221          133 EYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDG---  209 (329)
Q Consensus       133 e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~---  209 (329)
                      ||+++++|.+++..  ...+++..+..++.|++.||.|||+. |++||||||+||+++.++.+||+|||++......   
T Consensus        91 e~~~g~~L~~~l~~--~~~~~~~~~~~~~~qi~~~l~~lH~~-~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~  167 (294)
T 4eqm_A           91 EYIEGPTLSEYIES--HGPLSVDTAINFTNQILDGIKHAHDM-RIVHRDIKPQNILIDSNKTLKIFDFGIAKALSETSLT  167 (294)
T ss_dssp             ECCCSCBHHHHHHH--HCSCCHHHHHHHHHHHHHHHHHHHHT-TCCCCCCCGGGEEECTTSCEEECCCSSSTTC------
T ss_pred             eCCCCCCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHC-CcccCCCCHHHEEECCCCCEEEEeCCCcccccccccc
Confidence            99999999999963  45799999999999999999999999 9999999999999999999999999999765433   


Q ss_pred             --CCccCcccccCcccccCCCCCCcccchhhhHHHHHHHhCCCCCCchhhHHHhhhchhhhccccccCCCChHHHHHHHH
Q 020221          210 --RSYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVR  287 (329)
Q Consensus       210 --~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  287 (329)
                        ....||+.|+|||.+.+..++.++||||||+++|+|++|..||................... .....+...++.+.+
T Consensus       168 ~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~l~~  246 (294)
T 4eqm_A          168 QTNHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPPFNGETAVSIAIKHIQDSVPN-VTTDVRKDIPQSLSN  246 (294)
T ss_dssp             -------CCSSCCHHHHHTCCCCTTHHHHHHHHHHHHHHHSSCSSCSSCHHHHHHHHHSSCCCC-HHHHSCTTSCHHHHH
T ss_pred             ccCccccCccccCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhhccCCC-cchhcccCCCHHHHH
Confidence              23457999999999999999999999999999999999999887654332222222111111 111233456788999


Q ss_pred             HHHHhcccCCCCCC-CHHHHHHHHHhhhhcc
Q 020221          288 LASRCLQYEPRERP-NPRSLVTALVTLQKDT  317 (329)
Q Consensus       288 li~~cl~~dp~~Rp-s~~~~l~~L~~~~~~~  317 (329)
                      ++.+||+.||++|| +++++.+.|+.+..+.
T Consensus       247 li~~~l~~dp~~R~~~~~~l~~~l~~~~~~~  277 (294)
T 4eqm_A          247 VILRATEKDKANRYKTIQEMKDDLSSVLHEN  277 (294)
T ss_dssp             HHHHHSCSSGGGSCSSHHHHHHHHHTSSSSS
T ss_pred             HHHHHhcCCHhHccccHHHHHHHHHHHHhhc
Confidence            99999999999998 9999999999987643

>1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B

Probab=100.00  E-value=2.1e-48  Score=362.58  Aligned_cols=254  Identities=20%  Similarity=0.307  Sum_probs=213.6

Q ss_pred             CcccccccCCCCCCcEEEEEEeCCCCEEEEEEeCCCCChhHHHHHHHHHHHhcCCCccccccceeeeeCCeeEEEEecCC
Q 020221           57 AMENIVSEHGEKAPNVVYKGKLENQFRIAVKRFNRSAWPDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAEYMP  136 (329)
Q Consensus        57 ~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~  136 (329)
                      ..+++.+.||+|+||.||+|...++..||||+++... ...+.+.+|+.+++.++||||+++++++. ....++||||++
T Consensus       188 ~~~~~~~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~l~~~~~-~~~~~lv~e~~~  265 (454)
T 1qcf_A          188 ESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGS-MSVEAFLAEANVMKTLQHDKLVKLHAVVT-KEPIYIITEFMA  265 (454)
T ss_dssp             GGEEEEEEEECCSSEEEEEEEETTTEEEEEEEECTTS-BCHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSSCEEEECCCT
T ss_pred             HHeEEEEEcccCCceEEEEEEECCccEEEEEEecCCC-ccHHHHHHHHHHHhhCCCCCEeeEEEEEe-CCccEEEEeecC
Confidence            3466778889999999999998888899999998755 34678999999999999999999999986 668999999999


Q ss_pred             CCCHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCCCCCeeeecccCcccCCCC-----CC
Q 020221          137 NDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDG-----RS  211 (329)
Q Consensus       137 ~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~-----~~  211 (329)
                      +|+|.+++.......+++..+..++.||+.||+|||++ +++||||||+|||++.++.+||+|||+++.....     ..
T Consensus       266 ~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~-~ivHrDlkp~Nill~~~~~~kl~DFG~a~~~~~~~~~~~~~  344 (454)
T 1qcf_A          266 KGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQR-NYIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREG  344 (454)
T ss_dssp             TCBHHHHHHSHHHHTCCHHHHHHHHHHHHHHHHHHHHT-TCCCSSCSGGGEEECTTCCEEECSTTGGGGBCCHHHHTTCS
T ss_pred             CCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhC-CccCCCCCHHHEEECCCCcEEEeeCCCceEcCCCceeccCC
Confidence            99999999743334689999999999999999999999 9999999999999999999999999999865432     22


Q ss_pred             ccCcccccCcccccCCCCCCcccchhhhHHHHHHHh-CCCCCCchhhHHHhhhchhhhccccccCCCChHHHHHHHHHHH
Q 020221          212 YSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLS-GKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLAS  290 (329)
Q Consensus       212 ~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t-g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~  290 (329)
                      ..+++.|+|||++.+..++.++||||||+++|||++ |..||..............     ..+...+..+++++.+++.
T Consensus       345 ~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~~-----~~~~~~~~~~~~~l~~li~  419 (454)
T 1qcf_A          345 AKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALER-----GYRMPRPENCPEELYNIMM  419 (454)
T ss_dssp             SSSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHH-----TCCCCCCTTSCHHHHHHHH
T ss_pred             CcccccccCHHHhccCCCCcHHHHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHc-----CCCCCCCCCCCHHHHHHHH
Confidence            345678999999998899999999999999999999 8888765433322222111     1222345567889999999


Q ss_pred             HhcccCCCCCCCHHHHHHHHHhhhhccc
Q 020221          291 RCLQYEPRERPNPRSLVTALVTLQKDTE  318 (329)
Q Consensus       291 ~cl~~dp~~Rps~~~~l~~L~~~~~~~~  318 (329)
                      +||+.||++|||+.++++.|+.+....+
T Consensus       420 ~cl~~dp~~RPt~~~i~~~L~~~~~~~~  447 (454)
T 1qcf_A          420 RCWKNRPEERPTFEYIQSVLDDFYTATE  447 (454)
T ss_dssp             HHTCSSGGGSCCHHHHHHHHHTSSSSSC
T ss_pred             HHccCChhHCcCHHHHHHHHHHHHhccc
Confidence            9999999999999999999999876543

>1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ...

Probab=100.00  E-value=3.2e-48  Score=349.28  Aligned_cols=245  Identities=17%  Similarity=0.175  Sum_probs=208.6

Q ss_pred             CCCcccccccCCCCCCcEEEEEEe-CCCCEEEEEEeCCCC---ChhHHHHHHHHHHHhcCCCccccccceeeeeCCeeEE
Q 020221           55 GFAMENIVSEHGEKAPNVVYKGKL-ENQFRIAVKRFNRSA---WPDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLL  130 (329)
Q Consensus        55 ~~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l  130 (329)
                      ....|++++.||+|+||.||++.. .+++.||+|++....   ....+.+.+|+.+++.++||||+++++++.+....++
T Consensus        39 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~l  118 (350)
T 1rdq_E           39 QLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYM  118 (350)
T ss_dssp             CGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEE
T ss_pred             CHHHCEEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEEE
Confidence            345688889999999999999994 578999999986532   1235678899999999999999999999999999999


Q ss_pred             EEecCCCCCHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCCCCCeeeecccCcccCCCC-
Q 020221          131 VAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDG-  209 (329)
Q Consensus       131 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~-  209 (329)
                      ||||+++|+|.+++.+  ...+++..+..++.||+.||.|||++ ||+||||||+|||++.++.+||+|||+++..... 
T Consensus       119 v~e~~~gg~L~~~l~~--~~~~~~~~~~~~~~qi~~aL~~LH~~-~ivHrDlkp~NIll~~~g~~kL~DFg~a~~~~~~~  195 (350)
T 1rdq_E          119 VMEYVAGGEMFSHLRR--IGRFSEPHARFYAAQIVLTFEYLHSL-DLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRT  195 (350)
T ss_dssp             EEECCTTCBHHHHHHH--HCCCCHHHHHHHHHHHHHHHHHHHHT-TEECCCCSGGGEEECTTSCEEECCCTTCEECSSCB
T ss_pred             EEcCCCCCcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHC-CcccccCccceEEECCCCCEEEcccccceeccCCc
Confidence            9999999999999973  35699999999999999999999999 9999999999999999999999999999865543 


Q ss_pred             CCccCcccccCcccccCCCCCCcccchhhhHHHHHHHhCCCCCCchhhHHHhhhchhhhccccccCCCChHHHHHHHHHH
Q 020221          210 RSYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLA  289 (329)
Q Consensus       210 ~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li  289 (329)
                      ....||+.|+|||++.+..++.++||||||+++|+|++|..||...............      ...++...++++.+++
T Consensus       196 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~------~~~~p~~~~~~~~~li  269 (350)
T 1rdq_E          196 WTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSG------KVRFPSHFSSDLKDLL  269 (350)
T ss_dssp             CCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHC------CCCCCTTCCHHHHHHH
T ss_pred             ccccCCccccCHHHhcCCCCCCcCCEecccHhHhHHhhCCCCCCCCCHHHHHHHHHcC------CCCCCCCCCHHHHHHH
Confidence            3457899999999999989999999999999999999999988765433332222211      1234556788999999


Q ss_pred             HHhcccCCCCCCC-----HHHHHH
Q 020221          290 SRCLQYEPRERPN-----PRSLVT  308 (329)
Q Consensus       290 ~~cl~~dp~~Rps-----~~~~l~  308 (329)
                      .+||+.||++||+     +.++++
T Consensus       270 ~~lL~~dp~~R~~~~~~~~~ei~~  293 (350)
T 1rdq_E          270 RNLLQVDLTKRFGNLKNGVNDIKN  293 (350)
T ss_dssp             HHHSCSCTTTCTTSSTTTTHHHHT
T ss_pred             HHHhhcCHHhccCCccCCHHHHHh
Confidence            9999999999998     788876

>3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A*

Probab=100.00  E-value=3.9e-48  Score=336.16  Aligned_cols=254  Identities=20%  Similarity=0.315  Sum_probs=212.4

Q ss_pred             CCCcccccccCCCCCCcEEEEEEeCCCCEEEEEEeCCCCC--hhHHHHHHHHHHHhcCCCccccccceeeeeC--CeeEE
Q 020221           55 GFAMENIVSEHGEKAPNVVYKGKLENQFRIAVKRFNRSAW--PDARQFLEEARAVGQLRNRRLANLLGCCCEG--DERLL  130 (329)
Q Consensus        55 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~--~~~~l  130 (329)
                      .+..|++++.||+|+||+||+|... +..||+|++.....  ...+.+.+|+.+++.++||||+++++++.+.  ...++
T Consensus         8 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~l   86 (271)
T 3kmu_A            8 DFKQLNFLTKLNENHSGELWKGRWQ-GNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAPHPTL   86 (271)
T ss_dssp             CGGGCEEEEEEEEETTEEEEEEEET-TEEEEEEEECCTTCCHHHHHHHHHHGGGGCCCSCTTEECEEEEECTTTSSSCEE
T ss_pred             CHHHhHHHHHhcCCCcceEEEEEEC-CeeEEEEEecccccCHHHHHHHHHHHHHHHhcCCCchhheEEEEccCCCCCeEe
Confidence            3466788889999999999999985 77899999987542  2345689999999999999999999999876  78899


Q ss_pred             EEecCCCCCHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCC--ccccccCCCceeeCCCCCeeeecccCcccCCC
Q 020221          131 VAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKER--ALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRD  208 (329)
Q Consensus       131 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~--ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~  208 (329)
                      ||||+++|+|.+++.......+++..++.++.|++.||.|||+. +  ++|+||||+||+++.++.++|+|||++.....
T Consensus        87 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~-~~~i~H~dikp~Nil~~~~~~~~l~~~~~~~~~~~  165 (271)
T 3kmu_A           87 ITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLHTL-EPLIPRHALNSRSVMIDEDMTARISMADVKFSFQS  165 (271)
T ss_dssp             EEECCTTCBHHHHHHSCSSCCCCHHHHHHHHHHHHHHHHHHTTS-SSCCTTCCCSGGGEEECTTSCEEEEGGGSCCTTSC
T ss_pred             eecccCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcC-CCceecCCCccceEEEcCCcceeEEeccceeeecc
Confidence            99999999999999764445689999999999999999999998 8  99999999999999999999999998765333


Q ss_pred             CCCccCcccccCcccccCCCCCC---cccchhhhHHHHHHHhCCCCCCchhhHHHhhhchhhhccccccCCCChHHHHHH
Q 020221          209 GRSYSTNLAFTPPEYLRTGRVTP---ESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTEL  285 (329)
Q Consensus       209 ~~~~~~~~~y~aPE~~~~~~~~~---~~DvwslG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  285 (329)
                       ....+|+.|+|||.+.+..++.   ++||||||+++|+|++|..||...........    ..........+...++++
T Consensus       166 -~~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~  240 (271)
T 3kmu_A          166 -PGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNMEIGMK----VALEGLRPTIPPGISPHV  240 (271)
T ss_dssp             -TTCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTSCHHHHHHH----HHHSCCCCCCCTTCCHHH
T ss_pred             -cCccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCccccChHHHHHH----HHhcCCCCCCCCCCCHHH
Confidence             3456789999999998766554   79999999999999999988865433322221    111222334556678899


Q ss_pred             HHHHHHhcccCCCCCCCHHHHHHHHHhhhh
Q 020221          286 VRLASRCLQYEPRERPNPRSLVTALVTLQK  315 (329)
Q Consensus       286 ~~li~~cl~~dp~~Rps~~~~l~~L~~~~~  315 (329)
                      .+++..||+.||++|||+.++++.|+++.+
T Consensus       241 ~~li~~~l~~~p~~Rps~~~il~~L~~l~~  270 (271)
T 3kmu_A          241 SKLMKICMNEDPAKRPKFDMIVPILEKMQD  270 (271)
T ss_dssp             HHHHHHHTCSSGGGSCCHHHHHHHHHHHCC
T ss_pred             HHHHHHHcCCChhhCcCHHHHHHHHHHhhc
Confidence            999999999999999999999999999865

>4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus}

Probab=100.00  E-value=2.7e-48  Score=354.35  Aligned_cols=244  Identities=16%  Similarity=0.216  Sum_probs=199.9

Q ss_pred             CCCcccccccCCCCCCcEEEEEE-eCCCCEEEEEEeCCCCCh---hHHHHHHHHHHHhcC-CCccccccceeeeeCCeeE
Q 020221           55 GFAMENIVSEHGEKAPNVVYKGK-LENQFRIAVKRFNRSAWP---DARQFLEEARAVGQL-RNRRLANLLGCCCEGDERL  129 (329)
Q Consensus        55 ~~~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~---~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~  129 (329)
                      ....+++++.||+|+||.||+++ ..+++.||+|+++.....   ..+.+.+|..++..+ +||||+++++++.+.+..+
T Consensus        50 ~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~  129 (396)
T 4dc2_A           50 GLQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLF  129 (396)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEE
T ss_pred             ChhHcEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEECCEEE
Confidence            44568888999999999999999 456889999999764322   233477899998887 8999999999999999999


Q ss_pred             EEEecCCCCCHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCCCCCeeeecccCcccCCC-
Q 020221          130 LVAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRD-  208 (329)
Q Consensus       130 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~-  208 (329)
                      +||||+++|+|..++.  ....+++..+..++.||+.||.|||++ ||+||||||+|||++.++.+||+|||+++.... 
T Consensus       130 lV~E~~~gg~L~~~l~--~~~~l~~~~~~~~~~qi~~aL~~LH~~-givHrDLKp~NILl~~~g~ikL~DFGla~~~~~~  206 (396)
T 4dc2_A          130 FVIEYVNGGDLMFHMQ--RQRKLPEEHARFYSAEISLALNYLHER-GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRP  206 (396)
T ss_dssp             EEEECCTTCBHHHHHH--HHSSCCHHHHHHHHHHHHHHHHHHHHT-TCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCT
T ss_pred             EEEEcCCCCcHHHHHH--HcCCCCHHHHHHHHHHHHHHHHHHHHC-CEEeccCCHHHEEECCCCCEEEeecceeeecccC
Confidence            9999999999999986  345799999999999999999999999 999999999999999999999999999975322 


Q ss_pred             ---CCCccCcccccCcccccCCCCCCcccchhhhHHHHHHHhCCCCCCchhhHHHh-----hhchhhhccccccCCCChH
Q 020221          209 ---GRSYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIR-----DRNIQTLTDSCLEGQFSSD  280 (329)
Q Consensus       209 ---~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~  280 (329)
                         .....||+.|+|||++.+..++.++||||||+++|||++|..||.........     ......+..  ....++..
T Consensus       207 ~~~~~~~~gt~~Y~aPE~l~~~~~~~~~DiwslGvllyell~G~~Pf~~~~~~~~~~~~~~~~~~~~i~~--~~~~~p~~  284 (396)
T 4dc2_A          207 GDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILE--KQIRIPRS  284 (396)
T ss_dssp             TCCBCCCCBCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSTTTTC------CCHHHHHHHHHH--CCCCCCTT
T ss_pred             CCccccccCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCcccccccccchhhHHHHHHHHhc--cccCCCCc
Confidence               23457899999999999999999999999999999999999988532111000     001111111  12235566


Q ss_pred             HHHHHHHHHHHhcccCCCCCCCH
Q 020221          281 EGTELVRLASRCLQYEPRERPNP  303 (329)
Q Consensus       281 ~~~~~~~li~~cl~~dp~~Rps~  303 (329)
                      .++++.+|+.+||+.||++||++
T Consensus       285 ~s~~~~~li~~lL~~dP~~R~~~  307 (396)
T 4dc2_A          285 LSVKAASVLKSFLNKDPKERLGC  307 (396)
T ss_dssp             SCHHHHHHHHHHTCSCTTTSTTC
T ss_pred             CCHHHHHHHHHHhcCCHhHcCCC
Confidence            78899999999999999999996

>1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A*

Probab=100.00  E-value=1.1e-48  Score=351.33  Aligned_cols=245  Identities=18%  Similarity=0.219  Sum_probs=205.2

Q ss_pred             CCCcccccccCCCCCCcEEEEEEe-CCCCEEEEEEeCCCC---ChhHHHHHHHHHHHhcC-CCccccccceeeeeCCeeE
Q 020221           55 GFAMENIVSEHGEKAPNVVYKGKL-ENQFRIAVKRFNRSA---WPDARQFLEEARAVGQL-RNRRLANLLGCCCEGDERL  129 (329)
Q Consensus        55 ~~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~  129 (329)
                      ....|.+++.||+|+||.||+|.. .+++.||+|+++...   ....+.+..|..++..+ +||||+++++++.+....+
T Consensus        15 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~~~~~~   94 (345)
T 1xjd_A           15 KIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLF   94 (345)
T ss_dssp             -CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEE
T ss_pred             ChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEeCCEEE
Confidence            345677888889999999999995 568899999997532   22345678899998876 8999999999999999999


Q ss_pred             EEEecCCCCCHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCCCCCeeeecccCcccCCC-
Q 020221          130 LVAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRD-  208 (329)
Q Consensus       130 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~-  208 (329)
                      +||||+++|+|.+++..  ...+++..+..++.||+.||.|||++ ||+||||||+|||++.++.+||+|||+++.... 
T Consensus        95 lv~E~~~gg~L~~~l~~--~~~~~~~~~~~~~~qi~~aL~~LH~~-~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~  171 (345)
T 1xjd_A           95 FVMEYLNGGDLMYHIQS--CHKFDLSRATFYAAEIILGLQFLHSK-GIVYRDLKLDNILLDKDGHIKIADFGMCKENMLG  171 (345)
T ss_dssp             EEEECCTTCBHHHHHHH--HSSCCHHHHHHHHHHHHHHHHHHHHT-TCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCT
T ss_pred             EEEeCCCCCcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHC-CeEeCCCChhhEEECCCCCEEEeEChhhhhcccC
Confidence            99999999999999963  35789999999999999999999999 999999999999999999999999999976432 


Q ss_pred             ---CCCccCcccccCcccccCCCCCCcccchhhhHHHHHHHhCCCCCCchhhHHHhhhchhhhccccccCCCChHHHHHH
Q 020221          209 ---GRSYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTEL  285 (329)
Q Consensus       209 ---~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  285 (329)
                         .....||+.|+|||++.+..++.++||||||+++|||++|..||...............      ...++...++++
T Consensus       172 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~------~~~~p~~~s~~~  245 (345)
T 1xjd_A          172 DAKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMD------NPFYPRWLEKEA  245 (345)
T ss_dssp             TCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHC------CCCCCTTSCHHH
T ss_pred             CCcccCCCCCcccCChhhhcCCCCCChhhhHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhC------CCCCCcccCHHH
Confidence               23457899999999999989999999999999999999999988765443332222111      123455677899


Q ss_pred             HHHHHHhcccCCCCCCCHH-HHHH
Q 020221          286 VRLASRCLQYEPRERPNPR-SLVT  308 (329)
Q Consensus       286 ~~li~~cl~~dp~~Rps~~-~~l~  308 (329)
                      .+++.+||..||++||++. ++++
T Consensus       246 ~~li~~lL~~dp~~R~~~~~~i~~  269 (345)
T 1xjd_A          246 KDLLVKLFVREPEKRLGVRGDIRQ  269 (345)
T ss_dssp             HHHHHHHSCSSGGGSBTTBSCGGG
T ss_pred             HHHHHHHhcCCHhHcCCChHHHHc
Confidence            9999999999999999997 6654

>2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A*

Probab=100.00  E-value=3.2e-47  Score=336.81  Aligned_cols=272  Identities=28%  Similarity=0.470  Sum_probs=222.1

Q ss_pred             cccccCHHHHHHHhcCCCcccc---cccCCCCCCcEEEEEEeCCCCEEEEEEeCCCC----ChhHHHHHHHHHHHhcCCC
Q 020221           40 VFCEYSIETLRTATSGFAMENI---VSEHGEKAPNVVYKGKLENQFRIAVKRFNRSA----WPDARQFLEEARAVGQLRN  112 (329)
Q Consensus        40 ~~~~~~~~~~~~~~~~~~~~~~---~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~----~~~~~~~~~e~~~l~~l~h  112 (329)
                      ....|++.++..++++|+...+   .+.||+|+||.||+|.. +++.||+|++....    ....+.+.+|+.+++.++|
T Consensus        11 ~~~~~~~~~l~~~~~~f~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h   89 (307)
T 2nru_A           11 RFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQH   89 (307)
T ss_dssp             CCEECCHHHHHHHTTTTCCSBTTTTCCEEEECSSEEEEEEES-SSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCCC
T ss_pred             CCCcccHHHHHHHHcccccccccccCCccccCCCeEEEEEEE-CCceEEEEEEecccCcchHHHHHHHHHHHHHHHhcCC
Confidence            4577899999999999987632   25569999999999987 56799999987542    2335678999999999999


Q ss_pred             ccccccceeeeeCCeeEEEEecCCCCCHHhhhccC-CCCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCC
Q 020221          113 RRLANLLGCCCEGDERLLVAEYMPNDTLAKHLFHW-ETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDD  191 (329)
Q Consensus       113 ~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~-~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~  191 (329)
                      |||+++++++.+.+..++||||+++++|.+++... ....+++..++.++.|++.||.|||+. |++|+||||+||+++.
T Consensus        90 ~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~-~i~H~dlkp~Nili~~  168 (307)
T 2nru_A           90 ENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHEN-HHIHRDIKSANILLDE  168 (307)
T ss_dssp             TTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHTGGGCCCCCHHHHHHHHHHHHHHHHHHHHT-TEECSCCCGGGEEECT
T ss_pred             CCeEEEEEEEecCCceEEEEEecCCCcHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhcC-CeecCCCCHHHEEEcC
Confidence            99999999999999999999999999999998642 235689999999999999999999999 9999999999999999


Q ss_pred             CCCeeeecccCcccCCCC------CCccCcccccCcccccCCCCCCcccchhhhHHHHHHHhCCCCCCchhhHH----Hh
Q 020221          192 DVNPRLSCFGLMKNSRDG------RSYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDL----IR  261 (329)
Q Consensus       192 ~~~~kl~Dfg~a~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~----~~  261 (329)
                      ++.++|+|||++......      ....+++.|+|||.+.+ .++.++||||||+++|+|++|..||.......    +.
T Consensus       169 ~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~  247 (307)
T 2nru_A          169 AFTAKISDFGLARASEKFAQTVMTSRIVGTTAYMAPEALRG-EITPKSDIYSFGVVLLEIITGLPAVDEHREPQLLLDIK  247 (307)
T ss_dssp             TCCEEECCCTTCEECCSCSSCEECSSCCSCGGGCCHHHHTT-EECTHHHHHHHHHHHHHHHHCCCSBCTTBSSSBTTHHH
T ss_pred             CCcEEEeecccccccccccccccccccCCCcCcCChHHhcC-CCCccchhHHHHHHHHHHHHCCCCcccCcchHHHHHHH
Confidence            999999999998765432      23467899999998874 58889999999999999999998875432111    00


Q ss_pred             h------hchhhhccccccCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhh
Q 020221          262 D------RNIQTLTDSCLEGQFSSDEGTELVRLASRCLQYEPRERPNPRSLVTALVTLQK  315 (329)
Q Consensus       262 ~------~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~~~l~~L~~~~~  315 (329)
                      .      .......+.. ....+...++.+.+++.+||+.||++|||+.++++.|+++..
T Consensus       248 ~~~~~~~~~~~~~~~~~-~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~l~~~L~~l~~  306 (307)
T 2nru_A          248 EEIEDEEKTIEDYIDKK-MNDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQEMTA  306 (307)
T ss_dssp             HHHHTTSCCHHHHSCSS-CSCCCHHHHHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHC-
T ss_pred             HHhhhhhhhhhhhcccc-ccccchHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHhc
Confidence            0      0011111211 123456788999999999999999999999999999998753

>3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A*

Probab=100.00  E-value=1.9e-48  Score=347.25  Aligned_cols=247  Identities=17%  Similarity=0.135  Sum_probs=201.3

Q ss_pred             CCcccccccCCCCCCcEEEEEEe-CCCCEEEEEEeCCCCCh-hHHHHHHHHHHHhcCCCccccccceeeeeCCeeEEEEe
Q 020221           56 FAMENIVSEHGEKAPNVVYKGKL-ENQFRIAVKRFNRSAWP-DARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAE  133 (329)
Q Consensus        56 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  133 (329)
                      +..|++++.||+|+||+||++.. .+++.||+|++...... ..+.+.+|+.+++.++||||+++++++.+++..++|||
T Consensus         6 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e   85 (323)
T 3tki_A            6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLE   85 (323)
T ss_dssp             TTCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred             hhhceeeeEEecCCCEEEEEEEECCCCcEEEEEEEEcccccchHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEEEE
Confidence            46788889999999999999994 47889999998755422 23558899999999999999999999999999999999


Q ss_pred             cCCCCCHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCCCCCeeeecccCcccCCCC----
Q 020221          134 YMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDG----  209 (329)
Q Consensus       134 ~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~----  209 (329)
                      |+++++|.+++.  ....+++..+..++.|++.||.|||+. |++||||||+||+++.++.+||+|||++......    
T Consensus        86 ~~~~~~L~~~l~--~~~~~~~~~~~~i~~qi~~aL~~LH~~-givH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~  162 (323)
T 3tki_A           86 YCSGGELFDRIE--PDIGMPEPDAQRFFHQLMAGVVYLHGI-GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRER  162 (323)
T ss_dssp             CCTTEEGGGGSB--TTTBCCHHHHHHHHHHHHHHHHHHHHT-TEECSCCSGGGEEECTTCCEEECCCTTCEECEETTEEC
T ss_pred             cCCCCcHHHHHh--hcCCCCHHHHHHHHHHHHHHHHHHHHC-CccccccchHHEEEeCCCCEEEEEeeccceeccCCccc
Confidence            999999999986  445799999999999999999999999 9999999999999999999999999999754322    


Q ss_pred             --CCccCcccccCcccccCCCC-CCcccchhhhHHHHHHHhCCCCCCchhhHHHhhhchhhhccccccCCCChHHHHHHH
Q 020221          210 --RSYSTNLAFTPPEYLRTGRV-TPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELV  286 (329)
Q Consensus       210 --~~~~~~~~y~aPE~~~~~~~-~~~~DvwslG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  286 (329)
                        ....||+.|+|||++.+..+ +.++||||||+++|+|++|..||...........   ...............++++.
T Consensus       163 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~  239 (323)
T 3tki_A          163 LLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYS---DWKEKKTYLNPWKKIDSAPL  239 (323)
T ss_dssp             CBCSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSCTTSHHHH---HHHTTCTTSTTGGGSCHHHH
T ss_pred             ccCCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCchHHHHHH---HHhcccccCCccccCCHHHH
Confidence              24568999999999987775 6789999999999999999998864322111100   00111111111245678899


Q ss_pred             HHHHHhcccCCCCCCCHHHHHH
Q 020221          287 RLASRCLQYEPRERPNPRSLVT  308 (329)
Q Consensus       287 ~li~~cl~~dp~~Rps~~~~l~  308 (329)
                      +|+.+||..||++|||+.++++
T Consensus       240 ~li~~~L~~dP~~R~t~~eil~  261 (323)
T 3tki_A          240 ALLHKILVENPSARITIPDIKK  261 (323)
T ss_dssp             HHHHHHSCSSTTTSCCHHHHTT
T ss_pred             HHHHHHccCChhhCcCHHHHhh
Confidence            9999999999999999999987

>1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A

Probab=100.00  E-value=5.2e-48  Score=338.99  Aligned_cols=249  Identities=17%  Similarity=0.235  Sum_probs=200.6

Q ss_pred             CcccccccCCCCCCcEEEEEEeCCCCEEEEEEeCCCCCh--hHHHHHHHHHHHhcCCCccccccceeeeeCCeeEEEEec
Q 020221           57 AMENIVSEHGEKAPNVVYKGKLENQFRIAVKRFNRSAWP--DARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAEY  134 (329)
Q Consensus        57 ~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~--~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  134 (329)
                      +.|++++.||+|+||+||+|...+++.||+|++......  ..+.+.+|+++++.++||||+++++++.+.+..++||||
T Consensus         2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~   81 (288)
T 1ob3_A            2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEH   81 (288)
T ss_dssp             CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred             ccchhhhhcccCCCEEEEEEEcCCCCEEEEEEEeccccccccchhHHHHHHHHHhcCCCCEeeeeeEEccCCeEEEEEEe
Confidence            467888899999999999999878899999999765422  235688999999999999999999999999999999999


Q ss_pred             CCCCCHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCCCCCeeeecccCcccCCCC----C
Q 020221          135 MPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDG----R  210 (329)
Q Consensus       135 ~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~----~  210 (329)
                      +++ +|.+++.. ....+++..+..++.|++.||.|||++ |++||||||+||+++.++.+||+|||++......    .
T Consensus        82 ~~~-~l~~~~~~-~~~~~~~~~~~~~~~qi~~~l~~lH~~-~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~  158 (288)
T 1ob3_A           82 LDQ-DLKKLLDV-CEGGLESVTAKSFLLQLLNGIAYCHDR-RVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYT  158 (288)
T ss_dssp             CSE-EHHHHHHT-STTCCCHHHHHHHHHHHHHHHHHHHHT-TCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC------
T ss_pred             cCC-CHHHHHHh-cccCCCHHHHHHHHHHHHHHHHHHHHC-CeecCCCCHHHEEEcCCCCEEEeECccccccCccccccc
Confidence            986 89998864 346789999999999999999999999 9999999999999999999999999998754322    2


Q ss_pred             CccCcccccCcccccCC-CCCCcccchhhhHHHHHHHhCCCCCCchhhHHHhhhchhhhc----------------cccc
Q 020221          211 SYSTNLAFTPPEYLRTG-RVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLT----------------DSCL  273 (329)
Q Consensus       211 ~~~~~~~y~aPE~~~~~-~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~~~~~~~~~~----------------~~~~  273 (329)
                      ...+|+.|+|||++.+. .++.++||||||+++|+|++|..||.................                .+..
T Consensus       159 ~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (288)
T 1ob3_A          159 HEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDPNF  238 (288)
T ss_dssp             ---CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTCCTTC
T ss_pred             cccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHHCCCChhhchhhhccccccccc
Confidence            34678999999998764 489999999999999999999988865432221111111000                0000


Q ss_pred             -------cCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 020221          274 -------EGQFSSDEGTELVRLASRCLQYEPRERPNPRSLVT  308 (329)
Q Consensus       274 -------~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~~~l~  308 (329)
                             ........++++.+++.+||+.||++|||+.++++
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~  280 (288)
T 1ob3_A          239 TVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE  280 (288)
T ss_dssp             CCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             ccccCccHHHHhhhcCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence                   00112345788999999999999999999999998

>3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A*

Probab=100.00  E-value=5.7e-48  Score=347.04  Aligned_cols=243  Identities=16%  Similarity=0.226  Sum_probs=199.9

Q ss_pred             CCcccccccCCCCCCcEEEEEEe-CCCCEEEEEEeCCCCC---hhHHHHHHHHHHHhcC-CCccccccceeeeeCCeeEE
Q 020221           56 FAMENIVSEHGEKAPNVVYKGKL-ENQFRIAVKRFNRSAW---PDARQFLEEARAVGQL-RNRRLANLLGCCCEGDERLL  130 (329)
Q Consensus        56 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~l  130 (329)
                      ...|++++.||+|+||.||++.. .+++.||+|++.....   ...+.+.+|..++..+ +||||+++++++.+....++
T Consensus         8 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~l   87 (345)
T 3a8x_A            8 LQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFF   87 (345)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEE
T ss_pred             hhheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEeCCEEEE
Confidence            35678888899999999999994 5688999999976432   2345578899999988 89999999999999999999


Q ss_pred             EEecCCCCCHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCCCCCeeeecccCcccCCC--
Q 020221          131 VAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRD--  208 (329)
Q Consensus       131 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~--  208 (329)
                      ||||+++|+|.+++.+  ...+++..++.++.||+.||.|||++ ||+||||||+|||++.++.+||+|||+++....  
T Consensus        88 v~e~~~gg~L~~~l~~--~~~l~~~~~~~~~~qi~~aL~~LH~~-~ivHrDlkp~NIll~~~g~~kL~DFG~a~~~~~~~  164 (345)
T 3a8x_A           88 VIEYVNGGDLMFHMQR--QRKLPEEHARFYSAEISLALNYLHER-GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPG  164 (345)
T ss_dssp             EECCCCSCBHHHHHHH--HSSCCHHHHHHHHHHHHHHHHHHHHT-TCBCCCCCGGGEEECTTSCEEECCGGGCBCSCCTT
T ss_pred             EEeCCCCCcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHC-CceecCCCHHHEEECCCCCEEEEeccccccccCCC
Confidence            9999999999999863  35799999999999999999999999 999999999999999999999999999975322  


Q ss_pred             --CCCccCcccccCcccccCCCCCCcccchhhhHHHHHHHhCCCCCCchhhHH-----HhhhchhhhccccccCCCChHH
Q 020221          209 --GRSYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDL-----IRDRNIQTLTDSCLEGQFSSDE  281 (329)
Q Consensus       209 --~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~  281 (329)
                        .....||+.|+|||++.+..++.++||||||+++|||++|..||.......     ........+...  ...++...
T Consensus       165 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~i~~~--~~~~p~~~  242 (345)
T 3a8x_A          165 DTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEK--QIRIPRSL  242 (345)
T ss_dssp             CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTTTC-------CHHHHHHHHHHC--CCCCCTTS
T ss_pred             CcccccCCCccccCccccCCCCCChHHhHHHHHHHHHHHHhCCCCcCCcccccccccccHHHHHHHHHcC--CCCCCCCC
Confidence              234578999999999999899999999999999999999998885311100     000001111111  12345667


Q ss_pred             HHHHHHHHHHhcccCCCCCCCH
Q 020221          282 GTELVRLASRCLQYEPRERPNP  303 (329)
Q Consensus       282 ~~~~~~li~~cl~~dp~~Rps~  303 (329)
                      ++++.+++.+||+.||++||++
T Consensus       243 s~~~~~li~~lL~~dP~~R~~~  264 (345)
T 3a8x_A          243 SVKAASVLKSFLNKDPKERLGC  264 (345)
T ss_dssp             CHHHHHHHHHHTCSSTTTSTTC
T ss_pred             CHHHHHHHHHHhcCCHhHCCCC
Confidence            8899999999999999999996

>3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens}

Probab=100.00  E-value=2.7e-48  Score=352.21  Aligned_cols=256  Identities=21%  Similarity=0.313  Sum_probs=210.9

Q ss_pred             CcccccccCCCCCCcEEEEEEeC------CCCEEEEEEeCCCCC-hhHHHHHHHHHHHhcCCCccccccceeeeeCCeeE
Q 020221           57 AMENIVSEHGEKAPNVVYKGKLE------NQFRIAVKRFNRSAW-PDARQFLEEARAVGQLRNRRLANLLGCCCEGDERL  129 (329)
Q Consensus        57 ~~~~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~  129 (329)
                      ..+++++.||+|+||+||+|.+.      +++.||||++..... .....+.+|+.+++.++||||+++++++......+
T Consensus        71 ~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~  150 (367)
T 3l9p_A           71 KNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPRF  150 (367)
T ss_dssp             GGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCE
T ss_pred             hHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEecccccChhhHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCCE
Confidence            45678888999999999999843      466899999976533 33456889999999999999999999999999999


Q ss_pred             EEEecCCCCCHHhhhccCC-----CCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCCCC---Ceeeeccc
Q 020221          130 LVAEYMPNDTLAKHLFHWE-----TQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDV---NPRLSCFG  201 (329)
Q Consensus       130 lv~e~~~~gsL~~~l~~~~-----~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~---~~kl~Dfg  201 (329)
                      +||||+++|+|.+++....     ...+++.+++.++.||+.||.|||++ ||+||||||+|||++.++   .+||+|||
T Consensus       151 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~-~ivHrDlkp~NIll~~~~~~~~~kL~DFG  229 (367)
T 3l9p_A          151 ILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEEN-HFIHRDIAARNCLLTCPGPGRVAKIGDFG  229 (367)
T ss_dssp             EEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHHT-TCCCSCCCGGGEEESCSSTTCCEEECCCH
T ss_pred             EEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHhC-CeeCCCCChhhEEEecCCCCceEEECCCc
Confidence            9999999999999997532     24589999999999999999999999 999999999999999555   59999999


Q ss_pred             CcccC------CCCCCccCcccccCcccccCCCCCCcccchhhhHHHHHHHh-CCCCCCchhhHHHhhhchhhhcccccc
Q 020221          202 LMKNS------RDGRSYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLS-GKHIPPSHALDLIRDRNIQTLTDSCLE  274 (329)
Q Consensus       202 ~a~~~------~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t-g~~~~~~~~~~~~~~~~~~~~~~~~~~  274 (329)
                      +++..      .......+|+.|+|||++.+..++.++||||||+++|||++ |..||..............     ...
T Consensus       230 ~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~pf~~~~~~~~~~~i~~-----~~~  304 (367)
T 3l9p_A          230 MARDIYRAGYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTS-----GGR  304 (367)
T ss_dssp             HHHHHHHHSSCTTCCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHT-----TCC
T ss_pred             cccccccccccccCCCcCCcccEECHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHc-----CCC
Confidence            98643      22234456889999999998899999999999999999998 8877765443332222111     112


Q ss_pred             CCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhhccc
Q 020221          275 GQFSSDEGTELVRLASRCLQYEPRERPNPRSLVTALVTLQKDTE  318 (329)
Q Consensus       275 ~~~~~~~~~~~~~li~~cl~~dp~~Rps~~~~l~~L~~~~~~~~  318 (329)
                      ...+..+++++.+++.+||+.||++|||+.++++.|+.+.....
T Consensus       305 ~~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~l~~~~~~~~  348 (367)
T 3l9p_A          305 MDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQDPD  348 (367)
T ss_dssp             CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHCHH
T ss_pred             CCCCccCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhhChh
Confidence            23345667889999999999999999999999999999987654

>3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A*

Probab=100.00  E-value=1.8e-48  Score=347.34  Aligned_cols=256  Identities=15%  Similarity=0.201  Sum_probs=202.6

Q ss_pred             CcccccccCCCCCCcEEEEEEeCCCCEEEEEEeCCCCChhHHHHHHHHHHHhcCCCccccccceeeeeCC----eeEEEE
Q 020221           57 AMENIVSEHGEKAPNVVYKGKLENQFRIAVKRFNRSAWPDARQFLEEARAVGQLRNRRLANLLGCCCEGD----ERLLVA  132 (329)
Q Consensus        57 ~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~----~~~lv~  132 (329)
                      ..|++++.||+|+||+||+|... ++.||||++.... .......+|+.+++.++||||+++++++....    ..++||
T Consensus        24 ~~y~~~~~lg~G~~g~Vy~~~~~-~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~lv~  101 (322)
T 3soc_A           24 MPLQLLEVKARGRFGCVWKAQLL-NEYVAVKIFPIQD-KQSWQNEYEVYSLPGMKHENILQFIGAEKRGTSVDVDLWLIT  101 (322)
T ss_dssp             EEEEEEEEEECSTTCEEEEEEET-TEEEEEEEECGGG-HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEE
T ss_pred             hhchhhheecccCceEEEEEEEC-CCEEEEEEeecCc-hHHHHHHHHHHHHhcCCCCCchhhcceeccCCCCCceEEEEE
Confidence            45778888999999999999875 6799999997654 23345667899999999999999999997754    369999


Q ss_pred             ecCCCCCHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCC---------CccccccCCCceeeCCCCCeeeecccCc
Q 020221          133 EYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKE---------RALYHDLNAYRIVFDDDVNPRLSCFGLM  203 (329)
Q Consensus       133 e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~---------~ivH~dlkp~Nil~~~~~~~kl~Dfg~a  203 (329)
                      ||+++|+|.+++..   ..+++..+..++.|++.||.|||+..         +++||||||+||+++.++.+||+|||++
T Consensus       102 e~~~~g~L~~~l~~---~~~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~ivH~Dlkp~Nill~~~~~~kL~DFg~a  178 (322)
T 3soc_A          102 AFHEKGSLSDFLKA---NVVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLA  178 (322)
T ss_dssp             ECCTTCBHHHHHHH---CCBCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECEEECSCCSGGGEEECTTCCEEECCCTTC
T ss_pred             ecCCCCCHHHHHHh---cCCCHHHHHHHHHHHHHHHHHHHhhccccccccCCCEEeCCCChHhEEECCCCeEEEccCCcc
Confidence            99999999999953   45999999999999999999999752         8999999999999999999999999999


Q ss_pred             ccCCCC------CCccCcccccCcccccCC-----CCCCcccchhhhHHHHHHHhCCCCCCchhhH------HH------
Q 020221          204 KNSRDG------RSYSTNLAFTPPEYLRTG-----RVTPESVMYSFGTLLLDLLSGKHIPPSHALD------LI------  260 (329)
Q Consensus       204 ~~~~~~------~~~~~~~~y~aPE~~~~~-----~~~~~~DvwslG~il~el~tg~~~~~~~~~~------~~------  260 (329)
                      +.....      ....+|+.|+|||++.+.     .++.++||||||+++|||++|..||......      ..      
T Consensus       179 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~  258 (322)
T 3soc_A          179 LKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPFEEEIGQHPS  258 (322)
T ss_dssp             EEECTTSCCCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSSCCCCCCCTTHHHHCSSCC
T ss_pred             cccccccCccccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCCCcchhccchhhhhccCCc
Confidence            754432      224689999999999863     3556889999999999999999887532110      00      


Q ss_pred             hhhchhhhccccccCCC-----ChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhhcc
Q 020221          261 RDRNIQTLTDSCLEGQF-----SSDEGTELVRLASRCLQYEPRERPNPRSLVTALVTLQKDT  317 (329)
Q Consensus       261 ~~~~~~~~~~~~~~~~~-----~~~~~~~~~~li~~cl~~dp~~Rps~~~~l~~L~~~~~~~  317 (329)
                      .................     ....++++.+++.+||+.||++|||+.++++.|+++.+..
T Consensus       259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~l~~~~  320 (322)
T 3soc_A          259 LEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSAGCVGERITQMQRLT  320 (322)
T ss_dssp             HHHHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHC
T ss_pred             hhhhhhhhhcccCCCCccccccccchHHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHh
Confidence            00000001111111111     2345778999999999999999999999999999998754

>3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe}

Probab=100.00  E-value=5.5e-49  Score=352.11  Aligned_cols=244  Identities=19%  Similarity=0.234  Sum_probs=204.3

Q ss_pred             CCCcccccccCCCCCCcEEEEEE-eCCCCEEEEEEeCCCC---ChhHHHHHHHHHHHhcCCCccccccceeeeeCCeeEE
Q 020221           55 GFAMENIVSEHGEKAPNVVYKGK-LENQFRIAVKRFNRSA---WPDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLL  130 (329)
Q Consensus        55 ~~~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l  130 (329)
                      .+..|.+++.||+|+||.||+|. ..+++.||+|++....   ......+.+|+.+++.++||||+++++++.+.+..++
T Consensus         7 ~i~~Y~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~l   86 (336)
T 3h4j_B            7 HIGPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVITTPTDIVM   86 (336)
T ss_dssp             EETTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEE
T ss_pred             ccCCEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEE
Confidence            34668888999999999999999 4678999999986432   1123468899999999999999999999999999999


Q ss_pred             EEecCCCCCHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCCCCCeeeecccCcccCCCC-
Q 020221          131 VAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDG-  209 (329)
Q Consensus       131 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~-  209 (329)
                      ||||+ +|+|.+++..  ...+++..+..++.|++.||.|||+. |++||||||+||++++++.+||+|||++...... 
T Consensus        87 v~E~~-~g~l~~~l~~--~~~l~~~~~~~i~~qi~~aL~~LH~~-givH~Dlkp~NIll~~~~~~kl~DFG~s~~~~~~~  162 (336)
T 3h4j_B           87 VIEYA-GGELFDYIVE--KKRMTEDEGRRFFQQIICAIEYCHRH-KIVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGN  162 (336)
T ss_dssp             EECCC-CEEHHHHHHH--HCSCCHHHHHHHHHHHHHHHHHHHHH-TCCCCCCSTTTEEECTTCCEEECCSSCTBTTTTSB
T ss_pred             EEECC-CCcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHC-CeEecCCchhhEEEcCCCCEEEEEeccceeccCCc
Confidence            99999 6789998863  45799999999999999999999999 9999999999999999999999999999865544 


Q ss_pred             --CCccCcccccCcccccCCCC-CCcccchhhhHHHHHHHhCCCCCCchhhHHHhhhchhhhccccccCCCChHHHHHHH
Q 020221          210 --RSYSTNLAFTPPEYLRTGRV-TPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELV  286 (329)
Q Consensus       210 --~~~~~~~~y~aPE~~~~~~~-~~~~DvwslG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  286 (329)
                        ....||+.|+|||++.+..+ +.++||||||+++|+|++|..||...........    +..  .....+...++++.
T Consensus       163 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~----i~~--~~~~~p~~~s~~~~  236 (336)
T 3h4j_B          163 FLKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNLFKK----VNS--CVYVMPDFLSPGAQ  236 (336)
T ss_dssp             TTCCCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCSSSTTCBCC----CCS--SCCCCCTTSCHHHH
T ss_pred             ccccccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCCccHHHHHHH----HHc--CCCCCcccCCHHHH
Confidence              34568999999999988775 6799999999999999999998865432211111    111  11234556788999


Q ss_pred             HHHHHhcccCCCCCCCHHHHHH
Q 020221          287 RLASRCLQYEPRERPNPRSLVT  308 (329)
Q Consensus       287 ~li~~cl~~dp~~Rps~~~~l~  308 (329)
                      +++.+||+.||++|||+.++++
T Consensus       237 ~li~~~L~~dP~~Rpt~~eil~  258 (336)
T 3h4j_B          237 SLIRRMIVADPMQRITIQEIRR  258 (336)
T ss_dssp             HHHHTTSCSSGGGSCCHHHHTT
T ss_pred             HHHHHHcCCChhHCcCHHHHHh
Confidence            9999999999999999999987

>1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A

Probab=100.00  E-value=4.6e-48  Score=359.77  Aligned_cols=253  Identities=25%  Similarity=0.355  Sum_probs=211.3

Q ss_pred             CCCcccccccCCCCCCcEEEEEEeCCCCEEEEEEeCCCCChhHHHHHHHHHHHhcCCCccccccceeeeeCC-eeEEEEe
Q 020221           55 GFAMENIVSEHGEKAPNVVYKGKLENQFRIAVKRFNRSAWPDARQFLEEARAVGQLRNRRLANLLGCCCEGD-ERLLVAE  133 (329)
Q Consensus        55 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~-~~~lv~e  133 (329)
                      +...+++++.||+|+||.||+|... ++.||||+++...  ..+.+.+|+++++.++||||+++++++.... ..++|||
T Consensus       191 ~~~~~~~~~~lG~G~fg~V~~~~~~-~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~iv~e  267 (450)
T 1k9a_A          191 NMKELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTE  267 (450)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEET-TEEEEEEEESSCT--TSHHHHHHHHHHHTCCCTTBCCEEEEEECTTSCEEEEEE
T ss_pred             ChHHeEEEeeecCcCCeeEEEEEec-CCeEEEEEeCCch--HHHHHHHHHHHHHhccCCCEEEEEEEEEcCCCceEEEEE
Confidence            3456778889999999999999985 6699999998754  4567899999999999999999999987655 7899999


Q ss_pred             cCCCCCHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCCCCCeeeecccCcccCCCC-CCc
Q 020221          134 YMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDG-RSY  212 (329)
Q Consensus       134 ~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~-~~~  212 (329)
                      |+++|+|.+++.......+++..+..++.|++.||+|||++ +++||||||+|||++.++.+||+|||+++..... ...
T Consensus       268 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~-~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~  346 (450)
T 1k9a_A          268 YMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGN-NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTG  346 (450)
T ss_dssp             CCTTCBHHHHHHHHCTTTCCHHHHHHHHHHHHHHHHHHHHT-TEECSCCCGGGEEECTTSCEEECCCTTCEECC------
T ss_pred             ecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhC-CeeCCCCCHhhEEECCCCCEEEeeCCCcccccccccCC
Confidence            99999999999764444579999999999999999999999 9999999999999999999999999999754433 233


Q ss_pred             cCcccccCcccccCCCCCCcccchhhhHHHHHHHh-CCCCCCchhhHHHhhhchhhhccccccCCCChHHHHHHHHHHHH
Q 020221          213 STNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLS-GKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLASR  291 (329)
Q Consensus       213 ~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t-g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~  291 (329)
                      .+++.|+|||++.+..++.++||||||+++|||++ |..||+..........     +....+...+..+++++.+++.+
T Consensus       347 ~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~~~~-----i~~~~~~~~p~~~~~~l~~li~~  421 (450)
T 1k9a_A          347 KLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPR-----VEKGYKMDAPDGCPPAVYDVMKN  421 (450)
T ss_dssp             CCCTTTSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTTCCSSTTSCTTTHHHH-----HHTTCCCCCCTTCCHHHHHHHHH
T ss_pred             CCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHH-----HHcCCCCCCCCcCCHHHHHHHHH
Confidence            56789999999999999999999999999999998 8887765432222111     11112334556778899999999


Q ss_pred             hcccCCCCCCCHHHHHHHHHhhhhc
Q 020221          292 CLQYEPRERPNPRSLVTALVTLQKD  316 (329)
Q Consensus       292 cl~~dp~~Rps~~~~l~~L~~~~~~  316 (329)
                      ||+.||++|||+.++++.|+.+...
T Consensus       422 cl~~dp~~Rpt~~~l~~~L~~i~~~  446 (450)
T 1k9a_A          422 CWHLDAATRPTFLQLREQLEHIRTH  446 (450)
T ss_dssp             HTCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred             HcCCChhHCcCHHHHHHHHHHHHHh
Confidence            9999999999999999999998754

>1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7

Probab=100.00  E-value=5.8e-48  Score=346.67  Aligned_cols=260  Identities=23%  Similarity=0.302  Sum_probs=212.8

Q ss_pred             cCCCcccccccCCCCCCcEEEEEEeC------CCCEEEEEEeCCCCChh-HHHHHHHHHHHhcCCCccccccceeeeeCC
Q 020221           54 SGFAMENIVSEHGEKAPNVVYKGKLE------NQFRIAVKRFNRSAWPD-ARQFLEEARAVGQLRNRRLANLLGCCCEGD  126 (329)
Q Consensus        54 ~~~~~~~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~~~~-~~~~~~e~~~l~~l~h~niv~~~~~~~~~~  126 (329)
                      -....|++++.||+|+||.||+|...      +++.||+|+++...... .+.+.+|+.+++.++||||+++++++.+.+
T Consensus        44 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~  123 (343)
T 1luf_A           44 YPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAVGK  123 (343)
T ss_dssp             CCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSS
T ss_pred             ecHHHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEccCC
Confidence            34456778888999999999999953      34789999998764333 456899999999999999999999999999


Q ss_pred             eeEEEEecCCCCCHHhhhccCC----------------------CCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCC
Q 020221          127 ERLLVAEYMPNDTLAKHLFHWE----------------------TQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNA  184 (329)
Q Consensus       127 ~~~lv~e~~~~gsL~~~l~~~~----------------------~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp  184 (329)
                      ..++||||+++|+|.+++....                      ...+++.+++.++.||+.||.|||++ |++||||||
T Consensus       124 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~-~ivH~Dlkp  202 (343)
T 1luf_A          124 PMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSER-KFVHRDLAT  202 (343)
T ss_dssp             SCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHT-TCCCSCCSG
T ss_pred             ceEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhC-CeecCCCCc
Confidence            9999999999999999997532                      15689999999999999999999999 999999999


Q ss_pred             CceeeCCCCCeeeecccCcccCCC------CCCccCcccccCcccccCCCCCCcccchhhhHHHHHHHh-CCCCCCchhh
Q 020221          185 YRIVFDDDVNPRLSCFGLMKNSRD------GRSYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLS-GKHIPPSHAL  257 (329)
Q Consensus       185 ~Nil~~~~~~~kl~Dfg~a~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t-g~~~~~~~~~  257 (329)
                      +||+++.++.+||+|||++.....      .....+++.|+|||++.+..++.++||||||+++|+|++ |..||.....
T Consensus       203 ~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~  282 (343)
T 1luf_A          203 RNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGMAH  282 (343)
T ss_dssp             GGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCH
T ss_pred             ceEEECCCCeEEEeecCCCcccccCccccccCCCcccceecChhhhccCCcCcccccHHHHHHHHHHHhcCCCcCCCCCh
Confidence            999999999999999999875432      223456889999999998889999999999999999999 8877765443


Q ss_pred             HHHhhhchhhhccccccCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhhcccc
Q 020221          258 DLIRDRNIQTLTDSCLEGQFSSDEGTELVRLASRCLQYEPRERPNPRSLVTALVTLQKDTEL  319 (329)
Q Consensus       258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~~~l~~L~~~~~~~~~  319 (329)
                      ..........     .....+..+++++.+++.+||+.||++|||+.++++.|+++.+..+.
T Consensus       283 ~~~~~~~~~~-----~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~L~~~~~~~~~  339 (343)
T 1luf_A          283 EEVIYYVRDG-----NILACPENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRMCERAEG  339 (343)
T ss_dssp             HHHHHHHHTT-----CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTC----
T ss_pred             HHHHHHHhCC-----CcCCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHHHHHHhhhhh
Confidence            3322221111     11234556678999999999999999999999999999999876543

>4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A*

Probab=100.00  E-value=7.1e-49  Score=344.35  Aligned_cols=252  Identities=21%  Similarity=0.332  Sum_probs=209.2

Q ss_pred             CcccccccCCCCCCcEEEEEEeC-CC-------CEEEEEEeCCCCChhHHHHHHHHHHHhcCCCccccccceeeeeCCee
Q 020221           57 AMENIVSEHGEKAPNVVYKGKLE-NQ-------FRIAVKRFNRSAWPDARQFLEEARAVGQLRNRRLANLLGCCCEGDER  128 (329)
Q Consensus        57 ~~~~~~~~lg~G~~g~V~~~~~~-~~-------~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~  128 (329)
                      ..|.+.+.||+|+||+||+|... ++       ..||+|++........+.+.+|+.+++.++||||+++++++.+++..
T Consensus         8 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~   87 (289)
T 4fvq_A            8 EDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLVLNYGVCVCGDEN   87 (289)
T ss_dssp             GGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGGGGGHHHHHHHHHHHHTSCCTTBCCEEEEECCTTCC
T ss_pred             hHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhcccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEeCCCC
Confidence            45778888899999999999843 33       46999999876656677899999999999999999999999999999


Q ss_pred             EEEEecCCCCCHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCCCCC--------eeeecc
Q 020221          129 LLVAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVN--------PRLSCF  200 (329)
Q Consensus       129 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~--------~kl~Df  200 (329)
                      ++||||+++++|.+++.. ....+++..+..++.|++.||.|||++ +++||||||+||+++.++.        +||+||
T Consensus        88 ~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~~i~~qi~~~L~~LH~~-~ivH~Dlkp~NIll~~~~~~~~~~~~~~kl~Df  165 (289)
T 4fvq_A           88 ILVQEFVKFGSLDTYLKK-NKNCINILWKLEVAKQLAAAMHFLEEN-TLIHGNVCAKNILLIREEDRKTGNPPFIKLSDP  165 (289)
T ss_dssp             EEEEECCTTCBHHHHHHH-TGGGCCHHHHHHHHHHHHHHHHHHHHT-TCCCCCCCGGGEEEEECCBGGGTBCCEEEECCC
T ss_pred             EEEEECCCCCCHHHHHHh-CCCCCCHHHHHHHHHHHHHHHHHHhhC-CeECCCcCcceEEEecCCcccccccceeeeccC
Confidence            999999999999999975 334589999999999999999999999 9999999999999998887        999999


Q ss_pred             cCcccCCCCCCccCcccccCcccccC-CCCCCcccchhhhHHHHHHHhCCCCCCchhhHHHhhhchhhhccccccCCCCh
Q 020221          201 GLMKNSRDGRSYSTNLAFTPPEYLRT-GRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSS  279 (329)
Q Consensus       201 g~a~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  279 (329)
                      |++..........+++.|+|||++.+ ..++.++||||||+++|+|++|..|+...............      ....+.
T Consensus       166 g~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~~~~~~~~~~~~~~~~~------~~~~~~  239 (289)
T 4fvq_A          166 GISITVLPKDILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQRKLQFYED------RHQLPA  239 (289)
T ss_dssp             CSCTTTSCHHHHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHT------TCCCCC
T ss_pred             cccccccCccccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCCCccccchHHHHHHhhc------cCCCCC
Confidence            99987766656678899999999987 66899999999999999999977665543222111111111      112233


Q ss_pred             HHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhhc
Q 020221          280 DEGTELVRLASRCLQYEPRERPNPRSLVTALVTLQKD  316 (329)
Q Consensus       280 ~~~~~~~~li~~cl~~dp~~Rps~~~~l~~L~~~~~~  316 (329)
                      ..++++.+++.+||+.||++|||+.++++.|+++...
T Consensus       240 ~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~l~~p  276 (289)
T 4fvq_A          240 PKAAELANLINNCMDYEPDHRPSFRAIIRDLNSLFTP  276 (289)
T ss_dssp             CSSCTTHHHHHHHSCSSGGGSCCHHHHHHHHHTCC--
T ss_pred             CCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcCC
Confidence            3456789999999999999999999999999999763

>2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens}

Probab=100.00  E-value=3.1e-48  Score=352.36  Aligned_cols=245  Identities=19%  Similarity=0.168  Sum_probs=199.7

Q ss_pred             cccccCCCCCCcEEEEEE-eCCCCEEEEEEeCCCCChhHHHHHHHHHHHhcCCCccccccceeeeeCCeeEEEEecCCCC
Q 020221           60 NIVSEHGEKAPNVVYKGK-LENQFRIAVKRFNRSAWPDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAEYMPND  138 (329)
Q Consensus        60 ~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g  138 (329)
                      ...+.||+|+||.||+|. ..+++.||+|++........+.+.+|+++++.++||||+++++++.+.+..++||||++++
T Consensus        92 ~~~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~~~~~  171 (373)
T 2x4f_A           92 SKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEYVDGG  171 (373)
T ss_dssp             EEEEECC-----CEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCTTC
T ss_pred             ecceEEecCcCEEEEEEEEcCCCcEEEEEEEcccccccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeCCCCC
Confidence            335568999999999998 4678999999998776556778999999999999999999999999999999999999999


Q ss_pred             CHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceee--CCCCCeeeecccCcccCCCCC---Ccc
Q 020221          139 TLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVF--DDDVNPRLSCFGLMKNSRDGR---SYS  213 (329)
Q Consensus       139 sL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~--~~~~~~kl~Dfg~a~~~~~~~---~~~  213 (329)
                      +|.+++.. ....+++..+..++.||+.||.|||+. +|+||||||+|||+  +.++.+||+|||++.......   ...
T Consensus       172 ~L~~~l~~-~~~~l~~~~~~~i~~qi~~aL~~LH~~-~ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~~~~~~~~~~  249 (373)
T 2x4f_A          172 ELFDRIID-ESYNLTELDTILFMKQICEGIRHMHQM-YILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREKLKVNF  249 (373)
T ss_dssp             EEHHHHHH-TGGGCCHHHHHHHHHHHHHHHHHHHHT-TEECCCCCGGGEEEEETTTTEEEECCCSSCEECCTTCBCCCCC
T ss_pred             cHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHHC-CcccccCCHHHEEEecCCCCcEEEEeCCCceecCCcccccccc
Confidence            99998864 345689999999999999999999999 99999999999999  567889999999998765432   345


Q ss_pred             CcccccCcccccCCCCCCcccchhhhHHHHHHHhCCCCCCchhhHHHhhhchhhhccccccCCCChHHHHHHHHHHHHhc
Q 020221          214 TNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLASRCL  293 (329)
Q Consensus       214 ~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl  293 (329)
                      ||+.|+|||++.+..++.++||||||+++|+|++|..||..................  .........++++.+|+.+||
T Consensus       250 gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~--~~~~~~~~~~~~~~~li~~~L  327 (373)
T 2x4f_A          250 GTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLGDNDAETLNNILACRWD--LEDEEFQDISEEAKEFISKLL  327 (373)
T ss_dssp             SSCTTCCHHHHTTCBCCHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCC--SCSGGGTTSCHHHHHHHHTTS
T ss_pred             CCCcEeChhhccCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCC--CChhhhccCCHHHHHHHHHHc
Confidence            899999999999888999999999999999999999988765433222222211111  011112345788999999999


Q ss_pred             ccCCCCCCCHHHHHH
Q 020221          294 QYEPRERPNPRSLVT  308 (329)
Q Consensus       294 ~~dp~~Rps~~~~l~  308 (329)
                      +.||++|||+.++++
T Consensus       328 ~~dp~~Rps~~e~l~  342 (373)
T 2x4f_A          328 IKEKSWRISASEALK  342 (373)
T ss_dssp             CSSGGGSCCHHHHHH
T ss_pred             CCChhhCCCHHHHhc
Confidence            999999999999998

>2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A*

Probab=100.00  E-value=4.9e-48  Score=348.24  Aligned_cols=245  Identities=19%  Similarity=0.240  Sum_probs=205.3

Q ss_pred             CCCcccccccCCCCCCcEEEEEEeC-CCCEEEEEEeCCCC---ChhHHHHHHHHHHHhcC-CCccccccceeeeeCCeeE
Q 020221           55 GFAMENIVSEHGEKAPNVVYKGKLE-NQFRIAVKRFNRSA---WPDARQFLEEARAVGQL-RNRRLANLLGCCCEGDERL  129 (329)
Q Consensus        55 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~  129 (329)
                      ....|++++.||+|+||.||++... +++.||+|++....   ....+.+..|..++..+ +||||+++++++.+.+..+
T Consensus        18 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~   97 (353)
T 2i0e_A           18 KLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLY   97 (353)
T ss_dssp             -CTTEEEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEECSSEEE
T ss_pred             chHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEEcCCEEE
Confidence            3466788888999999999999954 57899999997542   12355678899999988 7999999999999999999


Q ss_pred             EEEecCCCCCHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCCCCCeeeecccCcccCCC-
Q 020221          130 LVAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRD-  208 (329)
Q Consensus       130 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~-  208 (329)
                      +||||+++|+|.+++..  ...+++..++.++.||+.||.|||++ ||+||||||+|||++.++.+||+|||+++.... 
T Consensus        98 lv~E~~~gg~L~~~l~~--~~~~~~~~~~~~~~qi~~aL~~LH~~-givHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~  174 (353)
T 2i0e_A           98 FVMEYVNGGDLMYHIQQ--VGRFKEPHAVFYAAEIAIGLFFLQSK-GIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWD  174 (353)
T ss_dssp             EEEECCCSCBHHHHHHH--HSSCCHHHHHHHHHHHHHHHHHHHHT-TCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCT
T ss_pred             EEEeCCCCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHC-CEEeccCCHHHEEEcCCCcEEEEeCCcccccccC
Confidence            99999999999999963  35699999999999999999999999 999999999999999999999999999986322 


Q ss_pred             ---CCCccCcccccCcccccCCCCCCcccchhhhHHHHHHHhCCCCCCchhhHHHhhhchhhhccccccCCCChHHHHHH
Q 020221          209 ---GRSYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTEL  285 (329)
Q Consensus       209 ---~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  285 (329)
                         .....||+.|+|||++.+..++.++||||||+++|||++|..||...............      ...++...++++
T Consensus       175 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~------~~~~p~~~s~~~  248 (353)
T 2i0e_A          175 GVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEH------NVAYPKSMSKEA  248 (353)
T ss_dssp             TCCBCCCCSCGGGCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHC------CCCCCTTSCHHH
T ss_pred             CcccccccCCccccChhhhcCCCcCCcccccchHHHHHHHHcCCCCCCCCCHHHHHHHHHhC------CCCCCCCCCHHH
Confidence               23457899999999999999999999999999999999999988765443333222221      123456678899


Q ss_pred             HHHHHHhcccCCCCCCC-----HHHHHH
Q 020221          286 VRLASRCLQYEPRERPN-----PRSLVT  308 (329)
Q Consensus       286 ~~li~~cl~~dp~~Rps-----~~~~l~  308 (329)
                      .+++.+||..||++||+     +.++++
T Consensus       249 ~~li~~lL~~dP~~R~~~~~~~~~~i~~  276 (353)
T 2i0e_A          249 VAICKGLMTKHPGKRLGCGPEGERDIKE  276 (353)
T ss_dssp             HHHHHHHTCSCTTSCTTCSTTHHHHHHT
T ss_pred             HHHHHHHhhcCHHHcCCCCCCCHHHHhc
Confidence            99999999999999996     466665

>3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B*

Probab=100.00  E-value=7.5e-48  Score=352.08  Aligned_cols=251  Identities=14%  Similarity=0.147  Sum_probs=201.4

Q ss_pred             CcccccccCCCC--CCcEEEEEEe-CCCCEEEEEEeCCCCC--hhHHHHHHHHHHHhcCCCccccccceeeeeCCeeEEE
Q 020221           57 AMENIVSEHGEK--APNVVYKGKL-ENQFRIAVKRFNRSAW--PDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLV  131 (329)
Q Consensus        57 ~~~~~~~~lg~G--~~g~V~~~~~-~~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv  131 (329)
                      ..|++++.||+|  +||+||++.. .+++.||||++.....  ...+.+.+|+.+++.++||||+++++++.+.+..++|
T Consensus        25 ~~y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv  104 (389)
T 3gni_B           25 GCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVV  104 (389)
T ss_dssp             GGEEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred             CcEEEEecccCCcCCceEEEEEEEcCCCCEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCCCcEeEEEEECCEEEEE
Confidence            457888889999  9999999995 4789999999976532  2345688899999999999999999999999999999


Q ss_pred             EecCCCCCHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCCCCCeeeecccCcccCCC---
Q 020221          132 AEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRD---  208 (329)
Q Consensus       132 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~---  208 (329)
                      |||+++|+|.+++.......+++..+..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||.+.....   
T Consensus       105 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~-~ivHrDlkp~NIll~~~~~~kl~dfg~~~~~~~~~~  183 (389)
T 3gni_B          105 TSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKALDYIHHM-GYVHRSVKASHILISVDGKVYLSGLRSNLSMISHGQ  183 (389)
T ss_dssp             EECCTTCBHHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHT-TEECCCCSGGGEEECTTCCEEECCGGGCEECEETTE
T ss_pred             EEccCCCCHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHhC-CeecCCCCHHHEEEcCCCCEEEcccccceeeccccc
Confidence            9999999999999765557799999999999999999999999 999999999999999999999999998754321   


Q ss_pred             --------CCCccCcccccCcccccC--CCCCCcccchhhhHHHHHHHhCCCCCCchhhHHHhhhchhhhcc--------
Q 020221          209 --------GRSYSTNLAFTPPEYLRT--GRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTD--------  270 (329)
Q Consensus       209 --------~~~~~~~~~y~aPE~~~~--~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~--------  270 (329)
                              .....+|+.|+|||++.+  ..++.++||||||+++|+|++|..||..................        
T Consensus       184 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  263 (389)
T 3gni_B          184 RQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCLLDTSTI  263 (389)
T ss_dssp             ECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTTTCCSTTHHHHC--------------
T ss_pred             cccccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcCCCCcccccccc
Confidence                    122367889999999987  56999999999999999999999988653211111111000000        


Q ss_pred             --------------------------------ccccCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 020221          271 --------------------------------SCLEGQFSSDEGTELVRLASRCLQYEPRERPNPRSLVT  308 (329)
Q Consensus       271 --------------------------------~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~~~l~  308 (329)
                                                      .......+...++++.+|+.+||+.||++|||+.++++
T Consensus       264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~ell~  333 (389)
T 3gni_B          264 PAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRNPDARPSASTLLN  333 (389)
T ss_dssp             ------------------------------------------CCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred             ccccccccccccccccccccccccCccccccCCCCCCccccccCHHHHHHHHHHhhcCcccCCCHHHHhc
Confidence                                            00001123445788999999999999999999999997

>3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A*

Probab=100.00  E-value=9.3e-48  Score=343.44  Aligned_cols=243  Identities=17%  Similarity=0.217  Sum_probs=197.7

Q ss_pred             CcccccccCCCCCCcEEEEEEe----CCCCEEEEEEeCCCCC----hhHHHHHHHHHHHhcCCCccccccceeeeeCCee
Q 020221           57 AMENIVSEHGEKAPNVVYKGKL----ENQFRIAVKRFNRSAW----PDARQFLEEARAVGQLRNRRLANLLGCCCEGDER  128 (329)
Q Consensus        57 ~~~~~~~~lg~G~~g~V~~~~~----~~~~~vavK~~~~~~~----~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~  128 (329)
                      ..|++++.||+|+||.||++..    .+++.||+|++.....    .....+.+|+.+++.++||||+++++++...+..
T Consensus        17 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~   96 (327)
T 3a62_A           17 ECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQTGGKL   96 (327)
T ss_dssp             GGEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEEEECSSCE
T ss_pred             HHeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEEEEcCCEE
Confidence            4578888899999999999985    5789999999976531    2244578899999999999999999999999999


Q ss_pred             EEEEecCCCCCHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCCCCCeeeecccCcccCCC
Q 020221          129 LLVAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRD  208 (329)
Q Consensus       129 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~  208 (329)
                      ++||||+++++|.+++..  ...+++..+..++.||+.||.|||++ |++||||||+||+++.++.+||+|||+++....
T Consensus        97 ~lv~e~~~~~~L~~~l~~--~~~~~~~~~~~~~~qi~~al~~lH~~-~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~  173 (327)
T 3a62_A           97 YLILEYLSGGELFMQLER--EGIFMEDTACFYLAEISMALGHLHQK-GIIYRDLKPENIMLNHQGHVKLTDFGLCKESIH  173 (327)
T ss_dssp             EEEEECCTTEEHHHHHHH--HSSCCHHHHHHHHHHHHHHHHHHHHT-TCCCCCCCTTTEEECTTSCEEECCCSCC-----
T ss_pred             EEEEeCCCCCcHHHHHHh--CCCCCHHHHHHHHHHHHHHHHHHHhC-CEEcccCCHHHeEECCCCcEEEEeCCccccccc
Confidence            999999999999999863  45689999999999999999999999 999999999999999999999999999875432


Q ss_pred             C----CCccCcccccCcccccCCCCCCcccchhhhHHHHHHHhCCCCCCchhhHHHhhhchhhhccccccCCCChHHHHH
Q 020221          209 G----RSYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTE  284 (329)
Q Consensus       209 ~----~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  284 (329)
                      .    ....||+.|+|||++.+..++.++||||||+++|+|++|..||...............      ....+...+++
T Consensus       174 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~------~~~~p~~~~~~  247 (327)
T 3a62_A          174 DGTVTHTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGENRKKTIDKILKC------KLNLPPYLTQE  247 (327)
T ss_dssp             -----CTTSSCCTTSCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHT------CCCCCTTSCHH
T ss_pred             CCccccccCCCcCccCHhhCcCCCCCCcccchhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhC------CCCCCCCCCHH
Confidence            2    3456899999999999888999999999999999999999988765433332222111      12344566789


Q ss_pred             HHHHHHHhcccCCCCCC-----CHHHHHH
Q 020221          285 LVRLASRCLQYEPRERP-----NPRSLVT  308 (329)
Q Consensus       285 ~~~li~~cl~~dp~~Rp-----s~~~~l~  308 (329)
                      +.+++.+||..||++||     ++.++++
T Consensus       248 ~~~li~~~L~~dp~~R~~~~~~~~~e~l~  276 (327)
T 3a62_A          248 ARDLLKKLLKRNAASRLGAGPGDAGEVQA  276 (327)
T ss_dssp             HHHHHHHHSCSCGGGSTTSSTTTHHHHHH
T ss_pred             HHHHHHHHHhcCHhhccCCCCCCHHHHHc
Confidence            99999999999999999     7778876

>2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ...

Probab=100.00  E-value=6.8e-48  Score=350.20  Aligned_cols=253  Identities=22%  Similarity=0.287  Sum_probs=201.3

Q ss_pred             cccccccCCCCCCcEEEEEEeC----CCCEEEEEEeCCCCCh-hHHHHHHHHHHHhcCCCccccccceeeeeCCeeEEEE
Q 020221           58 MENIVSEHGEKAPNVVYKGKLE----NQFRIAVKRFNRSAWP-DARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVA  132 (329)
Q Consensus        58 ~~~~~~~lg~G~~g~V~~~~~~----~~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~  132 (329)
                      .+.+.+.||+|+||.||+|...    ++..||||.++..... ..+.+.+|+.+++.++||||+++++++......++||
T Consensus        46 ~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~  125 (373)
T 2qol_A           46 NISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVT  125 (373)
T ss_dssp             GCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEEEE
T ss_pred             hceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCceEEEE
Confidence            4667778899999999999853    5678999999865432 3457899999999999999999999999999999999


Q ss_pred             ecCCCCCHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCCCCCeeeecccCcccCCCCCC-
Q 020221          133 EYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDGRS-  211 (329)
Q Consensus       133 e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~~-  211 (329)
                      ||+++|+|.+++.. ....+++.++..++.||+.||+|||++ +++||||||+||+++.++.+||+|||+++....... 
T Consensus       126 e~~~~~sL~~~l~~-~~~~~~~~~~~~i~~qi~~aL~~LH~~-~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~  203 (373)
T 2qol_A          126 EYMENGSLDSFLRK-HDAQFTVIQLVGMLRGIASGMKYLSDM-GYVHRDLAARNILINSNLVCKVSDFGLGRVLEDDPEA  203 (373)
T ss_dssp             ECCTTCBHHHHHHT-TTTCSCHHHHHHHHHHHHHHHHHHHHT-TCCCSCCCGGGEEECTTCCEEECCC------------
T ss_pred             eCCCCCcHHHHHHh-CCCCCCHHHHHHHHHHHHHHHHHHHHC-CeeCCCCCcceEEEcCCCCEEECcCccccccccCCcc
Confidence            99999999999964 345799999999999999999999999 999999999999999999999999999986544321 


Q ss_pred             ------ccCcccccCcccccCCCCCCcccchhhhHHHHHHHh-CCCCCCchhhHHHhhhchhhhccccccCCCChHHHHH
Q 020221          212 ------YSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLS-GKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTE  284 (329)
Q Consensus       212 ------~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t-g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  284 (329)
                            ..+++.|+|||++.+..++.++||||||+++|||++ |..||.............     .......+..++.+
T Consensus       204 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt~g~~P~~~~~~~~~~~~i~-----~~~~~~~~~~~~~~  278 (373)
T 2qol_A          204 AYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVD-----EGYRLPPPMDCPAA  278 (373)
T ss_dssp             ----------CTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTC-CTTTTCCHHHHHHHHH-----TTEECCCCTTCBHH
T ss_pred             ceeccCCCcCCCccChhhhccCCcCchhcHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHH-----cCCCCCCCccccHH
Confidence                  123568999999998899999999999999999998 888776543322222111     11222334566789


Q ss_pred             HHHHHHHhcccCCCCCCCHHHHHHHHHhhhhcc
Q 020221          285 LVRLASRCLQYEPRERPNPRSLVTALVTLQKDT  317 (329)
Q Consensus       285 ~~~li~~cl~~dp~~Rps~~~~l~~L~~~~~~~  317 (329)
                      +.+++.+||+.||++||++.++++.|+++.+..
T Consensus       279 l~~li~~cl~~dp~~RPs~~~i~~~L~~~~~~~  311 (373)
T 2qol_A          279 LYQLMLDCWQKDRNNRPKFEQIVSILDKLIRNP  311 (373)
T ss_dssp             HHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHCG
T ss_pred             HHHHHHHHhCcChhhCcCHHHHHHHHHHHHhCc
Confidence            999999999999999999999999999997653

>3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0

Probab=100.00  E-value=8e-48  Score=334.57  Aligned_cols=250  Identities=20%  Similarity=0.264  Sum_probs=199.4

Q ss_pred             CCCcccccccCCCCCCcEEEEEEeCCCCEEEEEEeCCCCCh----hHHHHHHHHHHHhcCCCccccccceeeeeCCeeEE
Q 020221           55 GFAMENIVSEHGEKAPNVVYKGKLENQFRIAVKRFNRSAWP----DARQFLEEARAVGQLRNRRLANLLGCCCEGDERLL  130 (329)
Q Consensus        55 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~----~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l  130 (329)
                      ++..+++.+.||+|+||.||++... +..||+|++......    ..+.+.+|+++++.++||||+++++++...+..++
T Consensus         5 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l   83 (271)
T 3dtc_A            5 DFAELTLEEIIGIGGFGKVYRAFWI-GDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLKEPNLCL   83 (271)
T ss_dssp             CTTSEEEEEEEEEETTEEEEEEEET-TEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEECCC--CEE
T ss_pred             chhheeeeeeeccCCCeEEEEEEEc-CCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCCceEE
Confidence            3566788888999999999999974 778999998765322    24678899999999999999999999999999999


Q ss_pred             EEecCCCCCHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCC---ccccccCCCceeeCC--------CCCeeeec
Q 020221          131 VAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKER---ALYHDLNAYRIVFDD--------DVNPRLSC  199 (329)
Q Consensus       131 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~---ivH~dlkp~Nil~~~--------~~~~kl~D  199 (329)
                      ||||+++++|.+++   ....+++..++.++.|++.||.|||++ +   ++|+||||+||+++.        ++.++|+|
T Consensus        84 v~e~~~~~~L~~~~---~~~~~~~~~~~~i~~~l~~~l~~lH~~-~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~kl~D  159 (271)
T 3dtc_A           84 VMEFARGGPLNRVL---SGKRIPPDILVNWAVQIARGMNYLHDE-AIVPIIHRDLKSSNILILQKVENGDLSNKILKITD  159 (271)
T ss_dssp             EEECCTTEEHHHHH---TSSCCCHHHHHHHHHHHHHHHHHHHHS-SSSCCCCSCCSGGGEEESSCCSSSCCSSCCEEECC
T ss_pred             EEEcCCCCCHHHHh---hcCCCCHHHHHHHHHHHHHHHHHHHhC-CCCceeecCCchHHEEEecccccccccCcceEEcc
Confidence            99999999999998   456799999999999999999999999 8   899999999999986        77899999


Q ss_pred             ccCcccCCCC--CCccCcccccCcccccCCCCCCcccchhhhHHHHHHHhCCCCCCchhhHHHhhhchhhhccccccCCC
Q 020221          200 FGLMKNSRDG--RSYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQF  277 (329)
Q Consensus       200 fg~a~~~~~~--~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  277 (329)
                      ||++......  ....+++.|+|||.+.+..++.++||||||+++|+|++|..||............    .........
T Consensus       160 fg~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~----~~~~~~~~~  235 (271)
T 3dtc_A          160 FGLAREWHRTTKMSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDGLAVAYGV----AMNKLALPI  235 (271)
T ss_dssp             CCC-------------CCGGGSCHHHHHHCCCSHHHHHHHHHHHHHHHHHCCCTTTTSCHHHHHHHH----HTSCCCCCC
T ss_pred             CCcccccccccccCCCCccceeCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHhh----hcCCCCCCC
Confidence            9999765433  2346889999999999888999999999999999999999888654332222111    111222334


Q ss_pred             ChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhh
Q 020221          278 SSDEGTELVRLASRCLQYEPRERPNPRSLVTALVTL  313 (329)
Q Consensus       278 ~~~~~~~~~~li~~cl~~dp~~Rps~~~~l~~L~~~  313 (329)
                      +...++++.+++.+||+.||++|||+.++++.|+++
T Consensus       236 ~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~L~~l  271 (271)
T 3dtc_A          236 PSTCPEPFAKLMEDCWNPDPHSRPSFTNILDQLTTI  271 (271)
T ss_dssp             CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHC-
T ss_pred             CcccCHHHHHHHHHHhcCCcccCcCHHHHHHHHhcC
Confidence            566778999999999999999999999999999864

>3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A

Probab=100.00  E-value=9.6e-48  Score=346.63  Aligned_cols=247  Identities=19%  Similarity=0.189  Sum_probs=201.6

Q ss_pred             cccccccCCCCCCcEEEEEE-eCCCCEEEEEEeCCCC-----ChhHHHHHHHHHHHhcCCCccccccceeeeeCCeeEEE
Q 020221           58 MENIVSEHGEKAPNVVYKGK-LENQFRIAVKRFNRSA-----WPDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLV  131 (329)
Q Consensus        58 ~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~-----~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv  131 (329)
                      .|++++.||+|+||+||++. ..+++.||+|++....     ....+.+.+|+.+++.++||||+++++++.+.+..++|
T Consensus        25 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv  104 (351)
T 3c0i_A           25 VYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSDGMLYMV  104 (351)
T ss_dssp             HEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred             ceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEE
Confidence            47788889999999999998 4578999999985321     12356789999999999999999999999999999999


Q ss_pred             EecCCCCCHHhhhccC--CCCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCCCCC---eeeecccCcccC
Q 020221          132 AEYMPNDTLAKHLFHW--ETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVN---PRLSCFGLMKNS  206 (329)
Q Consensus       132 ~e~~~~gsL~~~l~~~--~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~---~kl~Dfg~a~~~  206 (329)
                      |||+++++|.+.+...  ....+++..+..++.||+.||.|||++ +++||||||+|||++.++.   +||+|||++...
T Consensus       105 ~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~-~ivHrDlkp~NIl~~~~~~~~~vkl~Dfg~a~~~  183 (351)
T 3c0i_A          105 FEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDN-NIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQL  183 (351)
T ss_dssp             EECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHT-TEECSCCSGGGEEECSSSTTCCEEECCCTTCEEC
T ss_pred             EeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHC-CceeccCChHHeEEecCCCCCcEEEecCcceeEe
Confidence            9999999998877542  234589999999999999999999999 9999999999999986554   999999999766


Q ss_pred             CCCC----CccCcccccCcccccCCCCCCcccchhhhHHHHHHHhCCCCCCchhhHHHhhhchhhhccccccCCCChHHH
Q 020221          207 RDGR----SYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEG  282 (329)
Q Consensus       207 ~~~~----~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  282 (329)
                      ....    ...||+.|+|||++.+..++.++||||||+++|+|++|..||......... .........  ........+
T Consensus       184 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~-~i~~~~~~~--~~~~~~~~s  260 (351)
T 3c0i_A          184 GESGLVAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYGTKERLFE-GIIKGKYKM--NPRQWSHIS  260 (351)
T ss_dssp             CTTSCBCCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCSSHHHHHH-HHHHTCCCC--CHHHHTTSC
T ss_pred             cCCCeeecCCcCCcCccCHHHHcCCCCCchHhhHHHHHHHHHHHHCCCCCCCcHHHHHH-HHHcCCCCC--CccccccCC
Confidence            5432    346899999999999989999999999999999999999988764322111 111110000  000012356


Q ss_pred             HHHHHHHHHhcccCCCCCCCHHHHHH
Q 020221          283 TELVRLASRCLQYEPRERPNPRSLVT  308 (329)
Q Consensus       283 ~~~~~li~~cl~~dp~~Rps~~~~l~  308 (329)
                      +++.+|+.+||+.||++|||+.++++
T Consensus       261 ~~~~~li~~~L~~dP~~R~s~~e~l~  286 (351)
T 3c0i_A          261 ESAKDLVRRMLMLDPAERITVYEALN  286 (351)
T ss_dssp             HHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             HHHHHHHHHHCCCChhHCcCHHHHhc
Confidence            78999999999999999999999986

>3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens}

Probab=100.00  E-value=1.8e-47  Score=348.65  Aligned_cols=254  Identities=21%  Similarity=0.296  Sum_probs=212.2

Q ss_pred             CcccccccCCCCCCcEEEEEEe--------CCCCEEEEEEeCCCCCh-hHHHHHHHHHHHhcC-CCccccccceeeeeCC
Q 020221           57 AMENIVSEHGEKAPNVVYKGKL--------ENQFRIAVKRFNRSAWP-DARQFLEEARAVGQL-RNRRLANLLGCCCEGD  126 (329)
Q Consensus        57 ~~~~~~~~lg~G~~g~V~~~~~--------~~~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~  126 (329)
                      ..+.+.+.||+|+||+||+|..        ..+..||+|++...... ..+.+.+|+++++.+ +||||+++++++...+
T Consensus        69 ~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~  148 (382)
T 3tt0_A           69 DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDG  148 (382)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred             hheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeeccccCHHHHHHHHHHHHHHHHhcCCchhhhheeeeccCC
Confidence            4567788899999999999984        22357999999876433 346789999999999 8999999999999999


Q ss_pred             eeEEEEecCCCCCHHhhhccCC--------------CCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCCC
Q 020221          127 ERLLVAEYMPNDTLAKHLFHWE--------------TQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDD  192 (329)
Q Consensus       127 ~~~lv~e~~~~gsL~~~l~~~~--------------~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~  192 (329)
                      ..++||||+++|+|.+++....              ...+++..++.++.||+.||.|||+. +++||||||+|||++.+
T Consensus       149 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~-~ivH~Dlkp~NIll~~~  227 (382)
T 3tt0_A          149 PLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASK-KCIHRDLAARNVLVTED  227 (382)
T ss_dssp             SCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHHT-TCCCSCCCGGGEEECTT
T ss_pred             ceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhC-CEecCCCCcceEEEcCC
Confidence            9999999999999999997533              24589999999999999999999999 99999999999999999


Q ss_pred             CCeeeecccCcccCCCC------CCccCcccccCcccccCCCCCCcccchhhhHHHHHHHh-CCCCCCchhhHHHhhhch
Q 020221          193 VNPRLSCFGLMKNSRDG------RSYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLS-GKHIPPSHALDLIRDRNI  265 (329)
Q Consensus       193 ~~~kl~Dfg~a~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t-g~~~~~~~~~~~~~~~~~  265 (329)
                      +.+||+|||++......      ....+++.|+|||++.+..++.++||||||+++|+|++ |..|+.............
T Consensus       228 ~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~ellt~g~~p~~~~~~~~~~~~~~  307 (382)
T 3tt0_A          228 NVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKLLK  307 (382)
T ss_dssp             CCEEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHH
T ss_pred             CcEEEcccCcccccccccccccccCCCCCcceeCHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHH
Confidence            99999999999865432      22345788999999999999999999999999999999 888776544333322211


Q ss_pred             hhhccccccCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhhc
Q 020221          266 QTLTDSCLEGQFSSDEGTELVRLASRCLQYEPRERPNPRSLVTALVTLQKD  316 (329)
Q Consensus       266 ~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~~~l~~L~~~~~~  316 (329)
                      .     ......+..+++++.+++.+||+.||++|||+.++++.|+++...
T Consensus       308 ~-----~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~  353 (382)
T 3tt0_A          308 E-----GHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVAL  353 (382)
T ss_dssp             T-----TCCCCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             c-----CCCCCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHH
Confidence            1     122234456678999999999999999999999999999999754

>3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A*

Probab=100.00  E-value=1.3e-47  Score=332.45  Aligned_cols=252  Identities=21%  Similarity=0.319  Sum_probs=213.0

Q ss_pred             CcccccccCCCCCCcEEEEEEeCCCCEEEEEEeCCCCChhHHHHHHHHHHHhcCCCccccccceeeeeCCeeEEEEecCC
Q 020221           57 AMENIVSEHGEKAPNVVYKGKLENQFRIAVKRFNRSAWPDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAEYMP  136 (329)
Q Consensus        57 ~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~  136 (329)
                      +.|++++.||+|+||.||++...++..||+|++..... ..+.+.+|+++++.++||||+++++++.+.+..++||||++
T Consensus         8 ~~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~   86 (267)
T 3t9t_A            8 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAM-SEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVTEFME   86 (267)
T ss_dssp             GGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTTB-CHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEEEECCCT
T ss_pred             hheeeeeEecCCCceeEEEEEecCCCeEEEEEccccCC-CHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCeEEEEeCCC
Confidence            56778888999999999999987888999999987653 35678999999999999999999999999999999999999


Q ss_pred             CCCHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCCCCCeeeecccCcccCCCC-----CC
Q 020221          137 NDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDG-----RS  211 (329)
Q Consensus       137 ~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~-----~~  211 (329)
                      +++|.+++.. ....+++..+..++.|++.||.|||++ +++|+||||+||+++.++.++|+|||++......     ..
T Consensus        87 ~~~L~~~~~~-~~~~~~~~~~~~~~~~i~~~l~~lH~~-~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~~~~~~~  164 (267)
T 3t9t_A           87 HGCLSDYLRT-QRGLFAAETLLGMCLDVCEGMAYLEEA-CVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTG  164 (267)
T ss_dssp             TCBHHHHHHH-TTTCCCHHHHHHHHHHHHHHHHHHHHT-TCCCSSCCGGGEEECGGGCEEECCTTGGGGBCCHHHHSTTS
T ss_pred             CCcHHHHHhh-CcccCCHHHHHHHHHHHHHHHHHHHhC-CcccCCCchheEEECCCCCEEEccccccccccccccccccc
Confidence            9999999965 345689999999999999999999999 9999999999999999999999999998765432     23


Q ss_pred             ccCcccccCcccccCCCCCCcccchhhhHHHHHHHh-CCCCCCchhhHHHhhhchhhhccccccCCCChHHHHHHHHHHH
Q 020221          212 YSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLS-GKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLAS  290 (329)
Q Consensus       212 ~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t-g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~  290 (329)
                      ..++..|+|||++.+..++.++||||||+++|+|++ |..||...............     .....+...++++.+++.
T Consensus       165 ~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~i~~~-----~~~~~~~~~~~~l~~li~  239 (267)
T 3t9t_A          165 TKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTG-----FRLYKPRLASTHVYQIMN  239 (267)
T ss_dssp             TTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTT-----CCCCCCTTSCHHHHHHHH
T ss_pred             ccccccccChhhhcCCCccchhchhhhHHHHHHHhccCCCCCCCCCHHHHHHHHhcC-----CcCCCCccCcHHHHHHHH
Confidence            355778999999998889999999999999999999 77776544332222211111     122234456788999999


Q ss_pred             HhcccCCCCCCCHHHHHHHHHhhhhc
Q 020221          291 RCLQYEPRERPNPRSLVTALVTLQKD  316 (329)
Q Consensus       291 ~cl~~dp~~Rps~~~~l~~L~~~~~~  316 (329)
                      +||+.||++|||+.++++.|+++.++
T Consensus       240 ~~l~~~p~~Rps~~~ll~~L~~l~~~  265 (267)
T 3t9t_A          240 HCWRERPEDRPAFSRLLRQLAEIAES  265 (267)
T ss_dssp             HHTCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred             HHccCChhhCcCHHHHHHHHHHHHhc
Confidence            99999999999999999999998763

>3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A*

Probab=100.00  E-value=2.6e-48  Score=356.12  Aligned_cols=250  Identities=16%  Similarity=0.132  Sum_probs=205.9

Q ss_pred             hcCCCcccccccCCCCCCcEEEEEEe-CCCCEEEEEEeCCCC---ChhHHHHHHHHHHHhcCCCccccccceeeeeCCee
Q 020221           53 TSGFAMENIVSEHGEKAPNVVYKGKL-ENQFRIAVKRFNRSA---WPDARQFLEEARAVGQLRNRRLANLLGCCCEGDER  128 (329)
Q Consensus        53 ~~~~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~  128 (329)
                      .-....|++++.||+|+||+||++.. .+++.||+|++....   ....+.+.+|+.+++.++||||+++++++.+....
T Consensus        65 ~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~  144 (410)
T 3v8s_A           65 RMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYL  144 (410)
T ss_dssp             SCCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred             ccCccccEEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEE
Confidence            34556788888999999999999994 568899999986421   11123477899999999999999999999999999


Q ss_pred             EEEEecCCCCCHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCCCCCeeeecccCcccCCC
Q 020221          129 LLVAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRD  208 (329)
Q Consensus       129 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~  208 (329)
                      ++||||+++|+|.+++.+   ..+++..+..++.||+.||.|||++ ||+||||||+|||++.++.+||+|||+++....
T Consensus       145 ~lV~E~~~gg~L~~~l~~---~~~~e~~~~~~~~qi~~aL~~LH~~-givHrDLKp~NILl~~~g~ikL~DFG~a~~~~~  220 (410)
T 3v8s_A          145 YMVMEYMPGGDLVNLMSN---YDVPEKWARFYTAEVVLALDAIHSM-GFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNK  220 (410)
T ss_dssp             EEEECCCTTEEHHHHHHH---CCCCHHHHHHHHHHHHHHHHHHHHT-TEECCCCSGGGEEECTTSCEEECCCTTCEECCT
T ss_pred             EEEEeCCCCCcHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHC-CeEeccCCHHHeeECCCCCEEEeccceeEeecc
Confidence            999999999999999853   4689999999999999999999999 999999999999999999999999999976554


Q ss_pred             C-----CCccCcccccCcccccCCC----CCCcccchhhhHHHHHHHhCCCCCCchhhHHHhhhchhhhccccccCCCCh
Q 020221          209 G-----RSYSTNLAFTPPEYLRTGR----VTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSS  279 (329)
Q Consensus       209 ~-----~~~~~~~~y~aPE~~~~~~----~~~~~DvwslG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  279 (329)
                      .     ....||+.|+|||++.+..    ++.++||||||+++|||++|..||..................  .......
T Consensus       221 ~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~--~~~p~~~  298 (410)
T 3v8s_A          221 EGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNS--LTFPDDN  298 (410)
T ss_dssp             TSEEECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHHH--CCCCTTC
T ss_pred             CCcccccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCCCChhhHHHHHHhcccc--ccCCCcc
Confidence            3     2557899999999998665    788999999999999999999998765443333222221111  1111123


Q ss_pred             HHHHHHHHHHHHhcccCCCC--CCCHHHHHH
Q 020221          280 DEGTELVRLASRCLQYEPRE--RPNPRSLVT  308 (329)
Q Consensus       280 ~~~~~~~~li~~cl~~dp~~--Rps~~~~l~  308 (329)
                      ..++++.+|+.+||..+|++  ||++.++++
T Consensus       299 ~~s~~~~~li~~lL~~~~~rlgR~~~~ei~~  329 (410)
T 3v8s_A          299 DISKEAKNLICAFLTDREVRLGRNGVEEIKR  329 (410)
T ss_dssp             CCCHHHHHHHHHHSSCGGGCTTSSCHHHHHT
T ss_pred             cccHHHHHHHHHHccChhhhCCCCCHHHHhc
Confidence            46789999999999999988  999999998

>1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A

Probab=100.00  E-value=4.5e-48  Score=363.74  Aligned_cols=254  Identities=21%  Similarity=0.351  Sum_probs=214.8

Q ss_pred             CcccccccCCCCCCcEEEEEEeC-CCCEEEEEEeCCCCChhHHHHHHHHHHHhcCCCccccccceeeeeCCeeEEEEecC
Q 020221           57 AMENIVSEHGEKAPNVVYKGKLE-NQFRIAVKRFNRSAWPDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAEYM  135 (329)
Q Consensus        57 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~  135 (329)
                      ..+++.+.||+|+||.||+|.+. ++..||||.+.... ...+.+.+|+.+++.++||||+++++++......++||||+
T Consensus       220 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~E~~  298 (495)
T 1opk_A          220 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFM  298 (495)
T ss_dssp             GGEEEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSSS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECC
T ss_pred             HHceeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCcc-cchHHHHHHHHHHHhcCCCCEeeEEEEEecCCcEEEEEEcc
Confidence            44677788999999999999954 47899999998754 34678999999999999999999999999999999999999


Q ss_pred             CCCCHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCCCCCeeeecccCcccCCCCC-----
Q 020221          136 PNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDGR-----  210 (329)
Q Consensus       136 ~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~-----  210 (329)
                      ++|+|.+++.......+++..+..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+++......     
T Consensus       299 ~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~-~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~  377 (495)
T 1opk_A          299 TYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKK-NFIHRNLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHA  377 (495)
T ss_dssp             TTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHT-TEECSCCSGGGEEECGGGCEEECCTTCEECCTTCCEECCT
T ss_pred             CCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhC-CcccCCCChhhEEECCCCcEEEeecccceeccCCceeecC
Confidence            999999999765566799999999999999999999999 99999999999999999999999999998654322     


Q ss_pred             CccCcccccCcccccCCCCCCcccchhhhHHHHHHHh-CCCCCCchhhHHHhhhchhhhccccccCCCChHHHHHHHHHH
Q 020221          211 SYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLS-GKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLA  289 (329)
Q Consensus       211 ~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t-g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li  289 (329)
                      ...+++.|+|||++.+..++.++||||||+++|||++ |..|+.......+..     .+....+...+..+++++.+|+
T Consensus       378 ~~~~~~~y~aPE~~~~~~~~~~sDvwSlG~~l~el~t~g~~p~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~l~~li  452 (495)
T 1opk_A          378 GAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYE-----LLEKDYRMERPEGCPEKVYELM  452 (495)
T ss_dssp             TCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHH-----HHHTTCCCCCCTTCCHHHHHHH
T ss_pred             CCcCCcceeCHhHHhcCCCCcHHhHHhHHHHHHHHHhCCCCCCCCCCHHHHHH-----HHHcCCCCCCCCCCCHHHHHHH
Confidence            2234678999999998889999999999999999999 777776543222211     1222223344566788999999


Q ss_pred             HHhcccCCCCCCCHHHHHHHHHhhhhcc
Q 020221          290 SRCLQYEPRERPNPRSLVTALVTLQKDT  317 (329)
Q Consensus       290 ~~cl~~dp~~Rps~~~~l~~L~~~~~~~  317 (329)
                      .+||+.||++|||+.++++.|+.+....
T Consensus       453 ~~cl~~dP~~RPs~~el~~~L~~~~~~~  480 (495)
T 1opk_A          453 RACWQWNPSDRPSFAEIHQAFETMFQES  480 (495)
T ss_dssp             HHHTCSSGGGSCCHHHHHHHHHTSCSSS
T ss_pred             HHHcCcChhHCcCHHHHHHHHHHHHhcc
Confidence            9999999999999999999999986543

>3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A*

Probab=100.00  E-value=5.4e-48  Score=340.61  Aligned_cols=250  Identities=17%  Similarity=0.225  Sum_probs=196.8

Q ss_pred             CcccccccCCCCCCcEEEEEEeCCCCEEEEEEeCCCCChhHHHHHHHHHHHhc--CCCccccccceeeee----CCeeEE
Q 020221           57 AMENIVSEHGEKAPNVVYKGKLENQFRIAVKRFNRSAWPDARQFLEEARAVGQ--LRNRRLANLLGCCCE----GDERLL  130 (329)
Q Consensus        57 ~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~--l~h~niv~~~~~~~~----~~~~~l  130 (329)
                      ..|++++.||+|+||+||+|.. +++.||||++...   ....+.+|.+++..  ++||||+++++++..    ....++
T Consensus         8 ~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~---~~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~~~~~~~~l   83 (301)
T 3q4u_A            8 RDITLLECVGKGRYGEVWRGSW-QGENVAVKIFSSR---DEKSWFRETELYNTVMLRHENILGFIASDMTSRHSSTQLWL   83 (301)
T ss_dssp             GGCEEEEEEEECSSEEEEEEEE-TTEEEEEEEECGG---GHHHHHHHHHHHHHTCCCCTTBCCEEEEEEEEETTEEEEEE
T ss_pred             CcEEEEEeeccCCCcEEEEEEE-CCEEEEEEEeccc---cchhhHHHHHHHHHhhccCcCeeeEEEeeccccCCCceeEE
Confidence            3567788889999999999998 5789999999753   34455666666666  799999999998654    246899


Q ss_pred             EEecCCCCCHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhh--------cCCCccccccCCCceeeCCCCCeeeecccC
Q 020221          131 VAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCT--------SKERALYHDLNAYRIVFDDDVNPRLSCFGL  202 (329)
Q Consensus       131 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH--------~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~  202 (329)
                      ||||+++|+|.+++   ....+++..+..++.|++.||+|||        +. +++||||||+|||++.++.+||+|||+
T Consensus        84 v~e~~~~g~L~~~l---~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~-~ivH~Dlkp~Nill~~~~~~kl~Dfg~  159 (301)
T 3q4u_A           84 ITHYHEMGSLYDYL---QLTTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKP-AIAHRDLKSKNILVKKNGQCCIADLGL  159 (301)
T ss_dssp             EECCCTTCBHHHHH---TTCCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBC-EEECSCCCGGGEEECTTSCEEECCCTT
T ss_pred             ehhhccCCCHHHHH---hhcccCHHHHHHHHHHHHHHHHHHHHhhhhccCCC-CeecCCCChHhEEEcCCCCEEEeeCCC
Confidence            99999999999999   4467999999999999999999999        88 999999999999999999999999999


Q ss_pred             cccCCCC--------CCccCcccccCcccccCC------CCCCcccchhhhHHHHHHHhC----------CCCCCchh--
Q 020221          203 MKNSRDG--------RSYSTNLAFTPPEYLRTG------RVTPESVMYSFGTLLLDLLSG----------KHIPPSHA--  256 (329)
Q Consensus       203 a~~~~~~--------~~~~~~~~y~aPE~~~~~------~~~~~~DvwslG~il~el~tg----------~~~~~~~~--  256 (329)
                      +......        ....||+.|+|||++.+.      .++.++||||||+++|||++|          ..||....  
T Consensus       160 a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~pf~~~~~~  239 (301)
T 3q4u_A          160 AVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDVVPN  239 (301)
T ss_dssp             CEEEETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTSCS
T ss_pred             eeecccccccccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCccccccccccccccCCC
Confidence            8654332        223689999999999876      344689999999999999999          66664321  


Q ss_pred             ---hHHHhhhchhhhc-cccccCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhh
Q 020221          257 ---LDLIRDRNIQTLT-DSCLEGQFSSDEGTELVRLASRCLQYEPRERPNPRSLVTALVTLQ  314 (329)
Q Consensus       257 ---~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~~~l~~L~~~~  314 (329)
                         ............. ........+...++++.+++.+||+.||++|||+.++++.|++++
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i~  301 (301)
T 3q4u_A          240 DPSFEDMRKVVCVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTLTKID  301 (301)
T ss_dssp             SCCHHHHHHHHTTSCCCCCCCGGGGGSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHHHC
T ss_pred             CcchhhhhHHHhccCCCCCCChhhccCccHHHHHHHHHHHhhcChhhCCCHHHHHHHHhccC
Confidence               1111111100000 111111123457889999999999999999999999999999863

>2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A*

Probab=100.00  E-value=1.1e-47  Score=341.52  Aligned_cols=250  Identities=17%  Similarity=0.243  Sum_probs=189.5

Q ss_pred             CcccccccCCCCCCcEEEEEE-eCCCCEEEEEEeCCCCC-hhHHHHHHHHHHHhcCCCccccccceeeeeCCeeEEEEec
Q 020221           57 AMENIVSEHGEKAPNVVYKGK-LENQFRIAVKRFNRSAW-PDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAEY  134 (329)
Q Consensus        57 ~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  134 (329)
                      ..|++++.||+|+||.||+|. ..+++.||+|++..... ...+.+.+|+++++.++||||+++++++...+..++||||
T Consensus         5 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~   84 (317)
T 2pmi_A            5 SQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELKHENIVRLYDVIHTENKLTLVFEF   84 (317)
T ss_dssp             --------------CEEEEEECSSSCCEEEEEEEECCSTTCSCHHHHHHHHHHTTCCBTTBCCEEEEECCTTEEEEEEEC
T ss_pred             cceeEeeEECCCCCEEEEEEEECCCCcEEEEEEeecccccccHHHHHHHHHHHHhcCCCCcceEEEEEEECCeEEEEEEe
Confidence            457788888999999999999 45689999999976532 2345688999999999999999999999999999999999


Q ss_pred             CCCCCHHhhhccC----CCCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCCCCCeeeecccCcccCCCC-
Q 020221          135 MPNDTLAKHLFHW----ETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDG-  209 (329)
Q Consensus       135 ~~~gsL~~~l~~~----~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~-  209 (329)
                      ++ ++|.+++...    ....+++..+..++.||+.||.|||++ |++||||||+||+++.++.+||+|||++...... 
T Consensus        85 ~~-~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~-~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~  162 (317)
T 2pmi_A           85 MD-NDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHEN-KILHRDLKPQNLLINKRGQLKLGDFGLARAFGIPV  162 (317)
T ss_dssp             CC-CBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHHT-TEECCCCCGGGEEECTTCCEEECCCSSCEETTSCC
T ss_pred             cC-CCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHHC-CeeeCCCChHHeEEcCCCCEEECcCccceecCCCc
Confidence            98 4899988642    124689999999999999999999999 9999999999999999999999999999765432 


Q ss_pred             ---CCccCcccccCcccccCC-CCCCcccchhhhHHHHHHHhCCCCCCchhhHHHhhhchhhh-------ccc-------
Q 020221          210 ---RSYSTNLAFTPPEYLRTG-RVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTL-------TDS-------  271 (329)
Q Consensus       210 ---~~~~~~~~y~aPE~~~~~-~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~~~~~~~~~-------~~~-------  271 (329)
                         ....+|+.|+|||++.+. .++.++||||||+++|+|++|..||................       ...       
T Consensus       163 ~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~  242 (317)
T 2pmi_A          163 NTFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQLKLIFDIMGTPNESLWPSVTKLPKY  242 (317)
T ss_dssp             CCCCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCTTTCGGGGGCTTC
T ss_pred             ccCCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhHhhhhhhhhhc
Confidence               334678999999999764 58999999999999999999999887653322211111000       000       


Q ss_pred             --------------cccCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 020221          272 --------------CLEGQFSSDEGTELVRLASRCLQYEPRERPNPRSLVT  308 (329)
Q Consensus       272 --------------~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~~~l~  308 (329)
                                    ......+...++++.+|+.+||+.||++|||+.++++
T Consensus       243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l~  293 (317)
T 2pmi_A          243 NPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQALH  293 (317)
T ss_dssp             CTTCCCCCCCCSHHHHGGGCSSCCCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred             ccccccccchhHHHhhcccccccCCHHHHHHHHHHCCCCcccCCCHHHHhC
Confidence                          0000111235678999999999999999999999997

>4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A*

Probab=100.00  E-value=3.8e-47  Score=333.09  Aligned_cols=251  Identities=22%  Similarity=0.368  Sum_probs=205.2

Q ss_pred             CcccccccCCCCCCcEEEEEEe-CCCCEEEEEEeCCCCChh-------HHHHHHHHHHHhcCCCccccccceeeeeCCee
Q 020221           57 AMENIVSEHGEKAPNVVYKGKL-ENQFRIAVKRFNRSAWPD-------ARQFLEEARAVGQLRNRRLANLLGCCCEGDER  128 (329)
Q Consensus        57 ~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~-------~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~  128 (329)
                      ..|++.+.||+|+||+||+|.. .+++.||+|++.......       .+.+.+|+++++.++||||+++++++.+..  
T Consensus        19 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~--   96 (287)
T 4f0f_A           19 NEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHNPP--   96 (287)
T ss_dssp             TTEEEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEETTTT--
T ss_pred             ccceehhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhheeecCCC--
Confidence            4577888899999999999994 678899999987644221       156889999999999999999999986544  


Q ss_pred             EEEEecCCCCCHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCC--ccccccCCCceeeCCCCC-----eeeeccc
Q 020221          129 LLVAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKER--ALYHDLNAYRIVFDDDVN-----PRLSCFG  201 (329)
Q Consensus       129 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~--ivH~dlkp~Nil~~~~~~-----~kl~Dfg  201 (329)
                      ++||||+++++|.+++.. ....+++..++.++.|++.||+|||+. +  ++|+||||+||+++.++.     +||+|||
T Consensus        97 ~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~~~l~~~l~~lH~~-~~~ivH~dikp~Nil~~~~~~~~~~~~kl~Dfg  174 (287)
T 4f0f_A           97 RMVMEFVPCGDLYHRLLD-KAHPIKWSVKLRLMLDIALGIEYMQNQ-NPPIVHRDLRSPNIFLQSLDENAPVCAKVADFG  174 (287)
T ss_dssp             EEEEECCTTCBHHHHHHC-TTSCCCHHHHHHHHHHHHHHHHHHHTS-SSCCBCSCCSGGGEEESCCCTTCSCCEEECCCT
T ss_pred             eEEEEecCCCCHHHHHhc-ccCCccHHHHHHHHHHHHHHHHHHHhC-CCCeecCCCCcceEEEeccCCCCceeEEeCCCC
Confidence            799999999999998865 456799999999999999999999999 9  999999999999987776     9999999


Q ss_pred             CcccCCCC-CCccCcccccCccccc--CCCCCCcccchhhhHHHHHHHhCCCCCCchhhHHHhhhchhhhccccccCCCC
Q 020221          202 LMKNSRDG-RSYSTNLAFTPPEYLR--TGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFS  278 (329)
Q Consensus       202 ~a~~~~~~-~~~~~~~~y~aPE~~~--~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  278 (329)
                      ++...... ....+++.|+|||++.  ...++.++||||||+++|+|++|..||..........  .............+
T Consensus       175 ~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~--~~~~~~~~~~~~~~  252 (287)
T 4f0f_A          175 LSQQSVHSVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKF--INMIREEGLRPTIP  252 (287)
T ss_dssp             TCBCCSSCEECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTTCCCCHHHH--HHHHHHSCCCCCCC
T ss_pred             ccccccccccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCccccccHHHH--HHHHhccCCCCCCC
Confidence            99765443 3456899999999984  4457889999999999999999998886432221110  11111222333455


Q ss_pred             hHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhh
Q 020221          279 SDEGTELVRLASRCLQYEPRERPNPRSLVTALVTL  313 (329)
Q Consensus       279 ~~~~~~~~~li~~cl~~dp~~Rps~~~~l~~L~~~  313 (329)
                      ..+++++.+++.+||+.||++|||+.++++.|+++
T Consensus       253 ~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~l  287 (287)
T 4f0f_A          253 EDCPPRLRNVIELCWSGDPKKRPHFSYIVKELSEL  287 (287)
T ss_dssp             TTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTC
T ss_pred             cccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHhC
Confidence            67788999999999999999999999999999864

>2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens}

Probab=100.00  E-value=1.2e-47  Score=345.71  Aligned_cols=244  Identities=20%  Similarity=0.225  Sum_probs=189.6

Q ss_pred             cccccccCCCCCCcEEEEEEe-CCCCEEEEEEeCCCCChhHHHHHHHHHHHhcCCCccccccceeeeeCCeeEEEEecCC
Q 020221           58 MENIVSEHGEKAPNVVYKGKL-ENQFRIAVKRFNRSAWPDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAEYMP  136 (329)
Q Consensus        58 ~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~  136 (329)
                      .|++.+.||+|+||.||+|.. .+++.||+|++....  ..+.+.+|+++++.++||||+++++++......++||||++
T Consensus        54 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~  131 (349)
T 2w4o_A           54 FFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTV--DKKIVRTEIGVLLRLSHPNIIKLKEIFETPTEISLVLELVT  131 (349)
T ss_dssp             TEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC------------CHHHHHCCCTTBCCEEEEEECSSEEEEEECCCC
T ss_pred             cEEEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccch--hHHHHHHHHHHHHhCCCCCCcceeeeEecCCeEEEEEEeCC
Confidence            366778889999999999995 467899999997643  34567889999999999999999999999999999999999


Q ss_pred             CCCHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCC---CCCeeeecccCcccCCCC---C
Q 020221          137 NDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDD---DVNPRLSCFGLMKNSRDG---R  210 (329)
Q Consensus       137 ~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~---~~~~kl~Dfg~a~~~~~~---~  210 (329)
                      +++|.+++.  ....+++..+..++.|++.||.|||+. +++||||||+||+++.   ++.+||+|||++......   .
T Consensus       132 ~~~L~~~l~--~~~~~~~~~~~~i~~qi~~~L~~LH~~-~ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a~~~~~~~~~~  208 (349)
T 2w4o_A          132 GGELFDRIV--EKGYYSERDAADAVKQILEAVAYLHEN-GIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQVLMK  208 (349)
T ss_dssp             SCBHHHHHT--TCSSCCHHHHHHHHHHHHHHHHHHHHT-TCCCCCCCGGGEEESSSSTTCCEEECCCC------------
T ss_pred             CCCHHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHHC-CeEecCCCcccEEEecCCCCCCEEEccCccccccCcccccc
Confidence            999999986  445689999999999999999999999 9999999999999975   889999999999865443   2


Q ss_pred             CccCcccccCcccccCCCCCCcccchhhhHHHHHHHhCCCCCCchhhHH-HhhhchhhhccccccCCCChHHHHHHHHHH
Q 020221          211 SYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDL-IRDRNIQTLTDSCLEGQFSSDEGTELVRLA  289 (329)
Q Consensus       211 ~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~li  289 (329)
                      ...||+.|+|||++.+..++.++||||||+++|+|++|..||....... ..........  ..........+.++.+|+
T Consensus       209 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~i~~~~~--~~~~~~~~~~~~~~~~li  286 (349)
T 2w4o_A          209 TVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEPFYDERGDQFMFRRILNCEY--YFISPWWDEVSLNAKDLV  286 (349)
T ss_dssp             ----CGGGSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCTTCHHHHHHHHHTTCC--CCCTTTTTTSCHHHHHHH
T ss_pred             cccCCCCccCHHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCcccHHHHHHHHhCCC--ccCCchhhhCCHHHHHHH
Confidence            4568999999999999899999999999999999999999886543322 1111111100  011122345678899999


Q ss_pred             HHhcccCCCCCCCHHHHHH
Q 020221          290 SRCLQYEPRERPNPRSLVT  308 (329)
Q Consensus       290 ~~cl~~dp~~Rps~~~~l~  308 (329)
                      .+||+.||++|||+.++++
T Consensus       287 ~~~L~~dP~~Rpt~~e~l~  305 (349)
T 2w4o_A          287 RKLIVLDPKKRLTTFQALQ  305 (349)
T ss_dssp             HTTSCSSGGGSCCHHHHHH
T ss_pred             HHHccCChhhCcCHHHHhc
Confidence            9999999999999999998

>1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A*

Probab=100.00  E-value=6.1e-48  Score=347.35  Aligned_cols=244  Identities=19%  Similarity=0.221  Sum_probs=203.9

Q ss_pred             ccccccCCCCCCcEEEEEE-eCCCCEEEEEEeCCCCCh---hHHHHHHHHHHHhcCCCccccccceeeeeCCeeEEEEec
Q 020221           59 ENIVSEHGEKAPNVVYKGK-LENQFRIAVKRFNRSAWP---DARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAEY  134 (329)
Q Consensus        59 ~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~---~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  134 (329)
                      |.+++.||+|+||+||+|. ..+++.||||++......   ..+.+.+|+++++.++||||+++++++...+..++||||
T Consensus        56 y~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~  135 (348)
T 1u5q_A           56 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEY  135 (348)
T ss_dssp             EEEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred             eeeeeEEccCCCEEEEEEEEccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCeEEEEEec
Confidence            6677888999999999999 467889999999765322   235688999999999999999999999999999999999


Q ss_pred             CCCCCHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCCCCCeeeecccCcccCCCCCCccC
Q 020221          135 MPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDGRSYST  214 (329)
Q Consensus       135 ~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~~~  214 (329)
                      +. |+|.+++.. ....+++..+..++.|++.||.|||+. +++||||||+|||++.++.+||+|||++..........+
T Consensus       136 ~~-g~l~~~l~~-~~~~l~~~~~~~i~~qi~~aL~~LH~~-~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~g  212 (348)
T 1u5q_A          136 CL-GSASDLLEV-HKKPLQEVEIAAVTHGALQGLAYLHSH-NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANSFVG  212 (348)
T ss_dssp             CS-EEHHHHHHH-HTSCCCHHHHHHHHHHHHHHHHHHHHT-TCBCCCCSGGGEEEETTTEEEECCCTTCBSSSSBCCCCS
T ss_pred             CC-CCHHHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHhC-CeeeCCCCHHHEEECCCCCEEEeeccCceecCCCCcccC
Confidence            97 588887753 346799999999999999999999999 999999999999999999999999999988777777789


Q ss_pred             cccccCccccc---CCCCCCcccchhhhHHHHHHHhCCCCCCchhhHHHhhhchhhhccccccCCCChHHHHHHHHHHHH
Q 020221          215 NLAFTPPEYLR---TGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLASR  291 (329)
Q Consensus       215 ~~~y~aPE~~~---~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~  291 (329)
                      |+.|+|||++.   +..++.++||||||+++|||++|..||..............    .......+...++.+.+++.+
T Consensus       213 t~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~----~~~~~~~~~~~~~~l~~li~~  288 (348)
T 1u5q_A          213 TPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQ----NESPALQSGHWSEYFRNFVDS  288 (348)
T ss_dssp             CGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHH----SCCCCCCCTTSCHHHHHHHHH
T ss_pred             CcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHh----cCCCCCCCCCCCHHHHHHHHH
Confidence            99999999984   56789999999999999999999988765432221111111    111112234557789999999


Q ss_pred             hcccCCCCCCCHHHHHHH
Q 020221          292 CLQYEPRERPNPRSLVTA  309 (329)
Q Consensus       292 cl~~dp~~Rps~~~~l~~  309 (329)
                      ||+.||++|||+.+++++
T Consensus       289 ~l~~dP~~Rps~~~ll~h  306 (348)
T 1u5q_A          289 CLQKIPQDRPTSEVLLKH  306 (348)
T ss_dssp             HTCSSGGGSCCHHHHTTC
T ss_pred             HcccChhhCcCHHHHhhC
Confidence            999999999999999873

>1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ...

Probab=100.00  E-value=6.3e-48  Score=359.04  Aligned_cols=254  Identities=24%  Similarity=0.336  Sum_probs=209.4

Q ss_pred             CcccccccCCCCCCcEEEEEEeCCCCEEEEEEeCCCCChhHHHHHHHHHHHhcCCCccccccceeeeeCCeeEEEEecCC
Q 020221           57 AMENIVSEHGEKAPNVVYKGKLENQFRIAVKRFNRSAWPDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAEYMP  136 (329)
Q Consensus        57 ~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~  136 (329)
                      ..+++.+.||+|+||.||+|.+.++..||||+++... ...+.+.+|+++++.++||||+++++++.+ ...++||||++
T Consensus       184 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-~~~~iv~e~~~  261 (452)
T 1fmk_A          184 ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYMS  261 (452)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECCCT
T ss_pred             hHceeeeeecCCCCeEEEEEEECCCceEEEEEeccCC-CCHHHHHHHHHHHHhCCCCCEeeEEEEEcC-CceEEEehhhc
Confidence            3466778889999999999998887889999998755 345679999999999999999999999865 77899999999


Q ss_pred             CCCHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCCCCCeeeecccCcccCCCCC-----C
Q 020221          137 NDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDGR-----S  211 (329)
Q Consensus       137 ~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~-----~  211 (329)
                      +|+|.+++.......+++..+..++.|++.||+|||++ +++||||||+|||++.++.+||+|||+++......     .
T Consensus       262 ~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~-~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~~  340 (452)
T 1fmk_A          262 KGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERM-NYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQG  340 (452)
T ss_dssp             TCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHT-TCCCSCCSGGGEEECGGGCEEECCCCTTC------------
T ss_pred             CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhC-CeeCCCCChhhEEECCCCCEEECCCccceecCCCceecccC
Confidence            99999999643345689999999999999999999999 99999999999999999999999999998654321     2


Q ss_pred             ccCcccccCcccccCCCCCCcccchhhhHHHHHHHh-CCCCCCchhhHHHhhhchhhhccccccCCCChHHHHHHHHHHH
Q 020221          212 YSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLS-GKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLAS  290 (329)
Q Consensus       212 ~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t-g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~  290 (329)
                      ..+++.|+|||.+.+..++.++||||||+++|||++ |..|+.............     ...+...+..+++.+.+++.
T Consensus       341 ~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~-----~~~~~~~~~~~~~~l~~li~  415 (452)
T 1fmk_A          341 AKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVE-----RGYRMPCPPECPESLHDLMC  415 (452)
T ss_dssp             --CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHH-----TTCCCCCCTTSCHHHHHHHH
T ss_pred             CcccccccCHhHHhcCCCCccccHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHH-----cCCCCCCCCCCCHHHHHHHH
Confidence            345678999999998899999999999999999999 787776543322222211     11223345667889999999


Q ss_pred             HhcccCCCCCCCHHHHHHHHHhhhhccc
Q 020221          291 RCLQYEPRERPNPRSLVTALVTLQKDTE  318 (329)
Q Consensus       291 ~cl~~dp~~Rps~~~~l~~L~~~~~~~~  318 (329)
                      +||+.||++|||+.++++.|+.+....+
T Consensus       416 ~cl~~dP~~Rpt~~~l~~~L~~~~~~~~  443 (452)
T 1fmk_A          416 QCWRKEPEERPTFEYLQAFLEDYFTSTE  443 (452)
T ss_dssp             HHTCSSGGGSCCHHHHHHHHHTTTSCSC
T ss_pred             HHccCChhhCcCHHHHHHHHHHHhccCC
Confidence            9999999999999999999999876543

>4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A*

Probab=100.00  E-value=4.9e-48  Score=359.40  Aligned_cols=244  Identities=20%  Similarity=0.247  Sum_probs=199.5

Q ss_pred             CCcccccccCCCCCCcEEEEEE-eCCCCEEEEEEeCCC---CChhHHHHHHHHHHHhcCCCccccccceeeeeCCeeEEE
Q 020221           56 FAMENIVSEHGEKAPNVVYKGK-LENQFRIAVKRFNRS---AWPDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLV  131 (329)
Q Consensus        56 ~~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv  131 (329)
                      ...|++++.||+|+||.||++. ..+++.||+|++...   .......+.+|+.+++.++||||+++++++...+..++|
T Consensus       147 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lv  226 (446)
T 4ejn_A          147 MNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFV  226 (446)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC-------------CCCCCSCTTSCCEEEEEEETTEEEEE
T ss_pred             hHHcEEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEEeeCCEEEEE
Confidence            3567888899999999999999 567899999998753   222345678899999999999999999999999999999


Q ss_pred             EecCCCCCHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhc-CCCccccccCCCceeeCCCCCeeeecccCcccCCCC-
Q 020221          132 AEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTS-KERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDG-  209 (329)
Q Consensus       132 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~-~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~-  209 (329)
                      |||+++|+|.+++.  ....+++..+..++.||+.||+|||+ . ||+||||||+|||++.++.+||+|||+++..... 
T Consensus       227 ~e~~~~~~L~~~l~--~~~~~~~~~~~~~~~qi~~aL~~LH~~~-giiHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~  303 (446)
T 4ejn_A          227 MEYANGGELFFHLS--RERVFSEDRARFYGAEIVSALDYLHSEK-NVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDG  303 (446)
T ss_dssp             ECCCSSCBHHHHHH--HHSCCCHHHHHHHHHHHHHHHHHHHHHT-CCCCCCCCGGGEEECSSSCEEECCCCCCCTTCC--
T ss_pred             EeeCCCCcHHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHhhcC-CEEECCCCHHHEEECCCCCEEEccCCCceeccCCC
Confidence            99999999999986  34578999999999999999999998 7 9999999999999999999999999999764322 


Q ss_pred             ---CCccCcccccCcccccCCCCCCcccchhhhHHHHHHHhCCCCCCchhhHHHhhhchhhhccccccCCCChHHHHHHH
Q 020221          210 ---RSYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELV  286 (329)
Q Consensus       210 ---~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  286 (329)
                         ....||+.|+|||++.+..++.++||||||+++|||++|..||...............      ...++...++++.
T Consensus       304 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~------~~~~p~~~~~~~~  377 (446)
T 4ejn_A          304 ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILME------EIRFPRTLGPEAK  377 (446)
T ss_dssp             ---CCSSSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHC------CCCCCTTSCHHHH
T ss_pred             cccccccCCccccCHhhcCCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHHHHHHHHHhC------CCCCCccCCHHHH
Confidence               3457899999999999999999999999999999999999998765443333222211      1224556778999


Q ss_pred             HHHHHhcccCCCCCC-----CHHHHHH
Q 020221          287 RLASRCLQYEPRERP-----NPRSLVT  308 (329)
Q Consensus       287 ~li~~cl~~dp~~Rp-----s~~~~l~  308 (329)
                      +|+.+||+.||++||     ++.++++
T Consensus       378 ~li~~~L~~dP~~R~~~~~~t~~ell~  404 (446)
T 4ejn_A          378 SLLSGLLKKDPKQRLGGGSEDAKEIMQ  404 (446)
T ss_dssp             HHHHHHTCSSTTTSTTCSTTTHHHHHT
T ss_pred             HHHHHHcccCHHHhCCCCCCCHHHHHh
Confidence            999999999999999     9999987

>3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens}

Probab=100.00  E-value=1.1e-47  Score=340.73  Aligned_cols=239  Identities=18%  Similarity=0.174  Sum_probs=193.5

Q ss_pred             cccccccCCCCCCcEEEEEEe-CCCCEEEEEEeCCCCChh--HHHHHHHHHHHhcC-CCccccccceeeeeCCeeEEEEe
Q 020221           58 MENIVSEHGEKAPNVVYKGKL-ENQFRIAVKRFNRSAWPD--ARQFLEEARAVGQL-RNRRLANLLGCCCEGDERLLVAE  133 (329)
Q Consensus        58 ~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~--~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e  133 (329)
                      .|++++.||+|+||+||+|.. .+++.||||++.......  ......|+..+..+ +||||+++++++.+++..++|||
T Consensus        58 ~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~~~~~~~lv~e  137 (311)
T 3p1a_A           58 SFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEGGILYLQTE  137 (311)
T ss_dssp             HEEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCCSHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             heeeeheeccCCCeEEEEEEECCCCeEEEEEEecccccChHHHHHHHHHHHHHHHhcCCCcEEEEEEEEEeCCEEEEEEe
Confidence            467778889999999999995 478999999987654322  33455566655555 89999999999999999999999


Q ss_pred             cCCCCCHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCCCCCeeeecccCcccCCCC---C
Q 020221          134 YMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDG---R  210 (329)
Q Consensus       134 ~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~---~  210 (329)
                      |+ +++|.+++.. ....+++..++.++.|++.||.|||+. +|+||||||+|||++.++.+||+|||++......   .
T Consensus       138 ~~-~~~L~~~~~~-~~~~l~~~~~~~i~~qi~~aL~~LH~~-~ivH~Dikp~NIll~~~~~~kl~DFG~a~~~~~~~~~~  214 (311)
T 3p1a_A          138 LC-GPSLQQHCEA-WGASLPEAQVWGYLRDTLLALAHLHSQ-GLVHLDVKPANIFLGPRGRCKLGDFGLLVELGTAGAGE  214 (311)
T ss_dssp             CC-CCBHHHHHHH-HCSCCCHHHHHHHHHHHHHHHHHHHHT-TEECCCCSGGGEEECGGGCEEECCCTTCEECC------
T ss_pred             cc-CCCHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHHC-CEecCCCCHHHEEECCCCCEEEccceeeeecccCCCCc
Confidence            99 6689998865 345799999999999999999999999 9999999999999999999999999998765433   2


Q ss_pred             CccCcccccCcccccCCCCCCcccchhhhHHHHHHHhCCCCCCchhh-HHHhhhchhhhccccccCCCChHHHHHHHHHH
Q 020221          211 SYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHAL-DLIRDRNIQTLTDSCLEGQFSSDEGTELVRLA  289 (329)
Q Consensus       211 ~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li  289 (329)
                      ...||+.|+|||++.+ .++.++||||||+++|||++|..+|..... ..+...        ......+...++++.+++
T Consensus       215 ~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~el~~g~~~~~~~~~~~~~~~~--------~~~~~~~~~~~~~l~~li  285 (311)
T 3p1a_A          215 VQEGDPRYMAPELLQG-SYGTAADVFSLGLTILEVACNMELPHGGEGWQQLRQG--------YLPPEFTAGLSSELRSVL  285 (311)
T ss_dssp             CCCCCGGGCCGGGGGT-CCSTHHHHHHHHHHHHHHHHTCCCCSSHHHHHHHTTT--------CCCHHHHTTSCHHHHHHH
T ss_pred             ccCCCccccCHhHhcC-CCCchhhHHHHHHHHHHHHhCCCCCCCccHHHHHhcc--------CCCcccccCCCHHHHHHH
Confidence            3468999999999886 789999999999999999999876654321 111111        111112234567899999


Q ss_pred             HHhcccCCCCCCCHHHHHH
Q 020221          290 SRCLQYEPRERPNPRSLVT  308 (329)
Q Consensus       290 ~~cl~~dp~~Rps~~~~l~  308 (329)
                      .+||+.||++|||+.++++
T Consensus       286 ~~~L~~dP~~Rpt~~ell~  304 (311)
T 3p1a_A          286 VMMLEPDPKLRATAEALLA  304 (311)
T ss_dssp             HHHSCSSTTTSCCHHHHHT
T ss_pred             HHHcCCChhhCcCHHHHHh
Confidence            9999999999999999998

>3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7}

Probab=100.00  E-value=5.8e-47  Score=342.58  Aligned_cols=247  Identities=19%  Similarity=0.177  Sum_probs=200.5

Q ss_pred             cccccccCCCCCCcEEEEEEe-CCCCEEEEEEeCCCCChhHHHHHHHHHHHhcCC-----CccccccceeeeeCCeeEEE
Q 020221           58 MENIVSEHGEKAPNVVYKGKL-ENQFRIAVKRFNRSAWPDARQFLEEARAVGQLR-----NRRLANLLGCCCEGDERLLV  131 (329)
Q Consensus        58 ~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-----h~niv~~~~~~~~~~~~~lv  131 (329)
                      .|.+++.||+|+||+||+|.. .+++.||||++.... ...+.+..|+.+++.++     ||||+++++++...+..++|
T Consensus        36 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~e~~~l~~l~~~~~~h~~iv~~~~~~~~~~~~~lv  114 (360)
T 3llt_A           36 AFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNIK-KYTRSAKIEADILKKIQNDDINNNNIVKYHGKFMYYDHMCLI  114 (360)
T ss_dssp             TEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSCH-HHHHHHHHHHHHHHHTCCCSTTGGGBCCEEEEEEETTEEEEE
T ss_pred             EEEEEEEEcccCCeEEEEEEECCCCeEEEEEEeccch-hhhhhhHHHHHHHHHhcccCCCCCCeecccceeeECCeeEEE
Confidence            477888889999999999994 678899999997533 33456788999999986     99999999999999999999


Q ss_pred             EecCCCCCHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCC--------------------
Q 020221          132 AEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDD--------------------  191 (329)
Q Consensus       132 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~--------------------  191 (329)
                      |||+ +++|.+++.......+++..+..++.||+.||+|||+. ||+||||||+|||++.                    
T Consensus       115 ~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~-~ivHrDlkp~NIll~~~~~~~~~~~~~~~~~~~~~~  192 (360)
T 3llt_A          115 FEPL-GPSLYEIITRNNYNGFHIEDIKLYCIEILKALNYLRKM-SLTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQ  192 (360)
T ss_dssp             ECCC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHT-TEECSCCSGGGEEESCTTCCEEEEEEECTTTCCEEE
T ss_pred             EcCC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHC-CeeeCCCCcccEEEccccccccccchhccccccccc
Confidence            9999 88999999865556799999999999999999999999 9999999999999975                    


Q ss_pred             -----CCCeeeecccCcccCCCC-CCccCcccccCcccccCCCCCCcccchhhhHHHHHHHhCCCCCCchhhHHHhhhch
Q 020221          192 -----DVNPRLSCFGLMKNSRDG-RSYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNI  265 (329)
Q Consensus       192 -----~~~~kl~Dfg~a~~~~~~-~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~~~~~~  265 (329)
                           ++.+||+|||++...... ....+|+.|+|||++.+..++.++||||||+++|+|++|..||.............
T Consensus       193 ~~~~~~~~~kl~DFG~a~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~  272 (360)
T 3llt_A          193 IYRTKSTGIKLIDFGCATFKSDYHGSIINTRQYRAPEVILNLGWDVSSDMWSFGCVLAELYTGSLLFRTHEHMEHLAMME  272 (360)
T ss_dssp             EEEESCCCEEECCCTTCEETTSCCCSCCSCGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHH
T ss_pred             ccccCCCCEEEEeccCceecCCCCcCccCcccccCcHHHcCCCCCCccchHHHHHHHHHHHHCCCCCCCCcHHHHHHHHH
Confidence                 789999999999865443 45578999999999999999999999999999999999999886543221111100


Q ss_pred             hhhccc---------------------cccCCCC--------------------hHHHHHHHHHHHHhcccCCCCCCCHH
Q 020221          266 QTLTDS---------------------CLEGQFS--------------------SDEGTELVRLASRCLQYEPRERPNPR  304 (329)
Q Consensus       266 ~~~~~~---------------------~~~~~~~--------------------~~~~~~~~~li~~cl~~dp~~Rps~~  304 (329)
                       ....+                     .....++                    ...++.+.+|+.+||+.||++|||+.
T Consensus       273 -~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpta~  351 (360)
T 3llt_A          273 -SIIQPIPKNMLYEATKTNGSKYVNKDELKLAWPENASSINSIKHVKKCLPLYKIIKHELFCDFLYSILQIDPTLRPSPA  351 (360)
T ss_dssp             -HHTCCCCHHHHHHHTTSGGGGGEETTTTEECTTTTCSCHHHHHHHHTCCCHHHHCCCHHHHHHHHHHCCSSGGGSCCHH
T ss_pred             -HhcCCCCHHHHhhhhhccCccccCcccceecCcccccchhhhhhhhhcccccccchHHHHHHHHHHHhcCChhhCCCHH
Confidence             00000                     0000000                    01126788999999999999999999


Q ss_pred             HHHH
Q 020221          305 SLVT  308 (329)
Q Consensus       305 ~~l~  308 (329)
                      ++++
T Consensus       352 elL~  355 (360)
T 3llt_A          352 ELLK  355 (360)
T ss_dssp             HHTT
T ss_pred             HHhc
Confidence            9998

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus}

Probab=100.00  E-value=4.7e-47  Score=338.88  Aligned_cols=244  Identities=17%  Similarity=0.227  Sum_probs=195.3

Q ss_pred             CcccccccCCCCCCcEEEEEEe-CCCCEEEEEEeCCCCC-hhHHHHHHHHHHHhcCCCccccccceeeeeCC--------
Q 020221           57 AMENIVSEHGEKAPNVVYKGKL-ENQFRIAVKRFNRSAW-PDARQFLEEARAVGQLRNRRLANLLGCCCEGD--------  126 (329)
Q Consensus        57 ~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~--------  126 (329)
                      ..|++++.||+|+||.||+|.. .+++.||||++..... ...+.+.+|+++++.++||||+++++++.+..        
T Consensus         6 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~   85 (332)
T 3qd2_B            6 TDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKWQEEM   85 (332)
T ss_dssp             HHEEEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCSTTTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCHHHHHH
T ss_pred             hcCceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCCchhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccchhhhhh
Confidence            3477888889999999999995 4789999999975443 34567899999999999999999999886543        


Q ss_pred             -------------------------------------------------eeEEEEecCCCCCHHhhhccCCC-CCCCHHH
Q 020221          127 -------------------------------------------------ERLLVAEYMPNDTLAKHLFHWET-QPMKWAM  156 (329)
Q Consensus       127 -------------------------------------------------~~~lv~e~~~~gsL~~~l~~~~~-~~~~~~~  156 (329)
                                                                       ..++||||+++++|.+++..... ...++..
T Consensus        86 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~  165 (332)
T 3qd2_B           86 DEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHGV  165 (332)
T ss_dssp             HC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCCSGGGSCHHH
T ss_pred             hhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccCccchhhHH
Confidence                                                             37999999999999999975322 3356778


Q ss_pred             HHHHHHHHHHHHHHhhcCCCccccccCCCceeeCCCCCeeeecccCcccCCCC----------------CCccCcccccC
Q 020221          157 RLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDG----------------RSYSTNLAFTP  220 (329)
Q Consensus       157 ~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~----------------~~~~~~~~y~a  220 (329)
                      ++.++.||+.||+|||++ |++||||||+||+++.++.+||+|||++......                ....||+.|+|
T Consensus       166 ~~~i~~qi~~aL~~LH~~-~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~a  244 (332)
T 3qd2_B          166 CLHIFIQIAEAVEFLHSK-GLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLYMS  244 (332)
T ss_dssp             HHHHHHHHHHHHHHHHHT-TEECCCCCGGGEEECTTCCEEECCCTTCEECSCC--------------CCCSCC-CGGGSC
T ss_pred             HHHHHHHHHHHHHHHHhC-CeeecCCCcccEEEeCCCCEEEeecCcccccccchhhccccccccccccccccCCCcCccC
Confidence            899999999999999999 9999999999999999999999999999865543                23458999999


Q ss_pred             cccccCCCCCCcccchhhhHHHHHHHhCCCCCCchhhHHHhhhchhhhccccccCCCChHHHHHHHHHHHHhcccCCCCC
Q 020221          221 PEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLASRCLQYEPRER  300 (329)
Q Consensus       221 PE~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~R  300 (329)
                      ||++.+..++.++||||||+++|+|++|..|+...  ......    .... .........++++.+++.+||+.||++|
T Consensus       245 PE~~~~~~~~~~~Di~slG~il~el~~~~~~~~~~--~~~~~~----~~~~-~~~~~~~~~~~~~~~li~~~l~~~p~~R  317 (332)
T 3qd2_B          245 PEQIHGNNYSHKVDIFSLGLILFELLYSFSTQMER--VRIITD----VRNL-KFPLLFTQKYPQEHMMVQDMLSPSPTER  317 (332)
T ss_dssp             HHHHHCCCCCTHHHHHHHHHHHHHHHSCCCCHHHH--HHHHHH----HHTT-CCCHHHHHHCHHHHHHHHHHHCSSGGGS
T ss_pred             hHHhcCCCCcchhhHHHHHHHHHHHHHcCCChhHH--HHHHHH----hhcc-CCCcccccCChhHHHHHHHHccCCCCcC
Confidence            99999989999999999999999999987543211  111111    1000 0111123456788999999999999999


Q ss_pred             CCHHHHHH
Q 020221          301 PNPRSLVT  308 (329)
Q Consensus       301 ps~~~~l~  308 (329)
                      ||+.++++
T Consensus       318 ps~~~~l~  325 (332)
T 3qd2_B          318 PEATDIIE  325 (332)
T ss_dssp             CCHHHHHH
T ss_pred             CCHHHHhh
Confidence            99999998

>3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A*

Probab=100.00  E-value=6.9e-48  Score=344.22  Aligned_cols=265  Identities=20%  Similarity=0.254  Sum_probs=212.2

Q ss_pred             CcccccccCCCCCCcEEEEEEe-----CCCCEEEEEEeCCCCChhHHHHHHHHHHHhcCCCccccccceeee--eCCeeE
Q 020221           57 AMENIVSEHGEKAPNVVYKGKL-----ENQFRIAVKRFNRSAWPDARQFLEEARAVGQLRNRRLANLLGCCC--EGDERL  129 (329)
Q Consensus        57 ~~~~~~~~lg~G~~g~V~~~~~-----~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~--~~~~~~  129 (329)
                      ..|++++.||+|+||.||++.+     .+++.||+|++........+.+.+|+++++.++||||+++++++.  .....+
T Consensus        23 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~  102 (327)
T 3lxl_A           23 RHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYRGVSYGPGRQSLR  102 (327)
T ss_dssp             GGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSSCEEE
T ss_pred             hhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccCCHHHHHHHHHHHHHHHhcCCCceeEEEEEEecCCCceEE
Confidence            3577888999999999999983     467899999998876566677999999999999999999999886  456789


Q ss_pred             EEEecCCCCCHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCCCCCeeeecccCcccCCCC
Q 020221          130 LVAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDG  209 (329)
Q Consensus       130 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~  209 (329)
                      +||||+++++|.+++.. ....+++..++.++.|++.||+|||+. +++|+||||+||+++.++.+||+|||++......
T Consensus       103 lv~e~~~~~~L~~~l~~-~~~~~~~~~~~~i~~qi~~al~~lH~~-~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~~~~  180 (327)
T 3lxl_A          103 LVMEYLPSGCLRDFLQR-HRARLDASRLLLYSSQICKGMEYLGSR-RCVHRDLAARNILVESEAHVKIADFGLAKLLPLD  180 (327)
T ss_dssp             EEEECCTTCBHHHHHHH-HGGGCCHHHHHHHHHHHHHHHHHHHHT-TEECSCCSGGGEEEEETTEEEECCGGGCEECCTT
T ss_pred             EEEeecCCCCHHHHHHh-cccCCCHHHHHHHHHHHHHHHHHHHhC-CccCCCCChhhEEECCCCCEEEcccccceecccC
Confidence            99999999999999864 234689999999999999999999999 9999999999999999999999999999865433


Q ss_pred             C-------CccCcccccCcccccCCCCCCcccchhhhHHHHHHHhCCCCCCchhhHHHhhh----------chhhhcccc
Q 020221          210 R-------SYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDR----------NIQTLTDSC  272 (329)
Q Consensus       210 ~-------~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~~~~----------~~~~~~~~~  272 (329)
                      .       ...++..|+|||++.+..++.++||||||+++|+|++|..||...........          .........
T Consensus       181 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  260 (327)
T 3lxl_A          181 KDYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDVPALSRLLELLEEG  260 (327)
T ss_dssp             CSEEECSSCCCSCGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHCC----CCHHHHHHHHHHTT
T ss_pred             CccceeeccCCccccccCHHHhccCCCChHHhHHHHHHHHHHHHhCCCCCccccchhhhhcccccccccHHHHHHHhhcc
Confidence            2       23467789999999988899999999999999999999987755433221110          111112222


Q ss_pred             ccCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhhccccccCc
Q 020221          273 LEGQFSSDEGTELVRLASRCLQYEPRERPNPRSLVTALVTLQKDTELYLSL  323 (329)
Q Consensus       273 ~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~~~l~~L~~~~~~~~~~~~~  323 (329)
                      .....+..+++++.+++.+||+.||++|||+.++++.|+.+..........
T Consensus       261 ~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~~~~~~~~  311 (327)
T 3lxl_A          261 QRLPAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQLDMLWSGSRGCETH  311 (327)
T ss_dssp             CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHC----------
T ss_pred             cCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhhhcCcccc
Confidence            233445667889999999999999999999999999999997755444433

>1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A*

Probab=100.00  E-value=1.9e-47  Score=336.69  Aligned_cols=265  Identities=15%  Similarity=0.145  Sum_probs=212.4

Q ss_pred             CcccccccCCCCCCcEEEEEE-eCCCCEEEEEEeCCCCChhHHHHHHHHHHHhcC-CCccccccceeeeeCCeeEEEEec
Q 020221           57 AMENIVSEHGEKAPNVVYKGK-LENQFRIAVKRFNRSAWPDARQFLEEARAVGQL-RNRRLANLLGCCCEGDERLLVAEY  134 (329)
Q Consensus        57 ~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~  134 (329)
                      ..|++.+.||+|+||.||+|. ..+++.||+|++....  ..+.+.+|+.+++.+ +|+|++++++++......++||||
T Consensus        10 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv~e~   87 (298)
T 1csn_A           10 VHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRS--DAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVIDL   87 (298)
T ss_dssp             TTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCT--TSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEEC
T ss_pred             cceEEEEEEeecCCEEEEEEEECCCCcEEEEEEeccCC--ccHHHHHHHHHHHHHhcCCCCCeEEeecCCCceeEEEEEe
Confidence            347788888999999999999 4678999999986543  234578899999999 799999999999999999999999


Q ss_pred             CCCCCHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCCCCC-----eeeecccCcccCCCC
Q 020221          135 MPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVN-----PRLSCFGLMKNSRDG  209 (329)
Q Consensus       135 ~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~-----~kl~Dfg~a~~~~~~  209 (329)
                      + +++|.+++.. ....+++..+..++.|++.||.|||++ |++||||||+||+++.++.     +||+|||++......
T Consensus        88 ~-~~~L~~~l~~-~~~~~~~~~~~~i~~qi~~~l~~lH~~-~ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg~~~~~~~~  164 (298)
T 1csn_A           88 L-GPSLEDLLDL-CGRKFSVKTVAMAAKQMLARVQSIHEK-SLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDP  164 (298)
T ss_dssp             C-CCBHHHHHHH-TTTCCCHHHHHHHHHHHHHHHHHHHTT-TEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEESBCT
T ss_pred             c-CCCHHHHHHH-hccCCCHHHHHHHHHHHHHHHHHHHhC-CEecCCCCHHHEEeccCCCCCCCeEEEEECccccccccc
Confidence            9 8999999975 345699999999999999999999999 9999999999999987766     999999999765432


Q ss_pred             -----------CCccCcccccCcccccCCCCCCcccchhhhHHHHHHHhCCCCCCchh---hHHHhhhchhhhccccccC
Q 020221          210 -----------RSYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHA---LDLIRDRNIQTLTDSCLEG  275 (329)
Q Consensus       210 -----------~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~---~~~~~~~~~~~~~~~~~~~  275 (329)
                                 ....||+.|+|||++.+..++.++||||||+++|+|++|..||....   ............... ...
T Consensus       165 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~-~~~  243 (298)
T 1csn_A          165 VTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQST-PLR  243 (298)
T ss_dssp             TTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHHHS-CHH
T ss_pred             cccccccccCccCCCCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHcCCCCcchhhccccHHHHHHHHhhccCc-cHH
Confidence                       23458899999999999899999999999999999999999886521   111111110000000 000


Q ss_pred             CCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhhcccc--ccCccccc
Q 020221          276 QFSSDEGTELVRLASRCLQYEPRERPNPRSLVTALVTLQKDTEL--YLSLPWVM  327 (329)
Q Consensus       276 ~~~~~~~~~~~~li~~cl~~dp~~Rps~~~~l~~L~~~~~~~~~--~~~~p~~~  327 (329)
                      .....+++++.+++..||+.||++|||+.++++.|+++.+....  .....|.+
T Consensus       244 ~~~~~~~~~l~~li~~~l~~dp~~RP~~~~l~~~l~~~~~~~~~~~~~~~dw~~  297 (298)
T 1csn_A          244 ELCAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLERLNTTEDENFDWNL  297 (298)
T ss_dssp             HHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHHTTCCSCSCCGGGC
T ss_pred             HHHhhCcHHHHHHHHHHhcCCcccCCCHHHHHHHHHHHHHhcCCCCCCccccCC
Confidence            11234567899999999999999999999999999999875443  44455554

>3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ...

Probab=100.00  E-value=8.3e-48  Score=337.41  Aligned_cols=255  Identities=21%  Similarity=0.345  Sum_probs=215.4

Q ss_pred             CcccccccCCCCCCcEEEEEEe-CCCCEEEEEEeCCCCChhHHHHHHHHHHHhcCCCccccccceeeeeCCeeEEEEecC
Q 020221           57 AMENIVSEHGEKAPNVVYKGKL-ENQFRIAVKRFNRSAWPDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAEYM  135 (329)
Q Consensus        57 ~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~  135 (329)
                      ..+++.+.||+|+||+||+|.. .++..||+|.+.... ...+.+.+|+++++.++||||+++++++.+....++||||+
T Consensus        13 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~   91 (288)
T 3kfa_A           13 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFM   91 (288)
T ss_dssp             GGEEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECSCS-THHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEEECC
T ss_pred             cceeEEeecCCCCceeEEEeEecCCCEEEEEEecCcCH-HHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCEEEEEEcC
Confidence            4567788899999999999995 458889999998654 34677899999999999999999999999999999999999


Q ss_pred             CCCCHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCCCCCeeeecccCcccCCCCC-----
Q 020221          136 PNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDGR-----  210 (329)
Q Consensus       136 ~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~-----  210 (329)
                      ++++|.+++.......+++..++.++.|++.||.|||+. +++|+||||+||+++.++.++|+|||++.......     
T Consensus        92 ~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~-~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~  170 (288)
T 3kfa_A           92 TYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKK-NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHA  170 (288)
T ss_dssp             TTEEHHHHHHHCCTTTSCHHHHHHHHHHHHHHHHHHHHH-TCCCSCCSGGGEEECGGGCEEECCCCGGGTSCSSSSEEET
T ss_pred             CCCcHHHHHHhcccCCccHhHHHHHHHHHHHHHHHHHHC-CccCCCCCcceEEEcCCCCEEEccCccceeccCCcccccc
Confidence            999999999865667799999999999999999999999 99999999999999999999999999998655432     


Q ss_pred             CccCcccccCcccccCCCCCCcccchhhhHHHHHHHh-CCCCCCchhhHHHhhhchhhhccccccCCCChHHHHHHHHHH
Q 020221          211 SYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLS-GKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLA  289 (329)
Q Consensus       211 ~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t-g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li  289 (329)
                      ...+++.|+|||.+.+..++.++||||||+++|+|++ |..|+...........     .........+..+++++.+++
T Consensus       171 ~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~~g~~p~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~l~~li  245 (288)
T 3kfa_A          171 GAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYEL-----LEKDYRMERPEGCPEKVYELM  245 (288)
T ss_dssp             TEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHH-----HHTTCCCCCCTTCCHHHHHHH
T ss_pred             CCccccCcCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHH-----HhccCCCCCCCCCCHHHHHHH
Confidence            2234678999999998899999999999999999999 7777754432222211     111222334556778999999


Q ss_pred             HHhcccCCCCCCCHHHHHHHHHhhhhccc
Q 020221          290 SRCLQYEPRERPNPRSLVTALVTLQKDTE  318 (329)
Q Consensus       290 ~~cl~~dp~~Rps~~~~l~~L~~~~~~~~  318 (329)
                      .+||+.||++|||+.++++.|+.+.....
T Consensus       246 ~~~l~~dp~~Rps~~~~~~~l~~~~~~~~  274 (288)
T 3kfa_A          246 RACWQWNPSDRPSFAEIHQAFETMFQESS  274 (288)
T ss_dssp             HHHTCSSGGGSCCHHHHHHHHHHHHHHHH
T ss_pred             HHHhCCChhhCcCHHHHHHHHHHHHHhcc
Confidence            99999999999999999999999876543

>2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus}

Probab=100.00  E-value=2.2e-47  Score=356.07  Aligned_cols=243  Identities=19%  Similarity=0.264  Sum_probs=206.6

Q ss_pred             CcccccccCCCCCCcEEEEEEe-CCCCEEEEEEeCCCC---ChhHHHHHHHHHHHhcCCCccccccceeeeeCCeeEEEE
Q 020221           57 AMENIVSEHGEKAPNVVYKGKL-ENQFRIAVKRFNRSA---WPDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVA  132 (329)
Q Consensus        57 ~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~  132 (329)
                      ..|.+.+.||+|+||.||+|.. .+|+.||||++....   ......+.+|+.+++.++||||+++++++.+.+..++||
T Consensus        16 ~~Y~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lv~   95 (476)
T 2y94_A           16 GHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVISTPSDIFMVM   95 (476)
T ss_dssp             TTEEEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             cCEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEE
Confidence            4577888899999999999995 478999999996532   123457889999999999999999999999999999999


Q ss_pred             ecCCCCCHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCCCCCeeeecccCcccCCCC---
Q 020221          133 EYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDG---  209 (329)
Q Consensus       133 e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~---  209 (329)
                      ||+++|+|.+++.  ....+++..+..++.||+.||.|||+. |++||||||+||+++.++.+||+|||++......   
T Consensus        96 E~~~gg~L~~~l~--~~~~l~~~~~~~i~~qi~~aL~~LH~~-givHrDLkp~NIll~~~~~vkL~DFG~a~~~~~~~~~  172 (476)
T 2y94_A           96 EYVSGGELFDYIC--KNGRLDEKESRRLFQQILSGVDYCHRH-MVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFL  172 (476)
T ss_dssp             ECCSSEEHHHHTT--SSSSCCHHHHHHHHHHHHHHHHHHHTT-TEECSCCSGGGEEECTTCCEEECCCSSCEECCTTCCB
T ss_pred             eCCCCCcHHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHHC-CCCcccccHHHEEEecCCCeEEEeccchhhccccccc
Confidence            9999999999996  456799999999999999999999999 9999999999999999999999999999876543   


Q ss_pred             CCccCcccccCcccccCCCC-CCcccchhhhHHHHHHHhCCCCCCchhhHHHhhhchhhhccccccCCCChHHHHHHHHH
Q 020221          210 RSYSTNLAFTPPEYLRTGRV-TPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRL  288 (329)
Q Consensus       210 ~~~~~~~~y~aPE~~~~~~~-~~~~DvwslG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  288 (329)
                      ....||+.|+|||++.+..+ +.++||||||+++|+|++|..||................      ...+...++++.+|
T Consensus       173 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~------~~~p~~~s~~~~~L  246 (476)
T 2y94_A          173 RTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHVPTLFKKICDGI------FYTPQYLNPSVISL  246 (476)
T ss_dssp             CCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCCSSSHHHHHHHHTTC------CCCCTTCCHHHHHH
T ss_pred             cccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCCCCHHHHHHHHhcCC------cCCCccCCHHHHHH
Confidence            34568999999999998775 679999999999999999999887654333322222111      12344567889999


Q ss_pred             HHHhcccCCCCCCCHHHHHH
Q 020221          289 ASRCLQYEPRERPNPRSLVT  308 (329)
Q Consensus       289 i~~cl~~dp~~Rps~~~~l~  308 (329)
                      +.+||..||++|||+.++++
T Consensus       247 i~~~L~~dP~~Rpt~~eil~  266 (476)
T 2y94_A          247 LKHMLQVDPMKRATIKDIRE  266 (476)
T ss_dssp             HHHHTCSSTTTSCCHHHHHT
T ss_pred             HHHHcCCCchhCcCHHHHHh
Confidence            99999999999999999997

>2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A*

Probab=100.00  E-value=1.2e-47  Score=347.94  Aligned_cols=247  Identities=19%  Similarity=0.204  Sum_probs=197.7

Q ss_pred             CCcccccccCCCCCCcEEEEEEe-CCCCEEEEEEeCCCCC---hhHHHHHHHHHH-HhcCCCccccccceeeeeCCeeEE
Q 020221           56 FAMENIVSEHGEKAPNVVYKGKL-ENQFRIAVKRFNRSAW---PDARQFLEEARA-VGQLRNRRLANLLGCCCEGDERLL  130 (329)
Q Consensus        56 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~---~~~~~~~~e~~~-l~~l~h~niv~~~~~~~~~~~~~l  130 (329)
                      .+.|++++.||+|+||.||++.. .+++.||+|++.....   .....+.+|..+ ++.++||||+++++++.+.+..++
T Consensus        37 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~~~~~~l  116 (373)
T 2r5t_A           37 PSDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYF  116 (373)
T ss_dssp             GGGEEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEEECSSEEEE
T ss_pred             hhheEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEEEeCCEEEE
Confidence            35678888899999999999994 5688999999976532   223446667776 567899999999999999999999


Q ss_pred             EEecCCCCCHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCCCCCeeeecccCcccCCC--
Q 020221          131 VAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRD--  208 (329)
Q Consensus       131 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~--  208 (329)
                      ||||+++|+|.+++.+  ...+++..++.++.||+.||.|||++ ||+||||||+|||++.++.+||+|||+++....  
T Consensus       117 v~E~~~gg~L~~~l~~--~~~~~~~~~~~~~~qi~~aL~~LH~~-givHrDlkp~NIll~~~g~ikL~DFG~a~~~~~~~  193 (373)
T 2r5t_A          117 VLDYINGGELFYHLQR--ERCFLEPRARFYAAEIASALGYLHSL-NIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHN  193 (373)
T ss_dssp             EEECCCSCBHHHHHHH--HSSCCHHHHHHHHHHHHHHHHHHHHT-TCCCCCCCGGGEEECTTSCEEECCCCBCGGGBCCC
T ss_pred             EEeCCCCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHC-CceecCCCHHHEEECCCCCEEEeeCccccccccCC
Confidence            9999999999999863  45789999999999999999999999 999999999999999999999999999975322  


Q ss_pred             --CCCccCcccccCcccccCCCCCCcccchhhhHHHHHHHhCCCCCCchhhHHHhhhchhhhccccccCCCChHHHHHHH
Q 020221          209 --GRSYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELV  286 (329)
Q Consensus       209 --~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  286 (329)
                        .....||+.|+|||++.+..++.++||||||+++|||++|..||...............      ...++...+.++.
T Consensus       194 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~------~~~~~~~~~~~~~  267 (373)
T 2r5t_A          194 STTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILNK------PLQLKPNITNSAR  267 (373)
T ss_dssp             CCCCSBSCCCCCCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSBHHHHHHHHHHS------CCCCCSSSCHHHH
T ss_pred             CccccccCCccccCHHHhCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhc------ccCCCCCCCHHHH
Confidence              23457899999999999999999999999999999999999998765443333222221      1123455678899


Q ss_pred             HHHHHhcccCCCCCCCHHHHHHHHH
Q 020221          287 RLASRCLQYEPRERPNPRSLVTALV  311 (329)
Q Consensus       287 ~li~~cl~~dp~~Rps~~~~l~~L~  311 (329)
                      +++.+||+.||++||++.+.++.+.
T Consensus       268 ~li~~lL~~dp~~R~~~~~~~~~i~  292 (373)
T 2r5t_A          268 HLLEGLLQKDRTKRLGAKDDFMEIK  292 (373)
T ss_dssp             HHHHHHTCSSGGGSTTTTTTHHHHH
T ss_pred             HHHHHHcccCHHhCCCCCCCHHHHh
Confidence            9999999999999999864444333

>4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A*

Probab=100.00  E-value=8.7e-48  Score=355.28  Aligned_cols=251  Identities=17%  Similarity=0.130  Sum_probs=204.7

Q ss_pred             CCCcccccccCCCCCCcEEEEEEe-CCCCEEEEEEeCCCCC---hhHHHHHHHHHHHhcCCCccccccceeeeeCCeeEE
Q 020221           55 GFAMENIVSEHGEKAPNVVYKGKL-ENQFRIAVKRFNRSAW---PDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLL  130 (329)
Q Consensus        55 ~~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l  130 (329)
                      ....+++++.||+|+||+||++.. .+++.||+|++.....   .....+.+|..++..++||||+++++++.+....++
T Consensus        72 ~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~~~~~l  151 (437)
T 4aw2_A           72 HREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAFQDDNNLYL  151 (437)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTBCCEEEEEECSSEEEE
T ss_pred             ChhheEEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCEEEE
Confidence            345677888889999999999995 4578999999865221   112237889999999999999999999999999999


Q ss_pred             EEecCCCCCHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCCCCCeeeecccCcccCCCCC
Q 020221          131 VAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDGR  210 (329)
Q Consensus       131 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~  210 (329)
                      ||||+++|+|.+++.+ ....+++..+..++.||+.||.|||+. +|+||||||+|||++.++.+||+|||+++......
T Consensus       152 V~Ey~~gg~L~~~l~~-~~~~l~e~~~~~~~~qi~~aL~~LH~~-giiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~  229 (437)
T 4aw2_A          152 VMDYYVGGDLLTLLSK-FEDRLPEEMARFYLAEMVIAIDSVHQL-HYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDG  229 (437)
T ss_dssp             EECCCTTCBHHHHHHT-TTTCCCHHHHHHHHHHHHHHHHHHHHT-TEECCCCSGGGEEECTTSCEEECCCTTCEECCTTS
T ss_pred             EEecCCCCcHHHHHHH-ccCCCCHHHHHHHHHHHHHHHHHHHhC-CeEecccCHHHeeEcCCCCEEEcchhhhhhcccCC
Confidence            9999999999999964 346799999999999999999999999 99999999999999999999999999997654432


Q ss_pred             -----CccCcccccCccccc-----CCCCCCcccchhhhHHHHHHHhCCCCCCchhhHHHhhhchhhhccccccCCCChH
Q 020221          211 -----SYSTNLAFTPPEYLR-----TGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSD  280 (329)
Q Consensus       211 -----~~~~~~~y~aPE~~~-----~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  280 (329)
                           ...||+.|+|||++.     +..++.++||||||+++|||++|..||................... ..+.....
T Consensus       230 ~~~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~-~~p~~~~~  308 (437)
T 4aw2_A          230 TVQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKERF-QFPTQVTD  308 (437)
T ss_dssp             CEECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHHHC-CCCSSCCC
T ss_pred             CcccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCCCChhHHHHhhhhccccc-cCCccccc
Confidence                 357899999999987     4569999999999999999999999987654433332222111110 11112234


Q ss_pred             HHHHHHHHHHHhcccCCCC--CCCHHHHHH
Q 020221          281 EGTELVRLASRCLQYEPRE--RPNPRSLVT  308 (329)
Q Consensus       281 ~~~~~~~li~~cl~~dp~~--Rps~~~~l~  308 (329)
                      .++++.+|+.+||..+|++  ||++.++++
T Consensus       309 ~s~~~~dLi~~lL~~~~~r~~r~~~~eil~  338 (437)
T 4aw2_A          309 VSENAKDLIRRLICSREHRLGQNGIEDFKK  338 (437)
T ss_dssp             SCHHHHHHHHTTSSCGGGCTTTTTTHHHHT
T ss_pred             CCHHHHHHHHHHhcccccccCCCCHHHHhC
Confidence            6789999999999988888  999999987

>4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens}

Probab=100.00  E-value=5.5e-47  Score=337.23  Aligned_cols=259  Identities=13%  Similarity=0.131  Sum_probs=207.6

Q ss_pred             CcccccccCCCCCCcEEEEEEe-CCCCEEEEEEeCCCC-ChhHHHHHHHHHHHhcCCCccccccceeeeeCC--eeEEEE
Q 020221           57 AMENIVSEHGEKAPNVVYKGKL-ENQFRIAVKRFNRSA-WPDARQFLEEARAVGQLRNRRLANLLGCCCEGD--ERLLVA  132 (329)
Q Consensus        57 ~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~--~~~lv~  132 (329)
                      ..|.+.+.||+|+||+||+|.. .+++.||||++.... ....+.+.+|+++++.++||||+++++++....  ..++||
T Consensus         9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~   88 (319)
T 4euu_A            9 HLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLIM   88 (319)
T ss_dssp             EEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEEE
T ss_pred             CCEEEEEEecCCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCcceEEEEeecCCCceEEEEE
Confidence            3577888899999999999994 458899999997643 233567889999999999999999999987654  789999


Q ss_pred             ecCCCCCHHhhhccCC-CCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceee----CCCCCeeeecccCcccCC
Q 020221          133 EYMPNDTLAKHLFHWE-TQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVF----DDDVNPRLSCFGLMKNSR  207 (329)
Q Consensus       133 e~~~~gsL~~~l~~~~-~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~----~~~~~~kl~Dfg~a~~~~  207 (329)
                      ||+++++|.+++.... ...+++..++.++.|++.||.|||+. |++||||||+||++    +.++.+||+|||++....
T Consensus        89 e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~-~ivH~Dlkp~NIll~~~~~~~~~~kL~Dfg~a~~~~  167 (319)
T 4euu_A           89 EFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLREN-GIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELE  167 (319)
T ss_dssp             ECCTTCBHHHHHHSGGGTTCCCHHHHHHHHHHHHHHHHHHHHT-TEECSCCSGGGEEEEECTTSCEEEEECCCTTCEECC
T ss_pred             eCCCCCCHHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHC-CEecCCCCHHHEEEeccCCCCceEEEccCCCceecC
Confidence            9999999999997532 23489999999999999999999999 99999999999999    778889999999998755


Q ss_pred             CCC---CccCcccccCccccc--------CCCCCCcccchhhhHHHHHHHhCCCCCCchhh----HHHhhhchhhhcc--
Q 020221          208 DGR---SYSTNLAFTPPEYLR--------TGRVTPESVMYSFGTLLLDLLSGKHIPPSHAL----DLIRDRNIQTLTD--  270 (329)
Q Consensus       208 ~~~---~~~~~~~y~aPE~~~--------~~~~~~~~DvwslG~il~el~tg~~~~~~~~~----~~~~~~~~~~~~~--  270 (329)
                      ...   ...+|+.|+|||++.        +..++.++||||||+++|||++|..||.....    .............  
T Consensus       168 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~p~~~  247 (319)
T 4euu_A          168 DDEQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGKPSGA  247 (319)
T ss_dssp             TTCCBCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEECTTCGGGCHHHHHHHHHHCCTTC
T ss_pred             CCCceeecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCccchhHHHHHHHhcCCCccc
Confidence            443   346889999999886        56789999999999999999999988742211    1111111111000  


Q ss_pred             -----------------ccccCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhhc
Q 020221          271 -----------------SCLEGQFSSDEGTELVRLASRCLQYEPRERPNPRSLVTALVTLQKD  316 (329)
Q Consensus       271 -----------------~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~~~l~~L~~~~~~  316 (329)
                                       .......+...++.+.+++.+||+.||++|||+.+++++......-
T Consensus       248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~R~s~~ell~h~~d~~~~  310 (319)
T 4euu_A          248 ISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDILHR  310 (319)
T ss_dssp             CEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHHTC-
T ss_pred             chhhhcccCCccccCccCCcccccchhHHHHhHHHHHHhccCChhhhccHHHhhhccHHHhhc
Confidence                             0011234567889999999999999999999999999998876543

>2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A

Probab=100.00  E-value=3.3e-47  Score=339.02  Aligned_cols=246  Identities=18%  Similarity=0.203  Sum_probs=204.7

Q ss_pred             cccccccCCCCCCcEEEEEEe-CCCCEEEEEEeCCCCCh------hHHHHHHHHHHHhcCCCccccccceeeeeCCeeEE
Q 020221           58 MENIVSEHGEKAPNVVYKGKL-ENQFRIAVKRFNRSAWP------DARQFLEEARAVGQLRNRRLANLLGCCCEGDERLL  130 (329)
Q Consensus        58 ~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~------~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l  130 (329)
                      .|++.+.||+|+||.||++.. .+++.||+|++......      ..+.+.+|+.+++.++||||+++++++.+....++
T Consensus        13 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l   92 (321)
T 2a2a_A           13 FYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENRTDVVL   92 (321)
T ss_dssp             HEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred             cEEEeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEEEE
Confidence            367888889999999999994 56889999998764322      35678999999999999999999999999999999


Q ss_pred             EEecCCCCCHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCCCC----CeeeecccCcccC
Q 020221          131 VAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDV----NPRLSCFGLMKNS  206 (329)
Q Consensus       131 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~----~~kl~Dfg~a~~~  206 (329)
                      ||||+++++|.+++.  ....+++..+..++.|++.||.|||+. |++|+||||+||+++.++    .++|+|||++...
T Consensus        93 v~e~~~~~~L~~~l~--~~~~~~~~~~~~i~~qi~~aL~~lH~~-~ivH~dikp~NIl~~~~~~~~~~~kl~Dfg~~~~~  169 (321)
T 2a2a_A           93 ILELVSGGELFDFLA--QKESLSEEEATSFIKQILDGVNYLHTK-KIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEI  169 (321)
T ss_dssp             EECCCCSCBHHHHHH--TCSCEEHHHHHHHHHHHHHHHHHHHHT-TEECCCCSGGGEEESCTTSSSCCEEECCCTTCEEC
T ss_pred             EEEcCCCCcHHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHhC-CeecCCCChHHEEEecCCCCcCCEEEccCccceec
Confidence            999999999999996  445789999999999999999999999 999999999999999887    7999999999865


Q ss_pred             CCC---CCccCcccccCcccccCCCCCCcccchhhhHHHHHHHhCCCCCCchhhHHHhhhchhhhccccccCCCChHHHH
Q 020221          207 RDG---RSYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGT  283 (329)
Q Consensus       207 ~~~---~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  283 (329)
                      ...   ....+|+.|+|||++.+..++.++||||||+++|+|++|..||..................  .........++
T Consensus       170 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~--~~~~~~~~~~~  247 (321)
T 2a2a_A          170 EDGVEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITSVSYD--FDEEFFSHTSE  247 (321)
T ss_dssp             CTTCCCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCCC--CCHHHHTTCCH
T ss_pred             CccccccccCCCCCccCcccccCCCCCCccccHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcccc--cChhhhcccCH
Confidence            543   3346899999999999889999999999999999999999988655433222221111100  00001123467


Q ss_pred             HHHHHHHHhcccCCCCCCCHHHHHH
Q 020221          284 ELVRLASRCLQYEPRERPNPRSLVT  308 (329)
Q Consensus       284 ~~~~li~~cl~~dp~~Rps~~~~l~  308 (329)
                      .+.+++.+||..||++|||+.++++
T Consensus       248 ~~~~li~~~l~~dp~~Rps~~e~l~  272 (321)
T 2a2a_A          248 LAKDFIRKLLVKETRKRLTIQEALR  272 (321)
T ss_dssp             HHHHHHHTTSCSSTTTSCCHHHHHH
T ss_pred             HHHHHHHHHcCCChhhCcCHHHHhc
Confidence            8999999999999999999999998

>3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ...

Probab=100.00  E-value=1.7e-47  Score=334.06  Aligned_cols=244  Identities=21%  Similarity=0.298  Sum_probs=204.0

Q ss_pred             CCcccccccCCCCCCcEEEEEE-eCCCCEEEEEEeCCCCC---hhHHHHHHHHHHHhcCCCccccccceeeeeCCeeEEE
Q 020221           56 FAMENIVSEHGEKAPNVVYKGK-LENQFRIAVKRFNRSAW---PDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLV  131 (329)
Q Consensus        56 ~~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv  131 (329)
                      +..|++.+.||+|+||+||++. ..+++.||+|++.....   .....+.+|+.+++.++||||+++++++.+....++|
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   87 (279)
T 3fdn_A            8 LEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLI   87 (279)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             cccEEEeeEEecCCCeEEEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhheEecCCEEEEE
Confidence            4567888889999999999998 45678999999865321   1245688999999999999999999999999999999


Q ss_pred             EecCCCCCHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCCCCCeeeecccCcccCCCC--
Q 020221          132 AEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDG--  209 (329)
Q Consensus       132 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~--  209 (329)
                      |||+++++|.+++..  ...+++..+..++.|++.||.|||+. |++|+||||+||+++.++.++|+|||++......  
T Consensus        88 ~e~~~~~~l~~~l~~--~~~~~~~~~~~~~~qi~~~l~~LH~~-~i~H~dlkp~Nili~~~~~~~l~Dfg~~~~~~~~~~  164 (279)
T 3fdn_A           88 LEYAPLGTVYRELQK--LSKFDEQRTATYITELANALSYCHSK-RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRR  164 (279)
T ss_dssp             ECCCTTEEHHHHHHH--HSSCCHHHHHHHHHHHHHHHHHHHTT-TCEECCCCGGGEEECTTSCEEECSCCEESCC-----
T ss_pred             EecCCCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhC-CEecccCChHhEEEcCCCCEEEEeccccccCCcccc
Confidence            999999999999863  35689999999999999999999999 9999999999999999999999999998654433  


Q ss_pred             CCccCcccccCcccccCCCCCCcccchhhhHHHHHHHhCCCCCCchhhHHHhhhchhhhccccccCCCChHHHHHHHHHH
Q 020221          210 RSYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLA  289 (329)
Q Consensus       210 ~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li  289 (329)
                      ....+++.|+|||.+.+..++.++||||||+++|+|++|..||..............      .....+...++++.+++
T Consensus       165 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~------~~~~~~~~~~~~~~~li  238 (279)
T 3fdn_A          165 TDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISR------VEFTFPDFVTEGARDLI  238 (279)
T ss_dssp             ---CCCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHH------TCCCCCTTSCHHHHHHH
T ss_pred             cccCCCCCccCHhHhccCCCCccchhHhHHHHHHHHHHCCCCCCCCcHHHHHHHHHh------CCCCCCCcCCHHHHHHH
Confidence            345688999999999998899999999999999999999998876543333222111      11234455678899999


Q ss_pred             HHhcccCCCCCCCHHHHHH
Q 020221          290 SRCLQYEPRERPNPRSLVT  308 (329)
Q Consensus       290 ~~cl~~dp~~Rps~~~~l~  308 (329)
                      .+||+.||++|||+.++++
T Consensus       239 ~~~l~~~p~~Rps~~e~l~  257 (279)
T 3fdn_A          239 SRLLKHNPSQRPMLREVLE  257 (279)
T ss_dssp             HHHCCSSGGGSCCHHHHHH
T ss_pred             HHHhccChhhCCCHHHHhh
Confidence            9999999999999999998

>3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens}

Probab=100.00  E-value=8.4e-47  Score=334.39  Aligned_cols=250  Identities=15%  Similarity=0.152  Sum_probs=198.4

Q ss_pred             CcccccccCCCCCCcEEEEEE-eCCCCEEEEEEeCCCCC-----hhHHHHHHHHHHHhcC---CCccccccceeeeeCC-
Q 020221           57 AMENIVSEHGEKAPNVVYKGK-LENQFRIAVKRFNRSAW-----PDARQFLEEARAVGQL---RNRRLANLLGCCCEGD-  126 (329)
Q Consensus        57 ~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~-----~~~~~~~~e~~~l~~l---~h~niv~~~~~~~~~~-  126 (329)
                      ..|++++.||+|+||+||+|. ..+++.||+|++.....     .....+.+|+.+++.+   +||||+++++++.... 
T Consensus         9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~~~~~   88 (308)
T 3g33_A            9 SRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCATSRT   88 (308)
T ss_dssp             -CCEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEEECCS
T ss_pred             cceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeeeccCC
Confidence            357788888999999999999 46788999999864321     1124566777777666   4999999999997754 


Q ss_pred             ----eeEEEEecCCCCCHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCCCCCeeeecccC
Q 020221          127 ----ERLLVAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGL  202 (329)
Q Consensus       127 ----~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~  202 (329)
                          ..+++|||+. ++|.+++.......+++..+..++.|++.||+|||++ +++||||||+||+++.++.+||+|||+
T Consensus        89 ~~~~~~~lv~e~~~-~~L~~~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~-~ivH~Dlkp~Nil~~~~~~~kl~Dfg~  166 (308)
T 3g33_A           89 DREIKVTLVFEHVD-QDLRTYLDKAPPPGLPAETIKDLMRQFLRGLDFLHAN-CIVHRDLKPENILVTSGGTVKLADFGL  166 (308)
T ss_dssp             SSEEEEEEEEECCC-CBHHHHHHTCCTTCSCHHHHHHHHHHHHHHHHHHHHT-TCCCSCCCTTTEEECTTSCEEECSCSC
T ss_pred             CCceeEEEEehhhh-cCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHC-CcccCCCCHHHEEEcCCCCEEEeeCcc
Confidence                5799999997 4999999765555699999999999999999999999 999999999999999999999999999


Q ss_pred             cccCCCCC---CccCcccccCcccccCCCCCCcccchhhhHHHHHHHhCCCCCCchhhHHHhhhchhhhccc---c----
Q 020221          203 MKNSRDGR---SYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDS---C----  272 (329)
Q Consensus       203 a~~~~~~~---~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~---~----  272 (329)
                      +.......   ...+|+.|+|||++.+..++.++||||||+++|+|++|..||..................+   .    
T Consensus       167 a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  246 (308)
T 3g33_A          167 ARIYSYQMALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWPRD  246 (308)
T ss_dssp             TTTSTTCCCSGGGGCCCSSCCHHHHHTSCCCSTHHHHHHHHHHHHTTTSSCSCCCSSHHHHHHHHHHHHCCCCTTTSCSS
T ss_pred             ccccCCCcccCCccccccccCchHHcCCCCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhccch
Confidence            98655432   3467999999999999999999999999999999999999886554332222211110000   0    


Q ss_pred             -------ccC-------CCChHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 020221          273 -------LEG-------QFSSDEGTELVRLASRCLQYEPRERPNPRSLVT  308 (329)
Q Consensus       273 -------~~~-------~~~~~~~~~~~~li~~cl~~dp~~Rps~~~~l~  308 (329)
                             ...       ......++++.+|+.+||+.||++|||+.++++
T Consensus       247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~  296 (308)
T 3g33_A          247 VSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQ  296 (308)
T ss_dssp             CSSCGGGSCCCCCCCHHHHSCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             hhccccccCCCCCCcHHHhCccccHHHHHHHHHHhcCCCccCCCHHHHhc
Confidence                   000       011235678999999999999999999999998

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A*

Probab=100.00  E-value=6.7e-48  Score=348.48  Aligned_cols=255  Identities=20%  Similarity=0.278  Sum_probs=207.9

Q ss_pred             CcccccccCCCCCCcEEEEEEe------CCCCEEEEEEeCCCCCh-hHHHHHHHHHHHhcC-CCccccccceeeeeCC-e
Q 020221           57 AMENIVSEHGEKAPNVVYKGKL------ENQFRIAVKRFNRSAWP-DARQFLEEARAVGQL-RNRRLANLLGCCCEGD-E  127 (329)
Q Consensus        57 ~~~~~~~~lg~G~~g~V~~~~~------~~~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~-~  127 (329)
                      ..|++.+.||+|+||.||+|.+      .+++.||||++...... ..+.+.+|+++++.+ +||||+++++++.+.+ .
T Consensus        22 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~~~~~~  101 (359)
T 3vhe_A           22 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGP  101 (359)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTSC
T ss_pred             cceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCcCCHHHHHHHHHHHHHHHhhcCCcceeeeeeeeecCCCc
Confidence            4577788889999999999973      24578999999875433 345689999999999 7999999999987755 4


Q ss_pred             eEEEEecCCCCCHHhhhccCCC----------------------------------------------------------
Q 020221          128 RLLVAEYMPNDTLAKHLFHWET----------------------------------------------------------  149 (329)
Q Consensus       128 ~~lv~e~~~~gsL~~~l~~~~~----------------------------------------------------------  149 (329)
                      .++||||+++|+|.+++.....                                                          
T Consensus       102 ~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  181 (359)
T 3vhe_A          102 LMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEA  181 (359)
T ss_dssp             CEEEEECCTTEEHHHHHHTTTTSBCSCC----------------------------------------------------
T ss_pred             eEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCccccccccccccccccchhhhccc
Confidence            8999999999999999975321                                                          


Q ss_pred             ------CCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCCCCCeeeecccCcccCCCCC------CccCccc
Q 020221          150 ------QPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDGR------SYSTNLA  217 (329)
Q Consensus       150 ------~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~------~~~~~~~  217 (329)
                            ..+++..++.++.||+.||.|||++ +++||||||+||+++.++.+||+|||++.......      ...+|+.
T Consensus       182 ~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~-~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~t~~  260 (359)
T 3vhe_A          182 PEDLYKDFLTLEHLICYSFQVAKGMEFLASR-KCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLK  260 (359)
T ss_dssp             --CTTTTCBCHHHHHHHHHHHHHHHHHHHHT-TCCCSCCSGGGEEECGGGCEEECCCGGGSCTTSCTTCEEC--CEECGG
T ss_pred             ccchhccccCHHHHHHHHHHHHHHHHHHHHC-CcccCCCChhhEEEcCCCcEEEEeccceeeecccccchhccccCCCce
Confidence                  1288999999999999999999999 99999999999999999999999999998654332      2346788


Q ss_pred             ccCcccccCCCCCCcccchhhhHHHHHHHh-CCCCCCchhhHHHhhhchhhhccccccCCCChHHHHHHHHHHHHhcccC
Q 020221          218 FTPPEYLRTGRVTPESVMYSFGTLLLDLLS-GKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLASRCLQYE  296 (329)
Q Consensus       218 y~aPE~~~~~~~~~~~DvwslG~il~el~t-g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~d  296 (329)
                      |+|||++.+..++.++||||||+++|+|++ |..||...........    ..........+...++++.+++.+||+.|
T Consensus       261 y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~l~~li~~~l~~d  336 (359)
T 3vhe_A          261 WMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCR----RLKEGTRMRAPDYTTPEMYQTMLDCWHGE  336 (359)
T ss_dssp             GCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHHHH----HHHHTCCCCCCTTCCHHHHHHHHHHTCSS
T ss_pred             eEChhhhcCCCCCchhhhhhHHHHHHHHHhcCCCCCCccchhHHHHH----HHHcCCCCCCCCCCCHHHHHHHHHHccCC
Confidence            999999998899999999999999999998 8888765432211111    11111222345556788999999999999


Q ss_pred             CCCCCCHHHHHHHHHhhhhc
Q 020221          297 PRERPNPRSLVTALVTLQKD  316 (329)
Q Consensus       297 p~~Rps~~~~l~~L~~~~~~  316 (329)
                      |++|||+.+++++|+.+.+.
T Consensus       337 P~~Rps~~ell~~L~~~~~~  356 (359)
T 3vhe_A          337 PSQRPTFSELVEHLGNLLQA  356 (359)
T ss_dssp             GGGSCCHHHHHHHHHHHHHH
T ss_pred             hhhCCCHHHHHHHHHHHHHH
Confidence            99999999999999998753

>2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A*

Probab=100.00  E-value=2.4e-47  Score=338.38  Aligned_cols=254  Identities=20%  Similarity=0.287  Sum_probs=210.7

Q ss_pred             CcccccccCCCCCCcEEEEEEe------CCCCEEEEEEeCCCCC-hhHHHHHHHHHHHhcCCCccccccceeeeeCCeeE
Q 020221           57 AMENIVSEHGEKAPNVVYKGKL------ENQFRIAVKRFNRSAW-PDARQFLEEARAVGQLRNRRLANLLGCCCEGDERL  129 (329)
Q Consensus        57 ~~~~~~~~lg~G~~g~V~~~~~------~~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~  129 (329)
                      ..|.+.+.||+|+||.||++..      .++..||+|++..... ...+.+.+|+++++.++||||+++++++...+..+
T Consensus        23 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~  102 (314)
T 2ivs_A           23 KNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIKLYGACSQDGPLL  102 (314)
T ss_dssp             GGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCE
T ss_pred             hheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCceeeEEEEEecCCceE
Confidence            4567788889999999999984      3457899999986543 33567899999999999999999999999999999


Q ss_pred             EEEecCCCCCHHhhhccCCC----------------------CCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCce
Q 020221          130 LVAEYMPNDTLAKHLFHWET----------------------QPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRI  187 (329)
Q Consensus       130 lv~e~~~~gsL~~~l~~~~~----------------------~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Ni  187 (329)
                      +||||+++++|.+++.....                      ..+++.+++.++.||+.||.|||++ +++|+||||+||
T Consensus       103 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~-~ivH~dikp~NI  181 (314)
T 2ivs_A          103 LIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEM-KLVHRDLAARNI  181 (314)
T ss_dssp             EEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHHT-TEECCCCSGGGE
T ss_pred             EEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHHC-CCcccccchheE
Confidence            99999999999999975322                      3478999999999999999999999 999999999999


Q ss_pred             eeCCCCCeeeecccCcccCCCCC------CccCcccccCcccccCCCCCCcccchhhhHHHHHHHh-CCCCCCchhhHHH
Q 020221          188 VFDDDVNPRLSCFGLMKNSRDGR------SYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLS-GKHIPPSHALDLI  260 (329)
Q Consensus       188 l~~~~~~~kl~Dfg~a~~~~~~~------~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t-g~~~~~~~~~~~~  260 (329)
                      +++.++.+||+|||++.......      ...+++.|+|||.+.+..++.++||||||+++|+|++ |..||........
T Consensus       182 li~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~  261 (314)
T 2ivs_A          182 LVAEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIPPERL  261 (314)
T ss_dssp             EEETTTEEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGH
T ss_pred             EEcCCCCEEEccccccccccccccceeccCCCCcccccChhhhcCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHH
Confidence            99999999999999997654332      2345788999999998889999999999999999999 8877765432222


Q ss_pred             hhhchhhhccccccCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhhc
Q 020221          261 RDRNIQTLTDSCLEGQFSSDEGTELVRLASRCLQYEPRERPNPRSLVTALVTLQKD  316 (329)
Q Consensus       261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~~~l~~L~~~~~~  316 (329)
                      ...     .........+...++++.+++.+||+.||++|||+.++++.|+++..+
T Consensus       262 ~~~-----~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~  312 (314)
T 2ivs_A          262 FNL-----LKTGHRMERPDNCSEEMYRLMLQCWKQEPDKRPVFADISKDLEKMMVK  312 (314)
T ss_dssp             HHH-----HHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred             HHH-----hhcCCcCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhh
Confidence            211     111122234556778999999999999999999999999999998653

>2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A*

Probab=100.00  E-value=2.8e-47  Score=340.78  Aligned_cols=256  Identities=16%  Similarity=0.106  Sum_probs=206.9

Q ss_pred             CcccccccCCCCCCcEEEEEE-eCCCCEEEEEEeCCCCChhHHHHHHHHHHHhcC-CCccccccceeeeeCCeeEEEEec
Q 020221           57 AMENIVSEHGEKAPNVVYKGK-LENQFRIAVKRFNRSAWPDARQFLEEARAVGQL-RNRRLANLLGCCCEGDERLLVAEY  134 (329)
Q Consensus        57 ~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~  134 (329)
                      ..|++.+.||+|+||.||+|. ..+++.||||++.....  .+.+.+|+++++.+ +||||+++++++......++||||
T Consensus         9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e~   86 (330)
T 2izr_A            9 PNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSR--APQLHLEYRFYKQLGSGDGIPQVYYFGPCGKYNAMVLEL   86 (330)
T ss_dssp             TTEEEEEECCC-CTTSEEEEEETTTTEEEEEEEEETTCS--SCCHHHHHHHHHHHCSCTTSCCEEEEEEETTEEEEEEEC
T ss_pred             CCeEEEEEeeccCCceEEEEEECCCCcEEEEEEeccccc--hHHHHHHHHHHHHhhCCCCCCEEEEEEecCCccEEEEEe
Confidence            346778888999999999999 46788999999876542  23578899999999 899999999999999999999999


Q ss_pred             CCCCCHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCCCCC-----eeeecccCcccCCCC
Q 020221          135 MPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVN-----PRLSCFGLMKNSRDG  209 (329)
Q Consensus       135 ~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~-----~kl~Dfg~a~~~~~~  209 (329)
                      + +++|.+++.. ....+++..+..++.|++.||+|||+. +++||||||+|||++.++.     +||+|||++......
T Consensus        87 ~-~~~L~~~~~~-~~~~~~~~~~~~i~~qi~~~l~~LH~~-~iiHrDlkp~Nill~~~~~~~~~~~kl~DFg~a~~~~~~  163 (330)
T 2izr_A           87 L-GPSLEDLFDL-CDRTFSLKTVLMIAIQLISRMEYVHSK-NLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEYIDP  163 (330)
T ss_dssp             C-CCBHHHHHHH-TTTCCCHHHHHHHHHHHHHHHHHHHHT-TEECCCCCGGGEEECCGGGTCTTSEEECCCTTCEESBCT
T ss_pred             C-CCCHHHHHHH-cCCCCCHHHHHHHHHHHHHHHHHHHhC-CeeccCCCHHHeeeccCCCCCCceEEEEEcccceeeecC
Confidence            9 8999999965 256799999999999999999999999 9999999999999998887     999999999864332


Q ss_pred             -----------CCccCcccccCcccccCCCCCCcccchhhhHHHHHHHhCCCCCCchhhH---HHhhhchhhhccccccC
Q 020221          210 -----------RSYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALD---LIRDRNIQTLTDSCLEG  275 (329)
Q Consensus       210 -----------~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~---~~~~~~~~~~~~~~~~~  275 (329)
                                 ....||+.|+|||++.+..++.++||||||+++|||++|..||......   ............ ....
T Consensus       164 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~~~~~-~~~~  242 (330)
T 2izr_A          164 ETKKHIPYREHKSLTGTARYMSINTHLGKEQSRRDDLEALGHMFMYFLRGSLPWQGLKADTLKERYQKIGDTKRA-TPIE  242 (330)
T ss_dssp             TTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCSSHHHHHHHHHHHHHH-SCHH
T ss_pred             CCCccccccccCCcCCCccccChHHHcCCCCCchhHHHHHHHHHHHHhcCCCCccccccccHHHHHHHHHhhhcc-CCHH
Confidence                       2456899999999999999999999999999999999999988653211   111110000000 0000


Q ss_pred             CCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhhcccc
Q 020221          276 QFSSDEGTELVRLASRCLQYEPRERPNPRSLVTALVTLQKDTEL  319 (329)
Q Consensus       276 ~~~~~~~~~~~~li~~cl~~dp~~Rps~~~~l~~L~~~~~~~~~  319 (329)
                      ......+ ++.+++..||+.||++||++.++++.|+.+.+....
T Consensus       243 ~~~~~~p-~~~~li~~~l~~~p~~RP~~~~l~~~l~~~~~~~~~  285 (330)
T 2izr_A          243 VLCENFP-EMATYLRYVRRLDFFEKPDYDYLRKLFTDLFDRKGY  285 (330)
T ss_dssp             HHTTTCH-HHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHHTTC
T ss_pred             HHhccCh-HHHHHHHHHHhCCCCCCCCHHHHHHHHHHHHHHcCC
Confidence            0111234 899999999999999999999999999998765433

>3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1.5e-46  Score=330.82  Aligned_cols=253  Identities=21%  Similarity=0.276  Sum_probs=205.9

Q ss_pred             cccccCCCCCCcEEEEEEe-CCCC---EEEEEEeCCCCCh-hHHHHHHHHHHHhcCCCccccccceeeeeCCee-EEEEe
Q 020221           60 NIVSEHGEKAPNVVYKGKL-ENQF---RIAVKRFNRSAWP-DARQFLEEARAVGQLRNRRLANLLGCCCEGDER-LLVAE  133 (329)
Q Consensus        60 ~~~~~lg~G~~g~V~~~~~-~~~~---~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~-~lv~e  133 (329)
                      ++.+.||+|+||+||+|.. .++.   .+|+|.+...... ..+.+.+|+.+++.++||||+++++++.+.+.. ++++|
T Consensus        24 ~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~v~e  103 (298)
T 3pls_A           24 HSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPEGLPHVLLP  103 (298)
T ss_dssp             EEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEEEEC
T ss_pred             ccCceeccCCCceEEEEEEecCCCceeeeeeeeccccccHHHHHHHHHHHHHHHhCCCCCeeeEEEEEecCCCCcEEEEe
Confidence            3447789999999999984 3333   7999999865433 356788999999999999999999999776655 99999


Q ss_pred             cCCCCCHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCCCCCeeeecccCcccCCCC----
Q 020221          134 YMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDG----  209 (329)
Q Consensus       134 ~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~----  209 (329)
                      |+.+++|.+++.. ....+++..+..++.|++.||+|||+. |++|+||||+||+++.++.+||+|||++......    
T Consensus       104 ~~~~~~L~~~~~~-~~~~~~~~~~~~i~~qi~~~l~~LH~~-~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~  181 (298)
T 3pls_A          104 YMCHGDLLQFIRS-PQRNPTVKDLISFGLQVARGMEYLAEQ-KFVHRDLAARNCMLDESFTVKVADFGLARDILDREYYS  181 (298)
T ss_dssp             CCTTCBHHHHHHC-TTCCCBHHHHHHHHHHHHHHHHHHHHT-TCCCSCCSGGGEEECTTCCEEECCTTSSCTTTTGGGGC
T ss_pred             cccCCCHHHHHhc-cccCCCHHHHHHHHHHHHHHHHHHHhC-CcccCCCCcceEEEcCCCcEEeCcCCCcccccCCcccc
Confidence            9999999999965 456789999999999999999999999 9999999999999999999999999999754332    


Q ss_pred             ----CCccCcccccCcccccCCCCCCcccchhhhHHHHHHHhCCCCCCchhhHHHhhhchhhhccccccCCCChHHHHHH
Q 020221          210 ----RSYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTEL  285 (329)
Q Consensus       210 ----~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  285 (329)
                          ....+++.|+|||.+.+..++.++||||||+++|+|++|+.|+.........    ............+...++++
T Consensus       182 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~l  257 (298)
T 3pls_A          182 VQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHIDPFDL----THFLAQGRRLPQPEYCPDSL  257 (298)
T ss_dssp             SCCSSCTTCGGGGSCHHHHTTCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCGGGH----HHHHHTTCCCCCCTTCCHHH
T ss_pred             cccCcCCCCCccccChhhhccCCCChhhchhhHHHHHHHHhhCCCCCCccCCHHHH----HHHhhcCCCCCCCccchHHH
Confidence                2345678999999999989999999999999999999977665443211111    11111111223345567889


Q ss_pred             HHHHHHhcccCCCCCCCHHHHHHHHHhhhhccc
Q 020221          286 VRLASRCLQYEPRERPNPRSLVTALVTLQKDTE  318 (329)
Q Consensus       286 ~~li~~cl~~dp~~Rps~~~~l~~L~~~~~~~~  318 (329)
                      .+++.+||+.||++|||+.++++.|+++.+...
T Consensus       258 ~~li~~~l~~~p~~Rps~~~ll~~l~~~~~~l~  290 (298)
T 3pls_A          258 YQVMQQCWEADPAVRPTFRVLVGEVEQIVSALL  290 (298)
T ss_dssp             HHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHCC
T ss_pred             HHHHHHHccCChhhCcCHHHHHHHHHHHHHHHh
Confidence            999999999999999999999999999987653

>1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C

Probab=100.00  E-value=1.4e-47  Score=351.25  Aligned_cols=247  Identities=16%  Similarity=0.134  Sum_probs=191.2

Q ss_pred             Cccccc-ccCCCCCCcEEEEEE-eCCCCEEEEEEeCCCCChhHHHHHHHHHHHh-cCCCccccccceeeee----CCeeE
Q 020221           57 AMENIV-SEHGEKAPNVVYKGK-LENQFRIAVKRFNRSAWPDARQFLEEARAVG-QLRNRRLANLLGCCCE----GDERL  129 (329)
Q Consensus        57 ~~~~~~-~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~-~l~h~niv~~~~~~~~----~~~~~  129 (329)
                      ..|.++ +.||+|+||+||++. ..+++.||||++...     ..+.+|+.++. ..+||||+++++++..    ...++
T Consensus        61 ~~y~~~~~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~~-----~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~~~~~~~~  135 (400)
T 1nxk_A           61 DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLL  135 (400)
T ss_dssp             GTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS-----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEE
T ss_pred             ccceeccceeeeccCeEEEEEEECCCCCEEEEEEeCcc-----hhHHHHHHHHHHhcCCCCcceEeEEEeecccCCcEEE
Confidence            345555 568999999999999 456889999998632     35677888874 4589999999998865    56789


Q ss_pred             EEEecCCCCCHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCC---CCCeeeecccCcccC
Q 020221          130 LVAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDD---DVNPRLSCFGLMKNS  206 (329)
Q Consensus       130 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~---~~~~kl~Dfg~a~~~  206 (329)
                      +||||+++|+|.+++.......+++..+..++.||+.||.|||+. ||+||||||+|||++.   ++.+||+|||+++..
T Consensus       136 lv~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~-~ivHrDlkp~Nill~~~~~~~~~kl~DFG~a~~~  214 (400)
T 1nxk_A          136 IVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSI-NIAHRDVKPENLLYTSKRPNAILKLTDFGFAKET  214 (400)
T ss_dssp             EEEECCCSEEHHHHHHCC---CCBHHHHHHHHHHHHHHHHHHHHT-TEECCCCCGGGEEESSSSTTCCEEECCCTTCEEC
T ss_pred             EEEEeCCCCcHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHC-CccccCcCcceEEEecCCCCccEEEEeccccccc
Confidence            999999999999999764455799999999999999999999999 9999999999999997   789999999999865


Q ss_pred             CCC---CCccCcccccCcccccCCCCCCcccchhhhHHHHHHHhCCCCCCchhhHHHhhhchhhhcccc--ccCCCChHH
Q 020221          207 RDG---RSYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSC--LEGQFSSDE  281 (329)
Q Consensus       207 ~~~---~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~  281 (329)
                      ...   ....+|+.|+|||++.+..++.++||||||+++|+|++|..||...............+....  ........+
T Consensus       215 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~  294 (400)
T 1nxk_A          215 TSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEV  294 (400)
T ss_dssp             C-----------CTTCCGGGSCCCCSSSHHHHHHHHHHHHHHHHSSCSCCCCTTCSSCCSHHHHHHHTCCCCCTTTTTTS
T ss_pred             CCCCccccCCCCCCccCHhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCccccccHHHHHHHHcCcccCCCcccccC
Confidence            433   344679999999999988999999999999999999999998864321110000000111000  111112356


Q ss_pred             HHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 020221          282 GTELVRLASRCLQYEPRERPNPRSLVTA  309 (329)
Q Consensus       282 ~~~~~~li~~cl~~dp~~Rps~~~~l~~  309 (329)
                      ++++.+|+.+||+.||++|||+.+++++
T Consensus       295 s~~~~~li~~~L~~dP~~Rpt~~eil~h  322 (400)
T 1nxk_A          295 SEEVKMLIRNLLKTEPTQRMTITEFMNH  322 (400)
T ss_dssp             CHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred             CHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence            7889999999999999999999999983

>3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A*

Probab=100.00  E-value=5.1e-47  Score=331.70  Aligned_cols=247  Identities=18%  Similarity=0.211  Sum_probs=206.1

Q ss_pred             CcccccccCCCCCCcEEEEEE-eCCCCEEEEEEeCCCCC--hhHHHHHHHHHHHhcCCCccccccceeeeeCCeeEEEEe
Q 020221           57 AMENIVSEHGEKAPNVVYKGK-LENQFRIAVKRFNRSAW--PDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAE  133 (329)
Q Consensus        57 ~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  133 (329)
                      ..|++++.||+|+||.||+|. ..+++.||+|++.....  ...+.+.+|+.+++.++||||+++++++...+..++|||
T Consensus         6 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e   85 (284)
T 3kk8_A            6 DNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVFD   85 (284)
T ss_dssp             TTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred             hhhhhhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccCCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEcCCEEEEEEe
Confidence            457788889999999999999 45688999999876432  234668899999999999999999999999999999999


Q ss_pred             cCCCCCHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCCCCC---eeeecccCcccCCCCC
Q 020221          134 YMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVN---PRLSCFGLMKNSRDGR  210 (329)
Q Consensus       134 ~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~---~kl~Dfg~a~~~~~~~  210 (329)
                      |+++++|.+.+..  ...+++..+..++.|++.||.|||+. +++|+||||+||+++.++.   +||+|||++.......
T Consensus        86 ~~~~~~l~~~~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~-~i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~~~~~~~~  162 (284)
T 3kk8_A           86 LVTGGELFEDIVA--REFYSEADASHCIQQILESIAYCHSN-GIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSE  162 (284)
T ss_dssp             CCCSCBHHHHHHH--HSSCCHHHHHHHHHHHHHHHHHHHHT-TEECSCCCGGGEEESSSSTTCCEEECCCTTCEECCSSC
T ss_pred             cCCCCCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHC-CcCcCCCCHHHEEEecCCCCCcEEEeeceeeEEcccCc
Confidence            9999999988863  45689999999999999999999999 9999999999999986655   9999999997655443


Q ss_pred             ---CccCcccccCcccccCCCCCCcccchhhhHHHHHHHhCCCCCCchhhHHHhhhchhhhccccccCCCChHHHHHHHH
Q 020221          211 ---SYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVR  287 (329)
Q Consensus       211 ---~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  287 (329)
                         ...+++.|+|||++.+..++.++||||||+++|+|++|..||..................  .........++++.+
T Consensus       163 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~  240 (284)
T 3kk8_A          163 AWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYD--YPSPEWDTVTPEAKS  240 (284)
T ss_dssp             BCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCC--CCTTTTTTSCHHHHH
T ss_pred             cccCCCCCcCCcCchhhcCCCCCcccchHHHHHHHHHHHHCCCCCCCCchhHHHHHHHhcccc--CCchhhcccCHHHHH
Confidence               356899999999999999999999999999999999999988765443333222221111  111122356788999


Q ss_pred             HHHHhcccCCCCCCCHHHHHH
Q 020221          288 LASRCLQYEPRERPNPRSLVT  308 (329)
Q Consensus       288 li~~cl~~dp~~Rps~~~~l~  308 (329)
                      ++.+||+.||++|||+.++++
T Consensus       241 li~~~l~~dp~~Rps~~~~l~  261 (284)
T 3kk8_A          241 LIDSMLTVNPKKRITADQALK  261 (284)
T ss_dssp             HHHHHSCSSTTTSCCHHHHTT
T ss_pred             HHHHHcccChhhCCCHHHHhc
Confidence            999999999999999999998

>2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A*

Probab=100.00  E-value=2.7e-47  Score=337.75  Aligned_cols=267  Identities=17%  Similarity=0.202  Sum_probs=204.4

Q ss_pred             cCCCcccccccCCCCCCcEEEEEE-eCCCCEEEEEEeCCCC---ChhHHHHHHHHHHHhcCCCccccccceeeeeCCeeE
Q 020221           54 SGFAMENIVSEHGEKAPNVVYKGK-LENQFRIAVKRFNRSA---WPDARQFLEEARAVGQLRNRRLANLLGCCCEGDERL  129 (329)
Q Consensus        54 ~~~~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~  129 (329)
                      ..+..|++.+.||+|+||.||+|. ..+++.||+|++....   ......+.+|+.+++.++||||+++++++...+..+
T Consensus        29 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~  108 (310)
T 2wqm_A           29 NTLANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELN  108 (310)
T ss_dssp             SSGGGEEEEEEEECC--CEEEEEEETTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEE
T ss_pred             ccccceEEEEeecCCCCceEEEEEEcCCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCcEE
Confidence            345568888999999999999999 4678999999997633   223456889999999999999999999999999999


Q ss_pred             EEEecCCCCCHHhhhccC--CCCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCCCCCeeeecccCcccCC
Q 020221          130 LVAEYMPNDTLAKHLFHW--ETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSR  207 (329)
Q Consensus       130 lv~e~~~~gsL~~~l~~~--~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~  207 (329)
                      +||||+++++|.+++...  ....+++..++.++.|++.||.|||+. |++|+||||+||+++.++.++|+|||++....
T Consensus       109 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~-~i~H~dl~p~NIl~~~~~~~kl~Dfg~~~~~~  187 (310)
T 2wqm_A          109 IVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSR-RVMHRDIKPANVFITATGVVKLGDLGLGRFFS  187 (310)
T ss_dssp             EEEECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHT-TCCCCCCCGGGEEECTTSCEEECCC-------
T ss_pred             EEEecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHhhC-CeeCCCCcHHHEEEcCCCCEEEEeccceeeec
Confidence            999999999999988532  345689999999999999999999999 99999999999999999999999999987654


Q ss_pred             CC----CCccCcccccCcccccCCCCCCcccchhhhHHHHHHHhCCCCCCchhhHHHhhhchhhhccccccCCCChHHHH
Q 020221          208 DG----RSYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGT  283 (329)
Q Consensus       208 ~~----~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  283 (329)
                      ..    ....+++.|+|||.+.+..++.++||||||+++|+|++|..||..........  ...+.............++
T Consensus       188 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~  265 (310)
T 2wqm_A          188 SKTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSL--CKKIEQCDYPPLPSDHYSE  265 (310)
T ss_dssp             -----------CCSSCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTC---CCHHHH--HHHHHTTCSCCCCTTTSCH
T ss_pred             CCCccccccCCCeeEeChHHhCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchhHHHH--HHHhhcccCCCCcccccCH
Confidence            33    23457899999999998889999999999999999999998886542211100  0001111111112245678


Q ss_pred             HHHHHHHHhcccCCCCCCCHHHHHHHHHhhhhccccccCc
Q 020221          284 ELVRLASRCLQYEPRERPNPRSLVTALVTLQKDTELYLSL  323 (329)
Q Consensus       284 ~~~~li~~cl~~dp~~Rps~~~~l~~L~~~~~~~~~~~~~  323 (329)
                      ++.+++.+||+.||++|||+.++++.|+++......+.++
T Consensus       266 ~l~~li~~~l~~dp~~Rps~~~il~~l~~l~~~~~~~~~~  305 (310)
T 2wqm_A          266 ELRQLVNMCINPDPEKRPDVTYVYDVAKRMHACTASSLEH  305 (310)
T ss_dssp             HHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHC-----
T ss_pred             HHHHHHHHHcCCChhhCCCHHHHHHHHHHHHHhhhhhhhh
Confidence            8999999999999999999999999999999876655543

>3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus}

Probab=100.00  E-value=3.1e-47  Score=339.30  Aligned_cols=255  Identities=19%  Similarity=0.280  Sum_probs=196.4

Q ss_pred             CcccccccCCCCCCcEEEEEEeCC-C---CEEEEEEeCCC--CChhHHHHHHHHHHHhcCCCccccccceeeeeCCee--
Q 020221           57 AMENIVSEHGEKAPNVVYKGKLEN-Q---FRIAVKRFNRS--AWPDARQFLEEARAVGQLRNRRLANLLGCCCEGDER--  128 (329)
Q Consensus        57 ~~~~~~~~lg~G~~g~V~~~~~~~-~---~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~--  128 (329)
                      ..|++.+.||+|+||+||+|.... +   ..||+|++...  .....+.+.+|+++++.++||||+++++++......  
T Consensus        23 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~  102 (323)
T 3qup_A           23 QQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKLVGVSLRSRAKGR  102 (323)
T ss_dssp             --CEEEEEEEEETTEEEEEEEC-------CEEEEEEC------CHHHHHHHHHHHHHTTCCCTTBCCCCEEEECC-----
T ss_pred             hHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEecccccCHHHHHHHHHHHHHHHHCCCCceehhhceeeccccccC
Confidence            456778888999999999998543 3   27999999765  334467799999999999999999999999776554  


Q ss_pred             ----EEEEecCCCCCHHhhhccC----CCCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCCCCCeeeecc
Q 020221          129 ----LLVAEYMPNDTLAKHLFHW----ETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCF  200 (329)
Q Consensus       129 ----~lv~e~~~~gsL~~~l~~~----~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Df  200 (329)
                          ++||||+++|+|.+++...    ....+++..++.++.|++.||.|||++ |++||||||+||+++.++.+||+||
T Consensus       103 ~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~-~ivH~Dikp~NIli~~~~~~kl~Df  181 (323)
T 3qup_A          103 LPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSR-NFIHRDLAARNCMLAEDMTVCVADF  181 (323)
T ss_dssp             --CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHHT-TCCCSCCSGGGEEECTTSCEEECCC
T ss_pred             CCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHcC-CcccCCCCcceEEEcCCCCEEEeec
Confidence                9999999999999988532    122689999999999999999999999 9999999999999999999999999


Q ss_pred             cCcccCCCCC------CccCcccccCcccccCCCCCCcccchhhhHHHHHHHh-CCCCCCchhhHHHhhhchhhhccccc
Q 020221          201 GLMKNSRDGR------SYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLS-GKHIPPSHALDLIRDRNIQTLTDSCL  273 (329)
Q Consensus       201 g~a~~~~~~~------~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t-g~~~~~~~~~~~~~~~~~~~~~~~~~  273 (329)
                      |++.......      ...+++.|+|||.+.+..++.++||||||+++|+|++ |..||..............     ..
T Consensus       182 g~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~~-----~~  256 (323)
T 3qup_A          182 GLSRKIYSGDYYRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENAEIYNYLIG-----GN  256 (323)
T ss_dssp             CC-----------------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHT-----TC
T ss_pred             cccccccccccccccccccCcccccCchhhcCCCCCCccchhhHHHHHHHHHhCCCCCccccChHHHHHHHhc-----CC
Confidence            9997654332      2345678999999998899999999999999999999 7777654332222211111     11


Q ss_pred             cCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhhcc
Q 020221          274 EGQFSSDEGTELVRLASRCLQYEPRERPNPRSLVTALVTLQKDT  317 (329)
Q Consensus       274 ~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~~~l~~L~~~~~~~  317 (329)
                      ....+...++++.+++.+||+.||++|||+.++++.|+++....
T Consensus       257 ~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~l~~~  300 (323)
T 3qup_A          257 RLKQPPECMEEVYDLMYQCWSADPKQRPSFTCLRMELENILGHL  300 (323)
T ss_dssp             CCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHC-
T ss_pred             CCCCCCccCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHh
Confidence            22334566788999999999999999999999999999997754

>3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A*

Probab=100.00  E-value=8.7e-47  Score=352.02  Aligned_cols=246  Identities=16%  Similarity=0.208  Sum_probs=192.9

Q ss_pred             CcccccccCCCCCCcEEEEEE-eCCCCEEEEEEeCCC--CChhHHHHHHHHHHHhcCCCccccccceeeeeC------Ce
Q 020221           57 AMENIVSEHGEKAPNVVYKGK-LENQFRIAVKRFNRS--AWPDARQFLEEARAVGQLRNRRLANLLGCCCEG------DE  127 (329)
Q Consensus        57 ~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~------~~  127 (329)
                      ..|++++.||+|+||+||+|. ..+++.||||++...  .....+.+.+|+.+++.++||||+++++++...      ..
T Consensus        62 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~~  141 (464)
T 3ttj_A           62 KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQD  141 (464)
T ss_dssp             TTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEESGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCCE
T ss_pred             CCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEECccccChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCccccCCe
Confidence            457788889999999999998 556889999999764  223356788999999999999999999998654      35


Q ss_pred             eEEEEecCCCCCHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCCCCCeeeecccCcccCC
Q 020221          128 RLLVAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSR  207 (329)
Q Consensus       128 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~  207 (329)
                      .++||||+++ +|.+.+.    ..+++..+..++.||+.||+|||+. ||+||||||+|||++.++.+||+|||+++...
T Consensus       142 ~~lv~E~~~~-~l~~~~~----~~l~~~~~~~~~~qil~aL~~lH~~-~iiHrDlkp~NIll~~~~~~kl~DFG~a~~~~  215 (464)
T 3ttj_A          142 VYLVMELMDA-NLCQVIQ----MELDHERMSYLLYQMLCGIKHLHSA-GIIHRDLKPSNIVVKSDCTLKILDFGLARTAG  215 (464)
T ss_dssp             EEEEEECCSE-EHHHHHT----SCCCHHHHHHHHHHHHHHHHHHHHT-TCCCCCCCGGGEEECTTSCEEECCCCCC----
T ss_pred             EEEEEeCCCC-CHHHHHh----hcCCHHHHHHHHHHHHHHHHHHHHC-CcccCCCChHhEEEeCCCCEEEEEEEeeeecC
Confidence            7999999987 5777663    2489999999999999999999999 99999999999999999999999999998765


Q ss_pred             CC---CCccCcccccCcccccCCCCCCcccchhhhHHHHHHHhCCCCCCchhhHHHhhhchhhh----------------
Q 020221          208 DG---RSYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTL----------------  268 (329)
Q Consensus       208 ~~---~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~~~~~~~~~----------------  268 (329)
                      ..   ....+|+.|+|||++.+..++.++|||||||++|||++|+.||................                
T Consensus       216 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pF~g~~~~~~~~~i~~~lg~p~~~~~~~~~~~~~  295 (464)
T 3ttj_A          216 TSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVR  295 (464)
T ss_dssp             -CCCC----CCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHHTTSCHHHH
T ss_pred             CCcccCCCcccccccCHHHHcCCCCCHHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHcchhhh
Confidence            43   34578999999999999999999999999999999999999987643221111111000                


Q ss_pred             --ccccc--c-----CCCC-----------hHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 020221          269 --TDSCL--E-----GQFS-----------SDEGTELVRLASRCLQYEPRERPNPRSLVT  308 (329)
Q Consensus       269 --~~~~~--~-----~~~~-----------~~~~~~~~~li~~cl~~dp~~Rps~~~~l~  308 (329)
                        .....  .     ..++           ...++++.+|+.+||..||++|||+.++++
T Consensus       296 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~  355 (464)
T 3ttj_A          296 NYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQ  355 (464)
T ss_dssp             HHHTTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred             hHhhcccccCCCChHHhCcccccccccccccccCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence              00000  0     0000           123778999999999999999999999998

>3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A*

Probab=100.00  E-value=4.9e-47  Score=337.49  Aligned_cols=256  Identities=22%  Similarity=0.298  Sum_probs=211.2

Q ss_pred             ccccccCCCCCCcEEEEEEe-----CCCCEEEEEEeCCCCCh-hHHHHHHHHHHHhcCCCccccccceeeeeC--CeeEE
Q 020221           59 ENIVSEHGEKAPNVVYKGKL-----ENQFRIAVKRFNRSAWP-DARQFLEEARAVGQLRNRRLANLLGCCCEG--DERLL  130 (329)
Q Consensus        59 ~~~~~~lg~G~~g~V~~~~~-----~~~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~~~~~~~~~--~~~~l  130 (329)
                      +++++.||+|+||+||++.+     .+++.||+|++...... ..+.+.+|+++++.++||||+++++++.+.  ...++
T Consensus        33 ~~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~l  112 (318)
T 3lxp_A           33 LKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGAASLQL  112 (318)
T ss_dssp             EEEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTTTEEEE
T ss_pred             HhhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEeccccChHHHHHHHHHHHHHHhCCCcchhhEEEEEecCCCceEEE
Confidence            37888899999999998864     26788999999876432 355689999999999999999999999874  67899


Q ss_pred             EEecCCCCCHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCCCCCeeeecccCcccCCCCC
Q 020221          131 VAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDGR  210 (329)
Q Consensus       131 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~  210 (329)
                      ||||+++++|.+++..   ..+++..++.++.|++.||.|||+. |++|+||||+||+++.++.+||+|||++.......
T Consensus       113 v~e~~~~~~L~~~l~~---~~~~~~~~~~i~~~l~~~l~~LH~~-~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~~~~  188 (318)
T 3lxp_A          113 VMEYVPLGSLRDYLPR---HSIGLAQLLLFAQQICEGMAYLHAQ-HYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGH  188 (318)
T ss_dssp             EECCCTTCBHHHHGGG---SCCCHHHHHHHHHHHHHHHHHHHHT-TEECSCCSGGGEEECTTCCEEECCGGGCEECCTTC
T ss_pred             EEecccCCcHHHHHhh---CCCCHHHHHHHHHHHHHHHHHHHhC-CccCCCCchheEEEcCCCCEEECCccccccccccc
Confidence            9999999999999953   4599999999999999999999999 99999999999999999999999999998765432


Q ss_pred             -------CccCcccccCcccccCCCCCCcccchhhhHHHHHHHhCCCCCCchhhHHH----------hhhchhhhccccc
Q 020221          211 -------SYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLI----------RDRNIQTLTDSCL  273 (329)
Q Consensus       211 -------~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~----------~~~~~~~~~~~~~  273 (329)
                             ...++..|+|||.+.+..++.++||||||+++|+|++|..|+........          .............
T Consensus       189 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  268 (318)
T 3lxp_A          189 EYYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMTVLRLTELLERGE  268 (318)
T ss_dssp             SEEEC---CCCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCHHHHHHHHHHHHHTTC
T ss_pred             cccccccCCCCCceeeChHHhcCCCCCcHHHHHHHHHHHHHHHhCCCcccccchhhhhhhcccccchhHHHHHHHHhccc
Confidence                   23467789999999988899999999999999999999987754322211          0111122222223


Q ss_pred             cCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhhccc
Q 020221          274 EGQFSSDEGTELVRLASRCLQYEPRERPNPRSLVTALVTLQKDTE  318 (329)
Q Consensus       274 ~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~~~l~~L~~~~~~~~  318 (329)
                      ....+..+++++.+++.+||+.||++|||+.++++.|+.+.+...
T Consensus       269 ~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~~~~~  313 (318)
T 3lxp_A          269 RLPRPDKCPAEVYHLMKNCWETEASFRPTFENLIPILKTVHEKYQ  313 (318)
T ss_dssp             CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHH
T ss_pred             CCCCCccccHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHHhhc
Confidence            334556778899999999999999999999999999999987654

>3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A

Probab=100.00  E-value=1.9e-47  Score=346.45  Aligned_cols=262  Identities=15%  Similarity=0.156  Sum_probs=206.3

Q ss_pred             CcccccccCCCCCCcEEEEEEeCC------CCEEEEEEeCCCCChhH-----------HHHHHHHHHHhcCCCccccccc
Q 020221           57 AMENIVSEHGEKAPNVVYKGKLEN------QFRIAVKRFNRSAWPDA-----------RQFLEEARAVGQLRNRRLANLL  119 (329)
Q Consensus        57 ~~~~~~~~lg~G~~g~V~~~~~~~------~~~vavK~~~~~~~~~~-----------~~~~~e~~~l~~l~h~niv~~~  119 (329)
                      ..|++.+.||+|+||.||+|...+      ++.||+|++........           ..+.+|+..+..++||||++++
T Consensus        35 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~  114 (364)
T 3op5_A           35 AAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPKYW  114 (364)
T ss_dssp             CEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSCCEE
T ss_pred             CeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCCeEE
Confidence            357888889999999999998644      47899999876552211           1233456677788999999999


Q ss_pred             eeeeeC----CeeEEEEecCCCCCHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeC--CCC
Q 020221          120 GCCCEG----DERLLVAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFD--DDV  193 (329)
Q Consensus       120 ~~~~~~----~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~--~~~  193 (329)
                      +++...    ...++||||+ +++|.+++.. ....+++..++.++.||+.||.|||++ +|+||||||+|||++  .++
T Consensus       115 ~~~~~~~~~~~~~~lv~e~~-g~~L~~~~~~-~~~~l~~~~~~~i~~qi~~~l~~lH~~-~iiHrDlkp~Nill~~~~~~  191 (364)
T 3op5_A          115 GSGLHDKNGKSYRFMIMDRF-GSDLQKIYEA-NAKRFSRKTVLQLSLRILDILEYIHEH-EYVHGDIKASNLLLNYKNPD  191 (364)
T ss_dssp             EEEEEEETTEEEEEEEEECE-EEEHHHHHHH-TTSCCCHHHHHHHHHHHHHHHHHHHHT-TEECCCCCGGGEEEESSCTT
T ss_pred             eeeeeccCCcceEEEEEeCC-CCCHHHHHHh-ccCCCCHHHHHHHHHHHHHHHHHHHHC-CeEEecCCHHHEEEecCCCC
Confidence            998764    4589999999 9999999975 446799999999999999999999999 999999999999999  889


Q ss_pred             CeeeecccCcccCCCC-----------CCccCcccccCcccccCCCCCCcccchhhhHHHHHHHhCCCCCCchhhHHHh-
Q 020221          194 NPRLSCFGLMKNSRDG-----------RSYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIR-  261 (329)
Q Consensus       194 ~~kl~Dfg~a~~~~~~-----------~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~~-  261 (329)
                      .+||+|||+++.....           ....||+.|+|||++.+..++.++||||||+++|||++|..||......... 
T Consensus       192 ~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~Pf~~~~~~~~~~  271 (364)
T 3op5_A          192 QVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGHLPWEDNLKDPKYV  271 (364)
T ss_dssp             CEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGGTTCHHHH
T ss_pred             eEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCCCCCCchhhHHHHHHHHHHHHhCCCCccccccCHHHH
Confidence            9999999999754322           2234899999999999989999999999999999999999988643211110 


Q ss_pred             -------hhchhhhccccccCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhhccccccCcc
Q 020221          262 -------DRNIQTLTDSCLEGQFSSDEGTELVRLASRCLQYEPRERPNPRSLVTALVTLQKDTELYLSLP  324 (329)
Q Consensus       262 -------~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~~~l~~L~~~~~~~~~~~~~p  324 (329)
                             ........+.++.   ....++++.+++..||+.||++||++.++++.|+.+.+......+.+
T Consensus       272 ~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~li~~cl~~~p~~RP~~~~l~~~l~~~~~~~~~~~~~~  338 (364)
T 3op5_A          272 RDSKIRYRENIASLMDKCFP---AANAPGEIAKYMETVKLLDYTEKPLYENLRDILLQGLKAIGSKDDGK  338 (364)
T ss_dssp             HHHHHHHHHCHHHHHHHHSC---TTCCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHHTTCCCCCC
T ss_pred             HHHHHHhhhhHHHHHHHhcc---cccCHHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHcCCCcCCc
Confidence                   0111222222211   13446789999999999999999999999999999987655544433

>3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A*

Probab=100.00  E-value=7.9e-47  Score=329.44  Aligned_cols=241  Identities=18%  Similarity=0.223  Sum_probs=203.7

Q ss_pred             cccccccCCCCCCcEEEEEEe-CCCCEEEEEEeCCCCChhHHHHHHHHHHHhcCCCccccccceeeeeCCeeEEEEecCC
Q 020221           58 MENIVSEHGEKAPNVVYKGKL-ENQFRIAVKRFNRSAWPDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAEYMP  136 (329)
Q Consensus        58 ~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~  136 (329)
                      .|.+.+.||+|+||.||+|.. .++..+|+|++........+.+.+|+++++.++||||+++++++.+....++||||++
T Consensus        10 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~   89 (277)
T 3f3z_A           10 YYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYETFEDNTDIYLVMELCT   89 (277)
T ss_dssp             HEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEECCC
T ss_pred             hEEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCeEEEEEeccC
Confidence            467778889999999999994 5578899999987655667789999999999999999999999999999999999999


Q ss_pred             CCCHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceee---CCCCCeeeecccCcccCCCC---C
Q 020221          137 NDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVF---DDDVNPRLSCFGLMKNSRDG---R  210 (329)
Q Consensus       137 ~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~---~~~~~~kl~Dfg~a~~~~~~---~  210 (329)
                      +++|.+++..  ...+++..+..++.|++.||.|||++ |++|+||||+||++   +.++.++|+|||++......   .
T Consensus        90 ~~~L~~~~~~--~~~~~~~~~~~i~~~i~~~l~~lH~~-~i~H~dlkp~Nil~~~~~~~~~~~l~Dfg~~~~~~~~~~~~  166 (277)
T 3f3z_A           90 GGELFERVVH--KRVFRESDAARIMKDVLSAVAYCHKL-NVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKMMR  166 (277)
T ss_dssp             SCBHHHHHHH--HCSCCHHHHHHHHHHHHHHHHHHHHT-TEECCCCSGGGEEESSSSTTCCEEECCCTTCEECCTTSCBC
T ss_pred             CCcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHC-CccCCCCCHHHEEEecCCCCCcEEEEecccceeccCccchh
Confidence            9999998863  45689999999999999999999999 99999999999999   78899999999999765543   2


Q ss_pred             CccCcccccCcccccCCCCCCcccchhhhHHHHHHHhCCCCCCchhhHHHhhhchhhhccccccCCCCh----HHHHHHH
Q 020221          211 SYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSS----DEGTELV  286 (329)
Q Consensus       211 ~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~  286 (329)
                      ...+|+.|+|||++.+ .++.++||||||+++|+|++|..||................      ...+.    ..++++.
T Consensus       167 ~~~~t~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~------~~~~~~~~~~~~~~~~  239 (277)
T 3f3z_A          167 TKVGTPYYVSPQVLEG-LYGPECDEWSAGVMMYVLLCGYPPFSAPTDSEVMLKIREGT------FTFPEKDWLNVSPQAE  239 (277)
T ss_dssp             CCCSCTTTCCHHHHTT-CBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCC------CCCCHHHHTTSCHHHH
T ss_pred             ccCCCCCccChHHhcc-cCCchhhehhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCC------CCCCchhhhcCCHHHH
Confidence            4468899999999875 48999999999999999999999887644332222211111      11122    3567899


Q ss_pred             HHHHHhcccCCCCCCCHHHHHH
Q 020221          287 RLASRCLQYEPRERPNPRSLVT  308 (329)
Q Consensus       287 ~li~~cl~~dp~~Rps~~~~l~  308 (329)
                      +++.+||+.||++|||+.++++
T Consensus       240 ~li~~~l~~dp~~R~s~~~~l~  261 (277)
T 3f3z_A          240 SLIRRLLTKSPKQRITSLQALE  261 (277)
T ss_dssp             HHHHHHTCSSTTTSCCHHHHTT
T ss_pred             HHHHHHccCChhhCcCHHHHhc
Confidence            9999999999999999999987

>1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ...

Probab=100.00  E-value=3e-47  Score=332.41  Aligned_cols=253  Identities=23%  Similarity=0.335  Sum_probs=210.7

Q ss_pred             CcccccccCCCCCCcEEEEEEeCCCCEEEEEEeCCCCChhHHHHHHHHHHHhcCCCccccccceeeeeCCeeEEEEecCC
Q 020221           57 AMENIVSEHGEKAPNVVYKGKLENQFRIAVKRFNRSAWPDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAEYMP  136 (329)
Q Consensus        57 ~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~  136 (329)
                      ..+++++.||+|+||.||+|...++..||+|.+.... ...+.+.+|+++++.++||||+++++++. .+..++||||++
T Consensus        13 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~~~   90 (279)
T 1qpc_A           13 ETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYAVVT-QEPIYIITEYME   90 (279)
T ss_dssp             GGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSSCEEEEECCT
T ss_pred             HhhhheeeecCCCCeEEEEEEEcCCcEEEEEEecCCc-ccHHHHHHHHHHHHhCCCcCcceEEEEEc-CCCcEEEEecCC
Confidence            4577888899999999999998888899999997654 34667899999999999999999999885 456899999999


Q ss_pred             CCCHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCCCCCeeeecccCcccCCCCC-----C
Q 020221          137 NDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDGR-----S  211 (329)
Q Consensus       137 ~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~-----~  211 (329)
                      +++|.+++.......+++..+..++.|++.||.|||+. |++|+||||+||++++++.++|+|||++.......     .
T Consensus        91 ~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~-~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~  169 (279)
T 1qpc_A           91 NGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEER-NYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREG  169 (279)
T ss_dssp             TCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHT-TEECSCCSGGGEEECTTSCEEECCCTTCEECSSSCEECCTT
T ss_pred             CCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHC-CeeccCCCHhhEEEcCCCCEEECCCcccccccCcccccccC
Confidence            99999999642223689999999999999999999999 99999999999999999999999999998654432     2


Q ss_pred             ccCcccccCcccccCCCCCCcccchhhhHHHHHHHh-CCCCCCchhhHHHhhhchhhhccccccCCCChHHHHHHHHHHH
Q 020221          212 YSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLS-GKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLAS  290 (329)
Q Consensus       212 ~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t-g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~  290 (329)
                      ..++..|+|||.+.+..++.++||||||+++|+|++ |..|+..............     ......+...++++.+++.
T Consensus       170 ~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~-----~~~~~~~~~~~~~l~~li~  244 (279)
T 1qpc_A          170 AKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLER-----GYRMVRPDNCPEELYQLMR  244 (279)
T ss_dssp             CCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHT-----TCCCCCCTTCCHHHHHHHH
T ss_pred             CCCccCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCcccCHHHHHHHHhc-----ccCCCCcccccHHHHHHHH
Confidence            345678999999998889999999999999999999 7777755433222211111     1122334566789999999


Q ss_pred             HhcccCCCCCCCHHHHHHHHHhhhhcc
Q 020221          291 RCLQYEPRERPNPRSLVTALVTLQKDT  317 (329)
Q Consensus       291 ~cl~~dp~~Rps~~~~l~~L~~~~~~~  317 (329)
                      +||+.||++|||+.++++.|+.+....
T Consensus       245 ~~l~~~p~~Rps~~~l~~~l~~~~~~~  271 (279)
T 1qpc_A          245 LCWKERPEDRPTFDYLRSVLEDFFTAT  271 (279)
T ss_dssp             HHTCSSGGGSCCHHHHHHHHHHHHHHC
T ss_pred             HHhccChhhCCCHHHHHHHHHHHHHhc
Confidence            999999999999999999999987654

>1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A*

Probab=100.00  E-value=4.7e-47  Score=331.67  Aligned_cols=252  Identities=20%  Similarity=0.278  Sum_probs=198.6

Q ss_pred             CcccccccCCCCCCcEEEEEEeCC----CCEEEEEEeCCCCCh-hHHHHHHHHHHHhcCCCccccccceeeeeCCeeEEE
Q 020221           57 AMENIVSEHGEKAPNVVYKGKLEN----QFRIAVKRFNRSAWP-DARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLV  131 (329)
Q Consensus        57 ~~~~~~~~lg~G~~g~V~~~~~~~----~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv  131 (329)
                      ..|++.+.||+|+||.||+|....    +..||+|.+...... ..+.+.+|+.+++.++||||+++++++ ..+..++|
T Consensus        15 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~-~~~~~~lv   93 (281)
T 1mp8_A           15 ERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVI-TENPVWII   93 (281)
T ss_dssp             GGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEE-CSSSCEEE
T ss_pred             HHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCccceEEEEE-ccCccEEE
Confidence            457788889999999999998532    456999998765433 345688999999999999999999998 45678999


Q ss_pred             EecCCCCCHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCCCCCeeeecccCcccCCCCC-
Q 020221          132 AEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDGR-  210 (329)
Q Consensus       132 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~-  210 (329)
                      |||+++++|.+++.. ....+++..+..++.|++.||.|||+. |++||||||+||+++.++.+||+|||++....... 
T Consensus        94 ~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~~qi~~~l~~lH~~-~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~  171 (281)
T 1mp8_A           94 MELCTLGELRSFLQV-RKYSLDLASLILYAYQLSTALAYLESK-RFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTY  171 (281)
T ss_dssp             EECCTTEEHHHHHHH-TTTTSCHHHHHHHHHHHHHHHHHHHHT-TCCCSCCSGGGEEEEETTEEEECC------------
T ss_pred             EecCCCCCHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHhC-CeecccccHHHEEECCCCCEEECccccccccCcccc
Confidence            999999999999965 345689999999999999999999999 99999999999999999999999999997654432 


Q ss_pred             ----CccCcccccCcccccCCCCCCcccchhhhHHHHHHHh-CCCCCCchhhHHHhhhchhhhccccccCCCChHHHHHH
Q 020221          211 ----SYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLS-GKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTEL  285 (329)
Q Consensus       211 ----~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t-g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  285 (329)
                          ...+++.|+|||++.+..++.++||||||+++|+|++ |..||............     ........+..+++++
T Consensus       172 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~pf~~~~~~~~~~~i-----~~~~~~~~~~~~~~~l  246 (281)
T 1mp8_A          172 YKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRI-----ENGERLPMPPNCPPTL  246 (281)
T ss_dssp             -------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHH-----HTTCCCCCCTTCCHHH
T ss_pred             cccccCCCcccccChhhcccCCCCCccCchHHHHHHHHHHhcCCCCCCcCCHHHHHHHH-----HcCCCCCCCCCCCHHH
Confidence                2345678999999998889999999999999999997 77777543222111111     1111223455677899


Q ss_pred             HHHHHHhcccCCCCCCCHHHHHHHHHhhhhc
Q 020221          286 VRLASRCLQYEPRERPNPRSLVTALVTLQKD  316 (329)
Q Consensus       286 ~~li~~cl~~dp~~Rps~~~~l~~L~~~~~~  316 (329)
                      .+++.+||+.||++|||+.++++.|+++.+.
T Consensus       247 ~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~  277 (281)
T 1mp8_A          247 YSLMTKCWAYDPSRRPRFTELKAQLSTILEE  277 (281)
T ss_dssp             HHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             HHHHHHHccCChhhCcCHHHHHHHHHHHHHH
Confidence            9999999999999999999999999998764

>2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A

Probab=100.00  E-value=8e-47  Score=333.90  Aligned_cols=246  Identities=15%  Similarity=0.165  Sum_probs=203.2

Q ss_pred             cccccccCCCCCCcEEEEEEe-CCCCEEEEEEeCCCCChhHHHHHHHHHHHhcCCCccccccceeeeeCCeeEEEEecCC
Q 020221           58 MENIVSEHGEKAPNVVYKGKL-ENQFRIAVKRFNRSAWPDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAEYMP  136 (329)
Q Consensus        58 ~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~  136 (329)
                      .|.+++.||+|+||.||++.. .+++.||+|++........+.+.+|+.+++.++||||+++++++.+....++||||++
T Consensus        10 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~   89 (304)
T 2jam_A           10 TFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLEDIYESTTHYYLVMQLVS   89 (304)
T ss_dssp             HEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC------HHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCCC
T ss_pred             cceeeeeccCCCCceEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHhCCCCCeeehhhhcccCCEEEEEEEcCC
Confidence            467788889999999999994 5788999999987654445678899999999999999999999999999999999999


Q ss_pred             CCCHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceee---CCCCCeeeecccCcccCCCCC--C
Q 020221          137 NDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVF---DDDVNPRLSCFGLMKNSRDGR--S  211 (329)
Q Consensus       137 ~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~---~~~~~~kl~Dfg~a~~~~~~~--~  211 (329)
                      +++|.+++..  ...+++..+..++.|++.||.|||+. |++|+||||+||++   +.++.++|+|||++.......  .
T Consensus        90 ~~~L~~~l~~--~~~~~~~~~~~~~~qi~~~l~~lH~~-~i~H~dikp~NIl~~~~~~~~~~kl~Dfg~~~~~~~~~~~~  166 (304)
T 2jam_A           90 GGELFDRILE--RGVYTEKDASLVIQQVLSAVKYLHEN-GIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNGIMST  166 (304)
T ss_dssp             SCBHHHHHHH--HSCCCHHHHHHHHHHHHHHHHHHHHT-TCCCCSCCGGGCEESSSSTTCCEEBCSCSTTCCCCCBTTHH
T ss_pred             CccHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHC-CccccCCCHHHEEEecCCCCCCEEEccCCcceecCCCcccc
Confidence            9999998863  45689999999999999999999999 99999999999999   788999999999987654432  2


Q ss_pred             ccCcccccCcccccCCCCCCcccchhhhHHHHHHHhCCCCCCchhhHHHhhhchhhhccccccCCCChHHHHHHHHHHHH
Q 020221          212 YSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLASR  291 (329)
Q Consensus       212 ~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~  291 (329)
                      ..+++.|+|||.+.+..++.++||||||+++|+|++|..||..................  .........++++.+++.+
T Consensus       167 ~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~--~~~~~~~~~~~~~~~li~~  244 (304)
T 2jam_A          167 ACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPPFYEETESKLFEKIKEGYYE--FESPFWDDISESAKDFICH  244 (304)
T ss_dssp             HHSCCCBCCTTTBSSCSCCHHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHCCCC--CCTTTTTTSCHHHHHHHHH
T ss_pred             ccCCCCccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCC--CCccccccCCHHHHHHHHH
Confidence            35789999999999988999999999999999999999888654433222221111111  1122334567899999999


Q ss_pred             hcccCCCCCCCHHHHHH
Q 020221          292 CLQYEPRERPNPRSLVT  308 (329)
Q Consensus       292 cl~~dp~~Rps~~~~l~  308 (329)
                      ||..||++|||+.++++
T Consensus       245 ~l~~dp~~Rps~~~~l~  261 (304)
T 2jam_A          245 LLEKDPNERYTCEKALS  261 (304)
T ss_dssp             HHCSSTTTSCCHHHHHT
T ss_pred             HcCCChhHCcCHHHHhc
Confidence            99999999999999997

>3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ...

Probab=100.00  E-value=2.3e-47  Score=340.95  Aligned_cols=252  Identities=18%  Similarity=0.278  Sum_probs=202.2

Q ss_pred             CcccccccCCCCCCcEEEEEEe-CCCCE----EEEEEeCCCC-ChhHHHHHHHHHHHhcCCCccccccceeeeeCCeeEE
Q 020221           57 AMENIVSEHGEKAPNVVYKGKL-ENQFR----IAVKRFNRSA-WPDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLL  130 (329)
Q Consensus        57 ~~~~~~~~lg~G~~g~V~~~~~-~~~~~----vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l  130 (329)
                      ..|++++.||+|+||+||+|.. .+++.    ||+|.+.... ....+.+.+|+.+++.++||||+++++++..+ ..++
T Consensus        15 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~-~~~~   93 (327)
T 3poz_A           15 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQL   93 (327)
T ss_dssp             GGEEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC-------CHHHHHHHHHHHHHCCBTTBCCEEEEEESS-SEEE
T ss_pred             HHcccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecC-CeEE
Confidence            3467788889999999999984 34443    6888886543 23456789999999999999999999999765 5789


Q ss_pred             EEecCCCCCHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCCCCCeeeecccCcccCCCCC
Q 020221          131 VAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDGR  210 (329)
Q Consensus       131 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~  210 (329)
                      ++||+.+|+|.+++.. ....+++..++.++.|++.||.|||++ +++||||||+|||++.++.+||+|||+++......
T Consensus        94 v~e~~~~g~L~~~l~~-~~~~~~~~~~~~~~~qi~~~l~~LH~~-~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~  171 (327)
T 3poz_A           94 ITQLMPFGCLLDYVRE-HKDNIGSQYLLNWCVQIAKGMNYLEDR-RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEE  171 (327)
T ss_dssp             EEECCTTCBHHHHHHH-STTSCCHHHHHHHHHHHHHHHHHHHHT-TCCCSCCCGGGEEEEETTEEEECCTTHHHHHTTTC
T ss_pred             EEEecCCCcHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHhhC-CeeCCCCChheEEECCCCCEEEccCcceeEccCCc
Confidence            9999999999999975 346799999999999999999999999 99999999999999999999999999987654332


Q ss_pred             ------CccCcccccCcccccCCCCCCcccchhhhHHHHHHHh-CCCCCCchhhHHHhhhchhhhccccccCCCChHHHH
Q 020221          211 ------SYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLS-GKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGT  283 (329)
Q Consensus       211 ------~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t-g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  283 (329)
                            ...+|+.|+|||++.+..++.++||||||+++|||++ |..||.........     ...........+..++.
T Consensus       172 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~-----~~~~~~~~~~~~~~~~~  246 (327)
T 3poz_A          172 KEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEIS-----SILEKGERLPQPPICTI  246 (327)
T ss_dssp             C-------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHH-----HHHHTTCCCCCCTTBCH
T ss_pred             ccccccCCCccccccChHHhccCCCCchhhhhhhHHHHHHHHhcCCCCccCCCHHHHH-----HHHHcCCCCCCCccCCH
Confidence                  2245778999999999999999999999999999999 88777543322221     11212222334556778


Q ss_pred             HHHHHHHHhcccCCCCCCCHHHHHHHHHhhhhc
Q 020221          284 ELVRLASRCLQYEPRERPNPRSLVTALVTLQKD  316 (329)
Q Consensus       284 ~~~~li~~cl~~dp~~Rps~~~~l~~L~~~~~~  316 (329)
                      ++.+++.+||+.||++|||+.++++.|+.+...
T Consensus       247 ~~~~li~~~l~~~p~~Rps~~ell~~l~~~~~~  279 (327)
T 3poz_A          247 DVYMIMVKCWMIDADSRPKFRELIIEFSKMARD  279 (327)
T ss_dssp             HHHHHHHHHTCSCGGGSCCHHHHHHHHHHHHTS
T ss_pred             HHHHHHHHHcCCChhhCCCHHHHHHHHHHHHhh
Confidence            899999999999999999999999999998764

>2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens}

Probab=100.00  E-value=2.5e-47  Score=349.88  Aligned_cols=251  Identities=18%  Similarity=0.124  Sum_probs=202.9

Q ss_pred             cCCCcccccccCCCCCCcEEEEEEe-CCCCEEEEEEeCCCCC---hhHHHHHHHHHHHhcCCCccccccceeeeeCCeeE
Q 020221           54 SGFAMENIVSEHGEKAPNVVYKGKL-ENQFRIAVKRFNRSAW---PDARQFLEEARAVGQLRNRRLANLLGCCCEGDERL  129 (329)
Q Consensus        54 ~~~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~  129 (329)
                      -....+++++.||+|+||.||++.. .+++.||+|++.....   ...+.+.+|..++..++||||+++++++.+.+..+
T Consensus        58 ~~~~~f~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~~~~~  137 (412)
T 2vd5_A           58 LQRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAFQDENYLY  137 (412)
T ss_dssp             CCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTBCCEEEEEECSSEEE
T ss_pred             CChhhEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEE
Confidence            3446677888889999999999995 5789999999965321   11234788999999999999999999999999999


Q ss_pred             EEEecCCCCCHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCCCCCeeeecccCcccCCCC
Q 020221          130 LVAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDG  209 (329)
Q Consensus       130 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~  209 (329)
                      +||||+++|+|.+++.+ ....+++..+..++.||+.||.|||++ +|+||||||+|||++.++++||+|||+++.....
T Consensus       138 lVmE~~~gg~L~~~l~~-~~~~l~~~~~~~~~~qi~~aL~~LH~~-giiHrDLKp~NILld~~g~vkL~DFGla~~~~~~  215 (412)
T 2vd5_A          138 LVMEYYVGGDLLTLLSK-FGERIPAEMARFYLAEIVMAIDSVHRL-GYVHRDIKPDNILLDRCGHIRLADFGSCLKLRAD  215 (412)
T ss_dssp             EEECCCCSCBHHHHHHH-HSSCCCHHHHHHHHHHHHHHHHHHHHT-TEECCCCSGGGEEECTTSCEEECCCTTCEECCTT
T ss_pred             EEEcCCCCCcHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHHC-CeeecccCHHHeeecCCCCEEEeechhheeccCC
Confidence            99999999999999964 234799999999999999999999999 9999999999999999999999999999765543


Q ss_pred             C-----CccCcccccCccccc-------CCCCCCcccchhhhHHHHHHHhCCCCCCchhhHHHhhhchhhhccccccCCC
Q 020221          210 R-----SYSTNLAFTPPEYLR-------TGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQF  277 (329)
Q Consensus       210 ~-----~~~~~~~y~aPE~~~-------~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  277 (329)
                      .     ...||+.|+|||++.       +..++.++||||||+++|||++|..||................. ....+..
T Consensus       216 ~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~-~~~~p~~  294 (412)
T 2vd5_A          216 GTVRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTAETYGKIVHYKE-HLSLPLV  294 (412)
T ss_dssp             SCEECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHH-HCCCC--
T ss_pred             CccccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCCCCHHHHHHHHHhccc-CcCCCcc
Confidence            2     347899999999987       35689999999999999999999999876544333222221110 0001112


Q ss_pred             ChHHHHHHHHHHHHhcccCCCCC---CCHHHHHH
Q 020221          278 SSDEGTELVRLASRCLQYEPRER---PNPRSLVT  308 (329)
Q Consensus       278 ~~~~~~~~~~li~~cl~~dp~~R---ps~~~~l~  308 (329)
                      +...++++.+|+.+||. +|++|   |++.++++
T Consensus       295 ~~~~s~~~~dli~~lL~-~p~~Rlgr~~~~ei~~  327 (412)
T 2vd5_A          295 DEGVPEEARDFIQRLLC-PPETRLGRGGAGDFRT  327 (412)
T ss_dssp             --CCCHHHHHHHHTTSS-CGGGCTTTTTHHHHHT
T ss_pred             ccCCCHHHHHHHHHHcC-ChhhcCCCCCHHHHhc
Confidence            34567899999999999 99998   58888876

>2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A

Probab=100.00  E-value=9e-47  Score=335.22  Aligned_cols=246  Identities=17%  Similarity=0.178  Sum_probs=196.4

Q ss_pred             ccccc-ccCCCCCCcEEEEEE-eCCCCEEEEEEeCCCCChhHHHHHHHHHHHhcC-CCccccccceeeeeCCeeEEEEec
Q 020221           58 MENIV-SEHGEKAPNVVYKGK-LENQFRIAVKRFNRSAWPDARQFLEEARAVGQL-RNRRLANLLGCCCEGDERLLVAEY  134 (329)
Q Consensus        58 ~~~~~-~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~  134 (329)
                      .|.++ +.||+|+||+||++. ..+++.||||++........+.+.+|++++..+ +||||+++++++.+.+..++||||
T Consensus        13 ~y~i~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~   92 (316)
T 2ac3_A           13 VYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVFEK   92 (316)
T ss_dssp             SCEECCCCCCCCSSEEEEEEECSSSCCEEEEEEEECCSSCCHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred             eEEecCceecCCceEEEEEEEEcCCCcEEEEEEEeeCcchhHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEEEEEEc
Confidence            35564 568999999999999 567899999999876655577899999999885 799999999999999999999999


Q ss_pred             CCCCCHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCCCCC---eeeecccCcccCCCC--
Q 020221          135 MPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVN---PRLSCFGLMKNSRDG--  209 (329)
Q Consensus       135 ~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~---~kl~Dfg~a~~~~~~--  209 (329)
                      +++++|.+++..  ...+++..+..++.|++.||+|||++ +++||||||+||+++.++.   +||+|||++......  
T Consensus        93 ~~~~~L~~~l~~--~~~~~~~~~~~i~~qi~~~l~~lH~~-~ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~~~~~~~~~~  169 (316)
T 2ac3_A           93 MRGGSILSHIHK--RRHFNELEASVVVQDVASALDFLHNK-GIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGD  169 (316)
T ss_dssp             CTTCBHHHHHHH--HSSCCHHHHHHHHHHHHHHHHHHHHT-TCCCCCCCGGGEEESCSSSSCSEEECCTTCCC-------
T ss_pred             CCCCcHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHhC-CceeCCCCHHHEEEccCCCcCceEEEEccCccccccCCc
Confidence            999999999963  35789999999999999999999999 9999999999999998776   999999998754321  


Q ss_pred             ---------CCccCcccccCcccccC-----CCCCCcccchhhhHHHHHHHhCCCCCCchhhHH-----------Hhhhc
Q 020221          210 ---------RSYSTNLAFTPPEYLRT-----GRVTPESVMYSFGTLLLDLLSGKHIPPSHALDL-----------IRDRN  264 (329)
Q Consensus       210 ---------~~~~~~~~y~aPE~~~~-----~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~-----------~~~~~  264 (329)
                               ....+|+.|+|||++.+     ..++.++||||||+++|+|++|..||.......           .....
T Consensus       170 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~  249 (316)
T 2ac3_A          170 CSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQNML  249 (316)
T ss_dssp             ------------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCCCCCSCSCC----CCHHHHHHH
T ss_pred             cccccccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCCcccccccccccccccchhHHHHH
Confidence                     12348899999999875     458899999999999999999999886432100           00000


Q ss_pred             hhhhccccccCCCC----hHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 020221          265 IQTLTDSCLEGQFS----SDEGTELVRLASRCLQYEPRERPNPRSLVT  308 (329)
Q Consensus       265 ~~~~~~~~~~~~~~----~~~~~~~~~li~~cl~~dp~~Rps~~~~l~  308 (329)
                      ...+....  ...+    ...++++.+|+.+||+.||++|||+.++++
T Consensus       250 ~~~i~~~~--~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~  295 (316)
T 2ac3_A          250 FESIQEGK--YEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQ  295 (316)
T ss_dssp             HHHHHHCC--CCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred             HHHHhccC--cccCchhcccCCHHHHHHHHHHhhCChhhCCCHHHHhc
Confidence            01111110  1122    135678999999999999999999999998

>3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens}

Probab=100.00  E-value=2.8e-47  Score=332.45  Aligned_cols=248  Identities=17%  Similarity=0.208  Sum_probs=187.9

Q ss_pred             hcCCCcccccccCCCCCCcEEEEEEe-CCCCEEEEEEeCCCCC---hhHHHHHHHHHHHhcCCCccccccceeeeeCCee
Q 020221           53 TSGFAMENIVSEHGEKAPNVVYKGKL-ENQFRIAVKRFNRSAW---PDARQFLEEARAVGQLRNRRLANLLGCCCEGDER  128 (329)
Q Consensus        53 ~~~~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~  128 (329)
                      ...+..|++.+.||+|+||.||+|.. .+++.||+|.+.....   ...+.+.+|+.+++.++||||+++++++.+.+..
T Consensus         7 g~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~   86 (278)
T 3cok_A            7 GEKIEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFEDSNYV   86 (278)
T ss_dssp             CSSGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEEECSSEE
T ss_pred             ccccccceeeeeecCCCceEEEEEEEccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEEccCCeE
Confidence            34556788889999999999999994 6788999999865321   2246788999999999999999999999999999


Q ss_pred             EEEEecCCCCCHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCCCCCeeeecccCcccCCC
Q 020221          129 LLVAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRD  208 (329)
Q Consensus       129 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~  208 (329)
                      ++||||+++++|.+++.. ....+++..++.++.|++.||.|||+. +++|+||||+||+++.++.++|+|||++.....
T Consensus        87 ~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~~qi~~~l~~lH~~-~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~  164 (278)
T 3cok_A           87 YLVLEMCHNGEMNRYLKN-RVKPFSENEARHFMHQIITGMLYLHSH-GILHRDLTLSNLLLTRNMNIKIADFGLATQLKM  164 (278)
T ss_dssp             EEEEECCTTEEHHHHHHT-CSSCCCHHHHHHHHHHHHHHHHHHHHT-TEECSSCCGGGEEECTTCCEEECCCTTCEECC-
T ss_pred             EEEEecCCCCcHHHHHhh-ccCCCCHHHHHHHHHHHHHHHHHHHHC-CeecCCCCHHHEEEcCCCCEEEEeecceeeccC
Confidence            999999999999999864 346789999999999999999999999 999999999999999999999999999876543


Q ss_pred             C----CCccCcccccCcccccCCCCCCcccchhhhHHHHHHHhCCCCCCchhhHHHhhhchhhhccccccCCCChHHHHH
Q 020221          209 G----RSYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTE  284 (329)
Q Consensus       209 ~----~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  284 (329)
                      .    ....+++.|+|||.+.+..++.++||||||+++|+|++|..||............    ..  .....+...+.+
T Consensus       165 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~----~~--~~~~~~~~~~~~  238 (278)
T 3cok_A          165 PHEKHYTLCGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNTLNKV----VL--ADYEMPSFLSIE  238 (278)
T ss_dssp             ---------------------------CTHHHHHHHHHHHHHHSSCSSCCCSCC-----C----CS--SCCCCCTTSCHH
T ss_pred             CCCcceeccCCCCcCCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCChhHHHHHHHH----hh--cccCCccccCHH
Confidence            2    2346789999999999888999999999999999999999888654322111111    10  011234556788


Q ss_pred             HHHHHHHhcccCCCCCCCHHHHHH
Q 020221          285 LVRLASRCLQYEPRERPNPRSLVT  308 (329)
Q Consensus       285 ~~~li~~cl~~dp~~Rps~~~~l~  308 (329)
                      +.+++.+||+.||++|||+.++++
T Consensus       239 ~~~li~~~l~~dp~~Rps~~~~l~  262 (278)
T 3cok_A          239 AKDLIHQLLRRNPADRLSLSSVLD  262 (278)
T ss_dssp             HHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred             HHHHHHHHcccCHhhCCCHHHHhc
Confidence            999999999999999999999997

>3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ...

Probab=100.00  E-value=6.6e-47  Score=332.14  Aligned_cols=253  Identities=20%  Similarity=0.316  Sum_probs=196.3

Q ss_pred             CcccccccCCCCCCcEEEEEEeCCCCEEEEEEeCCCCCh--hHHHHHHHHHHHhcCCCccccccceeeeeCCeeEEEEec
Q 020221           57 AMENIVSEHGEKAPNVVYKGKLENQFRIAVKRFNRSAWP--DARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAEY  134 (329)
Q Consensus        57 ~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~--~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  134 (329)
                      ..|++.+.||+|+||+||+|...+  .||+|++......  ..+.+.+|+.+++.++||||+++++++ .....++||||
T Consensus        24 ~~y~~~~~lG~G~~g~Vy~~~~~~--~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-~~~~~~lv~e~  100 (289)
T 3og7_A           24 GQITVGQRIGSGSFGTVYKGKWHG--DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS-TAPQLAIVTQW  100 (289)
T ss_dssp             TSCEEEEEEEECSSEEEEEEESSS--EEEEEEESCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEE-CSSSCEEEEEC
T ss_pred             cceeeeeEecCCCCeEEEEEEEcC--ceEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCcEEEEEeec-cCCccEEEEEe
Confidence            346777888999999999998644  5999999765432  346689999999999999999999965 55678999999


Q ss_pred             CCCCCHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCCCCCeeeecccCcccCCCC-----
Q 020221          135 MPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDG-----  209 (329)
Q Consensus       135 ~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~-----  209 (329)
                      +++++|.+++.. ....+++..+..++.|++.||.|||+. +++|+||||+||+++.++.++|+|||++......     
T Consensus       101 ~~~~~L~~~l~~-~~~~~~~~~~~~i~~qi~~~L~~lH~~-~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~  178 (289)
T 3og7_A          101 CEGSSLYHHLHA-SETKFEMKKLIDIARQTARGMDYLHAK-SIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQ  178 (289)
T ss_dssp             CCEEEHHHHHTT-C---CCHHHHHHHHHHHHHHHHHHHHT-TCCCSCCCGGGEEEETTTEEEECCCC-------------
T ss_pred             cCCCcHHHHHhh-ccCCCCHHHHHHHHHHHHHHHHHHHhC-CcccccCccceEEECCCCCEEEccceecccccccccccc
Confidence            999999999854 446789999999999999999999999 9999999999999999999999999998754321     


Q ss_pred             -CCccCcccccCccccc---CCCCCCcccchhhhHHHHHHHhCCCCCCchhhHH-HhhhchhhhccccccCCCChHHHHH
Q 020221          210 -RSYSTNLAFTPPEYLR---TGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDL-IRDRNIQTLTDSCLEGQFSSDEGTE  284 (329)
Q Consensus       210 -~~~~~~~~y~aPE~~~---~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~  284 (329)
                       ....+|+.|+|||.+.   +..++.++||||||+++|+|++|..||....... ............. .......++++
T Consensus       179 ~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~  257 (289)
T 3og7_A          179 FEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIEMVGRGSLSPD-LSKVRSNCPKR  257 (289)
T ss_dssp             -----CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTSSCCCHHHHHHHHHHTSCCCC-TTSSCTTSCHH
T ss_pred             ccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCccccchHHHHHHHhcccccCcc-hhhccccCCHH
Confidence             2346789999999986   5568889999999999999999998886532211 1111111111111 11233456789


Q ss_pred             HHHHHHHhcccCCCCCCCHHHHHHHHHhhhh
Q 020221          285 LVRLASRCLQYEPRERPNPRSLVTALVTLQK  315 (329)
Q Consensus       285 ~~~li~~cl~~dp~~Rps~~~~l~~L~~~~~  315 (329)
                      +.+++.+||+.||++|||+.++++.|+++.+
T Consensus       258 l~~li~~~l~~~p~~Rps~~ell~~L~~l~~  288 (289)
T 3og7_A          258 MKRLMAECLKKKRDERPSFPRILAEIEELAR  288 (289)
T ss_dssp             HHHHHHHHTCSSGGGSCCHHHHHHHHHHTTC
T ss_pred             HHHHHHHHccCChhhCCCHHHHHHHHHHHhh
Confidence            9999999999999999999999999999865

>3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=4.1e-47  Score=347.12  Aligned_cols=248  Identities=21%  Similarity=0.285  Sum_probs=189.7

Q ss_pred             CcccccccCCCCCCcEEEEEE-eCCCCEEEEEEeCCCC--ChhHHHHHHHHHHHhcCC-CccccccceeeeeCC--eeEE
Q 020221           57 AMENIVSEHGEKAPNVVYKGK-LENQFRIAVKRFNRSA--WPDARQFLEEARAVGQLR-NRRLANLLGCCCEGD--ERLL  130 (329)
Q Consensus        57 ~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~--~~~l  130 (329)
                      ..|++++.||+|+||.||+|. ..+++.||+|++....  ....+.+.+|+.+++.+. ||||+++++++...+  ..++
T Consensus         9 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~l   88 (388)
T 3oz6_A            9 RKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLNVLRADNDRDVYL   88 (388)
T ss_dssp             TTEEEEEC-------CEEEEEETTTCCEEEEEEECC--CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTTSSCEEE
T ss_pred             CceEEEEEeeeCCCeEEEEEEECCCCCEEEEEEecccccChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecCCCCEEEE
Confidence            457788889999999999998 5678999999986542  234556889999999997 999999999997544  7899


Q ss_pred             EEecCCCCCHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCCCCCeeeecccCcccCCC--
Q 020221          131 VAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRD--  208 (329)
Q Consensus       131 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~--  208 (329)
                      ||||++ ++|..++..   ..+++..+..++.||+.||+|||+. ||+||||||+|||++.++.+||+|||+++....  
T Consensus        89 v~e~~~-~~L~~~~~~---~~~~~~~~~~i~~qi~~~L~~LH~~-~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~  163 (388)
T 3oz6_A           89 VFDYME-TDLHAVIRA---NILEPVHKQYVVYQLIKVIKYLHSG-GLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIR  163 (388)
T ss_dssp             EEECCS-EEHHHHHHH---TCCCHHHHHHHHHHHHHHHHHHHHT-TEECCCCCGGGEEECTTCCEEECCCTTCEESSSCC
T ss_pred             EecccC-cCHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHhC-CEEeCCCCHHHeEEcCCCCEEecCCcccccccccc
Confidence            999997 589998853   5789999999999999999999999 999999999999999999999999999975432  


Q ss_pred             -----------------------CCCccCcccccCcccccC-CCCCCcccchhhhHHHHHHHhCCCCCCchhhHHHhhhc
Q 020221          209 -----------------------GRSYSTNLAFTPPEYLRT-GRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRN  264 (329)
Q Consensus       209 -----------------------~~~~~~~~~y~aPE~~~~-~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~~~~~  264 (329)
                                             .....||+.|+|||++.+ ..++.++|||||||++|||++|..||+...........
T Consensus       164 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i  243 (388)
T 3oz6_A          164 RVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGSSTMNQLERI  243 (388)
T ss_dssp             CCCCCGGGCCC---------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHH
T ss_pred             cccccccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Confidence                                   123468999999999986 56899999999999999999999988765322221111


Q ss_pred             hhhhccc-----------------------------cccC------------CCChHHHHHHHHHHHHhcccCCCCCCCH
Q 020221          265 IQTLTDS-----------------------------CLEG------------QFSSDEGTELVRLASRCLQYEPRERPNP  303 (329)
Q Consensus       265 ~~~~~~~-----------------------------~~~~------------~~~~~~~~~~~~li~~cl~~dp~~Rps~  303 (329)
                      ....-.+                             ....            ......++++.+|+.+||..||++|||+
T Consensus       244 ~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~dP~~R~t~  323 (388)
T 3oz6_A          244 IGVIDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPKADCNEEALDLLDKLLQFNPNKRISA  323 (388)
T ss_dssp             HHHHCCCCHHHHHTSCCSSHHHHHHHHHHHCC-----CCCCHHHHHHHHHHHCTTCCCCHHHHHHHHHHCCSSGGGSCCH
T ss_pred             HHhcCCCCHHHHHhccCHHHHHHHHhCcccccccCCCHHHhCcchhhhcccccccccCCHHHHHHHHHhhccCcccCCCH
Confidence            1000000                             0000            0011346789999999999999999999


Q ss_pred             HHHHHH
Q 020221          304 RSLVTA  309 (329)
Q Consensus       304 ~~~l~~  309 (329)
                      .+++++
T Consensus       324 ~e~l~H  329 (388)
T 3oz6_A          324 NDALKH  329 (388)
T ss_dssp             HHHTTS
T ss_pred             HHHhCC
Confidence            999983

>2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A*

Probab=100.00  E-value=1.8e-47  Score=361.83  Aligned_cols=249  Identities=20%  Similarity=0.254  Sum_probs=206.9

Q ss_pred             CcccccccCCCCCCcEEEEEEe-CCCCEEEEEEeCCCC---ChhHHHHHHHHHHHhcCCCccccccceeeeeCCeeEEEE
Q 020221           57 AMENIVSEHGEKAPNVVYKGKL-ENQFRIAVKRFNRSA---WPDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVA  132 (329)
Q Consensus        57 ~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~  132 (329)
                      ..+++++.||+|+||.||++.. .+|+.||+|++....   ......+.+|+++++.++||||+++++++.+.+..++||
T Consensus       184 ~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lVm  263 (576)
T 2acx_A          184 NTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVL  263 (576)
T ss_dssp             GGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             cceEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEEEEeeCCEEEEEE
Confidence            4567788889999999999994 578999999986532   123456789999999999999999999999999999999


Q ss_pred             ecCCCCCHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCCCCCeeeecccCcccCCCCC--
Q 020221          133 EYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDGR--  210 (329)
Q Consensus       133 e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~--  210 (329)
                      ||+++|+|.+++.......+++..+..++.||+.||.|||++ ||+||||||+|||++.++.+||+|||++.......  
T Consensus       264 Ey~~gg~L~~~l~~~~~~~l~e~~~~~i~~qIl~aL~yLH~~-gIvHrDLKPeNILld~~g~vKL~DFGla~~~~~~~~~  342 (576)
T 2acx_A          264 TLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLHRE-RIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQTI  342 (576)
T ss_dssp             CCCCSCBHHHHHHSSSSCCCCHHHHHHHHHHHHHHHHHHHHT-TEECCCCCGGGEEECTTSCEEECCCTTCEECCTTCCE
T ss_pred             EcCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHC-CEeccCCchheEEEeCCCCeEEEecccceecccCccc
Confidence            999999999999765555699999999999999999999999 99999999999999999999999999998765442  


Q ss_pred             -CccCcccccCcccccCCCCCCcccchhhhHHHHHHHhCCCCCCchhhHHHhhhchhhhccccccCCCChHHHHHHHHHH
Q 020221          211 -SYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLA  289 (329)
Q Consensus       211 -~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li  289 (329)
                       ...||+.|+|||++.+..++.++||||||+++|||++|..||...............+..  ....++...++++.+|+
T Consensus       343 ~~~~GT~~Y~APEvl~~~~~~~~~DiwSLGvilyeLltG~~PF~~~~~~~~~~~i~~~i~~--~~~~~p~~~s~~~~dLI  420 (576)
T 2acx_A          343 KGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKE--VPEEYSERFSPQARSLC  420 (576)
T ss_dssp             ECCCSCGGGCCHHHHTTCEESSHHHHHHHHHHHHHHHHSSCSSSCSSSCCCHHHHHHHHHH--CCCCCCTTSCHHHHHHH
T ss_pred             cccCCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCcccccchhHHHHHHHhhc--ccccCCccCCHHHHHHH
Confidence             357899999999999888999999999999999999999988653211000000011111  12234566788999999


Q ss_pred             HHhcccCCCCCC-----CHHHHHH
Q 020221          290 SRCLQYEPRERP-----NPRSLVT  308 (329)
Q Consensus       290 ~~cl~~dp~~Rp-----s~~~~l~  308 (329)
                      .+||+.||++||     ++.++++
T Consensus       421 ~~lL~~dP~~R~g~~~~sa~eil~  444 (576)
T 2acx_A          421 SQLLCKDPAERLGCRGGSAREVKE  444 (576)
T ss_dssp             HHHTCSSGGGSTTCSSSHHHHHHT
T ss_pred             HHhccCCHHHcCCCCCCCHHHHHh
Confidence            999999999999     7788886

>3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens}

Probab=100.00  E-value=3.8e-47  Score=341.72  Aligned_cols=245  Identities=18%  Similarity=0.239  Sum_probs=198.6

Q ss_pred             CcccccccCCCCCCcEEEEEEeCCCCEEEEEEeCCCCC--hhHHHHHHHHHHHhcCCC--ccccccceeeeeCCeeEEEE
Q 020221           57 AMENIVSEHGEKAPNVVYKGKLENQFRIAVKRFNRSAW--PDARQFLEEARAVGQLRN--RRLANLLGCCCEGDERLLVA  132 (329)
Q Consensus        57 ~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h--~niv~~~~~~~~~~~~~lv~  132 (329)
                      ..|++++.||+|+||.||++...+++.||+|++.....  ...+.+.+|+.+++.++|  +||+++++++......++||
T Consensus         9 ~~y~i~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~lv~   88 (343)
T 3dbq_A            9 RIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVM   88 (343)
T ss_dssp             CEEEEEEEESCCSSEEEEEEECTTSCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEE
T ss_pred             CEEEEEEEEecCCCeEEEEEEeCCCCEEEEEEeeccccchHHHHHHHHHHHHHHhhhhcCCceEEEeeeEeeCCEEEEEE
Confidence            35788889999999999999988899999999876532  234668899999999976  99999999999999999999


Q ss_pred             ecCCCCCHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCCCCCeeeecccCcccCCCCC--
Q 020221          133 EYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDGR--  210 (329)
Q Consensus       133 e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~--  210 (329)
                      |+ .+++|.+++..  ...+++..+..++.||+.||.|||+. +|+||||||+|||++ ++.+||+|||++.......  
T Consensus        89 e~-~~~~L~~~l~~--~~~~~~~~~~~i~~qi~~al~~lH~~-~iiHrDikp~NIll~-~~~~kl~DFG~a~~~~~~~~~  163 (343)
T 3dbq_A           89 EC-GNIDLNSWLKK--KKSIDPWERKSYWKNMLEAVHTIHQH-GIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTTS  163 (343)
T ss_dssp             CC-CSEEHHHHHHH--SCCCCHHHHHHHHHHHHHHHHHHHHT-TCCCCCCCGGGEEEE-TTEEEECCCSSSCCC------
T ss_pred             eC-CCCCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhC-CeecCCCCcceEEEE-CCcEEEeecccccccCccccc
Confidence            94 57799999974  46789999999999999999999999 999999999999997 6789999999998654332  


Q ss_pred             ----CccCcccccCcccccC-----------CCCCCcccchhhhHHHHHHHhCCCCCCchhhHHHhhhchhhhccccccC
Q 020221          211 ----SYSTNLAFTPPEYLRT-----------GRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEG  275 (329)
Q Consensus       211 ----~~~~~~~y~aPE~~~~-----------~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~  275 (329)
                          ...||+.|+|||++.+           ..++.++||||||+++|+|++|..||........   ............
T Consensus       164 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~---~~~~~~~~~~~~  240 (343)
T 3dbq_A          164 VVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQIS---KLHAIIDPNHEI  240 (343)
T ss_dssp             ------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHH---HHHHHHCTTSCC
T ss_pred             ccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchhhhhHHH---HHHHHhcCCccc
Confidence                3468999999999864           5688899999999999999999988864221111   111222222333


Q ss_pred             CCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 020221          276 QFSSDEGTELVRLASRCLQYEPRERPNPRSLVTA  309 (329)
Q Consensus       276 ~~~~~~~~~~~~li~~cl~~dp~~Rps~~~~l~~  309 (329)
                      .++...+.++.+++..||+.||++|||+.+++++
T Consensus       241 ~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~h  274 (343)
T 3dbq_A          241 EFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAH  274 (343)
T ss_dssp             CCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred             CCcccCCHHHHHHHHHHcCCChhHCCCHHHHHhC
Confidence            4455556789999999999999999999999973

>2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis}

Probab=100.00  E-value=1.1e-46  Score=334.00  Aligned_cols=260  Identities=16%  Similarity=0.186  Sum_probs=204.7

Q ss_pred             HhcCCCcccccccCCCCCCcEEEEEEe-CCCCEEEEEEeCCCCChh---HHHHHHHHHHHhcCCCccccccceeeeeCCe
Q 020221           52 ATSGFAMENIVSEHGEKAPNVVYKGKL-ENQFRIAVKRFNRSAWPD---ARQFLEEARAVGQLRNRRLANLLGCCCEGDE  127 (329)
Q Consensus        52 ~~~~~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~---~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~  127 (329)
                      ....+..|++++.||+|+||.||++.. .+++.||+|++.......   .+.+.+|+.+++.++||||+++++++...+.
T Consensus        29 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~  108 (309)
T 2h34_A           29 EGTQFGPYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEIDGQ  108 (309)
T ss_dssp             -----CCEEEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTE
T ss_pred             CCcEeccEEEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEeeCCe
Confidence            345567889999999999999999994 478899999997653222   3568899999999999999999999999999


Q ss_pred             eEEEEecCCCCCHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCCCCCeeeecccCcccCC
Q 020221          128 RLLVAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSR  207 (329)
Q Consensus       128 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~  207 (329)
                      .++||||+++++|.+++..  ...+++..+..++.|++.||.|||+. +++|+||||+||+++.++.+||+|||++....
T Consensus       109 ~~lv~e~~~~~~L~~~l~~--~~~~~~~~~~~i~~qi~~~l~~lH~~-~i~H~dlkp~NIl~~~~~~~kl~Dfg~~~~~~  185 (309)
T 2h34_A          109 LYVDMRLINGVDLAAMLRR--QGPLAPPRAVAIVRQIGSALDAAHAA-GATHRDVKPENILVSADDFAYLVDFGIASATT  185 (309)
T ss_dssp             EEEEEECCCCEEHHHHHHH--HCSCCHHHHHHHHHHHHHHHHHHHHT-TCCCSCCCGGGEEECTTSCEEECSCCC-----
T ss_pred             EEEEEEecCCCCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHC-cCCcCCCChHHEEEcCCCCEEEecCccCcccc
Confidence            9999999999999999963  35689999999999999999999999 99999999999999999999999999987654


Q ss_pred             CC-----CCccCcccccCcccccCCCCCCcccchhhhHHHHHHHhCCCCCCchhhHHHhhhchhhhccccccCCCChHHH
Q 020221          208 DG-----RSYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEG  282 (329)
Q Consensus       208 ~~-----~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  282 (329)
                      ..     ....+++.|+|||.+.+..++.++||||||+++|+|++|..||..................   ....+...+
T Consensus       186 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~---~~~~~~~~~  262 (309)
T 2h34_A          186 DEKLTQLGNTVGTLYYMAPERFSESHATYRADIYALTCVLYECLTGSPPYQGDQLSVMGAHINQAIPR---PSTVRPGIP  262 (309)
T ss_dssp             -----------CCGGGCCGGGTCC----CCCHHHHHHHHHHHHHHSSCSSCSCHHHHHHHHHHSCCCC---GGGTSTTCC
T ss_pred             ccccccccccCCCcCccCHHHHcCCCCCchHhHHHHHHHHHHHHHCCCCCCCchHHHHHHHhccCCCC---ccccCCCCC
Confidence            33     2346789999999999888999999999999999999999988765443222211111111   112344567


Q ss_pred             HHHHHHHHHhcccCCCCCC-CHHHHHHHHHhhhhcc
Q 020221          283 TELVRLASRCLQYEPRERP-NPRSLVTALVTLQKDT  317 (329)
Q Consensus       283 ~~~~~li~~cl~~dp~~Rp-s~~~~l~~L~~~~~~~  317 (329)
                      +++.+++.+||+.||++|| ++.++++.|+.+....
T Consensus       263 ~~l~~li~~~l~~dP~~Rp~s~~~l~~~l~~~l~~~  298 (309)
T 2h34_A          263 VAFDAVIARGMAKNPEDRYVTCGDLSAAAHAALATA  298 (309)
T ss_dssp             THHHHHHHHHTCSSGGGSCSSHHHHHHHHHHTCC--
T ss_pred             HHHHHHHHHhccCCHHHHHHhHHHHHHHHHHHHHhh
Confidence            7899999999999999999 9999999999887654

>1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A*

Probab=100.00  E-value=4.5e-47  Score=332.23  Aligned_cols=241  Identities=17%  Similarity=0.201  Sum_probs=202.0

Q ss_pred             cccccccCCCCCCcEEEEEEe-CCCCEEEEEEeCCCC--ChhHHHHHHHHHHHhcC-CCccccccceeeeeCCeeEEEEe
Q 020221           58 MENIVSEHGEKAPNVVYKGKL-ENQFRIAVKRFNRSA--WPDARQFLEEARAVGQL-RNRRLANLLGCCCEGDERLLVAE  133 (329)
Q Consensus        58 ~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e  133 (329)
                      .|++++.||+|+||+||+|.. .+++.||+|++....  ......+.+|+..+..+ +||||+++++++.+.+..++|||
T Consensus        12 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~~~~~lv~e   91 (289)
T 1x8b_A           12 EFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAWAEDDHMLIQNE   91 (289)
T ss_dssp             HEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCTTSHHHHHHHHHHHHHHHSCSCTTBCCEEEEEEETTEEEEEEE
T ss_pred             hhhhhhhhcCCCceEEEEEEEcCCCceEEEEEecccccccHHHHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEEE
Confidence            467788889999999999995 478999999997643  23456688999999999 89999999999999999999999


Q ss_pred             cCCCCCHHhhhccCC--CCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCCC-------------------
Q 020221          134 YMPNDTLAKHLFHWE--TQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDD-------------------  192 (329)
Q Consensus       134 ~~~~gsL~~~l~~~~--~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~-------------------  192 (329)
                      |+++++|.+++....  ...+++..++.++.||+.||.|||++ +++||||||+||+++.+                   
T Consensus        92 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~-~ivH~Dikp~NIl~~~~~~~~~~~~~~~~~~~~~~~  170 (289)
T 1x8b_A           92 YCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSM-SLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNK  170 (289)
T ss_dssp             CCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHT-TEECSCCSGGGEEEC--------------------C
T ss_pred             ecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHHhC-CEeecCCCHHHEEEcCCCCCcccccccccccccCCc
Confidence            999999999996421  25689999999999999999999999 99999999999999844                   


Q ss_pred             CCeeeecccCcccCCCCCCccCcccccCcccccCC-CCCCcccchhhhHHHHHHHhCCCCCCchhh-HHHhhhchhhhcc
Q 020221          193 VNPRLSCFGLMKNSRDGRSYSTNLAFTPPEYLRTG-RVTPESVMYSFGTLLLDLLSGKHIPPSHAL-DLIRDRNIQTLTD  270 (329)
Q Consensus       193 ~~~kl~Dfg~a~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DvwslG~il~el~tg~~~~~~~~~-~~~~~~~~~~~~~  270 (329)
                      ..++|+|||.+..........+++.|+|||.+.+. .++.++||||||+++|+|++|..++..... .....        
T Consensus       171 ~~~kl~Dfg~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~~~~~~--------  242 (289)
T 1x8b_A          171 VMFKIGDLGHVTRISSPQVEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNGDQWHEIRQ--------  242 (289)
T ss_dssp             CCEEECCCTTCEETTCSCCCCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTTCCCCCSSSHHHHHHHT--------
T ss_pred             eEEEEcccccccccCCccccCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHhcCCCCCcchhHHHHHHc--------
Confidence            47999999999888777777899999999999876 466799999999999999999976543321 11111        


Q ss_pred             ccccCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 020221          271 SCLEGQFSSDEGTELVRLASRCLQYEPRERPNPRSLVT  308 (329)
Q Consensus       271 ~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~~~l~  308 (329)
                      . .....+...++++.+++.+||+.||++|||+.++++
T Consensus       243 ~-~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~  279 (289)
T 1x8b_A          243 G-RLPRIPQVLSQEFTELLKVMIHPDPERRPSAMALVK  279 (289)
T ss_dssp             T-CCCCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             C-CCCCCCcccCHHHHHHHHHHhCCCcccCCCHHHHhh
Confidence            1 112344556788999999999999999999999998

>1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A*

Probab=100.00  E-value=4.5e-47  Score=336.55  Aligned_cols=256  Identities=20%  Similarity=0.312  Sum_probs=211.3

Q ss_pred             CcccccccCCCCCCcEEEEEEe------CCCCEEEEEEeCCCCCh-hHHHHHHHHHHHhcC-CCccccccceeeeeCCee
Q 020221           57 AMENIVSEHGEKAPNVVYKGKL------ENQFRIAVKRFNRSAWP-DARQFLEEARAVGQL-RNRRLANLLGCCCEGDER  128 (329)
Q Consensus        57 ~~~~~~~~lg~G~~g~V~~~~~------~~~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~  128 (329)
                      ..|++.+.||+|+||.||+|..      .+++.||+|++...... ..+.+.+|+.+++.+ +||||+++++++..++..
T Consensus        23 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~  102 (313)
T 1t46_A           23 NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGPT  102 (313)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred             hhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcchhHHHHHHHHHHHHHHhhcccCCCeeeEEEEEecCCCc
Confidence            4577888889999999999984      34678999999866532 356789999999999 899999999999999999


Q ss_pred             EEEEecCCCCCHHhhhccCCC----------------CCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCCC
Q 020221          129 LLVAEYMPNDTLAKHLFHWET----------------QPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDD  192 (329)
Q Consensus       129 ~lv~e~~~~gsL~~~l~~~~~----------------~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~  192 (329)
                      ++||||+++|+|.+++.....                ..+++..++.++.|++.||.|||+. +++|+||||+||+++.+
T Consensus       103 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~-~i~H~dlkp~Nil~~~~  181 (313)
T 1t46_A          103 LVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASK-NCIHRDLAARNILLTHG  181 (313)
T ss_dssp             EEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHT-TCCCSCCSGGGEEEETT
T ss_pred             EEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHHC-CeecCCCccceEEEcCC
Confidence            999999999999999975332                2489999999999999999999999 99999999999999999


Q ss_pred             CCeeeecccCcccCCCCC------CccCcccccCcccccCCCCCCcccchhhhHHHHHHHh-CCCCCCchhhHHHhhhch
Q 020221          193 VNPRLSCFGLMKNSRDGR------SYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLS-GKHIPPSHALDLIRDRNI  265 (329)
Q Consensus       193 ~~~kl~Dfg~a~~~~~~~------~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t-g~~~~~~~~~~~~~~~~~  265 (329)
                      +.+||+|||++.......      ...+++.|+|||.+.+..++.++||||||+++|+|++ |..||...........  
T Consensus       182 ~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~--  259 (313)
T 1t46_A          182 RITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFYK--  259 (313)
T ss_dssp             TEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSSHHHHH--
T ss_pred             CCEEEccccccccccccccceeccCCCCcceeeChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCCcccchhHHHH--
Confidence            999999999998765443      2235678999999998899999999999999999999 8877754322111111  


Q ss_pred             hhhccccccCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhhcc
Q 020221          266 QTLTDSCLEGQFSSDEGTELVRLASRCLQYEPRERPNPRSLVTALVTLQKDT  317 (329)
Q Consensus       266 ~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~~~l~~L~~~~~~~  317 (329)
                        ..........+...++++.+++.+||+.||++|||+.++++.|+++..+.
T Consensus       260 --~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~  309 (313)
T 1t46_A          260 --MIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQISES  309 (313)
T ss_dssp             --HHHHTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHT
T ss_pred             --HhccCCCCCCcccCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHHHh
Confidence              11111222334556788999999999999999999999999999987643

>3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii}

Probab=100.00  E-value=1.5e-46  Score=350.57  Aligned_cols=248  Identities=16%  Similarity=0.187  Sum_probs=183.3

Q ss_pred             CcccccccCCCCCCcEEEEEE-eCCCCEEEEEEeCCCCC--hhHHHHHHHHHHHhcCCCccccccceeeeeC-----Cee
Q 020221           57 AMENIVSEHGEKAPNVVYKGK-LENQFRIAVKRFNRSAW--PDARQFLEEARAVGQLRNRRLANLLGCCCEG-----DER  128 (329)
Q Consensus        57 ~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~-----~~~  128 (329)
                      ..|++++.||+|+||+||+|. ..+++.||||++.....  ...+.+.+|+++|+.++||||+++++++...     ...
T Consensus        53 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~  132 (458)
T 3rp9_A           53 DRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFDEL  132 (458)
T ss_dssp             TTEEECCC-------CEEEEEECC--CEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCCE
T ss_pred             CCeEEeeEeeecCCeEEEEEEECCCCcEEEEEEechhhcCHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCCcccCceE
Confidence            458889999999999999998 55788999999976432  2356788999999999999999999998443     578


Q ss_pred             EEEEecCCCCCHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCCCCCeeeecccCcccCCC
Q 020221          129 LLVAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRD  208 (329)
Q Consensus       129 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~  208 (329)
                      ++||||+. ++|.+++.  ....+++..+..++.||+.||+|||+. ||+||||||+|||++.++.+||+|||+++....
T Consensus       133 ~lv~e~~~-~~L~~~~~--~~~~l~~~~~~~~~~qi~~aL~~LH~~-~iiHrDlKp~NILl~~~~~~kl~DFGla~~~~~  208 (458)
T 3rp9_A          133 YVVLEIAD-SDFKKLFR--TPVYLTELHIKTLLYNLLVGVKYVHSA-GILHRDLKPANCLVNQDCSVKVCDFGLARTVDY  208 (458)
T ss_dssp             EEEECCCS-EEHHHHHH--SSCCCCHHHHHHHHHHHHHHHHHHHHT-TCBCCCCCGGGEEECTTCCEEECCCTTCBCTTS
T ss_pred             EEEEeccc-cchhhhcc--cCCCCCHHHHHHHHHHHHHHHHHHHhC-CcCCCCCChhhEEECCCCCEeecccccchhccC
Confidence            99999985 68999886  456799999999999999999999999 999999999999999999999999999986532


Q ss_pred             C-------------------------------CCccCcccccCcccc-cCCCCCCcccchhhhHHHHHHHh---------
Q 020221          209 G-------------------------------RSYSTNLAFTPPEYL-RTGRVTPESVMYSFGTLLLDLLS---------  247 (329)
Q Consensus       209 ~-------------------------------~~~~~~~~y~aPE~~-~~~~~~~~~DvwslG~il~el~t---------  247 (329)
                      .                               ....||+.|+|||++ .+..++.++|||||||++|||++         
T Consensus       209 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il~elltg~~~~~~~~  288 (458)
T 3rp9_A          209 PENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNMIKENVAYH  288 (458)
T ss_dssp             CTTCCCCCC---------------------------CCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHTTSTTTCSSG
T ss_pred             ccccccccccCccccccccccccccccccccccCCcccccccChHHhhCCCCCCcHhHHHHHHHHHHHHHHhcccccccc
Confidence            1                               223568999999976 45669999999999999999999         


Q ss_pred             --CCCCCCchhh---------------------HHHhh------------------hchhhh---cccccc---CCCChH
Q 020221          248 --GKHIPPSHAL---------------------DLIRD------------------RNIQTL---TDSCLE---GQFSSD  280 (329)
Q Consensus       248 --g~~~~~~~~~---------------------~~~~~------------------~~~~~~---~~~~~~---~~~~~~  280 (329)
                        |+++|+....                     +....                  ......   ......   ......
T Consensus       289 ~~~~p~f~g~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  368 (458)
T 3rp9_A          289 ADRGPLFPGSSCFPLSPDQKAGNDFKFHTRGNRDQLNVIFNILGTPSEEDIEALEKEDAKRYIRIFPKREGTDLAERFPA  368 (458)
T ss_dssp             GGCCCSCC--------------------CHHHHHHHHHHHHHHCCCCHHHHHTSSCHHHHHHHTTSCCCCCCCGGGGSTT
T ss_pred             ccccccCCCCccccccccccccccccccccCCHHHHHHHHHHcCCCCHHHHhhcCCHHHHHHHHhcCCCCCCCHHHHCCC
Confidence              5555543210                     00000                  000000   000000   001123


Q ss_pred             HHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 020221          281 EGTELVRLASRCLQYEPRERPNPRSLVT  308 (329)
Q Consensus       281 ~~~~~~~li~~cl~~dp~~Rps~~~~l~  308 (329)
                      .++++.+|+.+||..||++|||+.++++
T Consensus       369 ~s~~~~dLl~~mL~~dP~~R~t~~e~L~  396 (458)
T 3rp9_A          369 SSADAIHLLKRMLVFNPNKRITINECLA  396 (458)
T ss_dssp             SCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred             CCHHHHHHHHHHhccCccccCCHHHHhc
Confidence            4788999999999999999999999998

>4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens}

Probab=100.00  E-value=1.2e-46  Score=333.68  Aligned_cols=249  Identities=20%  Similarity=0.228  Sum_probs=198.1

Q ss_pred             CcccccccCCCCCCcEEEEEEe-CCCCEEEEEEeCCCCChh--HHHHHHHHHHHhcCCCccccccceeeeeCCeeEEEEe
Q 020221           57 AMENIVSEHGEKAPNVVYKGKL-ENQFRIAVKRFNRSAWPD--ARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAE  133 (329)
Q Consensus        57 ~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~--~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  133 (329)
                      ..|++++.||+|+||+||+|.. .+++.||+|++.......  .+.+.+|+++++.++||||+++++++...+..++|||
T Consensus         3 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   82 (311)
T 4agu_A            3 EKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEVFRRKRRLHLVFE   82 (311)
T ss_dssp             CCEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCCCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             ccceEeeEEeecCCeEEEEEEeCCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhCCCCCccchhheeecCCeEEEEEE
Confidence            4678888999999999999995 568999999987654332  4557899999999999999999999999999999999


Q ss_pred             cCCCCCHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCCCCCeeeecccCcccCCCC----
Q 020221          134 YMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDG----  209 (329)
Q Consensus       134 ~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~----  209 (329)
                      |+++++|.+++.  ....+++..+..++.|++.||.|||+. |++|+||||+||+++.++.++|+|||++......    
T Consensus        83 ~~~~~~l~~~~~--~~~~~~~~~~~~i~~~l~~~l~~lH~~-~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~  159 (311)
T 4agu_A           83 YCDHTVLHELDR--YQRGVPEHLVKSITWQTLQAVNFCHKH-NCIHRDVKPENILITKHSVIKLCDFGFARLLTGPSDYY  159 (311)
T ss_dssp             CCSEEHHHHHHH--TSSCCCHHHHHHHHHHHHHHHHHHHHT-TEECCCCSGGGEEECTTSCEEECCCTTCEECC------
T ss_pred             eCCCchHHHHHh--hhcCCCHHHHHHHHHHHHHHHHHHHHC-CCcCCCCChhhEEEcCCCCEEEeeCCCchhccCccccc
Confidence            999999988876  456799999999999999999999999 9999999999999999999999999999765432    


Q ss_pred             CCccCcccccCcccccC-CCCCCcccchhhhHHHHHHHhCCCCCCchhhHHHhhhchhhh----------------ccc-
Q 020221          210 RSYSTNLAFTPPEYLRT-GRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTL----------------TDS-  271 (329)
Q Consensus       210 ~~~~~~~~y~aPE~~~~-~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~~~~~~~~~----------------~~~-  271 (329)
                      ....+++.|+|||++.+ ..++.++||||||+++|+|++|..||................                ... 
T Consensus       160 ~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (311)
T 4agu_A          160 DDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDLIPRHQQVFSTNQYFSGV  239 (311)
T ss_dssp             ------GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHTCGGGTTC
T ss_pred             CCCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhcccccccccccccccccccC
Confidence            23467899999999876 568999999999999999999998886543222111100000                000 


Q ss_pred             ---cccCC-----CChHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 020221          272 ---CLEGQ-----FSSDEGTELVRLASRCLQYEPRERPNPRSLVT  308 (329)
Q Consensus       272 ---~~~~~-----~~~~~~~~~~~li~~cl~~dp~~Rps~~~~l~  308 (329)
                         .....     .....++++.+++.+||+.||++|||+.++++
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  284 (311)
T 4agu_A          240 KIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLH  284 (311)
T ss_dssp             CCCCCSSCCCHHHHCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHT
T ss_pred             cCCCccccchhhhhcccccHHHHHHHHHHccCChhhcCCHHHHhc
Confidence               00000     00235678999999999999999999999997

>1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=8.9e-47  Score=330.91  Aligned_cols=255  Identities=20%  Similarity=0.249  Sum_probs=210.7

Q ss_pred             cccccc-cCCCCCCcEEEEEEe---CCCCEEEEEEeCCCCC-hhHHHHHHHHHHHhcCCCccccccceeeeeCCeeEEEE
Q 020221           58 MENIVS-EHGEKAPNVVYKGKL---ENQFRIAVKRFNRSAW-PDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVA  132 (329)
Q Consensus        58 ~~~~~~-~lg~G~~g~V~~~~~---~~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~  132 (329)
                      .+.+++ .||+|+||.||+|..   .++..||+|++..... ...+.+.+|+++++.++||||+++++++ ..+..++||
T Consensus        10 ~~~i~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-~~~~~~lv~   88 (287)
T 1u59_A           10 NLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVC-QAEALMLVM   88 (287)
T ss_dssp             GEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-ESSSEEEEE
T ss_pred             HhhhhhccccccCceeEEEeEeccCCCcceEEEEecCCccchhHHHHHHHHHHHHHhCCCCCEeEEEEEe-cCCCcEEEE
Confidence            355665 789999999999984   3577899999987543 3456789999999999999999999999 556799999


Q ss_pred             ecCCCCCHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCCCCCeeeecccCcccCCCCC--
Q 020221          133 EYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDGR--  210 (329)
Q Consensus       133 e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~--  210 (329)
                      ||+++++|.+++.. ....+++..+..++.|++.||.|||+. +++|+||||+||+++.++.++|+|||++.......  
T Consensus        89 e~~~~~~L~~~l~~-~~~~~~~~~~~~~~~qi~~~l~~lH~~-~i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~  166 (287)
T 1u59_A           89 EMAGGGPLHKFLVG-KREEIPVSNVAELLHQVSMGMKYLEEK-NFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSY  166 (287)
T ss_dssp             ECCTTEEHHHHHTT-CTTTSCHHHHHHHHHHHHHHHHHHHHT-TEECCCCSGGGEEEEETTEEEECCCTTCEECTTCSCE
T ss_pred             EeCCCCCHHHHHHh-CCccCCHHHHHHHHHHHHHHHHHHHHC-CEeeCCCchheEEEcCCCCEEECcccceeeeccCcce
Confidence            99999999999864 445699999999999999999999999 99999999999999999999999999997654332  


Q ss_pred             -----CccCcccccCcccccCCCCCCcccchhhhHHHHHHHh-CCCCCCchhhHHHhhhchhhhccccccCCCChHHHHH
Q 020221          211 -----SYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLS-GKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTE  284 (329)
Q Consensus       211 -----~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t-g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  284 (329)
                           ...+++.|+|||.+.+..++.++||||||+++|+|++ |..||.............     .......+..++++
T Consensus       167 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~i~-----~~~~~~~~~~~~~~  241 (287)
T 1u59_A          167 YTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIE-----QGKRMECPPECPPE  241 (287)
T ss_dssp             ECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHHHHHHH-----TTCCCCCCTTCCHH
T ss_pred             eeccccccccccccCHHHhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHh-----cCCcCCCCCCcCHH
Confidence                 2245788999999988889999999999999999998 888876543322221111     11223345667889


Q ss_pred             HHHHHHHhcccCCCCCCCHHHHHHHHHhhhhccccc
Q 020221          285 LVRLASRCLQYEPRERPNPRSLVTALVTLQKDTELY  320 (329)
Q Consensus       285 ~~~li~~cl~~dp~~Rps~~~~l~~L~~~~~~~~~~  320 (329)
                      +.+++.+||+.||++|||+.++++.|+.+..+....
T Consensus       242 l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~~~~  277 (287)
T 1u59_A          242 LYALMSDCWIYKWEDRPDFLTVEQRMRACYYSLASK  277 (287)
T ss_dssp             HHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHHHHTT
T ss_pred             HHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhcCCc
Confidence            999999999999999999999999999998765443

>4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A*

Probab=100.00  E-value=3.8e-47  Score=335.42  Aligned_cols=255  Identities=18%  Similarity=0.303  Sum_probs=206.3

Q ss_pred             ccccccCCCCCCcEEEEEEe-----CCCCEEEEEEeCCCC-ChhHHHHHHHHHHHhcCCCccccccceeeeeC--CeeEE
Q 020221           59 ENIVSEHGEKAPNVVYKGKL-----ENQFRIAVKRFNRSA-WPDARQFLEEARAVGQLRNRRLANLLGCCCEG--DERLL  130 (329)
Q Consensus        59 ~~~~~~lg~G~~g~V~~~~~-----~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~--~~~~l  130 (329)
                      +++++.||+|+||.||++.+     .+++.||+|++.... ....+.+.+|+++++.++||||+++++++...  ...++
T Consensus        23 ~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~l  102 (302)
T 4e5w_A           23 LKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGIKL  102 (302)
T ss_dssp             EEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC-----CCHHHHHHHHHHHHTCCCTTBCCEEEEEEC---CCEEE
T ss_pred             hhhhhccCCCCceEEEEEEEccccCccCeEEEEEEecccccchhHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCceEEE
Confidence            67888899999999999983     468899999998653 23356789999999999999999999999776  66899


Q ss_pred             EEecCCCCCHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCCCCCeeeecccCcccCCCCC
Q 020221          131 VAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDGR  210 (329)
Q Consensus       131 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~  210 (329)
                      ||||+++++|.+++.. ....+++..++.++.|++.||+|||+. +++|+||||+||+++.++.++|+|||++.......
T Consensus       103 v~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~~~i~~~l~~lH~~-~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~  180 (302)
T 4e5w_A          103 IMEFLPSGSLKEYLPK-NKNKINLKQQLKYAVQICKGMDYLGSR-QYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDK  180 (302)
T ss_dssp             EEECCTTCBHHHHHHH-HTTTCCHHHHHHHHHHHHHHHHHHHHT-TEECSCCSGGGEEEEETTEEEECCCTTCEECCTTC
T ss_pred             EEEeCCCCcHHHHHHh-ccccCCHHHHHHHHHHHHHHHHHhhcC-CcccCCCchheEEEcCCCCEEECcccccccccCCC
Confidence            9999999999999954 345699999999999999999999999 99999999999999999999999999997655432


Q ss_pred             -------CccCcccccCcccccCCCCCCcccchhhhHHHHHHHhCCCCCCchhhHHHh----------hhchhhhccccc
Q 020221          211 -------SYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIR----------DRNIQTLTDSCL  273 (329)
Q Consensus       211 -------~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~~----------~~~~~~~~~~~~  273 (329)
                             ...+|..|+|||.+.+..++.++||||||+++|+|++|..|+.........          ............
T Consensus       181 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  260 (302)
T 4e5w_A          181 EYYTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQMTVTRLVNTLKEGK  260 (302)
T ss_dssp             CEEECCCCTTCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCGGGHHHHHHHHHHTTC
T ss_pred             cceeccCCCCCCccccCCeeecCCCCCcchhHHHHHHHHHHHHHccCCCcchhhHHhhccCCcccccCHHHHHHHHhccC
Confidence                   345677899999999888999999999999999999999764322111000          001111111222


Q ss_pred             cCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhh
Q 020221          274 EGQFSSDEGTELVRLASRCLQYEPRERPNPRSLVTALVTLQK  315 (329)
Q Consensus       274 ~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~~~l~~L~~~~~  315 (329)
                      ....+..+++++.+++.+||+.||++|||+.++++.|+.+.+
T Consensus       261 ~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~ll~  302 (302)
T 4e5w_A          261 RLPCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIEGFEALLK  302 (302)
T ss_dssp             CCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHC
T ss_pred             CCCCCCCCCHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHhC
Confidence            334456678899999999999999999999999999998753

>1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=3.2e-46  Score=334.35  Aligned_cols=257  Identities=21%  Similarity=0.285  Sum_probs=206.7

Q ss_pred             CcccccccCCCCCCcEEEEEEeCC-----CCEEEEEEeCCCCCh-hHHHHHHHHHHHhcCCCccccccceeeeeCCeeEE
Q 020221           57 AMENIVSEHGEKAPNVVYKGKLEN-----QFRIAVKRFNRSAWP-DARQFLEEARAVGQLRNRRLANLLGCCCEGDERLL  130 (329)
Q Consensus        57 ~~~~~~~~lg~G~~g~V~~~~~~~-----~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l  130 (329)
                      ..+.+.+.||+|+||+||+|....     +..||+|.+...... ....+.+|+.+++.++||||+++++++...+..++
T Consensus        44 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l  123 (333)
T 1mqb_A           44 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMI  123 (333)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEE
T ss_pred             HHhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCCcEE
Confidence            346667788999999999998432     235999999865433 34568899999999999999999999999999999


Q ss_pred             EEecCCCCCHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCCCCCeeeecccCcccCCCCC
Q 020221          131 VAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDGR  210 (329)
Q Consensus       131 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~  210 (329)
                      ||||+++++|.+++.. ....+++..++.++.|++.||.|||+. |++|+||||+||+++.++.+||+|||++.......
T Consensus       124 v~e~~~~~~L~~~l~~-~~~~~~~~~~~~i~~qi~~aL~~LH~~-~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~~~~~  201 (333)
T 1mqb_A          124 ITEYMENGALDKFLRE-KDGEFSVLQLVGMLRGIAAGMKYLANM-NYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDP  201 (333)
T ss_dssp             EEECCTTEEHHHHHHH-TTTCSCHHHHHHHHHHHHHHHHHHHHT-TCCCSCCCGGGEEECTTCCEEECCCCC--------
T ss_pred             EEeCCCCCcHHHHHHh-CCCCCCHHHHHHHHHHHHHHHHHHHhC-CeeCCCCChheEEECCCCcEEECCCCcchhhcccc
Confidence            9999999999999965 446799999999999999999999999 99999999999999999999999999997654332


Q ss_pred             -------CccCcccccCcccccCCCCCCcccchhhhHHHHHHHh-CCCCCCchhhHHHhhhchhhhccccccCCCChHHH
Q 020221          211 -------SYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLS-GKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEG  282 (329)
Q Consensus       211 -------~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t-g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  282 (329)
                             ...+++.|+|||++.+..++.++||||||+++|+|++ |..||..............     ......+..++
T Consensus       202 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~~~~~~~~-----~~~~~~~~~~~  276 (333)
T 1mqb_A          202 EATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAIND-----GFRLPTPMDCP  276 (333)
T ss_dssp             ---------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHT-----TCCCCCCTTCB
T ss_pred             ccccccCCCCccccccCchhcccCCCCchhhhHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHC-----CCcCCCcccCC
Confidence                   1234678999999998899999999999999999999 8887754433222211111     11223345667


Q ss_pred             HHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhhccccc
Q 020221          283 TELVRLASRCLQYEPRERPNPRSLVTALVTLQKDTELY  320 (329)
Q Consensus       283 ~~~~~li~~cl~~dp~~Rps~~~~l~~L~~~~~~~~~~  320 (329)
                      +++.+++.+||+.||++||++.++++.|+++.+.....
T Consensus       277 ~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~~~~~~~~  314 (333)
T 1mqb_A          277 SAIYQLMMQCWQQERARRPKFADIVSILDKLIRAPDSL  314 (333)
T ss_dssp             HHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHSGGGG
T ss_pred             HHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhcchhh
Confidence            88999999999999999999999999999997765443

>3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=3.7e-47  Score=341.76  Aligned_cols=248  Identities=19%  Similarity=0.145  Sum_probs=197.4

Q ss_pred             cccccccCCCCCCcEEEEEE-eCCCCEEEEEEeCCC-----CChhHHHHHHHHHHHhcCCCccccccceeeeeCCeeEEE
Q 020221           58 MENIVSEHGEKAPNVVYKGK-LENQFRIAVKRFNRS-----AWPDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLV  131 (329)
Q Consensus        58 ~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~-----~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv  131 (329)
                      .|++++.||+|+||+||+|. ..+++.||+|++...     .....+.+.+|+++++.++||||+++++++.+.+..++|
T Consensus        27 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv  106 (345)
T 3hko_A           27 KYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYEDEQYICLV  106 (345)
T ss_dssp             HEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred             heeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeehhhccCCeEEEE
Confidence            36777888999999999999 466889999998643     223456789999999999999999999999999999999


Q ss_pred             EecCCCCCHHhhhccCC--------------------------------------CCCCCHHHHHHHHHHHHHHHHHhhc
Q 020221          132 AEYMPNDTLAKHLFHWE--------------------------------------TQPMKWAMRLRVALHIAEALEYCTS  173 (329)
Q Consensus       132 ~e~~~~gsL~~~l~~~~--------------------------------------~~~~~~~~~~~i~~~i~~~l~~lH~  173 (329)
                      |||+++|+|.+++....                                      ...+++..++.++.||+.||.|||+
T Consensus       107 ~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~  186 (345)
T 3hko_A          107 MELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLHN  186 (345)
T ss_dssp             EECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHHHHHHHHHH
T ss_pred             EeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHH
Confidence            99999999999884210                                      1123577888999999999999999


Q ss_pred             CCCccccccCCCceeeCCCC--CeeeecccCcccCCC--------CCCccCcccccCcccccC--CCCCCcccchhhhHH
Q 020221          174 KERALYHDLNAYRIVFDDDV--NPRLSCFGLMKNSRD--------GRSYSTNLAFTPPEYLRT--GRVTPESVMYSFGTL  241 (329)
Q Consensus       174 ~~~ivH~dlkp~Nil~~~~~--~~kl~Dfg~a~~~~~--------~~~~~~~~~y~aPE~~~~--~~~~~~~DvwslG~i  241 (329)
                      + +++||||||+||+++.++  .+||+|||++.....        .....+|+.|+|||++.+  ..++.++||||||++
T Consensus       187 ~-~ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~i  265 (345)
T 3hko_A          187 Q-GICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDAWSAGVL  265 (345)
T ss_dssp             T-TEECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTCSSSCCCTHHHHHHHHHH
T ss_pred             C-CccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccccCchhhccCCCCCCcHHHHHHHHHH
Confidence            9 999999999999998776  899999999975432        124468899999999875  568899999999999


Q ss_pred             HHHHHhCCCCCCchhhHHHhhhchhhhccccccCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 020221          242 LLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLASRCLQYEPRERPNPRSLVT  308 (329)
Q Consensus       242 l~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~~~l~  308 (329)
                      +|+|++|..||..................  .........++++.+++.+||+.||++|||+.++++
T Consensus       266 l~el~~g~~pf~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~  330 (345)
T 3hko_A          266 LHLLLMGAVPFPGVNDADTISQVLNKKLC--FENPNYNVLSPLARDLLSNLLNRNVDERFDAMRALQ  330 (345)
T ss_dssp             HHHHHHSSCSSCCSSHHHHHHHHHHCCCC--TTSGGGGGSCHHHHHHHHHHSCSCTTTSCCHHHHHH
T ss_pred             HHHHHHCCCCCCCCChHHHHHHHHhcccc--cCCcccccCCHHHHHHHHHHcCCChhHCCCHHHHhc
Confidence            99999999988654433222222111110  111112345788999999999999999999999998

>2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ...

Probab=100.00  E-value=1.3e-46  Score=336.99  Aligned_cols=254  Identities=20%  Similarity=0.303  Sum_probs=209.7

Q ss_pred             CcccccccCCCCCCcEEEEEEe--------CCCCEEEEEEeCCCCCh-hHHHHHHHHHHHhcC-CCccccccceeeeeCC
Q 020221           57 AMENIVSEHGEKAPNVVYKGKL--------ENQFRIAVKRFNRSAWP-DARQFLEEARAVGQL-RNRRLANLLGCCCEGD  126 (329)
Q Consensus        57 ~~~~~~~~lg~G~~g~V~~~~~--------~~~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~  126 (329)
                      ..|.+.+.||+|+||.||+|..        .++..||+|++...... ..+.+.+|+++++.+ +||||+++++++...+
T Consensus        35 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~  114 (334)
T 2pvf_A           35 DKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDG  114 (334)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred             hHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCCcHHHHHHHHHHHHHHHHhhcCCCEeeEEEEEccCC
Confidence            4577888889999999999985        34678999999865432 356688999999999 8999999999999999


Q ss_pred             eeEEEEecCCCCCHHhhhccCCC--------------CCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCCC
Q 020221          127 ERLLVAEYMPNDTLAKHLFHWET--------------QPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDD  192 (329)
Q Consensus       127 ~~~lv~e~~~~gsL~~~l~~~~~--------------~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~  192 (329)
                      ..++||||+++|+|.+++.....              ..+++..++.++.||+.||.|||+. |++|+||||+||+++.+
T Consensus       115 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~-~ivH~Dlkp~NIll~~~  193 (334)
T 2pvf_A          115 PLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQ-KCIHRDLAARNVLVTEN  193 (334)
T ss_dssp             CCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHHT-TEECSCCSGGGEEECTT
T ss_pred             ceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhC-CeeCCCCccceEEEcCC
Confidence            99999999999999999975321              2489999999999999999999999 99999999999999999


Q ss_pred             CCeeeecccCcccCCCCC------CccCcccccCcccccCCCCCCcccchhhhHHHHHHHh-CCCCCCchhhHHHhhhch
Q 020221          193 VNPRLSCFGLMKNSRDGR------SYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLS-GKHIPPSHALDLIRDRNI  265 (329)
Q Consensus       193 ~~~kl~Dfg~a~~~~~~~------~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t-g~~~~~~~~~~~~~~~~~  265 (329)
                      +.+||+|||++.......      ...+++.|+|||++.+..++.++||||||+++|+|++ |..|+.............
T Consensus       194 ~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~  273 (334)
T 2pvf_A          194 NVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFKLLK  273 (334)
T ss_dssp             CCEEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHH
T ss_pred             CCEEEccccccccccccccccccCCCCcccceeChHHhcCCCcChHHHHHHHHHHHHHHHhCCCCCcCcCCHHHHHHHHh
Confidence            999999999997654432      2345688999999988889999999999999999999 887776543333222111


Q ss_pred             hhhccccccCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhhc
Q 020221          266 QTLTDSCLEGQFSSDEGTELVRLASRCLQYEPRERPNPRSLVTALVTLQKD  316 (329)
Q Consensus       266 ~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~~~l~~L~~~~~~  316 (329)
                      .     ......+..++.++.+++.+||+.||++|||+.++++.|+++...
T Consensus       274 ~-----~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~l~~~  319 (334)
T 2pvf_A          274 E-----GHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILTL  319 (334)
T ss_dssp             H-----TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             c-----CCCCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhc
Confidence            1     112234456678899999999999999999999999999999763

>2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ...

Probab=100.00  E-value=7.3e-47  Score=330.90  Aligned_cols=245  Identities=18%  Similarity=0.260  Sum_probs=206.5

Q ss_pred             CCCcccccccCCCCCCcEEEEEEe-CCCCEEEEEEeCCCC---ChhHHHHHHHHHHHhcCCCccccccceeeeeCCeeEE
Q 020221           55 GFAMENIVSEHGEKAPNVVYKGKL-ENQFRIAVKRFNRSA---WPDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLL  130 (329)
Q Consensus        55 ~~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l  130 (329)
                      ....|++.+.||+|+||.||++.. .+++.||+|++....   ....+.+.+|+++++.++||||+++++++.+.+..++
T Consensus        12 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l   91 (284)
T 2vgo_A           12 TIDDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFHDRKRIYL   91 (284)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEE
T ss_pred             hhhhceeeheecCCCCeEEEEEEEcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEEEEEcCCEEEE
Confidence            446688888999999999999995 467889999986532   1224568899999999999999999999999999999


Q ss_pred             EEecCCCCCHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCCCCCeeeecccCcccCCCC-
Q 020221          131 VAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDG-  209 (329)
Q Consensus       131 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~-  209 (329)
                      ||||+++++|.+++..  ...+++..+..++.|++.||.|||+. |++|+||||+||+++.++.++|+|||++...... 
T Consensus        92 v~e~~~~~~L~~~l~~--~~~~~~~~~~~~~~qi~~~l~~lH~~-~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~~  168 (284)
T 2vgo_A           92 MLEFAPRGELYKELQK--HGRFDEQRSATFMEELADALHYCHER-KVIHRDIKPENLLMGYKGELKIADFGWSVHAPSLR  168 (284)
T ss_dssp             EECCCTTEEHHHHHHH--HSSCCHHHHHHHHHHHHHHHHHHHTT-TEECCCCSGGGEEECTTCCEEECCCTTCEECSSSC
T ss_pred             EEEeCCCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHC-CceecCCCHHHEEEcCCCCEEEecccccccCcccc
Confidence            9999999999999863  35689999999999999999999999 9999999999999999999999999998655432 


Q ss_pred             -CCccCcccccCcccccCCCCCCcccchhhhHHHHHHHhCCCCCCchhhHHHhhhchhhhccccccCCCChHHHHHHHHH
Q 020221          210 -RSYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRL  288 (329)
Q Consensus       210 -~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  288 (329)
                       ....+++.|+|||++.+..++.++||||||+++|+|++|..||..............      ....++...+.++.++
T Consensus       169 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~------~~~~~~~~~~~~~~~l  242 (284)
T 2vgo_A          169 RRTMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHTETHRRIVN------VDLKFPPFLSDGSKDL  242 (284)
T ss_dssp             BCCCCSCGGGCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHT------TCCCCCTTSCHHHHHH
T ss_pred             cccccCCCCcCCHHHhccCCCCcccchhhHHHHHHHHHHCCCCCCCCCHhHHHHHHhc------cccCCCCcCCHHHHHH
Confidence             345688999999999998999999999999999999999988865433222211111      1123445567889999


Q ss_pred             HHHhcccCCCCCCCHHHHHH
Q 020221          289 ASRCLQYEPRERPNPRSLVT  308 (329)
Q Consensus       289 i~~cl~~dp~~Rps~~~~l~  308 (329)
                      +.+||+.||++|||+.++++
T Consensus       243 i~~~l~~~p~~Rps~~~ll~  262 (284)
T 2vgo_A          243 ISKLLRYHPPQRLPLKGVME  262 (284)
T ss_dssp             HHHHSCSSGGGSCCHHHHHT
T ss_pred             HHHHhhcCHhhCCCHHHHhh
Confidence            99999999999999999997

>2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens}

Probab=100.00  E-value=2.4e-46  Score=331.42  Aligned_cols=254  Identities=18%  Similarity=0.279  Sum_probs=201.3

Q ss_pred             CCCcccccccCCCCCCcEEEEEEeCCCCEEEEEEeCCCCChhHHHHHHHHHHHhcCCCccccccceeeeeCCeeEEEEec
Q 020221           55 GFAMENIVSEHGEKAPNVVYKGKLENQFRIAVKRFNRSAWPDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAEY  134 (329)
Q Consensus        55 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  134 (329)
                      ++..+++.+.||+|+||+||++... ++.||+|.+....  ..+.+.+|+++++.++||||+++++++.  +..++||||
T Consensus         6 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~~--~~~~~~~E~~~l~~l~hp~iv~~~~~~~--~~~~lv~e~   80 (307)
T 2eva_A            6 DYKEIEVEEVVGRGAFGVVCKAKWR-AKDVAIKQIESES--ERKAFIVELRQLSRVNHPNIVKLYGACL--NPVCLVMEY   80 (307)
T ss_dssp             CGGGEEEEEEEECCSSSEEEEEEET-TEEEEEEECSSTT--HHHHHHHHHHHHHHCCCTTBCCEEEBCT--TTTEEEEEC
T ss_pred             CHhHeeeeeEeecCCCceEEEEEEC-CeeEEEEEecChh--HHHHHHHHHHHHhcCCCCCcCeEEEEEc--CCcEEEEEc
Confidence            3456788888999999999999975 6789999987543  4567899999999999999999999886  458999999


Q ss_pred             CCCCCHHhhhccCCC-CCCCHHHHHHHHHHHHHHHHHhhc---CCCccccccCCCceeeCCCCC-eeeecccCcccCCCC
Q 020221          135 MPNDTLAKHLFHWET-QPMKWAMRLRVALHIAEALEYCTS---KERALYHDLNAYRIVFDDDVN-PRLSCFGLMKNSRDG  209 (329)
Q Consensus       135 ~~~gsL~~~l~~~~~-~~~~~~~~~~i~~~i~~~l~~lH~---~~~ivH~dlkp~Nil~~~~~~-~kl~Dfg~a~~~~~~  209 (329)
                      +++++|.+++..... ..+++..+..++.|++.||.|||+   + |++||||||+||+++.++. +||+|||++......
T Consensus        81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~-~ivH~dlkp~NIll~~~~~~~kl~Dfg~~~~~~~~  159 (307)
T 2eva_A           81 AEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPK-ALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTH  159 (307)
T ss_dssp             CTTCBHHHHHHCSSSEECCCHHHHHHHHHHHHHHHHHHHTCSSS-CCCCCCCSGGGEEEETTTTEEEECCCCC-------
T ss_pred             CCCCCHHHHHhccCCCCccCHHHHHHHHHHHHHHHHHHHhCCCC-CeecCCCChhHEEEeCCCCEEEEcccccccccccc
Confidence            999999999974322 247889999999999999999999   7 8999999999999998887 799999998765432


Q ss_pred             -CCccCcccccCcccccCCCCCCcccchhhhHHHHHHHhCCCCCCchhhHHHhhhchhhhccccccCCCChHHHHHHHHH
Q 020221          210 -RSYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRL  288 (329)
Q Consensus       210 -~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  288 (329)
                       ....+|+.|+|||++.+..++.++||||||+++|+|++|..||..........  .. ..........+...++.+.++
T Consensus       160 ~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~--~~-~~~~~~~~~~~~~~~~~l~~l  236 (307)
T 2eva_A          160 MTNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAFRI--MW-AVHNGTRPPLIKNLPKPIESL  236 (307)
T ss_dssp             -----CCTTSSCHHHHTCCCCCTHHHHHHHHHHHHHHHHTCCTTTTTCSSHHHH--HH-HHHTTCCCCCBTTCCHHHHHH
T ss_pred             cccCCCCCceEChhhhCCCCCCcHHHHHHHHHHHHHHHHCCCCchhhCccHHHH--HH-HHhcCCCCCcccccCHHHHHH
Confidence             34468999999999999899999999999999999999998875421111100  00 001111223344567889999


Q ss_pred             HHHhcccCCCCCCCHHHHHHHHHhhhhcc
Q 020221          289 ASRCLQYEPRERPNPRSLVTALVTLQKDT  317 (329)
Q Consensus       289 i~~cl~~dp~~Rps~~~~l~~L~~~~~~~  317 (329)
                      +.+||+.||++|||+.++++.|+.+.+..
T Consensus       237 i~~~l~~dp~~Rps~~ell~~L~~~~~~~  265 (307)
T 2eva_A          237 MTRCWSKDPSQRPSMEEIVKIMTHLMRYF  265 (307)
T ss_dssp             HHHHTCSSGGGSCCHHHHHHHHHHHGGGC
T ss_pred             HHHHhcCChhhCcCHHHHHHHHHHHHHhc
Confidence            99999999999999999999999997643

>2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7

Probab=100.00  E-value=4.4e-47  Score=360.13  Aligned_cols=254  Identities=24%  Similarity=0.337  Sum_probs=212.7

Q ss_pred             CcccccccCCCCCCcEEEEEEeCCCCEEEEEEeCCCCChhHHHHHHHHHHHhcCCCccccccceeeeeCCeeEEEEecCC
Q 020221           57 AMENIVSEHGEKAPNVVYKGKLENQFRIAVKRFNRSAWPDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAEYMP  136 (329)
Q Consensus        57 ~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~  136 (329)
                      ..+++.+.||+|+||.||+|.+.++..||||+++... ...+.+.+|+++|+.++||||+++++++.+ ...++||||+.
T Consensus       267 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~-~~~~lv~e~~~  344 (535)
T 2h8h_A          267 ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYMS  344 (535)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECCCT
T ss_pred             hhhhhheecccCCCeEEEEEEECCCceEEEEEeCCCC-CCHHHHHHHHHHHHhCCCCCEeeEEEEEee-ccceEeeehhc
Confidence            3456778889999999999998887889999998755 345679999999999999999999999865 77899999999


Q ss_pred             CCCHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCCCCCeeeecccCcccCCCC-----CC
Q 020221          137 NDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDG-----RS  211 (329)
Q Consensus       137 ~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~-----~~  211 (329)
                      +|+|.+++.......+++.++..++.||+.||+|||++ +++||||||+|||++.++.+||+|||+++.....     ..
T Consensus       345 ~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~-~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~  423 (535)
T 2h8h_A          345 KGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERM-NYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQG  423 (535)
T ss_dssp             TEEHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHT-TCCCSCCSGGGEEECGGGCEEECCTTSTTTCCCHHHHTTCS
T ss_pred             CCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhC-CeeCCCCCHhhEEEcCCCcEEEcccccceecCCCceecccC
Confidence            99999999643345689999999999999999999999 9999999999999999999999999999865432     23


Q ss_pred             ccCcccccCcccccCCCCCCcccchhhhHHHHHHHh-CCCCCCchhhHHHhhhchhhhccccccCCCChHHHHHHHHHHH
Q 020221          212 YSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLS-GKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLAS  290 (329)
Q Consensus       212 ~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t-g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~  290 (329)
                      ..++..|+|||++.+..++.++||||||+++|||++ |..||.......+.....     ...+...+..+++++.+||.
T Consensus       424 ~~~~~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~t~g~~P~~~~~~~~~~~~i~-----~~~~~~~~~~~~~~l~~li~  498 (535)
T 2h8h_A          424 AKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVE-----RGYRMPCPPECPESLHDLMC  498 (535)
T ss_dssp             TTSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTTCCSSTTCCHHHHHHHHH-----TTCCCCCCTTCCHHHHHHHH
T ss_pred             CcCcccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHH-----cCCCCCCCCCCCHHHHHHHH
Confidence            345788999999998899999999999999999999 787776543332222211     11222345567889999999


Q ss_pred             HhcccCCCCCCCHHHHHHHHHhhhhccc
Q 020221          291 RCLQYEPRERPNPRSLVTALVTLQKDTE  318 (329)
Q Consensus       291 ~cl~~dp~~Rps~~~~l~~L~~~~~~~~  318 (329)
                      +||+.||++|||+.+|++.|+.+....+
T Consensus       499 ~cl~~dP~~RPt~~~l~~~L~~~~~~~~  526 (535)
T 2h8h_A          499 QCWRKEPEERPTFEYLQAFLEDYFTSTE  526 (535)
T ss_dssp             HHTCSSGGGSCCHHHHHHHHHTSSCCCS
T ss_pred             HHcCCChhHCcCHHHHHHHHHHHhhccC
Confidence            9999999999999999999999876543

>3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens}

Probab=100.00  E-value=2.9e-47  Score=339.86  Aligned_cols=249  Identities=18%  Similarity=0.258  Sum_probs=195.0

Q ss_pred             CcccccccCCCCCCcEEEEEEe-CCCCEEEEEEeCCCCChhH-HHHHHHHHHHhcCCCccccccceeeeeCCeeEEEEec
Q 020221           57 AMENIVSEHGEKAPNVVYKGKL-ENQFRIAVKRFNRSAWPDA-RQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAEY  134 (329)
Q Consensus        57 ~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~-~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  134 (329)
                      +.|.+++.||+|+||+||+|.. .+++.||+|++........ ..+.+|+++++.++||||+++++++...+..++||||
T Consensus         2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~   81 (324)
T 3mtl_A            2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEY   81 (324)
T ss_dssp             CSEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECC------CCCCCCCHHHHSCCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred             CceEEEEEEcCCCCEEEEEEEECCCCcEEEEEEEecccccccchhHHHHHHHHHhcCCCCCCeeeeEEeeCCEEEEEecc
Confidence            5678889999999999999995 4788999999976542211 1355799999999999999999999999999999999


Q ss_pred             CCCCCHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCCCCCeeeecccCcccCCCC----C
Q 020221          135 MPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDG----R  210 (329)
Q Consensus       135 ~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~----~  210 (329)
                      +++ +|.+++.. ....+++..+..++.|++.||.|||+. |++||||||+||+++.++.+||+|||++......    .
T Consensus        82 ~~~-~l~~~~~~-~~~~~~~~~~~~~~~qi~~aL~~LH~~-~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~~~~~  158 (324)
T 3mtl_A           82 LDK-DLKQYLDD-CGNIINMHNVKLFLFQLLRGLAYCHRQ-KVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYD  158 (324)
T ss_dssp             CSE-EHHHHHHH-TTTCCCHHHHHHHHHHHHHHHHHHHHT-TEEESSCCGGGEEECTTCCEEECSSSEEECC--------
T ss_pred             ccc-CHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHHC-CccCCCcCHHHEEECCCCCEEEccCcccccccCCccccc
Confidence            975 89998865 345689999999999999999999999 9999999999999999999999999998754432    2


Q ss_pred             CccCcccccCcccccC-CCCCCcccchhhhHHHHHHHhCCCCCCchhhHHHhhhchhhhccc-------ccc--------
Q 020221          211 SYSTNLAFTPPEYLRT-GRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDS-------CLE--------  274 (329)
Q Consensus       211 ~~~~~~~y~aPE~~~~-~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~-------~~~--------  274 (329)
                      ...+|+.|+|||++.+ ..++.++||||||+++|+|++|..||..................+       ...        
T Consensus       159 ~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~  238 (324)
T 3mtl_A          159 NEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNEEFKTYN  238 (324)
T ss_dssp             ----CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGCHHHHHTC
T ss_pred             cccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHhchhhhcchhhcccc
Confidence            3457899999999876 458999999999999999999999887654332221111100000       000        


Q ss_pred             --C-------CCChHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 020221          275 --G-------QFSSDEGTELVRLASRCLQYEPRERPNPRSLVT  308 (329)
Q Consensus       275 --~-------~~~~~~~~~~~~li~~cl~~dp~~Rps~~~~l~  308 (329)
                        .       ......++++.+|+.+||+.||++|||+.++++
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~  281 (324)
T 3mtl_A          239 YPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMK  281 (324)
T ss_dssp             CCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred             cccccchhhhhhcCCCCHHHHHHHHHHcCcCcccCCCHHHHhc
Confidence              0       001234678999999999999999999999998

>1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=3.6e-47  Score=341.79  Aligned_cols=256  Identities=21%  Similarity=0.280  Sum_probs=206.4

Q ss_pred             CcccccccCCCCCCcEEEEEEe------CCCCEEEEEEeCCCC-ChhHHHHHHHHHHHhcC-CCccccccceeeeeCCee
Q 020221           57 AMENIVSEHGEKAPNVVYKGKL------ENQFRIAVKRFNRSA-WPDARQFLEEARAVGQL-RNRRLANLLGCCCEGDER  128 (329)
Q Consensus        57 ~~~~~~~~lg~G~~g~V~~~~~------~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~  128 (329)
                      ..+++.+.||+|+||.||+|..      .++..||+|++.... ....+.+.+|+.+++.+ +||||+++++++...+..
T Consensus        45 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~  124 (344)
T 1rjb_A           45 ENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSGPI  124 (344)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred             HHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEecccccCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEeeCCcc
Confidence            4567788889999999999984      245679999997643 22345789999999999 899999999999999999


Q ss_pred             EEEEecCCCCCHHhhhccCCC---------------------CCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCce
Q 020221          129 LLVAEYMPNDTLAKHLFHWET---------------------QPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRI  187 (329)
Q Consensus       129 ~lv~e~~~~gsL~~~l~~~~~---------------------~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Ni  187 (329)
                      ++||||+++|+|.+++.....                     ..+++..++.++.||+.||.|||+. |++||||||+||
T Consensus       125 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~-~ivH~Dikp~NI  203 (344)
T 1rjb_A          125 YLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFK-SCVHRDLAARNV  203 (344)
T ss_dssp             EEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHT-TEEETTCSGGGE
T ss_pred             EEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHhC-CcccCCCChhhE
Confidence            999999999999999975322                     2378999999999999999999999 999999999999


Q ss_pred             eeCCCCCeeeecccCcccCCCCC------CccCcccccCcccccCCCCCCcccchhhhHHHHHHHh-CCCCCCchhhHHH
Q 020221          188 VFDDDVNPRLSCFGLMKNSRDGR------SYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLS-GKHIPPSHALDLI  260 (329)
Q Consensus       188 l~~~~~~~kl~Dfg~a~~~~~~~------~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t-g~~~~~~~~~~~~  260 (329)
                      +++.++.+||+|||++.......      ...+|+.|+|||.+.+..++.++||||||+++|+|+| |..||........
T Consensus       204 ll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~  283 (344)
T 1rjb_A          204 LVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPVDAN  283 (344)
T ss_dssp             EEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHH
T ss_pred             EEcCCCcEEeCCCccCcccccCccceeccCccCccCccCHHHhccCCCChhHhHHHHHHHHHHHHcCCCCCcccCCcHHH
Confidence            99999999999999997654332      2345678999999998889999999999999999998 8877755322111


Q ss_pred             hhhchhhhccccccCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhhcc
Q 020221          261 RDRNIQTLTDSCLEGQFSSDEGTELVRLASRCLQYEPRERPNPRSLVTALVTLQKDT  317 (329)
Q Consensus       261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~~~l~~L~~~~~~~  317 (329)
                      ..    ...........+...++++.+++.+||+.||++|||+.++++.|+.+....
T Consensus       284 ~~----~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~~  336 (344)
T 1rjb_A          284 FY----KLIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLGCQLADA  336 (344)
T ss_dssp             HH----HHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC---
T ss_pred             HH----HHHhcCCCCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHHHH
Confidence            11    111111223345556789999999999999999999999999999987653

>3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii}

Probab=100.00  E-value=1.9e-46  Score=328.59  Aligned_cols=246  Identities=15%  Similarity=0.189  Sum_probs=199.4

Q ss_pred             cccccccCCCCCCcEEEEEE-eCCCCEEEEEEeCCCC-ChhHHHHHHHHHHHhcCCCccccccceeeeeCCeeEEEEecC
Q 020221           58 MENIVSEHGEKAPNVVYKGK-LENQFRIAVKRFNRSA-WPDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAEYM  135 (329)
Q Consensus        58 ~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~  135 (329)
                      .|.+.+.||+|+||.||++. ..++..+|+|++.... ....+.+.+|+++++.++||||+++++++.+....++||||+
T Consensus        23 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~  102 (285)
T 3is5_A           23 LFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEVFEDYHNMYIVMETC  102 (285)
T ss_dssp             HEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECCC
T ss_pred             heeecceeccCCCeEEEEEEEccCCceEEEEEeeccccchhHHHHHHHHHHHHhCCCchHHhHHHheecCCeEEEEEEeC
Confidence            36777888999999999999 4568899999987653 234677899999999999999999999999999999999999


Q ss_pred             CCCCHHhhhccC--CCCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceee---CCCCCeeeecccCcccCCCC-
Q 020221          136 PNDTLAKHLFHW--ETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVF---DDDVNPRLSCFGLMKNSRDG-  209 (329)
Q Consensus       136 ~~gsL~~~l~~~--~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~---~~~~~~kl~Dfg~a~~~~~~-  209 (329)
                      ++++|.+++...  ....+++..++.++.|++.||.|||+. |++|+||||+||++   +.++.+||+|||++...... 
T Consensus       103 ~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~-~ivH~dikp~NIl~~~~~~~~~~kl~Dfg~a~~~~~~~  181 (285)
T 3is5_A          103 EGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQ-HVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSDE  181 (285)
T ss_dssp             SCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHT-TCCCCCCSGGGEEESSSSTTCCEEECCCCCCCC-----
T ss_pred             CCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHHhC-CEEECCCCHHHEEEecCCCCCCEEEEeeecceecCCcc
Confidence            999999988532  236799999999999999999999999 99999999999999   45688999999999765433 


Q ss_pred             --CCccCcccccCcccccCCCCCCcccchhhhHHHHHHHhCCCCCCchhhHHHhhhchhhhccccccCCCChHHHHHHHH
Q 020221          210 --RSYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVR  287 (329)
Q Consensus       210 --~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  287 (329)
                        ....+++.|+|||.+. ..++.++||||||+++|+|++|..||...................  . ......++++.+
T Consensus       182 ~~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~--~-~~~~~~~~~~~~  257 (285)
T 3is5_A          182 HSTNAAGTALYMAPEVFK-RDVTFKCDIWSAGVVMYFLLTGCLPFTGTSLEEVQQKATYKEPNY--A-VECRPLTPQAVD  257 (285)
T ss_dssp             -----CTTGGGCCHHHHT-TCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCC--C-C--CCCCHHHHH
T ss_pred             cCcCcccccCcCChHHhc-cCCCcccCeehHHHHHHHHHhCCCCCCCCCHHHHHhhhccCCccc--c-cccCcCCHHHHH
Confidence              3446789999999986 568889999999999999999999887654443332221111110  0 111224678999


Q ss_pred             HHHHhcccCCCCCCCHHHHHH
Q 020221          288 LASRCLQYEPRERPNPRSLVT  308 (329)
Q Consensus       288 li~~cl~~dp~~Rps~~~~l~  308 (329)
                      ++.+||+.||++|||+.++++
T Consensus       258 li~~~L~~dP~~Rps~~e~l~  278 (285)
T 3is5_A          258 LLKQMLTKDPERRPSAAQVLH  278 (285)
T ss_dssp             HHHHHTCSCTTTSCCHHHHHT
T ss_pred             HHHHHccCChhhCcCHHHHhc
Confidence            999999999999999999998

>3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A

Probab=100.00  E-value=2.8e-47  Score=340.01  Aligned_cols=239  Identities=17%  Similarity=0.218  Sum_probs=179.0

Q ss_pred             ccCCCCCCcEEEEEEe-CCCCEEEEEEeCCCCChhHHHHHHHHHHHhcCC-CccccccceeeeeCCeeEEEEecCCCCCH
Q 020221           63 SEHGEKAPNVVYKGKL-ENQFRIAVKRFNRSAWPDARQFLEEARAVGQLR-NRRLANLLGCCCEGDERLLVAEYMPNDTL  140 (329)
Q Consensus        63 ~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~~~~lv~e~~~~gsL  140 (329)
                      +.||+|+||+||++.. .+++.||+|++...   ....+.+|+.+++.+. ||||+++++++.+....++||||+++|+|
T Consensus        17 ~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~e~~~l~~l~~h~niv~~~~~~~~~~~~~lv~e~~~~~~L   93 (325)
T 3kn6_A           17 KPLGEGSFSICRKCVHKKSNQAFAVKIISKR---MEANTQKEITALKLCEGHPNIVKLHEVFHDQLHTFLVMELLNGGEL   93 (325)
T ss_dssp             CCSEEETTEEEEEEEETTTCCEEEEEEEEGG---GHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEECCCCSCBH
T ss_pred             CccccCCCeEEEEEEECCCCCEEEEEEEChh---hhhhHHHHHHHHHHhcCCCCeeEEEEEEEcCCEEEEEEEccCCCcH
Confidence            5689999999999994 56889999999653   3456788999999997 99999999999999999999999999999


Q ss_pred             HhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCCCC---CeeeecccCcccCCCC----CCcc
Q 020221          141 AKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDV---NPRLSCFGLMKNSRDG----RSYS  213 (329)
Q Consensus       141 ~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~---~~kl~Dfg~a~~~~~~----~~~~  213 (329)
                      .+++..  ...+++..+..++.|++.||.|||++ +++||||||+||+++.++   .+||+|||++......    ....
T Consensus        94 ~~~l~~--~~~~~~~~~~~i~~qi~~~l~~LH~~-~ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~  170 (325)
T 3kn6_A           94 FERIKK--KKHFSETEASYIMRKLVSAVSHMHDV-GVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPLKTPC  170 (325)
T ss_dssp             HHHHHH--CSCCCHHHHHHHHHHHHHHHHHHHHT-TEECCCCCGGGEEEEC----CEEEECCCTTCEECCC---------
T ss_pred             HHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHC-CCeecCCCHHHEEEecCCCcccEEEeccccceecCCCCCcccccC
Confidence            999974  46799999999999999999999999 999999999999997665   7999999999765433    2345


Q ss_pred             CcccccCcccccCCCCCCcccchhhhHHHHHHHhCCCCCCchhhHHHhhhchhhhccccccCC--CC----hHHHHHHHH
Q 020221          214 TNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQ--FS----SDEGTELVR  287 (329)
Q Consensus       214 ~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~----~~~~~~~~~  287 (329)
                      +|+.|+|||++.+..++.++||||||+++|+|++|..||......... ..............  .+    ...++++.+
T Consensus       171 ~t~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~-~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~  249 (325)
T 3kn6_A          171 FTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTC-TSAVEIMKKIKKGDFSFEGEAWKNVSQEAKD  249 (325)
T ss_dssp             -------------CCCCHHHHHHHHHHHHHHHHHSSCTTC-------C-CCHHHHHHHHTTTCCCCCSHHHHTSCHHHHH
T ss_pred             CCcCccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCcccccc-ccHHHHHHHHHcCCCCCCcccccCCCHHHHH
Confidence            789999999999989999999999999999999999888653221100 00001111111111  11    235789999


Q ss_pred             HHHHhcccCCCCCCCHHHHHH
Q 020221          288 LASRCLQYEPRERPNPRSLVT  308 (329)
Q Consensus       288 li~~cl~~dp~~Rps~~~~l~  308 (329)
                      |+.+||..||++|||+.++++
T Consensus       250 li~~~L~~dP~~Rpt~~ell~  270 (325)
T 3kn6_A          250 LIQGLLTVDPNKRLKMSGLRY  270 (325)
T ss_dssp             HHHHHHCCCTTTCCCTTTSTT
T ss_pred             HHHHHCCCChhHCCCHHHHhc
Confidence            999999999999999999986

>3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A*

Probab=100.00  E-value=2.6e-47  Score=340.24  Aligned_cols=253  Identities=17%  Similarity=0.264  Sum_probs=205.1

Q ss_pred             CcccccccCCCCCCcEEEEEEe-CCCCE----EEEEEeCCCC-ChhHHHHHHHHHHHhcCCCccccccceeeeeCCeeEE
Q 020221           57 AMENIVSEHGEKAPNVVYKGKL-ENQFR----IAVKRFNRSA-WPDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLL  130 (329)
Q Consensus        57 ~~~~~~~~lg~G~~g~V~~~~~-~~~~~----vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l  130 (329)
                      ..|++++.||+|+||+||+|.. .+++.    ||+|.+.... ....+.+.+|+.+++.++||||+++++++. ....++
T Consensus        13 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~   91 (325)
T 3kex_A           13 TELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRLLGLCP-GSSLQL   91 (325)
T ss_dssp             TTEEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTTSCSCBCSCCHHHHHHHTCCCTTBCCEEEEEC-BSSEEE
T ss_pred             hHceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEeccccccHHHHHHHHHHHHHHhcCCCCCcCeEEEEEc-CCccEE
Confidence            4577888899999999999984 44544    8888876543 222345778999999999999999999885 567899


Q ss_pred             EEecCCCCCHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCCCCCeeeecccCcccCCCCC
Q 020221          131 VAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDGR  210 (329)
Q Consensus       131 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~  210 (329)
                      ||||+.+|+|.+++.. ....+++..+..++.|++.||.|||+. |++||||||+|||++.++.+||+|||+++......
T Consensus        92 v~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~~qi~~~l~~lH~~-~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~~~~  169 (325)
T 3kex_A           92 VTQYLPLGSLLDHVRQ-HRGALGPQLLLNWGVQIAKGMYYLEEH-GMVHRNLAARNVLLKSPSQVQVADFGVADLLPPDD  169 (325)
T ss_dssp             EEECCTTCBSHHHHHS-SGGGSCTTHHHHHHHHHHHHHHHHHHT-TCCCSCCSSTTEEESSSSCEEECSCSGGGGSCCCT
T ss_pred             EEEeCCCCCHHHHHHH-ccccCCHHHHHHHHHHHHHHHHHHHhC-CCCCCccchheEEECCCCeEEECCCCcccccCccc
Confidence            9999999999999964 345789999999999999999999999 99999999999999999999999999998754432


Q ss_pred             ------CccCcccccCcccccCCCCCCcccchhhhHHHHHHHh-CCCCCCchhhHHHhhhchhhhccccccCCCChHHHH
Q 020221          211 ------SYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLS-GKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGT  283 (329)
Q Consensus       211 ------~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t-g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  283 (329)
                            ...++..|+|||++.+..++.++||||||+++|+|++ |..||...........     .........+..++.
T Consensus       170 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~-----~~~~~~~~~~~~~~~  244 (325)
T 3kex_A          170 KQLLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLAEVPDL-----LEKGERLAQPQICTI  244 (325)
T ss_dssp             TCCC-----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCTTHHHHH-----HHTTCBCCCCTTBCT
T ss_pred             ccccccCCCCcccccChHHhccCCCChhhHhHHhHHHHHHHHhCCCCCccccCHHHHHHH-----HHcCCCCCCCCcCcH
Confidence                  2346778999999998899999999999999999999 8888765432222211     111112233445667


Q ss_pred             HHHHHHHHhcccCCCCCCCHHHHHHHHHhhhhcc
Q 020221          284 ELVRLASRCLQYEPRERPNPRSLVTALVTLQKDT  317 (329)
Q Consensus       284 ~~~~li~~cl~~dp~~Rps~~~~l~~L~~~~~~~  317 (329)
                      ++.+++.+||+.||++|||+.++++.|+++.+..
T Consensus       245 ~~~~li~~~l~~dp~~Rps~~el~~~l~~~~~~~  278 (325)
T 3kex_A          245 DVYMVMVKCWMIDENIRPTFKELANEFTRMARDP  278 (325)
T ss_dssp             TTTHHHHHHTCSCTTTSCCHHHHHHHHHHHTTSH
T ss_pred             HHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhcc
Confidence            8899999999999999999999999999997653

>3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens}

Probab=100.00  E-value=9.5e-47  Score=337.95  Aligned_cols=237  Identities=19%  Similarity=0.195  Sum_probs=200.7

Q ss_pred             CcccccccCCCCCCcEEEEEE-eCCCCEEEEEEeCCCCCh--------hHHHHHHHHHHHhcCCCccccccceeeeeCCe
Q 020221           57 AMENIVSEHGEKAPNVVYKGK-LENQFRIAVKRFNRSAWP--------DARQFLEEARAVGQLRNRRLANLLGCCCEGDE  127 (329)
Q Consensus        57 ~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~--------~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~  127 (329)
                      ..|++++.||+|+||+||+|. ..+++.||+|++......        ..+.+.+|+.+++.++||||+++++++.+.+.
T Consensus        24 ~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~  103 (335)
T 3dls_A           24 QKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFENQGF  103 (335)
T ss_dssp             HHEEEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEEECSSE
T ss_pred             cceEEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEeeCCE
Confidence            457788889999999999998 567889999999765321        22346789999999999999999999999999


Q ss_pred             eEEEEecCCCC-CHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCCCCCeeeecccCcccC
Q 020221          128 RLLVAEYMPND-TLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNS  206 (329)
Q Consensus       128 ~~lv~e~~~~g-sL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~  206 (329)
                      .++||||+.+| +|.+++.  ....+++..+..++.|++.||.|||++ |++||||||+||+++.++.+||+|||++...
T Consensus       104 ~~lv~e~~~~g~~l~~~~~--~~~~l~~~~~~~i~~qi~~~L~~LH~~-~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~  180 (335)
T 3dls_A          104 FQLVMEKHGSGLDLFAFID--RHPRLDEPLASYIFRQLVSAVGYLRLK-DIIHRDIKDENIVIAEDFTIKLIDFGSAAYL  180 (335)
T ss_dssp             EEEEEECCTTSCBHHHHHH--TCCCCCHHHHHHHHHHHHHHHHHHHHT-TEECSCCSGGGEEECTTSCEEECCCTTCEEC
T ss_pred             EEEEEEeCCCCccHHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHhC-CeEEeccCHHHEEEcCCCcEEEeecccceEC
Confidence            99999999776 9999986  445799999999999999999999999 9999999999999999999999999999876


Q ss_pred             CCCC---CccCcccccCcccccCCCC-CCcccchhhhHHHHHHHhCCCCCCchhhHHHhhhchhhhccccccCCCChHHH
Q 020221          207 RDGR---SYSTNLAFTPPEYLRTGRV-TPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEG  282 (329)
Q Consensus       207 ~~~~---~~~~~~~y~aPE~~~~~~~-~~~~DvwslG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  282 (329)
                      ....   ...||+.|+|||++.+..+ +.++||||||+++|+|++|..||....          ......  ...+...+
T Consensus       181 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~----------~~~~~~--~~~~~~~~  248 (335)
T 3dls_A          181 ERGKLFYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELE----------ETVEAA--IHPPYLVS  248 (335)
T ss_dssp             CTTCCBCEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSSGG----------GGTTTC--CCCSSCCC
T ss_pred             CCCCceeccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhhHH----------HHHhhc--cCCCcccC
Confidence            5443   3468999999999998876 778999999999999999998875421          011111  11233457


Q ss_pred             HHHHHHHHHhcccCCCCCCCHHHHHH
Q 020221          283 TELVRLASRCLQYEPRERPNPRSLVT  308 (329)
Q Consensus       283 ~~~~~li~~cl~~dp~~Rps~~~~l~  308 (329)
                      +++.+++.+||+.||++|||+.++++
T Consensus       249 ~~l~~li~~~L~~dP~~Rps~~ell~  274 (335)
T 3dls_A          249 KELMSLVSGLLQPVPERRTTLEKLVT  274 (335)
T ss_dssp             HHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             HHHHHHHHHHccCChhhCcCHHHHhc
Confidence            78999999999999999999999998

>1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=2.9e-46  Score=338.84  Aligned_cols=247  Identities=16%  Similarity=0.227  Sum_probs=194.2

Q ss_pred             CcccccccCCCCCCcEEEEEEe-CCCCEEEEEEeCCCCC--hhHHHHHHHHHHHhcCCCccccccceeeeeC------Ce
Q 020221           57 AMENIVSEHGEKAPNVVYKGKL-ENQFRIAVKRFNRSAW--PDARQFLEEARAVGQLRNRRLANLLGCCCEG------DE  127 (329)
Q Consensus        57 ~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~------~~  127 (329)
                      ..|++++.||+|+||.||+|.. .+|+.||||++.....  ...+.+.+|+++++.++||||+++++++...      ..
T Consensus        25 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~~  104 (367)
T 1cm8_A           25 AVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFTD  104 (367)
T ss_dssp             SSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCCC
T ss_pred             ceEEEeEEeeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCCccccCce
Confidence            4577888899999999999994 6789999999965432  2345688999999999999999999998765      34


Q ss_pred             eEEEEecCCCCCHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCCCCCeeeecccCcccCC
Q 020221          128 RLLVAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSR  207 (329)
Q Consensus       128 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~  207 (329)
                      .++||||+ +++|.+++..   ..+++..+..++.||+.||+|||+. |++||||||+||+++.++.+||+|||+++...
T Consensus       105 ~~lv~e~~-~~~L~~~~~~---~~l~~~~~~~~~~qi~~~L~~LH~~-~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~  179 (367)
T 1cm8_A          105 FYLVMPFM-GTDLGKLMKH---EKLGEDRIQFLVYQMLKGLRYIHAA-GIIHRDLKPGNLAVNEDCELKILDFGLARQAD  179 (367)
T ss_dssp             CEEEEECC-SEEHHHHHHH---CCCCHHHHHHHHHHHHHHHHHHHHT-TEECCCCCGGGEEECTTCCEEECCCTTCEECC
T ss_pred             EEEEEecC-CCCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHC-CccccCcCHHHEEEcCCCCEEEEeeecccccc
Confidence            69999999 7799999853   5689999999999999999999999 99999999999999999999999999998754


Q ss_pred             CC-CCccCcccccCcccccC-CCCCCcccchhhhHHHHHHHhCCCCCCchhhHHHhhhchhh------------------
Q 020221          208 DG-RSYSTNLAFTPPEYLRT-GRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQT------------------  267 (329)
Q Consensus       208 ~~-~~~~~~~~y~aPE~~~~-~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~~~~~~~~------------------  267 (329)
                      .. ....+|+.|+|||++.+ ..++.++|||||||+++||++|+.||...............                  
T Consensus       180 ~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~~~~~~~~~~  259 (367)
T 1cm8_A          180 SEMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSDEAK  259 (367)
T ss_dssp             SSCCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHTCSCHHHH
T ss_pred             cccCcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHhhhHHHH
Confidence            43 34578999999999887 67999999999999999999999988754322111110000                  


Q ss_pred             -h---cccccc---CCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 020221          268 -L---TDSCLE---GQFSSDEGTELVRLASRCLQYEPRERPNPRSLVT  308 (329)
Q Consensus       268 -~---~~~~~~---~~~~~~~~~~~~~li~~cl~~dp~~Rps~~~~l~  308 (329)
                       .   ......   .......++++.+|+.+||..||++|||+.++++
T Consensus       260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~mL~~dP~~R~t~~e~l~  307 (367)
T 1cm8_A          260 NYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALA  307 (367)
T ss_dssp             HHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred             HHHHhCCCCCCCCHHHHCCCCCHHHHHHHHHHccCChhHCCCHHHHhc
Confidence             0   000000   0122345788999999999999999999999998

>3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ...

Probab=100.00  E-value=2.6e-46  Score=329.56  Aligned_cols=254  Identities=22%  Similarity=0.300  Sum_probs=204.4

Q ss_pred             CcccccccCCCCCCcEEEEEEeCC----CCEEEEEEeCCCCC-hhHHHHHHHHHHHhcCCCccccccceeee-eCCeeEE
Q 020221           57 AMENIVSEHGEKAPNVVYKGKLEN----QFRIAVKRFNRSAW-PDARQFLEEARAVGQLRNRRLANLLGCCC-EGDERLL  130 (329)
Q Consensus        57 ~~~~~~~~lg~G~~g~V~~~~~~~----~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~-~~~~~~l  130 (329)
                      ..+++.+.||+|+||+||+|...+    ...+|+|.+..... ...+.+.+|+.+++.++||||+++++++. ..+..++
T Consensus        25 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~  104 (298)
T 3f66_A           25 LIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLV  104 (298)
T ss_dssp             EEEEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEE
T ss_pred             eehhhcceeeecCCceEEEEEEecCCCceeEEEEEecccCCCHHHHHHHHHHHHHHHhCCCCCEeeeeeEEEcCCCceEE
Confidence            446777889999999999998432    23589999886543 33567899999999999999999999854 4568899


Q ss_pred             EEecCCCCCHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCCCCCeeeecccCcccCCCC-
Q 020221          131 VAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDG-  209 (329)
Q Consensus       131 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~-  209 (329)
                      ||||+++|+|.+++.. ....+++..+..++.|++.||.|||++ +++||||||+||+++.++.+||+|||++...... 
T Consensus       105 v~e~~~~~~L~~~l~~-~~~~~~~~~~~~i~~ql~~~l~~lH~~-~i~H~dikp~Nil~~~~~~~kl~Dfg~a~~~~~~~  182 (298)
T 3f66_A          105 VLPYMKHGDLRNFIRN-ETHNPTVKDLIGFGLQVAKGMKYLASK-KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKE  182 (298)
T ss_dssp             EEECCTTCBHHHHHHC-TTCCCCHHHHHHHHHHHHHHHHHHHHT-TCCCSCCSGGGEEECTTCCEEECSCGGGCCCSCGG
T ss_pred             EEeCCCCCCHHHHHHh-cccCCCHHHHHHHHHHHHHHHHHHHhC-CccCCCCchheEEECCCCCEEECcccccccccccc
Confidence            9999999999999964 456789999999999999999999999 9999999999999999999999999999765432 


Q ss_pred             -------CCccCcccccCcccccCCCCCCcccchhhhHHHHHHHhCCCCCCchh-hHHHhhhchhhhccccccCCCChHH
Q 020221          210 -------RSYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHA-LDLIRDRNIQTLTDSCLEGQFSSDE  281 (329)
Q Consensus       210 -------~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~  281 (329)
                             ....+++.|+|||.+.+..++.++||||||+++|+|++|..|+.... .........     .......+...
T Consensus       183 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~~~~~~~~~-----~~~~~~~~~~~  257 (298)
T 3f66_A          183 YYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLL-----QGRRLLQPEYC  257 (298)
T ss_dssp             GCBC-----CCBCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTSCTTTHHHHHH-----TTCCCCCCTTC
T ss_pred             hhccccccCCCCCccccChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCccCCHHHHHHHHh-----cCCCCCCCccC
Confidence                   22345678999999998899999999999999999999665543321 111111111     11122234456


Q ss_pred             HHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhhcc
Q 020221          282 GTELVRLASRCLQYEPRERPNPRSLVTALVTLQKDT  317 (329)
Q Consensus       282 ~~~~~~li~~cl~~dp~~Rps~~~~l~~L~~~~~~~  317 (329)
                      ++++.+++.+||+.||++|||+.++++.|+.+....
T Consensus       258 ~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~~~  293 (298)
T 3f66_A          258 PDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTF  293 (298)
T ss_dssp             CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTS
T ss_pred             CHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhh
Confidence            778999999999999999999999999999987754

>3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A*

Probab=100.00  E-value=7.2e-47  Score=338.00  Aligned_cols=251  Identities=17%  Similarity=0.225  Sum_probs=194.7

Q ss_pred             cCCCcccccccCCCCCCcEEEEEE-eCCCCEEEEEEeCCCCChh--HHHHHHHHHHHhcCCCccccccceeeeeCCeeEE
Q 020221           54 SGFAMENIVSEHGEKAPNVVYKGK-LENQFRIAVKRFNRSAWPD--ARQFLEEARAVGQLRNRRLANLLGCCCEGDERLL  130 (329)
Q Consensus        54 ~~~~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~--~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l  130 (329)
                      ..+..|++++.||+|+||+||++. ..+++.||+|++.......  .+.+.+|+++++.++||||+++++++.+....++
T Consensus        31 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l  110 (329)
T 3gbz_A           31 TSIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSVIHHNHRLHL  110 (329)
T ss_dssp             -CGGGEEEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC--------CHHHHHHGGGCCCTTBCCEEEEEEETTEEEE
T ss_pred             cchhhEEEEEEEEecCCeEEEEEEECCCCceEEEEEEcccccccccchhHHHHHHHHHHcCCCCcceEEEEEecCCEEEE
Confidence            345678889999999999999998 5578899999997654322  3457899999999999999999999999999999


Q ss_pred             EEecCCCCCHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeC-----CCCCeeeecccCccc
Q 020221          131 VAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFD-----DDVNPRLSCFGLMKN  205 (329)
Q Consensus       131 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~-----~~~~~kl~Dfg~a~~  205 (329)
                      ||||+++ +|.+++..  ...+++..+..++.||+.||.|||++ +|+||||||+|||++     .++.+||+|||++..
T Consensus       111 v~e~~~~-~L~~~~~~--~~~~~~~~~~~i~~ql~~~l~~LH~~-~ivH~Dlkp~NIll~~~~~~~~~~~kl~Dfg~a~~  186 (329)
T 3gbz_A          111 IFEYAEN-DLKKYMDK--NPDVSMRVIKSFLYQLINGVNFCHSR-RCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARA  186 (329)
T ss_dssp             EEECCSE-EHHHHHHH--CTTCCHHHHHHHHHHHHHHHHHHHHT-TCCCSCCCGGGEEEEC-----CCEEEECCTTHHHH
T ss_pred             EEecCCC-CHHHHHhh--cCCCCHHHHHHHHHHHHHHHHHHHhC-CEECCCCCHHHEEEecCCCCccceEEECcCCCccc
Confidence            9999985 99999873  45699999999999999999999999 999999999999994     455699999999876


Q ss_pred             CCCC----CCccCcccccCcccccCCC-CCCcccchhhhHHHHHHHhCCCCCCchhhHHHhhhchhhhcccc--------
Q 020221          206 SRDG----RSYSTNLAFTPPEYLRTGR-VTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSC--------  272 (329)
Q Consensus       206 ~~~~----~~~~~~~~y~aPE~~~~~~-~~~~~DvwslG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~--------  272 (329)
                      ....    ....+|+.|+|||++.+.. ++.++||||||+++|+|++|..||..................+.        
T Consensus       187 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  266 (329)
T 3gbz_A          187 FGIPIRQFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEIDQLFKIFEVLGLPDDTTWPGVT  266 (329)
T ss_dssp             HC-----------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSTTGG
T ss_pred             cCCcccccCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcCCCCHHHHHHHHHHHhCCCchhhhhhhh
Confidence            4422    2345689999999998754 89999999999999999999998875433222111111000000        


Q ss_pred             ----ccCC------------CChHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 020221          273 ----LEGQ------------FSSDEGTELVRLASRCLQYEPRERPNPRSLVT  308 (329)
Q Consensus       273 ----~~~~------------~~~~~~~~~~~li~~cl~~dp~~Rps~~~~l~  308 (329)
                          ....            .+...++++.+|+.+||+.||++|||+.++++
T Consensus       267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~  318 (329)
T 3gbz_A          267 ALPDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALE  318 (329)
T ss_dssp             GSTTCCTTCCCCCCCCHHHHHGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             hhhhhhhhhhhhccccHhhhcccccCHHHHHHHHHHccCChhhCCCHHHHhC
Confidence                0000            01125678999999999999999999999998

>2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens}

Probab=100.00  E-value=1.1e-46  Score=336.37  Aligned_cols=259  Identities=19%  Similarity=0.293  Sum_probs=211.8

Q ss_pred             CcccccccCCCCCCcEEEEEEe-----CCCCEEEEEEeCCCCChhHHHHHHHHHHHhcCCCccccccceeeeeCC--eeE
Q 020221           57 AMENIVSEHGEKAPNVVYKGKL-----ENQFRIAVKRFNRSAWPDARQFLEEARAVGQLRNRRLANLLGCCCEGD--ERL  129 (329)
Q Consensus        57 ~~~~~~~~lg~G~~g~V~~~~~-----~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~--~~~  129 (329)
                      ..+++++.||+|+||.||++.+     .+++.||+|++........+.+.+|+++++.++||||+++++++...+  ..+
T Consensus        41 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~  120 (326)
T 2w1i_A           41 RHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLK  120 (326)
T ss_dssp             GGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSCCSHHHHHHHHHHHHHHTCCCTTBCCEEEEECC----CCE
T ss_pred             HHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEecCCCceE
Confidence            3467888999999999999983     368899999998876666778999999999999999999999886543  789


Q ss_pred             EEEecCCCCCHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCCCCCeeeecccCcccCCCC
Q 020221          130 LVAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDG  209 (329)
Q Consensus       130 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~  209 (329)
                      +||||+++++|.+++.. ....+++..++.++.|++.||.|||+. +++|+||||+||+++.++.+||+|||++......
T Consensus       121 lv~e~~~~~~L~~~l~~-~~~~~~~~~~~~i~~qi~~aL~~LH~~-~ivH~dikp~NIli~~~~~~kL~Dfg~~~~~~~~  198 (326)
T 2w1i_A          121 LIMEYLPYGSLRDYLQK-HKERIDHIKLLQYTSQICKGMEYLGTK-RYIHRDLATRNILVENENRVKIGDFGLTKVLPQD  198 (326)
T ss_dssp             EEECCCTTCBHHHHHHH-STTSSCHHHHHHHHHHHHHHHHHHHHT-TEECSCCCGGGEEEEETTEEEECCCTTCEECCSS
T ss_pred             EEEECCCCCCHHHHHHh-cccCCCHHHHHHHHHHHHHHHHHHHhC-CEeccCCCcceEEEcCCCcEEEecCcchhhcccc
Confidence            99999999999999975 335689999999999999999999999 9999999999999999999999999999865443


Q ss_pred             C-------CccCcccccCcccccCCCCCCcccchhhhHHHHHHHhCCCCCCchhhHHHh-----------hhchhhhccc
Q 020221          210 R-------SYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIR-----------DRNIQTLTDS  271 (329)
Q Consensus       210 ~-------~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~~-----------~~~~~~~~~~  271 (329)
                      .       ...++..|+|||.+.+..++.++||||||+++|+|++|..|+.........           .......+..
T Consensus       199 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  278 (326)
T 2w1i_A          199 KEYYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLKN  278 (326)
T ss_dssp             CSEEECSSCCSCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHHTTCGGGSHHHHHHHHHCTTCCTHHHHHHHHHHHHT
T ss_pred             ccccccccCCCCceeEECchhhcCCCCCchhhHHHHHHHHHHHHhcCCCCCCCHHHHHHhhccccchhhhHHHHHHHhhc
Confidence            2       234567899999999888999999999999999999999776433211110           0011111111


Q ss_pred             cccCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhhcc
Q 020221          272 CLEGQFSSDEGTELVRLASRCLQYEPRERPNPRSLVTALVTLQKDT  317 (329)
Q Consensus       272 ~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~~~l~~L~~~~~~~  317 (329)
                      ......+..+++++.+++.+||+.||++|||+.++++.|+++.+..
T Consensus       279 ~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~el~~~L~~l~~~l  324 (326)
T 2w1i_A          279 NGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDQM  324 (326)
T ss_dssp             TCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred             CCCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHHh
Confidence            2223345667889999999999999999999999999999997653

>3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ...

Probab=100.00  E-value=6.3e-47  Score=342.43  Aligned_cols=250  Identities=18%  Similarity=0.230  Sum_probs=202.9

Q ss_pred             CcccccccCCCCCCcEEEEEEe-CCCCEEEEEEeCCCCCh-hHHHHHHHHHHHhcCCCccccccceeeeeCCeeEEEEec
Q 020221           57 AMENIVSEHGEKAPNVVYKGKL-ENQFRIAVKRFNRSAWP-DARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAEY  134 (329)
Q Consensus        57 ~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  134 (329)
                      ..|++++.||+|+||+||++.. .+++.||+|++...... ..+.+.+|+.+++.++||||+++++++.+.+..++||||
T Consensus        33 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~  112 (360)
T 3eqc_A           33 DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEH  112 (360)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECCCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEETTEEEEEECC
T ss_pred             ccceeeeeecCCCCeEEEEEEECCCCcEEEEEEeccccCHHHHHHHHHHHHHHHHCCCCCEEEEeEEEEECCEEEEEEEC
Confidence            4578888999999999999995 47889999999876433 345689999999999999999999999999999999999


Q ss_pred             CCCCCHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCCCCCeeeecccCcccCC--CCCCc
Q 020221          135 MPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSR--DGRSY  212 (329)
Q Consensus       135 ~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~--~~~~~  212 (329)
                      +++++|.+++..  ...+++..+..++.|++.||.|||++++++|+||||+||+++.++.++|+|||++....  .....
T Consensus       113 ~~~~~L~~~l~~--~~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~  190 (360)
T 3eqc_A          113 MDGGSLDQVLKK--AGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSF  190 (360)
T ss_dssp             CTTCBHHHHHHH--HSSCCHHHHHHHHHHHHHHHHHHHHHHCCCCSCCSGGGEEECTTCCEEECCCCCCHHHHHHC----
T ss_pred             CCCCCHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHhCCEEcCCccHHHEEECCCCCEEEEECCCCcccccccccCC
Confidence            999999999963  35689999999999999999999984389999999999999999999999999986432  22345


Q ss_pred             cCcccccCcccccCCCCCCcccchhhhHHHHHHHhCCCCCCchhhHHHhhhc----------------------------
Q 020221          213 STNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRN----------------------------  264 (329)
Q Consensus       213 ~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~~~~~----------------------------  264 (329)
                      .+|+.|+|||++.+..++.++||||||+++|+|++|..||............                            
T Consensus       191 ~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  270 (360)
T 3eqc_A          191 VGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLNKFGMD  270 (360)
T ss_dssp             CCCCTTCCHHHHTTCCCSHHHHHHHHHHHHHHHHHTSCCSSCCCHHHHHHHHC---------------------------
T ss_pred             CCCCCeECHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccCCCCCCCcccCCCcccccccC
Confidence            7899999999999989999999999999999999999988654322211100                            


Q ss_pred             ----------hhhhccccccCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 020221          265 ----------IQTLTDSCLEGQFSSDEGTELVRLASRCLQYEPRERPNPRSLVT  308 (329)
Q Consensus       265 ----------~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~~~l~  308 (329)
                                ...+.............+.++.+|+.+||+.||++|||+.++++
T Consensus       271 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  324 (360)
T 3eqc_A          271 SRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMV  324 (360)
T ss_dssp             ---CCCHHHHHHHHHHSCCCCCCTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHT
T ss_pred             CCCcccchhhhhHHhccCCCCCCcccccHHHHHHHHHHhhcChhhCCCHHHHhh
Confidence                      00000000011112235778999999999999999999999997

>3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A*

Probab=100.00  E-value=2e-46  Score=352.22  Aligned_cols=246  Identities=19%  Similarity=0.196  Sum_probs=203.2

Q ss_pred             cccccccCCCCCCcEEEEEEe-CCCCEEEEEEeCCCC--ChhHHHHHHHHHHHhcCCCccccccceeeeeCCeeEEEEec
Q 020221           58 MENIVSEHGEKAPNVVYKGKL-ENQFRIAVKRFNRSA--WPDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAEY  134 (329)
Q Consensus        58 ~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  134 (329)
                      .|++++.||+|+||+||++.. .+++.||+|++....  ......+.+|+++++.++||||+++++++.+....++||||
T Consensus        23 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~  102 (486)
T 3mwu_A           23 RYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVGEL  102 (486)
T ss_dssp             HEEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHBCSCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECC
T ss_pred             ceEEeEEEeecCCEEEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHHHhCCCCCcCeEEEEEEcCCEEEEEEEc
Confidence            478888999999999999994 578899999986431  23456789999999999999999999999999999999999


Q ss_pred             CCCCCHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeC---CCCCeeeecccCcccCCCC--
Q 020221          135 MPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFD---DDVNPRLSCFGLMKNSRDG--  209 (329)
Q Consensus       135 ~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~---~~~~~kl~Dfg~a~~~~~~--  209 (329)
                      +.+|+|.+.+..  ...+++..+..++.||+.||.|||++ ||+||||||+|||++   .++.+||+|||++......  
T Consensus       103 ~~~~~L~~~~~~--~~~~~~~~~~~i~~qi~~al~~lH~~-~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~~~~  179 (486)
T 3mwu_A          103 YTGGELFDEIIK--RKRFSEHDAARIIKQVFSGITYMHKH-NIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTK  179 (486)
T ss_dssp             CCSCBHHHHHHH--HSSCCHHHHHHHHHHHHHHHHHHHHT-TCCCSCCSGGGEEESSSSTTCCEEECSCSCTTTBCCC--
T ss_pred             CCCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHC-CeEeccCchHHEEEecCCCCCCEEEEECCcCeECCCCCc
Confidence            999999998863  45799999999999999999999999 999999999999995   5567999999999865543  


Q ss_pred             -CCccCcccccCcccccCCCCCCcccchhhhHHHHHHHhCCCCCCchhhHHHhhhchhhhccccccCCCChHHHHHHHHH
Q 020221          210 -RSYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRL  288 (329)
Q Consensus       210 -~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  288 (329)
                       ....||+.|+|||++.+ .++.++||||||+++|+|++|..||..................  .........++++.+|
T Consensus       180 ~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~--~~~~~~~~~s~~~~~l  256 (486)
T 3mwu_A          180 MKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYA--FDLPQWRTISDDAKDL  256 (486)
T ss_dssp             --CCTTGGGGCCGGGGGS-CCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCC--SCSGGGGGSCHHHHHH
T ss_pred             cCCCcCCCCCCCHHHhCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCC--CCCcccCCCCHHHHHH
Confidence             24468999999999885 5899999999999999999999998765433332222111111  0111123467889999


Q ss_pred             HHHhcccCCCCCCCHHHHHHH
Q 020221          289 ASRCLQYEPRERPNPRSLVTA  309 (329)
Q Consensus       289 i~~cl~~dp~~Rps~~~~l~~  309 (329)
                      +.+||+.||++|||+.+++++
T Consensus       257 i~~~L~~dp~~R~t~~~~l~h  277 (486)
T 3mwu_A          257 IRKMLTFHPSLRITATQCLEH  277 (486)
T ss_dssp             HHHHTCSSTTTSCCHHHHHHC
T ss_pred             HHHHcCCChhhCcCHHHHhcC
Confidence            999999999999999999983

>2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A*

Probab=100.00  E-value=1.6e-46  Score=343.26  Aligned_cols=244  Identities=18%  Similarity=0.241  Sum_probs=198.0

Q ss_pred             cccccccCCCCCCcEEEEEEeCCCCEEEEEEeCCCCC--hhHHHHHHHHHHHhcCC--CccccccceeeeeCCeeEEEEe
Q 020221           58 MENIVSEHGEKAPNVVYKGKLENQFRIAVKRFNRSAW--PDARQFLEEARAVGQLR--NRRLANLLGCCCEGDERLLVAE  133 (329)
Q Consensus        58 ~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~--h~niv~~~~~~~~~~~~~lv~e  133 (329)
                      .|.+++.||+|+||.||++...+++.||||++.....  ...+.+.+|+.+++.++  ||||+++++++...+..++|||
T Consensus        57 ~y~~~~~LG~G~fg~Vy~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~~~~~~lv~E  136 (390)
T 2zmd_A           57 IYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVME  136 (390)
T ss_dssp             EEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEEE
T ss_pred             ceEEEEEEccCCCeEEEEEEcCCCCEEEEEEEecccccHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEecCCEEEEEEe
Confidence            4788889999999999999977789999999876532  33567899999999996  5999999999999999999999


Q ss_pred             cCCCCCHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCCCCCeeeecccCcccCCCC----
Q 020221          134 YMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDG----  209 (329)
Q Consensus       134 ~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~----  209 (329)
                       +.+++|.+++..  ...+++..+..++.||+.||.|||+. +|+||||||+|||++ ++.+||+|||++......    
T Consensus       137 -~~~~~L~~~l~~--~~~~~~~~~~~i~~qi~~aL~~lH~~-~ivHrDlkp~NIll~-~~~~kl~DFG~a~~~~~~~~~~  211 (390)
T 2zmd_A          137 -CGNIDLNSWLKK--KKSIDPWERKSYWKNMLEAVHTIHQH-GIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTTSV  211 (390)
T ss_dssp             -CCSEEHHHHHHH--CSSCCHHHHHHHHHHHHHHHHHHHTT-TCCCCCCCGGGEEES-SSCEEECCCSSSCCC-------
T ss_pred             -cCCCCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHC-CeeecCCCHHHEEEE-CCeEEEEecCccccccCCCccc
Confidence             567899999974  45789999999999999999999999 999999999999996 589999999999865433    


Q ss_pred             --CCccCcccccCcccccC-----------CCCCCcccchhhhHHHHHHHhCCCCCCchhhHHHhhhchhhhccccccCC
Q 020221          210 --RSYSTNLAFTPPEYLRT-----------GRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQ  276 (329)
Q Consensus       210 --~~~~~~~~y~aPE~~~~-----------~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~  276 (329)
                        ....||+.|+|||++.+           ..++.++||||||+++|||++|..||.......   .....+........
T Consensus       212 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~---~~~~~~~~~~~~~~  288 (390)
T 2zmd_A          212 VKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQI---SKLHAIIDPNHEIE  288 (390)
T ss_dssp             --CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTCCCHH---HHHHHHHCTTSCCC
T ss_pred             cCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhhhHHH---HHHHHHhCccccCC
Confidence              23468999999999875           358889999999999999999998886432111   01112222222223


Q ss_pred             CChHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 020221          277 FSSDEGTELVRLASRCLQYEPRERPNPRSLVTA  309 (329)
Q Consensus       277 ~~~~~~~~~~~li~~cl~~dp~~Rps~~~~l~~  309 (329)
                      ++...+.++.+|+.+||+.||++|||+.+++++
T Consensus       289 ~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~h  321 (390)
T 2zmd_A          289 FPDIPEKDLQDVLKCCLKRDPKQRISIPELLAH  321 (390)
T ss_dssp             CCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred             CCccchHHHHHHHHHHcccChhhCCCHHHHhhC
Confidence            344456789999999999999999999999973

>1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A*

Probab=100.00  E-value=1.3e-46  Score=336.03  Aligned_cols=258  Identities=22%  Similarity=0.302  Sum_probs=209.0

Q ss_pred             CCcccccccCCCCCCcEEEEEE-eCCCCE--EEEEEeCCCC-ChhHHHHHHHHHHHhcC-CCccccccceeeeeCCeeEE
Q 020221           56 FAMENIVSEHGEKAPNVVYKGK-LENQFR--IAVKRFNRSA-WPDARQFLEEARAVGQL-RNRRLANLLGCCCEGDERLL  130 (329)
Q Consensus        56 ~~~~~~~~~lg~G~~g~V~~~~-~~~~~~--vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~l  130 (329)
                      +..|++.+.||+|+||.||++. ..++..  +|+|.+.... ....+.+.+|+++++.+ +||||+++++++.+.+..++
T Consensus        24 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~l  103 (327)
T 1fvr_A           24 WNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYL  103 (327)
T ss_dssp             GGGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEE
T ss_pred             HHHccceeeeecCCCceEEEEEEccCCcccceeeeeeccccchHHHHHHHHHHHHHHhccCCCchhhhceeeeeCCceEE
Confidence            3567788888999999999998 445654  4999987543 23345688999999999 89999999999999999999


Q ss_pred             EEecCCCCCHHhhhccCC--------------CCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCCCCCee
Q 020221          131 VAEYMPNDTLAKHLFHWE--------------TQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPR  196 (329)
Q Consensus       131 v~e~~~~gsL~~~l~~~~--------------~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~k  196 (329)
                      ||||+++++|.+++....              ...+++..++.++.||+.||.|||++ |++||||||+||+++.++.+|
T Consensus       104 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~-~ivH~dlkp~NIl~~~~~~~k  182 (327)
T 1fvr_A          104 AIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK-QFIHRDLAARNILVGENYVAK  182 (327)
T ss_dssp             EECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHT-TEECSCCSGGGEEECGGGCEE
T ss_pred             EEecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhC-CccCCCCccceEEEcCCCeEE
Confidence            999999999999997432              24689999999999999999999999 999999999999999999999


Q ss_pred             eecccCcccCCC---CCCccCcccccCcccccCCCCCCcccchhhhHHHHHHHh-CCCCCCchhhHHHhhhchhhhcccc
Q 020221          197 LSCFGLMKNSRD---GRSYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLS-GKHIPPSHALDLIRDRNIQTLTDSC  272 (329)
Q Consensus       197 l~Dfg~a~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t-g~~~~~~~~~~~~~~~~~~~~~~~~  272 (329)
                      |+|||++.....   .....+++.|+|||.+.+..++.++||||||+++|+|++ |..||..............     .
T Consensus       183 L~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~~~~~~~~-----~  257 (327)
T 1fvr_A          183 IADFGLSRGQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQ-----G  257 (327)
T ss_dssp             ECCTTCEESSCEECCC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHGGG-----T
T ss_pred             EcccCcCccccccccccCCCCCccccChhhhccccCCchhcchHHHHHHHHHHcCCCCCCCCCcHHHHHHHhhc-----C
Confidence            999999874332   223345788999999988889999999999999999998 8888765443332222111     1


Q ss_pred             ccCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhhcccc
Q 020221          273 LEGQFSSDEGTELVRLASRCLQYEPRERPNPRSLVTALVTLQKDTEL  319 (329)
Q Consensus       273 ~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~~~l~~L~~~~~~~~~  319 (329)
                      .....+...++++.+++.+||+.||++|||+.++++.|+++......
T Consensus       258 ~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~~~  304 (327)
T 1fvr_A          258 YRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEERKT  304 (327)
T ss_dssp             CCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSSSC
T ss_pred             CCCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhhcC
Confidence            22234456678999999999999999999999999999999876543

>2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A*

Probab=100.00  E-value=1.2e-46  Score=332.18  Aligned_cols=247  Identities=18%  Similarity=0.225  Sum_probs=199.3

Q ss_pred             CcccccccCCCCCCcEEEEEEe-CCCCEEEEEEeCCCCChhHHHHHHHHHHHhcCCCccccccceeeeeCCeeEEEEecC
Q 020221           57 AMENIVSEHGEKAPNVVYKGKL-ENQFRIAVKRFNRSAWPDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAEYM  135 (329)
Q Consensus        57 ~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~  135 (329)
                      ..|++++.||+|+||.||+|.. .+++.||+|++........+.+.+|+++++.++||||+++++++...+..++||||+
T Consensus        19 ~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   98 (302)
T 2j7t_A           19 EVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAYYHDGKLWIMIEFC   98 (302)
T ss_dssp             GTEEEEEEEECSTTCCEEEEEETTTCCEEEEEEEC----CCHHHHHHHHHHHHHCCCTTBCCEEEEEECC-CEEEEEECC
T ss_pred             cceeecceeccCCCeEEEEEEEcCCCcEEEEEEecCCCHHHHHHHHHHHHHHhcCCCCCEeeeeeeeeeCCeEEEEEEeC
Confidence            4577888899999999999995 468899999998776566778999999999999999999999999999999999999


Q ss_pred             CCCCHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCCCCCeeeecccCcccC----CCCCC
Q 020221          136 PNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNS----RDGRS  211 (329)
Q Consensus       136 ~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~----~~~~~  211 (329)
                      ++++|.+++.. ....+++..+..++.|++.||.|||+. |++|+||||+||+++.++.++|+|||++...    .....
T Consensus        99 ~~~~l~~~~~~-~~~~~~~~~~~~~~~~i~~~l~~lH~~-~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~  176 (302)
T 2j7t_A           99 PGGAVDAIMLE-LDRGLTEPQIQVVCRQMLEALNFLHSK-RIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKRDS  176 (302)
T ss_dssp             TTEEHHHHHHH-HTSCCCHHHHHHHHHHHHHHHHHHHHT-TCCCCCCSGGGEEECTTSCEEECCCHHHHHHHHHHHC---
T ss_pred             CCCcHHHHHHh-hccCCCHHHHHHHHHHHHHHHHHHhcC-CcccCCCCHHHEEECCCCCEEEEECCCCcccccccccccc
Confidence            99999998864 345699999999999999999999999 9999999999999999999999999987532    12234


Q ss_pred             ccCcccccCcccc-----cCCCCCCcccchhhhHHHHHHHhCCCCCCchhhHHHhhhchhhhccccccCCCChHHHHHHH
Q 020221          212 YSTNLAFTPPEYL-----RTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELV  286 (329)
Q Consensus       212 ~~~~~~y~aPE~~-----~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  286 (329)
                      ..+++.|+|||++     .+..++.++||||||+++|+|++|..|+.................   .....+...+.++.
T Consensus       177 ~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~l~  253 (302)
T 2j7t_A          177 FIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSDP---PTLLTPSKWSVEFR  253 (302)
T ss_dssp             --CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCC---CCCSSGGGSCHHHH
T ss_pred             ccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCccCCHHHHHHHHhccCC---cccCCccccCHHHH
Confidence            5688999999998     356788999999999999999999988765432222111111110   11122455678899


Q ss_pred             HHHHHhcccCCCCCCCHHHHHH
Q 020221          287 RLASRCLQYEPRERPNPRSLVT  308 (329)
Q Consensus       287 ~li~~cl~~dp~~Rps~~~~l~  308 (329)
                      +++.+||+.||++|||+.++++
T Consensus       254 ~li~~~l~~dp~~Rps~~~ll~  275 (302)
T 2j7t_A          254 DFLKIALDKNPETRPSAAQLLE  275 (302)
T ss_dssp             HHHHHHSCSCTTTSCCHHHHTT
T ss_pred             HHHHHHcccChhhCCCHHHHhc
Confidence            9999999999999999999987

>3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B

Probab=100.00  E-value=9.4e-47  Score=355.89  Aligned_cols=250  Identities=16%  Similarity=0.211  Sum_probs=205.5

Q ss_pred             CCcccccccCCCCCCcEEEEEEe-CCCCEEEEEEeCCCC---ChhHHHHHHHHHHHhcCCCccccccceeeeeCCeeEEE
Q 020221           56 FAMENIVSEHGEKAPNVVYKGKL-ENQFRIAVKRFNRSA---WPDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLV  131 (329)
Q Consensus        56 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv  131 (329)
                      .+.+++++.||+|+||.||++.. .+|+.||+|++....   ....+.+.+|+++++.++||||+++++++.+....++|
T Consensus       184 ~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lV  263 (543)
T 3c4z_A          184 EDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFETKTDLCLV  263 (543)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred             hhheEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEEeeCCEEEEE
Confidence            35677778889999999999995 568999999996532   12345688999999999999999999999999999999


Q ss_pred             EecCCCCCHHhhhccCC--CCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCCCCCeeeecccCcccCCCC
Q 020221          132 AEYMPNDTLAKHLFHWE--TQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDG  209 (329)
Q Consensus       132 ~e~~~~gsL~~~l~~~~--~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~  209 (329)
                      |||+++|+|.+++....  ...+++..+..++.||+.||.|||++ ||+||||||+|||++.++.+||+|||+++.....
T Consensus       264 mE~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~~-gIvHrDLKP~NILl~~~g~vkL~DFGla~~~~~~  342 (543)
T 3c4z_A          264 MTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQR-NIIYRDLKPENVLLDDDGNVRISDLGLAVELKAG  342 (543)
T ss_dssp             ECCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHHHT-TEECCCCCGGGEEECTTSCEEECCCTTCEECCTT
T ss_pred             EEeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHHHc-CCcccCCChHHEEEeCCCCEEEeecceeeeccCC
Confidence            99999999999986533  45689999999999999999999999 9999999999999999999999999999865543


Q ss_pred             C----CccCcccccCcccccCCCCCCcccchhhhHHHHHHHhCCCCCCchhhHHHhhhchhhhccccccCCCChHHHHHH
Q 020221          210 R----SYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTEL  285 (329)
Q Consensus       210 ~----~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  285 (329)
                      .    ...||+.|+|||++.+..++.++|||||||++|||++|..||...............+...  ...++...++++
T Consensus       343 ~~~~~~~~GT~~Y~APE~l~~~~~~~~~DiwSlGvilyelltG~~PF~~~~~~~~~~~~~~~i~~~--~~~~p~~~s~~~  420 (543)
T 3c4z_A          343 QTKTKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRVLEQ--AVTYPDKFSPAS  420 (543)
T ss_dssp             CCCBCCCCSCTTTSCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCTTCCCCHHHHHHHHHHC--CCCCCTTSCHHH
T ss_pred             CcccccccCCccccChhhhcCCCCChHHhcCcchHHHHHHHhCCCCCCCCccchhHHHHHHHHhhc--ccCCCcccCHHH
Confidence            2    3478999999999999899999999999999999999999886542100000111111111  123456678899


Q ss_pred             HHHHHHhcccCCCCCCCH-----HHHHH
Q 020221          286 VRLASRCLQYEPRERPNP-----RSLVT  308 (329)
Q Consensus       286 ~~li~~cl~~dp~~Rps~-----~~~l~  308 (329)
                      .+++.+||+.||++||++     .++++
T Consensus       421 ~~li~~lL~~dP~~R~~~~~~~a~ei~~  448 (543)
T 3c4z_A          421 KDFCEALLQKDPEKRLGFRDGSCDGLRT  448 (543)
T ss_dssp             HHHHHHHSCSSGGGSCCCBTTBSHHHHT
T ss_pred             HHHHHHhccCCHhHCCCCcccCHHHHHc
Confidence            999999999999999975     55654

>1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A*

Probab=100.00  E-value=5.3e-47  Score=330.80  Aligned_cols=252  Identities=25%  Similarity=0.351  Sum_probs=202.8

Q ss_pred             CCcccccccCCCCCCcEEEEEEeCCCCEEEEEEeCCCCChhHHHHHHHHHHHhcCCCccccccceeeeeC-CeeEEEEec
Q 020221           56 FAMENIVSEHGEKAPNVVYKGKLENQFRIAVKRFNRSAWPDARQFLEEARAVGQLRNRRLANLLGCCCEG-DERLLVAEY  134 (329)
Q Consensus        56 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~-~~~~lv~e~  134 (329)
                      ...|++++.||+|+||+||++... ++.||+|++....  ..+.+.+|+++++.++||||+++++++... +..++||||
T Consensus        20 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~   96 (278)
T 1byg_A           20 MKELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEY   96 (278)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEET-TEEEEEEECCCCC----HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECC
T ss_pred             hhhceEEeEEecCCCceEEEEEEc-CCEEEEEEecchh--HHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCCceEEEEec
Confidence            456888889999999999999874 7799999997654  456789999999999999999999987554 578999999


Q ss_pred             CCCCCHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCCCCCeeeecccCcccCCCC-CCcc
Q 020221          135 MPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDG-RSYS  213 (329)
Q Consensus       135 ~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~-~~~~  213 (329)
                      +++++|.+++.......+++..+..++.|++.||.|||++ |++|+||||+||+++.++.++|+|||++...... ....
T Consensus        97 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~-~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~~~~~  175 (278)
T 1byg_A           97 MAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGN-NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGK  175 (278)
T ss_dssp             CTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHT-TCCCSCCSGGGEEECTTSCEEECCCCC------------
T ss_pred             CCCCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHhC-CccccCCCcceEEEeCCCcEEEeeccccccccccccCCC
Confidence            9999999999643333488999999999999999999999 9999999999999999999999999998765443 2335


Q ss_pred             CcccccCcccccCCCCCCcccchhhhHHHHHHHh-CCCCCCchhhHHHhhhchhhhccccccCCCChHHHHHHHHHHHHh
Q 020221          214 TNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLS-GKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLASRC  292 (329)
Q Consensus       214 ~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t-g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~c  292 (329)
                      +++.|+|||.+.+..++.++||||||+++|+|++ |..|+............     ........+...++++.+++.+|
T Consensus       176 ~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~l~~li~~~  250 (278)
T 1byg_A          176 LPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRV-----EKGYKMDAPDGCPPAVYEVMKNC  250 (278)
T ss_dssp             CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGHHHHH-----TTTCCCCCCTTCCHHHHHHHHHH
T ss_pred             ccccccCHHHhCCCCCCchhcHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHH-----hcCCCCCCcccCCHHHHHHHHHH
Confidence            6789999999998889999999999999999998 88777644322221111     11122334556778999999999


Q ss_pred             cccCCCCCCCHHHHHHHHHhhhhc
Q 020221          293 LQYEPRERPNPRSLVTALVTLQKD  316 (329)
Q Consensus       293 l~~dp~~Rps~~~~l~~L~~~~~~  316 (329)
                      |+.||++|||+.++++.|+.+...
T Consensus       251 l~~~p~~Rps~~~l~~~L~~i~~~  274 (278)
T 1byg_A          251 WHLDAAMRPSFLQLREQLEHIKTH  274 (278)
T ss_dssp             TCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             hcCChhhCCCHHHHHHHHHHHHhh
Confidence            999999999999999999998754

>3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens}

Probab=100.00  E-value=1.7e-46  Score=335.36  Aligned_cols=253  Identities=18%  Similarity=0.276  Sum_probs=203.3

Q ss_pred             CcccccccCCCCCCcEEEEEEe-CCCCE----EEEEEeCCCC-ChhHHHHHHHHHHHhcCCCccccccceeeeeCCeeEE
Q 020221           57 AMENIVSEHGEKAPNVVYKGKL-ENQFR----IAVKRFNRSA-WPDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLL  130 (329)
Q Consensus        57 ~~~~~~~~lg~G~~g~V~~~~~-~~~~~----vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l  130 (329)
                      ..|++++.||+|+||+||+|.. .+++.    ||+|.+.... ....+.+.+|+.+++.++||||+++++++... ..++
T Consensus        15 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~-~~~~   93 (327)
T 3lzb_A           15 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQL   93 (327)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCSSCCCHHHHHHHHHHHTTCCBTTBCCCCEEEESS-SEEE
T ss_pred             hHceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeeccccCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEecC-CceE
Confidence            4577888899999999999984 44543    5788776543 33467789999999999999999999999765 4889


Q ss_pred             EEecCCCCCHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCCCCCeeeecccCcccCCCCC
Q 020221          131 VAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDGR  210 (329)
Q Consensus       131 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~  210 (329)
                      +++|+.+|+|.+++.. ....+++..++.++.|++.||.|||+. +++||||||+||+++.++.+||+|||++.......
T Consensus        94 v~~~~~~g~L~~~l~~-~~~~~~~~~~~~i~~qi~~aL~~LH~~-~ivH~Dikp~NIl~~~~~~~kL~DfG~a~~~~~~~  171 (327)
T 3lzb_A           94 ITQLMPFGCLLDYVRE-HKDNIGSQYLLNWCVQIAKGMNYLEDR-RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEE  171 (327)
T ss_dssp             EECCCSSCBHHHHHHH-TTTCCCHHHHHHHHHHHHHHHHHHHHT-TCCCSCCCGGGEEEEETTEEEECCTTC--------
T ss_pred             EEEecCCCcHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHhhC-CCcCCCCCHHHEEEcCCCCEEEccCcceeEccCcc
Confidence            9999999999999975 345799999999999999999999999 99999999999999999999999999997654332


Q ss_pred             ------CccCcccccCcccccCCCCCCcccchhhhHHHHHHHh-CCCCCCchhhHHHhhhchhhhccccccCCCChHHHH
Q 020221          211 ------SYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLS-GKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGT  283 (329)
Q Consensus       211 ------~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t-g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  283 (329)
                            ...+++.|+|||.+.+..++.++||||||+++|+|++ |..||..........     ..........+...+.
T Consensus       172 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~-----~~~~~~~~~~~~~~~~  246 (327)
T 3lzb_A          172 KEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISS-----ILEKGERLPQPPICTI  246 (327)
T ss_dssp             --------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHH-----HHHTTCCCCCCTTBCH
T ss_pred             ccccccCCCccccccCHHHHcCCCCChHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHH-----HHHcCCCCCCCccCCH
Confidence                  2345678999999999999999999999999999999 887775433222211     1111222334556778


Q ss_pred             HHHHHHHHhcccCCCCCCCHHHHHHHHHhhhhcc
Q 020221          284 ELVRLASRCLQYEPRERPNPRSLVTALVTLQKDT  317 (329)
Q Consensus       284 ~~~~li~~cl~~dp~~Rps~~~~l~~L~~~~~~~  317 (329)
                      ++.+++.+||+.||++|||+.++++.|+++.+..
T Consensus       247 ~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~  280 (327)
T 3lzb_A          247 DVYMIMRKCWMIDADSRPKFRELIIEFSKMARDP  280 (327)
T ss_dssp             HHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHTSH
T ss_pred             HHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhCc
Confidence            8999999999999999999999999999997654

>2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens}

Probab=100.00  E-value=2.5e-46  Score=359.99  Aligned_cols=253  Identities=19%  Similarity=0.250  Sum_probs=208.4

Q ss_pred             cCCCCCCcEEEEEEeC---CCCEEEEEEeCCCC-ChhHHHHHHHHHHHhcCCCccccccceeeeeCCeeEEEEecCCCCC
Q 020221           64 EHGEKAPNVVYKGKLE---NQFRIAVKRFNRSA-WPDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAEYMPNDT  139 (329)
Q Consensus        64 ~lg~G~~g~V~~~~~~---~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gs  139 (329)
                      .||+|+||.||+|.+.   ++..||||+++... ....+.+.+|+++++.++||||+++++++.. +..++||||+++|+
T Consensus       343 ~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~-~~~~lv~E~~~~g~  421 (613)
T 2ozo_A          343 ELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLVMEMAGGGP  421 (613)
T ss_dssp             EEEECSSSEEEEEEEECSSCEEEEEEEECCCCCSSTTHHHHHHHHHHHTTCCCTTBCCEEEEEES-SSEEEEEECCTTCB
T ss_pred             EEecCCCcEEEEEEEecCCCcEEEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEecc-CCeEEEEEeCCCCc
Confidence            5899999999999853   45679999998753 2346789999999999999999999999865 57999999999999


Q ss_pred             HHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCCCCCeeeecccCcccCCCCCC-------c
Q 020221          140 LAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDGRS-------Y  212 (329)
Q Consensus       140 L~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~~-------~  212 (329)
                      |.+++.. ....+++..+..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+++.......       .
T Consensus       422 L~~~l~~-~~~~l~~~~~~~i~~qi~~~L~~LH~~-~iiHrDlkp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~~~  499 (613)
T 2ozo_A          422 LHKFLVG-KREEIPVSNVAELLHQVSMGMKYLEEK-NFVHRNLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAG  499 (613)
T ss_dssp             HHHHHTT-CTTTSCHHHHHHHHHHHHHHHHHHHHT-TCCCSCCSGGGEEEEETTEEEECCCSTTTTCC------------
T ss_pred             HHHHHhh-ccCCCCHHHHHHHHHHHHHHHHHHHHC-CEEcCcCCHHHEEEcCCCcEEEeeccCcccccCCCceeeeccCC
Confidence            9999964 455799999999999999999999999 999999999999999999999999999987543321       2


Q ss_pred             cCcccccCcccccCCCCCCcccchhhhHHHHHHHh-CCCCCCchhhHHHhhhchhhhccccccCCCChHHHHHHHHHHHH
Q 020221          213 STNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLS-GKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLASR  291 (329)
Q Consensus       213 ~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t-g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~  291 (329)
                      .+++.|+|||++.+..++.++||||||+++|||++ |..||.......+....     ....+...+..+++++.+++..
T Consensus       500 ~~~~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~~~~i-----~~~~~~~~p~~~~~~l~~li~~  574 (613)
T 2ozo_A          500 KWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFI-----EQGKRMECPPECPPELYALMSD  574 (613)
T ss_dssp             --CCTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCSHHHHHHH-----HTTCCCCCCTTCCHHHHHHHHH
T ss_pred             CCccceeCHhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHH-----HcCCCCCCCCcCCHHHHHHHHH
Confidence            34578999999998899999999999999999998 88887654333222211     1122334556678899999999


Q ss_pred             hcccCCCCCCCHHHHHHHHHhhhhccccccCcc
Q 020221          292 CLQYEPRERPNPRSLVTALVTLQKDTELYLSLP  324 (329)
Q Consensus       292 cl~~dp~~Rps~~~~l~~L~~~~~~~~~~~~~p  324 (329)
                      ||+.||++||++.++++.|+.+....+.....+
T Consensus       575 cl~~dP~~RPs~~~l~~~L~~~~~~~~~~~~~~  607 (613)
T 2ozo_A          575 CWIYKWEDRPDFLTVEQRMRACYYSLASKVEGG  607 (613)
T ss_dssp             TTCSSTTTSCCHHHHHHHHHHHHHHHSCSCCCS
T ss_pred             HcCCChhHCcCHHHHHHHHHHHHHHhccccCCc
Confidence            999999999999999999999877665555444

>3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1.6e-46  Score=341.10  Aligned_cols=252  Identities=22%  Similarity=0.288  Sum_probs=195.8

Q ss_pred             ccccccCCCCCCcEEEEEEeC--CC--CEEEEEEeCCCC-ChhHHHHHHHHHHHhcCCCccccccceeeee-CCeeEEEE
Q 020221           59 ENIVSEHGEKAPNVVYKGKLE--NQ--FRIAVKRFNRSA-WPDARQFLEEARAVGQLRNRRLANLLGCCCE-GDERLLVA  132 (329)
Q Consensus        59 ~~~~~~lg~G~~g~V~~~~~~--~~--~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~-~~~~~lv~  132 (329)
                      +++.+.||+|+||+||+|...  ++  ..||+|.+.... ....+.+.+|+.+++.++||||+++++++.. .+..++||
T Consensus        91 ~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~lv~  170 (373)
T 3c1x_A           91 VHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVL  170 (373)
T ss_dssp             EEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSCSCSHHHHHHHHHHTTSTTCCCTTBCCCCEEECCCSSCCEEEE
T ss_pred             eecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCCCeEEEE
Confidence            456678899999999999842  22  468999987543 3446679999999999999999999998654 46789999


Q ss_pred             ecCCCCCHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCCCCCeeeecccCcccCCCC---
Q 020221          133 EYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDG---  209 (329)
Q Consensus       133 e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~---  209 (329)
                      ||+++|+|.+++.. ....+++..+..++.|++.||.|||++ +++||||||+||+++.++.+||+|||+++.....   
T Consensus       171 e~~~~g~L~~~l~~-~~~~~~~~~~~~i~~qi~~aL~~LH~~-~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~~~~~~  248 (373)
T 3c1x_A          171 PYMKHGDLRNFIRN-ETHNPTVKDLIGFGLQVAKGMKFLASK-KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFD  248 (373)
T ss_dssp             ECCTTCBHHHHHHC-TTCCCBHHHHHHHHHHHHHHHHHHHHT-TCCCSCCCGGGEEECTTCCEEECCC------------
T ss_pred             ECCCCCCHHHHHhh-cccCCCHHHHHHHHHHHHHHHHHHHHC-CEecCccchheEEECCCCCEEEeeccccccccccccc
Confidence            99999999999964 445689999999999999999999999 9999999999999999999999999999754332   


Q ss_pred             -----CCccCcccccCcccccCCCCCCcccchhhhHHHHHHHhCCC-CCCchhhHHHhhhchhhhccccccCCCChHHHH
Q 020221          210 -----RSYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKH-IPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGT  283 (329)
Q Consensus       210 -----~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  283 (329)
                           ....+++.|+|||.+.+..++.++||||||+++|||++|+. |+...........     .........+..++.
T Consensus       249 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt~~~~p~~~~~~~~~~~~-----~~~~~~~~~p~~~~~  323 (373)
T 3c1x_A          249 SVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVY-----LLQGRRLLQPEYCPD  323 (373)
T ss_dssp             ---------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCSSCHHHH-----HHTTCCCCCCTTCCH
T ss_pred             cccccCCCCCcccccChHHhcCCCCCcHHHHHHHHHHHHHHHhCcCCCCCCCCHHHHHHH-----HHcCCCCCCCCCCCH
Confidence                 12345678999999998899999999999999999999554 4432211111111     111112223455678


Q ss_pred             HHHHHHHHhcccCCCCCCCHHHHHHHHHhhhhcc
Q 020221          284 ELVRLASRCLQYEPRERPNPRSLVTALVTLQKDT  317 (329)
Q Consensus       284 ~~~~li~~cl~~dp~~Rps~~~~l~~L~~~~~~~  317 (329)
                      ++.+++.+||+.||++|||+.++++.|+.+....
T Consensus       324 ~l~~li~~cl~~dp~~RPs~~ell~~L~~i~~~~  357 (373)
T 3c1x_A          324 PLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTF  357 (373)
T ss_dssp             HHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTC
T ss_pred             HHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhc
Confidence            8999999999999999999999999999997654

>3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A*

Probab=100.00  E-value=1.3e-46  Score=353.41  Aligned_cols=245  Identities=18%  Similarity=0.160  Sum_probs=204.9

Q ss_pred             cccccccCCCCCCcEEEEEEe-CCCCEEEEEEeCCCC---ChhHHHHHHHHHHHhcCCCccccccceeeeeCCeeEEEEe
Q 020221           58 MENIVSEHGEKAPNVVYKGKL-ENQFRIAVKRFNRSA---WPDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAE  133 (329)
Q Consensus        58 ~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  133 (329)
                      .|++.+.||+|+||.||++.. .+++.||||++....   ....+.+.+|+.+++.++||||+++++++.+....++|||
T Consensus        27 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e  106 (484)
T 3nyv_A           27 RYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYLVGE  106 (484)
T ss_dssp             HEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred             ceEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEEEe
Confidence            477888899999999999994 578999999986543   2346778999999999999999999999999999999999


Q ss_pred             cCCCCCHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceee---CCCCCeeeecccCcccCCCCC
Q 020221          134 YMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVF---DDDVNPRLSCFGLMKNSRDGR  210 (329)
Q Consensus       134 ~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~---~~~~~~kl~Dfg~a~~~~~~~  210 (329)
                      |+.+|+|.+++.  ....+++..+..++.||+.||.|||++ ||+||||||+|||+   +.++.+||+|||++.......
T Consensus       107 ~~~~~~L~~~~~--~~~~~~~~~~~~i~~qi~~~l~~lH~~-~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~~~  183 (484)
T 3nyv_A          107 VYTGGELFDEII--SRKRFSEVDAARIIRQVLSGITYMHKN-KIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASK  183 (484)
T ss_dssp             CCCSCBHHHHHH--TCSCCBHHHHHHHHHHHHHHHHHHHHT-TCCCSCCCGGGEEESSSSTTCCEEECCTTHHHHBCCCC
T ss_pred             cCCCCCHHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHHC-CeeeCCCCHHHEEEecCCCCCcEEEEeeeeeEEccccc
Confidence            999999999887  456799999999999999999999999 99999999999999   567899999999998665443


Q ss_pred             ---CccCcccccCcccccCCCCCCcccchhhhHHHHHHHhCCCCCCchhhHHHhhhchhhhccccccCCCChHHHHHHHH
Q 020221          211 ---SYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVR  287 (329)
Q Consensus       211 ---~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  287 (329)
                         ...||+.|+|||++.+ .++.++||||||+++|+|++|..||..................  .........++++.+
T Consensus       184 ~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~--~~~~~~~~~s~~~~~  260 (484)
T 3nyv_A          184 KMKDKIGTAYYIAPEVLHG-TYDEKCDVWSTGVILYILLSGCPPFNGANEYDILKKVEKGKYT--FELPQWKKVSESAKD  260 (484)
T ss_dssp             SHHHHTTGGGTCCHHHHHT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCC--CCSGGGGGSCHHHHH
T ss_pred             ccccCCCCccccCceeecC-CCCCcceeHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCC--CCCcccccCCHHHHH
Confidence               3468999999999876 6899999999999999999999988765433322222111111  011112356789999


Q ss_pred             HHHHhcccCCCCCCCHHHHHH
Q 020221          288 LASRCLQYEPRERPNPRSLVT  308 (329)
Q Consensus       288 li~~cl~~dp~~Rps~~~~l~  308 (329)
                      |+.+||+.||++|||+.++++
T Consensus       261 li~~~L~~dp~~R~s~~e~l~  281 (484)
T 3nyv_A          261 LIRKMLTYVPSMRISARDALD  281 (484)
T ss_dssp             HHHHHTCSSGGGSCCHHHHHT
T ss_pred             HHHHHCCCChhHCcCHHHHhh
Confidence            999999999999999999997

>2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens}

Probab=100.00  E-value=7.4e-47  Score=340.99  Aligned_cols=261  Identities=15%  Similarity=0.128  Sum_probs=207.0

Q ss_pred             CcccccccCCCCCCcEEEEEEeC---------CCCEEEEEEeCCCCChhHHHHHHHHHHHhcCCCccccc----------
Q 020221           57 AMENIVSEHGEKAPNVVYKGKLE---------NQFRIAVKRFNRSAWPDARQFLEEARAVGQLRNRRLAN----------  117 (329)
Q Consensus        57 ~~~~~~~~lg~G~~g~V~~~~~~---------~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~----------  117 (329)
                      ..|.+.+.||+|+||.||+|...         +++.||+|.+...     +.+.+|+++++.++||||++          
T Consensus        42 ~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~-----~~~~~E~~~l~~l~h~niv~~~~~~~~~~~  116 (352)
T 2jii_A           42 RQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD-----GRLFNEQNFFQRAAKPLQVNKWKKLYSTPL  116 (352)
T ss_dssp             CEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT-----STHHHHHHHHHHHCCHHHHHHHHHHTTCTT
T ss_pred             CeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc-----chHHHHHHHHHHhcccchhhhhhhhccCCc
Confidence            46778888999999999999954         3789999998754     35678999999999999998          


Q ss_pred             -----cceeeee-CCeeEEEEecCCCCCHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCC
Q 020221          118 -----LLGCCCE-GDERLLVAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDD  191 (329)
Q Consensus       118 -----~~~~~~~-~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~  191 (329)
                           +++++.. ....++||||+ +++|.+++.......+++..++.++.||+.||.|||++ +++||||||+||+++.
T Consensus       117 ~~i~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~-~ivH~Dikp~NIl~~~  194 (352)
T 2jii_A          117 LAIPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVSPKHVLSERSVLQVACRLLDALEFLHEN-EYVHGNVTAENIFVDP  194 (352)
T ss_dssp             CSCCCCCEEEEETTTEEEEEEECC-CEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHT-TCBCSCCCGGGEEEET
T ss_pred             cCccchhhccccCCcEEEEEecCC-CcCHHHHHHhCCcCCCCHHHHHHHHHHHHHHHHHHHhC-CccCCCCCHHHEEEcC
Confidence                 5566655 67889999999 99999999754346799999999999999999999999 9999999999999999


Q ss_pred             CC--CeeeecccCcccCCCC-----------CCccCcccccCcccccCCCCCCcccchhhhHHHHHHHhCCCCCCchh--
Q 020221          192 DV--NPRLSCFGLMKNSRDG-----------RSYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHA--  256 (329)
Q Consensus       192 ~~--~~kl~Dfg~a~~~~~~-----------~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~--  256 (329)
                      ++  .+||+|||+++.....           ....+|+.|+|||++.+..++.++||||||+++|+|++|..||....  
T Consensus       195 ~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~  274 (352)
T 2jii_A          195 EDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGCGPSRRSDLQSLGYCMLKWLYGFLPWTNCLPN  274 (352)
T ss_dssp             TEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGGTTC
T ss_pred             CCCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCcccCCcC
Confidence            98  8999999999764422           23367899999999999899999999999999999999998886542  


Q ss_pred             hHHHhhhch--hhhccccccC-CCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhhccccccCcc
Q 020221          257 LDLIRDRNI--QTLTDSCLEG-QFSSDEGTELVRLASRCLQYEPRERPNPRSLVTALVTLQKDTELYLSLP  324 (329)
Q Consensus       257 ~~~~~~~~~--~~~~~~~~~~-~~~~~~~~~~~~li~~cl~~dp~~Rps~~~~l~~L~~~~~~~~~~~~~p  324 (329)
                      .........  .......... ......++++.+++.+||+.||++|||+.++++.|+++.+......+.|
T Consensus       275 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~~~~~~~~~~  345 (352)
T 2jii_A          275 TEDIMKQKQKFVDKPGPFVGPCGHWIRPSETLQKYLKVVMALTYEEKPPYAMLRNNLEALLQDLRVSPYDP  345 (352)
T ss_dssp             HHHHHHHHHHHHHSCCCEECTTSCEECCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHHTTCCTTSC
T ss_pred             HHHHHHHHHhccCChhhhhhhccccCCCcHHHHHHHHHHHhCChhhCCCHHHHHHHHHHHHHhcCCCcCcc
Confidence            111111110  1011111000 0112346889999999999999999999999999999988766554444

>1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ...

Probab=100.00  E-value=8.9e-47  Score=336.12  Aligned_cols=254  Identities=20%  Similarity=0.322  Sum_probs=208.3

Q ss_pred             cccccccCCCCCCcEEEEEEeC------CCCEEEEEEeCCCCCh-hHHHHHHHHHHHhcCCCccccccceeeeeCCeeEE
Q 020221           58 MENIVSEHGEKAPNVVYKGKLE------NQFRIAVKRFNRSAWP-DARQFLEEARAVGQLRNRRLANLLGCCCEGDERLL  130 (329)
Q Consensus        58 ~~~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l  130 (329)
                      .|++.+.||+|+||.||+|...      +++.||+|.+...... ....+.+|+.+++.++||||+++++++.+.+..++
T Consensus        26 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~l  105 (322)
T 1p4o_A           26 KITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLV  105 (322)
T ss_dssp             GEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECSSSSCEE
T ss_pred             heeeeeEeccCCceEEEeeeecCccCCCCceEEEEEecccccCHHHHHHHHHHHHHHHhcCCCCEeeeEEEEccCCccEE
Confidence            4677788899999999999843      3678999999865432 34568899999999999999999999999999999


Q ss_pred             EEecCCCCCHHhhhccCC--------CCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCCCCCeeeecccC
Q 020221          131 VAEYMPNDTLAKHLFHWE--------TQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGL  202 (329)
Q Consensus       131 v~e~~~~gsL~~~l~~~~--------~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~  202 (329)
                      ||||+++|+|.+++....        ...+++..+..++.|++.||.|||++ |++||||||+||+++.++.+||+|||+
T Consensus       106 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~-~i~H~dikp~NIli~~~~~~kl~Dfg~  184 (322)
T 1p4o_A          106 IMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNAN-KFVHRDLAARNCMVAEDFTVKIGDFGM  184 (322)
T ss_dssp             EEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHT-TCBCSCCSGGGEEECTTCCEEECCTTC
T ss_pred             EEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHHC-CCccCCCccceEEEcCCCeEEECcCcc
Confidence            999999999999986421        24578999999999999999999999 999999999999999999999999999


Q ss_pred             cccCCCCC------CccCcccccCcccccCCCCCCcccchhhhHHHHHHHh-CCCCCCchhhHHHhhhchhhhccccccC
Q 020221          203 MKNSRDGR------SYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLS-GKHIPPSHALDLIRDRNIQTLTDSCLEG  275 (329)
Q Consensus       203 a~~~~~~~------~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t-g~~~~~~~~~~~~~~~~~~~~~~~~~~~  275 (329)
                      +.......      ...+++.|+|||.+.+..++.++||||||+++|+|++ |..|+...............     ...
T Consensus       185 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~-----~~~  259 (322)
T 1p4o_A          185 TRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVMEG-----GLL  259 (322)
T ss_dssp             CCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHHHHHHHHTT-----CCC
T ss_pred             ccccccccccccccCCCCCCCccChhhhccCCCCchhhHHHHHHHHHHHHhcCCCccccCCHHHHHHHHHcC-----CcC
Confidence            87543322      2345788999999998889999999999999999999 67666543332222211111     112


Q ss_pred             CCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhhcc
Q 020221          276 QFSSDEGTELVRLASRCLQYEPRERPNPRSLVTALVTLQKDT  317 (329)
Q Consensus       276 ~~~~~~~~~~~~li~~cl~~dp~~Rps~~~~l~~L~~~~~~~  317 (329)
                      ..+...++++.+++.+||+.||++|||+.++++.|+++....
T Consensus       260 ~~~~~~~~~l~~li~~~l~~dp~~Rps~~e~l~~L~~~~~~~  301 (322)
T 1p4o_A          260 DKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEMEPG  301 (322)
T ss_dssp             CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSCTT
T ss_pred             CCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHhhccC
Confidence            234566788999999999999999999999999999886543

>3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A

Probab=100.00  E-value=2.1e-46  Score=363.78  Aligned_cols=245  Identities=19%  Similarity=0.234  Sum_probs=206.9

Q ss_pred             CCCcccccccCCCCCCcEEEEEE-eCCCCEEEEEEeCCCC---ChhHHHHHHHHHHHhcC-CCccccccceeeeeCCeeE
Q 020221           55 GFAMENIVSEHGEKAPNVVYKGK-LENQFRIAVKRFNRSA---WPDARQFLEEARAVGQL-RNRRLANLLGCCCEGDERL  129 (329)
Q Consensus        55 ~~~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~  129 (329)
                      ....|++++.||+|+||.||++. ..+++.||||+++...   ....+.+..|..++..+ +||||+++++++.+.+.++
T Consensus       339 ~~~~f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~~~~~~  418 (674)
T 3pfq_A          339 KLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLY  418 (674)
T ss_dssp             -CTTEEEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEECBCSSEEE
T ss_pred             cccceEEEEEEccCCCEEEEEEEECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEEEeCCEEE
Confidence            35668888999999999999999 5568899999987531   22345678899999988 7999999999999999999


Q ss_pred             EEEecCCCCCHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCCCCCeeeecccCcccCCC-
Q 020221          130 LVAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRD-  208 (329)
Q Consensus       130 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~-  208 (329)
                      +||||+++|+|.+++..  ...+++..+..++.||+.||.|||++ +|+||||||+|||++.++.+||+|||+++.... 
T Consensus       419 lV~E~~~gg~L~~~l~~--~~~~~~~~~~~~~~qi~~aL~~LH~~-gIiHrDLKp~NILl~~~g~ikL~DFGla~~~~~~  495 (674)
T 3pfq_A          419 FVMEYVNGGDLMYHIQQ--VGRFKEPHAVFYAAEIAIGLFFLQSK-GIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWD  495 (674)
T ss_dssp             EEEECCCSCBHHHHHHH--HSSCCHHHHHHHHHHHHHHHHHHHHT-SEECCCCCSTTEEECSSSCEEECCCTTCEECCCT
T ss_pred             EEEeCcCCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhC-CeEeccCChhhEEEcCCCcEEEeecceeeccccC
Confidence            99999999999999973  35799999999999999999999999 999999999999999999999999999985322 


Q ss_pred             ---CCCccCcccccCcccccCCCCCCcccchhhhHHHHHHHhCCCCCCchhhHHHhhhchhhhccccccCCCChHHHHHH
Q 020221          209 ---GRSYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTEL  285 (329)
Q Consensus       209 ---~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  285 (329)
                         .....||+.|+|||++.+..++.++||||||+++|||++|..||...............      ...++...++++
T Consensus       496 ~~~~~~~~GT~~Y~APE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~------~~~~p~~~s~~~  569 (674)
T 3pfq_A          496 GVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEH------NVAYPKSMSKEA  569 (674)
T ss_dssp             TCCBCCCCSCSSSCCHHHHTCCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHSS------CCCCCTTSCHHH
T ss_pred             CcccccccCCCcccCHhhhcCCCCCccceEechHHHHHHHHcCCCCCCCCCHHHHHHHHHhC------CCCCCccCCHHH
Confidence               23457899999999999999999999999999999999999998765444333322221      123556778899


Q ss_pred             HHHHHHhcccCCCCCCCH-----HHHHH
Q 020221          286 VRLASRCLQYEPRERPNP-----RSLVT  308 (329)
Q Consensus       286 ~~li~~cl~~dp~~Rps~-----~~~l~  308 (329)
                      .+|+.+||+.||++||++     .+|++
T Consensus       570 ~~li~~lL~~dP~~R~~~~~~~~~ei~~  597 (674)
T 3pfq_A          570 VAICKGLMTKHPGKRLGCGPEGERDIKE  597 (674)
T ss_dssp             HHHHHHHSCSSSTTCTTCSTTHHHHHHS
T ss_pred             HHHHHHHccCCHHHCCCCCCCcHHHHhc
Confidence            999999999999999997     66654

>3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A*

Probab=100.00  E-value=7.6e-46  Score=334.19  Aligned_cols=250  Identities=17%  Similarity=0.212  Sum_probs=197.8

Q ss_pred             CCCcccccccCCCCCCcEEEEEEe-CCCCEEEEEEeCCCCCh--hHHHHHHHHHHHhcCCCccccccceeeee-------
Q 020221           55 GFAMENIVSEHGEKAPNVVYKGKL-ENQFRIAVKRFNRSAWP--DARQFLEEARAVGQLRNRRLANLLGCCCE-------  124 (329)
Q Consensus        55 ~~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~--~~~~~~~e~~~l~~l~h~niv~~~~~~~~-------  124 (329)
                      ....|++++.||+|+||+||+|.. .+++.||+|++......  ....+.+|+.+++.++||||+++++++..       
T Consensus        15 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~   94 (351)
T 3mi9_A           15 EVSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNR   94 (351)
T ss_dssp             BGGGEEEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSCSSSSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC------
T ss_pred             cccceeEEEEEecCCCcEEEEEEECCCCCEEEEEEEecccccccchHHHHHHHHHHHhccCCCcccHhheeecccccccc
Confidence            346788999999999999999995 67899999998655322  24567899999999999999999999876       


Q ss_pred             -CCeeEEEEecCCCCCHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCCCCCeeeecccCc
Q 020221          125 -GDERLLVAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLM  203 (329)
Q Consensus       125 -~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a  203 (329)
                       .+..++||||+++ +|.+.+.. ....+++..+..++.|++.||.|||++ |++||||||+||+++.++.+||+|||++
T Consensus        95 ~~~~~~lv~e~~~~-~l~~~l~~-~~~~~~~~~~~~i~~qi~~~l~~LH~~-~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a  171 (351)
T 3mi9_A           95 CKGSIYLVFDFCEH-DLAGLLSN-VLVKFTLSEIKRVMQMLLNGLYYIHRN-KILHRDMKAANVLITRDGVLKLADFGLA  171 (351)
T ss_dssp             --CEEEEEEECCSE-EHHHHHHC-TTSCCCHHHHHHHHHHHHHHHHHHHHT-TEECCCCSGGGEEECTTSCEEECCCTTC
T ss_pred             CCceEEEEEeccCC-CHHHHHhh-ccCCCCHHHHHHHHHHHHHHHHHHHHC-CeeCCCCCHHHEEEcCCCCEEEccchhc
Confidence             3468999999986 78777754 345699999999999999999999999 9999999999999999999999999998


Q ss_pred             ccCCCC--------CCccCcccccCcccccCC-CCCCcccchhhhHHHHHHHhCCCCCCchhhHHHhhhchhhhcccccc
Q 020221          204 KNSRDG--------RSYSTNLAFTPPEYLRTG-RVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLE  274 (329)
Q Consensus       204 ~~~~~~--------~~~~~~~~y~aPE~~~~~-~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~  274 (329)
                      ......        ....+|+.|+|||++.+. .++.++||||||+++|+|++|..||.............. .......
T Consensus       172 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~-~~~~~~~  250 (351)
T 3mi9_A          172 RAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQ-LCGSITP  250 (351)
T ss_dssp             EECCCCSSSSCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHH-HHCCCCT
T ss_pred             ccccccccccccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHH-HhCCCCh
Confidence            754321        234578999999998764 489999999999999999999988865433222111110 0000000


Q ss_pred             CCCC----------------------h-----HHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 020221          275 GQFS----------------------S-----DEGTELVRLASRCLQYEPRERPNPRSLVT  308 (329)
Q Consensus       275 ~~~~----------------------~-----~~~~~~~~li~~cl~~dp~~Rps~~~~l~  308 (329)
                      ..++                      .     ..++++.+|+.+||+.||++|||+.++++
T Consensus       251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~  311 (351)
T 3mi9_A          251 EVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALN  311 (351)
T ss_dssp             TTSTTGGGCGGGTSSCCCSSCCCCHHHHHHHHHCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             hhccccccchhhcccccccccccCHHHHhhhccCChHHHHHHHHHhcCChhhCCCHHHHhC
Confidence            0000                      0     01567899999999999999999999998

>2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B*

Probab=100.00  E-value=9.6e-47  Score=329.75  Aligned_cols=246  Identities=19%  Similarity=0.292  Sum_probs=204.6

Q ss_pred             cccccccCCCCCCcEEEEEEeC-CCCEEEEEEeCCCCChhHHHHHHHHHHHhcCCCccccccceeeee------------
Q 020221           58 MENIVSEHGEKAPNVVYKGKLE-NQFRIAVKRFNRSAWPDARQFLEEARAVGQLRNRRLANLLGCCCE------------  124 (329)
Q Consensus        58 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~------------  124 (329)
                      .|++++.||+|+||.||++... +++.||+|.+....    +.+.+|+++++.++||||+++++++..            
T Consensus        12 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~~   87 (284)
T 2a19_B           12 DFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN----EKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETSSKNS   87 (284)
T ss_dssp             HEEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECCS----GGGHHHHHHHHHCCCTTBCCEEEEEEEEEEC--------
T ss_pred             ccceeeeeccCCceEEEEEEEcCCCeEEEEEEecccc----HHHHHHHHHHHhCCCCCEEEEeeeEeccccCcccccccc
Confidence            3667778899999999999954 78999999997654    346689999999999999999998754            


Q ss_pred             ----CCeeEEEEecCCCCCHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCCCCCeeeecc
Q 020221          125 ----GDERLLVAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCF  200 (329)
Q Consensus       125 ----~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Df  200 (329)
                          ....++||||+++++|.+++.......+++..++.++.|++.||.|||+. |++|+||||+||+++.++.++|+||
T Consensus        88 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~-~i~H~dlkp~Nil~~~~~~~kl~Df  166 (284)
T 2a19_B           88 SRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIHSK-KLINRDLKPSNIFLVDTKQVKIGDF  166 (284)
T ss_dssp             -CCEEEEEEEEECCCCSCBHHHHHHHGGGSCCCHHHHHHHHHHHHHHHHHHHHT-TEECSCCSGGGEEEEETTEEEECCC
T ss_pred             cccCcceEEEEEeccCCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhC-CeeeccCCHHHEEEcCCCCEEECcc
Confidence                34589999999999999999754456799999999999999999999999 9999999999999999999999999


Q ss_pred             cCcccCCCC---CCccCcccccCcccccCCCCCCcccchhhhHHHHHHHhCCCCCCchhhHHHhhhchhhhccccccCCC
Q 020221          201 GLMKNSRDG---RSYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQF  277 (329)
Q Consensus       201 g~a~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  277 (329)
                      |++......   ....+++.|+|||.+.+..++.++||||||+++|+|++|..|+.... . ..    ....    ....
T Consensus       167 g~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~-~-~~----~~~~----~~~~  236 (284)
T 2a19_B          167 GLVTSLKNDGKRTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFETS-K-FF----TDLR----DGII  236 (284)
T ss_dssp             TTCEESSCCSCCCCCCSCCTTSCHHHHHCSCCCTHHHHHHHHHHHHHHHSCCSSHHHHH-H-HH----HHHH----TTCC
T ss_pred             hhheeccccccccccCCcccccChhhhccCCCcchhhhHHHHHHHHHHHhcCCcchhHH-H-HH----HHhh----cccc
Confidence            998765543   33467899999999998889999999999999999999997653221 1 11    1111    1123


Q ss_pred             ChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhhccc
Q 020221          278 SSDEGTELVRLASRCLQYEPRERPNPRSLVTALVTLQKDTE  318 (329)
Q Consensus       278 ~~~~~~~~~~li~~cl~~dp~~Rps~~~~l~~L~~~~~~~~  318 (329)
                      +...+..+.+++.+||+.||++|||+.++++.|..+.+..+
T Consensus       237 ~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~l~~~~~~~~  277 (284)
T 2a19_B          237 SDIFDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVWKKSPE  277 (284)
T ss_dssp             CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHTC---
T ss_pred             cccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhhCCC
Confidence            34456789999999999999999999999999999987654

>3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A*

Probab=100.00  E-value=2.6e-46  Score=331.93  Aligned_cols=255  Identities=22%  Similarity=0.305  Sum_probs=199.0

Q ss_pred             CcccccccCCCCCCcEEEEEEeC----CCCEEEEEEeCCCCC--hhHHHHHHHHHHHhcCCCccccccceeeeeCC----
Q 020221           57 AMENIVSEHGEKAPNVVYKGKLE----NQFRIAVKRFNRSAW--PDARQFLEEARAVGQLRNRRLANLLGCCCEGD----  126 (329)
Q Consensus        57 ~~~~~~~~lg~G~~g~V~~~~~~----~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~----  126 (329)
                      ..|.+.+.||+|+||.||+|...    ++..||+|.+.....  ...+.+.+|+.+++.++||||+++++++.+..    
T Consensus        34 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~  113 (313)
T 3brb_A           34 NLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGVCIEMSSQGI  113 (313)
T ss_dssp             GGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEC------
T ss_pred             HHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEeccccchhHHHHHHHHHHHHhcCCCCCeeeeeEEEeeccccCC
Confidence            45677788899999999999843    345799999976532  23456899999999999999999999987654    


Q ss_pred             -eeEEEEecCCCCCHHhhhccC----CCCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCCCCCeeeeccc
Q 020221          127 -ERLLVAEYMPNDTLAKHLFHW----ETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFG  201 (329)
Q Consensus       127 -~~~lv~e~~~~gsL~~~l~~~----~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg  201 (329)
                       ..++||||+++++|.+++...    ....+++..++.++.|++.||.|||++ +++||||||+||+++.++.+||+|||
T Consensus       114 ~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~-~ivH~dikp~NIli~~~~~~kl~Dfg  192 (313)
T 3brb_A          114 PKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNR-NFLHRDLAARNCMLRDDMTVCVADFG  192 (313)
T ss_dssp             -CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHTT-TCCCCCCSGGGEEECTTSCEEECSCS
T ss_pred             cccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHhC-CcccCCCCcceEEEcCCCcEEEeecC
Confidence             359999999999999998431    345789999999999999999999999 99999999999999999999999999


Q ss_pred             CcccCCCC------CCccCcccccCcccccCCCCCCcccchhhhHHHHHHHh-CCCCCCchhhHHHhhhchhhhcccccc
Q 020221          202 LMKNSRDG------RSYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLS-GKHIPPSHALDLIRDRNIQTLTDSCLE  274 (329)
Q Consensus       202 ~a~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t-g~~~~~~~~~~~~~~~~~~~~~~~~~~  274 (329)
                      ++......      ....+++.|+|||.+.+..++.++||||||+++|+|++ |..|+..............     ...
T Consensus       193 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~-----~~~  267 (313)
T 3brb_A          193 LSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNHEMYDYLLH-----GHR  267 (313)
T ss_dssp             CC----------------CCGGGSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHT-----TCC
T ss_pred             cceecccccccCcccccCCCccccCchhhcCCCccchhhhHHHHHHHHHHHhcCCCCCccCCHHHHHHHHHc-----CCC
Confidence            99765432      22345788999999999899999999999999999999 7666654332222211111     112


Q ss_pred             CCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhhcc
Q 020221          275 GQFSSDEGTELVRLASRCLQYEPRERPNPRSLVTALVTLQKDT  317 (329)
Q Consensus       275 ~~~~~~~~~~~~~li~~cl~~dp~~Rps~~~~l~~L~~~~~~~  317 (329)
                      ...+...++++.+++.+||+.||++|||+.++++.|+.+.+..
T Consensus       268 ~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~l~~~l  310 (313)
T 3brb_A          268 LKQPEDCLDELYEIMYSCWRTDPLDRPTFSVLRLQLEKLLESL  310 (313)
T ss_dssp             CCCBTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHHC
T ss_pred             CCCCccccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhc
Confidence            2344566788999999999999999999999999999987653

>2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A

Probab=100.00  E-value=8.2e-47  Score=339.12  Aligned_cols=243  Identities=19%  Similarity=0.234  Sum_probs=197.7

Q ss_pred             CcccccccCCCCCCcEEEEEEe-CCCCEEEEEEeCCCCChhHHHHHHHHHHHhcC-CCccccccceeeeeCCeeEEEEec
Q 020221           57 AMENIVSEHGEKAPNVVYKGKL-ENQFRIAVKRFNRSAWPDARQFLEEARAVGQL-RNRRLANLLGCCCEGDERLLVAEY  134 (329)
Q Consensus        57 ~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~  134 (329)
                      +.|++++.||+|+||.||++.. .+++.||+|++......    ..+|++++..+ +||||+++++++.++...++||||
T Consensus        22 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~----~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~   97 (342)
T 2qr7_A           22 DGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKRD----PTEEIEILLRYGQHPNIITLKDVYDDGKYVYVVTEL   97 (342)
T ss_dssp             HHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTTCC----CHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEECC
T ss_pred             ccEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEcccCC----hHHHHHHHHHhcCCCCcCeEEEEEEcCCEEEEEEeC
Confidence            3477888899999999999994 56889999999765432    34688888887 799999999999999999999999


Q ss_pred             CCCCCHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCCC-C---CeeeecccCcccCCCC-
Q 020221          135 MPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDD-V---NPRLSCFGLMKNSRDG-  209 (329)
Q Consensus       135 ~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~-~---~~kl~Dfg~a~~~~~~-  209 (329)
                      +++|+|.+++.  ....+++..+..++.||+.||.|||++ |++||||||+||++.+. +   .+||+|||++...... 
T Consensus        98 ~~gg~L~~~i~--~~~~~~~~~~~~~~~qi~~al~~lH~~-givHrDlkp~NIl~~~~~~~~~~~kl~Dfg~a~~~~~~~  174 (342)
T 2qr7_A           98 MKGGELLDKIL--RQKFFSEREASAVLFTITKTVEYLHAQ-GVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAEN  174 (342)
T ss_dssp             CCSCBHHHHHH--TCTTCCHHHHHHHHHHHHHHHHHHHHT-TEECSCCCGGGEEESSSSCSGGGEEECCCTTCEECBCTT
T ss_pred             CCCCcHHHHHH--HcCCCCHHHHHHHHHHHHHHHHHHHHC-CcEeccCCHHHEEEecCCCCcCeEEEEECCCcccCcCCC
Confidence            99999999987  446799999999999999999999999 99999999999998533 3   4999999999865433 


Q ss_pred             ---CCccCcccccCcccccCCCCCCcccchhhhHHHHHHHhCCCCCCchh---hHHHhhhchhhhccccccCCCChHHHH
Q 020221          210 ---RSYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHA---LDLIRDRNIQTLTDSCLEGQFSSDEGT  283 (329)
Q Consensus       210 ---~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~  283 (329)
                         ....+|+.|+|||++.+..++.++||||||+++|+|++|..||....   ...+.........  ..........++
T Consensus       175 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~~~~--~~~~~~~~~~s~  252 (342)
T 2qr7_A          175 GLLMTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANGPDDTPEEILARIGSGKF--SLSGGYWNSVSD  252 (342)
T ss_dssp             CCBCCSSCCSSCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHSSCSSCSSTTSCHHHHHHHHHHCCC--CCCSTTTTTSCH
T ss_pred             CceeccCCCccccCHHHhcCCCCCCccCeeeHhHHHHHHhcCCCCCCCCCcCCHHHHHHHHccCCc--ccCccccccCCH
Confidence               23467899999999988778999999999999999999999886421   1111111111111  111223345678


Q ss_pred             HHHHHHHHhcccCCCCCCCHHHHHH
Q 020221          284 ELVRLASRCLQYEPRERPNPRSLVT  308 (329)
Q Consensus       284 ~~~~li~~cl~~dp~~Rps~~~~l~  308 (329)
                      ++.+|+.+||..||++|||+.++++
T Consensus       253 ~~~~li~~~L~~dP~~R~t~~~il~  277 (342)
T 2qr7_A          253 TAKDLVSKMLHVDPHQRLTAALVLR  277 (342)
T ss_dssp             HHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred             HHHHHHHHHCCCChhHCcCHHHHhc
Confidence            9999999999999999999999987

>3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A*

Probab=100.00  E-value=2.2e-46  Score=352.61  Aligned_cols=245  Identities=16%  Similarity=0.179  Sum_probs=198.7

Q ss_pred             cccccccCCCCCCcEEEEEEe-CCCCEEEEEEeCCCC--ChhHHHHHHHHHHHhcCCCccccccceeeeeCCeeEEEEec
Q 020221           58 MENIVSEHGEKAPNVVYKGKL-ENQFRIAVKRFNRSA--WPDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAEY  134 (329)
Q Consensus        58 ~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  134 (329)
                      .|++++.||+|+||+||+|.. .++..||+|++....  ......+.+|+.+++.++||||+++++++.+....++||||
T Consensus        38 ~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~  117 (494)
T 3lij_A           38 MYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLVMEC  117 (494)
T ss_dssp             HEEEEEEEECC---EEEEEEETTTCCEEEEEEEEC-----CTTHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred             CeEEeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEEec
Confidence            478888999999999999994 578899999997653  22356788999999999999999999999999999999999


Q ss_pred             CCCCCHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCC---CCCeeeecccCcccCCCC--
Q 020221          135 MPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDD---DVNPRLSCFGLMKNSRDG--  209 (329)
Q Consensus       135 ~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~---~~~~kl~Dfg~a~~~~~~--  209 (329)
                      +++|+|.+.+.  ....+++..+..++.||+.||.|||++ ||+||||||+|||++.   ++.+||+|||++......  
T Consensus       118 ~~~g~L~~~~~--~~~~~~~~~~~~i~~qi~~~l~~lH~~-~ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a~~~~~~~~  194 (494)
T 3lij_A          118 YKGGELFDEII--HRMKFNEVDAAVIIKQVLSGVTYLHKH-NIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQKK  194 (494)
T ss_dssp             CCSCBHHHHHH--HHSSCCHHHHHHHHHHHHHHHHHHHHT-TEECSCCSGGGEEESCSSTTCCEEECCCTTCEECBTTBC
T ss_pred             CCCCcHHHHHH--HcCCCCHHHHHHHHHHHHHHHHHHHHC-CceeccCChhhEEEeCCCCCCcEEEEECCCCeECCCCcc
Confidence            99999999886  345789999999999999999999999 9999999999999976   455999999999765543  


Q ss_pred             -CCccCcccccCcccccCCCCCCcccchhhhHHHHHHHhCCCCCCchhhHHHhhhchhhhccccccCCCChHHHHHHHHH
Q 020221          210 -RSYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRL  288 (329)
Q Consensus       210 -~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  288 (329)
                       ....||+.|+|||++. ..++.++||||||+++|+|++|..||...................  ........++++.+|
T Consensus       195 ~~~~~gt~~y~aPE~l~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~--~~~~~~~~s~~~~~l  271 (494)
T 3lij_A          195 MKERLGTAYYIAPEVLR-KKYDEKCDVWSIGVILFILLAGYPPFGGQTDQEILRKVEKGKYTF--DSPEWKNVSEGAKDL  271 (494)
T ss_dssp             BCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCC--CSGGGTTSCHHHHHH
T ss_pred             ccccCCCcCeeCHHHHc-ccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCC--CchhcccCCHHHHHH
Confidence             3456899999999987 569999999999999999999999887654433322222111110  011113457889999


Q ss_pred             HHHhcccCCCCCCCHHHHHH
Q 020221          289 ASRCLQYEPRERPNPRSLVT  308 (329)
Q Consensus       289 i~~cl~~dp~~Rps~~~~l~  308 (329)
                      +.+||+.||++|||+.++++
T Consensus       272 i~~~L~~dp~~R~s~~e~l~  291 (494)
T 3lij_A          272 IKQMLQFDSQRRISAQQALE  291 (494)
T ss_dssp             HHHHTCSSTTTSCCHHHHHT
T ss_pred             HHHHCCCChhhCccHHHHhc
Confidence            99999999999999999996

>3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A*

Probab=100.00  E-value=5.3e-46  Score=343.75  Aligned_cols=248  Identities=18%  Similarity=0.212  Sum_probs=199.6

Q ss_pred             cccccccCCCCCCcEEEEEE-eCCCCEEEEEEeCCCCChhHHHHHHHHHHHhcC------CCccccccceeeeeCCeeEE
Q 020221           58 MENIVSEHGEKAPNVVYKGK-LENQFRIAVKRFNRSAWPDARQFLEEARAVGQL------RNRRLANLLGCCCEGDERLL  130 (329)
Q Consensus        58 ~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l------~h~niv~~~~~~~~~~~~~l  130 (329)
                      .|++++.||+|+||+||+|. ..+++.||||++.... ...+.+.+|+++++.+      .|+||+++++++......++
T Consensus        98 ry~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~~-~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~~~~~~~l  176 (429)
T 3kvw_A           98 RYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNEK-RFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTFRNHICM  176 (429)
T ss_dssp             TEEEEEEEEESSSEEEEEEEETTTTEEEEEEEECSCH-HHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEEETTEEEE
T ss_pred             cEEEEEEcccCccEEEEEEEECCCCcEEEEEEECCcc-chHHHHHHHHHHHHHHhhccccCCcCEEEEEeecccCCeEEE
Confidence            47788889999999999998 4568899999997643 3345677788887776      57799999999999999999


Q ss_pred             EEecCCCCCHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCCCCC--eeeecccCcccCCC
Q 020221          131 VAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVN--PRLSCFGLMKNSRD  208 (329)
Q Consensus       131 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~--~kl~Dfg~a~~~~~  208 (329)
                      ||||+. ++|.+++.......+++..+..++.||+.||+|||+. +|+||||||+|||++.++.  +||+|||++.....
T Consensus       177 v~e~~~-~~L~~~l~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~-~ivHrDlKp~NILl~~~~~~~vkL~DFG~a~~~~~  254 (429)
T 3kvw_A          177 TFELLS-MNLYELIKKNKFQGFSLPLVRKFAHSILQCLDALHKN-RIIHCDLKPENILLKQQGRSGIKVIDFGSSCYEHQ  254 (429)
T ss_dssp             EECCCC-CBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHH-TEECSCCSGGGEEESSTTSCCEEECCCTTCEETTC
T ss_pred             EEeccC-CCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHC-CeecCCCCHHHeEEccCCCcceEEeecccceecCC
Confidence            999996 5899999765556799999999999999999999999 9999999999999999887  99999999976544


Q ss_pred             C-CCccCcccccCcccccCCCCCCcccchhhhHHHHHHHhCCCCCCchhhHHHhhhchhh-----------------hcc
Q 020221          209 G-RSYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQT-----------------LTD  270 (329)
Q Consensus       209 ~-~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~~~~~~~~-----------------~~~  270 (329)
                      . ....+|+.|+|||++.+..++.++|||||||++|||++|..||...............                 ...
T Consensus       255 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~l~~i~~~~~~p~~~~~~~~~~~~~~~~  334 (429)
T 3kvw_A          255 RVYTYIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTGYPLLPGEDEGDQLACMIELLGMPSQKLLDASKRAKNFVS  334 (429)
T ss_dssp             CCCSSCSCGGGCCHHHHHTBCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHTBTTHHHHBC
T ss_pred             cccccCCCCCccChHHHhCCCCCchHHHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHhhhhhhhccC
Confidence            3 3457899999999999999999999999999999999999888654322111110000                 000


Q ss_pred             cc---------------------------cc-C--------CCChHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 020221          271 SC---------------------------LE-G--------QFSSDEGTELVRLASRCLQYEPRERPNPRSLVT  308 (329)
Q Consensus       271 ~~---------------------------~~-~--------~~~~~~~~~~~~li~~cl~~dp~~Rps~~~~l~  308 (329)
                      ..                           .. .        ..+...++++.+|+.+||+.||++|||+.++++
T Consensus       335 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~dli~~~L~~dP~~Rpta~e~L~  408 (429)
T 3kvw_A          335 SKGYPRYCTVTTLSDGSVVLNGGRSRRGKLRGPPESREWGNALKGCDDPLFLDFLKQCLEWDPAVRMTPGQALR  408 (429)
T ss_dssp             TTSCBTTSCEECCCC--CEECCEECTTCCEECSTTCSCHHHHTTTCCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             CCCCcccccccccccccccccccccchhhccCCccchhhHhhccccchHHHHHHHHHHCCCChhhCCCHHHHhC
Confidence            00                           00 0        001122578999999999999999999999998

>3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A*

Probab=100.00  E-value=3e-46  Score=333.73  Aligned_cols=247  Identities=16%  Similarity=0.128  Sum_probs=202.2

Q ss_pred             cccc-ccCCCCCCcEEEEEE-eCCCCEEEEEEeCCCCC--hhHHHHHHHHHHHhcC-CCccccccceeeeeCCeeEEEEe
Q 020221           59 ENIV-SEHGEKAPNVVYKGK-LENQFRIAVKRFNRSAW--PDARQFLEEARAVGQL-RNRRLANLLGCCCEGDERLLVAE  133 (329)
Q Consensus        59 ~~~~-~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e  133 (329)
                      |.+. +.||+|+||.||++. ..+++.||+|++.....  .....+.+|+.+++.+ .||||+++++++......++|||
T Consensus        30 y~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~iv~~~~~~~~~~~~~lv~e  109 (327)
T 3lm5_A           30 YILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHEVYENTSEIILILE  109 (327)
T ss_dssp             EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESEETTEECHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEEE
T ss_pred             EeeccceeCCCCCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHhccCCCCEEEEEEEEEeCCeEEEEEE
Confidence            4454 668999999999999 45689999999876432  2356789999999999 46999999999999999999999


Q ss_pred             cCCCCCHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCC---CCCeeeecccCcccCCCC-
Q 020221          134 YMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDD---DVNPRLSCFGLMKNSRDG-  209 (329)
Q Consensus       134 ~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~---~~~~kl~Dfg~a~~~~~~-  209 (329)
                      |+++|+|.+++.......+++..++.++.|++.||+|||+. |++||||||+||+++.   ++.+||+|||++...... 
T Consensus       110 ~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~L~~LH~~-givH~Dikp~NIl~~~~~~~~~~kL~Dfg~a~~~~~~~  188 (327)
T 3lm5_A          110 YAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYLHQN-NIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHAC  188 (327)
T ss_dssp             CCTTEEGGGGGSSCC-CCCCHHHHHHHHHHHHHHHHHHHHT-TEECSCCCGGGEEESCBTTBCCEEECCGGGCEEC----
T ss_pred             ecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHC-CeecCcCChHHEEEecCCCCCcEEEeeCccccccCCcc
Confidence            99999999998654557799999999999999999999999 9999999999999997   789999999999865543 


Q ss_pred             --CCccCcccccCcccccCCCCCCcccchhhhHHHHHHHhCCCCCCchhhHHHhhhchhhhccccccCCCChHHHHHHHH
Q 020221          210 --RSYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVR  287 (329)
Q Consensus       210 --~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  287 (329)
                        ....+++.|+|||++.+..++.++||||||+++|+|++|..||.................  ..........++.+.+
T Consensus       189 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~--~~~~~~~~~~~~~~~~  266 (327)
T 3lm5_A          189 ELREIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSPFVGEDNQETYLNISQVNV--DYSEETFSSVSQLATD  266 (327)
T ss_dssp             -----CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCC--CCCTTTTTTSCHHHHH
T ss_pred             ccccccCCcCccCCeeecCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHhccc--ccCchhhcccCHHHHH
Confidence              234689999999999999999999999999999999999998866543322222111111  1122233456788999


Q ss_pred             HHHHhcccCCCCCCCHHHHHH
Q 020221          288 LASRCLQYEPRERPNPRSLVT  308 (329)
Q Consensus       288 li~~cl~~dp~~Rps~~~~l~  308 (329)
                      ++.+||+.||++|||+.++++
T Consensus       267 li~~~L~~dP~~Rpt~~~ll~  287 (327)
T 3lm5_A          267 FIQSLLVKNPEKRPTAEICLS  287 (327)
T ss_dssp             HHHHHSCSSGGGSCCHHHHTT
T ss_pred             HHHHHcCCChhhCcCHHHHhC
Confidence            999999999999999999987

>3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ...

Probab=100.00  E-value=2.5e-46  Score=334.40  Aligned_cols=243  Identities=17%  Similarity=0.205  Sum_probs=197.9

Q ss_pred             CcccccccCCCCCCcEEEEEE-eCCCCEEEEEEeCCCCChhHHHHHHHHHHHhcCC-Cccccccceeeee--CCeeEEEE
Q 020221           57 AMENIVSEHGEKAPNVVYKGK-LENQFRIAVKRFNRSAWPDARQFLEEARAVGQLR-NRRLANLLGCCCE--GDERLLVA  132 (329)
Q Consensus        57 ~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~--~~~~~lv~  132 (329)
                      ..|++++.||+|+||+||+|. ..+++.||+|++....   .+.+.+|+.+++.++ ||||+++++++..  ....++||
T Consensus        36 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~lv~  112 (330)
T 3nsz_A           36 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK---KKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVF  112 (330)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSCC---HHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCCEEEEE
T ss_pred             CceEEEEEecccCCeEEEEEEECCCCcEEEEEEecccc---hHHHHHHHHHHHHcCCCCCEEEeeeeeccCCCCceEEEE
Confidence            567888999999999999998 5678999999997543   567889999999997 9999999999987  56789999


Q ss_pred             ecCCCCCHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCCCC-CeeeecccCcccCCCC--
Q 020221          133 EYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDV-NPRLSCFGLMKNSRDG--  209 (329)
Q Consensus       133 e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~-~~kl~Dfg~a~~~~~~--  209 (329)
                      ||+.+++|.+++.     .+++..+..++.|++.||+|||+. |++||||||+|||++.++ .+||+|||++......  
T Consensus       113 e~~~~~~l~~~~~-----~~~~~~~~~~~~qi~~~l~~lH~~-~ivH~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~~  186 (330)
T 3nsz_A          113 EHVNNTDFKQLYQ-----TLTDYDIRFYMYEILKALDYCHSM-GIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQE  186 (330)
T ss_dssp             ECCCCCCHHHHGG-----GCCHHHHHHHHHHHHHHHHHHHHT-TEECCCCSGGGEEEETTTTEEEECCCTTCEECCTTCC
T ss_pred             eccCchhHHHHHH-----hCCHHHHHHHHHHHHHHHHHHHhC-CeeeCCCCHHHEEEcCCCCEEEEEeCCCceEcCCCCc
Confidence            9999999999884     388999999999999999999999 999999999999999776 8999999999865443  


Q ss_pred             -CCccCcccccCcccccC-CCCCCcccchhhhHHHHHHHhCCCCCCchhhHH--Hhh-------hchh------------
Q 020221          210 -RSYSTNLAFTPPEYLRT-GRVTPESVMYSFGTLLLDLLSGKHIPPSHALDL--IRD-------RNIQ------------  266 (329)
Q Consensus       210 -~~~~~~~~y~aPE~~~~-~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~--~~~-------~~~~------------  266 (329)
                       ....++..|+|||.+.+ ..++.++||||||+++|+|++|..||.......  ...       ....            
T Consensus       187 ~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~  266 (330)
T 3nsz_A          187 YNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDP  266 (330)
T ss_dssp             CCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTCCCCT
T ss_pred             cccccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCcccCCchHHHHHHHHHhcCCchhhhHHHHhcccccc
Confidence             33467899999999887 568999999999999999999998884321110  000       0000            


Q ss_pred             -----------hhccccccCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 020221          267 -----------TLTDSCLEGQFSSDEGTELVRLASRCLQYEPRERPNPRSLVT  308 (329)
Q Consensus       267 -----------~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~~~l~  308 (329)
                                 ...........+...++++.+|+.+||+.||++|||+.++++
T Consensus       267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~e~l~  319 (330)
T 3nsz_A          267 RFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAME  319 (330)
T ss_dssp             HHHHHHCCCCCCCGGGGCCTTTGGGCCHHHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred             chhhhhhhccccchhhhccccccccCCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence                       000011111222336789999999999999999999999998

>4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A*

Probab=100.00  E-value=1.1e-46  Score=336.98  Aligned_cols=251  Identities=18%  Similarity=0.268  Sum_probs=199.9

Q ss_pred             CCCcccccccCCCCCCcEEEEEEe-CCCCEEEEEEeCCCCChh--HHHHHHHHHHHhcCCCccccccceeeeeCCeeEEE
Q 020221           55 GFAMENIVSEHGEKAPNVVYKGKL-ENQFRIAVKRFNRSAWPD--ARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLV  131 (329)
Q Consensus        55 ~~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~--~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv  131 (329)
                      .+..|++++.||+|+||.||++.. .+++.||+|++.......  .+.+.+|+.+++.++||||+++++++.+.+..++|
T Consensus        23 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv  102 (331)
T 4aaa_A           23 SMEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEVCKKKKRWYLV  102 (331)
T ss_dssp             CGGGEEEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCSSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred             hhhhheeeeEEeecCCEEEEEEEECCCCceEEEEEEecCCCchHHHHHHHHHHHHHhhCCCCCEeeEEEEeecCCEEEEE
Confidence            446788899999999999999995 558899999986654322  44578999999999999999999999999999999


Q ss_pred             EecCCCCCHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCCCCCeeeecccCcccCCCC--
Q 020221          132 AEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDG--  209 (329)
Q Consensus       132 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~--  209 (329)
                      |||+++++|.+++.  ....+++..+..++.|++.||.|||+. |++|+||||+||+++.++.+||+|||++......  
T Consensus       103 ~e~~~~~~l~~~~~--~~~~~~~~~~~~~~~qi~~~l~~LH~~-~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~  179 (331)
T 4aaa_A          103 FEFVDHTILDDLEL--FPNGLDYQVVQKYLFQIINGIGFCHSH-NIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGE  179 (331)
T ss_dssp             EECCSEEHHHHHHH--STTCCCHHHHHHHHHHHHHHHHHHHHT-TCCCCCCCGGGEEECTTSCEEECCCTTC--------
T ss_pred             EecCCcchHHHHHh--hccCCCHHHHHHHHHHHHHHHHHHHHC-CEEccCcChheEEEcCCCcEEEEeCCCceeecCCcc
Confidence            99999998888765  445799999999999999999999999 9999999999999999999999999999764432  


Q ss_pred             --CCccCcccccCcccccCC-CCCCcccchhhhHHHHHHHhCCCCCCchhhHHHhhhchhh-------------------
Q 020221          210 --RSYSTNLAFTPPEYLRTG-RVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQT-------------------  267 (329)
Q Consensus       210 --~~~~~~~~y~aPE~~~~~-~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~~~~~~~~-------------------  267 (329)
                        ....+++.|+|||++.+. .++.++||||||+++|+|++|..||...............                   
T Consensus       180 ~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  259 (331)
T 4aaa_A          180 VYDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCLGNLIPRHQELFNKNPVFA  259 (331)
T ss_dssp             ----CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHHCGGGT
T ss_pred             ccCCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhHhhhccccc
Confidence              234678999999999876 6889999999999999999999888654322111111000                   


Q ss_pred             -hccccccCC-----CChHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 020221          268 -LTDSCLEGQ-----FSSDEGTELVRLASRCLQYEPRERPNPRSLVT  308 (329)
Q Consensus       268 -~~~~~~~~~-----~~~~~~~~~~~li~~cl~~dp~~Rps~~~~l~  308 (329)
                       ...+.....     .....++++.+|+.+||+.||++|||+.++++
T Consensus       260 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~  306 (331)
T 4aaa_A          260 GVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLH  306 (331)
T ss_dssp             TCCCCCCSSCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCGGGGGG
T ss_pred             cccCccccccchhhhcccchhHHHHHHHHHHhccCcccCCCHHHHhc
Confidence             000000000     01235788999999999999999999999997

>2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens}

Probab=100.00  E-value=5.3e-46  Score=326.92  Aligned_cols=246  Identities=17%  Similarity=0.231  Sum_probs=199.9

Q ss_pred             ccccccCCCCCCcEEEEEE-eCCCCEEEEEEeCCCCChhHHHHHHHHHHHhcCCCccccccceeeeeCCeeEEEEecCCC
Q 020221           59 ENIVSEHGEKAPNVVYKGK-LENQFRIAVKRFNRSAWPDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAEYMPN  137 (329)
Q Consensus        59 ~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~  137 (329)
                      +.....||+|+||.||+|. ..+++.||+|.+........+.+.+|+.+++.++||||+++++++...+..++||||+++
T Consensus        24 ~~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~  103 (295)
T 2clq_A           24 NGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFSENGFIKIFMEQVPG  103 (295)
T ss_dssp             TSSBCEEEECSSSEEEEEEETTTCCEEEEEEEECCCC---HHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCSE
T ss_pred             CCCcEEEeecCcEEEEEEEECCCCeEEEEEEccCCchHHHHHHHHHHHHHHhCCCCCEeeEeeEEEeCCcEEEEEEeCCC
Confidence            3344467999999999999 467889999999877655567799999999999999999999999999999999999999


Q ss_pred             CCHHhhhccCC-CCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCC-CCCeeeecccCcccCCCC----CC
Q 020221          138 DTLAKHLFHWE-TQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDD-DVNPRLSCFGLMKNSRDG----RS  211 (329)
Q Consensus       138 gsL~~~l~~~~-~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~-~~~~kl~Dfg~a~~~~~~----~~  211 (329)
                      ++|.+++.... ...+++..+..++.|++.||.|||+. |++|+||||+||+++. ++.++|+|||++......    ..
T Consensus       104 ~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~-~i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~~~~~~~~~~~~  182 (295)
T 2clq_A          104 GSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDN-QIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPCTET  182 (295)
T ss_dssp             EEHHHHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHT-TEECCCCSGGGEEEETTTCCEEECCTTTCEESCC-----CC
T ss_pred             CCHHHHHHhhccCCCccHHHHHHHHHHHHHHHHHHHhC-CEEccCCChhhEEEECCCCCEEEeecccccccCCCCCcccc
Confidence            99999997532 23567899999999999999999999 9999999999999987 899999999999765432    34


Q ss_pred             ccCcccccCcccccCCC--CCCcccchhhhHHHHHHHhCCCCCCchhhHHHhhhchhhhccccccCCCChHHHHHHHHHH
Q 020221          212 YSTNLAFTPPEYLRTGR--VTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLA  289 (329)
Q Consensus       212 ~~~~~~y~aPE~~~~~~--~~~~~DvwslG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li  289 (329)
                      ..+++.|+|||++.+..  ++.++||||||+++|+|++|..||............   ..........+...++++.+++
T Consensus       183 ~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~li  259 (295)
T 2clq_A          183 FTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQAAMFK---VGMFKVHPEIPESMSAEAKAFI  259 (295)
T ss_dssp             CCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGGSSHHHHHHH---HHHHCCCCCCCTTSCHHHHHHH
T ss_pred             cCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCCCchhHHHHh---hccccccccccccCCHHHHHHH
Confidence            46789999999987654  788999999999999999999887543211111000   0001122334566788999999


Q ss_pred             HHhcccCCCCCCCHHHHHH
Q 020221          290 SRCLQYEPRERPNPRSLVT  308 (329)
Q Consensus       290 ~~cl~~dp~~Rps~~~~l~  308 (329)
                      .+||+.||++|||+.++++
T Consensus       260 ~~~l~~dp~~Rps~~~ll~  278 (295)
T 2clq_A          260 LKCFEPDPDKRACANDLLV  278 (295)
T ss_dssp             HHTTCSSTTTSCCHHHHHT
T ss_pred             HHHccCChhhCCCHHHHhc
Confidence            9999999999999999997

>2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ...

Probab=100.00  E-value=5.6e-46  Score=323.68  Aligned_cols=246  Identities=17%  Similarity=0.134  Sum_probs=201.8

Q ss_pred             CcccccccCCCCCCcEEEEEEe-CCCCEEEEEEeCCCC-ChhHHHHHHHHHHHhcCCCccccccceeeeeCCeeEEEEec
Q 020221           57 AMENIVSEHGEKAPNVVYKGKL-ENQFRIAVKRFNRSA-WPDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAEY  134 (329)
Q Consensus        57 ~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  134 (329)
                      ..|++++.||+|+||.||+|.. .+++.||+|++.... ....+.+.+|+.+++.++||||+++++++.+.+..++||||
T Consensus         7 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   86 (276)
T 2yex_A            7 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEY   86 (276)
T ss_dssp             HHEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGCTTHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred             cceEEEEEeecCCCcEEEEEEECCCCcEEEEEEeeeccchhhhHHHHHHHHHHHhcCCCCceeeeeEEEcCCEEEEEEEe
Confidence            3477888889999999999995 478899999987543 23356789999999999999999999999999999999999


Q ss_pred             CCCCCHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCCCCCeeeecccCcccCCC------
Q 020221          135 MPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRD------  208 (329)
Q Consensus       135 ~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~------  208 (329)
                      +++++|.+++.  ....+++..+..++.|++.||.|||+. |++|+||||+||+++.++.++|+|||++.....      
T Consensus        87 ~~~~~L~~~l~--~~~~~~~~~~~~~~~~i~~~l~~lH~~-~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~  163 (276)
T 2yex_A           87 CSGGELFDRIE--PDIGMPEPDAQRFFHQLMAGVVYLHGI-GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERL  163 (276)
T ss_dssp             CTTEEGGGGSB--TTTBCCHHHHHHHHHHHHHHHHHHHHT-TEECSCCSGGGEEECTTCCEEECCCTTCEECEETTEECC
T ss_pred             cCCCcHHHHHh--hccCCCHHHHHHHHHHHHHHHHHHHhC-CeeccCCChHHEEEccCCCEEEeeCCCccccCCCcchhc
Confidence            99999999986  445789999999999999999999999 999999999999999999999999999875432      


Q ss_pred             CCCccCcccccCcccccCCCC-CCcccchhhhHHHHHHHhCCCCCCchhhHHHhhhchhhhccccccCCCChHHHHHHHH
Q 020221          209 GRSYSTNLAFTPPEYLRTGRV-TPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVR  287 (329)
Q Consensus       209 ~~~~~~~~~y~aPE~~~~~~~-~~~~DvwslG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  287 (329)
                      .....+++.|+|||.+.+..+ +.++||||||+++|+|++|..||............   ..............++.+.+
T Consensus       164 ~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~  240 (276)
T 2yex_A          164 LNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSD---WKEKKTYLNPWKKIDSAPLA  240 (276)
T ss_dssp             BCCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSCTTSHHHHH---HHTTCTTSTTGGGSCHHHHH
T ss_pred             ccCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHHHHHHH---hhhcccccCchhhcCHHHHH
Confidence            234467899999999987765 67899999999999999999888643221110000   00000111112356788999


Q ss_pred             HHHHhcccCCCCCCCHHHHHH
Q 020221          288 LASRCLQYEPRERPNPRSLVT  308 (329)
Q Consensus       288 li~~cl~~dp~~Rps~~~~l~  308 (329)
                      ++.+||+.||++|||+.++++
T Consensus       241 li~~~l~~~p~~Rps~~~il~  261 (276)
T 2yex_A          241 LLHKILVENPSARITIPDIKK  261 (276)
T ss_dssp             HHHHHSCSSTTTSCCHHHHTT
T ss_pred             HHHHHCCCCchhCCCHHHHhc
Confidence            999999999999999999987

>3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A

Probab=100.00  E-value=6.6e-46  Score=326.47  Aligned_cols=262  Identities=16%  Similarity=0.184  Sum_probs=209.6

Q ss_pred             CcccccccCCCCCCcEEEEEE-eCCCCEEEEEEeCCCCChhHHHHHHHHHHHhcCCCccccccceee-eeCCeeEEEEec
Q 020221           57 AMENIVSEHGEKAPNVVYKGK-LENQFRIAVKRFNRSAWPDARQFLEEARAVGQLRNRRLANLLGCC-CEGDERLLVAEY  134 (329)
Q Consensus        57 ~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~-~~~~~~~lv~e~  134 (329)
                      ..|++.+.||+|+||.||+|. ..+++.||+|++.....  .+.+.+|+.+++.++|++++..+..+ ......++||||
T Consensus         9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e~   86 (296)
T 3uzp_A            9 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK--HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMEL   86 (296)
T ss_dssp             TTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCSS--CCHHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEEEC
T ss_pred             cEEEEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCcc--hhHHHHHHHHHHHhhcCCCCCccccccCCCCceEEEEEe
Confidence            356778888999999999999 46789999999876543  24578999999999988877766655 556788999999


Q ss_pred             CCCCCHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceee---CCCCCeeeecccCcccCCCC--
Q 020221          135 MPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVF---DDDVNPRLSCFGLMKNSRDG--  209 (329)
Q Consensus       135 ~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~---~~~~~~kl~Dfg~a~~~~~~--  209 (329)
                      + +++|.+++.. ....+++..+..++.|++.||.|||++ +++||||||+||++   +.++.+||+|||++......  
T Consensus        87 ~-~~~L~~~~~~-~~~~~~~~~~~~i~~qi~~~l~~lH~~-~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~~~~~~  163 (296)
T 3uzp_A           87 L-GPSLEDLFNF-CSRKFSLKTVLLLADQMISRIEYIHSK-NFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDART  163 (296)
T ss_dssp             C-CCBHHHHHHH-TTTCCCHHHHHHHHHHHHHHHHHHHHT-TEECSCCCGGGEEECCGGGTTCEEECCCTTCEECBCTTT
T ss_pred             c-CCCHHHHHHh-hccCCCHHHHHHHHHHHHHHHHHHHhC-CeeeCCCCHHHeEEecCCCCCeEEEeeCCCccccccccc
Confidence            9 8899999964 345799999999999999999999999 99999999999999   48899999999998765433  


Q ss_pred             ---------CCccCcccccCcccccCCCCCCcccchhhhHHHHHHHhCCCCCCchhh-------HHHhhhchhhhccccc
Q 020221          210 ---------RSYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHAL-------DLIRDRNIQTLTDSCL  273 (329)
Q Consensus       210 ---------~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~-------~~~~~~~~~~~~~~~~  273 (329)
                               ....+++.|+|||.+.+..++.++||||||+++|+|++|..||.....       ............    
T Consensus       164 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~----  239 (296)
T 3uzp_A          164 HQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPI----  239 (296)
T ss_dssp             CCBCCCCCSCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHSCH----
T ss_pred             ccccccccccccccccccCChhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcCchhhhhhhhhhcccccCCch----
Confidence                     234678999999999998999999999999999999999988864211       111111110000    


Q ss_pred             cCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhhccccccC--cccccc
Q 020221          274 EGQFSSDEGTELVRLASRCLQYEPRERPNPRSLVTALVTLQKDTELYLS--LPWVML  328 (329)
Q Consensus       274 ~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~~~l~~L~~~~~~~~~~~~--~p~~~~  328 (329)
                       .......++++.+++.+||+.||++|||+.++++.|+++........+  ..|.++
T Consensus       240 -~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~~~~~~~~~~dw~~~  295 (296)
T 3uzp_A          240 -EVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGFSYDYVFDWNML  295 (296)
T ss_dssp             -HHHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHHHHTTCCSSCCCGGGGC
T ss_pred             -HHHHhhCCHHHHHHHHHHHhcCcCcCCCHHHHHHHHHHHHHhcCCccccccccccc
Confidence             011234567899999999999999999999999999999876655444  456543

>3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A*

Probab=100.00  E-value=5.4e-46  Score=328.38  Aligned_cols=244  Identities=16%  Similarity=0.239  Sum_probs=205.9

Q ss_pred             cccccccCCCCCCcEEEEEE-eCCCCEEEEEEeCCCC-ChhHHHHHHHHHHHhcCCCccccccceeeeeCCeeEEEEecC
Q 020221           58 MENIVSEHGEKAPNVVYKGK-LENQFRIAVKRFNRSA-WPDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAEYM  135 (329)
Q Consensus        58 ~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~  135 (329)
                      .|++++.||+|+||.||+|. ..+++.||+|++.... ....+.+.+|+.+++.++||||+++++++......++||||+
T Consensus        23 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~  102 (303)
T 3a7i_A           23 LFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYL  102 (303)
T ss_dssp             TEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTTCSTTHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred             HHHHhhhhcccCCeEEEEEEECCCCcEEEEEEecccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEEeC
Confidence            36778888999999999998 4568899999997654 334677899999999999999999999999999999999999


Q ss_pred             CCCCHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCCCCCeeeecccCcccCCCC----CC
Q 020221          136 PNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDG----RS  211 (329)
Q Consensus       136 ~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~----~~  211 (329)
                      ++++|.+++.   ...+++..+..++.|++.||.|||+. |++|+||||+||+++.++.++|+|||++......    ..
T Consensus       103 ~~~~L~~~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~-~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~  178 (303)
T 3a7i_A          103 GGGSALDLLE---PGPLDETQIATILREILKGLDYLHSE-KKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNT  178 (303)
T ss_dssp             TTEEHHHHHT---TSCCCHHHHHHHHHHHHHHHHHHHHT-TEECCCCSGGGEEECTTSCEEECCCTTCEECBTTBCCBCC
T ss_pred             CCCcHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHC-CCccCCCChheEEECCCCCEEEeecccceecCccccccCc
Confidence            9999999984   46799999999999999999999999 9999999999999999999999999999765443    23


Q ss_pred             ccCcccccCcccccCCCCCCcccchhhhHHHHHHHhCCCCCCchhhHHHhhhchhhhccccccCCCChHHHHHHHHHHHH
Q 020221          212 YSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLASR  291 (329)
Q Consensus       212 ~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~  291 (329)
                      ..+++.|+|||++.+..++.++||||||+++|+|++|..|+.............     .......+...+..+.+++.+
T Consensus       179 ~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~-----~~~~~~~~~~~~~~l~~li~~  253 (303)
T 3a7i_A          179 FVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSELHPMKVLFLIP-----KNNPPTLEGNYSKPLKEFVEA  253 (303)
T ss_dssp             CCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHH-----HSCCCCCCSSCCHHHHHHHHH
T ss_pred             cCCCcCccCHHHHhcCCCCchhhhHHHHHHHHHHccCCCCCCCcCHHHHHHHhh-----cCCCCCCccccCHHHHHHHHH
Confidence            467899999999999899999999999999999999998876433222111111     111223344567789999999


Q ss_pred             hcccCCCCCCCHHHHHHHH
Q 020221          292 CLQYEPRERPNPRSLVTAL  310 (329)
Q Consensus       292 cl~~dp~~Rps~~~~l~~L  310 (329)
                      ||+.||++|||+.+++++.
T Consensus       254 ~l~~dp~~Rps~~~ll~~~  272 (303)
T 3a7i_A          254 CLNKEPSFRPTAKELLKHK  272 (303)
T ss_dssp             HCCSSGGGSCCHHHHTTCH
T ss_pred             HcCCChhhCcCHHHHhhCh
Confidence            9999999999999999843

>2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens}

Probab=100.00  E-value=3.9e-46  Score=331.25  Aligned_cols=258  Identities=18%  Similarity=0.202  Sum_probs=206.8

Q ss_pred             CcccccccCCCCCCcEEEEEEe-CCCCEEEEEEeCCCCChhHHHHHHHHHHHhcCCCccccccceeeee----CCeeEEE
Q 020221           57 AMENIVSEHGEKAPNVVYKGKL-ENQFRIAVKRFNRSAWPDARQFLEEARAVGQLRNRRLANLLGCCCE----GDERLLV  131 (329)
Q Consensus        57 ~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~----~~~~~lv  131 (329)
                      ..|++++.||+|+||.||++.. .+++.||+|++........+.+.+|+++++.++||||+++++++..    ....++|
T Consensus        29 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~lv  108 (317)
T 2buj_A           29 KHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVAYCLRERGAKHEAWLL  108 (317)
T ss_dssp             EEEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEEETTEEEEEEE
T ss_pred             eEEEEEEEecCCCCeEEEEEEecCCCcEEEEEEEecCCHHHHHHHHHHHHHHhhcCCCCeeeEEEEEEeccCCCceeEEE
Confidence            4578888899999999999994 6789999999876655566778999999999999999999999863    3478999


Q ss_pred             EecCCCCCHHhhhccC--CCCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCCCCCeeeecccCcccCCCC
Q 020221          132 AEYMPNDTLAKHLFHW--ETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDG  209 (329)
Q Consensus       132 ~e~~~~gsL~~~l~~~--~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~  209 (329)
                      |||+++|+|.+++...  ....+++..++.++.|++.||.|||+. +++|+||||+||+++.++.++|+|||++......
T Consensus       109 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~-~ivH~dlkp~NIl~~~~~~~kl~dfg~~~~~~~~  187 (317)
T 2buj_A          109 LPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAK-GYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIH  187 (317)
T ss_dssp             EECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHT-TEECCCCCGGGEEECTTSCEEECCCSSCEESCEE
T ss_pred             EEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC-CcccCCCCHHHEEEcCCCCEEEEecCcchhcccc
Confidence            9999999999988642  346789999999999999999999999 9999999999999999999999999998754321


Q ss_pred             C-------------CccCcccccCcccccCCC---CCCcccchhhhHHHHHHHhCCCCCCchhhHHHhhhchhhhccccc
Q 020221          210 R-------------SYSTNLAFTPPEYLRTGR---VTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCL  273 (329)
Q Consensus       210 ~-------------~~~~~~~y~aPE~~~~~~---~~~~~DvwslG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~  273 (329)
                      .             ...+++.|+|||++.+..   ++.++||||||+++|+|++|..||......   ............
T Consensus       188 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~---~~~~~~~~~~~~  264 (317)
T 2buj_A          188 VEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQK---GDSVALAVQNQL  264 (317)
T ss_dssp             EESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHHHHHT---TSCHHHHHHCC-
T ss_pred             cccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhhhhcc---cchhhHHhhccC
Confidence            1             124588999999987654   788999999999999999999877432110   001111111111


Q ss_pred             cCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhhccc
Q 020221          274 EGQFSSDEGTELVRLASRCLQYEPRERPNPRSLVTALVTLQKDTE  318 (329)
Q Consensus       274 ~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~~~l~~L~~~~~~~~  318 (329)
                      ....+...++++.+++.+||+.||++|||+.++++.|+.+.....
T Consensus       265 ~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~~~~~  309 (317)
T 2buj_A          265 SIPQSPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQLEALQPPAP  309 (317)
T ss_dssp             -CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTCCCCC
T ss_pred             CCCccccCCHHHHHHHHHHhhcChhhCCCHHHHHHHhhhcCCCCC
Confidence            222334567889999999999999999999999999999876443

>4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A

Probab=100.00  E-value=5.3e-46  Score=326.97  Aligned_cols=265  Identities=15%  Similarity=0.178  Sum_probs=206.8

Q ss_pred             cccccccCCCCCCcEEEEEE-eCCCCEEEEEEeCCCCChhHHHHHHHHHHHhcCCCccccccceee-eeCCeeEEEEecC
Q 020221           58 MENIVSEHGEKAPNVVYKGK-LENQFRIAVKRFNRSAWPDARQFLEEARAVGQLRNRRLANLLGCC-CEGDERLLVAEYM  135 (329)
Q Consensus        58 ~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~-~~~~~~~lv~e~~  135 (329)
                      .|++.+.||+|+||.||+|. ..+++.||+|++.....  .+.+.+|+.+++.++|++++..+..+ ......++||||+
T Consensus        10 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e~~   87 (296)
T 4hgt_A           10 RYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK--HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELL   87 (296)
T ss_dssp             -CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC-----CCCHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEEECC
T ss_pred             ceEEeeeecCCCCeEEEEEEEcCCCceEEEEeeccccc--chHHHHHHHHHHHhcCCCCCCeeeeecCCCCceEEEEEcc
Confidence            46677788999999999999 46788999998765432  23477899999999988877776665 5667889999999


Q ss_pred             CCCCHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceee---CCCCCeeeecccCcccCCCC---
Q 020221          136 PNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVF---DDDVNPRLSCFGLMKNSRDG---  209 (329)
Q Consensus       136 ~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~---~~~~~~kl~Dfg~a~~~~~~---  209 (329)
                       +++|.+++.. ....+++..+..++.|++.||.|||+. +++||||||+||++   +.++.+||+|||++......   
T Consensus        88 -~~~L~~~~~~-~~~~~~~~~~~~i~~qi~~~l~~LH~~-~ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg~a~~~~~~~~~  164 (296)
T 4hgt_A           88 -GPSLEDLFNF-CSRKFSLKTVLLLADQMISRIEYIHSK-NFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTH  164 (296)
T ss_dssp             -CCBHHHHHHH-TTSCCCHHHHHHHHHHHHHHHHHHHHT-TEECSCCSGGGEEECCGGGTTCEEECCCTTCEECBCTTTC
T ss_pred             -CCCHHHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHHC-CeecCCCCHHHeeeeccCCCCeEEEecCccceeccCcccC
Confidence             8899999864 345799999999999999999999999 99999999999999   78999999999999765432   


Q ss_pred             --------CCccCcccccCcccccCCCCCCcccchhhhHHHHHHHhCCCCCCchhhHHHhhhchhhhccccccC---CCC
Q 020221          210 --------RSYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEG---QFS  278 (329)
Q Consensus       210 --------~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~  278 (329)
                              ....+|+.|+|||.+.+..++.++||||||+++|+|++|..||......... .............   ...
T Consensus       165 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~-~~~~~~~~~~~~~~~~~~~  243 (296)
T 4hgt_A          165 QHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKR-QKYERISEKKMSTPIEVLC  243 (296)
T ss_dssp             CBCCCCCSCCCCSCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSS-SHHHHHHHHHHHSCHHHHT
T ss_pred             ccCCCCcccccCCCccccchHHhcCCCCCchhHHHHHHHHHHHHhcCCCCCcccchhhhh-hhhhhhhcccccchhhhhh
Confidence                    2346789999999999999999999999999999999999988642111000 0000000000000   011


Q ss_pred             hHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhhccccccCc--ccccc
Q 020221          279 SDEGTELVRLASRCLQYEPRERPNPRSLVTALVTLQKDTELYLSL--PWVML  328 (329)
Q Consensus       279 ~~~~~~~~~li~~cl~~dp~~Rps~~~~l~~L~~~~~~~~~~~~~--p~~~~  328 (329)
                      ...++++.+++.+||+.||++|||+.++++.|+.+.+......+.  .|.++
T Consensus       244 ~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~~~~~~~~~~~~~~dw~~~  295 (296)
T 4hgt_A          244 KGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGFSYDYVFDWNML  295 (296)
T ss_dssp             TTSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHHHHHTCCTTCCCGGGGC
T ss_pred             ccCCHHHHHHHHHHHhcCCCCCCCHHHHHHHHHHHHHHhCCCccCccchhhc
Confidence            334678999999999999999999999999999998876655543  45443

>1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A

Probab=100.00  E-value=5.5e-46  Score=326.30  Aligned_cols=243  Identities=19%  Similarity=0.240  Sum_probs=197.6

Q ss_pred             cccccccCCCCCCcEEEEEE-eCCCCEEEEEEeCCCC--ChhHHHHHHHHHHHhcCCCccccccceeeee----CCeeEE
Q 020221           58 MENIVSEHGEKAPNVVYKGK-LENQFRIAVKRFNRSA--WPDARQFLEEARAVGQLRNRRLANLLGCCCE----GDERLL  130 (329)
Q Consensus        58 ~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~----~~~~~l  130 (329)
                      .+++.+.||+|+||+||+|. ..++..||+|.+....  ....+.+.+|+.+++.++||||+++++++..    ....++
T Consensus        27 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~l  106 (290)
T 1t4h_A           27 FLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVL  106 (290)
T ss_dssp             EEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEE
T ss_pred             eEEeeeeccCCCCeEEEEeEecCCceEEEEEEecchhhCHHHHHHHHHHHHHHHhCCCCCeeeeeeeeccccCCCceEEE
Confidence            46677788999999999998 4568899999987643  2335568899999999999999999998865    356899


Q ss_pred             EEecCCCCCHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCC--ccccccCCCceeeC-CCCCeeeecccCcccCC
Q 020221          131 VAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKER--ALYHDLNAYRIVFD-DDVNPRLSCFGLMKNSR  207 (329)
Q Consensus       131 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~--ivH~dlkp~Nil~~-~~~~~kl~Dfg~a~~~~  207 (329)
                      ||||+++++|.+++..  ...+++..++.++.|++.||.|||+. +  ++|+||||+||+++ .++.+||+|||++....
T Consensus       107 v~e~~~~~~L~~~l~~--~~~~~~~~~~~~~~qi~~~l~~lH~~-~~~i~H~dikp~Nil~~~~~~~~kl~Dfg~~~~~~  183 (290)
T 1t4h_A          107 VTELMTSGTLKTYLKR--FKVMKIKVLRSWCRQILKGLQFLHTR-TPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKR  183 (290)
T ss_dssp             EEECCCSCBHHHHHHH--HSSCCHHHHHHHHHHHHHHHHHHHTS-SSCCCCSCCCGGGEEESSTTSCEEECCTTGGGGCC
T ss_pred             EEEecCCCCHHHHHHH--ccCCCHHHHHHHHHHHHHHHHHHHcC-CCCEEECCCCHHHEEEECCCCCEEEeeCCCccccc
Confidence            9999999999999963  35789999999999999999999999 8  99999999999998 88999999999997654


Q ss_pred             CCC--CccCcccccCcccccCCCCCCcccchhhhHHHHHHHhCCCCCCchhhH-HHhhhchhhhccccccCCCChHHHHH
Q 020221          208 DGR--SYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALD-LIRDRNIQTLTDSCLEGQFSSDEGTE  284 (329)
Q Consensus       208 ~~~--~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~  284 (329)
                      ...  ...+++.|+|||++. +.++.++||||||+++|+|++|..||...... ...........    ....+...+++
T Consensus       184 ~~~~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~  258 (290)
T 1t4h_A          184 ASFAKAVIGTPEFMAPEMYE-EKYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVK----PASFDKVAIPE  258 (290)
T ss_dssp             TTSBEESCSSCCCCCGGGGG-TCCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTCC----CGGGGGCCCHH
T ss_pred             ccccccccCCcCcCCHHHHh-ccCCCcchHHHHHHHHHHHHhCCCCCCCcCcHHHHHHHHhccCC----ccccCCCCCHH
Confidence            432  346889999999887 45899999999999999999999888653221 11111111111    11122334578


Q ss_pred             HHHHHHHhcccCCCCCCCHHHHHH
Q 020221          285 LVRLASRCLQYEPRERPNPRSLVT  308 (329)
Q Consensus       285 ~~~li~~cl~~dp~~Rps~~~~l~  308 (329)
                      +.+++.+||+.||++|||+.++++
T Consensus       259 l~~li~~~l~~dp~~Rps~~ell~  282 (290)
T 1t4h_A          259 VKEIIEGCIRQNKDERYSIKDLLN  282 (290)
T ss_dssp             HHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             HHHHHHHHccCChhhCCCHHHHhh
Confidence            999999999999999999999998

>3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A*

Probab=100.00  E-value=3.1e-46  Score=326.39  Aligned_cols=252  Identities=21%  Similarity=0.275  Sum_probs=204.9

Q ss_pred             CcccccccCCCCCCcEEEEEEeCC----CCEEEEEEeCCCCC-hhHHHHHHHHHHHhcCCCccccccceeeeeCCeeEEE
Q 020221           57 AMENIVSEHGEKAPNVVYKGKLEN----QFRIAVKRFNRSAW-PDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLV  131 (329)
Q Consensus        57 ~~~~~~~~lg~G~~g~V~~~~~~~----~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv  131 (329)
                      ..|.+.+.||+|+||+||+|...+    +..||+|.+..... ...+.+.+|+.+++.++||||+++++++.+ +..++|
T Consensus        12 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~~v   90 (281)
T 3cc6_A           12 EDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLIGIIEE-EPTWII   90 (281)
T ss_dssp             GGEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTSCHHHHHHHHHHHHHHHHHCCTTBCCEEEEECS-SSCEEE
T ss_pred             cceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEecccccCchHHHHHHHHHHHHHhCCCCCcceEEEEEcC-CCCEEE
Confidence            456777888999999999998432    23599999987643 345678999999999999999999999864 567899


Q ss_pred             EecCCCCCHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCCCCCeeeecccCcccCCCCC-
Q 020221          132 AEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDGR-  210 (329)
Q Consensus       132 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~-  210 (329)
                      |||+++++|.+++.. ....+++..+..++.|++.||.|||+. |++|+||||+||+++.++.+||+|||++....... 
T Consensus        91 ~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~~~i~~~l~~lH~~-~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~  168 (281)
T 3cc6_A           91 MELYPYGELGHYLER-NKNSLKVLTLVLYSLQICKAMAYLESI-NCVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDY  168 (281)
T ss_dssp             EECCTTCBHHHHHHH-HTTTCCHHHHHHHHHHHHHHHHHHHHT-TCCCCCCSGGGEEEEETTEEEECCCCGGGCC-----
T ss_pred             EecCCCCCHHHHHHh-ccccCCHHHHHHHHHHHHHHHHHHHHC-CcccCCCccceEEECCCCcEEeCccCCCcccccccc
Confidence            999999999999964 345689999999999999999999999 99999999999999999999999999988654432 


Q ss_pred             ----CccCcccccCcccccCCCCCCcccchhhhHHHHHHHh-CCCCCCchhhHHHhhhchhhhccccccCCCChHHHHHH
Q 020221          211 ----SYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLS-GKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTEL  285 (329)
Q Consensus       211 ----~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t-g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  285 (329)
                          ...+++.|+|||.+.+..++.++||||||+++|+|++ |..||...........     .........+...++.+
T Consensus       169 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~llt~g~~p~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~l  243 (281)
T 3cc6_A          169 YKASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENKDVIGV-----LEKGDRLPKPDLCPPVL  243 (281)
T ss_dssp             ----CCCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCGGGHHHH-----HHHTCCCCCCTTCCHHH
T ss_pred             cccccCCCCcceeCchhhccCCCCchhccHHHHHHHHHHHhCCCCCcccCChHHHHHH-----HhcCCCCCCCCCCCHHH
Confidence                2345778999999998889999999999999999998 8888754322221111     11111223345567889


Q ss_pred             HHHHHHhcccCCCCCCCHHHHHHHHHhhhhc
Q 020221          286 VRLASRCLQYEPRERPNPRSLVTALVTLQKD  316 (329)
Q Consensus       286 ~~li~~cl~~dp~~Rps~~~~l~~L~~~~~~  316 (329)
                      .+++.+||+.||++|||+.++++.|+.+.+.
T Consensus       244 ~~li~~~l~~~p~~Rps~~ell~~L~~~~~~  274 (281)
T 3cc6_A          244 YTLMTRCWDYDPSDRPRFTELVCSLSDVYQM  274 (281)
T ss_dssp             HHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             HHHHHHHccCCchhCcCHHHHHHHHHHHHHh
Confidence            9999999999999999999999999998653

>1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A*

Probab=100.00  E-value=1.8e-46  Score=329.69  Aligned_cols=252  Identities=21%  Similarity=0.255  Sum_probs=206.6

Q ss_pred             Ccccccc-cCCCCCCcEEEEEEe---CCCCEEEEEEeCCCCC--hhHHHHHHHHHHHhcCCCccccccceeeeeCCeeEE
Q 020221           57 AMENIVS-EHGEKAPNVVYKGKL---ENQFRIAVKRFNRSAW--PDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLL  130 (329)
Q Consensus        57 ~~~~~~~-~lg~G~~g~V~~~~~---~~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l  130 (329)
                      ..+.+.+ .||+|+||+||+|..   .+++.||+|++.....  ...+.+.+|+++++.++||||+++++++ .....++
T Consensus        16 ~~y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-~~~~~~l   94 (291)
T 1xbb_A           16 KLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGIC-EAESWML   94 (291)
T ss_dssp             GGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEE-ESSSEEE
T ss_pred             hhhhhccCccccccCeeeEeeeecCCCceeeEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEE-CCCCcEE
Confidence            4466666 789999999999953   3467899999986532  2256789999999999999999999998 5678899


Q ss_pred             EEecCCCCCHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCCCCCeeeecccCcccCCCCC
Q 020221          131 VAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDGR  210 (329)
Q Consensus       131 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~  210 (329)
                      ||||+++++|.+++..  ...+++..++.++.|++.||.|||+. +++|+||||+||+++.++.++|+|||++.......
T Consensus        95 v~e~~~~~~L~~~l~~--~~~~~~~~~~~i~~qi~~~l~~LH~~-~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~  171 (291)
T 1xbb_A           95 VMEMAELGPLNKYLQQ--NRHVKDKNIIELVHQVSMGMKYLEES-NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADE  171 (291)
T ss_dssp             EEECCTTEEHHHHHHH--CTTCCHHHHHHHHHHHHHHHHHHHHT-TEECSCCSGGGEEEEETTEEEECCCTTCEECCTTC
T ss_pred             EEEeCCCCCHHHHHHh--CcCCCHHHHHHHHHHHHHHHHHHHhC-CeEcCCCCcceEEEeCCCcEEEccCCcceeeccCC
Confidence            9999999999999974  45689999999999999999999999 99999999999999999999999999997654432


Q ss_pred             C-------ccCcccccCcccccCCCCCCcccchhhhHHHHHHHh-CCCCCCchhhHHHhhhchhhhccccccCCCChHHH
Q 020221          211 S-------YSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLS-GKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEG  282 (329)
Q Consensus       211 ~-------~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t-g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  282 (329)
                      .       ..+++.|+|||.+.+..++.++||||||+++|+|++ |..||.............     .......+..++
T Consensus       172 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~-----~~~~~~~~~~~~  246 (291)
T 1xbb_A          172 NYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLE-----KGERMGCPAGCP  246 (291)
T ss_dssp             SEEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHH-----TTCCCCCCTTCC
T ss_pred             CcccccccCCCCceeeChHHhccCCCChhhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHH-----cCCCCCCCCCCC
Confidence            1       234678999999988889999999999999999999 888876543332222111     112233455678


Q ss_pred             HHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhhcc
Q 020221          283 TELVRLASRCLQYEPRERPNPRSLVTALVTLQKDT  317 (329)
Q Consensus       283 ~~~~~li~~cl~~dp~~Rps~~~~l~~L~~~~~~~  317 (329)
                      +++.+++.+||+.||++|||+.++++.|+.+-...
T Consensus       247 ~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~~~  281 (291)
T 1xbb_A          247 REMYDLMNLCWTYDVENRPGFAAVELRLRNYYYDV  281 (291)
T ss_dssp             HHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHHH
T ss_pred             HHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHHH
Confidence            89999999999999999999999999999997654

>3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A

Probab=100.00  E-value=1.6e-46  Score=346.28  Aligned_cols=246  Identities=15%  Similarity=0.172  Sum_probs=189.5

Q ss_pred             CcccccccCCCCCCcEEEEEE-eCCCCEEEEEEeCCCCC--------hhHHHHHHHHHHHhcCCCccccccceeeeeCCe
Q 020221           57 AMENIVSEHGEKAPNVVYKGK-LENQFRIAVKRFNRSAW--------PDARQFLEEARAVGQLRNRRLANLLGCCCEGDE  127 (329)
Q Consensus        57 ~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~--------~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~  127 (329)
                      ..|.+.+.||+|+||+||+|. ..+++.||+|++.....        .....+.+|+.+++.++||||+++++++. ...
T Consensus       135 ~~y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~-~~~  213 (419)
T 3i6u_A          135 DEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFD-AED  213 (419)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEEE-SSE
T ss_pred             ccEEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEEe-cCc
Confidence            346777888999999999998 56688999999865321        11224789999999999999999999974 566


Q ss_pred             eEEEEecCCCCCHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCCC---CCeeeecccCcc
Q 020221          128 RLLVAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDD---VNPRLSCFGLMK  204 (329)
Q Consensus       128 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~---~~~kl~Dfg~a~  204 (329)
                      .++||||+++|+|.+++.  ....+++..+..++.|++.||+|||++ +++||||||+|||++.+   +.+||+|||+++
T Consensus       214 ~~lv~e~~~~g~L~~~l~--~~~~~~~~~~~~i~~qi~~~l~~LH~~-~ivHrDlkp~NIll~~~~~~~~~kl~DFG~a~  290 (419)
T 3i6u_A          214 YYIVLELMEGGELFDKVV--GNKRLKEATCKLYFYQMLLAVQYLHEN-GIIHRDLKPENVLLSSQEEDCLIKITDFGHSK  290 (419)
T ss_dssp             EEEEEECCTTCBGGGGTS--SSCCCCHHHHHHHHHHHHHHHHHHHHT-TCCCSCCCGGGEEESSSSSSCCEEECCSSTTT
T ss_pred             eEEEEEcCCCCcHHHHHh--ccCCCCHHHHHHHHHHHHHHHHHHHHC-CccccCCChHhEEEecCCCcceEEEeecccce
Confidence            899999999999999886  456799999999999999999999999 99999999999999754   459999999998


Q ss_pred             cCCCC---CCccCcccccCcccccC---CCCCCcccchhhhHHHHHHHhCCCCCCchhhHH-HhhhchhhhccccccCCC
Q 020221          205 NSRDG---RSYSTNLAFTPPEYLRT---GRVTPESVMYSFGTLLLDLLSGKHIPPSHALDL-IRDRNIQTLTDSCLEGQF  277 (329)
Q Consensus       205 ~~~~~---~~~~~~~~y~aPE~~~~---~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~  277 (329)
                      .....   ....||+.|+|||++.+   ..++.++||||||+++|+|++|..||....... ............  ....
T Consensus       291 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~i~~~~~~~--~~~~  368 (419)
T 3i6u_A          291 ILGETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNF--IPEV  368 (419)
T ss_dssp             SCC-----------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCCSSSCCHHHHHHTTCCCC--CHHH
T ss_pred             ecCCCccccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCcchHHHHHHHhcCCCCC--Cchh
Confidence            76543   24568999999999863   557889999999999999999999886432110 000000000000  0001


Q ss_pred             ChHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 020221          278 SSDEGTELVRLASRCLQYEPRERPNPRSLVT  308 (329)
Q Consensus       278 ~~~~~~~~~~li~~cl~~dp~~Rps~~~~l~  308 (329)
                      ....++++.+++.+||+.||++|||+.++++
T Consensus       369 ~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~  399 (419)
T 3i6u_A          369 WAEVSEKALDLVKKLLVVDPKARFTTEEALR  399 (419)
T ss_dssp             HTTSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred             hcccCHHHHHHHHHHccCChhHCcCHHHHhC
Confidence            1235678999999999999999999999998

>3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens}

Probab=100.00  E-value=9.3e-46  Score=328.42  Aligned_cols=246  Identities=15%  Similarity=0.183  Sum_probs=200.3

Q ss_pred             CCcccccccCCCCCCcEEEEEEe-CCCCEEEEEEeCCCCChhHHHHHHHHHHHhcCCCccccccceeeeeCCeeEEEEec
Q 020221           56 FAMENIVSEHGEKAPNVVYKGKL-ENQFRIAVKRFNRSAWPDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAEY  134 (329)
Q Consensus        56 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  134 (329)
                      ...|++++.||+|+||.||+|.. .+++.||+|.+....  ..+.+.+|+.+++.++||||+++++++......++||||
T Consensus        28 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~  105 (314)
T 3com_A           28 EEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVES--DLQEIIKEISIMQQCDSPHVVKYYGSYFKNTDLWIVMEY  105 (314)
T ss_dssp             --CEEEEEECC----CEEEEEEETTTCCEEEEEEEETTS--CCHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred             hhhhhhheeeccCCCeEEEEEEECCCCCEEEEEecCchH--HHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEeec
Confidence            35577888899999999999995 468899999997644  346788999999999999999999999999999999999


Q ss_pred             CCCCCHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCCCCCeeeecccCcccCCCC----C
Q 020221          135 MPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDG----R  210 (329)
Q Consensus       135 ~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~----~  210 (329)
                      +++++|.+++.. ....+++..+..++.|++.||.|||+. |++|+||||+||+++.++.++|+|||++......    .
T Consensus       106 ~~~~~L~~~~~~-~~~~~~~~~~~~i~~~i~~~l~~lH~~-~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~  183 (314)
T 3com_A          106 CGAGSVSDIIRL-RNKTLTEDEIATILQSTLKGLEYLHFM-RKIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTMAKRN  183 (314)
T ss_dssp             CTTEEHHHHHHH-HTCCCCHHHHHHHHHHHHHHHHHHHHT-TEECCCCSGGGEEECTTCCEEECCCTTCEECBTTBSCBC
T ss_pred             CCCCCHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHhC-CCcCCCcCHHHEEECCCCCEEEeecccchhhhhhccccC
Confidence            999999999853 346789999999999999999999999 9999999999999999999999999998765433    2


Q ss_pred             CccCcccccCcccccCCCCCCcccchhhhHHHHHHHhCCCCCCchhhHHHhhhchhhhccccccCCCChHHHHHHHHHHH
Q 020221          211 SYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLAS  290 (329)
Q Consensus       211 ~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~  290 (329)
                      ...+++.|+|||.+.+..++.++||||||+++|+|++|..||.............. ...  .....+...+.++.+++.
T Consensus       184 ~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~-~~~--~~~~~~~~~~~~l~~li~  260 (314)
T 3com_A          184 TVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYADIHPMRAIFMIPT-NPP--PTFRKPELWSDNFTDFVK  260 (314)
T ss_dssp             CCCSCGGGCCHHHHSSSCBCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHH-SCC--CCCSSGGGSCHHHHHHHH
T ss_pred             ccCCCCCccChhhcCCCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhc-CCC--cccCCcccCCHHHHHHHH
Confidence            34678999999999998999999999999999999999988764322211111000 000  111223456788999999


Q ss_pred             HhcccCCCCCCCHHHHHH
Q 020221          291 RCLQYEPRERPNPRSLVT  308 (329)
Q Consensus       291 ~cl~~dp~~Rps~~~~l~  308 (329)
                      +||+.||++|||+.++++
T Consensus       261 ~~l~~dp~~Rpt~~~ll~  278 (314)
T 3com_A          261 QCLVKSPEQRATATQLLQ  278 (314)
T ss_dssp             HHTCSCTTTSCCHHHHTT
T ss_pred             HHccCChhhCcCHHHHHh
Confidence            999999999999999987

>3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ...

Probab=100.00  E-value=2.4e-46  Score=327.31  Aligned_cols=246  Identities=17%  Similarity=0.195  Sum_probs=201.3

Q ss_pred             cccccccCCCCCCcEEEEEEe-CCCCEEEEEEeCCCCCh------hHHHHHHHHHHHhcCCCccccccceeeeeCCeeEE
Q 020221           58 MENIVSEHGEKAPNVVYKGKL-ENQFRIAVKRFNRSAWP------DARQFLEEARAVGQLRNRRLANLLGCCCEGDERLL  130 (329)
Q Consensus        58 ~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~------~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l  130 (329)
                      .|++++.||+|+||.||++.. .+++.||+|.+......      ..+.+.+|+.+++.++||||+++++++.+....++
T Consensus         6 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~l   85 (283)
T 3bhy_A            6 HYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFENKTDVVL   85 (283)
T ss_dssp             HEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred             hhhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhheecCCCeEEE
Confidence            367788889999999999995 46889999998754321      35678999999999999999999999999999999


Q ss_pred             EEecCCCCCHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCCCC----CeeeecccCcccC
Q 020221          131 VAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDV----NPRLSCFGLMKNS  206 (329)
Q Consensus       131 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~----~~kl~Dfg~a~~~  206 (329)
                      ||||+++++|.+++..  ...+++..+..++.|++.||.|||+. +++|+||||+||+++.++    .++|+|||++...
T Consensus        86 v~e~~~~~~L~~~l~~--~~~~~~~~~~~~~~~i~~~l~~lH~~-~i~H~dl~p~Nil~~~~~~~~~~~kl~dfg~~~~~  162 (283)
T 3bhy_A           86 ILELVSGGELFDFLAE--KESLTEDEATQFLKQILDGVHYLHSK-RIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKI  162 (283)
T ss_dssp             EEECCCSCBHHHHHHH--HSSCCHHHHHHHHHHHHHHHHHHHHT-TEECSCCSGGGEEESCSSSSSCCEEECCCTTCEEC
T ss_pred             EEeecCCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhC-CccCCCCChHHEEEecCCCCCCceEEEecccceec
Confidence            9999999999999963  45789999999999999999999999 999999999999998877    8999999999765


Q ss_pred             CCC---CCccCcccccCcccccCCCCCCcccchhhhHHHHHHHhCCCCCCchhhHHHhhhchhhhccccccCCCChHHHH
Q 020221          207 RDG---RSYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGT  283 (329)
Q Consensus       207 ~~~---~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  283 (329)
                      ...   ....+++.|+|||++.+..++.++||||||+++|+|++|..||..................  .........++
T Consensus       163 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~  240 (283)
T 3bhy_A          163 EAGNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGETKQETLTNISAVNYD--FDEEYFSNTSE  240 (283)
T ss_dssp             C--------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTCCC--CCHHHHTTCCH
T ss_pred             cCCCcccccCCCcCccCcceecCCCCCcchhhhhHHHHHHHHHHCCCCCCCcchHHHHHHhHhcccC--CcchhcccCCH
Confidence            443   2345789999999999889999999999999999999999988654332222111110000  00001123467


Q ss_pred             HHHHHHHHhcccCCCCCCCHHHHHH
Q 020221          284 ELVRLASRCLQYEPRERPNPRSLVT  308 (329)
Q Consensus       284 ~~~~li~~cl~~dp~~Rps~~~~l~  308 (329)
                      .+.+++.+||..||++|||+.++++
T Consensus       241 ~~~~li~~~l~~dp~~Rps~~~~l~  265 (283)
T 3bhy_A          241 LAKDFIRRLLVKDPKRRMTIAQSLE  265 (283)
T ss_dssp             HHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred             HHHHHHHHHccCCHhHCcCHHHHHh
Confidence            8999999999999999999999997

>3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A*

Probab=100.00  E-value=5.8e-47  Score=335.94  Aligned_cols=254  Identities=17%  Similarity=0.209  Sum_probs=198.4

Q ss_pred             CcccccccCCCCCCcEEEEEE-eCCCCEEEEEEeCCCCChh---HHHHHHHHHHHhcCCCccccccceeeeeCCe----e
Q 020221           57 AMENIVSEHGEKAPNVVYKGK-LENQFRIAVKRFNRSAWPD---ARQFLEEARAVGQLRNRRLANLLGCCCEGDE----R  128 (329)
Q Consensus        57 ~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~---~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~----~  128 (329)
                      ..|++++.||+|+||.||++. ..+++.||+|++.......   ...+.+|+++++.++||||+++++++.....    .
T Consensus        12 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~~   91 (311)
T 3ork_A           12 DRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPLP   91 (311)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEETTEEEE
T ss_pred             CcEEEEEEEccCCCEEEEEEEECCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEeeeccCCCCccc
Confidence            457788889999999999999 4678899999998754332   3468899999999999999999999876543    4


Q ss_pred             EEEEecCCCCCHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCCCCCeeeecccCcccCCC
Q 020221          129 LLVAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRD  208 (329)
Q Consensus       129 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~  208 (329)
                      ++||||+++++|.+++..  ...+++..++.++.|++.||.|||++ +++||||||+||+++.++.+||+|||++.....
T Consensus        92 ~lv~e~~~g~~L~~~l~~--~~~~~~~~~~~~~~qi~~~l~~lH~~-~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~  168 (311)
T 3ork_A           92 YIVMEYVDGVTLRDIVHT--EGPMTPKRAIEVIADACQALNFSHQN-GIIHRDVKPANIMISATNAVKVMDFGIARAIAD  168 (311)
T ss_dssp             EEEEECCCEEEHHHHHHH--HCSCCHHHHHHHHHHHHHHHHHHHHT-TCCCCCCCGGGEEEETTSCEEECCCSCC-----
T ss_pred             EEEEecCCCCCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHC-CCCcCCCCHHHEEEcCCCCEEEeeccCcccccc
Confidence            999999999999999963  45789999999999999999999999 999999999999999999999999999976543


Q ss_pred             C-------CCccCcccccCcccccCCCCCCcccchhhhHHHHHHHhCCCCCCchhhHHHhhhchhhhccccccCCCChHH
Q 020221          209 G-------RSYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDE  281 (329)
Q Consensus       209 ~-------~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  281 (329)
                      .       ....||+.|+|||++.+..++.++||||||+++|+|++|..||...................  ........
T Consensus       169 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~--~~~~~~~~  246 (311)
T 3ork_A          169 SGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIP--PSARHEGL  246 (311)
T ss_dssp             -------------CCTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCCCCC--HHHHSTTC
T ss_pred             cccccccccccCcCcccCCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCCCCC--cccccCCC
Confidence            2       22357999999999999899999999999999999999999887654332222211111100  00112235


Q ss_pred             HHHHHHHHHHhcccCCCCCCCHHHH-HHHHHhhhh
Q 020221          282 GTELVRLASRCLQYEPRERPNPRSL-VTALVTLQK  315 (329)
Q Consensus       282 ~~~~~~li~~cl~~dp~~Rps~~~~-l~~L~~~~~  315 (329)
                      ++++.+++.+||+.||++||++.++ ...+.+...
T Consensus       247 ~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~~~  281 (311)
T 3ork_A          247 SADLDAVVLKALAKNPENRYQTAAEMRADLVRVHN  281 (311)
T ss_dssp             CHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHHT
T ss_pred             CHHHHHHHHHHHhcCHhhChhhHHHHHHHHHHHhc
Confidence            6789999999999999999965554 455655543

>3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei}

Probab=100.00  E-value=3.6e-46  Score=351.95  Aligned_cols=246  Identities=15%  Similarity=0.151  Sum_probs=200.5

Q ss_pred             CcccccccCCCCCCcEEEEEE-eCCCCEEEEEEeCCCCC-------------hhHHHHHHHHHHHhcCCCccccccceee
Q 020221           57 AMENIVSEHGEKAPNVVYKGK-LENQFRIAVKRFNRSAW-------------PDARQFLEEARAVGQLRNRRLANLLGCC  122 (329)
Q Consensus        57 ~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~-------------~~~~~~~~e~~~l~~l~h~niv~~~~~~  122 (329)
                      ..|.+++.||+|+||+||+|. ..+++.||+|++.....             ...+.+.+|+.+++.++||||+++++++
T Consensus        36 ~~Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~  115 (504)
T 3q5i_A           36 ESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFDVF  115 (504)
T ss_dssp             GTEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCCEEEEE
T ss_pred             cceEEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCeEEEEE
Confidence            457788889999999999999 45688999999876431             2245688999999999999999999999


Q ss_pred             eeCCeeEEEEecCCCCCHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCCCC---Ceeeec
Q 020221          123 CEGDERLLVAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDV---NPRLSC  199 (329)
Q Consensus       123 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~---~~kl~D  199 (329)
                      .+....++||||+++|+|.+++..  ...+++..+..++.||+.||.|||+. ||+||||||+||+++.++   .+||+|
T Consensus       116 ~~~~~~~lv~e~~~gg~L~~~l~~--~~~~~~~~~~~i~~qi~~~l~~lH~~-~ivH~Dlkp~Nil~~~~~~~~~~kl~D  192 (504)
T 3q5i_A          116 EDKKYFYLVTEFYEGGELFEQIIN--RHKFDECDAANIMKQILSGICYLHKH-NIVHRDIKPENILLENKNSLLNIKIVD  192 (504)
T ss_dssp             ECSSEEEEEEECCTTCBHHHHHHH--HSCCCHHHHHHHHHHHHHHHHHHHHT-TEECSCCSGGGEEESSTTCCSSEEECC
T ss_pred             EcCCEEEEEEecCCCCcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHC-CeEeCCCcHHHEEEecCCCCccEEEEE
Confidence            999999999999999999998863  45799999999999999999999999 999999999999998776   699999


Q ss_pred             ccCcccCCCC---CCccCcccccCcccccCCCCCCcccchhhhHHHHHHHhCCCCCCchhhHHHhhhchhhhccccccCC
Q 020221          200 FGLMKNSRDG---RSYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQ  276 (329)
Q Consensus       200 fg~a~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~  276 (329)
                      ||++......   ....||+.|+|||++. ..++.++||||||+++|+|++|..||...................  ...
T Consensus       193 fg~a~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~--~~~  269 (504)
T 3q5i_A          193 FGLSSFFSKDYKLRDRLGTAYYIAPEVLK-KKYNEKCDVWSCGVIMYILLCGYPPFGGQNDQDIIKKVEKGKYYF--DFN  269 (504)
T ss_dssp             CTTCEECCTTSCBCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCC--CHH
T ss_pred             CCCCEEcCCCCccccccCCcCCCCHHHhc-cCCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCC--Ccc
Confidence            9999866543   3456899999999987 468999999999999999999999987654433322222111100  000


Q ss_pred             CChHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 020221          277 FSSDEGTELVRLASRCLQYEPRERPNPRSLVT  308 (329)
Q Consensus       277 ~~~~~~~~~~~li~~cl~~dp~~Rps~~~~l~  308 (329)
                      .....++++.+|+.+||..||++|||+.++++
T Consensus       270 ~~~~~s~~~~~li~~~L~~dp~~R~t~~e~l~  301 (504)
T 3q5i_A          270 DWKNISDEAKELIKLMLTYDYNKRCTAEEALN  301 (504)
T ss_dssp             HHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             ccCCCCHHHHHHHHHHcCCChhHCCCHHHHhc
Confidence            01235688999999999999999999999997

>2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A*

Probab=100.00  E-value=1.1e-46  Score=337.20  Aligned_cols=256  Identities=18%  Similarity=0.286  Sum_probs=208.4

Q ss_pred             CCcccccccCCCCCCcEEEEEEeC-CC-----CEEEEEEeCCCCCh-hHHHHHHHHHHHhcC-CCccccccceeeeeCCe
Q 020221           56 FAMENIVSEHGEKAPNVVYKGKLE-NQ-----FRIAVKRFNRSAWP-DARQFLEEARAVGQL-RNRRLANLLGCCCEGDE  127 (329)
Q Consensus        56 ~~~~~~~~~lg~G~~g~V~~~~~~-~~-----~~vavK~~~~~~~~-~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~  127 (329)
                      ...+.+.+.||+|+||.||+|... ++     ..||+|.+...... ..+.+.+|+.+++.+ +||||+++++++...+.
T Consensus        45 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~  124 (333)
T 2i1m_A           45 RNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGACTHGGP  124 (333)
T ss_dssp             TTSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred             HHHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhcccccChHHHHHHHHHHHHHHhhcCCCCeeeEEEEEecCCc
Confidence            356778888899999999999853 22     47999999876433 355688999999999 89999999999999999


Q ss_pred             eEEEEecCCCCCHHhhhccCC------------CCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCCCCCe
Q 020221          128 RLLVAEYMPNDTLAKHLFHWE------------TQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNP  195 (329)
Q Consensus       128 ~~lv~e~~~~gsL~~~l~~~~------------~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~  195 (329)
                      .++||||+++|+|.+++....            ...+++..++.++.|++.||.|||+. |++|+||||+||+++.++.+
T Consensus       125 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~-~ivH~Dlkp~NIl~~~~~~~  203 (333)
T 2i1m_A          125 VLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASK-NCIHRDVAARNVLLTNGHVA  203 (333)
T ss_dssp             CEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHHT-TEECSCCSGGGCEEEGGGEE
T ss_pred             eEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhcC-CcccCCcccceEEECCCCeE
Confidence            999999999999999986421            34679999999999999999999999 99999999999999999999


Q ss_pred             eeecccCcccCCCCC------CccCcccccCcccccCCCCCCcccchhhhHHHHHHHh-CCCCCCchhhHHHhhhchhhh
Q 020221          196 RLSCFGLMKNSRDGR------SYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLS-GKHIPPSHALDLIRDRNIQTL  268 (329)
Q Consensus       196 kl~Dfg~a~~~~~~~------~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t-g~~~~~~~~~~~~~~~~~~~~  268 (329)
                      ||+|||++.......      ...+++.|+|||.+.+..++.++||||||+++|+|++ |..||...........    .
T Consensus       204 kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~----~  279 (333)
T 2i1m_A          204 KIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVNSKFYK----L  279 (333)
T ss_dssp             EBCCCGGGCCGGGCTTSEECSSCEECGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCSSHHHHH----H
T ss_pred             EECccccccccccccceeecCCCCCCccccCHHHhccCCCChHHHHHHHHHHHHHHHcCCCCCCcccchhHHHHH----H
Confidence            999999997654332      2345678999999998889999999999999999999 7777654322111111    1


Q ss_pred             ccccccCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhhc
Q 020221          269 TDSCLEGQFSSDEGTELVRLASRCLQYEPRERPNPRSLVTALVTLQKD  316 (329)
Q Consensus       269 ~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~~~l~~L~~~~~~  316 (329)
                      .........+...++++.+++.+||+.||++|||+.++++.|+.+...
T Consensus       280 ~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~~~~  327 (333)
T 2i1m_A          280 VKDGYQMAQPAFAPKNIYSIMQACWALEPTHRPTFQQICSFLQEQAQE  327 (333)
T ss_dssp             HHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             HhcCCCCCCCCCCCHHHHHHHHHHhccChhhCcCHHHHHHHHHHHHHh
Confidence            111122223445578899999999999999999999999999988654

>1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=4.5e-46  Score=335.09  Aligned_cols=250  Identities=19%  Similarity=0.204  Sum_probs=195.2

Q ss_pred             CCcccccccCCCCCCcEEEEEEe-CCCCEEEEEEeCCCCChh-----HHHHHHHHHHHhcCCCccccccceeeeeCCeeE
Q 020221           56 FAMENIVSEHGEKAPNVVYKGKL-ENQFRIAVKRFNRSAWPD-----ARQFLEEARAVGQLRNRRLANLLGCCCEGDERL  129 (329)
Q Consensus        56 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~-----~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~  129 (329)
                      ...|++++.||+|+||.||+|.. .+++.||+|++.......     .+.+.+|+++++.++||||+++++++.+.+..+
T Consensus         9 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~   88 (346)
T 1ua2_A            9 AKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNIS   88 (346)
T ss_dssp             ----CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCE
T ss_pred             hcccEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEEeeCCceE
Confidence            45577888889999999999994 568999999997543221     235789999999999999999999999999999


Q ss_pred             EEEecCCCCCHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCCCCCeeeecccCcccCCCC
Q 020221          130 LVAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDG  209 (329)
Q Consensus       130 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~  209 (329)
                      +||||+++ +|.+++.. ....+++..+..++.|++.||.|||+. |++||||||+||+++.++.+||+|||++......
T Consensus        89 lv~e~~~~-~l~~~~~~-~~~~~~~~~~~~~~~qi~~~l~~lH~~-~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~  165 (346)
T 1ua2_A           89 LVFDFMET-DLEVIIKD-NSLVLTPSHIKAYMLMTLQGLEYLHQH-WILHRDLKPNNLLLDENGVLKLADFGLAKSFGSP  165 (346)
T ss_dssp             EEEECCSE-EHHHHHTT-CCSSCCSSHHHHHHHHHHHHHHHHHHT-TCCCCCCCGGGEEECTTCCEEECCCGGGSTTTSC
T ss_pred             EEEEcCCC-CHHHHHHh-cCcCCCHHHHHHHHHHHHHHHHHHHHC-CEECCCCCHHHEEEcCCCCEEEEecccceeccCC
Confidence            99999986 89888864 345688999999999999999999999 9999999999999999999999999999865432


Q ss_pred             ----CCccCcccccCcccccCC-CCCCcccchhhhHHHHHHHhCCCCCCchhhHHHhhhchhhhccc---cc--------
Q 020221          210 ----RSYSTNLAFTPPEYLRTG-RVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDS---CL--------  273 (329)
Q Consensus       210 ----~~~~~~~~y~aPE~~~~~-~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~---~~--------  273 (329)
                          ....+|+.|+|||++.+. .++.++||||||+++|+|++|..||..................+   ..        
T Consensus       166 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~  245 (346)
T 1ua2_A          166 NRAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPD  245 (346)
T ss_dssp             CCCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSSSTTSSTT
T ss_pred             cccCCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHcCCCChhhhhhhccCcc
Confidence                234678999999998765 48889999999999999999998876543322211111110000   00        


Q ss_pred             ------cCCC-----ChHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 020221          274 ------EGQF-----SSDEGTELVRLASRCLQYEPRERPNPRSLVT  308 (329)
Q Consensus       274 ------~~~~-----~~~~~~~~~~li~~cl~~dp~~Rps~~~~l~  308 (329)
                            ....     ....++++.+|+.+||..||++|||+.++++
T Consensus       246 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  291 (346)
T 1ua2_A          246 YVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALK  291 (346)
T ss_dssp             CCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHT
T ss_pred             cccccccCCCChHHhhccCCHHHHHHHHHHhccChhhCCCHHHHhc
Confidence                  0000     1334688999999999999999999999998

>3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A*

Probab=100.00  E-value=4.3e-46  Score=344.81  Aligned_cols=248  Identities=16%  Similarity=0.188  Sum_probs=192.6

Q ss_pred             CcccccccCCCCCCcEEEEEE-eCCCCEEEEEEeCCCCC--hhHHHHHHHHHHHhcCCCccccccceeeeeC-----Cee
Q 020221           57 AMENIVSEHGEKAPNVVYKGK-LENQFRIAVKRFNRSAW--PDARQFLEEARAVGQLRNRRLANLLGCCCEG-----DER  128 (329)
Q Consensus        57 ~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~-----~~~  128 (329)
                      ..|.+++.||+|+||.||+|. ..+++.||||++.....  ...+.+.+|+++++.++||||+++++++...     ...
T Consensus        26 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~  105 (432)
T 3n9x_A           26 DNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKFDEL  105 (432)
T ss_dssp             TTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSTTTSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCCE
T ss_pred             CCEEEEEEEeecCCEEEEEEEECCCCcEEEEEEeCchhcChHHHHHHHHHHHHHHHcCCCCcceEEEEEecCCCCcCCeE
Confidence            457788888999999999999 55688999999976432  2356789999999999999999999998766     578


Q ss_pred             EEEEecCCCCCHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCCCCCeeeecccCcccCCC
Q 020221          129 LLVAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRD  208 (329)
Q Consensus       129 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~  208 (329)
                      ++||||+. ++|.+++.  ....+++..+..++.||+.||+|||+. ||+||||||+|||++.++.+||+|||+++....
T Consensus       106 ~lv~e~~~-~~L~~~~~--~~~~l~~~~~~~i~~qil~aL~~LH~~-givHrDlkp~NILl~~~~~~kL~DFGla~~~~~  181 (432)
T 3n9x_A          106 YIVLEIAD-SDLKKLFK--TPIFLTEEHIKTILYNLLLGENFIHES-GIIHRDLKPANCLLNQDCSVKVCDFGLARTINS  181 (432)
T ss_dssp             EEEEECCS-EEHHHHHH--SSCCCCHHHHHHHHHHHHHHHHHHHHT-TEECCCCCGGGEEECTTCCEEECCCTTCEEC--
T ss_pred             EEEEecCC-cCHHHHHh--ccCCCCHHHHHHHHHHHHHHHHHHHHC-CCCCCCCCHHHeEECCCCCEEEccCCCcccccc
Confidence            99999986 49999996  456799999999999999999999999 999999999999999999999999999986543


Q ss_pred             C--------------------------CCccCcccccCcccc-cCCCCCCcccchhhhHHHHHHHhCCCC----------
Q 020221          209 G--------------------------RSYSTNLAFTPPEYL-RTGRVTPESVMYSFGTLLLDLLSGKHI----------  251 (329)
Q Consensus       209 ~--------------------------~~~~~~~~y~aPE~~-~~~~~~~~~DvwslG~il~el~tg~~~----------  251 (329)
                      .                          ....+|+.|+|||++ .+..++.++|||||||++|||++|..|          
T Consensus       182 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~p  261 (432)
T 3n9x_A          182 EKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSHINDPTNRFP  261 (432)
T ss_dssp             -----------------------------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHTTCTTTCSSGGGCCC
T ss_pred             cccccccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccchHHHHHHHHHhcccccccccccccc
Confidence            2                          345679999999986 455699999999999999999985433          


Q ss_pred             -CCchh------------------hHHHh------------------hhchhhhccccc-cCCC-----ChHHHHHHHHH
Q 020221          252 -PPSHA------------------LDLIR------------------DRNIQTLTDSCL-EGQF-----SSDEGTELVRL  288 (329)
Q Consensus       252 -~~~~~------------------~~~~~------------------~~~~~~~~~~~~-~~~~-----~~~~~~~~~~l  288 (329)
                       |+...                  .+...                  ............ ....     ....++++.+|
T Consensus       262 ~f~g~~~~~~~~~~~~~~~~~~~~~~ql~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dL  341 (432)
T 3n9x_A          262 LFPGSSCFPLSPDRNSKKVHEKSNRDQLNIIFNIIGTPTEDDLKNINKPEVIKYIKLFPHRKPINLKQKYPSISDDGINL  341 (432)
T ss_dssp             SCCCSCSCC----------CHHHHHHHHHHHHHHHCSCCHHHHHTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHH
T ss_pred             cCCCccccccCcccccccccccchHHHHHHHHHhcCCCCHHHHHhccCHHHHHHHHhCCCCCCCCHHHHCCCCCHHHHHH
Confidence             22210                  00000                  000000000000 0000     02357889999


Q ss_pred             HHHhcccCCCCCCCHHHHHH
Q 020221          289 ASRCLQYEPRERPNPRSLVT  308 (329)
Q Consensus       289 i~~cl~~dp~~Rps~~~~l~  308 (329)
                      +.+||..||++|||+.++++
T Consensus       342 l~~mL~~dP~~R~ta~e~L~  361 (432)
T 3n9x_A          342 LESMLKFNPNKRITIDQALD  361 (432)
T ss_dssp             HHHHSCSSTTTSCCHHHHHT
T ss_pred             HHHHhcCCcccCCCHHHHhc
Confidence            99999999999999999998

>3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=9.2e-46  Score=331.44  Aligned_cols=251  Identities=17%  Similarity=0.250  Sum_probs=199.1

Q ss_pred             cccccccCCCCCCcEEEEEEeCCCCEEEEEEeCCCCChhHHHHHHHHHHHhcC--CCccccccceeeeeC----CeeEEE
Q 020221           58 MENIVSEHGEKAPNVVYKGKLENQFRIAVKRFNRSAWPDARQFLEEARAVGQL--RNRRLANLLGCCCEG----DERLLV  131 (329)
Q Consensus        58 ~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l--~h~niv~~~~~~~~~----~~~~lv  131 (329)
                      .|++++.||+|+||.||+|... ++.||||++....   ...+.+|.+++..+  +||||+++++++...    ...++|
T Consensus        38 ~y~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~~---~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~lv  113 (337)
T 3mdy_A           38 QIQMVKQIGKGRYGEVWMGKWR-GEKVAVKVFFTTE---EASWFRETEIYQTVLMRHENILGFIAADIKGTGSWTQLYLI  113 (337)
T ss_dssp             HCEEEEEEEEETTEEEEEEEET-TEEEEEEEEEGGG---HHHHHHHHHHHTSTTCCCTTBCCEEEEEEESCGGGCEEEEE
T ss_pred             ceEEEeEeecCCCeEEEEEEEC-CceEEEEEEeccc---cchhhhHHHHHHHHhhcCCCeeeEEEEEccCCCCCCceEEE
Confidence            4678888899999999999975 7899999986533   33445566666554  899999999999877    789999


Q ss_pred             EecCCCCCHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCC-------CccccccCCCceeeCCCCCeeeecccCcc
Q 020221          132 AEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKE-------RALYHDLNAYRIVFDDDVNPRLSCFGLMK  204 (329)
Q Consensus       132 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~-------~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~  204 (329)
                      |||+++|+|.+++..   ..+++..++.++.|++.||.|||+..       +++||||||+||+++.++.+||+|||++.
T Consensus       114 ~e~~~~g~L~~~l~~---~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfg~a~  190 (337)
T 3mdy_A          114 TDYHENGSLYDYLKS---TTLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAV  190 (337)
T ss_dssp             ECCCTTCBHHHHHHH---CCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCTTCE
T ss_pred             EeccCCCcHHHHhhc---cCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCEEecccchHHEEECCCCCEEEEeCCCce
Confidence            999999999999953   46999999999999999999999752       89999999999999999999999999997


Q ss_pred             cCCCCC--------CccCcccccCcccccCCCCCCc------ccchhhhHHHHHHHhC----------CCCCCchh----
Q 020221          205 NSRDGR--------SYSTNLAFTPPEYLRTGRVTPE------SVMYSFGTLLLDLLSG----------KHIPPSHA----  256 (329)
Q Consensus       205 ~~~~~~--------~~~~~~~y~aPE~~~~~~~~~~------~DvwslG~il~el~tg----------~~~~~~~~----  256 (329)
                      ......        ...||+.|+|||++.+......      +||||||+++|||++|          ..|+....    
T Consensus       191 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~~~~~~~~~~~p~~~~~~~~~  270 (337)
T 3mdy_A          191 KFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPYHDLVPSDP  270 (337)
T ss_dssp             ECC---------CCSSCSCGGGCCHHHHTTCCCTTCTHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTSCSSC
T ss_pred             eeccccccccCCCCCCccCcceeChhhcccccCCccccCccccchHHHHHHHHHHHhccCcccccccccccHhhhcCCCC
Confidence            544322        3468999999999987776665      9999999999999999          44443211    


Q ss_pred             -hHHHhhhchhhhccccccCCCC-----hHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhhcccc
Q 020221          257 -LDLIRDRNIQTLTDSCLEGQFS-----SDEGTELVRLASRCLQYEPRERPNPRSLVTALVTLQKDTEL  319 (329)
Q Consensus       257 -~~~~~~~~~~~~~~~~~~~~~~-----~~~~~~~~~li~~cl~~dp~~Rps~~~~l~~L~~~~~~~~~  319 (329)
                       .......    ..........+     ..+++++.+++.+||+.||++|||+.+++++|+.+.+..+.
T Consensus       271 ~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~~~~~~  335 (337)
T 3mdy_A          271 SYEDMREI----VCIKKLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKTLAKMSESQDI  335 (337)
T ss_dssp             CHHHHHHH----HTTSCCCCCCCGGGGGSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHTTTC
T ss_pred             chhhhHHH----HhhhccCccccccchhhHHHHHHHHHHHHhhhhChhhCCCHHHHHHHHHHHHhhccc
Confidence             0111111    11111122222     36788999999999999999999999999999999886653

>3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens}

Probab=100.00  E-value=3.6e-46  Score=333.83  Aligned_cols=257  Identities=16%  Similarity=0.184  Sum_probs=193.8

Q ss_pred             cccccccCCCCCCcEEEEEE-eCCCCEEEEEEeCCCCChhHHHHHHHHHHHhcCC-Cccccccceeee--------eCCe
Q 020221           58 MENIVSEHGEKAPNVVYKGK-LENQFRIAVKRFNRSAWPDARQFLEEARAVGQLR-NRRLANLLGCCC--------EGDE  127 (329)
Q Consensus        58 ~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~~~~~~~--------~~~~  127 (329)
                      .|++.+.||+|+||.||++. ..+++.||+|++........+.+.+|+.+++.+. ||||+++++++.        ....
T Consensus        29 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~~~~~~~  108 (337)
T 3ll6_A           29 RLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESDTGQAE  108 (337)
T ss_dssp             EEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEECTTTSTTSSEE
T ss_pred             eEEEEEEEccCCceEEEEEEECCCCcEEEEEEecCCchHHHHHHHHHHHHHHHhccCCChhhccccccccccccccCCce
Confidence            47788888999999999999 4578899999987666555677899999999996 999999999983        3345


Q ss_pred             eEEEEecCCCCCHHhhhccC-CCCCCCHHHHHHHHHHHHHHHHHhhcCCC--ccccccCCCceeeCCCCCeeeecccCcc
Q 020221          128 RLLVAEYMPNDTLAKHLFHW-ETQPMKWAMRLRVALHIAEALEYCTSKER--ALYHDLNAYRIVFDDDVNPRLSCFGLMK  204 (329)
Q Consensus       128 ~~lv~e~~~~gsL~~~l~~~-~~~~~~~~~~~~i~~~i~~~l~~lH~~~~--ivH~dlkp~Nil~~~~~~~kl~Dfg~a~  204 (329)
                      .+++|||+. |+|.+++... ....+++..++.++.||+.||.|||+. +  ++|+||||+||+++.++.+||+|||++.
T Consensus       109 ~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~-~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~  186 (337)
T 3ll6_A          109 FLLLTELCK-GQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHRQ-KPPIIHRDLKVENLLLSNQGTIKLCDFGSAT  186 (337)
T ss_dssp             EEEEEECCS-EEHHHHHHHHHTTCSCCHHHHHHHHHHHHHHHHHHHTS-SSCCBCCCCCGGGCEECTTSCEEBCCCTTCB
T ss_pred             EEEEEEecC-CCHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhC-CCCEEEccCCcccEEECCCCCEEEecCccce
Confidence            899999996 6899888542 345699999999999999999999999 8  9999999999999999999999999998


Q ss_pred             cCCCCC----------------CccCcccccCcccc---cCCCCCCcccchhhhHHHHHHHhCCCCCCchhhHHHhhhch
Q 020221          205 NSRDGR----------------SYSTNLAFTPPEYL---RTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNI  265 (329)
Q Consensus       205 ~~~~~~----------------~~~~~~~y~aPE~~---~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~~~~~~  265 (329)
                      ......                ...+|+.|+|||++   .+..++.++||||||+++|+|++|..||.........    
T Consensus       187 ~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~----  262 (337)
T 3ll6_A          187 TISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGAKLRIV----  262 (337)
T ss_dssp             CCSSCC-------------------------------CCTTSCSSHHHHHHHHHHHHHHHHHSSCCC-------------
T ss_pred             eccccCcccccccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHHHhCCCCCcchhHHHhh----
Confidence            654432                23478899999998   4566888999999999999999999888643222111    


Q ss_pred             hhhccccccCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhhccccccCcc
Q 020221          266 QTLTDSCLEGQFSSDEGTELVRLASRCLQYEPRERPNPRSLVTALVTLQKDTELYLSLP  324 (329)
Q Consensus       266 ~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~~~l~~L~~~~~~~~~~~~~p  324 (329)
                          ............+..+.+++.+||+.||++|||+.++++.|+.+..........|
T Consensus       263 ----~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~~~~~~~~~~~~~~  317 (337)
T 3ll6_A          263 ----NGKYSIPPHDTQYTVFHSLIRAMLQVNPEERLSIAEVVHQLQEIAAARNVNPKSP  317 (337)
T ss_dssp             -------CCCCTTCCSSGGGHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHHTTCCTTSC
T ss_pred             ----cCcccCCcccccchHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhccCCCCCcc
Confidence                1111112223345568899999999999999999999999999987655444443

>2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ...

Probab=100.00  E-value=3.2e-46  Score=338.41  Aligned_cols=247  Identities=18%  Similarity=0.234  Sum_probs=182.2

Q ss_pred             CcccccccCCCCCCcEEEEEE-eCCCCEEEEEEeCCCCC--hhHHHHHHHHHHHhcCCCccccccceeeeeC------Ce
Q 020221           57 AMENIVSEHGEKAPNVVYKGK-LENQFRIAVKRFNRSAW--PDARQFLEEARAVGQLRNRRLANLLGCCCEG------DE  127 (329)
Q Consensus        57 ~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~------~~  127 (329)
                      ..|++++.||+|+||.||+|. ..+|+.||||++.....  ...+.+.+|+.+++.++||||+++++++...      ..
T Consensus        29 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~~  108 (367)
T 2fst_X           29 ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFND  108 (367)
T ss_dssp             TTEEEEEECC----CCEEEEEETTTTEEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCCC
T ss_pred             CceEEeeEEeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCccccCCe
Confidence            457788889999999999998 56788999999976432  2355688999999999999999999998654      56


Q ss_pred             eEEEEecCCCCCHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCCCCCeeeecccCcccCC
Q 020221          128 RLLVAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSR  207 (329)
Q Consensus       128 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~  207 (329)
                      .++++|++ +++|.+++.   ...+++..+..++.||+.||.|||+. |++||||||+||+++.++.+||+|||+++...
T Consensus       109 ~~lv~e~~-~~~L~~~~~---~~~l~~~~~~~i~~qi~~aL~~LH~~-givH~Dlkp~NIll~~~~~~kL~DFG~a~~~~  183 (367)
T 2fst_X          109 VYLVTHLM-GADLNNIVK---CQKLTDDHVQFLIYQILRGLKYIHSA-DIIHRDLKPSNLAVNEDCELKILDFGLARHTA  183 (367)
T ss_dssp             CEEEEECC-CEECC--------CCCCHHHHHHHHHHHHHHHHHHHHT-TCCCCCCCGGGEEECTTCCEEECC--------
T ss_pred             EEEEeccc-CCCHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHC-CeeeCCCCHhhEEECCCCCEEEeecccccccc
Confidence            79999999 679998884   36799999999999999999999999 99999999999999999999999999998654


Q ss_pred             CC-CCccCcccccCcccccC-CCCCCcccchhhhHHHHHHHhCCCCCCchhhHHHhhhchhh------------------
Q 020221          208 DG-RSYSTNLAFTPPEYLRT-GRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQT------------------  267 (329)
Q Consensus       208 ~~-~~~~~~~~y~aPE~~~~-~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~~~~~~~~------------------  267 (329)
                      .. ....+|+.|+|||++.+ ..++.++||||||+++|+|++|+.||+..............                  
T Consensus       184 ~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~  263 (367)
T 2fst_X          184 DEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESAR  263 (367)
T ss_dssp             -------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHTTCCCHHHH
T ss_pred             ccCCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHhhhHHHH
Confidence            43 34578999999999887 56899999999999999999999988764322111111000                  


Q ss_pred             -hccccc---cCC---CChHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 020221          268 -LTDSCL---EGQ---FSSDEGTELVRLASRCLQYEPRERPNPRSLVT  308 (329)
Q Consensus       268 -~~~~~~---~~~---~~~~~~~~~~~li~~cl~~dp~~Rps~~~~l~  308 (329)
                       ......   ...   .....++++.+|+.+||..||++|||+.++++
T Consensus       264 ~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~t~~e~L~  311 (367)
T 2fst_X          264 NYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALA  311 (367)
T ss_dssp             HHHHTSCCCCCCCHHHHTTTCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             HHHhccCCCCCCCHHHHCCCCCHHHHHHHHHhCCCCcccCcCHHHHhc
Confidence             000000   000   01234678999999999999999999999997

>2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens}

Probab=100.00  E-value=8.1e-47  Score=339.82  Aligned_cols=255  Identities=17%  Similarity=0.145  Sum_probs=197.0

Q ss_pred             CcccccccCCCCCCcEEEEEEeC----CCCEEEEEEeCCCCChhH-----------HHHHHHHHHHhcCCCcccccccee
Q 020221           57 AMENIVSEHGEKAPNVVYKGKLE----NQFRIAVKRFNRSAWPDA-----------RQFLEEARAVGQLRNRRLANLLGC  121 (329)
Q Consensus        57 ~~~~~~~~lg~G~~g~V~~~~~~----~~~~vavK~~~~~~~~~~-----------~~~~~e~~~l~~l~h~niv~~~~~  121 (329)
                      ..|.+.+.||+|+||.||+|...    ++..+|+|++........           ..+.+|+..++.++||||++++++
T Consensus        37 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~~~~~  116 (345)
T 2v62_A           37 NQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLFYGS  116 (345)
T ss_dssp             CEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCCEEEE
T ss_pred             ceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCcceeecc
Confidence            45788889999999999999954    578899999986643211           235678889999999999999999


Q ss_pred             eee----CCeeEEEEecCCCCCHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCCCC--Ce
Q 020221          122 CCE----GDERLLVAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDV--NP  195 (329)
Q Consensus       122 ~~~----~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~--~~  195 (329)
                      +..    ....++||||+ +++|.+++..  ...+++..++.++.||+.||.|||+. +++||||||+||+++.++  .+
T Consensus       117 ~~~~~~~~~~~~lv~e~~-~~~L~~~l~~--~~~~~~~~~~~i~~qi~~aL~~LH~~-~ivH~Dlkp~NIll~~~~~~~~  192 (345)
T 2v62_A          117 GLTEFKGRSYRFMVMERL-GIDLQKISGQ--NGTFKKSTVLQLGIRMLDVLEYIHEN-EYVHGDIKAANLLLGYKNPDQV  192 (345)
T ss_dssp             EEEESSSCEEEEEEEECE-EEEHHHHCBG--GGBCCHHHHHHHHHHHHHHHHHHHHT-TEECSCCSGGGEEEESSSTTSE
T ss_pred             cccccCCCcEEEEEEecc-CCCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhC-CeeCCCcCHHHEEEccCCCCcE
Confidence            987    67899999999 9999999964  33799999999999999999999999 999999999999998877  99


Q ss_pred             eeecccCcccCCCC-----------CCccCcccccCcccccCCCCCCcccchhhhHHHHHHHhCCCCCCchhhHHH----
Q 020221          196 RLSCFGLMKNSRDG-----------RSYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLI----  260 (329)
Q Consensus       196 kl~Dfg~a~~~~~~-----------~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~----  260 (329)
                      ||+|||+++.....           ....+|+.|+|||++.+..++.++||||||+++|||++|..||........    
T Consensus       193 kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~~  272 (345)
T 2v62_A          193 YLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGVALSRRSDVEILGYCMLRWLCGKLPWEQNLKDPVAVQT  272 (345)
T ss_dssp             EECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCTTGGGTTCHHHHHH
T ss_pred             EEEeCCCceecccccccccchhccccccCCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCccccccccHHHHH
Confidence            99999999754322           234678999999999998899999999999999999999988854211111    


Q ss_pred             -hhhchhhhccccccCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhh
Q 020221          261 -RDRNIQTLTDSCLEGQFSSDEGTELVRLASRCLQYEPRERPNPRSLVTALVTLQK  315 (329)
Q Consensus       261 -~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~~~l~~L~~~~~  315 (329)
                       .....................++++.+++..||+.||++|||+.++++.|+.+..
T Consensus       273 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~  328 (345)
T 2v62_A          273 AKTNLLDELPQSVLKWAPSGSSCCEIAQFLVCAHSLAYDEKPNYQALKKILNPHGI  328 (345)
T ss_dssp             HHHHHHHTTTHHHHHHSCTTSCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHCTTCC
T ss_pred             HHHhhcccccHHHHhhccccccHHHHHHHHHHHhhcCcccCCCHHHHHHHHhccCC
Confidence             0010110000000000111456789999999999999999999999999998754

>2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A*

Probab=100.00  E-value=3.9e-46  Score=334.05  Aligned_cols=244  Identities=16%  Similarity=0.148  Sum_probs=205.7

Q ss_pred             CCcccccccCCCCCCcEEEEEEe-CCCCEEEEEEeCCCC---ChhHHHHHHHHHHHhcCCCccccccceeeeeCCeeEEE
Q 020221           56 FAMENIVSEHGEKAPNVVYKGKL-ENQFRIAVKRFNRSA---WPDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLV  131 (329)
Q Consensus        56 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv  131 (329)
                      ...|.+.+.||+|+||.||++.. .+++.||+|++....   ....+.+.+|+.+++.++||||+++++++.+.+..++|
T Consensus        40 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv  119 (335)
T 2owb_A           40 RRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVV  119 (335)
T ss_dssp             TEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             CCceEEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEE
Confidence            35677888899999999999994 567899999987542   22355688999999999999999999999999999999


Q ss_pred             EecCCCCCHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCCCCCeeeecccCcccCCCC--
Q 020221          132 AEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDG--  209 (329)
Q Consensus       132 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~--  209 (329)
                      |||+++++|.+++..  ...+++..++.++.||+.||.|||++ |++|+||||+||+++.++.+||+|||++......  
T Consensus       120 ~e~~~~~~L~~~~~~--~~~l~~~~~~~i~~qi~~aL~~LH~~-~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~  196 (335)
T 2owb_A          120 LELCRRRSLLELHKR--RKALTEPEARYYLRQIVLGCQYLHRN-RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGE  196 (335)
T ss_dssp             ECCCTTCBHHHHHHH--HCSCCHHHHHHHHHHHHHHHHHHHHT-TEECSCCCGGGEEECTTCCEEECCCTTCEECCSTTC
T ss_pred             EecCCCCCHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHHC-CCEecCCCchhEEEcCCCCEEEeeccCceecccCcc
Confidence            999999999998863  45789999999999999999999999 9999999999999999999999999999765422  


Q ss_pred             --CCccCcccccCcccccCCCCCCcccchhhhHHHHHHHhCCCCCCchhhHHHhhhchhhhccccccCCCChHHHHHHHH
Q 020221          210 --RSYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVR  287 (329)
Q Consensus       210 --~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  287 (329)
                        ....++..|+|||++.+..++.++||||||+++|+|++|..||...............      ....+...++++.+
T Consensus       197 ~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~------~~~~~~~~~~~~~~  270 (335)
T 2owb_A          197 RKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKN------EYSIPKHINPVAAS  270 (335)
T ss_dssp             CBCCCCSCCSSCCHHHHHTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHT------CCCCCTTSCHHHHH
T ss_pred             cccccCCCccccCHHHhccCCCCchhhHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHhcC------CCCCCccCCHHHHH
Confidence              2346789999999999888999999999999999999999988654433222111111      11234556778999


Q ss_pred             HHHHhcccCCCCCCCHHHHHH
Q 020221          288 LASRCLQYEPRERPNPRSLVT  308 (329)
Q Consensus       288 li~~cl~~dp~~Rps~~~~l~  308 (329)
                      ++.+||+.||++|||+.++++
T Consensus       271 li~~~l~~dp~~Rps~~ell~  291 (335)
T 2owb_A          271 LIQKMLQTDPTARPTINELLN  291 (335)
T ss_dssp             HHHHHTCSSGGGSCCGGGGGG
T ss_pred             HHHHHccCChhHCcCHHHHhc
Confidence            999999999999999999997

>2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A*

Probab=100.00  E-value=5.4e-46  Score=326.98  Aligned_cols=244  Identities=16%  Similarity=0.152  Sum_probs=205.4

Q ss_pred             CcccccccCCCCCCcEEEEEEe-CCCCEEEEEEeCCCC---ChhHHHHHHHHHHHhcCCCccccccceeeeeCCeeEEEE
Q 020221           57 AMENIVSEHGEKAPNVVYKGKL-ENQFRIAVKRFNRSA---WPDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVA  132 (329)
Q Consensus        57 ~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~  132 (329)
                      ..|.+.+.||+|+||.||++.. .+++.+|+|++....   ....+.+.+|+.+++.++||||+++++++.+.+..++||
T Consensus        15 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~   94 (294)
T 2rku_A           15 RRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVVL   94 (294)
T ss_dssp             EEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             cceEEEEEEeecCCEEEEEEEECCCCceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCEEEEEE
Confidence            4577888889999999999995 467899999987542   223456889999999999999999999999999999999


Q ss_pred             ecCCCCCHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCCCCCeeeecccCcccCCCC---
Q 020221          133 EYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDG---  209 (329)
Q Consensus       133 e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~---  209 (329)
                      ||+++++|.+++.  ....+++..+..++.|++.||.|||++ |++|+||||+||+++.++.++|+|||++......   
T Consensus        95 e~~~~~~L~~~~~--~~~~~~~~~~~~i~~qi~~~l~~lH~~-~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~  171 (294)
T 2rku_A           95 ELCRRRSLLELHK--RRKALTEPEARYYLRQIVLGCQYLHRN-RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGER  171 (294)
T ss_dssp             ECCTTCBHHHHHH--HHCSCCHHHHHHHHHHHHHHHHHHHHT-TEECCCCCGGGEEECTTCCEEECCCTTCEECCSTTCC
T ss_pred             ecCCCCCHHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHHC-CccccCCChHhEEEcCCCCEEEEeccCceecccCccc
Confidence            9999999999886  345789999999999999999999999 9999999999999999999999999998765422   


Q ss_pred             -CCccCcccccCcccccCCCCCCcccchhhhHHHHHHHhCCCCCCchhhHHHhhhchhhhccccccCCCChHHHHHHHHH
Q 020221          210 -RSYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRL  288 (329)
Q Consensus       210 -~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  288 (329)
                       ....+++.|+|||.+.+..++.++||||||+++|+|++|..||..............    .  ....+...++.+.++
T Consensus       172 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~----~--~~~~~~~~~~~~~~l  245 (294)
T 2rku_A          172 KKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKK----N--EYSIPKHINPVAASL  245 (294)
T ss_dssp             BCCCCSCCSSCCHHHHTTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHT----T--CCCCCTTSCHHHHHH
T ss_pred             cccccCCCCcCCcchhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhh----c--cCCCccccCHHHHHH
Confidence             234678999999999988899999999999999999999988865443322211111    1  112345567889999


Q ss_pred             HHHhcccCCCCCCCHHHHHHH
Q 020221          289 ASRCLQYEPRERPNPRSLVTA  309 (329)
Q Consensus       289 i~~cl~~dp~~Rps~~~~l~~  309 (329)
                      +.+||+.||++|||+.+++++
T Consensus       246 i~~~l~~~p~~Rps~~~ll~~  266 (294)
T 2rku_A          246 IQKMLQTDPTARPTINELLND  266 (294)
T ss_dssp             HHHHTCSSGGGSCCGGGGGGS
T ss_pred             HHHHcccChhhCcCHHHHhhC
Confidence            999999999999999999974

>2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A*

Probab=100.00  E-value=6.3e-46  Score=331.52  Aligned_cols=255  Identities=20%  Similarity=0.304  Sum_probs=206.4

Q ss_pred             CcccccccCCCCCCcEEEEEEe------CCCCEEEEEEeCCCCC-hhHHHHHHHHHHHhcCCCccccccceeeeeCCeeE
Q 020221           57 AMENIVSEHGEKAPNVVYKGKL------ENQFRIAVKRFNRSAW-PDARQFLEEARAVGQLRNRRLANLLGCCCEGDERL  129 (329)
Q Consensus        57 ~~~~~~~~lg~G~~g~V~~~~~------~~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~  129 (329)
                      ..|++++.||+|+||.||+|..      .++..||+|.+..... .....+.+|+.+++.++||||+++++++......+
T Consensus        30 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~  109 (327)
T 2yfx_A           30 KNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPRF  109 (327)
T ss_dssp             GGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCE
T ss_pred             hheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEeccccchhhHHHHHHHHHHHhhCCCCCCCeEEEEEcCCCCcE
Confidence            4577888899999999999983      3467899999975532 33556889999999999999999999999999999


Q ss_pred             EEEecCCCCCHHhhhccCCC-----CCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCC---CCCeeeeccc
Q 020221          130 LVAEYMPNDTLAKHLFHWET-----QPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDD---DVNPRLSCFG  201 (329)
Q Consensus       130 lv~e~~~~gsL~~~l~~~~~-----~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~---~~~~kl~Dfg  201 (329)
                      +||||+++++|.+++.....     ..+++..++.++.|++.||.|||+. |++|+||||+||+++.   +..++|+|||
T Consensus       110 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~-~i~H~dlkp~NIli~~~~~~~~~kl~Dfg  188 (327)
T 2yfx_A          110 ILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEEN-HFIHRDIAARNCLLTCPGPGRVAKIGDFG  188 (327)
T ss_dssp             EEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHHT-TCCCSCCCGGGEEESCSSTTCCEEECCCH
T ss_pred             EEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhhC-CeecCcCCHhHEEEecCCCcceEEECccc
Confidence            99999999999999975322     4589999999999999999999999 9999999999999984   4569999999


Q ss_pred             CcccCCC------CCCccCcccccCcccccCCCCCCcccchhhhHHHHHHHh-CCCCCCchhhHHHhhhchhhhcccccc
Q 020221          202 LMKNSRD------GRSYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLS-GKHIPPSHALDLIRDRNIQTLTDSCLE  274 (329)
Q Consensus       202 ~a~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t-g~~~~~~~~~~~~~~~~~~~~~~~~~~  274 (329)
                      ++.....      .....+++.|+|||.+.+..++.++||||||+++|+|++ |..||..............     ...
T Consensus       189 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~-----~~~  263 (327)
T 2yfx_A          189 MARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTS-----GGR  263 (327)
T ss_dssp             HHHHHHC------CCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHT-----TCC
T ss_pred             cccccccccccccCCCcCCCcceeCHhHhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCcCHHHHHHHHhc-----CCC
Confidence            9864322      223456889999999998889999999999999999998 7777765433322221111     112


Q ss_pred             CCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhhcc
Q 020221          275 GQFSSDEGTELVRLASRCLQYEPRERPNPRSLVTALVTLQKDT  317 (329)
Q Consensus       275 ~~~~~~~~~~~~~li~~cl~~dp~~Rps~~~~l~~L~~~~~~~  317 (329)
                      ...+..+++.+.+++.+||+.||++|||+.++++.|+.+....
T Consensus       264 ~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~~~  306 (327)
T 2yfx_A          264 MDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQDP  306 (327)
T ss_dssp             CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHCH
T ss_pred             CCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHhcCH
Confidence            2334556788999999999999999999999999999997754

>2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A*

Probab=100.00  E-value=6.6e-46  Score=323.31  Aligned_cols=243  Identities=18%  Similarity=0.242  Sum_probs=197.8

Q ss_pred             CcccccccCCCCCCcEEEEEEe-CCCCEEEEEEeCCCC---ChhHHHHHHHHHHHhcCCCccccccceeeeeCCeeEEEE
Q 020221           57 AMENIVSEHGEKAPNVVYKGKL-ENQFRIAVKRFNRSA---WPDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVA  132 (329)
Q Consensus        57 ~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~  132 (329)
                      ..|.+.+.||+|+||.||++.. .+++.||+|++....   ....+.+.+|+.+++.++||||+++++++...+..++||
T Consensus        11 ~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   90 (276)
T 2h6d_A           11 GHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVISTPTDFFMVM   90 (276)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             ccEEEEeeecCCCCeEEEEEEECCCCceEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCeEEEEE
Confidence            4577888899999999999995 478899999986532   123457889999999999999999999999999999999


Q ss_pred             ecCCCCCHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCCCCCeeeecccCcccCCCCC--
Q 020221          133 EYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDGR--  210 (329)
Q Consensus       133 e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~--  210 (329)
                      ||+++++|.+++..  ...+++..+..++.|++.||.|||++ +++|+||||+||+++.++.++|+|||++.......  
T Consensus        91 e~~~~~~L~~~l~~--~~~~~~~~~~~~~~qi~~~l~~lH~~-~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~~  167 (276)
T 2h6d_A           91 EYVSGGELFDYICK--HGRVEEMEARRLFQQILSAVDYCHRH-MVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFL  167 (276)
T ss_dssp             ECCCSCBHHHHHHH--HCSCCHHHHHHHHHHHHHHHHHHHHH-CSSCCCCCGGGEEECTTSCEEECCCCGGGCCCC----
T ss_pred             eccCCCcHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHHC-CCccCCCChhhEEECCCCCEEEeecccccccCCCcce
Confidence            99999999999963  35689999999999999999999999 99999999999999999999999999998765432  


Q ss_pred             -CccCcccccCcccccCCCC-CCcccchhhhHHHHHHHhCCCCCCchhhHHHhhhchhhhccccccCCCChHHHHHHHHH
Q 020221          211 -SYSTNLAFTPPEYLRTGRV-TPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRL  288 (329)
Q Consensus       211 -~~~~~~~y~aPE~~~~~~~-~~~~DvwslG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  288 (329)
                       ...+++.|+|||.+.+..+ +.++||||||+++|+|++|..||...............      ....+...+.++.++
T Consensus       168 ~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~------~~~~~~~~~~~l~~l  241 (276)
T 2h6d_A          168 RTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEHVPTLFKKIRGG------VFYIPEYLNRSVATL  241 (276)
T ss_dssp             ---------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHC------CCCCCTTSCHHHHHH
T ss_pred             ecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhhcC------cccCchhcCHHHHHH
Confidence             3457899999999987765 57999999999999999999888655433222221111      112344567789999


Q ss_pred             HHHhcccCCCCCCCHHHHHH
Q 020221          289 ASRCLQYEPRERPNPRSLVT  308 (329)
Q Consensus       289 i~~cl~~dp~~Rps~~~~l~  308 (329)
                      +.+||+.||++|||+.++++
T Consensus       242 i~~~l~~~p~~Rps~~~~l~  261 (276)
T 2h6d_A          242 LMHMLQVDPLKRATIKDIRE  261 (276)
T ss_dssp             HHHHTCSSGGGSCCHHHHHH
T ss_pred             HHHHccCChhhCCCHHHHHh
Confidence            99999999999999999998

>2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A*

Probab=100.00  E-value=3.7e-46  Score=325.39  Aligned_cols=250  Identities=16%  Similarity=0.210  Sum_probs=204.0

Q ss_pred             CCCcccccccCCCCCCcEEEEEEe-CCCCEEEEEEeCCCCC--hhHHHHHHHHHHHhcCCCccccccceeeee--CCeeE
Q 020221           55 GFAMENIVSEHGEKAPNVVYKGKL-ENQFRIAVKRFNRSAW--PDARQFLEEARAVGQLRNRRLANLLGCCCE--GDERL  129 (329)
Q Consensus        55 ~~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~~~~~~~~--~~~~~  129 (329)
                      ....|++++.||+|+||.||++.. .+++.||+|.+.....  ...+.+.+|+++++.++||||+++++++..  ....+
T Consensus         4 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~   83 (279)
T 2w5a_A            4 RAEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLY   83 (279)
T ss_dssp             CGGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEGGGTEEE
T ss_pred             chhheeeehhccCCCCcEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhcCCCCCCeEEEEEecCCCceEE
Confidence            345688888999999999999994 5789999999976542  234568899999999999999999998743  57899


Q ss_pred             EEEecCCCCCHHhhhccC--CCCCCCHHHHHHHHHHHHHHHHHhhcCCC-----ccccccCCCceeeCCCCCeeeecccC
Q 020221          130 LVAEYMPNDTLAKHLFHW--ETQPMKWAMRLRVALHIAEALEYCTSKER-----ALYHDLNAYRIVFDDDVNPRLSCFGL  202 (329)
Q Consensus       130 lv~e~~~~gsL~~~l~~~--~~~~~~~~~~~~i~~~i~~~l~~lH~~~~-----ivH~dlkp~Nil~~~~~~~kl~Dfg~  202 (329)
                      +||||+++++|.+++...  ....+++..++.++.|++.||.|||+. +     ++|+||||+||+++.++.+||+|||+
T Consensus        84 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~-~~~~~~ivH~dl~p~NIl~~~~~~~kl~dfg~  162 (279)
T 2w5a_A           84 IVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRR-SDGGHTVLHRDLKPANVFLDGKQNVKLGDFGL  162 (279)
T ss_dssp             EEEECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHH-C------CCCCCSGGGEEECSSSCEEECCCCH
T ss_pred             EEEeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcc-cCCCCeeEEeccchhhEEEcCCCCEEEecCch
Confidence            999999999999998642  234589999999999999999999998 8     99999999999999999999999999


Q ss_pred             cccCCCCC----CccCcccccCcccccCCCCCCcccchhhhHHHHHHHhCCCCCCchhhHHHhhhchhhhccccccCCCC
Q 020221          203 MKNSRDGR----SYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFS  278 (329)
Q Consensus       203 a~~~~~~~----~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  278 (329)
                      +.......    ...+++.|+|||.+.+..++.++||||||+++|+|++|..||...............     .....+
T Consensus       163 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~i~~~-----~~~~~~  237 (279)
T 2w5a_A          163 ARILNHDTSFAKTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREG-----KFRRIP  237 (279)
T ss_dssp             HHHC---CHHHHHHHSCCTTCCHHHHHCC-CCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHT-----CCCCCC
T ss_pred             heeeccccccccccCCCccccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCcccCHHHHHHHHhhc-----ccccCC
Confidence            87665432    235789999999999888999999999999999999999888654333222221111     112344


Q ss_pred             hHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 020221          279 SDEGTELVRLASRCLQYEPRERPNPRSLVTAL  310 (329)
Q Consensus       279 ~~~~~~~~~li~~cl~~dp~~Rps~~~~l~~L  310 (329)
                      ...++++.+++.+||+.||++|||+.++++++
T Consensus       238 ~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~~  269 (279)
T 2w5a_A          238 YRYSDELNEIITRMLNLKDYHRPSVEEILENP  269 (279)
T ss_dssp             TTSCHHHHHHHHHHTCSSGGGSCCHHHHHTST
T ss_pred             cccCHHHHHHHHHHcCCCcccCCCHHHHHhCh
Confidence            56678999999999999999999999999844

>3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A

Probab=100.00  E-value=2e-47  Score=347.87  Aligned_cols=239  Identities=15%  Similarity=0.106  Sum_probs=187.3

Q ss_pred             CcccccccCCCCCCcEEEEEE-eCCCCEEEEEEeCCC---CChhHHHHHHHH---HHHhcCCCccccccc-------eee
Q 020221           57 AMENIVSEHGEKAPNVVYKGK-LENQFRIAVKRFNRS---AWPDARQFLEEA---RAVGQLRNRRLANLL-------GCC  122 (329)
Q Consensus        57 ~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~---~~~~~~~~~~e~---~~l~~l~h~niv~~~-------~~~  122 (329)
                      ..|.+.+.||+|+||+||+|. ..+++.||||++...   .....+.+.+|+   +.++.++||||++++       +++
T Consensus        73 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~~~~  152 (377)
T 3byv_A           73 RTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLV  152 (377)
T ss_dssp             EEEEEEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCSEEE
T ss_pred             ceEEEcceeecCCCEEEEEEEECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhhhhh
Confidence            456678889999999999999 467899999999743   333456788999   455556899999998       555


Q ss_pred             eeCC-----------------eeEEEEecCCCCCHHhhhccCC-----CCCCCHHHHHHHHHHHHHHHHHhhcCCCcccc
Q 020221          123 CEGD-----------------ERLLVAEYMPNDTLAKHLFHWE-----TQPMKWAMRLRVALHIAEALEYCTSKERALYH  180 (329)
Q Consensus       123 ~~~~-----------------~~~lv~e~~~~gsL~~~l~~~~-----~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~  180 (329)
                      .+.+                 ..+++|||+ +|+|.+++....     ...+++..+..++.||+.||+|||++ ||+||
T Consensus       153 ~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~-~ivHr  230 (377)
T 3byv_A          153 KDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHY-GLVHT  230 (377)
T ss_dssp             ECTTSCSEEEC------CEEESEEEEEECC-SEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHHHT-TEECS
T ss_pred             hccCCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHHhC-CeecC
Confidence            4432                 378999999 579999996421     12234588889999999999999999 99999


Q ss_pred             ccCCCceeeCCCCCeeeecccCcccCCCC-CCccCcccccCcccccCC-----------CCCCcccchhhhHHHHHHHhC
Q 020221          181 DLNAYRIVFDDDVNPRLSCFGLMKNSRDG-RSYSTNLAFTPPEYLRTG-----------RVTPESVMYSFGTLLLDLLSG  248 (329)
Q Consensus       181 dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~-~~~~~~~~y~aPE~~~~~-----------~~~~~~DvwslG~il~el~tg  248 (329)
                      ||||+|||++.++.+||+|||+++..... ....| +.|+|||++.+.           .++.++||||||+++|||++|
T Consensus       231 Dikp~NIll~~~~~~kL~DFG~a~~~~~~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DvwSlG~il~elltg  309 (377)
T 3byv_A          231 YLRPVDIVLDQRGGVFLTGFEHLVRDGARVVSSVS-RGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWIWCA  309 (377)
T ss_dssp             CCCGGGEEECTTCCEEECCGGGCEETTCEEECCCC-TTCCCHHHHHHHTSTHHHHCCEEECCHHHHHHHHHHHHHHHHHS
T ss_pred             CCCHHHEEEcCCCCEEEEechhheecCCcccCCCC-cCccChhhhcccccccccccccccCChhhhHHHHHHHHHHHHHC
Confidence            99999999999999999999999865443 23456 999999999877           799999999999999999999


Q ss_pred             CCCCCchhhHHHhhhchhhhccccccCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 020221          249 KHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLASRCLQYEPRERPNPRSLVT  308 (329)
Q Consensus       249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~~~l~  308 (329)
                      ..||.......    ....+..      ....+++++.+++.+||+.||++|||+.++++
T Consensus       310 ~~Pf~~~~~~~----~~~~~~~------~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~  359 (377)
T 3byv_A          310 DLPITKDAALG----GSEWIFR------SCKNIPQPVRALLEGFLRYPKEDRLLPLQAME  359 (377)
T ss_dssp             SCCC------C----CSGGGGS------SCCCCCHHHHHHHHHHTCSSGGGCCCHHHHHT
T ss_pred             CCCCccccccc----chhhhhh------hccCCCHHHHHHHHHHcCCCchhCCCHHHHhh
Confidence            98876432211    1111111      11345678999999999999999999999997

>2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ...

Probab=100.00  E-value=3.9e-46  Score=330.94  Aligned_cols=257  Identities=20%  Similarity=0.272  Sum_probs=208.3

Q ss_pred             CCcccccccCCCCCCcEEEEEEe------CCCCEEEEEEeCCCCCh-hHHHHHHHHHHHhcC-CCccccccceeeeeCC-
Q 020221           56 FAMENIVSEHGEKAPNVVYKGKL------ENQFRIAVKRFNRSAWP-DARQFLEEARAVGQL-RNRRLANLLGCCCEGD-  126 (329)
Q Consensus        56 ~~~~~~~~~lg~G~~g~V~~~~~------~~~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~-  126 (329)
                      ...|++.+.||+|+||+||+|..      .+++.||+|++...... ..+.+.+|+.+++.+ +||||+++++++...+ 
T Consensus        26 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~  105 (316)
T 2xir_A           26 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGG  105 (316)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECCTTS
T ss_pred             hhheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCCCcHHHHHHHHHHHHHHhcccCCCeeeEEEEEecCCC
Confidence            35677888889999999999973      34678999999876433 345688999999999 7999999999987654 


Q ss_pred             eeEEEEecCCCCCHHhhhccCCC--------------CCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCCC
Q 020221          127 ERLLVAEYMPNDTLAKHLFHWET--------------QPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDD  192 (329)
Q Consensus       127 ~~~lv~e~~~~gsL~~~l~~~~~--------------~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~  192 (329)
                      ..++||||+++++|.+++.....              ..+++..++.++.|++.||.|||+. +++|+||||+||+++.+
T Consensus       106 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~-~i~H~dikp~Nil~~~~  184 (316)
T 2xir_A          106 PLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR-KCIHRDLAARNILLSEK  184 (316)
T ss_dssp             CCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHHT-TCCCSCCSGGGEEECGG
T ss_pred             ceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHhC-CcccccCccceEEECCC
Confidence            58999999999999999975322              1278999999999999999999999 99999999999999999


Q ss_pred             CCeeeecccCcccCCCCC------CccCcccccCcccccCCCCCCcccchhhhHHHHHHHh-CCCCCCchhhHHHhhhch
Q 020221          193 VNPRLSCFGLMKNSRDGR------SYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLS-GKHIPPSHALDLIRDRNI  265 (329)
Q Consensus       193 ~~~kl~Dfg~a~~~~~~~------~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t-g~~~~~~~~~~~~~~~~~  265 (329)
                      +.+||+|||++.......      ...+++.|+|||++.+..++.++||||||+++|+|++ |..||...........  
T Consensus       185 ~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~~--  262 (316)
T 2xir_A          185 NVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCR--  262 (316)
T ss_dssp             GCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCCSHHHHH--
T ss_pred             CCEEECCCccccccccCccceeccCCCcceeecCchhhccccccchhHHHHHHHHHHHHHhCCCCCCcccchhHHHHH--
Confidence            999999999998654432      2345778999999998889999999999999999998 8877754322111111  


Q ss_pred             hhhccccccCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhhcc
Q 020221          266 QTLTDSCLEGQFSSDEGTELVRLASRCLQYEPRERPNPRSLVTALVTLQKDT  317 (329)
Q Consensus       266 ~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~~~l~~L~~~~~~~  317 (329)
                        ..........+...++++.+++.+||+.||++|||+.+++++|+.+.+..
T Consensus       263 --~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~  312 (316)
T 2xir_A          263 --RLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQAN  312 (316)
T ss_dssp             --HHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred             --HhccCccCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhhh
Confidence              11111122334556788999999999999999999999999999987643

>3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A*

Probab=100.00  E-value=7.5e-47  Score=343.36  Aligned_cols=247  Identities=12%  Similarity=0.035  Sum_probs=181.4

Q ss_pred             cccccccCCCCCCcEEEEEE-eCCCCEEEEEEeCCCCCh---hHHHHHHHH---HHHhcCCCccccccc-------eeee
Q 020221           58 MENIVSEHGEKAPNVVYKGK-LENQFRIAVKRFNRSAWP---DARQFLEEA---RAVGQLRNRRLANLL-------GCCC  123 (329)
Q Consensus        58 ~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~---~~~~~~~e~---~~l~~l~h~niv~~~-------~~~~  123 (329)
                      .|.+++.||+|+||+||+|. ..+++.||+|++......   ..+.+.+|+   +.|+. +||||++++       +++.
T Consensus        63 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~-~hp~iv~~~~~~~~p~d~~~  141 (371)
T 3q60_A           63 KLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLG-ESPEEARDRRRLLLPSDAVA  141 (371)
T ss_dssp             EEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC-----------CBCCCCEEEE
T ss_pred             eeeeeeeccCCCCEEEEEEEECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcc-cChhhhhhceeEEeeehhee
Confidence            36778889999999999999 457889999999876532   244567775   45555 799988755       3333


Q ss_pred             eC-----------------CeeEEEEecCCCCCHHhhhccCCCCCCCHHHH------HHHHHHHHHHHHHhhcCCCcccc
Q 020221          124 EG-----------------DERLLVAEYMPNDTLAKHLFHWETQPMKWAMR------LRVALHIAEALEYCTSKERALYH  180 (329)
Q Consensus       124 ~~-----------------~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~------~~i~~~i~~~l~~lH~~~~ivH~  180 (329)
                      ..                 ...++||||++ |+|.+++... ...+++..+      ..++.||+.||+|||++ ||+||
T Consensus       142 ~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~-~~~~~~~~~~~~~vk~~i~~qi~~aL~~LH~~-~ivHr  218 (371)
T 3q60_A          142 VQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTL-DFVYVFRGDEGILALHILTAQLIRLAANLQSK-GLVHG  218 (371)
T ss_dssp             ETTSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHH-HHSCCCCHHHHHHHHHHHHHHHHHHHHHHHHT-TEEET
T ss_pred             cCCCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHh-ccccchhhhhhhhhHHHHHHHHHHHHHHHHHC-CCccC
Confidence            22                 34799999998 7999999742 233455555      67889999999999999 99999


Q ss_pred             ccCCCceeeCCCCCeeeecccCcccCCCCC-CccCcccccCcccccC--CCCCCcccchhhhHHHHHHHhCCCCCCchhh
Q 020221          181 DLNAYRIVFDDDVNPRLSCFGLMKNSRDGR-SYSTNLAFTPPEYLRT--GRVTPESVMYSFGTLLLDLLSGKHIPPSHAL  257 (329)
Q Consensus       181 dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~-~~~~~~~y~aPE~~~~--~~~~~~~DvwslG~il~el~tg~~~~~~~~~  257 (329)
                      ||||+|||++.++.+||+|||+++...... ...+++.|+|||++.+  ..++.++||||||+++|+|++|..||.....
T Consensus       219 Dikp~NIll~~~~~~kL~DFG~a~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~  298 (371)
T 3q60_A          219 HFTPDNLFIMPDGRLMLGDVSALWKVGTRGPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLPFGLVTP  298 (371)
T ss_dssp             TCSGGGEEECTTSCEEECCGGGEEETTCEEEGGGSCGGGCCHHHHTCSEEECCHHHHHHHHHHHHHHHHHSSCSTTBCCT
T ss_pred             cCCHHHEEECCCCCEEEEecceeeecCCCccCccCCcCCcChhhccCCCCCcCccccHHHHHHHHHHHHhCCCCCCCcCc
Confidence            999999999999999999999998776554 4567799999999987  6699999999999999999999988865422


Q ss_pred             HHHhhhch---hhhccccccCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 020221          258 DLIRDRNI---QTLTDSCLEGQFSSDEGTELVRLASRCLQYEPRERPNPRSLVT  308 (329)
Q Consensus       258 ~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~~~l~  308 (329)
                      ........   ................++++.+|+.+||+.||++|||+.++++
T Consensus       299 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~  352 (371)
T 3q60_A          299 GIKGSWKRPSLRVPGTDSLAFGSCTPLPDFVKTLIGRFLNFDRRRRLLPLEAME  352 (371)
T ss_dssp             TCTTCCCBCCTTSCCCCSCCCTTSSCCCHHHHHHHHHHTCSSTTTCCCHHHHTT
T ss_pred             ccccchhhhhhhhccccccchhhccCCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence            11110000   0000111111122356789999999999999999999999986

>2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A

Probab=100.00  E-value=1.1e-45  Score=334.76  Aligned_cols=246  Identities=19%  Similarity=0.203  Sum_probs=200.1

Q ss_pred             cccccccCCCCCCcEEEEEEe-CCCCEEEEEEeCCCCCh--------hHHHHHHHHHHHhcC-CCccccccceeeeeCCe
Q 020221           58 MENIVSEHGEKAPNVVYKGKL-ENQFRIAVKRFNRSAWP--------DARQFLEEARAVGQL-RNRRLANLLGCCCEGDE  127 (329)
Q Consensus        58 ~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~--------~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~  127 (329)
                      .|++.+.||+|+||.||+|.. .+|+.||||++......        ..+.+.+|+.+++.+ +||||+++++++.....
T Consensus        95 ~y~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~  174 (365)
T 2y7j_A           95 KYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSYESSSF  174 (365)
T ss_dssp             HEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEBSSE
T ss_pred             hcccceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEEEEEeeCCE
Confidence            466777889999999999995 47899999998765321        134578899999999 79999999999999999


Q ss_pred             eEEEEecCCCCCHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCCCCCeeeecccCcccCC
Q 020221          128 RLLVAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSR  207 (329)
Q Consensus       128 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~  207 (329)
                      .++||||+++++|.+++..  ...+++..+..++.||+.||.|||+. |++|+||||+||+++.++.++|+|||++....
T Consensus       175 ~~lv~e~~~g~~L~~~l~~--~~~l~~~~~~~i~~qi~~~L~~LH~~-gi~H~Dlkp~NIl~~~~~~ikl~DfG~~~~~~  251 (365)
T 2y7j_A          175 MFLVFDLMRKGELFDYLTE--KVALSEKETRSIMRSLLEAVSFLHAN-NIVHRDLKPENILLDDNMQIRLSDFGFSCHLE  251 (365)
T ss_dssp             EEEEECCCTTCBHHHHHHH--HSSCCHHHHHHHHHHHHHHHHHHHHT-TEECSCCSGGGEEECTTCCEEECCCTTCEECC
T ss_pred             EEEEEEeCCCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhC-CeecCCCCHHHEEECCCCCEEEEecCcccccC
Confidence            9999999999999999863  45799999999999999999999999 99999999999999999999999999987655


Q ss_pred             CC---CCccCcccccCcccccC------CCCCCcccchhhhHHHHHHHhCCCCCCchhhHHHhhhchhhhccccccCCCC
Q 020221          208 DG---RSYSTNLAFTPPEYLRT------GRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFS  278 (329)
Q Consensus       208 ~~---~~~~~~~~y~aPE~~~~------~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  278 (329)
                      ..   ....||+.|+|||++.+      ..++.++||||||+++|+|++|..||....................  ....
T Consensus       252 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~--~~~~  329 (365)
T 2y7j_A          252 PGEKLRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQILMLRMIMEGQYQFS--SPEW  329 (365)
T ss_dssp             TTCCBCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCC--HHHH
T ss_pred             CCcccccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCC--Cccc
Confidence            43   34568999999998863      3588899999999999999999998865432222211111111000  0000


Q ss_pred             hHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 020221          279 SDEGTELVRLASRCLQYEPRERPNPRSLVT  308 (329)
Q Consensus       279 ~~~~~~~~~li~~cl~~dp~~Rps~~~~l~  308 (329)
                      ...+.++.+++.+||+.||++|||+.++++
T Consensus       330 ~~~~~~~~~li~~~L~~dP~~Rps~~ell~  359 (365)
T 2y7j_A          330 DDRSSTVKDLISRLLQVDPEARLTAEQALQ  359 (365)
T ss_dssp             SSSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred             ccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence            234678999999999999999999999999

>2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A*

Probab=100.00  E-value=4e-46  Score=328.84  Aligned_cols=252  Identities=18%  Similarity=0.259  Sum_probs=185.2

Q ss_pred             CCcccccccCCCCCCcEEEEEE-eCCCCEEEEEEeCCCC-ChhHHHHHHHHHHHhcCCCccccccceeeeeCCeeEEEEe
Q 020221           56 FAMENIVSEHGEKAPNVVYKGK-LENQFRIAVKRFNRSA-WPDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAE  133 (329)
Q Consensus        56 ~~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  133 (329)
                      ...|++.+.||+|+||.||++. ..+++.||+|.+.... ....+.+.+|+.+++.++||||+++++++...+..++|||
T Consensus        14 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   93 (303)
T 2vwi_A           14 RDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKDELWLVMK   93 (303)
T ss_dssp             CCCCEEEEECC---CCCEEEEEC----CEEEEECCC----------------CCCCCCCTTBCCEEEEEESSSCEEEEEE
T ss_pred             hhhhhhhheeccccceEEEEEEECCCCcEEEEEEEEhhhcchhHHHHHHHHHHHhhcCCCCEeeEEEEEeecCCcEEEeh
Confidence            4567888889999999999998 4578899999987643 2234568899999999999999999999999999999999


Q ss_pred             cCCCCCHHhhhccC------CCCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCCCCCeeeecccCcccCC
Q 020221          134 YMPNDTLAKHLFHW------ETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSR  207 (329)
Q Consensus       134 ~~~~gsL~~~l~~~------~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~  207 (329)
                      |+++++|.+++...      ....+++..+..++.|++.||.|||+. |++|+||||+||+++.++.++|+|||++....
T Consensus        94 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~-~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~  172 (303)
T 2vwi_A           94 LLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKN-GQIHRDVKAGNILLGEDGSVQIADFGVSAFLA  172 (303)
T ss_dssp             CCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHHT-TCCCCCCSGGGEEECTTCCEEECCCHHHHHCC
T ss_pred             hccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhC-CCCCCCCChhhEEEcCCCCEEEEeccchheec
Confidence            99999999988631      245689999999999999999999999 99999999999999999999999999986543


Q ss_pred             CC---------CCccCcccccCcccccC-CCCCCcccchhhhHHHHHHHhCCCCCCchhhHHHhhhchhhhc----cccc
Q 020221          208 DG---------RSYSTNLAFTPPEYLRT-GRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLT----DSCL  273 (329)
Q Consensus       208 ~~---------~~~~~~~~y~aPE~~~~-~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~~~~~~~~~~----~~~~  273 (329)
                      ..         ....+++.|+|||++.+ ..++.++||||||+++|+|++|..||.................    ....
T Consensus       173 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  252 (303)
T 2vwi_A          173 TGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKVLMLTLQNDPPSLETGVQ  252 (303)
T ss_dssp             ---------------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHHHHTSSCCCTTC---
T ss_pred             cCCCccchhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHhCCCCCccCchhhHHHHHhccCCCccccccc
Confidence            32         23457899999999875 4688999999999999999999988765322111111111100    0011


Q ss_pred             cCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 020221          274 EGQFSSDEGTELVRLASRCLQYEPRERPNPRSLVT  308 (329)
Q Consensus       274 ~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~~~l~  308 (329)
                      ........++++.+++.+||+.||++|||+.++++
T Consensus       253 ~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~  287 (303)
T 2vwi_A          253 DKEMLKKYGKSFRKMISLCLQKDPEKRPTAAELLR  287 (303)
T ss_dssp             --CCCCCCCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred             cchhhhhhhHHHHHHHHHHccCChhhCcCHHHHhh
Confidence            11222345678999999999999999999999998

>2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ...

Probab=100.00  E-value=1.9e-45  Score=334.10  Aligned_cols=246  Identities=15%  Similarity=0.188  Sum_probs=190.9

Q ss_pred             CcccccccCCCCCCcEEEEEE-eCCCCEEEEEEeCCCCC--hhHHHHHHHHHHHhcCCCccccccceeeeeCC------e
Q 020221           57 AMENIVSEHGEKAPNVVYKGK-LENQFRIAVKRFNRSAW--PDARQFLEEARAVGQLRNRRLANLLGCCCEGD------E  127 (329)
Q Consensus        57 ~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~------~  127 (329)
                      ..|++++.||+|+||.||+|. ..+++.||||++.....  ...+.+.+|+.+++.++||||+++++++....      .
T Consensus        25 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~  104 (371)
T 2xrw_A           25 KRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQD  104 (371)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCSTTTCCE
T ss_pred             hheeEeeeeEecCCEEEEEEEECCCCceEEEEEeccccCChHHHHHHHHHHHHHHhcCCCCccceEEeeccccccccccc
Confidence            457888889999999999998 45688999999976432  23456889999999999999999999987654      7


Q ss_pred             eEEEEecCCCCCHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCCCCCeeeecccCcccCC
Q 020221          128 RLLVAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSR  207 (329)
Q Consensus       128 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~  207 (329)
                      .++||||+++ +|.+.+.    ..+++..+..++.||+.||.|||++ |++||||||+||+++.++.+||+|||++....
T Consensus       105 ~~lv~e~~~~-~l~~~~~----~~~~~~~~~~i~~qi~~al~~lH~~-~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~~~~  178 (371)
T 2xrw_A          105 VYIVMELMDA-NLCQVIQ----MELDHERMSYLLYQMLCGIKHLHSA-GIIHRDLKPSNIVVKSDCTLKILDFGLARTAG  178 (371)
T ss_dssp             EEEEEECCSE-EHHHHHH----SCCCHHHHHHHHHHHHHHHHHHHHT-TCCCSCCCGGGEEECTTSCEEECCCCC-----
T ss_pred             eEEEEEcCCC-CHHHHHh----hccCHHHHHHHHHHHHHHHHHHHHC-CeecccCCHHHEEEcCCCCEEEEEeecccccc
Confidence            8999999975 7888874    3589999999999999999999999 99999999999999999999999999998654


Q ss_pred             CC---CCccCcccccCcccccCCCCCCcccchhhhHHHHHHHhCCCCCCchhhHHHhhhchhhhc---------------
Q 020221          208 DG---RSYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLT---------------  269 (329)
Q Consensus       208 ~~---~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~~~~~~~~~~---------------  269 (329)
                      ..   ....+|+.|+|||++.+..++.++||||||+++|+|++|..||.................               
T Consensus       179 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~  258 (371)
T 2xrw_A          179 TSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQPTVR  258 (371)
T ss_dssp             -----------CTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHC-CCCCCHHHHTTSCHHHH
T ss_pred             cccccCCceecCCccCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHhhhHHH
Confidence            43   345688999999999998999999999999999999999998875432211111110000               


Q ss_pred             ------------------cccccCC---CChHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 020221          270 ------------------DSCLEGQ---FSSDEGTELVRLASRCLQYEPRERPNPRSLVT  308 (329)
Q Consensus       270 ------------------~~~~~~~---~~~~~~~~~~~li~~cl~~dp~~Rps~~~~l~  308 (329)
                                        .....+.   .....++++.+|+.+||..||++|||+.++++
T Consensus       259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~  318 (371)
T 2xrw_A          259 TYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQ  318 (371)
T ss_dssp             HHHHSSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred             HHHhhCccccccchhhhcccccCcccccccccccHHHHHHHHHHCcCChhhCCCHHHHhC
Confidence                              0000000   01224788999999999999999999999998

>1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A*

Probab=100.00  E-value=1.1e-46  Score=344.77  Aligned_cols=250  Identities=14%  Similarity=0.168  Sum_probs=199.8

Q ss_pred             CcccccccCCCCCCcEEEEEE-eCCCCEEEEEEeCCCCChhHHHHHHHHHHHhcCC--------Cccccccceeee----
Q 020221           57 AMENIVSEHGEKAPNVVYKGK-LENQFRIAVKRFNRSAWPDARQFLEEARAVGQLR--------NRRLANLLGCCC----  123 (329)
Q Consensus        57 ~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~--------h~niv~~~~~~~----  123 (329)
                      ..|++++.||+|+||+||+|. ..+++.||+|++.... ...+.+.+|+.+++.++        |+||+++++++.    
T Consensus        37 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~~~~~~~~~  115 (397)
T 1wak_A           37 GRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSAE-HYTETALDEIRLLKSVRNSDPNDPNREMVVQLLDDFKISGV  115 (397)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCH-HHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEEEEEEEEET
T ss_pred             CeEEEEEEeeecCCeeEEEEEecCCCeEEEEEEEecCC-cchHHHHHHHHHHHHHhhcCCCCCCcceeeeeecceeecCC
Confidence            457888899999999999998 5668899999997543 33567889999999985        788999999987    


Q ss_pred             eCCeeEEEEecCCCCCHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCCCC----------
Q 020221          124 EGDERLLVAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDV----------  193 (329)
Q Consensus       124 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~----------  193 (329)
                      .....++||||+ +++|.+.+.......+++..++.++.||+.||.|||++.||+||||||+|||++.++          
T Consensus       116 ~~~~~~lv~e~~-~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~givHrDikp~NIll~~~~~~~~~~~~~~  194 (397)
T 1wak_A          116 NGTHICMVFEVL-GHHLLKWIIKSNYQGLPLPCVKKIIQQVLQGLDYLHTKCRIIHTDIKPENILLSVNEQYIRRLAAEA  194 (397)
T ss_dssp             TEEEEEEEECCC-CCBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECCCCSGGGEEECCCHHHHHHHHHHH
T ss_pred             CCceEEEEEecc-CccHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHeeEeccchhhhhhhhhh
Confidence            456899999999 557777776545567999999999999999999999854899999999999999775          


Q ss_pred             ---------------------------------------CeeeecccCcccCCCC-CCccCcccccCcccccCCCCCCcc
Q 020221          194 ---------------------------------------NPRLSCFGLMKNSRDG-RSYSTNLAFTPPEYLRTGRVTPES  233 (329)
Q Consensus       194 ---------------------------------------~~kl~Dfg~a~~~~~~-~~~~~~~~y~aPE~~~~~~~~~~~  233 (329)
                                                             .+||+|||++...... ....+|+.|+|||++.+..++.++
T Consensus       195 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~  274 (397)
T 1wak_A          195 TEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKHFTEDIQTRQYRSLEVLIGSGYNTPA  274 (397)
T ss_dssp             C---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBCSCSCCSCGGGCCHHHHHTSCCCTHH
T ss_pred             HHHhhcCCCCCCCCccccCCcccccccccccccccccccceEeccccccccccccCccCCCCCcccCChhhcCCCCCcHH
Confidence                                                   8999999999765433 345689999999999998999999


Q ss_pred             cchhhhHHHHHHHhCCCCCCchhhHH-----Hhhhchhhh------------------ccc-------------------
Q 020221          234 VMYSFGTLLLDLLSGKHIPPSHALDL-----IRDRNIQTL------------------TDS-------------------  271 (329)
Q Consensus       234 DvwslG~il~el~tg~~~~~~~~~~~-----~~~~~~~~~------------------~~~-------------------  271 (329)
                      ||||||+++|+|++|..||.......     .........                  ...                   
T Consensus       275 DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  354 (397)
T 1wak_A          275 DIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSKEFFTKKGDLKHITKLKPWGLFEVL  354 (397)
T ss_dssp             HHHHHHHHHHHHHHSSCSCCCCCCSSSCHHHHHHHHHHHHHCSCCHHHHHHCTTGGGTBCTTSSBSSCCCCCCCCHHHHH
T ss_pred             HHHHHHHHHHHHhhCCCCCCCCcccccCchHHHHHHHHHhcCCCChHHhhcccccccccCCccccccccccCCcchhHhh
Confidence            99999999999999998885321100     000000000                  000                   


Q ss_pred             cccCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 020221          272 CLEGQFSSDEGTELVRLASRCLQYEPRERPNPRSLVT  308 (329)
Q Consensus       272 ~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~~~l~  308 (329)
                      ......+...++++.+|+.+||+.||++|||+.++++
T Consensus       355 ~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~  391 (397)
T 1wak_A          355 VEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLR  391 (397)
T ss_dssp             HHTSCCCHHHHHHHHHHHGGGGCSSGGGSCCHHHHHT
T ss_pred             hhhcccchhhHHHHHHHHHHHhccChhhcCCHHHHhh
Confidence            0011245677889999999999999999999999998

>1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A*

Probab=100.00  E-value=1.8e-45  Score=324.16  Aligned_cols=250  Identities=18%  Similarity=0.153  Sum_probs=204.7

Q ss_pred             cCCCcccccccCCCCCCcEEEEEEe-CCCCEEEEEEeCCCCC---------hhHHHHHHHHHHHhcCC-Cccccccceee
Q 020221           54 SGFAMENIVSEHGEKAPNVVYKGKL-ENQFRIAVKRFNRSAW---------PDARQFLEEARAVGQLR-NRRLANLLGCC  122 (329)
Q Consensus        54 ~~~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~---------~~~~~~~~e~~~l~~l~-h~niv~~~~~~  122 (329)
                      .-+..|++.+.||+|+||.||+|.. .+++.||+|++.....         ...+.+.+|+++++.+. ||||+++++++
T Consensus        14 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~   93 (298)
T 1phk_A           14 GFYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTY   93 (298)
T ss_dssp             -CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEE
T ss_pred             chhhccceeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeeee
Confidence            3456788888999999999999995 5688999999976531         11345788999999995 99999999999


Q ss_pred             eeCCeeEEEEecCCCCCHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCCCCCeeeecccC
Q 020221          123 CEGDERLLVAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGL  202 (329)
Q Consensus       123 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~  202 (329)
                      ......++||||+++++|.+++..  ...+++..+..++.|++.||.|||+. |++|+||||+||+++.++.++|+|||+
T Consensus        94 ~~~~~~~lv~e~~~~~~L~~~l~~--~~~~~~~~~~~~~~qi~~~l~~lH~~-~i~H~dl~p~Nil~~~~~~~kl~dfg~  170 (298)
T 1phk_A           94 ETNTFFFLVFDLMKKGELFDYLTE--KVTLSEKETRKIMRALLEVICALHKL-NIVHRDLKPENILLDDDMNIKLTDFGF  170 (298)
T ss_dssp             ECSSEEEEEEECCTTCBHHHHHHH--HSSCCHHHHHHHHHHHHHHHHHHHHT-TEECSCCSGGGEEECTTCCEEECCCTT
T ss_pred             ccCCeEEEEEeccCCCcHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHHC-CcccCCCCcceEEEcCCCcEEEecccc
Confidence            999999999999999999999963  45789999999999999999999999 999999999999999999999999999


Q ss_pred             cccCCCC---CCccCcccccCccccc------CCCCCCcccchhhhHHHHHHHhCCCCCCchhhHHHhhhchhhhccccc
Q 020221          203 MKNSRDG---RSYSTNLAFTPPEYLR------TGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCL  273 (329)
Q Consensus       203 a~~~~~~---~~~~~~~~y~aPE~~~------~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~  273 (329)
                      +......   ....+++.|+|||++.      ...++.++||||||+++|+|++|..|+..................  .
T Consensus       171 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~--~  248 (298)
T 1phk_A          171 SCQLDPGEKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQ--F  248 (298)
T ss_dssp             CEECCTTCCBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCC--C
T ss_pred             hhhcCCCcccccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcCccHHHHHHHHhcCCcc--c
Confidence            8765443   2346789999999885      456889999999999999999999888654333222211111111  1


Q ss_pred             cCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 020221          274 EGQFSSDEGTELVRLASRCLQYEPRERPNPRSLVT  308 (329)
Q Consensus       274 ~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~~~l~  308 (329)
                      ........+.++.+++.+||+.||++|||+.++++
T Consensus       249 ~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~  283 (298)
T 1phk_A          249 GSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALA  283 (298)
T ss_dssp             CTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTT
T ss_pred             CcccccccCHHHHHHHHHHccCCcccCCCHHHHHh
Confidence            11122456788999999999999999999999998

>1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1.5e-46  Score=339.36  Aligned_cols=249  Identities=16%  Similarity=0.202  Sum_probs=201.2

Q ss_pred             CCcccccccCCCCCCcEEEEEEe----CCCCEEEEEEeCCCCC----hhHHHHHHHHHHHhcC-CCccccccceeeeeCC
Q 020221           56 FAMENIVSEHGEKAPNVVYKGKL----ENQFRIAVKRFNRSAW----PDARQFLEEARAVGQL-RNRRLANLLGCCCEGD  126 (329)
Q Consensus        56 ~~~~~~~~~lg~G~~g~V~~~~~----~~~~~vavK~~~~~~~----~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~  126 (329)
                      ...|++++.||+|+||.||++..    .+++.||||+++....    ...+.+.+|+++++.+ +||||+++++++....
T Consensus        53 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~  132 (355)
T 1vzo_A           53 IENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTET  132 (355)
T ss_dssp             GGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETT
T ss_pred             ccceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEeeCc
Confidence            35678888899999999999986    4688999999875321    2234567799999999 6999999999999999


Q ss_pred             eeEEEEecCCCCCHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCCCCCeeeecccCcccC
Q 020221          127 ERLLVAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNS  206 (329)
Q Consensus       127 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~  206 (329)
                      ..++||||+++++|.+++..  ...+++..+..++.||+.||.|||++ +|+||||||+|||++.++.+||+|||+++..
T Consensus       133 ~~~lv~e~~~~~~L~~~l~~--~~~~~~~~~~~~~~qi~~aL~~LH~~-~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~  209 (355)
T 1vzo_A          133 KLHLILDYINGGELFTHLSQ--RERFTEHEVQIYVGEIVLALEHLHKL-GIIYRDIKLENILLDSNGHVVLTDFGLSKEF  209 (355)
T ss_dssp             EEEEEECCCCSCBHHHHHHH--HSCCCHHHHHHHHHHHHHHHHHHHHT-TCCCCCCCGGGEEECTTSCEEESCSSEEEEC
T ss_pred             eEEEEeecCCCCCHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHC-CcccCCCCHHHEEECCCCcEEEeeCCCCeec
Confidence            99999999999999999963  35689999999999999999999999 9999999999999999999999999998754


Q ss_pred             CCC-----CCccCcccccCcccccCC--CCCCcccchhhhHHHHHHHhCCCCCCchhhHHHhhhchhhhccccccCCCCh
Q 020221          207 RDG-----RSYSTNLAFTPPEYLRTG--RVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSS  279 (329)
Q Consensus       207 ~~~-----~~~~~~~~y~aPE~~~~~--~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  279 (329)
                      ...     ....||+.|+|||++.+.  .++.++||||||+++|+|++|..||..................  ....++.
T Consensus       210 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~--~~~~~~~  287 (355)
T 1vzo_A          210 VADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILK--SEPPYPQ  287 (355)
T ss_dssp             CGGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHHHH--CCCCCCT
T ss_pred             ccCCCCcccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccCCccchHHHHHHHHhc--cCCCCCc
Confidence            322     234689999999999864  4788999999999999999999888643211111111111111  1223456


Q ss_pred             HHHHHHHHHHHHhcccCCCCCC-----CHHHHHHH
Q 020221          280 DEGTELVRLASRCLQYEPRERP-----NPRSLVTA  309 (329)
Q Consensus       280 ~~~~~~~~li~~cl~~dp~~Rp-----s~~~~l~~  309 (329)
                      ..++.+.+|+.+||..||++||     ++.+++++
T Consensus       288 ~~~~~~~~li~~~L~~dP~~R~~~~~~s~~ell~h  322 (355)
T 1vzo_A          288 EMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEH  322 (355)
T ss_dssp             TSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTS
T ss_pred             ccCHHHHHHHHHHhhhCHHHhcCCCCCCHHHHHcC
Confidence            6778899999999999999999     99999873

>2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens}

Probab=100.00  E-value=1.1e-45  Score=329.53  Aligned_cols=247  Identities=14%  Similarity=0.189  Sum_probs=197.5

Q ss_pred             CCcccccccCCCCCCcEEEEEEe-CCCCEEEEEEeCCCCChhHHHHHHHHHHHhcC-CCccccccceeeee------CCe
Q 020221           56 FAMENIVSEHGEKAPNVVYKGKL-ENQFRIAVKRFNRSAWPDARQFLEEARAVGQL-RNRRLANLLGCCCE------GDE  127 (329)
Q Consensus        56 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~------~~~  127 (329)
                      ...|++++.||+|+||.||+|.. .+++.||+|++..... ..+.+.+|+.+++.+ +||||+++++++..      ...
T Consensus        23 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~-~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~~~  101 (326)
T 2x7f_A           23 AGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGD-EEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQ  101 (326)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSS-TTHHHHHHHHHHHHHCCSTTBCCEEEEEEECC--CCCCE
T ss_pred             CCcEEEEEEeccCCCEEEEEEEECCCCCeEEEEEEecCcc-cHHHHHHHHHHHHhccCCCCeeeeeeEEeeccCccccce
Confidence            35577888889999999999994 5788999999976542 346788999999999 79999999999976      467


Q ss_pred             eEEEEecCCCCCHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCCCCCeeeecccCcccCC
Q 020221          128 RLLVAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSR  207 (329)
Q Consensus       128 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~  207 (329)
                      .++||||+++++|.+++.......+++..++.++.||+.||.|||+. |++|+||||+||+++.++.+||+|||++....
T Consensus       102 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~-~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~  180 (326)
T 2x7f_A          102 LWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQH-KVIHRDIKGQNVLLTENAEVKLVDFGVSAQLD  180 (326)
T ss_dssp             EEEEEECCTTEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHT-TCCCCCCSGGGEEECTTCCEEECCCTTTC---
T ss_pred             EEEEEEcCCCCcHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHC-CccccCCcHHHEEEcCCCCEEEeeCcCceecC
Confidence            89999999999999999764456799999999999999999999999 99999999999999999999999999987654


Q ss_pred             CC----CCccCcccccCccccc-----CCCCCCcccchhhhHHHHHHHhCCCCCCchhhHHHhhhchhhhccccccCCCC
Q 020221          208 DG----RSYSTNLAFTPPEYLR-----TGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFS  278 (329)
Q Consensus       208 ~~----~~~~~~~~y~aPE~~~-----~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  278 (329)
                      ..    ....+++.|+|||++.     +..++.++||||||+++|+|++|..||..............    .......+
T Consensus       181 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~----~~~~~~~~  256 (326)
T 2x7f_A          181 RTVGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPR----NPAPRLKS  256 (326)
T ss_dssp             ----------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHH----SCCCCCSC
T ss_pred             cCccccccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhhc----CccccCCc
Confidence            32    2346789999999987     45688999999999999999999988764332211111111    11111123


Q ss_pred             hHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 020221          279 SDEGTELVRLASRCLQYEPRERPNPRSLVT  308 (329)
Q Consensus       279 ~~~~~~~~~li~~cl~~dp~~Rps~~~~l~  308 (329)
                      ...++.+.+++.+||..||++|||+.++++
T Consensus       257 ~~~~~~l~~li~~~l~~dp~~Rps~~~ll~  286 (326)
T 2x7f_A          257 KKWSKKFQSFIESCLVKNHSQRPATEQLMK  286 (326)
T ss_dssp             SCSCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred             cccCHHHHHHHHHHhccChhhCCCHHHHhh
Confidence            445778999999999999999999999997

>2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens}

Probab=100.00  E-value=2.7e-45  Score=323.98  Aligned_cols=245  Identities=18%  Similarity=0.173  Sum_probs=200.2

Q ss_pred             CcccccccCCCCCCcEEEEEEe-CCCCEEEEEEeCCCC----ChhHHHHHHHHHHHhcCCCccccccceee--eeCCeeE
Q 020221           57 AMENIVSEHGEKAPNVVYKGKL-ENQFRIAVKRFNRSA----WPDARQFLEEARAVGQLRNRRLANLLGCC--CEGDERL  129 (329)
Q Consensus        57 ~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~----~~~~~~~~~e~~~l~~l~h~niv~~~~~~--~~~~~~~  129 (329)
                      ..|++.+.||+|+||.||++.. .+++.||+|++....    ......+.+|+++++.++||||+++++++  .+....+
T Consensus         5 ~~y~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~   84 (305)
T 2wtk_C            5 GKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQKMY   84 (305)
T ss_dssp             CCBCCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC---CEE
T ss_pred             cceeEeeEEecCCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCeEE
Confidence            4677888889999999999994 578899999997542    22356789999999999999999999998  4456889


Q ss_pred             EEEecCCCCCHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCCCCCeeeecccCcccCCCC
Q 020221          130 LVAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDG  209 (329)
Q Consensus       130 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~  209 (329)
                      +||||++++ |.+++.......+++..+..++.|++.||.|||++ |++|+||||+||+++.++.++|+|||++......
T Consensus        85 lv~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~-~i~H~dlkp~NIl~~~~~~~kl~dfg~~~~~~~~  162 (305)
T 2wtk_C           85 MVMEYCVCG-MQEMLDSVPEKRFPVCQAHGYFCQLIDGLEYLHSQ-GIVHKDIKPGNLLLTTGGTLKISALGVAEALHPF  162 (305)
T ss_dssp             EEEECCSEE-HHHHHHHSTTCSCCHHHHHHHHHHHHHHHHHHHHT-TEECSCCSGGGEEECTTCCEEECCCTTCEECCTT
T ss_pred             EEehhccCC-HHHHHHhCcccccCHHHHHHHHHHHHHHHHHHHHC-CeeecCCCcccEEEcCCCcEEeeccccccccCcc
Confidence            999999876 77777665567899999999999999999999999 9999999999999999999999999999765432


Q ss_pred             ------CCccCcccccCcccccCCC--CCCcccchhhhHHHHHHHhCCCCCCchhhHHHhhhchhhhccccccCCCChHH
Q 020221          210 ------RSYSTNLAFTPPEYLRTGR--VTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDE  281 (329)
Q Consensus       210 ------~~~~~~~~y~aPE~~~~~~--~~~~~DvwslG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  281 (329)
                            ....+++.|+|||++.+..  ++.++||||||+++|+|++|..||...............      ....+..+
T Consensus       163 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~i~~~------~~~~~~~~  236 (305)
T 2wtk_C          163 AADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNIYKLFENIGKG------SYAIPGDC  236 (305)
T ss_dssp             CSSCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHC------CCCCCSSS
T ss_pred             ccccccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCCchHHHHHHHHhcC------CCCCCCcc
Confidence                  2345789999999988654  467999999999999999999988765433222221111      11234556


Q ss_pred             HHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 020221          282 GTELVRLASRCLQYEPRERPNPRSLVTA  309 (329)
Q Consensus       282 ~~~~~~li~~cl~~dp~~Rps~~~~l~~  309 (329)
                      ++.+.+++.+||+.||++|||+.+++++
T Consensus       237 ~~~l~~li~~~l~~dp~~Rps~~~ll~~  264 (305)
T 2wtk_C          237 GPPLSDLLKGMLEYEPAKRFSIRQIRQH  264 (305)
T ss_dssp             CHHHHHHHHHHTCSSTTTSCCHHHHHHS
T ss_pred             CHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence            7889999999999999999999999974

>1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A*

Probab=100.00  E-value=4.2e-45  Score=327.00  Aligned_cols=249  Identities=17%  Similarity=0.171  Sum_probs=202.6

Q ss_pred             CcccccccCCCCCCcEEEEEEe--CCCCEEEEEEeCCCCChhHHHHHHHHHHHhcCCCcc------ccccceeeeeCCee
Q 020221           57 AMENIVSEHGEKAPNVVYKGKL--ENQFRIAVKRFNRSAWPDARQFLEEARAVGQLRNRR------LANLLGCCCEGDER  128 (329)
Q Consensus        57 ~~~~~~~~lg~G~~g~V~~~~~--~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~n------iv~~~~~~~~~~~~  128 (329)
                      ..|++++.||+|+||.||++..  .+++.||+|++.... ...+.+.+|+++++.++|++      ++++++++...+..
T Consensus        14 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~~~~~~~~   92 (339)
T 1z57_A           14 ARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNVD-RYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWFEHHGHI   92 (339)
T ss_dssp             TTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSSH-HHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEEEEEETTEE
T ss_pred             CceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEecCC-chhHHHHHHHHHHHHhhhcCCCCceeeEeeecccccCCcE
Confidence            4578888899999999999985  467899999997543 33566888999999887664      99999999999999


Q ss_pred             EEEEecCCCCCHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCC-----------------
Q 020221          129 LLVAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDD-----------------  191 (329)
Q Consensus       129 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~-----------------  191 (329)
                      ++||||+ +++|.+++.......+++..+..++.|++.||+|||++ |++||||||+||+++.                 
T Consensus        93 ~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~-~ivH~Dlkp~Nil~~~~~~~~~~~~~~~~~~~~  170 (339)
T 1z57_A           93 CIVFELL-GLSTYDFIKENGFLPFRLDHIRKMAYQICKSVNFLHSN-KLTHTDLKPENILFVQSDYTEAYNPKIKRDERT  170 (339)
T ss_dssp             EEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHT-TEECCCCCGGGEEESCCCEEEEEC----CEEEE
T ss_pred             EEEEcCC-CCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHC-CCcCCCCCHHHEEEeccccccccCCcccccccc
Confidence            9999999 78999999765555789999999999999999999999 9999999999999987                 


Q ss_pred             --CCCeeeecccCcccCCCC-CCccCcccccCcccccCCCCCCcccchhhhHHHHHHHhCCCCCCchhhHHHhhhchhhh
Q 020221          192 --DVNPRLSCFGLMKNSRDG-RSYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTL  268 (329)
Q Consensus       192 --~~~~kl~Dfg~a~~~~~~-~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~~~~~~~~~  268 (329)
                        ++.+||+|||++...... ....+|+.|+|||++.+..++.++||||||+++|||++|..||+...............
T Consensus       171 ~~~~~~kl~Dfg~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~  250 (339)
T 1z57_A          171 LINPDIKVVDFGSATYDDEHHSTLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLGFTVFPTHDSKEHLAMMERIL  250 (339)
T ss_dssp             ESCCCEEECCCSSCEETTSCCCSSCSCGGGCCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSCHHHHHHHHHHHH
T ss_pred             ccCCCceEeeCcccccCccccccccCCccccChHHhhCCCCCcchhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHh
Confidence              678999999999865443 34578999999999998899999999999999999999999887543222111000000


Q ss_pred             -------------------------------------cccc-ccCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 020221          269 -------------------------------------TDSC-LEGQFSSDEGTELVRLASRCLQYEPRERPNPRSLVT  308 (329)
Q Consensus       269 -------------------------------------~~~~-~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~~~l~  308 (329)
                                                           ..+. .........++++.+|+.+||+.||++|||+.++++
T Consensus       251 ~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~  328 (339)
T 1z57_A          251 GPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERLFDLIQKMLEYDPAKRITLREALK  328 (339)
T ss_dssp             CSCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred             CCCCHHHHhhccchhHHhhccccccccccccchhhhcCcchhhhcccchhhHHHHHHHHHHHhCcCcccccCHHHHhc
Confidence                                                 0000 001123456789999999999999999999999997

>3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ...

Probab=100.00  E-value=9.7e-46  Score=335.19  Aligned_cols=246  Identities=19%  Similarity=0.254  Sum_probs=196.9

Q ss_pred             cccccccCCCCCCcEEEEEE-eCCCCEEEEEEeCCCCCh-hHHHHHHHHHHHhcCCCccccccceeeeeC-----CeeEE
Q 020221           58 MENIVSEHGEKAPNVVYKGK-LENQFRIAVKRFNRSAWP-DARQFLEEARAVGQLRNRRLANLLGCCCEG-----DERLL  130 (329)
Q Consensus        58 ~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~~~~~~~~~-----~~~~l  130 (329)
                      .|.+++.||+|+||.||++. ..+++.||+|++...... ..+.+.+|+++++.++||||+++++++...     ...++
T Consensus        28 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~i  107 (364)
T 3qyz_A           28 RYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVYI  107 (364)
T ss_dssp             TEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCEEE
T ss_pred             cEEEEEEeecCCCeEEEEEEECCCCeEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCccceeEEecCCccccceEEE
Confidence            57788888999999999998 457888999999764433 346788999999999999999999998654     36899


Q ss_pred             EEecCCCCCHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCCCCCeeeecccCcccCCCC-
Q 020221          131 VAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDG-  209 (329)
Q Consensus       131 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~-  209 (329)
                      ||||+.+ +|.+++.   ...+++..+..++.|++.||.|||++ |++||||||+||+++.++.+||+|||++...... 
T Consensus       108 v~e~~~~-~L~~~l~---~~~~~~~~~~~i~~qi~~aL~~LH~~-~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~  182 (364)
T 3qyz_A          108 VQDLMET-DLYKLLK---TQHLSNDHICYFLYQILRGLKYIHSA-NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDH  182 (364)
T ss_dssp             EEECCSE-EHHHHHH---HCCCCHHHHHHHHHHHHHHHHHHHHT-TEECCCCCGGGEEECTTCCEEECCCTTCEECCGGG
T ss_pred             EEcccCc-CHHHHHH---hCCCCHHHHHHHHHHHHHHHHHHHHC-CeecCCCChHhEEECCCCCEEEEeCcceEecCCCC
Confidence            9999975 8999885   35699999999999999999999999 9999999999999999999999999999765432 


Q ss_pred             ------CCccCcccccCcccccCC-CCCCcccchhhhHHHHHHHhCCCCCCchhhHHHhhhchhhhcc------------
Q 020221          210 ------RSYSTNLAFTPPEYLRTG-RVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTD------------  270 (329)
Q Consensus       210 ------~~~~~~~~y~aPE~~~~~-~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~------------  270 (329)
                            ....+|+.|+|||++.+. .++.++||||||+++|+|++|..||..................            
T Consensus       183 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  262 (364)
T 3qyz_A          183 DHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINL  262 (364)
T ss_dssp             CBCCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSSCCSSGGGHHHHHHHHHCSCCHHHHHTCCCH
T ss_pred             CccccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhhhh
Confidence                  234689999999987644 4899999999999999999999888654322111111100000            


Q ss_pred             -------ccc-cCC-----CChHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 020221          271 -------SCL-EGQ-----FSSDEGTELVRLASRCLQYEPRERPNPRSLVT  308 (329)
Q Consensus       271 -------~~~-~~~-----~~~~~~~~~~~li~~cl~~dp~~Rps~~~~l~  308 (329)
                             ... ...     .....++++.+|+.+||+.||++|||+.++++
T Consensus       263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~  313 (364)
T 3qyz_A          263 KARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALA  313 (364)
T ss_dssp             HHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             hHHHHHHhcCCccCCCHHHhCCCCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence                   000 000     11234678999999999999999999999997

>2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X*

Probab=100.00  E-value=1e-45  Score=332.81  Aligned_cols=250  Identities=17%  Similarity=0.166  Sum_probs=202.9

Q ss_pred             CcccccccCCCCCCcEEEEEEeCCCCEEEEEEeCCCCChh-----------------HHHHHHHHHHHhcCCCccccccc
Q 020221           57 AMENIVSEHGEKAPNVVYKGKLENQFRIAVKRFNRSAWPD-----------------ARQFLEEARAVGQLRNRRLANLL  119 (329)
Q Consensus        57 ~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~-----------------~~~~~~e~~~l~~l~h~niv~~~  119 (329)
                      ..|++++.||+|+||.||++.. +++.||+|.+.......                 .+.+.+|+.+++.++||||++++
T Consensus        31 ~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~  109 (348)
T 2pml_X           31 NDYRIIRTLNQGKFNKIILCEK-DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCLTCE  109 (348)
T ss_dssp             TTEEEEEEEECCSSCCEEEEEE-TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCTTBCCCS
T ss_pred             CceEEEEEEcCCCCeEEEEEEc-CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCCCcceEE
Confidence            5678888899999999999999 88999999986532111                 16789999999999999999999


Q ss_pred             eeeeeCCeeEEEEecCCCCCHHhh------hccCCCCCCCHHHHHHHHHHHHHHHHHhhc-CCCccccccCCCceeeCCC
Q 020221          120 GCCCEGDERLLVAEYMPNDTLAKH------LFHWETQPMKWAMRLRVALHIAEALEYCTS-KERALYHDLNAYRIVFDDD  192 (329)
Q Consensus       120 ~~~~~~~~~~lv~e~~~~gsL~~~------l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~-~~~ivH~dlkp~Nil~~~~  192 (329)
                      +++.+.+..++||||+++++|.++      +.......+++..++.++.|++.||.|||+ . |++|+||||+||+++.+
T Consensus       110 ~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~-~i~H~dl~p~Nil~~~~  188 (348)
T 2pml_X          110 GIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHNEK-NICHRDVKPSNILMDKN  188 (348)
T ss_dssp             EEEESSSEEEEEEECCTTCBSSEESSSEESSCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTS-CEECCCCCGGGEEECTT
T ss_pred             EEEeeCCeEEEEEeccCCCcHHHHHHHhhhhhhccccCCCHHHHHHHHHHHHHHHHHHhccC-CEeecCCChHhEEEcCC
Confidence            999999999999999999999998      654336789999999999999999999999 8 99999999999999999


Q ss_pred             CCeeeecccCcccCCCC--CCccCcccccCcccccCC-CCCC-cccchhhhHHHHHHHhCCCCCCchhh-HHHhhhchhh
Q 020221          193 VNPRLSCFGLMKNSRDG--RSYSTNLAFTPPEYLRTG-RVTP-ESVMYSFGTLLLDLLSGKHIPPSHAL-DLIRDRNIQT  267 (329)
Q Consensus       193 ~~~kl~Dfg~a~~~~~~--~~~~~~~~y~aPE~~~~~-~~~~-~~DvwslG~il~el~tg~~~~~~~~~-~~~~~~~~~~  267 (329)
                      +.++|+|||++......  ....++..|+|||.+.+. .++. ++||||||+++|+|++|..||..... ..........
T Consensus       189 ~~~kl~dfg~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~i~~~  268 (348)
T 2pml_X          189 GRVKLSDFGESEYMVDKKIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISLVELFNNIRTK  268 (348)
T ss_dssp             SCEEECCCTTCEECBTTEECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHHSSCSSCCSSCSHHHHHHHTSC
T ss_pred             CcEEEeccccccccccccccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhcc
Confidence            99999999999865433  345688999999999887 5666 99999999999999999988865432 1111111111


Q ss_pred             hccccc-------------cCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 020221          268 LTDSCL-------------EGQFSSDEGTELVRLASRCLQYEPRERPNPRSLVT  308 (329)
Q Consensus       268 ~~~~~~-------------~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~~~l~  308 (329)
                      ......             ........++++.+++.+||+.||++|||+.++++
T Consensus       269 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~e~l~  322 (348)
T 2pml_X          269 NIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDALK  322 (348)
T ss_dssp             CCCCCCSSSSSTTTTCC--------CCCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred             CcCCccchhhhhccccccccccchhhcCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence            000000             00011446788999999999999999999999998

>4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A*

Probab=100.00  E-value=6.8e-46  Score=357.88  Aligned_cols=244  Identities=21%  Similarity=0.251  Sum_probs=202.7

Q ss_pred             cCCCCCCcEEEEEEe---CCCCEEEEEEeCCCCC--hhHHHHHHHHHHHhcCCCccccccceeeeeCCeeEEEEecCCCC
Q 020221           64 EHGEKAPNVVYKGKL---ENQFRIAVKRFNRSAW--PDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAEYMPND  138 (329)
Q Consensus        64 ~lg~G~~g~V~~~~~---~~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g  138 (329)
                      .||+|+||.||+|.+   .+++.||||+++....  ...+.+.+|+++++.++||||+++++++. ....++||||+++|
T Consensus       376 ~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~-~~~~~lv~E~~~~g  454 (635)
T 4fl3_A          376 ELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICE-AESWMLVMEMAELG  454 (635)
T ss_dssp             EEEECSSEEEEEEEEECSSCEEEEEEEEECGGGGCGGGHHHHHHHHHHHHHCCCTTBCCEEEEEE-SSSEEEEEECCTTE
T ss_pred             EeccCCCEEEEEEEEcCCCcceEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEe-cCCEEEEEEccCCC
Confidence            589999999999964   3467899999986432  23577999999999999999999999985 45688999999999


Q ss_pred             CHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCCCCCeeeecccCcccCCCCC-------C
Q 020221          139 TLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDGR-------S  211 (329)
Q Consensus       139 sL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~-------~  211 (329)
                      +|.+++.  ....+++..+..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+++......       .
T Consensus       455 ~L~~~l~--~~~~l~~~~~~~i~~qi~~~L~yLH~~-~iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~  531 (635)
T 4fl3_A          455 PLNKYLQ--QNRHVKDKNIIELVHQVSMGMKYLEES-NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTH  531 (635)
T ss_dssp             EHHHHHH--HCTTCCHHHHHHHHHHHHHHHHHHHHT-TCCCSCCSGGGEEEEETTEEEECCTTHHHHTTC----------
T ss_pred             CHHHHHh--hCCCCCHHHHHHHHHHHHHHHHHHHHC-CEeCCCCChHhEEEeCCCCEEEEEcCCccccccCccccccccC
Confidence            9999996  446799999999999999999999999 99999999999999999999999999998654332       2


Q ss_pred             ccCcccccCcccccCCCCCCcccchhhhHHHHHHHh-CCCCCCchhhHHHhhhchhhhccccccCCCChHHHHHHHHHHH
Q 020221          212 YSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLS-GKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLAS  290 (329)
Q Consensus       212 ~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t-g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~  290 (329)
                      ..+++.|+|||++.+..++.++||||||+++|||++ |..||.......+.....     .......+..+++++.+++.
T Consensus       532 ~~~t~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~~~~i~-----~~~~~~~p~~~~~~l~~li~  606 (635)
T 4fl3_A          532 GKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLE-----KGERMGCPAGCPREMYDLMN  606 (635)
T ss_dssp             ---CGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHH-----TTCCCCCCTTCCHHHHHHHH
T ss_pred             CCCceeeeChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHH-----cCCCCCCCCCCCHHHHHHHH
Confidence            235678999999998899999999999999999998 888886554333322221     11223445667889999999


Q ss_pred             HhcccCCCCCCCHHHHHHHHHhhhhc
Q 020221          291 RCLQYEPRERPNPRSLVTALVTLQKD  316 (329)
Q Consensus       291 ~cl~~dp~~Rps~~~~l~~L~~~~~~  316 (329)
                      .||+.||++|||+.++++.|+.+-.+
T Consensus       607 ~cl~~dP~~RPs~~~l~~~L~~~~~~  632 (635)
T 4fl3_A          607 LCWTYDVENRPGFAAVELRLRNYYYD  632 (635)
T ss_dssp             HHTCSSTTTSCCHHHHHHHHHHHHHH
T ss_pred             HHcCCCHhHCcCHHHHHHHHHHHHHH
Confidence            99999999999999999999987543

>3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=9.7e-46  Score=337.42  Aligned_cols=246  Identities=18%  Similarity=0.203  Sum_probs=194.0

Q ss_pred             CcccccccCCCCCCcEEEEEE-eCCCCEEEEEEeCCCCChhHHHHHHHHHHHhcCCCccccccceeeeeC----------
Q 020221           57 AMENIVSEHGEKAPNVVYKGK-LENQFRIAVKRFNRSAWPDARQFLEEARAVGQLRNRRLANLLGCCCEG----------  125 (329)
Q Consensus        57 ~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~----------  125 (329)
                      ..|++++.||+|+||+||+|. ..+++.||+|++......    ..+|+++++.++||||+++++++...          
T Consensus         7 ~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~~----~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~   82 (383)
T 3eb0_A            7 KKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPRY----KNRELDIMKVLDHVNIIKLVDYFYTTGDEEPKPPQP   82 (383)
T ss_dssp             TTEEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECCTTS----CCHHHHHHTTCCCTTBCCEEEEEEEC----------
T ss_pred             ceEEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecCcch----HHHHHHHHHHcCCCCccchhheeeecCccccccccc
Confidence            357788888999999999998 567899999998755322    23699999999999999999998442          


Q ss_pred             ----------------------------CeeEEEEecCCCCCHHhhhcc--CCCCCCCHHHHHHHHHHHHHHHHHhhcCC
Q 020221          126 ----------------------------DERLLVAEYMPNDTLAKHLFH--WETQPMKWAMRLRVALHIAEALEYCTSKE  175 (329)
Q Consensus       126 ----------------------------~~~~lv~e~~~~gsL~~~l~~--~~~~~~~~~~~~~i~~~i~~~l~~lH~~~  175 (329)
                                                  ...++||||+++ +|.+.+..  .....+++..+..++.||+.||+|||+. 
T Consensus        83 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~-~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~-  160 (383)
T 3eb0_A           83 PDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVPD-TLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHSL-  160 (383)
T ss_dssp             ---------------------------CCEEEEEECCCSE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTT-
T ss_pred             ccccccccccccccccccccccccCCCceEEEEEEecCCc-cHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC-
Confidence                                        348899999985 77777653  1456799999999999999999999999 


Q ss_pred             CccccccCCCceeeC-CCCCeeeecccCcccCCCC---CCccCcccccCcccccCCC-CCCcccchhhhHHHHHHHhCCC
Q 020221          176 RALYHDLNAYRIVFD-DDVNPRLSCFGLMKNSRDG---RSYSTNLAFTPPEYLRTGR-VTPESVMYSFGTLLLDLLSGKH  250 (329)
Q Consensus       176 ~ivH~dlkp~Nil~~-~~~~~kl~Dfg~a~~~~~~---~~~~~~~~y~aPE~~~~~~-~~~~~DvwslG~il~el~tg~~  250 (329)
                      ||+||||||+||+++ .++.+||+|||++......   ....+|+.|+|||++.+.. ++.++||||||+++|+|++|..
T Consensus       161 gi~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~  240 (383)
T 3eb0_A          161 GICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSEPSVAYICSRFYRAPELMLGATEYTPSIDLWSIGCVFGELILGKP  240 (383)
T ss_dssp             TEECSCCCGGGEEEETTTTEEEECCCTTCEECCTTSCCCCCCCCSSCCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSC
T ss_pred             cCccCccCHHHEEEcCCCCcEEEEECCCCcccCCCCCCcCcccCCCccCHHHhcCCCCCCcchhhhhHHHHHHHHHhCCC
Confidence            999999999999998 6889999999999865433   3456789999999988755 8999999999999999999999


Q ss_pred             CCCchhhHHHhhhchhhhc-----------------------cccccCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHH
Q 020221          251 IPPSHALDLIRDRNIQTLT-----------------------DSCLEGQFSSDEGTELVRLASRCLQYEPRERPNPRSLV  307 (329)
Q Consensus       251 ~~~~~~~~~~~~~~~~~~~-----------------------~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~~~l  307 (329)
                      ||................-                       ...+...++...++++.+|+.+||+.||++|||+.+++
T Consensus       241 pf~~~~~~~~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l  320 (383)
T 3eb0_A          241 LFSGETSIDQLVRIIQIMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKILPEGTPSLAIDLLEQILRYEPDLRINPYEAM  320 (383)
T ss_dssp             SSCCSSHHHHHHHHHHHHCCCCHHHHHHHCTTC--CCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHH
T ss_pred             CCCCCChHHHHHHHHHHhCCCCHHHHHHhCcccccccCCccCcccHHhhCCCCCCHHHHHHHHHHccCChhhCCCHHHHh
Confidence            8876432221111110000                       00011113344678899999999999999999999999


Q ss_pred             H
Q 020221          308 T  308 (329)
Q Consensus       308 ~  308 (329)
                      +
T Consensus       321 ~  321 (383)
T 3eb0_A          321 A  321 (383)
T ss_dssp             T
T ss_pred             c
Confidence            6

>1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A

Probab=100.00  E-value=3.2e-45  Score=322.75  Aligned_cols=244  Identities=19%  Similarity=0.252  Sum_probs=193.0

Q ss_pred             cccccccCCCCCCcEEEEEEe-CCCCEEEEEEeCCCCChhHHHHHHHHHHHhcCCCccccccceeeee------------
Q 020221           58 MENIVSEHGEKAPNVVYKGKL-ENQFRIAVKRFNRSAWPDARQFLEEARAVGQLRNRRLANLLGCCCE------------  124 (329)
Q Consensus        58 ~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~------------  124 (329)
                      .|++++.||+|+||.||+|.. .+++.||+|++.... ...+.+.+|+.+++.++||||+++++++.+            
T Consensus         7 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~~   85 (303)
T 1zy4_A            7 DFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTE-EKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKPMTAVK   85 (303)
T ss_dssp             HEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEEEH-HHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC------
T ss_pred             cchhhheeccCCcEEEEEEEEcCCCeEEEEEEEeccH-HHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhhhhcccc
Confidence            467778889999999999994 578999999996533 345678899999999999999999998754            


Q ss_pred             -CCeeEEEEecCCCCCHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCCCCCeeeecccCc
Q 020221          125 -GDERLLVAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLM  203 (329)
Q Consensus       125 -~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a  203 (329)
                       ....++||||+++++|.+++.. ....+++..++.++.|++.||.|||++ |++|+||||+||+++.++.+||+|||++
T Consensus        86 ~~~~~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~~i~~qi~~~l~~LH~~-~i~H~dlkp~Nil~~~~~~~kl~dfg~~  163 (303)
T 1zy4_A           86 KKSTLFIQMEYCENGTLYDLIHS-ENLNQQRDEYWRLFRQILEALSYIHSQ-GIIHRDLKPMNIFIDESRNVKIGDFGLA  163 (303)
T ss_dssp             CEEEEEEEEECCCSCBHHHHHHH-SCGGGCHHHHHHHHHHHHHHHHHHHHT-TCCCSCCCGGGEEECTTSCEEECCCCCC
T ss_pred             cCCceEEEEecCCCCCHHHhhhc-cccccchHHHHHHHHHHHHHHHHHHhC-CeecccCCHHhEEEcCCCCEEEeeCcch
Confidence             3568999999999999999965 345678899999999999999999999 9999999999999999999999999998


Q ss_pred             ccCCCC------------------CCccCcccccCcccccCC-CCCCcccchhhhHHHHHHHhCCCCCCchhhHHHhhhc
Q 020221          204 KNSRDG------------------RSYSTNLAFTPPEYLRTG-RVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRN  264 (329)
Q Consensus       204 ~~~~~~------------------~~~~~~~~y~aPE~~~~~-~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~~~~~  264 (329)
                      ......                  ....+++.|+|||++.+. .++.++||||||+++|+|++   |+............
T Consensus       164 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~---p~~~~~~~~~~~~~  240 (303)
T 1zy4_A          164 KNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY---PFSTGMERVNILKK  240 (303)
T ss_dssp             SCTTC-------------------------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHS---CCSSHHHHHHHHHH
T ss_pred             hhcccccchhccccccccccccccccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHHh---ccCCchhHHHHHHh
Confidence            765421                  233578899999999865 68999999999999999998   34322111111111


Q ss_pred             hhhhccccccCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 020221          265 IQTLTDSCLEGQFSSDEGTELVRLASRCLQYEPRERPNPRSLVT  308 (329)
Q Consensus       265 ~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~~~l~  308 (329)
                      ... ........++...++.+.+++.+||+.||++|||+.++++
T Consensus       241 ~~~-~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~  283 (303)
T 1zy4_A          241 LRS-VSIEFPPDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLN  283 (303)
T ss_dssp             HHS-TTCCCCTTCCTTTSHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             ccc-cccccCccccccchHHHHHHHHHHHhcCcccCcCHHHHhC
Confidence            111 1111223345566788999999999999999999999998

>4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens}

Probab=100.00  E-value=6.2e-46  Score=340.09  Aligned_cols=259  Identities=13%  Similarity=0.136  Sum_probs=207.5

Q ss_pred             CcccccccCCCCCCcEEEEEEe-CCCCEEEEEEeCCCCC-hhHHHHHHHHHHHhcCCCccccccceeeeeCC--eeEEEE
Q 020221           57 AMENIVSEHGEKAPNVVYKGKL-ENQFRIAVKRFNRSAW-PDARQFLEEARAVGQLRNRRLANLLGCCCEGD--ERLLVA  132 (329)
Q Consensus        57 ~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~--~~~lv~  132 (329)
                      ..|.+.+.||+|+||+||+|.. .+++.||+|++..... ...+.+.+|+++++.++||||+++++++....  ..++||
T Consensus         9 ~~y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~lv~   88 (396)
T 4eut_A            9 HLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLIM   88 (396)
T ss_dssp             EEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEEE
T ss_pred             CceEEEEEEEcCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCCCeEEEeeccCCCCeeEEEE
Confidence            3577888899999999999994 4588999999976432 23567889999999999999999999987654  789999


Q ss_pred             ecCCCCCHHhhhccCC-CCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceee----CCCCCeeeecccCcccCC
Q 020221          133 EYMPNDTLAKHLFHWE-TQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVF----DDDVNPRLSCFGLMKNSR  207 (329)
Q Consensus       133 e~~~~gsL~~~l~~~~-~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~----~~~~~~kl~Dfg~a~~~~  207 (329)
                      ||+++|+|.+++.... ...+++..++.++.|++.||+|||+. ||+||||||+||++    +.++.+||+|||+++...
T Consensus        89 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~-~ivH~Dlkp~NIll~~~~~~~~~~kL~DFG~a~~~~  167 (396)
T 4eut_A           89 EFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLREN-GIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELE  167 (396)
T ss_dssp             CCCTTEEHHHHTTSGGGTTCCCHHHHHHHHHHHHHHHHHHHHT-TEECCCCCGGGEEEEECTTSCEEEEECCGGGCEECC
T ss_pred             ecCCCCCHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHHC-CEEECCcCHHHEEEeecCCCceeEEEecCCCceEcc
Confidence            9999999999996432 23389999999999999999999999 99999999999999    777889999999998655


Q ss_pred             CCC---CccCcccccCcccccC--------CCCCCcccchhhhHHHHHHHhCCCCCCchhh----HHHhhhchhhhcc--
Q 020221          208 DGR---SYSTNLAFTPPEYLRT--------GRVTPESVMYSFGTLLLDLLSGKHIPPSHAL----DLIRDRNIQTLTD--  270 (329)
Q Consensus       208 ~~~---~~~~~~~y~aPE~~~~--------~~~~~~~DvwslG~il~el~tg~~~~~~~~~----~~~~~~~~~~~~~--  270 (329)
                      ...   ...+|+.|+|||++.+        ..++.++||||||+++|||++|..||.....    .............  
T Consensus       168 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~p~~~  247 (396)
T 4eut_A          168 DDEQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGKPSGA  247 (396)
T ss_dssp             CGGGSSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEECTTCTTTCHHHHHHHHHSCCTTC
T ss_pred             CCCccccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcccchHHHHHHHhcCCCccc
Confidence            432   3468999999999865        4577899999999999999999988743111    1111111110000  


Q ss_pred             -----------------ccccCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhhc
Q 020221          271 -----------------SCLEGQFSSDEGTELVRLASRCLQYEPRERPNPRSLVTALVTLQKD  316 (329)
Q Consensus       271 -----------------~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~~~l~~L~~~~~~  316 (329)
                                       .......+...++.+.+++..||+.||++||++.++++.++.+...
T Consensus       248 ~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~ll~~~L~~dP~~R~s~~e~l~~l~~il~~  310 (396)
T 4eut_A          248 ISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDILHR  310 (396)
T ss_dssp             CEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHHHTC
T ss_pred             chhheeccCCCcccCccCCcccccchHHHhhchHHHHHhhccChhhhccHHHHHHHHHHHhhc
Confidence                             0011124467889999999999999999999999999999998764

>1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A*

Probab=100.00  E-value=1.8e-45  Score=330.30  Aligned_cols=249  Identities=16%  Similarity=0.219  Sum_probs=201.7

Q ss_pred             cccccccCCCCCCcEEEEEEeCCCCEEEEEEeCCCCChhHHHHHHHHHHHhc--CCCccccccceeeeeCC----eeEEE
Q 020221           58 MENIVSEHGEKAPNVVYKGKLENQFRIAVKRFNRSAWPDARQFLEEARAVGQ--LRNRRLANLLGCCCEGD----ERLLV  131 (329)
Q Consensus        58 ~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~--l~h~niv~~~~~~~~~~----~~~lv  131 (329)
                      .|.+.+.||+|+||.||+|.. +++.||+|++...   ....+.+|.+++..  ++||||+++++++....    ..++|
T Consensus        43 ~y~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~---~~~~~~~e~~~~~~~~l~h~ni~~~~~~~~~~~~~~~~~~lv  118 (342)
T 1b6c_B           43 TIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSR---EERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLV  118 (342)
T ss_dssp             HCEEEEEEEEETTEEEEEEEE-TTEEEEEEEECGG---GHHHHHHHHHHHHHSCCCCTTBCCEEEEEECCCSSCCCEEEE
T ss_pred             cEEEEeeecCCCCcEEEEEEE-cCccEEEEEeCch---hHHHHHHHHHHHHHhhcCCCcEEEEEeeecccCCccceeEEE
Confidence            356777789999999999998 4789999999653   34567788888887  68999999999998765    78999


Q ss_pred             EecCCCCCHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhh--------cCCCccccccCCCceeeCCCCCeeeecccCc
Q 020221          132 AEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCT--------SKERALYHDLNAYRIVFDDDVNPRLSCFGLM  203 (329)
Q Consensus       132 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH--------~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a  203 (329)
                      |||+++|+|.+++.+   ..+++..++.++.|++.||.|||        +. +++||||||+||+++.++.+||+|||++
T Consensus       119 ~e~~~~g~L~~~l~~---~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~-~ivH~Dlkp~NIll~~~~~~kL~Dfg~~  194 (342)
T 1b6c_B          119 SDYHEHGSLFDYLNR---YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKP-AIAHRDLKSKNILVKKNGTCCIADLGLA  194 (342)
T ss_dssp             ECCCTTCBHHHHHHH---CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBC-EEECSCCSGGGEEECTTSCEEECCCTTC
T ss_pred             EeecCCCcHHHHHhc---cCccHHHHHHHHHHHHHHHHHHHHHHhhhcccC-CeeeCCCCHHHEEECCCCCEEEEECCCc
Confidence            999999999999953   46899999999999999999999        77 9999999999999999999999999998


Q ss_pred             ccCCCC--------CCccCcccccCcccccCCC------CCCcccchhhhHHHHHHHhC----------CCCCCchh---
Q 020221          204 KNSRDG--------RSYSTNLAFTPPEYLRTGR------VTPESVMYSFGTLLLDLLSG----------KHIPPSHA---  256 (329)
Q Consensus       204 ~~~~~~--------~~~~~~~~y~aPE~~~~~~------~~~~~DvwslG~il~el~tg----------~~~~~~~~---  256 (329)
                      ......        ....+|+.|+|||++.+..      ++.++||||||+++|||++|          ..||....   
T Consensus       195 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~p~~~~~~~~  274 (342)
T 1b6c_B          195 VRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSD  274 (342)
T ss_dssp             EEEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTSCSS
T ss_pred             eeccccccccccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhccCcCCcccccccCccccCcCc
Confidence            764432        2346889999999998653      33689999999999999999          55554321   


Q ss_pred             --hHHHhhhchhhhccccccCCC-----ChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhhccc
Q 020221          257 --LDLIRDRNIQTLTDSCLEGQF-----SSDEGTELVRLASRCLQYEPRERPNPRSLVTALVTLQKDTE  318 (329)
Q Consensus       257 --~~~~~~~~~~~~~~~~~~~~~-----~~~~~~~~~~li~~cl~~dp~~Rps~~~~l~~L~~~~~~~~  318 (329)
                        .......    +.....+...     ....+..+.+++.+||+.||++|||+.+++++|+++.++..
T Consensus       275 ~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~i~~~L~~i~~~~~  339 (342)
T 1b6c_B          275 PSVEEMRKV----VCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQEG  339 (342)
T ss_dssp             CCHHHHHHH----HTTSCCCCCCCGGGGTSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHHHHHTTC
T ss_pred             ccHHHHHHH----HHHHHhCCCCcccccchhHHHHHHHHHHHHhccChhhCCCHHHHHHHHHHHHHHhc
Confidence              1111111    1111122222     23677899999999999999999999999999999987654

>3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens}

Probab=100.00  E-value=1.3e-45  Score=330.58  Aligned_cols=256  Identities=20%  Similarity=0.242  Sum_probs=195.3

Q ss_pred             cCCCcccccccCCCCCCcEEEEEEeCCCCEEEEEEeCCCCChhHHHHHHHHHH--HhcCCCccccccceeeee-----CC
Q 020221           54 SGFAMENIVSEHGEKAPNVVYKGKLENQFRIAVKRFNRSAWPDARQFLEEARA--VGQLRNRRLANLLGCCCE-----GD  126 (329)
Q Consensus        54 ~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~--l~~l~h~niv~~~~~~~~-----~~  126 (329)
                      -++..|++++.||+|+||.||+|.. +++.||||++....   ...+..|.++  +..++||||+++++.+..     ..
T Consensus        10 ~~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~---~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~   85 (336)
T 3g2f_A           10 LDLDNLKLLELIGRGRYGAVYKGSL-DERPVAVKVFSFAN---RQNFINEKNIYRVPLMEHDNIARFIVGDERVTADGRM   85 (336)
T ss_dssp             CCTTSEEEEEEEEECSSEEEEEEEE-TTEEEEEEEEEGGG---HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECTTSCE
T ss_pred             cChHHhheeeecccCCCeEEEEEEE-CCeEEEEEEeeccc---hhhHHHHHHHHHHHhccCcchhhheecccccccCCCc
Confidence            3566788899999999999999987 57799999997543   3344444444  555899999999975432     23


Q ss_pred             eeEEEEecCCCCCHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCC--------CccccccCCCceeeCCCCCeeee
Q 020221          127 ERLLVAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKE--------RALYHDLNAYRIVFDDDVNPRLS  198 (329)
Q Consensus       127 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~--------~ivH~dlkp~Nil~~~~~~~kl~  198 (329)
                      ..++||||+++|+|.+++..   ...++..+..++.||+.||.|||+..        +++||||||+|||++.++.+||+
T Consensus        86 ~~~lv~e~~~~g~L~~~l~~---~~~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~ivH~Dikp~Nill~~~~~~kL~  162 (336)
T 3g2f_A           86 EYLLVMEYYPNGSLXKYLSL---HTSDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVIS  162 (336)
T ss_dssp             EEEEEECCCTTCBHHHHHHH---CCBCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCCEECSSCSGGGEEECTTSCEEEC
T ss_pred             eEEEEEecCCCCcHHHHHhh---cccchhHHHHHHHHHHHHHHHHHhhhccccccccceeecccccceEEEcCCCcEEEe
Confidence            67899999999999999953   45589999999999999999999752        89999999999999999999999


Q ss_pred             cccCcccCCCC------------CCccCcccccCcccccC-------CCCCCcccchhhhHHHHHHHhCCCCCCchhhH-
Q 020221          199 CFGLMKNSRDG------------RSYSTNLAFTPPEYLRT-------GRVTPESVMYSFGTLLLDLLSGKHIPPSHALD-  258 (329)
Q Consensus       199 Dfg~a~~~~~~------------~~~~~~~~y~aPE~~~~-------~~~~~~~DvwslG~il~el~tg~~~~~~~~~~-  258 (329)
                      |||++......            ....||+.|+|||++.+       ..++.++||||||+++|||++|..|+...... 
T Consensus       163 DFG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~  242 (336)
T 3g2f_A          163 DFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGESVP  242 (336)
T ss_dssp             CCTTCEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTBGGGSTTSCCC
T ss_pred             eccceeecccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhcCCcCCCccchh
Confidence            99999765422            13358999999999986       34667899999999999999997665332110 


Q ss_pred             HHh-------------hhchhhhccccccCCC------ChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhhc
Q 020221          259 LIR-------------DRNIQTLTDSCLEGQF------SSDEGTELVRLASRCLQYEPRERPNPRSLVTALVTLQKD  316 (329)
Q Consensus       259 ~~~-------------~~~~~~~~~~~~~~~~------~~~~~~~~~~li~~cl~~dp~~Rps~~~~l~~L~~~~~~  316 (329)
                      ...             ............+..+      ....++++.+++.+||+.||++|||+.++++.|+.+...
T Consensus       243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~e~l~~L~~ll~~  319 (336)
T 3g2f_A          243 EYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETIEDCWDQDAEARLTAQXAEERMAELMMI  319 (336)
T ss_dssp             CCCCTTHHHHCSSCCHHHHHHHHTTSCCCCCCCTTCCCCSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred             HHHHhhhcccCCCchHHHHHhhhcccccCCCCCcccccccchHHHHHHHHHHHhcCChhhCcchHHHHHHHHHHHHH
Confidence            000             0000000001111111      234778999999999999999999999999999998754

>3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A*

Probab=100.00  E-value=2.4e-45  Score=332.23  Aligned_cols=256  Identities=16%  Similarity=0.200  Sum_probs=194.8

Q ss_pred             HHHHHHhcCCCcccccccCCCCCCcEEEEEEeCCCCEEEEEEeCCCCCh-----------hHHHHHHHHHHHhcCCCccc
Q 020221           47 ETLRTATSGFAMENIVSEHGEKAPNVVYKGKLENQFRIAVKRFNRSAWP-----------DARQFLEEARAVGQLRNRRL  115 (329)
Q Consensus        47 ~~~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~-----------~~~~~~~e~~~l~~l~h~ni  115 (329)
                      .++....+   .|.+++.||+|+||.||+|...+++.||||++......           ..+.+.+|+++++.++||||
T Consensus        15 ~~~~~~~~---~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i   91 (362)
T 3pg1_A           15 AELHAMQS---PYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNI   91 (362)
T ss_dssp             HHHHHTTC---SCEEEEEEEEETTEEEEEEECTTSCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTTB
T ss_pred             HHHHHhcc---ceEEeEEeccCCCEEEEEEECCCCCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcCc
Confidence            34444444   45667777999999999999777999999998654321           13678999999999999999


Q ss_pred             cccceeeee-----CCeeEEEEecCCCCCHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeC
Q 020221          116 ANLLGCCCE-----GDERLLVAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFD  190 (329)
Q Consensus       116 v~~~~~~~~-----~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~  190 (329)
                      +++++++..     ....++||||+. |+|.+++.. ....+++..+..++.||+.||.|||+. |++|+||||+||+++
T Consensus        92 v~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~-~~~~~~~~~~~~~~~qi~~~l~~lH~~-~ivH~Dlkp~NIl~~  168 (362)
T 3pg1_A           92 LGLRDIFVHFEEPAMHKLYLVTELMR-TDLAQVIHD-QRIVISPQHIQYFMYHILLGLHVLHEA-GVVHRDLHPGNILLA  168 (362)
T ss_dssp             CCCSEEEEECCTTTCCEEEEEEECCS-EEHHHHHHC-TTSCCCHHHHHHHHHHHHHHHHHHHHT-TCCCCCCCGGGEEEC
T ss_pred             cceeeeEEeccCCCcceEEEEEccCC-CCHHHHHHh-cccCCCHHHHHHHHHHHHHHHHHHHHC-cCEecCCChHHEEEc
Confidence            999999844     346899999998 588888864 445799999999999999999999999 999999999999999


Q ss_pred             CCCCeeeecccCcccCCCC---CCccCcccccCcccccC-CCCCCcccchhhhHHHHHHHhCCCCCCchhhHHHhhhchh
Q 020221          191 DDVNPRLSCFGLMKNSRDG---RSYSTNLAFTPPEYLRT-GRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQ  266 (329)
Q Consensus       191 ~~~~~kl~Dfg~a~~~~~~---~~~~~~~~y~aPE~~~~-~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~~~~~~~  266 (329)
                      .++.+||+|||++......   ....+++.|+|||++.+ ..++.++||||||+++|+|++|..||..............
T Consensus       169 ~~~~~kl~Dfg~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~  248 (362)
T 3pg1_A          169 DNNDITICDFNLAREDTADANKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYNQLNKIVE  248 (362)
T ss_dssp             TTCCEEECCTTC---------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHH
T ss_pred             CCCCEEEEecCcccccccccccceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHH
Confidence            9999999999999754433   23467899999999887 5689999999999999999999998876432222111111


Q ss_pred             hh-------------------ccccccC-------CCChHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 020221          267 TL-------------------TDSCLEG-------QFSSDEGTELVRLASRCLQYEPRERPNPRSLVT  308 (329)
Q Consensus       267 ~~-------------------~~~~~~~-------~~~~~~~~~~~~li~~cl~~dp~~Rps~~~~l~  308 (329)
                      ..                   .......       ......++.+.+|+.+||+.||++|||+.++++
T Consensus       249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  316 (362)
T 3pg1_A          249 VVGTPKIEDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRISTEQALR  316 (362)
T ss_dssp             HHCCCCHHHHHHTSCHHHHHHTTTCCCCCCCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             HcCCCChHHhhhccchhhhHHHHhhcccCChhhHHhhCCCCCHHHHHHHHHHhcCChhhCCCHHHHHc
Confidence            00                   0000000       011234678999999999999999999999997

>1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B*

Probab=100.00  E-value=9.9e-46  Score=324.56  Aligned_cols=253  Identities=21%  Similarity=0.281  Sum_probs=198.3

Q ss_pred             CcccccccCCCCCCcEEEEEEeC--CCC--EEEEEEeCCCC---ChhHHHHHHHHHHHhcCCCccccccceeeeeCCeeE
Q 020221           57 AMENIVSEHGEKAPNVVYKGKLE--NQF--RIAVKRFNRSA---WPDARQFLEEARAVGQLRNRRLANLLGCCCEGDERL  129 (329)
Q Consensus        57 ~~~~~~~~lg~G~~g~V~~~~~~--~~~--~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~  129 (329)
                      ..|++++.||+|+||+||+|.+.  ++.  .||+|+++...   ....+.+.+|+++++.++||||+++++++... ..+
T Consensus        18 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-~~~   96 (291)
T 1u46_A           18 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTP-PMK   96 (291)
T ss_dssp             GGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS-SCE
T ss_pred             hHeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEccC-Cce
Confidence            45788889999999999999842  333  68999987642   23456789999999999999999999998765 489


Q ss_pred             EEEecCCCCCHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCCCCCeeeecccCcccCCCC
Q 020221          130 LVAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDG  209 (329)
Q Consensus       130 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~  209 (329)
                      +|+||+++++|.+++.. ....+++..+..++.|++.||.|||+. +++|+||||+||+++.++.+||+|||++......
T Consensus        97 ~v~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~~~i~~~l~~lH~~-~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~  174 (291)
T 1u46_A           97 MVTELAPLGSLLDRLRK-HQGHFLLGTLSRYAVQVAEGMGYLESK-RFIHRDLAARNLLLATRDLVKIGDFGLMRALPQN  174 (291)
T ss_dssp             EEEECCTTCBHHHHHHH-HGGGSCHHHHHHHHHHHHHHHHHHHHT-TEECSCCCGGGEEEEETTEEEECCCTTCEECCC-
T ss_pred             eeEecccCCCHHHHHHh-ccCCcCHHHHHHHHHHHHHHHHHHHhC-CcccCCCchheEEEcCCCCEEEcccccccccccc
Confidence            99999999999999864 235689999999999999999999999 9999999999999999999999999998765443


Q ss_pred             C-------CccCcccccCcccccCCCCCCcccchhhhHHHHHHHh-CCCCCCchhhHHHhhhchhhhccccccCCCChHH
Q 020221          210 R-------SYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLS-GKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDE  281 (329)
Q Consensus       210 ~-------~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t-g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  281 (329)
                      .       ...++..|+|||.+.+..++.++||||||+++|+|++ |..||............    .........+...
T Consensus       175 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~----~~~~~~~~~~~~~  250 (291)
T 1u46_A          175 DDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKI----DKEGERLPRPEDC  250 (291)
T ss_dssp             CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHH----HTSCCCCCCCTTC
T ss_pred             ccchhhhccCCCCceeeCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCcccCCHHHHHHHH----HccCCCCCCCcCc
Confidence            2       2345678999999988889999999999999999999 88877654333222211    1111122334566


Q ss_pred             HHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhhc
Q 020221          282 GTELVRLASRCLQYEPRERPNPRSLVTALVTLQKD  316 (329)
Q Consensus       282 ~~~~~~li~~cl~~dp~~Rps~~~~l~~L~~~~~~  316 (329)
                      ++++.+++.+||+.||++|||+.++++.|+++...
T Consensus       251 ~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~  285 (291)
T 1u46_A          251 PQDIYNVMVQCWAHKPEDRPTFVALRDFLLEAQPT  285 (291)
T ss_dssp             CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC--
T ss_pred             CHHHHHHHHHHccCCcccCcCHHHHHHHHHHhCcc
Confidence            78999999999999999999999999999988754

>3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A

Probab=100.00  E-value=2e-45  Score=322.45  Aligned_cols=248  Identities=17%  Similarity=0.201  Sum_probs=186.7

Q ss_pred             CcccccccCCCCCCcEEEEEE-eCCCCEEEEEEeCCCCChh-HHH-HHHHHHHHhcCCCccccccceeeeeCCeeEEEEe
Q 020221           57 AMENIVSEHGEKAPNVVYKGK-LENQFRIAVKRFNRSAWPD-ARQ-FLEEARAVGQLRNRRLANLLGCCCEGDERLLVAE  133 (329)
Q Consensus        57 ~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~-~~~-~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  133 (329)
                      ..|++++.||+|+||+||++. ..+++.||+|++....... ... +.++...++.++||||+++++++.+.+..++|||
T Consensus         7 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~~~~~~lv~e   86 (290)
T 3fme_A            7 DDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGALFREGDVWICME   86 (290)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC---CHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSSEEEEEE
T ss_pred             HhhhhHHhcCCCCCeEEEEEEecCCCeEEEEEEeecccCcHHHHHHHHHHHHHHHhCCCCeEEEEeeeeeccCCEEEEEe
Confidence            457788889999999999999 4678899999998654332 222 4445556788899999999999999999999999


Q ss_pred             cCCCCCHHhhhccC--CCCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCCCCCeeeecccCcccCCCCC-
Q 020221          134 YMPNDTLAKHLFHW--ETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDGR-  210 (329)
Q Consensus       134 ~~~~gsL~~~l~~~--~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~-  210 (329)
                      |+++ +|.+++...  ....+++..++.++.|++.||.|||++.|++|+||||+||+++.++.+||+|||++....... 
T Consensus        87 ~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~  165 (290)
T 3fme_A           87 LMDT-SLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLSVIHRDVKPSNVLINALGQVKMCDFGISGYLVDDVA  165 (290)
T ss_dssp             CCSE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHSCCCCCCCSGGGCEECTTCCEEBCCC-----------
T ss_pred             hhcc-chHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCeecCCCCHHHEEECCCCCEEEeecCCccccccccc
Confidence            9975 887776531  356799999999999999999999985489999999999999999999999999997654432 


Q ss_pred             --CccCcccccCcccc----cCCCCCCcccchhhhHHHHHHHhCCCCCCchhhHHHhhhchhhhccccccCCCChHHHHH
Q 020221          211 --SYSTNLAFTPPEYL----RTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTE  284 (329)
Q Consensus       211 --~~~~~~~y~aPE~~----~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  284 (329)
                        ...+++.|+|||.+    .+..++.++||||||+++|+|++|..||..........   ............+...+++
T Consensus       166 ~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~  242 (290)
T 3fme_A          166 KDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQQL---KQVVEEPSPQLPADKFSAE  242 (290)
T ss_dssp             ----CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCCCSCHHHHH---HHHHHSCCCCCCTTTSCHH
T ss_pred             ccccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCccccCchHHHH---HHHhccCCCCcccccCCHH
Confidence              33688999999996    45568899999999999999999998886422111111   1111111111223456788


Q ss_pred             HHHHHHHhcccCCCCCCCHHHHHH
Q 020221          285 LVRLASRCLQYEPRERPNPRSLVT  308 (329)
Q Consensus       285 ~~~li~~cl~~dp~~Rps~~~~l~  308 (329)
                      +.+++.+||+.||++|||+.++++
T Consensus       243 ~~~li~~~l~~~p~~Rpt~~e~l~  266 (290)
T 3fme_A          243 FVDFTSQCLKKNSKERPTYPELMQ  266 (290)
T ss_dssp             HHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred             HHHHHHHHhhcChhhCcCHHHHHh
Confidence            999999999999999999999998

>2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens}

Probab=100.00  E-value=1.5e-45  Score=327.47  Aligned_cols=247  Identities=17%  Similarity=0.225  Sum_probs=191.9

Q ss_pred             CcccccccCCCCCCcEEEEEEe-CCCCEEEEEEeCCCCChhHHHHHHHHHHHhcCCCccccccceeee------------
Q 020221           57 AMENIVSEHGEKAPNVVYKGKL-ENQFRIAVKRFNRSAWPDARQFLEEARAVGQLRNRRLANLLGCCC------------  123 (329)
Q Consensus        57 ~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~------------  123 (329)
                      ..|++++.||+|+||.||+|.. .+++.||+|++........+.+.+|+++++.++||||+++++++.            
T Consensus        11 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~   90 (320)
T 2i6l_A           11 SRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQLTDDVGS   90 (320)
T ss_dssp             TTEEEEEECC-----CEEEEEETTTTEEEEEEEEECCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSCBCCC----
T ss_pred             CceeEEEEeccCCCeEEEEEEECCCCeEEEEEEEecCChHHHHHHHHHHHHHHhcCCCCeeEEEEecccccccccccccc
Confidence            4578888999999999999995 458899999998766556678899999999999999999998873            


Q ss_pred             --eCCeeEEEEecCCCCCHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeC-CCCCeeeecc
Q 020221          124 --EGDERLLVAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFD-DDVNPRLSCF  200 (329)
Q Consensus       124 --~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~-~~~~~kl~Df  200 (329)
                        .....++||||+. |+|.+++.   ...+++..++.++.|++.||+|||+. |++|+||||+||+++ +++.+||+||
T Consensus        91 ~~~~~~~~lv~e~~~-~~L~~~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~-~i~H~dlkp~Nil~~~~~~~~kl~Df  165 (320)
T 2i6l_A           91 LTELNSVYIVQEYME-TDLANVLE---QGPLLEEHARLFMYQLLRGLKYIHSA-NVLHRDLKPANLFINTEDLVLKIGDF  165 (320)
T ss_dssp             CCSCSEEEEEEECCS-EEHHHHHT---TCCCCHHHHHHHHHHHHHHHHHHHHT-TCBCCCCSGGGEEEETTTTEEEECCC
T ss_pred             ccccCceeEEeeccC-CCHHHHhh---cCCccHHHHHHHHHHHHHHHHHHHhC-CEecCCCCHHHEEEcCCCCeEEEccC
Confidence              3467899999998 59999984   46789999999999999999999999 999999999999997 5678999999


Q ss_pred             cCcccCCCC-------CCccCcccccCcccccC-CCCCCcccchhhhHHHHHHHhCCCCCCchhhHHHhhhchhhhc---
Q 020221          201 GLMKNSRDG-------RSYSTNLAFTPPEYLRT-GRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLT---  269 (329)
Q Consensus       201 g~a~~~~~~-------~~~~~~~~y~aPE~~~~-~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~~~~~~~~~~---  269 (329)
                      |++......       ....++..|+|||.+.+ ..++.++||||||+++|+|++|..||.................   
T Consensus       166 g~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~  245 (320)
T 2i6l_A          166 GLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQMQLILESIPVVH  245 (320)
T ss_dssp             TTCBCC--------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHSCCCC
T ss_pred             ccccccCCCcccccccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCc
Confidence            999865432       22345888999998865 5688999999999999999999998865432211111110000   


Q ss_pred             ---------------ccccc-C-----CCChHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 020221          270 ---------------DSCLE-G-----QFSSDEGTELVRLASRCLQYEPRERPNPRSLVT  308 (329)
Q Consensus       270 ---------------~~~~~-~-----~~~~~~~~~~~~li~~cl~~dp~~Rps~~~~l~  308 (329)
                                     ..... .     ......++++.+++.+||+.||++|||+.++++
T Consensus       246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  305 (320)
T 2i6l_A          246 EEDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLTAEEALS  305 (320)
T ss_dssp             HHHHHHHHTTSCHHHHHHTTSCCCCHHHHSTTCCHHHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred             hhhhhhhhhcCcccccccccCCCCChhHhcchhhHHHHHHHHHHcCCCccccCCHHHHhC
Confidence                           00000 0     011235788999999999999999999999997

>4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A

Probab=100.00  E-value=7.3e-45  Score=330.24  Aligned_cols=245  Identities=15%  Similarity=0.202  Sum_probs=194.1

Q ss_pred             cccccccCCCCCCcEEEEEE-eCCCCEEEEEEeCCCCCh--hHHHHHHHHHHHhcCCCccccccceeeeeCCee------
Q 020221           58 MENIVSEHGEKAPNVVYKGK-LENQFRIAVKRFNRSAWP--DARQFLEEARAVGQLRNRRLANLLGCCCEGDER------  128 (329)
Q Consensus        58 ~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~--~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~------  128 (329)
                      .|.+.+.||+|+||.||+|. ..+++.||+|++......  ..+.+.+|+.+++.++||||+++++++...+..      
T Consensus        43 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~  122 (371)
T 4exu_A           43 TYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFYDF  122 (371)
T ss_dssp             TEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSSTTCCCC
T ss_pred             cEEEEeEEecCCCeEEEEEEECCCCCEEEEEEecccccchhHHHHHHHHHHHHHhcCCCCchhhhhheeccCCcccceeE
Confidence            46677888999999999998 557889999999865432  245688999999999999999999999776654      


Q ss_pred             EEEEecCCCCCHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCCCCCeeeecccCcccCCC
Q 020221          129 LLVAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRD  208 (329)
Q Consensus       129 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~  208 (329)
                      ++||||+. ++|.+.+.    ..+++..+..++.|++.||.|||+. |++||||||+||+++.++.+||+|||++.....
T Consensus       123 ~lv~e~~~-~~l~~~~~----~~~~~~~~~~i~~qi~~aL~~LH~~-~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~~  196 (371)
T 4exu_A          123 YLVMPFMQ-TDLQKIMG----MEFSEEKIQYLVYQMLKGLKYIHSA-GVVHRDLKPGNLAVNEDCELKILDFGLARHADA  196 (371)
T ss_dssp             EEEEECCC-EEHHHHTT----SCCCHHHHHHHHHHHHHHHHHHHHT-TCCCSCCCGGGEEECTTCCEEECSTTCC-----
T ss_pred             EEEEcccc-ccHHHHhh----cCCCHHHHHHHHHHHHHHHHHHHHC-CCcCCCcCHHHeEECCCCCEEEEecCccccccc
Confidence            99999997 58888773    3499999999999999999999999 999999999999999999999999999986544


Q ss_pred             C-CCccCcccccCcccccC-CCCCCcccchhhhHHHHHHHhCCCCCCchhhHHHhhhchhhh------------------
Q 020221          209 G-RSYSTNLAFTPPEYLRT-GRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTL------------------  268 (329)
Q Consensus       209 ~-~~~~~~~~y~aPE~~~~-~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~~~~~~~~~------------------  268 (329)
                      . ....+|+.|+|||++.+ ..++.++||||||+++|+|++|..||................                  
T Consensus       197 ~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~  276 (371)
T 4exu_A          197 EMTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQKLNDKAAKS  276 (371)
T ss_dssp             ---CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHTTCSCHHHHH
T ss_pred             CcCCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCcHHHHHHhhhhhhhh
Confidence            3 34567999999999887 679999999999999999999999887543222111111000                  


Q ss_pred             -cc---ccccC---CCChHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 020221          269 -TD---SCLEG---QFSSDEGTELVRLASRCLQYEPRERPNPRSLVT  308 (329)
Q Consensus       269 -~~---~~~~~---~~~~~~~~~~~~li~~cl~~dp~~Rps~~~~l~  308 (329)
                       ..   .....   ......++++.+|+.+||+.||++|||+.++++
T Consensus       277 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  323 (371)
T 4exu_A          277 YIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALT  323 (371)
T ss_dssp             HHHHSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSCTTTSCCHHHHHT
T ss_pred             hhhccCCCcchhHHHhccccChHHHHHHHHHCCCChhhcCCHHHHhc
Confidence             00   00000   011234788999999999999999999999997

>2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A*

Probab=100.00  E-value=1.5e-45  Score=328.48  Aligned_cols=245  Identities=15%  Similarity=0.171  Sum_probs=192.9

Q ss_pred             cccccccCCCCCCcEEEEEEe-CCCCEEEEEEeCCCCC--------hhHHHHHHHHHHHhcCCCccccccceeeeeCCee
Q 020221           58 MENIVSEHGEKAPNVVYKGKL-ENQFRIAVKRFNRSAW--------PDARQFLEEARAVGQLRNRRLANLLGCCCEGDER  128 (329)
Q Consensus        58 ~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~--------~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~  128 (329)
                      .|.+++.||+|+||.||+|.. .+++.||||++.....        .....+.+|+++++.++||||+++++++... ..
T Consensus        11 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~-~~   89 (322)
T 2ycf_A           11 EYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAE-DY   89 (322)
T ss_dssp             HEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEEESS-SE
T ss_pred             ceeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEEcCC-ce
Confidence            477888889999999999984 5688999999875431        1123478999999999999999999998654 48


Q ss_pred             EEEEecCCCCCHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCCCCC---eeeecccCccc
Q 020221          129 LLVAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVN---PRLSCFGLMKN  205 (329)
Q Consensus       129 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~---~kl~Dfg~a~~  205 (329)
                      ++||||+++++|.+++.  ....+++..+..++.||+.||.|||++ |++|+||||+||+++.++.   +||+|||++..
T Consensus        90 ~lv~e~~~~~~L~~~~~--~~~~~~~~~~~~~~~qi~~~l~~lH~~-~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~  166 (322)
T 2ycf_A           90 YIVLELMEGGELFDKVV--GNKRLKEATCKLYFYQMLLAVQYLHEN-GIIHRDLKPENVLLSSQEEDCLIKITDFGHSKI  166 (322)
T ss_dssp             EEEEECCTTEETHHHHS--TTCCCCHHHHHHHHHHHHHHHHHHHHT-TEECCCCSGGGEEESSSSSSCCEEECCCTTCEE
T ss_pred             EEEEecCCCCcHHHHHh--ccCCCCHHHHHHHHHHHHHHHHHHHHC-CeeccCCCHHHEEEecCCCCCeEEEccCcccee
Confidence            99999999999999886  456799999999999999999999999 9999999999999987654   99999999987


Q ss_pred             CCCCC---CccCcccccCccccc---CCCCCCcccchhhhHHHHHHHhCCCCCCchhhHH-HhhhchhhhccccccCCCC
Q 020221          206 SRDGR---SYSTNLAFTPPEYLR---TGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDL-IRDRNIQTLTDSCLEGQFS  278 (329)
Q Consensus       206 ~~~~~---~~~~~~~y~aPE~~~---~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~  278 (329)
                      .....   ...+++.|+|||++.   ...++.++||||||+++|+|++|..||....... ...........  ......
T Consensus       167 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~--~~~~~~  244 (322)
T 2ycf_A          167 LGETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYN--FIPEVW  244 (322)
T ss_dssp             CCCCHHHHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTTCSSCHHHHHHHTCCC--CCHHHH
T ss_pred             cccccccccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchHHHHHHHHHhCccc--cCchhh
Confidence            65442   335789999999874   4568899999999999999999998886432110 00000000000  000011


Q ss_pred             hHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 020221          279 SDEGTELVRLASRCLQYEPRERPNPRSLVT  308 (329)
Q Consensus       279 ~~~~~~~~~li~~cl~~dp~~Rps~~~~l~  308 (329)
                      ...++++.+++.+||+.||++|||+.++++
T Consensus       245 ~~~~~~~~~li~~~l~~dP~~Rps~~~~l~  274 (322)
T 2ycf_A          245 AEVSEKALDLVKKLLVVDPKARFTTEEALR  274 (322)
T ss_dssp             TTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred             hhcCHHHHHHHHHHcccCHhhCCCHHHHhh
Confidence            234678999999999999999999999986

>2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A*

Probab=100.00  E-value=7.3e-45  Score=327.84  Aligned_cols=247  Identities=15%  Similarity=0.195  Sum_probs=196.4

Q ss_pred             CcccccccCCCCCCcEEEEEEe-CCCCEEEEEEeCCCCCh-hHHHHHHHHHHHhcCCCccccccceeeeeC-----CeeE
Q 020221           57 AMENIVSEHGEKAPNVVYKGKL-ENQFRIAVKRFNRSAWP-DARQFLEEARAVGQLRNRRLANLLGCCCEG-----DERL  129 (329)
Q Consensus        57 ~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~~~~~~~~~-----~~~~  129 (329)
                      ..|.+.+.||+|+||.||+|.. .+++.||||++...... ....+.+|+++++.++||||+++++++...     ...+
T Consensus        11 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~   90 (353)
T 2b9h_A           11 SDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHENIITIFNIQRPDSFENFNEVY   90 (353)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCSTTCCCEE
T ss_pred             cceEEeeEEcCCCCeEEEEEEECCCCcEEEEEeecccccchHHHHHHHHHHHHHhCcCCCcCCeeeeecccccCccceEE
Confidence            4577888889999999999995 46889999999754432 345678999999999999999999987654     6789


Q ss_pred             EEEecCCCCCHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCCCCCeeeecccCcccCCCC
Q 020221          130 LVAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDG  209 (329)
Q Consensus       130 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~  209 (329)
                      +||||+. ++|.+++..   ..+++..+..++.|++.||.|||+. |++||||||+||+++.++.+||+|||++......
T Consensus        91 lv~e~~~-~~L~~~~~~---~~~~~~~~~~~~~qi~~~L~~LH~~-~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~  165 (353)
T 2b9h_A           91 IIQELMQ-TDLHRVIST---QMLSDDHIQYFIYQTLRAVKVLHGS-NVIHRDLKPSNLLINSNCDLKVCDFGLARIIDES  165 (353)
T ss_dssp             EEECCCS-EEHHHHHHH---CCCCHHHHHHHHHHHHHHHHHHHHT-TEECSCCCGGGEEECTTCCEEECCCTTCEECC--
T ss_pred             EEEeccC-ccHHHHHhh---cCCCHHHHHHHHHHHHHHHHHHHHC-CeecCCCCHHHeEEcCCCcEEEEecccccccccc
Confidence            9999997 589998853   5799999999999999999999999 9999999999999999999999999998765422


Q ss_pred             --------------CCccCcccccCcccccC-CCCCCcccchhhhHHHHHHHhCCCCCCchhhHHHhhhchh--------
Q 020221          210 --------------RSYSTNLAFTPPEYLRT-GRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQ--------  266 (329)
Q Consensus       210 --------------~~~~~~~~y~aPE~~~~-~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~~~~~~~--------  266 (329)
                                    ....||+.|+|||++.+ ..++.++||||||+++|+|++|..||..............        
T Consensus       166 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~  245 (353)
T 2b9h_A          166 AADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLIFGIIGTPHSD  245 (353)
T ss_dssp             --------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCST
T ss_pred             cccccCccccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCchh
Confidence                          12357899999998764 6689999999999999999999998876532211110000        


Q ss_pred             ------------hhcccccc------CCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 020221          267 ------------TLTDSCLE------GQFSSDEGTELVRLASRCLQYEPRERPNPRSLVT  308 (329)
Q Consensus       267 ------------~~~~~~~~------~~~~~~~~~~~~~li~~cl~~dp~~Rps~~~~l~  308 (329)
                                  ........      .......++++.+++.+||+.||++|||+.++++
T Consensus       246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  305 (353)
T 2b9h_A          246 NDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALE  305 (353)
T ss_dssp             TTTTTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             ccccccccchhhHHhhcccCCCCcchhhhcccCCHHHHHHHHHhcCcCcccCCCHHHHhc
Confidence                        00000000      0011245788999999999999999999999997

>3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group}

Probab=100.00  E-value=1.3e-44  Score=337.90  Aligned_cols=251  Identities=17%  Similarity=0.196  Sum_probs=203.2

Q ss_pred             CcccccccCCCCCCcEEEEEE-eCCCCEEEEEEeCCCCChhHHHHHHHHHHHhcCCC-ccccccceeeeeCCeeEEEEec
Q 020221           57 AMENIVSEHGEKAPNVVYKGK-LENQFRIAVKRFNRSAWPDARQFLEEARAVGQLRN-RRLANLLGCCCEGDERLLVAEY  134 (329)
Q Consensus        57 ~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h-~niv~~~~~~~~~~~~~lv~e~  134 (329)
                      ..|++++.||+|+||.||+|. ..+++.||||++......  ..+.+|+++++.++| +++..+..++......++||||
T Consensus         7 ~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~--~~~~~E~~il~~L~~~~~i~~i~~~~~~~~~~~lvme~   84 (483)
T 3sv0_A            7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKH--PQLLYESKIYRILQGGTGIPNVRWFGVEGDYNVLVMDL   84 (483)
T ss_dssp             TTEECCCCCEECSSCEEEEEEETTTCCEEEEEEEETTCSS--CCHHHHHHHHHHTTTSTTCCCEEEEEEETTEEEEEEEC
T ss_pred             CcEEEEEEEeeCCCEEEEEEEECCCCcEEEEEEecccccc--HHHHHHHHHHHHhcCCCCCCeEEEEEeeCCEEEEEEEC
Confidence            357788889999999999999 467899999998765422  357889999999976 5566666666777889999999


Q ss_pred             CCCCCHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceee---CCCCCeeeecccCcccCCCCC-
Q 020221          135 MPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVF---DDDVNPRLSCFGLMKNSRDGR-  210 (329)
Q Consensus       135 ~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~---~~~~~~kl~Dfg~a~~~~~~~-  210 (329)
                      + +++|.+++.. ....+++..++.++.||+.||.|||++ +|+||||||+|||+   +.++.+||+|||+++...... 
T Consensus        85 ~-g~sL~~ll~~-~~~~l~~~~~~~i~~qi~~aL~yLH~~-gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~~~  161 (483)
T 3sv0_A           85 L-GPSLEDLFNF-CSRKLSLKTVLMLADQMINRVEFVHSK-SFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTST  161 (483)
T ss_dssp             C-CCBHHHHHHH-TTTCCCHHHHHHHHHHHHHHHHHHHHT-TEECCCCCGGGEEECCGGGTTCEEECCCTTCEECBCTTT
T ss_pred             C-CCCHHHHHHh-hcCCCCHHHHHHHHHHHHHHHHHHHHC-CEeecccCcceEEEecCCCCCeEEEEeCCcceeccCCcc
Confidence            9 8899999964 356799999999999999999999999 99999999999999   688999999999997654432 


Q ss_pred             ----------CccCcccccCcccccCCCCCCcccchhhhHHHHHHHhCCCCCCchhh-------HHHhhhchhhhccccc
Q 020221          211 ----------SYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHAL-------DLIRDRNIQTLTDSCL  273 (329)
Q Consensus       211 ----------~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~-------~~~~~~~~~~~~~~~~  273 (329)
                                ...||..|+|||++.+..++.++||||||+++|||++|..||.....       ..+...........  
T Consensus       162 ~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~--  239 (483)
T 3sv0_A          162 HQHIPYRENKNLTGTARYASVNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVATSIEA--  239 (483)
T ss_dssp             CCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSHHHHHHHHHHHHHHSCHHH--
T ss_pred             ccccccccccccCCCccccCHHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccchhHHHHHHHHhhccccccHHH--
Confidence                      45689999999999999999999999999999999999998865211       11111111111111  


Q ss_pred             cCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhhcc
Q 020221          274 EGQFSSDEGTELVRLASRCLQYEPRERPNPRSLVTALVTLQKDT  317 (329)
Q Consensus       274 ~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~~~l~~L~~~~~~~  317 (329)
                         ....+++++.+++..||+.||++||++.+|++.|+.+....
T Consensus       240 ---l~~~~p~~l~~li~~cl~~dP~~RPs~~el~~~L~~l~~~~  280 (483)
T 3sv0_A          240 ---LCRGYPTEFASYFHYCRSLRFDDKPDYSYLKRLFRDLFIRE  280 (483)
T ss_dssp             ---HHTTSCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHHT
T ss_pred             ---HhcCCcHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHHc
Confidence               11234678999999999999999999999999999996643

>3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens}

Probab=100.00  E-value=5.9e-45  Score=330.14  Aligned_cols=246  Identities=12%  Similarity=0.131  Sum_probs=201.3

Q ss_pred             CcccccccCCCCCCcEEEEEE------eCCCCEEEEEEeCCCCChhHHHHHHHHHHHhcCC---CccccccceeeeeCCe
Q 020221           57 AMENIVSEHGEKAPNVVYKGK------LENQFRIAVKRFNRSAWPDARQFLEEARAVGQLR---NRRLANLLGCCCEGDE  127 (329)
Q Consensus        57 ~~~~~~~~lg~G~~g~V~~~~------~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~---h~niv~~~~~~~~~~~  127 (329)
                      ..|.+.+.||+|+||+||+|.      ..+++.||+|++....   ...+.+|++++..++   |+||+++++++...+.
T Consensus        65 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~e~~~~~~l~~~~~~~iv~~~~~~~~~~~  141 (365)
T 3e7e_A           65 KLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPAN---PWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNG  141 (365)
T ss_dssp             SEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSCC---HHHHHHHHHHHHHSCGGGGGGBCCEEEEEECSSC
T ss_pred             EEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCCC---hhHHHHHHHHHHHhhhhhhhhhhhhheeeecCCC
Confidence            456777888999999999993      4568899999997654   456777888888886   9999999999999999


Q ss_pred             eEEEEecCCCCCHHhhhccC---CCCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCC-----------CC
Q 020221          128 RLLVAEYMPNDTLAKHLFHW---ETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDD-----------DV  193 (329)
Q Consensus       128 ~~lv~e~~~~gsL~~~l~~~---~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~-----------~~  193 (329)
                      .++||||+++|+|.+++...   ....+++..+..++.||+.||+|||+. +|+||||||+|||++.           ++
T Consensus       142 ~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~~-~ivHrDiKp~NIll~~~~~~~~~~~~~~~  220 (365)
T 3e7e_A          142 SVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDC-EIIHGDIKPDNFILGNGFLEQDDEDDLSA  220 (365)
T ss_dssp             EEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHTT-TEECCCCSGGGEEECGGGTCC------CT
T ss_pred             cEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhhC-CeecCCCCHHHEEecccccCccccccccC
Confidence            99999999999999999632   345799999999999999999999999 9999999999999998           89


Q ss_pred             CeeeecccCcccCC---CC---CCccCcccccCcccccCCCCCCcccchhhhHHHHHHHhCCCCCCchhhHHHhhhchhh
Q 020221          194 NPRLSCFGLMKNSR---DG---RSYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQT  267 (329)
Q Consensus       194 ~~kl~Dfg~a~~~~---~~---~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~~~~~~~~  267 (329)
                      .+||+|||+++...   ..   ....||+.|+|||++.+..++.++||||||+++|||++|+.||.......       .
T Consensus       221 ~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~-------~  293 (365)
T 3e7e_A          221 GLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGE-------C  293 (365)
T ss_dssp             TEEECCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCCCEEEETTE-------E
T ss_pred             CEEEeeCchhhhhhccCCCceeeeecCCCCCCChHHhcCCCCCccccHHHHHHHHHHHHhCCCccccCCCCc-------e
Confidence            99999999996432   11   34468999999999999999999999999999999999998875432110       0


Q ss_pred             hccccccCCCChHHHHHHHHHHHHhcccCCCCC-CCHHHHHHHHHhhhhc
Q 020221          268 LTDSCLEGQFSSDEGTELVRLASRCLQYEPRER-PNPRSLVTALVTLQKD  316 (329)
Q Consensus       268 ~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~R-ps~~~~l~~L~~~~~~  316 (329)
                      ....... ..  ..++.+.+++..|++.+|.+| |+++++.+.|+.+...
T Consensus       294 ~~~~~~~-~~--~~~~~~~~~~~~~l~~~p~~r~~~~~~l~~~l~~~l~~  340 (365)
T 3e7e_A          294 KPEGLFR-RL--PHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQ  340 (365)
T ss_dssp             EECSCCT-TC--SSHHHHHHHHHHHHCCCCTTCCCCHHHHHHHHHHHHHH
T ss_pred             eechhcc-cc--CcHHHHHHHHHHHcCCCCCCcchHHHHHHHHHHHHHHH
Confidence            0111111 11  236678999999999999998 5888888888887654

>1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B

Probab=100.00  E-value=5.5e-45  Score=325.03  Aligned_cols=250  Identities=18%  Similarity=0.210  Sum_probs=198.1

Q ss_pred             CcccccccCCCCCCcEEEEEEe--CCCCEEEEEEeCCCCCh--hHHHHHHHHHHHhcC---CCccccccceeee-----e
Q 020221           57 AMENIVSEHGEKAPNVVYKGKL--ENQFRIAVKRFNRSAWP--DARQFLEEARAVGQL---RNRRLANLLGCCC-----E  124 (329)
Q Consensus        57 ~~~~~~~~lg~G~~g~V~~~~~--~~~~~vavK~~~~~~~~--~~~~~~~e~~~l~~l---~h~niv~~~~~~~-----~  124 (329)
                      ..|++++.||+|+||.||++..  .+++.||+|++......  ....+.+|+.+++.+   +||||+++++++.     .
T Consensus        11 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~   90 (326)
T 1blx_A           11 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDR   90 (326)
T ss_dssp             GTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECSS
T ss_pred             hceeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCcccccCCchhhHHHHHHHhhhccCCCCeEeeeeeeeecccCC
Confidence            4577888889999999999996  46788999998653211  122455677766655   8999999999986     4


Q ss_pred             CCeeEEEEecCCCCCHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCCCCCeeeecccCcc
Q 020221          125 GDERLLVAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMK  204 (329)
Q Consensus       125 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~  204 (329)
                      ....++||||+. |+|.+++.......+++..+..++.|++.||.|||+. |++|+||||+||+++.++.+||+|||++.
T Consensus        91 ~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~-gi~H~dlkp~Nili~~~~~~kl~Dfg~~~  168 (326)
T 1blx_A           91 ETKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSH-RVVHRDLKPQNILVTSSGQIKLADFGLAR  168 (326)
T ss_dssp             EEEEEEEEECCS-CBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHT-TCCCCCCCGGGEEECTTCCEEECSCCSCC
T ss_pred             CceEEEEEecCC-CCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHC-CceeccCCHHHeEEcCCCCEEEecCcccc
Confidence            567899999998 5999999765556699999999999999999999999 99999999999999999999999999997


Q ss_pred             cCCCC---CCccCcccccCcccccCCCCCCcccchhhhHHHHHHHhCCCCCCchhhHHHhhhchhhhc-------c----
Q 020221          205 NSRDG---RSYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLT-------D----  270 (329)
Q Consensus       205 ~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~~~~~~~~~~-------~----  270 (329)
                      .....   ....++..|+|||++.+..++.++||||||+++|+|++|..||.................       .    
T Consensus       169 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  248 (326)
T 1blx_A          169 IYSFQMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDVA  248 (326)
T ss_dssp             CCCGGGGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCGGGSCTTCS
T ss_pred             cccCCCCccccccccceeCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCcccCccccc
Confidence            65432   334678999999999988999999999999999999999988865432222111111000       0    


Q ss_pred             ----------ccccCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 020221          271 ----------SCLEGQFSSDEGTELVRLASRCLQYEPRERPNPRSLVT  308 (329)
Q Consensus       271 ----------~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~~~l~  308 (329)
                                ...........++.+.+|+.+||+.||++|||+.++++
T Consensus       249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~  296 (326)
T 1blx_A          249 LPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS  296 (326)
T ss_dssp             SCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred             cchhhhcccCcchhhhccccCCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence                      00001122446788999999999999999999999996

>2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A*

Probab=100.00  E-value=2.3e-44  Score=328.19  Aligned_cols=249  Identities=16%  Similarity=0.153  Sum_probs=198.0

Q ss_pred             CcccccccCCCCCCcEEEEEE-eCCCCEEEEEEeCCCCChhHHHHHHHHHHHhcCC-Cc-----cccccceeeeeCCeeE
Q 020221           57 AMENIVSEHGEKAPNVVYKGK-LENQFRIAVKRFNRSAWPDARQFLEEARAVGQLR-NR-----RLANLLGCCCEGDERL  129 (329)
Q Consensus        57 ~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h~-----niv~~~~~~~~~~~~~  129 (329)
                      ..|++++.||+|+||+||+|. ..+++.||||++.... .....+.+|+.+++.++ |+     +|+++.+++...+..+
T Consensus        54 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~~~~~~~~~  132 (382)
T 2vx3_A           54 DRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKK-AFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFMFRNHLC  132 (382)
T ss_dssp             TTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSSH-HHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEEEEETTEEE
T ss_pred             eeEEEEEEEeecCCEEEEEEEEcCCCcEEEEEEEeccH-HHHHHHHHHHHHHHHHHhcccccceeEEEeeeeeccCCceE
Confidence            457788888999999999998 4568899999997543 33456778888888874 44     4999999999999999


Q ss_pred             EEEecCCCCCHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhc--CCCccccccCCCceeeC--CCCCeeeecccCccc
Q 020221          130 LVAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTS--KERALYHDLNAYRIVFD--DDVNPRLSCFGLMKN  205 (329)
Q Consensus       130 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~--~~~ivH~dlkp~Nil~~--~~~~~kl~Dfg~a~~  205 (329)
                      +||||+.+ +|.+++.......+++..+..++.|++.||.|||.  . ||+||||||+|||++  .++.+||+|||++..
T Consensus       133 lv~e~~~~-~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~-~ivHrDlkp~NIll~~~~~~~~kL~DFG~a~~  210 (382)
T 2vx3_A          133 LVFEMLSY-NLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLATPEL-SIIHCDLKPENILLCNPKRSAIKIVDFGSSCQ  210 (382)
T ss_dssp             EEEECCCC-BHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHTSTTT-CEECCCCSGGGEEESSTTSCCEEECCCTTCEE
T ss_pred             EEEecCCC-CHHHHHhhcCcCCCCHHHHHHHHHHHHHHHHHhccCCC-CEEcCCCCcccEEEecCCCCcEEEEeccCcee
Confidence            99999965 99999976555679999999999999999999994  5 999999999999995  578899999999987


Q ss_pred             CCCC-CCccCcccccCcccccCCCCCCcccchhhhHHHHHHHhCCCCCCchhhHHHhhhchhh-----------------
Q 020221          206 SRDG-RSYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQT-----------------  267 (329)
Q Consensus       206 ~~~~-~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~~~~~~~~-----------------  267 (329)
                      .... ....+|+.|+|||++.+..++.++||||||+++|||++|..||...............                 
T Consensus       211 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~  290 (382)
T 2vx3_A          211 LGQRIYQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSGANEVDQMNKIVEVLGIPPAHILDQAPKARK  290 (382)
T ss_dssp             TTCCCCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHHTTCTTHHH
T ss_pred             cccccccccCCccccChHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhhHHHHH
Confidence            6543 4557899999999999999999999999999999999999988754322111111000                 


Q ss_pred             hcccccc-----------------------------------------CCCChHHHHHHHHHHHHhcccCCCCCCCHHHH
Q 020221          268 LTDSCLE-----------------------------------------GQFSSDEGTELVRLASRCLQYEPRERPNPRSL  306 (329)
Q Consensus       268 ~~~~~~~-----------------------------------------~~~~~~~~~~~~~li~~cl~~dp~~Rps~~~~  306 (329)
                      .......                                         ........+++.+|+.+||+.||++|||+.++
T Consensus       291 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~Rpta~e~  370 (382)
T 2vx3_A          291 FFEKLPDGTWNLKKTKDGKREYKPPGTRKLHNILGVETGGPGGRRAGESGHTVADYLKFKDLILRMLDYDPKTRIQPYYA  370 (382)
T ss_dssp             HEEECTTSCEEECCCCTTCCCSCCTTCSCHHHHHTTTTTSGGGTTTTCTTCCHHHHHHHHHHHHHHTCSCTTTSCCHHHH
T ss_pred             HHHhccccccccccccccccccCCcchhhHHHHhhccccCCCccccccccccchhhHHHHHHHHHhcCCChhhCCCHHHH
Confidence            0000000                                         00112234689999999999999999999999


Q ss_pred             HH
Q 020221          307 VT  308 (329)
Q Consensus       307 l~  308 (329)
                      ++
T Consensus       371 L~  372 (382)
T 2vx3_A          371 LQ  372 (382)
T ss_dssp             TT
T ss_pred             hc
Confidence            98

>3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major}

Probab=100.00  E-value=7.1e-45  Score=328.76  Aligned_cols=250  Identities=17%  Similarity=0.202  Sum_probs=185.0

Q ss_pred             CCcccccccCCCCCCcEEEEEEe-CCCCEEEEEEeCCCCChhHHHHHHHHHHHhcCCCccccccceeeeeCCe-------
Q 020221           56 FAMENIVSEHGEKAPNVVYKGKL-ENQFRIAVKRFNRSAWPDARQFLEEARAVGQLRNRRLANLLGCCCEGDE-------  127 (329)
Q Consensus        56 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~-------  127 (329)
                      +..|++.+.||+|+||+||+|.. .+++.||||++..... ......++++.+..++||||+++++++.....       
T Consensus        22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~  100 (360)
T 3e3p_A           22 MDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPR-FRNRELQIMQDLAVLHHPNIVQLQSYFYTLGERDRRDIY  100 (360)
T ss_dssp             HTTEEEC----------CEEEEETTTCCEEEEEEEECCTT-CCCHHHHHHHHHHHHCCTTBCCEEEEEEEECSSCTTCEE
T ss_pred             ccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEecCcc-ccHHHHHHHHHHHhcCCCCcccHHHhhhcccccccccee
Confidence            34567778889999999999995 5688999999865432 23356678888899999999999999865433       


Q ss_pred             eEEEEecCCCCCHHhhhcc--CCCCCCCHHHHHHHHHHHHHHHHHhh--cCCCccccccCCCceeeCC-CCCeeeecccC
Q 020221          128 RLLVAEYMPNDTLAKHLFH--WETQPMKWAMRLRVALHIAEALEYCT--SKERALYHDLNAYRIVFDD-DVNPRLSCFGL  202 (329)
Q Consensus       128 ~~lv~e~~~~gsL~~~l~~--~~~~~~~~~~~~~i~~~i~~~l~~lH--~~~~ivH~dlkp~Nil~~~-~~~~kl~Dfg~  202 (329)
                      .++||||+++ +|...+..  .....+++..+..++.|++.||.|||  +. |++||||||+|||++. ++.+||+|||+
T Consensus       101 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~-~ivH~Dlkp~NIll~~~~~~~kl~Dfg~  178 (360)
T 3e3p_A          101 LNVVMEYVPD-TLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSV-NVCHRDIKPHNVLVNEADGTLKLCDFGS  178 (360)
T ss_dssp             EEEEEECCSC-BHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTSTTT-CCBCSCCCGGGEEEETTTTEEEECCCTT
T ss_pred             EEEEeecccc-cHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCCCC-CeecCcCCHHHEEEeCCCCcEEEeeCCC
Confidence            7899999987 55544432  24567899999999999999999999  88 9999999999999996 89999999999


Q ss_pred             cccCCCCC---CccCcccccCcccccCCC-CCCcccchhhhHHHHHHHhCCCCCCchhhHHHhhhchhhhccc-------
Q 020221          203 MKNSRDGR---SYSTNLAFTPPEYLRTGR-VTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDS-------  271 (329)
Q Consensus       203 a~~~~~~~---~~~~~~~y~aPE~~~~~~-~~~~~DvwslG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~-------  271 (329)
                      +.......   ...+|+.|+|||++.+.. ++.++||||||+++|+|++|..||..................+       
T Consensus       179 a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  258 (360)
T 3e3p_A          179 AKKLSPSEPNVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAGQLHEIVRVLGCPSREVLRK  258 (360)
T ss_dssp             CBCCCTTSCCCSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHH
T ss_pred             ceecCCCCCcccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCcCCCChHHHHHHHHHHcCCCCHHHHHh
Confidence            98755433   346789999999987655 8999999999999999999999887643322221111100000       


Q ss_pred             -------------------cccCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 020221          272 -------------------CLEGQFSSDEGTELVRLASRCLQYEPRERPNPRSLVT  308 (329)
Q Consensus       272 -------------------~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~~~l~  308 (329)
                                         ..........++++.+|+.+||+.||++|||+.++++
T Consensus       259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~  314 (360)
T 3e3p_A          259 LNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYEALC  314 (360)
T ss_dssp             HCTTCCCGGGGCCCCCCHHHHTTTCCCTTHHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred             cccchhhccccccccCCcccccchhhccccHHHHHHHHHHhccCccccCCHHHHhc
Confidence                               0001122235789999999999999999999999997

>2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens}

Probab=100.00  E-value=6.6e-45  Score=323.55  Aligned_cols=255  Identities=19%  Similarity=0.249  Sum_probs=200.8

Q ss_pred             CCCcccccccCCCCCCcEEEEEEeCCCCEEEEEEeCCCCC--hhHHHHHHHHHHHhcCCCccccccceeeeeCCeeEEEE
Q 020221           55 GFAMENIVSEHGEKAPNVVYKGKLENQFRIAVKRFNRSAW--PDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVA  132 (329)
Q Consensus        55 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~  132 (329)
                      .+..+++.+.||+|+||.||+|...+  .+|+|++.....  ...+.+.+|+.+++.++||||+++++++.+....+++|
T Consensus        31 ~~~~~~~~~~lg~G~~g~V~~~~~~~--~~avk~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~iv~  108 (319)
T 2y4i_B           31 PFEQLEIGELIGKGRFGQVYHGRWHG--EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMSPPHLAIIT  108 (319)
T ss_dssp             CCSCEECCCBCCCSSSSEEEEEEESS--SEEEEECCCCSCCCCCCCCCCTTGGGGTTCCCTTBCCCCEEEECSSCEEEEC
T ss_pred             CHHHeEEeeEeccCCceEEEEEEEcC--eEEEEEeecCCCCHHHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCceEEEe
Confidence            35667888999999999999999754  499999875432  22345778999999999999999999999999999999


Q ss_pred             ecCCCCCHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCCCCCeeeecccCcccCCC----
Q 020221          133 EYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRD----  208 (329)
Q Consensus       133 e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~----  208 (329)
                      ||+++++|.+++.. ....+++..+..++.|++.||.|||+. |++|+||||+||+++ ++.++|+|||++.....    
T Consensus       109 e~~~~~~L~~~l~~-~~~~~~~~~~~~i~~qi~~al~~lH~~-~i~H~dlkp~NIl~~-~~~~~l~Dfg~~~~~~~~~~~  185 (319)
T 2y4i_B          109 SLCKGRTLYSVVRD-AKIVLDVNKTRQIAQEIVKGMGYLHAK-GILHKDLKSKNVFYD-NGKVVITDFGLFSISGVLQAG  185 (319)
T ss_dssp             BCCCSEEHHHHTTS-SCCCCCSHHHHHHHHHHHHHHHHHHHT-TCCCCCCCSTTEEEC---CCEECCCSCCC--------
T ss_pred             ecccCCcHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHhC-CccccCCChhhEEEe-CCCEEEeecCCcccccccccc
Confidence            99999999999964 345689999999999999999999999 999999999999998 68999999999765421    


Q ss_pred             -----CCCccCcccccCcccccC---------CCCCCcccchhhhHHHHHHHhCCCCCCchhhHHHhhhchhhhcccccc
Q 020221          209 -----GRSYSTNLAFTPPEYLRT---------GRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLE  274 (329)
Q Consensus       209 -----~~~~~~~~~y~aPE~~~~---------~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~  274 (329)
                           .....+++.|+|||.+.+         ..++.++||||||+++|+|++|..||...................   
T Consensus       186 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~---  262 (319)
T 2y4i_B          186 RREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAEAIIWQMGTGMKPN---  262 (319)
T ss_dssp             --CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSCCHHHHHHHHHTTCCCC---
T ss_pred             ccccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhccCCCCC---
Confidence                 122357899999999874         347889999999999999999998886554333322221111111   


Q ss_pred             CCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhhccc
Q 020221          275 GQFSSDEGTELVRLASRCLQYEPRERPNPRSLVTALVTLQKDTE  318 (329)
Q Consensus       275 ~~~~~~~~~~~~~li~~cl~~dp~~Rps~~~~l~~L~~~~~~~~  318 (329)
                       ..+...+.++.+++.+||+.||++|||+.++++.|+.+.+...
T Consensus       263 -~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~l~~~~~  305 (319)
T 2y4i_B          263 -LSQIGMGKEISDILLFCWAFEQEERPTFTKLMDMLEKLPKRNR  305 (319)
T ss_dssp             -CCCSSCCTTHHHHHHHHHCSSTTTSCCHHHHHHHHTTC-----
T ss_pred             -CCcCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHhhc
Confidence             1122356679999999999999999999999999999987643

>1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ...

Probab=100.00  E-value=1.9e-45  Score=339.20  Aligned_cols=245  Identities=22%  Similarity=0.235  Sum_probs=190.8

Q ss_pred             cccccccCCCCCCcEEEEEEe-CCCCEEEEEEeCCCCChhHHHHHHHHHHHhcCCCccccccceeeeeC------CeeEE
Q 020221           58 MENIVSEHGEKAPNVVYKGKL-ENQFRIAVKRFNRSAWPDARQFLEEARAVGQLRNRRLANLLGCCCEG------DERLL  130 (329)
Q Consensus        58 ~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~------~~~~l  130 (329)
                      .|++++.||+|+||.||+|.. .+++.||||++.....    ...+|+++++.++||||+++++++...      ..+++
T Consensus        55 ~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~----~~~~E~~il~~l~hpniv~l~~~~~~~~~~~~~~~~~l  130 (420)
T 1j1b_A           55 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR----FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNL  130 (420)
T ss_dssp             EEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECCTT----SCCHHHHHHHTCCCTTBCCEEEEEEEEETTTTEEEEEE
T ss_pred             eEEeeeEEeeCCCEEEEEEEECCCCcEEEEEEecccch----hHHHHHHHHHHcCCCCccceeeEEeccCCCCcceeEEe
Confidence            477788889999999999995 5689999999875432    234699999999999999999988542      23679


Q ss_pred             EEecCCCCCHHhhhcc--CCCCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCCC-CCeeeecccCcccCC
Q 020221          131 VAEYMPNDTLAKHLFH--WETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDD-VNPRLSCFGLMKNSR  207 (329)
Q Consensus       131 v~e~~~~gsL~~~l~~--~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~-~~~kl~Dfg~a~~~~  207 (329)
                      ||||+++ +|.+.+..  .....+++..+..++.||+.||.|||+. ||+||||||+|||++.+ +.+||+|||+++...
T Consensus       131 v~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~-~ivHrDlkp~NILl~~~~~~~kl~DFG~a~~~~  208 (420)
T 1j1b_A          131 VLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSF-GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLV  208 (420)
T ss_dssp             EEECCCE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTT-TEECSCCSGGGEEEETTTTEEEECCCTTCEECC
T ss_pred             ehhcccc-cHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHC-CccccCCChhhEEEeCCCCeEEeccchhhhhcc
Confidence            9999986 66665542  1356799999999999999999999999 99999999999999965 568999999998654


Q ss_pred             CC---CCccCcccccCcccccCC-CCCCcccchhhhHHHHHHHhCCCCCCchhhHHHhhhchh-----------hhcccc
Q 020221          208 DG---RSYSTNLAFTPPEYLRTG-RVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQ-----------TLTDSC  272 (329)
Q Consensus       208 ~~---~~~~~~~~y~aPE~~~~~-~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~~~~~~~-----------~~~~~~  272 (329)
                      ..   ....+|+.|+|||++.+. .++.++|||||||++|||++|+.||..............           ......
T Consensus       209 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~l~~i~~~lg~p~~~~~~~~~~~~  288 (420)
T 1j1b_A          209 RGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNY  288 (420)
T ss_dssp             TTCCCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHHHHHCSCC
T ss_pred             cCCCceeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhhChhh
Confidence            33   345689999999998765 689999999999999999999998876432111111110           000000


Q ss_pred             ------------ccCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 020221          273 ------------LEGQFSSDEGTELVRLASRCLQYEPRERPNPRSLVT  308 (329)
Q Consensus       273 ------------~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~~~l~  308 (329)
                                  +...++...++++.+|+.+||..||++|||+.++++
T Consensus       289 ~~~~~p~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~R~t~~e~l~  336 (420)
T 1j1b_A          289 TEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACA  336 (420)
T ss_dssp             CCCCCCCCCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             hhhccCccCCCCHHHhcCCCCCHHHHHHHHHhccCChhHCCCHHHHhC
Confidence                        000122345789999999999999999999999996

>4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis}

Probab=100.00  E-value=2.9e-45  Score=335.37  Aligned_cols=245  Identities=19%  Similarity=0.209  Sum_probs=191.2

Q ss_pred             cccccccCCCCCCcEEEEEEeCCCCEEEEEEeCCCCChhHHHHHHHHHHHhcCCCccccccceeeeeCC------eeEEE
Q 020221           58 MENIVSEHGEKAPNVVYKGKLENQFRIAVKRFNRSAWPDARQFLEEARAVGQLRNRRLANLLGCCCEGD------ERLLV  131 (329)
Q Consensus        58 ~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~------~~~lv  131 (329)
                      .|.+++.||+|+||+||+|....+..+|+|++......    ..+|+++++.++||||+++++++....      ..++|
T Consensus        41 ~Y~~~~~lG~G~~g~V~~a~~~~~~~~aikk~~~~~~~----~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~~lv  116 (394)
T 4e7w_A           41 AYTNCKVIGNGSFGVVFQAKLVESDEVAIKKVLQDKRF----KNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFLNLV  116 (394)
T ss_dssp             EEEEEEEEEEETTEEEEEEEETTTEEEEEEEEECCTTS----CCHHHHHHHTCCCTTBCCEEEEEEEESSSSSCEEEEEE
T ss_pred             eEEEeEEEeeCCCeEEEEEEECCCCeEEEEEEecCcch----HHHHHHHHHhCCCCCcceEEEEEEecCCCCCceEEEEE
Confidence            47788889999999999999766667999988654322    236999999999999999999985543      37899


Q ss_pred             EecCCCCCHHhhhcc--CCCCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeC-CCCCeeeecccCcccCCC
Q 020221          132 AEYMPNDTLAKHLFH--WETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFD-DDVNPRLSCFGLMKNSRD  208 (329)
Q Consensus       132 ~e~~~~gsL~~~l~~--~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~-~~~~~kl~Dfg~a~~~~~  208 (329)
                      |||++++ +...+..  .....+++..+..++.||+.||+|||+. ||+||||||+|||++ .++.+||+|||+++....
T Consensus       117 ~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~-~ivHrDlkp~Nill~~~~~~~kL~DFG~a~~~~~  194 (394)
T 4e7w_A          117 LEYVPET-VYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSI-GICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIA  194 (394)
T ss_dssp             EECCSEE-HHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHT-TEECSCCSGGGEEEETTTTEEEECCCTTCEECCT
T ss_pred             eeccCcc-HHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHC-CccCCCCCHHHEEEcCCCCcEEEeeCCCcccccC
Confidence            9999875 4443321  1356799999999999999999999999 999999999999999 799999999999976543


Q ss_pred             C---CCccCcccccCcccccCC-CCCCcccchhhhHHHHHHHhCCCCCCchhhHHHhhhchhh---------------hc
Q 020221          209 G---RSYSTNLAFTPPEYLRTG-RVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQT---------------LT  269 (329)
Q Consensus       209 ~---~~~~~~~~y~aPE~~~~~-~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~~~~~~~~---------------~~  269 (329)
                      .   ....+|+.|+|||++.+. .++.++||||||+++|||++|..||...............               ..
T Consensus       195 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~  274 (394)
T 4e7w_A          195 GEPNVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGIDQLVEIIKVLGTPSREQIKTMNPNYM  274 (394)
T ss_dssp             TCCCCSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCGGGS
T ss_pred             CCCCcccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhhChhhh
Confidence            3   345679999999998765 4899999999999999999999988765322111111100               00


Q ss_pred             ccc--------ccCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 020221          270 DSC--------LEGQFSSDEGTELVRLASRCLQYEPRERPNPRSLVT  308 (329)
Q Consensus       270 ~~~--------~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~~~l~  308 (329)
                      ...        +...++...++++.+|+.+||+.||++|||+.++++
T Consensus       275 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~  321 (394)
T 4e7w_A          275 EHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALC  321 (394)
T ss_dssp             SSCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred             hhccccccCCcHHHhccccCCHHHHHHHHHHhCCChhhCCCHHHHhc
Confidence            000        000122346789999999999999999999999997

>3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A*

Probab=100.00  E-value=3.6e-45  Score=327.93  Aligned_cols=246  Identities=15%  Similarity=0.147  Sum_probs=172.9

Q ss_pred             cccccc-cCCCCCCcEEEEEEe-CCCCEEEEEEeCCCCChhHHHHHHHHHHHhcCCCccccccceeeee----CCeeEEE
Q 020221           58 MENIVS-EHGEKAPNVVYKGKL-ENQFRIAVKRFNRSAWPDARQFLEEARAVGQLRNRRLANLLGCCCE----GDERLLV  131 (329)
Q Consensus        58 ~~~~~~-~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~----~~~~~lv  131 (329)
                      .|.+++ .||+|+||+||+|.. .+++.||+|++....    .........++.++||||+++++++..    ....++|
T Consensus        29 ~y~i~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~lv  104 (336)
T 3fhr_A           29 DYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDSP----KARQEVDHHWQASGGPHIVCILDVYENMHHGKRCLLII  104 (336)
T ss_dssp             TEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESSH----HHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEEE
T ss_pred             eeEecceeeeeCCCeEEEEEEECCCCCEEEEEEecCcH----HHHHHHHHHHHhcCCCChHHHHHHHhhccCCCceEEEE
Confidence            356654 479999999999995 478999999986532    122223334666799999999999876    4558999


Q ss_pred             EecCCCCCHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCC---CCCeeeecccCcccCCC
Q 020221          132 AEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDD---DVNPRLSCFGLMKNSRD  208 (329)
Q Consensus       132 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~---~~~~kl~Dfg~a~~~~~  208 (329)
                      |||+++|+|.+++.......+++..++.++.|++.||.|||++ |++||||||+||+++.   ++.+||+|||++.....
T Consensus       105 ~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~-~ivH~dlkp~NIll~~~~~~~~~kl~Dfg~~~~~~~  183 (336)
T 3fhr_A          105 MECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLHSH-NIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQ  183 (336)
T ss_dssp             EECCTTEEHHHHHHTC-CCCCBHHHHHHHHHHHHHHHHHHHHT-TEECSCCSGGGEEESCSSTTCCEEECCCTTCEEC--
T ss_pred             EeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhC-CeecCCCCHHHEEEEecCCCceEEEeccccceeccc
Confidence            9999999999999865556799999999999999999999999 9999999999999976   45599999999976543


Q ss_pred             C--CCccCcccccCcccccCCCCCCcccchhhhHHHHHHHhCCCCCCchhhHHHhhhchhhhccc--cccCCCChHHHHH
Q 020221          209 G--RSYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDS--CLEGQFSSDEGTE  284 (329)
Q Consensus       209 ~--~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~  284 (329)
                      .  ....+|+.|+|||++.+..++.++||||||+++|+|++|..||...................  ..........+++
T Consensus       184 ~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  263 (336)
T 3fhr_A          184 NALQTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISPGMKRRIRLGQYGFPNPEWSEVSED  263 (336)
T ss_dssp             --------------------CHHHHHHHHHHHHHHHHHHHHSSCCC---------------------CCCTTTSTTCCHH
T ss_pred             cccccCCCCcCccChhhhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCccchhhhhhHHHhhhccccccCchhhccCCHH
Confidence            3  34467899999999988889999999999999999999998886543322211111111111  1111122456788


Q ss_pred             HHHHHHHhcccCCCCCCCHHHHHH
Q 020221          285 LVRLASRCLQYEPRERPNPRSLVT  308 (329)
Q Consensus       285 ~~~li~~cl~~dp~~Rps~~~~l~  308 (329)
                      +.+++.+||+.||++|||+.++++
T Consensus       264 ~~~li~~~L~~dP~~Rpt~~ell~  287 (336)
T 3fhr_A          264 AKQLIRLLLKTDPTERLTITQFMN  287 (336)
T ss_dssp             HHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred             HHHHHHHHCCCChhHCcCHHHHhc
Confidence            999999999999999999999998

>2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A*

Probab=100.00  E-value=2.7e-44  Score=323.91  Aligned_cols=249  Identities=16%  Similarity=0.143  Sum_probs=199.1

Q ss_pred             CcccccccCCCCCCcEEEEEEe-CCC-CEEEEEEeCCCCChhHHHHHHHHHHHhcCCCcc------ccccceeeeeCCee
Q 020221           57 AMENIVSEHGEKAPNVVYKGKL-ENQ-FRIAVKRFNRSAWPDARQFLEEARAVGQLRNRR------LANLLGCCCEGDER  128 (329)
Q Consensus        57 ~~~~~~~~lg~G~~g~V~~~~~-~~~-~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~n------iv~~~~~~~~~~~~  128 (329)
                      ..|++++.||+|+||+||++.. .++ +.||+|+++... ...+.+.+|+.+++.++|++      ++.+.+++...+..
T Consensus        19 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~   97 (355)
T 2eu9_A           19 ERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNVG-KYREAARLEINVLKKIKEKDKENKFLCVLMSDWFNFHGHM   97 (355)
T ss_dssp             TTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSCH-HHHHHHHHHHHHHHHHHHHCTTSCSCBCCEEEEEEETTEE
T ss_pred             ccEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEcccc-cchhHHHHHHHHHHHHhhcCCCCceeEEEeeeeeeeCCeE
Confidence            4578888899999999999984 344 689999997543 33556888999999997766      88899999999999


Q ss_pred             EEEEecCCCCCHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceee-------------------
Q 020221          129 LLVAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVF-------------------  189 (329)
Q Consensus       129 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~-------------------  189 (329)
                      ++||||+ +++|.+++.......+++..+..++.||+.||.|||++ ||+||||||+|||+                   
T Consensus        98 ~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~-~ivH~Dlkp~NIll~~~~~~~~~~~~~~~~~~~  175 (355)
T 2eu9_A           98 CIAFELL-GKNTFEFLKENNFQPYPLPHVRHMAYQLCHALRFLHEN-QLTHTDLKPENILFVNSEFETLYNEHKSCEEKS  175 (355)
T ss_dssp             EEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHTT-TEECCCCCGGGEEESCCCEEEEECCC-CCCEEE
T ss_pred             EEEEecc-CCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHC-CcccCCCCHHHEEEecccccccccccccccccc
Confidence            9999999 56787777654556799999999999999999999999 99999999999999                   


Q ss_pred             CCCCCeeeecccCcccCCCC-CCccCcccccCcccccCCCCCCcccchhhhHHHHHHHhCCCCCCchhhHHHhhhchhhh
Q 020221          190 DDDVNPRLSCFGLMKNSRDG-RSYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTL  268 (329)
Q Consensus       190 ~~~~~~kl~Dfg~a~~~~~~-~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~~~~~~~~~  268 (329)
                      +.++.+||+|||++...... ....+|+.|+|||++.+..++.++||||||+++|||++|..||................
T Consensus       176 ~~~~~~kl~Dfg~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~  255 (355)
T 2eu9_A          176 VKNTSIRVADFGSATFDHEHHTTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRGFTLFQTHENREHLVMMEKIL  255 (355)
T ss_dssp             ESCCCEEECCCTTCEETTSCCCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHH
T ss_pred             cCCCcEEEeecCccccccccccCCcCCCcccCCeeeecCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHc
Confidence            56789999999999865443 34578999999999999899999999999999999999999886543221111000000


Q ss_pred             -------------------------------------cccc-ccCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 020221          269 -------------------------------------TDSC-LEGQFSSDEGTELVRLASRCLQYEPRERPNPRSLVT  308 (329)
Q Consensus       269 -------------------------------------~~~~-~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~~~l~  308 (329)
                                                           .... .........+.++.+|+.+||+.||++|||+.++++
T Consensus       256 ~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l~  333 (355)
T 2eu9_A          256 GPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQLFDLMRRMLEFDPAQRITLAEALL  333 (355)
T ss_dssp             CCCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred             CCCcHHHhhhccchhhhcccccccccccchhccccccCCcccccccccchhHHHHHHHHHHHhcCChhhCcCHHHHhc
Confidence                                                 0000 000122345778999999999999999999999997

>3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens}

Probab=100.00  E-value=2e-44  Score=331.06  Aligned_cols=246  Identities=15%  Similarity=0.219  Sum_probs=179.3

Q ss_pred             cccc-ccCCCCCCcEEEEEEeC---CCCEEEEEEeCCCCChhHHHHHHHHHHHhcCCCccccccceeeee--CCeeEEEE
Q 020221           59 ENIV-SEHGEKAPNVVYKGKLE---NQFRIAVKRFNRSAWPDARQFLEEARAVGQLRNRRLANLLGCCCE--GDERLLVA  132 (329)
Q Consensus        59 ~~~~-~~lg~G~~g~V~~~~~~---~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~--~~~~~lv~  132 (329)
                      |++. +.||+|+||+||+|...   +++.||+|++.....  ...+.+|+.+++.++||||+++++++..  ....++||
T Consensus        22 y~~~g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~~--~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~lv~   99 (405)
T 3rgf_A           22 FEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGI--SMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLF   99 (405)
T ss_dssp             EECSSCCCC-----EEEEEEESSSSCCCCEEEEECSSSSC--CHHHHHHHHHHHHCCCTTBCCCCEEEEETTTTEEEEEE
T ss_pred             hhhcCcEeeecCCeEEEEEEEccCCCCeEEEEEEECCCCC--CHHHHHHHHHHHhcCCCCeeeEeeEEecCCCCeEEEEE
Confidence            3443 36899999999999954   578899999976543  3467899999999999999999999954  67899999


Q ss_pred             ecCCCCCHHhhhccC-------CCCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceee----CCCCCeeeeccc
Q 020221          133 EYMPNDTLAKHLFHW-------ETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVF----DDDVNPRLSCFG  201 (329)
Q Consensus       133 e~~~~gsL~~~l~~~-------~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~----~~~~~~kl~Dfg  201 (329)
                      ||+.+ +|.+++...       ....+++..++.++.||+.||.|||+. +|+||||||+|||+    +.++.+||+|||
T Consensus       100 e~~~~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~-~ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg  177 (405)
T 3rgf_A          100 DYAEH-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHAN-WVLHRDLKPANILVMGEGPERGRVKIADMG  177 (405)
T ss_dssp             ECCSE-EHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHHT-TCCCCCCCGGGEEECCSSTTTTCEEECCTT
T ss_pred             eCCCC-CHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHhC-CEeCCCcCHHHeEEecCCCCCCcEEEEECC
Confidence            99975 788877521       123589999999999999999999999 99999999999999    678999999999


Q ss_pred             CcccCCCC-------CCccCcccccCcccccCCC-CCCcccchhhhHHHHHHHhCCCCCCchhhHH---------Hhhhc
Q 020221          202 LMKNSRDG-------RSYSTNLAFTPPEYLRTGR-VTPESVMYSFGTLLLDLLSGKHIPPSHALDL---------IRDRN  264 (329)
Q Consensus       202 ~a~~~~~~-------~~~~~~~~y~aPE~~~~~~-~~~~~DvwslG~il~el~tg~~~~~~~~~~~---------~~~~~  264 (329)
                      ++......       ....||+.|+|||++.+.. ++.++|||||||++|+|++|..||.....+.         .....
T Consensus       178 ~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~l~~i  257 (405)
T 3rgf_A          178 FARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRI  257 (405)
T ss_dssp             CCC----------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHHSSCTTCCCC------CCCCHHHHHHH
T ss_pred             CceecCCCCcccccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHHHhCCCCCCCccccccccccchHHHHHHH
Confidence            99865432       2356799999999998754 8999999999999999999998885432110         00000


Q ss_pred             hhh------------------------hccccccC--------CCChHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 020221          265 IQT------------------------LTDSCLEG--------QFSSDEGTELVRLASRCLQYEPRERPNPRSLVT  308 (329)
Q Consensus       265 ~~~------------------------~~~~~~~~--------~~~~~~~~~~~~li~~cl~~dp~~Rps~~~~l~  308 (329)
                      ...                        ........        ......++++.+|+.+||..||++|||+.++++
T Consensus       258 ~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ll~~~L~~dP~~R~ta~e~L~  333 (405)
T 3rgf_A          258 FNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQAMQ  333 (405)
T ss_dssp             HHHHCCCCTTTCGGGGGSTTHHHHHHHCCGGGGTTCCHHHHHHTTTCCTTSHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             HHhhCCCChhhcchhhcCcchhhhhhhccccCCCcchhhhhHhhcCCCCCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence            000                        00000000        000111567899999999999999999999998

>3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens}

Probab=100.00  E-value=4.1e-44  Score=323.17  Aligned_cols=246  Identities=15%  Similarity=0.194  Sum_probs=194.4

Q ss_pred             CcccccccCCCCCCcEEEEEEe-CCCCEEEEEEeCCCCCh--hHHHHHHHHHHHhcCCCccccccceeeeeCCe------
Q 020221           57 AMENIVSEHGEKAPNVVYKGKL-ENQFRIAVKRFNRSAWP--DARQFLEEARAVGQLRNRRLANLLGCCCEGDE------  127 (329)
Q Consensus        57 ~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~--~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~------  127 (329)
                      ..|.+.+.||+|+||.||+|.. .+|+.||||++......  ..+.+.+|+.+++.++||||+++++++.....      
T Consensus        24 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~  103 (353)
T 3coi_A           24 KTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFYD  103 (353)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEESSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCCC
T ss_pred             ceEEEeeeEecCCCeEEEEEEECCCCCEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCcccHhheEeccccccccee
Confidence            3467778889999999999994 57899999999765422  24568899999999999999999999977654      


Q ss_pred             eEEEEecCCCCCHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCCCCCeeeecccCcccCC
Q 020221          128 RLLVAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSR  207 (329)
Q Consensus       128 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~  207 (329)
                      .++||||+. ++|.+++.    ..+++..+..++.||+.||.|||++ |++||||||+||+++.++.+||+|||++....
T Consensus       104 ~~lv~e~~~-~~l~~~~~----~~~~~~~~~~i~~qi~~al~~LH~~-~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~  177 (353)
T 3coi_A          104 FYLVMPFMQ-TDLQKIMG----LKFSEEKIQYLVYQMLKGLKYIHSA-GVVHRDLKPGNLAVNEDCELKILDFGLARHAD  177 (353)
T ss_dssp             CEEEEECCS-EEGGGTTT----SCCCHHHHHHHHHHHHHHHHHHHHT-TCCCSSCCGGGEEECTTCCEEECSTTCTTC--
T ss_pred             EEEEecccc-CCHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC-CcccCCCCHHHEeECCCCcEEEeecccccCCC
Confidence            499999997 58888773    3599999999999999999999999 99999999999999999999999999998654


Q ss_pred             CC-CCccCcccccCcccccC-CCCCCcccchhhhHHHHHHHhCCCCCCchhhHHHhhhchhh------------------
Q 020221          208 DG-RSYSTNLAFTPPEYLRT-GRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQT------------------  267 (329)
Q Consensus       208 ~~-~~~~~~~~y~aPE~~~~-~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~~~~~~~~------------------  267 (329)
                      .. ....+|+.|+|||++.+ ..++.++||||||+++|+|++|..||...............                  
T Consensus       178 ~~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~  257 (353)
T 3coi_A          178 AEMTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQKLNDKAAK  257 (353)
T ss_dssp             ------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSBSSCHHHHHHHHHHHHCBCCHHHHTTCSCHHHH
T ss_pred             CCccccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHHhhHHHH
Confidence            33 33467899999999887 56899999999999999999999888654322111110000                  


Q ss_pred             -h---cccccc---CCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 020221          268 -L---TDSCLE---GQFSSDEGTELVRLASRCLQYEPRERPNPRSLVT  308 (329)
Q Consensus       268 -~---~~~~~~---~~~~~~~~~~~~~li~~cl~~dp~~Rps~~~~l~  308 (329)
                       .   ......   .......++++.+++.+||..||++|||+.++++
T Consensus       258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~  305 (353)
T 3coi_A          258 SYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALT  305 (353)
T ss_dssp             HHHHTSCBCSSCCTTTTCTTSCHHHHHHHHHHSCSCTTTSCCHHHHHT
T ss_pred             HHHHhCcCCCCccHHHhcCCcCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence             0   000000   1122356789999999999999999999999997

>2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A*

Probab=100.00  E-value=2.1e-44  Score=315.84  Aligned_cols=246  Identities=18%  Similarity=0.181  Sum_probs=200.7

Q ss_pred             CcccccccCCCCCCcEEEEEEe-CCCCEEEEEEeCCCC--ChhHHHHHHHHHHHhcCCCccccccceeeeeCCeeEEEEe
Q 020221           57 AMENIVSEHGEKAPNVVYKGKL-ENQFRIAVKRFNRSA--WPDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAE  133 (329)
Q Consensus        57 ~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  133 (329)
                      ..|++++.||+|+||.||++.. .+++.||+|++....  ....+.+.+|+++++.++||||+++++++......++|+|
T Consensus        22 ~~y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e  101 (287)
T 2wei_A           22 ERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVGE  101 (287)
T ss_dssp             HHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBSSSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred             hcceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHHHHHHHhccCCCccEEEEEEeCCCeEEEEEE
Confidence            3577888889999999999995 478899999986542  2346678999999999999999999999999999999999


Q ss_pred             cCCCCCHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCCC---CCeeeecccCcccCCCCC
Q 020221          134 YMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDD---VNPRLSCFGLMKNSRDGR  210 (329)
Q Consensus       134 ~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~---~~~kl~Dfg~a~~~~~~~  210 (329)
                      |+++++|.+++..  ...+++..++.++.|++.||.|||++ |++|+||||+||+++.+   +.+||+|||++.......
T Consensus       102 ~~~~~~L~~~l~~--~~~~~~~~~~~i~~qi~~~l~~LH~~-~i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~~~~~~~~~  178 (287)
T 2wei_A          102 LYTGGELFDEIIK--RKRFSEHDAARIIKQVFSGITYMHKH-NIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNT  178 (287)
T ss_dssp             CCCSCBHHHHHHH--HSSCCHHHHHHHHHHHHHHHHHHHHT-TCCCSCCCGGGEEESCSSTTCCEEECSTTGGGTBCCCS
T ss_pred             ccCCCCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHC-CeeccCCChhhEEEecCCCcccEEEeccCcceeecCCC
Confidence            9999999998863  35689999999999999999999999 99999999999999754   469999999987655433


Q ss_pred             ---CccCcccccCcccccCCCCCCcccchhhhHHHHHHHhCCCCCCchhhHHHhhhchhhhccccccCCCChHHHHHHHH
Q 020221          211 ---SYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVR  287 (329)
Q Consensus       211 ---~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  287 (329)
                         ...+++.|+|||.+.+ .++.++||||||+++|+|++|..||...................  ........++++.+
T Consensus       179 ~~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~  255 (287)
T 2wei_A          179 KMKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAF--DLPQWRTISDDAKD  255 (287)
T ss_dssp             SCSCHHHHHTTCCHHHHTT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCC--CSGGGTTSCHHHHH
T ss_pred             ccccccCcccccChHHhcC-CCCCchhhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCC--CchhhhhcCHHHHH
Confidence               2346889999999875 48899999999999999999998886544332222211111100  00011345678999


Q ss_pred             HHHHhcccCCCCCCCHHHHHH
Q 020221          288 LASRCLQYEPRERPNPRSLVT  308 (329)
Q Consensus       288 li~~cl~~dp~~Rps~~~~l~  308 (329)
                      ++.+||+.||++|||+.++++
T Consensus       256 li~~~l~~dp~~Rps~~ell~  276 (287)
T 2wei_A          256 LIRKMLTFHPSLRITATQCLE  276 (287)
T ss_dssp             HHHHHTCSSGGGSCCHHHHHH
T ss_pred             HHHHHcccChhhCcCHHHHhc
Confidence            999999999999999999998

>2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A*

Probab=100.00  E-value=2.2e-44  Score=348.52  Aligned_cols=252  Identities=20%  Similarity=0.266  Sum_probs=206.2

Q ss_pred             CcccccccCCCCCCcEEEEEEeC----CCCEEEEEEeCCCCCh-hHHHHHHHHHHHhcCCCccccccceeeeeCCeeEEE
Q 020221           57 AMENIVSEHGEKAPNVVYKGKLE----NQFRIAVKRFNRSAWP-DARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLV  131 (329)
Q Consensus        57 ~~~~~~~~lg~G~~g~V~~~~~~----~~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv  131 (329)
                      ..+++.+.||+|+||.||+|...    .+..||+|.+...... ..+.+.+|+.+++.++||||+++++++. .+..++|
T Consensus       390 ~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~~~~lv  468 (656)
T 2j0j_A          390 ERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVWII  468 (656)
T ss_dssp             GGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSSTTCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSSCEEE
T ss_pred             ccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEe-cCceEEE
Confidence            44677788999999999999853    2457999998765433 3467899999999999999999999984 5678999


Q ss_pred             EecCCCCCHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCCCCCeeeecccCcccCCCCC-
Q 020221          132 AEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDGR-  210 (329)
Q Consensus       132 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~-  210 (329)
                      |||+++|+|.+++.. ....+++..+..++.|++.||.|||++ |++||||||+|||++.++.+||+|||++....... 
T Consensus       469 ~E~~~~g~L~~~l~~-~~~~l~~~~~~~i~~qi~~aL~~LH~~-givHrDikp~NILl~~~~~vkL~DFG~a~~~~~~~~  546 (656)
T 2j0j_A          469 MELCTLGELRSFLQV-RKFSLDLASLILYAYQLSTALAYLESK-RFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTY  546 (656)
T ss_dssp             EECCTTCBHHHHHHH-TTTTCCHHHHHHHHHHHHHHHHHHHHT-TCCCSCCSGGGEEEEETTEEEECCCCCCCSCCC---
T ss_pred             EEcCCCCcHHHHHHh-ccCCCCHHHHHHHHHHHHHHHHHHHhC-CccccccchHhEEEeCCCCEEEEecCCCeecCCCcc
Confidence            999999999999965 345689999999999999999999999 99999999999999999999999999998765432 


Q ss_pred             ----CccCcccccCcccccCCCCCCcccchhhhHHHHHHHh-CCCCCCchhhHHHhhhchhhhccccccCCCChHHHHHH
Q 020221          211 ----SYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLS-GKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTEL  285 (329)
Q Consensus       211 ----~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t-g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  285 (329)
                          ...+++.|+|||++.+..++.++||||||+++|||++ |..||..............     ......+..+++++
T Consensus       547 ~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~~~~~i~~-----~~~~~~~~~~~~~l  621 (656)
T 2j0j_A          547 YKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIEN-----GERLPMPPNCPPTL  621 (656)
T ss_dssp             -------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHH-----TCCCCCCTTCCHHH
T ss_pred             eeccCCCCCcceeCHHHhcCCCCCchhhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHc-----CCCCCCCccccHHH
Confidence                2345678999999998899999999999999999997 7777764433222211111     11223456677899


Q ss_pred             HHHHHHhcccCCCCCCCHHHHHHHHHhhhhc
Q 020221          286 VRLASRCLQYEPRERPNPRSLVTALVTLQKD  316 (329)
Q Consensus       286 ~~li~~cl~~dp~~Rps~~~~l~~L~~~~~~  316 (329)
                      .+++.+||+.||++|||+.++++.|+.+.+.
T Consensus       622 ~~li~~~l~~dP~~RPs~~el~~~L~~il~~  652 (656)
T 2j0j_A          622 YSLMTKCWAYDPSRRPRFTELKAQLSTILEE  652 (656)
T ss_dssp             HHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             HHHHHHHcCCChhHCcCHHHHHHHHHHHHHH
Confidence            9999999999999999999999999998654

>3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A*

Probab=100.00  E-value=9.1e-45  Score=323.96  Aligned_cols=251  Identities=16%  Similarity=0.193  Sum_probs=180.0

Q ss_pred             CCcccccccCCCCCCcEEEEEEe-CCCCEEEEEEeCCCCCh-hHHHHHHHHH-HHhcCCCccccccceeeeeCCeeEEEE
Q 020221           56 FAMENIVSEHGEKAPNVVYKGKL-ENQFRIAVKRFNRSAWP-DARQFLEEAR-AVGQLRNRRLANLLGCCCEGDERLLVA  132 (329)
Q Consensus        56 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~-~~~~~~~e~~-~l~~l~h~niv~~~~~~~~~~~~~lv~  132 (329)
                      ...|++++.||+|+||.||++.. .+++.||+|++...... ....+..|+. +++.++||||+++++++...+..++||
T Consensus        21 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~h~niv~~~~~~~~~~~~~lv~  100 (327)
T 3aln_A           21 AEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGALFREGDCWICM  100 (327)
T ss_dssp             SCSEEC-CEEEECSSEEEEEEEETTTTEEEEEEEEECCCCHHHHHHHHHHHHHHHSSCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             HHHhhehheeccCCCEEEEEEEEcCCCCEEEEEEeecccCchHHHHHHHHHHHHHHcCCCCcEeeeeeEEEeCCceEEEE
Confidence            35677888899999999999995 57889999999765432 2345566666 677789999999999999999999999


Q ss_pred             ecCCCCCHHhhhcc---CCCCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCCCCCeeeecccCcccCCCC
Q 020221          133 EYMPNDTLAKHLFH---WETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDG  209 (329)
Q Consensus       133 e~~~~gsL~~~l~~---~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~  209 (329)
                      ||+.+ +|.+++..   .....+++..+..++.|++.||.|||+..|++|+||||+||+++.++.+||+|||++......
T Consensus       101 e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~  179 (327)
T 3aln_A          101 ELMST-SFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENLKIIHRDIKPSNILLDRSGNIKLCDFGISGQLVDS  179 (327)
T ss_dssp             CCCSE-EHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHHHSCCCSCCCGGGEEEETTTEEEECCCSSSCC----
T ss_pred             eecCC-ChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhccCCEeECCCCHHHEEEcCCCCEEEccCCCceecccc
Confidence            99986 78777642   235678999999999999999999998548999999999999999999999999999765443


Q ss_pred             C---CccCcccccCcccc----cCCCCCCcccchhhhHHHHHHHhCCCCCCchhhHH-HhhhchhhhccccccCCCChHH
Q 020221          210 R---SYSTNLAFTPPEYL----RTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDL-IRDRNIQTLTDSCLEGQFSSDE  281 (329)
Q Consensus       210 ~---~~~~~~~y~aPE~~----~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~  281 (329)
                      .   ...+++.|+|||++    .+..++.++||||||+++|+|++|..||....... ........ ..+..........
T Consensus       180 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~  258 (327)
T 3aln_A          180 IAKTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVFDQLTQVVKG-DPPQLSNSEEREF  258 (327)
T ss_dssp             --------------------------CCSHHHHHHHHHHHHHHHHSCCCSSCC-------CCCCCS-CCCCCCCCSSCCC
T ss_pred             cccccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCCCCCCCcchHHHHHHHHhcC-CCCCCCCcccccC
Confidence            2   23678999999998    45568999999999999999999998886432110 00011110 0111111122346


Q ss_pred             HHHHHHHHHHhcccCCCCCCCHHHHHH
Q 020221          282 GTELVRLASRCLQYEPRERPNPRSLVT  308 (329)
Q Consensus       282 ~~~~~~li~~cl~~dp~~Rps~~~~l~  308 (329)
                      ++++.+++.+||+.||++|||+.++++
T Consensus       259 ~~~l~~li~~~l~~dp~~Rps~~ell~  285 (327)
T 3aln_A          259 SPSFINFVNLCLTKDESKRPKYKELLK  285 (327)
T ss_dssp             CHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred             CHHHHHHHHHHhhCChhhCcCHHHHHh
Confidence            788999999999999999999999986

>3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A*

Probab=100.00  E-value=1.3e-44  Score=321.08  Aligned_cols=244  Identities=18%  Similarity=0.241  Sum_probs=196.2

Q ss_pred             CcccccccCCCCCCcEEEEEEeCCCCEEEEEEeCCCCC--hhHHHHHHHHHHHhcCC--CccccccceeeeeCCeeEEEE
Q 020221           57 AMENIVSEHGEKAPNVVYKGKLENQFRIAVKRFNRSAW--PDARQFLEEARAVGQLR--NRRLANLLGCCCEGDERLLVA  132 (329)
Q Consensus        57 ~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~--h~niv~~~~~~~~~~~~~lv~  132 (329)
                      ..|++++.||+|+||.||++...+++.||+|++.....  ...+.+.+|+++++.++  |+||+++++++......+++|
T Consensus        28 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~lv~  107 (313)
T 3cek_A           28 RIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVM  107 (313)
T ss_dssp             EEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECSSCCHHHHHHHHHHHHHHHHHGGGCTTBCCEEEEEECSSEEEEEE
T ss_pred             ceEEEEEEecCCCCEEEEEEEcCCCcEEEEEEeccccccccchHHHHHHHHHHHhccccCCceEEEEEEeecCCEEEEEE
Confidence            45778888999999999999987889999999975432  33567899999999997  599999999999999999999


Q ss_pred             ecCCCCCHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCCCCCeeeecccCcccCCCCC--
Q 020221          133 EYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDGR--  210 (329)
Q Consensus       133 e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~--  210 (329)
                      | +.+++|.+++..  ...+++..+..++.|++.||.|||+. +++|+||||+||++++ +.+||+|||++.......  
T Consensus       108 e-~~~~~L~~~l~~--~~~~~~~~~~~i~~qi~~aL~~LH~~-~ivH~dlkp~NIl~~~-~~~kL~Dfg~~~~~~~~~~~  182 (313)
T 3cek_A          108 E-CGNIDLNSWLKK--KKSIDPWERKSYWKNMLEAVHTIHQH-GIVHSDLKPANFLIVD-GMLKLIDFGIANQMQPDTTS  182 (313)
T ss_dssp             C-CCSEEHHHHHHH--CSSCCHHHHHHHHHHHHHHHHHHHHT-TCCCCCCCGGGEEEET-TEEEECCCSSSCC-------
T ss_pred             e-cCCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHC-CceecCCCcccEEEEC-CeEEEeeccccccccCcccc
Confidence            9 567899999974  45789999999999999999999999 9999999999999974 899999999998654332  


Q ss_pred             ----CccCcccccCcccccC-----------CCCCCcccchhhhHHHHHHHhCCCCCCchhhHHHhhhchhhhccccccC
Q 020221          211 ----SYSTNLAFTPPEYLRT-----------GRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEG  275 (329)
Q Consensus       211 ----~~~~~~~y~aPE~~~~-----------~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~  275 (329)
                          ...+++.|+|||.+.+           ..++.++||||||+++|+|++|..||........   ............
T Consensus       183 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~---~~~~~~~~~~~~  259 (313)
T 3cek_A          183 VVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQIS---KLHAIIDPNHEI  259 (313)
T ss_dssp             -------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHH---HHHHHHCTTSCC
T ss_pred             ccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhhHHHHHH---HHHHHHhccccc
Confidence                3457899999999875           4688899999999999999999988754321111   111122222222


Q ss_pred             CCChHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 020221          276 QFSSDEGTELVRLASRCLQYEPRERPNPRSLVT  308 (329)
Q Consensus       276 ~~~~~~~~~~~~li~~cl~~dp~~Rps~~~~l~  308 (329)
                      ..+...+.++.+++.+||+.||++|||+.++++
T Consensus       260 ~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~  292 (313)
T 3cek_A          260 EFPDIPEKDLQDVLKCCLKRDPKQRISIPELLA  292 (313)
T ss_dssp             CCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             CCcccchHHHHHHHHHHccCCcccCcCHHHHhc
Confidence            344445678999999999999999999999997

>1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A

Probab=100.00  E-value=8.9e-45  Score=329.57  Aligned_cols=250  Identities=16%  Similarity=0.221  Sum_probs=199.0

Q ss_pred             CcccccccCCCCCCcEEEEEE-eCCCCEEEEEEeCCCCChhHHHHHHHHHHHhcCC-----------Cccccccceeeee
Q 020221           57 AMENIVSEHGEKAPNVVYKGK-LENQFRIAVKRFNRSAWPDARQFLEEARAVGQLR-----------NRRLANLLGCCCE  124 (329)
Q Consensus        57 ~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-----------h~niv~~~~~~~~  124 (329)
                      ..|.+++.||+|+||+||+|. ..+++.||+|++.... ...+.+.+|+.+++.++           |+||+++++++..
T Consensus        19 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~~~~~~~   97 (373)
T 1q8y_A           19 ARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDK-VYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNH   97 (373)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCH-HHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEE
T ss_pred             CeEEEEEeeeecCCeEEEEEEecCCCcEEEEEEecCCc-cchhhhhHHHHHHHHhhcccccchhccccchHHHHHHHhhc
Confidence            457888889999999999999 4678899999997543 33456788999988886           8899999999876


Q ss_pred             CC----eeEEEEecCCCCCHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeC------CCCC
Q 020221          125 GD----ERLLVAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFD------DDVN  194 (329)
Q Consensus       125 ~~----~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~------~~~~  194 (329)
                      .+    ..+++|||+ +++|.+++.......+++..+..++.||+.||.|||++.|++||||||+|||++      ..+.
T Consensus        98 ~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~~ivH~Dikp~NIll~~~~~~~~~~~  176 (373)
T 1q8y_A           98 KGPNGVHVVMVFEVL-GENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQ  176 (373)
T ss_dssp             EETTEEEEEEEECCC-CEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECSCCSGGGEEEEEEETTTTEEE
T ss_pred             cCCCCceEEEEEecC-CCCHHHHHHHhhccCCcHHHHHHHHHHHHHHHHHHHhcCCEEecCCChHHeEEeccCCCcCcce
Confidence            44    789999999 889999998655667999999999999999999999954899999999999994      4457


Q ss_pred             eeeecccCcccCCCC-CCccCcccccCcccccCCCCCCcccchhhhHHHHHHHhCCCCCCchhhHHH------hhhchhh
Q 020221          195 PRLSCFGLMKNSRDG-RSYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLI------RDRNIQT  267 (329)
Q Consensus       195 ~kl~Dfg~a~~~~~~-~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~------~~~~~~~  267 (329)
                      +||+|||++...... ....+|+.|+|||++.+..++.++||||||+++|+|++|..||........      .......
T Consensus       177 ~kl~Dfg~a~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~  256 (373)
T 1q8y_A          177 IKIADLGNACWYDEHYTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQIIEL  256 (373)
T ss_dssp             EEECCCTTCEETTBCCCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CHHHHHHHHHHH
T ss_pred             EEEcccccccccCCCCCCCCCCccccCcHHHhCCCCCchHhHHHHHHHHHHHHhCCCCCCCCcccccCChHHHHHHHHHh
Confidence            999999999765443 345789999999999999999999999999999999999988864321100      0000000


Q ss_pred             -----------------------hccc-------------cccCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 020221          268 -----------------------LTDS-------------CLEGQFSSDEGTELVRLASRCLQYEPRERPNPRSLVT  308 (329)
Q Consensus       268 -----------------------~~~~-------------~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~~~l~  308 (329)
                                             ....             .....++...++++.+|+.+||+.||++|||+.++++
T Consensus       257 ~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  333 (373)
T 1q8y_A          257 LGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAGGLVN  333 (373)
T ss_dssp             HCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCHHHHHT
T ss_pred             cCCCCHHHHhccchhhhhcCCcchhcccccccccchhhhhhhcccCCcchHHHHHHHHHHHhccCccccCCHHHHhh
Confidence                                   0000             0011345678899999999999999999999999998

>2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A*

Probab=100.00  E-value=7.9e-44  Score=329.78  Aligned_cols=240  Identities=18%  Similarity=0.148  Sum_probs=183.6

Q ss_pred             cccCCCCCCcEEEEEEeCCCCEEEEEEeCCCCChhHHHHHHHHHHHhcC-CCccccccceeeeeCCeeEEEEecCCCCCH
Q 020221           62 VSEHGEKAPNVVYKGKLENQFRIAVKRFNRSAWPDARQFLEEARAVGQL-RNRRLANLLGCCCEGDERLLVAEYMPNDTL  140 (329)
Q Consensus        62 ~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~~~gsL  140 (329)
                      .+.||+|+||+||.+...+|+.||||++....   .+.+.+|+++++.+ +||||+++++++.+....++||||+. |+|
T Consensus        20 ~~~LG~G~~g~V~~~~~~~g~~vAvK~~~~~~---~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~lv~E~~~-gsL   95 (434)
T 2rio_A           20 EKILGYGSSGTVVFQGSFQGRPVAVKRMLIDF---CDIALMEIKLLTESDDHPNVIRYYCSETTDRFLYIALELCN-LNL   95 (434)
T ss_dssp             EEEEEECSTTCEEEEEESSSSEEEEEEEEGGG---HHHHHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEECCCS-EEH
T ss_pred             cCeEeeCCCeEEEEEEEECCeEEEEEEEcHHH---HHHHHHHHHHHHhccCCCCcCeEEEEEecCCeEEEEEecCC-CCH
Confidence            45679999999987766678999999986532   45678899999876 89999999999999999999999996 599


Q ss_pred             HhhhccCCCCC-----CCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCCC-------------CCeeeecccC
Q 020221          141 AKHLFHWETQP-----MKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDD-------------VNPRLSCFGL  202 (329)
Q Consensus       141 ~~~l~~~~~~~-----~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~-------------~~~kl~Dfg~  202 (329)
                      .+++.......     .++..++.++.||+.||+|||+. +|+||||||+|||++.+             +.+||+|||+
T Consensus        96 ~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~-~ivHrDLkp~NILl~~~~~~~~~~~~~~~~~~~kL~DFG~  174 (434)
T 2rio_A           96 QDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSL-KIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGL  174 (434)
T ss_dssp             HHHHHTC------------CCHHHHHHHHHHHHHHHHHT-TEECCCCSGGGEEEECCHHHHSCCTTCCCSCEEEECCCTT
T ss_pred             HHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHHC-CccccCCChHhEEEecCcccccccccCCCceEEEEccccc
Confidence            99996432111     12334578999999999999999 99999999999999654             4799999999


Q ss_pred             cccCCCCC--------CccCcccccCcccccC-------CCCCCcccchhhhHHHHHHHh-CCCCCCchhhHHHhhhchh
Q 020221          203 MKNSRDGR--------SYSTNLAFTPPEYLRT-------GRVTPESVMYSFGTLLLDLLS-GKHIPPSHALDLIRDRNIQ  266 (329)
Q Consensus       203 a~~~~~~~--------~~~~~~~y~aPE~~~~-------~~~~~~~DvwslG~il~el~t-g~~~~~~~~~~~~~~~~~~  266 (329)
                      +.......        ...||+.|+|||++.+       ..++.++|||||||++|||++ |..||........  ....
T Consensus       175 a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~~--~i~~  252 (434)
T 2rio_A          175 CKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSRES--NIIR  252 (434)
T ss_dssp             CEECCC--------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCCTTCSTTTHHH--HHHH
T ss_pred             ceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCCCCCCCchhhHH--HHhc
Confidence            98765432        2468999999999875       568899999999999999999 7777654322111  1111


Q ss_pred             hhcc-ccccCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 020221          267 TLTD-SCLEGQFSSDEGTELVRLASRCLQYEPRERPNPRSLVT  308 (329)
Q Consensus       267 ~~~~-~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~~~l~  308 (329)
                      .... ...........++++.+++.+||+.||++|||+.++++
T Consensus       253 ~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~  295 (434)
T 2rio_A          253 GIFSLDEMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLR  295 (434)
T ss_dssp             TCCCCCCCTTCCCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             CCCCcccccccccccchHHHHHHHHHHhhCChhhCCCHHHHHh
Confidence            1111 11111224567899999999999999999999999986

>3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ...

Probab=100.00  E-value=1.4e-44  Score=321.99  Aligned_cols=238  Identities=18%  Similarity=0.274  Sum_probs=198.3

Q ss_pred             CCcccccccCCCCCCcEEEEEE-eCCCCEEEEEEeCCCCCh------hHHHHHHHHHHHhcCC--CccccccceeeeeCC
Q 020221           56 FAMENIVSEHGEKAPNVVYKGK-LENQFRIAVKRFNRSAWP------DARQFLEEARAVGQLR--NRRLANLLGCCCEGD  126 (329)
Q Consensus        56 ~~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~------~~~~~~~e~~~l~~l~--h~niv~~~~~~~~~~  126 (329)
                      ...|++.+.||+|+||.||+|. ..+++.||+|++......      ..+.+.+|+.+++.++  |+||+++++++...+
T Consensus        42 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~~~~~~~~  121 (320)
T 3a99_A           42 ESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPD  121 (320)
T ss_dssp             TTTEEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSS
T ss_pred             cCceEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEEEEEecCC
Confidence            3557888889999999999998 567889999998764322      1234667999999996  599999999999999


Q ss_pred             eeEEEEecCCC-CCHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeC-CCCCeeeecccCcc
Q 020221          127 ERLLVAEYMPN-DTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFD-DDVNPRLSCFGLMK  204 (329)
Q Consensus       127 ~~~lv~e~~~~-gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~-~~~~~kl~Dfg~a~  204 (329)
                      ..++|+|++.+ ++|.+++..  ...+++..++.++.|++.||.|||+. +++||||||+||+++ +++.+||+|||++.
T Consensus       122 ~~~lv~e~~~~~~~L~~~l~~--~~~l~~~~~~~i~~qi~~~L~~LH~~-~ivH~Dlkp~NIll~~~~~~~kL~Dfg~~~  198 (320)
T 3a99_A          122 SFVLILERPEPVQDLFDFITE--RGALQEELARSFFWQVLEAVRHCHNC-GVLHRDIKDENILIDLNRGELKLIDFGSGA  198 (320)
T ss_dssp             EEEEEEECCSSEEEHHHHHHH--HCSCCHHHHHHHHHHHHHHHHHHHHT-TEECCCCSGGGEEEETTTTEEEECCCTTCE
T ss_pred             cEEEEEEcCCCCccHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHHC-CcEeCCCCHHHEEEeCCCCCEEEeeCcccc
Confidence            99999999976 899999863  45789999999999999999999999 999999999999999 78999999999987


Q ss_pred             cCCCC--CCccCcccccCcccccCCCC-CCcccchhhhHHHHHHHhCCCCCCchhhHHHhhhchhhhccccccCCCChHH
Q 020221          205 NSRDG--RSYSTNLAFTPPEYLRTGRV-TPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDE  281 (329)
Q Consensus       205 ~~~~~--~~~~~~~~y~aPE~~~~~~~-~~~~DvwslG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  281 (329)
                      .....  ....+|+.|+|||++.+..+ +.++||||||+++|+|++|..||.....  ....          ....+...
T Consensus       199 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~--~~~~----------~~~~~~~~  266 (320)
T 3a99_A          199 LLKDTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEE--IIRG----------QVFFRQRV  266 (320)
T ss_dssp             ECCSSCBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHH--HHHC----------CCCCSSCC
T ss_pred             ccccccccCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCCCCChhh--hhcc----------cccccccC
Confidence            65543  33468999999999887765 6789999999999999999988764321  1110          01123445


Q ss_pred             HHHHHHHHHHhcccCCCCCCCHHHHHH
Q 020221          282 GTELVRLASRCLQYEPRERPNPRSLVT  308 (329)
Q Consensus       282 ~~~~~~li~~cl~~dp~~Rps~~~~l~  308 (329)
                      ++++.+++.+||+.||++|||+.++++
T Consensus       267 ~~~~~~li~~~l~~dp~~Rps~~~ll~  293 (320)
T 3a99_A          267 SSECQHLIRWCLALRPSDRPTFEEIQN  293 (320)
T ss_dssp             CHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             CHHHHHHHHHHccCChhhCcCHHHHhc
Confidence            678999999999999999999999997

>2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens}

Probab=100.00  E-value=3.3e-44  Score=318.22  Aligned_cols=237  Identities=20%  Similarity=0.299  Sum_probs=191.9

Q ss_pred             CcccccccCCCCCCcEEEEEE-eCCCCEEEEEEeCCCCCh------hHHHHHHHHHHHhcC----CCccccccceeeeeC
Q 020221           57 AMENIVSEHGEKAPNVVYKGK-LENQFRIAVKRFNRSAWP------DARQFLEEARAVGQL----RNRRLANLLGCCCEG  125 (329)
Q Consensus        57 ~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~------~~~~~~~e~~~l~~l----~h~niv~~~~~~~~~  125 (329)
                      ..|++.+.||+|+||.||+|. ..+++.||+|++......      ....+.+|+.++..+    +||||+++++++...
T Consensus        31 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~~~~~~~  110 (312)
T 2iwi_A           31 AEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLLDWFETQ  110 (312)
T ss_dssp             --CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEEEEC---
T ss_pred             hceEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEEEEEecC
Confidence            347777888999999999998 467889999999765432      122356788888888    899999999999988


Q ss_pred             CeeEEEEec-CCCCCHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeC-CCCCeeeecccCc
Q 020221          126 DERLLVAEY-MPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFD-DDVNPRLSCFGLM  203 (329)
Q Consensus       126 ~~~~lv~e~-~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~-~~~~~kl~Dfg~a  203 (329)
                      +..++|+|+ +.+++|.+++..  ...+++..++.++.|++.||.|||+. |++|+||||+||+++ .++.++|+|||++
T Consensus       111 ~~~~~v~e~~~~~~~L~~~l~~--~~~~~~~~~~~~~~qi~~~l~~lH~~-~i~H~dlkp~Nil~~~~~~~~kl~dfg~~  187 (312)
T 2iwi_A          111 EGFMLVLERPLPAQDLFDYITE--KGPLGEGPSRCFFGQVVAAIQHCHSR-GVVHRDIKDENILIDLRRGCAKLIDFGSG  187 (312)
T ss_dssp             --CEEEEECCSSEEEHHHHHHH--HCSCCHHHHHHHHHHHHHHHHHHHHH-TEECCCCSGGGEEEETTTTEEEECCCSSC
T ss_pred             CeEEEEEEecCCCCCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHC-CeeecCCChhhEEEeCCCCeEEEEEcchh
Confidence            999999999 789999999973  45689999999999999999999999 999999999999999 8899999999998


Q ss_pred             ccCCCC--CCccCcccccCcccccCCCCC-CcccchhhhHHHHHHHhCCCCCCchhhHHHhhhchhhhccccccCCCChH
Q 020221          204 KNSRDG--RSYSTNLAFTPPEYLRTGRVT-PESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSD  280 (329)
Q Consensus       204 ~~~~~~--~~~~~~~~y~aPE~~~~~~~~-~~~DvwslG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  280 (329)
                      ......  ....++..|+|||++.+..+. .++||||||+++|+|++|..||.....  ...        .  ...++..
T Consensus       188 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~--~~~--------~--~~~~~~~  255 (312)
T 2iwi_A          188 ALLHDEPYTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERDQE--ILE--------A--ELHFPAH  255 (312)
T ss_dssp             EECCSSCBCCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHH--HHH--------T--CCCCCTT
T ss_pred             hhcccCcccccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCCCChHH--Hhh--------h--ccCCccc
Confidence            765443  344678999999998877664 489999999999999999988764321  111        0  1123455


Q ss_pred             HHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 020221          281 EGTELVRLASRCLQYEPRERPNPRSLVT  308 (329)
Q Consensus       281 ~~~~~~~li~~cl~~dp~~Rps~~~~l~  308 (329)
                      .+.++.+++.+||+.||++|||+.++++
T Consensus       256 ~~~~~~~li~~~l~~~p~~Rps~~e~l~  283 (312)
T 2iwi_A          256 VSPDCCALIRRCLAPKPSSRPSLEEILL  283 (312)
T ss_dssp             SCHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred             CCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence            6788999999999999999999999998

>3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens}

Probab=100.00  E-value=2.2e-43  Score=326.14  Aligned_cols=242  Identities=14%  Similarity=0.125  Sum_probs=184.6

Q ss_pred             cccccccCCCCCCcEEEEEEeCCCCEEEEEEeCCCCChhHHHHHHHHHHHhcC-CCccccccceeeeeCCeeEEEEecCC
Q 020221           58 MENIVSEHGEKAPNVVYKGKLENQFRIAVKRFNRSAWPDARQFLEEARAVGQL-RNRRLANLLGCCCEGDERLLVAEYMP  136 (329)
Q Consensus        58 ~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~~  136 (329)
                      .+.+.+.||+|+||+|+.....+++.||||++......   .+.+|+++++.+ +||||+++++++.+....++||||+.
T Consensus        25 ~y~~~~~LG~G~~G~V~~~~~~~~~~vAvK~~~~~~~~---~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~~lv~E~~~  101 (432)
T 3p23_A           25 SFCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPECFS---FADREVQLLRESDEHPNVIRYFCTEKDRQFQYIAIELCA  101 (432)
T ss_dssp             EEEEEEEEEECGGGCEEEEEESSSSEEEEEEECTTTEE---ECHHHHHHHHHSCCCTTBCCEEEEEEETTEEEEEEECCS
T ss_pred             EEecCCeeecCcCEEEEEEEEeCCeEEEEEEECHHHHH---HHHHHHHHHHhccCCCCcCeEEEEEecCCEEEEEEECCC
Confidence            35566777999999976555567889999999765432   346799999999 79999999999999999999999996


Q ss_pred             CCCHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCC-----CCCeeeecccCcccCCCC--
Q 020221          137 NDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDD-----DVNPRLSCFGLMKNSRDG--  209 (329)
Q Consensus       137 ~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~-----~~~~kl~Dfg~a~~~~~~--  209 (329)
                       |+|.+++.. ......+..+..++.||+.||.|||+. +|+||||||+|||++.     ...+||+|||+++.....  
T Consensus       102 -g~L~~~l~~-~~~~~~~~~~~~i~~qi~~aL~~LH~~-~ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~a~~~~~~~~  178 (432)
T 3p23_A          102 -ATLQEYVEQ-KDFAHLGLEPITLLQQTTSGLAHLHSL-NIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRH  178 (432)
T ss_dssp             -EEHHHHHHS-SSCCCCSSCHHHHHHHHHHHHHHHHHT-TCCCCCCSTTSEEECCCBTTTBCCEEECCTTEEECC-----
T ss_pred             -CCHHHHHHh-cCCCccchhHHHHHHHHHHHHHHHHHC-cCEeCCCCHHHEEEecCCCCCceeEEEecccceeeccCCCc
Confidence             599999975 333455556778999999999999999 9999999999999953     335789999999765432  


Q ss_pred             -----CCccCcccccCcccccC---CCCCCcccchhhhHHHHHHHh-CCCCCCchhhHHHhhhchhhhccccccCCCChH
Q 020221          210 -----RSYSTNLAFTPPEYLRT---GRVTPESVMYSFGTLLLDLLS-GKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSD  280 (329)
Q Consensus       210 -----~~~~~~~~y~aPE~~~~---~~~~~~~DvwslG~il~el~t-g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  280 (329)
                           ....||+.|+|||++.+   ..++.++|||||||++|||++ |..||........... .......  .......
T Consensus       179 ~~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~~~~~~~~~-~~~~~~~--~~~~~~~  255 (432)
T 3p23_A          179 SFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQANIL-LGACSLD--CLHPEKH  255 (432)
T ss_dssp             -------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBSTTTHHHHHH-TTCCCCT--TSCTTCH
T ss_pred             ceeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcchhhHHHHHHH-hccCCcc--ccCcccc
Confidence                 23468999999999984   557889999999999999999 6666543322211111 1100000  1112345


Q ss_pred             HHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 020221          281 EGTELVRLASRCLQYEPRERPNPRSLVT  308 (329)
Q Consensus       281 ~~~~~~~li~~cl~~dp~~Rps~~~~l~  308 (329)
                      .+..+.+|+.+||+.||++|||+.++++
T Consensus       256 ~~~~~~~li~~~L~~dP~~Rps~~evl~  283 (432)
T 3p23_A          256 EDVIARELIEKMIAMDPQKRPSAKHVLK  283 (432)
T ss_dssp             HHHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             ccHHHHHHHHHHHhCCHhhCCCHHHHHh
Confidence            6778999999999999999999999996

>2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens}

Probab=100.00  E-value=2.5e-43  Score=313.06  Aligned_cols=248  Identities=17%  Similarity=0.231  Sum_probs=180.4

Q ss_pred             CCcccccccCCCCCCcEEEEEEe-CCCCEEEEEEeCCCCChh-HHH-HHHHHHHHhcCCCccccccceeeeeCCeeEEEE
Q 020221           56 FAMENIVSEHGEKAPNVVYKGKL-ENQFRIAVKRFNRSAWPD-ARQ-FLEEARAVGQLRNRRLANLLGCCCEGDERLLVA  132 (329)
Q Consensus        56 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~-~~~-~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~  132 (329)
                      +..|++++.||+|+||.||++.. .+++.||+|++....... ... +..+..+++.++||||+++++++...+..++||
T Consensus        24 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lv~  103 (318)
T 2dyl_A           24 INDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFITNTDVFIAM  103 (318)
T ss_dssp             GGGEEEEEEC------CEEEEEETTTCCEEEEEEEETTSCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEE
T ss_pred             hccccccceeeecCCeeEEEEEEecCCeEEEEEEecccccchHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcEEEEE
Confidence            45678888999999999999995 578899999997654332 223 444455788889999999999999999999999


Q ss_pred             ecCCCCCHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCCCCCeeeecccCcccCCCC---
Q 020221          133 EYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDG---  209 (329)
Q Consensus       133 e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~---  209 (329)
                      ||+ ++.+..+... ....+++..+..++.|++.||.|||++.|++|+||||+||+++.++.+||+|||++......   
T Consensus       104 e~~-~~~~~~l~~~-~~~~~~~~~~~~~~~~i~~~l~~lH~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~  181 (318)
T 2dyl_A          104 ELM-GTCAEKLKKR-MQGPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILLDERGQIKLCDFGISGRLVDDKAK  181 (318)
T ss_dssp             CCC-SEEHHHHHHH-HTSCCCHHHHHHHHHHHHHHHHHHHHHHCCCCCCCCGGGEEECTTSCEEECCCTTC---------
T ss_pred             ecc-CCcHHHHHHH-hccCCCHHHHHHHHHHHHHHHHHHHhhCCEEeCCCCHHHEEECCCCCEEEEECCCchhccCCccc
Confidence            999 4455555432 35678999999999999999999998338999999999999999999999999998765433   


Q ss_pred             CCccCcccccCccccc-----CCCCCCcccchhhhHHHHHHHhCCCCCCchhhH-HHhhhchhhhccccccCCCChHHHH
Q 020221          210 RSYSTNLAFTPPEYLR-----TGRVTPESVMYSFGTLLLDLLSGKHIPPSHALD-LIRDRNIQTLTDSCLEGQFSSDEGT  283 (329)
Q Consensus       210 ~~~~~~~~y~aPE~~~-----~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~  283 (329)
                      ....+++.|+|||++.     +..++.++||||||+++|+|++|..||...... ........... ..  .......++
T Consensus       182 ~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~-~~--~~~~~~~~~  258 (318)
T 2dyl_A          182 DRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTDFEVLTKVLQEEP-PL--LPGHMGFSG  258 (318)
T ss_dssp             -----CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHHHSCC-CC--CCSSSCCCH
T ss_pred             cccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCCCCccHHHHHHHhccCC-CC--CCccCCCCH
Confidence            2346789999999985     456888999999999999999999887642211 11111111111 10  011124577


Q ss_pred             HHHHHHHHhcccCCCCCCCHHHHHH
Q 020221          284 ELVRLASRCLQYEPRERPNPRSLVT  308 (329)
Q Consensus       284 ~~~~li~~cl~~dp~~Rps~~~~l~  308 (329)
                      ++.+++.+||+.||++|||+.++++
T Consensus       259 ~l~~li~~~l~~dp~~Rps~~~ll~  283 (318)
T 2dyl_A          259 DFQSFVKDCLTKDHRKRPKYNKLLE  283 (318)
T ss_dssp             HHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred             HHHHHHHHHccCChhHCcCHHHHhh
Confidence            8999999999999999999999986

>3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A*

Probab=100.00  E-value=1.1e-43  Score=339.50  Aligned_cols=260  Identities=18%  Similarity=0.183  Sum_probs=200.7

Q ss_pred             CCCcccccccCCCCCCcEEEEEEe-CCCCEEEEEEeCCCCC-hhHHHHHHHHHHHhcCCCccccccceeeee------CC
Q 020221           55 GFAMENIVSEHGEKAPNVVYKGKL-ENQFRIAVKRFNRSAW-PDARQFLEEARAVGQLRNRRLANLLGCCCE------GD  126 (329)
Q Consensus        55 ~~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~------~~  126 (329)
                      .+..|++.+.||+|+||+||+|.. .+++.||+|++..... ...+.+.+|+++++.++||||+++++++..      .+
T Consensus        12 ~~grY~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~~~~~   91 (676)
T 3qa8_A           12 TCGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPND   91 (676)
T ss_dssp             -----CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSCCCHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCCCCTTS
T ss_pred             CCCCeEEEEEEeeCCCeEEEEEEECCCCcEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCceeeeecccccccCCC
Confidence            345688889999999999999984 5688999999876532 335568999999999999999999998755      66


Q ss_pred             eeEEEEecCCCCCHHhhhccCC-CCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCCCCC---eeeecccC
Q 020221          127 ERLLVAEYMPNDTLAKHLFHWE-TQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVN---PRLSCFGL  202 (329)
Q Consensus       127 ~~~lv~e~~~~gsL~~~l~~~~-~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~---~kl~Dfg~  202 (329)
                      ..++||||+++|+|.+++.... ...+++..++.++.|++.||.|||+. |++|+||||+||+++.++.   ++|+|||+
T Consensus        92 ~~~LVmEy~~ggsL~~~L~~~~~~~~lse~~i~~I~~QLl~aL~yLHs~-gIVHrDLKP~NILl~~~g~~~~vKL~DFG~  170 (676)
T 3qa8_A           92 LPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHEN-RIIHRDLKPENIVLQPGPQRLIHKIIDLGY  170 (676)
T ss_dssp             SCCCEEECCSSCBHHHHHHSSSCTTCCCSSHHHHHHHHHHHHHHHHHHT-TBCCCCCCSTTEEEECCSSSCEEEECSCCC
T ss_pred             eEEEEEEeCCCCCHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHC-CCccCCCCHHHeEeecCCCceeEEEccccc
Confidence            7899999999999999997532 23688999999999999999999999 9999999999999997765   89999999


Q ss_pred             cccCCCC---CCccCcccccCcccccCCCCCCcccchhhhHHHHHHHhCCCCCCchhhHHHhhh----------chhhhc
Q 020221          203 MKNSRDG---RSYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDR----------NIQTLT  269 (329)
Q Consensus       203 a~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~~~~----------~~~~~~  269 (329)
                      +......   ....+++.|+|||.+.+..++.++||||||+++|+|++|..||...........          ......
T Consensus       171 a~~~~~~~~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSLGviLyeLltG~~Pf~~~~~~~~~~~~i~~~~~~~~~~~~~l  250 (676)
T 3qa8_A          171 AKELDQGELCTEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQPVQWHGKVREKSNEHIVVYDDL  250 (676)
T ss_dssp             CCBTTSCCCCCCCCSCCTTCSSCSSCCSCCSTTHHHHHHHHHHHHHHSSCSSCCSSCHHHHSSTTCC------CCSCCCC
T ss_pred             ccccccccccccccCCcccCChHHhccCCCCchhHHHHHHHHHHHHHHCCCCCCcccchhhhhhhhhcccchhhhhhhhh
Confidence            9876543   234688999999999999999999999999999999999988864321110000          000000


Q ss_pred             cc--------cccCCCChHHHHHHHHHHHHhcccCCCCCCCHHHH-----HHHHHhhhh
Q 020221          270 DS--------CLEGQFSSDEGTELVRLASRCLQYEPRERPNPRSL-----VTALVTLQK  315 (329)
Q Consensus       270 ~~--------~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~~~-----l~~L~~~~~  315 (329)
                      ..        ..........++.+.+++..||..||++|||+.++     .+.++.+..
T Consensus       251 ~g~~~~~~~lp~p~~l~~~ls~~L~dLI~~mL~~DP~kRPTa~elL~hp~F~~l~~iL~  309 (676)
T 3qa8_A          251 TGAVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQNPNVGCFQALDSILS  309 (676)
T ss_dssp             SSSCCCCSSSCCSCCCCGGGHHHHHHHHHHHSCSSCC---CCTTCCCCTTHHHHHHHHC
T ss_pred             ccccccccccCCchhhchhhhHHHHHHHHHHccCCHhhCcCHHHHhcCHHHHHHHHHHh
Confidence            00        01122445688999999999999999999999884     455555543

>3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A*

Probab=100.00  E-value=1.1e-42  Score=306.80  Aligned_cols=226  Identities=16%  Similarity=0.151  Sum_probs=180.0

Q ss_pred             Cccccc-ccCCCCCCcEEEEEE-eCCCCEEEEEEeCCCCChhHHHHHHHHHHH-hcCCCccccccceeeee----CCeeE
Q 020221           57 AMENIV-SEHGEKAPNVVYKGK-LENQFRIAVKRFNRSAWPDARQFLEEARAV-GQLRNRRLANLLGCCCE----GDERL  129 (329)
Q Consensus        57 ~~~~~~-~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~e~~~l-~~l~h~niv~~~~~~~~----~~~~~  129 (329)
                      ..|.++ +.||+|+||.||++. ..+++.||+|++...     ..+.+|+.++ +..+||||+++++++..    ....+
T Consensus        17 ~~y~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-----~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~   91 (299)
T 3m2w_A           17 DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLL   91 (299)
T ss_dssp             GTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS-----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEE
T ss_pred             cchhhcCcccccCCCeEEEEEEEcCCCcEEEEEEeccc-----HHHHHHHHHHHHhccCCCchhHHhhhhhhcCCCceEE
Confidence            345566 568999999999999 467889999998642     3567788887 55699999999999876    67789


Q ss_pred             EEEecCCCCCHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCC---CCCeeeecccCcccC
Q 020221          130 LVAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDD---DVNPRLSCFGLMKNS  206 (329)
Q Consensus       130 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~---~~~~kl~Dfg~a~~~  206 (329)
                      +||||+++++|.+++.......+++..++.++.|++.||.|||+. +++||||||+||+++.   ++.++|+|||++...
T Consensus        92 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~-~i~H~dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~  170 (299)
T 3m2w_A           92 IVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSI-NIAHRDVKPENLLYTSKRPNAILKLTDFGFAKET  170 (299)
T ss_dssp             EEECCCCSCBHHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHT-TEECCCCSGGGEEESSSSTTCCEEECCCTTCEEC
T ss_pred             EEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhC-CcccCCCCHHHEEEecCCCCCcEEEecccccccc
Confidence            999999999999999865556799999999999999999999999 9999999999999997   788999999998643


Q ss_pred             CCCCCccCcccccCcccccCCCCCCcccchhhhHHHHHHHhCCCCCCchhhHHHhhhchhhhccccccCCCC----hHHH
Q 020221          207 RDGRSYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFS----SDEG  282 (329)
Q Consensus       207 ~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~  282 (329)
                      .                  +..++.++||||||+++|+|++|..||....................  ...+    ...+
T Consensus       171 ~------------------~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~  230 (299)
T 3m2w_A          171 T------------------GEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQ--YEFPNPEWSEVS  230 (299)
T ss_dssp             T------------------TCGGGGHHHHHHHHHHHHHHHHSSCSCCC-------CCSCCSSCTTC--CSSCHHHHTTSC
T ss_pred             c------------------cccCCchhhHHHHHHHHHHHHHCCCCCCCCcchhhhHHHHHHHhhcc--ccCCchhcccCC
Confidence            2                  24577899999999999999999988865432221111111111111  1112    2357


Q ss_pred             HHHHHHHHHhcccCCCCCCCHHHHHH
Q 020221          283 TELVRLASRCLQYEPRERPNPRSLVT  308 (329)
Q Consensus       283 ~~~~~li~~cl~~dp~~Rps~~~~l~  308 (329)
                      +++.+++.+||+.||++|||+.++++
T Consensus       231 ~~~~~li~~~l~~dP~~Rps~~e~l~  256 (299)
T 3m2w_A          231 EEVKMLIRNLLKTEPTQRMTITEFMN  256 (299)
T ss_dssp             HHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             HHHHHHHHHHcccChhhCCCHHHHhc
Confidence            89999999999999999999999997

>2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A

Probab=100.00  E-value=3.6e-43  Score=314.91  Aligned_cols=240  Identities=12%  Similarity=0.073  Sum_probs=185.9

Q ss_pred             CcccccccCCCCCCcEEEEEEeCCCCEEEEEEeCCCCC--------hhHHHHHHHHHHHhcCC-----------------
Q 020221           57 AMENIVSEHGEKAPNVVYKGKLENQFRIAVKRFNRSAW--------PDARQFLEEARAVGQLR-----------------  111 (329)
Q Consensus        57 ~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~--------~~~~~~~~e~~~l~~l~-----------------  111 (329)
                      ..|++++.||+|+||+||+|.. +++.||||++.....        ...+.+.+|+.+++.++                 
T Consensus        20 ~~y~~~~~lG~G~~g~V~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv~l~   98 (336)
T 2vuw_A           20 EKLQRCEKIGEGVFGEVFQTIA-DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIGLN   98 (336)
T ss_dssp             HHHHTCEEEEEETTEEEEEEEE-TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBCCEE
T ss_pred             ccchheeeecccCceEEEEEEe-CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCchhhhc
Confidence            4577888889999999999998 678999999976532        22467889999988886                 


Q ss_pred             ---------Cccccccceeeee-------------CCeeEEEEecCCCCCHHhhhccCCCCCCCHHHHHHHHHHHHHHHH
Q 020221          112 ---------NRRLANLLGCCCE-------------GDERLLVAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALE  169 (329)
Q Consensus       112 ---------h~niv~~~~~~~~-------------~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~  169 (329)
                               ||||+++++++.+             ....++||||+++|++.+.+.   ...+++..+..++.||+.||.
T Consensus        99 ~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~---~~~~~~~~~~~i~~qi~~aL~  175 (336)
T 2vuw_A           99 SVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMR---TKLSSLATAKSILHQLTASLA  175 (336)
T ss_dssp             EEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGT---TTCCCHHHHHHHHHHHHHHHH
T ss_pred             ceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHH---hcCCCHHHHHHHHHHHHHHHH
Confidence                     5666666666554             688999999999998777773   356899999999999999999


Q ss_pred             Hhh-cCCCccccccCCCceeeCCCC--------------------CeeeecccCcccCCCCCCccCcccccCcccccCCC
Q 020221          170 YCT-SKERALYHDLNAYRIVFDDDV--------------------NPRLSCFGLMKNSRDGRSYSTNLAFTPPEYLRTGR  228 (329)
Q Consensus       170 ~lH-~~~~ivH~dlkp~Nil~~~~~--------------------~~kl~Dfg~a~~~~~~~~~~~~~~y~aPE~~~~~~  228 (329)
                      ||| +. +|+||||||+|||++.++                    .+||+|||+++..... ...||+.|+|||++.+..
T Consensus       176 ~lH~~~-~ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~~-~~~gt~~y~aPE~~~g~~  253 (336)
T 2vuw_A          176 VAEASL-RFEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDG-IVVFCDVSMDEDLFTGDG  253 (336)
T ss_dssp             HHHHHH-CCBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEETT-EEECCCCTTCSGGGCCCS
T ss_pred             HHHHhC-CEeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCCC-cEEEeecccChhhhcCCC
Confidence            999 88 999999999999999887                    8999999999876543 447899999999998766


Q ss_pred             CCCcccchhhhHH-HHHHHhCCCCCCchhh-HHHhhhchhhh-ccccccCCCChHHHHHHHHHHHHhcccCCCCCCCHHH
Q 020221          229 VTPESVMYSFGTL-LLDLLSGKHIPPSHAL-DLIRDRNIQTL-TDSCLEGQFSSDEGTELVRLASRCLQYEPRERPNPRS  305 (329)
Q Consensus       229 ~~~~~DvwslG~i-l~el~tg~~~~~~~~~-~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~~  305 (329)
                       +.++||||++++ .+++++|..|+....+ ........... .........+...++++.+|+.+||+.|     |+.+
T Consensus       254 -~~~~Diwsl~~~~~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~d-----sa~e  327 (336)
T 2vuw_A          254 -DYQFDIYRLMKKENNNRWGEYHPYSNVLWLHYLTDKMLKQMTFKTKCNTPAMKQIKRKIQEFHRTMLNFS-----SATD  327 (336)
T ss_dssp             -SHHHHHHHHHHHHHTTCTTSCCTHHHHHHHHHHHHHHHHTCCCSSCCCSHHHHHHHHHHHHHHHHGGGSS-----SHHH
T ss_pred             -ccceehhhhhCCCCcccccccCCCcchhhhhHHHHhhhhhhccCcccchhhhhhcCHHHHHHHHHHhccC-----CHHH
Confidence             889999998777 7778888877644221 11111111111 1111111123468899999999999976     9999


Q ss_pred             HH-H
Q 020221          306 LV-T  308 (329)
Q Consensus       306 ~l-~  308 (329)
                      ++ +
T Consensus       328 ~l~~  331 (336)
T 2vuw_A          328 LLCQ  331 (336)
T ss_dssp             HHHH
T ss_pred             HHhc
Confidence            99 8

>3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A

Probab=100.00  E-value=5.1e-42  Score=300.51  Aligned_cols=232  Identities=13%  Similarity=0.106  Sum_probs=184.3

Q ss_pred             CcccccccCCCCCCcEEEEEEe-CCCCEEEEEEeCCCCChh---HHHHHHHHHHHhcCCCccccccceeeeeCCeeEEEE
Q 020221           57 AMENIVSEHGEKAPNVVYKGKL-ENQFRIAVKRFNRSAWPD---ARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVA  132 (329)
Q Consensus        57 ~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~---~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~  132 (329)
                      ..|++++.||+|+||.||+|.. .+++.||+|++.......   .+.+.+|+..+..++||||+++++++.+.+..++||
T Consensus        31 ~~y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~  110 (286)
T 3uqc_A           31 GRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVHTRAGGLVVA  110 (286)
T ss_dssp             TTEEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             CcEEEEEEEcccCCeEEEEEEecCCCceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeEEEEECCcEEEEE
Confidence            3477888899999999999995 458899999998764332   367899999999999999999999999999999999


Q ss_pred             ecCCCCCHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCCCCCeeeecccCcccCCCCCCc
Q 020221          133 EYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDGRSY  212 (329)
Q Consensus       133 e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~  212 (329)
                      ||+++++|.+++.+   . ....++..++.|++.||.|||++ |++||||||+||+++.++.+||++++           
T Consensus       111 e~~~g~~L~~~l~~---~-~~~~~~~~i~~ql~~aL~~lH~~-givH~Dikp~NIll~~~g~~kl~~~~-----------  174 (286)
T 3uqc_A          111 EWIRGGSLQEVADT---S-PSPVGAIRAMQSLAAAADAAHRA-GVALSIDHPSRVRVSIDGDVVLAYPA-----------  174 (286)
T ss_dssp             ECCCEEEHHHHHTT---C-CCHHHHHHHHHHHHHHHHHHHHT-TCCCCCCSGGGEEEETTSCEEECSCC-----------
T ss_pred             EecCCCCHHHHHhc---C-CChHHHHHHHHHHHHHHHHHHHC-CCccCCCCcccEEEcCCCCEEEEecc-----------
Confidence            99999999999842   2 35567889999999999999999 99999999999999999999998554           


Q ss_pred             cCcccccCcccccCCCCCCcccchhhhHHHHHHHhCCCCCCchhhHHHhhhchhhhcccc-ccCCCChHHHHHHHHHHHH
Q 020221          213 STNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSC-LEGQFSSDEGTELVRLASR  291 (329)
Q Consensus       213 ~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~li~~  291 (329)
                           |++       .++.++||||||+++|+|++|+.||.................... .........++++.+++.+
T Consensus       175 -----~~~-------~~~~~~Di~slG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~  242 (286)
T 3uqc_A          175 -----TMP-------DANPQDDIRGIGASLYALLVNRWPLPEAGVRSGLAPAERDTAGQPIEPADIDRDIPFQISAVAAR  242 (286)
T ss_dssp             -----CCT-------TCCHHHHHHHHHHHHHHHHHSEECSCCCSBCCCSEECCBCTTSCBCCHHHHCTTSCHHHHHHHHH
T ss_pred             -----ccC-------CCCchhHHHHHHHHHHHHHHCCCCCCcCCcchhhHHHHHHhccCCCChhhcccCCCHHHHHHHHH
Confidence                 333       368899999999999999999998865422110000000000000 0001223467889999999


Q ss_pred             hcccCCCCCCCHHHHHHHHHhhhhcc
Q 020221          292 CLQYEPRERPNPRSLVTALVTLQKDT  317 (329)
Q Consensus       292 cl~~dp~~Rps~~~~l~~L~~~~~~~  317 (329)
                      ||+.||++| |+.++++.|+++....
T Consensus       243 ~l~~dP~~R-s~~el~~~L~~~~~~~  267 (286)
T 3uqc_A          243 SVQGDGGIR-SASTLLNLMQQATAVA  267 (286)
T ss_dssp             HHCTTSSCC-CHHHHHHHHHHHHC--
T ss_pred             HcccCCccC-CHHHHHHHHHHHhccC
Confidence            999999999 9999999999987643

>2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis}

Probab=100.00  E-value=4.8e-42  Score=334.61  Aligned_cols=240  Identities=18%  Similarity=0.211  Sum_probs=195.5

Q ss_pred             CcccccccCCCCCCcEEEEEEeC--CCCEEEEEEeCCCCCh-hHHHHHHHHHHHhcCCCccccccceeeeeCCe-----e
Q 020221           57 AMENIVSEHGEKAPNVVYKGKLE--NQFRIAVKRFNRSAWP-DARQFLEEARAVGQLRNRRLANLLGCCCEGDE-----R  128 (329)
Q Consensus        57 ~~~~~~~~lg~G~~g~V~~~~~~--~~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~-----~  128 (329)
                      ..|++++.||+|+||.||++...  +++.||||++...... ....+.+|+++++.++||||+++++++...+.     .
T Consensus        80 ~~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~~~  159 (681)
T 2pzi_A           80 GQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRHGDPVG  159 (681)
T ss_dssp             TTEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSSCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEECTTSCEEE
T ss_pred             CceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCccCCHHHHHHHHHHHHHHHhcCCCCcCeEeeeEeecCCCCCcee
Confidence            45788888999999999999954  6889999998765432 34568899999999999999999999987655     7


Q ss_pred             EEEEecCCCCCHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCCCCCeeeecccCcccCCC
Q 020221          129 LLVAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRD  208 (329)
Q Consensus       129 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~  208 (329)
                      ++||||+++++|.+++.    ..+++.++..++.||+.||.|||++ ||+||||||+||+++.+ .+||+|||+++....
T Consensus       160 ~lv~E~~~g~~L~~~~~----~~l~~~~~~~~~~qi~~aL~~lH~~-giiHrDlkp~NIll~~~-~~kl~DFG~a~~~~~  233 (681)
T 2pzi_A          160 YIVMEYVGGQSLKRSKG----QKLPVAEAIAYLLEILPALSYLHSI-GLVYNDLKPENIMLTEE-QLKLIDLGAVSRINS  233 (681)
T ss_dssp             EEEEECCCCEECC--------CCCCHHHHHHHHHHHHHHHHHHHHT-TEECCCCSGGGEEECSS-CEEECCCTTCEETTC
T ss_pred             EEEEEeCCCCcHHHHHh----CCCCHHHHHHHHHHHHHHHHHHHHC-CCeecccChHHeEEeCC-cEEEEecccchhccc
Confidence            99999999999988763    2799999999999999999999999 99999999999999975 999999999998877


Q ss_pred             CCCccCcccccCcccccCCCCCCcccchhhhHHHHHHHhCCCCCCchhhHHHhhhchhhhccccccCCCChHHHHHHHHH
Q 020221          209 GRSYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRL  288 (329)
Q Consensus       209 ~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  288 (329)
                      .....||+.|+|||++.+.. +.++||||||+++|+|++|..|+.....        .    ...........++.+.++
T Consensus       234 ~~~~~gt~~y~aPE~~~~~~-~~~sDi~slG~~l~~l~~g~~~~~~~~~--------~----~~~~~~~~~~~~~~l~~l  300 (681)
T 2pzi_A          234 FGYLYGTPGFQAPEIVRTGP-TVATDIYTVGRTLAALTLDLPTRNGRYV--------D----GLPEDDPVLKTYDSYGRL  300 (681)
T ss_dssp             CSCCCCCTTTSCTTHHHHCS-CHHHHHHHHHHHHHHHHSCCCEETTEEC--------S----SCCTTCHHHHHCHHHHHH
T ss_pred             CCccCCCccccCHHHHcCCC-CCceehhhhHHHHHHHHhCCCCCccccc--------c----cccccccccccCHHHHHH
Confidence            77778999999999987654 8899999999999999999866543110        0    000001112345789999


Q ss_pred             HHHhcccCCCCCC-CHHHHHHHHHhhhh
Q 020221          289 ASRCLQYEPRERP-NPRSLVTALVTLQK  315 (329)
Q Consensus       289 i~~cl~~dp~~Rp-s~~~~l~~L~~~~~  315 (329)
                      +.+||+.||++|| +++++.+.|..+..
T Consensus       301 i~~~l~~dP~~R~~~~~~l~~~l~~~~~  328 (681)
T 2pzi_A          301 LRRAIDPDPRQRFTTAEEMSAQLTGVLR  328 (681)
T ss_dssp             HHHHTCSSGGGSCSSHHHHHHHHHHHHH
T ss_pred             HhhhccCChhhCCCHHHHHHHHHHHHHH
Confidence            9999999999999 56667777776643

>3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii}

Probab=100.00  E-value=4.8e-42  Score=315.84  Aligned_cols=237  Identities=16%  Similarity=0.087  Sum_probs=178.5

Q ss_pred             ccccccCCCCCCcEEEEEE-eCCCCEEEEEEeCCCCChh---HHHHHHHHHHHhcCCC-cccccccee------------
Q 020221           59 ENIVSEHGEKAPNVVYKGK-LENQFRIAVKRFNRSAWPD---ARQFLEEARAVGQLRN-RRLANLLGC------------  121 (329)
Q Consensus        59 ~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~---~~~~~~e~~~l~~l~h-~niv~~~~~------------  121 (329)
                      +.+.+.||+|+||+||+|. ..+|+.||||++.......   .+.+.+|+.+++.++| +|......+            
T Consensus        80 ~~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~  159 (413)
T 3dzo_A           80 LVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLVKD  159 (413)
T ss_dssp             EEEEEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCCCEEEEC
T ss_pred             EEEecccccCCCEEEEEEEecCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccchhhccc
Confidence            4455678999999999999 5678999999998543332   4678899999999976 322111111            


Q ss_pred             ---------eee-----CCeeEEEEecCCCCCHHhhhc-----cCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccc
Q 020221          122 ---------CCE-----GDERLLVAEYMPNDTLAKHLF-----HWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDL  182 (329)
Q Consensus       122 ---------~~~-----~~~~~lv~e~~~~gsL~~~l~-----~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dl  182 (329)
                               +..     ....+++|+++ +++|.+++.     ......+++..+..++.||+.||+|||++ +|+||||
T Consensus       160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~-~iiHrDi  237 (413)
T 3dzo_A          160 PQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHY-GLVHTYL  237 (413)
T ss_dssp             CC---------------CCSEEEEEECC-SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHT-TEECSCC
T ss_pred             CCCCccccccCCCccccccceEEEeehh-cCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHhC-CcccCCc
Confidence                     111     12456777766 569999884     21345578889999999999999999999 9999999


Q ss_pred             CCCceeeCCCCCeeeecccCcccCCCC-CCccCcccccCcccc----------cCCCCCCcccchhhhHHHHHHHhCCCC
Q 020221          183 NAYRIVFDDDVNPRLSCFGLMKNSRDG-RSYSTNLAFTPPEYL----------RTGRVTPESVMYSFGTLLLDLLSGKHI  251 (329)
Q Consensus       183 kp~Nil~~~~~~~kl~Dfg~a~~~~~~-~~~~~~~~y~aPE~~----------~~~~~~~~~DvwslG~il~el~tg~~~  251 (329)
                      ||+|||++.++.+||+|||+++..... ....| +.|+|||++          .+..++.++||||||+++|||++|+.|
T Consensus       238 Kp~NILl~~~~~~kL~DFG~a~~~~~~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~DvwSlGvil~elltg~~P  316 (413)
T 3dzo_A          238 RPVDIVLDQRGGVFLTGFEHLVRDGASAVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCADLP  316 (413)
T ss_dssp             CGGGEEECTTCCEEECCGGGCEETTEEECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHHHHHHHHHHHHHHHSSCC
T ss_pred             ccceEEEecCCeEEEEeccceeecCCccccCCC-CceeCchhhhccccccccccCcCCCchhhHHHHHHHHHHHHHCCCC
Confidence            999999999999999999998765443 33456 999999998          555588899999999999999999998


Q ss_pred             CCchhhHHHhhhchhhhccccccCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 020221          252 PPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLASRCLQYEPRERPNPRSLVT  308 (329)
Q Consensus       252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~~~l~  308 (329)
                      |........    .......      ....++++.+|+.+||+.||++||++.++++
T Consensus       317 f~~~~~~~~----~~~~~~~------~~~~~~~~~~li~~~l~~dP~~Rpt~~~~l~  363 (413)
T 3dzo_A          317 NTDDAALGG----SEWIFRS------CKNIPQPVRALLEGFLRYPKEDRLLPLQAME  363 (413)
T ss_dssp             CCTTGGGSC----SGGGGSS------CCCCCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred             CCCcchhhh----HHHHHhh------cccCCHHHHHHHHHHccCChhhCcCHHHHHh
Confidence            865432111    1111111      1234578999999999999999999888764

>4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A*

Probab=100.00  E-value=4e-34  Score=272.19  Aligned_cols=179  Identities=12%  Similarity=0.063  Sum_probs=128.0

Q ss_pred             cCCCCCCcEEEEEE-eCCCCEEEEEEeCCCCC----------hhHHHHHHHHHHHhcC-CCccccccceeeeeCCeeEEE
Q 020221           64 EHGEKAPNVVYKGK-LENQFRIAVKRFNRSAW----------PDARQFLEEARAVGQL-RNRRLANLLGCCCEGDERLLV  131 (329)
Q Consensus        64 ~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~----------~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~lv  131 (329)
                      ..+.|++|.+..++ .-.|+.+++|.+.....          ...+++.+|+++|+.+ .|+||+++++++++....|||
T Consensus       241 ~~~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~~~~yLV  320 (569)
T 4azs_A          241 QPYAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGENAQSGWLV  320 (569)
T ss_dssp             C-C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECSSEEEEE
T ss_pred             ccccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEECCEEEEE
Confidence            34667777666655 44578899999976531          1245689999999999 799999999999999999999


Q ss_pred             EecCCCCCHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCCCCCeeeecccCcccCCCCC-
Q 020221          132 AEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDGR-  210 (329)
Q Consensus       132 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~-  210 (329)
                      |||++|++|.++|.  ....++..   .|+.||+.||+|+|++ |||||||||+|||++.+|.+||+|||+|+...... 
T Consensus       321 MEyv~G~~L~d~i~--~~~~l~~~---~I~~QIl~AL~ylH~~-GIIHRDIKPeNILL~~dg~vKL~DFGlAr~~~~~~~  394 (569)
T 4azs_A          321 MEKLPGRLLSDMLA--AGEEIDRE---KILGSLLRSLAALEKQ-GFWHDDVRPWNVMVDARQHARLIDFGSIVTTPQDCS  394 (569)
T ss_dssp             EECCCSEEHHHHHH--TTCCCCHH---HHHHHHHHHHHHHHHT-TCEESCCCGGGEEECTTSCEEECCCTTEESCC---C
T ss_pred             EecCCCCcHHHHHH--hCCCCCHH---HHHHHHHHHHHHHHHC-CceeccCchHhEEECCCCCEEEeecccCeeCCCCCc
Confidence            99999999999997  44566654   5889999999999999 99999999999999999999999999998765443 


Q ss_pred             ---CccCcccccCcccccCCCCCCcccchhhhHHHHHHHhCC
Q 020221          211 ---SYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGK  249 (329)
Q Consensus       211 ---~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~  249 (329)
                         ...||+.|+|||++.+ .+..++|+||+|++++++.++.
T Consensus       395 ~~~t~vGTp~YmAPE~l~g-~~~~~~d~~s~g~~~~~l~~~~  435 (569)
T 4azs_A          395 WPTNLVQSFFVFVNELFAE-NKSWNGFWRSAPVHPFNLPQPW  435 (569)
T ss_dssp             CSHHHHHHHHHHHHHHC------------------CCCCTTH
T ss_pred             cccCceechhhccHHHhCC-CCCCcccccccccchhhhcccc
Confidence               3457899999999985 4667899999999988876654

>3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A*

Probab=99.95  E-value=2e-29  Score=238.56  Aligned_cols=176  Identities=14%  Similarity=0.125  Sum_probs=142.9

Q ss_pred             ccCCCCCCcEEEEEEeCCCCEEEEEEeCCCCCh--h------HHHHHHHHHHHhcCCCccccccceeeeeCCeeEEEEec
Q 020221           63 SEHGEKAPNVVYKGKLENQFRIAVKRFNRSAWP--D------ARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAEY  134 (329)
Q Consensus        63 ~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~--~------~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  134 (329)
                      +.||+|+||.||++.. .+..+++|+.......  .      .+.+.+|+++++.++||||+++..++...+..++||||
T Consensus       342 ~~LG~G~fg~Vy~~~~-~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lVmE~  420 (540)
T 3en9_A          342 HLIGKGAEADIKRDSY-LDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVDLDNKRIMMSY  420 (540)
T ss_dssp             ------CCEEEEEEEC-SSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEETTTTEEEEEC
T ss_pred             CEEeeCCCEEEEEEEE-CCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEeCCccEEEEEC
Confidence            3569999999999965 4568999986553221  1      23478999999999999999777777778888999999


Q ss_pred             CCCCCHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCCCCCeeeecccCcccCCCC-----
Q 020221          135 MPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDG-----  209 (329)
Q Consensus       135 ~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~-----  209 (329)
                      +++++|.+++..          +..++.|++.||.|||++ +|+||||||+|||++.  .+||+|||+++.....     
T Consensus       421 ~~ggsL~~~l~~----------~~~i~~qi~~aL~~LH~~-gIiHrDiKp~NILl~~--~~kL~DFGla~~~~~~~~~~~  487 (540)
T 3en9_A          421 INGKLAKDVIED----------NLDIAYKIGEIVGKLHKN-DVIHNDLTTSNFIFDK--DLYIIDFGLGKISNLDEDKAV  487 (540)
T ss_dssp             CCSEEHHHHSTT----------CTHHHHHHHHHHHHHHHT-TEECTTCCTTSEEESS--SEEECCCTTCEECCCHHHHHH
T ss_pred             CCCCCHHHHHHH----------HHHHHHHHHHHHHHHHHC-cCccCCCCHHHEEECC--eEEEEECccCEECCCcccccc
Confidence            999999999852          568999999999999999 9999999999999998  9999999999887653     


Q ss_pred             ------CCccCcccccCcccccC--CCCCCcccchhhhHHHHHHHhCCCCC
Q 020221          210 ------RSYSTNLAFTPPEYLRT--GRVTPESVMYSFGTLLLDLLSGKHIP  252 (329)
Q Consensus       210 ------~~~~~~~~y~aPE~~~~--~~~~~~~DvwslG~il~el~tg~~~~  252 (329)
                            ....||+.|+|||++.+  ..|+...|+||..+-.++-+.++.++
T Consensus       488 ~~~~~~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl~~l~~v~~r~rY  538 (540)
T 3en9_A          488 DLIVFKKAVLSTHHEKFDEIWERFLEGYKSVYDRWEIILELMKDVERRARY  538 (540)
T ss_dssp             HHHHHHHHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHHHHHHHHHHTCSCC
T ss_pred             chhhhhhhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHhcccc
Confidence                  23467999999999986  45888899999999888887766443

>1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A*

Probab=99.93  E-value=2.9e-26  Score=199.72  Aligned_cols=154  Identities=16%  Similarity=0.058  Sum_probs=122.0

Q ss_pred             HHHHHhcCCCcccccccCCCCCCcEEEEEEeCCCCEEEEEEeCCCCC------------------hhHHHHHHHHHHHhc
Q 020221           48 TLRTATSGFAMENIVSEHGEKAPNVVYKGKLENQFRIAVKRFNRSAW------------------PDARQFLEEARAVGQ  109 (329)
Q Consensus        48 ~~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~------------------~~~~~~~~e~~~l~~  109 (329)
                      .+....+.-..+.+.+.||+|+||.||+|...+|+.||+|.++....                  .....+.+|+.+++.
T Consensus        81 ~l~~~~~~~~~~~~~~~iG~G~~g~Vy~~~~~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~  160 (282)
T 1zar_A           81 SLHRLVRSGKVDAIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQK  160 (282)
T ss_dssp             HHHHHHHTTSCSEEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHH
T ss_pred             HHHHHHhCCeEEEecCEeccCCCceEEEEEeCCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHh
Confidence            33344444455556688899999999999987789999999975432                  124468899999999


Q ss_pred             CCCccccccceeeeeCCeeEEEEecCCCCCHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceee
Q 020221          110 LRNRRLANLLGCCCEGDERLLVAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVF  189 (329)
Q Consensus       110 l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~  189 (329)
                      ++  | +++.+++. .+..++||||+++++|.+ +..        .....++.|++.||.|||+. |++||||||+|||+
T Consensus       161 l~--~-~~v~~~~~-~~~~~lvmE~~~g~~L~~-l~~--------~~~~~i~~qi~~~l~~lH~~-giiHrDlkp~NILl  226 (282)
T 1zar_A          161 LQ--G-LAVPKVYA-WEGNAVLMELIDAKELYR-VRV--------ENPDEVLDMILEEVAKFYHR-GIVHGDLSQYNVLV  226 (282)
T ss_dssp             TT--T-SSSCCEEE-EETTEEEEECCCCEEGGG-CCC--------SCHHHHHHHHHHHHHHHHHT-TEECSCCSTTSEEE
T ss_pred             cc--C-CCcCeEEe-ccceEEEEEecCCCcHHH-cch--------hhHHHHHHHHHHHHHHHHHC-CCEeCCCCHHHEEE
Confidence            99  5 77777654 356799999999999988 521        13457999999999999999 99999999999999


Q ss_pred             CCCCCeeeecccCcccCCCCCCccCcccccCccccc
Q 020221          190 DDDVNPRLSCFGLMKNSRDGRSYSTNLAFTPPEYLR  225 (329)
Q Consensus       190 ~~~~~~kl~Dfg~a~~~~~~~~~~~~~~y~aPE~~~  225 (329)
                      + ++.+||+|||++...         ..+.|||++.
T Consensus       227 ~-~~~vkl~DFG~a~~~---------~~~~a~e~l~  252 (282)
T 1zar_A          227 S-EEGIWIIDFPQSVEV---------GEEGWREILE  252 (282)
T ss_dssp             E-TTEEEECCCTTCEET---------TSTTHHHHHH
T ss_pred             E-CCcEEEEECCCCeEC---------CCCCHHHHHH
Confidence            9 999999999998643         3468888875

>1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A*

Probab=99.86  E-value=5.5e-22  Score=170.58  Aligned_cols=149  Identities=13%  Similarity=0.068  Sum_probs=112.2

Q ss_pred             HHHHHHHhcCCCcccccccCCCCCCcEEEEEEe-CCCCE--EEEEEeCCCCCh------------------------hHH
Q 020221           46 IETLRTATSGFAMENIVSEHGEKAPNVVYKGKL-ENQFR--IAVKRFNRSAWP------------------------DAR   98 (329)
Q Consensus        46 ~~~~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~-~~~~~--vavK~~~~~~~~------------------------~~~   98 (329)
                      ...+....+.-..+.+.+.||+|+||.||+|.. .+|+.  ||||+++.....                        ...
T Consensus        36 ~~~l~~~~~~~~~~~i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  115 (258)
T 1zth_A           36 LKTLYKLSAKGYITAMGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFI  115 (258)
T ss_dssp             HHHHHHHHHTTSEEEEEEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHH
T ss_pred             HHHHHHHHhCCCchhhCCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHH
Confidence            334444444445567788899999999999996 77888  999997653211                        012


Q ss_pred             HHHHHHHHHhcCCCccc--cccceeeeeCCeeEEEEecCCC-C----CHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHh
Q 020221           99 QFLEEARAVGQLRNRRL--ANLLGCCCEGDERLLVAEYMPN-D----TLAKHLFHWETQPMKWAMRLRVALHIAEALEYC  171 (329)
Q Consensus        99 ~~~~e~~~l~~l~h~ni--v~~~~~~~~~~~~~lv~e~~~~-g----sL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~l  171 (329)
                      .+.+|+..+..+.|+++  ...++.    ...++||||+.+ |    +|.+....     .++..+..++.|++.+|.||
T Consensus       116 ~~~~E~~~l~~l~~~~i~~p~~~~~----~~~~lVmE~~g~~g~~~~~L~~~~~~-----~~~~~~~~i~~qi~~~l~~l  186 (258)
T 1zth_A          116 WTEKEFRNLERAKEAGVSVPQPYTY----MKNVLLMEFIGEDELPAPTLVELGRE-----LKELDVEGIFNDVVENVKRL  186 (258)
T ss_dssp             HHHHHHHHHHHHHHTTCCCCCEEEE----ETTEEEEECCEETTEECCBHHHHGGG-----GGGSCHHHHHHHHHHHHHHH
T ss_pred             HHHHHHHHHHHHHhCCCCCCeEEEc----CCCEEEEEecCCCCCccccHHHHhhc-----cChHHHHHHHHHHHHHHHHH
Confidence            57889999999988764  233322    357899999942 3    67665531     23456788999999999999


Q ss_pred             h-cCCCccccccCCCceeeCCCCCeeeecccCcccC
Q 020221          172 T-SKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNS  206 (329)
Q Consensus       172 H-~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~  206 (329)
                      | +. |++||||||+|||++.  .++|+|||+|...
T Consensus       187 H~~~-givHrDlkp~NILl~~--~~~liDFG~a~~~  219 (258)
T 1zth_A          187 YQEA-ELVHADLSEYNIMYID--KVYFIDMGQAVTL  219 (258)
T ss_dssp             HHTS-CEECSSCSTTSEEESS--SEEECCCTTCEET
T ss_pred             HHHC-CEEeCCCCHHHEEEcC--cEEEEECcccccC
Confidence            9 88 9999999999999998  9999999999754

>4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A

Probab=99.77  E-value=2.8e-19  Score=160.22  Aligned_cols=150  Identities=10%  Similarity=0.054  Sum_probs=104.5

Q ss_pred             HHHHHHHhcCCCcccccccCCCCCCcEEEEEEeCCCCEEEEEEeCCCCCh--------------hHHHH--------HHH
Q 020221           46 IETLRTATSGFAMENIVSEHGEKAPNVVYKGKLENQFRIAVKRFNRSAWP--------------DARQF--------LEE  103 (329)
Q Consensus        46 ~~~~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~--------------~~~~~--------~~e  103 (329)
                      +-.|....+.=..|.+.+.||+|++|.||+|...+|+.||||+++.....              .....        .+|
T Consensus        84 ~LAL~~L~~rg~iY~I~~~IG~Gk~a~VY~a~d~~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE  163 (397)
T 4gyi_A           84 YLALHTHAARKDVYSVGSRIGVGKESDIMIVADEKGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKE  163 (397)
T ss_dssp             HHHHHHHHHTTSCSEEEEEEEECSSEEEEEEECTTCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHH
T ss_pred             HHHHHHHHHCCCEEEecCEeeeCCceEEEEEECCCCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHH
Confidence            44455555555668889999999999999999888999999997642100              01111        234


Q ss_pred             HHHHhcCCCccccccceeeeeCCeeEEEEecCCCCCHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccC
Q 020221          104 ARAVGQLRNRRLANLLGCCCEGDERLLVAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLN  183 (329)
Q Consensus       104 ~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlk  183 (329)
                      ...|..+.+.++....-+..  ...+|||||+++++|..+..      .  .....++.|++.+|.+||.. |+||||||
T Consensus       164 ~~nL~rL~~~gv~vp~p~~~--~~~~LVME~i~G~~L~~l~~------~--~~~~~l~~qll~~l~~lH~~-gIVHrDLK  232 (397)
T 4gyi_A          164 FAFMKALYEEGFPVPEPIAQ--SRHTIVMSLVDALPMRQVSS------V--PDPASLYADLIALILRLAKH-GLIHGDFN  232 (397)
T ss_dssp             HHHHHHHHHTTCSCCCEEEE--ETTEEEEECCSCEEGGGCCC------C--SCHHHHHHHHHHHHHHHHHT-TEECSCCS
T ss_pred             HHHHHHHHhcCCCCCeeeec--cCceEEEEecCCccHhhhcc------c--HHHHHHHHHHHHHHHHHHHC-CCcCCCCC
Confidence            55555553333221111111  23479999999988866542      1  13456889999999999999 99999999


Q ss_pred             CCceeeCCCCC----------eeeecccCcccC
Q 020221          184 AYRIVFDDDVN----------PRLSCFGLMKNS  206 (329)
Q Consensus       184 p~Nil~~~~~~----------~kl~Dfg~a~~~  206 (329)
                      |.|||+++++.          +.|+||+-+...
T Consensus       233 p~NILl~~dgd~~d~~~~~~~~~iID~~Q~V~~  265 (397)
T 4gyi_A          233 EFNILIREEKDAEDPSSITLTPIIIXFPQMVSM  265 (397)
T ss_dssp             TTSEEEEEEECSSCTTSEEEEEEECCCTTCEET
T ss_pred             HHHEEEeCCCCcccccccccceEEEEeCCcccC
Confidence            99999987763          889999977543

>3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A*

Probab=99.46  E-value=2e-13  Score=117.22  Aligned_cols=137  Identities=14%  Similarity=-0.011  Sum_probs=106.9

Q ss_pred             ccccccCCCCCCcEEEEEEeCCCCEEEEEEeCCCCChhHHHHHHHHHHHhcCC-CccccccceeeeeCCeeEEEEecCCC
Q 020221           59 ENIVSEHGEKAPNVVYKGKLENQFRIAVKRFNRSAWPDARQFLEEARAVGQLR-NRRLANLLGCCCEGDERLLVAEYMPN  137 (329)
Q Consensus        59 ~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~~~~lv~e~~~~  137 (329)
                      +.+...++.|+.+.||+.... +..+++|............+.+|+.+++.+. +..+.++++++...+..++||||++|
T Consensus        16 ~~~~~~~~g~s~~~v~~~~~~-~~~~vlK~~~~~~~~~~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~i~G   94 (263)
T 3tm0_A           16 YRCVKDTEGMSPAKVYKLVGE-NENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLLMSEADG   94 (263)
T ss_dssp             SEEEECCSCCSSSEEEEEECS-SCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCSS
T ss_pred             ceeEeeccCCCCCeEEEEECC-CCcEEEEeCCcccCCCHHHHHHHHHHHHHHhcCCCCCeEEEEEecCCceEEEEEecCC
Confidence            555666688888999999864 5689999987532222345788999999884 67788899998888899999999999


Q ss_pred             CCHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhc--------------------------------------------
Q 020221          138 DTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTS--------------------------------------------  173 (329)
Q Consensus       138 gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~--------------------------------------------  173 (329)
                      .+|.+.+.       +......++.+++.+|..||+                                            
T Consensus        95 ~~l~~~~~-------~~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  167 (263)
T 3tm0_A           95 VLCSEEYE-------DEQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDTPFKDP  167 (263)
T ss_dssp             EEHHHHCC-------TTTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGGGGSTTCSSSSH
T ss_pred             eehhhccC-------CcccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhccccccccccccccccCCCH
Confidence            99987642       112234678899999999998                                            


Q ss_pred             ---------------CCCccccccCCCceeeCCCCCeeeecccCcc
Q 020221          174 ---------------KERALYHDLNAYRIVFDDDVNPRLSCFGLMK  204 (329)
Q Consensus       174 ---------------~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~  204 (329)
                                     . .++|+|++|.||+++++..+.|+||+.+.
T Consensus       168 ~~l~~~l~~~~~~~~~-~l~HgDl~~~Nil~~~~~~~~lIDwe~a~  212 (263)
T 3tm0_A          168 RELYDFLKTEKPEEEL-VFSHGDLGDSNIFVKDGKVSGFIDLGRSG  212 (263)
T ss_dssp             HHHHHHHHHCCCCCCE-EEECSSCCTTSEEEETTEEEEECCCTTCE
T ss_pred             HHHHHHHHhcCCCCCc-eEECCCCCcCcEEEECCcEEEEEEchhcc
Confidence                           2 58899999999999876666799999764

>1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6

Probab=99.33  E-value=2.3e-12  Score=110.14  Aligned_cols=126  Identities=14%  Similarity=0.087  Sum_probs=94.9

Q ss_pred             CCCCCcEEEEEEeCCCCEEEEEEeCCCCChhHHHHHHHHHHHhcCCCcc--ccccceeeeeCCeeEEEEecCCCCCHHhh
Q 020221           66 GEKAPNVVYKGKLENQFRIAVKRFNRSAWPDARQFLEEARAVGQLRNRR--LANLLGCCCEGDERLLVAEYMPNDTLAKH  143 (329)
Q Consensus        66 g~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~n--iv~~~~~~~~~~~~~lv~e~~~~gsL~~~  143 (329)
                      +.|..+.||+....+|..+++|......   ...+.+|+.+++.+.+.+  +.+++++...++..++||||++|.+|.  
T Consensus        29 ~gg~~~~v~~~~~~~g~~~vlK~~~~~~---~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~~~~~~v~e~i~G~~l~--  103 (264)
T 1nd4_A           29 IGCSDAAVFRLSAQGRPVLFVKTDLSGA---LNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQDLL--  103 (264)
T ss_dssp             CTTSSCEEEEEECTTSCCEEEEEECSCT---TSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSEETT--
T ss_pred             cCCCCceEEEEecCCCCeEEEEeCCccc---chhhhHHHHHHHHHHhCCCCCCeEEEeccCCCCCEEEEEecCCcccC--
Confidence            4566699999987777789999986542   234678899888885434  456788877777889999999998874  


Q ss_pred             hccCCCCCCCHHHHHHHHHHHHHHHHHhhcCC------------------------------------------------
Q 020221          144 LFHWETQPMKWAMRLRVALHIAEALEYCTSKE------------------------------------------------  175 (329)
Q Consensus       144 l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~------------------------------------------------  175 (329)
                      ..   .  .+   ...++.+++..|..||+..                                                
T Consensus       104 ~~---~--~~---~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~  175 (264)
T 1nd4_A          104 SS---H--LA---PAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPAELFARLK  175 (264)
T ss_dssp             TS---C--CC---HHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHHHHHHHHH
T ss_pred             cC---c--CC---HhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhhhhccCccHHHHHHHHH
Confidence            21   1  11   2356777888888888641                                                


Q ss_pred             ---------CccccccCCCceeeCCCCCeeeecccCcc
Q 020221          176 ---------RALYHDLNAYRIVFDDDVNPRLSCFGLMK  204 (329)
Q Consensus       176 ---------~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~  204 (329)
                               .++|+|++|.||++++++.+.|+||+.+.
T Consensus       176 ~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~liD~~~a~  213 (264)
T 1nd4_A          176 ARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLG  213 (264)
T ss_dssp             HTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCE
T ss_pred             HhcCCCCCeEEECCCCCCCcEEEECCcEEEEEcchhcc
Confidence                     28999999999999877667799999864

>3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134}

Probab=99.25  E-value=3.4e-11  Score=108.05  Aligned_cols=145  Identities=14%  Similarity=0.139  Sum_probs=107.1

Q ss_pred             CCcccccccCCCCCCcEEEEEEeCCCCEEEEEEeC--CCC-ChhHHHHHHHHHHHhcCC--CccccccceeeeeC---Ce
Q 020221           56 FAMENIVSEHGEKAPNVVYKGKLENQFRIAVKRFN--RSA-WPDARQFLEEARAVGQLR--NRRLANLLGCCCEG---DE  127 (329)
Q Consensus        56 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~--~~~-~~~~~~~~~e~~~l~~l~--h~niv~~~~~~~~~---~~  127 (329)
                      +.....++.++.|.++.||+....+ ..+++|+..  ... ......+.+|..+++.+.  +..+.+++.++.+.   +.
T Consensus        37 ~~~~~~~~~l~~G~sn~~y~v~~~~-~~~vlr~~~~p~~~~~~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~g~  115 (359)
T 3dxp_A           37 FAGPLSVEQFKGGQSNPTFKLVTPG-QTYVMRAKPGPKSKLLPSAHAIEREYRVMDALAGTDVPVAKMYALCEDESVIGR  115 (359)
T ss_dssp             CCCCCEEEECCC-CCSCEEEEECSS-CEEEEECCCC----------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTTSS
T ss_pred             CCCCceEEEcCCcccceEEEEEECC-ceEEEEeCCCCCCCCCCcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCccCC
Confidence            3333445677999999999998755 478888876  332 122346788999999986  45577888887665   45


Q ss_pred             eEEEEecCCCCCHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcC---------------------------------
Q 020221          128 RLLVAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSK---------------------------------  174 (329)
Q Consensus       128 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~---------------------------------  174 (329)
                      .++||||++|.++.+..    ...++..+...++.+++..|..||+.                                 
T Consensus       116 ~~~vme~v~G~~l~~~~----~~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  191 (359)
T 3dxp_A          116 AFYIMEFVSGRVLWDQS----LPGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSET  191 (359)
T ss_dssp             CEEEEECCCCBCCCCTT----CTTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCC
T ss_pred             eEEEEEecCCeecCCCc----cccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcCC
Confidence            89999999998775422    23467888899999999999999971                                 


Q ss_pred             ------------------------CCccccccCCCceeeCCCCC--eeeecccCccc
Q 020221          175 ------------------------ERALYHDLNAYRIVFDDDVN--PRLSCFGLMKN  205 (329)
Q Consensus       175 ------------------------~~ivH~dlkp~Nil~~~~~~--~kl~Dfg~a~~  205 (329)
                                              ..++|+|+++.||+++.++.  +.|+||+.+..
T Consensus       192 ~~~~~~~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~  248 (359)
T 3dxp_A          192 ESIPAMDSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTL  248 (359)
T ss_dssp             SCCHHHHHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEE
T ss_pred             cCChHHHHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECcccccc
Confidence                                    26899999999999997753  68999998764

>3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A

Probab=99.05  E-value=5e-11  Score=104.45  Aligned_cols=181  Identities=13%  Similarity=0.104  Sum_probs=117.6

Q ss_pred             cccCCCCCCcEEEEEEeCCCCEEEEEEeCCCCChhHHHHHHHHHHHhcCC-Ccc--ccccceeeeeCC---eeEEEEecC
Q 020221           62 VSEHGEKAPNVVYKGKLENQFRIAVKRFNRSAWPDARQFLEEARAVGQLR-NRR--LANLLGCCCEGD---ERLLVAEYM  135 (329)
Q Consensus        62 ~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h~n--iv~~~~~~~~~~---~~~lv~e~~  135 (329)
                      ++.++.|..+.||+..    ..+++|+....  .....+.+|..+++.+. +..  +.+.+.......   ..|+||+++
T Consensus        25 i~~~~~G~~n~v~~v~----~~~vlR~~~~~--~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~~~vm~~i   98 (304)
T 3sg8_A           25 IEISGEGNDCIAYEIN----RDFIFKFPKHS--RGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMSFAGFTKI   98 (304)
T ss_dssp             CCEEEECSSEEEEEST----TSEEEEEESSH--HHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCSCEEEECC
T ss_pred             eEecCCCCcceEEEEC----CEEEEEecCCc--chHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcceEEEccc
Confidence            3446889999988863    36889986543  33567889999998873 333  333444332222   358899999


Q ss_pred             CCCCHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcC-----------------------------------------
Q 020221          136 PNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSK-----------------------------------------  174 (329)
Q Consensus       136 ~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~-----------------------------------------  174 (329)
                      +|.+|.....    ..++..+...++.+++..|+.||+.                                         
T Consensus        99 ~G~~l~~~~~----~~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~  174 (304)
T 3sg8_A           99 KGVPLTPLLL----NNLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQMKKVD  174 (304)
T ss_dssp             CCEECCHHHH----HTSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHHHHHHH
T ss_pred             CCeECCcccc----ccCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCcccHHHHH
Confidence            9988765332    2466777778888888888888851                                         


Q ss_pred             ----------------CCccccccCCCceeeCC--CCCeeeecccCcccCCCCCCccCcccc---cCcccccC-----C-
Q 020221          175 ----------------ERALYHDLNAYRIVFDD--DVNPRLSCFGLMKNSRDGRSYSTNLAF---TPPEYLRT-----G-  227 (329)
Q Consensus       175 ----------------~~ivH~dlkp~Nil~~~--~~~~kl~Dfg~a~~~~~~~~~~~~~~y---~aPE~~~~-----~-  227 (329)
                                      ..++|+|++|.||++++  ...+.++||+.+....+.........+   ..|+....     + 
T Consensus       175 ~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~~~~~Dl~~~~~~~~~~~~~~~~~~l~~Y~~  254 (304)
T 3sg8_A          175 DFYRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAISDPDNDFISLMEDDEEYGMEFVSKILNHYKH  254 (304)
T ss_dssp             HHHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEECTTHHHHTTCCTTTSCCHHHHHHHHHHHTC
T ss_pred             HHHHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccCChHHHHHHHHhhccccCHHHHHHHHHHcCC
Confidence                            13699999999999998  456789999987654332111111111   12221110     0 


Q ss_pred             --------CCCCcccchhhhHHHHHHHhCCCCC
Q 020221          228 --------RVTPESVMYSFGTLLLDLLSGKHIP  252 (329)
Q Consensus       228 --------~~~~~~DvwslG~il~el~tg~~~~  252 (329)
                              ......+.|+++.++|.+.+|..++
T Consensus       255 ~~~~~~~~r~~~~~~~~~l~~~~~~~~~g~~~~  287 (304)
T 3sg8_A          255 KDIPTVLEKYRMKEKYWSFEKIIYGKEYGYMDW  287 (304)
T ss_dssp             SCHHHHHHHHHHHHHHHHHHHHHHHHHTTCHHH
T ss_pred             CCcHHHHHHHHHHHHHHHHHHHHHHHHcCCHHH
Confidence                    0111257899999999999999544

>3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A*

Probab=98.61  E-value=1.9e-07  Score=81.74  Aligned_cols=133  Identities=13%  Similarity=0.042  Sum_probs=89.8

Q ss_pred             ccCCCCCCcEEEEEEeCCCCEEEEEEeCCCCChhHHHHHHHHHHHhcCCCc---cccccceeee-eCCeeEEEEecCCCC
Q 020221           63 SEHGEKAPNVVYKGKLENQFRIAVKRFNRSAWPDARQFLEEARAVGQLRNR---RLANLLGCCC-EGDERLLVAEYMPND  138 (329)
Q Consensus        63 ~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~---niv~~~~~~~-~~~~~~lv~e~~~~g  138 (329)
                      ..++.|....||+.    +..+++|+...  ......+.+|.++|+.+.+.   .+.+.+.++. ..+..+++||+++|.
T Consensus        25 ~~l~~G~~n~v~~v----g~~~VlR~~~~--~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~~g~~~~v~e~i~G~   98 (306)
T 3tdw_A           25 ESLGEGFRNYAILV----NGDWVFRFPKS--QQGADELNKEIQLLPLLVGCVKVNIPQYVYIGKRSDGNPFVGYRKVQGQ   98 (306)
T ss_dssp             EEEEECSSEEEEEE----TTTEEEEEESS--HHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEECTTSCEEEEEECCCSE
T ss_pred             eecCCCcceeEEEE----CCEEEEEecCC--chHHHHHHHHHHHHHHHHhcCCCCCCCeEeecccCCCceEEEEeccCCe
Confidence            34577888889988    45688998532  22345788999999999642   2455555553 345678999999998


Q ss_pred             CHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcC--------------------------------------------
Q 020221          139 TLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSK--------------------------------------------  174 (329)
Q Consensus       139 sL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~--------------------------------------------  174 (329)
                      +|.....    ..++..+...++.+++..|+.||+.                                            
T Consensus        99 ~l~~~~~----~~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l~~~~~~~l~~  174 (306)
T 3tdw_A           99 ILGEDGM----AVLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLLDESLRDYLTL  174 (306)
T ss_dssp             ECHHHHH----TTSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGSCHHHHHHHHH
T ss_pred             ECchhhh----hhCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhcccccchhhHHHHHH
Confidence            8766321    1234444555555555555555532                                            


Q ss_pred             ---------------CCccccccCCCceeeCC---CCC-eeeecccCccc
Q 020221          175 ---------------ERALYHDLNAYRIVFDD---DVN-PRLSCFGLMKN  205 (329)
Q Consensus       175 ---------------~~ivH~dlkp~Nil~~~---~~~-~kl~Dfg~a~~  205 (329)
                                     ..++|+|++|.||+++.   ++. +.|+||+.+..
T Consensus       175 ~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~  224 (306)
T 3tdw_A          175 RFQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAI  224 (306)
T ss_dssp             HHHHHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCEE
T ss_pred             HHHHHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcCC
Confidence                           13589999999999987   455 48999998753

>4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A*

Probab=98.54  E-value=6.3e-07  Score=76.69  Aligned_cols=125  Identities=15%  Similarity=0.050  Sum_probs=88.5

Q ss_pred             cEEEEEEe-CCCCEEEEEEeCCCCChhHHHHHHHHHHHhcCC-CccccccceeeeeCCeeEEEEecCCCCCHHhhhccCC
Q 020221           71 NVVYKGKL-ENQFRIAVKRFNRSAWPDARQFLEEARAVGQLR-NRRLANLLGCCCEGDERLLVAEYMPNDTLAKHLFHWE  148 (329)
Q Consensus        71 g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~  148 (329)
                      +.||+... .++..+.+|+-..   .....+.+|...|+.+. +--+.++++++.+++..++|||+++|.++.+....  
T Consensus        39 ~~v~rl~~~~~~~~~~lk~~~~---~~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~~~~~lvme~l~G~~~~~~~~~--  113 (272)
T 4gkh_A           39 ATIYRLYGKPNAPELFLKHGKG---SVANDVTDEMVRLNWLTAFMPLPTIKHFIRTPDDAWLLTTAIPGKTAFQVLEE--  113 (272)
T ss_dssp             CEEEEEECCTTCCCEEEEEEET---HHHHHHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCCSEEHHHHHHH--
T ss_pred             CeEEEEEecCCCeEEEEEECCC---CCHhHHHHHHHHHHHhccCCCcCeEEEEEEECCeEEEEEEeeCCccccccccC--
Confidence            46898874 4566799998654   23556788999888874 33366778888888999999999999887765421  


Q ss_pred             CCCCCHHHHHHHHHHHHHHHHHhhcC------------------------------------------------------
Q 020221          149 TQPMKWAMRLRVALHIAEALEYCTSK------------------------------------------------------  174 (329)
Q Consensus       149 ~~~~~~~~~~~i~~~i~~~l~~lH~~------------------------------------------------------  174 (329)
                          .......+..+++..|.-||..                                                      
T Consensus       114 ----~~~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~  189 (272)
T 4gkh_A          114 ----YPDSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGWPVEQVWKEMHKLLPF  189 (272)
T ss_dssp             ----CGGGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGTTCCHHHHHHHHHTTCCC
T ss_pred             ----CHHHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhccccccchHHHHHHHHHHhcccc
Confidence                1112233445555555555531                                                      


Q ss_pred             ---CCccccccCCCceeeCCCCCeeeecccCcc
Q 020221          175 ---ERALYHDLNAYRIVFDDDVNPRLSCFGLMK  204 (329)
Q Consensus       175 ---~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~  204 (329)
                         ..++|+|+.+.||++++++.+-|+||+.+.
T Consensus       190 ~~~~~l~HGDl~~~Nil~~~~~~~~viDwe~a~  222 (272)
T 4gkh_A          190 SPDSVVTHGDFSLDNLIFDEGKLIGCIDVGRVG  222 (272)
T ss_dssp             CCCEEEECSCCCTTSEEEETTEEEEECCCTTCE
T ss_pred             cCCcEEEcCCCCCCeEEEECCeEEEEEECcccc
Confidence               026899999999999987777899999864

>3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A*

Probab=98.42  E-value=2.8e-07  Score=82.33  Aligned_cols=81  Identities=5%  Similarity=-0.050  Sum_probs=53.6

Q ss_pred             cccC-CCCCCcEEEEEEeC-------CCCEEEEEEeCCCC---ChhHHHHHHHHHHHhcCC-C--ccccccceeeeeC--
Q 020221           62 VSEH-GEKAPNVVYKGKLE-------NQFRIAVKRFNRSA---WPDARQFLEEARAVGQLR-N--RRLANLLGCCCEG--  125 (329)
Q Consensus        62 ~~~l-g~G~~g~V~~~~~~-------~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~-h--~niv~~~~~~~~~--  125 (329)
                      ++.+ +.|..+.+|+....       ++..+++|......   ......+.+|..+++.+. +  -.+.+++.++.+.  
T Consensus        25 ~~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~~~~~~~E~~~l~~L~~~~~vpvP~v~~~~~~~~~  104 (357)
T 3ats_A           25 ESGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFPTYRLDHQFEVIRLVGELTDVPVPRVRWIETTGDV  104 (357)
T ss_dssp             EEEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSSCCCHHHHHHHHHHHHHHCCSCCCCEEEEECSSTT
T ss_pred             EEECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccCchhHHHHHHHHHHHHhhcCCCCCCcEEEEccCCCc
Confidence            3456 77888999988754       25678899865432   101234677888888774 2  2466677766544  


Q ss_pred             -CeeEEEEecCCCCCHHh
Q 020221          126 -DERLLVAEYMPNDTLAK  142 (329)
Q Consensus       126 -~~~~lv~e~~~~gsL~~  142 (329)
                       +..++|||+++|.++.+
T Consensus       105 ~g~~~~v~e~l~G~~l~~  122 (357)
T 3ats_A          105 LGTPFFLMDYVEGVVPPD  122 (357)
T ss_dssp             TSSCEEEEECCCCBCCCB
T ss_pred             cCCceEEEEecCCCChhh
Confidence             35689999999876543

>2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A*

Probab=98.23  E-value=6.3e-06  Score=74.62  Aligned_cols=75  Identities=15%  Similarity=0.069  Sum_probs=48.5

Q ss_pred             cccCCCCCCcEEEEEEeC-CCCEEEEEEeCCCCC-------hhHHHHHHHHHHHhcCCC--ccc-cccceeeeeCCeeEE
Q 020221           62 VSEHGEKAPNVVYKGKLE-NQFRIAVKRFNRSAW-------PDARQFLEEARAVGQLRN--RRL-ANLLGCCCEGDERLL  130 (329)
Q Consensus        62 ~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~-------~~~~~~~~e~~~l~~l~h--~ni-v~~~~~~~~~~~~~l  130 (329)
                      ++.+|.|..+.||++... ++..+++|.......       .....+..|.++++.+..  +.. .+++.+  +....++
T Consensus        35 ~~~lg~G~~n~vyrv~~~~~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~--d~~~~~l  112 (397)
T 2olc_A           35 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVT  112 (397)
T ss_dssp             EEECCSSSSEEEEEEEC----CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEE
T ss_pred             EEECCCCceEEEEEEEECCCCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEE--cCCccEE
Confidence            456799999999999743 467899998653211       123346778888887732  333 344433  4556789


Q ss_pred             EEecCCCC
Q 020221          131 VAEYMPND  138 (329)
Q Consensus       131 v~e~~~~g  138 (329)
                      |||++++.
T Consensus       113 vmE~l~g~  120 (397)
T 2olc_A          113 VMEDLSHL  120 (397)
T ss_dssp             EECCCTTS
T ss_pred             EEEeCCCc
Confidence            99999764

>2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis}

Probab=98.20  E-value=1.7e-05  Score=69.96  Aligned_cols=137  Identities=11%  Similarity=0.124  Sum_probs=77.0

Q ss_pred             ccCCCCCCcEEEEEEeCCCCEEEEEEeCCCCChhHHHHHHHHHHHhcCCC--ccccccce------eeeeCCeeEEEEec
Q 020221           63 SEHGEKAPNVVYKGKLENQFRIAVKRFNRSAWPDARQFLEEARAVGQLRN--RRLANLLG------CCCEGDERLLVAEY  134 (329)
Q Consensus        63 ~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h--~niv~~~~------~~~~~~~~~lv~e~  134 (329)
                      ..++.|..+.||+....++ .+++|+....    ...+..|..+++.+..  -.+.+++.      +....+..+++++|
T Consensus        38 ~~l~gG~~n~~~~v~~~~~-~~vlk~~~~~----~~~~~~e~~~l~~L~~~g~~vp~~~~~~~g~~~~~~~~~~~~l~~~  112 (346)
T 2q83_A           38 DVIQGNQMALVWKVHTDSG-AVCLKRIHRP----EKKALFSIFAQDYLAKKGMNVPGILPNKKGSLYSKHGSFLFVVYDW  112 (346)
T ss_dssp             EECC----CEEEEEEETTE-EEEEEEECSC----HHHHHHHHHHHHHHHHHTCSSCCBCCCTTSCSCEEETTEEEEEEEC
T ss_pred             eeccccccCcEEEEEeCCC-CEEEEecCCC----HHHHHHHHHHHHHHHHcCCCCCceeecCCCCEEEEECCEEEEEEEe
Confidence            3455567889999987665 5899998752    2333345555554421  12333332      11345678999999


Q ss_pred             CCCCCHH-----------hhh---cc----CC-CC-------CCCHHHH-------------------------------
Q 020221          135 MPNDTLA-----------KHL---FH----WE-TQ-------PMKWAMR-------------------------------  157 (329)
Q Consensus       135 ~~~gsL~-----------~~l---~~----~~-~~-------~~~~~~~-------------------------------  157 (329)
                      ++|.++.           ..+   +.    .. ..       ...|...                               
T Consensus       113 i~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~  192 (346)
T 2q83_A          113 IEGRPFELTVKQDLEFIMKGLADFHTASVGYQPPNGVPIFTKLGRWPNHYTKRCKQMETWKLMAEAEKEDPFSQLYLQEI  192 (346)
T ss_dssp             CCCBCCCTTSHHHHHHHHHHHHHHHHHHTTCCCCTTCCCCBCTTCHHHHHHHHHHHHHHHHHHHHHCSSCHHHHHHHHHH
T ss_pred             ecCccCCCCCHHHHHHHHHHHHHHHHhCCCCCCCccchhcccccchHHHHHHHHHHHHHHHHHHHhccCCcHHHHHHHHH
Confidence            9986542           111   10    00 00       0122211                               


Q ss_pred             HHHHHHHHHHHHHhhc------------CCCccccccCCCceeeCCCCCeeeecccCcc
Q 020221          158 LRVALHIAEALEYCTS------------KERALYHDLNAYRIVFDDDVNPRLSCFGLMK  204 (329)
Q Consensus       158 ~~i~~~i~~~l~~lH~------------~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~  204 (329)
                      ..+...+..++.+|+.            ...++|+|+++.||+++.++.+.|+||+.+.
T Consensus       193 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDfe~a~  251 (346)
T 2q83_A          193 DGFIEDGLRIKDRLLQSTYVPWTEQLKKSPNLCHQDYGTGNTLLGENEQIWVIDLDTVS  251 (346)
T ss_dssp             HHHHHHHHHHHHHHHHTTHHHHHHHHHHSCCEECSSCSTTSEEECGGGCEEECCCTTCE
T ss_pred             HHHHHHHHHHHHHHHhchHHHHHHhccccCceecCCCCcccEEEeCCCcEEEEehhhcc
Confidence            1111223345556642            2379999999999999888899999999764

>2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A

Probab=97.97  E-value=2.8e-05  Score=63.25  Aligned_cols=145  Identities=12%  Similarity=0.000  Sum_probs=93.3

Q ss_pred             CCHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhc-CCCccccccCCCceeeCCCCCeeeecccCcccCCCCCCccCcc
Q 020221          138 DTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTS-KERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDGRSYSTNL  216 (329)
Q Consensus       138 gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~-~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~  216 (329)
                      -||.+.|.. .+.++++.++|.++.|.+.+|.-+-. + .-..+=+.|..|++..+|.+.+.+ +.+        .....
T Consensus        33 vSL~eIL~~-~~~PlsEEqaWALc~Qc~~~L~~~~~~~-~~~~~i~~~~~i~l~~dG~V~f~~-~~s--------~~~~~  101 (229)
T 2yle_A           33 LSLEEILRL-YNQPINEEQAWAVCYQCCGSLRAAARRR-QPRHRVRSAAQIRVWRDGAVTLAP-AAD--------DAGEP  101 (229)
T ss_dssp             EEHHHHHHH-HTSCCCHHHHHHHHHHHHHHHHHHHHTT-CCCCCCCSGGGEEEETTSCEEECC-C---------------
T ss_pred             ccHHHHHHH-cCCCcCHHHHHHHHHHHHHHHHhhhhcc-cCCceecCCcceEEecCCceeccc-ccc--------ccccc
Confidence            478888865 56899999999999999999877622 2 112233456889999999887764 111        11234


Q ss_pred             cccCcccccCCCCCCcccchhhhHHHHHHHhCCCCCCchhhHHHhhhchhhhccccccCCCChHHHHHHHHHHHHhccc-
Q 020221          217 AFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLASRCLQY-  295 (329)
Q Consensus       217 ~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~-  295 (329)
                      .+.|||... ...+.+.-|||||+++|.-+--+.+..                       .+...|+.+-+||..|... 
T Consensus       102 ~~~~pe~~~-~~~te~~~IysLG~tLY~ALDygL~e~-----------------------eE~eLS~~LE~LL~~Mt~~~  157 (229)
T 2yle_A          102 PPVAGKLGY-SQCMETEVIESLGIIIYKALDYGLKEN-----------------------EERELSPPLEQLIDHMANTV  157 (229)
T ss_dssp             -----CCSS-SSSCHHHHHHHHHHHHHHHHTTTCCTT-----------------------EEECCCHHHHHHHHHHTTCC
T ss_pred             CCCChhhcc-ccchHHHHHHHHHHHHHHHhhcCCCcc-----------------------cchhhCHHHHHHHHHHHhcc
Confidence            567888763 345577889999999999987664322                       1233456677777777655 


Q ss_pred             ------------------------CCCCCCCHHHHHHHHHhhhhcc
Q 020221          296 ------------------------EPRERPNPRSLVTALVTLQKDT  317 (329)
Q Consensus       296 ------------------------dp~~Rps~~~~l~~L~~~~~~~  317 (329)
                                              .+..|++.++|++.=..-.+..
T Consensus       158 ~d~~~~DeG~~~~~eg~~d~~~~~~~~~~~sl~~Vi~~C~~hl~~p  203 (229)
T 2yle_A          158 EADGSNDEGYEAAEEGLGDEDEKRKISAIRSYRDVMKLCAAHLPTE  203 (229)
T ss_dssp             C--------------------CCSCCCCCCSHHHHHHHHHTTSSSG
T ss_pred             cccccccccccccccccccccccccccCcCCHHHHHHHHHhhccCc
Confidence                                    2457888888887766665543

>3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX}

Probab=97.92  E-value=2.5e-05  Score=67.35  Aligned_cols=74  Identities=23%  Similarity=0.283  Sum_probs=53.3

Q ss_pred             cccCCCCCCcEEEEEEeCCCCEEEEEEeCCCCChhHHHHHHHHHHHhcCCCc---cccccceeeeeCCeeEEEEecCCCC
Q 020221           62 VSEHGEKAPNVVYKGKLENQFRIAVKRFNRSAWPDARQFLEEARAVGQLRNR---RLANLLGCCCEGDERLLVAEYMPND  138 (329)
Q Consensus        62 ~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~---niv~~~~~~~~~~~~~lv~e~~~~g  138 (329)
                      ++.+|.|..+.||+.+..+|+.|.+|+...........+..|...|+.+.-.   -+.+.+++    +..++||||++++
T Consensus        20 v~~~g~G~~~~vyrv~l~DG~~~~vK~~~~~~~~~~~~~~~Ea~~L~~L~~~~~vpvP~v~~~----~~~~lv~e~l~~~   95 (288)
T 3f7w_A           20 VAERGHSHRWHLYRVELADGTPLFVKALPDDAPALDGLFRAEALGLDWLGRSFGSPVPQVAGW----DDRTLAMEWVDER   95 (288)
T ss_dssp             EEEEEEETTEEEEEEEETTSCEEEEEECCTTCCCCTTHHHHHHHHHHHHTCSTTCCSCCEEEE----ETTEEEEECCCCC
T ss_pred             EEecCCCCCeEEEEEEECCCCEEEEEEeCCCCcchhhHHHHHHHHHHHHHhhCCCCcceEEec----cCceEEEEeeccc
Confidence            4556899999999999999999999987765444445678899988887422   23334433    2347899998775


Q ss_pred             C
Q 020221          139 T  139 (329)
Q Consensus       139 s  139 (329)
                      .
T Consensus        96 ~   96 (288)
T 3f7w_A           96 P   96 (288)
T ss_dssp             C
T ss_pred             C
Confidence            4

>2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6

Probab=97.77  E-value=0.00013  Score=63.81  Aligned_cols=161  Identities=11%  Similarity=0.133  Sum_probs=87.1

Q ss_pred             ccccCHHHHHHHhcCCCccc--ccccCCCCCCcEEEEEEeCCCCEEEEEEeCCCCChhHHHHHHHHHHHhcCCCcc--cc
Q 020221           41 FCEYSIETLRTATSGFAMEN--IVSEHGEKAPNVVYKGKLENQFRIAVKRFNRSAWPDARQFLEEARAVGQLRNRR--LA  116 (329)
Q Consensus        41 ~~~~~~~~~~~~~~~~~~~~--~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~n--iv  116 (329)
                      +..++.+++......|....  -++.++.|....+|+....++ .+++|......  ....+..|..++..+...+  +.
T Consensus         4 ~~~~~~~~l~~~l~~~~~~~~~~~~~i~~G~~n~~~~v~~~~g-~~vlk~~~~~~--~~~~l~~e~~~l~~L~~~g~~vP   80 (322)
T 2ppq_A            4 YTDITEDELRNFLTQYDVGSLTSYKGIAEGVENSNFLLHTTKD-PLILTLYEKRV--EKNDLPFFLGLMQHLAAKGLSCP   80 (322)
T ss_dssp             -CCCCHHHHHHHHTTBCCCCEEEEEEECC---EEEEEEEESSC-CEEEEEECC-----CCHHHHHHHHHHHHHHTTCCCC
T ss_pred             cccCCHHHHHHHHHhCCCCcceEeeccCCCcccceEEEEeCCc-cEEEEEeCCCC--CHHHHHHHHHHHHHHHHCCCCCC
Confidence            34466677776666665422  245567788889999987666 68899887631  1223455666666653212  23


Q ss_pred             cccee------eeeCCeeEEEEecCCCCCHHh-----------h---hc----cCCCC---CC---CHHHHHH-------
Q 020221          117 NLLGC------CCEGDERLLVAEYMPNDTLAK-----------H---LF----HWETQ---PM---KWAMRLR-------  159 (329)
Q Consensus       117 ~~~~~------~~~~~~~~lv~e~~~~gsL~~-----------~---l~----~~~~~---~~---~~~~~~~-------  159 (329)
                      +++..      ....+..+++++|++|..+..           .   ++    .....   ..   .|.....       
T Consensus        81 ~~~~~~~g~~~~~~~g~~~~l~~~l~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~  160 (322)
T 2ppq_A           81 LPLPRKDGELLGELSGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERAD  160 (322)
T ss_dssp             CBCCBTTCCSCEEETTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGG
T ss_pred             cccCCCCCCEEEEECCEEEEEEEeCCCcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHHHHHHH
Confidence            33321      122356789999998854311           0   11    00110   01   1221100       


Q ss_pred             -----HHHHHHHHHHHhhc------CCCccccccCCCceeeCCCCCeeeecccCcc
Q 020221          160 -----VALHIAEALEYCTS------KERALYHDLNAYRIVFDDDVNPRLSCFGLMK  204 (329)
Q Consensus       160 -----i~~~i~~~l~~lH~------~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~  204 (329)
                           +...+...+..+..      ..+++|+|+++.||++++++.+.++||+.+.
T Consensus       161 ~~~~~l~~~l~~~~~~l~~~~~~~~~~~liHgDl~~~Nil~~~~~~~~lIDf~~a~  216 (322)
T 2ppq_A          161 EVEKGLREEIRPEIDYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFAC  216 (322)
T ss_dssp             GTSTTHHHHHHHHHHHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred             hhhhhhHHHHHHHHHHHHhhCcccCCcccCCCCCCccCEEEeCCceEEEecchhcc
Confidence                 00113334444432      1268999999999999987666899999764

>2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana}

Probab=97.73  E-value=0.00028  Score=64.22  Aligned_cols=75  Identities=13%  Similarity=0.062  Sum_probs=46.1

Q ss_pred             cCCCccccccCCCceeeCCCCCeeeecccCcccCCCCCCccC-----cccccCcccccCC---CCCCcccchhhhHHHHH
Q 020221          173 SKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDGRSYST-----NLAFTPPEYLRTG---RVTPESVMYSFGTLLLD  244 (329)
Q Consensus       173 ~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~~~-----~~~y~aPE~~~~~---~~~~~~DvwslG~il~e  244 (329)
                      .. .++|+|++|.||+++.++ ++++||+.+....+.-....     ...|.+|+.....   .-....++.+....+|+
T Consensus       231 ~~-~liHGDl~~~Nil~~~~~-~~lID~e~a~~G~p~~Dla~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  308 (420)
T 2pyw_A          231 AQ-ALIHGDLHTGSVMVTQDS-TQVIDPEFSFYGPMGFDIGAYLGNLILAFFAQDGHATQENDRKEYKQWILRTIEQTWN  308 (420)
T ss_dssp             CC-EEECSCCSGGGEEECSSC-EEECCCTTCEEECHHHHHHHHHHHHHHHHHHGGGGCCSSCCSHHHHHHHHHHHHHHHH
T ss_pred             CC-eEEecCCCCCcEEEeCCC-CEEEeCcccccCchHHHHHHHHHHHHHHHHhcccccccccchHHHHHHHHHHHHHHHH
Confidence            44 799999999999999776 99999998765432211110     1345666544311   11122444566777777


Q ss_pred             HHhCC
Q 020221          245 LLSGK  249 (329)
Q Consensus       245 l~tg~  249 (329)
                      .+++.
T Consensus       309 ~y~~~  313 (420)
T 2pyw_A          309 LFNKR  313 (420)
T ss_dssp             HHHHH
T ss_pred             HHHHH
Confidence            76643

>3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT}

Probab=97.71  E-value=0.00027  Score=61.59  Aligned_cols=75  Identities=17%  Similarity=0.081  Sum_probs=58.0

Q ss_pred             cccCCCCCCcEEEEEEeCCCCEEEEEEeCCCCChhHHHHHHHHHHHhcCC---CccccccceeeeeCCeeEEEEecCCCC
Q 020221           62 VSEHGEKAPNVVYKGKLENQFRIAVKRFNRSAWPDARQFLEEARAVGQLR---NRRLANLLGCCCEGDERLLVAEYMPND  138 (329)
Q Consensus        62 ~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~---h~niv~~~~~~~~~~~~~lv~e~~~~g  138 (329)
                      ++.++.|....+|+.... +..+++|.....   ....+..|...|+.+.   ...+.+.+.+....+..++||||+++.
T Consensus        41 ~~~l~gG~~n~~y~v~~~-~~~~vlK~~~~~---~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~g~~~lvme~l~G~  116 (312)
T 3jr1_A           41 KEKLYSGEMNEIWLINDE-VQTVFVKINERS---YRSMFRAEADQLALLAKTNSINVPLVYGIGNSQGHSFLLLEALNKS  116 (312)
T ss_dssp             EEEECCSSSSEEEEEESS-SCEEEEEEEEGG---GHHHHHHHHHHHHHHHHTTSSBCCCEEEEEECSSEEEEEEECCCCC
T ss_pred             eEEeCCccceeeeEEEEC-CCeEEEEeCCcc---cHHHHHHHHHHHHHHHhhCCCCcceEEEEeecCCceEEEEEeccCC
Confidence            345688999999999864 558889987643   3556788988888873   356778888877778899999999987


Q ss_pred             CH
Q 020221          139 TL  140 (329)
Q Consensus       139 sL  140 (329)
                      .+
T Consensus       117 ~~  118 (312)
T 3jr1_A          117 KN  118 (312)
T ss_dssp             CC
T ss_pred             CC
Confidence            54

>1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6

Probab=97.67  E-value=0.0014  Score=57.23  Aligned_cols=97  Identities=22%  Similarity=0.192  Sum_probs=57.2

Q ss_pred             ccccCHHHHHHHhcCCCcc--cccccCCCCCCcEEEEEEeCCCCEEEEEEeCCCCChhHHHHHHHHHHHhcCCCcc--cc
Q 020221           41 FCEYSIETLRTATSGFAME--NIVSEHGEKAPNVVYKGKLENQFRIAVKRFNRSAWPDARQFLEEARAVGQLRNRR--LA  116 (329)
Q Consensus        41 ~~~~~~~~~~~~~~~~~~~--~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~n--iv  116 (329)
                      +...+.+.+......+...  .-+..++ |....||+....+|+.+++|....... ....+..|..+++.+...+  ++
T Consensus         8 ~~~l~~~~i~~~l~~~g~~~~~~~~~l~-g~~n~~y~v~~~~g~~~vlK~~~~~~~-~~~~~~~E~~~~~~L~~~g~~vp   85 (328)
T 1zyl_A            8 FQTLHPDTIMDALFEHGIRVDSGLTPLN-SYENRVYQFQDEDRRRFVVKFYRPERW-TADQILEEHQFALQLVNDEVPVA   85 (328)
T ss_dssp             CCCCCHHHHHHHHHHTTCCCCSCCEEEC-CSSSEEEEECCTTCCCEEEEEECTTTS-CHHHHHHHHHHHHHHHHTTCSBC
T ss_pred             CCCCCHHHHHHHHHHcCCCCCceEEeec-CcccceEEEEcCCCCEEEEEEcCCCCC-CHHHHHHHHHHHHHHHHcCCeec
Confidence            4445555555444333221  1233445 777899998876777899999874422 3445667777777763212  34


Q ss_pred             cccee-----eeeCCeeEEEEecCCCCC
Q 020221          117 NLLGC-----CCEGDERLLVAEYMPNDT  139 (329)
Q Consensus       117 ~~~~~-----~~~~~~~~lv~e~~~~gs  139 (329)
                      +++..     ....+..++++++++|.+
T Consensus        86 ~~~~~~g~~~~~~~g~~~~l~~~i~G~~  113 (328)
T 1zyl_A           86 APVAFNGQTLLNHQGFYFAVFPSVGGRQ  113 (328)
T ss_dssp             CCCCBTTBSCEEETTEEEEEEECCCCEE
T ss_pred             ceeecCCcEEEEECCEEEEEEEecCCCC
Confidence            44432     122456688999998754

>3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti}

Probab=97.53  E-value=0.00018  Score=62.31  Aligned_cols=71  Identities=14%  Similarity=0.159  Sum_probs=42.8

Q ss_pred             cccCCCCCCcEEEEEEeCCCCEEEEEEeCCCCChhHHHHHHHHHHHhcCCCccc-cccceeeeeCCeeEEEEecC-CCCC
Q 020221           62 VSEHGEKAPNVVYKGKLENQFRIAVKRFNRSAWPDARQFLEEARAVGQLRNRRL-ANLLGCCCEGDERLLVAEYM-PNDT  139 (329)
Q Consensus        62 ~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~ni-v~~~~~~~~~~~~~lv~e~~-~~gs  139 (329)
                      ++.++.|....+|+.     ..+++|+....... .....+|..+++.+...++ .++++.  +...-++++||+ ++.+
T Consensus        23 i~~l~gG~tN~~~~~-----~~~vlR~~~~~~~~-~~~r~~E~~~l~~l~~~g~~P~~~~~--~~~~~~~v~e~i~~g~~   94 (301)
T 3dxq_A           23 PLERLGGLTNLVFRA-----GDLCLRIPGKGTEE-YINRANEAVAAREAAKAGVSPEVLHV--DPATGVMVTRYIAGAQT   94 (301)
T ss_dssp             CEEEESCSSEEEEEE-----TTEEEEEECC-----CCCHHHHHHHHHHHHHTTSSCCEEEE--CTTTCCEEEECCTTCEE
T ss_pred             eeEcCCcccccccee-----eeEEEECCCCCccc-eeCHHHHHHHHHHHHHcCCCCceEEE--ECCCCEEEEeecCCCcc
Confidence            445678888999998     46899988753211 1123457777776643233 344443  344467899999 6544


Q ss_pred             H
Q 020221          140 L  140 (329)
Q Consensus       140 L  140 (329)
                      +
T Consensus        95 l   95 (301)
T 3dxq_A           95 M   95 (301)
T ss_dssp             C
T ss_pred             C
Confidence            4

>3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP}

Probab=97.50  E-value=0.00055  Score=60.15  Aligned_cols=32  Identities=13%  Similarity=0.084  Sum_probs=27.2

Q ss_pred             CccccccCCCceeeCCC----CCeeeecccCcccCC
Q 020221          176 RALYHDLNAYRIVFDDD----VNPRLSCFGLMKNSR  207 (329)
Q Consensus       176 ~ivH~dlkp~Nil~~~~----~~~kl~Dfg~a~~~~  207 (329)
                      .++|+|+.+.||+++.+    +.+.++||+.+....
T Consensus       184 ~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~G~  219 (333)
T 3csv_A          184 VFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKLGH  219 (333)
T ss_dssp             EEECSCCSGGGEEECTTSCGGGGEEECCCTTCEEEC
T ss_pred             eeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCcCC
Confidence            78999999999999874    678999999876443

>1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8

Probab=97.36  E-value=0.00053  Score=62.62  Aligned_cols=73  Identities=18%  Similarity=0.327  Sum_probs=48.2

Q ss_pred             cccCCCCCCcEEEEEEeCC--------CCEEEEEEeCCCCChhHHHHHHHHHHHhcCCCccc-cccceeeeeCCeeEEEE
Q 020221           62 VSEHGEKAPNVVYKGKLEN--------QFRIAVKRFNRSAWPDARQFLEEARAVGQLRNRRL-ANLLGCCCEGDERLLVA  132 (329)
Q Consensus        62 ~~~lg~G~~g~V~~~~~~~--------~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~ni-v~~~~~~~~~~~~~lv~  132 (329)
                      ++.++.|....+|+....+        +..+++|+.....  ....+.+|..+++.+...++ .++++.+..    .+|+
T Consensus        78 v~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~~--~~~~li~E~~~l~~L~~~g~~P~l~~~~~~----g~v~  151 (429)
T 1nw1_A           78 ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNPE--TESHLVAESVIFTLLSERHLGPKLYGIFSG----GRLE  151 (429)
T ss_dssp             EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSCC--CHHHHHHHHHHHHHHHHTTSSSCEEEEETT----EEEE
T ss_pred             EEEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCCC--cHHHHHHHHHHHHHHHhCCCCCcEEEEeCC----CEEE
Confidence            3456778889999998643        4689999985422  12445678888888853333 556655432    3899


Q ss_pred             ecCCCCCH
Q 020221          133 EYMPNDTL  140 (329)
Q Consensus       133 e~~~~gsL  140 (329)
                      ||++|.+|
T Consensus       152 e~l~G~~l  159 (429)
T 1nw1_A          152 EYIPSRPL  159 (429)
T ss_dssp             CCCCEEEC
T ss_pred             EEeCCccc
Confidence            99986443

>3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A*

Probab=97.22  E-value=0.00081  Score=60.23  Aligned_cols=137  Identities=15%  Similarity=0.152  Sum_probs=80.3

Q ss_pred             ccCCCCCCcEEEEEEeC--------CCCEEEEEEeCCCCChhHHHHHHHHHHHhcCCCcc-ccccceeeeeCCeeEEEEe
Q 020221           63 SEHGEKAPNVVYKGKLE--------NQFRIAVKRFNRSAWPDARQFLEEARAVGQLRNRR-LANLLGCCCEGDERLLVAE  133 (329)
Q Consensus        63 ~~lg~G~~g~V~~~~~~--------~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~n-iv~~~~~~~~~~~~~lv~e  133 (329)
                      +.+.-|-...+|+....        ++..+++|+..... .......+|..+++.+...+ ..++++.+.+    .+|+|
T Consensus        56 ~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~~~-~~~~~~~rE~~vl~~L~~~gv~P~ll~~~~~----g~v~e  130 (379)
T 3feg_A           56 YPVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGAIL-QGVDSLVLESVMFAILAERSLGPQLYGVFPE----GRLEQ  130 (379)
T ss_dssp             EEC-----CCEEEEECCTTSCCCSSCCSEEEEEECC----CCHHHHHHHHHHHHHHHHTTSSCCEEEEETT----EEEEE
T ss_pred             EEcCCcccccEEEEEeCCCccccCCCCCeEEEEECCCcc-chHHHHHHHHHHHHHHHhcCCCCeEEEEcCC----ccEEE
Confidence            34566777889999864        24689999864322 23556678999888884322 3555655533    39999


Q ss_pred             cCCCCCHHhh--------------hc---cCC---CCCC--CHHHHHHHHHHHHH-------------------HHHHhh
Q 020221          134 YMPNDTLAKH--------------LF---HWE---TQPM--KWAMRLRVALHIAE-------------------ALEYCT  172 (329)
Q Consensus       134 ~~~~gsL~~~--------------l~---~~~---~~~~--~~~~~~~i~~~i~~-------------------~l~~lH  172 (329)
                      |++|.+|...              |.   ...   ....  -+.++.++..++..                   .+..|.
T Consensus       131 ~i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~~~~~L~  210 (379)
T 3feg_A          131 YIPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMYSLKDEMGNLR  210 (379)
T ss_dssp             CCSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHTTHHHHHHHHH
T ss_pred             EecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhhhhHHHHHHHHHHH
Confidence            9987554311              11   100   1112  24555555544422                   122222


Q ss_pred             ----c---CCCccccccCCCceeeCCC----CCeeeecccCcc
Q 020221          173 ----S---KERALYHDLNAYRIVFDDD----VNPRLSCFGLMK  204 (329)
Q Consensus       173 ----~---~~~ivH~dlkp~Nil~~~~----~~~kl~Dfg~a~  204 (329)
                          .   ...++|+|+.+.||+++.+    +.+.++||..+.
T Consensus       211 ~~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~  253 (379)
T 3feg_A          211 KLLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSS  253 (379)
T ss_dssp             HHHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCE
T ss_pred             HHHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCC
Confidence                1   1257999999999999876    789999999875

>3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A*

Probab=97.09  E-value=0.00081  Score=60.00  Aligned_cols=74  Identities=14%  Similarity=0.213  Sum_probs=43.2

Q ss_pred             cccCCCCCCcEEEEEEeCC---------CCEEEEEEeCCCCChhHHHHHHHHHHHhcCCCcc-ccccceeeeeCCeeEEE
Q 020221           62 VSEHGEKAPNVVYKGKLEN---------QFRIAVKRFNRSAWPDARQFLEEARAVGQLRNRR-LANLLGCCCEGDERLLV  131 (329)
Q Consensus        62 ~~~lg~G~~g~V~~~~~~~---------~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~n-iv~~~~~~~~~~~~~lv  131 (329)
                      +..++.|....+|+....+         +..+++|+..... ........|..+++.+...+ ..++++..  .  -++|
T Consensus        38 ~~~l~~G~~N~~y~v~~~~~~~~~~~~~~~~~vlRi~~~~~-~~~~~~~~E~~~l~~L~~~g~~P~~~~~~--~--~~~v  112 (369)
T 3c5i_A           38 VKQILSGLTNQLFEVGLKEETANNYNSIRTRVLFRIYGKHV-DELYNTISEFEVYKTMSKYKIAPQLLNTF--N--GGRI  112 (369)
T ss_dssp             EEEC----CCEEEEEEECHHHHTTCTTSCCEEEEEECCTTG-GGTSCHHHHHHHHHHHHHTTSSCCEEEEE--T--TEEE
T ss_pred             EEEeCCcccceEEEEEeCCCCcccccCCCceEEEEecCCCc-cceecHHHHHHHHHHHHhcCCCCceEEec--C--CcEE
Confidence            4456778888999998654         2588899876532 11112356777777774333 33555443  2  3789


Q ss_pred             EecCCCCCH
Q 020221          132 AEYMPNDTL  140 (329)
Q Consensus       132 ~e~~~~gsL  140 (329)
                      +||++|.++
T Consensus       113 ~e~i~G~~l  121 (369)
T 3c5i_A          113 EEWLYGDPL  121 (369)
T ss_dssp             EECCCSEEC
T ss_pred             EEEecCCcC
Confidence            999987543

>3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A*

Probab=96.89  E-value=0.0092  Score=52.50  Aligned_cols=30  Identities=7%  Similarity=-0.033  Sum_probs=26.8

Q ss_pred             CccccccCCCceeeCCCCCeeeecccCccc
Q 020221          176 RALYHDLNAYRIVFDDDVNPRLSCFGLMKN  205 (329)
Q Consensus       176 ~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~  205 (329)
                      .++|+|+.+.||++++++.+.++||+.+..
T Consensus       207 ~~~HgD~~~~N~l~~~~~~~~~iD~e~~~~  236 (339)
T 3i1a_A          207 VLCHSDIHAGNVLVGNEESIYIIDWDEPML  236 (339)
T ss_dssp             EEECSCCCGGGEEECGGGCEEECCCSSCEE
T ss_pred             eeEeCCCCcCCEEEeCCCeEEEEECCCCee
Confidence            689999999999999888899999987653

>2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax}

Probab=96.75  E-value=0.0055  Score=56.25  Aligned_cols=73  Identities=14%  Similarity=0.086  Sum_probs=45.4

Q ss_pred             ccCCCCCCcEEEEEEeCC-CCEEEEEEeCCCCChhHHHHHHHHHHHhcCCCccc-cccceeeeeCCeeEEEEecCCCCCH
Q 020221           63 SEHGEKAPNVVYKGKLEN-QFRIAVKRFNRSAWPDARQFLEEARAVGQLRNRRL-ANLLGCCCEGDERLLVAEYMPNDTL  140 (329)
Q Consensus        63 ~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~ni-v~~~~~~~~~~~~~lv~e~~~~gsL  140 (329)
                      +.++.|-...+|+....+ +..+++|+....... .-...+|..+++.+...++ .++++.+.  +  .+|+||++|.+|
T Consensus       114 ~~lsgG~tN~~y~v~~~~~~~~~vLRi~g~~~~~-~idR~~E~~vl~~L~~~gl~P~ll~~~~--~--G~v~e~I~G~~l  188 (458)
T 2qg7_A          114 QIINGGITNILIKVKDMSKQAKYLIRLYGPKTDE-IINREREKKISCILYNKNIAKKIYVFFT--N--GRIEEFMDGYAL  188 (458)
T ss_dssp             EEECC--CEEEEEEEETTTTEEEEEEEECC-CCS-CSCHHHHHHHHHHHTTSSSBCCEEEEET--T--EEEEECCCSEEC
T ss_pred             EEcCCCeEeEEEEEEECCCCceEEEEECCCChhh-hcCHHHHHHHHHHHHhcCCCCCEEEEeC--C--eEEEEeeCCccC
Confidence            345677788999998765 468889987543211 1112478888888864444 45666552  2  359999987444

>3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum}

Probab=96.08  E-value=0.021  Score=51.75  Aligned_cols=74  Identities=15%  Similarity=0.138  Sum_probs=46.8

Q ss_pred             cccCCCCCCcEEEEEEeCC--------CCEEEEEEeCCCCChhHHHHHHHHHHHhcCCCcc-ccccceeeeeCCeeEEEE
Q 020221           62 VSEHGEKAPNVVYKGKLEN--------QFRIAVKRFNRSAWPDARQFLEEARAVGQLRNRR-LANLLGCCCEGDERLLVA  132 (329)
Q Consensus        62 ~~~lg~G~~g~V~~~~~~~--------~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~n-iv~~~~~~~~~~~~~lv~  132 (329)
                      ++.+.-|-...+|+....+        +..+++|+..... ...-...+|..+++.+...+ ..++++.+  .  -++|+
T Consensus        75 v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlRi~g~~t-~~~idR~~E~~~l~~L~~~gi~P~l~~~~--~--~~~I~  149 (424)
T 3mes_A           75 VKQIFSGLTNQLFVVSIVNESMSLSLKHPRILFRIYGKHV-GKFYDSKVELDVFRYLSNINIAPNIIADF--P--EGRIE  149 (424)
T ss_dssp             EEEECCCSSSEEEEEEECCC-----CCCSEEEEEECCCCC--CCCCHHHHHHHHHHHHHTTSSCCEEEEE--T--TEEEE
T ss_pred             EEEcCCCcccceEEEEeCCCcccccCCCCeEEEEECCCCc-chhcCHHHHHHHHHHHHhcCCCCCEEEEc--C--CCEEE
Confidence            3456678888999998653        5789999965432 11112356888877774323 34445433  2  37899


Q ss_pred             ecCCCCCH
Q 020221          133 EYMPNDTL  140 (329)
Q Consensus       133 e~~~~gsL  140 (329)
                      ||++|.+|
T Consensus       150 efI~G~~l  157 (424)
T 3mes_A          150 EFIDGEPL  157 (424)
T ss_dssp             ECCCSEEC
T ss_pred             EEeCCccC
Confidence            99998654

>4ann_A ESSB; membrane protein, membrane secretion, ESS type VII secretion virulence; 1.05A {Staphylococcus aureus subsp}

Probab=92.66  E-value=0.25  Score=39.96  Aligned_cols=113  Identities=16%  Similarity=0.143  Sum_probs=75.2

Q ss_pred             CCccccccceeeeeCCeeEEEEecCCCC-CHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceee
Q 020221          111 RNRRLANLLGCCCEGDERLLVAEYMPND-TLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVF  189 (329)
Q Consensus       111 ~h~niv~~~~~~~~~~~~~lv~e~~~~g-sL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~  189 (329)
                      .||+++.. .+-.+.+.+.+.++.-+.+ ++.. +     +..+....++++.+|+....+++..   +|--++|+|+++
T Consensus        43 ~~~~Fl~~-~I~e~eD~v~~~y~~~~~~~~f~~-i-----k~~~~~eKlr~l~ni~~l~~~~~~r---~tf~L~P~NL~f  112 (215)
T 4ann_A           43 HSPYFIDA-ELTELRDSFQIHYDINDNHTPFDN-I-----KSFTKNEKLRYLLNIKNLEEVNRTR---YTFVLAPDELFF  112 (215)
T ss_dssp             CCTTBCCE-EEEECSSEEEEEECCCTTSEEGGG-G-----GGSCHHHHHHHHHHGGGGGGGGGSS---EECCCSGGGEEE
T ss_pred             cCCcccce-EEEEcccEEEEEEEcCcccCCHHH-H-----HhcCHHHHHHHHHHHHHHHHHhcCc---eEEEEecceEEE
Confidence            57877765 4555566666666664432 2222 3     3478889999999999888666544   688899999999


Q ss_pred             CCCCCeeeecccCcccCCCCCCccCcccccCcccccCCCCCCccc-chhhhHHHHHHHhCCCCC
Q 020221          190 DDDVNPRLSCFGLMKNSRDGRSYSTNLAFTPPEYLRTGRVTPESV-MYSFGTLLLDLLSGKHIP  252 (329)
Q Consensus       190 ~~~~~~kl~Dfg~a~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~D-vwslG~il~el~tg~~~~  252 (329)
                      +.++.+++.-.|+.....             |.-     .+ ..| .-.+=+++..+++++..|
T Consensus       113 ~~~~~p~i~~RGik~~l~-------------P~~-----~~-ee~fL~qyKAliiall~~K~~F  157 (215)
T 4ann_A          113 TRDGLPIAKTRGLQNVVD-------------PLP-----VS-EAEFLTRYKALVICAFNEKQSF  157 (215)
T ss_dssp             CTTSCEEESCCEETTTBS-------------CCC-----CC-HHHHHHHHHHHHHHHHCTTCCH
T ss_pred             cCCCCEEEEEccCccCCC-------------CCC-----CC-HHHHHHHHHHHHHHHHcCCCCH
Confidence            999999999888643222             211     01 112 225666788888887543

>4ano_A ESSB; membrane protein, membrane secretion, ESS type V secretion S; HET: MSE; 1.70A {Geobacillus thermodenitrificans ng80-2organism_taxid}

Probab=92.25  E-value=0.41  Score=38.86  Aligned_cols=111  Identities=14%  Similarity=0.224  Sum_probs=73.9

Q ss_pred             CCccccccceeeeeCCeeEEEEecCCCCCHHhhhccCCCCCCCHHHHHHHHHHHHHHHH-HhhcCCCccccccCCCceee
Q 020221          111 RNRRLANLLGCCCEGDERLLVAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALE-YCTSKERALYHDLNAYRIVF  189 (329)
Q Consensus       111 ~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~-~lH~~~~ivH~dlkp~Nil~  189 (329)
                      .||++  -..+-.+.+.+.+.++.-+++.=...+     ..++...+++++.+|+.... +++..   +|--++|+|+++
T Consensus        48 ~~~~f--~~~I~~~eD~~~i~y~~~~~~~~f~~i-----~~~~~~eKlrll~nl~~L~~~~~~~r---~tf~l~P~NL~f  117 (219)
T 4ano_A           48 VDPCI--VRDIDVSEDEVKVVIKPPSSFLTFAAI-----RKTTLLSRIRAAIHLVSKVKHHSARR---LIFIVCPENLMF  117 (219)
T ss_dssp             SCSSS--EEEEEECSSEEEEEEECCTTCEEHHHH-----HTSCHHHHHHHHHHHHHHHSSCCSSS---EECCCCGGGEEE
T ss_pred             cCCCC--CeEEEEeCCEEEEEEEcCcccCcHHHH-----HhcCHHHHHHHHHHHHHHHHHhhhCc---eeEEEeCceEEE
Confidence            57777  333445667777777765443222334     25788899999999988777 55544   788899999999


Q ss_pred             CCCCCeeeecccCcccCCCCCCccCcccccCcccccCCCCCCcccch-hhhHHHHHHHhCCC
Q 020221          190 DDDVNPRLSCFGLMKNSRDGRSYSTNLAFTPPEYLRTGRVTPESVMY-SFGTLLLDLLSGKH  250 (329)
Q Consensus       190 ~~~~~~kl~Dfg~a~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dvw-slG~il~el~tg~~  250 (329)
                      +.++.+++.-.|+-..             ++|.-+.      ..|.| ++=+++..++.++.
T Consensus       118 ~~~~~p~i~hRGi~~~-------------lpP~e~~------ee~fl~qyKali~all~~K~  160 (219)
T 4ano_A          118 NRALEPFFLHVGVKES-------------LPPDEWD------DERLLREVKATVLALTEGEY  160 (219)
T ss_dssp             CTTCCEEESCCEETTT-------------BSSCSCC------HHHHHHHHHHHHHHHTTCSS
T ss_pred             eCCCcEEEEEcCCccc-------------CCCCCCC------HHHHHHHHHHHHHHHHcCCC
Confidence            9999999998886432             2332211      12222 56667788888874

>3cxl_A N-chimerin; SH2, RHO-GAP, structural genomics consortium, SGC, gtpas activation, metal-binding, phorbol-ester binding, SH2 domai finger; 2.60A {Homo sapiens} PDB: 1xa6_A

Probab=85.83  E-value=0.1  Score=47.82  Aligned_cols=61  Identities=5%  Similarity=0.011  Sum_probs=17.7

Q ss_pred             cccccCCCCCCcEEEEEEeCC-CCEEEE------EEeCCCCC--hhHHHHHHHHHHHhcCCCccccccceeee
Q 020221           60 NIVSEHGEKAPNVVYKGKLEN-QFRIAV------KRFNRSAW--PDARQFLEEARAVGQLRNRRLANLLGCCC  123 (329)
Q Consensus        60 ~~~~~lg~G~~g~V~~~~~~~-~~~vav------K~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~~~~~~~  123 (329)
                      .+.+.+|   ||.||+|.+.. ..+||+      |..+....  .....+.+|..+++.++|||+++.+++..
T Consensus       145 ~l~~~lG---fG~v~~g~~~~~~~~Vav~~~~~~K~~~~~~~~~e~~~~~~rea~l~~~~~H~niv~~h~f~~  214 (463)
T 3cxl_A          145 PIYEHVG---YTTLNREPAYKKHMPVLKETHDERDSTGQDGVSEKRLTSLVRRATLKENEQIPKYEKIHNFKV  214 (463)
T ss_dssp             CSTTTSS---BCCC---------CCBGGGC-----------------------------------CBCCCEEE
T ss_pred             cccccCC---chhhhcccccccCCchhhhhccCccccccccccccccccccccccccccccccccCCCcceEE
Confidence            4455666   99999999654 467888      76654321  22345778888889999999999887653

---

Homologous Structure Domains

Structure Domains Detected by RPS-BLAST

Original result of RPS-BLAST against SCOP70(version1.75) database

ID	Length	Definition	E-value
Query	329
d1k2pa_	258	d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum	1e-42
d1sm2a_	263	d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu	4e-42
d1byga_	262	d.144.1.7 (A:) Carboxyl-terminal src kinase (csk)	3e-41
d1qpca_	272	d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom	1e-39
d1opja_	287	d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou	3e-39
d1jpaa_	299	d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou	5e-39
d1fmka3	285	d.144.1.7 (A:249-533) c-src tyrosine kinase {Human	6e-39
d1uwha_	276	d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens)	5e-38
d2j4za1	263	d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur	7e-37
d1s9ja_	322	d.144.1.7 (A:) Dual specificity mitogen-activated	3e-36
d1p4oa_	308	d.144.1.7 (A:) Insulin-like growth factor 1 recept	4e-36
d1xbba_	277	d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human	2e-35
d1u59a_	285	d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum	2e-35
d1u5ra_	309	d.144.1.7 (A:) Serine/threonine protein kinase TAO	3e-35
d1r0pa_	311	d.144.1.7 (A:) Hepatocyte growth factor receptor,	4e-35
d1lufa_	301	d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n	1e-34
d1xkka_	317	d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-	2e-34
d1fvra_	309	d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [	2e-34
d2java1	269	d.144.1.7 (A:3-271) Serine/threonine-protein kinas	2e-34
d2jfla1	288	d.144.1.7 (A:21-308) STE20-like serine/threonine-p	2e-33
d1yhwa1	293	d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [	1e-32
d1mqba_	283	d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum	2e-32
d1rjba_	325	d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s	2e-32
d1t46a_	311	d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens	3e-32
d1koaa2	350	d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C	9e-32
d1vjya_	303	d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human	1e-31
d1nvra_	271	d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {	2e-31
d1mp8a_	273	d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma	4e-31
d1t4ha_	270	d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa	5e-31
d1u46a_	273	d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum	1e-30
d1koba_	352	d.144.1.7 (A:) Twitchin, kinase domain {California	1e-29
d1uu3a_	288	d.144.1.7 (A:) 3-phosphoinositide dependent protei	5e-29
d1a06a_	307	d.144.1.7 (A:) Calmodulin-dependent protein kinase	7e-29
d1o6ya_	277	d.144.1.7 (A:) Mycobacterial protein kinase PknB,	4e-28
d1tkia_	321	d.144.1.7 (A:) Titin, kinase domain {Human (Homo s	4e-28
d1ywna1	299	d.144.1.7 (A:818-1166) Vascular endothelial growth	6e-27
d1fota_	316	d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni	1e-26
d1fgka_	299	d.144.1.7 (A:) Fibroblast growth factor receptor 1	2e-26
d1omwa3	364	d.144.1.7 (A:186-549) G-protein coupled receptor k	5e-26
d1xjda_	320	d.144.1.7 (A:) Protein kinase C, theta type {Human	6e-26
d1jksa_	293	d.144.1.7 (A:) Death-associated protein kinase, Da	8e-26
d1phka_	277	d.144.1.7 (A:) gamma-subunit of glycogen phosphory	3e-25
d1xwsa_	273	d.144.1.7 (A:) Proto-oncogene serine/threonine-pro	6e-24
d1ckia_	299	d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n	1e-23
d1ua2a_	299	d.144.1.7 (A:) Cell division protein kinase 7, CDK	2e-23
d1csna_	293	d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast	3e-23
d1ob3a_	286	d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod	4e-23
d1q5ka_	350	d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs	6e-23
d1gz8a_	298	d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H	2e-22
d1pmea_	345	d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien	4e-22
d1o6la_	337	d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap	2e-21
d2ozaa1	335	d.144.1.7 (A:51-385) MAP kinase activated protein	3e-21
d1cm8a_	346	d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s	2e-20
d1blxa_	305	d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H	1e-19
d1unla_	292	d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H	3e-19
d1rdqe_	350	d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni	1e-18
d3blha1	318	d.144.1.7 (A:8-325) Cell division protein kinase 9	9e-18
d1vzoa_	322	d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5	3e-16
d2gfsa1	348	d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa	6e-15
d3bqca1	328	d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu	5e-14
d1q8ya_	362	d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces	7e-14
d2b1pa1	355	d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3	1e-13
d1zara2	191	d.144.1.9 (A:91-281) Rio2 serine protein kinase C-	1e-06

>d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Bruton's tyrosine kinase (Btk)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  145 bits (368), Expect = 1e-42
 Identities = 56/245 (22%), Positives = 106/245 (43%), Gaps = 12/245 (4%)

Query: 72  VVYKGKLENQFRIAVKRFNRSAWPDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLV 131
           VV  GK   Q+ +A+K     +  +  +F+EEA+ +  L + +L  L G C +     ++
Sbjct: 19  VVKYGKWRGQYDVAIKMIKEGSMSE-DEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFII 77

Query: 132 AEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDD 191
            EYM N  L  +L        +    L +   + EA+EY  SK + L+ DL A   + +D
Sbjct: 78  TEYMANGCLLNYL-REMRHRFQTQQLLEMCKDVCEAMEYLESK-QFLHRDLAARNCLVND 135

Query: 192 DVNPRLSCFGLMKNSRDGRSYSTN-----LAFTPPEYLRTGRVTPESVMYSFGTLLLDLL 246
               ++S FGL +   D    S+      + ++PPE L   + + +S +++FG L+ ++ 
Sbjct: 136 QGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIY 195

Query: 247 SGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLASRCLQYEPRERPNPRSL 306
           S   +P         +          L          ++  +   C   +  ERP  + L
Sbjct: 196 SLGKMPYER----FTNSETAEHIAQGLRLYRPHLASEKVYTIMYSCWHEKADERPTFKIL 251

Query: 307 VTALV 311
           ++ ++
Sbjct: 252 LSNIL 256

>d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase Itk/Tsk
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  144 bits (365), Expect = 4e-42
 Identities = 51/249 (20%), Positives = 104/249 (41%), Gaps = 12/249 (4%)

Query: 72  VVYKGKLENQFRIAVKRFNRSAWPDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLV 131
           +V+ G   N+ ++A+K     A  +   F+EEA  + +L + +L  L G C E     LV
Sbjct: 20  LVHLGYWLNKDKVAIKTIREGAMSE-EDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLV 78

Query: 132 AEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDD 191
            E+M +  L+ +    +         L + L + E + Y       ++ DL A   +  +
Sbjct: 79  FEFMEHGCLSDY-LRTQRGLFAAETLLGMCLDVCEGMAYLEEA-CVIHRDLAARNCLVGE 136

Query: 192 DVNPRLSCFGLMKNSRDGRSYSTN-----LAFTPPEYLRTGRVTPESVMYSFGTLLLDLL 246
           +   ++S FG+ +   D +  S+      + +  PE     R + +S ++SFG L+ ++ 
Sbjct: 137 NQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVF 196

Query: 247 SGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLASRCLQYEPRERPNPRSL 306
           S   IP  +      +  +     +           T + ++ + C +  P +RP    L
Sbjct: 197 SEGKIPYEN----RSNSEVVEDISTGFRLYKPRLASTHVYQIMNHCWKERPEDRPAFSRL 252

Query: 307 VTALVTLQK 315
           +  L  + +
Sbjct: 253 LRQLAEIAE 261

>d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Carboxyl-terminal src kinase (csk)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  142 bits (360), Expect = 3e-41
 Identities = 62/251 (24%), Positives = 101/251 (40%), Gaps = 20/251 (7%)

Query: 72  VVYKGKLENQFRIAVKRFNRSAWPDARQFLEEARAVGQLRNRRLANLLGCCCEGDERL-L 130
            V  G      ++AVK     A   A+ FL EA  + QLR+  L  LLG   E    L +
Sbjct: 22  DVMLGDYRGN-KVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYI 78

Query: 131 VAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFD 190
           V EYM   +L  +L       +     L+ +L + EA+EY       ++ DL A  ++  
Sbjct: 79  VTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGN-NFVHRDLAARNVLVS 137

Query: 191 DDVNPRLSCFGLMKN-SRDGRSYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGK 249
           +D   ++S FGL K  S    +    + +T PE LR  + + +S ++SFG LL ++ S  
Sbjct: 138 EDNVAKVSDFGLTKEASSTQDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFG 197

Query: 250 HIP-----PSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLASRCLQYEPRERPNPR 304
            +P         +  +         D C            +  +   C   +   RP+  
Sbjct: 198 RVPYPRIPLKDVVPRVEKGYKMDAPDGCPP---------AVYEVMKNCWHLDAAMRPSFL 248

Query: 305 SLVTALVTLQK 315
            L   L  ++ 
Sbjct: 249 QLREQLEHIKT 259

>d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Lymphocyte kinase (lck)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  138 bits (349), Expect = 1e-39
 Identities = 59/249 (23%), Positives = 105/249 (42%), Gaps = 22/249 (8%)

Query: 72  VVYKGKLENQFRIAVKRFNRSAWPDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLV 131
            V+ G      ++AVK   + +      FL EA  + QL+++RL  L     + +   ++
Sbjct: 28  EVWMGYYNGHTKVAVKSLKQGSM-SPDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIYII 85

Query: 132 AEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDD 191
            EYM N +L   L       +     L +A  IAE + +   +   ++ DL A  I+  D
Sbjct: 86  TEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNY-IHRDLRAANILVSD 144

Query: 192 DVNPRLSCFGLMKNSRDGRSYSTN-----LAFTPPEYLRTGRVTPESVMYSFGTLLLDLL 246
            ++ +++ FGL +   D    +       + +T PE +  G  T +S ++SFG LL +++
Sbjct: 145 TLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIV 204

Query: 247 SGKHIP-----PSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLASRCLQYEPRERP 301
           +   IP         +  +         D+C E         EL +L   C +  P +RP
Sbjct: 205 THGRIPYPGMTNPEVIQNLERGYRMVRPDNCPE---------ELYQLMRLCWKERPEDRP 255

Query: 302 NPRSLVTAL 310
               L + L
Sbjct: 256 TFDYLRSVL 264

>d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Abelsone tyrosine kinase (abl)
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  138 bits (348), Expect = 3e-39
 Identities = 54/254 (21%), Positives = 110/254 (43%), Gaps = 12/254 (4%)

Query: 72  VVYKGKL-ENQFRIAVKRFNRSAWPDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLL 130
            VY+G   +    +AVK        +  +FL+EA  + ++++  L  LLG C       +
Sbjct: 32  EVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYI 90

Query: 131 VAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFD 190
           + E+M    L  +L     Q +   + L +A  I+ A+EY   K   ++ DL A   +  
Sbjct: 91  ITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNF-IHRDLAARNCLVG 149

Query: 191 DDVNPRLSCFGLMKNSRDGRSYST-----NLAFTPPEYLRTGRVTPESVMYSFGTLLLDL 245
           ++   +++ FGL +        +       + +T PE L   + + +S +++FG LL ++
Sbjct: 150 ENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEI 209

Query: 246 LSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLASRCLQYEPRERPNPRS 305
            +     P   +DL     +  L +     +       ++  L   C Q+ P +RP+   
Sbjct: 210 ATYGM-SPYPGIDL---SQVYELLEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAE 265

Query: 306 LVTALVTLQKDTEL 319
           +  A  T+ +++ +
Sbjct: 266 IHQAFETMFQESSI 279

>d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: ephb2 receptor tyrosine kinase
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  137 bits (346), Expect = 5e-39
 Identities = 57/293 (19%), Positives = 113/293 (38%), Gaps = 26/293 (8%)

Query: 44  YSIETLRTATSGFAMENIVSEH------GEKAPNVVYKGKL----ENQFRIAVKRFNRSA 93
           ++ E    A   FA E  +S        G      V  G L    + +  +A+K      
Sbjct: 7   FTFEDPNEAVREFAKEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGY 66

Query: 94  WPDA-RQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAEYMPNDTLAKHLFHWETQPM 152
                R FL EA  +GQ  +  + +L G   +    +++ E+M N +L            
Sbjct: 67  TEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSL-DSFLRQNDGQF 125

Query: 153 KWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDGRSY 212
                + +   IA  ++Y       ++ DL A  I+ + ++  ++S FGL +   D  S 
Sbjct: 126 TVIQLVGMLRGIAAGMKYLADM-NYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSD 184

Query: 213 STN---------LAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDR 263
            T          + +T PE ++  + T  S ++S+G ++ +++S    P       + ++
Sbjct: 185 PTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWD----MTNQ 240

Query: 264 NIQTLTDSCLEGQFSSDEGTELVRLASRCLQYEPRERPNPRSLVTALVTLQKD 316
           ++    +         D  + L +L   C Q +   RP    +V  L  + ++
Sbjct: 241 DVINAIEQDYRLPPPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNTLDKMIRN 293

>d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-src tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  137 bits (345), Expect = 6e-39
 Identities = 57/244 (23%), Positives = 101/244 (41%), Gaps = 12/244 (4%)

Query: 72  VVYKGKLENQFRIAVKRFNRSAWPDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLV 131
            V+ G      R+A+K            FL+EA+ + +LR+ +L  L     E +   +V
Sbjct: 32  EVWMGTWNGTTRVAIKTLKPGTM-SPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIV 89

Query: 132 AEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDD 191
            EYM   +L   L     + ++    + +A  IA  + Y       ++ DL A  I+  +
Sbjct: 90  TEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERM-NYVHRDLRAANILVGE 148

Query: 192 DVNPRLSCFGLMKNSRDGRSYSTN-----LAFTPPEYLRTGRVTPESVMYSFGTLLLDLL 246
           ++  +++ FGL +   D    +       + +T PE    GR T +S ++SFG LL +L 
Sbjct: 149 NLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELT 208

Query: 247 SGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLASRCLQYEPRERPNPRSL 306
           +   +P       + +R +    +         +    L  L  +C + EP ERP    L
Sbjct: 209 TKGRVPYPG----MVNREVLDQVERGYRMPCPPECPESLHDLMCQCWRKEPEERPTFEYL 264

Query: 307 VTAL 310
              L
Sbjct: 265 QAFL 268

>d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: B-Raf kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  134 bits (338), Expect = 5e-38
 Identities = 53/266 (19%), Positives = 108/266 (40%), Gaps = 26/266 (9%)

Query: 72  VVYKGKLENQFRIAVKRFNRSAWPDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLV 131
            VYKGK      + +           + F  E   + + R+  +   +G      +  +V
Sbjct: 23  TVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMG-YSTAPQLAIV 81

Query: 132 AEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDD 191
            ++    +L  HL   ET   +    + +A   A+ ++Y  +K   ++ DL +  I   +
Sbjct: 82  TQWCEGSSLYHHLHIIET-KFEMIKLIDIARQTAQGMDYLHAK-SIIHRDLKSNNIFLHE 139

Query: 192 DVNPRLSCFGL--MKNSRDGRSYSTNLAFTP----PEYLRT---GRVTPESVMYSFGTLL 242
           D+  ++  FGL  +K+   G      L+ +     PE +R       + +S +Y+FG +L
Sbjct: 140 DLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVL 199

Query: 243 LDLLSGK----HIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLASRCLQYEPR 298
            +L++G+    +I     +  +  R   +   S +           + RL + CL+ +  
Sbjct: 200 YELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSKVRSNCPK----AMKRLMAECLKKKRD 255

Query: 299 ERPNPRSLVTALVTLQKDTELYLSLP 324
           ERP    ++ ++  L +      SLP
Sbjct: 256 ERPLFPQILASIELLAR------SLP 275

>d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Aurora-related kinase 1 (aurora-2)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  131 bits (330), Expect = 7e-37
 Identities = 55/260 (21%), Positives = 100/260 (38%), Gaps = 17/260 (6%)

Query: 56  FAMEN--IVSEHGEKAPNVVYKGKL-ENQFRIAVKRFNRSAWPDA---RQFLEEARAVGQ 109
           +A+E+  I    G+     VY  +  +++F +A+K   ++    A    Q   E      
Sbjct: 3   WALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSH 62

Query: 110 LRNRRLANLLGCCCEGDERLLVAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALE 169
           LR+  +  L G   +     L+ EY P  T+ + L                   +A AL 
Sbjct: 63  LRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKL--SKFDEQRTATYITELANALS 120

Query: 170 YCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDGRSYSTN--LAFTPPEYLRTG 227
           YC SK R ++ D+    ++       +++ FG   ++   R  +    L + PPE +   
Sbjct: 121 YCHSK-RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTTLCGTLDYLPPEMIEGR 179

Query: 228 RVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVR 287
               +  ++S G L  + L GK    ++       R  +      +E  F          
Sbjct: 180 MHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISR------VEFTFPDFVTEGARD 233

Query: 288 LASRCLQYEPRERPNPRSLV 307
           L SR L++ P +RP  R ++
Sbjct: 234 LISRLLKHNPSQRPMLREVL 253

>d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  130 bits (329), Expect = 3e-36
 Identities = 49/277 (17%), Positives = 98/277 (35%), Gaps = 44/277 (15%)

Query: 72  VVYKGK-LENQFRIAVKRFNRSAWPDAR-QFLEEARAVGQLRNRRLANLLGCCCEGDERL 129
           VV+K     +   +A K  +    P  R Q + E + + +  +  +    G      E  
Sbjct: 21  VVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEIS 80

Query: 130 LVAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVF 189
           +  E+M   +L + L   +   +   +  +V++ + + L Y   K + ++ D+    I+ 
Sbjct: 81  ICMEHMDGGSLDQVL--KKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILV 138

Query: 190 DDDVNPRLSCFGLMKNSRDGRSYST--NLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLS 247
           +     +L  FG+     D  + S     ++  PE L+    + +S ++S G  L+++  
Sbjct: 139 NSRGEIKLCDFGVSGQLIDSMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAV 198

Query: 248 GKH-IPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGT----------------------- 283
           G++ IPP  A +L      Q   D+          G                        
Sbjct: 199 GRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLSSYGMDSRPPMAIFELLDYIV 258

Query: 284 --------------ELVRLASRCLQYEPRERPNPRSL 306
                         E     ++CL   P ER + + L
Sbjct: 259 NEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQL 295

>d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Insulin-like growth factor 1 receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  130 bits (327), Expect = 4e-36
 Identities = 57/265 (21%), Positives = 110/265 (41%), Gaps = 36/265 (13%)

Query: 72  VVYKGKL------ENQFRIAVKRFNRSAWPDAR-QFLEEARAVGQLRNRRLANLLGCCCE 124
           +VY+G        E + R+A+K  N +A    R +FL EA  + +     +  LLG   +
Sbjct: 35  MVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQ 94

Query: 125 GDERLLVAEYMPNDTLAKHLFHW--------ETQPMKWAMRLRVALHIAEALEYCTSKER 176
           G   L++ E M    L  +L              P   +  +++A  IA+ + Y  +  +
Sbjct: 95  GQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNAN-K 153

Query: 177 ALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDGRSYSTN------LAFTPPEYLRTGRVT 230
            ++ DL A   +  +D   ++  FG+ ++  +   Y         + +  PE L+ G  T
Sbjct: 154 FVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFT 213

Query: 231 PESVMYSFGTLLLDLLSGKHIP-----PSHALDLIRDRNIQTLTDSCLEGQFSSDEGTEL 285
             S ++SFG +L ++ +    P         L  + +  +    D+C +          L
Sbjct: 214 TYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVMEGGLLDKPDNCPD---------ML 264

Query: 286 VRLASRCLQYEPRERPNPRSLVTAL 310
             L   C QY P+ RP+   +++++
Sbjct: 265 FELMRMCWQYNPKMRPSFLEIISSI 289

>d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase SYK
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  127 bits (321), Expect = 2e-35
 Identities = 53/256 (20%), Positives = 97/256 (37%), Gaps = 30/256 (11%)

Query: 72  VVYKGKLENQ---FRIAVKRFNRSAWPDA--RQFLEEARAVGQLRNRRLANLLGCCCEGD 126
            V KG  + +     +AVK     A   A   + L EA  + QL N  +  ++G C E +
Sbjct: 22  TVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGIC-EAE 80

Query: 127 ERLLVAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYR 186
             +LV E      L K+L   + + +K    + +   ++  ++Y       ++ DL A  
Sbjct: 81  SWMLVMEMAELGPLNKYL--QQNRHVKDKNIIELVHQVSMGMKYLEES-NFVHRDLAARN 137

Query: 187 IVFDDDVNPRLSCFGLMKNSRDGRSYSTN-------LAFTPPEYLRTGRVTPESVMYSFG 239
           ++       ++S FGL K  R   +Y          + +  PE +   + + +S ++SFG
Sbjct: 138 VLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFG 197

Query: 240 TLLLDLLSGKHIP-----PSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLASRCLQ 294
            L+ +  S    P      S    ++           C           E+  L + C  
Sbjct: 198 VLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMGCPAGCPR---------EMYDLMNLCWT 248

Query: 295 YEPRERPNPRSLVTAL 310
           Y+   RP   ++   L
Sbjct: 249 YDVENRPGFAAVELRL 264

>d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase ZAP-70
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  127 bits (321), Expect = 2e-35
 Identities = 52/255 (20%), Positives = 97/255 (38%), Gaps = 28/255 (10%)

Query: 72  VVYKGKL---ENQFRIAVKRFNRSAWP-DARQFLEEARAVGQLRNRRLANLLGCCCEGDE 127
            V +G     + Q  +A+K   +     D  + + EA+ + QL N  +  L+G C + + 
Sbjct: 24  SVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVC-QAEA 82

Query: 128 RLLVAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRI 187
            +LV E      L K L     + +  +    +   ++  ++Y   K   ++ DL A  +
Sbjct: 83  LMLVMEMAGGGPLHKFLVGKR-EEIPVSNVAELLHQVSMGMKYLEEK-NFVHRDLAARNV 140

Query: 188 VFDDDVNPRLSCFGLMKNSRDGRSYSTN-------LAFTPPEYLRTGRVTPESVMYSFGT 240
           +  +    ++S FGL K      SY T        L +  PE +   + +  S ++S+G 
Sbjct: 141 LLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGV 200

Query: 241 LLLDLLSGKHIP-----PSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLASRCLQY 295
            + + LS    P         +  I           C           EL  L S C  Y
Sbjct: 201 TMWEALSYGQKPYKKMKGPEVMAFIEQGKRMECPPECPP---------ELYALMSDCWIY 251

Query: 296 EPRERPNPRSLVTAL 310
           +  +RP+  ++   +
Sbjct: 252 KWEDRPDFLTVEQRM 266

>d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine protein kinase TAO2
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  128 bits (322), Expect = 3e-35
 Identities = 46/243 (18%), Positives = 84/243 (34%), Gaps = 14/243 (5%)

Query: 72  VVYKGK-LENQFRIAVKRFNRSAWPD---ARQFLEEARAVGQLRNRRLANLLGCCCEGDE 127
            VY  + + N   +A+K+ + S        +  ++E R + +LR+       GC      
Sbjct: 30  AVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHT 89

Query: 128 RLLVAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRI 187
             LV EY           H   +P++      V     + L Y  S    ++ D+ A  I
Sbjct: 90  AWLVMEYCLGSASDLLEVH--KKPLQEVEIAAVTHGALQGLAYLHSH-NMIHRDVKAGNI 146

Query: 188 VFDDDVNPRLSCFGLMKNSRDGRSYSTNLAFTPPEYLRT---GRVTPESVMYSFGTLLLD 244
           +  +    +L  FG         S+     +  PE +     G+   +  ++S G   ++
Sbjct: 147 LLSEPGLVKLGDFGSASIMAPANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIE 206

Query: 245 LLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLASRCLQYEPRERPNPR 304
           L   K    +           Q  + +   G +S             CLQ  P++RP   
Sbjct: 207 LAERKPPLFNMNAMSALYHIAQNESPALQSGHWSE----YFRNFVDSCLQKIPQDRPTSE 262

Query: 305 SLV 307
            L+
Sbjct: 263 VLL 265

>d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Hepatocyte growth factor receptor, c-MET
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  127 bits (321), Expect = 4e-35
 Identities = 60/262 (22%), Positives = 109/262 (41%), Gaps = 26/262 (9%)

Query: 72  VVYKGKLEN----QFRIAVKRFNRSAWP-DARQFLEEARAVGQLRNRRLANLLGCCCEGD 126
            VY G L +    +   AVK  NR     +  QFL E   +    +  + +LLG C   +
Sbjct: 42  CVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSE 101

Query: 127 ER-LLVAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAY 185
              L+V  YM +  L ++    ET        +   L +A+ +++  SK + ++ DL A 
Sbjct: 102 GSPLVVLPYMKHGDL-RNFIRNETHNPTVKDLIGFGLQVAKGMKFLASK-KFVHRDLAAR 159

Query: 186 RIVFDDDVNPRLSCFGLMKNSRDGRSYSTN--------LAFTPPEYLRTGRVTPESVMYS 237
             + D+    +++ FGL ++  D    S +        + +   E L+T + T +S ++S
Sbjct: 160 NCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWS 219

Query: 238 FGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQ---FSSDEGTELVRLASRCLQ 294
           FG LL +L++    P         D N   +T   L+G+           L  +  +C  
Sbjct: 220 FGVLLWELMTRGAPPYP-------DVNTFDITVYLLQGRRLLQPEYCPDPLYEVMLKCWH 272

Query: 295 YEPRERPNPRSLVTALVTLQKD 316
            +   RP+   LV+ +  +   
Sbjct: 273 PKAEMRPSFSELVSRISAIFST 294

>d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Musk tyrosine kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  126 bits (317), Expect = 1e-34
 Identities = 59/279 (21%), Positives = 105/279 (37%), Gaps = 50/279 (17%)

Query: 72  VVYKGKLENQFR------IAVKRFNRSAWPDAR-QFLEEARAVGQLRNRRLANLLGCCCE 124
            V++ +            +AVK     A  D +  F  EA  + +  N  +  LLG C  
Sbjct: 28  RVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAV 87

Query: 125 GDERLLVAEYMPNDTLAKHLFHW----------------------ETQPMKWAMRLRVAL 162
           G    L+ EYM    L + L                            P+  A +L +A 
Sbjct: 88  GKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIAR 147

Query: 163 HIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDGRSYSTN------L 216
            +A  + Y + + + ++ DL     +  +++  +++ FGL +N      Y  +      +
Sbjct: 148 QVAAGMAYLSER-KFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPI 206

Query: 217 AFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIP-----PSHALDLIRDRNIQTLTDS 271
            + PPE +   R T ES ++++G +L ++ S    P         +  +RD NI    ++
Sbjct: 207 RWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGMAHEEVIYYVRDGNILACPEN 266

Query: 272 CLEGQFSSDEGTELVRLASRCLQYEPRERPNPRSLVTAL 310
           C           EL  L   C    P +RP+  S+   L
Sbjct: 267 CPL---------ELYNLMRLCWSKLPADRPSFCSIHRIL 296

>d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: EGF receptor tyrosine kinase, Erbb-1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  126 bits (317), Expect = 2e-34
 Identities = 50/265 (18%), Positives = 104/265 (39%), Gaps = 19/265 (7%)

Query: 72  VVYKGKL-----ENQFRIAVKRFNRSAWPDA-RQFLEEARAVGQLRNRRLANLLGCCCEG 125
            VYKG       + +  +A+K    +  P A ++ L+EA  +  + N  +  LLG C   
Sbjct: 24  TVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS 83

Query: 126 DERLLVAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAY 185
             +L+  + MP   L  +        +     L   + IA+ + Y   + R ++ DL A 
Sbjct: 84  TVQLIT-QLMPFGCLLDY-VREHKDNIGSQYLLNWCVQIAKGMNYLEDR-RLVHRDLAAR 140

Query: 186 RIVFDDDVNPRLSCFGLMK--NSRDGRSYSTNLAFTP----PEYLRTGRVTPESVMYSFG 239
            ++     + +++ FGL K   + +   ++            E +     T +S ++S+G
Sbjct: 141 NVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYG 200

Query: 240 TLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLASRCLQYEPRE 299
             + +L++    P     D I    I ++ +             ++  +  +C   +   
Sbjct: 201 VTVWELMTFGSKPY----DGIPASEISSILEKGERLPQPPICTIDVYMIMVKCWMIDADS 256

Query: 300 RPNPRSLVTALVTLQKDTELYLSLP 324
           RP  R L+     + +D + YL + 
Sbjct: 257 RPKFRELIIEFSKMARDPQRYLVIQ 281

>d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tie2 kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  126 bits (316), Expect = 2e-34
 Identities = 55/276 (19%), Positives = 108/276 (39%), Gaps = 33/276 (11%)

Query: 72  VVYKGKLEN---QFRIAVKRFNRSAWPDA-RQFLEEARAVGQLRNRR-LANLLGCCCEGD 126
            V K +++    +   A+KR    A  D  R F  E   + +L +   + NLLG C    
Sbjct: 25  QVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRG 84

Query: 127 ERLLVAEYMPNDTLAKHL--------------FHWETQPMKWAMRLRVALHIAEALEYCT 172
              L  EY P+  L   L               +     +     L  A  +A  ++Y +
Sbjct: 85  YLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLS 144

Query: 173 SKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDGRSYSTN---LAFTPPEYLRTGRV 229
            K + ++ DL A  I+  ++   +++ FGL +        +     + +   E L     
Sbjct: 145 QK-QFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKKTMGRLPVRWMAIESLNYSVY 203

Query: 230 TPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEG---QFSSDEGTELV 286
           T  S ++S+G LL +++S    P               L +   +G   +   +   E+ 
Sbjct: 204 TTNSDVWSYGVLLWEIVSLGGTPY-------CGMTCAELYEKLPQGYRLEKPLNCDDEVY 256

Query: 287 RLASRCLQYEPRERPNPRSLVTALVTLQKDTELYLS 322
            L  +C + +P ERP+   ++ +L  + ++ + Y++
Sbjct: 257 DLMRQCWREKPYERPSFAQILVSLNRMLEERKTYVN 292

>d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine-protein kinase Nek2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  124 bits (313), Expect = 2e-34
 Identities = 46/255 (18%), Positives = 87/255 (34%), Gaps = 28/255 (10%)

Query: 72  VVYKGK-LENQFRIAVKRFNRSAWPDA--RQFLEEARAVGQLRNRRLANLLGCCCEGDER 128
              K +   +   +  K  +  +  +A  +  + E   + +L++  +        +    
Sbjct: 19  RCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNT 78

Query: 129 LL--VAEYMPNDTLAKHLFHW--ETQPMKWAMRLRVALHIAEALEYCTSKERALYH---- 180
            L  V EY     LA  +     E Q +     LRV   +  AL+ C  +    +     
Sbjct: 79  TLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHR 138

Query: 181 DLNAYRIVFDDDVNPRLSCFGLMKNSRDGRSYSTNLAFTP----PEYLRTGRVTPESVMY 236
           DL    +  D   N +L  FGL +      S++     TP    PE +       +S ++
Sbjct: 139 DLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKAFVGTPYYMSPEQMNRMSYNEKSDIW 198

Query: 237 SFGTLLLDLLSGKH----IPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLASRC 292
           S G LL +L +                IR+   + +     +         EL  + +R 
Sbjct: 199 SLGCLLYELCALMPPFTAFSQKELAGKIREGKFRRIPYRYSD---------ELNEIITRM 249

Query: 293 LQYEPRERPNPRSLV 307
           L  +   RP+   ++
Sbjct: 250 LNLKDYHRPSVEEIL 264

>d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: STE20-like serine/threonine-protein kinase, SLK
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  122 bits (308), Expect = 2e-33
 Identities = 44/256 (17%), Positives = 90/256 (35%), Gaps = 15/256 (5%)

Query: 61  IVSEHGEKAPNVVYKGK-LENQFRIAVKRFNRSAWPDARQFLEEARAVGQLRNRRLANLL 119
           I+ E G+ A   VYK +  E     A K  +  +  +   ++ E   +    +  +  LL
Sbjct: 16  IIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLL 75

Query: 120 GCCCEGDERLLVAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALY 179
                 +   ++ E+     +   +   E +P+  +    V     +AL Y     + ++
Sbjct: 76  DAFYYENNLWILIEFCAGGAVDAVMLELE-RPLTESQIQVVCKQTLDALNYLHDN-KIIH 133

Query: 180 HDLNAYRIVFDDDVNPRLSCFGLMKNSRDGRSYST----NLAFTPPEYLRT-----GRVT 230
            DL A  I+F  D + +L+ FG+   +               +  PE +           
Sbjct: 134 RDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSFIGTPYWMAPEVVMCETSKDRPYD 193

Query: 231 PESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLAS 290
            ++ ++S G  L+++   +  PP H L+ +R    +            S   +       
Sbjct: 194 YKADVWSLGITLIEMAEIE--PPHHELNPMRVLL-KIAKSEPPTLAQPSRWSSNFKDFLK 250

Query: 291 RCLQYEPRERPNPRSL 306
           +CL+     R     L
Sbjct: 251 KCLEKNVDARWTTSQL 266

>d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: pak1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  120 bits (302), Expect = 1e-32
 Identities = 49/244 (20%), Positives = 92/244 (37%), Gaps = 20/244 (8%)

Query: 72  VVYKGK-LENQFRIAVKRFNRSAWPDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLL 130
            VY    +     +A+++ N    P     + E   + + +N  + N L     GDE  +
Sbjct: 35  TVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWV 94

Query: 131 VAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFD 190
           V EY+   +L   +       M       V     +ALE+  S  + ++ D+ +  I+  
Sbjct: 95  VMEYLAGGSLTDVVTET---CMDEGQIAAVCRECLQALEFLHSN-QVIHRDIKSDNILLG 150

Query: 191 DDVNPRLSCFGLMKNSRDGRSYSTNLAFTP----PEYLRTGRVTPESVMYSFGTLLLDLL 246
            D + +L+ FG        +S  + +  TP    PE +      P+  ++S G + ++++
Sbjct: 151 MDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMI 210

Query: 247 SGKH----IPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLASRCLQYEPRERPN 302
            G+       P  AL LI       L       Q             +RCL  +  +R +
Sbjct: 211 EGEPPYLNENPLRALYLIATNGTPEL-------QNPEKLSAIFRDFLNRCLDMDVEKRGS 263

Query: 303 PRSL 306
            + L
Sbjct: 264 AKEL 267

>d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: epha2 receptor tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  119 bits (300), Expect = 2e-32
 Identities = 54/284 (19%), Positives = 109/284 (38%), Gaps = 22/284 (7%)

Query: 54  SGFAMENIVSEHGEKAPNVVYKGKLEN-----QFRIAVKRFNRSAWPDAR-QFLEEARAV 107
           S    + ++   G      VYKG L+      +  +A+K          R  FL EA  +
Sbjct: 7   SCVTRQKVI---GAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIM 63

Query: 108 GQLRNRRLANLLGCCCEGDERLLVAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEA 167
           GQ  +  +  L G   +    +++ EYM N          +         + +   IA  
Sbjct: 64  GQFSHHNIIRLEGVISKYKPMMIITEYMENGA-LDKFLREKDGEFSVLQLVGMLRGIAAG 122

Query: 168 LEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDGRSYSTN-------LAFTP 220
           ++Y  +    ++ DL A  I+ + ++  ++S FGL +   D    +         + +T 
Sbjct: 123 MKYLANM-NYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTA 181

Query: 221 PEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSD 280
           PE +   + T  S ++SFG ++ ++++    P       + +  +    +         D
Sbjct: 182 PEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWE----LSNHEVMKAINDGFRLPTPMD 237

Query: 281 EGTELVRLASRCLQYEPRERPNPRSLVTALVTLQKDTELYLSLP 324
             + + +L  +C Q E   RP    +V+ L  L +  +   +L 
Sbjct: 238 CPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRAPDSLKTLA 281

>d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fl cytokine receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  121 bits (303), Expect = 2e-32
 Identities = 54/274 (19%), Positives = 99/274 (36%), Gaps = 39/274 (14%)

Query: 72  VVYKG------KLENQFRIAVKRFNRSAWPDARQ-FLEEARAVGQLRN-RRLANLLGCCC 123
            V         K     ++AVK     A    R+  + E + + QL +   + NLLG C 
Sbjct: 52  KVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACT 111

Query: 124 EGDERLLVAEYMPNDTLAKHLF---------------------HWETQPMKWAMRLRVAL 162
                 L+ EY     L  +L                        +   + +   L  A 
Sbjct: 112 LSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAY 171

Query: 163 HIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDGRSYSTN------L 216
            +A+ +E+   K   ++ DL A  ++       ++  FGL ++     +Y         +
Sbjct: 172 QVAKGMEFLEFK-SCVHRDLAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPV 230

Query: 217 AFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQ 276
            +  PE L  G  T +S ++S+G LL ++ S    P      +  D N   L  +  +  
Sbjct: 231 KWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYP---GIPVDANFYKLIQNGFKMD 287

Query: 277 FSSDEGTELVRLASRCLQYEPRERPNPRSLVTAL 310
                  E+  +   C  ++ R+RP+  +L + L
Sbjct: 288 QPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFL 321

>d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-KIT receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  119 bits (300), Expect = 3e-32
 Identities = 51/269 (18%), Positives = 94/269 (34%), Gaps = 34/269 (12%)

Query: 72  VVYKGKLENQFR------IAVKRFNRSAWPDARQ-FLEEARAVGQLRN-RRLANLLGCCC 123
            V +       +      +AVK    SA    R+  + E + +  L N   + NLLG C 
Sbjct: 38  KVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACT 97

Query: 124 EGDERLLVAEYMPNDTLAKHLFHW----------------ETQPMKWAMRLRVALHIAEA 167
            G   L++ EY     L   L                   +   +     L  +  +A+ 
Sbjct: 98  IGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKG 157

Query: 168 LEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDGRSYSTN------LAFTPP 221
           + +  SK   ++ DL A  I+       ++  FGL ++ ++  +Y         + +  P
Sbjct: 158 MAFLASK-NCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAP 216

Query: 222 EYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDE 281
           E +     T ES ++S+G  L +L S    P      +  D     +             
Sbjct: 217 ESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPG---MPVDSKFYKMIKEGFRMLSPEHA 273

Query: 282 GTELVRLASRCLQYEPRERPNPRSLVTAL 310
             E+  +   C   +P +RP  + +V  +
Sbjct: 274 PAEMYDIMKTCWDADPLKRPTFKQIVQLI 302

>d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: Caenorhabditis elegans, pjk4 [TaxId: 6239]

 Score =  119 bits (300), Expect = 9e-32
 Identities = 45/241 (18%), Positives = 77/241 (31%), Gaps = 10/241 (4%)

Query: 72  VVYKGK-LENQFRIAVKRFNRSAWPDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLL 130
           VV++          A K        D     +E + +  LR+  L NL     + +E ++
Sbjct: 41  VVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVM 100

Query: 131 VAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFD 190
           + E+M    L + +   E   M     +     + + L +       ++ DL    I+F 
Sbjct: 101 IYEFMSGGELFEKVAD-EHNKMSEDEAVEYMRQVCKGLCHMHEN-NYVHLDLKPENIMFT 158

Query: 191 DDVNPR--LSCFGLMKNSRDGRSYST---NLAFTPPEYLRTGRVTPESVMYSFGTLLLDL 245
              +    L  FGL  +    +S         F  PE      V   + M+S G L   L
Sbjct: 159 TKRSNELKLIDFGLTAHLDPKQSVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYIL 218

Query: 246 LSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLASRCLQYEPRERPNPRS 305
           LSG    P    +           D  ++    S    +      + L  +P  R     
Sbjct: 219 LSGL--SPFGGENDDETLRNVKSCDWNMDDSAFSGISEDGKDFIRKLLLADPNTRMTIHQ 276

Query: 306 L 306
            
Sbjct: 277 A 277

>d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Type I TGF-beta receptor R4
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  118 bits (296), Expect = 1e-31
 Identities = 42/288 (14%), Positives = 91/288 (31%), Gaps = 50/288 (17%)

Query: 72  VVYKGKLENQFRIAVKRFNRSAWPDARQFLEEA--RAVGQLRNRRLANLLGCCCEGD--- 126
            V++GK   +  +AVK F+     + R +  EA       LR+  +   +    + +   
Sbjct: 18  EVWRGKWRGE-EVAVKIFSSR---EERSWFREAEIYQTVMLRHENILGFIAADNKDNGTW 73

Query: 127 -ERLLVAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYC-------TSKERAL 178
            +  LV++Y  + +L  +L       +     +++AL  A  L +          K    
Sbjct: 74  TQLWLVSDYHEHGSLFDYLNR---YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIA 130

Query: 179 YHDLNAYRIVFDDDVNPRLSCFGLMKNSRDGRSY----STNLAFTP----PEYLRT---- 226
           + DL +  I+   +    ++  GL                +   T     PE L      
Sbjct: 131 HRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINM 190

Query: 227 --GRVTPESVMYSFGTLLLDLLSGKHIPPSH---------------ALDLIRDRNIQTLT 269
                   + +Y+ G +  ++     I   H               +++ +R    +   
Sbjct: 191 KHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMRKVVCEQKL 250

Query: 270 DSCLEGQFSSDEGT-ELVRLASRCLQYEPRERPNPRSLVTALVTLQKD 316
              +  ++ S E    + ++   C       R     +   L  L + 
Sbjct: 251 RPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQ 298

>d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell cycle checkpoint kinase chk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  117 bits (293), Expect = 2e-31
 Identities = 40/240 (16%), Positives = 73/240 (30%), Gaps = 15/240 (6%)

Query: 72  VVYKGK-LENQFRIAVKRFNRSAWPDARQ-FLEEARAVGQLRNRRLANLLGCCCEGDERL 129
            V        +  +AVK  +     D  +   +E      L +  +    G   EG+ + 
Sbjct: 20  EVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQY 79

Query: 130 LVAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVF 189
           L  EY     L   +       M      R    +   + Y        + D+    ++ 
Sbjct: 80  LFLEYCSGGELFDRIEP--DIGMPEPDAQRFFHQLMAGVVYLHGI-GITHRDIKPENLLL 136

Query: 190 DDDVNPRLSCFGLMKNSRDGRSYSTN------LAFTPPEYLRTGRVTPESV-MYSFGTLL 242
           D+  N ++S FGL    R              L +  PE L+      E V ++S G +L
Sbjct: 137 DERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVL 196

Query: 243 LDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLASRCLQYEPRERPN 302
             +L+G+      +       + +         +        L+    + L   P  R  
Sbjct: 197 TAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLALLH---KILVENPSARIT 253

>d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Focal adhesion kinase 1 (fak)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  116 bits (290), Expect = 4e-31
 Identities = 51/262 (19%), Positives = 98/262 (37%), Gaps = 27/262 (10%)

Query: 72  VVYKGKL----ENQFRIAVKRFNRSAWPDARQ-FLEEARAVGQLRNRRLANLLGCCCEGD 126
            V++G           +A+K          R+ FL+EA  + Q  +  +  L+G   E +
Sbjct: 22  DVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVITE-N 80

Query: 127 ERLLVAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYR 186
              ++ E      L +         +  A  +  A  ++ AL Y  SK R ++ D+ A  
Sbjct: 81  PVWIIMELCTLGEL-RSFLQVRKYSLDLASLILYAYQLSTALAYLESK-RFVHRDIAARN 138

Query: 187 IVFDDDVNPRLSCFGLMKNSRDGRSYSTNLAFTPPEY-----LRTGRVTPESVMYSFGTL 241
           ++   +   +L  FGL +   D   Y  +    P ++     +   R T  S ++ FG  
Sbjct: 139 VLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVC 198

Query: 242 LLDLLSGKHIP-----PSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLASRCLQYE 296
           + ++L     P      +  +  I +     +  +C            L  L ++C  Y+
Sbjct: 199 MWEILMHGVKPFQGVKNNDVIGRIENGERLPMPPNCPP---------TLYSLMTKCWAYD 249

Query: 297 PRERPNPRSLVTALVTLQKDTE 318
           P  RP    L   L T+ ++ +
Sbjct: 250 PSRRPRFTELKAQLSTILEEEK 271

>d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase wnk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  115 bits (290), Expect = 5e-31
 Identities = 45/247 (18%), Positives = 90/247 (36%), Gaps = 17/247 (6%)

Query: 72  VVYKGKL-ENQFRIAVKRFNRSAWPDA--RQFLEEARAVGQLRNRRLANLLGCCCEGDER 128
            VYKG   E    +A           +  ++F EEA  +  L++  +           + 
Sbjct: 24  TVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKG 83

Query: 129 ----LLVAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYH-DLN 183
               +LV E M + TL  +L     + MK  +       I + L++  ++   + H DL 
Sbjct: 84  KKCIVLVTELMTSGTLKTYLK--RFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLK 141

Query: 184 AYRIVFDD-DVNPRLSCFGLMKNSRDGRSYST--NLAFTPPEYLRTGRVTPESVMYSFGT 240
              I       + ++   GL    R   + +      F  PE     +      +Y+FG 
Sbjct: 142 CDNIFITGPTGSVKIGDLGLATLKRASFAKAVIGTPEFMAPEMYE-EKYDESVDVYAFGM 200

Query: 241 LLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLASRCLQYEPRER 300
            +L++ + ++ P S   +    +  + +T       F      E+  +   C++    ER
Sbjct: 201 CMLEMATSEY-PYSECQN--AAQIYRRVTSGVKPASFDKVAIPEVKEIIEGCIRQNKDER 257

Query: 301 PNPRSLV 307
            + + L+
Sbjct: 258 YSIKDLL 264

>d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Activated CDC42 kinase 1, ACK1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  114 bits (287), Expect = 1e-30
 Identities = 51/257 (19%), Positives = 91/257 (35%), Gaps = 20/257 (7%)

Query: 72  VVYKGKLE----NQFRIAVKRFNRSAWPDA---RQFLEEARAVGQLRNRRLANLLGCCCE 124
           VV +G+ +        +AVK               F+ E  A+  L +R L  L G    
Sbjct: 23  VVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLT 82

Query: 125 GDERLLVAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNA 184
              + +V E  P  +L                  R A+ +AE + Y  SK   ++ DL A
Sbjct: 83  PPMK-MVTELAPLGSLLDR-LRKHQGHFLLGTLSRYAVQVAEGMGYLESKRF-IHRDLAA 139

Query: 185 YRIVFDDDVNPRLSCFGLMKNSRDGRSYSTN-------LAFTPPEYLRTGRVTPESVMYS 237
             ++       ++  FGLM+       +           A+  PE L+T   +  S  + 
Sbjct: 140 RNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWM 199

Query: 238 FGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLASRCLQYEP 297
           FG  L ++ +    P      L   + +  +           D   ++  +  +C  ++P
Sbjct: 200 FGVTLWEMFTYGQEPWI---GLNGSQILHKIDKEGERLPRPEDCPQDIYNVMVQCWAHKP 256

Query: 298 RERPNPRSLVTALVTLQ 314
            +RP   +L   L+  Q
Sbjct: 257 EDRPTFVALRDFLLEAQ 273

>d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]

 Score =  114 bits (285), Expect = 1e-29
 Identities = 49/244 (20%), Positives = 83/244 (34%), Gaps = 16/244 (6%)

Query: 72  VVYKGK-LENQFRIAVKRFNRSAWPDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLL 130
           VV++            K  N     D      E   + QL + +L NL     +  E +L
Sbjct: 44  VVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVL 103

Query: 131 VAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFD 190
           + E++    L   +   E   M  A  +       E L++       ++ D+    I+ +
Sbjct: 104 ILEFLSGGELFDRI-AAEDYKMSEAEVINYMRQACEGLKHMHEH-SIVHLDIKPENIMCE 161

Query: 191 DDVNPR--LSCFGLMKNSRDGRS---YSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDL 245
                   +  FGL             +    F  PE +    V   + M++ G L   L
Sbjct: 162 TKKASSVKIIDFGLATKLNPDEIVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVL 221

Query: 246 LSGKH-IPPSHALDLIRDRNIQTLTDSCLEGQFS--SDEGTELVRLASRCLQYEPRERPN 302
           LSG         L+ +  +N++       E  FS  S E  + ++     LQ EPR+R  
Sbjct: 222 LSGLSPFAGEDDLETL--QNVKRCDWEFDEDAFSSVSPEAKDFIK---NLLQKEPRKRLT 276

Query: 303 PRSL 306
               
Sbjct: 277 VHDA 280

>d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: 3-phosphoinositide dependent protein kinase-1 Pdk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  110 bits (277), Expect = 5e-29
 Identities = 40/255 (15%), Positives = 80/255 (31%), Gaps = 23/255 (9%)

Query: 72  VVYKGK-LENQFRIAVKRFNRSAWPDA---RQFLEEARAVGQLRNRRLANLLGCCCEGDE 127
            V   + L      A+K   +              E   + +L +     L     + ++
Sbjct: 23  TVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEK 82

Query: 128 RLLVAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRI 187
                 Y  N  L K++                   I  ALEY   K   ++ DL    I
Sbjct: 83  LYFGLSYAKNGELLKYIRKI--GSFDETCTRFYTAEIVSALEYLHGK-GIIHRDLKPENI 139

Query: 188 VFDDDVNPRLSCFGLMKNSRDG------RSYSTNLAFTPPEYLRTGRVTPESVMYSFGTL 241
           + ++D++ +++ FG  K            S+     +  PE L        S +++ G +
Sbjct: 140 LLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCI 199

Query: 242 LLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGT--ELVRLASRCLQYEPRE 299
           +  L++G   PP       R  N   +    ++ ++   E    +   L  + L  +  +
Sbjct: 200 IYQLVAGL--PP------FRAGNEYLIFQKIIKLEYDFPEKFFPKARDLVEKLLVLDATK 251

Query: 300 RPNPRSLVTALVTLQ 314
           R     +        
Sbjct: 252 RLGCEEMEGYGPLKA 266

>d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Calmodulin-dependent protein kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  110 bits (277), Expect = 7e-29
 Identities = 38/242 (15%), Positives = 73/242 (30%), Gaps = 11/242 (4%)

Query: 72  VVYKGK-LENQFRIAVKRFNRSAWPDARQ-FLEEARAVGQLRNRRLANLLGCCCEGDERL 129
            V   +    Q  +A+K   + A          E   + ++++  +  L      G    
Sbjct: 24  EVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDDIYESGGHLY 83

Query: 130 LVAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERA--LYHDLNAYRI 187
           L+ + +    L   +   E          R+   + +A++Y              N    
Sbjct: 84  LIMQLVSGGELFDRIV--EKGFYTERDASRLIFQVLDAVKYLHDLGIVHRDLKPENLLYY 141

Query: 188 VFDDDVNPRLSCFGLMKNSRDGRSYST---NLAFTPPEYLRTGRVTPESVMYSFGTLLLD 244
             D+D    +S FGL K    G   ST      +  PE L     +     +S G +   
Sbjct: 142 SLDEDSKIMISDFGLSKMEDPGSVLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYI 201

Query: 245 LLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLASRCLQYEPRERPNPR 304
           LL G   PP +  +  +        +   +  +  D            ++ +P +R    
Sbjct: 202 LLCGY--PPFYDENDAKLFEQILKAEYEFDSPYWDDISDSAKDFIRHLMEKDPEKRFTCE 259

Query: 305 SL 306
             
Sbjct: 260 QA 261

>d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Mycobacterial protein kinase PknB, catalytic domain
species: Mycobacterium tuberculosis [TaxId: 1773]

 Score =  108 bits (270), Expect = 4e-28
 Identities = 45/245 (18%), Positives = 79/245 (32%), Gaps = 20/245 (8%)

Query: 72  VVYKGK-LENQFRIAVKRFNRSAWPDA---RQFLEEARAVGQLRNRRLANLLGCCCE--- 124
            V+  + L     +AVK        D     +F  EA+    L +  +  +         
Sbjct: 22  EVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETP 81

Query: 125 -GDERLLVAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLN 183
            G    +V EY+   TL   +      PM     + V     +AL +       ++ D+ 
Sbjct: 82  AGPLPYIVMEYVDGVTLRDIVHTE--GPMTPKRAIEVIADACQALNFSHQN-GIIHRDVK 138

Query: 184 AYRIVFDDDVNPRLSCFGLMKNSRDGRSYSTNL-------AFTPPEYLRTGRVTPESVMY 236
              I+       ++  FG+ +   D  +  T          +  PE  R   V   S +Y
Sbjct: 139 PANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVY 198

Query: 237 SFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLASRCLQYE 296
           S G +L ++L+G+  PP      +         D             +L  +  + L   
Sbjct: 199 SLGCVLYEVLTGE--PPFTGDSPVSVAYQHVREDPIPPSARHEGLSADLDAVVLKALAKN 256

Query: 297 PRERP 301
           P  R 
Sbjct: 257 PENRY 261

>d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Titin, kinase domain
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  108 bits (272), Expect = 4e-28
 Identities = 40/258 (15%), Positives = 92/258 (35%), Gaps = 23/258 (8%)

Query: 61  IVSEHGEKAPNVVYKGK-LENQFRIAVKRFNRSAWPDARQFLEEARAVGQLRNRRLANLL 119
           I  + G     +V++     ++     K        D     +E   +   R+R + +L 
Sbjct: 9   IAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKG-TDQVLVKKEISILNIARHRNILHLH 67

Query: 120 GCCCEGDERLLVAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALY 179
                 +E +++ E++    + + + +     +     +     + EAL++  S     +
Sbjct: 68  ESFESMEELVMIFEFISGLDIFERI-NTSAFELNEREIVSYVHQVCEALQFLHSHNIG-H 125

Query: 180 HDLNAYRIVFDDDVNPR--LSCFGLMKNSRDGRSYSTN---LAFTPPEYLRTGRVTPESV 234
            D+    I++    +    +  FG  +  + G ++        +  PE  +   V+  + 
Sbjct: 126 FDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLLFTAPEYYAPEVHQHDVVSTATD 185

Query: 235 MYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGT------ELVRL 288
           M+S GTL+  LLSG +               Q + ++ +  +++ DE        E +  
Sbjct: 186 MWSLGTLVYVLLSGIN--------PFLAETNQQIIENIMNAEYTFDEEAFKEISIEAMDF 237

Query: 289 ASRCLQYEPRERPNPRSL 306
             R L  E + R      
Sbjct: 238 VDRLLVKERKSRMTASEA 255

>d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Vascular endothelial growth factor receptor 2 (kdr)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  105 bits (262), Expect = 6e-27
 Identities = 48/271 (17%), Positives = 91/271 (33%), Gaps = 33/271 (12%)

Query: 72  VVYKG------KLENQFRIAVKRFNRSAWP-DARQFLEEARAVGQLRNRRLANLLGCCC- 123
            V +       K      +AVK     A   + R  + E + +  + +      L   C 
Sbjct: 28  QVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACT 87

Query: 124 -EGDERLLVAEYMPNDTLAKHLFH--------------WETQPMKWAMRLRVALHIAEAL 168
             G   +++ E+     L+ +L                     +     +  +  +A+ +
Sbjct: 88  KPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGM 147

Query: 169 EYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDGRSYSTN------LAFTPPE 222
           E+  S+ + ++ DL A  I+  +    ++  FGL ++      Y         L +  PE
Sbjct: 148 EFLASR-KCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPE 206

Query: 223 YLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEG 282
            +     T +S ++SFG LL ++ S    P      +  D             +      
Sbjct: 207 TIFDRVYTIQSDVWSFGVLLWEIFSLGASPYP---GVKIDEEFCRRLKEGTRMRAPDYTT 263

Query: 283 TELVRLASRCLQYEPRERPNPRSLVTALVTL 313
            E+ +    C   EP +RP    LV  L  L
Sbjct: 264 PEMYQTMLDCWHGEPSQRPTFSELVEHLGNL 294

>d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score =  104 bits (261), Expect = 1e-26
 Identities = 44/258 (17%), Positives = 94/258 (36%), Gaps = 20/258 (7%)

Query: 56  FAMEN--IVSEHGEKAPNVVYKGK-LENQFRIAVKRFNRSAWPDARQ---FLEEARAVGQ 109
           +++++  I+   G  +   V+  +   N    A+K   +      +Q     +E   +  
Sbjct: 1   YSLQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSI 60

Query: 110 LRNRRLANLLGCCCEGDERLLVAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALE 169
           + +  +  + G   +  +  ++ +Y+    L       ++Q     +    A  +  ALE
Sbjct: 61  VTHPFIIRMWGTFQDAQQIFMIMDYIEGGEL--FSLLRKSQRFPNPVAKFYAAEVCLALE 118

Query: 170 YCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRD-GRSYSTNLAFTPPEYLRTGR 228
           Y  SK   +Y DL    I+ D + + +++ FG  K   D   +      +  PE + T  
Sbjct: 119 YLHSK-DIIYRDLKPENILLDKNGHIKITDFGFAKYVPDVTYTLCGTPDYIAPEVVSTKP 177

Query: 229 VTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGT--ELV 286
                  +SFG L+ ++L+G             D N     +  L  +         ++ 
Sbjct: 178 YNKSIDWWSFGILIYEMLAGYTPFY--------DSNTMKTYEKILNAELRFPPFFNEDVK 229

Query: 287 RLASRCLQYEPRERPNPR 304
            L SR +  +  +R    
Sbjct: 230 DLLSRLITRDLSQRLGNL 247

>d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fibroblast growth factor receptor 1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  104 bits (259), Expect = 2e-26
 Identities = 52/269 (19%), Positives = 97/269 (36%), Gaps = 35/269 (13%)

Query: 72  VVYKGKL--------ENQFRIAVKRFNRSAWP-DARQFLEEARAVGQL-RNRRLANLLGC 121
            V   +             ++AVK     A   D    + E   +  + +++ + NLLG 
Sbjct: 28  QVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGA 87

Query: 122 CCEGDERLLVAEYMPNDTLAKHLFHW--------------ETQPMKWAMRLRVALHIAEA 167
           C +     ++ EY     L ++L                   + +     +  A  +A  
Sbjct: 88  CTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARG 147

Query: 168 LEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDGRSYSTN------LAFTPP 221
           +EY  SK + ++ DL A  ++  +D   +++ FGL ++      Y         + +  P
Sbjct: 148 MEYLASK-KCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAP 206

Query: 222 EYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDE 281
           E L     T +S ++SFG LL ++ +    P       +    +  L          S+ 
Sbjct: 207 EALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPG----VPVEELFKLLKEGHRMDKPSNC 262

Query: 282 GTELVRLASRCLQYEPRERPNPRSLVTAL 310
             EL  +   C    P +RP  + LV  L
Sbjct: 263 TNELYMMMRDCWHAVPSQRPTFKQLVEDL 291

>d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: G-protein coupled receptor kinase 2
species: Cow (Bos taurus) [TaxId: 9913]

 Score =  104 bits (259), Expect = 5e-26
 Identities = 45/240 (18%), Positives = 78/240 (32%), Gaps = 16/240 (6%)

Query: 72  VVYKGK-LENQFRIAVKRFNRSAWPD------ARQFLEEARAVGQLRNRRLANLLGCCCE 124
            VY  +  +     A+K  ++           A         V       +  +      
Sbjct: 19  EVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHT 78

Query: 125 GDERLLVAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNA 184
            D+   + + M    L  HL          A     A  I   LE+  ++   +Y DL  
Sbjct: 79  PDKLSFILDLMNGGDLHYHLSQH--GVFSEADMRFYAAEIILGLEHMHNR-FVVYRDLKP 135

Query: 185 YRIVFDDDVNPRLSCFGLMKNSRDGRSYSTN--LAFTPPEYLRTGR-VTPESVMYSFGTL 241
             I+ D+  + R+S  GL  +    + +++     +  PE L+ G      +  +S G +
Sbjct: 136 ANILLDEHGHVRISDLGLACDFSKKKPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCM 195

Query: 242 LLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLASRCLQYEPRERP 301
           L  LL G      H      + +  TLT +       S E   L+      LQ +   R 
Sbjct: 196 LFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDSFSPELRSLLE---GLLQRDVNRRL 252

>d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase C, theta type
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  103 bits (257), Expect = 6e-26
 Identities = 45/242 (18%), Positives = 81/242 (33%), Gaps = 22/242 (9%)

Query: 72  VVYKGK-LENQFRIAVKRFNRSAW---PDARQFLEEARAVG-QLRNRRLANLLGCCCEGD 126
            V+  +  +     A+K   +       D    + E R +     +  L ++       +
Sbjct: 17  KVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKE 76

Query: 127 ERLLVAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYR 186
               V EY+    L  H+          +     A  I   L++  SK   +Y DL    
Sbjct: 77  NLFFVMEYLNGGDLMYHIQ--SCHKFDLSRATFYAAEIILGLQFLHSK-GIVYRDLKLDN 133

Query: 187 IVFDDDVNPRLSCFGLMKNSRDGRSYSTNLAFT----PPEYLRTGRVTPESVMYSFGTLL 242
           I+ D D + +++ FG+ K +  G + +     T     PE L   +       +SFG LL
Sbjct: 134 ILLDKDGHIKIADFGMCKENMLGDAKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLL 193

Query: 243 LDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEG--TELVRLASRCLQYEPRER 300
            ++L G+             ++ + L  S              E   L  +    EP +R
Sbjct: 194 YEMLIGQSPFH--------GQDEEELFHSIRMDNPFYPRWLEKEAKDLLVKLFVREPEKR 245

Query: 301 PN 302
             
Sbjct: 246 LG 247

>d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Death-associated protein kinase, Dap
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  102 bits (255), Expect = 8e-26
 Identities = 44/253 (17%), Positives = 82/253 (32%), Gaps = 27/253 (10%)

Query: 72  VVYKGK-LENQFRIAVKRFNRSAWPDARQ------FLEEARAVGQLRNRRLANLLGCCCE 124
           VV K +      + A K   +     +R+         E   + ++++  +  L      
Sbjct: 25  VVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYEN 84

Query: 125 GDERLLVAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNA 184
             + +L+ E +    L       E + +           I   + Y  S + A + DL  
Sbjct: 85  KTDVILILELVAGGELFDF--LAEKESLTEEEATEFLKQILNGVYYLHSLQIA-HFDLKP 141

Query: 185 YRIVFDDDVNPR----LSCFGLMKNSRDGRSYSTNL---AFTPPEYLRTGRVTPESVMYS 237
             I+  D   P+    +  FGL      G  +        F  PE +    +  E+ M+S
Sbjct: 142 ENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPEIVNYEPLGLEADMWS 201

Query: 238 FGTLLLDLLSGKHIPPSH----ALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLASRCL 293
            G +   LLSG            L  +   N +       E ++ S+          R L
Sbjct: 202 IGVITYILLSGASPFLGDTKQETLANVSAVNYE------FEDEYFSNTSALAKDFIRRLL 255

Query: 294 QYEPRERPNPRSL 306
             +P++R   +  
Sbjct: 256 VKDPKKRMTIQDS 268

>d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: gamma-subunit of glycogen phosphorylase kinase (Phk)
species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]

 Score =  100 bits (250), Expect = 3e-25
 Identities = 44/255 (17%), Positives = 79/255 (30%), Gaps = 25/255 (9%)

Query: 72  VVYKGK-LENQFRIAVKRFNRSAWPDA---------RQFLEEARAVGQLRN-RRLANLLG 120
           VV +          AVK  + +                 L+E   + ++     +  L  
Sbjct: 18  VVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKD 77

Query: 121 CCCEGDERLLVAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYH 180
                    LV + M    L  +L   E   +      ++   + E +         ++ 
Sbjct: 78  TYETNTFFFLVFDLMKKGELFDYLT--EKVTLSEKETRKIMRALLEVICALHKL-NIVHR 134

Query: 181 DLNAYRIVFDDDVNPRLSCFGLMKNSRDGRSYST---NLAFTPPEYLRTGRV------TP 231
           DL    I+ DDD+N +L+ FG       G          ++  PE +             
Sbjct: 135 DLKPENILLDDDMNIKLTDFGFSCQLDPGEKLREVCGTPSYLAPEIIECSMNDNHPGYGK 194

Query: 232 ESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLASR 291
           E  M+S G ++  LL+G   PP      +    +    +         D    +  L SR
Sbjct: 195 EVDMWSTGVIMYTLLAGS--PPFWHRKQMLMLRMIMSGNYQFGSPEWDDYSDTVKDLVSR 252

Query: 292 CLQYEPRERPNPRSL 306
            L  +P++R      
Sbjct: 253 FLVVQPQKRYTAEEA 267

>d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Proto-oncogene serine/threonine-protein kinase Pim-1
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 96.7 bits (240), Expect = 6e-24
 Identities = 48/248 (19%), Positives = 90/248 (36%), Gaps = 27/248 (10%)

Query: 72  VVYKGK-LENQFRIAVKRFNRS------AWPDARQFLEEARAVGQLRN--RRLANLLGCC 122
            VY G  + +   +A+K   +         P+  +   E   + ++ +    +  LL   
Sbjct: 19  SVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWF 78

Query: 123 CEGDERLLVAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDL 182
              D  +L+ E              E   ++  +       + EA+ +C +    L+ D+
Sbjct: 79  ERPDSFVLILERPEPVQDLFDFIT-ERGALQEELARSFFWQVLEAVRHCHNCGV-LHRDI 136

Query: 183 NAYRIVFD-DDVNPRLSCFGLMKNSRDGRSYSTN--LAFTPPEYLRTGRVTPESV-MYSF 238
               I+ D +    +L  FG     +D      +    ++PPE++R  R    S  ++S 
Sbjct: 137 KDENILIDLNRGELKLIDFGSGALLKDTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSL 196

Query: 239 GTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLASRCLQYEPR 298
           G LL D++ G   P  H  ++IR +             F     +E   L   CL   P 
Sbjct: 197 GILLYDMVCGDI-PFEHDEEIIRGQVF-----------FRQRVSSECQHLIRWCLALRPS 244

Query: 299 ERPNPRSL 306
           +RP    +
Sbjct: 245 DRPTFEEI 252

>d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score = 96.8 bits (240), Expect = 1e-23
 Identities = 38/257 (14%), Positives = 76/257 (29%), Gaps = 23/257 (8%)

Query: 72  VVYKGK-LENQFRIAVKRFNRSAWPDARQFLEEARAVGQLRNRRLANLLGCCC-EGDERL 129
            +Y G  +     +A+K           Q   E++    ++       +  C  EGD  +
Sbjct: 22  DIYLGTDIAAGEEVAIKLECVKT--KHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNV 79

Query: 130 LVAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVF 189
           +V E +        LF++ ++       L +A  +   +EY  SK   ++ D+     + 
Sbjct: 80  MVMELLGPSLE--DLFNFCSRKFSLKTVLLLADQMISRIEYIHSK-NFIHRDVKPDNFLM 136

Query: 190 ---DDDVNPRLSCFGLMKNSRDGRSYSTN-----------LAFTPPEYLRTGRVTPESVM 235
                     +  FGL K  RD R++                +           +    +
Sbjct: 137 GLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDL 196

Query: 236 YSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTD--SCLEGQFSSDEGTELVRLASRCL 293
            S G +L+    G            R +  +      S           +E     + C 
Sbjct: 197 ESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVLCKGYPSEFATYLNFCR 256

Query: 294 QYEPRERPNPRSLVTAL 310
                ++P+   L    
Sbjct: 257 SLRFDDKPDYSYLRQLF 273

>d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 7, CDK7
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 96.1 bits (238), Expect = 2e-23
 Identities = 47/268 (17%), Positives = 82/268 (30%), Gaps = 36/268 (13%)

Query: 72  VVYKGK-LENQFRIAVKRFNRSAWPDA-----RQFLEEARAVGQLRNRRLANLLGCCCEG 125
            VYK +       +A+K+       +A     R  L E + + +L +  +  LL      
Sbjct: 13  TVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHK 72

Query: 126 DERLLVAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAY 185
               LV ++M  D     +    +  +  +      L   + LEY        + DL   
Sbjct: 73  SNISLVFDFMETDLE--VIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHWIL-HRDLKPN 129

Query: 186 RIVFDDDVNPRLSCFGLMKNSRDGRSYSTNLAFT-----PPEYLRTGRVTPESVMYSFGT 240
            ++ D++   +L+ FGL K+        T+   T     P              M++ G 
Sbjct: 130 NLLLDENGVLKLADFGLAKSFGSPNRAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGC 189

Query: 241 LLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLE----------------------GQFS 278
           +L +LL      P  +      R  +TL     E                          
Sbjct: 190 ILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYVTFKSFPGIPLHHIF 249

Query: 279 SDEGTELVRLASRCLQYEPRERPNPRSL 306
           S  G +L+ L      + P  R      
Sbjct: 250 SAAGDDLLDLIQGLFLFNPCARITATQA 277

>d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

 Score = 95.3 bits (236), Expect = 3e-23
 Identities = 44/298 (14%), Positives = 86/298 (28%), Gaps = 34/298 (11%)

Query: 60  NIVSEH-------GEKAPNVVYKGK-LENQFRIAVKRFNRSAWPDARQFLEEARAVGQLR 111
           N+V  H       GE +  V+++G  L N  ++A+K   R +  DA Q  +E R    L 
Sbjct: 1   NVVGVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRS--DAPQLRDEYRTYKLLA 58

Query: 112 NRR-LANLLGCCCEGDERLLVAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEY 170
               + N+     EG   +LV + +        L     +          A  +   ++ 
Sbjct: 59  GCTGIPNVYYFGQEGLHNVLVIDLLGPSLE--DLLDLCGRKFSVKTVAMAAKQMLARVQS 116

Query: 171 CTSKERALYHDLNAYRIVFDDDVNPRLSC-----FGLMKNSRDGRSYSTN---------- 215
              K   +Y D+     +     +   +      FG++K  RD  +              
Sbjct: 117 IHEK-SLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSG 175

Query: 216 -LAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPP--SHALDLIRDRNIQTLTDSC 272
              +           +    + + G + +  L G         A +  +   I     S 
Sbjct: 176 TARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQST 235

Query: 273 LEGQFSSDEGTELVRLASRCLQYEPRERPNPRSLVTALVTLQKDTELYLSLP--WVML 328
              +  +    E  +             P+   L      + +           W +L
Sbjct: 236 PLRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLERLNTTEDENFDWNLL 293

>d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: (Plasmodium falciparum) [TaxId: 5833]

 Score = 94.6 bits (234), Expect = 4e-23
 Identities = 42/281 (14%), Positives = 95/281 (33%), Gaps = 35/281 (12%)

Query: 58  MEN--IVSEHGEKAPNVVYKGKLENQFRIAVKRFNRSAWPDA--RQFLEEARAVGQLRNR 113
           ME    + + GE    VVYK +       A+K+       +      + E   + +L++ 
Sbjct: 1   MEKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHS 60

Query: 114 RLANLLGCCCEGDERLLVAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTS 173
            +  L          +LV E++  D     L       ++        L +   + YC  
Sbjct: 61  NIVKLYDVIHTKKRLVLVFEHLDQDLK--KLLDVCEGGLESVTAKSFLLQLLNGIAYCHD 118

Query: 174 KERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDGRSYSTNLAFTP-----PEYLRTGR 228
           + R L+ DL    ++ + +   +++ FGL +         T+   T         + + +
Sbjct: 119 R-RVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEIVTLWYRAPDVLMGSKK 177

Query: 229 VTPESVMYSFGTLLLDLLSGKHIPPS-----------------------HALDLIRDRNI 265
            +    ++S G +  ++++G  + P                        +  +L +    
Sbjct: 178 YSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDPN 237

Query: 266 QTLTDSCLEGQFSSDEGTELVRLASRCLQYEPRERPNPRSL 306
            T+ +      F        + L S+ L+ +P +R   +  
Sbjct: 238 FTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQA 278

>d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Glycogen synthase kinase-3 beta (Gsk3b)
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 95.2 bits (236), Expect = 6e-23
 Identities = 50/271 (18%), Positives = 85/271 (31%), Gaps = 41/271 (15%)

Query: 72  VVYKGKL-ENQFRIAVKRFNRSAWPDARQFLEEARAVGQLRNRRLANLLGCCCEGDER-- 128
           VVY+ KL ++   +A+K+  +    D R    E + + +L +  +  L        E+  
Sbjct: 35  VVYQAKLCDSGELVAIKKVLQ----DKRFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKD 90

Query: 129 ----LLVAEYMPNDTLAKHLFHWET-QPMKWAMRLRVALHIAEALEYCTSKERALYHDLN 183
                LV +Y+P         +    Q +           +  +L Y  S     + D+ 
Sbjct: 91  EVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSF-GICHRDIK 149

Query: 184 AYRIVFDDD-VNPRLSCFGLMKNSRDGRSYSTNLAFT----PPEYLRTGRVTPESVMYSF 238
              ++ D D    +L  FG  K    G    + +       P         T    ++S 
Sbjct: 150 PQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSA 209

Query: 239 GTLLLDLLSGKHI----PPSHALDLI-------------------RDRNIQTLTDSCLEG 275
           G +L +LL G+ I         L  I                    +     +       
Sbjct: 210 GCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKAHPWTK 269

Query: 276 QFSSDEGTELVRLASRCLQYEPRERPNPRSL 306
            F      E + L SR L+Y P  R  P   
Sbjct: 270 VFRPRTPPEAIALCSRLLEYTPTARLTPLEA 300

>d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 93.0 bits (230), Expect = 2e-22
 Identities = 51/282 (18%), Positives = 103/282 (36%), Gaps = 35/282 (12%)

Query: 58  MEN--IVSEHGEKAPNVVYKGK-LENQFRIAVKRFNRSAWPD--ARQFLEEARAVGQLRN 112
           MEN   V + GE    VVYK +       +A+K+       +      + E   + +L +
Sbjct: 1   MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNH 60

Query: 113 RRLANLLGCCCEGDERLLVAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCT 172
             +  LL      ++  LV E++  D L K +       +   +       + + L +C 
Sbjct: 61  PNIVKLLDVIHTENKLYLVFEFLHQD-LKKFMDASALTGIPLPLIKSYLFQLLQGLAFCH 119

Query: 173 SKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDGRSYSTNLAFT-----PPEYLRTG 227
           S  R L+ DL    ++ + +   +L+ FGL +         T+   T     P   L   
Sbjct: 120 SH-RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCK 178

Query: 228 RVTPESVMYSFGTLLLDLLSGKHI-PPSHALDLIRD--RNIQTLTDSCLEGQFSSDE--- 281
             +    ++S G +  ++++ + + P    +D +    R + T  +    G  S  +   
Sbjct: 179 YYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKP 238

Query: 282 -----------------GTELVRLASRCLQYEPRERPNPRSL 306
                              +   L S+ L Y+P +R + ++ 
Sbjct: 239 SFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAA 280

>d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase Erk2
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 93.0 bits (230), Expect = 4e-22
 Identities = 38/271 (14%), Positives = 91/271 (33%), Gaps = 37/271 (13%)

Query: 72  VVYKGK-LENQFRIAVKRFNRSAWP-DARQFLEEARAVGQLRNRRLANLLGCCCEGDERL 129
           +V       N+ R+A+K+ +        ++ L E + + + R+  +  +           
Sbjct: 23  MVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQ 82

Query: 130 LVAEYMPNDTLAKHLFHW-ETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIV 188
           +   Y+    +   L+   +TQ +           I   L+Y  S    L+ DL    ++
Sbjct: 83  MKDVYLVTHLMGADLYKLLKTQHLSNDHICYFLYQILRGLKYIHSA-NVLHRDLKPSNLL 141

Query: 189 FDDDVNPRLSCFGLMKNSRDGRSYST-------NLAFTPPEYLRTGRVTPESV-MYSFGT 240
            +   + ++  FGL + +     ++           +  PE +   +   +S+ ++S G 
Sbjct: 142 LNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGC 201

Query: 241 LLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLE-------------------------G 275
           +L ++LS + I P        +  +  L     E                          
Sbjct: 202 ILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARNYLLSLPHKNKVPWN 261

Query: 276 QFSSDEGTELVRLASRCLQYEPRERPNPRSL 306
           +   +  ++ + L  + L + P +R      
Sbjct: 262 RLFPNADSKALDLLDKMLTFNPHKRIEVEQA 292

>d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Pkb kinase (Akt-2)
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 91.0 bits (225), Expect = 2e-21
 Identities = 45/242 (18%), Positives = 82/242 (33%), Gaps = 17/242 (7%)

Query: 72  VVYKGK-LENQFRIAVKRFNRS---AWPDARQFLEEARAVGQLRNRRLANLLGCCCEGDE 127
            V   +        A+K   +    A  +    + E+R +   R+  L  L       D 
Sbjct: 20  KVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDR 79

Query: 128 RLLVAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRI 187
              V EY     L  HL        + A        I  ALEY  S+   +Y D+    +
Sbjct: 80  LCFVMEYANGGELFFHLSRERVFTEERARFY--GAEIVSALEYLHSR-DVVYRDIKLENL 136

Query: 188 VFDDDVNPRLSCFGLMKNSRDGRSYSTNLAFTP----PEYLRTGRVTPESVMYSFGTLLL 243
           + D D + +++ FGL K      +       TP    PE L           +  G ++ 
Sbjct: 137 MLDKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMY 196

Query: 244 DLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLASRCLQYEPRERPNP 303
           +++ G+    +   + + +  +        E +F      E   L +  L+ +P++R   
Sbjct: 197 EMMCGRLPFYNQDHERLFELILME------EIRFPRTLSPEAKSLLAGLLKKDPKQRLGG 250

Query: 304 RS 305
             
Sbjct: 251 GP 252

>d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase activated protein kinase 2, mapkap2
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 90.2 bits (223), Expect = 3e-21
 Identities = 42/249 (16%), Positives = 77/249 (30%), Gaps = 20/249 (8%)

Query: 72  VVYKGK-LENQFRIAVKRFNRSAWPDARQFLEEARAVGQL-RNRRLANLLGCC----CEG 125
            V +      Q + A+K        D  +   E     +  +   +  ++          
Sbjct: 27  KVLQIFNKRTQEKFALKMLQ-----DCPKARREVELHWRASQCPHIVRIVDVYENLYAGR 81

Query: 126 DERLLVAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAY 185
              L+V E +    L   +     Q         +   I EA++Y  S     + D+   
Sbjct: 82  KCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSI-NIAHRDVKPE 140

Query: 186 RIVFDDDVNP---RLSCFGLMKNSRDGRSYSTN---LAFTPPEYLRTGRVTPESVMYSFG 239
            +++         +L+ FG  K +    S +T      +  PE L   +      M+S G
Sbjct: 141 NLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLG 200

Query: 240 TLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLE--GQFSSDEGTELVRLASRCLQYEP 297
            ++  LL G     S+    I       +     E      S+   E+  L    L+ EP
Sbjct: 201 VIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEP 260

Query: 298 RERPNPRSL 306
            +R      
Sbjct: 261 TQRMTITEF 269

>d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38-gamma
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 88.3 bits (218), Expect = 2e-20
 Identities = 37/271 (13%), Positives = 88/271 (32%), Gaps = 41/271 (15%)

Query: 72  VVYKGK-LENQFRIAVKRFNRS--AWPDARQFLEEARAVGQLRNRRLANLLGCCCEGD-- 126
            V          ++A+K+  R   +   A++   E R +  +R+  +  LL      +  
Sbjct: 33  AVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETL 92

Query: 127 ----ERLLVAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDL 182
               +  LV  +M  D         + + +       +   + + L Y  +    ++ DL
Sbjct: 93  DDFTDFYLVMPFMGTD----LGKLMKHEKLGEDRIQFLVYQMLKGLRYIHAA-GIIHRDL 147

Query: 183 NAYRIVFDDDVNPRLSCFGLMKNSRDGRSYSTNLAF--TPPEYLRTGRVTPESVMYSFGT 240
               +  ++D   ++  FGL + +    +      +   P   L   R T    ++S G 
Sbjct: 148 KPGNLAVNEDCELKILDFGLARQADSEMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGC 207

Query: 241 LLLDLLSGKHI-------------------PPSHALDLIRDRNIQTLTDSCLE------G 275
           ++ ++++GK +                   PP+  +  ++    +       E       
Sbjct: 208 IMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSDEAKNYMKGLPELEKKDFA 267

Query: 276 QFSSDEGTELVRLASRCLQYEPRERPNPRSL 306
              ++     V L  + L  +  +R      
Sbjct: 268 SILTNASPLAVNLLEKMLVLDAEQRVTAGEA 298

>d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK6
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 85.3 bits (210), Expect = 1e-19
 Identities = 41/281 (14%), Positives = 85/281 (30%), Gaps = 36/281 (12%)

Query: 61  IVSEHGEKAPNVVYKGK--LENQFRIAVKRFNRSAWPD-----ARQFLEEARAVGQLRNR 113
            V+E GE A   V+K +        +A+KR       +       + +   R +    + 
Sbjct: 11  CVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHP 70

Query: 114 RLANLLGCCCEGDERLLVAEYMPNDTLA----KHLFHWETQPMKWAMRLRVALHIAEALE 169
            +  L   C            +  + +      +L       +       +   +   L+
Sbjct: 71  NVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLD 130

Query: 170 YCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDGRSYSTN---LAFTPPEYLRT 226
           +  S  R ++ DL    I+       +L+ FGL +      + ++    L +  PE L  
Sbjct: 131 FLHSH-RVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSVVVTLWYRAPEVLLQ 189

Query: 227 GRVTPESVMYSFGTLLLDLLSGKHI---------------------PPSHALDLIRDRNI 265
                   ++S G +  ++   K +                           D+   R  
Sbjct: 190 SSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDVALPRQA 249

Query: 266 QTLTDSCLEGQFSSDEGTELVRLASRCLQYEPRERPNPRSL 306
                +    +F +D       L  +CL + P +R +  S 
Sbjct: 250 FHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSA 290

>d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK5
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 84.2 bits (207), Expect = 3e-19
 Identities = 40/283 (14%), Positives = 80/283 (28%), Gaps = 37/283 (13%)

Query: 58  MEN--IVSEHGEKAPNVVYKGK-LENQFRIAVKRFNRSAWPDA--RQFLEEARAVGQLRN 112
           M+    + + GE     V+K K  E    +A+KR       +      L E   + +L++
Sbjct: 1   MQKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKH 60

Query: 113 RRLANLLGCCCEGDERLLVAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCT 172
           + +  L        +  LV E+   D      F      +   +       + + L +C 
Sbjct: 61  KNIVRLHDVLHSDKKLTLVFEFCDQDLK--KYFDSCNGDLDPEIVKSFLFQLLKGLGFCH 118

Query: 173 SKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDGRSYSTNLAFT-----PPEYLRTG 227
           S+   L+ DL    ++ + +   +L+ FGL +         +    T     P       
Sbjct: 119 SR-NVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGAK 177

Query: 228 RVTPESVMYSFGTLLLDLLSGKHIP------------------------PSHALDLIRDR 263
             +    M+S G +  +L +                                   L   +
Sbjct: 178 LYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYK 237

Query: 264 NIQTLTDSCLEGQFSSDEGTELVRLASRCLQYEPRERPNPRSL 306
                  +                L    L+  P +R +    
Sbjct: 238 PYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEA 280

>d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Mouse (Mus musculus) [TaxId: 10090]

 Score = 83.3 bits (205), Expect = 1e-18
 Identities = 45/236 (19%), Positives = 76/236 (32%), Gaps = 14/236 (5%)

Query: 72  VVYKGK-LENQFRIAVKRFNRSAWPDARQ---FLEEARAVGQLRNRRLANLLGCCCEGDE 127
            V   K  E+    A+K  ++      +Q    L E R +  +    L  L     +   
Sbjct: 56  RVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSN 115

Query: 128 RLLVAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRI 187
             +V EY+    +  HL                A  I    EY  S    +Y DL    +
Sbjct: 116 LYMVMEYVAGGEMFSHL--RRIGRFSEPHARFYAAQIVLTFEYLHSL-DLIYRDLKPENL 172

Query: 188 VFDDDVNPRLSCFGLMKNSRD-GRSYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLL 246
           + D     +++ FG  K  +    +         PE + +         ++ G L+ ++ 
Sbjct: 173 LIDQQGYIQVTDFGFAKRVKGRTWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMA 232

Query: 247 SGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLASRCLQYEPRERPN 302
           +G   PP  A   I+               FSS    +L  L    LQ +  +R  
Sbjct: 233 AGY--PPFFADQPIQIYEKIVSGKVRFPSHFSS----DLKDLLRNLLQVDLTKRFG 282

>d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 9, CDK9
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 80.3 bits (197), Expect = 9e-18
 Identities = 45/292 (15%), Positives = 95/292 (32%), Gaps = 49/292 (16%)

Query: 61  IVSEHGEKAPNVVYKGK-LENQFRIAVKRFNRSAWPDA--RQFLEEARAVGQLRNRRLAN 117
            +++ G+     V+K +  +   ++A+K+       +      L E + +  L++  + N
Sbjct: 14  KLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVN 73

Query: 118 LLGCCCEGDER--------LLVAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALE 169
           L+  C               LV ++  +D     L          +   RV   +   L 
Sbjct: 74  LIEICRTKASPYNRCKGSIYLVFDFCEHDLA--GLLSNVLVKFTLSEIKRVMQMLLNGLY 131

Query: 170 YCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDGRSYSTN--------LAFTPP 221
           Y     + L+ D+ A  ++   D   +L+ FGL +     ++   N        L + PP
Sbjct: 132 YIHRN-KILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVVTLWYRPP 190

Query: 222 EYLRTGR-VTPESVMYSFGTLLLDLLSGKHIPPS----HALDLIRD-------------- 262
           E L   R   P   ++  G ++ ++ +   I       H L LI                
Sbjct: 191 ELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEVWPNVD 250

Query: 263 --------RNIQTLTDSCLEGQFSSDEGTELVRLASRCLQYEPRERPNPRSL 306
                     ++       +   +       + L  + L  +P +R +    
Sbjct: 251 NYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDA 302

>d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Ribosomal protein S6 kinase alpha 5, Msk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 76.0 bits (186), Expect = 3e-16
 Identities = 46/262 (17%), Positives = 84/262 (32%), Gaps = 23/262 (8%)

Query: 58  MEN--IVSEHGEKAPNVVYKGKL----ENQFRIAVKRFNRSAWPD----ARQFLEEARAV 107
           +EN  ++   G  A   V+  +     +     A+K   ++              E + +
Sbjct: 23  IENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVL 82

Query: 108 GQLRNRRLANLLGCCCEGDERLLVA-EYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAE 166
             +R       L    + + +L +  +Y+    L  HL   E               I  
Sbjct: 83  EHIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQRERFTEHEVQI--YVGEIVL 140

Query: 167 ALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDGRSYSTNLAFTPPEY--- 223
           ALE+       +Y D+    I+ D + +  L+ FGL K      +          EY   
Sbjct: 141 ALEHLHKL-GIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDFCGTIEYMAP 199

Query: 224 --LRTGR--VTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSS 279
             +R G          +S G L+ +LL+G    P         +   +      E  +  
Sbjct: 200 DIVRGGDSGHDKAVDWWSLGVLMYELLTGA--SPFTVDGEKNSQAEISRRILKSEPPYPQ 257

Query: 280 DEGTELVRLASRCLQYEPRERP 301
           +       L  R L  +P++R 
Sbjct: 258 EMSALAKDLIQRLLMKDPKKRL 279

>d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 72.2 bits (176), Expect = 6e-15
 Identities = 42/278 (15%), Positives = 84/278 (30%), Gaps = 33/278 (11%)

Query: 61  IVSEHGEKAPNVVYKGK-LENQFRIAVKRFNRS--AWPDARQFLEEARAVGQLRNRRLAN 117
            +S  G  A   V      +   R+AVK+ +R   +   A++   E R +  +++  +  
Sbjct: 22  NLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIG 81

Query: 118 LLGCCCEGDERLLVAEYMPNDTLAKHLFH--WETQPMKWAMRLRVALHIAEALEYCTSKE 175
           LL             +      L     +   + Q +       +   I   L+Y  S  
Sbjct: 82  LLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSA- 140

Query: 176 RALYHDLNAYRIVFDDDVNPRLSCFGL--MKNSRDGRSYSTNLAFTPPEYLRTGRVTPES 233
             ++ DL    +  ++D   ++  FGL    +       +T     P   L         
Sbjct: 141 DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATRWYRAPEIMLNWMHYNQTV 200

Query: 234 VMYSFGTLLLDLLSGKH-------------------IPPSHALDLIRDRNIQTLTDSCLE 274
            ++S G ++ +LL+G+                     P +  L  I   + +    S  +
Sbjct: 201 DIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQ 260

Query: 275 ------GQFSSDEGTELVRLASRCLQYEPRERPNPRSL 306
                            V L  + L  +  +R      
Sbjct: 261 MPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQA 298

>d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase CK2, alpha subunit
species: Rattus norvegicus [TaxId: 10116]

 Score = 69.5 bits (169), Expect = 5e-14
 Identities = 42/276 (15%), Positives = 87/276 (31%), Gaps = 50/276 (18%)

Query: 72  VVYKGK-LENQFRIAVKRFNRSAWPDARQFLEEARAVGQLR-NRRLANLLGCCCEGDERL 129
            V++   + N  ++ VK          ++   E + +  LR    +  L     +   R 
Sbjct: 50  EVFEAINITNNEKVVVKILKPV---KKKKIKREIKILENLRGGPNIITLADIVKDPVSRT 106

Query: 130 --LVAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRI 187
             LV E++ N    +       Q +           I +AL+YC S    ++ D+  + +
Sbjct: 107 PALVFEHVNNTDFKQLY-----QTLTDYDIRFYMYEILKALDYCHSM-GIMHRDVKPHNV 160

Query: 188 VFD-DDVNPRLSCFGLMKNSRDGRSYS----TNLAFTPPEYLRTGRVTPESVMYSFGTLL 242
           + D +    RL  +GL +    G+ Y+    +     P   +          M+S G +L
Sbjct: 161 MIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCML 220

Query: 243 LDLLSGKH--------------------------------IPPSHALDLIRDRNIQTLTD 270
             ++  K                                 I      + I  R+ +   +
Sbjct: 221 ASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWE 280

Query: 271 SCLEGQFSSDEGTELVRLASRCLQYEPRERPNPRSL 306
             +  +       E +    + L+Y+ + R   R  
Sbjct: 281 RFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREA 316

>d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Sky1p
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score = 69.3 bits (168), Expect = 7e-14
 Identities = 42/299 (14%), Positives = 91/299 (30%), Gaps = 65/299 (21%)

Query: 72  VVYKGK-LENQFRIAVKRFNRSAWPDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLL 130
            V+  K + N   +A+K              +E + + ++ +               +LL
Sbjct: 28  TVWLAKDMVNNTHVAMKIVRGDK-VYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLL 86

Query: 131 VAEYMPNDTLAKHLFHWE--------------TQPMKWAMRLRVALHIAEALEYCTSKER 176
                        +  +E               + +      +++  +   L+Y   +  
Sbjct: 87  DHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCG 146

Query: 177 ALYHDLNAYRIVFDDD------VNPRLSCFGLMKNSRDGRSYS-TNLAFTPPEYLRTGRV 229
            ++ D+    ++ +        +  +++  G      +  + S     +  PE L     
Sbjct: 147 IIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNSIQTREYRSPEVLLGAPW 206

Query: 230 TPESVMYSFGTLLLDLLSGKHI-------------------------PPSHALDLIRD-- 262
              + ++S   L+ +L++G  +                          PS+ L   +   
Sbjct: 207 GCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQIIELLGELPSYLLRNGKYTR 266

Query: 263 ---------RNIQTLTDSCLEG------QFSSDEGTELVRLASRCLQYEPRERPNPRSL 306
                    RNI  L    LE       +FS DE  E+    S  LQ +PR+R +   L
Sbjct: 267 TFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAGGL 325

>d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-jun N-terminal kinase (jnk3s)
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 68.8 bits (167), Expect = 1e-13
 Identities = 39/294 (13%), Positives = 90/294 (30%), Gaps = 54/294 (18%)

Query: 61  IVSEHGEKAPNVVYKGK-LENQFRIAVKRFNRSA--WPDARQFLEEARAVGQLRNRRLAN 117
            +   G  A  +V           +A+K+ +R       A++   E   +  + ++ + +
Sbjct: 21  NLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIS 80

Query: 118 LLGCCC------EGDERLLVAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYC 171
           LL          E  +  LV E M  +         +           +   +   +++ 
Sbjct: 81  LLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELD-----HERMSYLLYQMLCGIKHL 135

Query: 172 TSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDGRSYSTN---LAFTPPEYLRTGR 228
            S    ++ DL    IV   D   ++  FGL + +      +       +  PE +    
Sbjct: 136 HSAGI-IHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMG 194

Query: 229 VTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLE-------------- 274
                 ++S G ++ +++  K + P        ++ I+ L   C E              
Sbjct: 195 YKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVE 254

Query: 275 ----------------------GQFSSDEGTELVRLASRCLQYEPRERPNPRSL 306
                                  + +  + ++   L S+ L  +P +R +    
Sbjct: 255 NRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDA 308

>d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: RIO1-like kinases
domain: Rio2 serine protein kinase C-terminal domain
species: Archaeoglobus fulgidus [TaxId: 2234]

 Score = 45.9 bits (108), Expect = 1e-06
 Identities = 20/147 (13%), Positives = 35/147 (23%), Gaps = 25/147 (17%)

Query: 72  VVYKGKLENQFRIAVKRFNRSA----------WPDARQFLEEARAVGQLRNRRLANLLGC 121
            V+    E      VK                      F   A    +   R L  L G 
Sbjct: 15  AVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGL 74

Query: 122 CC----EGDERLLVAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERA 177
                   +   ++ E +            E   ++      V   I E +     +   
Sbjct: 75  AVPKVYAWEGNAVLMELI---------DAKELYRVRVENPDEVLDMILEEVAKFYHR-GI 124

Query: 178 LYHDLNAYRIVFDDDVNPRLSCFGLMK 204
           ++ DL+ Y  V   +    +  F    
Sbjct: 125 VHGDLSQY-NVLVSEEGIWIIDFPQSV 150

Homologous Domains Detected by HHsearch

Original result of HHsearch against SCOP70(version1.75) database

ID	Length	Definition	Probability
Query	329
d1yhwa1	293	pak1 {Human (Homo sapiens) [TaxId: 9606]}	100.0
d2j4za1	263	Aurora-related kinase 1 (aurora-2) {Human (Homo sa	100.0
d1sm2a_	263	Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie	100.0
d1opja_	287	Abelsone tyrosine kinase (abl) {Mouse (Mus musculu	100.0
d1nvra_	271	Cell cycle checkpoint kinase chk1 {Human (Homo sap	100.0
d1jpaa_	299	ephb2 receptor tyrosine kinase {Mouse (Mus musculu	100.0
d2jfla1	288	STE20-like serine/threonine-protein kinase, SLK {H	100.0
d1uwha_	276	B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]}	100.0
d2java1	269	Serine/threonine-protein kinase Nek2 {Human (Homo	100.0
d1qpca_	272	Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax	100.0
d1u5ra_	309	Serine/threonine protein kinase TAO2 {Rat (Rattus	100.0
d1a06a_	307	Calmodulin-dependent protein kinase {Rat (Rattus n	100.0
d1k2pa_	258	Bruton's tyrosine kinase (Btk) {Human (Homo sapien	100.0
d1s9ja_	322	Dual specificity mitogen-activated protein kinase	100.0
d1t4ha_	270	Protein kinase wnk1 {Human (Homo sapiens) [TaxId:	100.0
d1mqba_	283	epha2 receptor tyrosine kinase {Human (Homo sapien	100.0
d1koba_	352	Twitchin, kinase domain {California sea hare (Aply	100.0
d1koaa2	350	Twitchin, kinase domain {Caenorhabditis elegans, p	100.0
d1uu3a_	288	3-phosphoinositide dependent protein kinase-1 Pdk1	100.0
d1o6la_	337	Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9	100.0
d1u59a_	285	Tyrosine-protein kinase ZAP-70 {Human (Homo sapien	100.0
d1jksa_	293	Death-associated protein kinase, Dap {Human (Homo	100.0
d1fota_	316	cAMP-dependent PK, catalytic subunit {Baker's yeas	100.0
d1fmka3	285	c-src tyrosine kinase {Human (Homo sapiens) [TaxId	100.0
d1xbba_	277	Tyrosine-protein kinase SYK {Human (Homo sapiens)	100.0
d1rjba_	325	Fl cytokine receptor {Human (Homo sapiens) [TaxId:	100.0
d1byga_	262	Carboxyl-terminal src kinase (csk) {Human (Homo sa	100.0
d1phka_	277	gamma-subunit of glycogen phosphorylase kinase (Ph	100.0
d1rdqe_	350	cAMP-dependent PK, catalytic subunit {Mouse (Mus m	100.0
d1tkia_	321	Titin, kinase domain {Human (Homo sapiens) [TaxId:	100.0
d1mp8a_	273	Focal adhesion kinase 1 (fak) {Human (Homo sapiens	100.0
d1lufa_	301	Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax	100.0
d1xjda_	320	Protein kinase C, theta type {Human (Homo sapiens)	100.0
d1omwa3	364	G-protein coupled receptor kinase 2 {Cow (Bos taur	100.0
d1xkka_	317	EGF receptor tyrosine kinase, Erbb-1 {Human (Homo	100.0
d2ozaa1	335	MAP kinase activated protein kinase 2, mapkap2 {Hu	100.0
d1o6ya_	277	Mycobacterial protein kinase PknB, catalytic domai	100.0
d1fvra_	309	Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1u46a_	273	Activated CDC42 kinase 1, ACK1 {Human (Homo sapien	100.0
d1ua2a_	299	Cell division protein kinase 7, CDK7 {Human (Homo	100.0
d1r0pa_	311	Hepatocyte growth factor receptor, c-MET {Human (H	100.0
d1ywna1	299	Vascular endothelial growth factor receptor 2 (kdr	100.0
d1fgka_	299	Fibroblast growth factor receptor 1 {Human (Homo s	100.0
d1gz8a_	298	Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T	100.0
d1ob3a_	286	Cyclin-dependent PK, CDK2 {(Plasmodium falciparum)	100.0
d1t46a_	311	c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]	100.0
d1p4oa_	308	Insulin-like growth factor 1 receptor {Human (Homo	100.0
d1xwsa_	273	Proto-oncogene serine/threonine-protein kinase Pim	100.0
d1vjya_	303	Type I TGF-beta receptor R4 {Human (Homo sapiens)	100.0
d1blxa_	305	Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T	100.0
d1cm8a_	346	MAP kinase p38-gamma {Human (Homo sapiens) [TaxId:	100.0
d3blha1	318	Cell division protein kinase 9, CDK9 {Human (Homo	100.0
d1pmea_	345	MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606	100.0
d1unla_	292	Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T	100.0
d3bqca1	328	Protein kinase CK2, alpha subunit {Rattus norvegic	100.0
d1q5ka_	350	Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho	100.0
d1csna_	293	Casein kinase-1, CK1 {Fission yeast (Schizosacchar	100.0
d1vzoa_	322	Ribosomal protein S6 kinase alpha 5, Msk1 {Human (	100.0
d2b1pa1	355	c-jun N-terminal kinase (jnk3s) {Human (Homo sapie	100.0
d1ckia_	299	Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax	100.0
d2gfsa1	348	MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]	100.0
d1q8ya_	362	Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T	100.0
d1zara2	191	Rio2 serine protein kinase C-terminal domain {Arch	99.92
d1j7la_	263	Type IIIa 3',5"-aminoglycoside phosphotransferase	98.62
d1nd4a_	255	Aminoglycoside 3'-phosphotransferase IIa (Kanamyci	98.1
d2pula1	392	Methylthioribose kinase MtnK {Bacillus subtilis [T	97.99
d1zyla1	325	RdoA {Escherichia coli [TaxId: 562]}	97.72
d1nw1a_	395	Choline kinase {Caenorhabditis elegans [TaxId: 623	96.98
d2ppqa1	316	Homoserine kinase ThrB {Agrobacterium tumefaciens	96.92

>d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: pak1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=8.3e-60  Score=411.10  Aligned_cols=245  Identities=18%  Similarity=0.246  Sum_probs=210.4

Q ss_pred             CcccccccCCCCCCcEEEEEE-eCCCCEEEEEEeCCCCChhHHHHHHHHHHHhcCCCccccccceeeeeCCeeEEEEecC
Q 020221           57 AMENIVSEHGEKAPNVVYKGK-LENQFRIAVKRFNRSAWPDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAEYM  135 (329)
Q Consensus        57 ~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~  135 (329)
                      ..|++++.||+|+||+||+|. ..+|+.||||++........+.+.+|+++++.++||||+++++++.+.+..++||||+
T Consensus        20 ~~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmEy~   99 (293)
T d1yhwa1          20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYL   99 (293)
T ss_dssp             TTBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred             cccEEEEEEecCcCcEEEEEEECCCCCEEEEEEEecccChHHHHHHHHHHHHHhCCCCCEeeEeEEEEECCEEEEEEEec
Confidence            358889999999999999999 5678999999998765556778999999999999999999999999999999999999


Q ss_pred             CCCCHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCCCCCeeeecccCcccCCCC----CC
Q 020221          136 PNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDG----RS  211 (329)
Q Consensus       136 ~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~----~~  211 (329)
                      ++|+|.+++.+   ..+++.++..++.||+.||+|||++ ||+||||||+|||++.++.+||+|||+++.....    ..
T Consensus       100 ~gg~L~~~~~~---~~l~~~~~~~i~~qi~~aL~yLH~~-~iiHrDiKp~NILl~~~~~vkl~DFG~a~~~~~~~~~~~~  175 (293)
T d1yhwa1         100 AGGSLTDVVTE---TCMDEGQIAAVCRECLQALEFLHSN-QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRST  175 (293)
T ss_dssp             TTCBHHHHHHH---SCCCHHHHHHHHHHHHHHHHHHHHT-TEECCCCSGGGEEECTTCCEEECCCTTCEECCSTTCCBCC
T ss_pred             CCCcHHHHhhc---cCCCHHHHHHHHHHHHHHHHHHHHC-CCcccCCcHHHeEECCCCcEeeccchhheeeccccccccc
Confidence            99999998853   4699999999999999999999999 9999999999999999999999999999875433    34


Q ss_pred             ccCcccccCcccccCCCCCCcccchhhhHHHHHHHhCCCCCCchhhHHHhhhchhhhccccccCCCChHHHHHHHHHHHH
Q 020221          212 YSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLASR  291 (329)
Q Consensus       212 ~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~  291 (329)
                      ..||+.|+|||++.+..++.++|||||||++|+|++|..||...............   .......+..+++++.+|+.+
T Consensus       176 ~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~~~~---~~~~~~~~~~~s~~~~~li~~  252 (293)
T d1yhwa1         176 MVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATN---GTPELQNPEKLSAIFRDFLNR  252 (293)
T ss_dssp             CCSCGGGCCHHHHSSSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHH---CSCCCSSGGGSCHHHHHHHHH
T ss_pred             cccCCCccChhhhcCCCCCchhceehHhHHHHHHhhCCCCCCCCCHHHHHHHHHhC---CCCCCCCcccCCHHHHHHHHH
Confidence            46899999999999999999999999999999999999988654322222111111   111123456678899999999


Q ss_pred             hcccCCCCCCCHHHHHH
Q 020221          292 CLQYEPRERPNPRSLVT  308 (329)
Q Consensus       292 cl~~dp~~Rps~~~~l~  308 (329)
                      ||+.||++|||+.++++
T Consensus       253 ~L~~dP~~R~s~~eil~  269 (293)
T d1yhwa1         253 CLDMDVEKRGSAKELLQ  269 (293)
T ss_dssp             HTCSSTTTSCCHHHHTT
T ss_pred             HccCChhHCcCHHHHhc
Confidence            99999999999999987

>d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Aurora-related kinase 1 (aurora-2)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.5e-59  Score=402.33  Aligned_cols=243  Identities=21%  Similarity=0.294  Sum_probs=209.7

Q ss_pred             CcccccccCCCCCCcEEEEEEe-CCCCEEEEEEeCCCC---ChhHHHHHHHHHHHhcCCCccccccceeeeeCCeeEEEE
Q 020221           57 AMENIVSEHGEKAPNVVYKGKL-ENQFRIAVKRFNRSA---WPDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVA  132 (329)
Q Consensus        57 ~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~  132 (329)
                      ++|++++.||+|+||+||+|.. .+++.||+|++....   ....+.+.+|+++++.++||||+++++++.+.+..++||
T Consensus         6 ~dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~ivm   85 (263)
T d2j4za1           6 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLIL   85 (263)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             hHeEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEEEEECCEEEEEE
Confidence            4578888999999999999994 578899999986432   223567889999999999999999999999999999999


Q ss_pred             ecCCCCCHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCCCCCeeeecccCcccCCCC--C
Q 020221          133 EYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDG--R  210 (329)
Q Consensus       133 e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~--~  210 (329)
                      ||+++|+|.+++.  ....+++..+..++.||+.||+|||++ ||+||||||+|||++.++.+||+|||+|+.....  .
T Consensus        86 Ey~~~g~L~~~l~--~~~~l~e~~~~~i~~qi~~al~~lH~~-~ivHrDiKp~Nill~~~~~~kl~DFG~a~~~~~~~~~  162 (263)
T d2j4za1          86 EYAPLGTVYRELQ--KLSKFDEQRTATYITELANALSYCHSK-RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRT  162 (263)
T ss_dssp             ECCTTCBHHHHHH--HHSSCCHHHHHHHHHHHHHHHHHHHHT-TCCCCCCCGGGEEECTTSCEEECCCCSCSCCCCCCCE
T ss_pred             eecCCCcHHHHHh--hcCCCCHHHHHHHHHHHHHHHHHHHHC-CeeeeeeccccceecCCCCEeecccceeeecCCCccc
Confidence            9999999999996  345799999999999999999999999 9999999999999999999999999999876544  3


Q ss_pred             CccCcccccCcccccCCCCCCcccchhhhHHHHHHHhCCCCCCchhhHHHhhhchhhhccccccCCCChHHHHHHHHHHH
Q 020221          211 SYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLAS  290 (329)
Q Consensus       211 ~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~  290 (329)
                      ...||+.|+|||++.+..++.++|||||||++|||++|+.||..............      ....++...++++.+|+.
T Consensus       163 ~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~------~~~~~p~~~s~~~~~li~  236 (263)
T d2j4za1         163 TLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISR------VEFTFPDFVTEGARDLIS  236 (263)
T ss_dssp             ETTEEGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHT------TCCCCCTTSCHHHHHHHH
T ss_pred             ccCCCCcccCHHHHcCCCCCchhhhhhHhHHHHHHhcCCCCCCCCCHHHHHHHHHc------CCCCCCccCCHHHHHHHH
Confidence            45689999999999999999999999999999999999999876544333222111      112345667889999999


Q ss_pred             HhcccCCCCCCCHHHHHH
Q 020221          291 RCLQYEPRERPNPRSLVT  308 (329)
Q Consensus       291 ~cl~~dp~~Rps~~~~l~  308 (329)
                      +||+.||++|||++++++
T Consensus       237 ~~L~~dp~~R~t~~eil~  254 (263)
T d2j4za1         237 RLLKHNPSQRPMLREVLE  254 (263)
T ss_dssp             HHTCSSGGGSCCHHHHHT
T ss_pred             HHccCCHhHCcCHHHHHc
Confidence            999999999999999998

>d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase Itk/Tsk
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.7e-59  Score=402.15  Aligned_cols=252  Identities=21%  Similarity=0.330  Sum_probs=206.8

Q ss_pred             CcccccccCCCCCCcEEEEEEeCCCCEEEEEEeCCCCChhHHHHHHHHHHHhcCCCccccccceeeeeCCeeEEEEecCC
Q 020221           57 AMENIVSEHGEKAPNVVYKGKLENQFRIAVKRFNRSAWPDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAEYMP  136 (329)
Q Consensus        57 ~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~  136 (329)
                      +++++++.||+|+||+||+|.+.+++.||||+++... ...+++.+|+++++.++||||++++|++.+.+..++||||++
T Consensus         5 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~-~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~lv~E~~~   83 (263)
T d1sm2a_           5 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGA-MSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFME   83 (263)
T ss_dssp             SCEEEEEEEECCSSCCEEEEEETTTEEEEEEECCSSS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCT
T ss_pred             HHcEEEEEEeeCCCeEEEEEEECCCCEEEEEEECCCc-CcHHHHHHHHHHHHhcCCCCcccccceeccCCceEEEEEecC
Confidence            4577888899999999999998888899999998755 345679999999999999999999999999999999999999


Q ss_pred             CCCHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCCCCCeeeecccCcccCCCCC-----C
Q 020221          137 NDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDGR-----S  211 (329)
Q Consensus       137 ~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~-----~  211 (329)
                      +|+|.+++.. ....+++..+..++.|++.||+|||++ +|+||||||+|||+++++.+||+|||+++......     .
T Consensus        84 ~g~L~~~l~~-~~~~~~~~~~~~i~~qia~gl~~lH~~-~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~  161 (263)
T d1sm2a_          84 HGCLSDYLRT-QRGLFAAETLLGMCLDVCEGMAYLEEA-CVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTG  161 (263)
T ss_dssp             TCBHHHHHHT-TTTCCCHHHHHHHHHHHHHHHHHHHHT-TCCCTTCSGGGEEECGGGCEEECSCC---------------
T ss_pred             CCcHHHHhhc-cccCCCHHHHHHHHHHHHHHHHhhhcc-ceeecccchhheeecCCCCeEecccchheeccCCCceeecc
Confidence            9999999864 446789999999999999999999999 99999999999999999999999999998654332     2


Q ss_pred             ccCcccccCcccccCCCCCCcccchhhhHHHHHHHhCCCCCCch-hhHHHhhhchhhhccccccCCCChHHHHHHHHHHH
Q 020221          212 YSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSH-ALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLAS  290 (329)
Q Consensus       212 ~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~  290 (329)
                      ..||+.|+|||++.+..++.++||||||+++|||+|++.|+... ....+...     +....+...|..+++++.+++.
T Consensus       162 ~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvil~el~t~~~~~~~~~~~~~~~~~-----i~~~~~~~~p~~~~~~l~~li~  236 (263)
T d1sm2a_         162 TKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVED-----ISTGFRLYKPRLASTHVYQIMN  236 (263)
T ss_dssp             ---CTTSCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSCCHHHHHHH-----HHHTCCCCCCTTSCHHHHHHHH
T ss_pred             eecCcccCChHHhcCCCCCchhhhcchHHHHHHHHHCCCCCCCCCCHHHHHHH-----HHhcCCCCCccccCHHHHHHHH
Confidence            45788999999999999999999999999999999966555433 22222211     1112233345667789999999


Q ss_pred             HhcccCCCCCCCHHHHHHHHHhhhhc
Q 020221          291 RCLQYEPRERPNPRSLVTALVTLQKD  316 (329)
Q Consensus       291 ~cl~~dp~~Rps~~~~l~~L~~~~~~  316 (329)
                      +||+.||++|||+++++++|+++.++
T Consensus       237 ~cl~~~p~~Rps~~~il~~L~~i~es  262 (263)
T d1sm2a_         237 HCWKERPEDRPAFSRLLRQLAEIAES  262 (263)
T ss_dssp             HHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             HHccCCHhHCcCHHHHHHHHHHHHhC
Confidence            99999999999999999999998753

>d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Abelsone tyrosine kinase (abl)
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=5.3e-59  Score=405.71  Aligned_cols=255  Identities=21%  Similarity=0.313  Sum_probs=217.1

Q ss_pred             CcccccccCCCCCCcEEEEEEe-CCCCEEEEEEeCCCCChhHHHHHHHHHHHhcCCCccccccceeeeeCCeeEEEEecC
Q 020221           57 AMENIVSEHGEKAPNVVYKGKL-ENQFRIAVKRFNRSAWPDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAEYM  135 (329)
Q Consensus        57 ~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~  135 (329)
                      +.+++.+.||+|+||+||+|.+ .+++.||||+++.+. ...+++.+|+++++.++|||||++++++.+++..++||||+
T Consensus        17 ~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~-~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~iv~E~~   95 (287)
T d1opja_          17 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFM   95 (287)
T ss_dssp             GGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTTC-SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECC
T ss_pred             HHeEEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCcc-chHHHHHHHHHHHHhCCCCCEecCCccEeeCCeeEEEeecc
Confidence            4567788899999999999995 468899999998665 34678999999999999999999999999999999999999


Q ss_pred             CCCCHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCCCCCeeeecccCcccCCCCCC----
Q 020221          136 PNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDGRS----  211 (329)
Q Consensus       136 ~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~~----  211 (329)
                      ++|+|.+++.+.....+++..+..++.||+.||+|||++ ||+||||||+|||+++++.+||+|||+++.......    
T Consensus        96 ~~g~l~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~-~iiHrDlKp~NILl~~~~~~Kl~DFG~a~~~~~~~~~~~~  174 (287)
T d1opja_          96 TYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKK-NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHA  174 (287)
T ss_dssp             TTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHT-TCCCSCCSGGGEEECGGGCEEECCCCCTTTCCSSSSEEET
T ss_pred             cCcchHHHhhhccccchHHHHHHHHHHHHHHHHHHHHHC-CcccCccccCeEEECCCCcEEEccccceeecCCCCceeec
Confidence            999999999765667899999999999999999999999 999999999999999999999999999987654322    


Q ss_pred             -ccCcccccCcccccCCCCCCcccchhhhHHHHHHHhCCCCCCchhhHHHhhhchhhhccccccCCCChHHHHHHHHHHH
Q 020221          212 -YSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLAS  290 (329)
Q Consensus       212 -~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~  290 (329)
                       ..+++.|+|||++.+..++.++||||||+++|||++|+.||........    ....+....+...+..+++++.+|+.
T Consensus       175 ~~~g~~~y~aPE~~~~~~~~~k~DiwS~Gv~l~ell~~~~p~~~~~~~~~----~~~~i~~~~~~~~~~~~~~~l~~li~  250 (287)
T d1opja_         175 GAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQ----VYELLEKDYRMERPEGCPEKVYELMR  250 (287)
T ss_dssp             TEEECGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCSSTTCCHHH----HHHHHHTTCCCCCCTTCCHHHHHHHH
T ss_pred             cccccccccChHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCcchHHH----HHHHHhcCCCCCCCccchHHHHHHHH
Confidence             2467889999999999999999999999999999998776654322111    11122222334556677889999999


Q ss_pred             HhcccCCCCCCCHHHHHHHHHhhhhcc
Q 020221          291 RCLQYEPRERPNPRSLVTALVTLQKDT  317 (329)
Q Consensus       291 ~cl~~dp~~Rps~~~~l~~L~~~~~~~  317 (329)
                      +||+.||++|||+.++++.|+.+.+..
T Consensus       251 ~cl~~dP~~Rps~~ei~~~L~~~~~~~  277 (287)
T d1opja_         251 ACWQWNPSDRPSFAEIHQAFETMFQES  277 (287)
T ss_dssp             HHTCSSGGGSCCHHHHHHHHHHTTSSS
T ss_pred             HHcCCCHhHCcCHHHHHHHHHHHHHhC
Confidence            999999999999999999999886654

>d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell cycle checkpoint kinase chk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.3e-59  Score=402.39  Aligned_cols=246  Identities=17%  Similarity=0.135  Sum_probs=202.6

Q ss_pred             CcccccccCCCCCCcEEEEEEe-CCCCEEEEEEeCCCCCh-hHHHHHHHHHHHhcCCCccccccceeeeeCCeeEEEEec
Q 020221           57 AMENIVSEHGEKAPNVVYKGKL-ENQFRIAVKRFNRSAWP-DARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAEY  134 (329)
Q Consensus        57 ~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  134 (329)
                      ++|++++.||+|+||+||+|.. .+|+.||||++...... ..+.+.+|+++++.++||||+++++++.+++..++||||
T Consensus         5 ~dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~~~~~ivmEy   84 (271)
T d1nvra_           5 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEY   84 (271)
T ss_dssp             TEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred             cceEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHhCCCCCEeeEeeeeccCceeEEEEec
Confidence            4578889999999999999994 67899999999765422 345689999999999999999999999999999999999


Q ss_pred             CCCCCHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCCCCCeeeecccCcccCCCC-----
Q 020221          135 MPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDG-----  209 (329)
Q Consensus       135 ~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~-----  209 (329)
                      +++|+|.+++.  ....+++.++..++.||+.||+|||++ ||+||||||+|||+++++.+||+|||+|+.....     
T Consensus        85 ~~gg~L~~~l~--~~~~l~e~~~~~i~~qi~~al~ylH~~-~IiHrDiKp~NILl~~~~~~KL~DFG~a~~~~~~~~~~~  161 (271)
T d1nvra_          85 CSGGELFDRIE--PDIGMPEPDAQRFFHQLMAGVVYLHGI-GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERL  161 (271)
T ss_dssp             CTTEEGGGGSB--TTTBCCHHHHHHHHHHHHHHHHHHHHT-TEECSCCCGGGEEECTTCCEEECCCTTCEECEETTEECC
T ss_pred             cCCCcHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHc-CCccCcccHHHEEECCCCCEEEccchhheeeccCCcccc
Confidence            99999999996  456799999999999999999999999 9999999999999999999999999999865322     


Q ss_pred             -CCccCcccccCcccccCCCC-CCcccchhhhHHHHHHHhCCCCCCchhhHHHhhhchhhhccccccCCCChHHHHHHHH
Q 020221          210 -RSYSTNLAFTPPEYLRTGRV-TPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVR  287 (329)
Q Consensus       210 -~~~~~~~~y~aPE~~~~~~~-~~~~DvwslG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  287 (329)
                       ....||+.|+|||++.+..+ +.++|||||||++|||++|+.||...........   ...............++++.+
T Consensus       162 ~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~---~~~~~~~~~~~~~~~s~~~~~  238 (271)
T d1nvra_         162 LNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYS---DWKEKKTYLNPWKKIDSAPLA  238 (271)
T ss_dssp             BCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTSHHHH---HHHTTCTTSTTGGGSCHHHHH
T ss_pred             ccceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCCChHHHHHH---HHhcCCCCCCccccCCHHHHH
Confidence             34578999999999988876 5689999999999999999988854321111100   011111111223456788999


Q ss_pred             HHHHhcccCCCCCCCHHHHHH
Q 020221          288 LASRCLQYEPRERPNPRSLVT  308 (329)
Q Consensus       288 li~~cl~~dp~~Rps~~~~l~  308 (329)
                      |+.+||+.||++|||++++++
T Consensus       239 li~~~L~~dP~~R~t~~eil~  259 (271)
T d1nvra_         239 LLHKILVENPSARITIPDIKK  259 (271)
T ss_dssp             HHHHHSCSSTTTSCCHHHHTT
T ss_pred             HHHHHcCCChhHCcCHHHHhc
Confidence            999999999999999999987

>d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: ephb2 receptor tyrosine kinase
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=1.2e-58  Score=405.82  Aligned_cols=256  Identities=20%  Similarity=0.275  Sum_probs=205.0

Q ss_pred             CcccccccCCCCCCcEEEEEEeC-CC---CEEEEEEeCCCCCh-hHHHHHHHHHHHhcCCCccccccceeeeeCCeeEEE
Q 020221           57 AMENIVSEHGEKAPNVVYKGKLE-NQ---FRIAVKRFNRSAWP-DARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLV  131 (329)
Q Consensus        57 ~~~~~~~~lg~G~~g~V~~~~~~-~~---~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv  131 (329)
                      +.+++.+.||+|+||+||+|... ++   ..||||.+...... ..+.+.+|+++|+.++|||||+++|++.+++..++|
T Consensus        26 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~iv  105 (299)
T d1jpaa_          26 SCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMII  105 (299)
T ss_dssp             GGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEEE
T ss_pred             hhcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEEEE
Confidence            44667788899999999999853 33   35899998765433 355799999999999999999999999999999999


Q ss_pred             EecCCCCCHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCCCCCeeeecccCcccCCCCC-
Q 020221          132 AEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDGR-  210 (329)
Q Consensus       132 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~-  210 (329)
                      |||+++|+|.+++.. ....+++.++..++.||+.||+|||++ +++||||||+|||++.++.+||+|||+++...... 
T Consensus       106 ~Ey~~~g~L~~~~~~-~~~~l~~~~~~~i~~qia~gl~yLH~~-~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~~~~~  183 (299)
T d1jpaa_         106 TEFMENGSLDSFLRQ-NDGQFTVIQLVGMLRGIAAGMKYLADM-NYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTS  183 (299)
T ss_dssp             EECCTTEEHHHHHHT-TTTCSCHHHHHHHHHHHHHHHHHHHHT-TCCCSCCCGGGEEECTTCCEEECCC-----------
T ss_pred             EEecCCCcceeeecc-ccCCCCHHHHHHHHHHHHHHHHHHhhC-CCccCccccceEEECCCCcEEECCcccceEccCCCC
Confidence            999999999998864 445799999999999999999999999 99999999999999999999999999998654332 


Q ss_pred             --------CccCcccccCcccccCCCCCCcccchhhhHHHHHHHh-CCCCCCchhhHHHhhhchhhhccccccCCCChHH
Q 020221          211 --------SYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLS-GKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDE  281 (329)
Q Consensus       211 --------~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t-g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  281 (329)
                              ...+|+.|+|||.+.+..++.++|||||||++|||+| |..||.......+.....     ...+...+..+
T Consensus       184 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~~~~~~~~~i~-----~~~~~~~~~~~  258 (299)
T d1jpaa_         184 DPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQDVINAIE-----QDYRLPPPMDC  258 (299)
T ss_dssp             ------------CGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHH-----TTCCCCCCTTC
T ss_pred             cceeeecccccCCccccCHHHHhcCCCCcccccccchHHHHHHHhCCCCCCCCCCHHHHHHHHH-----cCCCCCCCccc
Confidence                    1245789999999999999999999999999999998 777776543332222211     12233445667


Q ss_pred             HHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhhcccc
Q 020221          282 GTELVRLASRCLQYEPRERPNPRSLVTALVTLQKDTEL  319 (329)
Q Consensus       282 ~~~~~~li~~cl~~dp~~Rps~~~~l~~L~~~~~~~~~  319 (329)
                      ++++.+|+.+||+.||++|||+.++++.|+++.+.++.
T Consensus       259 ~~~l~~li~~cl~~~P~~RPs~~ei~~~L~~~l~~p~s  296 (299)
T d1jpaa_         259 PSALHQLMLDCWQKDRNHRPKFGQIVNTLDKMIRNPNS  296 (299)
T ss_dssp             CHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHSGGG
T ss_pred             hHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhcChhh
Confidence            88999999999999999999999999999998876543

>d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: STE20-like serine/threonine-protein kinase, SLK
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.4e-59  Score=406.00  Aligned_cols=246  Identities=16%  Similarity=0.206  Sum_probs=208.2

Q ss_pred             cccccccCCCCCCcEEEEEE-eCCCCEEEEEEeCCCCChhHHHHHHHHHHHhcCCCccccccceeeeeCCeeEEEEecCC
Q 020221           58 MENIVSEHGEKAPNVVYKGK-LENQFRIAVKRFNRSAWPDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAEYMP  136 (329)
Q Consensus        58 ~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~  136 (329)
                      .|++++.||+|+||+||+|. ..+++.||||++........+.+.+|+++++.++|||||++++++.+.+..++||||++
T Consensus        13 ~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lvmEy~~   92 (288)
T d2jfla1          13 FWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCA   92 (288)
T ss_dssp             TEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSSSGGGGGTHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCT
T ss_pred             CeEEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCeEEEEEecCC
Confidence            47888999999999999999 46789999999987766667789999999999999999999999999999999999999


Q ss_pred             CCCHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCCCCCeeeecccCcccCCCC----CCc
Q 020221          137 NDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDG----RSY  212 (329)
Q Consensus       137 ~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~----~~~  212 (329)
                      +|+|.+++.+ ....+++.++..++.||+.||.|||++ ||+||||||+|||++.++.+||+|||+|+.....    ...
T Consensus        93 ~g~L~~~~~~-~~~~l~e~~~~~i~~qi~~gL~ylH~~-~ivHrDiKp~NIll~~~~~~Kl~DFG~a~~~~~~~~~~~~~  170 (288)
T d2jfla1          93 GGAVDAVMLE-LERPLTESQIQVVCKQTLDALNYLHDN-KIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSF  170 (288)
T ss_dssp             TEEHHHHHHH-HTSCCCHHHHHHHHHHHHHHHHHHHHT-TEECCCCSGGGEEECTTSCEEECCCTTCEECHHHHHHHTCC
T ss_pred             CCcHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHHC-CEEEeecChhheeECCCCCEEEEechhhhccCCCccccccc
Confidence            9999998764 345799999999999999999999999 9999999999999999999999999998754322    356


Q ss_pred             cCcccccCccccc-----CCCCCCcccchhhhHHHHHHHhCCCCCCchhhHHHhhhchhhhccccccCCCChHHHHHHHH
Q 020221          213 STNLAFTPPEYLR-----TGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVR  287 (329)
Q Consensus       213 ~~~~~y~aPE~~~-----~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  287 (329)
                      .||+.|+|||++.     +..++.++|||||||++|||++|..||.................   .....+...++++.+
T Consensus       171 ~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~~~~~~~i~~~~~---~~~~~~~~~s~~~~~  247 (288)
T d2jfla1         171 IGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIAKSEP---PTLAQPSRWSSNFKD  247 (288)
T ss_dssp             CSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHHHHHSCC---CCCSSGGGSCHHHHH
T ss_pred             ccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHHcCCC---CCCCccccCCHHHHH
Confidence            7899999999984     44588999999999999999999998865432222211111111   112234567889999


Q ss_pred             HHHHhcccCCCCCCCHHHHHH
Q 020221          288 LASRCLQYEPRERPNPRSLVT  308 (329)
Q Consensus       288 li~~cl~~dp~~Rps~~~~l~  308 (329)
                      |+.+||+.||++|||+.++++
T Consensus       248 li~~~L~~dp~~R~t~~ell~  268 (288)
T d2jfla1         248 FLKKCLEKNVDARWTTSQLLQ  268 (288)
T ss_dssp             HHHHHSCSSTTTSCCHHHHTT
T ss_pred             HHHHHccCChhHCcCHHHHhc
Confidence            999999999999999999987

>d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: B-Raf kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.6e-58  Score=398.88  Aligned_cols=255  Identities=20%  Similarity=0.291  Sum_probs=205.6

Q ss_pred             CCcccccccCCCCCCcEEEEEEeCCCCEEEEEEeCCCC--ChhHHHHHHHHHHHhcCCCccccccceeeeeCCeeEEEEe
Q 020221           56 FAMENIVSEHGEKAPNVVYKGKLENQFRIAVKRFNRSA--WPDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAE  133 (329)
Q Consensus        56 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  133 (329)
                      .+.+++.+.||+|+||+||+|+.++  .||||+++...  ....+.+.+|+++++.++|||||++++++. ....++|||
T Consensus         7 ~~~~~~~~~lG~G~fg~Vy~~~~~~--~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~-~~~~~lv~E   83 (276)
T d1uwha_           7 DGQITVGQRIGSGSFGTVYKGKWHG--DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYST-APQLAIVTQ   83 (276)
T ss_dssp             TTCCCCCSEEEECSSCEEEEEESSS--EEEEEECCCSSCCTTHHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSSCEEEEE
T ss_pred             cccEEEEEEEeeCCCcEEEEEEECC--EEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeeeEEEe-ccEEEEEEe
Confidence            3456778888999999999998654  59999987543  334677999999999999999999999875 467899999


Q ss_pred             cCCCCCHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCCCCCeeeecccCcccCCCC----
Q 020221          134 YMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDG----  209 (329)
Q Consensus       134 ~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~----  209 (329)
                      |+++|+|.+++.. ....+++..+..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+|+.....    
T Consensus        84 y~~~g~L~~~l~~-~~~~~~~~~~~~i~~qi~~gl~yLH~~-~ivHrDlKp~NiLl~~~~~~Kl~DFGla~~~~~~~~~~  161 (276)
T d1uwha_          84 WCEGSSLYHHLHI-IETKFEMIKLIDIARQTAQGMDYLHAK-SIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSH  161 (276)
T ss_dssp             CCCEEEHHHHHHT-SCCCCCHHHHHHHHHHHHHHHHHHHHT-TCCCSCCCGGGEEEETTSSEEECCCCCSCC--------
T ss_pred             cCCCCCHHHHHhh-ccCCCCHHHHHHHHHHHHHHHHHHhcC-CEeccccCHHHEEEcCCCCEEEccccceeeccccCCcc
Confidence            9999999999964 345699999999999999999999999 9999999999999999999999999999765432    


Q ss_pred             --CCccCcccccCcccccCC---CCCCcccchhhhHHHHHHHhCCCCCCchhhH-HHhhhchhhhccccccCCCChHHHH
Q 020221          210 --RSYSTNLAFTPPEYLRTG---RVTPESVMYSFGTLLLDLLSGKHIPPSHALD-LIRDRNIQTLTDSCLEGQFSSDEGT  283 (329)
Q Consensus       210 --~~~~~~~~y~aPE~~~~~---~~~~~~DvwslG~il~el~tg~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~  283 (329)
                        ....||+.|+|||++.+.   .++.++|||||||++|||+||+.||...... ............+. ....+..+++
T Consensus       162 ~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~~p~-~~~~~~~~~~  240 (276)
T d1uwha_         162 QFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPD-LSKVRSNCPK  240 (276)
T ss_dssp             ----CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHHTSCCCC-GGGSCTTCCH
T ss_pred             cccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCCChHHHHHHHHhcCCCCCc-chhccccchH
Confidence              234689999999998643   4888999999999999999999988653221 11111111111111 1123456678


Q ss_pred             HHHHHHHHhcccCCCCCCCHHHHHHHHHhhhhc
Q 020221          284 ELVRLASRCLQYEPRERPNPRSLVTALVTLQKD  316 (329)
Q Consensus       284 ~~~~li~~cl~~dp~~Rps~~~~l~~L~~~~~~  316 (329)
                      ++.+|+.+||+.||++|||+.++++.|+.+.+.
T Consensus       241 ~l~~li~~cl~~dp~~RPt~~~il~~Le~l~~~  273 (276)
T d1uwha_         241 AMKRLMAECLKKKRDERPLFPQILASIELLARS  273 (276)
T ss_dssp             HHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred             HHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHc
Confidence            999999999999999999999999999998764

>d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine-protein kinase Nek2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=8.5e-59  Score=400.49  Aligned_cols=246  Identities=17%  Similarity=0.225  Sum_probs=199.1

Q ss_pred             CcccccccCCCCCCcEEEEEE-eCCCCEEEEEEeCCCCCh--hHHHHHHHHHHHhcCCCccccccceeeee--CCeeEEE
Q 020221           57 AMENIVSEHGEKAPNVVYKGK-LENQFRIAVKRFNRSAWP--DARQFLEEARAVGQLRNRRLANLLGCCCE--GDERLLV  131 (329)
Q Consensus        57 ~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~--~~~~~~~e~~~l~~l~h~niv~~~~~~~~--~~~~~lv  131 (329)
                      ++|++++.||+|+||+||+|. ..+|+.||+|.+......  ..+.+.+|+++++.++||||+++++++.+  .+.+++|
T Consensus         4 edy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~iv   83 (269)
T d2java1           4 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIV   83 (269)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSCHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC----CEEEE
T ss_pred             hhCEEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhCCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEeCCCCEEEEE
Confidence            568889999999999999998 567899999999776432  34568899999999999999999999864  4568999


Q ss_pred             EecCCCCCHHhhhccC--CCCCCCHHHHHHHHHHHHHHHHHhhcCCC-----ccccccCCCceeeCCCCCeeeecccCcc
Q 020221          132 AEYMPNDTLAKHLFHW--ETQPMKWAMRLRVALHIAEALEYCTSKER-----ALYHDLNAYRIVFDDDVNPRLSCFGLMK  204 (329)
Q Consensus       132 ~e~~~~gsL~~~l~~~--~~~~~~~~~~~~i~~~i~~~l~~lH~~~~-----ivH~dlkp~Nil~~~~~~~kl~Dfg~a~  204 (329)
                      |||+++|+|.+++.+.  ....+++..++.++.||+.||.|||++ +     |+||||||+|||++.++.+||+|||+++
T Consensus        84 mEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~-~~~~~~IiHrDiKp~NIll~~~~~vkl~DFG~a~  162 (269)
T d2java1          84 MEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRR-SDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLAR  162 (269)
T ss_dssp             EECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHH-CC---------CCGGGEEECTTSCEEECCHHHHH
T ss_pred             EecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHh-cCCCCCEEeCcCchhhcCcCCCCcEEEeecccee
Confidence            9999999999988532  346799999999999999999999987 5     9999999999999999999999999998


Q ss_pred             cCCCC----CCccCcccccCcccccCCCCCCcccchhhhHHHHHHHhCCCCCCchhhHHHhhhchhhhccccccCCCChH
Q 020221          205 NSRDG----RSYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSD  280 (329)
Q Consensus       205 ~~~~~----~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  280 (329)
                      .....    ....||+.|+|||++.+..++.++|||||||++|||+||..||.......+........     ....+..
T Consensus       163 ~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyel~tg~~Pf~~~~~~~~~~~i~~~~-----~~~~~~~  237 (269)
T d2java1         163 ILNHDTSFAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGK-----FRRIPYR  237 (269)
T ss_dssp             HC-----------CCCSCCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTC-----CCCCCTT
T ss_pred             ecccCCCccccCCCCcccCCHHHHcCCCCChHHHHHhhCHHHHHHhhCCCCCCCCCHHHHHHHHHcCC-----CCCCCcc
Confidence            75543    24568999999999999999999999999999999999999887654443332222211     1234556


Q ss_pred             HHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 020221          281 EGTELVRLASRCLQYEPRERPNPRSLVT  308 (329)
Q Consensus       281 ~~~~~~~li~~cl~~dp~~Rps~~~~l~  308 (329)
                      .++++.+|+.+||+.||++|||+.++++
T Consensus       238 ~s~~l~~li~~~L~~dp~~Rps~~ell~  265 (269)
T d2java1         238 YSDELNEIITRMLNLKDYHRPSVEEILE  265 (269)
T ss_dssp             SCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             cCHHHHHHHHHHcCCChhHCcCHHHHHh
Confidence            7889999999999999999999999998

>d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Lymphocyte kinase (lck)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.1e-58  Score=399.13  Aligned_cols=251  Identities=23%  Similarity=0.336  Sum_probs=210.9

Q ss_pred             CcccccccCCCCCCcEEEEEEeCCCCEEEEEEeCCCCChhHHHHHHHHHHHhcCCCccccccceeeeeCCeeEEEEecCC
Q 020221           57 AMENIVSEHGEKAPNVVYKGKLENQFRIAVKRFNRSAWPDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAEYMP  136 (329)
Q Consensus        57 ~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~  136 (329)
                      +.+++++.||+|+||+||+|.++++..||||+++... ...+.+.+|+++++.++|||||++++++. .+..++||||++
T Consensus        13 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~~~~~~-~~~~~~~~E~~~l~~l~HpnIv~~~g~~~-~~~~~iv~Ey~~   90 (272)
T d1qpca_          13 ETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYAVVT-QEPIYIITEYME   90 (272)
T ss_dssp             GGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSSCEEEEECCT
T ss_pred             HHeEEeEEEecCCCcEEEEEEECCCCEEEEEEEccCc-CCHHHHHHHHHHHHhCCCCCEeEEEeeec-cCCeEEEEEeCC
Confidence            4577888899999999999998888899999998655 34667999999999999999999999875 467899999999


Q ss_pred             CCCHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCCCCCeeeecccCcccCCCC-----CC
Q 020221          137 NDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDG-----RS  211 (329)
Q Consensus       137 ~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~-----~~  211 (329)
                      +|+|.+++.......+++..+..++.||+.||.|||++ +|+||||||+|||+++++.+||+|||+|+.....     ..
T Consensus        91 ~g~L~~~~~~~~~~~l~~~~~~~i~~qi~~gl~~lH~~-~ivHrDiKp~NIll~~~~~~Kl~DFGla~~~~~~~~~~~~~  169 (272)
T d1qpca_          91 NGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEER-NYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREG  169 (272)
T ss_dssp             TCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHT-TEECSCCSGGGEEECTTSCEEECCCTTCEECSSSCEECCTT
T ss_pred             CCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhC-CcccCccchhheeeecccceeeccccceEEccCCccccccc
Confidence            99999988644445699999999999999999999999 9999999999999999999999999999876543     23


Q ss_pred             ccCcccccCcccccCCCCCCcccchhhhHHHHHHHhCCCCCCchh-hHHHhhhchhhhccccccCCCChHHHHHHHHHHH
Q 020221          212 YSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHA-LDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLAS  290 (329)
Q Consensus       212 ~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~  290 (329)
                      ..+|+.|+|||++.+..++.++|||||||++|||+||+.|+.... .......     +....+...+..+++++.+|+.
T Consensus       170 ~~gt~~y~APE~~~~~~~~~~sDvwS~Gvvl~ellt~~~~~~~~~~~~~~~~~-----i~~~~~~~~p~~~~~~l~~li~  244 (272)
T d1qpca_         170 AKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQN-----LERGYRMVRPDNCPEELYQLMR  244 (272)
T ss_dssp             CCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHH-----HHTTCCCCCCTTCCHHHHHHHH
T ss_pred             cCCcccccChHHHhCCCCCchhhhhhhHHHHHHHHhCCCCCCCCCCHHHHHHH-----HHhcCCCCCcccChHHHHHHHH
Confidence            457889999999998889999999999999999999776654432 2111111     1112233445667889999999


Q ss_pred             HhcccCCCCCCCHHHHHHHHHhhhh
Q 020221          291 RCLQYEPRERPNPRSLVTALVTLQK  315 (329)
Q Consensus       291 ~cl~~dp~~Rps~~~~l~~L~~~~~  315 (329)
                      +||+.||++|||+.++++.|+.+-.
T Consensus       245 ~cl~~~P~~Rpt~~ei~~~L~~~ft  269 (272)
T d1qpca_         245 LCWKERPEDRPTFDYLRSVLEDFFT  269 (272)
T ss_dssp             HHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             HHcCCCHhHCcCHHHHHHHhhhhhh
Confidence            9999999999999999999987643

>d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine protein kinase TAO2
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=4.2e-58  Score=403.46  Aligned_cols=243  Identities=19%  Similarity=0.216  Sum_probs=207.2

Q ss_pred             ccccccCCCCCCcEEEEEE-eCCCCEEEEEEeCCCCChh---HHHHHHHHHHHhcCCCccccccceeeeeCCeeEEEEec
Q 020221           59 ENIVSEHGEKAPNVVYKGK-LENQFRIAVKRFNRSAWPD---ARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAEY  134 (329)
Q Consensus        59 ~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~---~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  134 (329)
                      |++++.||+|+||+||+|. ..+++.||||++.......   .+.+.+|+++++.++|||||++++++.+++..++||||
T Consensus        17 y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv~E~   96 (309)
T d1u5ra_          17 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEY   96 (309)
T ss_dssp             EEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred             cEeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEECCEEEEEEEe
Confidence            7788899999999999998 5678899999997654322   35688999999999999999999999999999999999


Q ss_pred             CCCCCHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCCCCCeeeecccCcccCCCCCCccC
Q 020221          135 MPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDGRSYST  214 (329)
Q Consensus       135 ~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~~~  214 (329)
                      |.+|+|..++.  ....+++.+++.++.||+.||.|||++ ||+||||||+|||++.++.+||+|||+|..........|
T Consensus        97 ~~~g~l~~~~~--~~~~l~e~~~~~i~~qi~~aL~yLH~~-~iiHrDiKp~NILl~~~~~~Kl~DFG~a~~~~~~~~~~G  173 (309)
T d1u5ra_          97 CLGSASDLLEV--HKKPLQEVEIAAVTHGALQGLAYLHSH-NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANSFVG  173 (309)
T ss_dssp             CSEEHHHHHHH--HTSCCCHHHHHHHHHHHHHHHHHHHHT-TCBCCCCSGGGEEEETTTEEEECCCTTCBSSSSBCCCCS
T ss_pred             cCCCchHHHHH--hCCCCCHHHHHHHHHHHHHHHHHHHhC-CEeccCCCcceEEECCCCCEEEeecccccccCCCCcccc
Confidence            99999877665  446799999999999999999999999 999999999999999999999999999998888888899


Q ss_pred             cccccCcccccC---CCCCCcccchhhhHHHHHHHhCCCCCCchhhHHHhhhchhhhccccccCCCChHHHHHHHHHHHH
Q 020221          215 NLAFTPPEYLRT---GRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLASR  291 (329)
Q Consensus       215 ~~~y~aPE~~~~---~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~  291 (329)
                      |+.|+|||++.+   +.++.++|||||||++|||++|..||..............    .......+...++++.+|+.+
T Consensus       174 T~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~~~~~~~~i~~----~~~~~~~~~~~s~~~~~li~~  249 (309)
T d1u5ra_         174 TPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQ----NESPALQSGHWSEYFRNFVDS  249 (309)
T ss_dssp             CGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHH----SCCCCCSCTTSCHHHHHHHHH
T ss_pred             CccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCCCHHHHHHHHHh----CCCCCCCCCCCCHHHHHHHHH
Confidence            999999999864   4589999999999999999999998865433222221111    111112234567899999999


Q ss_pred             hcccCCCCCCCHHHHHH
Q 020221          292 CLQYEPRERPNPRSLVT  308 (329)
Q Consensus       292 cl~~dp~~Rps~~~~l~  308 (329)
                      ||+.||++|||+.++++
T Consensus       250 ~L~~dP~~Rpt~~ell~  266 (309)
T d1u5ra_         250 CLQKIPQDRPTSEVLLK  266 (309)
T ss_dssp             HTCSSGGGSCCHHHHTT
T ss_pred             HCcCChhHCcCHHHHHh
Confidence            99999999999999986

>d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Calmodulin-dependent protein kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=1.9e-57  Score=399.12  Aligned_cols=246  Identities=15%  Similarity=0.183  Sum_probs=194.8

Q ss_pred             cccccccCCCCCCcEEEEEEe-CCCCEEEEEEeCCCCCh-hHHHHHHHHHHHhcCCCccccccceeeeeCCeeEEEEecC
Q 020221           58 MENIVSEHGEKAPNVVYKGKL-ENQFRIAVKRFNRSAWP-DARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAEYM  135 (329)
Q Consensus        58 ~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~  135 (329)
                      .|++++.||+|+||+||+|.. .+++.||||++...... ....+.+|+.+++.++||||+++++++.+++..++||||+
T Consensus        10 ~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lvmE~~   89 (307)
T d1a06a_          10 IYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIMQLV   89 (307)
T ss_dssp             TEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC----------CHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECCC
T ss_pred             ceEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhhhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEecc
Confidence            378888999999999999994 57889999999765432 2345789999999999999999999999999999999999


Q ss_pred             CCCCHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeC---CCCCeeeecccCcccCCCC---
Q 020221          136 PNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFD---DDVNPRLSCFGLMKNSRDG---  209 (329)
Q Consensus       136 ~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~---~~~~~kl~Dfg~a~~~~~~---  209 (329)
                      ++|+|.+++.  ....+++..+..++.||+.||+|||++ ||+||||||+||++.   +++.+||+|||+++.....   
T Consensus        90 ~gg~L~~~l~--~~~~l~e~~~~~~~~qi~~al~ylH~~-~iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~~~~~~~~  166 (307)
T d1a06a_          90 SGGELFDRIV--EKGFYTERDASRLIFQVLDAVKYLHDL-GIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVL  166 (307)
T ss_dssp             CSCBHHHHHH--TCSCCCHHHHHHHHHHHHHHHHHHHHT-TCCCSCCCGGGEEESSSSTTCCEEECCC------------
T ss_pred             CCCcHHHhhh--cccCCCHHHHHHHHHHHHHHHHhhhhc-eeeeEEecccceeecccCCCceEEEeccceeEEccCCCee
Confidence            9999999997  456799999999999999999999999 999999999999994   5789999999999866544   


Q ss_pred             CCccCcccccCcccccCCCCCCcccchhhhHHHHHHHhCCCCCCchhhHHHhhhchhhhccccccCCCChHHHHHHHHHH
Q 020221          210 RSYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLA  289 (329)
Q Consensus       210 ~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li  289 (329)
                      ....||+.|+|||++.+..++.++|||||||++|||++|..||..................  .....+...|+++.+|+
T Consensus       167 ~~~~GT~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~~~--~~~~~~~~~s~~~~~li  244 (307)
T d1a06a_         167 STACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEYE--FDSPYWDDISDSAKDFI  244 (307)
T ss_dssp             ------CTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHTTCCC--CCTTTTTTSCHHHHHHH
T ss_pred             eeeeeCccccCcHHHcCCCCCcHHHhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHhccCCC--CCCccccCCCHHHHHHH
Confidence            3456899999999999999999999999999999999999998765444333222221111  12233456788999999


Q ss_pred             HHhcccCCCCCCCHHHHHH
Q 020221          290 SRCLQYEPRERPNPRSLVT  308 (329)
Q Consensus       290 ~~cl~~dp~~Rps~~~~l~  308 (329)
                      .+||+.||++|||+.|+++
T Consensus       245 ~~~L~~dP~~R~s~~eil~  263 (307)
T d1a06a_         245 RHLMEKDPEKRFTCEQALQ  263 (307)
T ss_dssp             HHHSCSSGGGSCCHHHHHH
T ss_pred             HHHccCCHhHCcCHHHHhc
Confidence            9999999999999999998

>d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Bruton's tyrosine kinase (Btk)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.3e-57  Score=387.43  Aligned_cols=249  Identities=24%  Similarity=0.360  Sum_probs=213.0

Q ss_pred             CcccccccCCCCCCcEEEEEEeCCCCEEEEEEeCCCCChhHHHHHHHHHHHhcCCCccccccceeeeeCCeeEEEEecCC
Q 020221           57 AMENIVSEHGEKAPNVVYKGKLENQFRIAVKRFNRSAWPDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAEYMP  136 (329)
Q Consensus        57 ~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~  136 (329)
                      +++++++.||+|+||+||+|++++++.||||+++.... ..+++.+|+.+++.++||||++++|++.+.+.+++||||++
T Consensus         4 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~l~~~~~-~~~~~~~Ev~~~~~l~HpnIv~~~g~~~~~~~~~iv~Ey~~   82 (258)
T d1k2pa_           4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSM-SEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMA   82 (258)
T ss_dssp             CCCCCCCCCCEETTEEEEEEEETTTEEEEEEEEESSSS-CHHHHHHHHHHHHTCCCTTBCCEEEEECCSSSEEEEEECCT
T ss_pred             HHCEEeEEEecCCCeEEEEEEECCCCEEEEEEECcCcC-CHHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEEEccC
Confidence            45678888999999999999998888999999987653 45689999999999999999999999999999999999999


Q ss_pred             CCCHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCCCCCeeeecccCcccCCCCC-----C
Q 020221          137 NDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDGR-----S  211 (329)
Q Consensus       137 ~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~-----~  211 (329)
                      +|+|..++.. ....+++..+.+++.|+++||+|||++ ||+||||||+||++++++.+||+|||+++......     .
T Consensus        83 ~g~l~~~~~~-~~~~~~~~~~~~i~~qi~~gl~~LH~~-~iiH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~~  160 (258)
T d1k2pa_          83 NGCLLNYLRE-MRHRFQTQQLLEMCKDVCEAMEYLESK-QFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVG  160 (258)
T ss_dssp             TEEHHHHHHS-GGGCCCHHHHHHHHHHHHHHHHHHHHT-TBCCSCCSGGGEEECTTCCEEECCCSSCCBCSSSSCCCCCC
T ss_pred             CCcHHHhhhc-cccCCcHHHHHHHHHHHHHHHHHHhhc-CcccccccceeEEEcCCCcEEECcchhheeccCCCceeecc
Confidence            9999998754 456789999999999999999999999 99999999999999999999999999997544332     2


Q ss_pred             ccCcccccCcccccCCCCCCcccchhhhHHHHHHHh-CCCCCCchhhHHHhhhchhhhccccccCCCChHHHHHHHHHHH
Q 020221          212 YSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLS-GKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLAS  290 (329)
Q Consensus       212 ~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t-g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~  290 (329)
                      ..+|+.|+|||.+.+..++.++||||||+++|||+| |+.||.......+......     ..+...|...++++.+|+.
T Consensus       161 ~~~t~~y~aPE~~~~~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~~~~~~~~i~~-----~~~~~~p~~~~~~l~~li~  235 (258)
T d1k2pa_         161 SKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQ-----GLRLYRPHLASEKVYTIMY  235 (258)
T ss_dssp             SCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHHHHHHHT-----TCCCCCCTTCCHHHHHHHH
T ss_pred             cCCCCCcCCcHHhcCCCCCcceeecccchhhHhHHhcCCCCCCCCCHHHHHHHHHh-----CCCCCCcccccHHHHHHHH
Confidence            457889999999999999999999999999999998 6767665444333322221     2233456677889999999


Q ss_pred             HhcccCCCCCCCHHHHHHHHHhh
Q 020221          291 RCLQYEPRERPNPRSLVTALVTL  313 (329)
Q Consensus       291 ~cl~~dp~~Rps~~~~l~~L~~~  313 (329)
                      +||+.||++|||+++++++|..+
T Consensus       236 ~cl~~dP~~RPt~~eil~~L~di  258 (258)
T d1k2pa_         236 SCWHEKADERPTFKILLSNILDV  258 (258)
T ss_dssp             HTTCSSGGGSCCHHHHHHHHHCC
T ss_pred             HHccCCHhHCcCHHHHHHHhhCC
Confidence            99999999999999999998653

>d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.2e-58  Score=405.65  Aligned_cols=249  Identities=18%  Similarity=0.229  Sum_probs=203.0

Q ss_pred             cccccccCCCCCCcEEEEEE-eCCCCEEEEEEeCCCCC-hhHHHHHHHHHHHhcCCCccccccceeeeeCCeeEEEEecC
Q 020221           58 MENIVSEHGEKAPNVVYKGK-LENQFRIAVKRFNRSAW-PDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAEYM  135 (329)
Q Consensus        58 ~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~  135 (329)
                      +|++++.||+|+||+||+|. ..+|+.||+|+++.... ...+.+.+|+.+|+.++|||||++++++.+.+..++||||+
T Consensus         7 ~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~iVmEy~   86 (322)
T d1s9ja_           7 DFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHM   86 (322)
T ss_dssp             GEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCCCTTHHHHHHHHGGGGGGCCCTTBCCEEEEEECSSEEEEEEECC
T ss_pred             CCEEEEEEecCCCeEEEEEEECCCCcEEEEEEEChhhCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEcC
Confidence            57788889999999999999 46789999999976533 33567899999999999999999999999999999999999


Q ss_pred             CCCCHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCCCCCeeeecccCcccCCC--CCCcc
Q 020221          136 PNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRD--GRSYS  213 (329)
Q Consensus       136 ~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~--~~~~~  213 (329)
                      ++|+|.+++.+  ...+++..+..++.|++.||.|||+++||+||||||+|||++.++.+||+|||+|+...+  .....
T Consensus        87 ~gg~L~~~l~~--~~~l~~~~~~~~~~qil~aL~yLH~~~~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~~~~~~~  164 (322)
T d1s9ja_          87 DGGSLDQVLKK--AGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFV  164 (322)
T ss_dssp             TTEEHHHHHHH--HSSCCHHHHHHHHHHHHHHHHHHHHHHCCCCSCCSGGGEEECTTCCEEECCCCCCHHHHHHTC---C
T ss_pred             CCCcHHHHHhh--cCCCCHHHHHHHHHHHHHHHHHHHHhCCEEccccCHHHeeECCCCCEEEeeCCCccccCCCcccccc
Confidence            99999999963  456999999999999999999999743899999999999999999999999999986432  34568


Q ss_pred             CcccccCcccccCCCCCCcccchhhhHHHHHHHhCCCCCCchhhHHHhhhchhh--------------------------
Q 020221          214 TNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQT--------------------------  267 (329)
Q Consensus       214 ~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~~~~~~~~--------------------------  267 (329)
                      ||+.|+|||++.+..++.++||||+||++|||++|+.||...............                          
T Consensus       165 GT~~Y~APEvl~~~~y~~~~DiWSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  244 (322)
T d1s9ja_         165 GTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLSSYGMDS  244 (322)
T ss_dssp             CSSCCCCHHHHHCSCCCTTHHHHHHHHHHHHHHHSSCCSSCCCTTHHHHHC-----------------------------
T ss_pred             CCccccCchHHcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhcCCcccCCccccccccccccccccc
Confidence            999999999999999999999999999999999999998654221110000000                          


Q ss_pred             --------hccc---cccCCCC-hHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 020221          268 --------LTDS---CLEGQFS-SDEGTELVRLASRCLQYEPRERPNPRSLVT  308 (329)
Q Consensus       268 --------~~~~---~~~~~~~-~~~~~~~~~li~~cl~~dp~~Rps~~~~l~  308 (329)
                              ....   ......+ ...+.++.+|+.+||..||++|||++|+++
T Consensus       245 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~L~  297 (322)
T d1s9ja_         245 RPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMV  297 (322)
T ss_dssp             -CCCCHHHHHHHHHTSCCCCCCBTTBCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             ccchhHHHHHhhhhccCCccCccccCCHHHHHHHHHHcCCChhHCcCHHHHhh
Confidence                    0000   0000111 224678999999999999999999999998

>d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase wnk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.2e-57  Score=390.60  Aligned_cols=242  Identities=19%  Similarity=0.243  Sum_probs=197.8

Q ss_pred             ccccccCCCCCCcEEEEEEe-CCCCEEEEEEeCCCC--ChhHHHHHHHHHHHhcCCCccccccceeeee----CCeeEEE
Q 020221           59 ENIVSEHGEKAPNVVYKGKL-ENQFRIAVKRFNRSA--WPDARQFLEEARAVGQLRNRRLANLLGCCCE----GDERLLV  131 (329)
Q Consensus        59 ~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~----~~~~~lv  131 (329)
                      +++.++||+|+||+||+|.. .+++.||+|++....  ....+.+.+|+++|+.++|||||++++++.+    ...+++|
T Consensus        11 ~~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~~~iv   90 (270)
T d1t4ha_          11 LKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLV   90 (270)
T ss_dssp             EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEEE
T ss_pred             EEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeccccCCEEEEE
Confidence            34556789999999999994 568899999987653  2335568999999999999999999999865    3468999


Q ss_pred             EecCCCCCHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCC--ccccccCCCceeeC-CCCCeeeecccCcccCCC
Q 020221          132 AEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKER--ALYHDLNAYRIVFD-DDVNPRLSCFGLMKNSRD  208 (329)
Q Consensus       132 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~--ivH~dlkp~Nil~~-~~~~~kl~Dfg~a~~~~~  208 (329)
                      |||+++|+|.+++.  ....+++..+..++.||+.||+|||++ +  |+||||||+|||++ +++.+||+|||+++....
T Consensus        91 mE~~~~g~L~~~l~--~~~~~~~~~~~~~~~qi~~gl~yLH~~-~~~IiHrDiKp~NILl~~~~~~~Kl~DFGla~~~~~  167 (270)
T d1t4ha_          91 TELMTSGTLKTYLK--RFKVMKIKVLRSWCRQILKGLQFLHTR-TPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRA  167 (270)
T ss_dssp             EECCCSCBHHHHHH--HHSSCCHHHHHHHHHHHHHHHHHHHTS-SSCCCCSCCCGGGEEESSTTSCEEECCTTGGGGCCT
T ss_pred             EeCCCCCcHHHHHh--ccccccHHHHHHHHHHHHHHHHHHHHC-CCCEEeCCcChhhceeeCCCCCEEEeecCcceeccC
Confidence            99999999999996  345799999999999999999999998 7  99999999999996 588999999999986544


Q ss_pred             C--CCccCcccccCcccccCCCCCCcccchhhhHHHHHHHhCCCCCCchhh-HHHhhhchhhhccccccCCCChHHHHHH
Q 020221          209 G--RSYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHAL-DLIRDRNIQTLTDSCLEGQFSSDEGTEL  285 (329)
Q Consensus       209 ~--~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~  285 (329)
                      .  ....||+.|+|||++.+ .++.++|||||||++|||++|+.||..... ............    ...++...++++
T Consensus       168 ~~~~~~~GT~~Y~aPE~~~~-~~~~~~DIwSlGvilyel~~g~~Pf~~~~~~~~~~~~i~~~~~----~~~~~~~~~~~~  242 (270)
T d1t4ha_         168 SFAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVK----PASFDKVAIPEV  242 (270)
T ss_dssp             TSBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTCC----CGGGGGCCCHHH
T ss_pred             CccCCcccCccccCHHHhCC-CCCCcCchhhHHHHHHHHHHCCCCCCCcccHHHHHHHHHcCCC----CcccCccCCHHH
Confidence            3  34578999999999875 699999999999999999999998864321 111111111111    112233456789


Q ss_pred             HHHHHHhcccCCCCCCCHHHHHH
Q 020221          286 VRLASRCLQYEPRERPNPRSLVT  308 (329)
Q Consensus       286 ~~li~~cl~~dp~~Rps~~~~l~  308 (329)
                      .+|+.+||+.||++|||+.|+++
T Consensus       243 ~~li~~~l~~dp~~R~s~~ell~  265 (270)
T d1t4ha_         243 KEIIEGCIRQNKDERYSIKDLLN  265 (270)
T ss_dssp             HHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             HHHHHHHccCCHhHCcCHHHHhC
Confidence            99999999999999999999998

>d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: epha2 receptor tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.4e-56  Score=389.98  Aligned_cols=258  Identities=21%  Similarity=0.285  Sum_probs=207.7

Q ss_pred             ccccccCCCCCCcEEEEEEeCC-C----CEEEEEEeCCCCChh-HHHHHHHHHHHhcCCCccccccceeeeeCCeeEEEE
Q 020221           59 ENIVSEHGEKAPNVVYKGKLEN-Q----FRIAVKRFNRSAWPD-ARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVA  132 (329)
Q Consensus        59 ~~~~~~lg~G~~g~V~~~~~~~-~----~~vavK~~~~~~~~~-~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~  132 (329)
                      +++.+.||+|+||+||+|.+.+ +    ..||||++....... ...+.+|+++++.++|||||+++|++.+....++||
T Consensus         9 ~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~~~~~~~v~   88 (283)
T d1mqba_           9 VTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMIIT   88 (283)
T ss_dssp             EEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEE
T ss_pred             eEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECcccChHHHHHHHHHHHHHHhcCCCCEeeeeEEEecCCceEEEE
Confidence            4555667999999999998543 2    369999997654333 446899999999999999999999999999999999


Q ss_pred             ecCCCCCHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCCCCCeeeecccCcccCCCCC--
Q 020221          133 EYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDGR--  210 (329)
Q Consensus       133 e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~--  210 (329)
                      ||+.++++.+++.. ....+++.++..++.|++.||+|||++ +|+||||||+|||++.++.+||+|||+++......  
T Consensus        89 e~~~~~~l~~~~~~-~~~~~~~~~~~~i~~~i~~gl~~lH~~-~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~~~~~~  166 (283)
T d1mqba_          89 EYMENGALDKFLRE-KDGEFSVLQLVGMLRGIAAGMKYLANM-NYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEA  166 (283)
T ss_dssp             ECCTTEEHHHHHHH-TTTCSCHHHHHHHHHHHHHHHHHHHHT-TCCCSCCCGGGEEECTTCCEEECCCCC----------
T ss_pred             EecccCcchhhhhc-ccccccHHHHHHHHHHHHHhhhhcccc-ccccCccccceEEECCCCeEEEcccchhhcccCCCcc
Confidence            99999999998765 456799999999999999999999999 99999999999999999999999999998654321  


Q ss_pred             -----CccCcccccCcccccCCCCCCcccchhhhHHHHHHHhCCCCCCchhhHHHhhhchhhhccccccCCCChHHHHHH
Q 020221          211 -----SYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTEL  285 (329)
Q Consensus       211 -----~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  285 (329)
                           ...||+.|+|||++.+..++.++||||||+++|||++++.|+........    ....+....+...+..++.++
T Consensus       167 ~~~~~~~~gt~~Y~APE~l~~~~~~~~sDI~S~Gvil~el~t~~~~~~~~~~~~~----~~~~i~~~~~~~~~~~~~~~l  242 (283)
T d1mqba_         167 TYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHE----VMKAINDGFRLPTPMDCPSAI  242 (283)
T ss_dssp             -------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH----HHHHHHTTCCCCCCTTCBHHH
T ss_pred             ceEeccCCCCccccCHHHHccCCCCCcccccccHHHHHHHHhCCCCccccCCHHH----HHHHHhccCCCCCchhhHHHH
Confidence                 23568899999999999999999999999999999998766654322111    111122223345566778899


Q ss_pred             HHHHHHhcccCCCCCCCHHHHHHHHHhhhhccccccC
Q 020221          286 VRLASRCLQYEPRERPNPRSLVTALVTLQKDTELYLS  322 (329)
Q Consensus       286 ~~li~~cl~~dp~~Rps~~~~l~~L~~~~~~~~~~~~  322 (329)
                      .+|+.+||+.||++|||+.+|++.|+++.+.++...+
T Consensus       243 ~~li~~cl~~~p~~RPt~~eil~~L~~l~~~p~~l~~  279 (283)
T d1mqba_         243 YQLMMQCWQQERARRPKFADIVSILDKLIRAPDSLKT  279 (283)
T ss_dssp             HHHHHHHTCSSTTTSCCHHHHHHHHHHHHHSGGGGGS
T ss_pred             HHHHHHHCcCCHhHCcCHHHHHHHHHHHhhCcccccc
Confidence            9999999999999999999999999999876554433

>d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]

Probab=100.00  E-value=6e-57  Score=402.84  Aligned_cols=249  Identities=19%  Similarity=0.161  Sum_probs=212.6

Q ss_pred             CCcccccccCCCCCCcEEEEEE-eCCCCEEEEEEeCCCCChhHHHHHHHHHHHhcCCCccccccceeeeeCCeeEEEEec
Q 020221           56 FAMENIVSEHGEKAPNVVYKGK-LENQFRIAVKRFNRSAWPDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAEY  134 (329)
Q Consensus        56 ~~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  134 (329)
                      ++.|++++.||+|+||+||+|. ..+|+.||||++........+.+.+|+++|+.++|||||++++++.+++.+++||||
T Consensus        28 ~d~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivmE~  107 (352)
T d1koba_          28 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEF  107 (352)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEEC
T ss_pred             ccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCcchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEc
Confidence            4568899999999999999999 467999999999876655566788999999999999999999999999999999999


Q ss_pred             CCCCCHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeC--CCCCeeeecccCcccCCCCC--
Q 020221          135 MPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFD--DDVNPRLSCFGLMKNSRDGR--  210 (329)
Q Consensus       135 ~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~--~~~~~kl~Dfg~a~~~~~~~--  210 (329)
                      |++|+|.+.+.. ....+++.+++.++.||+.||+|||++ ||+||||||+|||++  .++.+||+|||+|.......  
T Consensus       108 ~~gg~L~~~~~~-~~~~l~e~~~~~i~~qi~~aL~ylH~~-~iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~~~~~~~  185 (352)
T d1koba_         108 LSGGELFDRIAA-EDYKMSEAEVINYMRQACEGLKHMHEH-SIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIV  185 (352)
T ss_dssp             CCCCBHHHHTTC-TTCCBCHHHHHHHHHHHHHHHHHHHHT-TEECCCCCGGGEEESSTTCCCEEECCCTTCEECCTTSCE
T ss_pred             CCCChHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHHC-CeeecccccccccccccCCCeEEEeecccceecCCCCce
Confidence            999999988754 445799999999999999999999999 999999999999998  67899999999998776543  


Q ss_pred             -CccCcccccCcccccCCCCCCcccchhhhHHHHHHHhCCCCCCchhhHHHhhhchhhhccccccCCCChHHHHHHHHHH
Q 020221          211 -SYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLA  289 (329)
Q Consensus       211 -~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li  289 (329)
                       ...+|+.|+|||++.+..++.++|||||||++|+|+||..||.................  ..........++++.+|+
T Consensus       186 ~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~--~~~~~~~~~~s~~~~~li  263 (352)
T d1koba_         186 KVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDW--EFDEDAFSSVSPEAKDFI  263 (352)
T ss_dssp             EEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHCCC--CCCSSTTTTSCHHHHHHH
T ss_pred             eeccCcccccCHHHHcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCC--CCCcccccCCCHHHHHHH
Confidence             34689999999999999999999999999999999999999876543333222211111  112223456788999999


Q ss_pred             HHhcccCCCCCCCHHHHHH
Q 020221          290 SRCLQYEPRERPNPRSLVT  308 (329)
Q Consensus       290 ~~cl~~dp~~Rps~~~~l~  308 (329)
                      .+||+.||++|||+.++++
T Consensus       264 ~~~L~~dp~~R~s~~eil~  282 (352)
T d1koba_         264 KNLLQKEPRKRLTVHDALE  282 (352)
T ss_dssp             HTTSCSSGGGSCCHHHHHT
T ss_pred             HHHccCChhHCcCHHHHhc
Confidence            9999999999999999987

>d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: Caenorhabditis elegans, pjk4 [TaxId: 6239]

Probab=100.00  E-value=9.9e-57  Score=401.15  Aligned_cols=248  Identities=19%  Similarity=0.155  Sum_probs=210.6

Q ss_pred             CcccccccCCCCCCcEEEEEE-eCCCCEEEEEEeCCCCChhHHHHHHHHHHHhcCCCccccccceeeeeCCeeEEEEecC
Q 020221           57 AMENIVSEHGEKAPNVVYKGK-LENQFRIAVKRFNRSAWPDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAEYM  135 (329)
Q Consensus        57 ~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~  135 (329)
                      +.|++++.||+|+||+||+|. ..+|+.||||++........+.+.+|+.+|+.++|||||++++++.+.+..++|||||
T Consensus        26 ~~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmE~~  105 (350)
T d1koaa2          26 DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFM  105 (350)
T ss_dssp             GTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEEETTEEEEEECCC
T ss_pred             cCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEcccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEcC
Confidence            357888899999999999999 4678999999998776666677899999999999999999999999999999999999


Q ss_pred             CCCCHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeC--CCCCeeeecccCcccCCCCC---
Q 020221          136 PNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFD--DDVNPRLSCFGLMKNSRDGR---  210 (329)
Q Consensus       136 ~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~--~~~~~kl~Dfg~a~~~~~~~---  210 (329)
                      ++|+|.+++.+ ....+++..+..++.||+.||.|||++ ||+||||||+|||++  .++.+||+|||+++......   
T Consensus       106 ~gg~L~~~l~~-~~~~l~e~~~~~i~~qi~~aL~ylH~~-~iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~~~~~~~~  183 (350)
T d1koaa2         106 SGGELFEKVAD-EHNKMSEDEAVEYMRQVCKGLCHMHEN-NYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVK  183 (350)
T ss_dssp             CSCBHHHHHTC-TTSCBCHHHHHHHHHHHHHHHHHHHHT-TEECCCCCGGGEEESSTTSCCEEECCCTTCEECCTTSCEE
T ss_pred             CCCCHHHHHHh-hcCCCCHHHHHHHHHHHHHHHHHHHhc-CCeeeeechhHeeeccCCCCeEEEeecchheecccccccc
Confidence            99999999854 345699999999999999999999999 999999999999996  46789999999998765543   


Q ss_pred             CccCcccccCcccccCCCCCCcccchhhhHHHHHHHhCCCCCCchhhHHHhhhchhhhccccccCCCChHHHHHHHHHHH
Q 020221          211 SYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLAS  290 (329)
Q Consensus       211 ~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~  290 (329)
                      ...||+.|+|||++.+..++.++|||||||++|+|++|..||..................  .........++++.+|+.
T Consensus       184 ~~~gT~~Y~aPEv~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~--~~~~~~~~~s~~~~~li~  261 (350)
T d1koaa2         184 VTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWN--MDDSAFSGISEDGKDFIR  261 (350)
T ss_dssp             EECSCTTTCCHHHHHTCCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCC--SCCGGGGGCCHHHHHHHH
T ss_pred             eecCcccccCHHHHcCCCCChhHhhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCC--CCcccccCCCHHHHHHHH
Confidence            357899999999999999999999999999999999999998765433332222111111  111122456789999999


Q ss_pred             HhcccCCCCCCCHHHHHH
Q 020221          291 RCLQYEPRERPNPRSLVT  308 (329)
Q Consensus       291 ~cl~~dp~~Rps~~~~l~  308 (329)
                      +||..||++|||+.++++
T Consensus       262 ~~L~~dP~~R~t~~eil~  279 (350)
T d1koaa2         262 KLLLADPNTRMTIHQALE  279 (350)
T ss_dssp             HHCCSSGGGSCCHHHHHH
T ss_pred             HHccCChhHCcCHHHHhc
Confidence            999999999999999998

>d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: 3-phosphoinositide dependent protein kinase-1 Pdk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.3e-57  Score=394.84  Aligned_cols=244  Identities=17%  Similarity=0.173  Sum_probs=208.3

Q ss_pred             CcccccccCCCCCCcEEEEEEe-CCCCEEEEEEeCCCC---ChhHHHHHHHHHHHhcCCCccccccceeeeeCCeeEEEE
Q 020221           57 AMENIVSEHGEKAPNVVYKGKL-ENQFRIAVKRFNRSA---WPDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVA  132 (329)
Q Consensus        57 ~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~  132 (329)
                      ++|++++.||+|+||+||+|.. .+++.||||++....   ....+.+.+|+++++.++||||+++++++.+.+..++||
T Consensus         8 ~dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~ivm   87 (288)
T d1uu3a_           8 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGL   87 (288)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEECSSEEEEEE
T ss_pred             CCCEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEEEECCEEEEEE
Confidence            5688899999999999999994 678999999986432   223567899999999999999999999999999999999


Q ss_pred             ecCCCCCHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCCCCCeeeecccCcccCCCC---
Q 020221          133 EYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDG---  209 (329)
Q Consensus       133 e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~---  209 (329)
                      ||+++|+|.+++.  ....+++..+..++.|++.||+|||++ ||+||||||+|||+++++.+||+|||+|+.....   
T Consensus        88 Ey~~gg~L~~~~~--~~~~l~e~~~~~~~~qi~~al~ylH~~-~iiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~~~~~  164 (288)
T d1uu3a_          88 SYAKNGELLKYIR--KIGSFDETCTRFYTAEIVSALEYLHGK-GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQ  164 (288)
T ss_dssp             CCCTTEEHHHHHH--HHSSCCHHHHHHHHHHHHHHHHHHHHT-TEECSCCSGGGEEECTTSCEEECCCTTCEECC-----
T ss_pred             EccCCCCHHHhhh--ccCCCCHHHHHHHHHHHHHHHHhhccc-cEEcCcCCccccccCCCceEEecccccceecccCCcc
Confidence            9999999999886  446799999999999999999999999 9999999999999999999999999999865432   


Q ss_pred             ---CCccCcccccCcccccCCCCCCcccchhhhHHHHHHHhCCCCCCchhhHHHhhhchhhhccccccCCCChHHHHHHH
Q 020221          210 ---RSYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELV  286 (329)
Q Consensus       210 ---~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  286 (329)
                         ....||+.|+|||++.+..++.++|||||||++|||++|..||...............      ...++...++++.
T Consensus       165 ~~~~~~~GT~~Y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~------~~~~p~~~s~~~~  238 (288)
T d1uu3a_         165 ARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKL------EYDFPEKFFPKAR  238 (288)
T ss_dssp             -----CCCCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHTT------CCCCCTTCCHHHH
T ss_pred             cccccccCCccccCceeeccCCCCcccceehhhHHHHHHhhCCCCCCCcCHHHHHHHHHcC------CCCCCccCCHHHH
Confidence               2346899999999999999999999999999999999999998765443333222211      1234566788999


Q ss_pred             HHHHHhcccCCCCCCCHHHHHHH
Q 020221          287 RLASRCLQYEPRERPNPRSLVTA  309 (329)
Q Consensus       287 ~li~~cl~~dp~~Rps~~~~l~~  309 (329)
                      +|+.+||+.||++|||++|+++.
T Consensus       239 ~li~~~L~~dP~~R~t~~e~~~~  261 (288)
T d1uu3a_         239 DLVEKLLVLDATKRLGCEEMEGY  261 (288)
T ss_dssp             HHHHTTSCSSGGGSTTSGGGTCH
T ss_pred             HHHHHHccCCHhHCcCHHHHcCC
Confidence            99999999999999999998653

>d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Pkb kinase (Akt-2)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.3e-56  Score=394.17  Aligned_cols=243  Identities=17%  Similarity=0.227  Sum_probs=210.2

Q ss_pred             CcccccccCCCCCCcEEEEEE-eCCCCEEEEEEeCCCC---ChhHHHHHHHHHHHhcCCCccccccceeeeeCCeeEEEE
Q 020221           57 AMENIVSEHGEKAPNVVYKGK-LENQFRIAVKRFNRSA---WPDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVA  132 (329)
Q Consensus        57 ~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~  132 (329)
                      ++|++++.||+|+||.||+|. ..+++.||||++....   ....+.+.+|+.+|+.++||||+++++++.+.+.+++||
T Consensus         5 ~dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~iv~   84 (337)
T d1o6la_           5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVM   84 (337)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             HhcEEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEeeeccccccccce
Confidence            468888899999999999999 5679999999997532   223567889999999999999999999999999999999


Q ss_pred             ecCCCCCHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCCCCCeeeecccCcccCCCC---
Q 020221          133 EYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDG---  209 (329)
Q Consensus       133 e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~---  209 (329)
                      ||+++|+|.+++.  ....+++..++.++.||+.||+|||++ ||+||||||+|||++.+|.+||+|||+|+.....   
T Consensus        85 ey~~gg~L~~~~~--~~~~~~e~~~~~~~~qil~al~ylH~~-~iiHRDlKP~NILl~~~g~vkl~DFG~a~~~~~~~~~  161 (337)
T d1o6la_          85 EYANGGELFFHLS--RERVFTEERARFYGAEIVSALEYLHSR-DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGAT  161 (337)
T ss_dssp             ECCTTCBHHHHHH--HHSCCCHHHHHHHHHHHHHHHHHHHHT-TCBCCCCCGGGEEECTTSCEEECCCTTCBCSCCTTCC
T ss_pred             eccCCCchhhhhh--cccCCcHHHHHHHHHHHhhhhhhhhhc-CccccccCHHHeEecCCCCEEEeecccccccccCCcc
Confidence            9999999999987  456789999999999999999999999 9999999999999999999999999999865432   


Q ss_pred             -CCccCcccccCcccccCCCCCCcccchhhhHHHHHHHhCCCCCCchhhHHHhhhchhhhccccccCCCChHHHHHHHHH
Q 020221          210 -RSYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRL  288 (329)
Q Consensus       210 -~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  288 (329)
                       ....||+.|+|||++.+..++.++|||||||++|||++|..||.......+.......      ...+|...++++.+|
T Consensus       162 ~~~~~GT~~Y~aPE~~~~~~y~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~i~~~------~~~~p~~~s~~~~dl  235 (337)
T d1o6la_         162 MKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILME------EIRFPRTLSPEAKSL  235 (337)
T ss_dssp             BCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHC------CCCCCTTSCHHHHHH
T ss_pred             cccceeCHHHhhhhhccCCCCChhhcccchhhHHHHHHHCCCCCCCcCHHHHHHHHhcC------CCCCCccCCHHHHHH
Confidence             2457899999999999999999999999999999999999998876554443322221      123566778899999


Q ss_pred             HHHhcccCCCCCCC-----HHHHHH
Q 020221          289 ASRCLQYEPRERPN-----PRSLVT  308 (329)
Q Consensus       289 i~~cl~~dp~~Rps-----~~~~l~  308 (329)
                      |.+||+.||++||+     +.++++
T Consensus       236 i~~~L~~dP~~R~~~~~~~~~eil~  260 (337)
T d1o6la_         236 LAGLLKKDPKQRLGGGPSDAKEVME  260 (337)
T ss_dssp             HHHHTCSSTTTSTTCSTTTHHHHHT
T ss_pred             HHhhccCCchhhcccccccHHHHHc
Confidence            99999999999995     778776

>d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase ZAP-70
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.1e-56  Score=385.99  Aligned_cols=245  Identities=20%  Similarity=0.275  Sum_probs=204.8

Q ss_pred             cCCCCCCcEEEEEEeC---CCCEEEEEEeCCCCC-hhHHHHHHHHHHHhcCCCccccccceeeeeCCeeEEEEecCCCCC
Q 020221           64 EHGEKAPNVVYKGKLE---NQFRIAVKRFNRSAW-PDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAEYMPNDT  139 (329)
Q Consensus        64 ~lg~G~~g~V~~~~~~---~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gs  139 (329)
                      +||+|+||+||+|.+.   ++..||||+++.... ...+.+.+|+++|+.++|||||+++|++.+ +..++||||+++|+
T Consensus        16 ~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~-~~~~lvmE~~~~g~   94 (285)
T d1u59a_          16 ELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLVMEMAGGGP   94 (285)
T ss_dssp             EEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEEEEECCTTEE
T ss_pred             EEecccCeEEEEEEEecCCCcEEEEEEEEChhcCHHHHHHHHHHHHHHHhCCCCCEeeEeeeecc-CeEEEEEEeCCCCc
Confidence            3799999999999743   355799999976543 335679999999999999999999999864 56899999999999


Q ss_pred             HHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCCCCCeeeecccCcccCCCCC-------Cc
Q 020221          140 LAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDGR-------SY  212 (329)
Q Consensus       140 L~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~-------~~  212 (329)
                      |.+++.. ....+++.++..++.||+.||+|||++ +++||||||+||+++.++.+||+|||+++......       ..
T Consensus        95 L~~~l~~-~~~~l~~~~~~~i~~qi~~gL~ylH~~-~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~  172 (285)
T d1u59a_          95 LHKFLVG-KREEIPVSNVAELLHQVSMGMKYLEEK-NFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAG  172 (285)
T ss_dssp             HHHHHTT-CTTTSCHHHHHHHHHHHHHHHHHHHHT-TEECCCCSGGGEEEEETTEEEECCCTTCEECTTCSCEECCCCSS
T ss_pred             HHHHhhc-cccCCCHHHHHHHHHHHHHHHHHHHhC-CeecCcCchhheeeccCCceeeccchhhhccccccccccccccc
Confidence            9998754 446799999999999999999999999 99999999999999999999999999998654332       33


Q ss_pred             cCcccccCcccccCCCCCCcccchhhhHHHHHHHh-CCCCCCchhhHHHhhhchhhhccccccCCCChHHHHHHHHHHHH
Q 020221          213 STNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLS-GKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLASR  291 (329)
Q Consensus       213 ~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t-g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~  291 (329)
                      .+|+.|+|||++.++.++.++|||||||++|||+| |..||.......+...     +....+...+..+++++.+|+.+
T Consensus       173 ~gt~~y~aPE~~~~~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~~~~~~~-----i~~~~~~~~p~~~~~~l~~li~~  247 (285)
T d1u59a_         173 KWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAF-----IEQGKRMECPPECPPELYALMSD  247 (285)
T ss_dssp             CCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHHHHH-----HHTTCCCCCCTTCCHHHHHHHHH
T ss_pred             ccCccccChHHHhCCCCCccchhhcchHHHHHHHhCCCCCCCCCCHHHHHHH-----HHcCCCCCCCCcCCHHHHHHHHH
Confidence            57889999999998899999999999999999998 7887765433222211     11222344567788999999999


Q ss_pred             hcccCCCCCCCHHHHHHHHHhhhhc
Q 020221          292 CLQYEPRERPNPRSLVTALVTLQKD  316 (329)
Q Consensus       292 cl~~dp~~Rps~~~~l~~L~~~~~~  316 (329)
                      ||+.||++|||+.+|++.|+..-..
T Consensus       248 cl~~~p~~RPs~~~i~~~L~~~~~~  272 (285)
T d1u59a_         248 CWIYKWEDRPDFLTVEQRMRACYYS  272 (285)
T ss_dssp             TTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             HcCCCHhHCcCHHHHHHHHHHHHHH
Confidence            9999999999999999999876543

>d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Death-associated protein kinase, Dap
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.6e-56  Score=389.42  Aligned_cols=246  Identities=17%  Similarity=0.169  Sum_probs=205.9

Q ss_pred             cccccccCCCCCCcEEEEEEe-CCCCEEEEEEeCCCCC------hhHHHHHHHHHHHhcCCCccccccceeeeeCCeeEE
Q 020221           58 MENIVSEHGEKAPNVVYKGKL-ENQFRIAVKRFNRSAW------PDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLL  130 (329)
Q Consensus        58 ~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~------~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l  130 (329)
                      .|++++.||+|+||+||+|.. .+|+.||||++.....      ...+.+.+|+++|+.++|||||++++++.+.+..++
T Consensus        11 ~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~i   90 (293)
T d1jksa_          11 YYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVIL   90 (293)
T ss_dssp             TEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred             CEEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEE
Confidence            478889999999999999994 6789999999864321      235678999999999999999999999999999999


Q ss_pred             EEecCCCCCHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCCCC----CeeeecccCcccC
Q 020221          131 VAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDV----NPRLSCFGLMKNS  206 (329)
Q Consensus       131 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~----~~kl~Dfg~a~~~  206 (329)
                      |||||++|+|.+++.+  ...+++..++.++.|++.||+|||+. +|+||||||+||+++.++    .+|++|||++...
T Consensus        91 v~E~~~gg~L~~~i~~--~~~l~~~~~~~~~~qi~~al~yLH~~-~ivHrDiKp~Nill~~~~~~~~~vkl~DfG~a~~~  167 (293)
T d1jksa_          91 ILELVAGGELFDFLAE--KESLTEEEATEFLKQILNGVYYLHSL-QIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKI  167 (293)
T ss_dssp             EEECCCSCBHHHHHHH--HSSCCHHHHHHHHHHHHHHHHHHHHT-TEECCCCSGGGEEESCSSSSSCCEEECCCTTCEEC
T ss_pred             EEEcCCCccccchhcc--ccccchhHHHHHHHHHHHHHHhhhhc-ceeecccccceEEEecCCCcccceEecchhhhhhc
Confidence            9999999999999963  45799999999999999999999999 999999999999998776    4999999999876


Q ss_pred             CCC---CCccCcccccCcccccCCCCCCcccchhhhHHHHHHHhCCCCCCchhhHHHhhhchhhhccccccCCCChHHHH
Q 020221          207 RDG---RSYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGT  283 (329)
Q Consensus       207 ~~~---~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  283 (329)
                      ...   ....+|+.|+|||++.+..++.++|||||||++|||++|..||..................  .....+...++
T Consensus       168 ~~~~~~~~~~~t~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~~~--~~~~~~~~~s~  245 (293)
T d1jksa_         168 DFGNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYE--FEDEYFSNTSA  245 (293)
T ss_dssp             TTSCBCSCCCCCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHTTCCC--CCHHHHTTSCH
T ss_pred             CCCccccccCCCCcccCHHHHcCCCCCCcccchhhhHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCC--CCchhcCCCCH
Confidence            543   3456889999999999989999999999999999999999998765433322221111110  01111234577


Q ss_pred             HHHHHHHHhcccCCCCCCCHHHHHH
Q 020221          284 ELVRLASRCLQYEPRERPNPRSLVT  308 (329)
Q Consensus       284 ~~~~li~~cl~~dp~~Rps~~~~l~  308 (329)
                      ++.+|+.+||+.||++|||+.++++
T Consensus       246 ~~~~li~~~L~~dP~~R~s~~eil~  270 (293)
T d1jksa_         246 LAKDFIRRLLVKDPKKRMTIQDSLQ  270 (293)
T ss_dssp             HHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred             HHHHHHHHHccCChhHCcCHHHHhc
Confidence            8999999999999999999999997

>d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=100.00  E-value=1e-55  Score=389.62  Aligned_cols=243  Identities=18%  Similarity=0.212  Sum_probs=209.7

Q ss_pred             CcccccccCCCCCCcEEEEEE-eCCCCEEEEEEeCCCC---ChhHHHHHHHHHHHhcCCCccccccceeeeeCCeeEEEE
Q 020221           57 AMENIVSEHGEKAPNVVYKGK-LENQFRIAVKRFNRSA---WPDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVA  132 (329)
Q Consensus        57 ~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~  132 (329)
                      ++|++++.||+|+||+||+|+ ..+|+.||||+++...   ....+.+.+|+.+++.++||||+++++++.+.+..++||
T Consensus         4 ~dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivm   83 (316)
T d1fota_           4 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIM   83 (316)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEE
T ss_pred             hHeEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeEeeCCeeeeEe
Confidence            457889999999999999999 4678999999986432   233567899999999999999999999999999999999


Q ss_pred             ecCCCCCHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCCCCCeeeecccCcccCCCC-CC
Q 020221          133 EYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDG-RS  211 (329)
Q Consensus       133 e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~-~~  211 (329)
                      ||+++|+|..++.  ....+++..+..++.||+.||+|||++ ||+||||||+|||++.++.+||+|||+|+..... ..
T Consensus        84 E~~~gg~l~~~~~--~~~~~~~~~~~~~~~qi~~al~~lH~~-~iiHrDiKp~NILl~~~g~vkL~DFG~a~~~~~~~~~  160 (316)
T d1fota_          84 DYIEGGELFSLLR--KSQRFPNPVAKFYAAEVCLALEYLHSK-DIIYRDLKPENILLDKNGHIKITDFGFAKYVPDVTYT  160 (316)
T ss_dssp             CCCCSCBHHHHHH--HTSSCCHHHHHHHHHHHHHHHHHHHTT-TEECCCCCGGGEEECTTSCEEECCCSSCEECSSCBCC
T ss_pred             eecCCcccccccc--ccccccccHHHHHHHHHHHhhhhhccC-cEEccccCchheeEcCCCCEEEecCccceEecccccc
Confidence            9999999999887  456788999999999999999999999 9999999999999999999999999999876544 35


Q ss_pred             ccCcccccCcccccCCCCCCcccchhhhHHHHHHHhCCCCCCchhhHHHhhhchhhhccccccCCCChHHHHHHHHHHHH
Q 020221          212 YSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLASR  291 (329)
Q Consensus       212 ~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~  291 (329)
                      ..||+.|+|||++.+..++.++|||||||++|+|++|..||...............      ...++...++++.+++.+
T Consensus       161 ~~Gt~~Y~APE~l~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~------~~~~p~~~s~~~~~li~~  234 (316)
T d1fota_         161 LCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNA------ELRFPPFFNEDVKDLLSR  234 (316)
T ss_dssp             CCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHC------CCCCCTTSCHHHHHHHHH
T ss_pred             ccCcccccCHHHHcCCCCCchhhccccchhHHHHHhCCCCCCCcCHHHHHHHHHcC------CCCCCCCCCHHHHHHHHH
Confidence            67999999999999999999999999999999999999998765444333322221      123456678899999999


Q ss_pred             hcccCCCCCC-----CHHHHHH
Q 020221          292 CLQYEPRERP-----NPRSLVT  308 (329)
Q Consensus       292 cl~~dp~~Rp-----s~~~~l~  308 (329)
                      ||..||++|+     |++++++
T Consensus       235 ~L~~dp~~R~~~~r~t~~~il~  256 (316)
T d1fota_         235 LITRDLSQRLGNLQNGTEDVKN  256 (316)
T ss_dssp             HTCSCTTTCTTSSTTTTHHHHT
T ss_pred             HhhhCHHhccccchhhHHHHHc
Confidence            9999999996     8899887

>d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-src tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.5e-56  Score=387.80  Aligned_cols=253  Identities=23%  Similarity=0.338  Sum_probs=209.6

Q ss_pred             CcccccccCCCCCCcEEEEEEeCCCCEEEEEEeCCCCChhHHHHHHHHHHHhcCCCccccccceeeeeCCeeEEEEecCC
Q 020221           57 AMENIVSEHGEKAPNVVYKGKLENQFRIAVKRFNRSAWPDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAEYMP  136 (329)
Q Consensus        57 ~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~  136 (329)
                      +.+++.+.||+|+||+||+|..++++.||||+++... ...+.+.+|+.+++.++|||||++++++. .+..++||||++
T Consensus        17 ~~~~i~~~iG~G~fg~Vy~~~~~~~~~vAiK~l~~~~-~~~~~~~~E~~~l~~l~h~nIv~~~g~~~-~~~~~lv~Ey~~   94 (285)
T d1fmka3          17 ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVS-EEPIYIVTEYMS   94 (285)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSSCEEEECCCT
T ss_pred             HHEEEeeEEeeCCCeEEEEEEECCCCEEEEEEECccc-CCHHHHHHHHHHHHhcccCCEeEEEEEEe-cCCeEEEEEecC
Confidence            5678888999999999999998888889999997655 34678999999999999999999999985 467899999999


Q ss_pred             CCCHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCCCCCeeeecccCcccCCCCC-----C
Q 020221          137 NDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDGR-----S  211 (329)
Q Consensus       137 ~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~-----~  211 (329)
                      +|+|..++.......+++.+++.++.||+.||+|||++ +++||||||+|||++.++.+||+|||+++......     .
T Consensus        95 ~g~l~~~~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~-~ivH~DlKp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~  173 (285)
T d1fmka3          95 KGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERM-NYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQG  173 (285)
T ss_dssp             TCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHT-TCCCSCCSGGGEEECGGGCEEECCCCTTC------------
T ss_pred             CCchhhhhhhcccccchHHHHHHHHHHHHHHHHHHhhh-heecccccceEEEECCCCcEEEcccchhhhccCCCceeecc
Confidence            99999988754456799999999999999999999999 99999999999999999999999999998654332     2


Q ss_pred             ccCcccccCcccccCCCCCCcccchhhhHHHHHHHhCCCCCCchhhH-HHhhhchhhhccccccCCCChHHHHHHHHHHH
Q 020221          212 YSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALD-LIRDRNIQTLTDSCLEGQFSSDEGTELVRLAS  290 (329)
Q Consensus       212 ~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~  290 (329)
                      ..+|+.|+|||++.+..++.++||||||+++|||++|+.|+...... ......     ....+...+..+++++.+++.
T Consensus       174 ~~gt~~y~aPE~~~~~~~~~ksDI~S~Giil~el~t~~~p~~~~~~~~~~~~~i-----~~~~~~~~~~~~~~~l~~li~  248 (285)
T d1fmka3         174 AKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQV-----ERGYRMPCPPECPESLHDLMC  248 (285)
T ss_dssp             --CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHH-----HTTCCCCCCTTSCHHHHHHHH
T ss_pred             ccccccccChHHHhCCCCCcHHhhhcchHHHHHHHhCCCCCCCCCCHHHHHHHH-----HhcCCCCCCcccCHHHHHHHH
Confidence            45789999999999999999999999999999999987766543322 111111     111233456677889999999


Q ss_pred             HhcccCCCCCCCHHHHHHHHHhhhhcc
Q 020221          291 RCLQYEPRERPNPRSLVTALVTLQKDT  317 (329)
Q Consensus       291 ~cl~~dp~~Rps~~~~l~~L~~~~~~~  317 (329)
                      +||+.||++|||+.+|++.|+..-...
T Consensus       249 ~cl~~dP~~Rps~~~i~~~L~~~~~~~  275 (285)
T d1fmka3         249 QCWRKEPEERPTFEYLQAFLEDYFTST  275 (285)
T ss_dssp             HHTCSSGGGSCCHHHHHHHHHTTTSCS
T ss_pred             HHcccCHhHCcCHHHHHHHHhhhhcCC
Confidence            999999999999999999998866443

>d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase SYK
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=8.5e-56  Score=383.43  Aligned_cols=242  Identities=21%  Similarity=0.260  Sum_probs=199.9

Q ss_pred             cCCCCCCcEEEEEEeC---CCCEEEEEEeCCCCC--hhHHHHHHHHHHHhcCCCccccccceeeeeCCeeEEEEecCCCC
Q 020221           64 EHGEKAPNVVYKGKLE---NQFRIAVKRFNRSAW--PDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAEYMPND  138 (329)
Q Consensus        64 ~lg~G~~g~V~~~~~~---~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g  138 (329)
                      +||+|+||+||+|.+.   .++.||||+++....  ...+.+.+|+++++.++|||||++++++.. +..++||||+++|
T Consensus        14 ~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~-~~~~lvmE~~~~g   92 (277)
T d1xbba_          14 ELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAELG   92 (277)
T ss_dssp             EEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEES-SSEEEEEECCTTE
T ss_pred             CcccCCCeEEEEEEEccCCcCeEEEEEEEChhhCCHHHHHHHHHHHHHHHhCCCCCCceEEEEecc-CCEEEEEEcCCCC
Confidence            5799999999999853   346799999975432  235679999999999999999999999854 5678999999999


Q ss_pred             CHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCCCCCeeeecccCcccCCCCC-------C
Q 020221          139 TLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDGR-------S  211 (329)
Q Consensus       139 sL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~-------~  211 (329)
                      +|.+++.  ....+++..+..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+++......       .
T Consensus        93 ~L~~~l~--~~~~l~~~~~~~i~~qi~~gl~ylH~~-~iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~~~~~~~~~~~  169 (277)
T d1xbba_          93 PLNKYLQ--QNRHVKDKNIIELVHQVSMGMKYLEES-NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTH  169 (277)
T ss_dssp             EHHHHHH--HCTTCCHHHHHHHHHHHHHHHHHHHHT-TEECSCCSGGGEEEEETTEEEECCCTTCEECCTTCSEEEC---
T ss_pred             cHHHHHh--hccCCCHHHHHHHHHHHHHHHhhHHhC-CcccCCCcchhhcccccCcccccchhhhhhccccccccccccc
Confidence            9999987  456799999999999999999999999 99999999999999999999999999998654332       2


Q ss_pred             ccCcccccCcccccCCCCCCcccchhhhHHHHHHHh-CCCCCCchhhHHHhhhchhhhccccccCCCChHHHHHHHHHHH
Q 020221          212 YSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLS-GKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLAS  290 (329)
Q Consensus       212 ~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t-g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~  290 (329)
                      ..||+.|+|||.+.+..++.++|||||||++|||+| |..||.......+...     +....+...+..+++++.+|+.
T Consensus       170 ~~gt~~y~APE~l~~~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~~~~~~~~-----i~~~~~~~~p~~~~~~~~~li~  244 (277)
T d1xbba_         170 GKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAM-----LEKGERMGCPAGCPREMYDLMN  244 (277)
T ss_dssp             -CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHH-----HHTTCCCCCCTTCCHHHHHHHH
T ss_pred             cCCCceecCchhhcCCCCCchhhhccchhhhhHHhhCCCCCCCCCCHHHHHHH-----HHcCCCCCCCcccCHHHHHHHH
Confidence            357899999999998899999999999999999998 7877765433222211     1122233456677889999999


Q ss_pred             HhcccCCCCCCCHHHHHHHHHhhh
Q 020221          291 RCLQYEPRERPNPRSLVTALVTLQ  314 (329)
Q Consensus       291 ~cl~~dp~~Rps~~~~l~~L~~~~  314 (329)
                      +||+.||++|||+++|++.|+..-
T Consensus       245 ~cl~~dp~~RPs~~~i~~~L~~~~  268 (277)
T d1xbba_         245 LCWTYDVENRPGFAAVELRLRNYY  268 (277)
T ss_dssp             HHTCSSTTTSCCHHHHHHHHHHHH
T ss_pred             HHcCCCHhHCcCHHHHHHHhhCHH
Confidence            999999999999999999888753

>d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fl cytokine receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.3e-56  Score=393.69  Aligned_cols=250  Identities=21%  Similarity=0.280  Sum_probs=204.4

Q ss_pred             CcccccccCCCCCCcEEEEEEeC-CC-----CEEEEEEeCCCCC-hhHHHHHHHHHHHhcC-CCccccccceeeeeCCee
Q 020221           57 AMENIVSEHGEKAPNVVYKGKLE-NQ-----FRIAVKRFNRSAW-PDARQFLEEARAVGQL-RNRRLANLLGCCCEGDER  128 (329)
Q Consensus        57 ~~~~~~~~lg~G~~g~V~~~~~~-~~-----~~vavK~~~~~~~-~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~  128 (329)
                      +.+++.+.||+|+||+||+|+.. .+     ..||+|.+..... .....+.+|+.++..+ +|||||++++++.+.+..
T Consensus        37 ~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~  116 (325)
T d1rjba_          37 ENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSGPI  116 (325)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred             HHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEeccccCHHHHHHHHHHHHHHHHhcCCCcEeEEEEEEeeCCeE
Confidence            45678888899999999999843 22     3699999876532 2345688999999998 899999999999999999


Q ss_pred             EEEEecCCCCCHHhhhccCCC---------------------CCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCce
Q 020221          129 LLVAEYMPNDTLAKHLFHWET---------------------QPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRI  187 (329)
Q Consensus       129 ~lv~e~~~~gsL~~~l~~~~~---------------------~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Ni  187 (329)
                      ++|||||++|+|.+++.....                     ..+++..++.++.||+.||+|||++ +|+||||||+||
T Consensus       117 ~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~-~IiHRDlKp~Ni  195 (325)
T d1rjba_         117 YLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFK-SCVHRDLAARNV  195 (325)
T ss_dssp             EEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHT-TEEETTCSGGGE
T ss_pred             EEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhC-CeeeccCchhcc
Confidence            999999999999999975321                     3589999999999999999999999 999999999999


Q ss_pred             eeCCCCCeeeecccCcccCCCCC------CccCcccccCcccccCCCCCCcccchhhhHHHHHHHh-CCCCCCchhhHHH
Q 020221          188 VFDDDVNPRLSCFGLMKNSRDGR------SYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLS-GKHIPPSHALDLI  260 (329)
Q Consensus       188 l~~~~~~~kl~Dfg~a~~~~~~~------~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t-g~~~~~~~~~~~~  260 (329)
                      |++.++.+||+|||+|+......      ...+|+.|+|||++.++.++.++|||||||++|||+| |..||........
T Consensus       196 ll~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwS~Gvil~emlt~g~~Pf~~~~~~~~  275 (325)
T d1rjba_         196 LVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPVDAN  275 (325)
T ss_dssp             EEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHH
T ss_pred             ccccCCeEEEeeccccccccCCCceeeeccccCCCccCChHHHcCCCCCcceeccchhHHHHHHHhCCCCCCCCCCHHHH
Confidence            99999999999999998654432      2346889999999999999999999999999999998 7877754322211


Q ss_pred             hhhchhhhccccccCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 020221          261 RDRNIQTLTDSCLEGQFSSDEGTELVRLASRCLQYEPRERPNPRSLVTALV  311 (329)
Q Consensus       261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~~~l~~L~  311 (329)
                      .    ..++....+...+..+++++.+|+.+||+.||++|||+++|+++|.
T Consensus       276 ~----~~~~~~~~~~~~p~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~  322 (325)
T d1rjba_         276 F----YKLIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLG  322 (325)
T ss_dssp             H----HHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred             H----HHHHhcCCCCCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHh
Confidence            1    1122222334456677889999999999999999999999999986

>d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Carboxyl-terminal src kinase (csk)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7.3e-56  Score=380.45  Aligned_cols=250  Identities=24%  Similarity=0.338  Sum_probs=202.0

Q ss_pred             CcccccccCCCCCCcEEEEEEeCCCCEEEEEEeCCCCChhHHHHHHHHHHHhcCCCccccccceeeee-CCeeEEEEecC
Q 020221           57 AMENIVSEHGEKAPNVVYKGKLENQFRIAVKRFNRSAWPDARQFLEEARAVGQLRNRRLANLLGCCCE-GDERLLVAEYM  135 (329)
Q Consensus        57 ~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~-~~~~~lv~e~~  135 (329)
                      +++++++.||+|+||.||+|.++ |..||||+++...  ..+.+.+|+++++.++||||++++|++.+ .+.+++||||+
T Consensus         7 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~vAvK~i~~~~--~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~ey~   83 (262)
T d1byga_           7 KELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYM   83 (262)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEET-TEEEEEEECCCCC----HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECCC
T ss_pred             HHeEEeEEEecCCCeEEEEEEEC-CeEEEEEEECcHH--HHHHHHHHHHHHHhCCCCCEeeEEEEEEecCCcEEEEEecc
Confidence            45677888999999999999984 6689999997644  35679999999999999999999999855 45689999999


Q ss_pred             CCCCHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCCCCCeeeecccCcccCCCC-CCccC
Q 020221          136 PNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDG-RSYST  214 (329)
Q Consensus       136 ~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~-~~~~~  214 (329)
                      ++|+|.+++.......+++..+..++.||+.||.|||++ +++||||||+||+++.++.+|++|||+++..... ....+
T Consensus        84 ~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~al~ylH~~-~ivH~dlkp~Nil~~~~~~~kl~dfg~s~~~~~~~~~~~~  162 (262)
T d1byga_          84 AKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGN-NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKL  162 (262)
T ss_dssp             TTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHT-TCCCSCCSGGGEEECTTSCEEECCCCC------------C
T ss_pred             CCCCHHHHHHhcCCCCCCHHHHHHHHHHHHhhccccccC-ceeccccchHhheecCCCCEeecccccceecCCCCccccc
Confidence            999999999653344689999999999999999999999 9999999999999999999999999999875443 34467


Q ss_pred             cccccCcccccCCCCCCcccchhhhHHHHHHHhC-CCCCCchhhHHHhhhchhhhccccccCCCChHHHHHHHHHHHHhc
Q 020221          215 NLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSG-KHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLASRCL  293 (329)
Q Consensus       215 ~~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl  293 (329)
                      ++.|+|||++.+..++.++||||||+++|||+|+ +.|+.......+...     +....+...+..+++++.+|+.+||
T Consensus       163 ~~~y~aPE~l~~~~~t~~sDIwSfG~il~el~t~~~~p~~~~~~~~~~~~-----i~~~~~~~~~~~~~~~~~~li~~cl  237 (262)
T d1byga_         163 PVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPR-----VEKGYKMDAPDGCPPAVYEVMKNCW  237 (262)
T ss_dssp             CTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGHHHH-----HTTTCCCCCCTTCCHHHHHHHHHHT
T ss_pred             cccCCChHHHhCCCCChHHHHHhHHHHHHHHHHCCCCCCCCCCHHHHHHH-----HHcCCCCCCCccCCHHHHHHHHHHc
Confidence            8899999999989999999999999999999995 544443322222211     1222344566777889999999999


Q ss_pred             ccCCCCCCCHHHHHHHHHhhhh
Q 020221          294 QYEPRERPNPRSLVTALVTLQK  315 (329)
Q Consensus       294 ~~dp~~Rps~~~~l~~L~~~~~  315 (329)
                      +.||++|||+.+++++|++++.
T Consensus       238 ~~dP~~Rps~~~l~~~L~~i~~  259 (262)
T d1byga_         238 HLDAAMRPSFLQLREQLEHIKT  259 (262)
T ss_dssp             CSSGGGSCCHHHHHHHHHHHHH
T ss_pred             ccCHhHCcCHHHHHHHHHHHHh
Confidence            9999999999999999999864

>d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: gamma-subunit of glycogen phosphorylase kinase (Phk)
species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]

Probab=100.00  E-value=4.2e-55  Score=378.68  Aligned_cols=248  Identities=18%  Similarity=0.169  Sum_probs=208.2

Q ss_pred             CCcccccccCCCCCCcEEEEEE-eCCCCEEEEEEeCCCCChh---------HHHHHHHHHHHhcCC-Cccccccceeeee
Q 020221           56 FAMENIVSEHGEKAPNVVYKGK-LENQFRIAVKRFNRSAWPD---------ARQFLEEARAVGQLR-NRRLANLLGCCCE  124 (329)
Q Consensus        56 ~~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~---------~~~~~~e~~~l~~l~-h~niv~~~~~~~~  124 (329)
                      ++.|++++.||+|+||+||+|+ ..+++.||||++.......         .+.+.+|+.+++.++ ||||+++++++.+
T Consensus         2 ~~~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~   81 (277)
T d1phka_           2 YENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYET   81 (277)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEC
T ss_pred             cccCEEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeeccc
Confidence            4678899999999999999999 4678999999987653221         235789999999997 9999999999999


Q ss_pred             CCeeEEEEecCCCCCHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCCCCCeeeecccCcc
Q 020221          125 GDERLLVAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMK  204 (329)
Q Consensus       125 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~  204 (329)
                      ++..++||||+++|+|.+++.  ....+++.+++.++.||+.||+|||++ ||+||||||+||+++.++.+||+|||+++
T Consensus        82 ~~~~~ivmE~~~~g~L~~~l~--~~~~l~e~~~~~~~~qi~~al~~lH~~-~ivHrDlkp~Nill~~~~~~kl~DFG~a~  158 (277)
T d1phka_          82 NTFFFLVFDLMKKGELFDYLT--EKVTLSEKETRKIMRALLEVICALHKL-NIVHRDLKPENILLDDDMNIKLTDFGFSC  158 (277)
T ss_dssp             SSEEEEEEECCTTCBHHHHHH--HHSSCCHHHHHHHHHHHHHHHHHHHHT-TEECSCCSGGGEEECTTCCEEECCCTTCE
T ss_pred             CcceEEEEEcCCCchHHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHHc-CCcccccccceEEEcCCCCeEEccchhee
Confidence            999999999999999999997  345799999999999999999999999 99999999999999999999999999998


Q ss_pred             cCCCC---CCccCcccccCcccccC------CCCCCcccchhhhHHHHHHHhCCCCCCchhhHHHhhhchhhhccccccC
Q 020221          205 NSRDG---RSYSTNLAFTPPEYLRT------GRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEG  275 (329)
Q Consensus       205 ~~~~~---~~~~~~~~y~aPE~~~~------~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~  275 (329)
                      .....   ....||+.|+|||++.+      ..++.++||||+||++|+|++|+.||..................  ...
T Consensus       159 ~~~~~~~~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~~~~~~~~i~~~~~~--~~~  236 (277)
T d1phka_         159 QLDPGEKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQ--FGS  236 (277)
T ss_dssp             ECCTTCCBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCC--CCT
T ss_pred             EccCCCceeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCCCHHHHHHHHHhCCCC--CCC
Confidence            76543   34568999999998853      34788999999999999999999998766543333222221111  122


Q ss_pred             CCChHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 020221          276 QFSSDEGTELVRLASRCLQYEPRERPNPRSLVT  308 (329)
Q Consensus       276 ~~~~~~~~~~~~li~~cl~~dp~~Rps~~~~l~  308 (329)
                      ......|+++.+|+.+||+.||++|||+.++++
T Consensus       237 ~~~~~~s~~~~~li~~~L~~~p~~R~s~~eil~  269 (277)
T d1phka_         237 PEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALA  269 (277)
T ss_dssp             TTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTT
T ss_pred             cccccCCHHHHHHHHHHccCChhHCcCHHHHHc
Confidence            233467889999999999999999999999988

>d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=6.3e-55  Score=389.65  Aligned_cols=244  Identities=17%  Similarity=0.177  Sum_probs=209.8

Q ss_pred             CCcccccccCCCCCCcEEEEEEe-CCCCEEEEEEeCCCC---ChhHHHHHHHHHHHhcCCCccccccceeeeeCCeeEEE
Q 020221           56 FAMENIVSEHGEKAPNVVYKGKL-ENQFRIAVKRFNRSA---WPDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLV  131 (329)
Q Consensus        56 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv  131 (329)
                      .+.|++++.||+|+||.||+|.. .+|+.||||++....   ....+.+.+|+++|+.++||||+++++++.+....++|
T Consensus        40 ld~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~v  119 (350)
T d1rdqe_          40 LDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMV  119 (350)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             ccCeEEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeecccccccccccccc
Confidence            35689999999999999999994 679999999986432   22356788999999999999999999999999999999


Q ss_pred             EecCCCCCHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCCCCCeeeecccCcccCCCC-C
Q 020221          132 AEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDG-R  210 (329)
Q Consensus       132 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~-~  210 (329)
                      |||+.+|+|..++.  ....+++..+..++.||+.||.|||++ +|+||||||+|||++.++.+||+|||+|+..... .
T Consensus       120 ~e~~~~g~l~~~l~--~~~~l~e~~~~~i~~qi~~aL~yLH~~-~iiHRDIKP~NILl~~~g~ikL~DFG~a~~~~~~~~  196 (350)
T d1rdqe_         120 MEYVAGGEMFSHLR--RIGRFSEPHARFYAAQIVLTFEYLHSL-DLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTW  196 (350)
T ss_dssp             EECCTTCBHHHHHH--HHCCCCHHHHHHHHHHHHHHHHHHHHT-TEECCCCSGGGEEECTTSCEEECCCTTCEECSSCBC
T ss_pred             cccccccchhhhHh--hcCCCCHHHHHHHHHHHHHHHHHHHhC-CEecCcCCHHHcccCCCCCEEeeeceeeeecccccc
Confidence            99999999999986  345799999999999999999999999 9999999999999999999999999999876544 3


Q ss_pred             CccCcccccCcccccCCCCCCcccchhhhHHHHHHHhCCCCCCchhhHHHhhhchhhhccccccCCCChHHHHHHHHHHH
Q 020221          211 SYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLAS  290 (329)
Q Consensus       211 ~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~  290 (329)
                      ...||+.|+|||++.+..++.++|||||||++|||+||..||...............      ....+...++++.+++.
T Consensus       197 ~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~------~~~~p~~~s~~~~~li~  270 (350)
T d1rdqe_         197 TLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSG------KVRFPSHFSSDLKDLLR  270 (350)
T ss_dssp             CCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHC------CCCCCTTCCHHHHHHHH
T ss_pred             cccCccccCCHHHHcCCCCCccccccchhHHHHHHHhCCCCCCCcCHHHHHHHHhcC------CCCCCccCCHHHHHHHH
Confidence            467899999999999999999999999999999999999998765443333222221      12345567889999999


Q ss_pred             HhcccCCCCCC-----CHHHHHH
Q 020221          291 RCLQYEPRERP-----NPRSLVT  308 (329)
Q Consensus       291 ~cl~~dp~~Rp-----s~~~~l~  308 (329)
                      +||..||++|+     |++++++
T Consensus       271 ~~L~~dP~kR~~~~r~t~~ell~  293 (350)
T d1rdqe_         271 NLLQVDLTKRFGNLKNGVNDIKN  293 (350)
T ss_dssp             HHSCSCTTTCTTSSTTTTHHHHT
T ss_pred             HHhhhCHHhccccccccHHHHHc
Confidence            99999999994     8999886

>d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Titin, kinase domain
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.4e-55  Score=386.57  Aligned_cols=249  Identities=16%  Similarity=0.179  Sum_probs=208.7

Q ss_pred             CCCcccccccCCCCCCcEEEEEEe-CCCCEEEEEEeCCCCChhHHHHHHHHHHHhcCCCccccccceeeeeCCeeEEEEe
Q 020221           55 GFAMENIVSEHGEKAPNVVYKGKL-ENQFRIAVKRFNRSAWPDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAE  133 (329)
Q Consensus        55 ~~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  133 (329)
                      -|+.|++++.||+|+||+||+|.. .+++.||||+++... .+...+.+|+++|+.++||||+++++++.+.+.+++|||
T Consensus         3 ~~~rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~-~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~lvmE   81 (321)
T d1tkia_           3 LYEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKG-TDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFE   81 (321)
T ss_dssp             CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCT-HHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEEC
T ss_pred             CccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCCc-ccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEe
Confidence            467899999999999999999994 578899999998765 334568899999999999999999999999999999999


Q ss_pred             cCCCCCHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCC--CCCeeeecccCcccCCCCC-
Q 020221          134 YMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDD--DVNPRLSCFGLMKNSRDGR-  210 (329)
Q Consensus       134 ~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~--~~~~kl~Dfg~a~~~~~~~-  210 (329)
                      ||++|+|.+++.. ....+++.++..++.||+.||+|||++ ||+||||||+|||++.  ...+||+|||++....... 
T Consensus        82 ~~~gg~L~~~i~~-~~~~l~e~~~~~i~~qi~~al~yLH~~-~iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~~~~~~  159 (321)
T d1tkia_          82 FISGLDIFERINT-SAFELNEREIVSYVHQVCEALQFLHSH-NIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDN  159 (321)
T ss_dssp             CCCCCBHHHHHTS-SSCCCCHHHHHHHHHHHHHHHHHHHHT-TEECCCCCGGGEEESSSSCCCEEECCCTTCEECCTTCE
T ss_pred             cCCCCcHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHHc-CCCcccccccceeecCCCceEEEEcccchhhccccCCc
Confidence            9999999999964 334799999999999999999999999 9999999999999984  4579999999998765543 


Q ss_pred             --CccCcccccCcccccCCCCCCcccchhhhHHHHHHHhCCCCCCchhhHHHhhhchhhhccccccCCCChHHHHHHHHH
Q 020221          211 --SYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRL  288 (329)
Q Consensus       211 --~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  288 (329)
                        ...+++.|+|||.+.+..++.++|||||||++|+|++|..||..................  .........++++.+|
T Consensus       160 ~~~~~~t~~y~ape~~~~~~~~~~~DiWSlGvily~ll~G~~Pf~~~~~~~~~~~i~~~~~~--~~~~~~~~~s~~~~~l  237 (321)
T d1tkia_         160 FRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYT--FDEEAFKEISIEAMDF  237 (321)
T ss_dssp             EEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCC--CCHHHHTTSCHHHHHH
T ss_pred             ccccccccccccchhccCCCCCchhhcccHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCC--CChhhccCCCHHHHHH
Confidence              345789999999999999999999999999999999999998766543333222211110  0000112357789999


Q ss_pred             HHHhcccCCCCCCCHHHHHH
Q 020221          289 ASRCLQYEPRERPNPRSLVT  308 (329)
Q Consensus       289 i~~cl~~dp~~Rps~~~~l~  308 (329)
                      +.+||..||++|||+.++++
T Consensus       238 i~~~L~~dp~~R~s~~eil~  257 (321)
T d1tkia_         238 VDRLLVKERKSRMTASEALQ  257 (321)
T ss_dssp             HHTTSCSSGGGSCCHHHHHH
T ss_pred             HHHHccCChhHCcCHHHHhc
Confidence            99999999999999999997

>d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Focal adhesion kinase 1 (fak)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=9.1e-55  Score=376.82  Aligned_cols=252  Identities=20%  Similarity=0.274  Sum_probs=200.8

Q ss_pred             CcccccccCCCCCCcEEEEEEeCC----CCEEEEEEeCCCCChh-HHHHHHHHHHHhcCCCccccccceeeeeCCeeEEE
Q 020221           57 AMENIVSEHGEKAPNVVYKGKLEN----QFRIAVKRFNRSAWPD-ARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLV  131 (329)
Q Consensus        57 ~~~~~~~~lg~G~~g~V~~~~~~~----~~~vavK~~~~~~~~~-~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv  131 (329)
                      +.+++.+.||+|+||+||+|.+..    +..||||.++...... .+.+.+|+++++.++||||+++++++. .+..++|
T Consensus         7 ~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~~~~iv   85 (273)
T d1mp8a_           7 ERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVWII   85 (273)
T ss_dssp             GGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSCEEE
T ss_pred             HHeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEe-cCeEEEE
Confidence            467888889999999999998532    3568999987654333 456899999999999999999999985 5688999


Q ss_pred             EecCCCCCHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCCCCCeeeecccCcccCCCC--
Q 020221          132 AEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDG--  209 (329)
Q Consensus       132 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~--  209 (329)
                      |||+++|+|.+++.. ....+++..++.++.||+.||.|||++ +++||||||+||+++.++.+||+|||+++.....  
T Consensus        86 ~E~~~~g~l~~~~~~-~~~~l~~~~~~~~~~qi~~gl~ylH~~-~iiHrDlKp~NIll~~~~~~Kl~DfG~a~~~~~~~~  163 (273)
T d1mp8a_          86 MELCTLGELRSFLQV-RKYSLDLASLILYAYQLSTALAYLESK-RFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTY  163 (273)
T ss_dssp             EECCTTEEHHHHHHH-TTTTSCHHHHHHHHHHHHHHHHHHHHT-TCCCSCCSGGGEEEEETTEEEECC------------
T ss_pred             EEeccCCcHHhhhhc-cCCCCCHHHHHHHHHHHHHHhhhhccc-CeeccccchhheeecCCCcEEEccchhheeccCCcc
Confidence            999999999998764 456789999999999999999999999 9999999999999999999999999999865433  


Q ss_pred             ---CCccCcccccCcccccCCCCCCcccchhhhHHHHHHHh-CCCCCCchhhHHHhhhchhhhccccccCCCChHHHHHH
Q 020221          210 ---RSYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLS-GKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTEL  285 (329)
Q Consensus       210 ---~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t-g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  285 (329)
                         ....+|+.|+|||++.+..++.++|||||||++|||+| |..|+.......+.....     ...+...+..+++++
T Consensus       164 ~~~~~~~gt~~y~apE~l~~~~~~~~~DiwSlGvil~e~lt~g~~P~~~~~~~~~~~~i~-----~~~~~~~~~~~~~~~  238 (273)
T d1mp8a_         164 YKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIE-----NGERLPMPPNCPPTL  238 (273)
T ss_dssp             -------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHH-----TTCCCCCCTTCCHHH
T ss_pred             eeccceecCcccchhhHhccCCCCCccccccchHHHHHHHhcCCCCCCCCCHHHHHHHHH-----cCCCCCCCCCCCHHH
Confidence               23356889999999999999999999999999999998 666665433222221111     112234566778899


Q ss_pred             HHHHHHhcccCCCCCCCHHHHHHHHHhhhhc
Q 020221          286 VRLASRCLQYEPRERPNPRSLVTALVTLQKD  316 (329)
Q Consensus       286 ~~li~~cl~~dp~~Rps~~~~l~~L~~~~~~  316 (329)
                      .+|+.+||+.||++|||+.+|++.|+++.++
T Consensus       239 ~~li~~cl~~dp~~Rps~~ei~~~L~~i~~~  269 (273)
T d1mp8a_         239 YSLMTKCWAYDPSRRPRFTELKAQLSTILEE  269 (273)
T ss_dssp             HHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             HHHHHHHcCCCHhHCcCHHHHHHHHHHHHHH
Confidence            9999999999999999999999999998654

>d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Musk tyrosine kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=1.3e-54  Score=380.95  Aligned_cols=253  Identities=23%  Similarity=0.311  Sum_probs=209.3

Q ss_pred             CcccccccCCCCCCcEEEEEEeC------CCCEEEEEEeCCCCChh-HHHHHHHHHHHhcCCCccccccceeeeeCCeeE
Q 020221           57 AMENIVSEHGEKAPNVVYKGKLE------NQFRIAVKRFNRSAWPD-ARQFLEEARAVGQLRNRRLANLLGCCCEGDERL  129 (329)
Q Consensus        57 ~~~~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~~~~-~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~  129 (329)
                      +.+++++.||+|+||+||+|++.      +++.||||+++...... .+++.+|+++++.++||||+++++++.+....+
T Consensus        13 ~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~   92 (301)
T d1lufa_          13 NNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAVGKPMC   92 (301)
T ss_dssp             GGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCE
T ss_pred             HHcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhcChHHHHHHHHHHHHHHhcCCCCcccceeeeccCCceE
Confidence            35678888899999999999853      35789999998765443 456999999999999999999999999999999


Q ss_pred             EEEecCCCCCHHhhhccCC----------------------CCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCce
Q 020221          130 LVAEYMPNDTLAKHLFHWE----------------------TQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRI  187 (329)
Q Consensus       130 lv~e~~~~gsL~~~l~~~~----------------------~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Ni  187 (329)
                      ++|||+++|+|.+++....                      ...+++..+..++.|++.||+|||++ +++||||||+||
T Consensus        93 ~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~-~ivHrDlKp~NI  171 (301)
T d1lufa_          93 LLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSER-KFVHRDLATRNC  171 (301)
T ss_dssp             EEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHT-TCCCSCCSGGGE
T ss_pred             EEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcccC-CeEeeEEcccce
Confidence            9999999999999986421                      23478999999999999999999999 999999999999


Q ss_pred             eeCCCCCeeeecccCcccCCCC------CCccCcccccCcccccCCCCCCcccchhhhHHHHHHHhCCCC-CCchhhHHH
Q 020221          188 VFDDDVNPRLSCFGLMKNSRDG------RSYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHI-PPSHALDLI  260 (329)
Q Consensus       188 l~~~~~~~kl~Dfg~a~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~~-~~~~~~~~~  260 (329)
                      |++.++.+||+|||+++.....      ....+++.|+|||.+.+..++.++|||||||++|||++|..| +........
T Consensus       172 Lld~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~t~ksDVwS~Gvvl~ell~~~~~p~~~~~~~e~  251 (301)
T d1lufa_         172 LVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGMAHEEV  251 (301)
T ss_dssp             EECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHH
T ss_pred             EECCCCcEEEccchhheeccCCccccccCCCCcCcCcCCHHHHccCCCChhhhhccchhhHHHHHccCCCCCCCCCHHHH
Confidence            9999999999999998754322      234577899999999999999999999999999999999754 443322222


Q ss_pred             hhhchhhhccccccCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhh
Q 020221          261 RDRNIQTLTDSCLEGQFSSDEGTELVRLASRCLQYEPRERPNPRSLVTALVTLQK  315 (329)
Q Consensus       261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~~~l~~L~~~~~  315 (329)
                      ....    .. ......+..+++++.+|+..||+.||++||||.+|++.|+++.+
T Consensus       252 ~~~v----~~-~~~~~~p~~~~~~~~~li~~cl~~~P~~RPt~~ev~~~L~~i~~  301 (301)
T d1lufa_         252 IYYV----RD-GNILACPENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRMCE  301 (301)
T ss_dssp             HHHH----HT-TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTC
T ss_pred             HHHH----Hc-CCCCCCCccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcC
Confidence            2211    11 12234566778899999999999999999999999999999864

>d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase C, theta type
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.2e-54  Score=383.32  Aligned_cols=243  Identities=18%  Similarity=0.229  Sum_probs=205.4

Q ss_pred             CcccccccCCCCCCcEEEEEE-eCCCCEEEEEEeCCCC---ChhHHHHHHHHHHHh-cCCCccccccceeeeeCCeeEEE
Q 020221           57 AMENIVSEHGEKAPNVVYKGK-LENQFRIAVKRFNRSA---WPDARQFLEEARAVG-QLRNRRLANLLGCCCEGDERLLV  131 (329)
Q Consensus        57 ~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~-~l~h~niv~~~~~~~~~~~~~lv  131 (329)
                      ++|++++.||+|+||+||+|. ..+++.||||+++...   ....+.+..|..++. .++||||+++++++.+++..++|
T Consensus         2 ddy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~~~yiv   81 (320)
T d1xjda_           2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFV   81 (320)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEE
T ss_pred             CCeEEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEccCCceeEE
Confidence            467888899999999999999 5678999999997532   223455677777665 68999999999999999999999


Q ss_pred             EecCCCCCHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCCCCCeeeecccCcccCCCC--
Q 020221          132 AEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDG--  209 (329)
Q Consensus       132 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~--  209 (329)
                      |||+++|+|.+++.  ....+++.++..++.||+.||+|||++ +++||||||+|||+++++.+||+|||+++.....  
T Consensus        82 mEy~~~g~L~~~i~--~~~~~~e~~~~~~~~qi~~al~ylH~~-~iiHrDikp~NiL~~~~~~~kl~DFG~a~~~~~~~~  158 (320)
T d1xjda_          82 MEYLNGGDLMYHIQ--SCHKFDLSRATFYAAEIILGLQFLHSK-GIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDA  158 (320)
T ss_dssp             EECCTTCBHHHHHH--HHSSCCHHHHHHHHHHHHHHHHHHHHT-TCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCTTC
T ss_pred             EeecCCCcHHHHhh--ccCCCCHHHHHHHHHHHHHHHHHHHhC-CeeeccCcccceeecCCCceeccccchhhhcccccc
Confidence            99999999999997  445789999999999999999999999 9999999999999999999999999999864432  


Q ss_pred             --CCccCcccccCcccccCCCCCCcccchhhhHHHHHHHhCCCCCCchhhHHHhhhchhhhccccccCCCChHHHHHHHH
Q 020221          210 --RSYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVR  287 (329)
Q Consensus       210 --~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  287 (329)
                        ....||+.|+|||++.+..++.++|||||||++|||++|+.||.......+.......      ...++...++++.+
T Consensus       159 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~------~~~~p~~~s~~~~d  232 (320)
T d1xjda_         159 KTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMD------NPFYPRWLEKEAKD  232 (320)
T ss_dssp             CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHC------CCCCCTTSCHHHHH
T ss_pred             cccccCCCCCcCCHHHHcCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHcC------CCCCCccCCHHHHH
Confidence              2356899999999999999999999999999999999999998765544333322211      22345667889999


Q ss_pred             HHHHhcccCCCCCCCHH-HHHH
Q 020221          288 LASRCLQYEPRERPNPR-SLVT  308 (329)
Q Consensus       288 li~~cl~~dp~~Rps~~-~~l~  308 (329)
                      |+.+||..||++|||+. ++++
T Consensus       233 li~~~L~~dP~~R~s~~~~l~~  254 (320)
T d1xjda_         233 LLVKLFVREPEKRLGVRGDIRQ  254 (320)
T ss_dssp             HHHHHSCSSGGGSBTTBSCGGG
T ss_pred             HHHHhcccCCCCCcCHHHHHHh
Confidence            99999999999999996 6764

>d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: G-protein coupled receptor kinase 2
species: Cow (Bos taurus) [TaxId: 9913]

Probab=100.00  E-value=3.4e-54  Score=386.85  Aligned_cols=246  Identities=17%  Similarity=0.137  Sum_probs=200.2

Q ss_pred             CcccccccCCCCCCcEEEEEE-eCCCCEEEEEEeCCCCC---hhHHHHH---HHHHHHhcCCCccccccceeeeeCCeeE
Q 020221           57 AMENIVSEHGEKAPNVVYKGK-LENQFRIAVKRFNRSAW---PDARQFL---EEARAVGQLRNRRLANLLGCCCEGDERL  129 (329)
Q Consensus        57 ~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~---~~~~~~~---~e~~~l~~l~h~niv~~~~~~~~~~~~~  129 (329)
                      ++|++++.||+|+||.||+|. ..+|+.||||++.....   .....+.   +++++++.++|||||++++++.+.+..+
T Consensus         4 ddy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~~~~~   83 (364)
T d1omwa3           4 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLS   83 (364)
T ss_dssp             TTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEEE
T ss_pred             HhCeeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEEECCEEE
Confidence            467888889999999999999 45789999999864321   1122233   4467788889999999999999999999


Q ss_pred             EEEecCCCCCHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCCCCCeeeecccCcccCCCC
Q 020221          130 LVAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDG  209 (329)
Q Consensus       130 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~  209 (329)
                      +||||+++|+|.+++.  ....+++..+..++.||+.||.|||++ ||+||||||+|||++.++.+||+|||+|+.....
T Consensus        84 ivmE~~~gg~L~~~l~--~~~~~~e~~~~~~~~qi~~aL~ylH~~-~iiHrDlKP~NILl~~~g~iKl~DFGla~~~~~~  160 (364)
T d1omwa3          84 FILDLMNGGDLHYHLS--QHGVFSEADMRFYAAEIILGLEHMHNR-FVVYRDLKPANILLDEHGHVRISDLGLACDFSKK  160 (364)
T ss_dssp             EEECCCCSCBHHHHHH--HHCSCCHHHHHHHHHHHHHHHHHHHHT-TEECCCCSGGGEEECSSSCEEECCCTTCEECSSS
T ss_pred             EEEEecCCCcHHHHHH--hcccccHHHHHHHHHHHHHHHHHHHHC-CccceeeccceeEEcCCCcEEEeeeceeeecCCC
Confidence            9999999999999997  346789999999999999999999999 9999999999999999999999999999866543


Q ss_pred             --CCccCcccccCcccccC-CCCCCcccchhhhHHHHHHHhCCCCCCchhhHHHhhhchhhhccccccCCCChHHHHHHH
Q 020221          210 --RSYSTNLAFTPPEYLRT-GRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELV  286 (329)
Q Consensus       210 --~~~~~~~~y~aPE~~~~-~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  286 (329)
                        ....||+.|+|||++.+ ..++.++|||||||++|||+||+.||.......... ......  ......+..+++++.
T Consensus       161 ~~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~-~~~~~~--~~~~~~~~~~s~~~~  237 (364)
T d1omwa3         161 KPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHE-IDRMTL--TMAVELPDSFSPELR  237 (364)
T ss_dssp             CCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSSCHHH-HHHHSS--SCCCCCCSSSCHHHH
T ss_pred             cccccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCCCHHHHHH-HHHhcc--cCCCCCCCCCCHHHH
Confidence              34578999999999875 458999999999999999999999986532211110 001111  112234556788999


Q ss_pred             HHHHHhcccCCCCCCC-----HHHHHH
Q 020221          287 RLASRCLQYEPRERPN-----PRSLVT  308 (329)
Q Consensus       287 ~li~~cl~~dp~~Rps-----~~~~l~  308 (329)
                      +||.+||+.||++|||     ++++++
T Consensus       238 ~li~~~L~~dP~~R~t~~~~~a~eil~  264 (364)
T d1omwa3         238 SLLEGLLQRDVNRRLGCLGRGAQEVKE  264 (364)
T ss_dssp             HHHHHHTCSSTTTSTTTSSSTHHHHHT
T ss_pred             HHHHHHcccCHHHhCCCcccCHHHHHc
Confidence            9999999999999999     688886

>d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: EGF receptor tyrosine kinase, Erbb-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2e-54  Score=382.32  Aligned_cols=252  Identities=18%  Similarity=0.273  Sum_probs=204.8

Q ss_pred             CcccccccCCCCCCcEEEEEEe-CCCC----EEEEEEeCCCC-ChhHHHHHHHHHHHhcCCCccccccceeeeeCCeeEE
Q 020221           57 AMENIVSEHGEKAPNVVYKGKL-ENQF----RIAVKRFNRSA-WPDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLL  130 (329)
Q Consensus        57 ~~~~~~~~lg~G~~g~V~~~~~-~~~~----~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l  130 (329)
                      ++|++++.||+|+||+||+|.+ .+|+    .||+|.++... ....+.+.+|+++++.++|||||+++|++.+ ...++
T Consensus         9 ~dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~-~~~~~   87 (317)
T d1xkka_           9 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLT-STVQL   87 (317)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC----CTHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEE
T ss_pred             HHCEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec-CCeeE
Confidence            4588889999999999999984 4443    58999987543 2346679999999999999999999999976 46778


Q ss_pred             EEecCCCCCHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCCCCCeeeecccCcccCCCCC
Q 020221          131 VAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDGR  210 (329)
Q Consensus       131 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~  210 (329)
                      ++||+.+|+|.+.+.. ....+++..++.++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+++......
T Consensus        88 v~e~~~~~~l~~~~~~-~~~~~~~~~~~~i~~qi~~gl~yLH~~-~iiHrDlKp~NIll~~~~~~kl~DFGla~~~~~~~  165 (317)
T d1xkka_          88 ITQLMPFGCLLDYVRE-HKDNIGSQYLLNWCVQIAKGMNYLEDR-RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEE  165 (317)
T ss_dssp             EEECCTTCBHHHHHHH-TSSSCCHHHHHHHHHHHHHHHHHHHHT-TCCCSCCCGGGEEEEETTEEEECCCSHHHHTTTTC
T ss_pred             EEEeccCCcccccccc-cccCCCHHHHHHHHHHHHHHHHHHHHc-CcccCcchhhcceeCCCCCeEeeccccceeccccc
Confidence            8999999999998865 556799999999999999999999999 99999999999999999999999999998654332


Q ss_pred             ------CccCcccccCcccccCCCCCCcccchhhhHHHHHHHh-CCCCCCchhhHHHhhhchhhhccccccCCCChHHHH
Q 020221          211 ------SYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLS-GKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGT  283 (329)
Q Consensus       211 ------~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t-g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  283 (329)
                            ...||+.|+|||++.++.++.++||||||+++|||+| |..||.......+.     ..+....+...+..+++
T Consensus       166 ~~~~~~~~~gt~~y~APE~l~~~~~~~~sDvwS~Gvil~el~t~g~~p~~~~~~~~~~-----~~i~~~~~~~~p~~~~~  240 (317)
T d1xkka_         166 KEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEIS-----SILEKGERLPQPPICTI  240 (317)
T ss_dssp             C--------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCGGGHH-----HHHHHTCCCCCCTTBCH
T ss_pred             ccccccccccCccccChHHHhcCCCChhhhhhhHHHHHHHHHHCCCCCCCCCCHHHHH-----HHHHcCCCCCCCcccCH
Confidence                  2357899999999999999999999999999999999 55555433222221     12222233345667788


Q ss_pred             HHHHHHHHhcccCCCCCCCHHHHHHHHHhhhhc
Q 020221          284 ELVRLASRCLQYEPRERPNPRSLVTALVTLQKD  316 (329)
Q Consensus       284 ~~~~li~~cl~~dp~~Rps~~~~l~~L~~~~~~  316 (329)
                      ++.+|+.+||+.||++|||+.+++++|..+.+.
T Consensus       241 ~~~~li~~cl~~dP~~RPs~~eil~~l~~~~~~  273 (317)
T d1xkka_         241 DVYMIMVKCWMIDADSRPKFRELIIEFSKMARD  273 (317)
T ss_dssp             HHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHS
T ss_pred             HHHHHHHHhCCCChhhCcCHHHHHHHHHHHHhC
Confidence            999999999999999999999999999988654

>d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase activated protein kinase 2, mapkap2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.3e-54  Score=383.95  Aligned_cols=246  Identities=17%  Similarity=0.149  Sum_probs=198.0

Q ss_pred             Cccccccc-CCCCCCcEEEEEE-eCCCCEEEEEEeCCCCChhHHHHHHHHHHHhc-CCCccccccceeeee----CCeeE
Q 020221           57 AMENIVSE-HGEKAPNVVYKGK-LENQFRIAVKRFNRSAWPDARQFLEEARAVGQ-LRNRRLANLLGCCCE----GDERL  129 (329)
Q Consensus        57 ~~~~~~~~-lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~-l~h~niv~~~~~~~~----~~~~~  129 (329)
                      +.|+++++ ||+|+||+||+|. ..+++.||||+++.     ...+.+|+.++.+ .+||||+++++++.+    ...++
T Consensus        11 ~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~-----~~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~~~~~~~   85 (335)
T d2ozaa1          11 DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD-----CPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLL   85 (335)
T ss_dssp             GTEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEC-----SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEE
T ss_pred             cCEEEeeEEeeeccCeEEEEEEECCCCCEEEEEEECC-----cHHHHHHHHHHHHhcCCCCCCeEEEEEeecccCCCEEE
Confidence            45777754 8999999999999 46789999999864     2456789998655 589999999999865    36789


Q ss_pred             EEEecCCCCCHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCC---CCCeeeecccCcccC
Q 020221          130 LVAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDD---DVNPRLSCFGLMKNS  206 (329)
Q Consensus       130 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~---~~~~kl~Dfg~a~~~  206 (329)
                      +|||||++|+|.+++.+.....+++.+++.++.||+.||+|||++ ||+||||||+|||++.   ++.+||+|||+|+..
T Consensus        86 ivmEy~~gg~L~~~i~~~~~~~l~e~~~~~i~~qi~~al~ylH~~-~iiHRDiKp~NIll~~~~~~~~~Kl~DFG~a~~~  164 (335)
T d2ozaa1          86 IVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSI-NIAHRDVKPENLLYTSKRPNAILKLTDFGFAKET  164 (335)
T ss_dssp             EEEECCCSEEHHHHHHSCSCCCEEHHHHHHHHHHHHHHHHHHHHT-TEECCCCSGGGEEESCSSTTCCEEECCCTTCEEC
T ss_pred             EEEECCCCCcHHHHHHhcCCCCcCHHHHHHHHHHHHHHHHHHHHc-CCccccccccccccccccccccccccccceeeec
Confidence            999999999999999764556799999999999999999999999 9999999999999985   567999999999865


Q ss_pred             CCC---CCccCcccccCcccccCCCCCCcccchhhhHHHHHHHhCCCCCCchhhHHHhhhchhhhcccccc--CCCChHH
Q 020221          207 RDG---RSYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLE--GQFSSDE  281 (329)
Q Consensus       207 ~~~---~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~  281 (329)
                      ...   ....||+.|+|||++.+..++.++|||||||++|+|+||..||...............+......  ......+
T Consensus       165 ~~~~~~~~~~gt~~y~aPE~~~~~~y~~~~DiwSlGvily~lltg~~Pf~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~  244 (335)
T d2ozaa1         165 TSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEV  244 (335)
T ss_dssp             CCCCCCCCCSCCCSSCCCCCCCGGGGSHHHHHHHHHHHHHHHTTSSCSCEETTCC--------CCCSCSSSCCTTHHHHS
T ss_pred             cCCCccccccCCcccCCcHHHcCCCCCHHHHHHhhchhHHHHhhCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCcccccC
Confidence            443   34578999999999999899999999999999999999999886543211111111111111111  1111356


Q ss_pred             HHHHHHHHHHhcccCCCCCCCHHHHHH
Q 020221          282 GTELVRLASRCLQYEPRERPNPRSLVT  308 (329)
Q Consensus       282 ~~~~~~li~~cl~~dp~~Rps~~~~l~  308 (329)
                      ++++.+|+.+||+.||++|||+.++++
T Consensus       245 s~~~~~li~~~L~~dP~~R~s~~eil~  271 (335)
T d2ozaa1         245 SEEVKMLIRNLLKTEPTQRMTITEFMN  271 (335)
T ss_dssp             CHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred             CHHHHHHHHHHccCChhHCcCHHHHHc
Confidence            789999999999999999999999998

>d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Mycobacterial protein kinase PknB, catalytic domain
species: Mycobacterium tuberculosis [TaxId: 1773]

Probab=100.00  E-value=3.7e-54  Score=373.85  Aligned_cols=254  Identities=17%  Similarity=0.193  Sum_probs=205.3

Q ss_pred             CcccccccCCCCCCcEEEEEE-eCCCCEEEEEEeCCCCCh---hHHHHHHHHHHHhcCCCccccccceeeeeCC----ee
Q 020221           57 AMENIVSEHGEKAPNVVYKGK-LENQFRIAVKRFNRSAWP---DARQFLEEARAVGQLRNRRLANLLGCCCEGD----ER  128 (329)
Q Consensus        57 ~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~---~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~----~~  128 (329)
                      +.|++++.||+|+||+||+|. ..+++.||||+++.....   ..+.+.+|+++++.++||||+++++++...+    ..
T Consensus         7 drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~~~~~   86 (277)
T d1o6ya_           7 DRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPLP   86 (277)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSSSEEE
T ss_pred             ceeEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCcccceeeeccCCCceE
Confidence            357888899999999999999 567899999999765432   2456899999999999999999999987654    37


Q ss_pred             EEEEecCCCCCHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCCCCCeeeecccCcccCCC
Q 020221          129 LLVAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRD  208 (329)
Q Consensus       129 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~  208 (329)
                      ++||||+++++|.+++.  ....+++.++..++.||+.||+|||++ ||+||||||+|||++.++..+++|||.+.....
T Consensus        87 ~lvmE~~~g~~L~~~~~--~~~~l~~~~~~~i~~qi~~al~~lH~~-~iiHrDiKP~NIll~~~~~~~l~d~~~~~~~~~  163 (277)
T d1o6ya_          87 YIVMEYVDGVTLRDIVH--TEGPMTPKRAIEVIADACQALNFSHQN-GIIHRDVKPANIMISATNAVKVMDFGIARAIAD  163 (277)
T ss_dssp             EEEEECCCEEEHHHHHH--HHCSCCHHHHHHHHHHHHHHHHHHHHT-TEECCCCSGGGEEEETTSCEEECCCTTCEECC-
T ss_pred             EEEEECCCCCEehhhhc--ccCCCCHHHHHHHHHHHHHHHHHHHhC-CccCccccCcccccCccccceeehhhhhhhhcc
Confidence            89999999999999886  445799999999999999999999999 999999999999999999999999998765432


Q ss_pred             C-------CCccCcccccCcccccCCCCCCcccchhhhHHHHHHHhCCCCCCchhhHHHhhhchhhhccccccCCCChHH
Q 020221          209 G-------RSYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDE  281 (329)
Q Consensus       209 ~-------~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  281 (329)
                      .       ....||+.|+|||++.+..++.++|||||||++|||+||..||.................  ..........
T Consensus       164 ~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~~~~~~~--~~~~~~~~~~  241 (277)
T d1o6ya_         164 SGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDP--IPPSARHEGL  241 (277)
T ss_dssp             ---------------TTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCCC--CCGGGTSSSC
T ss_pred             ccccccccccccCcccccCHHHHcCCCCCcceecccchHHHHHHHhCCCCCCCcCHHHHHHHHHhcCC--CCCchhccCC
Confidence            2       234689999999999998999999999999999999999999876543332222211111  1111223456


Q ss_pred             HHHHHHHHHHhcccCCCCCC-CHHHHHHHHHhhhh
Q 020221          282 GTELVRLASRCLQYEPRERP-NPRSLVTALVTLQK  315 (329)
Q Consensus       282 ~~~~~~li~~cl~~dp~~Rp-s~~~~l~~L~~~~~  315 (329)
                      |+++.+++.+||+.||++|| |++++++.|.++..
T Consensus       242 s~~l~~li~~~L~~dp~~R~~sa~~l~~~l~r~~n  276 (277)
T d1o6ya_         242 SADLDAVVLKALAKNPENRYQTAAEMRADLVRVHN  276 (277)
T ss_dssp             CHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHHC
T ss_pred             CHHHHHHHHHHccCCHhHCHhHHHHHHHHHHHHhC
Confidence            78999999999999999999 89999999988754

>d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tie2 kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.9e-54  Score=380.00  Aligned_cols=259  Identities=21%  Similarity=0.294  Sum_probs=210.0

Q ss_pred             CCCcccccccCCCCCCcEEEEEEe-CCCC--EEEEEEeCCCC-ChhHHHHHHHHHHHhcC-CCccccccceeeeeCCeeE
Q 020221           55 GFAMENIVSEHGEKAPNVVYKGKL-ENQF--RIAVKRFNRSA-WPDARQFLEEARAVGQL-RNRRLANLLGCCCEGDERL  129 (329)
Q Consensus        55 ~~~~~~~~~~lg~G~~g~V~~~~~-~~~~--~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~  129 (329)
                      +|+++++.+.||+|+||+||+|.+ .++.  .||||.++... ....+.+.+|+++|+.+ +||||+++++++.+.+..+
T Consensus         8 ~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~   87 (309)
T d1fvra_           8 DWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLY   87 (309)
T ss_dssp             CGGGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEE
T ss_pred             CHHHcEEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECcccChHHHHHHHHHHHHHHhccCCCCEeeEEEEEecCCeeE
Confidence            345677778889999999999985 3443  47888876443 23455789999999999 7999999999999999999


Q ss_pred             EEEecCCCCCHHhhhccC--------------CCCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCCCCCe
Q 020221          130 LVAEYMPNDTLAKHLFHW--------------ETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNP  195 (329)
Q Consensus       130 lv~e~~~~gsL~~~l~~~--------------~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~  195 (329)
                      +||||+++|+|.+++...              ....+++..+..++.||+.||.|||++ +++||||||+|||++.++.+
T Consensus        88 iV~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~-~iiHrDlkp~NIL~~~~~~~  166 (309)
T d1fvra_          88 LAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK-QFIHRDLAARNILVGENYVA  166 (309)
T ss_dssp             EEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHT-TEECSCCSGGGEEECGGGCE
T ss_pred             EEEEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhcC-CccccccccceEEEcCCCce
Confidence            999999999999998642              235789999999999999999999999 99999999999999999999


Q ss_pred             eeecccCcccCCCC---CCccCcccccCcccccCCCCCCcccchhhhHHHHHHHhCCCCCC-chhhHHHhhhchhhhccc
Q 020221          196 RLSCFGLMKNSRDG---RSYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPP-SHALDLIRDRNIQTLTDS  271 (329)
Q Consensus       196 kl~Dfg~a~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~~~~-~~~~~~~~~~~~~~~~~~  271 (329)
                      ||+|||+++.....   ....+|..|+|||.+.+..++.++||||||+++|||++|..||. ......+.....     .
T Consensus       167 kl~DfG~a~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSfGvil~ell~~~~~p~~~~~~~~~~~~i~-----~  241 (309)
T d1fvra_         167 KIADFGLSRGQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLP-----Q  241 (309)
T ss_dssp             EECCTTCEESSCEECCC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHGG-----G
T ss_pred             EEccccccccccccccccceecCCcccchHHhccCCCCccceeehhHHHHHHHHhcCCCCCCCCCHHHHHHHHH-----h
Confidence            99999999765433   23457899999999999999999999999999999999876543 332222222111     1


Q ss_pred             cccCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhhcccc
Q 020221          272 CLEGQFSSDEGTELVRLASRCLQYEPRERPNPRSLVTALVTLQKDTEL  319 (329)
Q Consensus       272 ~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~~~l~~L~~~~~~~~~  319 (329)
                      ..+...+..+++++.+|+.+||+.||++|||+.+|++.|+++.+....
T Consensus       242 ~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L~~i~~~~~~  289 (309)
T d1fvra_         242 GYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEERKT  289 (309)
T ss_dssp             TCCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSSSC
T ss_pred             cCCCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhcCcC
Confidence            223445667789999999999999999999999999999999865443

>d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Activated CDC42 kinase 1, ACK1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.6e-54  Score=374.57  Aligned_cols=251  Identities=22%  Similarity=0.298  Sum_probs=199.8

Q ss_pred             CcccccccCCCCCCcEEEEEEeC--CC--CEEEEEEeCCCC---ChhHHHHHHHHHHHhcCCCccccccceeeeeCCeeE
Q 020221           57 AMENIVSEHGEKAPNVVYKGKLE--NQ--FRIAVKRFNRSA---WPDARQFLEEARAVGQLRNRRLANLLGCCCEGDERL  129 (329)
Q Consensus        57 ~~~~~~~~lg~G~~g~V~~~~~~--~~--~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~  129 (329)
                      .++++++.||+|+||.||+|...  ++  ..||||++....   ....+.+.+|+.+++.++||||++++|++.+ ...+
T Consensus         8 ~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~-~~~~   86 (273)
T d1u46a_           8 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLT-PPMK   86 (273)
T ss_dssp             GGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCE
T ss_pred             HHeEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEee-cchh
Confidence            45788999999999999999842  22  368999987643   2335679999999999999999999999965 5778


Q ss_pred             EEEecCCCCCHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCCCCCeeeecccCcccCCCC
Q 020221          130 LVAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDG  209 (329)
Q Consensus       130 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~  209 (329)
                      +||||+++|+|.+++.. ....+++..+..++.|++.||.|||++ +|+||||||+||+++.++.+||+|||+++.....
T Consensus        87 lv~e~~~~~~l~~~~~~-~~~~l~~~~~~~~~~qi~~gl~ylH~~-~iiHrDikp~NIll~~~~~vkl~DfGl~~~~~~~  164 (273)
T d1u46a_          87 MVTELAPLGSLLDRLRK-HQGHFLLGTLSRYAVQVAEGMGYLESK-RFIHRDLAARNLLLATRDLVKIGDFGLMRALPQN  164 (273)
T ss_dssp             EEEECCTTCBHHHHHHH-HGGGSCHHHHHHHHHHHHHHHHHHHHT-TEECSCCCGGGEEEEETTEEEECCCTTCEECCC-
T ss_pred             eeeeeecCcchhhhhhc-ccCCCCHHHHHHHHHHHHHHHHHhhhC-CEeeeeecHHHhccccccceeeccchhhhhcccC
Confidence            99999999999998764 345699999999999999999999999 9999999999999999999999999999876443


Q ss_pred             C-------CccCcccccCcccccCCCCCCcccchhhhHHHHHHHh-CCCCCCchhhHHHhhhchhhhccccccCCCChHH
Q 020221          210 R-------SYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLS-GKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDE  281 (329)
Q Consensus       210 ~-------~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t-g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  281 (329)
                      .       ...++..|+|||.+.+..++.++||||||+++|||+| |..||...........    +.....+...+..+
T Consensus       165 ~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~S~Gvil~emlt~G~~Pf~~~~~~~~~~~----i~~~~~~~~~~~~~  240 (273)
T d1u46a_         165 DDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHK----IDKEGERLPRPEDC  240 (273)
T ss_dssp             CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHH----HHTSCCCCCCCTTC
T ss_pred             CCcceecCccccCcccCCHHHHhCCCCCcchhhhhhHHHHHHHHhCCCCCCCCcCHHHHHHH----HHhCCCCCCCcccc
Confidence            2       2346789999999999899999999999999999998 7877765443333222    22222333455667


Q ss_pred             HHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhh
Q 020221          282 GTELVRLASRCLQYEPRERPNPRSLVTALVTLQ  314 (329)
Q Consensus       282 ~~~~~~li~~cl~~dp~~Rps~~~~l~~L~~~~  314 (329)
                      ++++.+|+.+||+.||++|||+.+|++.|++.+
T Consensus       241 ~~~l~~li~~cl~~dp~~RPt~~ei~~~L~~~~  273 (273)
T d1u46a_         241 PQDIYNVMVQCWAHKPEDRPTFVALRDFLLEAQ  273 (273)
T ss_dssp             CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC
T ss_pred             cHHHHHHHHHHcCCChhHCcCHHHHHHHHHhcC
Confidence            889999999999999999999999999988753

>d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 7, CDK7
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.5e-54  Score=378.14  Aligned_cols=245  Identities=20%  Similarity=0.202  Sum_probs=193.7

Q ss_pred             ccccCCCCCCcEEEEEE-eCCCCEEEEEEeCCCCChh-----HHHHHHHHHHHhcCCCccccccceeeeeCCeeEEEEec
Q 020221           61 IVSEHGEKAPNVVYKGK-LENQFRIAVKRFNRSAWPD-----ARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAEY  134 (329)
Q Consensus        61 ~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~-----~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  134 (329)
                      .++.||+|+||+||+|. ..+|+.||||+++......     .+.+.+|+++++.++|||||++++++.+.+..++||||
T Consensus         2 ~l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~~~~ivmE~   81 (299)
T d1ua2a_           2 KLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDF   81 (299)
T ss_dssp             EEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEEEC
T ss_pred             cceEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeeccCCceeehhhh
Confidence            45677999999999999 5678999999997653222     23578999999999999999999999999999999999


Q ss_pred             CCCCCHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCCCCCeeeecccCcccCCCC----C
Q 020221          135 MPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDG----R  210 (329)
Q Consensus       135 ~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~----~  210 (329)
                      +.++++..+..  ....+++..+..++.||+.||+|||++ ||+||||||+|||++.++.+||+|||+++.....    .
T Consensus        82 ~~~~~~~~~~~--~~~~l~~~~~~~~~~qil~aL~~lH~~-~iiHrDiKp~NIli~~~~~~KL~DFG~a~~~~~~~~~~~  158 (299)
T d1ua2a_          82 METDLEVIIKD--NSLVLTPSHIKAYMLMTLQGLEYLHQH-WILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYT  158 (299)
T ss_dssp             CSEEHHHHHTT--CCSSCCSSHHHHHHHHHHHHHHHHHHT-TCCCCCCCGGGEEECTTCCEEECCCGGGSTTTSCCCCCC
T ss_pred             hcchHHhhhhh--cccCCCHHHHHHHHHHHHHHHHHhhcc-ceecccCCcceEEecCCCccccccCccccccCCCccccc
Confidence            99887766653  456789999999999999999999999 9999999999999999999999999999765543    2


Q ss_pred             CccCcccccCcccccCC-CCCCcccchhhhHHHHHHHhCCCCCCchhhHHHhhhchhhh-------cccc-------c--
Q 020221          211 SYSTNLAFTPPEYLRTG-RVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTL-------TDSC-------L--  273 (329)
Q Consensus       211 ~~~~~~~y~aPE~~~~~-~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~~~~~~~~~-------~~~~-------~--  273 (329)
                      ...+|+.|+|||++.+. .++.++|||||||++|||++|..||................       ....       .  
T Consensus       159 ~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~l~~i~~~~~~~~~~~~~~~~~~~~~~~~~  238 (299)
T d1ua2a_         159 HQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYVTFK  238 (299)
T ss_dssp             CSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSSSTTSSTTCCCCC
T ss_pred             ceecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCCCCCHHHHHHHHHHhcCCCChhhccchhccchhhhhc
Confidence            34689999999998755 57999999999999999999998886543222211111100       0000       0  


Q ss_pred             -cCCC-----ChHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 020221          274 -EGQF-----SSDEGTELVRLASRCLQYEPRERPNPRSLVT  308 (329)
Q Consensus       274 -~~~~-----~~~~~~~~~~li~~cl~~dp~~Rps~~~~l~  308 (329)
                       ....     ....++++.+|+.+||+.||++|||++|+++
T Consensus       239 ~~~~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~sa~e~L~  279 (299)
T d1ua2a_         239 SFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALK  279 (299)
T ss_dssp             CCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHT
T ss_pred             cCCCCChHHhcccCCHHHHHHHHHHccCChhhCcCHHHHhC
Confidence             0000     1234678999999999999999999999997

>d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Hepatocyte growth factor receptor, c-MET
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.8e-53  Score=373.37  Aligned_cols=248  Identities=23%  Similarity=0.317  Sum_probs=203.4

Q ss_pred             ccCCCCCCcEEEEEEeCCC----CEEEEEEeCCC-CChhHHHHHHHHHHHhcCCCccccccceeeee-CCeeEEEEecCC
Q 020221           63 SEHGEKAPNVVYKGKLENQ----FRIAVKRFNRS-AWPDARQFLEEARAVGQLRNRRLANLLGCCCE-GDERLLVAEYMP  136 (329)
Q Consensus        63 ~~lg~G~~g~V~~~~~~~~----~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~-~~~~~lv~e~~~  136 (329)
                      +.||+|+||+||+|.+.++    ..||||+++.. .....+.+.+|++++++++||||++++|++.. +...++||||++
T Consensus        33 ~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~E~~~  112 (311)
T d1r0pa_          33 EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMK  112 (311)
T ss_dssp             EEEEEETTEEEEEEEECC----CEEEEEEEECCCCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTTEEEEEEECCT
T ss_pred             eEEeecCCeEEEEEEEECCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEecCCceEEEEEEee
Confidence            3579999999999985332    35899999754 33345679999999999999999999999876 468999999999


Q ss_pred             CCCHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCCCCCeeeecccCcccCCCCC------
Q 020221          137 NDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDGR------  210 (329)
Q Consensus       137 ~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~------  210 (329)
                      +|+|.+++.. ....+++..+..++.|++.||.|||+. +|+||||||+|||+++++.+||+|||+++......      
T Consensus       113 ~g~l~~~~~~-~~~~~~~~~~~~i~~qia~gL~~lH~~-~iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~~~~~~~~~~  190 (311)
T d1r0pa_         113 HGDLRNFIRN-ETHNPTVKDLIGFGLQVAKGMKFLASK-KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHN  190 (311)
T ss_dssp             TCBHHHHHHC-TTCCCBHHHHHHHHHHHHHHHHHHHHT-TCCCSCCSGGGEEECTTCCEEECSSGGGCCTTTTTCCCTTC
T ss_pred             cCchhhhhcc-ccccchHHHHHHHHHHHHHhhhhhccc-CcccCCccHHhEeECCCCCEEEecccchhhcccccccccee
Confidence            9999998864 455678899999999999999999999 99999999999999999999999999998654332      


Q ss_pred             --CccCcccccCcccccCCCCCCcccchhhhHHHHHHHhCCCCCCchhhHHHhhhchhhhccccccCCCChHHHHHHHHH
Q 020221          211 --SYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRL  288 (329)
Q Consensus       211 --~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  288 (329)
                        ...||+.|+|||.+.+..++.++||||||+++|||+||+.||........    ....+....+...+..+++++.+|
T Consensus       191 ~~~~~gt~~y~aPE~~~~~~~~~ksDI~SfGivl~El~t~~~p~~~~~~~~~----~~~~i~~g~~~~~p~~~~~~l~~l  266 (311)
T d1r0pa_         191 KTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFD----ITVYLLQGRRLLQPEYCPDPLYEV  266 (311)
T ss_dssp             TTCSSCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCC----------CHHHHHTTCCCCCCTTCCHHHHHH
T ss_pred             cccccccccccChHHHhcCCCCChhHhhhhHHHHHHHHHCCCCCCCCCCHHH----HHHHHHcCCCCCCcccCcHHHHHH
Confidence              23578899999999999999999999999999999998887765432111    111111112333456677899999


Q ss_pred             HHHhcccCCCCCCCHHHHHHHHHhhhhc
Q 020221          289 ASRCLQYEPRERPNPRSLVTALVTLQKD  316 (329)
Q Consensus       289 i~~cl~~dp~~Rps~~~~l~~L~~~~~~  316 (329)
                      +.+||+.||++|||+.+|+++|+++.+.
T Consensus       267 i~~cl~~dP~~RPs~~ei~~~L~~i~~~  294 (311)
T d1r0pa_         267 MLKCWHPKAEMRPSFSELVSRISAIFST  294 (311)
T ss_dssp             HHHHTCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred             HHHHcCCCHhHCcCHHHHHHHHHHHHHh
Confidence            9999999999999999999999999865

>d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Vascular endothelial growth factor receptor 2 (kdr)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6e-54  Score=376.61  Aligned_cols=255  Identities=20%  Similarity=0.252  Sum_probs=197.7

Q ss_pred             CcccccccCCCCCCcEEEEEEeC------CCCEEEEEEeCCCCCh-hHHHHHHHHHHHhcC-CCccccccceeeeeC-Ce
Q 020221           57 AMENIVSEHGEKAPNVVYKGKLE------NQFRIAVKRFNRSAWP-DARQFLEEARAVGQL-RNRRLANLLGCCCEG-DE  127 (329)
Q Consensus        57 ~~~~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~-~~  127 (329)
                      +.|++.+.||+|+||.||+|...      +++.||||+++..... ..+.+.+|...+..+ +|+||+.+++++... ..
T Consensus        13 ~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~   92 (299)
T d1ywna1          13 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGP   92 (299)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC----CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTSC
T ss_pred             HHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEccccCcHHHHHHHHHHHHHHhhcCCCeEEEeeeeeccCCCe
Confidence            56788889999999999999842      2468999999765433 345678888888777 689999999987664 46


Q ss_pred             eEEEEecCCCCCHHhhhccCC--------------CCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCCCC
Q 020221          128 RLLVAEYMPNDTLAKHLFHWE--------------TQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDV  193 (329)
Q Consensus       128 ~~lv~e~~~~gsL~~~l~~~~--------------~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~  193 (329)
                      .++|||||++|+|.+++....              ...+++.++..++.||+.||+|||++ +|+||||||+|||++.++
T Consensus        93 ~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~-~ivHrDlKp~NILl~~~~  171 (299)
T d1ywna1          93 LMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR-KCIHRDLAARNILLSEKN  171 (299)
T ss_dssp             CEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHT-TCCCSCCCGGGEEECGGG
T ss_pred             EEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHhC-CCcCCcCCccceeECCCC
Confidence            899999999999999996432              23588999999999999999999999 999999999999999999


Q ss_pred             CeeeecccCcccCCCC------CCccCcccccCcccccCCCCCCcccchhhhHHHHHHHhCCCC-CCchhhHHHhhhchh
Q 020221          194 NPRLSCFGLMKNSRDG------RSYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHI-PPSHALDLIRDRNIQ  266 (329)
Q Consensus       194 ~~kl~Dfg~a~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~~-~~~~~~~~~~~~~~~  266 (329)
                      .+||+|||+|+.....      ....||+.|+|||++.+..++.++|||||||++|||+||..+ |.........    .
T Consensus       172 ~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gvil~ellt~~~~p~~~~~~~~~~----~  247 (299)
T d1ywna1         172 VVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEF----C  247 (299)
T ss_dssp             CEEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCCSHHH----H
T ss_pred             cEEEccCcchhhccccccccccCceeeCccccchhHhhcCCCCcccceeehHHHHHHHHhCCCCCCCCCCHHHHH----H
Confidence            9999999999764432      234688999999999999999999999999999999998654 4332211111    1


Q ss_pred             hhccccccCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhhc
Q 020221          267 TLTDSCLEGQFSSDEGTELVRLASRCLQYEPRERPNPRSLVTALVTLQKD  316 (329)
Q Consensus       267 ~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~~~l~~L~~~~~~  316 (329)
                      ..+....+...+..+++++.+++.+||+.||++|||+.+++++|+++.+.
T Consensus       248 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~eil~~L~~ilq~  297 (299)
T d1ywna1         248 RRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQA  297 (299)
T ss_dssp             HHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             HHHhcCCCCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhC
Confidence            11112223345666788999999999999999999999999999998653

>d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fibroblast growth factor receptor 1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.6e-53  Score=370.56  Aligned_cols=253  Identities=22%  Similarity=0.305  Sum_probs=206.2

Q ss_pred             CcccccccCCCCCCcEEEEEEeC-C-------CCEEEEEEeCCCCCh-hHHHHHHHHHHHhcC-CCccccccceeeeeCC
Q 020221           57 AMENIVSEHGEKAPNVVYKGKLE-N-------QFRIAVKRFNRSAWP-DARQFLEEARAVGQL-RNRRLANLLGCCCEGD  126 (329)
Q Consensus        57 ~~~~~~~~lg~G~~g~V~~~~~~-~-------~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~  126 (329)
                      +.+++.+.||+|+||.||+|+.. .       +..||||+++..... ...++.+|...+..+ +|||||++++++.+.+
T Consensus        13 ~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~e~~~l~~~~~HpnIv~~~~~~~~~~   92 (299)
T d1fgka_          13 DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDG   92 (299)
T ss_dssp             GGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred             HHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECcccChHHHHHHHHHHHHHHHhcCCCeEEecccccccCC
Confidence            56788899999999999999842 2       247999999876543 346788899998888 7999999999999999


Q ss_pred             eeEEEEecCCCCCHHhhhccCC--------------CCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCCC
Q 020221          127 ERLLVAEYMPNDTLAKHLFHWE--------------TQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDD  192 (329)
Q Consensus       127 ~~~lv~e~~~~gsL~~~l~~~~--------------~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~  192 (329)
                      ..++||||+++|+|.+++....              ...+++.+++.++.||+.||+|||+. +++||||||+|||++.+
T Consensus        93 ~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~-~ivHrDiKp~NiLl~~~  171 (299)
T d1fgka_          93 PLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASK-KCIHRDLAARNVLVTED  171 (299)
T ss_dssp             SCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHT-TCCCSCCSGGGEEECTT
T ss_pred             eEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhhC-CEEeeeecccceeecCC
Confidence            9999999999999999996432              24589999999999999999999999 99999999999999999


Q ss_pred             CCeeeecccCcccCCCC------CCccCcccccCcccccCCCCCCcccchhhhHHHHHHHh-CCCCCCchhhHHHhhhch
Q 020221          193 VNPRLSCFGLMKNSRDG------RSYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLS-GKHIPPSHALDLIRDRNI  265 (329)
Q Consensus       193 ~~~kl~Dfg~a~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t-g~~~~~~~~~~~~~~~~~  265 (329)
                      +.+||+|||+++.....      ....+++.|+|||.+.++.++.++||||||+++|||++ |..||.......+..   
T Consensus       172 ~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~y~~k~DiwS~Gvvl~ell~~g~~p~~~~~~~~~~~---  248 (299)
T d1fgka_         172 NVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFK---  248 (299)
T ss_dssp             CCEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHH---
T ss_pred             CCeEeccchhhccccccccccccccCCCChhhhhhhHhcCCCCCchhhhHHhHHHHHHhccCCCCCCCCCCHHHHHH---
Confidence            99999999998865433      23467889999999999999999999999999999998 565555443332222   


Q ss_pred             hhhccccccCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhh
Q 020221          266 QTLTDSCLEGQFSSDEGTELVRLASRCLQYEPRERPNPRSLVTALVTLQK  315 (329)
Q Consensus       266 ~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~~~l~~L~~~~~  315 (329)
                        .+....+...+..+++++.+|+.+||+.||++|||+.+|++.|+++..
T Consensus       249 --~i~~~~~~~~p~~~~~~l~~li~~cl~~dP~~Rps~~eil~~L~~i~a  296 (299)
T d1fgka_         249 --LLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVA  296 (299)
T ss_dssp             --HHHTTCCCCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             --HHHcCCCCCCCccchHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHhh
Confidence              122223344566678899999999999999999999999999998854

>d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.1e-52  Score=368.31  Aligned_cols=250  Identities=18%  Similarity=0.238  Sum_probs=198.9

Q ss_pred             CcccccccCCCCCCcEEEEEE-eCCCCEEEEEEeCCCCC--hhHHHHHHHHHHHhcCCCccccccceeeeeCCeeEEEEe
Q 020221           57 AMENIVSEHGEKAPNVVYKGK-LENQFRIAVKRFNRSAW--PDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAE  133 (329)
Q Consensus        57 ~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  133 (329)
                      +.|++++.||+|+||+||+|. ..+++.||||+++....  ...+.+.+|+++++.++||||+++++++.+++..++|||
T Consensus         2 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~~~~iv~e   81 (298)
T d1gz8a_           2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFE   81 (298)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             CCCEeccEEecCcCeEEEEEEECCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEEeccccccccceeEEEe
Confidence            468888999999999999999 46789999999976432  224578899999999999999999999999999999999


Q ss_pred             cCCCCCHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCCCCCeeeecccCcccCCCC----
Q 020221          134 YMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDG----  209 (329)
Q Consensus       134 ~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~----  209 (329)
                      |+.+ ++.+++.......+++..+..++.||+.||+|||++ ||+||||||+|||++.++.+||+|||+++.....    
T Consensus        82 ~~~~-~~~~~~~~~~~~~l~e~~~~~~~~qil~~L~yLH~~-~IiHrDiKpeNIl~~~~~~~kl~DFG~a~~~~~~~~~~  159 (298)
T d1gz8a_          82 FLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSH-RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTY  159 (298)
T ss_dssp             CCSE-EHHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHT-TCCCSCCCGGGEEECTTSCEEECSTTHHHHHCCCSBCT
T ss_pred             ecCC-chhhhhhhhcccCCCHHHHHHHHHHHHHHHHHhhcC-CEEccccCchheeecccCcceeccCCcceeccCCcccc
Confidence            9976 455555444567799999999999999999999999 9999999999999999999999999999765432    


Q ss_pred             CCccCcccccCcccccCCC-CCCcccchhhhHHHHHHHhCCCCCCchhhHHHhhhchhhh-------ccc-----cccCC
Q 020221          210 RSYSTNLAFTPPEYLRTGR-VTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTL-------TDS-----CLEGQ  276 (329)
Q Consensus       210 ~~~~~~~~y~aPE~~~~~~-~~~~~DvwslG~il~el~tg~~~~~~~~~~~~~~~~~~~~-------~~~-----~~~~~  276 (329)
                      ....||+.|+|||.+.... ++.++|||||||++|+|++|+.||................       ...     .....
T Consensus       160 ~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~  239 (298)
T d1gz8a_         160 THEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPS  239 (298)
T ss_dssp             TCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTCCTT
T ss_pred             eeecccceeeehhhhccccCCCccccccccchhhhHHhhCCCCCCCCCHHHHHHHHHHhcCCCchhhccccccccccccc
Confidence            3347899999999887666 5789999999999999999999987543222111110000       000     00000


Q ss_pred             -----------CChHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 020221          277 -----------FSSDEGTELVRLASRCLQYEPRERPNPRSLVT  308 (329)
Q Consensus       277 -----------~~~~~~~~~~~li~~cl~~dp~~Rps~~~~l~  308 (329)
                                 .....++++.+|+.+||..||++|||+.|+++
T Consensus       240 ~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t~~ell~  282 (298)
T d1gz8a_         240 FPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALA  282 (298)
T ss_dssp             SCCCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             cccccccchhhhccCCCHHHHHHHHHHccCChhHCcCHHHHhC
Confidence                       01234678999999999999999999999998

>d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: (Plasmodium falciparum) [TaxId: 5833]

Probab=100.00  E-value=1.6e-52  Score=365.32  Aligned_cols=249  Identities=16%  Similarity=0.215  Sum_probs=200.7

Q ss_pred             CcccccccCCCCCCcEEEEEEeCCCCEEEEEEeCCCCCh--hHHHHHHHHHHHhcCCCccccccceeeeeCCeeEEEEec
Q 020221           57 AMENIVSEHGEKAPNVVYKGKLENQFRIAVKRFNRSAWP--DARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAEY  134 (329)
Q Consensus        57 ~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~--~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  134 (329)
                      +.|++++.||+|+||+||+|..++|+.||||+++.....  ..+.+.+|+.+|+.++||||+++++++.+.+..++++||
T Consensus         2 ~~Y~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~i~~e~   81 (286)
T d1ob3a_           2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEH   81 (286)
T ss_dssp             CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred             CCceeccEEecCCCcEEEEEEeCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEeeeeecccCCceeEEEEe
Confidence            467889999999999999999888999999999765422  246789999999999999999999999999999999999


Q ss_pred             CCCCCHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCCCCCeeeecccCcccCCCC----C
Q 020221          135 MPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDG----R  210 (329)
Q Consensus       135 ~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~----~  210 (329)
                      +.++.+..+..  ....+++..+..++.||+.||+|||+. +|+||||||+|||++.++.+|++|||.+......    .
T Consensus        82 ~~~~~~~~~~~--~~~~l~~~~~~~i~~qi~~~L~~LH~~-~IvHrDiKp~NIll~~~~~~kl~DfG~a~~~~~~~~~~~  158 (286)
T d1ob3a_          82 LDQDLKKLLDV--CEGGLESVTAKSFLLQLLNGIAYCHDR-RVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYT  158 (286)
T ss_dssp             CSEEHHHHHHT--STTCCCHHHHHHHHHHHHHHHHHHHHT-TCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC------
T ss_pred             ehhhhHHHHHh--hcCCcchhhhHHHHHHHHHHHHHhccC-cEEecCCCCceeeEcCCCCEEecccccceecccCccccc
Confidence            98876666654  457799999999999999999999999 9999999999999999999999999998765432    3


Q ss_pred             CccCcccccCcccccCCC-CCCcccchhhhHHHHHHHhCCCCCCchhhHHHhhhchhhhc--------------------
Q 020221          211 SYSTNLAFTPPEYLRTGR-VTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLT--------------------  269 (329)
Q Consensus       211 ~~~~~~~y~aPE~~~~~~-~~~~~DvwslG~il~el~tg~~~~~~~~~~~~~~~~~~~~~--------------------  269 (329)
                      ...+++.|+|||.+.+.. ++.++|||||||++|||++|+.||.................                    
T Consensus       159 ~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~  238 (286)
T d1ob3a_         159 HEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDPNF  238 (286)
T ss_dssp             ---CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTCCTTC
T ss_pred             eecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCChhhccchhhhhhccccc
Confidence            345789999999987654 78999999999999999999998865432211111100000                    


Q ss_pred             ---cccccCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 020221          270 ---DSCLEGQFSSDEGTELVRLASRCLQYEPRERPNPRSLVT  308 (329)
Q Consensus       270 ---~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~~~l~  308 (329)
                         ............++++.+|+.+||..||++|||++|+++
T Consensus       239 ~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s~~ell~  280 (286)
T d1ob3a_         239 TVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE  280 (286)
T ss_dssp             CCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             ccccCcchhhhcccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence               000001122345788999999999999999999999997

>d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-KIT receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.1e-52  Score=370.24  Aligned_cols=255  Identities=20%  Similarity=0.300  Sum_probs=210.0

Q ss_pred             CcccccccCCCCCCcEEEEEEe------CCCCEEEEEEeCCCCCh-hHHHHHHHHHHHhcC-CCccccccceeeeeCCee
Q 020221           57 AMENIVSEHGEKAPNVVYKGKL------ENQFRIAVKRFNRSAWP-DARQFLEEARAVGQL-RNRRLANLLGCCCEGDER  128 (329)
Q Consensus        57 ~~~~~~~~lg~G~~g~V~~~~~------~~~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~  128 (329)
                      +.+++.+.||+|+||.||+|++      .+++.||||+++..... ....+.+|+.+++.+ +|||||++++++.++...
T Consensus        23 ~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~~~~~~~  102 (311)
T d1t46a_          23 NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGPT  102 (311)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred             HHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECcccCHHHHHHHHHHHHHHHhccCCCCEEEEEEEEeeCCEE
Confidence            4567788899999999999984      34578999999875433 345689999999999 699999999999999999


Q ss_pred             EEEEecCCCCCHHhhhccCC----------------CCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCCC
Q 020221          129 LLVAEYMPNDTLAKHLFHWE----------------TQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDD  192 (329)
Q Consensus       129 ~lv~e~~~~gsL~~~l~~~~----------------~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~  192 (329)
                      ++||||+++|+|.+++....                ...+++..+..++.||+.||+|||++ +++||||||+||+++.+
T Consensus       103 ~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~-~ivHrDLKp~NIl~~~~  181 (311)
T d1t46a_         103 LVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASK-NCIHRDLAARNILLTHG  181 (311)
T ss_dssp             EEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHT-TCCCSCCSGGGEEEETT
T ss_pred             EEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhC-Ceeeccccccccccccc
Confidence            99999999999999987532                22588999999999999999999999 99999999999999999


Q ss_pred             CCeeeecccCcccCCCCC------CccCcccccCcccccCCCCCCcccchhhhHHHHHHHhCCCCCCch-hhHHHhhhch
Q 020221          193 VNPRLSCFGLMKNSRDGR------SYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSH-ALDLIRDRNI  265 (329)
Q Consensus       193 ~~~kl~Dfg~a~~~~~~~------~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~-~~~~~~~~~~  265 (329)
                      +.++++|||+++......      ...+|+.|+|||++.+..++.++||||||+++|||+|++.|+... .....    .
T Consensus       182 ~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwS~G~~l~ellt~g~p~~~~~~~~~~----~  257 (311)
T d1t46a_         182 RITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSK----F  257 (311)
T ss_dssp             TEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSSHH----H
T ss_pred             CcccccccchheeccCCCcceEeeecccChHHcCHHHhcCCCCCCcccccchHHHHHHHHhCCCCCCCCCCHHHH----H
Confidence            999999999998765432      235689999999999999999999999999999999965554432 21111    1


Q ss_pred             hhhccccccCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhhc
Q 020221          266 QTLTDSCLEGQFSSDEGTELVRLASRCLQYEPRERPNPRSLVTALVTLQKD  316 (329)
Q Consensus       266 ~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~~~l~~L~~~~~~  316 (329)
                      ..++....+...+...++++.+|+.+||+.||++|||+.+|++.|+++..+
T Consensus       258 ~~~i~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~~il~~L~~~i~~  308 (311)
T d1t46a_         258 YKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQISE  308 (311)
T ss_dssp             HHHHHHTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             HHHHhcCCCCCCcccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhhcc
Confidence            112222233344566778999999999999999999999999999987554

>d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Insulin-like growth factor 1 receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.5e-52  Score=367.31  Aligned_cols=253  Identities=21%  Similarity=0.309  Sum_probs=208.2

Q ss_pred             CcccccccCCCCCCcEEEEEEeC------CCCEEEEEEeCCCCCh-hHHHHHHHHHHHhcCCCccccccceeeeeCCeeE
Q 020221           57 AMENIVSEHGEKAPNVVYKGKLE------NQFRIAVKRFNRSAWP-DARQFLEEARAVGQLRNRRLANLLGCCCEGDERL  129 (329)
Q Consensus        57 ~~~~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~  129 (329)
                      +.+++.+.||+|+||+||+|.+.      +++.||||+++..... ....+.+|+++++.++||||+++++++......+
T Consensus        20 ~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~   99 (308)
T d1p4oa_          20 EKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTL   99 (308)
T ss_dssp             GGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECSSSSCE
T ss_pred             HHeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECcccChHHHHHHHHHHHHHHHcCCCCEeeeeeEEecCCcee
Confidence            45677788899999999999853      2568999999765433 3346899999999999999999999999999999


Q ss_pred             EEEecCCCCCHHhhhccC--------CCCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCCCCCeeeeccc
Q 020221          130 LVAEYMPNDTLAKHLFHW--------ETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFG  201 (329)
Q Consensus       130 lv~e~~~~gsL~~~l~~~--------~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg  201 (329)
                      +||||+++|+|.+++...        ....+++..+..++.|++.||.|||++ +|+||||||+|||+++++++||+|||
T Consensus       100 lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~-~ivHrDlk~~NiLld~~~~~Kl~DFG  178 (308)
T d1p4oa_         100 VIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNAN-KFVHRDLAARNCMVAEDFTVKIGDFG  178 (308)
T ss_dssp             EEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHT-TCBCSCCSGGGEEECTTCCEEECCTT
T ss_pred             EEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhhC-CeeeceEcCCceeecCCceEEEeecc
Confidence            999999999999988532        224578999999999999999999999 99999999999999999999999999


Q ss_pred             CcccCCCC------CCccCcccccCcccccCCCCCCcccchhhhHHHHHHHhCCCC-CCchhhHHHhhhchhhhcccccc
Q 020221          202 LMKNSRDG------RSYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHI-PPSHALDLIRDRNIQTLTDSCLE  274 (329)
Q Consensus       202 ~a~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~~-~~~~~~~~~~~~~~~~~~~~~~~  274 (329)
                      +++.....      ....+++.|+|||.+.+..++.++||||||+++|||+||..+ +............    .+ ...
T Consensus       179 la~~~~~~~~~~~~~~~~~t~~y~aPe~l~~~~~~~~~Dv~S~G~il~El~t~~~~p~~~~~~~~~~~~i----~~-~~~  253 (308)
T d1p4oa_         179 MTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFV----ME-GGL  253 (308)
T ss_dssp             CCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHHHHHHH----HT-TCC
T ss_pred             cceeccCCcceeeccceecccccCCHHHHccCCCCcccccccHHHHHHHHHhCCCCCCCCCCHHHHHHHH----Hh-CCC
Confidence            99865433      223568999999999999999999999999999999999654 4333222222211    11 122


Q ss_pred             CCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhh
Q 020221          275 GQFSSDEGTELVRLASRCLQYEPRERPNPRSLVTALVTLQK  315 (329)
Q Consensus       275 ~~~~~~~~~~~~~li~~cl~~dp~~Rps~~~~l~~L~~~~~  315 (329)
                      ...+..+++.+.+++.+||+.||++|||+.+|++.|++..+
T Consensus       254 ~~~p~~~~~~l~~li~~cl~~~P~~RPs~~~il~~L~~~~~  294 (308)
T d1p4oa_         254 LDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEME  294 (308)
T ss_dssp             CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSC
T ss_pred             CCCcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcC
Confidence            33456678899999999999999999999999999988754

>d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Proto-oncogene serine/threonine-protein kinase Pim-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.6e-53  Score=367.36  Aligned_cols=236  Identities=19%  Similarity=0.276  Sum_probs=196.6

Q ss_pred             cccccccCCCCCCcEEEEEE-eCCCCEEEEEEeCCCCCh------hHHHHHHHHHHHhcCC--CccccccceeeeeCCee
Q 020221           58 MENIVSEHGEKAPNVVYKGK-LENQFRIAVKRFNRSAWP------DARQFLEEARAVGQLR--NRRLANLLGCCCEGDER  128 (329)
Q Consensus        58 ~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~------~~~~~~~e~~~l~~l~--h~niv~~~~~~~~~~~~  128 (329)
                      .|++.+.||+|+||+||+|. ..+++.||||++......      ....+.+|+.+++.++  ||||+++++++.+++..
T Consensus         5 ~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~~~~   84 (273)
T d1xwsa_           5 QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSF   84 (273)
T ss_dssp             TEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSSEE
T ss_pred             eEEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEeeCCeE
Confidence            57788889999999999999 567899999998753211      1233668999999986  89999999999999999


Q ss_pred             EEEEecCCC-CCHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCC-CCCeeeecccCcccC
Q 020221          129 LLVAEYMPN-DTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDD-DVNPRLSCFGLMKNS  206 (329)
Q Consensus       129 ~lv~e~~~~-gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~-~~~~kl~Dfg~a~~~  206 (329)
                      ++||||+.+ +++.+++.  ....+++..++.++.||+.||+|||++ ||+||||||+|||++. ++.+||+|||+++..
T Consensus        85 ~lv~e~~~~~~~l~~~~~--~~~~l~e~~~~~~~~qi~~al~~lH~~-~iiHrDiKp~NIll~~~~~~vkl~DFG~a~~~  161 (273)
T d1xwsa_          85 VLILERPEPVQDLFDFIT--ERGALQEELARSFFWQVLEAVRHCHNC-GVLHRDIKDENILIDLNRGELKLIDFGSGALL  161 (273)
T ss_dssp             EEEEECCSSEEEHHHHHH--HHCSCCHHHHHHHHHHHHHHHHHHHHT-TEECSCCSGGGEEEETTTTEEEECCCTTCEEC
T ss_pred             EEEEEeccCcchHHHHHh--ccCCCCHHHHHHHHHHHHHHHHHHHHC-CCccccCcccceEEecCCCeEEECccccceec
Confidence            999999976 57777776  346799999999999999999999999 9999999999999985 478999999999865


Q ss_pred             CCC--CCccCcccccCcccccCCCC-CCcccchhhhHHHHHHHhCCCCCCchhhHHHhhhchhhhccccccCCCChHHHH
Q 020221          207 RDG--RSYSTNLAFTPPEYLRTGRV-TPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGT  283 (329)
Q Consensus       207 ~~~--~~~~~~~~y~aPE~~~~~~~-~~~~DvwslG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  283 (329)
                      ...  ....||+.|+|||++.+..+ +.++|||||||++|||++|..||....  .+...          ...++...|+
T Consensus       162 ~~~~~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~--~i~~~----------~~~~~~~~s~  229 (273)
T d1xwsa_         162 KDTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE--EIIRG----------QVFFRQRVSS  229 (273)
T ss_dssp             CSSCBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH--HHHHC----------CCCCSSCCCH
T ss_pred             ccccccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCCCch--HHhhc----------ccCCCCCCCH
Confidence            443  34678999999999987775 567899999999999999998886532  11111          1123445678


Q ss_pred             HHHHHHHHhcccCCCCCCCHHHHHH
Q 020221          284 ELVRLASRCLQYEPRERPNPRSLVT  308 (329)
Q Consensus       284 ~~~~li~~cl~~dp~~Rps~~~~l~  308 (329)
                      ++.+|+.+||+.||++|||++++++
T Consensus       230 ~~~~li~~~L~~dp~~R~s~~eil~  254 (273)
T d1xwsa_         230 ECQHLIRWCLALRPSDRPTFEEIQN  254 (273)
T ss_dssp             HHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             HHHHHHHHHccCCHhHCcCHHHHhc
Confidence            8999999999999999999999997

>d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Type I TGF-beta receptor R4
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.3e-52  Score=364.77  Aligned_cols=254  Identities=15%  Similarity=0.197  Sum_probs=195.3

Q ss_pred             ccccccCCCCCCcEEEEEEeCCCCEEEEEEeCCCCChhHHHHH--HHHHHHhcCCCccccccceeeeeCC----eeEEEE
Q 020221           59 ENIVSEHGEKAPNVVYKGKLENQFRIAVKRFNRSAWPDARQFL--EEARAVGQLRNRRLANLLGCCCEGD----ERLLVA  132 (329)
Q Consensus        59 ~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~--~e~~~l~~l~h~niv~~~~~~~~~~----~~~lv~  132 (329)
                      +.+.+.||+|+||+||+|++ +|+.||||+++...   .+.+.  .|+..+..++||||+++++++.+.+    .+++||
T Consensus         5 ~~l~~~iG~G~fg~Vy~~~~-~g~~vAvK~~~~~~---~~~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~~~~lv~   80 (303)
T d1vjya_           5 IVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSRE---ERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVS   80 (303)
T ss_dssp             EEEEEEEECCSSSEEEEEEE-TTEEEEEEEECGGG---HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEE
T ss_pred             EEEEEEEeeCCCeEEEEEEE-CCEEEEEEEECccc---hhHHHHHHHHHHHhhCCCCcCcceEEEEEeCCCcceEEEEEE
Confidence            44556789999999999997 57799999997543   33333  4555556789999999999997654    579999


Q ss_pred             ecCCCCCHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcC-------CCccccccCCCceeeCCCCCeeeecccCccc
Q 020221          133 EYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSK-------ERALYHDLNAYRIVFDDDVNPRLSCFGLMKN  205 (329)
Q Consensus       133 e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~-------~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~  205 (329)
                      ||+++|+|.+++.+   ..+++.++..++.|++.||.|||+.       .||+||||||+|||++.++.+||+|||+++.
T Consensus        81 Ey~~~g~L~~~l~~---~~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~Kl~DFGl~~~  157 (303)
T d1vjya_          81 DYHEHGSLFDYLNR---YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVR  157 (303)
T ss_dssp             ECCTTCBHHHHHHH---CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCTTCEE
T ss_pred             ecccCCCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCCCeEEEecCcccc
Confidence            99999999999954   4699999999999999999999961       3999999999999999999999999999876


Q ss_pred             CCCC--------CCccCcccccCcccccCCC------CCCcccchhhhHHHHHHHhCCCCCCchhhHH-----------H
Q 020221          206 SRDG--------RSYSTNLAFTPPEYLRTGR------VTPESVMYSFGTLLLDLLSGKHIPPSHALDL-----------I  260 (329)
Q Consensus       206 ~~~~--------~~~~~~~~y~aPE~~~~~~------~~~~~DvwslG~il~el~tg~~~~~~~~~~~-----------~  260 (329)
                      ....        ....||+.|+|||++.+..      ++.++|||||||++|||+||..|+.......           .
T Consensus       158 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~~~~~~~~~~~~~  237 (303)
T d1vjya_         158 HDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPS  237 (303)
T ss_dssp             EETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSSCC
T ss_pred             ccCCCcceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCcccccccchhhcccccch
Confidence            5432        2356899999999987643      5668999999999999999986653211000           0


Q ss_pred             hhhchhhhccccccCCC-----ChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhhcccc
Q 020221          261 RDRNIQTLTDSCLEGQF-----SSDEGTELVRLASRCLQYEPRERPNPRSLVTALVTLQKDTEL  319 (329)
Q Consensus       261 ~~~~~~~~~~~~~~~~~-----~~~~~~~~~~li~~cl~~dp~~Rps~~~~l~~L~~~~~~~~~  319 (329)
                      .............++..     +...+..+.+|+.+||+.||++|||+.+|++.|+++......
T Consensus       238 ~~~~~~~~~~~~~~p~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ei~~~L~~i~~~~~~  301 (303)
T d1vjya_         238 VEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQEGI  301 (303)
T ss_dssp             HHHHHHHHTTSCCCCCCCGGGGGCHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHHHHHCC
T ss_pred             HHHHHHHHhccccCCCCCcccCChHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHHhcCC
Confidence            00001111111122222     234567799999999999999999999999999999876543

>d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK6
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.5e-52  Score=366.46  Aligned_cols=250  Identities=18%  Similarity=0.198  Sum_probs=195.7

Q ss_pred             CcccccccCCCCCCcEEEEEEe-CC-CCEEEEEEeCCCCCh--hHHHHHHHHHHHhcC---CCccccccceeeee-----
Q 020221           57 AMENIVSEHGEKAPNVVYKGKL-EN-QFRIAVKRFNRSAWP--DARQFLEEARAVGQL---RNRRLANLLGCCCE-----  124 (329)
Q Consensus        57 ~~~~~~~~lg~G~~g~V~~~~~-~~-~~~vavK~~~~~~~~--~~~~~~~e~~~l~~l---~h~niv~~~~~~~~-----  124 (329)
                      +.|++++.||+|+||+||+|.. .+ ++.||||+++.....  ....+.+|+.+++.+   +||||+++++++..     
T Consensus         7 ~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~~~   86 (305)
T d1blxa_           7 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDR   86 (305)
T ss_dssp             GTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECSS
T ss_pred             CCEEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccchHHHHHHHHHHHHHHHhhcCCCCcceeeeeeccccccc
Confidence            4688999999999999999985 44 667999998653211  123456677766655   79999999999853     


Q ss_pred             CCeeEEEEecCCCCCHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCCCCCeeeecccCcc
Q 020221          125 GDERLLVAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMK  204 (329)
Q Consensus       125 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~  204 (329)
                      ....+++|||+.++++..... .....+++..++.++.|++.||+|||++ +|+||||||+|||++.++.+||+|||++.
T Consensus        87 ~~~~~~~~e~~~~~~~~~~~~-~~~~~~~~~~~~~~~~qi~~aL~yLH~~-~ivHrDiKp~NILi~~~~~~kl~dfg~~~  164 (305)
T d1blxa_          87 ETKLTLVFEHVDQDLTTYLDK-VPEPGVPTETIKDMMFQLLRGLDFLHSH-RVVHRDLKPQNILVTSSGQIKLADFGLAR  164 (305)
T ss_dssp             EEEEEEEEECCSCBHHHHHHH-SCTTCSCHHHHHHHHHHHHHHHHHHHHT-TCCCCCCCGGGEEECTTCCEEECSCCSCC
T ss_pred             CceEEEEEEeccCCchhhhhh-ccCCCCCHHHHHHHHHHHHHHHHHHHhC-CEEecCCCccEEEEcCCCCeeecchhhhh
Confidence            346899999998876654433 3567789999999999999999999999 99999999999999999999999999987


Q ss_pred             cCCCC---CCccCcccccCcccccCCCCCCcccchhhhHHHHHHHhCCCCCCchhhHHHhhhchhhhc------------
Q 020221          205 NSRDG---RSYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLT------------  269 (329)
Q Consensus       205 ~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~~~~~~~~~~------------  269 (329)
                      .....   ....||+.|+|||++.+..++.++||||+||++|||++|+.||.................            
T Consensus       165 ~~~~~~~~~~~~gT~~Y~APE~~~~~~y~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  244 (305)
T d1blxa_         165 IYSFQMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDVA  244 (305)
T ss_dssp             CCCGGGGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCGGGSCTTCS
T ss_pred             hhcccccCCCcccChhhcCcchhcCCCCChhehhhchHHHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCchhccccccc
Confidence            65433   356789999999999999999999999999999999999999876533222111111000            


Q ss_pred             ---------cccccCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 020221          270 ---------DSCLEGQFSSDEGTELVRLASRCLQYEPRERPNPRSLVT  308 (329)
Q Consensus       270 ---------~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~~~l~  308 (329)
                               ............++++.+|+.+||+.||++|||+.|+++
T Consensus       245 ~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~sa~e~L~  292 (305)
T d1blxa_         245 LPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS  292 (305)
T ss_dssp             SCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred             chhhhhccccccchhhccccCCHHHHHHHHHHCcCChhHCcCHHHHhc
Confidence                     000001123446788999999999999999999999998

>d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38-gamma
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.6e-50  Score=361.91  Aligned_cols=247  Identities=16%  Similarity=0.212  Sum_probs=192.9

Q ss_pred             CcccccccCCCCCCcEEEEEE-eCCCCEEEEEEeCCCCCh--hHHHHHHHHHHHhcCCCccccccceeeeeCC------e
Q 020221           57 AMENIVSEHGEKAPNVVYKGK-LENQFRIAVKRFNRSAWP--DARQFLEEARAVGQLRNRRLANLLGCCCEGD------E  127 (329)
Q Consensus        57 ~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~--~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~------~  127 (329)
                      +.|++++.||+|+||+||+|. ..+|+.||||+++.....  ..+.+.+|+++|+.++|||||++++++...+      .
T Consensus        18 ~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~~~~   97 (346)
T d1cm8a_          18 AVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFTD   97 (346)
T ss_dssp             SSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCCC
T ss_pred             CcEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEchhhcChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCccccccce
Confidence            457888999999999999999 467999999999865322  3556889999999999999999999997654      5


Q ss_pred             eEEEEecCCCCCHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCCCCCeeeecccCcccCC
Q 020221          128 RLLVAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSR  207 (329)
Q Consensus       128 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~  207 (329)
                      +++||||+ +.+|.....   ...+++..++.++.||+.||.|||++ ||+||||||+|||++.++.+|++|||+++...
T Consensus        98 ~~lv~e~~-~~~l~~~~~---~~~l~~~~~~~~~~qi~~aL~~LH~~-~IiHrDiKp~NIL~~~~~~~kl~Dfg~a~~~~  172 (346)
T d1cm8a_          98 FYLVMPFM-GTDLGKLMK---HEKLGEDRIQFLVYQMLKGLRYIHAA-GIIHRDLKPGNLAVNEDCELKILDFGLARQAD  172 (346)
T ss_dssp             CEEEEECC-SEEHHHHHH---HCCCCHHHHHHHHHHHHHHHHHHHHT-TEECCCCCGGGEEECTTCCEEECCCTTCEECC
T ss_pred             EEEEEecc-cccHHHHHH---hccccHHHHHHHHHHHHHHHHHHHhC-CCcccccCcchhhcccccccccccccceeccC
Confidence            79999999 557877774   45799999999999999999999999 99999999999999999999999999998765


Q ss_pred             CC-CCccCcccccCcccccCC-CCCCcccchhhhHHHHHHHhCCCCCCchhhHHHhhhchh-------------------
Q 020221          208 DG-RSYSTNLAFTPPEYLRTG-RVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQ-------------------  266 (329)
Q Consensus       208 ~~-~~~~~~~~y~aPE~~~~~-~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~~~~~~~-------------------  266 (329)
                      .. ....+|+.|+|||++.+. .++.++||||+||++|+|++|..||..............                   
T Consensus       173 ~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  252 (346)
T d1cm8a_         173 SEMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSDEAK  252 (346)
T ss_dssp             SSCCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHTCSCHHHH
T ss_pred             CccccccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCCCCCChHHHHHHHHhccCCCcHHHHhhhcchhhh
Confidence            44 345789999999998765 478899999999999999999988865422111100000                   


Q ss_pred             ---hhccccc---cCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 020221          267 ---TLTDSCL---EGQFSSDEGTELVRLASRCLQYEPRERPNPRSLVT  308 (329)
Q Consensus       267 ---~~~~~~~---~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~~~l~  308 (329)
                         .......   ........++++.+|+.+||..||++|||+.++++
T Consensus       253 ~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~eiL~  300 (346)
T d1cm8a_         253 NYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALA  300 (346)
T ss_dssp             HHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred             hhhccCCcccccchHHhccCCCHHHHHHHHHHCcCChhHCcCHHHHhc
Confidence               0000000   01122345788999999999999999999999998

>d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 9, CDK9
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.9e-50  Score=356.12  Aligned_cols=252  Identities=15%  Similarity=0.173  Sum_probs=194.9

Q ss_pred             cCCCcccccccCCCCCCcEEEEEEe-CCCCEEEEEEeCCCCC--hhHHHHHHHHHHHhcCCCccccccceeeee------
Q 020221           54 SGFAMENIVSEHGEKAPNVVYKGKL-ENQFRIAVKRFNRSAW--PDARQFLEEARAVGQLRNRRLANLLGCCCE------  124 (329)
Q Consensus        54 ~~~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~~~~~~~~------  124 (329)
                      +..+.|++++.||+|+||+||+|.. .+|+.||||++.....  ...+++.+|+++|+.++||||+++++++..      
T Consensus         7 ~~~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~   86 (318)
T d3blha1           7 DEVSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYN   86 (318)
T ss_dssp             CBGGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CTTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC------
T ss_pred             CccCCEEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHHhcCCCccceEeeeeccccccc
Confidence            3456789999999999999999994 6789999999865432  234568899999999999999999998855      


Q ss_pred             --CCeeEEEEecCCCCCHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCCCCCeeeecccC
Q 020221          125 --GDERLLVAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGL  202 (329)
Q Consensus       125 --~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~  202 (329)
                        .+..+++|||+.++.+.....  ....++...++.++.|++.||.|||++ ||+||||||+|||++.++.+||+|||+
T Consensus        87 ~~~~~~~iv~e~~~~~~~~~~~~--~~~~~~~~~~~~i~~qil~~l~~lH~~-~ivHrDlKp~NILl~~~~~~kl~dfg~  163 (318)
T d3blha1          87 RCKGSIYLVFDFCEHDLAGLLSN--VLVKFTLSEIKRVMQMLLNGLYYIHRN-KILHRDMKAANVLITRDGVLKLADFGL  163 (318)
T ss_dssp             ----CEEEEEECCCEEHHHHHTC--TTCCCCHHHHHHHHHHHHHHHHHHHHT-TEECCCCCGGGEEECTTSCEEECCCTT
T ss_pred             ccCceEEEEEeccCCCccchhhh--cccccccHHHHHHHHHHHHHHHHhccC-CEEecCcCchheeecCCCcEEeeecce
Confidence              346899999998876655443  456789999999999999999999999 999999999999999999999999999


Q ss_pred             cccCCCC--------CCccCcccccCcccccCC-CCCCcccchhhhHHHHHHHhCCCCCCchhhHHHhhhchhhhcc---
Q 020221          203 MKNSRDG--------RSYSTNLAFTPPEYLRTG-RVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTD---  270 (329)
Q Consensus       203 a~~~~~~--------~~~~~~~~y~aPE~~~~~-~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~---  270 (329)
                      +......        ....||+.|+|||++.+. .++.++|||||||++|||++|+.||..................   
T Consensus       164 ~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~  243 (318)
T d3blha1         164 ARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITP  243 (318)
T ss_dssp             CEECCC-----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCT
T ss_pred             eeecccccccccccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCCCCCCHHHHHHHHHHhcCCCCh
Confidence            9754422        234689999999998765 5899999999999999999999888654322221111110000   


Q ss_pred             cc----------------ccCCCC-------hHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 020221          271 SC----------------LEGQFS-------SDEGTELVRLASRCLQYEPRERPNPRSLVT  308 (329)
Q Consensus       271 ~~----------------~~~~~~-------~~~~~~~~~li~~cl~~dp~~Rps~~~~l~  308 (329)
                      ..                .....+       ...++++.+|+.+||..||++|||++|+++
T Consensus       244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~sa~elL~  304 (318)
T d3blha1         244 EVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALN  304 (318)
T ss_dssp             TTSTTCCCC-------CCSSCCBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred             hhccccchhhhhhhhcccccccccchhhhccccCCHHHHHHHHHHCcCChhHCcCHHHHHc
Confidence            00                000000       112567889999999999999999999998

>d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase Erk2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.9e-50  Score=361.02  Aligned_cols=247  Identities=17%  Similarity=0.222  Sum_probs=192.4

Q ss_pred             cccccccCCCCCCcEEEEEE-eCCCCEEEEEEeCCCCC-hhHHHHHHHHHHHhcCCCccccccceeeeeCC----eeEEE
Q 020221           58 MENIVSEHGEKAPNVVYKGK-LENQFRIAVKRFNRSAW-PDARQFLEEARAVGQLRNRRLANLLGCCCEGD----ERLLV  131 (329)
Q Consensus        58 ~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~----~~~lv  131 (329)
                      .|++++.||+|+||+||+|. ..+|+.||||++..... ...+.+.+|+++|+.++||||+++++++....    ..+++
T Consensus         9 rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~~~~~l   88 (345)
T d1pmea_           9 RYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVYL   88 (345)
T ss_dssp             TEEEEEECC---CCCEEEEEETTTCSEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCEEE
T ss_pred             CeEEEEEEeeccCeEEEEEEECCCCcEEEEEEEehhcChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeeccccccceEEE
Confidence            48899999999999999998 56899999999976543 33567889999999999999999999986543    23455


Q ss_pred             EecCCCCCHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCCCCCeeeecccCcccCCCC--
Q 020221          132 AEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDG--  209 (329)
Q Consensus       132 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~--  209 (329)
                      ++|+.+|+|.+++..   ..+++..+..++.||+.||+|||++ ||+||||||+|||++.++.+||+|||++......  
T Consensus        89 ~~~~~~g~L~~~l~~---~~l~~~~i~~i~~qil~al~yLH~~-~iiHRDIKp~NILl~~~~~~kl~DfG~a~~~~~~~~  164 (345)
T d1pmea_          89 VTHLMGADLYKLLKT---QHLSNDHICYFLYQILRGLKYIHSA-NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHD  164 (345)
T ss_dssp             EEECCCEEHHHHHHH---CCCCHHHHHHHHHHHHHHHHHHHHT-TEECCCCCGGGEEECTTCCEEECCCTTCEECCGGGC
T ss_pred             EEeecCCchhhhhhc---CCCCHHHHHHHHHHHHHHHHHHHHC-CCcCCCCCcceEEECCCCCEEEcccCceeeccCCCc
Confidence            566778999999953   4699999999999999999999999 9999999999999999999999999998754332  


Q ss_pred             -----CCccCcccccCcccccCC-CCCCcccchhhhHHHHHHHhCCCCCCchhhHHHhhhchhhh---------------
Q 020221          210 -----RSYSTNLAFTPPEYLRTG-RVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTL---------------  268 (329)
Q Consensus       210 -----~~~~~~~~y~aPE~~~~~-~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~~~~~~~~~---------------  268 (329)
                           ....||+.|+|||++... .++.++||||+|+++|+|++|..||................               
T Consensus       165 ~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  244 (345)
T d1pmea_         165 HTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLK  244 (345)
T ss_dssp             BCCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHTCCCHH
T ss_pred             cceeeccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCCCCCCCCHHHHHHHHhhhccCCChhhhhhhhhhh
Confidence                 334678999999998544 57889999999999999999999886543211111110000               


Q ss_pred             -------ccccccC---CCChHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 020221          269 -------TDSCLEG---QFSSDEGTELVRLASRCLQYEPRERPNPRSLVT  308 (329)
Q Consensus       269 -------~~~~~~~---~~~~~~~~~~~~li~~cl~~dp~~Rps~~~~l~  308 (329)
                             .......   ......++++.+|+.+||..||++|||+.++++
T Consensus       245 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~ta~e~L~  294 (345)
T d1pmea_         245 ARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALA  294 (345)
T ss_dssp             HHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred             hhcccccCCccCCCCHHHhCCCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence                   0000000   011234578999999999999999999999997

>d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK5
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7.1e-50  Score=349.52  Aligned_cols=249  Identities=16%  Similarity=0.161  Sum_probs=202.8

Q ss_pred             CcccccccCCCCCCcEEEEEE-eCCCCEEEEEEeCCCCC--hhHHHHHHHHHHHhcCCCccccccceeeeeCCeeEEEEe
Q 020221           57 AMENIVSEHGEKAPNVVYKGK-LENQFRIAVKRFNRSAW--PDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAE  133 (329)
Q Consensus        57 ~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  133 (329)
                      +.|++++.||+|+||+||+|+ ..+++.||||+++....  .....+.+|+.+++.++||||+++++++.+....+++++
T Consensus         2 ~ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~iv~~   81 (292)
T d1unla_           2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE   81 (292)
T ss_dssp             CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred             CCCEeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhhCChHHHHHHHHHHHHHHhcCcCCEEeeccccccccceeEEee
Confidence            468899999999999999999 56788999999865532  335678999999999999999999999999999999999


Q ss_pred             cCCCCCHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCCCCCeeeecccCcccCCCCC---
Q 020221          134 YMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDGR---  210 (329)
Q Consensus       134 ~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~---  210 (329)
                      ++.+++|..++.  ....+++..+..++.|++.||+|||++ ||+||||||+|||++.++.+||+|||.++......   
T Consensus        82 ~~~~~~l~~~~~--~~~~~~~~~~~~~~~q~~~aL~~lH~~-~IvHrDiKP~NIli~~~~~~kl~DFG~a~~~~~~~~~~  158 (292)
T d1unla_          82 FCDQDLKKYFDS--CNGDLDPEIVKSFLFQLLKGLGFCHSR-NVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCY  158 (292)
T ss_dssp             CCSEEHHHHHHH--TTTCCCHHHHHHHHHHHHHHHHHHHHT-TEECCCCSGGGEEECTTCCEEECCCTTCEECCSCCSCC
T ss_pred             eccccccccccc--cccccchhHHHHHHHHHHHHHHHhhcC-CEeeecccCcccccccCCceeeeecchhhcccCCCccc
Confidence            999998888775  556789999999999999999999999 99999999999999999999999999998655432   


Q ss_pred             -CccCcccccCcccccCCC-CCCcccchhhhHHHHHHHhCCCCCCchhhHHHhhhchhhhc-------------------
Q 020221          211 -SYSTNLAFTPPEYLRTGR-VTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLT-------------------  269 (329)
Q Consensus       211 -~~~~~~~y~aPE~~~~~~-~~~~~DvwslG~il~el~tg~~~~~~~~~~~~~~~~~~~~~-------------------  269 (329)
                       ...++..|+|||.+.+.. ++.++|||||||++|||++|+.||.................                   
T Consensus       159 ~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (292)
T d1unla_         159 SAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYKP  238 (292)
T ss_dssp             CSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGGGSTTCCC
T ss_pred             eeeccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCCCCCCHHHHHHHHHhhcCCCChhhhhhhhhcccccc
Confidence             335678899999988665 68899999999999999999988643321110000000000                   


Q ss_pred             -----cccccCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 020221          270 -----DSCLEGQFSSDEGTELVRLASRCLQYEPRERPNPRSLVT  308 (329)
Q Consensus       270 -----~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~~~l~  308 (329)
                           ............++++.+|+.+||+.||.+||||+|+++
T Consensus       239 ~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e~L~  282 (292)
T d1unla_         239 YPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQ  282 (292)
T ss_dssp             CCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred             cccccccchhhhccccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence                 000011123455788999999999999999999999998

>d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase CK2, alpha subunit
species: Rattus norvegicus [TaxId: 10116]

Probab=100.00  E-value=2.1e-50  Score=358.48  Aligned_cols=245  Identities=18%  Similarity=0.205  Sum_probs=196.9

Q ss_pred             CCCcccccccCCCCCCcEEEEEE-eCCCCEEEEEEeCCCCChhHHHHHHHHHHHhcCC-CccccccceeeeeC--CeeEE
Q 020221           55 GFAMENIVSEHGEKAPNVVYKGK-LENQFRIAVKRFNRSAWPDARQFLEEARAVGQLR-NRRLANLLGCCCEG--DERLL  130 (329)
Q Consensus        55 ~~~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~--~~~~l  130 (329)
                      +.+.|++++.||+|+||+||+|+ ..+++.||||+++...   .+.+.+|+++|+.++ ||||+++++++...  ...++
T Consensus        33 ~~d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~---~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~~~~  109 (328)
T d3bqca1          33 NQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK---KKKIKREIKILENLRGGPNIITLADIVKDPVSRTPAL  109 (328)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSSC---HHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCSEEE
T ss_pred             CCcCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEECHHH---HHHHHHHHHHHHhccCCCCCcEEEEEEEecCCCceeE
Confidence            34578899999999999999999 4678999999997543   567889999999995 99999999998744  56899


Q ss_pred             EEecCCCCCHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCCCC-CeeeecccCcccCCCC
Q 020221          131 VAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDV-NPRLSCFGLMKNSRDG  209 (329)
Q Consensus       131 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~-~~kl~Dfg~a~~~~~~  209 (329)
                      ||||+.+++|..+.     +.+++..+..++.||+.||.|||++ ||+||||||+|||++.++ .+||+|||++......
T Consensus       110 v~e~~~~~~L~~~~-----~~l~e~~i~~i~~qil~aL~~LH~~-gIvHrDiKp~NILi~~~~~~vkl~DFG~a~~~~~~  183 (328)
T d3bqca1         110 VFEHVNNTDFKQLY-----QTLTDYDIRFYMYEILKALDYCHSM-GIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPG  183 (328)
T ss_dssp             EEECCCSCBGGGTT-----TSCCHHHHHHHHHHHHHHHHHHHHT-TEECCCCSGGGEEEETTTTEEEECCGGGCEECCTT
T ss_pred             EEeecCCCcHHHHh-----cCCCHHHHHHHHHHHHHHHHHHhhc-ccccccccccceEEcCCCCeeeecccccceeccCC
Confidence            99999999987764     3689999999999999999999999 999999999999998655 5899999999876543


Q ss_pred             ---CCccCcccccCcccccCCC-CCCcccchhhhHHHHHHHhCCCCCCchhhHHHhhhch--------------------
Q 020221          210 ---RSYSTNLAFTPPEYLRTGR-VTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNI--------------------  265 (329)
Q Consensus       210 ---~~~~~~~~y~aPE~~~~~~-~~~~~DvwslG~il~el~tg~~~~~~~~~~~~~~~~~--------------------  265 (329)
                         ....+|+.|+|||.+.+.. ++.++||||+|+++++|++|+.||.............                    
T Consensus       184 ~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~  263 (328)
T d3bqca1         184 QEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIEL  263 (328)
T ss_dssp             CCCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTCCC
T ss_pred             CcccccccCccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCCCCchhHHHHHHHHHHHCCchhhhhhhhccccc
Confidence               3456789999999988665 7899999999999999999998875432111000000                    


Q ss_pred             ----hhhc--------cccccCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 020221          266 ----QTLT--------DSCLEGQFSSDEGTELVRLASRCLQYEPRERPNPRSLVT  308 (329)
Q Consensus       266 ----~~~~--------~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~~~l~  308 (329)
                          ....        ............++++.+|+.+||..||++|||++|+++
T Consensus       264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~e~L~  318 (328)
T d3bqca1         264 DPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAME  318 (328)
T ss_dssp             CGGGGGTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             CcccchhcccccccchhhcccccccccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence                0000        000111122346789999999999999999999999998

>d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Glycogen synthase kinase-3 beta (Gsk3b)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.6e-50  Score=358.10  Aligned_cols=246  Identities=21%  Similarity=0.215  Sum_probs=191.1

Q ss_pred             cccccccCCCCCCcEEEEEEe-CCCCEEEEEEeCCCCChhHHHHHHHHHHHhcCCCccccccceeeeeC------CeeEE
Q 020221           58 MENIVSEHGEKAPNVVYKGKL-ENQFRIAVKRFNRSAWPDARQFLEEARAVGQLRNRRLANLLGCCCEG------DERLL  130 (329)
Q Consensus        58 ~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~------~~~~l  130 (329)
                      .|+.++.||+|+||+||+|+. .+|+.||||++......    ..+|+++|+.++||||+++++++...      .++++
T Consensus        21 ~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~----~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~~~~l   96 (350)
T d1q5ka_          21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRF----KNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNL   96 (350)
T ss_dssp             EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSSS----CCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCCEEEE
T ss_pred             CcEeeeEEeeCcCeEEEEEEECCCCCEEEEEEECccchH----HHHHHHHHHhcCCCCCCcEEEEEEecCccCCceEEEE
Confidence            366777889999999999994 57899999999765422    34799999999999999999998543      35789


Q ss_pred             EEecCCCCCHHhhhc-cCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCCCC-CeeeecccCcccCCC
Q 020221          131 VAEYMPNDTLAKHLF-HWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDV-NPRLSCFGLMKNSRD  208 (329)
Q Consensus       131 v~e~~~~gsL~~~l~-~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~-~~kl~Dfg~a~~~~~  208 (329)
                      ||||++++.+..+.. ......+++.+++.++.||+.||+|||++ ||+||||||+|||++.++ .+||+|||++.....
T Consensus        97 v~Ey~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH~~-~IiHrDiKp~NILl~~~~~~~kl~DFG~a~~~~~  175 (350)
T d1q5ka_          97 VLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSF-GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVR  175 (350)
T ss_dssp             EEECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTT-TEECCCCCGGGEEECTTTCCEEECCCTTCEECCT
T ss_pred             EEeccCCccHHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHHhc-CCcccCCCcceEEEecCCCceeEecccchhhccC
Confidence            999998764333321 11456799999999999999999999999 999999999999999775 899999999986544


Q ss_pred             C---CCccCcccccCcccccCC-CCCCcccchhhhHHHHHHHhCCCCCCchhhHHHhhhchh-----------hhccc--
Q 020221          209 G---RSYSTNLAFTPPEYLRTG-RVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQ-----------TLTDS--  271 (329)
Q Consensus       209 ~---~~~~~~~~y~aPE~~~~~-~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~~~~~~~-----------~~~~~--  271 (329)
                      .   ....|+..|+|||.+.+. .++.++||||+||++|||++|+.||..............           .....  
T Consensus       176 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~~~~~~~~~  255 (350)
T d1q5ka_         176 GEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYT  255 (350)
T ss_dssp             TSCCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCC---
T ss_pred             CcccccccccccccChHHhhcccCCCcceeecccceEEEehhhCCCCCCCCCHHHHHHHHHHHhCCChHHhhhhhccchh
Confidence            3   345688999999987754 589999999999999999999998865432211111000           00000  


Q ss_pred             ----------cccCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 020221          272 ----------CLEGQFSSDEGTELVRLASRCLQYEPRERPNPRSLVT  308 (329)
Q Consensus       272 ----------~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~~~l~  308 (329)
                                ..........++++.+|+.+||..||++|||+.|+++
T Consensus       256 ~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~  302 (350)
T d1q5ka_         256 EFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACA  302 (350)
T ss_dssp             CCCCCCCCCCCGGGTSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             hccccccccCchhhhcccCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence                      0001122346788999999999999999999999997

>d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

Probab=100.00  E-value=8.2e-50  Score=348.81  Aligned_cols=265  Identities=15%  Similarity=0.145  Sum_probs=209.2

Q ss_pred             cccccccCCCCCCcEEEEEE-eCCCCEEEEEEeCCCCChhHHHHHHHHHHHhcCCC-ccccccceeeeeCCeeEEEEecC
Q 020221           58 MENIVSEHGEKAPNVVYKGK-LENQFRIAVKRFNRSAWPDARQFLEEARAVGQLRN-RRLANLLGCCCEGDERLLVAEYM  135 (329)
Q Consensus        58 ~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h-~niv~~~~~~~~~~~~~lv~e~~  135 (329)
                      .|++++.||+|+||+||+|+ ..+++.||||++....  ....+.+|++.++.++| +|++.+++++..+...++||||+
T Consensus         6 ~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~--~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~~vme~~   83 (293)
T d1csna_           6 HYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRS--DAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVIDLL   83 (293)
T ss_dssp             TEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCT--TSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEECC
T ss_pred             ceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEcccc--CcHHHHHHHHHHHHhcCCCCCCEEEEEeecCCccEEEEEec
Confidence            46788889999999999999 4578899999986543  22356789999999965 89999999999999999999999


Q ss_pred             CCCCHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCC-----CCCeeeecccCcccCCCC-
Q 020221          136 PNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDD-----DVNPRLSCFGLMKNSRDG-  209 (329)
Q Consensus       136 ~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~-----~~~~kl~Dfg~a~~~~~~-  209 (329)
                       +++|.+++.. ....+++.++..++.|++.||+|||++ ||+||||||+||+++.     ++.+||+|||+|+..... 
T Consensus        84 -~~~l~~~~~~-~~~~~~~~~~~~i~~q~~~~l~~lH~~-giiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a~~~~~~~  160 (293)
T d1csna_          84 -GPSLEDLLDL-CGRKFSVKTVAMAAKQMLARVQSIHEK-SLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPV  160 (293)
T ss_dssp             -CCBHHHHHHH-TTTCCCHHHHHHHHHHHHHHHHHHHTT-TEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEESBCTT
T ss_pred             -CCCHHHHHHh-hccchhhHHHHHHHHHHHHHHHHHHHC-CceeccCCccceeecCcccccCCceEEcccceeEEcccCc
Confidence             6799998865 456799999999999999999999999 9999999999999974     578999999999764422 


Q ss_pred             ----------CCccCcccccCcccccCCCCCCcccchhhhHHHHHHHhCCCCCCchhhHHH--hhhchhhhccccccCCC
Q 020221          210 ----------RSYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLI--RDRNIQTLTDSCLEGQF  277 (329)
Q Consensus       210 ----------~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~  277 (329)
                                ....||+.|+|||.+.+..++.++||||||+++|||++|..||........  .................
T Consensus       161 ~~~~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l  240 (293)
T d1csna_         161 TKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQSTPLREL  240 (293)
T ss_dssp             TCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHHHSCHHHH
T ss_pred             cccceeecccCceEEchhhcCHHHhcCCCCChHHHHHHhhHHHHHHHhCCCcCCCccchhHHHHHHHHHhccCCCChHHh
Confidence                      234689999999999999999999999999999999999998864311100  00000000000000111


Q ss_pred             ChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhhccccccCcc--ccc
Q 020221          278 SSDEGTELVRLASRCLQYEPRERPNPRSLVTALVTLQKDTELYLSLP--WVM  327 (329)
Q Consensus       278 ~~~~~~~~~~li~~cl~~dp~~Rps~~~~l~~L~~~~~~~~~~~~~p--~~~  327 (329)
                      ...+|+++.+++..||+.+|++||+++.+.+.|+++.+......+.|  |-+
T Consensus       241 ~~~~p~~l~~ii~~~~~~~~~~rP~y~~l~~~l~~~~~~~~~~~~~~~Dw~~  292 (293)
T d1csna_         241 CAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLERLNTTEDENFDWNL  292 (293)
T ss_dssp             TTTSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHHTTCCSCSCCGGGC
T ss_pred             cCCCCHHHHHHHHHHhcCCcccCcCHHHHHHHHHHHHHHcCCCCCCCCCCCc
Confidence            23456789999999999999999999999999999876655554443  544

>d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Ribosomal protein S6 kinase alpha 5, Msk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.7e-50  Score=357.21  Aligned_cols=248  Identities=17%  Similarity=0.204  Sum_probs=201.4

Q ss_pred             CCcccccccCCCCCCcEEEEEEe----CCCCEEEEEEeCCCC----ChhHHHHHHHHHHHhcCCC-ccccccceeeeeCC
Q 020221           56 FAMENIVSEHGEKAPNVVYKGKL----ENQFRIAVKRFNRSA----WPDARQFLEEARAVGQLRN-RRLANLLGCCCEGD  126 (329)
Q Consensus        56 ~~~~~~~~~lg~G~~g~V~~~~~----~~~~~vavK~~~~~~----~~~~~~~~~e~~~l~~l~h-~niv~~~~~~~~~~  126 (329)
                      .++|++++.||+|+||+||+|..    .+|+.||||+++...    ....+.+.+|++++++++| |||+++++++.+..
T Consensus        23 l~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~~~  102 (322)
T d1vzoa_          23 IENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTET  102 (322)
T ss_dssp             GGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETT
T ss_pred             hhceEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeeccCC
Confidence            35588899999999999999983    247899999987532    1224567889999999966 89999999999999


Q ss_pred             eeEEEEecCCCCCHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCCCCCeeeecccCcccC
Q 020221          127 ERLLVAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNS  206 (329)
Q Consensus       127 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~  206 (329)
                      ..+++|||+.+|+|.+++.  ....+++..+..++.||+.||+|||++ +++||||||+|||++.++.+||+|||+++..
T Consensus       103 ~~~~v~e~~~~~~L~~~i~--~~~~~~e~~~~~~~~Qi~~al~~lH~~-~ivHrDiKp~Nill~~~~~vkL~DFG~a~~~  179 (322)
T d1vzoa_         103 KLHLILDYINGGELFTHLS--QRERFTEHEVQIYVGEIVLALEHLHKL-GIIYRDIKLENILLDSNGHVVLTDFGLSKEF  179 (322)
T ss_dssp             EEEEEECCCCSCBHHHHHH--HHSCCCHHHHHHHHHHHHHHHHHHHHT-TCCCCCCCGGGEEECTTSCEEESCSSEEEEC
T ss_pred             ceeeeeecccccHHHHHHH--hcccccHHHHHHHHHHHHHHHHHhhcC-CEEeccCCccceeecCCCCEEEeeccchhhh
Confidence            9999999999999999986  445678899999999999999999999 9999999999999999999999999999764


Q ss_pred             CCC-----CCccCcccccCcccccCCC--CCCcccchhhhHHHHHHHhCCCCCCchhhHHHhhhchhhhccccccCCCCh
Q 020221          207 RDG-----RSYSTNLAFTPPEYLRTGR--VTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSS  279 (329)
Q Consensus       207 ~~~-----~~~~~~~~y~aPE~~~~~~--~~~~~DvwslG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  279 (329)
                      ...     ....+++.|+|||.+.+..  ++.++|||||||+||+|++|..||..................  .....+.
T Consensus       180 ~~~~~~~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~~~~~i~~~~~~--~~~~~~~  257 (322)
T d1vzoa_         180 VADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILK--SEPPYPQ  257 (322)
T ss_dssp             CGGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHHHH--CCCCCCT
T ss_pred             cccccccccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhccc--CCCCCcc
Confidence            332     2346789999999987653  778999999999999999999998654322111111111111  1223456


Q ss_pred             HHHHHHHHHHHHhcccCCCCCCC-----HHHHHH
Q 020221          280 DEGTELVRLASRCLQYEPRERPN-----PRSLVT  308 (329)
Q Consensus       280 ~~~~~~~~li~~cl~~dp~~Rps-----~~~~l~  308 (329)
                      ..++++.+|+.+||..||++|||     ++|+++
T Consensus       258 ~~s~~~~~li~~~l~~dP~~R~s~~~~t~~eil~  291 (322)
T d1vzoa_         258 EMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKE  291 (322)
T ss_dssp             TSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHT
T ss_pred             cCCHHHHHHHHHHcccCHHHcCCCCcccHHHHHc
Confidence            77899999999999999999994     788876

>d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-jun N-terminal kinase (jnk3s)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7.3e-49  Score=351.96  Aligned_cols=246  Identities=16%  Similarity=0.191  Sum_probs=189.0

Q ss_pred             CcccccccCCCCCCcEEEEEEe-CCCCEEEEEEeCCCCC--hhHHHHHHHHHHHhcCCCccccccceeeee------CCe
Q 020221           57 AMENIVSEHGEKAPNVVYKGKL-ENQFRIAVKRFNRSAW--PDARQFLEEARAVGQLRNRRLANLLGCCCE------GDE  127 (329)
Q Consensus        57 ~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~~~~~~~~------~~~  127 (329)
                      ..|++++.||+|+||+||+|.. .+|+.||||++.....  .....+.+|+.+++.++||||+++++++..      ...
T Consensus        17 ~~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~~~   96 (355)
T d2b1pa1          17 KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQD   96 (355)
T ss_dssp             TTEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCCE
T ss_pred             CCeEEEEEeecCcCeEEEEEEECCCCCEEEEEEEChhhcCHHHHHHHHHHHHHHHhcCCCCeeEEEEEEecccccccCce
Confidence            3588999999999999999994 5799999999976542  234568899999999999999999999853      368


Q ss_pred             eEEEEecCCCCCHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCCCCCeeeecccCcccCC
Q 020221          128 RLLVAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSR  207 (329)
Q Consensus       128 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~  207 (329)
                      .++||||+.++ +.+.+.    ..+++..++.++.||+.||.|||++ ||+||||||+|||++.++.++++|||+++...
T Consensus        97 ~~iv~Ey~~~~-l~~~~~----~~~~~~~i~~~~~qil~gl~~LH~~-giiHrDlKP~Nil~~~~~~~kl~df~~~~~~~  170 (355)
T d2b1pa1          97 VYLVMELMDAN-LCQVIQ----MELDHERMSYLLYQMLCGIKHLHSA-GIIHRDLKPSNIVVKSDCTLKILDFGLARTAG  170 (355)
T ss_dssp             EEEEEECCSEE-HHHHHT----SCCCHHHHHHHHHHHHHHHHHHHHT-TCCCSCCCGGGEEECTTCCEEECCCCC-----
T ss_pred             eEEEEeccchH-HHHhhh----cCCCHHHHHHHHHHHHHHHHHhhhc-ccccccCCccccccccccceeeechhhhhccc
Confidence            89999999775 444442    4589999999999999999999999 99999999999999999999999999987654


Q ss_pred             CC---CCccCcccccCcccccCCCCCCcccchhhhHHHHHHHhCCCCCCchhhHHHhhhchhhh----------------
Q 020221          208 DG---RSYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTL----------------  268 (329)
Q Consensus       208 ~~---~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~~~~~~~~~----------------  268 (329)
                      ..   ....+|+.|+|||++.+..++.++||||+||++++|++|+.||................                
T Consensus       171 ~~~~~~~~~~t~~y~aPE~l~~~~~~~~~DiwSlG~~l~ell~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~  250 (355)
T d2b1pa1         171 TSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVR  250 (355)
T ss_dssp             ----------CCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHTTSCHHHH
T ss_pred             cccccccccccccccChhhhcCCCCCCCcccccccchHHHHhhCCCCCCCCCHHHHHHHHHHhccCCCHHHHHHhhhhHH
Confidence            43   34467899999999999999999999999999999999998886543221111100000                


Q ss_pred             -----------------ccccccC---CCChHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 020221          269 -----------------TDSCLEG---QFSSDEGTELVRLASRCLQYEPRERPNPRSLVT  308 (329)
Q Consensus       269 -----------------~~~~~~~---~~~~~~~~~~~~li~~cl~~dp~~Rps~~~~l~  308 (329)
                                       .......   ......++++.+|+.+||..||++||||+|+++
T Consensus       251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~ta~elL~  310 (355)
T d2b1pa1         251 NYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQ  310 (355)
T ss_dssp             HHHHTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred             HHhhcCccccccccccccccccccccccccccCCHHHHHHHHHHCcCChhHCcCHHHHhc
Confidence                             0000000   011346789999999999999999999999997

>d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=2.1e-49  Score=347.60  Aligned_cols=255  Identities=15%  Similarity=0.129  Sum_probs=197.7

Q ss_pred             cccccccCCCCCCcEEEEEE-eCCCCEEEEEEeCCCCChhHHHHHHHHHHHhcCCCcccccc-ceeeeeCCeeEEEEecC
Q 020221           58 MENIVSEHGEKAPNVVYKGK-LENQFRIAVKRFNRSAWPDARQFLEEARAVGQLRNRRLANL-LGCCCEGDERLLVAEYM  135 (329)
Q Consensus        58 ~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~-~~~~~~~~~~~lv~e~~  135 (329)
                      .|++++.||+|+||+||+|. ..+++.||||++.....  .+++.+|+++++.++|+|++.. .+++.+.+..++||||+
T Consensus         8 rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~--~~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~~~ivme~~   85 (299)
T d1ckia_           8 RYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK--HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELL   85 (299)
T ss_dssp             TEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCTT--SCCHHHHHHHHHHSTTSTTCCCEEEEEEETTEEEEEEECC
T ss_pred             EEEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhcc--CHHHHHHHHHHHHccCCCcccEEEEEEecCCEEEEEEEEc
Confidence            47788899999999999998 46788999999876542  2357889999999987765555 55557778899999999


Q ss_pred             CCCCHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeC---CCCCeeeecccCcccCCCC---
Q 020221          136 PNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFD---DDVNPRLSCFGLMKNSRDG---  209 (329)
Q Consensus       136 ~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~---~~~~~kl~Dfg~a~~~~~~---  209 (329)
                      . ++|...+.. ....+++..+..++.|++.||+|||++ ||+||||||+|||++   .+..++|+|||+|+.....   
T Consensus        86 ~-~~l~~~~~~-~~~~~~~~~~~~~~~qi~~~l~~lH~~-~iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~~~~~~~  162 (299)
T d1ckia_          86 G-PSLEDLFNF-CSRKFSLKTVLLLADQMISRIEYIHSK-NFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTH  162 (299)
T ss_dssp             C-CBHHHHHHH-TTTCCCHHHHHHHHHHHHHHHHHHHHT-TEECSCCCGGGEEECCGGGTTCEEECCCSSCEECBCTTTC
T ss_pred             C-Cchhhhhhh-ccCCCcHHHHHHHHHHHHHHHHHHHHC-CeeeccCCHhhccccccCCCceeeeeccCcceeccccccc
Confidence            5 467666644 456799999999999999999999999 999999999999875   4567999999999865432   


Q ss_pred             --------CCccCcccccCcccccCCCCCCcccchhhhHHHHHHHhCCCCCCchhhHHHhhhc--hhhhccccccCCCCh
Q 020221          210 --------RSYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRN--IQTLTDSCLEGQFSS  279 (329)
Q Consensus       210 --------~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~  279 (329)
                              ....||+.|+|||.+.+..++.++|||||||++|||++|..||............  ...............
T Consensus       163 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  242 (299)
T d1ckia_         163 QHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVLCK  242 (299)
T ss_dssp             CBCCCCBCCSCCCCSSSCCHHHHTTBCCCHHHHHHHHHHHHHHHHHSSCTTCCCC-------HHHHHHHHHHSCHHHHTT
T ss_pred             cceeccccCCcCCCccccCHHHHhCCCCCChhhEEecCHHHHHHHhCCCcccccchHHHHHHHHHhhcccCCCChhHhcc
Confidence                    2346899999999999999999999999999999999999988653222111110  000000000011223


Q ss_pred             HHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhhcc
Q 020221          280 DEGTELVRLASRCLQYEPRERPNPRSLVTALVTLQKDT  317 (329)
Q Consensus       280 ~~~~~~~~li~~cl~~dp~~Rps~~~~l~~L~~~~~~~  317 (329)
                      .+|+++.+++..||+.||++||++.++.+.|+.+....
T Consensus       243 ~~p~~~~~li~~cl~~~p~~RP~~~~i~~~l~~~~~~~  280 (299)
T d1ckia_         243 GYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQ  280 (299)
T ss_dssp             TSCHHHHHHHHHHHHSCTTCCCCHHHHHHHHHHHHHHH
T ss_pred             CCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHHHc
Confidence            45688999999999999999999999999999875543

>d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.7e-49  Score=354.22  Aligned_cols=248  Identities=17%  Similarity=0.215  Sum_probs=194.7

Q ss_pred             CcccccccCCCCCCcEEEEEE-eCCCCEEEEEEeCCCCCh--hHHHHHHHHHHHhcCCCccccccceeeeeC-----Cee
Q 020221           57 AMENIVSEHGEKAPNVVYKGK-LENQFRIAVKRFNRSAWP--DARQFLEEARAVGQLRNRRLANLLGCCCEG-----DER  128 (329)
Q Consensus        57 ~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~--~~~~~~~e~~~l~~l~h~niv~~~~~~~~~-----~~~  128 (329)
                      +.|++++.||+|+||+||+|. ..+|+.||||++......  ..+.+.+|+++|+.++|||++++++++...     ...
T Consensus        18 ~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~~~~   97 (348)
T d2gfsa1          18 ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFND   97 (348)
T ss_dssp             TTEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTTCCC
T ss_pred             CCeEEEEEEecCCCeEEEEEEECCCCCEEEEEEECchhcChHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeccccccCce
Confidence            358899999999999999999 567999999999865432  345688999999999999999999998543     344


Q ss_pred             EEEEecCCCCCHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCCCCCeeeecccCcccCCC
Q 020221          129 LLVAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRD  208 (329)
Q Consensus       129 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~  208 (329)
                      +++++|+.+|+|.+++.   .+.+++..+..++.||+.||+|||++ ||+||||||+|||++.++.+|++|||++.....
T Consensus        98 ~~i~~~~~gg~L~~~~~---~~~l~e~~~~~i~~qil~aL~~LH~~-giiHrDiKp~NILi~~~~~~kl~dfg~a~~~~~  173 (348)
T d2gfsa1          98 VYLVTHLMGADLNNIVK---CQKLTDDHVQFLIYQILRGLKYIHSA-DIIHRDLKPSNLAVNEDCELKILDFGLARHTDD  173 (348)
T ss_dssp             CEEEEECCSEEHHHHHT---TCCCCHHHHHHHHHHHHHHHHHHHHT-TCCCCCCCGGGEEECTTCCEEECCC----CCTG
T ss_pred             EEEEEeecCCchhhhcc---cccccHHHHHHHHHHHHHHHHHHHhC-CCcccccCCccccccccccccccccchhcccCc
Confidence            67778888999999984   45799999999999999999999999 999999999999999999999999999876543


Q ss_pred             C-CCccCcccccCcccccCCC-CCCcccchhhhHHHHHHHhCCCCCCchhhHHHhhhchhhhcc----------------
Q 020221          209 G-RSYSTNLAFTPPEYLRTGR-VTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTD----------------  270 (329)
Q Consensus       209 ~-~~~~~~~~y~aPE~~~~~~-~~~~~DvwslG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~----------------  270 (329)
                      . ....|++.|+|||.+.+.. ++.++|||||||++|+|++|..||..................                
T Consensus       174 ~~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~  253 (348)
T d2gfsa1         174 EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARN  253 (348)
T ss_dssp             GGSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHTTCCCHHHHH
T ss_pred             ccccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChHHhhhccchhhhh
Confidence            3 4456789999999877654 688999999999999999999988754322111111100000                


Q ss_pred             ---cccc-CC-----CChHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 020221          271 ---SCLE-GQ-----FSSDEGTELVRLASRCLQYEPRERPNPRSLVT  308 (329)
Q Consensus       271 ---~~~~-~~-----~~~~~~~~~~~li~~cl~~dp~~Rps~~~~l~  308 (329)
                         .... ..     .....++++.+||.+||..||++|||+.|+++
T Consensus       254 ~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~elL~  300 (348)
T d2gfsa1         254 YIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALA  300 (348)
T ss_dssp             HHTTSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             hhhhcccCCCcchhhhcCCCCHHHHHHHHHHCcCChhhCcCHHHHhc
Confidence               0000 00     01234678999999999999999999999998

>d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Sky1p
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=100.00  E-value=3.6e-43  Score=315.91  Aligned_cols=250  Identities=16%  Similarity=0.192  Sum_probs=189.1

Q ss_pred             cccccccCCCCCCcEEEEEE-eCCCCEEEEEEeCCCCChhHHHHHHHHHHHhcCC-----------Cccccccceeeee-
Q 020221           58 MENIVSEHGEKAPNVVYKGK-LENQFRIAVKRFNRSAWPDARQFLEEARAVGQLR-----------NRRLANLLGCCCE-  124 (329)
Q Consensus        58 ~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-----------h~niv~~~~~~~~-  124 (329)
                      .|++++.||+|+||+||+|+ ..+|+.||||+++... ...+.+.+|+++++.+.           |+||+++++++.. 
T Consensus        14 rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~~-~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~~~~~   92 (362)
T d1q8ya_          14 RYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDK-VYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNHK   92 (362)
T ss_dssp             TEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCH-HHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEEE
T ss_pred             cEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeccc-cchHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEEEeeec
Confidence            48899999999999999999 4679999999998654 23456788998888775           4789999988754 


Q ss_pred             -CCeeEEEEecCCCC-CHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCCCCC------ee
Q 020221          125 -GDERLLVAEYMPND-TLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVN------PR  196 (329)
Q Consensus       125 -~~~~~lv~e~~~~g-sL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~------~k  196 (329)
                       ....+++++++..+ +............+++..+..++.||+.||.|||+..||+||||||+|||++.++.      ++
T Consensus        93 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qil~al~~lh~~~~IvHrDlKp~NIll~~~~~~~~~~~~k  172 (362)
T d1q8ya_          93 GPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIK  172 (362)
T ss_dssp             ETTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECSCCSGGGEEEEEEETTTTEEEEE
T ss_pred             cccceeeeeeecccccccccccccccccCCcHHHHHHHHHHHHHHHHHHhhhcCcccccCChhHeeeeccCcccccceee
Confidence             34566666665443 33343434456778999999999999999999998339999999999999986554      89


Q ss_pred             eecccCcccCCC-CCCccCcccccCcccccCCCCCCcccchhhhHHHHHHHhCCCCCCchhhHH-------Hh-------
Q 020221          197 LSCFGLMKNSRD-GRSYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDL-------IR-------  261 (329)
Q Consensus       197 l~Dfg~a~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~-------~~-------  261 (329)
                      ++|||.+..... .....+|+.|+|||++.+..++.++||||+|+++++|++|+.||.......       ..       
T Consensus       173 l~dfg~s~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pF~~~~~~~~~~~~~~~~~~~~~lg  252 (362)
T d1q8ya_         173 IADLGNACWYDEHYTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQIIELLG  252 (362)
T ss_dssp             ECCCTTCEETTBCCCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CHHHHHHHHHHHHC
T ss_pred             EeecccccccccccccccccccccChhhccccCCCccccccchHHHHHHHHHCCCCCCCCccccccchhHHHHHHHHHhC
Confidence            999999875443 345578999999999999999999999999999999999998875321100       00       


Q ss_pred             --------hhc-hhhhcc------c-------------cccCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 020221          262 --------DRN-IQTLTD------S-------------CLEGQFSSDEGTELVRLASRCLQYEPRERPNPRSLVT  308 (329)
Q Consensus       262 --------~~~-~~~~~~------~-------------~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~~~l~  308 (329)
                              ... ......      .             ..........++++.+|+.+||..||++|||++|+++
T Consensus       253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~Rpta~e~L~  327 (362)
T d1q8ya_         253 ELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAGGLVN  327 (362)
T ss_dssp             SCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCHHHHHT
T ss_pred             CCCHHHhhcccccccccccchhhhccccccCCchhhhcccccccCcccCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence                    000 000000      0             0012234567899999999999999999999999997

>d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: RIO1-like kinases
domain: Rio2 serine protein kinase C-terminal domain
species: Archaeoglobus fulgidus [TaxId: 2234]

Probab=99.92  E-value=8.6e-26  Score=183.61  Aligned_cols=162  Identities=15%  Similarity=0.087  Sum_probs=117.6

Q ss_pred             ccccCCCCCCcEEEEEEeCCCCEEEEEEeCCCCCh------------------hHHHHHHHHHHHhcCCCccccccceee
Q 020221           61 IVSEHGEKAPNVVYKGKLENQFRIAVKRFNRSAWP------------------DARQFLEEARAVGQLRNRRLANLLGCC  122 (329)
Q Consensus        61 ~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~------------------~~~~~~~e~~~l~~l~h~niv~~~~~~  122 (329)
                      +-+.||+|+||+||+|...+|+.||||+++.....                  ......+|...+..+.|.+++..+++.
T Consensus         4 vg~~IG~G~~g~Vy~a~~~~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~~~~   83 (191)
T d1zara2           4 IGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVYAWE   83 (191)
T ss_dssp             EEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEEEEE
T ss_pred             hCCEeeeCcceEEEEEECCCCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEEEec
Confidence            34567999999999999888999999987642111                  012345688899999999998877653


Q ss_pred             eeCCeeEEEEecCCCCCHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCCCCCeeeecccC
Q 020221          123 CEGDERLLVAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGL  202 (329)
Q Consensus       123 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~  202 (329)
                          ..+++|||+++..+..         ++......++.|++.+|.|||++ |++||||||+|||+++++ ++|+|||.
T Consensus        84 ----~~~lvme~~~~~~~~~---------l~~~~~~~i~~ql~~~l~~lH~~-giiHrDiKP~NILv~~~~-~~liDFG~  148 (191)
T d1zara2          84 ----GNAVLMELIDAKELYR---------VRVENPDEVLDMILEEVAKFYHR-GIVHGDLSQYNVLVSEEG-IWIIDFPQ  148 (191)
T ss_dssp             ----TTEEEEECCCCEEGGG---------CCCSCHHHHHHHHHHHHHHHHHT-TEECSCCSTTSEEEETTE-EEECCCTT
T ss_pred             ----CCEEEEEeeccccccc---------hhhHHHHHHHHHHHHHHHHHhhC-CEEEccCChhheeeeCCC-EEEEECCC
Confidence                2379999998865433         23344567899999999999999 999999999999999654 89999999


Q ss_pred             cccCCCCCCccCcccccC------cccccCCCCCCcccchhhhHHH
Q 020221          203 MKNSRDGRSYSTNLAFTP------PEYLRTGRVTPESVMYSFGTLL  242 (329)
Q Consensus       203 a~~~~~~~~~~~~~~y~a------PE~~~~~~~~~~~DvwslG~il  242 (329)
                      |........    ..|..      .+.+ ...|..++|+||+.--+
T Consensus       149 a~~~~~~~~----~~~l~rd~~~~~~~f-~r~y~~~~d~~s~~~~~  189 (191)
T d1zara2         149 SVEVGEEGW----REILERDVRNIITYF-SRTYRTEKDINSAIDRI  189 (191)
T ss_dssp             CEETTSTTH----HHHHHHHHHHHHHHH-HHHHCCCCCHHHHHHHH
T ss_pred             cccCCCCCc----HHHHHHHHHHHHHHH-cCCCCCcccHHHHHHHH
Confidence            876543321    11111      1111 24578899999975433

>d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Type IIIa 3',5"-aminoglycoside phosphotransferase
species: Enterococcus faecalis [TaxId: 1351]

Probab=98.62  E-value=8.3e-08  Score=79.75  Aligned_cols=137  Identities=13%  Similarity=-0.007  Sum_probs=89.0

Q ss_pred             cccccCCCCCCcEEEEEEeCCCCEEEEEEeCCCCChhHHHHHHHHHHHhcCC-CccccccceeeeeCCeeEEEEecCCCC
Q 020221           60 NIVSEHGEKAPNVVYKGKLENQFRIAVKRFNRSAWPDARQFLEEARAVGQLR-NRRLANLLGCCCEGDERLLVAEYMPND  138 (329)
Q Consensus        60 ~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~~~~lv~e~~~~g  138 (329)
                      ++++..+-++.+.||+... +++.+.+|+...........+.+|...+..+. +--+.+++.+..+++..++||++++|.
T Consensus        17 ~~~~~~~G~s~~~v~rv~~-~~~~~vlk~~~~~~~~~~~~~~~E~~~l~~l~~~vpvP~vl~~~~~~~~~~lv~~~l~G~   95 (263)
T d1j7la_          17 RCVKDTEGMSPAKVYKLVG-ENENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLLMSEADGV   95 (263)
T ss_dssp             EEEECSCCCSSSEEEEEEC-SSCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCSSE
T ss_pred             EEEEcCCCCCCCcEEEEEe-CCCeEEEEEcCCCcccchhhHHHHHHHHHHHhccCCCCcEEEEEecCCceEEEEEecccc
Confidence            4444333344578998875 44478888877654344445677888877764 333567777777888999999999998


Q ss_pred             CHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcC--------------------------------------------
Q 020221          139 TLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSK--------------------------------------------  174 (329)
Q Consensus       139 sL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~--------------------------------------------  174 (329)
                      ++.+....    ...   ...++.+++..+..||+.                                            
T Consensus        96 ~~~~~~~~----~~~---~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  168 (263)
T d1j7la_          96 LCSEEYED----EQS---PEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDTPFKDPR  168 (263)
T ss_dssp             EHHHHTTT----CSC---HHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCCGGGGSTTCSCSSHH
T ss_pred             cccccccc----ccc---HHHHHHHHHHHHHHHhccCccccccCcchhhhhhhHHHHHHHHhhhhhhhcccccccchHHH
Confidence            77654421    011   112233333334433320                                            


Q ss_pred             --------------CCccccccCCCceeeCCCCCeeeecccCcc
Q 020221          175 --------------ERALYHDLNAYRIVFDDDVNPRLSCFGLMK  204 (329)
Q Consensus       175 --------------~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~  204 (329)
                                    ..++|+|+.|.||++++++.+.|+||+.+.
T Consensus       169 ~~~~~l~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDwe~a~  212 (263)
T d1j7la_         169 ELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG  212 (263)
T ss_dssp             HHHHHHHHSCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCE
T ss_pred             HHHHHHHhcCCcCCcEEEEeeccCcceeecCCceEEEeechhcc
Confidence                          126899999999999987767799999764

>d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase)
species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]

Probab=98.10  E-value=1.7e-05  Score=64.85  Aligned_cols=67  Identities=19%  Similarity=0.195  Sum_probs=49.1

Q ss_pred             cEEEEEEeCCCCEEEEEEeCCCCChhHHHHHHHHHHHhcCC--CccccccceeeeeCCeeEEEEecCCCCCH
Q 020221           71 NVVYKGKLENQFRIAVKRFNRSAWPDARQFLEEARAVGQLR--NRRLANLLGCCCEGDERLLVAEYMPNDTL  140 (329)
Q Consensus        71 g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~--h~niv~~~~~~~~~~~~~lv~e~~~~gsL  140 (329)
                      +.||+...+++..+.+|........   .+..|...++.+.  .-.+.+++.+..+++..++||++++|.++
T Consensus        25 ~~v~r~~~~~~~~~vlK~~~~~~~~---~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~~~~v~~~i~G~~~   93 (255)
T d1nd4a_          25 AAVFRLSAQGRPVLFVKTDLSGALN---ELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQDL   93 (255)
T ss_dssp             CEEEEEECTTSCCEEEEEECSCTTS---CHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSEET
T ss_pred             CeEEEEEeCCCCEEEEEeCCccCHh---HHHHHHHHHHHHHhcCCCCCceeeecccccceEEEEEeeecccc
Confidence            6799999878888999987665433   3556777776663  23356677777778889999999987654

>d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Methylthioribose kinase MtnK
species: Bacillus subtilis [TaxId: 1423]

Probab=97.99  E-value=2.9e-05  Score=68.03  Aligned_cols=76  Identities=13%  Similarity=0.057  Sum_probs=47.5

Q ss_pred             cccCCCCCCcEEEEEEe-CCCCEEEEEEeCCC------C-ChhHHHHHHHHHHHhcC-CC--ccccccceeeeeCCeeEE
Q 020221           62 VSEHGEKAPNVVYKGKL-ENQFRIAVKRFNRS------A-WPDARQFLEEARAVGQL-RN--RRLANLLGCCCEGDERLL  130 (329)
Q Consensus        62 ~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~------~-~~~~~~~~~e~~~l~~l-~h--~niv~~~~~~~~~~~~~l  130 (329)
                      .+.+|.|....||+... .+++.+++|.-...      . .........|.+.|+.+ .+  ..+.+++.+  ++...++
T Consensus        31 ~~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~--d~~~~~l  108 (392)
T d2pula1          31 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVT  108 (392)
T ss_dssp             EEECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEE
T ss_pred             EEEeCCCceEeEEEEEeCCCCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEEE--cCCCCEE
Confidence            34679999999999984 44678999964321      1 11233455678777766 22  334445443  4566789


Q ss_pred             EEecCCCCC
Q 020221          131 VAEYMPNDT  139 (329)
Q Consensus       131 v~e~~~~gs  139 (329)
                      |||++.+..
T Consensus       109 vmE~L~~~~  117 (392)
T d2pula1         109 VMEDLSHLK  117 (392)
T ss_dssp             EECCCTTSE
T ss_pred             EEeccCCcc
Confidence            999997654

>d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: RdoA
species: Escherichia coli [TaxId: 562]

Probab=97.72  E-value=7.9e-05  Score=63.37  Aligned_cols=68  Identities=25%  Similarity=0.229  Sum_probs=45.9

Q ss_pred             CcEEEEEEeCCCCEEEEEEeCCCCChhHHHHHHHHHHHhcCCCcccc--ccc-----eeeeeCCeeEEEEecCCCC
Q 020221           70 PNVVYKGKLENQFRIAVKRFNRSAWPDARQFLEEARAVGQLRNRRLA--NLL-----GCCCEGDERLLVAEYMPND  138 (329)
Q Consensus        70 ~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv--~~~-----~~~~~~~~~~lv~e~~~~g  138 (329)
                      -..||+....+|..+++|+.+.... ...++..|...+..|...++.  ..+     .........+.+++++.|.
T Consensus        35 EN~vy~v~~~dg~~~VlK~~rp~~~-s~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~~G~  109 (325)
T d1zyla1          35 ENRVYQFQDEDRRRFVVKFYRPERW-TADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGGR  109 (325)
T ss_dssp             SSEEEEECCTTCCCEEEEEECTTTS-CHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCCE
T ss_pred             cceeEEEEcCCCCEEEEEEeCCCCC-CHHHHHHHHHHHHHHHhcCCCCCCceecCCCeeeeeeeEEEEEEeecCCc
Confidence            4689999988999999999876543 356677888888777432221  111     1123356678899998763

>d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Choline kinase
domain: Choline kinase
species: Caenorhabditis elegans [TaxId: 6239]

Probab=96.98  E-value=0.0015  Score=56.68  Aligned_cols=73  Identities=18%  Similarity=0.326  Sum_probs=48.7

Q ss_pred             cccCCCCCCcEEEEEEeCC--------CCEEEEEEeCCCCChhHHHHHHHHHHHhcCCCccc-cccceeeeeCCeeEEEE
Q 020221           62 VSEHGEKAPNVVYKGKLEN--------QFRIAVKRFNRSAWPDARQFLEEARAVGQLRNRRL-ANLLGCCCEGDERLLVA  132 (329)
Q Consensus        62 ~~~lg~G~~g~V~~~~~~~--------~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~ni-v~~~~~~~~~~~~~lv~  132 (329)
                      ++.++-|--..+|+....+        .+.|.+++.....  ......+|..+++.+.-.++ .++++++.    -++|+
T Consensus        47 v~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g~~~--~~idr~~E~~i~~~ls~~gl~Pkll~~~~----~g~I~  120 (395)
T d1nw1a_          47 ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNPE--TESHLVAESVIFTLLSERHLGPKLYGIFS----GGRLE  120 (395)
T ss_dssp             EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSCC--CHHHHHHHHHHHHHHHHTTSSSCEEEEET----TEEEE
T ss_pred             EEEcCCccccceEEEEeCCCCccccCCCCcEEEEecCCcc--hhhHHHHHHHHHHHHHhCCCCCeEEEEcC----CceEE
Confidence            3566778888999998543        3567788776332  23456688888888843344 46666653    27899


Q ss_pred             ecCCCCCH
Q 020221          133 EYMPNDTL  140 (329)
Q Consensus       133 e~~~~gsL  140 (329)
                      ||+++.+|
T Consensus       121 efi~g~~l  128 (395)
T d1nw1a_         121 EYIPSRPL  128 (395)
T ss_dssp             CCCCEEEC
T ss_pred             EEeccccC
Confidence            99987544

>d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Homoserine kinase ThrB
species: Agrobacterium tumefaciens [TaxId: 358]

Probab=96.92  E-value=0.00083  Score=56.37  Aligned_cols=158  Identities=11%  Similarity=0.013  Sum_probs=82.5

Q ss_pred             cCHHHHHHHhcCCCcccccc--cCCCCCCcEEEEEEeCCCCEEEEEEeCCCCChhHHHHHHHHHHHhcCCC-----cccc
Q 020221           44 YSIETLRTATSGFAMENIVS--EHGEKAPNVVYKGKLENQFRIAVKRFNRSAWPDARQFLEEARAVGQLRN-----RRLA  116 (329)
Q Consensus        44 ~~~~~~~~~~~~~~~~~~~~--~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h-----~niv  116 (329)
                      .+.+++......|...++.+  .+..|--.+.|+...++| .+++|++.....  .+++..|++.+..+..     |..+
T Consensus         3 ls~~el~~~l~~Y~lg~~~~~~~i~~G~~N~ny~v~t~~g-~yVLri~~~~~~--~~~l~~~~~~l~~L~~~g~pvp~pi   79 (316)
T d2ppqa1           3 ITEDELRNFLTQYDVGSLTSYKGIAEGVENSNFLLHTTKD-PLILTLYEKRVE--KNDLPFFLGLMQHLAAKGLSCPLPL   79 (316)
T ss_dssp             CCHHHHHHHHTTBCCCCEEEEEEECC---EEEEEEEESSC-CEEEEEECC-----CCHHHHHHHHHHHHHHTTCCCCCBC
T ss_pred             CCHHHHHHHHHhCCCCCceEeecCCCCcccCeEEEEECCC-cEEEEEcCCCCC--HHHHHHHHHHHHhhhhccccccccc
Confidence            56677877777776545443  356677788999987666 589999865421  2234445666655532     2211


Q ss_pred             ccc-e--eeeeCCeeEEEEecCCCCCHHh-----------hh---c----cCCC---CCCC------------------H
Q 020221          117 NLL-G--CCCEGDERLLVAEYMPNDTLAK-----------HL---F----HWET---QPMK------------------W  154 (329)
Q Consensus       117 ~~~-~--~~~~~~~~~lv~e~~~~gsL~~-----------~l---~----~~~~---~~~~------------------~  154 (329)
                      ... |  +.........++.+..+.....           .+   .    ....   ....                  .
T Consensus        80 ~~~~g~~~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  159 (316)
T d2ppqa1          80 PRKDGELLGELSGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVE  159 (316)
T ss_dssp             CBTTCCSCEEETTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTS
T ss_pred             eecCCCcceeeecccceeeeecccccccccchhHHHHHHHHHHhhhhhhhhcccccccccchhhcchhhhHHHHhhhhcc
Confidence            111 1  1122345566677665532210           00   0    0000   0000                  0


Q ss_pred             HHHHHHHHHHHHHHHHhhc---CCCccccccCCCceeeCCCCCeeeecccCcc
Q 020221          155 AMRLRVALHIAEALEYCTS---KERALYHDLNAYRIVFDDDVNPRLSCFGLMK  204 (329)
Q Consensus       155 ~~~~~i~~~i~~~l~~lH~---~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~  204 (329)
                      ......+......+.-.+.   ..|++|+|+.++||+++++...-++||+.+.
T Consensus       160 ~~~~~~l~~~~~~~~~~~~~~L~~giIHgDl~~dNvl~~~~~v~gvIDF~~~~  212 (316)
T d2ppqa1         160 KGLREEIRPEIDYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFAC  212 (316)
T ss_dssp             TTHHHHHHHHHHHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred             hhHHHHHHHHHHhhhccCccccccccccCCcchhhhhcccccceeEecccccc
Confidence            0111222222233333222   1378999999999999988878899999864